Cell HMS LINCS ID	Cell Name	Small Molecule HMS LINCS ID	Small Molecule Name	Small Mol Concentration	Small Mol Conc Unit	Timepoint	Timepoint Unit	Raw Image	Registered Image	CycIF Round	Primary Antibody HMS LINCS ID	Primary Antibody Name	Secondary Antibody HMS LINCS ID	Secondary Antibody Name	Cytell filter	Protein Detected HMS LINCS ID	Protein Detected Name	Other Reagent Detected HMS LINCS ID	Other Reagent Detected Name	Measured Fluorescence Intensity (a.u.)	Well[1]	Well[2]	Field	Cell ID Number	X-coordinate	Y-coordinate	Cell Area (um^2)	Cell Perimeter (um)	Cell Circularity
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.1	B08		1	0001-0030	113.89	29.84	299	67.60	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.1	B08		1	0002-0029	168.91	28.72	294	66.18	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			372.3	B08		1	0003-0033	263.30	34.12	210	55.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			303.7	B08		1	0004-0039	463.46	39.70	310	65.36	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.8	B08		1	0005-0040	504.82	41.10	293	68.67	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			305.7	B08		1	0006-0040	720.01	40.44	289	75.74	0.633
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			655.0	B08		1	0007-0041	803.55	41.85	444	87.50	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			455.5	B08		1	0008-0042	418.82	41.04	267	61.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			576.5	B08		1	0009-0042	87.75	42.02	158	48.63	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			411.2	B08		1	0010-0045	289.33	45.56	376	71.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			357.7	B08		1	0011-0044	589.42	44.68	234	56.28	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			385.4	B08		1	0012-0045	693.34	45.35	223	54.87	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			409.0	B08		1	0013-0042	652.67	42.21	177	52.63	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			417.4	B08		1	0014-0047	771.72	47.09	254	59.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			327.2	B08		1	0015-0051	172.16	51.15	276	61.94	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			331.8	B08		1	0016-0050	534.61	50.03	323	66.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			388.2	B08		1	0017-0053	219.63	53.47	374	71.60	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			332.6	B08		1	0018-0052	134.85	52.43	234	56.53	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			513.1	B08		1	0019-0058	657.13	57.83	342	70.77	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			298.8	B08		1	0020-0061	258.75	61.24	390	73.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			323.1	B08		1	0021-0063	335.34	62.34	338	68.43	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			392.9	B08		1	0022-0062	630.45	62.65	266	64.28	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			412.0	B08		1	0023-0061	68.12	60.80	231	55.11	0.956
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			498.1	B08		1	0024-0069	569.59	69.83	433	81.26	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			310.8	B08		1	0025-0071	383.06	70.47	307	65.36	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			449.3	B08		1	0026-0072	533.10	71.85	285	67.60	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			299.3	B08		1	0027-0075	85.61	75.59	300	66.18	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			347.4	B08		1	0028-0072	179.49	71.47	229	60.28	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.9	B08		1	0029-0075	115.54	75.69	250	60.53	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			363.4	B08		1	0030-0081	364.92	80.88	146	47.46	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			439.9	B08		1	0031-0080	619.08	80.64	222	57.94	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			416.9	B08		1	0032-0081	759.36	80.85	245	58.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			431.9	B08		1	0033-0081	321.95	81.50	130	42.63	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			439.8	B08		1	0034-0088	460.95	87.74	314	66.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			397.8	B08		1	0035-0084	310.93	84.24	113	39.80	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			294.3	B08		1	0036-0090	175.85	90.55	267	61.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			324.4	B08		1	0037-0090	214.71	89.20	254	62.77	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			296.5	B08		1	0038-0092	424.90	91.91	289	65.01	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			386.0	B08		1	0039-0091	680.90	91.72	234	58.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.2	B08		1	0040-0094	944.76	95.13	265	65.01	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			403.3	B08		1	0041-0095	625.03	94.75	328	69.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			444.9	B08		1	0042-0103	829.16	103.44	270	62.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			341.3	B08		1	0043-0104	239.83	104.03	255	65.26	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			500.5	B08		1	0044-0104	882.82	104.11	328	67.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			379.3	B08		1	0045-0110	922.35	110.33	335	73.84	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			328.4	B08		1	0046-0109	293.74	110.26	248	62.77	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			324.7	B08		1	0047-0112	493.79	112.96	362	71.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			319.3	B08		1	0048-0114	778.16	114.52	464	84.43	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			316.4	B08		1	0049-0116	112.41	116.63	359	88.08	0.581
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			449.1	B08		1	0050-0116	259.31	115.12	221	56.77	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			339.9	B08		1	0051-0116	647.23	117.24	258	60.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			434.2	B08		1	0052-0117	677.05	116.66	246	60.77	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			468.0	B08		1	0053-0121	836.66	121.20	367	74.18	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.5	B08		1	0054-0122	164.49	121.49	263	63.01	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			327.7	B08		1	0055-0120	281.99	120.20	154	46.53	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			360.2	B08		1	0056-0125	949.09	125.05	224	54.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			337.9	B08		1	0057-0128	199.33	128.54	327	68.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			435.3	B08		1	0058-0126	268.66	127.47	256	63.50	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.7	B08		1	0059-0129	408.85	128.58	321	73.50	0.747
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			443.6	B08		1	0060-0132	426.69	132.76	233	57.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			327.2	B08		1	0061-0136	630.94	135.58	383	73.94	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			376.6	B08		1	0062-0137	26.05	136.99	233	57.60	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.8	B08		1	0063-0137	373.17	137.60	319	72.91	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			519.0	B08		1	0064-0139	329.68	138.96	328	66.18	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			559.5	B08		1	0065-0140	731.73	139.63	294	63.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			390.1	B08		1	0066-0148	178.70	148.16	375	71.84	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			397.0	B08		1	0067-0146	940.07	145.73	218	55.36	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			355.3	B08		1	0068-0149	527.48	149.03	352	71.60	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			671.7	B08		1	0069-0149	37.87	149.11	235	57.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			332.1	B08		1	0070-0150	469.38	149.40	312	67.11	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			367.2	B08		1	0071-0150	596.87	150.27	252	60.53	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			311.2	B08		1	0072-0152	796.78	151.98	299	66.18	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			502.4	B08		1	0073-0159	225.58	157.45	570	99.74	0.720
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			332.4	B08		1	0074-0155	282.20	154.87	260	62.18	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			685.1	B08		1	0075-0157	632.64	157.02	313	76.43	0.673
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			308.7	B08		1	0076-0158	153.69	157.45	204	55.70	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			623.9	B08		1	0077-0163	328.00	163.42	260	61.01	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			327.0	B08		1	0078-0163	125.94	162.81	221	58.77	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			361.5	B08		1	0079-0165	582.66	164.81	259	59.01	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			451.2	B08		1	0080-0168	806.15	168.59	186	50.28	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			328.9	B08		1	0081-0173	353.97	173.37	375	73.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			392.2	B08		1	0082-0176	393.44	175.46	308	66.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			375.9	B08		1	0083-0181	81.01	179.70	679	108.81	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			308.5	B08		1	0084-0181	37.82	180.94	317	68.67	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			412.3	B08		1	0085-0183	495.13	183.84	242	61.11	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			332.8	B08		1	0086-0186	183.20	185.11	281	70.77	0.705
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			318.2	B08		1	0087-0183	529.17	183.34	292	66.77	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			748.9	B08		1	0088-0188	592.87	187.56	324	71.26	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.6	B08		1	0089-0188	151.31	188.09	239	63.01	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			286.9	B08		1	0090-0186	472.32	186.20	273	62.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			471.7	B08		1	0091-0190	645.42	190.40	355	72.77	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			456.6	B08		1	0092-0189	740.53	189.40	262	61.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			518.5	B08		1	0093-0189	916.61	189.99	213	55.94	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			386.3	B08		1	0094-0199	661.63	199.51	212	54.53	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			437.9	B08		1	0095-0202	325.65	202.00	219	55.36	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			422.2	B08		1	0096-0203	781.21	202.87	198	52.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			337.5	B08		1	0097-0207	126.70	206.94	259	64.43	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			451.1	B08		1	0098-0208	842.96	208.21	277	62.53	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			425.0	B08		1	0099-0207	893.22	207.79	217	56.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			342.4	B08		1	0100-0211	47.78	209.92	245	71.84	0.597
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			400.4	B08		1	0101-0214	541.25	215.01	299	63.94	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			352.6	B08		1	0102-0214	757.81	214.78	388	73.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			520.1	B08		1	0103-0216	410.24	216.66	161	46.77	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			289.6	B08		1	0104-0223	491.65	222.90	275	63.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			395.6	B08		1	0105-0224	660.52	224.84	193	55.70	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			490.5	B08		1	0106-0227	19.25	227.66	223	54.77	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			350.5	B08		1	0107-0228	641.43	228.26	277	63.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			362.7	B08		1	0108-0230	932.04	229.58	285	68.67	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			318.2	B08		1	0109-0231	142.62	231.60	386	74.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			396.7	B08		1	0110-0230	561.73	229.80	229	55.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			400.1	B08		1	0111-0232	381.62	230.95	268	61.11	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			478.0	B08		1	0112-0230	462.01	230.23	249	61.11	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			357.8	B08		1	0113-0233	211.55	233.28	153	48.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			387.7	B08		1	0114-0243	589.35	243.57	309	68.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			363.8	B08		1	0115-0246	199.44	247.53	276	74.43	0.626
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			501.7	B08		1	0116-0244	317.01	244.90	203	53.11	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			336.9	B08		1	0117-0248	76.81	248.53	326	67.01	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			417.3	B08		1	0118-0247	524.13	246.74	325	66.18	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			366.5	B08		1	0119-0247	711.89	247.02	255	60.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			516.7	B08		1	0120-0248	409.52	248.96	336	67.60	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			397.8	B08		1	0121-0249	739.54	249.33	291	62.18	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			409.0	B08		1	0122-0250	840.18	251.21	283	64.43	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.0	B08		1	0123-0247	102.44	248.22	225	58.28	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			530.3	B08		1	0124-0252	47.31	252.01	327	67.26	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			371.9	B08		1	0125-0251	779.24	251.24	413	77.84	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.9	B08		1	0126-0257	151.50	256.98	248	61.36	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			321.8	B08		1	0127-0260	804.47	259.44	328	74.18	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			444.0	B08		1	0128-0261	359.21	260.93	227	57.94	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			418.4	B08		1	0129-0264	229.84	263.90	281	63.94	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			390.9	B08		1	0130-0263	576.99	262.76	251	59.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			719.6	B08		1	0131-0263	342.33	262.78	170	48.28	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			360.4	B08		1	0132-0265	453.23	264.74	269	63.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			338.1	B08		1	0133-0267	184.02	266.99	243	60.53	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			588.9	B08		1	0134-0271	400.65	271.07	303	64.43	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			685.9	B08		1	0135-0282	715.90	282.51	614	104.57	0.706
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			279.7	B08		1	0136-0278	136.40	278.88	316	67.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			325.8	B08		1	0137-0276	499.36	276.36	316	67.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			593.3	B08		1	0138-0278	325.49	278.13	242	57.11	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			380.4	B08		1	0139-0279	115.90	278.85	204	52.53	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			487.3	B08		1	0140-0280	248.03	279.94	274	63.70	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			558.0	B08		1	0141-0280	233.47	280.45	153	47.56	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			507.9	B08		1	0142-0283	831.39	284.12	232	58.77	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			504.6	B08		1	0143-0289	784.07	289.05	364	71.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			351.4	B08		1	0144-0285	871.41	284.96	211	56.04	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			324.2	B08		1	0145-0290	63.79	289.94	259	61.94	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			361.5	B08		1	0146-0294	198.94	293.80	275	68.77	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			326.3	B08		1	0147-0295	251.29	295.72	194	54.53	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			304.1	B08		1	0148-0293	442.69	293.36	247	58.28	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			369.0	B08		1	0149-0295	947.72	294.55	176	50.18	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			373.9	B08		1	0150-0299	539.19	299.01	298	64.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			351.8	B08		1	0151-0299	361.35	299.51	251	57.70	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			375.1	B08		1	0152-0298	577.27	297.82	248	60.53	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			372.9	B08		1	0153-0300	153.20	300.76	218	54.53	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			372.6	B08		1	0154-0304	861.89	303.83	366	74.53	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			386.0	B08		1	0155-0308	69.46	309.04	291	69.60	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			360.6	B08		1	0156-0307	940.82	307.36	244	61.60	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			547.6	B08		1	0157-0306	775.28	306.47	235	57.60	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			343.6	B08		1	0158-0309	925.21	309.35	226	56.28	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			410.5	B08		1	0159-0309	318.39	309.17	272	61.36	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			467.1	B08		1	0160-0314	651.65	313.60	420	79.50	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			356.0	B08		1	0161-0312	467.93	312.35	213	54.28	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			344.3	B08		1	0162-0317	437.95	317.77	267	64.53	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			334.9	B08		1	0163-0318	698.19	319.21	278	66.53	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			381.6	B08		1	0164-0322	42.02	322.21	328	67.94	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			458.6	B08		1	0165-0320	770.32	320.36	168	53.36	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			459.9	B08		1	0166-0327	754.43	327.63	324	66.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			387.6	B08		1	0167-0326	246.13	326.12	244	58.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			352.6	B08		1	0168-0330	596.47	330.76	289	65.60	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			470.3	B08		1	0169-0330	195.74	329.79	222	56.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			428.7	B08		1	0170-0331	512.72	332.12	223	57.11	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			680.8	B08		1	0171-0336	874.34	337.08	218	56.77	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			326.8	B08		1	0172-0340	922.60	340.37	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			504.1	B08		1	0173-0341	99.15	341.72	292	64.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			413.3	B08		1	0174-0341	120.32	340.55	219	53.11	0.976
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			362.1	B08		1	0175-0342	317.87	341.87	240	57.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			392.5	B08		1	0176-0344	477.32	345.31	233	58.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			320.4	B08		1	0177-0343	360.24	343.09	266	60.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			412.4	B08		1	0178-0348	187.38	348.07	297	64.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			366.4	B08		1	0179-0347	401.52	347.12	252	62.18	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			435.9	B08		1	0180-0348	451.21	348.03	240	59.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			421.7	B08		1	0181-0350	819.68	350.80	359	70.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			320.3	B08		1	0182-0357	235.83	357.38	253	60.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			403.6	B08		1	0183-0356	496.35	355.69	222	57.36	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			551.1	B08		1	0184-0358	158.02	357.54	284	62.43	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			350.6	B08		1	0185-0357	671.00	357.74	234	55.94	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			461.3	B08		1	0186-0359	721.04	359.92	342	71.84	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			343.5	B08		1	0187-0360	752.93	360.36	252	59.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			380.4	B08		1	0188-0365	470.68	365.36	211	57.36	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			419.2	B08		1	0189-0369	836.38	369.52	373	72.53	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			575.5	B08		1	0190-0368	510.44	367.95	374	72.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			312.3	B08		1	0191-0368	29.10	368.35	287	63.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			440.5	B08		1	0192-0368	85.72	368.45	306	65.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			324.6	B08		1	0193-0369	285.20	368.86	294	63.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			367.7	B08		1	0194-0369	644.13	368.90	224	53.70	0.976
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			329.9	B08		1	0195-0371	882.48	372.11	301	84.08	0.535
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			753.3	B08		1	0196-0372	342.42	372.83	297	62.43	0.958
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			438.3	B08		1	0197-0377	903.49	377.77	282	62.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			371.3	B08		1	0198-0382	236.02	382.05	232	61.01	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			283.5	B08		1	0199-0381	465.07	380.93	279	62.18	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			315.1	B08		1	0200-0382	422.53	381.58	245	57.01	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			384.5	B08		1	0201-0384	59.38	384.08	255	60.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			321.5	B08		1	0202-0382	204.75	382.54	279	65.60	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			349.9	B08		1	0203-0384	656.24	384.72	261	60.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			294.7	B08		1	0204-0387	568.05	386.72	328	69.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			369.2	B08		1	0205-0391	518.32	391.39	283	61.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			387.0	B08		1	0206-0390	169.49	389.75	206	54.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.9	B08		1	0207-0395	261.77	395.35	279	63.60	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			307.0	B08		1	0208-0395	803.93	394.56	282	63.94	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			339.0	B08		1	0209-0397	83.60	397.43	279	63.36	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			442.9	B08		1	0210-0404	36.94	403.87	278	63.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			363.5	B08		1	0211-0407	730.02	407.84	315	66.18	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			285.9	B08		1	0212-0408	843.73	407.57	293	64.18	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			234.8	B08		1	0213-0410	440.38	410.24	296	63.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			319.3	B08		1	0214-0410	550.82	411.36	275	66.43	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			607.2	B08		1	0215-0413	243.15	413.15	243	60.18	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			357.3	B08		1	0216-0413	516.77	413.09	281	62.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			396.2	B08		1	0217-0413	808.27	412.54	221	53.94	0.954
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			314.4	B08		1	0218-0414	919.87	414.30	185	55.60	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			376.0	B08		1	0219-0416	79.17	416.04	377	71.94	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			352.5	B08		1	0220-0418	163.55	418.03	252	61.36	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			405.4	B08		1	0221-0421	785.55	421.04	344	69.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			279.5	B08		1	0222-0422	409.14	422.85	249	63.01	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			322.0	B08		1	0223-0423	497.98	423.57	253	59.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			357.3	B08		1	0224-0424	532.48	424.18	237	58.04	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.9	B08		1	0225-0424	26.41	423.48	304	69.01	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			694.7	B08		1	0226-0426	354.97	425.99	314	67.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			516.7	B08		1	0227-0423	871.09	422.31	179	50.87	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			437.7	B08		1	0228-0427	250.22	427.44	230	57.70	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			399.6	B08		1	0229-0430	206.78	429.65	150	48.28	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			460.9	B08		1	0230-0433	719.33	433.69	222	55.70	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			650.2	B08		1	0231-0434	267.33	434.36	214	54.28	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			323.8	B08		1	0232-0437	480.58	437.58	240	60.18	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			694.7	B08		1	0233-0440	939.21	439.67	353	68.18	0.954
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			8241.3	B08		1	0234-0439	609.39	439.19	305	65.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			396.6	B08		1	0235-0441	87.56	441.59	397	78.77	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			496.8	B08		1	0236-0444	313.31	444.10	226	55.60	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			323.6	B08		1	0237-0449	566.89	449.14	471	87.74	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			277.5	B08		1	0238-0447	895.02	446.89	305	64.18	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			429.8	B08		1	0239-0451	447.93	451.30	249	59.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			420.4	B08		1	0240-0452	203.76	451.83	338	69.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			411.4	B08		1	0241-0452	707.34	452.53	248	58.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.0	B08		1	0242-0455	138.82	455.82	272	61.11	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			319.3	B08		1	0243-0455	169.80	454.52	249	57.94	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			391.4	B08		1	0244-0455	764.11	454.42	229	57.60	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			576.6	B08		1	0245-0460	338.08	460.12	261	59.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			306.9	B08		1	0246-0458	522.70	457.57	260	71.36	0.642
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			405.2	B08		1	0247-0462	684.36	462.23	245	58.53	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			24620.9	B08		1	0248-0461	929.63	463.41	105	54.28	0.448
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			399.0	B08		1	0249-0463	266.08	463.29	234	56.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			281.2	B08		1	0250-0462	371.30	462.35	222	54.28	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			333.2	B08		1	0251-0465	192.92	465.25	236	56.77	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			342.0	B08		1	0252-0469	19.74	469.00	232	58.18	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			323.7	B08		1	0253-0468	56.76	468.68	245	59.70	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			590.2	B08		1	0254-0473	454.50	473.71	359	71.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			344.4	B08		1	0255-0471	784.17	470.63	284	63.01	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			310.3	B08		1	0256-0471	889.75	471.18	283	62.28	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			27433.8	B08		1	0257-0476	110.21	476.73	284	80.67	0.548
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			376.8	B08		1	0258-0477	231.35	477.52	324	67.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			493.0	B08		1	0259-0477	939.35	477.30	305	64.18	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			767.9	B08		1	0260-0489	638.05	489.37	596	101.64	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			359.3	B08		1	0261-0485	756.79	486.02	376	71.84	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.8	B08		1	0262-0487	288.53	487.51	264	65.01	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			360.6	B08		1	0263-0486	314.59	485.45	245	59.94	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.3	B08		1	0264-0485	553.80	484.53	283	67.36	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			308.0	B08		1	0265-0484	369.54	483.67	268	64.28	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			313.7	B08		1	0266-0491	519.97	491.55	338	72.67	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			438.4	B08		1	0267-0497	99.83	497.16	370	71.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.5	B08		1	0268-0498	409.74	499.31	354	71.01	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			290.5	B08		1	0269-0498	872.62	499.24	184	54.18	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			312.9	B08		1	0270-0500	148.78	500.06	228	57.36	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			277.2	B08		1	0271-0503	468.71	503.63	320	68.43	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			393.2	B08		1	0272-0503	77.11	502.93	272	61.11	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			230.6	B08		1	0273-0505	268.93	504.90	270	68.43	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			366.2	B08		1	0274-0509	305.30	509.88	233	57.94	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			536.3	B08		1	0275-0517	207.07	517.49	344	71.01	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			530.6	B08		1	0276-0519	598.46	519.13	290	66.43	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			362.1	B08		1	0277-0518	854.85	517.24	228	61.11	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.4	B08		1	0278-0521	933.70	520.66	393	76.43	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			333.6	B08		1	0279-0520	166.61	520.71	241	58.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			373.6	B08		1	0280-0521	238.19	521.80	373	71.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			417.0	B08		1	0281-0521	411.27	521.04	435	79.26	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.8	B08		1	0282-0526	563.97	525.63	293	69.01	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			367.1	B08		1	0283-0522	34.32	522.15	220	58.77	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			478.4	B08		1	0284-0523	332.36	523.14	263	59.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.6	B08		1	0285-0523	894.77	523.05	222	57.94	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.7	B08		1	0286-0527	122.79	526.75	271	60.53	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			213.8	B08		1	0287-0530	535.34	531.28	286	74.67	0.645
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			431.6	B08		1	0288-0525	792.52	525.08	151	48.53	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			352.4	B08		1	0289-0529	377.36	529.29	221	54.53	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			410.8	B08		1	0290-0532	22.59	531.68	118	40.63	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			544.6	B08		1	0291-0534	849.54	533.57	281	64.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.1	B08		1	0292-0538	758.80	536.71	288	66.18	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			346.9	B08		1	0293-0538	190.19	539.06	304	68.43	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.3	B08		1	0294-0538	155.18	538.33	266	59.94	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.2	B08		1	0295-0540	274.52	540.55	302	67.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			295.7	B08		1	0296-0539	584.34	539.26	237	58.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			356.9	B08		1	0297-0541	34.95	541.02	186	53.11	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			385.2	B08		1	0298-0540	246.64	540.12	226	56.28	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.6	B08		1	0299-0540	619.66	540.31	228	56.28	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			554.7	B08		1	0300-0546	430.62	546.55	216	53.70	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			381.5	B08		1	0301-0550	48.08	551.22	273	61.11	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			348.8	B08		1	0302-0555	646.66	554.99	394	76.43	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			285.4	B08		1	0303-0551	880.94	551.27	291	63.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			521.9	B08		1	0304-0553	813.38	553.13	188	52.53	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			332.5	B08		1	0305-0557	216.26	557.91	246	60.53	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			369.9	B08		1	0306-0557	115.55	556.04	350	73.01	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			373.6	B08		1	0307-0557	241.89	557.57	344	69.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			431.8	B08		1	0308-0559	407.13	559.18	323	69.01	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			328.9	B08		1	0309-0560	168.93	559.78	333	71.50	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			290.6	B08		1	0310-0556	922.23	556.72	246	58.87	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			355.2	B08		1	0311-0559	458.31	559.38	200	54.53	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.5	B08		1	0312-0561	942.12	561.30	280	61.70	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.3	B08		1	0313-0565	523.32	564.27	301	67.94	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.7	B08		1	0314-0566	762.34	565.33	293	71.50	0.720
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			521.6	B08		1	0315-0564	798.47	565.28	374	85.84	0.638
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			341.1	B08		1	0316-0567	437.78	566.43	249	59.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			530.3	B08		1	0317-0573	192.43	574.30	411	84.33	0.726
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.7	B08		1	0318-0569	601.57	568.93	289	69.26	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			503.6	B08		1	0319-0570	381.08	570.75	320	65.60	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			304.4	B08		1	0320-0576	233.09	576.66	252	63.36	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			563.6	B08		1	0321-0575	697.19	575.95	224	56.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			308.3	B08		1	0322-0580	545.77	580.03	344	71.60	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			226.8	B08		1	0323-0577	251.94	576.50	225	55.36	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			370.4	B08		1	0324-0581	58.38	582.52	240	63.60	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			290.2	B08		1	0325-0583	630.98	583.13	273	65.01	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.0	B08		1	0326-0585	565.54	585.96	451	83.01	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			397.4	B08		1	0327-0581	463.23	580.17	265	65.11	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			379.7	B08		1	0328-0585	265.66	585.19	263	65.01	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			295.2	B08		1	0329-0588	28.86	587.78	250	61.26	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			515.3	B08		1	0330-0593	115.61	594.13	357	70.18	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.4	B08		1	0331-0591	593.95	590.81	268	66.67	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			321.2	B08		1	0332-0591	143.19	591.45	241	57.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.7	B08		1	0333-0592	225.25	592.21	260	62.53	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.4	B08		1	0334-0594	384.87	594.79	297	66.18	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			467.2	B08		1	0335-0597	284.93	597.01	365	71.26	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			355.2	B08		1	0336-0594	674.84	594.10	229	56.53	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			586.2	B08		1	0337-0592	712.12	592.96	178	51.21	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			325.6	B08		1	0338-0605	414.43	604.17	293	66.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			420.6	B08		1	0339-0605	806.30	605.10	223	55.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			437.5	B08		1	0340-0607	592.13	607.88	231	55.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			321.8	B08		1	0341-0609	744.09	608.82	287	62.77	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			268.4	B08		1	0342-0611	273.89	611.90	251	60.77	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			497.9	B08		1	0343-0612	849.76	611.86	288	65.01	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			349.3	B08		1	0344-0613	153.75	612.82	195	55.36	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			371.8	B08		1	0345-0614	302.75	614.32	232	55.70	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			428.5	B08		1	0346-0616	76.07	616.27	260	59.94	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			368.9	B08		1	0347-0618	198.86	617.72	200	57.60	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			456.8	B08		1	0348-0616	901.75	616.17	251	59.94	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			296.9	B08		1	0349-0620	479.57	620.33	262	63.01	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			454.1	B08		1	0350-0619	681.57	619.71	274	61.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			457.4	B08		1	0351-0623	362.48	623.47	330	71.36	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.1	B08		1	0352-0630	892.17	629.37	254	61.01	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			333.0	B08		1	0353-0630	162.83	629.67	272	62.53	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			411.2	B08		1	0354-0629	806.37	629.13	187	53.70	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			12953.9	B08		1	0355-0635	848.75	635.77	360	72.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.3	B08		1	0356-0634	489.75	634.91	317	71.84	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			309.7	B08		1	0357-0634	93.78	634.92	259	59.60	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			428.2	B08		1	0358-0636	243.32	636.51	374	72.67	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			405.3	B08		1	0359-0638	562.17	638.24	302	63.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			277.6	B08		1	0360-0642	508.02	640.75	239	59.60	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.7	B08		1	0361-0644	63.05	643.58	112	40.28	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			341.6	B08		1	0362-0644	693.93	644.85	228	56.87	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			306.3	B08		1	0363-0647	734.79	647.28	278	62.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.7	B08		1	0364-0650	783.99	651.00	192	58.53	0.704
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.4	B08		1	0365-0650	313.67	650.57	254	60.77	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.1	B08		1	0366-0649	401.23	648.55	262	61.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			544.0	B08		1	0367-0653	199.09	653.50	315	65.60	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			305.8	B08		1	0368-0653	447.88	652.57	345	68.77	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.9	B08		1	0369-0651	74.63	651.70	142	47.11	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			590.7	B08		1	0370-0663	237.20	663.32	593	97.98	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			285.2	B08		1	0371-0654	359.27	653.72	266	61.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			308.8	B08		1	0372-0659	46.25	659.41	273	61.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			415.7	B08		1	0373-0661	180.10	661.22	361	70.43	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.2	B08		1	0374-0661	327.81	660.85	284	63.01	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			307.5	B08		1	0375-0662	546.66	662.74	419	79.01	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.7	B08		1	0376-0664	121.03	664.38	276	64.18	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			334.5	B08		1	0377-0664	659.96	664.11	233	56.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.1	B08		1	0378-0665	939.18	664.58	280	64.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.7	B08		1	0379-0673	144.32	672.28	278	65.01	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			427.5	B08		1	0380-0675	705.98	673.83	168	59.94	0.588
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.9	B08		1	0381-0680	166.68	679.72	399	75.84	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			292.6	B08		1	0382-0679	285.98	678.49	255	61.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.2	B08		1	0383-0685	536.72	684.90	266	62.53	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			379.5	B08		1	0384-0684	365.64	683.42	216	57.36	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			365.0	B08		1	0385-0685	615.32	684.80	227	56.28	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			317.2	B08		1	0386-0686	309.17	686.79	228	56.28	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			306.0	B08		1	0387-0688	428.60	688.45	236	58.53	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			638.6	B08		1	0388-0688	264.40	688.51	320	67.11	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			621.3	B08		1	0389-0693	352.59	693.35	387	80.91	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			494.2	B08		1	0390-0688	916.93	687.99	140	47.11	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.6	B08		1	0391-0691	104.52	691.01	261	62.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.7	B08		1	0392-0693	133.18	692.16	261	63.70	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			214.0	B08		1	0393-0693	653.79	693.70	266	61.60	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			636.4	B08		1	0394-0693	720.47	693.60	320	65.84	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.5	B08		1	0395-0697	50.81	697.15	422	77.26	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			334.6	B08		1	0396-0697	878.17	697.43	330	67.01	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			582.0	B08		1	0397-0697	926.54	697.25	159	47.70	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			399.0	B08		1	0398-0698	944.56	697.57	170	51.11	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			202.1	B08		1	0399-0703	691.43	704.31	281	67.26	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			224.0	B08		1	0400-0706	315.64	706.08	250	63.01	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			320.7	B08		1	0401-0708	492.58	708.06	259	65.01	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			382.2	B08		1	0402-0710	415.79	710.17	212	52.87	0.953
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.5	B08		1	0403-0710	233.22	710.48	313	67.11	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			442.7	B08		2	0001-0029	259.68	29.83	527	96.57	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			428.7	B08		2	0002-0033	541.09	33.64	296	71.01	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			768.0	B08		2	0003-0034	151.54	34.40	223	55.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			621.0	B08		2	0004-0036	220.81	37.59	352	74.67	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			369.2	B08		2	0005-0036	793.54	36.16	268	61.11	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			298.4	B08		2	0006-0036	936.35	36.88	247	59.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			472.2	B08		2	0007-0038	126.12	39.14	253	58.53	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			509.8	B08		2	0008-0039	584.93	39.38	349	71.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			633.1	B08		2	0009-0042	767.09	42.65	281	62.53	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			329.2	B08		2	0010-0042	828.89	42.74	279	65.60	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.2	B08		2	0011-0049	53.05	49.74	437	85.26	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			370.2	B08		2	0012-0047	919.83	46.92	347	72.08	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			354.8	B08		2	0013-0046	639.79	45.79	330	68.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.7	B08		2	0014-0047	96.27	48.60	394	79.26	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			604.5	B08		2	0015-0048	735.18	48.81	336	69.01	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			325.5	B08		2	0016-0061	412.86	62.80	586	130.95	0.429
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			385.2	B08		2	0017-0052	199.96	51.48	256	60.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			392.8	B08		2	0018-0058	900.74	58.85	226	57.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			455.6	B08		2	0019-0060	248.56	59.83	237	58.87	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.0	B08		2	0020-0067	388.09	66.98	509	92.33	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			337.1	B08		2	0021-0062	828.67	62.91	291	70.18	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			417.4	B08		2	0022-0068	511.07	68.64	316	64.53	0.954
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			386.2	B08		2	0023-0071	734.71	70.64	328	67.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			388.3	B08		2	0024-0068	932.37	68.17	302	64.53	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			404.7	B08		2	0025-0072	673.71	72.26	200	52.53	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			374.0	B08		2	0026-0078	847.67	78.25	315	66.18	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			299.4	B08		2	0027-0081	341.98	81.08	352	81.84	0.660
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			365.6	B08		2	0028-0086	225.89	85.71	231	56.53	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.6	B08		2	0029-0093	68.18	93.30	308	80.08	0.603
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.1	B08		2	0030-0090	920.38	89.70	417	77.50	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			339.5	B08		2	0031-0089	162.29	89.72	246	60.43	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			408.4	B08		2	0032-0093	563.27	93.05	241	57.70	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			849.9	B08		2	0033-0096	697.39	95.95	324	66.43	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.4	B08		2	0034-0098	37.60	98.62	268	66.18	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			331.1	B08		2	0035-0097	782.11	98.03	395	73.26	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			320.8	B08		2	0036-0095	830.61	94.67	292	64.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			352.0	B08		2	0037-0095	141.99	95.57	298	73.26	0.698
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			416.2	B08		2	0038-0097	604.69	97.28	212	55.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			298.2	B08		2	0039-0102	647.74	101.72	272	61.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			327.4	B08		2	0040-0105	174.15	103.92	313	73.50	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.8	B08		2	0041-0104	294.08	103.98	338	70.18	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			338.3	B08		2	0042-0104	885.71	105.02	275	63.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			392.2	B08		2	0043-0114	713.14	113.75	286	61.94	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			284.5	B08		2	0044-0114	828.93	114.14	248	58.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			373.1	B08		2	0045-0119	450.89	118.43	288	67.01	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			357.2	B08		2	0046-0122	931.96	121.35	274	80.57	0.530
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			425.7	B08		2	0047-0123	516.32	123.01	286	63.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			464.7	B08		2	0048-0122	563.25	122.04	263	59.11	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			235.1	B08		2	0049-0128	97.77	128.00	262	60.53	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			353.3	B08		2	0050-0129	42.10	128.79	231	55.36	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			326.4	B08		2	0051-0128	207.62	128.42	259	59.60	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			354.9	B08		2	0052-0133	604.70	133.19	360	70.43	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			327.0	B08		2	0053-0130	759.25	130.71	251	58.18	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			347.7	B08		2	0054-0136	72.94	136.44	208	54.28	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			398.5	B08		2	0055-0137	550.32	136.78	274	61.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			531.1	B08		2	0056-0137	777.44	137.14	222	55.11	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			589.8	B08		2	0057-0137	794.18	136.40	218	53.70	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			315.0	B08		2	0058-0145	727.37	145.32	444	78.18	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			397.9	B08		2	0059-0142	874.27	142.34	224	55.36	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			402.8	B08		2	0060-0144	934.42	143.85	249	58.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			199.3	B08		2	0061-0148	155.76	148.52	292	65.84	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			420.9	B08		2	0062-0149	33.25	149.15	222	54.77	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.5	B08		2	0063-0150	106.39	149.81	237	57.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			306.9	B08		2	0064-0155	200.80	155.72	393	73.60	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			429.9	B08		2	0065-0155	471.21	154.30	254	59.01	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			396.4	B08		2	0066-0154	558.32	154.44	292	63.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			480.0	B08		2	0067-0154	254.47	153.92	308	67.36	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			315.3	B08		2	0068-0160	620.04	160.01	404	74.43	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			522.1	B08		2	0069-0164	917.28	164.36	356	70.43	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			364.3	B08		2	0070-0164	175.67	164.23	215	55.36	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			341.3	B08		2	0071-0167	665.68	166.85	405	73.94	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			324.5	B08		2	0072-0167	497.26	168.27	252	60.53	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			321.0	B08		2	0073-0168	67.29	167.45	226	57.70	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			402.8	B08		2	0074-0170	262.45	170.60	324	66.18	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			368.1	B08		2	0075-0172	753.94	172.38	431	78.91	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.7	B08		2	0076-0173	146.52	173.59	272	67.01	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			350.8	B08		2	0077-0178	596.57	178.25	306	65.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			601.6	B08		2	0078-0182	240.50	181.00	298	71.26	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			252.5	B08		2	0079-0182	734.11	182.39	234	58.53	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			303.2	B08		2	0080-0185	187.08	185.78	241	57.70	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			315.7	B08		2	0081-0186	122.92	186.07	343	74.67	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			441.0	B08		2	0082-0188	225.70	188.67	261	62.53	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			351.8	B08		2	0083-0191	677.56	192.15	364	71.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			463.8	B08		2	0084-0189	840.43	189.39	214	53.94	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			379.9	B08		2	0085-0194	563.06	194.27	385	72.18	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			578.6	B08		2	0086-0199	890.42	197.48	769	109.64	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			412.8	B08		2	0087-0193	258.30	193.27	200	52.77	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			482.0	B08		2	0088-0195	501.35	195.42	397	73.84	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			451.7	B08		2	0089-0203	329.23	203.08	327	67.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			335.0	B08		2	0090-0201	414.67	201.15	261	61.11	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			354.5	B08		2	0091-0203	943.10	202.94	298	63.36	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.2	B08		2	0092-0208	723.00	207.81	312	66.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			311.6	B08		2	0093-0208	386.86	207.98	248	58.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			583.3	B08		2	0094-0215	917.90	216.26	350	78.43	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.4	B08		2	0095-0213	164.52	213.57	360	71.01	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			652.5	B08		2	0096-0210	456.56	209.86	212	53.60	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			404.0	B08		2	0097-0211	269.62	210.63	212	55.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			323.9	B08		2	0098-0211	832.42	210.58	239	59.70	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			434.7	B08		2	0099-0217	693.56	217.43	398	75.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			236.6	B08		2	0100-0214	756.57	214.54	358	71.01	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			415.4	B08		2	0101-0219	443.84	218.95	289	65.60	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			348.1	B08		2	0102-0222	496.94	222.16	260	62.77	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			323.5	B08		2	0103-0228	869.43	228.89	429	80.91	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.1	B08		2	0104-0228	674.85	228.32	255	59.94	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			351.2	B08		2	0105-0234	25.12	233.33	292	68.43	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			656.0	B08		2	0106-0234	179.97	233.59	273	62.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			510.1	B08		2	0107-0231	759.55	230.71	145	45.56	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			556.5	B08		2	0108-0232	746.58	232.09	152	44.63	0.959
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			366.9	B08		2	0109-0240	201.34	240.69	354	69.60	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			334.1	B08		2	0110-0242	934.14	243.11	233	57.70	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.8	B08		2	0111-0246	816.39	245.60	275	63.84	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			381.3	B08		2	0112-0247	365.66	247.19	372	74.91	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.1	B08		2	0113-0249	780.40	249.74	260	63.01	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			373.0	B08		2	0114-0249	297.44	249.34	298	63.36	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			316.7	B08		2	0115-0256	481.04	256.10	403	83.74	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			497.0	B08		2	0116-0254	250.33	253.89	294	62.18	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			396.2	B08		2	0117-0253	66.16	253.85	295	64.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			390.6	B08		2	0118-0252	126.71	252.34	209	53.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			509.7	B08		2	0119-0259	149.90	258.96	393	73.60	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			722.0	B08		2	0120-0256	537.78	256.26	177	50.28	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			660.7	B08		2	0121-0260	519.45	260.14	348	75.84	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			492.5	B08		2	0122-0259	871.05	259.54	336	67.94	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			323.0	B08		2	0123-0261	412.65	261.32	297	64.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			356.6	B08		2	0124-0260	934.80	260.40	352	73.94	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			352.0	B08		2	0125-0264	282.78	263.77	217	55.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			287.7	B08		2	0126-0264	376.20	263.74	338	74.08	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			619.1	B08		2	0127-0265	343.44	265.30	320	66.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			335.7	B08		2	0128-0269	75.62	269.45	217	57.36	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			616.4	B08		2	0129-0270	241.05	269.89	292	63.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			285.6	B08		2	0130-0273	432.94	273.97	335	74.43	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			224.6	B08		2	0131-0274	761.98	273.08	264	64.53	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			349.3	B08		2	0132-0271	195.98	272.06	227	57.11	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			327.0	B08		2	0133-0274	687.54	274.55	410	79.60	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			479.5	B08		2	0134-0275	830.69	275.44	266	59.94	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			360.6	B08		2	0135-0277	718.89	277.48	276	60.77	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			375.7	B08		2	0136-0281	935.66	281.24	230	56.28	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			308.0	B08		2	0137-0286	67.07	286.17	261	64.18	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			490.1	B08		2	0138-0280	280.48	280.84	127	40.97	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			409.3	B08		2	0139-0289	85.91	287.86	217	55.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			488.5	B08		2	0140-0289	152.32	289.26	336	71.84	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			327.4	B08		2	0141-0293	537.38	292.84	374	74.18	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			339.6	B08		2	0142-0292	678.60	291.79	270	61.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			362.5	B08		2	0143-0296	882.82	296.27	234	59.11	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			501.6	B08		2	0144-0293	280.31	292.82	140	42.63	0.968
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			380.4	B08		2	0145-0298	40.65	298.33	181	49.94	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			482.2	B08		2	0146-0298	168.05	298.25	178	50.04	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			310.4	B08		2	0147-0303	768.05	302.95	314	67.84	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			318.0	B08		2	0148-0306	818.96	306.25	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			350.5	B08		2	0149-0306	550.67	305.06	341	76.67	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			412.5	B08		2	0150-0306	208.60	307.31	266	62.53	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			363.2	B08		2	0151-0311	33.99	311.18	233	60.18	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			400.9	B08		2	0152-0309	289.20	309.28	199	53.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			304.2	B08		2	0153-0312	18.54	312.73	229	55.70	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			332.7	B08		2	0154-0314	258.62	313.18	237	56.77	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			448.1	B08		2	0155-0313	347.76	313.31	209	54.04	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			486.9	B08		2	0156-0312	363.62	311.97	194	53.46	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			504.2	B08		2	0157-0321	490.22	320.56	399	77.84	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			321.8	B08		2	0158-0323	747.11	323.03	315	69.60	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			304.3	B08		2	0159-0324	590.58	323.80	257	62.28	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			363.4	B08		2	0160-0325	105.60	325.09	308	65.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			426.9	B08		2	0161-0327	604.71	327.85	195	52.63	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			353.2	B08		2	0162-0330	370.30	330.08	241	59.36	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			320.4	B08		2	0163-0331	246.12	331.06	328	68.77	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			347.5	B08		2	0164-0335	620.25	335.80	228	57.94	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			468.4	B08		2	0165-0338	914.11	337.65	337	69.26	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			338.0	B08		2	0166-0335	393.51	335.78	105	38.63	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			581.2	B08		2	0167-0337	227.09	336.83	153	45.11	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			346.8	B08		2	0168-0339	382.31	339.19	161	47.46	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			306.5	B08		2	0169-0342	57.86	342.30	285	70.77	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			308.2	B08		2	0170-0343	99.70	343.97	255	59.94	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			305.5	B08		2	0171-0346	464.96	346.86	304	68.77	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			281.4	B08		2	0172-0350	422.90	350.26	367	74.43	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.9	B08		2	0173-0355	124.11	355.02	258	62.67	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			501.2	B08		2	0174-0361	929.03	360.97	564	97.98	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			299.5	B08		2	0175-0356	543.50	355.84	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			518.9	B08		2	0176-0356	230.26	356.87	241	58.28	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			379.6	B08		2	0177-0359	656.85	359.38	304	65.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			320.8	B08		2	0178-0360	177.76	360.20	279	62.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			467.2	B08		2	0179-0359	626.60	359.51	217	54.28	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			293.8	B08		2	0180-0362	749.40	362.25	293	65.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			417.3	B08		2	0181-0365	65.16	364.96	220	57.94	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			315.2	B08		2	0182-0361	295.52	360.80	227	58.87	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			473.4	B08		2	0183-0367	321.79	367.32	204	54.53	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			361.1	B08		2	0184-0372	494.01	372.56	361	73.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			392.1	B08		2	0185-0380	438.30	380.98	434	80.33	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			356.8	B08		2	0186-0377	680.65	377.04	328	67.70	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			378.3	B08		2	0187-0378	885.68	377.64	448	79.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			347.2	B08		2	0188-0377	155.27	378.24	193	51.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			465.8	B08		2	0189-0382	203.77	382.92	217	64.08	0.664
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			434.4	B08		2	0190-0383	47.43	383.61	293	65.84	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.7	B08		2	0191-0389	360.18	390.60	317	79.84	0.625
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			308.3	B08		2	0192-0383	725.92	383.52	256	62.28	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			494.7	B08		2	0193-0393	183.07	392.87	351	71.84	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			502.3	B08		2	0194-0395	779.94	395.27	248	57.36	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			349.7	B08		2	0195-0398	88.89	398.15	280	63.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			801.5	B08		2	0196-0404	140.56	404.60	305	65.36	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			384.5	B08		2	0197-0408	229.43	408.85	175	51.70	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.6	B08		2	0198-0413	464.92	411.27	358	79.84	0.706
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			215.6	B08		2	0199-0413	926.13	412.15	263	61.70	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			502.6	B08		2	0200-0412	870.18	412.74	200	51.70	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.7	B08		2	0201-0419	156.19	419.70	250	65.36	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			316.9	B08		2	0202-0419	668.32	417.98	380	76.67	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			372.8	B08		2	0203-0421	113.25	420.36	310	69.84	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.5	B08		2	0204-0421	619.70	420.79	195	53.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.4	B08		2	0205-0422	731.26	421.55	354	80.91	0.680
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			562.0	B08		2	0206-0422	58.16	422.39	308	66.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			287.4	B08		2	0207-0424	694.88	425.02	328	69.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			360.4	B08		2	0208-0430	509.50	430.00	397	78.67	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			357.8	B08		2	0209-0430	238.31	430.70	262	64.43	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			654.2	B08		2	0210-0434	99.29	433.29	399	81.74	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			456.9	B08		2	0211-0432	192.14	432.66	306	64.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			616.2	B08		2	0212-0433	630.83	432.85	278	61.60	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			293.7	B08		2	0213-0434	768.89	433.81	220	57.46	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			264.4	B08		2	0214-0435	782.32	434.83	214	54.63	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			285.4	B08		2	0215-0442	809.55	442.16	233	61.11	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			677.7	B08		2	0216-0443	32.31	443.20	349	69.01	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.3	B08		2	0217-0446	937.21	447.18	437	81.26	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			325.5	B08		2	0218-0440	881.26	440.24	239	59.11	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			268.4	B08		2	0219-0442	399.14	441.87	294	65.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			687.9	B08		2	0220-0443	117.82	442.56	192	53.11	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			303.1	B08		2	0221-0451	573.60	451.88	375	84.08	0.667
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			286.7	B08		2	0222-0455	172.70	455.66	538	97.15	0.716
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			279.8	B08		2	0223-0447	159.35	447.29	107	39.11	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			294.6	B08		2	0224-0452	504.40	453.06	294	70.43	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			410.2	B08		2	0225-0451	248.87	451.17	219	59.70	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			296.5	B08		2	0226-0460	434.28	461.51	361	74.91	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			285.6	B08		2	0227-0453	465.39	453.60	198	58.63	0.724
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.8	B08		2	0228-0457	762.01	457.02	269	63.36	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			306.2	B08		2	0229-0458	127.88	457.68	242	60.18	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			406.5	B08		2	0230-0458	310.68	458.39	250	59.11	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			323.9	B08		2	0231-0464	534.43	464.78	362	73.84	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			28270.2	B08		2	0232-0465	15.86	463.09	121	65.11	0.359
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			279.1	B08		2	0233-0469	221.42	470.41	351	69.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			389.6	B08		2	0234-0470	858.17	471.00	295	63.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			522.0	B08		2	0235-0474	776.93	473.51	149	46.87	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			509.3	B08		2	0236-0481	32.34	481.04	295	63.36	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			302.5	B08		2	0237-0480	596.84	479.91	259	59.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			325.3	B08		2	0238-0481	712.94	481.18	237	56.28	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			349.8	B08		2	0239-0481	811.78	481.81	243	57.36	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			474.9	B08		2	0240-0482	346.62	482.36	157	46.87	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			495.6	B08		2	0241-0485	334.30	485.46	209	58.04	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.2	B08		2	0242-0487	401.77	486.60	330	85.98	0.561
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			533.1	B08		2	0243-0484	794.52	484.85	134	44.04	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			302.9	B08		2	0244-0490	268.59	489.77	219	55.70	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.9	B08		2	0245-0495	739.34	495.18	514	90.91	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.4	B08		2	0246-0489	873.21	488.82	152	47.70	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			362.9	B08		2	0247-0496	912.94	496.14	442	88.57	0.708
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			319.3	B08		2	0248-0498	569.45	497.41	356	72.77	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			291.4	B08		2	0249-0496	153.46	496.54	305	63.36	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			316.9	B08		2	0250-0496	181.71	495.69	317	65.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			349.9	B08		2	0251-0495	689.16	495.01	254	63.36	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			315.8	B08		2	0252-0495	883.61	495.94	150	46.28	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			329.8	B08		2	0253-0508	654.92	508.22	408	73.94	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			298.5	B08		2	0254-0509	417.01	509.34	242	57.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			283.7	B08		2	0255-0512	221.16	512.13	295	65.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			382.9	B08		2	0256-0512	503.00	512.88	347	68.18	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.9	B08		2	0257-0517	108.91	517.87	304	71.26	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			1739.0	B08		2	0258-0518	598.24	518.38	446	79.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			473.0	B08		2	0259-0519	266.95	518.57	261	62.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.4	B08		2	0260-0516	810.10	516.24	257	60.53	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			312.4	B08		2	0261-0516	901.90	515.64	216	56.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			281.0	B08		2	0262-0520	54.58	519.61	347	69.26	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			341.4	B08		2	0263-0517	693.80	518.29	260	60.28	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.0	B08		2	0264-0524	26.70	524.17	391	76.77	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			679.2	B08		2	0265-0524	292.11	523.96	313	66.18	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.4	B08		2	0266-0527	129.44	527.45	284	64.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			451.2	B08		2	0267-0528	464.51	528.09	334	68.08	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			415.3	B08		2	0268-0527	331.11	526.84	215	55.94	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.0	B08		2	0269-0529	767.18	529.22	288	65.11	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			287.6	B08		2	0270-0535	741.89	534.71	357	70.08	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.2	B08		2	0271-0534	170.99	534.05	301	68.77	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			375.6	B08		2	0272-0534	898.09	534.73	223	54.77	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			406.9	B08		2	0273-0537	371.82	537.32	366	71.01	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			334.9	B08		2	0274-0537	692.61	537.02	392	78.18	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			516.4	B08		2	0275-0539	311.64	538.90	281	63.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.1	B08		2	0276-0540	807.08	541.01	261	62.53	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			309.1	B08		2	0277-0547	92.38	547.24	225	55.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			471.3	B08		2	0278-0551	216.53	551.61	221	54.28	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			428.0	B08		2	0279-0554	258.15	553.87	246	59.11	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.0	B08		2	0280-0553	701.75	552.83	276	66.43	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			289.5	B08		2	0281-0560	189.67	560.55	376	75.36	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			399.6	B08		2	0282-0556	419.16	556.52	241	76.67	0.515
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			350.2	B08		2	0283-0557	573.40	556.84	232	56.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			608.0	B08		2	0284-0561	395.29	560.88	517	89.84	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			302.9	B08		2	0285-0557	489.28	557.20	298	73.60	0.691
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			446.3	B08		2	0286-0561	684.81	560.97	284	62.53	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			325.3	B08		2	0287-0563	53.34	564.04	254	64.77	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			327.2	B08		2	0288-0564	34.75	564.91	277	61.11	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.2	B08		2	0289-0564	800.42	563.66	262	62.43	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.9	B08		2	0290-0565	132.69	565.45	282	60.77	0.960
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			395.8	B08		2	0291-0569	298.45	569.75	305	66.77	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			226.9	B08		2	0292-0566	734.45	566.03	160	46.63	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			320.3	B08		2	0293-0572	546.80	572.13	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.7	B08		2	0294-0567	721.99	567.97	117	40.39	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			459.6	B08		2	0295-0569	337.10	569.57	268	62.77	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			301.1	B08		2	0296-0578	823.42	578.32	245	60.18	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			286.9	B08		2	0297-0576	861.26	576.46	224	58.77	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			332.8	B08		2	0298-0582	740.73	581.99	369	77.26	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			291.8	B08		2	0299-0583	563.98	583.98	248	59.46	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			327.5	B08		2	0300-0586	173.73	586.22	307	65.36	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			363.3	B08		2	0301-0583	658.97	583.84	245	57.11	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			287.7	B08		2	0302-0585	793.90	585.11	248	58.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			335.9	B08		2	0303-0590	227.90	590.27	281	63.11	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			420.7	B08		2	0304-0591	99.57	591.34	294	62.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			330.7	B08		2	0305-0593	505.03	593.37	339	69.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			328.6	B08		2	0306-0592	593.21	591.77	223	56.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			359.6	B08		2	0307-0597	133.78	597.69	338	71.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			430.5	B08		2	0308-0597	75.00	597.76	377	73.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.2	B08		2	0309-0598	764.49	598.03	268	61.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			325.0	B08		2	0310-0602	262.69	602.14	245	58.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.5	B08		2	0311-0603	370.78	603.27	328	68.53	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			369.2	B08		2	0312-0610	883.28	609.88	539	91.15	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			525.5	B08		2	0313-0609	585.95	609.56	224	57.01	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.4	B08		2	0314-0613	841.15	613.76	411	79.26	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			299.1	B08		2	0315-0612	936.63	612.62	227	55.94	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			291.1	B08		2	0316-0617	288.69	617.92	377	74.77	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			309.5	B08		2	0317-0614	609.59	615.13	257	63.60	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			293.1	B08		2	0318-0620	799.21	619.85	258	64.28	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.3	B08		2	0319-0620	96.60	619.31	283	61.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			336.2	B08		2	0320-0622	162.75	622.53	248	60.28	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			752.1	B08		2	0321-0633	664.99	632.93	460	84.43	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			15003.2	B08		2	0322-0636	342.57	636.72	552	91.50	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			431.6	B08		2	0323-0632	681.91	632.43	285	65.94	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			369.0	B08		2	0324-0636	909.48	635.73	392	75.84	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.7	B08		2	0325-0637	212.47	637.09	316	74.08	0.724
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.6	B08		2	0326-0639	419.96	639.41	505	90.57	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			503.7	B08		2	0327-0635	300.04	635.24	160	46.87	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			529.4	B08		2	0328-0634	311.80	633.78	111	39.56	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			353.6	B08		2	0329-0639	774.09	638.73	357	70.43	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.1	B08		2	0330-0640	47.64	639.90	268	61.01	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			292.8	B08		2	0331-0644	575.29	645.64	468	86.33	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.5	B08		2	0332-0637	497.09	637.30	111	40.04	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			475.6	B08		2	0333-0645	364.75	645.34	289	61.94	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.8	B08		2	0334-0652	503.38	652.97	353	73.01	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.8	B08		2	0335-0651	433.80	651.83	219	56.77	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			371.8	B08		2	0336-0656	474.14	655.54	417	82.91	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			561.5	B08		2	0337-0653	132.62	653.87	156	47.21	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			432.2	B08		2	0338-0660	148.53	660.75	228	58.53	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			340.4	B08		2	0339-0665	873.42	665.35	320	67.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			339.5	B08		2	0340-0664	794.21	664.84	230	54.77	0.964
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			369.8	B08		2	0341-0664	345.09	664.25	223	59.70	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			273.9	B08		2	0342-0668	31.79	668.05	280	65.60	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			423.6	B08		2	0343-0666	133.65	665.65	163	48.04	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			379.1	B08		2	0344-0673	488.29	673.97	375	76.77	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			341.9	B08		2	0345-0677	471.11	677.26	388	79.26	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			311.2	B08		2	0346-0674	676.26	675.27	352	69.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			233.3	B08		2	0347-0682	833.49	682.02	319	71.60	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.5	B08		2	0348-0681	177.91	682.12	282	64.43	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.4	B08		2	0349-0684	536.57	684.33	210	54.28	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			475.1	B08		2	0350-0684	270.18	683.97	243	59.11	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			506.8	B08		2	0351-0692	297.50	692.96	233	58.53	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			332.7	B08		2	0352-0688	897.09	688.15	191	53.94	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			321.6	B08		2	0353-0692	388.37	692.13	236	57.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			291.1	B08		2	0354-0695	559.28	695.50	349	71.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			307.4	B08		2	0355-0695	83.03	695.50	268	60.53	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			286.5	B08		2	0356-0697	649.23	697.13	455	80.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			342.8	B08		2	0357-0696	766.83	695.63	319	67.01	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			570.1	B08		2	0358-0700	19.22	700.80	156	47.46	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			295.6	B08		2	0359-0704	105.76	704.14	283	68.08	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			270.0	B08		2	0360-0701	846.09	700.80	249	58.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			408.3	B08		2	0361-0702	620.75	701.43	199	53.11	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			430.9	B08		2	0362-0702	37.15	701.76	192	53.11	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.0	B08		2	0363-0704	937.46	703.67	299	63.84	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.9	B08		2	0364-0708	355.31	708.03	272	62.53	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			515.5	B08		2	0365-0708	207.17	708.01	325	66.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			311.6	B08		2	0366-0708	440.81	708.12	253	58.77	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			346.7	B08		2	0367-0710	121.34	709.93	207	56.53	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			298.5	B08		3	0001-0032	174.22	32.04	249	67.01	0.697
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			299.3	B08		3	0002-0031	771.20	30.98	281	63.11	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			389.1	B08		3	0003-0035	76.25	35.00	272	62.53	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			335.1	B08		3	0004-0037	608.80	37.00	478	85.15	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			429.0	B08		3	0005-0036	648.22	35.64	324	66.18	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			698.8	B08		3	0006-0041	489.76	40.64	488	83.98	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			316.7	B08		3	0007-0040	30.61	40.30	250	60.18	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			304.7	B08		3	0008-0043	704.69	44.35	231	60.87	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			393.8	B08		3	0009-0047	530.33	47.51	250	59.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			538.3	B08		3	0010-0054	456.56	54.71	277	61.36	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			39626.6	B08		3	0011-0058	476.96	59.41	445	79.50	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			592.9	B08		3	0012-0058	93.16	59.16	330	67.36	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			310.2	B08		3	0013-0055	207.76	54.54	245	60.77	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			347.4	B08		3	0014-0057	753.82	57.12	256	65.70	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			454.4	B08		3	0015-0060	911.18	59.84	358	69.01	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			320.1	B08		3	0016-0062	426.79	61.94	262	59.84	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			281.7	B08		3	0017-0064	817.54	63.85	291	69.60	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			356.4	B08		3	0018-0062	151.02	62.27	218	57.36	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			439.6	B08		3	0019-0063	563.29	63.40	270	65.01	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			574.8	B08		3	0020-0064	397.98	64.32	303	69.70	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			1070.9	B08		3	0021-0069	373.29	69.18	358	74.43	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			422.9	B08		3	0022-0070	444.27	70.30	315	71.01	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			357.9	B08		3	0023-0071	685.11	71.36	324	67.36	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			373.2	B08		3	0024-0071	26.79	71.61	292	63.94	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.7	B08		3	0025-0078	63.72	77.41	368	76.08	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			311.5	B08		3	0026-0077	152.86	78.01	324	68.18	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			372.7	B08		3	0027-0076	180.82	77.29	251	61.01	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			323.5	B08		3	0028-0084	869.55	83.92	383	84.18	0.679
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			630.2	B08		3	0029-0081	349.15	80.59	353	70.18	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			339.5	B08		3	0030-0079	97.96	78.72	198	53.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.9	B08		3	0031-0081	595.59	80.53	323	70.18	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			480.2	B08		3	0032-0080	291.88	80.04	261	59.60	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			301.9	B08		3	0033-0079	750.97	79.77	269	64.43	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			489.9	B08		3	0034-0082	330.41	82.15	181	54.63	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.3	B08		3	0035-0087	940.87	86.52	272	61.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			491.6	B08		3	0036-0088	373.60	88.65	217	53.36	0.958
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			382.3	B08		3	0037-0092	638.43	92.74	241	59.60	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			535.2	B08		3	0038-0091	398.46	91.50	215	55.36	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			355.2	B08		3	0039-0093	565.31	92.96	263	62.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			316.0	B08		3	0040-0098	497.76	98.43	517	84.08	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			402.1	B08		3	0041-0094	191.15	94.77	294	63.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			340.9	B08		3	0042-0099	838.70	99.71	305	67.36	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			357.8	B08		3	0043-0098	448.56	98.24	272	63.01	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			452.2	B08		3	0044-0099	241.85	98.73	246	58.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			299.9	B08		3	0045-0103	791.31	103.40	351	70.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			452.8	B08		3	0046-0107	332.07	106.69	355	72.18	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			833.7	B08		3	0047-0105	545.14	104.91	297	63.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			349.7	B08		3	0048-0109	816.08	108.63	189	55.36	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			426.4	B08		3	0049-0110	101.79	110.50	272	61.60	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			500.6	B08		3	0050-0111	216.70	110.96	304	65.01	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			328.8	B08		3	0051-0111	413.08	111.64	277	62.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			624.3	B08		3	0052-0114	920.64	114.63	335	66.77	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			567.2	B08		3	0053-0117	699.14	116.59	301	64.18	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			393.3	B08		3	0054-0123	493.78	122.81	262	60.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			381.3	B08		3	0055-0125	27.26	124.27	249	74.91	0.558
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			424.9	B08		3	0056-0124	546.77	125.24	276	65.01	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			647.9	B08		3	0057-0125	448.58	125.20	208	55.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			818.2	B08		3	0058-0133	739.38	133.47	362	84.67	0.635
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			335.3	B08		3	0059-0131	145.90	131.35	332	68.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			585.1	B08		3	0060-0134	207.45	132.73	501	95.74	0.687
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			401.5	B08		3	0061-0135	350.90	134.26	255	58.77	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			334.6	B08		3	0062-0136	872.25	136.23	326	66.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			312.8	B08		3	0063-0136	625.52	136.69	299	63.11	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			662.8	B08		3	0064-0147	169.60	147.13	413	77.50	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			331.3	B08		3	0065-0144	487.88	143.45	271	61.60	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			433.6	B08		3	0066-0143	536.82	142.94	241	59.36	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			537.5	B08		3	0067-0146	275.38	145.38	227	58.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			378.3	B08		3	0068-0147	28.95	147.38	243	58.18	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			356.1	B08		3	0069-0153	309.34	153.10	345	69.84	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			35703.7	B08		3	0070-0156	204.86	155.46	204	92.81	0.298
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			387.2	B08		3	0071-0156	387.05	156.20	257	60.53	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			442.0	B08		3	0072-0155	469.56	155.29	230	58.77	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			301.9	B08		3	0073-0154	646.67	152.89	117	43.11	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.4	B08		3	0074-0160	722.52	160.55	319	75.50	0.703
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			309.5	B08		3	0075-0159	637.21	159.56	218	57.60	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			427.2	B08		3	0076-0159	779.82	159.08	225	56.28	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			367.9	B08		3	0077-0162	914.86	162.86	346	71.84	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			595.7	B08		3	0078-0167	815.28	167.59	368	75.60	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			363.5	B08		3	0079-0169	271.03	171.52	394	86.33	0.664
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			358.4	B08		3	0080-0168	751.03	167.95	468	85.15	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			442.6	B08		3	0081-0169	186.94	169.00	201	54.53	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			385.5	B08		3	0082-0167	695.55	166.22	183	51.94	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			432.7	B08		3	0083-0170	509.31	169.78	270	61.94	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			484.9	B08		3	0084-0175	838.62	175.55	367	82.08	0.684
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			434.2	B08		3	0085-0171	483.51	171.08	214	55.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			507.0	B08		3	0086-0172	684.74	173.33	136	44.53	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			343.3	B08		3	0087-0178	314.28	178.44	403	76.33	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			448.5	B08		3	0088-0177	66.17	177.18	206	53.70	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			431.5	B08		3	0089-0177	102.73	176.82	203	53.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			277.3	B08		3	0090-0179	253.70	178.90	239	63.60	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			392.1	B08		3	0091-0179	554.12	179.02	349	69.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			707.8	B08		3	0092-0179	444.19	179.66	221	53.11	0.984
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			423.2	B08		3	0093-0183	621.51	182.60	365	70.18	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			333.7	B08		3	0094-0185	210.48	185.09	250	60.18	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			351.3	B08		3	0095-0190	876.28	190.12	404	75.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			306.1	B08		3	0096-0188	297.16	188.57	244	58.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			1066.3	B08		3	0097-0188	370.51	188.18	292	67.60	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			633.3	B08		3	0098-0188	48.45	188.21	160	46.87	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			459.9	B08		3	0099-0191	339.92	191.37	276	61.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			465.9	B08		3	0100-0196	594.81	196.46	314	68.18	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			334.4	B08		3	0101-0199	914.47	198.34	298	66.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			303.1	B08		3	0102-0199	146.75	199.92	273	65.84	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.4	B08		3	0103-0202	173.10	202.21	303	65.84	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			429.6	B08		3	0104-0201	280.82	200.74	205	55.11	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			453.8	B08		3	0105-0203	402.51	203.32	287	61.94	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			581.8	B08		3	0106-0203	628.31	203.10	297	63.01	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			538.8	B08		3	0107-0204	366.33	204.23	184	51.11	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			338.5	B08		3	0108-0207	37.62	206.55	290	63.70	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			316.2	B08		3	0109-0207	893.74	207.76	249	60.43	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			341.6	B08		3	0110-0207	239.23	207.31	240	58.77	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.1	B08		3	0111-0208	948.07	208.67	267	60.43	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			464.4	B08		3	0112-0208	75.39	208.20	233	55.94	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			316.7	B08		3	0113-0209	551.99	209.65	257	59.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			374.2	B08		3	0114-0215	332.77	214.78	256	62.18	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			523.8	B08		3	0115-0220	115.19	220.15	386	74.43	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			392.3	B08		3	0116-0222	660.54	222.51	396	76.43	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.5	B08		3	0117-0219	850.80	219.39	168	53.36	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			369.9	B08		3	0118-0219	712.14	219.64	223	54.28	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.2	B08		3	0119-0221	286.32	222.07	258	61.01	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			334.8	B08		3	0120-0221	794.26	222.20	231	66.43	0.658
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			549.0	B08		3	0121-0224	354.14	224.73	337	69.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			685.1	B08		3	0122-0224	369.58	223.65	158	48.87	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			428.5	B08		3	0123-0227	613.88	227.23	233	58.28	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			477.2	B08		3	0124-0231	675.39	231.75	274	66.77	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			629.5	B08		3	0125-0237	219.89	236.54	310	68.18	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			334.0	B08		3	0126-0234	892.81	234.08	245	57.94	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			378.1	B08		3	0127-0238	828.42	238.70	314	66.18	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			318.9	B08		3	0128-0240	750.33	241.09	427	77.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			339.2	B08		3	0129-0243	411.02	244.58	306	68.18	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			411.5	B08		3	0130-0240	546.09	240.52	318	66.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			655.4	B08		3	0131-0244	566.82	244.27	300	64.18	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			422.4	B08		3	0132-0242	609.87	242.66	240	57.11	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			330.2	B08		3	0133-0246	923.15	246.57	256	64.18	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			290.8	B08		3	0134-0246	28.55	246.73	236	58.04	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			330.5	B08		3	0135-0247	204.55	247.05	275	63.94	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			284.9	B08		3	0136-0246	363.41	246.31	316	80.08	0.619
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			323.8	B08		3	0137-0249	494.35	248.84	250	59.26	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			330.2	B08		3	0138-0250	706.94	250.18	191	58.77	0.695
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			286.7	B08		3	0139-0256	100.15	256.98	240	66.53	0.681
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			399.1	B08		3	0140-0254	524.48	253.29	231	58.77	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.1	B08		3	0141-0252	723.12	252.69	191	51.11	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			414.3	B08		3	0142-0256	140.11	256.38	229	57.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			380.5	B08		3	0143-0257	158.04	257.32	212	57.36	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			353.7	B08		3	0144-0254	74.64	253.97	230	58.28	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			355.1	B08		3	0145-0256	307.56	255.86	206	54.28	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			336.3	B08		3	0146-0258	260.05	258.96	250	60.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			315.4	B08		3	0147-0265	589.80	263.58	278	65.94	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			326.0	B08		3	0148-0264	29.42	263.98	343	71.94	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			357.2	B08		3	0149-0269	464.95	269.24	284	64.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			440.8	B08		3	0150-0269	534.17	268.97	227	55.94	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			410.6	B08		3	0151-0271	775.21	271.35	302	65.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			354.7	B08		3	0152-0270	794.95	271.04	250	58.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			279.8	B08		3	0153-0275	631.78	274.75	307	69.60	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			301.2	B08		3	0154-0278	240.09	278.70	298	65.01	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			433.3	B08		3	0155-0278	841.64	278.32	175	52.18	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			230.3	B08		3	0156-0281	88.55	280.69	227	57.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			380.5	B08		3	0157-0279	735.63	279.66	312	67.01	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			505.4	B08		3	0158-0283	395.38	282.92	275	65.01	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			311.1	B08		3	0159-0286	274.36	287.66	322	67.60	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			361.8	B08		3	0160-0284	30.22	284.54	225	56.53	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.3	B08		3	0161-0286	122.17	287.01	279	63.60	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			771.0	B08		3	0162-0291	459.86	291.26	412	79.26	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			454.2	B08		3	0163-0287	941.61	287.60	362	71.60	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			387.0	B08		3	0164-0287	359.90	286.65	248	65.26	0.732
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			338.3	B08		3	0165-0289	160.78	289.29	255	58.53	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			365.4	B08		3	0166-0289	181.17	289.44	248	59.36	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			516.7	B08		3	0167-0292	833.48	292.34	404	76.67	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			385.9	B08		3	0168-0290	660.97	290.34	213	55.11	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			326.3	B08		3	0169-0292	813.19	291.83	258	64.18	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			332.9	B08		3	0170-0296	420.18	296.51	238	58.28	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			289.4	B08		3	0171-0295	676.56	294.96	235	58.28	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			430.8	B08		3	0172-0301	925.83	300.69	304	66.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			393.8	B08		3	0173-0301	883.05	301.44	343	68.43	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			479.2	B08		3	0174-0301	219.00	301.60	201	56.18	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			366.0	B08		3	0175-0309	106.17	309.78	331	67.84	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			283.9	B08		3	0176-0311	136.06	311.08	235	57.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.0	B08		3	0177-0315	459.87	315.36	306	67.84	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			437.6	B08		3	0178-0315	584.40	314.75	368	70.53	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			427.1	B08		3	0179-0316	734.41	316.36	369	73.84	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			353.9	B08		3	0180-0316	187.10	316.32	224	54.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			389.2	B08		3	0181-0318	254.15	318.24	231	57.94	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			284.2	B08		3	0182-0318	651.34	318.24	294	63.94	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			362.7	B08		3	0183-0323	410.89	322.62	364	73.84	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			596.3	B08		3	0184-0329	875.26	329.64	266	60.18	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			409.6	B08		3	0185-0328	286.92	328.69	215	53.70	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			279.0	B08		3	0186-0335	804.34	336.40	317	70.67	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			667.0	B08		3	0187-0334	360.46	334.07	193	51.11	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			390.7	B08		3	0188-0335	387.43	335.21	269	61.36	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.6	B08		3	0189-0335	536.82	335.92	294	64.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			501.7	B08		3	0190-0335	204.81	335.14	228	55.11	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			421.2	B08		3	0191-0338	650.73	337.72	323	67.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			382.7	B08		3	0192-0339	346.72	339.63	174	52.28	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			484.2	B08		3	0193-0341	725.24	341.64	215	54.28	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			498.6	B08		3	0194-0346	243.63	345.99	277	63.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.4	B08		3	0195-0345	317.67	345.39	210	58.77	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			319.5	B08		3	0196-0343	107.28	343.76	273	64.18	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			283.5	B08		3	0197-0344	608.80	343.82	285	64.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			390.3	B08		3	0198-0353	291.95	352.69	379	72.43	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			381.4	B08		3	0199-0354	331.61	354.07	229	56.87	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			358.3	B08		3	0200-0355	425.40	355.58	273	62.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			345.3	B08		3	0201-0355	828.37	355.45	372	72.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			846.1	B08		3	0202-0356	19.52	356.46	186	52.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			310.1	B08		3	0203-0358	179.96	357.71	224	55.70	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			379.9	B08		3	0204-0356	347.30	355.98	226	56.87	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			378.9	B08		3	0205-0356	452.60	356.90	253	59.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			349.0	B08		3	0206-0359	402.75	359.21	322	65.94	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			312.4	B08		3	0207-0355	684.95	355.37	203	55.70	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			290.0	B08		3	0208-0357	483.80	358.09	169	51.11	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			608.3	B08		3	0209-0358	112.39	358.32	148	45.46	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			315.4	B08		3	0210-0367	589.51	368.23	600	167.82	0.268
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			456.3	B08		3	0211-0365	513.79	364.74	343	70.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			364.9	B08		3	0212-0362	928.13	361.92	149	49.70	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			285.1	B08		3	0213-0365	165.18	365.39	230	59.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			291.5	B08		3	0214-0369	26.07	370.68	286	71.01	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			354.4	B08		3	0215-0367	315.45	367.37	307	66.43	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			479.7	B08		3	0216-0367	651.27	367.38	319	68.18	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			356.8	B08		3	0217-0371	910.25	370.76	309	70.43	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			435.8	B08		3	0218-0371	875.06	370.77	305	66.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			304.5	B08		3	0219-0371	374.83	371.79	255	60.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			369.2	B08		3	0220-0374	263.29	374.75	348	71.26	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			427.5	B08		3	0221-0377	712.73	377.14	273	63.36	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			295.1	B08		3	0222-0379	762.43	379.09	281	65.01	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			342.0	B08		3	0223-0379	841.85	379.72	226	58.77	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			291.6	B08		3	0224-0379	147.84	379.00	276	64.77	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.0	B08		3	0225-0383	54.65	383.69	298	68.18	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			403.9	B08		3	0226-0382	546.20	382.45	304	65.36	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			371.0	B08		3	0227-0383	352.41	382.21	226	57.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			403.5	B08		3	0228-0382	503.03	382.35	258	60.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.3	B08		3	0229-0382	89.21	382.66	219	53.70	0.954
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			369.0	B08		3	0230-0384	103.89	384.05	200	57.11	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			495.6	B08		3	0231-0384	685.58	384.47	259	60.28	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			389.6	B08		3	0232-0389	133.82	389.88	204	54.18	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			328.5	B08		3	0233-0392	335.87	392.05	229	61.11	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			329.4	B08		3	0234-0397	943.98	397.69	349	70.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			252.0	B08		3	0235-0396	248.74	396.06	266	64.77	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			356.4	B08		3	0236-0399	358.81	399.31	264	63.01	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			283.0	B08		3	0237-0396	400.64	395.69	284	70.77	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			392.1	B08		3	0238-0401	869.31	401.46	353	70.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			533.4	B08		3	0239-0399	477.95	398.80	152	47.46	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			593.9	B08		3	0240-0400	688.60	398.59	162	49.70	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.2	B08		3	0241-0409	450.59	409.76	472	81.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			595.0	B08		3	0242-0406	677.98	406.95	201	54.43	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.7	B08		3	0243-0410	59.30	410.76	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.7	B08		3	0244-0410	326.43	410.31	290	64.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			273.1	B08		3	0245-0411	187.48	411.62	229	59.01	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			397.8	B08		3	0246-0411	814.94	410.92	258	64.18	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			357.7	B08		3	0247-0413	918.78	412.65	255	61.01	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			495.9	B08		3	0248-0420	645.90	419.43	683	107.30	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			354.8	B08		3	0249-0418	594.22	418.68	419	80.33	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.3	B08		3	0250-0418	709.45	418.12	500	89.98	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			202.8	B08		3	0251-0416	20.37	415.64	244	59.36	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			340.0	B08		3	0252-0418	237.53	417.22	230	59.01	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.3	B08		3	0253-0418	369.35	417.47	296	64.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			304.3	B08		3	0254-0418	210.59	417.84	204	54.77	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			284.0	B08		3	0255-0419	164.81	418.96	326	69.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			473.2	B08		3	0256-0421	283.97	421.68	294	63.01	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			314.1	B08		3	0257-0425	308.25	424.38	257	60.53	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			366.5	B08		3	0258-0428	786.09	428.42	228	56.77	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			356.7	B08		3	0259-0425	862.34	425.22	116	41.21	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			375.2	B08		3	0260-0432	503.87	432.37	225	59.60	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			277.1	B08		3	0261-0435	408.07	435.04	291	69.60	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			305.7	B08		3	0262-0437	862.54	437.07	128	41.80	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			345.1	B08		3	0263-0442	807.62	442.76	329	75.26	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.4	B08		3	0264-0443	888.83	442.33	332	69.26	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			423.4	B08		3	0265-0443	531.39	443.83	328	67.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.4	B08		3	0266-0450	31.80	450.55	432	79.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.3	B08		3	0267-0449	933.81	450.02	256	61.11	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			273.8	B08		3	0268-0451	72.30	451.27	263	62.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			466.5	B08		3	0269-0453	371.01	453.85	319	68.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			346.0	B08		3	0270-0451	699.44	451.53	254	59.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.5	B08		3	0271-0455	185.28	455.49	283	65.01	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			210.3	B08		3	0272-0453	247.81	453.68	216	55.11	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.5	B08		3	0273-0455	748.33	454.75	174	50.63	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.2	B08		3	0274-0454	759.92	453.92	166	49.80	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			448.2	B08		3	0275-0454	508.66	454.74	219	59.36	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			786.4	B08		3	0276-0459	681.14	458.94	406	74.67	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			305.5	B08		3	0277-0458	140.86	458.00	306	64.77	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			287.7	B08		3	0278-0458	447.06	457.61	270	62.18	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			348.3	B08		3	0279-0458	311.78	458.48	236	58.18	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			382.2	B08		3	0280-0461	92.82	461.21	289	63.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			331.4	B08		3	0281-0466	276.12	465.89	268	62.77	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			364.1	B08		3	0282-0466	422.12	466.59	247	57.94	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.3	B08		3	0283-0469	324.75	469.28	258	60.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			307.4	B08		3	0284-0469	295.54	469.85	274	61.94	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			316.0	B08		3	0285-0473	383.72	473.38	260	61.01	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			311.2	B08		3	0286-0472	836.60	472.36	236	57.11	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			352.0	B08		3	0287-0476	177.39	476.77	357	72.33	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			303.3	B08		3	0288-0474	697.65	474.06	246	57.94	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			534.6	B08		3	0289-0476	722.76	476.66	332	68.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			294.5	B08		3	0290-0475	259.18	475.33	251	59.70	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			291.1	B08		3	0291-0478	204.42	479.05	212	56.77	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			332.1	B08		3	0292-0480	771.22	479.94	365	75.01	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.0	B08		3	0293-0480	363.30	480.13	231	56.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			357.3	B08		3	0294-0480	560.68	479.96	209	59.46	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			368.2	B08		3	0295-0484	501.01	484.07	285	62.53	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			313.5	B08		3	0296-0487	51.52	486.82	251	61.70	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			349.0	B08		3	0297-0486	616.39	487.05	226	56.53	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			400.3	B08		3	0298-0487	342.67	487.35	238	57.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			325.9	B08		3	0299-0488	826.68	488.29	293	62.77	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			402.9	B08		3	0300-0490	596.29	489.20	265	63.60	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			397.9	B08		3	0301-0495	558.65	494.36	331	69.94	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			551.6	B08		3	0302-0502	582.49	500.85	221	60.77	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			294.0	B08		3	0303-0500	808.99	500.75	139	45.70	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.1	B08		3	0304-0506	271.95	507.29	292	65.36	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			447.9	B08		3	0305-0506	197.87	506.15	325	67.94	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			353.7	B08		3	0306-0504	326.24	504.30	201	54.53	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			474.3	B08		3	0307-0506	749.41	506.57	218	54.87	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			412.6	B08		3	0308-0512	233.99	511.86	404	77.84	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			325.3	B08		3	0309-0508	309.33	507.70	254	59.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			396.0	B08		3	0310-0512	409.95	512.07	328	68.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			371.8	B08		3	0311-0512	920.21	511.04	368	74.43	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.4	B08		3	0312-0511	945.71	510.79	299	69.01	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			364.2	B08		3	0313-0513	162.91	512.93	234	55.70	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			302.9	B08		3	0314-0519	641.88	518.69	471	82.08	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.1	B08		3	0315-0518	433.87	518.13	300	65.60	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			277.6	B08		3	0316-0515	807.92	515.37	204	53.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			314.5	B08		3	0317-0516	879.29	515.82	275	62.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			351.5	B08		3	0318-0520	468.34	519.83	387	74.18	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			268.3	B08		3	0319-0525	92.32	525.27	242	61.94	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			371.7	B08		3	0320-0528	892.42	527.57	242	59.94	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			381.4	B08		3	0321-0534	563.20	534.52	290	64.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			425.3	B08		3	0322-0538	930.82	537.99	358	70.43	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.2	B08		3	0323-0544	338.86	544.18	447	80.08	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			371.9	B08		3	0324-0543	615.93	543.94	313	68.87	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			326.5	B08		3	0325-0545	291.44	545.26	385	74.91	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			389.1	B08		3	0326-0543	687.91	543.10	258	62.43	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			264.8	B08		3	0327-0542	802.99	542.92	224	57.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			335.5	B08		3	0328-0547	65.80	547.79	283	70.53	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			341.4	B08		3	0329-0545	519.42	545.54	393	73.26	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			312.9	B08		3	0330-0548	752.79	547.78	327	67.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			295.1	B08		3	0331-0547	817.45	547.43	200	54.28	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			290.0	B08		3	0332-0555	168.11	555.12	253	58.53	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			400.0	B08		3	0333-0554	206.92	554.21	165	48.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			409.1	B08		3	0334-0557	241.60	557.24	219	55.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			420.9	B08		3	0335-0558	680.32	558.84	172	50.04	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			406.1	B08		3	0336-0560	260.65	560.75	258	60.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.6	B08		3	0337-0560	437.42	560.49	282	66.18	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			348.7	B08		3	0338-0561	383.72	561.24	199	52.28	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.3	B08		3	0339-0564	908.31	563.81	257	60.77	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			452.1	B08		3	0340-0563	362.71	562.57	209	53.11	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			336.9	B08		3	0341-0565	113.81	566.31	220	55.70	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.7	B08		3	0342-0563	560.33	563.84	161	49.21	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			520.5	B08		3	0343-0574	707.12	574.45	382	76.18	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			310.6	B08		3	0344-0567	729.32	567.42	211	56.87	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.5	B08		3	0345-0577	307.82	577.16	266	66.18	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			331.4	B08		3	0346-0574	484.36	573.74	284	64.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.9	B08		3	0347-0578	839.35	579.04	248	60.53	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.0	B08		3	0348-0574	557.43	574.80	134	51.70	0.630
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			366.0	B08		3	0349-0579	81.38	579.01	225	56.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			335.8	B08		3	0350-0583	166.37	583.62	332	67.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			384.3	B08		3	0351-0583	187.26	583.22	278	61.46	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			317.1	B08		3	0352-0587	388.61	587.01	346	70.91	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			296.7	B08		3	0353-0587	584.27	587.10	318	81.50	0.602
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			479.0	B08		3	0354-0584	877.49	584.68	133	42.87	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			305.7	B08		3	0355-0588	898.46	588.43	311	67.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.5	B08		3	0356-0589	350.30	589.33	209	55.94	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			432.3	B08		3	0357-0588	862.60	588.17	134	44.28	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.0	B08		3	0358-0597	844.23	597.76	370	74.67	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			459.1	B08		3	0359-0594	253.57	593.03	169	49.36	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.2	B08		3	0360-0595	633.32	595.37	269	61.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			270.7	B08		3	0361-0598	524.68	598.04	293	62.77	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			334.8	B08		3	0362-0599	764.00	599.49	279	73.50	0.649
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			304.2	B08		3	0363-0604	126.58	605.15	339	68.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			494.7	B08		3	0364-0601	263.36	601.01	180	52.77	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.4	B08		3	0365-0605	322.60	606.03	261	62.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.3	B08		3	0366-0602	426.77	602.43	267	62.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			432.9	B08		3	0367-0605	554.18	605.19	350	68.18	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			440.6	B08		3	0368-0603	687.74	604.19	132	42.39	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			370.2	B08		3	0369-0607	616.33	606.87	234	59.84	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			322.3	B08		3	0370-0609	487.93	608.84	297	66.43	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			330.5	B08		3	0371-0608	936.57	607.73	257	64.77	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.4	B08		3	0372-0614	411.37	614.44	324	66.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			257.7	B08		3	0373-0613	439.78	613.99	280	63.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			340.2	B08		3	0374-0611	721.30	611.18	193	58.77	0.702
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			312.2	B08		3	0375-0615	30.94	616.00	225	55.36	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			301.7	B08		3	0376-0618	339.28	617.59	279	61.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			325.6	B08		3	0377-0620	63.06	620.52	228	58.53	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			529.0	B08		3	0378-0621	692.34	620.81	285	66.53	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			372.6	B08		3	0379-0621	883.29	620.36	279	63.11	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			385.4	B08		3	0380-0623	179.48	623.20	323	67.01	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			339.2	B08		3	0381-0621	232.61	622.39	272	61.11	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			273.1	B08		3	0382-0622	299.86	622.00	314	67.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			547.7	B08		3	0383-0621	263.45	621.84	183	52.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			393.4	B08		3	0384-0624	603.64	624.42	363	71.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			307.0	B08		3	0385-0625	751.75	625.19	266	63.11	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			391.0	B08		3	0386-0628	812.46	628.17	378	73.01	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			332.7	B08		3	0387-0628	276.37	628.67	229	57.70	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			680.8	B08		3	0388-0628	556.75	628.93	195	53.46	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.7	B08		3	0389-0637	876.35	637.96	295	68.43	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			315.6	B08		3	0390-0637	771.26	636.84	209	55.70	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			287.7	B08		3	0391-0639	114.14	640.11	204	52.87	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			308.2	B08		3	0392-0642	350.54	642.19	281	64.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			630.9	B08		3	0393-0640	514.81	640.74	269	61.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.9	B08		3	0394-0643	895.73	643.48	375	73.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			313.8	B08		3	0395-0642	204.93	642.22	248	60.18	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			358.1	B08		3	0396-0640	164.94	640.47	181	51.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			552.9	B08		3	0397-0642	556.40	641.47	162	48.63	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			268.2	B08		3	0398-0648	659.03	648.60	327	66.18	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			46799.4	B08		3	0399-0653	247.53	653.51	371	75.01	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.6	B08		3	0400-0654	388.11	654.36	401	76.43	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			404.6	B08		3	0401-0651	946.17	650.54	275	62.53	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			224.7	B08		3	0402-0656	425.26	656.70	372	71.60	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			344.3	B08		3	0403-0657	713.38	657.91	343	69.26	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			308.3	B08		3	0404-0661	108.19	660.40	327	71.36	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			303.2	B08		3	0405-0660	620.19	659.78	295	64.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			351.8	B08		3	0406-0660	553.77	659.85	269	60.53	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.3	B08		3	0407-0660	898.74	660.46	275	66.18	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			287.7	B08		3	0408-0661	175.78	660.96	239	61.60	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.9	B08		3	0409-0663	830.21	663.20	256	62.18	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.6	B08		3	0410-0663	806.27	663.94	252	60.53	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			298.0	B08		3	0411-0669	321.28	668.18	225	57.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			348.0	B08		3	0412-0674	687.29	674.80	384	75.50	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			198.7	B08		3	0413-0673	473.43	673.39	270	61.11	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			317.5	B08		3	0414-0674	732.78	674.35	260	59.11	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.2	B08		3	0415-0675	339.94	674.90	231	57.36	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.1	B08		3	0416-0680	911.95	680.09	390	111.88	0.392
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			394.7	B08		3	0417-0678	44.44	677.83	235	60.43	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			341.2	B08		3	0418-0681	448.52	681.25	260	61.36	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			420.5	B08		3	0419-0681	250.43	681.15	231	56.53	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			252.9	B08		3	0420-0682	310.84	682.87	248	58.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			401.3	B08		3	0421-0681	600.75	681.92	187	55.46	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			456.2	B08		3	0422-0682	392.98	682.79	147	46.63	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.3	B08		3	0423-0691	70.94	690.67	280	73.84	0.645
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.0	B08		3	0424-0686	842.30	686.28	245	59.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.0	B08		3	0425-0688	171.82	688.70	240	58.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			328.7	B08		3	0426-0691	568.47	691.37	235	62.77	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			399.8	B08		3	0427-0690	817.05	690.09	266	62.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			192.4	B08		3	0428-0693	204.94	693.32	427	79.84	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			516.7	B08		3	0429-0690	520.23	689.89	241	58.53	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.0	B08		3	0430-0695	880.75	694.32	235	59.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			308.4	B08		3	0431-0696	240.36	695.66	237	57.60	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			334.1	B08		3	0432-0695	294.42	694.86	346	69.94	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			864.1	B08		3	0433-0699	599.55	698.54	340	85.01	0.591
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			221.3	B08		3	0434-0697	389.64	697.22	344	71.84	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			219.8	B08		3	0435-0698	119.26	699.23	252	61.26	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			228.2	B08		3	0436-0707	31.70	707.18	300	66.08	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			281.0	B08		3	0437-0708	278.88	708.13	245	57.94	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			386.7	B08		4	0001-0025	601.39	24.22	237	57.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			285.6	B08		4	0002-0026	295.33	26.23	228	57.11	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			337.6	B08		4	0003-0028	414.67	27.91	247	60.53	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			693.4	B08		4	0004-0028	250.53	27.82	319	67.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			666.3	B08		4	0005-0032	338.83	32.81	380	77.84	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			304.0	B08		4	0006-0030	90.85	30.14	263	62.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.8	B08		4	0007-0032	119.56	31.29	266	64.53	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			235.5	B08		4	0008-0032	639.87	33.10	275	62.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			695.7	B08		4	0009-0033	706.63	33.30	326	67.26	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			490.6	B08		4	0010-0027	902.79	26.86	134	46.28	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			365.4	B08		4	0011-0036	37.02	36.05	423	77.26	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			379.1	B08		4	0012-0036	864.18	36.52	334	67.01	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			560.4	B08		4	0013-0036	912.23	36.29	173	49.46	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			421.9	B08		4	0014-0037	930.80	36.59	178	52.28	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			235.7	B08		4	0015-0043	677.40	43.66	298	68.08	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.3	B08		4	0016-0045	301.85	45.54	255	63.01	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			514.6	B08		4	0017-0051	613.77	48.86	342	82.91	0.625
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			298.9	B08		4	0018-0051	75.69	51.44	486	82.08	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			321.7	B08		4	0019-0048	478.80	47.48	271	66.18	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			314.0	B08		4	0020-0047	936.14	47.06	211	59.36	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			417.0	B08		4	0021-0050	401.86	49.78	218	54.53	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			325.4	B08		4	0022-0050	219.40	49.85	318	68.18	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			327.3	B08		4	0023-0058	740.53	58.83	424	78.57	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			335.1	B08		4	0024-0055	14.62	55.08	250	63.36	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.4	B08		4	0025-0056	524.41	56.31	353	71.26	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			308.5	B08		4	0026-0058	888.84	59.06	392	75.01	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			30479.6	B08		4	0027-0060	161.25	60.71	268	70.18	0.684
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			305.6	B08		4	0028-0058	312.75	57.64	272	62.53	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			380.7	B08		4	0029-0060	712.81	59.97	208	60.18	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			293.8	B08		4	0030-0062	766.83	63.27	211	54.87	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			362.9	B08		4	0031-0067	475.75	67.22	283	62.28	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			304.8	B08		4	0032-0069	538.58	69.33	492	86.33	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			341.6	B08		4	0033-0067	812.44	67.35	244	59.01	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			259.2	B08		4	0034-0078	318.23	77.48	282	65.01	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			398.7	B08		4	0035-0080	447.27	80.88	269	61.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			294.2	B08		4	0036-0083	227.30	83.62	238	57.70	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			343.3	B08		4	0037-0088	414.50	87.90	319	68.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			291.9	B08		4	0038-0090	269.16	90.06	247	59.70	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			349.4	B08		4	0039-0091	381.61	91.52	302	64.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.7	B08		4	0040-0094	159.26	95.10	397	74.08	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.8	B08		4	0041-0092	54.99	92.34	244	59.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			38838.7	B08		4	0042-0093	914.93	93.62	295	64.53	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			402.8	B08		4	0043-0097	678.35	97.15	251	59.94	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.5	B08		4	0044-0100	209.86	100.34	241	57.11	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			337.1	B08		4	0045-0106	848.60	106.41	340	68.77	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.7	B08		4	0046-0104	798.65	103.91	138	47.21	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.5	B08		4	0047-0104	810.06	105.10	155	47.21	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			308.7	B08		4	0048-0109	245.63	109.06	236	56.53	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			293.6	B08		4	0049-0113	274.94	112.69	293	69.26	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			316.5	B08		4	0050-0111	326.72	110.87	297	65.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			311.5	B08		4	0051-0119	62.82	119.71	273	61.60	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			358.3	B08		4	0052-0123	742.79	123.25	327	67.94	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			333.1	B08		4	0053-0130	181.11	130.31	271	64.77	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			351.4	B08		4	0054-0129	601.27	129.58	255	63.60	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			26954.4	B08		4	0055-0131	483.49	131.95	328	116.47	0.304
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.5	B08		4	0056-0131	714.45	131.62	301	67.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			318.6	B08		4	0057-0133	237.78	133.58	318	66.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			335.6	B08		4	0058-0134	84.87	133.92	219	55.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			393.2	B08		4	0059-0139	381.43	139.74	258	60.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			379.1	B08		4	0060-0141	350.79	140.88	431	83.84	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			603.0	B08		4	0061-0143	205.07	142.99	327	77.50	0.684
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.3	B08		4	0062-0141	302.22	141.46	315	73.60	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			319.0	B08		4	0063-0146	540.29	146.95	291	68.77	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			323.0	B08		4	0064-0146	578.61	146.38	219	60.53	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			414.8	B08		4	0065-0146	858.94	145.96	342	69.26	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			384.0	B08		4	0066-0146	610.35	145.78	215	53.46	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			368.4	B08		4	0067-0146	690.83	146.41	168	48.63	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			332.1	B08		4	0068-0154	145.03	154.58	440	78.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			431.4	B08		4	0069-0150	766.39	150.31	307	64.18	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			360.0	B08		4	0070-0149	434.55	149.47	229	58.28	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.6	B08		4	0071-0150	941.52	150.18	274	63.11	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			299.8	B08		4	0072-0152	63.41	152.90	231	58.43	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			287.7	B08		4	0073-0154	235.64	154.02	260	59.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			259.6	B08		4	0074-0156	501.76	155.35	336	70.67	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			345.4	B08		4	0075-0157	85.02	157.84	241	57.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			472.6	B08		4	0076-0158	632.22	157.63	165	47.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			407.3	B08		4	0077-0159	100.79	159.94	187	50.63	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			369.5	B08		4	0078-0160	656.24	160.82	256	62.77	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.8	B08		4	0079-0170	22.33	169.11	241	60.28	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			346.3	B08		4	0080-0178	791.21	178.94	515	84.91	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			324.1	B08		4	0081-0181	448.03	180.50	247	63.26	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.8	B08		4	0082-0182	233.32	181.46	300	68.18	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			318.8	B08		4	0083-0180	310.78	180.92	232	56.28	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			315.2	B08		4	0084-0185	70.87	183.78	239	60.77	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			393.5	B08		4	0085-0186	549.29	186.57	365	70.67	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.3	B08		4	0086-0189	897.78	188.80	401	76.08	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			356.3	B08		4	0087-0189	670.54	188.33	240	58.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			399.3	B08		4	0088-0192	286.83	192.36	336	70.08	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			402.2	B08		4	0089-0193	616.47	193.71	205	55.11	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			342.3	B08		4	0090-0199	343.20	198.44	387	74.91	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			294.3	B08		4	0091-0197	474.47	197.98	279	62.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			463.7	B08		4	0092-0200	270.94	200.21	198	54.53	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			368.5	B08		4	0093-0201	515.72	200.27	291	64.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			270.6	B08		4	0094-0203	936.46	203.12	246	60.43	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.3	B08		4	0095-0209	22.00	209.14	321	76.18	0.695
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			808.7	B08		4	0096-0205	578.42	204.94	380	71.36	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			400.7	B08		4	0097-0203	380.38	202.68	222	56.28	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			425.0	B08		4	0098-0204	131.18	204.17	215	55.94	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.3	B08		4	0099-0207	617.57	207.58	247	61.70	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			518.5	B08		4	0100-0214	706.96	213.52	297	64.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			462.1	B08		4	0101-0217	272.55	216.54	216	59.36	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.2	B08		4	0102-0218	120.50	218.74	275	64.53	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			376.4	B08		4	0103-0223	558.63	223.58	465	84.08	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			364.1	B08		4	0104-0220	86.17	220.59	199	52.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			391.9	B08		4	0105-0222	632.34	222.35	268	62.43	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			334.8	B08		4	0106-0223	422.80	223.32	251	59.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			333.8	B08		4	0107-0228	60.11	227.98	256	60.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			341.5	B08		4	0108-0226	587.53	226.41	257	59.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			374.6	B08		4	0109-0228	479.79	228.88	256	63.01	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.2	B08		4	0110-0231	242.52	231.78	371	74.18	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			451.5	B08		4	0111-0231	454.26	230.39	231	55.70	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			409.6	B08		4	0112-0240	795.06	239.85	337	68.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			426.4	B08		4	0113-0239	370.73	238.64	297	64.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			620.2	B08		4	0114-0238	395.07	237.47	198	53.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			383.4	B08		4	0115-0238	31.13	238.21	231	57.36	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			339.2	B08		4	0116-0243	163.34	243.94	364	71.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			482.7	B08		4	0117-0242	542.80	242.93	185	55.46	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			1125.1	B08		4	0118-0243	855.25	243.75	187	51.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			569.8	B08		4	0119-0246	261.20	246.46	213	54.53	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			433.1	B08		4	0120-0247	506.41	247.48	233	56.28	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			407.4	B08		4	0121-0253	424.23	252.69	261	61.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			363.7	B08		4	0122-0257	16.82	256.93	287	63.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			387.3	B08		4	0123-0259	587.93	260.00	252	65.01	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			40559.5	B08		4	0124-0255	869.18	255.90	154	73.74	0.356
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			412.9	B08		4	0125-0257	549.07	256.53	179	52.53	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			514.4	B08		4	0126-0259	820.99	259.13	215	56.53	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.2	B08		4	0127-0263	896.26	264.51	303	67.60	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			340.6	B08		4	0128-0265	370.12	264.64	226	55.70	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			285.4	B08		4	0129-0272	749.01	271.91	526	86.91	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			354.8	B08		4	0130-0270	108.85	270.49	342	69.60	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			411.1	B08		4	0131-0264	258.33	264.53	181	49.46	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			774.1	B08		4	0132-0268	199.78	268.16	272	61.36	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			501.9	B08		4	0133-0266	434.03	266.36	181	50.04	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			422.8	B08		4	0134-0270	132.52	270.68	237	57.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			786.5	B08		4	0135-0272	383.11	270.73	158	51.11	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			369.3	B08		4	0136-0275	601.91	274.79	252	59.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			428.4	B08		4	0137-0278	569.84	278.36	308	65.26	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			368.8	B08		4	0138-0278	50.14	278.38	250	59.11	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			304.5	B08		4	0139-0278	214.25	278.96	272	61.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			612.5	B08		4	0140-0278	396.04	277.77	240	59.60	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			409.3	B08		4	0141-0279	414.23	279.20	221	57.36	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			329.6	B08		4	0142-0287	479.47	286.64	258	61.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			337.0	B08		4	0143-0291	253.75	291.05	235	60.53	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			406.3	B08		4	0144-0290	556.80	290.27	231	61.01	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			301.8	B08		4	0145-0292	804.57	291.33	267	67.94	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			349.1	B08		4	0146-0293	833.47	292.81	236	57.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			629.7	B08		4	0147-0290	116.51	290.99	150	46.87	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			478.0	B08		4	0148-0291	134.88	291.50	224	54.28	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			333.6	B08		4	0149-0295	170.41	295.48	256	59.36	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			688.8	B08		4	0150-0300	79.90	299.71	377	73.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			327.8	B08		4	0151-0297	340.36	297.42	224	65.01	0.666
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			352.6	B08		4	0152-0306	848.96	306.04	363	70.43	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			435.3	B08		4	0153-0305	580.13	305.85	263	61.60	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			299.9	B08		4	0154-0306	266.38	306.65	255	63.70	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			415.1	B08		4	0155-0304	426.22	304.47	293	70.28	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			348.0	B08		4	0156-0308	771.97	308.78	268	61.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.8	B08		4	0157-0310	701.07	310.10	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			330.4	B08		4	0158-0314	241.79	314.07	223	55.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			407.5	B08		4	0159-0318	864.87	318.80	329	69.84	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			453.7	B08		4	0160-0316	426.73	316.36	194	54.87	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.7	B08		4	0161-0320	304.77	321.14	227	56.28	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			462.1	B08		4	0162-0327	383.06	326.66	361	74.53	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			645.1	B08		4	0163-0332	509.64	331.99	402	77.50	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			273.3	B08		4	0164-0335	204.03	334.75	270	60.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			334.6	B08		4	0165-0344	355.36	343.79	402	75.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			461.6	B08		4	0166-0339	57.70	339.44	229	57.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			418.3	B08		4	0167-0345	257.77	345.48	367	71.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			394.7	B08		4	0168-0348	683.97	347.91	269	62.18	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.8	B08		4	0169-0349	923.36	349.53	318	67.01	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			322.7	B08		4	0170-0350	306.71	349.98	262	60.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			427.4	B08		4	0171-0349	798.73	349.42	249	64.18	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			455.8	B08		4	0172-0354	856.66	353.38	287	62.43	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			385.5	B08		4	0173-0354	27.62	354.81	251	69.84	0.647
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			383.7	B08		4	0174-0361	69.30	360.62	363	70.77	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			393.5	B08		4	0175-0361	794.64	361.10	169	49.70	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			430.4	B08		4	0176-0366	871.02	366.20	355	72.18	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			465.1	B08		4	0177-0369	145.55	369.24	223	55.11	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			295.3	B08		4	0178-0381	287.82	381.21	479	88.33	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			308.8	B08		4	0179-0378	334.49	378.08	223	57.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			299.8	B08		4	0180-0384	670.09	383.67	289	64.18	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			374.5	B08		4	0181-0383	851.40	383.37	236	57.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.0	B08		4	0182-0383	917.72	383.24	299	64.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			576.5	B08		4	0183-0386	576.32	386.15	240	59.84	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			654.9	B08		4	0184-0387	418.73	387.11	311	64.18	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			576.2	B08		4	0185-0390	124.30	390.25	186	53.36	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.1	B08		4	0186-0394	365.20	394.49	281	66.67	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			369.5	B08		4	0187-0391	494.81	391.49	250	62.18	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			441.8	B08		4	0188-0398	183.49	398.08	301	66.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			528.3	B08		4	0189-0400	98.22	399.80	254	77.84	0.527
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			463.8	B08		4	0190-0400	135.37	401.02	223	54.77	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			395.5	B08		4	0191-0405	156.03	405.04	308	66.43	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			915.8	B08		4	0192-0408	821.50	408.19	249	62.77	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			523.7	B08		4	0193-0411	614.01	410.08	287	65.01	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			498.7	B08		4	0194-0410	649.13	410.07	302	67.01	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			20223.5	B08		4	0195-0417	395.36	417.62	367	72.67	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			314.4	B08		4	0196-0415	479.20	415.09	240	58.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			350.7	B08		4	0197-0416	556.77	415.96	302	66.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			337.6	B08		4	0198-0417	942.83	416.70	256	59.11	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			291.0	B08		4	0199-0419	913.28	418.81	232	57.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			306.3	B08		4	0200-0427	43.01	427.15	337	67.36	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			358.3	B08		4	0201-0426	245.01	425.35	253	63.36	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			611.1	B08		4	0202-0432	322.69	431.90	417	78.08	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			371.0	B08		4	0203-0430	351.01	431.03	219	58.53	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			312.4	B08		4	0204-0437	619.88	438.32	364	82.43	0.673
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			289.6	B08		4	0205-0437	93.59	437.36	451	82.08	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			318.4	B08		4	0206-0436	698.93	436.19	371	71.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			379.1	B08		4	0207-0440	172.17	439.91	341	68.18	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			287.2	B08		4	0208-0441	829.11	440.75	250	61.11	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			430.9	B08		4	0209-0443	796.47	444.09	188	50.53	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			283.8	B08		4	0210-0449	400.15	449.28	231	57.11	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			316.4	B08		4	0211-0454	763.35	453.28	232	57.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.9	B08		4	0212-0458	906.67	457.70	363	71.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			476.1	B08		4	0213-0460	423.06	460.13	251	60.28	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			317.2	B08		4	0214-0461	634.10	461.13	243	57.11	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.7	B08		4	0215-0463	862.53	463.11	269	61.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			326.4	B08		4	0216-0465	240.80	466.18	243	59.60	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			313.4	B08		4	0217-0464	500.68	464.47	268	60.87	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			509.3	B08		4	0218-0465	736.76	464.94	140	46.04	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.3	B08		4	0219-0467	924.68	467.49	402	74.18	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			404.3	B08		4	0220-0465	106.92	465.57	237	58.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			301.6	B08		4	0221-0473	551.33	473.05	269	63.94	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			1479.5	B08		4	0222-0466	748.72	466.50	110	38.63	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			476.0	B08		4	0223-0472	41.64	471.90	337	70.43	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			494.4	B08		4	0224-0474	434.46	474.20	297	66.77	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			544.9	B08		4	0225-0476	573.17	476.07	272	62.53	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			353.8	B08		4	0226-0478	296.05	477.74	264	63.26	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			418.0	B08		4	0227-0477	587.41	477.46	213	54.63	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			368.5	B08		4	0228-0477	624.85	477.87	249	57.36	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.6	B08		4	0229-0478	773.47	478.74	248	62.43	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			498.1	B08		4	0230-0479	751.17	479.18	167	47.11	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.7	B08		4	0231-0481	825.06	480.57	285	64.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.7	B08		4	0232-0485	189.56	485.76	327	69.60	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			341.8	B08		4	0233-0485	165.66	485.49	220	53.94	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			372.4	B08		4	0234-0487	331.71	486.88	242	60.28	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			316.6	B08		4	0235-0487	404.26	487.00	244	60.53	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			362.1	B08		4	0236-0489	876.92	489.21	241	57.11	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			333.4	B08		4	0237-0487	97.63	488.05	206	58.53	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.0	B08		4	0238-0491	603.73	490.85	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			317.3	B08		4	0239-0491	674.89	490.66	282	62.43	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			331.5	B08		4	0240-0491	378.68	492.19	243	59.11	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			436.6	B08		4	0241-0496	123.05	495.88	287	63.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			477.3	B08		4	0242-0494	814.64	495.00	192	53.11	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.2	B08		4	0243-0502	713.55	501.65	378	75.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			137.6	B08		4	0244-0499	510.71	499.10	178	50.87	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			752.5	B08		4	0245-0502	247.12	501.64	313	66.77	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.1	B08		4	0246-0503	465.57	503.07	296	69.36	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			437.1	B08		4	0247-0504	207.05	503.81	213	55.46	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			355.1	B08		4	0248-0505	317.37	506.23	205	58.87	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			143.5	B08		4	0249-0505	526.72	504.67	133	44.04	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			320.4	B08		4	0250-0509	893.48	509.56	256	58.53	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			310.0	B08		4	0251-0510	769.85	509.88	229	57.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			322.1	B08		4	0252-0515	912.53	515.34	272	63.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			367.1	B08		4	0253-0516	166.09	516.56	195	52.53	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			390.2	B08		4	0254-0519	324.07	518.57	206	56.53	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			452.3	B08		4	0255-0523	62.95	523.51	283	62.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			407.1	B08		4	0256-0521	408.93	520.60	252	59.01	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			392.9	B08		4	0257-0523	632.41	523.01	299	65.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			339.5	B08		4	0258-0524	349.28	523.74	255	61.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			597.1	B08		4	0259-0525	35.65	525.09	254	65.84	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			227.0	B08		4	0260-0525	667.34	525.91	286	66.43	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			383.2	B08		4	0261-0529	219.15	529.19	279	66.43	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			414.3	B08		4	0262-0527	823.19	526.28	182	51.11	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			395.1	B08		4	0263-0529	189.07	529.13	203	53.11	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			302.3	B08		4	0264-0535	305.67	536.40	353	71.94	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			316.0	B08		4	0265-0536	271.64	534.96	247	62.87	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			286.0	B08		4	0266-0538	853.41	538.09	256	62.43	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			313.3	B08		4	0267-0543	519.43	543.96	379	74.67	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			273.6	B08		4	0268-0543	462.46	543.84	146	47.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			264.7	B08		4	0269-0545	612.72	545.77	302	66.67	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			334.4	B08		4	0270-0546	483.70	546.75	285	67.60	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.0	B08		4	0271-0546	120.03	546.11	297	64.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			329.7	B08		4	0272-0551	386.36	551.34	382	75.50	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			286.2	B08		4	0273-0545	452.01	545.29	113	39.21	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			470.7	B08		4	0274-0549	826.28	549.64	208	55.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			359.8	B08		4	0275-0553	769.54	553.39	208	57.01	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			316.8	B08		4	0276-0553	896.29	553.02	252	59.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			302.6	B08		4	0277-0556	169.22	558.38	335	78.18	0.689
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			457.1	B08		4	0278-0552	257.75	552.29	134	46.04	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			305.4	B08		4	0279-0555	927.66	554.65	218	53.70	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			293.9	B08		4	0280-0562	695.36	561.59	340	69.84	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			318.5	B08		4	0281-0560	39.92	559.67	217	54.28	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			305.3	B08		4	0282-0559	792.50	558.57	225	55.94	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.5	B08		4	0283-0562	661.76	562.49	244	58.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			307.3	B08		4	0284-0566	442.11	565.66	250	59.11	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			591.1	B08		4	0285-0571	626.34	571.54	350	72.91	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			641.2	B08		4	0286-0573	745.64	573.60	268	64.28	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			435.0	B08		4	0287-0579	202.08	578.90	254	59.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			330.8	B08		4	0288-0580	355.71	580.32	261	71.26	0.646
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			350.6	B08		4	0289-0578	55.91	579.20	240	59.11	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			464.0	B08		4	0290-0584	101.22	583.64	271	62.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			411.5	B08		4	0291-0587	896.46	587.20	239	57.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			317.1	B08		4	0292-0590	503.77	590.15	227	55.70	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			214.0	B08		4	0293-0593	414.11	594.58	329	71.01	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			283.4	B08		4	0294-0594	466.09	594.47	170	48.63	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			486.6	B08		4	0295-0595	631.79	594.98	228	56.28	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			436.2	B08		4	0296-0599	330.30	599.10	240	58.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			324.3	B08		4	0297-0600	878.35	600.18	225	56.87	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			594.7	B08		4	0298-0604	265.33	603.70	313	65.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.4	B08		4	0299-0605	521.43	604.79	295	64.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			789.3	B08		4	0300-0603	612.33	602.58	160	46.87	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.7	B08		4	0301-0605	933.74	605.18	223	55.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.6	B08		4	0302-0606	483.26	606.68	184	53.36	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			422.3	B08		4	0303-0607	792.06	607.40	263	59.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			444.9	B08		4	0304-0610	238.36	610.41	227	56.28	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			349.3	B08		4	0305-0612	213.73	611.44	215	55.70	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			742.2	B08		4	0306-0615	619.13	615.35	176	49.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			376.6	B08		4	0307-0622	857.02	622.48	252	59.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			473.3	B08		4	0308-0620	180.51	620.54	198	53.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			303.5	B08		4	0309-0621	647.58	621.74	256	60.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			264.3	B08		4	0310-0626	931.96	626.09	277	71.60	0.679
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			313.6	B08		4	0311-0627	369.29	627.77	272	62.18	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			461.9	B08		4	0312-0628	240.10	627.52	191	51.11	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			345.9	B08		4	0313-0631	112.43	631.22	295	62.77	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			349.6	B08		4	0314-0631	594.04	631.05	250	59.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			390.7	B08		4	0315-0634	396.37	634.05	245	61.60	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			449.3	B08		4	0316-0636	439.91	636.09	375	71.60	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.5	B08		4	0317-0638	518.47	638.36	294	65.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			1045.5	B08		4	0318-0638	851.28	638.87	219	54.87	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			345.9	B08		4	0319-0639	71.19	639.60	175	49.80	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			393.0	B08		4	0320-0643	355.90	642.50	300	67.50	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			364.1	B08		4	0321-0643	720.20	643.02	246	59.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			334.4	B08		4	0322-0650	276.52	648.14	493	95.50	0.679
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			309.3	B08		4	0323-0648	471.83	647.96	344	69.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			318.6	B08		4	0324-0643	623.44	642.89	206	61.36	0.688
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			345.8	B08		4	0325-0651	550.39	650.86	460	82.33	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			471.1	B08		4	0326-0649	751.38	649.17	248	62.53	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.5	B08		4	0327-0655	677.54	656.14	307	64.18	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			353.3	B08		4	0328-0657	92.49	656.86	234	56.28	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			264.9	B08		4	0329-0665	419.08	665.94	283	62.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			340.9	B08		4	0330-0665	464.09	665.02	258	60.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			382.2	B08		4	0331-0668	138.91	668.35	265	62.18	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			312.1	B08		4	0332-0670	579.98	670.48	218	55.70	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			464.7	B08		4	0333-0669	157.98	669.52	183	52.53	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			409.4	B08		4	0334-0677	304.96	677.31	383	75.01	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			426.1	B08		4	0335-0676	369.06	676.55	337	71.84	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			408.6	B08		4	0336-0676	106.14	676.43	226	57.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.1	B08		4	0337-0681	489.96	681.89	293	70.53	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			316.8	B08		4	0338-0679	219.54	679.54	244	57.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			996.2	B08		4	0339-0682	439.59	681.45	316	65.60	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			463.8	B08		4	0340-0682	341.94	682.00	147	49.11	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			424.9	B08		4	0341-0686	771.81	686.37	246	59.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			452.6	B08		4	0342-0687	352.74	686.86	160	48.87	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			286.1	B08		4	0343-0689	66.90	688.40	228	58.28	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			309.1	B08		4	0344-0695	584.28	694.25	440	78.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			382.1	B08		4	0345-0693	190.14	693.68	257	58.77	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.6	B08		4	0346-0694	508.55	695.05	278	66.18	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			337.4	B08		4	0347-0699	91.54	698.54	186	51.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.1	B08		4	0348-0701	321.09	700.57	259	61.94	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.5	B08		4	0349-0701	852.08	700.68	243	63.01	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			335.5	B08		4	0350-0704	139.10	703.95	232	56.18	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			457.2	B08		4	0351-0707	82.78	707.84	131	43.11	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			421.1	B08		4	0352-0709	249.40	709.38	245	58.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			352.5	B08		4	0353-0708	826.55	707.85	222	55.36	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			579.4	B08		5	0001-0030	295.53	30.88	233	58.53	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			331.0	B08		5	0002-0025	894.81	25.66	191	53.70	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			311.7	B08		5	0003-0032	81.20	32.85	281	64.43	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			335.7	B08		5	0004-0030	386.33	30.11	243	57.36	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			312.8	B08		5	0005-0033	557.30	33.38	357	71.01	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.1	B08		5	0006-0035	647.06	35.19	464	81.50	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			349.9	B08		5	0007-0034	764.63	33.50	320	66.43	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			560.0	B08		5	0008-0038	17.47	38.56	167	48.28	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.5	B08		5	0009-0038	843.73	38.50	257	60.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			317.7	B08		5	0010-0042	103.70	41.70	286	67.01	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			409.2	B08		5	0011-0044	38.23	44.27	412	80.67	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			426.4	B08		5	0012-0040	618.67	39.46	201	53.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.1	B08		5	0013-0041	935.18	41.15	306	66.08	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			488.3	B08		5	0014-0045	205.15	45.67	328	68.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			320.9	B08		5	0015-0046	353.28	45.99	285	63.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			353.1	B08		5	0016-0046	438.62	46.09	260	60.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			350.6	B08		5	0017-0047	119.53	46.85	227	64.53	0.685
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			337.2	B08		5	0018-0053	699.81	51.11	402	85.50	0.691
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			332.1	B08		5	0019-0054	728.32	54.59	354	69.26	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			368.7	B08		5	0020-0053	890.76	53.19	218	61.84	0.716
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			412.2	B08		5	0021-0058	502.59	57.05	187	55.01	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			370.2	B08		5	0022-0061	125.53	61.72	186	57.60	0.705
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			394.9	B08		5	0023-0061	392.17	61.28	300	68.77	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			319.4	B08		5	0024-0063	865.42	63.69	284	63.36	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			517.3	B08		5	0025-0063	445.32	62.52	211	55.11	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.4	B08		5	0026-0068	600.83	67.82	454	81.74	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			414.2	B08		5	0027-0065	641.80	65.14	294	62.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			612.6	B08		5	0028-0072	240.01	71.95	365	82.33	0.677
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			366.4	B08		5	0029-0078	458.41	79.37	349	74.67	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.3	B08		5	0030-0074	786.62	75.24	278	64.53	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			312.7	B08		5	0031-0083	537.97	83.52	521	87.84	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			336.6	B08		5	0032-0080	179.82	80.24	229	56.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			390.1	B08		5	0033-0081	307.41	81.64	241	59.36	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.2	B08		5	0034-0088	583.99	88.43	520	87.50	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			312.3	B08		5	0035-0088	146.95	87.66	229	58.53	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			293.6	B08		5	0036-0087	849.53	86.85	227	55.94	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			283.2	B08		5	0037-0091	693.33	91.22	257	63.60	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.7	B08		5	0038-0093	756.68	92.98	318	65.84	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			342.8	B08		5	0039-0093	325.58	92.74	406	75.60	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			40490.6	B08		5	0040-0095	19.60	95.63	297	63.70	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.9	B08		5	0041-0096	621.58	96.99	278	64.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.2	B08		5	0042-0096	919.57	96.30	211	53.11	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			317.7	B08		5	0043-0099	829.40	98.50	296	63.94	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			459.0	B08		5	0044-0098	366.33	98.06	223	56.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			440.7	B08		5	0045-0102	285.85	102.24	239	58.77	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			182.6	B08		5	0046-0102	477.28	102.34	344	72.43	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			304.5	B08		5	0047-0105	179.89	105.00	227	57.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			428.0	B08		5	0048-0104	387.49	104.30	273	63.36	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			340.8	B08		5	0049-0110	219.10	111.22	376	75.01	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			299.5	B08		5	0050-0115	432.47	114.86	232	56.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			335.5	B08		5	0051-0122	262.18	122.33	412	75.26	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			351.6	B08		5	0052-0121	613.89	121.83	356	69.60	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			398.4	B08		5	0053-0123	124.96	123.50	317	64.77	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			346.6	B08		5	0054-0127	499.69	125.98	329	73.01	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			285.1	B08		5	0055-0125	317.65	125.28	227	55.94	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			318.4	B08		5	0056-0131	934.50	130.73	378	75.50	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			351.6	B08		5	0057-0128	671.91	127.74	201	52.53	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			313.9	B08		5	0058-0129	98.76	129.47	303	69.36	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			407.8	B08		5	0059-0132	181.45	131.89	279	62.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			345.4	B08		5	0060-0135	445.04	135.96	391	73.26	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.7	B08		5	0061-0134	731.47	134.75	276	64.18	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.7	B08		5	0062-0138	792.76	138.55	261	59.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			340.9	B08		5	0063-0135	814.56	134.93	256	61.70	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			438.5	B08		5	0064-0142	529.19	142.32	257	60.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.9	B08		5	0065-0141	863.11	141.44	233	57.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.8	B08		5	0066-0142	911.83	142.77	267	63.60	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			513.1	B08		5	0067-0154	221.83	153.34	667	103.64	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			378.6	B08		5	0068-0147	339.76	146.34	344	69.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			336.2	B08		5	0069-0146	572.14	145.82	248	57.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			311.2	B08		5	0070-0147	654.58	147.15	297	64.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			305.6	B08		5	0071-0147	817.26	148.11	194	56.04	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			443.9	B08		5	0072-0149	362.62	149.64	258	63.11	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			303.9	B08		5	0073-0153	468.98	152.96	303	65.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			597.6	B08		5	0074-0152	46.23	152.22	276	62.53	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			330.6	B08		5	0075-0155	326.26	154.69	198	53.60	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			414.7	B08		5	0076-0158	131.27	157.77	294	64.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			331.3	B08		5	0077-0160	412.59	160.42	281	64.53	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.1	B08		5	0078-0159	860.83	159.21	240	58.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			310.8	B08		5	0079-0168	300.99	166.56	212	59.11	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.4	B08		5	0080-0169	563.53	168.26	300	72.43	0.719
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			442.9	B08		5	0081-0169	283.17	169.11	340	70.77	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			306.0	B08		5	0082-0170	520.66	170.02	368	70.43	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.4	B08		5	0083-0173	714.30	172.85	300	76.43	0.645
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			346.9	B08		5	0084-0176	599.34	175.96	280	65.94	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			402.8	B08		5	0085-0177	767.45	177.37	261	62.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			511.4	B08		5	0086-0183	297.78	183.35	207	53.70	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			285.3	B08		5	0087-0188	458.13	187.82	262	61.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			361.9	B08		5	0088-0186	827.90	186.74	189	55.36	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			465.9	B08		5	0089-0190	123.16	189.82	298	64.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			381.3	B08		5	0090-0189	743.36	189.75	238	57.70	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			317.0	B08		5	0091-0191	435.58	190.96	270	59.94	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			219.6	B08		5	0092-0192	688.43	191.92	324	67.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			306.3	B08		5	0093-0195	802.67	195.07	270	67.26	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			317.8	B08		5	0094-0197	379.86	197.12	323	66.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.0	B08		5	0095-0200	532.69	199.42	324	68.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			388.1	B08		5	0096-0199	294.42	199.07	185	53.11	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			421.0	B08		5	0097-0201	256.90	201.30	177	48.87	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			431.7	B08		5	0098-0202	489.30	202.45	295	62.77	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.2	B08		5	0099-0205	89.56	204.45	266	63.60	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.7	B08		5	0100-0202	599.49	200.85	172	53.70	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			455.7	B08		5	0101-0203	855.77	204.11	257	60.28	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.3	B08		5	0102-0205	41.27	205.25	244	59.60	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			321.9	B08		5	0103-0209	559.41	208.92	460	83.26	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			412.3	B08		5	0104-0209	818.71	209.27	352	69.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.1	B08		5	0105-0212	363.48	212.07	256	61.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.3	B08		5	0106-0207	608.13	207.61	120	42.28	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			436.9	B08		5	0107-0213	243.40	213.91	322	69.26	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.6	B08		5	0108-0216	625.16	216.59	319	66.18	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			304.5	B08		5	0109-0223	312.51	224.14	373	80.33	0.726
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			386.9	B08		5	0110-0221	154.93	221.42	238	57.70	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			285.9	B08		5	0111-0222	388.83	221.77	269	61.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			322.1	B08		5	0112-0224	462.43	223.48	257	59.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			339.0	B08		5	0113-0227	527.41	227.24	242	57.46	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			487.4	B08		5	0114-0231	138.45	230.97	229	55.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			320.4	B08		5	0115-0231	354.39	231.96	211	54.53	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			705.0	B08		5	0116-0235	717.67	234.91	391	75.01	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			338.3	B08		5	0117-0232	327.87	231.96	209	53.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.6	B08		5	0118-0233	485.95	233.10	274	61.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			346.3	B08		5	0119-0234	549.68	234.97	201	53.36	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.7	B08		5	0120-0236	920.16	237.33	301	67.84	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			336.9	B08		5	0121-0238	698.47	238.19	231	56.53	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.7	B08		5	0122-0243	786.65	243.09	305	70.43	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			361.7	B08		5	0123-0243	182.01	242.88	185	52.53	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			293.0	B08		5	0124-0247	806.30	247.73	346	69.01	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			318.0	B08		5	0125-0248	342.03	248.20	243	61.60	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			345.3	B08		5	0126-0246	747.93	245.72	211	53.70	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.1	B08		5	0127-0251	627.61	251.69	278	63.70	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			312.4	B08		5	0128-0251	839.54	251.41	302	67.01	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			212.4	B08		5	0129-0253	672.20	253.35	290	66.67	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			340.7	B08		5	0130-0255	416.23	254.89	359	69.60	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			420.2	B08		5	0131-0257	234.72	258.05	280	62.18	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			327.4	B08		5	0132-0258	926.87	258.22	304	65.01	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			430.9	B08		5	0133-0259	529.60	259.62	179	50.28	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			389.8	B08		5	0134-0263	370.21	262.63	206	54.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.9	B08		5	0135-0265	886.90	264.94	301	63.94	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			284.2	B08		5	0136-0267	603.02	266.82	234	57.94	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.5	B08		5	0137-0271	722.33	270.70	281	65.26	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			217.9	B08		5	0138-0274	788.48	273.86	302	64.67	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			294.1	B08		5	0139-0274	286.41	274.47	246	58.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			422.7	B08		5	0140-0275	578.73	274.92	399	75.84	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			327.3	B08		5	0141-0278	471.49	278.13	376	72.43	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			211.1	B08		5	0142-0279	763.35	279.52	327	70.77	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			530.5	B08		5	0143-0285	683.06	284.72	557	96.81	0.747
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.1	B08		5	0144-0283	157.84	283.31	270	62.28	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			277.7	B08		5	0145-0282	931.41	282.99	332	68.77	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.1	B08		5	0146-0285	305.08	285.40	281	66.43	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.9	B08		5	0147-0289	855.11	291.27	292	73.26	0.684
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.4	B08		5	0148-0292	652.58	292.68	293	64.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			225.2	B08		5	0149-0293	254.65	293.39	363	72.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			364.8	B08		5	0150-0292	351.44	291.95	169	50.53	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			295.6	B08		5	0151-0296	832.99	296.12	326	66.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			344.5	B08		5	0152-0301	386.36	301.03	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			279.0	B08		5	0153-0297	621.94	297.75	232	59.46	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.9	B08		5	0154-0306	946.53	306.29	208	58.53	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			317.0	B08		5	0155-0305	480.20	305.32	257	61.94	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			455.8	B08		5	0156-0306	344.77	306.66	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			620.5	B08		5	0157-0310	929.56	310.24	264	59.36	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.6	B08		5	0158-0311	743.22	311.03	377	73.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			417.5	B08		5	0159-0312	518.81	312.77	358	71.01	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			315.6	B08		5	0160-0319	431.69	319.49	278	62.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			259.0	B08		5	0161-0321	867.44	320.62	300	65.01	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			350.7	B08		5	0162-0322	603.54	321.53	290	64.77	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			334.6	B08		5	0163-0324	762.76	324.64	284	64.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			335.5	B08		5	0164-0324	697.15	324.25	312	65.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.8	B08		5	0165-0328	256.84	329.58	236	62.77	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			340.4	B08		5	0166-0330	903.78	330.83	318	65.94	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			305.5	B08		5	0167-0332	640.93	332.77	255	59.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			352.8	B08		5	0168-0334	385.47	335.14	313	70.43	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			309.7	B08		5	0169-0339	199.53	339.86	402	79.26	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			433.5	B08		5	0170-0337	336.46	336.80	347	68.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			344.6	B08		5	0171-0337	109.22	337.39	234	55.70	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			363.6	B08		5	0172-0341	728.54	341.60	301	64.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.8	B08		5	0173-0348	247.30	348.39	312	73.01	0.735
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			308.8	B08		5	0174-0347	518.90	347.95	266	61.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			393.3	B08		5	0175-0350	550.53	349.87	304	66.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			220.6	B08		5	0176-0351	28.14	351.54	308	65.01	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.3	B08		5	0177-0351	671.10	352.07	300	66.43	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			346.8	B08		5	0178-0351	288.63	351.57	242	57.36	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			353.0	B08		5	0179-0353	605.08	353.64	328	67.84	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			338.7	B08		5	0180-0350	388.40	350.64	213	55.70	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			296.3	B08		5	0181-0355	313.02	354.74	290	68.67	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.0	B08		5	0182-0363	367.52	363.21	367	73.74	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.8	B08		5	0183-0361	868.51	361.52	228	55.70	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			283.4	B08		5	0184-0364	481.68	364.53	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			287.5	B08		5	0185-0366	744.53	366.18	361	73.84	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			433.2	B08		5	0186-0370	155.81	369.80	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			354.1	B08		5	0187-0368	583.87	367.91	293	63.01	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.2	B08		5	0188-0369	793.88	369.56	267	62.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			320.7	B08		5	0189-0374	425.48	374.39	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.1	B08		5	0190-0376	815.09	375.59	267	71.01	0.665
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			18874.8	B08		5	0191-0377	708.52	377.08	346	67.60	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.6	B08		5	0192-0379	228.04	379.25	321	67.60	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			384.6	B08		5	0193-0382	762.06	381.50	344	70.18	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			299.1	B08		5	0194-0384	331.51	384.50	264	59.94	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.3	B08		5	0195-0383	57.91	383.42	245	60.18	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			257.8	B08		5	0196-0384	638.43	383.82	173	55.36	0.709
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			301.4	B08		5	0197-0385	22.61	385.34	298	64.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			279.0	B08		5	0198-0387	437.65	386.44	260	61.70	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.4	B08		5	0199-0387	264.16	387.60	220	54.87	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.8	B08		5	0200-0388	941.49	389.46	247	73.26	0.578
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.4	B08		5	0201-0387	298.35	387.32	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			474.3	B08		5	0202-0388	545.48	388.10	243	57.70	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			404.3	B08		5	0203-0390	123.06	389.49	212	55.36	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			316.2	B08		5	0204-0390	474.10	389.95	175	51.36	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.6	B08		5	0205-0398	374.06	400.10	337	75.60	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.5	B08		5	0206-0399	415.64	399.44	436	78.33	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			372.9	B08		5	0207-0397	845.35	396.76	330	67.36	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			503.9	B08		5	0208-0396	924.48	396.26	284	64.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			310.8	B08		5	0209-0400	96.75	399.85	268	60.53	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			351.5	B08		5	0210-0400	184.98	400.23	329	68.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			296.1	B08		5	0211-0402	596.83	402.10	318	65.94	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			324.0	B08		5	0212-0400	767.01	400.97	234	57.11	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			314.4	B08		5	0213-0402	234.24	403.18	236	57.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			270.1	B08		5	0214-0405	880.80	404.72	302	65.84	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			488.0	B08		5	0215-0408	503.17	407.93	387	73.84	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			368.7	B08		5	0216-0412	850.68	411.78	215	55.70	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.7	B08		5	0217-0418	295.11	418.75	263	60.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.3	B08		5	0218-0417	753.99	417.39	295	65.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			322.4	B08		5	0219-0419	47.72	418.73	257	58.53	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			291.4	B08		5	0220-0418	264.96	418.82	253	58.77	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			315.0	B08		5	0221-0420	553.94	420.70	336	68.08	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.7	B08		5	0222-0421	18.23	420.86	230	57.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			298.8	B08		5	0223-0423	649.21	422.77	326	67.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			329.5	B08		5	0224-0419	716.50	418.66	237	59.36	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.3	B08		5	0225-0423	159.47	423.16	268	60.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			349.9	B08		5	0226-0425	207.15	424.76	172	50.63	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			338.5	B08		5	0227-0427	249.84	426.62	227	60.18	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			322.1	B08		5	0228-0427	107.31	427.34	224	63.70	0.694
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.7	B08		5	0229-0429	93.76	430.11	133	48.53	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.9	B08		5	0230-0431	771.38	430.11	262	61.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.6	B08		5	0231-0434	318.65	433.86	279	61.60	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.0	B08		5	0232-0436	825.71	436.90	333	77.26	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.7	B08		5	0233-0434	357.52	434.58	213	55.11	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			398.8	B08		5	0234-0436	338.58	436.41	238	56.77	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			323.7	B08		5	0235-0440	453.24	439.97	251	59.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			386.9	B08		5	0236-0440	716.10	440.61	294	67.01	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			270.8	B08		5	0237-0446	893.39	445.58	305	64.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			301.1	B08		5	0238-0446	397.03	446.42	252	59.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			418.4	B08		5	0239-0446	759.84	446.37	329	66.53	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			302.9	B08		5	0240-0453	613.76	454.39	375	73.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			341.2	B08		5	0241-0451	254.41	451.25	265	60.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			380.4	B08		5	0242-0449	646.18	449.41	106	40.04	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			216.4	B08		5	0243-0454	851.35	454.92	285	66.18	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			334.3	B08		5	0244-0454	459.56	455.29	210	58.53	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			268.4	B08		5	0245-0457	416.62	458.31	258	66.28	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			298.7	B08		5	0246-0459	474.40	458.61	271	62.04	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			292.3	B08		5	0247-0463	580.88	463.68	282	64.53	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.3	B08		5	0248-0462	679.75	461.14	229	58.77	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.1	B08		5	0249-0466	315.02	467.28	416	85.15	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			453.6	B08		5	0250-0466	340.97	464.47	322	79.84	0.635
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			348.0	B08		5	0251-0467	388.98	466.28	351	71.01	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			416.8	B08		5	0252-0464	512.97	464.52	247	58.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.8	B08		5	0253-0468	540.87	467.65	321	68.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			437.4	B08		5	0254-0468	712.10	468.59	270	61.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			294.0	B08		5	0255-0469	29.72	469.57	398	73.60	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			357.5	B08		5	0256-0469	164.99	469.79	233	57.94	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			301.6	B08		5	0257-0469	362.12	469.38	203	53.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.2	B08		5	0258-0469	881.30	468.81	265	61.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			353.0	B08		5	0259-0476	686.25	474.81	263	66.67	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			341.6	B08		5	0260-0473	210.69	474.10	179	51.11	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			448.0	B08		5	0261-0474	566.06	474.60	193	54.18	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			302.6	B08		5	0262-0477	259.90	477.08	208	61.01	0.702
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			225.2	B08		5	0263-0478	916.21	478.80	260	64.18	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			567.3	B08		5	0264-0484	226.41	484.79	327	75.50	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			332.6	B08		5	0265-0486	669.26	486.42	312	65.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			216.9	B08		5	0266-0487	312.59	487.82	276	63.01	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			301.0	B08		5	0267-0486	388.91	486.62	233	59.36	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			381.7	B08		5	0268-0486	560.86	485.82	117	40.28	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			586.3	B08		5	0269-0495	621.80	496.89	534	92.91	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			432.1	B08		5	0270-0491	782.00	491.75	311	66.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			312.5	B08		5	0271-0491	816.80	492.21	224	56.53	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			326.6	B08		5	0272-0493	248.22	493.46	176	48.87	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.2	B08		5	0273-0500	654.32	501.07	277	63.94	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.4	B08		5	0274-0503	300.62	504.45	260	62.77	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			481.8	B08		5	0275-0506	798.25	505.60	326	70.53	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			281.4	B08		5	0276-0505	82.77	505.79	367	73.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			502.0	B08		5	0277-0504	208.16	504.19	201	51.94	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			314.9	B08		5	0278-0509	168.81	509.67	238	62.77	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			406.4	B08		5	0279-0509	454.85	508.90	311	65.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			402.6	B08		5	0280-0510	567.98	510.19	257	60.28	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			316.9	B08		5	0281-0508	251.51	507.81	140	46.39	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			341.4	B08		5	0282-0514	580.97	514.25	225	62.28	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			221.5	B08		5	0283-0513	947.71	513.22	271	60.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			567.8	B08		5	0284-0514	814.93	514.00	223	58.87	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			420.2	B08		5	0285-0515	766.65	516.13	269	60.28	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.2	B08		5	0286-0517	17.14	517.56	263	61.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			323.7	B08		5	0287-0518	185.06	519.87	257	64.77	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			298.9	B08		5	0288-0515	907.14	515.25	189	53.36	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.8	B08		5	0289-0520	851.89	519.62	257	59.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			332.6	B08		5	0290-0525	152.92	525.78	265	64.53	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			343.0	B08		5	0291-0523	500.45	522.77	313	65.01	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			417.2	B08		5	0292-0521	247.66	521.15	148	44.87	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			315.9	B08		5	0293-0526	310.58	526.06	250	61.36	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			476.2	B08		5	0294-0530	232.78	529.58	310	66.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			423.1	B08		5	0295-0528	699.51	528.23	219	54.87	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			354.1	B08		5	0296-0529	807.78	529.93	285	66.18	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			453.9	B08		5	0297-0529	602.50	528.81	243	57.36	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			366.5	B08		5	0298-0530	464.02	530.85	276	63.94	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			341.9	B08		5	0299-0535	526.23	535.26	278	62.53	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			323.1	B08		5	0300-0534	194.17	534.36	146	49.46	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.3	B08		5	0301-0537	631.59	536.87	273	62.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			291.7	B08		5	0302-0538	203.78	538.71	112	38.39	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			295.5	B08		5	0303-0541	943.14	542.26	251	61.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			432.9	B08		5	0304-0544	285.41	544.89	227	58.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			405.0	B08		5	0305-0542	66.73	542.40	222	54.53	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			279.4	B08		5	0306-0545	394.84	545.45	237	57.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			391.1	B08		5	0307-0547	416.32	546.55	299	65.60	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			259.6	B08		5	0308-0549	501.07	550.03	257	67.01	0.719
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			290.3	B08		5	0309-0548	914.84	547.20	322	67.60	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			264.1	B08		5	0310-0547	861.68	547.45	240	58.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			285.8	B08		5	0311-0550	333.81	549.73	238	60.43	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			432.8	B08		5	0312-0552	96.40	551.94	339	71.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			534.7	B08		5	0313-0550	271.40	550.14	145	47.70	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			296.4	B08		5	0314-0558	159.75	557.98	250	57.94	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			310.8	B08		5	0315-0557	32.26	556.67	214	53.70	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			358.4	B08		5	0316-0560	226.45	559.89	257	66.77	0.724
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.6	B08		5	0317-0563	884.68	563.30	252	60.53	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			212.1	B08		5	0318-0563	187.93	563.47	259	60.18	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			325.2	B08		5	0319-0566	488.24	566.76	425	80.43	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			286.1	B08		5	0320-0567	726.77	566.37	288	65.01	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			419.8	B08		5	0321-0570	782.32	570.74	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.6	B08		5	0322-0572	138.28	572.28	266	60.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.7	B08		5	0323-0577	605.38	577.36	304	65.01	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			328.8	B08		5	0324-0577	257.41	577.32	212	53.36	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.8	B08		5	0325-0584	826.31	584.13	267	61.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			273.5	B08		5	0326-0589	905.56	588.89	251	63.60	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			338.6	B08		5	0327-0591	303.02	590.39	204	53.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.3	B08		5	0328-0592	671.11	592.34	289	61.94	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			290.8	B08		5	0329-0594	218.77	593.42	285	65.01	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			346.1	B08		5	0330-0593	842.59	593.52	206	53.94	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			322.8	B08		5	0331-0597	890.09	598.13	215	55.70	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			453.9	B08		5	0332-0601	172.79	601.25	348	76.67	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			370.9	B08		5	0333-0602	495.55	601.80	263	59.60	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			368.4	B08		5	0334-0602	698.64	601.29	225	56.53	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			277.8	B08		5	0335-0605	348.19	605.29	285	67.50	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			341.6	B08		5	0336-0606	585.00	606.28	382	74.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.3	B08		5	0337-0607	38.14	607.31	229	58.18	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			393.4	B08		5	0338-0610	540.02	609.60	234	59.01	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			301.4	B08		5	0339-0610	417.90	610.62	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			252.9	B08		5	0340-0612	509.01	612.46	249	59.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			365.2	B08		5	0341-0611	793.96	611.55	308	64.77	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			380.9	B08		5	0342-0614	923.70	614.42	241	56.77	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			406.7	B08		5	0343-0616	320.44	616.36	299	65.26	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			314.1	B08		5	0344-0619	712.48	618.24	295	63.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			443.8	B08		5	0345-0621	215.75	620.77	456	88.91	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.0	B08		5	0346-0620	757.65	620.59	258	61.94	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			341.2	B08		5	0347-0622	453.10	622.06	232	56.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			356.0	B08		5	0348-0624	546.22	624.36	285	65.01	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			337.7	B08		5	0349-0623	174.39	622.87	236	56.53	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			309.7	B08		5	0350-0622	870.83	622.71	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.3	B08		5	0351-0628	605.87	627.99	397	76.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			322.6	B08		5	0352-0624	946.97	624.84	281	62.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			279.3	B08		5	0353-0628	36.42	628.14	277	72.43	0.664
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			431.1	B08		5	0354-0627	248.60	627.74	260	59.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			402.7	B08		5	0355-0629	830.24	628.84	222	63.26	0.697
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			259.8	B08		5	0356-0633	370.33	632.80	275	64.77	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.4	B08		5	0357-0636	408.74	635.45	333	70.18	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			363.5	B08		5	0358-0634	559.32	634.44	189	51.46	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.5	B08		5	0359-0638	768.63	638.12	249	61.11	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.7	B08		5	0360-0644	477.73	644.58	285	65.60	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.7	B08		5	0361-0646	141.04	646.00	238	58.53	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			316.2	B08		5	0362-0645	624.71	644.66	226	55.70	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.7	B08		5	0363-0648	565.94	648.44	244	60.53	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.3	B08		5	0364-0655	923.94	655.47	386	75.60	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			330.4	B08		5	0365-0654	227.52	653.58	294	63.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.0	B08		5	0366-0653	685.29	652.45	228	58.77	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.7	B08		5	0367-0655	855.20	655.65	287	62.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.7	B08		5	0368-0656	278.26	655.64	249	62.53	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			270.0	B08		5	0369-0655	514.61	654.75	228	56.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			259.1	B08		5	0370-0656	649.18	656.57	234	57.94	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.4	B08		5	0371-0656	726.71	655.54	244	57.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			320.9	B08		5	0372-0663	819.55	663.14	272	61.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			346.3	B08		5	0373-0663	156.97	663.83	233	57.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			268.3	B08		5	0374-0668	103.57	668.66	288	64.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			348.8	B08		5	0375-0668	297.00	668.30	230	56.77	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			526.2	B08		5	0376-0676	637.78	676.57	328	67.94	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			546.6	B08		5	0377-0675	746.61	675.50	218	56.28	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			343.8	B08		5	0378-0673	784.03	672.98	198	54.53	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			286.8	B08		5	0379-0680	130.23	679.86	225	55.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.9	B08		5	0380-0681	352.98	681.85	262	60.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			341.7	B08		5	0381-0678	400.87	678.35	219	56.53	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.6	B08		5	0382-0680	564.26	680.36	266	60.18	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			326.6	B08		5	0383-0681	809.99	680.69	259	58.53	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.2	B08		5	0384-0681	260.11	680.66	242	61.11	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.9	B08		5	0385-0682	443.93	681.27	251	58.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.8	B08		5	0386-0681	518.84	681.30	267	61.94	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.0	B08		5	0387-0689	851.09	689.63	349	71.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			264.4	B08		5	0388-0685	944.31	685.34	228	57.11	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			364.3	B08		5	0389-0689	331.92	689.08	240	58.28	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			357.0	B08		5	0390-0688	175.30	688.12	233	61.60	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.9	B08		5	0391-0697	481.88	696.74	235	59.11	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.6	B08		5	0392-0696	499.67	696.24	222	59.36	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			357.6	B08		5	0393-0699	454.71	698.92	176	50.28	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.7	B08		5	0394-0702	763.55	701.67	360	71.84	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			364.2	B08		5	0395-0702	181.65	702.87	251	59.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			391.9	B08		5	0396-0704	832.21	704.19	334	67.60	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			221.8	B08		5	0397-0706	628.57	706.03	292	65.36	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			277.9	B08		5	0398-0707	607.56	708.06	218	56.28	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.8	B08		5	0399-0710	334.25	709.85	209	53.11	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			287.5	B08		5	0400-0711	275.53	711.28	216	59.70	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			362.4	B08		6	0001-0028	566.76	28.73	247	61.36	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			198.6	B08		6	0002-0030	203.14	30.57	437	79.26	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			381.3	B08		6	0003-0027	815.03	27.38	269	60.53	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			546.0	B08		6	0004-0028	518.48	27.57	250	59.94	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			220.1	B08		6	0005-0032	878.67	31.47	241	60.18	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			312.5	B08		6	0006-0034	238.40	33.37	239	58.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			387.7	B08		6	0007-0032	292.61	32.32	341	69.11	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			701.4	B08		6	0008-0042	603.48	42.80	661	124.71	0.534
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.1	B08		6	0009-0035	387.87	34.87	352	71.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.8	B08		6	0010-0036	117.52	36.42	257	60.77	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			287.2	B08		6	0011-0044	29.89	44.06	304	66.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			354.9	B08		6	0012-0047	136.17	48.47	208	63.36	0.651
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			381.2	B08		6	0013-0046	277.18	45.73	246	58.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			291.4	B08		6	0014-0048	920.08	48.74	236	58.53	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.6	B08		6	0015-0053	47.84	53.09	219	56.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			384.0	B08		6	0016-0057	391.41	57.27	229	56.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			350.4	B08		6	0017-0059	692.75	59.01	218	55.94	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			479.4	B08		6	0018-0062	852.91	61.86	412	77.50	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			425.3	B08		6	0019-0057	351.17	57.35	167	50.28	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			309.2	B08		6	0020-0061	204.10	61.84	226	55.94	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			495.3	B08		6	0021-0063	730.17	63.45	233	59.11	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			281.4	B08		6	0022-0064	498.72	63.16	245	69.01	0.646
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			313.0	B08		6	0023-0063	678.46	63.79	253	60.53	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			429.2	B08		6	0024-0062	800.33	61.85	244	58.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.1	B08		6	0025-0068	226.95	67.53	270	62.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			440.4	B08		6	0026-0066	278.84	66.39	246	60.18	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			384.6	B08		6	0027-0072	181.60	72.64	259	59.60	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			427.0	B08		6	0028-0073	303.97	72.75	142	50.87	0.690
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			389.5	B08		6	0029-0075	873.16	74.78	181	55.46	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			201.0	B08		6	0030-0077	137.57	77.45	281	70.77	0.705
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			429.8	B08		6	0031-0072	369.31	71.86	216	56.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			326.5	B08		6	0032-0074	93.35	74.42	277	66.18	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			351.9	B08		6	0033-0076	749.60	75.53	247	60.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			308.6	B08		6	0034-0074	828.53	75.12	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.4	B08		6	0035-0074	468.50	73.93	140	53.60	0.612
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			406.7	B08		6	0036-0075	887.21	74.53	157	46.28	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			454.5	B08		6	0037-0076	291.02	76.96	172	51.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			387.0	B08		6	0038-0078	326.11	77.87	206	53.11	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			361.5	B08		6	0039-0081	945.11	81.27	264	61.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			216.8	B08		6	0040-0083	475.33	83.97	171	69.50	0.445
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			428.4	B08		6	0041-0084	646.17	83.21	217	57.01	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			357.0	B08		6	0042-0084	782.09	84.02	216	62.43	0.697
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			644.8	B08		6	0043-0090	621.04	89.96	363	79.50	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			363.9	B08		6	0044-0090	264.22	90.64	234	58.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			464.4	B08		6	0045-0094	656.83	94.92	306	66.08	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			584.1	B08		6	0046-0095	382.88	95.30	152	47.46	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			338.5	B08		6	0047-0096	915.08	96.39	207	53.70	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			497.5	B08		6	0048-0101	758.37	101.39	211	57.46	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			535.3	B08		6	0049-0100	845.38	100.20	293	63.94	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			335.9	B08		6	0050-0102	96.53	102.95	297	64.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			367.1	B08		6	0051-0101	298.56	101.23	244	58.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			377.8	B08		6	0052-0100	798.87	100.66	225	56.28	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			353.8	B08		6	0053-0104	198.14	103.63	280	61.60	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			367.8	B08		6	0054-0103	877.50	103.52	247	58.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			455.0	B08		6	0055-0102	942.13	102.05	251	59.70	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			589.4	B08		6	0056-0107	744.36	107.67	162	47.21	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			712.7	B08		6	0057-0108	391.85	108.59	153	45.46	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.8	B08		6	0058-0113	78.79	113.28	277	65.36	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			358.0	B08		6	0059-0113	242.98	113.41	218	53.70	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			481.8	B08		6	0060-0116	766.18	115.78	150	48.04	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			423.6	B08		6	0061-0116	804.17	116.51	207	54.28	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			421.4	B08		6	0062-0119	279.97	119.87	232	56.28	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			395.5	B08		6	0063-0123	914.69	123.08	259	61.01	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			259.9	B08		6	0064-0122	429.92	122.38	403	79.60	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			378.1	B08		6	0065-0128	842.71	127.97	474	112.37	0.472
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			36846.0	B08		6	0066-0127	889.58	127.61	385	73.50	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			512.9	B08		6	0067-0125	389.34	124.73	336	69.36	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.5	B08		6	0068-0127	691.92	126.57	245	71.84	0.597
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			334.5	B08		6	0069-0127	175.41	127.89	218	53.36	0.962
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			365.6	B08		6	0070-0132	125.98	132.86	282	62.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			379.6	B08		6	0071-0134	29.09	133.61	376	76.08	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			303.1	B08		6	0072-0130	208.92	130.13	164	48.28	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			544.7	B08		6	0073-0131	813.04	132.02	186	52.87	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			292.1	B08		6	0074-0133	355.82	133.13	343	67.94	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			296.4	B08		6	0075-0138	732.48	138.25	276	61.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			193.5	B08		6	0076-0144	149.47	145.45	274	73.60	0.636
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			425.4	B08		6	0077-0140	309.01	139.24	216	55.94	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.1	B08		6	0078-0143	196.39	143.48	203	56.28	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			330.3	B08		6	0079-0149	786.60	150.31	291	65.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			331.5	B08		6	0080-0150	386.37	149.85	275	60.77	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			495.6	B08		6	0081-0148	817.30	148.22	250	75.01	0.558
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			329.1	B08		6	0082-0150	946.96	149.91	242	58.18	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			596.5	B08		6	0083-0153	273.24	154.02	289	65.01	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			210.4	B08		6	0084-0155	131.09	155.52	247	59.01	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			428.0	B08		6	0085-0157	246.98	157.73	337	69.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			399.9	B08		6	0086-0158	457.24	158.53	339	68.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.9	B08		6	0087-0158	208.77	158.21	242	58.18	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			302.3	B08		6	0088-0166	49.73	166.25	354	70.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			340.5	B08		6	0089-0166	287.54	166.76	248	58.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			217.7	B08		6	0090-0175	870.84	175.38	381	75.26	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.6	B08		6	0091-0172	735.60	172.28	234	59.36	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			257.0	B08		6	0092-0175	835.95	175.10	250	57.94	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			526.8	B08		6	0093-0179	464.94	179.35	215	56.28	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			397.4	B08		6	0094-0179	190.45	179.29	343	71.36	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			425.6	B08		6	0095-0182	76.79	183.02	272	67.01	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			41535.6	B08		6	0096-0182	373.99	181.65	227	79.98	0.446
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			304.0	B08		6	0097-0181	690.04	180.83	277	62.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			313.7	B08		6	0098-0181	231.23	181.50	233	55.94	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			400.2	B08		6	0099-0183	917.64	183.66	167	53.60	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			452.6	B08		6	0100-0184	776.85	184.50	201	52.53	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			376.7	B08		6	0101-0185	758.74	184.56	217	53.36	0.958
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			301.2	B08		6	0102-0188	800.20	188.71	333	70.43	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			346.1	B08		6	0103-0190	397.97	190.57	256	61.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			314.7	B08		6	0104-0192	899.37	192.46	295	64.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			652.6	B08		6	0105-0200	108.71	200.14	359	70.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			277.3	B08		6	0106-0201	56.29	200.70	237	57.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			326.1	B08		6	0107-0200	681.99	201.10	237	62.18	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			330.6	B08		6	0108-0201	834.80	200.47	355	73.26	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			259.1	B08		6	0109-0203	176.64	202.27	263	66.18	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.9	B08		6	0110-0209	310.51	208.53	366	75.94	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			451.2	B08		6	0111-0209	472.29	209.39	215	55.94	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			429.5	B08		6	0112-0214	606.09	213.84	242	58.53	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			349.3	B08		6	0113-0214	818.32	214.27	239	57.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			347.6	B08		6	0114-0217	248.87	217.11	332	67.01	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			439.6	B08		6	0115-0217	500.00	216.60	186	49.94	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			447.2	B08		6	0116-0220	568.92	220.19	257	58.77	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			520.8	B08		6	0117-0224	726.78	223.78	320	67.60	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			286.2	B08		6	0118-0225	142.72	225.23	246	57.60	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			309.9	B08		6	0119-0226	234.60	227.06	200	53.70	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			328.5	B08		6	0120-0230	948.80	230.29	228	56.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			421.0	B08		6	0121-0228	659.39	227.78	153	49.80	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			455.0	B08		6	0122-0236	910.61	235.65	274	68.43	0.735
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			563.6	B08		6	0123-0235	375.34	234.72	210	54.04	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			417.2	B08		6	0124-0234	790.33	235.13	163	49.36	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			199.7	B08		6	0125-0238	896.97	238.66	203	60.77	0.691
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			234.0	B08		6	0126-0240	625.02	239.52	279	64.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			291.8	B08		6	0127-0246	178.90	245.48	428	85.50	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			356.8	B08		6	0128-0245	438.35	245.28	355	72.77	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.7	B08		6	0129-0245	646.48	243.67	266	67.60	0.732
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			418.4	B08		6	0130-0239	663.76	238.35	168	49.21	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			344.6	B08		6	0131-0243	67.63	243.52	213	56.28	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			56751.0	B08		6	0132-0247	486.91	246.95	253	64.18	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			268.4	B08		6	0133-0248	531.09	248.44	249	61.01	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			281.4	B08		6	0134-0251	417.01	250.38	212	58.77	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			336.9	B08		6	0135-0253	118.79	252.54	264	60.43	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			294.3	B08		6	0136-0252	675.65	252.20	285	64.53	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			303.7	B08		6	0137-0256	749.14	256.19	300	66.18	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			457.7	B08		6	0138-0253	368.01	252.98	164	51.11	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			223.3	B08		6	0139-0259	598.98	259.20	285	64.87	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			867.4	B08		6	0140-0256	824.76	255.95	217	56.77	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			381.6	B08		6	0141-0259	797.20	259.04	239	58.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			304.5	B08		6	0142-0261	21.52	261.09	298	65.01	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			382.0	B08		6	0143-0259	875.37	259.08	221	56.77	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.7	B08		6	0144-0261	553.37	260.39	166	60.18	0.576
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			494.3	B08		6	0145-0263	328.58	263.39	305	65.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			413.3	B08		6	0146-0265	465.15	265.36	291	63.11	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			381.5	B08		6	0147-0271	68.92	272.53	363	108.23	0.389
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			320.3	B08		6	0148-0272	378.93	270.94	392	79.84	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			550.0	B08		6	0149-0267	850.10	267.54	159	47.70	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			416.3	B08		6	0150-0267	833.39	268.08	242	59.70	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			304.8	B08		6	0151-0270	502.39	270.25	255	61.11	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			286.1	B08		6	0152-0269	695.23	268.96	241	59.46	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			227.6	B08		6	0153-0274	150.00	273.10	270	66.43	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			344.2	B08		6	0154-0274	212.56	275.08	217	53.94	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			200.0	B08		6	0155-0272	548.82	271.76	128	44.87	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.1	B08		6	0156-0279	749.96	279.48	346	77.60	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			424.2	B08		6	0157-0284	596.70	283.79	306	64.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			279.3	B08		6	0158-0285	26.16	285.99	324	68.18	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			360.7	B08		6	0159-0287	859.77	287.10	212	55.36	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			385.3	B08		6	0160-0289	272.88	290.40	237	58.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			331.0	B08		6	0161-0300	476.24	299.32	489	97.88	0.641
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			380.0	B08		6	0162-0294	791.90	294.98	252	59.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.7	B08		6	0163-0297	932.42	297.09	289	64.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			344.9	B08		6	0164-0296	306.06	296.08	262	61.60	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			310.5	B08		6	0165-0298	403.47	297.49	312	65.60	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			421.7	B08		6	0166-0296	349.69	295.43	248	58.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.8	B08		6	0167-0295	433.52	295.30	274	64.77	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			717.4	B08		6	0168-0305	645.39	304.40	304	64.18	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			423.6	B08		6	0169-0305	706.26	305.14	243	59.11	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			484.8	B08		6	0170-0313	93.83	312.17	329	85.50	0.566
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			292.8	B08		6	0171-0309	41.27	308.98	197	57.11	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			460.3	B08		6	0172-0306	730.39	305.71	220	55.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			232.4	B08		6	0173-0312	150.84	313.41	276	66.77	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			604.8	B08		6	0174-0313	24.52	313.16	261	59.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			470.8	B08		6	0175-0313	793.17	313.02	264	59.70	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.3	B08		6	0176-0315	439.81	316.01	212	55.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.7	B08		6	0177-0317	396.13	317.87	407	81.01	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			395.1	B08		6	0178-0318	545.03	318.51	318	65.01	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			418.3	B08		6	0179-0327	754.74	327.17	263	61.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			873.9	B08		6	0180-0331	645.40	330.50	297	62.77	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			328.6	B08		6	0181-0334	491.61	334.18	219	55.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.8	B08		6	0182-0342	301.32	342.68	475	83.50	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			306.7	B08		6	0183-0340	61.74	339.55	158	51.11	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			422.7	B08		6	0184-0339	792.04	339.66	201	52.53	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			314.6	B08		6	0185-0342	72.89	343.66	231	63.11	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			516.9	B08		6	0186-0341	550.94	341.55	258	58.53	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			373.9	B08		6	0187-0345	938.04	345.64	413	76.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			365.3	B08		6	0188-0345	247.62	345.92	257	62.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			346.9	B08		6	0189-0345	736.76	345.12	222	56.18	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			304.7	B08		6	0190-0352	915.67	352.18	387	81.01	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			378.8	B08		6	0191-0352	377.14	351.79	219	57.70	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			347.8	B08		6	0192-0351	498.07	351.01	213	53.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			33064.1	B08		6	0193-0353	692.35	352.74	324	67.36	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			402.0	B08		6	0194-0357	364.46	357.85	224	56.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			467.0	B08		6	0195-0360	461.11	360.46	289	67.84	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			435.9	B08		6	0196-0361	649.92	360.91	230	56.53	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			350.2	B08		6	0197-0363	727.33	363.16	361	72.08	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			453.5	B08		6	0198-0362	812.22	361.84	247	58.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			489.1	B08		6	0199-0362	324.84	362.43	285	62.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			308.5	B08		6	0200-0364	433.33	364.31	205	53.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			485.9	B08		6	0201-0369	678.26	369.38	217	56.77	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			383.9	B08		6	0202-0376	638.40	376.92	207	56.18	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			213.5	B08		6	0203-0372	911.90	372.84	164	47.21	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.3	B08		6	0204-0379	717.08	380.18	358	71.26	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.0	B08		6	0205-0383	151.22	382.57	305	66.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			446.7	B08		6	0206-0382	289.74	381.60	226	57.36	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			326.9	B08		6	0207-0386	890.49	386.72	261	61.84	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			311.7	B08		6	0208-0387	834.65	386.96	213	56.87	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			287.1	B08		6	0209-0390	82.98	390.33	240	58.77	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			285.5	B08		6	0210-0392	36.05	392.71	211	67.01	0.590
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			396.2	B08		6	0211-0392	183.93	392.40	256	60.53	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			510.9	B08		6	0212-0392	298.98	391.86	144	51.01	0.695
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.4	B08		6	0213-0394	114.07	394.56	296	64.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			307.4	B08		6	0214-0394	281.33	394.54	232	57.11	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			398.3	B08		6	0215-0394	412.94	394.12	236	58.18	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			370.6	B08		6	0216-0397	433.84	396.77	302	64.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			334.5	B08		6	0217-0397	808.95	397.53	287	63.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			431.3	B08		6	0218-0399	16.41	398.13	187	55.36	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			576.9	B08		6	0219-0397	306.38	397.19	106	41.46	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			366.0	B08		6	0220-0401	566.73	401.12	273	61.60	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			310.7	B08		6	0221-0400	702.01	399.92	259	60.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.0	B08		6	0222-0402	262.75	402.44	261	59.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			286.8	B08		6	0223-0402	896.29	402.41	262	64.28	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			540.8	B08		6	0224-0402	917.05	402.60	176	50.53	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			416.4	B08		6	0225-0402	210.70	402.36	213	55.46	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			389.4	B08		6	0226-0406	634.54	405.98	182	52.53	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			346.5	B08		6	0227-0407	617.53	407.50	242	58.04	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			407.7	B08		6	0228-0410	844.46	410.10	232	59.11	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			424.5	B08		6	0229-0414	863.80	414.11	264	61.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			357.9	B08		6	0230-0419	316.94	419.35	384	73.50	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			322.2	B08		6	0231-0416	247.34	416.66	321	66.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			381.4	B08		6	0232-0418	543.53	418.25	242	59.36	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			293.2	B08		6	0233-0420	160.59	420.35	351	71.84	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.1	B08		6	0234-0420	689.89	420.40	331	71.01	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			505.8	B08		6	0235-0417	919.49	417.35	174	48.04	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			340.9	B08		6	0236-0420	650.08	420.06	260	61.36	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			325.0	B08		6	0237-0424	349.77	424.67	239	59.84	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			348.2	B08		6	0238-0422	529.94	422.92	197	54.28	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			225.3	B08		6	0239-0422	766.88	421.56	159	53.94	0.687
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			495.1	B08		6	0240-0430	842.47	430.45	339	69.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			228.2	B08		6	0241-0430	118.40	430.35	258	61.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			373.1	B08		6	0242-0431	611.93	431.41	318	67.01	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			388.1	B08		6	0243-0431	914.42	431.01	211	57.36	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			407.1	B08		6	0244-0432	934.62	432.12	214	58.53	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.3	B08		6	0245-0435	49.57	435.67	253	58.28	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.2	B08		6	0246-0432	771.14	431.83	128	51.70	0.602
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			450.8	B08		6	0247-0434	896.37	433.69	188	51.94	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			395.1	B08		6	0248-0443	875.29	443.91	144	50.53	0.709
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			308.1	B08		6	0249-0443	261.47	443.67	254	59.11	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			347.4	B08		6	0250-0444	558.68	443.73	283	64.53	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			323.1	B08		6	0251-0449	448.25	449.72	290	66.77	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			296.3	B08		6	0252-0448	228.27	448.43	318	67.94	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			585.6	B08		6	0253-0454	590.24	454.84	417	75.01	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			316.9	B08		6	0254-0455	50.24	454.70	312	65.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			310.9	B08		6	0255-0452	174.21	452.40	213	55.80	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.2	B08		6	0256-0455	701.19	455.85	283	66.67	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			364.2	B08		6	0257-0452	853.43	452.66	186	53.70	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			349.0	B08		6	0258-0457	671.01	456.28	211	57.94	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			311.7	B08		6	0259-0458	464.15	458.21	320	68.18	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			314.0	B08		6	0260-0458	747.26	458.97	233	64.43	0.705
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			285.4	B08		6	0261-0462	420.15	463.25	341	75.50	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			264.0	B08		6	0262-0459	85.49	459.20	238	57.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			277.0	B08		6	0263-0459	507.37	459.32	214	54.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			364.0	B08		6	0264-0465	314.66	465.76	333	71.01	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			375.7	B08		6	0265-0466	136.07	466.13	354	71.11	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.7	B08		6	0266-0468	172.72	467.77	250	63.70	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			289.4	B08		6	0267-0473	491.59	472.88	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			319.2	B08		6	0268-0473	815.16	473.17	253	59.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			236.6	B08		6	0269-0478	780.69	477.91	325	68.77	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			364.9	B08		6	0270-0475	227.97	475.28	214	57.11	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			285.8	B08		6	0271-0480	211.70	481.35	251	62.18	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			404.8	B08		6	0272-0483	859.42	482.86	271	64.18	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			308.1	B08		6	0273-0485	752.35	484.85	237	60.87	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			410.0	B08		6	0274-0483	585.53	483.73	243	63.36	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			502.6	B08		6	0275-0484	385.51	485.19	164	50.87	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			279.6	B08		6	0276-0488	89.40	489.15	395	75.01	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			386.5	B08		6	0277-0489	296.69	488.85	244	58.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			325.0	B08		6	0278-0492	143.08	492.32	228	55.36	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			398.0	B08		6	0279-0491	336.64	491.70	220	56.28	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.7	B08		6	0280-0492	513.77	492.88	252	59.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.4	B08		6	0281-0498	48.00	498.20	251	59.94	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			326.6	B08		6	0282-0498	852.36	498.53	283	65.60	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.3	B08		6	0283-0500	111.63	500.19	240	58.77	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			292.0	B08		6	0284-0500	478.43	499.97	207	51.46	0.982
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			389.5	B08		6	0285-0501	795.41	501.71	210	53.70	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			277.5	B08		6	0286-0503	443.46	502.86	393	76.67	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			487.9	B08		6	0287-0504	559.57	504.46	323	67.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			360.5	B08		6	0288-0504	831.86	504.47	290	62.53	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			355.3	B08		6	0289-0505	333.16	504.68	199	54.87	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			349.7	B08		6	0290-0509	934.43	509.12	471	88.57	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			277.6	B08		6	0291-0510	601.38	510.61	350	70.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			307.9	B08		6	0292-0512	911.09	511.98	298	68.18	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			309.6	B08		6	0293-0514	516.97	514.15	236	57.70	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			257.7	B08		6	0294-0515	42.43	515.91	283	62.18	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.9	B08		6	0295-0516	653.99	516.16	302	66.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.8	B08		6	0296-0518	896.99	517.89	228	60.77	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			320.1	B08		6	0297-0518	64.81	518.39	236	56.77	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.6	B08		6	0298-0521	259.18	521.20	288	64.43	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			323.9	B08		6	0299-0522	759.26	522.01	321	66.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.5	B08		6	0300-0521	695.19	521.83	316	67.84	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			313.1	B08		6	0301-0524	307.39	524.49	237	63.60	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			355.3	B08		6	0302-0524	537.36	523.04	202	57.36	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			461.5	B08		6	0303-0526	738.26	525.71	335	67.11	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			448.6	B08		6	0304-0530	442.40	529.89	215	53.94	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			295.5	B08		6	0305-0529	222.70	529.77	259	62.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			270.3	B08		6	0306-0533	148.88	533.45	266	64.77	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			331.2	B08		6	0307-0537	520.57	536.09	307	66.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			337.7	B08		6	0308-0540	795.24	540.18	237	62.77	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			268.2	B08		6	0309-0541	927.11	540.64	263	61.36	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			225.9	B08		6	0310-0541	111.28	540.83	251	61.94	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			423.0	B08		6	0311-0538	356.39	538.08	144	45.36	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			350.3	B08		6	0312-0542	430.57	542.86	238	62.43	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			305.3	B08		6	0313-0544	37.62	545.15	245	60.18	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			314.0	B08		6	0314-0547	665.59	548.67	353	72.67	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			413.9	B08		6	0315-0546	456.52	545.84	221	57.36	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			350.1	B08		6	0316-0549	376.55	548.79	276	62.87	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			273.0	B08		6	0317-0551	228.15	552.09	280	66.77	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.1	B08		6	0318-0547	558.15	547.60	267	61.94	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			411.8	B08		6	0319-0549	84.88	549.15	205	52.28	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			562.2	B08		6	0320-0548	343.66	548.44	170	50.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			287.5	B08		6	0321-0550	623.33	550.48	234	56.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			398.7	B08		6	0322-0553	852.44	553.40	224	58.53	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.5	B08		6	0323-0552	702.41	551.60	300	63.36	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.5	B08		6	0324-0555	65.46	554.14	214	59.70	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			727.7	B08		6	0325-0559	412.48	559.15	240	58.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			411.7	B08		6	0326-0556	466.53	556.84	195	54.53	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			628.4	B08		6	0327-0560	785.46	559.58	267	62.43	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			226.3	B08		6	0328-0560	950.45	560.92	238	60.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			291.0	B08		6	0329-0566	215.30	565.75	257	61.70	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			383.9	B08		6	0330-0569	328.41	568.40	269	61.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			312.5	B08		6	0331-0574	461.56	575.67	264	67.36	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			526.4	B08		6	0332-0573	871.02	573.07	373	70.18	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.2	B08		6	0333-0572	501.78	572.33	159	49.11	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.8	B08		6	0334-0578	44.25	578.31	327	75.01	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			404.3	B08		6	0335-0576	831.51	575.40	184	50.87	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			4058.1	B08		6	0336-0579	405.43	579.94	296	65.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.4	B08		6	0337-0580	940.14	579.77	260	61.94	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			593.0	B08		6	0338-0582	118.12	582.44	355	70.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.0	B08		6	0339-0581	545.71	581.43	267	62.43	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			361.9	B08		6	0340-0583	758.34	583.80	270	60.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			375.6	B08		6	0341-0590	861.76	590.73	212	56.28	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			216.0	B08		6	0342-0593	897.40	593.24	281	63.60	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.3	B08		6	0343-0595	503.64	594.99	153	46.28	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			340.8	B08		6	0344-0598	186.48	597.91	353	69.84	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.5	B08		6	0345-0598	925.56	598.86	254	59.11	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			327.1	B08		6	0346-0594	793.86	594.85	119	44.28	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.0	B08		6	0347-0601	45.57	601.17	270	62.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.4	B08		6	0348-0604	674.21	604.94	328	70.77	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			293.9	B08		6	0349-0605	300.47	604.75	327	68.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			328.9	B08		6	0350-0604	797.84	604.85	204	61.94	0.668
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			252.3	B08		6	0351-0610	121.59	610.26	241	58.53	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			497.7	B08		6	0352-0614	419.35	614.52	331	67.60	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			359.8	B08		6	0353-0617	18.20	617.26	228	54.53	0.964
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			897.8	B08		6	0354-0620	371.00	620.02	395	78.08	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			386.1	B08		6	0355-0618	818.54	619.07	286	63.11	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			284.4	B08		6	0356-0621	886.62	621.92	270	61.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.3	B08		6	0357-0624	540.31	624.49	305	65.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			316.0	B08		6	0358-0624	108.75	623.92	311	66.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			270.8	B08		6	0359-0624	238.42	623.48	277	64.53	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			344.2	B08		6	0360-0627	41.31	627.73	283	63.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			360.7	B08		6	0361-0632	771.16	631.75	395	74.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			235.1	B08		6	0362-0638	948.41	638.14	366	72.43	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			40586.9	B08		6	0363-0639	381.42	638.47	293	64.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			335.8	B08		6	0364-0642	841.54	642.68	274	63.84	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			305.9	B08		6	0365-0646	214.06	645.66	254	63.11	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.3	B08		6	0366-0646	912.19	645.78	237	57.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			364.1	B08		6	0367-0648	64.54	648.32	224	56.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.2	B08		6	0368-0650	489.58	649.78	282	63.01	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.5	B08		6	0369-0653	422.26	652.20	405	76.67	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			305.6	B08		6	0370-0648	826.17	648.23	215	54.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			295.9	B08		6	0371-0653	113.86	652.70	231	58.87	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			283.0	B08		6	0372-0653	602.39	653.01	329	69.01	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			213.6	B08		6	0373-0658	18.30	658.28	370	72.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.6	B08		6	0374-0655	712.94	655.48	293	65.36	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			519.8	B08		6	0375-0658	328.43	658.02	305	64.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			340.7	B08		6	0376-0664	781.20	663.74	247	59.36	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			308.6	B08		6	0377-0662	900.70	662.82	224	56.53	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.5	B08		6	0378-0664	148.61	664.67	220	53.94	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			303.4	B08		6	0379-0663	524.35	662.59	272	61.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			316.0	B08		6	0380-0665	835.11	664.12	225	61.01	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			350.4	B08		6	0381-0673	210.21	673.07	188	52.87	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			296.0	B08		6	0382-0672	430.67	672.77	245	58.87	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			359.0	B08		6	0383-0673	822.78	674.69	235	58.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.6	B08		6	0384-0675	614.54	674.84	272	63.01	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			368.1	B08		6	0385-0674	859.84	673.39	222	57.01	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.7	B08		6	0386-0675	663.73	675.40	406	77.01	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.6	B08		6	0387-0677	744.93	677.07	237	59.11	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.3	B08		6	0388-0683	78.83	682.69	354	73.26	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			410.0	B08		6	0389-0681	930.27	681.12	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			742.4	B08		6	0390-0686	260.52	686.06	309	64.18	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			317.1	B08		6	0391-0684	802.37	683.50	206	53.11	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			344.8	B08		6	0392-0686	126.55	686.41	213	56.28	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			446.0	B08		6	0393-0687	406.24	687.58	300	63.60	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.0	B08		6	0394-0688	38.48	688.08	219	55.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			444.8	B08		6	0395-0692	336.61	691.64	260	61.01	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.3	B08		6	0396-0693	377.30	693.73	143	47.80	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			283.5	B08		6	0397-0694	473.18	694.78	246	59.94	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			356.4	B08		6	0398-0700	708.19	700.42	393	75.01	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			299.9	B08		6	0399-0699	725.25	699.07	256	59.70	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			544.6	B08		6	0400-0703	517.50	703.30	205	54.53	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			310.8	B08		6	0401-0706	576.37	706.19	196	53.94	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			394.0	B08		6	0402-0707	116.69	707.16	302	66.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			212.3	B08		6	0403-0709	376.77	708.80	241	61.70	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			460.9	B08		7	0001-0026	81.39	26.79	137	43.94	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			464.8	B08		7	0002-0029	247.78	28.87	248	59.11	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			323.0	B08		7	0003-0028	824.82	27.21	222	55.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			408.5	B08		7	0004-0033	560.84	33.13	299	64.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			293.4	B08		7	0005-0031	711.12	31.85	252	59.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			425.8	B08		7	0006-0036	632.02	36.41	452	80.08	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			772.0	B08		7	0007-0036	390.73	36.07	154	54.28	0.657
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			284.5	B08		7	0008-0040	52.67	39.62	298	66.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			458.7	B08		7	0009-0037	403.64	36.79	145	43.80	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			381.7	B08		7	0010-0043	16.80	44.41	162	53.70	0.706
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			466.7	B08		7	0011-0040	381.00	39.87	117	42.87	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			393.5	B08		7	0012-0047	30.32	48.28	217	59.94	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			302.5	B08		7	0013-0047	435.38	48.08	253	60.53	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			314.2	B08		7	0014-0046	920.57	45.84	220	55.11	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			361.7	B08		7	0015-0051	272.52	52.16	262	67.50	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			485.7	B08		7	0016-0050	486.01	50.03	449	81.26	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			439.8	B08		7	0017-0057	78.11	57.33	229	56.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			650.6	B08		7	0018-0063	120.28	62.76	458	79.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			338.7	B08		7	0019-0063	57.27	62.60	233	62.77	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			485.5	B08		7	0020-0064	310.19	63.67	254	74.08	0.582
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			398.0	B08		7	0021-0067	750.66	66.50	391	72.67	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			403.3	B08		7	0022-0066	821.45	66.51	304	65.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			320.5	B08		7	0023-0066	167.52	66.48	242	59.94	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			322.8	B08		7	0024-0067	451.50	67.38	306	67.84	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			486.1	B08		7	0025-0073	68.84	72.68	197	51.70	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			365.0	B08		7	0026-0078	911.74	78.18	401	74.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			400.1	B08		7	0027-0081	195.65	81.18	335	69.26	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			389.6	B08		7	0028-0083	493.62	83.30	468	86.91	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			327.8	B08		7	0029-0081	336.24	81.83	194	56.18	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			268.9	B08		7	0030-0084	688.64	84.51	298	66.67	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			376.9	B08		7	0031-0084	776.67	84.47	260	60.18	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.6	B08		7	0032-0087	403.82	87.15	260	59.60	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			461.6	B08		7	0033-0092	240.65	92.13	310	64.77	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			322.7	B08		7	0034-0096	739.27	96.03	240	58.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			303.6	B08		7	0035-0102	295.43	101.57	365	80.43	0.709
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			283.5	B08		7	0036-0106	440.25	106.12	284	64.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			358.0	B08		7	0037-0112	414.56	114.02	365	86.91	0.607
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			220.0	B08		7	0038-0113	24.04	114.25	259	58.77	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.4	B08		7	0039-0115	912.85	115.08	264	62.43	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			370.1	B08		7	0040-0112	91.25	111.96	205	54.28	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.4	B08		7	0041-0116	861.89	116.11	264	61.36	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			428.2	B08		7	0042-0122	319.98	122.32	317	69.60	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			321.7	B08		7	0043-0121	338.52	120.85	147	52.63	0.667
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			347.5	B08		7	0044-0123	389.16	122.64	301	66.43	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			390.2	B08		7	0045-0121	188.05	120.87	238	64.77	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			557.3	B08		7	0046-0130	584.23	129.68	444	82.08	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			252.2	B08		7	0047-0127	632.15	126.73	300	77.26	0.632
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			434.7	B08		7	0048-0128	236.19	127.72	257	57.70	0.970
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			386.6	B08		7	0049-0132	83.70	132.95	279	65.36	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			416.6	B08		7	0050-0132	157.49	131.97	151	45.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			442.9	B08		7	0051-0132	199.98	133.12	219	57.94	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			316.2	B08		7	0052-0135	440.86	136.01	267	62.77	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			370.4	B08		7	0053-0138	378.41	138.40	250	61.94	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.0	B08		7	0054-0143	802.02	142.93	505	87.84	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			682.3	B08		7	0055-0140	183.23	140.29	197	52.28	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			629.4	B08		7	0056-0141	168.37	141.83	204	53.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			549.4	B08		7	0057-0146	272.79	146.49	375	76.18	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			408.0	B08		7	0058-0143	290.74	142.61	123	42.28	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.7	B08		7	0059-0147	689.43	148.17	378	74.08	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			332.5	B08		7	0060-0151	888.71	150.40	366	70.77	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.2	B08		7	0061-0155	242.33	155.57	246	59.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			1333.0	B08		7	0062-0159	495.41	159.53	476	81.26	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			549.2	B08		7	0063-0154	140.59	153.43	151	49.36	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			657.2	B08		7	0064-0161	339.70	161.13	531	97.40	0.703
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			932.3	B08		7	0065-0159	361.14	158.65	346	75.01	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.8	B08		7	0066-0159	674.90	159.46	220	57.60	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.7	B08		7	0067-0164	634.54	165.00	233	63.84	0.718
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			488.3	B08		7	0068-0163	134.49	163.21	162	51.60	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.0	B08		7	0069-0164	415.04	164.40	351	71.01	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			279.4	B08		7	0070-0164	465.84	164.38	268	60.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			454.4	B08		7	0071-0165	88.45	165.93	207	53.70	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			339.8	B08		7	0072-0167	43.25	167.63	240	56.28	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			356.1	B08		7	0073-0169	215.15	169.30	400	75.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.0	B08		7	0074-0174	818.62	173.99	505	87.26	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.0	B08		7	0075-0171	853.97	170.66	361	72.08	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.6	B08		7	0076-0171	607.12	171.03	221	55.70	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			548.3	B08		7	0077-0176	307.71	176.43	399	76.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			362.1	B08		7	0078-0174	773.89	174.10	219	53.94	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			49351.6	B08		7	0079-0173	920.75	174.10	151	66.43	0.430
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.5	B08		7	0080-0179	627.32	179.07	275	68.77	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			404.0	B08		7	0081-0183	92.24	182.24	227	58.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			332.1	B08		7	0082-0186	412.67	186.07	258	59.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			291.8	B08		7	0083-0191	529.97	191.30	400	74.91	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			353.3	B08		7	0084-0193	162.74	193.94	271	72.33	0.651
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			444.0	B08		7	0085-0194	571.70	194.47	302	64.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			395.6	B08		7	0086-0193	719.20	193.39	188	53.94	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			477.7	B08		7	0087-0196	899.44	197.36	350	72.18	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			373.0	B08		7	0088-0195	686.08	194.73	240	57.94	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			289.3	B08		7	0089-0197	218.70	197.96	244	59.36	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			324.8	B08		7	0090-0198	314.70	198.25	251	58.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			473.5	B08		7	0091-0196	613.26	196.59	204	56.87	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			302.3	B08		7	0092-0201	946.42	201.19	274	66.08	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			303.8	B08		7	0093-0206	58.01	206.48	258	61.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			313.0	B08		7	0094-0211	177.98	211.36	360	69.60	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			440.1	B08		7	0095-0216	397.84	216.51	337	69.26	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.9	B08		7	0096-0218	339.99	218.35	273	60.77	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			463.8	B08		7	0097-0221	569.60	222.01	391	87.50	0.642
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			293.2	B08		7	0098-0219	89.92	218.98	242	57.11	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			308.0	B08		7	0099-0225	446.62	225.98	396	76.43	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			315.4	B08		7	0100-0228	126.72	228.49	240	56.77	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			418.8	B08		7	0101-0228	413.78	228.49	276	61.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.4	B08		7	0102-0231	907.18	231.20	289	63.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			632.8	B08		7	0103-0232	720.98	231.94	236	62.67	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			633.5	B08		7	0104-0233	264.91	234.22	194	56.53	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			474.7	B08		7	0105-0234	283.80	234.69	332	68.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			329.4	B08		7	0106-0237	521.36	236.40	382	73.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			372.3	B08		7	0107-0236	947.56	236.18	340	68.77	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			312.0	B08		7	0108-0237	872.17	237.48	266	63.84	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			13588.8	B08		7	0109-0245	843.77	243.71	350	102.57	0.418
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			484.2	B08		7	0110-0243	51.98	243.74	182	49.70	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			352.0	B08		7	0111-0243	604.19	243.46	216	59.36	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			339.4	B08		7	0112-0246	378.93	246.46	256	59.36	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			293.4	B08		7	0113-0249	463.00	249.54	233	56.53	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			307.0	B08		7	0114-0249	587.12	249.49	180	50.87	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			228.9	B08		7	0115-0254	128.47	254.68	307	80.57	0.594
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			445.5	B08		7	0116-0254	247.69	254.10	326	66.43	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			375.3	B08		7	0117-0256	397.74	256.62	240	57.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			310.4	B08		7	0118-0259	553.97	259.30	371	73.01	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			277.0	B08		7	0119-0257	323.31	257.59	255	59.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			302.1	B08		7	0120-0264	877.21	264.15	243	65.94	0.702
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			449.2	B08		7	0121-0264	429.23	263.74	193	51.11	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			357.5	B08		7	0122-0265	682.52	264.78	242	60.18	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			295.9	B08		7	0123-0268	23.52	267.27	312	68.67	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			206.8	B08		7	0124-0273	942.28	273.29	228	55.11	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			321.4	B08		7	0125-0277	472.77	276.83	285	65.36	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.8	B08		7	0126-0279	591.93	279.81	335	67.60	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			379.4	B08		7	0127-0280	373.41	281.31	303	65.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.8	B08		7	0128-0281	97.96	280.43	287	68.18	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			406.2	B08		7	0129-0289	160.03	289.59	504	84.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			394.5	B08		7	0130-0286	717.44	286.35	251	59.94	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			335.7	B08		7	0131-0285	226.22	284.88	147	47.46	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			303.5	B08		7	0132-0287	884.60	287.66	261	63.01	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			345.8	B08		7	0133-0287	266.28	286.81	204	54.28	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			331.3	B08		7	0134-0295	42.73	293.97	470	84.67	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			472.0	B08		7	0135-0290	409.83	289.56	218	55.11	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			310.8	B08		7	0136-0296	638.34	296.98	357	70.43	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			364.2	B08		7	0137-0296	95.19	296.13	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			361.4	B08		7	0138-0300	300.90	299.53	352	70.18	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			426.7	B08		7	0139-0299	441.91	299.04	285	62.53	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			345.7	B08		7	0140-0303	747.06	302.21	284	64.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			614.4	B08		7	0141-0300	226.96	300.39	100	38.04	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.4	B08		7	0142-0307	921.16	307.62	285	79.50	0.567
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			305.1	B08		7	0143-0304	356.23	304.27	278	65.01	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			707.7	B08		7	0144-0303	621.62	304.04	199	53.11	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.5	B08		7	0145-0309	250.39	309.05	279	69.01	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			308.6	B08		7	0146-0312	495.72	311.78	412	83.98	0.734
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			316.1	B08		7	0147-0310	729.52	310.80	232	57.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			299.2	B08		7	0148-0311	762.11	310.96	229	57.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			371.5	B08		7	0149-0310	528.20	310.63	234	58.28	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.0	B08		7	0150-0312	795.82	311.91	291	64.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			337.4	B08		7	0151-0316	235.32	316.79	240	70.43	0.608
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			534.4	B08		7	0152-0312	410.34	312.51	248	58.63	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.6	B08		7	0153-0317	371.38	316.56	293	65.94	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			364.7	B08		7	0154-0316	266.32	316.82	171	48.87	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			344.5	B08		7	0155-0319	546.92	318.83	210	54.18	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			448.6	B08		7	0156-0321	27.86	321.46	191	51.36	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			367.8	B08		7	0157-0328	430.10	328.68	339	67.94	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			379.1	B08		7	0158-0327	847.85	326.72	221	54.28	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			820.2	B08		7	0159-0326	410.89	326.20	166	48.39	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			384.6	B08		7	0160-0331	450.98	331.32	320	66.53	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			322.0	B08		7	0161-0334	292.22	334.82	267	65.94	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			393.3	B08		7	0162-0336	930.56	336.09	198	53.60	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			608.7	B08		7	0163-0336	162.68	335.79	175	49.94	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			307.6	B08		7	0164-0338	896.94	338.98	324	67.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			551.1	B08		7	0165-0338	660.25	337.98	156	50.87	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			481.7	B08		7	0166-0341	646.64	340.59	261	61.11	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			484.3	B08		7	0167-0340	675.12	339.91	190	52.77	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.0	B08		7	0168-0342	707.87	342.91	276	69.84	0.711
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			729.8	B08		7	0169-0342	784.65	342.46	217	55.36	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			328.9	B08		7	0170-0343	309.89	343.09	258	60.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			587.9	B08		7	0171-0346	481.88	346.11	316	72.77	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			399.5	B08		7	0172-0349	217.80	349.32	361	71.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			417.9	B08		7	0173-0347	153.24	347.05	227	56.18	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			327.6	B08		7	0174-0350	859.26	351.10	336	68.53	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			557.0	B08		7	0175-0349	800.64	349.33	177	49.70	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.7	B08		7	0176-0353	338.93	352.34	261	60.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			419.1	B08		7	0177-0358	71.12	358.95	447	91.74	0.667
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			419.6	B08		7	0178-0353	817.46	353.46	233	59.70	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			538.5	B08		7	0179-0362	371.36	361.56	494	93.05	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			421.6	B08		7	0180-0367	99.04	367.18	454	85.74	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			669.3	B08		7	0181-0359	462.03	360.16	146	45.21	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			277.7	B08		7	0182-0369	691.26	369.39	264	64.08	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			377.5	B08		7	0183-0370	447.16	369.83	216	55.11	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			355.7	B08		7	0184-0370	843.94	370.61	319	66.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			216.0	B08		7	0185-0371	278.60	372.16	262	63.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			294.6	B08		7	0186-0375	503.14	375.57	260	65.36	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.0	B08		7	0187-0374	307.18	373.51	277	65.36	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			458.8	B08		7	0188-0373	354.76	374.48	147	49.36	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			651.8	B08		7	0189-0376	381.94	376.76	278	67.01	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.3	B08		7	0190-0380	727.75	380.71	335	69.84	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			392.3	B08		7	0191-0380	526.81	381.04	221	57.36	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.2	B08		7	0192-0384	684.62	383.73	275	63.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			354.8	B08		7	0193-0390	164.13	389.70	472	83.36	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			777.1	B08		7	0194-0387	798.47	387.55	357	70.43	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			404.8	B08		7	0195-0388	927.26	388.88	312	65.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			295.1	B08		7	0196-0394	185.85	393.76	261	63.01	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			562.2	B08		7	0197-0395	116.26	395.13	255	58.77	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.1	B08		7	0198-0393	840.15	393.95	241	57.70	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			306.8	B08		7	0199-0399	899.11	399.12	309	65.36	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			476.3	B08		7	0200-0400	555.73	400.33	333	71.01	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			418.4	B08		7	0201-0402	94.97	402.82	390	74.43	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			357.8	B08		7	0202-0403	503.44	403.91	240	59.70	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			453.2	B08		7	0203-0402	782.10	402.91	155	50.87	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.7	B08		7	0204-0406	870.45	407.13	285	71.01	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.7	B08		7	0205-0405	281.16	404.51	254	62.77	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			366.1	B08		7	0206-0408	439.39	407.70	223	57.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			379.3	B08		7	0207-0407	677.66	407.11	250	57.94	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			211.9	B08		7	0208-0409	946.76	409.94	278	67.01	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			309.9	B08		7	0209-0408	50.70	408.74	253	61.70	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.5	B08		7	0210-0408	329.76	408.12	319	72.43	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			135.1	B08		7	0211-0412	228.68	412.13	306	65.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			34599.7	B08		7	0212-0413	582.83	413.25	313	67.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			336.5	B08		7	0213-0409	753.48	408.41	161	49.70	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			279.4	B08		7	0214-0416	308.23	416.71	224	61.36	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			389.2	B08		7	0215-0419	544.64	418.65	204	51.94	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.4	B08		7	0216-0420	627.16	420.38	308	67.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.6	B08		7	0217-0423	938.35	422.78	276	65.26	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			264.7	B08		7	0218-0427	816.11	427.07	261	61.70	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.5	B08		7	0219-0428	330.82	429.26	299	66.43	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			315.0	B08		7	0220-0429	710.81	428.85	298	66.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			403.2	B08		7	0221-0431	199.59	430.66	279	63.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			257.7	B08		7	0222-0432	784.78	431.99	288	65.60	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			412.5	B08		7	0223-0436	80.45	436.11	367	73.11	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			452.0	B08		7	0224-0434	530.11	433.20	296	67.60	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			473.4	B08		7	0225-0437	547.31	438.14	267	65.26	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			318.0	B08		7	0226-0438	24.77	437.88	236	59.70	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			555.4	B08		7	0227-0437	102.70	437.10	222	58.18	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			402.2	B08		7	0228-0438	689.99	437.92	218	56.28	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			316.2	B08		7	0229-0444	644.17	443.89	414	80.67	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.0	B08		7	0230-0445	349.35	444.63	254	62.18	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			335.4	B08		7	0231-0448	673.60	448.71	311	67.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			301.0	B08		7	0232-0451	760.98	450.72	222	61.94	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.9	B08		7	0233-0451	577.59	451.76	277	63.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			673.3	B08		7	0234-0454	817.04	453.79	324	68.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			299.3	B08		7	0235-0456	455.98	456.45	269	64.18	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			505.6	B08		7	0236-0460	63.98	460.09	299	63.94	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			281.2	B08		7	0237-0466	864.93	466.05	302	80.91	0.580
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			408.4	B08		7	0238-0464	356.84	463.88	256	60.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			257.7	B08		7	0239-0466	513.38	466.70	281	63.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			444.8	B08		7	0240-0467	328.45	467.72	371	83.84	0.663
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			358.3	B08		7	0241-0468	849.84	468.20	184	53.46	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			466.9	B08		7	0242-0472	906.09	471.68	340	76.67	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			329.4	B08		7	0243-0470	203.00	469.81	222	58.18	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			320.1	B08		7	0244-0472	236.38	472.69	220	59.01	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			233.4	B08		7	0245-0477	934.34	478.49	318	72.43	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			384.2	B08		7	0246-0481	651.26	482.10	510	106.57	0.564
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			602.3	B08		7	0247-0486	129.79	486.75	499	86.67	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			389.2	B08		7	0248-0482	398.08	481.83	240	57.60	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			383.4	B08		7	0249-0484	782.53	484.13	397	75.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			370.0	B08		7	0250-0491	555.13	492.15	336	68.43	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			337.3	B08		7	0251-0493	488.53	493.04	280	65.01	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			312.5	B08		7	0252-0496	630.32	496.96	275	61.01	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			314.8	B08		7	0253-0504	76.36	503.82	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			291.2	B08		7	0254-0512	563.18	512.38	275	61.11	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			328.9	B08		7	0255-0515	929.60	515.28	331	67.84	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			337.4	B08		7	0256-0515	303.66	514.76	221	56.18	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			354.7	B08		7	0257-0517	419.55	516.60	219	54.87	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			268.3	B08		7	0258-0520	523.11	521.12	339	71.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			388.5	B08		7	0259-0523	102.70	523.12	267	67.94	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			424.6	B08		7	0260-0520	194.12	520.44	217	55.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.5	B08		7	0261-0521	781.22	521.50	240	62.18	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			390.0	B08		7	0262-0522	715.60	522.41	182	49.11	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			427.1	B08		7	0263-0529	225.10	528.94	309	65.11	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			446.8	B08		7	0264-0527	285.61	527.28	236	57.70	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			311.2	B08		7	0265-0530	149.38	529.94	288	65.94	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			380.4	B08		7	0266-0534	429.34	534.91	260	62.43	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.6	B08		7	0267-0536	770.17	537.07	227	56.18	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			290.6	B08		7	0268-0540	906.22	540.02	407	76.43	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			390.6	B08		7	0269-0540	335.32	539.97	212	55.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.0	B08		7	0270-0545	548.09	545.33	251	59.94	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			373.5	B08		7	0271-0545	270.40	544.99	189	51.94	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			354.5	B08		7	0272-0546	447.50	545.93	228	58.43	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			309.3	B08		7	0273-0553	804.74	553.28	232	58.77	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			332.5	B08		7	0274-0549	859.05	549.05	126	43.46	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			336.1	B08		7	0275-0551	482.79	550.94	212	53.70	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			315.4	B08		7	0276-0552	392.00	551.27	300	69.60	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			287.2	B08		7	0277-0553	821.00	553.94	198	56.18	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			461.1	B08		7	0278-0555	301.57	555.59	283	65.94	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			294.5	B08		7	0279-0558	776.62	558.39	269	62.53	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			507.9	B08		7	0280-0559	689.71	560.15	226	62.77	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			402.3	B08		7	0281-0560	339.19	559.53	187	51.36	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			336.9	B08		7	0282-0564	852.72	564.30	217	55.84	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			312.4	B08		7	0283-0565	273.27	565.52	251	61.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			319.2	B08		7	0284-0566	215.27	567.71	321	73.01	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			281.1	B08		7	0285-0568	794.53	567.90	241	58.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.9	B08		7	0286-0568	574.60	568.25	313	68.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			284.6	B08		7	0287-0571	97.09	571.01	324	68.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			350.5	B08		7	0288-0572	358.39	571.60	225	57.70	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			361.5	B08		7	0289-0568	451.12	568.59	194	50.87	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			324.3	B08		7	0290-0571	514.70	571.55	238	57.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			329.7	B08		7	0291-0575	818.21	576.01	261	63.11	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			363.5	B08		7	0292-0573	627.10	573.01	252	58.87	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			655.3	B08		7	0293-0587	161.52	585.95	593	107.05	0.650
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			414.4	B08		7	0294-0580	382.48	581.18	206	56.04	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			268.3	B08		7	0295-0582	856.68	582.60	241	59.84	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			501.0	B08		7	0296-0581	454.66	581.62	195	53.21	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			227.4	B08		7	0297-0584	20.47	584.14	229	57.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			308.8	B08		7	0298-0589	65.54	589.46	360	71.36	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			273.9	B08		7	0299-0589	202.30	589.49	276	69.01	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			289.2	B08		7	0300-0586	306.59	585.47	227	56.53	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			416.6	B08		7	0301-0587	540.11	586.99	191	51.36	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			389.9	B08		7	0302-0589	419.81	589.22	243	57.11	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			360.9	B08		7	0303-0589	641.78	589.13	208	54.28	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			339.3	B08		7	0304-0591	870.52	591.42	226	55.11	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			578.9	B08		7	0305-0592	401.35	592.08	206	54.28	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			755.1	B08		7	0306-0595	386.10	595.23	181	51.80	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.1	B08		7	0307-0599	934.08	598.75	396	74.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			696.4	B08		7	0308-0597	468.94	597.78	296	63.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			707.0	B08		7	0309-0599	531.68	600.05	232	55.36	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			293.6	B08		7	0310-0600	586.68	599.78	239	57.70	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			343.2	B08		7	0311-0603	237.89	602.51	256	58.53	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.6	B08		7	0312-0603	747.56	603.22	140	46.28	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			355.6	B08		7	0313-0607	275.96	606.98	234	56.53	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			304.9	B08		7	0314-0618	761.53	616.65	395	87.26	0.652
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			393.9	B08		7	0315-0618	317.58	618.43	245	59.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			371.4	B08		7	0316-0620	798.63	619.75	372	73.60	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			273.2	B08		7	0317-0619	184.08	618.67	255	59.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			397.1	B08		7	0318-0619	536.33	619.55	203	52.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			338.8	B08		7	0319-0619	732.67	618.91	225	58.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			289.7	B08		7	0320-0624	75.32	624.49	297	67.26	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			509.1	B08		7	0321-0626	149.52	625.62	378	74.18	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			268.2	B08		7	0322-0624	587.75	624.19	255	60.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			333.9	B08		7	0323-0628	266.79	628.79	272	64.77	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			301.0	B08		7	0324-0626	224.98	625.70	269	60.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			540.4	B08		7	0325-0631	33.55	631.63	372	75.84	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			389.0	B08		7	0326-0630	380.71	630.34	182	50.28	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			432.1	B08		7	0327-0632	742.45	633.18	264	63.60	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			329.7	B08		7	0328-0632	870.00	633.29	240	62.77	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			371.8	B08		7	0329-0638	418.93	637.29	242	58.18	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.4	B08		7	0330-0635	486.04	635.24	265	64.53	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			483.0	B08		7	0331-0636	884.42	636.28	183	50.63	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			342.5	B08		7	0332-0640	652.10	639.58	235	59.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.2	B08		7	0333-0642	303.25	642.62	278	63.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			374.5	B08		7	0334-0643	369.37	643.58	193	51.70	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			351.4	B08		7	0335-0647	536.33	647.18	228	57.01	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			330.3	B08		7	0336-0648	701.14	648.33	301	63.60	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			290.7	B08		7	0337-0655	825.26	654.58	343	71.50	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			321.0	B08		7	0338-0652	905.80	652.94	180	51.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			334.6	B08		7	0339-0656	494.86	656.41	261	60.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			370.5	B08		7	0340-0655	647.89	656.23	214	54.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			316.0	B08		7	0341-0660	619.43	660.42	307	68.53	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			268.5	B08		7	0342-0660	103.73	660.38	202	60.18	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			495.9	B08		7	0343-0661	331.53	661.26	282	62.28	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			405.6	B08		7	0344-0658	369.54	658.31	227	57.11	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			381.0	B08		7	0345-0659	935.36	658.91	181	52.43	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			368.5	B08		7	0346-0660	447.04	660.05	247	59.11	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.2	B08		7	0347-0665	250.08	665.56	256	60.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.4	B08		7	0348-0662	37.36	662.14	140	45.94	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			273.6	B08		7	0349-0668	273.05	667.94	244	60.18	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			317.6	B08		7	0350-0671	564.20	671.06	415	79.50	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			415.9	B08		7	0351-0668	724.95	667.73	304	64.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			291.8	B08		7	0352-0666	922.79	665.38	205	57.36	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			312.6	B08		7	0353-0670	193.80	670.59	269	61.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			382.7	B08		7	0354-0673	768.30	672.51	256	59.60	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			367.3	B08		7	0355-0672	377.96	672.48	212	55.46	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			281.6	B08		7	0356-0674	861.90	673.49	332	68.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			355.3	B08		7	0357-0676	85.23	676.00	223	57.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			233.1	B08		7	0358-0677	797.05	677.26	267	63.01	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			221.4	B08		7	0359-0675	34.76	675.73	175	50.28	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			362.2	B08		7	0360-0676	703.10	676.08	198	57.60	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			222.6	B08		7	0361-0678	52.72	679.35	218	59.36	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			528.1	B08		7	0362-0683	685.57	684.28	648	111.05	0.660
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			378.7	B08		7	0363-0680	448.23	679.47	224	55.36	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			181.3	B08		7	0364-0685	843.10	686.08	260	61.36	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			328.9	B08		7	0365-0688	618.11	687.90	248	63.84	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			376.7	B08		7	0366-0686	340.20	686.29	226	55.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			394.1	B08		7	0367-0692	413.83	691.73	372	73.26	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			533.2	B08		7	0368-0691	714.85	690.45	150	46.87	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			303.8	B08		7	0369-0694	912.92	694.90	229	57.94	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			292.0	B08		7	0370-0696	937.38	695.64	291	61.94	0.953
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.6	B08		7	0371-0697	52.33	696.50	224	55.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.3	B08		7	0372-0697	136.01	696.68	215	53.94	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			224.1	B08		7	0373-0702	234.35	703.26	290	67.36	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			339.2	B08		7	0374-0703	882.83	702.70	269	63.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			284.5	B08		7	0375-0704	371.40	704.40	237	58.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			400.1	B08		7	0376-0703	539.66	702.93	202	52.28	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			567.8	B08		7	0377-0700	690.84	700.22	159	45.70	0.957
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			359.6	B08		7	0378-0706	464.63	706.59	227	57.94	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			307.4	B08		7	0379-0706	646.96	706.78	211	53.11	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			198.7	B08		7	0380-0708	161.23	708.82	276	64.53	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			291.1	B08		8	0001-0027	605.94	27.87	215	56.28	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			218.6	B08		8	0002-0030	678.63	29.96	293	63.01	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			329.9	B08		8	0003-0030	332.84	29.76	212	53.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.1	B08		8	0004-0034	100.59	34.63	237	58.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			348.6	B08		8	0005-0030	274.05	30.58	219	59.70	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			294.5	B08		8	0006-0039	437.09	39.00	204	53.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			418.4	B08		8	0007-0041	321.69	41.81	212	54.28	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			439.2	B08		8	0008-0040	928.24	40.30	223	54.28	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.7	B08		8	0009-0043	461.70	44.14	285	63.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			315.9	B08		8	0010-0044	809.55	44.14	285	61.36	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.3	B08		8	0011-0045	569.92	43.93	174	54.43	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			317.1	B08		8	0012-0045	358.74	45.50	219	55.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			515.0	B08		8	0013-0045	633.25	45.14	254	60.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.0	B08		8	0014-0047	122.29	46.71	280	66.18	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.0	B08		8	0015-0048	25.24	47.86	211	53.11	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			442.3	B08		8	0016-0048	185.64	48.59	289	64.18	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			400.9	B08		8	0017-0049	384.18	48.78	310	66.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			354.7	B08		8	0018-0049	307.42	48.87	215	54.87	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.7	B08		8	0019-0050	580.11	51.04	112	44.87	0.699
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			320.3	B08		8	0020-0053	753.84	52.66	215	54.28	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			539.3	B08		8	0021-0053	254.99	53.81	251	60.53	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.2	B08		8	0022-0056	493.18	56.48	338	69.01	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			407.2	B08		8	0023-0054	940.44	54.25	205	52.28	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			314.5	B08		8	0024-0061	241.09	61.83	193	56.77	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			636.9	B08		8	0025-0056	768.83	55.64	147	45.80	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			478.4	B08		8	0026-0060	866.08	60.35	250	59.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.9	B08		8	0027-0063	559.18	62.41	294	67.60	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			355.3	B08		8	0028-0063	642.81	63.02	178	48.28	0.959
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			341.3	B08		8	0029-0064	701.82	64.72	262	60.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.4	B08		8	0030-0068	91.77	68.89	240	59.11	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			302.6	B08		8	0031-0070	346.19	69.91	273	61.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			306.5	B08		8	0032-0069	838.43	68.84	215	56.18	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			453.2	B08		8	0033-0070	765.62	69.56	157	46.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			448.8	B08		8	0034-0071	878.70	71.36	219	55.70	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			365.0	B08		8	0035-0075	248.18	76.27	218	55.36	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			501.6	B08		8	0036-0076	753.87	77.01	208	55.01	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			372.8	B08		8	0037-0078	789.59	77.65	266	62.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			409.0	B08		8	0038-0080	204.05	79.65	217	54.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.4	B08		8	0039-0082	535.30	81.33	202	55.46	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.8	B08		8	0040-0086	684.70	86.65	407	78.67	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			361.9	B08		8	0041-0081	911.11	81.40	246	57.70	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			379.5	B08		8	0042-0083	278.01	82.10	183	51.36	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			340.1	B08		8	0043-0083	422.56	82.95	209	52.87	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			359.3	B08		8	0044-0092	521.47	91.87	335	73.11	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.2	B08		8	0045-0087	654.93	87.18	272	62.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			369.1	B08		8	0046-0088	803.61	88.22	262	60.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.8	B08		8	0047-0085	312.89	85.51	156	48.04	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.7	B08		8	0048-0091	506.89	91.64	231	61.11	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			424.6	B08		8	0049-0093	265.32	92.69	347	69.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			50548.8	B08		8	0050-0089	466.44	89.42	126	64.67	0.379
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			670.4	B08		8	0051-0091	485.54	91.39	178	51.70	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			339.2	B08		8	0052-0095	578.56	94.28	158	52.53	0.720
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			705.5	B08		8	0053-0098	235.72	97.49	144	47.60	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.5	B08		8	0054-0097	312.79	96.29	117	40.63	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.8	B08		8	0055-0101	196.52	101.22	216	55.70	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			368.2	B08		8	0056-0109	168.10	109.50	416	84.08	0.739
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			286.6	B08		8	0057-0109	61.26	110.18	302	65.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.4	B08		8	0058-0109	325.70	109.43	285	64.53	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			625.6	B08		8	0059-0105	492.19	104.94	158	46.63	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			706.4	B08		8	0060-0109	225.69	109.46	155	46.53	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			212.3	B08		8	0061-0110	418.68	110.04	266	61.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			357.4	B08		8	0062-0110	740.53	109.96	202	53.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			338.2	B08		8	0063-0116	365.54	115.83	258	59.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.2	B08		8	0064-0117	17.34	117.17	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			341.1	B08		8	0065-0117	710.91	117.16	339	67.60	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			388.2	B08		8	0066-0114	692.08	114.01	112	40.04	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			220.2	B08		8	0067-0116	945.56	116.40	143	45.11	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			290.1	B08		8	0068-0119	476.58	119.53	226	55.94	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			310.8	B08		8	0069-0120	214.16	121.08	218	57.84	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			285.4	B08		8	0070-0123	458.80	122.27	270	66.18	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			270.8	B08		8	0071-0128	621.93	128.49	282	65.11	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.6	B08		8	0072-0126	810.83	124.99	255	63.36	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			328.5	B08		8	0073-0129	254.02	128.83	222	57.36	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			230.1	B08		8	0074-0126	312.43	126.66	288	67.94	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			299.9	B08		8	0075-0127	651.45	127.21	274	62.53	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			343.8	B08		8	0076-0124	693.52	124.41	100	38.63	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			508.5	B08		8	0077-0134	544.06	133.88	328	69.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			406.6	B08		8	0078-0131	834.06	131.69	238	57.36	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			426.3	B08		8	0079-0134	916.21	133.84	333	69.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			298.6	B08		8	0080-0139	433.99	140.31	312	67.60	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			423.8	B08		8	0081-0141	742.85	142.35	182	53.36	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.9	B08		8	0082-0142	371.39	142.67	287	66.18	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			385.3	B08		8	0083-0142	691.60	143.08	137	49.70	0.697
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			337.0	B08		8	0084-0147	102.87	147.30	221	58.28	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			321.0	B08		8	0085-0146	870.70	146.58	274	63.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.3	B08		8	0086-0145	813.59	145.20	244	62.53	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			326.1	B08		8	0087-0147	260.69	146.47	195	52.53	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			298.0	B08		8	0088-0151	610.95	151.63	257	69.60	0.667
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			348.3	B08		8	0089-0151	508.14	151.35	210	54.77	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			567.1	B08		8	0090-0152	201.67	152.39	324	67.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			419.2	B08		8	0091-0153	752.90	153.76	193	51.70	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.2	B08		8	0092-0154	646.52	153.18	233	58.53	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			222.4	B08		8	0093-0163	790.71	165.01	286	78.43	0.584
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.3	B08		8	0094-0160	115.51	160.99	260	59.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			211.1	B08		8	0095-0163	155.98	162.80	258	62.43	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.2	B08		8	0096-0167	638.49	167.91	284	66.67	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			207.4	B08		8	0097-0169	319.81	169.39	287	62.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			320.9	B08		8	0098-0170	387.76	170.51	216	54.53	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.1	B08		8	0099-0172	718.99	171.98	280	64.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.2	B08		8	0100-0174	444.36	173.61	393	78.43	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			366.6	B08		8	0101-0173	363.23	173.68	207	54.53	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			296.7	B08		8	0102-0172	824.23	172.48	190	52.14	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			522.2	B08		8	0103-0173	839.23	173.39	161	48.63	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			334.8	B08		8	0104-0174	855.85	173.78	202	54.53	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			781.2	B08		8	0105-0176	472.06	176.28	277	61.11	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			291.7	B08		8	0106-0176	589.15	176.50	204	53.11	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			50323.7	B08		8	0107-0174	24.47	175.02	132	43.46	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			47860.9	B08		8	0108-0181	916.02	180.69	140	89.98	0.217
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			385.1	B08		8	0109-0191	416.31	190.75	393	73.60	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.5	B08		8	0110-0190	557.40	189.97	233	57.36	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			423.7	B08		8	0111-0194	503.96	194.47	352	71.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			706.6	B08		8	0112-0193	528.14	193.10	302	65.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			346.2	B08		8	0113-0191	576.48	190.90	248	57.70	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			284.5	B08		8	0114-0196	82.44	197.40	250	59.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			347.7	B08		8	0115-0199	731.41	199.55	326	71.84	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			574.2	B08		8	0116-0206	797.58	204.88	608	103.98	0.707
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			290.7	B08		8	0117-0200	600.24	198.90	321	67.84	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.0	B08		8	0118-0201	706.38	200.68	275	65.60	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.4	B08		8	0119-0200	105.70	199.53	251	60.77	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			340.1	B08		8	0120-0203	51.33	203.14	263	64.67	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			188.5	B08		8	0121-0201	945.35	201.25	242	64.77	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			322.9	B08		8	0122-0202	841.47	202.21	265	59.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.5	B08		8	0123-0204	360.88	204.41	293	66.18	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.0	B08		8	0124-0203	473.99	203.12	291	67.36	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			475.4	B08		8	0125-0209	540.26	210.14	315	74.18	0.719
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			402.2	B08		8	0126-0207	210.90	207.35	301	65.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.8	B08		8	0127-0209	653.64	209.25	285	64.77	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			362.6	B08		8	0128-0216	905.41	216.77	342	71.60	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			428.5	B08		8	0129-0217	238.79	216.72	356	70.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			360.8	B08		8	0130-0219	326.08	218.78	230	67.11	0.642
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			360.3	B08		8	0131-0219	404.45	220.29	295	63.11	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.6	B08		8	0132-0222	573.44	222.43	240	57.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			438.7	B08		8	0133-0223	825.07	222.16	159	55.11	0.658
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			296.2	B08		8	0134-0228	177.37	228.44	252	65.60	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			345.3	B08		8	0135-0226	444.15	225.99	249	59.70	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			356.6	B08		8	0136-0226	297.91	225.97	241	57.01	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			306.0	B08		8	0137-0226	338.15	227.24	232	60.18	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			669.8	B08		8	0138-0225	836.01	225.90	134	47.94	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			259.9	B08		8	0139-0231	760.15	231.06	226	56.04	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.2	B08		8	0140-0233	362.12	232.89	237	60.18	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			212.9	B08		8	0141-0236	884.11	237.24	290	67.11	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			369.3	B08		8	0142-0238	52.62	238.34	342	68.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			308.8	B08		8	0143-0234	514.13	234.63	207	57.46	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			345.4	B08		8	0144-0239	844.35	239.44	239	58.77	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			308.1	B08		8	0145-0242	131.43	242.42	205	54.53	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			592.1	B08		8	0146-0241	497.89	242.11	176	49.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			211.4	B08		8	0147-0244	785.63	245.13	262	59.36	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.4	B08		8	0148-0244	401.72	243.93	213	54.53	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			303.6	B08		8	0149-0248	624.08	247.94	209	54.53	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			279.1	B08		8	0150-0249	726.50	248.48	254	59.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			475.9	B08		8	0151-0250	757.15	250.54	325	72.18	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			355.0	B08		8	0152-0249	644.05	249.45	254	60.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			48331.4	B08		8	0153-0252	104.77	251.94	312	65.11	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			313.4	B08		8	0154-0252	445.78	252.74	217	60.53	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			417.5	B08		8	0155-0256	571.64	257.18	211	59.70	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			468.3	B08		8	0156-0266	348.79	266.57	640	110.47	0.659
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.4	B08		8	0157-0258	883.69	257.58	273	61.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.9	B08		8	0158-0256	905.81	256.66	277	63.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			509.1	B08		8	0159-0260	833.84	260.57	489	90.08	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			307.8	B08		8	0160-0260	689.87	260.20	232	57.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			416.1	B08		8	0161-0262	492.09	262.56	290	63.60	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			259.4	B08		8	0162-0267	518.42	267.31	439	80.08	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.1	B08		8	0163-0265	186.17	265.60	250	78.91	0.505
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.0	B08		8	0164-0265	247.92	265.49	261	59.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.4	B08		8	0165-0270	618.28	270.58	224	61.94	0.734
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			500.7	B08		8	0166-0265	797.52	264.67	151	49.11	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			299.7	B08		8	0167-0269	923.08	268.60	250	58.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			319.3	B08		8	0168-0275	409.94	274.74	383	74.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			406.2	B08		8	0169-0276	133.40	275.48	241	61.01	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			211.0	B08		8	0170-0275	47.24	275.34	223	55.11	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			293.2	B08		8	0171-0280	278.01	279.85	388	77.50	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			333.6	B08		8	0172-0279	562.46	279.94	194	57.36	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			427.7	B08		8	0173-0278	458.98	277.90	219	55.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			268.8	B08		8	0174-0278	715.69	277.13	240	59.94	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			356.1	B08		8	0175-0282	119.51	282.12	188	54.53	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			310.8	B08		8	0176-0280	332.96	280.84	132	43.56	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			340.0	B08		8	0177-0290	891.19	289.75	238	58.18	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			447.0	B08		8	0178-0292	298.21	292.89	218	54.53	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			252.4	B08		8	0179-0295	95.73	294.43	249	61.36	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			312.1	B08		8	0180-0294	330.03	293.71	196	53.46	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			304.5	B08		8	0181-0297	860.98	297.75	317	65.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			578.0	B08		8	0182-0297	512.10	296.55	221	56.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.5	B08		8	0183-0303	430.37	303.46	354	71.60	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			320.9	B08		8	0184-0303	479.32	302.65	346	68.18	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			406.3	B08		8	0185-0302	497.46	302.33	187	51.11	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.4	B08		8	0186-0303	716.93	302.65	222	57.11	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			357.3	B08		8	0187-0305	830.82	305.53	256	57.94	0.958
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.8	B08		8	0188-0310	25.65	309.68	263	66.77	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			234.5	B08		8	0189-0309	198.99	308.92	288	70.67	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			411.4	B08		8	0190-0310	787.30	310.84	332	70.18	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			497.5	B08		8	0191-0309	934.28	309.96	218	56.28	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			228.8	B08		8	0192-0313	234.95	313.59	264	67.01	0.739
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			426.4	B08		8	0193-0313	297.10	313.57	317	67.01	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			356.0	B08		8	0194-0316	613.92	317.18	222	57.70	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			404.5	B08		8	0195-0319	126.34	319.24	196	63.26	0.616
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			52618.2	B08		8	0196-0320	567.44	319.73	136	47.11	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			667.4	B08		8	0197-0323	279.05	323.73	192	51.46	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			370.9	B08		8	0198-0328	673.08	328.40	224	62.18	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			471.6	B08		8	0199-0326	330.82	326.80	227	55.94	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			321.9	B08		8	0200-0329	94.74	329.33	229	57.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.1	B08		8	0201-0330	718.20	329.79	235	56.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			358.2	B08		8	0202-0331	696.05	331.99	248	57.70	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			317.6	B08		8	0203-0328	485.85	327.96	134	46.87	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			302.1	B08		8	0204-0333	831.68	332.64	270	60.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			389.8	B08		8	0205-0335	182.20	335.61	329	67.36	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			376.0	B08		8	0206-0338	35.69	338.17	193	52.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			605.9	B08		8	0207-0338	283.63	337.80	194	52.28	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			481.4	B08		8	0208-0341	442.74	341.90	307	66.43	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.1	B08		8	0209-0343	495.31	344.36	429	88.67	0.686
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.1	B08		8	0210-0341	749.53	341.13	261	59.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			474.7	B08		8	0211-0342	409.14	342.94	258	59.70	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			389.0	B08		8	0212-0344	786.04	343.56	228	55.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			294.5	B08		8	0213-0343	223.49	343.69	205	53.11	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.5	B08		8	0214-0345	72.07	344.02	253	60.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			208.7	B08		8	0215-0347	615.45	347.13	290	64.53	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.8	B08		8	0216-0349	847.39	348.96	278	64.08	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			291.0	B08		8	0217-0349	162.16	349.02	209	53.94	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			264.7	B08		8	0218-0352	904.73	351.46	230	59.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			539.4	B08		8	0219-0358	239.48	358.57	276	61.01	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			471.2	B08		8	0220-0361	372.20	361.46	328	68.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			304.9	B08		8	0221-0364	732.60	364.38	212	56.53	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.7	B08		8	0222-0365	669.58	364.77	308	69.94	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			453.4	B08		8	0223-0363	542.40	363.96	167	48.63	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.4	B08		8	0224-0367	825.59	367.27	264	63.01	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			316.8	B08		8	0225-0368	69.91	368.36	423	77.60	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			334.4	B08		8	0226-0367	509.82	366.75	165	49.11	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			295.5	B08		8	0227-0370	842.54	368.99	221	57.36	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			327.3	B08		8	0228-0370	904.68	370.38	299	63.94	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.7	B08		8	0229-0374	705.18	375.56	291	65.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			45421.3	B08		8	0230-0380	229.26	379.63	336	69.01	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			327.9	B08		8	0231-0381	625.58	381.14	261	59.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			345.9	B08		8	0232-0380	538.41	379.26	186	52.28	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			419.7	B08		8	0233-0380	122.53	380.11	176	49.46	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			357.7	B08		8	0234-0390	459.42	389.07	472	94.81	0.660
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.4	B08		8	0235-0385	174.02	384.99	229	55.11	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			378.3	B08		8	0236-0390	32.31	390.91	315	65.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.7	B08		8	0237-0390	476.96	389.92	250	59.46	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			529.3	B08		8	0238-0389	563.53	389.04	227	56.04	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.7	B08		8	0239-0392	96.37	392.44	221	54.53	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			305.9	B08		8	0240-0392	140.30	393.04	241	60.53	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			330.8	B08		8	0241-0394	517.34	394.43	226	57.36	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			392.3	B08		8	0242-0393	205.01	393.33	193	53.11	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			477.0	B08		8	0243-0396	357.48	395.76	326	68.43	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.7	B08		8	0244-0396	798.26	395.72	268	59.60	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			358.0	B08		8	0245-0393	115.88	393.18	177	49.70	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.5	B08		8	0246-0401	285.34	401.61	298	68.67	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			284.9	B08		8	0247-0403	854.48	404.25	271	62.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			330.5	B08		8	0248-0409	874.03	409.15	215	59.36	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			474.0	B08		8	0249-0410	535.95	410.12	210	57.21	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			330.2	B08		8	0250-0409	757.81	409.18	241	57.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			591.6	B08		8	0251-0408	385.95	408.25	148	47.36	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			259.1	B08		8	0252-0412	51.60	411.98	247	62.43	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			367.3	B08		8	0253-0413	306.91	413.24	351	68.77	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			363.7	B08		8	0254-0411	617.11	411.83	213	54.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			380.8	B08		8	0255-0413	920.61	413.25	248	59.11	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.5	B08		8	0256-0425	43.38	424.45	270	64.08	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			259.8	B08		8	0257-0424	197.36	424.82	291	65.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			626.8	B08		8	0258-0426	840.62	426.82	249	59.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.8	B08		8	0259-0425	90.69	425.05	252	59.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			448.2	B08		8	0260-0426	395.24	426.38	188	54.18	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			322.3	B08		8	0261-0430	798.43	429.42	316	67.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			193.8	B08		8	0262-0428	429.05	427.54	272	61.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			291.5	B08		8	0263-0430	685.11	429.79	228	59.11	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			301.0	B08		8	0264-0430	536.49	429.89	224	59.21	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			398.8	B08		8	0265-0433	292.44	431.71	270	62.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			283.8	B08		8	0266-0433	463.81	433.41	344	70.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			218.1	B08		8	0267-0440	612.69	440.34	286	66.18	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			316.7	B08		8	0268-0440	376.98	439.41	296	67.36	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			368.2	B08		8	0269-0441	917.64	440.86	239	59.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			492.4	B08		8	0270-0441	571.71	441.23	324	67.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			292.2	B08		8	0271-0448	119.36	447.66	377	73.60	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			334.8	B08		8	0272-0444	709.38	444.02	214	53.70	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			404.3	B08		8	0273-0446	210.10	445.78	171	49.70	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			676.3	B08		8	0274-0450	251.93	449.17	467	84.33	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			375.0	B08		8	0275-0445	284.42	445.95	125	42.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			310.8	B08		8	0276-0447	758.43	447.39	273	63.36	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			273.8	B08		8	0277-0447	510.30	448.26	285	65.60	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			402.3	B08		8	0278-0451	197.74	451.73	214	54.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			327.9	B08		8	0279-0452	679.58	452.71	229	56.53	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.9	B08		8	0280-0455	414.52	455.68	259	65.26	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			312.5	B08		8	0281-0458	645.04	457.69	235	57.70	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			351.4	B08		8	0282-0461	893.09	460.31	237	61.11	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.4	B08		8	0283-0461	806.05	461.06	265	61.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			286.0	B08		8	0284-0460	849.37	459.94	300	73.26	0.703
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			416.7	B08		8	0285-0467	482.18	466.42	278	65.36	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			493.3	B08		8	0286-0467	502.80	466.67	202	52.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			561.1	B08		8	0287-0468	175.68	468.11	131	44.39	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			438.8	B08		8	0288-0469	188.14	470.18	220	55.46	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			557.2	B08		8	0289-0470	164.58	470.70	133	44.87	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			299.7	B08		8	0290-0473	445.19	473.32	256	60.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			468.8	B08		8	0291-0476	340.33	476.43	305	64.43	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			370.7	B08		8	0292-0475	146.13	474.35	224	54.53	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			313.4	B08		8	0293-0476	594.06	476.63	181	50.28	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			470.7	B08		8	0294-0475	282.54	475.44	216	54.53	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			216.9	B08		8	0295-0480	38.72	480.74	281	66.67	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			350.0	B08		8	0296-0475	863.09	475.58	237	58.28	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			351.9	B08		8	0297-0476	670.54	476.17	223	56.28	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			446.5	B08		8	0298-0483	521.14	482.66	460	89.98	0.714
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			207.1	B08		8	0299-0486	72.47	487.20	271	64.77	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			392.2	B08		8	0300-0491	98.43	491.48	476	90.33	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.7	B08		8	0301-0489	681.87	489.05	240	57.94	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			344.7	B08		8	0302-0495	317.38	494.84	179	53.36	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			326.9	B08		8	0303-0498	424.53	498.54	275	61.60	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			377.1	B08		8	0304-0496	801.89	496.68	186	52.53	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			285.1	B08		8	0305-0496	568.46	496.21	140	45.46	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			305.9	B08		8	0306-0500	925.96	500.83	237	59.36	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.9	B08		8	0307-0506	409.35	506.26	265	71.36	0.654
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			293.1	B08		8	0308-0503	162.81	503.82	231	57.94	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			484.4	B08		8	0309-0502	252.53	502.28	254	61.11	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			323.5	B08		8	0310-0502	720.89	503.30	199	55.11	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			334.6	B08		8	0311-0506	118.28	506.07	213	55.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			304.8	B08		8	0312-0506	213.48	506.27	246	58.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.5	B08		8	0313-0505	513.95	505.20	270	61.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			213.7	B08		8	0314-0512	391.39	512.53	273	65.26	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.5	B08		8	0315-0508	573.78	508.38	197	52.63	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			394.2	B08		8	0316-0513	459.25	513.30	269	62.77	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			461.2	B08		8	0317-0516	279.40	515.67	340	72.91	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			358.7	B08		8	0318-0517	34.47	517.38	330	67.01	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			330.0	B08		8	0319-0519	191.56	519.29	327	67.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			277.7	B08		8	0320-0520	598.95	520.02	222	58.43	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			212.2	B08		8	0321-0521	490.02	521.05	227	55.70	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			279.3	B08		8	0322-0523	544.13	524.15	269	79.01	0.541
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.1	B08		8	0323-0524	373.61	524.93	246	58.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			349.9	B08		8	0324-0524	249.55	524.74	219	54.87	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			329.1	B08		8	0325-0528	587.81	528.57	220	57.26	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			365.6	B08		8	0326-0528	661.83	528.57	227	57.11	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			484.9	B08		8	0327-0529	741.26	528.96	331	66.18	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			418.5	B08		8	0328-0529	265.76	529.33	168	49.11	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			394.5	B08		8	0329-0530	886.67	530.57	195	53.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			336.1	B08		8	0330-0536	475.34	535.73	334	73.36	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			323.4	B08		8	0331-0532	693.26	532.27	262	62.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			292.1	B08		8	0332-0535	904.34	535.08	217	57.11	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.2	B08		8	0333-0540	503.66	539.29	356	73.01	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			358.9	B08		8	0334-0536	837.33	536.46	168	51.11	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			227.0	B08		8	0335-0540	618.73	540.15	265	63.60	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			305.4	B08		8	0336-0545	108.17	545.82	246	60.77	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			46910.6	B08		8	0337-0540	310.74	540.38	112	45.11	0.692
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			268.7	B08		8	0338-0544	540.04	543.04	278	84.91	0.485
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			296.7	B08		8	0339-0543	647.59	542.83	260	59.94	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			310.6	B08		8	0340-0543	228.87	543.02	213	53.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			397.4	B08		8	0341-0547	440.74	547.05	393	74.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			521.7	B08		8	0342-0547	294.62	547.99	340	68.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			284.4	B08		8	0343-0549	63.74	548.50	494	85.84	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.6	B08		8	0344-0547	405.03	547.38	199	53.94	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.0	B08		8	0345-0553	720.38	553.08	424	78.91	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.8	B08		8	0346-0555	585.25	555.47	238	57.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.7	B08		8	0347-0557	930.45	557.56	203	53.94	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			400.3	B08		8	0348-0561	829.71	561.23	214	54.53	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			427.6	B08		8	0349-0561	149.59	561.09	177	51.11	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			279.0	B08		8	0350-0565	359.49	565.73	275	60.28	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			299.2	B08		8	0351-0567	899.27	567.38	262	59.60	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			390.3	B08		8	0352-0583	151.66	583.78	549	92.33	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			339.7	B08		8	0353-0575	301.99	574.27	211	54.53	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			281.2	B08		8	0354-0579	446.16	578.94	247	60.43	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			279.5	B08		8	0355-0580	653.80	579.80	251	60.77	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.4	B08		8	0356-0578	881.69	578.52	187	50.28	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			198.7	B08		8	0357-0582	591.28	583.00	268	61.26	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			191.8	B08		8	0358-0586	635.36	586.45	320	72.43	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			220.5	B08		8	0359-0585	522.96	585.30	305	67.36	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			320.5	B08		8	0360-0587	364.23	587.18	323	67.01	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			317.3	B08		8	0361-0584	292.96	585.51	169	49.11	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			224.6	B08		8	0362-0586	710.05	586.60	261	61.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.6	B08		8	0363-0588	546.84	587.82	378	76.18	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			423.0	B08		8	0364-0585	746.54	585.66	197	52.28	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			299.4	B08		8	0365-0594	428.50	594.90	260	61.36	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			493.1	B08		8	0366-0591	791.24	591.44	157	44.87	0.980
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			290.9	B08		8	0367-0594	106.89	593.63	301	67.36	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			351.2	B08		8	0368-0597	409.77	597.79	382	73.26	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.0	B08		8	0369-0601	38.88	600.70	394	73.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			310.4	B08		8	0370-0599	245.03	599.26	215	57.11	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			422.2	B08		8	0371-0603	294.83	602.94	352	87.26	0.581
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.1	B08		8	0372-0603	122.93	603.29	228	56.77	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			284.8	B08		8	0373-0602	745.82	602.88	254	59.70	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			322.6	B08		8	0374-0608	772.61	607.70	396	82.08	0.739
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			446.7	B08		8	0375-0611	588.28	610.98	281	61.11	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			224.5	B08		8	0376-0612	691.92	612.85	280	65.36	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			218.5	B08		8	0377-0611	621.03	610.64	266	65.11	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.7	B08		8	0378-0615	660.18	615.09	219	54.77	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.2	B08		8	0379-0615	91.00	615.30	225	55.11	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			195.9	B08		8	0380-0622	353.66	621.48	274	67.60	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			380.0	B08		8	0381-0617	484.70	617.51	235	57.46	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			397.8	B08		8	0382-0619	283.71	620.14	193	51.46	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			220.2	B08		8	0383-0624	540.61	624.20	286	64.43	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.6	B08		8	0384-0623	809.43	623.21	223	55.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			393.9	B08		8	0385-0626	369.46	626.27	240	59.11	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			298.7	B08		8	0386-0628	750.05	628.17	455	80.08	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			349.5	B08		8	0387-0626	315.90	625.91	218	54.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.2	B08		8	0388-0630	400.01	630.46	315	65.01	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.4	B08		8	0389-0634	103.08	633.11	250	61.60	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			781.4	B08		8	0390-0633	301.76	632.85	182	52.77	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.2	B08		8	0391-0634	920.99	635.17	270	65.01	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			466.0	B08		8	0392-0641	826.35	642.57	525	91.01	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.1	B08		8	0393-0636	250.17	635.64	243	57.11	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			648.8	B08		8	0394-0636	286.29	635.91	299	67.11	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			295.7	B08		8	0395-0640	56.08	640.78	309	64.18	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			508.1	B08		8	0396-0645	176.16	644.35	531	89.74	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			543.0	B08		8	0397-0642	149.11	641.65	448	83.26	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			294.6	B08		8	0398-0641	548.88	641.16	219	57.01	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.3	B08		8	0399-0644	331.95	643.38	244	59.60	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			277.4	B08		8	0400-0644	615.31	644.31	242	60.53	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			289.4	B08		8	0401-0653	518.96	653.04	290	69.36	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			377.1	B08		8	0402-0654	562.67	654.67	315	66.18	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			346.1	B08		8	0403-0658	878.27	658.10	486	88.33	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			218.4	B08		8	0404-0659	685.60	660.49	274	65.60	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			46702.7	B08		8	0405-0660	134.72	659.99	277	61.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			317.3	B08		8	0406-0659	651.26	658.94	214	56.18	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			510.6	B08		8	0407-0662	215.01	661.71	477	97.64	0.629
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			353.4	B08		8	0408-0660	432.11	659.62	345	68.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			281.4	B08		8	0409-0661	746.57	660.93	266	60.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			211.9	B08		8	0410-0660	941.90	660.60	248	60.28	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			627.2	B08		8	0411-0660	189.48	661.10	161	49.11	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			381.7	B08		8	0412-0661	39.92	660.81	174	50.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			346.3	B08		8	0413-0664	81.31	663.61	225	57.70	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.6	B08		8	0414-0668	27.47	667.37	212	59.36	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			323.3	B08		8	0415-0670	173.32	670.15	233	58.53	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			319.3	B08		8	0416-0671	593.71	671.10	209	53.94	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.4	B08		8	0417-0679	567.36	678.71	242	59.84	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			222.7	B08		8	0418-0680	633.95	680.76	292	63.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			298.9	B08		8	0419-0685	777.50	685.49	371	71.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			511.2	B08		8	0420-0687	429.91	687.24	392	75.01	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			303.7	B08		8	0421-0684	263.38	684.17	218	56.53	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.5	B08		8	0422-0686	584.10	686.88	285	67.01	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.5	B08		8	0423-0680	903.82	679.87	100	37.21	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			309.6	B08		8	0424-0688	864.67	688.04	231	55.36	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			357.9	B08		8	0425-0688	80.75	689.10	232	57.11	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			303.4	B08		8	0426-0690	240.48	690.82	319	66.43	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			223.1	B08		8	0427-0693	719.10	693.26	270	60.53	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			268.7	B08		8	0428-0691	901.19	691.00	113	40.63	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			270.5	B08		8	0429-0697	17.33	697.09	223	56.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			313.4	B08		8	0430-0698	42.08	697.67	293	61.94	0.960
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			213.2	B08		8	0431-0699	548.17	698.83	224	56.28	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.2	B08		8	0432-0702	522.67	703.01	282	71.01	0.703
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			514.0	B08		8	0433-0703	351.47	703.31	310	65.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.1	B08		8	0434-0703	796.34	702.67	220	56.18	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			236.6	B08		8	0435-0702	574.57	702.78	210	54.28	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			207.8	B08		8	0436-0706	669.98	705.58	287	71.60	0.704
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.2	B08		9	0001-0029	375.41	28.74	246	63.11	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			518.0	B08		9	0002-0035	296.66	35.80	264	59.94	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.6	B08		9	0003-0036	644.36	36.42	315	66.53	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			547.3	B08		9	0004-0038	498.11	37.25	198	56.28	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			356.1	B08		9	0005-0041	524.43	41.73	478	87.74	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			308.7	B08		9	0006-0036	419.86	35.88	237	57.11	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.7	B08		9	0007-0037	916.03	37.79	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			451.5	B08		9	0008-0038	140.82	38.08	237	56.53	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			285.7	B08		9	0009-0041	868.08	40.29	256	63.26	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			306.3	B08		9	0010-0042	802.53	43.08	239	57.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			298.0	B08		9	0011-0045	752.63	45.65	300	67.94	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			347.4	B08		9	0012-0043	77.15	42.42	188	50.53	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			456.8	B08		9	0013-0043	22.75	43.23	221	55.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			557.1	B08		9	0014-0048	195.35	48.09	125	41.11	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			532.8	B08		9	0015-0057	182.56	57.31	447	82.91	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.1	B08		9	0016-0059	157.91	60.02	233	61.01	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			384.3	B08		9	0017-0057	34.87	57.15	199	51.70	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.8	B08		9	0018-0056	285.96	56.48	248	60.77	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			430.0	B08		9	0019-0062	107.83	62.92	258	61.94	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			309.9	B08		9	0020-0064	915.19	64.42	323	65.60	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			605.0	B08		9	0021-0069	346.07	69.89	504	96.57	0.679
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			366.8	B08		9	0022-0063	704.13	62.44	191	53.70	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			259.3	B08		9	0023-0066	436.04	66.09	338	70.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			289.7	B08		9	0024-0068	580.73	68.94	270	62.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			316.5	B08		9	0025-0070	725.46	70.06	223	58.77	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			287.2	B08		9	0026-0072	284.31	72.25	291	63.36	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			362.0	B08		9	0027-0075	862.66	75.75	196	53.11	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			287.3	B08		9	0028-0081	662.91	82.52	347	71.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			345.5	B08		9	0029-0080	395.44	80.30	251	58.87	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			286.5	B08		9	0030-0082	932.73	81.71	281	61.60	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			426.0	B08		9	0031-0086	835.57	86.40	322	67.01	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			220.9	B08		9	0032-0088	176.88	88.51	268	61.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.2	B08		9	0033-0089	413.59	90.14	246	62.77	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.2	B08		9	0034-0092	612.75	92.05	284	68.08	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			341.3	B08		9	0035-0089	761.59	88.86	231	57.70	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.7	B08		9	0036-0095	240.04	95.34	359	70.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			565.3	B08		9	0037-0092	365.95	91.80	166	51.70	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			42015.9	B08		9	0038-0097	107.13	96.97	346	69.01	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			531.4	B08		9	0039-0095	479.40	93.97	208	55.01	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			831.7	B08		9	0040-0095	395.91	94.90	126	44.28	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			730.1	B08		9	0041-0100	384.59	100.22	192	62.67	0.614
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.9	B08		9	0042-0101	710.55	101.66	287	74.08	0.657
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			610.6	B08		9	0043-0110	644.32	111.09	321	72.18	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			565.9	B08		9	0044-0106	372.78	107.06	198	52.77	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			737.2	B08		9	0045-0110	466.14	110.96	338	70.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.1	B08		9	0046-0112	75.69	112.16	235	56.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			221.6	B08		9	0047-0116	36.68	116.61	256	63.01	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			379.0	B08		9	0048-0118	294.42	117.84	409	74.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			381.6	B08		9	0049-0119	431.62	119.28	337	71.84	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			4478.5	B08		9	0050-0120	677.17	120.32	449	78.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			334.6	B08		9	0051-0121	411.39	121.23	277	62.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.2	B08		9	0052-0128	190.63	128.16	380	73.36	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.8	B08		9	0053-0126	224.06	125.99	270	63.94	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.7	B08		9	0054-0128	144.88	128.15	231	56.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.2	B08		9	0055-0133	746.35	133.64	381	73.26	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			233.4	B08		9	0056-0134	835.53	133.85	352	78.33	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			364.2	B08		9	0057-0139	253.74	138.75	396	74.67	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			376.5	B08		9	0058-0141	818.10	141.83	228	57.11	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			306.6	B08		9	0059-0144	47.69	143.22	250	61.36	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.7	B08		9	0060-0146	541.50	146.66	220	58.77	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.0	B08		9	0061-0150	866.35	150.41	235	57.60	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			302.9	B08		9	0062-0149	219.61	150.24	257	61.11	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			316.2	B08		9	0063-0153	936.51	153.32	219	56.53	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			281.3	B08		9	0064-0152	631.80	151.95	274	63.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			224.1	B08		9	0065-0156	715.63	156.14	264	59.94	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			433.2	B08		9	0066-0159	132.93	160.15	351	80.08	0.688
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			333.3	B08		9	0067-0159	577.05	159.47	210	55.70	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			334.8	B08		9	0068-0161	523.25	160.27	245	71.60	0.601
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			354.1	B08		9	0069-0166	589.08	166.62	279	68.18	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			935.3	B08		9	0070-0168	857.63	168.79	337	69.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			314.9	B08		9	0071-0168	163.28	168.37	218	58.77	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			194.7	B08		9	0072-0167	753.10	167.95	345	77.36	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			333.1	B08		9	0073-0170	813.41	169.51	207	59.11	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			369.2	B08		9	0074-0173	337.38	173.65	437	79.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.5	B08		9	0075-0173	53.07	173.78	231	57.94	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			210.4	B08		9	0076-0177	659.41	177.28	409	77.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			287.0	B08		9	0077-0177	903.32	177.17	420	77.26	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			544.8	B08		9	0078-0177	119.07	177.60	157	47.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			46410.2	B08		9	0079-0179	279.29	179.71	293	63.94	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			303.6	B08		9	0080-0180	544.45	179.49	254	59.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			315.7	B08		9	0081-0186	495.05	186.44	413	75.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.6	B08		9	0082-0189	700.98	189.95	318	74.67	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			268.7	B08		9	0083-0200	82.82	200.43	296	66.18	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			277.0	B08		9	0084-0201	898.68	200.80	261	61.84	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.0	B08		9	0085-0203	39.87	204.14	236	65.01	0.702
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			370.9	B08		9	0086-0210	142.72	209.61	345	69.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.4	B08		9	0087-0210	815.25	209.94	406	75.60	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			503.6	B08		9	0088-0215	585.72	215.59	294	65.60	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			550.6	B08		9	0089-0220	316.80	220.33	296	63.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			405.0	B08		9	0090-0225	761.42	225.12	457	83.26	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.2	B08		9	0091-0221	68.78	221.25	223	57.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			379.0	B08		9	0092-0222	712.47	222.20	219	55.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			326.5	B08		9	0093-0229	444.65	229.37	286	62.53	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			332.5	B08		9	0094-0229	257.22	228.54	248	60.77	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.4	B08		9	0095-0230	419.36	229.52	313	66.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			305.6	B08		9	0096-0228	934.52	228.45	208	55.11	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			427.6	B08		9	0097-0233	696.55	233.45	214	54.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			379.6	B08		9	0098-0232	866.73	232.18	273	61.60	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			500.5	B08		9	0099-0240	469.31	240.67	512	91.50	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			446.8	B08		9	0100-0231	583.41	230.91	168	48.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.2	B08		9	0101-0237	641.00	236.87	303	71.01	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			257.7	B08		9	0102-0237	786.48	236.79	348	67.60	0.957
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			327.9	B08		9	0103-0238	568.60	238.28	246	62.18	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			371.6	B08		9	0104-0243	188.18	242.63	287	63.94	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			281.9	B08		9	0105-0245	37.25	244.38	184	53.70	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			542.5	B08		9	0106-0247	51.01	246.24	250	65.36	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.3	B08		9	0107-0246	387.87	246.42	235	58.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			323.7	B08		9	0108-0247	668.56	246.78	218	58.53	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			570.4	B08		9	0109-0246	67.09	246.25	134	44.04	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			304.5	B08		9	0110-0249	757.96	250.41	242	59.84	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			342.5	B08		9	0111-0251	114.69	250.68	376	73.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			393.6	B08		9	0112-0249	731.62	249.28	190	51.70	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			313.7	B08		9	0113-0256	95.29	255.88	233	57.46	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			372.4	B08		9	0114-0264	314.31	264.28	268	63.11	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			354.8	B08		9	0115-0263	73.71	263.86	225	61.36	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			305.9	B08		9	0116-0262	474.21	262.79	286	65.94	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			307.4	B08		9	0117-0270	339.27	270.00	284	63.36	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			405.5	B08		9	0118-0269	535.85	268.73	309	66.18	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			419.3	B08		9	0119-0269	182.69	270.82	188	52.63	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			285.9	B08		9	0120-0272	17.79	271.66	249	58.53	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			293.3	B08		9	0121-0275	763.22	275.32	256	58.53	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			372.9	B08		9	0122-0277	555.54	277.08	261	60.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			332.5	B08		9	0123-0284	50.90	284.12	340	70.53	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.9	B08		9	0124-0281	99.05	281.25	217	54.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			305.7	B08		9	0125-0287	246.12	287.94	272	67.84	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			469.7	B08		9	0126-0292	726.80	291.74	517	93.15	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			466.6	B08		9	0127-0290	183.49	289.35	416	76.18	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			613.4	B08		9	0128-0289	334.17	289.12	270	59.94	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			599.4	B08		9	0129-0291	540.49	291.77	368	70.43	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			395.4	B08		9	0130-0292	449.98	292.00	252	57.11	0.971
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			329.8	B08		9	0131-0295	589.40	296.33	240	59.94	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			322.7	B08		9	0132-0294	801.72	294.94	278	69.84	0.716
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			406.9	B08		9	0133-0295	493.60	294.97	291	63.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			293.2	B08		9	0134-0300	260.29	300.34	263	68.77	0.699
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			311.5	B08		9	0135-0306	171.30	306.21	233	57.94	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			449.5	B08		9	0136-0312	29.03	312.93	218	56.53	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			336.9	B08		9	0137-0311	895.81	310.71	243	58.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			199.6	B08		9	0138-0318	53.27	318.60	345	82.08	0.643
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			326.7	B08		9	0139-0316	771.09	315.11	296	64.53	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			375.9	B08		9	0140-0318	229.24	318.55	191	51.70	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			332.6	B08		9	0141-0320	438.45	319.63	210	55.70	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			389.2	B08		9	0142-0321	467.78	320.33	229	56.28	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			329.2	B08		9	0143-0321	317.76	321.39	263	67.36	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			218.5	B08		9	0144-0328	922.76	328.97	281	67.11	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			284.3	B08		9	0145-0327	186.14	327.13	204	54.53	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			349.2	B08		9	0146-0334	85.06	333.61	377	76.18	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.6	B08		9	0147-0328	528.84	327.56	216	57.70	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			325.4	B08		9	0148-0337	300.90	337.37	226	68.91	0.598
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			324.9	B08		9	0149-0338	407.57	338.42	370	72.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.6	B08		9	0150-0340	108.35	340.54	212	56.28	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			325.3	B08		9	0151-0341	495.40	341.38	246	59.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			333.6	B08		9	0152-0341	755.99	340.88	209	54.28	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			339.2	B08		9	0153-0343	626.36	343.83	258	58.77	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			348.9	B08		9	0154-0344	427.02	344.31	229	57.46	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			357.8	B08		9	0155-0345	682.42	345.77	237	57.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.4	B08		9	0156-0352	877.69	351.77	267	62.87	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			281.3	B08		9	0157-0354	511.28	354.98	227	59.94	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			312.5	B08		9	0158-0355	359.05	355.36	404	74.18	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.8	B08		9	0159-0357	108.57	356.48	250	58.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			359.2	B08		9	0160-0362	712.63	362.15	219	55.36	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.9	B08		9	0161-0364	854.69	363.71	235	58.77	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			344.1	B08		9	0162-0374	762.71	374.69	251	58.53	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			23246.9	B08		9	0163-0382	541.62	381.84	369	69.84	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			324.2	B08		9	0164-0384	836.72	385.18	259	62.53	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.5	B08		9	0165-0388	132.56	388.06	423	79.84	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			391.3	B08		9	0166-0383	443.86	383.52	208	54.53	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			594.8	B08		9	0167-0385	591.05	385.30	269	63.36	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			365.3	B08		9	0168-0383	795.38	383.11	199	51.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.3	B08		9	0169-0386	880.30	385.53	249	63.84	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			437.7	B08		9	0170-0388	609.83	388.72	299	68.18	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			306.5	B08		9	0171-0392	751.60	392.00	346	68.18	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			309.7	B08		9	0172-0392	61.36	392.33	283	61.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			598.1	B08		9	0173-0398	557.28	397.94	324	66.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			306.5	B08		9	0174-0397	499.20	396.92	252	61.11	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			307.8	B08		9	0175-0403	283.02	403.64	278	66.53	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			219.5	B08		9	0176-0402	205.79	402.27	267	61.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			257.0	B08		9	0177-0403	233.59	403.91	230	58.28	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.8	B08		9	0178-0405	473.13	404.50	404	75.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			293.9	B08		9	0179-0406	83.40	406.15	256	65.60	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			365.2	B08		9	0180-0413	789.67	413.15	247	57.36	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			326.2	B08		9	0181-0416	426.35	416.54	220	56.53	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			293.1	B08		9	0182-0423	837.61	424.02	364	74.91	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			350.6	B08		9	0183-0421	305.15	420.27	213	56.53	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			233.4	B08		9	0184-0422	494.32	422.69	230	56.43	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			347.0	B08		9	0185-0426	371.17	426.66	319	67.01	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			287.2	B08		9	0186-0427	537.70	427.27	339	69.01	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			403.3	B08		9	0187-0432	685.33	431.98	231	59.36	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.5	B08		9	0188-0431	97.98	430.39	188	56.39	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			302.9	B08		9	0189-0433	54.32	433.29	233	60.53	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			346.1	B08		9	0190-0436	449.92	436.02	269	60.53	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.7	B08		9	0191-0442	519.64	442.54	258	64.87	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.3	B08		9	0192-0439	203.08	439.76	261	62.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			732.7	B08		9	0193-0437	789.12	437.27	116	40.63	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			474.2	B08		9	0194-0440	878.12	440.65	189	52.77	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.4	B08		9	0195-0443	98.41	442.84	227	59.11	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.0	B08		9	0196-0447	570.66	447.10	432	77.26	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			370.2	B08		9	0197-0448	170.09	448.37	247	57.94	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			296.7	B08		9	0198-0446	269.82	445.98	162	47.70	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			281.4	B08		9	0199-0446	254.95	446.32	123	39.70	0.981
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			360.3	B08		9	0200-0452	673.57	452.65	230	79.15	0.461
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			441.4	B08		9	0201-0452	307.23	451.83	314	65.60	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			340.0	B08		9	0202-0455	458.89	454.01	262	61.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			459.6	B08		9	0203-0454	867.79	454.33	272	60.77	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			320.5	B08		9	0204-0457	197.88	457.55	260	59.94	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			407.4	B08		9	0205-0458	886.30	458.69	261	59.11	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.8	B08		9	0206-0461	116.98	460.20	312	66.77	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			356.5	B08		9	0207-0457	382.26	457.42	169	48.87	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			289.6	B08		9	0208-0462	262.87	461.81	282	64.18	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.7	B08		9	0209-0462	492.45	462.02	229	58.77	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			574.9	B08		9	0210-0465	652.17	465.62	167	52.53	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			328.7	B08		9	0211-0467	447.34	467.17	217	56.53	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			318.4	B08		9	0212-0471	237.87	471.44	203	54.53	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			331.6	B08		9	0213-0475	615.13	476.07	237	61.94	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			338.2	B08		9	0214-0474	890.92	474.25	224	58.77	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			310.2	B08		9	0215-0477	410.11	477.40	250	60.28	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			318.7	B08		9	0216-0481	835.88	480.63	245	68.43	0.658
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.5	B08		9	0217-0482	131.20	482.57	312	67.36	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			317.2	B08		9	0218-0485	789.47	484.56	241	57.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			375.1	B08		9	0219-0488	293.83	487.81	344	69.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			232.1	B08		9	0220-0493	57.35	493.06	480	85.50	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			313.0	B08		9	0221-0491	203.22	491.41	302	64.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.5	B08		9	0222-0490	177.03	490.29	235	56.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.8	B08		9	0223-0495	751.21	495.28	280	66.77	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			215.2	B08		9	0224-0498	80.23	499.11	399	74.43	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			343.8	B08		9	0225-0497	922.77	497.48	204	57.70	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			268.8	B08		9	0226-0502	236.73	501.88	415	75.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			352.9	B08		9	0227-0498	573.39	498.78	297	62.53	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			500.4	B08		9	0228-0500	322.76	499.64	277	61.60	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			313.9	B08		9	0229-0502	506.79	501.80	248	58.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.6	B08		9	0230-0503	20.49	503.65	227	58.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			326.4	B08		9	0231-0503	613.53	503.98	219	57.60	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			311.8	B08		9	0232-0506	148.19	505.77	242	59.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			309.0	B08		9	0233-0507	431.14	506.84	291	62.53	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			319.9	B08		9	0234-0507	638.99	507.50	240	56.53	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			372.9	B08		9	0235-0513	402.86	513.41	325	66.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.0	B08		9	0236-0514	539.86	512.74	302	67.84	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			361.4	B08		9	0237-0515	869.62	515.16	264	61.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			333.0	B08		9	0238-0516	369.98	516.93	269	64.18	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.2	B08		9	0239-0519	104.22	518.97	321	67.26	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			357.7	B08		9	0240-0525	570.22	526.36	302	65.94	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			295.7	B08		9	0241-0528	304.28	527.73	282	63.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			287.0	B08		9	0242-0532	817.06	532.15	301	66.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			551.0	B08		9	0243-0529	424.39	528.53	175	47.94	0.957
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.2	B08		9	0244-0536	692.32	536.35	300	71.01	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			332.5	B08		9	0245-0535	203.65	535.32	324	70.77	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			373.6	B08		9	0246-0534	332.49	534.09	240	59.60	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			309.0	B08		9	0247-0535	479.98	535.04	241	57.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			352.4	B08		9	0248-0535	624.18	535.37	228	54.53	0.964
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.9	B08		9	0249-0541	520.93	541.71	289	66.08	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			423.3	B08		9	0250-0540	436.99	540.78	196	51.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.2	B08		9	0251-0542	849.90	542.58	274	61.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			347.8	B08		9	0252-0547	578.88	546.35	334	73.26	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			292.9	B08		9	0253-0547	64.50	546.90	227	56.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			303.2	B08		9	0254-0548	272.23	548.62	433	82.67	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			369.7	B08		9	0255-0549	125.58	549.29	309	65.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.8	B08		9	0256-0552	634.80	553.72	295	69.01	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			392.0	B08		9	0257-0554	757.50	554.76	286	61.94	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			295.0	B08		9	0258-0558	555.44	558.53	254	60.77	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.7	B08		9	0259-0560	24.96	560.43	200	53.70	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			331.3	B08		9	0260-0562	697.90	561.96	263	64.77	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.9	B08		9	0261-0563	849.83	563.63	267	62.77	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			307.7	B08		9	0262-0566	598.76	565.95	287	64.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.6	B08		9	0263-0565	51.84	565.11	217	53.94	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.0	B08		9	0264-0568	888.61	568.11	289	68.43	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			293.4	B08		9	0265-0572	386.02	571.90	243	58.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			312.0	B08		9	0266-0575	514.40	575.95	281	61.70	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			299.9	B08		9	0267-0581	532.87	581.25	353	71.94	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			323.9	B08		9	0268-0579	287.29	578.41	257	65.84	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.1	B08		9	0269-0584	864.73	583.81	303	73.26	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			330.6	B08		9	0270-0584	646.24	584.16	276	63.01	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			289.6	B08		9	0271-0585	50.25	586.00	238	56.53	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			343.6	B08		9	0272-0588	179.41	588.74	349	70.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			349.6	B08		9	0273-0590	332.10	590.35	315	67.36	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			628.7	B08		9	0274-0586	763.04	585.73	159	46.28	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			356.5	B08		9	0275-0592	716.93	591.83	260	62.43	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			299.6	B08		9	0276-0596	84.07	595.42	314	70.43	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			233.1	B08		9	0277-0596	569.57	597.08	525	102.57	0.627
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			294.2	B08		9	0278-0595	813.75	595.63	252	65.36	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.8	B08		9	0279-0592	473.14	591.49	225	56.87	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			295.4	B08		9	0280-0596	369.67	596.03	280	62.18	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			560.9	B08		9	0281-0596	774.53	596.67	295	65.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			343.3	B08		9	0282-0601	122.68	601.11	241	61.84	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			298.6	B08		9	0283-0598	437.42	599.28	254	61.94	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			294.3	B08		9	0284-0604	937.38	603.42	278	62.53	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			333.1	B08		9	0285-0604	397.84	603.82	232	55.36	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			449.1	B08		9	0286-0609	894.82	608.75	206	54.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.9	B08		9	0287-0616	115.39	616.74	322	71.60	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			339.8	B08		9	0288-0614	727.58	614.63	374	73.01	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.7	B08		9	0289-0615	291.21	615.32	234	60.18	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			404.8	B08		9	0290-0611	909.17	611.05	147	46.04	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			287.9	B08		9	0291-0616	59.21	615.88	279	62.18	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			402.9	B08		9	0292-0616	645.44	616.87	345	73.26	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			361.6	B08		9	0293-0617	868.69	617.47	490	92.81	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			320.0	B08		9	0294-0618	309.51	618.88	216	61.84	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			296.1	B08		9	0295-0618	274.72	618.27	204	54.53	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			287.3	B08		9	0296-0622	927.25	621.70	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			322.2	B08		9	0297-0624	218.76	623.81	309	63.60	0.960
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			377.4	B08		9	0298-0628	473.80	627.67	178	52.53	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			342.8	B08		9	0299-0629	88.26	629.56	283	62.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			330.4	B08		9	0300-0629	777.02	628.82	261	61.01	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			235.6	B08		9	0301-0635	568.32	635.08	290	73.84	0.668
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			314.7	B08		9	0302-0631	810.05	630.69	249	63.26	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.1	B08		9	0303-0630	383.60	630.36	218	53.36	0.962
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			311.2	B08		9	0304-0632	640.10	632.53	232	59.70	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			357.5	B08		9	0305-0633	902.89	632.87	350	68.18	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			293.3	B08		9	0306-0631	325.68	632.39	263	60.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			408.7	B08		9	0307-0633	688.22	633.46	306	63.94	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.9	B08		9	0308-0640	182.52	640.32	330	69.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			338.1	B08		9	0309-0639	110.84	638.95	229	56.53	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			345.7	B08		9	0310-0642	264.97	641.97	190	53.36	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.5	B08		9	0311-0642	946.31	642.26	211	55.94	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			539.3	B08		9	0312-0653	717.73	653.94	494	85.15	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.4	B08		9	0313-0650	429.31	649.95	196	52.28	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.8	B08		9	0314-0655	504.15	656.17	268	64.18	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.6	B08		9	0315-0652	657.70	652.90	261	59.11	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			347.9	B08		9	0316-0654	70.78	654.67	174	51.11	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.0	B08		9	0317-0657	339.71	657.78	226	56.53	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.8	B08		9	0318-0655	383.03	655.64	149	48.87	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.5	B08		9	0319-0657	200.29	656.11	247	59.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			343.5	B08		9	0320-0658	839.59	659.58	154	49.70	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.8	B08		9	0321-0657	444.85	658.14	127	47.11	0.719
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			336.9	B08		9	0322-0661	623.12	662.42	258	63.60	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			426.0	B08		9	0323-0658	568.08	658.62	172	49.70	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			386.3	B08		9	0324-0659	790.18	659.37	206	54.28	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			188.9	B08		9	0325-0663	35.78	663.64	240	57.94	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			295.1	B08		9	0326-0662	404.60	661.96	211	57.36	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			273.8	B08		9	0327-0664	162.23	664.66	252	61.94	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			281.4	B08		9	0328-0670	140.52	670.03	284	64.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.7	B08		9	0329-0672	297.72	672.30	288	66.43	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			325.7	B08		9	0330-0674	875.21	673.40	244	60.53	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			328.0	B08		9	0331-0676	380.69	676.33	270	67.84	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			294.6	B08		9	0332-0675	91.03	674.87	253	59.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			356.8	B08		9	0333-0676	937.72	675.75	245	59.11	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			407.9	B08		9	0334-0674	786.59	674.75	198	50.87	0.962
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			235.1	B08		9	0335-0684	887.77	684.20	229	60.77	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.6	B08		9	0336-0686	264.85	686.00	246	60.53	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			310.5	B08		9	0337-0692	837.75	693.34	241	64.43	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.1	B08		9	0338-0695	451.42	695.09	247	59.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.0	B08		9	0339-0698	629.42	698.59	368	72.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			312.8	B08		9	0340-0696	691.70	698.16	252	70.43	0.638
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			320.8	B08		9	0341-0695	937.50	695.64	242	57.11	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			182.1	B08		9	0342-0697	110.29	698.24	232	66.18	0.666
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.7	B08		9	0343-0703	749.84	702.22	218	59.11	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			344.6	B08		9	0344-0703	45.50	703.45	308	66.43	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			213.3	B08		9	0345-0708	150.33	708.96	334	70.43	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			216.8	B08		9	0346-0706	185.63	705.56	275	66.43	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			326.4	B08		9	0347-0703	907.57	703.18	102	37.80	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.8	B08		9	0348-0708	216.50	709.43	226	57.36	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			547.9	C08		1	0001-0025	822.14	25.96	373	78.43	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			518.6	C08		1	0002-0032	681.57	32.38	336	70.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			342.4	C08		1	0003-0031	209.13	31.38	259	59.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			309.9	C08		1	0004-0035	598.48	35.02	291	65.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			322.3	C08		1	0005-0033	294.09	33.97	277	61.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			447.1	C08		1	0006-0037	95.05	37.30	267	59.36	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			441.4	C08		1	0007-0038	133.57	38.49	299	64.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.3	C08		1	0008-0040	943.98	40.01	322	66.77	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			475.1	C08		1	0009-0040	72.15	41.03	262	61.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			353.9	C08		1	0010-0039	525.47	39.38	257	59.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			513.6	C08		1	0011-0041	554.92	42.34	237	63.60	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.6	C08		1	0012-0041	925.52	41.93	290	61.94	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			341.4	C08		1	0013-0045	740.21	45.84	288	63.84	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			498.8	C08		1	0014-0050	351.70	51.05	330	68.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			508.8	C08		1	0015-0054	703.39	54.41	393	100.57	0.488
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			571.8	C08		1	0016-0050	831.85	50.06	209	52.28	0.961
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			307.6	C08		1	0017-0054	308.76	53.84	288	64.43	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			234.1	C08		1	0018-0058	877.05	57.46	291	64.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.0	C08		1	0019-0061	784.13	62.60	326	70.18	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			372.1	C08		1	0020-0061	248.09	60.88	258	61.01	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			488.0	C08		1	0021-0063	901.93	63.40	246	58.18	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			295.5	C08		1	0022-0065	450.72	64.22	288	63.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			338.9	C08		1	0023-0070	278.90	71.24	278	66.18	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			321.1	C08		1	0024-0072	603.94	72.36	320	66.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			310.9	C08		1	0025-0072	740.78	71.77	255	64.43	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			585.5	C08		1	0026-0072	691.94	72.87	204	67.26	0.567
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			259.8	C08		1	0027-0072	50.25	71.85	260	59.94	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.3	C08		1	0028-0074	438.92	74.68	303	65.26	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			3452.4	C08		1	0029-0079	190.55	76.48	356	97.64	0.469
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			257.5	C08		1	0030-0075	870.05	76.04	277	65.36	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			293.4	C08		1	0031-0085	158.34	84.95	308	67.60	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			373.9	C08		1	0032-0085	93.65	85.12	246	58.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			375.6	C08		1	0033-0086	125.51	86.38	303	68.08	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.5	C08		1	0034-0086	411.37	86.47	305	64.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			458.2	C08		1	0035-0086	333.45	86.21	307	67.36	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			393.4	C08		1	0036-0095	644.36	95.56	264	61.94	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			383.7	C08		1	0037-0095	520.50	94.48	257	62.77	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.2	C08		1	0038-0096	764.15	95.07	320	71.01	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			481.9	C08		1	0039-0100	537.98	100.04	222	57.94	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			668.9	C08		1	0040-0101	506.98	101.49	188	52.53	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			385.9	C08		1	0041-0103	259.99	103.05	262	59.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			532.1	C08		1	0042-0105	493.19	105.07	201	53.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			308.8	C08		1	0043-0106	37.63	106.01	252	59.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			302.9	C08		1	0044-0109	240.13	108.48	280	63.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.5	C08		1	0045-0108	558.40	108.86	306	65.36	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.4	C08		1	0046-0108	577.01	108.07	250	57.36	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.7	C08		1	0047-0107	811.47	107.51	328	67.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			205.2	C08		1	0048-0110	851.09	110.29	317	67.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			342.1	C08		1	0049-0108	445.47	107.83	261	66.77	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			367.7	C08		1	0050-0117	119.82	117.36	249	60.53	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			690.7	C08		1	0051-0119	649.82	119.59	358	69.60	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			382.0	C08		1	0052-0120	103.19	120.90	254	61.11	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			390.3	C08		1	0053-0119	946.75	118.29	260	63.60	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.1	C08		1	0054-0118	743.02	118.79	290	64.53	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			259.1	C08		1	0055-0121	58.32	121.55	260	60.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			306.9	C08		1	0056-0131	85.34	132.15	262	61.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.9	C08		1	0057-0131	452.43	130.72	300	64.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			219.2	C08		1	0058-0138	487.67	137.96	255	65.84	0.739
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.0	C08		1	0059-0137	502.83	137.54	193	57.01	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			442.4	C08		1	0060-0139	210.02	137.63	516	101.40	0.631
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			573.7	C08		1	0061-0138	670.61	138.33	241	56.53	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			284.0	C08		1	0062-0143	149.45	143.21	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			336.4	C08		1	0063-0140	372.06	140.09	251	59.01	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.6	C08		1	0064-0145	749.21	144.31	314	68.18	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			287.9	C08		1	0065-0145	920.96	145.33	331	71.50	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			561.5	C08		1	0066-0146	39.71	146.68	341	69.94	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			321.3	C08		1	0067-0147	173.79	147.27	267	61.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			264.9	C08		1	0068-0153	551.00	153.54	283	63.26	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.3	C08		1	0069-0151	813.05	150.94	259	59.36	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			301.9	C08		1	0070-0158	513.00	157.99	546	99.15	0.698
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			236.9	C08		1	0071-0153	446.25	153.63	170	52.77	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			183.9	C08		1	0072-0155	845.90	155.03	319	67.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			432.2	C08		1	0073-0154	334.70	154.51	259	60.18	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			335.3	C08		1	0074-0152	624.74	152.68	246	59.11	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.3	C08		1	0075-0156	784.87	156.36	297	65.60	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.0	C08		1	0076-0159	884.42	159.25	315	70.43	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.8	C08		1	0077-0160	127.31	160.31	303	65.36	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			381.8	C08		1	0078-0162	305.18	162.32	272	63.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			344.4	C08		1	0079-0168	288.46	168.54	311	67.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			190.5	C08		1	0080-0171	832.81	171.77	291	68.18	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			375.5	C08		1	0081-0174	42.34	174.21	262	63.36	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			368.9	C08		1	0082-0170	729.21	170.50	271	61.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.5	C08		1	0083-0173	590.40	173.08	296	63.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			424.1	C08		1	0084-0178	83.14	178.73	315	65.01	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			436.1	C08		1	0085-0177	171.65	177.29	246	57.36	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			339.0	C08		1	0086-0182	691.21	182.38	284	63.36	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			289.8	C08		1	0087-0186	447.87	186.68	253	59.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			477.7	C08		1	0088-0188	242.39	187.62	194	51.94	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			577.9	C08		1	0089-0193	516.56	193.62	611	101.98	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			299.6	C08		1	0090-0190	635.08	190.19	316	70.43	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.0	C08		1	0091-0192	872.76	192.02	284	61.36	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			303.7	C08		1	0092-0193	736.41	192.47	313	65.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			362.2	C08		1	0093-0194	386.17	193.83	254	58.53	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.9	C08		1	0094-0194	823.62	193.96	316	67.84	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.7	C08		1	0095-0196	920.81	196.20	290	64.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			285.6	C08		1	0096-0196	427.88	196.19	297	65.01	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			225.7	C08		1	0097-0201	117.09	201.51	288	64.28	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			303.4	C08		1	0098-0201	53.21	201.78	281	60.77	0.956
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			532.3	C08		1	0099-0200	257.81	199.94	205	56.77	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			453.1	C08		1	0100-0203	208.24	203.37	234	55.94	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.2	C08		1	0101-0206	669.23	206.07	274	62.53	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			489.3	C08		1	0102-0208	574.16	208.16	397	73.84	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.2	C08		1	0103-0204	331.29	205.07	268	64.28	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			330.3	C08		1	0104-0211	807.63	211.72	465	80.08	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			371.6	C08		1	0105-0211	246.49	212.01	282	62.43	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			305.5	C08		1	0106-0213	766.71	214.14	272	61.60	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			334.5	C08		1	0107-0227	200.15	227.05	513	92.08	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			450.1	C08		1	0108-0228	722.25	228.10	375	72.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			399.3	C08		1	0109-0230	145.31	230.74	242	58.77	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			648.6	C08		1	0110-0231	695.49	230.67	231	55.36	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			318.0	C08		1	0111-0231	567.25	231.61	293	66.53	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			316.6	C08		1	0112-0236	127.92	236.17	260	61.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			357.9	C08		1	0113-0237	501.37	237.45	245	57.94	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.8	C08		1	0114-0236	799.39	236.30	397	79.70	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			336.1	C08		1	0115-0240	324.51	240.08	251	58.53	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.9	C08		1	0116-0244	296.32	243.88	305	66.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.7	C08		1	0117-0248	90.39	247.75	310	65.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			832.9	C08		1	0118-0248	683.41	248.56	344	67.60	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			639.2	C08		1	0119-0245	744.24	245.15	204	53.11	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			377.7	C08		1	0120-0245	763.73	245.53	199	51.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			507.2	C08		1	0121-0250	345.88	250.19	248	57.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			677.2	C08		1	0122-0255	833.72	255.63	376	75.26	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			286.2	C08		1	0123-0253	578.67	252.77	255	61.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.3	C08		1	0124-0257	141.20	256.83	286	63.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			332.5	C08		1	0125-0262	225.24	261.63	430	78.67	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			216.8	C08		1	0126-0259	74.74	259.19	315	66.53	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			347.0	C08		1	0127-0259	284.48	259.09	366	71.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			22620.0	C08		1	0128-0259	366.80	258.66	326	67.01	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			450.3	C08		1	0129-0257	851.64	258.33	235	58.87	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			360.6	C08		1	0130-0267	526.09	266.69	533	94.57	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.4	C08		1	0131-0263	590.14	263.95	263	61.11	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			588.2	C08		1	0132-0266	877.93	266.67	240	58.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			475.9	C08		1	0133-0265	920.94	265.46	218	53.70	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			507.9	C08		1	0134-0271	614.64	271.53	413	74.67	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			390.3	C08		1	0135-0272	765.04	272.49	301	63.36	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			662.9	C08		1	0136-0272	934.67	272.12	175	51.36	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			338.0	C08		1	0137-0276	167.43	277.02	253	61.70	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.6	C08		1	0138-0276	674.37	275.96	323	67.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.5	C08		1	0139-0278	456.40	277.71	282	63.60	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			309.4	C08		1	0140-0279	829.32	278.74	284	64.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			354.7	C08		1	0141-0279	328.50	279.91	245	56.77	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			391.0	C08		1	0142-0287	283.61	286.97	406	75.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			291.6	C08		1	0143-0290	212.32	290.79	292	66.18	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			323.1	C08		1	0144-0287	406.95	287.56	318	70.77	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			332.6	C08		1	0145-0287	877.73	287.64	261	59.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			576.6	C08		1	0146-0284	940.74	284.64	148	44.28	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			302.3	C08		1	0147-0290	350.24	290.23	304	68.08	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			215.7	C08		1	0148-0293	88.23	293.47	271	63.36	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.3	C08		1	0149-0298	478.74	297.61	288	67.11	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			291.0	C08		1	0150-0299	30.29	299.17	312	65.11	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			440.7	C08		1	0151-0297	769.35	297.25	237	56.18	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.0	C08		1	0152-0298	577.12	298.30	242	62.18	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.6	C08		1	0153-0301	850.21	301.23	325	67.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			313.3	C08		1	0154-0301	793.81	300.67	249	59.60	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.7	C08		1	0155-0305	134.72	305.10	300	65.01	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			290.3	C08		1	0156-0305	415.61	306.08	322	69.60	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			330.7	C08		1	0157-0308	177.86	307.75	226	57.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.8	C08		1	0158-0311	161.71	310.71	226	56.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			324.0	C08		1	0159-0311	441.45	311.15	283	62.77	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.5	C08		1	0160-0310	572.11	310.90	264	63.70	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			318.9	C08		1	0161-0317	258.06	316.84	309	68.77	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.5	C08		1	0162-0320	664.01	318.99	331	66.77	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.9	C08		1	0163-0324	615.82	324.26	326	70.43	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			370.2	C08		1	0164-0324	23.47	324.39	299	63.60	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			293.5	C08		1	0165-0325	243.62	325.36	286	63.84	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			425.8	C08		1	0166-0325	394.36	325.64	297	64.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			295.7	C08		1	0167-0328	874.08	327.59	234	56.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			311.9	C08		1	0168-0328	899.15	329.03	260	61.94	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			296.7	C08		1	0169-0333	90.84	332.85	266	62.43	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.1	C08		1	0170-0333	126.02	332.87	298	67.60	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			407.5	C08		1	0171-0337	818.17	337.25	353	68.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			448.9	C08		1	0172-0336	529.02	336.98	248	59.94	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.5	C08		1	0173-0335	936.43	335.59	267	61.36	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			456.9	C08		1	0174-0342	377.70	341.70	254	63.60	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			430.9	C08		1	0175-0341	751.57	340.97	254	61.60	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			352.2	C08		1	0176-0344	76.38	343.86	228	55.36	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			405.2	C08		1	0177-0345	460.57	344.62	193	52.53	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			318.5	C08		1	0178-0351	681.74	350.99	338	69.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.0	C08		1	0179-0349	577.92	349.82	294	64.43	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			285.0	C08		1	0180-0351	291.85	350.98	292	63.84	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			310.0	C08		1	0181-0352	489.82	352.37	300	65.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			384.7	C08		1	0182-0352	327.35	351.69	252	61.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			347.2	C08		1	0183-0353	446.60	353.32	231	56.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			387.8	C08		1	0184-0354	805.06	354.07	247	59.70	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			325.2	C08		1	0185-0359	872.13	359.11	311	67.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			593.6	C08		1	0186-0363	132.70	363.09	329	68.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			285.0	C08		1	0187-0365	336.31	364.68	263	59.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			285.8	C08		1	0188-0364	410.22	363.79	327	69.01	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			313.1	C08		1	0189-0367	502.64	368.11	257	61.84	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			235.8	C08		1	0190-0376	921.44	376.79	551	108.95	0.583
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.0	C08		1	0191-0369	593.60	369.66	279	63.70	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.7	C08		1	0192-0375	268.02	375.42	298	69.36	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			308.5	C08		1	0193-0372	752.98	371.61	257	60.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.5	C08		1	0194-0377	634.41	376.32	349	72.43	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.1	C08		1	0195-0379	880.14	379.02	319	70.43	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			355.9	C08		1	0196-0377	119.73	376.80	305	72.77	0.724
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.2	C08		1	0197-0382	700.82	381.97	292	65.60	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			223.8	C08		1	0198-0382	220.40	381.71	287	64.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			689.5	C08		1	0199-0382	446.89	381.74	234	56.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			329.7	C08		1	0200-0384	428.95	384.84	299	64.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			554.8	C08		1	0201-0387	282.57	387.37	421	76.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.8	C08		1	0202-0387	25.30	387.85	243	61.94	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			403.4	C08		1	0203-0393	364.86	393.85	475	94.23	0.672
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			284.8	C08		1	0204-0386	840.01	386.59	291	66.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			209.6	C08		1	0205-0392	728.70	393.05	303	68.18	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			363.3	C08		1	0206-0395	87.04	395.30	245	57.94	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.9	C08		1	0207-0395	516.66	395.19	277	61.36	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			302.6	C08		1	0208-0404	108.05	404.45	252	58.18	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			368.3	C08		1	0209-0408	417.91	407.79	261	63.01	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			277.3	C08		1	0210-0413	504.12	413.06	284	62.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			273.5	C08		1	0211-0413	684.04	412.94	283	62.18	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			264.8	C08		1	0212-0418	45.73	418.54	308	64.18	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			517.0	C08		1	0213-0420	133.94	419.89	318	65.84	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			207.2	C08		1	0214-0424	879.01	423.32	332	79.74	0.656
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			270.2	C08		1	0215-0420	815.78	420.19	308	63.36	0.964
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			463.9	C08		1	0216-0420	439.51	420.26	208	54.04	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			303.8	C08		1	0217-0422	290.62	422.02	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.1	C08		1	0218-0426	192.46	426.07	432	78.43	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			389.3	C08		1	0219-0425	457.42	425.06	257	61.70	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.5	C08		1	0220-0425	908.76	426.11	267	63.94	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			385.5	C08		1	0221-0430	759.47	429.63	435	88.67	0.695
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.3	C08		1	0222-0428	253.32	428.39	295	66.18	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.9	C08		1	0223-0431	555.02	431.98	323	95.15	0.448
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.1	C08		1	0224-0430	599.73	430.23	285	65.60	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			309.8	C08		1	0225-0433	317.04	433.41	275	62.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.1	C08		1	0226-0433	103.24	433.39	402	75.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.9	C08		1	0227-0438	640.55	438.85	580	100.57	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			294.2	C08		1	0228-0435	845.96	435.40	258	62.28	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.5	C08		1	0229-0438	720.28	437.38	302	67.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			420.2	C08		1	0230-0439	18.11	439.59	340	68.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			232.3	C08		1	0231-0441	169.96	442.00	318	66.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			353.9	C08		1	0232-0444	771.12	444.45	230	57.36	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			273.5	C08		1	0233-0447	477.66	447.79	262	61.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			352.8	C08		1	0234-0456	438.10	457.77	540	95.40	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			200.3	C08		1	0235-0456	881.35	455.43	335	78.57	0.682
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.4	C08		1	0236-0456	265.11	456.45	313	65.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			402.3	C08		1	0237-0460	511.98	459.79	454	81.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			483.1	C08		1	0238-0456	409.18	456.62	214	53.36	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.7	C08		1	0239-0461	38.50	461.65	307	66.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.0	C08		1	0240-0462	165.64	462.71	309	71.60	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			320.1	C08		1	0241-0468	330.38	467.02	250	58.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			424.0	C08		1	0242-0470	569.44	470.56	357	69.84	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			379.5	C08		1	0243-0470	930.07	470.50	260	59.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			284.6	C08		1	0244-0471	789.81	471.64	322	67.01	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			540.8	C08		1	0245-0474	229.06	473.77	379	73.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			442.8	C08		1	0246-0471	387.85	471.68	248	58.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			365.4	C08		1	0247-0472	706.29	472.14	277	63.11	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			404.3	C08		1	0248-0481	321.87	481.24	242	58.77	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			548.1	C08		1	0249-0485	380.17	485.37	224	55.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.5	C08		1	0250-0486	625.83	486.05	324	66.18	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.0	C08		1	0251-0487	260.40	486.47	279	63.01	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			321.0	C08		1	0252-0488	501.49	489.01	313	66.77	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.8	C08		1	0253-0492	911.58	492.21	260	59.70	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			512.9	C08		1	0254-0494	593.95	494.04	348	70.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.8	C08		1	0255-0495	665.13	495.70	312	69.11	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			368.9	C08		1	0256-0494	159.72	493.86	232	57.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			421.8	C08		1	0257-0496	474.83	495.59	304	64.77	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			286.0	C08		1	0258-0500	942.76	500.59	410	78.43	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			235.6	C08		1	0259-0499	73.34	499.05	270	61.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			328.7	C08		1	0260-0501	746.05	501.11	444	77.26	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.8	C08		1	0261-0500	189.28	499.86	272	61.11	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			374.2	C08		1	0262-0505	546.03	505.10	455	80.91	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			234.0	C08		1	0263-0503	299.59	503.95	272	63.01	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.3	C08		1	0264-0501	110.04	501.73	271	61.70	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			32384.6	C08		1	0265-0505	789.60	505.62	115	92.43	0.169
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.6	C08		1	0266-0510	829.21	510.02	266	60.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.3	C08		1	0267-0509	37.93	509.58	271	61.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			533.7	C08		1	0268-0511	426.05	511.33	325	66.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			353.4	C08		1	0269-0514	270.46	514.21	363	71.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			279.2	C08		1	0270-0511	672.74	511.00	271	68.28	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			462.1	C08		1	0271-0516	129.22	517.00	317	67.36	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			374.0	C08		1	0272-0516	194.76	516.95	280	64.53	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.8	C08		1	0273-0521	857.97	520.82	269	61.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			380.2	C08		1	0274-0520	584.05	520.77	274	60.77	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			385.8	C08		1	0275-0522	441.51	522.16	302	64.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			342.1	C08		1	0276-0522	713.75	522.25	263	61.70	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			306.7	C08		1	0277-0526	530.57	526.08	301	64.43	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			420.7	C08		1	0278-0533	763.47	532.72	242	59.36	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			350.9	C08		1	0279-0534	795.61	533.70	277	61.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.3	C08		1	0280-0533	83.50	533.87	305	73.01	0.719
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			364.7	C08		1	0281-0535	213.46	535.24	213	53.11	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.2	C08		1	0282-0539	273.70	539.14	294	68.67	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			296.5	C08		1	0283-0537	619.01	536.78	268	61.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			16951.3	C08		1	0284-0544	727.47	543.99	343	68.43	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			480.6	C08		1	0285-0547	679.63	546.69	355	71.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			380.9	C08		1	0286-0547	351.77	547.50	250	59.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			220.6	C08		1	0287-0549	43.38	549.11	280	63.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.2	C08		1	0288-0548	164.29	548.21	254	59.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			469.9	C08		1	0289-0548	540.05	548.03	188	49.70	0.956
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			214.5	C08		1	0290-0550	835.32	549.74	270	61.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.1	C08		1	0291-0549	145.49	549.09	265	62.04	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.1	C08		1	0292-0552	920.15	551.59	294	63.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.1	C08		1	0293-0553	312.34	553.07	308	65.01	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			413.0	C08		1	0294-0553	786.10	553.31	341	71.84	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			322.6	C08		1	0295-0556	560.59	557.44	266	59.60	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.1	C08		1	0296-0559	390.52	558.51	297	64.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			314.1	C08		1	0297-0563	482.05	562.86	252	58.18	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			296.7	C08		1	0298-0563	675.45	563.22	272	63.11	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			194.3	C08		1	0299-0564	92.34	564.16	140	51.11	0.673
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			331.3	C08		1	0300-0569	793.86	569.65	318	66.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			674.5	C08		1	0301-0567	268.09	568.13	164	47.21	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.1	C08		1	0302-0571	593.86	571.40	272	60.53	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			194.3	C08		1	0303-0572	205.22	572.62	276	67.60	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			32066.5	C08		1	0304-0571	518.31	570.42	129	68.53	0.345
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.3	C08		1	0305-0579	898.28	579.25	364	71.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.9	C08		1	0306-0575	245.48	575.14	169	47.46	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			355.2	C08		1	0307-0576	559.64	575.69	245	58.53	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.7	C08		1	0308-0578	732.89	578.70	294	64.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.4	C08		1	0309-0580	875.88	579.73	285	62.18	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			185.7	C08		1	0310-0581	82.77	581.36	293	63.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			471.3	C08		1	0311-0587	262.45	585.43	422	83.60	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			407.4	C08		1	0312-0584	449.27	583.89	246	57.11	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			577.4	C08		1	0313-0585	537.45	585.66	219	55.36	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			235.7	C08		1	0314-0588	301.52	587.94	322	67.60	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			595.4	C08		1	0315-0589	927.47	589.16	304	65.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			298.6	C08		1	0316-0589	150.69	589.40	378	72.77	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			218.8	C08		1	0317-0592	810.14	592.40	297	64.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			219.5	C08		1	0318-0595	27.14	595.40	266	63.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			330.4	C08		1	0319-0597	944.27	597.18	229	55.70	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			341.8	C08		1	0320-0605	525.30	604.34	263	62.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			311.9	C08		1	0321-0603	766.04	603.99	261	61.70	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.9	C08		1	0322-0607	199.34	607.04	248	62.77	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			388.7	C08		1	0323-0608	393.01	608.28	288	63.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			213.7	C08		1	0324-0609	74.76	609.25	262	59.60	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			232.8	C08		1	0325-0612	704.10	611.88	297	64.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			234.0	C08		1	0326-0614	844.13	613.52	296	63.60	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			312.0	C08		1	0327-0612	482.55	611.88	271	62.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			407.0	C08		1	0328-0621	28.06	620.90	218	54.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.2	C08		1	0329-0619	763.88	618.42	260	63.11	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.4	C08		1	0330-0624	650.46	623.74	294	66.43	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			608.8	C08		1	0331-0625	262.52	625.35	205	51.70	0.964
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			431.5	C08		1	0332-0633	595.61	632.78	244	57.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			320.7	C08		1	0333-0634	879.26	634.12	249	57.94	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			472.1	C08		1	0334-0638	623.32	638.35	297	62.77	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			323.9	C08		1	0335-0643	419.35	643.64	263	62.53	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.9	C08		1	0336-0646	176.89	645.51	593	98.57	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			294.7	C08		1	0337-0645	219.75	645.23	306	69.60	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			309.6	C08		1	0338-0648	126.69	647.81	281	64.77	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			364.5	C08		1	0339-0646	727.56	646.82	268	61.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.7	C08		1	0340-0650	88.89	650.61	376	73.01	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.9	C08		1	0341-0649	316.53	648.68	283	62.77	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			327.8	C08		1	0342-0650	522.00	651.01	317	68.43	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			331.9	C08		1	0343-0651	570.73	650.76	211	55.11	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.9	C08		1	0344-0651	800.58	651.10	287	63.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			233.4	C08		1	0345-0648	909.49	648.45	257	60.53	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.2	C08		1	0346-0654	254.61	654.82	304	67.36	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			342.5	C08		1	0347-0653	445.55	652.66	256	59.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.2	C08		1	0348-0654	367.50	653.95	286	62.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.3	C08		1	0349-0656	762.40	655.48	294	64.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			330.1	C08		1	0350-0664	667.52	664.31	302	63.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			409.4	C08		1	0351-0671	601.16	671.67	341	67.60	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			354.5	C08		1	0352-0672	812.39	672.34	244	58.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			370.6	C08		1	0353-0676	939.29	676.50	264	61.11	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			484.0	C08		1	0354-0678	275.20	678.07	250	57.70	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			307.2	C08		1	0355-0681	711.96	681.31	295	64.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			364.5	C08		1	0356-0682	315.97	682.29	268	61.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.1	C08		1	0357-0681	863.81	681.07	227	57.11	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			613.4	C08		1	0358-0683	583.00	683.42	165	46.87	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.7	C08		1	0359-0688	917.00	688.43	243	58.18	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			292.3	C08		1	0360-0688	653.24	687.57	269	60.28	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			447.8	C08		1	0361-0693	825.13	693.11	264	63.26	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			292.0	C08		1	0362-0692	465.12	692.45	299	67.60	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.8	C08		1	0363-0695	164.66	695.52	270	60.53	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			197.7	C08		1	0364-0697	406.64	696.45	298	62.77	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.0	C08		1	0365-0696	862.07	696.93	302	67.94	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			316.9	C08		1	0366-0699	197.60	698.93	257	59.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			345.7	C08		1	0367-0697	564.69	698.02	245	58.87	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			319.6	C08		1	0368-0700	335.60	700.91	255	58.77	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			176.9	C08		1	0369-0702	19.92	703.24	288	63.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			194.6	C08		1	0370-0705	367.96	704.81	288	66.67	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			287.3	C08		1	0371-0705	91.70	705.53	250	60.53	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			252.9	C08		2	0001-0024	128.41	23.60	288	63.84	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			321.0	C08		2	0002-0025	174.92	24.72	270	61.94	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			304.1	C08		2	0003-0032	871.75	31.68	248	60.77	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			423.0	C08		2	0004-0033	68.62	32.87	192	51.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.5	C08		2	0005-0040	397.91	40.47	375	72.18	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			285.7	C08		2	0006-0037	551.14	37.65	274	62.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			344.2	C08		2	0007-0038	680.72	39.05	242	56.77	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			257.8	C08		2	0008-0042	48.52	41.52	316	66.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			257.1	C08		2	0009-0043	30.09	43.27	294	62.53	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			199.7	C08		2	0010-0043	231.80	43.46	334	67.60	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			400.8	C08		2	0011-0044	186.15	45.23	269	63.26	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.2	C08		2	0012-0048	487.71	49.18	332	70.77	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.4	C08		2	0013-0047	649.05	47.26	310	64.53	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			305.7	C08		2	0014-0048	797.12	49.02	408	78.08	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			408.1	C08		2	0015-0052	99.99	52.40	411	74.67	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			339.8	C08		2	0016-0049	205.02	49.46	206	53.46	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.3	C08		2	0017-0052	737.79	51.91	283	62.18	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			295.3	C08		2	0018-0055	716.07	54.90	288	63.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			350.9	C08		2	0019-0055	576.86	55.80	420	81.60	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			428.3	C08		2	0020-0062	153.35	62.35	313	65.01	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			320.1	C08		2	0021-0066	837.30	66.55	305	69.26	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			289.5	C08		2	0022-0064	854.66	63.94	218	55.11	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			298.2	C08		2	0023-0066	291.41	66.74	292	65.60	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			328.5	C08		2	0024-0068	355.25	67.73	270	61.94	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			306.6	C08		2	0025-0071	448.16	70.63	285	63.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.6	C08		2	0026-0075	427.60	74.95	326	66.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.2	C08		2	0027-0075	776.54	75.29	255	58.28	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			217.7	C08		2	0028-0082	244.28	81.66	317	68.43	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			334.0	C08		2	0029-0084	285.37	84.39	339	73.60	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.7	C08		2	0030-0082	659.88	82.54	285	63.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			299.7	C08		2	0031-0087	605.90	89.87	370	80.18	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			318.1	C08		2	0032-0082	618.92	81.58	168	50.87	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			453.2	C08		2	0033-0085	328.68	85.58	227	56.28	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			373.2	C08		2	0034-0084	576.11	84.68	291	63.01	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			311.7	C08		2	0035-0088	830.95	88.00	311	65.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			397.9	C08		2	0036-0087	550.38	87.01	216	53.94	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			345.1	C08		2	0037-0091	72.87	91.06	245	65.84	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			377.3	C08		2	0038-0092	485.02	92.27	221	54.87	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			361.4	C08		2	0039-0092	774.10	91.27	225	57.36	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.0	C08		2	0040-0098	696.24	97.15	290	63.60	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			289.1	C08		2	0041-0102	296.21	101.87	305	65.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			218.0	C08		2	0042-0104	886.08	103.99	341	68.18	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			323.4	C08		2	0043-0106	204.77	105.73	293	64.18	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			6899.1	C08		2	0044-0107	99.82	106.94	343	68.77	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			306.3	C08		2	0045-0110	741.92	109.44	252	62.28	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			298.6	C08		2	0046-0111	628.60	111.41	280	60.77	0.953
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.4	C08		2	0047-0113	944.04	114.24	441	81.50	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.3	C08		2	0048-0112	424.05	112.01	281	62.18	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.7	C08		2	0049-0115	340.36	115.59	316	65.60	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			307.6	C08		2	0050-0115	524.22	116.08	258	60.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			264.9	C08		2	0051-0116	404.44	116.68	286	62.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			388.3	C08		2	0052-0120	51.63	119.87	261	61.94	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			199.8	C08		2	0053-0122	257.66	121.89	391	76.08	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			283.2	C08		2	0054-0122	784.64	122.43	214	53.94	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.1	C08		2	0055-0124	572.99	124.69	321	66.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			213.0	C08		2	0056-0126	892.41	125.50	423	81.26	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.9	C08		2	0057-0128	359.94	128.35	310	65.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			322.5	C08		2	0058-0128	127.19	128.48	284	65.84	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			365.0	C08		2	0059-0130	172.43	130.44	391	73.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			503.9	C08		2	0060-0127	67.80	127.03	189	50.87	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			357.5	C08		2	0061-0131	621.82	131.00	285	64.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			296.5	C08		2	0062-0132	711.18	132.55	340	68.18	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			309.2	C08		2	0063-0137	516.40	137.02	356	72.91	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			293.2	C08		2	0064-0137	775.48	136.06	200	57.26	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			333.8	C08		2	0065-0140	460.31	140.21	426	77.01	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			391.1	C08		2	0066-0139	81.33	139.65	215	52.77	0.970
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			293.7	C08		2	0067-0140	823.51	140.83	256	60.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.6	C08		2	0068-0147	25.40	146.81	324	69.50	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.7	C08		2	0069-0150	221.02	149.90	439	80.43	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			379.2	C08		2	0070-0148	661.59	147.75	298	66.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			831.6	C08		2	0071-0151	277.86	151.60	306	64.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			292.3	C08		2	0072-0150	620.04	149.78	315	67.60	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			301.6	C08		2	0073-0156	748.99	155.98	202	55.70	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			413.0	C08		2	0074-0162	485.58	162.08	325	69.36	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			373.7	C08		2	0075-0159	562.03	159.43	209	54.28	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			451.1	C08		2	0076-0160	681.59	160.78	171	51.36	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			264.7	C08		2	0077-0171	363.75	171.30	328	69.26	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			233.0	C08		2	0078-0170	929.17	169.79	323	68.18	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			407.0	C08		2	0079-0170	58.63	170.19	217	53.11	0.967
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.8	C08		2	0080-0171	155.29	171.07	270	63.60	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			264.3	C08		2	0081-0172	587.56	172.32	252	59.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			326.4	C08		2	0082-0174	416.12	173.89	277	60.77	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			564.4	C08		2	0083-0178	456.76	175.89	289	74.18	0.660
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.4	C08		2	0084-0175	280.35	175.27	341	71.01	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			298.7	C08		2	0085-0176	136.98	176.47	272	63.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			336.3	C08		2	0086-0179	526.31	179.88	250	58.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			209.6	C08		2	0087-0181	242.03	181.06	335	69.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.7	C08		2	0088-0183	781.58	182.81	340	69.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			430.9	C08		2	0089-0184	103.01	184.47	203	54.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			205.7	C08		2	0090-0188	599.94	188.31	310	66.18	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			308.3	C08		2	0091-0192	481.83	192.42	247	63.70	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.4	C08		2	0092-0195	425.92	194.89	295	66.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.5	C08		2	0093-0198	25.57	197.78	289	63.60	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			284.7	C08		2	0094-0197	114.02	196.94	260	63.60	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			351.6	C08		2	0095-0200	525.18	199.68	315	65.94	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			379.5	C08		2	0096-0207	650.18	206.99	239	59.11	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.5	C08		2	0097-0204	722.48	204.95	239	56.18	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.8	C08		2	0098-0205	182.25	204.45	297	67.36	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.0	C08		2	0099-0211	436.75	211.44	299	67.94	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.1	C08		2	0100-0209	55.77	209.90	260	61.36	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			289.1	C08		2	0101-0212	318.78	212.16	308	66.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			321.5	C08		2	0102-0220	586.21	220.27	445	81.26	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.6	C08		2	0103-0223	186.02	223.61	263	59.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			234.3	C08		2	0104-0225	229.36	225.31	286	63.70	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			295.0	C08		2	0105-0225	923.17	225.16	242	57.11	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.1	C08		2	0106-0227	610.82	226.84	275	60.77	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			225.5	C08		2	0107-0227	100.50	227.54	284	64.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			281.3	C08		2	0108-0230	790.69	229.96	292	65.01	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			283.7	C08		2	0109-0230	383.79	229.79	303	63.94	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.8	C08		2	0110-0232	505.35	232.95	268	61.94	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			194.7	C08		2	0111-0231	64.38	230.32	272	61.11	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.8	C08		2	0112-0233	469.77	232.81	290	63.36	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			446.4	C08		2	0113-0233	823.19	232.39	260	61.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			394.2	C08		2	0114-0235	667.08	235.64	249	59.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.7	C08		2	0115-0241	271.81	241.68	289	65.84	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.1	C08		2	0116-0245	139.28	244.70	550	87.74	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.4	C08		2	0117-0245	190.45	245.11	306	64.77	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			386.3	C08		2	0118-0244	426.11	244.68	265	60.53	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			235.7	C08		2	0119-0250	256.58	250.75	311	67.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.0	C08		2	0120-0254	553.92	254.42	325	66.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			332.1	C08		2	0121-0253	727.06	253.50	243	57.94	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			451.7	C08		2	0122-0254	885.66	254.38	199	53.36	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			295.5	C08		2	0123-0259	302.12	259.35	329	68.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			252.8	C08		2	0124-0260	748.76	259.74	392	74.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			354.3	C08		2	0125-0261	432.64	261.36	196	53.21	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.2	C08		2	0126-0268	343.10	268.18	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			407.1	C08		2	0127-0267	25.78	266.73	231	56.18	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			388.9	C08		2	0128-0266	78.02	266.30	192	51.70	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			215.9	C08		2	0129-0267	114.11	267.03	287	64.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			337.0	C08		2	0130-0266	815.10	266.10	269	61.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			408.1	C08		2	0131-0272	91.72	271.87	183	50.28	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			294.0	C08		2	0132-0273	203.04	273.31	316	68.77	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			388.6	C08		2	0133-0275	569.95	274.68	442	79.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			635.9	C08		2	0134-0274	39.33	273.68	180	51.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			598.3	C08		2	0135-0277	672.47	276.66	294	65.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			236.3	C08		2	0136-0278	287.66	278.62	311	77.74	0.647
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			383.3	C08		2	0137-0281	688.77	281.41	190	52.28	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.3	C08		2	0138-0284	222.82	283.66	313	66.53	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			462.5	C08		2	0139-0286	317.64	285.56	222	55.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			545.4	C08		2	0140-0286	45.41	286.24	160	46.28	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.5	C08		2	0141-0290	149.01	291.47	268	60.53	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			354.9	C08		2	0142-0293	422.51	293.81	423	75.84	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			592.0	C08		2	0143-0291	677.08	291.79	126	44.04	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			365.8	C08		2	0144-0296	375.86	295.72	231	56.53	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.9	C08		2	0145-0297	89.16	296.62	270	61.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.6	C08		2	0146-0295	125.55	295.30	340	70.43	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			10683.6	C08		2	0147-0295	480.48	294.97	101	38.97	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			309.9	C08		2	0148-0305	868.84	305.13	300	65.60	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			324.2	C08		2	0149-0310	390.61	310.17	246	60.28	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			268.8	C08		2	0150-0308	254.84	307.98	242	58.28	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			436.2	C08		2	0151-0313	171.36	313.64	405	74.18	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.9	C08		2	0152-0317	189.73	317.29	313	71.36	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			573.2	C08		2	0153-0316	589.99	315.67	255	61.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.3	C08		2	0154-0319	724.22	320.00	324	67.36	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.0	C08		2	0155-0321	260.97	321.64	282	68.77	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			443.1	C08		2	0156-0322	782.33	322.48	265	61.11	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			426.5	C08		2	0157-0322	765.53	321.86	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.8	C08		2	0158-0324	91.62	324.21	284	63.01	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			384.1	C08		2	0159-0324	203.04	324.48	204	54.04	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			498.1	C08		2	0160-0324	219.56	324.07	184	49.70	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.0	C08		2	0161-0326	319.77	326.20	239	59.60	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			309.2	C08		2	0162-0326	445.11	325.63	279	63.60	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			336.2	C08		2	0163-0328	745.68	327.32	292	63.36	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			296.1	C08		2	0164-0326	375.73	326.79	238	56.87	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			308.0	C08		2	0165-0328	799.72	328.72	283	62.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.3	C08		2	0166-0329	69.68	329.37	267	62.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.0	C08		2	0167-0332	828.95	332.49	265	59.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			207.2	C08		2	0168-0333	137.34	333.96	297	63.36	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.0	C08		2	0169-0337	333.87	337.33	476	82.67	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.8	C08		2	0170-0339	655.25	338.63	375	71.60	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.6	C08		2	0171-0337	41.30	337.01	267	59.94	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			383.7	C08		2	0172-0341	449.37	341.53	237	57.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			372.9	C08		2	0173-0344	578.50	344.16	261	59.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			465.2	C08		2	0174-0345	271.53	344.95	333	70.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.9	C08		2	0175-0362	199.91	361.99	283	62.18	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.7	C08		2	0176-0362	744.59	362.13	297	63.36	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			378.7	C08		2	0177-0367	844.22	367.25	476	86.67	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			230.8	C08		2	0178-0367	31.63	367.08	200	55.01	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			236.4	C08		2	0179-0368	356.06	368.90	286	63.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			386.0	C08		2	0180-0371	425.28	370.81	245	58.28	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			315.0	C08		2	0181-0373	472.93	373.74	266	60.18	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			403.0	C08		2	0182-0374	894.56	374.92	213	56.87	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			214.5	C08		2	0183-0377	113.54	377.52	265	61.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			222.0	C08		2	0184-0383	23.22	384.93	341	76.67	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			279.0	C08		2	0185-0378	156.27	377.70	268	60.53	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			441.7	C08		2	0186-0387	229.76	388.44	416	82.08	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.1	C08		2	0187-0383	267.30	383.62	237	57.60	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.9	C08		2	0188-0384	394.23	383.70	325	67.01	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.0	C08		2	0189-0383	521.82	382.94	130	43.46	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.3	C08		2	0190-0395	516.46	396.09	209	58.77	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			350.4	C08		2	0191-0398	438.54	398.30	245	57.60	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.6	C08		2	0192-0393	534.58	393.96	160	49.80	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			343.9	C08		2	0193-0400	62.70	399.55	259	61.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			326.2	C08		2	0194-0404	289.85	404.07	638	93.84	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			290.5	C08		2	0195-0400	365.27	399.62	250	59.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.5	C08		2	0196-0405	724.18	405.92	363	72.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			259.1	C08		2	0197-0409	829.94	409.26	358	70.43	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			364.4	C08		2	0198-0409	463.33	409.72	301	66.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			211.8	C08		2	0199-0405	535.33	405.06	151	46.04	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.5	C08		2	0200-0409	700.43	408.69	295	64.53	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			295.3	C08		2	0201-0409	380.18	410.01	304	65.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			291.0	C08		2	0202-0415	154.53	415.43	294	73.50	0.684
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.7	C08		2	0203-0416	884.62	415.94	289	64.53	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			429.4	C08		2	0204-0415	56.75	416.08	327	67.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.0	C08		2	0205-0416	925.04	416.90	278	64.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			290.9	C08		2	0206-0419	663.17	419.11	335	67.36	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			350.1	C08		2	0207-0420	264.27	421.78	251	59.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			428.6	C08		2	0208-0420	498.43	420.59	204	55.11	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.4	C08		2	0209-0422	133.84	422.17	248	58.28	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			309.3	C08		2	0210-0424	724.51	424.08	312	66.53	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.0	C08		2	0211-0427	13.61	427.56	258	62.53	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			268.4	C08		2	0212-0429	945.19	429.48	286	65.36	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			313.0	C08		2	0213-0428	701.23	428.05	270	62.53	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			342.7	C08		2	0214-0433	190.90	433.18	238	58.53	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			373.7	C08		2	0215-0434	225.32	434.19	271	61.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.3	C08		2	0216-0437	87.04	437.77	287	62.77	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			360.5	C08		2	0217-0435	173.26	435.41	244	58.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			495.6	C08		2	0218-0436	260.95	436.35	185	49.80	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			312.8	C08		2	0219-0441	873.85	440.57	308	64.28	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			290.4	C08		2	0220-0444	375.81	444.45	323	66.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			369.3	C08		2	0221-0446	566.04	446.26	348	69.84	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			506.2	C08		2	0222-0449	332.26	449.77	560	94.33	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			291.4	C08		2	0223-0447	424.52	447.61	335	67.94	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			309.5	C08		2	0224-0448	922.18	447.91	265	61.60	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			236.7	C08		2	0225-0449	462.86	449.06	289	65.01	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			336.8	C08		2	0226-0451	604.85	451.48	265	63.60	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			381.5	C08		2	0227-0459	549.21	459.53	351	69.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.2	C08		2	0228-0458	143.34	458.86	324	68.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			337.8	C08		2	0229-0459	261.60	459.85	248	57.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			277.1	C08		2	0230-0458	400.63	459.11	238	59.46	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.7	C08		2	0231-0466	491.10	466.15	301	69.60	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			356.9	C08		2	0232-0462	632.32	462.23	266	60.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			323.4	C08		2	0233-0472	34.89	471.98	262	59.11	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			279.9	C08		2	0234-0469	119.89	468.96	262	61.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			422.8	C08		2	0235-0477	405.92	477.24	489	96.67	0.658
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.0	C08		2	0236-0480	815.69	480.06	304	75.01	0.679
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			298.5	C08		2	0237-0479	914.13	478.71	270	61.11	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			304.1	C08		2	0238-0480	225.31	480.10	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			364.6	C08		2	0239-0477	326.87	477.58	241	59.94	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			296.3	C08		2	0240-0481	871.99	481.61	262	60.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.2	C08		2	0241-0484	568.43	484.08	272	61.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			426.0	C08		2	0242-0489	750.74	489.51	488	84.33	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			304.2	C08		2	0243-0488	169.56	487.86	284	62.18	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			416.6	C08		2	0244-0488	679.30	488.67	269	61.70	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			462.4	C08		2	0245-0488	307.68	487.95	359	71.60	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			306.4	C08		2	0246-0489	630.43	488.96	323	68.18	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			220.9	C08		2	0247-0493	16.24	493.55	254	59.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			230.1	C08		2	0248-0493	507.23	493.06	269	63.60	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			337.7	C08		2	0249-0502	47.73	502.09	427	77.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			412.6	C08		2	0250-0500	246.57	500.67	312	66.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			390.0	C08		2	0251-0500	533.77	500.29	219	54.53	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			355.3	C08		2	0252-0504	66.26	503.58	297	64.53	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			292.2	C08		2	0253-0505	699.10	505.70	368	73.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			339.3	C08		2	0254-0501	204.12	501.50	231	59.11	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			364.2	C08		2	0255-0502	433.05	502.56	215	54.87	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			291.5	C08		2	0256-0507	619.58	507.08	300	67.94	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.6	C08		2	0257-0511	948.45	510.67	280	67.26	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			334.8	C08		2	0258-0512	475.01	511.55	298	65.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			326.2	C08		2	0259-0513	867.81	513.90	265	61.36	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			292.7	C08		2	0260-0516	850.85	516.77	257	59.60	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			270.2	C08		2	0261-0516	146.95	516.06	263	59.36	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			315.3	C08		2	0262-0523	580.94	523.79	157	47.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			203.8	C08		2	0263-0524	902.61	524.32	334	71.01	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			336.7	C08		2	0264-0524	171.12	524.21	247	58.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			464.8	C08		2	0265-0529	743.25	528.55	460	81.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			320.9	C08		2	0266-0529	338.24	529.73	255	61.36	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			228.3	C08		2	0267-0531	547.18	530.79	348	70.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			433.8	C08		2	0268-0532	520.09	532.34	249	59.60	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			347.1	C08		2	0269-0534	822.04	534.95	290	65.36	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			218.1	C08		2	0270-0536	121.32	535.69	443	79.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.4	C08		2	0271-0536	253.91	537.11	303	64.77	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			234.0	C08		2	0272-0540	73.04	539.97	266	60.43	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.6	C08		2	0273-0540	438.67	540.09	274	60.53	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.2	C08		2	0274-0543	474.92	543.22	497	82.43	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			366.5	C08		2	0275-0543	495.38	542.73	251	57.94	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			222.0	C08		2	0276-0545	179.70	545.24	306	69.94	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			285.2	C08		2	0277-0548	795.48	548.99	303	64.43	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.6	C08		2	0278-0551	945.99	550.84	288	62.53	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			217.6	C08		2	0279-0553	24.96	553.10	285	62.18	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			334.2	C08		2	0280-0557	618.00	556.84	266	63.11	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			320.9	C08		2	0281-0561	641.94	560.82	711	101.98	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			408.5	C08		2	0282-0560	291.60	560.59	518	83.01	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.6	C08		2	0283-0562	86.27	562.76	232	58.18	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			338.5	C08		2	0284-0563	339.83	563.42	303	64.43	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			306.3	C08		2	0285-0564	707.60	563.60	155	50.53	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			264.8	C08		2	0286-0567	555.67	567.57	297	65.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			389.3	C08		2	0287-0568	213.50	569.92	207	64.43	0.627
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			421.7	C08		2	0288-0569	583.10	568.94	301	64.28	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			291.8	C08		2	0289-0573	171.22	574.28	290	66.77	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			264.6	C08		2	0290-0573	882.89	572.56	272	63.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.5	C08		2	0291-0573	241.29	573.36	271	60.53	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			603.6	C08		2	0292-0577	185.71	576.57	160	48.63	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.6	C08		2	0293-0579	907.88	578.08	277	63.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			277.4	C08		2	0294-0581	57.33	580.98	258	59.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			257.2	C08		2	0295-0587	724.98	587.15	316	67.60	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.8	C08		2	0296-0587	134.80	587.12	175	50.53	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			331.4	C08		2	0297-0588	505.48	588.00	251	57.60	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			351.1	C08		2	0298-0590	87.90	590.70	192	53.70	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			594.3	C08		2	0299-0591	31.88	590.68	317	65.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			333.9	C08		2	0300-0591	764.21	591.57	269	61.36	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.4	C08		2	0301-0596	797.64	596.34	275	64.18	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			370.5	C08		2	0302-0598	49.01	598.53	246	58.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			328.7	C08		2	0303-0601	207.24	601.43	355	70.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			235.5	C08		2	0304-0599	600.60	599.30	324	68.18	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.5	C08		2	0305-0602	438.82	602.72	334	68.18	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.0	C08		2	0306-0603	746.91	602.13	251	59.84	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			304.2	C08		2	0307-0606	543.49	606.34	266	60.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			215.4	C08		2	0308-0604	250.39	605.09	296	66.18	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.6	C08		2	0309-0609	387.02	608.81	269	63.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.7	C08		2	0310-0608	335.62	607.84	280	64.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			334.6	C08		2	0311-0610	944.87	609.75	210	53.11	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			284.7	C08		2	0312-0613	119.39	614.07	255	64.77	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			405.3	C08		2	0313-0615	291.31	615.17	248	60.18	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			295.1	C08		2	0314-0621	566.88	622.06	251	60.77	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			372.8	C08		2	0315-0625	840.51	624.99	239	57.36	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			358.2	C08		2	0316-0628	67.91	628.06	236	55.70	0.956
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			346.1	C08		2	0317-0627	266.18	626.84	274	63.94	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			389.5	C08		2	0318-0632	346.98	632.17	263	60.43	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			293.0	C08		2	0319-0634	393.30	633.93	334	75.01	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			232.6	C08		2	0320-0634	670.15	633.03	101	41.70	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			294.1	C08		2	0321-0638	851.24	638.19	292	64.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			411.9	C08		2	0322-0639	445.95	639.26	253	59.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			290.2	C08		2	0323-0642	157.39	640.87	253	62.28	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			369.6	C08		2	0324-0640	174.32	640.06	262	61.46	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.6	C08		2	0325-0644	425.47	643.95	353	70.77	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			321.3	C08		2	0326-0644	307.30	643.62	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			187.0	C08		2	0327-0645	630.33	645.35	309	65.01	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			230.8	C08		2	0328-0648	727.88	648.50	296	64.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.1	C08		2	0329-0647	119.09	647.07	268	60.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			208.2	C08		2	0330-0650	679.59	650.26	310	68.77	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			209.4	C08		2	0331-0650	246.41	650.38	298	69.36	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.3	C08		2	0332-0650	13.97	649.82	250	58.87	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			443.7	C08		2	0333-0650	470.51	649.83	248	60.87	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.1	C08		2	0334-0653	588.67	652.30	269	62.77	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.3	C08		2	0335-0655	563.64	655.36	249	59.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			216.8	C08		2	0336-0655	263.18	654.92	281	64.77	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.8	C08		2	0337-0669	407.40	670.15	329	70.43	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			306.9	C08		2	0338-0669	371.39	669.49	271	61.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			674.0	C08		2	0339-0674	544.22	674.03	278	64.53	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.0	C08		2	0340-0674	283.60	674.11	316	67.60	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			415.4	C08		2	0341-0677	50.74	676.48	504	93.74	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			384.9	C08		2	0342-0677	529.26	677.28	241	57.70	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			326.1	C08		2	0343-0679	637.19	678.71	458	80.43	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			352.5	C08		2	0344-0684	829.52	684.32	312	64.77	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.1	C08		2	0345-0685	100.70	685.98	251	58.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			331.8	C08		2	0346-0687	352.25	686.86	227	58.28	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			312.4	C08		2	0347-0686	391.95	685.78	302	65.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			374.6	C08		2	0348-0689	565.33	688.86	432	79.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			559.3	C08		2	0349-0687	806.47	688.39	341	72.43	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.8	C08		2	0350-0690	21.42	689.99	247	57.36	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			212.1	C08		2	0351-0690	142.77	690.36	295	65.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			448.5	C08		2	0352-0694	479.41	694.54	338	67.60	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			198.9	C08		2	0353-0700	209.29	699.63	276	63.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			259.2	C08		2	0354-0697	630.69	697.57	233	57.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			223.9	C08		2	0355-0699	247.97	699.45	266	60.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			384.5	C08		2	0356-0702	759.80	701.69	264	60.43	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			205.5	C08		2	0357-0710	176.17	709.98	264	60.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			296.0	C08		3	0001-0023	532.57	23.39	244	57.60	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			390.0	C08		3	0002-0028	327.48	30.03	247	65.36	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			437.9	C08		3	0003-0029	465.12	29.36	299	67.01	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			341.4	C08		3	0004-0029	685.49	28.96	237	60.63	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			453.3	C08		3	0005-0029	253.25	28.93	221	54.53	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			308.6	C08		3	0006-0032	58.32	32.64	327	66.43	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.2	C08		3	0007-0031	771.33	31.27	277	60.77	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			422.0	C08		3	0008-0032	938.39	31.96	323	66.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			277.6	C08		3	0009-0032	428.60	32.82	242	58.28	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.3	C08		3	0010-0041	489.88	41.38	564	96.57	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			264.9	C08		3	0011-0034	658.31	34.47	313	66.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.5	C08		3	0012-0040	199.61	39.73	314	70.18	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.0	C08		3	0013-0039	448.67	39.33	289	63.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			320.6	C08		3	0014-0037	547.08	37.85	227	57.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			418.3	C08		3	0015-0041	721.42	40.98	365	73.01	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			311.3	C08		3	0016-0039	566.60	40.06	313	69.01	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			321.6	C08		3	0017-0040	922.00	40.34	223	66.67	0.630
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			219.6	C08		3	0018-0044	596.63	44.21	304	66.43	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			453.8	C08		3	0019-0041	813.20	41.28	179	51.46	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.9	C08		3	0020-0049	113.44	49.20	334	67.84	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			314.6	C08		3	0021-0053	359.25	53.25	278	65.01	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.1	C08		3	0022-0049	430.55	48.90	263	61.11	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			270.1	C08		3	0023-0055	223.57	55.22	314	66.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			391.4	C08		3	0024-0053	396.70	52.83	352	69.01	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			407.1	C08		3	0025-0055	809.25	55.67	224	55.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.6	C08		3	0026-0059	148.23	58.99	225	59.60	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			357.6	C08		3	0027-0064	280.55	64.35	314	67.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			381.6	C08		3	0028-0063	544.03	63.30	254	57.70	0.959
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			284.3	C08		3	0029-0064	884.27	64.14	186	51.70	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			460.7	C08		3	0030-0066	516.31	65.67	264	63.36	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			292.0	C08		3	0031-0066	137.84	67.13	100	36.87	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			306.1	C08		3	0032-0073	467.13	73.35	280	67.84	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			353.2	C08		3	0033-0082	290.55	82.99	431	79.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.9	C08		3	0034-0081	885.37	80.56	222	56.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			794.4	C08		3	0035-0084	53.08	83.10	310	65.84	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.1	C08		3	0036-0084	137.48	84.03	298	65.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			389.7	C08		3	0037-0082	269.27	81.66	220	57.46	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.4	C08		3	0038-0085	905.06	84.63	292	63.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			365.5	C08		3	0039-0088	663.25	88.70	423	77.50	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			186.9	C08		3	0040-0087	397.19	87.20	335	70.08	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			602.8	C08		3	0041-0091	639.02	90.74	485	81.01	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			311.7	C08		3	0042-0087	769.24	87.52	258	59.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			325.4	C08		3	0043-0090	219.09	90.97	283	63.01	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			363.7	C08		3	0044-0097	238.14	97.34	325	69.60	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			173.0	C08		3	0045-0100	948.51	100.66	304	64.18	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			283.9	C08		3	0046-0106	703.27	106.15	301	71.01	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			218.3	C08		3	0047-0104	412.83	104.58	343	69.36	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.5	C08		3	0048-0106	858.33	105.98	240	57.94	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.5	C08		3	0049-0114	169.00	114.22	297	65.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			351.0	C08		3	0050-0112	786.67	113.07	223	55.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.1	C08		3	0051-0116	38.58	116.93	429	80.08	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.4	C08		3	0052-0116	528.84	115.97	313	66.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			709.9	C08		3	0053-0119	387.92	119.01	319	66.18	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			487.8	C08		3	0054-0132	365.36	135.16	821	132.47	0.588
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			379.2	C08		3	0055-0129	748.67	130.15	442	92.23	0.653
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			389.1	C08		3	0056-0128	920.91	127.37	349	69.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			398.0	C08		3	0057-0125	566.78	124.73	293	63.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.5	C08		3	0058-0127	626.53	128.10	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.5	C08		3	0059-0130	770.46	128.58	300	69.01	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			342.7	C08		3	0060-0135	789.23	134.60	222	61.60	0.735
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			347.7	C08		3	0061-0134	817.31	134.17	319	68.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			428.4	C08		3	0062-0142	89.03	141.16	280	67.11	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			377.9	C08		3	0063-0141	165.57	141.85	330	68.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			362.0	C08		3	0064-0138	224.78	138.64	223	55.70	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			534.7	C08		3	0065-0141	396.66	141.25	271	61.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			331.0	C08		3	0066-0141	497.15	141.74	275	63.11	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.6	C08		3	0067-0142	861.03	142.03	262	59.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			524.2	C08		3	0068-0142	337.85	142.39	270	65.11	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			348.4	C08		3	0069-0145	703.67	145.81	261	61.36	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			331.6	C08		3	0070-0148	266.12	148.80	285	65.60	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			236.2	C08		3	0071-0155	897.36	154.70	365	73.26	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.6	C08		3	0072-0152	653.92	152.55	284	64.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.4	C08		3	0073-0161	237.53	161.53	297	65.01	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			349.9	C08		3	0074-0164	69.27	165.07	267	63.60	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			345.1	C08		3	0075-0164	520.53	163.95	253	61.01	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			461.3	C08		3	0076-0166	620.29	165.68	383	73.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			332.3	C08		3	0077-0164	465.07	164.49	227	57.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			382.3	C08		3	0078-0165	749.54	165.08	432	77.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			233.8	C08		3	0079-0172	869.02	171.91	382	74.33	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.7	C08		3	0080-0173	23.84	172.42	302	65.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			296.7	C08		3	0081-0174	592.35	173.61	452	83.84	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.4	C08		3	0082-0174	274.69	173.21	288	67.36	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			305.4	C08		3	0083-0178	545.77	178.99	262	66.53	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.2	C08		3	0084-0178	148.43	178.01	338	73.84	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			401.4	C08		3	0085-0176	514.15	177.00	189	52.77	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			355.6	C08		3	0086-0177	679.31	177.37	240	58.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			411.8	C08		3	0087-0181	696.46	181.97	249	59.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.3	C08		3	0088-0180	794.34	180.45	254	60.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			419.3	C08		3	0089-0181	108.76	180.88	230	55.11	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			268.5	C08		3	0090-0193	414.72	192.56	330	68.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			321.9	C08		3	0091-0190	64.99	189.93	227	55.11	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			384.1	C08		3	0092-0195	99.27	195.98	234	56.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			338.4	C08		3	0093-0196	202.97	195.97	316	69.01	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			205.9	C08		3	0094-0198	831.79	197.32	370	75.60	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			329.3	C08		3	0095-0197	49.38	196.72	237	58.18	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			401.4	C08		3	0096-0197	513.77	197.29	315	65.01	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			286.5	C08		3	0097-0204	457.17	203.08	271	61.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.6	C08		3	0098-0203	704.26	203.91	332	73.01	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.1	C08		3	0099-0204	354.49	204.48	347	73.01	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			227.2	C08		3	0100-0208	569.50	207.85	443	78.67	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			294.0	C08		3	0101-0210	948.56	209.54	264	63.11	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.0	C08		3	0102-0214	469.57	213.88	255	59.94	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.8	C08		3	0103-0225	924.52	225.67	367	87.15	0.607
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			264.8	C08		3	0104-0228	644.11	227.88	315	70.77	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.4	C08		3	0105-0225	61.98	224.71	299	70.67	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			200.3	C08		3	0106-0225	160.87	224.84	322	69.84	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.2	C08		3	0107-0229	862.41	228.41	317	68.67	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.0	C08		3	0108-0228	18.02	227.83	235	55.94	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			295.2	C08		3	0109-0234	751.08	233.32	289	64.18	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			463.7	C08		3	0110-0236	782.55	236.23	246	57.36	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.8	C08		3	0111-0240	93.05	240.20	308	66.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			290.4	C08		3	0112-0238	892.29	239.00	287	65.01	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.0	C08		3	0113-0240	235.55	240.11	332	67.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.8	C08		3	0114-0237	585.30	237.86	152	46.87	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			289.4	C08		3	0115-0241	269.32	240.96	307	66.77	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			369.4	C08		3	0116-0248	610.00	249.03	258	62.28	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			210.3	C08		3	0117-0246	373.04	246.03	343	76.43	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			367.6	C08		3	0118-0248	765.67	248.01	239	67.01	0.669
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			343.0	C08		3	0119-0248	806.76	248.02	239	55.70	0.968
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			799.7	C08		3	0120-0251	678.80	251.79	260	59.94	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			357.1	C08		3	0121-0250	583.42	250.39	234	68.04	0.635
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			270.5	C08		3	0122-0258	131.40	259.27	494	84.33	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			391.3	C08		3	0123-0256	150.97	255.71	274	63.84	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			259.3	C08		3	0124-0260	490.75	261.11	264	64.18	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			470.7	C08		3	0125-0261	49.17	260.94	240	58.77	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			285.2	C08		3	0126-0261	447.80	260.90	268	65.01	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.8	C08		3	0127-0266	406.69	265.92	281	63.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			349.9	C08		3	0128-0263	942.26	262.18	227	57.70	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			303.7	C08		3	0129-0266	729.09	265.65	222	54.53	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.4	C08		3	0130-0271	632.23	271.21	387	98.47	0.502
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			343.8	C08		3	0131-0276	877.95	276.41	209	53.46	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			488.9	C08		3	0132-0280	532.20	280.58	357	69.01	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			322.1	C08		3	0133-0283	898.83	283.28	321	65.60	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			257.6	C08		3	0134-0287	309.24	286.78	291	63.60	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			296.7	C08		3	0135-0290	800.71	289.32	280	63.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			431.0	C08		3	0136-0289	858.29	289.80	228	56.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			326.1	C08		3	0137-0293	677.33	293.41	287	63.94	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			453.8	C08		3	0138-0291	459.36	291.79	320	66.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			233.4	C08		3	0139-0297	354.38	297.64	401	79.50	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			389.9	C08		3	0140-0294	757.01	294.27	198	55.11	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			221.0	C08		3	0141-0299	576.94	298.66	443	79.60	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.8	C08		3	0142-0298	265.74	298.65	267	61.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			350.2	C08		3	0143-0299	72.18	299.74	253	58.77	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.7	C08		3	0144-0304	788.08	303.48	234	59.01	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			360.7	C08		3	0145-0311	518.79	311.58	293	63.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			304.2	C08		3	0146-0311	866.10	311.35	321	66.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			214.9	C08		3	0147-0313	114.14	313.03	312	67.84	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.3	C08		3	0148-0316	281.76	314.32	322	72.77	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			336.9	C08		3	0149-0314	216.74	314.24	240	57.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			421.1	C08		3	0150-0316	462.68	315.95	374	71.84	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			349.3	C08		3	0151-0312	671.78	312.33	293	66.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			299.0	C08		3	0152-0319	404.30	319.33	365	90.33	0.562
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			232.4	C08		3	0153-0317	916.73	316.91	325	68.43	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.1	C08		3	0154-0321	486.15	320.62	376	90.91	0.572
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.2	C08		3	0155-0321	749.58	321.63	264	61.94	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			359.7	C08		3	0156-0320	800.65	320.44	228	56.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			367.6	C08		3	0157-0322	187.82	322.48	247	57.11	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			283.9	C08		3	0158-0325	595.66	325.86	278	63.70	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.9	C08		3	0159-0330	310.51	329.78	303	69.60	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			420.6	C08		3	0160-0335	57.67	335.14	295	64.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.0	C08		3	0161-0340	769.12	339.27	267	65.36	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.1	C08		3	0162-0337	643.36	337.38	259	60.28	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			371.6	C08		3	0163-0342	782.81	341.49	203	57.11	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			341.9	C08		3	0164-0342	707.27	341.53	243	57.94	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			323.5	C08		3	0165-0347	686.39	347.35	273	61.11	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.6	C08		3	0166-0349	864.22	349.06	308	67.60	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			296.7	C08		3	0167-0353	197.73	352.76	262	66.18	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.8	C08		3	0168-0356	948.80	356.74	354	73.50	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.4	C08		3	0169-0351	635.22	351.36	265	63.94	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.0	C08		3	0170-0352	215.58	351.55	130	45.36	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			401.3	C08		3	0171-0355	559.53	355.31	290	65.60	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			286.2	C08		3	0172-0358	54.25	359.06	261	61.01	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			4984.1	C08		3	0173-0363	341.37	363.34	449	81.01	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			391.6	C08		3	0174-0359	778.66	359.31	223	55.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			228.1	C08		3	0175-0363	359.28	363.10	324	70.53	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.8	C08		3	0176-0367	464.46	366.77	345	71.01	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			224.7	C08		3	0177-0367	727.94	367.19	277	61.36	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.8	C08		3	0178-0368	906.35	368.80	281	62.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			380.5	C08		3	0179-0368	189.77	367.86	245	57.36	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.3	C08		3	0180-0369	213.15	368.99	220	53.94	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.4	C08		3	0181-0372	857.11	373.24	323	71.60	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			357.6	C08		3	0182-0374	698.26	374.09	239	60.18	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			302.9	C08		3	0183-0377	303.40	376.96	313	67.01	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			398.1	C08		3	0184-0377	544.99	377.60	241	59.36	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			656.4	C08		3	0185-0383	44.56	382.58	380	73.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			317.1	C08		3	0186-0389	434.90	390.02	536	103.40	0.630
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.9	C08		3	0187-0382	792.69	380.81	322	71.84	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.5	C08		3	0188-0387	381.32	386.98	316	72.77	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.5	C08		3	0189-0390	610.76	389.98	481	86.33	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			298.3	C08		3	0190-0389	695.86	388.97	303	68.43	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			236.1	C08		3	0191-0392	841.59	392.05	299	65.94	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			496.1	C08		3	0192-0394	134.16	394.28	212	54.53	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			322.9	C08		3	0193-0398	670.63	398.30	256	59.11	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.3	C08		3	0194-0402	272.23	402.84	428	76.91	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.5	C08		3	0195-0408	507.87	407.51	311	66.53	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.2	C08		3	0196-0410	807.87	410.34	346	69.84	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			307.2	C08		3	0197-0409	472.96	409.63	281	61.60	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			305.5	C08		3	0198-0411	322.05	410.94	282	63.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			225.0	C08		3	0199-0413	571.30	413.44	318	66.53	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			223.8	C08		3	0200-0414	759.60	414.30	348	71.84	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.6	C08		3	0201-0414	89.37	414.72	261	60.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.4	C08		3	0202-0417	190.24	417.81	315	66.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			259.1	C08		3	0203-0419	20.26	419.74	274	65.36	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.1	C08		3	0204-0425	422.94	424.10	347	74.43	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			302.9	C08		3	0205-0422	719.69	422.40	292	65.36	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.7	C08		3	0206-0425	354.68	425.44	306	65.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.5	C08		3	0207-0429	315.29	430.42	404	77.50	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.6	C08		3	0208-0427	212.29	427.79	284	63.94	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			219.4	C08		3	0209-0429	585.97	429.94	328	67.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.0	C08		3	0210-0432	39.94	432.05	266	62.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			440.3	C08		3	0211-0433	109.61	432.71	202	55.11	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			259.1	C08		3	0212-0438	716.99	437.68	332	76.43	0.714
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			322.4	C08		3	0213-0443	151.37	443.99	239	57.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			437.3	C08		3	0214-0441	866.29	441.56	144	48.04	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			268.1	C08		3	0215-0448	705.39	449.09	366	71.84	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			412.1	C08		3	0216-0445	115.33	445.73	189	51.94	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			361.3	C08		3	0217-0444	904.95	445.08	292	66.53	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			18827.8	C08		3	0218-0450	642.85	450.12	331	87.74	0.540
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			298.2	C08		3	0219-0449	247.18	448.68	163	52.18	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			252.4	C08		3	0220-0450	17.02	450.61	255	60.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			437.4	C08		3	0221-0451	528.31	450.92	220	56.87	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			383.0	C08		3	0222-0450	169.22	450.25	225	55.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			279.7	C08		3	0223-0451	232.54	451.54	225	62.28	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			230.7	C08		3	0224-0452	283.27	452.69	218	63.01	0.690
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			511.9	C08		3	0225-0452	833.38	452.54	187	51.46	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			536.8	C08		3	0226-0454	884.15	454.05	199	53.11	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			412.1	C08		3	0227-0451	868.05	451.00	108	41.80	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			335.2	C08		3	0228-0460	783.55	460.00	397	73.60	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			695.4	C08		3	0229-0457	81.69	456.53	160	48.53	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			295.2	C08		3	0230-0459	599.55	459.37	223	55.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			317.6	C08		3	0231-0467	409.14	467.44	277	63.94	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			518.6	C08		3	0232-0463	896.21	463.67	180	50.53	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			670.0	C08		3	0233-0471	73.92	471.13	260	60.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			414.9	C08		3	0234-0470	370.62	469.91	330	66.77	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			449.8	C08		3	0235-0470	909.28	470.32	193	54.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			739.8	C08		3	0236-0474	658.09	474.07	236	108.47	0.252
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.9	C08		3	0237-0477	757.68	477.45	310	68.18	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.6	C08		3	0238-0483	861.58	482.86	294	67.36	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			270.9	C08		3	0239-0482	135.99	482.81	302	65.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.7	C08		3	0240-0481	782.06	481.84	320	70.18	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			477.3	C08		3	0241-0484	619.12	484.95	307	67.60	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			487.6	C08		3	0242-0487	230.78	487.27	221	56.77	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			6315.4	C08		3	0243-0488	501.96	488.48	303	95.15	0.421
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.3	C08		3	0244-0492	845.54	492.39	295	67.01	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			359.7	C08		3	0245-0496	592.35	495.95	308	67.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			151.3	C08		3	0246-0494	948.35	494.15	209	56.28	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.0	C08		3	0247-0495	927.22	495.11	272	63.11	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			277.8	C08		3	0248-0497	887.16	497.36	310	68.43	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.9	C08		3	0249-0508	730.86	507.47	308	68.18	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.2	C08		3	0250-0510	714.33	510.41	265	63.11	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			169.5	C08		3	0251-0505	944.95	505.82	128	46.63	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			347.8	C08		3	0252-0511	456.37	510.33	310	65.94	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			264.5	C08		3	0253-0513	43.13	513.37	269	63.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			374.2	C08		3	0254-0516	514.45	515.97	247	62.18	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.1	C08		3	0255-0520	646.15	520.03	381	72.67	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			293.6	C08		3	0256-0519	399.86	519.23	316	67.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.6	C08		3	0257-0522	197.60	521.91	304	64.77	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			337.6	C08		3	0258-0524	879.76	523.49	273	63.36	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.5	C08		3	0259-0526	159.70	527.09	306	67.94	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			353.1	C08		3	0260-0523	483.04	523.55	269	63.94	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			213.4	C08		3	0261-0531	810.81	531.43	365	72.18	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			327.9	C08		3	0262-0528	565.57	527.76	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.8	C08		3	0263-0530	782.86	529.80	316	67.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			295.3	C08		3	0264-0530	756.84	529.87	273	60.77	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			305.6	C08		3	0265-0531	367.86	531.22	203	54.04	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			218.8	C08		3	0266-0534	608.04	534.55	326	68.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			234.2	C08		3	0267-0537	119.51	536.59	320	66.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			315.6	C08		3	0268-0538	740.19	538.23	288	63.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			341.5	C08		3	0269-0546	675.65	545.16	234	61.70	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			299.1	C08		3	0270-0549	529.42	550.06	285	65.60	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.5	C08		3	0271-0551	426.59	551.08	333	68.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.3	C08		3	0272-0551	267.71	551.18	295	63.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			333.9	C08		3	0273-0550	703.60	550.46	250	58.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			294.5	C08		3	0274-0554	40.63	553.53	281	62.53	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.8	C08		3	0275-0553	861.92	552.97	283	63.11	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.3	C08		3	0276-0552	904.61	552.64	264	62.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			313.5	C08		3	0277-0562	81.73	563.11	229	57.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.6	C08		3	0278-0560	180.90	560.41	289	65.11	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			378.6	C08		3	0279-0564	689.94	564.74	395	73.60	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			325.8	C08		3	0280-0566	65.60	566.35	283	61.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.9	C08		3	0281-0566	890.89	566.66	302	64.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.8	C08		3	0282-0568	447.87	568.48	399	73.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.8	C08		3	0283-0567	848.99	567.07	160	48.04	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			349.7	C08		3	0284-0568	726.85	569.11	263	59.46	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			230.0	C08		3	0285-0574	501.01	573.94	304	68.18	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.5	C08		3	0286-0576	103.26	576.46	271	63.11	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			290.0	C08		3	0287-0577	288.58	576.72	309	67.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			397.8	C08		3	0288-0571	588.60	571.12	203	56.28	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			311.1	C08		3	0289-0580	322.17	580.19	286	62.18	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			302.0	C08		3	0290-0582	304.21	582.90	279	63.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			514.4	C08		3	0291-0587	610.80	586.71	430	81.26	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			190.9	C08		3	0292-0583	908.91	583.67	336	71.60	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			314.0	C08		3	0293-0587	357.14	587.71	211	54.87	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			443.5	C08		3	0294-0583	584.48	583.09	206	56.28	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			366.0	C08		3	0295-0584	760.43	583.31	202	53.11	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.8	C08		3	0296-0586	839.51	587.03	244	59.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			354.4	C08		3	0297-0588	726.94	587.22	223	56.28	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			252.7	C08		3	0298-0592	227.26	591.41	284	62.43	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			464.6	C08		3	0299-0596	537.39	596.63	274	62.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			418.8	C08		3	0300-0596	628.00	596.63	204	54.53	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.4	C08		3	0301-0598	53.36	598.16	263	59.36	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.6	C08		3	0302-0601	490.88	601.10	323	68.18	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.7	C08		3	0303-0598	800.23	598.26	318	66.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			227.4	C08		3	0304-0606	86.25	606.24	265	59.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.5	C08		3	0305-0606	873.17	605.88	286	63.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			302.0	C08		3	0306-0605	758.47	605.61	197	56.18	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.3	C08		3	0307-0612	193.94	611.97	326	68.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			230.2	C08		3	0308-0612	153.56	612.34	281	63.36	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			329.0	C08		3	0309-0612	39.38	612.41	207	52.87	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			311.0	C08		3	0310-0617	654.98	617.44	437	77.26	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			381.1	C08		3	0311-0620	691.40	620.80	264	62.77	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.6	C08		3	0312-0622	316.84	621.70	292	62.77	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			494.6	C08		3	0313-0628	613.04	628.45	215	54.87	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			390.4	C08		3	0314-0632	119.71	632.15	422	75.36	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.2	C08		3	0315-0630	340.94	629.63	275	65.60	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			366.4	C08		3	0316-0635	406.97	634.37	580	95.98	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			351.1	C08		3	0317-0634	44.10	633.95	263	62.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			305.8	C08		3	0318-0637	939.48	637.54	249	58.53	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			513.9	C08		3	0319-0643	596.50	643.24	346	69.60	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			233.4	C08		3	0320-0642	345.82	643.74	326	71.01	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			375.6	C08		3	0321-0643	892.99	643.52	199	54.87	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			348.2	C08		3	0322-0645	755.67	644.84	283	62.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.4	C08		3	0323-0647	849.47	645.85	284	66.43	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			342.3	C08		3	0324-0645	915.19	645.36	189	50.53	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			359.1	C08		3	0325-0648	719.79	648.20	266	63.60	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			295.5	C08		3	0326-0650	46.59	649.98	241	58.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.6	C08		3	0327-0654	672.21	654.89	277	62.77	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			308.9	C08		3	0328-0659	482.69	658.41	319	68.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.5	C08		3	0329-0656	415.05	657.27	273	64.18	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			339.6	C08		3	0330-0661	817.85	661.10	226	55.11	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.3	C08		3	0331-0662	381.27	662.38	254	60.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			259.2	C08		3	0332-0664	602.31	664.16	276	61.94	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			557.9	C08		3	0333-0665	260.71	665.53	161	46.87	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			225.6	C08		3	0334-0669	166.07	669.08	291	63.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.4	C08		3	0335-0673	211.95	673.34	288	68.53	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			539.7	C08		3	0336-0672	244.53	673.82	262	64.53	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			505.1	C08		3	0337-0678	779.05	677.79	266	59.36	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			313.0	C08		3	0338-0679	734.95	678.14	297	63.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.1	C08		3	0339-0681	865.04	680.29	300	66.77	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			343.5	C08		3	0340-0682	910.16	681.82	303	65.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			553.4	C08		3	0341-0682	754.15	682.31	293	63.01	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			318.9	C08		3	0342-0681	883.02	681.72	260	61.01	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.0	C08		3	0343-0681	559.94	681.50	269	63.36	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			325.1	C08		3	0344-0687	817.17	687.40	326	67.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			236.4	C08		3	0345-0688	615.97	687.25	257	61.11	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.9	C08		3	0346-0694	384.31	694.38	318	68.53	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.5	C08		3	0347-0697	418.34	698.00	305	66.77	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			303.0	C08		3	0348-0701	679.16	701.08	282	67.36	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			315.5	C08		3	0349-0701	229.03	700.26	253	67.84	0.691
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			291.4	C08		3	0350-0705	619.82	705.13	278	63.94	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			421.9	C08		3	0351-0702	848.61	702.61	245	59.94	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			277.3	C08		3	0352-0709	943.83	708.13	287	64.77	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			162.1	C08		3	0353-0709	56.23	709.62	258	61.70	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			214.3	C08		3	0354-0711	333.46	711.20	309	69.11	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			305.0	C08		4	0001-0023	195.30	23.30	268	61.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			336.8	C08		4	0002-0022	562.22	22.54	257	61.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			384.3	C08		4	0003-0021	820.66	21.45	146	46.04	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			194.7	C08		4	0004-0026	17.68	27.12	282	63.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			382.7	C08		4	0005-0025	333.33	25.35	262	59.36	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.1	C08		4	0006-0029	365.76	29.28	324	70.67	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			380.1	C08		4	0007-0029	89.76	29.68	255	61.36	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			454.0	C08		4	0008-0033	621.79	33.53	356	70.43	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			310.0	C08		4	0009-0038	108.79	38.32	321	66.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.2	C08		4	0010-0042	214.26	42.85	281	64.77	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			311.9	C08		4	0011-0045	786.35	45.55	257	61.11	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			440.8	C08		4	0012-0046	321.66	46.11	241	57.11	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			303.1	C08		4	0013-0046	703.80	46.36	280	65.11	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.8	C08		4	0014-0048	943.16	49.11	232	56.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			448.2	C08		4	0015-0055	52.27	55.75	711	116.13	0.663
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.8	C08		4	0016-0052	448.90	51.61	395	72.77	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			360.7	C08		4	0017-0056	116.59	56.15	287	64.77	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			359.3	C08		4	0018-0057	857.49	56.52	218	55.11	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			322.0	C08		4	0019-0062	138.71	62.85	301	69.26	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.9	C08		4	0020-0063	660.87	63.64	333	68.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			416.9	C08		4	0021-0063	268.62	63.38	243	59.60	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			204.3	C08		4	0022-0067	498.94	66.82	322	70.18	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			450.5	C08		4	0023-0063	541.75	63.22	257	60.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			257.0	C08		4	0024-0062	762.42	62.81	263	60.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			212.8	C08		4	0025-0065	921.79	64.05	293	66.43	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			366.8	C08		4	0026-0072	306.40	72.35	280	63.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			514.2	C08		4	0027-0072	555.04	71.69	231	57.94	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			264.2	C08		4	0028-0077	228.36	77.22	311	66.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			868.1	C08		4	0029-0080	255.87	80.63	419	76.08	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			333.7	C08		4	0030-0080	861.20	80.08	233	56.87	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			236.1	C08		4	0031-0080	902.41	80.33	276	62.77	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			374.9	C08		4	0032-0083	625.71	83.44	278	63.94	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			628.8	C08		4	0033-0083	563.68	83.38	211	54.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			470.1	C08		4	0034-0086	418.74	86.24	264	60.43	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			412.5	C08		4	0035-0087	108.03	87.68	255	60.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			401.1	C08		4	0036-0093	591.99	93.38	413	82.08	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			310.4	C08		4	0037-0086	761.03	86.31	272	63.94	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			309.0	C08		4	0038-0087	185.57	87.49	289	61.94	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.0	C08		4	0039-0093	461.42	93.14	342	73.74	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.3	C08		4	0040-0092	701.97	91.78	300	66.18	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			257.1	C08		4	0041-0100	738.97	99.96	308	65.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			333.4	C08		4	0042-0102	52.13	101.74	260	59.94	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			24281.9	C08		4	0043-0110	367.52	110.02	740	103.30	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			49333.4	C08		4	0044-0103	837.97	102.66	133	98.13	0.174
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			235.8	C08		4	0045-0104	544.63	104.79	309	65.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.2	C08		4	0046-0107	942.98	106.80	304	64.77	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			342.8	C08		4	0047-0107	89.01	106.82	202	55.11	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			320.6	C08		4	0048-0112	288.36	112.59	289	63.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			373.4	C08		4	0049-0118	163.66	118.71	229	59.70	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			338.0	C08		4	0050-0121	427.35	120.78	283	63.26	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			39211.5	C08		4	0051-0128	672.34	128.38	325	67.01	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			401.5	C08		4	0052-0132	440.24	131.62	293	65.26	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			383.6	C08		4	0053-0132	641.24	132.40	265	63.01	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			416.2	C08		4	0054-0135	321.50	135.13	286	69.11	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			435.0	C08		4	0055-0133	195.76	132.94	243	58.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			321.1	C08		4	0056-0141	832.51	140.76	395	73.01	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			475.8	C08		4	0057-0141	698.12	140.93	279	61.94	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			329.7	C08		4	0058-0144	401.87	144.67	298	65.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.9	C08		4	0059-0141	608.51	141.51	293	63.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			406.2	C08		4	0060-0143	890.55	143.94	350	69.01	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			295.0	C08		4	0061-0147	281.89	147.32	272	62.53	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			511.7	C08		4	0062-0155	211.91	154.96	244	59.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			366.0	C08		4	0063-0155	546.55	155.53	283	63.70	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			450.8	C08		4	0064-0157	650.36	156.76	250	58.18	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			445.0	C08		4	0065-0162	471.64	161.79	460	83.98	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			437.0	C08		4	0066-0162	875.55	162.57	335	67.01	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			386.7	C08		4	0067-0165	392.06	164.70	252	60.87	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.1	C08		4	0068-0162	908.00	162.89	262	59.11	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			283.6	C08		4	0069-0166	15.51	165.91	257	61.01	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			330.5	C08		4	0070-0165	626.78	165.37	265	61.36	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			299.6	C08		4	0071-0169	55.25	169.81	268	63.94	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.4	C08		4	0072-0173	930.06	173.44	334	73.60	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			467.8	C08		4	0073-0171	572.45	171.06	277	65.01	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			394.4	C08		4	0074-0175	117.62	175.02	347	70.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			456.4	C08		4	0075-0174	608.69	174.77	343	72.67	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			546.7	C08		4	0076-0176	709.60	175.55	246	58.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			412.5	C08		4	0077-0182	743.35	181.60	249	57.94	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.6	C08		4	0078-0187	260.34	187.52	305	68.43	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			398.1	C08		4	0079-0187	396.30	186.68	288	65.01	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			360.6	C08		4	0080-0189	524.11	189.77	271	62.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			257.3	C08		4	0081-0192	303.68	191.71	332	70.77	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			485.0	C08		4	0082-0193	77.16	194.14	250	58.87	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			361.2	C08		4	0083-0204	189.14	203.70	711	106.91	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			407.0	C08		4	0084-0195	564.72	195.48	236	56.53	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			546.2	C08		4	0085-0197	603.83	197.14	195	51.70	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			317.8	C08		4	0086-0201	361.27	201.37	278	62.18	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			320.5	C08		4	0087-0203	910.95	203.03	256	64.53	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			505.4	C08		4	0088-0200	621.21	201.45	183	52.53	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			295.3	C08		4	0089-0208	451.61	208.79	227	59.94	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			409.4	C08		4	0090-0205	142.26	204.59	219	54.53	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			363.0	C08		4	0091-0211	77.12	210.81	245	58.63	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			259.5	C08		4	0092-0214	212.55	213.45	279	62.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.7	C08		4	0093-0215	882.23	215.37	291	63.36	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			303.5	C08		4	0094-0218	788.07	218.22	272	63.94	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.3	C08		4	0095-0220	822.27	219.43	310	65.36	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			397.4	C08		4	0096-0221	236.96	221.31	270	60.18	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			281.0	C08		4	0097-0223	700.20	224.18	270	61.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			322.1	C08		4	0098-0225	11.64	225.33	233	56.28	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			403.9	C08		4	0099-0224	907.71	224.45	290	74.43	0.658
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.3	C08		4	0100-0231	46.45	231.41	275	62.18	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			563.8	C08		4	0101-0231	289.29	231.64	353	70.18	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			441.9	C08		4	0102-0233	398.28	233.18	267	64.18	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			344.6	C08		4	0103-0237	156.70	237.75	481	90.57	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			327.8	C08		4	0104-0241	555.48	240.85	356	74.91	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			522.8	C08		4	0105-0241	479.61	240.40	254	60.28	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			386.7	C08		4	0106-0245	716.17	245.07	436	77.60	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			320.0	C08		4	0107-0247	327.17	247.13	466	82.43	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			485.5	C08		4	0108-0246	134.48	245.89	176	49.36	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			374.7	C08		4	0109-0253	433.59	253.15	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			452.0	C08		4	0110-0253	587.73	252.99	305	65.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			279.7	C08		4	0111-0256	80.26	256.04	257	61.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			486.1	C08		4	0112-0257	247.39	255.62	261	61.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			356.5	C08		4	0113-0256	364.30	256.01	292	63.94	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			283.3	C08		4	0114-0254	936.70	254.54	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			336.4	C08		4	0115-0257	755.30	256.76	273	62.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.6	C08		4	0116-0257	864.11	257.95	306	66.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			313.0	C08		4	0117-0258	384.05	257.99	249	58.28	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			295.8	C08		4	0118-0260	777.97	259.88	263	59.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.2	C08		4	0119-0265	223.78	265.45	272	63.94	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			337.7	C08		4	0120-0264	502.47	264.27	314	66.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			395.8	C08		4	0121-0265	114.70	264.56	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			493.9	C08		4	0122-0271	280.71	271.29	271	61.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			353.2	C08		4	0123-0271	834.78	271.50	274	61.01	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			323.6	C08		4	0124-0274	894.80	274.10	305	65.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.9	C08		4	0125-0278	522.30	279.48	304	69.01	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.3	C08		4	0126-0276	602.65	276.21	294	62.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			421.1	C08		4	0127-0284	128.97	286.07	617	101.40	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			519.3	C08		4	0128-0277	254.08	276.78	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			212.3	C08		4	0129-0286	42.86	285.69	296	64.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			303.3	C08		4	0130-0286	158.65	286.05	218	55.70	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			497.6	C08		4	0131-0288	942.68	288.02	330	69.01	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			315.0	C08		4	0132-0289	406.39	289.20	301	67.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			312.8	C08		4	0133-0289	695.37	289.37	262	62.18	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			366.3	C08		4	0134-0294	340.79	295.23	513	90.91	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			329.1	C08		4	0135-0293	917.77	293.73	271	61.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			522.1	C08		4	0136-0296	250.70	296.90	422	77.84	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			385.5	C08		4	0137-0293	712.56	293.65	264	63.36	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			306.7	C08		4	0138-0294	560.23	293.96	274	64.43	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			305.5	C08		4	0139-0299	471.38	299.56	304	65.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.4	C08		4	0140-0301	392.38	301.52	280	64.18	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			193.3	C08		4	0141-0307	13.11	307.38	287	63.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			598.9	C08		4	0142-0306	80.29	306.31	181	50.87	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			285.7	C08		4	0143-0307	523.17	306.77	252	59.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			330.8	C08		4	0144-0306	612.94	307.01	227	54.77	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.4	C08		4	0145-0309	816.53	308.49	292	66.77	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			413.4	C08		4	0146-0315	425.75	315.11	295	63.01	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			202.6	C08		4	0147-0319	940.38	319.78	301	64.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.9	C08		4	0148-0318	803.67	318.62	290	69.84	0.747
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			354.4	C08		4	0149-0317	849.12	317.73	271	60.18	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			498.3	C08		4	0150-0323	559.21	322.24	321	73.26	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			569.4	C08		4	0151-0321	87.18	321.12	225	56.28	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			435.7	C08		4	0152-0322	452.39	323.15	367	71.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			285.0	C08		4	0153-0327	162.06	328.11	249	59.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			573.3	C08		4	0154-0330	710.27	330.78	319	65.36	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			375.9	C08		4	0155-0328	886.53	328.26	263	60.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			257.1	C08		4	0156-0338	594.01	337.91	595	97.98	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			341.8	C08		4	0157-0337	646.17	337.01	297	63.60	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			349.8	C08		4	0158-0337	116.88	337.20	284	63.36	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			296.6	C08		4	0159-0341	39.77	340.92	273	63.60	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			334.8	C08		4	0160-0341	454.84	340.21	289	67.11	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			478.3	C08		4	0161-0346	304.57	345.75	260	61.36	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			362.0	C08		4	0162-0346	271.11	346.10	266	59.11	0.957
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			294.9	C08		4	0163-0350	752.50	350.43	324	67.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			273.8	C08		4	0164-0350	384.43	350.60	255	57.94	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			469.2	C08		4	0165-0356	74.61	354.29	497	93.74	0.711
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			215.9	C08		4	0166-0357	29.79	358.18	297	66.18	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			645.6	C08		4	0167-0358	176.42	358.89	387	72.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.7	C08		4	0168-0359	793.52	358.98	294	63.84	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.2	C08		4	0169-0361	514.26	361.31	283	61.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.4	C08		4	0170-0360	594.36	360.58	300	66.43	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			337.9	C08		4	0171-0361	685.12	361.13	274	61.11	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			264.7	C08		4	0172-0365	840.24	364.88	336	71.26	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			458.6	C08		4	0173-0368	155.00	368.36	278	62.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			210.8	C08		4	0174-0368	933.68	367.98	277	63.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			228.7	C08		4	0175-0368	547.58	368.08	268	61.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			285.7	C08		4	0176-0373	905.43	372.43	254	62.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			259.8	C08		4	0177-0378	76.68	377.50	293	64.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			590.8	C08		4	0178-0379	403.55	378.78	400	75.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			402.4	C08		4	0179-0381	916.77	381.15	265	65.11	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			354.2	C08		4	0180-0380	783.74	380.76	267	61.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			224.8	C08		4	0181-0381	868.36	381.50	273	62.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			268.0	C08		4	0182-0380	582.62	380.44	267	62.77	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			316.8	C08		4	0183-0387	197.99	387.76	271	62.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			339.3	C08		4	0184-0388	386.37	388.18	276	63.60	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			341.8	C08		4	0185-0393	451.71	392.80	425	77.50	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			353.5	C08		4	0186-0392	327.20	391.44	230	59.01	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.2	C08		4	0187-0391	646.40	391.28	327	69.60	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			737.2	C08		4	0188-0393	265.53	394.10	264	71.60	0.647
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			389.0	C08		4	0189-0398	487.40	398.43	243	57.94	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			560.1	C08		4	0190-0407	338.35	406.82	452	79.26	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.4	C08		4	0191-0407	428.75	406.70	308	67.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.3	C08		4	0192-0406	835.29	405.58	284	63.36	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			402.2	C08		4	0193-0406	219.83	405.82	314	75.01	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			403.0	C08		4	0194-0412	39.19	412.53	379	73.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.5	C08		4	0195-0414	718.29	413.31	316	70.67	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.1	C08		4	0196-0415	616.94	415.67	305	71.11	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			400.6	C08		4	0197-0418	537.24	418.53	261	60.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			324.4	C08		4	0198-0419	314.66	418.81	257	60.77	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			332.2	C08		4	0199-0423	23.37	424.02	327	68.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			219.1	C08		4	0200-0426	443.84	426.38	435	78.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.5	C08		4	0201-0422	497.94	422.24	234	59.94	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			296.9	C08		4	0202-0421	782.63	422.18	227	57.46	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			456.8	C08		4	0203-0428	102.54	428.54	257	59.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			534.5	C08		4	0204-0428	353.63	428.13	233	58.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			306.9	C08		4	0205-0431	175.61	431.06	260	61.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			470.9	C08		4	0206-0436	869.49	435.52	344	69.26	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.2	C08		4	0207-0437	399.03	437.24	300	65.84	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			270.2	C08		4	0208-0435	785.70	435.21	299	67.46	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.5	C08		4	0209-0442	844.50	442.06	300	68.08	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.6	C08		4	0210-0439	899.85	439.43	274	63.94	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.4	C08		4	0211-0444	533.74	444.45	275	63.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			232.2	C08		4	0212-0451	210.14	451.51	293	67.01	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			344.6	C08		4	0213-0452	160.79	452.29	236	59.70	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			294.6	C08		4	0214-0454	600.75	454.31	294	65.60	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			273.8	C08		4	0215-0451	736.90	451.79	266	61.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			298.0	C08		4	0216-0454	895.33	454.25	259	61.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			216.3	C08		4	0217-0458	478.62	458.38	287	65.84	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			295.3	C08		4	0218-0461	694.69	460.92	532	86.91	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.0	C08		4	0219-0459	44.19	459.42	281	64.43	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			235.3	C08		4	0220-0459	342.19	460.03	284	62.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			306.6	C08		4	0221-0462	933.42	462.17	236	57.70	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			290.5	C08		4	0222-0465	256.68	465.55	257	60.77	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.4	C08		4	0223-0471	643.70	471.56	319	67.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.2	C08		4	0224-0473	375.99	473.75	283	64.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			319.3	C08		4	0225-0478	95.76	477.80	297	67.94	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			344.5	C08		4	0226-0480	226.39	480.27	289	68.53	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.7	C08		4	0227-0482	578.29	482.37	597	107.88	0.645
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			235.3	C08		4	0228-0482	355.23	481.80	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			212.0	C08		4	0229-0483	515.35	483.79	278	63.70	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			209.8	C08		4	0230-0487	464.61	487.29	316	68.67	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			312.5	C08		4	0231-0486	656.31	486.55	381	76.18	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			333.9	C08		4	0232-0489	306.55	488.32	222	57.60	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			273.9	C08		4	0233-0491	261.19	491.53	318	66.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.7	C08		4	0234-0492	900.56	491.75	258	62.43	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			679.5	C08		4	0235-0493	119.60	493.37	322	66.43	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			207.6	C08		4	0236-0493	532.25	493.24	329	67.36	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			384.9	C08		4	0237-0496	152.27	496.95	290	63.60	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			233.8	C08		4	0238-0498	496.09	498.57	275	61.36	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			351.1	C08		4	0239-0506	296.91	506.63	510	89.40	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			486.3	C08		4	0240-0503	747.65	501.76	382	82.77	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.9	C08		4	0241-0505	190.44	504.87	303	66.43	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			325.2	C08		4	0242-0506	585.31	506.50	368	79.01	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			407.6	C08		4	0243-0506	914.71	505.80	385	72.08	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			342.6	C08		4	0244-0507	75.06	506.49	407	77.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			322.2	C08		4	0245-0508	940.54	508.37	248	59.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			283.9	C08		4	0246-0514	460.98	514.37	282	66.18	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.0	C08		4	0247-0515	344.87	515.17	256	58.77	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			445.9	C08		4	0248-0513	752.20	513.18	104	37.56	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.6	C08		4	0249-0519	797.87	519.53	305	66.77	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			374.5	C08		4	0250-0523	21.03	522.78	367	71.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			277.3	C08		4	0251-0524	677.56	524.40	267	63.11	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.8	C08		4	0252-0525	857.33	525.76	293	63.60	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.2	C08		4	0253-0528	605.21	528.13	260	60.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.7	C08		4	0254-0530	81.41	530.67	265	59.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.4	C08		4	0255-0532	425.71	531.58	294	64.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			1650.7	C08		4	0256-0534	143.33	533.49	348	69.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.4	C08		4	0257-0536	337.79	536.17	304	64.77	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			305.3	C08		4	0258-0540	705.37	540.44	283	67.60	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			230.9	C08		4	0259-0540	375.55	540.29	282	61.36	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			335.2	C08		4	0260-0542	264.94	543.10	283	64.18	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.2	C08		4	0261-0540	769.06	541.00	227	55.70	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			43418.4	C08		4	0262-0546	504.88	544.75	144	58.18	0.535
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.1	C08		4	0263-0545	786.77	545.17	241	58.28	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			357.6	C08		4	0264-0548	466.92	548.01	289	65.60	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.9	C08		4	0265-0551	193.95	551.35	335	75.36	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.9	C08		4	0266-0551	210.43	550.77	270	61.70	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			369.1	C08		4	0267-0553	564.18	553.75	284	62.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			193.6	C08		4	0268-0551	918.25	551.13	317	66.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			41090.6	C08		4	0269-0550	498.75	550.63	113	46.04	0.670
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			203.6	C08		4	0270-0553	125.79	553.98	155	46.87	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			538.1	C08		4	0271-0563	41.40	563.91	377	82.43	0.697
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			225.0	C08		4	0272-0562	294.63	562.32	316	67.60	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			320.1	C08		4	0273-0561	645.15	561.41	241	61.36	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.7	C08		4	0274-0566	848.78	566.92	594	97.40	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.9	C08		4	0275-0565	518.57	564.82	266	61.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			731.5	C08		4	0276-0565	593.65	565.42	274	60.77	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			340.9	C08		4	0277-0568	97.71	568.65	271	62.77	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.6	C08		4	0278-0566	436.79	566.91	284	68.43	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			293.9	C08		4	0279-0583	385.93	583.07	254	58.53	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.2	C08		4	0280-0582	551.56	582.54	274	61.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			294.1	C08		4	0281-0586	588.04	585.62	294	67.60	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			232.3	C08		4	0282-0585	806.99	584.50	330	70.43	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			233.3	C08		4	0283-0588	656.39	587.82	317	68.67	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			320.6	C08		4	0284-0585	915.70	585.09	232	55.94	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			391.0	C08		4	0285-0586	752.14	586.11	259	59.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			304.4	C08		4	0286-0589	453.57	588.43	297	65.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			285.0	C08		4	0287-0596	680.62	596.36	294	65.01	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.8	C08		4	0288-0597	370.78	597.13	269	60.87	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			405.1	C08		4	0289-0598	906.51	598.67	284	67.01	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.8	C08		4	0290-0602	472.15	602.78	265	62.77	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.3	C08		4	0291-0606	407.31	605.77	311	66.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			293.8	C08		4	0292-0610	596.24	611.18	339	74.43	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			314.3	C08		4	0293-0606	124.51	606.33	248	59.11	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.5	C08		4	0294-0604	150.87	603.91	160	48.87	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.7	C08		4	0295-0608	221.37	608.45	282	67.01	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.0	C08		4	0296-0611	107.12	611.29	310	67.60	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			479.9	C08		4	0297-0608	891.26	607.66	201	53.36	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.8	C08		4	0298-0617	251.36	617.11	262	63.26	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.4	C08		4	0299-0617	546.69	617.58	314	66.18	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.2	C08		4	0300-0621	164.67	621.23	270	65.70	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			344.6	C08		4	0301-0617	298.05	616.51	243	57.36	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.6	C08		4	0302-0623	508.75	622.51	536	104.13	0.621
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			197.1	C08		4	0303-0621	860.48	620.95	301	66.53	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			199.2	C08		4	0304-0621	89.78	621.50	220	54.18	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			336.2	C08		4	0305-0626	363.21	626.25	240	63.84	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.6	C08		4	0306-0623	19.85	623.15	257	57.94	0.962
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			328.7	C08		4	0307-0626	446.30	626.23	296	65.84	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.6	C08		4	0308-0628	276.95	627.68	296	65.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			234.3	C08		4	0309-0632	393.23	631.71	281	63.60	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			308.1	C08		4	0310-0629	712.87	629.97	259	61.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			290.8	C08		4	0311-0633	197.52	634.07	279	62.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			326.1	C08		4	0312-0642	488.06	641.33	754	112.47	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			321.9	C08		4	0313-0637	829.47	636.54	263	61.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			352.4	C08		4	0314-0644	345.03	644.26	229	55.70	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.1	C08		4	0315-0641	608.85	641.57	282	65.36	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			399.3	C08		4	0316-0647	814.22	647.40	352	70.67	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			178.9	C08		4	0317-0648	411.99	648.90	283	67.84	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.6	C08		4	0318-0654	217.20	652.52	594	101.74	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			33843.5	C08		4	0319-0647	372.52	646.90	117	54.67	0.492
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			25586.9	C08		4	0320-0651	366.21	653.00	129	56.43	0.509
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			277.5	C08		4	0321-0657	751.75	656.75	276	64.77	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			325.7	C08		4	0322-0661	29.53	660.50	527	89.26	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			203.5	C08		4	0323-0658	948.14	657.79	286	63.60	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.9	C08		4	0324-0664	526.90	664.58	255	62.53	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.7	C08		4	0325-0661	625.34	660.88	249	57.94	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			218.3	C08		4	0326-0664	562.53	664.41	309	68.43	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.1	C08		4	0327-0667	784.11	667.20	269	63.36	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			232.4	C08		4	0328-0665	139.16	664.90	285	63.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.6	C08		4	0329-0670	586.29	670.21	256	59.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			421.2	C08		4	0330-0670	914.77	670.05	225	54.87	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			224.5	C08		4	0331-0674	415.34	674.71	314	66.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.0	C08		4	0332-0677	471.76	677.87	291	65.94	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.0	C08		4	0333-0679	539.42	678.57	287	67.36	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.1	C08		4	0334-0682	65.29	680.87	252	65.36	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			174.2	C08		4	0335-0683	495.42	683.29	294	66.53	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			301.4	C08		4	0336-0681	348.32	681.31	250	58.18	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			232.7	C08		4	0337-0682	512.00	682.29	273	61.21	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			327.3	C08		4	0338-0685	29.24	685.85	265	61.36	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			203.3	C08		4	0339-0687	261.52	686.48	285	65.36	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			336.3	C08		4	0340-0687	845.32	687.10	233	56.18	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			209.0	C08		4	0341-0692	717.19	692.78	251	61.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			470.5	C08		4	0342-0691	292.89	692.24	199	53.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			214.0	C08		4	0343-0694	754.00	694.29	290	65.60	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.5	C08		4	0344-0696	193.12	695.75	276	62.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			364.7	C08		4	0345-0697	54.64	698.43	341	70.43	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			355.5	C08		4	0346-0696	135.31	695.85	323	66.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			202.1	C08		4	0347-0699	793.59	700.20	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			301.6	C08		4	0348-0699	474.12	699.64	273	62.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.1	C08		4	0349-0701	733.39	701.49	303	67.36	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			294.7	C08		4	0350-0705	877.22	705.20	108	42.04	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			150.9	C08		4	0351-0707	930.89	707.77	266	65.01	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.6	C08		4	0352-0710	358.48	709.73	291	63.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			190.3	C08		5	0001-0025	207.22	24.73	281	63.36	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			268.9	C08		5	0002-0023	628.36	23.18	228	56.28	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			388.2	C08		5	0003-0027	757.57	26.69	263	60.43	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			252.1	C08		5	0004-0025	245.80	25.00	263	60.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.2	C08		5	0005-0035	174.04	35.25	268	60.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			506.6	C08		5	0006-0036	402.63	35.76	271	61.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.7	C08		5	0007-0037	66.40	37.22	253	59.11	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			316.7	C08		5	0008-0039	746.47	39.01	243	59.84	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			213.1	C08		5	0009-0041	937.37	41.10	272	64.18	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			654.0	C08		5	0010-0045	583.63	46.23	377	80.18	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			1015.3	C08		5	0011-0041	602.48	40.47	210	54.87	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			252.5	C08		5	0012-0046	510.44	45.61	319	65.01	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			316.3	C08		5	0013-0047	417.06	47.14	262	70.67	0.659
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			344.2	C08		5	0014-0048	325.88	48.14	252	59.70	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			392.9	C08		5	0015-0048	864.11	48.79	362	71.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			321.9	C08		5	0016-0051	538.31	51.75	284	63.94	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.8	C08		5	0017-0049	663.18	49.26	245	56.77	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			318.4	C08		5	0018-0051	47.74	51.33	240	58.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			350.8	C08		5	0019-0051	887.77	51.56	252	57.94	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			303.7	C08		5	0020-0056	264.29	55.56	497	91.74	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			452.8	C08		5	0021-0055	482.62	55.53	232	56.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			236.3	C08		5	0022-0063	305.30	62.56	282	66.67	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			208.2	C08		5	0023-0062	186.19	63.10	290	65.60	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			374.9	C08		5	0024-0064	806.78	64.54	201	56.43	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			198.8	C08		5	0025-0067	26.26	66.14	274	64.43	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			293.6	C08		5	0026-0066	117.58	65.66	227	59.60	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			232.7	C08		5	0027-0071	231.30	71.55	281	65.60	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			317.5	C08		5	0028-0071	753.60	71.94	276	61.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			279.6	C08		5	0029-0072	559.09	72.36	265	60.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			285.2	C08		5	0030-0076	379.29	75.97	313	67.01	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			301.4	C08		5	0031-0080	123.83	80.49	366	76.18	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			228.4	C08		5	0032-0075	165.25	74.41	288	65.70	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.9	C08		5	0033-0078	613.99	77.76	256	58.53	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			227.8	C08		5	0034-0079	923.97	79.38	259	59.70	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.1	C08		5	0035-0081	60.39	81.99	265	64.18	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.3	C08		5	0036-0084	505.04	84.26	310	65.94	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.6	C08		5	0037-0090	693.12	90.15	316	68.18	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			294.3	C08		5	0038-0088	724.22	87.61	299	63.60	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			335.4	C08		5	0039-0087	254.08	87.36	238	58.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.6	C08		5	0040-0089	87.63	89.57	252	58.53	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.0	C08		5	0041-0090	184.69	90.96	419	81.26	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			360.3	C08		5	0042-0094	281.23	94.20	346	70.18	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.0	C08		5	0043-0093	162.46	93.63	217	59.70	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.6	C08		5	0044-0097	316.17	98.03	272	60.77	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.1	C08		5	0045-0105	858.99	106.45	309	76.77	0.659
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.5	C08		5	0046-0101	651.89	101.10	345	69.84	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.9	C08		5	0047-0102	503.46	101.78	273	62.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.8	C08		5	0048-0105	894.66	104.84	302	69.84	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.3	C08		5	0049-0105	342.24	105.07	235	55.94	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			259.2	C08		5	0050-0107	788.00	107.40	286	64.77	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			224.6	C08		5	0051-0109	47.58	108.98	289	62.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			546.1	C08		5	0052-0108	208.12	107.97	321	66.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			289.0	C08		5	0053-0109	829.80	108.41	263	60.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			393.7	C08		5	0054-0110	550.61	109.80	235	57.46	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			197.5	C08		5	0055-0114	939.47	113.65	286	65.94	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			386.1	C08		5	0056-0114	535.56	114.61	220	58.18	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.5	C08		5	0057-0115	814.85	115.25	248	61.60	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			227.8	C08		5	0058-0116	125.20	116.96	275	64.67	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			313.6	C08		5	0059-0116	583.58	116.19	253	57.94	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			323.8	C08		5	0060-0117	451.18	117.39	235	63.01	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			335.2	C08		5	0061-0130	293.94	130.74	532	96.57	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			367.1	C08		5	0062-0127	763.95	126.43	390	74.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			292.5	C08		5	0063-0129	241.70	129.15	279	63.01	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			219.8	C08		5	0064-0128	945.76	129.18	307	67.60	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			324.3	C08		5	0065-0130	709.15	129.47	285	63.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.4	C08		5	0066-0132	205.96	132.26	302	67.01	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			219.2	C08		5	0067-0131	83.68	131.34	282	64.77	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			445.3	C08		5	0068-0132	462.85	132.67	223	56.63	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			273.2	C08		5	0069-0142	511.66	141.97	346	70.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			331.5	C08		5	0070-0142	779.76	142.04	281	64.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			226.9	C08		5	0071-0146	124.86	145.69	304	69.01	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			322.1	C08		5	0072-0147	401.83	145.94	226	60.53	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			296.5	C08		5	0073-0149	538.49	149.60	263	65.01	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			226.7	C08		5	0074-0148	704.63	148.28	295	65.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			309.0	C08		5	0075-0148	826.93	148.52	278	62.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			384.3	C08		5	0076-0150	644.94	149.72	309	65.36	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			488.7	C08		5	0077-0148	467.80	148.00	227	55.70	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			259.2	C08		5	0078-0154	206.08	154.12	273	60.77	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			336.0	C08		5	0079-0155	564.25	155.96	469	80.08	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			226.5	C08		5	0080-0153	71.19	152.62	267	62.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.5	C08		5	0081-0156	224.25	156.24	260	59.70	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			277.1	C08		5	0082-0159	918.75	158.85	309	71.36	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.5	C08		5	0083-0161	670.33	161.54	283	65.26	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			333.8	C08		5	0084-0159	901.80	159.44	190	52.28	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			480.0	C08		5	0085-0161	411.74	160.23	259	61.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			233.3	C08		5	0086-0164	12.84	165.13	248	57.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.7	C08		5	0087-0167	149.27	167.38	232	56.18	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.0	C08		5	0088-0168	837.22	167.15	248	61.94	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			301.6	C08		5	0089-0175	34.74	175.89	304	70.77	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			314.1	C08		5	0090-0176	348.13	175.84	308	67.60	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			310.8	C08		5	0091-0176	595.11	176.03	445	77.26	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.2	C08		5	0092-0177	174.77	177.75	256	58.18	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			325.8	C08		5	0093-0179	752.26	178.85	297	65.60	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			347.1	C08		5	0094-0182	139.86	182.31	239	57.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			341.3	C08		5	0095-0179	480.19	178.89	257	60.53	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			339.8	C08		5	0096-0180	773.20	180.22	253	59.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			359.5	C08		5	0097-0178	819.77	178.06	127	42.97	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			403.8	C08		5	0098-0181	830.53	181.19	108	38.39	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			187.7	C08		5	0099-0189	195.63	189.09	273	62.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			610.5	C08		5	0100-0194	94.39	194.00	361	74.43	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.7	C08		5	0101-0192	356.51	192.32	250	61.60	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			201.0	C08		5	0102-0193	111.20	192.63	270	61.70	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			407.0	C08		5	0103-0196	316.62	195.93	423	74.43	0.960
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			640.6	C08		5	0104-0192	277.15	191.83	127	62.43	0.410
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.7	C08		5	0105-0197	255.39	196.94	291	65.11	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			310.3	C08		5	0106-0199	238.00	199.22	270	60.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			292.2	C08		5	0107-0197	755.16	197.21	333	73.84	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.7	C08		5	0108-0203	377.95	202.93	389	73.84	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			373.6	C08		5	0109-0202	729.24	202.66	282	62.28	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			291.3	C08		5	0110-0205	15.79	205.08	242	62.53	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.5	C08		5	0111-0201	152.68	200.91	278	65.11	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.9	C08		5	0112-0213	531.46	212.95	638	109.64	0.667
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			369.2	C08		5	0113-0208	451.28	209.15	386	77.60	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			504.8	C08		5	0114-0207	707.83	207.15	275	61.70	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			302.2	C08		5	0115-0208	417.03	208.07	264	60.77	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			516.1	C08		5	0116-0212	806.62	212.34	352	71.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			382.9	C08		5	0117-0213	468.08	213.85	235	59.11	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			199.4	C08		5	0118-0215	79.24	215.03	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			360.2	C08		5	0119-0216	916.03	216.05	260	60.18	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.7	C08		5	0120-0216	754.19	217.04	271	60.53	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			373.7	C08		5	0121-0220	861.49	220.57	261	61.46	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			348.7	C08		5	0122-0220	846.92	220.50	226	56.53	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			291.9	C08		5	0123-0220	155.45	219.99	235	58.53	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			476.4	C08		5	0124-0227	305.10	227.85	461	79.84	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			301.3	C08		5	0125-0230	209.14	229.56	465	82.18	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			291.5	C08		5	0126-0228	629.67	228.20	214	54.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			211.2	C08		5	0127-0234	566.31	234.22	319	71.60	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			478.1	C08		5	0128-0234	179.64	233.99	323	67.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			332.9	C08		5	0129-0235	160.19	235.37	256	64.18	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			362.3	C08		5	0130-0236	282.88	236.18	299	64.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			411.1	C08		5	0131-0236	649.81	235.52	223	55.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.5	C08		5	0132-0237	120.78	237.25	243	58.18	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			359.4	C08		5	0133-0245	368.24	245.87	246	57.60	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.4	C08		5	0134-0246	583.97	245.73	309	67.70	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			336.9	C08		5	0135-0246	746.79	246.21	272	67.01	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			313.4	C08		5	0136-0251	154.83	251.42	213	57.36	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			351.3	C08		5	0137-0257	41.66	256.83	302	66.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			480.2	C08		5	0138-0261	915.84	261.05	264	62.77	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			232.0	C08		5	0139-0268	672.13	267.50	285	65.01	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.2	C08		5	0140-0270	701.57	270.34	435	77.26	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			205.7	C08		5	0141-0268	165.69	268.34	279	64.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			362.2	C08		5	0142-0271	272.79	270.58	228	59.01	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			264.4	C08		5	0143-0272	781.36	271.85	315	68.18	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			415.8	C08		5	0144-0274	218.26	274.24	234	58.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			320.1	C08		5	0145-0274	336.63	274.33	263	61.36	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			42337.7	C08		5	0146-0275	403.63	274.97	100	53.94	0.432
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.8	C08		5	0147-0277	614.54	277.62	293	63.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			303.6	C08		5	0148-0282	637.91	282.17	280	62.18	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			304.0	C08		5	0149-0285	826.66	284.99	417	75.84	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			312.9	C08		5	0150-0283	727.36	283.45	236	57.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			373.0	C08		5	0151-0284	368.25	284.96	238	57.36	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.9	C08		5	0152-0286	122.52	286.93	271	62.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.4	C08		5	0153-0288	523.62	287.86	321	69.26	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			539.3	C08		5	0154-0290	47.31	290.37	349	69.01	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			205.5	C08		5	0155-0288	145.49	288.97	279	64.43	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			188.7	C08		5	0156-0293	892.36	293.38	289	65.60	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.2	C08		5	0157-0292	100.14	291.43	254	61.94	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			324.8	C08		5	0158-0290	326.27	290.42	232	60.18	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.2	C08		5	0159-0294	83.86	294.02	274	62.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			293.7	C08		5	0160-0293	484.95	293.15	340	72.18	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			293.1	C08		5	0161-0296	22.78	295.96	261	59.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			296.0	C08		5	0162-0297	451.94	296.90	263	62.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			432.0	C08		5	0163-0298	240.29	298.78	366	71.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			884.2	C08		5	0164-0302	652.45	303.48	138	61.94	0.452
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.3	C08		5	0165-0304	280.60	304.06	270	61.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.0	C08		5	0166-0305	217.05	305.63	289	63.84	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			180.1	C08		5	0167-0307	930.59	307.42	323	67.01	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			234.2	C08		5	0168-0310	729.44	309.48	269	62.18	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			218.8	C08		5	0169-0312	158.18	312.84	271	59.94	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			182.5	C08		5	0170-0316	189.03	316.58	267	63.36	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			310.2	C08		5	0171-0316	69.13	316.27	257	58.53	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.2	C08		5	0172-0318	89.27	318.53	265	59.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.3	C08		5	0173-0317	799.68	316.63	286	63.60	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			235.5	C08		5	0174-0321	45.21	322.00	284	63.36	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			279.9	C08		5	0175-0320	845.17	320.63	253	58.18	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.7	C08		5	0176-0320	136.44	320.06	267	61.70	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			290.8	C08		5	0177-0322	397.22	323.48	278	62.87	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			356.8	C08		5	0178-0322	870.34	322.03	266	60.18	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			707.4	C08		5	0179-0331	461.27	330.50	403	123.30	0.333
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			277.8	C08		5	0180-0327	348.68	327.24	254	59.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.8	C08		5	0181-0336	635.50	336.28	311	67.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.4	C08		5	0182-0339	704.62	340.13	296	69.01	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			578.6	C08		5	0183-0339	450.08	339.58	202	57.36	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			425.4	C08		5	0184-0341	684.57	341.42	259	59.11	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			270.3	C08		5	0185-0342	157.89	341.75	248	58.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			424.8	C08		5	0186-0341	401.12	341.19	280	63.11	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			206.6	C08		5	0187-0342	227.55	343.12	260	58.53	0.954
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			200.1	C08		5	0188-0349	287.08	348.91	530	90.08	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.3	C08		5	0189-0348	528.05	348.36	309	64.77	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			375.6	C08		5	0190-0349	862.51	349.51	310	65.70	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.2	C08		5	0191-0350	111.55	349.91	286	63.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			208.2	C08		5	0192-0351	185.97	351.54	249	59.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			532.9	C08		5	0193-0351	484.60	351.12	260	59.46	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			291.5	C08		5	0194-0351	626.22	351.50	270	60.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			218.2	C08		5	0195-0355	259.67	355.61	272	62.43	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			412.1	C08		5	0196-0355	379.09	355.60	217	55.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.9	C08		5	0197-0357	925.07	357.27	292	67.01	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			317.1	C08		5	0198-0359	132.19	358.49	242	57.36	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			438.9	C08		5	0199-0358	402.98	357.83	219	56.53	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			219.1	C08		5	0200-0360	231.80	360.52	300	66.53	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.4	C08		5	0201-0363	330.82	363.80	293	67.84	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			467.4	C08		5	0202-0362	570.58	361.86	347	68.43	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.1	C08		5	0203-0363	801.77	362.94	302	65.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			403.2	C08		5	0204-0362	692.19	362.38	273	62.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			284.5	C08		5	0205-0362	455.04	362.52	265	59.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			349.6	C08		5	0206-0367	753.07	367.37	195	53.70	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			215.5	C08		5	0207-0370	250.40	370.10	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			359.7	C08		5	0208-0367	489.65	367.26	252	61.70	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			184.5	C08		5	0209-0370	38.62	370.24	269	61.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			224.8	C08		5	0210-0371	65.11	370.95	267	63.60	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			298.0	C08		5	0211-0379	16.47	379.21	528	92.33	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			378.9	C08		5	0212-0374	897.56	373.81	358	70.43	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			509.9	C08		5	0213-0374	392.69	373.41	227	57.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.4	C08		5	0214-0372	607.12	372.07	244	59.70	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			287.2	C08		5	0215-0377	715.45	377.60	258	60.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			222.8	C08		5	0216-0380	170.63	380.29	261	60.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.7	C08		5	0217-0380	79.57	380.62	269	65.94	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			291.6	C08		5	0218-0380	826.62	380.14	234	67.94	0.637
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			310.7	C08		5	0219-0385	845.60	385.45	276	64.77	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.9	C08		5	0220-0393	409.82	393.55	669	106.13	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			352.2	C08		5	0221-0388	931.71	388.88	307	65.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			301.9	C08		5	0222-0389	620.66	388.59	300	65.94	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			203.2	C08		5	0223-0391	280.28	391.24	286	63.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.7	C08		5	0224-0394	742.34	394.65	218	56.28	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			435.9	C08		5	0225-0397	576.47	397.02	193	53.11	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			295.1	C08		5	0226-0408	234.72	408.22	478	85.98	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			362.1	C08		5	0227-0401	128.22	400.74	230	57.70	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			302.9	C08		5	0228-0403	640.40	402.75	245	59.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			319.3	C08		5	0229-0402	674.17	402.64	236	56.87	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			376.5	C08		5	0230-0407	256.61	407.32	259	58.53	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			235.5	C08		5	0231-0408	197.58	408.15	263	62.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			264.7	C08		5	0232-0408	809.21	408.51	286	65.11	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			340.7	C08		5	0233-0413	653.05	413.47	257	58.53	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			319.4	C08		5	0234-0413	121.53	413.71	248	60.53	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.4	C08		5	0235-0415	880.15	415.33	325	70.18	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.2	C08		5	0236-0415	332.75	415.60	283	61.36	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			314.9	C08		5	0237-0420	699.61	420.50	272	61.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			351.9	C08		5	0238-0421	179.91	421.12	203	53.36	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			38426.7	C08		5	0239-0422	547.27	421.79	185	51.94	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			324.4	C08		5	0240-0423	604.43	422.81	241	56.53	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.9	C08		5	0241-0425	750.67	425.26	311	67.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			210.6	C08		5	0242-0428	861.17	428.79	347	72.43	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			317.2	C08		5	0243-0429	357.07	429.49	449	79.01	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			302.2	C08		5	0244-0427	425.56	426.68	266	62.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			311.2	C08		5	0245-0428	813.06	427.42	298	67.36	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			383.0	C08		5	0246-0429	910.70	428.36	341	67.60	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			9009.3	C08		5	0247-0432	534.22	431.66	315	71.01	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			378.3	C08		5	0248-0432	446.12	431.85	275	61.36	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			233.2	C08		5	0249-0435	62.73	435.07	267	60.53	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			305.0	C08		5	0250-0437	691.92	437.49	220	55.11	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			294.9	C08		5	0251-0441	127.60	441.77	461	86.33	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			2793.1	C08		5	0252-0442	555.58	441.73	334	74.43	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			318.2	C08		5	0253-0442	168.94	442.03	258	60.87	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			311.1	C08		5	0254-0445	236.30	444.92	500	88.91	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.1	C08		5	0255-0445	612.34	445.07	298	64.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.7	C08		5	0256-0447	719.95	447.96	315	72.43	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			447.2	C08		5	0257-0445	380.07	445.62	201	53.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			210.3	C08		5	0258-0449	909.18	450.90	311	69.84	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			228.1	C08		5	0259-0453	469.88	453.62	288	63.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			279.0	C08		5	0260-0452	66.84	451.78	252	60.18	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.7	C08		5	0261-0456	201.00	456.33	242	58.53	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			461.4	C08		5	0262-0458	181.80	458.11	142	57.01	0.549
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			355.1	C08		5	0263-0464	794.80	464.01	517	83.26	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			305.0	C08		5	0264-0460	504.68	460.60	232	55.36	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.3	C08		5	0265-0463	416.40	463.13	287	63.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			307.9	C08		5	0266-0463	661.43	462.91	449	82.43	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			205.6	C08		5	0267-0465	556.12	465.52	281	61.84	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			287.6	C08		5	0268-0464	38.15	464.42	234	57.11	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			309.6	C08		5	0269-0468	577.43	468.57	287	61.94	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			427.6	C08		5	0270-0473	300.85	472.61	357	71.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			298.4	C08		5	0271-0468	741.95	468.06	257	59.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			257.4	C08		5	0272-0472	885.89	472.06	331	67.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.3	C08		5	0273-0473	402.60	473.38	290	65.26	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			232.4	C08		5	0274-0479	229.15	479.36	269	63.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			379.6	C08		5	0275-0484	122.14	484.11	446	81.01	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			318.2	C08		5	0276-0489	271.42	487.98	509	94.57	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.4	C08		5	0277-0482	846.77	481.46	271	61.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			200.0	C08		5	0278-0484	334.88	483.78	279	63.36	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			337.6	C08		5	0279-0495	616.96	495.63	262	61.60	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			225.5	C08		5	0280-0493	792.78	494.13	275	65.60	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			358.4	C08		5	0281-0496	452.03	495.40	259	59.36	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.3	C08		5	0282-0497	717.65	497.06	232	59.36	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			289.8	C08		5	0283-0501	197.27	500.70	468	85.74	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			206.0	C08		5	0284-0499	473.75	499.76	257	61.94	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			292.1	C08		5	0285-0501	96.90	501.47	294	65.01	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			298.3	C08		5	0286-0501	901.81	501.38	250	58.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			212.3	C08		5	0287-0502	370.13	501.78	271	62.77	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			364.1	C08		5	0288-0503	936.65	503.74	242	57.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			299.0	C08		5	0289-0504	493.62	504.39	252	59.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			368.0	C08		5	0290-0506	631.65	505.45	265	64.18	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			374.3	C08		5	0291-0507	19.27	507.99	386	74.33	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.4	C08		5	0292-0509	249.77	508.81	512	95.40	0.707
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			236.0	C08		5	0293-0509	557.64	509.71	257	65.01	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			808.5	C08		5	0294-0511	442.12	511.25	301	66.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			362.2	C08		5	0295-0510	45.20	510.71	245	58.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			196.4	C08		5	0296-0513	334.12	513.95	289	62.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.7	C08		5	0297-0514	286.74	514.68	251	57.94	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			210.6	C08		5	0298-0515	832.59	515.15	339	71.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			506.5	C08		5	0299-0515	468.55	515.56	195	53.70	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			320.8	C08		5	0300-0519	138.33	518.67	241	59.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			316.0	C08		5	0301-0519	526.25	519.51	272	60.53	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.8	C08		5	0302-0520	92.26	520.68	300	70.18	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			329.1	C08		5	0303-0523	624.45	523.58	297	65.01	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.1	C08		5	0304-0525	394.75	525.32	283	66.43	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.1	C08		5	0305-0528	769.98	528.55	280	67.50	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.8	C08		5	0306-0532	425.08	531.78	268	63.11	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			208.0	C08		5	0307-0533	151.14	533.56	258	63.01	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			538.3	C08		5	0308-0534	197.35	533.64	319	73.84	0.735
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			232.8	C08		5	0309-0539	534.98	538.32	273	65.60	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			416.9	C08		5	0310-0537	607.50	537.37	220	54.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			211.5	C08		5	0311-0541	382.06	542.72	366	75.01	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			216.3	C08		5	0312-0541	832.18	541.50	310	67.36	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			407.3	C08		5	0313-0543	470.35	543.09	177	48.53	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.3	C08		5	0314-0551	946.10	550.58	385	77.36	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			350.8	C08		5	0315-0546	321.13	546.71	242	57.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			348.9	C08		5	0316-0548	678.45	548.70	313	65.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.4	C08		5	0317-0546	741.53	546.09	268	60.18	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.2	C08		5	0318-0551	553.24	551.57	308	68.43	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			230.4	C08		5	0319-0551	99.70	551.78	270	60.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			235.2	C08		5	0320-0553	231.82	553.69	305	70.08	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			206.0	C08		5	0321-0553	22.92	553.49	287	63.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			216.9	C08		5	0322-0559	495.91	559.76	300	70.28	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.1	C08		5	0323-0559	389.91	558.86	287	63.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			227.9	C08		5	0324-0559	821.93	559.31	314	67.36	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.6	C08		5	0325-0559	248.37	560.21	257	63.36	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			299.6	C08		5	0326-0562	168.02	561.67	248	62.77	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.3	C08		5	0327-0564	702.70	564.62	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.2	C08		5	0328-0567	510.91	566.78	301	69.11	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			332.4	C08		5	0329-0564	315.06	563.80	239	59.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.4	C08		5	0330-0566	736.12	565.92	242	57.36	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.6	C08		5	0331-0569	150.59	569.48	302	65.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			442.7	C08		5	0332-0567	677.72	567.46	254	60.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			211.3	C08		5	0333-0571	274.35	571.63	273	66.67	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.4	C08		5	0334-0576	918.32	576.50	354	70.18	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			283.6	C08		5	0335-0575	342.32	575.76	263	64.28	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			359.4	C08		5	0336-0577	429.97	576.35	383	73.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.3	C08		5	0337-0578	632.34	578.02	292	65.94	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			193.6	C08		5	0338-0575	859.79	575.79	290	71.36	0.716
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			273.5	C08		5	0339-0580	67.90	580.53	477	87.74	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			264.0	C08		5	0340-0581	898.80	581.22	331	68.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			315.9	C08		5	0341-0583	574.86	583.16	299	66.77	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			286.3	C08		5	0342-0579	91.81	578.80	240	58.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.4	C08		5	0343-0582	313.75	583.24	272	64.28	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			338.8	C08		5	0344-0581	391.81	581.10	270	60.18	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			338.5	C08		5	0345-0581	716.10	581.79	223	55.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.1	C08		5	0346-0582	362.15	581.71	266	62.28	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			210.9	C08		5	0347-0580	790.21	579.80	287	68.53	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			362.8	C08		5	0348-0584	229.14	583.82	241	58.28	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			329.4	C08		5	0349-0587	20.24	587.47	224	55.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.8	C08		5	0350-0596	595.37	596.05	322	69.84	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			207.0	C08		5	0351-0600	354.65	600.31	282	62.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			270.8	C08		5	0352-0608	474.80	606.92	607	102.57	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.3	C08		5	0353-0601	167.12	600.87	304	66.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			308.7	C08		5	0354-0609	148.91	609.45	253	61.11	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.5	C08		5	0355-0610	719.24	610.32	321	66.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.1	C08		5	0356-0610	533.40	608.97	311	69.26	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			296.1	C08		5	0357-0610	187.17	610.71	253	59.70	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.1	C08		5	0358-0611	258.04	611.58	267	61.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.1	C08		5	0359-0613	805.81	613.19	270	61.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			205.7	C08		5	0360-0613	940.84	612.97	258	63.01	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.3	C08		5	0361-0617	413.46	616.96	307	68.08	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			368.1	C08		5	0362-0616	61.84	615.87	222	55.11	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			208.5	C08		5	0363-0614	320.99	615.05	262	61.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			183.4	C08		5	0364-0616	295.85	616.52	265	59.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			213.1	C08		5	0365-0619	385.46	618.83	296	65.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.8	C08		5	0366-0620	207.44	620.08	266	60.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			445.2	C08		5	0367-0623	671.13	622.99	256	59.36	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			293.7	C08		5	0368-0624	137.19	624.25	240	57.70	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			214.0	C08		5	0369-0629	444.51	629.51	296	65.94	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.4	C08		5	0370-0629	186.09	628.77	271	62.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			213.9	C08		5	0371-0634	897.40	633.89	524	91.64	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			359.7	C08		5	0372-0633	864.86	633.43	286	63.60	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			211.5	C08		5	0373-0634	497.57	633.42	289	62.53	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.4	C08		5	0374-0647	794.04	647.11	321	69.50	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			388.6	C08		5	0375-0647	539.38	647.38	241	57.70	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			530.0	C08		5	0376-0649	154.97	648.54	220	54.53	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			289.6	C08		5	0377-0647	646.40	647.40	204	53.11	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			353.5	C08		5	0378-0651	195.60	651.23	248	57.70	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			219.0	C08		5	0379-0652	247.90	652.79	293	63.94	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			218.7	C08		5	0380-0650	817.91	650.42	277	63.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			189.8	C08		5	0381-0648	335.51	648.81	154	48.63	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			376.1	C08		5	0382-0654	433.37	654.60	247	57.94	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			330.8	C08		5	0383-0655	686.50	654.73	395	73.84	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			264.1	C08		5	0384-0656	555.80	656.01	283	64.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.3	C08		5	0385-0660	52.60	659.90	289	62.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			185.6	C08		5	0386-0661	313.70	661.95	212	55.70	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			382.3	C08		5	0387-0662	629.58	661.88	213	56.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			203.3	C08		5	0388-0664	337.75	662.55	268	63.01	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			194.3	C08		5	0389-0668	589.42	667.54	275	63.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			316.4	C08		5	0390-0666	147.08	666.75	252	61.60	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.9	C08		5	0391-0666	671.76	667.21	262	63.01	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.0	C08		5	0392-0669	739.67	669.43	297	65.01	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			202.4	C08		5	0393-0679	330.09	679.10	404	84.57	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			428.7	C08		5	0394-0672	19.02	672.27	225	57.94	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			387.8	C08		5	0395-0674	160.45	674.70	206	54.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			169.3	C08		5	0396-0676	930.18	676.57	245	64.18	0.747
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			6956.0	C08		5	0397-0683	405.39	682.87	637	109.54	0.667
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			192.9	C08		5	0398-0675	547.03	675.66	282	63.94	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			155.4	C08		5	0399-0678	284.16	677.62	271	60.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			329.4	C08		5	0400-0680	625.14	680.18	214	55.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.8	C08		5	0401-0684	804.27	684.54	262	59.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			284.9	C08		5	0402-0687	751.15	687.58	259	61.94	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			185.3	C08		5	0403-0688	348.96	687.26	159	58.43	0.585
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.8	C08		5	0404-0688	897.14	688.21	252	60.77	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			350.8	C08		5	0405-0691	869.78	690.90	275	78.67	0.558
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			326.3	C08		5	0406-0690	205.49	690.05	230	56.53	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			311.4	C08		5	0407-0690	683.30	690.68	230	56.77	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			320.4	C08		5	0408-0693	612.16	693.49	247	58.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			198.5	C08		5	0409-0706	467.36	706.23	279	61.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			204.4	C08		5	0410-0706	549.06	706.22	255	59.01	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			175.7	C08		5	0411-0709	35.80	710.01	288	66.77	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			203.8	C08		5	0412-0708	182.19	708.34	229	56.53	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			189.2	C08		5	0413-0709	233.40	709.62	261	59.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			212.3	C08		5	0414-0710	56.38	709.78	280	65.94	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			318.8	C08		6	0001-0023	416.28	23.63	327	71.01	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			331.2	C08		6	0002-0027	676.92	26.76	287	65.94	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			322.3	C08		6	0003-0027	227.08	26.02	257	69.60	0.667
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			328.7	C08		6	0004-0031	617.58	31.04	275	63.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			474.5	C08		6	0005-0028	846.42	28.00	237	59.94	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			285.1	C08		6	0006-0034	941.60	33.31	301	65.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			180.5	C08		6	0007-0035	54.36	34.91	270	63.70	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.8	C08		6	0008-0036	331.47	37.01	311	69.36	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			291.9	C08		6	0009-0047	440.88	47.58	646	109.88	0.672
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			355.8	C08		6	0010-0041	515.00	41.24	407	74.08	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.0	C08		6	0011-0044	31.94	44.26	257	62.77	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			214.3	C08		6	0012-0042	91.51	42.05	298	65.26	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.7	C08		6	0013-0043	788.36	43.35	291	63.11	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.2	C08		6	0014-0043	641.23	43.00	272	64.53	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			524.0	C08		6	0015-0043	838.81	43.77	348	70.77	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			362.8	C08		6	0016-0048	351.26	47.98	345	68.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			310.7	C08		6	0017-0050	557.36	49.98	316	65.84	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			314.0	C08		6	0018-0056	256.61	56.18	262	60.53	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			473.9	C08		6	0019-0060	857.26	60.45	424	84.91	0.739
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			333.5	C08		6	0020-0058	283.61	58.25	216	55.60	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			627.2	C08		6	0021-0057	302.72	56.67	194	53.11	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			301.6	C08		6	0022-0056	466.92	56.20	294	66.18	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			277.6	C08		6	0023-0058	170.81	57.00	285	73.84	0.657
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			293.2	C08		6	0024-0060	224.81	58.82	486	99.40	0.618
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			571.5	C08		6	0025-0071	610.72	70.65	290	64.53	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.1	C08		6	0026-0071	707.96	71.26	316	65.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			213.3	C08		6	0027-0070	53.10	70.92	267	65.60	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.7	C08		6	0028-0075	520.80	74.96	302	64.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			343.4	C08		6	0029-0075	161.24	74.69	204	55.94	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			460.9	C08		6	0030-0081	905.91	81.12	542	88.57	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.0	C08		6	0031-0077	134.01	77.10	233	58.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.9	C08		6	0032-0082	18.69	82.46	248	60.18	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			234.7	C08		6	0033-0086	284.39	86.76	297	64.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			321.6	C08		6	0034-0086	173.60	86.45	261	65.36	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			569.2	C08		6	0035-0090	927.11	89.89	390	78.18	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			334.4	C08		6	0036-0092	722.25	92.38	341	69.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.5	C08		6	0037-0095	346.33	95.23	319	67.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			322.2	C08		6	0038-0098	391.71	98.21	293	65.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			587.8	C08		6	0039-0096	766.53	96.92	175	49.46	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			306.7	C08		6	0040-0101	64.36	100.97	241	64.28	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			318.9	C08		6	0041-0101	96.92	101.23	221	56.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			285.5	C08		6	0042-0104	835.92	104.70	279	63.60	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			394.8	C08		6	0043-0106	601.66	106.72	274	63.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			614.3	C08		6	0044-0104	916.53	104.14	224	58.18	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.2	C08		6	0045-0106	799.62	106.51	315	68.77	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.7	C08		6	0046-0108	535.89	108.15	327	66.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			340.7	C08		6	0047-0111	651.77	112.71	282	62.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			206.1	C08		6	0048-0117	34.30	117.20	284	65.60	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			340.3	C08		6	0049-0115	577.40	115.08	245	58.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			568.7	C08		6	0050-0120	617.95	120.33	382	73.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			209.7	C08		6	0051-0118	135.04	118.42	287	70.18	0.732
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			305.3	C08		6	0052-0121	491.85	120.78	273	62.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			542.1	C08		6	0053-0119	376.22	120.22	193	50.87	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			326.0	C08		6	0054-0123	462.38	123.29	262	58.77	0.953
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			334.9	C08		6	0055-0125	853.84	124.76	210	57.60	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			649.9	C08		6	0056-0126	235.33	125.45	140	50.53	0.689
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			289.3	C08		6	0057-0128	680.24	129.14	265	60.18	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.1	C08		6	0058-0127	904.54	127.02	257	59.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			211.0	C08		6	0059-0131	40.69	132.16	280	65.60	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			324.3	C08		6	0060-0135	423.61	135.31	289	63.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.8	C08		6	0061-0133	716.97	133.81	268	63.70	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			585.2	C08		6	0062-0135	377.72	135.14	202	53.46	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			345.6	C08		6	0063-0142	340.72	141.79	264	63.01	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			373.3	C08		6	0064-0142	817.92	142.04	234	58.43	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			325.2	C08		6	0065-0144	514.97	144.61	291	63.36	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			778.1	C08		6	0066-0144	251.74	145.29	181	56.53	0.712
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			392.4	C08		6	0067-0144	594.22	144.32	242	58.53	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			224.0	C08		6	0068-0147	159.52	146.71	303	67.01	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			553.0	C08		6	0069-0150	764.60	150.14	234	56.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			346.9	C08		6	0070-0158	303.10	158.52	238	57.70	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			380.2	C08		6	0071-0157	888.64	157.38	362	71.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			467.5	C08		6	0072-0157	825.04	157.14	224	57.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			468.9	C08		6	0073-0163	537.54	161.94	332	68.77	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			461.7	C08		6	0074-0157	588.91	158.29	128	42.39	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			345.9	C08		6	0075-0161	614.35	161.31	263	60.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			543.1	C08		6	0076-0162	747.17	161.79	249	58.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			304.2	C08		6	0077-0163	676.84	163.38	424	77.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.9	C08		6	0078-0166	166.00	166.54	242	59.11	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			435.6	C08		6	0079-0166	400.03	166.05	225	57.70	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			349.5	C08		6	0080-0169	487.03	168.76	277	62.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			227.3	C08		6	0081-0171	109.83	171.44	282	64.77	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			468.3	C08		6	0082-0172	591.26	172.29	241	63.70	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			264.2	C08		6	0083-0182	835.67	182.33	328	69.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.7	C08		6	0084-0184	172.45	184.33	281	65.94	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			395.6	C08		6	0085-0186	705.00	185.93	345	68.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.3	C08		6	0086-0187	75.88	187.63	216	56.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.6	C08		6	0087-0187	859.67	187.16	303	68.43	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			284.4	C08		6	0088-0188	60.61	188.80	270	61.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			498.2	C08		6	0089-0187	803.04	186.83	178	60.18	0.618
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			281.6	C08		6	0090-0191	672.91	190.78	309	70.18	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			372.6	C08		6	0091-0193	940.32	193.32	259	59.70	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			309.6	C08		6	0092-0198	822.87	198.48	341	74.67	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			279.3	C08		6	0093-0203	625.45	203.38	295	65.84	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			359.5	C08		6	0094-0202	909.82	202.56	250	58.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			578.1	C08		6	0095-0201	807.76	202.00	102	63.01	0.323
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			213.1	C08		6	0096-0206	129.34	206.23	298	64.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			306.9	C08		6	0097-0209	397.85	209.34	257	61.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			390.1	C08		6	0098-0211	432.42	211.02	231	61.11	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			339.1	C08		6	0099-0210	500.04	211.04	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			299.0	C08		6	0100-0210	568.93	209.67	290	63.60	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			285.8	C08		6	0101-0215	215.75	215.14	308	65.01	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			330.2	C08		6	0102-0218	279.31	219.19	265	61.46	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			312.8	C08		6	0103-0222	723.31	222.66	271	62.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.8	C08		6	0104-0225	618.20	224.48	300	63.60	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			307.5	C08		6	0105-0229	887.94	229.13	329	68.18	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			551.9	C08		6	0106-0231	59.71	230.72	334	66.77	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			228.3	C08		6	0107-0236	91.16	236.34	285	63.26	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			437.0	C08		6	0108-0237	773.38	237.52	324	67.36	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.8	C08		6	0109-0236	279.03	236.04	389	74.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			315.5	C08		6	0110-0236	669.75	236.45	282	62.43	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.7	C08		6	0111-0238	343.16	238.63	321	67.84	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			268.3	C08		6	0112-0242	573.88	243.29	297	69.84	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			287.6	C08		6	0113-0244	756.21	244.60	290	66.18	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			290.4	C08		6	0114-0240	940.51	240.31	252	60.77	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.6	C08		6	0115-0247	198.46	246.56	301	67.84	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.2	C08		6	0116-0247	874.65	247.80	241	57.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			393.0	C08		6	0117-0251	833.26	251.71	322	76.91	0.684
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			420.7	C08		6	0118-0254	386.96	253.92	280	66.67	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.6	C08		6	0119-0254	542.86	253.92	303	64.77	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			369.7	C08		6	0120-0252	181.83	252.52	254	61.36	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			286.1	C08		6	0121-0253	560.66	254.21	262	62.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.4	C08		6	0122-0256	469.07	255.36	254	64.53	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.3	C08		6	0123-0259	334.87	258.49	264	63.70	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.9	C08		6	0124-0263	605.14	262.77	302	65.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			329.1	C08		6	0125-0261	147.85	260.95	217	53.46	0.954
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			365.9	C08		6	0126-0264	729.34	264.18	365	74.08	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.5	C08		6	0127-0274	797.83	272.58	730	118.71	0.651
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.0	C08		6	0128-0265	913.08	265.02	285	63.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			344.5	C08		6	0129-0268	368.30	267.57	260	61.01	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.7	C08		6	0130-0271	50.84	271.45	275	64.18	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			312.0	C08		6	0131-0275	466.40	274.78	474	81.26	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.4	C08		6	0132-0271	683.27	271.56	311	66.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			252.0	C08		6	0133-0272	566.82	272.48	293	64.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.9	C08		6	0134-0285	173.94	285.56	273	63.11	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.6	C08		6	0135-0291	636.52	291.53	287	61.36	0.958
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			414.4	C08		6	0136-0297	351.39	296.39	280	67.84	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.4	C08		6	0137-0295	554.38	295.52	265	61.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			223.6	C08		6	0138-0295	254.50	295.29	293	65.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.0	C08		6	0139-0296	850.40	297.06	334	67.01	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			343.9	C08		6	0140-0298	712.21	299.02	442	94.08	0.627
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			257.8	C08		6	0141-0302	901.12	301.88	321	69.60	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			295.6	C08		6	0142-0301	666.58	301.64	262	59.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.9	C08		6	0143-0307	917.49	306.26	335	71.01	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			299.4	C08		6	0144-0311	771.61	312.57	588	94.81	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			317.2	C08		6	0145-0307	375.36	307.73	255	58.77	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			203.9	C08		6	0146-0310	25.03	310.38	279	61.94	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.2	C08		6	0147-0312	509.64	311.64	257	60.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			475.5	C08		6	0148-0317	462.42	314.77	271	76.33	0.585
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.1	C08		6	0149-0313	945.18	313.34	263	62.87	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.5	C08		6	0150-0327	581.53	327.68	325	69.36	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			273.9	C08		6	0151-0323	859.49	323.86	256	63.94	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			441.2	C08		6	0152-0328	930.26	328.02	378	71.36	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			191.7	C08		6	0153-0332	300.21	332.99	315	73.01	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			292.3	C08		6	0154-0332	136.47	332.64	402	73.84	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			582.8	C08		6	0155-0331	741.68	331.35	299	63.36	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.1	C08		6	0156-0334	415.15	333.75	322	69.26	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.7	C08		6	0157-0336	57.05	335.97	361	70.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			273.4	C08		6	0158-0336	705.21	336.45	327	70.18	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			449.2	C08		6	0159-0337	247.85	337.10	231	57.94	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			283.0	C08		6	0160-0338	873.94	339.03	219	55.80	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.5	C08		6	0161-0346	319.24	345.76	246	62.28	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			211.4	C08		6	0162-0347	649.01	347.45	361	70.43	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			441.7	C08		6	0163-0346	262.33	345.89	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			488.5	C08		6	0164-0346	195.54	347.46	207	57.94	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			458.3	C08		6	0165-0349	751.50	349.29	219	55.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			405.5	C08		6	0166-0351	433.65	351.56	202	55.94	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			528.9	C08		6	0167-0355	275.20	356.19	224	54.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			333.5	C08		6	0168-0358	330.88	357.70	234	60.18	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			317.1	C08		6	0169-0358	510.68	358.42	247	66.67	0.698
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			323.6	C08		6	0170-0353	874.29	352.74	227	58.28	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			293.1	C08		6	0171-0360	458.55	360.08	306	69.94	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			268.4	C08		6	0172-0356	782.57	356.41	305	64.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.7	C08		6	0173-0359	612.70	359.17	310	65.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			206.2	C08		6	0174-0360	19.86	360.13	273	65.84	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			397.2	C08		6	0175-0362	759.16	362.11	203	55.94	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			191.3	C08		6	0176-0365	107.78	365.12	297	67.36	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			204.1	C08		6	0177-0369	650.63	368.91	309	65.36	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			442.1	C08		6	0178-0368	427.61	368.25	236	56.87	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			380.7	C08		6	0179-0370	895.90	370.77	278	63.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			368.6	C08		6	0180-0371	917.35	371.10	266	62.43	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.7	C08		6	0181-0378	630.45	378.26	301	65.60	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			440.3	C08		6	0182-0380	518.18	380.51	214	56.53	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.1	C08		6	0183-0380	806.29	380.14	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			214.6	C08		6	0184-0387	132.88	387.35	285	63.94	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			322.7	C08		6	0185-0388	874.32	387.72	253	62.77	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			315.3	C08		6	0186-0391	26.53	391.88	312	65.01	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.1	C08		6	0187-0392	680.81	391.79	302	64.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			323.9	C08		6	0188-0400	718.10	399.93	292	65.36	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			459.2	C08		6	0189-0398	935.14	397.83	207	54.53	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.5	C08		6	0190-0401	766.60	400.19	271	62.43	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.3	C08		6	0191-0399	913.54	399.39	284	62.53	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.6	C08		6	0192-0405	563.90	405.58	300	64.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			294.8	C08		6	0193-0411	271.86	410.40	553	103.30	0.651
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			264.0	C08		6	0194-0408	529.67	408.35	277	62.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.9	C08		6	0195-0409	753.00	409.86	266	63.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			215.6	C08		6	0196-0412	855.78	412.42	248	60.43	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			341.6	C08		6	0197-0413	71.26	413.34	383	73.36	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			312.0	C08		6	0198-0418	106.82	418.53	319	68.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			264.4	C08		6	0199-0423	452.60	421.94	336	71.01	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.9	C08		6	0200-0425	791.00	425.65	290	64.53	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.2	C08		6	0201-0424	807.62	423.86	267	62.53	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			414.3	C08		6	0202-0429	398.58	429.08	509	89.74	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			257.9	C08		6	0203-0426	839.61	426.67	230	58.18	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			286.4	C08		6	0204-0424	125.23	424.74	219	57.70	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.8	C08		6	0205-0430	238.86	429.93	284	65.01	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			270.8	C08		6	0206-0431	597.16	431.73	291	64.43	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			427.5	C08		6	0207-0432	349.09	432.09	224	57.11	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			295.6	C08		6	0208-0441	207.55	440.41	573	90.33	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			304.2	C08		6	0209-0439	417.80	439.51	276	63.94	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.4	C08		6	0210-0442	168.49	442.08	272	60.77	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			366.9	C08		6	0211-0442	623.74	441.87	263	58.53	0.965
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			503.4	C08		6	0212-0442	651.19	442.34	231	56.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			286.6	C08		6	0213-0445	705.41	445.49	224	61.84	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.9	C08		6	0214-0443	85.27	443.29	281	64.77	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			232.6	C08		6	0215-0449	263.69	449.21	290	65.84	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			388.1	C08		6	0216-0455	601.71	455.23	403	75.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			353.6	C08		6	0217-0454	928.96	453.89	209	55.11	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			404.9	C08		6	0218-0456	369.96	456.02	224	55.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.8	C08		6	0219-0458	284.97	458.20	295	63.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			334.7	C08		6	0220-0459	943.71	459.04	258	60.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.0	C08		6	0221-0461	875.56	460.42	304	63.94	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			291.4	C08		6	0222-0459	82.57	458.98	243	58.53	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			283.0	C08		6	0223-0462	308.85	462.86	247	59.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			347.7	C08		6	0224-0467	636.12	467.79	262	65.01	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			286.0	C08		6	0225-0464	133.52	463.37	241	63.36	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.6	C08		6	0226-0466	799.00	466.29	240	57.46	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.7	C08		6	0227-0467	814.53	466.96	274	63.11	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			328.7	C08		6	0228-0471	698.92	470.94	320	67.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			307.8	C08		6	0229-0472	764.64	471.85	388	74.08	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			270.8	C08		6	0230-0471	216.16	471.88	246	59.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			273.8	C08		6	0231-0474	430.19	473.76	325	70.43	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			309.9	C08		6	0232-0475	125.39	475.45	271	64.77	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			373.6	C08		6	0233-0477	601.43	476.81	257	59.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			328.7	C08		6	0234-0480	543.61	480.42	248	58.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.9	C08		6	0235-0485	754.39	485.62	321	69.01	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			330.1	C08		6	0236-0487	833.43	487.54	169	51.94	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			356.8	C08		6	0237-0489	147.26	489.54	262	60.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.4	C08		6	0238-0488	520.89	488.47	281	62.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			287.7	C08		6	0239-0489	211.36	489.19	253	59.11	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			461.5	C08		6	0240-0488	260.82	488.71	235	57.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			404.7	C08		6	0241-0491	897.82	492.01	384	73.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			206.8	C08		6	0242-0496	108.89	496.36	258	60.53	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			477.0	C08		6	0243-0498	794.85	497.72	251	66.53	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			177.0	C08		6	0244-0502	61.85	502.04	264	61.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			216.3	C08		6	0245-0501	431.48	500.98	254	61.60	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			296.9	C08		6	0246-0503	937.07	503.41	305	65.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			400.2	C08		6	0247-0505	703.45	504.80	339	68.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			471.0	C08		6	0248-0503	810.14	503.90	196	54.04	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			296.1	C08		6	0249-0506	31.37	506.93	235	57.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.0	C08		6	0250-0507	586.64	507.21	243	58.53	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			216.3	C08		6	0251-0508	414.86	507.96	281	63.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			439.5	C08		6	0252-0508	345.69	507.83	243	59.11	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			391.5	C08		6	0253-0512	150.39	512.45	210	52.87	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			560.5	C08		6	0254-0514	456.22	515.05	348	70.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			348.4	C08		6	0255-0516	164.03	515.62	232	59.46	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			306.6	C08		6	0256-0521	826.80	521.72	313	71.01	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.4	C08		6	0257-0523	945.53	522.89	229	56.53	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.2	C08		6	0258-0526	105.07	526.30	388	72.43	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			230.5	C08		6	0259-0522	268.65	522.06	172	50.87	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			424.3	C08		6	0260-0526	664.33	526.56	233	57.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			226.6	C08		6	0261-0527	250.42	526.89	188	53.11	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			181.9	C08		6	0262-0527	381.97	527.90	304	66.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			307.2	C08		6	0263-0528	611.87	528.20	324	68.43	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.6	C08		6	0264-0529	437.19	529.34	264	59.94	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			292.8	C08		6	0265-0535	483.76	535.17	268	63.36	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.1	C08		6	0266-0537	901.00	537.63	246	57.60	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			331.2	C08		6	0267-0541	269.74	541.75	257	61.01	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			279.4	C08		6	0268-0544	829.03	543.72	294	66.18	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			324.7	C08		6	0269-0554	41.10	553.69	394	79.60	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.8	C08		6	0270-0551	571.25	551.38	298	63.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			284.9	C08		6	0271-0551	62.85	551.76	261	61.26	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			206.2	C08		6	0272-0551	931.25	551.41	306	67.60	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			338.4	C08		6	0273-0553	753.50	553.00	266	60.18	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			286.5	C08		6	0274-0553	869.76	553.40	256	61.11	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			206.0	C08		6	0275-0557	389.14	557.68	305	66.77	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			324.4	C08		6	0276-0558	694.81	558.28	271	61.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			317.2	C08		6	0277-0564	160.05	564.71	337	67.01	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.5	C08		6	0278-0566	80.09	565.96	235	59.36	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			221.9	C08		6	0279-0572	425.35	572.97	289	64.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			369.7	C08		6	0280-0571	641.61	572.09	266	60.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.7	C08		6	0281-0573	137.07	573.98	236	59.36	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.6	C08		6	0282-0573	444.69	573.46	262	61.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			303.1	C08		6	0283-0579	51.66	578.45	330	70.53	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			205.1	C08		6	0284-0579	325.79	579.36	274	62.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			284.4	C08		6	0285-0578	843.81	579.39	334	69.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.5	C08		6	0286-0581	120.36	580.63	248	58.28	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			194.7	C08		6	0287-0584	914.41	584.32	316	66.18	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.0	C08		6	0288-0586	224.69	586.27	267	61.70	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			252.5	C08		6	0289-0591	744.26	590.33	323	68.18	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			211.7	C08		6	0290-0592	357.62	591.89	378	71.84	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.2	C08		6	0291-0589	447.52	589.20	262	62.53	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.2	C08		6	0292-0594	397.81	594.55	286	64.77	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			312.1	C08		6	0293-0596	478.63	597.04	265	60.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			302.2	C08		6	0294-0600	548.72	600.30	269	59.70	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			312.2	C08		6	0295-0606	768.79	606.37	348	75.50	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			322.0	C08		6	0296-0608	453.66	607.22	275	63.46	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.7	C08		6	0297-0611	871.03	611.29	313	65.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			296.9	C08		6	0298-0613	608.91	612.29	306	66.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			293.4	C08		6	0299-0612	155.25	612.80	258	66.77	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			222.3	C08		6	0300-0616	281.60	616.02	269	61.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			236.4	C08		6	0301-0621	101.66	620.83	457	83.26	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			198.6	C08		6	0302-0616	242.90	616.27	280	64.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			209.3	C08		6	0303-0619	793.31	619.27	289	65.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			221.8	C08		6	0304-0616	35.45	615.89	238	60.18	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.4	C08		6	0305-0619	934.38	618.80	234	59.70	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			325.6	C08		6	0306-0622	715.31	622.01	232	56.18	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			257.4	C08		6	0307-0623	490.18	623.40	266	61.60	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.4	C08		6	0308-0625	892.09	625.63	320	68.18	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			353.0	C08		6	0309-0627	922.07	627.14	220	57.94	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			215.7	C08		6	0310-0633	652.51	633.11	316	65.84	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.8	C08		6	0311-0633	318.81	632.76	239	59.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			449.7	C08		6	0312-0636	362.01	636.69	341	69.84	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.7	C08		6	0313-0638	466.43	637.42	320	68.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.7	C08		6	0314-0642	67.30	642.39	465	81.84	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			277.5	C08		6	0315-0639	244.92	639.76	419	78.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			372.0	C08		6	0316-0639	559.40	639.37	227	59.01	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			361.9	C08		6	0317-0639	817.75	639.85	284	61.60	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			342.0	C08		6	0318-0646	718.33	646.71	316	71.60	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			413.1	C08		6	0319-0647	754.67	646.84	230	57.60	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.2	C08		6	0320-0649	447.54	648.81	246	57.94	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			216.3	C08		6	0321-0652	950.46	652.40	258	59.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			340.7	C08		6	0322-0653	368.94	653.00	209	56.53	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			373.3	C08		6	0323-0657	286.04	657.54	398	75.84	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			205.8	C08		6	0324-0657	420.01	656.43	218	56.77	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			298.6	C08		6	0325-0659	874.28	659.13	245	58.53	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			199.7	C08		6	0326-0659	245.72	659.02	300	66.77	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.9	C08		6	0327-0665	617.34	666.04	321	69.84	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			292.5	C08		6	0328-0666	734.34	665.61	289	65.01	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.6	C08		6	0329-0670	799.68	670.44	295	71.50	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			325.2	C08		6	0330-0676	165.38	676.19	237	56.77	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			186.2	C08		6	0331-0679	24.32	679.38	222	60.18	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			252.0	C08		6	0332-0679	281.96	678.70	245	63.94	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.5	C08		6	0333-0681	852.07	682.12	305	65.36	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			196.2	C08		6	0334-0684	480.38	683.80	293	67.36	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			290.3	C08		6	0335-0683	870.51	683.10	248	62.18	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.9	C08		6	0336-0686	518.61	686.26	352	68.77	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			342.5	C08		6	0337-0683	715.86	683.20	246	59.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			290.6	C08		6	0338-0688	230.41	688.88	253	60.18	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			182.9	C08		6	0339-0689	103.32	689.98	231	58.53	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			215.1	C08		6	0340-0693	583.34	693.72	373	76.08	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			286.0	C08		6	0341-0701	163.75	701.44	242	58.28	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			427.9	C08		7	0001-0023	51.83	23.84	298	69.84	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.1	C08		7	0002-0026	872.40	25.70	203	61.60	0.672
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.0	C08		7	0003-0025	731.35	25.70	305	67.94	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			200.6	C08		7	0004-0031	928.55	31.22	283	66.18	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.7	C08		7	0005-0034	824.17	35.30	298	65.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.6	C08		7	0006-0035	617.33	35.30	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.1	C08		7	0007-0034	356.66	33.84	315	65.94	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			454.6	C08		7	0008-0037	580.19	36.57	282	63.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.2	C08		7	0009-0037	316.66	36.54	320	71.60	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			322.1	C08		7	0010-0036	32.18	36.12	266	61.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			427.9	C08		7	0011-0037	90.78	38.03	232	57.70	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			321.6	C08		7	0012-0043	840.82	43.08	252	58.28	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.1	C08		7	0013-0044	643.67	43.90	303	65.94	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.1	C08		7	0014-0048	19.83	48.94	291	63.60	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			257.9	C08		7	0015-0053	249.97	53.20	305	64.53	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			800.4	C08		7	0016-0055	90.75	55.31	288	65.94	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			395.9	C08		7	0017-0057	556.33	57.88	320	67.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.9	C08		7	0018-0057	409.54	57.82	326	68.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			283.3	C08		7	0019-0062	520.71	62.39	288	63.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			411.6	C08		7	0020-0064	837.98	65.31	438	89.84	0.682
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			304.1	C08		7	0021-0061	944.96	60.36	110	42.04	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			568.0	C08		7	0022-0063	177.25	63.58	268	62.18	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.6	C08		7	0023-0067	871.06	67.00	240	61.84	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			383.6	C08		7	0024-0064	113.77	64.84	266	63.94	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			453.0	C08		7	0025-0073	730.13	72.18	431	81.01	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			460.9	C08		7	0026-0077	24.61	76.57	208	54.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			222.7	C08		7	0027-0087	684.99	87.09	311	67.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.1	C08		7	0028-0087	251.91	87.09	337	69.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.4	C08		7	0029-0087	288.99	87.22	286	62.53	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			307.9	C08		7	0030-0097	586.15	96.15	584	110.23	0.604
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.8	C08		7	0031-0088	132.75	87.65	315	69.01	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			312.8	C08		7	0032-0087	200.86	87.04	298	64.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			257.9	C08		7	0033-0087	361.81	87.33	303	64.77	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			295.5	C08		7	0034-0091	448.08	91.39	393	77.01	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			495.5	C08		7	0035-0092	17.29	92.61	173	49.94	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.6	C08		7	0036-0095	722.59	94.21	265	63.60	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			214.3	C08		7	0037-0100	638.36	99.46	299	66.18	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			835.1	C08		7	0038-0102	816.65	102.78	353	74.08	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			279.2	C08		7	0039-0102	694.93	102.80	276	65.94	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			401.0	C08		7	0040-0106	621.07	106.28	316	67.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			310.6	C08		7	0041-0106	787.14	105.81	284	65.01	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.9	C08		7	0042-0108	440.48	108.24	311	67.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.2	C08		7	0043-0110	510.10	110.55	295	64.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			302.2	C08		7	0044-0109	766.18	108.84	275	62.53	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			296.1	C08		7	0045-0113	314.83	112.82	264	59.94	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			212.2	C08		7	0046-0115	914.68	115.50	288	63.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			226.3	C08		7	0047-0116	91.75	116.26	293	62.77	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.9	C08		7	0048-0117	563.72	117.16	314	65.60	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			283.1	C08		7	0049-0116	351.44	116.42	305	66.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			264.9	C08		7	0050-0123	180.27	122.55	320	70.18	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			429.5	C08		7	0051-0128	251.79	127.33	470	88.57	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			379.1	C08		7	0052-0120	404.21	120.23	270	62.53	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			399.3	C08		7	0053-0122	67.75	122.10	269	60.28	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			193.8	C08		7	0054-0128	728.23	127.56	314	68.43	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			330.0	C08		7	0055-0129	226.70	128.77	264	60.77	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			516.7	C08		7	0056-0130	853.09	130.34	358	69.60	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.3	C08		7	0057-0131	893.96	131.48	307	65.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			257.0	C08		7	0058-0133	668.02	134.08	273	64.18	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			293.7	C08		7	0059-0136	10.94	136.29	264	59.11	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.0	C08		7	0060-0141	311.82	141.79	298	65.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			220.7	C08		7	0061-0143	141.61	143.51	294	65.01	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			205.4	C08		7	0062-0143	722.81	144.64	318	71.26	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			317.7	C08		7	0063-0147	212.29	146.48	286	63.70	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			311.5	C08		7	0064-0152	192.31	151.77	275	66.18	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.7	C08		7	0065-0151	635.38	151.20	336	69.11	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			290.2	C08		7	0066-0160	561.54	160.14	535	98.57	0.692
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.0	C08		7	0067-0153	791.77	152.66	322	67.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			352.5	C08		7	0068-0157	417.30	157.18	496	84.08	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.7	C08		7	0069-0160	95.47	160.60	301	64.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			235.5	C08		7	0070-0162	816.09	162.44	317	67.01	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			302.5	C08		7	0071-0162	354.78	162.27	283	68.43	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			327.3	C08		7	0072-0166	235.28	166.37	452	78.43	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			316.1	C08		7	0073-0169	947.12	169.62	436	77.50	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			311.2	C08		7	0074-0168	27.73	168.95	257	59.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			281.8	C08		7	0075-0167	650.18	167.83	282	63.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			324.9	C08		7	0076-0170	492.83	170.51	237	58.77	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			379.1	C08		7	0077-0173	187.93	172.95	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			217.9	C08		7	0078-0171	706.65	171.49	311	68.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.6	C08		7	0079-0173	366.75	173.55	297	67.01	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			331.1	C08		7	0080-0173	479.10	174.12	130	47.46	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			292.0	C08		7	0081-0174	47.24	175.03	264	60.77	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			375.0	C08		7	0082-0176	425.03	175.77	300	65.60	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			302.1	C08		7	0083-0181	306.37	181.78	380	72.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.3	C08		7	0084-0184	131.58	183.79	278	62.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			284.8	C08		7	0085-0185	518.78	185.64	312	65.60	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			335.8	C08		7	0086-0186	549.39	185.57	270	66.08	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.1	C08		7	0087-0185	848.61	185.47	297	64.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.2	C08		7	0088-0189	673.09	189.38	273	60.53	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			319.2	C08		7	0089-0190	380.05	189.97	274	61.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			23693.1	C08		7	0090-0193	99.98	191.93	164	69.26	0.430
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			315.8	C08		7	0091-0192	702.90	192.63	273	60.77	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.5	C08		7	0092-0194	628.35	194.17	269	62.18	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			373.8	C08		7	0093-0198	586.04	197.99	258	59.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.9	C08		7	0094-0201	417.61	201.11	287	64.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			209.9	C08		7	0095-0201	42.76	201.33	298	66.08	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			232.2	C08		7	0096-0201	872.92	201.31	246	58.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			234.7	C08		7	0097-0202	306.87	201.56	294	63.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			538.9	C08		7	0098-0204	754.31	203.36	420	82.43	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			252.9	C08		7	0099-0203	239.40	202.95	291	63.60	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			228.5	C08		7	0100-0205	436.00	204.90	300	67.01	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.5	C08		7	0101-0207	892.77	207.98	246	57.36	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.8	C08		7	0102-0213	353.83	213.62	279	61.94	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			216.2	C08		7	0103-0214	850.75	214.10	297	67.01	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.1	C08		7	0104-0213	925.26	213.62	261	59.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.9	C08		7	0105-0216	140.33	216.11	277	61.60	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			214.9	C08		7	0106-0218	448.62	218.90	296	65.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			430.6	C08		7	0107-0217	547.32	216.90	235	56.53	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			426.8	C08		7	0108-0216	734.27	216.55	278	63.94	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			252.2	C08		7	0109-0222	203.83	221.45	318	67.36	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			223.0	C08		7	0110-0221	314.48	220.98	295	66.67	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			185.6	C08		7	0111-0222	394.80	221.93	308	66.18	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			221.7	C08		7	0112-0220	493.45	219.93	292	65.60	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			301.6	C08		7	0113-0225	124.54	226.17	266	61.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			387.5	C08		7	0114-0229	825.06	229.84	372	72.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			219.2	C08		7	0115-0228	613.49	228.12	286	63.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			377.9	C08		7	0116-0232	560.43	232.21	247	58.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			333.0	C08		7	0117-0229	686.19	229.62	305	68.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			353.4	C08		7	0118-0238	248.32	238.50	299	65.60	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			343.3	C08		7	0119-0243	123.31	242.39	241	58.87	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			313.3	C08		7	0120-0245	676.71	245.31	306	72.77	0.726
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			224.0	C08		7	0121-0250	341.73	250.33	328	67.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			270.9	C08		7	0122-0257	274.37	257.90	311	68.43	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			233.7	C08		7	0123-0259	512.98	259.48	298	67.94	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.5	C08		7	0124-0255	86.50	255.95	260	59.11	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			223.6	C08		7	0125-0257	381.59	257.67	288	62.53	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			331.7	C08		7	0126-0261	157.63	261.08	323	67.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.6	C08		7	0127-0261	480.12	261.93	293	64.18	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.6	C08		7	0128-0261	434.67	261.82	291	64.53	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			268.0	C08		7	0129-0267	177.11	266.96	476	83.84	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			228.2	C08		7	0130-0262	319.73	262.56	312	65.60	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			268.4	C08		7	0131-0262	908.50	262.01	260	61.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			314.4	C08		7	0132-0264	610.11	263.52	277	63.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.8	C08		7	0133-0266	633.45	266.54	293	63.94	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			281.8	C08		7	0134-0270	225.67	270.95	303	71.26	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.2	C08		7	0135-0275	848.09	274.96	591	103.05	0.699
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			337.2	C08		7	0136-0270	563.50	270.12	245	56.53	0.964
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.6	C08		7	0137-0273	923.56	272.85	264	62.28	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			216.5	C08		7	0138-0275	36.30	275.45	296	66.18	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			340.1	C08		7	0139-0276	74.24	275.93	249	65.46	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.6	C08		7	0140-0272	710.08	272.03	295	68.18	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			420.1	C08		7	0141-0279	875.73	278.69	210	55.94	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			283.7	C08		7	0142-0280	436.92	279.64	319	66.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.5	C08		7	0143-0283	376.15	283.21	297	65.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			202.7	C08		7	0144-0283	791.94	283.20	287	64.77	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.7	C08		7	0145-0284	394.43	284.19	285	62.53	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			309.0	C08		7	0146-0287	280.72	287.25	263	60.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			388.8	C08		7	0147-0290	884.23	291.40	239	57.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.7	C08		7	0148-0293	518.71	293.39	317	68.08	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			235.4	C08		7	0149-0291	610.49	291.17	303	66.53	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			307.4	C08		7	0150-0292	686.06	292.11	296	68.18	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			4673.2	C08		7	0151-0296	263.56	296.73	307	108.71	0.326
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			415.8	C08		7	0152-0297	142.76	296.77	247	58.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			285.6	C08		7	0153-0298	700.97	298.74	265	63.36	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			236.9	C08		7	0154-0299	754.67	298.77	304	65.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			301.7	C08		7	0155-0304	472.50	304.34	414	76.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			210.2	C08		7	0156-0301	564.05	301.27	298	64.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			372.0	C08		7	0157-0305	335.27	304.40	377	72.67	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			324.1	C08		7	0158-0305	293.40	305.22	296	63.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			235.6	C08		7	0159-0303	409.14	303.46	295	64.28	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.9	C08		7	0160-0309	742.48	309.82	249	59.84	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.9	C08		7	0161-0313	442.94	313.73	318	65.60	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.1	C08		7	0162-0318	942.53	318.48	418	76.08	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			230.0	C08		7	0163-0322	870.12	321.84	473	82.43	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			210.1	C08		7	0164-0320	325.90	321.12	282	65.01	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			363.5	C08		7	0165-0318	74.38	317.81	250	58.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			273.1	C08		7	0166-0319	776.38	318.80	223	55.11	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			396.1	C08		7	0167-0321	384.45	321.54	317	67.01	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.2	C08		7	0168-0326	801.22	326.23	276	62.53	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			404.5	C08		7	0169-0326	100.75	325.66	233	55.94	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			215.8	C08		7	0170-0328	540.33	328.26	275	61.94	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			218.0	C08		7	0171-0325	618.90	325.47	308	69.11	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			273.2	C08		7	0172-0332	355.64	332.73	326	66.43	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.1	C08		7	0173-0333	827.91	332.60	260	61.94	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			358.3	C08		7	0174-0333	59.54	333.52	229	57.94	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			234.7	C08		7	0175-0340	679.98	340.54	324	70.28	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			286.8	C08		7	0176-0341	182.75	341.17	277	67.60	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			277.6	C08		7	0177-0337	234.22	337.39	279	65.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.1	C08		7	0178-0341	393.39	341.51	322	67.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			359.1	C08		7	0179-0344	273.12	344.76	273	60.53	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			339.4	C08		7	0180-0347	443.34	347.29	297	69.50	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.4	C08		7	0181-0345	903.28	345.78	250	58.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			516.6	C08		7	0182-0349	511.96	349.53	294	97.64	0.388
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			213.2	C08		7	0183-0352	834.55	351.67	322	68.18	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			482.3	C08		7	0184-0351	480.64	350.76	450	82.43	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.9	C08		7	0185-0349	596.52	349.28	272	61.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			279.1	C08		7	0186-0351	734.48	350.94	281	62.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			228.3	C08		7	0187-0354	21.01	354.39	300	63.36	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			298.6	C08		7	0188-0357	136.51	357.68	257	62.77	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			290.2	C08		7	0189-0363	277.83	363.11	282	65.36	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.9	C08		7	0190-0369	804.38	370.02	353	76.91	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.6	C08		7	0191-0370	623.76	369.67	290	63.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.8	C08		7	0192-0371	729.37	370.37	299	70.43	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			222.5	C08		7	0193-0371	883.25	370.76	286	62.18	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			431.1	C08		7	0194-0370	421.52	370.61	212	52.87	0.953
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			334.1	C08		7	0195-0373	440.77	372.81	369	71.94	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			283.7	C08		7	0196-0375	244.52	375.02	278	61.36	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			212.5	C08		7	0197-0386	779.94	386.38	519	100.33	0.648
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.1	C08		7	0198-0377	71.45	377.30	298	66.53	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			368.8	C08		7	0199-0381	358.69	381.63	304	67.26	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			334.3	C08		7	0200-0384	480.38	383.90	280	62.53	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			222.3	C08		7	0201-0383	594.58	383.38	302	67.36	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			383.5	C08		7	0202-0387	497.35	387.35	255	59.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			378.9	C08		7	0203-0388	159.68	388.14	279	64.18	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.1	C08		7	0204-0387	211.60	387.59	296	66.43	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			342.1	C08		7	0205-0389	307.95	388.57	241	57.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.0	C08		7	0206-0391	538.00	391.84	277	63.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			516.5	C08		7	0207-0391	340.85	392.48	347	75.50	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			223.8	C08		7	0208-0391	895.57	390.50	309	67.60	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.7	C08		7	0209-0392	273.69	392.24	311	66.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			234.0	C08		7	0210-0392	731.74	391.93	291	66.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.7	C08		7	0211-0394	685.93	394.07	333	70.43	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			290.3	C08		7	0212-0397	667.40	397.52	258	63.94	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			264.6	C08		7	0213-0399	588.90	399.42	299	66.77	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			180.5	C08		7	0214-0400	944.59	400.47	310	69.01	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			405.9	C08		7	0215-0405	62.74	405.46	318	72.28	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			375.9	C08		7	0216-0403	315.97	403.96	284	64.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			371.1	C08		7	0217-0403	136.00	402.95	262	59.36	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			277.0	C08		7	0218-0405	648.86	405.48	283	64.18	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			510.7	C08		7	0219-0408	242.85	408.79	298	64.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			504.6	C08		7	0220-0407	454.24	407.57	291	63.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.2	C08		7	0221-0408	727.38	408.60	319	67.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			205.3	C08		7	0222-0413	806.08	413.94	299	65.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			290.5	C08		7	0223-0413	848.18	413.71	226	57.70	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			336.7	C08		7	0224-0424	158.66	424.24	430	77.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			598.9	C08		7	0225-0426	575.46	425.45	392	95.88	0.536
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			618.0	C08		7	0226-0424	443.56	423.89	283	62.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			454.6	C08		7	0227-0428	70.13	428.66	468	82.77	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			551.0	C08		7	0228-0429	302.95	428.77	307	67.84	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			583.0	C08		7	0229-0433	604.50	433.16	423	82.33	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.8	C08		7	0230-0432	651.00	431.62	293	64.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.3	C08		7	0231-0429	917.79	429.61	133	42.87	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			277.1	C08		7	0232-0435	902.21	434.55	192	52.18	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.5	C08		7	0233-0439	201.66	439.00	288	64.18	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.6	C08		7	0234-0441	136.25	440.56	313	66.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			235.8	C08		7	0235-0451	551.08	451.54	738	125.30	0.591
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			335.9	C08		7	0236-0447	733.50	447.24	319	66.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			610.0	C08		7	0237-0448	237.40	448.75	413	75.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			190.5	C08		7	0238-0451	171.67	451.56	290	65.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			433.5	C08		7	0239-0452	50.62	451.91	266	63.94	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			350.3	C08		7	0240-0449	372.36	448.99	256	62.53	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.9	C08		7	0241-0451	479.06	451.16	238	58.18	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			493.1	C08		7	0242-0467	133.33	469.17	904	137.10	0.604
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			330.7	C08		7	0243-0458	493.89	458.38	335	69.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			294.8	C08		7	0244-0458	332.53	458.42	279	63.01	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.2	C08		7	0245-0460	632.80	460.02	261	66.43	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			303.2	C08		7	0246-0456	274.08	455.57	268	61.70	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			634.2	C08		7	0247-0458	414.12	457.91	197	52.28	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			306.7	C08		7	0248-0463	79.81	463.03	259	62.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.5	C08		7	0249-0468	822.05	468.25	531	87.15	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			678.7	C08		7	0250-0465	393.47	464.98	215	54.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			336.7	C08		7	0251-0465	800.97	465.27	182	52.04	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			322.0	C08		7	0252-0466	695.06	466.10	242	59.36	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			207.3	C08		7	0253-0468	778.09	468.76	311	67.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			209.7	C08		7	0254-0471	731.50	470.88	306	65.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			327.0	C08		7	0255-0481	682.59	481.48	527	94.08	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.1	C08		7	0256-0475	432.38	475.66	298	63.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			273.4	C08		7	0257-0476	888.40	476.51	278	63.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			235.0	C08		7	0258-0476	863.53	476.24	285	64.77	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			232.7	C08		7	0259-0479	615.49	479.10	308	65.84	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.9	C08		7	0260-0480	758.16	480.43	318	69.60	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			339.4	C08		7	0261-0489	489.59	489.12	471	81.26	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			323.6	C08		7	0262-0486	905.96	486.58	296	64.18	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			423.7	C08		7	0263-0490	579.07	489.41	186	57.60	0.705
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			417.8	C08		7	0264-0493	259.07	493.34	275	60.77	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.8	C08		7	0265-0497	773.89	497.11	282	64.77	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			381.3	C08		7	0266-0497	234.03	496.95	259	58.53	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			304.8	C08		7	0267-0502	658.63	502.20	266	60.18	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			208.3	C08		7	0268-0503	846.58	503.79	333	68.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.2	C08		7	0269-0506	122.20	506.82	276	62.53	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			212.1	C08		7	0270-0508	532.58	508.24	317	65.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			549.8	C08		7	0271-0513	340.54	511.95	653	107.40	0.711
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.1	C08		7	0272-0511	201.18	511.35	298	66.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.3	C08		7	0273-0509	374.99	510.00	260	58.77	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.2	C08		7	0274-0514	779.70	514.47	297	65.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.2	C08		7	0275-0514	163.92	514.24	276	63.60	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.6	C08		7	0276-0515	474.02	515.23	306	64.43	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.6	C08		7	0277-0520	285.23	519.48	281	66.43	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.7	C08		7	0278-0523	554.66	522.46	299	65.60	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.7	C08		7	0279-0527	595.61	527.94	333	69.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			285.4	C08		7	0280-0530	462.19	530.53	273	65.26	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			200.5	C08		7	0281-0531	50.04	531.24	281	65.01	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			211.8	C08		7	0282-0532	83.20	532.26	287	62.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			393.9	C08		7	0283-0538	235.20	538.13	469	80.08	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.0	C08		7	0284-0537	720.99	537.06	278	66.43	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.0	C08		7	0285-0537	643.63	536.71	328	67.84	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			291.6	C08		7	0286-0536	769.83	536.82	260	64.67	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			277.0	C08		7	0287-0539	187.08	539.05	290	69.50	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.3	C08		7	0288-0536	390.77	535.62	261	61.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			306.1	C08		7	0289-0539	914.20	540.18	320	67.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			375.2	C08		7	0290-0544	701.47	543.96	434	77.74	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.6	C08		7	0291-0544	12.36	544.12	314	67.84	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			590.8	C08		7	0292-0543	264.67	542.86	258	59.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			360.6	C08		7	0293-0551	298.73	551.61	248	58.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			586.2	C08		7	0294-0551	213.99	551.36	300	65.70	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.5	C08		7	0295-0553	929.54	553.86	299	66.18	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.3	C08		7	0296-0558	801.50	557.38	377	72.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.9	C08		7	0297-0559	382.14	558.96	278	63.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			206.2	C08		7	0298-0561	350.08	560.94	292	64.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			359.0	C08		7	0299-0562	322.63	561.88	258	59.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			313.4	C08		7	0300-0563	518.11	563.04	271	61.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			433.3	C08		7	0301-0564	133.95	564.75	242	57.11	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.7	C08		7	0302-0569	241.13	569.70	307	67.01	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			291.0	C08		7	0303-0571	696.96	572.13	336	72.43	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			424.3	C08		7	0304-0571	588.57	571.12	288	63.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			399.9	C08		7	0305-0579	282.97	579.38	397	73.60	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			396.2	C08		7	0306-0585	763.47	587.36	746	117.64	0.677
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.1	C08		7	0307-0579	94.84	579.64	289	64.43	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			481.4	C08		7	0308-0576	649.55	576.07	254	59.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			232.2	C08		7	0309-0583	415.09	583.38	302	67.94	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.6	C08		7	0310-0583	893.16	583.45	375	71.60	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.5	C08		7	0311-0584	615.58	583.79	264	60.77	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.3	C08		7	0312-0588	460.21	588.56	306	64.53	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			386.9	C08		7	0313-0591	583.80	591.02	473	82.18	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.2	C08		7	0314-0595	538.06	595.67	433	77.01	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			236.1	C08		7	0315-0592	700.27	592.00	281	62.87	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			222.3	C08		7	0316-0599	945.31	598.79	258	64.43	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			362.9	C08		7	0317-0599	353.56	599.04	283	64.04	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			458.1	C08		7	0318-0605	336.14	604.94	412	78.18	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			420.3	C08		7	0319-0602	56.90	602.87	252	59.70	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			264.0	C08		7	0320-0606	399.11	607.57	277	63.11	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.0	C08		7	0321-0609	855.32	609.79	272	62.53	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			302.0	C08		7	0322-0613	636.26	612.94	273	64.77	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			216.6	C08		7	0323-0613	936.53	613.28	315	67.84	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			326.5	C08		7	0324-0612	678.10	613.04	256	60.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			368.7	C08		7	0325-0621	104.10	620.20	457	78.43	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.2	C08		7	0326-0623	291.51	624.26	627	100.91	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			484.8	C08		7	0327-0629	395.95	629.48	448	79.60	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			213.4	C08		7	0328-0628	572.60	628.89	290	62.77	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			230.9	C08		7	0329-0632	748.01	632.18	289	64.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			327.0	C08		7	0330-0636	776.79	636.68	256	60.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			222.5	C08		7	0331-0640	373.08	640.16	281	62.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.7	C08		7	0332-0647	710.25	648.24	283	65.60	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.3	C08		7	0333-0651	822.58	651.72	261	61.94	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			221.8	C08		7	0334-0652	204.53	653.05	300	64.18	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			209.8	C08		7	0335-0655	48.52	654.60	298	66.77	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.2	C08		7	0336-0658	138.48	657.73	287	62.77	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			235.2	C08		7	0337-0660	500.08	659.81	310	69.36	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			304.9	C08		7	0338-0659	631.58	659.79	261	60.87	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			224.5	C08		7	0339-0663	91.38	663.46	295	63.36	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.5	C08		7	0340-0661	302.24	661.91	258	61.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			220.2	C08		7	0341-0665	867.73	665.18	310	67.60	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.9	C08		7	0342-0670	424.56	670.17	396	75.84	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			307.0	C08		7	0343-0666	665.60	666.59	260	59.11	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.8	C08		7	0344-0668	699.28	668.58	267	61.94	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.9	C08		7	0345-0667	566.92	667.45	265	64.53	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			287.5	C08		7	0346-0674	186.53	673.98	438	80.18	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			355.7	C08		7	0347-0677	313.68	677.71	433	78.43	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			499.3	C08		7	0348-0676	807.34	676.26	246	58.18	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.7	C08		7	0349-0677	628.99	676.79	257	63.21	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.8	C08		7	0350-0679	645.06	678.65	325	71.94	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			312.8	C08		7	0351-0682	946.39	682.20	232	58.53	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			310.4	C08		7	0352-0684	666.11	684.21	246	57.70	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			329.2	C08		7	0353-0687	759.57	688.18	370	71.84	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			362.9	C08		7	0354-0687	736.92	686.21	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			227.1	C08		7	0355-0688	24.13	688.30	298	65.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			543.2	C08		7	0356-0691	252.88	690.83	430	77.26	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			296.6	C08		7	0357-0688	713.65	688.11	263	63.36	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			180.0	C08		7	0358-0693	469.47	692.93	302	67.70	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.9	C08		7	0359-0691	123.37	691.78	285	63.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			234.9	C08		7	0360-0698	43.62	698.59	290	65.60	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			332.1	C08		7	0361-0698	939.07	698.25	235	59.36	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			211.5	C08		7	0362-0700	533.23	700.56	301	65.60	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			22468.6	C08		7	0363-0702	438.97	702.40	410	75.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			358.8	C08		7	0364-0702	374.62	702.30	278	61.36	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.6	C08		7	0365-0705	762.74	705.83	240	58.87	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			312.0	C08		7	0366-0710	613.25	710.49	186	53.36	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.4	C08		8	0001-0030	465.68	30.42	295	61.94	0.966
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.0	C08		8	0002-0031	547.19	30.38	278	62.18	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			222.7	C08		8	0003-0033	709.44	32.90	255	63.84	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			190.2	C08		8	0004-0033	33.60	33.54	273	64.77	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			236.5	C08		8	0005-0032	180.29	32.17	229	56.53	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			379.6	C08		8	0006-0032	778.32	31.86	180	51.11	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			216.7	C08		8	0007-0033	54.01	33.46	295	67.70	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			235.9	C08		8	0008-0033	231.55	33.54	264	59.11	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.4	C08		8	0009-0037	693.47	37.68	251	59.94	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			283.7	C08		8	0010-0039	522.67	38.53	294	65.94	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			440.6	C08		8	0011-0040	792.13	40.86	333	76.91	0.707
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.0	C08		8	0012-0042	311.06	41.33	294	65.26	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			388.0	C08		8	0013-0048	380.46	46.13	438	89.84	0.682
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			400.6	C08		8	0014-0045	501.66	45.04	449	78.67	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			657.5	C08		8	0015-0044	660.94	45.37	156	80.91	0.299
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.8	C08		8	0016-0054	712.35	54.21	264	66.18	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			321.3	C08		8	0017-0053	742.37	52.85	277	63.84	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			230.4	C08		8	0018-0056	837.09	55.92	164	55.11	0.679
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			259.1	C08		8	0019-0057	860.26	57.03	272	62.18	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			706.5	C08		8	0020-0059	448.63	59.29	134	60.18	0.465
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			320.8	C08		8	0021-0068	67.82	67.59	498	87.50	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.7	C08		8	0022-0064	909.20	64.16	300	67.36	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			312.3	C08		8	0023-0062	790.69	61.81	207	52.28	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			590.2	C08		8	0024-0063	121.72	63.89	242	57.36	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			200.9	C08		8	0025-0067	286.68	66.55	297	76.57	0.637
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.4	C08		8	0026-0067	591.04	66.94	314	70.77	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			322.7	C08		8	0027-0063	50.38	63.06	108	40.63	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			429.7	C08		8	0028-0074	188.81	72.64	695	116.23	0.647
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			283.4	C08		8	0029-0069	345.83	69.59	243	57.11	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			331.2	C08		8	0030-0071	848.67	70.96	252	61.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			835.3	C08		8	0031-0073	106.00	73.30	218	58.77	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			349.3	C08		8	0032-0080	165.89	77.84	532	95.36	0.735
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.3	C08		8	0033-0075	629.52	75.54	309	69.26	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			233.1	C08		8	0034-0073	932.67	73.63	278	64.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			354.8	C08		8	0035-0074	236.53	74.59	247	59.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.7	C08		8	0036-0081	544.67	81.33	299	68.43	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			222.1	C08		8	0037-0087	824.73	86.97	303	67.84	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.7	C08		8	0038-0086	481.64	86.30	296	64.67	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			273.8	C08		8	0039-0086	319.20	85.87	282	62.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			286.4	C08		8	0040-0089	665.56	89.80	432	80.67	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			44523.3	C08		8	0041-0100	83.83	100.10	294	64.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			290.2	C08		8	0042-0100	227.32	99.74	258	63.36	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			323.5	C08		8	0043-0099	773.95	99.27	234	56.87	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			293.0	C08		8	0044-0100	367.51	100.60	291	65.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			394.2	C08		8	0045-0100	757.50	100.78	259	58.87	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			326.9	C08		8	0046-0108	581.33	108.58	288	65.01	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.2	C08		8	0047-0110	902.90	110.16	303	64.18	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			209.7	C08		8	0048-0110	821.66	109.99	266	61.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			332.7	C08		8	0049-0111	720.99	110.99	228	55.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			214.0	C08		8	0050-0117	19.36	117.48	250	58.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			412.2	C08		8	0051-0122	401.85	120.99	617	103.15	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			317.2	C08		8	0052-0117	602.92	117.43	243	58.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.2	C08		8	0053-0117	536.09	116.93	268	61.94	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			428.9	C08		8	0054-0123	645.10	123.14	239	57.36	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			353.5	C08		8	0055-0126	433.22	126.58	256	59.36	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			304.1	C08		8	0056-0125	475.67	125.87	307	65.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			48592.4	C08		8	0057-0131	104.76	131.71	320	68.43	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			374.3	C08		8	0058-0129	288.05	129.53	218	55.11	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			286.2	C08		8	0059-0135	847.79	134.33	444	84.91	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			387.3	C08		8	0060-0132	811.21	132.13	224	56.63	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.3	C08		8	0061-0135	207.21	134.94	252	61.36	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			286.2	C08		8	0062-0138	798.43	138.91	261	64.28	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.9	C08		8	0063-0140	527.91	140.89	280	63.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.5	C08		8	0064-0142	711.25	142.30	314	70.43	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			434.0	C08		8	0065-0142	375.28	142.34	231	56.28	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			295.5	C08		8	0066-0143	476.59	142.54	270	62.53	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			218.1	C08		8	0067-0148	775.29	148.00	280	62.18	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.7	C08		8	0068-0152	124.19	152.91	275	63.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			296.5	C08		8	0069-0148	299.03	147.82	247	59.70	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			395.1	C08		8	0070-0152	814.13	152.03	197	51.70	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			223.0	C08		8	0071-0155	675.60	155.47	270	63.60	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			226.9	C08		8	0072-0155	741.61	154.87	253	59.94	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			257.9	C08		8	0073-0159	614.15	159.31	289	65.70	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			492.8	C08		8	0074-0158	355.70	157.95	353	69.01	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.9	C08		8	0075-0158	72.97	157.87	271	61.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			346.2	C08		8	0076-0166	468.52	166.65	303	69.60	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			319.8	C08		8	0077-0171	52.32	171.42	447	79.50	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.4	C08		8	0078-0173	161.92	173.06	261	61.36	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.2	C08		8	0079-0173	222.76	173.00	257	59.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.5	C08		8	0080-0169	397.95	169.91	274	67.94	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			366.4	C08		8	0081-0172	449.89	172.11	212	55.70	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.0	C08		8	0082-0176	674.84	176.11	285	66.18	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			444.1	C08		8	0083-0184	538.83	184.41	214	56.53	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.6	C08		8	0084-0186	105.76	186.28	271	60.18	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.5	C08		8	0085-0190	896.93	190.67	512	89.74	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.0	C08		8	0086-0197	328.77	196.94	376	71.60	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			327.2	C08		8	0087-0194	398.31	194.01	237	58.18	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			293.7	C08		8	0088-0198	481.48	198.28	282	64.53	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.6	C08		8	0089-0200	669.44	199.84	309	70.18	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			206.9	C08		8	0090-0199	286.00	199.11	279	63.36	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			354.5	C08		8	0091-0199	513.10	198.22	311	69.11	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			216.9	C08		8	0092-0203	773.71	202.19	159	50.18	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			216.3	C08		8	0093-0208	848.75	208.73	304	70.91	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			330.0	C08		8	0094-0208	385.94	208.71	392	80.33	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.7	C08		8	0095-0210	762.42	209.98	316	75.74	0.692
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			199.4	C08		8	0096-0210	784.83	210.44	120	41.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.1	C08		8	0097-0214	718.57	214.37	222	59.36	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			307.0	C08		8	0098-0215	30.22	215.69	254	59.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.0	C08		8	0099-0214	509.59	215.05	284	65.36	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.1	C08		8	0100-0221	901.61	221.67	392	74.67	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			293.0	C08		8	0101-0219	401.57	219.53	273	63.01	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			330.9	C08		8	0102-0227	600.21	227.79	229	56.53	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.7	C08		8	0103-0228	180.24	228.63	265	62.77	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			203.7	C08		8	0104-0232	123.88	234.13	341	79.26	0.682
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			361.1	C08		8	0105-0230	684.46	229.47	250	59.70	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			404.8	C08		8	0106-0230	821.39	229.68	262	60.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			368.6	C08		8	0107-0228	846.38	228.77	224	55.36	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			495.0	C08		8	0108-0235	216.03	234.74	373	71.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			372.1	C08		8	0109-0233	263.29	233.49	159	47.46	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			259.2	C08		8	0110-0241	702.98	240.60	210	55.94	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.8	C08		8	0111-0244	483.81	244.58	343	71.01	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			273.6	C08		8	0112-0247	651.99	247.34	454	81.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.5	C08		8	0113-0246	183.27	246.76	242	59.46	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			257.0	C08		8	0114-0247	567.50	246.42	307	65.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			202.9	C08		8	0115-0248	622.51	248.87	293	63.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			207.7	C08		8	0116-0251	64.62	250.71	270	66.67	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			405.4	C08		8	0117-0252	339.09	252.28	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			11970.7	C08		8	0118-0252	746.86	252.39	370	71.26	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			203.7	C08		8	0119-0253	909.42	252.76	302	68.18	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			189.4	C08		8	0120-0256	927.02	256.12	338	72.18	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			335.0	C08		8	0121-0257	507.86	257.96	460	79.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.1	C08		8	0122-0257	775.18	257.04	242	57.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			234.2	C08		8	0123-0263	113.49	262.03	264	61.26	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.9	C08		8	0124-0265	13.44	264.14	247	61.60	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			415.2	C08		8	0125-0266	570.91	266.69	224	54.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			270.7	C08		8	0126-0270	431.50	270.56	276	63.36	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			322.6	C08		8	0127-0271	642.41	271.75	266	63.11	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.0	C08		8	0128-0275	28.09	274.67	247	61.36	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			211.8	C08		8	0129-0273	96.59	273.71	293	71.15	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.2	C08		8	0130-0278	177.48	278.78	258	61.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			317.6	C08		8	0131-0275	348.47	275.37	282	62.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			225.7	C08		8	0132-0282	790.68	282.00	280	63.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			599.0	C08		8	0133-0280	616.38	280.19	218	54.53	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			303.8	C08		8	0134-0286	411.59	286.65	516	86.43	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			338.4	C08		8	0135-0289	593.91	290.18	522	96.33	0.707
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.7	C08		8	0136-0291	657.83	291.43	401	77.60	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.4	C08		8	0137-0292	198.52	292.19	254	62.77	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			320.0	C08		8	0138-0291	503.11	291.22	264	61.36	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.7	C08		8	0139-0293	169.12	293.03	223	57.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			277.9	C08		8	0140-0296	858.63	296.66	278	65.70	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			289.8	C08		8	0141-0296	473.07	295.39	310	66.43	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			346.4	C08		8	0142-0296	631.22	296.87	243	59.94	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.2	C08		8	0143-0300	872.90	300.22	285	64.87	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			192.6	C08		8	0144-0300	97.94	300.00	282	66.18	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			301.3	C08		8	0145-0308	702.25	308.18	503	88.43	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			257.1	C08		8	0146-0309	152.79	309.85	475	88.57	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			257.3	C08		8	0147-0310	280.31	309.79	416	77.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			308.6	C08		8	0148-0310	386.42	309.73	244	58.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.2	C08		8	0149-0309	745.08	308.93	281	62.18	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			284.3	C08		8	0150-0315	216.42	314.77	287	65.60	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			257.5	C08		8	0151-0320	47.35	320.46	420	75.26	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			306.9	C08		8	0152-0320	593.64	319.21	252	59.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			299.4	C08		8	0153-0325	528.95	325.66	304	66.77	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			217.1	C08		8	0154-0325	422.95	324.32	285	64.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			170.4	C08		8	0155-0325	910.94	325.64	306	67.84	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			182.7	C08		8	0156-0327	98.64	326.80	373	76.08	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			298.8	C08		8	0157-0326	326.66	326.76	238	58.18	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.0	C08		8	0158-0337	772.26	337.59	305	66.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.3	C08		8	0159-0341	818.10	341.48	280	65.01	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			316.2	C08		8	0160-0339	871.33	338.94	242	59.11	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			203.4	C08		8	0161-0345	115.39	344.75	275	62.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			538.7	C08		8	0162-0348	525.87	348.58	366	73.84	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			291.3	C08		8	0163-0345	711.92	344.44	249	59.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.9	C08		8	0164-0352	559.11	352.20	276	61.94	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.0	C08		8	0165-0351	597.71	351.17	268	60.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.7	C08		8	0166-0352	682.45	351.91	255	62.77	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.5	C08		8	0167-0352	731.46	352.60	283	62.18	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.5	C08		8	0168-0359	263.84	359.46	487	88.91	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.2	C08		8	0169-0354	210.23	354.93	263	59.60	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			295.0	C08		8	0170-0356	631.68	356.32	268	61.11	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			328.1	C08		8	0171-0356	355.10	356.18	258	59.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.4	C08		8	0172-0357	416.89	357.57	307	70.43	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.0	C08		8	0173-0357	925.03	357.68	273	61.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			225.6	C08		8	0174-0361	468.53	360.83	292	64.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			235.7	C08		8	0175-0362	649.11	362.38	323	69.60	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			309.1	C08		8	0176-0365	171.66	365.70	227	55.70	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			219.0	C08		8	0177-0365	288.04	365.90	287	67.60	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			381.3	C08		8	0178-0366	59.86	366.56	248	58.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			431.4	C08		8	0179-0380	760.61	380.58	357	70.18	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			403.4	C08		8	0180-0380	811.00	379.21	217	55.01	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			268.4	C08		8	0181-0383	196.62	383.55	280	62.18	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.4	C08		8	0182-0384	217.55	384.18	269	61.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			4902.3	C08		8	0183-0383	334.32	383.75	119	50.04	0.597
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.4	C08		8	0184-0389	824.12	389.42	309	65.11	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.1	C08		8	0185-0388	948.43	389.19	264	59.70	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			45641.2	C08		8	0186-0396	578.23	395.14	311	67.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			230.7	C08		8	0187-0396	492.26	397.89	297	69.84	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			212.4	C08		8	0188-0398	874.23	398.40	276	62.77	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			548.9	C08		8	0189-0402	378.12	401.83	338	72.67	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.1	C08		8	0190-0397	921.02	397.62	284	63.01	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			212.2	C08		8	0191-0401	295.72	402.10	276	61.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			178.2	C08		8	0192-0402	49.43	402.45	275	65.60	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			566.7	C08		8	0193-0404	558.15	404.14	249	59.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			37830.7	C08		8	0194-0404	725.10	404.57	103	63.50	0.321
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			299.1	C08		8	0195-0418	319.07	417.56	255	60.28	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			469.4	C08		8	0196-0418	390.15	417.76	412	76.08	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.1	C08		8	0197-0420	245.09	420.66	268	64.43	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			444.8	C08		8	0198-0420	684.61	420.01	187	50.53	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			292.4	C08		8	0199-0423	613.93	423.00	244	58.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			312.6	C08		8	0200-0424	562.83	424.34	275	60.77	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.3	C08		8	0201-0426	180.00	427.29	275	63.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			312.7	C08		8	0202-0426	827.92	426.59	247	57.70	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.3	C08		8	0203-0432	147.17	431.93	238	57.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.7	C08		8	0204-0434	261.57	433.98	293	67.94	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			217.0	C08		8	0205-0437	846.62	437.04	304	67.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			294.4	C08		8	0206-0442	340.32	442.00	273	63.36	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			429.2	C08		8	0207-0440	699.29	439.71	234	55.94	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			332.1	C08		8	0208-0442	417.13	442.32	230	56.28	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			317.0	C08		8	0209-0444	718.59	444.25	348	69.60	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			234.6	C08		8	0210-0444	545.86	444.24	272	61.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			369.4	C08		8	0211-0445	458.64	445.50	258	59.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			5050.9	C08		8	0212-0448	868.82	448.96	248	59.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			327.6	C08		8	0213-0449	925.97	448.03	219	57.11	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.8	C08		8	0214-0453	372.89	453.38	318	70.67	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			264.4	C08		8	0215-0453	608.77	452.64	278	62.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			259.3	C08		8	0216-0458	565.00	458.24	488	82.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			294.1	C08		8	0217-0461	64.26	460.83	476	83.74	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			230.0	C08		8	0218-0461	387.49	461.48	279	63.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.8	C08		8	0219-0460	837.21	459.77	248	58.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			304.6	C08		8	0220-0461	921.28	462.13	248	62.77	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			283.8	C08		8	0221-0462	256.23	461.92	220	54.53	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			332.8	C08		8	0222-0461	282.52	461.62	206	54.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			447.1	C08		8	0223-0463	668.71	463.60	263	64.18	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.9	C08		8	0224-0467	319.69	467.01	282	63.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			500.4	C08		8	0225-0464	804.55	463.14	229	56.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			374.2	C08		8	0226-0471	787.93	471.14	285	63.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.6	C08		8	0227-0477	149.23	477.60	560	102.57	0.669
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			413.3	C08		8	0228-0474	640.90	473.26	224	54.53	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			224.8	C08		8	0229-0477	425.01	478.02	269	62.18	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			298.1	C08		8	0230-0478	292.01	479.06	271	64.53	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			386.0	C08		8	0231-0481	678.51	481.71	247	59.11	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			566.6	C08		8	0232-0479	711.23	479.80	241	57.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.1	C08		8	0233-0479	902.02	479.72	270	60.53	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.3	C08		8	0234-0481	941.03	481.25	232	57.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			40789.2	C08		8	0235-0484	211.36	483.62	105	43.11	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			38344.3	C08		8	0236-0487	201.58	488.12	131	48.53	0.699
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			343.3	C08		8	0237-0487	269.16	487.87	231	58.53	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			324.4	C08		8	0238-0489	620.16	488.89	288	65.11	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			349.1	C08		8	0239-0492	554.03	492.40	349	70.67	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			284.0	C08		8	0240-0491	365.53	491.03	225	56.18	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			292.7	C08		8	0241-0500	171.28	499.87	344	68.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.7	C08		8	0242-0498	716.02	498.20	226	60.43	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.8	C08		8	0243-0497	109.61	497.63	238	59.60	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.0	C08		8	0244-0500	238.91	501.10	239	58.87	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			287.2	C08		8	0245-0502	380.62	502.20	268	63.01	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.1	C08		8	0246-0507	930.95	506.66	409	77.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			399.6	C08		8	0247-0504	625.16	504.98	238	60.28	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			362.5	C08		8	0248-0503	273.40	503.05	238	58.28	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.3	C08		8	0249-0514	89.34	515.12	507	91.15	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			374.2	C08		8	0250-0509	438.00	509.74	255	58.53	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			407.2	C08		8	0251-0510	696.79	510.30	311	66.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.1	C08		8	0252-0512	878.28	512.44	244	59.46	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			524.0	C08		8	0253-0514	310.30	513.18	186	51.70	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			353.5	C08		8	0254-0515	201.80	515.64	228	56.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			341.3	C08		8	0255-0517	759.40	516.79	294	64.67	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			351.6	C08		8	0256-0519	811.58	519.44	486	87.98	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			289.2	C08		8	0257-0516	596.04	516.40	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.3	C08		8	0258-0520	237.04	519.50	330	71.11	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			293.2	C08		8	0259-0522	253.68	522.36	228	59.11	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.9	C08		8	0260-0523	488.73	522.70	295	62.77	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			369.0	C08		8	0261-0524	661.48	523.87	227	55.70	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			373.1	C08		8	0262-0527	742.40	526.95	260	60.43	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.1	C08		8	0263-0530	876.58	529.37	283	62.77	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			316.7	C08		8	0264-0532	356.26	532.79	284	62.53	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			306.9	C08		8	0265-0533	279.96	532.58	250	58.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			402.8	C08		8	0266-0533	631.26	533.79	257	59.60	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			305.8	C08		8	0267-0540	312.82	539.80	275	63.11	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			308.1	C08		8	0268-0544	136.31	544.19	542	91.15	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.9	C08		8	0269-0542	19.31	542.57	283	65.01	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			322.6	C08		8	0270-0541	710.78	541.56	213	55.11	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.2	C08		8	0271-0547	528.35	547.46	266	63.60	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			392.9	C08		8	0272-0547	659.37	547.28	221	55.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			329.1	C08		8	0273-0548	340.98	548.12	299	66.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.9	C08		8	0274-0551	158.34	550.80	237	57.70	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			595.1	C08		8	0275-0558	593.14	559.17	376	84.43	0.663
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			360.6	C08		8	0276-0557	882.02	557.74	446	77.60	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			236.8	C08		8	0277-0555	34.35	555.92	277	66.43	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.7	C08		8	0278-0558	212.69	558.00	294	64.53	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			322.2	C08		8	0279-0556	618.51	556.04	242	56.53	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			325.4	C08		8	0280-0557	686.65	556.60	238	59.60	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			225.8	C08		8	0281-0560	179.36	560.21	253	62.77	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			351.8	C08		8	0282-0558	246.73	557.92	240	58.77	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.3	C08		8	0283-0562	830.98	562.33	447	79.26	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			224.5	C08		8	0284-0566	803.90	565.85	314	66.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.0	C08		8	0285-0569	497.77	569.36	276	64.53	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			220.7	C08		8	0286-0567	759.84	567.25	272	63.01	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			234.3	C08		8	0287-0569	119.71	570.06	268	63.94	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			285.2	C08		8	0288-0571	461.61	571.35	266	61.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			328.7	C08		8	0289-0580	59.92	580.69	231	56.87	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			355.7	C08		8	0290-0579	303.55	579.25	251	58.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			318.8	C08		8	0291-0579	624.67	579.37	252	58.53	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.1	C08		8	0292-0583	361.19	583.79	256	61.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			310.2	C08		8	0293-0587	654.64	588.15	349	74.33	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.9	C08		8	0294-0589	456.73	589.69	307	70.18	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.1	C08		8	0295-0586	529.34	586.84	286	61.94	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			335.6	C08		8	0296-0586	117.58	586.24	206	54.97	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.8	C08		8	0297-0596	295.90	596.50	237	62.77	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			342.2	C08		8	0298-0593	868.74	593.33	202	51.70	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			218.5	C08		8	0299-0601	50.38	600.85	254	64.43	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			315.9	C08		8	0300-0599	701.52	599.57	413	75.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			191.4	C08		8	0301-0598	843.25	598.26	291	64.67	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			296.8	C08		8	0302-0600	63.45	600.21	210	57.46	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			210.2	C08		8	0303-0602	559.38	602.13	283	63.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			218.2	C08		8	0304-0602	185.08	602.33	240	61.01	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			219.6	C08		8	0305-0601	405.74	600.46	280	65.70	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			236.6	C08		8	0306-0605	120.49	605.06	281	62.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			302.0	C08		8	0307-0607	825.57	607.00	248	58.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			342.3	C08		8	0308-0611	359.21	612.16	250	61.94	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			219.0	C08		8	0309-0610	721.85	609.54	302	65.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.8	C08		8	0310-0613	943.88	612.85	291	65.60	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			204.7	C08		8	0311-0615	41.12	614.97	308	69.50	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			314.5	C08		8	0312-0615	239.39	614.86	257	61.70	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.8	C08		8	0313-0616	916.21	616.39	283	64.08	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			217.2	C08		8	0314-0618	207.71	618.12	223	60.77	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			195.4	C08		8	0315-0617	761.84	618.20	286	63.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			403.4	C08		8	0316-0618	306.06	618.28	239	56.53	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			227.8	C08		8	0317-0620	588.43	620.73	279	62.43	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			515.1	C08		8	0318-0622	404.32	622.59	304	64.18	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			202.5	C08		8	0319-0629	517.58	629.12	284	63.84	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			313.0	C08		8	0320-0632	459.52	631.89	370	71.84	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			293.0	C08		8	0321-0636	76.39	636.01	364	70.18	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			328.0	C08		8	0322-0637	110.24	637.03	317	65.36	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			337.5	C08		8	0323-0640	879.84	640.53	526	93.74	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.2	C08		8	0324-0639	391.61	638.97	319	68.18	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.0	C08		8	0325-0643	248.85	643.59	323	70.43	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			177.1	C08		8	0326-0645	505.10	645.84	306	66.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.6	C08		8	0327-0645	768.94	645.84	266	62.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			360.1	C08		8	0328-0651	671.28	651.61	246	60.18	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.7	C08		8	0329-0653	706.64	652.08	543	92.91	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.9	C08		8	0330-0654	300.37	654.17	247	58.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			189.9	C08		8	0331-0656	925.47	655.80	301	68.08	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.6	C08		8	0332-0656	362.05	656.09	299	64.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			220.2	C08		8	0333-0658	141.52	658.42	252	70.67	0.634
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			225.1	C08		8	0334-0658	97.64	658.60	267	61.94	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			211.4	C08		8	0335-0662	326.33	662.00	309	69.01	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			203.9	C08		8	0336-0664	412.07	664.33	320	67.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.6	C08		8	0337-0663	542.20	662.74	269	62.53	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			341.1	C08		8	0338-0671	679.72	670.55	583	99.98	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			234.9	C08		8	0339-0670	559.96	669.94	306	65.94	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			341.9	C08		8	0340-0671	522.06	670.94	257	60.53	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			259.4	C08		8	0341-0676	839.62	675.96	277	64.43	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			177.1	C08		8	0342-0677	592.10	676.95	301	64.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.0	C08		8	0343-0681	426.87	681.11	257	61.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			307.9	C08		8	0344-0680	825.91	680.22	200	55.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			305.5	C08		8	0345-0681	496.51	681.74	226	55.94	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			307.1	C08		8	0346-0684	50.65	684.36	234	58.53	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			330.5	C08		8	0347-0689	254.18	690.21	283	64.43	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.3	C08		8	0348-0688	868.57	687.80	244	57.70	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			324.8	C08		8	0349-0690	188.82	689.63	237	57.70	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			227.0	C08		8	0350-0690	937.26	690.82	252	61.11	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			205.6	C08		8	0351-0694	901.66	693.47	276	65.60	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			208.4	C08		8	0352-0701	762.65	700.30	321	72.77	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.7	C08		8	0353-0700	43.43	700.32	233	61.01	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.3	C08		8	0354-0703	119.57	703.64	249	58.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.0	C08		8	0355-0705	520.70	705.43	283	62.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.6	C08		8	0356-0706	389.73	707.25	207	55.94	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			219.8	C08		8	0357-0707	328.37	707.55	294	67.70	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			279.3	C08		9	0001-0024	161.85	25.29	246	59.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			341.2	C08		9	0002-0035	665.72	35.66	214	57.11	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			391.1	C08		9	0003-0039	312.75	39.43	433	76.67	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			292.9	C08		9	0004-0037	420.03	37.46	346	69.01	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			219.7	C08		9	0005-0040	374.47	40.18	320	66.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.4	C08		9	0006-0045	820.05	45.39	381	73.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			213.1	C08		9	0007-0047	72.02	46.73	268	64.18	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			390.7	C08		9	0008-0049	676.39	49.76	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			19267.7	C08		9	0009-0050	207.06	50.12	309	65.01	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.5	C08		9	0010-0052	170.76	52.19	245	58.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			347.4	C08		9	0011-0055	511.16	55.20	391	73.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			314.7	C08		9	0012-0055	553.62	56.11	265	61.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			216.0	C08		9	0013-0056	84.67	55.33	253	63.60	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			270.9	C08		9	0014-0060	764.20	59.77	410	76.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.3	C08		9	0015-0057	111.31	57.22	247	63.94	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.6	C08		9	0016-0063	641.28	63.47	291	67.11	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.9	C08		9	0017-0063	618.58	62.86	295	65.70	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			390.9	C08		9	0018-0066	660.27	66.16	281	62.18	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			370.2	C08		9	0019-0065	260.89	65.33	267	59.94	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			299.5	C08		9	0020-0065	919.29	65.62	278	62.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			331.6	C08		9	0021-0068	834.44	67.84	321	68.43	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.0	C08		9	0022-0074	466.68	74.75	307	65.11	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			203.8	C08		9	0023-0076	27.12	76.64	262	61.60	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			214.7	C08		9	0024-0077	188.25	77.36	293	67.01	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			326.9	C08		9	0025-0078	237.21	78.41	255	61.01	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			209.1	C08		9	0026-0083	329.86	83.01	316	70.08	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.1	C08		9	0027-0090	387.72	90.27	630	94.81	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			310.1	C08		9	0028-0084	822.71	84.46	238	56.77	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			194.7	C08		9	0029-0087	949.16	87.00	283	63.01	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			332.8	C08		9	0030-0088	499.50	88.20	272	61.36	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			393.7	C08		9	0031-0095	273.32	94.68	232	57.60	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.3	C08		9	0032-0099	837.52	99.21	297	64.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			392.9	C08		9	0033-0103	732.27	102.56	218	57.36	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.8	C08		9	0034-0103	439.24	102.90	295	65.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			371.4	C08		9	0035-0104	717.93	103.97	242	57.70	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			444.0	C08		9	0036-0107	610.82	107.38	251	58.28	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			315.4	C08		9	0037-0108	762.14	108.40	290	63.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			380.2	C08		9	0038-0114	213.27	114.06	257	59.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			232.9	C08		9	0039-0119	68.38	119.09	248	64.87	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			350.7	C08		9	0040-0120	50.66	120.43	362	73.36	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.0	C08		9	0041-0121	287.36	120.29	279	61.11	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			330.8	C08		9	0042-0121	647.54	121.67	265	61.11	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			228.5	C08		9	0043-0121	943.79	120.02	245	59.94	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			560.3	C08		9	0044-0122	243.16	121.57	263	83.50	0.474
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			322.0	C08		9	0045-0124	862.97	124.53	312	66.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.8	C08		9	0046-0126	496.69	125.44	297	64.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			429.9	C08		9	0047-0131	422.92	130.66	210	55.01	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			575.9	C08		9	0048-0130	383.67	130.77	198	53.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			316.8	C08		9	0049-0133	667.11	133.29	248	58.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.8	C08		9	0050-0138	68.40	138.48	334	74.77	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			318.7	C08		9	0051-0142	113.99	141.80	371	73.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.1	C08		9	0052-0142	192.16	141.80	284	66.67	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			316.7	C08		9	0053-0140	302.18	140.57	275	62.04	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			385.9	C08		9	0054-0143	433.34	143.34	286	62.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			363.7	C08		9	0055-0141	733.55	141.16	244	57.36	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			344.2	C08		9	0056-0142	885.59	142.48	299	63.84	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			341.8	C08		9	0057-0139	772.04	139.76	219	54.87	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			407.1	C08		9	0058-0145	230.77	145.19	399	73.01	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			294.0	C08		9	0059-0147	345.61	146.60	335	67.84	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			314.5	C08		9	0060-0146	132.54	146.26	261	61.94	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			382.8	C08		9	0061-0159	616.86	156.80	390	84.91	0.680
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			389.8	C08		9	0062-0152	166.12	151.85	223	57.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			379.4	C08		9	0063-0153	634.50	153.00	116	38.97	0.960
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			219.2	C08		9	0064-0156	770.74	155.75	343	68.87	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			362.6	C08		9	0065-0156	449.47	155.91	231	55.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			325.8	C08		9	0066-0156	302.96	155.49	244	60.28	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			326.7	C08		9	0067-0162	490.83	162.58	358	71.26	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			324.1	C08		9	0068-0165	572.41	165.15	422	76.18	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.9	C08		9	0069-0166	807.34	166.84	302	69.60	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			413.6	C08		9	0070-0170	532.91	170.34	246	59.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			349.6	C08		9	0071-0173	140.65	173.84	242	57.70	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			317.9	C08		9	0072-0177	414.21	176.85	464	80.67	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			307.1	C08		9	0073-0177	251.09	177.59	287	62.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			433.0	C08		9	0074-0177	660.80	177.44	227	56.53	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.3	C08		9	0075-0182	827.81	182.46	333	68.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			427.2	C08		9	0076-0186	396.07	188.05	451	86.67	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			284.4	C08		9	0077-0185	750.71	185.11	320	66.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			292.3	C08		9	0078-0184	456.37	184.52	346	75.84	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.3	C08		9	0079-0186	559.50	186.39	310	65.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			323.4	C08		9	0080-0189	116.64	189.13	234	55.94	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			222.2	C08		9	0081-0188	167.35	187.41	309	70.53	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			304.2	C08		9	0082-0191	520.39	190.47	422	77.84	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			228.0	C08		9	0083-0192	77.49	191.97	280	63.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			223.7	C08		9	0084-0193	187.40	192.97	270	61.94	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.3	C08		9	0085-0191	902.35	191.72	342	71.11	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.1	C08		9	0086-0196	324.22	196.80	336	67.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.7	C08		9	0087-0199	842.93	200.02	236	57.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			310.9	C08		9	0088-0210	372.57	210.16	458	81.84	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.7	C08		9	0089-0206	233.49	206.79	240	58.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.6	C08		9	0090-0207	900.41	206.94	299	67.70	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.2	C08		9	0091-0211	734.28	211.95	285	63.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			201.4	C08		9	0092-0214	251.54	213.93	326	72.77	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			257.7	C08		9	0093-0211	773.03	210.77	302	64.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			450.7	C08		9	0094-0219	463.37	219.42	274	64.53	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			375.9	C08		9	0095-0217	682.78	217.22	230	57.36	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			348.2	C08		9	0096-0219	500.76	219.35	234	57.70	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			361.9	C08		9	0097-0222	127.39	221.66	282	63.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			252.4	C08		9	0098-0220	637.31	220.35	277	61.36	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.0	C08		9	0099-0221	78.75	221.20	239	62.18	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			201.6	C08		9	0100-0222	206.90	222.08	262	62.18	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			408.1	C08		9	0101-0227	722.82	226.89	261	63.36	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.6	C08		9	0102-0224	928.66	223.68	354	71.01	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			332.4	C08		9	0103-0227	522.97	227.72	319	67.36	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			357.8	C08		9	0104-0238	321.22	237.77	481	81.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			281.8	C08		9	0105-0231	741.47	231.83	261	62.87	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			330.7	C08		9	0106-0236	137.63	236.28	389	72.43	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.0	C08		9	0107-0237	777.38	237.02	324	69.01	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			227.6	C08		9	0108-0238	853.32	238.03	340	72.08	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.8	C08		9	0109-0238	916.87	238.35	294	65.70	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			365.9	C08		9	0110-0240	623.11	240.28	311	65.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			182.1	C08		9	0111-0243	71.18	243.47	298	66.77	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			311.7	C08		9	0112-0247	451.64	247.20	263	59.36	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.0	C08		9	0113-0247	227.38	246.53	271	60.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.4	C08		9	0114-0252	290.88	251.22	323	68.08	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			217.0	C08		9	0115-0251	178.20	251.43	263	58.53	0.965
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			606.5	C08		9	0116-0252	539.18	251.95	102	77.98	0.211
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			181.9	C08		9	0117-0259	21.87	259.08	306	69.01	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.7	C08		9	0118-0257	148.94	257.02	237	57.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			456.5	C08		9	0119-0257	338.39	257.67	235	56.53	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			398.6	C08		9	0120-0259	806.27	259.06	291	63.11	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.8	C08		9	0121-0263	711.79	263.00	343	70.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			301.5	C08		9	0122-0264	280.54	265.02	288	64.08	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			364.3	C08		9	0123-0260	430.89	259.94	241	60.53	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			318.2	C08		9	0124-0264	683.93	264.17	260	60.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			311.6	C08		9	0125-0264	875.82	264.11	313	68.18	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.3	C08		9	0126-0271	96.00	269.37	542	99.15	0.693
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			378.2	C08		9	0127-0266	851.68	266.28	250	60.18	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			320.1	C08		9	0128-0268	651.45	267.92	241	61.01	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			327.0	C08		9	0129-0269	616.96	268.57	313	66.77	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			222.2	C08		9	0130-0270	215.06	270.05	331	70.18	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.5	C08		9	0131-0275	124.19	275.22	276	64.18	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			442.6	C08		9	0132-0276	434.10	275.58	263	61.11	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			401.4	C08		9	0133-0277	320.08	277.26	241	59.36	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.7	C08		9	0134-0281	232.65	281.28	261	61.11	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.3	C08		9	0135-0284	345.92	284.36	258	59.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			188.1	C08		9	0136-0289	67.16	289.77	297	68.18	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			317.1	C08		9	0137-0288	931.47	288.01	293	65.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			353.5	C08		9	0138-0291	169.84	291.45	302	65.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			451.2	C08		9	0139-0293	132.68	292.15	267	64.53	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			307.3	C08		9	0140-0292	731.38	291.66	311	69.60	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			336.5	C08		9	0141-0299	107.70	299.35	444	81.84	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			294.0	C08		9	0142-0298	434.80	298.10	239	56.53	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			381.0	C08		9	0143-0303	239.39	302.15	539	92.91	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			211.6	C08		9	0144-0300	377.66	300.14	294	64.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			408.1	C08		9	0145-0302	549.83	302.46	337	66.77	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.8	C08		9	0146-0301	764.47	301.35	306	65.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.6	C08		9	0147-0309	392.37	309.45	358	77.36	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			364.1	C08		9	0148-0309	347.42	309.38	218	60.28	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.9	C08		9	0149-0310	896.98	310.50	288	62.18	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			393.8	C08		9	0150-0311	577.44	310.83	300	63.36	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			307.4	C08		9	0151-0312	216.08	312.50	255	60.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.4	C08		9	0152-0314	494.42	314.03	302	69.26	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			518.2	C08		9	0153-0316	284.47	316.16	255	61.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			402.9	C08		9	0154-0318	168.21	318.26	221	53.94	0.954
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			301.6	C08		9	0155-0317	772.86	317.30	215	55.11	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			422.0	C08		9	0156-0326	316.42	327.16	303	68.43	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.8	C08		9	0157-0329	100.11	329.05	280	63.01	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			311.8	C08		9	0158-0328	399.84	329.06	255	61.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			277.5	C08		9	0159-0331	473.65	331.97	309	69.94	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			264.2	C08		9	0160-0335	827.11	334.40	269	65.01	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			314.4	C08		9	0161-0334	653.21	334.08	294	63.94	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			481.8	C08		9	0162-0337	158.65	337.24	315	66.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			232.7	C08		9	0163-0339	906.65	338.05	301	66.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			47129.2	C08		9	0164-0341	280.12	341.05	159	46.87	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			290.5	C08		9	0165-0346	405.37	345.82	260	64.53	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.4	C08		9	0166-0346	501.49	346.23	253	57.94	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			452.6	C08		9	0167-0349	610.54	349.77	277	61.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			305.3	C08		9	0168-0351	141.79	350.62	239	59.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			371.1	C08		9	0169-0351	658.83	350.93	212	54.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			44596.4	C08		9	0170-0350	285.21	350.41	164	53.70	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			358.5	C08		9	0171-0356	820.54	356.82	457	79.50	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.3	C08		9	0172-0356	448.40	356.50	293	63.26	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			208.0	C08		9	0173-0355	476.70	354.62	261	60.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.4	C08		9	0174-0357	577.40	356.95	299	68.77	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			337.4	C08		9	0175-0358	238.80	359.38	238	58.18	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.2	C08		9	0176-0357	419.39	357.22	250	59.70	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.7	C08		9	0177-0361	555.88	361.12	311	71.01	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			317.6	C08		9	0178-0361	65.88	360.72	247	58.18	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			226.7	C08		9	0179-0361	19.97	360.70	264	61.11	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			320.0	C08		9	0180-0361	132.83	362.58	260	61.84	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			197.4	C08		9	0181-0364	345.75	364.55	320	67.84	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			474.0	C08		9	0182-0362	689.31	362.03	220	55.11	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			345.6	C08		9	0183-0365	192.24	365.31	356	69.60	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			337.9	C08		9	0184-0369	298.99	368.75	288	61.36	0.961
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			199.0	C08		9	0185-0376	361.42	376.48	319	71.11	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			333.1	C08		9	0186-0374	649.12	373.54	234	59.11	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			313.9	C08		9	0187-0380	597.95	380.23	274	64.18	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			291.1	C08		9	0188-0380	707.53	380.45	241	58.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			382.6	C08		9	0189-0381	678.68	381.16	240	57.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.3	C08		9	0190-0381	225.76	381.28	250	57.94	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			433.5	C08		9	0191-0383	756.09	383.91	241	59.94	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			355.0	C08		9	0192-0391	779.07	391.01	340	72.67	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.6	C08		9	0193-0390	799.10	391.04	245	59.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.0	C08		9	0194-0392	89.33	392.36	270	62.18	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.7	C08		9	0195-0391	43.24	392.06	257	60.53	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.1	C08		9	0196-0395	609.25	395.53	320	67.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			332.4	C08		9	0197-0393	699.56	393.71	208	55.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.3	C08		9	0198-0400	15.94	400.42	270	60.18	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			268.6	C08		9	0199-0400	309.65	400.91	265	59.36	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			232.0	C08		9	0200-0400	833.98	400.08	295	62.53	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			235.5	C08		9	0201-0407	902.30	406.64	274	62.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.8	C08		9	0202-0412	521.72	412.19	305	67.94	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			317.9	C08		9	0203-0408	697.46	408.03	236	57.11	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.9	C08		9	0204-0421	330.18	420.87	469	82.57	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.4	C08		9	0205-0416	730.08	415.55	217	55.36	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			224.5	C08		9	0206-0421	857.42	421.28	284	64.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			346.5	C08		9	0207-0424	657.84	423.98	250	59.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			277.4	C08		9	0208-0430	96.02	429.79	282	62.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			517.0	C08		9	0209-0430	53.43	430.31	184	59.36	0.656
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			306.8	C08		9	0210-0429	272.80	429.35	252	63.70	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			308.0	C08		9	0211-0436	937.67	435.69	355	72.18	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			399.8	C08		9	0212-0434	404.28	434.71	268	60.53	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			471.4	C08		9	0213-0434	221.85	434.00	235	56.53	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			784.4	C08		9	0214-0437	835.72	437.04	437	77.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			287.1	C08		9	0215-0433	741.32	433.53	271	64.28	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			259.2	C08		9	0216-0441	183.31	440.67	278	63.36	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			314.9	C08		9	0217-0445	118.89	445.84	253	59.94	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			301.0	C08		9	0218-0445	276.34	444.55	334	71.01	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			550.9	C08		9	0219-0446	568.93	446.43	359	69.60	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			302.1	C08		9	0220-0450	509.86	450.39	295	67.26	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			299.0	C08		9	0221-0451	20.54	450.78	221	57.11	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			290.6	C08		9	0222-0451	92.12	451.47	252	58.53	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			290.1	C08		9	0223-0455	199.91	454.64	259	58.87	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.7	C08		9	0224-0457	140.99	457.34	266	61.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			252.8	C08		9	0225-0458	292.70	459.22	301	65.50	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			311.4	C08		9	0226-0464	16.19	464.87	249	61.70	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			29524.5	C08		9	0227-0466	246.15	466.00	365	69.84	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			400.4	C08		9	0228-0465	774.80	465.10	224	57.11	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			407.8	C08		9	0229-0473	845.32	474.29	456	80.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.6	C08		9	0230-0473	943.11	472.67	290	64.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			342.0	C08		9	0231-0474	586.90	473.65	236	56.77	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			294.4	C08		9	0232-0477	117.41	476.98	231	56.53	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			281.1	C08		9	0233-0479	533.86	479.51	256	61.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			346.8	C08		9	0234-0477	780.99	477.30	204	56.87	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			405.7	C08		9	0235-0486	732.95	485.44	478	90.33	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			287.5	C08		9	0236-0484	35.89	484.22	231	57.36	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			323.8	C08		9	0237-0489	799.12	490.26	263	62.53	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			346.0	C08		9	0238-0492	865.20	491.40	373	74.08	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			370.5	C08		9	0239-0491	170.18	491.71	244	57.70	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			293.3	C08		9	0240-0494	360.13	494.65	280	61.11	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			362.9	C08		9	0241-0496	397.72	496.43	237	57.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			317.7	C08		9	0242-0497	709.02	498.02	186	53.36	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.3	C08		9	0243-0501	889.82	500.72	276	63.01	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			397.0	C08		9	0244-0501	745.35	500.87	258	59.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			279.8	C08		9	0245-0509	25.61	509.50	411	76.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			268.1	C08		9	0246-0506	187.12	506.63	263	64.18	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			355.0	C08		9	0247-0508	630.19	507.52	302	65.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			313.8	C08		9	0248-0509	793.51	508.92	295	66.53	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			356.8	C08		9	0249-0513	765.22	513.46	253	60.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			386.9	C08		9	0250-0515	427.69	515.11	257	60.53	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			273.6	C08		9	0251-0520	600.81	520.37	291	64.43	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.8	C08		9	0252-0521	190.24	520.79	236	61.94	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			225.2	C08		9	0253-0526	312.34	526.57	272	63.26	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			307.3	C08		9	0254-0523	382.37	523.68	259	60.87	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			264.2	C08		9	0255-0532	900.91	532.53	282	61.60	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.7	C08		9	0256-0534	743.07	534.31	283	63.60	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			387.0	C08		9	0257-0536	72.15	535.68	229	58.18	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			326.6	C08		9	0258-0536	345.34	536.25	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			341.5	C08		9	0259-0541	115.02	540.89	231	57.11	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			305.0	C08		9	0260-0541	388.16	540.96	250	62.04	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.1	C08		9	0261-0544	146.31	544.72	261	59.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			497.7	C08		9	0262-0550	208.62	549.77	372	71.01	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			322.8	C08		9	0263-0549	530.58	548.82	256	59.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.7	C08		9	0264-0552	65.45	553.53	305	69.74	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			390.5	C08		9	0265-0551	462.86	551.05	255	61.36	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			295.9	C08		9	0266-0558	187.19	558.95	291	65.11	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			343.4	C08		9	0267-0560	131.96	560.28	266	60.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			375.2	C08		9	0268-0560	300.81	559.95	236	57.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.8	C08		9	0269-0562	939.43	562.66	339	69.60	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.4	C08		9	0270-0563	49.26	563.13	288	64.18	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			284.3	C08		9	0271-0564	85.36	565.00	271	66.43	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			337.3	C08		9	0272-0566	339.62	565.46	310	65.36	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.4	C08		9	0273-0569	464.96	569.44	300	63.36	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.5	C08		9	0274-0575	736.81	575.78	288	64.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			214.3	C08		9	0275-0577	412.79	577.08	301	67.36	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			305.6	C08		9	0276-0584	694.25	583.79	271	64.53	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			224.5	C08		9	0277-0583	193.20	583.45	294	65.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			315.3	C08		9	0278-0588	385.14	587.73	347	73.36	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			228.2	C08		9	0279-0589	72.04	589.28	271	63.70	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.3	C08		9	0280-0593	212.91	593.17	300	64.53	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.2	C08		9	0281-0595	369.24	595.55	270	63.94	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.0	C08		9	0282-0597	146.27	597.00	301	64.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			285.7	C08		9	0283-0600	756.21	600.54	250	60.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			347.9	C08		9	0284-0609	524.75	609.24	263	60.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			215.8	C08		9	0285-0616	38.28	615.69	283	63.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.3	C08		9	0286-0619	933.03	619.84	281	62.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			313.0	C08		9	0287-0622	196.88	622.44	282	62.87	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.9	C08		9	0288-0623	881.73	623.66	287	62.77	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			301.8	C08		9	0289-0627	467.98	627.32	335	68.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.1	C08		9	0290-0632	89.86	632.14	284	64.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.5	C08		9	0291-0637	150.45	637.26	292	63.36	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			335.6	C08		9	0292-0649	202.97	648.00	683	104.33	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			284.8	C08		9	0293-0648	124.90	648.49	260	61.36	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			279.0	C08		9	0294-0651	511.67	651.43	319	67.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.4	C08		9	0295-0651	69.79	650.22	248	61.36	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			289.3	C08		9	0296-0650	744.16	649.99	267	60.53	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			327.6	C08		9	0297-0650	263.16	650.76	250	60.53	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			166.8	C08		9	0298-0659	19.67	658.90	268	63.60	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			199.5	C08		9	0299-0665	66.46	665.98	267	64.77	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			386.6	C08		9	0300-0668	184.98	667.40	248	60.77	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			322.7	C08		9	0301-0666	264.82	665.46	286	72.77	0.679
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			370.8	C08		9	0302-0671	207.75	671.46	339	71.94	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			315.8	C08		9	0303-0668	387.01	668.37	303	66.43	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			268.9	C08		9	0304-0669	475.83	669.81	291	64.77	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.6	C08		9	0305-0673	781.40	673.09	311	67.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			322.1	C08		9	0306-0675	172.35	675.41	223	57.70	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			205.8	C08		9	0307-0677	111.57	677.69	283	61.36	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.8	C08		9	0308-0683	936.29	683.92	458	86.43	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.5	C08		9	0309-0678	251.31	678.44	264	60.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.1	C08		9	0310-0684	140.58	684.18	241	63.11	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			13932.7	C08		9	0311-0690	321.34	691.53	581	89.74	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.2	C08		9	0312-0689	360.96	689.61	257	60.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			214.2	C08		9	0313-0693	31.45	693.71	260	61.70	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.0	C08		9	0314-0695	888.76	694.75	257	61.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			227.5	C08		9	0315-0695	57.33	695.07	272	64.18	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			368.4	C08		9	0316-0699	199.59	698.64	226	56.67	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.2	C08		9	0317-0702	750.25	702.11	297	63.60	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			171.6	C08		9	0318-0703	950.13	704.06	183	53.70	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			174.4	C08		9	0319-0704	937.61	703.39	120	41.56	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			306.3	C08		9	0320-0707	214.24	708.02	262	62.18	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.0	D08		1	0001-0031	502.05	32.10	433	78.91	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.6	D08		1	0002-0035	683.37	35.30	402	74.43	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			290.3	D08		1	0003-0039	168.05	39.26	489	82.67	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			334.7	D08		1	0004-0037	106.24	37.36	378	72.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			431.4	D08		1	0005-0049	326.88	48.58	751	107.30	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			439.6	D08		1	0006-0044	231.54	43.76	386	72.67	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			337.0	D08		1	0007-0053	916.42	53.65	703	101.50	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.2	D08		1	0008-0051	573.73	51.36	507	86.18	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			530.3	D08		1	0009-0051	450.99	50.66	464	82.91	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.1	D08		1	0010-0054	799.48	53.77	390	77.26	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			252.3	D08		1	0011-0059	633.85	59.36	412	77.50	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.5	D08		1	0012-0069	747.78	68.50	777	107.05	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			414.7	D08		1	0013-0069	470.40	69.42	494	89.26	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			338.9	D08		1	0014-0072	394.62	72.16	441	76.43	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.2	D08		1	0015-0074	600.83	74.82	443	84.08	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			290.6	D08		1	0016-0076	493.85	76.67	503	87.60	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.2	D08		1	0017-0075	232.83	75.37	381	73.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.3	D08		1	0018-0075	574.54	74.86	434	79.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			324.7	D08		1	0019-0079	724.21	79.27	424	78.08	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.3	D08		1	0020-0082	109.11	82.07	363	71.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			316.2	D08		1	0021-0086	26.13	85.99	531	87.50	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			357.5	D08		1	0022-0086	935.26	86.56	381	73.50	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			371.2	D08		1	0023-0096	306.50	96.09	417	79.36	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.4	D08		1	0024-0106	533.49	106.01	807	108.23	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.6	D08		1	0025-0101	285.13	101.97	407	79.01	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			252.7	D08		1	0026-0103	635.68	103.29	852	117.54	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			252.9	D08		1	0027-0105	186.52	104.86	373	75.26	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.4	D08		1	0028-0108	789.69	108.23	359	73.60	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			620.6	D08		1	0029-0112	834.07	111.51	371	73.01	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			298.6	D08		1	0030-0113	391.56	113.78	401	74.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			418.8	D08		1	0031-0115	699.70	115.21	399	75.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			318.6	D08		1	0032-0123	159.83	123.97	830	116.37	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			366.3	D08		1	0033-0117	446.57	117.74	434	79.50	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			257.9	D08		1	0034-0120	612.49	120.72	422	79.15	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.2	D08		1	0035-0121	926.26	121.01	392	72.18	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			295.4	D08		1	0036-0123	73.44	123.49	376	71.01	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.8	D08		1	0037-0126	735.15	126.18	452	81.26	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			532.5	D08		1	0038-0134	420.57	133.51	950	125.88	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			259.1	D08		1	0039-0128	783.39	127.59	449	85.26	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			25557.6	D08		1	0040-0144	506.95	143.84	677	95.50	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			342.5	D08		1	0041-0143	905.12	143.51	392	73.60	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.3	D08		1	0042-0142	824.88	142.30	383	75.26	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			323.7	D08		1	0043-0146	297.25	145.43	396	74.08	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			217.7	D08		1	0044-0158	642.35	158.75	393	74.67	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.1	D08		1	0045-0159	714.83	158.98	388	76.67	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			562.2	D08		1	0046-0164	277.35	164.21	729	105.05	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			449.0	D08		1	0047-0160	227.30	159.90	390	76.08	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			345.4	D08		1	0048-0166	117.67	165.95	373	72.67	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			234.2	D08		1	0049-0166	578.16	166.33	390	74.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			264.2	D08		1	0050-0180	678.45	180.31	399	78.33	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			311.8	D08		1	0051-0179	809.52	179.24	398	73.84	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			285.7	D08		1	0052-0180	338.38	179.91	418	81.01	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.3	D08		1	0053-0181	167.78	181.14	400	75.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			292.4	D08		1	0054-0182	444.35	182.31	382	73.84	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.3	D08		1	0055-0187	316.80	187.46	409	78.77	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.4	D08		1	0056-0187	207.94	187.03	397	77.50	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			313.7	D08		1	0057-0194	513.29	194.35	400	73.26	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			228.7	D08		1	0058-0197	940.92	197.02	399	76.43	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.1	D08		1	0059-0199	37.04	199.58	382	73.84	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.3	D08		1	0060-0209	253.78	208.26	925	123.78	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			252.7	D08		1	0061-0198	887.77	198.92	427	75.84	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			335.7	D08		1	0062-0199	798.35	199.86	390	73.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.2	D08		1	0063-0201	719.56	201.34	398	76.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			527.4	D08		1	0064-0206	71.18	205.95	602	90.91	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			268.8	D08		1	0065-0204	764.36	204.33	390	73.26	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			398.0	D08		1	0066-0207	562.41	208.31	379	75.94	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			204.5	D08		1	0067-0213	135.78	212.78	380	75.50	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.0	D08		1	0068-0221	927.57	220.99	385	72.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			560.9	D08		1	0069-0227	202.54	226.91	603	97.98	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.2	D08		1	0070-0224	615.97	224.41	409	76.67	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			277.5	D08		1	0071-0224	851.76	224.07	404	75.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			293.2	D08		1	0072-0232	271.35	234.30	725	103.78	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			284.3	D08		1	0073-0227	357.51	227.54	399	78.33	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.1	D08		1	0074-0229	482.77	228.83	357	74.18	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			380.5	D08		1	0075-0229	563.89	228.90	504	88.77	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			409.0	D08		1	0076-0238	890.09	239.12	727	104.13	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			319.8	D08		1	0077-0237	506.66	236.92	730	101.50	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			328.1	D08		1	0078-0240	540.09	240.67	552	94.91	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			454.2	D08		1	0079-0236	136.86	236.60	377	74.18	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			345.9	D08		1	0080-0242	58.13	242.18	440	77.84	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			210.2	D08		1	0081-0256	20.39	256.84	381	76.08	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.8	D08		1	0082-0258	459.44	258.25	392	73.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			252.0	D08		1	0083-0259	112.01	259.70	374	75.26	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			320.1	D08		1	0084-0271	746.54	271.87	414	75.60	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			434.5	D08		1	0085-0273	854.96	273.67	395	74.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			440.8	D08		1	0086-0279	180.41	278.30	384	73.01	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			301.9	D08		1	0087-0280	697.87	280.13	419	78.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.7	D08		1	0088-0281	315.70	280.31	405	76.67	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.6	D08		1	0089-0282	813.95	282.55	410	77.26	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			188.8	D08		1	0090-0287	936.07	287.70	382	73.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.9	D08		1	0091-0289	296.01	290.63	412	80.67	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.3	D08		1	0092-0294	641.46	293.41	420	77.26	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			562.9	D08		1	0093-0299	840.45	299.21	344	68.18	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			294.7	D08		1	0094-0300	899.82	300.36	385	72.43	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			327.8	D08		1	0095-0304	436.31	304.50	925	116.23	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			304.4	D08		1	0096-0303	219.20	302.97	382	71.60	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.8	D08		1	0097-0306	109.51	306.11	396	77.26	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			566.9	D08		1	0098-0310	175.48	310.67	613	96.81	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			296.3	D08		1	0099-0305	37.12	304.96	376	74.08	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			349.8	D08		1	0100-0309	549.31	309.07	383	71.60	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			295.7	D08		1	0101-0319	681.97	319.46	401	75.01	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.5	D08		1	0102-0319	393.65	319.13	386	73.84	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.6	D08		1	0103-0327	934.12	327.39	370	71.26	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.1	D08		1	0104-0333	774.77	333.03	392	73.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.4	D08		1	0105-0333	582.47	333.28	913	135.05	0.629
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			368.6	D08		1	0106-0336	729.96	335.83	392	73.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			208.7	D08		1	0107-0340	823.92	339.51	324	70.33	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			236.4	D08		1	0108-0344	144.33	344.39	395	74.08	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			218.3	D08		1	0109-0345	180.49	344.57	405	77.50	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.4	D08		1	0110-0347	37.82	347.41	374	73.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			311.5	D08		1	0111-0354	298.60	353.98	743	108.13	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.9	D08		1	0112-0351	352.83	351.52	398	74.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			330.0	D08		1	0113-0354	106.35	354.35	382	73.84	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			281.4	D08		1	0114-0357	622.14	357.04	652	97.98	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.9	D08		1	0115-0365	201.37	366.55	896	121.98	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			279.6	D08		1	0116-0370	707.79	370.13	433	79.50	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			306.9	D08		1	0117-0373	644.17	373.30	598	93.74	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			26643.5	D08		1	0118-0373	567.86	374.36	591	92.18	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.9	D08		1	0119-0382	920.26	382.67	916	122.23	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			299.8	D08		1	0120-0375	771.27	375.83	427	77.50	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			388.1	D08		1	0121-0381	879.09	380.59	377	71.84	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			333.9	D08		1	0122-0383	134.35	382.33	377	72.91	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.8	D08		1	0123-0388	404.24	388.60	396	75.26	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			308.1	D08		1	0124-0397	151.05	397.56	433	81.15	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			378.2	D08		1	0125-0400	578.04	398.64	909	124.47	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			325.8	D08		1	0126-0397	686.35	397.94	414	75.84	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			320.4	D08		1	0127-0402	757.16	401.49	427	78.67	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			225.9	D08		1	0128-0407	603.82	407.99	414	77.74	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.5	D08		1	0129-0416	320.94	415.48	832	111.64	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			317.9	D08		1	0130-0412	201.41	411.91	398	75.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			329.6	D08		1	0131-0412	876.19	412.31	396	74.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			230.3	D08		1	0132-0420	769.40	420.86	452	86.91	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			289.2	D08		1	0133-0428	492.31	428.55	399	75.84	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.0	D08		1	0134-0433	432.61	433.37	389	73.84	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.5	D08		1	0135-0433	655.07	433.40	396	74.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			219.3	D08		1	0136-0446	370.45	445.64	871	123.88	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.4	D08		1	0137-0443	99.12	443.74	373	70.43	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			343.6	D08		1	0138-0446	931.58	445.38	330	72.77	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.6	D08		1	0139-0446	464.85	446.15	392	73.26	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			304.6	D08		1	0140-0449	914.46	449.53	412	80.18	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			277.2	D08		1	0141-0450	293.65	450.79	391	75.50	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			310.9	D08		1	0142-0453	562.54	453.36	701	99.64	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.6	D08		1	0143-0449	715.45	448.99	390	76.08	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			346.2	D08		1	0144-0454	142.77	454.03	401	77.50	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			209.8	D08		1	0145-0455	946.44	455.06	407	78.08	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			292.5	D08		1	0146-0465	186.09	465.22	378	73.50	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.5	D08		1	0147-0473	48.87	472.73	757	108.81	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			206.9	D08		1	0148-0468	763.11	467.65	373	73.26	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			295.5	D08		1	0149-0479	695.70	479.85	998	122.81	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.9	D08		1	0150-0476	640.27	476.07	384	73.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.2	D08		1	0151-0480	336.26	480.21	402	76.77	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.6	D08		1	0152-0483	393.22	482.93	564	89.98	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.4	D08		1	0153-0480	849.69	480.79	391	74.77	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.8	D08		1	0154-0484	443.37	484.11	426	77.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			294.7	D08		1	0155-0484	213.28	483.94	379	71.60	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			286.1	D08		1	0156-0487	770.70	487.97	410	79.15	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.6	D08		1	0157-0490	533.71	490.14	403	78.08	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.6	D08		1	0158-0489	573.51	488.99	384	74.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			252.0	D08		1	0159-0488	313.19	488.37	428	79.60	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.0	D08		1	0160-0497	87.71	497.66	366	71.84	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			298.2	D08		1	0161-0499	866.23	499.79	410	78.08	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			279.0	D08		1	0162-0499	922.02	498.94	359	69.60	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			230.4	D08		1	0163-0506	45.32	507.06	382	78.91	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			304.7	D08		1	0164-0508	817.58	507.77	374	72.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.7	D08		1	0165-0509	17.93	509.60	362	72.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			350.5	D08		1	0166-0510	188.53	509.87	383	71.84	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.6	D08		1	0167-0512	606.62	511.74	393	76.08	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			315.9	D08		1	0168-0513	745.60	513.60	376	73.01	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			232.2	D08		1	0169-0513	487.28	512.82	395	76.08	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			192.4	D08		1	0170-0517	895.51	516.63	393	75.50	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			232.7	D08		1	0171-0521	326.02	521.07	373	71.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			310.5	D08		1	0172-0523	118.03	523.23	386	72.18	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			292.3	D08		1	0173-0525	289.17	524.87	410	76.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.1	D08		1	0174-0525	420.66	525.54	395	76.08	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.0	D08		1	0175-0528	648.78	528.16	396	74.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			307.6	D08		1	0176-0530	163.13	530.49	391	74.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			427.0	D08		1	0177-0530	771.34	530.25	390	73.01	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			268.0	D08		1	0178-0533	199.57	533.05	381	73.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			222.7	D08		1	0179-0540	385.59	540.73	417	78.91	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.1	D08		1	0180-0539	543.36	539.82	398	75.84	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.5	D08		1	0181-0547	897.72	547.42	433	85.40	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			232.6	D08		1	0182-0544	40.20	544.43	338	70.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			357.3	D08		1	0183-0548	473.27	547.35	620	101.40	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			492.6	D08		1	0184-0562	275.66	562.66	620	92.91	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			312.5	D08		1	0185-0571	557.83	571.47	817	113.78	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			252.0	D08		1	0186-0565	658.42	565.82	393	73.84	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			339.8	D08		1	0187-0570	94.36	570.37	340	68.18	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			289.5	D08		1	0188-0570	756.96	569.72	404	76.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.1	D08		1	0189-0573	890.54	574.05	415	78.43	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			375.1	D08		1	0190-0575	718.87	575.35	418	79.15	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			215.1	D08		1	0191-0584	443.06	584.72	994	128.02	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			281.1	D08		1	0192-0581	202.82	581.40	407	77.84	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			281.2	D08		1	0193-0584	360.11	584.44	373	73.26	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			327.0	D08		1	0194-0585	610.58	584.79	382	73.26	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.5	D08		1	0195-0583	861.48	583.27	393	78.33	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			283.2	D08		1	0196-0591	809.80	591.24	406	78.91	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			268.3	D08		1	0197-0602	194.05	601.73	235	60.77	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			223.6	D08		1	0198-0606	401.04	605.93	421	77.26	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			223.7	D08		1	0199-0607	249.23	606.40	392	78.67	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.7	D08		1	0200-0607	715.39	607.94	388	76.67	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			220.4	D08		1	0201-0609	886.12	609.68	379	75.84	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			358.5	D08		1	0202-0613	662.08	613.08	400	74.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			228.0	D08		1	0203-0613	81.87	613.13	432	82.81	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			311.2	D08		1	0204-0619	359.78	619.40	408	77.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.9	D08		1	0205-0623	500.22	622.62	416	77.50	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			233.5	D08		1	0206-0632	54.26	631.53	380	72.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			203.2	D08		1	0207-0634	156.18	634.61	438	77.84	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.8	D08		1	0208-0632	314.53	632.31	371	75.60	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.3	D08		1	0209-0635	337.73	634.71	468	90.18	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			210.2	D08		1	0210-0639	845.81	638.80	759	104.33	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			221.4	D08		1	0211-0637	182.83	636.98	452	85.40	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.7	D08		1	0212-0638	479.84	638.61	466	84.91	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.9	D08		1	0213-0643	360.80	643.00	528	91.84	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			308.0	D08		1	0214-0643	403.72	643.53	391	72.43	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.3	D08		1	0215-0644	797.68	644.62	380	74.43	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			384.9	D08		1	0216-0648	23.17	647.57	369	76.18	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			279.2	D08		1	0217-0653	447.13	653.51	845	118.02	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.5	D08		1	0218-0650	266.50	650.23	286	67.60	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.0	D08		1	0219-0650	606.93	650.53	444	79.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			290.1	D08		1	0220-0654	76.29	654.09	364	70.43	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			257.9	D08		1	0221-0657	213.13	657.27	388	76.08	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			223.0	D08		1	0222-0660	914.73	660.25	368	72.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			296.6	D08		1	0223-0665	714.94	664.98	405	77.01	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			220.7	D08		1	0224-0666	743.38	666.07	459	82.91	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			268.1	D08		1	0225-0666	648.30	666.58	374	70.43	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			521.5	D08		1	0226-0675	326.89	674.93	673	97.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			338.9	D08		1	0227-0680	772.33	679.99	356	70.43	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.3	D08		1	0228-0688	812.57	689.08	726	108.43	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			226.3	D08		1	0229-0686	489.12	685.84	367	75.74	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			207.5	D08		1	0230-0687	143.02	687.83	440	78.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			185.8	D08		1	0231-0690	871.85	690.33	358	72.43	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			222.9	D08		1	0232-0690	191.96	690.27	398	77.50	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.7	D08		1	0233-0696	352.59	695.18	460	83.50	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			233.5	D08		1	0234-0700	530.30	700.74	818	111.88	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			227.0	D08		1	0235-0700	579.33	700.33	362	73.50	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.5	D08		1	0236-0705	67.56	705.01	383	74.08	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			273.9	D08		3	0001-0032	610.87	32.70	388	77.15	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			218.4	D08		3	0002-0038	761.28	37.99	356	70.43	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			291.5	D08		3	0003-0042	860.23	42.15	366	72.18	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			201.0	D08		3	0004-0041	227.10	41.65	345	72.67	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			264.4	D08		3	0005-0043	410.65	43.52	431	78.67	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.6	D08		3	0006-0044	45.88	44.22	373	79.60	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			232.3	D08		3	0007-0047	258.54	47.53	359	75.98	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			348.3	D08		3	0008-0045	550.76	44.87	362	72.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			285.4	D08		3	0009-0049	839.59	49.01	381	77.50	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			331.2	D08		3	0010-0051	694.22	51.36	349	70.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			200.8	D08		3	0011-0053	23.37	52.47	350	73.01	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			204.8	D08		3	0012-0055	131.62	55.52	364	76.67	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			289.3	D08		3	0013-0058	54.92	58.96	377	80.43	0.732
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			273.2	D08		3	0014-0064	74.21	63.65	384	77.26	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			310.1	D08		3	0015-0063	927.38	63.53	352	71.26	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			308.8	D08		3	0016-0065	350.14	65.53	386	73.84	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			383.7	D08		3	0017-0069	250.38	69.79	363	77.26	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.6	D08		3	0018-0067	904.78	67.76	366	72.33	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			364.1	D08		3	0019-0072	180.20	72.28	368	75.74	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			479.6	D08		3	0020-0072	231.46	72.41	371	74.87	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.0	D08		3	0021-0073	787.16	73.24	361	74.08	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			23764.6	D08		3	0022-0080	733.46	80.24	325	113.64	0.316
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			201.1	D08		3	0023-0086	89.85	85.99	341	71.84	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			615.9	D08		3	0024-0091	165.10	92.46	712	105.40	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			294.2	D08		3	0025-0088	659.30	87.84	389	77.50	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			306.5	D08		3	0026-0087	685.00	87.49	373	74.33	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			876.7	D08		3	0027-0089	473.46	89.44	376	74.91	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			401.6	D08		3	0028-0091	502.43	91.20	384	76.91	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			289.4	D08		3	0029-0090	753.67	90.95	380	74.08	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			365.7	D08		3	0030-0093	429.24	93.02	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			383.8	D08		3	0031-0093	230.83	92.37	369	72.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			295.4	D08		3	0032-0097	546.64	97.18	360	72.67	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.2	D08		3	0033-0098	833.39	98.43	356	70.18	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.6	D08		3	0034-0105	125.31	106.25	731	109.54	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			359.7	D08		3	0035-0102	376.54	102.10	373	73.84	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			490.8	D08		3	0036-0106	904.74	106.07	302	66.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			327.1	D08		3	0037-0110	488.71	110.65	412	86.57	0.691
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			287.8	D08		3	0038-0113	641.59	113.02	367	75.84	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			301.0	D08		3	0039-0114	312.85	115.19	368	72.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			236.0	D08		3	0040-0116	69.56	116.39	359	76.33	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			257.4	D08		3	0041-0123	31.77	123.36	329	69.01	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			600.6	D08		3	0042-0121	723.76	121.05	350	73.84	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			372.6	D08		3	0043-0132	913.74	132.69	582	92.81	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.8	D08		3	0044-0129	456.50	128.80	387	75.50	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			292.7	D08		3	0045-0131	273.44	130.78	321	67.94	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			326.1	D08		3	0046-0132	293.91	132.21	440	84.67	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.0	D08		3	0047-0136	627.21	136.50	365	74.33	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			287.2	D08		3	0048-0138	384.28	138.48	386	75.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			252.8	D08		3	0049-0139	491.76	139.37	370	75.26	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.6	D08		3	0050-0142	83.52	141.45	354	71.01	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			324.6	D08		3	0051-0142	173.87	142.35	347	72.08	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.9	D08		3	0052-0141	810.52	140.67	331	69.84	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			416.3	D08		3	0053-0148	544.92	147.95	411	76.91	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			467.9	D08		3	0054-0150	859.07	149.48	299	66.18	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			290.5	D08		3	0055-0153	243.01	153.61	398	76.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.3	D08		3	0056-0154	761.70	154.94	330	68.28	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			307.2	D08		3	0057-0158	219.30	157.52	385	77.50	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			341.8	D08		3	0058-0163	139.16	162.74	404	77.26	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.9	D08		3	0059-0165	43.97	164.94	345	69.84	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			295.9	D08		3	0060-0169	414.27	168.40	409	78.91	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			323.1	D08		3	0061-0166	592.25	165.95	388	77.50	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			298.5	D08		3	0062-0171	912.62	171.55	375	73.50	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			299.0	D08		3	0063-0179	646.07	177.21	720	110.61	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			351.2	D08		3	0064-0173	850.67	172.97	350	69.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.7	D08		3	0065-0181	434.16	179.91	762	118.51	0.682
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			317.5	D08		3	0066-0175	759.81	175.04	560	90.18	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.2	D08		3	0067-0178	879.52	178.93	356	73.01	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.8	D08		3	0068-0178	341.98	177.70	347	70.43	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.0	D08		3	0069-0196	97.38	195.27	747	118.95	0.663
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			303.0	D08		3	0070-0195	488.00	194.77	353	72.67	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			532.5	D08		3	0071-0195	523.35	194.58	307	65.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.4	D08		3	0072-0197	687.05	197.04	347	73.26	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			283.3	D08		3	0073-0198	557.78	198.27	394	76.18	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			234.4	D08		3	0074-0202	742.04	202.12	370	73.26	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.8	D08		3	0075-0205	147.56	205.28	333	70.43	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			284.2	D08		3	0076-0206	387.38	207.07	366	76.33	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			226.3	D08		3	0077-0207	296.40	206.55	341	72.91	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			222.0	D08		3	0078-0210	650.95	210.77	392	76.43	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			235.6	D08		3	0079-0213	252.24	212.90	344	70.67	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.4	D08		3	0080-0212	787.19	212.30	356	70.18	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			171.9	D08		3	0081-0215	82.89	215.35	335	72.43	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.8	D08		3	0082-0215	903.13	215.44	324	71.26	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.5	D08		3	0083-0214	361.40	214.09	349	74.57	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			294.9	D08		3	0084-0220	196.70	219.96	359	72.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.0	D08		3	0085-0221	607.95	221.25	364	73.36	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			412.3	D08		3	0086-0224	414.68	224.53	323	67.01	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			309.6	D08		3	0087-0234	477.37	234.22	752	114.95	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.7	D08		3	0088-0233	941.28	233.09	368	71.01	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.7	D08		3	0089-0234	649.87	234.42	381	79.50	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			222.2	D08		3	0090-0235	41.27	235.00	329	71.74	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			359.3	D08		3	0091-0238	109.05	238.19	359	74.91	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			205.6	D08		3	0092-0244	607.29	243.39	370	77.36	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			213.4	D08		3	0093-0246	299.57	245.76	362	86.81	0.604
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.2	D08		3	0094-0245	164.28	245.60	361	72.43	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.5	D08		3	0095-0246	673.03	245.73	328	69.70	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.7	D08		3	0096-0247	762.15	246.68	347	68.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.3	D08		3	0097-0248	868.88	248.01	373	73.26	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			286.7	D08		3	0098-0249	373.11	248.75	358	76.33	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.7	D08		3	0099-0249	552.28	249.29	371	75.74	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			305.9	D08		3	0100-0251	693.24	251.37	374	76.18	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.0	D08		3	0101-0252	811.85	252.49	441	81.84	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			304.8	D08		3	0102-0258	249.65	258.22	341	71.84	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			313.1	D08		3	0103-0259	944.24	258.82	301	67.60	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			449.8	D08		3	0104-0265	587.53	265.22	377	73.26	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.2	D08		3	0105-0267	341.59	266.56	373	74.67	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			286.4	D08		3	0106-0268	312.72	268.76	348	77.50	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			222.6	D08		3	0107-0267	24.76	267.70	326	69.84	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.2	D08		3	0108-0283	649.13	284.09	965	130.61	0.711
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			213.9	D08		3	0109-0273	627.87	274.18	281	66.28	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			252.0	D08		3	0110-0277	156.82	276.89	359	72.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			355.1	D08		3	0111-0276	609.90	276.26	304	65.11	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.4	D08		3	0112-0282	79.15	282.69	371	75.50	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			636.4	D08		3	0113-0280	897.30	280.57	260	86.23	0.439
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			273.6	D08		3	0114-0281	410.64	281.07	378	75.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			356.6	D08		3	0115-0283	207.48	282.75	296	63.60	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			299.9	D08		3	0116-0280	688.08	279.99	198	53.60	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			350.9	D08		3	0117-0285	118.58	285.09	470	87.50	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			221.8	D08		3	0118-0288	850.70	288.52	361	72.08	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			505.6	D08		3	0119-0290	251.86	290.01	326	69.26	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			324.1	D08		3	0120-0295	573.61	295.23	352	70.67	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			409.9	D08		3	0121-0308	528.74	309.81	752	114.71	0.718
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			264.1	D08		3	0122-0303	354.73	302.37	387	81.74	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			225.7	D08		3	0123-0314	395.21	313.95	362	76.57	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.0	D08		3	0124-0313	466.54	313.88	394	77.50	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.2	D08		3	0125-0313	915.48	313.75	355	73.84	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			212.7	D08		3	0126-0316	28.55	315.24	376	77.98	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			495.0	D08		3	0127-0317	283.02	317.11	315	65.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			185.8	D08		3	0128-0319	102.04	319.05	333	71.01	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.6	D08		3	0129-0328	423.72	328.52	377	75.50	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			234.0	D08		3	0130-0330	854.33	329.72	363	74.91	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			323.9	D08		3	0131-0330	592.86	329.42	402	81.84	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.6	D08		3	0132-0332	142.97	332.76	382	76.08	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			286.4	D08		3	0133-0336	321.90	335.75	386	81.98	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			318.7	D08		3	0134-0338	833.06	338.06	514	88.67	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.9	D08		3	0135-0338	236.53	338.87	364	74.91	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			226.2	D08		3	0136-0339	675.27	339.86	348	71.84	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.0	D08		3	0137-0341	539.42	341.78	376	73.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.4	D08		3	0138-0342	45.16	342.09	343	72.67	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.4	D08		3	0139-0341	360.98	341.59	365	71.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.6	D08		3	0140-0342	741.96	343.01	367	72.43	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.4	D08		3	0141-0343	814.07	343.20	311	71.01	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.0	D08		3	0142-0352	180.69	352.91	376	80.91	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.4	D08		3	0143-0351	911.96	351.27	378	74.91	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.4	D08		3	0144-0354	313.52	354.52	377	78.33	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			192.3	D08		3	0145-0355	79.89	355.22	324	72.57	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.9	D08		3	0146-0364	113.88	364.88	334	72.91	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			230.2	D08		3	0147-0368	472.96	368.59	712	106.57	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			227.1	D08		3	0148-0373	521.62	372.76	374	76.33	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.0	D08		3	0149-0376	665.34	376.52	366	74.91	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.8	D08		3	0150-0376	394.46	376.46	359	71.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.3	D08		3	0151-0374	711.16	374.31	395	76.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			178.0	D08		3	0152-0378	147.07	378.11	334	78.57	0.680
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			212.5	D08		3	0153-0378	329.62	377.69	360	78.33	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			211.5	D08		3	0154-0382	866.90	381.25	375	76.91	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.4	D08		3	0155-0381	32.21	381.87	321	68.43	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.0	D08		3	0156-0381	919.31	381.04	350	70.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			355.1	D08		3	0157-0384	258.75	383.93	340	71.26	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			224.6	D08		3	0158-0388	195.57	388.17	350	74.33	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			556.7	D08		3	0159-0387	732.51	386.63	311	66.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			314.4	D08		3	0160-0389	547.02	389.11	374	74.91	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.2	D08		3	0161-0395	231.76	395.64	345	74.91	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.0	D08		3	0162-0395	819.43	395.72	362	71.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			310.9	D08		3	0163-0396	119.41	396.33	326	69.26	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			421.5	D08		3	0164-0398	477.43	398.21	310	64.77	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.9	D08		3	0165-0399	751.44	398.79	398	77.74	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			310.2	D08		3	0166-0402	304.30	401.92	380	73.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			225.2	D08		3	0167-0410	371.75	410.15	720	105.88	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			252.6	D08		3	0168-0403	438.20	403.57	370	74.08	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.0	D08		3	0169-0421	593.76	420.87	363	78.91	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			259.8	D08		3	0170-0421	718.80	421.57	380	77.15	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			232.3	D08		3	0171-0423	774.90	423.59	361	75.84	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.3	D08		3	0172-0428	33.62	428.69	325	72.91	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			207.2	D08		3	0173-0431	269.61	431.74	353	76.91	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.5	D08		3	0174-0431	528.13	432.17	372	77.94	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			334.1	D08		3	0175-0436	693.67	436.44	627	99.64	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			270.4	D08		3	0176-0447	421.89	446.54	748	106.95	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			234.9	D08		3	0177-0440	641.30	440.64	368	74.57	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			284.2	D08		3	0178-0446	162.63	445.35	712	105.88	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			26355.7	D08		3	0179-0443	218.47	442.01	246	66.18	0.706
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			16339.0	D08		3	0180-0444	231.04	446.37	219	63.70	0.678
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.2	D08		3	0181-0448	196.51	448.67	338	72.43	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.8	D08		3	0182-0447	315.10	447.79	367	74.91	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.1	D08		3	0183-0452	248.41	451.51	349	71.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.1	D08		3	0184-0455	527.89	453.68	409	81.84	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			205.8	D08		3	0185-0461	105.25	461.70	375	81.15	0.716
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			215.3	D08		3	0186-0463	71.14	463.23	353	73.26	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			218.5	D08		3	0187-0465	761.22	465.32	369	71.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.2	D08		3	0188-0473	624.44	473.31	375	72.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			206.4	D08		3	0189-0476	471.95	476.54	334	72.91	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			236.6	D08		3	0190-0475	851.66	474.90	353	71.01	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			181.5	D08		3	0191-0476	125.82	475.90	352	77.98	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			218.0	D08		3	0192-0482	929.08	482.82	380	78.33	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.2	D08		3	0193-0481	238.90	481.00	375	78.57	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.3	D08		3	0194-0484	565.52	484.47	368	73.26	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.2	D08		3	0195-0488	798.10	488.09	378	76.43	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			320.0	D08		3	0196-0490	720.05	490.02	371	72.67	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.2	D08		3	0197-0495	687.56	495.55	364	71.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			228.6	D08		3	0198-0502	601.36	502.21	361	73.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.5	D08		3	0199-0504	491.17	503.98	359	76.08	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.5	D08		3	0200-0507	230.55	507.90	370	78.33	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			306.0	D08		3	0201-0504	441.48	503.77	353	71.26	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			270.3	D08		3	0202-0506	356.38	506.34	353	72.43	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			234.7	D08		3	0203-0506	76.00	505.92	340	70.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.1	D08		3	0204-0510	806.46	509.69	392	81.40	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.2	D08		3	0205-0523	274.92	522.77	728	119.78	0.638
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			373.3	D08		3	0206-0520	851.06	520.43	723	112.13	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.6	D08		3	0207-0523	183.08	523.49	582	96.81	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.2	D08		3	0208-0520	757.32	519.80	372	73.60	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.2	D08		3	0209-0522	314.99	522.71	377	72.67	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.7	D08		3	0210-0522	481.03	522.56	359	72.67	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			294.7	D08		3	0211-0527	637.44	527.40	373	76.33	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			329.3	D08		3	0212-0525	673.36	524.83	333	68.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			285.5	D08		3	0213-0538	359.97	537.89	341	72.91	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.1	D08		3	0214-0537	580.54	536.99	352	72.67	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			194.6	D08		3	0215-0541	941.09	541.53	352	74.57	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			197.7	D08		3	0216-0542	537.15	541.76	363	72.67	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			204.2	D08		3	0217-0557	213.58	557.20	748	119.92	0.654
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			210.8	D08		3	0218-0553	484.31	553.43	396	77.26	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			216.5	D08		3	0219-0554	506.06	554.20	357	72.53	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			305.7	D08		3	0220-0556	736.72	556.00	352	72.91	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			283.5	D08		3	0221-0560	682.76	559.13	385	76.67	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			177.0	D08		3	0222-0561	74.33	561.65	327	68.67	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			232.3	D08		3	0223-0565	910.29	565.48	745	106.57	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			554.8	D08		3	0224-0565	782.87	565.60	625	96.57	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			222.8	D08		3	0225-0567	301.69	568.06	352	79.74	0.696
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.3	D08		3	0226-0569	343.30	569.80	330	68.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			384.9	D08		3	0227-0571	427.05	571.92	349	71.84	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			235.5	D08		3	0228-0587	52.37	586.47	695	104.57	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			283.0	D08		3	0229-0589	257.48	589.00	357	73.60	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			221.6	D08		3	0230-0588	216.44	588.13	373	76.08	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			281.6	D08		3	0231-0588	675.96	588.21	372	74.08	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.3	D08		3	0232-0589	132.62	588.97	371	74.91	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			548.1	D08		3	0233-0596	504.56	596.61	816	112.13	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			321.1	D08		3	0234-0590	747.04	590.11	349	71.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			330.9	D08		3	0235-0598	541.23	597.72	647	103.40	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.2	D08		3	0236-0596	632.60	596.40	377	78.57	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			232.7	D08		3	0237-0603	585.14	603.71	378	75.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			710.8	D08		3	0238-0600	373.07	600.30	254	59.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			302.7	D08		3	0239-0603	923.84	602.96	310	66.43	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.2	D08		3	0240-0604	114.56	604.19	360	79.15	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			390.0	D08		3	0241-0621	767.20	622.36	953	139.78	0.613
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.3	D08		3	0242-0608	873.87	607.69	343	75.15	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			228.9	D08		3	0243-0619	887.26	619.02	411	81.15	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			221.9	D08		3	0244-0617	824.32	617.02	347	70.67	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			257.2	D08		3	0245-0621	358.11	621.50	605	95.40	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.4	D08		3	0246-0620	736.77	620.01	369	81.98	0.690
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			631.2	D08		3	0247-0619	389.04	619.47	348	72.08	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			442.7	D08		3	0248-0626	210.28	626.97	308	71.36	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			228.6	D08		3	0249-0631	692.35	631.02	357	79.98	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			659.1	D08		3	0250-0632	846.96	632.32	249	57.36	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.8	D08		3	0251-0636	620.94	636.44	368	73.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			287.6	D08		3	0252-0638	328.05	638.02	417	85.15	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.3	D08		3	0253-0642	35.07	642.13	314	71.01	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.3	D08		3	0254-0643	168.48	643.62	337	71.50	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			318.3	D08		3	0255-0645	212.27	643.20	363	77.60	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.9	D08		3	0256-0650	129.25	650.17	437	81.74	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			621.1	D08		3	0257-0649	798.87	649.68	206	73.50	0.479
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			321.2	D08		3	0258-0654	92.12	653.99	352	70.67	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			252.0	D08		3	0259-0653	558.56	653.05	375	73.84	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			281.4	D08		3	0260-0653	675.92	653.29	342	73.84	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			287.3	D08		3	0261-0659	342.21	659.10	369	83.98	0.657
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			365.9	D08		3	0262-0660	203.39	661.36	396	79.98	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			207.3	D08		3	0263-0663	904.83	662.51	330	69.26	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			222.4	D08		3	0264-0667	947.34	667.52	341	73.84	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			311.2	D08		3	0265-0669	683.59	669.86	372	78.43	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.0	D08		3	0266-0674	610.07	674.02	369	74.91	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			363.5	D08		3	0267-0672	488.26	672.92	362	72.67	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			469.0	D08		3	0268-0675	720.71	675.02	357	74.67	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			302.3	D08		3	0269-0685	89.67	685.35	313	65.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.4	D08		3	0270-0684	138.76	684.98	315	66.43	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.5	D08		3	0271-0688	179.16	688.67	338	71.50	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.4	D08		3	0272-0690	896.32	690.52	318	72.33	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			291.1	D08		3	0273-0700	25.13	699.98	615	97.40	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			201.2	D08		3	0274-0697	699.75	697.18	375	76.08	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			527.4	D08		3	0275-0693	363.48	693.79	196	72.77	0.465
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			205.1	D08		3	0276-0707	831.30	707.12	348	71.70	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			323.2	D08		4	0001-0039	733.93	39.86	628	95.74	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			295.5	D08		4	0002-0049	816.27	48.21	984	128.23	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			314.0	D08		4	0003-0047	340.50	45.67	547	92.47	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.6	D08		4	0004-0045	603.98	44.77	467	82.91	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			283.0	D08		4	0005-0048	902.79	48.58	451	79.50	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			325.0	D08		4	0006-0049	366.86	49.04	475	82.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			273.1	D08		4	0007-0053	759.08	52.52	483	88.67	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			322.3	D08		4	0008-0055	249.77	55.49	442	78.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.1	D08		4	0009-0056	945.82	56.49	406	75.26	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.7	D08		4	0010-0056	99.02	56.17	435	83.50	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.5	D08		4	0011-0061	322.34	62.53	456	81.98	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			330.0	D08		4	0012-0064	75.47	64.64	501	87.94	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			308.8	D08		4	0013-0066	620.14	67.05	499	85.98	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.9	D08		4	0014-0071	446.82	70.23	938	125.44	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.4	D08		4	0015-0073	669.51	73.09	432	76.43	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.2	D08		4	0016-0077	835.66	77.03	516	88.71	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.8	D08		4	0017-0077	744.64	78.29	438	80.43	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.7	D08		4	0018-0080	545.97	80.59	922	121.30	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			235.8	D08		4	0019-0086	80.39	85.76	433	82.08	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			326.1	D08		4	0020-0090	179.51	90.53	727	103.64	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			226.0	D08		4	0021-0096	849.52	96.88	428	81.15	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			298.6	D08		4	0022-0097	118.83	97.58	763	103.40	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			230.6	D08		4	0023-0100	519.10	99.71	481	85.74	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.5	D08		4	0024-0100	348.91	100.90	383	75.50	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			207.3	D08		4	0025-0102	889.05	102.48	431	77.26	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			235.0	D08		4	0026-0105	706.22	105.50	424	76.67	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.6	D08		4	0027-0114	78.30	115.10	429	85.26	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			298.1	D08		4	0028-0113	624.49	113.53	484	84.33	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.0	D08		4	0029-0115	801.67	114.62	416	77.50	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			328.0	D08		4	0030-0116	387.80	116.12	561	90.08	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.5	D08		4	0031-0123	266.03	123.08	434	78.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.0	D08		4	0032-0124	770.35	123.97	438	80.91	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.8	D08		4	0033-0124	676.92	124.50	422	76.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			283.3	D08		4	0034-0142	319.72	142.15	433	79.74	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.6	D08		4	0035-0148	217.28	148.11	423	76.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.6	D08		4	0036-0153	718.54	153.51	431	82.77	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			216.3	D08		4	0037-0159	843.33	158.44	853	112.71	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.5	D08		4	0038-0158	145.77	159.32	864	116.23	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			295.9	D08		4	0039-0168	270.56	168.62	924	119.88	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			313.8	D08		4	0040-0168	358.99	168.27	488	84.33	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.5	D08		4	0041-0166	664.94	166.66	434	79.50	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			313.5	D08		4	0042-0172	406.55	172.28	479	82.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.8	D08		4	0043-0173	716.05	172.21	435	79.11	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			373.7	D08		4	0044-0175	24.26	175.99	395	75.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.7	D08		4	0045-0180	572.58	180.40	513	88.91	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.8	D08		4	0046-0181	609.93	180.72	439	78.08	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.3	D08		4	0047-0184	543.08	183.36	499	87.40	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.4	D08		4	0048-0185	883.86	185.73	451	79.26	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			226.2	D08		4	0049-0195	792.79	195.10	446	78.91	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			400.6	D08		4	0050-0195	215.19	194.82	391	71.60	0.958
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			444.8	D08		4	0051-0196	183.93	196.02	391	72.18	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			540.9	D08		4	0052-0198	266.48	198.05	625	94.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			186.3	D08		4	0053-0197	858.04	196.41	430	79.50	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.0	D08		4	0054-0201	452.45	201.56	438	79.50	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			235.1	D08		4	0055-0201	145.36	200.44	437	79.26	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			202.1	D08		4	0056-0202	916.56	202.45	431	77.26	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			202.8	D08		4	0057-0213	537.22	213.14	511	91.40	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			203.7	D08		4	0058-0212	735.76	212.22	435	81.50	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			331.7	D08		4	0059-0225	336.76	224.68	832	114.81	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			308.8	D08		4	0060-0227	206.08	226.23	399	79.15	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.7	D08		4	0061-0226	418.21	226.03	428	79.50	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			346.9	D08		4	0062-0227	890.19	227.21	818	116.67	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.2	D08		4	0063-0245	648.73	245.57	889	123.05	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.6	D08		4	0064-0239	554.99	239.38	488	86.33	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.1	D08		4	0065-0248	196.20	249.17	476	90.81	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			235.8	D08		4	0066-0249	602.93	249.45	434	78.33	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			195.7	D08		4	0067-0255	723.00	255.13	440	78.67	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.0	D08		4	0068-0258	391.21	258.14	441	77.26	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			206.4	D08		4	0069-0263	692.44	264.22	439	79.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			289.0	D08		4	0070-0268	225.86	267.89	430	78.91	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			234.4	D08		4	0071-0267	259.01	267.57	426	79.50	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			273.1	D08		4	0072-0273	54.20	273.66	414	80.33	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			329.2	D08		4	0073-0275	426.18	274.91	483	83.50	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.2	D08		4	0074-0282	565.08	282.42	965	129.78	0.720
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			214.4	D08		4	0075-0274	917.38	275.01	446	79.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.6	D08		4	0076-0276	842.17	276.79	446	82.91	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			220.6	D08		4	0077-0286	325.72	285.68	477	84.91	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			212.6	D08		4	0078-0291	690.26	290.59	484	87.01	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			459.9	D08		4	0079-0289	163.66	288.76	423	75.26	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			372.5	D08		4	0080-0295	69.01	296.21	555	93.01	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			222.8	D08		4	0081-0298	631.28	298.98	823	111.30	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			406.3	D08		4	0082-0297	92.75	297.45	410	76.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			232.4	D08		4	0083-0298	486.50	297.74	444	79.50	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			191.9	D08		4	0084-0296	730.71	296.02	421	77.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			290.6	D08		4	0085-0309	336.67	309.13	741	102.91	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			213.7	D08		4	0086-0310	792.80	310.62	440	79.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			203.3	D08		4	0087-0314	583.95	314.44	503	91.84	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			197.7	D08		4	0088-0319	915.92	319.07	927	119.20	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.3	D08		4	0089-0323	526.57	322.61	442	78.08	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			213.2	D08		4	0090-0329	369.87	328.39	447	80.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			210.9	D08		4	0091-0333	741.86	333.44	431	77.26	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			202.7	D08		4	0092-0335	405.26	335.05	449	79.50	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.5	D08		4	0093-0338	442.23	337.84	665	97.64	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			328.4	D08		4	0094-0339	696.49	338.86	459	81.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			215.4	D08		4	0095-0341	573.65	341.09	457	84.91	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.3	D08		4	0096-0341	279.50	340.56	475	82.91	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.3	D08		4	0097-0345	217.15	344.72	442	78.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			257.7	D08		4	0098-0350	353.90	350.58	483	87.74	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			185.4	D08		4	0099-0350	829.44	351.06	433	78.33	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			217.9	D08		4	0100-0357	882.34	358.36	885	117.54	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.8	D08		4	0101-0353	512.95	353.82	454	80.08	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.1	D08		4	0102-0357	263.78	357.96	479	86.23	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.7	D08		4	0103-0361	645.71	361.63	519	88.67	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			224.3	D08		4	0104-0364	616.45	364.48	490	86.57	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.6	D08		4	0105-0365	788.10	365.64	480	81.84	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			207.1	D08		4	0106-0369	420.08	369.56	434	79.26	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			224.5	D08		4	0107-0378	935.44	378.34	450	80.67	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			150.3	D08		4	0108-0378	149.62	378.56	429	75.84	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			208.9	D08		4	0109-0384	640.88	384.35	489	87.60	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.7	D08		4	0110-0384	307.53	384.07	449	79.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			227.6	D08		4	0111-0390	83.47	390.26	414	78.33	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			327.7	D08		4	0112-0398	358.78	397.74	826	108.47	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			183.5	D08		4	0113-0398	798.87	397.96	445	84.33	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			358.4	D08		4	0114-0402	595.24	401.63	512	86.23	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.2	D08		4	0115-0405	654.01	406.06	567	92.57	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			374.2	D08		4	0116-0405	260.98	405.31	536	88.57	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			232.5	D08		4	0117-0411	535.96	411.71	918	120.23	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.8	D08		4	0118-0415	484.12	415.53	806	109.74	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			292.3	D08		4	0119-0415	210.19	414.84	911	116.23	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.2	D08		4	0120-0419	869.62	418.01	472	82.08	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			192.5	D08		4	0121-0420	459.39	420.85	457	85.01	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.5	D08		4	0122-0423	568.03	423.12	489	85.01	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			285.9	D08		4	0123-0427	783.26	427.75	947	124.47	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			270.1	D08		4	0124-0426	125.16	426.22	419	76.91	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			340.7	D08		4	0125-0431	755.86	431.24	422	80.77	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.3	D08		4	0126-0432	385.87	432.72	436	78.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			264.8	D08		4	0127-0435	285.51	435.86	415	75.01	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			190.7	D08		4	0128-0441	66.09	440.53	406	76.43	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.5	D08		4	0129-0448	28.71	448.46	574	88.67	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			227.8	D08		4	0130-0449	849.09	449.39	468	81.26	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			226.0	D08		4	0131-0449	896.40	449.15	435	81.15	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.2	D08		4	0132-0455	176.90	455.44	435	78.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			221.7	D08		4	0133-0461	630.96	461.45	461	83.74	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			402.9	D08		4	0134-0465	564.54	465.61	437	78.08	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.2	D08		4	0135-0465	763.23	465.37	464	82.43	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.8	D08		4	0136-0472	232.27	472.22	487	86.57	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			309.9	D08		4	0137-0470	509.73	470.31	422	79.36	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			273.3	D08		4	0138-0469	699.93	469.21	469	81.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			310.0	D08		4	0139-0472	734.89	472.71	504	85.15	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			392.2	D08		4	0140-0473	528.11	473.56	367	75.94	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			212.9	D08		4	0141-0478	96.54	477.90	456	84.08	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.2	D08		4	0142-0476	414.40	476.81	439	79.50	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			349.6	D08		4	0143-0484	252.34	484.70	460	84.57	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			234.9	D08		4	0144-0488	937.61	487.58	406	76.08	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			206.8	D08		4	0145-0487	820.13	486.87	287	65.84	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			312.8	D08		4	0146-0491	902.85	490.85	434	78.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			214.6	D08		4	0147-0493	703.55	492.97	483	86.43	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.2	D08		4	0148-0496	143.65	496.51	421	78.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			284.4	D08		4	0149-0501	304.77	501.57	431	77.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.0	D08		4	0150-0506	60.78	505.86	443	79.26	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.1	D08		4	0151-0510	915.79	510.77	476	84.33	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			227.3	D08		4	0152-0512	522.77	512.19	463	82.57	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			226.9	D08		4	0153-0518	459.30	518.98	448	80.08	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.7	D08		4	0154-0525	620.07	525.23	571	92.33	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			295.2	D08		4	0155-0527	836.57	527.33	282	64.18	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			345.6	D08		4	0156-0529	360.05	529.94	429	79.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			408.0	D08		4	0157-0536	213.40	535.85	972	125.30	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			222.4	D08		4	0158-0534	407.41	533.57	504	85.74	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.9	D08		4	0159-0535	579.10	535.16	529	91.40	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			319.4	D08		4	0160-0534	23.69	534.42	407	75.26	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			264.7	D08		4	0161-0535	718.74	534.88	466	81.26	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			347.8	D08		4	0162-0550	73.80	550.34	433	80.08	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			310.0	D08		4	0163-0551	781.30	551.45	459	79.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			439.4	D08		4	0164-0552	361.37	551.17	526	89.60	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			308.1	D08		4	0165-0554	444.12	555.08	426	78.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			221.1	D08		4	0166-0560	496.05	559.90	449	79.26	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			273.0	D08		4	0167-0561	717.51	561.75	514	86.33	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.2	D08		4	0168-0562	409.60	562.68	472	82.33	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			236.1	D08		4	0169-0567	933.70	566.31	553	96.13	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			225.0	D08		4	0170-0565	628.41	565.59	465	80.67	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			227.3	D08		4	0171-0568	32.00	567.88	411	75.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			310.7	D08		4	0172-0573	259.57	571.93	451	81.40	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.6	D08		4	0173-0574	546.75	574.82	461	81.26	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			447.4	D08		4	0174-0577	109.77	577.72	423	75.26	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.4	D08		4	0175-0581	316.05	581.14	554	88.08	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			361.1	D08		4	0176-0584	909.84	584.85	803	114.95	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.6	D08		4	0177-0579	803.61	578.83	480	81.50	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			228.5	D08		4	0178-0581	649.40	580.88	509	88.81	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.5	D08		4	0179-0590	244.16	591.10	457	84.23	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			193.1	D08		4	0180-0594	470.06	594.13	422	77.01	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			220.6	D08		4	0181-0595	357.99	594.48	437	77.84	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			453.0	D08		4	0182-0601	707.62	600.99	472	81.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.9	D08		4	0183-0603	861.60	603.94	748	106.91	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.6	D08		4	0184-0602	593.70	602.36	432	78.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			321.9	D08		4	0185-0605	803.17	605.81	480	84.53	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.4	D08		4	0186-0605	189.40	604.80	467	80.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			230.1	D08		4	0187-0605	682.74	605.51	455	78.67	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.2	D08		4	0188-0608	829.34	608.71	803	110.53	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			217.8	D08		4	0189-0609	407.77	609.26	430	77.84	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.3	D08		4	0190-0617	48.28	617.11	419	76.08	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			306.1	D08		4	0191-0618	73.94	618.25	435	80.33	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			316.7	D08		4	0192-0620	534.59	620.39	454	83.15	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			306.7	D08		4	0193-0629	652.35	629.74	426	76.43	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			204.7	D08		4	0194-0630	464.45	630.65	459	81.50	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			222.9	D08		4	0195-0631	347.40	631.22	432	76.43	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			349.6	D08		4	0196-0637	166.84	637.00	673	98.81	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.5	D08		4	0197-0633	766.19	633.25	448	77.84	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			334.0	D08		4	0198-0637	824.14	634.50	444	83.50	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			213.7	D08		4	0199-0647	616.31	647.51	434	80.08	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			181.6	D08		4	0200-0648	893.26	647.73	452	83.74	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.8	D08		4	0201-0647	413.25	647.58	436	79.74	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			273.6	D08		4	0202-0649	811.68	650.31	462	82.47	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			307.8	D08		4	0203-0655	284.65	655.64	972	129.68	0.726
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.6	D08		4	0204-0650	16.51	650.72	409	75.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			530.7	D08		4	0205-0652	564.80	652.91	437	77.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			287.1	D08		4	0206-0655	245.76	654.93	477	87.40	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.0	D08		4	0207-0654	60.03	654.59	350	73.36	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			219.5	D08		4	0208-0664	490.73	665.09	551	88.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			366.8	D08		4	0209-0666	107.18	667.24	437	78.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			323.0	D08		4	0210-0670	130.35	670.03	437	81.01	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			286.1	D08		4	0211-0673	66.05	672.95	487	87.01	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.3	D08		4	0212-0675	315.43	675.38	458	79.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			218.8	D08		4	0213-0674	384.40	674.78	439	78.91	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			192.2	D08		4	0214-0676	671.90	676.16	437	77.84	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.5	D08		4	0215-0677	806.78	677.74	428	79.98	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			290.6	D08		4	0216-0678	219.18	677.65	431	79.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			222.3	D08		4	0217-0680	741.32	680.44	490	87.40	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			331.9	D08		4	0218-0687	521.67	686.81	448	80.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			331.4	D08		4	0219-0690	185.53	690.11	483	87.15	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			211.3	D08		4	0220-0691	426.22	691.59	414	78.18	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.2	D08		4	0221-0698	66.48	698.47	483	87.01	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.0	D08		4	0222-0697	210.17	697.67	479	90.91	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			209.2	D08		4	0223-0698	848.47	697.67	448	77.84	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			476.7	D08		4	0224-0707	801.44	707.13	338	68.77	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			302.4	D08		5	0001-0033	823.63	32.06	394	74.57	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			358.4	D08		5	0002-0040	391.44	40.78	457	81.84	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.7	D08		5	0003-0045	808.53	46.12	380	75.15	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			230.5	D08		5	0004-0045	921.84	46.04	389	78.18	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			351.1	D08		5	0005-0057	318.33	57.37	778	114.23	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			364.7	D08		5	0006-0057	470.15	57.03	421	78.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.8	D08		5	0007-0059	50.54	59.00	386	73.84	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			461.1	D08		5	0008-0059	875.92	59.73	269	82.67	0.495
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			347.2	D08		5	0009-0064	397.42	64.22	486	85.84	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			264.4	D08		5	0010-0072	670.92	70.92	819	114.67	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.5	D08		5	0011-0071	701.38	70.53	485	87.26	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			348.8	D08		5	0012-0078	543.90	78.14	825	118.71	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			697.4	D08		5	0013-0079	388.66	79.65	130	44.87	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			468.7	D08		5	0014-0085	382.58	87.38	154	58.53	0.565
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			437.5	D08		5	0015-0088	516.98	88.31	354	71.94	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			290.8	D08		5	0016-0093	277.12	93.36	398	75.50	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.9	D08		5	0017-0096	633.80	96.06	425	79.26	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			205.1	D08		5	0018-0092	945.00	92.43	416	78.43	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.6	D08		5	0019-0099	599.93	98.67	415	77.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.8	D08		5	0020-0098	798.67	98.19	423	77.84	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			325.8	D08		5	0021-0100	350.48	100.44	400	75.84	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			296.6	D08		5	0022-0103	71.65	102.95	395	74.67	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			436.9	D08		5	0023-0108	561.28	107.76	640	93.74	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.9	D08		5	0024-0112	237.80	112.01	503	85.60	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			319.1	D08		5	0025-0115	454.33	115.52	438	81.74	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			294.2	D08		5	0026-0117	179.42	116.83	392	74.67	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.9	D08		5	0027-0118	842.12	118.62	387	73.84	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			405.5	D08		5	0028-0128	945.20	127.33	658	98.67	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			293.2	D08		5	0029-0147	230.98	146.68	883	128.37	0.673
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			365.3	D08		5	0030-0139	417.82	138.92	432	76.43	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.8	D08		5	0031-0140	799.39	139.77	419	79.01	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			197.7	D08		5	0032-0143	72.31	143.04	380	72.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.9	D08		5	0033-0146	778.08	146.59	408	77.01	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			338.2	D08		5	0034-0149	501.54	148.63	457	80.08	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.1	D08		5	0035-0147	714.83	147.15	405	76.08	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			354.0	D08		5	0036-0160	304.21	160.53	837	111.54	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			331.4	D08		5	0037-0160	551.40	160.00	437	81.26	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.6	D08		5	0038-0159	625.81	159.03	413	75.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			308.3	D08		5	0039-0163	379.49	163.25	810	111.15	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.9	D08		5	0040-0174	218.07	175.08	417	82.33	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.8	D08		5	0041-0179	124.30	179.69	857	121.40	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			319.3	D08		5	0042-0182	593.02	181.99	397	76.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			188.6	D08		5	0043-0184	800.09	184.08	393	76.33	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			298.1	D08		5	0044-0195	190.64	195.14	411	81.74	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.4	D08		5	0045-0200	860.90	200.69	769	107.64	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.3	D08		5	0046-0195	714.01	195.36	418	78.43	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			192.2	D08		5	0047-0204	21.44	204.91	378	76.08	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			223.7	D08		5	0048-0205	71.47	204.85	372	72.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			195.6	D08		5	0049-0211	769.60	211.45	384	74.43	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			352.8	D08		5	0050-0211	468.68	211.28	418	76.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.2	D08		5	0051-0214	390.48	213.72	396	75.26	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.2	D08		5	0052-0214	734.86	213.37	442	81.01	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.8	D08		5	0053-0216	210.48	216.18	445	86.91	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			472.8	D08		5	0054-0212	116.41	212.94	148	51.70	0.696
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			344.6	D08		5	0055-0217	343.50	217.58	399	75.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			422.2	D08		5	0056-0219	649.48	218.86	377	75.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			353.3	D08		5	0057-0225	668.86	226.35	406	82.08	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			321.8	D08		5	0058-0233	554.22	233.81	778	108.23	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			230.7	D08		5	0059-0240	133.89	240.37	385	76.08	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.6	D08		5	0060-0248	172.10	248.69	390	74.08	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			224.9	D08		5	0061-0249	56.46	249.02	394	76.08	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.3	D08		5	0062-0252	262.48	252.37	426	77.01	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.5	D08		5	0063-0252	522.43	252.74	411	80.91	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.8	D08		5	0064-0259	941.70	259.65	758	108.71	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			264.9	D08		5	0065-0263	621.63	263.24	862	124.51	0.699
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.6	D08		5	0066-0268	474.24	267.82	820	112.81	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.7	D08		5	0067-0265	748.25	265.65	425	76.67	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			194.5	D08		5	0068-0268	784.21	268.90	423	82.57	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			673.3	D08		5	0069-0274	346.42	275.00	450	80.43	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			429.1	D08		5	0070-0280	397.61	280.07	764	105.54	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			233.7	D08		5	0071-0274	865.76	273.84	395	74.08	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			226.3	D08		5	0072-0278	121.12	277.83	379	73.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			201.3	D08		5	0073-0277	22.55	277.44	368	73.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.0	D08		5	0074-0285	547.62	284.98	407	77.74	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			389.4	D08		5	0075-0285	323.56	284.72	457	81.26	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			222.4	D08		5	0076-0287	260.67	287.23	413	79.50	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			230.0	D08		5	0077-0301	806.06	301.60	896	117.40	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			287.8	D08		5	0078-0301	685.93	301.04	293	63.94	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			268.2	D08		5	0079-0310	430.22	310.43	398	80.33	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.4	D08		5	0080-0316	97.58	316.25	428	80.33	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.5	D08		5	0081-0314	859.62	313.58	405	78.57	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			211.0	D08		5	0082-0321	21.04	321.60	824	115.68	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			442.8	D08		5	0083-0314	518.69	314.61	381	77.84	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.1	D08		5	0084-0323	283.64	323.05	405	78.08	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			217.7	D08		5	0085-0327	344.62	327.27	406	78.33	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.9	D08		5	0086-0328	873.27	329.35	403	77.50	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			456.8	D08		5	0087-0330	907.98	329.91	310	64.77	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			294.6	D08		5	0088-0333	223.33	333.96	410	75.26	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			294.3	D08		5	0089-0337	410.57	337.30	756	107.74	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			221.4	D08		5	0090-0338	169.04	337.99	379	77.50	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.5	D08		5	0091-0336	660.17	336.80	610	97.15	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.1	D08		5	0092-0343	929.00	343.31	782	113.88	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.6	D08		5	0093-0344	722.89	344.38	405	76.67	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			308.5	D08		5	0094-0351	438.25	351.57	739	106.57	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			279.3	D08		5	0095-0346	552.67	346.48	413	77.26	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.1	D08		5	0096-0347	786.35	346.22	441	83.60	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.1	D08		5	0097-0354	761.47	354.39	397	77.84	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			196.3	D08		5	0098-0359	854.76	359.24	407	77.50	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.6	D08		5	0099-0360	135.44	360.45	392	76.91	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			371.9	D08		5	0100-0363	589.18	362.90	402	74.43	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			335.1	D08		5	0101-0367	273.26	367.66	450	81.74	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.6	D08		5	0102-0365	897.87	364.97	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			311.4	D08		5	0103-0376	484.26	375.96	819	108.71	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.7	D08		5	0104-0375	377.85	374.63	416	78.08	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			214.5	D08		5	0105-0378	304.46	378.42	424	78.67	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.3	D08		5	0106-0380	40.49	380.98	425	78.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			217.4	D08		5	0107-0386	833.52	386.16	399	75.84	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.2	D08		5	0108-0388	630.64	387.98	450	82.33	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.6	D08		5	0109-0396	411.42	396.40	397	76.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			227.6	D08		5	0110-0401	740.54	401.57	418	77.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.0	D08		5	0111-0404	366.68	404.38	414	76.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			213.9	D08		5	0112-0406	217.90	406.82	369	74.67	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.4	D08		5	0113-0408	175.02	408.75	399	76.91	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.8	D08		5	0114-0411	715.24	410.60	451	84.33	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			224.5	D08		5	0115-0412	535.17	412.48	466	85.15	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			293.9	D08		5	0116-0418	907.23	417.81	194	52.53	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			232.2	D08		5	0117-0426	802.16	426.03	435	81.74	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			252.6	D08		5	0118-0427	257.71	426.72	386	73.84	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.2	D08		5	0119-0427	610.99	426.01	452	86.57	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			190.1	D08		5	0120-0427	511.47	427.34	436	80.91	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			197.4	D08		5	0121-0426	869.44	427.90	301	66.28	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			225.6	D08		5	0122-0430	942.75	429.56	334	72.77	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			230.7	D08		5	0123-0433	475.18	432.91	417	79.50	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			220.5	D08		5	0124-0438	60.42	438.38	370	77.50	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.6	D08		5	0125-0443	929.10	443.80	381	72.91	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			218.1	D08		5	0126-0447	231.28	446.57	418	88.08	0.677
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			217.3	D08		5	0127-0447	869.40	446.16	338	70.87	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.7	D08		5	0128-0455	318.95	455.36	393	78.33	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.4	D08		5	0129-0462	835.61	462.47	606	91.50	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			301.3	D08		5	0130-0461	121.51	461.01	426	79.50	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			212.4	D08		5	0131-0460	443.24	460.54	409	77.50	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			285.3	D08		5	0132-0462	254.37	461.53	431	78.43	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			314.1	D08		5	0133-0466	215.21	467.13	426	78.91	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			212.7	D08		5	0134-0467	783.67	467.61	406	76.67	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			202.9	D08		5	0135-0472	525.52	471.82	416	76.91	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.1	D08		5	0136-0482	99.73	482.31	414	75.26	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.4	D08		5	0137-0485	143.43	484.89	386	75.26	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			402.5	D08		5	0138-0485	294.49	485.32	292	62.77	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			259.6	D08		5	0139-0490	42.99	490.22	383	74.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			234.8	D08		5	0140-0493	370.45	493.36	377	74.91	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			203.1	D08		5	0141-0496	644.54	496.59	415	76.91	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			208.2	D08		5	0142-0498	489.71	498.57	453	82.33	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			299.8	D08		5	0143-0502	831.89	502.01	368	72.67	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			216.5	D08		5	0144-0505	939.56	504.88	436	78.08	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			382.7	D08		5	0145-0508	68.46	508.47	432	79.94	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			234.7	D08		5	0146-0511	887.28	511.66	578	90.08	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			236.7	D08		5	0147-0513	20.77	513.26	404	82.08	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			191.0	D08		5	0148-0521	754.52	520.67	409	79.50	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.9	D08		5	0149-0523	586.44	523.30	406	78.57	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			216.6	D08		5	0150-0524	298.76	524.83	424	77.26	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			212.5	D08		5	0151-0525	442.76	524.94	407	78.67	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.2	D08		5	0152-0528	529.27	528.32	415	77.50	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.8	D08		5	0153-0532	108.82	532.31	738	105.64	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			305.6	D08		5	0154-0531	148.05	531.10	448	80.57	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			216.1	D08		5	0155-0529	482.41	529.37	398	74.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			209.9	D08		5	0156-0530	666.31	530.21	407	77.50	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			230.1	D08		5	0157-0531	67.98	529.96	405	77.36	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			223.5	D08		5	0158-0535	709.02	534.75	398	76.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			219.9	D08		5	0159-0550	905.81	549.96	845	121.64	0.718
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			397.1	D08		5	0160-0541	804.22	541.10	367	73.26	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			304.5	D08		5	0161-0543	390.29	543.81	425	79.01	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			209.5	D08		5	0162-0553	412.75	553.04	430	81.26	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			224.9	D08		5	0163-0559	149.09	559.16	557	89.98	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			207.5	D08		5	0164-0560	464.84	560.33	400	78.33	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			199.2	D08		5	0165-0569	757.35	568.12	809	107.88	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.1	D08		5	0166-0564	348.33	564.29	444	81.98	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.4	D08		5	0167-0569	39.10	568.04	453	84.47	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			230.7	D08		5	0168-0567	599.41	567.21	398	75.84	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.8	D08		5	0169-0582	279.61	582.60	861	126.71	0.674
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.1	D08		5	0170-0581	25.58	580.97	352	75.15	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			220.3	D08		5	0171-0579	110.23	579.37	378	73.84	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			329.2	D08		5	0172-0581	667.06	581.06	445	80.57	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.0	D08		5	0173-0584	58.54	584.46	433	79.15	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.2	D08		5	0174-0598	387.24	598.06	913	122.51	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			347.0	D08		5	0175-0592	848.30	591.58	355	69.01	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.2	D08		5	0176-0601	452.23	600.94	405	78.57	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			228.4	D08		5	0177-0604	636.33	604.11	417	77.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			211.2	D08		5	0178-0605	707.85	604.88	396	75.84	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			230.6	D08		5	0179-0603	894.34	602.57	424	80.67	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			467.7	D08		5	0180-0611	815.51	611.80	316	65.60	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			296.1	D08		5	0181-0617	749.57	616.84	418	75.84	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			208.0	D08		5	0182-0619	670.03	619.32	407	77.50	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			206.4	D08		5	0183-0627	85.01	627.41	849	117.20	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			368.6	D08		5	0184-0623	380.27	623.57	412	79.98	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			373.8	D08		5	0185-0624	486.57	623.68	408	75.50	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			209.1	D08		5	0186-0636	229.62	636.89	400	80.23	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.7	D08		5	0187-0637	896.43	636.89	386	74.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			233.1	D08		5	0188-0639	432.10	639.78	760	107.01	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			302.4	D08		5	0189-0641	399.89	641.34	684	104.91	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			307.2	D08		5	0190-0639	702.72	639.73	363	71.70	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			330.4	D08		5	0191-0641	684.59	641.16	340	70.04	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			420.6	D08		5	0192-0641	833.67	641.18	407	77.26	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			299.6	D08		5	0193-0641	578.90	641.25	386	74.67	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			221.6	D08		5	0194-0644	503.10	644.83	399	75.84	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			307.1	D08		5	0195-0646	792.39	647.04	771	113.05	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			223.2	D08		5	0196-0651	154.62	650.94	391	77.84	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			224.6	D08		5	0197-0653	362.74	653.67	433	81.50	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			220.1	D08		5	0198-0669	557.75	669.58	859	118.02	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			223.7	D08		5	0199-0667	730.14	666.77	409	76.33	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			228.3	D08		5	0200-0669	620.03	669.13	394	76.33	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			204.8	D08		5	0201-0668	678.40	668.34	407	77.26	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			227.5	D08		5	0202-0675	431.90	674.98	414	76.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			175.7	D08		5	0203-0674	318.41	674.03	391	77.01	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			215.3	D08		5	0204-0680	259.83	680.16	394	74.67	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			183.3	D08		5	0205-0682	774.12	682.45	378	72.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			184.6	D08		5	0206-0694	727.59	694.73	419	81.15	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			214.7	D08		5	0207-0694	519.50	694.35	396	74.67	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.1	D08		5	0208-0699	210.55	699.05	729	105.88	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			205.0	D08		5	0209-0698	806.63	698.16	371	73.26	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			222.3	D08		5	0210-0704	886.47	704.50	369	71.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			208.6	D08		5	0211-0706	606.42	706.48	384	75.50	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			211.7	D08		6	0001-0031	828.76	31.67	370	71.94	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			196.3	D08		6	0002-0037	847.51	38.12	368	77.60	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.7	D08		6	0003-0036	327.60	35.24	339	72.43	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.2	D08		6	0004-0042	302.39	41.52	863	121.78	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			393.5	D08		6	0005-0040	923.26	40.40	314	67.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			302.7	D08		6	0006-0048	798.39	47.76	768	107.98	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			228.0	D08		6	0007-0042	130.25	42.06	351	69.60	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.5	D08		6	0008-0045	391.38	45.09	404	77.50	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.3	D08		6	0009-0049	556.89	49.61	411	80.43	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.9	D08		6	0010-0048	597.94	48.65	393	75.50	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			217.0	D08		6	0011-0048	16.62	48.20	323	75.01	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			329.9	D08		6	0012-0053	446.87	53.50	949	121.15	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			233.0	D08		6	0013-0051	666.15	50.88	389	74.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.8	D08		6	0014-0065	197.75	64.91	752	110.71	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			230.7	D08		6	0015-0066	900.72	66.61	403	75.84	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.6	D08		6	0016-0075	285.42	75.45	803	119.44	0.707
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.0	D08		6	0017-0073	628.35	74.13	785	115.64	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			334.3	D08		6	0018-0074	434.92	74.70	330	70.77	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			332.8	D08		6	0019-0078	746.11	77.93	391	73.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			284.8	D08		6	0020-0087	113.81	87.17	714	109.40	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			210.3	D08		6	0021-0082	859.99	81.94	372	74.91	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.4	D08		6	0022-0085	374.04	84.87	392	73.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			333.5	D08		6	0023-0094	723.11	93.67	421	78.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.6	D08		6	0024-0093	487.55	92.71	394	76.43	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.4	D08		6	0025-0094	774.76	94.30	418	78.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			204.7	D08		6	0026-0095	39.55	95.36	380	73.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.9	D08		6	0027-0102	836.77	101.45	590	115.05	0.560
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.0	D08		6	0028-0099	255.89	99.19	382	75.50	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			324.6	D08		6	0029-0100	595.90	99.78	365	72.67	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			302.3	D08		6	0030-0109	422.07	109.20	401	74.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			375.0	D08		6	0031-0126	484.81	126.11	881	126.71	0.690
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			502.2	D08		6	0032-0131	39.36	130.44	645	96.08	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			219.8	D08		6	0033-0131	549.78	131.58	381	73.84	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			286.7	D08		6	0034-0131	623.75	131.32	378	73.01	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.3	D08		6	0035-0132	172.95	132.44	376	77.26	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.5	D08		6	0036-0138	663.74	138.16	402	76.08	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.5	D08		6	0037-0140	893.42	140.11	365	71.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.1	D08		6	0038-0141	808.06	140.48	388	75.84	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			206.6	D08		6	0039-0144	271.47	144.83	389	76.57	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			380.7	D08		6	0040-0146	420.14	146.29	720	105.98	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			477.6	D08		6	0041-0145	457.69	145.41	336	70.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			312.6	D08		6	0042-0145	731.89	144.61	357	71.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.1	D08		6	0043-0147	106.08	147.62	398	74.67	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			227.9	D08		6	0044-0146	132.63	146.74	389	80.57	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			209.4	D08		6	0045-0148	301.61	148.60	373	73.50	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.1	D08		6	0046-0148	505.48	148.16	399	77.01	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.5	D08		6	0047-0149	838.37	149.10	369	72.67	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.9	D08		6	0048-0153	190.42	152.90	356	80.43	0.692
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.3	D08		6	0049-0159	767.90	159.50	381	75.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.5	D08		6	0050-0159	605.24	159.53	411	76.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			219.0	D08		6	0051-0163	326.95	162.93	371	72.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.2	D08		6	0052-0162	560.70	162.97	397	76.67	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			217.9	D08		6	0053-0165	928.56	164.82	391	73.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			233.4	D08		6	0054-0167	685.73	167.59	399	73.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.8	D08		6	0055-0167	474.63	166.86	391	76.18	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			220.3	D08		6	0056-0171	364.60	171.26	369	73.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			318.6	D08		6	0057-0177	70.64	177.11	396	78.18	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.5	D08		6	0058-0178	578.94	178.43	399	75.84	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			474.0	D08		6	0059-0178	93.26	177.67	356	71.94	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.9	D08		6	0060-0180	519.28	180.24	369	71.26	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			475.5	D08		6	0061-0188	811.84	187.98	356	71.60	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			257.8	D08		6	0062-0188	732.47	188.22	376	73.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			285.3	D08		6	0063-0188	398.67	187.91	374	72.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.4	D08		6	0064-0188	459.42	188.42	391	75.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.2	D08		6	0065-0192	707.38	192.26	387	74.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.9	D08		6	0066-0194	832.11	193.10	379	75.84	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.3	D08		6	0067-0201	129.67	201.14	384	77.26	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			222.4	D08		6	0068-0203	551.30	203.08	376	73.50	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			310.5	D08		6	0069-0204	902.38	204.65	333	66.77	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			224.3	D08		6	0070-0206	355.13	206.40	358	74.43	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			220.1	D08		6	0071-0212	635.35	212.48	399	75.01	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			217.1	D08		6	0072-0214	848.73	215.28	377	77.60	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.8	D08		6	0073-0218	932.27	216.97	345	69.26	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			221.7	D08		6	0074-0220	522.35	220.95	391	73.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			230.4	D08		6	0075-0221	324.97	222.47	425	81.01	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			270.3	D08		6	0076-0230	353.42	229.76	822	112.23	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.7	D08		6	0077-0233	441.72	232.72	428	80.91	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			227.3	D08		6	0078-0234	887.17	234.36	369	71.36	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			438.1	D08		6	0079-0237	83.22	237.34	399	76.67	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			175.2	D08		6	0080-0240	933.40	241.20	378	72.08	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.9	D08		6	0081-0243	854.49	242.67	365	73.84	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			313.5	D08		6	0082-0245	401.20	245.71	365	71.84	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.4	D08		6	0083-0244	460.99	244.95	355	75.60	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			202.0	D08		6	0084-0250	217.98	250.08	357	76.33	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.7	D08		6	0085-0253	628.92	252.95	378	72.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			210.6	D08		6	0086-0253	263.39	253.75	360	73.26	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.4	D08		6	0087-0262	36.17	262.36	722	103.05	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			235.9	D08		6	0088-0260	310.00	260.65	362	73.50	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			194.0	D08		6	0089-0260	102.18	261.17	346	70.43	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			377.6	D08		6	0090-0268	185.69	268.48	884	146.51	0.518
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.2	D08		6	0091-0263	454.94	263.11	449	84.67	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			446.9	D08		6	0092-0262	553.62	262.03	325	66.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			227.9	D08		6	0093-0270	678.00	270.01	375	72.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			372.4	D08		6	0094-0273	586.06	273.25	364	72.08	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.0	D08		6	0095-0275	369.55	275.52	397	75.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			415.1	D08		6	0096-0276	849.51	275.27	363	72.91	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			187.9	D08		6	0097-0278	235.02	278.33	349	72.43	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			222.7	D08		6	0098-0284	128.71	284.50	355	74.08	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			610.2	D08		6	0099-0287	632.49	287.12	274	61.84	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			236.4	D08		6	0100-0292	864.52	292.16	407	77.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			353.4	D08		6	0101-0296	383.05	296.44	374	73.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			358.0	D08		6	0102-0297	407.90	296.89	387	73.01	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.5	D08		6	0103-0297	509.90	297.42	392	72.43	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.3	D08		6	0104-0298	44.09	298.72	352	72.08	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.9	D08		6	0105-0303	766.26	302.90	352	73.26	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.0	D08		6	0106-0310	276.35	310.18	394	75.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.9	D08		6	0107-0310	593.44	310.26	370	72.67	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			311.9	D08		6	0108-0310	548.75	310.52	382	74.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			368.1	D08		6	0109-0311	832.11	310.47	382	73.26	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.2	D08		6	0110-0315	475.27	315.03	395	74.18	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			331.1	D08		6	0111-0319	683.10	318.92	642	100.47	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			211.8	D08		6	0112-0319	301.13	319.45	382	73.84	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.1	D08		6	0113-0327	211.18	328.27	839	117.88	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.6	D08		6	0114-0320	566.22	320.72	385	75.50	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			366.6	D08		6	0115-0320	898.68	319.64	306	67.84	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.6	D08		6	0116-0322	354.69	321.99	394	75.50	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			477.0	D08		6	0117-0322	717.14	322.36	564	101.26	0.691
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			209.5	D08		6	0118-0328	640.59	328.33	362	75.26	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.0	D08		6	0119-0334	269.16	334.69	433	86.08	0.734
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			284.9	D08		6	0120-0332	495.27	331.52	399	74.18	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.4	D08		6	0121-0337	817.75	337.00	419	78.33	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			455.8	D08		6	0122-0339	909.62	339.16	468	81.74	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			290.0	D08		6	0123-0340	792.67	339.73	461	82.33	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.0	D08		6	0124-0346	23.77	346.14	733	109.64	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			234.5	D08		6	0125-0347	629.09	348.15	482	91.15	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.2	D08		6	0126-0349	772.87	349.59	347	73.74	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			330.5	D08		6	0127-0350	932.91	350.68	699	110.81	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			313.2	D08		6	0128-0353	876.46	352.96	385	73.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.2	D08		6	0129-0358	727.31	358.52	378	72.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.3	D08		6	0130-0371	408.14	370.44	795	118.02	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			277.7	D08		6	0131-0366	226.35	365.77	908	116.33	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			372.8	D08		6	0132-0372	118.56	372.22	342	68.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.8	D08		6	0133-0380	171.75	380.43	359	71.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.5	D08		6	0134-0381	686.19	380.93	378	72.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.4	D08		6	0135-0386	356.86	385.91	362	71.84	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			273.2	D08		6	0136-0386	898.63	385.61	350	70.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			230.7	D08		6	0137-0389	582.02	388.69	403	77.26	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.8	D08		6	0138-0393	465.08	393.73	397	76.33	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.6	D08		6	0139-0396	531.89	396.65	383	73.60	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			328.5	D08		6	0140-0398	404.18	398.80	397	75.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			319.8	D08		6	0141-0399	263.14	398.89	376	72.43	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.3	D08		6	0142-0406	755.66	406.81	828	112.81	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.1	D08		6	0143-0400	846.75	399.69	373	72.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			223.7	D08		6	0144-0404	713.06	404.11	418	78.91	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			230.9	D08		6	0145-0406	671.17	405.85	361	71.26	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.6	D08		6	0146-0413	138.98	413.47	371	79.74	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.7	D08		6	0147-0418	488.43	418.69	409	76.08	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			206.7	D08		6	0148-0420	205.89	419.93	366	72.67	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.3	D08		6	0149-0430	813.04	431.09	381	73.26	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.4	D08		6	0150-0431	347.02	431.33	380	73.01	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.1	D08		6	0151-0432	434.56	432.26	372	75.26	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			279.1	D08		6	0152-0433	386.89	433.27	332	67.01	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			236.8	D08		6	0153-0436	534.23	436.43	387	74.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			224.8	D08		6	0154-0436	566.83	435.94	392	77.50	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.3	D08		6	0155-0448	223.60	447.98	776	111.20	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			206.3	D08		6	0156-0444	25.13	445.46	410	79.64	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			236.9	D08		6	0157-0442	879.80	442.45	368	73.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.3	D08		6	0158-0453	629.25	451.93	805	122.61	0.673
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			471.1	D08		6	0159-0450	286.83	449.76	498	109.40	0.523
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			315.1	D08		6	0160-0455	546.95	455.76	440	81.26	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			195.9	D08		6	0161-0473	695.65	471.41	849	123.44	0.700
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			200.3	D08		6	0162-0463	767.08	463.73	453	79.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.3	D08		6	0163-0470	934.85	469.19	674	102.33	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			259.7	D08		6	0164-0464	910.91	463.51	355	70.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.0	D08		6	0165-0469	376.31	469.53	372	70.18	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			355.6	D08		6	0166-0471	177.58	471.75	413	78.67	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			232.3	D08		6	0167-0472	54.05	472.63	343	69.01	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			213.5	D08		6	0168-0475	592.81	474.91	415	75.26	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.6	D08		6	0169-0480	324.79	480.81	759	105.74	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.3	D08		6	0170-0479	435.04	479.50	376	72.18	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.0	D08		6	0171-0483	813.03	483.23	375	74.43	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.6	D08		6	0172-0490	770.88	489.39	662	102.91	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.2	D08		6	0173-0486	201.54	486.03	380	75.60	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			390.3	D08		6	0174-0487	278.85	487.89	358	69.84	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			283.3	D08		6	0175-0490	245.27	490.50	362	71.84	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			482.9	D08		6	0176-0491	477.77	491.04	428	78.08	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			216.9	D08		6	0177-0498	678.58	499.23	426	79.74	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			205.2	D08		6	0178-0503	118.99	502.66	441	82.57	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			211.8	D08		6	0179-0501	369.40	501.07	369	71.01	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			206.4	D08		6	0180-0503	572.50	503.11	376	74.08	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			185.9	D08		6	0181-0507	34.40	507.78	383	74.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			218.2	D08		6	0182-0509	934.67	508.54	372	73.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.0	D08		6	0183-0515	705.36	514.46	392	76.08	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.1	D08		6	0184-0512	735.76	512.62	377	75.26	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			411.3	D08		6	0185-0515	198.35	514.67	343	69.60	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.0	D08		6	0186-0516	403.12	516.95	377	75.50	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			204.0	D08		6	0187-0528	142.35	527.67	783	122.61	0.655
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.0	D08		6	0188-0521	640.20	521.47	403	76.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.3	D08		6	0189-0526	248.39	526.31	355	74.91	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.3	D08		6	0190-0528	434.65	528.06	364	72.08	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			321.6	D08		6	0191-0539	888.16	539.47	358	68.43	0.961
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.8	D08		6	0192-0542	349.12	542.31	386	77.74	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			234.6	D08		6	0193-0550	301.34	550.65	719	105.05	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			165.7	D08		6	0194-0551	111.29	551.67	350	72.91	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			214.7	D08		6	0195-0554	594.03	554.14	397	74.43	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			224.9	D08		6	0196-0555	943.52	555.19	380	73.50	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.1	D08		6	0197-0560	443.60	560.66	366	71.84	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			167.3	D08		6	0198-0565	548.38	565.67	372	72.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			217.5	D08		6	0199-0566	171.46	566.61	359	71.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.3	D08		6	0200-0571	341.12	571.02	415	82.57	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			290.6	D08		6	0201-0577	784.16	577.07	769	108.81	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			401.7	D08		6	0202-0572	251.05	572.93	407	78.67	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.2	D08		6	0203-0572	619.51	572.04	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			335.0	D08		6	0204-0579	74.03	580.39	662	103.40	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			233.6	D08		6	0205-0580	287.78	580.05	376	74.43	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			199.0	D08		6	0206-0579	367.26	578.81	401	77.74	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			227.2	D08		6	0207-0580	819.65	579.49	354	70.43	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			289.0	D08		6	0208-0580	416.10	580.75	378	72.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			298.6	D08		6	0209-0590	474.71	590.58	792	118.47	0.709
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			208.4	D08		6	0210-0582	229.54	582.17	384	74.43	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			273.3	D08		6	0211-0584	716.08	583.65	355	71.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			252.8	D08		6	0212-0590	110.68	589.95	361	72.91	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.2	D08		6	0213-0593	326.52	594.57	419	80.91	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.0	D08		6	0214-0597	508.27	597.88	502	83.50	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			213.2	D08		6	0215-0598	50.21	597.98	354	72.43	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			252.2	D08		6	0216-0597	558.93	597.18	395	77.01	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			299.2	D08		6	0217-0607	748.76	606.91	688	100.23	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			289.0	D08		6	0218-0603	376.33	604.40	395	79.74	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			324.1	D08		6	0219-0605	166.55	604.53	415	78.18	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			212.0	D08		6	0220-0611	220.68	610.92	370	74.67	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.2	D08		6	0221-0613	581.72	612.72	410	78.18	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			219.8	D08		6	0222-0616	412.19	617.09	369	73.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			268.1	D08		6	0223-0624	98.62	624.57	714	100.81	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			331.3	D08		6	0224-0625	180.36	625.83	398	80.43	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.5	D08		6	0225-0623	537.52	622.87	384	75.26	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.2	D08		6	0226-0635	454.28	635.05	378	73.01	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			204.3	D08		6	0227-0640	821.88	639.14	554	88.57	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.8	D08		6	0228-0644	624.45	644.80	425	77.26	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			203.3	D08		6	0229-0645	276.57	645.18	379	74.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.1	D08		6	0230-0648	571.47	648.92	714	103.40	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			236.6	D08		6	0231-0647	189.76	646.38	378	79.26	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			268.9	D08		6	0232-0654	371.70	653.98	762	108.47	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.7	D08		6	0233-0654	804.65	654.82	380	74.91	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.0	D08		6	0234-0650	679.35	650.37	197	55.11	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			216.2	D08		6	0235-0661	46.26	661.50	326	70.18	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			196.8	D08		6	0236-0663	320.64	663.16	378	72.67	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.1	D08		6	0237-0666	492.29	665.81	354	70.43	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			211.3	D08		6	0238-0670	135.52	670.49	346	73.26	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			205.5	D08		6	0239-0671	107.79	671.25	366	74.91	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			315.0	D08		6	0240-0676	444.57	675.86	391	73.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			320.5	D08		6	0241-0677	193.75	677.33	365	71.84	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			206.4	D08		6	0242-0680	830.19	680.26	357	70.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			223.8	D08		6	0243-0683	520.86	683.19	371	75.74	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			201.1	D08		6	0244-0686	287.13	685.70	375	73.26	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.6	D08		6	0245-0693	909.27	692.95	359	69.84	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.8	D08		6	0246-0696	601.90	695.47	367	73.98	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			191.5	D08		6	0247-0703	803.69	703.90	373	74.43	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			206.1	D08		6	0248-0703	212.96	703.48	341	67.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.1	D08		6	0249-0708	315.46	708.28	363	75.01	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			307.5	D08		7	0001-0038	138.70	38.64	783	109.88	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			569.6	D08		7	0002-0034	800.14	34.58	338	69.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			209.5	D08		7	0003-0039	895.20	39.35	401	77.26	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.3	D08		7	0004-0038	601.43	38.88	500	84.91	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.9	D08		7	0005-0042	281.00	42.21	836	111.64	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			213.1	D08		7	0006-0049	348.32	49.45	926	126.02	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			281.6	D08		7	0007-0044	702.80	44.53	423	77.26	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.5	D08		7	0008-0059	821.65	58.95	463	82.91	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			315.3	D08		7	0009-0066	79.13	65.78	449	81.15	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.3	D08		7	0010-0071	851.75	70.91	773	109.64	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			235.9	D08		7	0011-0070	394.91	69.33	475	86.91	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			219.7	D08		7	0012-0068	431.23	68.86	349	75.84	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.6	D08		7	0013-0078	251.23	76.72	434	79.74	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.6	D08		7	0014-0081	185.35	81.82	462	82.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.5	D08		7	0015-0087	704.28	87.06	423	77.26	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			257.4	D08		7	0016-0086	911.36	85.55	459	81.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.9	D08		7	0017-0090	439.34	90.38	570	96.67	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			219.1	D08		7	0018-0090	387.39	89.99	430	83.01	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			320.8	D08		7	0019-0089	534.01	89.23	451	81.50	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			235.0	D08		7	0020-0091	755.54	92.27	522	89.74	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			182.8	D08		7	0021-0091	938.49	90.77	487	85.50	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.6	D08		7	0022-0092	650.55	92.57	472	82.08	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.4	D08		7	0023-0093	237.84	94.47	446	80.57	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			224.0	D08		7	0024-0094	319.02	94.51	414	78.91	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.4	D08		7	0025-0096	815.37	96.64	456	87.40	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.1	D08		7	0026-0095	69.91	95.59	424	79.74	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			252.1	D08		7	0027-0098	845.18	97.93	502	87.15	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			210.7	D08		7	0028-0105	118.84	105.54	422	79.26	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.5	D08		7	0029-0106	732.48	106.57	433	80.91	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			520.2	D08		7	0030-0121	299.24	120.12	332	71.50	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.3	D08		7	0031-0124	358.14	124.35	404	76.67	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.8	D08		7	0032-0127	686.23	126.65	419	77.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			225.7	D08		7	0033-0126	894.96	126.18	404	76.67	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			257.9	D08		7	0034-0127	281.81	128.32	393	78.08	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			312.5	D08		7	0035-0134	17.37	135.18	431	82.91	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.4	D08		7	0036-0135	649.93	135.03	457	80.33	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			221.4	D08		7	0037-0137	769.78	137.10	439	82.91	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.1	D08		7	0038-0140	523.99	140.31	478	84.33	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.2	D08		7	0039-0142	721.43	141.48	426	78.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			329.3	D08		7	0040-0146	451.98	146.47	778	109.74	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.4	D08		7	0041-0146	107.97	146.29	445	79.26	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.0	D08		7	0042-0148	135.96	147.29	444	84.33	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			215.6	D08		7	0043-0149	316.88	149.62	395	74.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			216.9	D08		7	0044-0154	781.79	154.36	461	87.15	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			174.9	D08		7	0045-0156	845.85	156.05	488	85.74	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			236.1	D08		7	0046-0162	363.17	161.47	444	84.67	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.8	D08		7	0047-0166	385.36	167.21	434	82.77	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			475.8	D08		7	0048-0172	184.53	172.77	562	92.81	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.5	D08		7	0049-0173	454.80	171.96	385	78.18	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.9	D08		7	0050-0177	288.22	177.19	491	92.81	0.716
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			234.2	D08		7	0051-0178	528.37	178.22	462	85.15	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			259.2	D08		7	0052-0182	51.09	181.36	409	81.05	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			339.7	D08		7	0053-0194	217.97	194.61	776	108.47	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.8	D08		7	0054-0197	36.31	198.74	416	81.15	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.5	D08		7	0055-0194	138.10	194.57	402	78.08	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			193.4	D08		7	0056-0201	825.33	201.22	458	81.50	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			232.1	D08		7	0057-0208	730.55	207.85	446	88.57	0.714
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			211.0	D08		7	0058-0208	651.04	208.27	465	82.33	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			273.5	D08		7	0059-0209	931.10	209.15	402	78.18	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			259.8	D08		7	0060-0210	274.48	209.99	433	78.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.4	D08		7	0061-0213	760.79	212.74	447	80.91	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			219.1	D08		7	0062-0214	792.02	214.30	410	78.33	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			252.5	D08		7	0063-0221	335.11	221.41	436	81.50	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.5	D08		7	0064-0221	686.85	220.76	434	77.26	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			234.3	D08		7	0065-0226	873.19	225.05	349	72.33	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			226.6	D08		7	0066-0235	496.90	234.92	499	86.57	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			337.6	D08		7	0067-0239	853.50	238.86	887	116.37	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			289.9	D08		7	0068-0242	232.59	242.28	472	86.57	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			429.0	D08		7	0069-0250	596.44	249.54	397	76.81	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			259.9	D08		7	0070-0250	392.33	250.19	439	78.08	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			488.1	D08		7	0071-0253	203.63	253.94	172	82.91	0.314
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			357.6	D08		7	0072-0262	582.42	264.15	519	91.64	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			209.9	D08		7	0073-0274	91.69	274.93	849	123.54	0.699
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			217.3	D08		7	0074-0270	456.40	270.98	443	81.50	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			355.8	D08		7	0075-0276	191.03	275.28	408	79.40	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			217.4	D08		7	0076-0275	698.99	275.48	495	84.91	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			296.9	D08		7	0077-0279	151.50	279.75	427	83.40	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.3	D08		7	0078-0280	370.65	281.07	732	107.64	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.8	D08		7	0079-0279	493.68	278.87	455	82.33	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			291.5	D08		7	0080-0284	593.04	284.29	489	89.26	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.4	D08		7	0081-0295	181.32	296.34	462	87.15	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			327.4	D08		7	0082-0293	287.27	293.14	439	78.08	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			343.3	D08		7	0083-0293	398.40	293.43	479	89.15	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			464.3	D08		7	0084-0295	218.71	295.12	453	81.84	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			212.9	D08		7	0085-0315	421.37	315.20	835	113.88	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.0	D08		7	0086-0310	316.18	309.58	428	79.74	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			283.7	D08		7	0087-0314	523.18	314.28	453	82.91	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			365.2	D08		7	0088-0316	619.29	316.35	441	79.26	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			454.3	D08		7	0089-0316	210.40	316.01	418	82.43	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			341.6	D08		7	0090-0329	749.51	328.37	902	121.64	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			218.7	D08		7	0091-0324	675.43	324.14	441	81.60	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.7	D08		7	0092-0324	697.35	323.76	542	89.01	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			213.7	D08		7	0093-0330	923.70	330.27	449	81.74	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.6	D08		7	0094-0333	865.05	333.11	417	79.50	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.8	D08		7	0095-0334	184.98	334.20	426	78.08	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.3	D08		7	0096-0340	353.74	339.76	780	111.88	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			235.3	D08		7	0097-0337	503.83	337.39	471	87.98	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.0	D08		7	0098-0342	475.99	341.85	503	87.40	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			348.1	D08		7	0099-0352	433.49	352.00	279	62.18	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.8	D08		7	0100-0355	632.91	355.63	454	79.26	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			212.3	D08		7	0101-0357	886.90	357.71	400	75.01	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.4	D08		7	0102-0365	831.24	365.48	778	105.64	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.7	D08		7	0103-0372	28.17	372.53	757	109.84	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			389.3	D08		7	0104-0379	122.49	379.22	502	90.18	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			279.0	D08		7	0105-0383	142.26	381.40	342	74.43	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			212.3	D08		7	0106-0384	326.48	383.91	537	91.15	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			259.4	D08		7	0107-0385	592.79	385.21	478	82.91	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			252.0	D08		7	0108-0390	198.62	390.20	396	77.26	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			221.7	D08		7	0109-0390	648.07	390.05	430	79.26	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.7	D08		7	0110-0392	353.79	391.83	524	97.64	0.691
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			221.6	D08		7	0111-0395	155.03	396.14	484	86.81	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.5	D08		7	0112-0393	388.35	393.40	457	80.91	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.1	D08		7	0113-0401	715.27	400.99	439	83.74	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			211.5	D08		7	0114-0401	910.08	400.87	410	77.26	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.8	D08		7	0115-0402	80.39	401.50	410	78.08	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.9	D08		7	0116-0408	115.91	409.20	851	116.95	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			292.6	D08		7	0117-0406	47.71	407.15	428	79.60	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			215.6	D08		7	0118-0417	672.49	417.03	472	85.50	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			349.5	D08		7	0119-0419	258.24	419.29	418	75.26	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			217.8	D08		7	0120-0419	852.42	418.87	438	77.84	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.7	D08		7	0121-0422	462.95	422.00	463	84.57	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.5	D08		7	0122-0428	737.20	428.53	799	106.23	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.7	D08		7	0123-0426	357.00	426.46	420	78.91	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			222.3	D08		7	0124-0433	207.82	432.94	401	76.67	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.3	D08		7	0125-0439	548.38	439.23	853	114.71	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.1	D08		7	0126-0445	130.87	445.13	436	81.15	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			214.7	D08		7	0127-0446	872.69	446.15	435	79.50	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.2	D08		7	0128-0450	177.60	449.89	471	86.57	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			438.3	D08		7	0129-0458	504.55	457.94	831	112.13	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.2	D08		7	0130-0453	617.91	452.19	430	79.98	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.0	D08		7	0131-0460	330.60	460.23	433	78.08	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.3	D08		7	0132-0469	633.26	470.21	488	85.40	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.2	D08		7	0133-0468	685.96	468.34	437	78.91	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.7	D08		7	0134-0469	439.37	469.24	443	79.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			377.9	D08		7	0135-0469	568.45	470.06	280	84.08	0.498
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.9	D08		7	0136-0482	928.02	481.95	894	116.95	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			235.5	D08		7	0137-0483	224.25	482.98	421	78.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.8	D08		7	0138-0488	77.97	488.45	444	86.23	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.1	D08		7	0139-0489	119.46	489.20	400	77.74	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.7	D08		7	0140-0503	605.96	503.79	865	116.95	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.6	D08		7	0141-0497	448.54	497.80	458	85.15	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.4	D08		7	0142-0497	732.17	496.51	436	82.33	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			286.1	D08		7	0143-0497	846.56	496.51	448	80.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.9	D08		7	0144-0503	791.27	504.05	818	111.40	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.1	D08		7	0145-0504	534.13	504.29	423	77.26	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			363.8	D08		7	0146-0515	397.56	515.35	711	101.40	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			295.0	D08		7	0147-0514	492.38	514.36	432	78.08	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			252.0	D08		7	0148-0520	198.34	520.33	422	77.84	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.5	D08		7	0149-0530	560.96	529.57	474	82.57	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			227.4	D08		7	0150-0531	79.84	531.52	448	83.74	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.9	D08		7	0151-0534	692.82	534.27	465	85.74	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			313.8	D08		7	0152-0535	859.44	536.14	554	92.47	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			304.8	D08		7	0153-0539	427.78	539.12	414	80.67	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			284.5	D08		7	0154-0547	781.55	547.27	855	118.27	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			283.0	D08		7	0155-0543	216.52	543.56	474	84.33	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			191.1	D08		7	0156-0545	16.05	545.35	394	75.60	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			234.7	D08		7	0157-0546	129.51	546.04	410	80.81	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			195.3	D08		7	0158-0546	542.56	547.35	493	85.98	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			296.8	D08		7	0159-0548	312.37	548.53	846	119.05	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.7	D08		7	0160-0556	876.68	556.26	486	84.33	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			438.7	D08		7	0161-0559	421.15	559.94	631	96.91	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.8	D08		7	0162-0558	643.98	558.24	421	78.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			295.3	D08		7	0163-0559	697.13	559.46	444	83.50	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			294.7	D08		7	0164-0570	241.67	569.63	417	77.50	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.3	D08		7	0165-0574	335.74	574.52	423	81.98	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			303.1	D08		7	0166-0582	939.06	582.12	412	79.60	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			321.4	D08		7	0167-0585	53.65	585.14	766	105.64	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			284.0	D08		7	0168-0583	619.72	583.61	431	76.43	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			217.7	D08		7	0169-0585	567.84	585.96	426	78.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			290.2	D08		7	0170-0587	200.56	587.01	459	81.50	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.4	D08		7	0171-0586	381.16	586.27	433	80.91	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			235.4	D08		7	0172-0602	84.26	601.97	412	79.98	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			252.4	D08		7	0173-0608	779.71	607.96	426	77.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			368.4	D08		7	0174-0610	934.27	610.47	448	84.91	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.8	D08		7	0175-0612	143.13	612.04	417	84.57	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			252.3	D08		7	0176-0613	692.71	612.59	428	79.26	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			232.3	D08		7	0177-0615	439.99	614.55	437	80.08	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			235.1	D08		7	0178-0622	309.28	622.42	452	80.91	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			577.2	D08		7	0179-0623	216.34	623.50	469	83.26	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.5	D08		7	0180-0634	512.13	633.38	446	82.33	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.5	D08		7	0181-0636	62.85	636.45	401	76.67	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			319.9	D08		7	0182-0643	332.89	641.98	838	120.13	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			235.4	D08		7	0183-0645	399.66	644.48	449	81.84	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.9	D08		7	0184-0647	279.46	648.02	378	80.33	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.1	D08		7	0185-0651	639.67	650.98	435	79.01	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			222.2	D08		7	0186-0651	360.99	651.61	463	84.08	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.1	D08		7	0187-0655	250.20	654.26	469	86.57	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			268.1	D08		7	0188-0659	500.84	660.70	463	85.74	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			223.7	D08		7	0189-0655	433.42	656.14	379	75.70	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			230.0	D08		7	0190-0660	835.93	660.18	449	80.91	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			236.0	D08		7	0191-0669	391.30	670.27	462	88.81	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.1	D08		7	0192-0667	17.13	667.33	458	80.91	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			289.3	D08		7	0193-0667	193.70	667.19	437	79.50	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			322.6	D08		7	0194-0664	222.97	664.04	250	64.43	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			236.1	D08		7	0195-0669	130.34	669.31	415	83.15	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			227.2	D08		7	0196-0671	563.62	671.83	434	80.33	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			441.6	D08		7	0197-0674	744.60	674.36	401	75.50	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			433.4	D08		7	0198-0675	434.96	673.95	430	80.53	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			313.0	D08		7	0199-0680	247.12	680.98	481	89.15	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			235.9	D08		7	0200-0680	297.85	680.08	407	76.43	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			222.1	D08		7	0201-0679	881.66	679.17	397	75.01	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.5	D08		7	0202-0683	463.49	683.36	413	78.33	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			327.1	D08		7	0203-0689	910.76	689.07	428	78.67	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			216.8	D08		7	0204-0690	55.66	689.63	424	76.67	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			209.6	D08		7	0205-0698	689.45	697.40	443	86.23	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			216.4	D08		7	0206-0698	656.88	697.85	407	79.15	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			216.2	D08		7	0207-0703	605.62	703.64	412	76.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.0	D08		7	0208-0704	351.70	704.08	420	77.26	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			223.8	D08		7	0209-0704	531.98	704.73	484	84.67	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			359.4	D08		7	0210-0704	215.33	704.39	385	72.43	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			216.4	D08		7	0211-0709	508.12	709.51	296	69.84	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			212.7	D08		8	0001-0032	884.95	31.78	381	72.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			224.0	D08		8	0002-0036	369.69	35.91	465	82.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.5	D08		8	0003-0034	604.87	34.26	413	78.08	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.4	D08		8	0004-0039	695.81	39.74	434	85.64	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			223.3	D08		8	0005-0039	424.75	39.71	513	90.57	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.7	D08		8	0006-0042	59.13	41.84	406	76.67	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.4	D08		8	0007-0042	116.37	41.58	475	85.40	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.4	D08		8	0008-0053	446.51	51.28	509	86.23	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			198.7	D08		8	0009-0060	500.17	59.63	448	81.74	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			337.6	D08		8	0010-0061	133.24	61.79	472	84.33	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			264.7	D08		8	0011-0062	572.17	62.39	818	115.78	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			224.5	D08		8	0012-0065	460.15	66.11	402	78.23	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.7	D08		8	0013-0063	918.16	63.17	393	76.33	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			277.0	D08		8	0014-0066	744.30	66.04	400	75.01	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			287.6	D08		8	0015-0073	691.30	73.55	412	75.01	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			205.6	D08		8	0016-0073	860.83	73.44	448	82.57	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.0	D08		8	0017-0075	834.89	75.31	412	77.26	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			230.3	D08		8	0018-0078	776.98	78.13	421	78.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.2	D08		8	0019-0082	174.03	82.31	390	78.08	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			315.1	D08		8	0020-0083	273.25	83.30	414	77.26	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			279.6	D08		8	0021-0092	219.98	92.53	851	121.05	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			443.9	D08		8	0022-0085	109.71	85.02	386	72.43	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			206.7	D08		8	0023-0088	17.17	87.83	451	82.08	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			205.3	D08		8	0024-0093	44.18	92.84	455	81.50	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			207.9	D08		8	0025-0094	894.42	94.34	407	76.43	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			224.5	D08		8	0026-0098	431.25	98.10	437	83.15	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.5	D08		8	0027-0100	366.00	100.19	409	76.67	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			361.7	D08		8	0028-0110	622.43	110.49	865	119.98	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			226.0	D08		8	0029-0107	652.75	107.06	446	81.01	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			214.1	D08		8	0030-0111	703.55	110.95	404	76.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.1	D08		8	0031-0113	73.92	113.83	409	77.84	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			232.4	D08		8	0032-0114	142.14	114.63	404	78.91	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			496.1	D08		8	0033-0116	682.50	115.95	406	75.36	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			222.3	D08		8	0034-0119	820.27	119.15	422	77.26	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			352.4	D08		8	0035-0132	728.98	132.30	480	86.57	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.5	D08		8	0036-0131	552.04	130.76	407	76.67	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			227.3	D08		8	0037-0141	469.46	141.36	908	135.68	0.620
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			330.0	D08		8	0038-0132	614.30	132.68	390	79.36	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			306.8	D08		8	0039-0144	279.56	144.71	608	95.64	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.0	D08		8	0040-0143	414.75	143.33	406	77.50	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			222.8	D08		8	0041-0154	61.26	154.33	437	80.33	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			217.8	D08		8	0042-0153	869.81	153.09	405	77.26	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			222.6	D08		8	0043-0157	138.42	157.09	429	82.08	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			309.6	D08		8	0044-0157	562.84	158.13	412	80.33	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			232.2	D08		8	0045-0159	165.70	159.40	498	90.81	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.7	D08		8	0046-0165	521.33	164.82	413	76.67	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.5	D08		8	0047-0167	739.78	167.56	428	78.08	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			416.6	D08		8	0048-0168	624.74	168.55	454	80.77	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			303.2	D08		8	0049-0183	567.41	184.60	849	121.78	0.719
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.7	D08		8	0050-0183	384.62	183.38	418	79.50	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.8	D08		8	0051-0184	277.53	185.34	517	86.53	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			333.7	D08		8	0052-0184	694.35	183.56	388	75.26	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.0	D08		8	0053-0186	890.52	186.22	434	79.84	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.4	D08		8	0054-0195	913.07	195.23	848	119.15	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			303.6	D08		8	0055-0198	206.93	198.85	984	120.71	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			554.2	D08		8	0056-0192	625.24	191.31	474	84.18	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			514.5	D08		8	0057-0200	484.87	201.08	671	104.37	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			284.7	D08		8	0058-0199	359.06	199.18	446	83.15	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			225.0	D08		8	0059-0200	527.88	200.43	408	79.15	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			233.2	D08		8	0060-0204	711.12	205.37	848	118.13	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			264.5	D08		8	0061-0205	666.68	205.58	439	80.67	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.9	D08		8	0062-0206	779.10	206.07	414	77.26	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.9	D08		8	0063-0214	276.88	213.77	792	116.43	0.734
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			291.0	D08		8	0064-0211	35.92	211.97	421	83.01	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.7	D08		8	0065-0211	447.74	211.02	441	84.23	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.4	D08		8	0066-0216	96.43	217.15	848	116.71	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			217.5	D08		8	0067-0217	253.06	216.84	436	81.01	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.7	D08		8	0068-0224	158.37	224.36	418	77.50	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.2	D08		8	0069-0228	583.30	228.46	464	85.15	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			285.1	D08		8	0070-0226	851.41	226.38	407	75.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			303.2	D08		8	0071-0237	309.49	237.76	822	113.40	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.4	D08		8	0072-0241	284.94	240.54	473	87.36	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			197.1	D08		8	0073-0242	529.69	242.68	413	77.26	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			233.2	D08		8	0074-0240	630.78	239.82	350	72.67	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.0	D08		8	0075-0244	789.97	244.51	403	78.33	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			279.7	D08		8	0076-0247	607.99	247.34	445	82.91	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			257.2	D08		8	0077-0260	332.57	260.05	459	82.67	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			379.8	D08		8	0078-0259	477.08	259.25	378	72.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.6	D08		8	0079-0260	692.38	261.20	452	80.53	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.2	D08		8	0080-0277	257.21	277.66	846	112.37	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			445.8	D08		8	0081-0276	832.37	276.41	609	96.33	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.9	D08		8	0082-0274	77.86	273.62	372	74.33	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.3	D08		8	0083-0277	649.69	277.28	452	78.67	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			228.9	D08		8	0084-0279	438.27	278.77	417	77.26	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			221.7	D08		8	0085-0284	185.71	284.27	400	77.74	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			318.6	D08		8	0086-0282	884.17	282.00	325	67.01	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			212.7	D08		8	0087-0284	913.06	284.55	406	75.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			286.8	D08		8	0088-0285	118.78	285.70	421	81.40	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			217.5	D08		8	0089-0284	691.85	283.76	461	83.36	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			205.5	D08		8	0090-0286	590.33	286.02	441	83.40	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			473.3	D08		8	0091-0289	62.19	290.24	495	87.05	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			289.0	D08		8	0092-0289	215.23	288.87	428	76.67	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.0	D08		8	0093-0292	545.64	292.36	775	106.23	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.1	D08		8	0094-0292	733.36	292.72	814	108.57	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			211.2	D08		8	0095-0292	385.56	292.55	865	120.81	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.7	D08		8	0096-0294	505.09	292.74	453	88.47	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			181.9	D08		8	0097-0301	945.77	302.32	413	79.26	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			232.2	D08		8	0098-0321	99.54	320.91	400	76.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			236.3	D08		8	0099-0321	502.87	321.41	431	77.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.8	D08		8	0100-0319	659.31	318.85	429	79.26	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.5	D08		8	0101-0336	890.29	336.90	826	119.68	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			209.8	D08		8	0102-0329	912.12	328.16	412	82.33	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			210.1	D08		8	0103-0332	28.83	332.23	415	79.15	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			233.7	D08		8	0104-0336	249.69	335.89	411	79.74	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			191.8	D08		8	0105-0334	844.38	334.08	456	79.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			230.1	D08		8	0106-0339	425.15	339.81	395	77.60	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.5	D08		8	0107-0340	652.93	341.37	469	84.91	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			225.2	D08		8	0108-0342	342.76	342.06	413	78.67	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.4	D08		8	0109-0341	386.82	341.56	467	83.50	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.0	D08		8	0110-0342	786.67	342.22	406	76.67	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.4	D08		8	0111-0348	449.67	347.65	724	104.91	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.2	D08		8	0112-0347	166.15	347.14	412	77.50	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.9	D08		8	0113-0358	547.03	358.86	868	122.85	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			319.6	D08		8	0114-0349	211.63	349.20	437	79.50	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.7	D08		8	0115-0357	711.60	357.80	419	78.91	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			215.3	D08		8	0116-0363	399.47	362.29	445	81.84	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.6	D08		8	0117-0372	497.55	372.35	460	81.84	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			225.1	D08		8	0118-0374	757.54	374.67	449	80.91	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.0	D08		8	0119-0376	601.74	376.51	426	79.74	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			210.9	D08		8	0120-0378	784.90	377.44	438	79.50	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			215.8	D08		8	0121-0381	304.43	382.27	420	80.18	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			206.6	D08		8	0122-0389	60.15	389.85	389	76.33	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.2	D08		8	0123-0393	428.91	394.39	864	118.37	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			287.5	D08		8	0124-0400	117.36	399.99	841	114.13	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.0	D08		8	0125-0391	520.05	391.20	456	84.91	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.9	D08		8	0126-0394	689.93	393.77	429	76.43	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			270.9	D08		8	0127-0396	907.28	396.73	421	79.84	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			208.6	D08		8	0128-0401	177.10	400.90	434	80.08	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			187.7	D08		8	0129-0403	15.32	402.92	373	72.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			225.4	D08		8	0130-0407	308.11	406.08	476	84.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			281.5	D08		8	0131-0405	651.10	405.55	421	78.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			324.3	D08		8	0132-0411	850.74	411.27	371	71.60	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.6	D08		8	0133-0413	581.10	413.40	417	79.74	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			324.7	D08		8	0134-0426	901.74	426.81	747	111.15	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.6	D08		8	0135-0421	543.54	421.25	415	78.08	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.1	D08		8	0136-0426	135.22	426.07	471	82.91	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			225.3	D08		8	0137-0427	707.94	427.17	405	75.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			268.3	D08		8	0138-0427	750.29	427.15	422	75.84	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			204.0	D08		8	0139-0434	360.23	432.85	438	79.40	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			220.2	D08		8	0140-0443	91.35	443.73	610	94.33	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			218.5	D08		8	0141-0443	856.02	443.55	415	77.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.4	D08		8	0142-0443	661.35	442.96	454	83.26	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			226.2	D08		8	0143-0444	808.91	444.31	394	76.08	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			225.5	D08		8	0144-0453	345.48	453.66	469	86.81	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			270.0	D08		8	0145-0451	637.49	450.89	417	77.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			200.4	D08		8	0146-0454	399.22	454.11	446	81.01	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			204.7	D08		8	0147-0455	420.93	455.57	486	86.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			202.8	D08		8	0148-0465	921.78	465.12	432	78.43	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			331.8	D08		8	0149-0465	558.52	464.69	343	71.26	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			211.0	D08		8	0150-0471	252.94	470.44	407	78.77	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			232.2	D08		8	0151-0477	732.29	477.24	423	78.91	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			199.2	D08		8	0152-0476	882.86	476.52	399	73.84	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			233.4	D08		8	0153-0485	32.98	484.12	857	113.54	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			206.2	D08		8	0154-0480	451.55	479.73	419	78.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			217.0	D08		8	0155-0481	500.13	481.23	432	84.33	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			214.1	D08		8	0156-0483	808.31	482.90	444	80.08	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.7	D08		8	0157-0482	830.66	481.79	391	81.01	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			279.2	D08		8	0158-0482	622.88	482.80	407	76.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			222.4	D08		8	0159-0485	145.41	485.34	387	77.50	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			202.0	D08		8	0160-0486	206.87	486.52	415	77.50	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			214.3	D08		8	0161-0488	778.91	488.46	406	77.50	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			208.2	D08		8	0162-0493	848.55	493.51	516	89.50	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			299.0	D08		8	0163-0488	409.37	488.78	298	66.08	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			219.8	D08		8	0164-0493	365.42	493.59	435	79.50	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.1	D08		8	0165-0496	569.92	495.85	422	79.50	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			210.3	D08		8	0166-0505	741.58	505.90	442	83.60	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.1	D08		8	0167-0506	480.71	505.89	443	81.84	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			183.5	D08		8	0168-0518	915.18	518.32	720	110.57	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			270.1	D08		8	0169-0515	647.73	514.94	420	78.08	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			223.8	D08		8	0170-0518	256.99	518.51	433	79.50	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			205.8	D08		8	0171-0523	135.34	522.72	392	76.08	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			173.3	D08		8	0172-0526	814.97	525.92	410	80.33	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			188.3	D08		8	0173-0526	194.48	526.48	394	76.08	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			124.6	D08		8	0174-0525	931.41	524.85	175	53.11	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			214.8	D08		8	0175-0535	746.35	535.25	891	126.47	0.700
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			335.1	D08		8	0176-0527	460.85	527.21	391	72.77	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.0	D08		8	0177-0528	366.17	528.27	407	78.67	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			270.8	D08		8	0178-0533	545.31	532.49	555	92.57	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			283.0	D08		8	0179-0544	226.15	544.19	422	78.08	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			226.6	D08		8	0180-0546	793.33	547.02	405	80.91	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.4	D08		8	0181-0552	696.30	551.94	410	78.67	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			216.6	D08		8	0182-0560	85.58	559.71	859	121.54	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.5	D08		8	0183-0556	404.04	556.74	407	75.50	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			540.0	D08		8	0184-0562	515.01	562.26	465	81.50	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			209.0	D08		8	0185-0564	800.48	565.21	445	86.08	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			214.2	D08		8	0186-0569	173.02	569.09	399	75.50	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			210.4	D08		8	0187-0573	556.41	572.86	403	75.60	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.0	D08		8	0188-0578	641.51	577.83	422	78.08	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			214.4	D08		8	0189-0579	740.58	578.80	406	75.50	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			236.2	D08		8	0190-0580	875.42	580.14	437	78.67	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			303.1	D08		8	0191-0585	44.22	584.44	406	84.81	0.709
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.4	D08		8	0192-0581	586.30	581.20	404	75.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.9	D08		8	0193-0583	324.64	583.53	438	79.50	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.0	D08		8	0194-0589	212.22	589.69	435	82.08	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.1	D08		8	0195-0595	263.91	595.35	398	77.50	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			221.2	D08		8	0196-0598	426.67	598.42	443	82.08	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			340.3	D08		8	0197-0612	39.00	612.44	432	80.57	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.1	D08		8	0198-0611	929.51	611.62	403	79.26	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			5485.2	D08		8	0199-0621	82.16	621.05	720	100.57	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			315.4	D08		8	0200-0621	208.06	621.77	573	90.33	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.5	D08		8	0201-0619	718.53	619.30	403	74.67	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			236.9	D08		8	0202-0622	429.32	621.30	451	81.26	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.0	D08		8	0203-0624	604.82	624.31	425	79.98	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.4	D08		8	0204-0627	514.44	626.81	430	80.33	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			442.0	D08		8	0205-0639	318.06	638.75	414	76.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			277.1	D08		8	0206-0639	773.47	638.91	418	77.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			205.1	D08		8	0207-0641	142.44	641.40	392	76.57	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.3	D08		8	0208-0646	177.28	646.96	409	76.67	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			230.1	D08		8	0209-0650	67.26	650.15	436	79.26	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.5	D08		8	0210-0654	406.54	654.12	430	80.33	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.4	D08		8	0211-0660	226.56	660.44	421	78.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			228.5	D08		8	0212-0678	607.91	679.11	851	119.88	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.6	D08		8	0213-0674	926.64	673.75	396	75.26	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			311.0	D08		8	0214-0684	414.35	684.91	457	82.67	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			442.4	D08		8	0215-0693	180.42	693.41	765	108.13	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			317.3	D08		8	0216-0691	15.47	691.18	411	78.57	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.8	D08		8	0217-0695	389.16	695.35	428	82.57	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			217.1	D08		8	0218-0706	316.19	706.84	392	73.26	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			199.0	D08		9	0001-0031	802.21	31.36	377	73.60	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.8	D08		9	0002-0031	211.44	31.27	365	70.43	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			326.5	D08		9	0003-0036	582.69	37.25	373	73.74	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			347.1	D08		9	0004-0037	315.18	36.46	417	77.94	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			264.0	D08		9	0005-0040	243.56	39.76	391	75.26	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			211.0	D08		9	0006-0040	69.25	40.63	358	71.26	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.8	D08		9	0007-0043	158.62	42.87	383	74.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			230.8	D08		9	0008-0044	549.39	44.18	431	78.67	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			287.3	D08		9	0009-0044	838.91	44.74	396	74.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			212.5	D08		9	0010-0049	433.97	48.43	422	76.43	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			202.1	D08		9	0011-0056	108.85	56.12	370	71.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			224.2	D08		9	0012-0061	197.89	61.33	371	70.18	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			223.7	D08		9	0013-0063	232.85	63.48	376	74.77	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.7	D08		9	0014-0066	12.61	65.95	363	72.67	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.5	D08		9	0015-0074	412.99	73.90	420	78.18	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.0	D08		9	0016-0073	311.53	73.06	398	75.60	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			227.9	D08		9	0017-0078	615.73	77.56	424	77.84	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			217.9	D08		9	0018-0078	693.87	78.19	421	80.91	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.8	D08		9	0019-0081	174.00	80.92	364	74.43	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			230.4	D08		9	0020-0082	740.74	81.87	394	75.26	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.2	D08		9	0021-0084	358.91	84.33	395	74.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			347.6	D08		9	0022-0085	480.27	85.05	398	73.60	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			220.7	D08		9	0023-0091	867.98	90.87	374	72.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.0	D08		9	0024-0095	909.04	95.92	425	77.84	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			186.5	D08		9	0025-0095	122.55	94.82	359	70.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.4	D08		9	0026-0096	307.62	95.97	396	75.84	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			216.0	D08		9	0027-0100	709.31	100.82	473	83.26	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.0	D08		9	0028-0104	165.47	104.90	558	90.91	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.3	D08		9	0029-0102	609.70	102.70	415	76.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.6	D08		9	0030-0104	250.84	103.66	451	81.64	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.7	D08		9	0031-0101	932.48	101.56	414	79.11	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			233.7	D08		9	0032-0111	651.76	110.71	396	74.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.3	D08		9	0033-0117	265.59	118.91	350	71.15	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			236.7	D08		9	0034-0120	94.20	120.25	375	72.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			215.2	D08		9	0035-0127	711.28	125.36	426	82.33	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			201.3	D08		9	0036-0130	208.51	130.00	397	76.67	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.5	D08		9	0037-0134	141.97	134.27	378	75.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			220.1	D08		9	0038-0135	693.09	136.57	410	78.08	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			281.0	D08		9	0039-0138	866.97	137.64	357	70.43	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			499.4	D08		9	0040-0139	51.12	140.05	347	69.01	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			270.9	D08		9	0041-0140	353.61	139.65	376	72.18	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			268.9	D08		9	0042-0139	414.94	138.93	402	79.60	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.8	D08		9	0043-0140	286.49	139.79	389	74.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			346.8	D08		9	0044-0140	439.97	140.48	424	77.94	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			257.3	D08		9	0045-0145	914.10	145.16	386	72.43	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			355.3	D08		9	0046-0149	481.63	148.96	445	79.26	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.2	D08		9	0047-0159	553.86	159.17	840	114.91	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			228.4	D08		9	0048-0153	211.82	153.04	407	76.43	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.5	D08		9	0049-0159	99.45	159.36	413	77.74	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.4	D08		9	0050-0159	341.79	159.62	373	73.84	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			460.7	D08		9	0051-0159	277.39	159.59	351	69.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.4	D08		9	0052-0163	636.04	163.74	429	78.77	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			223.0	D08		9	0053-0163	660.28	162.67	412	76.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.7	D08		9	0054-0169	602.12	169.55	466	80.18	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			257.6	D08		9	0055-0169	465.80	168.72	422	78.67	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			197.2	D08		9	0056-0173	48.26	174.07	357	72.43	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			224.3	D08		9	0057-0179	376.57	178.90	426	79.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			273.4	D08		9	0058-0180	860.74	180.33	366	70.77	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.5	D08		9	0059-0187	683.04	187.15	393	76.43	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.9	D08		9	0060-0186	178.54	186.46	374	72.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.1	D08		9	0061-0196	298.97	196.05	817	112.91	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.5	D08		9	0062-0196	783.01	196.00	386	74.91	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.9	D08		9	0063-0204	102.44	205.02	417	78.91	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			233.1	D08		9	0064-0206	210.89	206.94	381	77.60	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			277.3	D08		9	0065-0209	412.21	209.50	459	80.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			209.2	D08		9	0066-0212	241.57	212.44	368	74.43	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			298.2	D08		9	0067-0210	391.73	210.62	391	73.70	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			301.3	D08		9	0068-0214	460.20	214.19	731	100.81	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			218.7	D08		9	0069-0212	681.99	212.12	440	80.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			198.6	D08		9	0070-0211	641.53	211.36	385	75.26	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.0	D08		9	0071-0215	571.82	215.76	385	74.67	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.2	D08		9	0072-0221	357.76	220.80	429	79.26	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			200.6	D08		9	0073-0222	309.49	222.98	389	78.18	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			303.9	D08		9	0074-0223	739.20	223.72	392	76.08	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.9	D08		9	0075-0227	205.50	226.76	434	80.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.9	D08		9	0076-0233	522.04	232.65	722	103.40	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			295.2	D08		9	0077-0233	717.89	233.06	548	93.40	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			413.8	D08		9	0078-0232	882.86	231.82	374	71.60	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			329.5	D08		9	0079-0242	370.93	242.04	567	91.74	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			281.9	D08		9	0080-0244	793.57	244.69	404	75.26	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.3	D08		9	0081-0247	296.20	247.12	377	73.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			235.7	D08		9	0082-0251	259.12	251.10	369	72.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			235.7	D08		9	0083-0251	549.31	251.59	444	78.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.0	D08		9	0084-0250	180.46	250.07	376	73.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			233.7	D08		9	0085-0252	587.08	251.82	386	75.84	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.1	D08		9	0086-0255	153.26	255.91	388	75.50	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			252.0	D08		9	0087-0256	77.61	256.50	386	74.43	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.7	D08		9	0088-0258	514.86	258.37	395	75.84	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			257.8	D08		9	0089-0258	846.26	258.51	396	73.01	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			332.1	D08		9	0090-0264	324.38	263.88	658	94.91	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			225.9	D08		9	0091-0262	671.84	262.19	432	80.91	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.8	D08		9	0092-0257	915.92	257.74	364	71.94	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			230.8	D08		9	0093-0264	887.34	264.27	349	75.36	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.4	D08		9	0094-0273	410.97	273.28	409	75.01	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			570.4	D08		9	0095-0274	472.81	274.16	308	64.77	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			195.8	D08		9	0096-0280	581.72	280.94	420	76.08	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			381.9	D08		9	0097-0281	658.64	281.64	406	74.67	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.1	D08		9	0098-0283	791.94	282.76	373	73.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			215.3	D08		9	0099-0282	893.76	282.59	393	79.70	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			259.1	D08		9	0100-0289	208.49	288.97	393	76.08	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			286.0	D08		9	0101-0297	517.43	296.76	791	111.40	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.7	D08		9	0102-0291	73.87	291.40	377	71.84	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			190.6	D08		9	0103-0295	920.34	294.67	394	75.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			264.0	D08		9	0104-0296	719.32	296.25	389	76.08	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			230.6	D08		9	0105-0297	820.86	296.95	387	73.84	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.8	D08		9	0106-0304	162.89	304.23	724	104.57	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			233.3	D08		9	0107-0296	383.18	295.94	379	73.01	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.8	D08		9	0108-0298	261.09	298.23	391	73.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			204.1	D08		9	0109-0301	126.12	301.54	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.8	D08		9	0110-0301	900.33	301.91	402	82.18	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			192.8	D08		9	0111-0305	40.73	305.65	391	77.01	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			218.0	D08		9	0112-0306	200.21	307.44	419	82.91	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			219.0	D08		9	0113-0312	434.13	312.14	409	75.26	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.7	D08		9	0114-0316	880.46	315.48	381	73.50	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			204.7	D08		9	0115-0323	60.64	322.66	395	77.84	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			235.0	D08		9	0116-0324	317.09	323.94	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.2	D08		9	0117-0326	248.09	326.70	408	73.60	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.9	D08		9	0118-0325	635.30	324.89	385	73.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			234.6	D08		9	0119-0328	373.64	328.69	414	76.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.0	D08		9	0120-0333	478.24	333.17	391	73.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.9	D08		9	0121-0334	518.50	334.38	419	77.01	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.1	D08		9	0122-0340	574.93	340.26	413	75.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			214.0	D08		9	0123-0342	132.05	341.66	397	74.08	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.2	D08		9	0124-0346	929.21	345.80	380	75.94	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.4	D08		9	0125-0351	225.07	350.96	642	95.74	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			221.8	D08		9	0126-0349	846.02	349.50	381	73.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.1	D08		9	0127-0354	682.81	354.31	438	83.98	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			264.0	D08		9	0128-0358	520.07	357.55	423	78.18	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.5	D08		9	0129-0361	313.84	360.59	408	78.18	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.4	D08		9	0130-0361	810.32	360.87	426	77.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.9	D08		9	0131-0368	888.14	368.11	827	118.81	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			223.8	D08		9	0132-0365	295.33	366.12	359	75.21	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			225.1	D08		9	0133-0368	275.28	367.58	453	82.04	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			203.0	D08		9	0134-0369	122.11	369.40	389	76.43	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			215.9	D08		9	0135-0373	189.40	373.03	404	79.15	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			206.7	D08		9	0136-0384	71.53	384.19	382	74.43	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.9	D08		9	0137-0388	237.86	388.08	742	104.23	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			287.7	D08		9	0138-0391	207.08	391.67	461	83.84	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			259.3	D08		9	0139-0390	590.14	390.31	388	74.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.2	D08		9	0140-0391	753.46	391.08	394	74.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			5109.0	D08		9	0141-0405	506.02	405.02	627	95.64	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			270.3	D08		9	0142-0409	630.87	409.11	412	75.60	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			284.9	D08		9	0143-0415	912.32	415.15	681	102.81	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			397.8	D08		9	0144-0413	410.62	413.37	395	73.84	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.7	D08		9	0145-0416	296.49	416.09	609	92.91	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			287.2	D08		9	0146-0415	210.30	414.22	360	72.53	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			233.8	D08		9	0147-0421	943.69	422.81	390	94.57	0.548
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			252.9	D08		9	0148-0424	144.14	422.40	940	120.95	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.1	D08		9	0149-0418	568.80	418.83	391	73.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.1	D08		9	0150-0426	458.36	426.56	387	71.60	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			226.7	D08		9	0151-0433	80.54	432.57	370	74.91	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.5	D08		9	0152-0439	352.40	439.52	386	74.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			193.3	D08		9	0153-0447	256.37	447.18	381	78.67	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.2	D08		9	0154-0450	757.46	449.77	377	73.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			227.9	D08		9	0155-0454	560.48	453.62	385	73.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			326.0	D08		9	0156-0458	870.25	458.05	663	95.74	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			218.6	D08		9	0157-0458	205.69	458.53	371	71.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			284.4	D08		9	0158-0458	329.27	458.74	406	75.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			283.4	D08		9	0159-0458	650.51	458.66	398	75.26	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.1	D08		9	0160-0462	520.47	462.25	402	75.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			211.7	D08		9	0161-0467	263.57	467.17	452	83.26	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			199.3	D08		9	0162-0468	16.54	467.93	374	71.84	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.6	D08		9	0163-0472	403.79	472.47	402	76.18	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			273.9	D08		9	0164-0477	903.92	477.48	517	86.33	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			214.0	D08		9	0165-0492	90.84	491.39	786	115.40	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			235.7	D08		9	0166-0487	942.99	487.59	362	71.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			218.0	D08		9	0167-0499	186.12	500.16	391	75.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.7	D08		9	0168-0502	514.94	502.30	403	74.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.1	D08		9	0169-0509	862.02	509.84	373	71.84	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			303.4	D08		9	0170-0512	468.13	511.72	397	75.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			277.7	D08		9	0171-0513	775.33	513.07	380	74.67	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.5	D08		9	0172-0517	556.44	516.30	415	79.50	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.5	D08		9	0173-0520	270.30	519.66	642	94.33	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			214.0	D08		9	0174-0520	181.41	520.11	444	82.18	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.3	D08		9	0175-0532	226.41	531.71	396	73.84	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			340.0	D08		9	0176-0537	542.74	538.48	362	74.77	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			281.1	D08		9	0177-0540	403.69	540.32	346	69.94	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			413.3	D08		9	0178-0545	561.00	545.00	297	67.60	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			230.3	D08		9	0179-0544	944.64	544.28	384	73.26	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			373.7	D08		9	0180-0546	841.98	546.34	389	72.43	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			298.7	D08		9	0181-0550	301.68	550.16	392	73.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.5	D08		9	0182-0561	415.75	561.58	694	106.23	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			551.9	D08		9	0183-0555	544.47	555.11	252	61.46	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			235.5	D08		9	0184-0562	514.95	562.28	417	76.67	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.6	D08		9	0185-0569	793.03	569.10	400	75.84	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.7	D08		9	0186-0572	258.47	571.14	339	70.91	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.7	D08		9	0187-0582	210.17	582.11	368	73.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			316.6	D08		9	0188-0584	273.44	585.56	492	85.88	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.2	D08		9	0189-0583	903.29	582.47	449	79.50	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			304.7	D08		9	0190-0586	660.06	585.62	380	73.84	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			298.8	D08		9	0191-0595	175.90	595.08	377	73.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			298.3	D08		9	0192-0601	327.94	601.43	383	73.01	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.9	D08		9	0193-0602	461.92	602.65	373	71.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.3	D08		9	0194-0611	659.43	611.53	398	74.67	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			216.4	D08		9	0195-0611	904.60	611.52	385	73.26	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			268.8	D08		9	0196-0615	23.70	614.59	387	75.01	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.9	D08		9	0197-0621	489.54	621.59	400	74.43	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.9	D08		9	0198-0623	814.69	623.36	394	74.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			211.2	D08		9	0199-0627	281.70	626.41	385	73.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.2	D08		9	0200-0631	862.18	631.39	385	73.60	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			223.3	D08		9	0201-0634	165.99	634.41	427	77.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.1	D08		9	0202-0648	628.33	646.60	406	78.33	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.9	D08		9	0203-0647	399.11	647.27	413	76.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			311.1	D08		9	0204-0647	522.59	648.08	369	73.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			283.5	D08		9	0205-0652	900.01	652.45	351	69.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.9	D08		9	0206-0655	100.16	655.09	375	76.33	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			322.7	D08		9	0207-0663	616.05	664.54	508	86.57	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			257.5	D08		9	0208-0667	123.12	666.61	455	80.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.2	D08		9	0209-0669	561.54	668.87	382	72.43	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			219.5	D08		9	0210-0676	20.62	676.36	402	73.84	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			212.3	D08		9	0211-0678	512.28	677.79	408	75.50	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			203.0	D08		9	0212-0678	676.22	677.75	470	82.08	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			222.3	D08		9	0213-0694	165.23	693.52	415	76.91	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.1	D08		9	0214-0699	536.83	699.76	921	117.30	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.9	D08		9	0215-0693	258.74	693.52	405	75.26	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.6	D08		9	0216-0696	605.92	696.41	379	73.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			228.5	D08		9	0217-0700	784.99	699.49	381	74.67	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			227.2	E08		1	0001-0030	45.07	30.65	419	80.67	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			304.6	E08		1	0002-0042	167.76	42.28	443	77.60	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			370.5	E08		1	0003-0041	625.93	41.06	415	75.01	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			449.4	E08		1	0004-0042	714.23	42.07	387	73.01	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			502.0	E08		1	0005-0046	412.33	45.77	490	84.57	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			289.4	E08		1	0006-0048	453.57	48.42	492	82.08	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			327.2	E08		1	0007-0053	567.12	53.63	471	82.08	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			397.7	E08		1	0008-0063	182.59	62.93	485	84.33	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			347.1	E08		1	0009-0067	34.57	67.11	550	86.91	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			338.9	E08		1	0010-0075	78.32	74.79	442	77.84	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			502.8	E08		1	0011-0073	829.94	73.27	221	56.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			327.2	E08		1	0012-0088	611.67	88.17	454	79.26	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			363.0	E08		1	0013-0088	502.07	88.60	548	90.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			308.1	E08		1	0014-0086	852.50	87.02	282	66.53	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			373.6	E08		1	0015-0091	719.29	91.65	462	80.08	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			310.3	E08		1	0016-0091	524.71	92.67	373	76.53	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			294.0	E08		1	0017-0098	47.05	98.76	435	77.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			377.2	E08		1	0018-0100	168.02	100.31	424	76.43	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			320.6	E08		1	0019-0100	281.75	99.91	402	73.60	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			306.7	E08		1	0020-0101	804.02	101.06	404	76.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.9	E08		1	0021-0101	759.55	101.44	445	79.84	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			393.8	E08		1	0022-0107	241.68	107.62	782	109.05	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			341.5	E08		1	0023-0107	355.42	107.05	439	76.43	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			473.6	E08		1	0024-0114	690.88	114.24	486	81.84	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			315.5	E08		1	0025-0121	127.38	120.85	508	89.74	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			279.6	E08		1	0026-0128	900.25	128.11	430	79.60	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			310.6	E08		1	0027-0133	881.34	132.98	363	74.18	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			334.2	E08		1	0028-0136	456.29	136.38	497	86.77	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			348.0	E08		1	0029-0143	481.89	143.29	489	88.67	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			472.2	E08		1	0030-0146	52.86	146.04	428	76.43	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			321.6	E08		1	0031-0149	733.33	148.93	470	84.08	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.4	E08		1	0032-0152	636.15	151.24	411	81.50	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			289.5	E08		1	0033-0156	179.65	155.98	413	75.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			315.1	E08		1	0034-0158	695.52	158.70	454	79.26	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			323.1	E08		1	0035-0163	356.63	163.51	438	80.67	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			567.2	E08		1	0036-0167	538.52	166.59	422	77.26	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.5	E08		1	0037-0167	625.67	168.24	495	85.74	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			524.4	E08		1	0038-0181	256.69	180.51	798	105.40	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			401.3	E08		1	0039-0177	940.24	176.77	643	113.98	0.622
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			378.4	E08		1	0040-0182	919.56	184.38	246	70.43	0.623
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			290.4	E08		1	0041-0188	417.75	187.91	483	82.91	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.7	E08		1	0042-0193	890.39	193.06	442	76.67	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			285.1	E08		1	0043-0198	114.34	198.34	433	77.84	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			279.8	E08		1	0044-0197	159.98	196.69	427	75.84	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			331.3	E08		1	0045-0199	194.67	198.65	454	80.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			324.7	E08		1	0046-0201	473.12	201.79	429	77.26	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.3	E08		1	0047-0203	52.74	203.81	405	75.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.5	E08		1	0048-0205	90.17	204.94	458	80.91	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			306.0	E08		1	0049-0205	597.63	204.93	433	76.43	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			631.5	E08		1	0050-0207	801.58	207.66	443	78.67	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			322.8	E08		1	0051-0216	416.35	216.78	451	79.50	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.2	E08		1	0052-0222	646.65	223.11	432	79.50	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			323.7	E08		1	0053-0228	871.80	227.91	434	78.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.4	E08		1	0054-0226	549.57	226.53	449	78.43	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			353.8	E08		1	0055-0228	840.53	228.39	456	82.33	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.1	E08		1	0056-0230	38.92	230.56	395	73.26	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.4	E08		1	0057-0245	203.72	245.39	997	129.78	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.1	E08		1	0058-0242	477.31	241.90	432	77.26	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			294.4	E08		1	0059-0243	328.76	243.39	580	90.08	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			440.4	E08		1	0060-0251	898.82	251.02	446	77.84	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			296.8	E08		1	0061-0252	519.77	252.54	428	77.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			311.0	E08		1	0062-0253	294.10	253.48	444	77.84	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			290.5	E08		1	0063-0253	767.58	253.20	426	77.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.7	E08		1	0064-0262	151.82	262.30	429	77.01	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			492.0	E08		1	0065-0269	833.89	269.22	638	92.91	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.6	E08		1	0066-0272	70.77	270.22	706	105.30	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			232.8	E08		1	0067-0269	232.72	268.95	431	77.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.6	E08		1	0068-0269	364.87	269.58	436	79.50	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			362.6	E08		1	0069-0270	581.58	269.89	455	79.26	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.0	E08		1	0070-0281	485.61	280.87	432	78.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			270.4	E08		1	0071-0289	84.53	290.53	682	104.71	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			209.7	E08		1	0072-0289	194.45	288.69	460	80.67	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.1	E08		1	0073-0288	264.75	288.32	431	77.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.7	E08		1	0074-0293	797.62	293.31	481	84.08	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.5	E08		1	0075-0305	755.92	305.48	433	77.26	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			308.2	E08		1	0076-0304	24.11	305.07	407	77.26	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			218.5	E08		1	0077-0304	106.05	305.36	391	74.08	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			313.1	E08		1	0078-0311	708.14	311.30	480	83.74	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.9	E08		1	0079-0324	426.88	324.06	459	80.67	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.8	E08		1	0080-0325	155.70	324.92	410	75.26	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.1	E08		1	0081-0325	510.81	325.96	429	79.50	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			340.6	E08		1	0082-0328	277.00	327.76	413	75.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			290.9	E08		1	0083-0342	555.08	342.00	894	117.64	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			332.8	E08		1	0084-0345	354.40	344.76	908	122.57	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.9	E08		1	0085-0336	328.34	336.14	460	79.60	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			332.1	E08		1	0086-0337	189.42	337.44	426	77.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			614.5	E08		1	0087-0339	465.96	338.48	395	75.70	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.5	E08		1	0088-0339	801.06	339.25	480	81.26	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			478.7	E08		1	0089-0341	484.56	340.81	352	70.87	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.4	E08		1	0090-0351	904.71	350.58	428	78.08	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.6	E08		1	0091-0352	928.99	351.53	454	80.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			234.0	E08		1	0092-0351	95.71	351.12	406	75.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			326.4	E08		1	0093-0357	647.60	356.77	433	78.91	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			386.4	E08		1	0094-0370	457.83	370.44	943	123.64	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			303.9	E08		1	0095-0361	501.42	360.90	351	71.94	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			390.8	E08		1	0096-0371	663.63	371.45	456	84.57	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.8	E08		1	0097-0368	188.22	368.04	436	79.50	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			293.7	E08		1	0098-0371	596.97	371.40	448	79.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			215.6	E08		1	0099-0370	63.32	370.48	412	78.08	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.7	E08		1	0100-0369	275.88	369.77	423	76.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			303.5	E08		1	0101-0379	508.26	379.37	483	86.67	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			472.3	E08		1	0102-0380	816.50	380.84	437	79.50	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			540.4	E08		1	0103-0392	674.25	392.50	491	83.26	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.3	E08		1	0104-0392	134.34	392.60	425	76.43	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			367.2	E08		1	0105-0395	787.89	394.74	460	80.08	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			499.8	E08		1	0106-0397	710.62	397.69	428	77.84	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			316.6	E08		1	0107-0404	622.35	404.81	425	77.26	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			332.3	E08		1	0108-0408	927.12	408.71	622	92.91	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.6	E08		1	0109-0408	202.68	407.87	460	82.08	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			294.3	E08		1	0110-0410	447.45	410.02	447	79.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.7	E08		1	0111-0410	524.60	409.87	428	77.26	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.8	E08		1	0112-0412	230.55	412.57	450	80.08	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			222.2	E08		1	0113-0421	62.27	421.92	824	114.71	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			397.9	E08		1	0114-0414	389.83	414.33	420	76.91	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.9	E08		1	0115-0418	264.20	418.41	416	76.67	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			289.3	E08		1	0116-0419	884.01	419.03	418	77.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.3	E08		1	0117-0420	149.68	421.22	460	85.50	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			301.4	E08		1	0118-0424	786.24	424.27	462	82.18	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			396.6	E08		1	0119-0424	585.75	424.81	484	82.08	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.4	E08		1	0120-0424	113.98	424.14	456	78.67	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			338.5	E08		1	0121-0430	738.05	430.83	419	75.84	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.1	E08		1	0122-0437	548.25	437.22	430	77.26	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			298.7	E08		1	0123-0443	679.62	443.50	452	78.43	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			307.2	E08		1	0124-0452	452.68	451.69	956	125.68	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			183.0	E08		1	0125-0455	21.35	455.63	811	114.33	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			545.1	E08		1	0126-0448	861.22	449.47	388	74.04	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			252.9	E08		1	0127-0452	942.36	452.57	419	78.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.9	E08		1	0128-0455	97.13	455.50	413	79.84	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			426.5	E08		1	0129-0458	378.27	458.43	435	76.67	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.1	E08		1	0130-0461	192.39	459.84	436	78.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.2	E08		1	0131-0460	249.49	459.97	406	74.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			268.7	E08		1	0132-0463	493.64	462.81	434	78.08	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.5	E08		1	0133-0462	739.66	462.49	417	77.26	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			320.3	E08		1	0134-0470	301.00	469.97	456	82.08	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			316.9	E08		1	0135-0469	532.78	469.25	421	78.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			419.2	E08		1	0136-0467	582.60	466.82	405	74.18	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			370.9	E08		1	0137-0473	855.50	471.79	473	91.84	0.705
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.9	E08		1	0138-0475	110.41	475.53	551	93.60	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.6	E08		1	0139-0477	875.10	477.05	463	83.15	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.4	E08		1	0140-0476	680.21	476.62	444	77.84	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.8	E08		1	0141-0480	136.78	480.05	414	77.36	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.4	E08		1	0142-0490	209.33	490.94	904	124.23	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.7	E08		1	0143-0486	620.14	486.40	460	80.67	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.3	E08		1	0144-0485	752.77	484.45	423	76.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.9	E08		1	0145-0495	165.67	495.01	458	79.26	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.5	E08		1	0146-0498	885.52	498.56	448	80.33	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			363.3	E08		1	0147-0496	358.26	496.12	412	75.84	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			291.4	E08		1	0148-0502	272.90	501.84	428	78.08	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.4	E08		1	0149-0503	538.56	503.36	440	79.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			270.8	E08		1	0150-0504	591.68	504.75	436	77.84	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			291.6	E08		1	0151-0508	54.27	507.66	446	82.33	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			296.0	E08		1	0152-0510	455.95	510.37	437	78.91	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			273.8	E08		1	0153-0520	219.13	519.44	450	81.36	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.0	E08		1	0154-0522	187.38	522.40	432	83.50	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			360.0	E08		1	0155-0523	792.97	523.36	427	78.67	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			353.5	E08		1	0156-0527	307.68	528.11	430	80.53	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			387.8	E08		1	0157-0531	68.21	531.31	459	82.08	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.1	E08		1	0158-0529	624.88	529.41	418	77.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			259.3	E08		1	0159-0530	716.03	530.46	419	75.84	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			481.9	E08		1	0160-0529	850.33	529.04	149	80.57	0.288
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			399.3	E08		1	0161-0537	112.53	537.02	423	76.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			204.0	E08		1	0162-0543	18.86	543.23	388	76.08	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			306.3	E08		1	0163-0545	650.13	545.60	446	80.33	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			221.7	E08		1	0164-0546	936.83	546.77	456	82.43	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			299.9	E08		1	0165-0547	407.42	546.67	432	77.26	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.9	E08		1	0166-0549	307.82	547.82	469	84.53	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.7	E08		1	0167-0550	162.08	550.18	396	76.43	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			279.0	E08		1	0168-0550	588.08	550.21	436	76.43	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			233.0	E08		1	0169-0558	202.67	558.45	848	115.54	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			234.4	E08		1	0170-0555	49.17	555.21	173	51.11	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			373.2	E08		1	0171-0559	264.46	558.77	440	77.60	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.4	E08		1	0172-0567	884.03	567.85	446	79.84	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.5	E08		1	0173-0568	916.26	568.48	440	81.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			386.6	E08		1	0174-0569	340.67	568.74	461	80.91	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.2	E08		1	0175-0575	375.94	575.06	717	100.57	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			309.6	E08		1	0176-0572	492.05	571.93	452	79.26	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.7	E08		1	0177-0584	120.96	583.77	855	117.50	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.9	E08		1	0178-0588	729.45	587.53	442	78.67	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.6	E08		1	0179-0600	777.15	599.75	450	80.67	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.7	E08		1	0180-0601	931.97	601.38	424	78.91	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.7	E08		1	0181-0604	627.24	604.09	475	82.91	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			378.1	E08		1	0182-0606	347.15	606.58	459	81.26	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			388.3	E08		1	0183-0618	391.24	618.44	390	73.84	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			252.9	E08		1	0184-0620	797.93	620.38	546	91.60	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.2	E08		1	0185-0637	64.60	637.63	890	119.30	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			259.2	E08		1	0186-0631	719.70	631.93	467	81.60	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			310.5	E08		1	0187-0631	176.97	631.35	403	76.67	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			358.0	E08		1	0188-0631	697.91	631.62	408	74.53	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.0	E08		1	0189-0632	215.71	632.05	430	79.50	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			220.1	E08		1	0190-0637	18.73	637.73	398	78.91	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.8	E08		1	0191-0635	553.23	634.85	420	77.26	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			364.0	E08		1	0192-0640	93.70	640.64	451	79.74	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.5	E08		1	0193-0639	869.53	638.74	414	76.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			442.5	E08		1	0194-0643	330.43	643.90	423	76.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			302.5	E08		1	0195-0655	426.54	655.75	880	119.05	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.6	E08		1	0196-0651	773.20	651.09	440	77.84	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.4	E08		1	0197-0655	649.45	655.53	469	82.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			413.1	E08		1	0198-0655	388.48	654.75	422	78.67	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			530.0	E08		1	0199-0654	481.44	654.30	409	75.01	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.1	E08		1	0200-0660	517.44	660.08	452	80.91	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.8	E08		1	0201-0661	932.46	661.06	366	71.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			356.0	E08		1	0202-0662	256.71	662.73	437	83.60	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			378.9	E08		1	0203-0666	826.30	664.91	413	79.15	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			337.6	E08		1	0204-0678	175.43	678.36	407	77.11	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.7	E08		1	0205-0678	554.22	678.45	450	81.26	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.5	E08		1	0206-0678	633.42	677.98	463	82.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.4	E08		1	0207-0678	841.42	678.77	388	74.33	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			350.0	E08		1	0208-0682	195.20	682.98	450	81.11	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			410.5	E08		1	0209-0683	262.51	682.34	435	82.18	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			211.9	E08		1	0210-0688	499.60	687.89	420	78.43	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			336.2	E08		1	0211-0690	890.26	690.34	383	71.60	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			227.7	E08		1	0212-0693	757.85	693.38	439	78.08	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.4	E08		1	0213-0695	110.13	695.18	404	77.50	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			228.9	E08		1	0214-0702	565.03	701.68	495	86.08	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			228.0	E08		1	0215-0707	378.50	706.73	399	75.84	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			460.1	E08		1	0216-0708	471.87	707.00	351	73.26	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			298.8	E08		2	0001-0027	890.67	26.94	374	73.01	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.0	E08		2	0002-0034	802.74	33.78	411	77.26	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			281.1	E08		2	0003-0044	398.89	44.05	408	77.50	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.0	E08		2	0004-0045	267.59	45.26	384	75.01	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			273.6	E08		2	0005-0060	539.47	60.49	420	77.26	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			294.0	E08		2	0006-0061	333.18	61.84	459	82.67	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.2	E08		2	0007-0062	725.90	61.80	405	76.67	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			362.4	E08		2	0008-0070	697.13	69.59	751	109.40	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.0	E08		2	0009-0064	854.95	64.08	402	74.43	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			443.0	E08		2	0010-0068	564.60	67.98	393	74.43	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			401.4	E08		2	0011-0069	311.70	68.45	377	75.60	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.9	E08		2	0012-0074	139.75	73.75	380	73.26	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			293.0	E08		2	0013-0079	623.33	79.13	403	75.84	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			259.9	E08		2	0014-0080	806.89	80.21	477	87.26	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.7	E08		2	0015-0080	193.12	80.01	410	78.33	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.3	E08		2	0016-0080	243.00	80.22	382	75.26	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			306.2	E08		2	0017-0079	410.94	79.08	423	77.60	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			346.7	E08		2	0018-0084	785.43	83.93	358	70.53	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			235.7	E08		2	0019-0093	67.94	93.43	387	76.08	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			536.0	E08		2	0020-0097	274.93	97.74	306	64.77	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			530.6	E08		2	0021-0104	136.10	104.59	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			273.2	E08		2	0022-0108	442.80	108.17	426	76.43	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			493.6	E08		2	0023-0111	362.97	110.55	364	71.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			273.6	E08		2	0024-0121	683.13	121.47	785	109.88	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.0	E08		2	0025-0123	483.35	123.12	381	73.26	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			283.9	E08		2	0026-0127	775.47	127.33	423	78.67	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.5	E08		2	0027-0130	354.62	131.04	437	81.50	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			312.6	E08		2	0028-0133	175.78	133.20	395	76.08	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.9	E08		2	0029-0133	850.39	133.45	427	78.67	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			332.0	E08		2	0030-0135	378.24	135.97	430	77.26	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.3	E08		2	0031-0140	234.73	139.82	400	76.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			330.6	E08		2	0032-0138	422.68	138.62	400	76.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			377.7	E08		2	0033-0147	100.48	147.50	491	83.50	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.5	E08		2	0034-0148	724.33	148.39	411	77.50	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			286.0	E08		2	0035-0149	909.00	149.21	391	75.60	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			291.1	E08		2	0036-0161	572.53	161.61	429	78.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.7	E08		2	0037-0166	805.96	164.76	428	77.98	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			345.5	E08		2	0038-0167	461.77	167.52	388	73.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			458.9	E08		2	0039-0169	138.99	169.37	396	73.01	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			226.3	E08		2	0040-0176	668.51	175.77	408	76.08	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			529.7	E08		2	0041-0170	27.63	170.20	115	43.11	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.6	E08		2	0042-0177	314.08	177.40	384	74.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			391.2	E08		2	0043-0179	46.42	178.70	548	92.57	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.7	E08		2	0044-0178	790.37	179.08	372	73.74	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.9	E08		2	0045-0182	402.87	182.10	409	75.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			284.5	E08		2	0046-0193	513.15	193.35	924	119.05	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			311.1	E08		2	0047-0184	24.07	185.47	235	66.43	0.669
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			435.3	E08		2	0048-0187	77.70	186.86	377	72.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.6	E08		2	0049-0187	877.36	186.70	392	74.08	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.1	E08		2	0050-0195	621.74	195.76	405	75.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			227.6	E08		2	0051-0193	258.36	193.62	382	75.60	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.4	E08		2	0052-0194	724.88	193.94	428	82.08	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.5	E08		2	0053-0203	168.99	203.55	395	76.67	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			458.5	E08		2	0054-0206	420.38	205.55	442	79.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.9	E08		2	0055-0207	827.80	207.35	418	75.01	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.6	E08		2	0056-0210	51.74	209.85	399	75.50	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.3	E08		2	0057-0222	369.13	222.56	396	74.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			504.1	E08		2	0058-0220	809.97	219.30	252	61.84	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			218.7	E08		2	0059-0225	138.35	225.82	377	76.33	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			326.7	E08		2	0060-0225	744.58	224.81	387	72.43	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			214.2	E08		2	0061-0227	215.53	227.48	439	82.67	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			315.2	E08		2	0062-0227	794.99	228.06	380	80.18	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			252.6	E08		2	0063-0238	563.83	238.32	597	91.26	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.2	E08		2	0064-0234	268.82	234.46	438	79.01	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.4	E08		2	0065-0248	329.53	248.37	391	74.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			286.7	E08		2	0066-0248	76.01	248.58	386	72.43	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.4	E08		2	0067-0258	791.77	257.78	926	128.23	0.708
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			283.8	E08		2	0068-0251	221.60	250.53	395	78.67	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.1	E08		2	0069-0251	679.71	251.58	412	75.01	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.3	E08		2	0070-0256	913.82	256.63	581	89.50	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.5	E08		2	0071-0260	634.98	259.87	382	72.77	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.4	E08		2	0072-0266	169.77	266.61	555	96.23	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.9	E08		2	0073-0264	451.20	264.72	414	76.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			235.5	E08		2	0074-0266	525.51	266.37	435	83.74	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.0	E08		2	0075-0274	371.77	274.85	796	111.64	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.4	E08		2	0076-0271	411.01	271.76	403	74.67	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			336.2	E08		2	0077-0270	500.82	269.96	400	77.01	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.8	E08		2	0078-0293	308.49	292.92	419	77.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.2	E08		2	0079-0294	470.07	294.22	400	77.50	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.0	E08		2	0080-0297	67.35	297.65	383	73.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.3	E08		2	0081-0302	901.77	302.16	369	72.87	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			437.7	E08		2	0082-0302	923.60	301.95	389	74.28	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			430.6	E08		2	0083-0305	581.73	305.14	373	71.84	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.3	E08		2	0084-0310	171.84	310.52	381	72.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.4	E08		2	0085-0312	544.73	312.04	408	74.18	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.9	E08		2	0086-0313	622.31	313.79	659	123.98	0.539
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.3	E08		2	0087-0318	272.44	318.88	401	73.36	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.7	E08		2	0088-0327	478.15	327.67	419	81.50	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.3	E08		2	0089-0329	142.75	328.87	383	71.60	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			374.3	E08		2	0090-0336	451.27	335.94	416	79.50	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.1	E08		2	0091-0339	252.17	339.52	404	75.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			349.9	E08		2	0092-0342	303.53	342.63	382	73.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.1	E08		2	0093-0344	403.85	343.81	406	78.91	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			349.3	E08		2	0094-0347	823.72	347.14	383	72.43	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			210.9	E08		2	0095-0348	69.00	348.26	383	74.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			268.6	E08		2	0096-0348	226.00	348.72	398	75.84	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			227.9	E08		2	0097-0352	33.51	352.30	399	76.91	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			428.1	E08		2	0098-0351	882.76	350.71	322	69.70	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			289.9	E08		2	0099-0362	151.49	362.52	394	74.67	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.7	E08		2	0100-0367	622.50	367.96	417	75.84	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			357.4	E08		2	0101-0371	347.12	371.36	439	78.67	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.3	E08		2	0102-0372	879.45	371.13	475	87.50	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			273.0	E08		2	0103-0380	574.82	380.03	402	76.08	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.6	E08		2	0104-0390	709.91	389.84	825	113.88	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			293.8	E08		2	0105-0388	95.79	388.54	386	75.50	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			324.3	E08		2	0106-0388	199.33	387.52	442	82.33	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			252.6	E08		2	0107-0390	526.13	389.65	420	80.57	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			268.3	E08		2	0108-0401	820.21	401.50	419	77.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.4	E08		2	0109-0402	510.01	403.04	445	80.08	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			203.2	E08		2	0110-0402	654.01	401.98	422	76.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			306.7	E08		2	0111-0406	219.36	406.64	536	89.64	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.1	E08		2	0112-0404	292.52	404.38	753	105.50	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			307.4	E08		2	0113-0409	30.77	409.53	628	93.15	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.2	E08		2	0114-0406	173.15	406.25	382	73.84	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			257.7	E08		2	0115-0408	120.03	408.10	388	75.26	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.4	E08		2	0116-0410	779.56	411.26	437	84.43	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.3	E08		2	0117-0413	750.21	412.69	398	75.60	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			347.0	E08		2	0118-0441	495.53	441.66	922	128.81	0.698
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			209.4	E08		2	0119-0435	202.35	435.47	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			347.1	E08		2	0120-0436	438.90	436.64	395	75.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			204.8	E08		2	0121-0439	144.52	438.62	374	72.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			259.0	E08		2	0122-0444	560.08	444.52	417	76.43	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.1	E08		2	0123-0453	46.63	453.32	389	75.84	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			397.5	E08		2	0124-0451	476.99	452.07	314	69.94	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.4	E08		2	0125-0449	761.44	448.87	161	77.50	0.337
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.2	E08		2	0126-0454	380.38	454.11	412	76.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.9	E08		2	0127-0457	649.09	457.94	398	76.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			292.2	E08		2	0128-0460	248.91	459.73	375	74.91	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			193.7	E08		2	0129-0471	91.12	471.08	805	114.47	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.9	E08		2	0130-0466	923.56	466.10	402	74.67	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			349.1	E08		2	0131-0477	221.96	477.90	722	103.05	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			236.5	E08		2	0132-0473	126.82	472.96	380	72.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			439.9	E08		2	0133-0472	870.35	472.08	319	66.18	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			286.4	E08		2	0134-0475	296.63	475.43	382	75.50	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			234.2	E08		2	0135-0477	173.58	476.81	382	73.84	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			466.7	E08		2	0136-0481	602.06	481.41	489	82.67	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.2	E08		2	0137-0490	676.30	490.47	392	75.26	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.4	E08		2	0138-0500	890.82	500.70	374	72.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.8	E08		2	0139-0501	940.01	500.65	370	73.01	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.1	E08		2	0140-0499	617.99	499.08	269	64.43	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			344.3	E08		2	0141-0506	302.68	506.09	559	89.40	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.3	E08		2	0142-0504	163.22	503.63	432	81.40	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			312.4	E08		2	0143-0504	847.40	504.03	393	74.43	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			539.4	E08		2	0144-0513	603.02	513.03	283	82.08	0.528
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			462.4	E08		2	0145-0527	375.90	526.51	730	103.05	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.6	E08		2	0146-0531	777.66	531.02	435	78.67	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			270.6	E08		2	0147-0540	145.54	540.61	745	109.15	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.4	E08		2	0148-0533	531.60	533.96	399	77.50	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			416.6	E08		2	0149-0534	666.34	534.51	401	74.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			491.2	E08		2	0150-0541	707.75	541.05	253	77.84	0.525
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.6	E08		2	0151-0547	41.41	547.08	409	78.67	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			311.4	E08		2	0152-0548	73.99	548.39	407	75.26	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			390.0	E08		2	0153-0555	105.27	555.72	398	75.84	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			298.9	E08		2	0154-0551	653.87	551.61	207	52.53	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			212.7	E08		2	0155-0558	832.33	558.28	416	79.26	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.6	E08		2	0156-0559	572.73	560.47	817	118.57	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			208.0	E08		2	0157-0560	929.68	559.82	380	74.43	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			202.7	E08		2	0158-0569	20.54	569.14	412	80.33	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			321.0	E08		2	0159-0566	270.34	566.66	420	77.26	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.4	E08		2	0160-0576	633.39	576.43	400	73.60	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			409.5	E08		2	0161-0581	471.44	581.79	526	85.50	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.4	E08		2	0162-0580	347.13	580.43	396	75.84	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.7	E08		2	0163-0582	505.16	581.77	399	73.84	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			352.4	E08		2	0164-0589	591.50	589.08	371	71.26	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			373.7	E08		2	0165-0591	682.30	591.53	370	71.84	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			221.2	E08		2	0166-0600	105.82	600.27	371	71.60	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			321.8	E08		2	0167-0601	285.15	601.69	377	71.84	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.3	E08		2	0168-0600	717.83	600.31	422	77.84	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			222.3	E08		2	0169-0602	35.81	602.43	398	73.84	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			303.9	E08		2	0170-0604	200.19	604.23	457	82.08	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			356.2	E08		2	0171-0604	540.79	603.75	393	73.84	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			268.5	E08		2	0172-0609	327.17	609.00	407	77.26	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			325.4	E08		2	0173-0609	774.63	609.18	414	75.36	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			232.8	E08		2	0174-0613	797.36	612.87	461	80.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.1	E08		2	0175-0626	196.09	626.48	437	81.60	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			396.4	E08		2	0176-0632	421.06	632.33	407	77.26	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			387.4	E08		2	0177-0646	106.32	646.56	414	76.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			235.7	E08		2	0178-0660	737.33	659.93	429	84.47	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.2	E08		2	0179-0657	466.58	656.53	399	79.26	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.5	E08		2	0180-0660	350.58	660.47	385	73.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.4	E08		2	0181-0661	524.65	661.60	401	74.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			310.7	E08		2	0182-0661	774.24	662.08	435	81.74	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			257.8	E08		2	0183-0662	36.19	661.90	361	71.84	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.1	E08		2	0184-0671	157.97	671.75	818	111.40	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			337.2	E08		2	0185-0662	872.90	662.01	666	128.61	0.506
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			307.1	E08		2	0186-0666	289.22	666.21	380	74.08	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			212.0	E08		2	0187-0674	70.95	674.70	366	75.01	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.5	E08		2	0188-0677	235.00	676.63	377	73.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			285.8	E08		2	0189-0684	563.26	684.31	396	73.84	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.1	E08		2	0190-0691	449.32	690.88	405	76.91	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			218.9	E08		2	0191-0696	716.43	696.13	248	75.50	0.547
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.1	E08		2	0192-0702	342.18	702.41	490	87.40	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			358.5	E08		2	0193-0702	591.30	701.65	379	73.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			222.7	E08		3	0001-0028	415.24	28.39	399	76.08	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.0	E08		3	0002-0036	582.81	36.50	835	114.95	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			378.6	E08		3	0003-0047	790.25	47.08	573	92.81	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			270.0	E08		3	0004-0047	632.71	47.54	348	69.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			220.7	E08		3	0005-0049	842.21	49.68	380	74.08	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			391.2	E08		3	0006-0059	49.64	58.78	679	99.98	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.3	E08		3	0007-0060	451.37	60.22	416	75.84	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			435.5	E08		3	0008-0064	479.63	62.90	740	108.81	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			191.5	E08		3	0009-0067	192.44	67.96	397	75.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.1	E08		3	0010-0067	523.81	67.54	485	83.26	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			211.1	E08		3	0011-0073	252.22	73.24	390	75.50	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.0	E08		3	0012-0076	425.67	75.91	395	75.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			338.3	E08		3	0013-0076	760.09	75.86	341	69.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			351.4	E08		3	0014-0076	803.99	77.07	365	72.18	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.5	E08		3	0015-0079	104.63	79.58	364	71.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			214.7	E08		3	0016-0081	144.10	81.90	430	80.08	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			560.4	E08		3	0017-0087	231.50	86.77	441	82.91	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			324.3	E08		3	0018-0093	904.56	92.91	288	64.18	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.8	E08		3	0019-0099	632.40	98.90	380	75.50	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.1	E08		3	0020-0099	801.64	99.31	406	77.36	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.8	E08		3	0021-0101	606.85	101.13	443	82.33	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			232.3	E08		3	0022-0104	69.86	104.40	367	71.60	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.6	E08		3	0023-0109	554.71	109.17	424	76.67	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.0	E08		3	0024-0111	520.13	111.51	384	73.01	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			264.7	E08		3	0025-0117	491.15	117.00	391	73.36	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.5	E08		3	0026-0121	454.17	121.55	394	75.94	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			360.4	E08		3	0027-0120	664.67	120.27	349	68.77	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.6	E08		3	0028-0125	605.34	126.10	451	82.43	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.5	E08		3	0029-0128	760.48	127.64	369	73.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			359.7	E08		3	0030-0133	283.91	133.14	379	77.74	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			428.5	E08		3	0031-0139	43.87	140.08	647	96.33	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.8	E08		3	0032-0141	838.44	141.63	356	70.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			289.8	E08		3	0033-0144	462.69	143.91	345	71.60	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			315.7	E08		3	0034-0147	403.48	147.68	423	79.74	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			293.1	E08		3	0035-0145	556.73	145.56	373	72.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.8	E08		3	0036-0148	936.63	147.82	359	70.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			155.2	E08		3	0037-0161	105.56	160.15	819	113.74	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			268.3	E08		3	0038-0161	159.37	161.40	377	74.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.0	E08		3	0039-0164	694.96	163.46	415	78.57	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			321.3	E08		3	0040-0165	620.89	164.85	366	71.84	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			367.1	E08		3	0041-0168	542.45	167.59	374	70.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			233.3	E08		3	0042-0172	861.79	172.65	398	74.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.2	E08		3	0043-0174	581.78	175.04	388	72.43	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			286.5	E08		3	0044-0177	683.05	178.30	328	70.91	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			303.9	E08		3	0045-0180	195.44	180.37	403	77.84	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			2107.1	E08		3	0046-0181	308.26	180.58	310	72.53	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			304.8	E08		3	0047-0192	761.51	191.65	599	91.26	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.1	E08		3	0048-0194	31.71	193.70	709	107.74	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			1498.0	E08		3	0049-0193	307.19	192.85	192	57.11	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			360.9	E08		3	0050-0210	253.54	209.53	363	71.26	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			233.4	E08		3	0051-0214	662.03	214.98	374	73.84	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			395.9	E08		3	0052-0225	202.17	225.33	359	70.67	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			277.0	E08		3	0053-0233	894.48	232.88	741	113.20	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			219.8	E08		3	0054-0226	681.37	224.84	416	77.74	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			319.7	E08		3	0055-0226	622.13	226.02	368	72.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			440.4	E08		3	0056-0230	231.70	229.44	406	77.50	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			327.8	E08		3	0057-0229	432.85	229.64	372	71.84	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			804.2	E08		3	0058-0233	377.23	232.95	380	72.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			215.0	E08		3	0059-0238	698.28	238.85	444	79.15	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			427.3	E08		3	0060-0239	113.51	238.68	366	72.67	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			277.8	E08		3	0061-0248	500.11	247.44	356	70.67	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			292.0	E08		3	0062-0251	752.47	251.41	385	75.26	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			234.7	E08		3	0063-0256	162.63	255.61	376	76.91	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.4	E08		3	0064-0276	640.98	276.20	848	126.02	0.671
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			284.7	E08		3	0065-0267	864.53	267.31	398	74.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.3	E08		3	0066-0277	682.08	277.03	520	85.50	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			296.0	E08		3	0067-0280	937.73	280.03	369	72.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.5	E08		3	0068-0282	619.21	283.03	418	80.67	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			322.7	E08		3	0069-0283	243.07	283.34	402	77.50	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			320.3	E08		3	0070-0286	502.83	286.56	398	75.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			350.4	E08		3	0071-0297	168.63	296.89	692	98.33	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			333.0	E08		3	0072-0293	818.20	293.63	379	73.01	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			658.2	E08		3	0073-0295	365.72	296.06	381	73.26	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.5	E08		3	0074-0299	700.88	298.65	369	72.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			409.2	E08		3	0075-0304	116.70	303.98	384	75.26	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			337.2	E08		3	0076-0316	211.94	316.42	415	75.01	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			310.4	E08		3	0077-0329	802.76	329.64	374	71.01	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			318.1	E08		3	0078-0326	851.75	326.91	277	65.60	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			221.2	E08		3	0079-0340	682.57	340.35	401	76.67	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			472.0	E08		3	0080-0346	414.42	345.62	377	70.77	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.1	E08		3	0081-0351	596.96	351.22	418	77.60	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.6	E08		3	0082-0353	446.26	353.58	383	73.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			306.6	E08		3	0083-0355	895.73	355.83	370	72.67	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			330.4	E08		3	0084-0363	202.60	363.08	387	74.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			118.0	E08		3	0085-0368	142.99	367.77	372	77.84	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			340.4	E08		3	0086-0368	796.25	368.49	398	75.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.9	E08		3	0087-0370	633.01	370.73	390	73.84	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			399.7	E08		3	0088-0373	817.02	373.12	337	67.11	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			283.4	E08		3	0089-0376	858.96	376.34	183	53.94	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			145.9	E08		3	0090-0381	323.92	381.41	369	71.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.5	E08		3	0091-0384	710.82	384.50	772	107.74	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			519.6	E08		3	0092-0392	230.06	392.60	411	78.91	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.7	E08		3	0093-0389	667.16	389.10	379	75.01	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			287.4	E08		3	0094-0390	911.86	389.80	341	71.60	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.6	E08		3	0095-0393	139.73	394.28	338	68.18	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			236.0	E08		3	0096-0397	444.60	396.62	591	99.84	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			419.0	E08		3	0097-0399	533.28	399.79	365	72.67	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			219.9	E08		3	0098-0402	246.58	402.44	379	75.26	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			233.8	E08		3	0099-0404	357.90	403.92	369	72.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.6	E08		3	0100-0415	486.20	414.77	845	118.61	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			204.5	E08		3	0101-0421	164.73	421.37	387	76.43	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			199.7	E08		3	0102-0421	285.05	421.10	395	73.84	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			298.7	E08		3	0103-0427	465.41	427.88	436	79.98	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			219.4	E08		3	0104-0427	322.12	427.69	395	73.26	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			299.2	E08		3	0105-0430	638.37	430.24	746	107.05	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			307.2	E08		3	0106-0430	686.73	430.73	378	73.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.1	E08		3	0107-0434	108.10	433.85	387	73.84	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.0	E08		3	0108-0437	59.84	437.40	376	72.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			511.6	E08		3	0109-0439	611.79	439.72	327	67.26	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			455.1	E08		3	0110-0452	856.28	453.15	186	66.77	0.524
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			379.1	E08		3	0111-0462	894.04	461.91	377	72.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.4	E08		3	0112-0469	598.73	470.62	823	111.54	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.7	E08		3	0113-0466	199.40	465.88	395	76.43	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.3	E08		3	0114-0463	864.99	464.80	169	61.11	0.569
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.9	E08		3	0115-0468	18.62	468.60	375	72.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			217.4	E08		3	0116-0477	537.51	477.00	395	73.84	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			226.7	E08		3	0117-0480	53.51	480.49	349	71.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.3	E08		3	0118-0489	512.63	489.10	419	78.33	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			219.4	E08		3	0119-0487	713.79	487.75	393	75.01	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			296.7	E08		3	0120-0488	757.30	487.96	396	76.43	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.1	E08		3	0121-0496	472.71	496.72	389	73.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			214.9	E08		3	0122-0498	409.66	497.78	366	71.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			211.8	E08		3	0123-0503	35.08	503.00	328	68.77	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			218.6	E08		3	0124-0506	169.29	506.84	401	77.60	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			531.2	E08		3	0125-0503	870.94	502.71	369	74.43	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			226.1	E08		3	0126-0513	109.46	513.19	361	72.43	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			277.1	E08		3	0127-0525	449.52	527.03	799	124.81	0.645
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			259.3	E08		3	0128-0515	252.53	515.56	362	73.84	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			203.1	E08		3	0129-0517	190.70	517.05	390	76.33	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			294.2	E08		3	0130-0517	776.83	517.42	340	68.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			298.7	E08		3	0131-0515	808.51	515.00	361	70.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			222.2	E08		3	0132-0521	742.37	520.71	393	75.26	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			252.5	E08		3	0133-0523	296.24	523.06	380	73.26	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			469.9	E08		3	0134-0527	339.69	527.96	523	127.30	0.406
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.0	E08		3	0135-0526	587.22	526.52	410	75.36	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			292.5	E08		3	0136-0530	680.35	529.55	417	77.26	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			213.8	E08		3	0137-0531	419.13	531.53	366	72.43	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.7	E08		3	0138-0534	548.07	534.35	414	78.08	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			338.2	E08		3	0139-0540	362.14	540.66	391	77.50	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.6	E08		3	0140-0545	139.63	544.61	373	77.50	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.6	E08		3	0141-0549	525.84	548.52	465	82.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			196.0	E08		3	0142-0556	83.76	556.33	752	107.40	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			368.2	E08		3	0143-0545	688.86	545.38	210	58.77	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			294.1	E08		3	0144-0552	271.47	551.69	372	76.08	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.1	E08		3	0145-0557	400.75	557.74	400	75.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			259.9	E08		3	0146-0558	57.64	557.53	415	78.67	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			542.5	E08		3	0147-0557	669.21	557.34	312	65.36	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			224.6	E08		3	0148-0562	24.51	562.19	357	71.60	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.2	E08		3	0149-0563	135.43	563.83	398	77.84	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			259.6	E08		3	0150-0563	342.88	563.66	410	79.01	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			228.0	E08		3	0151-0571	182.53	571.83	359	72.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			235.0	E08		3	0152-0581	582.33	580.93	438	79.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.5	E08		3	0153-0590	358.55	589.37	813	117.40	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.5	E08		3	0154-0586	902.42	586.52	384	73.26	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			277.6	E08		3	0155-0589	448.82	589.10	400	76.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.0	E08		3	0156-0593	768.02	593.82	407	74.08	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.8	E08		3	0157-0595	502.68	596.04	364	71.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			281.1	E08		3	0158-0604	831.40	603.98	362	73.60	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.3	E08		3	0159-0609	640.19	610.11	432	80.33	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.0	E08		3	0160-0611	850.23	611.63	370	74.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			277.9	E08		3	0161-0615	610.75	615.08	382	74.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			226.2	E08		3	0162-0628	536.77	627.71	417	78.08	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.2	E08		3	0163-0629	888.03	629.44	361	69.84	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			218.6	E08		3	0164-0638	173.63	638.96	773	108.23	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			291.4	E08		3	0165-0632	368.35	632.47	374	72.18	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			226.3	E08		3	0166-0635	289.51	635.13	365	72.43	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.6	E08		3	0167-0635	466.65	635.64	364	71.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.8	E08		3	0168-0640	241.54	639.77	373	75.01	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.1	E08		3	0169-0646	811.99	645.99	397	76.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			468.5	E08		3	0170-0653	50.79	652.78	721	100.23	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.3	E08		3	0171-0657	403.07	657.42	389	75.94	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			319.1	E08		3	0172-0669	131.11	669.24	419	79.74	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			234.4	E08		3	0173-0666	790.26	666.03	364	71.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			234.8	E08		3	0174-0669	769.70	669.44	437	82.67	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.1	E08		3	0175-0670	282.60	669.71	408	77.50	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			210.1	E08		3	0176-0670	336.02	669.89	373	72.67	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.2	E08		3	0177-0676	711.71	675.45	327	70.67	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			233.8	E08		3	0178-0675	902.93	675.77	440	80.57	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.4	E08		3	0179-0678	399.08	677.28	461	83.26	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.5	E08		3	0180-0679	461.52	678.85	335	71.70	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			204.3	E08		3	0181-0681	480.11	681.06	401	74.87	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			235.8	E08		3	0182-0683	883.11	684.29	410	76.33	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.7	E08		3	0183-0686	522.20	685.85	368	71.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			197.1	E08		3	0184-0687	119.99	686.81	247	61.26	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			178.4	E08		3	0185-0690	171.31	690.63	386	73.84	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			185.5	E08		3	0186-0692	290.70	692.65	416	78.67	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			327.3	E08		3	0187-0693	698.95	693.60	331	68.43	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			227.8	E08		3	0188-0696	753.16	696.63	394	74.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.5	E08		3	0189-0702	238.41	702.66	741	105.40	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			236.9	E08		4	0001-0029	376.31	29.33	422	79.50	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			453.5	E08		4	0002-0030	469.53	29.71	401	77.50	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.6	E08		4	0003-0032	326.73	31.62	416	76.67	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			286.3	E08		4	0004-0035	166.80	35.50	385	74.67	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.3	E08		4	0005-0034	539.01	34.48	445	82.43	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			335.1	E08		4	0006-0034	38.45	34.57	375	74.33	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			347.4	E08		4	0007-0036	206.75	36.76	415	80.57	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.4	E08		4	0008-0042	639.40	41.71	375	73.50	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.5	E08		4	0009-0047	481.05	47.22	481	85.98	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			375.0	E08		4	0010-0051	403.40	51.21	468	82.33	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			222.7	E08		4	0011-0061	606.13	61.23	465	82.08	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			233.9	E08		4	0012-0061	870.01	62.05	423	76.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			307.2	E08		4	0013-0064	814.30	64.40	384	72.77	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			310.7	E08		4	0014-0070	776.89	69.91	432	80.08	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			273.3	E08		4	0015-0069	362.99	69.22	421	80.33	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			225.6	E08		4	0016-0075	690.51	75.10	436	78.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			310.0	E08		4	0017-0076	236.77	76.65	410	77.50	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.1	E08		4	0018-0077	538.56	77.41	475	87.15	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			298.2	E08		4	0019-0084	839.75	83.66	374	72.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			202.4	E08		4	0020-0087	511.66	87.27	484	87.15	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.0	E08		4	0021-0100	67.65	99.83	411	77.26	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			277.0	E08		4	0022-0102	191.26	101.85	442	80.67	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.3	E08		4	0023-0106	411.29	105.96	766	104.91	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			380.8	E08		4	0024-0103	436.90	103.15	459	81.36	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			236.4	E08		4	0025-0103	24.48	103.70	398	75.84	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.2	E08		4	0026-0108	564.96	108.42	928	128.95	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			222.1	E08		4	0027-0110	667.55	110.64	870	122.95	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.2	E08		4	0028-0108	915.24	107.70	423	78.43	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			371.9	E08		4	0029-0119	369.86	119.71	872	117.64	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.0	E08		4	0030-0117	483.56	116.96	693	99.98	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.1	E08		4	0031-0133	735.08	133.36	872	128.51	0.664
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			236.9	E08		4	0032-0132	793.21	132.41	434	79.50	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			367.3	E08		4	0033-0135	590.91	134.99	441	78.91	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			291.0	E08		4	0034-0138	284.81	138.69	455	83.15	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			279.6	E08		4	0035-0141	624.33	140.81	426	82.57	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			449.9	E08		4	0036-0140	258.61	140.15	317	69.50	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			337.5	E08		4	0037-0144	195.41	144.54	413	77.50	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.6	E08		4	0038-0144	893.43	144.56	395	74.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			369.3	E08		4	0039-0148	364.65	148.27	417	80.33	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			382.1	E08		4	0040-0164	122.86	165.55	853	117.78	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			315.8	E08		4	0041-0158	345.00	157.93	466	85.15	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.1	E08		4	0042-0158	658.78	158.60	415	76.67	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			279.7	E08		4	0043-0162	39.75	161.75	398	74.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			376.1	E08		4	0044-0163	477.58	162.65	392	73.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			196.8	E08		4	0045-0171	757.86	171.71	411	81.50	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.1	E08		4	0046-0179	690.09	179.95	451	82.91	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.4	E08		4	0047-0181	509.76	179.71	436	82.47	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			424.8	E08		4	0048-0180	423.86	179.86	449	82.91	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.4	E08		4	0049-0188	634.58	188.58	481	83.74	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			313.8	E08		4	0050-0191	491.16	193.10	435	82.33	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			227.0	E08		4	0051-0192	794.75	192.31	428	78.08	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			307.4	E08		4	0052-0197	550.39	197.01	414	79.26	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			290.2	E08		4	0053-0197	831.67	197.45	401	76.08	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			289.7	E08		4	0054-0202	411.77	202.14	485	90.33	0.747
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.8	E08		4	0055-0211	606.56	211.27	947	125.44	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.8	E08		4	0056-0206	385.02	206.39	456	82.67	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			318.9	E08		4	0057-0209	242.02	207.81	446	81.88	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			268.9	E08		4	0058-0212	67.31	211.81	423	79.26	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			348.9	E08		4	0059-0210	286.99	210.26	423	78.08	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			226.6	E08		4	0060-0216	726.80	215.88	427	77.50	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			291.7	E08		4	0061-0221	226.57	222.17	395	78.23	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			408.2	E08		4	0062-0222	544.15	222.08	490	86.18	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			213.6	E08		4	0063-0220	777.29	220.48	419	76.67	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			294.0	E08		4	0064-0230	350.24	230.09	407	76.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.1	E08		4	0065-0235	698.65	235.23	431	82.81	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			343.8	E08		4	0066-0235	390.33	235.47	392	75.50	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			298.9	E08		4	0067-0243	108.57	243.69	401	77.50	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			221.2	E08		4	0068-0246	838.49	246.20	452	80.91	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.3	E08		4	0069-0248	543.64	247.86	431	78.43	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			212.7	E08		4	0070-0248	753.37	248.95	404	77.50	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.3	E08		4	0071-0248	451.53	248.74	468	84.77	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.1	E08		4	0072-0252	323.73	252.20	406	77.26	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.1	E08		4	0073-0254	473.20	254.32	420	80.18	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			345.1	E08		4	0074-0255	912.05	255.95	362	71.26	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.8	E08		4	0075-0258	640.31	258.51	486	85.50	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.1	E08		4	0076-0260	665.44	259.77	452	83.50	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.2	E08		4	0077-0263	872.41	263.11	474	83.50	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.3	E08		4	0078-0266	367.06	265.64	415	76.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			370.3	E08		4	0079-0268	780.52	268.02	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.0	E08		4	0080-0274	179.37	274.15	430	77.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.3	E08		4	0081-0280	251.34	280.48	399	75.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			321.4	E08		4	0082-0286	526.38	286.29	418	77.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			341.0	E08		4	0083-0291	805.27	290.90	691	98.57	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.1	E08		4	0084-0289	415.43	289.20	429	80.08	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.6	E08		4	0085-0303	165.61	303.77	430	77.84	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.0	E08		4	0086-0308	709.10	308.30	472	83.26	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.7	E08		4	0087-0311	288.03	311.72	406	79.50	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			211.8	E08		4	0088-0312	901.72	311.94	422	76.43	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			301.0	E08		4	0089-0318	685.82	317.83	441	80.67	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			10999.4	E08		4	0090-0323	249.96	323.02	742	104.47	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.4	E08		4	0091-0322	624.79	322.52	399	76.08	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.8	E08		4	0092-0322	943.40	322.65	381	73.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.1	E08		4	0093-0347	676.81	348.17	412	76.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			233.5	E08		4	0094-0349	750.47	349.19	842	119.64	0.739
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.3	E08		4	0095-0349	136.05	348.74	396	76.91	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			328.2	E08		4	0096-0353	704.85	353.22	416	78.91	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			293.2	E08		4	0097-0361	338.63	362.11	810	111.88	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.4	E08		4	0098-0357	564.43	357.09	460	82.77	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			236.9	E08		4	0099-0359	203.75	359.23	427	80.33	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.5	E08		4	0100-0362	531.38	361.51	870	114.57	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.0	E08		4	0101-0364	616.58	364.28	423	75.84	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.7	E08		4	0102-0370	180.75	369.39	448	80.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.3	E08		4	0103-0375	83.23	375.25	391	78.33	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			343.0	E08		4	0104-0377	425.81	377.11	425	78.91	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			303.3	E08		4	0105-0386	288.74	385.59	897	123.88	0.734
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			530.5	E08		4	0106-0384	871.17	383.61	342	68.18	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.7	E08		4	0107-0389	24.18	389.00	376	74.67	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			318.4	E08		4	0108-0387	258.24	387.51	410	78.53	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.3	E08		4	0109-0393	491.32	393.10	437	83.15	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.7	E08		4	0110-0396	552.04	394.76	415	80.23	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			209.3	E08		4	0111-0398	738.64	397.49	397	74.43	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			355.0	E08		4	0112-0399	684.04	398.75	412	76.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			399.8	E08		4	0113-0407	389.42	406.76	529	94.91	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.2	E08		4	0114-0407	589.34	406.88	420	78.67	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.0	E08		4	0115-0406	920.59	406.58	440	77.26	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			370.4	E08		4	0116-0413	532.50	414.86	753	104.47	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.1	E08		4	0117-0413	233.92	412.73	412	77.26	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.1	E08		4	0118-0411	359.40	410.70	415	78.08	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.8	E08		4	0119-0413	630.06	411.74	381	77.64	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.3	E08		4	0120-0419	285.91	418.45	839	108.81	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.6	E08		4	0121-0421	695.14	420.42	479	90.81	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.3	E08		4	0122-0419	436.31	419.40	407	76.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.1	E08		4	0123-0425	110.14	425.64	562	94.81	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			321.6	E08		4	0124-0426	645.96	426.73	455	80.57	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.8	E08		4	0125-0425	866.84	425.04	392	76.91	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.5	E08		4	0126-0426	382.97	426.70	214	60.77	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.2	E08		4	0127-0431	777.43	430.82	454	83.15	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.2	E08		4	0128-0436	705.74	437.07	413	81.98	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.6	E08		4	0129-0435	319.58	435.80	410	76.08	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.8	E08		4	0130-0446	599.20	446.02	744	100.81	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			404.0	E08		4	0131-0448	163.99	448.51	430	78.08	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.3	E08		4	0132-0456	276.89	456.42	424	78.08	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.2	E08		4	0133-0459	905.75	457.52	380	75.98	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			270.9	E08		4	0134-0468	888.60	469.74	418	79.74	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			333.4	E08		4	0135-0474	695.70	474.53	764	106.23	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.7	E08		4	0136-0477	370.65	476.79	426	80.81	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.7	E08		4	0137-0481	112.68	481.24	401	78.33	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.7	E08		4	0138-0488	213.74	488.34	406	78.67	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.2	E08		4	0139-0486	603.59	485.86	424	78.91	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.6	E08		4	0140-0492	76.49	492.01	442	82.33	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.5	E08		4	0141-0490	307.38	490.29	448	81.50	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			316.1	E08		4	0142-0495	355.80	495.48	508	86.57	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.1	E08		4	0143-0498	530.91	497.54	426	78.43	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			270.3	E08		4	0144-0508	936.11	508.18	411	76.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			355.8	E08		4	0145-0516	640.42	515.71	391	73.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.5	E08		4	0146-0518	385.44	518.92	445	83.98	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			227.7	E08		4	0147-0526	569.04	526.32	431	80.33	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.6	E08		4	0148-0525	428.94	525.80	418	80.33	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			216.5	E08		4	0149-0528	701.21	528.02	431	79.50	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			331.0	E08		4	0150-0535	118.78	535.26	432	80.91	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			279.2	E08		4	0151-0535	367.11	534.85	449	81.74	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			273.9	E08		4	0152-0538	154.87	538.00	401	75.74	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			220.5	E08		4	0153-0542	403.90	541.72	447	84.33	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.6	E08		4	0154-0546	617.77	545.48	421	78.67	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			346.3	E08		4	0155-0553	247.29	552.85	707	100.23	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.3	E08		4	0156-0546	851.67	546.21	400	76.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.9	E08		4	0157-0551	755.90	550.92	400	75.01	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.9	E08		4	0158-0555	509.69	555.50	513	86.33	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			218.3	E08		4	0159-0566	449.55	566.71	846	114.47	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			259.4	E08		4	0160-0565	325.54	565.58	446	78.91	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			224.0	E08		4	0161-0565	718.66	565.16	417	77.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.2	E08		4	0162-0578	581.05	578.21	405	77.26	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.2	E08		4	0163-0584	352.77	585.09	409	78.91	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			284.8	E08		4	0164-0586	644.49	587.18	809	110.81	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.3	E08		4	0165-0599	386.32	598.68	902	122.02	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.5	E08		4	0166-0597	820.30	597.28	403	79.50	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			203.9	E08		4	0167-0597	902.14	597.37	399	74.43	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.9	E08		4	0168-0601	522.22	601.39	413	77.84	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.9	E08		4	0169-0610	858.65	610.57	427	79.50	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			302.2	E08		4	0170-0611	197.02	610.95	439	80.91	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			217.1	E08		4	0171-0610	713.64	610.13	416	77.84	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			385.3	E08		4	0172-0612	777.81	612.44	373	70.77	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			410.4	E08		4	0173-0617	442.56	617.16	390	75.50	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.1	E08		4	0174-0620	300.22	620.31	408	74.43	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.3	E08		4	0175-0623	818.13	622.92	476	84.08	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.8	E08		4	0176-0632	66.66	631.38	777	109.05	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			224.3	E08		4	0177-0638	333.96	638.20	438	79.74	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.3	E08		4	0178-0639	645.90	638.83	415	75.84	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.8	E08		4	0179-0644	254.30	643.97	410	75.84	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.3	E08		4	0180-0644	766.71	644.46	248	87.50	0.407
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			233.4	E08		4	0181-0649	475.70	648.79	796	111.64	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.4	E08		4	0182-0654	885.78	655.00	352	69.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			214.8	E08		4	0183-0656	36.38	656.07	390	73.26	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			187.4	E08		4	0184-0658	820.16	658.20	417	75.84	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			285.2	E08		4	0185-0666	109.47	665.99	445	80.91	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			209.3	E08		4	0186-0668	931.79	667.74	379	73.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.2	E08		4	0187-0670	764.69	670.90	426	79.74	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			209.2	E08		4	0188-0670	515.22	671.01	430	81.40	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			281.2	E08		4	0189-0672	228.59	672.38	446	80.67	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			217.9	E08		4	0190-0677	711.19	677.12	407	78.33	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			234.1	E08		4	0191-0680	362.66	680.49	407	74.18	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			224.9	E08		4	0192-0682	674.03	681.82	403	75.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			218.8	E08		4	0193-0688	31.90	688.55	387	75.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			177.2	E08		4	0194-0700	913.09	698.64	422	81.15	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			221.0	E08		4	0195-0699	177.40	699.16	425	77.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			187.7	E08		4	0196-0706	896.96	706.45	370	76.67	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			334.5	E08		4	0197-0705	451.24	705.04	393	73.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.8	E08		4	0198-0706	841.19	706.47	391	73.84	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.4	E08		5	0001-0036	912.92	36.08	697	97.74	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			549.7	E08		5	0002-0037	400.71	36.02	190	56.53	0.747
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			299.1	E08		5	0003-0042	383.54	44.47	533	95.15	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.2	E08		5	0004-0043	672.96	42.74	427	77.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			216.0	E08		5	0005-0047	55.66	46.50	612	93.98	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.0	E08		5	0006-0047	87.28	46.68	387	97.15	0.515
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.9	E08		5	0007-0044	186.17	44.47	395	73.84	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.3	E08		5	0008-0047	226.42	47.21	458	83.15	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			360.3	E08		5	0009-0048	129.84	47.85	425	77.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			348.4	E08		5	0010-0050	790.39	50.36	408	77.74	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			153.8	E08		5	0011-0051	101.71	52.26	139	54.53	0.587
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			284.8	E08		5	0012-0057	312.17	57.19	430	79.26	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.2	E08		5	0013-0068	489.97	68.32	441	79.50	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			296.9	E08		5	0014-0073	372.57	73.36	407	74.43	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			308.9	E08		5	0015-0074	412.97	74.21	406	77.50	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.0	E08		5	0016-0082	710.92	82.13	436	77.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			320.3	E08		5	0017-0089	155.98	89.08	370	72.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.5	E08		5	0018-0098	744.01	98.60	365	71.26	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			325.2	E08		5	0019-0101	112.51	100.66	349	70.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.8	E08		5	0020-0107	189.04	107.38	386	77.50	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			419.5	E08		5	0021-0106	912.13	105.94	263	75.50	0.580
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.7	E08		5	0022-0110	20.05	109.88	419	79.74	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.9	E08		5	0023-0113	684.55	113.61	430	78.08	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			672.7	E08		5	0024-0134	634.63	132.56	822	126.37	0.647
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.5	E08		5	0025-0135	217.50	135.58	433	79.84	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.4	E08		5	0026-0138	151.19	137.96	392	74.67	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			199.8	E08		5	0027-0139	694.30	139.48	432	78.91	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			447.9	E08		5	0028-0138	506.42	138.97	366	71.26	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			323.3	E08		5	0029-0153	739.43	153.21	377	71.01	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			323.3	E08		5	0030-0155	266.99	155.23	390	74.08	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			350.4	E08		5	0031-0158	364.21	158.24	390	74.43	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			314.9	E08		5	0032-0157	789.19	157.46	339	69.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			477.1	E08		5	0033-0161	428.45	161.27	415	79.15	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			366.1	E08		5	0034-0162	606.91	162.23	471	85.98	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.2	E08		5	0035-0164	102.21	164.37	385	74.91	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			315.6	E08		5	0036-0170	393.74	169.85	402	75.84	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			412.7	E08		5	0037-0173	45.29	173.71	724	105.50	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			520.9	E08		5	0038-0176	559.97	176.57	534	125.44	0.426
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.5	E08		5	0039-0182	182.79	182.45	382	74.33	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.1	E08		5	0040-0184	824.00	184.55	431	79.84	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.6	E08		5	0041-0189	630.02	190.57	822	113.54	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.2	E08		5	0042-0185	228.36	183.91	443	87.05	0.735
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			364.9	E08		5	0043-0202	452.20	201.93	838	110.57	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			400.5	E08		5	0044-0195	279.94	195.23	410	77.01	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			377.3	E08		5	0045-0202	155.62	202.56	473	86.08	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			323.6	E08		5	0046-0201	527.69	201.62	461	81.84	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.1	E08		5	0047-0203	752.82	203.24	401	76.08	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			310.5	E08		5	0048-0210	326.39	209.37	856	119.20	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			221.8	E08		5	0049-0207	228.68	207.78	408	82.23	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			222.7	E08		5	0050-0218	126.09	217.93	392	77.74	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			193.4	E08		5	0051-0219	938.78	219.02	391	74.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.7	E08		5	0052-0223	167.61	222.46	356	76.43	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			326.5	E08		5	0053-0229	91.30	229.29	380	74.67	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			223.1	E08		5	0054-0229	780.61	229.64	408	76.67	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			252.7	E08		5	0055-0233	833.52	233.37	660	96.57	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			202.8	E08		5	0056-0232	898.40	232.45	416	76.67	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			320.0	E08		5	0057-0241	397.59	241.52	526	87.74	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			380.8	E08		5	0058-0244	649.02	244.50	374	70.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			212.6	E08		5	0059-0248	294.41	247.83	388	74.67	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			448.0	E08		5	0060-0250	614.43	250.41	465	83.74	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			216.8	E08		5	0061-0253	247.78	252.38	415	81.40	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.9	E08		5	0062-0253	514.90	252.80	430	80.91	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			222.6	E08		5	0063-0254	738.72	254.37	418	79.01	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			313.6	E08		5	0064-0258	16.81	258.04	373	73.26	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			226.5	E08		5	0065-0260	71.67	260.48	388	73.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.1	E08		5	0066-0260	337.57	260.69	413	76.67	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.3	E08		5	0067-0261	717.98	261.28	407	79.26	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			425.5	E08		5	0068-0261	359.63	260.89	371	71.70	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			295.8	E08		5	0069-0268	867.65	268.12	368	72.08	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			221.3	E08		5	0070-0271	812.16	270.97	430	79.50	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.7	E08		5	0071-0274	164.80	274.49	398	76.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			279.4	E08		5	0072-0282	833.97	281.78	441	82.91	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			234.9	E08		5	0073-0285	930.92	285.11	411	75.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.3	E08		5	0074-0291	91.17	291.53	396	75.26	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			292.9	E08		5	0075-0291	480.15	291.94	443	80.33	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			203.5	E08		5	0076-0290	541.98	289.68	413	80.33	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			225.2	E08		5	0077-0297	744.79	296.42	423	79.74	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			270.7	E08		5	0078-0298	638.64	298.19	436	79.50	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.1	E08		5	0079-0299	696.64	299.44	421	77.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.6	E08		5	0080-0310	859.34	310.60	433	79.26	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.8	E08		5	0081-0311	211.24	311.25	384	73.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			268.5	E08		5	0082-0317	458.01	318.23	597	94.81	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			222.4	E08		5	0083-0316	756.38	317.12	453	82.08	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			233.8	E08		5	0084-0320	547.00	320.09	475	92.23	0.702
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			212.8	E08		5	0085-0322	522.21	322.03	409	79.84	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.0	E08		5	0086-0325	48.41	324.90	371	73.50	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			224.0	E08		5	0087-0325	111.70	324.44	389	75.01	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			438.7	E08		5	0088-0329	314.40	328.83	415	76.08	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.9	E08		5	0089-0331	582.08	332.17	403	76.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.6	E08		5	0090-0333	673.06	333.28	435	80.08	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.6	E08		5	0091-0331	899.74	331.41	398	77.26	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.9	E08		5	0092-0338	172.43	338.13	383	74.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			209.9	E08		5	0093-0339	223.79	339.76	383	74.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			208.4	E08		5	0094-0347	779.18	347.30	388	76.33	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.5	E08		5	0095-0349	689.37	349.18	454	81.74	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.1	E08		5	0096-0349	144.38	349.49	383	74.08	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			222.8	E08		5	0097-0351	272.80	350.88	394	76.08	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			331.3	E08		5	0098-0356	645.18	355.75	398	76.67	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			223.6	E08		5	0099-0371	89.56	371.12	398	75.26	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			187.8	E08		5	0100-0371	750.34	370.95	394	79.15	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			228.8	E08		5	0101-0375	859.09	374.62	419	77.50	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.8	E08		5	0102-0377	235.32	377.50	785	116.95	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.0	E08		5	0103-0385	597.11	385.01	934	125.68	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			259.8	E08		5	0104-0389	304.30	388.70	858	119.68	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			209.1	E08		5	0105-0383	122.06	383.52	392	76.57	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.8	E08		5	0106-0388	549.09	386.78	494	88.57	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.5	E08		5	0107-0388	493.48	388.54	448	86.57	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			234.7	E08		5	0108-0392	464.63	392.49	458	82.91	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.4	E08		5	0109-0398	361.87	397.81	415	76.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			213.5	E08		5	0110-0397	729.47	397.47	422	77.50	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			348.4	E08		5	0111-0402	644.21	402.75	401	75.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.8	E08		5	0112-0408	25.84	408.78	427	77.50	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			214.2	E08		5	0113-0412	687.08	412.42	423	78.67	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			252.7	E08		5	0114-0420	131.98	419.92	301	71.11	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.1	E08		5	0115-0420	149.08	419.68	190	53.21	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			312.7	E08		5	0116-0426	598.50	426.01	414	77.50	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			207.1	E08		5	0117-0428	881.31	428.51	431	80.33	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			197.5	E08		5	0118-0433	743.77	432.91	402	76.67	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			209.8	E08		5	0119-0436	519.01	436.38	420	78.08	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			225.4	E08		5	0120-0440	203.93	440.29	462	83.84	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.2	E08		5	0121-0442	226.39	442.23	462	81.60	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			315.5	E08		5	0122-0442	259.99	441.96	399	75.50	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.6	E08		5	0123-0442	396.28	441.63	404	77.26	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.8	E08		5	0124-0452	828.09	451.93	481	81.01	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			215.7	E08		5	0125-0454	567.20	454.24	407	76.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.1	E08		5	0126-0458	60.38	458.16	396	77.26	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.5	E08		5	0127-0464	462.94	463.98	444	82.91	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			218.4	E08		5	0128-0462	682.87	461.98	412	76.91	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.7	E08		5	0129-0466	727.81	466.33	689	100.47	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			207.9	E08		5	0130-0462	939.93	462.33	386	73.01	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.8	E08		5	0131-0480	545.63	480.82	800	118.71	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			201.7	E08		5	0132-0475	595.64	476.17	420	82.33	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.2	E08		5	0133-0486	337.27	486.65	436	83.40	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.6	E08		5	0134-0487	654.85	487.16	421	78.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			298.0	E08		5	0135-0498	312.01	498.08	791	114.95	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			219.9	E08		5	0136-0500	732.05	500.30	421	78.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			213.9	E08		5	0137-0510	41.05	510.31	392	74.67	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.2	E08		5	0138-0511	901.81	511.56	447	79.50	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.7	E08		5	0139-0514	171.32	513.56	408	78.57	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.9	E08		5	0140-0515	814.29	515.03	404	77.26	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.2	E08		5	0141-0517	762.03	517.57	409	75.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.8	E08		5	0142-0518	524.67	518.08	411	77.26	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			236.5	E08		5	0143-0530	669.23	530.32	405	76.67	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			323.7	E08		5	0144-0535	381.83	535.94	398	75.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.3	E08		5	0145-0537	450.65	536.69	413	79.26	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.9	E08		5	0146-0540	496.57	540.79	433	77.01	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.8	E08		5	0147-0543	575.29	542.93	427	80.33	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.6	E08		5	0148-0551	803.26	551.15	813	113.05	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			398.7	E08		5	0149-0551	922.87	550.54	310	66.18	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			217.7	E08		5	0150-0562	119.28	562.25	412	78.33	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			335.5	E08		5	0151-0565	243.17	565.20	397	74.91	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			216.6	E08		5	0152-0565	856.86	565.48	401	73.84	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			218.2	E08		5	0153-0572	309.73	571.73	409	79.50	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.2	E08		5	0154-0576	918.68	577.10	561	89.15	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.7	E08		5	0155-0579	350.68	579.12	403	75.50	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.9	E08		5	0156-0580	58.30	579.86	385	74.67	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			387.9	E08		5	0157-0584	284.01	584.18	751	105.64	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			234.9	E08		5	0158-0590	578.60	590.09	424	82.08	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			388.2	E08		5	0159-0593	777.12	593.57	371	75.74	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.5	E08		5	0160-0595	468.12	594.79	435	77.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			219.0	E08		5	0161-0607	390.67	607.42	853	115.88	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			284.2	E08		5	0162-0605	848.16	605.02	340	68.18	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.2	E08		5	0163-0609	726.45	609.57	390	73.26	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			318.3	E08		5	0164-0611	150.33	610.49	400	76.33	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			186.3	E08		5	0165-0614	112.83	614.69	392	74.08	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			225.9	E08		5	0166-0619	311.78	619.52	400	77.74	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			207.8	E08		5	0167-0620	53.42	619.82	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			499.5	E08		5	0168-0621	536.05	620.32	336	70.43	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.8	E08		5	0169-0626	822.73	625.75	397	76.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			257.9	E08		5	0170-0623	269.05	623.42	417	77.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			224.4	E08		5	0171-0630	552.07	630.35	420	83.50	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			198.7	E08		5	0172-0631	442.94	631.56	409	77.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			222.2	E08		5	0173-0635	917.01	635.15	376	74.08	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			217.7	E08		5	0174-0635	859.67	635.02	418	77.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			259.2	E08		5	0175-0649	331.63	649.34	432	80.33	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			226.6	E08		5	0176-0651	801.96	651.19	436	82.33	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			295.7	E08		5	0177-0648	142.89	648.94	365	74.43	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			218.2	E08		5	0178-0653	87.19	652.94	379	76.33	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			513.8	E08		5	0179-0654	490.62	655.31	427	97.40	0.566
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.0	E08		5	0180-0654	290.92	654.14	391	75.26	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.2	E08		5	0181-0658	122.51	658.29	430	78.08	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			293.8	E08		5	0182-0660	943.92	659.79	269	61.36	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			232.0	E08		5	0183-0665	450.32	665.15	408	76.67	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			233.1	E08		5	0184-0666	711.38	665.77	407	78.08	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			217.6	E08		5	0185-0665	388.66	665.79	387	76.08	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			215.1	E08		5	0186-0667	530.37	666.86	408	77.74	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			222.8	E08		5	0187-0670	36.41	670.08	383	75.50	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			226.4	E08		5	0188-0670	867.56	669.86	372	72.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.7	E08		5	0189-0687	601.90	686.94	404	75.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			222.7	E08		5	0190-0689	805.54	688.90	400	76.67	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			227.5	E08		5	0191-0691	754.41	691.52	398	75.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			194.5	E08		5	0192-0694	706.03	694.46	414	77.50	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			188.9	E08		5	0193-0695	182.32	695.39	392	74.67	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			211.0	E08		5	0194-0698	408.47	698.36	394	76.08	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			170.0	E08		5	0195-0701	18.07	700.07	363	77.40	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			232.6	E08		5	0196-0700	311.11	700.68	390	74.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			207.2	E08		5	0197-0707	882.43	706.19	366	72.81	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.6	E08		6	0001-0039	609.10	39.78	429	78.67	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			409.9	E08		6	0002-0037	360.26	37.48	370	71.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.4	E08		6	0003-0043	130.87	43.35	415	76.67	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			233.5	E08		6	0004-0044	937.28	43.85	447	83.26	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.1	E08		6	0005-0046	666.80	46.34	393	73.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			215.7	E08		6	0006-0051	182.30	50.93	439	79.84	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			259.2	E08		6	0007-0052	403.43	51.91	456	80.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			222.0	E08		6	0008-0056	835.63	55.83	437	82.67	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.9	E08		6	0009-0054	547.64	54.10	424	77.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.3	E08		6	0010-0056	445.92	56.36	434	79.26	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			221.3	E08		6	0011-0055	865.44	55.01	398	73.84	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			225.7	E08		6	0012-0056	99.44	56.56	204	59.36	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.7	E08		6	0013-0056	709.53	56.49	394	73.84	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			221.2	E08		6	0014-0057	56.19	57.15	276	62.77	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.0	E08		6	0015-0061	291.50	60.35	420	80.23	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			742.5	E08		6	0016-0071	649.24	69.38	188	65.01	0.559
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			286.6	E08		6	0017-0075	273.94	76.36	420	78.33	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			211.9	E08		6	0018-0082	865.23	82.94	421	76.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.5	E08		6	0019-0087	100.68	87.47	401	75.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			234.9	E08		6	0020-0085	790.76	85.89	405	77.01	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			298.3	E08		6	0021-0099	595.58	98.77	410	75.84	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			268.7	E08		6	0022-0100	401.27	100.66	401	75.26	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			366.4	E08		6	0023-0104	359.67	103.66	639	92.91	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			223.0	E08		6	0024-0101	917.18	101.30	370	71.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.9	E08		6	0025-0102	147.44	102.15	426	79.01	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.1	E08		6	0026-0104	203.96	103.60	391	73.84	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.3	E08		6	0027-0111	687.18	111.25	425	77.26	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.5	E08		6	0028-0114	311.62	114.67	409	76.67	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			437.1	E08		6	0029-0126	567.48	126.76	529	119.88	0.463
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			295.5	E08		6	0030-0124	514.48	124.06	399	73.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			217.9	E08		6	0031-0134	874.24	134.51	416	75.26	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.0	E08		6	0032-0136	443.35	136.30	428	77.26	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			252.0	E08		6	0033-0137	221.07	136.76	398	74.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			213.5	E08		6	0034-0138	802.41	138.59	416	75.01	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			222.1	E08		6	0035-0141	845.01	141.60	424	79.50	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			313.0	E08		6	0036-0145	932.34	145.11	411	78.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			224.9	E08		6	0037-0156	316.95	156.18	405	75.26	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			620.7	E08		6	0038-0173	180.35	172.98	600	120.37	0.520
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			279.6	E08		6	0039-0171	928.07	170.09	399	76.53	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.3	E08		6	0040-0176	889.94	176.64	383	76.67	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			252.8	E08		6	0041-0180	641.53	180.47	408	74.43	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.6	E08		6	0042-0181	254.12	181.22	431	79.84	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			303.9	E08		6	0043-0180	575.01	180.53	356	69.01	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			202.8	E08		6	0044-0185	769.00	185.35	487	85.84	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			295.6	E08		6	0045-0201	840.71	200.64	409	78.91	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			236.3	E08		6	0046-0201	402.79	201.96	404	75.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.3	E08		6	0047-0217	557.64	217.97	437	78.18	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			226.6	E08		6	0048-0222	65.75	222.55	402	75.84	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.3	E08		6	0049-0222	33.66	222.01	378	71.84	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.0	E08		6	0050-0230	461.89	228.95	884	118.71	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.5	E08		6	0051-0224	894.28	224.40	424	78.08	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.3	E08		6	0052-0235	146.72	235.75	423	77.26	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			218.6	E08		6	0053-0238	241.90	238.00	383	73.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			264.7	E08		6	0054-0237	315.12	237.17	411	77.01	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			305.5	E08		6	0055-0243	565.44	243.58	481	82.43	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			169.8	E08		6	0056-0246	675.69	246.47	385	73.26	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			217.1	E08		6	0057-0251	200.63	251.72	394	73.84	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.5	E08		6	0058-0254	390.06	254.58	396	73.01	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			318.6	E08		6	0059-0256	274.78	255.92	404	76.28	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.1	E08		6	0060-0258	297.14	258.14	451	81.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.6	E08		6	0061-0258	122.38	258.27	395	76.67	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			513.5	E08		6	0062-0262	826.81	262.42	397	77.74	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			217.5	E08		6	0063-0265	364.08	265.39	397	75.50	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.2	E08		6	0064-0266	66.07	266.07	380	73.01	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.6	E08		6	0065-0268	780.41	269.04	384	78.91	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			215.3	E08		6	0066-0276	942.40	276.55	414	77.26	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			286.3	E08		6	0067-0284	864.62	284.60	393	75.01	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			211.8	E08		6	0068-0288	919.98	288.51	425	80.67	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.1	E08		6	0069-0287	25.72	287.87	402	74.18	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			322.7	E08		6	0070-0291	794.39	291.48	427	84.91	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			227.3	E08		6	0071-0291	340.77	290.88	388	74.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			236.7	E08		6	0072-0292	733.23	292.36	414	78.08	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.0	E08		6	0073-0302	700.29	302.29	365	70.18	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.9	E08		6	0074-0307	593.62	308.24	459	83.98	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			209.3	E08		6	0075-0308	389.89	307.90	416	75.60	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.1	E08		6	0076-0316	97.64	316.85	772	105.98	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			233.2	E08		6	0077-0322	160.15	322.59	425	78.08	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			226.9	E08		6	0078-0323	429.71	323.83	412	76.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			220.9	E08		6	0079-0325	620.50	325.40	390	74.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.7	E08		6	0080-0324	673.88	324.71	368	71.01	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.0	E08		6	0081-0326	298.88	326.11	431	79.50	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			252.8	E08		6	0082-0338	840.47	338.66	399	74.43	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			216.4	E08		6	0083-0343	945.96	343.78	423	76.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			332.5	E08		6	0084-0348	94.01	348.05	361	75.26	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			236.4	E08		6	0085-0349	192.31	348.83	427	79.26	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			302.1	E08		6	0086-0355	743.75	355.90	402	75.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			386.5	E08		6	0087-0359	863.28	359.07	375	71.01	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.5	E08		6	0088-0361	410.56	360.93	417	76.91	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.1	E08		6	0089-0362	549.72	362.11	395	73.60	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			219.3	E08		6	0090-0366	86.07	366.13	430	81.84	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			230.1	E08		6	0091-0368	605.95	368.15	466	81.26	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.5	E08		6	0092-0368	461.92	368.59	404	75.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.9	E08		6	0093-0369	503.73	369.03	421	75.84	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			307.6	E08		6	0094-0388	126.33	388.29	676	96.33	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.1	E08		6	0095-0389	272.93	389.65	406	78.08	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.1	E08		6	0096-0397	897.17	397.47	378	76.08	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			340.4	E08		6	0097-0399	741.89	399.01	357	69.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			290.8	E08		6	0098-0401	489.83	401.65	393	73.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			230.8	E08		6	0099-0415	558.39	414.76	891	120.47	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			443.2	E08		6	0100-0418	759.37	417.69	385	73.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			221.7	E08		6	0101-0419	131.28	419.56	412	75.01	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			221.9	E08		6	0102-0428	222.85	428.22	398	75.84	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			224.7	E08		6	0103-0438	440.00	437.97	811	112.57	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			235.2	E08		6	0104-0429	888.69	429.98	388	77.26	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			225.1	E08		6	0105-0432	604.99	432.84	420	76.43	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.7	E08		6	0106-0431	803.92	430.66	397	75.01	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			219.5	E08		6	0107-0445	845.80	445.48	452	81.74	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			223.8	E08		6	0108-0449	472.86	450.16	419	76.43	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			216.8	E08		6	0109-0451	399.60	450.90	407	74.43	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			289.4	E08		6	0110-0452	901.77	451.81	344	68.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			296.1	E08		6	0111-0457	510.59	457.67	365	71.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			189.1	E08		6	0112-0458	271.58	458.37	398	75.26	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			235.0	E08		6	0113-0464	362.29	463.93	415	76.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			215.5	E08		6	0114-0465	34.79	465.26	372	71.01	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			233.9	E08		6	0115-0468	319.64	468.73	386	75.50	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			227.1	E08		6	0116-0468	204.85	468.31	403	74.43	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			227.4	E08		6	0117-0472	589.04	472.62	410	77.84	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.4	E08		6	0118-0485	130.94	485.17	784	114.57	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			236.8	E08		6	0119-0480	559.70	480.70	401	74.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.2	E08		6	0120-0485	765.12	485.12	414	75.01	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			217.2	E08		6	0121-0488	817.96	488.82	421	77.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			294.1	E08		6	0122-0487	700.13	487.33	456	79.60	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			222.5	E08		6	0123-0494	467.40	493.91	413	75.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.8	E08		6	0124-0497	519.65	497.45	378	73.01	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			227.0	E08		6	0125-0503	71.84	502.98	397	73.60	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			234.6	E08		6	0126-0510	312.54	510.67	394	76.91	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			209.5	E08		6	0127-0525	839.74	525.65	437	78.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			216.4	E08		6	0128-0527	540.65	527.67	412	75.26	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			312.8	E08		6	0129-0528	685.34	528.07	370	72.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.6	E08		6	0130-0531	408.66	531.66	427	82.91	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			227.3	E08		6	0131-0545	184.59	545.56	423	77.26	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			291.9	E08		6	0132-0550	783.64	550.56	434	78.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			368.8	E08		6	0133-0554	16.21	553.55	343	69.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			236.6	E08		6	0134-0558	889.37	558.36	399	75.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			224.0	E08		6	0135-0563	292.95	563.04	416	75.01	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.7	E08		6	0136-0566	246.05	566.66	403	75.26	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.2	E08		6	0137-0574	207.12	574.39	383	73.01	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.1	E08		6	0138-0580	407.06	580.07	744	102.91	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			270.8	E08		6	0139-0579	123.64	579.43	381	73.84	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			793.9	E08		6	0140-0584	648.20	584.41	298	79.26	0.596
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.6	E08		6	0141-0588	340.02	588.45	389	76.08	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.9	E08		6	0142-0591	512.96	591.21	414	76.08	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			347.7	E08		6	0143-0592	930.00	592.72	460	79.84	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			224.0	E08		6	0144-0600	604.74	599.99	396	74.67	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			463.7	E08		6	0145-0610	674.51	609.31	411	75.26	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			289.3	E08		6	0146-0613	833.51	613.41	434	77.26	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.8	E08		6	0147-0616	47.33	616.58	414	76.08	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.5	E08		6	0148-0615	120.49	615.56	390	73.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.9	E08		6	0149-0618	286.91	617.98	407	78.08	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			224.9	E08		6	0150-0621	579.64	621.75	407	74.43	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.2	E08		6	0151-0630	264.54	630.19	456	79.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.0	E08		6	0152-0633	530.57	633.89	542	86.91	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.6	E08		6	0153-0633	175.78	633.64	416	77.01	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			252.7	E08		6	0154-0644	342.89	645.15	398	75.50	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			264.5	E08		6	0155-0643	423.03	642.72	391	74.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.7	E08		6	0156-0649	707.56	648.55	332	71.60	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.1	E08		6	0157-0651	879.79	651.82	403	75.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			301.8	E08		6	0158-0654	830.07	653.96	335	68.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			208.2	E08		6	0159-0659	73.10	659.24	383	74.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.7	E08		6	0160-0662	37.75	662.74	306	64.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			209.8	E08		6	0161-0664	699.20	664.39	367	72.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			225.9	E08		6	0162-0669	294.23	669.17	425	77.84	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			357.2	E08		6	0163-0672	755.14	671.70	314	65.01	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			207.7	E08		6	0164-0685	651.76	685.15	402	76.43	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			202.8	E08		6	0165-0690	191.80	689.38	504	90.08	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.5	E08		6	0166-0688	241.93	688.34	391	75.26	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.2	E08		6	0167-0688	860.00	687.87	391	76.67	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			270.9	E08		6	0168-0695	394.10	695.29	375	75.84	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.6	E08		6	0169-0692	684.52	691.77	372	73.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			197.0	E08		6	0170-0698	175.02	699.26	445	82.67	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			387.6	E08		6	0171-0696	775.38	696.07	302	63.36	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			313.0	E08		6	0172-0701	605.07	701.16	380	72.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			217.9	E08		6	0173-0702	95.54	701.63	451	85.60	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			299.6	E08		6	0174-0704	120.66	703.75	188	52.63	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			215.6	E08		6	0175-0709	319.30	709.24	414	81.01	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			350.1	E08		7	0001-0031	448.84	30.88	428	78.08	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			281.8	E08		7	0002-0032	838.72	31.96	384	75.50	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			532.9	E08		7	0003-0036	597.08	35.70	508	86.43	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			277.2	E08		7	0004-0040	660.75	40.02	389	73.26	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			292.0	E08		7	0005-0043	46.37	43.18	436	80.08	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			485.2	E08		7	0006-0046	171.75	45.61	395	76.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			205.9	E08		7	0007-0056	779.49	56.58	762	105.40	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.8	E08		7	0008-0053	366.46	52.98	413	77.84	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			224.9	E08		7	0009-0061	736.50	60.83	821	110.33	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			226.7	E08		7	0010-0059	514.63	59.64	469	80.67	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.6	E08		7	0011-0060	622.88	60.55	447	81.01	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.8	E08		7	0012-0062	112.13	62.35	400	73.84	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.3	E08		7	0013-0064	827.38	64.14	397	73.01	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.3	E08		7	0014-0065	209.40	65.33	397	75.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			233.2	E08		7	0015-0068	474.31	68.46	445	77.84	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			218.4	E08		7	0016-0073	759.50	73.09	441	82.33	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.7	E08		7	0017-0071	25.96	71.16	395	74.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.4	E08		7	0018-0075	168.45	75.59	400	75.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.2	E08		7	0019-0076	649.96	75.19	460	84.91	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			230.4	E08		7	0020-0076	914.47	76.08	389	74.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			324.9	E08		7	0021-0081	412.73	81.20	410	77.01	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			310.3	E08		7	0022-0081	855.73	80.86	331	68.67	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.5	E08		7	0023-0090	806.94	90.08	426	77.50	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.3	E08		7	0024-0097	123.66	96.62	861	120.47	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.7	E08		7	0025-0100	724.72	101.48	808	111.30	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			235.4	E08		7	0026-0096	869.09	97.42	428	79.74	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			279.7	E08		7	0027-0096	384.45	96.22	436	77.26	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			306.2	E08		7	0028-0096	561.68	96.12	419	76.08	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			301.5	E08		7	0029-0103	764.31	103.27	401	74.08	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.9	E08		7	0030-0109	829.68	109.22	415	77.74	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			309.7	E08		7	0031-0108	325.77	108.69	389	74.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			160.2	E08		7	0032-0109	935.60	108.20	397	76.91	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			227.8	E08		7	0033-0115	706.49	115.81	360	73.50	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.6	E08		7	0034-0122	118.91	122.52	429	82.18	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			219.2	E08		7	0035-0124	923.18	123.79	412	82.23	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			336.5	E08		7	0036-0135	292.88	135.00	383	73.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.4	E08		7	0037-0135	354.72	135.33	404	75.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.9	E08		7	0038-0139	914.80	139.85	373	76.91	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.9	E08		7	0039-0143	59.89	143.01	419	81.84	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			327.9	E08		7	0040-0142	508.69	142.10	427	75.84	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			314.8	E08		7	0041-0140	651.23	140.11	271	60.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			298.9	E08		7	0042-0143	114.36	144.08	452	82.77	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			284.1	E08		7	0043-0145	174.82	145.47	397	74.43	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			313.0	E08		7	0044-0150	430.95	150.59	605	95.36	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.1	E08		7	0045-0151	682.39	151.18	397	75.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			481.4	E08		7	0046-0151	472.56	151.08	281	60.53	0.964
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.6	E08		7	0047-0153	408.79	153.93	304	67.94	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			328.8	E08		7	0048-0155	769.28	154.23	416	77.01	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.5	E08		7	0049-0160	729.61	159.76	426	78.91	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.6	E08		7	0050-0171	710.91	171.77	471	83.15	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.1	E08		7	0051-0176	84.38	176.01	398	74.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.6	E08		7	0052-0179	757.95	179.10	405	74.67	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			277.8	E08		7	0053-0183	829.21	183.92	409	76.18	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			358.8	E08		7	0054-0182	399.69	182.76	395	74.67	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			220.0	E08		7	0055-0190	561.34	189.93	399	74.43	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			279.3	E08		7	0056-0202	470.42	202.54	999	119.88	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.5	E08		7	0057-0196	663.68	196.18	453	79.26	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.7	E08		7	0058-0195	880.66	195.17	430	79.50	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			203.5	E08		7	0059-0196	922.97	196.10	429	78.67	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.9	E08		7	0060-0202	796.04	201.96	411	75.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			286.4	E08		7	0061-0206	348.07	206.46	389	73.01	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			228.2	E08		7	0062-0209	516.77	208.98	444	83.01	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			302.6	E08		7	0063-0220	186.65	219.98	420	76.33	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			317.1	E08		7	0064-0229	52.67	230.01	832	116.71	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			224.8	E08		7	0065-0221	413.57	222.10	437	84.18	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			378.5	E08		7	0066-0223	154.97	223.16	415	76.67	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.0	E08		7	0067-0225	212.81	225.04	416	76.67	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			287.9	E08		7	0068-0236	277.65	236.50	804	114.33	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			224.7	E08		7	0069-0230	717.96	230.20	468	83.26	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			236.2	E08		7	0070-0231	512.52	230.88	408	78.18	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			301.0	E08		7	0071-0231	660.78	231.47	409	76.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			214.8	E08		7	0072-0234	552.17	234.52	465	80.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			264.7	E08		7	0073-0235	743.94	234.70	468	82.91	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			221.9	E08		7	0074-0240	921.31	240.17	436	78.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.9	E08		7	0075-0244	349.58	244.76	421	79.50	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			233.0	E08		7	0076-0242	419.81	240.95	462	91.01	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			191.9	E08		7	0077-0245	587.43	245.28	446	79.26	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			284.6	E08		7	0078-0245	616.80	245.35	467	82.33	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.3	E08		7	0079-0256	244.72	256.65	411	74.43	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.0	E08		7	0080-0256	165.72	256.33	403	75.26	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			230.7	E08		7	0081-0256	546.41	255.98	391	77.36	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.0	E08		7	0082-0260	401.71	260.65	446	79.84	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			328.2	E08		7	0083-0261	770.98	261.39	409	76.08	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			252.7	E08		7	0084-0275	859.66	275.10	420	81.50	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			225.3	E08		7	0085-0280	15.81	280.22	382	76.08	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			228.1	E08		7	0086-0283	911.46	282.82	394	77.84	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.3	E08		7	0087-0287	812.91	286.93	384	75.26	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			366.5	E08		7	0088-0291	361.58	290.96	385	73.26	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			285.6	E08		7	0089-0296	449.18	296.56	453	80.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			287.8	E08		7	0090-0299	207.78	299.43	414	77.74	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			252.7	E08		7	0091-0300	615.41	300.01	425	79.26	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			257.9	E08		7	0092-0302	783.03	301.18	396	76.33	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			437.3	E08		7	0093-0305	287.31	304.99	408	75.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.7	E08		7	0094-0308	523.05	306.75	406	77.74	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			210.7	E08		7	0095-0304	581.87	304.39	434	78.08	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			217.6	E08		7	0096-0313	940.51	313.37	444	82.43	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			366.3	E08		7	0097-0310	418.35	310.49	410	75.84	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.5	E08		7	0098-0313	352.30	313.57	476	86.08	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.2	E08		7	0099-0311	766.95	312.50	385	76.33	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			226.1	E08		7	0100-0326	514.28	327.72	504	86.57	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.6	E08		7	0101-0333	365.09	333.64	458	82.67	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			308.8	E08		7	0102-0336	262.15	336.27	411	78.08	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.6	E08		7	0103-0346	486.60	346.09	878	119.64	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			209.6	E08		7	0104-0339	795.17	339.92	407	75.26	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			233.9	E08		7	0105-0340	576.51	340.22	421	76.67	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			227.2	E08		7	0106-0349	751.18	349.39	815	118.37	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			325.3	E08		7	0107-0342	176.49	342.38	406	75.26	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.9	E08		7	0108-0352	838.85	352.49	419	77.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.3	E08		7	0109-0353	37.15	353.91	411	77.26	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			408.9	E08		7	0110-0354	196.64	354.38	249	64.18	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			233.8	E08		7	0111-0357	911.74	356.92	410	77.50	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.4	E08		7	0112-0362	721.35	361.82	401	73.60	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			308.6	E08		7	0113-0375	307.67	373.54	822	118.37	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.8	E08		7	0114-0372	576.22	372.32	426	78.08	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			285.1	E08		7	0115-0379	255.42	379.49	555	88.33	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			268.8	E08		7	0116-0379	104.36	379.35	412	75.84	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.7	E08		7	0117-0383	353.55	383.66	403	78.08	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			213.8	E08		7	0118-0393	729.49	393.01	419	76.43	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			283.7	E08		7	0119-0399	411.40	399.13	422	78.67	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.1	E08		7	0120-0400	896.04	400.17	430	77.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.7	E08		7	0121-0412	547.67	412.36	432	77.26	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.8	E08		7	0122-0417	477.90	416.96	424	78.43	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.6	E08		7	0123-0421	798.64	421.39	816	108.13	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.2	E08		7	0124-0418	288.39	418.77	420	76.67	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			284.3	E08		7	0125-0422	221.78	422.33	394	75.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			211.8	E08		7	0126-0427	674.72	427.78	474	84.57	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.7	E08		7	0127-0435	647.25	434.77	971	126.37	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			268.2	E08		7	0128-0432	22.64	432.45	395	74.67	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			312.2	E08		7	0129-0428	852.61	427.21	311	66.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			299.2	E08		7	0130-0436	442.88	436.49	421	78.67	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			327.4	E08		7	0131-0438	413.29	438.11	427	78.91	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.6	E08		7	0132-0448	594.07	448.69	427	78.67	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			221.4	E08		7	0133-0449	916.60	449.00	410	75.84	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			252.1	E08		7	0134-0458	778.28	457.50	871	115.05	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			283.9	E08		7	0135-0453	284.13	453.88	402	74.67	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			314.8	E08		7	0136-0456	158.85	455.93	521	84.33	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			224.6	E08		7	0137-0458	703.47	458.41	431	80.91	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			284.7	E08		7	0138-0460	527.10	460.81	427	79.50	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			196.2	E08		7	0139-0461	851.90	460.82	426	77.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			390.2	E08		7	0140-0471	339.98	470.78	775	109.98	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.5	E08		7	0141-0483	82.00	482.90	404	76.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.7	E08		7	0142-0491	574.07	490.87	423	76.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			338.8	E08		7	0143-0493	110.84	492.98	414	76.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.7	E08		7	0144-0496	268.05	496.37	397	73.60	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.7	E08		7	0145-0497	225.62	496.98	383	72.43	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			177.6	E08		7	0146-0502	948.73	502.04	404	79.26	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			389.6	E08		7	0147-0507	728.18	506.57	400	77.60	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			219.7	E08		7	0148-0507	897.43	506.76	385	73.26	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			294.7	E08		7	0149-0515	409.47	515.53	400	75.84	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.0	E08		7	0150-0519	585.04	519.69	406	75.26	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			277.7	E08		7	0151-0524	723.90	525.32	292	66.18	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			314.1	E08		7	0152-0526	646.35	526.17	363	72.67	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			348.5	E08		7	0153-0530	160.90	531.09	418	77.11	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.5	E08		7	0154-0528	794.84	527.92	437	84.43	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			252.3	E08		7	0155-0538	62.81	537.91	537	87.26	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.9	E08		7	0156-0539	94.34	539.64	421	75.84	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.9	E08		7	0157-0537	526.23	537.55	407	76.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.8	E08		7	0158-0547	636.52	547.51	481	86.33	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.8	E08		7	0159-0546	361.37	546.65	416	76.67	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.5	E08		7	0160-0556	161.11	554.96	470	83.36	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			369.0	E08		7	0161-0556	830.91	556.71	355	72.08	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.7	E08		7	0162-0562	286.89	562.71	427	76.67	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			285.7	E08		7	0163-0563	565.56	563.25	427	76.43	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.8	E08		7	0164-0562	879.38	562.67	401	76.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			234.7	E08		7	0165-0563	239.98	563.72	432	77.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			356.9	E08		7	0166-0566	456.03	566.66	814	114.23	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			329.2	E08		7	0167-0578	40.49	578.42	753	104.81	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			302.0	E08		7	0168-0576	380.31	576.15	402	73.60	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.4	E08		7	0169-0594	904.98	594.13	711	103.64	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.4	E08		7	0170-0596	88.73	596.10	376	73.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			236.1	E08		7	0171-0605	117.62	605.11	407	76.67	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			234.7	E08		7	0172-0608	251.39	608.26	407	75.26	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.3	E08		7	0173-0609	171.24	609.16	393	73.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.1	E08		7	0174-0609	623.41	609.05	462	82.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.4	E08		7	0175-0622	508.45	622.39	442	79.26	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			359.6	E08		7	0176-0622	537.13	621.59	421	76.08	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.6	E08		7	0177-0629	839.20	629.32	388	73.60	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.8	E08		7	0178-0630	458.46	629.99	392	73.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			684.8	E08		7	0179-0630	375.06	630.96	424	77.84	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.0	E08		7	0180-0634	120.29	634.40	434	83.15	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			328.7	E08		7	0181-0638	566.69	638.48	419	78.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			233.0	E08		7	0182-0643	82.73	643.20	390	75.50	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.1	E08		7	0183-0641	31.35	641.60	353	68.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.1	E08		7	0184-0645	289.37	645.10	406	73.60	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.0	E08		7	0185-0644	599.43	644.18	456	81.50	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.9	E08		7	0186-0648	147.44	647.92	408	74.18	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			273.3	E08		7	0187-0651	710.26	650.69	404	75.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.2	E08		7	0188-0653	250.53	653.75	401	76.08	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			464.6	E08		7	0189-0657	392.64	657.16	439	78.43	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.0	E08		7	0190-0667	804.84	668.45	855	117.30	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			308.7	E08		7	0191-0664	204.68	664.59	410	75.01	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			354.6	E08		7	0192-0667	461.60	667.58	383	72.43	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.9	E08		7	0193-0668	870.91	668.58	360	70.43	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.8	E08		7	0194-0671	620.80	671.53	382	72.43	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.7	E08		7	0195-0682	727.61	681.81	759	105.74	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.7	E08		7	0196-0689	30.58	689.00	400	74.43	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			199.1	E08		7	0197-0698	843.13	698.26	329	72.43	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			321.1	E08		7	0198-0696	915.86	696.39	333	68.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.9	E08		7	0199-0702	286.34	702.25	615	92.91	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.7	E08		7	0200-0701	588.98	700.78	613	93.26	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			295.5	E08		7	0201-0703	676.76	703.24	449	80.08	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.2	E08		7	0202-0705	860.74	704.81	415	78.77	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.7	E08		7	0203-0706	339.00	705.36	365	71.01	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			187.2	E08		8	0001-0027	12.86	26.76	131	43.70	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			213.5	E08		8	0002-0034	878.19	33.39	456	81.98	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.7	E08		8	0003-0038	137.55	38.18	360	70.18	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.8	E08		8	0004-0036	208.64	36.46	369	71.26	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			206.9	E08		8	0005-0037	928.11	37.23	403	75.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			224.3	E08		8	0006-0039	338.64	39.54	422	77.50	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.9	E08		8	0007-0043	830.27	43.72	342	67.60	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			192.9	E08		8	0008-0044	858.88	44.83	369	73.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			252.8	E08		8	0009-0049	252.72	49.24	380	73.84	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.5	E08		8	0010-0052	703.68	51.91	725	99.74	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.6	E08		8	0011-0054	106.15	53.85	358	70.18	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			224.1	E08		8	0012-0056	435.56	56.02	435	77.26	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.5	E08		8	0013-0068	387.24	68.15	402	73.84	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.0	E08		8	0014-0072	502.28	72.23	432	79.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			387.7	E08		8	0015-0075	198.47	75.77	388	72.77	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.5	E08		8	0016-0076	825.57	76.69	447	78.67	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			200.6	E08		8	0017-0075	916.38	76.13	387	74.67	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			220.1	E08		8	0018-0078	19.55	78.07	365	71.01	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			216.4	E08		8	0019-0081	710.84	81.37	413	75.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			230.7	E08		8	0020-0090	169.84	90.08	388	74.67	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			285.3	E08		8	0021-0089	279.57	89.50	379	73.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.0	E08		8	0022-0093	359.40	92.93	391	73.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			216.0	E08		8	0023-0101	97.26	101.04	385	71.84	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			204.1	E08		8	0024-0106	129.43	105.80	377	72.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			181.9	E08		8	0025-0107	912.97	106.51	390	73.01	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			197.9	E08		8	0026-0111	40.25	110.23	367	75.40	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			336.3	E08		8	0027-0114	536.93	113.63	388	72.18	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			293.0	E08		8	0028-0121	790.30	121.16	840	112.08	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.8	E08		8	0029-0118	182.89	118.63	396	76.77	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			233.5	E08		8	0030-0117	426.66	117.08	409	75.26	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			222.0	E08		8	0031-0132	24.01	133.27	791	113.54	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			221.3	E08		8	0032-0129	510.23	128.96	385	73.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.0	E08		8	0033-0134	659.27	134.22	381	75.84	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			225.1	E08		8	0034-0142	147.05	142.44	399	74.18	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			206.7	E08		8	0035-0142	349.62	142.04	399	76.43	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			232.3	E08		8	0036-0143	184.85	143.18	431	79.94	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			353.8	E08		8	0037-0147	561.04	146.72	400	73.60	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			268.1	E08		8	0038-0152	592.10	151.51	558	98.57	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.6	E08		8	0039-0146	775.62	146.78	412	75.01	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.8	E08		8	0040-0154	270.66	154.46	398	73.01	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.2	E08		8	0041-0154	708.75	154.15	387	71.60	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.1	E08		8	0042-0155	221.46	155.64	376	71.01	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			224.7	E08		8	0043-0156	921.65	156.62	398	74.67	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			334.5	E08		8	0044-0157	303.73	157.44	396	73.60	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			389.0	E08		8	0045-0159	833.62	159.60	351	69.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			305.9	E08		8	0046-0166	471.01	165.99	897	114.81	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			232.8	E08		8	0047-0162	890.05	161.56	396	74.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			174.7	E08		8	0048-0161	61.84	161.17	363	71.60	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			227.6	E08		8	0049-0166	187.42	165.14	380	74.53	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.2	E08		8	0050-0166	341.97	166.42	401	75.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			230.0	E08		8	0051-0169	377.65	169.22	399	77.26	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			193.9	E08		8	0052-0167	102.73	166.88	363	71.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			287.3	E08		8	0053-0187	938.78	187.67	341	68.18	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.4	E08		8	0054-0188	676.21	188.44	420	76.67	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			299.0	E08		8	0055-0187	778.88	187.08	345	69.01	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.5	E08		8	0056-0189	823.38	189.83	386	71.60	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			279.7	E08		8	0057-0191	643.60	191.60	416	76.67	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.1	E08		8	0058-0194	529.74	194.47	406	75.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			208.3	E08		8	0059-0197	390.61	197.85	434	81.01	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			158.3	E08		8	0060-0198	28.08	198.47	395	78.67	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			215.2	E08		8	0061-0207	234.56	207.06	394	73.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			179.9	E08		8	0062-0210	98.04	210.49	783	110.81	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			204.8	E08		8	0063-0205	730.77	205.93	405	76.87	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			196.4	E08		8	0064-0210	51.96	209.98	417	77.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.4	E08		8	0065-0226	150.93	226.45	882	119.20	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			233.6	E08		8	0066-0227	766.45	227.43	385	74.43	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.8	E08		8	0067-0225	732.13	224.55	379	74.28	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.1	E08		8	0068-0230	517.07	230.49	396	75.26	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			257.2	E08		8	0069-0229	455.43	228.84	391	72.43	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.7	E08		8	0070-0234	704.14	234.14	436	77.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.5	E08		8	0071-0233	801.86	233.75	412	77.74	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.6	E08		8	0072-0235	280.81	235.53	442	79.50	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			198.8	E08		8	0073-0242	26.40	242.17	397	75.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.8	E08		8	0074-0239	883.39	239.10	387	73.26	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			236.5	E08		8	0075-0243	827.50	243.32	380	73.01	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.2	E08		8	0076-0245	304.28	244.81	430	84.08	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			296.7	E08		8	0077-0248	207.90	247.89	429	77.26	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			264.4	E08		8	0078-0247	338.34	247.62	403	76.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			216.5	E08		8	0079-0253	364.00	253.03	387	73.60	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			413.2	E08		8	0080-0269	645.93	267.39	970	133.05	0.689
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			184.4	E08		8	0081-0258	123.48	258.55	377	72.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			220.7	E08		8	0082-0263	453.70	263.14	404	75.26	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			388.4	E08		8	0083-0264	317.89	264.40	448	82.08	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			235.8	E08		8	0084-0266	75.47	265.97	413	76.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			209.6	E08		8	0085-0265	503.36	265.50	404	74.67	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.5	E08		8	0086-0267	273.87	266.82	456	81.15	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.7	E08		8	0087-0282	253.98	282.02	486	84.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			186.2	E08		8	0088-0285	16.72	284.89	358	71.60	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			232.4	E08		8	0089-0283	874.71	283.66	396	74.67	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.7	E08		8	0090-0301	365.86	301.03	389	73.01	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.7	E08		8	0091-0303	85.07	303.28	374	71.60	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.4	E08		8	0092-0305	493.41	304.96	634	98.57	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			309.0	E08		8	0093-0304	646.32	304.07	373	70.18	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			208.3	E08		8	0094-0307	801.56	307.47	422	76.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			324.7	E08		8	0095-0313	152.47	313.01	416	78.43	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			212.3	E08		8	0096-0315	45.71	315.47	403	79.01	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.8	E08		8	0097-0317	107.42	316.99	421	77.26	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.7	E08		8	0098-0324	435.57	323.86	409	76.08	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			220.5	E08		8	0099-0329	225.64	330.02	805	109.54	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			468.8	E08		8	0100-0323	884.08	323.71	276	59.94	0.965
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.8	E08		8	0101-0331	923.08	331.31	395	75.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			299.9	E08		8	0102-0334	353.64	334.44	365	71.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			193.9	E08		8	0103-0337	170.74	336.54	362	73.94	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			340.3	E08		8	0104-0338	558.10	338.35	477	80.67	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.2	E08		8	0105-0339	149.93	340.00	471	84.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			233.6	E08		8	0106-0341	811.52	341.33	405	75.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.9	E08		8	0107-0351	410.83	350.90	374	71.60	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			137.8	E08		8	0108-0353	298.83	353.05	332	67.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			562.6	E08		8	0109-0354	493.00	354.82	371	70.18	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.9	E08		8	0110-0358	665.66	358.28	390	74.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			216.9	E08		8	0111-0359	17.15	358.98	363	71.60	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			363.0	E08		8	0112-0357	346.39	357.41	317	65.36	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			198.4	E08		8	0113-0358	901.62	358.35	389	74.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			195.2	E08		8	0114-0371	862.43	370.96	842	117.15	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			235.2	E08		8	0115-0374	738.95	374.20	390	73.84	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			217.2	E08		8	0116-0377	785.88	377.58	417	77.84	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			400.0	E08		8	0117-0382	335.79	382.26	393	73.26	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.2	E08		8	0118-0394	112.36	393.65	782	110.37	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.2	E08		8	0119-0387	274.56	387.16	394	74.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			221.2	E08		8	0120-0390	208.40	390.43	381	74.91	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			350.8	E08		8	0121-0389	479.21	388.90	386	72.43	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			287.2	E08		8	0122-0401	168.44	400.19	458	87.26	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			264.5	E08		8	0123-0402	565.48	401.81	380	72.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			219.0	E08		8	0124-0406	362.72	406.66	424	79.84	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.7	E08		8	0125-0409	434.57	409.45	394	75.60	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			380.1	E08		8	0126-0412	476.60	412.46	404	75.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.3	E08		8	0127-0421	609.03	421.87	466	80.91	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.5	E08		8	0128-0421	828.47	421.78	413	76.67	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.2	E08		8	0129-0422	193.23	422.30	385	71.60	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			219.9	E08		8	0130-0421	261.09	421.26	380	73.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			226.2	E08		8	0131-0421	928.44	421.32	423	79.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			217.0	E08		8	0132-0431	84.88	431.14	373	73.26	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.8	E08		8	0133-0429	901.87	428.91	391	76.18	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			204.0	E08		8	0134-0434	390.13	434.87	380	73.01	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.2	E08		8	0135-0439	573.78	438.71	432	77.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.1	E08		8	0136-0443	677.38	443.35	419	75.01	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.4	E08		8	0137-0443	127.46	443.00	401	75.50	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			212.5	E08		8	0138-0443	298.30	442.84	387	74.67	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.4	E08		8	0139-0445	250.82	443.39	360	72.91	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			195.1	E08		8	0140-0451	21.71	450.93	367	71.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			201.0	E08		8	0141-0451	57.31	451.96	366	71.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			353.0	E08		8	0142-0456	266.57	457.00	385	74.57	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			230.6	E08		8	0143-0456	757.54	456.78	401	73.84	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			409.1	E08		8	0144-0465	695.31	464.74	333	66.77	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.5	E08		8	0145-0475	624.02	474.88	775	109.64	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			366.0	E08		8	0146-0472	545.34	472.55	230	55.94	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			233.8	E08		8	0147-0479	826.55	478.30	624	92.33	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.2	E08		8	0148-0480	103.11	480.20	386	73.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			307.6	E08		8	0149-0482	470.82	480.83	343	70.91	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.6	E08		8	0150-0483	257.38	482.81	373	70.77	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			381.2	E08		8	0151-0487	382.59	487.61	326	65.94	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			228.5	E08		8	0152-0497	88.68	497.40	427	77.50	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			228.7	E08		8	0153-0501	942.80	501.31	378	74.77	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			179.3	E08		8	0154-0504	53.78	503.94	355	73.60	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			212.4	E08		8	0155-0502	837.74	503.28	408	79.26	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			279.5	E08		8	0156-0506	117.26	506.08	442	81.01	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			213.9	E08		8	0157-0508	692.35	507.93	420	76.08	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			226.7	E08		8	0158-0510	631.74	509.82	395	73.84	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.7	E08		8	0159-0518	344.60	518.30	623	92.33	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			339.9	E08		8	0160-0520	502.68	521.89	473	97.40	0.627
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			212.9	E08		8	0161-0519	179.67	519.43	392	73.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.0	E08		8	0162-0531	133.80	531.30	437	83.50	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			221.1	E08		8	0163-0530	683.66	531.47	424	77.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			191.1	E08		8	0164-0535	109.15	534.66	422	78.08	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.4	E08		8	0165-0538	262.29	538.48	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			284.4	E08		8	0166-0546	422.62	547.19	423	78.43	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.4	E08		8	0167-0548	772.56	547.66	381	73.84	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			308.4	E08		8	0168-0549	741.84	549.81	294	64.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.8	E08		8	0169-0552	689.00	552.49	408	78.18	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			230.4	E08		8	0170-0554	612.03	554.10	392	73.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.1	E08		8	0171-0558	572.27	558.01	387	73.01	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			205.7	E08		8	0172-0558	818.49	558.24	379	72.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			236.0	E08		8	0173-0559	239.19	559.34	388	74.08	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			224.5	E08		8	0174-0567	401.42	566.65	432	77.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.7	E08		8	0175-0569	72.52	568.92	371	71.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			197.1	E08		8	0176-0568	115.15	567.72	380	74.08	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.4	E08		8	0177-0571	928.14	571.53	366	71.01	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.5	E08		8	0178-0573	894.54	573.35	385	73.26	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.9	E08		8	0179-0573	472.87	572.73	373	71.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			270.8	E08		8	0180-0578	365.59	578.38	422	77.94	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			191.5	E08		8	0181-0577	620.21	577.65	398	74.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			232.5	E08		8	0182-0579	657.58	579.15	397	75.50	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			283.2	E08		8	0183-0579	130.71	579.51	295	63.84	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.6	E08		8	0184-0586	870.14	586.32	352	70.43	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			283.7	E08		8	0185-0593	306.08	592.85	380	72.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			233.7	E08		8	0186-0591	574.66	591.46	375	72.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			197.7	E08		8	0187-0600	798.09	600.44	796	109.88	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			296.2	E08		8	0188-0598	344.16	598.08	407	76.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.8	E08		8	0189-0598	649.17	599.12	377	74.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			347.0	E08		8	0190-0606	189.49	605.77	406	77.11	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			327.4	E08		8	0191-0611	212.45	611.06	398	76.77	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.3	E08		8	0192-0609	498.57	609.64	381	75.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.3	E08		8	0193-0620	745.01	619.76	770	112.47	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.0	E08		8	0194-0615	622.23	614.51	375	72.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			226.4	E08		8	0195-0619	247.53	619.43	377	71.01	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.0	E08		8	0196-0623	315.00	623.18	422	76.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.4	E08		8	0197-0630	449.89	629.80	367	71.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			200.3	E08		8	0198-0630	117.57	630.45	386	73.01	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			207.5	E08		8	0199-0634	145.21	633.58	394	75.50	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			226.3	E08		8	0200-0633	650.83	633.13	404	76.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			228.8	E08		8	0201-0634	411.77	634.57	416	76.18	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			202.2	E08		8	0202-0633	940.43	632.74	121	41.80	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.8	E08		8	0203-0642	389.05	641.84	422	77.84	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.0	E08		8	0204-0644	535.73	644.60	394	73.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			226.0	E08		8	0205-0650	577.45	650.84	386	72.18	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			207.7	E08		8	0206-0655	104.11	655.06	400	79.01	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			204.8	E08		8	0207-0656	784.90	656.57	391	73.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			302.9	E08		8	0208-0657	274.18	656.98	365	71.01	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.5	E08		8	0209-0660	515.41	660.89	414	75.84	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			234.1	E08		8	0210-0662	465.97	662.53	397	74.18	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.3	E08		8	0211-0663	862.67	663.21	420	76.43	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			214.2	E08		8	0212-0675	611.14	675.90	404	78.91	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.3	E08		8	0213-0687	236.25	687.72	410	77.01	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			209.6	E08		8	0214-0688	937.61	688.35	351	72.18	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			210.4	E08		8	0215-0687	135.56	687.26	385	73.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			204.5	E08		8	0216-0690	767.50	688.49	390	77.98	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.9	E08		8	0217-0695	630.66	695.62	404	78.43	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.8	E08		8	0218-0698	20.54	698.45	342	67.84	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			217.5	E08		8	0219-0705	876.06	705.52	417	76.91	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.9	E08		9	0001-0035	446.94	35.52	381	76.53	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			323.2	E08		9	0002-0030	118.26	29.91	194	54.53	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.5	E08		9	0003-0037	467.14	37.29	461	81.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.9	E08		9	0004-0035	317.27	34.86	407	80.43	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			184.3	E08		9	0005-0039	22.73	39.90	388	76.91	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.4	E08		9	0006-0041	859.08	41.53	402	77.74	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.1	E08		9	0007-0048	501.51	48.32	417	77.26	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			213.1	E08		9	0008-0052	92.29	52.34	375	72.67	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.8	E08		9	0009-0051	682.41	51.08	408	75.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.5	E08		9	0010-0056	198.24	54.50	521	106.81	0.574
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.7	E08		9	0011-0053	750.74	53.84	362	71.60	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.1	E08		9	0012-0058	180.23	60.22	233	72.08	0.564
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			209.8	E08		9	0013-0059	124.69	58.76	368	74.67	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			259.4	E08		9	0014-0065	905.51	65.74	347	70.43	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			293.1	E08		9	0015-0067	424.89	67.01	396	75.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			296.5	E08		9	0016-0068	807.95	68.14	355	68.77	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			325.5	E08		9	0017-0080	716.35	80.08	379	75.36	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			306.2	E08		9	0018-0076	289.50	76.64	363	72.43	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			216.3	E08		9	0019-0079	840.09	78.86	418	77.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			586.2	E08		9	0020-0082	469.22	81.80	358	71.60	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			305.0	E08		9	0021-0086	533.45	85.87	390	75.84	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			393.2	E08		9	0022-0091	923.79	90.75	578	92.57	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			205.3	E08		9	0023-0090	79.93	89.86	378	73.50	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.8	E08		9	0024-0097	361.02	97.13	367	73.26	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			215.7	E08		9	0025-0100	832.20	99.85	407	77.84	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			226.3	E08		9	0026-0104	944.59	104.47	361	71.84	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			553.1	E08		9	0027-0114	400.72	115.10	887	115.98	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			279.1	E08		9	0028-0113	501.62	112.70	613	91.74	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			235.5	E08		9	0029-0124	118.68	124.31	366	71.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.0	E08		9	0030-0133	74.11	134.00	385	77.60	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.9	E08		9	0031-0136	215.57	136.49	367	71.60	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.6	E08		9	0032-0137	304.29	137.25	382	75.26	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			225.5	E08		9	0033-0142	849.97	142.28	397	76.67	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			312.4	E08		9	0034-0153	773.45	152.25	340	70.33	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.4	E08		9	0035-0155	71.06	153.87	405	76.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.9	E08		9	0036-0157	644.08	156.94	390	76.08	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.6	E08		9	0037-0159	16.79	159.26	372	72.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			338.8	E08		9	0038-0164	786.81	165.90	382	73.74	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			375.8	E08		9	0039-0170	711.99	170.25	341	68.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			305.1	E08		9	0040-0179	734.38	179.20	399	77.26	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			328.4	E08		9	0041-0182	557.51	181.49	421	78.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			292.3	E08		9	0042-0181	472.02	180.70	441	80.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.4	E08		9	0043-0183	320.29	182.67	391	75.26	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			323.8	E08		9	0044-0190	33.68	190.27	339	69.01	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			344.4	E08		9	0045-0190	662.58	189.98	368	74.43	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.6	E08		9	0046-0201	870.57	199.09	990	127.54	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.1	E08		9	0047-0198	642.58	198.23	392	75.60	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			299.6	E08		9	0048-0198	62.31	198.18	337	69.26	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.4	E08		9	0049-0204	137.30	204.06	380	75.84	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			283.3	E08		9	0050-0204	931.35	203.84	337	68.18	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.3	E08		9	0051-0207	116.09	206.71	381	75.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			310.7	E08		9	0052-0218	365.71	218.11	398	77.50	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			301.5	E08		9	0053-0223	202.20	223.22	396	76.08	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			226.4	E08		9	0054-0235	446.43	235.83	404	77.74	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.7	E08		9	0055-0234	300.74	233.79	385	75.26	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.7	E08		9	0056-0237	852.00	237.08	388	73.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.7	E08		9	0057-0246	898.77	247.10	689	110.37	0.711
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			289.6	E08		9	0058-0245	510.67	246.13	412	75.26	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			306.9	E08		9	0059-0250	571.60	249.66	391	73.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			283.5	E08		9	0060-0254	95.42	254.05	353	68.18	0.954
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			299.5	E08		9	0061-0261	257.36	261.65	412	80.43	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.8	E08		9	0062-0264	925.97	264.27	369	71.01	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			411.1	E08		9	0063-0267	276.08	268.10	156	48.87	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			299.0	E08		9	0064-0295	116.10	293.14	552	94.23	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			348.5	E08		9	0065-0296	865.27	296.47	330	67.94	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			284.8	E08		9	0066-0308	601.08	308.01	785	119.10	0.695
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			234.7	E08		9	0067-0312	311.36	313.08	807	110.37	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			333.7	E08		9	0068-0306	62.59	305.93	393	78.33	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			268.8	E08		9	0069-0310	160.91	310.08	362	74.91	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.4	E08		9	0070-0311	534.74	311.75	392	75.01	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.6	E08		9	0071-0312	103.15	311.94	275	61.36	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			279.0	E08		9	0072-0316	463.24	315.59	409	77.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			264.4	E08		9	0073-0318	253.19	318.38	397	76.33	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.8	E08		9	0074-0321	48.06	322.47	448	79.50	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			420.5	E08		9	0075-0322	843.07	321.93	318	66.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.5	E08		9	0076-0329	410.85	329.14	331	68.43	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			212.4	E08		9	0077-0334	18.36	333.96	364	73.50	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.7	E08		9	0078-0336	359.49	336.39	397	73.84	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.6	E08		9	0079-0361	46.64	361.56	375	76.18	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.2	E08		9	0080-0363	143.77	363.02	715	101.05	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			347.3	E08		9	0081-0357	942.03	357.06	341	68.18	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			480.8	E08		9	0082-0367	914.25	366.85	224	76.43	0.482
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.5	E08		9	0083-0371	291.66	371.35	368	72.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			221.0	E08		9	0084-0386	92.84	386.67	367	72.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.4	E08		9	0085-0400	243.83	400.34	375	73.26	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			286.3	E08		9	0086-0401	306.84	401.24	393	74.67	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.7	E08		9	0087-0409	193.29	408.93	388	73.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			204.7	E08		9	0088-0412	70.60	412.71	370	71.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			268.0	E08		9	0089-0421	506.18	420.74	402	75.50	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			222.7	E08		9	0090-0424	23.89	424.00	390	75.60	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			211.6	E08		9	0091-0438	122.48	438.09	377	74.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			194.7	E08		9	0092-0457	67.82	457.34	362	71.60	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			285.7	E08		9	0093-0460	378.98	459.94	408	74.43	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			286.1	E08		9	0094-0472	844.58	471.93	371	74.43	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.3	E08		9	0095-0493	233.99	494.65	661	106.23	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			259.0	E08		9	0096-0496	541.76	496.72	360	71.84	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.3	E08		9	0097-0502	57.45	502.91	432	82.28	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.0	E08		9	0098-0504	37.64	504.09	357	72.53	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.9	E08		9	0099-0505	610.27	505.12	422	75.26	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.5	E08		9	0100-0519	323.28	519.04	444	79.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.7	E08		9	0101-0523	206.62	522.81	376	73.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.7	E08		9	0102-0523	59.79	522.94	350	71.70	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			234.1	E08		9	0103-0540	338.97	540.23	445	79.26	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.2	E08		9	0104-0545	381.48	545.16	362	70.53	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			395.0	E08		9	0105-0545	571.83	544.20	311	67.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			338.5	E08		9	0106-0559	562.79	560.54	389	75.26	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.7	E08		9	0107-0574	22.91	574.25	342	69.60	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			273.7	E08		9	0108-0576	608.85	576.94	389	74.91	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.5	E08		9	0109-0587	590.60	587.81	393	75.26	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.9	E08		9	0110-0594	360.80	594.71	372	72.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			218.2	E08		9	0111-0597	50.96	597.50	346	71.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			367.9	E08		9	0112-0619	538.40	618.84	271	59.94	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			211.6	E08		9	0113-0632	114.79	632.78	368	71.84	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.8	E08		9	0114-0633	916.89	632.73	349	70.77	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.5	E08		9	0115-0637	723.10	636.85	398	76.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			221.2	E08		9	0116-0635	35.78	635.56	114	43.46	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.4	E08		9	0117-0647	330.91	646.43	963	121.30	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			312.2	E08		9	0118-0643	95.21	643.10	364	74.08	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			304.9	E08		9	0119-0646	831.47	646.01	365	71.84	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			332.8	E08		9	0120-0664	884.80	664.40	591	92.33	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			215.7	E08		9	0121-0688	282.03	688.56	384	75.84	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			208.0	E08		9	0122-0691	32.07	691.03	364	72.43	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.1	E08		9	0123-0696	492.71	697.00	914	118.23	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			203.1	E08		9	0124-0692	101.63	692.07	400	76.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			236.7	E08		9	0125-0695	371.28	694.61	380	75.50	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			301.0	E08		9	0126-0700	602.27	699.55	456	83.74	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			203.4	E08		9	0127-0701	453.77	701.32	370	71.84	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			301.4	F08		1	0001-0030	110.32	30.57	334	66.77	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			350.4	F08		1	0002-0030	292.69	29.76	335	69.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.0	F08		1	0003-0033	788.07	32.87	308	63.94	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			312.4	F08		1	0004-0036	632.11	35.77	388	76.67	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			273.2	F08		1	0005-0039	856.44	39.34	340	71.26	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			281.0	F08		1	0006-0046	812.65	45.96	342	69.60	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			424.4	F08		1	0007-0045	447.90	44.91	293	63.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.0	F08		1	0008-0050	42.39	51.20	369	72.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			422.9	F08		1	0009-0052	596.09	52.45	328	69.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.3	F08		1	0010-0056	175.27	55.94	409	77.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			356.2	F08		1	0011-0064	115.82	64.58	333	67.26	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.3	F08		1	0012-0066	924.28	65.51	402	78.08	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			287.9	F08		1	0013-0084	473.86	84.49	348	69.60	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			417.7	F08		1	0014-0088	249.65	88.08	246	61.84	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.9	F08		1	0015-0090	298.93	89.70	343	71.01	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			320.0	F08		1	0016-0097	626.12	97.82	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			279.2	F08		1	0017-0100	812.67	99.51	412	75.26	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			284.9	F08		1	0018-0101	37.70	101.14	322	67.01	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			279.5	F08		1	0019-0109	158.33	109.14	367	74.67	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			423.2	F08		1	0020-0110	918.49	110.83	230	55.70	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			399.6	F08		1	0021-0117	383.49	117.08	301	63.60	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			270.0	F08		1	0022-0120	224.09	120.30	352	71.84	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			313.4	F08		1	0023-0128	92.30	128.42	330	68.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			298.2	F08		1	0024-0129	304.76	129.88	332	69.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			289.7	F08		1	0025-0132	888.55	131.89	382	74.67	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			316.9	F08		1	0026-0133	624.07	132.24	400	75.84	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.5	F08		1	0027-0136	189.70	136.50	377	71.84	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			519.6	F08		1	0028-0139	38.80	139.33	355	71.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			317.6	F08		1	0029-0156	502.25	156.41	361	72.77	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			396.6	F08		1	0030-0159	245.97	159.58	262	60.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			317.4	F08		1	0031-0162	542.47	162.08	305	66.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.7	F08		1	0032-0170	856.80	169.98	448	81.26	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			289.2	F08		1	0033-0175	32.65	174.76	287	62.77	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.0	F08		1	0034-0180	296.19	180.25	357	70.67	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.4	F08		1	0035-0181	102.62	181.53	348	70.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.1	F08		1	0036-0191	622.34	191.15	356	70.53	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.2	F08		1	0037-0209	549.09	209.23	362	71.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			327.5	F08		1	0038-0216	173.16	216.49	298	64.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			474.5	F08		1	0039-0214	415.90	214.79	279	65.70	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			363.2	F08		1	0040-0218	132.55	218.67	313	65.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.0	F08		1	0041-0222	910.76	222.53	352	71.36	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			318.0	F08		1	0042-0227	265.38	226.89	346	70.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			312.2	F08		1	0043-0236	190.99	236.66	350	69.01	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			291.7	F08		1	0044-0238	460.98	238.44	327	74.08	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			413.3	F08		1	0045-0242	620.41	241.77	371	73.26	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.5	F08		1	0046-0241	540.92	241.27	310	65.11	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			777.3	F08		1	0047-0241	410.05	241.48	113	37.80	0.994
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			329.9	F08		1	0048-0250	839.25	249.93	357	73.26	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.0	F08		1	0049-0261	137.07	261.05	352	71.26	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.0	F08		1	0050-0262	571.15	261.52	381	73.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.5	F08		1	0051-0266	475.39	266.69	348	70.77	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.0	F08		1	0052-0270	530.89	271.01	334	69.84	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.1	F08		1	0053-0273	75.30	273.01	386	72.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			305.0	F08		1	0054-0279	210.55	279.03	249	60.43	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			336.0	F08		1	0055-0279	382.62	278.80	308	67.36	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.7	F08		1	0056-0282	904.38	282.65	390	74.43	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			283.9	F08		1	0057-0287	15.18	287.71	332	67.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.8	F08		1	0058-0300	517.08	299.90	373	73.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			286.5	F08		1	0059-0329	669.56	330.57	345	70.43	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			316.1	F08		1	0060-0329	210.55	329.94	319	64.77	0.956
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.4	F08		1	0061-0342	802.79	343.15	334	72.67	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.0	F08		1	0062-0344	183.62	344.44	354	70.43	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			292.1	F08		1	0063-0346	343.07	345.89	306	64.77	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			360.9	F08		1	0064-0343	518.02	343.86	284	64.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			281.3	F08		1	0065-0349	610.56	349.57	361	71.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			314.8	F08		1	0066-0349	313.63	348.58	294	67.26	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			343.4	F08		1	0067-0352	260.23	352.27	281	67.11	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			460.9	F08		1	0068-0354	442.75	354.67	287	63.94	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			334.5	F08		1	0069-0363	480.92	363.36	340	69.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			298.9	F08		1	0070-0367	299.40	366.87	304	65.36	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.6	F08		1	0071-0365	834.10	365.25	322	69.01	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			346.2	F08		1	0072-0368	527.07	367.61	294	64.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			294.1	F08		1	0073-0382	713.27	382.72	345	71.50	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.9	F08		1	0074-0384	173.41	384.36	362	72.77	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.5	F08		1	0075-0391	638.78	392.22	333	68.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.0	F08		1	0076-0405	573.29	404.87	344	69.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.0	F08		1	0077-0406	83.10	406.45	337	72.08	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.4	F08		1	0078-0409	594.00	410.00	382	76.43	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			454.5	F08		1	0079-0416	504.68	415.87	285	67.01	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			308.3	F08		1	0080-0418	699.52	417.20	307	69.50	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			356.5	F08		1	0081-0418	203.10	417.77	265	61.36	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			283.8	F08		1	0082-0428	690.61	428.69	321	68.91	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.2	F08		1	0083-0435	651.67	435.56	372	72.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.3	F08		1	0084-0437	450.85	437.17	367	70.77	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			348.6	F08		1	0085-0435	195.15	435.23	264	61.36	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			252.6	F08		1	0086-0441	111.14	440.70	368	73.84	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			335.5	F08		1	0087-0436	937.32	436.53	267	61.70	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			407.1	F08		1	0088-0444	253.50	444.16	346	118.71	0.309
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			290.6	F08		1	0089-0455	397.40	455.25	368	71.01	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			418.7	F08		1	0090-0464	825.17	463.78	237	57.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			324.7	F08		1	0091-0485	605.91	485.29	412	87.15	0.682
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			305.3	F08		1	0092-0484	359.10	485.15	381	72.18	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			289.9	F08		1	0093-0490	141.87	490.27	500	83.26	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			312.1	F08		1	0094-0485	304.73	485.23	290	63.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			357.4	F08		1	0095-0491	754.70	490.13	391	73.84	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			310.6	F08		1	0096-0498	265.06	497.74	288	63.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			585.8	F08		1	0097-0502	612.95	502.59	117	44.87	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.8	F08		1	0098-0527	10.59	527.92	305	65.70	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			277.0	F08		1	0099-0529	57.86	529.03	358	73.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.2	F08		1	0100-0535	452.49	535.43	640	112.47	0.636
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.7	F08		1	0101-0544	105.27	544.43	300	68.18	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.1	F08		1	0102-0546	231.84	545.25	339	71.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			423.1	F08		1	0103-0553	623.75	553.28	268	62.43	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.2	F08		1	0104-0555	850.95	555.28	286	62.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.0	F08		1	0105-0568	48.18	568.35	360	72.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			313.3	F08		1	0106-0574	819.63	574.22	350	69.11	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.6	F08		1	0107-0583	783.20	583.27	312	66.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			268.5	F08		1	0108-0584	710.81	582.51	423	89.50	0.664
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			202.2	F08		1	0109-0601	38.32	600.89	321	67.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.5	F08		1	0110-0600	607.81	600.05	367	76.08	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			223.1	F08		1	0111-0606	660.58	605.85	371	69.60	0.962
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			228.1	F08		1	0112-0610	748.21	610.84	319	68.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			390.7	F08		1	0113-0613	409.35	613.53	265	61.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			394.3	F08		1	0114-0617	366.01	617.49	295	65.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.2	F08		1	0115-0636	47.83	636.91	302	65.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			468.0	F08		1	0116-0637	228.92	636.45	239	59.84	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			320.6	F08		1	0117-0641	105.73	640.57	304	66.43	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			302.6	F08		1	0118-0640	623.25	640.90	283	65.50	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.9	F08		1	0119-0647	682.37	646.90	347	69.36	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			314.3	F08		1	0120-0655	768.36	655.13	297	65.11	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.6	F08		1	0121-0662	135.28	662.55	313	68.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			371.3	F08		1	0122-0666	210.92	665.60	261	60.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			326.2	F08		1	0123-0671	801.92	670.94	284	69.94	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			405.4	F08		1	0124-0667	75.29	666.23	255	61.01	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			216.4	F08		1	0125-0677	59.44	677.46	367	73.74	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			374.3	F08		1	0126-0683	690.93	683.68	237	57.11	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			228.4	F08		1	0127-0686	20.18	685.76	352	73.26	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			348.2	F08		1	0128-0684	273.91	684.26	249	60.87	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.9	F08		1	0129-0693	915.46	693.02	290	65.36	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.2	F08		1	0130-0701	579.21	702.80	368	72.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			383.0	F08		2	0001-0044	402.32	43.52	252	60.87	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.3	F08		2	0002-0047	546.79	46.75	377	74.43	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.8	F08		2	0003-0045	673.20	45.53	381	73.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			405.5	F08		2	0004-0049	443.67	49.45	286	65.01	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.9	F08		2	0005-0054	106.51	53.86	348	73.26	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			281.9	F08		2	0006-0052	743.31	52.03	279	62.43	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			308.6	F08		2	0007-0054	139.17	54.86	280	64.43	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			215.7	F08		2	0008-0067	28.86	65.71	380	74.67	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			386.1	F08		2	0009-0077	470.04	76.71	312	68.18	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			311.9	F08		2	0010-0072	721.48	72.01	287	65.94	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			314.4	F08		2	0011-0074	183.67	73.87	277	62.28	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			424.0	F08		2	0012-0080	815.81	78.97	283	65.50	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.4	F08		2	0013-0082	518.19	82.42	330	77.50	0.690
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			313.2	F08		2	0014-0083	889.92	82.14	281	62.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.7	F08		2	0015-0093	931.34	92.92	316	69.26	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			227.4	F08		2	0016-0102	144.94	102.35	374	75.50	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			318.9	F08		2	0017-0105	565.73	104.91	454	81.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			377.2	F08		2	0018-0111	22.99	111.27	235	56.53	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			308.2	F08		2	0019-0113	657.25	112.56	319	68.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			398.9	F08		2	0020-0117	207.77	117.49	239	59.70	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			417.9	F08		2	0021-0119	230.19	119.39	242	60.53	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			328.4	F08		2	0022-0134	856.86	133.97	276	62.43	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.4	F08		2	0023-0138	939.43	137.65	329	70.43	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			273.5	F08		2	0024-0143	330.89	143.01	345	68.77	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.9	F08		2	0025-0151	69.43	151.02	317	67.84	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			552.5	F08		2	0026-0156	215.70	157.45	411	85.50	0.707
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.2	F08		2	0027-0157	165.99	157.66	306	66.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			416.0	F08		2	0028-0162	411.80	162.46	265	61.36	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			388.0	F08		2	0029-0166	749.08	166.72	255	59.36	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.2	F08		2	0030-0170	119.40	169.22	339	71.01	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			376.0	F08		2	0031-0169	139.86	169.16	344	68.53	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.1	F08		2	0032-0176	510.70	176.42	377	72.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			351.8	F08		2	0033-0172	635.63	171.65	154	45.94	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			343.8	F08		2	0034-0178	457.29	178.32	334	68.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			353.0	F08		2	0035-0181	626.08	181.30	201	55.01	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			342.1	F08		2	0036-0187	645.35	186.92	276	63.60	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			429.7	F08		2	0037-0189	845.17	189.53	216	59.60	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.9	F08		2	0038-0193	325.10	193.61	304	64.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			283.5	F08		2	0039-0198	409.45	197.88	339	70.18	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.8	F08		2	0040-0209	535.17	208.71	386	73.26	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.4	F08		2	0041-0222	15.25	222.86	325	68.53	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			270.0	F08		2	0042-0224	616.40	224.46	300	65.01	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			289.7	F08		2	0043-0226	843.78	226.33	273	63.60	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.6	F08		2	0044-0230	121.18	229.88	332	68.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.1	F08		2	0045-0228	239.63	228.40	268	65.01	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			219.7	F08		2	0046-0230	652.00	230.29	317	67.84	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.8	F08		2	0047-0233	715.12	232.41	190	55.11	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			328.9	F08		2	0048-0235	323.12	235.58	304	71.11	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			310.6	F08		2	0049-0245	404.92	245.37	349	71.84	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			286.4	F08		2	0050-0250	276.28	249.47	274	63.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			289.9	F08		2	0051-0264	929.92	263.21	249	63.01	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.1	F08		2	0052-0261	191.74	262.17	309	69.36	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			537.8	F08		2	0053-0261	360.66	261.16	226	56.04	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			286.5	F08		2	0054-0268	54.40	268.60	344	69.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			407.7	F08		2	0055-0269	887.42	269.70	221	56.87	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			333.9	F08		2	0056-0270	341.91	269.66	282	63.94	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			284.0	F08		2	0057-0270	377.36	269.33	302	67.01	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			233.4	F08		2	0058-0280	724.41	279.94	346	72.18	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			315.3	F08		2	0059-0287	837.58	288.01	278	63.36	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			408.4	F08		2	0060-0297	127.28	297.86	214	57.94	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.3	F08		2	0061-0310	855.99	310.23	349	72.77	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			372.3	F08		2	0062-0317	259.32	317.68	288	65.70	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.7	F08		2	0063-0316	721.99	316.46	335	70.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			335.6	F08		2	0064-0321	376.65	320.95	305	66.67	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			336.4	F08		2	0065-0326	445.77	327.05	286	61.36	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			298.2	F08		2	0066-0330	180.19	329.23	325	67.36	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.8	F08		2	0067-0342	868.58	341.35	293	64.18	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.3	F08		2	0068-0348	366.56	348.52	336	68.18	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.5	F08		2	0069-0351	922.88	351.54	356	73.01	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			234.6	F08		2	0070-0356	941.20	356.11	350	71.60	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.3	F08		2	0071-0357	153.69	357.39	612	108.23	0.657
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.6	F08		2	0072-0374	406.60	374.81	483	84.43	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.3	F08		2	0073-0383	289.40	383.00	313	67.94	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.5	F08		2	0074-0383	102.55	383.68	245	59.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			324.1	F08		2	0075-0385	593.84	385.36	304	67.84	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.3	F08		2	0076-0387	356.28	387.46	294	66.43	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			221.9	F08		2	0077-0393	141.79	393.65	318	69.26	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.7	F08		2	0078-0397	212.63	398.04	322	65.60	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			268.5	F08		2	0079-0404	652.55	404.88	359	70.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.7	F08		2	0080-0409	431.96	408.57	379	72.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			306.6	F08		2	0081-0430	485.77	430.66	314	68.18	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.7	F08		2	0082-0436	193.76	436.75	316	68.43	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			342.1	F08		2	0083-0436	587.81	435.82	323	69.01	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			337.6	F08		2	0084-0437	42.06	436.96	271	61.11	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			869.3	F08		2	0085-0437	821.66	437.77	223	56.77	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			583.9	F08		2	0086-0448	660.63	448.83	239	58.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			223.5	F08		2	0087-0453	54.39	453.00	355	70.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			350.7	F08		2	0088-0459	340.67	458.85	249	61.84	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			452.1	F08		2	0089-0458	740.67	458.64	236	59.70	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			235.3	F08		2	0090-0467	519.60	467.21	345	69.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			425.1	F08		2	0091-0479	573.14	478.52	194	66.43	0.552
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.2	F08		2	0092-0489	169.47	489.35	315	70.77	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.4	F08		2	0093-0519	590.31	518.90	428	82.08	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			292.5	F08		2	0094-0517	202.43	517.49	317	67.36	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			368.7	F08		2	0095-0523	87.21	522.84	469	81.50	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			398.3	F08		2	0096-0521	771.81	521.83	313	68.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			291.4	F08		2	0097-0538	125.28	538.27	288	62.53	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			301.9	F08		2	0098-0537	646.98	536.44	248	62.18	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.4	F08		2	0099-0545	186.16	545.47	349	70.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			309.7	F08		2	0100-0562	460.22	561.46	366	74.43	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			289.3	F08		2	0101-0559	846.47	559.65	280	61.60	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			286.0	F08		2	0102-0581	830.65	580.36	296	64.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			285.1	F08		2	0103-0584	729.87	584.27	309	67.94	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.5	F08		2	0104-0583	136.86	584.11	355	70.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.6	F08		2	0105-0593	204.94	592.65	333	67.84	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.4	F08		2	0106-0599	657.62	599.28	352	72.77	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.1	F08		2	0107-0612	401.82	612.35	416	77.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			289.5	F08		2	0108-0613	282.94	613.38	336	69.60	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.7	F08		2	0109-0617	794.31	617.48	364	74.43	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.6	F08		2	0110-0627	564.76	627.74	304	68.33	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			334.0	F08		2	0111-0628	503.68	628.54	265	60.43	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.8	F08		2	0112-0640	468.48	639.76	358	74.77	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			389.6	F08		2	0113-0637	533.36	637.27	300	64.43	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			296.0	F08		2	0114-0638	142.53	638.49	284	62.28	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			311.3	F08		2	0115-0642	923.09	642.55	259	61.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			318.6	F08		2	0116-0649	490.89	649.79	358	75.60	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			220.8	F08		2	0117-0649	649.70	649.95	364	70.43	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			514.5	F08		2	0118-0651	340.95	651.50	256	60.53	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			426.5	F08		2	0119-0655	74.76	655.35	333	67.01	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.6	F08		2	0120-0656	384.32	656.20	315	68.43	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.2	F08		2	0121-0657	846.70	657.62	241	65.01	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			324.1	F08		2	0122-0664	526.49	664.41	282	62.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			342.5	F08		2	0123-0666	164.78	666.26	272	63.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			301.3	F08		2	0124-0667	290.75	666.98	342	68.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			222.2	F08		2	0125-0682	731.33	682.52	336	69.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.8	F08		2	0126-0684	931.88	683.94	264	62.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			210.1	F08		2	0127-0694	19.90	693.98	297	67.60	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.3	F08		2	0128-0705	744.81	704.87	312	65.84	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			374.1	F08		2	0129-0706	272.33	705.97	274	61.70	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			318.8	F08		2	0130-0704	664.77	704.13	313	65.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.4	F08		3	0001-0050	476.08	49.13	337	67.70	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			313.3	F08		3	0002-0055	782.98	55.56	261	61.11	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			451.4	F08		3	0003-0061	427.72	60.68	259	63.26	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			285.9	F08		3	0004-0062	393.22	62.02	308	63.36	0.964
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			380.7	F08		3	0005-0065	594.31	65.58	268	65.11	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			321.4	F08		3	0006-0068	325.54	68.02	284	62.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			401.4	F08		3	0007-0074	358.23	74.13	275	61.94	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			428.7	F08		3	0008-0089	435.52	89.44	268	60.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.6	F08		3	0009-0095	26.42	95.35	307	67.84	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			628.0	F08		3	0010-0109	138.49	108.04	205	67.26	0.570
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			576.8	F08		3	0011-0121	338.26	120.75	128	83.98	0.228
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			480.2	F08		3	0012-0130	591.11	130.17	181	52.87	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			225.4	F08		3	0013-0135	62.32	134.57	325	67.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			357.1	F08		3	0014-0142	436.10	142.21	309	66.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			306.3	F08		3	0015-0139	714.84	139.16	329	69.84	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			488.5	F08		3	0016-0141	34.55	140.24	322	71.01	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			302.7	F08		3	0017-0151	362.17	151.19	344	69.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			566.5	F08		3	0018-0146	686.46	146.15	203	58.28	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			317.5	F08		3	0019-0162	798.40	161.54	373	72.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			302.8	F08		3	0020-0164	305.82	164.51	279	61.94	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.3	F08		3	0021-0169	524.17	169.68	355	70.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			341.8	F08		3	0022-0176	41.37	176.90	331	73.50	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			233.8	F08		3	0023-0177	832.00	178.04	298	65.26	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			232.8	F08		3	0024-0180	761.07	179.65	319	70.18	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			378.2	F08		3	0025-0177	491.67	177.39	215	55.11	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			223.2	F08		3	0026-0188	796.60	188.30	334	69.36	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			778.7	F08		3	0027-0192	111.65	192.79	198	51.11	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			355.1	F08		3	0028-0201	382.46	201.75	271	63.26	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			277.8	F08		3	0029-0205	201.11	204.61	346	71.11	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			281.7	F08		3	0030-0209	706.89	208.43	356	71.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			319.8	F08		3	0031-0212	450.10	211.48	257	58.77	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.9	F08		3	0032-0220	833.52	220.04	327	70.67	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			423.2	F08		3	0033-0220	134.00	220.04	250	59.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			286.9	F08		3	0034-0227	404.98	227.52	305	64.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			349.2	F08		3	0035-0230	513.44	230.31	226	62.77	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			494.5	F08		3	0036-0234	547.93	234.56	240	58.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			316.3	F08		3	0037-0237	281.30	237.36	268	63.11	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			379.8	F08		3	0038-0255	675.34	254.68	236	58.53	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			281.3	F08		3	0039-0258	799.14	258.45	311	66.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			480.8	F08		3	0040-0262	553.47	262.69	241	58.53	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			279.2	F08		3	0041-0266	25.16	265.73	251	63.01	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			310.6	F08		3	0042-0265	863.12	265.41	274	63.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			357.7	F08		3	0043-0265	141.87	264.90	244	59.94	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			491.5	F08		3	0044-0269	487.64	268.24	132	54.77	0.553
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			320.1	F08		3	0045-0276	280.84	276.59	386	73.26	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			359.4	F08		3	0046-0283	412.01	282.93	270	61.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			441.3	F08		3	0047-0287	480.67	286.13	285	76.33	0.615
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			259.8	F08		3	0048-0285	614.69	285.54	353	71.01	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			287.2	F08		3	0049-0296	198.32	296.29	316	68.77	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			309.0	F08		3	0050-0294	808.99	294.66	306	65.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			416.3	F08		3	0051-0300	332.45	299.79	423	75.84	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			311.9	F08		3	0052-0300	512.00	299.74	300	64.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			417.0	F08		3	0053-0297	560.29	297.60	266	59.70	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.1	F08		3	0054-0305	631.55	304.42	320	68.18	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			330.8	F08		3	0055-0306	733.69	306.77	268	63.26	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			650.8	F08		3	0056-0305	416.53	305.25	160	48.63	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			461.9	F08		3	0057-0317	101.43	316.75	262	61.60	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			236.4	F08		3	0058-0318	58.86	318.20	366	72.08	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			328.5	F08		3	0059-0321	912.88	321.82	329	68.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			365.8	F08		3	0060-0321	412.84	321.14	247	64.77	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			301.9	F08		3	0061-0347	476.90	347.05	328	68.67	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			319.2	F08		3	0062-0349	536.15	349.97	293	67.11	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			314.0	F08		3	0063-0352	322.80	351.71	344	72.43	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			391.8	F08		3	0064-0354	218.01	354.14	410	78.43	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			273.2	F08		3	0065-0351	905.20	351.25	201	57.36	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			211.7	F08		3	0066-0354	18.49	354.18	350	72.18	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			225.2	F08		3	0067-0359	36.63	358.66	327	71.60	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.2	F08		3	0068-0361	443.07	361.30	317	74.77	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.2	F08		3	0069-0364	167.12	363.84	301	66.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			284.7	F08		3	0070-0375	797.76	374.43	377	74.43	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			454.4	F08		3	0071-0376	407.77	376.33	403	74.43	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			558.7	F08		3	0072-0383	548.09	383.47	271	61.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			335.9	F08		3	0073-0386	55.28	386.66	263	61.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.9	F08		3	0074-0389	468.20	389.24	355	71.01	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			287.3	F08		3	0075-0397	757.28	397.31	318	66.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.3	F08		3	0076-0407	593.49	407.72	303	65.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.1	F08		3	0077-0411	77.32	411.36	338	74.53	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.9	F08		3	0078-0415	667.54	414.74	411	79.26	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			236.8	F08		3	0079-0419	610.37	419.36	314	70.53	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			355.3	F08		3	0080-0418	171.29	417.35	336	70.67	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			379.9	F08		3	0081-0420	436.94	420.27	281	66.43	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			398.2	F08		3	0082-0432	899.32	432.10	265	65.60	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			298.2	F08		3	0083-0438	699.89	438.70	296	63.11	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			225.9	F08		3	0084-0444	43.31	444.10	338	70.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.9	F08		3	0085-0456	495.79	456.18	406	77.50	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			373.4	F08		3	0086-0460	909.25	460.74	187	53.94	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			327.5	F08		3	0087-0465	185.70	465.70	314	67.94	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			304.8	F08		3	0088-0474	639.22	474.30	345	69.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.7	F08		3	0089-0477	108.91	477.06	326	70.43	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			306.8	F08		3	0090-0483	496.72	482.98	270	66.43	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			236.8	F08		3	0091-0489	136.73	489.56	356	70.18	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			333.2	F08		3	0092-0490	780.75	490.99	267	61.36	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.0	F08		3	0093-0495	49.45	494.62	325	71.01	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			305.0	F08		3	0094-0500	347.91	499.38	295	64.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			283.5	F08		3	0095-0505	919.44	505.45	336	70.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			289.9	F08		3	0096-0508	250.88	507.89	557	95.74	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			281.6	F08		3	0097-0510	377.92	509.40	309	65.01	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.1	F08		3	0098-0527	730.49	527.19	370	73.60	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.7	F08		3	0099-0528	126.47	527.79	363	75.26	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.0	F08		3	0100-0534	225.35	534.16	299	67.01	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			324.0	F08		3	0101-0536	332.81	536.80	270	62.18	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.6	F08		3	0102-0543	554.02	544.15	343	69.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.7	F08		3	0103-0559	286.52	558.77	368	74.18	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			277.4	F08		3	0104-0566	404.65	567.19	357	75.60	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.9	F08		3	0105-0571	119.84	570.90	342	68.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.4	F08		3	0106-0577	154.39	576.28	301	68.43	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			289.8	F08		3	0107-0591	260.04	590.74	287	68.67	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			345.1	F08		3	0108-0616	365.65	616.72	298	71.50	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			399.2	F08		3	0109-0615	867.81	615.37	216	57.36	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			381.5	F08		3	0110-0619	937.72	619.86	247	60.53	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.1	F08		3	0111-0617	586.76	617.38	390	76.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.4	F08		3	0112-0630	903.23	629.42	344	73.50	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.8	F08		3	0113-0631	686.81	631.00	315	66.43	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.8	F08		3	0114-0638	664.80	638.76	311	67.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.0	F08		3	0115-0642	347.01	643.02	393	73.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.3	F08		3	0116-0644	17.93	645.04	252	59.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.5	F08		3	0117-0648	121.67	648.11	346	72.18	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			337.8	F08		3	0118-0651	291.92	651.05	242	62.77	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			235.7	F08		3	0119-0654	805.48	654.07	367	80.57	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			336.8	F08		3	0120-0652	309.59	653.07	239	60.77	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			312.2	F08		3	0121-0658	176.52	658.47	307	64.77	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			209.4	F08		3	0122-0658	839.55	658.18	315	69.84	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.4	F08		3	0123-0665	557.91	665.19	318	65.60	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			202.4	F08		3	0124-0672	147.01	672.49	294	63.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			221.2	F08		3	0125-0682	690.56	682.16	287	63.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			429.7	F08		3	0126-0686	535.26	685.35	203	55.21	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.6	F08		3	0127-0686	26.79	686.38	256	61.11	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			223.8	F08		3	0128-0694	675.48	694.25	328	67.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			292.5	F08		3	0129-0694	879.58	694.71	250	59.94	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			277.9	F08		3	0130-0704	182.73	704.55	273	61.60	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.5	F08		3	0131-0705	571.76	705.50	261	61.94	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			312.9	F08		4	0001-0029	171.82	29.32	261	60.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			517.7	F08		4	0002-0029	195.04	28.79	276	62.28	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			348.9	F08		4	0003-0032	144.75	32.73	257	61.70	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			286.8	F08		4	0004-0037	371.19	36.91	404	78.43	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.4	F08		4	0005-0064	872.22	63.25	356	72.43	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			308.9	F08		4	0006-0066	791.10	66.43	289	63.84	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			403.6	F08		4	0007-0069	51.72	68.97	255	61.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.1	F08		4	0008-0073	575.33	73.58	383	72.18	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.3	F08		4	0009-0076	110.78	76.17	321	67.94	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			236.9	F08		4	0010-0081	129.33	81.01	329	68.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.1	F08		4	0011-0096	634.11	95.81	337	70.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			230.6	F08		4	0012-0099	658.30	99.12	333	67.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			311.0	F08		4	0013-0106	475.01	106.70	414	83.26	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			390.2	F08		4	0014-0113	291.14	113.27	168	62.18	0.546
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			341.7	F08		4	0015-0121	83.65	120.58	291	65.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			418.7	F08		4	0016-0123	752.18	123.22	242	61.94	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			522.2	F08		4	0017-0121	785.98	121.79	202	51.94	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			307.1	F08		4	0018-0130	765.98	129.70	307	67.60	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.6	F08		4	0019-0132	574.14	131.92	314	67.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			382.8	F08		4	0020-0134	331.23	133.99	233	59.60	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			368.8	F08		4	0021-0136	432.75	135.71	287	64.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			376.2	F08		4	0022-0159	807.45	159.14	211	57.11	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			743.2	F08		4	0023-0161	233.88	160.59	280	61.94	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			339.2	F08		4	0024-0161	49.25	161.54	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			311.0	F08		4	0025-0164	601.52	164.49	295	64.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			264.8	F08		4	0026-0206	90.26	206.84	298	64.53	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			399.1	F08		4	0027-0209	531.51	209.16	307	68.18	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			313.7	F08		4	0028-0216	759.32	217.08	373	77.01	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.3	F08		4	0029-0212	912.03	211.82	314	67.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.9	F08		4	0030-0220	638.13	219.53	359	73.84	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			296.5	F08		4	0031-0225	408.56	225.08	339	71.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			374.8	F08		4	0032-0233	179.43	233.32	244	59.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.4	F08		4	0033-0240	333.77	239.81	310	66.43	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			463.0	F08		4	0034-0248	851.08	248.98	214	56.04	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			226.1	F08		4	0035-0257	43.47	257.21	343	70.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			360.5	F08		4	0036-0259	664.07	259.11	241	61.36	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.8	F08		4	0037-0270	424.07	270.27	299	66.18	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.3	F08		4	0038-0273	376.22	273.53	333	67.36	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			383.0	F08		4	0039-0272	180.26	272.05	242	58.77	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			411.3	F08		4	0040-0293	717.39	293.01	452	78.67	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.7	F08		4	0041-0297	20.10	297.46	353	70.18	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.8	F08		4	0042-0306	120.00	305.13	301	67.26	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.7	F08		4	0043-0306	917.57	306.35	266	63.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			330.9	F08		4	0044-0307	538.95	307.10	280	61.60	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			364.6	F08		4	0045-0309	667.97	309.75	240	61.60	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			513.6	F08		4	0046-0306	58.29	305.81	108	71.26	0.267
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			281.3	F08		4	0047-0311	377.59	311.42	323	68.77	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			313.0	F08		4	0048-0325	400.90	325.45	277	65.60	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			273.0	F08		4	0049-0329	359.73	329.52	366	72.43	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.7	F08		4	0050-0341	175.33	341.14	295	67.36	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.6	F08		4	0051-0338	296.96	338.14	314	68.43	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.8	F08		4	0052-0335	911.15	335.22	279	63.36	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			312.3	F08		4	0053-0339	454.32	339.21	317	67.60	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			421.8	F08		4	0054-0340	751.27	340.20	239	56.53	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			370.4	F08		4	0055-0347	199.86	347.24	232	57.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			284.0	F08		4	0056-0348	898.53	348.06	261	62.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.7	F08		4	0057-0353	925.53	352.89	270	61.94	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			350.8	F08		4	0058-0370	645.70	369.78	240	56.53	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.9	F08		4	0059-0374	765.64	375.08	305	63.60	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			307.5	F08		4	0060-0377	230.62	377.83	321	67.84	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			312.1	F08		4	0061-0375	75.09	374.82	228	58.87	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			301.6	F08		4	0062-0397	347.58	396.96	251	61.01	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			303.7	F08		4	0063-0400	196.29	400.36	253	59.11	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.4	F08		4	0064-0399	845.43	399.14	274	61.11	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.0	F08		4	0065-0405	765.45	405.15	309	65.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			270.7	F08		4	0066-0407	710.17	407.47	313	64.43	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			343.5	F08		4	0067-0411	327.72	411.45	279	64.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			334.8	F08		4	0068-0425	935.39	425.27	246	64.28	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.3	F08		4	0069-0426	227.43	425.84	276	63.60	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			324.1	F08		4	0070-0433	826.67	433.62	366	73.01	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			224.3	F08		4	0071-0433	792.34	434.04	296	65.26	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.1	F08		4	0072-0439	880.69	439.79	390	75.84	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.5	F08		4	0073-0458	342.98	457.95	303	68.53	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.5	F08		4	0074-0466	560.47	466.09	336	71.01	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			716.1	F08		4	0075-0477	753.31	477.02	509	85.50	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.0	F08		4	0076-0487	519.08	487.44	347	70.43	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			326.0	F08		4	0077-0489	901.11	489.35	224	59.70	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			220.3	F08		4	0078-0497	148.51	496.66	310	65.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			232.4	F08		4	0079-0504	288.85	504.09	327	67.26	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			352.4	F08		4	0080-0502	21.26	502.29	265	65.60	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.6	F08		4	0081-0502	230.11	502.30	295	68.43	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			314.3	F08		4	0082-0507	702.74	507.36	250	59.94	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			287.0	F08		4	0083-0518	434.28	517.40	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.8	F08		4	0084-0517	327.21	518.02	295	65.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			339.2	F08		4	0085-0532	654.71	531.73	370	71.36	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.8	F08		4	0086-0535	143.11	534.87	285	64.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.2	F08		4	0087-0536	197.18	535.93	334	68.18	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			366.6	F08		4	0088-0538	519.41	538.85	295	65.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			357.0	F08		4	0089-0547	598.89	547.62	236	57.11	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			457.5	F08		4	0090-0553	770.22	549.80	273	100.71	0.338
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.7	F08		4	0091-0553	308.70	552.52	334	68.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.5	F08		4	0092-0554	236.15	553.92	325	72.18	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			419.8	F08		4	0093-0553	374.13	553.74	227	60.43	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.8	F08		4	0094-0561	844.19	562.12	348	72.67	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			463.1	F08		4	0095-0561	791.09	560.82	264	83.50	0.476
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			235.4	F08		4	0096-0566	270.03	566.14	283	65.84	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			126.2	F08		4	0097-0565	19.85	565.60	260	60.53	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			268.4	F08		4	0098-0581	691.35	581.50	300	65.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			268.9	F08		4	0099-0583	767.19	583.34	293	65.11	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			257.1	F08		4	0100-0587	159.33	587.68	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			290.3	F08		4	0101-0593	844.08	593.08	290	64.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			290.1	F08		4	0102-0608	700.30	608.59	351	72.18	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.7	F08		4	0103-0611	330.70	610.79	260	62.18	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			228.2	F08		4	0104-0612	306.01	612.01	306	65.11	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.3	F08		4	0105-0615	576.64	615.24	375	74.67	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			531.8	F08		4	0106-0617	891.27	617.43	316	67.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			485.1	F08		4	0107-0628	95.11	628.12	255	61.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			413.7	F08		4	0108-0631	374.02	631.06	239	59.11	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.7	F08		4	0109-0636	235.67	635.97	293	68.77	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			347.7	F08		4	0110-0634	316.13	633.75	228	58.87	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.9	F08		4	0111-0647	665.33	646.45	365	72.18	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.1	F08		4	0112-0653	495.85	653.47	310	65.36	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			252.1	F08		4	0113-0659	788.18	658.88	344	69.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.5	F08		4	0114-0659	552.10	659.61	283	67.50	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.2	F08		4	0115-0666	282.01	665.44	321	67.60	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.5	F08		4	0116-0668	727.49	667.81	322	67.60	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			406.7	F08		4	0117-0680	397.53	679.43	239	57.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			281.3	F08		4	0118-0686	292.84	686.66	270	61.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.5	F08		4	0119-0695	861.38	694.59	324	73.50	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			218.1	F08		4	0120-0698	161.50	698.70	379	76.53	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			395.3	F08		4	0121-0700	903.67	700.99	382	111.88	0.383
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			220.8	F08		4	0122-0702	144.98	702.79	376	75.94	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			364.4	F08		4	0123-0699	828.87	699.10	217	57.60	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.5	F08		4	0124-0700	594.34	699.65	244	60.43	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.3	F08		4	0125-0701	642.94	700.49	282	62.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.3	F08		5	0001-0034	395.08	34.47	406	75.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			209.8	F08		5	0002-0038	646.42	38.21	370	70.77	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.4	F08		5	0003-0036	895.51	36.62	132	44.87	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.9	F08		5	0004-0053	63.91	53.11	294	64.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			387.7	F08		5	0005-0056	130.66	56.10	288	64.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			328.0	F08		5	0006-0053	176.55	53.72	267	61.94	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			188.4	F08		5	0007-0057	930.89	57.41	309	65.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			303.2	F08		5	0008-0059	214.33	59.15	311	67.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.1	F08		5	0009-0059	820.16	60.31	321	68.43	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			509.5	F08		5	0010-0064	611.99	63.41	263	61.11	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.2	F08		5	0011-0067	82.12	67.22	330	67.60	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			316.6	F08		5	0012-0070	116.97	70.49	285	65.60	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.6	F08		5	0013-0071	460.49	70.35	324	68.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			210.0	F08		5	0014-0076	867.42	76.30	428	91.40	0.644
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			503.4	F08		5	0015-0075	301.28	74.78	281	63.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.0	F08		5	0016-0074	439.08	73.56	341	70.18	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			236.5	F08		5	0017-0079	544.63	79.97	407	77.26	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.4	F08		5	0018-0077	652.81	76.34	386	75.60	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.9	F08		5	0019-0082	157.42	81.90	300	66.77	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			270.1	F08		5	0020-0085	343.85	86.51	368	83.84	0.658
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			560.6	F08		5	0021-0089	282.47	89.26	281	61.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			187.9	F08		5	0022-0092	892.22	92.42	341	70.18	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.8	F08		5	0023-0095	483.90	95.58	329	71.01	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			446.2	F08		5	0024-0109	219.92	109.22	269	61.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			268.6	F08		5	0025-0113	338.05	113.44	337	68.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			318.6	F08		5	0026-0111	115.25	110.85	245	61.94	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			268.0	F08		5	0027-0114	386.41	114.78	323	70.08	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			289.9	F08		5	0028-0114	427.91	114.12	383	73.60	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			206.8	F08		5	0029-0121	903.82	121.33	326	67.84	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.4	F08		5	0030-0131	793.61	131.16	271	63.84	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			464.4	F08		5	0031-0133	734.79	133.74	301	66.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			379.0	F08		5	0032-0134	751.30	133.33	292	63.70	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			551.0	F08		5	0033-0132	385.79	132.09	222	55.70	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.1	F08		5	0034-0138	86.64	137.47	341	69.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			384.8	F08		5	0035-0139	163.72	139.59	258	66.77	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			299.8	F08		5	0036-0145	476.49	144.75	396	74.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			328.0	F08		5	0037-0157	213.74	156.88	316	68.43	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			374.8	F08		5	0038-0169	274.16	168.88	351	71.01	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			316.9	F08		5	0039-0173	609.16	173.16	404	76.08	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			652.8	F08		5	0040-0175	653.57	175.14	222	66.43	0.632
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.0	F08		5	0041-0186	692.54	186.11	259	61.84	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.9	F08		5	0042-0189	790.81	189.35	316	66.18	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			264.5	F08		5	0043-0194	433.89	195.30	340	69.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.8	F08		5	0044-0192	569.76	192.11	337	69.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			366.3	F08		5	0045-0194	511.55	194.18	281	67.60	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.7	F08		5	0046-0198	605.20	198.50	312	67.01	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			340.3	F08		5	0047-0206	138.63	206.49	216	56.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			293.3	F08		5	0048-0211	405.29	211.43	319	71.36	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			323.6	F08		5	0049-0209	751.75	209.63	284	63.01	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			333.8	F08		5	0050-0211	70.94	211.56	255	59.36	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			583.6	F08		5	0051-0213	693.64	213.26	347	68.43	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.7	F08		5	0052-0213	17.38	213.79	300	66.18	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			334.7	F08		5	0053-0213	227.18	213.03	327	71.60	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			385.9	F08		5	0054-0215	509.11	214.86	203	52.53	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			462.8	F08		5	0055-0227	876.19	227.30	204	55.11	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.2	F08		5	0056-0234	567.51	233.40	287	68.08	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			226.6	F08		5	0057-0240	663.89	240.33	359	72.67	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			233.9	F08		5	0058-0241	438.76	241.98	335	68.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			316.5	F08		5	0059-0243	527.92	243.78	266	63.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			226.7	F08		5	0060-0247	706.19	247.96	330	70.77	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			310.2	F08		5	0061-0249	754.11	249.02	234	57.36	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			226.9	F08		5	0062-0254	389.43	254.59	364	70.67	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			363.1	F08		5	0063-0261	206.44	260.22	459	86.33	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.2	F08		5	0064-0270	895.35	270.24	417	76.67	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			209.4	F08		5	0065-0270	599.22	270.41	322	66.77	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			391.2	F08		5	0066-0273	348.28	273.69	299	66.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			378.3	F08		5	0067-0276	448.25	276.64	239	58.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.6	F08		5	0068-0278	835.77	278.27	321	71.01	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			292.2	F08		5	0069-0279	292.09	279.55	344	68.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			234.7	F08		5	0070-0281	537.85	281.40	333	68.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			200.5	F08		5	0071-0280	677.23	279.89	332	75.26	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			371.7	F08		5	0072-0296	347.47	296.08	330	69.11	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.2	F08		5	0073-0299	635.45	299.89	346	73.94	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			306.3	F08		5	0074-0297	788.73	297.15	291	66.43	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			222.2	F08		5	0075-0304	875.72	303.01	289	70.18	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.5	F08		5	0076-0304	729.81	304.02	340	68.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.4	F08		5	0077-0308	23.08	308.11	265	63.01	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.3	F08		5	0078-0305	939.78	305.35	304	67.11	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			281.9	F08		5	0079-0310	179.55	310.39	294	64.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.6	F08		5	0080-0311	598.75	311.32	354	71.84	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			319.9	F08		5	0081-0313	143.45	313.92	286	64.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			206.9	F08		5	0082-0313	690.74	313.03	348	77.26	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.1	F08		5	0083-0319	850.96	319.47	303	65.01	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			320.5	F08		5	0084-0322	104.40	321.87	295	62.77	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			285.6	F08		5	0085-0336	533.22	336.35	305	64.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.6	F08		5	0086-0337	16.83	337.26	281	63.70	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			344.0	F08		5	0087-0351	708.97	350.24	940	130.02	0.699
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.6	F08		5	0088-0353	484.07	354.05	355	77.60	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			293.0	F08		5	0089-0355	30.81	354.84	268	61.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.3	F08		5	0090-0368	604.98	368.12	312	65.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.7	F08		5	0091-0375	822.27	374.97	333	69.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			301.1	F08		5	0092-0381	723.88	381.54	231	58.77	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			227.6	F08		5	0093-0387	124.99	387.97	340	73.01	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			259.4	F08		5	0094-0394	576.29	394.42	289	63.11	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			425.5	F08		5	0095-0397	186.52	397.07	209	54.28	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.3	F08		5	0096-0402	650.80	402.61	306	65.01	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.0	F08		5	0097-0403	301.55	402.35	283	62.77	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			224.5	F08		5	0098-0407	729.66	406.83	335	68.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			285.5	F08		5	0099-0411	271.43	411.55	382	72.77	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.1	F08		5	0100-0411	806.69	411.17	317	66.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			257.5	F08		5	0101-0410	931.79	410.06	268	63.01	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.3	F08		5	0102-0416	163.49	417.53	505	84.33	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.9	F08		5	0103-0412	488.23	411.26	280	63.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			209.0	F08		5	0104-0415	603.65	415.15	316	68.18	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.9	F08		5	0105-0423	356.28	423.04	348	72.43	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			332.7	F08		5	0106-0427	40.59	427.14	247	64.53	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			318.1	F08		5	0107-0430	435.55	429.89	458	82.33	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			252.5	F08		5	0108-0440	211.05	440.67	269	62.77	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.5	F08		5	0109-0439	640.00	439.36	249	57.94	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			324.8	F08		5	0110-0442	417.16	442.94	262	61.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.3	F08		5	0111-0443	899.55	443.27	301	64.18	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			259.5	F08		5	0112-0447	476.08	447.55	363	70.67	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.5	F08		5	0113-0451	734.64	451.15	297	66.18	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.9	F08		5	0114-0456	242.30	455.90	332	69.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			295.8	F08		5	0115-0451	578.34	451.24	303	68.77	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.4	F08		5	0116-0469	58.94	469.69	252	61.60	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			228.2	F08		5	0117-0471	351.25	471.21	327	70.43	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			304.1	F08		5	0118-0472	551.99	471.88	329	67.11	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.9	F08		5	0119-0472	203.72	471.30	258	61.94	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			259.0	F08		5	0120-0478	503.26	478.79	262	67.11	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			236.7	F08		5	0121-0485	856.17	484.58	358	83.15	0.651
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.6	F08		5	0122-0485	677.69	485.26	282	61.36	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			225.6	F08		5	0123-0487	399.87	488.02	359	73.50	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			236.8	F08		5	0124-0490	440.42	490.09	294	65.01	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.3	F08		5	0125-0498	773.48	496.68	378	75.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.6	F08		5	0126-0496	309.69	496.05	294	69.84	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			215.7	F08		5	0127-0509	643.66	509.29	335	73.94	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			230.5	F08		5	0128-0509	589.08	509.68	338	69.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			279.4	F08		5	0129-0513	89.09	513.87	285	64.77	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.5	F08		5	0130-0514	719.54	514.93	320	72.91	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.4	F08		5	0131-0519	469.01	520.32	309	67.60	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.5	F08		5	0132-0523	618.72	522.90	329	77.36	0.691
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			234.0	F08		5	0133-0522	938.32	521.96	292	66.77	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.1	F08		5	0134-0534	72.21	534.62	230	59.60	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			234.3	F08		5	0135-0544	644.19	544.29	316	68.18	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			299.4	F08		5	0136-0567	420.55	567.04	430	77.84	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			213.3	F08		5	0137-0566	673.03	565.57	335	73.26	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.0	F08		5	0138-0565	870.81	565.19	320	72.18	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			368.1	F08		5	0139-0575	833.54	575.28	278	69.11	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			462.8	F08		5	0140-0590	131.65	590.88	210	55.11	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.1	F08		5	0141-0611	130.17	611.79	263	59.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.6	F08		5	0142-0617	860.75	617.22	361	73.26	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.2	F08		5	0143-0636	322.12	636.25	311	65.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.0	F08		5	0144-0638	552.97	637.55	285	63.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			290.7	F08		5	0145-0636	143.55	636.61	256	67.94	0.697
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.6	F08		5	0146-0646	243.79	646.06	331	70.53	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.3	F08		5	0147-0645	569.15	644.80	289	64.53	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			290.7	F08		5	0148-0656	209.72	658.89	589	110.33	0.608
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.8	F08		5	0149-0649	392.44	648.81	314	67.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.4	F08		5	0150-0651	477.69	651.41	393	74.43	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			289.3	F08		5	0151-0651	648.86	650.78	265	63.26	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			319.4	F08		5	0152-0656	839.71	656.03	262	65.60	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			216.1	F08		5	0153-0652	916.58	652.30	326	69.94	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			228.5	F08		5	0154-0660	61.87	660.43	318	67.84	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			281.2	F08		5	0155-0669	717.31	668.92	367	74.33	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			301.2	F08		5	0156-0675	309.34	674.77	300	67.01	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			211.7	F08		5	0157-0674	400.17	675.66	347	73.84	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			203.2	F08		5	0158-0679	451.47	679.38	325	69.84	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			450.5	F08		5	0159-0684	636.39	684.58	320	66.18	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			224.2	F08		5	0160-0696	906.66	696.33	348	73.01	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			232.4	F08		6	0001-0040	323.34	40.63	347	73.01	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			339.5	F08		6	0002-0047	782.00	47.24	273	67.26	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			442.7	F08		6	0003-0053	426.76	53.37	270	66.67	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			331.2	F08		6	0004-0055	149.57	55.43	286	63.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			203.9	F08		6	0005-0060	25.83	60.11	304	64.77	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			367.4	F08		6	0006-0061	823.37	60.79	253	65.84	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			436.5	F08		6	0007-0067	247.36	66.94	265	65.60	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.2	F08		6	0008-0077	673.88	77.38	377	71.84	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.4	F08		6	0009-0084	318.86	83.55	340	71.26	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			399.1	F08		6	0010-0082	527.49	83.00	305	64.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			273.2	F08		6	0011-0087	691.40	87.25	305	68.43	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			311.7	F08		6	0012-0093	196.33	91.42	299	70.18	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			374.6	F08		6	0013-0093	411.70	93.66	250	59.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			390.3	F08		6	0014-0104	612.42	106.23	346	102.23	0.416
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			236.7	F08		6	0015-0107	853.40	107.97	367	72.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			259.5	F08		6	0016-0113	298.91	113.41	347	71.84	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.8	F08		6	0017-0113	172.37	112.80	285	62.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			437.6	F08		6	0018-0114	334.39	113.57	226	58.53	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			315.2	F08		6	0019-0121	811.87	120.64	294	66.77	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			290.7	F08		6	0020-0128	489.88	127.29	314	69.50	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.6	F08		6	0021-0127	261.73	127.59	320	69.01	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.5	F08		6	0022-0130	584.41	129.80	379	79.50	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			523.7	F08		6	0023-0141	433.17	141.59	228	55.36	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.4	F08		6	0024-0149	770.71	149.75	427	77.26	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.0	F08		6	0025-0149	541.38	150.44	409	76.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			257.3	F08		6	0026-0155	854.32	156.19	321	72.18	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.5	F08		6	0027-0161	680.29	160.66	346	72.43	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			359.6	F08		6	0028-0164	506.03	165.14	481	90.91	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.4	F08		6	0029-0162	369.59	161.90	232	59.36	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			284.3	F08		6	0030-0164	279.54	163.75	252	61.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			313.7	F08		6	0031-0172	236.80	172.17	301	64.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.1	F08		6	0032-0176	320.72	175.64	352	72.18	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			310.2	F08		6	0033-0175	898.76	174.31	325	73.01	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			279.4	F08		6	0034-0174	375.98	174.89	226	57.46	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			264.4	F08		6	0035-0181	405.96	181.83	347	77.84	0.720
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			218.6	F08		6	0036-0184	582.05	185.12	389	76.43	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			1124.7	F08		6	0037-0189	183.13	190.35	103	56.77	0.402
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			228.9	F08		6	0038-0195	864.81	196.10	382	72.43	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			281.0	F08		6	0039-0206	939.73	206.24	363	72.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			551.5	F08		6	0040-0212	24.77	212.32	133	93.78	0.190
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.3	F08		6	0041-0211	247.08	211.41	342	71.84	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			393.0	F08		6	0042-0228	579.14	227.70	277	62.53	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.4	F08		6	0043-0232	258.80	231.53	298	66.43	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			281.7	F08		6	0044-0238	813.54	237.94	339	80.43	0.659
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			292.3	F08		6	0045-0241	724.82	241.12	241	61.01	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			312.7	F08		6	0046-0251	149.32	251.35	290	64.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			351.6	F08		6	0047-0255	441.49	255.10	296	63.94	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			206.2	F08		6	0048-0257	311.88	256.26	359	71.84	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			301.4	F08		6	0049-0262	774.37	261.17	308	71.01	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.2	F08		6	0050-0263	807.80	263.63	324	69.84	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.3	F08		6	0051-0265	748.05	265.21	392	77.26	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			334.0	F08		6	0052-0271	841.51	269.91	483	88.81	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			428.6	F08		6	0053-0273	604.82	273.45	298	69.01	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.9	F08		6	0054-0275	192.07	275.02	310	67.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			217.2	F08		6	0055-0285	273.81	284.59	342	71.11	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			291.4	F08		6	0056-0288	315.97	287.75	255	58.53	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			677.5	F08		6	0057-0288	238.03	289.05	118	69.84	0.304
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.6	F08		6	0058-0297	110.60	297.43	375	74.77	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.3	F08		6	0059-0300	402.45	299.81	395	73.01	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.4	F08		6	0060-0300	332.60	301.04	309	66.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.2	F08		6	0061-0304	919.18	304.82	341	79.26	0.682
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.7	F08		6	0062-0303	872.22	303.19	317	67.01	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			259.8	F08		6	0063-0307	380.17	306.95	348	69.84	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.4	F08		6	0064-0308	34.85	308.19	303	66.53	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.6	F08		6	0065-0314	529.80	314.65	360	71.84	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.4	F08		6	0066-0312	737.90	311.53	283	61.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			356.7	F08		6	0067-0319	460.36	319.32	245	57.94	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.4	F08		6	0068-0327	176.31	327.19	334	67.84	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			232.9	F08		6	0069-0327	267.39	326.87	358	72.43	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			215.8	F08		6	0070-0345	345.65	345.61	399	78.08	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			259.0	F08		6	0071-0349	652.12	348.88	388	74.67	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.3	F08		6	0072-0351	229.47	350.89	306	67.26	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.2	F08		6	0073-0357	860.37	356.93	306	69.01	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			279.3	F08		6	0074-0364	724.31	363.77	340	68.18	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			375.3	F08		6	0075-0367	220.38	367.40	249	61.60	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			220.5	F08		6	0076-0375	307.06	375.11	344	72.77	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			220.6	F08		6	0077-0374	379.82	374.77	371	73.84	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.0	F08		6	0078-0378	523.40	378.00	387	76.43	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.2	F08		6	0079-0372	777.01	372.70	209	54.28	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			302.8	F08		6	0080-0374	795.86	374.76	239	57.11	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			232.5	F08		6	0081-0390	896.09	390.31	343	70.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.2	F08		6	0082-0396	270.34	396.79	301	66.43	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			380.7	F08		6	0083-0400	75.64	400.55	294	63.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.2	F08		6	0084-0408	198.73	407.56	319	69.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			257.6	F08		6	0085-0407	558.86	406.76	351	70.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.4	F08		6	0086-0411	830.09	410.68	323	70.28	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.6	F08		6	0087-0413	26.87	412.80	273	63.01	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.6	F08		6	0088-0420	388.43	419.57	320	67.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			234.2	F08		6	0089-0420	699.00	419.51	331	69.01	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			236.1	F08		6	0090-0426	929.04	426.58	303	74.77	0.681
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			326.3	F08		6	0091-0422	80.11	422.33	281	63.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			224.4	F08		6	0092-0422	269.24	422.52	297	65.60	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			320.3	F08		6	0093-0425	495.24	425.58	231	61.70	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			215.4	F08		6	0094-0426	942.53	425.21	293	70.18	0.747
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.3	F08		6	0095-0427	654.26	427.01	298	65.01	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			323.2	F08		6	0096-0434	732.15	434.32	345	70.28	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			298.0	F08		6	0097-0434	899.88	434.35	368	72.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.7	F08		6	0098-0440	787.04	439.64	350	71.26	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			295.8	F08		6	0099-0444	313.51	444.25	248	63.70	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.9	F08		6	0100-0457	612.48	456.44	301	65.60	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.4	F08		6	0101-0466	541.75	465.82	314	67.84	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			299.3	F08		6	0102-0469	457.06	467.95	300	69.84	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			234.0	F08		6	0103-0472	899.47	472.04	331	68.43	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			375.9	F08		6	0104-0472	158.56	471.82	129	71.26	0.319
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			235.1	F08		6	0105-0483	421.15	482.38	284	65.01	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.9	F08		6	0106-0490	252.39	489.66	277	68.18	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.5	F08		6	0107-0488	290.18	488.41	322	68.43	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.6	F08		6	0108-0490	467.28	490.61	295	65.70	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			307.1	F08		6	0109-0495	132.47	495.84	269	67.70	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.6	F08		6	0110-0491	408.30	491.61	275	63.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			285.5	F08		6	0111-0497	182.57	498.42	305	67.94	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			283.2	F08		6	0112-0499	660.07	499.59	318	69.01	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			217.3	F08		6	0113-0502	370.65	502.53	343	74.43	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.8	F08		6	0114-0509	588.39	509.07	310	67.84	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			301.1	F08		6	0115-0515	827.71	515.63	344	68.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.2	F08		6	0116-0520	888.52	520.32	253	60.53	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.9	F08		6	0117-0522	753.11	521.82	355	70.08	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.8	F08		6	0118-0525	33.42	524.89	304	68.43	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.7	F08		6	0119-0523	315.91	522.86	302	65.94	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			343.2	F08		6	0120-0530	921.48	530.74	210	53.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			207.6	F08		6	0121-0538	399.98	537.73	342	69.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			302.6	F08		6	0122-0541	48.54	540.58	328	68.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			231.1	F08		6	0123-0546	728.83	546.54	317	66.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.0	F08		6	0124-0550	442.78	549.81	360	71.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.5	F08		6	0125-0555	695.22	557.17	392	118.13	0.353
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			350.9	F08		6	0126-0558	273.97	559.61	375	88.33	0.604
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			214.8	F08		6	0127-0558	504.41	558.87	368	73.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			236.9	F08		6	0128-0560	633.43	560.60	357	74.43	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			270.5	F08		6	0129-0564	806.22	564.04	342	73.60	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.1	F08		6	0130-0572	573.03	573.00	363	76.08	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			325.0	F08		6	0131-0570	899.87	570.25	219	55.70	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			341.8	F08		6	0132-0581	58.91	581.53	285	62.18	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.6	F08		6	0133-0585	191.91	585.57	308	69.26	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.8	F08		6	0134-0581	760.19	580.73	169	51.36	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			308.7	F08		6	0135-0586	779.09	586.58	318	73.70	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.4	F08		6	0136-0593	393.16	593.77	325	68.77	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.6	F08		6	0137-0598	524.28	598.86	360	74.43	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.6	F08		6	0138-0604	407.96	603.66	268	60.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.6	F08		6	0139-0606	719.80	606.67	342	71.60	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.2	F08		6	0140-0610	668.02	609.38	332	71.60	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			208.6	F08		6	0141-0610	944.17	610.24	325	67.36	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			197.9	F08		6	0142-0624	254.48	624.73	435	81.36	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			407.4	F08		6	0143-0620	473.85	620.29	254	59.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			257.9	F08		6	0144-0625	498.09	624.46	322	69.60	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			336.0	F08		6	0145-0621	588.56	622.24	126	47.11	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			257.9	F08		6	0146-0626	604.38	625.56	306	69.36	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.0	F08		6	0147-0631	399.30	631.24	270	60.18	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.0	F08		6	0148-0643	820.36	643.79	331	69.60	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			217.2	F08		6	0149-0647	762.95	647.48	391	74.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.0	F08		6	0150-0647	185.53	647.15	314	69.01	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			440.1	F08		6	0151-0650	467.28	649.78	254	58.53	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			232.0	F08		6	0152-0655	654.47	655.82	408	83.15	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			221.8	F08		6	0153-0657	227.78	657.24	307	67.36	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			210.5	F08		6	0154-0663	678.83	662.86	420	78.08	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			497.3	F08		6	0155-0660	152.33	659.97	228	56.28	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.2	F08		6	0156-0664	317.48	664.23	379	78.43	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			487.5	F08		6	0157-0667	131.53	667.22	214	54.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			224.8	F08		6	0158-0685	754.34	685.71	364	73.26	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.6	F08		6	0159-0683	214.80	683.17	312	65.01	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.3	F08		6	0160-0691	383.37	691.24	545	87.15	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.9	F08		6	0161-0691	921.86	691.84	327	67.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			226.1	F08		6	0162-0695	699.02	694.81	134	44.04	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.0	F08		6	0163-0703	335.59	703.62	544	86.91	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.3	F08		6	0164-0697	712.80	697.08	155	46.39	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.3	F08		6	0165-0703	115.04	703.15	344	69.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			264.1	F08		6	0166-0708	252.76	707.97	278	62.53	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			289.6	F08		7	0001-0033	92.68	32.93	251	60.18	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.7	F08		7	0002-0044	386.80	44.51	294	62.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			327.4	F08		7	0003-0048	477.35	48.14	278	66.67	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			294.8	F08		7	0004-0060	407.20	59.76	285	63.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			359.9	F08		7	0005-0062	678.12	62.81	233	55.36	0.956
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			331.2	F08		7	0006-0083	498.41	83.94	245	59.11	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.4	F08		7	0007-0088	102.28	88.41	272	64.28	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			508.2	F08		7	0008-0090	312.19	90.06	243	58.28	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			306.4	F08		7	0009-0088	857.80	88.23	243	58.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			359.0	F08		7	0010-0091	568.14	91.09	249	59.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			387.9	F08		7	0011-0090	922.36	90.77	285	69.36	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			270.2	F08		7	0012-0096	804.71	96.45	347	71.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			327.0	F08		7	0013-0099	159.09	99.23	396	76.91	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			342.2	F08		7	0014-0101	457.94	101.78	288	63.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			372.5	F08		7	0015-0105	635.09	105.00	234	59.36	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			378.5	F08		7	0016-0119	523.81	119.55	222	58.18	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			393.4	F08		7	0017-0126	686.97	125.86	193	53.94	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.1	F08		7	0018-0126	88.93	126.97	301	67.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			312.1	F08		7	0019-0132	641.72	132.74	273	63.60	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.6	F08		7	0020-0131	188.37	132.20	306	72.77	0.726
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			336.5	F08		7	0021-0135	281.43	134.70	262	61.60	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			226.2	F08		7	0022-0140	900.77	139.76	353	73.26	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			340.9	F08		7	0023-0140	559.10	140.54	300	64.43	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			359.4	F08		7	0024-0146	372.83	146.27	317	70.18	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			215.2	F08		7	0025-0153	132.29	153.66	301	66.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.3	F08		7	0026-0155	245.36	155.87	315	67.84	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			264.6	F08		7	0027-0154	331.26	154.32	290	63.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.3	F08		7	0028-0159	830.05	159.13	536	87.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.4	F08		7	0029-0163	779.09	162.97	296	65.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			338.1	F08		7	0030-0173	445.86	172.75	269	62.87	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			257.5	F08		7	0031-0180	31.92	180.27	332	72.43	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.6	F08		7	0032-0182	770.41	182.44	294	64.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			413.6	F08		7	0033-0201	821.36	201.88	239	57.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			390.2	F08		7	0034-0203	154.35	202.98	230	56.53	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			445.3	F08		7	0035-0230	658.69	229.95	258	61.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			234.3	F08		7	0036-0236	902.31	237.44	323	75.50	0.712
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			498.0	F08		7	0037-0240	807.18	241.35	115	44.53	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			310.6	F08		7	0038-0265	518.79	264.69	312	69.26	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			470.9	F08		7	0039-0265	544.89	264.71	246	64.18	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			388.1	F08		7	0040-0268	690.63	268.72	226	56.87	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			314.6	F08		7	0041-0273	36.28	273.02	267	65.01	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.1	F08		7	0042-0272	803.84	272.63	286	72.08	0.692
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			390.7	F08		7	0043-0279	430.76	279.79	262	60.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.5	F08		7	0044-0284	235.60	284.60	328	67.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			285.3	F08		7	0045-0288	629.87	288.63	303	65.01	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.6	F08		7	0046-0291	776.86	291.35	339	74.67	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			268.8	F08		7	0047-0299	663.58	299.86	310	67.94	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.7	F08		7	0048-0307	180.09	307.59	328	67.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			291.4	F08		7	0049-0307	322.57	307.02	304	65.36	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			372.4	F08		7	0050-0317	748.57	316.98	227	58.18	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			334.9	F08		7	0051-0317	637.80	317.35	248	58.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.3	F08		7	0052-0333	847.17	332.72	343	70.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			308.2	F08		7	0053-0334	147.60	333.67	253	61.70	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			347.2	F08		7	0054-0339	491.89	339.39	291	66.53	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			296.9	F08		7	0055-0352	133.12	352.78	247	64.43	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.6	F08		7	0056-0355	729.67	355.23	293	63.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.4	F08		7	0057-0366	284.61	366.61	267	59.70	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.5	F08		7	0058-0377	900.04	377.04	305	72.18	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.7	F08		7	0059-0377	130.33	376.64	342	70.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.1	F08		7	0060-0382	614.20	382.79	380	73.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.2	F08		7	0061-0386	419.80	385.79	329	69.84	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			294.3	F08		7	0062-0384	562.34	383.61	317	66.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			216.7	F08		7	0063-0392	845.59	392.78	308	67.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.7	F08		7	0064-0396	676.19	396.86	321	68.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.5	F08		7	0065-0397	781.94	396.61	342	69.84	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			427.2	F08		7	0066-0399	58.99	398.31	273	63.60	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.5	F08		7	0067-0409	352.76	410.17	340	72.67	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			327.3	F08		7	0068-0417	292.67	417.10	285	67.84	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			285.5	F08		7	0069-0423	37.19	423.02	275	69.26	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			335.9	F08		7	0070-0419	533.04	419.50	266	63.70	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			328.6	F08		7	0071-0426	229.90	425.89	293	66.43	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			320.3	F08		7	0072-0438	885.79	438.02	319	70.77	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			296.3	F08		7	0073-0437	138.79	436.51	217	59.94	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.8	F08		7	0074-0443	717.99	443.46	337	69.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.2	F08		7	0075-0448	449.95	447.65	306	67.84	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			447.3	F08		7	0076-0447	484.62	447.15	225	58.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			468.2	F08		7	0077-0453	631.77	455.68	387	93.98	0.551
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.2	F08		7	0078-0449	298.81	448.89	269	66.43	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			320.2	F08		7	0079-0468	104.09	467.16	106	44.53	0.672
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			257.2	F08		7	0080-0479	201.56	479.53	320	69.60	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			226.0	F08		7	0081-0481	581.58	480.98	335	68.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			302.8	F08		7	0082-0486	529.78	486.59	233	58.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			346.5	F08		7	0083-0494	302.87	494.27	285	62.43	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.9	F08		7	0084-0495	229.49	495.57	325	68.77	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			283.5	F08		7	0085-0499	904.47	499.00	292	65.60	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			226.9	F08		7	0086-0504	28.67	504.31	308	66.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			323.2	F08		7	0087-0508	444.17	508.44	343	70.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.3	F08		7	0088-0525	890.82	525.58	277	65.70	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.5	F08		7	0089-0535	193.24	534.84	316	68.77	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			432.0	F08		7	0090-0539	300.64	539.10	270	63.01	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			270.3	F08		7	0091-0539	379.44	538.81	304	65.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.2	F08		7	0092-0542	25.51	542.80	256	64.43	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			422.5	F08		7	0093-0549	343.44	548.80	214	55.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			322.5	F08		7	0094-0552	637.08	552.27	261	60.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			270.6	F08		7	0095-0574	164.62	573.41	429	86.08	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			403.9	F08		7	0096-0571	672.22	571.83	228	55.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			291.1	F08		7	0097-0573	507.45	573.46	280	63.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			257.2	F08		7	0098-0581	822.58	581.20	290	67.26	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			225.3	F08		7	0099-0592	714.37	592.57	393	83.74	0.704
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			363.4	F08		7	0100-0604	631.20	604.27	236	60.18	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			328.8	F08		7	0101-0615	95.84	614.75	325	69.36	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.5	F08		7	0102-0617	583.01	617.18	308	67.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.0	F08		7	0103-0632	208.27	633.24	340	68.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			414.8	F08		7	0104-0635	394.14	634.30	172	52.53	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			381.9	F08		7	0105-0642	602.53	640.54	365	120.71	0.315
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			329.2	F08		7	0106-0646	152.95	645.38	213	59.94	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			327.3	F08		7	0107-0649	403.03	649.67	189	54.53	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			460.2	F08		7	0108-0646	479.26	645.61	195	67.60	0.536
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			337.3	F08		7	0109-0654	434.14	654.28	282	62.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.8	F08		7	0110-0661	551.17	661.16	255	58.53	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.8	F08		7	0111-0676	429.53	676.20	341	69.50	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			381.2	F08		7	0112-0674	830.80	674.11	271	65.60	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			259.5	F08		7	0113-0679	201.81	678.48	306	66.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.0	F08		7	0114-0686	459.50	686.25	297	67.01	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.5	F08		7	0115-0687	594.89	687.09	301	69.36	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			439.1	F08		7	0116-0700	860.31	700.06	228	58.77	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			220.0	F08		7	0117-0712	829.75	712.75	159	50.04	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			304.4	F08		8	0001-0033	547.49	33.04	276	63.36	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			312.9	F08		8	0002-0039	390.98	39.49	312	68.87	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.5	F08		8	0003-0040	117.38	39.09	364	73.84	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			299.6	F08		8	0004-0043	468.83	43.14	273	63.60	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.8	F08		8	0005-0051	61.97	51.24	324	67.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			323.0	F08		8	0006-0057	813.53	56.57	270	65.60	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			264.7	F08		8	0007-0061	423.49	62.30	351	70.67	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			309.6	F08		8	0008-0063	351.36	64.01	288	63.94	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			453.6	F08		8	0009-0073	188.66	73.62	234	58.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			329.4	F08		8	0010-0078	534.60	77.39	546	85.74	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.8	F08		8	0011-0090	591.13	91.05	359	73.84	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			409.7	F08		8	0012-0093	27.34	92.73	300	71.60	0.735
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			220.6	F08		8	0013-0098	151.25	98.63	321	70.18	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			293.8	F08		8	0014-0094	862.10	94.33	251	58.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			291.2	F08		8	0015-0107	399.16	107.89	351	69.60	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.9	F08		8	0016-0116	77.68	116.31	300	65.60	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.9	F08		8	0017-0119	94.58	118.73	270	66.18	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			225.2	F08		8	0018-0117	144.91	118.43	327	67.94	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			344.4	F08		8	0019-0126	297.21	126.26	313	66.77	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			446.8	F08		8	0020-0127	571.17	127.19	260	64.67	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.7	F08		8	0021-0132	461.59	131.56	320	67.60	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			457.5	F08		8	0022-0137	524.65	137.50	266	61.46	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			247.7	F08		8	0023-0143	182.96	143.82	360	72.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.3	F08		8	0024-0144	858.72	143.84	286	62.53	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			208.0	F08		8	0025-0148	116.34	148.61	341	68.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			414.4	F08		8	0026-0148	631.03	147.91	212	54.53	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.8	F08		8	0027-0163	384.92	163.20	349	70.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.1	F08		8	0028-0162	498.33	161.44	241	60.77	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.8	F08		8	0029-0179	255.75	179.69	303	66.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			550.3	F08		8	0030-0193	903.86	192.59	363	77.60	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			210.8	F08		8	0031-0192	128.31	192.14	319	68.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.8	F08		8	0032-0198	834.68	198.26	273	61.36	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			341.2	F08		8	0033-0199	509.73	199.88	314	73.60	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			225.5	F08		8	0034-0200	934.39	200.06	339	68.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			218.9	F08		8	0035-0203	451.50	203.05	309	66.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			306.9	F08		8	0036-0212	809.27	211.52	260	59.94	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			252.8	F08		8	0037-0212	298.17	211.31	305	67.36	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			217.6	F08		8	0038-0219	171.70	218.50	349	70.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.5	F08		8	0039-0233	637.45	233.56	392	80.67	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			399.5	F08		8	0040-0231	389.44	231.39	302	67.36	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			346.7	F08		8	0041-0237	69.26	237.61	245	60.43	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			226.0	F08		8	0042-0246	216.23	246.26	271	64.43	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			485.5	F08		8	0043-0252	368.24	252.48	258	60.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.6	F08		8	0044-0255	555.78	254.76	308	67.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.7	F08		8	0045-0255	786.48	254.80	372	71.60	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.2	F08		8	0046-0255	269.76	254.60	284	66.43	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.5	F08		8	0047-0254	91.96	254.52	319	73.70	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			722.9	F08		8	0048-0259	345.30	258.91	262	60.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			222.1	F08		8	0049-0267	175.50	267.03	342	69.60	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			361.7	F08		8	0050-0268	413.70	268.21	323	71.50	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			302.9	F08		8	0051-0269	476.36	269.60	262	62.87	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.3	F08		8	0052-0267	608.28	266.91	333	69.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			377.0	F08		8	0053-0276	824.72	276.05	241	71.26	0.596
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.3	F08		8	0054-0280	327.52	280.38	308	69.94	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			268.8	F08		8	0055-0286	908.01	285.70	313	68.53	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.1	F08		8	0056-0287	257.30	287.08	289	64.18	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			273.6	F08		8	0057-0296	114.24	295.98	271	60.28	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			289.1	F08		8	0058-0301	527.71	301.18	325	70.43	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.7	F08		8	0059-0303	773.32	302.44	372	73.26	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			367.5	F08		8	0060-0301	67.03	300.89	265	60.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			232.4	F08		8	0061-0306	726.59	306.20	334	67.60	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.7	F08		8	0062-0307	454.46	307.65	280	64.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.3	F08		8	0063-0312	484.66	310.84	355	71.01	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.8	F08		8	0064-0309	802.16	310.13	312	67.01	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			302.5	F08		8	0065-0309	596.25	308.86	334	68.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			299.5	F08		8	0066-0316	693.21	316.50	327	69.94	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			404.7	F08		8	0067-0314	860.26	314.34	217	55.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			335.2	F08		8	0068-0321	66.27	321.41	288	64.18	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.1	F08		8	0069-0340	518.16	340.62	344	70.18	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.5	F08		8	0070-0341	265.73	342.16	331	68.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			287.5	F08		8	0071-0351	434.28	351.13	305	66.53	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			236.5	F08		8	0072-0351	157.55	350.65	335	67.60	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			285.2	F08		8	0073-0357	716.82	357.73	333	68.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			366.0	F08		8	0074-0359	201.87	358.41	290	62.18	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.9	F08		8	0075-0364	109.18	363.74	280	62.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.6	F08		8	0076-0362	599.31	361.65	263	64.53	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			281.1	F08		8	0077-0367	693.55	366.93	294	66.18	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.7	F08		8	0078-0368	311.75	368.05	298	66.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.3	F08		8	0079-0377	779.65	376.56	371	72.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.3	F08		8	0080-0388	69.99	388.89	308	67.60	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			335.1	F08		8	0081-0390	343.64	390.06	371	73.84	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			394.2	F08		8	0082-0386	263.47	386.26	253	61.11	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			221.5	F08		8	0083-0391	908.93	390.40	404	73.60	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			316.9	F08		8	0084-0391	611.42	391.77	274	69.50	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			235.3	F08		8	0085-0394	117.33	393.86	319	67.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			323.5	F08		8	0086-0399	228.50	398.65	247	60.53	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			352.2	F08		8	0087-0408	842.54	408.45	219	54.63	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.3	F08		8	0088-0416	556.27	416.95	354	69.60	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.1	F08		8	0089-0420	159.54	420.41	357	71.50	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			298.6	F08		8	0090-0423	731.25	422.91	279	63.01	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			334.9	F08		8	0091-0428	804.60	428.93	253	61.36	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			308.6	F08		8	0092-0436	487.98	436.01	325	66.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.9	F08		8	0093-0438	450.52	438.13	320	69.84	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			400.7	F08		8	0094-0441	747.09	440.58	241	61.11	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			235.1	F08		8	0095-0449	897.52	449.38	338	69.84	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.3	F08		8	0096-0449	761.52	449.23	256	62.53	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			281.5	F08		8	0097-0454	127.49	454.78	354	70.18	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.1	F08		8	0098-0459	837.61	458.78	342	69.84	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.5	F08		8	0099-0464	52.51	464.29	258	63.01	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.4	F08		8	0100-0475	743.13	475.27	277	63.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.5	F08		8	0101-0501	414.64	501.00	335	69.60	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.3	F08		8	0102-0507	566.44	507.64	333	69.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.9	F08		8	0103-0514	374.99	514.14	306	65.94	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			220.6	F08		8	0104-0513	334.32	513.20	159	48.53	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			238.5	F08		8	0105-0524	327.91	524.49	200	53.94	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			299.1	F08		8	0106-0524	268.31	524.45	261	62.53	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			312.2	F08		8	0107-0531	853.53	531.31	273	60.77	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			259.4	F08		8	0108-0535	604.96	534.87	366	72.18	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			257.5	F08		8	0109-0571	800.98	571.40	335	71.01	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			296.8	F08		8	0110-0569	210.82	568.62	319	65.60	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			303.4	F08		8	0111-0577	472.98	576.95	286	63.60	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.8	F08		8	0112-0581	98.85	581.31	272	62.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			208.7	F08		8	0113-0580	145.09	579.96	365	73.01	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.4	F08		8	0114-0590	882.83	590.92	326	71.26	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.0	F08		8	0115-0597	725.29	596.96	315	68.18	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.4	F08		8	0116-0597	624.95	597.75	362	73.26	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			324.8	F08		8	0117-0611	935.55	610.24	234	62.43	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			207.1	F08		8	0118-0618	164.12	619.05	342	69.84	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.2	F08		8	0119-0619	390.63	619.56	358	72.18	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.4	F08		8	0120-0624	311.05	624.35	393	74.53	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			240.8	F08		8	0121-0633	257.00	633.60	354	72.18	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			350.0	F08		8	0122-0629	887.85	629.27	229	59.36	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			580.3	F08		8	0123-0631	485.97	631.58	369	71.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			273.8	F08		8	0124-0644	205.67	643.32	267	76.91	0.567
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			259.7	F08		8	0125-0646	113.81	646.09	315	68.28	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.2	F08		8	0126-0648	646.66	648.33	311	64.77	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			453.3	F08		8	0127-0652	188.70	652.10	313	72.77	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			292.4	F08		8	0128-0662	807.99	662.37	371	72.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			259.1	F08		8	0129-0679	279.00	679.25	308	66.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.0	F08		8	0130-0681	511.91	681.69	286	62.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.3	F08		8	0131-0683	818.41	683.45	254	62.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.4	F08		8	0132-0700	318.53	700.43	351	71.84	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.9	F08		8	0133-0700	869.85	700.89	257	62.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.2	F08		8	0134-0703	138.26	703.54	301	64.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			194.3	F08		8	0135-0707	51.06	707.80	312	67.60	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.5	F08		9	0001-0027	112.91	26.93	344	68.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.0	F08		9	0002-0032	250.70	31.94	275	63.11	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			237.1	F08		9	0003-0037	590.02	36.73	360	76.08	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.2	F08		9	0004-0035	182.72	34.71	298	68.18	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			347.8	F08		9	0005-0039	511.18	38.74	272	60.53	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			330.0	F08		9	0006-0052	462.31	52.06	326	68.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			284.3	F08		9	0007-0061	289.42	61.34	340	69.84	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.9	F08		9	0008-0060	744.10	60.15	375	75.84	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			291.3	F08		9	0009-0059	539.40	60.03	288	63.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.5	F08		9	0010-0067	666.69	67.26	265	60.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			257.7	F08		9	0011-0067	106.69	66.90	298	65.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.0	F08		9	0012-0074	577.54	74.11	328	69.36	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.2	F08		9	0013-0085	351.37	85.44	320	68.77	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.9	F08		9	0014-0091	628.73	91.14	393	77.01	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			291.1	F08		9	0015-0103	150.33	103.48	271	69.26	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			282.0	F08		9	0016-0108	400.39	108.07	454	80.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			330.8	F08		9	0017-0105	858.93	105.72	285	66.53	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.3	F08		9	0018-0113	289.82	113.21	327	67.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			333.0	F08		9	0019-0109	606.04	109.78	240	56.53	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			379.9	F08		9	0020-0117	768.48	117.04	247	62.77	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			242.6	F08		9	0021-0125	539.18	124.32	438	80.67	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			625.4	F08		9	0022-0121	873.87	121.45	166	52.53	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			286.1	F08		9	0023-0127	260.01	127.38	302	67.01	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.6	F08		9	0024-0138	476.79	138.03	340	71.60	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.3	F08		9	0025-0149	319.13	148.94	327	67.11	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.9	F08		9	0026-0148	749.13	148.30	298	66.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			279.1	F08		9	0027-0158	503.51	157.38	320	73.60	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			277.5	F08		9	0028-0161	88.66	161.07	266	64.91	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			307.2	F08		9	0029-0159	241.91	159.07	237	59.01	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			361.5	F08		9	0030-0167	191.21	167.88	216	55.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			295.8	F08		9	0031-0175	444.89	175.23	302	65.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			603.0	F08		9	0032-0173	811.23	174.00	102	37.46	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			309.5	F08		9	0033-0186	771.64	186.50	258	63.36	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.1	F08		9	0034-0192	90.66	192.61	247	62.18	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.2	F08		9	0035-0195	168.87	195.46	266	68.77	0.707
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			416.5	F08		9	0036-0192	373.20	191.67	246	60.77	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			327.9	F08		9	0037-0199	632.74	199.12	474	83.26	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			205.9	F08		9	0038-0200	943.12	200.57	395	77.50	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			227.7	F08		9	0039-0204	909.33	203.92	372	77.84	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			246.8	F08		9	0040-0203	29.78	202.97	327	68.18	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.4	F08		9	0041-0216	678.42	216.04	314	73.01	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			286.5	F08		9	0042-0214	529.80	214.47	277	61.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			5921.8	F08		9	0043-0235	813.79	235.09	281	65.01	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			363.2	F08		9	0044-0237	767.12	236.64	289	67.84	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.0	F08		9	0045-0242	731.53	242.09	337	71.36	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			243.3	F08		9	0046-0239	229.65	240.27	253	58.87	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.0	F08		9	0047-0249	661.57	249.17	263	64.77	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.5	F08		9	0048-0252	46.14	252.59	303	63.94	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			364.1	F08		9	0049-0253	277.61	253.04	272	61.36	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			224.6	F08		9	0050-0260	938.09	260.43	364	71.50	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			220.2	F08		9	0051-0257	230.00	257.15	285	65.70	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.6	F08		9	0052-0266	426.54	266.69	295	65.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			251.8	F08		9	0053-0266	532.37	266.41	288	62.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			201.1	F08		9	0054-0275	141.22	275.50	320	67.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			211.1	F08		9	0055-0280	890.30	279.55	407	79.26	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			302.9	F08		9	0056-0282	381.39	281.55	283	62.18	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			292.2	F08		9	0057-0285	623.90	284.88	302	67.84	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			350.1	F08		9	0058-0298	223.21	298.43	264	59.60	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.0	F08		9	0059-0308	484.54	308.19	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.6	F08		9	0060-0313	56.31	313.12	372	74.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			268.9	F08		9	0061-0322	259.07	322.01	308	67.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			319.9	F08		9	0062-0327	728.12	326.58	310	69.36	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.5	F08		9	0063-0334	925.85	333.62	351	70.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.9	F08		9	0064-0333	831.25	333.40	333	69.26	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.6	F08		9	0065-0341	545.88	341.42	289	63.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.1	F08		9	0066-0341	871.51	341.54	301	64.43	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			205.7	F08		9	0067-0346	43.39	345.92	356	69.01	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			465.8	F08		9	0068-0350	225.43	350.33	358	73.26	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			346.2	F08		9	0069-0364	425.99	364.39	291	69.36	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.7	F08		9	0070-0363	784.03	363.41	333	68.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.4	F08		9	0071-0368	75.81	368.43	329	66.77	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			288.0	F08		9	0072-0370	728.14	370.19	368	71.84	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			266.8	F08		9	0073-0377	675.67	377.52	431	94.81	0.603
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			299.1	F08		9	0074-0384	562.15	380.29	405	96.47	0.547
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			239.7	F08		9	0075-0380	839.73	380.27	381	72.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			250.3	F08		9	0076-0395	607.01	394.57	312	70.67	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			309.1	F08		9	0077-0401	333.46	400.98	249	60.53	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			303.6	F08		9	0078-0401	429.53	401.57	283	62.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			323.6	F08		9	0079-0413	477.40	413.11	239	58.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.6	F08		9	0080-0418	752.22	417.97	326	67.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			216.5	F08		9	0081-0423	108.15	423.49	312	66.77	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.4	F08		9	0082-0422	136.76	422.43	323	67.84	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			314.8	F08		9	0083-0431	926.94	431.35	264	63.70	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			260.1	F08		9	0084-0436	663.61	435.45	326	68.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			283.9	F08		9	0085-0441	846.39	442.19	308	68.67	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			229.2	F08		9	0086-0453	788.02	452.55	346	70.43	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			212.7	F08		9	0087-0457	627.33	457.38	328	68.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			333.3	F08		9	0088-0460	250.17	459.58	271	62.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			356.3	F08		9	0089-0460	360.06	459.62	272	61.36	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.7	F08		9	0090-0466	762.09	465.46	350	71.01	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			273.5	F08		9	0091-0473	583.58	473.73	297	64.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			308.0	F08		9	0092-0483	354.63	482.60	295	64.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			335.8	F08		9	0093-0490	838.00	490.06	300	64.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			235.4	F08		9	0094-0496	656.41	496.27	342	72.53	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.1	F08		9	0095-0495	418.64	495.14	284	62.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			230.7	F08		9	0096-0498	792.53	497.76	331	69.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			226.8	F08		9	0097-0496	774.17	495.84	350	71.94	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.7	F08		9	0098-0499	52.74	498.30	283	62.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			324.6	F08		9	0099-0501	727.06	500.76	271	61.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			318.1	F08		9	0100-0505	207.71	504.91	249	58.18	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			263.2	F08		9	0101-0521	78.62	521.30	261	65.01	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			223.9	F08		9	0102-0521	614.23	521.50	371	70.18	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			308.0	F08		9	0103-0525	681.54	525.40	290	65.36	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.9	F08		9	0104-0524	710.85	524.45	293	63.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			303.0	F08		9	0105-0536	359.76	536.61	335	68.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			223.0	F08		9	0106-0539	624.88	539.71	358	72.08	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			291.5	F08		9	0107-0545	414.30	545.05	278	68.08	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.2	F08		9	0108-0543	740.94	544.00	305	65.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			223.3	F08		9	0109-0551	127.64	551.73	323	70.67	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			294.7	F08		9	0110-0555	376.56	555.19	274	60.77	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.4	F08		9	0111-0559	311.67	559.17	348	69.60	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			281.4	F08		9	0112-0570	464.67	570.15	303	67.60	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			341.7	F08		9	0113-0577	227.99	580.26	291	83.15	0.529
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.7	F08		9	0114-0584	723.59	584.53	331	68.67	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			273.3	F08		9	0115-0592	144.52	592.32	318	69.26	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			245.0	F08		9	0116-0591	674.89	590.99	317	66.53	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.0	F08		9	0117-0600	594.64	600.11	339	70.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.6	F08		9	0118-0599	296.56	598.65	303	67.84	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			312.1	F08		9	0119-0597	805.83	597.68	333	75.84	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			228.8	F08		9	0120-0602	928.18	602.38	277	62.77	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			244.2	F08		9	0121-0606	412.90	606.62	306	66.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			226.7	F08		9	0122-0607	466.79	607.03	331	67.84	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			293.5	F08		9	0123-0613	30.57	613.25	236	60.77	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.5	F08		9	0124-0615	239.99	615.89	244	63.94	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			219.2	F08		9	0125-0617	908.56	617.47	303	66.53	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			220.5	F08		9	0126-0625	671.13	625.54	417	79.26	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			293.0	F08		9	0127-0638	544.10	637.32	277	67.01	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			252.5	F08		9	0128-0648	205.49	647.63	330	67.60	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			254.7	F08		9	0129-0652	501.09	652.73	310	66.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.8	F08		9	0130-0658	185.37	657.89	315	67.84	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.1	F08		9	0131-0664	921.81	663.93	269	61.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			281.4	F08		9	0132-0667	677.49	666.70	275	62.18	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			287.1	F08		9	0133-0671	770.94	672.08	269	66.18	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			267.4	F08		9	0134-0674	398.05	674.25	276	63.36	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			290.1	F08		9	0135-0680	852.31	679.91	486	84.67	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			241.4	F08		9	0136-0682	319.34	683.00	307	65.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.1	F08		9	0137-0685	378.24	685.79	273	61.36	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			381.4	G08		1	0001-0032	204.59	33.10	257	63.01	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			391.3	G08		1	0002-0042	496.41	42.05	229	59.11	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			292.6	G08		1	0003-0056	98.31	56.55	335	72.08	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			381.6	G08		1	0004-0065	935.15	65.24	324	68.43	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			474.7	G08		1	0005-0075	282.41	75.08	268	64.04	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			272.0	G08		1	0006-0076	711.31	75.89	364	71.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			408.5	G08		1	0007-0083	664.99	83.53	405	80.57	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			281.5	G08		1	0008-0092	730.56	92.42	348	71.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			527.2	G08		1	0009-0092	567.38	92.61	154	68.43	0.413
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			450.7	G08		1	0010-0096	262.76	96.42	254	69.26	0.665
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.0	G08		1	0011-0100	77.40	101.22	295	66.18	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			255.4	G08		1	0012-0106	712.96	105.19	322	72.33	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			589.4	G08		1	0013-0107	844.87	105.02	171	73.50	0.398
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			455.8	G08		1	0014-0122	896.06	121.71	302	66.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			356.1	G08		1	0015-0194	835.35	194.66	279	62.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			334.6	G08		1	0016-0199	185.62	199.26	102	39.21	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			492.9	G08		1	0017-0225	584.08	224.71	214	58.04	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			481.2	G08		1	0018-0242	806.26	241.74	215	62.04	0.702
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			396.8	G08		1	0019-0268	829.39	268.12	262	59.36	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			401.1	G08		1	0020-0280	887.64	280.48	237	60.28	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			407.0	G08		1	0021-0288	639.34	288.26	221	57.94	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			397.5	G08		1	0022-0302	32.27	302.53	235	64.18	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			420.9	G08		1	0023-0306	478.27	306.20	195	58.18	0.724
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			307.7	G08		1	0024-0323	657.51	324.42	284	64.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			384.1	G08		1	0025-0343	280.32	343.85	258	62.53	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			416.3	G08		1	0026-0365	47.51	365.09	214	54.87	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			549.2	G08		1	0027-0369	350.54	368.34	227	62.87	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			364.9	G08		1	0028-0364	510.31	363.63	226	58.77	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			347.5	G08		1	0029-0367	623.42	366.98	274	63.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			484.3	G08		1	0030-0365	742.98	365.12	193	57.36	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			165.1	G08		1	0031-0368	147.46	368.35	242	61.36	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			440.1	G08		1	0032-0373	306.88	373.44	229	61.11	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			452.2	G08		1	0033-0383	675.69	383.47	240	63.11	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			326.3	G08		1	0034-0389	935.70	389.37	282	67.60	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			484.9	G08		1	0035-0407	210.27	407.15	209	58.77	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			377.1	G08		1	0036-0414	70.13	414.26	215	57.70	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			559.3	G08		1	0037-0416	890.73	415.95	225	57.70	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			373.1	G08		1	0038-0438	666.57	438.67	262	64.53	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			743.2	G08		1	0039-0444	858.60	443.31	109	75.98	0.237
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			572.1	G08		1	0040-0457	419.20	458.00	233	57.36	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			451.9	G08		1	0041-0462	730.98	462.08	237	61.94	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			562.4	G08		1	0042-0498	314.58	498.27	227	59.60	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			306.6	G08		1	0043-0524	563.97	524.23	303	66.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			437.4	G08		1	0044-0527	829.85	527.56	240	62.77	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			465.3	G08		1	0045-0536	719.53	536.54	205	58.18	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			347.4	G08		1	0046-0539	360.16	539.84	277	72.43	0.664
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			346.5	G08		1	0047-0539	688.61	539.21	272	60.77	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			507.7	G08		1	0048-0541	636.49	541.13	202	54.18	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			367.0	G08		1	0049-0548	12.47	547.60	261	61.36	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			445.7	G08		1	0050-0558	95.67	558.64	212	58.18	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			305.5	G08		1	0051-0568	648.28	568.31	304	68.18	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			361.7	G08		1	0052-0569	834.65	569.67	293	66.43	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			350.3	G08		1	0053-0605	697.52	605.52	252	58.77	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			325.5	G08		1	0054-0610	547.24	610.47	328	69.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			609.2	G08		1	0055-0610	598.30	610.74	166	53.94	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			486.9	G08		1	0056-0639	326.67	638.87	198	53.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			407.6	G08		1	0057-0697	329.28	697.00	230	59.84	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			359.4	G08		1	0058-0706	735.74	705.51	250	73.60	0.580
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			504.9	G08		2	0001-0033	490.85	32.69	260	66.28	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			365.9	G08		2	0002-0065	39.68	65.16	334	70.43	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			351.3	G08		2	0003-0071	263.62	70.95	321	73.26	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			392.2	G08		2	0004-0104	246.65	104.64	292	75.50	0.644
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			318.0	G08		2	0005-0207	403.66	206.99	276	68.18	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			453.0	G08		2	0006-0218	447.01	218.02	223	66.43	0.635
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			534.5	G08		2	0007-0233	670.79	232.76	279	104.81	0.319
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			283.7	G08		2	0008-0248	396.52	248.61	314	69.84	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			565.6	G08		2	0009-0248	449.88	249.51	100	47.46	0.558
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			573.1	G08		2	0010-0282	915.46	282.98	120	50.77	0.585
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			408.3	G08		2	0011-0354	665.79	353.71	302	68.18	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			312.5	G08		2	0012-0389	40.48	389.26	286	68.18	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			899.6	G08		2	0013-0396	667.73	395.75	228	57.01	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			447.6	G08		2	0014-0408	655.79	407.55	276	66.08	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			551.0	G08		2	0015-0409	559.15	408.44	277	64.18	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			340.8	G08		2	0016-0459	258.19	459.85	306	66.18	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			447.3	G08		2	0017-0511	49.96	511.64	225	57.70	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			344.7	G08		2	0018-0515	114.80	515.24	268	63.60	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			418.0	G08		2	0019-0613	133.89	613.28	223	60.53	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			422.2	G08		2	0020-0618	504.01	618.58	259	63.36	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			313.2	G08		2	0021-0635	637.25	635.23	302	66.53	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			285.5	G08		2	0022-0639	285.94	639.91	297	66.18	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			289.5	G08		2	0023-0644	591.27	644.02	278	63.70	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			308.0	G08		2	0024-0650	538.77	650.29	296	64.53	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			313.6	G08		2	0025-0654	224.91	653.80	279	63.70	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			292.9	G08		2	0026-0669	100.45	669.38	299	65.36	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			291.6	G08		2	0027-0672	582.47	672.12	374	76.08	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.8	G08		2	0028-0672	305.14	673.35	281	64.53	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			823.0	G08		2	0029-0686	316.60	686.53	125	45.11	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			298.0	G08		2	0030-0691	559.22	690.33	333	73.01	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			281.2	G08		2	0031-0697	615.07	697.26	277	62.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			843.0	G08		2	0032-0703	912.12	702.79	115	40.28	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			624.9	G08		3	0001-0051	392.71	51.40	201	55.36	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			387.8	G08		3	0002-0075	222.13	75.24	244	59.36	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			560.7	G08		3	0003-0084	824.96	84.25	264	61.94	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			427.7	G08		3	0004-0098	283.01	98.19	236	61.26	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			474.7	G08		3	0005-0107	865.02	107.68	209	59.26	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			416.6	G08		3	0006-0109	428.96	108.97	213	54.53	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			560.5	G08		3	0007-0117	337.10	117.22	177	52.18	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			443.9	G08		3	0008-0120	858.06	120.25	224	55.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			602.4	G08		3	0009-0140	463.15	140.84	127	57.60	0.481
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			385.6	G08		3	0010-0154	925.91	153.92	225	57.36	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			362.7	G08		3	0011-0159	132.00	159.59	256	62.53	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			365.1	G08		3	0012-0161	248.69	161.09	118	40.28	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			301.2	G08		3	0013-0170	238.79	170.81	151	46.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			639.8	G08		3	0014-0176	428.50	176.01	204	58.18	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			336.2	G08		3	0015-0181	503.87	181.33	291	66.77	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			536.1	G08		3	0016-0180	529.81	180.56	171	50.53	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			532.4	G08		3	0017-0197	582.62	198.37	177	56.18	0.705
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			465.0	G08		3	0018-0200	927.92	200.57	216	59.60	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			598.0	G08		3	0019-0218	416.36	218.30	165	50.04	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			487.5	G08		3	0020-0225	645.39	226.73	372	80.08	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			326.9	G08		3	0021-0230	534.48	231.10	267	63.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			431.8	G08		3	0022-0244	246.67	242.06	190	58.87	0.689
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			478.6	G08		3	0023-0252	396.23	252.19	223	54.53	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			334.3	G08		3	0024-0254	528.93	254.27	270	65.01	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			351.4	G08		3	0025-0258	249.56	257.64	117	41.70	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.2	G08		3	0026-0275	172.46	274.70	276	67.84	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			320.5	G08		3	0027-0281	631.58	281.17	262	59.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			477.7	G08		3	0028-0283	13.67	282.64	191	56.77	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			511.7	G08		3	0029-0291	854.26	290.53	224	59.60	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			524.7	G08		3	0030-0303	103.18	303.57	207	57.36	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			825.8	G08		3	0031-0312	777.94	311.63	151	51.46	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			567.6	G08		3	0032-0322	487.29	322.50	214	56.77	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			372.1	G08		3	0033-0343	170.81	343.65	233	58.28	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			642.8	G08		3	0034-0384	852.19	384.44	220	55.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			368.6	G08		3	0035-0385	203.48	384.96	224	61.70	0.739
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			361.6	G08		3	0036-0396	810.66	396.52	284	63.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			386.5	G08		3	0037-0402	50.40	402.63	241	60.77	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			431.9	G08		3	0038-0407	742.68	408.20	266	64.18	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			307.5	G08		3	0039-0408	893.26	407.85	285	67.26	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			436.8	G08		3	0040-0454	910.50	453.38	237	58.77	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			294.7	G08		3	0041-0486	783.43	486.83	257	62.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			483.1	G08		3	0042-0489	453.81	489.03	234	57.36	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			384.3	G08		3	0043-0499	369.03	498.82	247	60.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			328.8	G08		3	0044-0535	663.85	535.40	257	62.87	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			376.1	G08		3	0045-0539	343.31	539.41	471	89.74	0.735
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			551.8	G08		3	0046-0531	785.86	531.44	177	51.11	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			472.6	G08		3	0047-0549	945.50	548.90	266	68.63	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			320.8	G08		3	0048-0558	808.51	557.74	322	68.18	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			653.1	G08		3	0049-0560	315.90	559.69	220	93.40	0.317
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			318.3	G08		3	0050-0565	444.93	564.88	283	66.18	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			316.1	G08		3	0051-0575	624.95	575.22	373	72.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			306.5	G08		3	0052-0581	325.62	582.28	262	61.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			320.8	G08		3	0053-0609	835.51	610.13	302	66.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			522.4	G08		3	0054-0645	276.97	644.96	208	56.87	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			289.8	G08		3	0055-0663	699.65	662.76	264	65.36	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			436.5	G08		3	0056-0664	832.78	663.96	216	59.84	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			536.9	G08		3	0057-0666	97.42	666.26	212	53.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			317.2	G08		3	0058-0670	618.50	669.36	259	66.43	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			421.7	G08		4	0001-0035	57.39	34.95	202	56.77	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			371.9	G08		4	0002-0036	140.39	36.89	263	67.26	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.6	G08		4	0003-0065	897.16	64.19	268	63.26	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			329.1	G08		4	0004-0069	704.73	69.69	260	63.70	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			325.5	G08		4	0005-0087	675.87	87.02	277	61.70	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			381.9	G08		4	0006-0092	168.03	92.02	326	72.91	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			331.7	G08		4	0007-0097	488.16	97.07	264	62.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			445.0	G08		4	0008-0106	695.79	107.02	267	67.26	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			397.4	G08		4	0009-0129	134.25	130.00	186	56.87	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			450.0	G08		4	0010-0144	683.46	144.16	250	68.77	0.664
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			289.4	G08		4	0011-0184	270.60	185.09	156	47.46	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			318.4	G08		4	0012-0184	258.83	184.32	117	42.63	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			305.9	G08		4	0013-0198	252.47	198.14	271	61.60	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			301.8	G08		4	0014-0202	271.16	202.46	228	62.77	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			398.3	G08		4	0015-0222	683.17	222.21	211	63.60	0.656
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			313.0	G08		4	0016-0223	626.05	223.64	268	61.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			303.9	G08		4	0017-0230	296.16	230.32	363	80.67	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			321.0	G08		4	0018-0236	870.80	235.72	251	60.53	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			807.6	G08		4	0019-0248	297.88	248.35	171	67.84	0.467
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			317.0	G08		4	0020-0251	61.22	251.90	222	54.77	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			270.0	G08		4	0021-0252	929.07	252.31	258	60.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			295.4	G08		4	0022-0261	757.81	261.64	281	65.01	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			333.1	G08		4	0023-0260	858.20	260.13	218	61.70	0.720
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			333.9	G08		4	0024-0273	154.52	273.23	239	64.53	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.3	G08		4	0025-0274	848.11	274.54	288	65.94	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			456.9	G08		4	0026-0278	57.57	278.85	196	52.53	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			358.2	G08		4	0027-0290	821.95	289.82	232	58.53	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.3	G08		4	0028-0297	30.71	296.88	302	66.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			435.7	G08		4	0029-0300	383.48	300.35	174	49.11	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			389.6	G08		4	0030-0308	258.64	308.85	209	57.60	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			310.1	G08		4	0031-0310	101.43	310.42	257	62.53	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			326.1	G08		4	0032-0312	542.78	311.58	301	68.77	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			388.3	G08		4	0033-0325	554.36	324.38	243	67.01	0.680
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			340.2	G08		4	0034-0343	635.95	342.84	195	59.01	0.704
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			487.0	G08		4	0035-0351	370.80	351.24	187	53.70	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			318.0	G08		4	0036-0350	928.55	349.11	162	51.94	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.6	G08		4	0037-0355	938.44	356.34	139	44.28	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			339.0	G08		4	0038-0361	218.64	361.70	202	57.11	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			483.6	G08		4	0039-0373	278.48	373.34	189	51.46	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			656.1	G08		4	0040-0382	801.04	382.03	194	55.70	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			329.3	G08		4	0041-0388	284.57	388.10	256	62.53	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			323.2	G08		4	0042-0391	415.82	392.06	295	67.36	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			370.8	G08		4	0043-0390	53.66	390.17	240	60.18	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			291.9	G08		4	0044-0393	267.09	393.23	290	67.26	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			374.1	G08		4	0045-0401	830.60	401.78	210	53.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			383.6	G08		4	0046-0420	198.06	419.82	219	57.46	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			327.6	G08		4	0047-0424	944.84	423.39	270	62.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			313.0	G08		4	0048-0440	392.04	441.07	265	65.84	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			484.3	G08		4	0049-0447	554.05	446.96	215	56.18	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			432.1	G08		4	0050-0446	249.81	446.92	191	53.11	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			279.1	G08		4	0051-0477	904.87	477.53	234	57.70	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			374.7	G08		4	0052-0487	80.59	487.68	262	62.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			408.0	G08		4	0053-0502	230.11	501.89	197	53.46	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			537.2	G08		4	0054-0517	391.63	517.07	253	75.60	0.556
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			409.9	G08		4	0055-0521	120.17	521.56	214	55.36	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			402.0	G08		4	0056-0523	287.43	523.01	270	63.60	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			394.2	G08		4	0057-0530	144.08	530.84	219	55.46	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			382.4	G08		4	0058-0560	596.96	558.50	392	91.74	0.585
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			437.3	G08		4	0059-0564	877.39	564.54	192	51.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.6	G08		4	0060-0577	810.69	577.11	389	74.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			360.2	G08		4	0061-0591	113.98	591.55	247	59.94	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			327.0	G08		4	0062-0606	659.17	606.68	297	78.57	0.605
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			421.4	G08		4	0063-0617	452.28	617.65	211	56.77	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			450.4	G08		4	0064-0621	193.27	621.27	221	60.43	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			381.8	G08		4	0065-0637	190.91	637.47	228	60.18	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			371.3	G08		4	0066-0644	397.00	643.71	282	63.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			416.0	G08		4	0067-0653	92.97	652.55	189	56.53	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			572.2	G08		4	0068-0654	106.20	654.06	160	50.04	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			362.0	G08		4	0069-0663	678.63	663.18	247	64.43	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			397.9	G08		4	0070-0690	349.11	690.26	383	72.67	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			262.5	G08		4	0071-0691	367.79	690.82	276	66.18	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			321.2	G08		4	0072-0704	542.80	703.81	309	68.43	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.2	G08		4	0073-0703	589.98	703.36	281	69.11	0.739
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			496.9	G08		4	0074-0703	739.02	703.26	199	52.77	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			400.1	G08		4	0075-0707	196.86	706.90	154	46.53	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			365.4	G08		5	0001-0032	541.11	31.09	192	60.18	0.666
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			497.5	G08		5	0002-0042	152.37	43.12	227	64.53	0.685
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			589.5	G08		5	0003-0068	371.04	67.99	204	61.46	0.679
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			286.0	G08		5	0004-0094	130.78	94.41	220	57.70	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			586.4	G08		5	0005-0108	685.92	107.88	189	51.94	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			402.9	G08		5	0006-0108	655.21	107.84	265	63.36	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			678.7	G08		5	0007-0126	291.19	126.62	202	56.18	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			366.2	G08		5	0008-0163	606.40	162.70	224	68.43	0.601
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			448.6	G08		5	0009-0165	343.14	165.05	250	63.50	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			281.9	G08		5	0010-0175	940.52	174.15	253	63.11	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			488.0	G08		5	0011-0181	825.03	181.58	243	58.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			544.2	G08		5	0012-0189	442.10	189.27	227	64.18	0.692
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			480.2	G08		5	0013-0195	722.38	195.82	185	73.50	0.430
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			305.5	G08		5	0014-0222	93.53	222.62	278	65.94	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			362.1	G08		5	0015-0237	567.80	237.45	194	55.46	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.9	G08		5	0016-0239	139.04	239.55	271	62.77	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			382.6	G08		5	0017-0241	470.04	240.31	223	57.46	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			436.0	G08		5	0018-0240	624.42	240.17	185	53.36	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			480.0	G08		5	0019-0248	823.85	247.79	175	69.26	0.459
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.0	G08		5	0020-0253	34.52	253.68	252	59.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			2031.0	G08		5	0021-0263	132.45	263.34	299	67.84	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.7	G08		5	0022-0282	865.29	281.23	145	48.53	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			319.9	G08		5	0023-0292	260.85	292.40	275	62.18	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.6	G08		5	0024-0289	871.90	290.19	120	44.28	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			253.3	G08		5	0025-0292	905.12	292.44	265	63.01	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			905.8	G08		5	0026-0292	213.98	291.51	103	49.46	0.529
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			290.4	G08		5	0027-0316	61.57	315.91	259	68.53	0.693
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			435.1	G08		5	0028-0324	909.41	324.06	225	55.11	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			292.9	G08		5	0029-0351	34.16	350.35	160	51.11	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.8	G08		5	0030-0356	852.99	356.90	319	68.18	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			273.2	G08		5	0031-0357	43.91	357.60	134	43.46	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			364.3	G08		5	0032-0370	916.33	370.90	242	64.53	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			307.5	G08		5	0033-0388	478.45	387.91	263	61.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			512.3	G08		5	0034-0396	394.79	396.25	187	51.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			345.6	G08		5	0035-0412	692.19	411.81	233	56.28	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			393.6	G08		5	0036-0419	429.87	419.08	156	58.77	0.568
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			326.5	G08		5	0037-0425	50.46	424.75	261	63.60	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.0	G08		5	0038-0484	95.58	484.30	269	62.18	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			600.5	G08		5	0039-0483	930.96	483.42	201	53.70	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			390.6	G08		5	0040-0494	633.21	493.73	212	62.28	0.687
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			378.1	G08		5	0041-0497	769.80	497.55	253	61.70	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			353.9	G08		5	0042-0508	329.53	508.48	329	72.43	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			358.9	G08		5	0043-0527	286.51	526.75	220	61.01	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			406.9	G08		5	0044-0535	622.69	534.63	187	56.28	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			297.6	G08		5	0045-0550	220.89	550.54	202	57.94	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			392.1	G08		5	0046-0548	249.45	548.43	172	52.28	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			577.3	G08		5	0047-0563	153.70	562.95	110	53.36	0.486
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			314.2	G08		5	0048-0583	634.62	583.75	264	63.84	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			403.3	G08		5	0049-0594	129.69	594.89	191	54.18	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			341.9	G08		5	0050-0606	526.68	606.72	254	62.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			335.4	G08		5	0051-0621	548.39	620.38	261	60.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			527.0	G08		5	0052-0633	394.79	633.43	175	57.94	0.655
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.8	G08		5	0053-0649	879.38	648.46	267	62.77	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			378.6	G08		5	0054-0658	86.40	658.34	208	66.04	0.599
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			395.8	G08		5	0055-0659	146.43	658.61	215	57.11	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			313.4	G08		5	0056-0676	660.44	675.54	242	63.36	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			338.0	G08		5	0057-0680	392.72	679.46	237	61.94	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			523.8	G08		5	0058-0686	413.76	685.86	186	51.70	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			542.8	G08		5	0059-0701	377.39	701.40	197	55.70	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			627.0	G08		5	0060-0703	482.30	702.70	182	64.67	0.547
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			519.9	G08		6	0001-0056	930.28	56.78	245	59.11	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			381.1	G08		6	0002-0062	146.01	62.35	215	56.77	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			298.3	G08		6	0003-0073	880.87	72.50	278	64.43	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			631.7	G08		6	0004-0082	78.92	81.60	182	51.94	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			299.6	G08		6	0005-0093	752.88	94.14	288	67.01	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			439.1	G08		6	0006-0112	641.80	112.21	197	57.60	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			592.5	G08		6	0007-0120	317.19	120.41	213	53.11	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			392.5	G08		6	0008-0124	828.85	124.44	232	71.98	0.563
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			334.6	G08		6	0009-0133	761.87	133.64	241	61.01	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			249.9	G08		6	0010-0139	111.89	138.66	274	63.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			223.9	G08		6	0011-0145	96.13	144.50	281	64.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			325.3	G08		6	0012-0150	731.23	150.14	297	66.18	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			482.1	G08		6	0013-0153	946.07	153.21	217	55.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			326.2	G08		6	0014-0157	818.91	157.09	266	65.01	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.4	G08		6	0015-0177	35.63	176.53	252	61.11	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			680.1	G08		6	0016-0179	810.78	179.02	141	59.60	0.499
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			338.9	G08		6	0017-0183	491.89	183.08	192	56.43	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			280.7	G08		6	0018-0187	116.46	188.41	137	46.63	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			278.6	G08		6	0019-0200	117.38	199.99	117	41.80	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			291.8	G08		6	0020-0220	67.60	220.10	243	57.70	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			346.9	G08		6	0021-0225	588.78	225.28	263	64.43	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			386.8	G08		6	0022-0261	649.15	261.19	225	59.70	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			509.1	G08		6	0023-0323	648.24	322.86	229	59.94	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			506.5	G08		6	0024-0328	763.41	329.02	193	57.11	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			334.8	G08		6	0025-0339	100.89	339.06	230	57.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			367.0	G08		6	0026-0347	418.78	347.62	272	65.60	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			316.4	G08		6	0027-0369	308.09	369.43	309	66.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			324.4	G08		6	0028-0373	11.55	373.61	238	63.11	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			374.5	G08		6	0029-0373	577.93	372.96	231	62.63	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			291.6	G08		6	0030-0403	351.02	403.11	335	70.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			372.2	G08		6	0031-0413	837.42	412.60	249	59.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			408.2	G08		6	0032-0418	255.47	418.73	301	69.01	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			424.5	G08		6	0033-0426	394.41	426.17	186	53.46	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			362.6	G08		6	0034-0432	873.70	432.07	251	60.53	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			455.6	G08		6	0035-0454	596.99	454.12	299	82.91	0.547
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			583.9	G08		6	0036-0486	26.23	486.05	202	55.11	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			405.9	G08		6	0037-0513	579.88	512.79	289	64.53	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			347.0	G08		6	0038-0542	313.65	541.48	130	43.94	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			368.2	G08		6	0039-0546	303.22	547.24	144	45.11	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			549.8	G08		6	0040-0554	190.36	554.58	209	53.36	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			420.6	G08		6	0041-0567	183.14	566.73	172	51.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			320.3	G08		6	0042-0568	321.68	568.31	295	65.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			296.8	G08		6	0043-0582	382.57	582.43	275	67.70	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			443.9	G08		6	0044-0604	753.16	604.08	233	58.53	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			495.8	G08		6	0045-0611	859.18	611.21	210	59.36	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			408.6	G08		6	0046-0612	890.31	612.54	187	57.94	0.700
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			481.1	G08		6	0047-0614	613.01	614.72	215	56.87	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			287.9	G08		6	0048-0640	352.25	639.51	291	66.43	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			385.1	G08		6	0049-0646	575.91	645.49	232	59.60	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			474.0	G08		6	0050-0650	617.75	651.14	208	57.84	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			351.4	G08		6	0051-0653	123.89	653.61	205	60.53	0.703
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			425.8	G08		6	0052-0677	466.12	677.74	244	59.94	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			455.0	G08		6	0053-0686	593.53	685.73	205	59.94	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			500.4	G08		6	0054-0691	513.60	691.38	248	61.60	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			256.7	G08		6	0055-0700	351.11	699.46	279	62.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			292.2	G08		6	0056-0709	218.08	709.28	259	60.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			446.3	G08		6	0057-0709	832.68	709.43	206	58.28	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			547.8	G08		7	0001-0053	156.06	53.48	189	52.87	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			411.5	G08		7	0002-0055	530.23	55.22	234	56.87	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			324.7	G08		7	0003-0059	856.52	59.19	222	59.46	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			532.0	G08		7	0004-0066	818.80	66.19	139	61.60	0.460
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			365.4	G08		7	0005-0108	391.66	108.22	211	60.04	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			248.8	G08		7	0006-0106	876.52	106.30	260	62.77	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			577.9	G08		7	0007-0126	468.55	126.58	207	53.11	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			423.8	G08		7	0008-0146	857.50	145.91	227	61.60	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			539.8	G08		7	0009-0151	424.38	151.78	184	51.46	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			378.8	G08		7	0010-0155	165.33	155.02	235	60.53	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			307.1	G08		7	0011-0169	384.99	168.53	333	77.26	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			376.0	G08		7	0012-0218	214.01	218.13	266	65.01	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			284.5	G08		7	0013-0232	844.78	232.79	244	59.94	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			484.3	G08		7	0014-0246	70.36	245.62	187	57.01	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			621.6	G08		7	0015-0269	254.98	267.70	124	52.87	0.557
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			467.2	G08		7	0016-0278	542.09	277.90	194	55.01	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			315.1	G08		7	0017-0285	589.69	285.54	227	55.70	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			558.7	G08		7	0018-0295	792.60	296.21	261	62.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			295.3	G08		7	0019-0312	44.10	311.83	284	64.53	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			376.2	G08		7	0020-0310	581.07	310.05	230	59.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			504.0	G08		7	0021-0318	797.42	318.62	355	71.01	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			376.6	G08		7	0022-0320	20.50	319.46	217	56.28	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			284.4	G08		7	0023-0342	903.18	342.01	285	63.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			452.1	G08		7	0024-0346	432.50	346.92	216	56.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			271.2	G08		7	0025-0359	304.40	359.04	277	66.18	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			686.7	G08		7	0026-0385	226.98	385.39	107	39.46	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			281.6	G08		7	0027-0408	323.36	408.03	298	66.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			258.1	G08		7	0028-0414	130.61	414.08	313	71.50	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			342.7	G08		7	0029-0412	876.71	411.44	249	59.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			432.5	G08		7	0030-0415	227.08	415.55	205	57.01	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			403.4	G08		7	0031-0458	218.58	458.05	226	59.84	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			429.6	G08		7	0032-0465	900.13	464.79	272	63.01	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			599.0	G08		7	0033-0480	673.05	480.64	163	60.18	0.566
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			265.5	G08		7	0034-0483	154.74	483.15	141	46.87	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			453.6	G08		7	0035-0492	825.90	492.18	214	57.36	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			279.0	G08		7	0036-0494	159.32	495.01	131	49.46	0.673
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			610.1	G08		7	0037-0540	317.29	539.62	261	62.53	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			417.0	G08		7	0038-0537	118.17	537.42	196	57.36	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			394.3	G08		7	0039-0548	749.08	548.28	132	45.36	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			274.4	G08		7	0040-0555	541.81	554.98	291	65.26	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			365.2	G08		7	0041-0557	214.72	557.44	222	57.36	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			359.3	G08		7	0042-0555	735.78	555.98	120	42.28	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			420.1	G08		7	0043-0571	865.45	571.98	235	59.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			276.5	G08		7	0044-0581	458.87	581.32	299	65.26	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			377.6	G08		7	0045-0580	338.24	579.59	201	56.04	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			300.4	G08		7	0046-0584	557.07	584.80	257	61.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			409.5	G08		7	0047-0590	146.42	590.52	220	59.21	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			301.0	G08		7	0048-0590	379.40	589.54	316	66.67	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.3	G08		7	0049-0587	725.42	587.60	147	45.11	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			285.2	G08		7	0050-0596	715.02	597.07	151	46.87	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			344.1	G08		7	0051-0647	709.92	647.29	279	62.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			402.3	G08		7	0052-0649	283.27	650.15	195	53.94	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			337.8	G08		7	0053-0663	760.22	663.21	252	61.60	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			279.4	G08		7	0054-0665	58.61	665.53	298	63.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			347.2	G08		7	0055-0677	779.19	677.03	238	61.60	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			523.4	G08		7	0056-0692	383.49	691.93	179	49.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			358.6	G08		7	0057-0691	471.18	691.53	195	56.87	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			306.0	G08		8	0001-0031	936.98	31.62	278	65.60	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			392.0	G08		8	0002-0054	801.15	53.88	209	56.87	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			372.3	G08		8	0003-0061	843.75	61.43	216	66.04	0.622
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			378.4	G08		8	0004-0072	744.01	72.77	201	59.70	0.709
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			826.7	G08		8	0005-0110	290.92	109.83	264	63.01	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			486.3	G08		8	0006-0124	868.05	124.44	204	55.36	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			409.4	G08		8	0007-0136	397.97	136.22	279	62.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			488.0	G08		8	0008-0157	297.33	157.19	199	51.11	0.957
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			311.7	G08		8	0009-0177	236.55	176.67	260	64.53	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			573.5	G08		8	0010-0177	353.95	177.55	204	52.28	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			387.0	G08		8	0011-0182	141.63	182.29	215	60.43	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			442.4	G08		8	0012-0184	417.53	184.50	266	63.84	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			566.1	G08		8	0013-0195	580.65	195.20	189	53.11	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			322.3	G08		8	0014-0207	918.96	206.97	220	55.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			416.2	G08		8	0015-0214	236.87	214.53	211	59.01	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			423.5	G08		8	0016-0241	897.47	241.14	199	55.36	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			416.9	G08		8	0017-0260	527.98	260.45	217	56.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			445.6	G08		8	0018-0264	450.21	263.65	272	63.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			309.5	G08		8	0019-0297	861.92	297.03	274	63.94	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			331.7	G08		8	0020-0298	714.96	298.45	291	64.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			452.5	G08		8	0021-0330	699.62	330.32	173	47.46	0.965
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			334.9	G08		8	0022-0334	721.44	334.50	230	69.26	0.603
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			309.6	G08		8	0023-0343	708.13	343.65	123	45.11	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			303.4	G08		8	0024-0356	95.62	357.04	246	59.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			293.8	G08		8	0025-0358	770.82	358.20	230	63.60	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			403.7	G08		8	0026-0376	353.60	378.03	264	77.26	0.556
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			433.1	G08		8	0027-0378	259.72	378.03	213	55.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			322.4	G08		8	0028-0380	688.59	380.85	231	62.77	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			281.6	G08		8	0029-0388	424.72	387.92	305	67.84	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			345.5	G08		8	0030-0393	795.82	392.83	329	69.36	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			345.0	G08		8	0031-0421	214.39	421.11	189	56.53	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			552.7	G08		8	0032-0423	584.17	423.57	283	64.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			397.3	G08		8	0033-0426	527.98	426.91	228	57.70	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			352.7	G08		8	0034-0431	469.27	430.90	295	64.53	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			440.2	G08		8	0035-0446	174.24	446.17	205	59.26	0.734
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.0	G08		8	0036-0465	93.35	465.85	268	64.18	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			554.3	G08		8	0037-0478	172.46	478.59	190	52.77	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			357.2	G08		8	0038-0478	451.26	478.26	172	50.18	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			408.6	G08		8	0039-0485	204.35	484.39	245	61.60	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			365.3	G08		8	0040-0493	109.12	493.18	278	65.94	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			308.4	G08		8	0041-0514	550.29	513.57	307	69.94	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			296.1	G08		8	0042-0513	707.35	513.93	288	62.18	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			321.4	G08		8	0043-0518	868.54	518.43	202	61.01	0.682
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			287.0	G08		8	0044-0518	406.70	519.39	142	45.21	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			408.2	G08		8	0045-0536	565.66	536.59	212	64.04	0.650
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			316.5	G08		8	0046-0533	407.92	532.20	168	48.63	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			334.0	G08		8	0047-0534	301.31	534.72	230	59.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			375.5	G08		8	0048-0548	192.92	547.90	260	61.36	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			289.5	G08		8	0049-0556	511.92	556.09	302	66.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			431.7	G08		8	0050-0566	299.97	566.75	193	53.60	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			292.7	G08		8	0051-0580	924.69	579.23	294	65.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.9	G08		8	0052-0589	270.62	588.33	268	63.11	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			407.0	G08		8	0053-0595	880.07	594.80	355	73.36	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			294.2	G08		8	0054-0610	218.90	609.47	260	67.84	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			485.1	G08		8	0055-0621	146.69	622.02	198	57.11	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			419.6	G08		8	0056-0621	290.70	621.09	249	60.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			391.2	G08		8	0057-0639	577.61	640.06	225	62.53	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			426.6	G08		8	0058-0657	135.73	657.10	210	61.70	0.693
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			343.1	G08		8	0059-0652	674.40	652.07	277	69.36	0.724
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			535.2	G08		8	0060-0666	415.93	666.00	171	55.11	0.707
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			503.7	G08		8	0061-0699	370.97	699.10	183	51.70	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			398.2	G08		8	0062-0701	133.33	701.42	195	51.70	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			124.0	G08		8	0063-0709	842.07	709.27	198	51.70	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			261.6	G08		9	0001-0034	31.77	34.33	273	65.01	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			451.5	G08		9	0002-0034	411.40	35.09	286	64.77	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			298.8	G08		9	0003-0040	489.21	39.94	280	65.84	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			330.1	G08		9	0004-0049	727.83	49.69	258	61.11	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			10125.3	G08		9	0005-0071	43.56	71.40	286	64.28	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			643.3	G08		9	0006-0103	476.99	103.18	279	61.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			376.1	G08		9	0007-0106	354.74	106.26	246	59.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			466.3	G08		9	0008-0118	570.68	118.15	240	60.53	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			393.4	G08		9	0009-0145	347.01	145.15	199	53.11	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			605.2	G08		9	0010-0148	694.70	149.05	194	59.36	0.692
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			329.9	G08		9	0011-0150	125.25	150.20	225	59.46	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			357.2	G08		9	0012-0157	97.26	157.47	266	59.11	0.957
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			319.5	G08		9	0013-0183	323.97	183.54	246	61.60	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			401.3	G08		9	0014-0194	251.35	194.46	224	57.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			295.1	G08		9	0015-0206	858.14	205.90	261	62.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			364.2	G08		9	0016-0210	14.17	209.59	216	55.60	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			456.1	G08		9	0017-0211	377.37	210.79	172	54.04	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			419.8	G08		9	0018-0224	388.18	223.96	199	56.53	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			371.2	G08		9	0019-0235	80.57	235.54	201	56.18	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			486.8	G08		9	0020-0244	687.08	243.72	274	63.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			387.3	G08		9	0021-0246	299.45	245.54	343	72.43	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			385.9	G08		9	0022-0255	445.90	255.26	242	57.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			580.1	G08		9	0023-0268	478.14	267.59	245	58.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			357.1	G08		9	0024-0306	621.04	306.21	306	65.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			334.9	G08		9	0025-0336	263.52	336.65	255	77.50	0.534
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			281.5	G08		9	0026-0338	565.15	337.78	294	65.60	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			569.0	G08		9	0027-0352	423.01	352.32	230	57.36	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			549.3	G08		9	0028-0359	647.64	359.30	201	52.04	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			306.2	G08		9	0029-0366	121.04	366.56	347	72.08	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			332.8	G08		9	0030-0371	599.07	371.81	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			329.1	G08		9	0031-0392	112.90	392.27	302	70.18	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			373.4	G08		9	0032-0394	544.89	393.62	265	87.64	0.434
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			398.9	G08		9	0033-0396	427.88	397.25	206	56.77	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			337.1	G08		9	0034-0412	642.60	412.11	280	69.26	0.734
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			343.6	G08		9	0035-0416	462.97	416.38	197	60.28	0.681
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			313.7	G08		9	0036-0419	369.72	418.83	238	60.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			338.7	G08		9	0037-0428	443.00	427.25	275	64.77	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			330.8	G08		9	0038-0429	515.38	429.72	271	61.70	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			305.0	G08		9	0039-0440	364.69	440.16	252	61.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			460.0	G08		9	0040-0502	687.24	501.40	247	61.36	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			447.0	G08		9	0041-0505	670.84	506.14	206	54.63	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			342.0	G08		9	0042-0526	480.04	525.65	299	66.77	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			304.2	G08		9	0043-0560	241.00	560.24	284	66.77	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			269.6	G08		9	0044-0582	19.55	581.95	287	64.53	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			390.0	G08		9	0045-0581	306.88	581.25	226	58.18	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			350.3	G08		9	0046-0596	783.57	595.75	266	63.84	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			348.8	G08		9	0047-0601	698.86	601.44	250	62.53	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			302.9	G08		9	0048-0605	942.34	604.53	260	67.01	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			275.4	G08		9	0049-0613	300.09	612.81	325	66.43	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80001	H3 (pS10)	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201294	H3 (pS10)			284.6	G08		9	0050-0664	878.63	665.31	280	63.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1583.0	B08		1	0001-0030	113.89	29.84	299	67.60	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1957.3	B08		1	0002-0029	168.91	28.72	294	66.18	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2376.2	B08		1	0003-0033	263.30	34.12	210	55.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1552.2	B08		1	0004-0039	463.46	39.70	310	65.36	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1565.4	B08		1	0005-0040	504.82	41.10	293	68.67	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1547.8	B08		1	0006-0040	720.01	40.44	289	75.74	0.633
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4106.2	B08		1	0007-0041	803.55	41.85	444	87.50	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2085.5	B08		1	0008-0042	418.82	41.04	267	61.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3556.2	B08		1	0009-0042	87.75	42.02	158	48.63	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2481.3	B08		1	0010-0045	289.33	45.56	376	71.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3423.4	B08		1	0011-0044	589.42	44.68	234	56.28	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			692.5	B08		1	0012-0045	693.34	45.35	223	54.87	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3616.2	B08		1	0013-0042	652.67	42.21	177	52.63	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4012.3	B08		1	0014-0047	771.72	47.09	254	59.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3486.5	B08		1	0015-0051	172.16	51.15	276	61.94	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1997.0	B08		1	0016-0050	534.61	50.03	323	66.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2674.5	B08		1	0017-0053	219.63	53.47	374	71.60	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2185.4	B08		1	0018-0052	134.85	52.43	234	56.53	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2955.0	B08		1	0019-0058	657.13	57.83	342	70.77	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2457.6	B08		1	0020-0061	258.75	61.24	390	73.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2566.6	B08		1	0021-0063	335.34	62.34	338	68.43	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3117.5	B08		1	0022-0062	630.45	62.65	266	64.28	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			817.1	B08		1	0023-0061	68.12	60.80	231	55.11	0.956
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2704.8	B08		1	0024-0069	569.59	69.83	433	81.26	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2103.7	B08		1	0025-0071	383.06	70.47	307	65.36	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2815.3	B08		1	0026-0072	533.10	71.85	285	67.60	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1531.5	B08		1	0027-0075	85.61	75.59	300	66.18	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			499.7	B08		1	0028-0072	179.49	71.47	229	60.28	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1459.3	B08		1	0029-0075	115.54	75.69	250	60.53	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2739.8	B08		1	0030-0081	364.92	80.88	146	47.46	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2577.1	B08		1	0031-0080	619.08	80.64	222	57.94	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2352.8	B08		1	0032-0081	759.36	80.85	245	58.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2749.8	B08		1	0033-0081	321.95	81.50	130	42.63	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2254.0	B08		1	0034-0088	460.95	87.74	314	66.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3065.4	B08		1	0035-0084	310.93	84.24	113	39.80	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1383.2	B08		1	0036-0090	175.85	90.55	267	61.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1880.2	B08		1	0037-0090	214.71	89.20	254	62.77	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1899.4	B08		1	0038-0092	424.90	91.91	289	65.01	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1065.1	B08		1	0039-0091	680.90	91.72	234	58.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1457.3	B08		1	0040-0094	944.76	95.13	265	65.01	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3354.9	B08		1	0041-0095	625.03	94.75	328	69.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2733.5	B08		1	0042-0103	829.16	103.44	270	62.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2040.4	B08		1	0043-0104	239.83	104.03	255	65.26	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3325.5	B08		1	0044-0104	882.82	104.11	328	67.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1890.8	B08		1	0045-0110	922.35	110.33	335	73.84	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1967.8	B08		1	0046-0109	293.74	110.26	248	62.77	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2812.8	B08		1	0047-0112	493.79	112.96	362	71.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1393.8	B08		1	0048-0114	778.16	114.52	464	84.43	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			500.0	B08		1	0049-0116	112.41	116.63	359	88.08	0.581
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1697.5	B08		1	0050-0116	259.31	115.12	221	56.77	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3429.5	B08		1	0051-0116	647.23	117.24	258	60.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3513.0	B08		1	0052-0117	677.05	116.66	246	60.77	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2876.3	B08		1	0053-0121	836.66	121.20	367	74.18	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			605.3	B08		1	0054-0122	164.49	121.49	263	63.01	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2034.1	B08		1	0055-0120	281.99	120.20	154	46.53	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3109.2	B08		1	0056-0125	949.09	125.05	224	54.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3563.6	B08		1	0057-0128	199.33	128.54	327	68.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1043.4	B08		1	0058-0126	268.66	127.47	256	63.50	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			684.0	B08		1	0059-0129	408.85	128.58	321	73.50	0.747
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2558.4	B08		1	0060-0132	426.69	132.76	233	57.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2534.9	B08		1	0061-0136	630.94	135.58	383	73.94	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1211.3	B08		1	0062-0137	26.05	136.99	233	57.60	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			995.4	B08		1	0063-0137	373.17	137.60	319	72.91	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3976.1	B08		1	0064-0139	329.68	138.96	328	66.18	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3140.5	B08		1	0065-0140	731.73	139.63	294	63.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2617.5	B08		1	0066-0148	178.70	148.16	375	71.84	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3194.5	B08		1	0067-0146	940.07	145.73	218	55.36	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2438.4	B08		1	0068-0149	527.48	149.03	352	71.60	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			656.5	B08		1	0069-0149	37.87	149.11	235	57.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2924.1	B08		1	0070-0150	469.38	149.40	312	67.11	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3276.2	B08		1	0071-0150	596.87	150.27	252	60.53	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1548.3	B08		1	0072-0152	796.78	151.98	299	66.18	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2341.2	B08		1	0073-0159	225.58	157.45	570	99.74	0.720
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2708.4	B08		1	0074-0155	282.20	154.87	260	62.18	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3494.1	B08		1	0075-0157	632.64	157.02	313	76.43	0.673
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1423.7	B08		1	0076-0158	153.69	157.45	204	55.70	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3188.8	B08		1	0077-0163	328.00	163.42	260	61.01	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1764.4	B08		1	0078-0163	125.94	162.81	221	58.77	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2336.6	B08		1	0079-0165	582.66	164.81	259	59.01	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			728.6	B08		1	0080-0168	806.15	168.59	186	50.28	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2766.3	B08		1	0081-0173	353.97	173.37	375	73.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3523.8	B08		1	0082-0176	393.44	175.46	308	66.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3077.2	B08		1	0083-0181	81.01	179.70	679	108.81	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2713.6	B08		1	0084-0181	37.82	180.94	317	68.67	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2664.5	B08		1	0085-0183	495.13	183.84	242	61.11	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1857.6	B08		1	0086-0186	183.20	185.11	281	70.77	0.705
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1899.8	B08		1	0087-0183	529.17	183.34	292	66.77	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3230.0	B08		1	0088-0188	592.87	187.56	324	71.26	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1378.9	B08		1	0089-0188	151.31	188.09	239	63.01	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2268.9	B08		1	0090-0186	472.32	186.20	273	62.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3095.7	B08		1	0091-0190	645.42	190.40	355	72.77	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2630.3	B08		1	0092-0189	740.53	189.40	262	61.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1112.8	B08		1	0093-0189	916.61	189.99	213	55.94	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			949.5	B08		1	0094-0199	661.63	199.51	212	54.53	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			755.1	B08		1	0095-0202	325.65	202.00	219	55.36	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			660.8	B08		1	0096-0203	781.21	202.87	198	52.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			508.5	B08		1	0097-0207	126.70	206.94	259	64.43	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2652.2	B08		1	0098-0208	842.96	208.21	277	62.53	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2601.5	B08		1	0099-0207	893.22	207.79	217	56.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2344.7	B08		1	0100-0211	47.78	209.92	245	71.84	0.597
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3210.4	B08		1	0101-0214	541.25	215.01	299	63.94	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2355.3	B08		1	0102-0214	757.81	214.78	388	73.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2892.0	B08		1	0103-0216	410.24	216.66	161	46.77	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1256.5	B08		1	0104-0223	491.65	222.90	275	63.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			995.5	B08		1	0105-0224	660.52	224.84	193	55.70	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3417.5	B08		1	0106-0227	19.25	227.66	223	54.77	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2729.0	B08		1	0107-0228	641.43	228.26	277	63.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1914.3	B08		1	0108-0230	932.04	229.58	285	68.67	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1932.5	B08		1	0109-0231	142.62	231.60	386	74.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2272.3	B08		1	0110-0230	561.73	229.80	229	55.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2635.7	B08		1	0111-0232	381.62	230.95	268	61.11	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2266.9	B08		1	0112-0230	462.01	230.23	249	61.11	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1884.4	B08		1	0113-0233	211.55	233.28	153	48.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3693.6	B08		1	0114-0243	589.35	243.57	309	68.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1728.3	B08		1	0115-0246	199.44	247.53	276	74.43	0.626
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3947.7	B08		1	0116-0244	317.01	244.90	203	53.11	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2396.2	B08		1	0117-0248	76.81	248.53	326	67.01	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2492.3	B08		1	0118-0247	524.13	246.74	325	66.18	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2538.2	B08		1	0119-0247	711.89	247.02	255	60.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3275.3	B08		1	0120-0248	409.52	248.96	336	67.60	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3030.0	B08		1	0121-0249	739.54	249.33	291	62.18	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1387.0	B08		1	0122-0250	840.18	251.21	283	64.43	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2794.4	B08		1	0123-0247	102.44	248.22	225	58.28	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2896.4	B08		1	0124-0252	47.31	252.01	327	67.26	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2500.7	B08		1	0125-0251	779.24	251.24	413	77.84	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1784.3	B08		1	0126-0257	151.50	256.98	248	61.36	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2070.1	B08		1	0127-0260	804.47	259.44	328	74.18	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2212.7	B08		1	0128-0261	359.21	260.93	227	57.94	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1979.1	B08		1	0129-0264	229.84	263.90	281	63.94	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2492.1	B08		1	0130-0263	576.99	262.76	251	59.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3157.1	B08		1	0131-0263	342.33	262.78	170	48.28	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2193.6	B08		1	0132-0265	453.23	264.74	269	63.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2730.8	B08		1	0133-0267	184.02	266.99	243	60.53	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2607.3	B08		1	0134-0271	400.65	271.07	303	64.43	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3717.8	B08		1	0135-0282	715.90	282.51	614	104.57	0.706
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1551.0	B08		1	0136-0278	136.40	278.88	316	67.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2416.8	B08		1	0137-0276	499.36	276.36	316	67.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1152.7	B08		1	0138-0278	325.49	278.13	242	57.11	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3537.7	B08		1	0139-0279	115.90	278.85	204	52.53	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1726.1	B08		1	0140-0280	248.03	279.94	274	63.70	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1034.6	B08		1	0141-0280	233.47	280.45	153	47.56	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2924.7	B08		1	0142-0283	831.39	284.12	232	58.77	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1993.7	B08		1	0143-0289	784.07	289.05	364	71.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2279.9	B08		1	0144-0285	871.41	284.96	211	56.04	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1745.0	B08		1	0145-0290	63.79	289.94	259	61.94	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1858.3	B08		1	0146-0294	198.94	293.80	275	68.77	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1989.2	B08		1	0147-0295	251.29	295.72	194	54.53	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			992.1	B08		1	0148-0293	442.69	293.36	247	58.28	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3854.7	B08		1	0149-0295	947.72	294.55	176	50.18	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2759.7	B08		1	0150-0299	539.19	299.01	298	64.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			595.6	B08		1	0151-0299	361.35	299.51	251	57.70	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			607.1	B08		1	0152-0298	577.27	297.82	248	60.53	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3108.0	B08		1	0153-0300	153.20	300.76	218	54.53	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1735.5	B08		1	0154-0304	861.89	303.83	366	74.53	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3181.2	B08		1	0155-0308	69.46	309.04	291	69.60	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1885.1	B08		1	0156-0307	940.82	307.36	244	61.60	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2904.5	B08		1	0157-0306	775.28	306.47	235	57.60	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3214.2	B08		1	0158-0309	925.21	309.35	226	56.28	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2732.1	B08		1	0159-0309	318.39	309.17	272	61.36	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2582.9	B08		1	0160-0314	651.65	313.60	420	79.50	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2192.0	B08		1	0161-0312	467.93	312.35	213	54.28	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2332.1	B08		1	0162-0317	437.95	317.77	267	64.53	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2944.0	B08		1	0163-0318	698.19	319.21	278	66.53	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2786.8	B08		1	0164-0322	42.02	322.21	328	67.94	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2211.3	B08		1	0165-0320	770.32	320.36	168	53.36	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2428.9	B08		1	0166-0327	754.43	327.63	324	66.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1676.7	B08		1	0167-0326	246.13	326.12	244	58.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2786.4	B08		1	0168-0330	596.47	330.76	289	65.60	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3141.7	B08		1	0169-0330	195.74	329.79	222	56.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3596.8	B08		1	0170-0331	512.72	332.12	223	57.11	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1138.8	B08		1	0171-0336	874.34	337.08	218	56.77	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2735.2	B08		1	0172-0340	922.60	340.37	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2782.8	B08		1	0173-0341	99.15	341.72	292	64.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3243.1	B08		1	0174-0341	120.32	340.55	219	53.11	0.976
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2498.6	B08		1	0175-0342	317.87	341.87	240	57.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			673.2	B08		1	0176-0344	477.32	345.31	233	58.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1708.0	B08		1	0177-0343	360.24	343.09	266	60.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3147.2	B08		1	0178-0348	187.38	348.07	297	64.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			843.7	B08		1	0179-0347	401.52	347.12	252	62.18	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2602.1	B08		1	0180-0348	451.21	348.03	240	59.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3045.8	B08		1	0181-0350	819.68	350.80	359	70.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1513.3	B08		1	0182-0357	235.83	357.38	253	60.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3303.4	B08		1	0183-0356	496.35	355.69	222	57.36	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2539.2	B08		1	0184-0358	158.02	357.54	284	62.43	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1730.2	B08		1	0185-0357	671.00	357.74	234	55.94	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2766.6	B08		1	0186-0359	721.04	359.92	342	71.84	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1932.0	B08		1	0187-0360	752.93	360.36	252	59.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			685.8	B08		1	0188-0365	470.68	365.36	211	57.36	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2997.7	B08		1	0189-0369	836.38	369.52	373	72.53	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2439.6	B08		1	0190-0368	510.44	367.95	374	72.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2475.7	B08		1	0191-0368	29.10	368.35	287	63.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3066.1	B08		1	0192-0368	85.72	368.45	306	65.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1996.5	B08		1	0193-0369	285.20	368.86	294	63.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2364.5	B08		1	0194-0369	644.13	368.90	224	53.70	0.976
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1863.3	B08		1	0195-0371	882.48	372.11	301	84.08	0.535
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1272.6	B08		1	0196-0372	342.42	372.83	297	62.43	0.958
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1718.8	B08		1	0197-0377	903.49	377.77	282	62.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1653.2	B08		1	0198-0382	236.02	382.05	232	61.01	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2225.2	B08		1	0199-0381	465.07	380.93	279	62.18	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2647.9	B08		1	0200-0382	422.53	381.58	245	57.01	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1262.7	B08		1	0201-0384	59.38	384.08	255	60.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2102.4	B08		1	0202-0382	204.75	382.54	279	65.60	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2108.9	B08		1	0203-0384	656.24	384.72	261	60.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2266.0	B08		1	0204-0387	568.05	386.72	328	69.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			691.0	B08		1	0205-0391	518.32	391.39	283	61.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2270.8	B08		1	0206-0390	169.49	389.75	206	54.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1497.4	B08		1	0207-0395	261.77	395.35	279	63.60	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2745.4	B08		1	0208-0395	803.93	394.56	282	63.94	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1480.6	B08		1	0209-0397	83.60	397.43	279	63.36	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2734.8	B08		1	0210-0404	36.94	403.87	278	63.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2904.6	B08		1	0211-0407	730.02	407.84	315	66.18	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1652.1	B08		1	0212-0408	843.73	407.57	293	64.18	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1221.7	B08		1	0213-0410	440.38	410.24	296	63.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1212.8	B08		1	0214-0410	550.82	411.36	275	66.43	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3580.3	B08		1	0215-0413	243.15	413.15	243	60.18	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			618.9	B08		1	0216-0413	516.77	413.09	281	62.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2723.9	B08		1	0217-0413	808.27	412.54	221	53.94	0.954
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2549.2	B08		1	0218-0414	919.87	414.30	185	55.60	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2705.5	B08		1	0219-0416	79.17	416.04	377	71.94	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2222.3	B08		1	0220-0418	163.55	418.03	252	61.36	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2358.5	B08		1	0221-0421	785.55	421.04	344	69.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1324.3	B08		1	0222-0422	409.14	422.85	249	63.01	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			503.1	B08		1	0223-0423	497.98	423.57	253	59.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2200.6	B08		1	0224-0424	532.48	424.18	237	58.04	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2199.0	B08		1	0225-0424	26.41	423.48	304	69.01	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4139.7	B08		1	0226-0426	354.97	425.99	314	67.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3849.4	B08		1	0227-0423	871.09	422.31	179	50.87	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2155.9	B08		1	0228-0427	250.22	427.44	230	57.70	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			603.5	B08		1	0229-0430	206.78	429.65	150	48.28	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2862.0	B08		1	0230-0433	719.33	433.69	222	55.70	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1228.6	B08		1	0231-0434	267.33	434.36	214	54.28	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			564.4	B08		1	0232-0437	480.58	437.58	240	60.18	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1521.7	B08		1	0233-0440	939.21	439.67	353	68.18	0.954
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4241.3	B08		1	0234-0439	609.39	439.19	305	65.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2608.4	B08		1	0235-0441	87.56	441.59	397	78.77	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3638.2	B08		1	0236-0444	313.31	444.10	226	55.60	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2543.2	B08		1	0237-0449	566.89	449.14	471	87.74	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2272.0	B08		1	0238-0447	895.02	446.89	305	64.18	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3129.5	B08		1	0239-0451	447.93	451.30	249	59.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2800.0	B08		1	0240-0452	203.76	451.83	338	69.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			659.5	B08		1	0241-0452	707.34	452.53	248	58.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1636.0	B08		1	0242-0455	138.82	455.82	272	61.11	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1290.2	B08		1	0243-0455	169.80	454.52	249	57.94	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2512.1	B08		1	0244-0455	764.11	454.42	229	57.60	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			694.3	B08		1	0245-0460	338.08	460.12	261	59.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2049.2	B08		1	0246-0458	522.70	457.57	260	71.36	0.642
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1825.2	B08		1	0247-0462	684.36	462.23	245	58.53	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2757.2	B08		1	0248-0461	929.63	463.41	105	54.28	0.448
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			640.3	B08		1	0249-0463	266.08	463.29	234	56.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			580.7	B08		1	0250-0462	371.30	462.35	222	54.28	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			513.4	B08		1	0251-0465	192.92	465.25	236	56.77	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1540.3	B08		1	0252-0469	19.74	469.00	232	58.18	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1952.1	B08		1	0253-0468	56.76	468.68	245	59.70	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3007.0	B08		1	0254-0473	454.50	473.71	359	71.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2215.9	B08		1	0255-0471	784.17	470.63	284	63.01	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2906.5	B08		1	0256-0471	889.75	471.18	283	62.28	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2662.7	B08		1	0257-0476	110.21	476.73	284	80.67	0.548
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3564.6	B08		1	0258-0477	231.35	477.52	324	67.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1997.0	B08		1	0259-0477	939.35	477.30	305	64.18	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3878.2	B08		1	0260-0489	638.05	489.37	596	101.64	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2769.6	B08		1	0261-0485	756.79	486.02	376	71.84	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1832.6	B08		1	0262-0487	288.53	487.51	264	65.01	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2018.0	B08		1	0263-0486	314.59	485.45	245	59.94	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1278.9	B08		1	0264-0485	553.80	484.53	283	67.36	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2257.6	B08		1	0265-0484	369.54	483.67	268	64.28	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2159.2	B08		1	0266-0491	519.97	491.55	338	72.67	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3109.9	B08		1	0267-0497	99.83	497.16	370	71.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2262.2	B08		1	0268-0498	409.74	499.31	354	71.01	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2098.3	B08		1	0269-0498	872.62	499.24	184	54.18	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1538.6	B08		1	0270-0500	148.78	500.06	228	57.36	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1916.5	B08		1	0271-0503	468.71	503.63	320	68.43	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2931.5	B08		1	0272-0503	77.11	502.93	272	61.11	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			345.5	B08		1	0273-0505	268.93	504.90	270	68.43	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3376.8	B08		1	0274-0509	305.30	509.88	233	57.94	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2181.0	B08		1	0275-0517	207.07	517.49	344	71.01	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			832.8	B08		1	0276-0519	598.46	519.13	290	66.43	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1947.6	B08		1	0277-0518	854.85	517.24	228	61.11	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1717.8	B08		1	0278-0521	933.70	520.66	393	76.43	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1537.8	B08		1	0279-0520	166.61	520.71	241	58.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2616.9	B08		1	0280-0521	238.19	521.80	373	71.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2361.5	B08		1	0281-0521	411.27	521.04	435	79.26	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			987.3	B08		1	0282-0526	563.97	525.63	293	69.01	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			672.9	B08		1	0283-0522	34.32	522.15	220	58.77	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			784.7	B08		1	0284-0523	332.36	523.14	263	59.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2124.9	B08		1	0285-0523	894.77	523.05	222	57.94	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1924.4	B08		1	0286-0527	122.79	526.75	271	60.53	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1608.3	B08		1	0287-0530	535.34	531.28	286	74.67	0.645
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2558.0	B08		1	0288-0525	792.52	525.08	151	48.53	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2186.1	B08		1	0289-0529	377.36	529.29	221	54.53	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			729.9	B08		1	0290-0532	22.59	531.68	118	40.63	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4257.6	B08		1	0291-0534	849.54	533.57	281	64.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			364.6	B08		1	0292-0538	758.80	536.71	288	66.18	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2759.6	B08		1	0293-0538	190.19	539.06	304	68.43	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			381.5	B08		1	0294-0538	155.18	538.33	266	59.94	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1777.9	B08		1	0295-0540	274.52	540.55	302	67.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2989.5	B08		1	0296-0539	584.34	539.26	237	58.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			589.5	B08		1	0297-0541	34.95	541.02	186	53.11	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2688.8	B08		1	0298-0540	246.64	540.12	226	56.28	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2633.4	B08		1	0299-0540	619.66	540.31	228	56.28	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4046.1	B08		1	0300-0546	430.62	546.55	216	53.70	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2043.1	B08		1	0301-0550	48.08	551.22	273	61.11	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1659.6	B08		1	0302-0555	646.66	554.99	394	76.43	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1737.3	B08		1	0303-0551	880.94	551.27	291	63.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			843.2	B08		1	0304-0553	813.38	553.13	188	52.53	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2666.9	B08		1	0305-0557	216.26	557.91	246	60.53	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3309.0	B08		1	0306-0557	115.55	556.04	350	73.01	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			730.7	B08		1	0307-0557	241.89	557.57	344	69.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2900.3	B08		1	0308-0559	407.13	559.18	323	69.01	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2689.6	B08		1	0309-0560	168.93	559.78	333	71.50	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2236.9	B08		1	0310-0556	922.23	556.72	246	58.87	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2522.7	B08		1	0311-0559	458.31	559.38	200	54.53	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2378.1	B08		1	0312-0561	942.12	561.30	280	61.70	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1974.6	B08		1	0313-0565	523.32	564.27	301	67.94	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			464.2	B08		1	0314-0566	762.34	565.33	293	71.50	0.720
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			879.7	B08		1	0315-0564	798.47	565.28	374	85.84	0.638
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4095.1	B08		1	0316-0567	437.78	566.43	249	59.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1376.2	B08		1	0317-0573	192.43	574.30	411	84.33	0.726
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1484.9	B08		1	0318-0569	601.57	568.93	289	69.26	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1181.7	B08		1	0319-0570	381.08	570.75	320	65.60	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2035.1	B08		1	0320-0576	233.09	576.66	252	63.36	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			5196.4	B08		1	0321-0575	697.19	575.95	224	56.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2840.7	B08		1	0322-0580	545.77	580.03	344	71.60	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1949.7	B08		1	0323-0577	251.94	576.50	225	55.36	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			701.6	B08		1	0324-0581	58.38	582.52	240	63.60	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2591.5	B08		1	0325-0583	630.98	583.13	273	65.01	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1334.1	B08		1	0326-0585	565.54	585.96	451	83.01	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			530.6	B08		1	0327-0581	463.23	580.17	265	65.11	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3488.4	B08		1	0328-0585	265.66	585.19	263	65.01	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1363.6	B08		1	0329-0588	28.86	587.78	250	61.26	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3368.0	B08		1	0330-0593	115.61	594.13	357	70.18	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1461.5	B08		1	0331-0591	593.95	590.81	268	66.67	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3828.7	B08		1	0332-0591	143.19	591.45	241	57.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2438.9	B08		1	0333-0592	225.25	592.21	260	62.53	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1991.8	B08		1	0334-0594	384.87	594.79	297	66.18	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2911.9	B08		1	0335-0597	284.93	597.01	365	71.26	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2359.6	B08		1	0336-0594	674.84	594.10	229	56.53	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3875.4	B08		1	0337-0592	712.12	592.96	178	51.21	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2163.5	B08		1	0338-0605	414.43	604.17	293	66.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2750.3	B08		1	0339-0605	806.30	605.10	223	55.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2433.1	B08		1	0340-0607	592.13	607.88	231	55.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2348.6	B08		1	0341-0609	744.09	608.82	287	62.77	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1983.1	B08		1	0342-0611	273.89	611.90	251	60.77	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2550.5	B08		1	0343-0612	849.76	611.86	288	65.01	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			633.6	B08		1	0344-0613	153.75	612.82	195	55.36	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2513.6	B08		1	0345-0614	302.75	614.32	232	55.70	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2619.9	B08		1	0346-0616	76.07	616.27	260	59.94	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			554.1	B08		1	0347-0618	198.86	617.72	200	57.60	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3778.3	B08		1	0348-0616	901.75	616.17	251	59.94	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1783.1	B08		1	0349-0620	479.57	620.33	262	63.01	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2543.4	B08		1	0350-0619	681.57	619.71	274	61.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1936.7	B08		1	0351-0623	362.48	623.47	330	71.36	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1933.1	B08		1	0352-0630	892.17	629.37	254	61.01	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2832.7	B08		1	0353-0630	162.83	629.67	272	62.53	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2372.5	B08		1	0354-0629	806.37	629.13	187	53.70	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2628.3	B08		1	0355-0635	848.75	635.77	360	72.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1270.9	B08		1	0356-0634	489.75	634.91	317	71.84	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1778.9	B08		1	0357-0634	93.78	634.92	259	59.60	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2562.8	B08		1	0358-0636	243.32	636.51	374	72.67	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2909.4	B08		1	0359-0638	562.17	638.24	302	63.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1445.2	B08		1	0360-0642	508.02	640.75	239	59.60	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1575.6	B08		1	0361-0644	63.05	643.58	112	40.28	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3111.4	B08		1	0362-0644	693.93	644.85	228	56.87	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1374.4	B08		1	0363-0647	734.79	647.28	278	62.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			769.3	B08		1	0364-0650	783.99	651.00	192	58.53	0.704
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1743.3	B08		1	0365-0650	313.67	650.57	254	60.77	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1210.6	B08		1	0366-0649	401.23	648.55	262	61.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2413.0	B08		1	0367-0653	199.09	653.50	315	65.60	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2246.9	B08		1	0368-0653	447.88	652.57	345	68.77	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1564.7	B08		1	0369-0651	74.63	651.70	142	47.11	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2429.2	B08		1	0370-0663	237.20	663.32	593	97.98	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1810.6	B08		1	0371-0654	359.27	653.72	266	61.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2379.5	B08		1	0372-0659	46.25	659.41	273	61.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2588.2	B08		1	0373-0661	180.10	661.22	361	70.43	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1789.5	B08		1	0374-0661	327.81	660.85	284	63.01	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1702.4	B08		1	0375-0662	546.66	662.74	419	79.01	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1397.3	B08		1	0376-0664	121.03	664.38	276	64.18	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2876.1	B08		1	0377-0664	659.96	664.11	233	56.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2451.9	B08		1	0378-0665	939.18	664.58	280	64.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1697.2	B08		1	0379-0673	144.32	672.28	278	65.01	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3438.1	B08		1	0380-0675	705.98	673.83	168	59.94	0.588
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3202.4	B08		1	0381-0680	166.68	679.72	399	75.84	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2860.2	B08		1	0382-0679	285.98	678.49	255	61.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2004.9	B08		1	0383-0685	536.72	684.90	266	62.53	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2430.7	B08		1	0384-0684	365.64	683.42	216	57.36	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2048.6	B08		1	0385-0685	615.32	684.80	227	56.28	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1519.1	B08		1	0386-0686	309.17	686.79	228	56.28	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1283.0	B08		1	0387-0688	428.60	688.45	236	58.53	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2781.4	B08		1	0388-0688	264.40	688.51	320	67.11	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2909.5	B08		1	0389-0693	352.59	693.35	387	80.91	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2881.4	B08		1	0390-0688	916.93	687.99	140	47.11	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			473.9	B08		1	0391-0691	104.52	691.01	261	62.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			462.3	B08		1	0392-0693	133.18	692.16	261	63.70	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1420.6	B08		1	0393-0693	653.79	693.70	266	61.60	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3355.0	B08		1	0394-0693	720.47	693.60	320	65.84	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2091.0	B08		1	0395-0697	50.81	697.15	422	77.26	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2640.3	B08		1	0396-0697	878.17	697.43	330	67.01	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2328.3	B08		1	0397-0697	926.54	697.25	159	47.70	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2238.8	B08		1	0398-0698	944.56	697.57	170	51.11	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1145.8	B08		1	0399-0703	691.43	704.31	281	67.26	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2102.9	B08		1	0400-0706	315.64	706.08	250	63.01	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2062.0	B08		1	0401-0708	492.58	708.06	259	65.01	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2500.6	B08		1	0402-0710	415.79	710.17	212	52.87	0.953
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2603.8	B08		1	0403-0710	233.22	710.48	313	67.11	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2857.8	B08		2	0001-0029	259.68	29.83	527	96.57	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2151.8	B08		2	0002-0033	541.09	33.64	296	71.01	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1182.0	B08		2	0003-0034	151.54	34.40	223	55.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3622.4	B08		2	0004-0036	220.81	37.59	352	74.67	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2962.9	B08		2	0005-0036	793.54	36.16	268	61.11	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			439.2	B08		2	0006-0036	936.35	36.88	247	59.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3559.8	B08		2	0007-0038	126.12	39.14	253	58.53	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2880.2	B08		2	0008-0039	584.93	39.38	349	71.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1012.7	B08		2	0009-0042	767.09	42.65	281	62.53	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2214.1	B08		2	0010-0042	828.89	42.74	279	65.60	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1080.5	B08		2	0011-0049	53.05	49.74	437	85.26	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2849.3	B08		2	0012-0047	919.83	46.92	347	72.08	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2618.8	B08		2	0013-0046	639.79	45.79	330	68.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1870.0	B08		2	0014-0047	96.27	48.60	394	79.26	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4099.2	B08		2	0015-0048	735.18	48.81	336	69.01	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			667.5	B08		2	0016-0061	412.86	62.80	586	130.95	0.429
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2044.9	B08		2	0017-0052	199.96	51.48	256	60.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1406.7	B08		2	0018-0058	900.74	58.85	226	57.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2661.0	B08		2	0019-0060	248.56	59.83	237	58.87	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			659.6	B08		2	0020-0067	388.09	66.98	509	92.33	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2463.3	B08		2	0021-0062	828.67	62.91	291	70.18	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2667.9	B08		2	0022-0068	511.07	68.64	316	64.53	0.954
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2832.5	B08		2	0023-0071	734.71	70.64	328	67.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3004.5	B08		2	0024-0068	932.37	68.17	302	64.53	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3335.1	B08		2	0025-0072	673.71	72.26	200	52.53	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2557.8	B08		2	0026-0078	847.67	78.25	315	66.18	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1021.7	B08		2	0027-0081	341.98	81.08	352	81.84	0.660
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3779.8	B08		2	0028-0086	225.89	85.71	231	56.53	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1937.9	B08		2	0029-0093	68.18	93.30	308	80.08	0.603
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2336.7	B08		2	0030-0090	920.38	89.70	417	77.50	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2274.0	B08		2	0031-0089	162.29	89.72	246	60.43	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4076.4	B08		2	0032-0093	563.27	93.05	241	57.70	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4420.9	B08		2	0033-0096	697.39	95.95	324	66.43	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1467.6	B08		2	0034-0098	37.60	98.62	268	66.18	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2362.7	B08		2	0035-0097	782.11	98.03	395	73.26	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2492.5	B08		2	0036-0095	830.61	94.67	292	64.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			499.8	B08		2	0037-0095	141.99	95.57	298	73.26	0.698
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3903.1	B08		2	0038-0097	604.69	97.28	212	55.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1128.0	B08		2	0039-0102	647.74	101.72	272	61.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2665.5	B08		2	0040-0105	174.15	103.92	313	73.50	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			850.1	B08		2	0041-0104	294.08	103.98	338	70.18	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2306.7	B08		2	0042-0104	885.71	105.02	275	63.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2970.6	B08		2	0043-0114	713.14	113.75	286	61.94	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1966.8	B08		2	0044-0114	828.93	114.14	248	58.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1031.4	B08		2	0045-0119	450.89	118.43	288	67.01	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			856.5	B08		2	0046-0122	931.96	121.35	274	80.57	0.530
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3670.8	B08		2	0047-0123	516.32	123.01	286	63.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3497.9	B08		2	0048-0122	563.25	122.04	263	59.11	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			406.9	B08		2	0049-0128	97.77	128.00	262	60.53	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3153.4	B08		2	0050-0129	42.10	128.79	231	55.36	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2236.8	B08		2	0051-0128	207.62	128.42	259	59.60	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2858.2	B08		2	0052-0133	604.70	133.19	360	70.43	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2125.8	B08		2	0053-0130	759.25	130.71	251	58.18	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			530.2	B08		2	0054-0136	72.94	136.44	208	54.28	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3607.5	B08		2	0055-0137	550.32	136.78	274	61.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4180.2	B08		2	0056-0137	777.44	137.14	222	55.11	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4238.9	B08		2	0057-0137	794.18	136.40	218	53.70	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2207.8	B08		2	0058-0145	727.37	145.32	444	78.18	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2155.6	B08		2	0059-0142	874.27	142.34	224	55.36	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2735.0	B08		2	0060-0144	934.42	143.85	249	58.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			864.3	B08		2	0061-0148	155.76	148.52	292	65.84	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3140.4	B08		2	0062-0149	33.25	149.15	222	54.77	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2119.7	B08		2	0063-0150	106.39	149.81	237	57.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1881.6	B08		2	0064-0155	200.80	155.72	393	73.60	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4018.9	B08		2	0065-0155	471.21	154.30	254	59.01	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3780.9	B08		2	0066-0154	558.32	154.44	292	63.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4161.0	B08		2	0067-0154	254.47	153.92	308	67.36	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2381.2	B08		2	0068-0160	620.04	160.01	404	74.43	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3665.3	B08		2	0069-0164	917.28	164.36	356	70.43	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			633.6	B08		2	0070-0164	175.67	164.23	215	55.36	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2914.4	B08		2	0071-0167	665.68	166.85	405	73.94	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			604.0	B08		2	0072-0167	497.26	168.27	252	60.53	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			606.8	B08		2	0073-0168	67.29	167.45	226	57.70	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2665.7	B08		2	0074-0170	262.45	170.60	324	66.18	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1780.4	B08		2	0075-0172	753.94	172.38	431	78.91	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2322.2	B08		2	0076-0173	146.52	173.59	272	67.01	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2247.6	B08		2	0077-0178	596.57	178.25	306	65.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2687.1	B08		2	0078-0182	240.50	181.00	298	71.26	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			417.8	B08		2	0079-0182	734.11	182.39	234	58.53	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1835.5	B08		2	0080-0185	187.08	185.78	241	57.70	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1620.4	B08		2	0081-0186	122.92	186.07	343	74.67	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2578.8	B08		2	0082-0188	225.70	188.67	261	62.53	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2361.3	B08		2	0083-0191	677.56	192.15	364	71.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			736.0	B08		2	0084-0189	840.43	189.39	214	53.94	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3291.2	B08		2	0085-0194	563.06	194.27	385	72.18	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2558.8	B08		2	0086-0199	890.42	197.48	769	109.64	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			610.0	B08		2	0087-0193	258.30	193.27	200	52.77	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3461.4	B08		2	0088-0195	501.35	195.42	397	73.84	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3574.5	B08		2	0089-0203	329.23	203.08	327	67.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2274.9	B08		2	0090-0201	414.67	201.15	261	61.11	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2078.1	B08		2	0091-0203	943.10	202.94	298	63.36	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2007.5	B08		2	0092-0208	723.00	207.81	312	66.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1539.8	B08		2	0093-0208	386.86	207.98	248	58.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3070.1	B08		2	0094-0215	917.90	216.26	350	78.43	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3795.8	B08		2	0095-0213	164.52	213.57	360	71.01	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			5178.5	B08		2	0096-0210	456.56	209.86	212	53.60	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			675.2	B08		2	0097-0211	269.62	210.63	212	55.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			445.5	B08		2	0098-0211	832.42	210.58	239	59.70	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3076.5	B08		2	0099-0217	693.56	217.43	398	75.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1806.1	B08		2	0100-0214	756.57	214.54	358	71.01	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2687.4	B08		2	0101-0219	443.84	218.95	289	65.60	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			520.3	B08		2	0102-0222	496.94	222.16	260	62.77	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1728.0	B08		2	0103-0228	869.43	228.89	429	80.91	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			408.2	B08		2	0104-0228	674.85	228.32	255	59.94	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1820.1	B08		2	0105-0234	25.12	233.33	292	68.43	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3234.9	B08		2	0106-0234	179.97	233.59	273	62.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3041.5	B08		2	0107-0231	759.55	230.71	145	45.56	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3136.4	B08		2	0108-0232	746.58	232.09	152	44.63	0.959
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2415.6	B08		2	0109-0240	201.34	240.69	354	69.60	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2069.9	B08		2	0110-0242	934.14	243.11	233	57.70	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1686.5	B08		2	0111-0246	816.39	245.60	275	63.84	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3305.8	B08		2	0112-0247	365.66	247.19	372	74.91	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1135.8	B08		2	0113-0249	780.40	249.74	260	63.01	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3147.7	B08		2	0114-0249	297.44	249.34	298	63.36	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2539.0	B08		2	0115-0256	481.04	256.10	403	83.74	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1999.2	B08		2	0116-0254	250.33	253.89	294	62.18	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2605.0	B08		2	0117-0253	66.16	253.85	295	64.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3775.0	B08		2	0118-0252	126.71	252.34	209	53.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4200.0	B08		2	0119-0259	149.90	258.96	393	73.60	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3695.1	B08		2	0120-0256	537.78	256.26	177	50.28	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2381.0	B08		2	0121-0260	519.45	260.14	348	75.84	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2259.0	B08		2	0122-0259	871.05	259.54	336	67.94	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2948.9	B08		2	0123-0261	412.65	261.32	297	64.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2280.2	B08		2	0124-0260	934.80	260.40	352	73.94	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1656.8	B08		2	0125-0264	282.78	263.77	217	55.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1690.7	B08		2	0126-0264	376.20	263.74	338	74.08	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3279.1	B08		2	0127-0265	343.44	265.30	320	66.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1265.1	B08		2	0128-0269	75.62	269.45	217	57.36	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2408.1	B08		2	0129-0270	241.05	269.89	292	63.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1643.2	B08		2	0130-0273	432.94	273.97	335	74.43	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1062.9	B08		2	0131-0274	761.98	273.08	264	64.53	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2889.9	B08		2	0132-0271	195.98	272.06	227	57.11	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			550.9	B08		2	0133-0274	687.54	274.55	410	79.60	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4263.1	B08		2	0134-0275	830.69	275.44	266	59.94	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2351.2	B08		2	0135-0277	718.89	277.48	276	60.77	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1920.0	B08		2	0136-0281	935.66	281.24	230	56.28	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1427.2	B08		2	0137-0286	67.07	286.17	261	64.18	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3079.5	B08		2	0138-0280	280.48	280.84	127	40.97	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1445.3	B08		2	0139-0289	85.91	287.86	217	55.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2584.1	B08		2	0140-0289	152.32	289.26	336	71.84	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2271.2	B08		2	0141-0293	537.38	292.84	374	74.18	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			557.2	B08		2	0142-0292	678.60	291.79	270	61.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1828.4	B08		2	0143-0296	882.82	296.27	234	59.11	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2989.9	B08		2	0144-0293	280.31	292.82	140	42.63	0.968
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3981.3	B08		2	0145-0298	40.65	298.33	181	49.94	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2563.4	B08		2	0146-0298	168.05	298.25	178	50.04	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1999.6	B08		2	0147-0303	768.05	302.95	314	67.84	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1074.9	B08		2	0148-0306	818.96	306.25	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2562.5	B08		2	0149-0306	550.67	305.06	341	76.67	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3232.4	B08		2	0150-0306	208.60	307.31	266	62.53	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1787.3	B08		2	0151-0311	33.99	311.18	233	60.18	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1861.5	B08		2	0152-0309	289.20	309.28	199	53.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3073.6	B08		2	0153-0312	18.54	312.73	229	55.70	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2682.3	B08		2	0154-0314	258.62	313.18	237	56.77	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3929.8	B08		2	0155-0313	347.76	313.31	209	54.04	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3534.7	B08		2	0156-0312	363.62	311.97	194	53.46	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2881.5	B08		2	0157-0321	490.22	320.56	399	77.84	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1857.2	B08		2	0158-0323	747.11	323.03	315	69.60	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1412.9	B08		2	0159-0324	590.58	323.80	257	62.28	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4002.6	B08		2	0160-0325	105.60	325.09	308	65.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2287.6	B08		2	0161-0327	604.71	327.85	195	52.63	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3020.1	B08		2	0162-0330	370.30	330.08	241	59.36	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3091.2	B08		2	0163-0331	246.12	331.06	328	68.77	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2706.4	B08		2	0164-0335	620.25	335.80	228	57.94	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1341.6	B08		2	0165-0338	914.11	337.65	337	69.26	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1533.3	B08		2	0166-0335	393.51	335.78	105	38.63	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			5145.5	B08		2	0167-0337	227.09	336.83	153	45.11	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1714.4	B08		2	0168-0339	382.31	339.19	161	47.46	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2327.0	B08		2	0169-0342	57.86	342.30	285	70.77	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2123.8	B08		2	0170-0343	99.70	343.97	255	59.94	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1693.7	B08		2	0171-0346	464.96	346.86	304	68.77	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1662.9	B08		2	0172-0350	422.90	350.26	367	74.43	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1721.4	B08		2	0173-0355	124.11	355.02	258	62.67	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1910.0	B08		2	0174-0361	929.03	360.97	564	97.98	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1895.8	B08		2	0175-0356	543.50	355.84	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3001.8	B08		2	0176-0356	230.26	356.87	241	58.28	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2803.0	B08		2	0177-0359	656.85	359.38	304	65.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2536.9	B08		2	0178-0360	177.76	360.20	279	62.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2683.4	B08		2	0179-0359	626.60	359.51	217	54.28	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2027.1	B08		2	0180-0362	749.40	362.25	293	65.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			618.9	B08		2	0181-0365	65.16	364.96	220	57.94	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2634.4	B08		2	0182-0361	295.52	360.80	227	58.87	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3914.2	B08		2	0183-0367	321.79	367.32	204	54.53	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2561.8	B08		2	0184-0372	494.01	372.56	361	73.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2093.3	B08		2	0185-0380	438.30	380.98	434	80.33	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3272.4	B08		2	0186-0377	680.65	377.04	328	67.70	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1526.5	B08		2	0187-0378	885.68	377.64	448	79.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2353.5	B08		2	0188-0377	155.27	378.24	193	51.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3244.0	B08		2	0189-0382	203.77	382.92	217	64.08	0.664
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2160.2	B08		2	0190-0383	47.43	383.61	293	65.84	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1454.8	B08		2	0191-0389	360.18	390.60	317	79.84	0.625
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2038.9	B08		2	0192-0383	725.92	383.52	256	62.28	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3873.0	B08		2	0193-0393	183.07	392.87	351	71.84	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4559.5	B08		2	0194-0395	779.94	395.27	248	57.36	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2364.6	B08		2	0195-0398	88.89	398.15	280	63.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1181.2	B08		2	0196-0404	140.56	404.60	305	65.36	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			600.8	B08		2	0197-0408	229.43	408.85	175	51.70	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1372.2	B08		2	0198-0413	464.92	411.27	358	79.84	0.706
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1513.4	B08		2	0199-0413	926.13	412.15	263	61.70	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			792.4	B08		2	0200-0412	870.18	412.74	200	51.70	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2018.8	B08		2	0201-0419	156.19	419.70	250	65.36	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1646.2	B08		2	0202-0419	668.32	417.98	380	76.67	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2265.3	B08		2	0203-0421	113.25	420.36	310	69.84	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1293.8	B08		2	0204-0421	619.70	420.79	195	53.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1390.7	B08		2	0205-0422	731.26	421.55	354	80.91	0.680
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3240.7	B08		2	0206-0422	58.16	422.39	308	66.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1612.2	B08		2	0207-0424	694.88	425.02	328	69.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			533.2	B08		2	0208-0430	509.50	430.00	397	78.67	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2082.1	B08		2	0209-0430	238.31	430.70	262	64.43	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1861.5	B08		2	0210-0434	99.29	433.29	399	81.74	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3517.4	B08		2	0211-0432	192.14	432.66	306	64.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2338.6	B08		2	0212-0433	630.83	432.85	278	61.60	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1665.2	B08		2	0213-0434	768.89	433.81	220	57.46	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1688.2	B08		2	0214-0435	782.32	434.83	214	54.63	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2115.5	B08		2	0215-0442	809.55	442.16	233	61.11	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1432.8	B08		2	0216-0443	32.31	443.20	349	69.01	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1594.4	B08		2	0217-0446	937.21	447.18	437	81.26	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1857.9	B08		2	0218-0440	881.26	440.24	239	59.11	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2270.2	B08		2	0219-0442	399.14	441.87	294	65.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2584.8	B08		2	0220-0443	117.82	442.56	192	53.11	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1556.5	B08		2	0221-0451	573.60	451.88	375	84.08	0.667
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1888.4	B08		2	0222-0455	172.70	455.66	538	97.15	0.716
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1789.6	B08		2	0223-0447	159.35	447.29	107	39.11	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1714.3	B08		2	0224-0452	504.40	453.06	294	70.43	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3932.7	B08		2	0225-0451	248.87	451.17	219	59.70	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1395.0	B08		2	0226-0460	434.28	461.51	361	74.91	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1499.9	B08		2	0227-0453	465.39	453.60	198	58.63	0.724
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1813.3	B08		2	0228-0457	762.01	457.02	269	63.36	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2767.5	B08		2	0229-0458	127.88	457.68	242	60.18	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3852.1	B08		2	0230-0458	310.68	458.39	250	59.11	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2157.1	B08		2	0231-0464	534.43	464.78	362	73.84	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2721.4	B08		2	0232-0465	15.86	463.09	121	65.11	0.359
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2487.9	B08		2	0233-0469	221.42	470.41	351	69.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2856.1	B08		2	0234-0470	858.17	471.00	295	63.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1660.3	B08		2	0235-0474	776.93	473.51	149	46.87	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2015.0	B08		2	0236-0481	32.34	481.04	295	63.36	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2543.7	B08		2	0237-0480	596.84	479.91	259	59.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2916.2	B08		2	0238-0481	712.94	481.18	237	56.28	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			692.8	B08		2	0239-0481	811.78	481.81	243	57.36	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1815.1	B08		2	0240-0482	346.62	482.36	157	46.87	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1768.9	B08		2	0241-0485	334.30	485.46	209	58.04	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			732.1	B08		2	0242-0487	401.77	486.60	330	85.98	0.561
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2890.6	B08		2	0243-0484	794.52	484.85	134	44.04	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1618.2	B08		2	0244-0490	268.59	489.77	219	55.70	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1643.5	B08		2	0245-0495	739.34	495.18	514	90.91	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			394.2	B08		2	0246-0489	873.21	488.82	152	47.70	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2402.9	B08		2	0247-0496	912.94	496.14	442	88.57	0.708
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1328.4	B08		2	0248-0498	569.45	497.41	356	72.77	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2231.4	B08		2	0249-0496	153.46	496.54	305	63.36	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3064.2	B08		2	0250-0496	181.71	495.69	317	65.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1922.2	B08		2	0251-0495	689.16	495.01	254	63.36	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			400.0	B08		2	0252-0495	883.61	495.94	150	46.28	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1861.8	B08		2	0253-0508	654.92	508.22	408	73.94	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2828.3	B08		2	0254-0509	417.01	509.34	242	57.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2178.3	B08		2	0255-0512	221.16	512.13	295	65.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2147.9	B08		2	0256-0512	503.00	512.88	347	68.18	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			418.7	B08		2	0257-0517	108.91	517.87	304	71.26	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2203.6	B08		2	0258-0518	598.24	518.38	446	79.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2323.8	B08		2	0259-0519	266.95	518.57	261	62.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1229.6	B08		2	0260-0516	810.10	516.24	257	60.53	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1271.7	B08		2	0261-0516	901.90	515.64	216	56.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1878.4	B08		2	0262-0520	54.58	519.61	347	69.26	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3155.5	B08		2	0263-0517	693.80	518.29	260	60.28	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1689.0	B08		2	0264-0524	26.70	524.17	391	76.77	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			976.7	B08		2	0265-0524	292.11	523.96	313	66.18	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			344.1	B08		2	0266-0527	129.44	527.45	284	64.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2384.7	B08		2	0267-0528	464.51	528.09	334	68.08	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1889.3	B08		2	0268-0527	331.11	526.84	215	55.94	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1762.5	B08		2	0269-0529	767.18	529.22	288	65.11	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1345.6	B08		2	0270-0535	741.89	534.71	357	70.08	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1630.2	B08		2	0271-0534	170.99	534.05	301	68.77	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1405.1	B08		2	0272-0534	898.09	534.73	223	54.77	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3753.3	B08		2	0273-0537	371.82	537.32	366	71.01	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2245.5	B08		2	0274-0537	692.61	537.02	392	78.18	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			695.8	B08		2	0275-0539	311.64	538.90	281	63.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			349.9	B08		2	0276-0540	807.08	541.01	261	62.53	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			621.2	B08		2	0277-0547	92.38	547.24	225	55.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			590.6	B08		2	0278-0551	216.53	551.61	221	54.28	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3202.6	B08		2	0279-0554	258.15	553.87	246	59.11	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			360.6	B08		2	0280-0553	701.75	552.83	276	66.43	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1789.2	B08		2	0281-0560	189.67	560.55	376	75.36	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			599.4	B08		2	0282-0556	419.16	556.52	241	76.67	0.515
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2393.8	B08		2	0283-0557	573.40	556.84	232	56.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2426.9	B08		2	0284-0561	395.29	560.88	517	89.84	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1313.0	B08		2	0285-0557	489.28	557.20	298	73.60	0.691
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3991.9	B08		2	0286-0561	684.81	560.97	284	62.53	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1502.4	B08		2	0287-0563	53.34	564.04	254	64.77	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2440.4	B08		2	0288-0564	34.75	564.91	277	61.11	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1543.8	B08		2	0289-0564	800.42	563.66	262	62.43	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1888.1	B08		2	0290-0565	132.69	565.45	282	60.77	0.960
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3119.5	B08		2	0291-0569	298.45	569.75	305	66.77	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1361.1	B08		2	0292-0566	734.45	566.03	160	46.63	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1970.3	B08		2	0293-0572	546.80	572.13	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1164.2	B08		2	0294-0567	721.99	567.97	117	40.39	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3228.6	B08		2	0295-0569	337.10	569.57	268	62.77	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1144.0	B08		2	0296-0578	823.42	578.32	245	60.18	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1336.5	B08		2	0297-0576	861.26	576.46	224	58.77	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1480.3	B08		2	0298-0582	740.73	581.99	369	77.26	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			408.0	B08		2	0299-0583	563.98	583.98	248	59.46	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1716.7	B08		2	0300-0586	173.73	586.22	307	65.36	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2752.3	B08		2	0301-0583	658.97	583.84	245	57.11	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1765.5	B08		2	0302-0585	793.90	585.11	248	58.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			456.3	B08		2	0303-0590	227.90	590.27	281	63.11	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2895.9	B08		2	0304-0591	99.57	591.34	294	62.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2406.1	B08		2	0305-0593	505.03	593.37	339	69.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1066.0	B08		2	0306-0592	593.21	591.77	223	56.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1542.6	B08		2	0307-0597	133.78	597.69	338	71.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3204.1	B08		2	0308-0597	75.00	597.76	377	73.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1692.0	B08		2	0309-0598	764.49	598.03	268	61.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2792.3	B08		2	0310-0602	262.69	602.14	245	58.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1442.2	B08		2	0311-0603	370.78	603.27	328	68.53	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2459.2	B08		2	0312-0610	883.28	609.88	539	91.15	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3194.8	B08		2	0313-0609	585.95	609.56	224	57.01	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2157.3	B08		2	0314-0613	841.15	613.76	411	79.26	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2997.8	B08		2	0315-0612	936.63	612.62	227	55.94	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1413.7	B08		2	0316-0617	288.69	617.92	377	74.77	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1568.7	B08		2	0317-0614	609.59	615.13	257	63.60	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			453.4	B08		2	0318-0620	799.21	619.85	258	64.28	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2364.6	B08		2	0319-0620	96.60	619.31	283	61.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2423.1	B08		2	0320-0622	162.75	622.53	248	60.28	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3687.3	B08		2	0321-0633	664.99	632.93	460	84.43	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3956.6	B08		2	0322-0636	342.57	636.72	552	91.50	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3856.9	B08		2	0323-0632	681.91	632.43	285	65.94	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2158.7	B08		2	0324-0636	909.48	635.73	392	75.84	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1345.6	B08		2	0325-0637	212.47	637.09	316	74.08	0.724
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1150.8	B08		2	0326-0639	419.96	639.41	505	90.57	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2782.5	B08		2	0327-0635	300.04	635.24	160	46.87	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2564.8	B08		2	0328-0634	311.80	633.78	111	39.56	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3706.5	B08		2	0329-0639	774.09	638.73	357	70.43	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1107.5	B08		2	0330-0640	47.64	639.90	268	61.01	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1268.9	B08		2	0331-0644	575.29	645.64	468	86.33	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1996.7	B08		2	0332-0637	497.09	637.30	111	40.04	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2042.7	B08		2	0333-0645	364.75	645.34	289	61.94	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2330.5	B08		2	0334-0652	503.38	652.97	353	73.01	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			381.2	B08		2	0335-0651	433.80	651.83	219	56.77	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2860.6	B08		2	0336-0656	474.14	655.54	417	82.91	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			800.6	B08		2	0337-0653	132.62	653.87	156	47.21	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			661.5	B08		2	0338-0660	148.53	660.75	228	58.53	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2293.2	B08		2	0339-0665	873.42	665.35	320	67.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			620.2	B08		2	0340-0664	794.21	664.84	230	54.77	0.964
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2216.2	B08		2	0341-0664	345.09	664.25	223	59.70	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2487.9	B08		2	0342-0668	31.79	668.05	280	65.60	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			649.2	B08		2	0343-0666	133.65	665.65	163	48.04	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3703.0	B08		2	0344-0673	488.29	673.97	375	76.77	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3366.8	B08		2	0345-0677	471.11	677.26	388	79.26	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1952.5	B08		2	0346-0674	676.26	675.27	352	69.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1417.9	B08		2	0347-0682	833.49	682.02	319	71.60	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2642.8	B08		2	0348-0681	177.91	682.12	282	64.43	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2616.7	B08		2	0349-0684	536.57	684.33	210	54.28	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3400.4	B08		2	0350-0684	270.18	683.97	243	59.11	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3032.1	B08		2	0351-0692	297.50	692.96	233	58.53	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			434.5	B08		2	0352-0688	897.09	688.15	191	53.94	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1498.4	B08		2	0353-0692	388.37	692.13	236	57.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1723.3	B08		2	0354-0695	559.28	695.50	349	71.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1200.2	B08		2	0355-0695	83.03	695.50	268	60.53	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1023.9	B08		2	0356-0697	649.23	697.13	455	80.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3172.2	B08		2	0357-0696	766.83	695.63	319	67.01	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2304.1	B08		2	0358-0700	19.22	700.80	156	47.46	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1073.8	B08		2	0359-0704	105.76	704.14	283	68.08	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1684.0	B08		2	0360-0701	846.09	700.80	249	58.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3058.6	B08		2	0361-0702	620.75	701.43	199	53.11	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2216.2	B08		2	0362-0702	37.15	701.76	192	53.11	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2337.5	B08		2	0363-0704	937.46	703.67	299	63.84	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1460.5	B08		2	0364-0708	355.31	708.03	272	62.53	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2831.7	B08		2	0365-0708	207.17	708.01	325	66.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			958.4	B08		2	0366-0708	440.81	708.12	253	58.77	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			449.2	B08		2	0367-0710	121.34	709.93	207	56.53	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			320.2	B08		3	0001-0032	174.22	32.04	249	67.01	0.697
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1661.5	B08		3	0002-0031	771.20	30.98	281	63.11	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			472.4	B08		3	0003-0035	76.25	35.00	272	62.53	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1469.8	B08		3	0004-0037	608.80	37.00	478	85.15	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3487.5	B08		3	0005-0036	648.22	35.64	324	66.18	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1773.5	B08		3	0006-0041	489.76	40.64	488	83.98	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			412.8	B08		3	0007-0040	30.61	40.30	250	60.18	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2747.0	B08		3	0008-0043	704.69	44.35	231	60.87	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3547.4	B08		3	0009-0047	530.33	47.51	250	59.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2809.5	B08		3	0010-0054	456.56	54.71	277	61.36	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2667.8	B08		3	0011-0058	476.96	59.41	445	79.50	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2289.2	B08		3	0012-0058	93.16	59.16	330	67.36	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2562.0	B08		3	0013-0055	207.76	54.54	245	60.77	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1787.6	B08		3	0014-0057	753.82	57.12	256	65.70	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3165.3	B08		3	0015-0060	911.18	59.84	358	69.01	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2795.8	B08		3	0016-0062	426.79	61.94	262	59.84	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1916.0	B08		3	0017-0064	817.54	63.85	291	69.60	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2776.6	B08		3	0018-0062	151.02	62.27	218	57.36	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2265.2	B08		3	0019-0063	563.29	63.40	270	65.01	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2534.8	B08		3	0020-0064	397.98	64.32	303	69.70	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3012.4	B08		3	0021-0069	373.29	69.18	358	74.43	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2635.0	B08		3	0022-0070	444.27	70.30	315	71.01	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2182.2	B08		3	0023-0071	685.11	71.36	324	67.36	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2988.3	B08		3	0024-0071	26.79	71.61	292	63.94	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3425.2	B08		3	0025-0078	63.72	77.41	368	76.08	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2550.9	B08		3	0026-0077	152.86	78.01	324	68.18	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2237.9	B08		3	0027-0076	180.82	77.29	251	61.01	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2313.0	B08		3	0028-0084	869.55	83.92	383	84.18	0.679
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3629.6	B08		3	0029-0081	349.15	80.59	353	70.18	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2393.4	B08		3	0030-0079	97.96	78.72	198	53.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2529.2	B08		3	0031-0081	595.59	80.53	323	70.18	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			658.0	B08		3	0032-0080	291.88	80.04	261	59.60	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			399.2	B08		3	0033-0079	750.97	79.77	269	64.43	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			674.2	B08		3	0034-0082	330.41	82.15	181	54.63	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1701.7	B08		3	0035-0087	940.87	86.52	272	61.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2448.8	B08		3	0036-0088	373.60	88.65	217	53.36	0.958
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2705.6	B08		3	0037-0092	638.43	92.74	241	59.60	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1911.4	B08		3	0038-0091	398.46	91.50	215	55.36	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2266.8	B08		3	0039-0093	565.31	92.96	263	62.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1879.0	B08		3	0040-0098	497.76	98.43	517	84.08	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2355.2	B08		3	0041-0094	191.15	94.77	294	63.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2829.5	B08		3	0042-0099	838.70	99.71	305	67.36	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2264.0	B08		3	0043-0098	448.56	98.24	272	63.01	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2264.9	B08		3	0044-0099	241.85	98.73	246	58.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1657.6	B08		3	0045-0103	791.31	103.40	351	70.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2547.9	B08		3	0046-0107	332.07	106.69	355	72.18	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1325.1	B08		3	0047-0105	545.14	104.91	297	63.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1603.3	B08		3	0048-0109	816.08	108.63	189	55.36	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2995.1	B08		3	0049-0110	101.79	110.50	272	61.60	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3295.8	B08		3	0050-0111	216.70	110.96	304	65.01	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1080.9	B08		3	0051-0111	413.08	111.64	277	62.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3379.6	B08		3	0052-0114	920.64	114.63	335	66.77	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3440.3	B08		3	0053-0117	699.14	116.59	301	64.18	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			751.2	B08		3	0054-0123	493.78	122.81	262	60.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			791.1	B08		3	0055-0125	27.26	124.27	249	74.91	0.558
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2114.4	B08		3	0056-0124	546.77	125.24	276	65.01	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2406.1	B08		3	0057-0125	448.58	125.20	208	55.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1243.3	B08		3	0058-0133	739.38	133.47	362	84.67	0.635
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2335.4	B08		3	0059-0131	145.90	131.35	332	68.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1679.1	B08		3	0060-0134	207.45	132.73	501	95.74	0.687
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2383.2	B08		3	0061-0135	350.90	134.26	255	58.77	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2142.2	B08		3	0062-0136	872.25	136.23	326	66.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2357.9	B08		3	0063-0136	625.52	136.69	299	63.11	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2568.1	B08		3	0064-0147	169.60	147.13	413	77.50	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1657.4	B08		3	0065-0144	487.88	143.45	271	61.60	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3189.4	B08		3	0066-0143	536.82	142.94	241	59.36	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3187.6	B08		3	0067-0146	275.38	145.38	227	58.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2713.7	B08		3	0068-0147	28.95	147.38	243	58.18	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3502.7	B08		3	0069-0153	309.34	153.10	345	69.84	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3170.8	B08		3	0070-0156	204.86	155.46	204	92.81	0.298
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2762.4	B08		3	0071-0156	387.05	156.20	257	60.53	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2087.7	B08		3	0072-0155	469.56	155.29	230	58.77	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1883.9	B08		3	0073-0154	646.67	152.89	117	43.11	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			557.8	B08		3	0074-0160	722.52	160.55	319	75.50	0.703
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2134.1	B08		3	0075-0159	637.21	159.56	218	57.60	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3023.7	B08		3	0076-0159	779.82	159.08	225	56.28	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2032.4	B08		3	0077-0162	914.86	162.86	346	71.84	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2698.8	B08		3	0078-0167	815.28	167.59	368	75.60	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3060.0	B08		3	0079-0169	271.03	171.52	394	86.33	0.664
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2330.6	B08		3	0080-0168	751.03	167.95	468	85.15	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			587.4	B08		3	0081-0169	186.94	169.00	201	54.53	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2763.9	B08		3	0082-0167	695.55	166.22	183	51.94	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			541.1	B08		3	0083-0170	509.31	169.78	270	61.94	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3701.5	B08		3	0084-0175	838.62	175.55	367	82.08	0.684
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2113.8	B08		3	0085-0171	483.51	171.08	214	55.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2844.2	B08		3	0086-0172	684.74	173.33	136	44.53	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3260.4	B08		3	0087-0178	314.28	178.44	403	76.33	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1012.3	B08		3	0088-0177	66.17	177.18	206	53.70	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2478.7	B08		3	0089-0177	102.73	176.82	203	53.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1953.4	B08		3	0090-0179	253.70	178.90	239	63.60	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2647.6	B08		3	0091-0179	554.12	179.02	349	69.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3699.0	B08		3	0092-0179	444.19	179.66	221	53.11	0.984
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3055.6	B08		3	0093-0183	621.51	182.60	365	70.18	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2190.7	B08		3	0094-0185	210.48	185.09	250	60.18	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2140.5	B08		3	0095-0190	876.28	190.12	404	75.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2071.2	B08		3	0096-0188	297.16	188.57	244	58.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2792.1	B08		3	0097-0188	370.51	188.18	292	67.60	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2019.3	B08		3	0098-0188	48.45	188.21	160	46.87	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3132.3	B08		3	0099-0191	339.92	191.37	276	61.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2085.0	B08		3	0100-0196	594.81	196.46	314	68.18	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2360.6	B08		3	0101-0199	914.47	198.34	298	66.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2084.6	B08		3	0102-0199	146.75	199.92	273	65.84	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2073.1	B08		3	0103-0202	173.10	202.21	303	65.84	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1797.6	B08		3	0104-0201	280.82	200.74	205	55.11	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3651.7	B08		3	0105-0203	402.51	203.32	287	61.94	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4393.5	B08		3	0106-0203	628.31	203.10	297	63.01	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			871.1	B08		3	0107-0204	366.33	204.23	184	51.11	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2094.5	B08		3	0108-0207	37.62	206.55	290	63.70	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2804.0	B08		3	0109-0207	893.74	207.76	249	60.43	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2408.0	B08		3	0110-0207	239.23	207.31	240	58.77	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			930.2	B08		3	0111-0208	948.07	208.67	267	60.43	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2534.4	B08		3	0112-0208	75.39	208.20	233	55.94	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			475.6	B08		3	0113-0209	551.99	209.65	257	59.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			542.8	B08		3	0114-0215	332.77	214.78	256	62.18	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2648.2	B08		3	0115-0220	115.19	220.15	386	74.43	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3255.0	B08		3	0116-0222	660.54	222.51	396	76.43	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1222.7	B08		3	0117-0219	850.80	219.39	168	53.36	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1662.1	B08		3	0118-0219	712.14	219.64	223	54.28	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1983.4	B08		3	0119-0221	286.32	222.07	258	61.01	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2075.7	B08		3	0120-0221	794.26	222.20	231	66.43	0.658
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4444.9	B08		3	0121-0224	354.14	224.73	337	69.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1193.4	B08		3	0122-0224	369.58	223.65	158	48.87	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2694.8	B08		3	0123-0227	613.88	227.23	233	58.28	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2765.4	B08		3	0124-0231	675.39	231.75	274	66.77	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3260.8	B08		3	0125-0237	219.89	236.54	310	68.18	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1189.0	B08		3	0126-0234	892.81	234.08	245	57.94	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4232.7	B08		3	0127-0238	828.42	238.70	314	66.18	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2017.2	B08		3	0128-0240	750.33	241.09	427	77.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2572.6	B08		3	0129-0243	411.02	244.58	306	68.18	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2478.2	B08		3	0130-0240	546.09	240.52	318	66.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			5685.1	B08		3	0131-0244	566.82	244.27	300	64.18	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2821.7	B08		3	0132-0242	609.87	242.66	240	57.11	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1332.6	B08		3	0133-0246	923.15	246.57	256	64.18	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2041.4	B08		3	0134-0246	28.55	246.73	236	58.04	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2290.8	B08		3	0135-0247	204.55	247.05	275	63.94	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1263.9	B08		3	0136-0246	363.41	246.31	316	80.08	0.619
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1365.3	B08		3	0137-0249	494.35	248.84	250	59.26	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2707.1	B08		3	0138-0250	706.94	250.18	191	58.77	0.695
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			371.9	B08		3	0139-0256	100.15	256.98	240	66.53	0.681
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1837.5	B08		3	0140-0254	524.48	253.29	231	58.77	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1474.0	B08		3	0141-0252	723.12	252.69	191	51.11	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			624.7	B08		3	0142-0256	140.11	256.38	229	57.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1030.1	B08		3	0143-0257	158.04	257.32	212	57.36	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1698.4	B08		3	0144-0254	74.64	253.97	230	58.28	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1688.6	B08		3	0145-0256	307.56	255.86	206	54.28	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1866.1	B08		3	0146-0258	260.05	258.96	250	60.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1450.0	B08		3	0147-0265	589.80	263.58	278	65.94	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2190.4	B08		3	0148-0264	29.42	263.98	343	71.94	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1351.2	B08		3	0149-0269	464.95	269.24	284	64.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			620.4	B08		3	0150-0269	534.17	268.97	227	55.94	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2934.8	B08		3	0151-0271	775.21	271.35	302	65.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1612.0	B08		3	0152-0270	794.95	271.04	250	58.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			384.0	B08		3	0153-0275	631.78	274.75	307	69.60	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1851.1	B08		3	0154-0278	240.09	278.70	298	65.01	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3961.7	B08		3	0155-0278	841.64	278.32	175	52.18	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			362.4	B08		3	0156-0281	88.55	280.69	227	57.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2148.2	B08		3	0157-0279	735.63	279.66	312	67.01	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			751.6	B08		3	0158-0283	395.38	282.92	275	65.01	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1601.0	B08		3	0159-0286	274.36	287.66	322	67.60	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1929.3	B08		3	0160-0284	30.22	284.54	225	56.53	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1106.8	B08		3	0161-0286	122.17	287.01	279	63.60	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2316.7	B08		3	0162-0291	459.86	291.26	412	79.26	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3308.5	B08		3	0163-0287	941.61	287.60	362	71.60	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1587.1	B08		3	0164-0287	359.90	286.65	248	65.26	0.732
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2393.2	B08		3	0165-0289	160.78	289.29	255	58.53	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2389.3	B08		3	0166-0289	181.17	289.44	248	59.36	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1658.0	B08		3	0167-0292	833.48	292.34	404	76.67	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			857.2	B08		3	0168-0290	660.97	290.34	213	55.11	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2328.0	B08		3	0169-0292	813.19	291.83	258	64.18	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1112.7	B08		3	0170-0296	420.18	296.51	238	58.28	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2322.1	B08		3	0171-0295	676.56	294.96	235	58.28	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2095.1	B08		3	0172-0301	925.83	300.69	304	66.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2791.1	B08		3	0173-0301	883.05	301.44	343	68.43	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2166.7	B08		3	0174-0301	219.00	301.60	201	56.18	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2649.2	B08		3	0175-0309	106.17	309.78	331	67.84	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2135.5	B08		3	0176-0311	136.06	311.08	235	57.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			299.6	B08		3	0177-0315	459.87	315.36	306	67.84	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4144.2	B08		3	0178-0315	584.40	314.75	368	70.53	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2473.9	B08		3	0179-0316	734.41	316.36	369	73.84	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			530.0	B08		3	0180-0316	187.10	316.32	224	54.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2319.3	B08		3	0181-0318	254.15	318.24	231	57.94	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1475.7	B08		3	0182-0318	651.34	318.24	294	63.94	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1858.3	B08		3	0183-0323	410.89	322.62	364	73.84	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3770.0	B08		3	0184-0329	875.26	329.64	266	60.18	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1892.8	B08		3	0185-0328	286.92	328.69	215	53.70	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			389.8	B08		3	0186-0335	804.34	336.40	317	70.67	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2299.6	B08		3	0187-0334	360.46	334.07	193	51.11	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2562.3	B08		3	0188-0335	387.43	335.21	269	61.36	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			396.4	B08		3	0189-0335	536.82	335.92	294	64.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3145.9	B08		3	0190-0335	204.81	335.14	228	55.11	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2308.7	B08		3	0191-0338	650.73	337.72	323	67.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1758.7	B08		3	0192-0339	346.72	339.63	174	52.28	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2509.3	B08		3	0193-0341	725.24	341.64	215	54.28	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2485.1	B08		3	0194-0346	243.63	345.99	277	63.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2329.8	B08		3	0195-0345	317.67	345.39	210	58.77	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2269.7	B08		3	0196-0343	107.28	343.76	273	64.18	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			893.0	B08		3	0197-0344	608.80	343.82	285	64.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2213.6	B08		3	0198-0353	291.95	352.69	379	72.43	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1764.8	B08		3	0199-0354	331.61	354.07	229	56.87	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2396.7	B08		3	0200-0355	425.40	355.58	273	62.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2737.0	B08		3	0201-0355	828.37	355.45	372	72.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2908.3	B08		3	0202-0356	19.52	356.46	186	52.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2248.4	B08		3	0203-0358	179.96	357.71	224	55.70	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1379.4	B08		3	0204-0356	347.30	355.98	226	56.87	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2326.5	B08		3	0205-0356	452.60	356.90	253	59.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3562.9	B08		3	0206-0359	402.75	359.21	322	65.94	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2693.6	B08		3	0207-0355	684.95	355.37	203	55.70	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			429.0	B08		3	0208-0357	483.80	358.09	169	51.11	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1908.6	B08		3	0209-0358	112.39	358.32	148	45.46	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1279.5	B08		3	0210-0367	589.51	368.23	600	167.82	0.268
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2713.5	B08		3	0211-0365	513.79	364.74	343	70.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			628.3	B08		3	0212-0362	928.13	361.92	149	49.70	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2072.0	B08		3	0213-0365	165.18	365.39	230	59.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1403.8	B08		3	0214-0369	26.07	370.68	286	71.01	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2229.8	B08		3	0215-0367	315.45	367.37	307	66.43	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3165.0	B08		3	0216-0367	651.27	367.38	319	68.18	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2453.5	B08		3	0217-0371	910.25	370.76	309	70.43	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2615.7	B08		3	0218-0371	875.06	370.77	305	66.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1664.2	B08		3	0219-0371	374.83	371.79	255	60.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2386.9	B08		3	0220-0374	263.29	374.75	348	71.26	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			580.6	B08		3	0221-0377	712.73	377.14	273	63.36	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			505.1	B08		3	0222-0379	762.43	379.09	281	65.01	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2134.3	B08		3	0223-0379	841.85	379.72	226	58.77	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1803.8	B08		3	0224-0379	147.84	379.00	276	64.77	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1863.0	B08		3	0225-0383	54.65	383.69	298	68.18	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2427.1	B08		3	0226-0382	546.20	382.45	304	65.36	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2098.3	B08		3	0227-0383	352.41	382.21	226	57.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2196.7	B08		3	0228-0382	503.03	382.35	258	60.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1671.8	B08		3	0229-0382	89.21	382.66	219	53.70	0.954
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			727.0	B08		3	0230-0384	103.89	384.05	200	57.11	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1889.8	B08		3	0231-0384	685.58	384.47	259	60.28	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2480.0	B08		3	0232-0389	133.82	389.88	204	54.18	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2191.8	B08		3	0233-0392	335.87	392.05	229	61.11	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3139.3	B08		3	0234-0397	943.98	397.69	349	70.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			488.3	B08		3	0235-0396	248.74	396.06	266	64.77	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2767.4	B08		3	0236-0399	358.81	399.31	264	63.01	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1267.1	B08		3	0237-0396	400.64	395.69	284	70.77	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2307.4	B08		3	0238-0401	869.31	401.46	353	70.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			777.0	B08		3	0239-0399	477.95	398.80	152	47.46	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1101.1	B08		3	0240-0400	688.60	398.59	162	49.70	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1257.8	B08		3	0241-0409	450.59	409.76	472	81.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			976.1	B08		3	0242-0406	677.98	406.95	201	54.43	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1256.9	B08		3	0243-0410	59.30	410.76	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2055.9	B08		3	0244-0410	326.43	410.31	290	64.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1576.6	B08		3	0245-0411	187.48	411.62	229	59.01	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2026.2	B08		3	0246-0411	814.94	410.92	258	64.18	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1323.4	B08		3	0247-0413	918.78	412.65	255	61.01	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2667.2	B08		3	0248-0420	645.90	419.43	683	107.30	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1564.2	B08		3	0249-0418	594.22	418.68	419	80.33	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1686.0	B08		3	0250-0418	709.45	418.12	500	89.98	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1450.7	B08		3	0251-0416	20.37	415.64	244	59.36	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			458.2	B08		3	0252-0418	237.53	417.22	230	59.01	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2394.6	B08		3	0253-0418	369.35	417.47	296	64.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2054.0	B08		3	0254-0418	210.59	417.84	204	54.77	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2591.7	B08		3	0255-0419	164.81	418.96	326	69.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3383.6	B08		3	0256-0421	283.97	421.68	294	63.01	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2873.8	B08		3	0257-0425	308.25	424.38	257	60.53	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1828.3	B08		3	0258-0428	786.09	428.42	228	56.77	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1981.2	B08		3	0259-0425	862.34	425.22	116	41.21	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			776.2	B08		3	0260-0432	503.87	432.37	225	59.60	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1344.1	B08		3	0261-0435	408.07	435.04	291	69.60	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2084.5	B08		3	0262-0437	862.54	437.07	128	41.80	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2037.6	B08		3	0263-0442	807.62	442.76	329	75.26	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1903.5	B08		3	0264-0443	888.83	442.33	332	69.26	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2403.5	B08		3	0265-0443	531.39	443.83	328	67.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1546.8	B08		3	0266-0450	31.80	450.55	432	79.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			623.9	B08		3	0267-0449	933.81	450.02	256	61.11	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2308.7	B08		3	0268-0451	72.30	451.27	263	62.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			828.8	B08		3	0269-0453	371.01	453.85	319	68.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2351.3	B08		3	0270-0451	699.44	451.53	254	59.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			931.1	B08		3	0271-0455	185.28	455.49	283	65.01	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1536.1	B08		3	0272-0453	247.81	453.68	216	55.11	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1847.2	B08		3	0273-0455	748.33	454.75	174	50.63	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1657.3	B08		3	0274-0454	759.92	453.92	166	49.80	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			705.3	B08		3	0275-0454	508.66	454.74	219	59.36	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3677.4	B08		3	0276-0459	681.14	458.94	406	74.67	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			399.9	B08		3	0277-0458	140.86	458.00	306	64.77	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2025.2	B08		3	0278-0458	447.06	457.61	270	62.18	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			603.5	B08		3	0279-0458	311.78	458.48	236	58.18	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2665.7	B08		3	0280-0461	92.82	461.21	289	63.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1730.9	B08		3	0281-0466	276.12	465.89	268	62.77	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1928.2	B08		3	0282-0466	422.12	466.59	247	57.94	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			521.8	B08		3	0283-0469	324.75	469.28	258	60.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2069.0	B08		3	0284-0469	295.54	469.85	274	61.94	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3395.7	B08		3	0285-0473	383.72	473.38	260	61.01	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1853.9	B08		3	0286-0472	836.60	472.36	236	57.11	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2521.2	B08		3	0287-0476	177.39	476.77	357	72.33	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			622.7	B08		3	0288-0474	697.65	474.06	246	57.94	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4000.7	B08		3	0289-0476	722.76	476.66	332	68.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2092.8	B08		3	0290-0475	259.18	475.33	251	59.70	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			882.2	B08		3	0291-0478	204.42	479.05	212	56.77	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1643.1	B08		3	0292-0480	771.22	479.94	365	75.01	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2156.7	B08		3	0293-0480	363.30	480.13	231	56.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			556.5	B08		3	0294-0480	560.68	479.96	209	59.46	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2349.1	B08		3	0295-0484	501.01	484.07	285	62.53	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2133.2	B08		3	0296-0487	51.52	486.82	251	61.70	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2166.8	B08		3	0297-0486	616.39	487.05	226	56.53	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2238.4	B08		3	0298-0487	342.67	487.35	238	57.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			424.8	B08		3	0299-0488	826.68	488.29	293	62.77	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1880.3	B08		3	0300-0490	596.29	489.20	265	63.60	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3584.1	B08		3	0301-0495	558.65	494.36	331	69.94	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			795.9	B08		3	0302-0502	582.49	500.85	221	60.77	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1478.6	B08		3	0303-0500	808.99	500.75	139	45.70	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1601.6	B08		3	0304-0506	271.95	507.29	292	65.36	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3768.4	B08		3	0305-0506	197.87	506.15	325	67.94	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2059.0	B08		3	0306-0504	326.24	504.30	201	54.53	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1989.1	B08		3	0307-0506	749.41	506.57	218	54.87	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2593.0	B08		3	0308-0512	233.99	511.86	404	77.84	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1817.5	B08		3	0309-0508	309.33	507.70	254	59.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2290.8	B08		3	0310-0512	409.95	512.07	328	68.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1790.0	B08		3	0311-0512	920.21	511.04	368	74.43	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1829.9	B08		3	0312-0511	945.71	510.79	299	69.01	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2205.3	B08		3	0313-0513	162.91	512.93	234	55.70	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1459.3	B08		3	0314-0519	641.88	518.69	471	82.08	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1222.7	B08		3	0315-0518	433.87	518.13	300	65.60	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1564.0	B08		3	0316-0515	807.92	515.37	204	53.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2600.3	B08		3	0317-0516	879.29	515.82	275	62.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2284.6	B08		3	0318-0520	468.34	519.83	387	74.18	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1264.1	B08		3	0319-0525	92.32	525.27	242	61.94	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2330.0	B08		3	0320-0528	892.42	527.57	242	59.94	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1864.2	B08		3	0321-0534	563.20	534.52	290	64.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2030.3	B08		3	0322-0538	930.82	537.99	358	70.43	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1081.2	B08		3	0323-0544	338.86	544.18	447	80.08	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2712.7	B08		3	0324-0543	615.93	543.94	313	68.87	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1993.4	B08		3	0325-0545	291.44	545.26	385	74.91	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3379.1	B08		3	0326-0543	687.91	543.10	258	62.43	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			387.4	B08		3	0327-0542	802.99	542.92	224	57.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1600.4	B08		3	0328-0547	65.80	547.79	283	70.53	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1811.3	B08		3	0329-0545	519.42	545.54	393	73.26	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1572.2	B08		3	0330-0548	752.79	547.78	327	67.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			467.5	B08		3	0331-0547	817.45	547.43	200	54.28	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2349.8	B08		3	0332-0555	168.11	555.12	253	58.53	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2507.3	B08		3	0333-0554	206.92	554.21	165	48.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2238.0	B08		3	0334-0557	241.60	557.24	219	55.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			695.7	B08		3	0335-0558	680.32	558.84	172	50.04	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3137.6	B08		3	0336-0560	260.65	560.75	258	60.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1243.5	B08		3	0337-0560	437.42	560.49	282	66.18	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1727.4	B08		3	0338-0561	383.72	561.24	199	52.28	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1371.4	B08		3	0339-0564	908.31	563.81	257	60.77	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2443.0	B08		3	0340-0563	362.71	562.57	209	53.11	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2342.9	B08		3	0341-0565	113.81	566.31	220	55.70	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3303.9	B08		3	0342-0563	560.33	563.84	161	49.21	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2697.3	B08		3	0343-0574	707.12	574.45	382	76.18	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			981.6	B08		3	0344-0567	729.32	567.42	211	56.87	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			793.6	B08		3	0345-0577	307.82	577.16	266	66.18	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1869.5	B08		3	0346-0574	484.36	573.74	284	64.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1639.5	B08		3	0347-0578	839.35	579.04	248	60.53	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2689.2	B08		3	0348-0574	557.43	574.80	134	51.70	0.630
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1648.0	B08		3	0349-0579	81.38	579.01	225	56.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1856.1	B08		3	0350-0583	166.37	583.62	332	67.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3026.6	B08		3	0351-0583	187.26	583.22	278	61.46	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1815.7	B08		3	0352-0587	388.61	587.01	346	70.91	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3901.1	B08		3	0353-0587	584.27	587.10	318	81.50	0.602
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3535.4	B08		3	0354-0584	877.49	584.68	133	42.87	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1863.4	B08		3	0355-0588	898.46	588.43	311	67.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2188.7	B08		3	0356-0589	350.30	589.33	209	55.94	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3591.8	B08		3	0357-0588	862.60	588.17	134	44.28	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2241.2	B08		3	0358-0597	844.23	597.76	370	74.67	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1700.9	B08		3	0359-0594	253.57	593.03	169	49.36	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2094.1	B08		3	0360-0595	633.32	595.37	269	61.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1798.4	B08		3	0361-0598	524.68	598.04	293	62.77	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1704.5	B08		3	0362-0599	764.00	599.49	279	73.50	0.649
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1624.6	B08		3	0363-0604	126.58	605.15	339	68.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1837.5	B08		3	0364-0601	263.36	601.01	180	52.77	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1030.3	B08		3	0365-0605	322.60	606.03	261	62.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			412.1	B08		3	0366-0602	426.77	602.43	267	62.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2871.8	B08		3	0367-0605	554.18	605.19	350	68.18	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3649.2	B08		3	0368-0603	687.74	604.19	132	42.39	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2439.0	B08		3	0369-0607	616.33	606.87	234	59.84	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1990.4	B08		3	0370-0609	487.93	608.84	297	66.43	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1419.3	B08		3	0371-0608	936.57	607.73	257	64.77	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2100.8	B08		3	0372-0614	411.37	614.44	324	66.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			519.2	B08		3	0373-0613	439.78	613.99	280	63.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			441.6	B08		3	0374-0611	721.30	611.18	193	58.77	0.702
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2980.9	B08		3	0375-0615	30.94	616.00	225	55.36	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			396.3	B08		3	0376-0618	339.28	617.59	279	61.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1960.8	B08		3	0377-0620	63.06	620.52	228	58.53	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2608.9	B08		3	0378-0621	692.34	620.81	285	66.53	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4004.5	B08		3	0379-0621	883.29	620.36	279	63.11	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1839.3	B08		3	0380-0623	179.48	623.20	323	67.01	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1834.0	B08		3	0381-0621	232.61	622.39	272	61.11	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1728.1	B08		3	0382-0622	299.86	622.00	314	67.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1909.0	B08		3	0383-0621	263.45	621.84	183	52.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2280.3	B08		3	0384-0624	603.64	624.42	363	71.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3056.6	B08		3	0385-0625	751.75	625.19	266	63.11	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1446.8	B08		3	0386-0628	812.46	628.17	378	73.01	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			559.8	B08		3	0387-0628	276.37	628.67	229	57.70	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2845.2	B08		3	0388-0628	556.75	628.93	195	53.46	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			388.4	B08		3	0389-0637	876.35	637.96	295	68.43	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2541.2	B08		3	0390-0637	771.26	636.84	209	55.70	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1324.0	B08		3	0391-0639	114.14	640.11	204	52.87	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2501.8	B08		3	0392-0642	350.54	642.19	281	64.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2691.9	B08		3	0393-0640	514.81	640.74	269	61.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2032.4	B08		3	0394-0643	895.73	643.48	375	73.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			459.0	B08		3	0395-0642	204.93	642.22	248	60.18	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1989.2	B08		3	0396-0640	164.94	640.47	181	51.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3215.6	B08		3	0397-0642	556.40	641.47	162	48.63	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1926.8	B08		3	0398-0648	659.03	648.60	327	66.18	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2858.0	B08		3	0399-0653	247.53	653.51	371	75.01	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1200.6	B08		3	0400-0654	388.11	654.36	401	76.43	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2464.1	B08		3	0401-0651	946.17	650.54	275	62.53	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1535.9	B08		3	0402-0656	425.26	656.70	372	71.60	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2002.7	B08		3	0403-0657	713.38	657.91	343	69.26	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1884.7	B08		3	0404-0661	108.19	660.40	327	71.36	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2040.6	B08		3	0405-0660	620.19	659.78	295	64.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			522.8	B08		3	0406-0660	553.77	659.85	269	60.53	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1653.9	B08		3	0407-0660	898.74	660.46	275	66.18	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1578.7	B08		3	0408-0661	175.78	660.96	239	61.60	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1890.5	B08		3	0409-0663	830.21	663.20	256	62.18	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2247.1	B08		3	0410-0663	806.27	663.94	252	60.53	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1893.7	B08		3	0411-0669	321.28	668.18	225	57.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2937.7	B08		3	0412-0674	687.29	674.80	384	75.50	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			878.8	B08		3	0413-0673	473.43	673.39	270	61.11	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1756.6	B08		3	0414-0674	732.78	674.35	260	59.11	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1492.0	B08		3	0415-0675	339.94	674.90	231	57.36	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			318.9	B08		3	0416-0680	911.95	680.09	390	111.88	0.392
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1799.3	B08		3	0417-0678	44.44	677.83	235	60.43	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2024.8	B08		3	0418-0681	448.52	681.25	260	61.36	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2292.8	B08		3	0419-0681	250.43	681.15	231	56.53	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1815.8	B08		3	0420-0682	310.84	682.87	248	58.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2551.5	B08		3	0421-0681	600.75	681.92	187	55.46	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2445.1	B08		3	0422-0682	392.98	682.79	147	46.63	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1345.1	B08		3	0423-0691	70.94	690.67	280	73.84	0.645
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1706.9	B08		3	0424-0686	842.30	686.28	245	59.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2037.5	B08		3	0425-0688	171.82	688.70	240	58.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			462.8	B08		3	0426-0691	568.47	691.37	235	62.77	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2336.1	B08		3	0427-0690	817.05	690.09	266	62.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1601.4	B08		3	0428-0693	204.94	693.32	427	79.84	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1414.2	B08		3	0429-0690	520.23	689.89	241	58.53	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1263.0	B08		3	0430-0695	880.75	694.32	235	59.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2311.0	B08		3	0431-0696	240.36	695.66	237	57.60	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1512.0	B08		3	0432-0695	294.42	694.86	346	69.94	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1860.9	B08		3	0433-0699	599.55	698.54	340	85.01	0.591
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1357.0	B08		3	0434-0697	389.64	697.22	344	71.84	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2044.7	B08		3	0435-0698	119.26	699.23	252	61.26	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2301.2	B08		3	0436-0707	31.70	707.18	300	66.08	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2202.9	B08		3	0437-0708	278.88	708.13	245	57.94	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2205.1	B08		4	0001-0025	601.39	24.22	237	57.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1466.7	B08		4	0002-0026	295.33	26.23	228	57.11	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1408.3	B08		4	0003-0028	414.67	27.91	247	60.53	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2890.4	B08		4	0004-0028	250.53	27.82	319	67.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3125.1	B08		4	0005-0032	338.83	32.81	380	77.84	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			387.2	B08		4	0006-0030	90.85	30.14	263	62.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			332.6	B08		4	0007-0032	119.56	31.29	266	64.53	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1547.1	B08		4	0008-0032	639.87	33.10	275	62.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3492.2	B08		4	0009-0033	706.63	33.30	326	67.26	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3033.1	B08		4	0010-0027	902.79	26.86	134	46.28	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2198.9	B08		4	0011-0036	37.02	36.05	423	77.26	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2864.9	B08		4	0012-0036	864.18	36.52	334	67.01	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2392.7	B08		4	0013-0036	912.23	36.29	173	49.46	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2367.1	B08		4	0014-0037	930.80	36.59	178	52.28	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1261.1	B08		4	0015-0043	677.40	43.66	298	68.08	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2393.2	B08		4	0016-0045	301.85	45.54	255	63.01	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1197.3	B08		4	0017-0051	613.77	48.86	342	82.91	0.625
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3034.2	B08		4	0018-0051	75.69	51.44	486	82.08	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2314.9	B08		4	0019-0048	478.80	47.48	271	66.18	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2071.9	B08		4	0020-0047	936.14	47.06	211	59.36	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2876.5	B08		4	0021-0050	401.86	49.78	218	54.53	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2942.0	B08		4	0022-0050	219.40	49.85	318	68.18	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1914.1	B08		4	0023-0058	740.53	58.83	424	78.57	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2059.7	B08		4	0024-0055	14.62	55.08	250	63.36	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2365.4	B08		4	0025-0056	524.41	56.31	353	71.26	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2555.9	B08		4	0026-0058	888.84	59.06	392	75.01	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3163.0	B08		4	0027-0060	161.25	60.71	268	70.18	0.684
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2095.1	B08		4	0028-0058	312.75	57.64	272	62.53	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1899.6	B08		4	0029-0060	712.81	59.97	208	60.18	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			515.1	B08		4	0030-0062	766.83	63.27	211	54.87	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2633.6	B08		4	0031-0067	475.75	67.22	283	62.28	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1786.5	B08		4	0032-0069	538.58	69.33	492	86.33	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1509.6	B08		4	0033-0067	812.44	67.35	244	59.01	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2267.7	B08		4	0034-0078	318.23	77.48	282	65.01	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2434.3	B08		4	0035-0080	447.27	80.88	269	61.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			472.7	B08		4	0036-0083	227.30	83.62	238	57.70	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2678.6	B08		4	0037-0088	414.50	87.90	319	68.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			408.0	B08		4	0038-0090	269.16	90.06	247	59.70	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2405.9	B08		4	0039-0091	381.61	91.52	302	64.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1471.3	B08		4	0040-0094	159.26	95.10	397	74.08	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			401.2	B08		4	0041-0092	54.99	92.34	244	59.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3192.3	B08		4	0042-0093	914.93	93.62	295	64.53	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1924.0	B08		4	0043-0097	678.35	97.15	251	59.94	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			457.2	B08		4	0044-0100	209.86	100.34	241	57.11	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1708.1	B08		4	0045-0106	848.60	106.41	340	68.77	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1473.8	B08		4	0046-0104	798.65	103.91	138	47.21	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1435.9	B08		4	0047-0104	810.06	105.10	155	47.21	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1852.4	B08		4	0048-0109	245.63	109.06	236	56.53	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1945.4	B08		4	0049-0113	274.94	112.69	293	69.26	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2810.5	B08		4	0050-0111	326.72	110.87	297	65.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2754.5	B08		4	0051-0119	62.82	119.71	273	61.60	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2826.2	B08		4	0052-0123	742.79	123.25	327	67.94	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2681.8	B08		4	0053-0130	181.11	130.31	271	64.77	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			660.3	B08		4	0054-0129	601.27	129.58	255	63.60	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3977.0	B08		4	0055-0131	483.49	131.95	328	116.47	0.304
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1185.0	B08		4	0056-0131	714.45	131.62	301	67.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3025.3	B08		4	0057-0133	237.78	133.58	318	66.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2623.0	B08		4	0058-0134	84.87	133.92	219	55.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2343.6	B08		4	0059-0139	381.43	139.74	258	60.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2446.4	B08		4	0060-0141	350.79	140.88	431	83.84	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2949.5	B08		4	0061-0143	205.07	142.99	327	77.50	0.684
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1336.8	B08		4	0062-0141	302.22	141.46	315	73.60	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			676.4	B08		4	0063-0146	540.29	146.95	291	68.77	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1674.7	B08		4	0064-0146	578.61	146.38	219	60.53	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2016.9	B08		4	0065-0146	858.94	145.96	342	69.26	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2256.9	B08		4	0066-0146	610.35	145.78	215	53.46	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1623.2	B08		4	0067-0146	690.83	146.41	168	48.63	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1909.3	B08		4	0068-0154	145.03	154.58	440	78.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2542.5	B08		4	0069-0150	766.39	150.31	307	64.18	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2810.2	B08		4	0070-0149	434.55	149.47	229	58.28	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1761.3	B08		4	0071-0150	941.52	150.18	274	63.11	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2918.2	B08		4	0072-0152	63.41	152.90	231	58.43	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1349.1	B08		4	0073-0154	235.64	154.02	260	59.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2276.9	B08		4	0074-0156	501.76	155.35	336	70.67	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2375.9	B08		4	0075-0157	85.02	157.84	241	57.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3844.1	B08		4	0076-0158	632.22	157.63	165	47.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			555.7	B08		4	0077-0159	100.79	159.94	187	50.63	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2943.0	B08		4	0078-0160	656.24	160.82	256	62.77	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			399.0	B08		4	0079-0170	22.33	169.11	241	60.28	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1770.2	B08		4	0080-0178	791.21	178.94	515	84.91	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1658.9	B08		4	0081-0181	448.03	180.50	247	63.26	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1715.0	B08		4	0082-0182	233.32	181.46	300	68.18	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2655.1	B08		4	0083-0180	310.78	180.92	232	56.28	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			811.3	B08		4	0084-0185	70.87	183.78	239	60.77	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2730.9	B08		4	0085-0186	549.29	186.57	365	70.67	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1250.0	B08		4	0086-0189	897.78	188.80	401	76.08	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			521.5	B08		4	0087-0189	670.54	188.33	240	58.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3127.4	B08		4	0088-0192	286.83	192.36	336	70.08	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3197.8	B08		4	0089-0193	616.47	193.71	205	55.11	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2730.5	B08		4	0090-0199	343.20	198.44	387	74.91	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1758.7	B08		4	0091-0197	474.47	197.98	279	62.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4178.0	B08		4	0092-0200	270.94	200.21	198	54.53	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3603.1	B08		4	0093-0201	515.72	200.27	291	64.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			372.2	B08		4	0094-0203	936.46	203.12	246	60.43	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1504.2	B08		4	0095-0209	22.00	209.14	321	76.18	0.695
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2862.6	B08		4	0096-0205	578.42	204.94	380	71.36	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2241.4	B08		4	0097-0203	380.38	202.68	222	56.28	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1475.1	B08		4	0098-0204	131.18	204.17	215	55.94	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			552.0	B08		4	0099-0207	617.57	207.58	247	61.70	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3084.5	B08		4	0100-0214	706.96	213.52	297	64.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			789.6	B08		4	0101-0217	272.55	216.54	216	59.36	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1632.7	B08		4	0102-0218	120.50	218.74	275	64.53	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1926.2	B08		4	0103-0223	558.63	223.58	465	84.08	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2675.7	B08		4	0104-0220	86.17	220.59	199	52.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2922.4	B08		4	0105-0222	632.34	222.35	268	62.43	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1051.7	B08		4	0106-0223	422.80	223.32	251	59.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1596.0	B08		4	0107-0228	60.11	227.98	256	60.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1891.0	B08		4	0108-0226	587.53	226.41	257	59.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1822.5	B08		4	0109-0228	479.79	228.88	256	63.01	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1851.7	B08		4	0110-0231	242.52	231.78	371	74.18	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			738.7	B08		4	0111-0231	454.26	230.39	231	55.70	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2168.7	B08		4	0112-0240	795.06	239.85	337	68.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3346.2	B08		4	0113-0239	370.73	238.64	297	64.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3022.6	B08		4	0114-0238	395.07	237.47	198	53.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2953.4	B08		4	0115-0238	31.13	238.21	231	57.36	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2236.7	B08		4	0116-0243	163.34	243.94	364	71.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2355.4	B08		4	0117-0242	542.80	242.93	185	55.46	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2794.4	B08		4	0118-0243	855.25	243.75	187	51.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1061.1	B08		4	0119-0246	261.20	246.46	213	54.53	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2473.0	B08		4	0120-0247	506.41	247.48	233	56.28	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1464.5	B08		4	0121-0253	424.23	252.69	261	61.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2915.0	B08		4	0122-0257	16.82	256.93	287	63.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			495.0	B08		4	0123-0259	587.93	260.00	252	65.01	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2740.0	B08		4	0124-0255	869.18	255.90	154	73.74	0.356
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2229.7	B08		4	0125-0257	549.07	256.53	179	52.53	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1923.5	B08		4	0126-0259	820.99	259.13	215	56.53	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1025.1	B08		4	0127-0263	896.26	264.51	303	67.60	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			645.2	B08		4	0128-0265	370.12	264.64	226	55.70	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1301.5	B08		4	0129-0272	749.01	271.91	526	86.91	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2351.4	B08		4	0130-0270	108.85	270.49	342	69.60	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			866.3	B08		4	0131-0264	258.33	264.53	181	49.46	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4565.5	B08		4	0132-0268	199.78	268.16	272	61.36	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			855.2	B08		4	0133-0266	434.03	266.36	181	50.04	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2963.9	B08		4	0134-0270	132.52	270.68	237	57.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			5598.0	B08		4	0135-0272	383.11	270.73	158	51.11	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			972.6	B08		4	0136-0275	601.91	274.79	252	59.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2849.4	B08		4	0137-0278	569.84	278.36	308	65.26	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2157.5	B08		4	0138-0278	50.14	278.38	250	59.11	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2002.4	B08		4	0139-0278	214.25	278.96	272	61.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2659.5	B08		4	0140-0278	396.04	277.77	240	59.60	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1476.8	B08		4	0141-0279	414.23	279.20	221	57.36	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1770.6	B08		4	0142-0287	479.47	286.64	258	61.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1809.9	B08		4	0143-0291	253.75	291.05	235	60.53	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			553.3	B08		4	0144-0290	556.80	290.27	231	61.01	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1558.7	B08		4	0145-0292	804.57	291.33	267	67.94	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			737.2	B08		4	0146-0293	833.47	292.81	236	57.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3314.8	B08		4	0147-0290	116.51	290.99	150	46.87	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1919.6	B08		4	0148-0291	134.88	291.50	224	54.28	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			924.4	B08		4	0149-0295	170.41	295.48	256	59.36	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2649.3	B08		4	0150-0300	79.90	299.71	377	73.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3064.1	B08		4	0151-0297	340.36	297.42	224	65.01	0.666
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2221.8	B08		4	0152-0306	848.96	306.04	363	70.43	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			593.2	B08		4	0153-0305	580.13	305.85	263	61.60	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2074.0	B08		4	0154-0306	266.38	306.65	255	63.70	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2895.5	B08		4	0155-0304	426.22	304.47	293	70.28	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3052.2	B08		4	0156-0308	771.97	308.78	268	61.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1916.2	B08		4	0157-0310	701.07	310.10	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			486.5	B08		4	0158-0314	241.79	314.07	223	55.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4165.0	B08		4	0159-0318	864.87	318.80	329	69.84	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			629.5	B08		4	0160-0316	426.73	316.36	194	54.87	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1641.5	B08		4	0161-0320	304.77	321.14	227	56.28	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2234.1	B08		4	0162-0327	383.06	326.66	361	74.53	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2731.5	B08		4	0163-0332	509.64	331.99	402	77.50	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			436.7	B08		4	0164-0335	204.03	334.75	270	60.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3661.8	B08		4	0165-0344	355.36	343.79	402	75.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			818.6	B08		4	0166-0339	57.70	339.44	229	57.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2838.8	B08		4	0167-0345	257.77	345.48	367	71.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			563.7	B08		4	0168-0348	683.97	347.91	269	62.18	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1601.8	B08		4	0169-0349	923.36	349.53	318	67.01	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			473.6	B08		4	0170-0350	306.71	349.98	262	60.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1569.6	B08		4	0171-0349	798.73	349.42	249	64.18	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2083.4	B08		4	0172-0354	856.66	353.38	287	62.43	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			653.4	B08		4	0173-0354	27.62	354.81	251	69.84	0.647
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2231.6	B08		4	0174-0361	69.30	360.62	363	70.77	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1429.3	B08		4	0175-0361	794.64	361.10	169	49.70	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2186.4	B08		4	0176-0366	871.02	366.20	355	72.18	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			760.4	B08		4	0177-0369	145.55	369.24	223	55.11	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1470.6	B08		4	0178-0381	287.82	381.21	479	88.33	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			435.2	B08		4	0179-0378	334.49	378.08	223	57.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			532.7	B08		4	0180-0384	670.09	383.67	289	64.18	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2500.5	B08		4	0181-0383	851.40	383.37	236	57.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1934.6	B08		4	0182-0383	917.72	383.24	299	64.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2083.4	B08		4	0183-0386	576.32	386.15	240	59.84	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3499.0	B08		4	0184-0387	418.73	387.11	311	64.18	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1041.8	B08		4	0185-0390	124.30	390.25	186	53.36	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1231.0	B08		4	0186-0394	365.20	394.49	281	66.67	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3027.9	B08		4	0187-0391	494.81	391.49	250	62.18	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			680.5	B08		4	0188-0398	183.49	398.08	301	66.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2140.5	B08		4	0189-0400	98.22	399.80	254	77.84	0.527
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3739.7	B08		4	0190-0400	135.37	401.02	223	54.77	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2013.0	B08		4	0191-0405	156.03	405.04	308	66.43	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			979.4	B08		4	0192-0408	821.50	408.19	249	62.77	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2975.6	B08		4	0193-0411	614.01	410.08	287	65.01	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3068.6	B08		4	0194-0410	649.13	410.07	302	67.01	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3133.6	B08		4	0195-0417	395.36	417.62	367	72.67	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2062.8	B08		4	0196-0415	479.20	415.09	240	58.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2880.5	B08		4	0197-0416	556.77	415.96	302	66.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2002.6	B08		4	0198-0417	942.83	416.70	256	59.11	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1285.2	B08		4	0199-0419	913.28	418.81	232	57.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2261.6	B08		4	0200-0427	43.01	427.15	337	67.36	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2632.6	B08		4	0201-0426	245.01	425.35	253	63.36	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3175.7	B08		4	0202-0432	322.69	431.90	417	78.08	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1964.3	B08		4	0203-0430	351.01	431.03	219	58.53	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1521.0	B08		4	0204-0437	619.88	438.32	364	82.43	0.673
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1635.1	B08		4	0205-0437	93.59	437.36	451	82.08	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2585.0	B08		4	0206-0436	698.93	436.19	371	71.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2245.2	B08		4	0207-0440	172.17	439.91	341	68.18	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1651.5	B08		4	0208-0441	829.11	440.75	250	61.11	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2248.2	B08		4	0209-0443	796.47	444.09	188	50.53	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1774.7	B08		4	0210-0449	400.15	449.28	231	57.11	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2307.1	B08		4	0211-0454	763.35	453.28	232	57.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1200.4	B08		4	0212-0458	906.67	457.70	363	71.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3252.7	B08		4	0213-0460	423.06	460.13	251	60.28	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2483.7	B08		4	0214-0461	634.10	461.13	243	57.11	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1745.3	B08		4	0215-0463	862.53	463.11	269	61.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1485.0	B08		4	0216-0465	240.80	466.18	243	59.60	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1541.0	B08		4	0217-0464	500.68	464.47	268	60.87	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			698.2	B08		4	0218-0465	736.76	464.94	140	46.04	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1300.9	B08		4	0219-0467	924.68	467.49	402	74.18	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			586.5	B08		4	0220-0465	106.92	465.57	237	58.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1728.4	B08		4	0221-0473	551.33	473.05	269	63.94	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			974.9	B08		4	0222-0466	748.72	466.50	110	38.63	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2425.3	B08		4	0223-0472	41.64	471.90	337	70.43	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2702.4	B08		4	0224-0474	434.46	474.20	297	66.77	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3932.9	B08		4	0225-0476	573.17	476.07	272	62.53	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1342.8	B08		4	0226-0478	296.05	477.74	264	63.26	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3784.6	B08		4	0227-0477	587.41	477.46	213	54.63	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2367.5	B08		4	0228-0477	624.85	477.87	249	57.36	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2161.4	B08		4	0229-0478	773.47	478.74	248	62.43	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			727.6	B08		4	0230-0479	751.17	479.18	167	47.11	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1054.0	B08		4	0231-0481	825.06	480.57	285	64.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1977.1	B08		4	0232-0485	189.56	485.76	327	69.60	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1835.3	B08		4	0233-0485	165.66	485.49	220	53.94	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3074.7	B08		4	0234-0487	331.71	486.88	242	60.28	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2229.9	B08		4	0235-0487	404.26	487.00	244	60.53	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2045.7	B08		4	0236-0489	876.92	489.21	241	57.11	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			946.2	B08		4	0237-0487	97.63	488.05	206	58.53	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			376.7	B08		4	0238-0491	603.73	490.85	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2260.8	B08		4	0239-0491	674.89	490.66	282	62.43	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1819.0	B08		4	0240-0491	378.68	492.19	243	59.11	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2721.3	B08		4	0241-0496	123.05	495.88	287	63.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2223.0	B08		4	0242-0494	814.64	495.00	192	53.11	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1226.3	B08		4	0243-0502	713.55	501.65	378	75.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2830.2	B08		4	0244-0499	510.71	499.10	178	50.87	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3405.5	B08		4	0245-0502	247.12	501.64	313	66.77	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1767.8	B08		4	0246-0503	465.57	503.07	296	69.36	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2330.0	B08		4	0247-0504	207.05	503.81	213	55.46	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2340.8	B08		4	0248-0505	317.37	506.23	205	58.87	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3197.1	B08		4	0249-0505	526.72	504.67	133	44.04	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2778.0	B08		4	0250-0509	893.48	509.56	256	58.53	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			699.0	B08		4	0251-0510	769.85	509.88	229	57.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2056.5	B08		4	0252-0515	912.53	515.34	272	63.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			844.1	B08		4	0253-0516	166.09	516.56	195	52.53	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2421.9	B08		4	0254-0519	324.07	518.57	206	56.53	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2213.3	B08		4	0255-0523	62.95	523.51	283	62.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2401.9	B08		4	0256-0521	408.93	520.60	252	59.01	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3019.7	B08		4	0257-0523	632.41	523.01	299	65.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1982.0	B08		4	0258-0524	349.28	523.74	255	61.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3684.3	B08		4	0259-0525	35.65	525.09	254	65.84	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			307.3	B08		4	0260-0525	667.34	525.91	286	66.43	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2601.2	B08		4	0261-0529	219.15	529.19	279	66.43	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1911.7	B08		4	0262-0527	823.19	526.28	182	51.11	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1929.7	B08		4	0263-0529	189.07	529.13	203	53.11	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1619.5	B08		4	0264-0535	305.67	536.40	353	71.94	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1450.7	B08		4	0265-0536	271.64	534.96	247	62.87	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			857.6	B08		4	0266-0538	853.41	538.09	256	62.43	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2361.4	B08		4	0267-0543	519.43	543.96	379	74.67	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1123.6	B08		4	0268-0543	462.46	543.84	146	47.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1650.5	B08		4	0269-0545	612.72	545.77	302	66.67	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			720.4	B08		4	0270-0546	483.70	546.75	285	67.60	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1833.9	B08		4	0271-0546	120.03	546.11	297	64.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2357.3	B08		4	0272-0551	386.36	551.34	382	75.50	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1005.5	B08		4	0273-0545	452.01	545.29	113	39.21	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1553.0	B08		4	0274-0549	826.28	549.64	208	55.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1158.9	B08		4	0275-0553	769.54	553.39	208	57.01	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			387.2	B08		4	0276-0553	896.29	553.02	252	59.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2049.8	B08		4	0277-0556	169.22	558.38	335	78.18	0.689
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1175.3	B08		4	0278-0552	257.75	552.29	134	46.04	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2135.0	B08		4	0279-0555	927.66	554.65	218	53.70	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1851.1	B08		4	0280-0562	695.36	561.59	340	69.84	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			505.1	B08		4	0281-0560	39.92	559.67	217	54.28	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1502.7	B08		4	0282-0559	792.50	558.57	225	55.94	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			693.4	B08		4	0283-0562	661.76	562.49	244	58.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1081.3	B08		4	0284-0566	442.11	565.66	250	59.11	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3240.1	B08		4	0285-0571	626.34	571.54	350	72.91	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			963.9	B08		4	0286-0573	745.64	573.60	268	64.28	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3532.4	B08		4	0287-0579	202.08	578.90	254	59.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1540.9	B08		4	0288-0580	355.71	580.32	261	71.26	0.646
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1620.7	B08		4	0289-0578	55.91	579.20	240	59.11	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2790.4	B08		4	0290-0584	101.22	583.64	271	62.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			537.3	B08		4	0291-0587	896.46	587.20	239	57.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			391.0	B08		4	0292-0590	503.77	590.15	227	55.70	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1471.6	B08		4	0293-0593	414.11	594.58	329	71.01	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1636.3	B08		4	0294-0594	466.09	594.47	170	48.63	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			736.4	B08		4	0295-0595	631.79	594.98	228	56.28	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			712.2	B08		4	0296-0599	330.30	599.10	240	58.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1581.8	B08		4	0297-0600	878.35	600.18	225	56.87	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4745.6	B08		4	0298-0604	265.33	603.70	313	65.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2990.7	B08		4	0299-0605	521.43	604.79	295	64.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4011.4	B08		4	0300-0603	612.33	602.58	160	46.87	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			382.7	B08		4	0301-0605	933.74	605.18	223	55.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1565.9	B08		4	0302-0606	483.26	606.68	184	53.36	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2721.3	B08		4	0303-0607	792.06	607.40	263	59.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1905.6	B08		4	0304-0610	238.36	610.41	227	56.28	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3786.8	B08		4	0305-0612	213.73	611.44	215	55.70	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3492.7	B08		4	0306-0615	619.13	615.35	176	49.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2029.1	B08		4	0307-0622	857.02	622.48	252	59.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2818.3	B08		4	0308-0620	180.51	620.54	198	53.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1479.3	B08		4	0309-0621	647.58	621.74	256	60.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1230.5	B08		4	0310-0626	931.96	626.09	277	71.60	0.679
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1610.1	B08		4	0311-0627	369.29	627.77	272	62.18	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2761.5	B08		4	0312-0628	240.10	627.52	191	51.11	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2708.3	B08		4	0313-0631	112.43	631.22	295	62.77	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1288.2	B08		4	0314-0631	594.04	631.05	250	59.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1890.4	B08		4	0315-0634	396.37	634.05	245	61.60	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1865.4	B08		4	0316-0636	439.91	636.09	375	71.60	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2299.6	B08		4	0317-0638	518.47	638.36	294	65.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1449.4	B08		4	0318-0638	851.28	638.87	219	54.87	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1714.9	B08		4	0319-0639	71.19	639.60	175	49.80	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2314.7	B08		4	0320-0643	355.90	642.50	300	67.50	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2415.4	B08		4	0321-0643	720.20	643.02	246	59.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1517.0	B08		4	0322-0650	276.52	648.14	493	95.50	0.679
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2781.1	B08		4	0323-0648	471.83	647.96	344	69.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			409.6	B08		4	0324-0643	623.44	642.89	206	61.36	0.688
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1348.8	B08		4	0325-0651	550.39	650.86	460	82.33	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			634.0	B08		4	0326-0649	751.38	649.17	248	62.53	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2066.9	B08		4	0327-0655	677.54	656.14	307	64.18	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			728.9	B08		4	0328-0657	92.49	656.86	234	56.28	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1751.2	B08		4	0329-0665	419.08	665.94	283	62.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3319.4	B08		4	0330-0665	464.09	665.02	258	60.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2696.4	B08		4	0331-0668	138.91	668.35	265	62.18	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			560.8	B08		4	0332-0670	579.98	670.48	218	55.70	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2289.2	B08		4	0333-0669	157.98	669.52	183	52.53	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1964.1	B08		4	0334-0677	304.96	677.31	383	75.01	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2176.0	B08		4	0335-0676	369.06	676.55	337	71.84	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4172.5	B08		4	0336-0676	106.14	676.43	226	57.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1427.3	B08		4	0337-0681	489.96	681.89	293	70.53	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3033.3	B08		4	0338-0679	219.54	679.54	244	57.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3230.9	B08		4	0339-0682	439.59	681.45	316	65.60	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3570.6	B08		4	0340-0682	341.94	682.00	147	49.11	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2984.2	B08		4	0341-0686	771.81	686.37	246	59.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3375.6	B08		4	0342-0687	352.74	686.86	160	48.87	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2067.1	B08		4	0343-0689	66.90	688.40	228	58.28	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1388.9	B08		4	0344-0695	584.28	694.25	440	78.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			667.7	B08		4	0345-0693	190.14	693.68	257	58.77	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1360.8	B08		4	0346-0694	508.55	695.05	278	66.18	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2703.7	B08		4	0347-0699	91.54	698.54	186	51.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1373.0	B08		4	0348-0701	321.09	700.57	259	61.94	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			370.4	B08		4	0349-0701	852.08	700.68	243	63.01	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2752.6	B08		4	0350-0704	139.10	703.95	232	56.18	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1404.0	B08		4	0351-0707	82.78	707.84	131	43.11	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			920.3	B08		4	0352-0709	249.40	709.38	245	58.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2939.4	B08		4	0353-0708	826.55	707.85	222	55.36	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3404.6	B08		5	0001-0030	295.53	30.88	233	58.53	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			404.1	B08		5	0002-0025	894.81	25.66	191	53.70	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1222.9	B08		5	0003-0032	81.20	32.85	281	64.43	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1608.5	B08		5	0004-0030	386.33	30.11	243	57.36	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1888.4	B08		5	0005-0033	557.30	33.38	357	71.01	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1117.8	B08		5	0006-0035	647.06	35.19	464	81.50	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3442.7	B08		5	0007-0034	764.63	33.50	320	66.43	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2329.7	B08		5	0008-0038	17.47	38.56	167	48.28	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1803.4	B08		5	0009-0038	843.73	38.50	257	60.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1128.6	B08		5	0010-0042	103.70	41.70	286	67.01	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2240.1	B08		5	0011-0044	38.23	44.27	412	80.67	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3420.3	B08		5	0012-0040	618.67	39.46	201	53.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2540.4	B08		5	0013-0041	935.18	41.15	306	66.08	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3058.7	B08		5	0014-0045	205.15	45.67	328	68.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1617.8	B08		5	0015-0046	353.28	45.99	285	63.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1064.9	B08		5	0016-0046	438.62	46.09	260	60.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			458.3	B08		5	0017-0047	119.53	46.85	227	64.53	0.685
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2162.1	B08		5	0018-0053	699.81	51.11	402	85.50	0.691
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1832.5	B08		5	0019-0054	728.32	54.59	354	69.26	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			490.5	B08		5	0020-0053	890.76	53.19	218	61.84	0.716
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4621.7	B08		5	0021-0058	502.59	57.05	187	55.01	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			464.5	B08		5	0022-0061	125.53	61.72	186	57.60	0.705
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2183.7	B08		5	0023-0061	392.17	61.28	300	68.77	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1981.9	B08		5	0024-0063	865.42	63.69	284	63.36	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2751.0	B08		5	0025-0063	445.32	62.52	211	55.11	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1419.2	B08		5	0026-0068	600.83	67.82	454	81.74	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2716.7	B08		5	0027-0065	641.80	65.14	294	62.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4279.5	B08		5	0028-0072	240.01	71.95	365	82.33	0.677
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1368.5	B08		5	0029-0078	458.41	79.37	349	74.67	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2149.2	B08		5	0030-0074	786.62	75.24	278	64.53	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1539.5	B08		5	0031-0083	537.97	83.52	521	87.84	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2341.6	B08		5	0032-0080	179.82	80.24	229	56.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			839.2	B08		5	0033-0081	307.41	81.64	241	59.36	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1811.3	B08		5	0034-0088	583.99	88.43	520	87.50	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2143.7	B08		5	0035-0088	146.95	87.66	229	58.53	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1914.9	B08		5	0036-0087	849.53	86.85	227	55.94	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1633.4	B08		5	0037-0091	693.33	91.22	257	63.60	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1676.4	B08		5	0038-0093	756.68	92.98	318	65.84	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2147.0	B08		5	0039-0093	325.58	92.74	406	75.60	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3140.6	B08		5	0040-0095	19.60	95.63	297	63.70	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1281.0	B08		5	0041-0096	621.58	96.99	278	64.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2165.7	B08		5	0042-0096	919.57	96.30	211	53.11	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2246.1	B08		5	0043-0099	829.40	98.50	296	63.94	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2676.2	B08		5	0044-0098	366.33	98.06	223	56.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3113.0	B08		5	0045-0102	285.85	102.24	239	58.77	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1023.8	B08		5	0046-0102	477.28	102.34	344	72.43	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2082.3	B08		5	0047-0105	179.89	105.00	227	57.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2431.6	B08		5	0048-0104	387.49	104.30	273	63.36	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2007.6	B08		5	0049-0110	219.10	111.22	376	75.01	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2113.4	B08		5	0050-0115	432.47	114.86	232	56.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2289.2	B08		5	0051-0122	262.18	122.33	412	75.26	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2647.5	B08		5	0052-0121	613.89	121.83	356	69.60	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2677.5	B08		5	0053-0123	124.96	123.50	317	64.77	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2117.2	B08		5	0054-0127	499.69	125.98	329	73.01	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1502.6	B08		5	0055-0125	317.65	125.28	227	55.94	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1889.9	B08		5	0056-0131	934.50	130.73	378	75.50	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2589.2	B08		5	0057-0128	671.91	127.74	201	52.53	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1359.1	B08		5	0058-0129	98.76	129.47	303	69.36	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2334.4	B08		5	0059-0132	181.45	131.89	279	62.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2118.6	B08		5	0060-0135	445.04	135.96	391	73.26	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1584.1	B08		5	0061-0134	731.47	134.75	276	64.18	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1846.9	B08		5	0062-0138	792.76	138.55	261	59.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2046.7	B08		5	0063-0135	814.56	134.93	256	61.70	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4290.5	B08		5	0064-0142	529.19	142.32	257	60.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1264.3	B08		5	0065-0141	863.11	141.44	233	57.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1137.5	B08		5	0066-0142	911.83	142.77	267	63.60	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1751.8	B08		5	0067-0154	221.83	153.34	667	103.64	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2353.2	B08		5	0068-0147	339.76	146.34	344	69.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1984.7	B08		5	0069-0146	572.14	145.82	248	57.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2019.1	B08		5	0070-0147	654.58	147.15	297	64.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2587.3	B08		5	0071-0147	817.26	148.11	194	56.04	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2575.4	B08		5	0072-0149	362.62	149.64	258	63.11	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2032.8	B08		5	0073-0153	468.98	152.96	303	65.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1752.0	B08		5	0074-0152	46.23	152.22	276	62.53	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1528.1	B08		5	0075-0155	326.26	154.69	198	53.60	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2735.0	B08		5	0076-0158	131.27	157.77	294	64.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2734.3	B08		5	0077-0160	412.59	160.42	281	64.53	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1630.0	B08		5	0078-0159	860.83	159.21	240	58.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			508.0	B08		5	0079-0168	300.99	166.56	212	59.11	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1500.0	B08		5	0080-0169	563.53	168.26	300	72.43	0.719
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2689.0	B08		5	0081-0169	283.17	169.11	340	70.77	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1996.4	B08		5	0082-0170	520.66	170.02	368	70.43	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2278.6	B08		5	0083-0173	714.30	172.85	300	76.43	0.645
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2954.9	B08		5	0084-0176	599.34	175.96	280	65.94	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			530.8	B08		5	0085-0177	767.45	177.37	261	62.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3340.7	B08		5	0086-0183	297.78	183.35	207	53.70	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3393.3	B08		5	0087-0188	458.13	187.82	262	61.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1872.1	B08		5	0088-0186	827.90	186.74	189	55.36	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3049.2	B08		5	0089-0190	123.16	189.82	298	64.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1535.8	B08		5	0090-0189	743.36	189.75	238	57.70	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2512.2	B08		5	0091-0191	435.58	190.96	270	59.94	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1323.8	B08		5	0092-0192	688.43	191.92	324	67.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1325.6	B08		5	0093-0195	802.67	195.07	270	67.26	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2357.8	B08		5	0094-0197	379.86	197.12	323	66.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1796.9	B08		5	0095-0200	532.69	199.42	324	68.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3066.1	B08		5	0096-0199	294.42	199.07	185	53.11	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1300.8	B08		5	0097-0201	256.90	201.30	177	48.87	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3912.4	B08		5	0098-0202	489.30	202.45	295	62.77	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			333.6	B08		5	0099-0205	89.56	204.45	266	63.60	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1531.6	B08		5	0100-0202	599.49	200.85	172	53.70	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2659.0	B08		5	0101-0203	855.77	204.11	257	60.28	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			343.5	B08		5	0102-0205	41.27	205.25	244	59.60	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1886.9	B08		5	0103-0209	559.41	208.92	460	83.26	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2537.2	B08		5	0104-0209	818.71	209.27	352	69.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2268.6	B08		5	0105-0212	363.48	212.07	256	61.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1860.6	B08		5	0106-0207	608.13	207.61	120	42.28	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3068.1	B08		5	0107-0213	243.40	213.91	322	69.26	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1844.8	B08		5	0108-0216	625.16	216.59	319	66.18	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2108.9	B08		5	0109-0223	312.51	224.14	373	80.33	0.726
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2183.2	B08		5	0110-0221	154.93	221.42	238	57.70	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2470.1	B08		5	0111-0222	388.83	221.77	269	61.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1550.4	B08		5	0112-0224	462.43	223.48	257	59.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2374.8	B08		5	0113-0227	527.41	227.24	242	57.46	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1423.8	B08		5	0114-0231	138.45	230.97	229	55.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			476.1	B08		5	0115-0231	354.39	231.96	211	54.53	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2683.1	B08		5	0116-0235	717.67	234.91	391	75.01	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			545.2	B08		5	0117-0232	327.87	231.96	209	53.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2400.1	B08		5	0118-0233	485.95	233.10	274	61.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2197.7	B08		5	0119-0234	549.68	234.97	201	53.36	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1020.8	B08		5	0120-0236	920.16	237.33	301	67.84	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1676.5	B08		5	0121-0238	698.47	238.19	231	56.53	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1865.2	B08		5	0122-0243	786.65	243.09	305	70.43	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2576.8	B08		5	0123-0243	182.01	242.88	185	52.53	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1732.3	B08		5	0124-0247	806.30	247.73	346	69.01	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			521.9	B08		5	0125-0248	342.03	248.20	243	61.60	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			486.5	B08		5	0126-0246	747.93	245.72	211	53.70	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1151.6	B08		5	0127-0251	627.61	251.69	278	63.70	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1656.1	B08		5	0128-0251	839.54	251.41	302	67.01	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1872.3	B08		5	0129-0253	672.20	253.35	290	66.67	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2217.7	B08		5	0130-0255	416.23	254.89	359	69.60	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2987.0	B08		5	0131-0257	234.72	258.05	280	62.18	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2869.3	B08		5	0132-0258	926.87	258.22	304	65.01	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3223.2	B08		5	0133-0259	529.60	259.62	179	50.28	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			479.6	B08		5	0134-0263	370.21	262.63	206	54.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3237.6	B08		5	0135-0265	886.90	264.94	301	63.94	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			407.6	B08		5	0136-0267	603.02	266.82	234	57.94	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1506.0	B08		5	0137-0271	722.33	270.70	281	65.26	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1446.0	B08		5	0138-0274	788.48	273.86	302	64.67	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			542.2	B08		5	0139-0274	286.41	274.47	246	58.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2636.7	B08		5	0140-0275	578.73	274.92	399	75.84	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2141.2	B08		5	0141-0278	471.49	278.13	376	72.43	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1316.3	B08		5	0142-0279	763.35	279.52	327	70.77	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2827.8	B08		5	0143-0285	683.06	284.72	557	96.81	0.747
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2220.5	B08		5	0144-0283	157.84	283.31	270	62.28	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1768.2	B08		5	0145-0282	931.41	282.99	332	68.77	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1465.1	B08		5	0146-0285	305.08	285.40	281	66.43	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			360.5	B08		5	0147-0289	855.11	291.27	292	73.26	0.684
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1607.0	B08		5	0148-0292	652.58	292.68	293	64.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1842.1	B08		5	0149-0293	254.65	293.39	363	72.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			507.6	B08		5	0150-0292	351.44	291.95	169	50.53	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2065.9	B08		5	0151-0296	832.99	296.12	326	66.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2073.5	B08		5	0152-0301	386.36	301.03	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2130.6	B08		5	0153-0297	621.94	297.75	232	59.46	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1571.8	B08		5	0154-0306	946.53	306.29	208	58.53	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			460.4	B08		5	0155-0305	480.20	305.32	257	61.94	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2595.7	B08		5	0156-0306	344.77	306.66	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			907.7	B08		5	0157-0310	929.56	310.24	264	59.36	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2789.6	B08		5	0158-0311	743.22	311.03	377	73.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1816.0	B08		5	0159-0312	518.81	312.77	358	71.01	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1271.5	B08		5	0160-0319	431.69	319.49	278	62.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3442.2	B08		5	0161-0321	867.44	320.62	300	65.01	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2895.8	B08		5	0162-0322	603.54	321.53	290	64.77	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2959.7	B08		5	0163-0324	762.76	324.64	284	64.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1971.3	B08		5	0164-0324	697.15	324.25	312	65.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1534.1	B08		5	0165-0328	256.84	329.58	236	62.77	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2144.6	B08		5	0166-0330	903.78	330.83	318	65.94	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2552.1	B08		5	0167-0332	640.93	332.77	255	59.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1940.0	B08		5	0168-0334	385.47	335.14	313	70.43	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2265.0	B08		5	0169-0339	199.53	339.86	402	79.26	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2523.6	B08		5	0170-0337	336.46	336.80	347	68.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1875.9	B08		5	0171-0337	109.22	337.39	234	55.70	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2903.8	B08		5	0172-0341	728.54	341.60	301	64.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1410.2	B08		5	0173-0348	247.30	348.39	312	73.01	0.735
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1674.7	B08		5	0174-0347	518.90	347.95	266	61.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2799.9	B08		5	0175-0350	550.53	349.87	304	66.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1527.1	B08		5	0176-0351	28.14	351.54	308	65.01	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2078.4	B08		5	0177-0351	671.10	352.07	300	66.43	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			369.7	B08		5	0178-0351	288.63	351.57	242	57.36	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2368.5	B08		5	0179-0353	605.08	353.64	328	67.84	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			434.1	B08		5	0180-0350	388.40	350.64	213	55.70	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1804.7	B08		5	0181-0355	313.02	354.74	290	68.67	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1470.7	B08		5	0182-0363	367.52	363.21	367	73.74	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1454.8	B08		5	0183-0361	868.51	361.52	228	55.70	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2042.0	B08		5	0184-0364	481.68	364.53	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2187.9	B08		5	0185-0366	744.53	366.18	361	73.84	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			432.1	B08		5	0186-0370	155.81	369.80	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2139.0	B08		5	0187-0368	583.87	367.91	293	63.01	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			473.0	B08		5	0188-0369	793.88	369.56	267	62.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			350.1	B08		5	0189-0374	425.48	374.39	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			317.4	B08		5	0190-0376	815.09	375.59	267	71.01	0.665
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3535.5	B08		5	0191-0377	708.52	377.08	346	67.60	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1830.9	B08		5	0192-0379	228.04	379.25	321	67.60	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2176.1	B08		5	0193-0382	762.06	381.50	344	70.18	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			833.2	B08		5	0194-0384	331.51	384.50	264	59.94	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			475.6	B08		5	0195-0383	57.91	383.42	245	60.18	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			381.1	B08		5	0196-0384	638.43	383.82	173	55.36	0.709
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1789.5	B08		5	0197-0385	22.61	385.34	298	64.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1222.7	B08		5	0198-0387	437.65	386.44	260	61.70	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			314.8	B08		5	0199-0387	264.16	387.60	220	54.87	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			296.4	B08		5	0200-0388	941.49	389.46	247	73.26	0.578
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			322.5	B08		5	0201-0387	298.35	387.32	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4576.9	B08		5	0202-0388	545.48	388.10	243	57.70	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3375.3	B08		5	0203-0390	123.06	389.49	212	55.36	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2717.3	B08		5	0204-0390	474.10	389.95	175	51.36	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1316.8	B08		5	0205-0398	374.06	400.10	337	75.60	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1576.6	B08		5	0206-0399	415.64	399.44	436	78.33	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2548.5	B08		5	0207-0397	845.35	396.76	330	67.36	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			550.8	B08		5	0208-0396	924.48	396.26	284	64.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			601.6	B08		5	0209-0400	96.75	399.85	268	60.53	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2244.9	B08		5	0210-0400	184.98	400.23	329	68.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1750.0	B08		5	0211-0402	596.83	402.10	318	65.94	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			660.5	B08		5	0212-0400	767.01	400.97	234	57.11	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			377.6	B08		5	0213-0402	234.24	403.18	236	57.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1457.1	B08		5	0214-0405	880.80	404.72	302	65.84	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2382.2	B08		5	0215-0408	503.17	407.93	387	73.84	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2230.1	B08		5	0216-0412	850.68	411.78	215	55.70	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			303.9	B08		5	0217-0418	295.11	418.75	263	60.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1498.8	B08		5	0218-0417	753.99	417.39	295	65.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1929.3	B08		5	0219-0419	47.72	418.73	257	58.53	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			573.3	B08		5	0220-0418	264.96	418.82	253	58.77	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2272.6	B08		5	0221-0420	553.94	420.70	336	68.08	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1154.9	B08		5	0222-0421	18.23	420.86	230	57.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1683.7	B08		5	0223-0423	649.21	422.77	326	67.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			834.7	B08		5	0224-0419	716.50	418.66	237	59.36	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1676.2	B08		5	0225-0423	159.47	423.16	268	60.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2612.9	B08		5	0226-0425	207.15	424.76	172	50.63	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2174.1	B08		5	0227-0427	249.84	426.62	227	60.18	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3453.3	B08		5	0228-0427	107.31	427.34	224	63.70	0.694
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3695.9	B08		5	0229-0429	93.76	430.11	133	48.53	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1549.5	B08		5	0230-0431	771.38	430.11	262	61.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			357.5	B08		5	0231-0434	318.65	433.86	279	61.60	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1329.9	B08		5	0232-0436	825.71	436.90	333	77.26	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2235.4	B08		5	0233-0434	357.52	434.58	213	55.11	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2794.3	B08		5	0234-0436	338.58	436.41	238	56.77	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3651.5	B08		5	0235-0440	453.24	439.97	251	59.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2044.9	B08		5	0236-0440	716.10	440.61	294	67.01	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2267.3	B08		5	0237-0446	893.39	445.58	305	64.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			447.0	B08		5	0238-0446	397.03	446.42	252	59.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3801.4	B08		5	0239-0446	759.84	446.37	329	66.53	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2644.2	B08		5	0240-0453	613.76	454.39	375	73.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			427.6	B08		5	0241-0451	254.41	451.25	265	60.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			524.4	B08		5	0242-0449	646.18	449.41	106	40.04	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			481.2	B08		5	0243-0454	851.35	454.92	285	66.18	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1751.1	B08		5	0244-0454	459.56	455.29	210	58.53	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			962.8	B08		5	0245-0457	416.62	458.31	258	66.28	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1763.5	B08		5	0246-0459	474.40	458.61	271	62.04	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1308.3	B08		5	0247-0463	580.88	463.68	282	64.53	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			558.9	B08		5	0248-0462	679.75	461.14	229	58.77	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1719.0	B08		5	0249-0466	315.02	467.28	416	85.15	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			749.0	B08		5	0250-0466	340.97	464.47	322	79.84	0.635
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2379.1	B08		5	0251-0467	388.98	466.28	351	71.01	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3534.1	B08		5	0252-0464	512.97	464.52	247	58.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2054.5	B08		5	0253-0468	540.87	467.65	321	68.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3802.9	B08		5	0254-0468	712.10	468.59	270	61.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1239.8	B08		5	0255-0469	29.72	469.57	398	73.60	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			533.7	B08		5	0256-0469	164.99	469.79	233	57.94	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			962.6	B08		5	0257-0469	362.12	469.38	203	53.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			562.9	B08		5	0258-0469	881.30	468.81	265	61.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2699.4	B08		5	0259-0476	686.25	474.81	263	66.67	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			761.0	B08		5	0260-0473	210.69	474.10	179	51.11	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1756.9	B08		5	0261-0474	566.06	474.60	193	54.18	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1596.0	B08		5	0262-0477	259.90	477.08	208	61.01	0.702
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2378.5	B08		5	0263-0478	916.21	478.80	260	64.18	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2737.8	B08		5	0264-0484	226.41	484.79	327	75.50	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2265.3	B08		5	0265-0486	669.26	486.42	312	65.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1181.1	B08		5	0266-0487	312.59	487.82	276	63.01	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1015.6	B08		5	0267-0486	388.91	486.62	233	59.36	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1688.8	B08		5	0268-0486	560.86	485.82	117	40.28	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2321.1	B08		5	0269-0495	621.80	496.89	534	92.91	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2743.1	B08		5	0270-0491	782.00	491.75	311	66.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1202.2	B08		5	0271-0491	816.80	492.21	224	56.53	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1582.7	B08		5	0272-0493	248.22	493.46	176	48.87	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2195.4	B08		5	0273-0500	654.32	501.07	277	63.94	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1320.7	B08		5	0274-0503	300.62	504.45	260	62.77	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2918.0	B08		5	0275-0506	798.25	505.60	326	70.53	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1777.9	B08		5	0276-0505	82.77	505.79	367	73.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2246.6	B08		5	0277-0504	208.16	504.19	201	51.94	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2136.2	B08		5	0278-0509	168.81	509.67	238	62.77	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2062.2	B08		5	0279-0509	454.85	508.90	311	65.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3326.6	B08		5	0280-0510	567.98	510.19	257	60.28	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1772.1	B08		5	0281-0508	251.51	507.81	140	46.39	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			408.7	B08		5	0282-0514	580.97	514.25	225	62.28	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1773.5	B08		5	0283-0513	947.71	513.22	271	60.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4224.9	B08		5	0284-0514	814.93	514.00	223	58.87	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			579.0	B08		5	0285-0515	766.65	516.13	269	60.28	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1975.8	B08		5	0286-0517	17.14	517.56	263	61.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2491.2	B08		5	0287-0518	185.06	519.87	257	64.77	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2246.9	B08		5	0288-0515	907.14	515.25	189	53.36	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2949.2	B08		5	0289-0520	851.89	519.62	257	59.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1293.8	B08		5	0290-0525	152.92	525.78	265	64.53	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2548.8	B08		5	0291-0523	500.45	522.77	313	65.01	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3409.9	B08		5	0292-0521	247.66	521.15	148	44.87	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1573.9	B08		5	0293-0526	310.58	526.06	250	61.36	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2350.3	B08		5	0294-0530	232.78	529.58	310	66.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2829.7	B08		5	0295-0528	699.51	528.23	219	54.87	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3039.8	B08		5	0296-0529	807.78	529.93	285	66.18	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1528.8	B08		5	0297-0529	602.50	528.81	243	57.36	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1321.2	B08		5	0298-0530	464.02	530.85	276	63.94	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2685.4	B08		5	0299-0535	526.23	535.26	278	62.53	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2185.0	B08		5	0300-0534	194.17	534.36	146	49.46	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1360.0	B08		5	0301-0537	631.59	536.87	273	62.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2054.3	B08		5	0302-0538	203.78	538.71	112	38.39	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1444.0	B08		5	0303-0541	943.14	542.26	251	61.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2100.1	B08		5	0304-0544	285.41	544.89	227	58.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1424.2	B08		5	0305-0542	66.73	542.40	222	54.53	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			461.2	B08		5	0306-0545	394.84	545.45	237	57.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2175.7	B08		5	0307-0547	416.32	546.55	299	65.60	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1857.6	B08		5	0308-0549	501.07	550.03	257	67.01	0.719
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2118.3	B08		5	0309-0548	914.84	547.20	322	67.60	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1749.3	B08		5	0310-0547	861.68	547.45	240	58.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			396.6	B08		5	0311-0550	333.81	549.73	238	60.43	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1672.2	B08		5	0312-0552	96.40	551.94	339	71.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2650.7	B08		5	0313-0550	271.40	550.14	145	47.70	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2455.6	B08		5	0314-0558	159.75	557.98	250	57.94	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2103.1	B08		5	0315-0557	32.26	556.67	214	53.70	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1680.0	B08		5	0316-0560	226.45	559.89	257	66.77	0.724
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			523.9	B08		5	0317-0563	884.68	563.30	252	60.53	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1675.4	B08		5	0318-0563	187.93	563.47	259	60.18	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1518.3	B08		5	0319-0566	488.24	566.76	425	80.43	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1182.8	B08		5	0320-0567	726.77	566.37	288	65.01	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4196.3	B08		5	0321-0570	782.32	570.74	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			614.7	B08		5	0322-0572	138.28	572.28	266	60.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2292.8	B08		5	0323-0577	605.38	577.36	304	65.01	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2386.9	B08		5	0324-0577	257.41	577.32	212	53.36	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1436.1	B08		5	0325-0584	826.31	584.13	267	61.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			517.2	B08		5	0326-0589	905.56	588.89	251	63.60	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2401.4	B08		5	0327-0591	303.02	590.39	204	53.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1561.6	B08		5	0328-0592	671.11	592.34	289	61.94	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			401.6	B08		5	0329-0594	218.77	593.42	285	65.01	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1813.4	B08		5	0330-0593	842.59	593.52	206	53.94	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1808.0	B08		5	0331-0597	890.09	598.13	215	55.70	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2127.5	B08		5	0332-0601	172.79	601.25	348	76.67	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2529.2	B08		5	0333-0602	495.55	601.80	263	59.60	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2065.8	B08		5	0334-0602	698.64	601.29	225	56.53	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1934.5	B08		5	0335-0605	348.19	605.29	285	67.50	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1699.1	B08		5	0336-0606	585.00	606.28	382	74.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			439.5	B08		5	0337-0607	38.14	607.31	229	58.18	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2694.4	B08		5	0338-0610	540.02	609.60	234	59.01	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1543.1	B08		5	0339-0610	417.90	610.62	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1505.1	B08		5	0340-0612	509.01	612.46	249	59.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3048.5	B08		5	0341-0611	793.96	611.55	308	64.77	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2944.8	B08		5	0342-0614	923.70	614.42	241	56.77	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2243.5	B08		5	0343-0616	320.44	616.36	299	65.26	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1581.5	B08		5	0344-0619	712.48	618.24	295	63.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1605.8	B08		5	0345-0621	215.75	620.77	456	88.91	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1962.8	B08		5	0346-0620	757.65	620.59	258	61.94	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1635.2	B08		5	0347-0622	453.10	622.06	232	56.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2562.2	B08		5	0348-0624	546.22	624.36	285	65.01	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2029.7	B08		5	0349-0623	174.39	622.87	236	56.53	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1985.4	B08		5	0350-0622	870.83	622.71	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1980.8	B08		5	0351-0628	605.87	627.99	397	76.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2659.3	B08		5	0352-0624	946.97	624.84	281	62.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1264.2	B08		5	0353-0628	36.42	628.14	277	72.43	0.664
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1766.8	B08		5	0354-0627	248.60	627.74	260	59.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1931.4	B08		5	0355-0629	830.24	628.84	222	63.26	0.697
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			826.7	B08		5	0356-0633	370.33	632.80	275	64.77	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2168.8	B08		5	0357-0636	408.74	635.45	333	70.18	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1485.9	B08		5	0358-0634	559.32	634.44	189	51.46	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			878.8	B08		5	0359-0638	768.63	638.12	249	61.11	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1211.5	B08		5	0360-0644	477.73	644.58	285	65.60	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1462.5	B08		5	0361-0646	141.04	646.00	238	58.53	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2033.3	B08		5	0362-0645	624.71	644.66	226	55.70	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1628.2	B08		5	0363-0648	565.94	648.44	244	60.53	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1564.7	B08		5	0364-0655	923.94	655.47	386	75.60	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1568.6	B08		5	0365-0654	227.52	653.58	294	63.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1485.6	B08		5	0366-0653	685.29	652.45	228	58.77	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1667.3	B08		5	0367-0655	855.20	655.65	287	62.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1695.5	B08		5	0368-0656	278.26	655.64	249	62.53	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1603.4	B08		5	0369-0655	514.61	654.75	228	56.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1821.5	B08		5	0370-0656	649.18	656.57	234	57.94	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1355.4	B08		5	0371-0656	726.71	655.54	244	57.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1192.5	B08		5	0372-0663	819.55	663.14	272	61.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2058.8	B08		5	0373-0663	156.97	663.83	233	57.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2119.6	B08		5	0374-0668	103.57	668.66	288	64.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3060.8	B08		5	0375-0668	297.00	668.30	230	56.77	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2403.7	B08		5	0376-0676	637.78	676.57	328	67.94	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1749.1	B08		5	0377-0675	746.61	675.50	218	56.28	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1719.1	B08		5	0378-0673	784.03	672.98	198	54.53	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			860.4	B08		5	0379-0680	130.23	679.86	225	55.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1244.0	B08		5	0380-0681	352.98	681.85	262	60.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2253.2	B08		5	0381-0678	400.87	678.35	219	56.53	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			357.2	B08		5	0382-0680	564.26	680.36	266	60.18	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1290.5	B08		5	0383-0681	809.99	680.69	259	58.53	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1695.7	B08		5	0384-0681	260.11	680.66	242	61.11	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1594.6	B08		5	0385-0682	443.93	681.27	251	58.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			251.4	B08		5	0386-0681	518.84	681.30	267	61.94	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1911.7	B08		5	0387-0689	851.09	689.63	349	71.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1501.9	B08		5	0388-0685	944.31	685.34	228	57.11	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			460.5	B08		5	0389-0689	331.92	689.08	240	58.28	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			503.9	B08		5	0390-0688	175.30	688.12	233	61.60	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1781.5	B08		5	0391-0697	481.88	696.74	235	59.11	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1808.0	B08		5	0392-0696	499.67	696.24	222	59.36	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1835.8	B08		5	0393-0699	454.71	698.92	176	50.28	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1670.8	B08		5	0394-0702	763.55	701.67	360	71.84	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			774.8	B08		5	0395-0702	181.65	702.87	251	59.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2212.0	B08		5	0396-0704	832.21	704.19	334	67.60	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2292.4	B08		5	0397-0706	628.57	706.03	292	65.36	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			584.6	B08		5	0398-0707	607.56	708.06	218	56.28	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			443.9	B08		5	0399-0710	334.25	709.85	209	53.11	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			363.4	B08		5	0400-0711	275.53	711.28	216	59.70	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			424.4	B08		6	0001-0028	566.76	28.73	247	61.36	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1716.9	B08		6	0002-0030	203.14	30.57	437	79.26	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2553.6	B08		6	0003-0027	815.03	27.38	269	60.53	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1445.2	B08		6	0004-0028	518.48	27.57	250	59.94	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1359.8	B08		6	0005-0032	878.67	31.47	241	60.18	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2505.4	B08		6	0006-0034	238.40	33.37	239	58.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1642.5	B08		6	0007-0032	292.61	32.32	341	69.11	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2010.7	B08		6	0008-0042	603.48	42.80	661	124.71	0.534
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1546.7	B08		6	0009-0035	387.87	34.87	352	71.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2218.7	B08		6	0010-0036	117.52	36.42	257	60.77	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2532.4	B08		6	0011-0044	29.89	44.06	304	66.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1003.5	B08		6	0012-0047	136.17	48.47	208	63.36	0.651
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2591.9	B08		6	0013-0046	277.18	45.73	246	58.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2121.3	B08		6	0014-0048	920.08	48.74	236	58.53	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1549.5	B08		6	0015-0053	47.84	53.09	219	56.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			475.9	B08		6	0016-0057	391.41	57.27	229	56.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2634.0	B08		6	0017-0059	692.75	59.01	218	55.94	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1613.9	B08		6	0018-0062	852.91	61.86	412	77.50	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			504.7	B08		6	0019-0057	351.17	57.35	167	50.28	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2900.4	B08		6	0020-0061	204.10	61.84	226	55.94	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2551.1	B08		6	0021-0063	730.17	63.45	233	59.11	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			351.6	B08		6	0022-0064	498.72	63.16	245	69.01	0.646
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2669.1	B08		6	0023-0063	678.46	63.79	253	60.53	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			782.4	B08		6	0024-0062	800.33	61.85	244	58.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			295.9	B08		6	0025-0068	226.95	67.53	270	62.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2999.7	B08		6	0026-0066	278.84	66.39	246	60.18	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3098.8	B08		6	0027-0072	181.60	72.64	259	59.60	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2801.0	B08		6	0028-0073	303.97	72.75	142	50.87	0.690
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2979.4	B08		6	0029-0075	873.16	74.78	181	55.46	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			292.1	B08		6	0030-0077	137.57	77.45	281	70.77	0.705
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4024.4	B08		6	0031-0072	369.31	71.86	216	56.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1850.3	B08		6	0032-0074	93.35	74.42	277	66.18	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2564.7	B08		6	0033-0076	749.60	75.53	247	60.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1565.7	B08		6	0034-0074	828.53	75.12	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			277.3	B08		6	0035-0074	468.50	73.93	140	53.60	0.612
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3369.4	B08		6	0036-0075	887.21	74.53	157	46.28	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2601.3	B08		6	0037-0076	291.02	76.96	172	51.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1119.0	B08		6	0038-0078	326.11	77.87	206	53.11	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2350.5	B08		6	0039-0081	945.11	81.27	264	61.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			276.6	B08		6	0040-0083	475.33	83.97	171	69.50	0.445
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3549.3	B08		6	0041-0084	646.17	83.21	217	57.01	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2398.8	B08		6	0042-0084	782.09	84.02	216	62.43	0.697
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2050.5	B08		6	0043-0090	621.04	89.96	363	79.50	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1026.1	B08		6	0044-0090	264.22	90.64	234	58.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3427.5	B08		6	0045-0094	656.83	94.92	306	66.08	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3858.5	B08		6	0046-0095	382.88	95.30	152	47.46	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2178.3	B08		6	0047-0096	915.08	96.39	207	53.70	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3957.0	B08		6	0048-0101	758.37	101.39	211	57.46	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4228.8	B08		6	0049-0100	845.38	100.20	293	63.94	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2152.3	B08		6	0050-0102	96.53	102.95	297	64.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3224.1	B08		6	0051-0101	298.56	101.23	244	58.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2241.2	B08		6	0052-0100	798.87	100.66	225	56.28	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2253.1	B08		6	0053-0104	198.14	103.63	280	61.60	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			425.1	B08		6	0054-0103	877.50	103.52	247	58.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			648.0	B08		6	0055-0102	942.13	102.05	251	59.70	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3235.3	B08		6	0056-0107	744.36	107.67	162	47.21	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4296.3	B08		6	0057-0108	391.85	108.59	153	45.46	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1791.2	B08		6	0058-0113	78.79	113.28	277	65.36	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1386.8	B08		6	0059-0113	242.98	113.41	218	53.70	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3683.6	B08		6	0060-0116	766.18	115.78	150	48.04	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3880.2	B08		6	0061-0116	804.17	116.51	207	54.28	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3709.1	B08		6	0062-0119	279.97	119.87	232	56.28	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2106.5	B08		6	0063-0123	914.69	123.08	259	61.01	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1787.7	B08		6	0064-0122	429.92	122.38	403	79.60	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2764.2	B08		6	0065-0128	842.71	127.97	474	112.37	0.472
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2500.7	B08		6	0066-0127	889.58	127.61	385	73.50	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3702.2	B08		6	0067-0125	389.34	124.73	336	69.36	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			360.9	B08		6	0068-0127	691.92	126.57	245	71.84	0.597
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1492.3	B08		6	0069-0127	175.41	127.89	218	53.36	0.962
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3177.2	B08		6	0070-0132	125.98	132.86	282	62.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1804.7	B08		6	0071-0134	29.09	133.61	376	76.08	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			947.3	B08		6	0072-0130	208.92	130.13	164	48.28	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3990.3	B08		6	0073-0131	813.04	132.02	186	52.87	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1521.9	B08		6	0074-0133	355.82	133.13	343	67.94	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2154.3	B08		6	0075-0138	732.48	138.25	276	61.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			245.5	B08		6	0076-0144	149.47	145.45	274	73.60	0.636
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3495.1	B08		6	0077-0140	309.01	139.24	216	55.94	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1109.3	B08		6	0078-0143	196.39	143.48	203	56.28	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2357.3	B08		6	0079-0149	786.60	150.31	291	65.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2677.2	B08		6	0080-0150	386.37	149.85	275	60.77	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1233.5	B08		6	0081-0148	817.30	148.22	250	75.01	0.558
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			598.4	B08		6	0082-0150	946.96	149.91	242	58.18	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1722.7	B08		6	0083-0153	273.24	154.02	289	65.01	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1794.7	B08		6	0084-0155	131.09	155.52	247	59.01	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3617.6	B08		6	0085-0157	246.98	157.73	337	69.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1510.8	B08		6	0086-0158	457.24	158.53	339	68.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2037.1	B08		6	0087-0158	208.77	158.21	242	58.18	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1612.3	B08		6	0088-0166	49.73	166.25	354	70.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2873.4	B08		6	0089-0166	287.54	166.76	248	58.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1277.7	B08		6	0090-0175	870.84	175.38	381	75.26	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1344.3	B08		6	0091-0172	735.60	172.28	234	59.36	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1919.7	B08		6	0092-0175	835.95	175.10	250	57.94	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1395.1	B08		6	0093-0179	464.94	179.35	215	56.28	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2497.1	B08		6	0094-0179	190.45	179.29	343	71.36	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			500.4	B08		6	0095-0182	76.79	183.02	272	67.01	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3878.5	B08		6	0096-0182	373.99	181.65	227	79.98	0.446
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2233.2	B08		6	0097-0181	690.04	180.83	277	62.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1905.1	B08		6	0098-0181	231.23	181.50	233	55.94	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			579.7	B08		6	0099-0183	917.64	183.66	167	53.60	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2840.4	B08		6	0100-0184	776.85	184.50	201	52.53	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2444.6	B08		6	0101-0185	758.74	184.56	217	53.36	0.958
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1764.9	B08		6	0102-0188	800.20	188.71	333	70.43	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2359.5	B08		6	0103-0190	397.97	190.57	256	61.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2012.9	B08		6	0104-0192	899.37	192.46	295	64.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4849.8	B08		6	0105-0200	108.71	200.14	359	70.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2485.5	B08		6	0106-0201	56.29	200.70	237	57.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2475.4	B08		6	0107-0200	681.99	201.10	237	62.18	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1312.4	B08		6	0108-0201	834.80	200.47	355	73.26	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1862.0	B08		6	0109-0203	176.64	202.27	263	66.18	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1425.2	B08		6	0110-0209	310.51	208.53	366	75.94	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1925.3	B08		6	0111-0209	472.29	209.39	215	55.94	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2827.1	B08		6	0112-0214	606.09	213.84	242	58.53	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2966.0	B08		6	0113-0214	818.32	214.27	239	57.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2083.5	B08		6	0114-0217	248.87	217.11	332	67.01	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2035.5	B08		6	0115-0217	500.00	216.60	186	49.94	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1537.2	B08		6	0116-0220	568.92	220.19	257	58.77	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4659.1	B08		6	0117-0224	726.78	223.78	320	67.60	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1356.0	B08		6	0118-0225	142.72	225.23	246	57.60	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1269.0	B08		6	0119-0226	234.60	227.06	200	53.70	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2019.6	B08		6	0120-0230	948.80	230.29	228	56.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3662.7	B08		6	0121-0228	659.39	227.78	153	49.80	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2764.7	B08		6	0122-0236	910.61	235.65	274	68.43	0.735
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2558.5	B08		6	0123-0235	375.34	234.72	210	54.04	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2331.0	B08		6	0124-0234	790.33	235.13	163	49.36	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3576.2	B08		6	0125-0238	896.97	238.66	203	60.77	0.691
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1638.5	B08		6	0126-0240	625.02	239.52	279	64.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1361.9	B08		6	0127-0246	178.90	245.48	428	85.50	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3076.9	B08		6	0128-0245	438.35	245.28	355	72.77	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			925.1	B08		6	0129-0245	646.48	243.67	266	67.60	0.732
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2565.0	B08		6	0130-0239	663.76	238.35	168	49.21	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			613.9	B08		6	0131-0243	67.63	243.52	213	56.28	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4672.7	B08		6	0132-0247	486.91	246.95	253	64.18	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			585.5	B08		6	0133-0248	531.09	248.44	249	61.01	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1709.5	B08		6	0134-0251	417.01	250.38	212	58.77	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1123.6	B08		6	0135-0253	118.79	252.54	264	60.43	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1401.6	B08		6	0136-0252	675.65	252.20	285	64.53	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1591.9	B08		6	0137-0256	749.14	256.19	300	66.18	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2582.7	B08		6	0138-0253	368.01	252.98	164	51.11	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			989.6	B08		6	0139-0259	598.98	259.20	285	64.87	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2514.2	B08		6	0140-0256	824.76	255.95	217	56.77	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2239.5	B08		6	0141-0259	797.20	259.04	239	58.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2757.5	B08		6	0142-0261	21.52	261.09	298	65.01	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			984.5	B08		6	0143-0259	875.37	259.08	221	56.77	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1317.2	B08		6	0144-0261	553.37	260.39	166	60.18	0.576
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3954.4	B08		6	0145-0263	328.58	263.39	305	65.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2299.7	B08		6	0146-0265	465.15	265.36	291	63.11	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2406.6	B08		6	0147-0271	68.92	272.53	363	108.23	0.389
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2664.7	B08		6	0148-0272	378.93	270.94	392	79.84	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3258.7	B08		6	0149-0267	850.10	267.54	159	47.70	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2842.9	B08		6	0150-0267	833.39	268.08	242	59.70	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1784.9	B08		6	0151-0270	502.39	270.25	255	61.11	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2244.1	B08		6	0152-0269	695.23	268.96	241	59.46	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			909.1	B08		6	0153-0274	150.00	273.10	270	66.43	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1527.2	B08		6	0154-0274	212.56	275.08	217	53.94	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1348.0	B08		6	0155-0272	548.82	271.76	128	44.87	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1520.4	B08		6	0156-0279	749.96	279.48	346	77.60	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2879.1	B08		6	0157-0284	596.70	283.79	306	64.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1709.3	B08		6	0158-0285	26.16	285.99	324	68.18	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2935.0	B08		6	0159-0287	859.77	287.10	212	55.36	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2251.5	B08		6	0160-0289	272.88	290.40	237	58.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3482.5	B08		6	0161-0300	476.24	299.32	489	97.88	0.641
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2335.2	B08		6	0162-0294	791.90	294.98	252	59.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2189.4	B08		6	0163-0297	932.42	297.09	289	64.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			561.8	B08		6	0164-0296	306.06	296.08	262	61.60	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1206.8	B08		6	0165-0298	403.47	297.49	312	65.60	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3610.4	B08		6	0166-0296	349.69	295.43	248	58.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1335.9	B08		6	0167-0295	433.52	295.30	274	64.77	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4861.8	B08		6	0168-0305	645.39	304.40	304	64.18	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2824.7	B08		6	0169-0305	706.26	305.14	243	59.11	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3404.6	B08		6	0170-0313	93.83	312.17	329	85.50	0.566
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1607.3	B08		6	0171-0309	41.27	308.98	197	57.11	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2875.2	B08		6	0172-0306	730.39	305.71	220	55.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			585.3	B08		6	0173-0312	150.84	313.41	276	66.77	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			801.8	B08		6	0174-0313	24.52	313.16	261	59.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2968.1	B08		6	0175-0313	793.17	313.02	264	59.70	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1252.2	B08		6	0176-0315	439.81	316.01	212	55.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1583.1	B08		6	0177-0317	396.13	317.87	407	81.01	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3118.5	B08		6	0178-0318	545.03	318.51	318	65.01	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1970.0	B08		6	0179-0327	754.74	327.17	263	61.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3861.5	B08		6	0180-0331	645.40	330.50	297	62.77	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3018.1	B08		6	0181-0334	491.61	334.18	219	55.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1280.6	B08		6	0182-0342	301.32	342.68	475	83.50	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1661.4	B08		6	0183-0340	61.74	339.55	158	51.11	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2925.7	B08		6	0184-0339	792.04	339.66	201	52.53	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1603.1	B08		6	0185-0342	72.89	343.66	231	63.11	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2750.3	B08		6	0186-0341	550.94	341.55	258	58.53	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2166.3	B08		6	0187-0345	938.04	345.64	413	76.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1679.9	B08		6	0188-0345	247.62	345.92	257	62.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2326.8	B08		6	0189-0345	736.76	345.12	222	56.18	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2305.4	B08		6	0190-0352	915.67	352.18	387	81.01	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1699.0	B08		6	0191-0352	377.14	351.79	219	57.70	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2875.4	B08		6	0192-0351	498.07	351.01	213	53.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3751.8	B08		6	0193-0353	692.35	352.74	324	67.36	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2212.5	B08		6	0194-0357	364.46	357.85	224	56.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			607.1	B08		6	0195-0360	461.11	360.46	289	67.84	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3010.9	B08		6	0196-0361	649.92	360.91	230	56.53	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2634.6	B08		6	0197-0363	727.33	363.16	361	72.08	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2851.2	B08		6	0198-0362	812.22	361.84	247	58.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3151.3	B08		6	0199-0362	324.84	362.43	285	62.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2707.3	B08		6	0200-0364	433.33	364.31	205	53.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2245.1	B08		6	0201-0369	678.26	369.38	217	56.77	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3971.9	B08		6	0202-0376	638.40	376.92	207	56.18	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			883.8	B08		6	0203-0372	911.90	372.84	164	47.21	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1567.5	B08		6	0204-0379	717.08	380.18	358	71.26	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1209.4	B08		6	0205-0383	151.22	382.57	305	66.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2350.6	B08		6	0206-0382	289.74	381.60	226	57.36	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1453.2	B08		6	0207-0386	890.49	386.72	261	61.84	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			447.3	B08		6	0208-0387	834.65	386.96	213	56.87	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			934.7	B08		6	0209-0390	82.98	390.33	240	58.77	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			301.6	B08		6	0210-0392	36.05	392.71	211	67.01	0.590
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2516.3	B08		6	0211-0392	183.93	392.40	256	60.53	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3264.4	B08		6	0212-0392	298.98	391.86	144	51.01	0.695
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			307.6	B08		6	0213-0394	114.07	394.56	296	64.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2045.8	B08		6	0214-0394	281.33	394.54	232	57.11	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4873.9	B08		6	0215-0394	412.94	394.12	236	58.18	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2596.7	B08		6	0216-0397	433.84	396.77	302	64.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2796.4	B08		6	0217-0397	808.95	397.53	287	63.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			458.5	B08		6	0218-0399	16.41	398.13	187	55.36	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2871.2	B08		6	0219-0397	306.38	397.19	106	41.46	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			423.2	B08		6	0220-0401	566.73	401.12	273	61.60	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1819.5	B08		6	0221-0400	702.01	399.92	259	60.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			385.2	B08		6	0222-0402	262.75	402.44	261	59.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1169.0	B08		6	0223-0402	896.29	402.41	262	64.28	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2259.2	B08		6	0224-0402	917.05	402.60	176	50.53	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			964.5	B08		6	0225-0402	210.70	402.36	213	55.46	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2960.4	B08		6	0226-0406	634.54	405.98	182	52.53	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1255.0	B08		6	0227-0407	617.53	407.50	242	58.04	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			614.4	B08		6	0228-0410	844.46	410.10	232	59.11	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1361.1	B08		6	0229-0414	863.80	414.11	264	61.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2144.3	B08		6	0230-0419	316.94	419.35	384	73.50	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1939.8	B08		6	0231-0416	247.34	416.66	321	66.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			940.6	B08		6	0232-0418	543.53	418.25	242	59.36	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2214.2	B08		6	0233-0420	160.59	420.35	351	71.84	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1721.0	B08		6	0234-0420	689.89	420.40	331	71.01	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2292.6	B08		6	0235-0417	919.49	417.35	174	48.04	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2074.1	B08		6	0236-0420	650.08	420.06	260	61.36	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			618.6	B08		6	0237-0424	349.77	424.67	239	59.84	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			995.2	B08		6	0238-0422	529.94	422.92	197	54.28	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			301.7	B08		6	0239-0422	766.88	421.56	159	53.94	0.687
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2894.9	B08		6	0240-0430	842.47	430.45	339	69.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2075.5	B08		6	0241-0430	118.40	430.35	258	61.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2043.4	B08		6	0242-0431	611.93	431.41	318	67.01	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1676.5	B08		6	0243-0431	914.42	431.01	211	57.36	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1709.7	B08		6	0244-0432	934.62	432.12	214	58.53	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1675.4	B08		6	0245-0435	49.57	435.67	253	58.28	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			270.7	B08		6	0246-0432	771.14	431.83	128	51.70	0.602
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2496.6	B08		6	0247-0434	896.37	433.69	188	51.94	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1717.9	B08		6	0248-0443	875.29	443.91	144	50.53	0.709
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1617.8	B08		6	0249-0443	261.47	443.67	254	59.11	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1980.8	B08		6	0250-0444	558.68	443.73	283	64.53	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2981.0	B08		6	0251-0449	448.25	449.72	290	66.77	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1483.6	B08		6	0252-0448	228.27	448.43	318	67.94	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			779.3	B08		6	0253-0454	590.24	454.84	417	75.01	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			592.7	B08		6	0254-0455	50.24	454.70	312	65.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2095.6	B08		6	0255-0452	174.21	452.40	213	55.80	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1322.7	B08		6	0256-0455	701.19	455.85	283	66.67	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1753.9	B08		6	0257-0452	853.43	452.66	186	53.70	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2279.0	B08		6	0258-0457	671.01	456.28	211	57.94	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3110.7	B08		6	0259-0458	464.15	458.21	320	68.18	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1639.0	B08		6	0260-0458	747.26	458.97	233	64.43	0.705
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3087.2	B08		6	0261-0462	420.15	463.25	341	75.50	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2448.1	B08		6	0262-0459	85.49	459.20	238	57.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1545.2	B08		6	0263-0459	507.37	459.32	214	54.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2568.0	B08		6	0264-0465	314.66	465.76	333	71.01	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2460.0	B08		6	0265-0466	136.07	466.13	354	71.11	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1799.6	B08		6	0266-0468	172.72	467.77	250	63.70	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2306.9	B08		6	0267-0473	491.59	472.88	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1432.5	B08		6	0268-0473	815.16	473.17	253	59.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1556.8	B08		6	0269-0478	780.69	477.91	325	68.77	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2589.0	B08		6	0270-0475	227.97	475.28	214	57.11	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2772.3	B08		6	0271-0480	211.70	481.35	251	62.18	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2767.1	B08		6	0272-0483	859.42	482.86	271	64.18	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1547.9	B08		6	0273-0485	752.35	484.85	237	60.87	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1740.6	B08		6	0274-0483	585.53	483.73	243	63.36	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			514.0	B08		6	0275-0484	385.51	485.19	164	50.87	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1629.7	B08		6	0276-0488	89.40	489.15	395	75.01	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2376.7	B08		6	0277-0489	296.69	488.85	244	58.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2598.6	B08		6	0278-0492	143.08	492.32	228	55.36	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			512.8	B08		6	0279-0491	336.64	491.70	220	56.28	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1038.4	B08		6	0280-0492	513.77	492.88	252	59.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2190.5	B08		6	0281-0498	48.00	498.20	251	59.94	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2648.3	B08		6	0282-0498	852.36	498.53	283	65.60	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1501.6	B08		6	0283-0500	111.63	500.19	240	58.77	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1619.6	B08		6	0284-0500	478.43	499.97	207	51.46	0.982
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3502.1	B08		6	0285-0501	795.41	501.71	210	53.70	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1218.8	B08		6	0286-0503	443.46	502.86	393	76.67	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3187.7	B08		6	0287-0504	559.57	504.46	323	67.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2014.3	B08		6	0288-0504	831.86	504.47	290	62.53	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1393.7	B08		6	0289-0505	333.16	504.68	199	54.87	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1875.8	B08		6	0290-0509	934.43	509.12	471	88.57	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1803.5	B08		6	0291-0510	601.38	510.61	350	70.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2089.1	B08		6	0292-0512	911.09	511.98	298	68.18	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			460.0	B08		6	0293-0514	516.97	514.15	236	57.70	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1710.8	B08		6	0294-0515	42.43	515.91	283	62.18	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			720.7	B08		6	0295-0516	653.99	516.16	302	66.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1957.8	B08		6	0296-0518	896.99	517.89	228	60.77	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1817.3	B08		6	0297-0518	64.81	518.39	236	56.77	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2048.0	B08		6	0298-0521	259.18	521.20	288	64.43	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2124.7	B08		6	0299-0522	759.26	522.01	321	66.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			730.2	B08		6	0300-0521	695.19	521.83	316	67.84	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1485.8	B08		6	0301-0524	307.39	524.49	237	63.60	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			497.9	B08		6	0302-0524	537.36	523.04	202	57.36	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2740.6	B08		6	0303-0526	738.26	525.71	335	67.11	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2195.2	B08		6	0304-0530	442.40	529.89	215	53.94	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1680.3	B08		6	0305-0529	222.70	529.77	259	62.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1521.4	B08		6	0306-0533	148.88	533.45	266	64.77	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1980.9	B08		6	0307-0537	520.57	536.09	307	66.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2883.4	B08		6	0308-0540	795.24	540.18	237	62.77	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2028.7	B08		6	0309-0541	927.11	540.64	263	61.36	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1498.3	B08		6	0310-0541	111.28	540.83	251	61.94	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			510.3	B08		6	0311-0538	356.39	538.08	144	45.36	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1814.5	B08		6	0312-0542	430.57	542.86	238	62.43	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1388.9	B08		6	0313-0544	37.62	545.15	245	60.18	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1191.1	B08		6	0314-0547	665.59	548.67	353	72.67	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4085.8	B08		6	0315-0546	456.52	545.84	221	57.36	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			410.2	B08		6	0316-0549	376.55	548.79	276	62.87	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1282.7	B08		6	0317-0551	228.15	552.09	280	66.77	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1036.4	B08		6	0318-0547	558.15	547.60	267	61.94	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1705.3	B08		6	0319-0549	84.88	549.15	205	52.28	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			727.4	B08		6	0320-0548	343.66	548.44	170	50.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2003.5	B08		6	0321-0550	623.33	550.48	234	56.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2002.7	B08		6	0322-0553	852.44	553.40	224	58.53	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1983.4	B08		6	0323-0552	702.41	551.60	300	63.36	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1836.2	B08		6	0324-0555	65.46	554.14	214	59.70	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			5286.5	B08		6	0325-0559	412.48	559.15	240	58.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4646.5	B08		6	0326-0556	466.53	556.84	195	54.53	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2138.5	B08		6	0327-0560	785.46	559.58	267	62.43	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			345.6	B08		6	0328-0560	950.45	560.92	238	60.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			353.7	B08		6	0329-0566	215.30	565.75	257	61.70	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2121.5	B08		6	0330-0569	328.41	568.40	269	61.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1487.8	B08		6	0331-0574	461.56	575.67	264	67.36	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2045.7	B08		6	0332-0573	871.02	573.07	373	70.18	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			359.5	B08		6	0333-0572	501.78	572.33	159	49.11	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1690.0	B08		6	0334-0578	44.25	578.31	327	75.01	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			469.0	B08		6	0335-0576	831.51	575.40	184	50.87	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3448.5	B08		6	0336-0579	405.43	579.94	296	65.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1208.2	B08		6	0337-0580	940.14	579.77	260	61.94	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3050.3	B08		6	0338-0582	118.12	582.44	355	70.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1354.8	B08		6	0339-0581	545.71	581.43	267	62.43	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2300.3	B08		6	0340-0583	758.34	583.80	270	60.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2066.8	B08		6	0341-0590	861.76	590.73	212	56.28	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1883.8	B08		6	0342-0593	897.40	593.24	281	63.60	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			660.7	B08		6	0343-0595	503.64	594.99	153	46.28	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1660.7	B08		6	0344-0598	186.48	597.91	353	69.84	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			371.6	B08		6	0345-0598	925.56	598.86	254	59.11	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1470.3	B08		6	0346-0594	793.86	594.85	119	44.28	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1584.5	B08		6	0347-0601	45.57	601.17	270	62.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1971.2	B08		6	0348-0604	674.21	604.94	328	70.77	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1619.7	B08		6	0349-0605	300.47	604.75	327	68.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1398.9	B08		6	0350-0604	797.84	604.85	204	61.94	0.668
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			884.3	B08		6	0351-0610	121.59	610.26	241	58.53	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3213.1	B08		6	0352-0614	419.35	614.52	331	67.60	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2953.8	B08		6	0353-0617	18.20	617.26	228	54.53	0.964
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1501.2	B08		6	0354-0620	371.00	620.02	395	78.08	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1813.0	B08		6	0355-0618	818.54	619.07	286	63.11	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2656.2	B08		6	0356-0621	886.62	621.92	270	61.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1121.1	B08		6	0357-0624	540.31	624.49	305	65.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2294.1	B08		6	0358-0624	108.75	623.92	311	66.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1493.0	B08		6	0359-0624	238.42	623.48	277	64.53	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2669.2	B08		6	0360-0627	41.31	627.73	283	63.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2847.7	B08		6	0361-0632	771.16	631.75	395	74.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1274.6	B08		6	0362-0638	948.41	638.14	366	72.43	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2756.1	B08		6	0363-0639	381.42	638.47	293	64.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1497.4	B08		6	0364-0642	841.54	642.68	274	63.84	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2473.9	B08		6	0365-0646	214.06	645.66	254	63.11	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1324.7	B08		6	0366-0646	912.19	645.78	237	57.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2969.2	B08		6	0367-0648	64.54	648.32	224	56.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1425.6	B08		6	0368-0650	489.58	649.78	282	63.01	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			924.3	B08		6	0369-0653	422.26	652.20	405	76.67	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2586.7	B08		6	0370-0648	826.17	648.23	215	54.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1975.4	B08		6	0371-0653	113.86	652.70	231	58.87	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1951.2	B08		6	0372-0653	602.39	653.01	329	69.01	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1449.0	B08		6	0373-0658	18.30	658.28	370	72.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			355.2	B08		6	0374-0655	712.94	655.48	293	65.36	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2625.9	B08		6	0375-0658	328.43	658.02	305	64.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2653.0	B08		6	0376-0664	781.20	663.74	247	59.36	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			429.3	B08		6	0377-0662	900.70	662.82	224	56.53	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1615.2	B08		6	0378-0664	148.61	664.67	220	53.94	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1834.2	B08		6	0379-0663	524.35	662.59	272	61.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			928.9	B08		6	0380-0665	835.11	664.12	225	61.01	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2737.1	B08		6	0381-0673	210.21	673.07	188	52.87	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1997.5	B08		6	0382-0672	430.67	672.77	245	58.87	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2836.6	B08		6	0383-0673	822.78	674.69	235	58.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2036.2	B08		6	0384-0675	614.54	674.84	272	63.01	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3011.2	B08		6	0385-0674	859.84	673.39	222	57.01	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2112.0	B08		6	0386-0675	663.73	675.40	406	77.01	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			948.3	B08		6	0387-0677	744.93	677.07	237	59.11	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1664.0	B08		6	0388-0683	78.83	682.69	354	73.26	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1767.0	B08		6	0389-0681	930.27	681.12	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3100.7	B08		6	0390-0686	260.52	686.06	309	64.18	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			481.0	B08		6	0391-0684	802.37	683.50	206	53.11	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1663.9	B08		6	0392-0686	126.55	686.41	213	56.28	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2543.8	B08		6	0393-0687	406.24	687.58	300	63.60	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1513.0	B08		6	0394-0688	38.48	688.08	219	55.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2706.8	B08		6	0395-0692	336.61	691.64	260	61.01	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1475.1	B08		6	0396-0693	377.30	693.73	143	47.80	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1564.4	B08		6	0397-0694	473.18	694.78	246	59.94	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2860.8	B08		6	0398-0700	708.19	700.42	393	75.01	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1317.7	B08		6	0399-0699	725.25	699.07	256	59.70	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			691.7	B08		6	0400-0703	517.50	703.30	205	54.53	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2701.0	B08		6	0401-0706	576.37	706.19	196	53.94	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2863.3	B08		6	0402-0707	116.69	707.16	302	66.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1433.5	B08		6	0403-0709	376.77	708.80	241	61.70	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1249.5	B08		7	0001-0026	81.39	26.79	137	43.94	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			928.6	B08		7	0002-0029	247.78	28.87	248	59.11	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3193.5	B08		7	0003-0028	824.82	27.21	222	55.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2894.6	B08		7	0004-0033	560.84	33.13	299	64.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2069.2	B08		7	0005-0031	711.12	31.85	252	59.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3050.0	B08		7	0006-0036	632.02	36.41	452	80.08	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1525.5	B08		7	0007-0036	390.73	36.07	154	54.28	0.657
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2409.3	B08		7	0008-0040	52.67	39.62	298	66.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1141.9	B08		7	0009-0037	403.64	36.79	145	43.80	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3114.5	B08		7	0010-0043	16.80	44.41	162	53.70	0.706
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1352.0	B08		7	0011-0040	381.00	39.87	117	42.87	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2410.6	B08		7	0012-0047	30.32	48.28	217	59.94	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2696.1	B08		7	0013-0047	435.38	48.08	253	60.53	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1877.3	B08		7	0014-0046	920.57	45.84	220	55.11	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1417.4	B08		7	0015-0051	272.52	52.16	262	67.50	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1874.0	B08		7	0016-0050	486.01	50.03	449	81.26	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2972.3	B08		7	0017-0057	78.11	57.33	229	56.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2413.6	B08		7	0018-0063	120.28	62.76	458	79.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2030.8	B08		7	0019-0063	57.27	62.60	233	62.77	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1419.4	B08		7	0020-0064	310.19	63.67	254	74.08	0.582
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3033.7	B08		7	0021-0067	750.66	66.50	391	72.67	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3891.7	B08		7	0022-0066	821.45	66.51	304	65.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			568.9	B08		7	0023-0066	167.52	66.48	242	59.94	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2271.5	B08		7	0024-0067	451.50	67.38	306	67.84	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3876.2	B08		7	0025-0073	68.84	72.68	197	51.70	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2000.3	B08		7	0026-0078	911.74	78.18	401	74.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1998.1	B08		7	0027-0081	195.65	81.18	335	69.26	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1698.3	B08		7	0028-0083	493.62	83.30	468	86.91	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			536.8	B08		7	0029-0081	336.24	81.83	194	56.18	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1411.1	B08		7	0030-0084	688.64	84.51	298	66.67	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2877.9	B08		7	0031-0084	776.67	84.47	260	60.18	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2828.3	B08		7	0032-0087	403.82	87.15	260	59.60	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4101.9	B08		7	0033-0092	240.65	92.13	310	64.77	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			460.8	B08		7	0034-0096	739.27	96.03	240	58.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1530.8	B08		7	0035-0102	295.43	101.57	365	80.43	0.709
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			367.4	B08		7	0036-0106	440.25	106.12	284	64.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1825.6	B08		7	0037-0112	414.56	114.02	365	86.91	0.607
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2406.5	B08		7	0038-0113	24.04	114.25	259	58.77	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1271.4	B08		7	0039-0115	912.85	115.08	264	62.43	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2367.9	B08		7	0040-0112	91.25	111.96	205	54.28	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			420.6	B08		7	0041-0116	861.89	116.11	264	61.36	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2133.9	B08		7	0042-0122	319.98	122.32	317	69.60	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1447.6	B08		7	0043-0121	338.52	120.85	147	52.63	0.667
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2945.6	B08		7	0044-0123	389.16	122.64	301	66.43	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1799.1	B08		7	0045-0121	188.05	120.87	238	64.77	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2137.5	B08		7	0046-0130	584.23	129.68	444	82.08	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1024.5	B08		7	0047-0127	632.15	126.73	300	77.26	0.632
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2820.0	B08		7	0048-0128	236.19	127.72	257	57.70	0.970
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2292.5	B08		7	0049-0132	83.70	132.95	279	65.36	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			937.5	B08		7	0050-0132	157.49	131.97	151	45.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			701.8	B08		7	0051-0132	199.98	133.12	219	57.94	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2089.5	B08		7	0052-0135	440.86	136.01	267	62.77	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2247.8	B08		7	0053-0138	378.41	138.40	250	61.94	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1495.5	B08		7	0054-0143	802.02	142.93	505	87.84	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3417.7	B08		7	0055-0140	183.23	140.29	197	52.28	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1161.2	B08		7	0056-0141	168.37	141.83	204	53.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4909.1	B08		7	0057-0146	272.79	146.49	375	76.18	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2109.6	B08		7	0058-0143	290.74	142.61	123	42.28	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1834.5	B08		7	0059-0147	689.43	148.17	378	74.08	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2253.8	B08		7	0060-0151	888.71	150.40	366	70.77	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1599.8	B08		7	0061-0155	242.33	155.57	246	59.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1847.5	B08		7	0062-0159	495.41	159.53	476	81.26	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2028.6	B08		7	0063-0154	140.59	153.43	151	49.36	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2592.6	B08		7	0064-0161	339.70	161.13	531	97.40	0.703
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3224.8	B08		7	0065-0159	361.14	158.65	346	75.01	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			901.4	B08		7	0066-0159	674.90	159.46	220	57.60	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1508.6	B08		7	0067-0164	634.54	165.00	233	63.84	0.718
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1873.1	B08		7	0068-0163	134.49	163.21	162	51.60	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2703.0	B08		7	0069-0164	415.04	164.40	351	71.01	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			362.7	B08		7	0070-0164	465.84	164.38	268	60.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2184.5	B08		7	0071-0165	88.45	165.93	207	53.70	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			839.2	B08		7	0072-0167	43.25	167.63	240	56.28	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2857.3	B08		7	0073-0169	215.15	169.30	400	75.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1461.4	B08		7	0074-0174	818.62	173.99	505	87.26	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1378.5	B08		7	0075-0171	853.97	170.66	361	72.08	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1610.4	B08		7	0076-0171	607.12	171.03	221	55.70	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1221.9	B08		7	0077-0176	307.71	176.43	399	76.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1721.6	B08		7	0078-0174	773.89	174.10	219	53.94	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4086.5	B08		7	0079-0173	920.75	174.10	151	66.43	0.430
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1475.2	B08		7	0080-0179	627.32	179.07	275	68.77	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			597.5	B08		7	0081-0183	92.24	182.24	227	58.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2379.8	B08		7	0082-0186	412.67	186.07	258	59.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1509.0	B08		7	0083-0191	529.97	191.30	400	74.91	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1778.7	B08		7	0084-0193	162.74	193.94	271	72.33	0.651
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2806.0	B08		7	0085-0194	571.70	194.47	302	64.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1980.4	B08		7	0086-0193	719.20	193.39	188	53.94	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2357.7	B08		7	0087-0196	899.44	197.36	350	72.18	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			424.5	B08		7	0088-0195	686.08	194.73	240	57.94	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1720.5	B08		7	0089-0197	218.70	197.96	244	59.36	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2037.8	B08		7	0090-0198	314.70	198.25	251	58.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1268.8	B08		7	0091-0196	613.26	196.59	204	56.87	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2281.6	B08		7	0092-0201	946.42	201.19	274	66.08	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2653.8	B08		7	0093-0206	58.01	206.48	258	61.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2049.6	B08		7	0094-0211	177.98	211.36	360	69.60	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2760.1	B08		7	0095-0216	397.84	216.51	337	69.26	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			905.1	B08		7	0096-0218	339.99	218.35	273	60.77	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2229.6	B08		7	0097-0221	569.60	222.01	391	87.50	0.642
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1800.3	B08		7	0098-0219	89.92	218.98	242	57.11	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1503.1	B08		7	0099-0225	446.62	225.98	396	76.43	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1990.4	B08		7	0100-0228	126.72	228.49	240	56.77	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2644.6	B08		7	0101-0228	413.78	228.49	276	61.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1774.1	B08		7	0102-0231	907.18	231.20	289	63.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			795.3	B08		7	0103-0232	720.98	231.94	236	62.67	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2924.8	B08		7	0104-0233	264.91	234.22	194	56.53	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2312.7	B08		7	0105-0234	283.80	234.69	332	68.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2162.0	B08		7	0106-0237	521.36	236.40	382	73.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2521.5	B08		7	0107-0236	947.56	236.18	340	68.77	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1277.1	B08		7	0108-0237	872.17	237.48	266	63.84	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2856.5	B08		7	0109-0245	843.77	243.71	350	102.57	0.418
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2897.8	B08		7	0110-0243	51.98	243.74	182	49.70	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1788.3	B08		7	0111-0243	604.19	243.46	216	59.36	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2228.2	B08		7	0112-0246	378.93	246.46	256	59.36	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1870.0	B08		7	0113-0249	463.00	249.54	233	56.53	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1871.8	B08		7	0114-0249	587.12	249.49	180	50.87	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			933.0	B08		7	0115-0254	128.47	254.68	307	80.57	0.594
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2110.5	B08		7	0116-0254	247.69	254.10	326	66.43	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2949.5	B08		7	0117-0256	397.74	256.62	240	57.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2069.0	B08		7	0118-0259	553.97	259.30	371	73.01	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			975.4	B08		7	0119-0257	323.31	257.59	255	59.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			707.6	B08		7	0120-0264	877.21	264.15	243	65.94	0.702
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1869.3	B08		7	0121-0264	429.23	263.74	193	51.11	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2511.7	B08		7	0122-0265	682.52	264.78	242	60.18	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1864.4	B08		7	0123-0268	23.52	267.27	312	68.67	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			270.9	B08		7	0124-0273	942.28	273.29	228	55.11	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1508.6	B08		7	0125-0277	472.77	276.83	285	65.36	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1533.6	B08		7	0126-0279	591.93	279.81	335	67.60	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2470.9	B08		7	0127-0280	373.41	281.31	303	65.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			710.2	B08		7	0128-0281	97.96	280.43	287	68.18	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2031.2	B08		7	0129-0289	160.03	289.59	504	84.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2684.1	B08		7	0130-0286	717.44	286.35	251	59.94	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			500.8	B08		7	0131-0285	226.22	284.88	147	47.46	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2121.4	B08		7	0132-0287	884.60	287.66	261	63.01	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			449.8	B08		7	0133-0287	266.28	286.81	204	54.28	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1895.4	B08		7	0134-0295	42.73	293.97	470	84.67	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			571.6	B08		7	0135-0290	409.83	289.56	218	55.11	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1613.5	B08		7	0136-0296	638.34	296.98	357	70.43	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3218.7	B08		7	0137-0296	95.19	296.13	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2018.0	B08		7	0138-0300	300.90	299.53	352	70.18	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2461.8	B08		7	0139-0299	441.91	299.04	285	62.53	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2062.7	B08		7	0140-0303	747.06	302.21	284	64.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			957.3	B08		7	0141-0300	226.96	300.39	100	38.04	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			273.3	B08		7	0142-0307	921.16	307.62	285	79.50	0.567
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1813.4	B08		7	0143-0304	356.23	304.27	278	65.01	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1745.2	B08		7	0144-0303	621.62	304.04	199	53.11	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1944.0	B08		7	0145-0309	250.39	309.05	279	69.01	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1502.7	B08		7	0146-0312	495.72	311.78	412	83.98	0.734
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1963.3	B08		7	0147-0310	729.52	310.80	232	57.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2564.4	B08		7	0148-0311	762.11	310.96	229	57.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2355.4	B08		7	0149-0310	528.20	310.63	234	58.28	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2959.7	B08		7	0150-0312	795.82	311.91	291	64.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			724.7	B08		7	0151-0316	235.32	316.79	240	70.43	0.608
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1816.7	B08		7	0152-0312	410.34	312.51	248	58.63	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2315.7	B08		7	0153-0317	371.38	316.56	293	65.94	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			544.8	B08		7	0154-0316	266.32	316.82	171	48.87	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2769.9	B08		7	0155-0319	546.92	318.83	210	54.18	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2253.7	B08		7	0156-0321	27.86	321.46	191	51.36	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2065.2	B08		7	0157-0328	430.10	328.68	339	67.94	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2637.9	B08		7	0158-0327	847.85	326.72	221	54.28	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1977.4	B08		7	0159-0326	410.89	326.20	166	48.39	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2065.9	B08		7	0160-0331	450.98	331.32	320	66.53	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1766.4	B08		7	0161-0334	292.22	334.82	267	65.94	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3873.9	B08		7	0162-0336	930.56	336.09	198	53.60	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4337.6	B08		7	0163-0336	162.68	335.79	175	49.94	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2084.3	B08		7	0164-0338	896.94	338.98	324	67.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			801.2	B08		7	0165-0338	660.25	337.98	156	50.87	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2355.7	B08		7	0166-0341	646.64	340.59	261	61.11	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			641.0	B08		7	0167-0340	675.12	339.91	190	52.77	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1324.6	B08		7	0168-0342	707.87	342.91	276	69.84	0.711
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3297.3	B08		7	0169-0342	784.65	342.46	217	55.36	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			401.0	B08		7	0170-0343	309.89	343.09	258	60.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2610.1	B08		7	0171-0346	481.88	346.11	316	72.77	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2454.8	B08		7	0172-0349	217.80	349.32	361	71.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2746.7	B08		7	0173-0347	153.24	347.05	227	56.18	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2018.4	B08		7	0174-0350	859.26	351.10	336	68.53	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2228.3	B08		7	0175-0349	800.64	349.33	177	49.70	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			299.0	B08		7	0176-0353	338.93	352.34	261	60.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2672.7	B08		7	0177-0358	71.12	358.95	447	91.74	0.667
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2772.5	B08		7	0178-0353	817.46	353.46	233	59.70	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3390.8	B08		7	0179-0362	371.36	361.56	494	93.05	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1416.4	B08		7	0180-0367	99.04	367.18	454	85.74	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2465.5	B08		7	0181-0359	462.03	360.16	146	45.21	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1505.3	B08		7	0182-0369	691.26	369.39	264	64.08	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			419.2	B08		7	0183-0370	447.16	369.83	216	55.11	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2146.8	B08		7	0184-0370	843.94	370.61	319	66.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1569.3	B08		7	0185-0371	278.60	372.16	262	63.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2016.9	B08		7	0186-0375	503.14	375.57	260	65.36	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2011.2	B08		7	0187-0374	307.18	373.51	277	65.36	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3876.9	B08		7	0188-0373	354.76	374.48	147	49.36	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4014.8	B08		7	0189-0376	381.94	376.76	278	67.01	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1471.1	B08		7	0190-0380	727.75	380.71	335	69.84	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			507.8	B08		7	0191-0380	526.81	381.04	221	57.36	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			974.3	B08		7	0192-0384	684.62	383.73	275	63.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1383.0	B08		7	0193-0390	164.13	389.70	472	83.36	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			6111.0	B08		7	0194-0387	798.47	387.55	357	70.43	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2626.8	B08		7	0195-0388	927.26	388.88	312	65.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2219.4	B08		7	0196-0394	185.85	393.76	261	63.01	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3182.4	B08		7	0197-0395	116.26	395.13	255	58.77	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2031.1	B08		7	0198-0393	840.15	393.95	241	57.70	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1943.5	B08		7	0199-0399	899.11	399.12	309	65.36	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2410.9	B08		7	0200-0400	555.73	400.33	333	71.01	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2679.0	B08		7	0201-0402	94.97	402.82	390	74.43	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1335.5	B08		7	0202-0403	503.44	403.91	240	59.70	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2593.7	B08		7	0203-0402	782.10	402.91	155	50.87	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			395.1	B08		7	0204-0406	870.45	407.13	285	71.01	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1510.2	B08		7	0205-0405	281.16	404.51	254	62.77	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1731.2	B08		7	0206-0408	439.39	407.70	223	57.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			472.1	B08		7	0207-0407	677.66	407.11	250	57.94	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1801.5	B08		7	0208-0409	946.76	409.94	278	67.01	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1730.1	B08		7	0209-0408	50.70	408.74	253	61.70	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1465.1	B08		7	0210-0408	329.76	408.12	319	72.43	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3163.7	B08		7	0211-0412	228.68	412.13	306	65.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2772.2	B08		7	0212-0413	582.83	413.25	313	67.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2494.1	B08		7	0213-0409	753.48	408.41	161	49.70	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2255.7	B08		7	0214-0416	308.23	416.71	224	61.36	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			545.7	B08		7	0215-0419	544.64	418.65	204	51.94	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1947.1	B08		7	0216-0420	627.16	420.38	308	67.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1361.0	B08		7	0217-0423	938.35	422.78	276	65.26	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2065.9	B08		7	0218-0427	816.11	427.07	261	61.70	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1573.1	B08		7	0219-0428	330.82	429.26	299	66.43	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1617.5	B08		7	0220-0429	710.81	428.85	298	66.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1774.1	B08		7	0221-0431	199.59	430.66	279	63.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1356.3	B08		7	0222-0432	784.78	431.99	288	65.60	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3611.6	B08		7	0223-0436	80.45	436.11	367	73.11	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3222.0	B08		7	0224-0434	530.11	433.20	296	67.60	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			662.8	B08		7	0225-0437	547.31	438.14	267	65.26	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2539.1	B08		7	0226-0438	24.77	437.88	236	59.70	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3832.1	B08		7	0227-0437	102.70	437.10	222	58.18	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			524.8	B08		7	0228-0438	689.99	437.92	218	56.28	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1341.2	B08		7	0229-0444	644.17	443.89	414	80.67	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1754.4	B08		7	0230-0445	349.35	444.63	254	62.18	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1820.2	B08		7	0231-0448	673.60	448.71	311	67.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			528.3	B08		7	0232-0451	760.98	450.72	222	61.94	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			249.3	B08		7	0233-0451	577.59	451.76	277	63.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			990.0	B08		7	0234-0454	817.04	453.79	324	68.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1626.1	B08		7	0235-0456	455.98	456.45	269	64.18	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3717.6	B08		7	0236-0460	63.98	460.09	299	63.94	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			980.2	B08		7	0237-0466	864.93	466.05	302	80.91	0.580
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1808.4	B08		7	0238-0464	356.84	463.88	256	60.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			282.2	B08		7	0239-0466	513.38	466.70	281	63.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2304.1	B08		7	0240-0467	328.45	467.72	371	83.84	0.663
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			452.2	B08		7	0241-0468	849.84	468.20	184	53.46	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2356.8	B08		7	0242-0472	906.09	471.68	340	76.67	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2113.7	B08		7	0243-0470	203.00	469.81	222	58.18	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2160.9	B08		7	0244-0472	236.38	472.69	220	59.01	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1462.4	B08		7	0245-0477	934.34	478.49	318	72.43	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1305.9	B08		7	0246-0481	651.26	482.10	510	106.57	0.564
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			5285.0	B08		7	0247-0486	129.79	486.75	499	86.67	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3261.8	B08		7	0248-0482	398.08	481.83	240	57.60	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2113.9	B08		7	0249-0484	782.53	484.13	397	75.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2236.8	B08		7	0250-0491	555.13	492.15	336	68.43	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1545.6	B08		7	0251-0493	488.53	493.04	280	65.01	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1494.9	B08		7	0252-0496	630.32	496.96	275	61.01	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2203.5	B08		7	0253-0504	76.36	503.82	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2348.5	B08		7	0254-0512	563.18	512.38	275	61.11	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2798.3	B08		7	0255-0515	929.60	515.28	331	67.84	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2215.1	B08		7	0256-0515	303.66	514.76	221	56.18	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2124.0	B08		7	0257-0517	419.55	516.60	219	54.87	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1356.7	B08		7	0258-0520	523.11	521.12	339	71.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1469.6	B08		7	0259-0523	102.70	523.12	267	67.94	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3386.4	B08		7	0260-0520	194.12	520.44	217	55.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1751.9	B08		7	0261-0521	781.22	521.50	240	62.18	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			648.4	B08		7	0262-0522	715.60	522.41	182	49.11	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2617.0	B08		7	0263-0529	225.10	528.94	309	65.11	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2705.6	B08		7	0264-0527	285.61	527.28	236	57.70	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1834.5	B08		7	0265-0530	149.38	529.94	288	65.94	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2091.0	B08		7	0266-0534	429.34	534.91	260	62.43	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1824.7	B08		7	0267-0536	770.17	537.07	227	56.18	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1366.5	B08		7	0268-0540	906.22	540.02	407	76.43	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3177.3	B08		7	0269-0540	335.32	539.97	212	55.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1879.9	B08		7	0270-0545	548.09	545.33	251	59.94	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3253.7	B08		7	0271-0545	270.40	544.99	189	51.94	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			452.1	B08		7	0272-0546	447.50	545.93	228	58.43	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1732.1	B08		7	0273-0553	804.74	553.28	232	58.77	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			469.6	B08		7	0274-0549	859.05	549.05	126	43.46	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			426.8	B08		7	0275-0551	482.79	550.94	212	53.70	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1542.9	B08		7	0276-0552	392.00	551.27	300	69.60	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1512.0	B08		7	0277-0553	821.00	553.94	198	56.18	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			618.2	B08		7	0278-0555	301.57	555.59	283	65.94	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			726.3	B08		7	0279-0558	776.62	558.39	269	62.53	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2823.1	B08		7	0280-0559	689.71	560.15	226	62.77	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1799.2	B08		7	0281-0560	339.19	559.53	187	51.36	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			464.0	B08		7	0282-0564	852.72	564.30	217	55.84	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			972.0	B08		7	0283-0565	273.27	565.52	251	61.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1742.6	B08		7	0284-0566	215.27	567.71	321	73.01	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1081.0	B08		7	0285-0568	794.53	567.90	241	58.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1572.8	B08		7	0286-0568	574.60	568.25	313	68.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1863.0	B08		7	0287-0571	97.09	571.01	324	68.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1008.7	B08		7	0288-0572	358.39	571.60	225	57.70	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1611.2	B08		7	0289-0568	451.12	568.59	194	50.87	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			434.8	B08		7	0290-0571	514.70	571.55	238	57.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2724.3	B08		7	0291-0575	818.21	576.01	261	63.11	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2125.3	B08		7	0292-0573	627.10	573.01	252	58.87	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4036.1	B08		7	0293-0587	161.52	585.95	593	107.05	0.650
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			611.8	B08		7	0294-0580	382.48	581.18	206	56.04	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1580.4	B08		7	0295-0582	856.68	582.60	241	59.84	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1122.8	B08		7	0296-0581	454.66	581.62	195	53.21	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2322.3	B08		7	0297-0584	20.47	584.14	229	57.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1935.4	B08		7	0298-0589	65.54	589.46	360	71.36	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1604.5	B08		7	0299-0589	202.30	589.49	276	69.01	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1674.0	B08		7	0300-0586	306.59	585.47	227	56.53	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2891.1	B08		7	0301-0587	540.11	586.99	191	51.36	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1816.8	B08		7	0302-0589	419.81	589.22	243	57.11	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			546.8	B08		7	0303-0589	641.78	589.13	208	54.28	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1975.0	B08		7	0304-0591	870.52	591.42	226	55.11	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			917.3	B08		7	0305-0592	401.35	592.08	206	54.28	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1258.1	B08		7	0306-0595	386.10	595.23	181	51.80	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1813.7	B08		7	0307-0599	934.08	598.75	396	74.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			942.5	B08		7	0308-0597	468.94	597.78	296	63.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2709.4	B08		7	0309-0599	531.68	600.05	232	55.36	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1273.8	B08		7	0310-0600	586.68	599.78	239	57.70	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1850.9	B08		7	0311-0603	237.89	602.51	256	58.53	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2428.7	B08		7	0312-0603	747.56	603.22	140	46.28	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1724.9	B08		7	0313-0607	275.96	606.98	234	56.53	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1336.2	B08		7	0314-0618	761.53	616.65	395	87.26	0.652
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			564.3	B08		7	0315-0618	317.58	618.43	245	59.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2415.6	B08		7	0316-0620	798.63	619.75	372	73.60	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			402.6	B08		7	0317-0619	184.08	618.67	255	59.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1813.3	B08		7	0318-0619	536.33	619.55	203	52.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4147.0	B08		7	0319-0619	732.67	618.91	225	58.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1637.5	B08		7	0320-0624	75.32	624.49	297	67.26	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4791.9	B08		7	0321-0626	149.52	625.62	378	74.18	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2252.3	B08		7	0322-0624	587.75	624.19	255	60.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			874.6	B08		7	0323-0628	266.79	628.79	272	64.77	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			508.0	B08		7	0324-0626	224.98	625.70	269	60.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1892.5	B08		7	0325-0631	33.55	631.63	372	75.84	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3128.5	B08		7	0326-0630	380.71	630.34	182	50.28	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3424.1	B08		7	0327-0632	742.45	633.18	264	63.60	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2140.3	B08		7	0328-0632	870.00	633.29	240	62.77	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2992.3	B08		7	0329-0638	418.93	637.29	242	58.18	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1753.3	B08		7	0330-0635	486.04	635.24	265	64.53	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1997.6	B08		7	0331-0636	884.42	636.28	183	50.63	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1840.2	B08		7	0332-0640	652.10	639.58	235	59.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1781.5	B08		7	0333-0642	303.25	642.62	278	63.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2677.0	B08		7	0334-0643	369.37	643.58	193	51.70	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2261.1	B08		7	0335-0647	536.33	647.18	228	57.01	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3422.8	B08		7	0336-0648	701.14	648.33	301	63.60	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1625.1	B08		7	0337-0655	825.26	654.58	343	71.50	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1961.0	B08		7	0338-0652	905.80	652.94	180	51.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2126.3	B08		7	0339-0656	494.86	656.41	261	60.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1879.4	B08		7	0340-0655	647.89	656.23	214	54.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1421.9	B08		7	0341-0660	619.43	660.42	307	68.53	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			408.4	B08		7	0342-0660	103.73	660.38	202	60.18	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3998.2	B08		7	0343-0661	331.53	661.26	282	62.28	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2482.1	B08		7	0344-0658	369.54	658.31	227	57.11	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2772.7	B08		7	0345-0659	935.36	658.91	181	52.43	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2610.5	B08		7	0346-0660	447.04	660.05	247	59.11	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			558.6	B08		7	0347-0665	250.08	665.56	256	60.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1261.1	B08		7	0348-0662	37.36	662.14	140	45.94	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1366.7	B08		7	0349-0668	273.05	667.94	244	60.18	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1521.6	B08		7	0350-0671	564.20	671.06	415	79.50	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2383.8	B08		7	0351-0668	724.95	667.73	304	64.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3034.5	B08		7	0352-0666	922.79	665.38	205	57.36	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1620.1	B08		7	0353-0670	193.80	670.59	269	61.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2496.5	B08		7	0354-0673	768.30	672.51	256	59.60	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3297.6	B08		7	0355-0672	377.96	672.48	212	55.46	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2825.5	B08		7	0356-0674	861.90	673.49	332	68.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1098.6	B08		7	0357-0676	85.23	676.00	223	57.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1106.7	B08		7	0358-0677	797.05	677.26	267	63.01	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1264.6	B08		7	0359-0675	34.76	675.73	175	50.28	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2123.2	B08		7	0360-0676	703.10	676.08	198	57.60	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1195.3	B08		7	0361-0678	52.72	679.35	218	59.36	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2562.0	B08		7	0362-0683	685.57	684.28	648	111.05	0.660
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2945.3	B08		7	0363-0680	448.23	679.47	224	55.36	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			650.2	B08		7	0364-0685	843.10	686.08	260	61.36	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			419.2	B08		7	0365-0688	618.11	687.90	248	63.84	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2231.4	B08		7	0366-0686	340.20	686.29	226	55.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2313.1	B08		7	0367-0692	413.83	691.73	372	73.26	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2829.7	B08		7	0368-0691	714.85	690.45	150	46.87	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3214.0	B08		7	0369-0694	912.92	694.90	229	57.94	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1939.6	B08		7	0370-0696	937.38	695.64	291	61.94	0.953
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			624.2	B08		7	0371-0697	52.33	696.50	224	55.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			402.4	B08		7	0372-0697	136.01	696.68	215	53.94	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			870.4	B08		7	0373-0702	234.35	703.26	290	67.36	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2238.1	B08		7	0374-0703	882.83	702.70	269	63.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2460.2	B08		7	0375-0704	371.40	704.40	237	58.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2665.2	B08		7	0376-0703	539.66	702.93	202	52.28	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2667.0	B08		7	0377-0700	690.84	700.22	159	45.70	0.957
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2321.3	B08		7	0378-0706	464.63	706.59	227	57.94	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1239.4	B08		7	0379-0706	646.96	706.78	211	53.11	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1008.2	B08		7	0380-0708	161.23	708.82	276	64.53	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			587.5	B08		8	0001-0027	605.94	27.87	215	56.28	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1609.1	B08		8	0002-0030	678.63	29.96	293	63.01	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			418.8	B08		8	0003-0030	332.84	29.76	212	53.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1403.5	B08		8	0004-0034	100.59	34.63	237	58.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			307.8	B08		8	0005-0030	274.05	30.58	219	59.70	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1511.9	B08		8	0006-0039	437.09	39.00	204	53.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			459.2	B08		8	0007-0041	321.69	41.81	212	54.28	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3114.4	B08		8	0008-0040	928.24	40.30	223	54.28	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1166.9	B08		8	0009-0043	461.70	44.14	285	63.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1782.5	B08		8	0010-0044	809.55	44.14	285	61.36	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			544.5	B08		8	0011-0045	569.92	43.93	174	54.43	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			427.3	B08		8	0012-0045	358.74	45.50	219	55.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2679.1	B08		8	0013-0045	633.25	45.14	254	60.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			371.5	B08		8	0014-0047	122.29	46.71	280	66.18	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1787.5	B08		8	0015-0048	25.24	47.86	211	53.11	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4661.7	B08		8	0016-0048	185.64	48.59	289	64.18	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2250.8	B08		8	0017-0049	384.18	48.78	310	66.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			375.7	B08		8	0018-0049	307.42	48.87	215	54.87	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			441.7	B08		8	0019-0050	580.11	51.04	112	44.87	0.699
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			435.3	B08		8	0020-0053	753.84	52.66	215	54.28	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3986.0	B08		8	0021-0053	254.99	53.81	251	60.53	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1902.9	B08		8	0022-0056	493.18	56.48	338	69.01	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1726.7	B08		8	0023-0054	940.44	54.25	205	52.28	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2212.9	B08		8	0024-0061	241.09	61.83	193	56.77	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1871.6	B08		8	0025-0056	768.83	55.64	147	45.80	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1948.2	B08		8	0026-0060	866.08	60.35	250	59.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2062.8	B08		8	0027-0063	559.18	62.41	294	67.60	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			425.4	B08		8	0028-0063	642.81	63.02	178	48.28	0.959
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1690.9	B08		8	0029-0064	701.82	64.72	262	60.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1503.9	B08		8	0030-0068	91.77	68.89	240	59.11	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2354.3	B08		8	0031-0070	346.19	69.91	273	61.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3088.8	B08		8	0032-0069	838.43	68.84	215	56.18	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1773.3	B08		8	0033-0070	765.62	69.56	157	46.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2010.1	B08		8	0034-0071	878.70	71.36	219	55.70	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2299.2	B08		8	0035-0075	248.18	76.27	218	55.36	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3196.2	B08		8	0036-0076	753.87	77.01	208	55.01	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2107.2	B08		8	0037-0078	789.59	77.65	266	62.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			476.9	B08		8	0038-0080	204.05	79.65	217	54.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			341.5	B08		8	0039-0082	535.30	81.33	202	55.46	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1575.9	B08		8	0040-0086	684.70	86.65	407	78.67	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3888.7	B08		8	0041-0081	911.11	81.40	246	57.70	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			519.1	B08		8	0042-0083	278.01	82.10	183	51.36	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2768.2	B08		8	0043-0083	422.56	82.95	209	52.87	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2709.1	B08		8	0044-0092	521.47	91.87	335	73.11	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2316.0	B08		8	0045-0087	654.93	87.18	272	62.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1963.5	B08		8	0046-0088	803.61	88.22	262	60.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1490.9	B08		8	0047-0085	312.89	85.51	156	48.04	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2146.3	B08		8	0048-0091	506.89	91.64	231	61.11	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2627.5	B08		8	0049-0093	265.32	92.69	347	69.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3681.3	B08		8	0050-0089	466.44	89.42	126	64.67	0.379
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2752.4	B08		8	0051-0091	485.54	91.39	178	51.70	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			413.2	B08		8	0052-0095	578.56	94.28	158	52.53	0.720
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4838.0	B08		8	0053-0098	235.72	97.49	144	47.60	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1621.9	B08		8	0054-0097	312.79	96.29	117	40.63	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1556.7	B08		8	0055-0101	196.52	101.22	216	55.70	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1262.0	B08		8	0056-0109	168.10	109.50	416	84.08	0.739
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1642.7	B08		8	0057-0109	61.26	110.18	302	65.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1105.5	B08		8	0058-0109	325.70	109.43	285	64.53	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3446.0	B08		8	0059-0105	492.19	104.94	158	46.63	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4190.0	B08		8	0060-0109	225.69	109.46	155	46.53	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			452.6	B08		8	0061-0110	418.68	110.04	266	61.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2061.9	B08		8	0062-0110	740.53	109.96	202	53.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2463.5	B08		8	0063-0116	365.54	115.83	258	59.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1227.4	B08		8	0064-0117	17.34	117.17	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1633.2	B08		8	0065-0117	710.91	117.16	339	67.60	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			553.5	B08		8	0066-0114	692.08	114.01	112	40.04	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1186.4	B08		8	0067-0116	945.56	116.40	143	45.11	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2499.2	B08		8	0068-0119	476.58	119.53	226	55.94	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1772.5	B08		8	0069-0120	214.16	121.08	218	57.84	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1884.6	B08		8	0070-0123	458.80	122.27	270	66.18	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1682.1	B08		8	0071-0128	621.93	128.49	282	65.11	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			237.8	B08		8	0072-0126	810.83	124.99	255	63.36	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3033.8	B08		8	0073-0129	254.02	128.83	222	57.36	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1682.2	B08		8	0074-0126	312.43	126.66	288	67.94	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1717.7	B08		8	0075-0127	651.45	127.21	274	62.53	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			509.1	B08		8	0076-0124	693.52	124.41	100	38.63	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			520.8	B08		8	0077-0134	544.06	133.88	328	69.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2947.2	B08		8	0078-0131	834.06	131.69	238	57.36	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2309.0	B08		8	0079-0134	916.21	133.84	333	69.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4375.7	B08		8	0080-0139	433.99	140.31	312	67.60	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2425.6	B08		8	0081-0141	742.85	142.35	182	53.36	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1685.8	B08		8	0082-0142	371.39	142.67	287	66.18	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			809.9	B08		8	0083-0142	691.60	143.08	137	49.70	0.697
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2137.4	B08		8	0084-0147	102.87	147.30	221	58.28	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2064.2	B08		8	0085-0146	870.70	146.58	274	63.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			367.0	B08		8	0086-0145	813.59	145.20	244	62.53	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2699.9	B08		8	0087-0147	260.69	146.47	195	52.53	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1144.1	B08		8	0088-0151	610.95	151.63	257	69.60	0.667
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2292.4	B08		8	0089-0151	508.14	151.35	210	54.77	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			5051.9	B08		8	0090-0152	201.67	152.39	324	67.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1801.5	B08		8	0091-0153	752.90	153.76	193	51.70	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1449.2	B08		8	0092-0154	646.52	153.18	233	58.53	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			419.3	B08		8	0093-0163	790.71	165.01	286	78.43	0.584
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1987.8	B08		8	0094-0160	115.51	160.99	260	59.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1432.4	B08		8	0095-0163	155.98	162.80	258	62.43	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1599.5	B08		8	0096-0167	638.49	167.91	284	66.67	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			743.7	B08		8	0097-0169	319.81	169.39	287	62.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			391.2	B08		8	0098-0170	387.76	170.51	216	54.53	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1593.9	B08		8	0099-0172	718.99	171.98	280	64.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2152.4	B08		8	0100-0174	444.36	173.61	393	78.43	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1486.0	B08		8	0101-0173	363.23	173.68	207	54.53	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1896.1	B08		8	0102-0172	824.23	172.48	190	52.14	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			786.1	B08		8	0103-0173	839.23	173.39	161	48.63	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			814.7	B08		8	0104-0174	855.85	173.78	202	54.53	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4844.6	B08		8	0105-0176	472.06	176.28	277	61.11	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			365.1	B08		8	0106-0176	589.15	176.50	204	53.11	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4119.4	B08		8	0107-0174	24.47	175.02	132	43.46	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3829.5	B08		8	0108-0181	916.02	180.69	140	89.98	0.217
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2929.5	B08		8	0109-0191	416.31	190.75	393	73.60	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2120.2	B08		8	0110-0190	557.40	189.97	233	57.36	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3197.1	B08		8	0111-0194	503.96	194.47	352	71.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3815.5	B08		8	0112-0193	528.14	193.10	302	65.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1564.9	B08		8	0113-0191	576.48	190.90	248	57.70	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1213.8	B08		8	0114-0196	82.44	197.40	250	59.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1955.7	B08		8	0115-0199	731.41	199.55	326	71.84	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1274.0	B08		8	0116-0206	797.58	204.88	608	103.98	0.707
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1650.2	B08		8	0117-0200	600.24	198.90	321	67.84	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			355.2	B08		8	0118-0201	706.38	200.68	275	65.60	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			335.9	B08		8	0119-0200	105.70	199.53	251	60.77	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2212.5	B08		8	0120-0203	51.33	203.14	263	64.67	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			211.7	B08		8	0121-0201	945.35	201.25	242	64.77	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2725.4	B08		8	0122-0202	841.47	202.21	265	59.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1056.2	B08		8	0123-0204	360.88	204.41	293	66.18	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			278.5	B08		8	0124-0203	473.99	203.12	291	67.36	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2767.5	B08		8	0125-0209	540.26	210.14	315	74.18	0.719
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2321.4	B08		8	0126-0207	210.90	207.35	301	65.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1642.3	B08		8	0127-0209	653.64	209.25	285	64.77	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2211.4	B08		8	0128-0216	905.41	216.77	342	71.60	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2784.8	B08		8	0129-0217	238.79	216.72	356	70.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1786.8	B08		8	0130-0219	326.08	218.78	230	67.11	0.642
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2702.1	B08		8	0131-0219	404.45	220.29	295	63.11	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1954.9	B08		8	0132-0222	573.44	222.43	240	57.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			510.7	B08		8	0133-0223	825.07	222.16	159	55.11	0.658
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1861.8	B08		8	0134-0228	177.37	228.44	252	65.60	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2040.9	B08		8	0135-0226	444.15	225.99	249	59.70	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			911.3	B08		8	0136-0226	297.91	225.97	241	57.01	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1523.1	B08		8	0137-0226	338.15	227.24	232	60.18	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1983.1	B08		8	0138-0225	836.01	225.90	134	47.94	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1861.7	B08		8	0139-0231	760.15	231.06	226	56.04	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1527.0	B08		8	0140-0233	362.12	232.89	237	60.18	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1564.0	B08		8	0141-0236	884.11	237.24	290	67.11	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2433.7	B08		8	0142-0238	52.62	238.34	342	68.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			637.4	B08		8	0143-0234	514.13	234.63	207	57.46	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1499.1	B08		8	0144-0239	844.35	239.44	239	58.77	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			815.6	B08		8	0145-0242	131.43	242.42	205	54.53	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1044.8	B08		8	0146-0241	497.89	242.11	176	49.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			952.5	B08		8	0147-0244	785.63	245.13	262	59.36	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			290.5	B08		8	0148-0244	401.72	243.93	213	54.53	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2283.6	B08		8	0149-0248	624.08	247.94	209	54.53	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2357.7	B08		8	0150-0249	726.50	248.48	254	59.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2042.4	B08		8	0151-0250	757.15	250.54	325	72.18	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1977.6	B08		8	0152-0249	644.05	249.45	254	60.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2834.0	B08		8	0153-0252	104.77	251.94	312	65.11	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2590.4	B08		8	0154-0252	445.78	252.74	217	60.53	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1792.6	B08		8	0155-0256	571.64	257.18	211	59.70	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1588.4	B08		8	0156-0266	348.79	266.57	640	110.47	0.659
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1574.8	B08		8	0157-0258	883.69	257.58	273	61.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1965.2	B08		8	0158-0256	905.81	256.66	277	63.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1515.8	B08		8	0159-0260	833.84	260.57	489	90.08	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1259.1	B08		8	0160-0260	689.87	260.20	232	57.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2760.3	B08		8	0161-0262	492.09	262.56	290	63.60	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2122.6	B08		8	0162-0267	518.42	267.31	439	80.08	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1699.4	B08		8	0163-0265	186.17	265.60	250	78.91	0.505
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1570.0	B08		8	0164-0265	247.92	265.49	261	59.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1559.4	B08		8	0165-0270	618.28	270.58	224	61.94	0.734
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			555.3	B08		8	0166-0265	797.52	264.67	151	49.11	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3458.4	B08		8	0167-0269	923.08	268.60	250	58.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1575.3	B08		8	0168-0275	409.94	274.74	383	74.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1621.1	B08		8	0169-0276	133.40	275.48	241	61.01	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			269.1	B08		8	0170-0275	47.24	275.34	223	55.11	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2869.4	B08		8	0171-0280	278.01	279.85	388	77.50	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1718.9	B08		8	0172-0279	562.46	279.94	194	57.36	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2219.1	B08		8	0173-0278	458.98	277.90	219	55.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1373.8	B08		8	0174-0278	715.69	277.13	240	59.94	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1853.8	B08		8	0175-0282	119.51	282.12	188	54.53	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1909.5	B08		8	0176-0280	332.96	280.84	132	43.56	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2451.4	B08		8	0177-0290	891.19	289.75	238	58.18	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1880.7	B08		8	0178-0292	298.21	292.89	218	54.53	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			270.1	B08		8	0179-0295	95.73	294.43	249	61.36	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1839.5	B08		8	0180-0294	330.03	293.71	196	53.46	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3541.6	B08		8	0181-0297	860.98	297.75	317	65.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3228.5	B08		8	0182-0297	512.10	296.55	221	56.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2154.8	B08		8	0183-0303	430.37	303.46	354	71.60	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2033.5	B08		8	0184-0303	479.32	302.65	346	68.18	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3683.1	B08		8	0185-0302	497.46	302.33	187	51.11	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1518.8	B08		8	0186-0303	716.93	302.65	222	57.11	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3464.1	B08		8	0187-0305	830.82	305.53	256	57.94	0.958
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			284.1	B08		8	0188-0310	25.65	309.68	263	66.77	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1360.4	B08		8	0189-0309	198.99	308.92	288	70.67	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2692.2	B08		8	0190-0310	787.30	310.84	332	70.18	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			588.8	B08		8	0191-0309	934.28	309.96	218	56.28	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1277.0	B08		8	0192-0313	234.95	313.59	264	67.01	0.739
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2749.4	B08		8	0193-0313	297.10	313.57	317	67.01	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2241.3	B08		8	0194-0316	613.92	317.18	222	57.70	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			421.6	B08		8	0195-0319	126.34	319.24	196	63.26	0.616
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2848.3	B08		8	0196-0320	567.44	319.73	136	47.11	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2858.8	B08		8	0197-0323	279.05	323.73	192	51.46	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1007.5	B08		8	0198-0328	673.08	328.40	224	62.18	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4023.7	B08		8	0199-0326	330.82	326.80	227	55.94	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1434.2	B08		8	0200-0329	94.74	329.33	229	57.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			411.8	B08		8	0201-0330	718.20	329.79	235	56.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			393.3	B08		8	0202-0331	696.05	331.99	248	57.70	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			388.0	B08		8	0203-0328	485.85	327.96	134	46.87	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			366.0	B08		8	0204-0333	831.68	332.64	270	60.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1844.4	B08		8	0205-0335	182.20	335.61	329	67.36	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3846.0	B08		8	0206-0338	35.69	338.17	193	52.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2622.7	B08		8	0207-0338	283.63	337.80	194	52.28	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3471.9	B08		8	0208-0341	442.74	341.90	307	66.43	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			360.5	B08		8	0209-0343	495.31	344.36	429	88.67	0.686
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			706.5	B08		8	0210-0341	749.53	341.13	261	59.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3292.2	B08		8	0211-0342	409.14	342.94	258	59.70	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1999.2	B08		8	0212-0344	786.04	343.56	228	55.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			323.3	B08		8	0213-0343	223.49	343.69	205	53.11	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1184.1	B08		8	0214-0345	72.07	344.02	253	60.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1488.1	B08		8	0215-0347	615.45	347.13	290	64.53	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1409.2	B08		8	0216-0349	847.39	348.96	278	64.08	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1800.9	B08		8	0217-0349	162.16	349.02	209	53.94	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			536.1	B08		8	0218-0352	904.73	351.46	230	59.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2843.5	B08		8	0219-0358	239.48	358.57	276	61.01	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2301.7	B08		8	0220-0361	372.20	361.46	328	68.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			531.1	B08		8	0221-0364	732.60	364.38	212	56.53	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1197.5	B08		8	0222-0365	669.58	364.77	308	69.94	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2559.2	B08		8	0223-0363	542.40	363.96	167	48.63	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			697.3	B08		8	0224-0367	825.59	367.27	264	63.01	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1819.7	B08		8	0225-0368	69.91	368.36	423	77.60	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			421.1	B08		8	0226-0367	509.82	366.75	165	49.11	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			329.8	B08		8	0227-0370	842.54	368.99	221	57.36	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2504.4	B08		8	0228-0370	904.68	370.38	299	63.94	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2272.5	B08		8	0229-0374	705.18	375.56	291	65.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2221.1	B08		8	0230-0380	229.26	379.63	336	69.01	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1968.1	B08		8	0231-0381	625.58	381.14	261	59.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2865.3	B08		8	0232-0380	538.41	379.26	186	52.28	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2118.9	B08		8	0233-0380	122.53	380.11	176	49.46	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2644.0	B08		8	0234-0390	459.42	389.07	472	94.81	0.660
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1635.9	B08		8	0235-0385	174.02	384.99	229	55.11	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2526.5	B08		8	0236-0390	32.31	390.91	315	65.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1573.4	B08		8	0237-0390	476.96	389.92	250	59.46	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3006.3	B08		8	0238-0389	563.53	389.04	227	56.04	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			300.0	B08		8	0239-0392	96.37	392.44	221	54.53	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1801.8	B08		8	0240-0392	140.30	393.04	241	60.53	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3065.1	B08		8	0241-0394	517.34	394.43	226	57.36	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			377.6	B08		8	0242-0393	205.01	393.33	193	53.11	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2553.4	B08		8	0243-0396	357.48	395.76	326	68.43	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1172.8	B08		8	0244-0396	798.26	395.72	268	59.60	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1903.9	B08		8	0245-0393	115.88	393.18	177	49.70	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1440.0	B08		8	0246-0401	285.34	401.61	298	68.67	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1045.9	B08		8	0247-0403	854.48	404.25	271	62.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3614.6	B08		8	0248-0409	874.03	409.15	215	59.36	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2929.4	B08		8	0249-0410	535.95	410.12	210	57.21	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2196.3	B08		8	0250-0409	757.81	409.18	241	57.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1503.3	B08		8	0251-0408	385.95	408.25	148	47.36	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1830.6	B08		8	0252-0412	51.60	411.98	247	62.43	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1741.3	B08		8	0253-0413	306.91	413.24	351	68.77	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1778.6	B08		8	0254-0411	617.11	411.83	213	54.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3674.5	B08		8	0255-0413	920.61	413.25	248	59.11	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1360.1	B08		8	0256-0425	43.38	424.45	270	64.08	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1743.4	B08		8	0257-0424	197.36	424.82	291	65.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3239.0	B08		8	0258-0426	840.62	426.82	249	59.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1001.7	B08		8	0259-0425	90.69	425.05	252	59.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1354.2	B08		8	0260-0426	395.24	426.38	188	54.18	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2530.7	B08		8	0261-0430	798.43	429.42	316	67.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			795.7	B08		8	0262-0428	429.05	427.54	272	61.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2081.0	B08		8	0263-0430	685.11	429.79	228	59.11	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1240.5	B08		8	0264-0430	536.49	429.89	224	59.21	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2393.5	B08		8	0265-0433	292.44	431.71	270	62.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1666.9	B08		8	0266-0433	463.81	433.41	344	70.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1135.2	B08		8	0267-0440	612.69	440.34	286	66.18	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3513.0	B08		8	0268-0440	376.98	439.41	296	67.36	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1425.6	B08		8	0269-0441	917.64	440.86	239	59.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3441.7	B08		8	0270-0441	571.71	441.23	324	67.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2441.3	B08		8	0271-0448	119.36	447.66	377	73.60	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2204.2	B08		8	0272-0444	709.38	444.02	214	53.70	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2033.6	B08		8	0273-0446	210.10	445.78	171	49.70	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1540.1	B08		8	0274-0450	251.93	449.17	467	84.33	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2362.5	B08		8	0275-0445	284.42	445.95	125	42.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2034.7	B08		8	0276-0447	758.43	447.39	273	63.36	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			307.6	B08		8	0277-0447	510.30	448.26	285	65.60	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1802.1	B08		8	0278-0451	197.74	451.73	214	54.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1006.5	B08		8	0279-0452	679.58	452.71	229	56.53	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			837.7	B08		8	0280-0455	414.52	455.68	259	65.26	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			755.5	B08		8	0281-0458	645.04	457.69	235	57.70	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1452.7	B08		8	0282-0461	893.09	460.31	237	61.11	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2237.5	B08		8	0283-0461	806.05	461.06	265	61.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1574.3	B08		8	0284-0460	849.37	459.94	300	73.26	0.703
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3490.9	B08		8	0285-0467	482.18	466.42	278	65.36	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1550.1	B08		8	0286-0467	502.80	466.67	202	52.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2695.5	B08		8	0287-0468	175.68	468.11	131	44.39	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2729.5	B08		8	0288-0469	188.14	470.18	220	55.46	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2454.6	B08		8	0289-0470	164.58	470.70	133	44.87	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2224.7	B08		8	0290-0473	445.19	473.32	256	60.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2672.2	B08		8	0291-0476	340.33	476.43	305	64.43	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2874.1	B08		8	0292-0475	146.13	474.35	224	54.53	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			356.4	B08		8	0293-0476	594.06	476.63	181	50.28	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2299.4	B08		8	0294-0475	282.54	475.44	216	54.53	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1485.8	B08		8	0295-0480	38.72	480.74	281	66.67	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			381.0	B08		8	0296-0475	863.09	475.58	237	58.28	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2156.9	B08		8	0297-0476	670.54	476.17	223	56.28	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2483.9	B08		8	0298-0483	521.14	482.66	460	89.98	0.714
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1668.2	B08		8	0299-0486	72.47	487.20	271	64.77	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1283.7	B08		8	0300-0491	98.43	491.48	476	90.33	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			922.4	B08		8	0301-0489	681.87	489.05	240	57.94	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3285.7	B08		8	0302-0495	317.38	494.84	179	53.36	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2735.5	B08		8	0303-0498	424.53	498.54	275	61.60	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3022.9	B08		8	0304-0496	801.89	496.68	186	52.53	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1557.8	B08		8	0305-0496	568.46	496.21	140	45.46	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			360.6	B08		8	0306-0500	925.96	500.83	237	59.36	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1367.8	B08		8	0307-0506	409.35	506.26	265	71.36	0.654
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			445.7	B08		8	0308-0503	162.81	503.82	231	57.94	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2218.5	B08		8	0309-0502	252.53	502.28	254	61.11	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			377.9	B08		8	0310-0502	720.89	503.30	199	55.11	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			808.2	B08		8	0311-0506	118.28	506.07	213	55.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2688.9	B08		8	0312-0506	213.48	506.27	246	58.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			755.5	B08		8	0313-0505	513.95	505.20	270	61.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1108.8	B08		8	0314-0512	391.39	512.53	273	65.26	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1689.2	B08		8	0315-0508	573.78	508.38	197	52.63	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			442.3	B08		8	0316-0513	459.25	513.30	269	62.77	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2423.9	B08		8	0317-0516	279.40	515.67	340	72.91	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2748.0	B08		8	0318-0517	34.47	517.38	330	67.01	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1551.5	B08		8	0319-0519	191.56	519.29	327	67.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1088.1	B08		8	0320-0520	598.95	520.02	222	58.43	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			862.9	B08		8	0321-0521	490.02	521.05	227	55.70	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			328.9	B08		8	0322-0523	544.13	524.15	269	79.01	0.541
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1840.6	B08		8	0323-0524	373.61	524.93	246	58.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1549.4	B08		8	0324-0524	249.55	524.74	219	54.87	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2219.6	B08		8	0325-0528	587.81	528.57	220	57.26	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2102.8	B08		8	0326-0528	661.83	528.57	227	57.11	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1916.0	B08		8	0327-0529	741.26	528.96	331	66.18	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2421.4	B08		8	0328-0529	265.76	529.33	168	49.11	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1007.6	B08		8	0329-0530	886.67	530.57	195	53.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2350.6	B08		8	0330-0536	475.34	535.73	334	73.36	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			966.2	B08		8	0331-0532	693.26	532.27	262	62.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1602.5	B08		8	0332-0535	904.34	535.08	217	57.11	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1785.8	B08		8	0333-0540	503.66	539.29	356	73.01	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3075.3	B08		8	0334-0536	837.33	536.46	168	51.11	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			337.7	B08		8	0335-0540	618.73	540.15	265	63.60	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			325.4	B08		8	0336-0545	108.17	545.82	246	60.77	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2564.2	B08		8	0337-0540	310.74	540.38	112	45.11	0.692
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			331.6	B08		8	0338-0544	540.04	543.04	278	84.91	0.485
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2166.0	B08		8	0339-0543	647.59	542.83	260	59.94	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1634.3	B08		8	0340-0543	228.87	543.02	213	53.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2391.9	B08		8	0341-0547	440.74	547.05	393	74.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1861.3	B08		8	0342-0547	294.62	547.99	340	68.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1322.2	B08		8	0343-0549	63.74	548.50	494	85.84	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2337.0	B08		8	0344-0547	405.03	547.38	199	53.94	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1460.7	B08		8	0345-0553	720.38	553.08	424	78.91	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1634.5	B08		8	0346-0555	585.25	555.47	238	57.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			313.2	B08		8	0347-0557	930.45	557.56	203	53.94	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			809.2	B08		8	0348-0561	829.71	561.23	214	54.53	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1702.0	B08		8	0349-0561	149.59	561.09	177	51.11	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			294.1	B08		8	0350-0565	359.49	565.73	275	60.28	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			909.5	B08		8	0351-0567	899.27	567.38	262	59.60	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1662.2	B08		8	0352-0583	151.66	583.78	549	92.33	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2431.1	B08		8	0353-0575	301.99	574.27	211	54.53	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			873.9	B08		8	0354-0579	446.16	578.94	247	60.43	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1223.1	B08		8	0355-0580	653.80	579.80	251	60.77	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1809.6	B08		8	0356-0578	881.69	578.52	187	50.28	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1303.6	B08		8	0357-0582	591.28	583.00	268	61.26	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1183.6	B08		8	0358-0586	635.36	586.45	320	72.43	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			343.2	B08		8	0359-0585	522.96	585.30	305	67.36	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1796.1	B08		8	0360-0587	364.23	587.18	323	67.01	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1994.8	B08		8	0361-0584	292.96	585.51	169	49.11	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1796.8	B08		8	0362-0586	710.05	586.60	261	61.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1741.4	B08		8	0363-0588	546.84	587.82	378	76.18	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			624.1	B08		8	0364-0585	746.54	585.66	197	52.28	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			669.8	B08		8	0365-0594	428.50	594.90	260	61.36	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2250.6	B08		8	0366-0591	791.24	591.44	157	44.87	0.980
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1735.7	B08		8	0367-0594	106.89	593.63	301	67.36	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2426.4	B08		8	0368-0597	409.77	597.79	382	73.26	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1785.7	B08		8	0369-0601	38.88	600.70	394	73.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2238.0	B08		8	0370-0599	245.03	599.26	215	57.11	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2912.5	B08		8	0371-0603	294.83	602.94	352	87.26	0.581
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2161.4	B08		8	0372-0603	122.93	603.29	228	56.77	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1433.1	B08		8	0373-0602	745.82	602.88	254	59.70	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2034.6	B08		8	0374-0608	772.61	607.70	396	82.08	0.739
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			557.7	B08		8	0375-0611	588.28	610.98	281	61.11	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1218.7	B08		8	0376-0612	691.92	612.85	280	65.36	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1460.3	B08		8	0377-0611	621.03	610.64	266	65.11	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1067.9	B08		8	0378-0615	660.18	615.09	219	54.77	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			494.9	B08		8	0379-0615	91.00	615.30	225	55.11	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1264.8	B08		8	0380-0622	353.66	621.48	274	67.60	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			514.5	B08		8	0381-0617	484.70	617.51	235	57.46	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			550.9	B08		8	0382-0619	283.71	620.14	193	51.46	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1618.9	B08		8	0383-0624	540.61	624.20	286	64.43	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			706.8	B08		8	0384-0623	809.43	623.21	223	55.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2927.7	B08		8	0385-0626	369.46	626.27	240	59.11	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1944.1	B08		8	0386-0628	750.05	628.17	455	80.08	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1188.5	B08		8	0387-0626	315.90	625.91	218	54.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1790.5	B08		8	0388-0630	400.01	630.46	315	65.01	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1495.7	B08		8	0389-0634	103.08	633.11	250	61.60	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2600.8	B08		8	0390-0633	301.76	632.85	182	52.77	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			980.0	B08		8	0391-0634	920.99	635.17	270	65.01	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2520.9	B08		8	0392-0641	826.35	642.57	525	91.01	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1514.3	B08		8	0393-0636	250.17	635.64	243	57.11	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2618.6	B08		8	0394-0636	286.29	635.91	299	67.11	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2047.5	B08		8	0395-0640	56.08	640.78	309	64.18	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			688.9	B08		8	0396-0645	176.16	644.35	531	89.74	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2781.4	B08		8	0397-0642	149.11	641.65	448	83.26	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3735.9	B08		8	0398-0641	548.88	641.16	219	57.01	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3353.7	B08		8	0399-0644	331.95	643.38	244	59.60	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1696.9	B08		8	0400-0644	615.31	644.31	242	60.53	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			315.4	B08		8	0401-0653	518.96	653.04	290	69.36	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2404.0	B08		8	0402-0654	562.67	654.67	315	66.18	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1486.7	B08		8	0403-0658	878.27	658.10	486	88.33	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1754.2	B08		8	0404-0659	685.60	660.49	274	65.60	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3175.0	B08		8	0405-0660	134.72	659.99	277	61.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			373.6	B08		8	0406-0659	651.26	658.94	214	56.18	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1998.6	B08		8	0407-0662	215.01	661.71	477	97.64	0.629
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2887.5	B08		8	0408-0660	432.11	659.62	345	68.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1811.7	B08		8	0409-0661	746.57	660.93	266	60.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			320.5	B08		8	0410-0660	941.90	660.60	248	60.28	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1968.1	B08		8	0411-0660	189.48	661.10	161	49.11	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2891.9	B08		8	0412-0661	39.92	660.81	174	50.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2274.4	B08		8	0413-0664	81.31	663.61	225	57.70	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2918.8	B08		8	0414-0668	27.47	667.37	212	59.36	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1790.0	B08		8	0415-0670	173.32	670.15	233	58.53	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			373.0	B08		8	0416-0671	593.71	671.10	209	53.94	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1737.4	B08		8	0417-0679	567.36	678.71	242	59.84	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1419.7	B08		8	0418-0680	633.95	680.76	292	63.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1993.6	B08		8	0419-0685	777.50	685.49	371	71.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4124.8	B08		8	0420-0687	429.91	687.24	392	75.01	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			360.1	B08		8	0421-0684	263.38	684.17	218	56.53	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1211.8	B08		8	0422-0686	584.10	686.88	285	67.01	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1062.6	B08		8	0423-0680	903.82	679.87	100	37.21	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1102.6	B08		8	0424-0688	864.67	688.04	231	55.36	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1939.9	B08		8	0425-0688	80.75	689.10	232	57.11	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1919.6	B08		8	0426-0690	240.48	690.82	319	66.43	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1538.1	B08		8	0427-0693	719.10	693.26	270	60.53	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1010.7	B08		8	0428-0691	901.19	691.00	113	40.63	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3135.0	B08		8	0429-0697	17.33	697.09	223	56.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1995.7	B08		8	0430-0698	42.08	697.67	293	61.94	0.960
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			440.8	B08		8	0431-0699	548.17	698.83	224	56.28	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1087.0	B08		8	0432-0702	522.67	703.01	282	71.01	0.703
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2614.2	B08		8	0433-0703	351.47	703.31	310	65.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1883.7	B08		8	0434-0703	796.34	702.67	220	56.18	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1615.5	B08		8	0435-0702	574.57	702.78	210	54.28	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1433.7	B08		8	0436-0706	669.98	705.58	287	71.60	0.704
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1587.9	B08		9	0001-0029	375.41	28.74	246	63.11	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3368.9	B08		9	0002-0035	296.66	35.80	264	59.94	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2628.7	B08		9	0003-0036	644.36	36.42	315	66.53	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			643.8	B08		9	0004-0038	498.11	37.25	198	56.28	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1775.9	B08		9	0005-0041	524.43	41.73	478	87.74	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1760.4	B08		9	0006-0036	419.86	35.88	237	57.11	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1855.4	B08		9	0007-0037	916.03	37.79	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2964.0	B08		9	0008-0038	140.82	38.08	237	56.53	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2010.9	B08		9	0009-0041	868.08	40.29	256	63.26	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1846.0	B08		9	0010-0042	802.53	43.08	239	57.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			370.1	B08		9	0011-0045	752.63	45.65	300	67.94	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2634.2	B08		9	0012-0043	77.15	42.42	188	50.53	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3202.7	B08		9	0013-0043	22.75	43.23	221	55.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2611.5	B08		9	0014-0048	195.35	48.09	125	41.11	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3709.0	B08		9	0015-0057	182.56	57.31	447	82.91	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1383.9	B08		9	0016-0059	157.91	60.02	233	61.01	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1832.0	B08		9	0017-0057	34.87	57.15	199	51.70	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			279.8	B08		9	0018-0056	285.96	56.48	248	60.77	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2772.6	B08		9	0019-0062	107.83	62.92	258	61.94	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2138.7	B08		9	0020-0064	915.19	64.42	323	65.60	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2482.1	B08		9	0021-0069	346.07	69.89	504	96.57	0.679
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1117.9	B08		9	0022-0063	704.13	62.44	191	53.70	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1246.3	B08		9	0023-0066	436.04	66.09	338	70.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1869.9	B08		9	0024-0068	580.73	68.94	270	62.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1984.1	B08		9	0025-0070	725.46	70.06	223	58.77	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			320.2	B08		9	0026-0072	284.31	72.25	291	63.36	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			429.4	B08		9	0027-0075	862.66	75.75	196	53.11	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2069.0	B08		9	0028-0081	662.91	82.52	347	71.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2001.6	B08		9	0029-0080	395.44	80.30	251	58.87	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1808.5	B08		9	0030-0082	932.73	81.71	281	61.60	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3254.0	B08		9	0031-0086	835.57	86.40	322	67.01	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1160.0	B08		9	0032-0088	176.88	88.51	268	61.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1836.6	B08		9	0033-0089	413.59	90.14	246	62.77	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			543.4	B08		9	0034-0092	612.75	92.05	284	68.08	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2416.8	B08		9	0035-0089	761.59	88.86	231	57.70	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1584.1	B08		9	0036-0095	240.04	95.34	359	70.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2100.3	B08		9	0037-0092	365.95	91.80	166	51.70	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2153.1	B08		9	0038-0097	107.13	96.97	346	69.01	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2648.4	B08		9	0039-0095	479.40	93.97	208	55.01	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			866.6	B08		9	0040-0095	395.91	94.90	126	44.28	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2039.7	B08		9	0041-0100	384.59	100.22	192	62.67	0.614
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			901.0	B08		9	0042-0101	710.55	101.66	287	74.08	0.657
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3077.6	B08		9	0043-0110	644.32	111.09	321	72.18	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3869.0	B08		9	0044-0106	372.78	107.06	198	52.77	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			5690.5	B08		9	0045-0110	466.14	110.96	338	70.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1967.0	B08		9	0046-0112	75.69	112.16	235	56.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1256.9	B08		9	0047-0116	36.68	116.61	256	63.01	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4282.2	B08		9	0048-0118	294.42	117.84	409	74.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2872.8	B08		9	0049-0119	431.62	119.28	337	71.84	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2264.8	B08		9	0050-0120	677.17	120.32	449	78.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2261.9	B08		9	0051-0121	411.39	121.23	277	62.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1437.7	B08		9	0052-0128	190.63	128.16	380	73.36	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1641.2	B08		9	0053-0126	224.06	125.99	270	63.94	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			320.0	B08		9	0054-0128	144.88	128.15	231	56.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1866.2	B08		9	0055-0133	746.35	133.64	381	73.26	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1173.7	B08		9	0056-0134	835.53	133.85	352	78.33	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1494.6	B08		9	0057-0139	253.74	138.75	396	74.67	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			532.1	B08		9	0058-0141	818.10	141.83	228	57.11	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1522.3	B08		9	0059-0144	47.69	143.22	250	61.36	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2634.7	B08		9	0060-0146	541.50	146.66	220	58.77	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2567.3	B08		9	0061-0150	866.35	150.41	235	57.60	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2732.7	B08		9	0062-0149	219.61	150.24	257	61.11	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			492.2	B08		9	0063-0153	936.51	153.32	219	56.53	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1503.8	B08		9	0064-0152	631.80	151.95	274	63.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			248.6	B08		9	0065-0156	715.63	156.14	264	59.94	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1923.4	B08		9	0066-0159	132.93	160.15	351	80.08	0.688
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1870.9	B08		9	0067-0159	577.05	159.47	210	55.70	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1945.5	B08		9	0068-0161	523.25	160.27	245	71.60	0.601
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			426.5	B08		9	0069-0166	589.08	166.62	279	68.18	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3371.9	B08		9	0070-0168	857.63	168.79	337	69.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			373.6	B08		9	0071-0168	163.28	168.37	218	58.77	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1213.2	B08		9	0072-0167	753.10	167.95	345	77.36	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			401.0	B08		9	0073-0170	813.41	169.51	207	59.11	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1509.8	B08		9	0074-0173	337.38	173.65	437	79.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1800.0	B08		9	0075-0173	53.07	173.78	231	57.94	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			998.8	B08		9	0076-0177	659.41	177.28	409	77.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1725.1	B08		9	0077-0177	903.32	177.17	420	77.26	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2717.3	B08		9	0078-0177	119.07	177.60	157	47.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			5222.0	B08		9	0079-0179	279.29	179.71	293	63.94	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2176.3	B08		9	0080-0180	544.45	179.49	254	59.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1356.9	B08		9	0081-0186	495.05	186.44	413	75.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1499.0	B08		9	0082-0189	700.98	189.95	318	74.67	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1866.9	B08		9	0083-0200	82.82	200.43	296	66.18	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			561.7	B08		9	0084-0201	898.68	200.80	261	61.84	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			213.7	B08		9	0085-0203	39.87	204.14	236	65.01	0.702
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2185.3	B08		9	0086-0210	142.72	209.61	345	69.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1701.7	B08		9	0087-0210	815.25	209.94	406	75.60	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4427.7	B08		9	0088-0215	585.72	215.59	294	65.60	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3493.7	B08		9	0089-0220	316.80	220.33	296	63.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2324.6	B08		9	0090-0225	761.42	225.12	457	83.26	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1084.0	B08		9	0091-0221	68.78	221.25	223	57.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			595.1	B08		9	0092-0222	712.47	222.20	219	55.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2134.6	B08		9	0093-0229	444.65	229.37	286	62.53	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3607.1	B08		9	0094-0229	257.22	228.54	248	60.77	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1858.3	B08		9	0095-0230	419.36	229.52	313	66.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2265.4	B08		9	0096-0228	934.52	228.45	208	55.11	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2163.9	B08		9	0097-0233	696.55	233.45	214	54.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2462.8	B08		9	0098-0232	866.73	232.18	273	61.60	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1343.7	B08		9	0099-0240	469.31	240.67	512	91.50	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4755.2	B08		9	0100-0231	583.41	230.91	168	48.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			772.7	B08		9	0101-0237	641.00	236.87	303	71.01	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1752.4	B08		9	0102-0237	786.48	236.79	348	67.60	0.957
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2493.1	B08		9	0103-0238	568.60	238.28	246	62.18	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2930.5	B08		9	0104-0243	188.18	242.63	287	63.94	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			438.8	B08		9	0105-0245	37.25	244.38	184	53.70	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2587.3	B08		9	0106-0247	51.01	246.24	250	65.36	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1365.0	B08		9	0107-0246	387.87	246.42	235	58.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			450.1	B08		9	0108-0247	668.56	246.78	218	58.53	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2694.2	B08		9	0109-0246	67.09	246.25	134	44.04	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1431.9	B08		9	0110-0249	757.96	250.41	242	59.84	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2496.7	B08		9	0111-0251	114.69	250.68	376	73.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			763.8	B08		9	0112-0249	731.62	249.28	190	51.70	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			795.0	B08		9	0113-0256	95.29	255.88	233	57.46	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2437.6	B08		9	0114-0264	314.31	264.28	268	63.11	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2229.8	B08		9	0115-0263	73.71	263.86	225	61.36	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1780.3	B08		9	0116-0262	474.21	262.79	286	65.94	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2045.7	B08		9	0117-0270	339.27	270.00	284	63.36	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2893.4	B08		9	0118-0269	535.85	268.73	309	66.18	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4521.1	B08		9	0119-0269	182.69	270.82	188	52.63	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3371.0	B08		9	0120-0272	17.79	271.66	249	58.53	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1866.9	B08		9	0121-0275	763.22	275.32	256	58.53	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2100.0	B08		9	0122-0277	555.54	277.08	261	60.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2559.3	B08		9	0123-0284	50.90	284.12	340	70.53	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1724.4	B08		9	0124-0281	99.05	281.25	217	54.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			769.8	B08		9	0125-0287	246.12	287.94	272	67.84	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2724.0	B08		9	0126-0292	726.80	291.74	517	93.15	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2799.0	B08		9	0127-0290	183.49	289.35	416	76.18	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			5427.8	B08		9	0128-0289	334.17	289.12	270	59.94	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4475.0	B08		9	0129-0291	540.49	291.77	368	70.43	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1902.3	B08		9	0130-0292	449.98	292.00	252	57.11	0.971
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1902.1	B08		9	0131-0295	589.40	296.33	240	59.94	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1776.4	B08		9	0132-0294	801.72	294.94	278	69.84	0.716
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2329.9	B08		9	0133-0295	493.60	294.97	291	63.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1133.8	B08		9	0134-0300	260.29	300.34	263	68.77	0.699
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1912.8	B08		9	0135-0306	171.30	306.21	233	57.94	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			550.3	B08		9	0136-0312	29.03	312.93	218	56.53	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			739.4	B08		9	0137-0311	895.81	310.71	243	58.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1638.9	B08		9	0138-0318	53.27	318.60	345	82.08	0.643
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2478.0	B08		9	0139-0316	771.09	315.11	296	64.53	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			465.0	B08		9	0140-0318	229.24	318.55	191	51.70	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			409.9	B08		9	0141-0320	438.45	319.63	210	55.70	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3936.3	B08		9	0142-0321	467.78	320.33	229	56.28	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1288.2	B08		9	0143-0321	317.76	321.39	263	67.36	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1800.4	B08		9	0144-0328	922.76	328.97	281	67.11	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1676.3	B08		9	0145-0327	186.14	327.13	204	54.53	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2762.7	B08		9	0146-0334	85.06	333.61	377	76.18	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			406.7	B08		9	0147-0328	528.84	327.56	216	57.70	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			712.0	B08		9	0148-0337	300.90	337.37	226	68.91	0.598
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1730.1	B08		9	0149-0338	407.57	338.42	370	72.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			385.5	B08		9	0150-0340	108.35	340.54	212	56.28	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			963.6	B08		9	0151-0341	495.40	341.38	246	59.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2690.2	B08		9	0152-0341	755.99	340.88	209	54.28	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2293.3	B08		9	0153-0343	626.36	343.83	258	58.77	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			406.2	B08		9	0154-0344	427.02	344.31	229	57.46	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2269.4	B08		9	0155-0345	682.42	345.77	237	57.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1720.2	B08		9	0156-0352	877.69	351.77	267	62.87	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			318.7	B08		9	0157-0354	511.28	354.98	227	59.94	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1645.6	B08		9	0158-0355	359.05	355.36	404	74.18	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			370.3	B08		9	0159-0357	108.57	356.48	250	58.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2203.9	B08		9	0160-0362	712.63	362.15	219	55.36	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			339.7	B08		9	0161-0364	854.69	363.71	235	58.77	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2986.8	B08		9	0162-0374	762.71	374.69	251	58.53	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2404.3	B08		9	0163-0382	541.62	381.84	369	69.84	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3359.5	B08		9	0164-0384	836.72	385.18	259	62.53	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2142.2	B08		9	0165-0388	132.56	388.06	423	79.84	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2910.1	B08		9	0166-0383	443.86	383.52	208	54.53	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			780.1	B08		9	0167-0385	591.05	385.30	269	63.36	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2469.1	B08		9	0168-0383	795.38	383.11	199	51.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1401.4	B08		9	0169-0386	880.30	385.53	249	63.84	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			621.5	B08		9	0170-0388	609.83	388.72	299	68.18	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1825.1	B08		9	0171-0392	751.60	392.00	346	68.18	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2363.9	B08		9	0172-0392	61.36	392.33	283	61.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4609.9	B08		9	0173-0398	557.28	397.94	324	66.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			445.3	B08		9	0174-0397	499.20	396.92	252	61.11	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1344.8	B08		9	0175-0403	283.02	403.64	278	66.53	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1270.3	B08		9	0176-0402	205.79	402.27	267	61.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			682.7	B08		9	0177-0403	233.59	403.91	230	58.28	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1673.5	B08		9	0178-0405	473.13	404.50	404	75.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1338.0	B08		9	0179-0406	83.40	406.15	256	65.60	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2274.1	B08		9	0180-0413	789.67	413.15	247	57.36	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2354.0	B08		9	0181-0416	426.35	416.54	220	56.53	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1348.5	B08		9	0182-0423	837.61	424.02	364	74.91	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			429.0	B08		9	0183-0421	305.15	420.27	213	56.53	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			302.6	B08		9	0184-0422	494.32	422.69	230	56.43	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1512.3	B08		9	0185-0426	371.17	426.66	319	67.01	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2759.6	B08		9	0186-0427	537.70	427.27	339	69.01	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2301.1	B08		9	0187-0432	685.33	431.98	231	59.36	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			879.2	B08		9	0188-0431	97.98	430.39	188	56.39	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			444.6	B08		9	0189-0433	54.32	433.29	233	60.53	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2581.5	B08		9	0190-0436	449.92	436.02	269	60.53	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			349.1	B08		9	0191-0442	519.64	442.54	258	64.87	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1413.8	B08		9	0192-0439	203.08	439.76	261	62.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4117.6	B08		9	0193-0437	789.12	437.27	116	40.63	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1506.1	B08		9	0194-0440	878.12	440.65	189	52.77	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			922.6	B08		9	0195-0443	98.41	442.84	227	59.11	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2391.3	B08		9	0196-0447	570.66	447.10	432	77.26	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1847.7	B08		9	0197-0448	170.09	448.37	247	57.94	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2141.2	B08		9	0198-0446	269.82	445.98	162	47.70	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1809.7	B08		9	0199-0446	254.95	446.32	123	39.70	0.981
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			485.5	B08		9	0200-0452	673.57	452.65	230	79.15	0.461
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2592.9	B08		9	0201-0452	307.23	451.83	314	65.60	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1430.4	B08		9	0202-0455	458.89	454.01	262	61.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2786.5	B08		9	0203-0454	867.79	454.33	272	60.77	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2067.0	B08		9	0204-0457	197.88	457.55	260	59.94	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2515.4	B08		9	0205-0458	886.30	458.69	261	59.11	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2078.3	B08		9	0206-0461	116.98	460.20	312	66.77	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			424.0	B08		9	0207-0457	382.26	457.42	169	48.87	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2060.8	B08		9	0208-0462	262.87	461.81	282	64.18	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			351.3	B08		9	0209-0462	492.45	462.02	229	58.77	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3043.0	B08		9	0210-0465	652.17	465.62	167	52.53	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3105.7	B08		9	0211-0467	447.34	467.17	217	56.53	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1072.2	B08		9	0212-0471	237.87	471.44	203	54.53	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			412.5	B08		9	0213-0475	615.13	476.07	237	61.94	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2832.5	B08		9	0214-0474	890.92	474.25	224	58.77	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1558.7	B08		9	0215-0477	410.11	477.40	250	60.28	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1810.0	B08		9	0216-0481	835.88	480.63	245	68.43	0.658
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1973.5	B08		9	0217-0482	131.20	482.57	312	67.36	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2161.6	B08		9	0218-0485	789.47	484.56	241	57.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2807.9	B08		9	0219-0488	293.83	487.81	344	69.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1470.9	B08		9	0220-0493	57.35	493.06	480	85.50	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1863.6	B08		9	0221-0491	203.22	491.41	302	64.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			295.3	B08		9	0222-0490	177.03	490.29	235	56.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			363.0	B08		9	0223-0495	751.21	495.28	280	66.77	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1844.0	B08		9	0224-0498	80.23	499.11	399	74.43	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3048.0	B08		9	0225-0497	922.77	497.48	204	57.70	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1837.1	B08		9	0226-0502	236.73	501.88	415	75.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2839.2	B08		9	0227-0498	573.39	498.78	297	62.53	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			5027.1	B08		9	0228-0500	322.76	499.64	277	61.60	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2907.6	B08		9	0229-0502	506.79	501.80	248	58.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			365.3	B08		9	0230-0503	20.49	503.65	227	58.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1401.8	B08		9	0231-0503	613.53	503.98	219	57.60	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2697.3	B08		9	0232-0506	148.19	505.77	242	59.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2224.2	B08		9	0233-0507	431.14	506.84	291	62.53	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1740.5	B08		9	0234-0507	638.99	507.50	240	56.53	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2093.3	B08		9	0235-0513	402.86	513.41	325	66.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1726.8	B08		9	0236-0514	539.86	512.74	302	67.84	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1373.7	B08		9	0237-0515	869.62	515.16	264	61.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			656.2	B08		9	0238-0516	369.98	516.93	269	64.18	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2133.8	B08		9	0239-0519	104.22	518.97	321	67.26	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2871.2	B08		9	0240-0525	570.22	526.36	302	65.94	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3067.9	B08		9	0241-0528	304.28	527.73	282	63.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2278.2	B08		9	0242-0532	817.06	532.15	301	66.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			696.0	B08		9	0243-0529	424.39	528.53	175	47.94	0.957
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			389.6	B08		9	0244-0536	692.32	536.35	300	71.01	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			387.5	B08		9	0245-0535	203.65	535.32	324	70.77	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1619.6	B08		9	0246-0534	332.49	534.09	240	59.60	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1908.1	B08		9	0247-0535	479.98	535.04	241	57.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3216.4	B08		9	0248-0535	624.18	535.37	228	54.53	0.964
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1670.8	B08		9	0249-0541	520.93	541.71	289	66.08	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			619.9	B08		9	0250-0540	436.99	540.78	196	51.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2223.6	B08		9	0251-0542	849.90	542.58	274	61.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1992.0	B08		9	0252-0547	578.88	546.35	334	73.26	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			904.7	B08		9	0253-0547	64.50	546.90	227	56.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2149.1	B08		9	0254-0548	272.23	548.62	433	82.67	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1912.5	B08		9	0255-0549	125.58	549.29	309	65.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1884.5	B08		9	0256-0552	634.80	553.72	295	69.01	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2287.6	B08		9	0257-0554	757.50	554.76	286	61.94	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			422.7	B08		9	0258-0558	555.44	558.53	254	60.77	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			322.8	B08		9	0259-0560	24.96	560.43	200	53.70	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1765.4	B08		9	0260-0562	697.90	561.96	263	64.77	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1736.9	B08		9	0261-0563	849.83	563.63	267	62.77	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2475.5	B08		9	0262-0566	598.76	565.95	287	64.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			731.2	B08		9	0263-0565	51.84	565.11	217	53.94	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1894.2	B08		9	0264-0568	888.61	568.11	289	68.43	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1253.1	B08		9	0265-0572	386.02	571.90	243	58.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			628.5	B08		9	0266-0575	514.40	575.95	281	61.70	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1543.6	B08		9	0267-0581	532.87	581.25	353	71.94	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1695.0	B08		9	0268-0579	287.29	578.41	257	65.84	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1799.1	B08		9	0269-0584	864.73	583.81	303	73.26	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2468.2	B08		9	0270-0584	646.24	584.16	276	63.01	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			340.2	B08		9	0271-0585	50.25	586.00	238	56.53	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1701.1	B08		9	0272-0588	179.41	588.74	349	70.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2384.6	B08		9	0273-0590	332.10	590.35	315	67.36	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2613.2	B08		9	0274-0586	763.04	585.73	159	46.28	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			784.4	B08		9	0275-0592	716.93	591.83	260	62.43	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			991.1	B08		9	0276-0596	84.07	595.42	314	70.43	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1231.6	B08		9	0277-0596	569.57	597.08	525	102.57	0.627
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1474.0	B08		9	0278-0595	813.75	595.63	252	65.36	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1852.8	B08		9	0279-0592	473.14	591.49	225	56.87	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2247.0	B08		9	0280-0596	369.67	596.03	280	62.18	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2742.4	B08		9	0281-0596	774.53	596.67	295	65.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2886.6	B08		9	0282-0601	122.68	601.11	241	61.84	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1558.5	B08		9	0283-0598	437.42	599.28	254	61.94	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2246.0	B08		9	0284-0604	937.38	603.42	278	62.53	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1251.4	B08		9	0285-0604	397.84	603.82	232	55.36	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2259.1	B08		9	0286-0609	894.82	608.75	206	54.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1470.1	B08		9	0287-0616	115.39	616.74	322	71.60	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2192.6	B08		9	0288-0614	727.58	614.63	374	73.01	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1679.8	B08		9	0289-0615	291.21	615.32	234	60.18	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2246.3	B08		9	0290-0611	909.17	611.05	147	46.04	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3211.3	B08		9	0291-0616	59.21	615.88	279	62.18	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2698.9	B08		9	0292-0616	645.44	616.87	345	73.26	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2741.8	B08		9	0293-0617	868.69	617.47	490	92.81	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1414.6	B08		9	0294-0618	309.51	618.88	216	61.84	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2067.7	B08		9	0295-0618	274.72	618.27	204	54.53	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1499.5	B08		9	0296-0622	927.25	621.70	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3058.6	B08		9	0297-0624	218.76	623.81	309	63.60	0.960
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1319.3	B08		9	0298-0628	473.80	627.67	178	52.53	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2057.2	B08		9	0299-0629	88.26	629.56	283	62.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1758.7	B08		9	0300-0629	777.02	628.82	261	61.01	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1584.8	B08		9	0301-0635	568.32	635.08	290	73.84	0.668
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1393.5	B08		9	0302-0631	810.05	630.69	249	63.26	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1896.8	B08		9	0303-0630	383.60	630.36	218	53.36	0.962
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1574.5	B08		9	0304-0632	640.10	632.53	232	59.70	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2458.4	B08		9	0305-0633	902.89	632.87	350	68.18	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1392.2	B08		9	0306-0631	325.68	632.39	263	60.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2295.0	B08		9	0307-0633	688.22	633.46	306	63.94	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1862.9	B08		9	0308-0640	182.52	640.32	330	69.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			407.0	B08		9	0309-0639	110.84	638.95	229	56.53	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1659.6	B08		9	0310-0642	264.97	641.97	190	53.36	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2046.2	B08		9	0311-0642	946.31	642.26	211	55.94	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4247.0	B08		9	0312-0653	717.73	653.94	494	85.15	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			425.7	B08		9	0313-0650	429.31	649.95	196	52.28	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1485.6	B08		9	0314-0655	504.15	656.17	268	64.18	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			323.0	B08		9	0315-0652	657.70	652.90	261	59.11	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3677.2	B08		9	0316-0654	70.78	654.67	174	51.11	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1794.4	B08		9	0317-0657	339.71	657.78	226	56.53	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			301.2	B08		9	0318-0655	383.03	655.64	149	48.87	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1148.2	B08		9	0319-0657	200.29	656.11	247	59.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1537.4	B08		9	0320-0658	839.59	659.58	154	49.70	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			387.0	B08		9	0321-0657	444.85	658.14	127	47.11	0.719
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2602.1	B08		9	0322-0661	623.12	662.42	258	63.60	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2151.7	B08		9	0323-0658	568.08	658.62	172	49.70	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2298.4	B08		9	0324-0659	790.18	659.37	206	54.28	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			272.1	B08		9	0325-0663	35.78	663.64	240	57.94	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1861.7	B08		9	0326-0662	404.60	661.96	211	57.36	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			342.3	B08		9	0327-0664	162.23	664.66	252	61.94	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1887.5	B08		9	0328-0670	140.52	670.03	284	64.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1593.7	B08		9	0329-0672	297.72	672.30	288	66.43	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2365.3	B08		9	0330-0674	875.21	673.40	244	60.53	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1297.8	B08		9	0331-0676	380.69	676.33	270	67.84	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			410.4	B08		9	0332-0675	91.03	674.87	253	59.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2701.8	B08		9	0333-0676	937.72	675.75	245	59.11	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2426.5	B08		9	0334-0674	786.59	674.75	198	50.87	0.962
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			993.0	B08		9	0335-0684	887.77	684.20	229	60.77	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1199.6	B08		9	0336-0686	264.85	686.00	246	60.53	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1896.9	B08		9	0337-0692	837.75	693.34	241	64.43	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1675.6	B08		9	0338-0695	451.42	695.09	247	59.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2566.3	B08		9	0339-0698	629.42	698.59	368	72.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			416.4	B08		9	0340-0696	691.70	698.16	252	70.43	0.638
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2736.7	B08		9	0341-0695	937.50	695.64	242	57.11	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			247.4	B08		9	0342-0697	110.29	698.24	232	66.18	0.666
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1655.6	B08		9	0343-0703	749.84	702.22	218	59.11	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2682.1	B08		9	0344-0703	45.50	703.45	308	66.43	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2275.2	B08		9	0345-0708	150.33	708.96	334	70.43	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			379.4	B08		9	0346-0706	185.63	705.56	275	66.43	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2010.6	B08		9	0347-0703	907.57	703.18	102	37.80	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1520.1	B08		9	0348-0708	216.50	709.43	226	57.36	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1650.1	C08		1	0001-0025	822.14	25.96	373	78.43	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1307.4	C08		1	0002-0032	681.57	32.38	336	70.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			554.6	C08		1	0003-0031	209.13	31.38	259	59.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			456.0	C08		1	0004-0035	598.48	35.02	291	65.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			454.0	C08		1	0005-0033	294.09	33.97	277	61.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			748.4	C08		1	0006-0037	95.05	37.30	267	59.36	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			880.0	C08		1	0007-0038	133.57	38.49	299	64.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1100.4	C08		1	0008-0040	943.98	40.01	322	66.77	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			769.9	C08		1	0009-0040	72.15	41.03	262	61.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			712.7	C08		1	0010-0039	525.47	39.38	257	59.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			968.4	C08		1	0011-0041	554.92	42.34	237	63.60	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			535.8	C08		1	0012-0041	925.52	41.93	290	61.94	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			582.9	C08		1	0013-0045	740.21	45.84	288	63.84	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4116.9	C08		1	0014-0050	351.70	51.05	330	68.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1000.1	C08		1	0015-0054	703.39	54.41	393	100.57	0.488
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1174.1	C08		1	0016-0050	831.85	50.06	209	52.28	0.961
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			459.5	C08		1	0017-0054	308.76	53.84	288	64.43	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			370.7	C08		1	0018-0058	877.05	57.46	291	64.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			395.7	C08		1	0019-0061	784.13	62.60	326	70.18	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			596.6	C08		1	0020-0061	248.09	60.88	258	61.01	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1325.5	C08		1	0021-0063	901.93	63.40	246	58.18	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			509.6	C08		1	0022-0065	450.72	64.22	288	63.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			516.0	C08		1	0023-0070	278.90	71.24	278	66.18	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2962.0	C08		1	0024-0072	603.94	72.36	320	66.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			568.6	C08		1	0025-0072	740.78	71.77	255	64.43	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1082.6	C08		1	0026-0072	691.94	72.87	204	67.26	0.567
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			444.6	C08		1	0027-0072	50.25	71.85	260	59.94	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			507.0	C08		1	0028-0074	438.92	74.68	303	65.26	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1099.2	C08		1	0029-0079	190.55	76.48	356	97.64	0.469
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			393.8	C08		1	0030-0075	870.05	76.04	277	65.36	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			443.9	C08		1	0031-0085	158.34	84.95	308	67.60	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			637.9	C08		1	0032-0085	93.65	85.12	246	58.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			610.0	C08		1	0033-0086	125.51	86.38	303	68.08	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			407.7	C08		1	0034-0086	411.37	86.47	305	64.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			706.0	C08		1	0035-0086	333.45	86.21	307	67.36	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			635.2	C08		1	0036-0095	644.36	95.56	264	61.94	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			648.8	C08		1	0037-0095	520.50	94.48	257	62.77	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			387.2	C08		1	0038-0096	764.15	95.07	320	71.01	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			937.0	C08		1	0039-0100	537.98	100.04	222	57.94	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1292.8	C08		1	0040-0101	506.98	101.49	188	52.53	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			644.2	C08		1	0041-0103	259.99	103.05	262	59.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			913.6	C08		1	0042-0105	493.19	105.07	201	53.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1110.7	C08		1	0043-0106	37.63	106.01	252	59.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			478.0	C08		1	0044-0109	240.13	108.48	280	63.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			542.1	C08		1	0045-0108	558.40	108.86	306	65.36	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			434.1	C08		1	0046-0108	577.01	108.07	250	57.36	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			428.7	C08		1	0047-0107	811.47	107.51	328	67.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1014.6	C08		1	0048-0110	851.09	110.29	317	67.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			560.7	C08		1	0049-0108	445.47	107.83	261	66.77	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			522.3	C08		1	0050-0117	119.82	117.36	249	60.53	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1105.4	C08		1	0051-0119	649.82	119.59	358	69.60	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			624.7	C08		1	0052-0120	103.19	120.90	254	61.11	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			736.2	C08		1	0053-0119	946.75	118.29	260	63.60	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			433.8	C08		1	0054-0118	743.02	118.79	290	64.53	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			390.7	C08		1	0055-0121	58.32	121.55	260	60.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			484.7	C08		1	0056-0131	85.34	132.15	262	61.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			377.3	C08		1	0057-0131	452.43	130.72	300	64.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			387.8	C08		1	0058-0138	487.67	137.96	255	65.84	0.739
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			413.6	C08		1	0059-0137	502.83	137.54	193	57.01	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1563.3	C08		1	0060-0139	210.02	137.63	516	101.40	0.631
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1526.9	C08		1	0061-0138	670.61	138.33	241	56.53	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			411.3	C08		1	0062-0143	149.45	143.21	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			535.2	C08		1	0063-0140	372.06	140.09	251	59.01	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			369.2	C08		1	0064-0145	749.21	144.31	314	68.18	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1068.1	C08		1	0065-0145	920.96	145.33	331	71.50	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1218.6	C08		1	0066-0146	39.71	146.68	341	69.94	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			533.7	C08		1	0067-0147	173.79	147.27	267	61.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			453.4	C08		1	0068-0153	551.00	153.54	283	63.26	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			404.1	C08		1	0069-0151	813.05	150.94	259	59.36	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			502.4	C08		1	0070-0158	513.00	157.99	546	99.15	0.698
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			321.0	C08		1	0071-0153	446.25	153.63	170	52.77	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			326.5	C08		1	0072-0155	845.90	155.03	319	67.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1805.2	C08		1	0073-0154	334.70	154.51	259	60.18	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1371.1	C08		1	0074-0152	624.74	152.68	246	59.11	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			478.8	C08		1	0075-0156	784.87	156.36	297	65.60	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			327.3	C08		1	0076-0159	884.42	159.25	315	70.43	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			362.3	C08		1	0077-0160	127.31	160.31	303	65.36	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1659.0	C08		1	0078-0162	305.18	162.32	272	63.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			747.0	C08		1	0079-0168	288.46	168.54	311	67.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			358.5	C08		1	0080-0171	832.81	171.77	291	68.18	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			672.4	C08		1	0081-0174	42.34	174.21	262	63.36	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			526.2	C08		1	0082-0170	729.21	170.50	271	61.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			382.3	C08		1	0083-0173	590.40	173.08	296	63.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			845.1	C08		1	0084-0178	83.14	178.73	315	65.01	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			896.8	C08		1	0085-0177	171.65	177.29	246	57.36	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			536.2	C08		1	0086-0182	691.21	182.38	284	63.36	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			516.6	C08		1	0087-0186	447.87	186.68	253	59.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			767.2	C08		1	0088-0188	242.39	187.62	194	51.94	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1157.6	C08		1	0089-0193	516.56	193.62	611	101.98	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1576.4	C08		1	0090-0190	635.08	190.19	316	70.43	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			420.3	C08		1	0091-0192	872.76	192.02	284	61.36	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1815.2	C08		1	0092-0193	736.41	192.47	313	65.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			547.9	C08		1	0093-0194	386.17	193.83	254	58.53	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			463.2	C08		1	0094-0194	823.62	193.96	316	67.84	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			373.3	C08		1	0095-0196	920.81	196.20	290	64.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			469.3	C08		1	0096-0196	427.88	196.19	297	65.01	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			341.3	C08		1	0097-0201	117.09	201.51	288	64.28	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			553.5	C08		1	0098-0201	53.21	201.78	281	60.77	0.956
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2796.3	C08		1	0099-0200	257.81	199.94	205	56.77	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			788.1	C08		1	0100-0203	208.24	203.37	234	55.94	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			402.1	C08		1	0101-0206	669.23	206.07	274	62.53	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			829.0	C08		1	0102-0208	574.16	208.16	397	73.84	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			418.4	C08		1	0103-0204	331.29	205.07	268	64.28	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3003.9	C08		1	0104-0211	807.63	211.72	465	80.08	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			702.9	C08		1	0105-0211	246.49	212.01	282	62.43	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			448.9	C08		1	0106-0213	766.71	214.14	272	61.60	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			520.1	C08		1	0107-0227	200.15	227.05	513	92.08	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			843.6	C08		1	0108-0228	722.25	228.10	375	72.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			683.0	C08		1	0109-0230	145.31	230.74	242	58.77	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1403.1	C08		1	0110-0231	695.49	230.67	231	55.36	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			984.1	C08		1	0111-0231	567.25	231.61	293	66.53	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			506.5	C08		1	0112-0236	127.92	236.17	260	61.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			564.1	C08		1	0113-0237	501.37	237.45	245	57.94	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2115.2	C08		1	0114-0236	799.39	236.30	397	79.70	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			560.0	C08		1	0115-0240	324.51	240.08	251	58.53	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			943.4	C08		1	0116-0244	296.32	243.88	305	66.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1353.7	C08		1	0117-0248	90.39	247.75	310	65.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2163.5	C08		1	0118-0248	683.41	248.56	344	67.60	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1106.3	C08		1	0119-0245	744.24	245.15	204	53.11	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			635.3	C08		1	0120-0245	763.73	245.53	199	51.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3262.4	C08		1	0121-0250	345.88	250.19	248	57.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			687.3	C08		1	0122-0255	833.72	255.63	376	75.26	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			605.5	C08		1	0123-0253	578.67	252.77	255	61.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			402.7	C08		1	0124-0257	141.20	256.83	286	63.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1126.2	C08		1	0125-0262	225.24	261.63	430	78.67	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			403.8	C08		1	0126-0259	74.74	259.19	315	66.53	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1039.6	C08		1	0127-0259	284.48	259.09	366	71.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2852.2	C08		1	0128-0259	366.80	258.66	326	67.01	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			765.8	C08		1	0129-0257	851.64	258.33	235	58.87	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			649.8	C08		1	0130-0267	526.09	266.69	533	94.57	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			436.7	C08		1	0131-0263	590.14	263.95	263	61.11	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1353.5	C08		1	0132-0266	877.93	266.67	240	58.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			911.6	C08		1	0133-0265	920.94	265.46	218	53.70	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1628.5	C08		1	0134-0271	614.64	271.53	413	74.67	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			665.3	C08		1	0135-0272	765.04	272.49	301	63.36	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1230.8	C08		1	0136-0272	934.67	272.12	175	51.36	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			536.3	C08		1	0137-0276	167.43	277.02	253	61.70	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			498.4	C08		1	0138-0276	674.37	275.96	323	67.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			381.8	C08		1	0139-0278	456.40	277.71	282	63.60	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			852.5	C08		1	0140-0279	829.32	278.74	284	64.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1298.1	C08		1	0141-0279	328.50	279.91	245	56.77	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			742.1	C08		1	0142-0287	283.61	286.97	406	75.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			456.2	C08		1	0143-0290	212.32	290.79	292	66.18	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			494.5	C08		1	0144-0287	406.95	287.56	318	70.77	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			511.8	C08		1	0145-0287	877.73	287.64	261	59.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1077.6	C08		1	0146-0284	940.74	284.64	148	44.28	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			469.8	C08		1	0147-0290	350.24	290.23	304	68.08	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			388.3	C08		1	0148-0293	88.23	293.47	271	63.36	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			455.8	C08		1	0149-0298	478.74	297.61	288	67.11	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			872.1	C08		1	0150-0299	30.29	299.17	312	65.11	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			963.0	C08		1	0151-0297	769.35	297.25	237	56.18	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			417.7	C08		1	0152-0298	577.12	298.30	242	62.18	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			460.3	C08		1	0153-0301	850.21	301.23	325	67.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			592.6	C08		1	0154-0301	793.81	300.67	249	59.60	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			383.9	C08		1	0155-0305	134.72	305.10	300	65.01	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			433.4	C08		1	0156-0305	415.61	306.08	322	69.60	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			543.5	C08		1	0157-0308	177.86	307.75	226	57.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			459.8	C08		1	0158-0311	161.71	310.71	226	56.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			485.4	C08		1	0159-0311	441.45	311.15	283	62.77	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			448.3	C08		1	0160-0310	572.11	310.90	264	63.70	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			569.4	C08		1	0161-0317	258.06	316.84	309	68.77	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1280.8	C08		1	0162-0320	664.01	318.99	331	66.77	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			727.8	C08		1	0163-0324	615.82	324.26	326	70.43	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			643.3	C08		1	0164-0324	23.47	324.39	299	63.60	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			495.8	C08		1	0165-0325	243.62	325.36	286	63.84	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1177.1	C08		1	0166-0325	394.36	325.64	297	64.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			523.5	C08		1	0167-0328	874.08	327.59	234	56.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			538.0	C08		1	0168-0328	899.15	329.03	260	61.94	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			469.7	C08		1	0169-0333	90.84	332.85	266	62.43	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			451.2	C08		1	0170-0333	126.02	332.87	298	67.60	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			731.2	C08		1	0171-0337	818.17	337.25	353	68.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			766.1	C08		1	0172-0336	529.02	336.98	248	59.94	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			457.7	C08		1	0173-0335	936.43	335.59	267	61.36	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			757.0	C08		1	0174-0342	377.70	341.70	254	63.60	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			748.2	C08		1	0175-0341	751.57	340.97	254	61.60	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			574.0	C08		1	0176-0344	76.38	343.86	228	55.36	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			701.0	C08		1	0177-0345	460.57	344.62	193	52.53	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2700.1	C08		1	0178-0351	681.74	350.99	338	69.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			465.1	C08		1	0179-0349	577.92	349.82	294	64.43	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			421.6	C08		1	0180-0351	291.85	350.98	292	63.84	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			602.9	C08		1	0181-0352	489.82	352.37	300	65.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			607.4	C08		1	0182-0352	327.35	351.69	252	61.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			595.6	C08		1	0183-0353	446.60	353.32	231	56.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1349.4	C08		1	0184-0354	805.06	354.07	247	59.70	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			977.2	C08		1	0185-0359	872.13	359.11	311	67.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1799.8	C08		1	0186-0363	132.70	363.09	329	68.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			453.8	C08		1	0187-0365	336.31	364.68	263	59.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			468.3	C08		1	0188-0364	410.22	363.79	327	69.01	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			549.8	C08		1	0189-0367	502.64	368.11	257	61.84	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			373.5	C08		1	0190-0376	921.44	376.79	551	108.95	0.583
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			389.1	C08		1	0191-0369	593.60	369.66	279	63.70	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1113.1	C08		1	0192-0375	268.02	375.42	298	69.36	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			466.7	C08		1	0193-0372	752.98	371.61	257	60.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			387.6	C08		1	0194-0377	634.41	376.32	349	72.43	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			374.3	C08		1	0195-0379	880.14	379.02	319	70.43	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			658.9	C08		1	0196-0377	119.73	376.80	305	72.77	0.724
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2032.8	C08		1	0197-0382	700.82	381.97	292	65.60	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			327.6	C08		1	0198-0382	220.40	381.71	287	64.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1220.8	C08		1	0199-0382	446.89	381.74	234	56.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			530.8	C08		1	0200-0384	428.95	384.84	299	64.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1221.2	C08		1	0201-0387	282.57	387.37	421	76.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			571.7	C08		1	0202-0387	25.30	387.85	243	61.94	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			683.1	C08		1	0203-0393	364.86	393.85	475	94.23	0.672
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			455.2	C08		1	0204-0386	840.01	386.59	291	66.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			356.1	C08		1	0205-0392	728.70	393.05	303	68.18	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			607.7	C08		1	0206-0395	87.04	395.30	245	57.94	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			432.3	C08		1	0207-0395	516.66	395.19	277	61.36	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			474.8	C08		1	0208-0404	108.05	404.45	252	58.18	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2002.9	C08		1	0209-0408	417.91	407.79	261	63.01	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			468.2	C08		1	0210-0413	504.12	413.06	284	62.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1964.5	C08		1	0211-0413	684.04	412.94	283	62.18	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			503.7	C08		1	0212-0418	45.73	418.54	308	64.18	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2562.3	C08		1	0213-0420	133.94	419.89	318	65.84	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			293.9	C08		1	0214-0424	879.01	423.32	332	79.74	0.656
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			428.6	C08		1	0215-0420	815.78	420.19	308	63.36	0.964
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			736.0	C08		1	0216-0420	439.51	420.26	208	54.04	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			491.0	C08		1	0217-0422	290.62	422.02	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1025.4	C08		1	0218-0426	192.46	426.07	432	78.43	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			606.9	C08		1	0219-0425	457.42	425.06	257	61.70	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			438.6	C08		1	0220-0425	908.76	426.11	267	63.94	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			578.8	C08		1	0221-0430	759.47	429.63	435	88.67	0.695
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1501.2	C08		1	0222-0428	253.32	428.39	295	66.18	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			975.4	C08		1	0223-0431	555.02	431.98	323	95.15	0.448
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			375.7	C08		1	0224-0430	599.73	430.23	285	65.60	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			467.5	C08		1	0225-0433	317.04	433.41	275	62.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1779.6	C08		1	0226-0433	103.24	433.39	402	75.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			432.2	C08		1	0227-0438	640.55	438.85	580	100.57	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			455.3	C08		1	0228-0435	845.96	435.40	258	62.28	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			371.0	C08		1	0229-0438	720.28	437.38	302	67.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			819.8	C08		1	0230-0439	18.11	439.59	340	68.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			327.2	C08		1	0231-0441	169.96	442.00	318	66.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			546.0	C08		1	0232-0444	771.12	444.45	230	57.36	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			431.1	C08		1	0233-0447	477.66	447.79	262	61.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1218.9	C08		1	0234-0456	438.10	457.77	540	95.40	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			278.9	C08		1	0235-0456	881.35	455.43	335	78.57	0.682
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1482.0	C08		1	0236-0456	265.11	456.45	313	65.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2373.8	C08		1	0237-0460	511.98	459.79	454	81.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			827.1	C08		1	0238-0456	409.18	456.62	214	53.36	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1398.1	C08		1	0239-0461	38.50	461.65	307	66.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			564.8	C08		1	0240-0462	165.64	462.71	309	71.60	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			541.6	C08		1	0241-0468	330.38	467.02	250	58.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			884.2	C08		1	0242-0470	569.44	470.56	357	69.84	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			667.5	C08		1	0243-0470	930.07	470.50	260	59.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			374.8	C08		1	0244-0471	789.81	471.64	322	67.01	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2188.6	C08		1	0245-0474	229.06	473.77	379	73.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			765.6	C08		1	0246-0471	387.85	471.68	248	58.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			502.2	C08		1	0247-0472	706.29	472.14	277	63.11	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			737.4	C08		1	0248-0481	321.87	481.24	242	58.77	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			876.8	C08		1	0249-0485	380.17	485.37	224	55.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			376.3	C08		1	0250-0486	625.83	486.05	324	66.18	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			368.4	C08		1	0251-0487	260.40	486.47	279	63.01	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			443.3	C08		1	0252-0488	501.49	489.01	313	66.77	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			409.1	C08		1	0253-0492	911.58	492.21	260	59.70	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2599.6	C08		1	0254-0494	593.95	494.04	348	70.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			422.2	C08		1	0255-0495	665.13	495.70	312	69.11	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			602.6	C08		1	0256-0494	159.72	493.86	232	57.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2678.4	C08		1	0257-0496	474.83	495.59	304	64.77	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2712.9	C08		1	0258-0500	942.76	500.59	410	78.43	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			373.3	C08		1	0259-0499	73.34	499.05	270	61.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2504.1	C08		1	0260-0501	746.05	501.11	444	77.26	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			440.4	C08		1	0261-0500	189.28	499.86	272	61.11	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1613.3	C08		1	0262-0505	546.03	505.10	455	80.91	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			384.4	C08		1	0263-0503	299.59	503.95	272	63.01	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			445.3	C08		1	0264-0501	110.04	501.73	271	61.70	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3983.8	C08		1	0265-0505	789.60	505.62	115	92.43	0.169
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			347.9	C08		1	0266-0510	829.21	510.02	266	60.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			434.2	C08		1	0267-0509	37.93	509.58	271	61.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1303.9	C08		1	0268-0511	426.05	511.33	325	66.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			900.7	C08		1	0269-0514	270.46	514.21	363	71.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			389.6	C08		1	0270-0511	672.74	511.00	271	68.28	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			835.7	C08		1	0271-0516	129.22	517.00	317	67.36	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			666.4	C08		1	0272-0516	194.76	516.95	280	64.53	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			408.5	C08		1	0273-0521	857.97	520.82	269	61.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			772.4	C08		1	0274-0520	584.05	520.77	274	60.77	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			842.9	C08		1	0275-0522	441.51	522.16	302	64.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			530.3	C08		1	0276-0522	713.75	522.25	263	61.70	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			584.8	C08		1	0277-0526	530.57	526.08	301	64.43	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			816.1	C08		1	0278-0533	763.47	532.72	242	59.36	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			532.3	C08		1	0279-0534	795.61	533.70	277	61.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			808.3	C08		1	0280-0533	83.50	533.87	305	73.01	0.719
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			627.1	C08		1	0281-0535	213.46	535.24	213	53.11	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1020.4	C08		1	0282-0539	273.70	539.14	294	68.67	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			495.8	C08		1	0283-0537	619.01	536.78	268	61.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4354.6	C08		1	0284-0544	727.47	543.99	343	68.43	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2495.2	C08		1	0285-0547	679.63	546.69	355	71.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			599.8	C08		1	0286-0547	351.77	547.50	250	59.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			307.0	C08		1	0287-0549	43.38	549.11	280	63.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			385.6	C08		1	0288-0548	164.29	548.21	254	59.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1903.9	C08		1	0289-0548	540.05	548.03	188	49.70	0.956
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			295.3	C08		1	0290-0550	835.32	549.74	270	61.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			441.2	C08		1	0291-0549	145.49	549.09	265	62.04	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			394.8	C08		1	0292-0552	920.15	551.59	294	63.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			400.9	C08		1	0293-0553	312.34	553.07	308	65.01	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3109.1	C08		1	0294-0553	786.10	553.31	341	71.84	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			892.9	C08		1	0295-0556	560.59	557.44	266	59.60	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			589.5	C08		1	0296-0559	390.52	558.51	297	64.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			568.0	C08		1	0297-0563	482.05	562.86	252	58.18	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			501.8	C08		1	0298-0563	675.45	563.22	272	63.11	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			293.1	C08		1	0299-0564	92.34	564.16	140	51.11	0.673
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2008.2	C08		1	0300-0569	793.86	569.65	318	66.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1121.3	C08		1	0301-0567	268.09	568.13	164	47.21	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			416.1	C08		1	0302-0571	593.86	571.40	272	60.53	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			300.4	C08		1	0303-0572	205.22	572.62	276	67.60	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3690.0	C08		1	0304-0571	518.31	570.42	129	68.53	0.345
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2921.9	C08		1	0305-0579	898.28	579.25	364	71.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			445.9	C08		1	0306-0575	245.48	575.14	169	47.46	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			505.7	C08		1	0307-0576	559.64	575.69	245	58.53	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1549.5	C08		1	0308-0578	732.89	578.70	294	64.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			398.8	C08		1	0309-0580	875.88	579.73	285	62.18	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			313.1	C08		1	0310-0581	82.77	581.36	293	63.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			848.6	C08		1	0311-0587	262.45	585.43	422	83.60	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			749.2	C08		1	0312-0584	449.27	583.89	246	57.11	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1136.6	C08		1	0313-0585	537.45	585.66	219	55.36	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			368.2	C08		1	0314-0588	301.52	587.94	322	67.60	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4241.3	C08		1	0315-0589	927.47	589.16	304	65.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			692.9	C08		1	0316-0589	150.69	589.40	378	72.77	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			303.4	C08		1	0317-0592	810.14	592.40	297	64.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			346.6	C08		1	0318-0595	27.14	595.40	266	63.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			502.7	C08		1	0319-0597	944.27	597.18	229	55.70	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1068.9	C08		1	0320-0605	525.30	604.34	263	62.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			469.8	C08		1	0321-0603	766.04	603.99	261	61.70	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			391.3	C08		1	0322-0607	199.34	607.04	248	62.77	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1601.5	C08		1	0323-0608	393.01	608.28	288	63.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			376.5	C08		1	0324-0609	74.76	609.25	262	59.60	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			300.9	C08		1	0325-0612	704.10	611.88	297	64.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			309.4	C08		1	0326-0614	844.13	613.52	296	63.60	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			537.6	C08		1	0327-0612	482.55	611.88	271	62.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			752.6	C08		1	0328-0621	28.06	620.90	218	54.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			442.0	C08		1	0329-0619	763.88	618.42	260	63.11	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			363.0	C08		1	0330-0624	650.46	623.74	294	66.43	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1047.9	C08		1	0331-0625	262.52	625.35	205	51.70	0.964
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			675.7	C08		1	0332-0633	595.61	632.78	244	57.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			637.3	C08		1	0333-0634	879.26	634.12	249	57.94	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2536.2	C08		1	0334-0638	623.32	638.35	297	62.77	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			557.5	C08		1	0335-0643	419.35	643.64	263	62.53	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			406.8	C08		1	0336-0646	176.89	645.51	593	98.57	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1003.0	C08		1	0337-0645	219.75	645.23	306	69.60	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			428.7	C08		1	0338-0648	126.69	647.81	281	64.77	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1275.1	C08		1	0339-0646	727.56	646.82	268	61.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1916.1	C08		1	0340-0650	88.89	650.61	376	73.01	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			397.0	C08		1	0341-0649	316.53	648.68	283	62.77	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			501.5	C08		1	0342-0650	522.00	651.01	317	68.43	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			510.0	C08		1	0343-0651	570.73	650.76	211	55.11	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			340.5	C08		1	0344-0651	800.58	651.10	287	63.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			349.3	C08		1	0345-0648	909.49	648.45	257	60.53	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			392.0	C08		1	0346-0654	254.61	654.82	304	67.36	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			517.2	C08		1	0347-0653	445.55	652.66	256	59.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1218.2	C08		1	0348-0654	367.50	653.95	286	62.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			410.7	C08		1	0349-0656	762.40	655.48	294	64.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2297.3	C08		1	0350-0664	667.52	664.31	302	63.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3119.1	C08		1	0351-0671	601.16	671.67	341	67.60	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2641.0	C08		1	0352-0672	812.39	672.34	244	58.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			818.3	C08		1	0353-0676	939.29	676.50	264	61.11	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			771.0	C08		1	0354-0678	275.20	678.07	250	57.70	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			592.2	C08		1	0355-0681	711.96	681.31	295	64.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1182.1	C08		1	0356-0682	315.97	682.29	268	61.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			389.7	C08		1	0357-0681	863.81	681.07	227	57.11	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1040.7	C08		1	0358-0683	583.00	683.42	165	46.87	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			477.2	C08		1	0359-0688	917.00	688.43	243	58.18	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			397.8	C08		1	0360-0688	653.24	687.57	269	60.28	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			677.7	C08		1	0361-0693	825.13	693.11	264	63.26	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			369.9	C08		1	0362-0692	465.12	692.45	299	67.60	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			484.8	C08		1	0363-0695	164.66	695.52	270	60.53	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			337.2	C08		1	0364-0697	406.64	696.45	298	62.77	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			363.7	C08		1	0365-0696	862.07	696.93	302	67.94	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			539.7	C08		1	0366-0699	197.60	698.93	257	59.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			516.7	C08		1	0367-0697	564.69	698.02	245	58.87	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			605.7	C08		1	0368-0700	335.60	700.91	255	58.77	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			408.3	C08		1	0369-0702	19.92	703.24	288	63.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			350.0	C08		1	0370-0705	367.96	704.81	288	66.67	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1258.3	C08		1	0371-0705	91.70	705.53	250	60.53	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			283.7	C08		2	0001-0024	128.41	23.60	288	63.84	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			422.5	C08		2	0002-0025	174.92	24.72	270	61.94	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			490.8	C08		2	0003-0032	871.75	31.68	248	60.77	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			649.4	C08		2	0004-0033	68.62	32.87	192	51.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			561.7	C08		2	0005-0040	397.91	40.47	375	72.18	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			475.3	C08		2	0006-0037	551.14	37.65	274	62.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2123.9	C08		2	0007-0038	680.72	39.05	242	56.77	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1093.0	C08		2	0008-0042	48.52	41.52	316	66.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			477.6	C08		2	0009-0043	30.09	43.27	294	62.53	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			259.7	C08		2	0010-0043	231.80	43.46	334	67.60	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			700.4	C08		2	0011-0044	186.15	45.23	269	63.26	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			408.9	C08		2	0012-0048	487.71	49.18	332	70.77	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			376.7	C08		2	0013-0047	649.05	47.26	310	64.53	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1780.0	C08		2	0014-0048	797.12	49.02	408	78.08	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1034.0	C08		2	0015-0052	99.99	52.40	411	74.67	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1642.5	C08		2	0016-0049	205.02	49.46	206	53.46	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			461.8	C08		2	0017-0052	737.79	51.91	283	62.18	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			493.0	C08		2	0018-0055	716.07	54.90	288	63.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			636.7	C08		2	0019-0055	576.86	55.80	420	81.60	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1870.5	C08		2	0020-0062	153.35	62.35	313	65.01	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1000.9	C08		2	0021-0066	837.30	66.55	305	69.26	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			504.1	C08		2	0022-0064	854.66	63.94	218	55.11	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			466.5	C08		2	0023-0066	291.41	66.74	292	65.60	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			531.9	C08		2	0024-0068	355.25	67.73	270	61.94	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			450.3	C08		2	0025-0071	448.16	70.63	285	63.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			504.3	C08		2	0026-0075	427.60	74.95	326	66.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			741.2	C08		2	0027-0075	776.54	75.29	255	58.28	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			325.1	C08		2	0028-0082	244.28	81.66	317	68.43	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			974.3	C08		2	0029-0084	285.37	84.39	339	73.60	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			538.6	C08		2	0030-0082	659.88	82.54	285	63.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			795.0	C08		2	0031-0087	605.90	89.87	370	80.18	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1754.2	C08		2	0032-0082	618.92	81.58	168	50.87	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			750.0	C08		2	0033-0085	328.68	85.58	227	56.28	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			609.5	C08		2	0034-0084	576.11	84.68	291	63.01	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			575.1	C08		2	0035-0088	830.95	88.00	311	65.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1273.2	C08		2	0036-0087	550.38	87.01	216	53.94	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			499.9	C08		2	0037-0091	72.87	91.06	245	65.84	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			698.5	C08		2	0038-0092	485.02	92.27	221	54.87	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			569.5	C08		2	0039-0092	774.10	91.27	225	57.36	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			469.1	C08		2	0040-0098	696.24	97.15	290	63.60	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			865.5	C08		2	0041-0102	296.21	101.87	305	65.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			394.6	C08		2	0042-0104	886.08	103.99	341	68.18	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			551.8	C08		2	0043-0106	204.77	105.73	293	64.18	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3898.4	C08		2	0044-0107	99.82	106.94	343	68.77	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			500.1	C08		2	0045-0110	741.92	109.44	252	62.28	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1924.3	C08		2	0046-0111	628.60	111.41	280	60.77	0.953
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2155.7	C08		2	0047-0113	944.04	114.24	441	81.50	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			388.6	C08		2	0048-0112	424.05	112.01	281	62.18	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			437.7	C08		2	0049-0115	340.36	115.59	316	65.60	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			529.2	C08		2	0050-0115	524.22	116.08	258	60.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			412.7	C08		2	0051-0116	404.44	116.68	286	62.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			691.7	C08		2	0052-0120	51.63	119.87	261	61.94	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2288.4	C08		2	0053-0122	257.66	121.89	391	76.08	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			370.8	C08		2	0054-0122	784.64	122.43	214	53.94	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			388.2	C08		2	0055-0124	572.99	124.69	321	66.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1792.7	C08		2	0056-0126	892.41	125.50	423	81.26	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			428.3	C08		2	0057-0128	359.94	128.35	310	65.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			585.8	C08		2	0058-0128	127.19	128.48	284	65.84	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			698.6	C08		2	0059-0130	172.43	130.44	391	73.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			873.8	C08		2	0060-0127	67.80	127.03	189	50.87	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			584.7	C08		2	0061-0131	621.82	131.00	285	64.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2390.6	C08		2	0062-0132	711.18	132.55	340	68.18	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1486.0	C08		2	0063-0137	516.40	137.02	356	72.91	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			438.8	C08		2	0064-0137	775.48	136.06	200	57.26	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2192.1	C08		2	0065-0140	460.31	140.21	426	77.01	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			585.3	C08		2	0066-0139	81.33	139.65	215	52.77	0.970
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			488.0	C08		2	0067-0140	823.51	140.83	256	60.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			987.8	C08		2	0068-0147	25.40	146.81	324	69.50	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2044.8	C08		2	0069-0150	221.02	149.90	439	80.43	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1417.9	C08		2	0070-0148	661.59	147.75	298	66.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4367.7	C08		2	0071-0151	277.86	151.60	306	64.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2432.8	C08		2	0072-0150	620.04	149.78	315	67.60	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			486.3	C08		2	0073-0156	748.99	155.98	202	55.70	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			928.2	C08		2	0074-0162	485.58	162.08	325	69.36	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			691.2	C08		2	0075-0159	562.03	159.43	209	54.28	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			770.7	C08		2	0076-0160	681.59	160.78	171	51.36	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			370.2	C08		2	0077-0171	363.75	171.30	328	69.26	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			438.6	C08		2	0078-0170	929.17	169.79	323	68.18	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			619.1	C08		2	0079-0170	58.63	170.19	217	53.11	0.967
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			407.6	C08		2	0080-0171	155.29	171.07	270	63.60	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			472.3	C08		2	0081-0172	587.56	172.32	252	59.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			503.6	C08		2	0082-0174	416.12	173.89	277	60.77	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1026.9	C08		2	0083-0178	456.76	175.89	289	74.18	0.660
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			342.6	C08		2	0084-0175	280.35	175.27	341	71.01	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			477.2	C08		2	0085-0176	136.98	176.47	272	63.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			590.2	C08		2	0086-0179	526.31	179.88	250	58.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			379.2	C08		2	0087-0181	242.03	181.06	335	69.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			392.9	C08		2	0088-0183	781.58	182.81	340	69.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			708.0	C08		2	0089-0184	103.01	184.47	203	54.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			333.2	C08		2	0090-0188	599.94	188.31	310	66.18	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			511.3	C08		2	0091-0192	481.83	192.42	247	63.70	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			420.7	C08		2	0092-0195	425.92	194.89	295	66.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			336.3	C08		2	0093-0198	25.57	197.78	289	63.60	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			459.8	C08		2	0094-0197	114.02	196.94	260	63.60	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			621.8	C08		2	0095-0200	525.18	199.68	315	65.94	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			655.9	C08		2	0096-0207	650.18	206.99	239	59.11	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			492.5	C08		2	0097-0204	722.48	204.95	239	56.18	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			356.2	C08		2	0098-0205	182.25	204.45	297	67.36	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			412.7	C08		2	0099-0211	436.75	211.44	299	67.94	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			362.0	C08		2	0100-0209	55.77	209.90	260	61.36	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			437.3	C08		2	0101-0212	318.78	212.16	308	66.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2124.0	C08		2	0102-0220	586.21	220.27	445	81.26	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			444.0	C08		2	0103-0223	186.02	223.61	263	59.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			347.2	C08		2	0104-0225	229.36	225.31	286	63.70	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			491.9	C08		2	0105-0225	923.17	225.16	242	57.11	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			429.1	C08		2	0106-0227	610.82	226.84	275	60.77	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			319.0	C08		2	0107-0227	100.50	227.54	284	64.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			504.4	C08		2	0108-0230	790.69	229.96	292	65.01	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			474.9	C08		2	0109-0230	383.79	229.79	303	63.94	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			451.9	C08		2	0110-0232	505.35	232.95	268	61.94	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			315.6	C08		2	0111-0231	64.38	230.32	272	61.11	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2320.1	C08		2	0112-0233	469.77	232.81	290	63.36	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2447.4	C08		2	0113-0233	823.19	232.39	260	61.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			633.8	C08		2	0114-0235	667.08	235.64	249	59.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			309.3	C08		2	0115-0241	271.81	241.68	289	65.84	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			925.1	C08		2	0116-0245	139.28	244.70	550	87.74	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			366.2	C08		2	0117-0245	190.45	245.11	306	64.77	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			611.9	C08		2	0118-0244	426.11	244.68	265	60.53	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			369.0	C08		2	0119-0250	256.58	250.75	311	67.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2885.5	C08		2	0120-0254	553.92	254.42	325	66.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			876.8	C08		2	0121-0253	727.06	253.50	243	57.94	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			801.8	C08		2	0122-0254	885.66	254.38	199	53.36	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1493.9	C08		2	0123-0259	302.12	259.35	329	68.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2270.0	C08		2	0124-0260	748.76	259.74	392	74.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			582.0	C08		2	0125-0261	432.64	261.36	196	53.21	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2276.9	C08		2	0126-0268	343.10	268.18	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			771.2	C08		2	0127-0267	25.78	266.73	231	56.18	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			635.8	C08		2	0128-0266	78.02	266.30	192	51.70	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			620.0	C08		2	0129-0267	114.11	267.03	287	64.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2776.3	C08		2	0130-0266	815.10	266.10	269	61.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			683.7	C08		2	0131-0272	91.72	271.87	183	50.28	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1868.9	C08		2	0132-0273	203.04	273.31	316	68.77	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1259.3	C08		2	0133-0275	569.95	274.68	442	79.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1094.6	C08		2	0134-0274	39.33	273.68	180	51.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3372.4	C08		2	0135-0277	672.47	276.66	294	65.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			428.9	C08		2	0136-0278	287.66	278.62	311	77.74	0.647
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			682.7	C08		2	0137-0281	688.77	281.41	190	52.28	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			483.9	C08		2	0138-0284	222.82	283.66	313	66.53	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			759.2	C08		2	0139-0286	317.64	285.56	222	55.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			949.6	C08		2	0140-0286	45.41	286.24	160	46.28	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			443.1	C08		2	0141-0290	149.01	291.47	268	60.53	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1255.5	C08		2	0142-0293	422.51	293.81	423	75.84	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1257.8	C08		2	0143-0291	677.08	291.79	126	44.04	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			560.2	C08		2	0144-0296	375.86	295.72	231	56.53	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			407.4	C08		2	0145-0297	89.16	296.62	270	61.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			401.5	C08		2	0146-0295	125.55	295.30	340	70.43	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3121.8	C08		2	0147-0295	480.48	294.97	101	38.97	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			541.4	C08		2	0148-0305	868.84	305.13	300	65.60	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2531.8	C08		2	0149-0310	390.61	310.17	246	60.28	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			411.0	C08		2	0150-0308	254.84	307.98	242	58.28	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			703.4	C08		2	0151-0313	171.36	313.64	405	74.18	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			393.2	C08		2	0152-0317	189.73	317.29	313	71.36	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2683.2	C08		2	0153-0316	589.99	315.67	255	61.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			386.1	C08		2	0154-0319	724.22	320.00	324	67.36	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			395.4	C08		2	0155-0321	260.97	321.64	282	68.77	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			680.4	C08		2	0156-0322	782.33	322.48	265	61.11	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			706.0	C08		2	0157-0322	765.53	321.86	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			337.2	C08		2	0158-0324	91.62	324.21	284	63.01	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			660.7	C08		2	0159-0324	203.04	324.48	204	54.04	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			807.7	C08		2	0160-0324	219.56	324.07	184	49.70	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1063.9	C08		2	0161-0326	319.77	326.20	239	59.60	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2091.5	C08		2	0162-0326	445.11	325.63	279	63.60	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			513.0	C08		2	0163-0328	745.68	327.32	292	63.36	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			433.4	C08		2	0164-0326	375.73	326.79	238	56.87	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			454.4	C08		2	0165-0328	799.72	328.72	283	62.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			707.3	C08		2	0166-0329	69.68	329.37	267	62.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1228.1	C08		2	0167-0332	828.95	332.49	265	59.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			597.4	C08		2	0168-0333	137.34	333.96	297	63.36	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1989.5	C08		2	0169-0337	333.87	337.33	476	82.67	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1985.7	C08		2	0170-0339	655.25	338.63	375	71.60	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			425.1	C08		2	0171-0337	41.30	337.01	267	59.94	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			646.2	C08		2	0172-0341	449.37	341.53	237	57.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			730.1	C08		2	0173-0344	578.50	344.16	261	59.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			687.7	C08		2	0174-0345	271.53	344.95	333	70.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			426.1	C08		2	0175-0362	199.91	361.99	283	62.18	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			362.8	C08		2	0176-0362	744.59	362.13	297	63.36	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			690.9	C08		2	0177-0367	844.22	367.25	476	86.67	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			328.7	C08		2	0178-0367	31.63	367.08	200	55.01	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			397.3	C08		2	0179-0368	356.06	368.90	286	63.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			637.2	C08		2	0180-0371	425.28	370.81	245	58.28	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			515.1	C08		2	0181-0373	472.93	373.74	266	60.18	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1420.9	C08		2	0182-0374	894.56	374.92	213	56.87	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			374.2	C08		2	0183-0377	113.54	377.52	265	61.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			350.7	C08		2	0184-0383	23.22	384.93	341	76.67	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1307.0	C08		2	0185-0378	156.27	377.70	268	60.53	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			832.7	C08		2	0186-0387	229.76	388.44	416	82.08	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			443.2	C08		2	0187-0383	267.30	383.62	237	57.60	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			449.5	C08		2	0188-0384	394.23	383.70	325	67.01	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			414.6	C08		2	0189-0383	521.82	382.94	130	43.46	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			377.5	C08		2	0190-0395	516.46	396.09	209	58.77	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			565.3	C08		2	0191-0398	438.54	398.30	245	57.60	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			353.7	C08		2	0192-0393	534.58	393.96	160	49.80	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			619.8	C08		2	0193-0400	62.70	399.55	259	61.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			530.2	C08		2	0194-0404	289.85	404.07	638	93.84	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			443.3	C08		2	0195-0400	365.27	399.62	250	59.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			449.1	C08		2	0196-0405	724.18	405.92	363	72.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			387.3	C08		2	0197-0409	829.94	409.26	358	70.43	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			533.0	C08		2	0198-0409	463.33	409.72	301	66.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			308.4	C08		2	0199-0405	535.33	405.06	151	46.04	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			401.7	C08		2	0200-0409	700.43	408.69	295	64.53	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			519.2	C08		2	0201-0409	380.18	410.01	304	65.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			409.6	C08		2	0202-0415	154.53	415.43	294	73.50	0.684
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			368.6	C08		2	0203-0416	884.62	415.94	289	64.53	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			885.6	C08		2	0204-0415	56.75	416.08	327	67.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			406.9	C08		2	0205-0416	925.04	416.90	278	64.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1546.7	C08		2	0206-0419	663.17	419.11	335	67.36	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			577.6	C08		2	0207-0420	264.27	421.78	251	59.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			661.6	C08		2	0208-0420	498.43	420.59	204	55.11	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			615.9	C08		2	0209-0422	133.84	422.17	248	58.28	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			503.5	C08		2	0210-0424	724.51	424.08	312	66.53	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			360.4	C08		2	0211-0427	13.61	427.56	258	62.53	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			400.9	C08		2	0212-0429	945.19	429.48	286	65.36	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			460.0	C08		2	0213-0428	701.23	428.05	270	62.53	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			623.1	C08		2	0214-0433	190.90	433.18	238	58.53	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2161.2	C08		2	0215-0434	225.32	434.19	271	61.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			417.5	C08		2	0216-0437	87.04	437.77	287	62.77	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			627.0	C08		2	0217-0435	173.26	435.41	244	58.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			772.9	C08		2	0218-0436	260.95	436.35	185	49.80	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			454.4	C08		2	0219-0441	873.85	440.57	308	64.28	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			514.8	C08		2	0220-0444	375.81	444.45	323	66.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3322.4	C08		2	0221-0446	566.04	446.26	348	69.84	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2399.6	C08		2	0222-0449	332.26	449.77	560	94.33	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			526.4	C08		2	0223-0447	424.52	447.61	335	67.94	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			484.1	C08		2	0224-0448	922.18	447.91	265	61.60	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			404.8	C08		2	0225-0449	462.86	449.06	289	65.01	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			559.3	C08		2	0226-0451	604.85	451.48	265	63.60	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2979.7	C08		2	0227-0459	549.21	459.53	351	69.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			388.4	C08		2	0228-0458	143.34	458.86	324	68.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			480.1	C08		2	0229-0459	261.60	459.85	248	57.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			451.0	C08		2	0230-0458	400.63	459.11	238	59.46	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1279.0	C08		2	0231-0466	491.10	466.15	301	69.60	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			540.4	C08		2	0232-0462	632.32	462.23	266	60.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			602.5	C08		2	0233-0472	34.89	471.98	262	59.11	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			429.2	C08		2	0234-0469	119.89	468.96	262	61.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			828.5	C08		2	0235-0477	405.92	477.24	489	96.67	0.658
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			638.7	C08		2	0236-0480	815.69	480.06	304	75.01	0.679
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			634.0	C08		2	0237-0479	914.13	478.71	270	61.11	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			466.7	C08		2	0238-0480	225.31	480.10	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			577.1	C08		2	0239-0477	326.87	477.58	241	59.94	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			414.3	C08		2	0240-0481	871.99	481.61	262	60.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			419.6	C08		2	0241-0484	568.43	484.08	272	61.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			692.4	C08		2	0242-0489	750.74	489.51	488	84.33	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			486.9	C08		2	0243-0488	169.56	487.86	284	62.18	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			660.3	C08		2	0244-0488	679.30	488.67	269	61.70	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1886.4	C08		2	0245-0488	307.68	487.95	359	71.60	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			417.6	C08		2	0246-0489	630.43	488.96	323	68.18	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			352.3	C08		2	0247-0493	16.24	493.55	254	59.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			348.2	C08		2	0248-0493	507.23	493.06	269	63.60	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2575.4	C08		2	0249-0502	47.73	502.09	427	77.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2730.6	C08		2	0250-0500	246.57	500.67	312	66.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			744.5	C08		2	0251-0500	533.77	500.29	219	54.53	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			735.3	C08		2	0252-0504	66.26	503.58	297	64.53	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1201.6	C08		2	0253-0505	699.10	505.70	368	73.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			483.2	C08		2	0254-0501	204.12	501.50	231	59.11	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			500.6	C08		2	0255-0502	433.05	502.56	215	54.87	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			373.0	C08		2	0256-0507	619.58	507.08	300	67.94	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			385.9	C08		2	0257-0511	948.45	510.67	280	67.26	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			410.0	C08		2	0258-0512	475.01	511.55	298	65.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			594.8	C08		2	0259-0513	867.81	513.90	265	61.36	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			473.4	C08		2	0260-0516	850.85	516.77	257	59.60	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			367.6	C08		2	0261-0516	146.95	516.06	263	59.36	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			375.0	C08		2	0262-0523	580.94	523.79	157	47.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			310.6	C08		2	0263-0524	902.61	524.32	334	71.01	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			469.8	C08		2	0264-0524	171.12	524.21	247	58.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			725.9	C08		2	0265-0529	743.25	528.55	460	81.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			454.4	C08		2	0266-0529	338.24	529.73	255	61.36	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			864.9	C08		2	0267-0531	547.18	530.79	348	70.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1966.3	C08		2	0268-0532	520.09	532.34	249	59.60	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			594.9	C08		2	0269-0534	822.04	534.95	290	65.36	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1132.0	C08		2	0270-0536	121.32	535.69	443	79.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			328.8	C08		2	0271-0536	253.91	537.11	303	64.77	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			300.0	C08		2	0272-0540	73.04	539.97	266	60.43	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			300.8	C08		2	0273-0540	438.67	540.09	274	60.53	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1627.2	C08		2	0274-0543	474.92	543.22	497	82.43	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			594.1	C08		2	0275-0543	495.38	542.73	251	57.94	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			782.6	C08		2	0276-0545	179.70	545.24	306	69.94	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			976.2	C08		2	0277-0548	795.48	548.99	303	64.43	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			590.5	C08		2	0278-0551	945.99	550.84	288	62.53	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			322.4	C08		2	0279-0553	24.96	553.10	285	62.18	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			524.9	C08		2	0280-0557	618.00	556.84	266	63.11	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			427.7	C08		2	0281-0561	641.94	560.82	711	101.98	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2773.4	C08		2	0282-0560	291.60	560.59	518	83.01	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			401.2	C08		2	0283-0562	86.27	562.76	232	58.18	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			463.7	C08		2	0284-0563	339.83	563.42	303	64.43	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			381.3	C08		2	0285-0564	707.60	563.60	155	50.53	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			292.8	C08		2	0286-0567	555.67	567.57	297	65.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			589.4	C08		2	0287-0568	213.50	569.92	207	64.43	0.627
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2573.3	C08		2	0288-0569	583.10	568.94	301	64.28	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			399.4	C08		2	0289-0573	171.22	574.28	290	66.77	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1349.7	C08		2	0290-0573	882.89	572.56	272	63.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1240.4	C08		2	0291-0573	241.29	573.36	271	60.53	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			976.6	C08		2	0292-0577	185.71	576.57	160	48.63	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			368.7	C08		2	0293-0579	907.88	578.08	277	63.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			432.1	C08		2	0294-0581	57.33	580.98	258	59.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			292.2	C08		2	0295-0587	724.98	587.15	316	67.60	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1180.7	C08		2	0296-0587	134.80	587.12	175	50.53	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			392.8	C08		2	0297-0588	505.48	588.00	251	57.60	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			483.7	C08		2	0298-0590	87.90	590.70	192	53.70	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4032.6	C08		2	0299-0591	31.88	590.68	317	65.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			414.8	C08		2	0300-0591	764.21	591.57	269	61.36	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			321.9	C08		2	0301-0596	797.64	596.34	275	64.18	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			570.8	C08		2	0302-0598	49.01	598.53	246	58.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2968.8	C08		2	0303-0601	207.24	601.43	355	70.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			358.5	C08		2	0304-0599	600.60	599.30	324	68.18	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			445.8	C08		2	0305-0602	438.82	602.72	334	68.18	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			322.0	C08		2	0306-0603	746.91	602.13	251	59.84	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			782.0	C08		2	0307-0606	543.49	606.34	266	60.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			289.8	C08		2	0308-0604	250.39	605.09	296	66.18	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			276.0	C08		2	0309-0609	387.02	608.81	269	63.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			884.7	C08		2	0310-0608	335.62	607.84	280	64.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			503.0	C08		2	0311-0610	944.87	609.75	210	53.11	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			415.6	C08		2	0312-0613	119.39	614.07	255	64.77	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			601.6	C08		2	0313-0615	291.31	615.17	248	60.18	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			460.9	C08		2	0314-0621	566.88	622.06	251	60.77	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			585.5	C08		2	0315-0625	840.51	624.99	239	57.36	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			656.9	C08		2	0316-0628	67.91	628.06	236	55.70	0.956
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			478.9	C08		2	0317-0627	266.18	626.84	274	63.94	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3025.4	C08		2	0318-0632	346.98	632.17	263	60.43	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			355.4	C08		2	0319-0634	393.30	633.93	334	75.01	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			324.9	C08		2	0320-0634	670.15	633.03	101	41.70	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			450.0	C08		2	0321-0638	851.24	638.19	292	64.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			495.3	C08		2	0322-0639	445.95	639.26	253	59.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			458.7	C08		2	0323-0642	157.39	640.87	253	62.28	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			533.8	C08		2	0324-0640	174.32	640.06	262	61.46	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			698.2	C08		2	0325-0644	425.47	643.95	353	70.77	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			543.2	C08		2	0326-0644	307.30	643.62	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			254.0	C08		2	0327-0645	630.33	645.35	309	65.01	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			265.6	C08		2	0328-0648	727.88	648.50	296	64.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			401.7	C08		2	0329-0647	119.09	647.07	268	60.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			906.0	C08		2	0330-0650	679.59	650.26	310	68.77	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			293.1	C08		2	0331-0650	246.41	650.38	298	69.36	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			298.2	C08		2	0332-0650	13.97	649.82	250	58.87	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			595.8	C08		2	0333-0650	470.51	649.83	248	60.87	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			393.9	C08		2	0334-0653	588.67	652.30	269	62.77	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			385.3	C08		2	0335-0655	563.64	655.36	249	59.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			328.5	C08		2	0336-0655	263.18	654.92	281	64.77	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			299.8	C08		2	0337-0669	407.40	670.15	329	70.43	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2427.1	C08		2	0338-0669	371.39	669.49	271	61.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			953.0	C08		2	0339-0674	544.22	674.03	278	64.53	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			308.7	C08		2	0340-0674	283.60	674.11	316	67.60	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1330.3	C08		2	0341-0677	50.74	676.48	504	93.74	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2641.1	C08		2	0342-0677	529.26	677.28	241	57.70	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1884.0	C08		2	0343-0679	637.19	678.71	458	80.43	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			492.1	C08		2	0344-0684	829.52	684.32	312	64.77	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			521.4	C08		2	0345-0685	100.70	685.98	251	58.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			517.3	C08		2	0346-0687	352.25	686.86	227	58.28	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			408.8	C08		2	0347-0686	391.95	685.78	302	65.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2161.2	C08		2	0348-0689	565.33	688.86	432	79.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3500.9	C08		2	0349-0687	806.47	688.39	341	72.43	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			393.9	C08		2	0350-0690	21.42	689.99	247	57.36	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			331.7	C08		2	0351-0690	142.77	690.36	295	65.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2798.4	C08		2	0352-0694	479.41	694.54	338	67.60	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			247.1	C08		2	0353-0700	209.29	699.63	276	63.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			361.7	C08		2	0354-0697	630.69	697.57	233	57.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			311.2	C08		2	0355-0699	247.97	699.45	266	60.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2853.0	C08		2	0356-0702	759.80	701.69	264	60.43	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			341.9	C08		2	0357-0710	176.17	709.98	264	60.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			487.5	C08		3	0001-0023	532.57	23.39	244	57.60	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			599.3	C08		3	0002-0028	327.48	30.03	247	65.36	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			865.7	C08		3	0003-0029	465.12	29.36	299	67.01	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			566.6	C08		3	0004-0029	685.49	28.96	237	60.63	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			735.7	C08		3	0005-0029	253.25	28.93	221	54.53	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			468.7	C08		3	0006-0032	58.32	32.64	327	66.43	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			506.9	C08		3	0007-0031	771.33	31.27	277	60.77	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3271.8	C08		3	0008-0032	938.39	31.96	323	66.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			458.0	C08		3	0009-0032	428.60	32.82	242	58.28	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			433.4	C08		3	0010-0041	489.88	41.38	564	96.57	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			488.6	C08		3	0011-0034	658.31	34.47	313	66.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			362.9	C08		3	0012-0040	199.61	39.73	314	70.18	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			463.1	C08		3	0013-0039	448.67	39.33	289	63.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			521.8	C08		3	0014-0037	547.08	37.85	227	57.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			789.1	C08		3	0015-0041	721.42	40.98	365	73.01	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			510.2	C08		3	0016-0039	566.60	40.06	313	69.01	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			491.3	C08		3	0017-0040	922.00	40.34	223	66.67	0.630
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			446.2	C08		3	0018-0044	596.63	44.21	304	66.43	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			705.3	C08		3	0019-0041	813.20	41.28	179	51.46	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			386.8	C08		3	0020-0049	113.44	49.20	334	67.84	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			488.4	C08		3	0021-0053	359.25	53.25	278	65.01	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			357.2	C08		3	0022-0049	430.55	48.90	263	61.11	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			489.6	C08		3	0023-0055	223.57	55.22	314	66.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			845.4	C08		3	0024-0053	396.70	52.83	352	69.01	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			698.3	C08		3	0025-0055	809.25	55.67	224	55.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			520.9	C08		3	0026-0059	148.23	58.99	225	59.60	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			559.1	C08		3	0027-0064	280.55	64.35	314	67.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			689.9	C08		3	0028-0063	544.03	63.30	254	57.70	0.959
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1153.8	C08		3	0029-0064	884.27	64.14	186	51.70	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			977.0	C08		3	0030-0066	516.31	65.67	264	63.36	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			573.3	C08		3	0031-0066	137.84	67.13	100	36.87	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			498.5	C08		3	0032-0073	467.13	73.35	280	67.84	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			571.2	C08		3	0033-0082	290.55	82.99	431	79.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1106.9	C08		3	0034-0081	885.37	80.56	222	56.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1464.9	C08		3	0035-0084	53.08	83.10	310	65.84	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			390.5	C08		3	0036-0084	137.48	84.03	298	65.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			662.0	C08		3	0037-0082	269.27	81.66	220	57.46	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1693.0	C08		3	0038-0085	905.06	84.63	292	63.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1111.1	C08		3	0039-0088	663.25	88.70	423	77.50	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			309.3	C08		3	0040-0087	397.19	87.20	335	70.08	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1161.2	C08		3	0041-0091	639.02	90.74	485	81.01	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			481.5	C08		3	0042-0087	769.24	87.52	258	59.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			569.5	C08		3	0043-0090	219.09	90.97	283	63.01	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			698.8	C08		3	0044-0097	238.14	97.34	325	69.60	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1026.6	C08		3	0045-0100	948.51	100.66	304	64.18	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			487.0	C08		3	0046-0106	703.27	106.15	301	71.01	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			375.2	C08		3	0047-0104	412.83	104.58	343	69.36	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			455.3	C08		3	0048-0106	858.33	105.98	240	57.94	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			402.7	C08		3	0049-0114	169.00	114.22	297	65.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			527.2	C08		3	0050-0112	786.67	113.07	223	55.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2169.1	C08		3	0051-0116	38.58	116.93	429	80.08	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			412.8	C08		3	0052-0116	528.84	115.97	313	66.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1574.0	C08		3	0053-0119	387.92	119.01	319	66.18	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			851.1	C08		3	0054-0132	365.36	135.16	821	132.47	0.588
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			689.9	C08		3	0055-0129	748.67	130.15	442	92.23	0.653
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1080.0	C08		3	0056-0128	920.91	127.37	349	69.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			547.3	C08		3	0057-0125	566.78	124.73	293	63.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			543.6	C08		3	0058-0127	626.53	128.10	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			390.5	C08		3	0059-0130	770.46	128.58	300	69.01	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			614.0	C08		3	0060-0135	789.23	134.60	222	61.60	0.735
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1461.4	C08		3	0061-0134	817.31	134.17	319	68.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2054.6	C08		3	0062-0142	89.03	141.16	280	67.11	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2375.3	C08		3	0063-0141	165.57	141.85	330	68.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			668.0	C08		3	0064-0138	224.78	138.64	223	55.70	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			913.8	C08		3	0065-0141	396.66	141.25	271	61.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			519.1	C08		3	0066-0141	497.15	141.74	275	63.11	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			415.7	C08		3	0067-0142	861.03	142.03	262	59.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			869.3	C08		3	0068-0142	337.85	142.39	270	65.11	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			794.0	C08		3	0069-0145	703.67	145.81	261	61.36	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			606.6	C08		3	0070-0148	266.12	148.80	285	65.60	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2023.0	C08		3	0071-0155	897.36	154.70	365	73.26	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			387.5	C08		3	0072-0152	653.92	152.55	284	64.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1598.9	C08		3	0073-0161	237.53	161.53	297	65.01	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			645.9	C08		3	0074-0164	69.27	165.07	267	63.60	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			532.2	C08		3	0075-0164	520.53	163.95	253	61.01	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1229.9	C08		3	0076-0166	620.29	165.68	383	73.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			508.6	C08		3	0077-0164	465.07	164.49	227	57.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2229.4	C08		3	0078-0165	749.54	165.08	432	77.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1472.6	C08		3	0079-0172	869.02	171.91	382	74.33	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			399.9	C08		3	0080-0173	23.84	172.42	302	65.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1762.4	C08		3	0081-0174	592.35	173.61	452	83.84	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			341.9	C08		3	0082-0174	274.69	173.21	288	67.36	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			487.6	C08		3	0083-0178	545.77	178.99	262	66.53	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			359.4	C08		3	0084-0178	148.43	178.01	338	73.84	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			594.8	C08		3	0085-0176	514.15	177.00	189	52.77	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1021.1	C08		3	0086-0177	679.31	177.37	240	58.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1054.7	C08		3	0087-0181	696.46	181.97	249	59.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			464.3	C08		3	0088-0180	794.34	180.45	254	60.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			763.2	C08		3	0089-0181	108.76	180.88	230	55.11	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			416.0	C08		3	0090-0193	414.72	192.56	330	68.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			568.3	C08		3	0091-0190	64.99	189.93	227	55.11	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			747.6	C08		3	0092-0195	99.27	195.98	234	56.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1764.1	C08		3	0093-0196	202.97	195.97	316	69.01	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			332.7	C08		3	0094-0198	831.79	197.32	370	75.60	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			593.8	C08		3	0095-0197	49.38	196.72	237	58.18	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2133.3	C08		3	0096-0197	513.77	197.29	315	65.01	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			453.3	C08		3	0097-0204	457.17	203.08	271	61.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			430.8	C08		3	0098-0203	704.26	203.91	332	73.01	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1089.4	C08		3	0099-0204	354.49	204.48	347	73.01	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2479.0	C08		3	0100-0208	569.50	207.85	443	78.67	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			474.3	C08		3	0101-0210	948.56	209.54	264	63.11	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			402.9	C08		3	0102-0214	469.57	213.88	255	59.94	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			506.8	C08		3	0103-0225	924.52	225.67	367	87.15	0.607
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			493.0	C08		3	0104-0228	644.11	227.88	315	70.77	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			363.9	C08		3	0105-0225	61.98	224.71	299	70.67	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			326.5	C08		3	0106-0225	160.87	224.84	322	69.84	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			425.8	C08		3	0107-0229	862.41	228.41	317	68.67	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			429.8	C08		3	0108-0228	18.02	227.83	235	55.94	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			640.4	C08		3	0109-0234	751.08	233.32	289	64.18	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			926.2	C08		3	0110-0236	782.55	236.23	246	57.36	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			335.8	C08		3	0111-0240	93.05	240.20	308	66.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			480.5	C08		3	0112-0238	892.29	239.00	287	65.01	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1355.4	C08		3	0113-0240	235.55	240.11	332	67.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			446.6	C08		3	0114-0237	585.30	237.86	152	46.87	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1232.8	C08		3	0115-0241	269.32	240.96	307	66.77	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			598.6	C08		3	0116-0248	610.00	249.03	258	62.28	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			281.3	C08		3	0117-0246	373.04	246.03	343	76.43	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			686.6	C08		3	0118-0248	765.67	248.01	239	67.01	0.669
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			627.5	C08		3	0119-0248	806.76	248.02	239	55.70	0.968
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4923.4	C08		3	0120-0251	678.80	251.79	260	59.94	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2478.9	C08		3	0121-0250	583.42	250.39	234	68.04	0.635
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1689.7	C08		3	0122-0258	131.40	259.27	494	84.33	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1835.9	C08		3	0123-0256	150.97	255.71	274	63.84	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			421.9	C08		3	0124-0260	490.75	261.11	264	64.18	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			835.6	C08		3	0125-0261	49.17	260.94	240	58.77	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			445.6	C08		3	0126-0261	447.80	260.90	268	65.01	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			432.2	C08		3	0127-0266	406.69	265.92	281	63.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			683.2	C08		3	0128-0263	942.26	262.18	227	57.70	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1445.4	C08		3	0129-0266	729.09	265.65	222	54.53	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			391.0	C08		3	0130-0271	632.23	271.21	387	98.47	0.502
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			612.1	C08		3	0131-0276	877.95	276.41	209	53.46	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1679.0	C08		3	0132-0280	532.20	280.58	357	69.01	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			579.7	C08		3	0133-0283	898.83	283.28	321	65.60	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			725.1	C08		3	0134-0287	309.24	286.78	291	63.60	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			464.7	C08		3	0135-0290	800.71	289.32	280	63.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			865.8	C08		3	0136-0289	858.29	289.80	228	56.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			627.7	C08		3	0137-0293	677.33	293.41	287	63.94	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			697.2	C08		3	0138-0291	459.36	291.79	320	66.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1300.4	C08		3	0139-0297	354.38	297.64	401	79.50	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			762.4	C08		3	0140-0294	757.01	294.27	198	55.11	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1503.3	C08		3	0141-0299	576.94	298.66	443	79.60	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			424.7	C08		3	0142-0298	265.74	298.65	267	61.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			551.6	C08		3	0143-0299	72.18	299.74	253	58.77	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			522.3	C08		3	0144-0304	788.08	303.48	234	59.01	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1245.0	C08		3	0145-0311	518.79	311.58	293	63.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1035.2	C08		3	0146-0311	866.10	311.35	321	66.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			596.8	C08		3	0147-0313	114.14	313.03	312	67.84	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			338.4	C08		3	0148-0316	281.76	314.32	322	72.77	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			524.4	C08		3	0149-0314	216.74	314.24	240	57.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2111.6	C08		3	0150-0316	462.68	315.95	374	71.84	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			528.0	C08		3	0151-0312	671.78	312.33	293	66.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			439.8	C08		3	0152-0319	404.30	319.33	365	90.33	0.562
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			376.3	C08		3	0153-0317	916.73	316.91	325	68.43	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			356.1	C08		3	0154-0321	486.15	320.62	376	90.91	0.572
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			457.9	C08		3	0155-0321	749.58	321.63	264	61.94	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			599.6	C08		3	0156-0320	800.65	320.44	228	56.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			613.1	C08		3	0157-0322	187.82	322.48	247	57.11	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			418.0	C08		3	0158-0325	595.66	325.86	278	63.70	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			335.4	C08		3	0159-0330	310.51	329.78	303	69.60	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1418.6	C08		3	0160-0335	57.67	335.14	295	64.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			497.3	C08		3	0161-0340	769.12	339.27	267	65.36	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			470.1	C08		3	0162-0337	643.36	337.38	259	60.28	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1265.8	C08		3	0163-0342	782.81	341.49	203	57.11	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			556.3	C08		3	0164-0342	707.27	341.53	243	57.94	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			492.9	C08		3	0165-0347	686.39	347.35	273	61.11	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			550.4	C08		3	0166-0349	864.22	349.06	308	67.60	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			455.0	C08		3	0167-0353	197.73	352.76	262	66.18	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			862.3	C08		3	0168-0356	948.80	356.74	354	73.50	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			454.5	C08		3	0169-0351	635.22	351.36	265	63.94	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			396.2	C08		3	0170-0352	215.58	351.55	130	45.36	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			624.9	C08		3	0171-0355	559.53	355.31	290	65.60	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			447.5	C08		3	0172-0358	54.25	359.06	261	61.01	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2910.6	C08		3	0173-0363	341.37	363.34	449	81.01	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			891.9	C08		3	0174-0359	778.66	359.31	223	55.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2009.5	C08		3	0175-0363	359.28	363.10	324	70.53	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			361.8	C08		3	0176-0367	464.46	366.77	345	71.01	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			446.4	C08		3	0177-0367	727.94	367.19	277	61.36	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			730.8	C08		3	0178-0368	906.35	368.80	281	62.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			599.3	C08		3	0179-0368	189.77	367.86	245	57.36	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			445.6	C08		3	0180-0369	213.15	368.99	220	53.94	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			397.8	C08		3	0181-0372	857.11	373.24	323	71.60	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			863.6	C08		3	0182-0374	698.26	374.09	239	60.18	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			432.3	C08		3	0183-0377	303.40	376.96	313	67.01	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1350.6	C08		3	0184-0377	544.99	377.60	241	59.36	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1224.7	C08		3	0185-0383	44.56	382.58	380	73.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1475.2	C08		3	0186-0389	434.90	390.02	536	103.40	0.630
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			335.3	C08		3	0187-0382	792.69	380.81	322	71.84	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			357.0	C08		3	0188-0387	381.32	386.98	316	72.77	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2059.9	C08		3	0189-0390	610.76	389.98	481	86.33	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1330.1	C08		3	0190-0389	695.86	388.97	303	68.43	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			393.8	C08		3	0191-0392	841.59	392.05	299	65.94	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			839.2	C08		3	0192-0394	134.16	394.28	212	54.53	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2698.8	C08		3	0193-0398	670.63	398.30	256	59.11	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2241.6	C08		3	0194-0402	272.23	402.84	428	76.91	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			402.8	C08		3	0195-0408	507.87	407.51	311	66.53	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			339.1	C08		3	0196-0410	807.87	410.34	346	69.84	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			505.9	C08		3	0197-0409	472.96	409.63	281	61.60	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			483.1	C08		3	0198-0411	322.05	410.94	282	63.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			373.8	C08		3	0199-0413	571.30	413.44	318	66.53	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			342.7	C08		3	0200-0414	759.60	414.30	348	71.84	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			391.5	C08		3	0201-0414	89.37	414.72	261	60.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			881.5	C08		3	0202-0417	190.24	417.81	315	66.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			387.7	C08		3	0203-0419	20.26	419.74	274	65.36	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			380.1	C08		3	0204-0425	422.94	424.10	347	74.43	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			498.9	C08		3	0205-0422	719.69	422.40	292	65.36	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2414.0	C08		3	0206-0425	354.68	425.44	306	65.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2726.6	C08		3	0207-0429	315.29	430.42	404	77.50	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			423.9	C08		3	0208-0427	212.29	427.79	284	63.94	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			325.5	C08		3	0209-0429	585.97	429.94	328	67.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			387.0	C08		3	0210-0432	39.94	432.05	266	62.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			757.1	C08		3	0211-0433	109.61	432.71	202	55.11	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2125.2	C08		3	0212-0438	716.99	437.68	332	76.43	0.714
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1714.9	C08		3	0213-0443	151.37	443.99	239	57.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			747.6	C08		3	0214-0441	866.29	441.56	144	48.04	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1966.2	C08		3	0215-0448	705.39	449.09	366	71.84	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			631.8	C08		3	0216-0445	115.33	445.73	189	51.94	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			486.7	C08		3	0217-0444	904.95	445.08	292	66.53	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2268.5	C08		3	0218-0450	642.85	450.12	331	87.74	0.540
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			384.9	C08		3	0219-0449	247.18	448.68	163	52.18	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			382.5	C08		3	0220-0450	17.02	450.61	255	60.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			707.6	C08		3	0221-0451	528.31	450.92	220	56.87	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			737.6	C08		3	0222-0450	169.22	450.25	225	55.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			390.8	C08		3	0223-0451	232.54	451.54	225	62.28	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			349.6	C08		3	0224-0452	283.27	452.69	218	63.01	0.690
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			957.2	C08		3	0225-0452	833.38	452.54	187	51.46	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			986.1	C08		3	0226-0454	884.15	454.05	199	53.11	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			777.7	C08		3	0227-0451	868.05	451.00	108	41.80	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1031.2	C08		3	0228-0460	783.55	460.00	397	73.60	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			786.0	C08		3	0229-0457	81.69	456.53	160	48.53	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			409.7	C08		3	0230-0459	599.55	459.37	223	55.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			421.0	C08		3	0231-0467	409.14	467.44	277	63.94	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			978.3	C08		3	0232-0463	896.21	463.67	180	50.53	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			535.6	C08		3	0233-0471	73.92	471.13	260	60.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			583.2	C08		3	0234-0470	370.62	469.91	330	66.77	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			825.9	C08		3	0235-0470	909.28	470.32	193	54.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1227.2	C08		3	0236-0474	658.09	474.07	236	108.47	0.252
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			806.6	C08		3	0237-0477	757.68	477.45	310	68.18	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			386.1	C08		3	0238-0483	861.58	482.86	294	67.36	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			388.4	C08		3	0239-0482	135.99	482.81	302	65.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			492.6	C08		3	0240-0481	782.06	481.84	320	70.18	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			762.3	C08		3	0241-0484	619.12	484.95	307	67.60	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			699.2	C08		3	0242-0487	230.78	487.27	221	56.77	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1464.4	C08		3	0243-0488	501.96	488.48	303	95.15	0.421
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			418.1	C08		3	0244-0492	845.54	492.39	295	67.01	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			608.3	C08		3	0245-0496	592.35	495.95	308	67.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			243.3	C08		3	0246-0494	948.35	494.15	209	56.28	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			757.8	C08		3	0247-0495	927.22	495.11	272	63.11	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			412.4	C08		3	0248-0497	887.16	497.36	310	68.43	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			424.5	C08		3	0249-0508	730.86	507.47	308	68.18	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			471.4	C08		3	0250-0510	714.33	510.41	265	63.11	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			245.8	C08		3	0251-0505	944.95	505.82	128	46.63	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3281.0	C08		3	0252-0511	456.37	510.33	310	65.94	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			374.1	C08		3	0253-0513	43.13	513.37	269	63.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			542.0	C08		3	0254-0516	514.45	515.97	247	62.18	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2256.5	C08		3	0255-0520	646.15	520.03	381	72.67	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			403.2	C08		3	0256-0519	399.86	519.23	316	67.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			330.8	C08		3	0257-0522	197.60	521.91	304	64.77	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			787.6	C08		3	0258-0524	879.76	523.49	273	63.36	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			352.9	C08		3	0259-0526	159.70	527.09	306	67.94	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			504.8	C08		3	0260-0523	483.04	523.55	269	63.94	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			874.0	C08		3	0261-0531	810.81	531.43	365	72.18	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2871.1	C08		3	0262-0528	565.57	527.76	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			354.1	C08		3	0263-0530	782.86	529.80	316	67.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			426.1	C08		3	0264-0530	756.84	529.87	273	60.77	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			466.2	C08		3	0265-0531	367.86	531.22	203	54.04	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			396.8	C08		3	0266-0534	608.04	534.55	326	68.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			322.1	C08		3	0267-0537	119.51	536.59	320	66.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1927.1	C08		3	0268-0538	740.19	538.23	288	63.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			567.9	C08		3	0269-0546	675.65	545.16	234	61.70	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2523.1	C08		3	0270-0549	529.42	550.06	285	65.60	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			356.1	C08		3	0271-0551	426.59	551.08	333	68.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			311.4	C08		3	0272-0551	267.71	551.18	295	63.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			589.8	C08		3	0273-0550	703.60	550.46	250	58.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			572.9	C08		3	0274-0554	40.63	553.53	281	62.53	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			402.6	C08		3	0275-0553	861.92	552.97	283	63.11	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			388.2	C08		3	0276-0552	904.61	552.64	264	62.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			472.4	C08		3	0277-0562	81.73	563.11	229	57.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			343.1	C08		3	0278-0560	180.90	560.41	289	65.11	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2990.2	C08		3	0279-0564	689.94	564.74	395	73.60	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2617.5	C08		3	0280-0566	65.60	566.35	283	61.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			388.7	C08		3	0281-0566	890.89	566.66	302	64.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			965.7	C08		3	0282-0568	447.87	568.48	399	73.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			359.1	C08		3	0283-0567	848.99	567.07	160	48.04	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1731.9	C08		3	0284-0568	726.85	569.11	263	59.46	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			325.4	C08		3	0285-0574	501.01	573.94	304	68.18	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			307.1	C08		3	0286-0576	103.26	576.46	271	63.11	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			379.0	C08		3	0287-0577	288.58	576.72	309	67.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3591.8	C08		3	0288-0571	588.60	571.12	203	56.28	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			420.3	C08		3	0289-0580	322.17	580.19	286	62.18	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			398.9	C08		3	0290-0582	304.21	582.90	279	63.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2746.5	C08		3	0291-0587	610.80	586.71	430	81.26	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			294.0	C08		3	0292-0583	908.91	583.67	336	71.60	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			457.5	C08		3	0293-0587	357.14	587.71	211	54.87	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			692.4	C08		3	0294-0583	584.48	583.09	206	56.28	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			502.3	C08		3	0295-0584	760.43	583.31	202	53.11	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			411.8	C08		3	0296-0586	839.51	587.03	244	59.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			529.1	C08		3	0297-0588	726.94	587.22	223	56.28	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			322.4	C08		3	0298-0592	227.26	591.41	284	62.43	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			631.0	C08		3	0299-0596	537.39	596.63	274	62.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			711.8	C08		3	0300-0596	628.00	596.63	204	54.53	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			373.0	C08		3	0301-0598	53.36	598.16	263	59.36	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			321.2	C08		3	0302-0601	490.88	601.10	323	68.18	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			396.0	C08		3	0303-0598	800.23	598.26	318	66.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			299.3	C08		3	0304-0606	86.25	606.24	265	59.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			367.6	C08		3	0305-0606	873.17	605.88	286	63.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			415.5	C08		3	0306-0605	758.47	605.61	197	56.18	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1219.3	C08		3	0307-0612	193.94	611.97	326	68.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			344.9	C08		3	0308-0612	153.56	612.34	281	63.36	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			499.8	C08		3	0309-0612	39.38	612.41	207	52.87	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2582.4	C08		3	0310-0617	654.98	617.44	437	77.26	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1316.6	C08		3	0311-0620	691.40	620.80	264	62.77	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			341.3	C08		3	0312-0622	316.84	621.70	292	62.77	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			721.9	C08		3	0313-0628	613.04	628.45	215	54.87	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2212.7	C08		3	0314-0632	119.71	632.15	422	75.36	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			403.9	C08		3	0315-0630	340.94	629.63	275	65.60	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			455.6	C08		3	0316-0635	406.97	634.37	580	95.98	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			520.6	C08		3	0317-0634	44.10	633.95	263	62.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			462.5	C08		3	0318-0637	939.48	637.54	249	58.53	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2273.3	C08		3	0319-0643	596.50	643.24	346	69.60	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1499.5	C08		3	0320-0642	345.82	643.74	326	71.01	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			612.4	C08		3	0321-0643	892.99	643.52	199	54.87	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2716.7	C08		3	0322-0645	755.67	644.84	283	62.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			337.8	C08		3	0323-0647	849.47	645.85	284	66.43	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			623.5	C08		3	0324-0645	915.19	645.36	189	50.53	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			482.3	C08		3	0325-0648	719.79	648.20	266	63.60	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			593.3	C08		3	0326-0650	46.59	649.98	241	58.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			341.5	C08		3	0327-0654	672.21	654.89	277	62.77	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1438.6	C08		3	0328-0659	482.69	658.41	319	68.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			620.2	C08		3	0329-0656	415.05	657.27	273	64.18	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			501.5	C08		3	0330-0661	817.85	661.10	226	55.11	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			360.4	C08		3	0331-0662	381.27	662.38	254	60.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			377.5	C08		3	0332-0664	602.31	664.16	276	61.94	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			800.9	C08		3	0333-0665	260.71	665.53	161	46.87	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			313.0	C08		3	0334-0669	166.07	669.08	291	63.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			332.8	C08		3	0335-0673	211.95	673.34	288	68.53	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			702.6	C08		3	0336-0672	244.53	673.82	262	64.53	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			799.3	C08		3	0337-0678	779.05	677.79	266	59.36	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			471.6	C08		3	0338-0679	734.95	678.14	297	63.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1455.7	C08		3	0339-0681	865.04	680.29	300	66.77	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			618.9	C08		3	0340-0682	910.16	681.82	303	65.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			914.4	C08		3	0341-0682	754.15	682.31	293	63.01	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			584.0	C08		3	0342-0681	883.02	681.72	260	61.01	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			379.6	C08		3	0343-0681	559.94	681.50	269	63.36	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1715.2	C08		3	0344-0687	817.17	687.40	326	67.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			911.8	C08		3	0345-0688	615.97	687.25	257	61.11	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			428.2	C08		3	0346-0694	384.31	694.38	318	68.53	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			364.1	C08		3	0347-0697	418.34	698.00	305	66.77	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			403.9	C08		3	0348-0701	679.16	701.08	282	67.36	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			425.4	C08		3	0349-0701	229.03	700.26	253	67.84	0.691
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			418.4	C08		3	0350-0705	619.82	705.13	278	63.94	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			863.9	C08		3	0351-0702	848.61	702.61	245	59.94	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			388.4	C08		3	0352-0709	943.83	708.13	287	64.77	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			267.6	C08		3	0353-0709	56.23	709.62	258	61.70	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			331.6	C08		3	0354-0711	333.46	711.20	309	69.11	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			455.3	C08		4	0001-0023	195.30	23.30	268	61.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			496.2	C08		4	0002-0022	562.22	22.54	257	61.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			532.0	C08		4	0003-0021	820.66	21.45	146	46.04	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			218.4	C08		4	0004-0026	17.68	27.12	282	63.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			614.0	C08		4	0005-0025	333.33	25.35	262	59.36	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			348.6	C08		4	0006-0029	365.76	29.28	324	70.67	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1353.2	C08		4	0007-0029	89.76	29.68	255	61.36	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3084.1	C08		4	0008-0033	621.79	33.53	356	70.43	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			476.5	C08		4	0009-0038	108.79	38.32	321	66.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			442.0	C08		4	0010-0042	214.26	42.85	281	64.77	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			390.3	C08		4	0011-0045	786.35	45.55	257	61.11	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			941.1	C08		4	0012-0046	321.66	46.11	241	57.11	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1800.9	C08		4	0013-0046	703.80	46.36	280	65.11	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			400.5	C08		4	0014-0048	943.16	49.11	232	56.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			713.7	C08		4	0015-0055	52.27	55.75	711	116.13	0.663
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4179.8	C08		4	0016-0052	448.90	51.61	395	72.77	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			533.4	C08		4	0017-0056	116.59	56.15	287	64.77	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			473.5	C08		4	0018-0057	857.49	56.52	218	55.11	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			448.2	C08		4	0019-0062	138.71	62.85	301	69.26	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1223.0	C08		4	0020-0063	660.87	63.64	333	68.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			645.0	C08		4	0021-0063	268.62	63.38	243	59.60	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			957.7	C08		4	0022-0067	498.94	66.82	322	70.18	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			796.0	C08		4	0023-0063	541.75	63.22	257	60.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			362.1	C08		4	0024-0062	762.42	62.81	263	60.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			297.2	C08		4	0025-0065	921.79	64.05	293	66.43	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1657.1	C08		4	0026-0072	306.40	72.35	280	63.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			878.1	C08		4	0027-0072	555.04	71.69	231	57.94	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			411.3	C08		4	0028-0077	228.36	77.22	311	66.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1787.5	C08		4	0029-0080	255.87	80.63	419	76.08	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			411.2	C08		4	0030-0080	861.20	80.08	233	56.87	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			358.5	C08		4	0031-0080	902.41	80.33	276	62.77	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			522.7	C08		4	0032-0083	625.71	83.44	278	63.94	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2399.9	C08		4	0033-0083	563.68	83.38	211	54.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			680.8	C08		4	0034-0086	418.74	86.24	264	60.43	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			610.7	C08		4	0035-0087	108.03	87.68	255	60.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2729.4	C08		4	0036-0093	591.99	93.38	413	82.08	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			429.3	C08		4	0037-0086	761.03	86.31	272	63.94	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			494.9	C08		4	0038-0087	185.57	87.49	289	61.94	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			341.6	C08		4	0039-0093	461.42	93.14	342	73.74	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			335.6	C08		4	0040-0092	701.97	91.78	300	66.18	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1999.3	C08		4	0041-0100	738.97	99.96	308	65.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1042.9	C08		4	0042-0102	52.13	101.74	260	59.94	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			5342.8	C08		4	0043-0110	367.52	110.02	740	103.30	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3467.0	C08		4	0044-0103	837.97	102.66	133	98.13	0.174
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			481.5	C08		4	0045-0104	544.63	104.79	309	65.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			328.8	C08		4	0046-0107	942.98	106.80	304	64.77	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			494.3	C08		4	0047-0107	89.01	106.82	202	55.11	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			523.7	C08		4	0048-0112	288.36	112.59	289	63.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			509.9	C08		4	0049-0118	163.66	118.71	229	59.70	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			467.4	C08		4	0050-0121	427.35	120.78	283	63.26	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			8902.9	C08		4	0051-0128	672.34	128.38	325	67.01	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			548.7	C08		4	0052-0132	440.24	131.62	293	65.26	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			546.4	C08		4	0053-0132	641.24	132.40	265	63.01	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1715.0	C08		4	0054-0135	321.50	135.13	286	69.11	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			675.6	C08		4	0055-0133	195.76	132.94	243	58.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2373.6	C08		4	0056-0141	832.51	140.76	395	73.01	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1803.4	C08		4	0057-0141	698.12	140.93	279	61.94	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			452.2	C08		4	0058-0144	401.87	144.67	298	65.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			347.1	C08		4	0059-0141	608.51	141.51	293	63.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3170.8	C08		4	0060-0143	890.55	143.94	350	69.01	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			441.3	C08		4	0061-0147	281.89	147.32	272	62.53	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2379.8	C08		4	0062-0155	211.91	154.96	244	59.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			515.9	C08		4	0063-0155	546.55	155.53	283	63.70	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2541.6	C08		4	0064-0157	650.36	156.76	250	58.18	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			699.8	C08		4	0065-0162	471.64	161.79	460	83.98	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3258.0	C08		4	0066-0162	875.55	162.57	335	67.01	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2288.3	C08		4	0067-0165	392.06	164.70	252	60.87	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			370.5	C08		4	0068-0162	908.00	162.89	262	59.11	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			425.3	C08		4	0069-0166	15.51	165.91	257	61.01	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			474.4	C08		4	0070-0165	626.78	165.37	265	61.36	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			453.5	C08		4	0071-0169	55.25	169.81	268	63.94	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			373.2	C08		4	0072-0173	930.06	173.44	334	73.60	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			662.8	C08		4	0073-0171	572.45	171.06	277	65.01	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			545.4	C08		4	0074-0175	117.62	175.02	347	70.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3891.1	C08		4	0075-0174	608.69	174.77	343	72.67	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3400.9	C08		4	0076-0176	709.60	175.55	246	58.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			590.9	C08		4	0077-0182	743.35	181.60	249	57.94	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			373.6	C08		4	0078-0187	260.34	187.52	305	68.43	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3168.7	C08		4	0079-0187	396.30	186.68	288	65.01	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			546.0	C08		4	0080-0189	524.11	189.77	271	62.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1267.2	C08		4	0081-0192	303.68	191.71	332	70.77	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1853.4	C08		4	0082-0193	77.16	194.14	250	58.87	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			586.9	C08		4	0083-0204	189.14	203.70	711	106.91	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			590.9	C08		4	0084-0195	564.72	195.48	236	56.53	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			748.4	C08		4	0085-0197	603.83	197.14	195	51.70	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			501.8	C08		4	0086-0201	361.27	201.37	278	62.18	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			449.5	C08		4	0087-0203	910.95	203.03	256	64.53	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			721.3	C08		4	0088-0200	621.21	201.45	183	52.53	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2446.7	C08		4	0089-0208	451.61	208.79	227	59.94	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			592.0	C08		4	0090-0205	142.26	204.59	219	54.53	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			710.3	C08		4	0091-0211	77.12	210.81	245	58.63	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1210.8	C08		4	0092-0214	212.55	213.45	279	62.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			383.4	C08		4	0093-0215	882.23	215.37	291	63.36	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			572.7	C08		4	0094-0218	788.07	218.22	272	63.94	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			283.9	C08		4	0095-0220	822.27	219.43	310	65.36	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			561.5	C08		4	0096-0221	236.96	221.31	270	60.18	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			374.0	C08		4	0097-0223	700.20	224.18	270	61.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1275.0	C08		4	0098-0225	11.64	225.33	233	56.28	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2181.3	C08		4	0099-0224	907.71	224.45	290	74.43	0.658
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			342.5	C08		4	0100-0231	46.45	231.41	275	62.18	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3946.7	C08		4	0101-0231	289.29	231.64	353	70.18	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			826.9	C08		4	0102-0233	398.28	233.18	267	64.18	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			551.5	C08		4	0103-0237	156.70	237.75	481	90.57	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2117.2	C08		4	0104-0241	555.48	240.85	356	74.91	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			723.5	C08		4	0105-0241	479.61	240.40	254	60.28	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2667.0	C08		4	0106-0245	716.17	245.07	436	77.60	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1946.6	C08		4	0107-0247	327.17	247.13	466	82.43	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1195.3	C08		4	0108-0246	134.48	245.89	176	49.36	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			443.1	C08		4	0109-0253	433.59	253.15	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2248.9	C08		4	0110-0253	587.73	252.99	305	65.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			599.6	C08		4	0111-0256	80.26	256.04	257	61.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			785.7	C08		4	0112-0257	247.39	255.62	261	61.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1205.6	C08		4	0113-0256	364.30	256.01	292	63.94	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2380.7	C08		4	0114-0254	936.70	254.54	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			571.6	C08		4	0115-0257	755.30	256.76	273	62.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			373.0	C08		4	0116-0257	864.11	257.95	306	66.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			499.8	C08		4	0117-0258	384.05	257.99	249	58.28	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			423.3	C08		4	0118-0260	777.97	259.88	263	59.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			414.6	C08		4	0119-0265	223.78	265.45	272	63.94	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			448.6	C08		4	0120-0264	502.47	264.27	314	66.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			548.1	C08		4	0121-0265	114.70	264.56	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			705.3	C08		4	0122-0271	280.71	271.29	271	61.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			833.8	C08		4	0123-0271	834.78	271.50	274	61.01	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			429.9	C08		4	0124-0274	894.80	274.10	305	65.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			308.0	C08		4	0125-0278	522.30	279.48	304	69.01	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			360.8	C08		4	0126-0276	602.65	276.21	294	62.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1742.9	C08		4	0127-0284	128.97	286.07	617	101.40	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			838.4	C08		4	0128-0277	254.08	276.78	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			756.5	C08		4	0129-0286	42.86	285.69	296	64.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			503.1	C08		4	0130-0286	158.65	286.05	218	55.70	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4170.9	C08		4	0131-0288	942.68	288.02	330	69.01	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			375.0	C08		4	0132-0289	406.39	289.20	301	67.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			512.9	C08		4	0133-0289	695.37	289.37	262	62.18	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			453.9	C08		4	0134-0294	340.79	295.23	513	90.91	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			457.9	C08		4	0135-0293	917.77	293.73	271	61.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3175.5	C08		4	0136-0296	250.70	296.90	422	77.84	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			538.6	C08		4	0137-0293	712.56	293.65	264	63.36	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			374.1	C08		4	0138-0294	560.23	293.96	274	64.43	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			412.2	C08		4	0139-0299	471.38	299.56	304	65.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			379.7	C08		4	0140-0301	392.38	301.52	280	64.18	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			250.8	C08		4	0141-0307	13.11	307.38	287	63.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			940.9	C08		4	0142-0306	80.29	306.31	181	50.87	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			347.9	C08		4	0143-0307	523.17	306.77	252	59.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			466.8	C08		4	0144-0306	612.94	307.01	227	54.77	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			341.3	C08		4	0145-0309	816.53	308.49	292	66.77	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2294.4	C08		4	0146-0315	425.75	315.11	295	63.01	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			255.5	C08		4	0147-0319	940.38	319.78	301	64.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			646.4	C08		4	0148-0318	803.67	318.62	290	69.84	0.747
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			571.0	C08		4	0149-0317	849.12	317.73	271	60.18	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			714.9	C08		4	0150-0323	559.21	322.24	321	73.26	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			968.9	C08		4	0151-0321	87.18	321.12	225	56.28	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3154.9	C08		4	0152-0322	452.39	323.15	367	71.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			360.4	C08		4	0153-0327	162.06	328.11	249	59.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2446.8	C08		4	0154-0330	710.27	330.78	319	65.36	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			687.1	C08		4	0155-0328	886.53	328.26	263	60.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			331.7	C08		4	0156-0338	594.01	337.91	595	97.98	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			407.8	C08		4	0157-0337	646.17	337.01	297	63.60	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1494.2	C08		4	0158-0337	116.88	337.20	284	63.36	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			438.0	C08		4	0159-0341	39.77	340.92	273	63.60	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			590.9	C08		4	0160-0341	454.84	340.21	289	67.11	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			682.7	C08		4	0161-0346	304.57	345.75	260	61.36	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			512.3	C08		4	0162-0346	271.11	346.10	266	59.11	0.957
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			331.8	C08		4	0163-0350	752.50	350.43	324	67.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			315.0	C08		4	0164-0350	384.43	350.60	255	57.94	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			769.1	C08		4	0165-0356	74.61	354.29	497	93.74	0.711
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			255.5	C08		4	0166-0357	29.79	358.18	297	66.18	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2565.4	C08		4	0167-0358	176.42	358.89	387	72.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			336.9	C08		4	0168-0359	793.52	358.98	294	63.84	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			332.7	C08		4	0169-0361	514.26	361.31	283	61.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			436.5	C08		4	0170-0360	594.36	360.58	300	66.43	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			396.5	C08		4	0171-0361	685.12	361.13	274	61.11	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1010.3	C08		4	0172-0365	840.24	364.88	336	71.26	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1680.2	C08		4	0173-0368	155.00	368.36	278	62.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			289.7	C08		4	0174-0368	933.68	367.98	277	63.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			300.1	C08		4	0175-0368	547.58	368.08	268	61.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			447.7	C08		4	0176-0373	905.43	372.43	254	62.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			393.4	C08		4	0177-0378	76.68	377.50	293	64.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3252.2	C08		4	0178-0379	403.55	378.78	400	75.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1594.2	C08		4	0179-0381	916.77	381.15	265	65.11	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			408.0	C08		4	0180-0380	783.74	380.76	267	61.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			267.0	C08		4	0181-0381	868.36	381.50	273	62.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			288.0	C08		4	0182-0380	582.62	380.44	267	62.77	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			448.0	C08		4	0183-0387	197.99	387.76	271	62.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			509.8	C08		4	0184-0388	386.37	388.18	276	63.60	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2902.4	C08		4	0185-0393	451.71	392.80	425	77.50	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			501.0	C08		4	0186-0392	327.20	391.44	230	59.01	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			844.6	C08		4	0187-0391	646.40	391.28	327	69.60	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1856.8	C08		4	0188-0393	265.53	394.10	264	71.60	0.647
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			497.3	C08		4	0189-0398	487.40	398.43	243	57.94	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1794.8	C08		4	0190-0407	338.35	406.82	452	79.26	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			379.2	C08		4	0191-0407	428.75	406.70	308	67.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			304.3	C08		4	0192-0406	835.29	405.58	284	63.36	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			582.1	C08		4	0193-0406	219.83	405.82	314	75.01	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2741.7	C08		4	0194-0412	39.19	412.53	379	73.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			324.5	C08		4	0195-0414	718.29	413.31	316	70.67	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1621.3	C08		4	0196-0415	616.94	415.67	305	71.11	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			581.5	C08		4	0197-0418	537.24	418.53	261	60.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			430.7	C08		4	0198-0419	314.66	418.81	257	60.77	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1968.5	C08		4	0199-0423	23.37	424.02	327	68.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1518.4	C08		4	0200-0426	443.84	426.38	435	78.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			351.5	C08		4	0201-0422	497.94	422.24	234	59.94	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			441.5	C08		4	0202-0421	782.63	422.18	227	57.46	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			600.3	C08		4	0203-0428	102.54	428.54	257	59.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2762.9	C08		4	0204-0428	353.63	428.13	233	58.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			390.4	C08		4	0205-0431	175.61	431.06	260	61.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4348.7	C08		4	0206-0436	869.49	435.52	344	69.26	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			279.9	C08		4	0207-0437	399.03	437.24	300	65.84	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			347.4	C08		4	0208-0435	785.70	435.21	299	67.46	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			306.8	C08		4	0209-0442	844.50	442.06	300	68.08	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			366.5	C08		4	0210-0439	899.85	439.43	274	63.94	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			333.7	C08		4	0211-0444	533.74	444.45	275	63.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			276.2	C08		4	0212-0451	210.14	451.51	293	67.01	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			457.6	C08		4	0213-0452	160.79	452.29	236	59.70	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			346.7	C08		4	0214-0454	600.75	454.31	294	65.60	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			326.2	C08		4	0215-0451	736.90	451.79	266	61.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			406.1	C08		4	0216-0454	895.33	454.25	259	61.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			272.8	C08		4	0217-0458	478.62	458.38	287	65.84	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1386.8	C08		4	0218-0461	694.69	460.92	532	86.91	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			359.8	C08		4	0219-0459	44.19	459.42	281	64.43	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			281.6	C08		4	0220-0459	342.19	460.03	284	62.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			384.1	C08		4	0221-0462	933.42	462.17	236	57.70	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			753.3	C08		4	0222-0465	256.68	465.55	257	60.77	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1292.1	C08		4	0223-0471	643.70	471.56	319	67.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			311.6	C08		4	0224-0473	375.99	473.75	283	64.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			388.6	C08		4	0225-0478	95.76	477.80	297	67.94	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			407.1	C08		4	0226-0480	226.39	480.27	289	68.53	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1054.4	C08		4	0227-0482	578.29	482.37	597	107.88	0.645
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			293.5	C08		4	0228-0482	355.23	481.80	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			297.3	C08		4	0229-0483	515.35	483.79	278	63.70	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			904.3	C08		4	0230-0487	464.61	487.29	316	68.67	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2085.9	C08		4	0231-0486	656.31	486.55	381	76.18	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			412.8	C08		4	0232-0489	306.55	488.32	222	57.60	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			437.7	C08		4	0233-0491	261.19	491.53	318	66.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1349.3	C08		4	0234-0492	900.56	491.75	258	62.43	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3834.5	C08		4	0235-0493	119.60	493.37	322	66.43	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1043.7	C08		4	0236-0493	532.25	493.24	329	67.36	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			587.5	C08		4	0237-0496	152.27	496.95	290	63.60	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			278.7	C08		4	0238-0498	496.09	498.57	275	61.36	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2521.2	C08		4	0239-0506	296.91	506.63	510	89.40	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1324.4	C08		4	0240-0503	747.65	501.76	382	82.77	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			319.4	C08		4	0241-0505	190.44	504.87	303	66.43	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			481.3	C08		4	0242-0506	585.31	506.50	368	79.01	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2153.9	C08		4	0243-0506	914.71	505.80	385	72.08	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1850.9	C08		4	0244-0507	75.06	506.49	407	77.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			480.1	C08		4	0245-0508	940.54	508.37	248	59.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			386.2	C08		4	0246-0514	460.98	514.37	282	66.18	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			291.8	C08		4	0247-0515	344.87	515.17	256	58.77	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			707.3	C08		4	0248-0513	752.20	513.18	104	37.56	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			377.2	C08		4	0249-0519	797.87	519.53	305	66.77	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2518.3	C08		4	0250-0523	21.03	522.78	367	71.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			351.7	C08		4	0251-0524	677.56	524.40	267	63.11	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1410.1	C08		4	0252-0525	857.33	525.76	293	63.60	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			321.3	C08		4	0253-0528	605.21	528.13	260	60.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			371.3	C08		4	0254-0530	81.41	530.67	265	59.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			308.8	C08		4	0255-0532	425.71	531.58	294	64.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3120.2	C08		4	0256-0534	143.33	533.49	348	69.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			308.2	C08		4	0257-0536	337.79	536.17	304	64.77	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			921.8	C08		4	0258-0540	705.37	540.44	283	67.60	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			289.9	C08		4	0259-0540	375.55	540.29	282	61.36	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1371.4	C08		4	0260-0542	264.94	543.10	283	64.18	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			334.1	C08		4	0261-0540	769.06	541.00	227	55.70	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2112.7	C08		4	0262-0546	504.88	544.75	144	58.18	0.535
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			372.1	C08		4	0263-0545	786.77	545.17	241	58.28	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			493.4	C08		4	0264-0548	466.92	548.01	289	65.60	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			709.8	C08		4	0265-0551	193.95	551.35	335	75.36	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			513.5	C08		4	0266-0551	210.43	550.77	270	61.70	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2676.2	C08		4	0267-0553	564.18	553.75	284	62.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			250.1	C08		4	0268-0551	918.25	551.13	317	66.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2509.5	C08		4	0269-0550	498.75	550.63	113	46.04	0.670
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			940.6	C08		4	0270-0553	125.79	553.98	155	46.87	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			812.3	C08		4	0271-0563	41.40	563.91	377	82.43	0.697
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			283.4	C08		4	0272-0562	294.63	562.32	316	67.60	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			449.4	C08		4	0273-0561	645.15	561.41	241	61.36	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1358.4	C08		4	0274-0566	848.78	566.92	594	97.40	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			336.6	C08		4	0275-0565	518.57	564.82	266	61.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			319.7	C08		4	0276-0565	593.65	565.42	274	60.77	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			689.5	C08		4	0277-0568	97.71	568.65	271	62.77	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			365.8	C08		4	0278-0566	436.79	566.91	284	68.43	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			368.2	C08		4	0279-0583	385.93	583.07	254	58.53	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			292.7	C08		4	0280-0582	551.56	582.54	274	61.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			418.7	C08		4	0281-0586	588.04	585.62	294	67.60	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			507.9	C08		4	0282-0585	806.99	584.50	330	70.43	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			324.8	C08		4	0283-0588	656.39	587.82	317	68.67	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			567.6	C08		4	0284-0585	915.70	585.09	232	55.94	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1431.0	C08		4	0285-0586	752.14	586.11	259	59.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1132.8	C08		4	0286-0589	453.57	588.43	297	65.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1154.9	C08		4	0287-0596	680.62	596.36	294	65.01	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			350.8	C08		4	0288-0597	370.78	597.13	269	60.87	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			496.8	C08		4	0289-0598	906.51	598.67	284	67.01	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			312.9	C08		4	0290-0602	472.15	602.78	265	62.77	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			346.5	C08		4	0291-0606	407.31	605.77	311	66.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1187.6	C08		4	0292-0610	596.24	611.18	339	74.43	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1026.6	C08		4	0293-0606	124.51	606.33	248	59.11	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			991.5	C08		4	0294-0604	150.87	603.91	160	48.87	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			324.7	C08		4	0295-0608	221.37	608.45	282	67.01	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			433.6	C08		4	0296-0611	107.12	611.29	310	67.60	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			676.0	C08		4	0297-0608	891.26	607.66	201	53.36	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			382.2	C08		4	0298-0617	251.36	617.11	262	63.26	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			281.4	C08		4	0299-0617	546.69	617.58	314	66.18	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			347.1	C08		4	0300-0621	164.67	621.23	270	65.70	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			444.9	C08		4	0301-0617	298.05	616.51	243	57.36	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			255.6	C08		4	0302-0623	508.75	622.51	536	104.13	0.621
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			255.0	C08		4	0303-0621	860.48	620.95	301	66.53	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1303.6	C08		4	0304-0621	89.78	621.50	220	54.18	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			379.0	C08		4	0305-0626	363.21	626.25	240	63.84	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			315.7	C08		4	0306-0623	19.85	623.15	257	57.94	0.962
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			401.2	C08		4	0307-0626	446.30	626.23	296	65.84	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			322.8	C08		4	0308-0628	276.95	627.68	296	65.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			301.4	C08		4	0309-0632	393.23	631.71	281	63.60	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			390.1	C08		4	0310-0629	712.87	629.97	259	61.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			393.7	C08		4	0311-0633	197.52	634.07	279	62.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1649.9	C08		4	0312-0642	488.06	641.33	754	112.47	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			501.1	C08		4	0313-0637	829.47	636.54	263	61.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			481.5	C08		4	0314-0644	345.03	644.26	229	55.70	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			412.1	C08		4	0315-0641	608.85	641.57	282	65.36	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2647.1	C08		4	0316-0647	814.22	647.40	352	70.67	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			264.4	C08		4	0317-0648	411.99	648.90	283	67.84	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			409.4	C08		4	0318-0654	217.20	652.52	594	101.74	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3369.6	C08		4	0319-0647	372.52	646.90	117	54.67	0.492
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3226.0	C08		4	0320-0651	366.21	653.00	129	56.43	0.509
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			356.5	C08		4	0321-0657	751.75	656.75	276	64.77	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1311.8	C08		4	0322-0661	29.53	660.50	527	89.26	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			288.1	C08		4	0323-0658	948.14	657.79	286	63.60	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			290.9	C08		4	0324-0664	526.90	664.58	255	62.53	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			331.6	C08		4	0325-0661	625.34	660.88	249	57.94	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			276.5	C08		4	0326-0664	562.53	664.41	309	68.43	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			278.0	C08		4	0327-0667	784.11	667.20	269	63.36	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1150.3	C08		4	0328-0665	139.16	664.90	285	63.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			324.5	C08		4	0329-0670	586.29	670.21	256	59.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			624.4	C08		4	0330-0670	914.77	670.05	225	54.87	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			295.1	C08		4	0331-0674	415.34	674.71	314	66.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			709.6	C08		4	0332-0677	471.76	677.87	291	65.94	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			346.9	C08		4	0333-0679	539.42	678.57	287	67.36	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			397.0	C08		4	0334-0682	65.29	680.87	252	65.36	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			534.5	C08		4	0335-0683	495.42	683.29	294	66.53	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			390.6	C08		4	0336-0681	348.32	681.31	250	58.18	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			324.5	C08		4	0337-0682	512.00	682.29	273	61.21	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1257.7	C08		4	0338-0685	29.24	685.85	265	61.36	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			271.2	C08		4	0339-0687	261.52	686.48	285	65.36	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			476.4	C08		4	0340-0687	845.32	687.10	233	56.18	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			273.8	C08		4	0341-0692	717.19	692.78	251	61.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			715.4	C08		4	0342-0691	292.89	692.24	199	53.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			281.8	C08		4	0343-0694	754.00	694.29	290	65.60	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			896.9	C08		4	0344-0696	193.12	695.75	276	62.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2398.8	C08		4	0345-0697	54.64	698.43	341	70.43	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2202.7	C08		4	0346-0696	135.31	695.85	323	66.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			292.6	C08		4	0347-0699	793.59	700.20	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			378.5	C08		4	0348-0699	474.12	699.64	273	62.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			312.1	C08		4	0349-0701	733.39	701.49	303	67.36	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			335.2	C08		4	0350-0705	877.22	705.20	108	42.04	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			213.8	C08		4	0351-0707	930.89	707.77	266	65.01	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			401.5	C08		4	0352-0710	358.48	709.73	291	63.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			200.5	C08		5	0001-0025	207.22	24.73	281	63.36	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			335.5	C08		5	0002-0023	628.36	23.18	228	56.28	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3109.0	C08		5	0003-0027	757.57	26.69	263	60.43	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			285.0	C08		5	0004-0025	245.80	25.00	263	60.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			324.7	C08		5	0005-0035	174.04	35.25	268	60.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2425.4	C08		5	0006-0036	402.63	35.76	271	61.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			954.1	C08		5	0007-0037	66.40	37.22	253	59.11	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			444.0	C08		5	0008-0039	746.47	39.01	243	59.84	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			268.3	C08		5	0009-0041	937.37	41.10	272	64.18	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			864.6	C08		5	0010-0045	583.63	46.23	377	80.18	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1194.5	C08		5	0011-0041	602.48	40.47	210	54.87	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			350.4	C08		5	0012-0046	510.44	45.61	319	65.01	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1199.9	C08		5	0013-0047	417.06	47.14	262	70.67	0.659
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			375.9	C08		5	0014-0048	325.88	48.14	252	59.70	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2779.0	C08		5	0015-0048	864.11	48.79	362	71.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			393.0	C08		5	0016-0051	538.31	51.75	284	63.94	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			306.4	C08		5	0017-0049	663.18	49.26	245	56.77	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			438.7	C08		5	0018-0051	47.74	51.33	240	58.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			526.7	C08		5	0019-0051	887.77	51.56	252	57.94	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			423.7	C08		5	0020-0056	264.29	55.56	497	91.74	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			574.3	C08		5	0021-0055	482.62	55.53	232	56.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			284.1	C08		5	0022-0063	305.30	62.56	282	66.67	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			257.5	C08		5	0023-0062	186.19	63.10	290	65.60	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			540.3	C08		5	0024-0064	806.78	64.54	201	56.43	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			275.3	C08		5	0025-0067	26.26	66.14	274	64.43	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			412.3	C08		5	0026-0066	117.58	65.66	227	59.60	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			345.2	C08		5	0027-0071	231.30	71.55	281	65.60	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2093.8	C08		5	0028-0071	753.60	71.94	276	61.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			394.1	C08		5	0029-0072	559.09	72.36	265	60.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			369.8	C08		5	0030-0076	379.29	75.97	313	67.01	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1958.7	C08		5	0031-0080	123.83	80.49	366	76.18	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			332.9	C08		5	0032-0075	165.25	74.41	288	65.70	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			346.4	C08		5	0033-0078	613.99	77.76	256	58.53	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			282.3	C08		5	0034-0079	923.97	79.38	259	59.70	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			346.6	C08		5	0035-0081	60.39	81.99	265	64.18	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			342.3	C08		5	0036-0084	505.04	84.26	310	65.94	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			274.1	C08		5	0037-0090	693.12	90.15	316	68.18	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			467.3	C08		5	0038-0088	724.22	87.61	299	63.60	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			475.0	C08		5	0039-0087	254.08	87.36	238	58.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			283.3	C08		5	0040-0089	87.63	89.57	252	58.53	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1728.3	C08		5	0041-0090	184.69	90.96	419	81.26	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2881.5	C08		5	0042-0094	281.23	94.20	346	70.18	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			350.2	C08		5	0043-0093	162.46	93.63	217	59.70	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			288.3	C08		5	0044-0097	316.17	98.03	272	60.77	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			379.2	C08		5	0045-0105	858.99	106.45	309	76.77	0.659
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			333.4	C08		5	0046-0101	651.89	101.10	345	69.84	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			279.1	C08		5	0047-0102	503.46	101.78	273	62.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			343.0	C08		5	0048-0105	894.66	104.84	302	69.84	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			312.1	C08		5	0049-0105	342.24	105.07	235	55.94	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			295.8	C08		5	0050-0107	788.00	107.40	286	64.77	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			284.4	C08		5	0051-0109	47.58	108.98	289	62.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3986.1	C08		5	0052-0108	208.12	107.97	321	66.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			504.8	C08		5	0053-0109	829.80	108.41	263	60.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			477.7	C08		5	0054-0110	550.61	109.80	235	57.46	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1992.1	C08		5	0055-0114	939.47	113.65	286	65.94	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			444.8	C08		5	0056-0114	535.56	114.61	220	58.18	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			408.8	C08		5	0057-0115	814.85	115.25	248	61.60	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			276.8	C08		5	0058-0116	125.20	116.96	275	64.67	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			374.9	C08		5	0059-0116	583.58	116.19	253	57.94	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			324.5	C08		5	0060-0117	451.18	117.39	235	63.01	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			773.0	C08		5	0061-0130	293.94	130.74	532	96.57	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			528.6	C08		5	0062-0127	763.95	126.43	390	74.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1143.4	C08		5	0063-0129	241.70	129.15	279	63.01	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1093.1	C08		5	0064-0128	945.76	129.18	307	67.60	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			494.5	C08		5	0065-0130	709.15	129.47	285	63.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			298.7	C08		5	0066-0132	205.96	132.26	302	67.01	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			231.3	C08		5	0067-0131	83.68	131.34	282	64.77	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			507.7	C08		5	0068-0132	462.85	132.67	223	56.63	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			473.3	C08		5	0069-0142	511.66	141.97	346	70.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			437.4	C08		5	0070-0142	779.76	142.04	281	64.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			253.2	C08		5	0071-0146	124.86	145.69	304	69.01	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			375.1	C08		5	0072-0147	401.83	145.94	226	60.53	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			349.0	C08		5	0073-0149	538.49	149.60	263	65.01	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			307.3	C08		5	0074-0148	704.63	148.28	295	65.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2252.0	C08		5	0075-0148	826.93	148.52	278	62.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			499.1	C08		5	0076-0150	644.94	149.72	309	65.36	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1780.1	C08		5	0077-0148	467.80	148.00	227	55.70	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			287.4	C08		5	0078-0154	206.08	154.12	273	60.77	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3493.1	C08		5	0079-0155	564.25	155.96	469	80.08	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			281.7	C08		5	0080-0153	71.19	152.62	267	62.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			274.1	C08		5	0081-0156	224.25	156.24	260	59.70	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			433.5	C08		5	0082-0159	918.75	158.85	309	71.36	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			324.4	C08		5	0083-0161	670.33	161.54	283	65.26	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			523.6	C08		5	0084-0159	901.80	159.44	190	52.28	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			585.1	C08		5	0085-0161	411.74	160.23	259	61.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			304.9	C08		5	0086-0164	12.84	165.13	248	57.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1353.5	C08		5	0087-0167	149.27	167.38	232	56.18	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			494.3	C08		5	0088-0168	837.22	167.15	248	61.94	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			397.8	C08		5	0089-0175	34.74	175.89	304	70.77	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			370.2	C08		5	0090-0176	348.13	175.84	308	67.60	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2597.1	C08		5	0091-0176	595.11	176.03	445	77.26	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			540.7	C08		5	0092-0177	174.77	177.75	256	58.18	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			443.2	C08		5	0093-0179	752.26	178.85	297	65.60	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			480.5	C08		5	0094-0182	139.86	182.31	239	57.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			386.5	C08		5	0095-0179	480.19	178.89	257	60.53	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			447.6	C08		5	0096-0180	773.20	180.22	253	59.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			580.5	C08		5	0097-0178	819.77	178.06	127	42.97	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			674.4	C08		5	0098-0181	830.53	181.19	108	38.39	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			235.3	C08		5	0099-0189	195.63	189.09	273	62.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			518.0	C08		5	0100-0194	94.39	194.00	361	74.43	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			322.0	C08		5	0101-0192	356.51	192.32	250	61.60	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			234.3	C08		5	0102-0193	111.20	192.63	270	61.70	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3309.9	C08		5	0103-0196	316.62	195.93	423	74.43	0.960
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			853.1	C08		5	0104-0192	277.15	191.83	127	62.43	0.410
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			361.6	C08		5	0105-0197	255.39	196.94	291	65.11	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			432.3	C08		5	0106-0199	238.00	199.22	270	60.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			373.9	C08		5	0107-0197	755.16	197.21	333	73.84	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1063.4	C08		5	0108-0203	377.95	202.93	389	73.84	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2226.8	C08		5	0109-0202	729.24	202.66	282	62.28	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			334.5	C08		5	0110-0205	15.79	205.08	242	62.53	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			277.1	C08		5	0111-0201	152.68	200.91	278	65.11	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2273.6	C08		5	0112-0213	531.46	212.95	638	109.64	0.667
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1976.8	C08		5	0113-0208	451.28	209.15	386	77.60	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			681.5	C08		5	0114-0207	707.83	207.15	275	61.70	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			481.0	C08		5	0115-0208	417.03	208.07	264	60.77	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3997.3	C08		5	0116-0212	806.62	212.34	352	71.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			666.6	C08		5	0117-0213	468.08	213.85	235	59.11	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			290.2	C08		5	0118-0215	79.24	215.03	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2507.3	C08		5	0119-0216	916.03	216.05	260	60.18	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			352.8	C08		5	0120-0216	754.19	217.04	271	60.53	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			544.9	C08		5	0121-0220	861.49	220.57	261	61.46	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			543.3	C08		5	0122-0220	846.92	220.50	226	56.53	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			443.9	C08		5	0123-0220	155.45	219.99	235	58.53	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3343.2	C08		5	0124-0227	305.10	227.85	461	79.84	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			368.6	C08		5	0125-0230	209.14	229.56	465	82.18	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			391.6	C08		5	0126-0228	629.67	228.20	214	54.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			297.6	C08		5	0127-0234	566.31	234.22	319	71.60	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3236.7	C08		5	0128-0234	179.64	233.99	323	67.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2005.9	C08		5	0129-0235	160.19	235.37	256	64.18	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2549.8	C08		5	0130-0236	282.88	236.18	299	64.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			480.5	C08		5	0131-0236	649.81	235.52	223	55.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			369.0	C08		5	0132-0237	120.78	237.25	243	58.18	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			380.9	C08		5	0133-0245	368.24	245.87	246	57.60	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			327.1	C08		5	0134-0246	583.97	245.73	309	67.70	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			417.0	C08		5	0135-0246	746.79	246.21	272	67.01	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			415.8	C08		5	0136-0251	154.83	251.42	213	57.36	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2247.5	C08		5	0137-0257	41.66	256.83	302	66.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			650.3	C08		5	0138-0261	915.84	261.05	264	62.77	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			303.8	C08		5	0139-0268	672.13	267.50	285	65.01	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2339.6	C08		5	0140-0270	701.57	270.34	435	77.26	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1836.4	C08		5	0141-0268	165.69	268.34	279	64.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			505.3	C08		5	0142-0271	272.79	270.58	228	59.01	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			348.7	C08		5	0143-0272	781.36	271.85	315	68.18	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			525.9	C08		5	0144-0274	218.26	274.24	234	58.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			409.1	C08		5	0145-0274	336.63	274.33	263	61.36	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3029.3	C08		5	0146-0275	403.63	274.97	100	53.94	0.432
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			287.3	C08		5	0147-0277	614.54	277.62	293	63.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1808.8	C08		5	0148-0282	637.91	282.17	280	62.18	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2223.9	C08		5	0149-0285	826.66	284.99	417	75.84	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			429.4	C08		5	0150-0283	727.36	283.45	236	57.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			462.8	C08		5	0151-0284	368.25	284.96	238	57.36	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			246.2	C08		5	0152-0286	122.52	286.93	271	62.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			811.2	C08		5	0153-0288	523.62	287.86	321	69.26	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3903.7	C08		5	0154-0290	47.31	290.37	349	69.01	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			244.1	C08		5	0155-0288	145.49	288.97	279	64.43	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			261.7	C08		5	0156-0293	892.36	293.38	289	65.60	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			336.7	C08		5	0157-0292	100.14	291.43	254	61.94	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			401.8	C08		5	0158-0290	326.27	290.42	232	60.18	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			319.3	C08		5	0159-0294	83.86	294.02	274	62.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			371.5	C08		5	0160-0293	484.95	293.15	340	72.18	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			372.8	C08		5	0161-0296	22.78	295.96	261	59.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			414.8	C08		5	0162-0297	451.94	296.90	263	62.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3585.0	C08		5	0163-0298	240.29	298.78	366	71.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3051.2	C08		5	0164-0302	652.45	303.48	138	61.94	0.452
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			391.4	C08		5	0165-0304	280.60	304.06	270	61.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			356.9	C08		5	0166-0305	217.05	305.63	289	63.84	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			229.9	C08		5	0167-0307	930.59	307.42	323	67.01	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			301.7	C08		5	0168-0310	729.44	309.48	269	62.18	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			239.6	C08		5	0169-0312	158.18	312.84	271	59.94	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			185.7	C08		5	0170-0316	189.03	316.58	267	63.36	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			418.8	C08		5	0171-0316	69.13	316.27	257	58.53	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			310.8	C08		5	0172-0318	89.27	318.53	265	59.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			314.7	C08		5	0173-0317	799.68	316.63	286	63.60	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			249.7	C08		5	0174-0321	45.21	322.00	284	63.36	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			391.8	C08		5	0175-0320	845.17	320.63	253	58.18	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			254.5	C08		5	0176-0320	136.44	320.06	267	61.70	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1231.9	C08		5	0177-0322	397.22	323.48	278	62.87	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3131.1	C08		5	0178-0322	870.34	322.03	266	60.18	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			837.5	C08		5	0179-0331	461.27	330.50	403	123.30	0.333
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			342.7	C08		5	0180-0327	348.68	327.24	254	59.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			338.3	C08		5	0181-0336	635.50	336.28	311	67.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			962.4	C08		5	0182-0339	704.62	340.13	296	69.01	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			784.2	C08		5	0183-0339	450.08	339.58	202	57.36	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			569.7	C08		5	0184-0341	684.57	341.42	259	59.11	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			279.7	C08		5	0185-0342	157.89	341.75	248	58.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			585.6	C08		5	0186-0341	401.12	341.19	280	63.11	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			212.9	C08		5	0187-0342	227.55	343.12	260	58.53	0.954
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			240.2	C08		5	0188-0349	287.08	348.91	530	90.08	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			347.5	C08		5	0189-0348	528.05	348.36	309	64.77	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2890.2	C08		5	0190-0349	862.51	349.51	310	65.70	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			412.3	C08		5	0191-0350	111.55	349.91	286	63.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			220.3	C08		5	0192-0351	185.97	351.54	249	59.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			635.2	C08		5	0193-0351	484.60	351.12	260	59.46	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			351.6	C08		5	0194-0351	626.22	351.50	270	60.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			232.6	C08		5	0195-0355	259.67	355.61	272	62.43	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			521.3	C08		5	0196-0355	379.09	355.60	217	55.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			385.5	C08		5	0197-0357	925.07	357.27	292	67.01	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			305.7	C08		5	0198-0359	132.19	358.49	242	57.36	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			648.8	C08		5	0199-0358	402.98	357.83	219	56.53	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			265.1	C08		5	0200-0360	231.80	360.52	300	66.53	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			315.0	C08		5	0201-0363	330.82	363.80	293	67.84	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3434.6	C08		5	0202-0362	570.58	361.86	347	68.43	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			347.1	C08		5	0203-0363	801.77	362.94	302	65.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			529.0	C08		5	0204-0362	692.19	362.38	273	62.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			349.6	C08		5	0205-0362	455.04	362.52	265	59.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			411.1	C08		5	0206-0367	753.07	367.37	195	53.70	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			259.8	C08		5	0207-0370	250.40	370.10	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			447.6	C08		5	0208-0367	489.65	367.26	252	61.70	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			305.2	C08		5	0209-0370	38.62	370.24	269	61.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			305.3	C08		5	0210-0371	65.11	370.95	267	63.60	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			980.8	C08		5	0211-0379	16.47	379.21	528	92.33	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2559.0	C08		5	0212-0374	897.56	373.81	358	70.43	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1463.4	C08		5	0213-0374	392.69	373.41	227	57.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			390.4	C08		5	0214-0372	607.12	372.07	244	59.70	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1108.5	C08		5	0215-0377	715.45	377.60	258	60.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			229.2	C08		5	0216-0380	170.63	380.29	261	60.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			312.4	C08		5	0217-0380	79.57	380.62	269	65.94	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			337.9	C08		5	0218-0380	826.62	380.14	234	67.94	0.637
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			368.5	C08		5	0219-0385	845.60	385.45	276	64.77	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1207.4	C08		5	0220-0393	409.82	393.55	669	106.13	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2965.2	C08		5	0221-0388	931.71	388.88	307	65.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			392.5	C08		5	0222-0389	620.66	388.59	300	65.94	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			588.1	C08		5	0223-0391	280.28	391.24	286	63.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			360.6	C08		5	0224-0394	742.34	394.65	218	56.28	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			606.2	C08		5	0225-0397	576.47	397.02	193	53.11	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			368.3	C08		5	0226-0408	234.72	408.22	478	85.98	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			756.4	C08		5	0227-0401	128.22	400.74	230	57.70	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			363.7	C08		5	0228-0403	640.40	402.75	245	59.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			417.7	C08		5	0229-0402	674.17	402.64	236	56.87	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			471.5	C08		5	0230-0407	256.61	407.32	259	58.53	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			335.2	C08		5	0231-0408	197.58	408.15	263	62.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			334.8	C08		5	0232-0408	809.21	408.51	286	65.11	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			427.9	C08		5	0233-0413	653.05	413.47	257	58.53	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			773.2	C08		5	0234-0413	121.53	413.71	248	60.53	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1222.7	C08		5	0235-0415	880.15	415.33	325	70.18	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			286.1	C08		5	0236-0415	332.75	415.60	283	61.36	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			453.0	C08		5	0237-0420	699.61	420.50	272	61.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			452.3	C08		5	0238-0421	179.91	421.12	203	53.36	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			6332.1	C08		5	0239-0422	547.27	421.79	185	51.94	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			455.7	C08		5	0240-0423	604.43	422.81	241	56.53	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			253.7	C08		5	0241-0425	750.67	425.26	311	67.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1344.9	C08		5	0242-0428	861.17	428.79	347	72.43	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1787.5	C08		5	0243-0429	357.07	429.49	449	79.01	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			331.4	C08		5	0244-0427	425.56	426.68	266	62.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			387.5	C08		5	0245-0428	813.06	427.42	298	67.36	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2915.9	C08		5	0246-0429	910.70	428.36	341	67.60	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3704.2	C08		5	0247-0432	534.22	431.66	315	71.01	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			406.5	C08		5	0248-0432	446.12	431.85	275	61.36	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			272.6	C08		5	0249-0435	62.73	435.07	267	60.53	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			418.2	C08		5	0250-0437	691.92	437.49	220	55.11	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1117.2	C08		5	0251-0441	127.60	441.77	461	86.33	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			725.0	C08		5	0252-0442	555.58	441.73	334	74.43	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1460.0	C08		5	0253-0442	168.94	442.03	258	60.87	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			388.2	C08		5	0254-0445	236.30	444.92	500	88.91	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			284.0	C08		5	0255-0445	612.34	445.07	298	64.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1019.3	C08		5	0256-0447	719.95	447.96	315	72.43	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			590.1	C08		5	0257-0445	380.07	445.62	201	53.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			672.3	C08		5	0258-0449	909.18	450.90	311	69.84	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			487.1	C08		5	0259-0453	469.88	453.62	288	63.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			333.8	C08		5	0260-0452	66.84	451.78	252	60.18	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			290.9	C08		5	0261-0456	201.00	456.33	242	58.53	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			788.1	C08		5	0262-0458	181.80	458.11	142	57.01	0.549
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2938.8	C08		5	0263-0464	794.80	464.01	517	83.26	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			382.3	C08		5	0264-0460	504.68	460.60	232	55.36	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			336.0	C08		5	0265-0463	416.40	463.13	287	63.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			974.4	C08		5	0266-0463	661.43	462.91	449	82.43	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			298.3	C08		5	0267-0465	556.12	465.52	281	61.84	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			358.8	C08		5	0268-0464	38.15	464.42	234	57.11	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			652.3	C08		5	0269-0468	577.43	468.57	287	61.94	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4066.2	C08		5	0270-0473	300.85	472.61	357	71.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			369.0	C08		5	0271-0468	741.95	468.06	257	59.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1648.2	C08		5	0272-0472	885.89	472.06	331	67.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1073.5	C08		5	0273-0473	402.60	473.38	290	65.26	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			263.0	C08		5	0274-0479	229.15	479.36	269	63.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1242.6	C08		5	0275-0484	122.14	484.11	446	81.01	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			382.6	C08		5	0276-0489	271.42	487.98	509	94.57	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			368.3	C08		5	0277-0482	846.77	481.46	271	61.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			247.7	C08		5	0278-0484	334.88	483.78	279	63.36	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			492.6	C08		5	0279-0495	616.96	495.63	262	61.60	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			321.5	C08		5	0280-0493	792.78	494.13	275	65.60	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			418.2	C08		5	0281-0496	452.03	495.40	259	59.36	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			304.4	C08		5	0282-0497	717.65	497.06	232	59.36	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1170.6	C08		5	0283-0501	197.27	500.70	468	85.74	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			282.9	C08		5	0284-0499	473.75	499.76	257	61.94	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			302.6	C08		5	0285-0501	96.90	501.47	294	65.01	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			381.0	C08		5	0286-0501	901.81	501.38	250	58.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			250.6	C08		5	0287-0502	370.13	501.78	271	62.77	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			434.5	C08		5	0288-0503	936.65	503.74	242	57.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			421.5	C08		5	0289-0504	493.62	504.39	252	59.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1401.6	C08		5	0290-0506	631.65	505.45	265	64.18	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2027.3	C08		5	0291-0507	19.27	507.99	386	74.33	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			348.8	C08		5	0292-0509	249.77	508.81	512	95.40	0.707
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			265.3	C08		5	0293-0509	557.64	509.71	257	65.01	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			874.8	C08		5	0294-0511	442.12	511.25	301	66.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			419.2	C08		5	0295-0510	45.20	510.71	245	58.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			233.7	C08		5	0296-0513	334.12	513.95	289	62.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			287.0	C08		5	0297-0514	286.74	514.68	251	57.94	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			308.4	C08		5	0298-0515	832.59	515.15	339	71.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			672.5	C08		5	0299-0515	468.55	515.56	195	53.70	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			399.7	C08		5	0300-0519	138.33	518.67	241	59.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			415.3	C08		5	0301-0519	526.25	519.51	272	60.53	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			269.1	C08		5	0302-0520	92.26	520.68	300	70.18	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2145.1	C08		5	0303-0523	624.45	523.58	297	65.01	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			321.2	C08		5	0304-0525	394.75	525.32	283	66.43	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			322.1	C08		5	0305-0528	769.98	528.55	280	67.50	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			220.5	C08		5	0306-0532	425.08	531.78	268	63.11	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			278.6	C08		5	0307-0533	151.14	533.56	258	63.01	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			651.4	C08		5	0308-0534	197.35	533.64	319	73.84	0.735
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			244.2	C08		5	0309-0539	534.98	538.32	273	65.60	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			501.5	C08		5	0310-0537	607.50	537.37	220	54.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			548.2	C08		5	0311-0541	382.06	542.72	366	75.01	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			353.8	C08		5	0312-0541	832.18	541.50	310	67.36	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			463.5	C08		5	0313-0543	470.35	543.09	177	48.53	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1753.0	C08		5	0314-0551	946.10	550.58	385	77.36	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1290.5	C08		5	0315-0546	321.13	546.71	242	57.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1525.7	C08		5	0316-0548	678.45	548.70	313	65.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1004.8	C08		5	0317-0546	741.53	546.09	268	60.18	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			298.2	C08		5	0318-0551	553.24	551.57	308	68.43	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			258.1	C08		5	0319-0551	99.70	551.78	270	60.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			877.2	C08		5	0320-0553	231.82	553.69	305	70.08	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			247.3	C08		5	0321-0553	22.92	553.49	287	63.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			194.7	C08		5	0322-0559	495.91	559.76	300	70.28	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			330.9	C08		5	0323-0559	389.91	558.86	287	63.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1241.4	C08		5	0324-0559	821.93	559.31	314	67.36	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			367.5	C08		5	0325-0559	248.37	560.21	257	63.36	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			389.3	C08		5	0326-0562	168.02	561.67	248	62.77	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			316.3	C08		5	0327-0564	702.70	564.62	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			227.4	C08		5	0328-0567	510.91	566.78	301	69.11	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			367.2	C08		5	0329-0564	315.06	563.80	239	59.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			340.6	C08		5	0330-0566	736.12	565.92	242	57.36	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			317.9	C08		5	0331-0569	150.59	569.48	302	65.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			585.4	C08		5	0332-0567	677.72	567.46	254	60.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			258.1	C08		5	0333-0571	274.35	571.63	273	66.67	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1594.5	C08		5	0334-0576	918.32	576.50	354	70.18	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1617.5	C08		5	0335-0575	342.32	575.76	263	64.28	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2902.6	C08		5	0336-0577	429.97	576.35	383	73.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1538.5	C08		5	0337-0578	632.34	578.02	292	65.94	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			258.6	C08		5	0338-0575	859.79	575.79	290	71.36	0.716
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			337.8	C08		5	0339-0580	67.90	580.53	477	87.74	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2672.9	C08		5	0340-0581	898.80	581.22	331	68.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			340.2	C08		5	0341-0583	574.86	583.16	299	66.77	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			299.4	C08		5	0342-0579	91.81	578.80	240	58.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			299.1	C08		5	0343-0582	313.75	583.24	272	64.28	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1686.4	C08		5	0344-0581	391.81	581.10	270	60.18	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			391.8	C08		5	0345-0581	716.10	581.79	223	55.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			350.4	C08		5	0346-0582	362.15	581.71	266	62.28	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			277.8	C08		5	0347-0580	790.21	579.80	287	68.53	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			408.3	C08		5	0348-0584	229.14	583.82	241	58.28	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			572.2	C08		5	0349-0587	20.24	587.47	224	55.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1152.1	C08		5	0350-0596	595.37	596.05	322	69.84	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			227.7	C08		5	0351-0600	354.65	600.31	282	62.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			962.3	C08		5	0352-0608	474.80	606.92	607	102.57	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			307.6	C08		5	0353-0601	167.12	600.87	304	66.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			366.3	C08		5	0354-0609	148.91	609.45	253	61.11	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			364.1	C08		5	0355-0610	719.24	610.32	321	66.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			749.7	C08		5	0356-0610	533.40	608.97	311	69.26	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			394.4	C08		5	0357-0610	187.17	610.71	253	59.70	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1350.0	C08		5	0358-0611	258.04	611.58	267	61.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			297.9	C08		5	0359-0613	805.81	613.19	270	61.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			209.3	C08		5	0360-0613	940.84	612.97	258	63.01	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			272.9	C08		5	0361-0617	413.46	616.96	307	68.08	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			475.4	C08		5	0362-0616	61.84	615.87	222	55.11	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			245.7	C08		5	0363-0614	320.99	615.05	262	61.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			224.9	C08		5	0364-0616	295.85	616.52	265	59.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			242.5	C08		5	0365-0619	385.46	618.83	296	65.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			324.9	C08		5	0366-0620	207.44	620.08	266	60.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			598.4	C08		5	0367-0623	671.13	622.99	256	59.36	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			473.3	C08		5	0368-0624	137.19	624.25	240	57.70	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			323.8	C08		5	0369-0629	444.51	629.51	296	65.94	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			384.7	C08		5	0370-0629	186.09	628.77	271	62.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1047.3	C08		5	0371-0634	897.40	633.89	524	91.64	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2176.0	C08		5	0372-0633	864.86	633.43	286	63.60	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			263.0	C08		5	0373-0634	497.57	633.42	289	62.53	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			770.8	C08		5	0374-0647	794.04	647.11	321	69.50	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			475.7	C08		5	0375-0647	539.38	647.38	241	57.70	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			660.6	C08		5	0376-0649	154.97	648.54	220	54.53	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			356.8	C08		5	0377-0647	646.40	647.40	204	53.11	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			479.0	C08		5	0378-0651	195.60	651.23	248	57.70	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			619.1	C08		5	0379-0652	247.90	652.79	293	63.94	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			253.4	C08		5	0380-0650	817.91	650.42	277	63.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			281.1	C08		5	0381-0648	335.51	648.81	154	48.63	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			447.6	C08		5	0382-0654	433.37	654.60	247	57.94	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2699.9	C08		5	0383-0655	686.50	654.73	395	73.84	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			322.9	C08		5	0384-0656	555.80	656.01	283	64.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			292.4	C08		5	0385-0660	52.60	659.90	289	62.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			258.5	C08		5	0386-0661	313.70	661.95	212	55.70	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			460.6	C08		5	0387-0662	629.58	661.88	213	56.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			255.6	C08		5	0388-0664	337.75	662.55	268	63.01	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			266.3	C08		5	0389-0668	589.42	667.54	275	63.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2321.6	C08		5	0390-0666	147.08	666.75	252	61.60	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			371.4	C08		5	0391-0666	671.76	667.21	262	63.01	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1278.6	C08		5	0392-0669	739.67	669.43	297	65.01	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			251.8	C08		5	0393-0679	330.09	679.10	404	84.57	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			553.2	C08		5	0394-0672	19.02	672.27	225	57.94	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1656.4	C08		5	0395-0674	160.45	674.70	206	54.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			236.9	C08		5	0396-0676	930.18	676.57	245	64.18	0.747
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1850.2	C08		5	0397-0683	405.39	682.87	637	109.54	0.667
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			259.5	C08		5	0398-0675	547.03	675.66	282	63.94	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			187.2	C08		5	0399-0678	284.16	677.62	271	60.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			444.2	C08		5	0400-0680	625.14	680.18	214	55.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			305.2	C08		5	0401-0684	804.27	684.54	262	59.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			346.5	C08		5	0402-0687	751.15	687.58	259	61.94	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			210.7	C08		5	0403-0688	348.96	687.26	159	58.43	0.585
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			286.2	C08		5	0404-0688	897.14	688.21	252	60.77	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			409.1	C08		5	0405-0691	869.78	690.90	275	78.67	0.558
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			431.0	C08		5	0406-0690	205.49	690.05	230	56.53	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			346.9	C08		5	0407-0690	683.30	690.68	230	56.77	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			413.7	C08		5	0408-0693	612.16	693.49	247	58.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			265.9	C08		5	0409-0706	467.36	706.23	279	61.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			287.5	C08		5	0410-0706	549.06	706.22	255	59.01	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			241.6	C08		5	0411-0709	35.80	710.01	288	66.77	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			254.6	C08		5	0412-0708	182.19	708.34	229	56.53	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			275.2	C08		5	0413-0709	233.40	709.62	261	59.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			286.2	C08		5	0414-0710	56.38	709.78	280	65.94	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			296.7	C08		6	0001-0023	416.28	23.63	327	71.01	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			399.6	C08		6	0002-0027	676.92	26.76	287	65.94	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			427.2	C08		6	0003-0027	227.08	26.02	257	69.60	0.667
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			465.2	C08		6	0004-0031	617.58	31.04	275	63.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			865.2	C08		6	0005-0028	846.42	28.00	237	59.94	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			349.3	C08		6	0006-0034	941.60	33.31	301	65.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			251.7	C08		6	0007-0035	54.36	34.91	270	63.70	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			310.8	C08		6	0008-0036	331.47	37.01	311	69.36	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			997.0	C08		6	0009-0047	440.88	47.58	646	109.88	0.672
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3306.9	C08		6	0010-0041	515.00	41.24	407	74.08	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			238.7	C08		6	0011-0044	31.94	44.26	257	62.77	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			245.3	C08		6	0012-0042	91.51	42.05	298	65.26	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			328.0	C08		6	0013-0043	788.36	43.35	291	63.11	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			419.9	C08		6	0014-0043	641.23	43.00	272	64.53	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3193.7	C08		6	0015-0043	838.81	43.77	348	70.77	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3516.6	C08		6	0016-0048	351.26	47.98	345	68.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			420.8	C08		6	0017-0050	557.36	49.98	316	65.84	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			440.7	C08		6	0018-0056	256.61	56.18	262	60.53	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2625.5	C08		6	0019-0060	857.26	60.45	424	84.91	0.739
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			467.3	C08		6	0020-0058	283.61	58.25	216	55.60	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			834.2	C08		6	0021-0057	302.72	56.67	194	53.11	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			451.1	C08		6	0022-0056	466.92	56.20	294	66.18	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			377.9	C08		6	0023-0058	170.81	57.00	285	73.84	0.657
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			399.3	C08		6	0024-0060	224.81	58.82	486	99.40	0.618
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2674.8	C08		6	0025-0071	610.72	70.65	290	64.53	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			313.9	C08		6	0026-0071	707.96	71.26	316	65.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			276.0	C08		6	0027-0070	53.10	70.92	267	65.60	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			348.8	C08		6	0028-0075	520.80	74.96	302	64.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			531.5	C08		6	0029-0075	161.24	74.69	204	55.94	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2547.8	C08		6	0030-0081	905.91	81.12	542	88.57	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			389.1	C08		6	0031-0077	134.01	77.10	233	58.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			223.9	C08		6	0032-0082	18.69	82.46	248	60.18	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			317.1	C08		6	0033-0086	284.39	86.76	297	64.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			487.2	C08		6	0034-0086	173.60	86.45	261	65.36	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			944.1	C08		6	0035-0090	927.11	89.89	390	78.18	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2430.0	C08		6	0036-0092	722.25	92.38	341	69.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			278.3	C08		6	0037-0095	346.33	95.23	319	67.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			393.4	C08		6	0038-0098	391.71	98.21	293	65.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1173.0	C08		6	0039-0096	766.53	96.92	175	49.46	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			391.6	C08		6	0040-0101	64.36	100.97	241	64.28	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			373.4	C08		6	0041-0101	96.92	101.23	221	56.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			765.0	C08		6	0042-0104	835.92	104.70	279	63.60	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			569.6	C08		6	0043-0106	601.66	106.72	274	63.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			992.7	C08		6	0044-0104	916.53	104.14	224	58.18	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			370.8	C08		6	0045-0106	799.62	106.51	315	68.77	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			322.1	C08		6	0046-0108	535.89	108.15	327	66.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1298.8	C08		6	0047-0111	651.77	112.71	282	62.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1938.9	C08		6	0048-0117	34.30	117.20	284	65.60	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			424.7	C08		6	0049-0115	577.40	115.08	245	58.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4701.4	C08		6	0050-0120	617.95	120.33	382	73.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1612.5	C08		6	0051-0118	135.04	118.42	287	70.18	0.732
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			321.0	C08		6	0052-0121	491.85	120.78	273	62.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			668.3	C08		6	0053-0119	376.22	120.22	193	50.87	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			371.9	C08		6	0054-0123	462.38	123.29	262	58.77	0.953
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			474.8	C08		6	0055-0125	853.84	124.76	210	57.60	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			913.8	C08		6	0056-0126	235.33	125.45	140	50.53	0.689
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			645.6	C08		6	0057-0128	680.24	129.14	265	60.18	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			382.1	C08		6	0058-0127	904.54	127.02	257	59.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1092.0	C08		6	0059-0131	40.69	132.16	280	65.60	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			360.1	C08		6	0060-0135	423.61	135.31	289	63.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			738.5	C08		6	0061-0133	716.97	133.81	268	63.70	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			754.0	C08		6	0062-0135	377.72	135.14	202	53.46	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2432.5	C08		6	0063-0142	340.72	141.79	264	63.01	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			675.4	C08		6	0064-0142	817.92	142.04	234	58.43	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			411.1	C08		6	0065-0144	514.97	144.61	291	63.36	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1016.4	C08		6	0066-0144	251.74	145.29	181	56.53	0.712
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2098.8	C08		6	0067-0144	594.22	144.32	242	58.53	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			298.0	C08		6	0068-0147	159.52	146.71	303	67.01	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4391.4	C08		6	0069-0150	764.60	150.14	234	56.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			495.1	C08		6	0070-0158	303.10	158.52	238	57.70	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2254.0	C08		6	0071-0157	888.64	157.38	362	71.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			942.2	C08		6	0072-0157	825.04	157.14	224	57.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2553.1	C08		6	0073-0163	537.54	161.94	332	68.77	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			736.7	C08		6	0074-0157	588.91	158.29	128	42.39	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			524.9	C08		6	0075-0161	614.35	161.31	263	60.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2956.6	C08		6	0076-0162	747.17	161.79	249	58.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1809.0	C08		6	0077-0163	676.84	163.38	424	77.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			348.5	C08		6	0078-0166	166.00	166.54	242	59.11	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			532.6	C08		6	0079-0166	400.03	166.05	225	57.70	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			423.2	C08		6	0080-0169	487.03	168.76	277	62.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			231.0	C08		6	0081-0171	109.83	171.44	282	64.77	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			729.2	C08		6	0082-0172	591.26	172.29	241	63.70	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			354.9	C08		6	0083-0182	835.67	182.33	328	69.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			632.2	C08		6	0084-0184	172.45	184.33	281	65.94	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2123.2	C08		6	0085-0186	705.00	185.93	345	68.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			585.7	C08		6	0086-0187	75.88	187.63	216	56.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			333.1	C08		6	0087-0187	859.67	187.16	303	68.43	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			409.9	C08		6	0088-0188	60.61	188.80	270	61.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			758.2	C08		6	0089-0187	803.04	186.83	178	60.18	0.618
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			785.7	C08		6	0090-0191	672.91	190.78	309	70.18	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			533.0	C08		6	0091-0193	940.32	193.32	259	59.70	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2012.4	C08		6	0092-0198	822.87	198.48	341	74.67	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			354.2	C08		6	0093-0203	625.45	203.38	295	65.84	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			526.7	C08		6	0094-0202	909.82	202.56	250	58.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			856.5	C08		6	0095-0201	807.76	202.00	102	63.01	0.323
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1256.8	C08		6	0096-0206	129.34	206.23	298	64.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			404.8	C08		6	0097-0209	397.85	209.34	257	61.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			566.4	C08		6	0098-0211	432.42	211.02	231	61.11	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			445.3	C08		6	0099-0210	500.04	211.04	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			379.1	C08		6	0100-0210	568.93	209.67	290	63.60	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			328.6	C08		6	0101-0215	215.75	215.14	308	65.01	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2691.0	C08		6	0102-0218	279.31	219.19	265	61.46	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			342.9	C08		6	0103-0222	723.31	222.66	271	62.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			342.7	C08		6	0104-0225	618.20	224.48	300	63.60	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2711.3	C08		6	0105-0229	887.94	229.13	329	68.18	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4456.2	C08		6	0106-0231	59.71	230.72	334	66.77	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			259.2	C08		6	0107-0236	91.16	236.34	285	63.26	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3218.8	C08		6	0108-0237	773.38	237.52	324	67.36	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1526.8	C08		6	0109-0236	279.03	236.04	389	74.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			356.7	C08		6	0110-0236	669.75	236.45	282	62.43	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			302.0	C08		6	0111-0238	343.16	238.63	321	67.84	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			314.1	C08		6	0112-0242	573.88	243.29	297	69.84	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			856.6	C08		6	0113-0244	756.21	244.60	290	66.18	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			425.9	C08		6	0114-0240	940.51	240.31	252	60.77	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			598.4	C08		6	0115-0247	198.46	246.56	301	67.84	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			403.0	C08		6	0116-0247	874.65	247.80	241	57.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			319.8	C08		6	0117-0251	833.26	251.71	322	76.91	0.684
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			640.4	C08		6	0118-0254	386.96	253.92	280	66.67	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			343.9	C08		6	0119-0254	542.86	253.92	303	64.77	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			489.5	C08		6	0120-0252	181.83	252.52	254	61.36	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			339.8	C08		6	0121-0253	560.66	254.21	262	62.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			360.3	C08		6	0122-0256	469.07	255.36	254	64.53	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			333.9	C08		6	0123-0259	334.87	258.49	264	63.70	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			343.7	C08		6	0124-0263	605.14	262.77	302	65.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			465.5	C08		6	0125-0261	147.85	260.95	217	53.46	0.954
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2022.9	C08		6	0126-0264	729.34	264.18	365	74.08	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1484.0	C08		6	0127-0274	797.83	272.58	730	118.71	0.651
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			957.5	C08		6	0128-0265	913.08	265.02	285	63.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			429.7	C08		6	0129-0268	368.30	267.57	260	61.01	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			310.1	C08		6	0130-0271	50.84	271.45	275	64.18	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3497.1	C08		6	0131-0275	466.40	274.78	474	81.26	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			327.5	C08		6	0132-0271	683.27	271.56	311	66.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			340.9	C08		6	0133-0272	566.82	272.48	293	64.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			232.5	C08		6	0134-0285	173.94	285.56	273	63.11	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			357.2	C08		6	0135-0291	636.52	291.53	287	61.36	0.958
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			526.3	C08		6	0136-0297	351.39	296.39	280	67.84	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			356.8	C08		6	0137-0295	554.38	295.52	265	61.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			302.3	C08		6	0138-0295	254.50	295.29	293	65.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1126.8	C08		6	0139-0296	850.40	297.06	334	67.01	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			443.6	C08		6	0140-0298	712.21	299.02	442	94.08	0.627
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			909.7	C08		6	0141-0302	901.12	301.88	321	69.60	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			351.5	C08		6	0142-0301	666.58	301.64	262	59.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			901.8	C08		6	0143-0307	917.49	306.26	335	71.01	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			384.4	C08		6	0144-0311	771.61	312.57	588	94.81	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			384.8	C08		6	0145-0307	375.36	307.73	255	58.77	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			230.1	C08		6	0146-0310	25.03	310.38	279	61.94	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			339.5	C08		6	0147-0312	509.64	311.64	257	60.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			616.1	C08		6	0148-0317	462.42	314.77	271	76.33	0.585
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			435.2	C08		6	0149-0313	945.18	313.34	263	62.87	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			387.3	C08		6	0150-0327	581.53	327.68	325	69.36	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			385.0	C08		6	0151-0323	859.49	323.86	256	63.94	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4313.4	C08		6	0152-0328	930.26	328.02	378	71.36	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			253.8	C08		6	0153-0332	300.21	332.99	315	73.01	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2039.5	C08		6	0154-0332	136.47	332.64	402	73.84	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3949.6	C08		6	0155-0331	741.68	331.35	299	63.36	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			282.0	C08		6	0156-0334	415.15	333.75	322	69.26	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1606.8	C08		6	0157-0336	57.05	335.97	361	70.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1090.5	C08		6	0158-0336	705.21	336.45	327	70.18	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			649.6	C08		6	0159-0337	247.85	337.10	231	57.94	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			396.3	C08		6	0160-0338	873.94	339.03	219	55.80	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			407.6	C08		6	0161-0346	319.24	345.76	246	62.28	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			651.2	C08		6	0162-0347	649.01	347.45	361	70.43	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			627.9	C08		6	0163-0346	262.33	345.89	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			566.0	C08		6	0164-0346	195.54	347.46	207	57.94	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			652.9	C08		6	0165-0349	751.50	349.29	219	55.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			527.8	C08		6	0166-0351	433.65	351.56	202	55.94	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1594.3	C08		6	0167-0355	275.20	356.19	224	54.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			472.0	C08		6	0168-0358	330.88	357.70	234	60.18	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1494.6	C08		6	0169-0358	510.68	358.42	247	66.67	0.698
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			475.6	C08		6	0170-0353	874.29	352.74	227	58.28	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			337.6	C08		6	0171-0360	458.55	360.08	306	69.94	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			311.7	C08		6	0172-0356	782.57	356.41	305	64.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			333.6	C08		6	0173-0359	612.70	359.17	310	65.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			355.1	C08		6	0174-0360	19.86	360.13	273	65.84	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			541.9	C08		6	0175-0362	759.16	362.11	203	55.94	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			965.3	C08		6	0176-0365	107.78	365.12	297	67.36	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			311.9	C08		6	0177-0369	650.63	368.91	309	65.36	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			551.2	C08		6	0178-0368	427.61	368.25	236	56.87	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			522.0	C08		6	0179-0370	895.90	370.77	278	63.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1116.2	C08		6	0180-0371	917.35	371.10	266	62.43	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			599.3	C08		6	0181-0378	630.45	378.26	301	65.60	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1775.3	C08		6	0182-0380	518.18	380.51	214	56.53	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			322.3	C08		6	0183-0380	806.29	380.14	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			288.5	C08		6	0184-0387	132.88	387.35	285	63.94	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			481.8	C08		6	0185-0388	874.32	387.72	253	62.77	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2812.7	C08		6	0186-0391	26.53	391.88	312	65.01	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1137.6	C08		6	0187-0392	680.81	391.79	302	64.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1135.5	C08		6	0188-0400	718.10	399.93	292	65.36	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			653.4	C08		6	0189-0398	935.14	397.83	207	54.53	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			309.9	C08		6	0190-0401	766.60	400.19	271	62.43	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			435.4	C08		6	0191-0399	913.54	399.39	284	62.53	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1078.8	C08		6	0192-0405	563.90	405.58	300	64.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			643.0	C08		6	0193-0411	271.86	410.40	553	103.30	0.651
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			392.1	C08		6	0194-0408	529.67	408.35	277	62.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			307.0	C08		6	0195-0409	753.00	409.86	266	63.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			301.7	C08		6	0196-0412	855.78	412.42	248	60.43	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3725.9	C08		6	0197-0413	71.26	413.34	383	73.36	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			437.4	C08		6	0198-0418	106.82	418.53	319	68.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			328.5	C08		6	0199-0423	452.60	421.94	336	71.01	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			347.0	C08		6	0200-0425	791.00	425.65	290	64.53	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			337.3	C08		6	0201-0424	807.62	423.86	267	62.53	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			513.7	C08		6	0202-0429	398.58	429.08	509	89.74	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			308.5	C08		6	0203-0426	839.61	426.67	230	58.18	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			390.1	C08		6	0204-0424	125.23	424.74	219	57.70	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			307.3	C08		6	0205-0430	238.86	429.93	284	65.01	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			358.5	C08		6	0206-0431	597.16	431.73	291	64.43	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			645.6	C08		6	0207-0432	349.09	432.09	224	57.11	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			342.4	C08		6	0208-0441	207.55	440.41	573	90.33	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			384.8	C08		6	0209-0439	417.80	439.51	276	63.94	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			326.8	C08		6	0210-0442	168.49	442.08	272	60.77	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			496.1	C08		6	0211-0442	623.74	441.87	263	58.53	0.965
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			737.0	C08		6	0212-0442	651.19	442.34	231	56.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			392.3	C08		6	0213-0445	705.41	445.49	224	61.84	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			304.0	C08		6	0214-0443	85.27	443.29	281	64.77	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			515.2	C08		6	0215-0449	263.69	449.21	290	65.84	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2339.2	C08		6	0216-0455	601.71	455.23	403	75.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1658.9	C08		6	0217-0454	928.96	453.89	209	55.11	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			553.3	C08		6	0218-0456	369.96	456.02	224	55.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			345.3	C08		6	0219-0458	284.97	458.20	295	63.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			938.5	C08		6	0220-0459	943.71	459.04	258	60.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			341.1	C08		6	0221-0461	875.56	460.42	304	63.94	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			362.3	C08		6	0222-0459	82.57	458.98	243	58.53	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			608.6	C08		6	0223-0462	308.85	462.86	247	59.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			453.1	C08		6	0224-0467	636.12	467.79	262	65.01	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			306.1	C08		6	0225-0464	133.52	463.37	241	63.36	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			373.3	C08		6	0226-0466	799.00	466.29	240	57.46	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			353.1	C08		6	0227-0467	814.53	466.96	274	63.11	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			465.8	C08		6	0228-0471	698.92	470.94	320	67.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2735.1	C08		6	0229-0472	764.64	471.85	388	74.08	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			335.1	C08		6	0230-0471	216.16	471.88	246	59.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			376.0	C08		6	0231-0474	430.19	473.76	325	70.43	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			347.1	C08		6	0232-0475	125.39	475.45	271	64.77	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			476.6	C08		6	0233-0477	601.43	476.81	257	59.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			384.8	C08		6	0234-0480	543.61	480.42	248	58.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			329.6	C08		6	0235-0485	754.39	485.62	321	69.01	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			387.6	C08		6	0236-0487	833.43	487.54	169	51.94	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			378.5	C08		6	0237-0489	147.26	489.54	262	60.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			365.6	C08		6	0238-0488	520.89	488.47	281	62.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			335.8	C08		6	0239-0489	211.36	489.19	253	59.11	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			536.5	C08		6	0240-0488	260.82	488.71	235	57.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1854.3	C08		6	0241-0491	897.82	492.01	384	73.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			238.1	C08		6	0242-0496	108.89	496.36	258	60.53	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			654.0	C08		6	0243-0498	794.85	497.72	251	66.53	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			309.7	C08		6	0244-0502	61.85	502.04	264	61.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			328.6	C08		6	0245-0501	431.48	500.98	254	61.60	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			413.1	C08		6	0246-0503	937.07	503.41	305	65.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2542.6	C08		6	0247-0505	703.45	504.80	339	68.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			663.8	C08		6	0248-0503	810.14	503.90	196	54.04	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			411.1	C08		6	0249-0506	31.37	506.93	235	57.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			372.0	C08		6	0250-0507	586.64	507.21	243	58.53	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			311.0	C08		6	0251-0508	414.86	507.96	281	63.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			509.2	C08		6	0252-0508	345.69	507.83	243	59.11	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			450.3	C08		6	0253-0512	150.39	512.45	210	52.87	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3000.9	C08		6	0254-0514	456.22	515.05	348	70.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			393.4	C08		6	0255-0516	164.03	515.62	232	59.46	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			824.1	C08		6	0256-0521	826.80	521.72	313	71.01	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2384.7	C08		6	0257-0523	945.53	522.89	229	56.53	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2452.7	C08		6	0258-0526	105.07	526.30	388	72.43	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			274.7	C08		6	0259-0522	268.65	522.06	172	50.87	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			693.4	C08		6	0260-0526	664.33	526.56	233	57.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			385.9	C08		6	0261-0527	250.42	526.89	188	53.11	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			627.1	C08		6	0262-0527	381.97	527.90	304	66.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			384.6	C08		6	0263-0528	611.87	528.20	324	68.43	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			377.8	C08		6	0264-0529	437.19	529.34	264	59.94	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			301.8	C08		6	0265-0535	483.76	535.17	268	63.36	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1788.9	C08		6	0266-0537	901.00	537.63	246	57.60	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			336.3	C08		6	0267-0541	269.74	541.75	257	61.01	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			384.1	C08		6	0268-0544	829.03	543.72	294	66.18	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1758.3	C08		6	0269-0554	41.10	553.69	394	79.60	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			413.0	C08		6	0270-0551	571.25	551.38	298	63.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			297.2	C08		6	0271-0551	62.85	551.76	261	61.26	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			284.0	C08		6	0272-0551	931.25	551.41	306	67.60	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			495.0	C08		6	0273-0553	753.50	553.00	266	60.18	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			407.3	C08		6	0274-0553	869.76	553.40	256	61.11	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			290.6	C08		6	0275-0557	389.14	557.68	305	66.77	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			427.3	C08		6	0276-0558	694.81	558.28	271	61.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2923.9	C08		6	0277-0564	160.05	564.71	337	67.01	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			969.6	C08		6	0278-0566	80.09	565.96	235	59.36	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			298.0	C08		6	0279-0572	425.35	572.97	289	64.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			487.7	C08		6	0280-0571	641.61	572.09	266	60.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			362.3	C08		6	0281-0573	137.07	573.98	236	59.36	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			340.8	C08		6	0282-0573	444.69	573.46	262	61.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2001.4	C08		6	0283-0579	51.66	578.45	330	70.53	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			291.1	C08		6	0284-0579	325.79	579.36	274	62.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1812.4	C08		6	0285-0578	843.81	579.39	334	69.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			318.7	C08		6	0286-0581	120.36	580.63	248	58.28	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			258.9	C08		6	0287-0584	914.41	584.32	316	66.18	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			281.7	C08		6	0288-0586	224.69	586.27	267	61.70	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1079.4	C08		6	0289-0591	744.26	590.33	323	68.18	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1425.5	C08		6	0290-0592	357.62	591.89	378	71.84	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			320.4	C08		6	0291-0589	447.52	589.20	262	62.53	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			277.1	C08		6	0292-0594	397.81	594.55	286	64.77	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			412.9	C08		6	0293-0596	478.63	597.04	265	60.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			363.1	C08		6	0294-0600	548.72	600.30	269	59.70	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1986.6	C08		6	0295-0606	768.79	606.37	348	75.50	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			389.6	C08		6	0296-0608	453.66	607.22	275	63.46	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			779.7	C08		6	0297-0611	871.03	611.29	313	65.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			364.9	C08		6	0298-0613	608.91	612.29	306	66.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1093.8	C08		6	0299-0612	155.25	612.80	258	66.77	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			288.6	C08		6	0300-0616	281.60	616.02	269	61.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1711.4	C08		6	0301-0621	101.66	620.83	457	83.26	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			866.4	C08		6	0302-0616	242.90	616.27	280	64.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			261.9	C08		6	0303-0619	793.31	619.27	289	65.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			214.3	C08		6	0304-0616	35.45	615.89	238	60.18	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			412.0	C08		6	0305-0619	934.38	618.80	234	59.70	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			421.5	C08		6	0306-0622	715.31	622.01	232	56.18	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			316.6	C08		6	0307-0623	490.18	623.40	266	61.60	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1416.6	C08		6	0308-0625	892.09	625.63	320	68.18	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			487.3	C08		6	0309-0627	922.07	627.14	220	57.94	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			331.8	C08		6	0310-0633	652.51	633.11	316	65.84	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			397.1	C08		6	0311-0633	318.81	632.76	239	59.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1996.9	C08		6	0312-0636	362.01	636.69	341	69.84	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			388.2	C08		6	0313-0638	466.43	637.42	320	68.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1460.1	C08		6	0314-0642	67.30	642.39	465	81.84	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1664.2	C08		6	0315-0639	244.92	639.76	419	78.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			475.2	C08		6	0316-0639	559.40	639.37	227	59.01	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2268.5	C08		6	0317-0639	817.75	639.85	284	61.60	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			460.4	C08		6	0318-0646	718.33	646.71	316	71.60	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			579.3	C08		6	0319-0647	754.67	646.84	230	57.60	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			359.2	C08		6	0320-0649	447.54	648.81	246	57.94	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			373.7	C08		6	0321-0652	950.46	652.40	258	59.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			504.3	C08		6	0322-0653	368.94	653.00	209	56.53	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4250.3	C08		6	0323-0657	286.04	657.54	398	75.84	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			292.6	C08		6	0324-0657	420.01	656.43	218	56.77	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			351.8	C08		6	0325-0659	874.28	659.13	245	58.53	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1228.9	C08		6	0326-0659	245.72	659.02	300	66.77	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			580.8	C08		6	0327-0665	617.34	666.04	321	69.84	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			379.3	C08		6	0328-0666	734.34	665.61	289	65.01	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			941.0	C08		6	0329-0670	799.68	670.44	295	71.50	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			414.1	C08		6	0330-0676	165.38	676.19	237	56.77	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			227.2	C08		6	0331-0679	24.32	679.38	222	60.18	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			337.4	C08		6	0332-0679	281.96	678.70	245	63.94	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			342.2	C08		6	0333-0681	852.07	682.12	305	65.36	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			253.1	C08		6	0334-0684	480.38	683.80	293	67.36	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			365.7	C08		6	0335-0683	870.51	683.10	248	62.18	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2100.6	C08		6	0336-0686	518.61	686.26	352	68.77	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			815.1	C08		6	0337-0683	715.86	683.20	246	59.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			327.2	C08		6	0338-0688	230.41	688.88	253	60.18	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			277.8	C08		6	0339-0689	103.32	689.98	231	58.53	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1322.9	C08		6	0340-0693	583.34	693.72	373	76.08	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			343.4	C08		6	0341-0701	163.75	701.44	242	58.28	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2662.6	C08		7	0001-0023	51.83	23.84	298	69.84	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			298.0	C08		7	0002-0026	872.40	25.70	203	61.60	0.672
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			303.7	C08		7	0003-0025	731.35	25.70	305	67.94	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			201.8	C08		7	0004-0031	928.55	31.22	283	66.18	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			253.0	C08		7	0005-0034	824.17	35.30	298	65.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			280.5	C08		7	0006-0035	617.33	35.30	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			362.5	C08		7	0007-0034	356.66	33.84	315	65.94	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			523.7	C08		7	0008-0037	580.19	36.57	282	63.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			224.4	C08		7	0009-0037	316.66	36.54	320	71.60	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			395.1	C08		7	0010-0036	32.18	36.12	266	61.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			522.6	C08		7	0011-0037	90.78	38.03	232	57.70	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			338.5	C08		7	0012-0043	840.82	43.08	252	58.28	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			274.1	C08		7	0013-0044	643.67	43.90	303	65.94	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			359.4	C08		7	0014-0048	19.83	48.94	291	63.60	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1165.9	C08		7	0015-0053	249.97	53.20	305	64.53	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1051.5	C08		7	0016-0055	90.75	55.31	288	65.94	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			476.5	C08		7	0017-0057	556.33	57.88	320	67.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			325.4	C08		7	0018-0057	409.54	57.82	326	68.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			332.6	C08		7	0019-0062	520.71	62.39	288	63.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			479.9	C08		7	0020-0064	837.98	65.31	438	89.84	0.682
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			322.4	C08		7	0021-0061	944.96	60.36	110	42.04	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3294.8	C08		7	0022-0063	177.25	63.58	268	62.18	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1160.9	C08		7	0023-0067	871.06	67.00	240	61.84	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1370.5	C08		7	0024-0064	113.77	64.84	266	63.94	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			489.8	C08		7	0025-0073	730.13	72.18	431	81.01	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			606.1	C08		7	0026-0077	24.61	76.57	208	54.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			316.4	C08		7	0027-0087	684.99	87.09	311	67.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1844.1	C08		7	0028-0087	251.91	87.09	337	69.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			305.1	C08		7	0029-0087	288.99	87.22	286	62.53	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			840.4	C08		7	0030-0097	586.15	96.15	584	110.23	0.604
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			304.9	C08		7	0031-0088	132.75	87.65	315	69.01	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			892.8	C08		7	0032-0087	200.86	87.04	298	64.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			299.9	C08		7	0033-0087	361.81	87.33	303	64.77	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2002.9	C08		7	0034-0091	448.08	91.39	393	77.01	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			714.6	C08		7	0035-0092	17.29	92.61	173	49.94	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			390.3	C08		7	0036-0095	722.59	94.21	265	63.60	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			274.2	C08		7	0037-0100	638.36	99.46	299	66.18	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			972.6	C08		7	0038-0102	816.65	102.78	353	74.08	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			323.9	C08		7	0039-0102	694.93	102.80	276	65.94	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			474.2	C08		7	0040-0106	621.07	106.28	316	67.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			394.5	C08		7	0041-0106	787.14	105.81	284	65.01	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			963.1	C08		7	0042-0108	440.48	108.24	311	67.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			326.7	C08		7	0043-0110	510.10	110.55	295	64.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			354.0	C08		7	0044-0109	766.18	108.84	275	62.53	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			328.9	C08		7	0045-0113	314.83	112.82	264	59.94	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			217.9	C08		7	0046-0115	914.68	115.50	288	63.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			298.4	C08		7	0047-0116	91.75	116.26	293	62.77	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			701.7	C08		7	0048-0117	563.72	117.16	314	65.60	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1345.3	C08		7	0049-0116	351.44	116.42	305	66.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			247.8	C08		7	0050-0123	180.27	122.55	320	70.18	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			461.5	C08		7	0051-0128	251.79	127.33	470	88.57	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			453.5	C08		7	0052-0120	404.21	120.23	270	62.53	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1576.0	C08		7	0053-0122	67.75	122.10	269	60.28	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			255.0	C08		7	0054-0128	728.23	127.56	314	68.43	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			345.2	C08		7	0055-0129	226.70	128.77	264	60.77	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4043.9	C08		7	0056-0130	853.09	130.34	358	69.60	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			326.5	C08		7	0057-0131	893.96	131.48	307	65.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			269.7	C08		7	0058-0133	668.02	134.08	273	64.18	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1343.9	C08		7	0059-0136	10.94	136.29	264	59.11	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			804.7	C08		7	0060-0141	311.82	141.79	298	65.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			282.2	C08		7	0061-0143	141.61	143.51	294	65.01	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			260.9	C08		7	0062-0143	722.81	144.64	318	71.26	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1572.5	C08		7	0063-0147	212.29	146.48	286	63.70	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			319.9	C08		7	0064-0152	192.31	151.77	275	66.18	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			326.4	C08		7	0065-0151	635.38	151.20	336	69.11	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			569.1	C08		7	0066-0160	561.54	160.14	535	98.57	0.692
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1231.4	C08		7	0067-0153	791.77	152.66	322	67.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2175.4	C08		7	0068-0157	417.30	157.18	496	84.08	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			362.2	C08		7	0069-0160	95.47	160.60	301	64.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			578.4	C08		7	0070-0162	816.09	162.44	317	67.01	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1018.9	C08		7	0071-0162	354.78	162.27	283	68.43	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1927.5	C08		7	0072-0166	235.28	166.37	452	78.43	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3075.5	C08		7	0073-0169	947.12	169.62	436	77.50	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			426.3	C08		7	0074-0168	27.73	168.95	257	59.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1495.0	C08		7	0075-0167	650.18	167.83	282	63.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			471.7	C08		7	0076-0170	492.83	170.51	237	58.77	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1695.2	C08		7	0077-0173	187.93	172.95	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			287.2	C08		7	0078-0171	706.65	171.49	311	68.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			321.0	C08		7	0079-0173	366.75	173.55	297	67.01	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			456.1	C08		7	0080-0173	479.10	174.12	130	47.46	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			393.8	C08		7	0081-0174	47.24	175.03	264	60.77	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			583.1	C08		7	0082-0176	425.03	175.77	300	65.60	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			405.9	C08		7	0083-0181	306.37	181.78	380	72.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			417.3	C08		7	0084-0184	131.58	183.79	278	62.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			401.1	C08		7	0085-0185	518.78	185.64	312	65.60	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			420.3	C08		7	0086-0186	549.39	185.57	270	66.08	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			293.7	C08		7	0087-0185	848.61	185.47	297	64.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			252.7	C08		7	0088-0189	673.09	189.38	273	60.53	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1468.7	C08		7	0089-0190	380.05	189.97	274	61.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2985.2	C08		7	0090-0193	99.98	191.93	164	69.26	0.430
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1037.8	C08		7	0091-0192	702.90	192.63	273	60.77	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			366.0	C08		7	0092-0194	628.35	194.17	269	62.18	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			498.0	C08		7	0093-0198	586.04	197.99	258	59.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			306.7	C08		7	0094-0201	417.61	201.11	287	64.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			408.5	C08		7	0095-0201	42.76	201.33	298	66.08	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			267.7	C08		7	0096-0201	872.92	201.31	246	58.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			297.3	C08		7	0097-0202	306.87	201.56	294	63.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			722.8	C08		7	0098-0204	754.31	203.36	420	82.43	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1516.1	C08		7	0099-0203	239.40	202.95	291	63.60	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			259.6	C08		7	0100-0205	436.00	204.90	300	67.01	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			302.2	C08		7	0101-0207	892.77	207.98	246	57.36	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1234.8	C08		7	0102-0213	353.83	213.62	279	61.94	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			256.5	C08		7	0103-0214	850.75	214.10	297	67.01	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			356.4	C08		7	0104-0213	925.26	213.62	261	59.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			399.9	C08		7	0105-0216	140.33	216.11	277	61.60	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			257.7	C08		7	0106-0218	448.62	218.90	296	65.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			572.0	C08		7	0107-0217	547.32	216.90	235	56.53	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			623.5	C08		7	0108-0216	734.27	216.55	278	63.94	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			350.7	C08		7	0109-0222	203.83	221.45	318	67.36	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			292.8	C08		7	0110-0221	314.48	220.98	295	66.67	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			626.0	C08		7	0111-0222	394.80	221.93	308	66.18	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			277.5	C08		7	0112-0220	493.45	219.93	292	65.60	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1746.0	C08		7	0113-0225	124.54	226.17	266	61.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2189.4	C08		7	0114-0229	825.06	229.84	372	72.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			282.1	C08		7	0115-0228	613.49	228.12	286	63.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			489.0	C08		7	0116-0232	560.43	232.21	247	58.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1845.3	C08		7	0117-0229	686.19	229.62	305	68.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			398.1	C08		7	0118-0238	248.32	238.50	299	65.60	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			525.9	C08		7	0119-0243	123.31	242.39	241	58.87	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			349.9	C08		7	0120-0245	676.71	245.31	306	72.77	0.726
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1333.3	C08		7	0121-0250	341.73	250.33	328	67.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			336.3	C08		7	0122-0257	274.37	257.90	311	68.43	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			287.5	C08		7	0123-0259	512.98	259.48	298	67.94	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			419.6	C08		7	0124-0255	86.50	255.95	260	59.11	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			238.9	C08		7	0125-0257	381.59	257.67	288	62.53	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2086.2	C08		7	0126-0261	157.63	261.08	323	67.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			285.5	C08		7	0127-0261	480.12	261.93	293	64.18	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			273.4	C08		7	0128-0261	434.67	261.82	291	64.53	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1574.5	C08		7	0129-0267	177.11	266.96	476	83.84	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			755.7	C08		7	0130-0262	319.73	262.56	312	65.60	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			350.4	C08		7	0131-0262	908.50	262.01	260	61.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			401.2	C08		7	0132-0264	610.11	263.52	277	63.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			312.6	C08		7	0133-0266	633.45	266.54	293	63.94	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1696.8	C08		7	0134-0270	225.67	270.95	303	71.26	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			275.9	C08		7	0135-0275	848.09	274.96	591	103.05	0.699
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			448.6	C08		7	0136-0270	563.50	270.12	245	56.53	0.964
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			294.2	C08		7	0137-0273	923.56	272.85	264	62.28	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1280.3	C08		7	0138-0275	36.30	275.45	296	66.18	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			342.2	C08		7	0139-0276	74.24	275.93	249	65.46	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			298.9	C08		7	0140-0272	710.08	272.03	295	68.18	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			532.1	C08		7	0141-0279	875.73	278.69	210	55.94	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			326.8	C08		7	0142-0280	436.92	279.64	319	66.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			224.9	C08		7	0143-0283	376.15	283.21	297	65.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			256.6	C08		7	0144-0283	791.94	283.20	287	64.77	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			246.0	C08		7	0145-0284	394.43	284.19	285	62.53	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			355.1	C08		7	0146-0287	280.72	287.25	263	60.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			462.8	C08		7	0147-0290	884.23	291.40	239	57.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			326.6	C08		7	0148-0293	518.71	293.39	317	68.08	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			344.4	C08		7	0149-0291	610.49	291.17	303	66.53	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			969.6	C08		7	0150-0292	686.06	292.11	296	68.18	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1382.5	C08		7	0151-0296	263.56	296.73	307	108.71	0.326
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			622.5	C08		7	0152-0297	142.76	296.77	247	58.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			340.7	C08		7	0153-0298	700.97	298.74	265	63.36	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			298.8	C08		7	0154-0299	754.67	298.77	304	65.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1618.5	C08		7	0155-0304	472.50	304.34	414	76.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			284.7	C08		7	0156-0301	564.05	301.27	298	64.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2226.1	C08		7	0157-0305	335.27	304.40	377	72.67	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			345.8	C08		7	0158-0305	293.40	305.22	296	63.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			213.9	C08		7	0159-0303	409.14	303.46	295	64.28	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			332.0	C08		7	0160-0309	742.48	309.82	249	59.84	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1701.6	C08		7	0161-0313	442.94	313.73	318	65.60	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1749.4	C08		7	0162-0318	942.53	318.48	418	76.08	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1676.2	C08		7	0163-0322	870.12	321.84	473	82.43	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			312.3	C08		7	0164-0320	325.90	321.12	282	65.01	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			457.8	C08		7	0165-0318	74.38	317.81	250	58.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			360.2	C08		7	0166-0319	776.38	318.80	223	55.11	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1949.2	C08		7	0167-0321	384.45	321.54	317	67.01	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			302.4	C08		7	0168-0326	801.22	326.23	276	62.53	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			519.7	C08		7	0169-0326	100.75	325.66	233	55.94	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			260.9	C08		7	0170-0328	540.33	328.26	275	61.94	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			273.3	C08		7	0171-0325	618.90	325.47	308	69.11	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1935.5	C08		7	0172-0332	355.64	332.73	326	66.43	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			289.5	C08		7	0173-0333	827.91	332.60	260	61.94	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			778.1	C08		7	0174-0333	59.54	333.52	229	57.94	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			697.4	C08		7	0175-0340	679.98	340.54	324	70.28	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			358.6	C08		7	0176-0341	182.75	341.17	277	67.60	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			345.7	C08		7	0177-0337	234.22	337.39	279	65.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			960.4	C08		7	0178-0341	393.39	341.51	322	67.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2488.6	C08		7	0179-0344	273.12	344.76	273	60.53	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			451.8	C08		7	0180-0347	443.34	347.29	297	69.50	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			330.5	C08		7	0181-0345	903.28	345.78	250	58.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			642.7	C08		7	0182-0349	511.96	349.53	294	97.64	0.388
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			283.1	C08		7	0183-0352	834.55	351.67	322	68.18	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			568.7	C08		7	0184-0351	480.64	350.76	450	82.43	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			333.0	C08		7	0185-0349	596.52	349.28	272	61.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			354.1	C08		7	0186-0351	734.48	350.94	281	62.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1511.8	C08		7	0187-0354	21.01	354.39	300	63.36	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			414.3	C08		7	0188-0357	136.51	357.68	257	62.77	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1564.4	C08		7	0189-0363	277.83	363.11	282	65.36	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			281.9	C08		7	0190-0369	804.38	370.02	353	76.91	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			311.2	C08		7	0191-0370	623.76	369.67	290	63.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			272.8	C08		7	0192-0371	729.37	370.37	299	70.43	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			286.1	C08		7	0193-0371	883.25	370.76	286	62.18	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			519.2	C08		7	0194-0370	421.52	370.61	212	52.87	0.953
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1913.1	C08		7	0195-0373	440.77	372.81	369	71.94	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			960.4	C08		7	0196-0375	244.52	375.02	278	61.36	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			258.5	C08		7	0197-0386	779.94	386.38	519	100.33	0.648
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			339.6	C08		7	0198-0377	71.45	377.30	298	66.53	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			511.5	C08		7	0199-0381	358.69	381.63	304	67.26	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1614.2	C08		7	0200-0384	480.38	383.90	280	62.53	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			304.3	C08		7	0201-0383	594.58	383.38	302	67.36	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			515.7	C08		7	0202-0387	497.35	387.35	255	59.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			470.8	C08		7	0203-0388	159.68	388.14	279	64.18	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			318.8	C08		7	0204-0387	211.60	387.59	296	66.43	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			418.0	C08		7	0205-0389	307.95	388.57	241	57.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			345.6	C08		7	0206-0391	538.00	391.84	277	63.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			596.1	C08		7	0207-0391	340.85	392.48	347	75.50	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			986.2	C08		7	0208-0391	895.57	390.50	309	67.60	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			407.6	C08		7	0209-0392	273.69	392.24	311	66.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			275.3	C08		7	0210-0392	731.74	391.93	291	66.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			819.1	C08		7	0211-0394	685.93	394.07	333	70.43	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			462.4	C08		7	0212-0397	667.40	397.52	258	63.94	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			323.2	C08		7	0213-0399	588.90	399.42	299	66.77	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			217.5	C08		7	0214-0400	944.59	400.47	310	69.01	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			590.3	C08		7	0215-0405	62.74	405.46	318	72.28	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			452.1	C08		7	0216-0403	315.97	403.96	284	64.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1318.4	C08		7	0217-0403	136.00	402.95	262	59.36	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			312.8	C08		7	0218-0405	648.86	405.48	283	64.18	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			687.4	C08		7	0219-0408	242.85	408.79	298	64.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			627.5	C08		7	0220-0407	454.24	407.57	291	63.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			344.9	C08		7	0221-0408	727.38	408.60	319	67.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			240.1	C08		7	0222-0413	806.08	413.94	299	65.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			325.2	C08		7	0223-0413	848.18	413.71	226	57.70	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2925.0	C08		7	0224-0424	158.66	424.24	430	77.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2280.2	C08		7	0225-0426	575.46	425.45	392	95.88	0.536
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			781.4	C08		7	0226-0424	443.56	423.89	283	62.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2915.6	C08		7	0227-0428	70.13	428.66	468	82.77	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			778.9	C08		7	0228-0429	302.95	428.77	307	67.84	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4872.5	C08		7	0229-0433	604.50	433.16	423	82.33	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			240.6	C08		7	0230-0432	651.00	431.62	293	64.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			447.9	C08		7	0231-0429	917.79	429.61	133	42.87	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			548.4	C08		7	0232-0435	902.21	434.55	192	52.18	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			345.8	C08		7	0233-0439	201.66	439.00	288	64.18	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1002.6	C08		7	0234-0441	136.25	440.56	313	66.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			698.6	C08		7	0235-0451	551.08	451.54	738	125.30	0.591
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			410.9	C08		7	0236-0447	733.50	447.24	319	66.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1856.8	C08		7	0237-0448	237.40	448.75	413	75.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			221.3	C08		7	0238-0451	171.67	451.56	290	65.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			518.9	C08		7	0239-0452	50.62	451.91	266	63.94	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			845.5	C08		7	0240-0449	372.36	448.99	256	62.53	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			499.9	C08		7	0241-0451	479.06	451.16	238	58.18	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1490.1	C08		7	0242-0467	133.33	469.17	904	137.10	0.604
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2364.3	C08		7	0243-0458	493.89	458.38	335	69.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			330.7	C08		7	0244-0458	332.53	458.42	279	63.01	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			273.1	C08		7	0245-0460	632.80	460.02	261	66.43	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			331.4	C08		7	0246-0456	274.08	455.57	268	61.70	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			818.1	C08		7	0247-0458	414.12	457.91	197	52.28	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			416.1	C08		7	0248-0463	79.81	463.03	259	62.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			371.2	C08		7	0249-0468	822.05	468.25	531	87.15	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			794.5	C08		7	0250-0465	393.47	464.98	215	54.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1206.3	C08		7	0251-0465	800.97	465.27	182	52.04	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			394.6	C08		7	0252-0466	695.06	466.10	242	59.36	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			301.2	C08		7	0253-0468	778.09	468.76	311	67.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			460.3	C08		7	0254-0471	731.50	470.88	306	65.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			786.6	C08		7	0255-0481	682.59	481.48	527	94.08	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			326.4	C08		7	0256-0475	432.38	475.66	298	63.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			318.0	C08		7	0257-0476	888.40	476.51	278	63.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			353.8	C08		7	0258-0476	863.53	476.24	285	64.77	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			359.2	C08		7	0259-0479	615.49	479.10	308	65.84	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			357.8	C08		7	0260-0480	758.16	480.43	318	69.60	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1264.6	C08		7	0261-0489	489.59	489.12	471	81.26	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			805.9	C08		7	0262-0486	905.96	486.58	296	64.18	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			449.0	C08		7	0263-0490	579.07	489.41	186	57.60	0.705
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			521.1	C08		7	0264-0493	259.07	493.34	275	60.77	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			323.1	C08		7	0265-0497	773.89	497.11	282	64.77	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			418.6	C08		7	0266-0497	234.03	496.95	259	58.53	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			375.4	C08		7	0267-0502	658.63	502.20	266	60.18	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1032.4	C08		7	0268-0503	846.58	503.79	333	68.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			296.0	C08		7	0269-0506	122.20	506.82	276	62.53	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			441.6	C08		7	0270-0508	532.58	508.24	317	65.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			858.7	C08		7	0271-0513	340.54	511.95	653	107.40	0.711
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			257.5	C08		7	0272-0511	201.18	511.35	298	66.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			343.0	C08		7	0273-0509	374.99	510.00	260	58.77	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			319.5	C08		7	0274-0514	779.70	514.47	297	65.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			286.4	C08		7	0275-0514	163.92	514.24	276	63.60	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			352.9	C08		7	0276-0515	474.02	515.23	306	64.43	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			329.9	C08		7	0277-0520	285.23	519.48	281	66.43	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			319.4	C08		7	0278-0523	554.66	522.46	299	65.60	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			274.0	C08		7	0279-0527	595.61	527.94	333	69.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			380.8	C08		7	0280-0530	462.19	530.53	273	65.26	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			286.7	C08		7	0281-0531	50.04	531.24	281	65.01	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			317.7	C08		7	0282-0532	83.20	532.26	287	62.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2914.0	C08		7	0283-0538	235.20	538.13	469	80.08	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			278.8	C08		7	0284-0537	720.99	537.06	278	66.43	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1996.8	C08		7	0285-0537	643.63	536.71	328	67.84	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			289.9	C08		7	0286-0536	769.83	536.82	260	64.67	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			335.0	C08		7	0287-0539	187.08	539.05	290	69.50	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			330.8	C08		7	0288-0536	390.77	535.62	261	61.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			396.2	C08		7	0289-0539	914.20	540.18	320	67.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2384.0	C08		7	0290-0544	701.47	543.96	434	77.74	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			323.4	C08		7	0291-0544	12.36	544.12	314	67.84	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			776.8	C08		7	0292-0543	264.67	542.86	258	59.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			495.8	C08		7	0293-0551	298.73	551.61	248	58.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			817.8	C08		7	0294-0551	213.99	551.36	300	65.70	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			282.9	C08		7	0295-0553	929.54	553.86	299	66.18	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1804.5	C08		7	0296-0558	801.50	557.38	377	72.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			346.9	C08		7	0297-0559	382.14	558.96	278	63.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			833.4	C08		7	0298-0561	350.08	560.94	292	64.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			411.0	C08		7	0299-0562	322.63	561.88	258	59.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2647.6	C08		7	0300-0563	518.11	563.04	271	61.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			562.6	C08		7	0301-0564	133.95	564.75	242	57.11	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			257.2	C08		7	0302-0569	241.13	569.70	307	67.01	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2068.0	C08		7	0303-0571	696.96	572.13	336	72.43	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			518.8	C08		7	0304-0571	588.57	571.12	288	63.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2050.3	C08		7	0305-0579	282.97	579.38	397	73.60	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1558.2	C08		7	0306-0585	763.47	587.36	746	117.64	0.677
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			296.3	C08		7	0307-0579	94.84	579.64	289	64.43	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			939.5	C08		7	0308-0576	649.55	576.07	254	59.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			805.5	C08		7	0309-0583	415.09	583.38	302	67.94	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2670.3	C08		7	0310-0583	893.16	583.45	375	71.60	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			281.9	C08		7	0311-0584	615.58	583.79	264	60.77	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			392.2	C08		7	0312-0588	460.21	588.56	306	64.53	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			486.8	C08		7	0313-0591	583.80	591.02	473	82.18	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			432.0	C08		7	0314-0595	538.06	595.67	433	77.01	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			334.7	C08		7	0315-0592	700.27	592.00	281	62.87	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			256.1	C08		7	0316-0599	945.31	598.79	258	64.43	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1561.9	C08		7	0317-0599	353.56	599.04	283	64.04	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2143.6	C08		7	0318-0605	336.14	604.94	412	78.18	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			573.7	C08		7	0319-0602	56.90	602.87	252	59.70	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			379.6	C08		7	0320-0606	399.11	607.57	277	63.11	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			260.3	C08		7	0321-0609	855.32	609.79	272	62.53	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			314.2	C08		7	0322-0613	636.26	612.94	273	64.77	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			343.9	C08		7	0323-0613	936.53	613.28	315	67.84	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			359.7	C08		7	0324-0612	678.10	613.04	256	60.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2869.9	C08		7	0325-0621	104.10	620.20	457	78.43	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2115.8	C08		7	0326-0623	291.51	624.26	627	100.91	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2032.9	C08		7	0327-0629	395.95	629.48	448	79.60	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			756.0	C08		7	0328-0628	572.60	628.89	290	62.77	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			288.8	C08		7	0329-0632	748.01	632.18	289	64.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2562.1	C08		7	0330-0636	776.79	636.68	256	60.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			321.7	C08		7	0331-0640	373.08	640.16	281	62.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			263.0	C08		7	0332-0647	710.25	648.24	283	65.60	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			293.8	C08		7	0333-0651	822.58	651.72	261	61.94	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1086.8	C08		7	0334-0652	204.53	653.05	300	64.18	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			278.8	C08		7	0335-0655	48.52	654.60	298	66.77	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			313.8	C08		7	0336-0658	138.48	657.73	287	62.77	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			301.8	C08		7	0337-0660	500.08	659.81	310	69.36	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			346.1	C08		7	0338-0659	631.58	659.79	261	60.87	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1180.7	C08		7	0339-0663	91.38	663.46	295	63.36	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			402.6	C08		7	0340-0661	302.24	661.91	258	61.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			269.6	C08		7	0341-0665	867.73	665.18	310	67.60	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1763.3	C08		7	0342-0670	424.56	670.17	396	75.84	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			392.2	C08		7	0343-0666	665.60	666.59	260	59.11	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			299.8	C08		7	0344-0668	699.28	668.58	267	61.94	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			289.4	C08		7	0345-0667	566.92	667.45	265	64.53	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1994.0	C08		7	0346-0674	186.53	673.98	438	80.18	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3697.6	C08		7	0347-0677	313.68	677.71	433	78.43	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3744.3	C08		7	0348-0676	807.34	676.26	246	58.18	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			336.6	C08		7	0349-0677	628.99	676.79	257	63.21	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			290.4	C08		7	0350-0679	645.06	678.65	325	71.94	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2153.0	C08		7	0351-0682	946.39	682.20	232	58.53	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			381.0	C08		7	0352-0684	666.11	684.21	246	57.70	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3254.4	C08		7	0353-0687	759.57	688.18	370	71.84	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3281.3	C08		7	0354-0687	736.92	686.21	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1325.3	C08		7	0355-0688	24.13	688.30	298	65.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3173.2	C08		7	0356-0691	252.88	690.83	430	77.26	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			425.6	C08		7	0357-0688	713.65	688.11	263	63.36	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			290.3	C08		7	0358-0693	469.47	692.93	302	67.70	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			386.3	C08		7	0359-0691	123.37	691.78	285	63.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			293.2	C08		7	0360-0698	43.62	698.59	290	65.60	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2077.0	C08		7	0361-0698	939.07	698.25	235	59.36	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			274.6	C08		7	0362-0700	533.23	700.56	301	65.60	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2134.6	C08		7	0363-0702	438.97	702.40	410	75.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			769.6	C08		7	0364-0702	374.62	702.30	278	61.36	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			484.9	C08		7	0365-0705	762.74	705.83	240	58.87	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			397.5	C08		7	0366-0710	613.25	710.49	186	53.36	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			287.3	C08		8	0001-0030	465.68	30.42	295	61.94	0.966
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			262.8	C08		8	0002-0031	547.19	30.38	278	62.18	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			264.6	C08		8	0003-0033	709.44	32.90	255	63.84	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			204.5	C08		8	0004-0033	33.60	33.54	273	64.77	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			227.2	C08		8	0005-0032	180.29	32.17	229	56.53	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			477.8	C08		8	0006-0032	778.32	31.86	180	51.11	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			255.2	C08		8	0007-0033	54.01	33.46	295	67.70	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			228.0	C08		8	0008-0033	231.55	33.54	264	59.11	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			284.1	C08		8	0009-0037	693.47	37.68	251	59.94	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			303.8	C08		8	0010-0039	522.67	38.53	294	65.94	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			632.3	C08		8	0011-0040	792.13	40.86	333	76.91	0.707
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			246.9	C08		8	0012-0042	311.06	41.33	294	65.26	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			425.9	C08		8	0013-0048	380.46	46.13	438	89.84	0.682
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2411.9	C08		8	0014-0045	501.66	45.04	449	78.67	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			768.4	C08		8	0015-0044	660.94	45.37	156	80.91	0.299
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			282.6	C08		8	0016-0054	712.35	54.21	264	66.18	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			365.7	C08		8	0017-0053	742.37	52.85	277	63.84	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			289.3	C08		8	0018-0056	837.09	55.92	164	55.11	0.679
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			326.5	C08		8	0019-0057	860.26	57.03	272	62.18	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			774.4	C08		8	0020-0059	448.63	59.29	134	60.18	0.465
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			401.4	C08		8	0021-0068	67.82	67.59	498	87.50	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1848.2	C08		8	0022-0064	909.20	64.16	300	67.36	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			378.9	C08		8	0023-0062	790.69	61.81	207	52.28	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			671.6	C08		8	0024-0063	121.72	63.89	242	57.36	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			255.8	C08		8	0025-0067	286.68	66.55	297	76.57	0.637
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			272.0	C08		8	0026-0067	591.04	66.94	314	70.77	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			359.0	C08		8	0027-0063	50.38	63.06	108	40.63	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			481.4	C08		8	0028-0074	188.81	72.64	695	116.23	0.647
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			336.7	C08		8	0029-0069	345.83	69.59	243	57.11	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			388.2	C08		8	0030-0071	848.67	70.96	252	61.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			874.9	C08		8	0031-0073	106.00	73.30	218	58.77	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1176.5	C08		8	0032-0080	165.89	77.84	532	95.36	0.735
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			308.7	C08		8	0033-0075	629.52	75.54	309	69.26	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			303.0	C08		8	0034-0073	932.67	73.63	278	64.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			359.1	C08		8	0035-0074	236.53	74.59	247	59.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			291.5	C08		8	0036-0081	544.67	81.33	299	68.43	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			250.9	C08		8	0037-0087	824.73	86.97	303	67.84	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			252.5	C08		8	0038-0086	481.64	86.30	296	64.67	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			336.3	C08		8	0039-0086	319.20	85.87	282	62.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1381.9	C08		8	0040-0089	665.56	89.80	432	80.67	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2886.5	C08		8	0041-0100	83.83	100.10	294	64.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			291.5	C08		8	0042-0100	227.32	99.74	258	63.36	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1595.6	C08		8	0043-0099	773.95	99.27	234	56.87	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			374.3	C08		8	0044-0100	367.51	100.60	291	65.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			588.4	C08		8	0045-0100	757.50	100.78	259	58.87	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			372.0	C08		8	0046-0108	581.33	108.58	288	65.01	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			353.5	C08		8	0047-0110	902.90	110.16	303	64.18	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			501.7	C08		8	0048-0110	821.66	109.99	266	61.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			454.9	C08		8	0049-0111	720.99	110.99	228	55.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			251.8	C08		8	0050-0117	19.36	117.48	250	58.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1819.9	C08		8	0051-0122	401.85	120.99	617	103.15	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			329.5	C08		8	0052-0117	602.92	117.43	243	58.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			298.4	C08		8	0053-0117	536.09	116.93	268	61.94	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			506.9	C08		8	0054-0123	645.10	123.14	239	57.36	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			375.4	C08		8	0055-0126	433.22	126.58	256	59.36	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			326.8	C08		8	0056-0125	475.67	125.87	307	65.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2182.5	C08		8	0057-0131	104.76	131.71	320	68.43	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			581.4	C08		8	0058-0129	288.05	129.53	218	55.11	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			987.8	C08		8	0059-0135	847.79	134.33	444	84.91	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			447.7	C08		8	0060-0132	811.21	132.13	224	56.63	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			263.3	C08		8	0061-0135	207.21	134.94	252	61.36	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			309.5	C08		8	0062-0138	798.43	138.91	261	64.28	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			637.0	C08		8	0063-0140	527.91	140.89	280	63.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			288.8	C08		8	0064-0142	711.25	142.30	314	70.43	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			522.5	C08		8	0065-0142	375.28	142.34	231	56.28	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			554.5	C08		8	0066-0143	476.59	142.54	270	62.53	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			251.8	C08		8	0067-0148	775.29	148.00	280	62.18	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			268.1	C08		8	0068-0152	124.19	152.91	275	63.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			362.6	C08		8	0069-0148	299.03	147.82	247	59.70	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			455.4	C08		8	0070-0152	814.13	152.03	197	51.70	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			276.3	C08		8	0071-0155	675.60	155.47	270	63.60	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			228.9	C08		8	0072-0155	741.61	154.87	253	59.94	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			293.7	C08		8	0073-0159	614.15	159.31	289	65.70	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2830.0	C08		8	0074-0158	355.70	157.95	353	69.01	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			392.6	C08		8	0075-0158	72.97	157.87	271	61.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			410.3	C08		8	0076-0166	468.52	166.65	303	69.60	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2995.2	C08		8	0077-0171	52.32	171.42	447	79.50	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			267.3	C08		8	0078-0173	161.92	173.06	261	61.36	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			302.4	C08		8	0079-0173	222.76	173.00	257	59.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			975.7	C08		8	0080-0169	397.95	169.91	274	67.94	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			446.1	C08		8	0081-0172	449.89	172.11	212	55.70	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			348.3	C08		8	0082-0176	674.84	176.11	285	66.18	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			635.3	C08		8	0083-0184	538.83	184.41	214	56.53	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			270.7	C08		8	0084-0186	105.76	186.28	271	60.18	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			616.0	C08		8	0085-0190	896.93	190.67	512	89.74	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2639.0	C08		8	0086-0197	328.77	196.94	376	71.60	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			647.8	C08		8	0087-0194	398.31	194.01	237	58.18	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			358.3	C08		8	0088-0198	481.48	198.28	282	64.53	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			320.7	C08		8	0089-0200	669.44	199.84	309	70.18	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			976.6	C08		8	0090-0199	286.00	199.11	279	63.36	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2547.7	C08		8	0091-0199	513.10	198.22	311	69.11	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			263.1	C08		8	0092-0203	773.71	202.19	159	50.18	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			402.8	C08		8	0093-0208	848.75	208.73	304	70.91	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1867.6	C08		8	0094-0208	385.94	208.71	392	80.33	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1244.9	C08		8	0095-0210	762.42	209.98	316	75.74	0.692
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			210.0	C08		8	0096-0210	784.83	210.44	120	41.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			291.5	C08		8	0097-0214	718.57	214.37	222	59.36	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			396.2	C08		8	0098-0215	30.22	215.69	254	59.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			394.0	C08		8	0099-0214	509.59	215.05	284	65.36	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2569.2	C08		8	0100-0221	901.61	221.67	392	74.67	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			371.8	C08		8	0101-0219	401.57	219.53	273	63.01	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			399.6	C08		8	0102-0227	600.21	227.79	229	56.53	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			319.9	C08		8	0103-0228	180.24	228.63	265	62.77	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			231.6	C08		8	0104-0232	123.88	234.13	341	79.26	0.682
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			419.3	C08		8	0105-0230	684.46	229.47	250	59.70	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1614.9	C08		8	0106-0230	821.39	229.68	262	60.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			466.6	C08		8	0107-0228	846.38	228.77	224	55.36	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3384.1	C08		8	0108-0235	216.03	234.74	373	71.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			347.3	C08		8	0109-0233	263.29	233.49	159	47.46	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1374.9	C08		8	0110-0241	702.98	240.60	210	55.94	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2505.9	C08		8	0111-0244	483.81	244.58	343	71.01	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1367.9	C08		8	0112-0247	651.99	247.34	454	81.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			295.3	C08		8	0113-0246	183.27	246.76	242	59.46	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			323.7	C08		8	0114-0247	567.50	246.42	307	65.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			226.8	C08		8	0115-0248	622.51	248.87	293	63.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			249.7	C08		8	0116-0251	64.62	250.71	270	66.67	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			448.0	C08		8	0117-0252	339.09	252.28	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4138.9	C08		8	0118-0252	746.86	252.39	370	71.26	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1408.1	C08		8	0119-0253	909.42	252.76	302	68.18	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			919.9	C08		8	0120-0256	927.02	256.12	338	72.18	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2520.8	C08		8	0121-0257	507.86	257.96	460	79.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			265.7	C08		8	0122-0257	775.18	257.04	242	57.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			303.0	C08		8	0123-0263	113.49	262.03	264	61.26	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			302.3	C08		8	0124-0265	13.44	264.14	247	61.60	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			535.5	C08		8	0125-0266	570.91	266.69	224	54.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			324.4	C08		8	0126-0270	431.50	270.56	276	63.36	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			345.0	C08		8	0127-0271	642.41	271.75	266	63.11	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			255.5	C08		8	0128-0275	28.09	274.67	247	61.36	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			276.4	C08		8	0129-0273	96.59	273.71	293	71.15	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			334.1	C08		8	0130-0278	177.48	278.78	258	61.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1886.6	C08		8	0131-0275	348.47	275.37	282	62.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			354.8	C08		8	0132-0282	790.68	282.00	280	63.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			688.7	C08		8	0133-0280	616.38	280.19	218	54.53	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2078.3	C08		8	0134-0286	411.59	286.65	516	86.43	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			345.6	C08		8	0135-0289	593.91	290.18	522	96.33	0.707
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1512.7	C08		8	0136-0291	657.83	291.43	401	77.60	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			309.7	C08		8	0137-0292	198.52	292.19	254	62.77	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			339.5	C08		8	0138-0291	503.11	291.22	264	61.36	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			337.1	C08		8	0139-0293	169.12	293.03	223	57.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			358.7	C08		8	0140-0296	858.63	296.66	278	65.70	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			497.6	C08		8	0141-0296	473.07	295.39	310	66.43	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			356.2	C08		8	0142-0296	631.22	296.87	243	59.94	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1318.4	C08		8	0143-0300	872.90	300.22	285	64.87	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			423.4	C08		8	0144-0300	97.94	300.00	282	66.18	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1760.6	C08		8	0145-0308	702.25	308.18	503	88.43	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			636.0	C08		8	0146-0309	152.79	309.85	475	88.57	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1270.2	C08		8	0147-0310	280.31	309.79	416	77.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			375.5	C08		8	0148-0310	386.42	309.73	244	58.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			295.1	C08		8	0149-0309	745.08	308.93	281	62.18	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			384.8	C08		8	0150-0315	216.42	314.77	287	65.60	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1638.5	C08		8	0151-0320	47.35	320.46	420	75.26	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			285.5	C08		8	0152-0320	593.64	319.21	252	59.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			360.9	C08		8	0153-0325	528.95	325.66	304	66.77	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			280.5	C08		8	0154-0325	422.95	324.32	285	64.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			882.3	C08		8	0155-0325	910.94	325.64	306	67.84	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1822.4	C08		8	0156-0327	98.64	326.80	373	76.08	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			373.3	C08		8	0157-0326	326.66	326.76	238	58.18	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1144.6	C08		8	0158-0337	772.26	337.59	305	66.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			314.8	C08		8	0159-0341	818.10	341.48	280	65.01	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			403.4	C08		8	0160-0339	871.33	338.94	242	59.11	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			251.2	C08		8	0161-0345	115.39	344.75	275	62.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2715.6	C08		8	0162-0348	525.87	348.58	366	73.84	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			282.4	C08		8	0163-0345	711.92	344.44	249	59.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			274.8	C08		8	0164-0352	559.11	352.20	276	61.94	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			301.3	C08		8	0165-0351	597.71	351.17	268	60.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			262.0	C08		8	0166-0352	682.45	351.91	255	62.77	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			302.6	C08		8	0167-0352	731.46	352.60	283	62.18	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			303.5	C08		8	0168-0359	263.84	359.46	487	88.91	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			336.6	C08		8	0169-0354	210.23	354.93	263	59.60	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			406.9	C08		8	0170-0356	631.68	356.32	268	61.11	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			315.1	C08		8	0171-0356	355.10	356.18	258	59.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			340.8	C08		8	0172-0357	416.89	357.57	307	70.43	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			333.6	C08		8	0173-0357	925.03	357.68	273	61.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			393.1	C08		8	0174-0361	468.53	360.83	292	64.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1817.0	C08		8	0175-0362	649.11	362.38	323	69.60	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			373.9	C08		8	0176-0365	171.66	365.70	227	55.70	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			250.8	C08		8	0177-0365	288.04	365.90	287	67.60	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2923.9	C08		8	0178-0366	59.86	366.56	248	58.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2014.2	C08		8	0179-0380	760.61	380.58	357	70.18	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			434.2	C08		8	0180-0380	811.00	379.21	217	55.01	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			345.5	C08		8	0181-0383	196.62	383.55	280	62.18	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			334.1	C08		8	0182-0384	217.55	384.18	269	61.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1955.6	C08		8	0183-0383	334.32	383.75	119	50.04	0.597
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			283.8	C08		8	0184-0389	824.12	389.42	309	65.11	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			253.6	C08		8	0185-0388	948.43	389.19	264	59.70	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2472.0	C08		8	0186-0396	578.23	395.14	311	67.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			657.6	C08		8	0187-0396	492.26	397.89	297	69.84	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			263.4	C08		8	0188-0398	874.23	398.40	276	62.77	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			667.5	C08		8	0189-0402	378.12	401.83	338	72.67	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			334.2	C08		8	0190-0397	921.02	397.62	284	63.01	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			235.1	C08		8	0191-0401	295.72	402.10	276	61.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			236.0	C08		8	0192-0402	49.43	402.45	275	65.60	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			518.0	C08		8	0193-0404	558.15	404.14	249	59.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3051.3	C08		8	0194-0404	725.10	404.57	103	63.50	0.321
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1635.7	C08		8	0195-0418	319.07	417.56	255	60.28	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1933.2	C08		8	0196-0418	390.15	417.76	412	76.08	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			283.0	C08		8	0197-0420	245.09	420.66	268	64.43	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			473.3	C08		8	0198-0420	684.61	420.01	187	50.53	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			306.9	C08		8	0199-0423	613.93	423.00	244	58.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			296.7	C08		8	0200-0424	562.83	424.34	275	60.77	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			317.1	C08		8	0201-0426	180.00	427.29	275	63.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1331.8	C08		8	0202-0426	827.92	426.59	247	57.70	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1606.9	C08		8	0203-0432	147.17	431.93	238	57.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			318.2	C08		8	0204-0434	261.57	433.98	293	67.94	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			282.5	C08		8	0205-0437	846.62	437.04	304	67.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			327.0	C08		8	0206-0442	340.32	442.00	273	63.36	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			516.6	C08		8	0207-0440	699.29	439.71	234	55.94	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			347.1	C08		8	0208-0442	417.13	442.32	230	56.28	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1870.0	C08		8	0209-0444	718.59	444.25	348	69.60	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			305.9	C08		8	0210-0444	545.86	444.24	272	61.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			453.1	C08		8	0211-0445	458.64	445.50	258	59.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			8112.9	C08		8	0212-0448	868.82	448.96	248	59.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			387.5	C08		8	0213-0449	925.97	448.03	219	57.11	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			417.4	C08		8	0214-0453	372.89	453.38	318	70.67	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			224.5	C08		8	0215-0453	608.77	452.64	278	62.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1950.9	C08		8	0216-0458	565.00	458.24	488	82.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2540.8	C08		8	0217-0461	64.26	460.83	476	83.74	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			231.2	C08		8	0218-0461	387.49	461.48	279	63.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			459.2	C08		8	0219-0460	837.21	459.77	248	58.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			338.9	C08		8	0220-0461	921.28	462.13	248	62.77	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			293.3	C08		8	0221-0462	256.23	461.92	220	54.53	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			458.8	C08		8	0222-0461	282.52	461.62	206	54.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			412.2	C08		8	0223-0463	668.71	463.60	263	64.18	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			301.6	C08		8	0224-0467	319.69	467.01	282	63.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			667.7	C08		8	0225-0464	804.55	463.14	229	56.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			505.1	C08		8	0226-0471	787.93	471.14	285	63.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			286.4	C08		8	0227-0477	149.23	477.60	560	102.57	0.669
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			383.1	C08		8	0228-0474	640.90	473.26	224	54.53	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			256.8	C08		8	0229-0477	425.01	478.02	269	62.18	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1789.1	C08		8	0230-0478	292.01	479.06	271	64.53	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2184.5	C08		8	0231-0481	678.51	481.71	247	59.11	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2725.6	C08		8	0232-0479	711.23	479.80	241	57.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			310.5	C08		8	0233-0479	902.02	479.72	270	60.53	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			293.7	C08		8	0234-0481	941.03	481.25	232	57.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3491.4	C08		8	0235-0484	211.36	483.62	105	43.11	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3613.4	C08		8	0236-0487	201.58	488.12	131	48.53	0.699
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			397.8	C08		8	0237-0487	269.16	487.87	231	58.53	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			887.5	C08		8	0238-0489	620.16	488.89	288	65.11	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1620.9	C08		8	0239-0492	554.03	492.40	349	70.67	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1508.9	C08		8	0240-0491	365.53	491.03	225	56.18	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1393.2	C08		8	0241-0500	171.28	499.87	344	68.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			266.9	C08		8	0242-0498	716.02	498.20	226	60.43	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			301.2	C08		8	0243-0497	109.61	497.63	238	59.60	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			303.8	C08		8	0244-0500	238.91	501.10	239	58.87	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1362.8	C08		8	0245-0502	380.62	502.20	268	63.01	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4565.8	C08		8	0246-0507	930.95	506.66	409	77.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			440.0	C08		8	0247-0504	625.16	504.98	238	60.28	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			603.4	C08		8	0248-0503	273.40	503.05	238	58.28	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			316.5	C08		8	0249-0514	89.34	515.12	507	91.15	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2056.2	C08		8	0250-0509	438.00	509.74	255	58.53	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2862.2	C08		8	0251-0510	696.79	510.30	311	66.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			332.7	C08		8	0252-0512	878.28	512.44	244	59.46	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			545.0	C08		8	0253-0514	310.30	513.18	186	51.70	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			481.4	C08		8	0254-0515	201.80	515.64	228	56.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			461.9	C08		8	0255-0517	759.40	516.79	294	64.67	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			419.1	C08		8	0256-0519	811.58	519.44	486	87.98	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			301.7	C08		8	0257-0516	596.04	516.40	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			323.1	C08		8	0258-0520	237.04	519.50	330	71.11	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			324.5	C08		8	0259-0522	253.68	522.36	228	59.11	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1070.3	C08		8	0260-0523	488.73	522.70	295	62.77	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			395.8	C08		8	0261-0524	661.48	523.87	227	55.70	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2485.9	C08		8	0262-0527	742.40	526.95	260	60.43	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			304.6	C08		8	0263-0530	876.58	529.37	283	62.77	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			423.9	C08		8	0264-0532	356.26	532.79	284	62.53	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			355.2	C08		8	0265-0533	279.96	532.58	250	58.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			419.4	C08		8	0266-0533	631.26	533.79	257	59.60	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			326.5	C08		8	0267-0540	312.82	539.80	275	63.11	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1396.4	C08		8	0268-0544	136.31	544.19	542	91.15	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			311.6	C08		8	0269-0542	19.31	542.57	283	65.01	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			361.6	C08		8	0270-0541	710.78	541.56	213	55.11	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			284.2	C08		8	0271-0547	528.35	547.46	266	63.60	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1122.2	C08		8	0272-0547	659.37	547.28	221	55.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			339.2	C08		8	0273-0548	340.98	548.12	299	66.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			294.8	C08		8	0274-0551	158.34	550.80	237	57.70	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			642.0	C08		8	0275-0558	593.14	559.17	376	84.43	0.663
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1296.3	C08		8	0276-0557	882.02	557.74	446	77.60	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			267.8	C08		8	0277-0555	34.35	555.92	277	66.43	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			977.2	C08		8	0278-0558	212.69	558.00	294	64.53	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			331.7	C08		8	0279-0556	618.51	556.04	242	56.53	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			338.9	C08		8	0280-0557	686.65	556.60	238	59.60	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			224.9	C08		8	0281-0560	179.36	560.21	253	62.77	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			370.7	C08		8	0282-0558	246.73	557.92	240	58.77	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1637.2	C08		8	0283-0562	830.98	562.33	447	79.26	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			267.6	C08		8	0284-0566	803.90	565.85	314	66.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			246.8	C08		8	0285-0569	497.77	569.36	276	64.53	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			263.3	C08		8	0286-0567	759.84	567.25	272	63.01	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			274.5	C08		8	0287-0569	119.71	570.06	268	63.94	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			333.2	C08		8	0288-0571	461.61	571.35	266	61.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			723.2	C08		8	0289-0580	59.92	580.69	231	56.87	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			425.1	C08		8	0290-0579	303.55	579.25	251	58.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			818.9	C08		8	0291-0579	624.67	579.37	252	58.53	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			279.0	C08		8	0292-0583	361.19	583.79	256	61.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2002.5	C08		8	0293-0587	654.64	588.15	349	74.33	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			271.5	C08		8	0294-0589	456.73	589.69	307	70.18	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			254.4	C08		8	0295-0586	529.34	586.84	286	61.94	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			348.4	C08		8	0296-0586	117.58	586.24	206	54.97	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			290.2	C08		8	0297-0596	295.90	596.50	237	62.77	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			388.6	C08		8	0298-0593	868.74	593.33	202	51.70	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			273.3	C08		8	0299-0601	50.38	600.85	254	64.43	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2235.1	C08		8	0300-0599	701.52	599.57	413	75.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			226.8	C08		8	0301-0598	843.25	598.26	291	64.67	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			330.6	C08		8	0302-0600	63.45	600.21	210	57.46	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			257.9	C08		8	0303-0602	559.38	602.13	283	63.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			206.0	C08		8	0304-0602	185.08	602.33	240	61.01	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			257.5	C08		8	0305-0601	405.74	600.46	280	65.70	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			292.5	C08		8	0306-0605	120.49	605.06	281	62.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			382.2	C08		8	0307-0607	825.57	607.00	248	58.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1376.8	C08		8	0308-0611	359.21	612.16	250	61.94	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			841.4	C08		8	0309-0610	721.85	609.54	302	65.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			312.8	C08		8	0310-0613	943.88	612.85	291	65.60	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			372.2	C08		8	0311-0615	41.12	614.97	308	69.50	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2368.6	C08		8	0312-0615	239.39	614.86	257	61.70	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			245.0	C08		8	0313-0616	916.21	616.39	283	64.08	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			206.1	C08		8	0314-0618	207.71	618.12	223	60.77	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			199.5	C08		8	0315-0617	761.84	618.20	286	63.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			468.1	C08		8	0316-0618	306.06	618.28	239	56.53	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1062.8	C08		8	0317-0620	588.43	620.73	279	62.43	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1457.8	C08		8	0318-0622	404.32	622.59	304	64.18	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			266.8	C08		8	0319-0629	517.58	629.12	284	63.84	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1693.3	C08		8	0320-0632	459.52	631.89	370	71.84	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2466.3	C08		8	0321-0636	76.39	636.01	364	70.18	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1944.1	C08		8	0322-0637	110.24	637.03	317	65.36	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1859.7	C08		8	0323-0640	879.84	640.53	526	93.74	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1996.2	C08		8	0324-0639	391.61	638.97	319	68.18	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1282.9	C08		8	0325-0643	248.85	643.59	323	70.43	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			249.3	C08		8	0326-0645	505.10	645.84	306	66.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			287.7	C08		8	0327-0645	768.94	645.84	266	62.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3735.7	C08		8	0328-0651	671.28	651.61	246	60.18	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			320.3	C08		8	0329-0653	706.64	652.08	543	92.91	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			253.9	C08		8	0330-0654	300.37	654.17	247	58.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			548.0	C08		8	0331-0656	925.47	655.80	301	68.08	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			302.2	C08		8	0332-0656	362.05	656.09	299	64.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			220.4	C08		8	0333-0658	141.52	658.42	252	70.67	0.634
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			289.4	C08		8	0334-0658	97.64	658.60	267	61.94	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			254.4	C08		8	0335-0662	326.33	662.00	309	69.01	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			692.2	C08		8	0336-0664	412.07	664.33	320	67.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			328.9	C08		8	0337-0663	542.20	662.74	269	62.53	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1142.6	C08		8	0338-0671	679.72	670.55	583	99.98	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			992.8	C08		8	0339-0670	559.96	669.94	306	65.94	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			431.7	C08		8	0340-0671	522.06	670.94	257	60.53	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			500.8	C08		8	0341-0676	839.62	675.96	277	64.43	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			621.0	C08		8	0342-0677	592.10	676.95	301	64.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			252.4	C08		8	0343-0681	426.87	681.11	257	61.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			416.7	C08		8	0344-0680	825.91	680.22	200	55.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			340.1	C08		8	0345-0681	496.51	681.74	226	55.94	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2202.9	C08		8	0346-0684	50.65	684.36	234	58.53	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			396.3	C08		8	0347-0689	254.18	690.21	283	64.43	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			305.8	C08		8	0348-0688	868.57	687.80	244	57.70	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			353.4	C08		8	0349-0690	188.82	689.63	237	57.70	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			289.9	C08		8	0350-0690	937.26	690.82	252	61.11	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			263.6	C08		8	0351-0694	901.66	693.47	276	65.60	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			791.6	C08		8	0352-0701	762.65	700.30	321	72.77	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2052.0	C08		8	0353-0700	43.43	700.32	233	61.01	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			285.1	C08		8	0354-0703	119.57	703.64	249	58.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			231.0	C08		8	0355-0705	520.70	705.43	283	62.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			277.5	C08		8	0356-0706	389.73	707.25	207	55.94	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			246.9	C08		8	0357-0707	328.37	707.55	294	67.70	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			297.8	C08		9	0001-0024	161.85	25.29	246	59.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2541.9	C08		9	0002-0035	665.72	35.66	214	57.11	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2580.2	C08		9	0003-0039	312.75	39.43	433	76.67	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			294.0	C08		9	0004-0037	420.03	37.46	346	69.01	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			263.0	C08		9	0005-0040	374.47	40.18	320	66.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1899.8	C08		9	0006-0045	820.05	45.39	381	73.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1193.4	C08		9	0007-0047	72.02	46.73	268	64.18	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			527.9	C08		9	0008-0049	676.39	49.76	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3680.1	C08		9	0009-0050	207.06	50.12	309	65.01	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			318.7	C08		9	0010-0052	170.76	52.19	245	58.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3035.0	C08		9	0011-0055	511.16	55.20	391	73.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			410.3	C08		9	0012-0055	553.62	56.11	265	61.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			323.3	C08		9	0013-0056	84.67	55.33	253	63.60	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1648.8	C08		9	0014-0060	764.20	59.77	410	76.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			305.5	C08		9	0015-0057	111.31	57.22	247	63.94	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			256.2	C08		9	0016-0063	641.28	63.47	291	67.11	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			283.8	C08		9	0017-0063	618.58	62.86	295	65.70	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			438.4	C08		9	0018-0066	660.27	66.16	281	62.18	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			386.3	C08		9	0019-0065	260.89	65.33	267	59.94	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			425.4	C08		9	0020-0065	919.29	65.62	278	62.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			449.5	C08		9	0021-0068	834.44	67.84	321	68.43	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			352.8	C08		9	0022-0074	466.68	74.75	307	65.11	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			274.7	C08		9	0023-0076	27.12	76.64	262	61.60	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			286.8	C08		9	0024-0077	188.25	77.36	293	67.01	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			372.9	C08		9	0025-0078	237.21	78.41	255	61.01	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			668.5	C08		9	0026-0083	329.86	83.01	316	70.08	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3074.4	C08		9	0027-0090	387.72	90.27	630	94.81	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			473.9	C08		9	0028-0084	822.71	84.46	238	56.77	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			247.8	C08		9	0029-0087	949.16	87.00	283	63.01	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2288.4	C08		9	0030-0088	499.50	88.20	272	61.36	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			471.5	C08		9	0031-0095	273.32	94.68	232	57.60	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			373.0	C08		9	0032-0099	837.52	99.21	297	64.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			578.7	C08		9	0033-0103	732.27	102.56	218	57.36	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			327.1	C08		9	0034-0103	439.24	102.90	295	65.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			510.5	C08		9	0035-0104	717.93	103.97	242	57.70	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2476.9	C08		9	0036-0107	610.82	107.38	251	58.28	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			403.7	C08		9	0037-0108	762.14	108.40	290	63.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2609.2	C08		9	0038-0114	213.27	114.06	257	59.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1796.5	C08		9	0039-0119	68.38	119.09	248	64.87	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2785.5	C08		9	0040-0120	50.66	120.43	362	73.36	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1635.7	C08		9	0041-0121	287.36	120.29	279	61.11	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			446.3	C08		9	0042-0121	647.54	121.67	265	61.11	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			312.3	C08		9	0043-0121	943.79	120.02	245	59.94	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3694.6	C08		9	0044-0122	243.16	121.57	263	83.50	0.474
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			404.8	C08		9	0045-0124	862.97	124.53	312	66.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			445.6	C08		9	0046-0126	496.69	125.44	297	64.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2134.4	C08		9	0047-0131	422.92	130.66	210	55.01	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			640.3	C08		9	0048-0130	383.67	130.77	198	53.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			436.7	C08		9	0049-0133	667.11	133.29	248	58.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			366.3	C08		9	0050-0138	68.40	138.48	334	74.77	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2647.3	C08		9	0051-0142	113.99	141.80	371	73.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			281.7	C08		9	0052-0142	192.16	141.80	284	66.67	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			408.9	C08		9	0053-0140	302.18	140.57	275	62.04	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			549.9	C08		9	0054-0143	433.34	143.34	286	62.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			419.7	C08		9	0055-0141	733.55	141.16	244	57.36	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			387.4	C08		9	0056-0142	885.59	142.48	299	63.84	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			570.1	C08		9	0057-0139	772.04	139.76	219	54.87	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2853.1	C08		9	0058-0145	230.77	145.19	399	73.01	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2016.5	C08		9	0059-0147	345.61	146.60	335	67.84	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			622.9	C08		9	0060-0146	132.54	146.26	261	61.94	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			521.9	C08		9	0061-0159	616.86	156.80	390	84.91	0.680
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			488.9	C08		9	0062-0152	166.12	151.85	223	57.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			477.8	C08		9	0063-0153	634.50	153.00	116	38.97	0.960
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			272.6	C08		9	0064-0156	770.74	155.75	343	68.87	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1752.0	C08		9	0065-0156	449.47	155.91	231	55.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			380.3	C08		9	0066-0156	302.96	155.49	244	60.28	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2000.3	C08		9	0067-0162	490.83	162.58	358	71.26	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2421.3	C08		9	0068-0165	572.41	165.15	422	76.18	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			588.9	C08		9	0069-0166	807.34	166.84	302	69.60	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			511.3	C08		9	0070-0170	532.91	170.34	246	59.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			391.7	C08		9	0071-0173	140.65	173.84	242	57.70	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2106.5	C08		9	0072-0177	414.21	176.85	464	80.67	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			384.7	C08		9	0073-0177	251.09	177.59	287	62.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1657.2	C08		9	0074-0177	660.80	177.44	227	56.53	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			270.9	C08		9	0075-0182	827.81	182.46	333	68.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1762.4	C08		9	0076-0186	396.07	188.05	451	86.67	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			533.7	C08		9	0077-0185	750.71	185.11	320	66.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1658.6	C08		9	0078-0184	456.37	184.52	346	75.84	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			353.5	C08		9	0079-0186	559.50	186.39	310	65.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			354.0	C08		9	0080-0189	116.64	189.13	234	55.94	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			244.7	C08		9	0081-0188	167.35	187.41	309	70.53	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2186.8	C08		9	0082-0191	520.39	190.47	422	77.84	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			293.3	C08		9	0083-0192	77.49	191.97	280	63.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			293.2	C08		9	0084-0193	187.40	192.97	270	61.94	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			247.2	C08		9	0085-0191	902.35	191.72	342	71.11	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3257.9	C08		9	0086-0196	324.22	196.80	336	67.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			386.7	C08		9	0087-0199	842.93	200.02	236	57.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3140.0	C08		9	0088-0210	372.57	210.16	458	81.84	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			307.4	C08		9	0089-0206	233.49	206.79	240	58.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			265.2	C08		9	0090-0207	900.41	206.94	299	67.70	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			356.7	C08		9	0091-0211	734.28	211.95	285	63.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			322.3	C08		9	0092-0214	251.54	213.93	326	72.77	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1346.3	C08		9	0093-0211	773.03	210.77	302	64.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1879.0	C08		9	0094-0219	463.37	219.42	274	64.53	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			571.5	C08		9	0095-0217	682.78	217.22	230	57.36	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			394.4	C08		9	0096-0219	500.76	219.35	234	57.70	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2695.2	C08		9	0097-0222	127.39	221.66	282	63.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			348.6	C08		9	0098-0220	637.31	220.35	277	61.36	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			341.3	C08		9	0099-0221	78.75	221.20	239	62.18	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			222.2	C08		9	0100-0222	206.90	222.08	262	62.18	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2115.8	C08		9	0101-0227	722.82	226.89	261	63.36	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2254.4	C08		9	0102-0224	928.66	223.68	354	71.01	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1982.8	C08		9	0103-0227	522.97	227.72	319	67.36	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1832.1	C08		9	0104-0238	321.22	237.77	481	81.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1496.2	C08		9	0105-0231	741.47	231.83	261	62.87	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2597.3	C08		9	0106-0236	137.63	236.28	389	72.43	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			251.6	C08		9	0107-0237	777.38	237.02	324	69.01	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			281.6	C08		9	0108-0238	853.32	238.03	340	72.08	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			326.7	C08		9	0109-0238	916.87	238.35	294	65.70	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2519.9	C08		9	0110-0240	623.11	240.28	311	65.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1207.2	C08		9	0111-0243	71.18	243.47	298	66.77	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			398.9	C08		9	0112-0247	451.64	247.20	263	59.36	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			270.4	C08		9	0113-0247	227.38	246.53	271	60.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1760.3	C08		9	0114-0252	290.88	251.22	323	68.08	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			250.8	C08		9	0115-0251	178.20	251.43	263	58.53	0.965
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			706.2	C08		9	0116-0252	539.18	251.95	102	77.98	0.211
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			862.5	C08		9	0117-0259	21.87	259.08	306	69.01	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			291.4	C08		9	0118-0257	148.94	257.02	237	57.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2394.0	C08		9	0119-0257	338.39	257.67	235	56.53	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2211.2	C08		9	0120-0259	806.27	259.06	291	63.11	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1841.0	C08		9	0121-0263	711.79	263.00	343	70.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1943.3	C08		9	0122-0264	280.54	265.02	288	64.08	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			433.6	C08		9	0123-0260	430.89	259.94	241	60.53	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2446.0	C08		9	0124-0264	683.93	264.17	260	60.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2231.3	C08		9	0125-0264	875.82	264.11	313	68.18	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			977.5	C08		9	0126-0271	96.00	269.37	542	99.15	0.693
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			504.3	C08		9	0127-0266	851.68	266.28	250	60.18	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			369.6	C08		9	0128-0268	651.45	267.92	241	61.01	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			398.4	C08		9	0129-0269	616.96	268.57	313	66.77	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			597.1	C08		9	0130-0270	215.06	270.05	331	70.18	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			289.0	C08		9	0131-0275	124.19	275.22	276	64.18	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1515.2	C08		9	0132-0276	434.10	275.58	263	61.11	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1961.3	C08		9	0133-0277	320.08	277.26	241	59.36	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			324.8	C08		9	0134-0281	232.65	281.28	261	61.11	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			311.0	C08		9	0135-0284	345.92	284.36	258	59.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			178.7	C08		9	0136-0289	67.16	289.77	297	68.18	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1618.1	C08		9	0137-0288	931.47	288.01	293	65.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			407.0	C08		9	0138-0291	169.84	291.45	302	65.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			472.3	C08		9	0139-0293	132.68	292.15	267	64.53	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			376.7	C08		9	0140-0292	731.38	291.66	311	69.60	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			388.0	C08		9	0141-0299	107.70	299.35	444	81.84	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			317.7	C08		9	0142-0298	434.80	298.10	239	56.53	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1794.9	C08		9	0143-0303	239.39	302.15	539	92.91	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			282.2	C08		9	0144-0300	377.66	300.14	294	64.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2818.9	C08		9	0145-0302	549.83	302.46	337	66.77	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			356.7	C08		9	0146-0301	764.47	301.35	306	65.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			497.6	C08		9	0147-0309	392.37	309.45	358	77.36	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			415.4	C08		9	0148-0309	347.42	309.38	218	60.28	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			282.6	C08		9	0149-0310	896.98	310.50	288	62.18	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1972.6	C08		9	0150-0311	577.44	310.83	300	63.36	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1726.8	C08		9	0151-0312	216.08	312.50	255	60.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			319.1	C08		9	0152-0314	494.42	314.03	302	69.26	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			479.5	C08		9	0153-0316	284.47	316.16	255	61.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			482.9	C08		9	0154-0318	168.21	318.26	221	53.94	0.954
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			352.9	C08		9	0155-0317	772.86	317.30	215	55.11	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			413.9	C08		9	0156-0326	316.42	327.16	303	68.43	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			275.2	C08		9	0157-0329	100.11	329.05	280	63.01	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			383.1	C08		9	0158-0328	399.84	329.06	255	61.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			342.6	C08		9	0159-0331	473.65	331.97	309	69.94	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			361.7	C08		9	0160-0335	827.11	334.40	269	65.01	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1499.6	C08		9	0161-0334	653.21	334.08	294	63.94	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4097.3	C08		9	0162-0337	158.65	337.24	315	66.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			279.7	C08		9	0163-0339	906.65	338.05	301	66.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1291.5	C08		9	0164-0341	280.12	341.05	159	46.87	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			338.0	C08		9	0165-0346	405.37	345.82	260	64.53	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			380.7	C08		9	0166-0346	501.49	346.23	253	57.94	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2090.6	C08		9	0167-0349	610.54	349.77	277	61.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			364.5	C08		9	0168-0351	141.79	350.62	239	59.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			462.8	C08		9	0169-0351	658.83	350.93	212	54.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1075.8	C08		9	0170-0350	285.21	350.41	164	53.70	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1481.9	C08		9	0171-0356	820.54	356.82	457	79.50	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			347.3	C08		9	0172-0356	448.40	356.50	293	63.26	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			297.0	C08		9	0173-0355	476.70	354.62	261	60.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			324.3	C08		9	0174-0357	577.40	356.95	299	68.77	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			420.3	C08		9	0175-0358	238.80	359.38	238	58.18	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			307.7	C08		9	0176-0357	419.39	357.22	250	59.70	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1187.7	C08		9	0177-0361	555.88	361.12	311	71.01	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			368.7	C08		9	0178-0361	65.88	360.72	247	58.18	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			273.3	C08		9	0179-0361	19.97	360.70	264	61.11	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			319.0	C08		9	0180-0361	132.83	362.58	260	61.84	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			267.8	C08		9	0181-0364	345.75	364.55	320	67.84	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1021.7	C08		9	0182-0362	689.31	362.03	220	55.11	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2977.3	C08		9	0183-0365	192.24	365.31	356	69.60	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1662.3	C08		9	0184-0369	298.99	368.75	288	61.36	0.961
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1058.0	C08		9	0185-0376	361.42	376.48	319	71.11	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			356.0	C08		9	0186-0374	649.12	373.54	234	59.11	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			416.4	C08		9	0187-0380	597.95	380.23	274	64.18	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			382.1	C08		9	0188-0380	707.53	380.45	241	58.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1561.8	C08		9	0189-0381	678.68	381.16	240	57.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			315.0	C08		9	0190-0381	225.76	381.28	250	57.94	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1805.2	C08		9	0191-0383	756.09	383.91	241	59.94	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1821.9	C08		9	0192-0391	779.07	391.01	340	72.67	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			355.0	C08		9	0193-0390	799.10	391.04	245	59.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			279.0	C08		9	0194-0392	89.33	392.36	270	62.18	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			306.8	C08		9	0195-0391	43.24	392.06	257	60.53	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			956.4	C08		9	0196-0395	609.25	395.53	320	67.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			418.6	C08		9	0197-0393	699.56	393.71	208	55.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			254.3	C08		9	0198-0400	15.94	400.42	270	60.18	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			331.4	C08		9	0199-0400	309.65	400.91	265	59.36	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			278.1	C08		9	0200-0400	833.98	400.08	295	62.53	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			307.1	C08		9	0201-0407	902.30	406.64	274	62.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			310.3	C08		9	0202-0412	521.72	412.19	305	67.94	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			431.6	C08		9	0203-0408	697.46	408.03	236	57.11	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1098.4	C08		9	0204-0421	330.18	420.87	469	82.57	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			389.4	C08		9	0205-0416	730.08	415.55	217	55.36	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			290.3	C08		9	0206-0421	857.42	421.28	284	64.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1155.4	C08		9	0207-0424	657.84	423.98	250	59.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1593.7	C08		9	0208-0430	96.02	429.79	282	62.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			495.8	C08		9	0209-0430	53.43	430.31	184	59.36	0.656
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1728.9	C08		9	0210-0429	272.80	429.35	252	63.70	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1981.3	C08		9	0211-0436	937.67	435.69	355	72.18	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			496.6	C08		9	0212-0434	404.28	434.71	268	60.53	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			497.1	C08		9	0213-0434	221.85	434.00	235	56.53	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1485.9	C08		9	0214-0437	835.72	437.04	437	77.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			382.4	C08		9	0215-0433	741.32	433.53	271	64.28	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			287.8	C08		9	0216-0441	183.31	440.67	278	63.36	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			366.1	C08		9	0217-0445	118.89	445.84	253	59.94	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			405.2	C08		9	0218-0445	276.34	444.55	334	71.01	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4352.1	C08		9	0219-0446	568.93	446.43	359	69.60	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			358.7	C08		9	0220-0450	509.86	450.39	295	67.26	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			321.3	C08		9	0221-0451	20.54	450.78	221	57.11	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			318.2	C08		9	0222-0451	92.12	451.47	252	58.53	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			304.4	C08		9	0223-0455	199.91	454.64	259	58.87	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			313.5	C08		9	0224-0457	140.99	457.34	266	61.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			247.7	C08		9	0225-0458	292.70	459.22	301	65.50	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			311.3	C08		9	0226-0464	16.19	464.87	249	61.70	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3221.5	C08		9	0227-0466	246.15	466.00	365	69.84	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			508.1	C08		9	0228-0465	774.80	465.10	224	57.11	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1549.7	C08		9	0229-0473	845.32	474.29	456	80.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			296.5	C08		9	0230-0473	943.11	472.67	290	64.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			366.3	C08		9	0231-0474	586.90	473.65	236	56.77	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			340.1	C08		9	0232-0477	117.41	476.98	231	56.53	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			318.9	C08		9	0233-0479	533.86	479.51	256	61.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			455.2	C08		9	0234-0477	780.99	477.30	204	56.87	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			624.9	C08		9	0235-0486	732.95	485.44	478	90.33	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			308.1	C08		9	0236-0484	35.89	484.22	231	57.36	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			416.8	C08		9	0237-0489	799.12	490.26	263	62.53	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1806.8	C08		9	0238-0492	865.20	491.40	373	74.08	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1613.8	C08		9	0239-0491	170.18	491.71	244	57.70	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1037.2	C08		9	0240-0494	360.13	494.65	280	61.11	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			427.6	C08		9	0241-0496	397.72	496.43	237	57.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			503.0	C08		9	0242-0497	709.02	498.02	186	53.36	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			413.9	C08		9	0243-0501	889.82	500.72	276	63.01	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			508.7	C08		9	0244-0501	745.35	500.87	258	59.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4382.5	C08		9	0245-0509	25.61	509.50	411	76.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			304.7	C08		9	0246-0506	187.12	506.63	263	64.18	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1536.7	C08		9	0247-0508	630.19	507.52	302	65.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			391.5	C08		9	0248-0509	793.51	508.92	295	66.53	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			461.4	C08		9	0249-0513	765.22	513.46	253	60.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			396.1	C08		9	0250-0515	427.69	515.11	257	60.53	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			365.3	C08		9	0251-0520	600.81	520.37	291	64.43	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			272.5	C08		9	0252-0521	190.24	520.79	236	61.94	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			255.5	C08		9	0253-0526	312.34	526.57	272	63.26	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			398.5	C08		9	0254-0523	382.37	523.68	259	60.87	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			331.8	C08		9	0255-0532	900.91	532.53	282	61.60	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			372.4	C08		9	0256-0534	743.07	534.31	283	63.60	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			398.7	C08		9	0257-0536	72.15	535.68	229	58.18	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1480.9	C08		9	0258-0536	345.34	536.25	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			373.1	C08		9	0259-0541	115.02	540.89	231	57.11	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			355.6	C08		9	0260-0541	388.16	540.96	250	62.04	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			300.7	C08		9	0261-0544	146.31	544.72	261	59.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3665.0	C08		9	0262-0550	208.62	549.77	372	71.01	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			460.7	C08		9	0263-0549	530.58	548.82	256	59.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			252.2	C08		9	0264-0552	65.45	553.53	305	69.74	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			435.3	C08		9	0265-0551	462.86	551.05	255	61.36	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			315.1	C08		9	0266-0558	187.19	558.95	291	65.11	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1643.6	C08		9	0267-0560	131.96	560.28	266	60.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			414.6	C08		9	0268-0560	300.81	559.95	236	57.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			955.4	C08		9	0269-0562	939.43	562.66	339	69.60	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			251.0	C08		9	0270-0563	49.26	563.13	288	64.18	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			320.2	C08		9	0271-0564	85.36	565.00	271	66.43	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1593.5	C08		9	0272-0566	339.62	565.46	310	65.36	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			320.3	C08		9	0273-0569	464.96	569.44	300	63.36	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			348.1	C08		9	0274-0575	736.81	575.78	288	64.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			255.0	C08		9	0275-0577	412.79	577.08	301	67.36	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			358.3	C08		9	0276-0584	694.25	583.79	271	64.53	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			266.9	C08		9	0277-0583	193.20	583.45	294	65.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1336.2	C08		9	0278-0588	385.14	587.73	347	73.36	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			880.3	C08		9	0279-0589	72.04	589.28	271	63.70	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			297.9	C08		9	0280-0593	212.91	593.17	300	64.53	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			341.0	C08		9	0281-0595	369.24	595.55	270	63.94	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			305.9	C08		9	0282-0597	146.27	597.00	301	64.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			342.2	C08		9	0283-0600	756.21	600.54	250	60.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			429.8	C08		9	0284-0609	524.75	609.24	263	60.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			273.1	C08		9	0285-0616	38.28	615.69	283	63.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			340.6	C08		9	0286-0619	933.03	619.84	281	62.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			349.2	C08		9	0287-0622	196.88	622.44	282	62.87	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			879.0	C08		9	0288-0623	881.73	623.66	287	62.77	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			450.1	C08		9	0289-0627	467.98	627.32	335	68.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			968.2	C08		9	0290-0632	89.86	632.14	284	64.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1838.2	C08		9	0291-0637	150.45	637.26	292	63.36	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			403.0	C08		9	0292-0649	202.97	648.00	683	104.33	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			287.4	C08		9	0293-0648	124.90	648.49	260	61.36	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			783.0	C08		9	0294-0651	511.67	651.43	319	67.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			335.1	C08		9	0295-0651	69.79	650.22	248	61.36	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			348.9	C08		9	0296-0650	744.16	649.99	267	60.53	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			431.0	C08		9	0297-0650	263.16	650.76	250	60.53	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			538.2	C08		9	0298-0659	19.67	658.90	268	63.60	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			819.5	C08		9	0299-0665	66.46	665.98	267	64.77	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			583.6	C08		9	0300-0668	184.98	667.40	248	60.77	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			398.8	C08		9	0301-0666	264.82	665.46	286	72.77	0.679
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			474.5	C08		9	0302-0671	207.75	671.46	339	71.94	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			411.9	C08		9	0303-0668	387.01	668.37	303	66.43	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			327.7	C08		9	0304-0669	475.83	669.81	291	64.77	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			310.2	C08		9	0305-0673	781.40	673.09	311	67.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			389.8	C08		9	0306-0675	172.35	675.41	223	57.70	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1206.3	C08		9	0307-0677	111.57	677.69	283	61.36	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1982.1	C08		9	0308-0683	936.29	683.92	458	86.43	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			369.3	C08		9	0309-0678	251.31	678.44	264	60.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			315.3	C08		9	0310-0684	140.58	684.18	241	63.11	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2087.4	C08		9	0311-0690	321.34	691.53	581	89.74	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			312.6	C08		9	0312-0689	360.96	689.61	257	60.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			290.8	C08		9	0313-0693	31.45	693.71	260	61.70	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1104.7	C08		9	0314-0695	888.76	694.75	257	61.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			365.3	C08		9	0315-0695	57.33	695.07	272	64.18	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			483.3	C08		9	0316-0699	199.59	698.64	226	56.67	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			288.8	C08		9	0317-0702	750.25	702.11	297	63.60	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2028.1	C08		9	0318-0703	950.13	704.06	183	53.70	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1555.1	C08		9	0319-0704	937.61	703.39	120	41.56	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			714.8	C08		9	0320-0707	214.24	708.02	262	62.18	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			344.0	D08		1	0001-0031	502.05	32.10	433	78.91	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			329.6	D08		1	0002-0035	683.37	35.30	402	74.43	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1732.7	D08		1	0003-0039	168.05	39.26	489	82.67	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			979.4	D08		1	0004-0037	106.24	37.36	378	72.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			530.6	D08		1	0005-0049	326.88	48.58	751	107.30	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			542.3	D08		1	0006-0044	231.54	43.76	386	72.67	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			470.3	D08		1	0007-0053	916.42	53.65	703	101.50	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			237.8	D08		1	0008-0051	573.73	51.36	507	86.18	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			710.7	D08		1	0009-0051	450.99	50.66	464	82.91	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			976.2	D08		1	0010-0054	799.48	53.77	390	77.26	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			259.0	D08		1	0011-0059	633.85	59.36	412	77.50	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			327.8	D08		1	0012-0069	747.78	68.50	777	107.05	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			575.7	D08		1	0013-0069	470.40	69.42	494	89.26	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			472.4	D08		1	0014-0072	394.62	72.16	441	76.43	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			312.8	D08		1	0015-0074	600.83	74.82	443	84.08	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1161.1	D08		1	0016-0076	493.85	76.67	503	87.60	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			389.8	D08		1	0017-0075	232.83	75.37	381	73.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			303.6	D08		1	0018-0075	574.54	74.86	434	79.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			394.3	D08		1	0019-0079	724.21	79.27	424	78.08	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			287.4	D08		1	0020-0082	109.11	82.07	363	71.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2149.2	D08		1	0021-0086	26.13	85.99	531	87.50	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			520.7	D08		1	0022-0086	935.26	86.56	381	73.50	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			397.1	D08		1	0023-0096	306.50	96.09	417	79.36	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			406.2	D08		1	0024-0106	533.49	106.01	807	108.23	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			347.1	D08		1	0025-0101	285.13	101.97	407	79.01	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			331.6	D08		1	0026-0103	635.68	103.29	852	117.54	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			347.6	D08		1	0027-0105	186.52	104.86	373	75.26	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			251.3	D08		1	0028-0108	789.69	108.23	359	73.60	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			844.5	D08		1	0029-0112	834.07	111.51	371	73.01	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			363.1	D08		1	0030-0113	391.56	113.78	401	74.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			508.9	D08		1	0031-0115	699.70	115.21	399	75.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			427.9	D08		1	0032-0123	159.83	123.97	830	116.37	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			852.4	D08		1	0033-0117	446.57	117.74	434	79.50	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			347.5	D08		1	0034-0120	612.49	120.72	422	79.15	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			380.4	D08		1	0035-0121	926.26	121.01	392	72.18	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1095.1	D08		1	0036-0123	73.44	123.49	376	71.01	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			780.8	D08		1	0037-0126	735.15	126.18	452	81.26	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1434.3	D08		1	0038-0134	420.57	133.51	950	125.88	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			285.2	D08		1	0039-0128	783.39	127.59	449	85.26	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2363.2	D08		1	0040-0144	506.95	143.84	677	95.50	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			504.5	D08		1	0041-0143	905.12	143.51	392	73.60	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			271.4	D08		1	0042-0142	824.88	142.30	383	75.26	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			409.2	D08		1	0043-0146	297.25	145.43	396	74.08	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			282.8	D08		1	0044-0158	642.35	158.75	393	74.67	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			316.9	D08		1	0045-0159	714.83	158.98	388	76.67	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1221.6	D08		1	0046-0164	277.35	164.21	729	105.05	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			523.3	D08		1	0047-0160	227.30	159.90	390	76.08	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			444.7	D08		1	0048-0166	117.67	165.95	373	72.67	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			333.5	D08		1	0049-0166	578.16	166.33	390	74.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			424.0	D08		1	0050-0180	678.45	180.31	399	78.33	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			416.7	D08		1	0051-0179	809.52	179.24	398	73.84	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			386.4	D08		1	0052-0180	338.38	179.91	418	81.01	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			702.2	D08		1	0053-0181	167.78	181.14	400	75.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			365.5	D08		1	0054-0182	444.35	182.31	382	73.84	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			388.4	D08		1	0055-0187	316.80	187.46	409	78.77	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			322.5	D08		1	0056-0187	207.94	187.03	397	77.50	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			422.8	D08		1	0057-0194	513.29	194.35	400	73.26	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			323.0	D08		1	0058-0197	940.92	197.02	399	76.43	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			782.0	D08		1	0059-0199	37.04	199.58	382	73.84	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			789.0	D08		1	0060-0209	253.78	208.26	925	123.78	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			361.3	D08		1	0061-0198	887.77	198.92	427	75.84	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			423.2	D08		1	0062-0199	798.35	199.86	390	73.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			457.1	D08		1	0063-0201	719.56	201.34	398	76.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			671.7	D08		1	0064-0206	71.18	205.95	602	90.91	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			350.0	D08		1	0065-0204	764.36	204.33	390	73.26	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			452.1	D08		1	0066-0207	562.41	208.31	379	75.94	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			298.7	D08		1	0067-0213	135.78	212.78	380	75.50	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			347.0	D08		1	0068-0221	927.57	220.99	385	72.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			725.7	D08		1	0069-0227	202.54	226.91	603	97.98	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			477.3	D08		1	0070-0224	615.97	224.41	409	76.67	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			361.5	D08		1	0071-0224	851.76	224.07	404	75.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1089.2	D08		1	0072-0232	271.35	234.30	725	103.78	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			362.4	D08		1	0073-0227	357.51	227.54	399	78.33	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			321.1	D08		1	0074-0229	482.77	228.83	357	74.18	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			430.5	D08		1	0075-0229	563.89	228.90	504	88.77	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			598.2	D08		1	0076-0238	890.09	239.12	727	104.13	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1856.3	D08		1	0077-0237	506.66	236.92	730	101.50	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			376.9	D08		1	0078-0240	540.09	240.67	552	94.91	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			620.2	D08		1	0079-0236	136.86	236.60	377	74.18	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1451.8	D08		1	0080-0242	58.13	242.18	440	77.84	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			503.2	D08		1	0081-0256	20.39	256.84	381	76.08	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			349.5	D08		1	0082-0258	459.44	258.25	392	73.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			321.5	D08		1	0083-0259	112.01	259.70	374	75.26	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			381.6	D08		1	0084-0271	746.54	271.87	414	75.60	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			550.6	D08		1	0085-0273	854.96	273.67	395	74.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			541.2	D08		1	0086-0279	180.41	278.30	384	73.01	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			380.8	D08		1	0087-0280	697.87	280.13	419	78.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			371.2	D08		1	0088-0281	315.70	280.31	405	76.67	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			343.0	D08		1	0089-0282	813.95	282.55	410	77.26	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			816.2	D08		1	0090-0287	936.07	287.70	382	73.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			382.6	D08		1	0091-0289	296.01	290.63	412	80.67	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			329.3	D08		1	0092-0294	641.46	293.41	420	77.26	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			760.7	D08		1	0093-0299	840.45	299.21	344	68.18	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			399.7	D08		1	0094-0300	899.82	300.36	385	72.43	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1530.9	D08		1	0095-0304	436.31	304.50	925	116.23	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			325.7	D08		1	0096-0303	219.20	302.97	382	71.60	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			319.0	D08		1	0097-0306	109.51	306.11	396	77.26	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			786.2	D08		1	0098-0310	175.48	310.67	613	96.81	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			303.2	D08		1	0099-0305	37.12	304.96	376	74.08	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			465.0	D08		1	0100-0309	549.31	309.07	383	71.60	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			667.1	D08		1	0101-0319	681.97	319.46	401	75.01	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			633.8	D08		1	0102-0319	393.65	319.13	386	73.84	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			245.1	D08		1	0103-0327	934.12	327.39	370	71.26	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			358.2	D08		1	0104-0333	774.77	333.03	392	73.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			545.7	D08		1	0105-0333	582.47	333.28	913	135.05	0.629
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			433.8	D08		1	0106-0336	729.96	335.83	392	73.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			284.0	D08		1	0107-0340	823.92	339.51	324	70.33	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			295.2	D08		1	0108-0344	144.33	344.39	395	74.08	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			298.9	D08		1	0109-0345	180.49	344.57	405	77.50	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			300.3	D08		1	0110-0347	37.82	347.41	374	73.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			558.6	D08		1	0111-0354	298.60	353.98	743	108.13	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			673.8	D08		1	0112-0351	352.83	351.52	398	74.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			465.8	D08		1	0113-0354	106.35	354.35	382	73.84	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1505.5	D08		1	0114-0357	622.14	357.04	652	97.98	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			320.6	D08		1	0115-0365	201.37	366.55	896	121.98	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			350.5	D08		1	0116-0370	707.79	370.13	433	79.50	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1925.4	D08		1	0117-0373	644.17	373.30	598	93.74	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2495.9	D08		1	0118-0373	567.86	374.36	591	92.18	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1177.1	D08		1	0119-0382	920.26	382.67	916	122.23	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			327.1	D08		1	0120-0375	771.27	375.83	427	77.50	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			473.9	D08		1	0121-0381	879.09	380.59	377	71.84	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			403.3	D08		1	0122-0383	134.35	382.33	377	72.91	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			359.5	D08		1	0123-0388	404.24	388.60	396	75.26	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			385.3	D08		1	0124-0397	151.05	397.56	433	81.15	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			448.8	D08		1	0125-0400	578.04	398.64	909	124.47	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			324.6	D08		1	0126-0397	686.35	397.94	414	75.84	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			355.0	D08		1	0127-0402	757.16	401.49	427	78.67	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			258.1	D08		1	0128-0407	603.82	407.99	414	77.74	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			306.1	D08		1	0129-0416	320.94	415.48	832	111.64	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			422.5	D08		1	0130-0412	201.41	411.91	398	75.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1090.5	D08		1	0131-0412	876.19	412.31	396	74.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			274.9	D08		1	0132-0420	769.40	420.86	452	86.91	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			349.8	D08		1	0133-0428	492.31	428.55	399	75.84	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			556.6	D08		1	0134-0433	432.61	433.37	389	73.84	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			689.0	D08		1	0135-0433	655.07	433.40	396	74.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			280.4	D08		1	0136-0446	370.45	445.64	871	123.88	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			439.3	D08		1	0137-0443	99.12	443.74	373	70.43	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			399.7	D08		1	0138-0446	931.58	445.38	330	72.77	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			322.9	D08		1	0139-0446	464.85	446.15	392	73.26	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			388.9	D08		1	0140-0449	914.46	449.53	412	80.18	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			282.4	D08		1	0141-0450	293.65	450.79	391	75.50	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1657.3	D08		1	0142-0453	562.54	453.36	701	99.64	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			572.6	D08		1	0143-0449	715.45	448.99	390	76.08	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			619.4	D08		1	0144-0454	142.77	454.03	401	77.50	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			268.4	D08		1	0145-0455	946.44	455.06	407	78.08	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			309.1	D08		1	0146-0465	186.09	465.22	378	73.50	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			313.3	D08		1	0147-0473	48.87	472.73	757	108.81	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			384.4	D08		1	0148-0468	763.11	467.65	373	73.26	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1196.5	D08		1	0149-0479	695.70	479.85	998	122.81	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			255.1	D08		1	0150-0476	640.27	476.07	384	73.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			273.8	D08		1	0151-0480	336.26	480.21	402	76.77	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1805.6	D08		1	0152-0483	393.22	482.93	564	89.98	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			314.4	D08		1	0153-0480	849.69	480.79	391	74.77	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1029.5	D08		1	0154-0484	443.37	484.11	426	77.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			354.3	D08		1	0155-0484	213.28	483.94	379	71.60	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			339.3	D08		1	0156-0487	770.70	487.97	410	79.15	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			373.3	D08		1	0157-0490	533.71	490.14	403	78.08	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			285.5	D08		1	0158-0489	573.51	488.99	384	74.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			275.3	D08		1	0159-0488	313.19	488.37	428	79.60	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			595.3	D08		1	0160-0497	87.71	497.66	366	71.84	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			339.6	D08		1	0161-0499	866.23	499.79	410	78.08	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			371.5	D08		1	0162-0499	922.02	498.94	359	69.60	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			242.5	D08		1	0163-0506	45.32	507.06	382	78.91	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			363.5	D08		1	0164-0508	817.58	507.77	374	72.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			280.1	D08		1	0165-0509	17.93	509.60	362	72.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			443.2	D08		1	0166-0510	188.53	509.87	383	71.84	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			757.9	D08		1	0167-0512	606.62	511.74	393	76.08	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			386.9	D08		1	0168-0513	745.60	513.60	376	73.01	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			478.7	D08		1	0169-0513	487.28	512.82	395	76.08	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			202.3	D08		1	0170-0517	895.51	516.63	393	75.50	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			248.6	D08		1	0171-0521	326.02	521.07	373	71.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			375.2	D08		1	0172-0523	118.03	523.23	386	72.18	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			375.9	D08		1	0173-0525	289.17	524.87	410	76.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			318.8	D08		1	0174-0525	420.66	525.54	395	76.08	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			319.3	D08		1	0175-0528	648.78	528.16	396	74.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			340.3	D08		1	0176-0530	163.13	530.49	391	74.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			507.9	D08		1	0177-0530	771.34	530.25	390	73.01	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			322.9	D08		1	0178-0533	199.57	533.05	381	73.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			241.1	D08		1	0179-0540	385.59	540.73	417	78.91	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			341.0	D08		1	0180-0539	543.36	539.82	398	75.84	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			323.9	D08		1	0181-0547	897.72	547.42	433	85.40	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			306.0	D08		1	0182-0544	40.20	544.43	338	70.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			374.2	D08		1	0183-0548	473.27	547.35	620	101.40	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			591.5	D08		1	0184-0562	275.66	562.66	620	92.91	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			412.0	D08		1	0185-0571	557.83	571.47	817	113.78	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1097.5	D08		1	0186-0565	658.42	565.82	393	73.84	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			358.7	D08		1	0187-0570	94.36	570.37	340	68.18	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			356.2	D08		1	0188-0570	756.96	569.72	404	76.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			364.9	D08		1	0189-0573	890.54	574.05	415	78.43	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			458.9	D08		1	0190-0575	718.87	575.35	418	79.15	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			822.9	D08		1	0191-0584	443.06	584.72	994	128.02	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			395.1	D08		1	0192-0581	202.82	581.40	407	77.84	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			331.2	D08		1	0193-0584	360.11	584.44	373	73.26	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			370.5	D08		1	0194-0585	610.58	584.79	382	73.26	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			369.3	D08		1	0195-0583	861.48	583.27	393	78.33	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			380.3	D08		1	0196-0591	809.80	591.24	406	78.91	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			335.7	D08		1	0197-0602	194.05	601.73	235	60.77	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			621.2	D08		1	0198-0606	401.04	605.93	421	77.26	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			308.9	D08		1	0199-0607	249.23	606.40	392	78.67	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			317.9	D08		1	0200-0607	715.39	607.94	388	76.67	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			334.1	D08		1	0201-0609	886.12	609.68	379	75.84	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			435.8	D08		1	0202-0613	662.08	613.08	400	74.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			295.2	D08		1	0203-0613	81.87	613.13	432	82.81	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			333.7	D08		1	0204-0619	359.78	619.40	408	77.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			263.5	D08		1	0205-0623	500.22	622.62	416	77.50	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			287.3	D08		1	0206-0632	54.26	631.53	380	72.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			264.6	D08		1	0207-0634	156.18	634.61	438	77.84	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			358.5	D08		1	0208-0632	314.53	632.31	371	75.60	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			359.9	D08		1	0209-0635	337.73	634.71	468	90.18	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			287.1	D08		1	0210-0639	845.81	638.80	759	104.33	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			289.0	D08		1	0211-0637	182.83	636.98	452	85.40	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			298.0	D08		1	0212-0638	479.84	638.61	466	84.91	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			301.3	D08		1	0213-0643	360.80	643.00	528	91.84	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			314.7	D08		1	0214-0643	403.72	643.53	391	72.43	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			318.3	D08		1	0215-0644	797.68	644.62	380	74.43	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			470.4	D08		1	0216-0648	23.17	647.57	369	76.18	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			312.8	D08		1	0217-0653	447.13	653.51	845	118.02	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			267.6	D08		1	0218-0650	266.50	650.23	286	67.60	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1082.8	D08		1	0219-0650	606.93	650.53	444	79.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			332.7	D08		1	0220-0654	76.29	654.09	364	70.43	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			302.8	D08		1	0221-0657	213.13	657.27	388	76.08	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			225.8	D08		1	0222-0660	914.73	660.25	368	72.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			406.5	D08		1	0223-0665	714.94	664.98	405	77.01	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			791.5	D08		1	0224-0666	743.38	666.07	459	82.91	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			370.6	D08		1	0225-0666	648.30	666.58	374	70.43	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2213.5	D08		1	0226-0675	326.89	674.93	673	97.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			456.6	D08		1	0227-0680	772.33	679.99	356	70.43	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			317.4	D08		1	0228-0688	812.57	689.08	726	108.43	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			246.1	D08		1	0229-0686	489.12	685.84	367	75.74	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1232.2	D08		1	0230-0687	143.02	687.83	440	78.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			230.1	D08		1	0231-0690	871.85	690.33	358	72.43	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			597.5	D08		1	0232-0690	191.96	690.27	398	77.50	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			321.0	D08		1	0233-0696	352.59	695.18	460	83.50	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			490.0	D08		1	0234-0700	530.30	700.74	818	111.88	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			267.3	D08		1	0235-0700	579.33	700.33	362	73.50	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			308.2	D08		1	0236-0705	67.56	705.01	383	74.08	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			340.3	D08		3	0001-0032	610.87	32.70	388	77.15	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			281.0	D08		3	0002-0038	761.28	37.99	356	70.43	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			317.6	D08		3	0003-0042	860.23	42.15	366	72.18	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			227.0	D08		3	0004-0041	227.10	41.65	345	72.67	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			345.5	D08		3	0005-0043	410.65	43.52	431	78.67	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			435.9	D08		3	0006-0044	45.88	44.22	373	79.60	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			297.2	D08		3	0007-0047	258.54	47.53	359	75.98	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			424.2	D08		3	0008-0045	550.76	44.87	362	72.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			593.8	D08		3	0009-0049	839.59	49.01	381	77.50	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			471.7	D08		3	0010-0051	694.22	51.36	349	70.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			232.3	D08		3	0011-0053	23.37	52.47	350	73.01	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			281.2	D08		3	0012-0055	131.62	55.52	364	76.67	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1313.8	D08		3	0013-0058	54.92	58.96	377	80.43	0.732
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			364.6	D08		3	0014-0064	74.21	63.65	384	77.26	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			397.1	D08		3	0015-0063	927.38	63.53	352	71.26	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			390.7	D08		3	0016-0065	350.14	65.53	386	73.84	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			509.6	D08		3	0017-0069	250.38	69.79	363	77.26	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			261.6	D08		3	0018-0067	904.78	67.76	366	72.33	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			495.2	D08		3	0019-0072	180.20	72.28	368	75.74	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			647.5	D08		3	0020-0072	231.46	72.41	371	74.87	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			368.9	D08		3	0021-0073	787.16	73.24	361	74.08	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2986.2	D08		3	0022-0080	733.46	80.24	325	113.64	0.316
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			259.0	D08		3	0023-0086	89.85	85.99	341	71.84	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			816.2	D08		3	0024-0091	165.10	92.46	712	105.40	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			404.2	D08		3	0025-0088	659.30	87.84	389	77.50	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			466.3	D08		3	0026-0087	685.00	87.49	373	74.33	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			979.7	D08		3	0027-0089	473.46	89.44	376	74.91	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			500.1	D08		3	0028-0091	502.43	91.20	384	76.91	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			346.5	D08		3	0029-0090	753.67	90.95	380	74.08	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			434.4	D08		3	0030-0093	429.24	93.02	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			551.2	D08		3	0031-0093	230.83	92.37	369	72.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			335.3	D08		3	0032-0097	546.64	97.18	360	72.67	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			336.5	D08		3	0033-0098	833.39	98.43	356	70.18	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			372.0	D08		3	0034-0105	125.31	106.25	731	109.54	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			368.9	D08		3	0035-0102	376.54	102.10	373	73.84	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			626.8	D08		3	0036-0106	904.74	106.07	302	66.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			384.8	D08		3	0037-0110	488.71	110.65	412	86.57	0.691
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			353.2	D08		3	0038-0113	641.59	113.02	367	75.84	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			400.3	D08		3	0039-0114	312.85	115.19	368	72.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			295.5	D08		3	0040-0116	69.56	116.39	359	76.33	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			240.8	D08		3	0041-0123	31.77	123.36	329	69.01	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			804.5	D08		3	0042-0121	723.76	121.05	350	73.84	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1819.1	D08		3	0043-0132	913.74	132.69	582	92.81	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			950.6	D08		3	0044-0129	456.50	128.80	387	75.50	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			334.1	D08		3	0045-0131	273.44	130.78	321	67.94	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			430.5	D08		3	0046-0132	293.91	132.21	440	84.67	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			389.3	D08		3	0047-0136	627.21	136.50	365	74.33	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			332.4	D08		3	0048-0138	384.28	138.48	386	75.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			329.9	D08		3	0049-0139	491.76	139.37	370	75.26	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			313.4	D08		3	0050-0142	83.52	141.45	354	71.01	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			396.4	D08		3	0051-0142	173.87	142.35	347	72.08	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			359.9	D08		3	0052-0141	810.52	140.67	331	69.84	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2172.8	D08		3	0053-0148	544.92	147.95	411	76.91	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			636.4	D08		3	0054-0150	859.07	149.48	299	66.18	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			918.7	D08		3	0055-0153	243.01	153.61	398	76.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			383.0	D08		3	0056-0154	761.70	154.94	330	68.28	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			398.8	D08		3	0057-0158	219.30	157.52	385	77.50	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1594.6	D08		3	0058-0163	139.16	162.74	404	77.26	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			588.8	D08		3	0059-0165	43.97	164.94	345	69.84	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			414.6	D08		3	0060-0169	414.27	168.40	409	78.91	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			397.5	D08		3	0061-0166	592.25	165.95	388	77.50	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1182.7	D08		3	0062-0171	912.62	171.55	375	73.50	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			401.7	D08		3	0063-0179	646.07	177.21	720	110.61	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			506.6	D08		3	0064-0173	850.67	172.97	350	69.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			651.5	D08		3	0065-0181	434.16	179.91	762	118.51	0.682
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1523.4	D08		3	0066-0175	759.81	175.04	560	90.18	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			357.8	D08		3	0067-0178	879.52	178.93	356	73.01	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			296.2	D08		3	0068-0178	341.98	177.70	347	70.43	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			312.9	D08		3	0069-0196	97.38	195.27	747	118.95	0.663
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			376.1	D08		3	0070-0195	488.00	194.77	353	72.67	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			693.7	D08		3	0071-0195	523.35	194.58	307	65.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			260.9	D08		3	0072-0197	687.05	197.04	347	73.26	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			382.5	D08		3	0073-0198	557.78	198.27	394	76.18	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			357.4	D08		3	0074-0202	742.04	202.12	370	73.26	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			257.5	D08		3	0075-0205	147.56	205.28	333	70.43	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			304.3	D08		3	0076-0206	387.38	207.07	366	76.33	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			275.8	D08		3	0077-0207	296.40	206.55	341	72.91	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			272.2	D08		3	0078-0210	650.95	210.77	392	76.43	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			345.4	D08		3	0079-0213	252.24	212.90	344	70.67	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			379.5	D08		3	0080-0212	787.19	212.30	356	70.18	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			208.0	D08		3	0081-0215	82.89	215.35	335	72.43	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			358.4	D08		3	0082-0215	903.13	215.44	324	71.26	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			327.2	D08		3	0083-0214	361.40	214.09	349	74.57	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			371.1	D08		3	0084-0220	196.70	219.96	359	72.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			278.7	D08		3	0085-0221	607.95	221.25	364	73.36	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			428.8	D08		3	0086-0224	414.68	224.53	323	67.01	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			373.0	D08		3	0087-0234	477.37	234.22	752	114.95	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			333.2	D08		3	0088-0233	941.28	233.09	368	71.01	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			270.0	D08		3	0089-0234	649.87	234.42	381	79.50	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			281.3	D08		3	0090-0235	41.27	235.00	329	71.74	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			434.0	D08		3	0091-0238	109.05	238.19	359	74.91	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			235.1	D08		3	0092-0244	607.29	243.39	370	77.36	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			310.4	D08		3	0093-0246	299.57	245.76	362	86.81	0.604
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			669.6	D08		3	0094-0245	164.28	245.60	361	72.43	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			272.4	D08		3	0095-0246	673.03	245.73	328	69.70	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			322.3	D08		3	0096-0247	762.15	246.68	347	68.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			345.2	D08		3	0097-0248	868.88	248.01	373	73.26	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			264.1	D08		3	0098-0249	373.11	248.75	358	76.33	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			314.7	D08		3	0099-0249	552.28	249.29	371	75.74	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			303.0	D08		3	0100-0251	693.24	251.37	374	76.18	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1325.8	D08		3	0101-0252	811.85	252.49	441	81.84	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			331.9	D08		3	0102-0258	249.65	258.22	341	71.84	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			327.1	D08		3	0103-0259	944.24	258.82	301	67.60	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			540.6	D08		3	0104-0265	587.53	265.22	377	73.26	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			277.4	D08		3	0105-0267	341.59	266.56	373	74.67	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			312.6	D08		3	0106-0268	312.72	268.76	348	77.50	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			237.4	D08		3	0107-0267	24.76	267.70	326	69.84	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			319.0	D08		3	0108-0283	649.13	284.09	965	130.61	0.711
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			276.4	D08		3	0109-0273	627.87	274.18	281	66.28	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			635.9	D08		3	0110-0277	156.82	276.89	359	72.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			469.7	D08		3	0111-0276	609.90	276.26	304	65.11	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			285.7	D08		3	0112-0282	79.15	282.69	371	75.50	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			981.9	D08		3	0113-0280	897.30	280.57	260	86.23	0.439
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			297.5	D08		3	0114-0281	410.64	281.07	378	75.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			395.6	D08		3	0115-0283	207.48	282.75	296	63.60	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			305.7	D08		3	0116-0280	688.08	279.99	198	53.60	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1207.7	D08		3	0117-0285	118.58	285.09	470	87.50	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			310.6	D08		3	0118-0288	850.70	288.52	361	72.08	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			516.0	D08		3	0119-0290	251.86	290.01	326	69.26	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			400.5	D08		3	0120-0295	573.61	295.23	352	70.67	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			486.2	D08		3	0121-0308	528.74	309.81	752	114.71	0.718
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			278.5	D08		3	0122-0303	354.73	302.37	387	81.74	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			281.3	D08		3	0123-0314	395.21	313.95	362	76.57	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			312.1	D08		3	0124-0313	466.54	313.88	394	77.50	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			256.3	D08		3	0125-0313	915.48	313.75	355	73.84	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			245.9	D08		3	0126-0316	28.55	315.24	376	77.98	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			561.8	D08		3	0127-0317	283.02	317.11	315	65.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			226.2	D08		3	0128-0319	102.04	319.05	333	71.01	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			315.4	D08		3	0129-0328	423.72	328.52	377	75.50	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			330.2	D08		3	0130-0330	854.33	329.72	363	74.91	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1798.8	D08		3	0131-0330	592.86	329.42	402	81.84	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			625.4	D08		3	0132-0332	142.97	332.76	382	76.08	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			320.9	D08		3	0133-0336	321.90	335.75	386	81.98	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2081.0	D08		3	0134-0338	833.06	338.06	514	88.67	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			334.3	D08		3	0135-0338	236.53	338.87	364	74.91	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			289.9	D08		3	0136-0339	675.27	339.86	348	71.84	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			292.8	D08		3	0137-0341	539.42	341.78	376	73.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			246.9	D08		3	0138-0342	45.16	342.09	343	72.67	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			272.3	D08		3	0139-0341	360.98	341.59	365	71.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			376.3	D08		3	0140-0342	741.96	343.01	367	72.43	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			474.8	D08		3	0141-0343	814.07	343.20	311	71.01	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			778.7	D08		3	0142-0352	180.69	352.91	376	80.91	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			270.1	D08		3	0143-0351	911.96	351.27	378	74.91	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			313.7	D08		3	0144-0354	313.52	354.52	377	78.33	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			190.4	D08		3	0145-0355	79.89	355.22	324	72.57	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			288.2	D08		3	0146-0364	113.88	364.88	334	72.91	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			404.2	D08		3	0147-0368	472.96	368.59	712	106.57	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			710.5	D08		3	0148-0373	521.62	372.76	374	76.33	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			320.4	D08		3	0149-0376	665.34	376.52	366	74.91	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			245.2	D08		3	0150-0376	394.46	376.46	359	71.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			290.6	D08		3	0151-0374	711.16	374.31	395	76.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			221.5	D08		3	0152-0378	147.07	378.11	334	78.57	0.680
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			259.8	D08		3	0153-0378	329.62	377.69	360	78.33	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			261.0	D08		3	0154-0382	866.90	381.25	375	76.91	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			319.5	D08		3	0155-0381	32.21	381.87	321	68.43	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1214.2	D08		3	0156-0381	919.31	381.04	350	70.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			378.6	D08		3	0157-0384	258.75	383.93	340	71.26	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			254.4	D08		3	0158-0388	195.57	388.17	350	74.33	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			716.3	D08		3	0159-0387	732.51	386.63	311	66.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			326.6	D08		3	0160-0389	547.02	389.11	374	74.91	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			329.4	D08		3	0161-0395	231.76	395.64	345	74.91	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			336.9	D08		3	0162-0395	819.43	395.72	362	71.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			386.7	D08		3	0163-0396	119.41	396.33	326	69.26	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			503.7	D08		3	0164-0398	477.43	398.21	310	64.77	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			691.9	D08		3	0165-0399	751.44	398.79	398	77.74	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1515.4	D08		3	0166-0402	304.30	401.92	380	73.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			261.4	D08		3	0167-0410	371.75	410.15	720	105.88	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			293.0	D08		3	0168-0403	438.20	403.57	370	74.08	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			363.4	D08		3	0169-0421	593.76	420.87	363	78.91	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			306.7	D08		3	0170-0421	718.80	421.57	380	77.15	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			307.6	D08		3	0171-0423	774.90	423.59	361	75.84	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			287.6	D08		3	0172-0428	33.62	428.69	325	72.91	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			251.1	D08		3	0173-0431	269.61	431.74	353	76.91	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			269.6	D08		3	0174-0431	528.13	432.17	372	77.94	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1270.5	D08		3	0175-0436	693.67	436.44	627	99.64	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			315.5	D08		3	0176-0447	421.89	446.54	748	106.95	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			289.0	D08		3	0177-0440	641.30	440.64	368	74.57	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			322.2	D08		3	0178-0446	162.63	445.35	712	105.88	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2206.0	D08		3	0179-0443	218.47	442.01	246	66.18	0.706
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1773.9	D08		3	0180-0444	231.04	446.37	219	63.70	0.678
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			217.8	D08		3	0181-0448	196.51	448.67	338	72.43	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			275.6	D08		3	0182-0447	315.10	447.79	367	74.91	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			260.3	D08		3	0183-0452	248.41	451.51	349	71.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			299.0	D08		3	0184-0455	527.89	453.68	409	81.84	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			505.3	D08		3	0185-0461	105.25	461.70	375	81.15	0.716
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			256.4	D08		3	0186-0463	71.14	463.23	353	73.26	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			268.1	D08		3	0187-0465	761.22	465.32	369	71.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			359.0	D08		3	0188-0473	624.44	473.31	375	72.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			265.1	D08		3	0189-0476	471.95	476.54	334	72.91	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			322.9	D08		3	0190-0475	851.66	474.90	353	71.01	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			212.3	D08		3	0191-0476	125.82	475.90	352	77.98	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1027.6	D08		3	0192-0482	929.08	482.82	380	78.33	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			268.5	D08		3	0193-0481	238.90	481.00	375	78.57	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			269.2	D08		3	0194-0484	565.52	484.47	368	73.26	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			359.4	D08		3	0195-0488	798.10	488.09	378	76.43	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			428.1	D08		3	0196-0490	720.05	490.02	371	72.67	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			300.5	D08		3	0197-0495	687.56	495.55	364	71.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			276.1	D08		3	0198-0502	601.36	502.21	361	73.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			300.2	D08		3	0199-0504	491.17	503.98	359	76.08	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			286.7	D08		3	0200-0507	230.55	507.90	370	78.33	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			329.9	D08		3	0201-0504	441.48	503.77	353	71.26	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			331.8	D08		3	0202-0506	356.38	506.34	353	72.43	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			607.7	D08		3	0203-0506	76.00	505.92	340	70.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			356.1	D08		3	0204-0510	806.46	509.69	392	81.40	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			285.8	D08		3	0205-0523	274.92	522.77	728	119.78	0.638
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			874.6	D08		3	0206-0520	851.06	520.43	723	112.13	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1407.3	D08		3	0207-0523	183.08	523.49	582	96.81	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			788.5	D08		3	0208-0520	757.32	519.80	372	73.60	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			321.9	D08		3	0209-0522	314.99	522.71	377	72.67	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			316.6	D08		3	0210-0522	481.03	522.56	359	72.67	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			306.5	D08		3	0211-0527	637.44	527.40	373	76.33	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			390.7	D08		3	0212-0525	673.36	524.83	333	68.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			335.0	D08		3	0213-0538	359.97	537.89	341	72.91	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			275.1	D08		3	0214-0537	580.54	536.99	352	72.67	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			264.8	D08		3	0215-0541	941.09	541.53	352	74.57	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			283.5	D08		3	0216-0542	537.15	541.76	363	72.67	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			268.6	D08		3	0217-0557	213.58	557.20	748	119.92	0.654
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			297.8	D08		3	0218-0553	484.31	553.43	396	77.26	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			299.3	D08		3	0219-0554	506.06	554.20	357	72.53	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			387.9	D08		3	0220-0556	736.72	556.00	352	72.91	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			369.4	D08		3	0221-0560	682.76	559.13	385	76.67	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			777.5	D08		3	0222-0561	74.33	561.65	327	68.67	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			939.7	D08		3	0223-0565	910.29	565.48	745	106.57	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			643.0	D08		3	0224-0565	782.87	565.60	625	96.57	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			278.2	D08		3	0225-0567	301.69	568.06	352	79.74	0.696
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			331.8	D08		3	0226-0569	343.30	569.80	330	68.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			407.3	D08		3	0227-0571	427.05	571.92	349	71.84	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			677.8	D08		3	0228-0587	52.37	586.47	695	104.57	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			291.8	D08		3	0229-0589	257.48	589.00	357	73.60	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			241.3	D08		3	0230-0588	216.44	588.13	373	76.08	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			376.7	D08		3	0231-0588	675.96	588.21	372	74.08	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			272.8	D08		3	0232-0589	132.62	588.97	371	74.91	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			993.8	D08		3	0233-0596	504.56	596.61	816	112.13	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			380.8	D08		3	0234-0590	747.04	590.11	349	71.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			330.8	D08		3	0235-0598	541.23	597.72	647	103.40	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			286.7	D08		3	0236-0596	632.60	596.40	377	78.57	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			276.8	D08		3	0237-0603	585.14	603.71	378	75.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			825.7	D08		3	0238-0600	373.07	600.30	254	59.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			381.8	D08		3	0239-0603	923.84	602.96	310	66.43	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			784.3	D08		3	0240-0604	114.56	604.19	360	79.15	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			483.6	D08		3	0241-0621	767.20	622.36	953	139.78	0.613
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			310.5	D08		3	0242-0608	873.87	607.69	343	75.15	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			305.7	D08		3	0243-0619	887.26	619.02	411	81.15	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			351.7	D08		3	0244-0617	824.32	617.02	347	70.67	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2024.3	D08		3	0245-0621	358.11	621.50	605	95.40	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			258.7	D08		3	0246-0620	736.77	620.01	369	81.98	0.690
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			804.1	D08		3	0247-0619	389.04	619.47	348	72.08	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			478.8	D08		3	0248-0626	210.28	626.97	308	71.36	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			307.9	D08		3	0249-0631	692.35	631.02	357	79.98	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			897.8	D08		3	0250-0632	846.96	632.32	249	57.36	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			290.0	D08		3	0251-0636	620.94	636.44	368	73.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			614.6	D08		3	0252-0638	328.05	638.02	417	85.15	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			498.1	D08		3	0253-0642	35.07	642.13	314	71.01	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			260.3	D08		3	0254-0643	168.48	643.62	337	71.50	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			488.1	D08		3	0255-0645	212.27	643.20	363	77.60	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1326.6	D08		3	0256-0650	129.25	650.17	437	81.74	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			787.5	D08		3	0257-0649	798.87	649.68	206	73.50	0.479
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			319.1	D08		3	0258-0654	92.12	653.99	352	70.67	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1410.5	D08		3	0259-0653	558.56	653.05	375	73.84	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			371.5	D08		3	0260-0653	675.92	653.29	342	73.84	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			354.8	D08		3	0261-0659	342.21	659.10	369	83.98	0.657
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			433.3	D08		3	0262-0660	203.39	661.36	396	79.98	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			673.3	D08		3	0263-0663	904.83	662.51	330	69.26	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			315.3	D08		3	0264-0667	947.34	667.52	341	73.84	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			366.9	D08		3	0265-0669	683.59	669.86	372	78.43	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			263.5	D08		3	0266-0674	610.07	674.02	369	74.91	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			408.3	D08		3	0267-0672	488.26	672.92	362	72.67	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			580.1	D08		3	0268-0675	720.71	675.02	357	74.67	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			313.7	D08		3	0269-0685	89.67	685.35	313	65.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			200.6	D08		3	0270-0684	138.76	684.98	315	66.43	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			694.8	D08		3	0271-0688	179.16	688.67	338	71.50	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			726.3	D08		3	0272-0690	896.32	690.52	318	72.33	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			327.9	D08		3	0273-0700	25.13	699.98	615	97.40	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			285.1	D08		3	0274-0697	699.75	697.18	375	76.08	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			617.8	D08		3	0275-0693	363.48	693.79	196	72.77	0.465
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			239.4	D08		3	0276-0707	831.30	707.12	348	71.70	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1253.6	D08		4	0001-0039	733.93	39.86	628	95.74	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1362.2	D08		4	0002-0049	816.27	48.21	984	128.23	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			330.4	D08		4	0003-0047	340.50	45.67	547	92.47	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			294.8	D08		4	0004-0045	603.98	44.77	467	82.91	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			291.7	D08		4	0005-0048	902.79	48.58	451	79.50	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			333.7	D08		4	0006-0049	366.86	49.04	475	82.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			306.4	D08		4	0007-0053	759.08	52.52	483	88.67	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1269.9	D08		4	0008-0055	249.77	55.49	442	78.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			291.7	D08		4	0009-0056	945.82	56.49	406	75.26	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			288.5	D08		4	0010-0056	99.02	56.17	435	83.50	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			318.9	D08		4	0011-0061	322.34	62.53	456	81.98	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			339.2	D08		4	0012-0064	75.47	64.64	501	87.94	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			382.6	D08		4	0013-0066	620.14	67.05	499	85.98	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			611.1	D08		4	0014-0071	446.82	70.23	938	125.44	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			278.8	D08		4	0015-0073	669.51	73.09	432	76.43	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			289.8	D08		4	0016-0077	835.66	77.03	516	88.71	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			273.1	D08		4	0017-0077	744.64	78.29	438	80.43	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			278.8	D08		4	0018-0080	545.97	80.59	922	121.30	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			241.8	D08		4	0019-0086	80.39	85.76	433	82.08	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1406.1	D08		4	0020-0090	179.51	90.53	727	103.64	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			256.1	D08		4	0021-0096	849.52	96.88	428	81.15	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			988.2	D08		4	0022-0097	118.83	97.58	763	103.40	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			282.9	D08		4	0023-0100	519.10	99.71	481	85.74	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			379.4	D08		4	0024-0100	348.91	100.90	383	75.50	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			241.5	D08		4	0025-0102	889.05	102.48	431	77.26	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			277.3	D08		4	0026-0105	706.22	105.50	424	76.67	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			183.7	D08		4	0027-0114	78.30	115.10	429	85.26	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			305.4	D08		4	0028-0113	624.49	113.53	484	84.33	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			237.9	D08		4	0029-0115	801.67	114.62	416	77.50	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1441.3	D08		4	0030-0116	387.80	116.12	561	90.08	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			287.1	D08		4	0031-0123	266.03	123.08	434	78.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			265.3	D08		4	0032-0124	770.35	123.97	438	80.91	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			239.1	D08		4	0033-0124	676.92	124.50	422	76.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			283.0	D08		4	0034-0142	319.72	142.15	433	79.74	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			294.7	D08		4	0035-0148	217.28	148.11	423	76.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			248.3	D08		4	0036-0153	718.54	153.51	431	82.77	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			232.6	D08		4	0037-0159	843.33	158.44	853	112.71	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			303.3	D08		4	0038-0158	145.77	159.32	864	116.23	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			339.9	D08		4	0039-0168	270.56	168.62	924	119.88	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1423.6	D08		4	0040-0168	358.99	168.27	488	84.33	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			254.2	D08		4	0041-0166	664.94	166.66	434	79.50	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			594.6	D08		4	0042-0172	406.55	172.28	479	82.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			296.8	D08		4	0043-0173	716.05	172.21	435	79.11	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			391.7	D08		4	0044-0175	24.26	175.99	395	75.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			300.1	D08		4	0045-0180	572.58	180.40	513	88.91	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			316.6	D08		4	0046-0181	609.93	180.72	439	78.08	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			315.0	D08		4	0047-0184	543.08	183.36	499	87.40	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			251.8	D08		4	0048-0185	883.86	185.73	451	79.26	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			303.5	D08		4	0049-0195	792.79	195.10	446	78.91	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			449.1	D08		4	0050-0195	215.19	194.82	391	71.60	0.958
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			489.0	D08		4	0051-0196	183.93	196.02	391	72.18	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			505.9	D08		4	0052-0198	266.48	198.05	625	94.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			205.7	D08		4	0053-0197	858.04	196.41	430	79.50	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			266.7	D08		4	0054-0201	452.45	201.56	438	79.50	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			260.9	D08		4	0055-0201	145.36	200.44	437	79.26	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			230.3	D08		4	0056-0202	916.56	202.45	431	77.26	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			275.0	D08		4	0057-0213	537.22	213.14	511	91.40	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			303.6	D08		4	0058-0212	735.76	212.22	435	81.50	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			340.9	D08		4	0059-0225	336.76	224.68	832	114.81	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			323.5	D08		4	0060-0227	206.08	226.23	399	79.15	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			252.8	D08		4	0061-0226	418.21	226.03	428	79.50	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			715.8	D08		4	0062-0227	890.19	227.21	818	116.67	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			249.8	D08		4	0063-0245	648.73	245.57	889	123.05	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			322.5	D08		4	0064-0239	554.99	239.38	488	86.33	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			271.1	D08		4	0065-0248	196.20	249.17	476	90.81	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			248.9	D08		4	0066-0249	602.93	249.45	434	78.33	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			218.0	D08		4	0067-0255	723.00	255.13	440	78.67	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			260.0	D08		4	0068-0258	391.21	258.14	441	77.26	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			179.3	D08		4	0069-0263	692.44	264.22	439	79.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			278.8	D08		4	0070-0268	225.86	267.89	430	78.91	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			275.4	D08		4	0071-0267	259.01	267.57	426	79.50	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			333.5	D08		4	0072-0273	54.20	273.66	414	80.33	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			357.1	D08		4	0073-0275	426.18	274.91	483	83.50	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			289.3	D08		4	0074-0282	565.08	282.42	965	129.78	0.720
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			819.1	D08		4	0075-0274	917.38	275.01	446	79.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			892.5	D08		4	0076-0276	842.17	276.79	446	82.91	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			319.8	D08		4	0077-0286	325.72	285.68	477	84.91	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			224.0	D08		4	0078-0291	690.26	290.59	484	87.01	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			506.8	D08		4	0079-0289	163.66	288.76	423	75.26	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			420.3	D08		4	0080-0295	69.01	296.21	555	93.01	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			289.5	D08		4	0081-0298	631.28	298.98	823	111.30	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			432.0	D08		4	0082-0297	92.75	297.45	410	76.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1108.2	D08		4	0083-0298	486.50	297.74	444	79.50	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			186.8	D08		4	0084-0296	730.71	296.02	421	77.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1898.0	D08		4	0085-0309	336.67	309.13	741	102.91	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			402.7	D08		4	0086-0310	792.80	310.62	440	79.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			238.2	D08		4	0087-0314	583.95	314.44	503	91.84	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			263.2	D08		4	0088-0319	915.92	319.07	927	119.20	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			245.3	D08		4	0089-0323	526.57	322.61	442	78.08	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			197.3	D08		4	0090-0329	369.87	328.39	447	80.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			242.2	D08		4	0091-0333	741.86	333.44	431	77.26	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			241.9	D08		4	0092-0335	405.26	335.05	449	79.50	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1066.9	D08		4	0093-0338	442.23	337.84	665	97.64	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			341.7	D08		4	0094-0339	696.49	338.86	459	81.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			204.0	D08		4	0095-0341	573.65	341.09	457	84.91	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			704.9	D08		4	0096-0341	279.50	340.56	475	82.91	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			297.4	D08		4	0097-0345	217.15	344.72	442	78.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			262.4	D08		4	0098-0350	353.90	350.58	483	87.74	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			250.7	D08		4	0099-0350	829.44	351.06	433	78.33	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			258.1	D08		4	0100-0357	882.34	358.36	885	117.54	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			261.9	D08		4	0101-0353	512.95	353.82	454	80.08	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			301.3	D08		4	0102-0357	263.78	357.96	479	86.23	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			276.2	D08		4	0103-0361	645.71	361.63	519	88.67	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			403.1	D08		4	0104-0364	616.45	364.48	490	86.57	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1491.4	D08		4	0105-0365	788.10	365.64	480	81.84	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			258.4	D08		4	0106-0369	420.08	369.56	434	79.26	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			679.2	D08		4	0107-0378	935.44	378.34	450	80.67	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			561.0	D08		4	0108-0378	149.62	378.56	429	75.84	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			262.2	D08		4	0109-0384	640.88	384.35	489	87.60	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			324.5	D08		4	0110-0384	307.53	384.07	449	79.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			947.1	D08		4	0111-0390	83.47	390.26	414	78.33	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1336.7	D08		4	0112-0398	358.78	397.74	826	108.47	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			211.7	D08		4	0113-0398	798.87	397.96	445	84.33	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			432.8	D08		4	0114-0402	595.24	401.63	512	86.23	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1805.0	D08		4	0115-0405	654.01	406.06	567	92.57	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1494.9	D08		4	0116-0405	260.98	405.31	536	88.57	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			340.1	D08		4	0117-0411	535.96	411.71	918	120.23	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1651.7	D08		4	0118-0415	484.12	415.53	806	109.74	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			351.1	D08		4	0119-0415	210.19	414.84	911	116.23	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			298.5	D08		4	0120-0419	869.62	418.01	472	82.08	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			819.3	D08		4	0121-0420	459.39	420.85	457	85.01	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			291.1	D08		4	0122-0423	568.03	423.12	489	85.01	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			658.2	D08		4	0123-0427	783.26	427.75	947	124.47	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			334.5	D08		4	0124-0426	125.16	426.22	419	76.91	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1085.8	D08		4	0125-0431	755.86	431.24	422	80.77	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			298.9	D08		4	0126-0432	385.87	432.72	436	78.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			284.9	D08		4	0127-0435	285.51	435.86	415	75.01	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			235.3	D08		4	0128-0441	66.09	440.53	406	76.43	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1514.9	D08		4	0129-0448	28.71	448.46	574	88.67	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			282.7	D08		4	0130-0449	849.09	449.39	468	81.26	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			282.7	D08		4	0131-0449	896.40	449.15	435	81.15	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			724.6	D08		4	0132-0455	176.90	455.44	435	78.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			282.1	D08		4	0133-0461	630.96	461.45	461	83.74	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			481.7	D08		4	0134-0465	564.54	465.61	437	78.08	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			299.6	D08		4	0135-0465	763.23	465.37	464	82.43	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			285.0	D08		4	0136-0472	232.27	472.22	487	86.57	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			360.0	D08		4	0137-0470	509.73	470.31	422	79.36	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			323.8	D08		4	0138-0469	699.93	469.21	469	81.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			360.2	D08		4	0139-0472	734.89	472.71	504	85.15	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			434.9	D08		4	0140-0473	528.11	473.56	367	75.94	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			938.3	D08		4	0141-0478	96.54	477.90	456	84.08	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			262.1	D08		4	0142-0476	414.40	476.81	439	79.50	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			333.8	D08		4	0143-0484	252.34	484.70	460	84.57	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			248.0	D08		4	0144-0488	937.61	487.58	406	76.08	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			269.7	D08		4	0145-0487	820.13	486.87	287	65.84	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			312.8	D08		4	0146-0491	902.85	490.85	434	78.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			269.3	D08		4	0147-0493	703.55	492.97	483	86.43	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			647.9	D08		4	0148-0496	143.65	496.51	421	78.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			297.2	D08		4	0149-0501	304.77	501.57	431	77.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			740.0	D08		4	0150-0506	60.78	505.86	443	79.26	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			266.1	D08		4	0151-0510	915.79	510.77	476	84.33	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			835.7	D08		4	0152-0512	522.77	512.19	463	82.57	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			270.1	D08		4	0153-0518	459.30	518.98	448	80.08	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1075.7	D08		4	0154-0525	620.07	525.23	571	92.33	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			289.5	D08		4	0155-0527	836.57	527.33	282	64.18	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			444.4	D08		4	0156-0529	360.05	529.94	429	79.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			489.4	D08		4	0157-0536	213.40	535.85	972	125.30	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			281.8	D08		4	0158-0534	407.41	533.57	504	85.74	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1245.3	D08		4	0159-0535	579.10	535.16	529	91.40	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			376.0	D08		4	0160-0534	23.69	534.42	407	75.26	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			288.6	D08		4	0161-0535	718.74	534.88	466	81.26	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			903.0	D08		4	0162-0550	73.80	550.34	433	80.08	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			395.9	D08		4	0163-0551	781.30	551.45	459	79.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			532.4	D08		4	0164-0552	361.37	551.17	526	89.60	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			303.3	D08		4	0165-0554	444.12	555.08	426	78.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			277.2	D08		4	0166-0560	496.05	559.90	449	79.26	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			286.0	D08		4	0167-0561	717.51	561.75	514	86.33	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			233.8	D08		4	0168-0562	409.60	562.68	472	82.33	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			332.0	D08		4	0169-0567	933.70	566.31	553	96.13	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			253.5	D08		4	0170-0565	628.41	565.59	465	80.67	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			234.7	D08		4	0171-0568	32.00	567.88	411	75.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			340.9	D08		4	0172-0573	259.57	571.93	451	81.40	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			504.5	D08		4	0173-0574	546.75	574.82	461	81.26	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			490.0	D08		4	0174-0577	109.77	577.72	423	75.26	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1274.6	D08		4	0175-0581	316.05	581.14	554	88.08	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1300.0	D08		4	0176-0584	909.84	584.85	803	114.95	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			274.2	D08		4	0177-0579	803.61	578.83	480	81.50	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			295.2	D08		4	0178-0581	649.40	580.88	509	88.81	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			307.6	D08		4	0179-0590	244.16	591.10	457	84.23	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			203.5	D08		4	0180-0594	470.06	594.13	422	77.01	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			251.0	D08		4	0181-0595	357.99	594.48	437	77.84	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			488.2	D08		4	0182-0601	707.62	600.99	472	81.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			787.7	D08		4	0183-0603	861.60	603.94	748	106.91	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			255.2	D08		4	0184-0602	593.70	602.36	432	78.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			376.8	D08		4	0185-0605	803.17	605.81	480	84.53	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			323.7	D08		4	0186-0605	189.40	604.80	467	80.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			245.0	D08		4	0187-0605	682.74	605.51	455	78.67	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			274.2	D08		4	0188-0608	829.34	608.71	803	110.53	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			229.5	D08		4	0189-0609	407.77	609.26	430	77.84	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			228.5	D08		4	0190-0617	48.28	617.11	419	76.08	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			373.3	D08		4	0191-0618	73.94	618.25	435	80.33	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			318.0	D08		4	0192-0620	534.59	620.39	454	83.15	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			305.2	D08		4	0193-0629	652.35	629.74	426	76.43	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			250.0	D08		4	0194-0630	464.45	630.65	459	81.50	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			247.4	D08		4	0195-0631	347.40	631.22	432	76.43	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1762.1	D08		4	0196-0637	166.84	637.00	673	98.81	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1005.6	D08		4	0197-0633	766.19	633.25	448	77.84	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			425.1	D08		4	0198-0637	824.14	634.50	444	83.50	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			241.0	D08		4	0199-0647	616.31	647.51	434	80.08	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			547.0	D08		4	0200-0648	893.26	647.73	452	83.74	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			259.4	D08		4	0201-0647	413.25	647.58	436	79.74	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			277.7	D08		4	0202-0649	811.68	650.31	462	82.47	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			353.7	D08		4	0203-0655	284.65	655.64	972	129.68	0.726
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			234.0	D08		4	0204-0650	16.51	650.72	409	75.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			467.6	D08		4	0205-0652	564.80	652.91	437	77.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			299.4	D08		4	0206-0655	245.76	654.93	477	87.40	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			268.2	D08		4	0207-0654	60.03	654.59	350	73.36	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1179.8	D08		4	0208-0664	490.73	665.09	551	88.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			442.7	D08		4	0209-0666	107.18	667.24	437	78.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			383.6	D08		4	0210-0670	130.35	670.03	437	81.01	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			368.8	D08		4	0211-0673	66.05	672.95	487	87.01	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			260.9	D08		4	0212-0675	315.43	675.38	458	79.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			233.8	D08		4	0213-0674	384.40	674.78	439	78.91	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			231.8	D08		4	0214-0676	671.90	676.16	437	77.84	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			313.3	D08		4	0215-0677	806.78	677.74	428	79.98	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			328.5	D08		4	0216-0678	219.18	677.65	431	79.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			499.1	D08		4	0217-0680	741.32	680.44	490	87.40	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			338.4	D08		4	0218-0687	521.67	686.81	448	80.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			356.1	D08		4	0219-0690	185.53	690.11	483	87.15	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			226.9	D08		4	0220-0691	426.22	691.59	414	78.18	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			267.0	D08		4	0221-0698	66.48	698.47	483	87.01	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			314.5	D08		4	0222-0697	210.17	697.67	479	90.91	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			201.1	D08		4	0223-0698	848.47	697.67	448	77.84	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			515.9	D08		4	0224-0707	801.44	707.13	338	68.77	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			300.8	D08		5	0001-0033	823.63	32.06	394	74.57	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			400.0	D08		5	0002-0040	391.44	40.78	457	81.84	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			287.6	D08		5	0003-0045	808.53	46.12	380	75.15	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			252.3	D08		5	0004-0045	921.84	46.04	389	78.18	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			403.4	D08		5	0005-0057	318.33	57.37	778	114.23	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			913.5	D08		5	0006-0057	470.15	57.03	421	78.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			273.3	D08		5	0007-0059	50.54	59.00	386	73.84	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			542.5	D08		5	0008-0059	875.92	59.73	269	82.67	0.495
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			406.9	D08		5	0009-0064	397.42	64.22	486	85.84	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			353.6	D08		5	0010-0072	670.92	70.92	819	114.67	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			386.3	D08		5	0011-0071	701.38	70.53	485	87.26	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			463.6	D08		5	0012-0078	543.90	78.14	825	118.71	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			706.1	D08		5	0013-0079	388.66	79.65	130	44.87	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			540.9	D08		5	0014-0085	382.58	87.38	154	58.53	0.565
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			804.1	D08		5	0015-0088	516.98	88.31	354	71.94	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			335.1	D08		5	0016-0093	277.12	93.36	398	75.50	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			266.4	D08		5	0017-0096	633.80	96.06	425	79.26	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			599.9	D08		5	0018-0092	945.00	92.43	416	78.43	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			271.8	D08		5	0019-0099	599.93	98.67	415	77.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			323.7	D08		5	0020-0098	798.67	98.19	423	77.84	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			338.6	D08		5	0021-0100	350.48	100.44	400	75.84	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			355.2	D08		5	0022-0103	71.65	102.95	395	74.67	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1740.6	D08		5	0023-0108	561.28	107.76	640	93.74	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1401.8	D08		5	0024-0112	237.80	112.01	503	85.60	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			351.5	D08		5	0025-0115	454.33	115.52	438	81.74	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			304.5	D08		5	0026-0117	179.42	116.83	392	74.67	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			264.9	D08		5	0027-0118	842.12	118.62	387	73.84	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1073.1	D08		5	0028-0128	945.20	127.33	658	98.67	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			393.2	D08		5	0029-0147	230.98	146.68	883	128.37	0.673
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			374.4	D08		5	0030-0139	417.82	138.92	432	76.43	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			261.0	D08		5	0031-0140	799.39	139.77	419	79.01	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			242.5	D08		5	0032-0143	72.31	143.04	380	72.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			297.8	D08		5	0033-0146	778.08	146.59	408	77.01	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			345.1	D08		5	0034-0149	501.54	148.63	457	80.08	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			287.5	D08		5	0035-0147	714.83	147.15	405	76.08	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			437.0	D08		5	0036-0160	304.21	160.53	837	111.54	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			310.7	D08		5	0037-0160	551.40	160.00	437	81.26	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			316.0	D08		5	0038-0159	625.81	159.03	413	75.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			358.2	D08		5	0039-0163	379.49	163.25	810	111.15	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			284.3	D08		5	0040-0174	218.07	175.08	417	82.33	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			260.0	D08		5	0041-0179	124.30	179.69	857	121.40	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			354.2	D08		5	0042-0182	593.02	181.99	397	76.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			208.8	D08		5	0043-0184	800.09	184.08	393	76.33	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			290.4	D08		5	0044-0195	190.64	195.14	411	81.74	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			317.2	D08		5	0045-0200	860.90	200.69	769	107.64	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			301.8	D08		5	0046-0195	714.01	195.36	418	78.43	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			215.3	D08		5	0047-0204	21.44	204.91	378	76.08	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			223.3	D08		5	0048-0205	71.47	204.85	372	72.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			200.5	D08		5	0049-0211	769.60	211.45	384	74.43	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			422.2	D08		5	0050-0211	468.68	211.28	418	76.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			294.1	D08		5	0051-0214	390.48	213.72	396	75.26	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			786.3	D08		5	0052-0214	734.86	213.37	442	81.01	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			325.1	D08		5	0053-0216	210.48	216.18	445	86.91	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			544.3	D08		5	0054-0212	116.41	212.94	148	51.70	0.696
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			315.4	D08		5	0055-0217	343.50	217.58	399	75.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			659.0	D08		5	0056-0219	649.48	218.86	377	75.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1233.5	D08		5	0057-0225	668.86	226.35	406	82.08	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			338.2	D08		5	0058-0233	554.22	233.81	778	108.23	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			384.4	D08		5	0059-0240	133.89	240.37	385	76.08	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			948.8	D08		5	0060-0248	172.10	248.69	390	74.08	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			788.6	D08		5	0061-0249	56.46	249.02	394	76.08	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			314.7	D08		5	0062-0252	262.48	252.37	426	77.01	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			620.0	D08		5	0063-0252	522.43	252.74	411	80.91	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			354.3	D08		5	0064-0259	941.70	259.65	758	108.71	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			346.8	D08		5	0065-0263	621.63	263.24	862	124.51	0.699
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			302.1	D08		5	0066-0268	474.24	267.82	820	112.81	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1014.5	D08		5	0067-0265	748.25	265.65	425	76.67	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			257.9	D08		5	0068-0268	784.21	268.90	423	82.57	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			695.5	D08		5	0069-0274	346.42	275.00	450	80.43	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			446.2	D08		5	0070-0280	397.61	280.07	764	105.54	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			252.5	D08		5	0071-0274	865.76	273.84	395	74.08	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			203.8	D08		5	0072-0278	121.12	277.83	379	73.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			777.5	D08		5	0073-0277	22.55	277.44	368	73.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			301.6	D08		5	0074-0285	547.62	284.98	407	77.74	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			477.1	D08		5	0075-0285	323.56	284.72	457	81.26	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			308.4	D08		5	0076-0287	260.67	287.23	413	79.50	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1033.0	D08		5	0077-0301	806.06	301.60	896	117.40	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			304.0	D08		5	0078-0301	685.93	301.04	293	63.94	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			257.8	D08		5	0079-0310	430.22	310.43	398	80.33	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			504.0	D08		5	0080-0316	97.58	316.25	428	80.33	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			979.3	D08		5	0081-0314	859.62	313.58	405	78.57	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			230.5	D08		5	0082-0321	21.04	321.60	824	115.68	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			440.5	D08		5	0083-0314	518.69	314.61	381	77.84	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			346.6	D08		5	0084-0323	283.64	323.05	405	78.08	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			274.7	D08		5	0085-0327	344.62	327.27	406	78.33	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			317.1	D08		5	0086-0328	873.27	329.35	403	77.50	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			512.1	D08		5	0087-0330	907.98	329.91	310	64.77	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			295.7	D08		5	0088-0333	223.33	333.96	410	75.26	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1787.5	D08		5	0089-0337	410.57	337.30	756	107.74	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			230.3	D08		5	0090-0338	169.04	337.99	379	77.50	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			605.5	D08		5	0091-0336	660.17	336.80	610	97.15	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			371.5	D08		5	0092-0343	929.00	343.31	782	113.88	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			271.0	D08		5	0093-0344	722.89	344.38	405	76.67	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1350.1	D08		5	0094-0351	438.25	351.57	739	106.57	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			272.5	D08		5	0095-0346	552.67	346.48	413	77.26	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			255.5	D08		5	0096-0347	786.35	346.22	441	83.60	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			243.0	D08		5	0097-0354	761.47	354.39	397	77.84	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			196.1	D08		5	0098-0359	854.76	359.24	407	77.50	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			262.8	D08		5	0099-0360	135.44	360.45	392	76.91	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			383.4	D08		5	0100-0363	589.18	362.90	402	74.43	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			616.2	D08		5	0101-0367	273.26	367.66	450	81.74	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			247.8	D08		5	0102-0365	897.87	364.97	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			398.7	D08		5	0103-0376	484.26	375.96	819	108.71	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			249.4	D08		5	0104-0375	377.85	374.63	416	78.08	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			677.5	D08		5	0105-0378	304.46	378.42	424	78.67	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			716.5	D08		5	0106-0380	40.49	380.98	425	78.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			238.5	D08		5	0107-0386	833.52	386.16	399	75.84	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			294.9	D08		5	0108-0388	630.64	387.98	450	82.33	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			280.3	D08		5	0109-0396	411.42	396.40	397	76.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			259.4	D08		5	0110-0401	740.54	401.57	418	77.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			274.9	D08		5	0111-0404	366.68	404.38	414	76.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			208.5	D08		5	0112-0406	217.90	406.82	369	74.67	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			249.7	D08		5	0113-0408	175.02	408.75	399	76.91	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			352.3	D08		5	0114-0411	715.24	410.60	451	84.33	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			237.5	D08		5	0115-0412	535.17	412.48	466	85.15	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			284.6	D08		5	0116-0418	907.23	417.81	194	52.53	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			985.5	D08		5	0117-0426	802.16	426.03	435	81.74	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			245.3	D08		5	0118-0427	257.71	426.72	386	73.84	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			282.8	D08		5	0119-0427	610.99	426.01	452	86.57	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			227.8	D08		5	0120-0427	511.47	427.34	436	80.91	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			547.9	D08		5	0121-0426	869.44	427.90	301	66.28	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			238.7	D08		5	0122-0430	942.75	429.56	334	72.77	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			264.4	D08		5	0123-0433	475.18	432.91	417	79.50	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			270.1	D08		5	0124-0438	60.42	438.38	370	77.50	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			268.5	D08		5	0125-0443	929.10	443.80	381	72.91	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			232.6	D08		5	0126-0447	231.28	446.57	418	88.08	0.677
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			518.8	D08		5	0127-0447	869.40	446.16	338	70.87	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			217.1	D08		5	0128-0455	318.95	455.36	393	78.33	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1223.7	D08		5	0129-0462	835.61	462.47	606	91.50	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			331.5	D08		5	0130-0461	121.51	461.01	426	79.50	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			614.8	D08		5	0131-0460	443.24	460.54	409	77.50	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			285.2	D08		5	0132-0462	254.37	461.53	431	78.43	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			317.6	D08		5	0133-0466	215.21	467.13	426	78.91	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			864.7	D08		5	0134-0467	783.67	467.61	406	76.67	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			719.4	D08		5	0135-0472	525.52	471.82	416	76.91	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			262.3	D08		5	0136-0482	99.73	482.31	414	75.26	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			590.1	D08		5	0137-0485	143.43	484.89	386	75.26	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			411.4	D08		5	0138-0485	294.49	485.32	292	62.77	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			250.2	D08		5	0139-0490	42.99	490.22	383	74.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			269.1	D08		5	0140-0493	370.45	493.36	377	74.91	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			241.7	D08		5	0141-0496	644.54	496.59	415	76.91	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			234.0	D08		5	0142-0498	489.71	498.57	453	82.33	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			251.8	D08		5	0143-0502	831.89	502.01	368	72.67	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			207.8	D08		5	0144-0505	939.56	504.88	436	78.08	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			432.3	D08		5	0145-0508	68.46	508.47	432	79.94	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1486.3	D08		5	0146-0511	887.28	511.66	578	90.08	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			210.8	D08		5	0147-0513	20.77	513.26	404	82.08	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			247.2	D08		5	0148-0521	754.52	520.67	409	79.50	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			307.5	D08		5	0149-0523	586.44	523.30	406	78.57	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			278.6	D08		5	0150-0524	298.76	524.83	424	77.26	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			225.2	D08		5	0151-0525	442.76	524.94	407	78.67	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			223.0	D08		5	0152-0528	529.27	528.32	415	77.50	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1090.9	D08		5	0153-0532	108.82	532.31	738	105.64	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			306.4	D08		5	0154-0531	148.05	531.10	448	80.57	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			184.3	D08		5	0155-0529	482.41	529.37	398	74.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			229.8	D08		5	0156-0530	666.31	530.21	407	77.50	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			243.9	D08		5	0157-0531	67.98	529.96	405	77.36	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			221.4	D08		5	0158-0535	709.02	534.75	398	76.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			253.6	D08		5	0159-0550	905.81	549.96	845	121.64	0.718
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			435.2	D08		5	0160-0541	804.22	541.10	367	73.26	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			349.7	D08		5	0161-0543	390.29	543.81	425	79.01	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			245.1	D08		5	0162-0553	412.75	553.04	430	81.26	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			239.4	D08		5	0163-0559	149.09	559.16	557	89.98	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			240.5	D08		5	0164-0560	464.84	560.33	400	78.33	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			247.7	D08		5	0165-0569	757.35	568.12	809	107.88	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			300.7	D08		5	0166-0564	348.33	564.29	444	81.98	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			291.8	D08		5	0167-0569	39.10	568.04	453	84.47	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			222.6	D08		5	0168-0567	599.41	567.21	398	75.84	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			257.1	D08		5	0169-0582	279.61	582.60	861	126.71	0.674
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			384.7	D08		5	0170-0581	25.58	580.97	352	75.15	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			202.7	D08		5	0171-0579	110.23	579.37	378	73.84	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			369.9	D08		5	0172-0581	667.06	581.06	445	80.57	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			277.9	D08		5	0173-0584	58.54	584.46	433	79.15	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			271.8	D08		5	0174-0598	387.24	598.06	913	122.51	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			393.3	D08		5	0175-0592	848.30	591.58	355	69.01	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			240.4	D08		5	0176-0601	452.23	600.94	405	78.57	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			602.6	D08		5	0177-0604	636.33	604.11	417	77.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			227.7	D08		5	0178-0605	707.85	604.88	396	75.84	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			260.1	D08		5	0179-0603	894.34	602.57	424	80.67	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			548.9	D08		5	0180-0611	815.51	611.80	316	65.60	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			317.8	D08		5	0181-0617	749.57	616.84	418	75.84	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			226.6	D08		5	0182-0619	670.03	619.32	407	77.50	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			600.4	D08		5	0183-0627	85.01	627.41	849	117.20	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			386.5	D08		5	0184-0623	380.27	623.57	412	79.98	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			394.7	D08		5	0185-0624	486.57	623.68	408	75.50	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			819.9	D08		5	0186-0636	229.62	636.89	400	80.23	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			295.5	D08		5	0187-0637	896.43	636.89	386	74.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			265.7	D08		5	0188-0639	432.10	639.78	760	107.01	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1473.8	D08		5	0189-0641	399.89	641.34	684	104.91	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			330.0	D08		5	0190-0639	702.72	639.73	363	71.70	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			350.8	D08		5	0191-0641	684.59	641.16	340	70.04	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			532.7	D08		5	0192-0641	833.67	641.18	407	77.26	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			331.1	D08		5	0193-0641	578.90	641.25	386	74.67	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			270.0	D08		5	0194-0644	503.10	644.83	399	75.84	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			345.6	D08		5	0195-0646	792.39	647.04	771	113.05	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			290.3	D08		5	0196-0651	154.62	650.94	391	77.84	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			263.4	D08		5	0197-0653	362.74	653.67	433	81.50	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			256.9	D08		5	0198-0669	557.75	669.58	859	118.02	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			213.8	D08		5	0199-0667	730.14	666.77	409	76.33	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			303.9	D08		5	0200-0669	620.03	669.13	394	76.33	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			205.1	D08		5	0201-0668	678.40	668.34	407	77.26	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			248.6	D08		5	0202-0675	431.90	674.98	414	76.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			225.6	D08		5	0203-0674	318.41	674.03	391	77.01	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			238.0	D08		5	0204-0680	259.83	680.16	394	74.67	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			223.9	D08		5	0205-0682	774.12	682.45	378	72.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			197.6	D08		5	0206-0694	727.59	694.73	419	81.15	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			468.3	D08		5	0207-0694	519.50	694.35	396	74.67	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1387.6	D08		5	0208-0699	210.55	699.05	729	105.88	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			225.1	D08		5	0209-0698	806.63	698.16	371	73.26	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			287.3	D08		5	0210-0704	886.47	704.50	369	71.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			245.2	D08		5	0211-0706	606.42	706.48	384	75.50	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			254.7	D08		6	0001-0031	828.76	31.67	370	71.94	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			265.3	D08		6	0002-0037	847.51	38.12	368	77.60	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			261.9	D08		6	0003-0036	327.60	35.24	339	72.43	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			263.1	D08		6	0004-0042	302.39	41.52	863	121.78	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			580.4	D08		6	0005-0040	923.26	40.40	314	67.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			376.9	D08		6	0006-0048	798.39	47.76	768	107.98	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			216.7	D08		6	0007-0042	130.25	42.06	351	69.60	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1014.8	D08		6	0008-0045	391.38	45.09	404	77.50	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			613.1	D08		6	0009-0049	556.89	49.61	411	80.43	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			241.6	D08		6	0010-0048	597.94	48.65	393	75.50	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			167.1	D08		6	0011-0048	16.62	48.20	323	75.01	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			389.5	D08		6	0012-0053	446.87	53.50	949	121.15	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1060.8	D08		6	0013-0051	666.15	50.88	389	74.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			297.5	D08		6	0014-0065	197.75	64.91	752	110.71	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			258.9	D08		6	0015-0066	900.72	66.61	403	75.84	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			292.5	D08		6	0016-0075	285.42	75.45	803	119.44	0.707
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			324.5	D08		6	0017-0073	628.35	74.13	785	115.64	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			357.7	D08		6	0018-0074	434.92	74.70	330	70.77	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			725.1	D08		6	0019-0078	746.11	77.93	391	73.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			313.3	D08		6	0020-0087	113.81	87.17	714	109.40	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			261.5	D08		6	0021-0082	859.99	81.94	372	74.91	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1255.8	D08		6	0022-0085	374.04	84.87	392	73.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			390.0	D08		6	0023-0094	723.11	93.67	421	78.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			209.3	D08		6	0024-0093	487.55	92.71	394	76.43	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			304.1	D08		6	0025-0094	774.76	94.30	418	78.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			566.8	D08		6	0026-0095	39.55	95.36	380	73.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			936.2	D08		6	0027-0102	836.77	101.45	590	115.05	0.560
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			548.6	D08		6	0028-0099	255.89	99.19	382	75.50	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			368.4	D08		6	0029-0100	595.90	99.78	365	72.67	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			242.9	D08		6	0030-0109	422.07	109.20	401	74.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			401.3	D08		6	0031-0126	484.81	126.11	881	126.71	0.690
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			949.2	D08		6	0032-0131	39.36	130.44	645	96.08	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			207.2	D08		6	0033-0131	549.78	131.58	381	73.84	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			320.7	D08		6	0034-0131	623.75	131.32	378	73.01	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			260.8	D08		6	0035-0132	172.95	132.44	376	77.26	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			788.9	D08		6	0036-0138	663.74	138.16	402	76.08	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			272.4	D08		6	0037-0140	893.42	140.11	365	71.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			792.5	D08		6	0038-0141	808.06	140.48	388	75.84	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			256.8	D08		6	0039-0144	271.47	144.83	389	76.57	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			352.5	D08		6	0040-0146	420.14	146.29	720	105.98	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			445.3	D08		6	0041-0145	457.69	145.41	336	70.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			340.1	D08		6	0042-0145	731.89	144.61	357	71.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			287.7	D08		6	0043-0147	106.08	147.62	398	74.67	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			247.3	D08		6	0044-0146	132.63	146.74	389	80.57	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1366.9	D08		6	0045-0148	301.61	148.60	373	73.50	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			229.7	D08		6	0046-0148	505.48	148.16	399	77.01	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			287.3	D08		6	0047-0149	838.37	149.10	369	72.67	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			320.8	D08		6	0048-0153	190.42	152.90	356	80.43	0.692
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			264.0	D08		6	0049-0159	767.90	159.50	381	75.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			310.4	D08		6	0050-0159	605.24	159.53	411	76.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			803.2	D08		6	0051-0163	326.95	162.93	371	72.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			279.8	D08		6	0052-0162	560.70	162.97	397	76.67	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			766.1	D08		6	0053-0165	928.56	164.82	391	73.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			291.9	D08		6	0054-0167	685.73	167.59	399	73.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			241.5	D08		6	0055-0167	474.63	166.86	391	76.18	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			250.9	D08		6	0056-0171	364.60	171.26	369	73.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			336.8	D08		6	0057-0177	70.64	177.11	396	78.18	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			303.8	D08		6	0058-0178	578.94	178.43	399	75.84	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			474.1	D08		6	0059-0178	93.26	177.67	356	71.94	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			264.4	D08		6	0060-0180	519.28	180.24	369	71.26	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			595.6	D08		6	0061-0188	811.84	187.98	356	71.60	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			264.8	D08		6	0062-0188	732.47	188.22	376	73.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			459.6	D08		6	0063-0188	398.67	187.91	374	72.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			293.6	D08		6	0064-0188	459.42	188.42	391	75.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			310.6	D08		6	0065-0192	707.38	192.26	387	74.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			315.9	D08		6	0066-0194	832.11	193.10	379	75.84	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			270.5	D08		6	0067-0201	129.67	201.14	384	77.26	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			229.8	D08		6	0068-0203	551.30	203.08	376	73.50	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			354.7	D08		6	0069-0204	902.38	204.65	333	66.77	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			284.7	D08		6	0070-0206	355.13	206.40	358	74.43	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			682.2	D08		6	0071-0212	635.35	212.48	399	75.01	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			252.0	D08		6	0072-0214	848.73	215.28	377	77.60	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			290.3	D08		6	0073-0218	932.27	216.97	345	69.26	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			266.5	D08		6	0074-0220	522.35	220.95	391	73.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			455.5	D08		6	0075-0221	324.97	222.47	425	81.01	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			283.0	D08		6	0076-0230	353.42	229.76	822	112.23	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			239.5	D08		6	0077-0233	441.72	232.72	428	80.91	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			250.4	D08		6	0078-0234	887.17	234.36	369	71.36	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			433.5	D08		6	0079-0237	83.22	237.34	399	76.67	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			219.4	D08		6	0080-0240	933.40	241.20	378	72.08	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			300.9	D08		6	0081-0243	854.49	242.67	365	73.84	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			287.1	D08		6	0082-0245	401.20	245.71	365	71.84	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			250.2	D08		6	0083-0244	460.99	244.95	355	75.60	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			195.5	D08		6	0084-0250	217.98	250.08	357	76.33	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			338.8	D08		6	0085-0253	628.92	252.95	378	72.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			233.8	D08		6	0086-0253	263.39	253.75	360	73.26	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			350.0	D08		6	0087-0262	36.17	262.36	722	103.05	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			260.7	D08		6	0088-0260	310.00	260.65	362	73.50	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			245.4	D08		6	0089-0260	102.18	261.17	346	70.43	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			439.3	D08		6	0090-0268	185.69	268.48	884	146.51	0.518
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			278.4	D08		6	0091-0263	454.94	263.11	449	84.67	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			531.7	D08		6	0092-0262	553.62	262.03	325	66.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			281.8	D08		6	0093-0270	678.00	270.01	375	72.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			439.4	D08		6	0094-0273	586.06	273.25	364	72.08	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			342.9	D08		6	0095-0275	369.55	275.52	397	75.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			567.2	D08		6	0096-0276	849.51	275.27	363	72.91	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			207.3	D08		6	0097-0278	235.02	278.33	349	72.43	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			235.1	D08		6	0098-0284	128.71	284.50	355	74.08	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			688.3	D08		6	0099-0287	632.49	287.12	274	61.84	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			353.4	D08		6	0100-0292	864.52	292.16	407	77.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			352.2	D08		6	0101-0296	383.05	296.44	374	73.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			376.0	D08		6	0102-0297	407.90	296.89	387	73.01	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			307.4	D08		6	0103-0297	509.90	297.42	392	72.43	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			300.4	D08		6	0104-0298	44.09	298.72	352	72.08	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			255.9	D08		6	0105-0303	766.26	302.90	352	73.26	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			275.1	D08		6	0106-0310	276.35	310.18	394	75.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			269.5	D08		6	0107-0310	593.44	310.26	370	72.67	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			344.6	D08		6	0108-0310	548.75	310.52	382	74.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			502.0	D08		6	0109-0311	832.11	310.47	382	73.26	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			995.8	D08		6	0110-0315	475.27	315.03	395	74.18	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1887.5	D08		6	0111-0319	683.10	318.92	642	100.47	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			226.2	D08		6	0112-0319	301.13	319.45	382	73.84	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1004.9	D08		6	0113-0327	211.18	328.27	839	117.88	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			318.3	D08		6	0114-0320	566.22	320.72	385	75.50	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			448.5	D08		6	0115-0320	898.68	319.64	306	67.84	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			575.1	D08		6	0116-0322	354.69	321.99	394	75.50	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			527.1	D08		6	0117-0322	717.14	322.36	564	101.26	0.691
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			243.2	D08		6	0118-0328	640.59	328.33	362	75.26	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			284.0	D08		6	0119-0334	269.16	334.69	433	86.08	0.734
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			328.5	D08		6	0120-0332	495.27	331.52	399	74.18	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			300.3	D08		6	0121-0337	817.75	337.00	419	78.33	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			575.9	D08		6	0122-0339	909.62	339.16	468	81.74	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			409.6	D08		6	0123-0340	792.67	339.73	461	82.33	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			326.2	D08		6	0124-0346	23.77	346.14	733	109.64	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			278.7	D08		6	0125-0347	629.09	348.15	482	91.15	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			733.5	D08		6	0126-0349	772.87	349.59	347	73.74	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			409.4	D08		6	0127-0350	932.91	350.68	699	110.81	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1059.3	D08		6	0128-0353	876.46	352.96	385	73.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			306.9	D08		6	0129-0358	727.31	358.52	378	72.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			317.4	D08		6	0130-0371	408.14	370.44	795	118.02	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1726.1	D08		6	0131-0366	226.35	365.77	908	116.33	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			379.8	D08		6	0132-0372	118.56	372.22	342	68.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			245.6	D08		6	0133-0380	171.75	380.43	359	71.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			538.4	D08		6	0134-0381	686.19	380.93	378	72.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			271.7	D08		6	0135-0386	356.86	385.91	362	71.84	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			324.2	D08		6	0136-0386	898.63	385.61	350	70.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			256.3	D08		6	0137-0389	582.02	388.69	403	77.26	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			276.4	D08		6	0138-0393	465.08	393.73	397	76.33	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			273.4	D08		6	0139-0396	531.89	396.65	383	73.60	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			414.1	D08		6	0140-0398	404.18	398.80	397	75.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			307.1	D08		6	0141-0399	263.14	398.89	376	72.43	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			246.9	D08		6	0142-0406	755.66	406.81	828	112.81	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			860.9	D08		6	0143-0400	846.75	399.69	373	72.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			249.1	D08		6	0144-0404	713.06	404.11	418	78.91	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			261.1	D08		6	0145-0406	671.17	405.85	361	71.26	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			293.3	D08		6	0146-0413	138.98	413.47	371	79.74	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			308.4	D08		6	0147-0418	488.43	418.69	409	76.08	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			252.3	D08		6	0148-0420	205.89	419.93	366	72.67	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			750.3	D08		6	0149-0430	813.04	431.09	381	73.26	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			293.6	D08		6	0150-0431	347.02	431.33	380	73.01	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			239.5	D08		6	0151-0432	434.56	432.26	372	75.26	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			307.7	D08		6	0152-0433	386.89	433.27	332	67.01	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			299.2	D08		6	0153-0436	534.23	436.43	387	74.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			293.1	D08		6	0154-0436	566.83	435.94	392	77.50	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			318.9	D08		6	0155-0448	223.60	447.98	776	111.20	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			240.5	D08		6	0156-0444	25.13	445.46	410	79.64	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			703.5	D08		6	0157-0442	879.80	442.45	368	73.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			292.8	D08		6	0158-0453	629.25	451.93	805	122.61	0.673
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			558.8	D08		6	0159-0450	286.83	449.76	498	109.40	0.523
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			370.4	D08		6	0160-0455	546.95	455.76	440	81.26	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			287.4	D08		6	0161-0473	695.65	471.41	849	123.44	0.700
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			323.7	D08		6	0162-0463	767.08	463.73	453	79.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			329.9	D08		6	0163-0470	934.85	469.19	674	102.33	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			359.6	D08		6	0164-0464	910.91	463.51	355	70.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			251.5	D08		6	0165-0469	376.31	469.53	372	70.18	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			370.1	D08		6	0166-0471	177.58	471.75	413	78.67	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			244.6	D08		6	0167-0472	54.05	472.63	343	69.01	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			922.7	D08		6	0168-0475	592.81	474.91	415	75.26	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			267.8	D08		6	0169-0480	324.79	480.81	759	105.74	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			280.6	D08		6	0170-0479	435.04	479.50	376	72.18	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			240.8	D08		6	0171-0483	813.03	483.23	375	74.43	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			975.8	D08		6	0172-0490	770.88	489.39	662	102.91	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			269.1	D08		6	0173-0486	201.54	486.03	380	75.60	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			399.3	D08		6	0174-0487	278.85	487.89	358	69.84	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			287.8	D08		6	0175-0490	245.27	490.50	362	71.84	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1224.8	D08		6	0176-0491	477.77	491.04	428	78.08	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			249.4	D08		6	0177-0498	678.58	499.23	426	79.74	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			229.7	D08		6	0178-0503	118.99	502.66	441	82.57	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			200.5	D08		6	0179-0501	369.40	501.07	369	71.01	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			232.9	D08		6	0180-0503	572.50	503.11	376	74.08	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			281.0	D08		6	0181-0507	34.40	507.78	383	74.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			268.6	D08		6	0182-0509	934.67	508.54	372	73.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			430.2	D08		6	0183-0515	705.36	514.46	392	76.08	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			285.6	D08		6	0184-0512	735.76	512.62	377	75.26	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			405.8	D08		6	0185-0515	198.35	514.67	343	69.60	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			265.4	D08		6	0186-0516	403.12	516.95	377	75.50	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			238.3	D08		6	0187-0528	142.35	527.67	783	122.61	0.655
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			336.5	D08		6	0188-0521	640.20	521.47	403	76.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			271.1	D08		6	0189-0526	248.39	526.31	355	74.91	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			258.8	D08		6	0190-0528	434.65	528.06	364	72.08	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			353.3	D08		6	0191-0539	888.16	539.47	358	68.43	0.961
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			263.5	D08		6	0192-0542	349.12	542.31	386	77.74	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			210.3	D08		6	0193-0550	301.34	550.65	719	105.05	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			226.7	D08		6	0194-0551	111.29	551.67	350	72.91	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			213.3	D08		6	0195-0554	594.03	554.14	397	74.43	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			392.0	D08		6	0196-0555	943.52	555.19	380	73.50	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			267.7	D08		6	0197-0560	443.60	560.66	366	71.84	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			204.5	D08		6	0198-0565	548.38	565.67	372	72.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			276.4	D08		6	0199-0566	171.46	566.61	359	71.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			220.9	D08		6	0200-0571	341.12	571.02	415	82.57	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			387.2	D08		6	0201-0577	784.16	577.07	769	108.81	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			401.0	D08		6	0202-0572	251.05	572.93	407	78.67	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			249.4	D08		6	0203-0572	619.51	572.04	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			405.3	D08		6	0204-0579	74.03	580.39	662	103.40	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			188.2	D08		6	0205-0580	287.78	580.05	376	74.43	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			197.2	D08		6	0206-0579	367.26	578.81	401	77.74	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			256.1	D08		6	0207-0580	819.65	579.49	354	70.43	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			313.0	D08		6	0208-0580	416.10	580.75	378	72.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			349.8	D08		6	0209-0590	474.71	590.58	792	118.47	0.709
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			267.4	D08		6	0210-0582	229.54	582.17	384	74.43	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			275.1	D08		6	0211-0584	716.08	583.65	355	71.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			277.5	D08		6	0212-0590	110.68	589.95	361	72.91	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			209.4	D08		6	0213-0593	326.52	594.57	419	80.91	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1537.8	D08		6	0214-0597	508.27	597.88	502	83.50	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			255.3	D08		6	0215-0598	50.21	597.98	354	72.43	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			289.7	D08		6	0216-0597	558.93	597.18	395	77.01	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			334.3	D08		6	0217-0607	748.76	606.91	688	100.23	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			273.7	D08		6	0218-0603	376.33	604.40	395	79.74	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			736.5	D08		6	0219-0605	166.55	604.53	415	78.18	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			263.8	D08		6	0220-0611	220.68	610.92	370	74.67	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			290.3	D08		6	0221-0613	581.72	612.72	410	78.18	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			254.1	D08		6	0222-0616	412.19	617.09	369	73.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1112.9	D08		6	0223-0624	98.62	624.57	714	100.81	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			350.9	D08		6	0224-0625	180.36	625.83	398	80.43	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			809.9	D08		6	0225-0623	537.52	622.87	384	75.26	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			333.3	D08		6	0226-0635	454.28	635.05	378	73.01	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1915.9	D08		6	0227-0640	821.88	639.14	554	88.57	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			262.4	D08		6	0228-0644	624.45	644.80	425	77.26	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			249.4	D08		6	0229-0645	276.57	645.18	379	74.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			300.0	D08		6	0230-0648	571.47	648.92	714	103.40	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			293.2	D08		6	0231-0647	189.76	646.38	378	79.26	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			299.2	D08		6	0232-0654	371.70	653.98	762	108.47	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			320.5	D08		6	0233-0654	804.65	654.82	380	74.91	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			289.6	D08		6	0234-0650	679.35	650.37	197	55.11	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			287.7	D08		6	0235-0661	46.26	661.50	326	70.18	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			236.3	D08		6	0236-0663	320.64	663.16	378	72.67	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			246.8	D08		6	0237-0666	492.29	665.81	354	70.43	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			202.1	D08		6	0238-0670	135.52	670.49	346	73.26	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			313.5	D08		6	0239-0671	107.79	671.25	366	74.91	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			352.8	D08		6	0240-0676	444.57	675.86	391	73.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			341.6	D08		6	0241-0677	193.75	677.33	365	71.84	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			234.1	D08		6	0242-0680	830.19	680.26	357	70.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			540.9	D08		6	0243-0683	520.86	683.19	371	75.74	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			260.1	D08		6	0244-0686	287.13	685.70	375	73.26	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			295.0	D08		6	0245-0693	909.27	692.95	359	69.84	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			259.1	D08		6	0246-0696	601.90	695.47	367	73.98	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			221.3	D08		6	0247-0703	803.69	703.90	373	74.43	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			264.2	D08		6	0248-0703	212.96	703.48	341	67.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			332.3	D08		6	0249-0708	315.46	708.28	363	75.01	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			349.2	D08		7	0001-0038	138.70	38.64	783	109.88	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			541.0	D08		7	0002-0034	800.14	34.58	338	69.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			219.4	D08		7	0003-0039	895.20	39.35	401	77.26	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			258.7	D08		7	0004-0038	601.43	38.88	500	84.91	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			288.8	D08		7	0005-0042	281.00	42.21	836	111.64	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			402.4	D08		7	0006-0049	348.32	49.45	926	126.02	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			284.0	D08		7	0007-0044	702.80	44.53	423	77.26	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			829.3	D08		7	0008-0059	821.65	58.95	463	82.91	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			321.5	D08		7	0009-0066	79.13	65.78	449	81.15	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2655.3	D08		7	0010-0071	851.75	70.91	773	109.64	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			312.3	D08		7	0011-0070	394.91	69.33	475	86.91	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			271.8	D08		7	0012-0068	431.23	68.86	349	75.84	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			273.9	D08		7	0013-0078	251.23	76.72	434	79.74	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			376.2	D08		7	0014-0081	185.35	81.82	462	82.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			269.3	D08		7	0015-0087	704.28	87.06	423	77.26	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			261.4	D08		7	0016-0086	911.36	85.55	459	81.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			290.0	D08		7	0017-0090	439.34	90.38	570	96.67	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			586.5	D08		7	0018-0090	387.39	89.99	430	83.01	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			326.2	D08		7	0019-0089	534.01	89.23	451	81.50	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			187.1	D08		7	0020-0091	755.54	92.27	522	89.74	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			205.2	D08		7	0021-0091	938.49	90.77	487	85.50	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			236.2	D08		7	0022-0092	650.55	92.57	472	82.08	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			340.6	D08		7	0023-0093	237.84	94.47	446	80.57	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			244.0	D08		7	0024-0094	319.02	94.51	414	78.91	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			348.2	D08		7	0025-0096	815.37	96.64	456	87.40	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			239.3	D08		7	0026-0095	69.91	95.59	424	79.74	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			274.8	D08		7	0027-0098	845.18	97.93	502	87.15	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			828.2	D08		7	0028-0105	118.84	105.54	422	79.26	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			279.0	D08		7	0029-0106	732.48	106.57	433	80.91	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			605.8	D08		7	0030-0121	299.24	120.12	332	71.50	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			243.6	D08		7	0031-0124	358.14	124.35	404	76.67	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			263.1	D08		7	0032-0127	686.23	126.65	419	77.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			227.7	D08		7	0033-0126	894.96	126.18	404	76.67	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			804.9	D08		7	0034-0127	281.81	128.32	393	78.08	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			718.4	D08		7	0035-0134	17.37	135.18	431	82.91	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			250.7	D08		7	0036-0135	649.93	135.03	457	80.33	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			261.5	D08		7	0037-0137	769.78	137.10	439	82.91	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			343.6	D08		7	0038-0140	523.99	140.31	478	84.33	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			278.9	D08		7	0039-0142	721.43	141.48	426	78.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2380.7	D08		7	0040-0146	451.98	146.47	778	109.74	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			289.7	D08		7	0041-0146	107.97	146.29	445	79.26	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			255.5	D08		7	0042-0148	135.96	147.29	444	84.33	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			240.3	D08		7	0043-0149	316.88	149.62	395	74.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			233.4	D08		7	0044-0154	781.79	154.36	461	87.15	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			223.0	D08		7	0045-0156	845.85	156.05	488	85.74	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			252.6	D08		7	0046-0162	363.17	161.47	444	84.67	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			260.1	D08		7	0047-0166	385.36	167.21	434	82.77	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1610.0	D08		7	0048-0172	184.53	172.77	562	92.81	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			302.6	D08		7	0049-0173	454.80	171.96	385	78.18	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			285.2	D08		7	0050-0177	288.22	177.19	491	92.81	0.716
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			280.3	D08		7	0051-0178	528.37	178.22	462	85.15	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			345.5	D08		7	0052-0182	51.09	181.36	409	81.05	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			379.8	D08		7	0053-0194	217.97	194.61	776	108.47	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			335.8	D08		7	0054-0197	36.31	198.74	416	81.15	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			219.6	D08		7	0055-0194	138.10	194.57	402	78.08	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			235.7	D08		7	0056-0201	825.33	201.22	458	81.50	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			240.3	D08		7	0057-0208	730.55	207.85	446	88.57	0.714
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			288.6	D08		7	0058-0208	651.04	208.27	465	82.33	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			312.6	D08		7	0059-0209	931.10	209.15	402	78.18	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			242.5	D08		7	0060-0210	274.48	209.99	433	78.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			245.2	D08		7	0061-0213	760.79	212.74	447	80.91	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			226.8	D08		7	0062-0214	792.02	214.30	410	78.33	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			291.2	D08		7	0063-0221	335.11	221.41	436	81.50	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			268.6	D08		7	0064-0221	686.85	220.76	434	77.26	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			301.9	D08		7	0065-0226	873.19	225.05	349	72.33	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1176.8	D08		7	0066-0235	496.90	234.92	499	86.57	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			367.1	D08		7	0067-0239	853.50	238.86	887	116.37	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			262.3	D08		7	0068-0242	232.59	242.28	472	86.57	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			485.3	D08		7	0069-0250	596.44	249.54	397	76.81	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			290.6	D08		7	0070-0250	392.33	250.19	439	78.08	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			858.7	D08		7	0071-0253	203.63	253.94	172	82.91	0.314
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			414.4	D08		7	0072-0262	582.42	264.15	519	91.64	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			234.4	D08		7	0073-0274	91.69	274.93	849	123.54	0.699
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			247.1	D08		7	0074-0270	456.40	270.98	443	81.50	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			398.9	D08		7	0075-0276	191.03	275.28	408	79.40	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1143.9	D08		7	0076-0275	698.99	275.48	495	84.91	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			318.5	D08		7	0077-0279	151.50	279.75	427	83.40	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			278.5	D08		7	0078-0280	370.65	281.07	732	107.64	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			241.6	D08		7	0079-0279	493.68	278.87	455	82.33	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			342.7	D08		7	0080-0284	593.04	284.29	489	89.26	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			326.1	D08		7	0081-0295	181.32	296.34	462	87.15	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			344.9	D08		7	0082-0293	287.27	293.14	439	78.08	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			387.8	D08		7	0083-0293	398.40	293.43	479	89.15	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			527.7	D08		7	0084-0295	218.71	295.12	453	81.84	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			228.9	D08		7	0085-0315	421.37	315.20	835	113.88	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			246.2	D08		7	0086-0310	316.18	309.58	428	79.74	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			272.4	D08		7	0087-0314	523.18	314.28	453	82.91	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			338.5	D08		7	0088-0316	619.29	316.35	441	79.26	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			521.0	D08		7	0089-0316	210.40	316.01	418	82.43	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			967.7	D08		7	0090-0329	749.51	328.37	902	121.64	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			263.1	D08		7	0091-0324	675.43	324.14	441	81.60	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			222.8	D08		7	0092-0324	697.35	323.76	542	89.01	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			451.7	D08		7	0093-0330	923.70	330.27	449	81.74	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1123.7	D08		7	0094-0333	865.05	333.11	417	79.50	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			310.1	D08		7	0095-0334	184.98	334.20	426	78.08	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			264.6	D08		7	0096-0340	353.74	339.76	780	111.88	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			229.2	D08		7	0097-0337	503.83	337.39	471	87.98	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			205.6	D08		7	0098-0342	475.99	341.85	503	87.40	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			289.2	D08		7	0099-0352	433.49	352.00	279	62.18	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			307.4	D08		7	0100-0355	632.91	355.63	454	79.26	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			253.0	D08		7	0101-0357	886.90	357.71	400	75.01	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1133.6	D08		7	0102-0365	831.24	365.48	778	105.64	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1220.6	D08		7	0103-0372	28.17	372.53	757	109.84	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			412.2	D08		7	0104-0379	122.49	379.22	502	90.18	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			307.1	D08		7	0105-0383	142.26	381.40	342	74.43	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			898.4	D08		7	0106-0384	326.48	383.91	537	91.15	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			309.0	D08		7	0107-0385	592.79	385.21	478	82.91	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			239.1	D08		7	0108-0390	198.62	390.20	396	77.26	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			214.5	D08		7	0109-0390	648.07	390.05	430	79.26	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			297.6	D08		7	0110-0392	353.79	391.83	524	97.64	0.691
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			272.7	D08		7	0111-0395	155.03	396.14	484	86.81	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			304.1	D08		7	0112-0393	388.35	393.40	457	80.91	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			292.6	D08		7	0113-0401	715.27	400.99	439	83.74	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			253.6	D08		7	0114-0401	910.08	400.87	410	77.26	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			266.2	D08		7	0115-0402	80.39	401.50	410	78.08	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			246.6	D08		7	0116-0408	115.91	409.20	851	116.95	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			319.8	D08		7	0117-0406	47.71	407.15	428	79.60	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			222.7	D08		7	0118-0417	672.49	417.03	472	85.50	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			330.6	D08		7	0119-0419	258.24	419.29	418	75.26	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			278.8	D08		7	0120-0419	852.42	418.87	438	77.84	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			285.8	D08		7	0121-0422	462.95	422.00	463	84.57	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1059.2	D08		7	0122-0428	737.20	428.53	799	106.23	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			239.9	D08		7	0123-0426	357.00	426.46	420	78.91	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			237.9	D08		7	0124-0433	207.82	432.94	401	76.67	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			264.7	D08		7	0125-0439	548.38	439.23	853	114.71	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			236.3	D08		7	0126-0445	130.87	445.13	436	81.15	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			246.8	D08		7	0127-0446	872.69	446.15	435	79.50	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			265.7	D08		7	0128-0450	177.60	449.89	471	86.57	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			456.8	D08		7	0129-0458	504.55	457.94	831	112.13	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			296.3	D08		7	0130-0453	617.91	452.19	430	79.98	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			765.5	D08		7	0131-0460	330.60	460.23	433	78.08	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			267.4	D08		7	0132-0469	633.26	470.21	488	85.40	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			296.9	D08		7	0133-0468	685.96	468.34	437	78.91	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			248.3	D08		7	0134-0469	439.37	469.24	443	79.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			406.1	D08		7	0135-0469	568.45	470.06	280	84.08	0.498
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1076.7	D08		7	0136-0482	928.02	481.95	894	116.95	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			628.2	D08		7	0137-0483	224.25	482.98	421	78.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			593.7	D08		7	0138-0488	77.97	488.45	444	86.23	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			289.0	D08		7	0139-0489	119.46	489.20	400	77.74	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			322.0	D08		7	0140-0503	605.96	503.79	865	116.95	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			279.9	D08		7	0141-0497	448.54	497.80	458	85.15	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			286.6	D08		7	0142-0497	732.17	496.51	436	82.33	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			330.6	D08		7	0143-0497	846.56	496.51	448	80.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			533.0	D08		7	0144-0503	791.27	504.05	818	111.40	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			260.9	D08		7	0145-0504	534.13	504.29	423	77.26	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			426.2	D08		7	0146-0515	397.56	515.35	711	101.40	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			284.4	D08		7	0147-0514	492.38	514.36	432	78.08	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			358.1	D08		7	0148-0520	198.34	520.33	422	77.84	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			342.6	D08		7	0149-0530	560.96	529.57	474	82.57	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			659.1	D08		7	0150-0531	79.84	531.52	448	83.74	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			289.4	D08		7	0151-0534	692.82	534.27	465	85.74	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1144.6	D08		7	0152-0535	859.44	536.14	554	92.47	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			943.1	D08		7	0153-0539	427.78	539.12	414	80.67	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			290.8	D08		7	0154-0547	781.55	547.27	855	118.27	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			701.6	D08		7	0155-0543	216.52	543.56	474	84.33	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			219.1	D08		7	0156-0545	16.05	545.35	394	75.60	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			276.0	D08		7	0157-0546	129.51	546.04	410	80.81	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			249.2	D08		7	0158-0546	542.56	547.35	493	85.98	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			322.6	D08		7	0159-0548	312.37	548.53	846	119.05	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			340.1	D08		7	0160-0556	876.68	556.26	486	84.33	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			599.4	D08		7	0161-0559	421.15	559.94	631	96.91	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			245.7	D08		7	0162-0558	643.98	558.24	421	78.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			301.4	D08		7	0163-0559	697.13	559.46	444	83.50	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			327.0	D08		7	0164-0570	241.67	569.63	417	77.50	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			268.5	D08		7	0165-0574	335.74	574.52	423	81.98	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			343.9	D08		7	0166-0582	939.06	582.12	412	79.60	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1301.4	D08		7	0167-0585	53.65	585.14	766	105.64	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			248.0	D08		7	0168-0583	619.72	583.61	431	76.43	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			627.6	D08		7	0169-0585	567.84	585.96	426	78.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			313.8	D08		7	0170-0587	200.56	587.01	459	81.50	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			246.6	D08		7	0171-0586	381.16	586.27	433	80.91	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			264.3	D08		7	0172-0602	84.26	601.97	412	79.98	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			258.7	D08		7	0173-0608	779.71	607.96	426	77.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			382.9	D08		7	0174-0610	934.27	610.47	448	84.91	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			286.8	D08		7	0175-0612	143.13	612.04	417	84.57	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			270.0	D08		7	0176-0613	692.71	612.59	428	79.26	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			231.3	D08		7	0177-0615	439.99	614.55	437	80.08	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			259.8	D08		7	0178-0622	309.28	622.42	452	80.91	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			645.8	D08		7	0179-0623	216.34	623.50	469	83.26	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			258.7	D08		7	0180-0634	512.13	633.38	446	82.33	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			300.9	D08		7	0181-0636	62.85	636.45	401	76.67	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			354.3	D08		7	0182-0643	332.89	641.98	838	120.13	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			251.5	D08		7	0183-0645	399.66	644.48	449	81.84	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			270.4	D08		7	0184-0647	279.46	648.02	378	80.33	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			270.7	D08		7	0185-0651	639.67	650.98	435	79.01	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			274.0	D08		7	0186-0651	360.99	651.61	463	84.08	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			293.3	D08		7	0187-0655	250.20	654.26	469	86.57	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			287.5	D08		7	0188-0659	500.84	660.70	463	85.74	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			259.9	D08		7	0189-0655	433.42	656.14	379	75.70	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			275.9	D08		7	0190-0660	835.93	660.18	449	80.91	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			241.3	D08		7	0191-0669	391.30	670.27	462	88.81	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1144.5	D08		7	0192-0667	17.13	667.33	458	80.91	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			309.7	D08		7	0193-0667	193.70	667.19	437	79.50	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			320.3	D08		7	0194-0664	222.97	664.04	250	64.43	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			297.4	D08		7	0195-0669	130.34	669.31	415	83.15	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			743.7	D08		7	0196-0671	563.62	671.83	434	80.33	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			519.8	D08		7	0197-0674	744.60	674.36	401	75.50	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			441.8	D08		7	0198-0675	434.96	673.95	430	80.53	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			305.2	D08		7	0199-0680	247.12	680.98	481	89.15	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			251.8	D08		7	0200-0680	297.85	680.08	407	76.43	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			254.8	D08		7	0201-0679	881.66	679.17	397	75.01	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			264.2	D08		7	0202-0683	463.49	683.36	413	78.33	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			382.3	D08		7	0203-0689	910.76	689.07	428	78.67	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			284.1	D08		7	0204-0690	55.66	689.63	424	76.67	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			249.8	D08		7	0205-0698	689.45	697.40	443	86.23	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			229.9	D08		7	0206-0698	656.88	697.85	407	79.15	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			236.3	D08		7	0207-0703	605.62	703.64	412	76.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			270.0	D08		7	0208-0704	351.70	704.08	420	77.26	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			247.3	D08		7	0209-0704	531.98	704.73	484	84.67	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			358.4	D08		7	0210-0704	215.33	704.39	385	72.43	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			241.2	D08		7	0211-0709	508.12	709.51	296	69.84	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			200.7	D08		8	0001-0032	884.95	31.78	381	72.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			219.0	D08		8	0002-0036	369.69	35.91	465	82.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			231.0	D08		8	0003-0034	604.87	34.26	413	78.08	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			234.2	D08		8	0004-0039	695.81	39.74	434	85.64	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			210.4	D08		8	0005-0039	424.75	39.71	513	90.57	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			242.7	D08		8	0006-0042	59.13	41.84	406	76.67	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			553.3	D08		8	0007-0042	116.37	41.58	475	85.40	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			290.1	D08		8	0008-0053	446.51	51.28	509	86.23	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			236.4	D08		8	0009-0060	500.17	59.63	448	81.74	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			325.1	D08		8	0010-0061	133.24	61.79	472	84.33	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			268.2	D08		8	0011-0062	572.17	62.39	818	115.78	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			212.4	D08		8	0012-0065	460.15	66.11	402	78.23	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			293.2	D08		8	0013-0063	918.16	63.17	393	76.33	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			264.8	D08		8	0014-0066	744.30	66.04	400	75.01	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			279.2	D08		8	0015-0073	691.30	73.55	412	75.01	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			233.3	D08		8	0016-0073	860.83	73.44	448	82.57	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			249.5	D08		8	0017-0075	834.89	75.31	412	77.26	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			258.4	D08		8	0018-0078	776.98	78.13	421	78.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			347.5	D08		8	0019-0082	174.03	82.31	390	78.08	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1039.1	D08		8	0020-0083	273.25	83.30	414	77.26	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			276.6	D08		8	0021-0092	219.98	92.53	851	121.05	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			451.7	D08		8	0022-0085	109.71	85.02	386	72.43	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			242.0	D08		8	0023-0088	17.17	87.83	451	82.08	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			250.4	D08		8	0024-0093	44.18	92.84	455	81.50	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			690.2	D08		8	0025-0094	894.42	94.34	407	76.43	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1463.5	D08		8	0026-0098	431.25	98.10	437	83.15	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			261.4	D08		8	0027-0100	366.00	100.19	409	76.67	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			372.7	D08		8	0028-0110	622.43	110.49	865	119.98	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			247.3	D08		8	0029-0107	652.75	107.06	446	81.01	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			197.2	D08		8	0030-0111	703.55	110.95	404	76.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			213.1	D08		8	0031-0113	73.92	113.83	409	77.84	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			784.8	D08		8	0032-0114	142.14	114.63	404	78.91	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			554.9	D08		8	0033-0116	682.50	115.95	406	75.36	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			486.8	D08		8	0034-0119	820.27	119.15	422	77.26	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			281.4	D08		8	0035-0132	728.98	132.30	480	86.57	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			204.5	D08		8	0036-0131	552.04	130.76	407	76.67	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			356.8	D08		8	0037-0141	469.46	141.36	908	135.68	0.620
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			324.3	D08		8	0038-0132	614.30	132.68	390	79.36	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1745.5	D08		8	0039-0144	279.56	144.71	608	95.64	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			265.9	D08		8	0040-0143	414.75	143.33	406	77.50	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			641.9	D08		8	0041-0154	61.26	154.33	437	80.33	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			253.8	D08		8	0042-0153	869.81	153.09	405	77.26	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			235.0	D08		8	0043-0157	138.42	157.09	429	82.08	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			277.6	D08		8	0044-0157	562.84	158.13	412	80.33	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1110.8	D08		8	0045-0159	165.70	159.40	498	90.81	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			250.6	D08		8	0046-0165	521.33	164.82	413	76.67	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			240.4	D08		8	0047-0167	739.78	167.56	428	78.08	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			471.9	D08		8	0048-0168	624.74	168.55	454	80.77	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			304.4	D08		8	0049-0183	567.41	184.60	849	121.78	0.719
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			278.9	D08		8	0050-0183	384.62	183.38	418	79.50	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			251.0	D08		8	0051-0184	277.53	185.34	517	86.53	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			346.2	D08		8	0052-0184	694.35	183.56	388	75.26	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			264.4	D08		8	0053-0186	890.52	186.22	434	79.84	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			282.8	D08		8	0054-0195	913.07	195.23	848	119.15	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1190.9	D08		8	0055-0198	206.93	198.85	984	120.71	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			623.8	D08		8	0056-0192	625.24	191.31	474	84.18	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			613.9	D08		8	0057-0200	484.87	201.08	671	104.37	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			322.2	D08		8	0058-0199	359.06	199.18	446	83.15	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			237.3	D08		8	0059-0200	527.88	200.43	408	79.15	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			242.9	D08		8	0060-0204	711.12	205.37	848	118.13	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			858.2	D08		8	0061-0205	666.68	205.58	439	80.67	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			269.6	D08		8	0062-0206	779.10	206.07	414	77.26	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			541.7	D08		8	0063-0214	276.88	213.77	792	116.43	0.734
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			296.0	D08		8	0064-0211	35.92	211.97	421	83.01	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			293.0	D08		8	0065-0211	447.74	211.02	441	84.23	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			297.1	D08		8	0066-0216	96.43	217.15	848	116.71	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			212.6	D08		8	0067-0217	253.06	216.84	436	81.01	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			253.6	D08		8	0068-0224	158.37	224.36	418	77.50	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			258.7	D08		8	0069-0228	583.30	228.46	464	85.15	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			404.3	D08		8	0070-0226	851.41	226.38	407	75.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			349.7	D08		8	0071-0237	309.49	237.76	822	113.40	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			332.8	D08		8	0072-0241	284.94	240.54	473	87.36	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			211.0	D08		8	0073-0242	529.69	242.68	413	77.26	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			229.9	D08		8	0074-0240	630.78	239.82	350	72.67	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			275.6	D08		8	0075-0244	789.97	244.51	403	78.33	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			270.9	D08		8	0076-0247	607.99	247.34	445	82.91	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1063.7	D08		8	0077-0260	332.57	260.05	459	82.67	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			391.2	D08		8	0078-0259	477.08	259.25	378	72.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			262.5	D08		8	0079-0260	692.38	261.20	452	80.53	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			196.8	D08		8	0080-0277	257.21	277.66	846	112.37	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			707.5	D08		8	0081-0276	832.37	276.41	609	96.33	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			979.6	D08		8	0082-0274	77.86	273.62	372	74.33	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			267.5	D08		8	0083-0277	649.69	277.28	452	78.67	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			257.5	D08		8	0084-0279	438.27	278.77	417	77.26	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			255.0	D08		8	0085-0284	185.71	284.27	400	77.74	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			370.2	D08		8	0086-0282	884.17	282.00	325	67.01	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			243.3	D08		8	0087-0284	913.06	284.55	406	75.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			257.6	D08		8	0088-0285	118.78	285.70	421	81.40	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			234.4	D08		8	0089-0284	691.85	283.76	461	83.36	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			192.6	D08		8	0090-0286	590.33	286.02	441	83.40	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			521.1	D08		8	0091-0289	62.19	290.24	495	87.05	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			265.1	D08		8	0092-0289	215.23	288.87	428	76.67	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1494.4	D08		8	0093-0292	545.64	292.36	775	106.23	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			294.2	D08		8	0094-0292	733.36	292.72	814	108.57	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			252.1	D08		8	0095-0292	385.56	292.55	865	120.81	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			289.9	D08		8	0096-0294	505.09	292.74	453	88.47	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			182.9	D08		8	0097-0301	945.77	302.32	413	79.26	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			240.3	D08		8	0098-0321	99.54	320.91	400	76.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			219.2	D08		8	0099-0321	502.87	321.41	431	77.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			225.5	D08		8	0100-0319	659.31	318.85	429	79.26	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			277.7	D08		8	0101-0336	890.29	336.90	826	119.68	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			260.3	D08		8	0102-0329	912.12	328.16	412	82.33	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			410.2	D08		8	0103-0332	28.83	332.23	415	79.15	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			712.4	D08		8	0104-0336	249.69	335.89	411	79.74	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			241.6	D08		8	0105-0334	844.38	334.08	456	79.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			261.5	D08		8	0106-0339	425.15	339.81	395	77.60	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			225.6	D08		8	0107-0340	652.93	341.37	469	84.91	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			681.5	D08		8	0108-0342	342.76	342.06	413	78.67	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			234.7	D08		8	0109-0341	386.82	341.56	467	83.50	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			245.9	D08		8	0110-0342	786.67	342.22	406	76.67	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1404.7	D08		8	0111-0348	449.67	347.65	724	104.91	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			254.6	D08		8	0112-0347	166.15	347.14	412	77.50	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			562.4	D08		8	0113-0358	547.03	358.86	868	122.85	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			273.8	D08		8	0114-0349	211.63	349.20	437	79.50	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			276.9	D08		8	0115-0357	711.60	357.80	419	78.91	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			208.8	D08		8	0116-0363	399.47	362.29	445	81.84	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			287.4	D08		8	0117-0372	497.55	372.35	460	81.84	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			255.3	D08		8	0118-0374	757.54	374.67	449	80.91	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			317.0	D08		8	0119-0376	601.74	376.51	426	79.74	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			247.9	D08		8	0120-0378	784.90	377.44	438	79.50	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			216.5	D08		8	0121-0381	304.43	382.27	420	80.18	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			213.5	D08		8	0122-0389	60.15	389.85	389	76.33	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			926.0	D08		8	0123-0393	428.91	394.39	864	118.37	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			940.3	D08		8	0124-0400	117.36	399.99	841	114.13	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			264.6	D08		8	0125-0391	520.05	391.20	456	84.91	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			230.1	D08		8	0126-0394	689.93	393.77	429	76.43	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			299.3	D08		8	0127-0396	907.28	396.73	421	79.84	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			237.6	D08		8	0128-0401	177.10	400.90	434	80.08	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			202.6	D08		8	0129-0403	15.32	402.92	373	72.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			242.8	D08		8	0130-0407	308.11	406.08	476	84.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			255.3	D08		8	0131-0405	651.10	405.55	421	78.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			323.6	D08		8	0132-0411	850.74	411.27	371	71.60	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			287.2	D08		8	0133-0413	581.10	413.40	417	79.74	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			370.3	D08		8	0134-0426	901.74	426.81	747	111.15	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			268.2	D08		8	0135-0421	543.54	421.25	415	78.08	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			292.9	D08		8	0136-0426	135.22	426.07	471	82.91	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			215.9	D08		8	0137-0427	707.94	427.17	405	75.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			272.3	D08		8	0138-0427	750.29	427.15	422	75.84	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			603.1	D08		8	0139-0434	360.23	432.85	438	79.40	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1559.8	D08		8	0140-0443	91.35	443.73	610	94.33	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			287.8	D08		8	0141-0443	856.02	443.55	415	77.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			279.9	D08		8	0142-0443	661.35	442.96	454	83.26	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			246.7	D08		8	0143-0444	808.91	444.31	394	76.08	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			266.1	D08		8	0144-0453	345.48	453.66	469	86.81	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			317.6	D08		8	0145-0451	637.49	450.89	417	77.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			240.1	D08		8	0146-0454	399.22	454.11	446	81.01	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			472.4	D08		8	0147-0455	420.93	455.57	486	86.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			212.6	D08		8	0148-0465	921.78	465.12	432	78.43	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			313.7	D08		8	0149-0465	558.52	464.69	343	71.26	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			218.4	D08		8	0150-0471	252.94	470.44	407	78.77	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			250.7	D08		8	0151-0477	732.29	477.24	423	78.91	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			223.6	D08		8	0152-0476	882.86	476.52	399	73.84	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1053.5	D08		8	0153-0485	32.98	484.12	857	113.54	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			720.6	D08		8	0154-0480	451.55	479.73	419	78.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			213.6	D08		8	0155-0481	500.13	481.23	432	84.33	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			241.8	D08		8	0156-0483	808.31	482.90	444	80.08	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			278.9	D08		8	0157-0482	830.66	481.79	391	81.01	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			287.0	D08		8	0158-0482	622.88	482.80	407	76.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			231.0	D08		8	0159-0485	145.41	485.34	387	77.50	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			224.0	D08		8	0160-0486	206.87	486.52	415	77.50	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			233.6	D08		8	0161-0488	778.91	488.46	406	77.50	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			257.6	D08		8	0162-0493	848.55	493.51	516	89.50	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			279.8	D08		8	0163-0488	409.37	488.78	298	66.08	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			223.1	D08		8	0164-0493	365.42	493.59	435	79.50	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			287.7	D08		8	0165-0496	569.92	495.85	422	79.50	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			239.8	D08		8	0166-0505	741.58	505.90	442	83.60	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			238.2	D08		8	0167-0506	480.71	505.89	443	81.84	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2352.4	D08		8	0168-0518	915.18	518.32	720	110.57	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			288.7	D08		8	0169-0515	647.73	514.94	420	78.08	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			418.6	D08		8	0170-0518	256.99	518.51	433	79.50	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			249.8	D08		8	0171-0523	135.34	522.72	392	76.08	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			200.9	D08		8	0172-0526	814.97	525.92	410	80.33	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			221.7	D08		8	0173-0526	194.48	526.48	394	76.08	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1968.3	D08		8	0174-0525	931.41	524.85	175	53.11	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			233.5	D08		8	0175-0535	746.35	535.25	891	126.47	0.700
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			319.5	D08		8	0176-0527	460.85	527.21	391	72.77	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			540.3	D08		8	0177-0528	366.17	528.27	407	78.67	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1826.1	D08		8	0178-0533	545.31	532.49	555	92.57	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			298.6	D08		8	0179-0544	226.15	544.19	422	78.08	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			240.5	D08		8	0180-0546	793.33	547.02	405	80.91	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			505.1	D08		8	0181-0552	696.30	551.94	410	78.67	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			261.8	D08		8	0182-0560	85.58	559.71	859	121.54	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			250.0	D08		8	0183-0556	404.04	556.74	407	75.50	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			592.9	D08		8	0184-0562	515.01	562.26	465	81.50	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			220.2	D08		8	0185-0564	800.48	565.21	445	86.08	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			472.6	D08		8	0186-0569	173.02	569.09	399	75.50	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			228.1	D08		8	0187-0573	556.41	572.86	403	75.60	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			300.8	D08		8	0188-0578	641.51	577.83	422	78.08	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			213.4	D08		8	0189-0579	740.58	578.80	406	75.50	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			273.9	D08		8	0190-0580	875.42	580.14	437	78.67	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			288.4	D08		8	0191-0585	44.22	584.44	406	84.81	0.709
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			231.2	D08		8	0192-0581	586.30	581.20	404	75.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			543.7	D08		8	0193-0583	324.64	583.53	438	79.50	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			281.8	D08		8	0194-0589	212.22	589.69	435	82.08	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			234.7	D08		8	0195-0595	263.91	595.35	398	77.50	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			235.5	D08		8	0196-0598	426.67	598.42	443	82.08	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			299.9	D08		8	0197-0612	39.00	612.44	432	80.57	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			262.2	D08		8	0198-0611	929.51	611.62	403	79.26	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2302.2	D08		8	0199-0621	82.16	621.05	720	100.57	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1463.2	D08		8	0200-0621	208.06	621.77	573	90.33	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			292.6	D08		8	0201-0619	718.53	619.30	403	74.67	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			281.9	D08		8	0202-0622	429.32	621.30	451	81.26	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			276.1	D08		8	0203-0624	604.82	624.31	425	79.98	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			303.0	D08		8	0204-0627	514.44	626.81	430	80.33	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			592.3	D08		8	0205-0639	318.06	638.75	414	76.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			318.1	D08		8	0206-0639	773.47	638.91	418	77.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			226.5	D08		8	0207-0641	142.44	641.40	392	76.57	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			675.4	D08		8	0208-0646	177.28	646.96	409	76.67	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			263.2	D08		8	0209-0650	67.26	650.15	436	79.26	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			250.7	D08		8	0210-0654	406.54	654.12	430	80.33	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			281.8	D08		8	0211-0660	226.56	660.44	421	78.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			374.6	D08		8	0212-0678	607.91	679.11	851	119.88	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			266.7	D08		8	0213-0674	926.64	673.75	396	75.26	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			472.2	D08		8	0214-0684	414.35	684.91	457	82.67	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			466.7	D08		8	0215-0693	180.42	693.41	765	108.13	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			357.4	D08		8	0216-0691	15.47	691.18	411	78.57	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			258.8	D08		8	0217-0695	389.16	695.35	428	82.57	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			322.0	D08		8	0218-0706	316.19	706.84	392	73.26	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			206.3	D08		9	0001-0031	802.21	31.36	377	73.60	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			242.6	D08		9	0002-0031	211.44	31.27	365	70.43	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			308.5	D08		9	0003-0036	582.69	37.25	373	73.74	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			323.5	D08		9	0004-0037	315.18	36.46	417	77.94	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			302.2	D08		9	0005-0040	243.56	39.76	391	75.26	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			179.0	D08		9	0006-0040	69.25	40.63	358	71.26	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			285.8	D08		9	0007-0043	158.62	42.87	383	74.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			212.2	D08		9	0008-0044	549.39	44.18	431	78.67	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			287.8	D08		9	0009-0044	838.91	44.74	396	74.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			233.9	D08		9	0010-0049	433.97	48.43	422	76.43	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			211.9	D08		9	0011-0056	108.85	56.12	370	71.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			258.1	D08		9	0012-0061	197.89	61.33	371	70.18	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			276.3	D08		9	0013-0063	232.85	63.48	376	74.77	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			239.7	D08		9	0014-0066	12.61	65.95	363	72.67	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			635.3	D08		9	0015-0074	412.99	73.90	420	78.18	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			283.3	D08		9	0016-0073	311.53	73.06	398	75.60	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			372.4	D08		9	0017-0078	615.73	77.56	424	77.84	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			254.6	D08		9	0018-0078	693.87	78.19	421	80.91	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			269.2	D08		9	0019-0081	174.00	80.92	364	74.43	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			252.4	D08		9	0020-0082	740.74	81.87	394	75.26	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			259.7	D08		9	0021-0084	358.91	84.33	395	74.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			321.4	D08		9	0022-0085	480.27	85.05	398	73.60	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			266.4	D08		9	0023-0091	867.98	90.87	374	72.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			283.4	D08		9	0024-0095	909.04	95.92	425	77.84	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			207.9	D08		9	0025-0095	122.55	94.82	359	70.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			948.7	D08		9	0026-0096	307.62	95.97	396	75.84	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			258.6	D08		9	0027-0100	709.31	100.82	473	83.26	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1141.3	D08		9	0028-0104	165.47	104.90	558	90.91	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			355.6	D08		9	0029-0102	609.70	102.70	415	76.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			349.6	D08		9	0030-0104	250.84	103.66	451	81.64	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			302.5	D08		9	0031-0101	932.48	101.56	414	79.11	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			253.7	D08		9	0032-0111	651.76	110.71	396	74.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			262.3	D08		9	0033-0117	265.59	118.91	350	71.15	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			251.6	D08		9	0034-0120	94.20	120.25	375	72.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			251.1	D08		9	0035-0127	711.28	125.36	426	82.33	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			257.7	D08		9	0036-0130	208.51	130.00	397	76.67	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			255.1	D08		9	0037-0134	141.97	134.27	378	75.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			228.3	D08		9	0038-0135	693.09	136.57	410	78.08	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			342.3	D08		9	0039-0138	866.97	137.64	357	70.43	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			264.1	D08		9	0040-0139	51.12	140.05	347	69.01	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			261.9	D08		9	0041-0140	353.61	139.65	376	72.18	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			346.4	D08		9	0042-0139	414.94	138.93	402	79.60	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			247.0	D08		9	0043-0140	286.49	139.79	389	74.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			324.3	D08		9	0044-0140	439.97	140.48	424	77.94	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			285.9	D08		9	0045-0145	914.10	145.16	386	72.43	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1001.4	D08		9	0046-0149	481.63	148.96	445	79.26	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			289.1	D08		9	0047-0159	553.86	159.17	840	114.91	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			222.7	D08		9	0048-0153	211.82	153.04	407	76.43	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			290.5	D08		9	0049-0159	99.45	159.36	413	77.74	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			259.9	D08		9	0050-0159	341.79	159.62	373	73.84	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			438.5	D08		9	0051-0159	277.39	159.59	351	69.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			280.5	D08		9	0052-0163	636.04	163.74	429	78.77	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			221.4	D08		9	0053-0163	660.28	162.67	412	76.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1588.0	D08		9	0054-0169	602.12	169.55	466	80.18	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			298.9	D08		9	0055-0169	465.80	168.72	422	78.67	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			441.5	D08		9	0056-0173	48.26	174.07	357	72.43	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			582.0	D08		9	0057-0179	376.57	178.90	426	79.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			315.6	D08		9	0058-0180	860.74	180.33	366	70.77	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			222.7	D08		9	0059-0187	683.04	187.15	393	76.43	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			271.3	D08		9	0060-0186	178.54	186.46	374	72.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			224.4	D08		9	0061-0196	298.97	196.05	817	112.91	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			338.2	D08		9	0062-0196	783.01	196.00	386	74.91	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			283.6	D08		9	0063-0204	102.44	205.02	417	78.91	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			259.6	D08		9	0064-0206	210.89	206.94	381	77.60	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			350.6	D08		9	0065-0209	412.21	209.50	459	80.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			202.2	D08		9	0066-0212	241.57	212.44	368	74.43	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			319.3	D08		9	0067-0210	391.73	210.62	391	73.70	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2198.6	D08		9	0068-0214	460.20	214.19	731	100.81	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			460.0	D08		9	0069-0212	681.99	212.12	440	80.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			232.8	D08		9	0070-0211	641.53	211.36	385	75.26	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			266.0	D08		9	0071-0215	571.82	215.76	385	74.67	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			652.2	D08		9	0072-0221	357.76	220.80	429	79.26	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			196.1	D08		9	0073-0222	309.49	222.98	389	78.18	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			326.6	D08		9	0074-0223	739.20	223.72	392	76.08	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			290.5	D08		9	0075-0227	205.50	226.76	434	80.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1633.4	D08		9	0076-0233	522.04	232.65	722	103.40	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			349.2	D08		9	0077-0233	717.89	233.06	548	93.40	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			564.9	D08		9	0078-0232	882.86	231.82	374	71.60	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			293.9	D08		9	0079-0242	370.93	242.04	567	91.74	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1270.2	D08		9	0080-0244	793.57	244.69	404	75.26	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			196.9	D08		9	0081-0247	296.20	247.12	377	73.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			214.7	D08		9	0082-0251	259.12	251.10	369	72.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1404.1	D08		9	0083-0251	549.31	251.59	444	78.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			221.0	D08		9	0084-0250	180.46	250.07	376	73.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			234.3	D08		9	0085-0252	587.08	251.82	386	75.84	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			199.8	D08		9	0086-0255	153.26	255.91	388	75.50	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			223.5	D08		9	0087-0256	77.61	256.50	386	74.43	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			324.2	D08		9	0088-0258	514.86	258.37	395	75.84	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			744.5	D08		9	0089-0258	846.26	258.51	396	73.01	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1843.7	D08		9	0090-0264	324.38	263.88	658	94.91	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			258.4	D08		9	0091-0262	671.84	262.19	432	80.91	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			229.7	D08		9	0092-0257	915.92	257.74	364	71.94	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			240.3	D08		9	0093-0264	887.34	264.27	349	75.36	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			317.4	D08		9	0094-0273	410.97	273.28	409	75.01	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			606.5	D08		9	0095-0274	472.81	274.16	308	64.77	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			237.0	D08		9	0096-0280	581.72	280.94	420	76.08	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			380.2	D08		9	0097-0281	658.64	281.64	406	74.67	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			267.9	D08		9	0098-0283	791.94	282.76	373	73.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			211.1	D08		9	0099-0282	893.76	282.59	393	79.70	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			235.8	D08		9	0100-0289	208.49	288.97	393	76.08	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			318.0	D08		9	0101-0297	517.43	296.76	791	111.40	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			659.0	D08		9	0102-0291	73.87	291.40	377	71.84	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			274.8	D08		9	0103-0295	920.34	294.67	394	75.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			262.7	D08		9	0104-0296	719.32	296.25	389	76.08	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			268.7	D08		9	0105-0297	820.86	296.95	387	73.84	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			192.7	D08		9	0106-0304	162.89	304.23	724	104.57	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			234.7	D08		9	0107-0296	383.18	295.94	379	73.01	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			263.4	D08		9	0108-0298	261.09	298.23	391	73.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			481.9	D08		9	0109-0301	126.12	301.54	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			266.7	D08		9	0110-0301	900.33	301.91	402	82.18	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			180.7	D08		9	0111-0305	40.73	305.65	391	77.01	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			197.1	D08		9	0112-0306	200.21	307.44	419	82.91	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			259.7	D08		9	0113-0312	434.13	312.14	409	75.26	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			257.1	D08		9	0114-0316	880.46	315.48	381	73.50	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			211.3	D08		9	0115-0323	60.64	322.66	395	77.84	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			215.6	D08		9	0116-0324	317.09	323.94	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			265.7	D08		9	0117-0326	248.09	326.70	408	73.60	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			262.9	D08		9	0118-0325	635.30	324.89	385	73.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			223.3	D08		9	0119-0328	373.64	328.69	414	76.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			273.3	D08		9	0120-0333	478.24	333.17	391	73.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			302.0	D08		9	0121-0334	518.50	334.38	419	77.01	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			387.1	D08		9	0122-0340	574.93	340.26	413	75.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			240.9	D08		9	0123-0342	132.05	341.66	397	74.08	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			308.0	D08		9	0124-0346	929.21	345.80	380	75.94	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1300.5	D08		9	0125-0351	225.07	350.96	642	95.74	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			272.3	D08		9	0126-0349	846.02	349.50	381	73.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			345.2	D08		9	0127-0354	682.81	354.31	438	83.98	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			265.0	D08		9	0128-0358	520.07	357.55	423	78.18	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			239.8	D08		9	0129-0361	313.84	360.59	408	78.18	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			311.8	D08		9	0130-0361	810.32	360.87	426	77.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			836.9	D08		9	0131-0368	888.14	368.11	827	118.81	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			258.4	D08		9	0132-0365	295.33	366.12	359	75.21	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			228.9	D08		9	0133-0368	275.28	367.58	453	82.04	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			720.0	D08		9	0134-0369	122.11	369.40	389	76.43	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			229.7	D08		9	0135-0373	189.40	373.03	404	79.15	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			464.1	D08		9	0136-0384	71.53	384.19	382	74.43	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			240.3	D08		9	0137-0388	237.86	388.08	742	104.23	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			298.4	D08		9	0138-0391	207.08	391.67	461	83.84	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			284.0	D08		9	0139-0390	590.14	390.31	388	74.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			309.1	D08		9	0140-0391	753.46	391.08	394	74.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2823.5	D08		9	0141-0405	506.02	405.02	627	95.64	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			591.3	D08		9	0142-0409	630.87	409.11	412	75.60	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			334.4	D08		9	0143-0415	912.32	415.15	681	102.81	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			392.9	D08		9	0144-0413	410.62	413.37	395	73.84	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1142.4	D08		9	0145-0416	296.49	416.09	609	92.91	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			298.1	D08		9	0146-0415	210.30	414.22	360	72.53	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			309.8	D08		9	0147-0421	943.69	422.81	390	94.57	0.548
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			801.9	D08		9	0148-0424	144.14	422.40	940	120.95	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			323.4	D08		9	0149-0418	568.80	418.83	391	73.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			301.9	D08		9	0150-0426	458.36	426.56	387	71.60	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			670.1	D08		9	0151-0433	80.54	432.57	370	74.91	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			290.1	D08		9	0152-0439	352.40	439.52	386	74.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			704.4	D08		9	0153-0447	256.37	447.18	381	78.67	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			292.3	D08		9	0154-0450	757.46	449.77	377	73.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			663.4	D08		9	0155-0454	560.48	453.62	385	73.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1463.8	D08		9	0156-0458	870.25	458.05	663	95.74	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			557.3	D08		9	0157-0458	205.69	458.53	371	71.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1083.8	D08		9	0158-0458	329.27	458.74	406	75.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			273.0	D08		9	0159-0458	650.51	458.66	398	75.26	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			292.6	D08		9	0160-0462	520.47	462.25	402	75.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			535.6	D08		9	0161-0467	263.57	467.17	452	83.26	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			199.1	D08		9	0162-0468	16.54	467.93	374	71.84	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			300.1	D08		9	0163-0472	403.79	472.47	402	76.18	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1348.5	D08		9	0164-0477	903.92	477.48	517	86.33	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			244.7	D08		9	0165-0492	90.84	491.39	786	115.40	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			241.5	D08		9	0166-0487	942.99	487.59	362	71.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			256.3	D08		9	0167-0499	186.12	500.16	391	75.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			263.9	D08		9	0168-0502	514.94	502.30	403	74.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			624.2	D08		9	0169-0509	862.02	509.84	373	71.84	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			335.6	D08		9	0170-0512	468.13	511.72	397	75.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			445.9	D08		9	0171-0513	775.33	513.07	380	74.67	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			269.6	D08		9	0172-0517	556.44	516.30	415	79.50	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1124.4	D08		9	0173-0520	270.30	519.66	642	94.33	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			257.6	D08		9	0174-0520	181.41	520.11	444	82.18	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			292.5	D08		9	0175-0532	226.41	531.71	396	73.84	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1154.0	D08		9	0176-0537	542.74	538.48	362	74.77	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			415.0	D08		9	0177-0540	403.69	540.32	346	69.94	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			667.5	D08		9	0178-0545	561.00	545.00	297	67.60	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			253.9	D08		9	0179-0544	944.64	544.28	384	73.26	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			585.4	D08		9	0180-0546	841.98	546.34	389	72.43	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			320.0	D08		9	0181-0550	301.68	550.16	392	73.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1250.4	D08		9	0182-0561	415.75	561.58	694	106.23	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4501.3	D08		9	0183-0555	544.47	555.11	252	61.46	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			254.0	D08		9	0184-0562	514.95	562.28	417	76.67	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1206.8	D08		9	0185-0569	793.03	569.10	400	75.84	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			327.9	D08		9	0186-0572	258.47	571.14	339	70.91	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			297.2	D08		9	0187-0582	210.17	582.11	368	73.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			344.7	D08		9	0188-0584	273.44	585.56	492	85.88	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			681.8	D08		9	0189-0583	903.29	582.47	449	79.50	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			302.0	D08		9	0190-0586	660.06	585.62	380	73.84	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			331.9	D08		9	0191-0595	175.90	595.08	377	73.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			269.4	D08		9	0192-0601	327.94	601.43	383	73.01	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			249.1	D08		9	0193-0602	461.92	602.65	373	71.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			288.6	D08		9	0194-0611	659.43	611.53	398	74.67	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			275.1	D08		9	0195-0611	904.60	611.52	385	73.26	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			254.7	D08		9	0196-0615	23.70	614.59	387	75.01	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			326.1	D08		9	0197-0621	489.54	621.59	400	74.43	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			303.2	D08		9	0198-0623	814.69	623.36	394	74.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			199.1	D08		9	0199-0627	281.70	626.41	385	73.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			269.3	D08		9	0200-0631	862.18	631.39	385	73.60	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			276.7	D08		9	0201-0634	165.99	634.41	427	77.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			332.9	D08		9	0202-0648	628.33	646.60	406	78.33	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			327.1	D08		9	0203-0647	399.11	647.27	413	76.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			315.1	D08		9	0204-0647	522.59	648.08	369	73.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			304.2	D08		9	0205-0652	900.01	652.45	351	69.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			256.6	D08		9	0206-0655	100.16	655.09	375	76.33	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1494.3	D08		9	0207-0663	616.05	664.54	508	86.57	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1023.9	D08		9	0208-0667	123.12	666.61	455	80.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			245.9	D08		9	0209-0669	561.54	668.87	382	72.43	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			259.9	D08		9	0210-0676	20.62	676.36	402	73.84	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			237.3	D08		9	0211-0678	512.28	677.79	408	75.50	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1304.2	D08		9	0212-0678	676.22	677.75	470	82.08	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			741.2	D08		9	0213-0694	165.23	693.52	415	76.91	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1450.8	D08		9	0214-0699	536.83	699.76	921	117.30	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			822.0	D08		9	0215-0693	258.74	693.52	405	75.26	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			295.2	D08		9	0216-0696	605.92	696.41	379	73.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			288.4	D08		9	0217-0700	784.99	699.49	381	74.67	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			252.2	E08		1	0001-0030	45.07	30.65	419	80.67	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			407.5	E08		1	0002-0042	167.76	42.28	443	77.60	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			400.1	E08		1	0003-0041	625.93	41.06	415	75.01	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			523.2	E08		1	0004-0042	714.23	42.07	387	73.01	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			502.2	E08		1	0005-0046	412.33	45.77	490	84.57	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			382.5	E08		1	0006-0048	453.57	48.42	492	82.08	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			355.2	E08		1	0007-0053	567.12	53.63	471	82.08	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			555.4	E08		1	0008-0063	182.59	62.93	485	84.33	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1667.9	E08		1	0009-0067	34.57	67.11	550	86.91	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			395.6	E08		1	0010-0075	78.32	74.79	442	77.84	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			595.2	E08		1	0011-0073	829.94	73.27	221	56.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			382.4	E08		1	0012-0088	611.67	88.17	454	79.26	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			456.2	E08		1	0013-0088	502.07	88.60	548	90.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			409.9	E08		1	0014-0086	852.50	87.02	282	66.53	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			509.7	E08		1	0015-0091	719.29	91.65	462	80.08	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			404.0	E08		1	0016-0091	524.71	92.67	373	76.53	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			350.8	E08		1	0017-0098	47.05	98.76	435	77.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			520.5	E08		1	0018-0100	168.02	100.31	424	76.43	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			403.2	E08		1	0019-0100	281.75	99.91	402	73.60	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			420.6	E08		1	0020-0101	804.02	101.06	404	76.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			330.9	E08		1	0021-0101	759.55	101.44	445	79.84	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			507.3	E08		1	0022-0107	241.68	107.62	782	109.05	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			454.4	E08		1	0023-0107	355.42	107.05	439	76.43	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			554.6	E08		1	0024-0114	690.88	114.24	486	81.84	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1108.5	E08		1	0025-0121	127.38	120.85	508	89.74	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			403.1	E08		1	0026-0128	900.25	128.11	430	79.60	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			444.7	E08		1	0027-0133	881.34	132.98	363	74.18	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			371.1	E08		1	0028-0136	456.29	136.38	497	86.77	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			449.4	E08		1	0029-0143	481.89	143.29	489	88.67	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			308.9	E08		1	0030-0146	52.86	146.04	428	76.43	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			598.6	E08		1	0031-0149	733.33	148.93	470	84.08	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			317.8	E08		1	0032-0152	636.15	151.24	411	81.50	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			352.1	E08		1	0033-0156	179.65	155.98	413	75.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			408.4	E08		1	0034-0158	695.52	158.70	454	79.26	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			419.5	E08		1	0035-0163	356.63	163.51	438	80.67	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			668.2	E08		1	0036-0167	538.52	166.59	422	77.26	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			334.0	E08		1	0037-0167	625.67	168.24	495	85.74	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			625.2	E08		1	0038-0181	256.69	180.51	798	105.40	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			478.2	E08		1	0039-0177	940.24	176.77	643	113.98	0.622
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			592.5	E08		1	0040-0182	919.56	184.38	246	70.43	0.623
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			341.3	E08		1	0041-0188	417.75	187.91	483	82.91	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			303.9	E08		1	0042-0193	890.39	193.06	442	76.67	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			312.9	E08		1	0043-0198	114.34	198.34	433	77.84	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			368.3	E08		1	0044-0197	159.98	196.69	427	75.84	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			406.5	E08		1	0045-0199	194.67	198.65	454	80.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			391.9	E08		1	0046-0201	473.12	201.79	429	77.26	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			296.1	E08		1	0047-0203	52.74	203.81	405	75.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			340.8	E08		1	0048-0205	90.17	204.94	458	80.91	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			416.5	E08		1	0049-0205	597.63	204.93	433	76.43	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			687.3	E08		1	0050-0207	801.58	207.66	443	78.67	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			393.7	E08		1	0051-0216	416.35	216.78	451	79.50	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			358.5	E08		1	0052-0222	646.65	223.11	432	79.50	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1913.0	E08		1	0053-0228	871.80	227.91	434	78.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			335.7	E08		1	0054-0226	549.57	226.53	449	78.43	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			429.4	E08		1	0055-0228	840.53	228.39	456	82.33	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			291.6	E08		1	0056-0230	38.92	230.56	395	73.26	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			854.2	E08		1	0057-0245	203.72	245.39	997	129.78	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			316.4	E08		1	0058-0242	477.31	241.90	432	77.26	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1375.7	E08		1	0059-0243	328.76	243.39	580	90.08	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1813.8	E08		1	0060-0251	898.82	251.02	446	77.84	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			356.6	E08		1	0061-0252	519.77	252.54	428	77.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			424.7	E08		1	0062-0253	294.10	253.48	444	77.84	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1211.7	E08		1	0063-0253	767.58	253.20	426	77.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			280.1	E08		1	0064-0262	151.82	262.30	429	77.01	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2113.7	E08		1	0065-0269	833.89	269.22	638	92.91	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1826.6	E08		1	0066-0272	70.77	270.22	706	105.30	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			328.3	E08		1	0067-0269	232.72	268.95	431	77.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			345.5	E08		1	0068-0269	364.87	269.58	436	79.50	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			480.2	E08		1	0069-0270	581.58	269.89	455	79.26	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			339.8	E08		1	0070-0281	485.61	280.87	432	78.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1526.5	E08		1	0071-0289	84.53	290.53	682	104.71	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			304.7	E08		1	0072-0289	194.45	288.69	460	80.67	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			332.7	E08		1	0073-0288	264.75	288.32	431	77.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			319.1	E08		1	0074-0293	797.62	293.31	481	84.08	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			371.5	E08		1	0075-0305	755.92	305.48	433	77.26	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			358.7	E08		1	0076-0304	24.11	305.07	407	77.26	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			274.5	E08		1	0077-0304	106.05	305.36	391	74.08	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			393.1	E08		1	0078-0311	708.14	311.30	480	83.74	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			303.2	E08		1	0079-0324	426.88	324.06	459	80.67	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			302.7	E08		1	0080-0325	155.70	324.92	410	75.26	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			308.8	E08		1	0081-0325	510.81	325.96	429	79.50	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			409.9	E08		1	0082-0328	277.00	327.76	413	75.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			400.5	E08		1	0083-0342	555.08	342.00	894	117.64	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			414.4	E08		1	0084-0345	354.40	344.76	908	122.57	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			340.6	E08		1	0085-0336	328.34	336.14	460	79.60	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			358.8	E08		1	0086-0337	189.42	337.44	426	77.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			782.2	E08		1	0087-0339	465.96	338.48	395	75.70	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			720.0	E08		1	0088-0339	801.06	339.25	480	81.26	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			645.2	E08		1	0089-0341	484.56	340.81	352	70.87	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			339.0	E08		1	0090-0351	904.71	350.58	428	78.08	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			283.1	E08		1	0091-0352	928.99	351.53	454	80.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			228.4	E08		1	0092-0351	95.71	351.12	406	75.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			404.2	E08		1	0093-0357	647.60	356.77	433	78.91	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			473.1	E08		1	0094-0370	457.83	370.44	943	123.64	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			388.1	E08		1	0095-0361	501.42	360.90	351	71.94	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			484.8	E08		1	0096-0371	663.63	371.45	456	84.57	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			325.3	E08		1	0097-0368	188.22	368.04	436	79.50	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			377.1	E08		1	0098-0371	596.97	371.40	448	79.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			265.4	E08		1	0099-0370	63.32	370.48	412	78.08	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			358.4	E08		1	0100-0369	275.88	369.77	423	76.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			384.5	E08		1	0101-0379	508.26	379.37	483	86.67	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			576.1	E08		1	0102-0380	816.50	380.84	437	79.50	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			661.5	E08		1	0103-0392	674.25	392.50	491	83.26	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			248.1	E08		1	0104-0392	134.34	392.60	425	76.43	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			520.8	E08		1	0105-0395	787.89	394.74	460	80.08	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			552.6	E08		1	0106-0397	710.62	397.69	428	77.84	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			357.4	E08		1	0107-0404	622.35	404.81	425	77.26	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1329.4	E08		1	0108-0408	927.12	408.71	622	92.91	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			321.7	E08		1	0109-0408	202.68	407.87	460	82.08	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			329.2	E08		1	0110-0410	447.45	410.02	447	79.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			332.3	E08		1	0111-0410	524.60	409.87	428	77.26	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			326.9	E08		1	0112-0412	230.55	412.57	450	80.08	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			253.1	E08		1	0113-0421	62.27	421.92	824	114.71	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			481.3	E08		1	0114-0414	389.83	414.33	420	76.91	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			314.7	E08		1	0115-0418	264.20	418.41	416	76.67	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			407.6	E08		1	0116-0419	884.01	419.03	418	77.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			241.0	E08		1	0117-0420	149.68	421.22	460	85.50	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			339.7	E08		1	0118-0424	786.24	424.27	462	82.18	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			468.6	E08		1	0119-0424	585.75	424.81	484	82.08	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1038.0	E08		1	0120-0424	113.98	424.14	456	78.67	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			362.7	E08		1	0121-0430	738.05	430.83	419	75.84	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			282.9	E08		1	0122-0437	548.25	437.22	430	77.26	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			377.4	E08		1	0123-0443	679.62	443.50	452	78.43	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			366.8	E08		1	0124-0452	452.68	451.69	956	125.68	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			227.6	E08		1	0125-0455	21.35	455.63	811	114.33	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			642.6	E08		1	0126-0448	861.22	449.47	388	74.04	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			281.6	E08		1	0127-0452	942.36	452.57	419	78.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			254.4	E08		1	0128-0455	97.13	455.50	413	79.84	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			511.3	E08		1	0129-0458	378.27	458.43	435	76.67	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			376.1	E08		1	0130-0461	192.39	459.84	436	78.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			282.8	E08		1	0131-0460	249.49	459.97	406	74.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			255.3	E08		1	0132-0463	493.64	462.81	434	78.08	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			326.0	E08		1	0133-0462	739.66	462.49	417	77.26	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			363.8	E08		1	0134-0470	301.00	469.97	456	82.08	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			311.5	E08		1	0135-0469	532.78	469.25	421	78.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			478.8	E08		1	0136-0467	582.60	466.82	405	74.18	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			545.2	E08		1	0137-0473	855.50	471.79	473	91.84	0.705
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			307.7	E08		1	0138-0475	110.41	475.53	551	93.60	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			400.8	E08		1	0139-0477	875.10	477.05	463	83.15	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			274.7	E08		1	0140-0476	680.21	476.62	444	77.84	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			268.0	E08		1	0141-0480	136.78	480.05	414	77.36	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			307.9	E08		1	0142-0490	209.33	490.94	904	124.23	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			304.6	E08		1	0143-0486	620.14	486.40	460	80.67	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			324.3	E08		1	0144-0485	752.77	484.45	423	76.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			889.3	E08		1	0145-0495	165.67	495.01	458	79.26	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			303.3	E08		1	0146-0498	885.52	498.56	448	80.33	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			427.2	E08		1	0147-0496	358.26	496.12	412	75.84	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			291.5	E08		1	0148-0502	272.90	501.84	428	78.08	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			350.4	E08		1	0149-0503	538.56	503.36	440	79.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			324.0	E08		1	0150-0504	591.68	504.75	436	77.84	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			381.1	E08		1	0151-0508	54.27	507.66	446	82.33	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			360.9	E08		1	0152-0510	455.95	510.37	437	78.91	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			890.4	E08		1	0153-0520	219.13	519.44	450	81.36	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			290.9	E08		1	0154-0522	187.38	522.40	432	83.50	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			436.9	E08		1	0155-0523	792.97	523.36	427	78.67	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			354.8	E08		1	0156-0527	307.68	528.11	430	80.53	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			449.2	E08		1	0157-0531	68.21	531.31	459	82.08	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			295.3	E08		1	0158-0529	624.88	529.41	418	77.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			306.9	E08		1	0159-0530	716.03	530.46	419	75.84	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			785.1	E08		1	0160-0529	850.33	529.04	149	80.57	0.288
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			442.9	E08		1	0161-0537	112.53	537.02	423	76.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			210.5	E08		1	0162-0543	18.86	543.23	388	76.08	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			337.4	E08		1	0163-0545	650.13	545.60	446	80.33	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			292.6	E08		1	0164-0546	936.83	546.77	456	82.43	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			344.9	E08		1	0165-0547	407.42	546.67	432	77.26	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			330.9	E08		1	0166-0549	307.82	547.82	469	84.53	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			233.4	E08		1	0167-0550	162.08	550.18	396	76.43	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			338.4	E08		1	0168-0550	588.08	550.21	436	76.43	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			255.9	E08		1	0169-0558	202.67	558.45	848	115.54	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			233.1	E08		1	0170-0555	49.17	555.21	173	51.11	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			416.1	E08		1	0171-0559	264.46	558.77	440	77.60	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			893.8	E08		1	0172-0567	884.03	567.85	446	79.84	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			284.9	E08		1	0173-0568	916.26	568.48	440	81.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			480.9	E08		1	0174-0569	340.67	568.74	461	80.91	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1401.2	E08		1	0175-0575	375.94	575.06	717	100.57	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			433.6	E08		1	0176-0572	492.05	571.93	452	79.26	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			398.5	E08		1	0177-0584	120.96	583.77	855	117.50	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			340.8	E08		1	0178-0588	729.45	587.53	442	78.67	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			332.3	E08		1	0179-0600	777.15	599.75	450	80.67	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			261.3	E08		1	0180-0601	931.97	601.38	424	78.91	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1187.7	E08		1	0181-0604	627.24	604.09	475	82.91	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			417.6	E08		1	0182-0606	347.15	606.58	459	81.26	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			495.8	E08		1	0183-0618	391.24	618.44	390	73.84	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			300.2	E08		1	0184-0620	797.93	620.38	546	91.60	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			328.6	E08		1	0185-0637	64.60	637.63	890	119.30	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			337.0	E08		1	0186-0631	719.70	631.93	467	81.60	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			376.8	E08		1	0187-0631	176.97	631.35	403	76.67	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			374.0	E08		1	0188-0631	697.91	631.62	408	74.53	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			413.7	E08		1	0189-0632	215.71	632.05	430	79.50	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			840.0	E08		1	0190-0637	18.73	637.73	398	78.91	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			310.4	E08		1	0191-0635	553.23	634.85	420	77.26	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			365.0	E08		1	0192-0640	93.70	640.64	451	79.74	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			786.0	E08		1	0193-0639	869.53	638.74	414	76.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			511.9	E08		1	0194-0643	330.43	643.90	423	76.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			402.2	E08		1	0195-0655	426.54	655.75	880	119.05	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			294.1	E08		1	0196-0651	773.20	651.09	440	77.84	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			309.1	E08		1	0197-0655	649.45	655.53	469	82.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			491.5	E08		1	0198-0655	388.48	654.75	422	78.67	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			597.8	E08		1	0199-0654	481.44	654.30	409	75.01	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			615.3	E08		1	0200-0660	517.44	660.08	452	80.91	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			343.5	E08		1	0201-0661	932.46	661.06	366	71.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			491.9	E08		1	0202-0662	256.71	662.73	437	83.60	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			470.5	E08		1	0203-0666	826.30	664.91	413	79.15	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			506.7	E08		1	0204-0678	175.43	678.36	407	77.11	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			242.7	E08		1	0205-0678	554.22	678.45	450	81.26	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			339.5	E08		1	0206-0678	633.42	677.98	463	82.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			303.2	E08		1	0207-0678	841.42	678.77	388	74.33	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			463.9	E08		1	0208-0682	195.20	682.98	450	81.11	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			590.3	E08		1	0209-0683	262.51	682.34	435	82.18	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			234.0	E08		1	0210-0688	499.60	687.89	420	78.43	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			423.7	E08		1	0211-0690	890.26	690.34	383	71.60	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			295.9	E08		1	0212-0693	757.85	693.38	439	78.08	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			651.1	E08		1	0213-0695	110.13	695.18	404	77.50	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			269.9	E08		1	0214-0702	565.03	701.68	495	86.08	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			272.0	E08		1	0215-0707	378.50	706.73	399	75.84	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			536.2	E08		1	0216-0708	471.87	707.00	351	73.26	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			308.6	E08		2	0001-0027	890.67	26.94	374	73.01	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			275.6	E08		2	0002-0034	802.74	33.78	411	77.26	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			331.6	E08		2	0003-0044	398.89	44.05	408	77.50	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			310.6	E08		2	0004-0045	267.59	45.26	384	75.01	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			358.4	E08		2	0005-0060	539.47	60.49	420	77.26	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			368.0	E08		2	0006-0061	333.18	61.84	459	82.67	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			368.0	E08		2	0007-0062	725.90	61.80	405	76.67	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			496.0	E08		2	0008-0070	697.13	69.59	751	109.40	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			293.3	E08		2	0009-0064	854.95	64.08	402	74.43	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			548.5	E08		2	0010-0068	564.60	67.98	393	74.43	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			500.4	E08		2	0011-0069	311.70	68.45	377	75.60	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			283.4	E08		2	0012-0074	139.75	73.75	380	73.26	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			367.4	E08		2	0013-0079	623.33	79.13	403	75.84	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			299.3	E08		2	0014-0080	806.89	80.21	477	87.26	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			353.2	E08		2	0015-0080	193.12	80.01	410	78.33	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			370.6	E08		2	0016-0080	243.00	80.22	382	75.26	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			350.9	E08		2	0017-0079	410.94	79.08	423	77.60	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			449.9	E08		2	0018-0084	785.43	83.93	358	70.53	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			286.5	E08		2	0019-0093	67.94	93.43	387	76.08	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			664.2	E08		2	0020-0097	274.93	97.74	306	64.77	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			551.8	E08		2	0021-0104	136.10	104.59	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			314.9	E08		2	0022-0108	442.80	108.17	426	76.43	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			660.8	E08		2	0023-0111	362.97	110.55	364	71.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			367.8	E08		2	0024-0121	683.13	121.47	785	109.88	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			264.5	E08		2	0025-0123	483.35	123.12	381	73.26	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			345.3	E08		2	0026-0127	775.47	127.33	423	78.67	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			325.5	E08		2	0027-0130	354.62	131.04	437	81.50	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			383.1	E08		2	0028-0133	175.78	133.20	395	76.08	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			303.7	E08		2	0029-0133	850.39	133.45	427	78.67	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			387.6	E08		2	0030-0135	378.24	135.97	430	77.26	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			338.9	E08		2	0031-0140	234.73	139.82	400	76.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			384.7	E08		2	0032-0138	422.68	138.62	400	76.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1538.2	E08		2	0033-0147	100.48	147.50	491	83.50	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			296.0	E08		2	0034-0148	724.33	148.39	411	77.50	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			355.9	E08		2	0035-0149	909.00	149.21	391	75.60	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			394.8	E08		2	0036-0161	572.53	161.61	429	78.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			286.8	E08		2	0037-0166	805.96	164.76	428	77.98	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			394.4	E08		2	0038-0167	461.77	167.52	388	73.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			492.8	E08		2	0039-0169	138.99	169.37	396	73.01	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			291.7	E08		2	0040-0176	668.51	175.77	408	76.08	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			900.3	E08		2	0041-0170	27.63	170.20	115	43.11	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			351.7	E08		2	0042-0177	314.08	177.40	384	74.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			439.2	E08		2	0043-0179	46.42	178.70	548	92.57	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			260.2	E08		2	0044-0178	790.37	179.08	372	73.74	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			370.6	E08		2	0045-0182	402.87	182.10	409	75.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			397.0	E08		2	0046-0193	513.15	193.35	924	119.05	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			563.8	E08		2	0047-0184	24.07	185.47	235	66.43	0.669
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			451.7	E08		2	0048-0187	77.70	186.86	377	72.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			673.2	E08		2	0049-0187	877.36	186.70	392	74.08	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			315.6	E08		2	0050-0195	621.74	195.76	405	75.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			243.9	E08		2	0051-0193	258.36	193.62	382	75.60	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			329.4	E08		2	0052-0194	724.88	193.94	428	82.08	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			341.1	E08		2	0053-0203	168.99	203.55	395	76.67	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			549.5	E08		2	0054-0206	420.38	205.55	442	79.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			291.8	E08		2	0055-0207	827.80	207.35	418	75.01	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			251.7	E08		2	0056-0210	51.74	209.85	399	75.50	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			298.0	E08		2	0057-0222	369.13	222.56	396	74.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			525.0	E08		2	0058-0220	809.97	219.30	252	61.84	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			323.8	E08		2	0059-0225	138.35	225.82	377	76.33	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			347.8	E08		2	0060-0225	744.58	224.81	387	72.43	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			226.4	E08		2	0061-0227	215.53	227.48	439	82.67	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			355.5	E08		2	0062-0227	794.99	228.06	380	80.18	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			461.5	E08		2	0063-0238	563.83	238.32	597	91.26	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			324.9	E08		2	0064-0234	268.82	234.46	438	79.01	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			240.2	E08		2	0065-0248	329.53	248.37	391	74.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			322.2	E08		2	0066-0248	76.01	248.58	386	72.43	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			295.9	E08		2	0067-0258	791.77	257.78	926	128.23	0.708
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			317.2	E08		2	0068-0251	221.60	250.53	395	78.67	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			347.0	E08		2	0069-0251	679.71	251.58	412	75.01	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1468.6	E08		2	0070-0256	913.82	256.63	581	89.50	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			364.1	E08		2	0071-0260	634.98	259.87	382	72.77	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			301.5	E08		2	0072-0266	169.77	266.61	555	96.23	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			336.6	E08		2	0073-0264	451.20	264.72	414	76.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			328.7	E08		2	0074-0266	525.51	266.37	435	83.74	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			301.5	E08		2	0075-0274	371.77	274.85	796	111.64	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			328.1	E08		2	0076-0271	411.01	271.76	403	74.67	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			434.8	E08		2	0077-0270	500.82	269.96	400	77.01	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			734.2	E08		2	0078-0293	308.49	292.92	419	77.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			297.1	E08		2	0079-0294	470.07	294.22	400	77.50	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			325.5	E08		2	0080-0297	67.35	297.65	383	73.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			363.0	E08		2	0081-0302	901.77	302.16	369	72.87	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			515.7	E08		2	0082-0302	923.60	301.95	389	74.28	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			476.2	E08		2	0083-0305	581.73	305.14	373	71.84	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			277.6	E08		2	0084-0310	171.84	310.52	381	72.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			512.6	E08		2	0085-0312	544.73	312.04	408	74.18	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			691.5	E08		2	0086-0313	622.31	313.79	659	123.98	0.539
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			329.3	E08		2	0087-0318	272.44	318.88	401	73.36	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			379.1	E08		2	0088-0327	478.15	327.67	419	81.50	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			290.9	E08		2	0089-0329	142.75	328.87	383	71.60	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			449.5	E08		2	0090-0336	451.27	335.94	416	79.50	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			271.7	E08		2	0091-0339	252.17	339.52	404	75.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			390.9	E08		2	0092-0342	303.53	342.63	382	73.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			612.9	E08		2	0093-0344	403.85	343.81	406	78.91	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			410.1	E08		2	0094-0347	823.72	347.14	383	72.43	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			260.4	E08		2	0095-0348	69.00	348.26	383	74.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			283.0	E08		2	0096-0348	226.00	348.72	398	75.84	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			264.7	E08		2	0097-0352	33.51	352.30	399	76.91	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			502.2	E08		2	0098-0351	882.76	350.71	322	69.70	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			317.7	E08		2	0099-0362	151.49	362.52	394	74.67	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			318.6	E08		2	0100-0367	622.50	367.96	417	75.84	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			378.7	E08		2	0101-0371	347.12	371.36	439	78.67	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			323.6	E08		2	0102-0372	879.45	371.13	475	87.50	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			296.1	E08		2	0103-0380	574.82	380.03	402	76.08	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			299.6	E08		2	0104-0390	709.91	389.84	825	113.88	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			364.6	E08		2	0105-0388	95.79	388.54	386	75.50	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			460.6	E08		2	0106-0388	199.33	387.52	442	82.33	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			281.5	E08		2	0107-0390	526.13	389.65	420	80.57	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			259.8	E08		2	0108-0401	820.21	401.50	419	77.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			371.3	E08		2	0109-0402	510.01	403.04	445	80.08	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			864.8	E08		2	0110-0402	654.01	401.98	422	76.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1309.4	E08		2	0111-0406	219.36	406.64	536	89.64	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			333.3	E08		2	0112-0404	292.52	404.38	753	105.50	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1211.3	E08		2	0113-0409	30.77	409.53	628	93.15	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			302.8	E08		2	0114-0406	173.15	406.25	382	73.84	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			251.5	E08		2	0115-0408	120.03	408.10	388	75.26	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			267.4	E08		2	0116-0410	779.56	411.26	437	84.43	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			291.3	E08		2	0117-0413	750.21	412.69	398	75.60	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			430.5	E08		2	0118-0441	495.53	441.66	922	128.81	0.698
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			211.5	E08		2	0119-0435	202.35	435.47	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			372.9	E08		2	0120-0436	438.90	436.64	395	75.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			218.7	E08		2	0121-0439	144.52	438.62	374	72.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			295.3	E08		2	0122-0444	560.08	444.52	417	76.43	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			277.0	E08		2	0123-0453	46.63	453.32	389	75.84	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			434.4	E08		2	0124-0451	476.99	452.07	314	69.94	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			765.3	E08		2	0125-0449	761.44	448.87	161	77.50	0.337
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			367.7	E08		2	0126-0454	380.38	454.11	412	76.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			333.9	E08		2	0127-0457	649.09	457.94	398	76.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			309.2	E08		2	0128-0460	248.91	459.73	375	74.91	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			207.8	E08		2	0129-0471	91.12	471.08	805	114.47	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			277.4	E08		2	0130-0466	923.56	466.10	402	74.67	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			393.9	E08		2	0131-0477	221.96	477.90	722	103.05	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			279.3	E08		2	0132-0473	126.82	472.96	380	72.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			516.1	E08		2	0133-0472	870.35	472.08	319	66.18	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			546.4	E08		2	0134-0475	296.63	475.43	382	75.50	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			263.6	E08		2	0135-0477	173.58	476.81	382	73.84	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			561.9	E08		2	0136-0481	602.06	481.41	489	82.67	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			322.8	E08		2	0137-0490	676.30	490.47	392	75.26	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			286.2	E08		2	0138-0500	890.82	500.70	374	72.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			254.3	E08		2	0139-0501	940.01	500.65	370	73.01	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			286.2	E08		2	0140-0499	617.99	499.08	269	64.43	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			866.5	E08		2	0141-0506	302.68	506.09	559	89.40	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			450.1	E08		2	0142-0504	163.22	503.63	432	81.40	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			331.0	E08		2	0143-0504	847.40	504.03	393	74.43	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			623.4	E08		2	0144-0513	603.02	513.03	283	82.08	0.528
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			885.0	E08		2	0145-0527	375.90	526.51	730	103.05	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			724.0	E08		2	0146-0531	777.66	531.02	435	78.67	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			547.1	E08		2	0147-0540	145.54	540.61	745	109.15	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			297.6	E08		2	0148-0533	531.60	533.96	399	77.50	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			324.0	E08		2	0149-0534	666.34	534.51	401	74.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			566.4	E08		2	0150-0541	707.75	541.05	253	77.84	0.525
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			341.7	E08		2	0151-0547	41.41	547.08	409	78.67	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			339.4	E08		2	0152-0548	73.99	548.39	407	75.26	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			382.7	E08		2	0153-0555	105.27	555.72	398	75.84	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			571.8	E08		2	0154-0551	653.87	551.61	207	52.53	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			518.1	E08		2	0155-0558	832.33	558.28	416	79.26	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			310.1	E08		2	0156-0559	572.73	560.47	817	118.57	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			275.0	E08		2	0157-0560	929.68	559.82	380	74.43	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			247.3	E08		2	0158-0569	20.54	569.14	412	80.33	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			352.5	E08		2	0159-0566	270.34	566.66	420	77.26	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			701.9	E08		2	0160-0576	633.39	576.43	400	73.60	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1404.6	E08		2	0161-0581	471.44	581.79	526	85.50	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			635.8	E08		2	0162-0580	347.13	580.43	396	75.84	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			251.8	E08		2	0163-0582	505.16	581.77	399	73.84	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			401.8	E08		2	0164-0589	591.50	589.08	371	71.26	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			404.6	E08		2	0165-0591	682.30	591.53	370	71.84	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			281.4	E08		2	0166-0600	105.82	600.27	371	71.60	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			336.1	E08		2	0167-0601	285.15	601.69	377	71.84	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			284.2	E08		2	0168-0600	717.83	600.31	422	77.84	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			248.8	E08		2	0169-0602	35.81	602.43	398	73.84	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			393.5	E08		2	0170-0604	200.19	604.23	457	82.08	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			363.2	E08		2	0171-0604	540.79	603.75	393	73.84	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			319.0	E08		2	0172-0609	327.17	609.00	407	77.26	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			360.0	E08		2	0173-0609	774.63	609.18	414	75.36	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			283.3	E08		2	0174-0613	797.36	612.87	461	80.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			275.1	E08		2	0175-0626	196.09	626.48	437	81.60	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			413.4	E08		2	0176-0632	421.06	632.33	407	77.26	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			405.7	E08		2	0177-0646	106.32	646.56	414	76.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			238.4	E08		2	0178-0660	737.33	659.93	429	84.47	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			326.9	E08		2	0179-0657	466.58	656.53	399	79.26	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			326.0	E08		2	0180-0660	350.58	660.47	385	73.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			305.5	E08		2	0181-0661	524.65	661.60	401	74.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			311.5	E08		2	0182-0661	774.24	662.08	435	81.74	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			288.0	E08		2	0183-0662	36.19	661.90	361	71.84	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			288.3	E08		2	0184-0671	157.97	671.75	818	111.40	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			416.6	E08		2	0185-0662	872.90	662.01	666	128.61	0.506
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			305.5	E08		2	0186-0666	289.22	666.21	380	74.08	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			255.0	E08		2	0187-0674	70.95	674.70	366	75.01	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			277.9	E08		2	0188-0677	235.00	676.63	377	73.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			296.7	E08		2	0189-0684	563.26	684.31	396	73.84	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			684.6	E08		2	0190-0691	449.32	690.88	405	76.91	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			275.5	E08		2	0191-0696	716.43	696.13	248	75.50	0.547
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1133.5	E08		2	0192-0702	342.18	702.41	490	87.40	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			361.8	E08		2	0193-0702	591.30	701.65	379	73.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			219.3	E08		3	0001-0028	415.24	28.39	399	76.08	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			291.5	E08		3	0002-0036	582.81	36.50	835	114.95	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			437.1	E08		3	0003-0047	790.25	47.08	573	92.81	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			264.3	E08		3	0004-0047	632.71	47.54	348	69.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			278.5	E08		3	0005-0049	842.21	49.68	380	74.08	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			425.2	E08		3	0006-0059	49.64	58.78	679	99.98	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			264.8	E08		3	0007-0060	451.37	60.22	416	75.84	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1123.5	E08		3	0008-0064	479.63	62.90	740	108.81	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			301.3	E08		3	0009-0067	192.44	67.96	397	75.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1586.5	E08		3	0010-0067	523.81	67.54	485	83.26	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			880.1	E08		3	0011-0073	252.22	73.24	390	75.50	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			238.8	E08		3	0012-0076	425.67	75.91	395	75.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			396.6	E08		3	0013-0076	760.09	75.86	341	69.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			396.7	E08		3	0014-0076	803.99	77.07	365	72.18	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			309.0	E08		3	0015-0079	104.63	79.58	364	71.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1142.5	E08		3	0016-0081	144.10	81.90	430	80.08	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			368.0	E08		3	0017-0087	231.50	86.77	441	82.91	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			628.4	E08		3	0018-0093	904.56	92.91	288	64.18	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			263.3	E08		3	0019-0099	632.40	98.90	380	75.50	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			298.6	E08		3	0020-0099	801.64	99.31	406	77.36	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			241.9	E08		3	0021-0101	606.85	101.13	443	82.33	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			277.1	E08		3	0022-0104	69.86	104.40	367	71.60	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			281.8	E08		3	0023-0109	554.71	109.17	424	76.67	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			270.2	E08		3	0024-0111	520.13	111.51	384	73.01	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			276.5	E08		3	0025-0117	491.15	117.00	391	73.36	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			255.2	E08		3	0026-0121	454.17	121.55	394	75.94	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			468.5	E08		3	0027-0120	664.67	120.27	349	68.77	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			270.5	E08		3	0028-0125	605.34	126.10	451	82.43	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			292.1	E08		3	0029-0128	760.48	127.64	369	73.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			302.8	E08		3	0030-0133	283.91	133.14	379	77.74	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			319.7	E08		3	0031-0139	43.87	140.08	647	96.33	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			308.8	E08		3	0032-0141	838.44	141.63	356	70.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			290.9	E08		3	0033-0144	462.69	143.91	345	71.60	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1148.2	E08		3	0034-0147	403.48	147.68	423	79.74	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			357.0	E08		3	0035-0145	556.73	145.56	373	72.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			289.7	E08		3	0036-0148	936.63	147.82	359	70.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1103.9	E08		3	0037-0161	105.56	160.15	819	113.74	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			340.6	E08		3	0038-0161	159.37	161.40	377	74.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1270.5	E08		3	0039-0164	694.96	163.46	415	78.57	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			332.9	E08		3	0040-0165	620.89	164.85	366	71.84	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			397.9	E08		3	0041-0168	542.45	167.59	374	70.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			318.0	E08		3	0042-0172	861.79	172.65	398	74.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			307.9	E08		3	0043-0174	581.78	175.04	388	72.43	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			419.8	E08		3	0044-0177	683.05	178.30	328	70.91	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			683.5	E08		3	0045-0180	195.44	180.37	403	77.84	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2299.1	E08		3	0046-0181	308.26	180.58	310	72.53	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1978.8	E08		3	0047-0192	761.51	191.65	599	91.26	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			280.0	E08		3	0048-0194	31.71	193.70	709	107.74	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1991.9	E08		3	0049-0193	307.19	192.85	192	57.11	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			320.3	E08		3	0050-0210	253.54	209.53	363	71.26	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			253.7	E08		3	0051-0214	662.03	214.98	374	73.84	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			409.2	E08		3	0052-0225	202.17	225.33	359	70.67	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			327.5	E08		3	0053-0233	894.48	232.88	741	113.20	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			229.3	E08		3	0054-0226	681.37	224.84	416	77.74	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			334.9	E08		3	0055-0226	622.13	226.02	368	72.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			617.9	E08		3	0056-0230	231.70	229.44	406	77.50	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			315.7	E08		3	0057-0229	432.85	229.64	372	71.84	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			351.0	E08		3	0058-0233	377.23	232.95	380	72.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			239.2	E08		3	0059-0238	698.28	238.85	444	79.15	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			224.3	E08		3	0060-0239	113.51	238.68	366	72.67	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			278.0	E08		3	0061-0248	500.11	247.44	356	70.67	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1094.8	E08		3	0062-0251	752.47	251.41	385	75.26	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			666.9	E08		3	0063-0256	162.63	255.61	376	76.91	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			292.9	E08		3	0064-0276	640.98	276.20	848	126.02	0.671
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			381.8	E08		3	0065-0267	864.53	267.31	398	74.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1453.4	E08		3	0066-0277	682.08	277.03	520	85.50	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1415.3	E08		3	0067-0280	937.73	280.03	369	72.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			290.5	E08		3	0068-0282	619.21	283.03	418	80.67	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			972.5	E08		3	0069-0283	243.07	283.34	402	77.50	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			340.6	E08		3	0070-0286	502.83	286.56	398	75.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1401.8	E08		3	0071-0297	168.63	296.89	692	98.33	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			359.8	E08		3	0072-0293	818.20	293.63	379	73.01	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			333.1	E08		3	0073-0295	365.72	296.06	381	73.26	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			212.7	E08		3	0074-0299	700.88	298.65	369	72.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			181.9	E08		3	0075-0304	116.70	303.98	384	75.26	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			783.2	E08		3	0076-0316	211.94	316.42	415	75.01	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			377.1	E08		3	0077-0329	802.76	329.64	374	71.01	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			318.2	E08		3	0078-0326	851.75	326.91	277	65.60	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			276.8	E08		3	0079-0340	682.57	340.35	401	76.67	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1369.2	E08		3	0080-0346	414.42	345.62	377	70.77	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			334.0	E08		3	0081-0351	596.96	351.22	418	77.60	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			214.9	E08		3	0082-0353	446.26	353.58	383	73.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			338.3	E08		3	0083-0355	895.73	355.83	370	72.67	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			636.9	E08		3	0084-0363	202.60	363.08	387	74.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			177.5	E08		3	0085-0368	142.99	367.77	372	77.84	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			442.8	E08		3	0086-0368	796.25	368.49	398	75.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			286.0	E08		3	0087-0370	633.01	370.73	390	73.84	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			499.5	E08		3	0088-0373	817.02	373.12	337	67.11	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			286.9	E08		3	0089-0376	858.96	376.34	183	53.94	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			308.7	E08		3	0090-0381	323.92	381.41	369	71.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			375.5	E08		3	0091-0384	710.82	384.50	772	107.74	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			168.6	E08		3	0092-0392	230.06	392.60	411	78.91	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			239.9	E08		3	0093-0389	667.16	389.10	379	75.01	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			285.2	E08		3	0094-0390	911.86	389.80	341	71.60	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			318.8	E08		3	0095-0393	139.73	394.28	338	68.18	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			288.4	E08		3	0096-0397	444.60	396.62	591	99.84	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			389.4	E08		3	0097-0399	533.28	399.79	365	72.67	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			196.7	E08		3	0098-0402	246.58	402.44	379	75.26	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			217.7	E08		3	0099-0404	357.90	403.92	369	72.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			525.9	E08		3	0100-0415	486.20	414.77	845	118.61	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			217.6	E08		3	0101-0421	164.73	421.37	387	76.43	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			212.0	E08		3	0102-0421	285.05	421.10	395	73.84	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			344.9	E08		3	0103-0427	465.41	427.88	436	79.98	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			224.9	E08		3	0104-0427	322.12	427.69	395	73.26	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			350.9	E08		3	0105-0430	638.37	430.24	746	107.05	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			384.1	E08		3	0106-0430	686.73	430.73	378	73.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			255.1	E08		3	0107-0434	108.10	433.85	387	73.84	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			233.4	E08		3	0108-0437	59.84	437.40	376	72.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			549.1	E08		3	0109-0439	611.79	439.72	327	67.26	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			611.0	E08		3	0110-0452	856.28	453.15	186	66.77	0.524
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			436.6	E08		3	0111-0462	894.04	461.91	377	72.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			262.5	E08		3	0112-0469	598.73	470.62	823	111.54	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			278.1	E08		3	0113-0466	199.40	465.88	395	76.43	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			398.5	E08		3	0114-0463	864.99	464.80	169	61.11	0.569
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			257.1	E08		3	0115-0468	18.62	468.60	375	72.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			234.4	E08		3	0116-0477	537.51	477.00	395	73.84	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			224.8	E08		3	0117-0480	53.51	480.49	349	71.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			257.7	E08		3	0118-0489	512.63	489.10	419	78.33	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			246.7	E08		3	0119-0487	713.79	487.75	393	75.01	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			291.0	E08		3	0120-0488	757.30	487.96	396	76.43	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			259.8	E08		3	0121-0496	472.71	496.72	389	73.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			241.1	E08		3	0122-0498	409.66	497.78	366	71.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			226.2	E08		3	0123-0503	35.08	503.00	328	68.77	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			269.3	E08		3	0124-0506	169.29	506.84	401	77.60	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			608.0	E08		3	0125-0503	870.94	502.71	369	74.43	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			256.8	E08		3	0126-0513	109.46	513.19	361	72.43	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			279.0	E08		3	0127-0525	449.52	527.03	799	124.81	0.645
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			283.6	E08		3	0128-0515	252.53	515.56	362	73.84	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			255.0	E08		3	0129-0517	190.70	517.05	390	76.33	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			367.4	E08		3	0130-0517	776.83	517.42	340	68.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			360.6	E08		3	0131-0515	808.51	515.00	361	70.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			242.5	E08		3	0132-0521	742.37	520.71	393	75.26	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			278.8	E08		3	0133-0523	296.24	523.06	380	73.26	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			490.1	E08		3	0134-0527	339.69	527.96	523	127.30	0.406
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			248.2	E08		3	0135-0526	587.22	526.52	410	75.36	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			346.2	E08		3	0136-0530	680.35	529.55	417	77.26	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			216.9	E08		3	0137-0531	419.13	531.53	366	72.43	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			238.1	E08		3	0138-0534	548.07	534.35	414	78.08	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			370.2	E08		3	0139-0540	362.14	540.66	391	77.50	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			277.8	E08		3	0140-0545	139.63	544.61	373	77.50	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			252.3	E08		3	0141-0549	525.84	548.52	465	82.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			250.0	E08		3	0142-0556	83.76	556.33	752	107.40	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			401.6	E08		3	0143-0545	688.86	545.38	210	58.77	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			290.8	E08		3	0144-0552	271.47	551.69	372	76.08	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			259.4	E08		3	0145-0557	400.75	557.74	400	75.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			280.2	E08		3	0146-0558	57.64	557.53	415	78.67	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			573.9	E08		3	0147-0557	669.21	557.34	312	65.36	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			231.5	E08		3	0148-0562	24.51	562.19	357	71.60	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			301.3	E08		3	0149-0563	135.43	563.83	398	77.84	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			293.7	E08		3	0150-0563	342.88	563.66	410	79.01	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			231.5	E08		3	0151-0571	182.53	571.83	359	72.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			310.9	E08		3	0152-0581	582.33	580.93	438	79.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			281.8	E08		3	0153-0590	358.55	589.37	813	117.40	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			325.8	E08		3	0154-0586	902.42	586.52	384	73.26	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			299.3	E08		3	0155-0589	448.82	589.10	400	76.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			350.1	E08		3	0156-0593	768.02	593.82	407	74.08	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			302.6	E08		3	0157-0595	502.68	596.04	364	71.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			812.7	E08		3	0158-0604	831.40	603.98	362	73.60	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			309.7	E08		3	0159-0609	640.19	610.11	432	80.33	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			313.9	E08		3	0160-0611	850.23	611.63	370	74.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			344.9	E08		3	0161-0615	610.75	615.08	382	74.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			266.5	E08		3	0162-0628	536.77	627.71	417	78.08	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			276.3	E08		3	0163-0629	888.03	629.44	361	69.84	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			227.5	E08		3	0164-0638	173.63	638.96	773	108.23	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			328.3	E08		3	0165-0632	368.35	632.47	374	72.18	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			810.0	E08		3	0166-0635	289.51	635.13	365	72.43	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			345.7	E08		3	0167-0635	466.65	635.64	364	71.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			539.7	E08		3	0168-0640	241.54	639.77	373	75.01	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1928.2	E08		3	0169-0646	811.99	645.99	397	76.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			494.9	E08		3	0170-0653	50.79	652.78	721	100.23	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			221.3	E08		3	0171-0657	403.07	657.42	389	75.94	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			312.2	E08		3	0172-0669	131.11	669.24	419	79.74	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			274.6	E08		3	0173-0666	790.26	666.03	364	71.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			304.1	E08		3	0174-0669	769.70	669.44	437	82.67	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			228.0	E08		3	0175-0670	282.60	669.71	408	77.50	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			217.4	E08		3	0176-0670	336.02	669.89	373	72.67	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			278.0	E08		3	0177-0676	711.71	675.45	327	70.67	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			324.5	E08		3	0178-0675	902.93	675.77	440	80.57	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			254.8	E08		3	0179-0678	399.08	677.28	461	83.26	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			288.6	E08		3	0180-0679	461.52	678.85	335	71.70	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			232.6	E08		3	0181-0681	480.11	681.06	401	74.87	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			327.2	E08		3	0182-0683	883.11	684.29	410	76.33	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			265.6	E08		3	0183-0686	522.20	685.85	368	71.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			223.7	E08		3	0184-0687	119.99	686.81	247	61.26	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			195.6	E08		3	0185-0690	171.31	690.63	386	73.84	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			188.3	E08		3	0186-0692	290.70	692.65	416	78.67	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			425.6	E08		3	0187-0693	698.95	693.60	331	68.43	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			764.1	E08		3	0188-0696	753.16	696.63	394	74.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			268.0	E08		3	0189-0702	238.41	702.66	741	105.40	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			212.6	E08		4	0001-0029	376.31	29.33	422	79.50	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			521.5	E08		4	0002-0030	469.53	29.71	401	77.50	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			257.5	E08		4	0003-0032	326.73	31.62	416	76.67	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			238.8	E08		4	0004-0035	166.80	35.50	385	74.67	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			263.3	E08		4	0005-0034	539.01	34.48	445	82.43	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			255.2	E08		4	0006-0034	38.45	34.57	375	74.33	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			319.7	E08		4	0007-0036	206.75	36.76	415	80.57	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			312.4	E08		4	0008-0042	639.40	41.71	375	73.50	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			284.2	E08		4	0009-0047	481.05	47.22	481	85.98	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			391.1	E08		4	0010-0051	403.40	51.21	468	82.33	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			253.6	E08		4	0011-0061	606.13	61.23	465	82.08	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			312.1	E08		4	0012-0061	870.01	62.05	423	76.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			336.9	E08		4	0013-0064	814.30	64.40	384	72.77	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1134.0	E08		4	0014-0070	776.89	69.91	432	80.08	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			329.5	E08		4	0015-0069	362.99	69.22	421	80.33	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			296.1	E08		4	0016-0075	690.51	75.10	436	78.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			361.3	E08		4	0017-0076	236.77	76.65	410	77.50	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			282.2	E08		4	0018-0077	538.56	77.41	475	87.15	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			942.5	E08		4	0019-0084	839.75	83.66	374	72.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			244.9	E08		4	0020-0087	511.66	87.27	484	87.15	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			380.4	E08		4	0021-0100	67.65	99.83	411	77.26	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			323.9	E08		4	0022-0102	191.26	101.85	442	80.67	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1441.8	E08		4	0023-0106	411.29	105.96	766	104.91	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			426.3	E08		4	0024-0103	436.90	103.15	459	81.36	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			301.1	E08		4	0025-0103	24.48	103.70	398	75.84	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			297.4	E08		4	0026-0108	564.96	108.42	928	128.95	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			274.0	E08		4	0027-0110	667.55	110.64	870	122.95	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			318.9	E08		4	0028-0108	915.24	107.70	423	78.43	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			463.1	E08		4	0029-0119	369.86	119.71	872	117.64	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1466.3	E08		4	0030-0117	483.56	116.96	693	99.98	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			275.4	E08		4	0031-0133	735.08	133.36	872	128.51	0.664
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			234.9	E08		4	0032-0132	793.21	132.41	434	79.50	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			413.5	E08		4	0033-0135	590.91	134.99	441	78.91	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			343.2	E08		4	0034-0138	284.81	138.69	455	83.15	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			338.0	E08		4	0035-0141	624.33	140.81	426	82.57	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			538.6	E08		4	0036-0140	258.61	140.15	317	69.50	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			866.6	E08		4	0037-0144	195.41	144.54	413	77.50	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			287.7	E08		4	0038-0144	893.43	144.56	395	74.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			496.3	E08		4	0039-0148	364.65	148.27	417	80.33	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			496.0	E08		4	0040-0164	122.86	165.55	853	117.78	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			437.6	E08		4	0041-0158	345.00	157.93	466	85.15	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			277.2	E08		4	0042-0158	658.78	158.60	415	76.67	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			566.6	E08		4	0043-0162	39.75	161.75	398	74.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			418.0	E08		4	0044-0163	477.58	162.65	392	73.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			208.5	E08		4	0045-0171	757.86	171.71	411	81.50	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			520.8	E08		4	0046-0179	690.09	179.95	451	82.91	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			351.0	E08		4	0047-0181	509.76	179.71	436	82.47	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			450.8	E08		4	0048-0180	423.86	179.86	449	82.91	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			281.0	E08		4	0049-0188	634.58	188.58	481	83.74	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			358.3	E08		4	0050-0191	491.16	193.10	435	82.33	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			229.5	E08		4	0051-0192	794.75	192.31	428	78.08	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			395.9	E08		4	0052-0197	550.39	197.01	414	79.26	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			366.8	E08		4	0053-0197	831.67	197.45	401	76.08	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			367.9	E08		4	0054-0202	411.77	202.14	485	90.33	0.747
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			327.8	E08		4	0055-0211	606.56	211.27	947	125.44	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			603.1	E08		4	0056-0206	385.02	206.39	456	82.67	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			419.8	E08		4	0057-0209	242.02	207.81	446	81.88	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			356.6	E08		4	0058-0212	67.31	211.81	423	79.26	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			434.4	E08		4	0059-0210	286.99	210.26	423	78.08	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			259.3	E08		4	0060-0216	726.80	215.88	427	77.50	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			386.9	E08		4	0061-0221	226.57	222.17	395	78.23	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			542.2	E08		4	0062-0222	544.15	222.08	490	86.18	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			613.0	E08		4	0063-0220	777.29	220.48	419	76.67	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			304.8	E08		4	0064-0230	350.24	230.09	407	76.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			279.8	E08		4	0065-0235	698.65	235.23	431	82.81	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			431.4	E08		4	0066-0235	390.33	235.47	392	75.50	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			301.9	E08		4	0067-0243	108.57	243.69	401	77.50	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			278.8	E08		4	0068-0246	838.49	246.20	452	80.91	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			299.9	E08		4	0069-0248	543.64	247.86	431	78.43	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			233.0	E08		4	0070-0248	753.37	248.95	404	77.50	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			351.4	E08		4	0071-0248	451.53	248.74	468	84.77	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			272.2	E08		4	0072-0252	323.73	252.20	406	77.26	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			836.6	E08		4	0073-0254	473.20	254.32	420	80.18	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			358.2	E08		4	0074-0255	912.05	255.95	362	71.26	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			273.1	E08		4	0075-0258	640.31	258.51	486	85.50	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			235.9	E08		4	0076-0260	665.44	259.77	452	83.50	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1240.0	E08		4	0077-0263	872.41	263.11	474	83.50	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			720.8	E08		4	0078-0266	367.06	265.64	415	76.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			391.0	E08		4	0079-0268	780.52	268.02	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			331.0	E08		4	0080-0274	179.37	274.15	430	77.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			283.0	E08		4	0081-0280	251.34	280.48	399	75.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			382.7	E08		4	0082-0286	526.38	286.29	418	77.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1981.8	E08		4	0083-0291	805.27	290.90	691	98.57	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			249.9	E08		4	0084-0289	415.43	289.20	429	80.08	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			286.6	E08		4	0085-0303	165.61	303.77	430	77.84	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			368.7	E08		4	0086-0308	709.10	308.30	472	83.26	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			260.7	E08		4	0087-0311	288.03	311.72	406	79.50	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			238.8	E08		4	0088-0312	901.72	311.94	422	76.43	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			420.9	E08		4	0089-0318	685.82	317.83	441	80.67	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1703.5	E08		4	0090-0323	249.96	323.02	742	104.47	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			321.0	E08		4	0091-0322	624.79	322.52	399	76.08	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			303.1	E08		4	0092-0322	943.40	322.65	381	73.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			332.6	E08		4	0093-0347	676.81	348.17	412	76.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			302.0	E08		4	0094-0349	750.47	349.19	842	119.64	0.739
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			336.1	E08		4	0095-0349	136.05	348.74	396	76.91	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			448.1	E08		4	0096-0353	704.85	353.22	416	78.91	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			372.2	E08		4	0097-0361	338.63	362.11	810	111.88	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			254.4	E08		4	0098-0357	564.43	357.09	460	82.77	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			288.0	E08		4	0099-0359	203.75	359.23	427	80.33	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			303.9	E08		4	0100-0362	531.38	361.51	870	114.57	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			259.5	E08		4	0101-0364	616.58	364.28	423	75.84	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			271.3	E08		4	0102-0370	180.75	369.39	448	80.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			532.6	E08		4	0103-0375	83.23	375.25	391	78.33	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			389.9	E08		4	0104-0377	425.81	377.11	425	78.91	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			347.6	E08		4	0105-0386	288.74	385.59	897	123.88	0.734
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			637.0	E08		4	0106-0384	871.17	383.61	342	68.18	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			307.0	E08		4	0107-0389	24.18	389.00	376	74.67	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			399.8	E08		4	0108-0387	258.24	387.51	410	78.53	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			361.1	E08		4	0109-0393	491.32	393.10	437	83.15	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			334.8	E08		4	0110-0396	552.04	394.76	415	80.23	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			240.5	E08		4	0111-0398	738.64	397.49	397	74.43	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			444.2	E08		4	0112-0399	684.04	398.75	412	76.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			401.8	E08		4	0113-0407	389.42	406.76	529	94.91	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			242.0	E08		4	0114-0407	589.34	406.88	420	78.67	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1372.1	E08		4	0115-0406	920.59	406.58	440	77.26	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1851.3	E08		4	0116-0413	532.50	414.86	753	104.47	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			299.2	E08		4	0117-0413	233.92	412.73	412	77.26	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			286.8	E08		4	0118-0411	359.40	410.70	415	78.08	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			326.0	E08		4	0119-0413	630.06	411.74	381	77.64	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			271.3	E08		4	0120-0419	285.91	418.45	839	108.81	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			374.7	E08		4	0121-0421	695.14	420.42	479	90.81	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			300.5	E08		4	0122-0419	436.31	419.40	407	76.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1177.5	E08		4	0123-0425	110.14	425.64	562	94.81	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			370.0	E08		4	0124-0426	645.96	426.73	455	80.57	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			310.0	E08		4	0125-0425	866.84	425.04	392	76.91	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			571.4	E08		4	0126-0426	382.97	426.70	214	60.77	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			303.3	E08		4	0127-0431	777.43	430.82	454	83.15	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			312.1	E08		4	0128-0436	705.74	437.07	413	81.98	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			261.4	E08		4	0129-0435	319.58	435.80	410	76.08	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			296.6	E08		4	0130-0446	599.20	446.02	744	100.81	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			442.4	E08		4	0131-0448	163.99	448.51	430	78.08	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			242.7	E08		4	0132-0456	276.89	456.42	424	78.08	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			306.2	E08		4	0133-0459	905.75	457.52	380	75.98	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			303.0	E08		4	0134-0468	888.60	469.74	418	79.74	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			434.6	E08		4	0135-0474	695.70	474.53	764	106.23	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			316.6	E08		4	0136-0477	370.65	476.79	426	80.81	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			276.8	E08		4	0137-0481	112.68	481.24	401	78.33	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			347.2	E08		4	0138-0488	213.74	488.34	406	78.67	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			275.8	E08		4	0139-0486	603.59	485.86	424	78.91	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			358.3	E08		4	0140-0492	76.49	492.01	442	82.33	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			263.9	E08		4	0141-0490	307.38	490.29	448	81.50	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			412.6	E08		4	0142-0495	355.80	495.48	508	86.57	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			315.5	E08		4	0143-0498	530.91	497.54	426	78.43	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			265.9	E08		4	0144-0508	936.11	508.18	411	76.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			411.7	E08		4	0145-0516	640.42	515.71	391	73.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			332.0	E08		4	0146-0518	385.44	518.92	445	83.98	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			265.1	E08		4	0147-0526	569.04	526.32	431	80.33	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			251.9	E08		4	0148-0525	428.94	525.80	418	80.33	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			229.9	E08		4	0149-0528	701.21	528.02	431	79.50	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			372.3	E08		4	0150-0535	118.78	535.26	432	80.91	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			419.8	E08		4	0151-0535	367.11	534.85	449	81.74	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			319.7	E08		4	0152-0538	154.87	538.00	401	75.74	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			253.5	E08		4	0153-0542	403.90	541.72	447	84.33	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			305.2	E08		4	0154-0546	617.77	545.48	421	78.67	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			410.0	E08		4	0155-0553	247.29	552.85	707	100.23	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			287.5	E08		4	0156-0546	851.67	546.21	400	76.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			271.5	E08		4	0157-0551	755.90	550.92	400	75.01	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1238.0	E08		4	0158-0555	509.69	555.50	513	86.33	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			244.9	E08		4	0159-0566	449.55	566.71	846	114.47	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			315.7	E08		4	0160-0565	325.54	565.58	446	78.91	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			270.4	E08		4	0161-0565	718.66	565.16	417	77.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			324.1	E08		4	0162-0578	581.05	578.21	405	77.26	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			267.1	E08		4	0163-0584	352.77	585.09	409	78.91	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			367.3	E08		4	0164-0586	644.49	587.18	809	110.81	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			323.7	E08		4	0165-0599	386.32	598.68	902	122.02	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			311.0	E08		4	0166-0597	820.30	597.28	403	79.50	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			221.1	E08		4	0167-0597	902.14	597.37	399	74.43	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			290.8	E08		4	0168-0601	522.22	601.39	413	77.84	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			315.2	E08		4	0169-0610	858.65	610.57	427	79.50	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			356.1	E08		4	0170-0611	197.02	610.95	439	80.91	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			272.9	E08		4	0171-0610	713.64	610.13	416	77.84	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			427.4	E08		4	0172-0612	777.81	612.44	373	70.77	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			411.3	E08		4	0173-0617	442.56	617.16	390	75.50	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			301.5	E08		4	0174-0620	300.22	620.31	408	74.43	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1414.1	E08		4	0175-0623	818.13	622.92	476	84.08	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			293.5	E08		4	0176-0632	66.66	631.38	777	109.05	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			268.8	E08		4	0177-0638	333.96	638.20	438	79.74	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1327.6	E08		4	0178-0639	645.90	638.83	415	75.84	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			327.0	E08		4	0179-0644	254.30	643.97	410	75.84	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			463.7	E08		4	0180-0644	766.71	644.46	248	87.50	0.407
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			360.9	E08		4	0181-0649	475.70	648.79	796	111.64	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			440.0	E08		4	0182-0654	885.78	655.00	352	69.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			297.1	E08		4	0183-0656	36.38	656.07	390	73.26	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			209.7	E08		4	0184-0658	820.16	658.20	417	75.84	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			337.1	E08		4	0185-0666	109.47	665.99	445	80.91	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			251.9	E08		4	0186-0668	931.79	667.74	379	73.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			245.9	E08		4	0187-0670	764.69	670.90	426	79.74	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			266.2	E08		4	0188-0670	515.22	671.01	430	81.40	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			382.1	E08		4	0189-0672	228.59	672.38	446	80.67	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			243.3	E08		4	0190-0677	711.19	677.12	407	78.33	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			325.9	E08		4	0191-0680	362.66	680.49	407	74.18	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			265.4	E08		4	0192-0682	674.03	681.82	403	75.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			255.7	E08		4	0193-0688	31.90	688.55	387	75.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			224.3	E08		4	0194-0700	913.09	698.64	422	81.15	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			333.2	E08		4	0195-0699	177.40	699.16	425	77.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			242.5	E08		4	0196-0706	896.96	706.45	370	76.67	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			414.2	E08		4	0197-0705	451.24	705.04	393	73.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			316.4	E08		4	0198-0706	841.19	706.47	391	73.84	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1480.2	E08		5	0001-0036	912.92	36.08	697	97.74	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			375.1	E08		5	0002-0037	400.71	36.02	190	56.53	0.747
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			281.6	E08		5	0003-0042	383.54	44.47	533	95.15	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			295.2	E08		5	0004-0043	672.96	42.74	427	77.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			381.0	E08		5	0005-0047	55.66	46.50	612	93.98	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1381.4	E08		5	0006-0047	87.28	46.68	387	97.15	0.515
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			522.3	E08		5	0007-0044	186.17	44.47	395	73.84	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			307.6	E08		5	0008-0047	226.42	47.21	458	83.15	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			380.4	E08		5	0009-0048	129.84	47.85	425	77.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			386.1	E08		5	0010-0050	790.39	50.36	408	77.74	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2886.4	E08		5	0011-0051	101.71	52.26	139	54.53	0.587
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			261.8	E08		5	0012-0057	312.17	57.19	430	79.26	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			254.2	E08		5	0013-0068	489.97	68.32	441	79.50	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			297.5	E08		5	0014-0073	372.57	73.36	407	74.43	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			280.0	E08		5	0015-0074	412.97	74.21	406	77.50	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			342.5	E08		5	0016-0082	710.92	82.13	436	77.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			318.5	E08		5	0017-0089	155.98	89.08	370	72.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			319.1	E08		5	0018-0098	744.01	98.60	365	71.26	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			312.6	E08		5	0019-0101	112.51	100.66	349	70.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			253.8	E08		5	0020-0107	189.04	107.38	386	77.50	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			421.2	E08		5	0021-0106	912.13	105.94	263	75.50	0.580
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			283.2	E08		5	0022-0110	20.05	109.88	419	79.74	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			421.7	E08		5	0023-0113	684.55	113.61	430	78.08	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			848.3	E08		5	0024-0134	634.63	132.56	822	126.37	0.647
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			256.7	E08		5	0025-0135	217.50	135.58	433	79.84	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			266.5	E08		5	0026-0138	151.19	137.96	392	74.67	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			291.3	E08		5	0027-0139	694.30	139.48	432	78.91	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			418.2	E08		5	0028-0138	506.42	138.97	366	71.26	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			468.0	E08		5	0029-0153	739.43	153.21	377	71.01	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1521.7	E08		5	0030-0155	266.99	155.23	390	74.08	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			299.5	E08		5	0031-0158	364.21	158.24	390	74.43	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			280.2	E08		5	0032-0157	789.19	157.46	339	69.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			486.8	E08		5	0033-0161	428.45	161.27	415	79.15	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			434.2	E08		5	0034-0162	606.91	162.23	471	85.98	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			280.4	E08		5	0035-0164	102.21	164.37	385	74.91	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			304.9	E08		5	0036-0170	393.74	169.85	402	75.84	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			598.2	E08		5	0037-0173	45.29	173.71	724	105.50	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			594.0	E08		5	0038-0176	559.97	176.57	534	125.44	0.426
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			226.5	E08		5	0039-0182	182.79	182.45	382	74.33	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			266.2	E08		5	0040-0184	824.00	184.55	431	79.84	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			252.9	E08		5	0041-0189	630.02	190.57	822	113.54	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			229.3	E08		5	0042-0185	228.36	183.91	443	87.05	0.735
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			396.8	E08		5	0043-0202	452.20	201.93	838	110.57	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			356.3	E08		5	0044-0195	279.94	195.23	410	77.01	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1566.9	E08		5	0045-0202	155.62	202.56	473	86.08	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1805.2	E08		5	0046-0201	527.69	201.62	461	81.84	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			281.6	E08		5	0047-0203	752.82	203.24	401	76.08	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			334.8	E08		5	0048-0210	326.39	209.37	856	119.20	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			205.9	E08		5	0049-0207	228.68	207.78	408	82.23	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			514.9	E08		5	0050-0218	126.09	217.93	392	77.74	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			200.0	E08		5	0051-0219	938.78	219.02	391	74.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			271.2	E08		5	0052-0223	167.61	222.46	356	76.43	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			304.4	E08		5	0053-0229	91.30	229.29	380	74.67	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			250.3	E08		5	0054-0229	780.61	229.64	408	76.67	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1252.1	E08		5	0055-0233	833.52	233.37	660	96.57	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			267.3	E08		5	0056-0232	898.40	232.45	416	76.67	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1597.5	E08		5	0057-0241	397.59	241.52	526	87.74	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			345.3	E08		5	0058-0244	649.02	244.50	374	70.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			205.9	E08		5	0059-0248	294.41	247.83	388	74.67	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1613.9	E08		5	0060-0250	614.43	250.41	465	83.74	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			247.8	E08		5	0061-0253	247.78	252.38	415	81.40	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			286.0	E08		5	0062-0253	514.90	252.80	430	80.91	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			246.2	E08		5	0063-0254	738.72	254.37	418	79.01	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			342.7	E08		5	0064-0258	16.81	258.04	373	73.26	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			464.1	E08		5	0065-0260	71.67	260.48	388	73.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			231.3	E08		5	0066-0260	337.57	260.69	413	76.67	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			265.4	E08		5	0067-0261	717.98	261.28	407	79.26	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			399.7	E08		5	0068-0261	359.63	260.89	371	71.70	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			316.7	E08		5	0069-0268	867.65	268.12	368	72.08	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			278.8	E08		5	0070-0271	812.16	270.97	430	79.50	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			281.5	E08		5	0071-0274	164.80	274.49	398	76.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			728.0	E08		5	0072-0282	833.97	281.78	441	82.91	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			251.5	E08		5	0073-0285	930.92	285.11	411	75.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			213.9	E08		5	0074-0291	91.17	291.53	396	75.26	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			283.1	E08		5	0075-0291	480.15	291.94	443	80.33	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			230.2	E08		5	0076-0290	541.98	289.68	413	80.33	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			199.7	E08		5	0077-0297	744.79	296.42	423	79.74	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			266.7	E08		5	0078-0298	638.64	298.19	436	79.50	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			234.6	E08		5	0079-0299	696.64	299.44	421	77.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			254.1	E08		5	0080-0310	859.34	310.60	433	79.26	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			247.5	E08		5	0081-0311	211.24	311.25	384	73.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1706.5	E08		5	0082-0317	458.01	318.23	597	94.81	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			202.3	E08		5	0083-0316	756.38	317.12	453	82.08	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			637.7	E08		5	0084-0320	547.00	320.09	475	92.23	0.702
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			285.9	E08		5	0085-0322	522.21	322.03	409	79.84	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			282.1	E08		5	0086-0325	48.41	324.90	371	73.50	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			250.1	E08		5	0087-0325	111.70	324.44	389	75.01	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			408.6	E08		5	0088-0329	314.40	328.83	415	76.08	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			267.5	E08		5	0089-0331	582.08	332.17	403	76.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			258.5	E08		5	0090-0333	673.06	333.28	435	80.08	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			255.8	E08		5	0091-0331	899.74	331.41	398	77.26	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			231.1	E08		5	0092-0338	172.43	338.13	383	74.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			215.5	E08		5	0093-0339	223.79	339.76	383	74.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			236.6	E08		5	0094-0347	779.18	347.30	388	76.33	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			310.4	E08		5	0095-0349	689.37	349.18	454	81.74	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			226.8	E08		5	0096-0349	144.38	349.49	383	74.08	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			226.7	E08		5	0097-0351	272.80	350.88	394	76.08	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			346.2	E08		5	0098-0356	645.18	355.75	398	76.67	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			233.4	E08		5	0099-0371	89.56	371.12	398	75.26	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			243.4	E08		5	0100-0371	750.34	370.95	394	79.15	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			257.1	E08		5	0101-0375	859.09	374.62	419	77.50	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			282.6	E08		5	0102-0377	235.32	377.50	785	116.95	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			275.9	E08		5	0103-0385	597.11	385.01	934	125.68	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1004.3	E08		5	0104-0389	304.30	388.70	858	119.68	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			229.1	E08		5	0105-0383	122.06	383.52	392	76.57	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			292.0	E08		5	0106-0388	549.09	386.78	494	88.57	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			230.7	E08		5	0107-0388	493.48	388.54	448	86.57	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			264.6	E08		5	0108-0392	464.63	392.49	458	82.91	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			270.2	E08		5	0109-0398	361.87	397.81	415	76.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			229.2	E08		5	0110-0397	729.47	397.47	422	77.50	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			379.5	E08		5	0111-0402	644.21	402.75	401	75.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1317.1	E08		5	0112-0408	25.84	408.78	427	77.50	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			250.2	E08		5	0113-0412	687.08	412.42	423	78.67	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			245.7	E08		5	0114-0420	131.98	419.92	301	71.11	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			272.6	E08		5	0115-0420	149.08	419.68	190	53.21	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			341.2	E08		5	0116-0426	598.50	426.01	414	77.50	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			249.2	E08		5	0117-0428	881.31	428.51	431	80.33	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			202.8	E08		5	0118-0433	743.77	432.91	402	76.67	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			226.7	E08		5	0119-0436	519.01	436.38	420	78.08	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			458.7	E08		5	0120-0440	203.93	440.29	462	83.84	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			294.4	E08		5	0121-0442	226.39	442.23	462	81.60	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			361.7	E08		5	0122-0442	259.99	441.96	399	75.50	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			226.0	E08		5	0123-0442	396.28	441.63	404	77.26	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1755.0	E08		5	0124-0452	828.09	451.93	481	81.01	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			666.7	E08		5	0125-0454	567.20	454.24	407	76.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			280.7	E08		5	0126-0458	60.38	458.16	396	77.26	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			368.7	E08		5	0127-0464	462.94	463.98	444	82.91	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			223.3	E08		5	0128-0462	682.87	461.98	412	76.91	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1549.1	E08		5	0129-0466	727.81	466.33	689	100.47	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			273.4	E08		5	0130-0462	939.93	462.33	386	73.01	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			257.4	E08		5	0131-0480	545.63	480.82	800	118.71	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			410.8	E08		5	0132-0475	595.64	476.17	420	82.33	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			278.6	E08		5	0133-0486	337.27	486.65	436	83.40	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			215.5	E08		5	0134-0487	654.85	487.16	421	78.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			328.5	E08		5	0135-0498	312.01	498.08	791	114.95	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			203.9	E08		5	0136-0500	732.05	500.30	421	78.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			290.5	E08		5	0137-0510	41.05	510.31	392	74.67	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			312.6	E08		5	0138-0511	901.81	511.56	447	79.50	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			291.3	E08		5	0139-0514	171.32	513.56	408	78.57	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			445.0	E08		5	0140-0515	814.29	515.03	404	77.26	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			278.8	E08		5	0141-0517	762.03	517.57	409	75.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			287.9	E08		5	0142-0518	524.67	518.08	411	77.26	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			255.0	E08		5	0143-0530	669.23	530.32	405	76.67	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			625.9	E08		5	0144-0535	381.83	535.94	398	75.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			268.4	E08		5	0145-0537	450.65	536.69	413	79.26	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			203.1	E08		5	0146-0540	496.57	540.79	433	77.01	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			218.1	E08		5	0147-0543	575.29	542.93	427	80.33	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			217.8	E08		5	0148-0551	803.26	551.15	813	113.05	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			477.4	E08		5	0149-0551	922.87	550.54	310	66.18	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			464.6	E08		5	0150-0562	119.28	562.25	412	78.33	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			353.8	E08		5	0151-0565	243.17	565.20	397	74.91	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			243.5	E08		5	0152-0565	856.86	565.48	401	73.84	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			246.4	E08		5	0153-0572	309.73	571.73	409	79.50	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1978.2	E08		5	0154-0576	918.68	577.10	561	89.15	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			241.8	E08		5	0155-0579	350.68	579.12	403	75.50	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			309.5	E08		5	0156-0580	58.30	579.86	385	74.67	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			409.7	E08		5	0157-0584	284.01	584.18	751	105.64	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			504.6	E08		5	0158-0590	578.60	590.09	424	82.08	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			354.7	E08		5	0159-0593	777.12	593.57	371	75.74	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			297.5	E08		5	0160-0595	468.12	594.79	435	77.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			286.5	E08		5	0161-0607	390.67	607.42	853	115.88	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			316.3	E08		5	0162-0605	848.16	605.02	340	68.18	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			249.8	E08		5	0163-0609	726.45	609.57	390	73.26	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			356.4	E08		5	0164-0611	150.33	610.49	400	76.33	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			233.9	E08		5	0165-0614	112.83	614.69	392	74.08	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			219.3	E08		5	0166-0619	311.78	619.52	400	77.74	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			210.5	E08		5	0167-0620	53.42	619.82	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			478.1	E08		5	0168-0621	536.05	620.32	336	70.43	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			260.2	E08		5	0169-0626	822.73	625.75	397	76.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			255.1	E08		5	0170-0623	269.05	623.42	417	77.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			314.0	E08		5	0171-0630	552.07	630.35	420	83.50	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			234.2	E08		5	0172-0631	442.94	631.56	409	77.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			237.6	E08		5	0173-0635	917.01	635.15	376	74.08	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			626.0	E08		5	0174-0635	859.67	635.02	418	77.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1008.0	E08		5	0175-0649	331.63	649.34	432	80.33	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			506.9	E08		5	0176-0651	801.96	651.19	436	82.33	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			326.7	E08		5	0177-0648	142.89	648.94	365	74.43	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			219.3	E08		5	0178-0653	87.19	652.94	379	76.33	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1392.0	E08		5	0179-0654	490.62	655.31	427	97.40	0.566
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			268.1	E08		5	0180-0654	290.92	654.14	391	75.26	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			280.9	E08		5	0181-0658	122.51	658.29	430	78.08	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			283.1	E08		5	0182-0660	943.92	659.79	269	61.36	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			252.5	E08		5	0183-0665	450.32	665.15	408	76.67	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			257.7	E08		5	0184-0666	711.38	665.77	407	78.08	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			276.5	E08		5	0185-0665	388.66	665.79	387	76.08	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			228.2	E08		5	0186-0667	530.37	666.86	408	77.74	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			248.8	E08		5	0187-0670	36.41	670.08	383	75.50	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			219.1	E08		5	0188-0670	867.56	669.86	372	72.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			451.0	E08		5	0189-0687	601.90	686.94	404	75.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			212.5	E08		5	0190-0689	805.54	688.90	400	76.67	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			256.8	E08		5	0191-0691	754.41	691.52	398	75.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			262.9	E08		5	0192-0694	706.03	694.46	414	77.50	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			202.8	E08		5	0193-0695	182.32	695.39	392	74.67	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			222.4	E08		5	0194-0698	408.47	698.36	394	76.08	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			207.4	E08		5	0195-0701	18.07	700.07	363	77.40	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			257.1	E08		5	0196-0700	311.11	700.68	390	74.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			220.2	E08		5	0197-0707	882.43	706.19	366	72.81	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			271.4	E08		6	0001-0039	609.10	39.78	429	78.67	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			377.3	E08		6	0002-0037	360.26	37.48	370	71.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			227.9	E08		6	0003-0043	130.87	43.35	415	76.67	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			783.1	E08		6	0004-0044	937.28	43.85	447	83.26	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			256.7	E08		6	0005-0046	666.80	46.34	393	73.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			282.4	E08		6	0006-0051	182.30	50.93	439	79.84	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			269.1	E08		6	0007-0052	403.43	51.91	456	80.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			246.8	E08		6	0008-0056	835.63	55.83	437	82.67	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			254.1	E08		6	0009-0054	547.64	54.10	424	77.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			561.2	E08		6	0010-0056	445.92	56.36	434	79.26	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			244.3	E08		6	0011-0055	865.44	55.01	398	73.84	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			257.7	E08		6	0012-0056	99.44	56.56	204	59.36	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			271.9	E08		6	0013-0056	709.53	56.49	394	73.84	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			209.1	E08		6	0014-0057	56.19	57.15	276	62.77	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			245.6	E08		6	0015-0061	291.50	60.35	420	80.23	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			736.4	E08		6	0016-0071	649.24	69.38	188	65.01	0.559
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			302.2	E08		6	0017-0075	273.94	76.36	420	78.33	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			246.7	E08		6	0018-0082	865.23	82.94	421	76.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			235.9	E08		6	0019-0087	100.68	87.47	401	75.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			280.4	E08		6	0020-0085	790.76	85.89	405	77.01	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			319.9	E08		6	0021-0099	595.58	98.77	410	75.84	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			302.1	E08		6	0022-0100	401.27	100.66	401	75.26	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1866.3	E08		6	0023-0104	359.67	103.66	639	92.91	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			235.9	E08		6	0024-0101	917.18	101.30	370	71.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			246.6	E08		6	0025-0102	147.44	102.15	426	79.01	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			268.6	E08		6	0026-0104	203.96	103.60	391	73.84	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			302.9	E08		6	0027-0111	687.18	111.25	425	77.26	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			254.1	E08		6	0028-0114	311.62	114.67	409	76.67	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			496.6	E08		6	0029-0126	567.48	126.76	529	119.88	0.463
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			322.1	E08		6	0030-0124	514.48	124.06	399	73.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			253.1	E08		6	0031-0134	874.24	134.51	416	75.26	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			311.7	E08		6	0032-0136	443.35	136.30	428	77.26	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			257.9	E08		6	0033-0137	221.07	136.76	398	74.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			296.0	E08		6	0034-0138	802.41	138.59	416	75.01	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			212.8	E08		6	0035-0141	845.01	141.60	424	79.50	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			401.7	E08		6	0036-0145	932.34	145.11	411	78.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			286.9	E08		6	0037-0156	316.95	156.18	405	75.26	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			670.4	E08		6	0038-0173	180.35	172.98	600	120.37	0.520
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			289.9	E08		6	0039-0171	928.07	170.09	399	76.53	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			231.0	E08		6	0040-0176	889.94	176.64	383	76.67	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			282.5	E08		6	0041-0180	641.53	180.47	408	74.43	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			261.8	E08		6	0042-0181	254.12	181.22	431	79.84	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			322.5	E08		6	0043-0180	575.01	180.53	356	69.01	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			247.3	E08		6	0044-0185	769.00	185.35	487	85.84	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			313.7	E08		6	0045-0201	840.71	200.64	409	78.91	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			306.2	E08		6	0046-0201	402.79	201.96	404	75.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			298.5	E08		6	0047-0217	557.64	217.97	437	78.18	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			250.2	E08		6	0048-0222	65.75	222.55	402	75.84	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			213.2	E08		6	0049-0222	33.66	222.01	378	71.84	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			319.9	E08		6	0050-0230	461.89	228.95	884	118.71	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			245.1	E08		6	0051-0224	894.28	224.40	424	78.08	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			257.2	E08		6	0052-0235	146.72	235.75	423	77.26	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			250.5	E08		6	0053-0238	241.90	238.00	383	73.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			267.8	E08		6	0054-0237	315.12	237.17	411	77.01	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1635.3	E08		6	0055-0243	565.44	243.58	481	82.43	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			464.2	E08		6	0056-0246	675.69	246.47	385	73.26	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			241.9	E08		6	0057-0251	200.63	251.72	394	73.84	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			288.4	E08		6	0058-0254	390.06	254.58	396	73.01	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			338.0	E08		6	0059-0256	274.78	255.92	404	76.28	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			279.6	E08		6	0060-0258	297.14	258.14	451	81.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			245.3	E08		6	0061-0258	122.38	258.27	395	76.67	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			551.5	E08		6	0062-0262	826.81	262.42	397	77.74	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			253.8	E08		6	0063-0265	364.08	265.39	397	75.50	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			236.1	E08		6	0064-0266	66.07	266.07	380	73.01	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			317.0	E08		6	0065-0268	780.41	269.04	384	78.91	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			242.1	E08		6	0066-0276	942.40	276.55	414	77.26	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			314.7	E08		6	0067-0284	864.62	284.60	393	75.01	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			280.6	E08		6	0068-0288	919.98	288.51	425	80.67	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			235.0	E08		6	0069-0287	25.72	287.87	402	74.18	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			350.3	E08		6	0070-0291	794.39	291.48	427	84.91	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			227.2	E08		6	0071-0291	340.77	290.88	388	74.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			289.5	E08		6	0072-0292	733.23	292.36	414	78.08	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			298.9	E08		6	0073-0302	700.29	302.29	365	70.18	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			291.9	E08		6	0074-0307	593.62	308.24	459	83.98	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			259.0	E08		6	0075-0308	389.89	307.90	416	75.60	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1455.0	E08		6	0076-0316	97.64	316.85	772	105.98	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			244.9	E08		6	0077-0322	160.15	322.59	425	78.08	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			900.3	E08		6	0078-0323	429.71	323.83	412	76.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			237.0	E08		6	0079-0325	620.50	325.40	390	74.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			313.2	E08		6	0080-0324	673.88	324.71	368	71.01	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			272.8	E08		6	0081-0326	298.88	326.11	431	79.50	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			316.7	E08		6	0082-0338	840.47	338.66	399	74.43	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			289.5	E08		6	0083-0343	945.96	343.78	423	76.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			347.9	E08		6	0084-0348	94.01	348.05	361	75.26	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			240.3	E08		6	0085-0349	192.31	348.83	427	79.26	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			347.9	E08		6	0086-0355	743.75	355.90	402	75.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			423.2	E08		6	0087-0359	863.28	359.07	375	71.01	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			270.7	E08		6	0088-0361	410.56	360.93	417	76.91	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			269.9	E08		6	0089-0362	549.72	362.11	395	73.60	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			234.7	E08		6	0090-0366	86.07	366.13	430	81.84	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			272.6	E08		6	0091-0368	605.95	368.15	466	81.26	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			274.4	E08		6	0092-0368	461.92	368.59	404	75.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			957.8	E08		6	0093-0369	503.73	369.03	421	75.84	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1614.2	E08		6	0094-0388	126.33	388.29	676	96.33	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			247.7	E08		6	0095-0389	272.93	389.65	406	78.08	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			232.6	E08		6	0096-0397	897.17	397.47	378	76.08	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			437.9	E08		6	0097-0399	741.89	399.01	357	69.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			334.0	E08		6	0098-0401	489.83	401.65	393	73.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			268.2	E08		6	0099-0415	558.39	414.76	891	120.47	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			460.3	E08		6	0100-0418	759.37	417.69	385	73.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			272.2	E08		6	0101-0419	131.28	419.56	412	75.01	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			530.5	E08		6	0102-0428	222.85	428.22	398	75.84	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			270.2	E08		6	0103-0438	440.00	437.97	811	112.57	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			229.3	E08		6	0104-0429	888.69	429.98	388	77.26	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			636.0	E08		6	0105-0432	604.99	432.84	420	76.43	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			295.8	E08		6	0106-0431	803.92	430.66	397	75.01	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			244.1	E08		6	0107-0445	845.80	445.48	452	81.74	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			666.6	E08		6	0108-0449	472.86	450.16	419	76.43	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			263.8	E08		6	0109-0451	399.60	450.90	407	74.43	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			294.1	E08		6	0110-0452	901.77	451.81	344	68.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			305.6	E08		6	0111-0457	510.59	457.67	365	71.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			213.4	E08		6	0112-0458	271.58	458.37	398	75.26	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			638.8	E08		6	0113-0464	362.29	463.93	415	76.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			255.6	E08		6	0114-0465	34.79	465.26	372	71.01	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			605.0	E08		6	0115-0468	319.64	468.73	386	75.50	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			236.8	E08		6	0116-0468	204.85	468.31	403	74.43	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			573.8	E08		6	0117-0472	589.04	472.62	410	77.84	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			272.0	E08		6	0118-0485	130.94	485.17	784	114.57	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			241.9	E08		6	0119-0480	559.70	480.70	401	74.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1424.4	E08		6	0120-0485	765.12	485.12	414	75.01	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			248.4	E08		6	0121-0488	817.96	488.82	421	77.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			598.9	E08		6	0122-0487	700.13	487.33	456	79.60	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			296.0	E08		6	0123-0494	467.40	493.91	413	75.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			284.8	E08		6	0124-0497	519.65	497.45	378	73.01	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			267.3	E08		6	0125-0503	71.84	502.98	397	73.60	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			256.1	E08		6	0126-0510	312.54	510.67	394	76.91	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			240.6	E08		6	0127-0525	839.74	525.65	437	78.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			269.5	E08		6	0128-0527	540.65	527.67	412	75.26	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			305.6	E08		6	0129-0528	685.34	528.07	370	72.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			279.2	E08		6	0130-0531	408.66	531.66	427	82.91	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			447.7	E08		6	0131-0545	184.59	545.56	423	77.26	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			721.3	E08		6	0132-0550	783.64	550.56	434	78.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			419.4	E08		6	0133-0554	16.21	553.55	343	69.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			261.9	E08		6	0134-0558	889.37	558.36	399	75.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			312.9	E08		6	0135-0563	292.95	563.04	416	75.01	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			300.1	E08		6	0136-0566	246.05	566.66	403	75.26	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			294.1	E08		6	0137-0574	207.12	574.39	383	73.01	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			274.2	E08		6	0138-0580	407.06	580.07	744	102.91	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			289.9	E08		6	0139-0579	123.64	579.43	381	73.84	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			917.3	E08		6	0140-0584	648.20	584.41	298	79.26	0.596
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			267.3	E08		6	0141-0588	340.02	588.45	389	76.08	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			317.8	E08		6	0142-0591	512.96	591.21	414	76.08	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			437.8	E08		6	0143-0592	930.00	592.72	460	79.84	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			264.3	E08		6	0144-0600	604.74	599.99	396	74.67	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			489.7	E08		6	0145-0610	674.51	609.31	411	75.26	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			331.3	E08		6	0146-0613	833.51	613.41	434	77.26	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			268.6	E08		6	0147-0616	47.33	616.58	414	76.08	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			317.0	E08		6	0148-0615	120.49	615.56	390	73.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			275.9	E08		6	0149-0618	286.91	617.98	407	78.08	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			235.0	E08		6	0150-0621	579.64	621.75	407	74.43	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			284.5	E08		6	0151-0630	264.54	630.19	456	79.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1339.4	E08		6	0152-0633	530.57	633.89	542	86.91	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			293.2	E08		6	0153-0633	175.78	633.64	416	77.01	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			284.9	E08		6	0154-0644	342.89	645.15	398	75.50	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			295.4	E08		6	0155-0643	423.03	642.72	391	74.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			278.4	E08		6	0156-0649	707.56	648.55	332	71.60	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			291.1	E08		6	0157-0651	879.79	651.82	403	75.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			339.9	E08		6	0158-0654	830.07	653.96	335	68.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			244.2	E08		6	0159-0659	73.10	659.24	383	74.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			272.8	E08		6	0160-0662	37.75	662.74	306	64.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			247.8	E08		6	0161-0664	699.20	664.39	367	72.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			250.4	E08		6	0162-0669	294.23	669.17	425	77.84	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			380.2	E08		6	0163-0672	755.14	671.70	314	65.01	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			258.2	E08		6	0164-0685	651.76	685.15	402	76.43	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			265.6	E08		6	0165-0690	191.80	689.38	504	90.08	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			288.2	E08		6	0166-0688	241.93	688.34	391	75.26	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			283.4	E08		6	0167-0688	860.00	687.87	391	76.67	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			267.6	E08		6	0168-0695	394.10	695.29	375	75.84	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			225.1	E08		6	0169-0692	684.52	691.77	372	73.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			261.9	E08		6	0170-0698	175.02	699.26	445	82.67	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			419.7	E08		6	0171-0696	775.38	696.07	302	63.36	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			318.9	E08		6	0172-0701	605.07	701.16	380	72.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			249.8	E08		6	0173-0702	95.54	701.63	451	85.60	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			320.1	E08		6	0174-0704	120.66	703.75	188	52.63	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			265.9	E08		6	0175-0709	319.30	709.24	414	81.01	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			375.6	E08		7	0001-0031	448.84	30.88	428	78.08	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			285.0	E08		7	0002-0032	838.72	31.96	384	75.50	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			663.8	E08		7	0003-0036	597.08	35.70	508	86.43	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			280.4	E08		7	0004-0040	660.75	40.02	389	73.26	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			327.5	E08		7	0005-0043	46.37	43.18	436	80.08	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			527.2	E08		7	0006-0046	171.75	45.61	395	76.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			204.3	E08		7	0007-0056	779.49	56.58	762	105.40	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			311.6	E08		7	0008-0053	366.46	52.98	413	77.84	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			212.3	E08		7	0009-0061	736.50	60.83	821	110.33	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			853.2	E08		7	0010-0059	514.63	59.64	469	80.67	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			306.9	E08		7	0011-0060	622.88	60.55	447	81.01	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			278.7	E08		7	0012-0062	112.13	62.35	400	73.84	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			272.4	E08		7	0013-0064	827.38	64.14	397	73.01	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			304.9	E08		7	0014-0065	209.40	65.33	397	75.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			269.9	E08		7	0015-0068	474.31	68.46	445	77.84	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			207.8	E08		7	0016-0073	759.50	73.09	441	82.33	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			288.1	E08		7	0017-0071	25.96	71.16	395	74.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			263.7	E08		7	0018-0075	168.45	75.59	400	75.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			315.1	E08		7	0019-0076	649.96	75.19	460	84.91	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			257.9	E08		7	0020-0076	914.47	76.08	389	74.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			312.9	E08		7	0021-0081	412.73	81.20	410	77.01	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			341.1	E08		7	0022-0081	855.73	80.86	331	68.67	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			308.3	E08		7	0023-0090	806.94	90.08	426	77.50	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			356.9	E08		7	0024-0097	123.66	96.62	861	120.47	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			323.0	E08		7	0025-0100	724.72	101.48	808	111.30	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			277.4	E08		7	0026-0096	869.09	97.42	428	79.74	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			306.6	E08		7	0027-0096	384.45	96.22	436	77.26	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			315.9	E08		7	0028-0096	561.68	96.12	419	76.08	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			285.0	E08		7	0029-0103	764.31	103.27	401	74.08	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			198.5	E08		7	0030-0109	829.68	109.22	415	77.74	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			337.0	E08		7	0031-0108	325.77	108.69	389	74.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			194.2	E08		7	0032-0109	935.60	108.20	397	76.91	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			230.5	E08		7	0033-0115	706.49	115.81	360	73.50	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			310.6	E08		7	0034-0122	118.91	122.52	429	82.18	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			257.2	E08		7	0035-0124	923.18	123.79	412	82.23	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			345.7	E08		7	0036-0135	292.88	135.00	383	73.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			820.5	E08		7	0037-0135	354.72	135.33	404	75.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			264.4	E08		7	0038-0139	914.80	139.85	373	76.91	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			305.1	E08		7	0039-0143	59.89	143.01	419	81.84	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			369.3	E08		7	0040-0142	508.69	142.10	427	75.84	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			339.5	E08		7	0041-0140	651.23	140.11	271	60.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			331.7	E08		7	0042-0143	114.36	144.08	452	82.77	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			344.2	E08		7	0043-0145	174.82	145.47	397	74.43	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1296.8	E08		7	0044-0150	430.95	150.59	605	95.36	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			270.1	E08		7	0045-0151	682.39	151.18	397	75.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			565.9	E08		7	0046-0151	472.56	151.08	281	60.53	0.964
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			369.4	E08		7	0047-0153	408.79	153.93	304	67.94	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			330.8	E08		7	0048-0155	769.28	154.23	416	77.01	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			234.8	E08		7	0049-0160	729.61	159.76	426	78.91	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			266.0	E08		7	0050-0171	710.91	171.77	471	83.15	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			377.5	E08		7	0051-0176	84.38	176.01	398	74.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			236.5	E08		7	0052-0179	757.95	179.10	405	74.67	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			262.9	E08		7	0053-0183	829.21	183.92	409	76.18	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			451.4	E08		7	0054-0182	399.69	182.76	395	74.67	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			243.7	E08		7	0055-0190	561.34	189.93	399	74.43	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1457.6	E08		7	0056-0202	470.42	202.54	999	119.88	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			297.0	E08		7	0057-0196	663.68	196.18	453	79.26	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			308.8	E08		7	0058-0195	880.66	195.17	430	79.50	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			231.5	E08		7	0059-0196	922.97	196.10	429	78.67	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			259.5	E08		7	0060-0202	796.04	201.96	411	75.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			357.0	E08		7	0061-0206	348.07	206.46	389	73.01	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			335.0	E08		7	0062-0209	516.77	208.98	444	83.01	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			330.1	E08		7	0063-0220	186.65	219.98	420	76.33	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			465.8	E08		7	0064-0229	52.67	230.01	832	116.71	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1359.9	E08		7	0065-0221	413.57	222.10	437	84.18	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			474.9	E08		7	0066-0223	154.97	223.16	415	76.67	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			257.6	E08		7	0067-0225	212.81	225.04	416	76.67	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			351.0	E08		7	0068-0236	277.65	236.50	804	114.33	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			228.6	E08		7	0069-0230	717.96	230.20	468	83.26	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			712.0	E08		7	0070-0231	512.52	230.88	408	78.18	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			285.6	E08		7	0071-0231	660.78	231.47	409	76.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			231.9	E08		7	0072-0234	552.17	234.52	465	80.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			305.1	E08		7	0073-0235	743.94	234.70	468	82.91	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			252.3	E08		7	0074-0240	921.31	240.17	436	78.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			290.1	E08		7	0075-0244	349.58	244.76	421	79.50	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			416.5	E08		7	0076-0242	419.81	240.95	462	91.01	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			226.7	E08		7	0077-0245	587.43	245.28	446	79.26	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			325.5	E08		7	0078-0245	616.80	245.35	467	82.33	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			298.7	E08		7	0079-0256	244.72	256.65	411	74.43	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			307.0	E08		7	0080-0256	165.72	256.33	403	75.26	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			249.4	E08		7	0081-0256	546.41	255.98	391	77.36	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			251.2	E08		7	0082-0260	401.71	260.65	446	79.84	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			367.6	E08		7	0083-0261	770.98	261.39	409	76.08	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			285.8	E08		7	0084-0275	859.66	275.10	420	81.50	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			255.0	E08		7	0085-0280	15.81	280.22	382	76.08	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			251.9	E08		7	0086-0283	911.46	282.82	394	77.84	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			326.2	E08		7	0087-0287	812.91	286.93	384	75.26	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			454.3	E08		7	0088-0291	361.58	290.96	385	73.26	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			310.7	E08		7	0089-0296	449.18	296.56	453	80.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			299.0	E08		7	0090-0299	207.78	299.43	414	77.74	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			296.7	E08		7	0091-0300	615.41	300.01	425	79.26	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			351.1	E08		7	0092-0302	783.03	301.18	396	76.33	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			477.7	E08		7	0093-0305	287.31	304.99	408	75.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			323.6	E08		7	0094-0308	523.05	306.75	406	77.74	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			256.4	E08		7	0095-0304	581.87	304.39	434	78.08	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			670.6	E08		7	0096-0313	940.51	313.37	444	82.43	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			404.3	E08		7	0097-0310	418.35	310.49	410	75.84	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			288.4	E08		7	0098-0313	352.30	313.57	476	86.08	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			311.2	E08		7	0099-0311	766.95	312.50	385	76.33	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			246.8	E08		7	0100-0326	514.28	327.72	504	86.57	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			314.7	E08		7	0101-0333	365.09	333.64	458	82.67	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			340.4	E08		7	0102-0336	262.15	336.27	411	78.08	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			313.6	E08		7	0103-0346	486.60	346.09	878	119.64	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			261.1	E08		7	0104-0339	795.17	339.92	407	75.26	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			276.9	E08		7	0105-0340	576.51	340.22	421	76.67	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			260.3	E08		7	0106-0349	751.18	349.39	815	118.37	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			377.4	E08		7	0107-0342	176.49	342.38	406	75.26	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			258.1	E08		7	0108-0352	838.85	352.49	419	77.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			377.1	E08		7	0109-0353	37.15	353.91	411	77.26	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			406.7	E08		7	0110-0354	196.64	354.38	249	64.18	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			258.5	E08		7	0111-0357	911.74	356.92	410	77.50	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			246.3	E08		7	0112-0362	721.35	361.82	401	73.60	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			354.1	E08		7	0113-0375	307.67	373.54	822	118.37	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			311.0	E08		7	0114-0372	576.22	372.32	426	78.08	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1682.7	E08		7	0115-0379	255.42	379.49	555	88.33	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			297.2	E08		7	0116-0379	104.36	379.35	412	75.84	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			243.5	E08		7	0117-0383	353.55	383.66	403	78.08	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			223.2	E08		7	0118-0393	729.49	393.01	419	76.43	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1119.5	E08		7	0119-0399	411.40	399.13	422	78.67	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			260.2	E08		7	0120-0400	896.04	400.17	430	77.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			306.5	E08		7	0121-0412	547.67	412.36	432	77.26	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			249.9	E08		7	0122-0417	477.90	416.96	424	78.43	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			288.5	E08		7	0123-0421	798.64	421.39	816	108.13	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			283.5	E08		7	0124-0418	288.39	418.77	420	76.67	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			288.5	E08		7	0125-0422	221.78	422.33	394	75.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			233.5	E08		7	0126-0427	674.72	427.78	474	84.57	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			292.3	E08		7	0127-0435	647.25	434.77	971	126.37	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			344.1	E08		7	0128-0432	22.64	432.45	395	74.67	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			341.1	E08		7	0129-0428	852.61	427.21	311	66.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			960.9	E08		7	0130-0436	442.88	436.49	421	78.67	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			340.0	E08		7	0131-0438	413.29	438.11	427	78.91	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			322.4	E08		7	0132-0448	594.07	448.69	427	78.67	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			254.1	E08		7	0133-0449	916.60	449.00	410	75.84	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			274.6	E08		7	0134-0458	778.28	457.50	871	115.05	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			319.0	E08		7	0135-0453	284.13	453.88	402	74.67	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1474.0	E08		7	0136-0456	158.85	455.93	521	84.33	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			226.8	E08		7	0137-0458	703.47	458.41	431	80.91	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			330.8	E08		7	0138-0460	527.10	460.81	427	79.50	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			213.5	E08		7	0139-0461	851.90	460.82	426	77.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			491.3	E08		7	0140-0471	339.98	470.78	775	109.98	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			303.3	E08		7	0141-0483	82.00	482.90	404	76.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			329.8	E08		7	0142-0491	574.07	490.87	423	76.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			403.7	E08		7	0143-0493	110.84	492.98	414	76.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			316.2	E08		7	0144-0496	268.05	496.37	397	73.60	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			306.6	E08		7	0145-0497	225.62	496.98	383	72.43	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			166.3	E08		7	0146-0502	948.73	502.04	404	79.26	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			517.8	E08		7	0147-0507	728.18	506.57	400	77.60	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			262.8	E08		7	0148-0507	897.43	506.76	385	73.26	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			336.3	E08		7	0149-0515	409.47	515.53	400	75.84	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			299.2	E08		7	0150-0519	585.04	519.69	406	75.26	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			304.0	E08		7	0151-0524	723.90	525.32	292	66.18	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			358.1	E08		7	0152-0526	646.35	526.17	363	72.67	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			412.6	E08		7	0153-0530	160.90	531.09	418	77.11	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			315.9	E08		7	0154-0528	794.84	527.92	437	84.43	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1335.2	E08		7	0155-0538	62.81	537.91	537	87.26	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			375.7	E08		7	0156-0539	94.34	539.64	421	75.84	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			287.7	E08		7	0157-0537	526.23	537.55	407	76.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			354.1	E08		7	0158-0547	636.52	547.51	481	86.33	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			308.0	E08		7	0159-0546	361.37	546.65	416	76.67	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			337.8	E08		7	0160-0556	161.11	554.96	470	83.36	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			470.9	E08		7	0161-0556	830.91	556.71	355	72.08	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			362.9	E08		7	0162-0562	286.89	562.71	427	76.67	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			343.4	E08		7	0163-0563	565.56	563.25	427	76.43	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			326.1	E08		7	0164-0562	879.38	562.67	401	76.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			379.0	E08		7	0165-0563	239.98	563.72	432	77.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			471.9	E08		7	0166-0566	456.03	566.66	814	114.23	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			360.0	E08		7	0167-0578	40.49	578.42	753	104.81	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			349.6	E08		7	0168-0576	380.31	576.15	402	73.60	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			376.7	E08		7	0169-0594	904.98	594.13	711	103.64	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			236.2	E08		7	0170-0596	88.73	596.10	376	73.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			232.0	E08		7	0171-0605	117.62	605.11	407	76.67	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			281.9	E08		7	0172-0608	251.39	608.26	407	75.26	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			283.2	E08		7	0173-0609	171.24	609.16	393	73.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			314.4	E08		7	0174-0609	623.41	609.05	462	82.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			310.3	E08		7	0175-0622	508.45	622.39	442	79.26	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			367.2	E08		7	0176-0622	537.13	621.59	421	76.08	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			263.0	E08		7	0177-0629	839.20	629.32	388	73.60	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			391.5	E08		7	0178-0630	458.46	629.99	392	73.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			779.7	E08		7	0179-0630	375.06	630.96	424	77.84	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			242.8	E08		7	0180-0634	120.29	634.40	434	83.15	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			354.2	E08		7	0181-0638	566.69	638.48	419	78.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			221.5	E08		7	0182-0643	82.73	643.20	390	75.50	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			501.9	E08		7	0183-0641	31.35	641.60	353	68.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			287.2	E08		7	0184-0645	289.37	645.10	406	73.60	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			282.9	E08		7	0185-0644	599.43	644.18	456	81.50	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			298.2	E08		7	0186-0648	147.44	647.92	408	74.18	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			567.7	E08		7	0187-0651	710.26	650.69	404	75.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			263.2	E08		7	0188-0653	250.53	653.75	401	76.08	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			606.3	E08		7	0189-0657	392.64	657.16	439	78.43	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			280.8	E08		7	0190-0667	804.84	668.45	855	117.30	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			389.3	E08		7	0191-0664	204.68	664.59	410	75.01	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			445.9	E08		7	0192-0667	461.60	667.58	383	72.43	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			225.8	E08		7	0193-0668	870.91	668.58	360	70.43	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			298.2	E08		7	0194-0671	620.80	671.53	382	72.43	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			296.8	E08		7	0195-0682	727.61	681.81	759	105.74	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			303.5	E08		7	0196-0689	30.58	689.00	400	74.43	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			209.9	E08		7	0197-0698	843.13	698.26	329	72.43	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			378.0	E08		7	0198-0696	915.86	696.39	333	68.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1233.2	E08		7	0199-0702	286.34	702.25	615	92.91	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1213.8	E08		7	0200-0701	588.98	700.78	613	93.26	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			307.6	E08		7	0201-0703	676.76	703.24	449	80.08	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			260.0	E08		7	0202-0705	860.74	704.81	415	78.77	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			330.1	E08		7	0203-0706	339.00	705.36	365	71.01	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			177.5	E08		8	0001-0027	12.86	26.76	131	43.70	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			146.1	E08		8	0002-0034	878.19	33.39	456	81.98	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			237.7	E08		8	0003-0038	137.55	38.18	360	70.18	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			237.0	E08		8	0004-0036	208.64	36.46	369	71.26	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			181.4	E08		8	0005-0037	928.11	37.23	403	75.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			236.5	E08		8	0006-0039	338.64	39.54	422	77.50	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			316.3	E08		8	0007-0043	830.27	43.72	342	67.60	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			191.0	E08		8	0008-0044	858.88	44.83	369	73.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			255.9	E08		8	0009-0049	252.72	49.24	380	73.84	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2155.1	E08		8	0010-0052	703.68	51.91	725	99.74	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			226.4	E08		8	0011-0054	106.15	53.85	358	70.18	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			234.7	E08		8	0012-0056	435.56	56.02	435	77.26	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			242.4	E08		8	0013-0068	387.24	68.15	402	73.84	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			268.6	E08		8	0014-0072	502.28	72.23	432	79.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			389.5	E08		8	0015-0075	198.47	75.77	388	72.77	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			276.1	E08		8	0016-0076	825.57	76.69	447	78.67	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			233.5	E08		8	0017-0075	916.38	76.13	387	74.67	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			214.4	E08		8	0018-0078	19.55	78.07	365	71.01	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			256.8	E08		8	0019-0081	710.84	81.37	413	75.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			223.6	E08		8	0020-0090	169.84	90.08	388	74.67	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			260.5	E08		8	0021-0089	279.57	89.50	379	73.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			263.7	E08		8	0022-0093	359.40	92.93	391	73.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			285.7	E08		8	0023-0101	97.26	101.04	385	71.84	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			230.7	E08		8	0024-0106	129.43	105.80	377	72.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			214.8	E08		8	0025-0107	912.97	106.51	390	73.01	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			195.3	E08		8	0026-0111	40.25	110.23	367	75.40	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			368.7	E08		8	0027-0114	536.93	113.63	388	72.18	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1318.4	E08		8	0028-0121	790.30	121.16	840	112.08	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			316.0	E08		8	0029-0118	182.89	118.63	396	76.77	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			608.9	E08		8	0030-0117	426.66	117.08	409	75.26	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			205.2	E08		8	0031-0132	24.01	133.27	791	113.54	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			252.8	E08		8	0032-0129	510.23	128.96	385	73.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			256.6	E08		8	0033-0134	659.27	134.22	381	75.84	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			226.1	E08		8	0034-0142	147.05	142.44	399	74.18	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			262.5	E08		8	0035-0142	349.62	142.04	399	76.43	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			270.2	E08		8	0036-0143	184.85	143.18	431	79.94	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			423.9	E08		8	0037-0147	561.04	146.72	400	73.60	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			338.3	E08		8	0038-0152	592.10	151.51	558	98.57	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			263.6	E08		8	0039-0146	775.62	146.78	412	75.01	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			292.7	E08		8	0040-0154	270.66	154.46	398	73.01	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			251.6	E08		8	0041-0154	708.75	154.15	387	71.60	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			288.1	E08		8	0042-0155	221.46	155.64	376	71.01	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			255.9	E08		8	0043-0156	921.65	156.62	398	74.67	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			325.3	E08		8	0044-0157	303.73	157.44	396	73.60	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			466.5	E08		8	0045-0159	833.62	159.60	351	69.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			342.3	E08		8	0046-0166	471.01	165.99	897	114.81	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			292.6	E08		8	0047-0162	890.05	161.56	396	74.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			208.1	E08		8	0048-0161	61.84	161.17	363	71.60	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			255.0	E08		8	0049-0166	187.42	165.14	380	74.53	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			295.8	E08		8	0050-0166	341.97	166.42	401	75.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			241.9	E08		8	0051-0169	377.65	169.22	399	77.26	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			240.8	E08		8	0052-0167	102.73	166.88	363	71.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			290.9	E08		8	0053-0187	938.78	187.67	341	68.18	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			250.9	E08		8	0054-0188	676.21	188.44	420	76.67	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			283.6	E08		8	0055-0187	778.88	187.08	345	69.01	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			261.3	E08		8	0056-0189	823.38	189.83	386	71.60	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			282.1	E08		8	0057-0191	643.60	191.60	416	76.67	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			373.4	E08		8	0058-0194	529.74	194.47	406	75.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			249.6	E08		8	0059-0197	390.61	197.85	434	81.01	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			199.6	E08		8	0060-0198	28.08	198.47	395	78.67	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			262.9	E08		8	0061-0207	234.56	207.06	394	73.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			221.4	E08		8	0062-0210	98.04	210.49	783	110.81	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			214.0	E08		8	0063-0205	730.77	205.93	405	76.87	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			224.0	E08		8	0064-0210	51.96	209.98	417	77.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			733.8	E08		8	0065-0226	150.93	226.45	882	119.20	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			226.1	E08		8	0066-0227	766.45	227.43	385	74.43	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			281.1	E08		8	0067-0225	732.13	224.55	379	74.28	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			281.4	E08		8	0068-0230	517.07	230.49	396	75.26	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			319.4	E08		8	0069-0229	455.43	228.84	391	72.43	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			284.2	E08		8	0070-0234	704.14	234.14	436	77.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			215.4	E08		8	0071-0233	801.86	233.75	412	77.74	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			260.4	E08		8	0072-0235	280.81	235.53	442	79.50	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			220.3	E08		8	0073-0242	26.40	242.17	397	75.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			282.4	E08		8	0074-0239	883.39	239.10	387	73.26	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			209.2	E08		8	0075-0243	827.50	243.32	380	73.01	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			258.4	E08		8	0076-0245	304.28	244.81	430	84.08	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			308.0	E08		8	0077-0248	207.90	247.89	429	77.26	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			252.8	E08		8	0078-0247	338.34	247.62	403	76.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			244.0	E08		8	0079-0253	364.00	253.03	387	73.60	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			464.7	E08		8	0080-0269	645.93	267.39	970	133.05	0.689
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			208.4	E08		8	0081-0258	123.48	258.55	377	72.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			222.6	E08		8	0082-0263	453.70	263.14	404	75.26	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			387.2	E08		8	0083-0264	317.89	264.40	448	82.08	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			242.7	E08		8	0084-0266	75.47	265.97	413	76.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			266.4	E08		8	0085-0265	503.36	265.50	404	74.67	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			239.1	E08		8	0086-0267	273.87	266.82	456	81.15	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			268.9	E08		8	0087-0282	253.98	282.02	486	84.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			188.7	E08		8	0088-0285	16.72	284.89	358	71.60	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			221.7	E08		8	0089-0283	874.71	283.66	396	74.67	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			246.4	E08		8	0090-0301	365.86	301.03	389	73.01	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			215.3	E08		8	0091-0303	85.07	303.28	374	71.60	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			241.4	E08		8	0092-0305	493.41	304.96	634	98.57	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			364.7	E08		8	0093-0304	646.32	304.07	373	70.18	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			232.2	E08		8	0094-0307	801.56	307.47	422	76.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			328.5	E08		8	0095-0313	152.47	313.01	416	78.43	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			644.2	E08		8	0096-0315	45.71	315.47	403	79.01	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			236.7	E08		8	0097-0317	107.42	316.99	421	77.26	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			269.3	E08		8	0098-0324	435.57	323.86	409	76.08	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			218.4	E08		8	0099-0329	225.64	330.02	805	109.54	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			477.1	E08		8	0100-0323	884.08	323.71	276	59.94	0.965
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			254.2	E08		8	0101-0331	923.08	331.31	395	75.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			313.8	E08		8	0102-0334	353.64	334.44	365	71.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			217.6	E08		8	0103-0337	170.74	336.54	362	73.94	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1722.7	E08		8	0104-0338	558.10	338.35	477	80.67	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			265.5	E08		8	0105-0339	149.93	340.00	471	84.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			238.4	E08		8	0106-0341	811.52	341.33	405	75.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			293.6	E08		8	0107-0351	410.83	350.90	374	71.60	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			348.9	E08		8	0108-0353	298.83	353.05	332	67.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			587.1	E08		8	0109-0354	493.00	354.82	371	70.18	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			281.1	E08		8	0110-0358	665.66	358.28	390	74.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			251.4	E08		8	0111-0359	17.15	358.98	363	71.60	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			378.5	E08		8	0112-0357	346.39	357.41	317	65.36	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			351.0	E08		8	0113-0358	901.62	358.35	389	74.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			219.7	E08		8	0114-0371	862.43	370.96	842	117.15	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			262.5	E08		8	0115-0374	738.95	374.20	390	73.84	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			239.5	E08		8	0116-0377	785.88	377.58	417	77.84	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			392.8	E08		8	0117-0382	335.79	382.26	393	73.26	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			271.4	E08		8	0118-0394	112.36	393.65	782	110.37	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			286.3	E08		8	0119-0387	274.56	387.16	394	74.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			218.3	E08		8	0120-0390	208.40	390.43	381	74.91	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			335.1	E08		8	0121-0389	479.21	388.90	386	72.43	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			254.2	E08		8	0122-0401	168.44	400.19	458	87.26	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1219.8	E08		8	0123-0402	565.48	401.81	380	72.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			327.3	E08		8	0124-0406	362.72	406.66	424	79.84	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			286.1	E08		8	0125-0409	434.57	409.45	394	75.60	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			341.7	E08		8	0126-0412	476.60	412.46	404	75.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			268.1	E08		8	0127-0421	609.03	421.87	466	80.91	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			967.1	E08		8	0128-0421	828.47	421.78	413	76.67	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			244.8	E08		8	0129-0422	193.23	422.30	385	71.60	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			235.7	E08		8	0130-0421	261.09	421.26	380	73.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			285.8	E08		8	0131-0421	928.44	421.32	423	79.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			240.2	E08		8	0132-0431	84.88	431.14	373	73.26	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			258.3	E08		8	0133-0429	901.87	428.91	391	76.18	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			232.1	E08		8	0134-0434	390.13	434.87	380	73.01	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			873.8	E08		8	0135-0439	573.78	438.71	432	77.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			317.8	E08		8	0136-0443	677.38	443.35	419	75.01	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			265.0	E08		8	0137-0443	127.46	443.00	401	75.50	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			220.6	E08		8	0138-0443	298.30	442.84	387	74.67	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			331.7	E08		8	0139-0445	250.82	443.39	360	72.91	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			239.0	E08		8	0140-0451	21.71	450.93	367	71.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			213.2	E08		8	0141-0451	57.31	451.96	366	71.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1611.3	E08		8	0142-0456	266.57	457.00	385	74.57	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			216.0	E08		8	0143-0456	757.54	456.78	401	73.84	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			453.3	E08		8	0144-0465	695.31	464.74	333	66.77	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			253.0	E08		8	0145-0475	624.02	474.88	775	109.64	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			352.0	E08		8	0146-0472	545.34	472.55	230	55.94	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1035.1	E08		8	0147-0479	826.55	478.30	624	92.33	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			281.9	E08		8	0148-0480	103.11	480.20	386	73.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			301.4	E08		8	0149-0482	470.82	480.83	343	70.91	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			256.2	E08		8	0150-0483	257.38	482.81	373	70.77	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			396.5	E08		8	0151-0487	382.59	487.61	326	65.94	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			249.8	E08		8	0152-0497	88.68	497.40	427	77.50	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			305.5	E08		8	0153-0501	942.80	501.31	378	74.77	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			194.0	E08		8	0154-0504	53.78	503.94	355	73.60	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			241.7	E08		8	0155-0502	837.74	503.28	408	79.26	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			336.9	E08		8	0156-0506	117.26	506.08	442	81.01	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			212.8	E08		8	0157-0508	692.35	507.93	420	76.08	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			709.3	E08		8	0158-0510	631.74	509.82	395	73.84	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1442.6	E08		8	0159-0518	344.60	518.30	623	92.33	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			361.4	E08		8	0160-0520	502.68	521.89	473	97.40	0.627
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			579.9	E08		8	0161-0519	179.67	519.43	392	73.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			764.3	E08		8	0162-0531	133.80	531.30	437	83.50	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			254.0	E08		8	0163-0530	683.66	531.47	424	77.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			246.5	E08		8	0164-0535	109.15	534.66	422	78.08	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			261.6	E08		8	0165-0538	262.29	538.48	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			391.5	E08		8	0166-0546	422.62	547.19	423	78.43	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			278.4	E08		8	0167-0548	772.56	547.66	381	73.84	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			307.9	E08		8	0168-0549	741.84	549.81	294	64.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			274.0	E08		8	0169-0552	689.00	552.49	408	78.18	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			224.4	E08		8	0170-0554	612.03	554.10	392	73.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			252.3	E08		8	0171-0558	572.27	558.01	387	73.01	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			215.2	E08		8	0172-0558	818.49	558.24	379	72.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			254.9	E08		8	0173-0559	239.19	559.34	388	74.08	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			255.6	E08		8	0174-0567	401.42	566.65	432	77.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			214.3	E08		8	0175-0569	72.52	568.92	371	71.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			208.6	E08		8	0176-0568	115.15	567.72	380	74.08	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			296.5	E08		8	0177-0571	928.14	571.53	366	71.01	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			525.0	E08		8	0178-0573	894.54	573.35	385	73.26	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			274.2	E08		8	0179-0573	472.87	572.73	373	71.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			279.7	E08		8	0180-0578	365.59	578.38	422	77.94	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			202.4	E08		8	0181-0577	620.21	577.65	398	74.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			247.0	E08		8	0182-0579	657.58	579.15	397	75.50	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			297.7	E08		8	0183-0579	130.71	579.51	295	63.84	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			299.7	E08		8	0184-0586	870.14	586.32	352	70.43	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			287.2	E08		8	0185-0593	306.08	592.85	380	72.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			233.3	E08		8	0186-0591	574.66	591.46	375	72.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			235.1	E08		8	0187-0600	798.09	600.44	796	109.88	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			289.4	E08		8	0188-0598	344.16	598.08	407	76.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			221.4	E08		8	0189-0598	649.17	599.12	377	74.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			342.4	E08		8	0190-0606	189.49	605.77	406	77.11	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			329.3	E08		8	0191-0611	212.45	611.06	398	76.77	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			248.2	E08		8	0192-0609	498.57	609.64	381	75.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			297.9	E08		8	0193-0620	745.01	619.76	770	112.47	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			242.5	E08		8	0194-0615	622.23	614.51	375	72.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			212.5	E08		8	0195-0619	247.53	619.43	377	71.01	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			291.9	E08		8	0196-0623	315.00	623.18	422	76.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			253.0	E08		8	0197-0630	449.89	629.80	367	71.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			246.6	E08		8	0198-0630	117.57	630.45	386	73.01	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			449.0	E08		8	0199-0634	145.21	633.58	394	75.50	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			244.9	E08		8	0200-0633	650.83	633.13	404	76.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			256.4	E08		8	0201-0634	411.77	634.57	416	76.18	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			338.8	E08		8	0202-0633	940.43	632.74	121	41.80	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			250.3	E08		8	0203-0642	389.05	641.84	422	77.84	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			256.5	E08		8	0204-0644	535.73	644.60	394	73.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			258.0	E08		8	0205-0650	577.45	650.84	386	72.18	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			229.7	E08		8	0206-0655	104.11	655.06	400	79.01	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			249.9	E08		8	0207-0656	784.90	656.57	391	73.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			297.9	E08		8	0208-0657	274.18	656.98	365	71.01	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			280.8	E08		8	0209-0660	515.41	660.89	414	75.84	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			262.7	E08		8	0210-0662	465.97	662.53	397	74.18	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			318.7	E08		8	0211-0663	862.67	663.21	420	76.43	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			545.0	E08		8	0212-0675	611.14	675.90	404	78.91	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			308.3	E08		8	0213-0687	236.25	687.72	410	77.01	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			256.7	E08		8	0214-0688	937.61	688.35	351	72.18	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			243.1	E08		8	0215-0687	135.56	687.26	385	73.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			249.0	E08		8	0216-0690	767.50	688.49	390	77.98	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			277.8	E08		8	0217-0695	630.66	695.62	404	78.43	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			294.2	E08		8	0218-0698	20.54	698.45	342	67.84	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			236.8	E08		8	0219-0705	876.06	705.52	417	76.91	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			250.7	E08		9	0001-0035	446.94	35.52	381	76.53	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			258.8	E08		9	0002-0030	118.26	29.91	194	54.53	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			258.9	E08		9	0003-0037	467.14	37.29	461	81.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			236.3	E08		9	0004-0035	317.27	34.86	407	80.43	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			206.6	E08		9	0005-0039	22.73	39.90	388	76.91	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			235.9	E08		9	0006-0041	859.08	41.53	402	77.74	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			219.6	E08		9	0007-0048	501.51	48.32	417	77.26	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			199.2	E08		9	0008-0052	92.29	52.34	375	72.67	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			307.8	E08		9	0009-0051	682.41	51.08	408	75.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			359.5	E08		9	0010-0056	198.24	54.50	521	106.81	0.574
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			303.5	E08		9	0011-0053	750.74	53.84	362	71.60	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			374.2	E08		9	0012-0058	180.23	60.22	233	72.08	0.564
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			237.7	E08		9	0013-0059	124.69	58.76	368	74.67	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			296.4	E08		9	0014-0065	905.51	65.74	347	70.43	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			288.6	E08		9	0015-0067	424.89	67.01	396	75.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			337.2	E08		9	0016-0068	807.95	68.14	355	68.77	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			372.7	E08		9	0017-0080	716.35	80.08	379	75.36	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			374.6	E08		9	0018-0076	289.50	76.64	363	72.43	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			302.5	E08		9	0019-0079	840.09	78.86	418	77.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			573.4	E08		9	0020-0082	469.22	81.80	358	71.60	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			338.9	E08		9	0021-0086	533.45	85.87	390	75.84	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1681.2	E08		9	0022-0091	923.79	90.75	578	92.57	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			236.0	E08		9	0023-0090	79.93	89.86	378	73.50	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			279.7	E08		9	0024-0097	361.02	97.13	367	73.26	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			872.3	E08		9	0025-0100	832.20	99.85	407	77.84	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			288.2	E08		9	0026-0104	944.59	104.47	361	71.84	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			604.0	E08		9	0027-0114	400.72	115.10	887	115.98	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1837.7	E08		9	0028-0113	501.62	112.70	613	91.74	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			245.7	E08		9	0029-0124	118.68	124.31	366	71.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			323.8	E08		9	0030-0133	74.11	134.00	385	77.60	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			268.4	E08		9	0031-0136	215.57	136.49	367	71.60	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			301.5	E08		9	0032-0137	304.29	137.25	382	75.26	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			626.4	E08		9	0033-0142	849.97	142.28	397	76.67	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			376.7	E08		9	0034-0153	773.45	152.25	340	70.33	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			966.9	E08		9	0035-0155	71.06	153.87	405	76.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			320.8	E08		9	0036-0157	644.08	156.94	390	76.08	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			257.1	E08		9	0037-0159	16.79	159.26	372	72.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			383.0	E08		9	0038-0164	786.81	165.90	382	73.74	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			452.9	E08		9	0039-0170	711.99	170.25	341	68.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			352.6	E08		9	0040-0179	734.38	179.20	399	77.26	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			412.4	E08		9	0041-0182	557.51	181.49	421	78.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			392.9	E08		9	0042-0181	472.02	180.70	441	80.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			299.9	E08		9	0043-0183	320.29	182.67	391	75.26	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			337.6	E08		9	0044-0190	33.68	190.27	339	69.01	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			424.4	E08		9	0045-0190	662.58	189.98	368	74.43	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			841.4	E08		9	0046-0201	870.57	199.09	990	127.54	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			347.8	E08		9	0047-0198	642.58	198.23	392	75.60	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			293.0	E08		9	0048-0198	62.31	198.18	337	69.26	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			315.0	E08		9	0049-0204	137.30	204.06	380	75.84	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			338.9	E08		9	0050-0204	931.35	203.84	337	68.18	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			273.1	E08		9	0051-0207	116.09	206.71	381	75.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			392.8	E08		9	0052-0218	365.71	218.11	398	77.50	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			301.8	E08		9	0053-0223	202.20	223.22	396	76.08	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			309.4	E08		9	0054-0235	446.43	235.83	404	77.74	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			261.7	E08		9	0055-0234	300.74	233.79	385	75.26	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			268.7	E08		9	0056-0237	852.00	237.08	388	73.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			259.9	E08		9	0057-0246	898.77	247.10	689	110.37	0.711
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			340.7	E08		9	0058-0245	510.67	246.13	412	75.26	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			345.1	E08		9	0059-0250	571.60	249.66	391	73.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			272.1	E08		9	0060-0254	95.42	254.05	353	68.18	0.954
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			315.3	E08		9	0061-0261	257.36	261.65	412	80.43	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			316.5	E08		9	0062-0264	925.97	264.27	369	71.01	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			424.3	E08		9	0063-0267	276.08	268.10	156	48.87	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			314.8	E08		9	0064-0295	116.10	293.14	552	94.23	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			457.6	E08		9	0065-0296	865.27	296.47	330	67.94	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			358.8	E08		9	0066-0308	601.08	308.01	785	119.10	0.695
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			279.9	E08		9	0067-0312	311.36	313.08	807	110.37	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			384.5	E08		9	0068-0306	62.59	305.93	393	78.33	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			221.2	E08		9	0069-0310	160.91	310.08	362	74.91	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			255.7	E08		9	0070-0311	534.74	311.75	392	75.01	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			280.5	E08		9	0071-0312	103.15	311.94	275	61.36	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			250.1	E08		9	0072-0316	463.24	315.59	409	77.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			293.0	E08		9	0073-0318	253.19	318.38	397	76.33	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			313.5	E08		9	0074-0321	48.06	322.47	448	79.50	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			526.3	E08		9	0075-0322	843.07	321.93	318	66.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			294.4	E08		9	0076-0329	410.85	329.14	331	68.43	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			239.4	E08		9	0077-0334	18.36	333.96	364	73.50	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			250.3	E08		9	0078-0336	359.49	336.39	397	73.84	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			279.9	E08		9	0079-0361	46.64	361.56	375	76.18	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			264.1	E08		9	0080-0363	143.77	363.02	715	101.05	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			432.5	E08		9	0081-0357	942.03	357.06	341	68.18	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			573.9	E08		9	0082-0367	914.25	366.85	224	76.43	0.482
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			260.3	E08		9	0083-0371	291.66	371.35	368	72.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			247.3	E08		9	0084-0386	92.84	386.67	367	72.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			257.8	E08		9	0085-0400	243.83	400.34	375	73.26	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			283.3	E08		9	0086-0401	306.84	401.24	393	74.67	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			280.7	E08		9	0087-0409	193.29	408.93	388	73.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			241.1	E08		9	0088-0412	70.60	412.71	370	71.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			319.9	E08		9	0089-0421	506.18	420.74	402	75.50	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			222.8	E08		9	0090-0424	23.89	424.00	390	75.60	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			240.7	E08		9	0091-0438	122.48	438.09	377	74.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			222.4	E08		9	0092-0457	67.82	457.34	362	71.60	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			316.5	E08		9	0093-0460	378.98	459.94	408	74.43	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			295.1	E08		9	0094-0472	844.58	471.93	371	74.43	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			286.7	E08		9	0095-0493	233.99	494.65	661	106.23	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			283.0	E08		9	0096-0496	541.76	496.72	360	71.84	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			288.2	E08		9	0097-0502	57.45	502.91	432	82.28	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			267.6	E08		9	0098-0504	37.64	504.09	357	72.53	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			284.1	E08		9	0099-0505	610.27	505.12	422	75.26	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			359.6	E08		9	0100-0519	323.28	519.04	444	79.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			283.4	E08		9	0101-0523	206.62	522.81	376	73.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			313.1	E08		9	0102-0523	59.79	522.94	350	71.70	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			801.7	E08		9	0103-0540	338.97	540.23	445	79.26	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			275.4	E08		9	0104-0545	381.48	545.16	362	70.53	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			446.2	E08		9	0105-0545	571.83	544.20	311	67.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			394.1	E08		9	0106-0559	562.79	560.54	389	75.26	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			256.5	E08		9	0107-0574	22.91	574.25	342	69.60	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			293.2	E08		9	0108-0576	608.85	576.94	389	74.91	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			277.9	E08		9	0109-0587	590.60	587.81	393	75.26	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			266.7	E08		9	0110-0594	360.80	594.71	372	72.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			214.8	E08		9	0111-0597	50.96	597.50	346	71.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			361.8	E08		9	0112-0619	538.40	618.84	271	59.94	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			263.8	E08		9	0113-0632	114.79	632.78	368	71.84	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			281.4	E08		9	0114-0633	916.89	632.73	349	70.77	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			293.6	E08		9	0115-0637	723.10	636.85	398	76.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			250.4	E08		9	0116-0635	35.78	635.56	114	43.46	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			756.0	E08		9	0117-0647	330.91	646.43	963	121.30	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			345.3	E08		9	0118-0643	95.21	643.10	364	74.08	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1641.1	E08		9	0119-0646	831.47	646.01	365	71.84	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1531.6	E08		9	0120-0664	884.80	664.40	591	92.33	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			220.1	E08		9	0121-0688	282.03	688.56	384	75.84	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			229.0	E08		9	0122-0691	32.07	691.03	364	72.43	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1345.3	E08		9	0123-0696	492.71	697.00	914	118.23	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			236.8	E08		9	0124-0692	101.63	692.07	400	76.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			278.4	E08		9	0125-0695	371.28	694.61	380	75.50	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1094.5	E08		9	0126-0700	602.27	699.55	456	83.74	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			245.4	E08		9	0127-0701	453.77	701.32	370	71.84	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			355.5	F08		1	0001-0030	110.32	30.57	334	66.77	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			365.0	F08		1	0002-0030	292.69	29.76	335	69.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			391.8	F08		1	0003-0033	788.07	32.87	308	63.94	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			485.2	F08		1	0004-0036	632.11	35.77	388	76.67	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			332.0	F08		1	0005-0039	856.44	39.34	340	71.26	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			370.8	F08		1	0006-0046	812.65	45.96	342	69.60	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			539.8	F08		1	0007-0045	447.90	44.91	293	63.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			368.2	F08		1	0008-0050	42.39	51.20	369	72.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			603.2	F08		1	0009-0052	596.09	52.45	328	69.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			379.5	F08		1	0010-0056	175.27	55.94	409	77.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			466.1	F08		1	0011-0064	115.82	64.58	333	67.26	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1183.0	F08		1	0012-0066	924.28	65.51	402	78.08	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			459.3	F08		1	0013-0084	473.86	84.49	348	69.60	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			548.6	F08		1	0014-0088	249.65	88.08	246	61.84	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			401.5	F08		1	0015-0090	298.93	89.70	343	71.01	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			501.8	F08		1	0016-0097	626.12	97.82	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			385.3	F08		1	0017-0100	812.67	99.51	412	75.26	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			338.9	F08		1	0018-0101	37.70	101.14	322	67.01	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			392.8	F08		1	0019-0109	158.33	109.14	367	74.67	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			607.8	F08		1	0020-0110	918.49	110.83	230	55.70	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			575.5	F08		1	0021-0117	383.49	117.08	301	63.60	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			581.1	F08		1	0022-0120	224.09	120.30	352	71.84	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			417.3	F08		1	0023-0128	92.30	128.42	330	68.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			425.0	F08		1	0024-0129	304.76	129.88	332	69.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			441.8	F08		1	0025-0132	888.55	131.89	382	74.67	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1144.6	F08		1	0026-0133	624.07	132.24	400	75.84	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			438.4	F08		1	0027-0136	189.70	136.50	377	71.84	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			449.7	F08		1	0028-0139	38.80	139.33	355	71.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			542.1	F08		1	0029-0156	502.25	156.41	361	72.77	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			610.0	F08		1	0030-0159	245.97	159.58	262	60.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			485.1	F08		1	0031-0162	542.47	162.08	305	66.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			414.0	F08		1	0032-0170	856.80	169.98	448	81.26	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			520.6	F08		1	0033-0175	32.65	174.76	287	62.77	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			412.0	F08		1	0034-0180	296.19	180.25	357	70.67	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			403.7	F08		1	0035-0181	102.62	181.53	348	70.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			400.5	F08		1	0036-0191	622.34	191.15	356	70.53	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			392.9	F08		1	0037-0209	549.09	209.23	362	71.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			449.6	F08		1	0038-0216	173.16	216.49	298	64.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			671.2	F08		1	0039-0214	415.90	214.79	279	65.70	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			521.2	F08		1	0040-0218	132.55	218.67	313	65.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			438.1	F08		1	0041-0222	910.76	222.53	352	71.36	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			422.9	F08		1	0042-0227	265.38	226.89	346	70.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			456.8	F08		1	0043-0236	190.99	236.66	350	69.01	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			384.5	F08		1	0044-0238	460.98	238.44	327	74.08	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			522.3	F08		1	0045-0242	620.41	241.77	371	73.26	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			443.1	F08		1	0046-0241	540.92	241.27	310	65.11	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1072.5	F08		1	0047-0241	410.05	241.48	113	37.80	0.994
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			383.1	F08		1	0048-0250	839.25	249.93	357	73.26	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			426.5	F08		1	0049-0261	137.07	261.05	352	71.26	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			375.7	F08		1	0050-0262	571.15	261.52	381	73.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			348.4	F08		1	0051-0266	475.39	266.69	348	70.77	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			387.3	F08		1	0052-0270	530.89	271.01	334	69.84	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			422.1	F08		1	0053-0273	75.30	273.01	386	72.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			419.6	F08		1	0054-0279	210.55	279.03	249	60.43	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			461.9	F08		1	0055-0279	382.62	278.80	308	67.36	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1387.0	F08		1	0056-0282	904.38	282.65	390	74.43	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			407.9	F08		1	0057-0287	15.18	287.71	332	67.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			362.2	F08		1	0058-0300	517.08	299.90	373	73.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			831.6	F08		1	0059-0329	669.56	330.57	345	70.43	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			486.8	F08		1	0060-0329	210.55	329.94	319	64.77	0.956
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			387.5	F08		1	0061-0342	802.79	343.15	334	72.67	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			382.3	F08		1	0062-0344	183.62	344.44	354	70.43	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			393.4	F08		1	0063-0346	343.07	345.89	306	64.77	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			524.6	F08		1	0064-0343	518.02	343.86	284	64.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			416.3	F08		1	0065-0349	610.56	349.57	361	71.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			409.3	F08		1	0066-0349	313.63	348.58	294	67.26	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			469.1	F08		1	0067-0352	260.23	352.27	281	67.11	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			607.5	F08		1	0068-0354	442.75	354.67	287	63.94	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			483.8	F08		1	0069-0363	480.92	363.36	340	69.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			444.2	F08		1	0070-0367	299.40	366.87	304	65.36	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			383.3	F08		1	0071-0365	834.10	365.25	322	69.01	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			496.0	F08		1	0072-0368	527.07	367.61	294	64.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			362.5	F08		1	0073-0382	713.27	382.72	345	71.50	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			387.8	F08		1	0074-0384	173.41	384.36	362	72.77	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			398.1	F08		1	0075-0391	638.78	392.22	333	68.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			759.9	F08		1	0076-0405	573.29	404.87	344	69.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			356.3	F08		1	0077-0406	83.10	406.45	337	72.08	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			371.1	F08		1	0078-0409	594.00	410.00	382	76.43	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			599.2	F08		1	0079-0416	504.68	415.87	285	67.01	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			442.4	F08		1	0080-0418	699.52	417.20	307	69.50	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			485.3	F08		1	0081-0418	203.10	417.77	265	61.36	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			375.5	F08		1	0082-0428	690.61	428.69	321	68.91	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			877.8	F08		1	0083-0435	651.67	435.56	372	72.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			418.5	F08		1	0084-0437	450.85	437.17	367	70.77	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			467.5	F08		1	0085-0435	195.15	435.23	264	61.36	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			361.4	F08		1	0086-0441	111.14	440.70	368	73.84	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			514.4	F08		1	0087-0436	937.32	436.53	267	61.70	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			608.4	F08		1	0088-0444	253.50	444.16	346	118.71	0.309
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			402.7	F08		1	0089-0455	397.40	455.25	368	71.01	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			560.1	F08		1	0090-0464	825.17	463.78	237	57.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			476.0	F08		1	0091-0485	605.91	485.29	412	87.15	0.682
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			429.5	F08		1	0092-0484	359.10	485.15	381	72.18	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1294.4	F08		1	0093-0490	141.87	490.27	500	83.26	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			510.7	F08		1	0094-0485	304.73	485.23	290	63.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			561.3	F08		1	0095-0491	754.70	490.13	391	73.84	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			473.7	F08		1	0096-0498	265.06	497.74	288	63.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			765.3	F08		1	0097-0502	612.95	502.59	117	44.87	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			394.7	F08		1	0098-0527	10.59	527.92	305	65.70	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			385.0	F08		1	0099-0529	57.86	529.03	358	73.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			416.8	F08		1	0100-0535	452.49	535.43	640	112.47	0.636
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			403.8	F08		1	0101-0544	105.27	544.43	300	68.18	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			458.4	F08		1	0102-0546	231.84	545.25	339	71.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			556.5	F08		1	0103-0553	623.75	553.28	268	62.43	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			384.5	F08		1	0104-0555	850.95	555.28	286	62.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			389.8	F08		1	0105-0568	48.18	568.35	360	72.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			405.1	F08		1	0106-0574	819.63	574.22	350	69.11	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			338.1	F08		1	0107-0583	783.20	583.27	312	66.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			351.5	F08		1	0108-0584	710.81	582.51	423	89.50	0.664
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			344.7	F08		1	0109-0601	38.32	600.89	321	67.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			366.4	F08		1	0110-0600	607.81	600.05	367	76.08	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			327.7	F08		1	0111-0606	660.58	605.85	371	69.60	0.962
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			296.8	F08		1	0112-0610	748.21	610.84	319	68.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			532.1	F08		1	0113-0613	409.35	613.53	265	61.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			608.3	F08		1	0114-0617	366.01	617.49	295	65.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			407.0	F08		1	0115-0636	47.83	636.91	302	65.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			631.1	F08		1	0116-0637	228.92	636.45	239	59.84	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			438.1	F08		1	0117-0641	105.73	640.57	304	66.43	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			403.8	F08		1	0118-0640	623.25	640.90	283	65.50	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			365.3	F08		1	0119-0647	682.37	646.90	347	69.36	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			418.4	F08		1	0120-0655	768.36	655.13	297	65.11	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			437.5	F08		1	0121-0662	135.28	662.55	313	68.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			562.0	F08		1	0122-0666	210.92	665.60	261	60.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			534.1	F08		1	0123-0671	801.92	670.94	284	69.94	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			592.3	F08		1	0124-0667	75.29	666.23	255	61.01	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			365.1	F08		1	0125-0677	59.44	677.46	367	73.74	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			524.9	F08		1	0126-0683	690.93	683.68	237	57.11	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			333.9	F08		1	0127-0686	20.18	685.76	352	73.26	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			440.8	F08		1	0128-0684	273.91	684.26	249	60.87	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			380.4	F08		1	0129-0693	915.46	693.02	290	65.36	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			358.0	F08		1	0130-0701	579.21	702.80	368	72.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			457.3	F08		2	0001-0044	402.32	43.52	252	60.87	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1057.8	F08		2	0002-0047	546.79	46.75	377	74.43	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			343.9	F08		2	0003-0045	673.20	45.53	381	73.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			492.3	F08		2	0004-0049	443.67	49.45	286	65.01	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			396.1	F08		2	0005-0054	106.51	53.86	348	73.26	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			392.8	F08		2	0006-0052	743.31	52.03	279	62.43	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			327.4	F08		2	0007-0054	139.17	54.86	280	64.43	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1174.8	F08		2	0008-0067	28.86	65.71	380	74.67	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			472.7	F08		2	0009-0077	470.04	76.71	312	68.18	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			445.9	F08		2	0010-0072	721.48	72.01	287	65.94	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			405.3	F08		2	0011-0074	183.67	73.87	277	62.28	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			573.0	F08		2	0012-0080	815.81	78.97	283	65.50	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			392.8	F08		2	0013-0082	518.19	82.42	330	77.50	0.690
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			421.7	F08		2	0014-0083	889.92	82.14	281	62.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			336.6	F08		2	0015-0093	931.34	92.92	316	69.26	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			480.6	F08		2	0016-0102	144.94	102.35	374	75.50	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			505.6	F08		2	0017-0105	565.73	104.91	454	81.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			523.6	F08		2	0018-0111	22.99	111.27	235	56.53	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			467.7	F08		2	0019-0113	657.25	112.56	319	68.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			524.6	F08		2	0020-0117	207.77	117.49	239	59.70	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			569.0	F08		2	0021-0119	230.19	119.39	242	60.53	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			456.7	F08		2	0022-0134	856.86	133.97	276	62.43	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			333.6	F08		2	0023-0138	939.43	137.65	329	70.43	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			375.5	F08		2	0024-0143	330.89	143.01	345	68.77	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			334.1	F08		2	0025-0151	69.43	151.02	317	67.84	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			700.2	F08		2	0026-0156	215.70	157.45	411	85.50	0.707
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			377.1	F08		2	0027-0157	165.99	157.66	306	66.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			486.8	F08		2	0028-0162	411.80	162.46	265	61.36	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			559.0	F08		2	0029-0166	749.08	166.72	255	59.36	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			419.0	F08		2	0030-0170	119.40	169.22	339	71.01	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3052.7	F08		2	0031-0169	139.86	169.16	344	68.53	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			428.5	F08		2	0032-0176	510.70	176.42	377	72.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1988.6	F08		2	0033-0172	635.63	171.65	154	45.94	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			433.0	F08		2	0034-0178	457.29	178.32	334	68.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2011.0	F08		2	0035-0181	626.08	181.30	201	55.01	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2157.4	F08		2	0036-0187	645.35	186.92	276	63.60	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			590.5	F08		2	0037-0189	845.17	189.53	216	59.60	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			396.6	F08		2	0038-0193	325.10	193.61	304	64.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			389.5	F08		2	0039-0198	409.45	197.88	339	70.18	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			447.5	F08		2	0040-0209	535.17	208.71	386	73.26	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			366.5	F08		2	0041-0222	15.25	222.86	325	68.53	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			375.7	F08		2	0042-0224	616.40	224.46	300	65.01	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			400.9	F08		2	0043-0226	843.78	226.33	273	63.60	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			330.9	F08		2	0044-0230	121.18	229.88	332	68.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			466.1	F08		2	0045-0228	239.63	228.40	268	65.01	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			315.1	F08		2	0046-0230	652.00	230.29	317	67.84	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			430.1	F08		2	0047-0233	715.12	232.41	190	55.11	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			545.8	F08		2	0048-0235	323.12	235.58	304	71.11	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			443.2	F08		2	0049-0245	404.92	245.37	349	71.84	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			350.1	F08		2	0050-0250	276.28	249.47	274	63.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			396.9	F08		2	0051-0264	929.92	263.21	249	63.01	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			365.4	F08		2	0052-0261	191.74	262.17	309	69.36	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			828.3	F08		2	0053-0261	360.66	261.16	226	56.04	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			417.6	F08		2	0054-0268	54.40	268.60	344	69.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			558.2	F08		2	0055-0269	887.42	269.70	221	56.87	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			498.3	F08		2	0056-0270	341.91	269.66	282	63.94	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			384.1	F08		2	0057-0270	377.36	269.33	302	67.01	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			394.9	F08		2	0058-0280	724.41	279.94	346	72.18	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			466.3	F08		2	0059-0287	837.58	288.01	278	63.36	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			494.3	F08		2	0060-0297	127.28	297.86	214	57.94	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			373.3	F08		2	0061-0310	855.99	310.23	349	72.77	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			398.5	F08		2	0062-0317	259.32	317.68	288	65.70	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			891.1	F08		2	0063-0316	721.99	316.46	335	70.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			415.8	F08		2	0064-0321	376.65	320.95	305	66.67	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			468.8	F08		2	0065-0326	445.77	327.05	286	61.36	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			367.3	F08		2	0066-0330	180.19	329.23	325	67.36	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			372.8	F08		2	0067-0342	868.58	341.35	293	64.18	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			368.0	F08		2	0068-0348	366.56	348.52	336	68.18	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			334.5	F08		2	0069-0351	922.88	351.54	356	73.01	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			326.6	F08		2	0070-0356	941.20	356.11	350	71.60	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			352.3	F08		2	0071-0357	153.69	357.39	612	108.23	0.657
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1335.9	F08		2	0072-0374	406.60	374.81	483	84.43	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			354.5	F08		2	0073-0383	289.40	383.00	313	67.94	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			429.4	F08		2	0074-0383	102.55	383.68	245	59.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1716.0	F08		2	0075-0385	593.84	385.36	304	67.84	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			318.1	F08		2	0076-0387	356.28	387.46	294	66.43	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			317.7	F08		2	0077-0393	141.79	393.65	318	69.26	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			321.3	F08		2	0078-0397	212.63	398.04	322	65.60	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			380.4	F08		2	0079-0404	652.55	404.88	359	70.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			334.2	F08		2	0080-0409	431.96	408.57	379	72.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			427.7	F08		2	0081-0430	485.77	430.66	314	68.18	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			329.2	F08		2	0082-0436	193.76	436.75	316	68.43	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			505.6	F08		2	0083-0436	587.81	435.82	323	69.01	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			456.0	F08		2	0084-0437	42.06	436.96	271	61.11	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1404.5	F08		2	0085-0437	821.66	437.77	223	56.77	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			846.3	F08		2	0086-0448	660.63	448.83	239	58.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			340.0	F08		2	0087-0453	54.39	453.00	355	70.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			402.2	F08		2	0088-0459	340.67	458.85	249	61.84	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			694.6	F08		2	0089-0458	740.67	458.64	236	59.70	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			354.8	F08		2	0090-0467	519.60	467.21	345	69.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			584.0	F08		2	0091-0479	573.14	478.52	194	66.43	0.552
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			306.0	F08		2	0092-0489	169.47	489.35	315	70.77	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			919.1	F08		2	0093-0519	590.31	518.90	428	82.08	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			370.7	F08		2	0094-0517	202.43	517.49	317	67.36	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2299.5	F08		2	0095-0523	87.21	522.84	469	81.50	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			532.8	F08		2	0096-0521	771.81	521.83	313	68.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			435.6	F08		2	0097-0538	125.28	538.27	288	62.53	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			453.2	F08		2	0098-0537	646.98	536.44	248	62.18	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			350.2	F08		2	0099-0545	186.16	545.47	349	70.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			336.7	F08		2	0100-0562	460.22	561.46	366	74.43	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			419.6	F08		2	0101-0559	846.47	559.65	280	61.60	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			377.3	F08		2	0102-0581	830.65	580.36	296	64.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			426.4	F08		2	0103-0584	729.87	584.27	309	67.94	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			398.7	F08		2	0104-0583	136.86	584.11	355	70.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1082.2	F08		2	0105-0593	204.94	592.65	333	67.84	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			380.1	F08		2	0106-0599	657.62	599.28	352	72.77	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			918.8	F08		2	0107-0612	401.82	612.35	416	77.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			342.0	F08		2	0108-0613	282.94	613.38	336	69.60	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			334.8	F08		2	0109-0617	794.31	617.48	364	74.43	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			391.9	F08		2	0110-0627	564.76	627.74	304	68.33	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			423.2	F08		2	0111-0628	503.68	628.54	265	60.43	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			348.3	F08		2	0112-0640	468.48	639.76	358	74.77	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			552.3	F08		2	0113-0637	533.36	637.27	300	64.43	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			984.0	F08		2	0114-0638	142.53	638.49	284	62.28	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			419.8	F08		2	0115-0642	923.09	642.55	259	61.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2819.4	F08		2	0116-0649	490.89	649.79	358	75.60	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			276.8	F08		2	0117-0649	649.70	649.95	364	70.43	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			609.0	F08		2	0118-0651	340.95	651.50	256	60.53	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			596.5	F08		2	0119-0655	74.76	655.35	333	67.01	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			327.2	F08		2	0120-0656	384.32	656.20	315	68.43	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			325.3	F08		2	0121-0657	846.70	657.62	241	65.01	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			394.6	F08		2	0122-0664	526.49	664.41	282	62.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			405.4	F08		2	0123-0666	164.78	666.26	272	63.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			677.9	F08		2	0124-0667	290.75	666.98	342	68.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			304.0	F08		2	0125-0682	731.33	682.52	336	69.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			314.8	F08		2	0126-0684	931.88	683.94	264	62.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			397.5	F08		2	0127-0694	19.90	693.98	297	67.60	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			333.6	F08		2	0128-0705	744.81	704.87	312	65.84	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			387.7	F08		2	0129-0706	272.33	705.97	274	61.70	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1453.7	F08		2	0130-0704	664.77	704.13	313	65.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			344.0	F08		3	0001-0050	476.08	49.13	337	67.70	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			479.4	F08		3	0002-0055	782.98	55.56	261	61.11	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			650.7	F08		3	0003-0061	427.72	60.68	259	63.26	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			415.1	F08		3	0004-0062	393.22	62.02	308	63.36	0.964
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			513.7	F08		3	0005-0065	594.31	65.58	268	65.11	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			421.0	F08		3	0006-0068	325.54	68.02	284	62.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			546.6	F08		3	0007-0074	358.23	74.13	275	61.94	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			608.2	F08		3	0008-0089	435.52	89.44	268	60.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			320.4	F08		3	0009-0095	26.42	95.35	307	67.84	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			918.5	F08		3	0010-0109	138.49	108.04	205	67.26	0.570
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			846.6	F08		3	0011-0121	338.26	120.75	128	83.98	0.228
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			648.6	F08		3	0012-0130	591.11	130.17	181	52.87	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			356.9	F08		3	0013-0135	62.32	134.57	325	67.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			800.6	F08		3	0014-0142	436.10	142.21	309	66.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			477.3	F08		3	0015-0139	714.84	139.16	329	69.84	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			360.5	F08		3	0016-0141	34.55	140.24	322	71.01	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2586.8	F08		3	0017-0151	362.17	151.19	344	69.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			964.6	F08		3	0018-0146	686.46	146.15	203	58.28	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2193.5	F08		3	0019-0162	798.40	161.54	373	72.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			448.9	F08		3	0020-0164	305.82	164.51	279	61.94	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			411.8	F08		3	0021-0169	524.17	169.68	355	70.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			594.2	F08		3	0022-0176	41.37	176.90	331	73.50	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			383.6	F08		3	0023-0177	832.00	178.04	298	65.26	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			348.6	F08		3	0024-0180	761.07	179.65	319	70.18	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			556.6	F08		3	0025-0177	491.67	177.39	215	55.11	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			338.7	F08		3	0026-0188	796.60	188.30	334	69.36	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1213.4	F08		3	0027-0192	111.65	192.79	198	51.11	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			556.6	F08		3	0028-0201	382.46	201.75	271	63.26	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			442.7	F08		3	0029-0205	201.11	204.61	346	71.11	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			700.2	F08		3	0030-0209	706.89	208.43	356	71.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			502.7	F08		3	0031-0212	450.10	211.48	257	58.77	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			414.4	F08		3	0032-0220	833.52	220.04	327	70.67	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			542.8	F08		3	0033-0220	134.00	220.04	250	59.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			421.9	F08		3	0034-0227	404.98	227.52	305	64.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			479.2	F08		3	0035-0230	513.44	230.31	226	62.77	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			707.5	F08		3	0036-0234	547.93	234.56	240	58.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			413.9	F08		3	0037-0237	281.30	237.36	268	63.11	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			496.5	F08		3	0038-0255	675.34	254.68	236	58.53	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			356.1	F08		3	0039-0258	799.14	258.45	311	66.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			697.8	F08		3	0040-0262	553.47	262.69	241	58.53	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			382.2	F08		3	0041-0266	25.16	265.73	251	63.01	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			422.5	F08		3	0042-0265	863.12	265.41	274	63.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			480.1	F08		3	0043-0265	141.87	264.90	244	59.94	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			755.6	F08		3	0044-0269	487.64	268.24	132	54.77	0.553
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2303.2	F08		3	0045-0276	280.84	276.59	386	73.26	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			495.9	F08		3	0046-0283	412.01	282.93	270	61.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			701.8	F08		3	0047-0287	480.67	286.13	285	76.33	0.615
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			338.0	F08		3	0048-0285	614.69	285.54	353	71.01	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1022.4	F08		3	0049-0296	198.32	296.29	316	68.77	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			402.3	F08		3	0050-0294	808.99	294.66	306	65.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3150.6	F08		3	0051-0300	332.45	299.79	423	75.84	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			431.5	F08		3	0052-0300	512.00	299.74	300	64.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			616.6	F08		3	0053-0297	560.29	297.60	266	59.70	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			333.9	F08		3	0054-0305	631.55	304.42	320	68.18	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			501.8	F08		3	0055-0306	733.69	306.77	268	63.26	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			993.8	F08		3	0056-0305	416.53	305.25	160	48.63	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3329.2	F08		3	0057-0317	101.43	316.75	262	61.60	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			336.5	F08		3	0058-0318	58.86	318.20	366	72.08	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			458.2	F08		3	0059-0321	912.88	321.82	329	68.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			470.7	F08		3	0060-0321	412.84	321.14	247	64.77	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			450.0	F08		3	0061-0347	476.90	347.05	328	68.67	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			508.1	F08		3	0062-0349	536.15	349.97	293	67.11	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2807.0	F08		3	0063-0352	322.80	351.71	344	72.43	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2119.7	F08		3	0064-0354	218.01	354.14	410	78.43	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			305.8	F08		3	0065-0351	905.20	351.25	201	57.36	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			296.4	F08		3	0066-0354	18.49	354.18	350	72.18	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			315.2	F08		3	0067-0359	36.63	358.66	327	71.60	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			334.0	F08		3	0068-0361	443.07	361.30	317	74.77	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			334.2	F08		3	0069-0364	167.12	363.84	301	66.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			680.8	F08		3	0070-0375	797.76	374.43	377	74.43	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2800.7	F08		3	0071-0376	407.77	376.33	403	74.43	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			766.6	F08		3	0072-0383	548.09	383.47	271	61.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			486.1	F08		3	0073-0386	55.28	386.66	263	61.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			319.8	F08		3	0074-0389	468.20	389.24	355	71.01	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			371.7	F08		3	0075-0397	757.28	397.31	318	66.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			315.7	F08		3	0076-0407	593.49	407.72	303	65.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			381.9	F08		3	0077-0411	77.32	411.36	338	74.53	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1141.2	F08		3	0078-0415	667.54	414.74	411	79.26	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			364.9	F08		3	0079-0419	610.37	419.36	314	70.53	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			473.9	F08		3	0080-0418	171.29	417.35	336	70.67	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			411.0	F08		3	0081-0420	436.94	420.27	281	66.43	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			545.5	F08		3	0082-0432	899.32	432.10	265	65.60	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			375.7	F08		3	0083-0438	699.89	438.70	296	63.11	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			306.8	F08		3	0084-0444	43.31	444.10	338	70.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			851.7	F08		3	0085-0456	495.79	456.18	406	77.50	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			436.8	F08		3	0086-0460	909.25	460.74	187	53.94	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			421.6	F08		3	0087-0465	185.70	465.70	314	67.94	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			366.1	F08		3	0088-0474	639.22	474.30	345	69.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			290.1	F08		3	0089-0477	108.91	477.06	326	70.43	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			831.2	F08		3	0090-0483	496.72	482.98	270	66.43	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			297.5	F08		3	0091-0489	136.73	489.56	356	70.18	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			471.7	F08		3	0092-0490	780.75	490.99	267	61.36	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			314.3	F08		3	0093-0495	49.45	494.62	325	71.01	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			370.6	F08		3	0094-0500	347.91	499.38	295	64.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			401.8	F08		3	0095-0505	919.44	505.45	336	70.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			392.8	F08		3	0096-0508	250.88	507.89	557	95.74	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			360.6	F08		3	0097-0510	377.92	509.40	309	65.01	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			335.2	F08		3	0098-0527	730.49	527.19	370	73.60	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2301.0	F08		3	0099-0528	126.47	527.79	363	75.26	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			497.2	F08		3	0100-0534	225.35	534.16	299	67.01	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			429.8	F08		3	0101-0536	332.81	536.80	270	62.18	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			335.9	F08		3	0102-0543	554.02	544.15	343	69.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			297.2	F08		3	0103-0559	286.52	558.77	368	74.18	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			366.2	F08		3	0104-0566	404.65	567.19	357	75.60	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			343.5	F08		3	0105-0571	119.84	570.90	342	68.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			337.7	F08		3	0106-0577	154.39	576.28	301	68.43	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			336.1	F08		3	0107-0591	260.04	590.74	287	68.67	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			435.9	F08		3	0108-0616	365.65	616.72	298	71.50	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			542.8	F08		3	0109-0615	867.81	615.37	216	57.36	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2659.4	F08		3	0110-0619	937.72	619.86	247	60.53	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			331.8	F08		3	0111-0617	586.76	617.38	390	76.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			365.4	F08		3	0112-0630	903.23	629.42	344	73.50	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			558.5	F08		3	0113-0631	686.81	631.00	315	66.43	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			523.1	F08		3	0114-0638	664.80	638.76	311	67.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1303.6	F08		3	0115-0642	347.01	643.02	393	73.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			418.1	F08		3	0116-0644	17.93	645.04	252	59.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			446.3	F08		3	0117-0648	121.67	648.11	346	72.18	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			408.1	F08		3	0118-0651	291.92	651.05	242	62.77	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			323.7	F08		3	0119-0654	805.48	654.07	367	80.57	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			420.8	F08		3	0120-0652	309.59	653.07	239	60.77	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			633.3	F08		3	0121-0658	176.52	658.47	307	64.77	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			435.8	F08		3	0122-0658	839.55	658.18	315	69.84	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			319.6	F08		3	0123-0665	557.91	665.19	318	65.60	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			329.8	F08		3	0124-0672	147.01	672.49	294	63.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			309.9	F08		3	0125-0682	690.56	682.16	287	63.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			632.4	F08		3	0126-0686	535.26	685.35	203	55.21	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			345.5	F08		3	0127-0686	26.79	686.38	256	61.11	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			328.0	F08		3	0128-0694	675.48	694.25	328	67.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1008.6	F08		3	0129-0694	879.58	694.71	250	59.94	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			360.1	F08		3	0130-0704	182.73	704.55	273	61.60	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			424.5	F08		3	0131-0705	571.76	705.50	261	61.94	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			438.7	F08		4	0001-0029	171.82	29.32	261	60.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			720.5	F08		4	0002-0029	195.04	28.79	276	62.28	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			394.2	F08		4	0003-0032	144.75	32.73	257	61.70	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			393.0	F08		4	0004-0037	371.19	36.91	404	78.43	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			275.0	F08		4	0005-0064	872.22	63.25	356	72.43	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			409.8	F08		4	0006-0066	791.10	66.43	289	63.84	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			513.2	F08		4	0007-0069	51.72	68.97	255	61.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			372.9	F08		4	0008-0073	575.33	73.58	383	72.18	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			385.8	F08		4	0009-0076	110.78	76.17	321	67.94	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			360.4	F08		4	0010-0081	129.33	81.01	329	68.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			342.2	F08		4	0011-0096	634.11	95.81	337	70.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			360.6	F08		4	0012-0099	658.30	99.12	333	67.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			411.8	F08		4	0013-0106	475.01	106.70	414	83.26	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			683.9	F08		4	0014-0113	291.14	113.27	168	62.18	0.546
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			457.1	F08		4	0015-0121	83.65	120.58	291	65.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			694.3	F08		4	0016-0123	752.18	123.22	242	61.94	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			709.6	F08		4	0017-0121	785.98	121.79	202	51.94	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1514.7	F08		4	0018-0130	765.98	129.70	307	67.60	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			479.1	F08		4	0019-0132	574.14	131.92	314	67.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			488.2	F08		4	0020-0134	331.23	133.99	233	59.60	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			506.1	F08		4	0021-0136	432.75	135.71	287	64.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			418.7	F08		4	0022-0159	807.45	159.14	211	57.11	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			832.5	F08		4	0023-0161	233.88	160.59	280	61.94	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			657.1	F08		4	0024-0161	49.25	161.54	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			448.4	F08		4	0025-0164	601.52	164.49	295	64.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			390.5	F08		4	0026-0206	90.26	206.84	298	64.53	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1457.5	F08		4	0027-0209	531.51	209.16	307	68.18	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			769.5	F08		4	0028-0216	759.32	217.08	373	77.01	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			355.5	F08		4	0029-0212	912.03	211.82	314	67.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			367.3	F08		4	0030-0220	638.13	219.53	359	73.84	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			398.9	F08		4	0031-0225	408.56	225.08	339	71.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			451.9	F08		4	0032-0233	179.43	233.32	244	59.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			353.7	F08		4	0033-0240	333.77	239.81	310	66.43	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			557.8	F08		4	0034-0248	851.08	248.98	214	56.04	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			333.0	F08		4	0035-0257	43.47	257.21	343	70.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			525.5	F08		4	0036-0259	664.07	259.11	241	61.36	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			336.8	F08		4	0037-0270	424.07	270.27	299	66.18	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			413.7	F08		4	0038-0273	376.22	273.53	333	67.36	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			480.8	F08		4	0039-0272	180.26	272.05	242	58.77	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2358.5	F08		4	0040-0293	717.39	293.01	452	78.67	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			913.5	F08		4	0041-0297	20.10	297.46	353	70.18	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			376.2	F08		4	0042-0306	120.00	305.13	301	67.26	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			356.1	F08		4	0043-0306	917.57	306.35	266	63.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			422.6	F08		4	0044-0307	538.95	307.10	280	61.60	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			483.7	F08		4	0045-0309	667.97	309.75	240	61.60	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			725.5	F08		4	0046-0306	58.29	305.81	108	71.26	0.267
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			323.1	F08		4	0047-0311	377.59	311.42	323	68.77	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			430.4	F08		4	0048-0325	400.90	325.45	277	65.60	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			309.2	F08		4	0049-0329	359.73	329.52	366	72.43	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			344.4	F08		4	0050-0341	175.33	341.14	295	67.36	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			357.6	F08		4	0051-0338	296.96	338.14	314	68.43	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			311.0	F08		4	0052-0335	911.15	335.22	279	63.36	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			527.8	F08		4	0053-0339	454.32	339.21	317	67.60	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			564.0	F08		4	0054-0340	751.27	340.20	239	56.53	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			547.9	F08		4	0055-0347	199.86	347.24	232	57.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			319.9	F08		4	0056-0348	898.53	348.06	261	62.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			326.5	F08		4	0057-0353	925.53	352.89	270	61.94	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			491.3	F08		4	0058-0370	645.70	369.78	240	56.53	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			401.8	F08		4	0059-0374	765.64	375.08	305	63.60	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			413.7	F08		4	0060-0377	230.62	377.83	321	67.84	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			432.6	F08		4	0061-0375	75.09	374.82	228	58.87	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			458.5	F08		4	0062-0397	347.58	396.96	251	61.01	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			447.7	F08		4	0063-0400	196.29	400.36	253	59.11	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			320.1	F08		4	0064-0399	845.43	399.14	274	61.11	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			386.2	F08		4	0065-0405	765.45	405.15	309	65.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			421.4	F08		4	0066-0407	710.17	407.47	313	64.43	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			444.2	F08		4	0067-0411	327.72	411.45	279	64.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			400.1	F08		4	0068-0425	935.39	425.27	246	64.28	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			374.0	F08		4	0069-0426	227.43	425.84	276	63.60	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2512.2	F08		4	0070-0433	826.67	433.62	366	73.01	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			283.1	F08		4	0071-0433	792.34	434.04	296	65.26	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			404.7	F08		4	0072-0439	880.69	439.79	390	75.84	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			336.8	F08		4	0073-0458	342.98	457.95	303	68.53	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			367.3	F08		4	0074-0466	560.47	466.09	336	71.01	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2326.9	F08		4	0075-0477	753.31	477.02	509	85.50	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			404.1	F08		4	0076-0487	519.08	487.44	347	70.43	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			428.3	F08		4	0077-0489	901.11	489.35	224	59.70	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			340.7	F08		4	0078-0497	148.51	496.66	310	65.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			337.5	F08		4	0079-0504	288.85	504.09	327	67.26	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			479.9	F08		4	0080-0502	21.26	502.29	265	65.60	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			335.6	F08		4	0081-0502	230.11	502.30	295	68.43	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			373.9	F08		4	0082-0507	702.74	507.36	250	59.94	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			423.0	F08		4	0083-0518	434.28	517.40	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			385.2	F08		4	0084-0517	327.21	518.02	295	65.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1951.3	F08		4	0085-0532	654.71	531.73	370	71.36	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			341.1	F08		4	0086-0535	143.11	534.87	285	64.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			331.8	F08		4	0087-0536	197.18	535.93	334	68.18	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			518.5	F08		4	0088-0538	519.41	538.85	295	65.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			462.8	F08		4	0089-0547	598.89	547.62	236	57.11	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			590.0	F08		4	0090-0553	770.22	549.80	273	100.71	0.338
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			304.5	F08		4	0091-0553	308.70	552.52	334	68.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			357.1	F08		4	0092-0554	236.15	553.92	325	72.18	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			499.3	F08		4	0093-0553	374.13	553.74	227	60.43	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			295.3	F08		4	0094-0561	844.19	562.12	348	72.67	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			574.7	F08		4	0095-0561	791.09	560.82	264	83.50	0.476
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			331.6	F08		4	0096-0566	270.03	566.14	283	65.84	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			580.2	F08		4	0097-0565	19.85	565.60	260	60.53	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			361.9	F08		4	0098-0581	691.35	581.50	300	65.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			352.2	F08		4	0099-0583	767.19	583.34	293	65.11	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			366.7	F08		4	0100-0587	159.33	587.68	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			371.8	F08		4	0101-0593	844.08	593.08	290	64.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2490.5	F08		4	0102-0608	700.30	608.59	351	72.18	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			403.1	F08		4	0103-0611	330.70	610.79	260	62.18	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			350.4	F08		4	0104-0612	306.01	612.01	306	65.11	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			322.3	F08		4	0105-0615	576.64	615.24	375	74.67	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			700.3	F08		4	0106-0617	891.27	617.43	316	67.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			746.3	F08		4	0107-0628	95.11	628.12	255	61.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			646.0	F08		4	0108-0631	374.02	631.06	239	59.11	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			360.8	F08		4	0109-0636	235.67	635.97	293	68.77	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			505.8	F08		4	0110-0634	316.13	633.75	228	58.87	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			303.0	F08		4	0111-0647	665.33	646.45	365	72.18	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			347.0	F08		4	0112-0653	495.85	653.47	310	65.36	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			304.2	F08		4	0113-0659	788.18	658.88	344	69.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			368.0	F08		4	0114-0659	552.10	659.61	283	67.50	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			318.8	F08		4	0115-0666	282.01	665.44	321	67.60	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			304.8	F08		4	0116-0668	727.49	667.81	322	67.60	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			583.8	F08		4	0117-0680	397.53	679.43	239	57.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			382.9	F08		4	0118-0686	292.84	686.66	270	61.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			310.7	F08		4	0119-0695	861.38	694.59	324	73.50	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			297.6	F08		4	0120-0698	161.50	698.70	379	76.53	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			544.5	F08		4	0121-0700	903.67	700.99	382	111.88	0.383
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			324.0	F08		4	0122-0702	144.98	702.79	376	75.94	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			442.0	F08		4	0123-0699	828.87	699.10	217	57.60	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			556.2	F08		4	0124-0700	594.34	699.65	244	60.43	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			352.4	F08		4	0125-0701	642.94	700.49	282	62.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			281.2	F08		5	0001-0034	395.08	34.47	406	75.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			269.5	F08		5	0002-0038	646.42	38.21	370	70.77	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			288.3	F08		5	0003-0036	895.51	36.62	132	44.87	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			331.9	F08		5	0004-0053	63.91	53.11	294	64.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			838.0	F08		5	0005-0056	130.66	56.10	288	64.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			385.6	F08		5	0006-0053	176.55	53.72	267	61.94	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			260.5	F08		5	0007-0057	930.89	57.41	309	65.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			289.4	F08		5	0008-0059	214.33	59.15	311	67.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			327.8	F08		5	0009-0059	820.16	60.31	321	68.43	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			665.0	F08		5	0010-0064	611.99	63.41	263	61.11	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			302.1	F08		5	0011-0067	82.12	67.22	330	67.60	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			366.9	F08		5	0012-0070	116.97	70.49	285	65.60	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			288.3	F08		5	0013-0071	460.49	70.35	324	68.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			270.1	F08		5	0014-0076	867.42	76.30	428	91.40	0.644
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			436.6	F08		5	0015-0075	301.28	74.78	281	63.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			290.1	F08		5	0016-0074	439.08	73.56	341	70.18	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			283.9	F08		5	0017-0079	544.63	79.97	407	77.26	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			317.5	F08		5	0018-0077	652.81	76.34	386	75.60	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			304.5	F08		5	0019-0082	157.42	81.90	300	66.77	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			300.0	F08		5	0020-0085	343.85	86.51	368	83.84	0.658
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			425.4	F08		5	0021-0089	282.47	89.26	281	61.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			254.6	F08		5	0022-0092	892.22	92.42	341	70.18	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			284.4	F08		5	0023-0095	483.90	95.58	329	71.01	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			366.9	F08		5	0024-0109	219.92	109.22	269	61.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			304.6	F08		5	0025-0113	338.05	113.44	337	68.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			332.1	F08		5	0026-0111	115.25	110.85	245	61.94	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			332.3	F08		5	0027-0114	386.41	114.78	323	70.08	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			317.6	F08		5	0028-0114	427.91	114.12	383	73.60	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			250.2	F08		5	0029-0121	903.82	121.33	326	67.84	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			394.7	F08		5	0030-0131	793.61	131.16	271	63.84	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			612.1	F08		5	0031-0133	734.79	133.74	301	66.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			484.7	F08		5	0032-0134	751.30	133.33	292	63.70	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			653.0	F08		5	0033-0132	385.79	132.09	222	55.70	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			315.6	F08		5	0034-0138	86.64	137.47	341	69.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			342.0	F08		5	0035-0139	163.72	139.59	258	66.77	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			364.5	F08		5	0036-0145	476.49	144.75	396	74.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			302.3	F08		5	0037-0157	213.74	156.88	316	68.43	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			362.3	F08		5	0038-0169	274.16	168.88	351	71.01	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1899.4	F08		5	0039-0173	609.16	173.16	404	76.08	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4334.9	F08		5	0040-0175	653.57	175.14	222	66.43	0.632
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			387.7	F08		5	0041-0186	692.54	186.11	259	61.84	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			327.8	F08		5	0042-0189	790.81	189.35	316	66.18	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			350.0	F08		5	0043-0194	433.89	195.30	340	69.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			317.4	F08		5	0044-0192	569.76	192.11	337	69.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			385.6	F08		5	0045-0194	511.55	194.18	281	67.60	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			311.3	F08		5	0046-0198	605.20	198.50	312	67.01	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			395.8	F08		5	0047-0206	138.63	206.49	216	56.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			369.5	F08		5	0048-0211	405.29	211.43	319	71.36	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			402.4	F08		5	0049-0209	751.75	209.63	284	63.01	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			397.9	F08		5	0050-0211	70.94	211.56	255	59.36	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3443.5	F08		5	0051-0213	693.64	213.26	347	68.43	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			289.6	F08		5	0052-0213	17.38	213.79	300	66.18	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			310.2	F08		5	0053-0213	227.18	213.03	327	71.60	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			462.0	F08		5	0054-0215	509.11	214.86	203	52.53	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			596.6	F08		5	0055-0227	876.19	227.30	204	55.11	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			312.1	F08		5	0056-0234	567.51	233.40	287	68.08	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			275.4	F08		5	0057-0240	663.89	240.33	359	72.67	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			323.9	F08		5	0058-0241	438.76	241.98	335	68.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			401.7	F08		5	0059-0243	527.92	243.78	266	63.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			292.4	F08		5	0060-0247	706.19	247.96	330	70.77	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			368.6	F08		5	0061-0249	754.11	249.02	234	57.36	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			293.0	F08		5	0062-0254	389.43	254.59	364	70.67	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			467.4	F08		5	0063-0261	206.44	260.22	459	86.33	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1663.2	F08		5	0064-0270	895.35	270.24	417	76.67	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			307.4	F08		5	0065-0270	599.22	270.41	322	66.77	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			407.4	F08		5	0066-0273	348.28	273.69	299	66.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			428.2	F08		5	0067-0276	448.25	276.64	239	58.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			670.7	F08		5	0068-0278	835.77	278.27	321	71.01	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			961.4	F08		5	0069-0279	292.09	279.55	344	68.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			310.1	F08		5	0070-0281	537.85	281.40	333	68.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			246.2	F08		5	0071-0280	677.23	279.89	332	75.26	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			440.0	F08		5	0072-0296	347.47	296.08	330	69.11	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1207.5	F08		5	0073-0299	635.45	299.89	346	73.94	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			449.2	F08		5	0074-0297	788.73	297.15	291	66.43	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			291.4	F08		5	0075-0304	875.72	303.01	289	70.18	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			403.9	F08		5	0076-0304	729.81	304.02	340	68.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			323.6	F08		5	0077-0308	23.08	308.11	265	63.01	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			272.6	F08		5	0078-0305	939.78	305.35	304	67.11	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			397.5	F08		5	0079-0310	179.55	310.39	294	64.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			280.5	F08		5	0080-0311	598.75	311.32	354	71.84	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			370.8	F08		5	0081-0313	143.45	313.92	286	64.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			310.7	F08		5	0082-0313	690.74	313.03	348	77.26	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			337.7	F08		5	0083-0319	850.96	319.47	303	65.01	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			371.8	F08		5	0084-0322	104.40	321.87	295	62.77	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			353.6	F08		5	0085-0336	533.22	336.35	305	64.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			284.1	F08		5	0086-0337	16.83	337.26	281	63.70	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			454.4	F08		5	0087-0351	708.97	350.24	940	130.02	0.699
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			618.2	F08		5	0088-0353	484.07	354.05	355	77.60	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			349.0	F08		5	0089-0355	30.81	354.84	268	61.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			333.7	F08		5	0090-0368	604.98	368.12	312	65.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			347.1	F08		5	0091-0375	822.27	374.97	333	69.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			371.5	F08		5	0092-0381	723.88	381.54	231	58.77	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			293.2	F08		5	0093-0387	124.99	387.97	340	73.01	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			355.3	F08		5	0094-0394	576.29	394.42	289	63.11	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			597.3	F08		5	0095-0397	186.52	397.07	209	54.28	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			373.5	F08		5	0096-0402	650.80	402.61	306	65.01	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			322.0	F08		5	0097-0403	301.55	402.35	283	62.77	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			337.2	F08		5	0098-0407	729.66	406.83	335	68.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1921.8	F08		5	0099-0411	271.43	411.55	382	72.77	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			299.9	F08		5	0100-0411	806.69	411.17	317	66.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			315.3	F08		5	0101-0410	931.79	410.06	268	63.01	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1387.2	F08		5	0102-0416	163.49	417.53	505	84.33	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			288.5	F08		5	0103-0412	488.23	411.26	280	63.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			260.1	F08		5	0104-0415	603.65	415.15	316	68.18	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			297.6	F08		5	0105-0423	356.28	423.04	348	72.43	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			376.9	F08		5	0106-0427	40.59	427.14	247	64.53	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			461.7	F08		5	0107-0430	435.55	429.89	458	82.33	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			275.7	F08		5	0108-0440	211.05	440.67	269	62.77	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			299.9	F08		5	0109-0439	640.00	439.36	249	57.94	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			388.3	F08		5	0110-0442	417.16	442.94	262	61.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			308.3	F08		5	0111-0443	899.55	443.27	301	64.18	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			320.3	F08		5	0112-0447	476.08	447.55	363	70.67	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1972.5	F08		5	0113-0451	734.64	451.15	297	66.18	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			898.2	F08		5	0114-0456	242.30	455.90	332	69.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			383.9	F08		5	0115-0451	578.34	451.24	303	68.77	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			395.4	F08		5	0116-0469	58.94	469.69	252	61.60	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			227.7	F08		5	0117-0471	351.25	471.21	327	70.43	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2185.3	F08		5	0118-0472	551.99	471.88	329	67.11	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			308.1	F08		5	0119-0472	203.72	471.30	258	61.94	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			309.5	F08		5	0120-0478	503.26	478.79	262	67.11	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			323.2	F08		5	0121-0485	856.17	484.58	358	83.15	0.651
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			304.3	F08		5	0122-0485	677.69	485.26	282	61.36	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			289.8	F08		5	0123-0487	399.87	488.02	359	73.50	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			279.5	F08		5	0124-0490	440.42	490.09	294	65.01	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			251.8	F08		5	0125-0498	773.48	496.68	378	75.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			285.7	F08		5	0126-0496	309.69	496.05	294	69.84	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			246.4	F08		5	0127-0509	643.66	509.29	335	73.94	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			283.1	F08		5	0128-0509	589.08	509.68	338	69.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2190.9	F08		5	0129-0513	89.09	513.87	285	64.77	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			282.2	F08		5	0130-0514	719.54	514.93	320	72.91	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			319.8	F08		5	0131-0519	469.01	520.32	309	67.60	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			258.3	F08		5	0132-0523	618.72	522.90	329	77.36	0.691
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			319.3	F08		5	0133-0522	938.32	521.96	292	66.77	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			362.1	F08		5	0134-0534	72.21	534.62	230	59.60	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			292.0	F08		5	0135-0544	644.19	544.29	316	68.18	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1741.4	F08		5	0136-0567	420.55	567.04	430	77.84	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			260.3	F08		5	0137-0566	673.03	565.57	335	73.26	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			301.0	F08		5	0138-0565	870.81	565.19	320	72.18	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			445.6	F08		5	0139-0575	833.54	575.28	278	69.11	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			569.6	F08		5	0140-0590	131.65	590.88	210	55.11	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			330.3	F08		5	0141-0611	130.17	611.79	263	59.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			284.4	F08		5	0142-0617	860.75	617.22	361	73.26	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			343.8	F08		5	0143-0636	322.12	636.25	311	65.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			369.0	F08		5	0144-0638	552.97	637.55	285	63.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			353.7	F08		5	0145-0636	143.55	636.61	256	67.94	0.697
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			342.2	F08		5	0146-0646	243.79	646.06	331	70.53	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			324.3	F08		5	0147-0645	569.15	644.80	289	64.53	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1146.0	F08		5	0148-0656	209.72	658.89	589	110.33	0.608
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			362.6	F08		5	0149-0649	392.44	648.81	314	67.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1638.2	F08		5	0150-0651	477.69	651.41	393	74.43	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			350.2	F08		5	0151-0651	648.86	650.78	265	63.26	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1152.8	F08		5	0152-0656	839.71	656.03	262	65.60	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			889.7	F08		5	0153-0652	916.58	652.30	326	69.94	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			283.5	F08		5	0154-0660	61.87	660.43	318	67.84	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			293.8	F08		5	0155-0669	717.31	668.92	367	74.33	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			409.7	F08		5	0156-0675	309.34	674.77	300	67.01	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			313.5	F08		5	0157-0674	400.17	675.66	347	73.84	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			299.9	F08		5	0158-0679	451.47	679.38	325	69.84	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4268.5	F08		5	0159-0684	636.39	684.58	320	66.18	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			767.8	F08		5	0160-0696	906.66	696.33	348	73.01	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			278.2	F08		6	0001-0040	323.34	40.63	347	73.01	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			428.2	F08		6	0002-0047	782.00	47.24	273	67.26	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			505.4	F08		6	0003-0053	426.76	53.37	270	66.67	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			395.0	F08		6	0004-0055	149.57	55.43	286	63.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			273.5	F08		6	0005-0060	25.83	60.11	304	64.77	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			467.3	F08		6	0006-0061	823.37	60.79	253	65.84	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			571.9	F08		6	0007-0067	247.36	66.94	265	65.60	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			281.3	F08		6	0008-0077	673.88	77.38	377	71.84	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			273.9	F08		6	0009-0084	318.86	83.55	340	71.26	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			531.7	F08		6	0010-0082	527.49	83.00	305	64.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			354.8	F08		6	0011-0087	691.40	87.25	305	68.43	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			370.0	F08		6	0012-0093	196.33	91.42	299	70.18	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			491.8	F08		6	0013-0093	411.70	93.66	250	59.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			577.1	F08		6	0014-0104	612.42	106.23	346	102.23	0.416
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			259.4	F08		6	0015-0107	853.40	107.97	367	72.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			518.7	F08		6	0016-0113	298.91	113.41	347	71.84	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			322.9	F08		6	0017-0113	172.37	112.80	285	62.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			527.1	F08		6	0018-0114	334.39	113.57	226	58.53	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			412.1	F08		6	0019-0121	811.87	120.64	294	66.77	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			357.8	F08		6	0020-0128	489.88	127.29	314	69.50	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			361.0	F08		6	0021-0127	261.73	127.59	320	69.01	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			316.3	F08		6	0022-0130	584.41	129.80	379	79.50	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			694.0	F08		6	0023-0141	433.17	141.59	228	55.36	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			370.0	F08		6	0024-0149	770.71	149.75	427	77.26	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			336.1	F08		6	0025-0149	541.38	150.44	409	76.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			323.0	F08		6	0026-0155	854.32	156.19	321	72.18	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			332.8	F08		6	0027-0161	680.29	160.66	346	72.43	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			497.6	F08		6	0028-0164	506.03	165.14	481	90.91	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			371.0	F08		6	0029-0162	369.59	161.90	232	59.36	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			317.0	F08		6	0030-0164	279.54	163.75	252	61.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			382.0	F08		6	0031-0172	236.80	172.17	301	64.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			330.0	F08		6	0032-0176	320.72	175.64	352	72.18	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			372.1	F08		6	0033-0175	898.76	174.31	325	73.01	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			390.7	F08		6	0034-0174	375.98	174.89	226	57.46	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			336.2	F08		6	0035-0181	405.96	181.83	347	77.84	0.720
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			289.2	F08		6	0036-0184	582.05	185.12	389	76.43	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1312.7	F08		6	0037-0189	183.13	190.35	103	56.77	0.402
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			288.5	F08		6	0038-0195	864.81	196.10	382	72.43	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1421.5	F08		6	0039-0206	939.73	206.24	363	72.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			690.2	F08		6	0040-0212	24.77	212.32	133	93.78	0.190
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			302.9	F08		6	0041-0211	247.08	211.41	342	71.84	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			491.0	F08		6	0042-0228	579.14	227.70	277	62.53	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			279.9	F08		6	0043-0232	258.80	231.53	298	66.43	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			359.3	F08		6	0044-0238	813.54	237.94	339	80.43	0.659
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			360.0	F08		6	0045-0241	724.82	241.12	241	61.01	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			340.2	F08		6	0046-0251	149.32	251.35	290	64.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			391.4	F08		6	0047-0255	441.49	255.10	296	63.94	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			243.7	F08		6	0048-0257	311.88	256.26	359	71.84	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			385.1	F08		6	0049-0262	774.37	261.17	308	71.01	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			339.3	F08		6	0050-0263	807.80	263.63	324	69.84	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			331.2	F08		6	0051-0265	748.05	265.21	392	77.26	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			443.3	F08		6	0052-0271	841.51	269.91	483	88.81	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1894.0	F08		6	0053-0273	604.82	273.45	298	69.01	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			281.9	F08		6	0054-0275	192.07	275.02	310	67.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			252.7	F08		6	0055-0285	273.81	284.59	342	71.11	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			376.6	F08		6	0056-0288	315.97	287.75	255	58.53	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			819.2	F08		6	0057-0288	238.03	289.05	118	69.84	0.304
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1431.0	F08		6	0058-0297	110.60	297.43	375	74.77	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			303.8	F08		6	0059-0300	402.45	299.81	395	73.01	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			284.8	F08		6	0060-0300	332.60	301.04	309	66.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			354.1	F08		6	0061-0304	919.18	304.82	341	79.26	0.682
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			305.5	F08		6	0062-0303	872.22	303.19	317	67.01	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			284.8	F08		6	0063-0307	380.17	306.95	348	69.84	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			302.4	F08		6	0064-0308	34.85	308.19	303	66.53	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			298.8	F08		6	0065-0314	529.80	314.65	360	71.84	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			347.5	F08		6	0066-0312	737.90	311.53	283	61.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			427.6	F08		6	0067-0319	460.36	319.32	245	57.94	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			296.0	F08		6	0068-0327	176.31	327.19	334	67.84	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			330.2	F08		6	0069-0327	267.39	326.87	358	72.43	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			250.4	F08		6	0070-0345	345.65	345.61	399	78.08	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			387.5	F08		6	0071-0349	652.12	348.88	388	74.67	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			303.3	F08		6	0072-0351	229.47	350.89	306	67.26	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			338.4	F08		6	0073-0357	860.37	356.93	306	69.01	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			314.6	F08		6	0074-0364	724.31	363.77	340	68.18	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			477.3	F08		6	0075-0367	220.38	367.40	249	61.60	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			293.5	F08		6	0076-0375	307.06	375.11	344	72.77	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			319.3	F08		6	0077-0374	379.82	374.77	371	73.84	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1022.3	F08		6	0078-0378	523.40	378.00	387	76.43	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			376.1	F08		6	0079-0372	777.01	372.70	209	54.28	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			444.7	F08		6	0080-0374	795.86	374.76	239	57.11	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			279.3	F08		6	0081-0390	896.09	390.31	343	70.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			293.6	F08		6	0082-0396	270.34	396.79	301	66.43	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			463.8	F08		6	0083-0400	75.64	400.55	294	63.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			573.7	F08		6	0084-0408	198.73	407.56	319	69.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			315.1	F08		6	0085-0407	558.86	406.76	351	70.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			330.5	F08		6	0086-0411	830.09	410.68	323	70.28	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			297.9	F08		6	0087-0413	26.87	412.80	273	63.01	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			342.6	F08		6	0088-0420	388.43	419.57	320	67.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			291.8	F08		6	0089-0420	699.00	419.51	331	69.01	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			304.7	F08		6	0090-0426	929.04	426.58	303	74.77	0.681
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			418.0	F08		6	0091-0422	80.11	422.33	281	63.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			278.9	F08		6	0092-0422	269.24	422.52	297	65.60	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			367.2	F08		6	0093-0425	495.24	425.58	231	61.70	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			282.3	F08		6	0094-0426	942.53	425.21	293	70.18	0.747
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			305.9	F08		6	0095-0427	654.26	427.01	298	65.01	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3084.3	F08		6	0096-0434	732.15	434.32	345	70.28	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			364.5	F08		6	0097-0434	899.88	434.35	368	72.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			313.3	F08		6	0098-0440	787.04	439.64	350	71.26	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			321.9	F08		6	0099-0444	313.51	444.25	248	63.70	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			353.9	F08		6	0100-0457	612.48	456.44	301	65.60	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			331.4	F08		6	0101-0466	541.75	465.82	314	67.84	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			382.6	F08		6	0102-0469	457.06	467.95	300	69.84	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			374.3	F08		6	0103-0472	899.47	472.04	331	68.43	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			488.7	F08		6	0104-0472	158.56	471.82	129	71.26	0.319
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			330.9	F08		6	0105-0483	421.15	482.38	284	65.01	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			313.6	F08		6	0106-0490	252.39	489.66	277	68.18	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			296.8	F08		6	0107-0488	290.18	488.41	322	68.43	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			312.7	F08		6	0108-0490	467.28	490.61	295	65.70	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			323.7	F08		6	0109-0495	132.47	495.84	269	67.70	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			307.2	F08		6	0110-0491	408.30	491.61	275	63.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			316.4	F08		6	0111-0497	182.57	498.42	305	67.94	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			339.6	F08		6	0112-0499	660.07	499.59	318	69.01	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			279.7	F08		6	0113-0502	370.65	502.53	343	74.43	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			347.4	F08		6	0114-0509	588.39	509.07	310	67.84	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			358.1	F08		6	0115-0515	827.71	515.63	344	68.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			332.3	F08		6	0116-0520	888.52	520.32	253	60.53	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			320.1	F08		6	0117-0522	753.11	521.82	355	70.08	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			290.3	F08		6	0118-0525	33.42	524.89	304	68.43	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			283.6	F08		6	0119-0523	315.91	522.86	302	65.94	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			436.0	F08		6	0120-0530	921.48	530.74	210	53.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			286.3	F08		6	0121-0538	399.98	537.73	342	69.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			356.2	F08		6	0122-0541	48.54	540.58	328	68.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			312.6	F08		6	0123-0546	728.83	546.54	317	66.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			300.5	F08		6	0124-0550	442.78	549.81	360	71.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			311.8	F08		6	0125-0555	695.22	557.17	392	118.13	0.353
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			443.8	F08		6	0126-0558	273.97	559.61	375	88.33	0.604
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			264.6	F08		6	0127-0558	504.41	558.87	368	73.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			293.3	F08		6	0128-0560	633.43	560.60	357	74.43	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			290.0	F08		6	0129-0564	806.22	564.04	342	73.60	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			327.7	F08		6	0130-0572	573.03	573.00	363	76.08	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			408.3	F08		6	0131-0570	899.87	570.25	219	55.70	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			346.9	F08		6	0132-0581	58.91	581.53	285	62.18	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			346.5	F08		6	0133-0585	191.91	585.57	308	69.26	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			334.6	F08		6	0134-0581	760.19	580.73	169	51.36	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			337.2	F08		6	0135-0586	779.09	586.58	318	73.70	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			328.6	F08		6	0136-0593	393.16	593.77	325	68.77	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			272.1	F08		6	0137-0598	524.28	598.86	360	74.43	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			326.2	F08		6	0138-0604	407.96	603.66	268	60.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			269.7	F08		6	0139-0606	719.80	606.67	342	71.60	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			291.3	F08		6	0140-0610	668.02	609.38	332	71.60	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			280.1	F08		6	0141-0610	944.17	610.24	325	67.36	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1249.6	F08		6	0142-0624	254.48	624.73	435	81.36	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			521.2	F08		6	0143-0620	473.85	620.29	254	59.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			316.0	F08		6	0144-0625	498.09	624.46	322	69.60	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			429.7	F08		6	0145-0621	588.56	622.24	126	47.11	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			346.1	F08		6	0146-0626	604.38	625.56	306	69.36	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			303.6	F08		6	0147-0631	399.30	631.24	270	60.18	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			291.8	F08		6	0148-0643	820.36	643.79	331	69.60	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			325.7	F08		6	0149-0647	762.95	647.48	391	74.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			331.6	F08		6	0150-0647	185.53	647.15	314	69.01	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			547.5	F08		6	0151-0650	467.28	649.78	254	58.53	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			259.2	F08		6	0152-0655	654.47	655.82	408	83.15	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			278.5	F08		6	0153-0657	227.78	657.24	307	67.36	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			269.2	F08		6	0154-0663	678.83	662.86	420	78.08	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			604.0	F08		6	0155-0660	152.33	659.97	228	56.28	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			275.5	F08		6	0156-0664	317.48	664.23	379	78.43	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			611.3	F08		6	0157-0667	131.53	667.22	214	54.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			277.9	F08		6	0158-0685	754.34	685.71	364	73.26	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			274.8	F08		6	0159-0683	214.80	683.17	312	65.01	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1610.4	F08		6	0160-0691	383.37	691.24	545	87.15	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			390.8	F08		6	0161-0691	921.86	691.84	327	67.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			310.7	F08		6	0162-0695	699.02	694.81	134	44.04	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1878.3	F08		6	0163-0703	335.59	703.62	544	86.91	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			274.1	F08		6	0164-0697	712.80	697.08	155	46.39	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			308.6	F08		6	0165-0703	115.04	703.15	344	69.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			316.3	F08		6	0166-0708	252.76	707.97	278	62.53	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			363.8	F08		7	0001-0033	92.68	32.93	251	60.18	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			312.2	F08		7	0002-0044	386.80	44.51	294	62.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			385.2	F08		7	0003-0048	477.35	48.14	278	66.67	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			388.2	F08		7	0004-0060	407.20	59.76	285	63.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			516.7	F08		7	0005-0062	678.12	62.81	233	55.36	0.956
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			425.0	F08		7	0006-0083	498.41	83.94	245	59.11	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			361.7	F08		7	0007-0088	102.28	88.41	272	64.28	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			675.4	F08		7	0008-0090	312.19	90.06	243	58.28	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			427.9	F08		7	0009-0088	857.80	88.23	243	58.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			455.3	F08		7	0010-0091	568.14	91.09	249	59.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			465.3	F08		7	0011-0090	922.36	90.77	285	69.36	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			314.5	F08		7	0012-0096	804.71	96.45	347	71.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1852.0	F08		7	0013-0099	159.09	99.23	396	76.91	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			423.0	F08		7	0014-0101	457.94	101.78	288	63.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			438.2	F08		7	0015-0105	635.09	105.00	234	59.36	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			508.6	F08		7	0016-0119	523.81	119.55	222	58.18	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			537.8	F08		7	0017-0126	686.97	125.86	193	53.94	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			357.1	F08		7	0018-0126	88.93	126.97	301	67.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			406.9	F08		7	0019-0132	641.72	132.74	273	63.60	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			373.3	F08		7	0020-0131	188.37	132.20	306	72.77	0.726
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			438.7	F08		7	0021-0135	281.43	134.70	262	61.60	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			695.8	F08		7	0022-0140	900.77	139.76	353	73.26	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			431.4	F08		7	0023-0140	559.10	140.54	300	64.43	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			622.3	F08		7	0024-0146	372.83	146.27	317	70.18	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			328.9	F08		7	0025-0153	132.29	153.66	301	66.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			344.8	F08		7	0026-0155	245.36	155.87	315	67.84	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			396.2	F08		7	0027-0154	331.26	154.32	290	63.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1639.7	F08		7	0028-0159	830.05	159.13	536	87.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			313.1	F08		7	0029-0163	779.09	162.97	296	65.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			452.7	F08		7	0030-0173	445.86	172.75	269	62.87	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			552.2	F08		7	0031-0180	31.92	180.27	332	72.43	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			335.6	F08		7	0032-0182	770.41	182.44	294	64.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			479.5	F08		7	0033-0201	821.36	201.88	239	57.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			521.0	F08		7	0034-0203	154.35	202.98	230	56.53	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			549.2	F08		7	0035-0230	658.69	229.95	258	61.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			300.6	F08		7	0036-0236	902.31	237.44	323	75.50	0.712
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			533.8	F08		7	0037-0240	807.18	241.35	115	44.53	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			372.8	F08		7	0038-0265	518.79	264.69	312	69.26	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			605.9	F08		7	0039-0265	544.89	264.71	246	64.18	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			506.6	F08		7	0040-0268	690.63	268.72	226	56.87	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			435.4	F08		7	0041-0273	36.28	273.02	267	65.01	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			292.7	F08		7	0042-0272	803.84	272.63	286	72.08	0.692
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			509.3	F08		7	0043-0279	430.76	279.79	262	60.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			345.2	F08		7	0044-0284	235.60	284.60	328	67.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			364.9	F08		7	0045-0288	629.87	288.63	303	65.01	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			303.9	F08		7	0046-0291	776.86	291.35	339	74.67	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			329.1	F08		7	0047-0299	663.58	299.86	310	67.94	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			371.1	F08		7	0048-0307	180.09	307.59	328	67.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			314.5	F08		7	0049-0307	322.57	307.02	304	65.36	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			448.1	F08		7	0050-0317	748.57	316.98	227	58.18	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			412.8	F08		7	0051-0317	637.80	317.35	248	58.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			360.1	F08		7	0052-0333	847.17	332.72	343	70.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			380.4	F08		7	0053-0334	147.60	333.67	253	61.70	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			420.9	F08		7	0054-0339	491.89	339.39	291	66.53	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			362.0	F08		7	0055-0352	133.12	352.78	247	64.43	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			338.4	F08		7	0056-0355	729.67	355.23	293	63.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			372.2	F08		7	0057-0366	284.61	366.61	267	59.70	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			294.9	F08		7	0058-0377	900.04	377.04	305	72.18	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			345.3	F08		7	0059-0377	130.33	376.64	342	70.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			261.1	F08		7	0060-0382	614.20	382.79	380	73.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			366.8	F08		7	0061-0386	419.80	385.79	329	69.84	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			418.9	F08		7	0062-0384	562.34	383.61	317	66.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			287.7	F08		7	0063-0392	845.59	392.78	308	67.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			355.6	F08		7	0064-0396	676.19	396.86	321	68.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			305.8	F08		7	0065-0397	781.94	396.61	342	69.84	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			542.3	F08		7	0066-0399	58.99	398.31	273	63.60	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			307.7	F08		7	0067-0409	352.76	410.17	340	72.67	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			379.2	F08		7	0068-0417	292.67	417.10	285	67.84	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			389.7	F08		7	0069-0423	37.19	423.02	275	69.26	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			391.5	F08		7	0070-0419	533.04	419.50	266	63.70	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			410.4	F08		7	0071-0426	229.90	425.89	293	66.43	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			328.2	F08		7	0072-0438	885.79	438.02	319	70.77	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			404.8	F08		7	0073-0437	138.79	436.51	217	59.94	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			319.1	F08		7	0074-0443	717.99	443.46	337	69.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			322.8	F08		7	0075-0448	449.95	447.65	306	67.84	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			563.9	F08		7	0076-0447	484.62	447.15	225	58.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			545.9	F08		7	0077-0453	631.77	455.68	387	93.98	0.551
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			345.9	F08		7	0078-0449	298.81	448.89	269	66.43	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			405.7	F08		7	0079-0468	104.09	467.16	106	44.53	0.672
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			327.2	F08		7	0080-0479	201.56	479.53	320	69.60	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			317.6	F08		7	0081-0481	581.58	480.98	335	68.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			432.9	F08		7	0082-0486	529.78	486.59	233	58.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			405.8	F08		7	0083-0494	302.87	494.27	285	62.43	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			372.1	F08		7	0084-0495	229.49	495.57	325	68.77	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			331.1	F08		7	0085-0499	904.47	499.00	292	65.60	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			333.1	F08		7	0086-0504	28.67	504.31	308	66.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			419.5	F08		7	0087-0508	444.17	508.44	343	70.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			315.0	F08		7	0088-0525	890.82	525.58	277	65.70	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			345.6	F08		7	0089-0535	193.24	534.84	316	68.77	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			544.7	F08		7	0090-0539	300.64	539.10	270	63.01	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			389.3	F08		7	0091-0539	379.44	538.81	304	65.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			386.4	F08		7	0092-0542	25.51	542.80	256	64.43	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			504.5	F08		7	0093-0549	343.44	548.80	214	55.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			380.3	F08		7	0094-0552	637.08	552.27	261	60.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1655.5	F08		7	0095-0574	164.62	573.41	429	86.08	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			508.7	F08		7	0096-0571	672.22	571.83	228	55.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			378.2	F08		7	0097-0573	507.45	573.46	280	63.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			345.1	F08		7	0098-0581	822.58	581.20	290	67.26	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			286.8	F08		7	0099-0592	714.37	592.57	393	83.74	0.704
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			417.6	F08		7	0100-0604	631.20	604.27	236	60.18	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			456.8	F08		7	0101-0615	95.84	614.75	325	69.36	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			384.8	F08		7	0102-0617	583.01	617.18	308	67.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			365.7	F08		7	0103-0632	208.27	633.24	340	68.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			486.6	F08		7	0104-0635	394.14	634.30	172	52.53	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			504.5	F08		7	0105-0642	602.53	640.54	365	120.71	0.315
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			420.2	F08		7	0106-0646	152.95	645.38	213	59.94	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			388.4	F08		7	0107-0649	403.03	649.67	189	54.53	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			550.0	F08		7	0108-0646	479.26	645.61	195	67.60	0.536
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			399.6	F08		7	0109-0654	434.14	654.28	282	62.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			361.8	F08		7	0110-0661	551.17	661.16	255	58.53	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			328.5	F08		7	0111-0676	429.53	676.20	341	69.50	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			493.8	F08		7	0112-0674	830.80	674.11	271	65.60	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			374.4	F08		7	0113-0679	201.81	678.48	306	66.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			304.6	F08		7	0114-0686	459.50	686.25	297	67.01	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			332.5	F08		7	0115-0687	594.89	687.09	301	69.36	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			533.5	F08		7	0116-0700	860.31	700.06	228	58.77	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			344.9	F08		7	0117-0712	829.75	712.75	159	50.04	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			364.6	F08		8	0001-0033	547.49	33.04	276	63.36	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			320.6	F08		8	0002-0039	390.98	39.49	312	68.87	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			293.4	F08		8	0003-0040	117.38	39.09	364	73.84	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			306.3	F08		8	0004-0043	468.83	43.14	273	63.60	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			296.2	F08		8	0005-0051	61.97	51.24	324	67.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			341.0	F08		8	0006-0057	813.53	56.57	270	65.60	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			296.1	F08		8	0007-0061	423.49	62.30	351	70.67	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			321.6	F08		8	0008-0063	351.36	64.01	288	63.94	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			498.6	F08		8	0009-0073	188.66	73.62	234	58.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1907.3	F08		8	0010-0078	534.60	77.39	546	85.74	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			369.1	F08		8	0011-0090	591.13	91.05	359	73.84	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			449.1	F08		8	0012-0093	27.34	92.73	300	71.60	0.735
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			241.1	F08		8	0013-0098	151.25	98.63	321	70.18	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			401.2	F08		8	0014-0094	862.10	94.33	251	58.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1492.0	F08		8	0015-0107	399.16	107.89	351	69.60	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			262.7	F08		8	0016-0116	77.68	116.31	300	65.60	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			278.9	F08		8	0017-0119	94.58	118.73	270	66.18	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			262.2	F08		8	0018-0117	144.91	118.43	327	67.94	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			378.3	F08		8	0019-0126	297.21	126.26	313	66.77	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			550.5	F08		8	0020-0127	571.17	127.19	260	64.67	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			320.6	F08		8	0021-0132	461.59	131.56	320	67.60	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			4172.2	F08		8	0022-0137	524.65	137.50	266	61.46	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			288.0	F08		8	0023-0143	182.96	143.82	360	72.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			311.1	F08		8	0024-0144	858.72	143.84	286	62.53	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			228.1	F08		8	0025-0148	116.34	148.61	341	68.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1632.0	F08		8	0026-0148	631.03	147.91	212	54.53	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			314.3	F08		8	0027-0163	384.92	163.20	349	70.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			306.1	F08		8	0028-0162	498.33	161.44	241	60.77	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			283.3	F08		8	0029-0179	255.75	179.69	303	66.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			598.9	F08		8	0030-0193	903.86	192.59	363	77.60	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			252.7	F08		8	0031-0192	128.31	192.14	319	68.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			325.7	F08		8	0032-0198	834.68	198.26	273	61.36	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			451.7	F08		8	0033-0199	509.73	199.88	314	73.60	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			263.6	F08		8	0034-0200	934.39	200.06	339	68.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			311.1	F08		8	0035-0203	451.50	203.05	309	66.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			369.2	F08		8	0036-0212	809.27	211.52	260	59.94	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1009.0	F08		8	0037-0212	298.17	211.31	305	67.36	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1187.4	F08		8	0038-0219	171.70	218.50	349	70.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			353.9	F08		8	0039-0233	637.45	233.56	392	80.67	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			439.3	F08		8	0040-0231	389.44	231.39	302	67.36	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			378.7	F08		8	0041-0237	69.26	237.61	245	60.43	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			307.8	F08		8	0042-0246	216.23	246.26	271	64.43	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			513.4	F08		8	0043-0252	368.24	252.48	258	60.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			355.0	F08		8	0044-0255	555.78	254.76	308	67.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			315.1	F08		8	0045-0255	786.48	254.80	372	71.60	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			256.2	F08		8	0046-0255	269.76	254.60	284	66.43	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			276.4	F08		8	0047-0254	91.96	254.52	319	73.70	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			438.3	F08		8	0048-0259	345.30	258.91	262	60.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			320.9	F08		8	0049-0267	175.50	267.03	342	69.60	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			358.1	F08		8	0050-0268	413.70	268.21	323	71.50	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			333.4	F08		8	0051-0269	476.36	269.60	262	62.87	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			323.4	F08		8	0052-0267	608.28	266.91	333	69.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			929.1	F08		8	0053-0276	824.72	276.05	241	71.26	0.596
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			283.4	F08		8	0054-0280	327.52	280.38	308	69.94	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			298.0	F08		8	0055-0286	908.01	285.70	313	68.53	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			345.0	F08		8	0056-0287	257.30	287.08	289	64.18	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			289.3	F08		8	0057-0296	114.24	295.98	271	60.28	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			317.4	F08		8	0058-0301	527.71	301.18	325	70.43	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			289.3	F08		8	0059-0303	773.32	302.44	372	73.26	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			418.4	F08		8	0060-0301	67.03	300.89	265	60.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			265.8	F08		8	0061-0306	726.59	306.20	334	67.60	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			325.5	F08		8	0062-0307	454.46	307.65	280	64.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			279.3	F08		8	0063-0312	484.66	310.84	355	71.01	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			355.0	F08		8	0064-0309	802.16	310.13	312	67.01	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			357.0	F08		8	0065-0309	596.25	308.86	334	68.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			336.7	F08		8	0066-0316	693.21	316.50	327	69.94	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			457.0	F08		8	0067-0314	860.26	314.34	217	55.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			404.2	F08		8	0068-0321	66.27	321.41	288	64.18	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			272.8	F08		8	0069-0340	518.16	340.62	344	70.18	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			271.8	F08		8	0070-0341	265.73	342.16	331	68.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			321.1	F08		8	0071-0351	434.28	351.13	305	66.53	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			284.3	F08		8	0072-0351	157.55	350.65	335	67.60	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			326.2	F08		8	0073-0357	716.82	357.73	333	68.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2561.5	F08		8	0074-0359	201.87	358.41	290	62.18	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			321.4	F08		8	0075-0364	109.18	363.74	280	62.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			335.4	F08		8	0076-0362	599.31	361.65	263	64.53	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			357.2	F08		8	0077-0367	693.55	366.93	294	66.18	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			297.1	F08		8	0078-0368	311.75	368.05	298	66.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			267.0	F08		8	0079-0377	779.65	376.56	371	72.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			266.6	F08		8	0080-0388	69.99	388.89	308	67.60	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			362.0	F08		8	0081-0390	343.64	390.06	371	73.84	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			434.4	F08		8	0082-0386	263.47	386.26	253	61.11	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			351.8	F08		8	0083-0391	908.93	390.40	404	73.60	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			372.8	F08		8	0084-0391	611.42	391.77	274	69.50	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			295.7	F08		8	0085-0394	117.33	393.86	319	67.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			357.9	F08		8	0086-0399	228.50	398.65	247	60.53	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			404.9	F08		8	0087-0408	842.54	408.45	219	54.63	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			305.0	F08		8	0088-0416	556.27	416.95	354	69.60	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			332.9	F08		8	0089-0420	159.54	420.41	357	71.50	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			340.5	F08		8	0090-0423	731.25	422.91	279	63.01	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			439.5	F08		8	0091-0428	804.60	428.93	253	61.36	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			276.1	F08		8	0092-0436	487.98	436.01	325	66.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			296.3	F08		8	0093-0438	450.52	438.13	320	69.84	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			489.0	F08		8	0094-0441	747.09	440.58	241	61.11	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			466.7	F08		8	0095-0449	897.52	449.38	338	69.84	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			354.3	F08		8	0096-0449	761.52	449.23	256	62.53	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			339.3	F08		8	0097-0454	127.49	454.78	354	70.18	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			415.5	F08		8	0098-0459	837.61	458.78	342	69.84	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			271.1	F08		8	0099-0464	52.51	464.29	258	63.01	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			372.4	F08		8	0100-0475	743.13	475.27	277	63.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			285.6	F08		8	0101-0501	414.64	501.00	335	69.60	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			302.4	F08		8	0102-0507	566.44	507.64	333	69.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			272.0	F08		8	0103-0514	374.99	514.14	306	65.94	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			290.8	F08		8	0104-0513	334.32	513.20	159	48.53	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			266.4	F08		8	0105-0524	327.91	524.49	200	53.94	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			734.4	F08		8	0106-0524	268.31	524.45	261	62.53	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			385.9	F08		8	0107-0531	853.53	531.31	273	60.77	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			295.9	F08		8	0108-0535	604.96	534.87	366	72.18	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			325.3	F08		8	0109-0571	800.98	571.40	335	71.01	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			369.7	F08		8	0110-0569	210.82	568.62	319	65.60	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			335.4	F08		8	0111-0577	472.98	576.95	286	63.60	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			290.4	F08		8	0112-0581	98.85	581.31	272	62.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			232.6	F08		8	0113-0580	145.09	579.96	365	73.01	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			332.3	F08		8	0114-0590	882.83	590.92	326	71.26	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			333.2	F08		8	0115-0597	725.29	596.96	315	68.18	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			323.9	F08		8	0116-0597	624.95	597.75	362	73.26	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			539.7	F08		8	0117-0611	935.55	610.24	234	62.43	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			275.2	F08		8	0118-0618	164.12	619.05	342	69.84	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			344.5	F08		8	0119-0619	390.63	619.56	358	72.18	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			272.3	F08		8	0120-0624	311.05	624.35	393	74.53	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			288.6	F08		8	0121-0633	257.00	633.60	354	72.18	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			451.8	F08		8	0122-0629	887.85	629.27	229	59.36	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			663.7	F08		8	0123-0631	485.97	631.58	369	71.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			317.1	F08		8	0124-0644	205.67	643.32	267	76.91	0.567
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			770.7	F08		8	0125-0646	113.81	646.09	315	68.28	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			302.1	F08		8	0126-0648	646.66	648.33	311	64.77	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			512.6	F08		8	0127-0652	188.70	652.10	313	72.77	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2078.1	F08		8	0128-0662	807.99	662.37	371	72.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			321.9	F08		8	0129-0679	279.00	679.25	308	66.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			339.3	F08		8	0130-0681	511.91	681.69	286	62.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			316.2	F08		8	0131-0683	818.41	683.45	254	62.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			298.1	F08		8	0132-0700	318.53	700.43	351	71.84	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			310.2	F08		8	0133-0700	869.85	700.89	257	62.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			300.6	F08		8	0134-0703	138.26	703.54	301	64.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			293.5	F08		8	0135-0707	51.06	707.80	312	67.60	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			263.3	F08		9	0001-0027	112.91	26.93	344	68.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			329.5	F08		9	0002-0032	250.70	31.94	275	63.11	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			306.1	F08		9	0003-0037	590.02	36.73	360	76.08	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			298.6	F08		9	0004-0035	182.72	34.71	298	68.18	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			385.6	F08		9	0005-0039	511.18	38.74	272	60.53	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2339.4	F08		9	0006-0052	462.31	52.06	326	68.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			284.1	F08		9	0007-0061	289.42	61.34	340	69.84	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			302.1	F08		9	0008-0060	744.10	60.15	375	75.84	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			347.9	F08		9	0009-0059	539.40	60.03	288	63.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			319.1	F08		9	0010-0067	666.69	67.26	265	60.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			329.5	F08		9	0011-0067	106.69	66.90	298	65.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			309.4	F08		9	0012-0074	577.54	74.11	328	69.36	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			305.2	F08		9	0013-0085	351.37	85.44	320	68.77	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			311.7	F08		9	0014-0091	628.73	91.14	393	77.01	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			318.4	F08		9	0015-0103	150.33	103.48	271	69.26	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			337.8	F08		9	0016-0108	400.39	108.07	454	80.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			436.6	F08		9	0017-0105	858.93	105.72	285	66.53	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			322.4	F08		9	0018-0113	289.82	113.21	327	67.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			395.4	F08		9	0019-0109	606.04	109.78	240	56.53	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			432.6	F08		9	0020-0117	768.48	117.04	247	62.77	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1642.3	F08		9	0021-0125	539.18	124.32	438	80.67	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			625.8	F08		9	0022-0121	873.87	121.45	166	52.53	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			296.8	F08		9	0023-0127	260.01	127.38	302	67.01	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			337.6	F08		9	0024-0138	476.79	138.03	340	71.60	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			736.4	F08		9	0025-0149	319.13	148.94	327	67.11	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			307.1	F08		9	0026-0148	749.13	148.30	298	66.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			344.1	F08		9	0027-0158	503.51	157.38	320	73.60	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			374.2	F08		9	0028-0161	88.66	161.07	266	64.91	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			351.0	F08		9	0029-0159	241.91	159.07	237	59.01	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			407.0	F08		9	0030-0167	191.21	167.88	216	55.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			369.8	F08		9	0031-0175	444.89	175.23	302	65.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			674.6	F08		9	0032-0173	811.23	174.00	102	37.46	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			373.1	F08		9	0033-0186	771.64	186.50	258	63.36	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			310.6	F08		9	0034-0192	90.66	192.61	247	62.18	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			270.5	F08		9	0035-0195	168.87	195.46	266	68.77	0.707
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1456.2	F08		9	0036-0192	373.20	191.67	246	60.77	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			373.0	F08		9	0037-0199	632.74	199.12	474	83.26	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			249.0	F08		9	0038-0200	943.12	200.57	395	77.50	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			266.5	F08		9	0039-0204	909.33	203.92	372	77.84	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			265.6	F08		9	0040-0203	29.78	202.97	327	68.18	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			313.8	F08		9	0041-0216	678.42	216.04	314	73.01	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			390.6	F08		9	0042-0214	529.80	214.47	277	61.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			295.7	F08		9	0043-0235	813.79	235.09	281	65.01	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			376.7	F08		9	0044-0237	767.12	236.64	289	67.84	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			311.0	F08		9	0045-0242	731.53	242.09	337	71.36	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			304.5	F08		9	0046-0239	229.65	240.27	253	58.87	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			288.9	F08		9	0047-0249	661.57	249.17	263	64.77	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			298.7	F08		9	0048-0252	46.14	252.59	303	63.94	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			432.2	F08		9	0049-0253	277.61	253.04	272	61.36	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			275.5	F08		9	0050-0260	938.09	260.43	364	71.50	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			275.0	F08		9	0051-0257	230.00	257.15	285	65.70	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			328.8	F08		9	0052-0266	426.54	266.69	295	65.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			338.4	F08		9	0053-0266	532.37	266.41	288	62.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			304.2	F08		9	0054-0275	141.22	275.50	320	67.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			355.7	F08		9	0055-0280	890.30	279.55	407	79.26	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			319.5	F08		9	0056-0282	381.39	281.55	283	62.18	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			324.6	F08		9	0057-0285	623.90	284.88	302	67.84	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			376.3	F08		9	0058-0298	223.21	298.43	264	59.60	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			326.3	F08		9	0059-0308	484.54	308.19	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1725.9	F08		9	0060-0313	56.31	313.12	372	74.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			288.6	F08		9	0061-0322	259.07	322.01	308	67.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			325.9	F08		9	0062-0327	728.12	326.58	310	69.36	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			337.6	F08		9	0063-0334	925.85	333.62	351	70.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			296.8	F08		9	0064-0333	831.25	333.40	333	69.26	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			324.5	F08		9	0065-0341	545.88	341.42	289	63.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			334.7	F08		9	0066-0341	871.51	341.54	301	64.43	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			229.7	F08		9	0067-0346	43.39	345.92	356	69.01	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			558.7	F08		9	0068-0350	225.43	350.33	358	73.26	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			384.3	F08		9	0069-0364	425.99	364.39	291	69.36	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			331.2	F08		9	0070-0363	784.03	363.41	333	68.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			285.8	F08		9	0071-0368	75.81	368.43	329	66.77	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			367.5	F08		9	0072-0370	728.14	370.19	368	71.84	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			921.5	F08		9	0073-0377	675.67	377.52	431	94.81	0.603
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1926.4	F08		9	0074-0384	562.15	380.29	405	96.47	0.547
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			578.8	F08		9	0075-0380	839.73	380.27	381	72.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			293.7	F08		9	0076-0395	607.01	394.57	312	70.67	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			330.0	F08		9	0077-0401	333.46	400.98	249	60.53	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			346.4	F08		9	0078-0401	429.53	401.57	283	62.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			375.7	F08		9	0079-0413	477.40	413.11	239	58.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			286.9	F08		9	0080-0418	752.22	417.97	326	67.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			276.4	F08		9	0081-0423	108.15	423.49	312	66.77	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			305.2	F08		9	0082-0422	136.76	422.43	323	67.84	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			335.4	F08		9	0083-0431	926.94	431.35	264	63.70	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			320.5	F08		9	0084-0436	663.61	435.45	326	68.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			306.9	F08		9	0085-0441	846.39	442.19	308	68.67	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			253.5	F08		9	0086-0453	788.02	452.55	346	70.43	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			306.5	F08		9	0087-0457	627.33	457.38	328	68.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			403.8	F08		9	0088-0460	250.17	459.58	271	62.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			445.1	F08		9	0089-0460	360.06	459.62	272	61.36	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			262.4	F08		9	0090-0466	762.09	465.46	350	71.01	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			298.3	F08		9	0091-0473	583.58	473.73	297	64.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			388.8	F08		9	0092-0483	354.63	482.60	295	64.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			365.5	F08		9	0093-0490	838.00	490.06	300	64.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			899.8	F08		9	0094-0496	656.41	496.27	342	72.53	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			348.9	F08		9	0095-0495	418.64	495.14	284	62.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			286.9	F08		9	0096-0498	792.53	497.76	331	69.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			222.6	F08		9	0097-0496	774.17	495.84	350	71.94	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			444.4	F08		9	0098-0499	52.74	498.30	283	62.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			346.2	F08		9	0099-0501	727.06	500.76	271	61.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			393.5	F08		9	0100-0505	207.71	504.91	249	58.18	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			313.1	F08		9	0101-0521	78.62	521.30	261	65.01	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			547.4	F08		9	0102-0521	614.23	521.50	371	70.18	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			388.1	F08		9	0103-0525	681.54	525.40	290	65.36	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			315.8	F08		9	0104-0524	710.85	524.45	293	63.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			359.4	F08		9	0105-0536	359.76	536.61	335	68.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			394.2	F08		9	0106-0539	624.88	539.71	358	72.08	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			301.9	F08		9	0107-0545	414.30	545.05	278	68.08	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			407.2	F08		9	0108-0543	740.94	544.00	305	65.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			251.3	F08		9	0109-0551	127.64	551.73	323	70.67	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			346.8	F08		9	0110-0555	376.56	555.19	274	60.77	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			834.6	F08		9	0111-0559	311.67	559.17	348	69.60	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			356.1	F08		9	0112-0570	464.67	570.15	303	67.60	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			386.9	F08		9	0113-0577	227.99	580.26	291	83.15	0.529
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			347.2	F08		9	0114-0584	723.59	584.53	331	68.67	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			304.3	F08		9	0115-0592	144.52	592.32	318	69.26	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			308.8	F08		9	0116-0591	674.89	590.99	317	66.53	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			320.1	F08		9	0117-0600	594.64	600.11	339	70.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			327.4	F08		9	0118-0599	296.56	598.65	303	67.84	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			321.6	F08		9	0119-0597	805.83	597.68	333	75.84	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			284.3	F08		9	0120-0602	928.18	602.38	277	62.77	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			342.5	F08		9	0121-0606	412.90	606.62	306	66.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			563.2	F08		9	0122-0607	466.79	607.03	331	67.84	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			515.0	F08		9	0123-0613	30.57	613.25	236	60.77	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			339.4	F08		9	0124-0615	239.99	615.89	244	63.94	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			275.3	F08		9	0125-0617	908.56	617.47	303	66.53	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			273.7	F08		9	0126-0625	671.13	625.54	417	79.26	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			339.6	F08		9	0127-0638	544.10	637.32	277	67.01	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			338.3	F08		9	0128-0648	205.49	647.63	330	67.60	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			416.0	F08		9	0129-0652	501.09	652.73	310	66.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			320.2	F08		9	0130-0658	185.37	657.89	315	67.84	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			347.6	F08		9	0131-0664	921.81	663.93	269	61.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			327.6	F08		9	0132-0667	677.49	666.70	275	62.18	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			332.5	F08		9	0133-0671	770.94	672.08	269	66.18	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			328.1	F08		9	0134-0674	398.05	674.25	276	63.36	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1510.1	F08		9	0135-0680	852.31	679.91	486	84.67	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			336.2	F08		9	0136-0682	319.34	683.00	307	65.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			315.8	F08		9	0137-0685	378.24	685.79	273	61.36	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			462.8	G08		1	0001-0032	204.59	33.10	257	63.01	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			510.5	G08		1	0002-0042	496.41	42.05	229	59.11	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			399.1	G08		1	0003-0056	98.31	56.55	335	72.08	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			491.5	G08		1	0004-0065	935.15	65.24	324	68.43	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			675.5	G08		1	0005-0075	282.41	75.08	268	64.04	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			377.4	G08		1	0006-0076	711.31	75.89	364	71.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1697.3	G08		1	0007-0083	664.99	83.53	405	80.57	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			402.5	G08		1	0008-0092	730.56	92.42	348	71.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			713.8	G08		1	0009-0092	567.38	92.61	154	68.43	0.413
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			613.6	G08		1	0010-0096	262.76	96.42	254	69.26	0.665
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			394.9	G08		1	0011-0100	77.40	101.22	295	66.18	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			393.3	G08		1	0012-0106	712.96	105.19	322	72.33	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			802.1	G08		1	0013-0107	844.87	105.02	171	73.50	0.398
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			559.3	G08		1	0014-0122	896.06	121.71	302	66.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			442.3	G08		1	0015-0194	835.35	194.66	279	62.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			694.4	G08		1	0016-0199	185.62	199.26	102	39.21	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			636.2	G08		1	0017-0225	584.08	224.71	214	58.04	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			602.7	G08		1	0018-0242	806.26	241.74	215	62.04	0.702
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			893.7	G08		1	0019-0268	829.39	268.12	262	59.36	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			511.6	G08		1	0020-0280	887.64	280.48	237	60.28	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			516.5	G08		1	0021-0288	639.34	288.26	221	57.94	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			500.8	G08		1	0022-0302	32.27	302.53	235	64.18	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			521.6	G08		1	0023-0306	478.27	306.20	195	58.18	0.724
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			427.6	G08		1	0024-0323	657.51	324.42	284	64.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			485.3	G08		1	0025-0343	280.32	343.85	258	62.53	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			589.8	G08		1	0026-0365	47.51	365.09	214	54.87	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			631.4	G08		1	0027-0369	350.54	368.34	227	62.87	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			518.4	G08		1	0028-0364	510.31	363.63	226	58.77	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			419.4	G08		1	0029-0367	623.42	366.98	274	63.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			566.4	G08		1	0030-0365	742.98	365.12	193	57.36	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			744.5	G08		1	0031-0368	147.46	368.35	242	61.36	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			517.7	G08		1	0032-0373	306.88	373.44	229	61.11	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			651.2	G08		1	0033-0383	675.69	383.47	240	63.11	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			436.8	G08		1	0034-0389	935.70	389.37	282	67.60	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			639.7	G08		1	0035-0407	210.27	407.15	209	58.77	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			517.6	G08		1	0036-0414	70.13	414.26	215	57.70	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			690.7	G08		1	0037-0416	890.73	415.95	225	57.70	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			439.7	G08		1	0038-0438	666.57	438.67	262	64.53	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			950.4	G08		1	0039-0444	858.60	443.31	109	75.98	0.237
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			674.8	G08		1	0040-0457	419.20	458.00	233	57.36	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			610.1	G08		1	0041-0462	730.98	462.08	237	61.94	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			667.6	G08		1	0042-0498	314.58	498.27	227	59.60	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			398.9	G08		1	0043-0524	563.97	524.23	303	66.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			526.2	G08		1	0044-0527	829.85	527.56	240	62.77	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			581.7	G08		1	0045-0536	719.53	536.54	205	58.18	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			481.7	G08		1	0046-0539	360.16	539.84	277	72.43	0.664
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			399.3	G08		1	0047-0539	688.61	539.21	272	60.77	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			650.6	G08		1	0048-0541	636.49	541.13	202	54.18	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			515.3	G08		1	0049-0548	12.47	547.60	261	61.36	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			513.6	G08		1	0050-0558	95.67	558.64	212	58.18	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			438.8	G08		1	0051-0568	648.28	568.31	304	68.18	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			471.1	G08		1	0052-0569	834.65	569.67	293	66.43	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			428.4	G08		1	0053-0605	697.52	605.52	252	58.77	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			365.3	G08		1	0054-0610	547.24	610.47	328	69.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			738.0	G08		1	0055-0610	598.30	610.74	166	53.94	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			646.5	G08		1	0056-0639	326.67	638.87	198	53.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			519.3	G08		1	0057-0697	329.28	697.00	230	59.84	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			448.4	G08		1	0058-0706	735.74	705.51	250	73.60	0.580
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			615.6	G08		2	0001-0033	490.85	32.69	260	66.28	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			469.2	G08		2	0002-0065	39.68	65.16	334	70.43	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			448.6	G08		2	0003-0071	263.62	70.95	321	73.26	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			486.8	G08		2	0004-0104	246.65	104.64	292	75.50	0.644
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			424.7	G08		2	0005-0207	403.66	206.99	276	68.18	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			628.9	G08		2	0006-0218	447.01	218.02	223	66.43	0.635
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2159.2	G08		2	0007-0233	670.79	232.76	279	104.81	0.319
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			383.9	G08		2	0008-0248	396.52	248.61	314	69.84	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			584.2	G08		2	0009-0248	449.88	249.51	100	47.46	0.558
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			676.5	G08		2	0010-0282	915.46	282.98	120	50.77	0.585
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			506.4	G08		2	0011-0354	665.79	353.71	302	68.18	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			434.0	G08		2	0012-0389	40.48	389.26	286	68.18	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1265.8	G08		2	0013-0396	667.73	395.75	228	57.01	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			596.4	G08		2	0014-0408	655.79	407.55	276	66.08	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			719.2	G08		2	0015-0409	559.15	408.44	277	64.18	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			405.6	G08		2	0016-0459	258.19	459.85	306	66.18	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			540.2	G08		2	0017-0511	49.96	511.64	225	57.70	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			458.5	G08		2	0018-0515	114.80	515.24	268	63.60	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			525.9	G08		2	0019-0613	133.89	613.28	223	60.53	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			541.7	G08		2	0020-0618	504.01	618.58	259	63.36	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			375.9	G08		2	0021-0635	637.25	635.23	302	66.53	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			344.7	G08		2	0022-0639	285.94	639.91	297	66.18	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			357.3	G08		2	0023-0644	591.27	644.02	278	63.70	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			346.2	G08		2	0024-0650	538.77	650.29	296	64.53	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			366.0	G08		2	0025-0654	224.91	653.80	279	63.70	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			374.0	G08		2	0026-0669	100.45	669.38	299	65.36	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			377.6	G08		2	0027-0672	582.47	672.12	374	76.08	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			377.3	G08		2	0028-0672	305.14	673.35	281	64.53	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1044.0	G08		2	0029-0686	316.60	686.53	125	45.11	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			379.7	G08		2	0030-0691	559.22	690.33	333	73.01	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			340.7	G08		2	0031-0697	615.07	697.26	277	62.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1096.8	G08		2	0032-0703	912.12	702.79	115	40.28	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			781.1	G08		3	0001-0051	392.71	51.40	201	55.36	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			501.1	G08		3	0002-0075	222.13	75.24	244	59.36	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			739.1	G08		3	0003-0084	824.96	84.25	264	61.94	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			503.7	G08		3	0004-0098	283.01	98.19	236	61.26	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			653.9	G08		3	0005-0107	865.02	107.68	209	59.26	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			552.5	G08		3	0006-0109	428.96	108.97	213	54.53	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			636.1	G08		3	0007-0117	337.10	117.22	177	52.18	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			618.6	G08		3	0008-0120	858.06	120.25	224	55.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			797.6	G08		3	0009-0140	463.15	140.84	127	57.60	0.481
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			562.1	G08		3	0010-0154	925.91	153.92	225	57.36	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			877.2	G08		3	0011-0159	132.00	159.59	256	62.53	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			926.1	G08		3	0012-0161	248.69	161.09	118	40.28	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			821.1	G08		3	0013-0170	238.79	170.81	151	46.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			809.1	G08		3	0014-0176	428.50	176.01	204	58.18	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			438.3	G08		3	0015-0181	503.87	181.33	291	66.77	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			805.7	G08		3	0016-0180	529.81	180.56	171	50.53	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			771.4	G08		3	0017-0197	582.62	198.37	177	56.18	0.705
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			647.9	G08		3	0018-0200	927.92	200.57	216	59.60	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			728.7	G08		3	0019-0218	416.36	218.30	165	50.04	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			665.2	G08		3	0020-0225	645.39	226.73	372	80.08	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			471.8	G08		3	0021-0230	534.48	231.10	267	63.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			503.8	G08		3	0022-0244	246.67	242.06	190	58.87	0.689
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			610.4	G08		3	0023-0252	396.23	252.19	223	54.53	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			429.4	G08		3	0024-0254	528.93	254.27	270	65.01	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			468.9	G08		3	0025-0258	249.56	257.64	117	41.70	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			384.3	G08		3	0026-0275	172.46	274.70	276	67.84	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			421.8	G08		3	0027-0281	631.58	281.17	262	59.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			564.0	G08		3	0028-0283	13.67	282.64	191	56.77	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			708.6	G08		3	0029-0291	854.26	290.53	224	59.60	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			643.9	G08		3	0030-0303	103.18	303.57	207	57.36	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			985.7	G08		3	0031-0312	777.94	311.63	151	51.46	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			743.6	G08		3	0032-0322	487.29	322.50	214	56.77	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			430.7	G08		3	0033-0343	170.81	343.65	233	58.28	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			890.9	G08		3	0034-0384	852.19	384.44	220	55.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			459.8	G08		3	0035-0385	203.48	384.96	224	61.70	0.739
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			504.4	G08		3	0036-0396	810.66	396.52	284	63.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			515.2	G08		3	0037-0402	50.40	402.63	241	60.77	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			578.2	G08		3	0038-0407	742.68	408.20	266	64.18	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			411.4	G08		3	0039-0408	893.26	407.85	285	67.26	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			581.6	G08		3	0040-0454	910.50	453.38	237	58.77	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			377.8	G08		3	0041-0486	783.43	486.83	257	62.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			635.0	G08		3	0042-0489	453.81	489.03	234	57.36	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			496.3	G08		3	0043-0499	369.03	498.82	247	60.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			406.2	G08		3	0044-0535	663.85	535.40	257	62.87	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			509.5	G08		3	0045-0539	343.31	539.41	471	89.74	0.735
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			697.9	G08		3	0046-0531	785.86	531.44	177	51.11	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			623.7	G08		3	0047-0549	945.50	548.90	266	68.63	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			522.5	G08		3	0048-0558	808.51	557.74	322	68.18	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			905.7	G08		3	0049-0560	315.90	559.69	220	93.40	0.317
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			415.4	G08		3	0050-0565	444.93	564.88	283	66.18	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1834.1	G08		3	0051-0575	624.95	575.22	373	72.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			442.7	G08		3	0052-0581	325.62	582.28	262	61.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			504.2	G08		3	0053-0609	835.51	610.13	302	66.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			650.0	G08		3	0054-0645	276.97	644.96	208	56.87	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			383.0	G08		3	0055-0663	699.65	662.76	264	65.36	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			475.5	G08		3	0056-0664	832.78	663.96	216	59.84	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			726.2	G08		3	0057-0666	97.42	666.26	212	53.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			369.1	G08		3	0058-0670	618.50	669.36	259	66.43	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			449.8	G08		4	0001-0035	57.39	34.95	202	56.77	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			443.3	G08		4	0002-0036	140.39	36.89	263	67.26	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			341.4	G08		4	0003-0065	897.16	64.19	268	63.26	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			450.5	G08		4	0004-0069	704.73	69.69	260	63.70	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			433.6	G08		4	0005-0087	675.87	87.02	277	61.70	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			436.0	G08		4	0006-0092	168.03	92.02	326	72.91	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			448.0	G08		4	0007-0097	488.16	97.07	264	62.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			561.3	G08		4	0008-0106	695.79	107.02	267	67.26	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			459.1	G08		4	0009-0129	134.25	130.00	186	56.87	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			555.7	G08		4	0010-0144	683.46	144.16	250	68.77	0.664
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			392.8	G08		4	0011-0184	270.60	185.09	156	47.46	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			413.1	G08		4	0012-0184	258.83	184.32	117	42.63	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			375.0	G08		4	0013-0198	252.47	198.14	271	61.60	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			359.5	G08		4	0014-0202	271.16	202.46	228	62.77	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			500.5	G08		4	0015-0222	683.17	222.21	211	63.60	0.656
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			398.5	G08		4	0016-0223	626.05	223.64	268	61.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			367.6	G08		4	0017-0230	296.16	230.32	363	80.67	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			428.9	G08		4	0018-0236	870.80	235.72	251	60.53	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			977.5	G08		4	0019-0248	297.88	248.35	171	67.84	0.467
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			391.7	G08		4	0020-0251	61.22	251.90	222	54.77	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			512.5	G08		4	0021-0252	929.07	252.31	258	60.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			386.4	G08		4	0022-0261	757.81	261.64	281	65.01	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			405.3	G08		4	0023-0260	858.20	260.13	218	61.70	0.720
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			427.0	G08		4	0024-0273	154.52	273.23	239	64.53	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			378.2	G08		4	0025-0274	848.11	274.54	288	65.94	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			648.7	G08		4	0026-0278	57.57	278.85	196	52.53	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			485.2	G08		4	0027-0290	821.95	289.82	232	58.53	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			359.5	G08		4	0028-0297	30.71	296.88	302	66.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			499.5	G08		4	0029-0300	383.48	300.35	174	49.11	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			443.6	G08		4	0030-0308	258.64	308.85	209	57.60	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			371.7	G08		4	0031-0310	101.43	310.42	257	62.53	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			406.6	G08		4	0032-0312	542.78	311.58	301	68.77	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			450.5	G08		4	0033-0325	554.36	324.38	243	67.01	0.680
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			462.7	G08		4	0034-0343	635.95	342.84	195	59.01	0.704
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			591.1	G08		4	0035-0351	370.80	351.24	187	53.70	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			372.8	G08		4	0036-0350	928.55	349.11	162	51.94	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			366.8	G08		4	0037-0355	938.44	356.34	139	44.28	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			421.1	G08		4	0038-0361	218.64	361.70	202	57.11	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			584.8	G08		4	0039-0373	278.48	373.34	189	51.46	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			800.6	G08		4	0040-0382	801.04	382.03	194	55.70	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			397.0	G08		4	0041-0388	284.57	388.10	256	62.53	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			425.5	G08		4	0042-0391	415.82	392.06	295	67.36	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			398.1	G08		4	0043-0390	53.66	390.17	240	60.18	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			385.5	G08		4	0044-0393	267.09	393.23	290	67.26	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			494.7	G08		4	0045-0401	830.60	401.78	210	53.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			438.8	G08		4	0046-0420	198.06	419.82	219	57.46	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			423.8	G08		4	0047-0424	944.84	423.39	270	62.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			413.9	G08		4	0048-0440	392.04	441.07	265	65.84	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			642.9	G08		4	0049-0447	554.05	446.96	215	56.18	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			528.4	G08		4	0050-0446	249.81	446.92	191	53.11	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			379.2	G08		4	0051-0477	904.87	477.53	234	57.70	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			479.9	G08		4	0052-0487	80.59	487.68	262	62.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			457.3	G08		4	0053-0502	230.11	501.89	197	53.46	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3236.8	G08		4	0054-0517	391.63	517.07	253	75.60	0.556
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			495.5	G08		4	0055-0521	120.17	521.56	214	55.36	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			517.7	G08		4	0056-0523	287.43	523.01	270	63.60	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			465.9	G08		4	0057-0530	144.08	530.84	219	55.46	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			530.3	G08		4	0058-0560	596.96	558.50	392	91.74	0.585
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			588.5	G08		4	0059-0564	877.39	564.54	192	51.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1840.9	G08		4	0060-0577	810.69	577.11	389	74.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			421.2	G08		4	0061-0591	113.98	591.55	247	59.94	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			401.9	G08		4	0062-0606	659.17	606.68	297	78.57	0.605
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			559.0	G08		4	0063-0617	452.28	617.65	211	56.77	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			521.8	G08		4	0064-0621	193.27	621.27	221	60.43	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			481.6	G08		4	0065-0637	190.91	637.47	228	60.18	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			475.6	G08		4	0066-0644	397.00	643.71	282	63.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			541.2	G08		4	0067-0653	92.97	652.55	189	56.53	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			704.3	G08		4	0068-0654	106.20	654.06	160	50.04	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			430.3	G08		4	0069-0663	678.63	663.18	247	64.43	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2423.5	G08		4	0070-0690	349.11	690.26	383	72.67	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			360.1	G08		4	0071-0691	367.79	690.82	276	66.18	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			418.8	G08		4	0072-0704	542.80	703.81	309	68.43	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			306.9	G08		4	0073-0703	589.98	703.36	281	69.11	0.739
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			594.6	G08		4	0074-0703	739.02	703.26	199	52.77	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			509.6	G08		4	0075-0707	196.86	706.90	154	46.53	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			377.5	G08		5	0001-0032	541.11	31.09	192	60.18	0.666
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			624.1	G08		5	0002-0042	152.37	43.12	227	64.53	0.685
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			559.5	G08		5	0003-0068	371.04	67.99	204	61.46	0.679
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			456.3	G08		5	0004-0094	130.78	94.41	220	57.70	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			833.9	G08		5	0005-0108	685.92	107.88	189	51.94	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			538.8	G08		5	0006-0108	655.21	107.84	265	63.36	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			675.5	G08		5	0007-0126	291.19	126.62	202	56.18	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			433.3	G08		5	0008-0163	606.40	162.70	224	68.43	0.601
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			448.6	G08		5	0009-0165	343.14	165.05	250	63.50	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			327.4	G08		5	0010-0175	940.52	174.15	253	63.11	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			593.6	G08		5	0011-0181	825.03	181.58	243	58.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			599.1	G08		5	0012-0189	442.10	189.27	227	64.18	0.692
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			517.4	G08		5	0013-0195	722.38	195.82	185	73.50	0.430
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			398.2	G08		5	0014-0222	93.53	222.62	278	65.94	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			469.1	G08		5	0015-0237	567.80	237.45	194	55.46	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			322.7	G08		5	0016-0239	139.04	239.55	271	62.77	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			436.1	G08		5	0017-0241	470.04	240.31	223	57.46	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			548.4	G08		5	0018-0240	624.42	240.17	185	53.36	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			540.2	G08		5	0019-0248	823.85	247.79	175	69.26	0.459
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			463.7	G08		5	0020-0253	34.52	253.68	252	59.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			325.9	G08		5	0021-0263	132.45	263.34	299	67.84	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			358.9	G08		5	0022-0282	865.29	281.23	145	48.53	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			363.0	G08		5	0023-0292	260.85	292.40	275	62.18	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			333.7	G08		5	0024-0289	871.90	290.19	120	44.28	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			329.8	G08		5	0025-0292	905.12	292.44	265	63.01	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			990.4	G08		5	0026-0292	213.98	291.51	103	49.46	0.529
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			323.0	G08		5	0027-0316	61.57	315.91	259	68.53	0.693
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			578.3	G08		5	0028-0324	909.41	324.06	225	55.11	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			369.2	G08		5	0029-0351	34.16	350.35	160	51.11	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1479.4	G08		5	0030-0356	852.99	356.90	319	68.18	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			372.7	G08		5	0031-0357	43.91	357.60	134	43.46	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			401.4	G08		5	0032-0370	916.33	370.90	242	64.53	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			395.6	G08		5	0033-0388	478.45	387.91	263	61.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			633.4	G08		5	0034-0396	394.79	396.25	187	51.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			475.2	G08		5	0035-0412	692.19	411.81	233	56.28	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			485.3	G08		5	0036-0419	429.87	419.08	156	58.77	0.568
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			431.7	G08		5	0037-0425	50.46	424.75	261	63.60	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			377.5	G08		5	0038-0484	95.58	484.30	269	62.18	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			706.3	G08		5	0039-0483	930.96	483.42	201	53.70	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			479.0	G08		5	0040-0494	633.21	493.73	212	62.28	0.687
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			448.9	G08		5	0041-0497	769.80	497.55	253	61.70	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			355.9	G08		5	0042-0508	329.53	508.48	329	72.43	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			435.8	G08		5	0043-0527	286.51	526.75	220	61.01	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			459.7	G08		5	0044-0535	622.69	534.63	187	56.28	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			334.2	G08		5	0045-0550	220.89	550.54	202	57.94	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			425.7	G08		5	0046-0548	249.45	548.43	172	52.28	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			649.9	G08		5	0047-0563	153.70	562.95	110	53.36	0.486
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			394.2	G08		5	0048-0583	634.62	583.75	264	63.84	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			486.1	G08		5	0049-0594	129.69	594.89	191	54.18	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			395.0	G08		5	0050-0606	526.68	606.72	254	62.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			400.8	G08		5	0051-0621	548.39	620.38	261	60.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			616.9	G08		5	0052-0633	394.79	633.43	175	57.94	0.655
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			329.7	G08		5	0053-0649	879.38	648.46	267	62.77	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			469.3	G08		5	0054-0658	86.40	658.34	208	66.04	0.599
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			458.3	G08		5	0055-0659	146.43	658.61	215	57.11	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			415.5	G08		5	0056-0676	660.44	675.54	242	63.36	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			685.2	G08		5	0057-0680	392.72	679.46	237	61.94	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			664.8	G08		5	0058-0686	413.76	685.86	186	51.70	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			613.6	G08		5	0059-0701	377.39	701.40	197	55.70	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			737.4	G08		5	0060-0703	482.30	702.70	182	64.67	0.547
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			685.4	G08		6	0001-0056	930.28	56.78	245	59.11	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			429.7	G08		6	0002-0062	146.01	62.35	215	56.77	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			397.0	G08		6	0003-0073	880.87	72.50	278	64.43	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			701.7	G08		6	0004-0082	78.92	81.60	182	51.94	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			395.1	G08		6	0005-0093	752.88	94.14	288	67.01	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			485.4	G08		6	0006-0112	641.80	112.21	197	57.60	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			992.1	G08		6	0007-0120	317.19	120.41	213	53.11	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			483.4	G08		6	0008-0124	828.85	124.44	232	71.98	0.563
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			429.7	G08		6	0009-0133	761.87	133.64	241	61.01	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			346.6	G08		6	0010-0139	111.89	138.66	274	63.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			323.4	G08		6	0011-0145	96.13	144.50	281	64.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			432.9	G08		6	0012-0150	731.23	150.14	297	66.18	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			613.9	G08		6	0013-0153	946.07	153.21	217	55.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			426.9	G08		6	0014-0157	818.91	157.09	266	65.01	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			424.7	G08		6	0015-0177	35.63	176.53	252	61.11	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			853.0	G08		6	0016-0179	810.78	179.02	141	59.60	0.499
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			436.6	G08		6	0017-0183	491.89	183.08	192	56.43	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			392.9	G08		6	0018-0187	116.46	188.41	137	46.63	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			329.2	G08		6	0019-0200	117.38	199.99	117	41.80	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			373.8	G08		6	0020-0220	67.60	220.10	243	57.70	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			421.8	G08		6	0021-0225	588.78	225.28	263	64.43	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			441.4	G08		6	0022-0261	649.15	261.19	225	59.70	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			587.2	G08		6	0023-0323	648.24	322.86	229	59.94	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			504.9	G08		6	0024-0328	763.41	329.02	193	57.11	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			370.4	G08		6	0025-0339	100.89	339.06	230	57.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			416.9	G08		6	0026-0347	418.78	347.62	272	65.60	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			414.1	G08		6	0027-0369	308.09	369.43	309	66.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			349.7	G08		6	0028-0373	11.55	373.61	238	63.11	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			451.2	G08		6	0029-0373	577.93	372.96	231	62.63	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			379.7	G08		6	0030-0403	351.02	403.11	335	70.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			427.3	G08		6	0031-0413	837.42	412.60	249	59.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			462.4	G08		6	0032-0418	255.47	418.73	301	69.01	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			451.5	G08		6	0033-0426	394.41	426.17	186	53.46	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			448.8	G08		6	0034-0432	873.70	432.07	251	60.53	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			525.8	G08		6	0035-0454	596.99	454.12	299	82.91	0.547
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			656.9	G08		6	0036-0486	26.23	486.05	202	55.11	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			433.1	G08		6	0037-0513	579.88	512.79	289	64.53	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			400.4	G08		6	0038-0542	313.65	541.48	130	43.94	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			409.4	G08		6	0039-0546	303.22	547.24	144	45.11	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			697.0	G08		6	0040-0554	190.36	554.58	209	53.36	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			497.6	G08		6	0041-0567	183.14	566.73	172	51.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			736.2	G08		6	0042-0568	321.68	568.31	295	65.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			357.1	G08		6	0043-0582	382.57	582.43	275	67.70	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			451.2	G08		6	0044-0604	753.16	604.08	233	58.53	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			626.2	G08		6	0045-0611	859.18	611.21	210	59.36	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			484.4	G08		6	0046-0612	890.31	612.54	187	57.94	0.700
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			583.7	G08		6	0047-0614	613.01	614.72	215	56.87	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			388.1	G08		6	0048-0640	352.25	639.51	291	66.43	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			506.3	G08		6	0049-0646	575.91	645.49	232	59.60	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			539.3	G08		6	0050-0650	617.75	651.14	208	57.84	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			439.0	G08		6	0051-0653	123.89	653.61	205	60.53	0.703
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			460.5	G08		6	0052-0677	466.12	677.74	244	59.94	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			466.3	G08		6	0053-0686	593.53	685.73	205	59.94	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			487.4	G08		6	0054-0691	513.60	691.38	248	61.60	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			308.7	G08		6	0055-0700	351.11	699.46	279	62.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			1586.3	G08		6	0056-0709	218.08	709.28	259	60.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			486.5	G08		6	0057-0709	832.68	709.43	206	58.28	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			694.5	G08		7	0001-0053	156.06	53.48	189	52.87	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			488.6	G08		7	0002-0055	530.23	55.22	234	56.87	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			361.9	G08		7	0003-0059	856.52	59.19	222	59.46	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			585.6	G08		7	0004-0066	818.80	66.19	139	61.60	0.460
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			408.5	G08		7	0005-0108	391.66	108.22	211	60.04	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			300.0	G08		7	0006-0106	876.52	106.30	260	62.77	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			676.3	G08		7	0007-0126	468.55	126.58	207	53.11	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			469.9	G08		7	0008-0146	857.50	145.91	227	61.60	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			610.9	G08		7	0009-0151	424.38	151.78	184	51.46	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			444.7	G08		7	0010-0155	165.33	155.02	235	60.53	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			398.5	G08		7	0011-0169	384.99	168.53	333	77.26	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			429.6	G08		7	0012-0218	214.01	218.13	266	65.01	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			383.8	G08		7	0013-0232	844.78	232.79	244	59.94	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			556.5	G08		7	0014-0246	70.36	245.62	187	57.01	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			723.6	G08		7	0015-0269	254.98	267.70	124	52.87	0.557
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			524.5	G08		7	0016-0278	542.09	277.90	194	55.01	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			385.6	G08		7	0017-0285	589.69	285.54	227	55.70	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			678.3	G08		7	0018-0295	792.60	296.21	261	62.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			370.9	G08		7	0019-0312	44.10	311.83	284	64.53	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			491.0	G08		7	0020-0310	581.07	310.05	230	59.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2732.0	G08		7	0021-0318	797.42	318.62	355	71.01	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			451.0	G08		7	0022-0320	20.50	319.46	217	56.28	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			362.2	G08		7	0023-0342	903.18	342.01	285	63.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			596.6	G08		7	0024-0346	432.50	346.92	216	56.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			327.7	G08		7	0025-0359	304.40	359.04	277	66.18	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			832.0	G08		7	0026-0385	226.98	385.39	107	39.46	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			349.2	G08		7	0027-0408	323.36	408.03	298	66.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			380.6	G08		7	0028-0414	130.61	414.08	313	71.50	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			411.6	G08		7	0029-0412	876.71	411.44	249	59.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			725.1	G08		7	0030-0415	227.08	415.55	205	57.01	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			677.9	G08		7	0031-0458	218.58	458.05	226	59.84	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			474.9	G08		7	0032-0465	900.13	464.79	272	63.01	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			657.4	G08		7	0033-0480	673.05	480.64	163	60.18	0.566
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			404.1	G08		7	0034-0483	154.74	483.15	141	46.87	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			517.8	G08		7	0035-0492	825.90	492.18	214	57.36	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			384.3	G08		7	0036-0494	159.32	495.01	131	49.46	0.673
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			721.3	G08		7	0037-0540	317.29	539.62	261	62.53	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			525.8	G08		7	0038-0537	118.17	537.42	196	57.36	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			485.8	G08		7	0039-0548	749.08	548.28	132	45.36	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			324.9	G08		7	0040-0555	541.81	554.98	291	65.26	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			458.1	G08		7	0041-0557	214.72	557.44	222	57.36	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			418.0	G08		7	0042-0555	735.78	555.98	120	42.28	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			489.5	G08		7	0043-0571	865.45	571.98	235	59.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			328.7	G08		7	0044-0581	458.87	581.32	299	65.26	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			469.3	G08		7	0045-0580	338.24	579.59	201	56.04	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			362.0	G08		7	0046-0584	557.07	584.80	257	61.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			463.4	G08		7	0047-0590	146.42	590.52	220	59.21	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			367.4	G08		7	0048-0590	379.40	589.54	316	66.67	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			309.9	G08		7	0049-0587	725.42	587.60	147	45.11	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			316.0	G08		7	0050-0596	715.02	597.07	151	46.87	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			427.0	G08		7	0051-0647	709.92	647.29	279	62.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			508.2	G08		7	0052-0649	283.27	650.15	195	53.94	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			411.5	G08		7	0053-0663	760.22	663.21	252	61.60	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			390.9	G08		7	0054-0665	58.61	665.53	298	63.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			398.1	G08		7	0055-0677	779.19	677.03	238	61.60	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			638.7	G08		7	0056-0692	383.49	691.93	179	49.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			453.2	G08		7	0057-0691	471.18	691.53	195	56.87	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			275.5	G08		8	0001-0031	936.98	31.62	278	65.60	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			441.5	G08		8	0002-0054	801.15	53.88	209	56.87	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			412.7	G08		8	0003-0061	843.75	61.43	216	66.04	0.622
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			457.9	G08		8	0004-0072	744.01	72.77	201	59.70	0.709
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			956.3	G08		8	0005-0110	290.92	109.83	264	63.01	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			595.2	G08		8	0006-0124	868.05	124.44	204	55.36	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			470.7	G08		8	0007-0136	397.97	136.22	279	62.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			633.5	G08		8	0008-0157	297.33	157.19	199	51.11	0.957
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			389.0	G08		8	0009-0177	236.55	176.67	260	64.53	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			659.2	G08		8	0010-0177	353.95	177.55	204	52.28	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			423.7	G08		8	0011-0182	141.63	182.29	215	60.43	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			507.5	G08		8	0012-0184	417.53	184.50	266	63.84	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			669.7	G08		8	0013-0195	580.65	195.20	189	53.11	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			441.6	G08		8	0014-0207	918.96	206.97	220	55.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			441.7	G08		8	0015-0214	236.87	214.53	211	59.01	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			497.2	G08		8	0016-0241	897.47	241.14	199	55.36	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			491.5	G08		8	0017-0260	527.98	260.45	217	56.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			489.5	G08		8	0018-0264	450.21	263.65	272	63.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			378.3	G08		8	0019-0297	861.92	297.03	274	63.94	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			373.6	G08		8	0020-0298	714.96	298.45	291	64.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			401.0	G08		8	0021-0330	699.62	330.32	173	47.46	0.965
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			432.1	G08		8	0022-0334	721.44	334.50	230	69.26	0.603
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			355.0	G08		8	0023-0343	708.13	343.65	123	45.11	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			332.9	G08		8	0024-0356	95.62	357.04	246	59.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			329.3	G08		8	0025-0358	770.82	358.20	230	63.60	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			489.2	G08		8	0026-0376	353.60	378.03	264	77.26	0.556
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			496.6	G08		8	0027-0378	259.72	378.03	213	55.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			453.2	G08		8	0028-0380	688.59	380.85	231	62.77	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			353.1	G08		8	0029-0388	424.72	387.92	305	67.84	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			411.7	G08		8	0030-0393	795.82	392.83	329	69.36	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			423.3	G08		8	0031-0421	214.39	421.11	189	56.53	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			598.9	G08		8	0032-0423	584.17	423.57	283	64.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			482.0	G08		8	0033-0426	527.98	426.91	228	57.70	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			379.7	G08		8	0034-0431	469.27	430.90	295	64.53	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			504.6	G08		8	0035-0446	174.24	446.17	205	59.26	0.734
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			334.5	G08		8	0036-0465	93.35	465.85	268	64.18	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			637.2	G08		8	0037-0478	172.46	478.59	190	52.77	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			456.9	G08		8	0038-0478	451.26	478.26	172	50.18	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			491.5	G08		8	0039-0485	204.35	484.39	245	61.60	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			418.6	G08		8	0040-0493	109.12	493.18	278	65.94	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			376.2	G08		8	0041-0514	550.29	513.57	307	69.94	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			381.5	G08		8	0042-0513	707.35	513.93	288	62.18	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			356.9	G08		8	0043-0518	868.54	518.43	202	61.01	0.682
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			415.9	G08		8	0044-0518	406.70	519.39	142	45.21	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			446.3	G08		8	0045-0536	565.66	536.59	212	64.04	0.650
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			413.2	G08		8	0046-0533	407.92	532.20	168	48.63	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			388.6	G08		8	0047-0534	301.31	534.72	230	59.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			455.2	G08		8	0048-0548	192.92	547.90	260	61.36	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			357.4	G08		8	0049-0556	511.92	556.09	302	66.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			456.7	G08		8	0050-0566	299.97	566.75	193	53.60	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			351.1	G08		8	0051-0580	924.69	579.23	294	65.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			323.9	G08		8	0052-0589	270.62	588.33	268	63.11	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			2554.0	G08		8	0053-0595	880.07	594.80	355	73.36	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			324.8	G08		8	0054-0610	218.90	609.47	260	67.84	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			552.6	G08		8	0055-0621	146.69	622.02	198	57.11	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			524.9	G08		8	0056-0621	290.70	621.09	249	60.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			464.8	G08		8	0057-0639	577.61	640.06	225	62.53	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			473.7	G08		8	0058-0657	135.73	657.10	210	61.70	0.693
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			401.1	G08		8	0059-0652	674.40	652.07	277	69.36	0.724
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			668.0	G08		8	0060-0666	415.93	666.00	171	55.11	0.707
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			563.3	G08		8	0061-0699	370.97	699.10	183	51.70	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			484.2	G08		8	0062-0701	133.33	701.42	195	51.70	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			617.7	G08		8	0063-0709	842.07	709.27	198	51.70	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			350.4	G08		9	0001-0034	31.77	34.33	273	65.01	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			420.8	G08		9	0002-0034	411.40	35.09	286	64.77	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			287.0	G08		9	0003-0040	489.21	39.94	280	65.84	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			391.3	G08		9	0004-0049	727.83	49.69	258	61.11	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3199.5	G08		9	0005-0071	43.56	71.40	286	64.28	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			772.2	G08		9	0006-0103	476.99	103.18	279	61.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			399.7	G08		9	0007-0106	354.74	106.26	246	59.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			457.0	G08		9	0008-0118	570.68	118.15	240	60.53	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			424.2	G08		9	0009-0145	347.01	145.15	199	53.11	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			659.1	G08		9	0010-0148	694.70	149.05	194	59.36	0.692
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			424.4	G08		9	0011-0150	125.25	150.20	225	59.46	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			418.7	G08		9	0012-0157	97.26	157.47	266	59.11	0.957
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			371.9	G08		9	0013-0183	323.97	183.54	246	61.60	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			454.3	G08		9	0014-0194	251.35	194.46	224	57.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			385.6	G08		9	0015-0206	858.14	205.90	261	62.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			396.1	G08		9	0016-0210	14.17	209.59	216	55.60	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			492.8	G08		9	0017-0211	377.37	210.79	172	54.04	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			503.9	G08		9	0018-0224	388.18	223.96	199	56.53	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			447.3	G08		9	0019-0235	80.57	235.54	201	56.18	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			582.0	G08		9	0020-0244	687.08	243.72	274	63.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			3046.9	G08		9	0021-0246	299.45	245.54	343	72.43	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			465.9	G08		9	0022-0255	445.90	255.26	242	57.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			606.4	G08		9	0023-0268	478.14	267.59	245	58.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			406.4	G08		9	0024-0306	621.04	306.21	306	65.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			364.5	G08		9	0025-0336	263.52	336.65	255	77.50	0.534
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			325.5	G08		9	0026-0338	565.15	337.78	294	65.60	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			637.4	G08		9	0027-0352	423.01	352.32	230	57.36	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			610.9	G08		9	0028-0359	647.64	359.30	201	52.04	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			324.7	G08		9	0029-0366	121.04	366.56	347	72.08	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			398.6	G08		9	0030-0371	599.07	371.81	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			346.6	G08		9	0031-0392	112.90	392.27	302	70.18	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			515.3	G08		9	0032-0394	544.89	393.62	265	87.64	0.434
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			452.9	G08		9	0033-0396	427.88	397.25	206	56.77	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			382.4	G08		9	0034-0412	642.60	412.11	280	69.26	0.734
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			405.7	G08		9	0035-0416	462.97	416.38	197	60.28	0.681
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			375.5	G08		9	0036-0419	369.72	418.83	238	60.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			430.9	G08		9	0037-0428	443.00	427.25	275	64.77	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			384.8	G08		9	0038-0429	515.38	429.72	271	61.70	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			349.7	G08		9	0039-0440	364.69	440.16	252	61.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			535.7	G08		9	0040-0502	687.24	501.40	247	61.36	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			500.0	G08		9	0041-0505	670.84	506.14	206	54.63	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			430.9	G08		9	0042-0526	480.04	525.65	299	66.77	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			379.5	G08		9	0043-0560	241.00	560.24	284	66.77	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			323.4	G08		9	0044-0582	19.55	581.95	287	64.53	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			493.5	G08		9	0045-0581	306.88	581.25	226	58.18	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			417.9	G08		9	0046-0596	783.57	595.75	266	63.84	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			395.7	G08		9	0047-0601	698.86	601.44	250	62.53	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			331.6	G08		9	0048-0605	942.34	604.53	260	67.01	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			362.9	G08		9	0049-0613	300.09	612.81	325	66.43	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80004	Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy3	201297	Rb (pS807; pS811)			348.4	G08		9	0050-0664	878.63	665.31	280	63.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			231.5	B08		1	0001-0030	113.89	29.84	299	67.60	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			253.0	B08		1	0002-0029	168.91	28.72	294	66.18	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			577.5	B08		1	0003-0033	263.30	34.12	210	55.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			600.8	B08		1	0004-0039	463.46	39.70	310	65.36	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			216.5	B08		1	0005-0040	504.82	41.10	293	68.67	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			242.9	B08		1	0006-0040	720.01	40.44	289	75.74	0.633
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			453.3	B08		1	0007-0041	803.55	41.85	444	87.50	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3213.0	B08		1	0008-0042	418.82	41.04	267	61.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1665.3	B08		1	0009-0042	87.75	42.02	158	48.63	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			342.3	B08		1	0010-0045	289.33	45.56	376	71.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			261.3	B08		1	0011-0044	589.42	44.68	234	56.28	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1780.1	B08		1	0012-0045	693.34	45.35	223	54.87	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			295.0	B08		1	0013-0042	652.67	42.21	177	52.63	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			539.4	B08		1	0014-0047	771.72	47.09	254	59.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			225.6	B08		1	0015-0051	172.16	51.15	276	61.94	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			238.4	B08		1	0016-0050	534.61	50.03	323	66.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			348.2	B08		1	0017-0053	219.63	53.47	374	71.60	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			901.6	B08		1	0018-0052	134.85	52.43	234	56.53	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			275.6	B08		1	0019-0058	657.13	57.83	342	70.77	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			518.2	B08		1	0020-0061	258.75	61.24	390	73.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			331.2	B08		1	0021-0063	335.34	62.34	338	68.43	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			284.9	B08		1	0022-0062	630.45	62.65	266	64.28	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			7841.1	B08		1	0023-0061	68.12	60.80	231	55.11	0.956
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			760.5	B08		1	0024-0069	569.59	69.83	433	81.26	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			234.2	B08		1	0025-0071	383.06	70.47	307	65.36	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			281.9	B08		1	0026-0072	533.10	71.85	285	67.60	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			263.6	B08		1	0027-0075	85.61	75.59	300	66.18	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1621.1	B08		1	0028-0072	179.49	71.47	229	60.28	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			529.2	B08		1	0029-0075	115.54	75.69	250	60.53	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			369.5	B08		1	0030-0081	364.92	80.88	146	47.46	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2261.0	B08		1	0031-0080	619.08	80.64	222	57.94	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			598.7	B08		1	0032-0081	759.36	80.85	245	58.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			299.9	B08		1	0033-0081	321.95	81.50	130	42.63	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			347.5	B08		1	0034-0088	460.95	87.74	314	66.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			279.9	B08		1	0035-0084	310.93	84.24	113	39.80	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			437.0	B08		1	0036-0090	175.85	90.55	267	61.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			269.7	B08		1	0037-0090	214.71	89.20	254	62.77	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			227.5	B08		1	0038-0092	424.90	91.91	289	65.01	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2033.6	B08		1	0039-0091	680.90	91.72	234	58.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			198.5	B08		1	0040-0094	944.76	95.13	265	65.01	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			452.1	B08		1	0041-0095	625.03	94.75	328	69.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			259.9	B08		1	0042-0103	829.16	103.44	270	62.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			611.4	B08		1	0043-0104	239.83	104.03	255	65.26	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			604.8	B08		1	0044-0104	882.82	104.11	328	67.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			232.6	B08		1	0045-0110	922.35	110.33	335	73.84	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			216.5	B08		1	0046-0109	293.74	110.26	248	62.77	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			385.5	B08		1	0047-0112	493.79	112.96	362	71.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			360.9	B08		1	0048-0114	778.16	114.52	464	84.43	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4912.9	B08		1	0049-0116	112.41	116.63	359	88.08	0.581
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			328.5	B08		1	0050-0116	259.31	115.12	221	56.77	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			300.8	B08		1	0051-0116	647.23	117.24	258	60.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			312.1	B08		1	0052-0117	677.05	116.66	246	60.77	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			432.3	B08		1	0053-0121	836.66	121.20	367	74.18	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1370.2	B08		1	0054-0122	164.49	121.49	263	63.01	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			235.6	B08		1	0055-0120	281.99	120.20	154	46.53	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			879.2	B08		1	0056-0125	949.09	125.05	224	54.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			282.8	B08		1	0057-0128	199.33	128.54	327	68.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3445.0	B08		1	0058-0126	268.66	127.47	256	63.50	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1015.8	B08		1	0059-0129	408.85	128.58	321	73.50	0.747
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2057.5	B08		1	0060-0132	426.69	132.76	233	57.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			316.3	B08		1	0061-0136	630.94	135.58	383	73.94	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1364.3	B08		1	0062-0137	26.05	136.99	233	57.60	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1441.0	B08		1	0063-0137	373.17	137.60	319	72.91	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			356.6	B08		1	0064-0139	329.68	138.96	328	66.18	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1124.9	B08		1	0065-0140	731.73	139.63	294	63.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			370.9	B08		1	0066-0148	178.70	148.16	375	71.84	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			246.9	B08		1	0067-0146	940.07	145.73	218	55.36	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			324.7	B08		1	0068-0149	527.48	149.03	352	71.60	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1309.6	B08		1	0069-0149	37.87	149.11	235	57.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			448.3	B08		1	0070-0150	469.38	149.40	312	67.11	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			313.0	B08		1	0071-0150	596.87	150.27	252	60.53	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			229.6	B08		1	0072-0152	796.78	151.98	299	66.18	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2103.0	B08		1	0073-0159	225.58	157.45	570	99.74	0.720
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			427.2	B08		1	0074-0155	282.20	154.87	260	62.18	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			572.1	B08		1	0075-0157	632.64	157.02	313	76.43	0.673
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1709.8	B08		1	0076-0158	153.69	157.45	204	55.70	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			327.2	B08		1	0077-0163	328.00	163.42	260	61.01	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			348.7	B08		1	0078-0163	125.94	162.81	221	58.77	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1954.0	B08		1	0079-0165	582.66	164.81	259	59.01	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3729.8	B08		1	0080-0168	806.15	168.59	186	50.28	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			481.9	B08		1	0081-0173	353.97	173.37	375	73.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			560.3	B08		1	0082-0176	393.44	175.46	308	66.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1248.9	B08		1	0083-0181	81.01	179.70	679	108.81	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			248.6	B08		1	0084-0181	37.82	180.94	317	68.67	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			282.5	B08		1	0085-0183	495.13	183.84	242	61.11	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			253.1	B08		1	0086-0186	183.20	185.11	281	70.77	0.705
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1242.3	B08		1	0087-0183	529.17	183.34	292	66.77	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			594.2	B08		1	0088-0188	592.87	187.56	324	71.26	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			453.0	B08		1	0089-0188	151.31	188.09	239	63.01	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			591.1	B08		1	0090-0186	472.32	186.20	273	62.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			562.2	B08		1	0091-0190	645.42	190.40	355	72.77	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1638.4	B08		1	0092-0189	740.53	189.40	262	61.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2198.7	B08		1	0093-0189	916.61	189.99	213	55.94	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3683.5	B08		1	0094-0199	661.63	199.51	212	54.53	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			6089.6	B08		1	0095-0202	325.65	202.00	219	55.36	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2152.5	B08		1	0096-0203	781.21	202.87	198	52.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2493.4	B08		1	0097-0207	126.70	206.94	259	64.43	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			286.7	B08		1	0098-0208	842.96	208.21	277	62.53	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1252.9	B08		1	0099-0207	893.22	207.79	217	56.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1361.0	B08		1	0100-0211	47.78	209.92	245	71.84	0.597
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			369.5	B08		1	0101-0214	541.25	215.01	299	63.94	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			253.6	B08		1	0102-0214	757.81	214.78	388	73.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			693.0	B08		1	0103-0216	410.24	216.66	161	46.77	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			260.9	B08		1	0104-0223	491.65	222.90	275	63.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4335.1	B08		1	0105-0224	660.52	224.84	193	55.70	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			433.1	B08		1	0106-0227	19.25	227.66	223	54.77	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			402.2	B08		1	0107-0228	641.43	228.26	277	63.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			304.9	B08		1	0108-0230	932.04	229.58	285	68.67	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			258.5	B08		1	0109-0231	142.62	231.60	386	74.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1639.2	B08		1	0110-0230	561.73	229.80	229	55.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			253.1	B08		1	0111-0232	381.62	230.95	268	61.11	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			543.8	B08		1	0112-0230	462.01	230.23	249	61.11	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			404.7	B08		1	0113-0233	211.55	233.28	153	48.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			878.5	B08		1	0114-0243	589.35	243.57	309	68.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			383.7	B08		1	0115-0246	199.44	247.53	276	74.43	0.626
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			498.7	B08		1	0116-0244	317.01	244.90	203	53.11	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			286.0	B08		1	0117-0248	76.81	248.53	326	67.01	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			459.5	B08		1	0118-0247	524.13	246.74	325	66.18	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3633.3	B08		1	0119-0247	711.89	247.02	255	60.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			405.1	B08		1	0120-0248	409.52	248.96	336	67.60	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			437.4	B08		1	0121-0249	739.54	249.33	291	62.18	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			272.5	B08		1	0122-0250	840.18	251.21	283	64.43	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			238.6	B08		1	0123-0247	102.44	248.22	225	58.28	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			382.7	B08		1	0124-0252	47.31	252.01	327	67.26	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			264.1	B08		1	0125-0251	779.24	251.24	413	77.84	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			211.1	B08		1	0126-0257	151.50	256.98	248	61.36	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			234.6	B08		1	0127-0260	804.47	259.44	328	74.18	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			519.9	B08		1	0128-0261	359.21	260.93	227	57.94	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			367.3	B08		1	0129-0264	229.84	263.90	281	63.94	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1506.3	B08		1	0130-0263	576.99	262.76	251	59.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			638.7	B08		1	0131-0263	342.33	262.78	170	48.28	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			570.7	B08		1	0132-0265	453.23	264.74	269	63.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2411.3	B08		1	0133-0267	184.02	266.99	243	60.53	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1849.8	B08		1	0134-0271	400.65	271.07	303	64.43	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			828.9	B08		1	0135-0282	715.90	282.51	614	104.57	0.706
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			217.5	B08		1	0136-0278	136.40	278.88	316	67.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			405.0	B08		1	0137-0276	499.36	276.36	316	67.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			486.0	B08		1	0138-0278	325.49	278.13	242	57.11	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			316.4	B08		1	0139-0279	115.90	278.85	204	52.53	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			707.5	B08		1	0140-0280	248.03	279.94	274	63.70	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1113.2	B08		1	0141-0280	233.47	280.45	153	47.56	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			389.8	B08		1	0142-0283	831.39	284.12	232	58.77	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			846.4	B08		1	0143-0289	784.07	289.05	364	71.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			424.5	B08		1	0144-0285	871.41	284.96	211	56.04	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			274.1	B08		1	0145-0290	63.79	289.94	259	61.94	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			287.3	B08		1	0146-0294	198.94	293.80	275	68.77	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			656.0	B08		1	0147-0295	251.29	295.72	194	54.53	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			567.8	B08		1	0148-0293	442.69	293.36	247	58.28	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			686.5	B08		1	0149-0295	947.72	294.55	176	50.18	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			357.5	B08		1	0150-0299	539.19	299.01	298	64.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2191.9	B08		1	0151-0299	361.35	299.51	251	57.70	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			894.0	B08		1	0152-0298	577.27	297.82	248	60.53	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			301.1	B08		1	0153-0300	153.20	300.76	218	54.53	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			249.9	B08		1	0154-0304	861.89	303.83	366	74.53	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			351.6	B08		1	0155-0308	69.46	309.04	291	69.60	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			259.1	B08		1	0156-0307	940.82	307.36	244	61.60	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2035.4	B08		1	0157-0306	775.28	306.47	235	57.60	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			467.1	B08		1	0158-0309	925.21	309.35	226	56.28	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			284.2	B08		1	0159-0309	318.39	309.17	272	61.36	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			501.0	B08		1	0160-0314	651.65	313.60	420	79.50	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			539.7	B08		1	0161-0312	467.93	312.35	213	54.28	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			424.0	B08		1	0162-0317	437.95	317.77	267	64.53	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			291.1	B08		1	0163-0318	698.19	319.21	278	66.53	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			458.4	B08		1	0164-0322	42.02	322.21	328	67.94	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2250.4	B08		1	0165-0320	770.32	320.36	168	53.36	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			394.2	B08		1	0166-0327	754.43	327.63	324	66.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3735.0	B08		1	0167-0326	246.13	326.12	244	58.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			255.3	B08		1	0168-0330	596.47	330.76	289	65.60	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			775.6	B08		1	0169-0330	195.74	329.79	222	56.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			623.3	B08		1	0170-0331	512.72	332.12	223	57.11	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3359.0	B08		1	0171-0336	874.34	337.08	218	56.77	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			306.9	B08		1	0172-0340	922.60	340.37	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			369.8	B08		1	0173-0341	99.15	341.72	292	64.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			338.3	B08		1	0174-0341	120.32	340.55	219	53.11	0.976
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			291.9	B08		1	0175-0342	317.87	341.87	240	57.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			641.7	B08		1	0176-0344	477.32	345.31	233	58.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1730.9	B08		1	0177-0343	360.24	343.09	266	60.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			402.9	B08		1	0178-0348	187.38	348.07	297	64.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1606.4	B08		1	0179-0347	401.52	347.12	252	62.18	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			370.9	B08		1	0180-0348	451.21	348.03	240	59.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			373.6	B08		1	0181-0350	819.68	350.80	359	70.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			387.5	B08		1	0182-0357	235.83	357.38	253	60.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			665.1	B08		1	0183-0356	496.35	355.69	222	57.36	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			440.4	B08		1	0184-0358	158.02	357.54	284	62.43	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			828.0	B08		1	0185-0357	671.00	357.74	234	55.94	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			563.8	B08		1	0186-0359	721.04	359.92	342	71.84	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4782.3	B08		1	0187-0360	752.93	360.36	252	59.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			497.2	B08		1	0188-0365	470.68	365.36	211	57.36	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			319.6	B08		1	0189-0369	836.38	369.52	373	72.53	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			524.7	B08		1	0190-0368	510.44	367.95	374	72.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			219.9	B08		1	0191-0368	29.10	368.35	287	63.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			517.5	B08		1	0192-0368	85.72	368.45	306	65.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			242.9	B08		1	0193-0369	285.20	368.86	294	63.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2565.1	B08		1	0194-0369	644.13	368.90	224	53.70	0.976
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			270.8	B08		1	0195-0371	882.48	372.11	301	84.08	0.535
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1228.1	B08		1	0196-0372	342.42	372.83	297	62.43	0.958
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			486.4	B08		1	0197-0377	903.49	377.77	282	62.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			396.5	B08		1	0198-0382	236.02	382.05	232	61.01	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			397.3	B08		1	0199-0381	465.07	380.93	279	62.18	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			567.5	B08		1	0200-0382	422.53	381.58	245	57.01	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1039.8	B08		1	0201-0384	59.38	384.08	255	60.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			229.9	B08		1	0202-0382	204.75	382.54	279	65.60	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2527.2	B08		1	0203-0384	656.24	384.72	261	60.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			199.6	B08		1	0204-0387	568.05	386.72	328	69.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1515.2	B08		1	0205-0391	518.32	391.39	283	61.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			424.0	B08		1	0206-0390	169.49	389.75	206	54.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			676.9	B08		1	0207-0395	261.77	395.35	279	63.60	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			380.7	B08		1	0208-0395	803.93	394.56	282	63.94	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3914.3	B08		1	0209-0397	83.60	397.43	279	63.36	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			393.3	B08		1	0210-0404	36.94	403.87	278	63.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			455.3	B08		1	0211-0407	730.02	407.84	315	66.18	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2887.3	B08		1	0212-0408	843.73	407.57	293	64.18	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			224.2	B08		1	0213-0410	440.38	410.24	296	63.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3576.9	B08		1	0214-0410	550.82	411.36	275	66.43	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			402.6	B08		1	0215-0413	243.15	413.15	243	60.18	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1059.3	B08		1	0216-0413	516.77	413.09	281	62.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			374.0	B08		1	0217-0413	808.27	412.54	221	53.94	0.954
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			532.2	B08		1	0218-0414	919.87	414.30	185	55.60	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			477.2	B08		1	0219-0416	79.17	416.04	377	71.94	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			209.1	B08		1	0220-0418	163.55	418.03	252	61.36	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			381.0	B08		1	0221-0421	785.55	421.04	344	69.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			228.8	B08		1	0222-0422	409.14	422.85	249	63.01	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			750.5	B08		1	0223-0423	497.98	423.57	253	59.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			284.0	B08		1	0224-0424	532.48	424.18	237	58.04	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			189.1	B08		1	0225-0424	26.41	423.48	304	69.01	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			539.6	B08		1	0226-0426	354.97	425.99	314	67.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			518.0	B08		1	0227-0423	871.09	422.31	179	50.87	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1020.4	B08		1	0228-0427	250.22	427.44	230	57.70	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5413.6	B08		1	0229-0430	206.78	429.65	150	48.28	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			312.8	B08		1	0230-0433	719.33	433.69	222	55.70	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1631.6	B08		1	0231-0434	267.33	434.36	214	54.28	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			841.7	B08		1	0232-0437	480.58	437.58	240	60.18	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1396.1	B08		1	0233-0440	939.21	439.67	353	68.18	0.954
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			575.9	B08		1	0234-0439	609.39	439.19	305	65.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			354.2	B08		1	0235-0441	87.56	441.59	397	78.77	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			558.1	B08		1	0236-0444	313.31	444.10	226	55.60	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			400.5	B08		1	0237-0449	566.89	449.14	471	87.74	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			286.2	B08		1	0238-0447	895.02	446.89	305	64.18	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1493.0	B08		1	0239-0451	447.93	451.30	249	59.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			450.8	B08		1	0240-0452	203.76	451.83	338	69.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			357.6	B08		1	0241-0452	707.34	452.53	248	58.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4217.2	B08		1	0242-0455	138.82	455.82	272	61.11	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2870.4	B08		1	0243-0455	169.80	454.52	249	57.94	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			338.2	B08		1	0244-0455	764.11	454.42	229	57.60	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2273.3	B08		1	0245-0460	338.08	460.12	261	59.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			235.0	B08		1	0246-0458	522.70	457.57	260	71.36	0.642
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1994.9	B08		1	0247-0462	684.36	462.23	245	58.53	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			346.9	B08		1	0248-0461	929.63	463.41	105	54.28	0.448
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1450.8	B08		1	0249-0463	266.08	463.29	234	56.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1559.9	B08		1	0250-0462	371.30	462.35	222	54.28	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1866.4	B08		1	0251-0465	192.92	465.25	236	56.77	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			212.4	B08		1	0252-0469	19.74	469.00	232	58.18	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			431.0	B08		1	0253-0468	56.76	468.68	245	59.70	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			369.7	B08		1	0254-0473	454.50	473.71	359	71.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			386.0	B08		1	0255-0471	784.17	470.63	284	63.01	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			320.5	B08		1	0256-0471	889.75	471.18	283	62.28	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			569.7	B08		1	0257-0476	110.21	476.73	284	80.67	0.548
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			300.3	B08		1	0258-0477	231.35	477.52	324	67.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			389.9	B08		1	0259-0477	939.35	477.30	305	64.18	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			534.8	B08		1	0260-0489	638.05	489.37	596	101.64	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			344.9	B08		1	0261-0485	756.79	486.02	376	71.84	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1062.8	B08		1	0262-0487	288.53	487.51	264	65.01	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4383.7	B08		1	0263-0486	314.59	485.45	245	59.94	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			333.1	B08		1	0264-0485	553.80	484.53	283	67.36	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			687.3	B08		1	0265-0484	369.54	483.67	268	64.28	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			219.5	B08		1	0266-0491	519.97	491.55	338	72.67	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			271.6	B08		1	0267-0497	99.83	497.16	370	71.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			227.9	B08		1	0268-0498	409.74	499.31	354	71.01	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			282.2	B08		1	0269-0498	872.62	499.24	184	54.18	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1016.6	B08		1	0270-0500	148.78	500.06	228	57.36	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			390.9	B08		1	0271-0503	468.71	503.63	320	68.43	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			483.7	B08		1	0272-0503	77.11	502.93	272	61.11	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2554.4	B08		1	0273-0505	268.93	504.90	270	68.43	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			322.6	B08		1	0274-0509	305.30	509.88	233	57.94	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			600.2	B08		1	0275-0517	207.07	517.49	344	71.01	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4347.7	B08		1	0276-0519	598.46	519.13	290	66.43	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			237.0	B08		1	0277-0518	854.85	517.24	228	61.11	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			194.3	B08		1	0278-0521	933.70	520.66	393	76.43	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1136.1	B08		1	0279-0520	166.61	520.71	241	58.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			824.2	B08		1	0280-0521	238.19	521.80	373	71.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2286.8	B08		1	0281-0521	411.27	521.04	435	79.26	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			194.5	B08		1	0282-0526	563.97	525.63	293	69.01	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2618.6	B08		1	0283-0522	34.32	522.15	220	58.77	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			982.3	B08		1	0284-0523	332.36	523.14	263	59.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			243.3	B08		1	0285-0523	894.77	523.05	222	57.94	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2784.2	B08		1	0286-0527	122.79	526.75	271	60.53	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			201.8	B08		1	0287-0530	535.34	531.28	286	74.67	0.645
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1390.2	B08		1	0288-0525	792.52	525.08	151	48.53	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			268.3	B08		1	0289-0529	377.36	529.29	221	54.53	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2615.2	B08		1	0290-0532	22.59	531.68	118	40.63	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			544.3	B08		1	0291-0534	849.54	533.57	281	64.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			387.2	B08		1	0292-0538	758.80	536.71	288	66.18	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			279.6	B08		1	0293-0538	190.19	539.06	304	68.43	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2183.6	B08		1	0294-0538	155.18	538.33	266	59.94	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			428.8	B08		1	0295-0540	274.52	540.55	302	67.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1083.8	B08		1	0296-0539	584.34	539.26	237	58.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2647.6	B08		1	0297-0541	34.95	541.02	186	53.11	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			246.3	B08		1	0298-0540	246.64	540.12	226	56.28	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			442.6	B08		1	0299-0540	619.66	540.31	228	56.28	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			296.1	B08		1	0300-0546	430.62	546.55	216	53.70	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			287.0	B08		1	0301-0550	48.08	551.22	273	61.11	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			208.9	B08		1	0302-0555	646.66	554.99	394	76.43	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			253.0	B08		1	0303-0551	880.94	551.27	291	63.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			423.9	B08		1	0304-0553	813.38	553.13	188	52.53	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			269.9	B08		1	0305-0557	216.26	557.91	246	60.53	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			910.8	B08		1	0306-0557	115.55	556.04	350	73.01	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			512.5	B08		1	0307-0557	241.89	557.57	344	69.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			641.0	B08		1	0308-0559	407.13	559.18	323	69.01	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			319.0	B08		1	0309-0560	168.93	559.78	333	71.50	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2117.8	B08		1	0310-0556	922.23	556.72	246	58.87	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			250.1	B08		1	0311-0559	458.31	559.38	200	54.53	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			307.8	B08		1	0312-0561	942.12	561.30	280	61.70	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			266.6	B08		1	0313-0565	523.32	564.27	301	67.94	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			380.8	B08		1	0314-0566	762.34	565.33	293	71.50	0.720
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4153.6	B08		1	0315-0564	798.47	565.28	374	85.84	0.638
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			231.9	B08		1	0316-0567	437.78	566.43	249	59.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			875.8	B08		1	0317-0573	192.43	574.30	411	84.33	0.726
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1295.8	B08		1	0318-0569	601.57	568.93	289	69.26	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			409.4	B08		1	0319-0570	381.08	570.75	320	65.60	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			249.6	B08		1	0320-0576	233.09	576.66	252	63.36	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			432.1	B08		1	0321-0575	697.19	575.95	224	56.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			310.8	B08		1	0322-0580	545.77	580.03	344	71.60	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			634.1	B08		1	0323-0577	251.94	576.50	225	55.36	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4531.0	B08		1	0324-0581	58.38	582.52	240	63.60	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1192.9	B08		1	0325-0583	630.98	583.13	273	65.01	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			217.8	B08		1	0326-0585	565.54	585.96	451	83.01	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3001.7	B08		1	0327-0581	463.23	580.17	265	65.11	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			439.8	B08		1	0328-0585	265.66	585.19	263	65.01	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			268.8	B08		1	0329-0588	28.86	587.78	250	61.26	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			428.5	B08		1	0330-0593	115.61	594.13	357	70.18	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			849.3	B08		1	0331-0591	593.95	590.81	268	66.67	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			235.5	B08		1	0332-0591	143.19	591.45	241	57.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			582.2	B08		1	0333-0592	225.25	592.21	260	62.53	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			176.7	B08		1	0334-0594	384.87	594.79	297	66.18	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			898.9	B08		1	0335-0597	284.93	597.01	365	71.26	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			246.3	B08		1	0336-0594	674.84	594.10	229	56.53	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			548.0	B08		1	0337-0592	712.12	592.96	178	51.21	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			654.6	B08		1	0338-0605	414.43	604.17	293	66.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1894.1	B08		1	0339-0605	806.30	605.10	223	55.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1768.1	B08		1	0340-0607	592.13	607.88	231	55.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			280.3	B08		1	0341-0609	744.09	608.82	287	62.77	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			268.7	B08		1	0342-0611	273.89	611.90	251	60.77	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			381.2	B08		1	0343-0612	849.76	611.86	288	65.01	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			559.1	B08		1	0344-0613	153.75	612.82	195	55.36	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1005.5	B08		1	0345-0614	302.75	614.32	232	55.70	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			316.5	B08		1	0346-0616	76.07	616.27	260	59.94	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			394.2	B08		1	0347-0618	198.86	617.72	200	57.60	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			457.5	B08		1	0348-0616	901.75	616.17	251	59.94	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			336.3	B08		1	0349-0620	479.57	620.33	262	63.01	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			395.0	B08		1	0350-0619	681.57	619.71	274	61.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			390.6	B08		1	0351-0623	362.48	623.47	330	71.36	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			246.7	B08		1	0352-0630	892.17	629.37	254	61.01	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			219.6	B08		1	0353-0630	162.83	629.67	272	62.53	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1932.6	B08		1	0354-0629	806.37	629.13	187	53.70	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			351.6	B08		1	0355-0635	848.75	635.77	360	72.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			196.9	B08		1	0356-0634	489.75	634.91	317	71.84	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			298.2	B08		1	0357-0634	93.78	634.92	259	59.60	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			385.6	B08		1	0358-0636	243.32	636.51	374	72.67	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			295.1	B08		1	0359-0638	562.17	638.24	302	63.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			253.5	B08		1	0360-0642	508.02	640.75	239	59.60	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			244.4	B08		1	0361-0644	63.05	643.58	112	40.28	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1978.5	B08		1	0362-0644	693.93	644.85	228	56.87	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			219.8	B08		1	0363-0647	734.79	647.28	278	62.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			362.7	B08		1	0364-0650	783.99	651.00	192	58.53	0.704
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			456.9	B08		1	0365-0650	313.67	650.57	254	60.77	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			252.3	B08		1	0366-0649	401.23	648.55	262	61.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			413.3	B08		1	0367-0653	199.09	653.50	315	65.60	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			287.9	B08		1	0368-0653	447.88	652.57	345	68.77	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			218.0	B08		1	0369-0651	74.63	651.70	142	47.11	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			681.4	B08		1	0370-0663	237.20	663.32	593	97.98	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1744.1	B08		1	0371-0654	359.27	653.72	266	61.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			280.8	B08		1	0372-0659	46.25	659.41	273	61.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			577.2	B08		1	0373-0661	180.10	661.22	361	70.43	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			313.6	B08		1	0374-0661	327.81	660.85	284	63.01	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			331.5	B08		1	0375-0662	546.66	662.74	419	79.01	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			265.3	B08		1	0376-0664	121.03	664.38	276	64.18	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			251.7	B08		1	0377-0664	659.96	664.11	233	56.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			181.0	B08		1	0378-0665	939.18	664.58	280	64.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			228.3	B08		1	0379-0673	144.32	672.28	278	65.01	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			451.6	B08		1	0380-0675	705.98	673.83	168	59.94	0.588
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			275.3	B08		1	0381-0680	166.68	679.72	399	75.84	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			836.9	B08		1	0382-0679	285.98	678.49	255	61.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			217.8	B08		1	0383-0685	536.72	684.90	266	62.53	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1078.1	B08		1	0384-0684	365.64	683.42	216	57.36	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3184.9	B08		1	0385-0685	615.32	684.80	227	56.28	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			469.0	B08		1	0386-0686	309.17	686.79	228	56.28	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1486.0	B08		1	0387-0688	428.60	688.45	236	58.53	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			620.6	B08		1	0388-0688	264.40	688.51	320	67.11	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			350.1	B08		1	0389-0693	352.59	693.35	387	80.91	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			893.5	B08		1	0390-0688	916.93	687.99	140	47.11	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			187.0	B08		1	0391-0691	104.52	691.01	261	62.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			198.9	B08		1	0392-0693	133.18	692.16	261	63.70	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			187.0	B08		1	0393-0693	653.79	693.70	266	61.60	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			564.1	B08		1	0394-0693	720.47	693.60	320	65.84	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			228.2	B08		1	0395-0697	50.81	697.15	422	77.26	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			381.5	B08		1	0396-0697	878.17	697.43	330	67.01	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			759.7	B08		1	0397-0697	926.54	697.25	159	47.70	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1152.3	B08		1	0398-0698	944.56	697.57	170	51.11	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			206.6	B08		1	0399-0703	691.43	704.31	281	67.26	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			234.1	B08		1	0400-0706	315.64	706.08	250	63.01	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			205.1	B08		1	0401-0708	492.58	708.06	259	65.01	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1570.5	B08		1	0402-0710	415.79	710.17	212	52.87	0.953
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			308.7	B08		1	0403-0710	233.22	710.48	313	67.11	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1106.1	B08		2	0001-0029	259.68	29.83	527	96.57	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			248.0	B08		2	0002-0033	541.09	33.64	296	71.01	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			7590.3	B08		2	0003-0034	151.54	34.40	223	55.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1042.9	B08		2	0004-0036	220.81	37.59	352	74.67	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			333.7	B08		2	0005-0036	793.54	36.16	268	61.11	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4794.0	B08		2	0006-0036	936.35	36.88	247	59.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			276.1	B08		2	0007-0038	126.12	39.14	253	58.53	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			321.9	B08		2	0008-0039	584.93	39.38	349	71.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4641.3	B08		2	0009-0042	767.09	42.65	281	62.53	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			228.7	B08		2	0010-0042	828.89	42.74	279	65.60	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			415.6	B08		2	0011-0049	53.05	49.74	437	85.26	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			497.2	B08		2	0012-0047	919.83	46.92	347	72.08	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			276.6	B08		2	0013-0046	639.79	45.79	330	68.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			235.1	B08		2	0014-0047	96.27	48.60	394	79.26	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			768.1	B08		2	0015-0048	735.18	48.81	336	69.01	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			6012.2	B08		2	0016-0061	412.86	62.80	586	130.95	0.429
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			383.4	B08		2	0017-0052	199.96	51.48	256	60.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1874.7	B08		2	0018-0058	900.74	58.85	226	57.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			493.8	B08		2	0019-0060	248.56	59.83	237	58.87	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			6925.0	B08		2	0020-0067	388.09	66.98	509	92.33	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			249.2	B08		2	0021-0062	828.67	62.91	291	70.18	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			546.5	B08		2	0022-0068	511.07	68.64	316	64.53	0.954
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			391.4	B08		2	0023-0071	734.71	70.64	328	67.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			367.5	B08		2	0024-0068	932.37	68.17	302	64.53	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			699.3	B08		2	0025-0072	673.71	72.26	200	52.53	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			370.9	B08		2	0026-0078	847.67	78.25	315	66.18	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4040.7	B08		2	0027-0081	341.98	81.08	352	81.84	0.660
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			265.4	B08		2	0028-0086	225.89	85.71	231	56.53	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			204.8	B08		2	0029-0093	68.18	93.30	308	80.08	0.603
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			745.6	B08		2	0030-0090	920.38	89.70	417	77.50	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			359.8	B08		2	0031-0089	162.29	89.72	246	60.43	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			322.4	B08		2	0032-0093	563.27	93.05	241	57.70	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			936.0	B08		2	0033-0096	697.39	95.95	324	66.43	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			275.2	B08		2	0034-0098	37.60	98.62	268	66.18	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			422.6	B08		2	0035-0097	782.11	98.03	395	73.26	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			290.2	B08		2	0036-0095	830.61	94.67	292	64.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2866.4	B08		2	0037-0095	141.99	95.57	298	73.26	0.698
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1171.6	B08		2	0038-0097	604.69	97.28	212	55.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3402.9	B08		2	0039-0102	647.74	101.72	272	61.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			295.6	B08		2	0040-0105	174.15	103.92	313	73.50	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3635.9	B08		2	0041-0104	294.08	103.98	338	70.18	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			286.7	B08		2	0042-0104	885.71	105.02	275	63.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			299.3	B08		2	0043-0114	713.14	113.75	286	61.94	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			397.3	B08		2	0044-0114	828.93	114.14	248	58.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			693.6	B08		2	0045-0119	450.89	118.43	288	67.01	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5010.7	B08		2	0046-0122	931.96	121.35	274	80.57	0.530
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			324.6	B08		2	0047-0123	516.32	123.01	286	63.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			550.1	B08		2	0048-0122	563.25	122.04	263	59.11	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			207.3	B08		2	0049-0128	97.77	128.00	262	60.53	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			958.8	B08		2	0050-0129	42.10	128.79	231	55.36	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			284.0	B08		2	0051-0128	207.62	128.42	259	59.60	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			522.9	B08		2	0052-0133	604.70	133.19	360	70.43	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1203.2	B08		2	0053-0130	759.25	130.71	251	58.18	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			630.3	B08		2	0054-0136	72.94	136.44	208	54.28	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			349.8	B08		2	0055-0137	550.32	136.78	274	61.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			743.1	B08		2	0056-0137	777.44	137.14	222	55.11	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			453.7	B08		2	0057-0137	794.18	136.40	218	53.70	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1166.5	B08		2	0058-0145	727.37	145.32	444	78.18	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			516.7	B08		2	0059-0142	874.27	142.34	224	55.36	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			452.0	B08		2	0060-0144	934.42	143.85	249	58.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			261.5	B08		2	0061-0148	155.76	148.52	292	65.84	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			282.5	B08		2	0062-0149	33.25	149.15	222	54.77	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1946.6	B08		2	0063-0150	106.39	149.81	237	57.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			263.6	B08		2	0064-0155	200.80	155.72	393	73.60	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			846.5	B08		2	0065-0155	471.21	154.30	254	59.01	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			374.7	B08		2	0066-0154	558.32	154.44	292	63.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			343.6	B08		2	0067-0154	254.47	153.92	308	67.36	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			338.2	B08		2	0068-0160	620.04	160.01	404	74.43	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			292.9	B08		2	0069-0164	917.28	164.36	356	70.43	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			753.9	B08		2	0070-0164	175.67	164.23	215	55.36	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1359.6	B08		2	0071-0167	665.68	166.85	405	73.94	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			829.5	B08		2	0072-0167	497.26	168.27	252	60.53	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			457.4	B08		2	0073-0168	67.29	167.45	226	57.70	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			684.7	B08		2	0074-0170	262.45	170.60	324	66.18	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			241.7	B08		2	0075-0172	753.94	172.38	431	78.91	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1524.2	B08		2	0076-0173	146.52	173.59	272	67.01	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			697.8	B08		2	0077-0178	596.57	178.25	306	65.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			695.5	B08		2	0078-0182	240.50	181.00	298	71.26	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1299.8	B08		2	0079-0182	734.11	182.39	234	58.53	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			898.2	B08		2	0080-0185	187.08	185.78	241	57.70	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			201.7	B08		2	0081-0186	122.92	186.07	343	74.67	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			462.5	B08		2	0082-0188	225.70	188.67	261	62.53	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			422.7	B08		2	0083-0191	677.56	192.15	364	71.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			6069.7	B08		2	0084-0189	840.43	189.39	214	53.94	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			482.9	B08		2	0085-0194	563.06	194.27	385	72.18	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			967.4	B08		2	0086-0199	890.42	197.48	769	109.64	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1230.4	B08		2	0087-0193	258.30	193.27	200	52.77	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1109.0	B08		2	0088-0195	501.35	195.42	397	73.84	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			304.0	B08		2	0089-0203	329.23	203.08	327	67.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			246.0	B08		2	0090-0201	414.67	201.15	261	61.11	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			379.2	B08		2	0091-0203	943.10	202.94	298	63.36	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			394.4	B08		2	0092-0208	723.00	207.81	312	66.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			222.7	B08		2	0093-0208	386.86	207.98	248	58.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			645.3	B08		2	0094-0215	917.90	216.26	350	78.43	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			261.9	B08		2	0095-0213	164.52	213.57	360	71.01	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			453.6	B08		2	0096-0210	456.56	209.86	212	53.60	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1028.5	B08		2	0097-0211	269.62	210.63	212	55.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			7025.6	B08		2	0098-0211	832.42	210.58	239	59.70	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			779.0	B08		2	0099-0217	693.56	217.43	398	75.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			223.1	B08		2	0100-0214	756.57	214.54	358	71.01	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			585.9	B08		2	0101-0219	443.84	218.95	289	65.60	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2625.1	B08		2	0102-0222	496.94	222.16	260	62.77	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			250.4	B08		2	0103-0228	869.43	228.89	429	80.91	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2466.0	B08		2	0104-0228	674.85	228.32	255	59.94	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			284.8	B08		2	0105-0234	25.12	233.33	292	68.43	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			731.9	B08		2	0106-0234	179.97	233.59	273	62.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			346.7	B08		2	0107-0231	759.55	230.71	145	45.56	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			370.6	B08		2	0108-0232	746.58	232.09	152	44.63	0.959
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			362.4	B08		2	0109-0240	201.34	240.69	354	69.60	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1567.4	B08		2	0110-0242	934.14	243.11	233	57.70	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			905.2	B08		2	0111-0246	816.39	245.60	275	63.84	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1108.0	B08		2	0112-0247	365.66	247.19	372	74.91	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			268.9	B08		2	0113-0249	780.40	249.74	260	63.01	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			567.9	B08		2	0114-0249	297.44	249.34	298	63.36	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			290.7	B08		2	0115-0256	481.04	256.10	403	83.74	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			345.5	B08		2	0116-0254	250.33	253.89	294	62.18	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			349.8	B08		2	0117-0253	66.16	253.85	295	64.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			711.3	B08		2	0118-0252	126.71	252.34	209	53.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			491.5	B08		2	0119-0259	149.90	258.96	393	73.60	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			848.5	B08		2	0120-0256	537.78	256.26	177	50.28	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1641.9	B08		2	0121-0260	519.45	260.14	348	75.84	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			580.8	B08		2	0122-0259	871.05	259.54	336	67.94	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			345.9	B08		2	0123-0261	412.65	261.32	297	64.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			309.4	B08		2	0124-0260	934.80	260.40	352	73.94	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			263.9	B08		2	0125-0264	282.78	263.77	217	55.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			238.7	B08		2	0126-0264	376.20	263.74	338	74.08	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			728.2	B08		2	0127-0265	343.44	265.30	320	66.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			290.4	B08		2	0128-0269	75.62	269.45	217	57.36	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			486.7	B08		2	0129-0270	241.05	269.89	292	63.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			238.4	B08		2	0130-0273	432.94	273.97	335	74.43	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			233.0	B08		2	0131-0274	761.98	273.08	264	64.53	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3644.5	B08		2	0132-0271	195.98	272.06	227	57.11	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1097.5	B08		2	0133-0274	687.54	274.55	410	79.60	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			566.5	B08		2	0134-0275	830.69	275.44	266	59.94	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			292.9	B08		2	0135-0277	718.89	277.48	276	60.77	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2926.0	B08		2	0136-0281	935.66	281.24	230	56.28	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			218.7	B08		2	0137-0286	67.07	286.17	261	64.18	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			332.7	B08		2	0138-0280	280.48	280.84	127	40.97	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			282.1	B08		2	0139-0289	85.91	287.86	217	55.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			436.6	B08		2	0140-0289	152.32	289.26	336	71.84	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			213.8	B08		2	0141-0293	537.38	292.84	374	74.18	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1180.8	B08		2	0142-0292	678.60	291.79	270	61.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			972.9	B08		2	0143-0296	882.82	296.27	234	59.11	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			322.2	B08		2	0144-0293	280.31	292.82	140	42.63	0.968
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			744.4	B08		2	0145-0298	40.65	298.33	181	49.94	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			356.8	B08		2	0146-0298	168.05	298.25	178	50.04	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			379.5	B08		2	0147-0303	768.05	302.95	314	67.84	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1335.9	B08		2	0148-0306	818.96	306.25	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			233.7	B08		2	0149-0306	550.67	305.06	341	76.67	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2944.6	B08		2	0150-0306	208.60	307.31	266	62.53	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			264.7	B08		2	0151-0311	33.99	311.18	233	60.18	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			283.0	B08		2	0152-0309	289.20	309.28	199	53.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			408.6	B08		2	0153-0312	18.54	312.73	229	55.70	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			266.5	B08		2	0154-0314	258.62	313.18	237	56.77	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			294.6	B08		2	0155-0313	347.76	313.31	209	54.04	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			473.1	B08		2	0156-0312	363.62	311.97	194	53.46	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			429.8	B08		2	0157-0321	490.22	320.56	399	77.84	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			275.4	B08		2	0158-0323	747.11	323.03	315	69.60	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			666.5	B08		2	0159-0324	590.58	323.80	257	62.28	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			394.5	B08		2	0160-0325	105.60	325.09	308	65.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			999.0	B08		2	0161-0327	604.71	327.85	195	52.63	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			480.8	B08		2	0162-0330	370.30	330.08	241	59.36	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			328.5	B08		2	0163-0331	246.12	331.06	328	68.77	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			745.0	B08		2	0164-0335	620.25	335.80	228	57.94	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			500.9	B08		2	0165-0338	914.11	337.65	337	69.26	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			251.7	B08		2	0166-0335	393.51	335.78	105	38.63	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			373.2	B08		2	0167-0337	227.09	336.83	153	45.11	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			269.0	B08		2	0168-0339	382.31	339.19	161	47.46	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			221.9	B08		2	0169-0342	57.86	342.30	285	70.77	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			479.7	B08		2	0170-0343	99.70	343.97	255	59.94	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			229.5	B08		2	0171-0346	464.96	346.86	304	68.77	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			245.5	B08		2	0172-0350	422.90	350.26	367	74.43	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			197.4	B08		2	0173-0355	124.11	355.02	258	62.67	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			282.4	B08		2	0174-0361	929.03	360.97	564	97.98	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1005.4	B08		2	0175-0356	543.50	355.84	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			390.7	B08		2	0176-0356	230.26	356.87	241	58.28	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			426.3	B08		2	0177-0359	656.85	359.38	304	65.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			770.7	B08		2	0178-0360	177.76	360.20	279	62.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1218.1	B08		2	0179-0359	626.60	359.51	217	54.28	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			225.5	B08		2	0180-0362	749.40	362.25	293	65.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1153.3	B08		2	0181-0365	65.16	364.96	220	57.94	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			246.7	B08		2	0182-0361	295.52	360.80	227	58.87	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			360.5	B08		2	0183-0367	321.79	367.32	204	54.53	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			224.6	B08		2	0184-0372	494.01	372.56	361	73.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			332.5	B08		2	0185-0380	438.30	380.98	434	80.33	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			417.6	B08		2	0186-0377	680.65	377.04	328	67.70	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			367.4	B08		2	0187-0378	885.68	377.64	448	79.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			375.2	B08		2	0188-0377	155.27	378.24	193	51.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			641.7	B08		2	0189-0382	203.77	382.92	217	64.08	0.664
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			417.3	B08		2	0190-0383	47.43	383.61	293	65.84	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			217.4	B08		2	0191-0389	360.18	390.60	317	79.84	0.625
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			248.1	B08		2	0192-0383	725.92	383.52	256	62.28	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			379.2	B08		2	0193-0393	183.07	392.87	351	71.84	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			503.2	B08		2	0194-0395	779.94	395.27	248	57.36	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			257.5	B08		2	0195-0398	88.89	398.15	280	63.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1164.2	B08		2	0196-0404	140.56	404.60	305	65.36	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3036.1	B08		2	0197-0408	229.43	408.85	175	51.70	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			221.8	B08		2	0198-0413	464.92	411.27	358	79.84	0.706
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			418.6	B08		2	0199-0413	926.13	412.15	263	61.70	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			8130.1	B08		2	0200-0412	870.18	412.74	200	51.70	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			291.0	B08		2	0201-0419	156.19	419.70	250	65.36	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			312.7	B08		2	0202-0419	668.32	417.98	380	76.67	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			344.8	B08		2	0203-0421	113.25	420.36	310	69.84	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			230.5	B08		2	0204-0421	619.70	420.79	195	53.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			169.4	B08		2	0205-0422	731.26	421.55	354	80.91	0.680
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			717.3	B08		2	0206-0422	58.16	422.39	308	66.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			246.7	B08		2	0207-0424	694.88	425.02	328	69.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2330.4	B08		2	0208-0430	509.50	430.00	397	78.67	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			267.8	B08		2	0209-0430	238.31	430.70	262	64.43	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3620.1	B08		2	0210-0434	99.29	433.29	399	81.74	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			318.8	B08		2	0211-0432	192.14	432.66	306	64.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1832.3	B08		2	0212-0433	630.83	432.85	278	61.60	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			254.1	B08		2	0213-0434	768.89	433.81	220	57.46	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			239.4	B08		2	0214-0435	782.32	434.83	214	54.63	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			460.7	B08		2	0215-0442	809.55	442.16	233	61.11	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1430.6	B08		2	0216-0443	32.31	443.20	349	69.01	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			268.3	B08		2	0217-0446	937.21	447.18	437	81.26	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			774.6	B08		2	0218-0440	881.26	440.24	239	59.11	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			242.0	B08		2	0219-0442	399.14	441.87	294	65.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			417.3	B08		2	0220-0443	117.82	442.56	192	53.11	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			329.0	B08		2	0221-0451	573.60	451.88	375	84.08	0.667
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			202.4	B08		2	0222-0455	172.70	455.66	538	97.15	0.716
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			177.2	B08		2	0223-0447	159.35	447.29	107	39.11	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			248.9	B08		2	0224-0452	504.40	453.06	294	70.43	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			260.2	B08		2	0225-0451	248.87	451.17	219	59.70	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			201.0	B08		2	0226-0460	434.28	461.51	361	74.91	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			221.0	B08		2	0227-0453	465.39	453.60	198	58.63	0.724
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			242.0	B08		2	0228-0457	762.01	457.02	269	63.36	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			236.5	B08		2	0229-0458	127.88	457.68	242	60.18	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			302.0	B08		2	0230-0458	310.68	458.39	250	59.11	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			230.8	B08		2	0231-0464	534.43	464.78	362	73.84	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			378.7	B08		2	0232-0465	15.86	463.09	121	65.11	0.359
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			354.5	B08		2	0233-0469	221.42	470.41	351	69.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			688.8	B08		2	0234-0470	858.17	471.00	295	63.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			476.3	B08		2	0235-0474	776.93	473.51	149	46.87	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			407.8	B08		2	0236-0481	32.34	481.04	295	63.36	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			290.3	B08		2	0237-0480	596.84	479.91	259	59.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			407.7	B08		2	0238-0481	712.94	481.18	237	56.28	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			8328.5	B08		2	0239-0481	811.78	481.81	243	57.36	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2062.6	B08		2	0240-0482	346.62	482.36	157	46.87	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1913.9	B08		2	0241-0485	334.30	485.46	209	58.04	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			220.2	B08		2	0242-0487	401.77	486.60	330	85.98	0.561
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			606.7	B08		2	0243-0484	794.52	484.85	134	44.04	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1075.4	B08		2	0244-0490	268.59	489.77	219	55.70	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1083.8	B08		2	0245-0495	739.34	495.18	514	90.91	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3376.4	B08		2	0246-0489	873.21	488.82	152	47.70	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			318.0	B08		2	0247-0496	912.94	496.14	442	88.57	0.708
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			221.8	B08		2	0248-0498	569.45	497.41	356	72.77	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			278.3	B08		2	0249-0496	153.46	496.54	305	63.36	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			264.1	B08		2	0250-0496	181.71	495.69	317	65.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1021.2	B08		2	0251-0495	689.16	495.01	254	63.36	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2970.2	B08		2	0252-0495	883.61	495.94	150	46.28	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			464.8	B08		2	0253-0508	654.92	508.22	408	73.94	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			233.9	B08		2	0254-0509	417.01	509.34	242	57.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			257.7	B08		2	0255-0512	221.16	512.13	295	65.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			408.3	B08		2	0256-0512	503.00	512.88	347	68.18	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			247.4	B08		2	0257-0517	108.91	517.87	304	71.26	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			662.6	B08		2	0258-0518	598.24	518.38	446	79.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			479.0	B08		2	0259-0519	266.95	518.57	261	62.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1452.0	B08		2	0260-0516	810.10	516.24	257	60.53	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			303.2	B08		2	0261-0516	901.90	515.64	216	56.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			419.2	B08		2	0262-0520	54.58	519.61	347	69.26	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			442.1	B08		2	0263-0517	693.80	518.29	260	60.28	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			204.2	B08		2	0264-0524	26.70	524.17	391	76.77	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			11949.6	B08		2	0265-0524	292.11	523.96	313	66.18	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			201.3	B08		2	0266-0527	129.44	527.45	284	64.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			370.7	B08		2	0267-0528	464.51	528.09	334	68.08	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			764.3	B08		2	0268-0527	331.11	526.84	215	55.94	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			210.6	B08		2	0269-0529	767.18	529.22	288	65.11	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			268.6	B08		2	0270-0535	741.89	534.71	357	70.08	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			205.2	B08		2	0271-0534	170.99	534.05	301	68.77	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			258.1	B08		2	0272-0534	898.09	534.73	223	54.77	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			360.0	B08		2	0273-0537	371.82	537.32	366	71.01	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			234.5	B08		2	0274-0537	692.61	537.02	392	78.18	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			7906.2	B08		2	0275-0539	311.64	538.90	281	63.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			654.7	B08		2	0276-0540	807.08	541.01	261	62.53	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2122.2	B08		2	0277-0547	92.38	547.24	225	55.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			6731.7	B08		2	0278-0551	216.53	551.61	221	54.28	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			504.1	B08		2	0279-0554	258.15	553.87	246	59.11	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			975.5	B08		2	0280-0553	701.75	552.83	276	66.43	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			386.6	B08		2	0281-0560	189.67	560.55	376	75.36	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5502.8	B08		2	0282-0556	419.16	556.52	241	76.67	0.515
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			271.9	B08		2	0283-0557	573.40	556.84	232	56.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			630.9	B08		2	0284-0561	395.29	560.88	517	89.84	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			204.3	B08		2	0285-0557	489.28	557.20	298	73.60	0.691
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			410.3	B08		2	0286-0561	684.81	560.97	284	62.53	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			231.3	B08		2	0287-0563	53.34	564.04	254	64.77	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			317.3	B08		2	0288-0564	34.75	564.91	277	61.11	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			922.1	B08		2	0289-0564	800.42	563.66	262	62.43	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			286.9	B08		2	0290-0565	132.69	565.45	282	60.77	0.960
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			482.9	B08		2	0291-0569	298.45	569.75	305	66.77	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			504.7	B08		2	0292-0566	734.45	566.03	160	46.63	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			405.6	B08		2	0293-0572	546.80	572.13	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			436.4	B08		2	0294-0567	721.99	567.97	117	40.39	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			316.2	B08		2	0295-0569	337.10	569.57	268	62.77	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			536.8	B08		2	0296-0578	823.42	578.32	245	60.18	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			517.2	B08		2	0297-0576	861.26	576.46	224	58.77	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			270.7	B08		2	0298-0582	740.73	581.99	369	77.26	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1195.6	B08		2	0299-0583	563.98	583.98	248	59.46	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			203.8	B08		2	0300-0586	173.73	586.22	307	65.36	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			260.6	B08		2	0301-0583	658.97	583.84	245	57.11	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1193.3	B08		2	0302-0585	793.90	585.11	248	58.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4677.4	B08		2	0303-0590	227.90	590.27	281	63.11	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			540.9	B08		2	0304-0591	99.57	591.34	294	62.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			453.9	B08		2	0305-0593	505.03	593.37	339	69.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1304.9	B08		2	0306-0592	593.21	591.77	223	56.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			211.9	B08		2	0307-0597	133.78	597.69	338	71.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			294.3	B08		2	0308-0597	75.00	597.76	377	73.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			374.2	B08		2	0309-0598	764.49	598.03	268	61.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			229.5	B08		2	0310-0602	262.69	602.14	245	58.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			250.4	B08		2	0311-0603	370.78	603.27	328	68.53	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			569.0	B08		2	0312-0610	883.28	609.88	539	91.15	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			353.9	B08		2	0313-0609	585.95	609.56	224	57.01	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			306.1	B08		2	0314-0613	841.15	613.76	411	79.26	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			269.0	B08		2	0315-0612	936.63	612.62	227	55.94	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			187.2	B08		2	0316-0617	288.69	617.92	377	74.77	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			199.1	B08		2	0317-0614	609.59	615.13	257	63.60	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			573.8	B08		2	0318-0620	799.21	619.85	258	64.28	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			197.3	B08		2	0319-0620	96.60	619.31	283	61.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			244.8	B08		2	0320-0622	162.75	622.53	248	60.28	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1034.8	B08		2	0321-0633	664.99	632.93	460	84.43	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			457.2	B08		2	0322-0636	342.57	636.72	552	91.50	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			372.1	B08		2	0323-0632	681.91	632.43	285	65.94	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			777.2	B08		2	0324-0636	909.48	635.73	392	75.84	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2024.2	B08		2	0325-0637	212.47	637.09	316	74.08	0.724
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			780.2	B08		2	0326-0639	419.96	639.41	505	90.57	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			629.3	B08		2	0327-0635	300.04	635.24	160	46.87	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			558.0	B08		2	0328-0634	311.80	633.78	111	39.56	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			525.3	B08		2	0329-0639	774.09	638.73	357	70.43	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			214.9	B08		2	0330-0640	47.64	639.90	268	61.01	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			468.4	B08		2	0331-0644	575.29	645.64	468	86.33	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			323.9	B08		2	0332-0637	497.09	637.30	111	40.04	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			369.0	B08		2	0333-0645	364.75	645.34	289	61.94	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			329.3	B08		2	0334-0652	503.38	652.97	353	73.01	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1629.9	B08		2	0335-0651	433.80	651.83	219	56.77	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			667.0	B08		2	0336-0656	474.14	655.54	417	82.91	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2453.1	B08		2	0337-0653	132.62	653.87	156	47.21	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5411.1	B08		2	0338-0660	148.53	660.75	228	58.53	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			304.2	B08		2	0339-0665	873.42	665.35	320	67.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			578.3	B08		2	0340-0664	794.21	664.84	230	54.77	0.964
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1042.8	B08		2	0341-0664	345.09	664.25	223	59.70	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			191.1	B08		2	0342-0668	31.79	668.05	280	65.60	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2564.6	B08		2	0343-0666	133.65	665.65	163	48.04	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1074.0	B08		2	0344-0673	488.29	673.97	375	76.77	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			978.1	B08		2	0345-0677	471.11	677.26	388	79.26	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			316.8	B08		2	0346-0674	676.26	675.27	352	69.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			213.4	B08		2	0347-0682	833.49	682.02	319	71.60	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			207.9	B08		2	0348-0681	177.91	682.12	282	64.43	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			171.7	B08		2	0349-0684	536.57	684.33	210	54.28	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			554.4	B08		2	0350-0684	270.18	683.97	243	59.11	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			893.1	B08		2	0351-0692	297.50	692.96	233	58.53	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1228.5	B08		2	0352-0688	897.09	688.15	191	53.94	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2635.2	B08		2	0353-0692	388.37	692.13	236	57.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			305.5	B08		2	0354-0695	559.28	695.50	349	71.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1108.8	B08		2	0355-0695	83.03	695.50	268	60.53	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			251.9	B08		2	0356-0697	649.23	697.13	455	80.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			286.2	B08		2	0357-0696	766.83	695.63	319	67.01	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			798.6	B08		2	0358-0700	19.22	700.80	156	47.46	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1542.6	B08		2	0359-0704	105.76	704.14	283	68.08	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			909.7	B08		2	0360-0701	846.09	700.80	249	58.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			284.3	B08		2	0361-0702	620.75	701.43	199	53.11	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1225.5	B08		2	0362-0702	37.15	701.76	192	53.11	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			250.3	B08		2	0363-0704	937.46	703.67	299	63.84	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1664.0	B08		2	0364-0708	355.31	708.03	272	62.53	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			876.1	B08		2	0365-0708	207.17	708.01	325	66.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4668.5	B08		2	0366-0708	440.81	708.12	253	58.77	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			8286.6	B08		2	0367-0710	121.34	709.93	207	56.53	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3553.0	B08		3	0001-0032	174.22	32.04	249	67.01	0.697
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			219.3	B08		3	0002-0031	771.20	30.98	281	63.11	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2891.7	B08		3	0003-0035	76.25	35.00	272	62.53	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			356.8	B08		3	0004-0037	608.80	37.00	478	85.15	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			544.9	B08		3	0005-0036	648.22	35.64	324	66.18	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			313.0	B08		3	0006-0041	489.76	40.64	488	83.98	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5188.9	B08		3	0007-0040	30.61	40.30	250	60.18	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			474.0	B08		3	0008-0043	704.69	44.35	231	60.87	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2126.8	B08		3	0009-0047	530.33	47.51	250	59.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			230.6	B08		3	0010-0054	456.56	54.71	277	61.36	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			440.1	B08		3	0011-0058	476.96	59.41	445	79.50	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			565.2	B08		3	0012-0058	93.16	59.16	330	67.36	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			249.6	B08		3	0013-0055	207.76	54.54	245	60.77	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			536.1	B08		3	0014-0057	753.82	57.12	256	65.70	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			461.5	B08		3	0015-0060	911.18	59.84	358	69.01	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			241.2	B08		3	0016-0062	426.79	61.94	262	59.84	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			212.1	B08		3	0017-0064	817.54	63.85	291	69.60	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			881.1	B08		3	0018-0062	151.02	62.27	218	57.36	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			276.0	B08		3	0019-0063	563.29	63.40	270	65.01	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			401.9	B08		3	0020-0064	397.98	64.32	303	69.70	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			305.7	B08		3	0021-0069	373.29	69.18	358	74.43	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			261.8	B08		3	0022-0070	444.27	70.30	315	71.01	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			246.3	B08		3	0023-0071	685.11	71.36	324	67.36	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			392.6	B08		3	0024-0071	26.79	71.61	292	63.94	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			379.8	B08		3	0025-0078	63.72	77.41	368	76.08	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			387.9	B08		3	0026-0077	152.86	78.01	324	68.18	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			688.2	B08		3	0027-0076	180.82	77.29	251	61.01	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			394.6	B08		3	0028-0084	869.55	83.92	383	84.18	0.679
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1471.4	B08		3	0029-0081	349.15	80.59	353	70.18	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			984.2	B08		3	0030-0079	97.96	78.72	198	53.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			216.0	B08		3	0031-0081	595.59	80.53	323	70.18	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			10413.7	B08		3	0032-0080	291.88	80.04	261	59.60	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2604.5	B08		3	0033-0079	750.97	79.77	269	64.43	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3064.7	B08		3	0034-0082	330.41	82.15	181	54.63	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			584.5	B08		3	0035-0087	940.87	86.52	272	61.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			300.8	B08		3	0036-0088	373.60	88.65	217	53.36	0.958
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			941.9	B08		3	0037-0092	638.43	92.74	241	59.60	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			549.9	B08		3	0038-0091	398.46	91.50	215	55.36	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			229.4	B08		3	0039-0093	565.31	92.96	263	62.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			370.8	B08		3	0040-0098	497.76	98.43	517	84.08	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			408.9	B08		3	0041-0094	191.15	94.77	294	63.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			273.9	B08		3	0042-0099	838.70	99.71	305	67.36	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1333.7	B08		3	0043-0098	448.56	98.24	272	63.01	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2026.0	B08		3	0044-0099	241.85	98.73	246	58.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			198.8	B08		3	0045-0103	791.31	103.40	351	70.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			361.1	B08		3	0046-0107	332.07	106.69	355	72.18	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4124.3	B08		3	0047-0105	545.14	104.91	297	63.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			635.5	B08		3	0048-0109	816.08	108.63	189	55.36	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			447.5	B08		3	0049-0110	101.79	110.50	272	61.60	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			429.2	B08		3	0050-0111	216.70	110.96	304	65.01	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1962.1	B08		3	0051-0111	413.08	111.64	277	62.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			982.5	B08		3	0052-0114	920.64	114.63	335	66.77	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			528.2	B08		3	0053-0117	699.14	116.59	301	64.18	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			356.0	B08		3	0054-0123	493.78	122.81	262	60.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5365.1	B08		3	0055-0125	27.26	124.27	249	74.91	0.558
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1577.8	B08		3	0056-0124	546.77	125.24	276	65.01	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1924.8	B08		3	0057-0125	448.58	125.20	208	55.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			13100.7	B08		3	0058-0133	739.38	133.47	362	84.67	0.635
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			255.2	B08		3	0059-0131	145.90	131.35	332	68.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			852.1	B08		3	0060-0134	207.45	132.73	501	95.74	0.687
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			344.7	B08		3	0061-0135	350.90	134.26	255	58.77	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			340.1	B08		3	0062-0136	872.25	136.23	326	66.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			317.3	B08		3	0063-0136	625.52	136.69	299	63.11	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			947.5	B08		3	0064-0147	169.60	147.13	413	77.50	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			406.4	B08		3	0065-0144	487.88	143.45	271	61.60	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			542.9	B08		3	0066-0143	536.82	142.94	241	59.36	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			601.4	B08		3	0067-0146	275.38	145.38	227	58.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			470.3	B08		3	0068-0147	28.95	147.38	243	58.18	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			599.7	B08		3	0069-0153	309.34	153.10	345	69.84	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			668.6	B08		3	0070-0156	204.86	155.46	204	92.81	0.298
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			814.2	B08		3	0071-0156	387.05	156.20	257	60.53	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			659.0	B08		3	0072-0155	469.56	155.29	230	58.77	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			325.1	B08		3	0073-0154	646.67	152.89	117	43.11	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1958.6	B08		3	0074-0160	722.52	160.55	319	75.50	0.703
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			359.8	B08		3	0075-0159	637.21	159.56	218	57.60	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			549.2	B08		3	0076-0159	779.82	159.08	225	56.28	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			259.1	B08		3	0077-0162	914.86	162.86	346	71.84	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			373.5	B08		3	0078-0167	815.28	167.59	368	75.60	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			308.5	B08		3	0079-0169	271.03	171.52	394	86.33	0.664
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			280.0	B08		3	0080-0168	751.03	167.95	468	85.15	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1200.3	B08		3	0081-0169	186.94	169.00	201	54.53	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			333.2	B08		3	0082-0167	695.55	166.22	183	51.94	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			930.8	B08		3	0083-0170	509.31	169.78	270	61.94	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1290.3	B08		3	0084-0175	838.62	175.55	367	82.08	0.684
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1433.4	B08		3	0085-0171	483.51	171.08	214	55.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			388.7	B08		3	0086-0172	684.74	173.33	136	44.53	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			742.4	B08		3	0087-0178	314.28	178.44	403	76.33	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1813.1	B08		3	0088-0177	66.17	177.18	206	53.70	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			291.7	B08		3	0089-0177	102.73	176.82	203	53.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			964.2	B08		3	0090-0179	253.70	178.90	239	63.60	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			440.2	B08		3	0091-0179	554.12	179.02	349	69.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			437.0	B08		3	0092-0179	444.19	179.66	221	53.11	0.984
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1538.3	B08		3	0093-0183	621.51	182.60	365	70.18	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			705.3	B08		3	0094-0185	210.48	185.09	250	60.18	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			220.3	B08		3	0095-0190	876.28	190.12	404	75.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			449.9	B08		3	0096-0188	297.16	188.57	244	58.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			484.1	B08		3	0097-0188	370.51	188.18	292	67.60	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2109.3	B08		3	0098-0188	48.45	188.21	160	46.87	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			328.6	B08		3	0099-0191	339.92	191.37	276	61.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			468.9	B08		3	0100-0196	594.81	196.46	314	68.18	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			312.7	B08		3	0101-0199	914.47	198.34	298	66.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			420.2	B08		3	0102-0199	146.75	199.92	273	65.84	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			263.4	B08		3	0103-0202	173.10	202.21	303	65.84	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			385.4	B08		3	0104-0201	280.82	200.74	205	55.11	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			353.0	B08		3	0105-0203	402.51	203.32	287	61.94	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			918.9	B08		3	0106-0203	628.31	203.10	297	63.01	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1512.7	B08		3	0107-0204	366.33	204.23	184	51.11	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			373.5	B08		3	0108-0207	37.62	206.55	290	63.70	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			610.3	B08		3	0109-0207	893.74	207.76	249	60.43	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			295.1	B08		3	0110-0207	239.23	207.31	240	58.77	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			213.0	B08		3	0111-0208	948.07	208.67	267	60.43	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			505.9	B08		3	0112-0208	75.39	208.20	233	55.94	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			10071.4	B08		3	0113-0209	551.99	209.65	257	59.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2182.7	B08		3	0114-0215	332.77	214.78	256	62.18	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			602.7	B08		3	0115-0220	115.19	220.15	386	74.43	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			529.6	B08		3	0116-0222	660.54	222.51	396	76.43	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			216.7	B08		3	0117-0219	850.80	219.39	168	53.36	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1090.9	B08		3	0118-0219	712.14	219.64	223	54.28	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			250.4	B08		3	0119-0221	286.32	222.07	258	61.01	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			388.8	B08		3	0120-0221	794.26	222.20	231	66.43	0.658
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1630.3	B08		3	0121-0224	354.14	224.73	337	69.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1730.3	B08		3	0122-0224	369.58	223.65	158	48.87	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			316.7	B08		3	0123-0227	613.88	227.23	233	58.28	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			354.1	B08		3	0124-0231	675.39	231.75	274	66.77	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1191.2	B08		3	0125-0237	219.89	236.54	310	68.18	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			434.2	B08		3	0126-0234	892.81	234.08	245	57.94	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			348.7	B08		3	0127-0238	828.42	238.70	314	66.18	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			732.5	B08		3	0128-0240	750.33	241.09	427	77.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			234.8	B08		3	0129-0243	411.02	244.58	306	68.18	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			298.0	B08		3	0130-0240	546.09	240.52	318	66.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			792.1	B08		3	0131-0244	566.82	244.27	300	64.18	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			359.4	B08		3	0132-0242	609.87	242.66	240	57.11	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			874.8	B08		3	0133-0246	923.15	246.57	256	64.18	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1583.6	B08		3	0134-0246	28.55	246.73	236	58.04	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			306.3	B08		3	0135-0247	204.55	247.05	275	63.94	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			265.0	B08		3	0136-0246	363.41	246.31	316	80.08	0.619
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			861.0	B08		3	0137-0249	494.35	248.84	250	59.26	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			235.0	B08		3	0138-0250	706.94	250.18	191	58.77	0.695
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			927.9	B08		3	0139-0256	100.15	256.98	240	66.53	0.681
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1429.4	B08		3	0140-0254	524.48	253.29	231	58.77	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			202.3	B08		3	0141-0252	723.12	252.69	191	51.11	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			265.5	B08		3	0142-0256	140.11	256.38	229	57.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			255.4	B08		3	0143-0257	158.04	257.32	212	57.36	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			854.9	B08		3	0144-0254	74.64	253.97	230	58.28	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			250.2	B08		3	0145-0256	307.56	255.86	206	54.28	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			234.9	B08		3	0146-0258	260.05	258.96	250	60.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			763.8	B08		3	0147-0265	589.80	263.58	278	65.94	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			278.0	B08		3	0148-0264	29.42	263.98	343	71.94	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1025.3	B08		3	0149-0269	464.95	269.24	284	64.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1831.9	B08		3	0150-0269	534.17	268.97	227	55.94	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			429.6	B08		3	0151-0271	775.21	271.35	302	65.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			682.2	B08		3	0152-0270	794.95	271.04	250	58.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4991.9	B08		3	0153-0275	631.78	274.75	307	69.60	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			267.2	B08		3	0154-0278	240.09	278.70	298	65.01	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			726.0	B08		3	0155-0278	841.64	278.32	175	52.18	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			998.5	B08		3	0156-0281	88.55	280.69	227	57.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			358.6	B08		3	0157-0279	735.63	279.66	312	67.01	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			11249.8	B08		3	0158-0283	395.38	282.92	275	65.01	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			223.9	B08		3	0159-0286	274.36	287.66	322	67.60	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3069.2	B08		3	0160-0284	30.22	284.54	225	56.53	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			314.5	B08		3	0161-0286	122.17	287.01	279	63.60	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1521.9	B08		3	0162-0291	459.86	291.26	412	79.26	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			493.7	B08		3	0163-0287	941.61	287.60	362	71.60	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1801.5	B08		3	0164-0287	359.90	286.65	248	65.26	0.732
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2104.7	B08		3	0165-0289	160.78	289.29	255	58.53	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2605.1	B08		3	0166-0289	181.17	289.44	248	59.36	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			313.7	B08		3	0167-0292	833.48	292.34	404	76.67	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1599.3	B08		3	0168-0290	660.97	290.34	213	55.11	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			903.1	B08		3	0169-0292	813.19	291.83	258	64.18	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			348.5	B08		3	0170-0296	420.18	296.51	238	58.28	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			943.8	B08		3	0171-0295	676.56	294.96	235	58.28	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			292.3	B08		3	0172-0301	925.83	300.69	304	66.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			441.3	B08		3	0173-0301	883.05	301.44	343	68.43	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			706.1	B08		3	0174-0301	219.00	301.60	201	56.18	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			480.9	B08		3	0175-0309	106.17	309.78	331	67.84	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			252.6	B08		3	0176-0311	136.06	311.08	235	57.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3200.4	B08		3	0177-0315	459.87	315.36	306	67.84	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			701.3	B08		3	0178-0315	584.40	314.75	368	70.53	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			749.0	B08		3	0179-0316	734.41	316.36	369	73.84	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			7241.5	B08		3	0180-0316	187.10	316.32	224	54.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			597.7	B08		3	0181-0318	254.15	318.24	231	57.94	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			239.8	B08		3	0182-0318	651.34	318.24	294	63.94	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			274.8	B08		3	0183-0323	410.89	322.62	364	73.84	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			773.1	B08		3	0184-0329	875.26	329.64	266	60.18	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2323.9	B08		3	0185-0328	286.92	328.69	215	53.70	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2251.1	B08		3	0186-0335	804.34	336.40	317	70.67	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			395.5	B08		3	0187-0334	360.46	334.07	193	51.11	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			276.1	B08		3	0188-0335	387.43	335.21	269	61.36	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3942.3	B08		3	0189-0335	536.82	335.92	294	64.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			335.2	B08		3	0190-0335	204.81	335.14	228	55.11	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			748.0	B08		3	0191-0338	650.73	337.72	323	67.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			289.3	B08		3	0192-0339	346.72	339.63	174	52.28	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			416.2	B08		3	0193-0341	725.24	341.64	215	54.28	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			558.0	B08		3	0194-0346	243.63	345.99	277	63.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			265.3	B08		3	0195-0345	317.67	345.39	210	58.77	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			291.2	B08		3	0196-0343	107.28	343.76	273	64.18	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			621.1	B08		3	0197-0344	608.80	343.82	285	64.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			628.5	B08		3	0198-0353	291.95	352.69	379	72.43	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			396.6	B08		3	0199-0354	331.61	354.07	229	56.87	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			274.9	B08		3	0200-0355	425.40	355.58	273	62.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			364.1	B08		3	0201-0355	828.37	355.45	372	72.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			436.6	B08		3	0202-0356	19.52	356.46	186	52.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			661.3	B08		3	0203-0358	179.96	357.71	224	55.70	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			881.8	B08		3	0204-0356	347.30	355.98	226	56.87	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			320.8	B08		3	0205-0356	452.60	356.90	253	59.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			547.2	B08		3	0206-0359	402.75	359.21	322	65.94	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1859.2	B08		3	0207-0355	684.95	355.37	203	55.70	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2167.3	B08		3	0208-0357	483.80	358.09	169	51.11	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1218.1	B08		3	0209-0358	112.39	358.32	148	45.46	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			719.0	B08		3	0210-0367	589.51	368.23	600	167.82	0.268
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			451.2	B08		3	0211-0365	513.79	364.74	343	70.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5103.9	B08		3	0212-0362	928.13	361.92	149	49.70	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			472.7	B08		3	0213-0365	165.18	365.39	230	59.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			206.5	B08		3	0214-0369	26.07	370.68	286	71.01	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			457.3	B08		3	0215-0367	315.45	367.37	307	66.43	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1161.5	B08		3	0216-0367	651.27	367.38	319	68.18	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			521.8	B08		3	0217-0371	910.25	370.76	309	70.43	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			479.0	B08		3	0218-0371	875.06	370.77	305	66.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			234.1	B08		3	0219-0371	374.83	371.79	255	60.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			562.2	B08		3	0220-0374	263.29	374.75	348	71.26	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			12220.3	B08		3	0221-0377	712.73	377.14	273	63.36	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1222.3	B08		3	0222-0379	762.43	379.09	281	65.01	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			364.7	B08		3	0223-0379	841.85	379.72	226	58.77	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			292.8	B08		3	0224-0379	147.84	379.00	276	64.77	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			189.9	B08		3	0225-0383	54.65	383.69	298	68.18	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			379.4	B08		3	0226-0382	546.20	382.45	304	65.36	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			466.3	B08		3	0227-0383	352.41	382.21	226	57.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			486.0	B08		3	0228-0382	503.03	382.35	258	60.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			258.0	B08		3	0229-0382	89.21	382.66	219	53.70	0.954
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			641.9	B08		3	0230-0384	103.89	384.05	200	57.11	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			448.5	B08		3	0231-0384	685.58	384.47	259	60.28	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			301.3	B08		3	0232-0389	133.82	389.88	204	54.18	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			254.6	B08		3	0233-0392	335.87	392.05	229	61.11	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			291.4	B08		3	0234-0397	943.98	397.69	349	70.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3120.2	B08		3	0235-0396	248.74	396.06	266	64.77	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			256.8	B08		3	0236-0399	358.81	399.31	264	63.01	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			215.6	B08		3	0237-0396	400.64	395.69	284	70.77	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			423.6	B08		3	0238-0401	869.31	401.46	353	70.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5589.9	B08		3	0239-0399	477.95	398.80	152	47.46	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1554.7	B08		3	0240-0400	688.60	398.59	162	49.70	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			210.4	B08		3	0241-0409	450.59	409.76	472	81.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1149.9	B08		3	0242-0406	677.98	406.95	201	54.43	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			177.6	B08		3	0243-0410	59.30	410.76	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			259.1	B08		3	0244-0410	326.43	410.31	290	64.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			495.2	B08		3	0245-0411	187.48	411.62	229	59.01	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1670.0	B08		3	0246-0411	814.94	410.92	258	64.18	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1002.8	B08		3	0247-0413	918.78	412.65	255	61.01	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			388.1	B08		3	0248-0420	645.90	419.43	683	107.30	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			224.0	B08		3	0249-0418	594.22	418.68	419	80.33	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			903.4	B08		3	0250-0418	709.45	418.12	500	89.98	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			426.5	B08		3	0251-0416	20.37	415.64	244	59.36	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			6916.2	B08		3	0252-0418	237.53	417.22	230	59.01	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			237.3	B08		3	0253-0418	369.35	417.47	296	64.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			748.0	B08		3	0254-0418	210.59	417.84	204	54.77	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			230.4	B08		3	0255-0419	164.81	418.96	326	69.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			404.8	B08		3	0256-0421	283.97	421.68	294	63.01	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			203.8	B08		3	0257-0425	308.25	424.38	257	60.53	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1704.2	B08		3	0258-0428	786.09	428.42	228	56.77	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			404.9	B08		3	0259-0425	862.34	425.22	116	41.21	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1237.1	B08		3	0260-0432	503.87	432.37	225	59.60	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			257.0	B08		3	0261-0435	408.07	435.04	291	69.60	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			425.4	B08		3	0262-0437	862.54	437.07	128	41.80	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			247.6	B08		3	0263-0442	807.62	442.76	329	75.26	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			194.6	B08		3	0264-0443	888.83	442.33	332	69.26	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			488.0	B08		3	0265-0443	531.39	443.83	328	67.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			263.0	B08		3	0266-0450	31.80	450.55	432	79.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			430.0	B08		3	0267-0449	933.81	450.02	256	61.11	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1987.9	B08		3	0268-0451	72.30	451.27	263	62.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			8607.4	B08		3	0269-0453	371.01	453.85	319	68.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			288.5	B08		3	0270-0451	699.44	451.53	254	59.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			188.3	B08		3	0271-0455	185.28	455.49	283	65.01	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			704.3	B08		3	0272-0453	247.81	453.68	216	55.11	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			196.4	B08		3	0273-0455	748.33	454.75	174	50.63	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			163.2	B08		3	0274-0454	759.92	453.92	166	49.80	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3287.7	B08		3	0275-0454	508.66	454.74	219	59.36	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1348.1	B08		3	0276-0459	681.14	458.94	406	74.67	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4345.0	B08		3	0277-0458	140.86	458.00	306	64.77	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			317.2	B08		3	0278-0458	447.06	457.61	270	62.18	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3764.6	B08		3	0279-0458	311.78	458.48	236	58.18	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			300.1	B08		3	0280-0461	92.82	461.21	289	63.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			470.0	B08		3	0281-0466	276.12	465.89	268	62.77	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			802.5	B08		3	0282-0466	422.12	466.59	247	57.94	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3797.6	B08		3	0283-0469	324.75	469.28	258	60.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			359.8	B08		3	0284-0469	295.54	469.85	274	61.94	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			250.3	B08		3	0285-0473	383.72	473.38	260	61.01	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			492.0	B08		3	0286-0472	836.60	472.36	236	57.11	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			244.5	B08		3	0287-0476	177.39	476.77	357	72.33	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			257.2	B08		3	0288-0474	697.65	474.06	246	57.94	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			720.6	B08		3	0289-0476	722.76	476.66	332	68.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			236.5	B08		3	0290-0475	259.18	475.33	251	59.70	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1105.8	B08		3	0291-0478	204.42	479.05	212	56.77	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			261.2	B08		3	0292-0480	771.22	479.94	365	75.01	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			375.7	B08		3	0293-0480	363.30	480.13	231	56.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3860.1	B08		3	0294-0480	560.68	479.96	209	59.46	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			374.3	B08		3	0295-0484	501.01	484.07	285	62.53	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1964.9	B08		3	0296-0487	51.52	486.82	251	61.70	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			402.0	B08		3	0297-0486	616.39	487.05	226	56.53	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			352.6	B08		3	0298-0487	342.67	487.35	238	57.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1175.5	B08		3	0299-0488	826.68	488.29	293	62.77	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			277.9	B08		3	0300-0490	596.29	489.20	265	63.60	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			455.4	B08		3	0301-0495	558.65	494.36	331	69.94	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2730.6	B08		3	0302-0502	582.49	500.85	221	60.77	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			186.0	B08		3	0303-0500	808.99	500.75	139	45.70	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			250.1	B08		3	0304-0506	271.95	507.29	292	65.36	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			610.0	B08		3	0305-0506	197.87	506.15	325	67.94	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			404.2	B08		3	0306-0504	326.24	504.30	201	54.53	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			330.3	B08		3	0307-0506	749.41	506.57	218	54.87	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			496.6	B08		3	0308-0512	233.99	511.86	404	77.84	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1565.4	B08		3	0309-0508	309.33	507.70	254	59.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			982.8	B08		3	0310-0512	409.95	512.07	328	68.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			314.4	B08		3	0311-0512	920.21	511.04	368	74.43	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			178.0	B08		3	0312-0511	945.71	510.79	299	69.01	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1263.1	B08		3	0313-0513	162.91	512.93	234	55.70	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			300.7	B08		3	0314-0519	641.88	518.69	471	82.08	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			272.3	B08		3	0315-0518	433.87	518.13	300	65.60	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			203.7	B08		3	0316-0515	807.92	515.37	204	53.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			226.4	B08		3	0317-0516	879.29	515.82	275	62.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			458.7	B08		3	0318-0520	468.34	519.83	387	74.18	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			216.8	B08		3	0319-0525	92.32	525.27	242	61.94	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			552.0	B08		3	0320-0528	892.42	527.57	242	59.94	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			555.9	B08		3	0321-0534	563.20	534.52	290	64.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			300.6	B08		3	0322-0538	930.82	537.99	358	70.43	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			187.3	B08		3	0323-0544	338.86	544.18	447	80.08	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			304.2	B08		3	0324-0543	615.93	543.94	313	68.87	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			588.0	B08		3	0325-0545	291.44	545.26	385	74.91	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			501.9	B08		3	0326-0543	687.91	543.10	258	62.43	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			339.9	B08		3	0327-0542	802.99	542.92	224	57.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			250.6	B08		3	0328-0547	65.80	547.79	283	70.53	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			667.4	B08		3	0329-0545	519.42	545.54	393	73.26	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			253.1	B08		3	0330-0548	752.79	547.78	327	67.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			361.9	B08		3	0331-0547	817.45	547.43	200	54.28	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			229.9	B08		3	0332-0555	168.11	555.12	253	58.53	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			859.1	B08		3	0333-0554	206.92	554.21	165	48.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3790.9	B08		3	0334-0557	241.60	557.24	219	55.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2096.6	B08		3	0335-0558	680.32	558.84	172	50.04	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2304.4	B08		3	0336-0560	260.65	560.75	258	60.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2443.9	B08		3	0337-0560	437.42	560.49	282	66.18	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			237.2	B08		3	0338-0561	383.72	561.24	199	52.28	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1477.0	B08		3	0339-0564	908.31	563.81	257	60.77	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			254.6	B08		3	0340-0563	362.71	562.57	209	53.11	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			325.8	B08		3	0341-0565	113.81	566.31	220	55.70	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3933.4	B08		3	0342-0563	560.33	563.84	161	49.21	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			768.0	B08		3	0343-0574	707.12	574.45	382	76.18	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1404.7	B08		3	0344-0567	729.32	567.42	211	56.87	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2381.9	B08		3	0345-0577	307.82	577.16	266	66.18	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			256.9	B08		3	0346-0574	484.36	573.74	284	64.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			715.4	B08		3	0347-0578	839.35	579.04	248	60.53	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3303.8	B08		3	0348-0574	557.43	574.80	134	51.70	0.630
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			291.7	B08		3	0349-0579	81.38	579.01	225	56.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			400.7	B08		3	0350-0583	166.37	583.62	332	67.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			333.1	B08		3	0351-0583	187.26	583.22	278	61.46	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			237.7	B08		3	0352-0587	388.61	587.01	346	70.91	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			302.3	B08		3	0353-0587	584.27	587.10	318	81.50	0.602
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			671.1	B08		3	0354-0584	877.49	584.68	133	42.87	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			250.4	B08		3	0355-0588	898.46	588.43	311	67.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			239.3	B08		3	0356-0589	350.30	589.33	209	55.94	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			676.0	B08		3	0357-0588	862.60	588.17	134	44.28	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			262.7	B08		3	0358-0597	844.23	597.76	370	74.67	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			296.7	B08		3	0359-0594	253.57	593.03	169	49.36	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			257.1	B08		3	0360-0595	633.32	595.37	269	61.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			209.8	B08		3	0361-0598	524.68	598.04	293	62.77	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			214.7	B08		3	0362-0599	764.00	599.49	279	73.50	0.649
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			421.2	B08		3	0363-0604	126.58	605.15	339	68.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			303.2	B08		3	0364-0601	263.36	601.01	180	52.77	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			457.4	B08		3	0365-0605	322.60	606.03	261	62.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			423.4	B08		3	0366-0602	426.77	602.43	267	62.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			480.0	B08		3	0367-0605	554.18	605.19	350	68.18	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2537.9	B08		3	0368-0603	687.74	604.19	132	42.39	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			277.4	B08		3	0369-0607	616.33	606.87	234	59.84	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			288.7	B08		3	0370-0609	487.93	608.84	297	66.43	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			590.1	B08		3	0371-0608	936.57	607.73	257	64.77	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			379.5	B08		3	0372-0614	411.37	614.44	324	66.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			346.6	B08		3	0373-0613	439.78	613.99	280	63.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3207.3	B08		3	0374-0611	721.30	611.18	193	58.77	0.702
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			234.0	B08		3	0375-0615	30.94	616.00	225	55.36	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5710.6	B08		3	0376-0618	339.28	617.59	279	61.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			286.2	B08		3	0377-0620	63.06	620.52	228	58.53	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1406.5	B08		3	0378-0621	692.34	620.81	285	66.53	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			337.7	B08		3	0379-0621	883.29	620.36	279	63.11	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			263.0	B08		3	0380-0623	179.48	623.20	323	67.01	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			252.8	B08		3	0381-0621	232.61	622.39	272	61.11	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			243.6	B08		3	0382-0622	299.86	622.00	314	67.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			404.6	B08		3	0383-0621	263.45	621.84	183	52.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			406.4	B08		3	0384-0624	603.64	624.42	363	71.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2429.8	B08		3	0385-0625	751.75	625.19	266	63.11	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			585.5	B08		3	0386-0628	812.46	628.17	378	73.01	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			604.6	B08		3	0387-0628	276.37	628.67	229	57.70	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1655.8	B08		3	0388-0628	556.75	628.93	195	53.46	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1088.3	B08		3	0389-0637	876.35	637.96	295	68.43	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			289.5	B08		3	0390-0637	771.26	636.84	209	55.70	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			229.3	B08		3	0391-0639	114.14	640.11	204	52.87	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			312.4	B08		3	0392-0642	350.54	642.19	281	64.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			252.3	B08		3	0393-0640	514.81	640.74	269	61.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			282.9	B08		3	0394-0643	895.73	643.48	375	73.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			488.5	B08		3	0395-0642	204.93	642.22	248	60.18	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			533.9	B08		3	0396-0640	164.94	640.47	181	51.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1938.1	B08		3	0397-0642	556.40	641.47	162	48.63	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			323.7	B08		3	0398-0648	659.03	648.60	327	66.18	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			943.3	B08		3	0399-0653	247.53	653.51	371	75.01	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			197.8	B08		3	0400-0654	388.11	654.36	401	76.43	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			366.9	B08		3	0401-0651	946.17	650.54	275	62.53	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			243.4	B08		3	0402-0656	425.26	656.70	372	71.60	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			457.9	B08		3	0403-0657	713.38	657.91	343	69.26	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			269.8	B08		3	0404-0661	108.19	660.40	327	71.36	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			261.2	B08		3	0405-0660	620.19	659.78	295	64.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1137.5	B08		3	0406-0660	553.77	659.85	269	60.53	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1148.9	B08		3	0407-0660	898.74	660.46	275	66.18	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			782.5	B08		3	0408-0661	175.78	660.96	239	61.60	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			429.1	B08		3	0409-0663	830.21	663.20	256	62.18	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			795.6	B08		3	0410-0663	806.27	663.94	252	60.53	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			451.2	B08		3	0411-0669	321.28	668.18	225	57.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			485.3	B08		3	0412-0674	687.29	674.80	384	75.50	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2157.8	B08		3	0413-0673	473.43	673.39	270	61.11	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1876.9	B08		3	0414-0674	732.78	674.35	260	59.11	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1110.3	B08		3	0415-0675	339.94	674.90	231	57.36	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3326.2	B08		3	0416-0680	911.95	680.09	390	111.88	0.392
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			835.1	B08		3	0417-0678	44.44	677.83	235	60.43	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			345.4	B08		3	0418-0681	448.52	681.25	260	61.36	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			779.0	B08		3	0419-0681	250.43	681.15	231	56.53	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			412.0	B08		3	0420-0682	310.84	682.87	248	58.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1253.8	B08		3	0421-0681	600.75	681.92	187	55.46	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			632.4	B08		3	0422-0682	392.98	682.79	147	46.63	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			215.6	B08		3	0423-0691	70.94	690.67	280	73.84	0.645
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			267.3	B08		3	0424-0686	842.30	686.28	245	59.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2052.8	B08		3	0425-0688	171.82	688.70	240	58.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1163.3	B08		3	0426-0691	568.47	691.37	235	62.77	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			299.7	B08		3	0427-0690	817.05	690.09	266	62.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			260.0	B08		3	0428-0693	204.94	693.32	427	79.84	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			7641.1	B08		3	0429-0690	520.23	689.89	241	58.53	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			559.5	B08		3	0430-0695	880.75	694.32	235	59.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			520.4	B08		3	0431-0696	240.36	695.66	237	57.60	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			350.8	B08		3	0432-0695	294.42	694.86	346	69.94	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1193.3	B08		3	0433-0699	599.55	698.54	340	85.01	0.591
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			197.3	B08		3	0434-0697	389.64	697.22	344	71.84	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			273.6	B08		3	0435-0698	119.26	699.23	252	61.26	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			277.9	B08		3	0436-0707	31.70	707.18	300	66.08	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			313.7	B08		3	0437-0708	278.88	708.13	245	57.94	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3503.9	B08		4	0001-0025	601.39	24.22	237	57.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			488.4	B08		4	0002-0026	295.33	26.23	228	57.11	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1652.5	B08		4	0003-0028	414.67	27.91	247	60.53	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			711.1	B08		4	0004-0028	250.53	27.82	319	67.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			361.6	B08		4	0005-0032	338.83	32.81	380	77.84	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			215.8	B08		4	0006-0030	90.85	30.14	263	62.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			193.8	B08		4	0007-0032	119.56	31.29	266	64.53	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			230.5	B08		4	0008-0032	639.87	33.10	275	62.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			589.1	B08		4	0009-0033	706.63	33.30	326	67.26	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			959.9	B08		4	0010-0027	902.79	26.86	134	46.28	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			237.1	B08		4	0011-0036	37.02	36.05	423	77.26	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			411.2	B08		4	0012-0036	864.18	36.52	334	67.01	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			828.5	B08		4	0013-0036	912.23	36.29	173	49.46	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1287.5	B08		4	0014-0037	930.80	36.59	178	52.28	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			235.4	B08		4	0015-0043	677.40	43.66	298	68.08	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			263.4	B08		4	0016-0045	301.85	45.54	255	63.01	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			6264.8	B08		4	0017-0051	613.77	48.86	342	82.91	0.625
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			329.9	B08		4	0018-0051	75.69	51.44	486	82.08	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			213.5	B08		4	0019-0048	478.80	47.48	271	66.18	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1128.5	B08		4	0020-0047	936.14	47.06	211	59.36	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1856.6	B08		4	0021-0050	401.86	49.78	218	54.53	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			374.3	B08		4	0022-0050	219.40	49.85	318	68.18	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			421.6	B08		4	0023-0058	740.53	58.83	424	78.57	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			667.2	B08		4	0024-0055	14.62	55.08	250	63.36	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			372.0	B08		4	0025-0056	524.41	56.31	353	71.26	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			230.6	B08		4	0026-0058	888.84	59.06	392	75.01	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			504.8	B08		4	0027-0060	161.25	60.71	268	70.18	0.684
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1494.8	B08		4	0028-0058	312.75	57.64	272	62.53	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			632.6	B08		4	0029-0060	712.81	59.97	208	60.18	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			330.8	B08		4	0030-0062	766.83	63.27	211	54.87	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			333.7	B08		4	0031-0067	475.75	67.22	283	62.28	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			389.8	B08		4	0032-0069	538.58	69.33	492	86.33	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			766.2	B08		4	0033-0067	812.44	67.35	244	59.01	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			266.9	B08		4	0034-0078	318.23	77.48	282	65.01	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			451.1	B08		4	0035-0080	447.27	80.88	269	61.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			808.2	B08		4	0036-0083	227.30	83.62	238	57.70	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			393.8	B08		4	0037-0088	414.50	87.90	319	68.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3420.3	B08		4	0038-0090	269.16	90.06	247	59.70	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			370.0	B08		4	0039-0091	381.61	91.52	302	64.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			203.3	B08		4	0040-0094	159.26	95.10	397	74.08	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			493.0	B08		4	0041-0092	54.99	92.34	244	59.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			449.7	B08		4	0042-0093	914.93	93.62	295	64.53	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			606.2	B08		4	0043-0097	678.35	97.15	251	59.94	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			999.5	B08		4	0044-0100	209.86	100.34	241	57.11	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			380.3	B08		4	0045-0106	848.60	106.41	340	68.77	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1452.4	B08		4	0046-0104	798.65	103.91	138	47.21	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1403.8	B08		4	0047-0104	810.06	105.10	155	47.21	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			604.4	B08		4	0048-0109	245.63	109.06	236	56.53	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			226.1	B08		4	0049-0113	274.94	112.69	293	69.26	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			250.1	B08		4	0050-0111	326.72	110.87	297	65.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			430.2	B08		4	0051-0119	62.82	119.71	273	61.60	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			323.2	B08		4	0052-0123	742.79	123.25	327	67.94	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			248.2	B08		4	0053-0130	181.11	130.31	271	64.77	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2212.5	B08		4	0054-0129	601.27	129.58	255	63.60	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			981.0	B08		4	0055-0131	483.49	131.95	328	116.47	0.304
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			277.1	B08		4	0056-0131	714.45	131.62	301	67.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			375.8	B08		4	0057-0133	237.78	133.58	318	66.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			617.1	B08		4	0058-0134	84.87	133.92	219	55.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2181.3	B08		4	0059-0139	381.43	139.74	258	60.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			243.6	B08		4	0060-0141	350.79	140.88	431	83.84	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			333.4	B08		4	0061-0143	205.07	142.99	327	77.50	0.684
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			382.0	B08		4	0062-0141	302.22	141.46	315	73.60	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2271.5	B08		4	0063-0146	540.29	146.95	291	68.77	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			313.2	B08		4	0064-0146	578.61	146.38	219	60.53	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			531.3	B08		4	0065-0146	858.94	145.96	342	69.26	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			568.6	B08		4	0066-0146	610.35	145.78	215	53.46	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			633.8	B08		4	0067-0146	690.83	146.41	168	48.63	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			304.1	B08		4	0068-0154	145.03	154.58	440	78.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			413.9	B08		4	0069-0150	766.39	150.31	307	64.18	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1551.1	B08		4	0070-0149	434.55	149.47	229	58.28	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			480.0	B08		4	0071-0150	941.52	150.18	274	63.11	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			522.8	B08		4	0072-0152	63.41	152.90	231	58.43	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			525.3	B08		4	0073-0154	235.64	154.02	260	59.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			302.4	B08		4	0074-0156	501.76	155.35	336	70.67	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1828.1	B08		4	0075-0157	85.02	157.84	241	57.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			815.8	B08		4	0076-0158	632.22	157.63	165	47.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2328.1	B08		4	0077-0159	100.79	159.94	187	50.63	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			259.3	B08		4	0078-0160	656.24	160.82	256	62.77	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			621.5	B08		4	0079-0170	22.33	169.11	241	60.28	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			463.8	B08		4	0080-0178	791.21	178.94	515	84.91	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			286.1	B08		4	0081-0181	448.03	180.50	247	63.26	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			237.3	B08		4	0082-0182	233.32	181.46	300	68.18	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1771.7	B08		4	0083-0180	310.78	180.92	232	56.28	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			692.8	B08		4	0084-0185	70.87	183.78	239	60.77	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			290.3	B08		4	0085-0186	549.29	186.57	365	70.67	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			244.1	B08		4	0086-0189	897.78	188.80	401	76.08	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			322.7	B08		4	0087-0189	670.54	188.33	240	58.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			583.1	B08		4	0088-0192	286.83	192.36	336	70.08	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			791.8	B08		4	0089-0193	616.47	193.71	205	55.11	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			385.0	B08		4	0090-0199	343.20	198.44	387	74.91	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2370.2	B08		4	0091-0197	474.47	197.98	279	62.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			356.0	B08		4	0092-0200	270.94	200.21	198	54.53	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			352.5	B08		4	0093-0201	515.72	200.27	291	64.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			808.8	B08		4	0094-0203	936.46	203.12	246	60.43	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			178.6	B08		4	0095-0209	22.00	209.14	321	76.18	0.695
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2248.4	B08		4	0096-0205	578.42	204.94	380	71.36	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			329.3	B08		4	0097-0203	380.38	202.68	222	56.28	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5229.2	B08		4	0098-0204	131.18	204.17	215	55.94	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			303.5	B08		4	0099-0207	617.57	207.58	247	61.70	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			371.7	B08		4	0100-0214	706.96	213.52	297	64.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4634.8	B08		4	0101-0217	272.55	216.54	216	59.36	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			274.0	B08		4	0102-0218	120.50	218.74	275	64.53	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			596.2	B08		4	0103-0223	558.63	223.58	465	84.08	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			461.3	B08		4	0104-0220	86.17	220.59	199	52.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			236.5	B08		4	0105-0222	632.34	222.35	268	62.43	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			259.4	B08		4	0106-0223	422.80	223.32	251	59.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			264.2	B08		4	0107-0228	60.11	227.98	256	60.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2795.0	B08		4	0108-0226	587.53	226.41	257	59.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			586.4	B08		4	0109-0228	479.79	228.88	256	63.01	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			205.0	B08		4	0110-0231	242.52	231.78	371	74.18	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			722.1	B08		4	0111-0231	454.26	230.39	231	55.70	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			469.9	B08		4	0112-0240	795.06	239.85	337	68.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			489.3	B08		4	0113-0239	370.73	238.64	297	64.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			399.8	B08		4	0114-0238	395.07	237.47	198	53.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			210.0	B08		4	0115-0238	31.13	238.21	231	57.36	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			238.1	B08		4	0116-0243	163.34	243.94	364	71.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			272.4	B08		4	0117-0242	542.80	242.93	185	55.46	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			508.2	B08		4	0118-0243	855.25	243.75	187	51.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1297.8	B08		4	0119-0246	261.20	246.46	213	54.53	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2793.9	B08		4	0120-0247	506.41	247.48	233	56.28	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			863.7	B08		4	0121-0253	424.23	252.69	261	61.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1869.9	B08		4	0122-0257	16.82	256.93	287	63.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5531.9	B08		4	0123-0259	587.93	260.00	252	65.01	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			333.3	B08		4	0124-0255	869.18	255.90	154	73.74	0.356
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			236.0	B08		4	0125-0257	549.07	256.53	179	52.53	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			582.8	B08		4	0126-0259	820.99	259.13	215	56.53	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2493.3	B08		4	0127-0263	896.26	264.51	303	67.60	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1910.1	B08		4	0128-0265	370.12	264.64	226	55.70	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			408.5	B08		4	0129-0272	749.01	271.91	526	86.91	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			218.1	B08		4	0130-0270	108.85	270.49	342	69.60	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1171.4	B08		4	0131-0264	258.33	264.53	181	49.46	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			437.8	B08		4	0132-0268	199.78	268.16	272	61.36	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1098.8	B08		4	0133-0266	434.03	266.36	181	50.04	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			293.9	B08		4	0134-0270	132.52	270.68	237	57.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			944.3	B08		4	0135-0272	383.11	270.73	158	51.11	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1926.1	B08		4	0136-0275	601.91	274.79	252	59.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			397.2	B08		4	0137-0278	569.84	278.36	308	65.26	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			293.7	B08		4	0138-0278	50.14	278.38	250	59.11	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			228.9	B08		4	0139-0278	214.25	278.96	272	61.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4232.0	B08		4	0140-0278	396.04	277.77	240	59.60	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1809.8	B08		4	0141-0279	414.23	279.20	221	57.36	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			589.3	B08		4	0142-0287	479.47	286.64	258	61.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			929.4	B08		4	0143-0291	253.75	291.05	235	60.53	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4581.8	B08		4	0144-0290	556.80	290.27	231	61.01	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			623.7	B08		4	0145-0292	804.57	291.33	267	67.94	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			617.8	B08		4	0146-0293	833.47	292.81	236	57.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1598.6	B08		4	0147-0290	116.51	290.99	150	46.87	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1189.1	B08		4	0148-0291	134.88	291.50	224	54.28	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5512.1	B08		4	0149-0295	170.41	295.48	256	59.36	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			343.0	B08		4	0150-0300	79.90	299.71	377	73.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			364.6	B08		4	0151-0297	340.36	297.42	224	65.01	0.666
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			687.3	B08		4	0152-0306	848.96	306.04	363	70.43	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3146.6	B08		4	0153-0305	580.13	305.85	263	61.60	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			221.5	B08		4	0154-0306	266.38	306.65	255	63.70	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			331.0	B08		4	0155-0304	426.22	304.47	293	70.28	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			289.3	B08		4	0156-0308	771.97	308.78	268	61.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			284.2	B08		4	0157-0310	701.07	310.10	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2712.7	B08		4	0158-0314	241.79	314.07	223	55.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			511.2	B08		4	0159-0318	864.87	318.80	329	69.84	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1683.1	B08		4	0160-0316	426.73	316.36	194	54.87	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			291.6	B08		4	0161-0320	304.77	321.14	227	56.28	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1499.8	B08		4	0162-0327	383.06	326.66	361	74.53	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4545.9	B08		4	0163-0332	509.64	331.99	402	77.50	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5094.1	B08		4	0164-0335	204.03	334.75	270	60.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1345.7	B08		4	0165-0344	355.36	343.79	402	75.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1143.9	B08		4	0166-0339	57.70	339.44	229	57.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			273.6	B08		4	0167-0345	257.77	345.48	367	71.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			13719.6	B08		4	0168-0348	683.97	347.91	269	62.18	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			238.1	B08		4	0169-0349	923.36	349.53	318	67.01	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3508.9	B08		4	0170-0350	306.71	349.98	262	60.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			415.6	B08		4	0171-0349	798.73	349.42	249	64.18	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			481.0	B08		4	0172-0354	856.66	353.38	287	62.43	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3732.8	B08		4	0173-0354	27.62	354.81	251	69.84	0.647
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			287.8	B08		4	0174-0361	69.30	360.62	363	70.77	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			437.9	B08		4	0175-0361	794.64	361.10	169	49.70	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			265.5	B08		4	0176-0366	871.02	366.20	355	72.18	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			758.4	B08		4	0177-0369	145.55	369.24	223	55.11	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			304.0	B08		4	0178-0381	287.82	381.21	479	88.33	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3666.2	B08		4	0179-0378	334.49	378.08	223	57.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3051.5	B08		4	0180-0384	670.09	383.67	289	64.18	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			303.5	B08		4	0181-0383	851.40	383.37	236	57.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			264.6	B08		4	0182-0383	917.72	383.24	299	64.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3611.5	B08		4	0183-0386	576.32	386.15	240	59.84	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			431.4	B08		4	0184-0387	418.73	387.11	311	64.18	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1137.6	B08		4	0185-0390	124.30	390.25	186	53.36	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1268.6	B08		4	0186-0394	365.20	394.49	281	66.67	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			251.4	B08		4	0187-0391	494.81	391.49	250	62.18	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4924.7	B08		4	0188-0398	183.49	398.08	301	66.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			763.3	B08		4	0189-0400	98.22	399.80	254	77.84	0.527
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			315.7	B08		4	0190-0400	135.37	401.02	223	54.77	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			247.7	B08		4	0191-0405	156.03	405.04	308	66.43	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1256.3	B08		4	0192-0408	821.50	408.19	249	62.77	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			341.7	B08		4	0193-0411	614.01	410.08	287	65.01	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			322.4	B08		4	0194-0410	649.13	410.07	302	67.01	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1841.3	B08		4	0195-0417	395.36	417.62	367	72.67	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1001.2	B08		4	0196-0415	479.20	415.09	240	58.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			369.2	B08		4	0197-0416	556.77	415.96	302	66.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			222.4	B08		4	0198-0417	942.83	416.70	256	59.11	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			266.5	B08		4	0199-0419	913.28	418.81	232	57.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			428.8	B08		4	0200-0427	43.01	427.15	337	67.36	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2655.0	B08		4	0201-0426	245.01	425.35	253	63.36	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			687.6	B08		4	0202-0432	322.69	431.90	417	78.08	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			868.2	B08		4	0203-0430	351.01	431.03	219	58.53	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			275.5	B08		4	0204-0437	619.88	438.32	364	82.43	0.673
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			433.3	B08		4	0205-0437	93.59	437.36	451	82.08	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			356.3	B08		4	0206-0436	698.93	436.19	371	71.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			261.5	B08		4	0207-0440	172.17	439.91	341	68.18	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			770.3	B08		4	0208-0441	829.11	440.75	250	61.11	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			990.4	B08		4	0209-0443	796.47	444.09	188	50.53	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			477.5	B08		4	0210-0449	400.15	449.28	231	57.11	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			796.9	B08		4	0211-0454	763.35	453.28	232	57.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			286.7	B08		4	0212-0458	906.67	457.70	363	71.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			356.5	B08		4	0213-0460	423.06	460.13	251	60.28	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2116.8	B08		4	0214-0461	634.10	461.13	243	57.11	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			254.8	B08		4	0215-0463	862.53	463.11	269	61.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1441.5	B08		4	0216-0465	240.80	466.18	243	59.60	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			268.0	B08		4	0217-0464	500.68	464.47	268	60.87	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			635.9	B08		4	0218-0465	736.76	464.94	140	46.04	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			291.9	B08		4	0219-0467	924.68	467.49	402	74.18	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5656.9	B08		4	0220-0465	106.92	465.57	237	58.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1224.6	B08		4	0221-0473	551.33	473.05	269	63.94	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			819.3	B08		4	0222-0466	748.72	466.50	110	38.63	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			523.8	B08		4	0223-0472	41.64	471.90	337	70.43	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			314.9	B08		4	0224-0474	434.46	474.20	297	66.77	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			474.0	B08		4	0225-0476	573.17	476.07	272	62.53	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3643.5	B08		4	0226-0478	296.05	477.74	264	63.26	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			317.8	B08		4	0227-0477	587.41	477.46	213	54.63	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1126.4	B08		4	0228-0477	624.85	477.87	249	57.36	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1177.4	B08		4	0229-0478	773.47	478.74	248	62.43	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			606.0	B08		4	0230-0479	751.17	479.18	167	47.11	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1605.3	B08		4	0231-0481	825.06	480.57	285	64.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			280.1	B08		4	0232-0485	189.56	485.76	327	69.60	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			864.0	B08		4	0233-0485	165.66	485.49	220	53.94	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			555.7	B08		4	0234-0487	331.71	486.88	242	60.28	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			241.3	B08		4	0235-0487	404.26	487.00	244	60.53	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			234.3	B08		4	0236-0489	876.92	489.21	241	57.11	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			381.7	B08		4	0237-0487	97.63	488.05	206	58.53	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2608.3	B08		4	0238-0491	603.73	490.85	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			272.2	B08		4	0239-0491	674.89	490.66	282	62.43	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			328.3	B08		4	0240-0491	378.68	492.19	243	59.11	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			478.3	B08		4	0241-0496	123.05	495.88	287	63.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1043.5	B08		4	0242-0494	814.64	495.00	192	53.11	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			196.5	B08		4	0243-0502	713.55	501.65	378	75.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			146.7	B08		4	0244-0499	510.71	499.10	178	50.87	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			398.3	B08		4	0245-0502	247.12	501.64	313	66.77	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			256.5	B08		4	0246-0503	465.57	503.07	296	69.36	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			805.3	B08		4	0247-0504	207.05	503.81	213	55.46	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1853.1	B08		4	0248-0505	317.37	506.23	205	58.87	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			141.1	B08		4	0249-0505	526.72	504.67	133	44.04	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			227.1	B08		4	0250-0509	893.48	509.56	256	58.53	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1416.7	B08		4	0251-0510	769.85	509.88	229	57.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			232.7	B08		4	0252-0515	912.53	515.34	272	63.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			645.1	B08		4	0253-0516	166.09	516.56	195	52.53	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1950.1	B08		4	0254-0519	324.07	518.57	206	56.53	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			232.6	B08		4	0255-0523	62.95	523.51	283	62.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			303.5	B08		4	0256-0521	408.93	520.60	252	59.01	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			389.8	B08		4	0257-0523	632.41	523.01	299	65.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			657.9	B08		4	0258-0524	349.28	523.74	255	61.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			774.9	B08		4	0259-0525	35.65	525.09	254	65.84	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5240.8	B08		4	0260-0525	667.34	525.91	286	66.43	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			261.6	B08		4	0261-0529	219.15	529.19	279	66.43	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			254.6	B08		4	0262-0527	823.19	526.28	182	51.11	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			517.8	B08		4	0263-0529	189.07	529.13	203	53.11	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			405.9	B08		4	0264-0535	305.67	536.40	353	71.94	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			802.8	B08		4	0265-0536	271.64	534.96	247	62.87	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1166.1	B08		4	0266-0538	853.41	538.09	256	62.43	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			456.8	B08		4	0267-0543	519.43	543.96	379	74.67	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1514.6	B08		4	0268-0543	462.46	543.84	146	47.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1247.3	B08		4	0269-0545	612.72	545.77	302	66.67	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2308.9	B08		4	0270-0546	483.70	546.75	285	67.60	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			232.6	B08		4	0271-0546	120.03	546.11	297	64.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			265.2	B08		4	0272-0551	386.36	551.34	382	75.50	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1332.4	B08		4	0273-0545	452.01	545.29	113	39.21	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			242.8	B08		4	0274-0549	826.28	549.64	208	55.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			216.6	B08		4	0275-0553	769.54	553.39	208	57.01	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			477.2	B08		4	0276-0553	896.29	553.02	252	59.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			278.4	B08		4	0277-0556	169.22	558.38	335	78.18	0.689
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1239.7	B08		4	0278-0552	257.75	552.29	134	46.04	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1692.0	B08		4	0279-0555	927.66	554.65	218	53.70	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			313.7	B08		4	0280-0562	695.36	561.59	340	69.84	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1383.8	B08		4	0281-0560	39.92	559.67	217	54.28	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			380.5	B08		4	0282-0559	792.50	558.57	225	55.94	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			192.7	B08		4	0283-0562	661.76	562.49	244	58.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			337.9	B08		4	0284-0566	442.11	565.66	250	59.11	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			472.2	B08		4	0285-0571	626.34	571.54	350	72.91	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			8861.6	B08		4	0286-0573	745.64	573.60	268	64.28	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			526.4	B08		4	0287-0579	202.08	578.90	254	59.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			256.1	B08		4	0288-0580	355.71	580.32	261	71.26	0.646
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			396.0	B08		4	0289-0578	55.91	579.20	240	59.11	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			470.0	B08		4	0290-0584	101.22	583.64	271	62.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4266.1	B08		4	0291-0587	896.46	587.20	239	57.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2119.9	B08		4	0292-0590	503.77	590.15	227	55.70	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			208.6	B08		4	0293-0593	414.11	594.58	329	71.01	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			231.9	B08		4	0294-0594	466.09	594.47	170	48.63	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			6117.6	B08		4	0295-0595	631.79	594.98	228	56.28	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			6238.7	B08		4	0296-0599	330.30	599.10	240	58.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			408.3	B08		4	0297-0600	878.35	600.18	225	56.87	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			893.0	B08		4	0298-0604	265.33	603.70	313	65.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			312.5	B08		4	0299-0605	521.43	604.79	295	64.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1965.0	B08		4	0300-0603	612.33	602.58	160	46.87	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2160.0	B08		4	0301-0605	933.74	605.18	223	55.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			184.8	B08		4	0302-0606	483.26	606.68	184	53.36	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			384.1	B08		4	0303-0607	792.06	607.40	263	59.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1066.7	B08		4	0304-0610	238.36	610.41	227	56.28	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			601.8	B08		4	0305-0612	213.73	611.44	215	55.70	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1777.2	B08		4	0306-0615	619.13	615.35	176	49.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			359.5	B08		4	0307-0622	857.02	622.48	252	59.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			628.5	B08		4	0308-0620	180.51	620.54	198	53.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			228.1	B08		4	0309-0621	647.58	621.74	256	60.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			200.9	B08		4	0310-0626	931.96	626.09	277	71.60	0.679
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			385.6	B08		4	0311-0627	369.29	627.77	272	62.18	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			843.9	B08		4	0312-0628	240.10	627.52	191	51.11	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			448.4	B08		4	0313-0631	112.43	631.22	295	62.77	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1710.5	B08		4	0314-0631	594.04	631.05	250	59.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			256.2	B08		4	0315-0634	396.37	634.05	245	61.60	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			530.8	B08		4	0316-0636	439.91	636.09	375	71.60	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			247.4	B08		4	0317-0638	518.47	638.36	294	65.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4916.1	B08		4	0318-0638	851.28	638.87	219	54.87	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2156.0	B08		4	0319-0639	71.19	639.60	175	49.80	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			277.8	B08		4	0320-0643	355.90	642.50	300	67.50	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			309.3	B08		4	0321-0643	720.20	643.02	246	59.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			249.0	B08		4	0322-0650	276.52	648.14	493	95.50	0.679
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			409.4	B08		4	0323-0648	471.83	647.96	344	69.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2127.6	B08		4	0324-0643	623.44	642.89	206	61.36	0.688
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			202.7	B08		4	0325-0651	550.39	650.86	460	82.33	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4153.7	B08		4	0326-0649	751.38	649.17	248	62.53	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			218.7	B08		4	0327-0655	677.54	656.14	307	64.18	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2753.8	B08		4	0328-0657	92.49	656.86	234	56.28	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			243.5	B08		4	0329-0665	419.08	665.94	283	62.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			345.7	B08		4	0330-0665	464.09	665.02	258	60.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			309.6	B08		4	0331-0668	138.91	668.35	265	62.18	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3427.7	B08		4	0332-0670	579.98	670.48	218	55.70	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			553.8	B08		4	0333-0669	157.98	669.52	183	52.53	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			249.5	B08		4	0334-0677	304.96	677.31	383	75.01	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			388.0	B08		4	0335-0676	369.06	676.55	337	71.84	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			765.0	B08		4	0336-0676	106.14	676.43	226	57.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			226.1	B08		4	0337-0681	489.96	681.89	293	70.53	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			749.0	B08		4	0338-0679	219.54	679.54	244	57.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2986.9	B08		4	0339-0682	439.59	681.45	316	65.60	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			553.3	B08		4	0340-0682	341.94	682.00	147	49.11	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			338.8	B08		4	0341-0686	771.81	686.37	246	59.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			547.9	B08		4	0342-0687	352.74	686.86	160	48.87	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			239.5	B08		4	0343-0689	66.90	688.40	228	58.28	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			239.0	B08		4	0344-0695	584.28	694.25	440	78.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			9220.7	B08		4	0345-0693	190.14	693.68	257	58.77	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			463.4	B08		4	0346-0694	508.55	695.05	278	66.18	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1512.1	B08		4	0347-0699	91.54	698.54	186	51.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			164.6	B08		4	0348-0701	321.09	700.57	259	61.94	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			9308.0	B08		4	0349-0701	852.08	700.68	243	63.01	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1259.5	B08		4	0350-0704	139.10	703.95	232	56.18	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			702.1	B08		4	0351-0707	82.78	707.84	131	43.11	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3002.7	B08		4	0352-0709	249.40	709.38	245	58.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1497.0	B08		4	0353-0708	826.55	707.85	222	55.36	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			987.0	B08		5	0001-0030	295.53	30.88	233	58.53	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1375.7	B08		5	0002-0025	894.81	25.66	191	53.70	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1273.7	B08		5	0003-0032	81.20	32.85	281	64.43	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3046.5	B08		5	0004-0030	386.33	30.11	243	57.36	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			368.1	B08		5	0005-0033	557.30	33.38	357	71.01	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			297.0	B08		5	0006-0035	647.06	35.19	464	81.50	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			301.9	B08		5	0007-0034	764.63	33.50	320	66.43	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			844.6	B08		5	0008-0038	17.47	38.56	167	48.28	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			992.1	B08		5	0009-0038	843.73	38.50	257	60.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1632.7	B08		5	0010-0042	103.70	41.70	286	67.01	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1263.7	B08		5	0011-0044	38.23	44.27	412	80.67	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			340.0	B08		5	0012-0040	618.67	39.46	201	53.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			293.0	B08		5	0013-0041	935.18	41.15	306	66.08	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			955.4	B08		5	0014-0045	205.15	45.67	328	68.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1993.3	B08		5	0015-0046	353.28	45.99	285	63.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5487.5	B08		5	0016-0046	438.62	46.09	260	60.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			9496.1	B08		5	0017-0047	119.53	46.85	227	64.53	0.685
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			292.5	B08		5	0018-0053	699.81	51.11	402	85.50	0.691
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			380.1	B08		5	0019-0054	728.32	54.59	354	69.26	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1696.3	B08		5	0020-0053	890.76	53.19	218	61.84	0.716
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			295.3	B08		5	0021-0058	502.59	57.05	187	55.01	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			11972.3	B08		5	0022-0061	125.53	61.72	186	57.60	0.705
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			335.9	B08		5	0023-0061	392.17	61.28	300	68.77	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			391.4	B08		5	0024-0063	865.42	63.69	284	63.36	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			793.0	B08		5	0025-0063	445.32	62.52	211	55.11	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			389.1	B08		5	0026-0068	600.83	67.82	454	81.74	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			590.0	B08		5	0027-0065	641.80	65.14	294	62.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			559.2	B08		5	0028-0072	240.01	71.95	365	82.33	0.677
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			248.2	B08		5	0029-0078	458.41	79.37	349	74.67	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			454.1	B08		5	0030-0074	786.62	75.24	278	64.53	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			331.5	B08		5	0031-0083	537.97	83.52	521	87.84	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			795.4	B08		5	0032-0080	179.82	80.24	229	56.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1916.9	B08		5	0033-0081	307.41	81.64	241	59.36	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			223.2	B08		5	0034-0088	583.99	88.43	520	87.50	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			746.0	B08		5	0035-0088	146.95	87.66	229	58.53	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			232.1	B08		5	0036-0087	849.53	86.85	227	55.94	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			377.5	B08		5	0037-0091	693.33	91.22	257	63.60	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			589.9	B08		5	0038-0093	756.68	92.98	318	65.84	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			401.1	B08		5	0039-0093	325.58	92.74	406	75.60	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			427.4	B08		5	0040-0095	19.60	95.63	297	63.70	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			327.4	B08		5	0041-0096	621.58	96.99	278	64.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			793.9	B08		5	0042-0096	919.57	96.30	211	53.11	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			274.8	B08		5	0043-0099	829.40	98.50	296	63.94	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1111.4	B08		5	0044-0098	366.33	98.06	223	56.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			339.7	B08		5	0045-0102	285.85	102.24	239	58.77	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			167.0	B08		5	0046-0102	477.28	102.34	344	72.43	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			795.6	B08		5	0047-0105	179.89	105.00	227	57.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1256.1	B08		5	0048-0104	387.49	104.30	273	63.36	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			656.5	B08		5	0049-0110	219.10	111.22	376	75.01	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1067.7	B08		5	0050-0115	432.47	114.86	232	56.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			958.5	B08		5	0051-0122	262.18	122.33	412	75.26	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			965.6	B08		5	0052-0121	613.89	121.83	356	69.60	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			401.6	B08		5	0053-0123	124.96	123.50	317	64.77	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			382.4	B08		5	0054-0127	499.69	125.98	329	73.01	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			701.4	B08		5	0055-0125	317.65	125.28	227	55.94	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			320.0	B08		5	0056-0131	934.50	130.73	378	75.50	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			797.3	B08		5	0057-0128	671.91	127.74	201	52.53	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			219.9	B08		5	0058-0129	98.76	129.47	303	69.36	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			273.5	B08		5	0059-0132	181.45	131.89	279	62.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			351.7	B08		5	0060-0135	445.04	135.96	391	73.26	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			451.7	B08		5	0061-0134	731.47	134.75	276	64.18	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			302.5	B08		5	0062-0138	792.76	138.55	261	59.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			412.0	B08		5	0063-0135	814.56	134.93	256	61.70	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			336.7	B08		5	0064-0142	529.19	142.32	257	60.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			748.4	B08		5	0065-0141	863.11	141.44	233	57.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			247.6	B08		5	0066-0142	911.83	142.77	267	63.60	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			687.6	B08		5	0067-0154	221.83	153.34	667	103.64	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			410.2	B08		5	0068-0147	339.76	146.34	344	69.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3047.4	B08		5	0069-0146	572.14	145.82	248	57.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			355.2	B08		5	0070-0147	654.58	147.15	297	64.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			925.8	B08		5	0071-0147	817.26	148.11	194	56.04	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1454.6	B08		5	0072-0149	362.62	149.64	258	63.11	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			239.4	B08		5	0073-0153	468.98	152.96	303	65.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			793.9	B08		5	0074-0152	46.23	152.22	276	62.53	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			515.0	B08		5	0075-0155	326.26	154.69	198	53.60	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			551.0	B08		5	0076-0158	131.27	157.77	294	64.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			221.5	B08		5	0077-0160	412.59	160.42	281	64.53	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			485.6	B08		5	0078-0159	860.83	159.21	240	58.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			6214.8	B08		5	0079-0168	300.99	166.56	212	59.11	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			224.5	B08		5	0080-0169	563.53	168.26	300	72.43	0.719
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			410.2	B08		5	0081-0169	283.17	169.11	340	70.77	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			391.0	B08		5	0082-0170	520.66	170.02	368	70.43	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			262.0	B08		5	0083-0173	714.30	172.85	300	76.43	0.645
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			331.8	B08		5	0084-0176	599.34	175.96	280	65.94	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			6855.7	B08		5	0085-0177	767.45	177.37	261	62.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1352.2	B08		5	0086-0183	297.78	183.35	207	53.70	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			236.0	B08		5	0087-0188	458.13	187.82	262	61.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1309.4	B08		5	0088-0186	827.90	186.74	189	55.36	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1245.4	B08		5	0089-0190	123.16	189.82	298	64.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1397.2	B08		5	0090-0189	743.36	189.75	238	57.70	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			381.2	B08		5	0091-0191	435.58	190.96	270	59.94	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2294.0	B08		5	0092-0192	688.43	191.92	324	67.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			280.3	B08		5	0093-0195	802.67	195.07	270	67.26	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			305.3	B08		5	0094-0197	379.86	197.12	323	66.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			223.7	B08		5	0095-0200	532.69	199.42	324	68.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1431.5	B08		5	0096-0199	294.42	199.07	185	53.11	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5887.7	B08		5	0097-0201	256.90	201.30	177	48.87	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			424.0	B08		5	0098-0202	489.30	202.45	295	62.77	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			483.2	B08		5	0099-0205	89.56	204.45	266	63.60	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3041.7	B08		5	0100-0202	599.49	200.85	172	53.70	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			273.6	B08		5	0101-0203	855.77	204.11	257	60.28	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			847.5	B08		5	0102-0205	41.27	205.25	244	59.60	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			220.9	B08		5	0103-0209	559.41	208.92	460	83.26	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			464.7	B08		5	0104-0209	818.71	209.27	352	69.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			219.8	B08		5	0105-0212	363.48	212.07	256	61.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3632.5	B08		5	0106-0207	608.13	207.61	120	42.28	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			542.1	B08		5	0107-0213	243.40	213.91	322	69.26	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			352.5	B08		5	0108-0216	625.16	216.59	319	66.18	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			353.5	B08		5	0109-0223	312.51	224.14	373	80.33	0.726
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3052.7	B08		5	0110-0221	154.93	221.42	238	57.70	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			273.5	B08		5	0111-0222	388.83	221.77	269	61.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			270.2	B08		5	0112-0224	462.43	223.48	257	59.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1057.1	B08		5	0113-0227	527.41	227.24	242	57.46	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			801.7	B08		5	0114-0231	138.45	230.97	229	55.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			501.2	B08		5	0115-0231	354.39	231.96	211	54.53	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1990.2	B08		5	0116-0235	717.67	234.91	391	75.01	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			253.9	B08		5	0117-0232	327.87	231.96	209	53.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			227.5	B08		5	0118-0233	485.95	233.10	274	61.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1374.0	B08		5	0119-0234	549.68	234.97	201	53.36	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			199.1	B08		5	0120-0236	920.16	237.33	301	67.84	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			831.1	B08		5	0121-0238	698.47	238.19	231	56.53	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			912.0	B08		5	0122-0243	786.65	243.09	305	70.43	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			287.2	B08		5	0123-0243	182.01	242.88	185	52.53	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			307.6	B08		5	0124-0247	806.30	247.73	346	69.01	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			243.4	B08		5	0125-0248	342.03	248.20	243	61.60	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3825.0	B08		5	0126-0246	747.93	245.72	211	53.70	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3365.1	B08		5	0127-0251	627.61	251.69	278	63.70	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			253.6	B08		5	0128-0251	839.54	251.41	302	67.01	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			399.4	B08		5	0129-0253	672.20	253.35	290	66.67	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			650.0	B08		5	0130-0255	416.23	254.89	359	69.60	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4420.6	B08		5	0131-0257	234.72	258.05	280	62.18	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			416.8	B08		5	0132-0258	926.87	258.22	304	65.01	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1410.1	B08		5	0133-0259	529.60	259.62	179	50.28	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			362.5	B08		5	0134-0263	370.21	262.63	206	54.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			211.0	B08		5	0135-0265	886.90	264.94	301	63.94	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			291.9	B08		5	0136-0267	603.02	266.82	234	57.94	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			738.4	B08		5	0137-0271	722.33	270.70	281	65.26	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			534.9	B08		5	0138-0274	788.48	273.86	302	64.67	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2863.0	B08		5	0139-0274	286.41	274.47	246	58.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			489.2	B08		5	0140-0275	578.73	274.92	399	75.84	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			354.0	B08		5	0141-0278	471.49	278.13	376	72.43	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			205.3	B08		5	0142-0279	763.35	279.52	327	70.77	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1099.7	B08		5	0143-0285	683.06	284.72	557	96.81	0.747
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			239.8	B08		5	0144-0283	157.84	283.31	270	62.28	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			375.9	B08		5	0145-0282	931.41	282.99	332	68.77	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			361.6	B08		5	0146-0285	305.08	285.40	281	66.43	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3228.4	B08		5	0147-0289	855.11	291.27	292	73.26	0.684
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2297.6	B08		5	0148-0292	652.58	292.68	293	64.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			287.9	B08		5	0149-0293	254.65	293.39	363	72.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			611.8	B08		5	0150-0292	351.44	291.95	169	50.53	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			361.4	B08		5	0151-0296	832.99	296.12	326	66.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			423.6	B08		5	0152-0301	386.36	301.03	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			379.9	B08		5	0153-0297	621.94	297.75	232	59.46	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			187.9	B08		5	0154-0306	946.53	306.29	208	58.53	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			486.0	B08		5	0155-0305	480.20	305.32	257	61.94	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			722.0	B08		5	0156-0306	344.77	306.66	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3678.7	B08		5	0157-0310	929.56	310.24	264	59.36	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			549.1	B08		5	0158-0311	743.22	311.03	377	73.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			396.0	B08		5	0159-0312	518.81	312.77	358	71.01	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			242.1	B08		5	0160-0319	431.69	319.49	278	62.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			249.9	B08		5	0161-0321	867.44	320.62	300	65.01	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			581.4	B08		5	0162-0322	603.54	321.53	290	64.77	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			439.3	B08		5	0163-0324	762.76	324.64	284	64.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			406.7	B08		5	0164-0324	697.15	324.25	312	65.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			287.3	B08		5	0165-0328	256.84	329.58	236	62.77	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			397.2	B08		5	0166-0330	903.78	330.83	318	65.94	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			880.5	B08		5	0167-0332	640.93	332.77	255	59.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			258.7	B08		5	0168-0334	385.47	335.14	313	70.43	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			286.5	B08		5	0169-0339	199.53	339.86	402	79.26	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			499.1	B08		5	0170-0337	336.46	336.80	347	68.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			604.0	B08		5	0171-0337	109.22	337.39	234	55.70	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			364.0	B08		5	0172-0341	728.54	341.60	301	64.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			191.9	B08		5	0173-0348	247.30	348.39	312	73.01	0.735
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			318.4	B08		5	0174-0347	518.90	347.95	266	61.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			630.1	B08		5	0175-0350	550.53	349.87	304	66.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			240.2	B08		5	0176-0351	28.14	351.54	308	65.01	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			224.8	B08		5	0177-0351	671.10	352.07	300	66.43	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			541.9	B08		5	0178-0351	288.63	351.57	242	57.36	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			309.3	B08		5	0179-0353	605.08	353.64	328	67.84	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			308.8	B08		5	0180-0350	388.40	350.64	213	55.70	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			207.3	B08		5	0181-0355	313.02	354.74	290	68.67	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			184.1	B08		5	0182-0363	367.52	363.21	367	73.74	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			915.3	B08		5	0183-0361	868.51	361.52	228	55.70	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			894.3	B08		5	0184-0364	481.68	364.53	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			215.1	B08		5	0185-0366	744.53	366.18	361	73.84	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3893.5	B08		5	0186-0370	155.81	369.80	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			488.0	B08		5	0187-0368	583.87	367.91	293	63.01	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			539.3	B08		5	0188-0369	793.88	369.56	267	62.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			7073.7	B08		5	0189-0374	425.48	374.39	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1448.9	B08		5	0190-0376	815.09	375.59	267	71.01	0.665
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			722.2	B08		5	0191-0377	708.52	377.08	346	67.60	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			263.3	B08		5	0192-0379	228.04	379.25	321	67.60	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			671.1	B08		5	0193-0382	762.06	381.50	344	70.18	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			498.9	B08		5	0194-0384	331.51	384.50	264	59.94	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2550.7	B08		5	0195-0383	57.91	383.42	245	60.18	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2767.9	B08		5	0196-0384	638.43	383.82	173	55.36	0.709
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			256.7	B08		5	0197-0385	22.61	385.34	298	64.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			231.0	B08		5	0198-0387	437.65	386.44	260	61.70	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			988.3	B08		5	0199-0387	264.16	387.60	220	54.87	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			8027.9	B08		5	0200-0388	941.49	389.46	247	73.26	0.578
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1744.4	B08		5	0201-0387	298.35	387.32	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			444.0	B08		5	0202-0388	545.48	388.10	243	57.70	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3012.9	B08		5	0203-0390	123.06	389.49	212	55.36	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1120.5	B08		5	0204-0390	474.10	389.95	175	51.36	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			192.5	B08		5	0205-0398	374.06	400.10	337	75.60	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			230.4	B08		5	0206-0399	415.64	399.44	436	78.33	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			711.0	B08		5	0207-0397	845.35	396.76	330	67.36	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			9121.3	B08		5	0208-0396	924.48	396.26	284	64.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3651.6	B08		5	0209-0400	96.75	399.85	268	60.53	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			346.9	B08		5	0210-0400	184.98	400.23	329	68.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			255.1	B08		5	0211-0402	596.83	402.10	318	65.94	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3045.3	B08		5	0212-0400	767.01	400.97	234	57.11	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			696.1	B08		5	0213-0402	234.24	403.18	236	57.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			196.4	B08		5	0214-0405	880.80	404.72	302	65.84	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			310.6	B08		5	0215-0408	503.17	407.93	387	73.84	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			771.9	B08		5	0216-0412	850.68	411.78	215	55.70	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1267.7	B08		5	0217-0418	295.11	418.75	263	60.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			217.1	B08		5	0218-0417	753.99	417.39	295	65.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			273.2	B08		5	0219-0419	47.72	418.73	257	58.53	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1590.4	B08		5	0220-0418	264.96	418.82	253	58.77	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			331.0	B08		5	0221-0420	553.94	420.70	336	68.08	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			271.2	B08		5	0222-0421	18.23	420.86	230	57.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			368.2	B08		5	0223-0423	649.21	422.77	326	67.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			574.5	B08		5	0224-0419	716.50	418.66	237	59.36	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			343.5	B08		5	0225-0423	159.47	423.16	268	60.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			272.2	B08		5	0226-0425	207.15	424.76	172	50.63	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			256.9	B08		5	0227-0427	249.84	426.62	227	60.18	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			272.2	B08		5	0228-0427	107.31	427.34	224	63.70	0.694
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			194.5	B08		5	0229-0429	93.76	430.11	133	48.53	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			345.5	B08		5	0230-0431	771.38	430.11	262	61.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2409.8	B08		5	0231-0434	318.65	433.86	279	61.60	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			264.7	B08		5	0232-0436	825.71	436.90	333	77.26	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			618.8	B08		5	0233-0434	357.52	434.58	213	55.11	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			281.6	B08		5	0234-0436	338.58	436.41	238	56.77	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			239.9	B08		5	0235-0440	453.24	439.97	251	59.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			410.4	B08		5	0236-0440	716.10	440.61	294	67.01	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			294.3	B08		5	0237-0446	893.39	445.58	305	64.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			522.0	B08		5	0238-0446	397.03	446.42	252	59.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			591.7	B08		5	0239-0446	759.84	446.37	329	66.53	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			275.9	B08		5	0240-0453	613.76	454.39	375	73.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1989.5	B08		5	0241-0451	254.41	451.25	265	60.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2588.4	B08		5	0242-0449	646.18	449.41	106	40.04	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1616.5	B08		5	0243-0454	851.35	454.92	285	66.18	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			208.2	B08		5	0244-0454	459.56	455.29	210	58.53	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			195.4	B08		5	0245-0457	416.62	458.31	258	66.28	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			209.9	B08		5	0246-0459	474.40	458.61	271	62.04	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1025.6	B08		5	0247-0463	580.88	463.68	282	64.53	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3828.5	B08		5	0248-0462	679.75	461.14	229	58.77	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			272.7	B08		5	0249-0466	315.02	467.28	416	85.15	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			855.5	B08		5	0250-0466	340.97	464.47	322	79.84	0.635
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			346.8	B08		5	0251-0467	388.98	466.28	351	71.01	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			401.1	B08		5	0252-0464	512.97	464.52	247	58.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			205.6	B08		5	0253-0468	540.87	467.65	321	68.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			407.1	B08		5	0254-0468	712.10	468.59	270	61.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			322.4	B08		5	0255-0469	29.72	469.57	398	73.60	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3814.3	B08		5	0256-0469	164.99	469.79	233	57.94	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			895.4	B08		5	0257-0469	362.12	469.38	203	53.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2267.5	B08		5	0258-0469	881.30	468.81	265	61.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			258.0	B08		5	0259-0476	686.25	474.81	263	66.67	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1333.1	B08		5	0260-0473	210.69	474.10	179	51.11	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1529.2	B08		5	0261-0474	566.06	474.60	193	54.18	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			380.8	B08		5	0262-0477	259.90	477.08	208	61.01	0.702
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			374.3	B08		5	0263-0478	916.21	478.80	260	64.18	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			820.9	B08		5	0264-0484	226.41	484.79	327	75.50	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			302.0	B08		5	0265-0486	669.26	486.42	312	65.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1088.0	B08		5	0266-0487	312.59	487.82	276	63.01	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			195.9	B08		5	0267-0486	388.91	486.62	233	59.36	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1548.7	B08		5	0268-0486	560.86	485.82	117	40.28	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1654.4	B08		5	0269-0495	621.80	496.89	534	92.91	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			374.9	B08		5	0270-0491	782.00	491.75	311	66.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			617.4	B08		5	0271-0491	816.80	492.21	224	56.53	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			293.6	B08		5	0272-0493	248.22	493.46	176	48.87	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			224.9	B08		5	0273-0500	654.32	501.07	277	63.94	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			563.8	B08		5	0274-0503	300.62	504.45	260	62.77	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			439.2	B08		5	0275-0506	798.25	505.60	326	70.53	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			317.9	B08		5	0276-0505	82.77	505.79	367	73.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1292.7	B08		5	0277-0504	208.16	504.19	201	51.94	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			255.5	B08		5	0278-0509	168.81	509.67	238	62.77	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			267.9	B08		5	0279-0509	454.85	508.90	311	65.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			488.3	B08		5	0280-0510	567.98	510.19	257	60.28	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			248.1	B08		5	0281-0508	251.51	507.81	140	46.39	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			824.4	B08		5	0282-0514	580.97	514.25	225	62.28	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			163.5	B08		5	0283-0513	947.71	513.22	271	60.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1095.5	B08		5	0284-0514	814.93	514.00	223	58.87	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1261.1	B08		5	0285-0515	766.65	516.13	269	60.28	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			214.1	B08		5	0286-0517	17.14	517.56	263	61.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			220.7	B08		5	0287-0518	185.06	519.87	257	64.77	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1338.2	B08		5	0288-0515	907.14	515.25	189	53.36	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			239.3	B08		5	0289-0520	851.89	519.62	257	59.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3072.4	B08		5	0290-0525	152.92	525.78	265	64.53	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			417.9	B08		5	0291-0523	500.45	522.77	313	65.01	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			686.3	B08		5	0292-0521	247.66	521.15	148	44.87	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			252.1	B08		5	0293-0526	310.58	526.06	250	61.36	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			268.8	B08		5	0294-0530	232.78	529.58	310	66.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			282.8	B08		5	0295-0528	699.51	528.23	219	54.87	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			334.0	B08		5	0296-0529	807.78	529.93	285	66.18	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4847.9	B08		5	0297-0529	602.50	528.81	243	57.36	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			246.9	B08		5	0298-0530	464.02	530.85	276	63.94	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			423.7	B08		5	0299-0535	526.23	535.26	278	62.53	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			213.5	B08		5	0300-0534	194.17	534.36	146	49.46	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			199.5	B08		5	0301-0537	631.59	536.87	273	62.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			206.2	B08		5	0302-0538	203.78	538.71	112	38.39	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			168.4	B08		5	0303-0541	943.14	542.26	251	61.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			292.7	B08		5	0304-0544	285.41	544.89	227	58.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3148.7	B08		5	0305-0542	66.73	542.40	222	54.53	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1196.3	B08		5	0306-0545	394.84	545.45	237	57.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			280.1	B08		5	0307-0547	416.32	546.55	299	65.60	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			200.2	B08		5	0308-0549	501.07	550.03	257	67.01	0.719
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			258.5	B08		5	0309-0548	914.84	547.20	322	67.60	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			824.9	B08		5	0310-0547	861.68	547.45	240	58.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			731.0	B08		5	0311-0550	333.81	549.73	238	60.43	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			408.8	B08		5	0312-0552	96.40	551.94	339	71.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			487.0	B08		5	0313-0550	271.40	550.14	145	47.70	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			239.3	B08		5	0314-0558	159.75	557.98	250	57.94	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1789.9	B08		5	0315-0557	32.26	556.67	214	53.70	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1281.8	B08		5	0316-0560	226.45	559.89	257	66.77	0.724
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			614.1	B08		5	0317-0563	884.68	563.30	252	60.53	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1405.7	B08		5	0318-0563	187.93	563.47	259	60.18	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			207.2	B08		5	0319-0566	488.24	566.76	425	80.43	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1569.5	B08		5	0320-0567	726.77	566.37	288	65.01	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			494.7	B08		5	0321-0570	782.32	570.74	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			583.8	B08		5	0322-0572	138.28	572.28	266	60.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			240.4	B08		5	0323-0577	605.38	577.36	304	65.01	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			824.4	B08		5	0324-0577	257.41	577.32	212	53.36	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1209.8	B08		5	0325-0584	826.31	584.13	267	61.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			488.2	B08		5	0326-0589	905.56	588.89	251	63.60	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1049.6	B08		5	0327-0591	303.02	590.39	204	53.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			270.3	B08		5	0328-0592	671.11	592.34	289	61.94	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1524.2	B08		5	0329-0594	218.77	593.42	285	65.01	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			679.0	B08		5	0330-0593	842.59	593.52	206	53.94	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			575.4	B08		5	0331-0597	890.09	598.13	215	55.70	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1853.8	B08		5	0332-0601	172.79	601.25	348	76.67	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2476.1	B08		5	0333-0602	495.55	601.80	263	59.60	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1102.1	B08		5	0334-0602	698.64	601.29	225	56.53	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			239.2	B08		5	0335-0605	348.19	605.29	285	67.50	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			238.0	B08		5	0336-0606	585.00	606.28	382	74.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2300.5	B08		5	0337-0607	38.14	607.31	229	58.18	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			288.7	B08		5	0338-0610	540.02	609.60	234	59.01	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			899.0	B08		5	0339-0610	417.90	610.62	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			926.7	B08		5	0340-0612	509.01	612.46	249	59.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			286.3	B08		5	0341-0611	793.96	611.55	308	64.77	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			369.1	B08		5	0342-0614	923.70	614.42	241	56.77	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			439.7	B08		5	0343-0616	320.44	616.36	299	65.26	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			291.8	B08		5	0344-0619	712.48	618.24	295	63.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2357.5	B08		5	0345-0621	215.75	620.77	456	88.91	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			453.1	B08		5	0346-0620	757.65	620.59	258	61.94	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			854.8	B08		5	0347-0622	453.10	622.06	232	56.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			318.0	B08		5	0348-0624	546.22	624.36	285	65.01	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			212.7	B08		5	0349-0623	174.39	622.87	236	56.53	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			256.2	B08		5	0350-0622	870.83	622.71	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			249.1	B08		5	0351-0628	605.87	627.99	397	76.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			345.4	B08		5	0352-0624	946.97	624.84	281	62.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			232.0	B08		5	0353-0628	36.42	628.14	277	72.43	0.664
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			312.6	B08		5	0354-0627	248.60	627.74	260	59.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2684.1	B08		5	0355-0629	830.24	628.84	222	63.26	0.697
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			673.5	B08		5	0356-0633	370.33	632.80	275	64.77	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			334.2	B08		5	0357-0636	408.74	635.45	333	70.18	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1044.3	B08		5	0358-0634	559.32	634.44	189	51.46	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1303.5	B08		5	0359-0638	768.63	638.12	249	61.11	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2039.9	B08		5	0360-0644	477.73	644.58	285	65.60	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			269.6	B08		5	0361-0646	141.04	646.00	238	58.53	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			393.9	B08		5	0362-0645	624.71	644.66	226	55.70	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			782.6	B08		5	0363-0648	565.94	648.44	244	60.53	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			318.1	B08		5	0364-0655	923.94	655.47	386	75.60	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			221.8	B08		5	0365-0654	227.52	653.58	294	63.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			599.8	B08		5	0366-0653	685.29	652.45	228	58.77	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			191.4	B08		5	0367-0655	855.20	655.65	287	62.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			583.4	B08		5	0368-0656	278.26	655.64	249	62.53	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			655.8	B08		5	0369-0655	514.61	654.75	228	56.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			264.0	B08		5	0370-0656	649.18	656.57	234	57.94	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			498.8	B08		5	0371-0656	726.71	655.54	244	57.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			625.3	B08		5	0372-0663	819.55	663.14	272	61.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			542.3	B08		5	0373-0663	156.97	663.83	233	57.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			221.3	B08		5	0374-0668	103.57	668.66	288	64.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			356.7	B08		5	0375-0668	297.00	668.30	230	56.77	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			908.4	B08		5	0376-0676	637.78	676.57	328	67.94	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5515.9	B08		5	0377-0675	746.61	675.50	218	56.28	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			338.5	B08		5	0378-0673	784.03	672.98	198	54.53	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			197.9	B08		5	0379-0680	130.23	679.86	225	55.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1136.9	B08		5	0380-0681	352.98	681.85	262	60.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			438.5	B08		5	0381-0678	400.87	678.35	219	56.53	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1528.9	B08		5	0382-0680	564.26	680.36	266	60.18	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			548.1	B08		5	0383-0681	809.99	680.69	259	58.53	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			577.0	B08		5	0384-0681	260.11	680.66	242	61.11	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			440.4	B08		5	0385-0682	443.93	681.27	251	58.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1161.4	B08		5	0386-0681	518.84	681.30	267	61.94	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			258.2	B08		5	0387-0689	851.09	689.63	349	71.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1289.4	B08		5	0388-0685	944.31	685.34	228	57.11	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2307.5	B08		5	0389-0689	331.92	689.08	240	58.28	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			257.8	B08		5	0390-0688	175.30	688.12	233	61.60	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			192.7	B08		5	0391-0697	481.88	696.74	235	59.11	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			166.4	B08		5	0392-0696	499.67	696.24	222	59.36	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			819.3	B08		5	0393-0699	454.71	698.92	176	50.28	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			318.6	B08		5	0394-0702	763.55	701.67	360	71.84	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2485.4	B08		5	0395-0702	181.65	702.87	251	59.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			211.4	B08		5	0396-0704	832.21	704.19	334	67.60	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			194.9	B08		5	0397-0706	628.57	706.03	292	65.36	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			916.8	B08		5	0398-0707	607.56	708.06	218	56.28	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1455.8	B08		5	0399-0710	334.25	709.85	209	53.11	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1423.5	B08		5	0400-0711	275.53	711.28	216	59.70	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1339.9	B08		6	0001-0028	566.76	28.73	247	61.36	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			308.3	B08		6	0002-0030	203.14	30.57	437	79.26	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			349.6	B08		6	0003-0027	815.03	27.38	269	60.53	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			8097.0	B08		6	0004-0028	518.48	27.57	250	59.94	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			621.3	B08		6	0005-0032	878.67	31.47	241	60.18	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			560.7	B08		6	0006-0034	238.40	33.37	239	58.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			345.7	B08		6	0007-0032	292.61	32.32	341	69.11	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1164.3	B08		6	0008-0042	603.48	42.80	661	124.71	0.534
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			222.3	B08		6	0009-0035	387.87	34.87	352	71.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			310.5	B08		6	0010-0036	117.52	36.42	257	60.77	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			318.0	B08		6	0011-0044	29.89	44.06	304	66.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1146.4	B08		6	0012-0047	136.17	48.47	208	63.36	0.651
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			354.6	B08		6	0013-0046	277.18	45.73	246	58.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			250.0	B08		6	0014-0048	920.08	48.74	236	58.53	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1066.9	B08		6	0015-0053	47.84	53.09	219	56.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			7178.2	B08		6	0016-0057	391.41	57.27	229	56.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1604.2	B08		6	0017-0059	692.75	59.01	218	55.94	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1013.1	B08		6	0018-0062	852.91	61.86	412	77.50	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			7611.3	B08		6	0019-0057	351.17	57.35	167	50.28	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			949.4	B08		6	0020-0061	204.10	61.84	226	55.94	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2866.1	B08		6	0021-0063	730.17	63.45	233	59.11	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1822.5	B08		6	0022-0064	498.72	63.16	245	69.01	0.646
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1718.4	B08		6	0023-0063	678.46	63.79	253	60.53	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4177.9	B08		6	0024-0062	800.33	61.85	244	58.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2311.9	B08		6	0025-0068	226.95	67.53	270	62.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			358.6	B08		6	0026-0066	278.84	66.39	246	60.18	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			402.7	B08		6	0027-0072	181.60	72.64	259	59.60	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			841.2	B08		6	0028-0073	303.97	72.75	142	50.87	0.690
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			730.5	B08		6	0029-0075	873.16	74.78	181	55.46	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			187.2	B08		6	0030-0077	137.57	77.45	281	70.77	0.705
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			299.3	B08		6	0031-0072	369.31	71.86	216	56.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			255.5	B08		6	0032-0074	93.35	74.42	277	66.18	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			220.5	B08		6	0033-0076	749.60	75.53	247	60.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			332.9	B08		6	0034-0074	828.53	75.12	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2333.6	B08		6	0035-0074	468.50	73.93	140	53.60	0.612
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			867.2	B08		6	0036-0075	887.21	74.53	157	46.28	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			583.2	B08		6	0037-0076	291.02	76.96	172	51.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			444.4	B08		6	0038-0078	326.11	77.87	206	53.11	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			303.4	B08		6	0039-0081	945.11	81.27	264	61.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2420.3	B08		6	0040-0083	475.33	83.97	171	69.50	0.445
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1202.6	B08		6	0041-0084	646.17	83.21	217	57.01	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			796.9	B08		6	0042-0084	782.09	84.02	216	62.43	0.697
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			819.3	B08		6	0043-0090	621.04	89.96	363	79.50	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			383.0	B08		6	0044-0090	264.22	90.64	234	58.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			320.2	B08		6	0045-0094	656.83	94.92	306	66.08	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			519.0	B08		6	0046-0095	382.88	95.30	152	47.46	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			503.4	B08		6	0047-0096	915.08	96.39	207	53.70	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2101.2	B08		6	0048-0101	758.37	101.39	211	57.46	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			441.5	B08		6	0049-0100	845.38	100.20	293	63.94	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			960.7	B08		6	0050-0102	96.53	102.95	297	64.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			265.4	B08		6	0051-0101	298.56	101.23	244	58.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			626.4	B08		6	0052-0100	798.87	100.66	225	56.28	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			339.7	B08		6	0053-0104	198.14	103.63	280	61.60	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			706.9	B08		6	0054-0103	877.50	103.52	247	58.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1047.7	B08		6	0055-0102	942.13	102.05	251	59.70	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1267.6	B08		6	0056-0107	744.36	107.67	162	47.21	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			539.7	B08		6	0057-0108	391.85	108.59	153	45.46	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			261.3	B08		6	0058-0113	78.79	113.28	277	65.36	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1422.6	B08		6	0059-0113	242.98	113.41	218	53.70	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			310.2	B08		6	0060-0116	766.18	115.78	150	48.04	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1283.8	B08		6	0061-0116	804.17	116.51	207	54.28	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			283.8	B08		6	0062-0119	279.97	119.87	232	56.28	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			300.8	B08		6	0063-0123	914.69	123.08	259	61.01	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			419.5	B08		6	0064-0122	429.92	122.38	403	79.60	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			886.1	B08		6	0065-0128	842.71	127.97	474	112.37	0.472
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2602.9	B08		6	0066-0127	889.58	127.61	385	73.50	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			417.9	B08		6	0067-0125	389.34	124.73	336	69.36	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2395.2	B08		6	0068-0127	691.92	126.57	245	71.84	0.597
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3136.1	B08		6	0069-0127	175.41	127.89	218	53.36	0.962
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			507.4	B08		6	0070-0132	125.98	132.86	282	62.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			370.1	B08		6	0071-0134	29.09	133.61	376	76.08	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1771.2	B08		6	0072-0130	208.92	130.13	164	48.28	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			924.9	B08		6	0073-0131	813.04	132.02	186	52.87	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			245.6	B08		6	0074-0133	355.82	133.13	343	67.94	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			829.8	B08		6	0075-0138	732.48	138.25	276	61.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			189.7	B08		6	0076-0144	149.47	145.45	274	73.60	0.636
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1315.3	B08		6	0077-0140	309.01	139.24	216	55.94	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1486.8	B08		6	0078-0143	196.39	143.48	203	56.28	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1241.4	B08		6	0079-0149	786.60	150.31	291	65.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			277.8	B08		6	0080-0150	386.37	149.85	275	60.77	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1439.8	B08		6	0081-0148	817.30	148.22	250	75.01	0.558
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			8130.8	B08		6	0082-0150	946.96	149.91	242	58.18	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1781.5	B08		6	0083-0153	273.24	154.02	289	65.01	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			858.3	B08		6	0084-0155	131.09	155.52	247	59.01	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			583.9	B08		6	0085-0157	246.98	157.73	337	69.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			381.1	B08		6	0086-0158	457.24	158.53	339	68.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			635.6	B08		6	0087-0158	208.77	158.21	242	58.18	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			901.6	B08		6	0088-0166	49.73	166.25	354	70.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1440.8	B08		6	0089-0166	287.54	166.76	248	58.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			264.6	B08		6	0090-0175	870.84	175.38	381	75.26	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			855.1	B08		6	0091-0172	735.60	172.28	234	59.36	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			217.8	B08		6	0092-0175	835.95	175.10	250	57.94	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2890.9	B08		6	0093-0179	464.94	179.35	215	56.28	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			305.9	B08		6	0094-0179	190.45	179.29	343	71.36	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			11251.2	B08		6	0095-0182	76.79	183.02	272	67.01	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			553.9	B08		6	0096-0182	373.99	181.65	227	79.98	0.446
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1698.8	B08		6	0097-0181	690.04	180.83	277	62.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1479.6	B08		6	0098-0181	231.23	181.50	233	55.94	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3040.3	B08		6	0099-0183	917.64	183.66	167	53.60	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			535.7	B08		6	0100-0184	776.85	184.50	201	52.53	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			275.2	B08		6	0101-0185	758.74	184.56	217	53.36	0.958
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			303.7	B08		6	0102-0188	800.20	188.71	333	70.43	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			7158.3	B08		6	0103-0190	397.97	190.57	256	61.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2902.4	B08		6	0104-0192	899.37	192.46	295	64.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1841.2	B08		6	0105-0200	108.71	200.14	359	70.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			364.5	B08		6	0106-0201	56.29	200.70	237	57.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1064.9	B08		6	0107-0200	681.99	201.10	237	62.18	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			334.9	B08		6	0108-0201	834.80	200.47	355	73.26	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			227.9	B08		6	0109-0203	176.64	202.27	263	66.18	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			233.0	B08		6	0110-0209	310.51	208.53	366	75.94	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			492.5	B08		6	0111-0209	472.29	209.39	215	55.94	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			355.2	B08		6	0112-0214	606.09	213.84	242	58.53	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			443.9	B08		6	0113-0214	818.32	214.27	239	57.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			274.1	B08		6	0114-0217	248.87	217.11	332	67.01	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			516.7	B08		6	0115-0217	500.00	216.60	186	49.94	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4169.2	B08		6	0116-0220	568.92	220.19	257	58.77	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			560.4	B08		6	0117-0224	726.78	223.78	320	67.60	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1343.9	B08		6	0118-0225	142.72	225.23	246	57.60	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1321.3	B08		6	0119-0226	234.60	227.06	200	53.70	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1665.0	B08		6	0120-0230	948.80	230.29	228	56.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			328.2	B08		6	0121-0228	659.39	227.78	153	49.80	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			484.9	B08		6	0122-0236	910.61	235.65	274	68.43	0.735
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1803.4	B08		6	0123-0235	375.34	234.72	210	54.04	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			601.4	B08		6	0124-0234	790.33	235.13	163	49.36	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			237.3	B08		6	0125-0238	896.97	238.66	203	60.77	0.691
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1414.8	B08		6	0126-0240	625.02	239.52	279	64.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			366.6	B08		6	0127-0246	178.90	245.48	428	85.50	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			385.8	B08		6	0128-0245	438.35	245.28	355	72.77	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			493.4	B08		6	0129-0245	646.48	243.67	266	67.60	0.732
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			336.4	B08		6	0130-0239	663.76	238.35	168	49.21	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1406.5	B08		6	0131-0243	67.63	243.52	213	56.28	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1440.6	B08		6	0132-0247	486.91	246.95	253	64.18	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			626.8	B08		6	0133-0248	531.09	248.44	249	61.01	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1125.9	B08		6	0134-0251	417.01	250.38	212	58.77	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3527.9	B08		6	0135-0253	118.79	252.54	264	60.43	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			196.6	B08		6	0136-0252	675.65	252.20	285	64.53	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			197.9	B08		6	0137-0256	749.14	256.19	300	66.18	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1851.0	B08		6	0138-0253	368.01	252.98	164	51.11	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			494.9	B08		6	0139-0259	598.98	259.20	285	64.87	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1775.8	B08		6	0140-0256	824.76	255.95	217	56.77	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			761.0	B08		6	0141-0259	797.20	259.04	239	58.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			398.9	B08		6	0142-0261	21.52	261.09	298	65.01	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1673.4	B08		6	0143-0259	875.37	259.08	221	56.77	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1304.8	B08		6	0144-0261	553.37	260.39	166	60.18	0.576
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			713.7	B08		6	0145-0263	328.58	263.39	305	65.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			376.0	B08		6	0146-0265	465.15	265.36	291	63.11	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			385.4	B08		6	0147-0271	68.92	272.53	363	108.23	0.389
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			254.4	B08		6	0148-0272	378.93	270.94	392	79.84	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			955.3	B08		6	0149-0267	850.10	267.54	159	47.70	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1255.9	B08		6	0150-0267	833.39	268.08	242	59.70	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			716.9	B08		6	0151-0270	502.39	270.25	255	61.11	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			258.6	B08		6	0152-0269	695.23	268.96	241	59.46	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			186.7	B08		6	0153-0274	150.00	273.10	270	66.43	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			386.4	B08		6	0154-0274	212.56	275.08	217	53.94	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1308.0	B08		6	0155-0272	548.82	271.76	128	44.87	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			217.6	B08		6	0156-0279	749.96	279.48	346	77.60	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			787.1	B08		6	0157-0284	596.70	283.79	306	64.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			344.1	B08		6	0158-0285	26.16	285.99	324	68.18	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			668.0	B08		6	0159-0287	859.77	287.10	212	55.36	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3395.8	B08		6	0160-0289	272.88	290.40	237	58.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			465.0	B08		6	0161-0300	476.24	299.32	489	97.88	0.641
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3115.4	B08		6	0162-0294	791.90	294.98	252	59.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			331.4	B08		6	0163-0297	932.42	297.09	289	64.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4012.8	B08		6	0164-0296	306.06	296.08	262	61.60	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			364.6	B08		6	0165-0298	403.47	297.49	312	65.60	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			811.2	B08		6	0166-0296	349.69	295.43	248	58.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2485.5	B08		6	0167-0295	433.52	295.30	274	64.77	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1368.9	B08		6	0168-0305	645.39	304.40	304	64.18	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			438.2	B08		6	0169-0305	706.26	305.14	243	59.11	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			539.0	B08		6	0170-0313	93.83	312.17	329	85.50	0.566
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			213.3	B08		6	0171-0309	41.27	308.98	197	57.11	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			412.4	B08		6	0172-0306	730.39	305.71	220	55.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			224.4	B08		6	0173-0312	150.84	313.41	276	66.77	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3823.7	B08		6	0174-0313	24.52	313.16	261	59.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			422.5	B08		6	0175-0313	793.17	313.02	264	59.70	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1337.0	B08		6	0176-0315	439.81	316.01	212	55.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			480.9	B08		6	0177-0317	396.13	317.87	407	81.01	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			389.9	B08		6	0178-0318	545.03	318.51	318	65.01	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1635.8	B08		6	0179-0327	754.74	327.17	263	61.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1764.6	B08		6	0180-0331	645.40	330.50	297	62.77	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1251.4	B08		6	0181-0334	491.61	334.18	219	55.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			613.3	B08		6	0182-0342	301.32	342.68	475	83.50	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			932.8	B08		6	0183-0340	61.74	339.55	158	51.11	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2886.5	B08		6	0184-0339	792.04	339.66	201	52.53	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			948.9	B08		6	0185-0342	72.89	343.66	231	63.11	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			481.3	B08		6	0186-0341	550.94	341.55	258	58.53	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			475.9	B08		6	0187-0345	938.04	345.64	413	76.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			362.9	B08		6	0188-0345	247.62	345.92	257	62.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			247.5	B08		6	0189-0345	736.76	345.12	222	56.18	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			217.6	B08		6	0190-0352	915.67	352.18	387	81.01	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1317.6	B08		6	0191-0352	377.14	351.79	219	57.70	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			242.8	B08		6	0192-0351	498.07	351.01	213	53.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			484.5	B08		6	0193-0353	692.35	352.74	324	67.36	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3392.0	B08		6	0194-0357	364.46	357.85	224	56.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			7200.8	B08		6	0195-0360	461.11	360.46	289	67.84	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			322.3	B08		6	0196-0361	649.92	360.91	230	56.53	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			406.8	B08		6	0197-0363	727.33	363.16	361	72.08	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			316.6	B08		6	0198-0362	812.22	361.84	247	58.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			273.2	B08		6	0199-0362	324.84	362.43	285	62.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			399.3	B08		6	0200-0364	433.33	364.31	205	53.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2109.0	B08		6	0201-0369	678.26	369.38	217	56.77	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			277.5	B08		6	0202-0376	638.40	376.92	207	56.18	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			278.6	B08		6	0203-0372	911.90	372.84	164	47.21	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			192.2	B08		6	0204-0379	717.08	380.18	358	71.26	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			230.8	B08		6	0205-0383	151.22	382.57	305	66.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			378.4	B08		6	0206-0382	289.74	381.60	226	57.36	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1124.9	B08		6	0207-0386	890.49	386.72	261	61.84	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			881.4	B08		6	0208-0387	834.65	386.96	213	56.87	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			436.0	B08		6	0209-0390	82.98	390.33	240	58.77	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			8904.3	B08		6	0210-0392	36.05	392.71	211	67.01	0.590
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			401.3	B08		6	0211-0392	183.93	392.40	256	60.53	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			298.8	B08		6	0212-0392	298.98	391.86	144	51.01	0.695
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1683.0	B08		6	0213-0394	114.07	394.56	296	64.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			303.9	B08		6	0214-0394	281.33	394.54	232	57.11	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			323.2	B08		6	0215-0394	412.94	394.12	236	58.18	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			234.2	B08		6	0216-0397	433.84	396.77	302	64.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			292.8	B08		6	0217-0397	808.95	397.53	287	63.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			9311.1	B08		6	0218-0399	16.41	398.13	187	55.36	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			316.9	B08		6	0219-0397	306.38	397.19	106	41.46	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5193.5	B08		6	0220-0401	566.73	401.12	273	61.60	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			343.9	B08		6	0221-0400	702.01	399.92	259	60.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1272.2	B08		6	0222-0402	262.75	402.44	261	59.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			356.6	B08		6	0223-0402	896.29	402.41	262	64.28	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			397.9	B08		6	0224-0402	917.05	402.60	176	50.53	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1981.5	B08		6	0225-0402	210.70	402.36	213	55.46	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			526.5	B08		6	0226-0406	634.54	405.98	182	52.53	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			738.4	B08		6	0227-0407	617.53	407.50	242	58.04	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1221.5	B08		6	0228-0410	844.46	410.10	232	59.11	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3607.9	B08		6	0229-0414	863.80	414.11	264	61.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			869.7	B08		6	0230-0419	316.94	419.35	384	73.50	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			245.1	B08		6	0231-0416	247.34	416.66	321	66.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1781.2	B08		6	0232-0418	543.53	418.25	242	59.36	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			209.7	B08		6	0233-0420	160.59	420.35	351	71.84	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			220.8	B08		6	0234-0420	689.89	420.40	331	71.01	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			474.2	B08		6	0235-0417	919.49	417.35	174	48.04	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			296.5	B08		6	0236-0420	650.08	420.06	260	61.36	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1164.9	B08		6	0237-0424	349.77	424.67	239	59.84	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1848.8	B08		6	0238-0422	529.94	422.92	197	54.28	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4000.6	B08		6	0239-0422	766.88	421.56	159	53.94	0.687
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1147.1	B08		6	0240-0430	842.47	430.45	339	69.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2253.4	B08		6	0241-0430	118.40	430.35	258	61.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			580.5	B08		6	0242-0431	611.93	431.41	318	67.01	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			444.1	B08		6	0243-0431	914.42	431.01	211	57.36	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			602.9	B08		6	0244-0432	934.62	432.12	214	58.53	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			259.9	B08		6	0245-0435	49.57	435.67	253	58.28	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3967.2	B08		6	0246-0432	771.14	431.83	128	51.70	0.602
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1483.1	B08		6	0247-0434	896.37	433.69	188	51.94	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			507.2	B08		6	0248-0443	875.29	443.91	144	50.53	0.709
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1805.6	B08		6	0249-0443	261.47	443.67	254	59.11	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			380.6	B08		6	0250-0444	558.68	443.73	283	64.53	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3013.0	B08		6	0251-0449	448.25	449.72	290	66.77	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			301.0	B08		6	0252-0448	228.27	448.43	318	67.94	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1082.4	B08		6	0253-0454	590.24	454.84	417	75.01	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			7160.0	B08		6	0254-0455	50.24	454.70	312	65.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			239.7	B08		6	0255-0452	174.21	452.40	213	55.80	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1315.8	B08		6	0256-0455	701.19	455.85	283	66.67	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2379.6	B08		6	0257-0452	853.43	452.66	186	53.70	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			607.7	B08		6	0258-0457	671.01	456.28	211	57.94	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			404.1	B08		6	0259-0458	464.15	458.21	320	68.18	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			198.6	B08		6	0260-0458	747.26	458.97	233	64.43	0.705
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			247.7	B08		6	0261-0462	420.15	463.25	341	75.50	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1535.0	B08		6	0262-0459	85.49	459.20	238	57.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			458.6	B08		6	0263-0459	507.37	459.32	214	54.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			593.1	B08		6	0264-0465	314.66	465.76	333	71.01	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			272.7	B08		6	0265-0466	136.07	466.13	354	71.11	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			256.7	B08		6	0266-0468	172.72	467.77	250	63.70	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			280.0	B08		6	0267-0473	491.59	472.88	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1290.6	B08		6	0268-0473	815.16	473.17	253	59.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			146.9	B08		6	0269-0478	780.69	477.91	325	68.77	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			380.8	B08		6	0270-0475	227.97	475.28	214	57.11	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			303.0	B08		6	0271-0480	211.70	481.35	251	62.18	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			405.2	B08		6	0272-0483	859.42	482.86	271	64.18	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			221.2	B08		6	0273-0485	752.35	484.85	237	60.87	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			262.8	B08		6	0274-0483	585.53	483.73	243	63.36	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			9070.3	B08		6	0275-0484	385.51	485.19	164	50.87	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			223.3	B08		6	0276-0488	89.40	489.15	395	75.01	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			345.5	B08		6	0277-0489	296.69	488.85	244	58.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			458.4	B08		6	0278-0492	143.08	492.32	228	55.36	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2343.6	B08		6	0279-0491	336.64	491.70	220	56.28	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			207.9	B08		6	0280-0492	513.77	492.88	252	59.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1425.9	B08		6	0281-0498	48.00	498.20	251	59.94	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			312.8	B08		6	0282-0498	852.36	498.53	283	65.60	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			205.5	B08		6	0283-0500	111.63	500.19	240	58.77	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1144.0	B08		6	0284-0500	478.43	499.97	207	51.46	0.982
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			276.1	B08		6	0285-0501	795.41	501.71	210	53.70	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			431.5	B08		6	0286-0503	443.46	502.86	393	76.67	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			584.6	B08		6	0287-0504	559.57	504.46	323	67.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			466.1	B08		6	0288-0504	831.86	504.47	290	62.53	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1450.2	B08		6	0289-0505	333.16	504.68	199	54.87	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2223.4	B08		6	0290-0509	934.43	509.12	471	88.57	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			234.0	B08		6	0291-0510	601.38	510.61	350	70.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			284.8	B08		6	0292-0512	911.09	511.98	298	68.18	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			972.2	B08		6	0293-0514	516.97	514.15	236	57.70	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			187.4	B08		6	0294-0515	42.43	515.91	283	62.18	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			985.7	B08		6	0295-0516	653.99	516.16	302	66.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			794.2	B08		6	0296-0518	896.99	517.89	228	60.77	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			284.8	B08		6	0297-0518	64.81	518.39	236	56.77	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			232.8	B08		6	0298-0521	259.18	521.20	288	64.43	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			435.2	B08		6	0299-0522	759.26	522.01	321	66.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			875.0	B08		6	0300-0521	695.19	521.83	316	67.84	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			385.7	B08		6	0301-0524	307.39	524.49	237	63.60	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1099.9	B08		6	0302-0524	537.36	523.04	202	57.36	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			522.5	B08		6	0303-0526	738.26	525.71	335	67.11	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4094.5	B08		6	0304-0530	442.40	529.89	215	53.94	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			231.5	B08		6	0305-0529	222.70	529.77	259	62.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			196.1	B08		6	0306-0533	148.88	533.45	266	64.77	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			215.9	B08		6	0307-0537	520.57	536.09	307	66.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			837.5	B08		6	0308-0540	795.24	540.18	237	62.77	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			404.4	B08		6	0309-0541	927.11	540.64	263	61.36	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			217.1	B08		6	0310-0541	111.28	540.83	251	61.94	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			913.6	B08		6	0311-0538	356.39	538.08	144	45.36	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			596.0	B08		6	0312-0542	430.57	542.86	238	62.43	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			209.0	B08		6	0313-0544	37.62	545.15	245	60.18	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			245.6	B08		6	0314-0547	665.59	548.67	353	72.67	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			339.6	B08		6	0315-0546	456.52	545.84	221	57.36	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4044.0	B08		6	0316-0549	376.55	548.79	276	62.87	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			293.9	B08		6	0317-0551	228.15	552.09	280	66.77	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			228.2	B08		6	0318-0547	558.15	547.60	267	61.94	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1053.2	B08		6	0319-0549	84.88	549.15	205	52.28	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			967.5	B08		6	0320-0548	343.66	548.44	170	50.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			466.3	B08		6	0321-0550	623.33	550.48	234	56.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			270.3	B08		6	0322-0553	852.44	553.40	224	58.53	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			434.1	B08		6	0323-0552	702.41	551.60	300	63.36	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2536.1	B08		6	0324-0555	65.46	554.14	214	59.70	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			617.7	B08		6	0325-0559	412.48	559.15	240	58.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			374.4	B08		6	0326-0556	466.53	556.84	195	54.53	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			785.6	B08		6	0327-0560	785.46	559.58	267	62.43	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			292.5	B08		6	0328-0560	950.45	560.92	238	60.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4791.0	B08		6	0329-0566	215.30	565.75	257	61.70	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			286.3	B08		6	0330-0569	328.41	568.40	269	61.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			272.0	B08		6	0331-0574	461.56	575.67	264	67.36	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			336.9	B08		6	0332-0573	871.02	573.07	373	70.18	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1404.1	B08		6	0333-0572	501.78	572.33	159	49.11	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			510.1	B08		6	0334-0578	44.25	578.31	327	75.01	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			427.4	B08		6	0335-0576	831.51	575.40	184	50.87	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			550.8	B08		6	0336-0579	405.43	579.94	296	65.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			314.0	B08		6	0337-0580	940.14	579.77	260	61.94	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1139.1	B08		6	0338-0582	118.12	582.44	355	70.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			227.6	B08		6	0339-0581	545.71	581.43	267	62.43	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2030.7	B08		6	0340-0583	758.34	583.80	270	60.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			316.3	B08		6	0341-0590	861.76	590.73	212	56.28	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1079.8	B08		6	0342-0593	897.40	593.24	281	63.60	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1108.6	B08		6	0343-0595	503.64	594.99	153	46.28	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			334.3	B08		6	0344-0598	186.48	597.91	353	69.84	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			7887.0	B08		6	0345-0598	925.56	598.86	254	59.11	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			310.4	B08		6	0346-0594	793.86	594.85	119	44.28	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			274.1	B08		6	0347-0601	45.57	601.17	270	62.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			348.6	B08		6	0348-0604	674.21	604.94	328	70.77	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			267.3	B08		6	0349-0605	300.47	604.75	327	68.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			316.6	B08		6	0350-0604	797.84	604.85	204	61.94	0.668
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			275.0	B08		6	0351-0610	121.59	610.26	241	58.53	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			535.6	B08		6	0352-0614	419.35	614.52	331	67.60	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			423.9	B08		6	0353-0617	18.20	617.26	228	54.53	0.964
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1100.3	B08		6	0354-0620	371.00	620.02	395	78.08	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			298.2	B08		6	0355-0618	818.54	619.07	286	63.11	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			261.4	B08		6	0356-0621	886.62	621.92	270	61.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			232.3	B08		6	0357-0624	540.31	624.49	305	65.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			447.7	B08		6	0358-0624	108.75	623.92	311	66.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			194.7	B08		6	0359-0624	238.42	623.48	277	64.53	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			402.2	B08		6	0360-0627	41.31	627.73	283	63.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			324.9	B08		6	0361-0632	771.16	631.75	395	74.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			228.2	B08		6	0362-0638	948.41	638.14	366	72.43	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			850.5	B08		6	0363-0639	381.42	638.47	293	64.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			218.1	B08		6	0364-0642	841.54	642.68	274	63.84	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			204.0	B08		6	0365-0646	214.06	645.66	254	63.11	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2042.9	B08		6	0366-0646	912.19	645.78	237	57.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			520.5	B08		6	0367-0648	64.54	648.32	224	56.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			234.2	B08		6	0368-0650	489.58	649.78	282	63.01	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			216.8	B08		6	0369-0653	422.26	652.20	405	76.67	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			560.2	B08		6	0370-0648	826.17	648.23	215	54.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			397.4	B08		6	0371-0653	113.86	652.70	231	58.87	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			354.8	B08		6	0372-0653	602.39	653.01	329	69.01	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			286.7	B08		6	0373-0658	18.30	658.28	370	72.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3816.3	B08		6	0374-0655	712.94	655.48	293	65.36	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1032.9	B08		6	0375-0658	328.43	658.02	305	64.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3035.6	B08		6	0376-0664	781.20	663.74	247	59.36	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2167.1	B08		6	0377-0662	900.70	662.82	224	56.53	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			717.4	B08		6	0378-0664	148.61	664.67	220	53.94	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			223.4	B08		6	0379-0663	524.35	662.59	272	61.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			439.5	B08		6	0380-0665	835.11	664.12	225	61.01	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			524.0	B08		6	0381-0673	210.21	673.07	188	52.87	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			787.4	B08		6	0382-0672	430.67	672.77	245	58.87	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			548.5	B08		6	0383-0673	822.78	674.69	235	58.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1053.9	B08		6	0384-0675	614.54	674.84	272	63.01	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			802.4	B08		6	0385-0674	859.84	673.39	222	57.01	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			355.8	B08		6	0386-0675	663.73	675.40	406	77.01	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			191.1	B08		6	0387-0677	744.93	677.07	237	59.11	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			262.8	B08		6	0388-0683	78.83	682.69	354	73.26	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1736.4	B08		6	0389-0681	930.27	681.12	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			900.1	B08		6	0390-0686	260.52	686.06	309	64.18	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1566.7	B08		6	0391-0684	802.37	683.50	206	53.11	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			257.2	B08		6	0392-0686	126.55	686.41	213	56.28	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			378.5	B08		6	0393-0687	406.24	687.58	300	63.60	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1365.2	B08		6	0394-0688	38.48	688.08	219	55.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			526.3	B08		6	0395-0692	336.61	691.64	260	61.01	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			286.9	B08		6	0396-0693	377.30	693.73	143	47.80	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			224.1	B08		6	0397-0694	473.18	694.78	246	59.94	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			380.4	B08		6	0398-0700	708.19	700.42	393	75.01	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			208.5	B08		6	0399-0699	725.25	699.07	256	59.70	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			8015.7	B08		6	0400-0703	517.50	703.30	205	54.53	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1292.2	B08		6	0401-0706	576.37	706.19	196	53.94	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			343.8	B08		6	0402-0707	116.69	707.16	302	66.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			286.9	B08		6	0403-0709	376.77	708.80	241	61.70	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			804.1	B08		7	0001-0026	81.39	26.79	137	43.94	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3454.1	B08		7	0002-0029	247.78	28.87	248	59.11	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1761.5	B08		7	0003-0028	824.82	27.21	222	55.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			559.0	B08		7	0004-0033	560.84	33.13	299	64.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1620.3	B08		7	0005-0031	711.12	31.85	252	59.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2021.8	B08		7	0006-0036	632.02	36.41	452	80.08	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			659.8	B08		7	0007-0036	390.73	36.07	154	54.28	0.657
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			217.9	B08		7	0008-0040	52.67	39.62	298	66.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			507.2	B08		7	0009-0037	403.64	36.79	145	43.80	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1304.2	B08		7	0010-0043	16.80	44.41	162	53.70	0.706
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			581.6	B08		7	0011-0040	381.00	39.87	117	42.87	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2014.0	B08		7	0012-0047	30.32	48.28	217	59.94	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			417.6	B08		7	0013-0047	435.38	48.08	253	60.53	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			269.3	B08		7	0014-0046	920.57	45.84	220	55.11	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			298.4	B08		7	0015-0051	272.52	52.16	262	67.50	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			229.8	B08		7	0016-0050	486.01	50.03	449	81.26	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			271.3	B08		7	0017-0057	78.11	57.33	229	56.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			735.3	B08		7	0018-0063	120.28	62.76	458	79.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			412.5	B08		7	0019-0063	57.27	62.60	233	62.77	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2358.7	B08		7	0020-0064	310.19	63.67	254	74.08	0.582
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			387.9	B08		7	0021-0067	750.66	66.50	391	72.67	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			356.8	B08		7	0022-0066	821.45	66.51	304	65.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2121.3	B08		7	0023-0066	167.52	66.48	242	59.94	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			287.9	B08		7	0024-0067	451.50	67.38	306	67.84	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			346.2	B08		7	0025-0073	68.84	72.68	197	51.70	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			413.4	B08		7	0026-0078	911.74	78.18	401	74.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			219.2	B08		7	0027-0081	195.65	81.18	335	69.26	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			209.5	B08		7	0028-0083	493.62	83.30	468	86.91	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1286.2	B08		7	0029-0081	336.24	81.83	194	56.18	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			197.7	B08		7	0030-0084	688.64	84.51	298	66.67	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1735.0	B08		7	0031-0084	776.67	84.47	260	60.18	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			286.6	B08		7	0032-0087	403.82	87.15	260	59.60	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			388.6	B08		7	0033-0092	240.65	92.13	310	64.77	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1909.8	B08		7	0034-0096	739.27	96.03	240	58.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			190.0	B08		7	0035-0102	295.43	101.57	365	80.43	0.709
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5921.8	B08		7	0036-0106	440.25	106.12	284	64.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			322.4	B08		7	0037-0112	414.56	114.02	365	86.91	0.607
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1549.0	B08		7	0038-0113	24.04	114.25	259	58.77	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4061.4	B08		7	0039-0115	912.85	115.08	264	62.43	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			429.2	B08		7	0040-0112	91.25	111.96	205	54.28	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5244.6	B08		7	0041-0116	861.89	116.11	264	61.36	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1425.9	B08		7	0042-0122	319.98	122.32	317	69.60	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1366.8	B08		7	0043-0121	338.52	120.85	147	52.63	0.667
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			485.6	B08		7	0044-0123	389.16	122.64	301	66.43	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			286.0	B08		7	0045-0121	188.05	120.87	238	64.77	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			517.9	B08		7	0046-0130	584.23	129.68	444	82.08	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			185.0	B08		7	0047-0127	632.15	126.73	300	77.26	0.632
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			655.0	B08		7	0048-0128	236.19	127.72	257	57.70	0.970
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			270.4	B08		7	0049-0132	83.70	132.95	279	65.36	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			482.1	B08		7	0050-0132	157.49	131.97	151	45.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			530.5	B08		7	0051-0132	199.98	133.12	219	57.94	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1055.8	B08		7	0052-0135	440.86	136.01	267	62.77	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			306.2	B08		7	0053-0138	378.41	138.40	250	61.94	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			417.0	B08		7	0054-0143	802.02	142.93	505	87.84	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2310.5	B08		7	0055-0140	183.23	140.29	197	52.28	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1975.7	B08		7	0056-0141	168.37	141.83	204	53.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			801.5	B08		7	0057-0146	272.79	146.49	375	76.18	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2309.3	B08		7	0058-0143	290.74	142.61	123	42.28	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			247.3	B08		7	0059-0147	689.43	148.17	378	74.08	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			335.9	B08		7	0060-0151	888.71	150.40	366	70.77	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			278.5	B08		7	0061-0155	242.33	155.57	246	59.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			336.5	B08		7	0062-0159	495.41	159.53	476	81.26	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			507.9	B08		7	0063-0154	140.59	153.43	151	49.36	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			614.5	B08		7	0064-0161	339.70	161.13	531	97.40	0.703
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1659.9	B08		7	0065-0159	361.14	158.65	346	75.01	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1072.4	B08		7	0066-0159	674.90	159.46	220	57.60	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			184.9	B08		7	0067-0164	634.54	165.00	233	63.84	0.718
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			446.8	B08		7	0068-0163	134.49	163.21	162	51.60	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			368.0	B08		7	0069-0164	415.04	164.40	351	71.01	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1584.2	B08		7	0070-0164	465.84	164.38	268	60.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			395.5	B08		7	0071-0165	88.45	165.93	207	53.70	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3074.0	B08		7	0072-0167	43.25	167.63	240	56.28	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			850.4	B08		7	0073-0169	215.15	169.30	400	75.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			291.3	B08		7	0074-0174	818.62	173.99	505	87.26	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			276.5	B08		7	0075-0171	853.97	170.66	361	72.08	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			212.6	B08		7	0076-0171	607.12	171.03	221	55.70	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1774.2	B08		7	0077-0176	307.71	176.43	399	76.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1398.9	B08		7	0078-0174	773.89	174.10	219	53.94	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1277.9	B08		7	0079-0173	920.75	174.10	151	66.43	0.430
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			210.2	B08		7	0080-0179	627.32	179.07	275	68.77	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4163.5	B08		7	0081-0183	92.24	182.24	227	58.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1927.4	B08		7	0082-0186	412.67	186.07	258	59.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			219.8	B08		7	0083-0191	529.97	191.30	400	74.91	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1576.0	B08		7	0084-0193	162.74	193.94	271	72.33	0.651
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			599.3	B08		7	0085-0194	571.70	194.47	302	64.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1325.0	B08		7	0086-0193	719.20	193.39	188	53.94	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			270.4	B08		7	0087-0196	899.44	197.36	350	72.18	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4296.7	B08		7	0088-0195	686.08	194.73	240	57.94	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			255.4	B08		7	0089-0197	218.70	197.96	244	59.36	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3211.7	B08		7	0090-0198	314.70	198.25	251	58.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			839.5	B08		7	0091-0196	613.26	196.59	204	56.87	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			356.9	B08		7	0092-0201	946.42	201.19	274	66.08	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			383.2	B08		7	0093-0206	58.01	206.48	258	61.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			241.9	B08		7	0094-0211	177.98	211.36	360	69.60	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			418.4	B08		7	0095-0216	397.84	216.51	337	69.26	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1350.1	B08		7	0096-0218	339.99	218.35	273	60.77	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			309.0	B08		7	0097-0221	569.60	222.01	391	87.50	0.642
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			671.3	B08		7	0098-0219	89.92	218.98	242	57.11	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			185.7	B08		7	0099-0225	446.62	225.98	396	76.43	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			423.8	B08		7	0100-0228	126.72	228.49	240	56.77	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			518.8	B08		7	0101-0228	413.78	228.49	276	61.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			219.4	B08		7	0102-0231	907.18	231.20	289	63.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			14720.7	B08		7	0103-0232	720.98	231.94	236	62.67	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			461.0	B08		7	0104-0233	264.91	234.22	194	56.53	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			297.7	B08		7	0105-0234	283.80	234.69	332	68.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			603.8	B08		7	0106-0237	521.36	236.40	382	73.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			281.9	B08		7	0107-0236	947.56	236.18	340	68.77	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			709.8	B08		7	0108-0237	872.17	237.48	266	63.84	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			311.3	B08		7	0109-0245	843.77	243.71	350	102.57	0.418
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3269.2	B08		7	0110-0243	51.98	243.74	182	49.70	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			358.0	B08		7	0111-0243	604.19	243.46	216	59.36	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2054.0	B08		7	0112-0246	378.93	246.46	256	59.36	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			232.1	B08		7	0113-0249	463.00	249.54	233	56.53	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			370.8	B08		7	0114-0249	587.12	249.49	180	50.87	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			427.6	B08		7	0115-0254	128.47	254.68	307	80.57	0.594
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			321.8	B08		7	0116-0254	247.69	254.10	326	66.43	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			423.6	B08		7	0117-0256	397.74	256.62	240	57.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			267.6	B08		7	0118-0259	553.97	259.30	371	73.01	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1394.5	B08		7	0119-0257	323.31	257.59	255	59.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			427.7	B08		7	0120-0264	877.21	264.15	243	65.94	0.702
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			333.7	B08		7	0121-0264	429.23	263.74	193	51.11	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			684.0	B08		7	0122-0265	682.52	264.78	242	60.18	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			315.6	B08		7	0123-0268	23.52	267.27	312	68.67	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			278.5	B08		7	0124-0273	942.28	273.29	228	55.11	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2395.0	B08		7	0125-0277	472.77	276.83	285	65.36	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			262.3	B08		7	0126-0279	591.93	279.81	335	67.60	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			345.3	B08		7	0127-0280	373.41	281.31	303	65.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			497.0	B08		7	0128-0281	97.96	280.43	287	68.18	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			411.3	B08		7	0129-0289	160.03	289.59	504	84.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4736.2	B08		7	0130-0286	717.44	286.35	251	59.94	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1020.8	B08		7	0131-0285	226.22	284.88	147	47.46	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			567.7	B08		7	0132-0287	884.60	287.66	261	63.01	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			290.0	B08		7	0133-0287	266.28	286.81	204	54.28	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			219.2	B08		7	0134-0295	42.73	293.97	470	84.67	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2686.2	B08		7	0135-0290	409.83	289.56	218	55.11	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			224.0	B08		7	0136-0296	638.34	296.98	357	70.43	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			291.4	B08		7	0137-0296	95.19	296.13	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			283.4	B08		7	0138-0300	300.90	299.53	352	70.18	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1824.1	B08		7	0139-0299	441.91	299.04	285	62.53	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			280.7	B08		7	0140-0303	747.06	302.21	284	64.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1694.4	B08		7	0141-0300	226.96	300.39	100	38.04	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1737.5	B08		7	0142-0307	921.16	307.62	285	79.50	0.567
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			613.0	B08		7	0143-0304	356.23	304.27	278	65.01	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2757.6	B08		7	0144-0303	621.62	304.04	199	53.11	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			211.6	B08		7	0145-0309	250.39	309.05	279	69.01	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			249.0	B08		7	0146-0312	495.72	311.78	412	83.98	0.734
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2372.6	B08		7	0147-0310	729.52	310.80	232	57.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			210.1	B08		7	0148-0311	762.11	310.96	229	57.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3226.7	B08		7	0149-0310	528.20	310.63	234	58.28	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			386.7	B08		7	0150-0312	795.82	311.91	291	64.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1151.9	B08		7	0151-0316	235.32	316.79	240	70.43	0.608
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			457.5	B08		7	0152-0312	410.34	312.51	248	58.63	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1556.6	B08		7	0153-0317	371.38	316.56	293	65.94	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			343.2	B08		7	0154-0316	266.32	316.82	171	48.87	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1737.5	B08		7	0155-0319	546.92	318.83	210	54.18	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			855.1	B08		7	0156-0321	27.86	321.46	191	51.36	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			376.0	B08		7	0157-0328	430.10	328.68	339	67.94	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			264.2	B08		7	0158-0327	847.85	326.72	221	54.28	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			555.0	B08		7	0159-0326	410.89	326.20	166	48.39	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			329.1	B08		7	0160-0331	450.98	331.32	320	66.53	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			271.3	B08		7	0161-0334	292.22	334.82	267	65.94	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			313.1	B08		7	0162-0336	930.56	336.09	198	53.60	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			572.1	B08		7	0163-0336	162.68	335.79	175	49.94	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			228.4	B08		7	0164-0338	896.94	338.98	324	67.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			969.6	B08		7	0165-0338	660.25	337.98	156	50.87	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			917.5	B08		7	0166-0341	646.64	340.59	261	61.11	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			922.5	B08		7	0167-0340	675.12	339.91	190	52.77	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1400.6	B08		7	0168-0342	707.87	342.91	276	69.84	0.711
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1451.1	B08		7	0169-0342	784.65	342.46	217	55.36	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2414.8	B08		7	0170-0343	309.89	343.09	258	60.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			492.3	B08		7	0171-0346	481.88	346.11	316	72.77	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			455.0	B08		7	0172-0349	217.80	349.32	361	71.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			318.9	B08		7	0173-0347	153.24	347.05	227	56.18	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			385.2	B08		7	0174-0350	859.26	351.10	336	68.53	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1324.6	B08		7	0175-0349	800.64	349.33	177	49.70	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1349.3	B08		7	0176-0353	338.93	352.34	261	60.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			759.0	B08		7	0177-0358	71.12	358.95	447	91.74	0.667
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			230.8	B08		7	0178-0353	817.46	353.46	233	59.70	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2609.8	B08		7	0179-0362	371.36	361.56	494	93.05	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			260.0	B08		7	0180-0367	99.04	367.18	454	85.74	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			488.6	B08		7	0181-0359	462.03	360.16	146	45.21	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			199.5	B08		7	0182-0369	691.26	369.39	264	64.08	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3431.6	B08		7	0183-0370	447.16	369.83	216	55.11	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			410.9	B08		7	0184-0370	843.94	370.61	319	66.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			443.0	B08		7	0185-0371	278.60	372.16	262	63.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			236.8	B08		7	0186-0375	503.14	375.57	260	65.36	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			216.5	B08		7	0187-0374	307.18	373.51	277	65.36	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			443.0	B08		7	0188-0373	354.76	374.48	147	49.36	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1740.5	B08		7	0189-0376	381.94	376.76	278	67.01	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			217.9	B08		7	0190-0380	727.75	380.71	335	69.84	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4374.7	B08		7	0191-0380	526.81	381.04	221	57.36	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			191.5	B08		7	0192-0384	684.62	383.73	275	63.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			207.4	B08		7	0193-0390	164.13	389.70	472	83.36	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1681.9	B08		7	0194-0387	798.47	387.55	357	70.43	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			323.6	B08		7	0195-0388	927.26	388.88	312	65.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			201.0	B08		7	0196-0394	185.85	393.76	261	63.01	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			526.0	B08		7	0197-0395	116.26	395.13	255	58.77	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			428.9	B08		7	0198-0393	840.15	393.95	241	57.70	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			420.6	B08		7	0199-0399	899.11	399.12	309	65.36	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			349.4	B08		7	0200-0400	555.73	400.33	333	71.01	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			647.1	B08		7	0201-0402	94.97	402.82	390	74.43	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2573.0	B08		7	0202-0403	503.44	403.91	240	59.70	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			442.1	B08		7	0203-0402	782.10	402.91	155	50.87	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2266.1	B08		7	0204-0406	870.45	407.13	285	71.01	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			393.5	B08		7	0205-0405	281.16	404.51	254	62.77	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			592.5	B08		7	0206-0408	439.39	407.70	223	57.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5194.8	B08		7	0207-0407	677.66	407.11	250	57.94	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			316.2	B08		7	0208-0409	946.76	409.94	278	67.01	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			986.8	B08		7	0209-0408	50.70	408.74	253	61.70	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			215.4	B08		7	0210-0408	329.76	408.12	319	72.43	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			148.2	B08		7	0211-0412	228.68	412.13	306	65.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			433.2	B08		7	0212-0413	582.83	413.25	313	67.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			394.7	B08		7	0213-0409	753.48	408.41	161	49.70	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			223.1	B08		7	0214-0416	308.23	416.71	224	61.36	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1076.0	B08		7	0215-0419	544.64	418.65	204	51.94	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			233.5	B08		7	0216-0420	627.16	420.38	308	67.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1409.1	B08		7	0217-0423	938.35	422.78	276	65.26	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			318.2	B08		7	0218-0427	816.11	427.07	261	61.70	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			287.5	B08		7	0219-0428	330.82	429.26	299	66.43	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			261.3	B08		7	0220-0429	710.81	428.85	298	66.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			924.5	B08		7	0221-0431	199.59	430.66	279	63.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			504.7	B08		7	0222-0432	784.78	431.99	288	65.60	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			640.6	B08		7	0223-0436	80.45	436.11	367	73.11	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			772.8	B08		7	0224-0434	530.11	433.20	296	67.60	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2067.6	B08		7	0225-0437	547.31	438.14	267	65.26	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1355.5	B08		7	0226-0438	24.77	437.88	236	59.70	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			645.0	B08		7	0227-0437	102.70	437.10	222	58.18	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			9219.7	B08		7	0228-0438	689.99	437.92	218	56.28	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			218.6	B08		7	0229-0444	644.17	443.89	414	80.67	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			226.3	B08		7	0230-0445	349.35	444.63	254	62.18	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			228.2	B08		7	0231-0448	673.60	448.71	311	67.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4948.5	B08		7	0232-0451	760.98	450.72	222	61.94	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1126.2	B08		7	0233-0451	577.59	451.76	277	63.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3317.0	B08		7	0234-0454	817.04	453.79	324	68.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			252.1	B08		7	0235-0456	455.98	456.45	269	64.18	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			365.1	B08		7	0236-0460	63.98	460.09	299	63.94	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1512.7	B08		7	0237-0466	864.93	466.05	302	80.91	0.580
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1021.2	B08		7	0238-0464	356.84	463.88	256	60.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			864.5	B08		7	0239-0466	513.38	466.70	281	63.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1392.2	B08		7	0240-0467	328.45	467.72	371	83.84	0.663
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2902.4	B08		7	0241-0468	849.84	468.20	184	53.46	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			338.5	B08		7	0242-0472	906.09	471.68	340	76.67	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			232.8	B08		7	0243-0470	203.00	469.81	222	58.18	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			278.6	B08		7	0244-0472	236.38	472.69	220	59.01	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			174.6	B08		7	0245-0477	934.34	478.49	318	72.43	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1895.7	B08		7	0246-0481	651.26	482.10	510	106.57	0.564
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1932.5	B08		7	0247-0486	129.79	486.75	499	86.67	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			405.3	B08		7	0248-0482	398.08	481.83	240	57.60	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			956.9	B08		7	0249-0484	782.53	484.13	397	75.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			446.7	B08		7	0250-0491	555.13	492.15	336	68.43	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			216.5	B08		7	0251-0493	488.53	493.04	280	65.01	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			338.8	B08		7	0252-0496	630.32	496.96	275	61.01	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			439.2	B08		7	0253-0504	76.36	503.82	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			593.1	B08		7	0254-0512	563.18	512.38	275	61.11	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			389.2	B08		7	0255-0515	929.60	515.28	331	67.84	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			239.8	B08		7	0256-0515	303.66	514.76	221	56.18	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			328.5	B08		7	0257-0517	419.55	516.60	219	54.87	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			230.7	B08		7	0258-0520	523.11	521.12	339	71.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			249.0	B08		7	0259-0523	102.70	523.12	267	67.94	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1990.7	B08		7	0260-0520	194.12	520.44	217	55.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			402.9	B08		7	0261-0521	781.22	521.50	240	62.18	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			919.1	B08		7	0262-0522	715.60	522.41	182	49.11	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			284.5	B08		7	0263-0529	225.10	528.94	309	65.11	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			345.7	B08		7	0264-0527	285.61	527.28	236	57.70	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			246.1	B08		7	0265-0530	149.38	529.94	288	65.94	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			294.2	B08		7	0266-0534	429.34	534.91	260	62.43	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1828.0	B08		7	0267-0536	770.17	537.07	227	56.18	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			219.3	B08		7	0268-0540	906.22	540.02	407	76.43	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			716.1	B08		7	0269-0540	335.32	539.97	212	55.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1489.7	B08		7	0270-0545	548.09	545.33	251	59.94	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			627.0	B08		7	0271-0545	270.40	544.99	189	51.94	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			319.4	B08		7	0272-0546	447.50	545.93	228	58.43	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			936.1	B08		7	0273-0553	804.74	553.28	232	58.77	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1509.1	B08		7	0274-0549	859.05	549.05	126	43.46	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			224.9	B08		7	0275-0551	482.79	550.94	212	53.70	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			261.0	B08		7	0276-0552	392.00	551.27	300	69.60	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			351.2	B08		7	0277-0553	821.00	553.94	198	56.18	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5984.0	B08		7	0278-0555	301.57	555.59	283	65.94	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2650.9	B08		7	0279-0558	776.62	558.39	269	62.53	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			357.7	B08		7	0280-0559	689.71	560.15	226	62.77	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			534.1	B08		7	0281-0560	339.19	559.53	187	51.36	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1415.0	B08		7	0282-0564	852.72	564.30	217	55.84	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1259.7	B08		7	0283-0565	273.27	565.52	251	61.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			267.4	B08		7	0284-0566	215.27	567.71	321	73.01	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3292.6	B08		7	0285-0568	794.53	567.90	241	58.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			228.5	B08		7	0286-0568	574.60	568.25	313	68.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			215.1	B08		7	0287-0571	97.09	571.01	324	68.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			285.6	B08		7	0288-0572	358.39	571.60	225	57.70	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			571.6	B08		7	0289-0568	451.12	568.59	194	50.87	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1024.8	B08		7	0290-0571	514.70	571.55	238	57.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1451.5	B08		7	0291-0575	818.21	576.01	261	63.11	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			867.0	B08		7	0292-0573	627.10	573.01	252	58.87	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			680.3	B08		7	0293-0587	161.52	585.95	593	107.05	0.650
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3410.0	B08		7	0294-0580	382.48	581.18	206	56.04	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			858.6	B08		7	0295-0582	856.68	582.60	241	59.84	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			775.4	B08		7	0296-0581	454.66	581.62	195	53.21	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			721.4	B08		7	0297-0584	20.47	584.14	229	57.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			749.8	B08		7	0298-0589	65.54	589.46	360	71.36	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			209.4	B08		7	0299-0589	202.30	589.49	276	69.01	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			266.5	B08		7	0300-0586	306.59	585.47	227	56.53	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			325.6	B08		7	0301-0587	540.11	586.99	191	51.36	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			293.0	B08		7	0302-0589	419.81	589.22	243	57.11	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			546.5	B08		7	0303-0589	641.78	589.13	208	54.28	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			217.6	B08		7	0304-0591	870.52	591.42	226	55.11	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1051.5	B08		7	0305-0592	401.35	592.08	206	54.28	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1230.7	B08		7	0306-0595	386.10	595.23	181	51.80	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			368.3	B08		7	0307-0599	934.08	598.75	396	74.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			11377.0	B08		7	0308-0597	468.94	597.78	296	63.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			409.9	B08		7	0309-0599	531.68	600.05	232	55.36	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			513.5	B08		7	0310-0600	586.68	599.78	239	57.70	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			259.4	B08		7	0311-0603	237.89	602.51	256	58.53	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			349.8	B08		7	0312-0603	747.56	603.22	140	46.28	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			407.3	B08		7	0313-0607	275.96	606.98	234	56.53	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			201.6	B08		7	0314-0618	761.53	616.65	395	87.26	0.652
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4064.6	B08		7	0315-0618	317.58	618.43	245	59.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			602.1	B08		7	0316-0620	798.63	619.75	372	73.60	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5330.6	B08		7	0317-0619	184.08	618.67	255	59.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			519.9	B08		7	0318-0619	536.33	619.55	203	52.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			419.6	B08		7	0319-0619	732.67	618.91	225	58.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			247.4	B08		7	0320-0624	75.32	624.49	297	67.26	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			564.7	B08		7	0321-0626	149.52	625.62	378	74.18	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1028.1	B08		7	0322-0624	587.75	624.19	255	60.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			323.9	B08		7	0323-0628	266.79	628.79	272	64.77	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			337.5	B08		7	0324-0626	224.98	625.70	269	60.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			963.1	B08		7	0325-0631	33.55	631.63	372	75.84	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1550.5	B08		7	0326-0630	380.71	630.34	182	50.28	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1157.2	B08		7	0327-0632	742.45	633.18	264	63.60	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1719.4	B08		7	0328-0632	870.00	633.29	240	62.77	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			253.0	B08		7	0329-0638	418.93	637.29	242	58.18	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			995.6	B08		7	0330-0635	486.04	635.24	265	64.53	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1185.2	B08		7	0331-0636	884.42	636.28	183	50.63	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			613.3	B08		7	0332-0640	652.10	639.58	235	59.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			211.8	B08		7	0333-0642	303.25	642.62	278	63.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1189.3	B08		7	0334-0643	369.37	643.58	193	51.70	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			884.2	B08		7	0335-0647	536.33	647.18	228	57.01	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			392.8	B08		7	0336-0648	701.14	648.33	301	63.60	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			222.1	B08		7	0337-0655	825.26	654.58	343	71.50	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1124.2	B08		7	0338-0652	905.80	652.94	180	51.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1356.4	B08		7	0339-0656	494.86	656.41	261	60.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			226.2	B08		7	0340-0655	647.89	656.23	214	54.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			241.9	B08		7	0341-0660	619.43	660.42	307	68.53	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			8254.6	B08		7	0342-0660	103.73	660.38	202	60.18	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			389.1	B08		7	0343-0661	331.53	661.26	282	62.28	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1437.0	B08		7	0344-0658	369.54	658.31	227	57.11	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			321.8	B08		7	0345-0659	935.36	658.91	181	52.43	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			271.0	B08		7	0346-0660	447.04	660.05	247	59.11	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			445.7	B08		7	0347-0665	250.08	665.56	256	60.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1320.4	B08		7	0348-0662	37.36	662.14	140	45.94	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			849.2	B08		7	0349-0668	273.05	667.94	244	60.18	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			355.5	B08		7	0350-0671	564.20	671.06	415	79.50	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			421.6	B08		7	0351-0668	724.95	667.73	304	64.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			861.5	B08		7	0352-0666	922.79	665.38	205	57.36	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			234.2	B08		7	0353-0670	193.80	670.59	269	61.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			261.6	B08		7	0354-0673	768.30	672.51	256	59.60	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1107.4	B08		7	0355-0672	377.96	672.48	212	55.46	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			532.2	B08		7	0356-0674	861.90	673.49	332	68.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			425.6	B08		7	0357-0676	85.23	676.00	223	57.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			185.1	B08		7	0358-0677	797.05	677.26	267	63.01	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			717.7	B08		7	0359-0675	34.76	675.73	175	50.28	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			660.7	B08		7	0360-0676	703.10	676.08	198	57.60	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			910.8	B08		7	0361-0678	52.72	679.35	218	59.36	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			921.2	B08		7	0362-0683	685.57	684.28	648	111.05	0.660
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			307.7	B08		7	0363-0680	448.23	679.47	224	55.36	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			216.9	B08		7	0364-0685	843.10	686.08	260	61.36	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1056.1	B08		7	0365-0688	618.11	687.90	248	63.84	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			346.2	B08		7	0366-0686	340.20	686.29	226	55.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			401.8	B08		7	0367-0692	413.83	691.73	372	73.26	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			980.3	B08		7	0368-0691	714.85	690.45	150	46.87	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			324.1	B08		7	0369-0694	912.92	694.90	229	57.94	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			264.5	B08		7	0370-0696	937.38	695.64	291	61.94	0.953
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			367.2	B08		7	0371-0697	52.33	696.50	224	55.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			411.2	B08		7	0372-0697	136.01	696.68	215	53.94	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			168.9	B08		7	0373-0702	234.35	703.26	290	67.36	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			267.7	B08		7	0374-0703	882.83	702.70	269	63.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			363.6	B08		7	0375-0704	371.40	704.40	237	58.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			618.2	B08		7	0376-0703	539.66	702.93	202	52.28	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			808.5	B08		7	0377-0700	690.84	700.22	159	45.70	0.957
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			633.4	B08		7	0378-0706	464.63	706.59	227	57.94	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			244.2	B08		7	0379-0706	646.96	706.78	211	53.11	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			202.6	B08		7	0380-0708	161.23	708.82	276	64.53	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1016.1	B08		8	0001-0027	605.94	27.87	215	56.28	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			565.8	B08		8	0002-0030	678.63	29.96	293	63.01	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1694.2	B08		8	0003-0030	332.84	29.76	212	53.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			859.6	B08		8	0004-0034	100.59	34.63	237	58.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1712.1	B08		8	0005-0030	274.05	30.58	219	59.70	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			896.0	B08		8	0006-0039	437.09	39.00	204	53.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			850.1	B08		8	0007-0041	321.69	41.81	212	54.28	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			297.4	B08		8	0008-0040	928.24	40.30	223	54.28	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			198.7	B08		8	0009-0043	461.70	44.14	285	63.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			268.1	B08		8	0010-0044	809.55	44.14	285	61.36	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1835.3	B08		8	0011-0045	569.92	43.93	174	54.43	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1968.1	B08		8	0012-0045	358.74	45.50	219	55.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			310.9	B08		8	0013-0045	633.25	45.14	254	60.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			215.1	B08		8	0014-0047	122.29	46.71	280	66.18	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			273.4	B08		8	0015-0048	25.24	47.86	211	53.11	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			322.7	B08		8	0016-0048	185.64	48.59	289	64.18	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			248.5	B08		8	0017-0049	384.18	48.78	310	66.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			687.1	B08		8	0018-0049	307.42	48.87	215	54.87	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1556.6	B08		8	0019-0050	580.11	51.04	112	44.87	0.699
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			445.1	B08		8	0020-0053	753.84	52.66	215	54.28	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			375.4	B08		8	0021-0053	254.99	53.81	251	60.53	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			237.6	B08		8	0022-0056	493.18	56.48	338	69.01	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			260.1	B08		8	0023-0054	940.44	54.25	205	52.28	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			597.5	B08		8	0024-0061	241.09	61.83	193	56.77	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			378.9	B08		8	0025-0056	768.83	55.64	147	45.80	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			7256.8	B08		8	0026-0060	866.08	60.35	250	59.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			264.7	B08		8	0027-0063	559.18	62.41	294	67.60	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			14428.4	B08		8	0028-0063	642.81	63.02	178	48.28	0.959
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1631.2	B08		8	0029-0064	701.82	64.72	262	60.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			477.2	B08		8	0030-0068	91.77	68.89	240	59.11	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1175.0	B08		8	0031-0070	346.19	69.91	273	61.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			523.6	B08		8	0032-0069	838.43	68.84	215	56.18	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			290.0	B08		8	0033-0070	765.62	69.56	157	46.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			7365.5	B08		8	0034-0071	878.70	71.36	219	55.70	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3317.5	B08		8	0035-0075	248.18	76.27	218	55.36	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			328.2	B08		8	0036-0076	753.87	77.01	208	55.01	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			241.5	B08		8	0037-0078	789.59	77.65	266	62.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1411.3	B08		8	0038-0080	204.05	79.65	217	54.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1376.1	B08		8	0039-0082	535.30	81.33	202	55.46	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			405.0	B08		8	0040-0086	684.70	86.65	407	78.67	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			351.6	B08		8	0041-0081	911.11	81.40	246	57.70	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1906.9	B08		8	0042-0083	278.01	82.10	183	51.36	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1054.7	B08		8	0043-0083	422.56	82.95	209	52.87	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			347.2	B08		8	0044-0092	521.47	91.87	335	73.11	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1207.7	B08		8	0045-0087	654.93	87.18	272	62.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			266.2	B08		8	0046-0088	803.61	88.22	262	60.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			513.7	B08		8	0047-0085	312.89	85.51	156	48.04	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1501.6	B08		8	0048-0091	506.89	91.64	231	61.11	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			256.1	B08		8	0049-0093	265.32	92.69	347	69.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			511.4	B08		8	0050-0089	466.44	89.42	126	64.67	0.379
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			273.4	B08		8	0051-0091	485.54	91.39	178	51.70	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4070.6	B08		8	0052-0095	578.56	94.28	158	52.53	0.720
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3124.3	B08		8	0053-0098	235.72	97.49	144	47.60	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			550.8	B08		8	0054-0097	312.79	96.29	117	40.63	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			250.1	B08		8	0055-0101	196.52	101.22	216	55.70	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			995.0	B08		8	0056-0109	168.10	109.50	416	84.08	0.739
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			338.1	B08		8	0057-0109	61.26	110.18	302	65.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			197.9	B08		8	0058-0109	325.70	109.43	285	64.53	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			348.6	B08		8	0059-0105	492.19	104.94	158	46.63	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2605.8	B08		8	0060-0109	225.69	109.46	155	46.53	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1292.8	B08		8	0061-0110	418.68	110.04	266	61.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			806.2	B08		8	0062-0110	740.53	109.96	202	53.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4059.5	B08		8	0063-0116	365.54	115.83	258	59.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4256.6	B08		8	0064-0117	17.34	117.17	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			528.0	B08		8	0065-0117	710.91	117.16	339	67.60	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			319.6	B08		8	0066-0114	692.08	114.01	112	40.04	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			183.5	B08		8	0067-0116	945.56	116.40	143	45.11	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			790.1	B08		8	0068-0119	476.58	119.53	226	55.94	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			268.9	B08		8	0069-0120	214.16	121.08	218	57.84	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			250.1	B08		8	0070-0123	458.80	122.27	270	66.18	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			240.8	B08		8	0071-0128	621.93	128.49	282	65.11	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			624.2	B08		8	0072-0126	810.83	124.99	255	63.36	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			948.7	B08		8	0073-0129	254.02	128.83	222	57.36	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			516.8	B08		8	0074-0126	312.43	126.66	288	67.94	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			259.2	B08		8	0075-0127	651.45	127.21	274	62.53	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			350.3	B08		8	0076-0124	693.52	124.41	100	38.63	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			8357.5	B08		8	0077-0134	544.06	133.88	328	69.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			412.5	B08		8	0078-0131	834.06	131.69	238	57.36	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1043.0	B08		8	0079-0134	916.21	133.84	333	69.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			206.8	B08		8	0080-0139	433.99	140.31	312	67.60	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1025.8	B08		8	0081-0141	742.85	142.35	182	53.36	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			231.8	B08		8	0082-0142	371.39	142.67	287	66.18	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			544.4	B08		8	0083-0142	691.60	143.08	137	49.70	0.697
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			327.1	B08		8	0084-0147	102.87	147.30	221	58.28	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			272.6	B08		8	0085-0146	870.70	146.58	274	63.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			251.1	B08		8	0086-0145	813.59	145.20	244	62.53	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			819.5	B08		8	0087-0147	260.69	146.47	195	52.53	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			216.1	B08		8	0088-0151	610.95	151.63	257	69.60	0.667
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1788.5	B08		8	0089-0151	508.14	151.35	210	54.77	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			625.8	B08		8	0090-0152	201.67	152.39	324	67.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3938.2	B08		8	0091-0153	752.90	153.76	193	51.70	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			201.2	B08		8	0092-0154	646.52	153.18	233	58.53	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			330.3	B08		8	0093-0163	790.71	165.01	286	78.43	0.584
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2463.3	B08		8	0094-0160	115.51	160.99	260	59.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			263.7	B08		8	0095-0163	155.98	162.80	258	62.43	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			221.0	B08		8	0096-0167	638.49	167.91	284	66.67	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			190.2	B08		8	0097-0169	319.81	169.39	287	62.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1199.4	B08		8	0098-0170	387.76	170.51	216	54.53	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1061.4	B08		8	0099-0172	718.99	171.98	280	64.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			297.9	B08		8	0100-0174	444.36	173.61	393	78.43	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			6873.4	B08		8	0101-0173	363.23	173.68	207	54.53	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			294.3	B08		8	0102-0172	824.23	172.48	190	52.14	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1059.7	B08		8	0103-0173	839.23	173.39	161	48.63	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			879.6	B08		8	0104-0174	855.85	173.78	202	54.53	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1906.9	B08		8	0105-0176	472.06	176.28	277	61.11	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1171.3	B08		8	0106-0176	589.15	176.50	204	53.11	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1307.9	B08		8	0107-0174	24.47	175.02	132	43.46	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			331.6	B08		8	0108-0181	916.02	180.69	140	89.98	0.217
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			324.7	B08		8	0109-0191	416.31	190.75	393	73.60	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			428.7	B08		8	0110-0190	557.40	189.97	233	57.36	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			237.0	B08		8	0111-0194	503.96	194.47	352	71.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1465.3	B08		8	0112-0193	528.14	193.10	302	65.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			922.3	B08		8	0113-0191	576.48	190.90	248	57.70	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			220.4	B08		8	0114-0196	82.44	197.40	250	59.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			401.2	B08		8	0115-0199	731.41	199.55	326	71.84	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1940.7	B08		8	0116-0206	797.58	204.88	608	103.98	0.707
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			273.4	B08		8	0117-0200	600.24	198.90	321	67.84	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1395.5	B08		8	0118-0201	706.38	200.68	275	65.60	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			175.7	B08		8	0119-0200	105.70	199.53	251	60.77	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			411.5	B08		8	0120-0203	51.33	203.14	263	64.67	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1200.0	B08		8	0121-0201	945.35	201.25	242	64.77	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			189.8	B08		8	0122-0202	841.47	202.21	265	59.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			168.3	B08		8	0123-0204	360.88	204.41	293	66.18	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			403.6	B08		8	0124-0203	473.99	203.12	291	67.36	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			795.4	B08		8	0125-0209	540.26	210.14	315	74.18	0.719
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			271.6	B08		8	0126-0207	210.90	207.35	301	65.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			372.1	B08		8	0127-0209	653.64	209.25	285	64.77	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			769.5	B08		8	0128-0216	905.41	216.77	342	71.60	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			765.8	B08		8	0129-0217	238.79	216.72	356	70.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			303.9	B08		8	0130-0219	326.08	218.78	230	67.11	0.642
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			395.6	B08		8	0131-0219	404.45	220.29	295	63.11	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			531.1	B08		8	0132-0222	573.44	222.43	240	57.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1716.6	B08		8	0133-0223	825.07	222.16	159	55.11	0.658
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			304.6	B08		8	0134-0228	177.37	228.44	252	65.60	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			258.8	B08		8	0135-0226	444.15	225.99	249	59.70	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			9309.7	B08		8	0136-0226	297.91	225.97	241	57.01	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			325.7	B08		8	0137-0226	338.15	227.24	232	60.18	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1350.4	B08		8	0138-0225	836.01	225.90	134	47.94	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			515.1	B08		8	0139-0231	760.15	231.06	226	56.04	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			220.4	B08		8	0140-0233	362.12	232.89	237	60.18	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			247.0	B08		8	0141-0236	884.11	237.24	290	67.11	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			314.6	B08		8	0142-0238	52.62	238.34	342	68.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2225.4	B08		8	0143-0234	514.13	234.63	207	57.46	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			785.1	B08		8	0144-0239	844.35	239.44	239	58.77	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2790.9	B08		8	0145-0242	131.43	242.42	205	54.53	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3494.9	B08		8	0146-0241	497.89	242.11	176	49.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			470.2	B08		8	0147-0244	785.63	245.13	262	59.36	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1714.6	B08		8	0148-0244	401.72	243.93	213	54.53	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2170.9	B08		8	0149-0248	624.08	247.94	209	54.53	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			342.2	B08		8	0150-0249	726.50	248.48	254	59.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			278.6	B08		8	0151-0250	757.15	250.54	325	72.18	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			413.6	B08		8	0152-0249	644.05	249.45	254	60.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1773.6	B08		8	0153-0252	104.77	251.94	312	65.11	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1873.8	B08		8	0154-0252	445.78	252.74	217	60.53	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			287.1	B08		8	0155-0256	571.64	257.18	211	59.70	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			915.1	B08		8	0156-0266	348.79	266.57	640	110.47	0.659
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			179.4	B08		8	0157-0258	883.69	257.58	273	61.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			194.9	B08		8	0158-0256	905.81	256.66	277	63.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			525.1	B08		8	0159-0260	833.84	260.57	489	90.08	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			829.2	B08		8	0160-0260	689.87	260.20	232	57.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			388.6	B08		8	0161-0262	492.09	262.56	290	63.60	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			318.0	B08		8	0162-0267	518.42	267.31	439	80.08	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			672.4	B08		8	0163-0265	186.17	265.60	250	78.91	0.505
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1001.5	B08		8	0164-0265	247.92	265.49	261	59.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			848.0	B08		8	0165-0270	618.28	270.58	224	61.94	0.734
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3351.8	B08		8	0166-0265	797.52	264.67	151	49.11	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			262.8	B08		8	0167-0269	923.08	268.60	250	58.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			545.7	B08		8	0168-0275	409.94	274.74	383	74.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			250.6	B08		8	0169-0276	133.40	275.48	241	61.01	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			307.1	B08		8	0170-0275	47.24	275.34	223	55.11	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			393.9	B08		8	0171-0280	278.01	279.85	388	77.50	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			223.4	B08		8	0172-0279	562.46	279.94	194	57.36	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2633.5	B08		8	0173-0278	458.98	277.90	219	55.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			729.0	B08		8	0174-0278	715.69	277.13	240	59.94	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			237.1	B08		8	0175-0282	119.51	282.12	188	54.53	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			390.2	B08		8	0176-0280	332.96	280.84	132	43.56	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1509.8	B08		8	0177-0290	891.19	289.75	238	58.18	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			461.2	B08		8	0178-0292	298.21	292.89	218	54.53	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			381.5	B08		8	0179-0295	95.73	294.43	249	61.36	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			383.0	B08		8	0180-0294	330.03	293.71	196	53.46	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			342.0	B08		8	0181-0297	860.98	297.75	317	65.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			481.3	B08		8	0182-0297	512.10	296.55	221	56.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			215.5	B08		8	0183-0303	430.37	303.46	354	71.60	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			358.4	B08		8	0184-0303	479.32	302.65	346	68.18	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			356.6	B08		8	0185-0302	497.46	302.33	187	51.11	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1665.5	B08		8	0186-0303	716.93	302.65	222	57.11	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			362.6	B08		8	0187-0305	830.82	305.53	256	57.94	0.958
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1806.5	B08		8	0188-0310	25.65	309.68	263	66.77	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			177.8	B08		8	0189-0309	198.99	308.92	288	70.67	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			273.9	B08		8	0190-0310	787.30	310.84	332	70.18	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			463.6	B08		8	0191-0309	934.28	309.96	218	56.28	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			558.9	B08		8	0192-0313	234.95	313.59	264	67.01	0.739
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			585.5	B08		8	0193-0313	297.10	313.57	317	67.01	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1360.7	B08		8	0194-0316	613.92	317.18	222	57.70	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			21788.6	B08		8	0195-0319	126.34	319.24	196	63.26	0.616
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			581.3	B08		8	0196-0320	567.44	319.73	136	47.11	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1085.6	B08		8	0197-0323	279.05	323.73	192	51.46	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1379.8	B08		8	0198-0328	673.08	328.40	224	62.18	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			338.7	B08		8	0199-0326	330.82	326.80	227	55.94	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			354.9	B08		8	0200-0329	94.74	329.33	229	57.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			921.4	B08		8	0201-0330	718.20	329.79	235	56.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			743.1	B08		8	0202-0331	696.05	331.99	248	57.70	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3170.3	B08		8	0203-0328	485.85	327.96	134	46.87	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			860.4	B08		8	0204-0333	831.68	332.64	270	60.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			577.0	B08		8	0205-0335	182.20	335.61	329	67.36	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			337.8	B08		8	0206-0338	35.69	338.17	193	52.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1074.1	B08		8	0207-0338	283.63	337.80	194	52.28	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			576.5	B08		8	0208-0341	442.74	341.90	307	66.43	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2434.9	B08		8	0209-0343	495.31	344.36	429	88.67	0.686
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2654.1	B08		8	0210-0341	749.53	341.13	261	59.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			422.7	B08		8	0211-0342	409.14	342.94	258	59.70	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			749.0	B08		8	0212-0344	786.04	343.56	228	55.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			533.7	B08		8	0213-0343	223.49	343.69	205	53.11	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			320.8	B08		8	0214-0345	72.07	344.02	253	60.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			612.3	B08		8	0215-0347	615.45	347.13	290	64.53	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			414.2	B08		8	0216-0349	847.39	348.96	278	64.08	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			523.8	B08		8	0217-0349	162.16	349.02	209	53.94	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			223.9	B08		8	0218-0352	904.73	351.46	230	59.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			312.3	B08		8	0219-0358	239.48	358.57	276	61.01	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			380.6	B08		8	0220-0361	372.20	361.46	328	68.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1219.0	B08		8	0221-0364	732.60	364.38	212	56.53	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1634.4	B08		8	0222-0365	669.58	364.77	308	69.94	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1109.1	B08		8	0223-0363	542.40	363.96	167	48.63	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			256.3	B08		8	0224-0367	825.59	367.27	264	63.01	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			789.7	B08		8	0225-0368	69.91	368.36	423	77.60	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3430.8	B08		8	0226-0367	509.82	366.75	165	49.11	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			259.6	B08		8	0227-0370	842.54	368.99	221	57.36	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			351.2	B08		8	0228-0370	904.68	370.38	299	63.94	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			298.2	B08		8	0229-0374	705.18	375.56	291	65.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			490.8	B08		8	0230-0380	229.26	379.63	336	69.01	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			287.9	B08		8	0231-0381	625.58	381.14	261	59.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1208.4	B08		8	0232-0380	538.41	379.26	186	52.28	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			495.6	B08		8	0233-0380	122.53	380.11	176	49.46	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			586.5	B08		8	0234-0390	459.42	389.07	472	94.81	0.660
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			257.1	B08		8	0235-0385	174.02	384.99	229	55.11	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			305.1	B08		8	0236-0390	32.31	390.91	315	65.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1469.6	B08		8	0237-0390	476.96	389.92	250	59.46	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			666.5	B08		8	0238-0389	563.53	389.04	227	56.04	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			433.1	B08		8	0239-0392	96.37	392.44	221	54.53	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			968.0	B08		8	0240-0392	140.30	393.04	241	60.53	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			546.1	B08		8	0241-0394	517.34	394.43	226	57.36	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			877.9	B08		8	0242-0393	205.01	393.33	193	53.11	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			311.9	B08		8	0243-0396	357.48	395.76	326	68.43	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			312.5	B08		8	0244-0396	798.26	395.72	268	59.60	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			474.1	B08		8	0245-0393	115.88	393.18	177	49.70	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			208.0	B08		8	0246-0401	285.34	401.61	298	68.67	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			302.5	B08		8	0247-0403	854.48	404.25	271	62.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			273.3	B08		8	0248-0409	874.03	409.15	215	59.36	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3224.6	B08		8	0249-0410	535.95	410.12	210	57.21	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1156.2	B08		8	0250-0409	757.81	409.18	241	57.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5195.3	B08		8	0251-0408	385.95	408.25	148	47.36	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			330.0	B08		8	0252-0412	51.60	411.98	247	62.43	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			212.5	B08		8	0253-0413	306.91	413.24	351	68.77	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1447.4	B08		8	0254-0411	617.11	411.83	213	54.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			317.7	B08		8	0255-0413	920.61	413.25	248	59.11	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1455.0	B08		8	0256-0425	43.38	424.45	270	64.08	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			254.0	B08		8	0257-0424	197.36	424.82	291	65.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			875.0	B08		8	0258-0426	840.62	426.82	249	59.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			580.7	B08		8	0259-0425	90.69	425.05	252	59.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3834.6	B08		8	0260-0426	395.24	426.38	188	54.18	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			222.3	B08		8	0261-0430	798.43	429.42	316	67.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			231.8	B08		8	0262-0428	429.05	427.54	272	61.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			478.9	B08		8	0263-0430	685.11	429.79	228	59.11	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			231.0	B08		8	0264-0430	536.49	429.89	224	59.21	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			658.2	B08		8	0265-0433	292.44	431.71	270	62.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			290.5	B08		8	0266-0433	463.81	433.41	344	70.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			222.6	B08		8	0267-0440	612.69	440.34	286	66.18	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			209.8	B08		8	0268-0440	376.98	439.41	296	67.36	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			258.0	B08		8	0269-0441	917.64	440.86	239	59.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1202.3	B08		8	0270-0441	571.71	441.23	324	67.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			343.5	B08		8	0271-0448	119.36	447.66	377	73.60	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1342.7	B08		8	0272-0444	709.38	444.02	214	53.70	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			445.5	B08		8	0273-0446	210.10	445.78	171	49.70	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			476.6	B08		8	0274-0450	251.93	449.17	467	84.33	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			437.5	B08		8	0275-0445	284.42	445.95	125	42.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			257.4	B08		8	0276-0447	758.43	447.39	273	63.36	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3347.9	B08		8	0277-0447	510.30	448.26	285	65.60	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			412.6	B08		8	0278-0451	197.74	451.73	214	54.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1140.8	B08		8	0279-0452	679.58	452.71	229	56.53	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			253.6	B08		8	0280-0455	414.52	455.68	259	65.26	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1011.4	B08		8	0281-0458	645.04	457.69	235	57.70	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			247.0	B08		8	0282-0461	893.09	460.31	237	61.11	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			299.0	B08		8	0283-0461	806.05	461.06	265	61.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			271.6	B08		8	0284-0460	849.37	459.94	300	73.26	0.703
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			742.6	B08		8	0285-0467	482.18	466.42	278	65.36	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			578.4	B08		8	0286-0467	502.80	466.67	202	52.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			474.6	B08		8	0287-0468	175.68	468.11	131	44.39	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1349.4	B08		8	0288-0469	188.14	470.18	220	55.46	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			401.3	B08		8	0289-0470	164.58	470.70	133	44.87	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			227.0	B08		8	0290-0473	445.19	473.32	256	60.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			541.8	B08		8	0291-0476	340.33	476.43	305	64.43	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1493.6	B08		8	0292-0475	146.13	474.35	224	54.53	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			14092.8	B08		8	0293-0476	594.06	476.63	181	50.28	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5409.2	B08		8	0294-0475	282.54	475.44	216	54.53	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			196.3	B08		8	0295-0480	38.72	480.74	281	66.67	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			10928.9	B08		8	0296-0475	863.09	475.58	237	58.28	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1038.2	B08		8	0297-0476	670.54	476.17	223	56.28	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			589.2	B08		8	0298-0483	521.14	482.66	460	89.98	0.714
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			311.0	B08		8	0299-0486	72.47	487.20	271	64.77	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			367.9	B08		8	0300-0491	98.43	491.48	476	90.33	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			913.4	B08		8	0301-0489	681.87	489.05	240	57.94	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2061.1	B08		8	0302-0495	317.38	494.84	179	53.36	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			288.9	B08		8	0303-0498	424.53	498.54	275	61.60	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1364.2	B08		8	0304-0496	801.89	496.68	186	52.53	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			369.4	B08		8	0305-0496	568.46	496.21	140	45.46	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2445.0	B08		8	0306-0500	925.96	500.83	237	59.36	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			206.0	B08		8	0307-0506	409.35	506.26	265	71.36	0.654
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			7334.6	B08		8	0308-0503	162.81	503.82	231	57.94	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			379.8	B08		8	0309-0502	252.53	502.28	254	61.11	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1530.8	B08		8	0310-0502	720.89	503.30	199	55.11	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			444.6	B08		8	0311-0506	118.28	506.07	213	55.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			346.4	B08		8	0312-0506	213.48	506.27	246	58.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1832.1	B08		8	0313-0505	513.95	505.20	270	61.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			190.4	B08		8	0314-0512	391.39	512.53	273	65.26	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			306.4	B08		8	0315-0508	573.78	508.38	197	52.63	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			8325.0	B08		8	0316-0513	459.25	513.30	269	62.77	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			514.3	B08		8	0317-0516	279.40	515.67	340	72.91	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			390.5	B08		8	0318-0517	34.47	517.38	330	67.01	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			455.9	B08		8	0319-0519	191.56	519.29	327	67.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1648.5	B08		8	0320-0520	598.95	520.02	222	58.43	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2003.4	B08		8	0321-0521	490.02	521.05	227	55.70	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1306.3	B08		8	0322-0523	544.13	524.15	269	79.01	0.541
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			351.9	B08		8	0323-0524	373.61	524.93	246	58.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4340.0	B08		8	0324-0524	249.55	524.74	219	54.87	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			303.7	B08		8	0325-0528	587.81	528.57	220	57.26	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			276.5	B08		8	0326-0528	661.83	528.57	227	57.11	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			658.4	B08		8	0327-0529	741.26	528.96	331	66.18	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			508.4	B08		8	0328-0529	265.76	529.33	168	49.11	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2923.9	B08		8	0329-0530	886.67	530.57	195	53.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			573.2	B08		8	0330-0536	475.34	535.73	334	73.36	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3018.4	B08		8	0331-0532	693.26	532.27	262	62.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			892.2	B08		8	0332-0535	904.34	535.08	217	57.11	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			325.2	B08		8	0333-0540	503.66	539.29	356	73.01	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2003.0	B08		8	0334-0536	837.33	536.46	168	51.11	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1031.6	B08		8	0335-0540	618.73	540.15	265	63.60	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2484.4	B08		8	0336-0545	108.17	545.82	246	60.77	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			498.5	B08		8	0337-0540	310.74	540.38	112	45.11	0.692
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1125.6	B08		8	0338-0544	540.04	543.04	278	84.91	0.485
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			235.1	B08		8	0339-0543	647.59	542.83	260	59.94	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			372.9	B08		8	0340-0543	228.87	543.02	213	53.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			757.8	B08		8	0341-0547	440.74	547.05	393	74.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			490.0	B08		8	0342-0547	294.62	547.99	340	68.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			476.5	B08		8	0343-0549	63.74	548.50	494	85.84	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			487.4	B08		8	0344-0547	405.03	547.38	199	53.94	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			247.1	B08		8	0345-0553	720.38	553.08	424	78.91	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2049.1	B08		8	0346-0555	585.25	555.47	238	57.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			811.8	B08		8	0347-0557	930.45	557.56	203	53.94	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2912.7	B08		8	0348-0561	829.71	561.23	214	54.53	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1223.9	B08		8	0349-0561	149.59	561.09	177	51.11	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1096.8	B08		8	0350-0565	359.49	565.73	275	60.28	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			601.3	B08		8	0351-0567	899.27	567.38	262	59.60	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			909.5	B08		8	0352-0583	151.66	583.78	549	92.33	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			990.3	B08		8	0353-0575	301.99	574.27	211	54.53	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1500.6	B08		8	0354-0579	446.16	578.94	247	60.43	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			203.6	B08		8	0355-0580	653.80	579.80	251	60.77	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1057.1	B08		8	0356-0578	881.69	578.52	187	50.28	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			515.9	B08		8	0357-0582	591.28	583.00	268	61.26	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			168.9	B08		8	0358-0586	635.36	586.45	320	72.43	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5136.3	B08		8	0359-0585	522.96	585.30	305	67.36	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			332.0	B08		8	0360-0587	364.23	587.18	323	67.01	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			274.7	B08		8	0361-0584	292.96	585.51	169	49.11	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			244.2	B08		8	0362-0586	710.05	586.60	261	61.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			280.9	B08		8	0363-0588	546.84	587.82	378	76.18	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1484.2	B08		8	0364-0585	746.54	585.66	197	52.28	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1086.4	B08		8	0365-0594	428.50	594.90	260	61.36	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			694.3	B08		8	0366-0591	791.24	591.44	157	44.87	0.980
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			272.5	B08		8	0367-0594	106.89	593.63	301	67.36	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			410.2	B08		8	0368-0597	409.77	597.79	382	73.26	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			380.4	B08		8	0369-0601	38.88	600.70	394	73.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			789.3	B08		8	0370-0599	245.03	599.26	215	57.11	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			408.1	B08		8	0371-0603	294.83	602.94	352	87.26	0.581
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			599.1	B08		8	0372-0603	122.93	603.29	228	56.77	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1596.5	B08		8	0373-0602	745.82	602.88	254	59.70	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			310.2	B08		8	0374-0608	772.61	607.70	396	82.08	0.739
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			11813.1	B08		8	0375-0611	588.28	610.98	281	61.11	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			259.5	B08		8	0376-0612	691.92	612.85	280	65.36	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			458.3	B08		8	0377-0611	621.03	610.64	266	65.11	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			376.8	B08		8	0378-0615	660.18	615.09	219	54.77	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			615.9	B08		8	0379-0615	91.00	615.30	225	55.11	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			272.9	B08		8	0380-0622	353.66	621.48	274	67.60	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2130.5	B08		8	0381-0617	484.70	617.51	235	57.46	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1528.7	B08		8	0382-0619	283.71	620.14	193	51.46	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			188.7	B08		8	0383-0624	540.61	624.20	286	64.43	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			523.5	B08		8	0384-0623	809.43	623.21	223	55.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			402.4	B08		8	0385-0626	369.46	626.27	240	59.11	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			337.2	B08		8	0386-0628	750.05	628.17	455	80.08	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			408.7	B08		8	0387-0626	315.90	625.91	218	54.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			320.9	B08		8	0388-0630	400.01	630.46	315	65.01	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			418.7	B08		8	0389-0634	103.08	633.11	250	61.60	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			424.8	B08		8	0390-0633	301.76	632.85	182	52.77	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			994.5	B08		8	0391-0634	920.99	635.17	270	65.01	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			612.6	B08		8	0392-0641	826.35	642.57	525	91.01	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			307.2	B08		8	0393-0636	250.17	635.64	243	57.11	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			628.2	B08		8	0394-0636	286.29	635.91	299	67.11	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			243.2	B08		8	0395-0640	56.08	640.78	309	64.18	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			6380.7	B08		8	0396-0645	176.16	644.35	531	89.74	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			441.3	B08		8	0397-0642	149.11	641.65	448	83.26	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			269.2	B08		8	0398-0641	548.88	641.16	219	57.01	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			252.0	B08		8	0399-0644	331.95	643.38	244	59.60	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			369.5	B08		8	0400-0644	615.31	644.31	242	60.53	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3914.6	B08		8	0401-0653	518.96	653.04	290	69.36	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			287.3	B08		8	0402-0654	562.67	654.67	315	66.18	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			247.4	B08		8	0403-0658	878.27	658.10	486	88.33	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			221.9	B08		8	0404-0659	685.60	660.49	274	65.60	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			733.8	B08		8	0405-0660	134.72	659.99	277	61.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			591.3	B08		8	0406-0659	651.26	658.94	214	56.18	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			339.9	B08		8	0407-0662	215.01	661.71	477	97.64	0.629
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			682.2	B08		8	0408-0660	432.11	659.62	345	68.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			203.6	B08		8	0409-0661	746.57	660.93	266	60.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			853.2	B08		8	0410-0660	941.90	660.60	248	60.28	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			375.0	B08		8	0411-0660	189.48	661.10	161	49.11	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			362.1	B08		8	0412-0661	39.92	660.81	174	50.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2511.9	B08		8	0413-0664	81.31	663.61	225	57.70	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			887.8	B08		8	0414-0668	27.47	667.37	212	59.36	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1711.0	B08		8	0415-0670	173.32	670.15	233	58.53	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			593.0	B08		8	0416-0671	593.71	671.10	209	53.94	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			274.6	B08		8	0417-0679	567.36	678.71	242	59.84	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			398.5	B08		8	0418-0680	633.95	680.76	292	63.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			245.3	B08		8	0419-0685	777.50	685.49	371	71.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			206.8	B08		8	0420-0687	429.91	687.24	392	75.01	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1330.2	B08		8	0421-0684	263.38	684.17	218	56.53	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			259.6	B08		8	0422-0686	584.10	686.88	285	67.01	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			648.4	B08		8	0423-0680	903.82	679.87	100	37.21	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			570.3	B08		8	0424-0688	864.67	688.04	231	55.36	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			439.6	B08		8	0425-0688	80.75	689.10	232	57.11	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			329.3	B08		8	0426-0690	240.48	690.82	319	66.43	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			259.3	B08		8	0427-0693	719.10	693.26	270	60.53	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			621.3	B08		8	0428-0691	901.19	691.00	113	40.63	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			281.2	B08		8	0429-0697	17.33	697.09	223	56.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			307.3	B08		8	0430-0698	42.08	697.67	293	61.94	0.960
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			457.4	B08		8	0431-0699	548.17	698.83	224	56.28	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			610.7	B08		8	0432-0702	522.67	703.01	282	71.01	0.703
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			460.4	B08		8	0433-0703	351.47	703.31	310	65.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			603.6	B08		8	0434-0703	796.34	702.67	220	56.18	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2695.4	B08		8	0435-0702	574.57	702.78	210	54.28	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			173.1	B08		8	0436-0706	669.98	705.58	287	71.60	0.704
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			294.2	B08		9	0001-0029	375.41	28.74	246	63.11	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			398.6	B08		9	0002-0035	296.66	35.80	264	59.94	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			262.2	B08		9	0003-0036	644.36	36.42	315	66.53	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			7012.8	B08		9	0004-0038	498.11	37.25	198	56.28	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			780.3	B08		9	0005-0041	524.43	41.73	478	87.74	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			271.2	B08		9	0006-0036	419.86	35.88	237	57.11	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			765.4	B08		9	0007-0037	916.03	37.79	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			300.7	B08		9	0008-0038	140.82	38.08	237	56.53	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1164.4	B08		9	0009-0041	868.08	40.29	256	63.26	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			196.0	B08		9	0010-0042	802.53	43.08	239	57.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3048.3	B08		9	0011-0045	752.63	45.65	300	67.94	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1301.1	B08		9	0012-0043	77.15	42.42	188	50.53	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			265.8	B08		9	0013-0043	22.75	43.23	221	55.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			282.5	B08		9	0014-0048	195.35	48.09	125	41.11	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			392.1	B08		9	0015-0057	182.56	57.31	447	82.91	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			290.6	B08		9	0016-0059	157.91	60.02	233	61.01	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			283.2	B08		9	0017-0057	34.87	57.15	199	51.70	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1557.0	B08		9	0018-0056	285.96	56.48	248	60.77	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			383.3	B08		9	0019-0062	107.83	62.92	258	61.94	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			308.3	B08		9	0020-0064	915.19	64.42	323	65.60	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			603.7	B08		9	0021-0069	346.07	69.89	504	96.57	0.679
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			286.3	B08		9	0022-0063	704.13	62.44	191	53.70	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			184.9	B08		9	0023-0066	436.04	66.09	338	70.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2614.4	B08		9	0024-0068	580.73	68.94	270	62.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			252.4	B08		9	0025-0070	725.46	70.06	223	58.77	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1158.8	B08		9	0026-0072	284.31	72.25	291	63.36	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			237.1	B08		9	0027-0075	862.66	75.75	196	53.11	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			281.6	B08		9	0028-0081	662.91	82.52	347	71.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			571.2	B08		9	0029-0080	395.44	80.30	251	58.87	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			271.8	B08		9	0030-0082	932.73	81.71	281	61.60	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			286.5	B08		9	0031-0086	835.57	86.40	322	67.01	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			452.5	B08		9	0032-0088	176.88	88.51	268	61.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			241.4	B08		9	0033-0089	413.59	90.14	246	62.77	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2662.7	B08		9	0034-0092	612.75	92.05	284	68.08	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4991.1	B08		9	0035-0089	761.59	88.86	231	57.70	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			248.1	B08		9	0036-0095	240.04	95.34	359	70.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			368.7	B08		9	0037-0092	365.95	91.80	166	51.70	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			305.0	B08		9	0038-0097	107.13	96.97	346	69.01	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			266.0	B08		9	0039-0095	479.40	93.97	208	55.01	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			11239.2	B08		9	0040-0095	395.91	94.90	126	44.28	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2527.3	B08		9	0041-0100	384.59	100.22	192	62.67	0.614
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			290.8	B08		9	0042-0101	710.55	101.66	287	74.08	0.657
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			390.8	B08		9	0043-0110	644.32	111.09	321	72.18	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			371.1	B08		9	0044-0106	372.78	107.06	198	52.77	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1484.6	B08		9	0045-0110	466.14	110.96	338	70.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			427.6	B08		9	0046-0112	75.69	112.16	235	56.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			188.1	B08		9	0047-0116	36.68	116.61	256	63.01	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			243.5	B08		9	0048-0118	294.42	117.84	409	74.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			278.3	B08		9	0049-0119	431.62	119.28	337	71.84	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			272.2	B08		9	0050-0120	677.17	120.32	449	78.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			287.1	B08		9	0051-0121	411.39	121.23	277	62.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			181.8	B08		9	0052-0128	190.63	128.16	380	73.36	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1789.4	B08		9	0053-0126	224.06	125.99	270	63.94	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			957.8	B08		9	0054-0128	144.88	128.15	231	56.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			243.1	B08		9	0055-0133	746.35	133.64	381	73.26	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			206.9	B08		9	0056-0134	835.53	133.85	352	78.33	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			421.5	B08		9	0057-0139	253.74	138.75	396	74.67	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1193.9	B08		9	0058-0141	818.10	141.83	228	57.11	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			328.1	B08		9	0059-0144	47.69	143.22	250	61.36	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			236.3	B08		9	0060-0146	541.50	146.66	220	58.77	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			230.9	B08		9	0061-0150	866.35	150.41	235	57.60	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1154.0	B08		9	0062-0149	219.61	150.24	257	61.11	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			748.8	B08		9	0063-0153	936.51	153.32	219	56.53	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			342.2	B08		9	0064-0152	631.80	151.95	274	63.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1113.7	B08		9	0065-0156	715.63	156.14	264	59.94	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1377.2	B08		9	0066-0159	132.93	160.15	351	80.08	0.688
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1483.1	B08		9	0067-0159	577.05	159.47	210	55.70	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1186.3	B08		9	0068-0161	523.25	160.27	245	71.60	0.601
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5604.0	B08		9	0069-0166	589.08	166.62	279	68.18	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			381.8	B08		9	0070-0168	857.63	168.79	337	69.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1625.9	B08		9	0071-0168	163.28	168.37	218	58.77	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			249.3	B08		9	0072-0167	753.10	167.95	345	77.36	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1162.4	B08		9	0073-0170	813.41	169.51	207	59.11	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			231.4	B08		9	0074-0173	337.38	173.65	437	79.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			205.6	B08		9	0075-0173	53.07	173.78	231	57.94	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			197.7	B08		9	0076-0177	659.41	177.28	409	77.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			370.4	B08		9	0077-0177	903.32	177.17	420	77.26	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			864.1	B08		9	0078-0177	119.07	177.60	157	47.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			341.1	B08		9	0079-0179	279.29	179.71	293	63.94	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			247.0	B08		9	0080-0180	544.45	179.49	254	59.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			227.9	B08		9	0081-0186	495.05	186.44	413	75.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1613.6	B08		9	0082-0189	700.98	189.95	318	74.67	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			192.8	B08		9	0083-0200	82.82	200.43	296	66.18	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1526.1	B08		9	0084-0201	898.68	200.80	261	61.84	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1280.5	B08		9	0085-0203	39.87	204.14	236	65.01	0.702
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			347.5	B08		9	0086-0210	142.72	209.61	345	69.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			291.3	B08		9	0087-0210	815.25	209.94	406	75.60	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			546.0	B08		9	0088-0215	585.72	215.59	294	65.60	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			536.0	B08		9	0089-0220	316.80	220.33	296	63.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			369.0	B08		9	0090-0225	761.42	225.12	457	83.26	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			218.6	B08		9	0091-0221	68.78	221.25	223	57.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			343.1	B08		9	0092-0222	712.47	222.20	219	55.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			222.2	B08		9	0093-0229	444.65	229.37	286	62.53	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			247.2	B08		9	0094-0229	257.22	228.54	248	60.77	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			177.4	B08		9	0095-0230	419.36	229.52	313	66.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			667.3	B08		9	0096-0228	934.52	228.45	208	55.11	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1186.7	B08		9	0097-0233	696.55	233.45	214	54.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			440.9	B08		9	0098-0232	866.73	232.18	273	61.60	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1052.7	B08		9	0099-0240	469.31	240.67	512	91.50	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			632.4	B08		9	0100-0231	583.41	230.91	168	48.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3772.3	B08		9	0101-0237	641.00	236.87	303	71.01	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			213.5	B08		9	0102-0237	786.48	236.79	348	67.60	0.957
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			800.3	B08		9	0103-0238	568.60	238.28	246	62.18	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			232.3	B08		9	0104-0243	188.18	242.63	287	63.94	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			290.0	B08		9	0105-0245	37.25	244.38	184	53.70	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			769.8	B08		9	0106-0247	51.01	246.24	250	65.36	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			296.0	B08		9	0107-0246	387.87	246.42	235	58.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			213.1	B08		9	0108-0247	668.56	246.78	218	58.53	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			812.0	B08		9	0109-0246	67.09	246.25	134	44.04	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1189.9	B08		9	0110-0249	757.96	250.41	242	59.84	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			363.1	B08		9	0111-0251	114.69	250.68	376	73.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			253.4	B08		9	0112-0249	731.62	249.28	190	51.70	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			643.6	B08		9	0113-0256	95.29	255.88	233	57.46	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			455.5	B08		9	0114-0264	314.31	264.28	268	63.11	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			263.9	B08		9	0115-0263	73.71	263.86	225	61.36	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			339.4	B08		9	0116-0262	474.21	262.79	286	65.94	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			310.5	B08		9	0117-0270	339.27	270.00	284	63.36	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			326.9	B08		9	0118-0269	535.85	268.73	309	66.18	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			334.5	B08		9	0119-0269	182.69	270.82	188	52.63	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			209.5	B08		9	0120-0272	17.79	271.66	249	58.53	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			284.0	B08		9	0121-0275	763.22	275.32	256	58.53	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			390.8	B08		9	0122-0277	555.54	277.08	261	60.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			214.6	B08		9	0123-0284	50.90	284.12	340	70.53	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1492.7	B08		9	0124-0281	99.05	281.25	217	54.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			669.2	B08		9	0125-0287	246.12	287.94	272	67.84	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			404.1	B08		9	0126-0292	726.80	291.74	517	93.15	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			255.7	B08		9	0127-0290	183.49	289.35	416	76.18	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1752.7	B08		9	0128-0289	334.17	289.12	270	59.94	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1335.3	B08		9	0129-0291	540.49	291.77	368	70.43	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			976.3	B08		9	0130-0292	449.98	292.00	252	57.11	0.971
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			531.8	B08		9	0131-0295	589.40	296.33	240	59.94	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			299.1	B08		9	0132-0294	801.72	294.94	278	69.84	0.716
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			487.6	B08		9	0133-0295	493.60	294.97	291	63.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			246.4	B08		9	0134-0300	260.29	300.34	263	68.77	0.699
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			629.7	B08		9	0135-0306	171.30	306.21	233	57.94	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			423.6	B08		9	0136-0312	29.03	312.93	218	56.53	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2058.4	B08		9	0137-0311	895.81	310.71	243	58.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			246.6	B08		9	0138-0318	53.27	318.60	345	82.08	0.643
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			342.0	B08		9	0139-0316	771.09	315.11	296	64.53	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			532.6	B08		9	0140-0318	229.24	318.55	191	51.70	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1117.7	B08		9	0141-0320	438.45	319.63	210	55.70	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			391.7	B08		9	0142-0321	467.78	320.33	229	56.28	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			950.5	B08		9	0143-0321	317.76	321.39	263	67.36	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			232.4	B08		9	0144-0328	922.76	328.97	281	67.11	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			627.6	B08		9	0145-0327	186.14	327.13	204	54.53	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			876.4	B08		9	0146-0334	85.06	333.61	377	76.18	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2386.3	B08		9	0147-0328	528.84	327.56	216	57.70	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			870.2	B08		9	0148-0337	300.90	337.37	226	68.91	0.598
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			217.8	B08		9	0149-0338	407.57	338.42	370	72.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			695.5	B08		9	0150-0340	108.35	340.54	212	56.28	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2235.8	B08		9	0151-0341	495.40	341.38	246	59.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			283.3	B08		9	0152-0341	755.99	340.88	209	54.28	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			257.9	B08		9	0153-0343	626.36	343.83	258	58.77	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			582.6	B08		9	0154-0344	427.02	344.31	229	57.46	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			789.9	B08		9	0155-0345	682.42	345.77	237	57.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			451.6	B08		9	0156-0352	877.69	351.77	267	62.87	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4313.9	B08		9	0157-0354	511.28	354.98	227	59.94	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			231.9	B08		9	0158-0355	359.05	355.36	404	74.18	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			785.6	B08		9	0159-0357	108.57	356.48	250	58.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			264.9	B08		9	0160-0362	712.63	362.15	219	55.36	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1142.9	B08		9	0161-0364	854.69	363.71	235	58.77	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2460.4	B08		9	0162-0374	762.71	374.69	251	58.53	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			276.9	B08		9	0163-0382	541.62	381.84	369	69.84	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1368.0	B08		9	0164-0384	836.72	385.18	259	62.53	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			199.7	B08		9	0165-0388	132.56	388.06	423	79.84	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1187.4	B08		9	0166-0383	443.86	383.52	208	54.53	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			9761.7	B08		9	0167-0385	591.05	385.30	269	63.36	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2443.8	B08		9	0168-0383	795.38	383.11	199	51.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			501.2	B08		9	0169-0386	880.30	385.53	249	63.84	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4150.0	B08		9	0170-0388	609.83	388.72	299	68.18	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			324.0	B08		9	0171-0392	751.60	392.00	346	68.18	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			311.6	B08		9	0172-0392	61.36	392.33	283	61.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			789.5	B08		9	0173-0398	557.28	397.94	324	66.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			208.0	B08		9	0174-0397	499.20	396.92	252	61.11	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			242.8	B08		9	0175-0403	283.02	403.64	278	66.53	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			349.5	B08		9	0176-0402	205.79	402.27	267	61.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1215.8	B08		9	0177-0403	233.59	403.91	230	58.28	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			183.4	B08		9	0178-0405	473.13	404.50	404	75.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			242.7	B08		9	0179-0406	83.40	406.15	256	65.60	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2145.2	B08		9	0180-0413	789.67	413.15	247	57.36	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1386.4	B08		9	0181-0416	426.35	416.54	220	56.53	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			232.5	B08		9	0182-0423	837.61	424.02	364	74.91	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			987.5	B08		9	0183-0421	305.15	420.27	213	56.53	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			445.3	B08		9	0184-0422	494.32	422.69	230	56.43	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			352.1	B08		9	0185-0426	371.17	426.66	319	67.01	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			421.6	B08		9	0186-0427	537.70	427.27	339	69.01	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			738.9	B08		9	0187-0432	685.33	431.98	231	59.36	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			199.9	B08		9	0188-0431	97.98	430.39	188	56.39	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1768.1	B08		9	0189-0433	54.32	433.29	233	60.53	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			281.3	B08		9	0190-0436	449.92	436.02	269	60.53	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			274.8	B08		9	0191-0442	519.64	442.54	258	64.87	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			595.3	B08		9	0192-0439	203.08	439.76	261	62.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1148.2	B08		9	0193-0437	789.12	437.27	116	40.63	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			358.0	B08		9	0194-0440	878.12	440.65	189	52.77	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			179.2	B08		9	0195-0443	98.41	442.84	227	59.11	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			726.1	B08		9	0196-0447	570.66	447.10	432	77.26	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1575.1	B08		9	0197-0448	170.09	448.37	247	57.94	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			364.6	B08		9	0198-0446	269.82	445.98	162	47.70	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			387.6	B08		9	0199-0446	254.95	446.32	123	39.70	0.981
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4402.6	B08		9	0200-0452	673.57	452.65	230	79.15	0.461
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			382.1	B08		9	0201-0452	307.23	451.83	314	65.60	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			293.4	B08		9	0202-0455	458.89	454.01	262	61.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			392.4	B08		9	0203-0454	867.79	454.33	272	60.77	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			927.3	B08		9	0204-0457	197.88	457.55	260	59.94	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			409.0	B08		9	0205-0458	886.30	458.69	261	59.11	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			185.8	B08		9	0206-0461	116.98	460.20	312	66.77	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			893.8	B08		9	0207-0457	382.26	457.42	169	48.87	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			342.5	B08		9	0208-0462	262.87	461.81	282	64.18	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			233.5	B08		9	0209-0462	492.45	462.02	229	58.77	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			958.2	B08		9	0210-0465	652.17	465.62	167	52.53	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			327.9	B08		9	0211-0467	447.34	467.17	217	56.53	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1001.6	B08		9	0212-0471	237.87	471.44	203	54.53	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3230.1	B08		9	0213-0475	615.13	476.07	237	61.94	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1107.9	B08		9	0214-0474	890.92	474.25	224	58.77	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			433.5	B08		9	0215-0477	410.11	477.40	250	60.28	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			237.3	B08		9	0216-0481	835.88	480.63	245	68.43	0.658
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			251.9	B08		9	0217-0482	131.20	482.57	312	67.36	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2215.1	B08		9	0218-0485	789.47	484.56	241	57.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			464.0	B08		9	0219-0488	293.83	487.81	344	69.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			215.1	B08		9	0220-0493	57.35	493.06	480	85.50	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			349.6	B08		9	0221-0491	203.22	491.41	302	64.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2521.6	B08		9	0222-0490	177.03	490.29	235	56.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			223.5	B08		9	0223-0495	751.21	495.28	280	66.77	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			259.7	B08		9	0224-0498	80.23	499.11	399	74.43	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			922.1	B08		9	0225-0497	922.77	497.48	204	57.70	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			204.3	B08		9	0226-0502	236.73	501.88	415	75.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			396.4	B08		9	0227-0498	573.39	498.78	297	62.53	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			395.3	B08		9	0228-0500	322.76	499.64	277	61.60	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			629.9	B08		9	0229-0502	506.79	501.80	248	58.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2619.1	B08		9	0230-0503	20.49	503.65	227	58.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			231.9	B08		9	0231-0503	613.53	503.98	219	57.60	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2157.7	B08		9	0232-0506	148.19	505.77	242	59.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			273.9	B08		9	0233-0507	431.14	506.84	291	62.53	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			643.7	B08		9	0234-0507	638.99	507.50	240	56.53	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			607.4	B08		9	0235-0513	402.86	513.41	325	66.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			221.5	B08		9	0236-0514	539.86	512.74	302	67.84	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1111.4	B08		9	0237-0515	869.62	515.16	264	61.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			6899.4	B08		9	0238-0516	369.98	516.93	269	64.18	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			338.2	B08		9	0239-0519	104.22	518.97	321	67.26	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			315.9	B08		9	0240-0525	570.22	526.36	302	65.94	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			261.0	B08		9	0241-0528	304.28	527.73	282	63.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			449.9	B08		9	0242-0532	817.06	532.15	301	66.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			428.9	B08		9	0243-0529	424.39	528.53	175	47.94	0.957
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3022.8	B08		9	0244-0536	692.32	536.35	300	71.01	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			7133.0	B08		9	0245-0535	203.65	535.32	324	70.77	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			348.2	B08		9	0246-0534	332.49	534.09	240	59.60	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			736.1	B08		9	0247-0535	479.98	535.04	241	57.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			381.9	B08		9	0248-0535	624.18	535.37	228	54.53	0.964
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2108.6	B08		9	0249-0541	520.93	541.71	289	66.08	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			459.6	B08		9	0250-0540	436.99	540.78	196	51.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			263.5	B08		9	0251-0542	849.90	542.58	274	61.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			237.4	B08		9	0252-0547	578.88	546.35	334	73.26	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1990.8	B08		9	0253-0547	64.50	546.90	227	56.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			217.0	B08		9	0254-0548	272.23	548.62	433	82.67	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			310.3	B08		9	0255-0549	125.58	549.29	309	65.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			231.2	B08		9	0256-0552	634.80	553.72	295	69.01	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			432.6	B08		9	0257-0554	757.50	554.76	286	61.94	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1038.8	B08		9	0258-0558	555.44	558.53	254	60.77	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			860.4	B08		9	0259-0560	24.96	560.43	200	53.70	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			440.3	B08		9	0260-0562	697.90	561.96	263	64.77	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			239.9	B08		9	0261-0563	849.83	563.63	267	62.77	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			364.6	B08		9	0262-0566	598.76	565.95	287	64.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2321.7	B08		9	0263-0565	51.84	565.11	217	53.94	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			419.6	B08		9	0264-0568	888.61	568.11	289	68.43	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			672.0	B08		9	0265-0572	386.02	571.90	243	58.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5716.3	B08		9	0266-0575	514.40	575.95	281	61.70	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			226.0	B08		9	0267-0581	532.87	581.25	353	71.94	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1213.1	B08		9	0268-0579	287.29	578.41	257	65.84	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			216.6	B08		9	0269-0584	864.73	583.81	303	73.26	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			367.1	B08		9	0270-0584	646.24	584.16	276	63.01	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			972.3	B08		9	0271-0585	50.25	586.00	238	56.53	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			267.5	B08		9	0272-0588	179.41	588.74	349	70.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			350.8	B08		9	0273-0590	332.10	590.35	315	67.36	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1206.9	B08		9	0274-0586	763.04	585.73	159	46.28	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4514.1	B08		9	0275-0592	716.93	591.83	260	62.43	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			210.7	B08		9	0276-0596	84.07	595.42	314	70.43	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			193.0	B08		9	0277-0596	569.57	597.08	525	102.57	0.627
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			265.0	B08		9	0278-0595	813.75	595.63	252	65.36	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			669.7	B08		9	0279-0592	473.14	591.49	225	56.87	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			307.9	B08		9	0280-0596	369.67	596.03	280	62.18	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1201.9	B08		9	0281-0596	774.53	596.67	295	65.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1970.3	B08		9	0282-0601	122.68	601.11	241	61.84	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3792.3	B08		9	0283-0598	437.42	599.28	254	61.94	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			281.6	B08		9	0284-0604	937.38	603.42	278	62.53	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			435.9	B08		9	0285-0604	397.84	603.82	232	55.36	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			288.2	B08		9	0286-0609	894.82	608.75	206	54.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			266.6	B08		9	0287-0616	115.39	616.74	322	71.60	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			227.4	B08		9	0288-0614	727.58	614.63	374	73.01	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			321.0	B08		9	0289-0615	291.21	615.32	234	60.18	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			259.6	B08		9	0290-0611	909.17	611.05	147	46.04	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			381.8	B08		9	0291-0616	59.21	615.88	279	62.18	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			260.8	B08		9	0292-0616	645.44	616.87	345	73.26	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1194.6	B08		9	0293-0617	868.69	617.47	490	92.81	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			387.3	B08		9	0294-0618	309.51	618.88	216	61.84	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			263.7	B08		9	0295-0618	274.72	618.27	204	54.53	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2410.6	B08		9	0296-0622	927.25	621.70	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			295.8	B08		9	0297-0624	218.76	623.81	309	63.60	0.960
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			641.2	B08		9	0298-0628	473.80	627.67	178	52.53	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			484.7	B08		9	0299-0629	88.26	629.56	283	62.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			612.8	B08		9	0300-0629	777.02	628.82	261	61.01	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			177.2	B08		9	0301-0635	568.32	635.08	290	73.84	0.668
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			245.0	B08		9	0302-0631	810.05	630.69	249	63.26	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			284.6	B08		9	0303-0630	383.60	630.36	218	53.36	0.962
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			454.2	B08		9	0304-0632	640.10	632.53	232	59.70	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			489.5	B08		9	0305-0633	902.89	632.87	350	68.18	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			227.4	B08		9	0306-0631	325.68	632.39	263	60.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			471.6	B08		9	0307-0633	688.22	633.46	306	63.94	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			259.7	B08		9	0308-0640	182.52	640.32	330	69.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1516.6	B08		9	0309-0639	110.84	638.95	229	56.53	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			476.4	B08		9	0310-0642	264.97	641.97	190	53.36	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			245.4	B08		9	0311-0642	946.31	642.26	211	55.94	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			706.2	B08		9	0312-0653	717.73	653.94	494	85.15	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2264.3	B08		9	0313-0650	429.31	649.95	196	52.28	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			451.3	B08		9	0314-0655	504.15	656.17	268	64.18	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3081.2	B08		9	0315-0652	657.70	652.90	261	59.11	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1563.0	B08		9	0316-0654	70.78	654.67	174	51.11	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			506.6	B08		9	0317-0657	339.71	657.78	226	56.53	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1467.1	B08		9	0318-0655	383.03	655.64	149	48.87	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			640.3	B08		9	0319-0657	200.29	656.11	247	59.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5044.1	B08		9	0320-0658	839.59	659.58	154	49.70	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2661.9	B08		9	0321-0657	444.85	658.14	127	47.11	0.719
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			449.5	B08		9	0322-0661	623.12	662.42	258	63.60	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			404.4	B08		9	0323-0658	568.08	658.62	172	49.70	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			370.6	B08		9	0324-0659	790.18	659.37	206	54.28	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			893.5	B08		9	0325-0663	35.78	663.64	240	57.94	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			454.3	B08		9	0326-0662	404.60	661.96	211	57.36	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1836.3	B08		9	0327-0664	162.23	664.66	252	61.94	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			347.7	B08		9	0328-0670	140.52	670.03	284	64.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1492.5	B08		9	0329-0672	297.72	672.30	288	66.43	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1337.8	B08		9	0330-0674	875.21	673.40	244	60.53	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			205.1	B08		9	0331-0676	380.69	676.33	270	67.84	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3102.6	B08		9	0332-0675	91.03	674.87	253	59.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			300.8	B08		9	0333-0676	937.72	675.75	245	59.11	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			362.4	B08		9	0334-0674	786.59	674.75	198	50.87	0.962
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			234.7	B08		9	0335-0684	887.77	684.20	229	60.77	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			761.7	B08		9	0336-0686	264.85	686.00	246	60.53	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			434.8	B08		9	0337-0692	837.75	693.34	241	64.43	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			578.2	B08		9	0338-0695	451.42	695.09	247	59.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			267.4	B08		9	0339-0698	629.42	698.59	368	72.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3666.7	B08		9	0340-0696	691.70	698.16	252	70.43	0.638
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			199.8	B08		9	0341-0695	937.50	695.64	242	57.11	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1497.7	B08		9	0342-0697	110.29	698.24	232	66.18	0.666
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			361.5	B08		9	0343-0703	749.84	702.22	218	59.11	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			373.1	B08		9	0344-0703	45.50	703.45	308	66.43	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			305.6	B08		9	0345-0708	150.33	708.96	334	70.43	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2239.3	B08		9	0346-0706	185.63	705.56	275	66.43	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			260.4	B08		9	0347-0703	907.57	703.18	102	37.80	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			973.3	B08		9	0348-0708	216.50	709.43	226	57.36	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			651.3	C08		1	0001-0025	822.14	25.96	373	78.43	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			385.9	C08		1	0002-0032	681.57	32.38	336	70.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			256.4	C08		1	0003-0031	209.13	31.38	259	59.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			193.7	C08		1	0004-0035	598.48	35.02	291	65.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			248.9	C08		1	0005-0033	294.09	33.97	277	61.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			478.9	C08		1	0006-0037	95.05	37.30	267	59.36	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			261.7	C08		1	0007-0038	133.57	38.49	299	64.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			192.8	C08		1	0008-0040	943.98	40.01	322	66.77	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1091.7	C08		1	0009-0040	72.15	41.03	262	61.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			756.0	C08		1	0010-0039	525.47	39.38	257	59.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1417.9	C08		1	0011-0041	554.92	42.34	237	63.60	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1453.4	C08		1	0012-0041	925.52	41.93	290	61.94	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2133.5	C08		1	0013-0045	740.21	45.84	288	63.84	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			733.7	C08		1	0014-0050	351.70	51.05	330	68.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1982.5	C08		1	0015-0054	703.39	54.41	393	100.57	0.488
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			445.2	C08		1	0016-0050	831.85	50.06	209	52.28	0.961
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			226.4	C08		1	0017-0054	308.76	53.84	288	64.43	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			184.6	C08		1	0018-0058	877.05	57.46	291	64.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1019.3	C08		1	0019-0061	784.13	62.60	326	70.18	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1082.6	C08		1	0020-0061	248.09	60.88	258	61.01	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			884.1	C08		1	0021-0063	901.93	63.40	246	58.18	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			218.3	C08		1	0022-0065	450.72	64.22	288	63.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			870.5	C08		1	0023-0070	278.90	71.24	278	66.18	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			313.5	C08		1	0024-0072	603.94	72.36	320	66.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			313.7	C08		1	0025-0072	740.78	71.77	255	64.43	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1585.7	C08		1	0026-0072	691.94	72.87	204	67.26	0.567
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			205.7	C08		1	0027-0072	50.25	71.85	260	59.94	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			968.9	C08		1	0028-0074	438.92	74.68	303	65.26	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			883.5	C08		1	0029-0079	190.55	76.48	356	97.64	0.469
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			230.4	C08		1	0030-0075	870.05	76.04	277	65.36	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			236.7	C08		1	0031-0085	158.34	84.95	308	67.60	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			362.6	C08		1	0032-0085	93.65	85.12	246	58.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			245.7	C08		1	0033-0086	125.51	86.38	303	68.08	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2063.0	C08		1	0034-0086	411.37	86.47	305	64.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			702.4	C08		1	0035-0086	333.45	86.21	307	67.36	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1832.1	C08		1	0036-0095	644.36	95.56	264	61.94	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3302.1	C08		1	0037-0095	520.50	94.48	257	62.77	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			382.6	C08		1	0038-0096	764.15	95.07	320	71.01	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			781.8	C08		1	0039-0100	537.98	100.04	222	57.94	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1576.5	C08		1	0040-0101	506.98	101.49	188	52.53	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			913.1	C08		1	0041-0103	259.99	103.05	262	59.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1337.4	C08		1	0042-0105	493.19	105.07	201	53.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			391.4	C08		1	0043-0106	37.63	106.01	252	59.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			247.5	C08		1	0044-0109	240.13	108.48	280	63.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1851.3	C08		1	0045-0108	558.40	108.86	306	65.36	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3934.3	C08		1	0046-0108	577.01	108.07	250	57.36	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			481.0	C08		1	0047-0107	811.47	107.51	328	67.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			213.9	C08		1	0048-0110	851.09	110.29	317	67.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			233.7	C08		1	0049-0108	445.47	107.83	261	66.77	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			268.1	C08		1	0050-0117	119.82	117.36	249	60.53	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			587.7	C08		1	0051-0119	649.82	119.59	358	69.60	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			481.2	C08		1	0052-0120	103.19	120.90	254	61.11	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2207.8	C08		1	0053-0119	946.75	118.29	260	63.60	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			589.6	C08		1	0054-0118	743.02	118.79	290	64.53	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			183.6	C08		1	0055-0121	58.32	121.55	260	60.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			266.7	C08		1	0056-0131	85.34	132.15	262	61.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			864.8	C08		1	0057-0131	452.43	130.72	300	64.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1155.9	C08		1	0058-0138	487.67	137.96	255	65.84	0.739
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1267.5	C08		1	0059-0137	502.83	137.54	193	57.01	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			376.4	C08		1	0060-0139	210.02	137.63	516	101.40	0.631
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			689.7	C08		1	0061-0138	670.61	138.33	241	56.53	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			198.7	C08		1	0062-0143	149.45	143.21	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			583.1	C08		1	0063-0140	372.06	140.09	251	59.01	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			850.4	C08		1	0064-0145	749.21	144.31	314	68.18	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			227.5	C08		1	0065-0145	920.96	145.33	331	71.50	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			505.8	C08		1	0066-0146	39.71	146.68	341	69.94	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			570.8	C08		1	0067-0147	173.79	147.27	267	61.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			239.0	C08		1	0068-0153	551.00	153.54	283	63.26	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			340.3	C08		1	0069-0151	813.05	150.94	259	59.36	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			264.3	C08		1	0070-0158	513.00	157.99	546	99.15	0.698
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2485.9	C08		1	0071-0153	446.25	153.63	170	52.77	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1101.0	C08		1	0072-0155	845.90	155.03	319	67.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			416.8	C08		1	0073-0154	334.70	154.51	259	60.18	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			360.8	C08		1	0074-0152	624.74	152.68	246	59.11	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			283.3	C08		1	0075-0156	784.87	156.36	297	65.60	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			264.1	C08		1	0076-0159	884.42	159.25	315	70.43	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			752.0	C08		1	0077-0160	127.31	160.31	303	65.36	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			518.6	C08		1	0078-0162	305.18	162.32	272	63.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			246.2	C08		1	0079-0168	288.46	168.54	311	67.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			226.6	C08		1	0080-0171	832.81	171.77	291	68.18	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3579.7	C08		1	0081-0174	42.34	174.21	262	63.36	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			260.5	C08		1	0082-0170	729.21	170.50	271	61.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			358.2	C08		1	0083-0173	590.40	173.08	296	63.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			271.6	C08		1	0084-0178	83.14	178.73	315	65.01	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			707.6	C08		1	0085-0177	171.65	177.29	246	57.36	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			250.6	C08		1	0086-0182	691.21	182.38	284	63.36	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			282.0	C08		1	0087-0186	447.87	186.68	253	59.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			354.0	C08		1	0088-0188	242.39	187.62	194	51.94	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			425.2	C08		1	0089-0193	516.56	193.62	611	101.98	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			294.7	C08		1	0090-0190	635.08	190.19	316	70.43	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			200.9	C08		1	0091-0192	872.76	192.02	284	61.36	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			217.2	C08		1	0092-0193	736.41	192.47	313	65.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1068.6	C08		1	0093-0194	386.17	193.83	254	58.53	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			200.2	C08		1	0094-0194	823.62	193.96	316	67.84	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			522.2	C08		1	0095-0196	920.81	196.20	290	64.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3230.2	C08		1	0096-0196	427.88	196.19	297	65.01	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			334.5	C08		1	0097-0201	117.09	201.51	288	64.28	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1022.1	C08		1	0098-0201	53.21	201.78	281	60.77	0.956
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			403.7	C08		1	0099-0200	257.81	199.94	205	56.77	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			678.0	C08		1	0100-0203	208.24	203.37	234	55.94	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			209.1	C08		1	0101-0206	669.23	206.07	274	62.53	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			673.6	C08		1	0102-0208	574.16	208.16	397	73.84	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			202.0	C08		1	0103-0204	331.29	205.07	268	64.28	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			264.2	C08		1	0104-0211	807.63	211.72	465	80.08	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			325.2	C08		1	0105-0211	246.49	212.01	282	62.43	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			453.6	C08		1	0106-0213	766.71	214.14	272	61.60	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			305.8	C08		1	0107-0227	200.15	227.05	513	92.08	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			444.1	C08		1	0108-0228	722.25	228.10	375	72.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			740.4	C08		1	0109-0230	145.31	230.74	242	58.77	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			379.9	C08		1	0110-0231	695.49	230.67	231	55.36	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2214.7	C08		1	0111-0231	567.25	231.61	293	66.53	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			543.2	C08		1	0112-0236	127.92	236.17	260	61.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			570.5	C08		1	0113-0237	501.37	237.45	245	57.94	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			288.0	C08		1	0114-0236	799.39	236.30	397	79.70	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			333.4	C08		1	0115-0240	324.51	240.08	251	58.53	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1315.5	C08		1	0116-0244	296.32	243.88	305	66.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			715.0	C08		1	0117-0248	90.39	247.75	310	65.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			569.6	C08		1	0118-0248	683.41	248.56	344	67.60	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			509.3	C08		1	0119-0245	744.24	245.15	204	53.11	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			363.2	C08		1	0120-0245	763.73	245.53	199	51.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3490.9	C08		1	0121-0250	345.88	250.19	248	57.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			587.9	C08		1	0122-0255	833.72	255.63	376	75.26	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			302.7	C08		1	0123-0253	578.67	252.77	255	61.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			626.3	C08		1	0124-0257	141.20	256.83	286	63.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			264.4	C08		1	0125-0262	225.24	261.63	430	78.67	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			201.9	C08		1	0126-0259	74.74	259.19	315	66.53	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			285.3	C08		1	0127-0259	284.48	259.09	366	71.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			464.7	C08		1	0128-0259	366.80	258.66	326	67.01	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			336.7	C08		1	0129-0257	851.64	258.33	235	58.87	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2495.1	C08		1	0130-0267	526.09	266.69	533	94.57	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			277.3	C08		1	0131-0263	590.14	263.95	263	61.11	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			381.2	C08		1	0132-0266	877.93	266.67	240	58.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			457.5	C08		1	0133-0265	920.94	265.46	218	53.70	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			632.7	C08		1	0134-0271	614.64	271.53	413	74.67	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			304.6	C08		1	0135-0272	765.04	272.49	301	63.36	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			537.7	C08		1	0136-0272	934.67	272.12	175	51.36	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			229.4	C08		1	0137-0276	167.43	277.02	253	61.70	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2878.4	C08		1	0138-0276	674.37	275.96	323	67.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			551.5	C08		1	0139-0278	456.40	277.71	282	63.60	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			265.4	C08		1	0140-0279	829.32	278.74	284	64.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2382.0	C08		1	0141-0279	328.50	279.91	245	56.77	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			385.6	C08		1	0142-0287	283.61	286.97	406	75.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			222.5	C08		1	0143-0290	212.32	290.79	292	66.18	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1557.3	C08		1	0144-0287	406.95	287.56	318	70.77	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			665.4	C08		1	0145-0287	877.73	287.64	261	59.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			509.8	C08		1	0146-0284	940.74	284.64	148	44.28	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1474.5	C08		1	0147-0290	350.24	290.23	304	68.08	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			303.5	C08		1	0148-0293	88.23	293.47	271	63.36	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			426.5	C08		1	0149-0298	478.74	297.61	288	67.11	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1478.9	C08		1	0150-0299	30.29	299.17	312	65.11	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1244.0	C08		1	0151-0297	769.35	297.25	237	56.18	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			346.6	C08		1	0152-0298	577.12	298.30	242	62.18	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			228.6	C08		1	0153-0301	850.21	301.23	325	67.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			896.0	C08		1	0154-0301	793.81	300.67	249	59.60	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			310.8	C08		1	0155-0305	134.72	305.10	300	65.01	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1376.3	C08		1	0156-0305	415.61	306.08	322	69.60	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			264.8	C08		1	0157-0308	177.86	307.75	226	57.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			233.0	C08		1	0158-0311	161.71	310.71	226	56.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1281.5	C08		1	0159-0311	441.45	311.15	283	62.77	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			462.0	C08		1	0160-0310	572.11	310.90	264	63.70	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1136.7	C08		1	0161-0317	258.06	316.84	309	68.77	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1727.3	C08		1	0162-0320	664.01	318.99	331	66.77	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2470.7	C08		1	0163-0324	615.82	324.26	326	70.43	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1108.0	C08		1	0164-0324	23.47	324.39	299	63.60	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1188.9	C08		1	0165-0325	243.62	325.36	286	63.84	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1651.4	C08		1	0166-0325	394.36	325.64	297	64.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			323.5	C08		1	0167-0328	874.08	327.59	234	56.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			231.4	C08		1	0168-0328	899.15	329.03	260	61.94	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			441.1	C08		1	0169-0333	90.84	332.85	266	62.43	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			194.5	C08		1	0170-0333	126.02	332.87	298	67.60	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			407.2	C08		1	0171-0337	818.17	337.25	353	68.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			323.0	C08		1	0172-0336	529.02	336.98	248	59.94	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			404.9	C08		1	0173-0335	936.43	335.59	267	61.36	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			225.2	C08		1	0174-0342	377.70	341.70	254	63.60	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			813.4	C08		1	0175-0341	751.57	340.97	254	61.60	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			806.1	C08		1	0176-0344	76.38	343.86	228	55.36	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			460.4	C08		1	0177-0345	460.57	344.62	193	52.53	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			299.2	C08		1	0178-0351	681.74	350.99	338	69.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1843.8	C08		1	0179-0349	577.92	349.82	294	64.43	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			294.3	C08		1	0180-0351	291.85	350.98	292	63.84	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			620.4	C08		1	0181-0352	489.82	352.37	300	65.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			236.5	C08		1	0182-0352	327.35	351.69	252	61.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			425.9	C08		1	0183-0353	446.60	353.32	231	56.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			468.4	C08		1	0184-0354	805.06	354.07	247	59.70	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			284.2	C08		1	0185-0359	872.13	359.11	311	67.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			359.1	C08		1	0186-0363	132.70	363.09	329	68.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1341.0	C08		1	0187-0365	336.31	364.68	263	59.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			217.8	C08		1	0188-0364	410.22	363.79	327	69.01	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			239.6	C08		1	0189-0367	502.64	368.11	257	61.84	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			741.2	C08		1	0190-0376	921.44	376.79	551	108.95	0.583
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1133.4	C08		1	0191-0369	593.60	369.66	279	63.70	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			222.8	C08		1	0192-0375	268.02	375.42	298	69.36	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			420.7	C08		1	0193-0372	752.98	371.61	257	60.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1306.8	C08		1	0194-0377	634.41	376.32	349	72.43	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			203.0	C08		1	0195-0379	880.14	379.02	319	70.43	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			227.2	C08		1	0196-0377	119.73	376.80	305	72.77	0.724
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			208.3	C08		1	0197-0382	700.82	381.97	292	65.60	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			911.6	C08		1	0198-0382	220.40	381.71	287	64.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			396.1	C08		1	0199-0382	446.89	381.74	234	56.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			204.9	C08		1	0200-0384	428.95	384.84	299	64.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			248.0	C08		1	0201-0387	282.57	387.37	421	76.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			333.1	C08		1	0202-0387	25.30	387.85	243	61.94	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1125.7	C08		1	0203-0393	364.86	393.85	475	94.23	0.672
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			227.3	C08		1	0204-0386	840.01	386.59	291	66.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			344.9	C08		1	0205-0392	728.70	393.05	303	68.18	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			502.4	C08		1	0206-0395	87.04	395.30	245	57.94	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2613.9	C08		1	0207-0395	516.66	395.19	277	61.36	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			390.6	C08		1	0208-0404	108.05	404.45	252	58.18	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			253.5	C08		1	0209-0408	417.91	407.79	261	63.01	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1992.5	C08		1	0210-0413	504.12	413.06	284	62.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1867.8	C08		1	0211-0413	684.04	412.94	283	62.18	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1891.8	C08		1	0212-0418	45.73	418.54	308	64.18	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			323.0	C08		1	0213-0420	133.94	419.89	318	65.84	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			185.3	C08		1	0214-0424	879.01	423.32	332	79.74	0.656
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2271.2	C08		1	0215-0420	815.78	420.19	308	63.36	0.964
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			679.7	C08		1	0216-0420	439.51	420.26	208	54.04	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			751.2	C08		1	0217-0422	290.62	422.02	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			442.2	C08		1	0218-0426	192.46	426.07	432	78.43	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			272.5	C08		1	0219-0425	457.42	425.06	257	61.70	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1884.2	C08		1	0220-0425	908.76	426.11	267	63.94	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			506.8	C08		1	0221-0430	759.47	429.63	435	88.67	0.695
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			600.7	C08		1	0222-0428	253.32	428.39	295	66.18	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			593.5	C08		1	0223-0431	555.02	431.98	323	95.15	0.448
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			979.9	C08		1	0224-0430	599.73	430.23	285	65.60	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			214.4	C08		1	0225-0433	317.04	433.41	275	62.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			194.9	C08		1	0226-0433	103.24	433.39	402	75.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1161.8	C08		1	0227-0438	640.55	438.85	580	100.57	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1791.1	C08		1	0228-0435	845.96	435.40	258	62.28	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			492.2	C08		1	0229-0438	720.28	437.38	302	67.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			263.8	C08		1	0230-0439	18.11	439.59	340	68.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			709.9	C08		1	0231-0441	169.96	442.00	318	66.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			252.7	C08		1	0232-0444	771.12	444.45	230	57.36	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1217.9	C08		1	0233-0447	477.66	447.79	262	61.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			457.1	C08		1	0234-0456	438.10	457.77	540	95.40	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			180.4	C08		1	0235-0456	881.35	455.43	335	78.57	0.682
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			423.1	C08		1	0236-0456	265.11	456.45	313	65.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			491.3	C08		1	0237-0460	511.98	459.79	454	81.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			511.2	C08		1	0238-0456	409.18	456.62	214	53.36	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1556.9	C08		1	0239-0461	38.50	461.65	307	66.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1875.7	C08		1	0240-0462	165.64	462.71	309	71.60	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			899.4	C08		1	0241-0468	330.38	467.02	250	58.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			443.6	C08		1	0242-0470	569.44	470.56	357	69.84	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			587.8	C08		1	0243-0470	930.07	470.50	260	59.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3496.4	C08		1	0244-0471	789.81	471.64	322	67.01	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			352.6	C08		1	0245-0474	229.06	473.77	379	73.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			871.1	C08		1	0246-0471	387.85	471.68	248	58.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			316.9	C08		1	0247-0472	706.29	472.14	277	63.11	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			913.9	C08		1	0248-0481	321.87	481.24	242	58.77	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			810.8	C08		1	0249-0485	380.17	485.37	224	55.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			880.1	C08		1	0250-0486	625.83	486.05	324	66.18	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			220.1	C08		1	0251-0487	260.40	486.47	279	63.01	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2286.0	C08		1	0252-0488	501.49	489.01	313	66.77	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1577.0	C08		1	0253-0492	911.58	492.21	260	59.70	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			362.8	C08		1	0254-0494	593.95	494.04	348	70.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			237.9	C08		1	0255-0495	665.13	495.70	312	69.11	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			971.9	C08		1	0256-0494	159.72	493.86	232	57.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			429.0	C08		1	0257-0496	474.83	495.59	304	64.77	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			250.2	C08		1	0258-0500	942.76	500.59	410	78.43	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1472.9	C08		1	0259-0499	73.34	499.05	270	61.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			296.4	C08		1	0260-0501	746.05	501.11	444	77.26	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1539.2	C08		1	0261-0500	189.28	499.86	272	61.11	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			252.1	C08		1	0262-0505	546.03	505.10	455	80.91	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			277.8	C08		1	0263-0503	299.59	503.95	272	63.01	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			558.2	C08		1	0264-0501	110.04	501.73	271	61.70	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			749.1	C08		1	0265-0505	789.60	505.62	115	92.43	0.169
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1293.1	C08		1	0266-0510	829.21	510.02	266	60.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1261.0	C08		1	0267-0509	37.93	509.58	271	61.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			370.6	C08		1	0268-0511	426.05	511.33	325	66.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			328.1	C08		1	0269-0514	270.46	514.21	363	71.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			206.6	C08		1	0270-0511	672.74	511.00	271	68.28	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			364.8	C08		1	0271-0516	129.22	517.00	317	67.36	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			741.2	C08		1	0272-0516	194.76	516.95	280	64.53	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1275.0	C08		1	0273-0521	857.97	520.82	269	61.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			349.4	C08		1	0274-0520	584.05	520.77	274	60.77	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1747.8	C08		1	0275-0522	441.51	522.16	302	64.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3239.4	C08		1	0276-0522	713.75	522.25	263	61.70	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1754.0	C08		1	0277-0526	530.57	526.08	301	64.43	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			393.4	C08		1	0278-0533	763.47	532.72	242	59.36	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1936.9	C08		1	0279-0534	795.61	533.70	277	61.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			825.9	C08		1	0280-0533	83.50	533.87	305	73.01	0.719
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			628.2	C08		1	0281-0535	213.46	535.24	213	53.11	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1210.3	C08		1	0282-0539	273.70	539.14	294	68.67	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3925.3	C08		1	0283-0537	619.01	536.78	268	61.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			481.4	C08		1	0284-0544	727.47	543.99	343	68.43	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			552.0	C08		1	0285-0547	679.63	546.69	355	71.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1210.3	C08		1	0286-0547	351.77	547.50	250	59.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			724.7	C08		1	0287-0549	43.38	549.11	280	63.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1621.8	C08		1	0288-0548	164.29	548.21	254	59.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			529.1	C08		1	0289-0548	540.05	548.03	188	49.70	0.956
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			646.5	C08		1	0290-0550	835.32	549.74	270	61.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1372.9	C08		1	0291-0549	145.49	549.09	265	62.04	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1725.9	C08		1	0292-0552	920.15	551.59	294	63.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			748.5	C08		1	0293-0553	312.34	553.07	308	65.01	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			256.3	C08		1	0294-0553	786.10	553.31	341	71.84	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			443.2	C08		1	0295-0556	560.59	557.44	266	59.60	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			411.7	C08		1	0296-0559	390.52	558.51	297	64.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			904.1	C08		1	0297-0563	482.05	562.86	252	58.18	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1817.4	C08		1	0298-0563	675.45	563.22	272	63.11	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4190.7	C08		1	0299-0564	92.34	564.16	140	51.11	0.673
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			238.7	C08		1	0300-0569	793.86	569.65	318	66.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			425.5	C08		1	0301-0567	268.09	568.13	164	47.21	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			849.6	C08		1	0302-0571	593.86	571.40	272	60.53	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			182.0	C08		1	0303-0572	205.22	572.62	276	67.60	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			394.6	C08		1	0304-0571	518.31	570.42	129	68.53	0.345
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			341.5	C08		1	0305-0579	898.28	579.25	364	71.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1764.1	C08		1	0306-0575	245.48	575.14	169	47.46	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1098.0	C08		1	0307-0576	559.64	575.69	245	58.53	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			250.3	C08		1	0308-0578	732.89	578.70	294	64.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			562.0	C08		1	0309-0580	875.88	579.73	285	62.18	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			843.0	C08		1	0310-0581	82.77	581.36	293	63.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			309.1	C08		1	0311-0587	262.45	585.43	422	83.60	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			450.2	C08		1	0312-0584	449.27	583.89	246	57.11	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			358.9	C08		1	0313-0585	537.45	585.66	219	55.36	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			194.4	C08		1	0314-0588	301.52	587.94	322	67.60	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			673.0	C08		1	0315-0589	927.47	589.16	304	65.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			273.8	C08		1	0316-0589	150.69	589.40	378	72.77	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			527.7	C08		1	0317-0592	810.14	592.40	297	64.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			981.7	C08		1	0318-0595	27.14	595.40	266	63.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3653.9	C08		1	0319-0597	944.27	597.18	229	55.70	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1246.8	C08		1	0320-0605	525.30	604.34	263	62.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1368.7	C08		1	0321-0603	766.04	603.99	261	61.70	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			227.3	C08		1	0322-0607	199.34	607.04	248	62.77	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			280.3	C08		1	0323-0608	393.01	608.28	288	63.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			779.8	C08		1	0324-0609	74.76	609.25	262	59.60	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1252.9	C08		1	0325-0612	704.10	611.88	297	64.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			176.5	C08		1	0326-0614	844.13	613.52	296	63.60	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			822.6	C08		1	0327-0612	482.55	611.88	271	62.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			345.5	C08		1	0328-0621	28.06	620.90	218	54.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1300.0	C08		1	0329-0619	763.88	618.42	260	63.11	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1382.5	C08		1	0330-0624	650.46	623.74	294	66.43	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1023.9	C08		1	0331-0625	262.52	625.35	205	51.70	0.964
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1565.7	C08		1	0332-0633	595.61	632.78	244	57.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			502.2	C08		1	0333-0634	879.26	634.12	249	57.94	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			304.6	C08		1	0334-0638	623.32	638.35	297	62.77	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3340.0	C08		1	0335-0643	419.35	643.64	263	62.53	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			589.0	C08		1	0336-0646	176.89	645.51	593	98.57	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			225.7	C08		1	0337-0645	219.75	645.23	306	69.60	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1186.7	C08		1	0338-0648	126.69	647.81	281	64.77	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1877.3	C08		1	0339-0646	727.56	646.82	268	61.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			202.0	C08		1	0340-0650	88.89	650.61	376	73.01	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			992.6	C08		1	0341-0649	316.53	648.68	283	62.77	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4981.9	C08		1	0342-0650	522.00	651.01	317	68.43	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			277.3	C08		1	0343-0651	570.73	650.76	211	55.11	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			427.9	C08		1	0344-0651	800.58	651.10	287	63.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1385.7	C08		1	0345-0648	909.49	648.45	257	60.53	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			187.6	C08		1	0346-0654	254.61	654.82	304	67.36	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			488.8	C08		1	0347-0653	445.55	652.66	256	59.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1649.1	C08		1	0348-0654	367.50	653.95	286	62.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1105.2	C08		1	0349-0656	762.40	655.48	294	64.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			300.1	C08		1	0350-0664	667.52	664.31	302	63.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			455.2	C08		1	0351-0671	601.16	671.67	341	67.60	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			272.1	C08		1	0352-0672	812.39	672.34	244	58.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			644.4	C08		1	0353-0676	939.29	676.50	264	61.11	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			655.8	C08		1	0354-0678	275.20	678.07	250	57.70	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2024.7	C08		1	0355-0681	711.96	681.31	295	64.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2472.3	C08		1	0356-0682	315.97	682.29	268	61.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			324.6	C08		1	0357-0681	863.81	681.07	227	57.11	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			675.8	C08		1	0358-0683	583.00	683.42	165	46.87	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1096.2	C08		1	0359-0688	917.00	688.43	243	58.18	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			453.2	C08		1	0360-0688	653.24	687.57	269	60.28	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			400.4	C08		1	0361-0693	825.13	693.11	264	63.26	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1329.1	C08		1	0362-0692	465.12	692.45	299	67.60	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			638.8	C08		1	0363-0695	164.66	695.52	270	60.53	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3660.4	C08		1	0364-0697	406.64	696.45	298	62.77	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1489.4	C08		1	0365-0696	862.07	696.93	302	67.94	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			735.7	C08		1	0366-0699	197.60	698.93	257	59.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			231.0	C08		1	0367-0697	564.69	698.02	245	58.87	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			236.4	C08		1	0368-0700	335.60	700.91	255	58.77	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			146.9	C08		1	0369-0702	19.92	703.24	288	63.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2461.4	C08		1	0370-0705	367.96	704.81	288	66.67	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			330.5	C08		1	0371-0705	91.70	705.53	250	60.53	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1337.2	C08		2	0001-0024	128.41	23.60	288	63.84	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2178.3	C08		2	0002-0025	174.92	24.72	270	61.94	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1232.9	C08		2	0003-0032	871.75	31.68	248	60.77	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			999.9	C08		2	0004-0033	68.62	32.87	192	51.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1644.2	C08		2	0005-0040	397.91	40.47	375	72.18	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			936.3	C08		2	0006-0037	551.14	37.65	274	62.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			304.1	C08		2	0007-0038	680.72	39.05	242	56.77	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			239.5	C08		2	0008-0042	48.52	41.52	316	66.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1511.7	C08		2	0009-0043	30.09	43.27	294	62.53	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1410.6	C08		2	0010-0043	231.80	43.46	334	67.60	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1487.7	C08		2	0011-0044	186.15	45.23	269	63.26	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			555.9	C08		2	0012-0048	487.71	49.18	332	70.77	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			796.4	C08		2	0013-0047	649.05	47.26	310	64.53	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			223.8	C08		2	0014-0048	797.12	49.02	408	78.08	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			311.1	C08		2	0015-0052	99.99	52.40	411	74.67	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			524.5	C08		2	0016-0049	205.02	49.46	206	53.46	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1521.1	C08		2	0017-0052	737.79	51.91	283	62.18	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1102.8	C08		2	0018-0055	716.07	54.90	288	63.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1351.8	C08		2	0019-0055	576.86	55.80	420	81.60	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			457.2	C08		2	0020-0062	153.35	62.35	313	65.01	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			577.9	C08		2	0021-0066	837.30	66.55	305	69.26	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2728.0	C08		2	0022-0064	854.66	63.94	218	55.11	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			573.2	C08		2	0023-0066	291.41	66.74	292	65.60	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			800.3	C08		2	0024-0068	355.25	67.73	270	61.94	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1093.4	C08		2	0025-0071	448.16	70.63	285	63.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			517.7	C08		2	0026-0075	427.60	74.95	326	66.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			700.5	C08		2	0027-0075	776.54	75.29	255	58.28	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1047.5	C08		2	0028-0082	244.28	81.66	317	68.43	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			236.3	C08		2	0029-0084	285.37	84.39	339	73.60	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			222.2	C08		2	0030-0082	659.88	82.54	285	63.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1062.3	C08		2	0031-0087	605.90	89.87	370	80.18	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			310.8	C08		2	0032-0082	618.92	81.58	168	50.87	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			297.5	C08		2	0033-0085	328.68	85.58	227	56.28	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			220.8	C08		2	0034-0084	576.11	84.68	291	63.01	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1637.2	C08		2	0035-0088	830.95	88.00	311	65.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			243.7	C08		2	0036-0087	550.38	87.01	216	53.94	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			259.9	C08		2	0037-0091	72.87	91.06	245	65.84	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			245.6	C08		2	0038-0092	485.02	92.27	221	54.87	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			278.0	C08		2	0039-0092	774.10	91.27	225	57.36	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2280.9	C08		2	0040-0098	696.24	97.15	290	63.60	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			337.2	C08		2	0041-0102	296.21	101.87	305	65.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2144.2	C08		2	0042-0104	886.08	103.99	341	68.18	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			427.2	C08		2	0043-0106	204.77	105.73	293	64.18	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			606.9	C08		2	0044-0107	99.82	106.94	343	68.77	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			357.3	C08		2	0045-0110	741.92	109.44	252	62.28	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1367.2	C08		2	0046-0111	628.60	111.41	280	60.77	0.953
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			185.7	C08		2	0047-0113	944.04	114.24	441	81.50	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			451.9	C08		2	0048-0112	424.05	112.01	281	62.18	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			883.6	C08		2	0049-0115	340.36	115.59	316	65.60	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1381.8	C08		2	0050-0115	524.22	116.08	258	60.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			241.8	C08		2	0051-0116	404.44	116.68	286	62.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2342.8	C08		2	0052-0120	51.63	119.87	261	61.94	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			207.9	C08		2	0053-0122	257.66	121.89	391	76.08	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			703.7	C08		2	0054-0122	784.64	122.43	214	53.94	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2774.7	C08		2	0055-0124	572.99	124.69	321	66.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			181.5	C08		2	0056-0126	892.41	125.50	423	81.26	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1401.3	C08		2	0057-0128	359.94	128.35	310	65.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			348.1	C08		2	0058-0128	127.19	128.48	284	65.84	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			357.3	C08		2	0059-0130	172.43	130.44	391	73.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			838.3	C08		2	0060-0127	67.80	127.03	189	50.87	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			320.9	C08		2	0061-0131	621.82	131.00	285	64.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			245.3	C08		2	0062-0132	711.18	132.55	340	68.18	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			238.9	C08		2	0063-0137	516.40	137.02	356	72.91	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			898.8	C08		2	0064-0137	775.48	136.06	200	57.26	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			238.4	C08		2	0065-0140	460.31	140.21	426	77.01	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			751.5	C08		2	0066-0139	81.33	139.65	215	52.77	0.970
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1155.5	C08		2	0067-0140	823.51	140.83	256	60.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			236.3	C08		2	0068-0147	25.40	146.81	324	69.50	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			236.3	C08		2	0069-0150	221.02	149.90	439	80.43	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1606.8	C08		2	0070-0148	661.59	147.75	298	66.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			376.2	C08		2	0071-0151	277.86	151.60	306	64.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			297.8	C08		2	0072-0150	620.04	149.78	315	67.60	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			770.2	C08		2	0073-0156	748.99	155.98	202	55.70	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			325.3	C08		2	0074-0162	485.58	162.08	325	69.36	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			661.0	C08		2	0075-0159	562.03	159.43	209	54.28	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			337.5	C08		2	0076-0160	681.59	160.78	171	51.36	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			955.8	C08		2	0077-0171	363.75	171.30	328	69.26	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2029.9	C08		2	0078-0170	929.17	169.79	323	68.18	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1899.9	C08		2	0079-0170	58.63	170.19	217	53.11	0.967
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			866.1	C08		2	0080-0171	155.29	171.07	270	63.60	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			389.0	C08		2	0081-0172	587.56	172.32	252	59.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			658.2	C08		2	0082-0174	416.12	173.89	277	60.77	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3437.6	C08		2	0083-0178	456.76	175.89	289	74.18	0.660
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2668.8	C08		2	0084-0175	280.35	175.27	341	71.01	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1044.6	C08		2	0085-0176	136.98	176.47	272	63.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			331.3	C08		2	0086-0179	526.31	179.88	250	58.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3076.9	C08		2	0087-0181	242.03	181.06	335	69.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2839.9	C08		2	0088-0183	781.58	182.81	340	69.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1358.3	C08		2	0089-0184	103.01	184.47	203	54.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			516.0	C08		2	0090-0188	599.94	188.31	310	66.18	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			910.6	C08		2	0091-0192	481.83	192.42	247	63.70	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			480.0	C08		2	0092-0195	425.92	194.89	295	66.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			510.9	C08		2	0093-0198	25.57	197.78	289	63.60	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			739.1	C08		2	0094-0197	114.02	196.94	260	63.60	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			882.7	C08		2	0095-0200	525.18	199.68	315	65.94	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			270.2	C08		2	0096-0207	650.18	206.99	239	59.11	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			297.2	C08		2	0097-0204	722.48	204.95	239	56.18	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			685.8	C08		2	0098-0205	182.25	204.45	297	67.36	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			449.6	C08		2	0099-0211	436.75	211.44	299	67.94	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			684.9	C08		2	0100-0209	55.77	209.90	260	61.36	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2745.3	C08		2	0101-0212	318.78	212.16	308	66.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			270.3	C08		2	0102-0220	586.21	220.27	445	81.26	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			181.2	C08		2	0103-0223	186.02	223.61	263	59.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			419.4	C08		2	0104-0225	229.36	225.31	286	63.70	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			227.4	C08		2	0105-0225	923.17	225.16	242	57.11	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2009.8	C08		2	0106-0227	610.82	226.84	275	60.77	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1284.1	C08		2	0107-0227	100.50	227.54	284	64.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			843.9	C08		2	0108-0230	790.69	229.96	292	65.01	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4472.4	C08		2	0109-0230	383.79	229.79	303	63.94	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			264.8	C08		2	0110-0232	505.35	232.95	268	61.94	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			173.4	C08		2	0111-0231	64.38	230.32	272	61.11	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1171.3	C08		2	0112-0233	469.77	232.81	290	63.36	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			442.4	C08		2	0113-0233	823.19	232.39	260	61.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			266.2	C08		2	0114-0235	667.08	235.64	249	59.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			414.3	C08		2	0115-0241	271.81	241.68	289	65.84	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			193.7	C08		2	0116-0245	139.28	244.70	550	87.74	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			400.9	C08		2	0117-0245	190.45	245.11	306	64.77	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			679.1	C08		2	0118-0244	426.11	244.68	265	60.53	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1060.4	C08		2	0119-0250	256.58	250.75	311	67.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			325.5	C08		2	0120-0254	553.92	254.42	325	66.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			284.6	C08		2	0121-0253	727.06	253.50	243	57.94	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			330.2	C08		2	0122-0254	885.66	254.38	199	53.36	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			204.5	C08		2	0123-0259	302.12	259.35	329	68.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			218.9	C08		2	0124-0260	748.76	259.74	392	74.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			710.7	C08		2	0125-0261	432.64	261.36	196	53.21	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			272.2	C08		2	0126-0268	343.10	268.18	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			424.4	C08		2	0127-0267	25.78	266.73	231	56.18	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			944.6	C08		2	0128-0266	78.02	266.30	192	51.70	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			160.7	C08		2	0129-0267	114.11	267.03	287	64.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			533.7	C08		2	0130-0266	815.10	266.10	269	61.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1027.9	C08		2	0131-0272	91.72	271.87	183	50.28	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			227.4	C08		2	0132-0273	203.04	273.31	316	68.77	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			275.3	C08		2	0133-0275	569.95	274.68	442	79.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			562.6	C08		2	0134-0274	39.33	273.68	180	51.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			404.1	C08		2	0135-0277	672.47	276.66	294	65.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			356.1	C08		2	0136-0278	287.66	278.62	311	77.74	0.647
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			755.4	C08		2	0137-0281	688.77	281.41	190	52.28	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			222.7	C08		2	0138-0284	222.82	283.66	313	66.53	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			780.1	C08		2	0139-0286	317.64	285.56	222	55.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			501.7	C08		2	0140-0286	45.41	286.24	160	46.28	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			222.0	C08		2	0141-0290	149.01	291.47	268	60.53	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			410.1	C08		2	0142-0293	422.51	293.81	423	75.84	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			841.8	C08		2	0143-0291	677.08	291.79	126	44.04	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			327.9	C08		2	0144-0296	375.86	295.72	231	56.53	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			681.5	C08		2	0145-0297	89.16	296.62	270	61.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			171.9	C08		2	0146-0295	125.55	295.30	340	70.43	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			379.4	C08		2	0147-0295	480.48	294.97	101	38.97	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2217.2	C08		2	0148-0305	868.84	305.13	300	65.60	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			261.9	C08		2	0149-0310	390.61	310.17	246	60.28	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			488.2	C08		2	0150-0308	254.84	307.98	242	58.28	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			437.3	C08		2	0151-0313	171.36	313.64	405	74.18	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			215.6	C08		2	0152-0317	189.73	317.29	313	71.36	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			593.4	C08		2	0153-0316	589.99	315.67	255	61.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			630.9	C08		2	0154-0319	724.22	320.00	324	67.36	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			548.4	C08		2	0155-0321	260.97	321.64	282	68.77	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1168.4	C08		2	0156-0322	782.33	322.48	265	61.11	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			399.4	C08		2	0157-0322	765.53	321.86	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			865.0	C08		2	0158-0324	91.62	324.21	284	63.01	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			997.9	C08		2	0159-0324	203.04	324.48	204	54.04	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			646.5	C08		2	0160-0324	219.56	324.07	184	49.70	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			717.4	C08		2	0161-0326	319.77	326.20	239	59.60	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			520.9	C08		2	0162-0326	445.11	325.63	279	63.60	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1487.6	C08		2	0163-0328	745.68	327.32	292	63.36	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			332.4	C08		2	0164-0326	375.73	326.79	238	56.87	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1339.6	C08		2	0165-0328	799.72	328.72	283	62.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			261.5	C08		2	0166-0329	69.68	329.37	267	62.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			269.0	C08		2	0167-0332	828.95	332.49	265	59.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1069.8	C08		2	0168-0333	137.34	333.96	297	63.36	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			229.5	C08		2	0169-0337	333.87	337.33	476	82.67	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			286.6	C08		2	0170-0339	655.25	338.63	375	71.60	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			454.0	C08		2	0171-0337	41.30	337.01	267	59.94	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			283.9	C08		2	0172-0341	449.37	341.53	237	57.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			246.0	C08		2	0173-0344	578.50	344.16	261	59.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3220.4	C08		2	0174-0345	271.53	344.95	333	70.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			247.7	C08		2	0175-0362	199.91	361.99	283	62.18	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			889.2	C08		2	0176-0362	744.59	362.13	297	63.36	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1872.1	C08		2	0177-0367	844.22	367.25	476	86.67	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1075.4	C08		2	0178-0367	31.63	367.08	200	55.01	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1068.2	C08		2	0179-0368	356.06	368.90	286	63.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1273.6	C08		2	0180-0371	425.28	370.81	245	58.28	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1012.9	C08		2	0181-0373	472.93	373.74	266	60.18	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			796.1	C08		2	0182-0374	894.56	374.92	213	56.87	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1409.4	C08		2	0183-0377	113.54	377.52	265	61.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			554.2	C08		2	0184-0383	23.22	384.93	341	76.67	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			463.0	C08		2	0185-0378	156.27	377.70	268	60.53	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			823.4	C08		2	0186-0387	229.76	388.44	416	82.08	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			223.9	C08		2	0187-0383	267.30	383.62	237	57.60	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2352.4	C08		2	0188-0384	394.23	383.70	325	67.01	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3877.5	C08		2	0189-0383	521.82	382.94	130	43.46	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3939.9	C08		2	0190-0395	516.46	396.09	209	58.77	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2664.6	C08		2	0191-0398	438.54	398.30	245	57.60	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3548.4	C08		2	0192-0393	534.58	393.96	160	49.80	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			873.6	C08		2	0193-0400	62.70	399.55	259	61.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3201.2	C08		2	0194-0404	289.85	404.07	638	93.84	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2134.9	C08		2	0195-0400	365.27	399.62	250	59.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4786.7	C08		2	0196-0405	724.18	405.92	363	72.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			10730.3	C08		2	0197-0409	829.94	409.26	358	70.43	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			324.1	C08		2	0198-0409	463.33	409.72	301	66.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4502.9	C08		2	0199-0405	535.33	405.06	151	46.04	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3546.7	C08		2	0200-0409	700.43	408.69	295	64.53	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			896.1	C08		2	0201-0409	380.18	410.01	304	65.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			194.8	C08		2	0202-0415	154.53	415.43	294	73.50	0.684
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1477.7	C08		2	0203-0416	884.62	415.94	289	64.53	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			315.8	C08		2	0204-0415	56.75	416.08	327	67.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			240.1	C08		2	0205-0416	925.04	416.90	278	64.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1552.6	C08		2	0206-0419	663.17	419.11	335	67.36	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			229.6	C08		2	0207-0420	264.27	421.78	251	59.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2080.0	C08		2	0208-0420	498.43	420.59	204	55.11	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			281.2	C08		2	0209-0422	133.84	422.17	248	58.28	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4913.8	C08		2	0210-0424	724.51	424.08	312	66.53	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1897.9	C08		2	0211-0427	13.61	427.56	258	62.53	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			993.9	C08		2	0212-0429	945.19	429.48	286	65.36	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5569.2	C08		2	0213-0428	701.23	428.05	270	62.53	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2566.0	C08		2	0214-0433	190.90	433.18	238	58.53	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			259.7	C08		2	0215-0434	225.32	434.19	271	61.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			422.7	C08		2	0216-0437	87.04	437.77	287	62.77	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2980.4	C08		2	0217-0435	173.26	435.41	244	58.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			478.7	C08		2	0218-0436	260.95	436.35	185	49.80	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			229.4	C08		2	0219-0441	873.85	440.57	308	64.28	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			262.5	C08		2	0220-0444	375.81	444.45	323	66.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			289.0	C08		2	0221-0446	566.04	446.26	348	69.84	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			403.8	C08		2	0222-0449	332.26	449.77	560	94.33	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			956.5	C08		2	0223-0447	424.52	447.61	335	67.94	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1598.8	C08		2	0224-0448	922.18	447.91	265	61.60	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1833.7	C08		2	0225-0449	462.86	449.06	289	65.01	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			605.1	C08		2	0226-0451	604.85	451.48	265	63.60	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			294.5	C08		2	0227-0459	549.21	459.53	351	69.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2833.7	C08		2	0228-0458	143.34	458.86	324	68.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			476.4	C08		2	0229-0459	261.60	459.85	248	57.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			328.8	C08		2	0230-0458	400.63	459.11	238	59.46	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			515.2	C08		2	0231-0466	491.10	466.15	301	69.60	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			302.8	C08		2	0232-0462	632.32	462.23	266	60.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			570.2	C08		2	0233-0472	34.89	471.98	262	59.11	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2063.7	C08		2	0234-0469	119.89	468.96	262	61.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1683.3	C08		2	0235-0477	405.92	477.24	489	96.67	0.658
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1972.2	C08		2	0236-0480	815.69	480.06	304	75.01	0.679
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			548.6	C08		2	0237-0479	914.13	478.71	270	61.11	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1408.7	C08		2	0238-0480	225.31	480.10	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			500.0	C08		2	0239-0477	326.87	477.58	241	59.94	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			311.1	C08		2	0240-0481	871.99	481.61	262	60.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			206.2	C08		2	0241-0484	568.43	484.08	272	61.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5388.2	C08		2	0242-0489	750.74	489.51	488	84.33	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			892.5	C08		2	0243-0488	169.56	487.86	284	62.18	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			271.5	C08		2	0244-0488	679.30	488.67	269	61.70	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			256.2	C08		2	0245-0488	307.68	487.95	359	71.60	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			228.2	C08		2	0246-0489	630.43	488.96	323	68.18	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1604.8	C08		2	0247-0493	16.24	493.55	254	59.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			763.3	C08		2	0248-0493	507.23	493.06	269	63.60	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			246.8	C08		2	0249-0502	47.73	502.09	427	77.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			511.7	C08		2	0250-0500	246.57	500.67	312	66.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2247.5	C08		2	0251-0500	533.77	500.29	219	54.53	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1455.2	C08		2	0252-0504	66.26	503.58	297	64.53	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			228.9	C08		2	0253-0505	699.10	505.70	368	73.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			242.0	C08		2	0254-0501	204.12	501.50	231	59.11	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1100.0	C08		2	0255-0502	433.05	502.56	215	54.87	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			271.0	C08		2	0256-0507	619.58	507.08	300	67.94	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			628.0	C08		2	0257-0511	948.45	510.67	280	67.26	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			216.7	C08		2	0258-0512	475.01	511.55	298	65.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1729.5	C08		2	0259-0513	867.81	513.90	265	61.36	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			326.6	C08		2	0260-0516	850.85	516.77	257	59.60	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			189.4	C08		2	0261-0516	146.95	516.06	263	59.36	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			715.3	C08		2	0262-0523	580.94	523.79	157	47.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3737.6	C08		2	0263-0524	902.61	524.32	334	71.01	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			335.6	C08		2	0264-0524	171.12	524.21	247	58.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			6070.8	C08		2	0265-0529	743.25	528.55	460	81.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1823.0	C08		2	0266-0529	338.24	529.73	255	61.36	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1167.0	C08		2	0267-0531	547.18	530.79	348	70.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3232.2	C08		2	0268-0532	520.09	532.34	249	59.60	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			259.8	C08		2	0269-0534	822.04	534.95	290	65.36	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			176.5	C08		2	0270-0536	121.32	535.69	443	79.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3548.0	C08		2	0271-0536	253.91	537.11	303	64.77	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1158.7	C08		2	0272-0540	73.04	539.97	266	60.43	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1615.1	C08		2	0273-0540	438.67	540.09	274	60.53	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			230.5	C08		2	0274-0543	474.92	543.22	497	82.43	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2574.7	C08		2	0275-0543	495.38	542.73	251	57.94	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			184.5	C08		2	0276-0545	179.70	545.24	306	69.94	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			276.4	C08		2	0277-0548	795.48	548.99	303	64.43	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			407.0	C08		2	0278-0551	945.99	550.84	288	62.53	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1762.9	C08		2	0279-0553	24.96	553.10	285	62.18	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1290.6	C08		2	0280-0557	618.00	556.84	266	63.11	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			421.4	C08		2	0281-0561	641.94	560.82	711	101.98	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			421.1	C08		2	0282-0560	291.60	560.59	518	83.01	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			280.4	C08		2	0283-0562	86.27	562.76	232	58.18	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2708.9	C08		2	0284-0563	339.83	563.42	303	64.43	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			695.1	C08		2	0285-0564	707.60	563.60	155	50.53	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			751.9	C08		2	0286-0567	555.67	567.57	297	65.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2429.8	C08		2	0287-0568	213.50	569.92	207	64.43	0.627
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			317.5	C08		2	0288-0569	583.10	568.94	301	64.28	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			6914.9	C08		2	0289-0573	171.22	574.28	290	66.77	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1061.0	C08		2	0290-0573	882.89	572.56	272	63.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			212.1	C08		2	0291-0573	241.29	573.36	271	60.53	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			362.0	C08		2	0292-0577	185.71	576.57	160	48.63	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			186.1	C08		2	0293-0579	907.88	578.08	277	63.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1634.7	C08		2	0294-0581	57.33	580.98	258	59.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			238.3	C08		2	0295-0587	724.98	587.15	316	67.60	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			179.7	C08		2	0296-0587	134.80	587.12	175	50.53	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1552.5	C08		2	0297-0588	505.48	588.00	251	57.60	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			352.4	C08		2	0298-0590	87.90	590.70	192	53.70	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			674.3	C08		2	0299-0591	31.88	590.68	317	65.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			330.3	C08		2	0300-0591	764.21	591.57	269	61.36	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			899.4	C08		2	0301-0596	797.64	596.34	275	64.18	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3806.6	C08		2	0302-0598	49.01	598.53	246	58.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			263.8	C08		2	0303-0601	207.24	601.43	355	70.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			310.4	C08		2	0304-0599	600.60	599.30	324	68.18	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			780.3	C08		2	0305-0602	438.82	602.72	334	68.18	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			278.1	C08		2	0306-0603	746.91	602.13	251	59.84	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1295.3	C08		2	0307-0606	543.49	606.34	266	60.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			332.7	C08		2	0308-0604	250.39	605.09	296	66.18	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			606.9	C08		2	0309-0609	387.02	608.81	269	63.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1301.9	C08		2	0310-0608	335.62	607.84	280	64.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			412.8	C08		2	0311-0610	944.87	609.75	210	53.11	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2279.6	C08		2	0312-0613	119.39	614.07	255	64.77	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			462.3	C08		2	0313-0615	291.31	615.17	248	60.18	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			443.7	C08		2	0314-0621	566.88	622.06	251	60.77	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1918.9	C08		2	0315-0625	840.51	624.99	239	57.36	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3136.1	C08		2	0316-0628	67.91	628.06	236	55.70	0.956
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			427.5	C08		2	0317-0627	266.18	626.84	274	63.94	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			315.0	C08		2	0318-0632	346.98	632.17	263	60.43	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			278.3	C08		2	0319-0634	393.30	633.93	334	75.01	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1401.4	C08		2	0320-0634	670.15	633.03	101	41.70	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			294.3	C08		2	0321-0638	851.24	638.19	292	64.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			281.4	C08		2	0322-0639	445.95	639.26	253	59.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			806.1	C08		2	0323-0642	157.39	640.87	253	62.28	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			840.4	C08		2	0324-0640	174.32	640.06	262	61.46	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			247.8	C08		2	0325-0644	425.47	643.95	353	70.77	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4739.7	C08		2	0326-0644	307.30	643.62	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			192.7	C08		2	0327-0645	630.33	645.35	309	65.01	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1112.4	C08		2	0328-0648	727.88	648.50	296	64.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			408.3	C08		2	0329-0647	119.09	647.07	268	60.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1971.7	C08		2	0330-0650	679.59	650.26	310	68.77	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			784.0	C08		2	0331-0650	246.41	650.38	298	69.36	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1433.4	C08		2	0332-0650	13.97	649.82	250	58.87	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			278.9	C08		2	0333-0650	470.51	649.83	248	60.87	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			247.5	C08		2	0334-0653	588.67	652.30	269	62.77	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			553.3	C08		2	0335-0655	563.64	655.36	249	59.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1416.1	C08		2	0336-0655	263.18	654.92	281	64.77	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			191.7	C08		2	0337-0669	407.40	670.15	329	70.43	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			847.0	C08		2	0338-0669	371.39	669.49	271	61.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5682.8	C08		2	0339-0674	544.22	674.03	278	64.53	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1125.6	C08		2	0340-0674	283.60	674.11	316	67.60	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			588.7	C08		2	0341-0677	50.74	676.48	504	93.74	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			520.2	C08		2	0342-0677	529.26	677.28	241	57.70	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			220.9	C08		2	0343-0679	637.19	678.71	458	80.43	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			7485.8	C08		2	0344-0684	829.52	684.32	312	64.77	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1005.0	C08		2	0345-0685	100.70	685.98	251	58.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1595.5	C08		2	0346-0687	352.25	686.86	227	58.28	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			702.8	C08		2	0347-0686	391.95	685.78	302	65.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			355.5	C08		2	0348-0689	565.33	688.86	432	79.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			302.0	C08		2	0349-0687	806.47	688.39	341	72.43	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1117.5	C08		2	0350-0690	21.42	689.99	247	57.36	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			621.2	C08		2	0351-0690	142.77	690.36	295	65.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			264.6	C08		2	0352-0694	479.41	694.54	338	67.60	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			297.5	C08		2	0353-0700	209.29	699.63	276	63.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			173.9	C08		2	0354-0697	630.69	697.57	233	57.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			321.7	C08		2	0355-0699	247.97	699.45	266	60.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			273.0	C08		2	0356-0702	759.80	701.69	264	60.43	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			394.6	C08		2	0357-0710	176.17	709.98	264	60.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			893.2	C08		3	0001-0023	532.57	23.39	244	57.60	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			235.9	C08		3	0002-0028	327.48	30.03	247	65.36	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1114.5	C08		3	0003-0029	465.12	29.36	299	67.01	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			268.5	C08		3	0004-0029	685.49	28.96	237	60.63	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1868.8	C08		3	0005-0029	253.25	28.93	221	54.53	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2468.0	C08		3	0006-0032	58.32	32.64	327	66.43	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			327.4	C08		3	0007-0031	771.33	31.27	277	60.77	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			381.6	C08		3	0008-0032	938.39	31.96	323	66.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			828.8	C08		3	0009-0032	428.60	32.82	242	58.28	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			208.9	C08		3	0010-0041	489.88	41.38	564	96.57	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2195.9	C08		3	0011-0034	658.31	34.47	313	66.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2986.0	C08		3	0012-0040	199.61	39.73	314	70.18	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			231.9	C08		3	0013-0039	448.67	39.33	289	63.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			686.2	C08		3	0014-0037	547.08	37.85	227	57.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2641.4	C08		3	0015-0041	721.42	40.98	365	73.01	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			251.8	C08		3	0016-0039	566.60	40.06	313	69.01	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			671.9	C08		3	0017-0040	922.00	40.34	223	66.67	0.630
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			198.3	C08		3	0018-0044	596.63	44.21	304	66.43	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			544.1	C08		3	0019-0041	813.20	41.28	179	51.46	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2217.6	C08		3	0020-0049	113.44	49.20	334	67.84	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			226.1	C08		3	0021-0053	359.25	53.25	278	65.01	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			771.2	C08		3	0022-0049	430.55	48.90	263	61.11	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			214.2	C08		3	0023-0055	223.57	55.22	314	66.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			490.1	C08		3	0024-0053	396.70	52.83	352	69.01	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			483.1	C08		3	0025-0055	809.25	55.67	224	55.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			214.6	C08		3	0026-0059	148.23	58.99	225	59.60	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			542.0	C08		3	0027-0064	280.55	64.35	314	67.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1345.9	C08		3	0028-0063	544.03	63.30	254	57.70	0.959
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			226.9	C08		3	0029-0064	884.27	64.14	186	51.70	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			443.4	C08		3	0030-0066	516.31	65.67	264	63.36	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			266.4	C08		3	0031-0066	137.84	67.13	100	36.87	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			214.1	C08		3	0032-0073	467.13	73.35	280	67.84	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			539.3	C08		3	0033-0082	290.55	82.99	431	79.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			237.1	C08		3	0034-0081	885.37	80.56	222	56.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			438.1	C08		3	0035-0084	53.08	83.10	310	65.84	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3646.2	C08		3	0036-0084	137.48	84.03	298	65.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1121.3	C08		3	0037-0082	269.27	81.66	220	57.46	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			202.0	C08		3	0038-0085	905.06	84.63	292	63.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			273.6	C08		3	0039-0088	663.25	88.70	423	77.50	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			512.1	C08		3	0040-0087	397.19	87.20	335	70.08	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1356.0	C08		3	0041-0091	639.02	90.74	485	81.01	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			415.3	C08		3	0042-0087	769.24	87.52	258	59.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1809.4	C08		3	0043-0090	219.09	90.97	283	63.01	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			715.4	C08		3	0044-0097	238.14	97.34	325	69.60	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			272.4	C08		3	0045-0100	948.51	100.66	304	64.18	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			606.3	C08		3	0046-0106	703.27	106.15	301	71.01	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			594.5	C08		3	0047-0104	412.83	104.58	343	69.36	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			467.1	C08		3	0048-0106	858.33	105.98	240	57.94	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1327.1	C08		3	0049-0114	169.00	114.22	297	65.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			367.5	C08		3	0050-0112	786.67	113.07	223	55.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			190.7	C08		3	0051-0116	38.58	116.93	429	80.08	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2120.0	C08		3	0052-0116	528.84	115.97	313	66.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			583.5	C08		3	0053-0119	387.92	119.01	319	66.18	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2071.5	C08		3	0054-0132	365.36	135.16	821	132.47	0.588
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			599.1	C08		3	0055-0129	748.67	130.15	442	92.23	0.653
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			463.0	C08		3	0056-0128	920.91	127.37	349	69.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			298.5	C08		3	0057-0125	566.78	124.73	293	63.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			852.5	C08		3	0058-0127	626.53	128.10	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1389.9	C08		3	0059-0130	770.46	128.58	300	69.01	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			223.6	C08		3	0060-0135	789.23	134.60	222	61.60	0.735
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			234.1	C08		3	0061-0134	817.31	134.17	319	68.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			386.6	C08		3	0062-0142	89.03	141.16	280	67.11	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1021.1	C08		3	0063-0141	165.57	141.85	330	68.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1630.7	C08		3	0064-0138	224.78	138.64	223	55.70	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			386.8	C08		3	0065-0141	396.66	141.25	271	61.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			247.5	C08		3	0066-0141	497.15	141.74	275	63.11	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			462.9	C08		3	0067-0142	861.03	142.03	262	59.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4957.1	C08		3	0068-0142	337.85	142.39	270	65.11	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			707.0	C08		3	0069-0145	703.67	145.81	261	61.36	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2084.7	C08		3	0070-0148	266.12	148.80	285	65.60	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			295.9	C08		3	0071-0155	897.36	154.70	365	73.26	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			239.2	C08		3	0072-0152	653.92	152.55	284	64.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			392.6	C08		3	0073-0161	237.53	161.53	297	65.01	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			228.6	C08		3	0074-0164	69.27	165.07	267	63.60	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			246.1	C08		3	0075-0164	520.53	163.95	253	61.01	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			404.1	C08		3	0076-0166	620.29	165.68	383	73.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1319.7	C08		3	0077-0164	465.07	164.49	227	57.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			474.2	C08		3	0078-0165	749.54	165.08	432	77.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			681.2	C08		3	0079-0172	869.02	171.91	382	74.33	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2178.4	C08		3	0080-0173	23.84	172.42	302	65.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			451.4	C08		3	0081-0174	592.35	173.61	452	83.84	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1301.5	C08		3	0082-0174	274.69	173.21	288	67.36	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			950.7	C08		3	0083-0178	545.77	178.99	262	66.53	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1817.0	C08		3	0084-0178	148.43	178.01	338	73.84	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			274.2	C08		3	0085-0176	514.15	177.00	189	52.77	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1147.4	C08		3	0086-0177	679.31	177.37	240	58.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1580.3	C08		3	0087-0181	696.46	181.97	249	59.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			204.3	C08		3	0088-0180	794.34	180.45	254	60.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			380.9	C08		3	0089-0181	108.76	180.88	230	55.11	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			508.2	C08		3	0090-0193	414.72	192.56	330	68.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			983.2	C08		3	0091-0190	64.99	189.93	227	55.11	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			369.3	C08		3	0092-0195	99.27	195.98	234	56.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			228.4	C08		3	0093-0196	202.97	195.97	316	69.01	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1354.6	C08		3	0094-0198	831.79	197.32	370	75.60	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			703.4	C08		3	0095-0197	49.38	196.72	237	58.18	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			302.0	C08		3	0096-0197	513.77	197.29	315	65.01	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			356.8	C08		3	0097-0204	457.17	203.08	271	61.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			218.5	C08		3	0098-0203	704.26	203.91	332	73.01	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			364.6	C08		3	0099-0204	354.49	204.48	347	73.01	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			255.4	C08		3	0100-0208	569.50	207.85	443	78.67	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			460.2	C08		3	0101-0210	948.56	209.54	264	63.11	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			326.7	C08		3	0102-0214	469.57	213.88	255	59.94	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			520.5	C08		3	0103-0225	924.52	225.67	367	87.15	0.607
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			401.3	C08		3	0104-0228	644.11	227.88	315	70.77	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			193.2	C08		3	0105-0225	61.98	224.71	299	70.67	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			368.3	C08		3	0106-0225	160.87	224.84	322	69.84	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			269.6	C08		3	0107-0229	862.41	228.41	317	68.67	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			209.2	C08		3	0108-0228	18.02	227.83	235	55.94	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			395.8	C08		3	0109-0234	751.08	233.32	289	64.18	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			881.1	C08		3	0110-0236	782.55	236.23	246	57.36	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1662.9	C08		3	0111-0240	93.05	240.20	308	66.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			283.7	C08		3	0112-0238	892.29	239.00	287	65.01	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			194.9	C08		3	0113-0240	235.55	240.11	332	67.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1952.9	C08		3	0114-0237	585.30	237.86	152	46.87	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			411.3	C08		3	0115-0241	269.32	240.96	307	66.77	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1742.7	C08		3	0116-0248	610.00	249.03	258	62.28	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1302.4	C08		3	0117-0246	373.04	246.03	343	76.43	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			282.0	C08		3	0118-0248	765.67	248.01	239	67.01	0.669
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			364.6	C08		3	0119-0248	806.76	248.02	239	55.70	0.968
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			809.7	C08		3	0120-0251	678.80	251.79	260	59.94	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1207.9	C08		3	0121-0250	583.42	250.39	234	68.04	0.635
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			204.1	C08		3	0122-0258	131.40	259.27	494	84.33	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			822.3	C08		3	0123-0256	150.97	255.71	274	63.84	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			736.3	C08		3	0124-0260	490.75	261.11	264	64.18	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2483.5	C08		3	0125-0261	49.17	260.94	240	58.77	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			236.8	C08		3	0126-0261	447.80	260.90	268	65.01	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			231.3	C08		3	0127-0266	406.69	265.92	281	63.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			242.2	C08		3	0128-0263	942.26	262.18	227	57.70	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			247.1	C08		3	0129-0266	729.09	265.65	222	54.53	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			612.6	C08		3	0130-0271	632.23	271.21	387	98.47	0.502
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			294.1	C08		3	0131-0276	877.95	276.41	209	53.46	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			504.9	C08		3	0132-0280	532.20	280.58	357	69.01	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			302.5	C08		3	0133-0283	898.83	283.28	321	65.60	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			596.1	C08		3	0134-0287	309.24	286.78	291	63.60	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			252.5	C08		3	0135-0290	800.71	289.32	280	63.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			387.3	C08		3	0136-0289	858.29	289.80	228	56.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			746.1	C08		3	0137-0293	677.33	293.41	287	63.94	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1660.6	C08		3	0138-0291	459.36	291.79	320	66.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			196.4	C08		3	0139-0297	354.38	297.64	401	79.50	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			299.5	C08		3	0140-0294	757.01	294.27	198	55.11	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			188.6	C08		3	0141-0299	576.94	298.66	443	79.60	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1062.5	C08		3	0142-0298	265.74	298.65	267	61.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4680.5	C08		3	0143-0299	72.18	299.74	253	58.77	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			234.9	C08		3	0144-0304	788.08	303.48	234	59.01	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2434.5	C08		3	0145-0311	518.79	311.58	293	63.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1548.6	C08		3	0146-0311	866.10	311.35	321	66.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			236.5	C08		3	0147-0313	114.14	313.03	312	67.84	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			197.6	C08		3	0148-0316	281.76	314.32	322	72.77	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			429.6	C08		3	0149-0314	216.74	314.24	240	57.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			294.9	C08		3	0150-0316	462.68	315.95	374	71.84	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2063.5	C08		3	0151-0312	671.78	312.33	293	66.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3258.0	C08		3	0152-0319	404.30	319.33	365	90.33	0.562
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			221.5	C08		3	0153-0317	916.73	316.91	325	68.43	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3159.3	C08		3	0154-0321	486.15	320.62	376	90.91	0.572
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			204.8	C08		3	0155-0321	749.58	321.63	264	61.94	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			265.9	C08		3	0156-0320	800.65	320.44	228	56.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			667.9	C08		3	0157-0322	187.82	322.48	247	57.11	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1619.7	C08		3	0158-0325	595.66	325.86	278	63.70	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			220.2	C08		3	0159-0330	310.51	329.78	303	69.60	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			431.7	C08		3	0160-0335	57.67	335.14	295	64.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			216.0	C08		3	0161-0340	769.12	339.27	267	65.36	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			272.1	C08		3	0162-0337	643.36	337.38	259	60.28	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			293.9	C08		3	0163-0342	782.81	341.49	203	57.11	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			223.4	C08		3	0164-0342	707.27	341.53	243	57.94	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			221.3	C08		3	0165-0347	686.39	347.35	273	61.11	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1377.2	C08		3	0166-0349	864.22	349.06	308	67.60	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			240.4	C08		3	0167-0353	197.73	352.76	262	66.18	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			173.1	C08		3	0168-0356	948.80	356.74	354	73.50	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			230.2	C08		3	0169-0351	635.22	351.36	265	63.94	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			242.9	C08		3	0170-0352	215.58	351.55	130	45.36	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4183.3	C08		3	0171-0355	559.53	355.31	290	65.60	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			416.9	C08		3	0172-0358	54.25	359.06	261	61.01	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			334.1	C08		3	0173-0363	341.37	363.34	449	81.01	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			394.7	C08		3	0174-0359	778.66	359.31	223	55.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2331.9	C08		3	0175-0363	359.28	363.10	324	70.53	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2063.8	C08		3	0176-0367	464.46	366.77	345	71.01	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			206.0	C08		3	0177-0367	727.94	367.19	277	61.36	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			239.7	C08		3	0178-0368	906.35	368.80	281	62.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			914.4	C08		3	0179-0368	189.77	367.86	245	57.36	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			217.8	C08		3	0180-0369	213.15	368.99	220	53.94	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			232.1	C08		3	0181-0372	857.11	373.24	323	71.60	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1620.0	C08		3	0182-0374	698.26	374.09	239	60.18	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			301.1	C08		3	0183-0377	303.40	376.96	313	67.01	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			582.8	C08		3	0184-0377	544.99	377.60	241	59.36	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			659.9	C08		3	0185-0383	44.56	382.58	380	73.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			565.1	C08		3	0186-0389	434.90	390.02	536	103.40	0.630
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			201.7	C08		3	0187-0382	792.69	380.81	322	71.84	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1851.6	C08		3	0188-0387	381.32	386.98	316	72.77	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			254.7	C08		3	0189-0390	610.76	389.98	481	86.33	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1182.2	C08		3	0190-0389	695.86	388.97	303	68.43	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1286.6	C08		3	0191-0392	841.59	392.05	299	65.94	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			689.0	C08		3	0192-0394	134.16	394.28	212	54.53	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1666.9	C08		3	0193-0398	670.63	398.30	256	59.11	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			307.1	C08		3	0194-0402	272.23	402.84	428	76.91	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1345.7	C08		3	0195-0408	507.87	407.51	311	66.53	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			590.5	C08		3	0196-0410	807.87	410.34	346	69.84	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1405.4	C08		3	0197-0409	472.96	409.63	281	61.60	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			221.5	C08		3	0198-0411	322.05	410.94	282	63.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1674.4	C08		3	0199-0413	571.30	413.44	318	66.53	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			199.8	C08		3	0200-0414	759.60	414.30	348	71.84	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			710.8	C08		3	0201-0414	89.37	414.72	261	60.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			206.5	C08		3	0202-0417	190.24	417.81	315	66.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			207.4	C08		3	0203-0419	20.26	419.74	274	65.36	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			838.8	C08		3	0204-0425	422.94	424.10	347	74.43	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1631.1	C08		3	0205-0422	719.69	422.40	292	65.36	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			203.5	C08		3	0206-0425	354.68	425.44	306	65.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			314.7	C08		3	0207-0429	315.29	430.42	404	77.50	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			893.2	C08		3	0208-0427	212.29	427.79	284	63.94	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1262.4	C08		3	0209-0429	585.97	429.94	328	67.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1093.1	C08		3	0210-0432	39.94	432.05	266	62.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			517.3	C08		3	0211-0433	109.61	432.71	202	55.11	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			262.4	C08		3	0212-0438	716.99	437.68	332	76.43	0.714
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			989.0	C08		3	0213-0443	151.37	443.99	239	57.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1388.9	C08		3	0214-0441	866.29	441.56	144	48.04	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			207.7	C08		3	0215-0448	705.39	449.09	366	71.84	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			557.0	C08		3	0216-0445	115.33	445.73	189	51.94	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			249.6	C08		3	0217-0444	904.95	445.08	292	66.53	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			408.8	C08		3	0218-0450	642.85	450.12	331	87.74	0.540
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			224.3	C08		3	0219-0449	247.18	448.68	163	52.18	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1592.0	C08		3	0220-0450	17.02	450.61	255	60.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1978.5	C08		3	0221-0451	528.31	450.92	220	56.87	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1103.2	C08		3	0222-0450	169.22	450.25	225	55.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			212.2	C08		3	0223-0451	232.54	451.54	225	62.28	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			186.1	C08		3	0224-0452	283.27	452.69	218	63.01	0.690
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			352.8	C08		3	0225-0452	833.38	452.54	187	51.46	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			349.9	C08		3	0226-0454	884.15	454.05	199	53.11	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1205.8	C08		3	0227-0451	868.05	451.00	108	41.80	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			253.1	C08		3	0228-0460	783.55	460.00	397	73.60	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1013.8	C08		3	0229-0457	81.69	456.53	160	48.53	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			276.5	C08		3	0230-0459	599.55	459.37	223	55.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			230.4	C08		3	0231-0467	409.14	467.44	277	63.94	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			408.2	C08		3	0232-0463	896.21	463.67	180	50.53	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			657.7	C08		3	0233-0471	73.92	471.13	260	60.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4209.5	C08		3	0234-0470	370.62	469.91	330	66.77	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			383.8	C08		3	0235-0470	909.28	470.32	193	54.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			420.0	C08		3	0236-0474	658.09	474.07	236	108.47	0.252
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			352.3	C08		3	0237-0477	757.68	477.45	310	68.18	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			267.4	C08		3	0238-0483	861.58	482.86	294	67.36	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1054.8	C08		3	0239-0482	135.99	482.81	302	65.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2167.4	C08		3	0240-0481	782.06	481.84	320	70.18	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3233.4	C08		3	0241-0484	619.12	484.95	307	67.60	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4274.5	C08		3	0242-0487	230.78	487.27	221	56.77	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			636.4	C08		3	0243-0488	501.96	488.48	303	95.15	0.421
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1832.7	C08		3	0244-0492	845.54	492.39	295	67.01	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3227.0	C08		3	0245-0496	592.35	495.95	308	67.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1439.8	C08		3	0246-0494	948.35	494.15	209	56.28	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			312.8	C08		3	0247-0495	927.22	495.11	272	63.11	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			197.1	C08		3	0248-0497	887.16	497.36	310	68.43	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			204.2	C08		3	0249-0508	730.86	507.47	308	68.18	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			209.6	C08		3	0250-0510	714.33	510.41	265	63.11	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1246.9	C08		3	0251-0505	944.95	505.82	128	46.63	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			341.0	C08		3	0252-0511	456.37	510.33	310	65.94	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			705.1	C08		3	0253-0513	43.13	513.37	269	63.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			827.0	C08		3	0254-0516	514.45	515.97	247	62.18	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			183.2	C08		3	0255-0520	646.15	520.03	381	72.67	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			214.5	C08		3	0256-0519	399.86	519.23	316	67.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			190.7	C08		3	0257-0522	197.60	521.91	304	64.77	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			227.1	C08		3	0258-0524	879.76	523.49	273	63.36	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			186.8	C08		3	0259-0526	159.70	527.09	306	67.94	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			731.3	C08		3	0260-0523	483.04	523.55	269	63.94	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			623.7	C08		3	0261-0531	810.81	531.43	365	72.18	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1901.3	C08		3	0262-0528	565.57	527.76	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			175.7	C08		3	0263-0530	782.86	529.80	316	67.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			500.4	C08		3	0264-0530	756.84	529.87	273	60.77	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			527.4	C08		3	0265-0531	367.86	531.22	203	54.04	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			621.4	C08		3	0266-0534	608.04	534.55	326	68.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2257.9	C08		3	0267-0537	119.51	536.59	320	66.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			657.4	C08		3	0268-0538	740.19	538.23	288	63.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			499.6	C08		3	0269-0546	675.65	545.16	234	61.70	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1974.4	C08		3	0270-0549	529.42	550.06	285	65.60	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			213.6	C08		3	0271-0551	426.59	551.08	333	68.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			475.8	C08		3	0272-0551	267.71	551.18	295	63.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			338.7	C08		3	0273-0550	703.60	550.46	250	58.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			476.9	C08		3	0274-0554	40.63	553.53	281	62.53	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			221.5	C08		3	0275-0553	861.92	552.97	283	63.11	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2838.7	C08		3	0276-0552	904.61	552.64	264	62.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			644.9	C08		3	0277-0562	81.73	563.11	229	57.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			204.2	C08		3	0278-0560	180.90	560.41	289	65.11	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			323.1	C08		3	0279-0564	689.94	564.74	395	73.60	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			227.0	C08		3	0280-0566	65.60	566.35	283	61.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			201.3	C08		3	0281-0566	890.89	566.66	302	64.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			214.0	C08		3	0282-0568	447.87	568.48	399	73.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			200.5	C08		3	0283-0567	848.99	567.07	160	48.04	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			725.5	C08		3	0284-0568	726.85	569.11	263	59.46	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3623.1	C08		3	0285-0574	501.01	573.94	304	68.18	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			786.0	C08		3	0286-0576	103.26	576.46	271	63.11	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			444.4	C08		3	0287-0577	288.58	576.72	309	67.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			631.7	C08		3	0288-0571	588.60	571.12	203	56.28	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2554.9	C08		3	0289-0580	322.17	580.19	286	62.18	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1825.9	C08		3	0290-0582	304.21	582.90	279	63.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1113.6	C08		3	0291-0587	610.80	586.71	430	81.26	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			951.3	C08		3	0292-0583	908.91	583.67	336	71.60	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			763.4	C08		3	0293-0587	357.14	587.71	211	54.87	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			772.8	C08		3	0294-0583	584.48	583.09	206	56.28	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5467.6	C08		3	0295-0584	760.43	583.31	202	53.11	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			322.0	C08		3	0296-0586	839.51	587.03	244	59.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			277.6	C08		3	0297-0588	726.94	587.22	223	56.28	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			267.4	C08		3	0298-0592	227.26	591.41	284	62.43	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			562.7	C08		3	0299-0596	537.39	596.63	274	62.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3545.3	C08		3	0300-0596	628.00	596.63	204	54.53	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			287.5	C08		3	0301-0598	53.36	598.16	263	59.36	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			193.1	C08		3	0302-0601	490.88	601.10	323	68.18	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1625.0	C08		3	0303-0598	800.23	598.26	318	66.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			536.1	C08		3	0304-0606	86.25	606.24	265	59.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			959.1	C08		3	0305-0606	873.17	605.88	286	63.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			7069.1	C08		3	0306-0605	758.47	605.61	197	56.18	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			196.8	C08		3	0307-0612	193.94	611.97	326	68.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1305.0	C08		3	0308-0612	153.56	612.34	281	63.36	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			425.2	C08		3	0309-0612	39.38	612.41	207	52.87	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			338.9	C08		3	0310-0617	654.98	617.44	437	77.26	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			318.3	C08		3	0311-0620	691.40	620.80	264	62.77	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			313.5	C08		3	0312-0622	316.84	621.70	292	62.77	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1131.2	C08		3	0313-0628	613.04	628.45	215	54.87	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			412.7	C08		3	0314-0632	119.71	632.15	422	75.36	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			216.4	C08		3	0315-0630	340.94	629.63	275	65.60	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1383.1	C08		3	0316-0635	406.97	634.37	580	95.98	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			221.8	C08		3	0317-0634	44.10	633.95	263	62.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			206.1	C08		3	0318-0637	939.48	637.54	249	58.53	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			313.6	C08		3	0319-0643	596.50	643.24	346	69.60	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			228.6	C08		3	0320-0642	345.82	643.74	326	71.01	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1871.1	C08		3	0321-0643	892.99	643.52	199	54.87	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			262.5	C08		3	0322-0645	755.67	644.84	283	62.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1097.4	C08		3	0323-0647	849.47	645.85	284	66.43	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			252.7	C08		3	0324-0645	915.19	645.36	189	50.53	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2221.8	C08		3	0325-0648	719.79	648.20	266	63.60	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			280.2	C08		3	0326-0650	46.59	649.98	241	58.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			700.0	C08		3	0327-0654	672.21	654.89	277	62.77	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			185.1	C08		3	0328-0659	482.69	658.41	319	68.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			967.4	C08		3	0329-0656	415.05	657.27	273	64.18	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			414.4	C08		3	0330-0661	817.85	661.10	226	55.11	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			555.5	C08		3	0331-0662	381.27	662.38	254	60.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2346.1	C08		3	0332-0664	602.31	664.16	276	61.94	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			13645.8	C08		3	0333-0665	260.71	665.53	161	46.87	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			319.8	C08		3	0334-0669	166.07	669.08	291	63.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			746.3	C08		3	0335-0673	211.95	673.34	288	68.53	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			13871.6	C08		3	0336-0672	244.53	673.82	262	64.53	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2851.2	C08		3	0337-0678	779.05	677.79	266	59.36	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1527.4	C08		3	0338-0679	734.95	678.14	297	63.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			186.7	C08		3	0339-0681	865.04	680.29	300	66.77	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			257.8	C08		3	0340-0682	910.16	681.82	303	65.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			8594.2	C08		3	0341-0682	754.15	682.31	293	63.01	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			215.8	C08		3	0342-0681	883.02	681.72	260	61.01	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1184.2	C08		3	0343-0681	559.94	681.50	269	63.36	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			237.6	C08		3	0344-0687	817.17	687.40	326	67.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			208.0	C08		3	0345-0688	615.97	687.25	257	61.11	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			194.3	C08		3	0346-0694	384.31	694.38	318	68.53	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3435.9	C08		3	0347-0697	418.34	698.00	305	66.77	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1995.6	C08		3	0348-0701	679.16	701.08	282	67.36	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			221.3	C08		3	0349-0701	229.03	700.26	253	67.84	0.691
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			208.1	C08		3	0350-0705	619.82	705.13	278	63.94	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			218.9	C08		3	0351-0702	848.61	702.61	245	59.94	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			418.5	C08		3	0352-0709	943.83	708.13	287	64.77	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			195.9	C08		3	0353-0709	56.23	709.62	258	61.70	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			156.4	C08		3	0354-0711	333.46	711.20	309	69.11	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			806.9	C08		4	0001-0023	195.30	23.30	268	61.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			245.1	C08		4	0002-0022	562.22	22.54	257	61.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			434.8	C08		4	0003-0021	820.66	21.45	146	46.04	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			170.4	C08		4	0004-0026	17.68	27.12	282	63.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			280.3	C08		4	0005-0025	333.33	25.35	262	59.36	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2837.0	C08		4	0006-0029	365.76	29.28	324	70.67	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			323.9	C08		4	0007-0029	89.76	29.68	255	61.36	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			308.1	C08		4	0008-0033	621.79	33.53	356	70.43	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1472.9	C08		4	0009-0038	108.79	38.32	321	66.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			813.4	C08		4	0010-0042	214.26	42.85	281	64.77	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			283.0	C08		4	0011-0045	786.35	45.55	257	61.11	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			261.3	C08		4	0012-0046	321.66	46.11	241	57.11	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			426.9	C08		4	0013-0046	703.80	46.36	280	65.11	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3019.4	C08		4	0014-0048	943.16	49.11	232	56.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4666.4	C08		4	0015-0055	52.27	55.75	711	116.13	0.663
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			196.5	C08		4	0016-0052	448.90	51.61	395	72.77	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			668.0	C08		4	0017-0056	116.59	56.15	287	64.77	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			970.8	C08		4	0018-0057	857.49	56.52	218	55.11	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			224.8	C08		4	0019-0062	138.71	62.85	301	69.26	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			812.0	C08		4	0020-0063	660.87	63.64	333	68.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2418.3	C08		4	0021-0063	268.62	63.38	243	59.60	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			535.3	C08		4	0022-0067	498.94	66.82	322	70.18	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1471.4	C08		4	0023-0063	541.75	63.22	257	60.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			846.6	C08		4	0024-0062	762.42	62.81	263	60.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			618.5	C08		4	0025-0065	921.79	64.05	293	66.43	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			246.6	C08		4	0026-0072	306.40	72.35	280	63.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1883.9	C08		4	0027-0072	555.04	71.69	231	57.94	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			187.1	C08		4	0028-0077	228.36	77.22	311	66.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1171.4	C08		4	0029-0080	255.87	80.63	419	76.08	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1129.7	C08		4	0030-0080	861.20	80.08	233	56.87	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1454.3	C08		4	0031-0080	902.41	80.33	276	62.77	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			581.0	C08		4	0032-0083	625.71	83.44	278	63.94	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1627.5	C08		4	0033-0083	563.68	83.38	211	54.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			805.3	C08		4	0034-0086	418.74	86.24	264	60.43	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			264.8	C08		4	0035-0087	108.03	87.68	255	60.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			250.7	C08		4	0036-0093	591.99	93.38	413	82.08	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			342.8	C08		4	0037-0086	761.03	86.31	272	63.94	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1186.0	C08		4	0038-0087	185.57	87.49	289	61.94	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4487.9	C08		4	0039-0093	461.42	93.14	342	73.74	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2066.5	C08		4	0040-0092	701.97	91.78	300	66.18	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			236.8	C08		4	0041-0100	738.97	99.96	308	65.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			518.2	C08		4	0042-0102	52.13	101.74	260	59.94	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			934.3	C08		4	0043-0110	367.52	110.02	740	103.30	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			838.5	C08		4	0044-0103	837.97	102.66	133	98.13	0.174
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1458.2	C08		4	0045-0104	544.63	104.79	309	65.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1940.7	C08		4	0046-0107	942.98	106.80	304	64.77	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			255.1	C08		4	0047-0107	89.01	106.82	202	55.11	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1150.0	C08		4	0048-0112	288.36	112.59	289	63.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			953.4	C08		4	0049-0118	163.66	118.71	229	59.70	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			234.2	C08		4	0050-0121	427.35	120.78	283	63.26	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1382.1	C08		4	0051-0128	672.34	128.38	325	67.01	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			355.6	C08		4	0052-0132	440.24	131.62	293	65.26	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1382.3	C08		4	0053-0132	641.24	132.40	265	63.01	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			277.6	C08		4	0054-0135	321.50	135.13	286	69.11	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1461.0	C08		4	0055-0133	195.76	132.94	243	58.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			247.4	C08		4	0056-0141	832.51	140.76	395	73.01	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			708.7	C08		4	0057-0141	698.12	140.93	279	61.94	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1863.4	C08		4	0058-0144	401.87	144.67	298	65.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			595.9	C08		4	0059-0141	608.51	141.51	293	63.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			299.9	C08		4	0060-0143	890.55	143.94	350	69.01	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3088.6	C08		4	0061-0147	281.89	147.32	272	62.53	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			439.9	C08		4	0062-0155	211.91	154.96	244	59.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			252.8	C08		4	0063-0155	546.55	155.53	283	63.70	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			253.6	C08		4	0064-0157	650.36	156.76	250	58.18	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2065.1	C08		4	0065-0162	471.64	161.79	460	83.98	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			485.0	C08		4	0066-0162	875.55	162.57	335	67.01	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1173.6	C08		4	0067-0165	392.06	164.70	252	60.87	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4106.0	C08		4	0068-0162	908.00	162.89	262	59.11	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			300.2	C08		4	0069-0166	15.51	165.91	257	61.01	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			469.2	C08		4	0070-0165	626.78	165.37	265	61.36	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3032.3	C08		4	0071-0169	55.25	169.81	268	63.94	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1813.8	C08		4	0072-0173	930.06	173.44	334	73.60	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			276.3	C08		4	0073-0171	572.45	171.06	277	65.01	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2164.8	C08		4	0074-0175	117.62	175.02	347	70.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			517.7	C08		4	0075-0174	608.69	174.77	343	72.67	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			378.1	C08		4	0076-0176	709.60	175.55	246	58.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5510.2	C08		4	0077-0182	743.35	181.60	249	57.94	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1893.0	C08		4	0078-0187	260.34	187.52	305	68.43	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			336.8	C08		4	0079-0187	396.30	186.68	288	65.01	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2563.4	C08		4	0080-0189	524.11	189.77	271	62.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1112.3	C08		4	0081-0192	303.68	191.71	332	70.77	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			332.5	C08		4	0082-0193	77.16	194.14	250	58.87	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			294.7	C08		4	0083-0204	189.14	203.70	711	106.91	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			399.9	C08		4	0084-0195	564.72	195.48	236	56.53	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1266.3	C08		4	0085-0197	603.83	197.14	195	51.70	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			7411.1	C08		4	0086-0201	361.27	201.37	278	62.18	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			785.0	C08		4	0087-0203	910.95	203.03	256	64.53	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1074.3	C08		4	0088-0200	621.21	201.45	183	52.53	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			642.5	C08		4	0089-0208	451.61	208.79	227	59.94	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			321.0	C08		4	0090-0205	142.26	204.59	219	54.53	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			263.9	C08		4	0091-0211	77.12	210.81	245	58.63	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			810.4	C08		4	0092-0214	212.55	213.45	279	62.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3472.9	C08		4	0093-0215	882.23	215.37	291	63.36	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			472.8	C08		4	0094-0218	788.07	218.22	272	63.94	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1429.3	C08		4	0095-0220	822.27	219.43	310	65.36	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1807.2	C08		4	0096-0221	236.96	221.31	270	60.18	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1430.1	C08		4	0097-0223	700.20	224.18	270	61.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			518.0	C08		4	0098-0225	11.64	225.33	233	56.28	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			873.9	C08		4	0099-0224	907.71	224.45	290	74.43	0.658
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			192.7	C08		4	0100-0231	46.45	231.41	275	62.18	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2478.6	C08		4	0101-0231	289.29	231.64	353	70.18	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1900.2	C08		4	0102-0233	398.28	233.18	267	64.18	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			293.7	C08		4	0103-0237	156.70	237.75	481	90.57	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			291.7	C08		4	0104-0241	555.48	240.85	356	74.91	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1063.7	C08		4	0105-0241	479.61	240.40	254	60.28	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			566.5	C08		4	0106-0245	716.17	245.07	436	77.60	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			227.2	C08		4	0107-0247	327.17	247.13	466	82.43	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			329.7	C08		4	0108-0246	134.48	245.89	176	49.36	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2498.8	C08		4	0109-0253	433.59	253.15	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			338.5	C08		4	0110-0253	587.73	252.99	305	65.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			272.7	C08		4	0111-0256	80.26	256.04	257	61.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			711.5	C08		4	0112-0257	247.39	255.62	261	61.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1911.7	C08		4	0113-0256	364.30	256.01	292	63.94	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			216.3	C08		4	0114-0254	936.70	254.54	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			888.0	C08		4	0115-0257	755.30	256.76	273	62.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			273.5	C08		4	0116-0257	864.11	257.95	306	66.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3283.0	C08		4	0117-0258	384.05	257.99	249	58.28	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			507.4	C08		4	0118-0260	777.97	259.88	263	59.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1325.5	C08		4	0119-0265	223.78	265.45	272	63.94	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			324.0	C08		4	0120-0264	502.47	264.27	314	66.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			827.3	C08		4	0121-0265	114.70	264.56	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			11386.5	C08		4	0122-0271	280.71	271.29	271	61.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2455.2	C08		4	0123-0271	834.78	271.50	274	61.01	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2715.8	C08		4	0124-0274	894.80	274.10	305	65.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			220.2	C08		4	0125-0278	522.30	279.48	304	69.01	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1893.4	C08		4	0126-0276	602.65	276.21	294	62.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			626.0	C08		4	0127-0284	128.97	286.07	617	101.40	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			542.6	C08		4	0128-0277	254.08	276.78	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			500.6	C08		4	0129-0286	42.86	285.69	296	64.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1903.6	C08		4	0130-0286	158.65	286.05	218	55.70	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			368.0	C08		4	0131-0288	942.68	288.02	330	69.01	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			255.1	C08		4	0132-0289	406.39	289.20	301	67.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2236.6	C08		4	0133-0289	695.37	289.37	262	62.18	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			695.5	C08		4	0134-0294	340.79	295.23	513	90.91	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			825.6	C08		4	0135-0293	917.77	293.73	271	61.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			846.1	C08		4	0136-0296	250.70	296.90	422	77.84	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1744.5	C08		4	0137-0293	712.56	293.65	264	63.36	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			248.4	C08		4	0138-0294	560.23	293.96	274	64.43	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			297.9	C08		4	0139-0299	471.38	299.56	304	65.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			893.0	C08		4	0140-0301	392.38	301.52	280	64.18	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			628.4	C08		4	0141-0307	13.11	307.38	287	63.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			364.7	C08		4	0142-0306	80.29	306.31	181	50.87	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			467.4	C08		4	0143-0307	523.17	306.77	252	59.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			963.5	C08		4	0144-0306	612.94	307.01	227	54.77	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			255.3	C08		4	0145-0309	816.53	308.49	292	66.77	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			312.9	C08		4	0146-0315	425.75	315.11	295	63.01	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1901.7	C08		4	0147-0319	940.38	319.78	301	64.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			952.9	C08		4	0148-0318	803.67	318.62	290	69.84	0.747
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2366.0	C08		4	0149-0317	849.12	317.73	271	60.18	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			318.1	C08		4	0150-0323	559.21	322.24	321	73.26	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			350.1	C08		4	0151-0321	87.18	321.12	225	56.28	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			679.5	C08		4	0152-0322	452.39	323.15	367	71.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			251.7	C08		4	0153-0327	162.06	328.11	249	59.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			529.2	C08		4	0154-0330	710.27	330.78	319	65.36	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			611.3	C08		4	0155-0328	886.53	328.26	263	60.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			422.9	C08		4	0156-0338	594.01	337.91	595	97.98	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2189.0	C08		4	0157-0337	646.17	337.01	297	63.60	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1221.7	C08		4	0158-0337	116.88	337.20	284	63.36	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			252.1	C08		4	0159-0341	39.77	340.92	273	63.60	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1606.0	C08		4	0160-0341	454.84	340.21	289	67.11	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			7731.6	C08		4	0161-0346	304.57	345.75	260	61.36	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1500.4	C08		4	0162-0346	271.11	346.10	266	59.11	0.957
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1752.7	C08		4	0163-0350	752.50	350.43	324	67.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			466.0	C08		4	0164-0350	384.43	350.60	255	57.94	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			886.0	C08		4	0165-0356	74.61	354.29	497	93.74	0.711
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			438.5	C08		4	0166-0357	29.79	358.18	297	66.18	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			389.1	C08		4	0167-0358	176.42	358.89	387	72.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1278.7	C08		4	0168-0359	793.52	358.98	294	63.84	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5334.1	C08		4	0169-0361	514.26	361.31	283	61.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			474.6	C08		4	0170-0360	594.36	360.58	300	66.43	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1555.3	C08		4	0171-0361	685.12	361.13	274	61.11	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			197.8	C08		4	0172-0365	840.24	364.88	336	71.26	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1713.4	C08		4	0173-0368	155.00	368.36	278	62.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			982.1	C08		4	0174-0368	933.68	367.98	277	63.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1659.7	C08		4	0175-0368	547.58	368.08	268	61.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2412.9	C08		4	0176-0373	905.43	372.43	254	62.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1064.3	C08		4	0177-0378	76.68	377.50	293	64.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			692.5	C08		4	0178-0379	403.55	378.78	400	75.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			329.0	C08		4	0179-0381	916.77	381.15	265	65.11	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			252.1	C08		4	0180-0380	783.74	380.76	267	61.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			386.8	C08		4	0181-0381	868.36	381.50	273	62.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2093.2	C08		4	0182-0380	582.62	380.44	267	62.77	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			272.5	C08		4	0183-0387	197.99	387.76	271	62.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			772.0	C08		4	0184-0388	386.37	388.18	276	63.60	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			272.2	C08		4	0185-0393	451.71	392.80	425	77.50	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3318.5	C08		4	0186-0392	327.20	391.44	230	59.01	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			207.3	C08		4	0187-0391	646.40	391.28	327	69.60	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3187.8	C08		4	0188-0393	265.53	394.10	264	71.60	0.647
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4177.0	C08		4	0189-0398	487.40	398.43	243	57.94	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			326.2	C08		4	0190-0407	338.35	406.82	452	79.26	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1655.9	C08		4	0191-0407	428.75	406.70	308	67.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			352.8	C08		4	0192-0406	835.29	405.58	284	63.36	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			9647.8	C08		4	0193-0406	219.83	405.82	314	75.01	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			307.1	C08		4	0194-0412	39.19	412.53	379	73.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			220.0	C08		4	0195-0414	718.29	413.31	316	70.67	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1169.2	C08		4	0196-0415	616.94	415.67	305	71.11	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1065.3	C08		4	0197-0418	537.24	418.53	261	60.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			848.3	C08		4	0198-0419	314.66	418.81	257	60.77	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			269.4	C08		4	0199-0423	23.37	424.02	327	68.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			192.0	C08		4	0200-0426	443.84	426.38	435	78.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			213.8	C08		4	0201-0422	497.94	422.24	234	59.94	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1635.6	C08		4	0202-0421	782.63	422.18	227	57.46	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			7906.3	C08		4	0203-0428	102.54	428.54	257	59.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			301.7	C08		4	0204-0428	353.63	428.13	233	58.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			206.1	C08		4	0205-0431	175.61	431.06	260	61.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			450.5	C08		4	0206-0436	869.49	435.52	344	69.26	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2272.0	C08		4	0207-0437	399.03	437.24	300	65.84	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			397.6	C08		4	0208-0435	785.70	435.21	299	67.46	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			541.9	C08		4	0209-0442	844.50	442.06	300	68.08	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			216.2	C08		4	0210-0439	899.85	439.43	274	63.94	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			204.3	C08		4	0211-0444	533.74	444.45	275	63.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1595.4	C08		4	0212-0451	210.14	451.51	293	67.01	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			278.0	C08		4	0213-0452	160.79	452.29	236	59.70	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			700.1	C08		4	0214-0454	600.75	454.31	294	65.60	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			200.9	C08		4	0215-0451	736.90	451.79	266	61.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			405.1	C08		4	0216-0454	895.33	454.25	259	61.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1144.7	C08		4	0217-0458	478.62	458.38	287	65.84	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			198.1	C08		4	0218-0461	694.69	460.92	532	86.91	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1814.8	C08		4	0219-0459	44.19	459.42	281	64.43	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1307.1	C08		4	0220-0459	342.19	460.03	284	62.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			417.9	C08		4	0221-0462	933.42	462.17	236	57.70	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1190.6	C08		4	0222-0465	256.68	465.55	257	60.77	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			701.4	C08		4	0223-0471	643.70	471.56	319	67.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2101.2	C08		4	0224-0473	375.99	473.75	283	64.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			232.4	C08		4	0225-0478	95.76	477.80	297	67.94	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1673.2	C08		4	0226-0480	226.39	480.27	289	68.53	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			252.0	C08		4	0227-0482	578.29	482.37	597	107.88	0.645
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1382.0	C08		4	0228-0482	355.23	481.80	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			395.5	C08		4	0229-0483	515.35	483.79	278	63.70	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			441.3	C08		4	0230-0487	464.61	487.29	316	68.67	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			247.5	C08		4	0231-0486	656.31	486.55	381	76.18	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			561.0	C08		4	0232-0489	306.55	488.32	222	57.60	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1703.7	C08		4	0233-0491	261.19	491.53	318	66.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			684.9	C08		4	0234-0492	900.56	491.75	258	62.43	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			445.8	C08		4	0235-0493	119.60	493.37	322	66.43	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			235.1	C08		4	0236-0493	532.25	493.24	329	67.36	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			949.5	C08		4	0237-0496	152.27	496.95	290	63.60	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			177.8	C08		4	0238-0498	496.09	498.57	275	61.36	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			321.6	C08		4	0239-0506	296.91	506.63	510	89.40	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			523.6	C08		4	0240-0503	747.65	501.76	382	82.77	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2314.7	C08		4	0241-0505	190.44	504.87	303	66.43	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			426.9	C08		4	0242-0506	585.31	506.50	368	79.01	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			320.0	C08		4	0243-0506	914.71	505.80	385	72.08	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			300.1	C08		4	0244-0507	75.06	506.49	407	77.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1190.1	C08		4	0245-0508	940.54	508.37	248	59.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			234.2	C08		4	0246-0514	460.98	514.37	282	66.18	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			355.5	C08		4	0247-0515	344.87	515.17	256	58.77	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			306.1	C08		4	0248-0513	752.20	513.18	104	37.56	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			204.3	C08		4	0249-0519	797.87	519.53	305	66.77	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			450.3	C08		4	0250-0523	21.03	522.78	367	71.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			567.3	C08		4	0251-0524	677.56	524.40	267	63.11	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			679.0	C08		4	0252-0525	857.33	525.76	293	63.60	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			445.3	C08		4	0253-0528	605.21	528.13	260	60.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			197.3	C08		4	0254-0530	81.41	530.67	265	59.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			359.9	C08		4	0255-0532	425.71	531.58	294	64.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			330.2	C08		4	0256-0534	143.33	533.49	348	69.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3634.1	C08		4	0257-0536	337.79	536.17	304	64.77	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			252.8	C08		4	0258-0540	705.37	540.44	283	67.60	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			323.8	C08		4	0259-0540	375.55	540.29	282	61.36	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1218.2	C08		4	0260-0542	264.94	543.10	283	64.18	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			255.3	C08		4	0261-0540	769.06	541.00	227	55.70	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			310.4	C08		4	0262-0546	504.88	544.75	144	58.18	0.535
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			245.8	C08		4	0263-0545	786.77	545.17	241	58.28	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			235.8	C08		4	0264-0548	466.92	548.01	289	65.60	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			325.0	C08		4	0265-0551	193.95	551.35	335	75.36	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1827.2	C08		4	0266-0551	210.43	550.77	270	61.70	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			265.8	C08		4	0267-0553	564.18	553.75	284	62.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			492.9	C08		4	0268-0551	918.25	551.13	317	66.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			298.0	C08		4	0269-0550	498.75	550.63	113	46.04	0.670
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			223.7	C08		4	0270-0553	125.79	553.98	155	46.87	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			367.3	C08		4	0271-0563	41.40	563.91	377	82.43	0.697
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			246.9	C08		4	0272-0562	294.63	562.32	316	67.60	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			725.7	C08		4	0273-0561	645.15	561.41	241	61.36	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1469.1	C08		4	0274-0566	848.78	566.92	594	97.40	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			187.7	C08		4	0275-0565	518.57	564.82	266	61.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			913.3	C08		4	0276-0565	593.65	565.42	274	60.77	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2730.4	C08		4	0277-0568	97.71	568.65	271	62.77	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			220.7	C08		4	0278-0566	436.79	566.91	284	68.43	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			440.2	C08		4	0279-0583	385.93	583.07	254	58.53	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			194.8	C08		4	0280-0582	551.56	582.54	274	61.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			331.6	C08		4	0281-0586	588.04	585.62	294	67.60	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			183.2	C08		4	0282-0585	806.99	584.50	330	70.43	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			306.9	C08		4	0283-0588	656.39	587.82	317	68.67	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			242.4	C08		4	0284-0585	915.70	585.09	232	55.94	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			525.2	C08		4	0285-0586	752.14	586.11	259	59.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			219.1	C08		4	0286-0589	453.57	588.43	297	65.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			485.8	C08		4	0287-0596	680.62	596.36	294	65.01	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			419.2	C08		4	0288-0597	370.78	597.13	269	60.87	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			352.2	C08		4	0289-0598	906.51	598.67	284	67.01	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			733.0	C08		4	0290-0602	472.15	602.78	265	62.77	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3003.7	C08		4	0291-0606	407.31	605.77	311	66.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			219.7	C08		4	0292-0610	596.24	611.18	339	74.43	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			636.0	C08		4	0293-0606	124.51	606.33	248	59.11	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			582.2	C08		4	0294-0604	150.87	603.91	160	48.87	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			663.3	C08		4	0295-0608	221.37	608.45	282	67.01	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1017.0	C08		4	0296-0611	107.12	611.29	310	67.60	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			410.3	C08		4	0297-0608	891.26	607.66	201	53.36	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1240.6	C08		4	0298-0617	251.36	617.11	262	63.26	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			193.5	C08		4	0299-0617	546.69	617.58	314	66.18	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2287.5	C08		4	0300-0621	164.67	621.23	270	65.70	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			255.0	C08		4	0301-0617	298.05	616.51	243	57.36	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			607.0	C08		4	0302-0623	508.75	622.51	536	104.13	0.621
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			264.8	C08		4	0303-0621	860.48	620.95	301	66.53	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			283.9	C08		4	0304-0621	89.78	621.50	220	54.18	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			388.0	C08		4	0305-0626	363.21	626.25	240	63.84	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1372.5	C08		4	0306-0623	19.85	623.15	257	57.94	0.962
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4521.1	C08		4	0307-0626	446.30	626.23	296	65.84	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1951.6	C08		4	0308-0628	276.95	627.68	296	65.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1070.9	C08		4	0309-0632	393.23	631.71	281	63.60	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1362.0	C08		4	0310-0629	712.87	629.97	259	61.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			464.9	C08		4	0311-0633	197.52	634.07	279	62.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			258.9	C08		4	0312-0642	488.06	641.33	754	112.47	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1428.4	C08		4	0313-0637	829.47	636.54	263	61.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			470.1	C08		4	0314-0644	345.03	644.26	229	55.70	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			204.2	C08		4	0315-0641	608.85	641.57	282	65.36	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			302.8	C08		4	0316-0647	814.22	647.40	352	70.67	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1826.3	C08		4	0317-0648	411.99	648.90	283	67.84	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1473.4	C08		4	0318-0654	217.20	652.52	594	101.74	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			399.3	C08		4	0319-0647	372.52	646.90	117	54.67	0.492
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			351.1	C08		4	0320-0651	366.21	653.00	129	56.43	0.509
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1161.9	C08		4	0321-0657	751.75	656.75	276	64.77	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			730.9	C08		4	0322-0661	29.53	660.50	527	89.26	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			154.1	C08		4	0323-0658	948.14	657.79	286	63.60	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			159.4	C08		4	0324-0664	526.90	664.58	255	62.53	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			553.5	C08		4	0325-0661	625.34	660.88	249	57.94	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			186.5	C08		4	0326-0664	562.53	664.41	309	68.43	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			201.7	C08		4	0327-0667	784.11	667.20	269	63.36	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1174.3	C08		4	0328-0665	139.16	664.90	285	63.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			656.1	C08		4	0329-0670	586.29	670.21	256	59.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			579.9	C08		4	0330-0670	914.77	670.05	225	54.87	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			295.3	C08		4	0331-0674	415.34	674.71	314	66.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			255.4	C08		4	0332-0677	471.76	677.87	291	65.94	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			176.0	C08		4	0333-0679	539.42	678.57	287	67.36	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			600.6	C08		4	0334-0682	65.29	680.87	252	65.36	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			208.3	C08		4	0335-0683	495.42	683.29	294	66.53	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			432.2	C08		4	0336-0681	348.32	681.31	250	58.18	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			230.8	C08		4	0337-0682	512.00	682.29	273	61.21	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			270.8	C08		4	0338-0685	29.24	685.85	265	61.36	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1145.3	C08		4	0339-0687	261.52	686.48	285	65.36	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			739.5	C08		4	0340-0687	845.32	687.10	233	56.18	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			179.8	C08		4	0341-0692	717.19	692.78	251	61.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			306.7	C08		4	0342-0691	292.89	692.24	199	53.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			182.9	C08		4	0343-0694	754.00	694.29	290	65.60	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			228.1	C08		4	0344-0696	193.12	695.75	276	62.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			318.0	C08		4	0345-0697	54.64	698.43	341	70.43	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			294.8	C08		4	0346-0696	135.31	695.85	323	66.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2913.4	C08		4	0347-0699	793.59	700.20	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3947.9	C08		4	0348-0699	474.12	699.64	273	62.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			284.1	C08		4	0349-0701	733.39	701.49	303	67.36	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3597.4	C08		4	0350-0705	877.22	705.20	108	42.04	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			165.4	C08		4	0351-0707	930.89	707.77	266	65.01	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			388.6	C08		4	0352-0710	358.48	709.73	291	63.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			306.0	C08		5	0001-0025	207.22	24.73	281	63.36	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			203.3	C08		5	0002-0023	628.36	23.18	228	56.28	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			291.4	C08		5	0003-0027	757.57	26.69	263	60.43	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			345.0	C08		5	0004-0025	245.80	25.00	263	60.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			416.1	C08		5	0005-0035	174.04	35.25	268	60.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			373.5	C08		5	0006-0036	402.63	35.76	271	61.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			827.2	C08		5	0007-0037	66.40	37.22	253	59.11	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			758.6	C08		5	0008-0039	746.47	39.01	243	59.84	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			210.0	C08		5	0009-0041	937.37	41.10	272	64.18	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			662.6	C08		5	0010-0045	583.63	46.23	377	80.18	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1466.4	C08		5	0011-0041	602.48	40.47	210	54.87	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2194.2	C08		5	0012-0046	510.44	45.61	319	65.01	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			254.5	C08		5	0013-0047	417.06	47.14	262	70.67	0.659
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3079.2	C08		5	0014-0048	325.88	48.14	252	59.70	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			308.1	C08		5	0015-0048	864.11	48.79	362	71.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1188.7	C08		5	0016-0051	538.31	51.75	284	63.94	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3468.0	C08		5	0017-0049	663.18	49.26	245	56.77	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3294.9	C08		5	0018-0051	47.74	51.33	240	58.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3092.6	C08		5	0019-0051	887.77	51.56	252	57.94	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			395.4	C08		5	0020-0056	264.29	55.56	497	91.74	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4646.4	C08		5	0021-0055	482.62	55.53	232	56.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2212.3	C08		5	0022-0063	305.30	62.56	282	66.67	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			706.8	C08		5	0023-0062	186.19	63.10	290	65.60	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2822.9	C08		5	0024-0064	806.78	64.54	201	56.43	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			657.2	C08		5	0025-0067	26.26	66.14	274	64.43	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			247.9	C08		5	0026-0066	117.58	65.66	227	59.60	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			912.8	C08		5	0027-0071	231.30	71.55	281	65.60	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1116.1	C08		5	0028-0071	753.60	71.94	276	61.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			846.1	C08		5	0029-0072	559.09	72.36	265	60.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			219.6	C08		5	0030-0076	379.29	75.97	313	67.01	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			254.1	C08		5	0031-0080	123.83	80.49	366	76.18	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			692.1	C08		5	0032-0075	165.25	74.41	288	65.70	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			176.5	C08		5	0033-0078	613.99	77.76	256	58.53	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			176.0	C08		5	0034-0079	923.97	79.38	259	59.70	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			228.4	C08		5	0035-0081	60.39	81.99	265	64.18	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1496.2	C08		5	0036-0084	505.04	84.26	310	65.94	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			749.8	C08		5	0037-0090	693.12	90.15	316	68.18	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1315.5	C08		5	0038-0088	724.22	87.61	299	63.60	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1779.2	C08		5	0039-0087	254.08	87.36	238	58.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			291.0	C08		5	0040-0089	87.63	89.57	252	58.53	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			228.8	C08		5	0041-0090	184.69	90.96	419	81.26	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			335.4	C08		5	0042-0094	281.23	94.20	346	70.18	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			204.3	C08		5	0043-0093	162.46	93.63	217	59.70	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			452.5	C08		5	0044-0097	316.17	98.03	272	60.77	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			776.4	C08		5	0045-0105	858.99	106.45	309	76.77	0.659
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			835.1	C08		5	0046-0101	651.89	101.10	345	69.84	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			943.1	C08		5	0047-0102	503.46	101.78	273	62.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2187.9	C08		5	0048-0105	894.66	104.84	302	69.84	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			506.0	C08		5	0049-0105	342.24	105.07	235	55.94	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			914.8	C08		5	0050-0107	788.00	107.40	286	64.77	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2115.4	C08		5	0051-0109	47.58	108.98	289	62.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			279.2	C08		5	0052-0108	208.12	107.97	321	66.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1773.4	C08		5	0053-0109	829.80	108.41	263	60.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			367.3	C08		5	0054-0110	550.61	109.80	235	57.46	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1920.0	C08		5	0055-0114	939.47	113.65	286	65.94	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			386.9	C08		5	0056-0114	535.56	114.61	220	58.18	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4782.6	C08		5	0057-0115	814.85	115.25	248	61.60	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			197.1	C08		5	0058-0116	125.20	116.96	275	64.67	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3215.9	C08		5	0059-0116	583.58	116.19	253	57.94	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			790.0	C08		5	0060-0117	451.18	117.39	235	63.01	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			243.9	C08		5	0061-0130	293.94	130.74	532	96.57	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			561.5	C08		5	0062-0127	763.95	126.43	390	74.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			398.6	C08		5	0063-0129	241.70	129.15	279	63.01	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1909.0	C08		5	0064-0128	945.76	129.18	307	67.60	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1590.5	C08		5	0065-0130	709.15	129.47	285	63.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			905.3	C08		5	0066-0132	205.96	132.26	302	67.01	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			418.8	C08		5	0067-0131	83.68	131.34	282	64.77	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2312.1	C08		5	0068-0132	462.85	132.67	223	56.63	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1684.2	C08		5	0069-0142	511.66	141.97	346	70.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			273.0	C08		5	0070-0142	779.76	142.04	281	64.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1324.2	C08		5	0071-0146	124.86	145.69	304	69.01	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2666.5	C08		5	0072-0147	401.83	145.94	226	60.53	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			354.0	C08		5	0073-0149	538.49	149.60	263	65.01	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			711.9	C08		5	0074-0148	704.63	148.28	295	65.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			298.9	C08		5	0075-0148	826.93	148.52	278	62.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			13455.8	C08		5	0076-0150	644.94	149.72	309	65.36	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			871.5	C08		5	0077-0148	467.80	148.00	227	55.70	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			771.7	C08		5	0078-0154	206.08	154.12	273	60.77	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			391.8	C08		5	0079-0155	564.25	155.96	469	80.08	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			382.6	C08		5	0080-0153	71.19	152.62	267	62.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			671.6	C08		5	0081-0156	224.25	156.24	260	59.70	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4455.0	C08		5	0082-0159	918.75	158.85	309	71.36	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			798.1	C08		5	0083-0161	670.33	161.54	283	65.26	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2104.9	C08		5	0084-0159	901.80	159.44	190	52.28	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1875.1	C08		5	0085-0161	411.74	160.23	259	61.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4284.9	C08		5	0086-0164	12.84	165.13	248	57.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			511.3	C08		5	0087-0167	149.27	167.38	232	56.18	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2319.5	C08		5	0088-0168	837.22	167.15	248	61.94	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2006.2	C08		5	0089-0175	34.74	175.89	304	70.77	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			254.0	C08		5	0090-0176	348.13	175.84	308	67.60	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			266.2	C08		5	0091-0176	595.11	176.03	445	77.26	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			497.4	C08		5	0092-0177	174.77	177.75	256	58.18	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3460.2	C08		5	0093-0179	752.26	178.85	297	65.60	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1704.6	C08		5	0094-0182	139.86	182.31	239	57.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1855.8	C08		5	0095-0179	480.19	178.89	257	60.53	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			6748.6	C08		5	0096-0180	773.20	180.22	253	59.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3272.3	C08		5	0097-0178	819.77	178.06	127	42.97	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2197.3	C08		5	0098-0181	830.53	181.19	108	38.39	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			666.9	C08		5	0099-0189	195.63	189.09	273	62.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			582.5	C08		5	0100-0194	94.39	194.00	361	74.43	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			207.0	C08		5	0101-0192	356.51	192.32	250	61.60	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			672.9	C08		5	0102-0193	111.20	192.63	270	61.70	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			517.7	C08		5	0103-0196	316.62	195.93	423	74.43	0.960
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			354.3	C08		5	0104-0192	277.15	191.83	127	62.43	0.410
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1728.6	C08		5	0105-0197	255.39	196.94	291	65.11	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			7006.6	C08		5	0106-0199	238.00	199.22	270	60.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			222.4	C08		5	0107-0197	755.16	197.21	333	73.84	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			234.1	C08		5	0108-0203	377.95	202.93	389	73.84	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			339.2	C08		5	0109-0202	729.24	202.66	282	62.28	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			727.2	C08		5	0110-0205	15.79	205.08	242	62.53	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			775.6	C08		5	0111-0201	152.68	200.91	278	65.11	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			824.0	C08		5	0112-0213	531.46	212.95	638	109.64	0.667
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			284.7	C08		5	0113-0208	451.28	209.15	386	77.60	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			10022.0	C08		5	0114-0207	707.83	207.15	275	61.70	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2528.3	C08		5	0115-0208	417.03	208.07	264	60.77	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			441.2	C08		5	0116-0212	806.62	212.34	352	71.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1229.2	C08		5	0117-0213	468.08	213.85	235	59.11	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			320.3	C08		5	0118-0215	79.24	215.03	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1226.0	C08		5	0119-0216	916.03	216.05	260	60.18	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1024.3	C08		5	0120-0216	754.19	217.04	271	60.53	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			7694.4	C08		5	0121-0220	861.49	220.57	261	61.46	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1433.7	C08		5	0122-0220	846.92	220.50	226	56.53	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			822.9	C08		5	0123-0220	155.45	219.99	235	58.53	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			795.2	C08		5	0124-0227	305.10	227.85	461	79.84	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1372.0	C08		5	0125-0230	209.14	229.56	465	82.18	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			312.3	C08		5	0126-0228	629.67	228.20	214	54.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1098.6	C08		5	0127-0234	566.31	234.22	319	71.60	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			287.5	C08		5	0128-0234	179.64	233.99	323	67.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			758.6	C08		5	0129-0235	160.19	235.37	256	64.18	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			274.6	C08		5	0130-0236	282.88	236.18	299	64.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			384.2	C08		5	0131-0236	649.81	235.52	223	55.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1745.3	C08		5	0132-0237	120.78	237.25	243	58.18	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			620.3	C08		5	0133-0245	368.24	245.87	246	57.60	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			708.0	C08		5	0134-0246	583.97	245.73	309	67.70	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1659.7	C08		5	0135-0246	746.79	246.21	272	67.01	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3795.4	C08		5	0136-0251	154.83	251.42	213	57.36	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			279.3	C08		5	0137-0257	41.66	256.83	302	66.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			6180.1	C08		5	0138-0261	915.84	261.05	264	62.77	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			522.6	C08		5	0139-0268	672.13	267.50	285	65.01	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			303.8	C08		5	0140-0270	701.57	270.34	435	77.26	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			273.4	C08		5	0141-0268	165.69	268.34	279	64.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			344.2	C08		5	0142-0271	272.79	270.58	228	59.01	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			199.1	C08		5	0143-0272	781.36	271.85	315	68.18	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			6114.1	C08		5	0144-0274	218.26	274.24	234	58.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			567.4	C08		5	0145-0274	336.63	274.33	263	61.36	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1088.0	C08		5	0146-0275	403.63	274.97	100	53.94	0.432
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			387.6	C08		5	0147-0277	614.54	277.62	293	63.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			293.8	C08		5	0148-0282	637.91	282.17	280	62.18	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			542.7	C08		5	0149-0285	826.66	284.99	417	75.84	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			606.4	C08		5	0150-0283	727.36	283.45	236	57.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			611.8	C08		5	0151-0284	368.25	284.96	238	57.36	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1002.2	C08		5	0152-0286	122.52	286.93	271	62.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			240.0	C08		5	0153-0288	523.62	287.86	321	69.26	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			378.6	C08		5	0154-0290	47.31	290.37	349	69.01	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			190.9	C08		5	0155-0288	145.49	288.97	279	64.43	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2652.3	C08		5	0156-0293	892.36	293.38	289	65.60	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			196.3	C08		5	0157-0292	100.14	291.43	254	61.94	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			241.4	C08		5	0158-0290	326.27	290.42	232	60.18	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			193.0	C08		5	0159-0294	83.86	294.02	274	62.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1218.6	C08		5	0160-0293	484.95	293.15	340	72.18	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			818.1	C08		5	0161-0296	22.78	295.96	261	59.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			270.5	C08		5	0162-0297	451.94	296.90	263	62.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			320.3	C08		5	0163-0298	240.29	298.78	366	71.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			988.8	C08		5	0164-0302	652.45	303.48	138	61.94	0.452
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1012.1	C08		5	0165-0304	280.60	304.06	270	61.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2019.1	C08		5	0166-0305	217.05	305.63	289	63.84	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4926.4	C08		5	0167-0307	930.59	307.42	323	67.01	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1000.2	C08		5	0168-0310	729.44	309.48	269	62.18	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			177.6	C08		5	0169-0312	158.18	312.84	271	59.94	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			384.6	C08		5	0170-0316	189.03	316.58	267	63.36	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			336.7	C08		5	0171-0316	69.13	316.27	257	58.53	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1692.3	C08		5	0172-0318	89.27	318.53	265	59.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			943.9	C08		5	0173-0317	799.68	316.63	286	63.60	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2057.4	C08		5	0174-0321	45.21	322.00	284	63.36	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			282.5	C08		5	0175-0320	845.17	320.63	253	58.18	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			508.0	C08		5	0176-0320	136.44	320.06	267	61.70	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			233.1	C08		5	0177-0322	397.22	323.48	278	62.87	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			281.5	C08		5	0178-0322	870.34	322.03	266	60.18	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			431.6	C08		5	0179-0331	461.27	330.50	403	123.30	0.333
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			634.1	C08		5	0180-0327	348.68	327.24	254	59.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			203.7	C08		5	0181-0336	635.50	336.28	311	67.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			497.6	C08		5	0182-0339	704.62	340.13	296	69.01	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			378.1	C08		5	0183-0339	450.08	339.58	202	57.36	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4074.2	C08		5	0184-0341	684.57	341.42	259	59.11	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2997.3	C08		5	0185-0342	157.89	341.75	248	58.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			315.7	C08		5	0186-0341	401.12	341.19	280	63.11	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			664.3	C08		5	0187-0342	227.55	343.12	260	58.53	0.954
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			981.6	C08		5	0188-0349	287.08	348.91	530	90.08	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2228.3	C08		5	0189-0348	528.05	348.36	309	64.77	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			246.9	C08		5	0190-0349	862.51	349.51	310	65.70	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			821.9	C08		5	0191-0350	111.55	349.91	286	63.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			375.7	C08		5	0192-0351	185.97	351.54	249	59.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1329.9	C08		5	0193-0351	484.60	351.12	260	59.46	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			328.2	C08		5	0194-0351	626.22	351.50	270	60.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			606.8	C08		5	0195-0355	259.67	355.61	272	62.43	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1220.9	C08		5	0196-0355	379.09	355.60	217	55.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2210.8	C08		5	0197-0357	925.07	357.27	292	67.01	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			269.3	C08		5	0198-0359	132.19	358.49	242	57.36	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			933.3	C08		5	0199-0358	402.98	357.83	219	56.53	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			205.6	C08		5	0200-0360	231.80	360.52	300	66.53	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			193.4	C08		5	0201-0363	330.82	363.80	293	67.84	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			357.5	C08		5	0202-0362	570.58	361.86	347	68.43	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			843.4	C08		5	0203-0363	801.77	362.94	302	65.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			872.3	C08		5	0204-0362	692.19	362.38	273	62.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2496.6	C08		5	0205-0362	455.04	362.52	265	59.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			279.8	C08		5	0206-0367	753.07	367.37	195	53.70	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			208.2	C08		5	0207-0370	250.40	370.10	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1465.0	C08		5	0208-0367	489.65	367.26	252	61.70	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1002.1	C08		5	0209-0370	38.62	370.24	269	61.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1654.0	C08		5	0210-0371	65.11	370.95	267	63.60	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1350.8	C08		5	0211-0379	16.47	379.21	528	92.33	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			263.2	C08		5	0212-0374	897.56	373.81	358	70.43	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			561.5	C08		5	0213-0374	392.69	373.41	227	57.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			274.0	C08		5	0214-0372	607.12	372.07	244	59.70	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			242.7	C08		5	0215-0377	715.45	377.60	258	60.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3085.8	C08		5	0216-0380	170.63	380.29	261	60.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			765.0	C08		5	0217-0380	79.57	380.62	269	65.94	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			14022.5	C08		5	0218-0380	826.62	380.14	234	67.94	0.637
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			227.8	C08		5	0219-0385	845.60	385.45	276	64.77	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			512.8	C08		5	0220-0393	409.82	393.55	669	106.13	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			308.2	C08		5	0221-0388	931.71	388.88	307	65.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			207.9	C08		5	0222-0389	620.66	388.59	300	65.94	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			185.7	C08		5	0223-0391	280.28	391.24	286	63.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			313.0	C08		5	0224-0394	742.34	394.65	218	56.28	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1144.5	C08		5	0225-0397	576.47	397.02	193	53.11	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			220.6	C08		5	0226-0408	234.72	408.22	478	85.98	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			244.8	C08		5	0227-0401	128.22	400.74	230	57.70	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			971.2	C08		5	0228-0403	640.40	402.75	245	59.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			246.0	C08		5	0229-0402	674.17	402.64	236	56.87	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3028.3	C08		5	0230-0407	256.61	407.32	259	58.53	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1181.1	C08		5	0231-0408	197.58	408.15	263	62.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			233.3	C08		5	0232-0408	809.21	408.51	286	65.11	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			235.9	C08		5	0233-0413	653.05	413.47	257	58.53	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			201.4	C08		5	0234-0413	121.53	413.71	248	60.53	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			177.2	C08		5	0235-0415	880.15	415.33	325	70.18	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			184.0	C08		5	0236-0415	332.75	415.60	283	61.36	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			259.7	C08		5	0237-0420	699.61	420.50	272	61.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			545.0	C08		5	0238-0421	179.91	421.12	203	53.36	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			454.5	C08		5	0239-0422	547.27	421.79	185	51.94	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			652.5	C08		5	0240-0423	604.43	422.81	241	56.53	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			213.6	C08		5	0241-0425	750.67	425.26	311	67.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			312.2	C08		5	0242-0428	861.17	428.79	347	72.43	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			255.8	C08		5	0243-0429	357.07	429.49	449	79.01	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			733.9	C08		5	0244-0427	425.56	426.68	266	62.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1493.6	C08		5	0245-0428	813.06	427.42	298	67.36	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			261.7	C08		5	0246-0429	910.70	428.36	341	67.60	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			386.1	C08		5	0247-0432	534.22	431.66	315	71.01	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1492.1	C08		5	0248-0432	446.12	431.85	275	61.36	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2821.6	C08		5	0249-0435	62.73	435.07	267	60.53	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			251.6	C08		5	0250-0437	691.92	437.49	220	55.11	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			551.7	C08		5	0251-0441	127.60	441.77	461	86.33	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			302.0	C08		5	0252-0442	555.58	441.73	334	74.43	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			257.9	C08		5	0253-0442	168.94	442.03	258	60.87	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			255.1	C08		5	0254-0445	236.30	444.92	500	88.91	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1258.6	C08		5	0255-0445	612.34	445.07	298	64.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			199.2	C08		5	0256-0447	719.95	447.96	315	72.43	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1222.1	C08		5	0257-0445	380.07	445.62	201	53.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			226.6	C08		5	0258-0449	909.18	450.90	311	69.84	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			222.5	C08		5	0259-0453	469.88	453.62	288	63.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			403.5	C08		5	0260-0452	66.84	451.78	252	60.18	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			229.9	C08		5	0261-0456	201.00	456.33	242	58.53	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			287.6	C08		5	0262-0458	181.80	458.11	142	57.01	0.549
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1083.9	C08		5	0263-0464	794.80	464.01	517	83.26	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			272.0	C08		5	0264-0460	504.68	460.60	232	55.36	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1971.0	C08		5	0265-0463	416.40	463.13	287	63.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			232.3	C08		5	0266-0463	661.43	462.91	449	82.43	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			504.7	C08		5	0267-0465	556.12	465.52	281	61.84	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			427.4	C08		5	0268-0464	38.15	464.42	234	57.11	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2277.3	C08		5	0269-0468	577.43	468.57	287	61.94	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			405.4	C08		5	0270-0473	300.85	472.61	357	71.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			667.6	C08		5	0271-0468	741.95	468.06	257	59.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			221.8	C08		5	0272-0472	885.89	472.06	331	67.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			552.3	C08		5	0273-0473	402.60	473.38	290	65.26	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1437.7	C08		5	0274-0479	229.15	479.36	269	63.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			585.5	C08		5	0275-0484	122.14	484.11	446	81.01	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			278.8	C08		5	0276-0489	271.42	487.98	509	94.57	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1079.7	C08		5	0277-0482	846.77	481.46	271	61.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1816.8	C08		5	0278-0484	334.88	483.78	279	63.36	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1410.9	C08		5	0279-0495	616.96	495.63	262	61.60	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			206.7	C08		5	0280-0493	792.78	494.13	275	65.60	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			236.9	C08		5	0281-0496	452.03	495.40	259	59.36	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			332.6	C08		5	0282-0497	717.65	497.06	232	59.36	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			257.5	C08		5	0283-0501	197.27	500.70	468	85.74	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			349.6	C08		5	0284-0499	473.75	499.76	257	61.94	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			215.8	C08		5	0285-0501	96.90	501.47	294	65.01	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			256.2	C08		5	0286-0501	901.81	501.38	250	58.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			901.5	C08		5	0287-0502	370.13	501.78	271	62.77	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			468.3	C08		5	0288-0503	936.65	503.74	242	57.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			735.2	C08		5	0289-0504	493.62	504.39	252	59.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			699.5	C08		5	0290-0506	631.65	505.45	265	64.18	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			320.4	C08		5	0291-0507	19.27	507.99	386	74.33	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			343.0	C08		5	0292-0509	249.77	508.81	512	95.40	0.707
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1005.2	C08		5	0293-0509	557.64	509.71	257	65.01	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3053.4	C08		5	0294-0511	442.12	511.25	301	66.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1227.6	C08		5	0295-0510	45.20	510.71	245	58.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1999.0	C08		5	0296-0513	334.12	513.95	289	62.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			631.6	C08		5	0297-0514	286.74	514.68	251	57.94	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			173.8	C08		5	0298-0515	832.59	515.15	339	71.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			298.2	C08		5	0299-0515	468.55	515.56	195	53.70	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			389.2	C08		5	0300-0519	138.33	518.67	241	59.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1171.3	C08		5	0301-0519	526.25	519.51	272	60.53	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			508.8	C08		5	0302-0520	92.26	520.68	300	70.18	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			263.1	C08		5	0303-0523	624.45	523.58	297	65.01	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			186.6	C08		5	0304-0525	394.75	525.32	283	66.43	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			206.0	C08		5	0305-0528	769.98	528.55	280	67.50	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			456.9	C08		5	0306-0532	425.08	531.78	268	63.11	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			846.5	C08		5	0307-0533	151.14	533.56	258	63.01	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			590.8	C08		5	0308-0534	197.35	533.64	319	73.84	0.735
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			873.0	C08		5	0309-0539	534.98	538.32	273	65.60	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3030.9	C08		5	0310-0537	607.50	537.37	220	54.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			914.8	C08		5	0311-0541	382.06	542.72	366	75.01	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1358.4	C08		5	0312-0541	832.18	541.50	310	67.36	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			275.8	C08		5	0313-0543	470.35	543.09	177	48.53	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			263.7	C08		5	0314-0551	946.10	550.58	385	77.36	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			523.0	C08		5	0315-0546	321.13	546.71	242	57.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			291.6	C08		5	0316-0548	678.45	548.70	313	65.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			269.2	C08		5	0317-0546	741.53	546.09	268	60.18	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1187.5	C08		5	0318-0551	553.24	551.57	308	68.43	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1137.4	C08		5	0319-0551	99.70	551.78	270	60.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			237.3	C08		5	0320-0553	231.82	553.69	305	70.08	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			529.1	C08		5	0321-0553	22.92	553.49	287	63.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			204.4	C08		5	0322-0559	495.91	559.76	300	70.28	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			627.2	C08		5	0323-0559	389.91	558.86	287	63.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1570.3	C08		5	0324-0559	821.93	559.31	314	67.36	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			388.1	C08		5	0325-0559	248.37	560.21	257	63.36	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			287.8	C08		5	0326-0562	168.02	561.67	248	62.77	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			205.8	C08		5	0327-0564	702.70	564.62	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			174.5	C08		5	0328-0567	510.91	566.78	301	69.11	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			378.8	C08		5	0329-0564	315.06	563.80	239	59.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			346.1	C08		5	0330-0566	736.12	565.92	242	57.36	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			219.6	C08		5	0331-0569	150.59	569.48	302	65.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3737.5	C08		5	0332-0567	677.72	567.46	254	60.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			724.5	C08		5	0333-0571	274.35	571.63	273	66.67	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			209.9	C08		5	0334-0576	918.32	576.50	354	70.18	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			223.9	C08		5	0335-0575	342.32	575.76	263	64.28	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			269.0	C08		5	0336-0577	429.97	576.35	383	73.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			223.7	C08		5	0337-0578	632.34	578.02	292	65.94	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			397.9	C08		5	0338-0575	859.79	575.79	290	71.36	0.716
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5778.4	C08		5	0339-0580	67.90	580.53	477	87.74	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			183.6	C08		5	0340-0581	898.80	581.22	331	68.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			358.0	C08		5	0341-0583	574.86	583.16	299	66.77	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			14967.6	C08		5	0342-0579	91.81	578.80	240	58.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			505.8	C08		5	0343-0582	313.75	583.24	272	64.28	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			327.1	C08		5	0344-0581	391.81	581.10	270	60.18	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			418.5	C08		5	0345-0581	716.10	581.79	223	55.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			437.2	C08		5	0346-0582	362.15	581.71	266	62.28	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			601.3	C08		5	0347-0580	790.21	579.80	287	68.53	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			671.2	C08		5	0348-0584	229.14	583.82	241	58.28	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			222.6	C08		5	0349-0587	20.24	587.47	224	55.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			209.5	C08		5	0350-0596	595.37	596.05	322	69.84	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3095.7	C08		5	0351-0600	354.65	600.31	282	62.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3550.2	C08		5	0352-0608	474.80	606.92	607	102.57	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			210.7	C08		5	0353-0601	167.12	600.87	304	66.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3356.9	C08		5	0354-0609	148.91	609.45	253	61.11	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			594.4	C08		5	0355-0610	719.24	610.32	321	66.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			222.6	C08		5	0356-0610	533.40	608.97	311	69.26	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			245.2	C08		5	0357-0610	187.17	610.71	253	59.70	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			188.1	C08		5	0358-0611	258.04	611.58	267	61.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1615.1	C08		5	0359-0613	805.81	613.19	270	61.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1228.1	C08		5	0360-0613	940.84	612.97	258	63.01	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			195.1	C08		5	0361-0617	413.46	616.96	307	68.08	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			236.5	C08		5	0362-0616	61.84	615.87	222	55.11	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			6244.6	C08		5	0363-0614	320.99	615.05	262	61.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4735.1	C08		5	0364-0616	295.85	616.52	265	59.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			181.2	C08		5	0365-0619	385.46	618.83	296	65.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			591.8	C08		5	0366-0620	207.44	620.08	266	60.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2608.6	C08		5	0367-0623	671.13	622.99	256	59.36	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			225.8	C08		5	0368-0624	137.19	624.25	240	57.70	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1651.8	C08		5	0369-0629	444.51	629.51	296	65.94	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			445.1	C08		5	0370-0629	186.09	628.77	271	62.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			808.0	C08		5	0371-0634	897.40	633.89	524	91.64	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1764.7	C08		5	0372-0633	864.86	633.43	286	63.60	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2684.9	C08		5	0373-0634	497.57	633.42	289	62.53	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			313.7	C08		5	0374-0647	794.04	647.11	321	69.50	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			6273.4	C08		5	0375-0647	539.38	647.38	241	57.70	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			330.2	C08		5	0376-0649	154.97	648.54	220	54.53	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			455.8	C08		5	0377-0647	646.40	647.40	204	53.11	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			885.2	C08		5	0378-0651	195.60	651.23	248	57.70	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			203.9	C08		5	0379-0652	247.90	652.79	293	63.94	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			502.5	C08		5	0380-0650	817.91	650.42	277	63.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			942.5	C08		5	0381-0648	335.51	648.81	154	48.63	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4604.7	C08		5	0382-0654	433.37	654.60	247	57.94	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			326.0	C08		5	0383-0655	686.50	654.73	395	73.84	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4715.9	C08		5	0384-0656	555.80	656.01	283	64.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			189.9	C08		5	0385-0660	52.60	659.90	289	62.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1089.9	C08		5	0386-0661	313.70	661.95	212	55.70	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			506.7	C08		5	0387-0662	629.58	661.88	213	56.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1070.3	C08		5	0388-0664	337.75	662.55	268	63.01	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1587.8	C08		5	0389-0668	589.42	667.54	275	63.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			236.2	C08		5	0390-0666	147.08	666.75	252	61.60	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			221.3	C08		5	0391-0666	671.76	667.21	262	63.01	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			327.9	C08		5	0392-0669	739.67	669.43	297	65.01	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			852.7	C08		5	0393-0679	330.09	679.10	404	84.57	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			578.5	C08		5	0394-0672	19.02	672.27	225	57.94	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			277.7	C08		5	0395-0674	160.45	674.70	206	54.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			814.3	C08		5	0396-0676	930.18	676.57	245	64.18	0.747
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			927.8	C08		5	0397-0683	405.39	682.87	637	109.54	0.667
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2654.2	C08		5	0398-0675	547.03	675.66	282	63.94	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2597.1	C08		5	0399-0678	284.16	677.62	271	60.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3113.3	C08		5	0400-0680	625.14	680.18	214	55.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			614.5	C08		5	0401-0684	804.27	684.54	262	59.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			369.4	C08		5	0402-0687	751.15	687.58	259	61.94	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1070.8	C08		5	0403-0688	348.96	687.26	159	58.43	0.585
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1240.3	C08		5	0404-0688	897.14	688.21	252	60.77	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			216.2	C08		5	0405-0691	869.78	690.90	275	78.67	0.558
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			534.6	C08		5	0406-0690	205.49	690.05	230	56.53	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1293.6	C08		5	0407-0690	683.30	690.68	230	56.77	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			715.4	C08		5	0408-0693	612.16	693.49	247	58.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			951.8	C08		5	0409-0706	467.36	706.23	279	61.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			794.9	C08		5	0410-0706	549.06	706.22	255	59.01	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			168.4	C08		5	0411-0709	35.80	710.01	288	66.77	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			277.9	C08		5	0412-0708	182.19	708.34	229	56.53	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			277.8	C08		5	0413-0709	233.40	709.62	261	59.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			183.5	C08		5	0414-0710	56.38	709.78	280	65.94	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3927.9	C08		6	0001-0023	416.28	23.63	327	71.01	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2301.2	C08		6	0002-0027	676.92	26.76	287	65.94	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			206.0	C08		6	0003-0027	227.08	26.02	257	69.60	0.667
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			208.7	C08		6	0004-0031	617.58	31.04	275	63.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			286.9	C08		6	0005-0028	846.42	28.00	237	59.94	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			507.9	C08		6	0006-0034	941.60	33.31	301	65.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			262.3	C08		6	0007-0035	54.36	34.91	270	63.70	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			156.6	C08		6	0008-0036	331.47	37.01	311	69.36	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1779.0	C08		6	0009-0047	440.88	47.58	646	109.88	0.672
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			624.5	C08		6	0010-0041	515.00	41.24	407	74.08	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			159.9	C08		6	0011-0044	31.94	44.26	257	62.77	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2138.6	C08		6	0012-0042	91.51	42.05	298	65.26	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2319.9	C08		6	0013-0043	788.36	43.35	291	63.11	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			837.3	C08		6	0014-0043	641.23	43.00	272	64.53	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			637.1	C08		6	0015-0043	838.81	43.77	348	70.77	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			249.0	C08		6	0016-0048	351.26	47.98	345	68.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5978.3	C08		6	0017-0050	557.36	49.98	316	65.84	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			333.9	C08		6	0018-0056	256.61	56.18	262	60.53	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			415.2	C08		6	0019-0060	857.26	60.45	424	84.91	0.739
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			210.5	C08		6	0020-0058	283.61	58.25	216	55.60	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1666.2	C08		6	0021-0057	302.72	56.67	194	53.11	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1098.9	C08		6	0022-0056	466.92	56.20	294	66.18	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			204.7	C08		6	0023-0058	170.81	57.00	285	73.84	0.657
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			455.9	C08		6	0024-0060	224.81	58.82	486	99.40	0.618
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			488.8	C08		6	0025-0071	610.72	70.65	290	64.53	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1911.4	C08		6	0026-0071	707.96	71.26	316	65.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			204.1	C08		6	0027-0070	53.10	70.92	267	65.60	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2979.3	C08		6	0028-0075	520.80	74.96	302	64.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			229.4	C08		6	0029-0075	161.24	74.69	204	55.94	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			693.9	C08		6	0030-0081	905.91	81.12	542	88.57	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			442.2	C08		6	0031-0077	134.01	77.10	233	58.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			173.1	C08		6	0032-0082	18.69	82.46	248	60.18	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2947.5	C08		6	0033-0086	284.39	86.76	297	64.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			230.7	C08		6	0034-0086	173.60	86.45	261	65.36	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			897.4	C08		6	0035-0090	927.11	89.89	390	78.18	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			323.4	C08		6	0036-0092	722.25	92.38	341	69.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			7974.9	C08		6	0037-0095	346.33	95.23	319	67.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4762.8	C08		6	0038-0098	391.71	98.21	293	65.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			645.9	C08		6	0039-0096	766.53	96.92	175	49.46	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			230.0	C08		6	0040-0101	64.36	100.97	241	64.28	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			330.6	C08		6	0041-0101	96.92	101.23	221	56.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			605.0	C08		6	0042-0104	835.92	104.70	279	63.60	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			254.2	C08		6	0043-0106	601.66	106.72	274	63.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			401.9	C08		6	0044-0104	916.53	104.14	224	58.18	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			207.7	C08		6	0045-0106	799.62	106.51	315	68.77	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1953.0	C08		6	0046-0108	535.89	108.15	327	66.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			265.9	C08		6	0047-0111	651.77	112.71	282	62.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2033.8	C08		6	0048-0117	34.30	117.20	284	65.60	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			13827.7	C08		6	0049-0115	577.40	115.08	245	58.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1159.1	C08		6	0050-0120	617.95	120.33	382	73.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			277.6	C08		6	0051-0118	135.04	118.42	287	70.18	0.732
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			424.2	C08		6	0052-0121	491.85	120.78	273	62.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			859.5	C08		6	0053-0119	376.22	120.22	193	50.87	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			501.8	C08		6	0054-0123	462.38	123.29	262	58.77	0.953
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1241.6	C08		6	0055-0125	853.84	124.76	210	57.60	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3016.1	C08		6	0056-0126	235.33	125.45	140	50.53	0.689
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1664.2	C08		6	0057-0128	680.24	129.14	265	60.18	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			493.7	C08		6	0058-0127	904.54	127.02	257	59.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2011.0	C08		6	0059-0131	40.69	132.16	280	65.60	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2018.3	C08		6	0060-0135	423.61	135.31	289	63.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			205.0	C08		6	0061-0133	716.97	133.81	268	63.70	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			923.4	C08		6	0062-0135	377.72	135.14	202	53.46	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			365.9	C08		6	0063-0142	340.72	141.79	264	63.01	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1049.7	C08		6	0064-0142	817.92	142.04	234	58.43	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2167.1	C08		6	0065-0144	514.97	144.61	291	63.36	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			647.4	C08		6	0066-0144	251.74	145.29	181	56.53	0.712
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			505.0	C08		6	0067-0144	594.22	144.32	242	58.53	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1074.4	C08		6	0068-0147	159.52	146.71	303	67.01	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			440.7	C08		6	0069-0150	764.60	150.14	234	56.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			318.0	C08		6	0070-0158	303.10	158.52	238	57.70	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			299.0	C08		6	0071-0157	888.64	157.38	362	71.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			548.4	C08		6	0072-0157	825.04	157.14	224	57.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			280.5	C08		6	0073-0163	537.54	161.94	332	68.77	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			586.1	C08		6	0074-0157	588.91	158.29	128	42.39	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1287.3	C08		6	0075-0161	614.35	161.31	263	60.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1415.3	C08		6	0076-0162	747.17	161.79	249	58.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			278.5	C08		6	0077-0163	676.84	163.38	424	77.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			509.4	C08		6	0078-0166	166.00	166.54	242	59.11	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			883.0	C08		6	0079-0166	400.03	166.05	225	57.70	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1421.7	C08		6	0080-0169	487.03	168.76	277	62.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1974.1	C08		6	0081-0171	109.83	171.44	282	64.77	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			603.5	C08		6	0082-0172	591.26	172.29	241	63.70	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			250.0	C08		6	0083-0182	835.67	182.33	328	69.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			196.3	C08		6	0084-0184	172.45	184.33	281	65.94	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			437.8	C08		6	0085-0186	705.00	185.93	345	68.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1265.2	C08		6	0086-0187	75.88	187.63	216	56.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			344.0	C08		6	0087-0187	859.67	187.16	303	68.43	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1451.3	C08		6	0088-0188	60.61	188.80	270	61.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			300.6	C08		6	0089-0187	803.04	186.83	178	60.18	0.618
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			381.4	C08		6	0090-0191	672.91	190.78	309	70.18	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			252.5	C08		6	0091-0193	940.32	193.32	259	59.70	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			188.4	C08		6	0092-0198	822.87	198.48	341	74.67	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			776.9	C08		6	0093-0203	625.45	203.38	295	65.84	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			844.2	C08		6	0094-0202	909.82	202.56	250	58.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			286.3	C08		6	0095-0201	807.76	202.00	102	63.01	0.323
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			899.0	C08		6	0096-0206	129.34	206.23	298	64.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2132.2	C08		6	0097-0209	397.85	209.34	257	61.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			589.9	C08		6	0098-0211	432.42	211.02	231	61.11	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1299.7	C08		6	0099-0210	500.04	211.04	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1841.5	C08		6	0100-0210	568.93	209.67	290	63.60	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1068.5	C08		6	0101-0215	215.75	215.14	308	65.01	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			278.2	C08		6	0102-0218	279.31	219.19	265	61.46	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			504.5	C08		6	0103-0222	723.31	222.66	271	62.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			351.7	C08		6	0104-0225	618.20	224.48	300	63.60	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			275.5	C08		6	0105-0229	887.94	229.13	329	68.18	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			650.7	C08		6	0106-0231	59.71	230.72	334	66.77	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2825.7	C08		6	0107-0236	91.16	236.34	285	63.26	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			274.5	C08		6	0108-0237	773.38	237.52	324	67.36	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			242.6	C08		6	0109-0236	279.03	236.04	389	74.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			536.6	C08		6	0110-0236	669.75	236.45	282	62.43	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3556.5	C08		6	0111-0238	343.16	238.63	321	67.84	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			765.0	C08		6	0112-0242	573.88	243.29	297	69.84	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			213.5	C08		6	0113-0244	756.21	244.60	290	66.18	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			212.2	C08		6	0114-0240	940.51	240.31	252	60.77	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			299.3	C08		6	0115-0247	198.46	246.56	301	67.84	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			195.5	C08		6	0116-0247	874.65	247.80	241	57.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			635.9	C08		6	0117-0251	833.26	251.71	322	76.91	0.684
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			12508.8	C08		6	0118-0254	386.96	253.92	280	66.67	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			252.1	C08		6	0119-0254	542.86	253.92	303	64.77	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			408.8	C08		6	0120-0252	181.83	252.52	254	61.36	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			204.4	C08		6	0121-0253	560.66	254.21	262	62.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1194.1	C08		6	0122-0256	469.07	255.36	254	64.53	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			450.9	C08		6	0123-0259	334.87	258.49	264	63.70	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			216.1	C08		6	0124-0263	605.14	262.77	302	65.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			531.4	C08		6	0125-0261	147.85	260.95	217	53.46	0.954
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			236.7	C08		6	0126-0264	729.34	264.18	365	74.08	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			446.2	C08		6	0127-0274	797.83	272.58	730	118.71	0.651
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			212.9	C08		6	0128-0265	913.08	265.02	285	63.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			853.5	C08		6	0129-0268	368.30	267.57	260	61.01	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2420.8	C08		6	0130-0271	50.84	271.45	275	64.18	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			254.9	C08		6	0131-0275	466.40	274.78	474	81.26	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			442.0	C08		6	0132-0271	683.27	271.56	311	66.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			250.5	C08		6	0133-0272	566.82	272.48	293	64.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			186.8	C08		6	0134-0285	173.94	285.56	273	63.11	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			295.5	C08		6	0135-0291	636.52	291.53	287	61.36	0.958
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			9182.4	C08		6	0136-0297	351.39	296.39	280	67.84	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			702.1	C08		6	0137-0295	554.38	295.52	265	61.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			344.2	C08		6	0138-0295	254.50	295.29	293	65.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			208.3	C08		6	0139-0296	850.40	297.06	334	67.01	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			960.7	C08		6	0140-0298	712.21	299.02	442	94.08	0.627
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			600.3	C08		6	0141-0302	901.12	301.88	321	69.60	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			957.8	C08		6	0142-0301	666.58	301.64	262	59.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			510.3	C08		6	0143-0307	917.49	306.26	335	71.01	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1004.3	C08		6	0144-0311	771.61	312.57	588	94.81	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			689.6	C08		6	0145-0307	375.36	307.73	255	58.77	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5005.6	C08		6	0146-0310	25.03	310.38	279	61.94	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1369.5	C08		6	0147-0312	509.64	311.64	257	60.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			599.4	C08		6	0148-0317	462.42	314.77	271	76.33	0.585
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3337.0	C08		6	0149-0313	945.18	313.34	263	62.87	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			415.2	C08		6	0150-0327	581.53	327.68	325	69.36	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			225.1	C08		6	0151-0323	859.49	323.86	256	63.94	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			548.2	C08		6	0152-0328	930.26	328.02	378	71.36	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1982.3	C08		6	0153-0332	300.21	332.99	315	73.01	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			260.8	C08		6	0154-0332	136.47	332.64	402	73.84	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			652.1	C08		6	0155-0331	741.68	331.35	299	63.36	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1714.1	C08		6	0156-0334	415.15	333.75	322	69.26	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			218.9	C08		6	0157-0336	57.05	335.97	361	70.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			803.5	C08		6	0158-0336	705.21	336.45	327	70.18	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			557.1	C08		6	0159-0337	247.85	337.10	231	57.94	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			377.4	C08		6	0160-0338	873.94	339.03	219	55.80	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			219.7	C08		6	0161-0346	319.24	345.76	246	62.28	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			214.2	C08		6	0162-0347	649.01	347.45	361	70.43	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1563.9	C08		6	0163-0346	262.33	345.89	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			381.9	C08		6	0164-0346	195.54	347.46	207	57.94	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			481.9	C08		6	0165-0349	751.50	349.29	219	55.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1285.7	C08		6	0166-0351	433.65	351.56	202	55.94	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			333.4	C08		6	0167-0355	275.20	356.19	224	54.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1840.2	C08		6	0168-0358	330.88	357.70	234	60.18	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			301.4	C08		6	0169-0358	510.68	358.42	247	66.67	0.698
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			353.7	C08		6	0170-0353	874.29	352.74	227	58.28	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			341.5	C08		6	0171-0360	458.55	360.08	306	69.94	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1527.2	C08		6	0172-0356	782.57	356.41	305	64.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			222.7	C08		6	0173-0359	612.70	359.17	310	65.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2203.7	C08		6	0174-0360	19.86	360.13	273	65.84	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			453.7	C08		6	0175-0362	759.16	362.11	203	55.94	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1078.0	C08		6	0176-0365	107.78	365.12	297	67.36	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1180.9	C08		6	0177-0369	650.63	368.91	309	65.36	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			580.3	C08		6	0178-0368	427.61	368.25	236	56.87	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			294.2	C08		6	0179-0370	895.90	370.77	278	63.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			257.9	C08		6	0180-0371	917.35	371.10	266	62.43	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1799.8	C08		6	0181-0378	630.45	378.26	301	65.60	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			672.0	C08		6	0182-0380	518.18	380.51	214	56.53	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			185.3	C08		6	0183-0380	806.29	380.14	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1059.8	C08		6	0184-0387	132.88	387.35	285	63.94	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5317.8	C08		6	0185-0388	874.32	387.72	253	62.77	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			319.2	C08		6	0186-0391	26.53	391.88	312	65.01	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			359.5	C08		6	0187-0392	680.81	391.79	302	64.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2273.2	C08		6	0188-0400	718.10	399.93	292	65.36	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			363.5	C08		6	0189-0398	935.14	397.83	207	54.53	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			208.5	C08		6	0190-0401	766.60	400.19	271	62.43	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			768.3	C08		6	0191-0399	913.54	399.39	284	62.53	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			261.9	C08		6	0192-0405	563.90	405.58	300	64.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1164.9	C08		6	0193-0411	271.86	410.40	553	103.30	0.651
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			214.9	C08		6	0194-0408	529.67	408.35	277	62.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3782.6	C08		6	0195-0409	753.00	409.86	266	63.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			238.5	C08		6	0196-0412	855.78	412.42	248	60.43	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			304.6	C08		6	0197-0413	71.26	413.34	383	73.36	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			9658.5	C08		6	0198-0418	106.82	418.53	319	68.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			280.3	C08		6	0199-0423	452.60	421.94	336	71.01	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3885.4	C08		6	0200-0425	791.00	425.65	290	64.53	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			729.6	C08		6	0201-0424	807.62	423.86	267	62.53	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			596.3	C08		6	0202-0429	398.58	429.08	509	89.74	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			305.8	C08		6	0203-0426	839.61	426.67	230	58.18	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			289.8	C08		6	0204-0424	125.23	424.74	219	57.70	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1682.0	C08		6	0205-0430	238.86	429.93	284	65.01	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			220.0	C08		6	0206-0431	597.16	431.73	291	64.43	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			525.4	C08		6	0207-0432	349.09	432.09	224	57.11	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1020.0	C08		6	0208-0441	207.55	440.41	573	90.33	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1023.6	C08		6	0209-0439	417.80	439.51	276	63.94	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			209.1	C08		6	0210-0442	168.49	442.08	272	60.77	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			286.8	C08		6	0211-0442	623.74	441.87	263	58.53	0.965
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			951.3	C08		6	0212-0442	651.19	442.34	231	56.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			298.1	C08		6	0213-0445	705.41	445.49	224	61.84	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			415.7	C08		6	0214-0443	85.27	443.29	281	64.77	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1390.0	C08		6	0215-0449	263.69	449.21	290	65.84	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			261.2	C08		6	0216-0455	601.71	455.23	403	75.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			515.8	C08		6	0217-0454	928.96	453.89	209	55.11	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			431.2	C08		6	0218-0456	369.96	456.02	224	55.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			344.8	C08		6	0219-0458	284.97	458.20	295	63.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			853.6	C08		6	0220-0459	943.71	459.04	258	60.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1731.7	C08		6	0221-0461	875.56	460.42	304	63.94	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			440.3	C08		6	0222-0459	82.57	458.98	243	58.53	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1102.9	C08		6	0223-0462	308.85	462.86	247	59.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			256.5	C08		6	0224-0467	636.12	467.79	262	65.01	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			341.4	C08		6	0225-0464	133.52	463.37	241	63.36	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			195.2	C08		6	0226-0466	799.00	466.29	240	57.46	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			666.2	C08		6	0227-0467	814.53	466.96	274	63.11	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4586.9	C08		6	0228-0471	698.92	470.94	320	67.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			362.5	C08		6	0229-0472	764.64	471.85	388	74.08	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			526.2	C08		6	0230-0471	216.16	471.88	246	59.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			333.9	C08		6	0231-0474	430.19	473.76	325	70.43	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1751.7	C08		6	0232-0475	125.39	475.45	271	64.77	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1894.8	C08		6	0233-0477	601.43	476.81	257	59.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			714.2	C08		6	0234-0480	543.61	480.42	248	58.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			364.2	C08		6	0235-0485	754.39	485.62	321	69.01	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2980.6	C08		6	0236-0487	833.43	487.54	169	51.94	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			418.0	C08		6	0237-0489	147.26	489.54	262	60.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			270.5	C08		6	0238-0488	520.89	488.47	281	62.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			700.1	C08		6	0239-0489	211.36	489.19	253	59.11	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2622.7	C08		6	0240-0488	260.82	488.71	235	57.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			246.9	C08		6	0241-0491	897.82	492.01	384	73.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2306.3	C08		6	0242-0496	108.89	496.36	258	60.53	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			422.7	C08		6	0243-0498	794.85	497.72	251	66.53	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			181.2	C08		6	0244-0502	61.85	502.04	264	61.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			359.3	C08		6	0245-0501	431.48	500.98	254	61.60	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			697.3	C08		6	0246-0503	937.07	503.41	305	65.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			248.8	C08		6	0247-0505	703.45	504.80	339	68.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			442.9	C08		6	0248-0503	810.14	503.90	196	54.04	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			462.8	C08		6	0249-0506	31.37	506.93	235	57.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			613.7	C08		6	0250-0507	586.64	507.21	243	58.53	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1131.1	C08		6	0251-0508	414.86	507.96	281	63.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2230.6	C08		6	0252-0508	345.69	507.83	243	59.11	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			678.8	C08		6	0253-0512	150.39	512.45	210	52.87	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			487.0	C08		6	0254-0514	456.22	515.05	348	70.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			656.3	C08		6	0255-0516	164.03	515.62	232	59.46	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			169.4	C08		6	0256-0521	826.80	521.72	313	71.01	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			188.0	C08		6	0257-0523	945.53	522.89	229	56.53	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			203.1	C08		6	0258-0526	105.07	526.30	388	72.43	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			589.8	C08		6	0259-0522	268.65	522.06	172	50.87	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			585.9	C08		6	0260-0526	664.33	526.56	233	57.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			571.7	C08		6	0261-0527	250.42	526.89	188	53.11	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1292.6	C08		6	0262-0527	381.97	527.90	304	66.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			269.9	C08		6	0263-0528	611.87	528.20	324	68.43	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			801.3	C08		6	0264-0529	437.19	529.34	264	59.94	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			187.7	C08		6	0265-0535	483.76	535.17	268	63.36	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			745.3	C08		6	0266-0537	901.00	537.63	246	57.60	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			246.1	C08		6	0267-0541	269.74	541.75	257	61.01	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			257.1	C08		6	0268-0544	829.03	543.72	294	66.18	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			221.1	C08		6	0269-0554	41.10	553.69	394	79.60	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			225.2	C08		6	0270-0551	571.25	551.38	298	63.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3951.3	C08		6	0271-0551	62.85	551.76	261	61.26	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2041.8	C08		6	0272-0551	931.25	551.41	306	67.60	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			725.4	C08		6	0273-0553	753.50	553.00	266	60.18	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			340.4	C08		6	0274-0553	869.76	553.40	256	61.11	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2071.9	C08		6	0275-0557	389.14	557.68	305	66.77	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			555.6	C08		6	0276-0558	694.81	558.28	271	61.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			239.0	C08		6	0277-0564	160.05	564.71	337	67.01	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			230.1	C08		6	0278-0566	80.09	565.96	235	59.36	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1582.4	C08		6	0279-0572	425.35	572.97	289	64.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1330.7	C08		6	0280-0571	641.61	572.09	266	60.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			435.2	C08		6	0281-0573	137.07	573.98	236	59.36	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2168.1	C08		6	0282-0573	444.69	573.46	262	61.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			292.9	C08		6	0283-0579	51.66	578.45	330	70.53	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1154.4	C08		6	0284-0579	325.79	579.36	274	62.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			195.1	C08		6	0285-0578	843.81	579.39	334	69.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			206.1	C08		6	0286-0581	120.36	580.63	248	58.28	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2151.4	C08		6	0287-0584	914.41	584.32	316	66.18	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			311.5	C08		6	0288-0586	224.69	586.27	267	61.70	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			428.4	C08		6	0289-0591	744.26	590.33	323	68.18	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			259.6	C08		6	0290-0592	357.62	591.89	378	71.84	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			199.1	C08		6	0291-0589	447.52	589.20	262	62.53	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1276.3	C08		6	0292-0594	397.81	594.55	286	64.77	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2736.0	C08		6	0293-0596	478.63	597.04	265	60.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			252.6	C08		6	0294-0600	548.72	600.30	269	59.70	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2947.5	C08		6	0295-0606	768.79	606.37	348	75.50	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			873.0	C08		6	0296-0608	453.66	607.22	275	63.46	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1623.5	C08		6	0297-0611	871.03	611.29	313	65.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			201.7	C08		6	0298-0613	608.91	612.29	306	66.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			245.0	C08		6	0299-0612	155.25	612.80	258	66.77	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			385.7	C08		6	0300-0616	281.60	616.02	269	61.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			221.3	C08		6	0301-0621	101.66	620.83	457	83.26	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			602.2	C08		6	0302-0616	242.90	616.27	280	64.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			176.7	C08		6	0303-0619	793.31	619.27	289	65.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1307.9	C08		6	0304-0616	35.45	615.89	238	60.18	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2017.0	C08		6	0305-0619	934.38	618.80	234	59.70	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			243.7	C08		6	0306-0622	715.31	622.01	232	56.18	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			431.8	C08		6	0307-0623	490.18	623.40	266	61.60	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			189.9	C08		6	0308-0625	892.09	625.63	320	68.18	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			434.3	C08		6	0309-0627	922.07	627.14	220	57.94	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			605.7	C08		6	0310-0633	652.51	633.11	316	65.84	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			194.9	C08		6	0311-0633	318.81	632.76	239	59.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1369.5	C08		6	0312-0636	362.01	636.69	341	69.84	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2929.3	C08		6	0313-0638	466.43	637.42	320	68.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			201.9	C08		6	0314-0642	67.30	642.39	465	81.84	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			207.4	C08		6	0315-0639	244.92	639.76	419	78.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			255.1	C08		6	0316-0639	559.40	639.37	227	59.01	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			253.8	C08		6	0317-0639	817.75	639.85	284	61.60	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3256.1	C08		6	0318-0646	718.33	646.71	316	71.60	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			444.4	C08		6	0319-0647	754.67	646.84	230	57.60	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1152.0	C08		6	0320-0649	447.54	648.81	246	57.94	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			266.6	C08		6	0321-0652	950.46	652.40	258	59.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			362.6	C08		6	0322-0653	368.94	653.00	209	56.53	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			288.6	C08		6	0323-0657	286.04	657.54	398	75.84	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1041.4	C08		6	0324-0657	420.01	656.43	218	56.77	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			646.1	C08		6	0325-0659	874.28	659.13	245	58.53	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			178.7	C08		6	0326-0659	245.72	659.02	300	66.77	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2208.0	C08		6	0327-0665	617.34	666.04	321	69.84	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			198.7	C08		6	0328-0666	734.34	665.61	289	65.01	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			349.2	C08		6	0329-0670	799.68	670.44	295	71.50	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			801.5	C08		6	0330-0676	165.38	676.19	237	56.77	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			843.7	C08		6	0331-0679	24.32	679.38	222	60.18	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1716.4	C08		6	0332-0679	281.96	678.70	245	63.94	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1902.9	C08		6	0333-0681	852.07	682.12	305	65.36	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			709.5	C08		6	0334-0684	480.38	683.80	293	67.36	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			906.1	C08		6	0335-0683	870.51	683.10	248	62.18	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			250.7	C08		6	0336-0686	518.61	686.26	352	68.77	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2946.7	C08		6	0337-0683	715.86	683.20	246	59.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			188.5	C08		6	0338-0688	230.41	688.88	253	60.18	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1182.0	C08		6	0339-0689	103.32	689.98	231	58.53	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			192.7	C08		6	0340-0693	583.34	693.72	373	76.08	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			572.0	C08		6	0341-0701	163.75	701.44	242	58.28	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			333.1	C08		7	0001-0023	51.83	23.84	298	69.84	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3910.9	C08		7	0002-0026	872.40	25.70	203	61.60	0.672
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			246.6	C08		7	0003-0025	731.35	25.70	305	67.94	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			181.5	C08		7	0004-0031	928.55	31.22	283	66.18	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3176.1	C08		7	0005-0034	824.17	35.30	298	65.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2627.1	C08		7	0006-0035	617.33	35.30	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			407.5	C08		7	0007-0034	356.66	33.84	315	65.94	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			445.1	C08		7	0008-0037	580.19	36.57	282	63.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1540.3	C08		7	0009-0037	316.66	36.54	320	71.60	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			705.9	C08		7	0010-0036	32.18	36.12	266	61.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			653.5	C08		7	0011-0037	90.78	38.03	232	57.70	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			816.7	C08		7	0012-0043	840.82	43.08	252	58.28	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1501.7	C08		7	0013-0044	643.67	43.90	303	65.94	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2450.5	C08		7	0014-0048	19.83	48.94	291	63.60	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1451.1	C08		7	0015-0053	249.97	53.20	305	64.53	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			10518.1	C08		7	0016-0055	90.75	55.31	288	65.94	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			240.1	C08		7	0017-0057	556.33	57.88	320	67.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			189.2	C08		7	0018-0057	409.54	57.82	326	68.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			935.6	C08		7	0019-0062	520.71	62.39	288	63.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1449.6	C08		7	0020-0064	837.98	65.31	438	89.84	0.682
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1168.9	C08		7	0021-0061	944.96	60.36	110	42.04	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			416.2	C08		7	0022-0063	177.25	63.58	268	62.18	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1554.0	C08		7	0023-0067	871.06	67.00	240	61.84	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			335.6	C08		7	0024-0064	113.77	64.84	266	63.94	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			447.0	C08		7	0025-0073	730.13	72.18	431	81.01	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			301.8	C08		7	0026-0077	24.61	76.57	208	54.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			723.0	C08		7	0027-0087	684.99	87.09	311	67.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			207.7	C08		7	0028-0087	251.91	87.09	337	69.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			564.9	C08		7	0029-0087	288.99	87.22	286	62.53	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			998.3	C08		7	0030-0097	586.15	96.15	584	110.23	0.604
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1216.3	C08		7	0031-0088	132.75	87.65	315	69.01	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			642.8	C08		7	0032-0087	200.86	87.04	298	64.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			903.8	C08		7	0033-0087	361.81	87.33	303	64.77	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			276.8	C08		7	0034-0091	448.08	91.39	393	77.01	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			320.0	C08		7	0035-0092	17.29	92.61	173	49.94	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5492.4	C08		7	0036-0095	722.59	94.21	265	63.60	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			921.1	C08		7	0037-0100	638.36	99.46	299	66.18	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			7847.0	C08		7	0038-0102	816.65	102.78	353	74.08	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			292.9	C08		7	0039-0102	694.93	102.80	276	65.94	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			826.9	C08		7	0040-0106	621.07	106.28	316	67.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			767.3	C08		7	0041-0106	787.14	105.81	284	65.01	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			527.6	C08		7	0042-0108	440.48	108.24	311	67.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3039.8	C08		7	0043-0110	510.10	110.55	295	64.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2678.8	C08		7	0044-0109	766.18	108.84	275	62.53	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			610.4	C08		7	0045-0113	314.83	112.82	264	59.94	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1000.5	C08		7	0046-0115	914.68	115.50	288	63.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1070.3	C08		7	0047-0116	91.75	116.26	293	62.77	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			341.7	C08		7	0048-0117	563.72	117.16	314	65.60	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1779.7	C08		7	0049-0116	351.44	116.42	305	66.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1799.2	C08		7	0050-0123	180.27	122.55	320	70.18	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			274.9	C08		7	0051-0128	251.79	127.33	470	88.57	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			516.6	C08		7	0052-0120	404.21	120.23	270	62.53	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			570.4	C08		7	0053-0122	67.75	122.10	269	60.28	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			511.9	C08		7	0054-0128	728.23	127.56	314	68.43	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1407.5	C08		7	0055-0129	226.70	128.77	264	60.77	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			352.9	C08		7	0056-0130	853.09	130.34	358	69.60	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1084.7	C08		7	0057-0131	893.96	131.48	307	65.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			272.8	C08		7	0058-0133	668.02	134.08	273	64.18	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			682.8	C08		7	0059-0136	10.94	136.29	264	59.11	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			892.5	C08		7	0060-0141	311.82	141.79	298	65.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1349.6	C08		7	0061-0143	141.61	143.51	294	65.01	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1872.5	C08		7	0062-0143	722.81	144.64	318	71.26	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			549.7	C08		7	0063-0147	212.29	146.48	286	63.70	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			444.5	C08		7	0064-0152	192.31	151.77	275	66.18	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3149.9	C08		7	0065-0151	635.38	151.20	336	69.11	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			993.8	C08		7	0066-0160	561.54	160.14	535	98.57	0.692
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			637.8	C08		7	0067-0153	791.77	152.66	322	67.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			371.7	C08		7	0068-0157	417.30	157.18	496	84.08	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1645.9	C08		7	0069-0160	95.47	160.60	301	64.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			433.2	C08		7	0070-0162	816.09	162.44	317	67.01	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			504.9	C08		7	0071-0162	354.78	162.27	283	68.43	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			245.3	C08		7	0072-0166	235.28	166.37	452	78.43	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			503.2	C08		7	0073-0169	947.12	169.62	436	77.50	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			234.7	C08		7	0074-0168	27.73	168.95	257	59.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			233.6	C08		7	0075-0167	650.18	167.83	282	63.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			6356.2	C08		7	0076-0170	492.83	170.51	237	58.77	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3249.5	C08		7	0077-0173	187.93	172.95	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			958.7	C08		7	0078-0171	706.65	171.49	311	68.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			197.3	C08		7	0079-0173	366.75	173.55	297	67.01	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			7870.4	C08		7	0080-0173	479.10	174.12	130	47.46	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			272.3	C08		7	0081-0174	47.24	175.03	264	60.77	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1766.3	C08		7	0082-0176	425.03	175.77	300	65.60	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			6606.4	C08		7	0083-0181	306.37	181.78	380	72.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			261.2	C08		7	0084-0184	131.58	183.79	278	62.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3940.2	C08		7	0085-0185	518.78	185.64	312	65.60	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2061.9	C08		7	0086-0186	549.39	185.57	270	66.08	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2560.8	C08		7	0087-0185	848.61	185.47	297	64.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			851.9	C08		7	0088-0189	673.09	189.38	273	60.53	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			870.6	C08		7	0089-0190	380.05	189.97	274	61.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1071.6	C08		7	0090-0193	99.98	191.93	164	69.26	0.430
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			270.8	C08		7	0091-0192	702.90	192.63	273	60.77	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1229.6	C08		7	0092-0194	628.35	194.17	269	62.18	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1463.0	C08		7	0093-0198	586.04	197.99	258	59.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1292.4	C08		7	0094-0201	417.61	201.11	287	64.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1225.0	C08		7	0095-0201	42.76	201.33	298	66.08	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			776.4	C08		7	0096-0201	872.92	201.31	246	58.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			283.8	C08		7	0097-0202	306.87	201.56	294	63.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1068.2	C08		7	0098-0204	754.31	203.36	420	82.43	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			685.8	C08		7	0099-0203	239.40	202.95	291	63.60	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1780.4	C08		7	0100-0205	436.00	204.90	300	67.01	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			327.4	C08		7	0101-0207	892.77	207.98	246	57.36	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			653.5	C08		7	0102-0213	353.83	213.62	279	61.94	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			316.5	C08		7	0103-0214	850.75	214.10	297	67.01	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1847.0	C08		7	0104-0213	925.26	213.62	261	59.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			212.3	C08		7	0105-0216	140.33	216.11	277	61.60	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2145.6	C08		7	0106-0218	448.62	218.90	296	65.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			706.1	C08		7	0107-0217	547.32	216.90	235	56.53	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1333.1	C08		7	0108-0216	734.27	216.55	278	63.94	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1073.6	C08		7	0109-0222	203.83	221.45	318	67.36	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			601.0	C08		7	0110-0221	314.48	220.98	295	66.67	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			992.3	C08		7	0111-0222	394.80	221.93	308	66.18	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4177.7	C08		7	0112-0220	493.45	219.93	292	65.60	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			268.5	C08		7	0113-0225	124.54	226.17	266	61.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			302.6	C08		7	0114-0229	825.06	229.84	372	72.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1584.7	C08		7	0115-0228	613.49	228.12	286	63.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			338.6	C08		7	0116-0232	560.43	232.21	247	58.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			702.1	C08		7	0117-0229	686.19	229.62	305	68.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			734.6	C08		7	0118-0238	248.32	238.50	299	65.60	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			268.2	C08		7	0119-0243	123.31	242.39	241	58.87	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			200.2	C08		7	0120-0245	676.71	245.31	306	72.77	0.726
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			203.7	C08		7	0121-0250	341.73	250.33	328	67.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1289.7	C08		7	0122-0257	274.37	257.90	311	68.43	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1280.7	C08		7	0123-0259	512.98	259.48	298	67.94	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			418.2	C08		7	0124-0255	86.50	255.95	260	59.11	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			192.4	C08		7	0125-0257	381.59	257.67	288	62.53	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			287.2	C08		7	0126-0261	157.63	261.08	323	67.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4796.4	C08		7	0127-0261	480.12	261.93	293	64.18	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3576.9	C08		7	0128-0261	434.67	261.82	291	64.53	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			257.6	C08		7	0129-0267	177.11	266.96	476	83.84	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			241.4	C08		7	0130-0262	319.73	262.56	312	65.60	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			496.0	C08		7	0131-0262	908.50	262.01	260	61.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			250.9	C08		7	0132-0264	610.11	263.52	277	63.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			201.1	C08		7	0133-0266	633.45	266.54	293	63.94	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			360.7	C08		7	0134-0270	225.67	270.95	303	71.26	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2118.4	C08		7	0135-0275	848.09	274.96	591	103.05	0.699
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			331.5	C08		7	0136-0270	563.50	270.12	245	56.53	0.964
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1116.1	C08		7	0137-0273	923.56	272.85	264	62.28	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			319.3	C08		7	0138-0275	36.30	275.45	296	66.18	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3139.8	C08		7	0139-0276	74.24	275.93	249	65.46	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			800.7	C08		7	0140-0272	710.08	272.03	295	68.18	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			299.1	C08		7	0141-0279	875.73	278.69	210	55.94	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3805.5	C08		7	0142-0280	436.92	279.64	319	66.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			530.6	C08		7	0143-0283	376.15	283.21	297	65.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1450.5	C08		7	0144-0283	791.94	283.20	287	64.77	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1536.9	C08		7	0145-0284	394.43	284.19	285	62.53	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			275.6	C08		7	0146-0287	280.72	287.25	263	60.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			304.5	C08		7	0147-0290	884.23	291.40	239	57.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			219.6	C08		7	0148-0293	518.71	293.39	317	68.08	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3061.8	C08		7	0149-0291	610.49	291.17	303	66.53	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			249.1	C08		7	0150-0292	686.06	292.11	296	68.18	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			596.6	C08		7	0151-0296	263.56	296.73	307	108.71	0.326
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1939.4	C08		7	0152-0297	142.76	296.77	247	58.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			221.6	C08		7	0153-0298	700.97	298.74	265	63.36	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			206.4	C08		7	0154-0299	754.67	298.77	304	65.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			265.3	C08		7	0155-0304	472.50	304.34	414	76.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1877.6	C08		7	0156-0301	564.05	301.27	298	64.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			305.5	C08		7	0157-0305	335.27	304.40	377	72.67	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			237.9	C08		7	0158-0305	293.40	305.22	296	63.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			427.3	C08		7	0159-0303	409.14	303.46	295	64.28	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			360.8	C08		7	0160-0309	742.48	309.82	249	59.84	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			312.5	C08		7	0161-0313	442.94	313.73	318	65.60	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			183.3	C08		7	0162-0318	942.53	318.48	418	76.08	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			236.0	C08		7	0163-0322	870.12	321.84	473	82.43	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1149.8	C08		7	0164-0320	325.90	321.12	282	65.01	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1178.9	C08		7	0165-0318	74.38	317.81	250	58.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			630.4	C08		7	0166-0319	776.38	318.80	223	55.11	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			330.2	C08		7	0167-0321	384.45	321.54	317	67.01	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1208.3	C08		7	0168-0326	801.22	326.23	276	62.53	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1172.8	C08		7	0169-0326	100.75	325.66	233	55.94	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			873.1	C08		7	0170-0328	540.33	328.26	275	61.94	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2764.4	C08		7	0171-0325	618.90	325.47	308	69.11	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			229.6	C08		7	0172-0332	355.64	332.73	326	66.43	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			462.5	C08		7	0173-0333	827.91	332.60	260	61.94	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			508.6	C08		7	0174-0333	59.54	333.52	229	57.94	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			344.9	C08		7	0175-0340	679.98	340.54	324	70.28	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			212.8	C08		7	0176-0341	182.75	341.17	277	67.60	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			216.2	C08		7	0177-0337	234.22	337.39	279	65.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1485.4	C08		7	0178-0341	393.39	341.51	322	67.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			298.2	C08		7	0179-0344	273.12	344.76	273	60.53	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			235.1	C08		7	0180-0347	443.34	347.29	297	69.50	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1471.5	C08		7	0181-0345	903.28	345.78	250	58.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			428.3	C08		7	0182-0349	511.96	349.53	294	97.64	0.388
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1119.2	C08		7	0183-0352	834.55	351.67	322	68.18	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			456.0	C08		7	0184-0351	480.64	350.76	450	82.43	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			286.2	C08		7	0185-0349	596.52	349.28	272	61.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			317.6	C08		7	0186-0351	734.48	350.94	281	62.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			387.3	C08		7	0187-0354	21.01	354.39	300	63.36	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			222.4	C08		7	0188-0357	136.51	357.68	257	62.77	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			268.7	C08		7	0189-0363	277.83	363.11	282	65.36	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			756.6	C08		7	0190-0369	804.38	370.02	353	76.91	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			510.9	C08		7	0191-0370	623.76	369.67	290	63.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2374.1	C08		7	0192-0371	729.37	370.37	299	70.43	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3669.0	C08		7	0193-0371	883.25	370.76	286	62.18	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			307.9	C08		7	0194-0370	421.52	370.61	212	52.87	0.953
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			275.0	C08		7	0195-0373	440.77	372.81	369	71.94	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			792.1	C08		7	0196-0375	244.52	375.02	278	61.36	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			679.5	C08		7	0197-0386	779.94	386.38	519	100.33	0.648
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			694.3	C08		7	0198-0377	71.45	377.30	298	66.53	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			739.3	C08		7	0199-0381	358.69	381.63	304	67.26	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			250.0	C08		7	0200-0384	480.38	383.90	280	62.53	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2484.4	C08		7	0201-0383	594.58	383.38	302	67.36	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1302.8	C08		7	0202-0387	497.35	387.35	255	59.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			244.4	C08		7	0203-0388	159.68	388.14	279	64.18	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1168.7	C08		7	0204-0387	211.60	387.59	296	66.43	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			237.4	C08		7	0205-0389	307.95	388.57	241	57.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			224.6	C08		7	0206-0391	538.00	391.84	277	63.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			334.5	C08		7	0207-0391	340.85	392.48	347	75.50	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1666.1	C08		7	0208-0391	895.57	390.50	309	67.60	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1173.6	C08		7	0209-0392	273.69	392.24	311	66.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			363.4	C08		7	0210-0392	731.74	391.93	291	66.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			218.3	C08		7	0211-0394	685.93	394.07	333	70.43	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1067.1	C08		7	0212-0397	667.40	397.52	258	63.94	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			259.0	C08		7	0213-0399	588.90	399.42	299	66.77	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			156.8	C08		7	0214-0400	944.59	400.47	310	69.01	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			6984.8	C08		7	0215-0405	62.74	405.46	318	72.28	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			253.6	C08		7	0216-0403	315.97	403.96	284	64.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1769.7	C08		7	0217-0403	136.00	402.95	262	59.36	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1127.9	C08		7	0218-0405	648.86	405.48	283	64.18	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3501.8	C08		7	0219-0408	242.85	408.79	298	64.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1064.7	C08		7	0220-0407	454.24	407.57	291	63.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			603.9	C08		7	0221-0408	727.38	408.60	319	67.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1421.9	C08		7	0222-0413	806.08	413.94	299	65.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			250.3	C08		7	0223-0413	848.18	413.71	226	57.70	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			338.3	C08		7	0224-0424	158.66	424.24	430	77.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			348.6	C08		7	0225-0426	575.46	425.45	392	95.88	0.536
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			6436.2	C08		7	0226-0424	443.56	423.89	283	62.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			417.4	C08		7	0227-0428	70.13	428.66	468	82.77	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			947.6	C08		7	0228-0429	302.95	428.77	307	67.84	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			381.3	C08		7	0229-0433	604.50	433.16	423	82.33	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2356.2	C08		7	0230-0432	651.00	431.62	293	64.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1011.6	C08		7	0231-0429	917.79	429.61	133	42.87	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			928.7	C08		7	0232-0435	902.21	434.55	192	52.18	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			611.6	C08		7	0233-0439	201.66	439.00	288	64.18	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			333.6	C08		7	0234-0441	136.25	440.56	313	66.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1591.0	C08		7	0235-0451	551.08	451.54	738	125.30	0.591
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			9634.2	C08		7	0236-0447	733.50	447.24	319	66.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			294.7	C08		7	0237-0448	237.40	448.75	413	75.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			208.9	C08		7	0238-0451	171.67	451.56	290	65.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			10602.6	C08		7	0239-0452	50.62	451.91	266	63.94	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1520.6	C08		7	0240-0449	372.36	448.99	256	62.53	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			236.5	C08		7	0241-0451	479.06	451.16	238	58.18	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3622.1	C08		7	0242-0467	133.33	469.17	904	137.10	0.604
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			270.7	C08		7	0243-0458	493.89	458.38	335	69.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2603.2	C08		7	0244-0458	332.53	458.42	279	63.01	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			341.1	C08		7	0245-0460	632.80	460.02	261	66.43	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1030.6	C08		7	0246-0456	274.08	455.57	268	61.70	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1406.9	C08		7	0247-0458	414.12	457.91	197	52.28	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			561.7	C08		7	0248-0463	79.81	463.03	259	62.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1649.7	C08		7	0249-0468	822.05	468.25	531	87.15	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1505.9	C08		7	0250-0465	393.47	464.98	215	54.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			267.8	C08		7	0251-0465	800.97	465.27	182	52.04	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2202.5	C08		7	0252-0466	695.06	466.10	242	59.36	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			289.2	C08		7	0253-0468	778.09	468.76	311	67.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			271.7	C08		7	0254-0471	731.50	470.88	306	65.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			801.2	C08		7	0255-0481	682.59	481.48	527	94.08	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1021.9	C08		7	0256-0475	432.38	475.66	298	63.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2485.5	C08		7	0257-0476	888.40	476.51	278	63.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1019.3	C08		7	0258-0476	863.53	476.24	285	64.77	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3452.8	C08		7	0259-0479	615.49	479.10	308	65.84	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2562.9	C08		7	0260-0480	758.16	480.43	318	69.60	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			194.2	C08		7	0261-0489	489.59	489.12	471	81.26	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			687.6	C08		7	0262-0486	905.96	486.58	296	64.18	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			639.4	C08		7	0263-0490	579.07	489.41	186	57.60	0.705
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4003.2	C08		7	0264-0493	259.07	493.34	275	60.77	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			560.8	C08		7	0265-0497	773.89	497.11	282	64.77	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2258.8	C08		7	0266-0497	234.03	496.95	259	58.53	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			333.3	C08		7	0267-0502	658.63	502.20	266	60.18	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2404.6	C08		7	0268-0503	846.58	503.79	333	68.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1838.3	C08		7	0269-0506	122.20	506.82	276	62.53	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			746.6	C08		7	0270-0508	532.58	508.24	317	65.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1467.6	C08		7	0271-0513	340.54	511.95	653	107.40	0.711
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1685.8	C08		7	0272-0511	201.18	511.35	298	66.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1262.9	C08		7	0273-0509	374.99	510.00	260	58.77	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			661.9	C08		7	0274-0514	779.70	514.47	297	65.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1318.1	C08		7	0275-0514	163.92	514.24	276	63.60	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			333.9	C08		7	0276-0515	474.02	515.23	306	64.43	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1809.4	C08		7	0277-0520	285.23	519.48	281	66.43	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			518.1	C08		7	0278-0523	554.66	522.46	299	65.60	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1921.7	C08		7	0279-0527	595.61	527.94	333	69.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1337.8	C08		7	0280-0530	462.19	530.53	273	65.26	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1703.8	C08		7	0281-0531	50.04	531.24	281	65.01	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1240.2	C08		7	0282-0532	83.20	532.26	287	62.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			596.2	C08		7	0283-0538	235.20	538.13	469	80.08	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			391.0	C08		7	0284-0537	720.99	537.06	278	66.43	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			228.3	C08		7	0285-0537	643.63	536.71	328	67.84	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1109.6	C08		7	0286-0536	769.83	536.82	260	64.67	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1239.6	C08		7	0287-0539	187.08	539.05	290	69.50	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			383.0	C08		7	0288-0536	390.77	535.62	261	61.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5485.6	C08		7	0289-0539	914.20	540.18	320	67.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			255.7	C08		7	0290-0544	701.47	543.96	434	77.74	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1476.7	C08		7	0291-0544	12.36	544.12	314	67.84	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1765.0	C08		7	0292-0543	264.67	542.86	258	59.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			461.8	C08		7	0293-0551	298.73	551.61	248	58.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			6839.2	C08		7	0294-0551	213.99	551.36	300	65.70	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1619.2	C08		7	0295-0553	929.54	553.86	299	66.18	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			579.8	C08		7	0296-0558	801.50	557.38	377	72.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			211.4	C08		7	0297-0559	382.14	558.96	278	63.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			271.7	C08		7	0298-0561	350.08	560.94	292	64.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			692.2	C08		7	0299-0562	322.63	561.88	258	59.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1803.6	C08		7	0300-0563	518.11	563.04	271	61.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			462.5	C08		7	0301-0564	133.95	564.75	242	57.11	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			807.2	C08		7	0302-0569	241.13	569.70	307	67.01	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			281.1	C08		7	0303-0571	696.96	572.13	336	72.43	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			7904.2	C08		7	0304-0571	588.57	571.12	288	63.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			268.3	C08		7	0305-0579	282.97	579.38	397	73.60	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			397.6	C08		7	0306-0585	763.47	587.36	746	117.64	0.677
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1295.4	C08		7	0307-0579	94.84	579.64	289	64.43	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2324.1	C08		7	0308-0576	649.55	576.07	254	59.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			411.1	C08		7	0309-0583	415.09	583.38	302	67.94	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			240.9	C08		7	0310-0583	893.16	583.45	375	71.60	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			407.3	C08		7	0311-0584	615.58	583.79	264	60.77	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			606.2	C08		7	0312-0588	460.21	588.56	306	64.53	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			6011.5	C08		7	0313-0591	583.80	591.02	473	82.18	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4042.5	C08		7	0314-0595	538.06	595.67	433	77.01	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			251.4	C08		7	0315-0592	700.27	592.00	281	62.87	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			682.3	C08		7	0316-0599	945.31	598.79	258	64.43	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			241.2	C08		7	0317-0599	353.56	599.04	283	64.04	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			257.3	C08		7	0318-0605	336.14	604.94	412	78.18	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			510.9	C08		7	0319-0602	56.90	602.87	252	59.70	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			215.1	C08		7	0320-0606	399.11	607.57	277	63.11	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1373.8	C08		7	0321-0609	855.32	609.79	272	62.53	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			331.1	C08		7	0322-0613	636.26	612.94	273	64.77	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			594.4	C08		7	0323-0613	936.53	613.28	315	67.84	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			333.7	C08		7	0324-0612	678.10	613.04	256	60.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			374.1	C08		7	0325-0621	104.10	620.20	457	78.43	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			233.0	C08		7	0326-0623	291.51	624.26	627	100.91	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			365.3	C08		7	0327-0629	395.95	629.48	448	79.60	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1063.8	C08		7	0328-0628	572.60	628.89	290	62.77	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			306.7	C08		7	0329-0632	748.01	632.18	289	64.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			242.0	C08		7	0330-0636	776.79	636.68	256	60.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			516.0	C08		7	0331-0640	373.08	640.16	281	62.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			258.5	C08		7	0332-0647	710.25	648.24	283	65.60	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			206.4	C08		7	0333-0651	822.58	651.72	261	61.94	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			867.2	C08		7	0334-0652	204.53	653.05	300	64.18	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			440.2	C08		7	0335-0655	48.52	654.60	298	66.77	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2552.9	C08		7	0336-0658	138.48	657.73	287	62.77	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1138.9	C08		7	0337-0660	500.08	659.81	310	69.36	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			853.3	C08		7	0338-0659	631.58	659.79	261	60.87	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			819.8	C08		7	0339-0663	91.38	663.46	295	63.36	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			993.2	C08		7	0340-0661	302.24	661.91	258	61.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3438.8	C08		7	0341-0665	867.73	665.18	310	67.60	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			225.8	C08		7	0342-0670	424.56	670.17	396	75.84	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			343.8	C08		7	0343-0666	665.60	666.59	260	59.11	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			530.9	C08		7	0344-0668	699.28	668.58	267	61.94	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3056.5	C08		7	0345-0667	566.92	667.45	265	64.53	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			284.6	C08		7	0346-0674	186.53	673.98	438	80.18	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			279.3	C08		7	0347-0677	313.68	677.71	433	78.43	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			391.7	C08		7	0348-0676	807.34	676.26	246	58.18	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			807.7	C08		7	0349-0677	628.99	676.79	257	63.21	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1490.1	C08		7	0350-0679	645.06	678.65	325	71.94	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1723.1	C08		7	0351-0682	946.39	682.20	232	58.53	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			376.3	C08		7	0352-0684	666.11	684.21	246	57.70	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			259.3	C08		7	0353-0687	759.57	688.18	370	71.84	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			276.5	C08		7	0354-0687	736.92	686.21	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			798.3	C08		7	0355-0688	24.13	688.30	298	65.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			486.5	C08		7	0356-0691	252.88	690.83	430	77.26	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1507.2	C08		7	0357-0688	713.65	688.11	263	63.36	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			289.8	C08		7	0358-0693	469.47	692.93	302	67.70	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			755.5	C08		7	0359-0691	123.37	691.78	285	63.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			209.4	C08		7	0360-0698	43.62	698.59	290	65.60	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1495.7	C08		7	0361-0698	939.07	698.25	235	59.36	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1612.7	C08		7	0362-0700	533.23	700.56	301	65.60	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			334.7	C08		7	0363-0702	438.97	702.40	410	75.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1166.7	C08		7	0364-0702	374.62	702.30	278	61.36	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			250.6	C08		7	0365-0705	762.74	705.83	240	58.87	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			211.4	C08		7	0366-0710	613.25	710.49	186	53.36	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1031.3	C08		8	0001-0030	465.68	30.42	295	61.94	0.966
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			914.6	C08		8	0002-0031	547.19	30.38	278	62.18	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			598.1	C08		8	0003-0033	709.44	32.90	255	63.84	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			184.4	C08		8	0004-0033	33.60	33.54	273	64.77	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			335.0	C08		8	0005-0032	180.29	32.17	229	56.53	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			469.4	C08		8	0006-0032	778.32	31.86	180	51.11	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			185.5	C08		8	0007-0033	54.01	33.46	295	67.70	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			314.7	C08		8	0008-0033	231.55	33.54	264	59.11	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			218.1	C08		8	0009-0037	693.47	37.68	251	59.94	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3913.9	C08		8	0010-0039	522.67	38.53	294	65.94	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			840.9	C08		8	0011-0040	792.13	40.86	333	76.91	0.707
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			175.4	C08		8	0012-0042	311.06	41.33	294	65.26	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			404.0	C08		8	0013-0048	380.46	46.13	438	89.84	0.682
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			217.5	C08		8	0014-0045	501.66	45.04	449	78.67	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			359.8	C08		8	0015-0044	660.94	45.37	156	80.91	0.299
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			414.0	C08		8	0016-0054	712.35	54.21	264	66.18	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			222.2	C08		8	0017-0053	742.37	52.85	277	63.84	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1164.9	C08		8	0018-0056	837.09	55.92	164	55.11	0.679
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1763.6	C08		8	0019-0057	860.26	57.03	272	62.18	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			376.7	C08		8	0020-0059	448.63	59.29	134	60.18	0.465
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1041.4	C08		8	0021-0068	67.82	67.59	498	87.50	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			197.4	C08		8	0022-0064	909.20	64.16	300	67.36	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			344.0	C08		8	0023-0062	790.69	61.81	207	52.28	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			583.2	C08		8	0024-0063	121.72	63.89	242	57.36	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5478.0	C08		8	0025-0067	286.68	66.55	297	76.57	0.637
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			174.1	C08		8	0026-0067	591.04	66.94	314	70.77	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1311.2	C08		8	0027-0063	50.38	63.06	108	40.63	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			476.5	C08		8	0028-0074	188.81	72.64	695	116.23	0.647
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			184.1	C08		8	0029-0069	345.83	69.59	243	57.11	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			219.7	C08		8	0030-0071	848.67	70.96	252	61.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			724.5	C08		8	0031-0073	106.00	73.30	218	58.77	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			264.3	C08		8	0032-0080	165.89	77.84	532	95.36	0.735
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			181.3	C08		8	0033-0075	629.52	75.54	309	69.26	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			194.6	C08		8	0034-0073	932.67	73.63	278	64.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1376.3	C08		8	0035-0074	236.53	74.59	247	59.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			187.6	C08		8	0036-0081	544.67	81.33	299	68.43	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1742.9	C08		8	0037-0087	824.73	86.97	303	67.84	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1176.5	C08		8	0038-0086	481.64	86.30	296	64.67	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			227.3	C08		8	0039-0086	319.20	85.87	282	62.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			208.6	C08		8	0040-0089	665.56	89.80	432	80.67	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			662.7	C08		8	0041-0100	83.83	100.10	294	64.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			318.6	C08		8	0042-0100	227.32	99.74	258	63.36	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			228.7	C08		8	0043-0099	773.95	99.27	234	56.87	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1686.3	C08		8	0044-0100	367.51	100.60	291	65.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			340.7	C08		8	0045-0100	757.50	100.78	259	58.87	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			225.2	C08		8	0046-0108	581.33	108.58	288	65.01	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2861.7	C08		8	0047-0110	902.90	110.16	303	64.18	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			222.5	C08		8	0048-0110	821.66	109.99	266	61.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			312.4	C08		8	0049-0111	720.99	110.99	228	55.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1004.0	C08		8	0050-0117	19.36	117.48	250	58.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			419.1	C08		8	0051-0122	401.85	120.99	617	103.15	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2149.6	C08		8	0052-0117	602.92	117.43	243	58.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2884.4	C08		8	0053-0117	536.09	116.93	268	61.94	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			6078.1	C08		8	0054-0123	645.10	123.14	239	57.36	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1344.3	C08		8	0055-0126	433.22	126.58	256	59.36	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1790.5	C08		8	0056-0125	475.67	125.87	307	65.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			450.1	C08		8	0057-0131	104.76	131.71	320	68.43	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			848.6	C08		8	0058-0129	288.05	129.53	218	55.11	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			483.7	C08		8	0059-0135	847.79	134.33	444	84.91	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			810.6	C08		8	0060-0132	811.21	132.13	224	56.63	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			548.0	C08		8	0061-0135	207.21	134.94	252	61.36	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			981.8	C08		8	0062-0138	798.43	138.91	261	64.28	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			222.6	C08		8	0063-0140	527.91	140.89	280	63.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			192.0	C08		8	0064-0142	711.25	142.30	314	70.43	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1291.3	C08		8	0065-0142	375.28	142.34	231	56.28	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			708.5	C08		8	0066-0143	476.59	142.54	270	62.53	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			308.2	C08		8	0067-0148	775.29	148.00	280	62.18	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4558.7	C08		8	0068-0152	124.19	152.91	275	63.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			302.1	C08		8	0069-0148	299.03	147.82	247	59.70	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1311.0	C08		8	0070-0152	814.13	152.03	197	51.70	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			400.3	C08		8	0071-0155	675.60	155.47	270	63.60	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			352.7	C08		8	0072-0155	741.61	154.87	253	59.94	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			189.7	C08		8	0073-0159	614.15	159.31	289	65.70	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			305.0	C08		8	0074-0158	355.70	157.95	353	69.01	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			205.4	C08		8	0075-0158	72.97	157.87	271	61.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1722.0	C08		8	0076-0166	468.52	166.65	303	69.60	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			518.8	C08		8	0077-0171	52.32	171.42	447	79.50	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			929.4	C08		8	0078-0173	161.92	173.06	261	61.36	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			280.0	C08		8	0079-0173	222.76	173.00	257	59.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1866.0	C08		8	0080-0169	397.95	169.91	274	67.94	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			406.0	C08		8	0081-0172	449.89	172.11	212	55.70	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			204.8	C08		8	0082-0176	674.84	176.11	285	66.18	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			383.4	C08		8	0083-0184	538.83	184.41	214	56.53	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			478.8	C08		8	0084-0186	105.76	186.28	271	60.18	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			699.6	C08		8	0085-0190	896.93	190.67	512	89.74	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			222.5	C08		8	0086-0197	328.77	196.94	376	71.60	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			334.8	C08		8	0087-0194	398.31	194.01	237	58.18	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			239.3	C08		8	0088-0198	481.48	198.28	282	64.53	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			217.3	C08		8	0089-0200	669.44	199.84	309	70.18	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1459.3	C08		8	0090-0199	286.00	199.11	279	63.36	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			296.6	C08		8	0091-0199	513.10	198.22	311	69.11	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			269.8	C08		8	0092-0203	773.71	202.19	159	50.18	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			818.9	C08		8	0093-0208	848.75	208.73	304	70.91	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			241.1	C08		8	0094-0208	385.94	208.71	392	80.33	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			245.2	C08		8	0095-0210	762.42	209.98	316	75.74	0.692
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			264.3	C08		8	0096-0210	784.83	210.44	120	41.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1454.4	C08		8	0097-0214	718.57	214.37	222	59.36	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1912.4	C08		8	0098-0215	30.22	215.69	254	59.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			209.1	C08		8	0099-0214	509.59	215.05	284	65.36	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			307.2	C08		8	0100-0221	901.61	221.67	392	74.67	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			219.5	C08		8	0101-0219	401.57	219.53	273	63.01	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1640.2	C08		8	0102-0227	600.21	227.79	229	56.53	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			8454.7	C08		8	0103-0228	180.24	228.63	265	62.77	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4246.7	C08		8	0104-0232	123.88	234.13	341	79.26	0.682
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			228.2	C08		8	0105-0230	684.46	229.47	250	59.70	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			506.4	C08		8	0106-0230	821.39	229.68	262	60.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			770.2	C08		8	0107-0228	846.38	228.77	224	55.36	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			351.8	C08		8	0108-0235	216.03	234.74	373	71.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2403.7	C08		8	0109-0233	263.29	233.49	159	47.46	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2084.4	C08		8	0110-0241	702.98	240.60	210	55.94	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			223.6	C08		8	0111-0244	483.81	244.58	343	71.01	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			224.4	C08		8	0112-0247	651.99	247.34	454	81.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			243.7	C08		8	0113-0246	183.27	246.76	242	59.46	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			777.6	C08		8	0114-0247	567.50	246.42	307	65.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2342.7	C08		8	0115-0248	622.51	248.87	293	63.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1205.2	C08		8	0116-0251	64.62	250.71	270	66.67	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5958.0	C08		8	0117-0252	339.09	252.28	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			277.5	C08		8	0118-0252	746.86	252.39	370	71.26	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1023.0	C08		8	0119-0253	909.42	252.76	302	68.18	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			584.1	C08		8	0120-0256	927.02	256.12	338	72.18	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			264.9	C08		8	0121-0257	507.86	257.96	460	79.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			277.2	C08		8	0122-0257	775.18	257.04	242	57.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			882.8	C08		8	0123-0263	113.49	262.03	264	61.26	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			468.7	C08		8	0124-0265	13.44	264.14	247	61.60	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5026.9	C08		8	0125-0266	570.91	266.69	224	54.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			207.1	C08		8	0126-0270	431.50	270.56	276	63.36	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			489.9	C08		8	0127-0271	642.41	271.75	266	63.11	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1149.1	C08		8	0128-0275	28.09	274.67	247	61.36	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4602.0	C08		8	0129-0273	96.59	273.71	293	71.15	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			275.2	C08		8	0130-0278	177.48	278.78	258	61.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			869.2	C08		8	0131-0275	348.47	275.37	282	62.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1251.3	C08		8	0132-0282	790.68	282.00	280	63.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5226.0	C08		8	0133-0280	616.38	280.19	218	54.53	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1712.6	C08		8	0134-0286	411.59	286.65	516	86.43	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1066.0	C08		8	0135-0289	593.91	290.18	522	96.33	0.707
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			217.6	C08		8	0136-0291	657.83	291.43	401	77.60	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			689.0	C08		8	0137-0292	198.52	292.19	254	62.77	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4043.1	C08		8	0138-0291	503.11	291.22	264	61.36	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			797.7	C08		8	0139-0293	169.12	293.03	223	57.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2529.8	C08		8	0140-0296	858.63	296.66	278	65.70	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			213.4	C08		8	0141-0296	473.07	295.39	310	66.43	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			360.3	C08		8	0142-0296	631.22	296.87	243	59.94	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			368.9	C08		8	0143-0300	872.90	300.22	285	64.87	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			729.7	C08		8	0144-0300	97.94	300.00	282	66.18	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2073.0	C08		8	0145-0308	702.25	308.18	503	88.43	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			589.6	C08		8	0146-0309	152.79	309.85	475	88.57	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			197.0	C08		8	0147-0310	280.31	309.79	416	77.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			451.1	C08		8	0148-0310	386.42	309.73	244	58.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1679.4	C08		8	0149-0309	745.08	308.93	281	62.18	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2419.9	C08		8	0150-0315	216.42	314.77	287	65.60	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			192.3	C08		8	0151-0320	47.35	320.46	420	75.26	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			250.9	C08		8	0152-0320	593.64	319.21	252	59.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4550.0	C08		8	0153-0325	528.95	325.66	304	66.77	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2223.6	C08		8	0154-0325	422.95	324.32	285	64.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1010.3	C08		8	0155-0325	910.94	325.64	306	67.84	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			173.9	C08		8	0156-0327	98.64	326.80	373	76.08	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			426.0	C08		8	0157-0326	326.66	326.76	238	58.18	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4109.4	C08		8	0158-0337	772.26	337.59	305	66.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			557.2	C08		8	0159-0341	818.10	341.48	280	65.01	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			661.4	C08		8	0160-0339	871.33	338.94	242	59.11	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1056.9	C08		8	0161-0345	115.39	344.75	275	62.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			455.9	C08		8	0162-0348	525.87	348.58	366	73.84	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4151.8	C08		8	0163-0345	711.92	344.44	249	59.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1968.0	C08		8	0164-0352	559.11	352.20	276	61.94	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1512.9	C08		8	0165-0351	597.71	351.17	268	60.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2237.2	C08		8	0166-0352	682.45	351.91	255	62.77	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			985.8	C08		8	0167-0352	731.46	352.60	283	62.18	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			381.1	C08		8	0168-0359	263.84	359.46	487	88.91	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			236.0	C08		8	0169-0354	210.23	354.93	263	59.60	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			747.1	C08		8	0170-0356	631.68	356.32	268	61.11	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			850.0	C08		8	0171-0356	355.10	356.18	258	59.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2984.7	C08		8	0172-0357	416.89	357.57	307	70.43	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			333.4	C08		8	0173-0357	925.03	357.68	273	61.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			760.6	C08		8	0174-0361	468.53	360.83	292	64.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			301.3	C08		8	0175-0362	649.11	362.38	323	69.60	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			473.5	C08		8	0176-0365	171.66	365.70	227	55.70	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1003.2	C08		8	0177-0365	288.04	365.90	287	67.60	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			351.4	C08		8	0178-0366	59.86	366.56	248	58.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			265.5	C08		8	0179-0380	760.61	380.58	357	70.18	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2391.5	C08		8	0180-0380	811.00	379.21	217	55.01	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			245.5	C08		8	0181-0383	196.62	383.55	280	62.18	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			255.1	C08		8	0182-0384	217.55	384.18	269	61.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			376.3	C08		8	0183-0383	334.32	383.75	119	50.04	0.597
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2024.2	C08		8	0184-0389	824.12	389.42	309	65.11	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1172.3	C08		8	0185-0388	948.43	389.19	264	59.70	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			618.3	C08		8	0186-0396	578.23	395.14	311	67.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			573.6	C08		8	0187-0396	492.26	397.89	297	69.84	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1672.2	C08		8	0188-0398	874.23	398.40	276	62.77	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			480.1	C08		8	0189-0402	378.12	401.83	338	72.67	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1645.8	C08		8	0190-0397	921.02	397.62	284	63.01	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			809.7	C08		8	0191-0401	295.72	402.10	276	61.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			210.2	C08		8	0192-0402	49.43	402.45	275	65.60	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3098.6	C08		8	0193-0404	558.15	404.14	249	59.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			465.4	C08		8	0194-0404	725.10	404.57	103	63.50	0.321
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			303.8	C08		8	0195-0418	319.07	417.56	255	60.28	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			294.0	C08		8	0196-0418	390.15	417.76	412	76.08	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			195.6	C08		8	0197-0420	245.09	420.66	268	64.43	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			350.3	C08		8	0198-0420	684.61	420.01	187	50.53	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1068.9	C08		8	0199-0423	613.93	423.00	244	58.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1239.6	C08		8	0200-0424	562.83	424.34	275	60.77	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			476.0	C08		8	0201-0426	180.00	427.29	275	63.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			471.0	C08		8	0202-0426	827.92	426.59	247	57.70	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			583.7	C08		8	0203-0432	147.17	431.93	238	57.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			189.7	C08		8	0204-0434	261.57	433.98	293	67.94	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			180.8	C08		8	0205-0437	846.62	437.04	304	67.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1259.1	C08		8	0206-0442	340.32	442.00	273	63.36	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			333.4	C08		8	0207-0440	699.29	439.71	234	55.94	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			776.1	C08		8	0208-0442	417.13	442.32	230	56.28	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			269.6	C08		8	0209-0444	718.59	444.25	348	69.60	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1044.1	C08		8	0210-0444	545.86	444.24	272	61.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1925.1	C08		8	0211-0445	458.64	445.50	258	59.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3907.5	C08		8	0212-0448	868.82	448.96	248	59.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1365.3	C08		8	0213-0449	925.97	448.03	219	57.11	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3072.8	C08		8	0214-0453	372.89	453.38	318	70.67	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1305.9	C08		8	0215-0453	608.77	452.64	278	62.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			587.6	C08		8	0216-0458	565.00	458.24	488	82.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			692.2	C08		8	0217-0461	64.26	460.83	476	83.74	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			200.7	C08		8	0218-0461	387.49	461.48	279	63.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			369.5	C08		8	0219-0460	837.21	459.77	248	58.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1622.1	C08		8	0220-0461	921.28	462.13	248	62.77	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			203.9	C08		8	0221-0462	256.23	461.92	220	54.53	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			242.4	C08		8	0222-0461	282.52	461.62	206	54.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			456.4	C08		8	0223-0463	668.71	463.60	263	64.18	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1022.6	C08		8	0224-0467	319.69	467.01	282	63.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2585.9	C08		8	0225-0464	804.55	463.14	229	56.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2769.6	C08		8	0226-0471	787.93	471.14	285	63.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			282.4	C08		8	0227-0477	149.23	477.60	560	102.57	0.669
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			639.2	C08		8	0228-0474	640.90	473.26	224	54.53	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			223.5	C08		8	0229-0477	425.01	478.02	269	62.18	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			283.7	C08		8	0230-0478	292.01	479.06	271	64.53	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			363.5	C08		8	0231-0481	678.51	481.71	247	59.11	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			343.2	C08		8	0232-0479	711.23	479.80	241	57.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			426.3	C08		8	0233-0479	902.02	479.72	270	60.53	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			372.1	C08		8	0234-0481	941.03	481.25	232	57.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			551.0	C08		8	0235-0484	211.36	483.62	105	43.11	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			560.6	C08		8	0236-0487	201.58	488.12	131	48.53	0.699
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1062.8	C08		8	0237-0487	269.16	487.87	231	58.53	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			793.2	C08		8	0238-0489	620.16	488.89	288	65.11	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			292.2	C08		8	0239-0492	554.03	492.40	349	70.67	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			221.1	C08		8	0240-0491	365.53	491.03	225	56.18	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			236.3	C08		8	0241-0500	171.28	499.87	344	68.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			717.7	C08		8	0242-0498	716.02	498.20	226	60.43	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			307.6	C08		8	0243-0497	109.61	497.63	238	59.60	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1037.6	C08		8	0244-0500	238.91	501.10	239	58.87	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			263.7	C08		8	0245-0502	380.62	502.20	268	63.01	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			716.2	C08		8	0246-0507	930.95	506.66	409	77.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1297.9	C08		8	0247-0504	625.16	504.98	238	60.28	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			532.6	C08		8	0248-0503	273.40	503.05	238	58.28	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			186.6	C08		8	0249-0514	89.34	515.12	507	91.15	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			419.9	C08		8	0250-0509	438.00	509.74	255	58.53	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			539.5	C08		8	0251-0510	696.79	510.30	311	66.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			293.3	C08		8	0252-0512	878.28	512.44	244	59.46	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			289.5	C08		8	0253-0514	310.30	513.18	186	51.70	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1380.7	C08		8	0254-0515	201.80	515.64	228	56.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2015.5	C08		8	0255-0517	759.40	516.79	294	64.67	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1337.9	C08		8	0256-0519	811.58	519.44	486	87.98	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			200.5	C08		8	0257-0516	596.04	516.40	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			457.8	C08		8	0258-0520	237.04	519.50	330	71.11	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			516.6	C08		8	0259-0522	253.68	522.36	228	59.11	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			263.1	C08		8	0260-0523	488.73	522.70	295	62.77	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			376.8	C08		8	0261-0524	661.48	523.87	227	55.70	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			453.6	C08		8	0262-0527	742.40	526.95	260	60.43	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			472.3	C08		8	0263-0530	876.58	529.37	283	62.77	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			228.6	C08		8	0264-0532	356.26	532.79	284	62.53	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			266.8	C08		8	0265-0533	279.96	532.58	250	58.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			433.7	C08		8	0266-0533	631.26	533.79	257	59.60	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			496.3	C08		8	0267-0540	312.82	539.80	275	63.11	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			207.6	C08		8	0268-0544	136.31	544.19	542	91.15	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5773.4	C08		8	0269-0542	19.31	542.57	283	65.01	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			272.6	C08		8	0270-0541	710.78	541.56	213	55.11	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			351.5	C08		8	0271-0547	528.35	547.46	266	63.60	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			271.0	C08		8	0272-0547	659.37	547.28	221	55.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			229.0	C08		8	0273-0548	340.98	548.12	299	66.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			353.2	C08		8	0274-0551	158.34	550.80	237	57.70	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			435.2	C08		8	0275-0558	593.14	559.17	376	84.43	0.663
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			204.2	C08		8	0276-0557	882.02	557.74	446	77.60	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1719.9	C08		8	0277-0555	34.35	555.92	277	66.43	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			233.8	C08		8	0278-0558	212.69	558.00	294	64.53	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			236.4	C08		8	0279-0556	618.51	556.04	242	56.53	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			230.5	C08		8	0280-0557	686.65	556.60	238	59.60	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			297.4	C08		8	0281-0560	179.36	560.21	253	62.77	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			345.1	C08		8	0282-0558	246.73	557.92	240	58.77	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			201.1	C08		8	0283-0562	830.98	562.33	447	79.26	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			609.3	C08		8	0284-0566	803.90	565.85	314	66.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			200.6	C08		8	0285-0569	497.77	569.36	276	64.53	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1224.9	C08		8	0286-0567	759.84	567.25	272	63.01	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			412.8	C08		8	0287-0569	119.71	570.06	268	63.94	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			225.7	C08		8	0288-0571	461.61	571.35	266	61.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			821.1	C08		8	0289-0580	59.92	580.69	231	56.87	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1135.7	C08		8	0290-0579	303.55	579.25	251	58.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			364.2	C08		8	0291-0579	624.67	579.37	252	58.53	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			332.4	C08		8	0292-0583	361.19	583.79	256	61.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			223.2	C08		8	0293-0587	654.64	588.15	349	74.33	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			194.7	C08		8	0294-0589	456.73	589.69	307	70.18	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			528.2	C08		8	0295-0586	529.34	586.84	286	61.94	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			508.0	C08		8	0296-0586	117.58	586.24	206	54.97	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			493.9	C08		8	0297-0596	295.90	596.50	237	62.77	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			507.6	C08		8	0298-0593	868.74	593.33	202	51.70	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			762.9	C08		8	0299-0601	50.38	600.85	254	64.43	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			305.0	C08		8	0300-0599	701.52	599.57	413	75.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			836.7	C08		8	0301-0598	843.25	598.26	291	64.67	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			802.9	C08		8	0302-0600	63.45	600.21	210	57.46	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			387.9	C08		8	0303-0602	559.38	602.13	283	63.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4228.5	C08		8	0304-0602	185.08	602.33	240	61.01	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			225.2	C08		8	0305-0601	405.74	600.46	280	65.70	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			498.9	C08		8	0306-0605	120.49	605.06	281	62.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			216.5	C08		8	0307-0607	825.57	607.00	248	58.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			279.2	C08		8	0308-0611	359.21	612.16	250	61.94	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			520.6	C08		8	0309-0610	721.85	609.54	302	65.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			198.8	C08		8	0310-0613	943.88	612.85	291	65.60	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			656.1	C08		8	0311-0615	41.12	614.97	308	69.50	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			249.9	C08		8	0312-0615	239.39	614.86	257	61.70	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			152.6	C08		8	0313-0616	916.21	616.39	283	64.08	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1892.7	C08		8	0314-0618	207.71	618.12	223	60.77	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			997.6	C08		8	0315-0617	761.84	618.20	286	63.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			972.5	C08		8	0316-0618	306.06	618.28	239	56.53	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			415.9	C08		8	0317-0620	588.43	620.73	279	62.43	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			316.9	C08		8	0318-0622	404.32	622.59	304	64.18	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			523.3	C08		8	0319-0629	517.58	629.12	284	63.84	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			209.5	C08		8	0320-0632	459.52	631.89	370	71.84	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			231.0	C08		8	0321-0636	76.39	636.01	364	70.18	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			288.3	C08		8	0322-0637	110.24	637.03	317	65.36	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			400.4	C08		8	0323-0640	879.84	640.53	526	93.74	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			250.0	C08		8	0324-0639	391.61	638.97	319	68.18	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			230.4	C08		8	0325-0643	248.85	643.59	323	70.43	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			989.0	C08		8	0326-0645	505.10	645.84	306	66.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			200.2	C08		8	0327-0645	768.94	645.84	266	62.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			259.9	C08		8	0328-0651	671.28	651.61	246	60.18	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2424.4	C08		8	0329-0653	706.64	652.08	543	92.91	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			674.8	C08		8	0330-0654	300.37	654.17	247	58.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			172.5	C08		8	0331-0656	925.47	655.80	301	68.08	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			215.3	C08		8	0332-0656	362.05	656.09	299	64.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2396.6	C08		8	0333-0658	141.52	658.42	252	70.67	0.634
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			290.7	C08		8	0334-0658	97.64	658.60	267	61.94	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			202.9	C08		8	0335-0662	326.33	662.00	309	69.01	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			199.2	C08		8	0336-0664	412.07	664.33	320	67.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			679.6	C08		8	0337-0663	542.20	662.74	269	62.53	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			995.4	C08		8	0338-0671	679.72	670.55	583	99.98	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			317.8	C08		8	0339-0670	559.96	669.94	306	65.94	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			278.9	C08		8	0340-0671	522.06	670.94	257	60.53	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			191.2	C08		8	0341-0676	839.62	675.96	277	64.43	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			152.9	C08		8	0342-0677	592.10	676.95	301	64.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			218.9	C08		8	0343-0681	426.87	681.11	257	61.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			511.5	C08		8	0344-0680	825.91	680.22	200	55.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			269.5	C08		8	0345-0681	496.51	681.74	226	55.94	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2044.5	C08		8	0346-0684	50.65	684.36	234	58.53	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			225.4	C08		8	0347-0689	254.18	690.21	283	64.43	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			184.6	C08		8	0348-0688	868.57	687.80	244	57.70	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2695.3	C08		8	0349-0690	188.82	689.63	237	57.70	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			167.8	C08		8	0350-0690	937.26	690.82	252	61.11	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			609.6	C08		8	0351-0694	901.66	693.47	276	65.60	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			177.6	C08		8	0352-0701	762.65	700.30	321	72.77	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1679.9	C08		8	0353-0700	43.43	700.32	233	61.01	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3340.5	C08		8	0354-0703	119.57	703.64	249	58.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			168.9	C08		8	0355-0705	520.70	705.43	283	62.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2522.4	C08		8	0356-0706	389.73	707.25	207	55.94	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			6593.2	C08		8	0357-0707	328.37	707.55	294	67.70	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			613.7	C08		9	0001-0024	161.85	25.29	246	59.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			946.8	C08		9	0002-0035	665.72	35.66	214	57.11	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			462.6	C08		9	0003-0039	312.75	39.43	433	76.67	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2545.4	C08		9	0004-0037	420.03	37.46	346	69.01	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			720.8	C08		9	0005-0040	374.47	40.18	320	66.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			257.1	C08		9	0006-0045	820.05	45.39	381	73.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			905.5	C08		9	0007-0047	72.02	46.73	268	64.18	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			746.0	C08		9	0008-0049	676.39	49.76	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			327.9	C08		9	0009-0050	207.06	50.12	309	65.01	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			246.4	C08		9	0010-0052	170.76	52.19	245	58.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			206.2	C08		9	0011-0055	511.16	55.20	391	73.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1199.6	C08		9	0012-0055	553.62	56.11	265	61.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1831.7	C08		9	0013-0056	84.67	55.33	253	63.60	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			208.2	C08		9	0014-0060	764.20	59.77	410	76.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			500.3	C08		9	0015-0057	111.31	57.22	247	63.94	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1191.9	C08		9	0016-0063	641.28	63.47	291	67.11	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2788.2	C08		9	0017-0063	618.58	62.86	295	65.70	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			249.7	C08		9	0018-0066	660.27	66.16	281	62.18	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			395.3	C08		9	0019-0065	260.89	65.33	267	59.94	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			232.7	C08		9	0020-0065	919.29	65.62	278	62.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			261.2	C08		9	0021-0068	834.44	67.84	321	68.43	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3195.7	C08		9	0022-0074	466.68	74.75	307	65.11	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			192.6	C08		9	0023-0076	27.12	76.64	262	61.60	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			210.4	C08		9	0024-0077	188.25	77.36	293	67.01	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			216.0	C08		9	0025-0078	237.21	78.41	255	61.01	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			530.2	C08		9	0026-0083	329.86	83.01	316	70.08	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			266.7	C08		9	0027-0090	387.72	90.27	630	94.81	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1980.2	C08		9	0028-0084	822.71	84.46	238	56.77	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			810.7	C08		9	0029-0087	949.16	87.00	283	63.01	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			259.4	C08		9	0030-0088	499.50	88.20	272	61.36	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			507.3	C08		9	0031-0095	273.32	94.68	232	57.60	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			225.5	C08		9	0032-0099	837.52	99.21	297	64.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			614.0	C08		9	0033-0103	732.27	102.56	218	57.36	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			200.8	C08		9	0034-0103	439.24	102.90	295	65.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			991.0	C08		9	0035-0104	717.93	103.97	242	57.70	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			370.4	C08		9	0036-0107	610.82	107.38	251	58.28	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			415.6	C08		9	0037-0108	762.14	108.40	290	63.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			243.0	C08		9	0038-0114	213.27	114.06	257	59.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1311.8	C08		9	0039-0119	68.38	119.09	248	64.87	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			339.8	C08		9	0040-0120	50.66	120.43	362	73.36	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			396.6	C08		9	0041-0121	287.36	120.29	279	61.11	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			281.7	C08		9	0042-0121	647.54	121.67	265	61.11	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			726.3	C08		9	0043-0121	943.79	120.02	245	59.94	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			432.1	C08		9	0044-0122	243.16	121.57	263	83.50	0.474
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1316.1	C08		9	0045-0124	862.97	124.53	312	66.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			514.9	C08		9	0046-0126	496.69	125.44	297	64.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			519.7	C08		9	0047-0131	422.92	130.66	210	55.01	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5700.2	C08		9	0048-0130	383.67	130.77	198	53.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			655.9	C08		9	0049-0133	667.11	133.29	248	58.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			742.0	C08		9	0050-0138	68.40	138.48	334	74.77	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			275.3	C08		9	0051-0142	113.99	141.80	371	73.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			399.4	C08		9	0052-0142	192.16	141.80	284	66.67	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			431.5	C08		9	0053-0140	302.18	140.57	275	62.04	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			483.6	C08		9	0054-0143	433.34	143.34	286	62.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			274.3	C08		9	0055-0141	733.55	141.16	244	57.36	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2499.5	C08		9	0056-0142	885.59	142.48	299	63.84	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			350.1	C08		9	0057-0139	772.04	139.76	219	54.87	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			370.5	C08		9	0058-0145	230.77	145.19	399	73.01	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			373.5	C08		9	0059-0147	345.61	146.60	335	67.84	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1044.6	C08		9	0060-0146	132.54	146.26	261	61.94	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2150.3	C08		9	0061-0159	616.86	156.80	390	84.91	0.680
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			316.4	C08		9	0062-0152	166.12	151.85	223	57.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2088.8	C08		9	0063-0153	634.50	153.00	116	38.97	0.960
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1716.5	C08		9	0064-0156	770.74	155.75	343	68.87	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			426.3	C08		9	0065-0156	449.47	155.91	231	55.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			296.3	C08		9	0066-0156	302.96	155.49	244	60.28	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			241.8	C08		9	0067-0162	490.83	162.58	358	71.26	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			284.8	C08		9	0068-0165	572.41	165.15	422	76.18	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			413.0	C08		9	0069-0166	807.34	166.84	302	69.60	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4541.8	C08		9	0070-0170	532.91	170.34	246	59.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			252.9	C08		9	0071-0173	140.65	173.84	242	57.70	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			332.6	C08		9	0072-0177	414.21	176.85	464	80.67	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4702.2	C08		9	0073-0177	251.09	177.59	287	62.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			862.3	C08		9	0074-0177	660.80	177.44	227	56.53	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1525.2	C08		9	0075-0182	827.81	182.46	333	68.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			338.0	C08		9	0076-0186	396.07	188.05	451	86.67	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			845.6	C08		9	0077-0185	750.71	185.11	320	66.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			779.1	C08		9	0078-0184	456.37	184.52	346	75.84	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3463.0	C08		9	0079-0186	559.50	186.39	310	65.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			261.8	C08		9	0080-0189	116.64	189.13	234	55.94	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			203.5	C08		9	0081-0188	167.35	187.41	309	70.53	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			474.2	C08		9	0082-0191	520.39	190.47	422	77.84	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			926.7	C08		9	0083-0192	77.49	191.97	280	63.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5121.2	C08		9	0084-0193	187.40	192.97	270	61.94	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1686.0	C08		9	0085-0191	902.35	191.72	342	71.11	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			241.6	C08		9	0086-0196	324.22	196.80	336	67.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			266.8	C08		9	0087-0199	842.93	200.02	236	57.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			327.2	C08		9	0088-0210	372.57	210.16	458	81.84	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1872.1	C08		9	0089-0206	233.49	206.79	240	58.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2903.0	C08		9	0090-0207	900.41	206.94	299	67.70	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			217.6	C08		9	0091-0211	734.28	211.95	285	63.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			214.1	C08		9	0092-0214	251.54	213.93	326	72.77	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			788.8	C08		9	0093-0211	773.03	210.77	302	64.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			902.6	C08		9	0094-0219	463.37	219.42	274	64.53	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			506.0	C08		9	0095-0217	682.78	217.22	230	57.36	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1027.7	C08		9	0096-0219	500.76	219.35	234	57.70	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			317.7	C08		9	0097-0222	127.39	221.66	282	63.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			592.7	C08		9	0098-0220	637.31	220.35	277	61.36	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			251.1	C08		9	0099-0221	78.75	221.20	239	62.18	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			659.1	C08		9	0100-0222	206.90	222.08	262	62.18	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			791.9	C08		9	0101-0227	722.82	226.89	261	63.36	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			523.0	C08		9	0102-0224	928.66	223.68	354	71.01	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			254.1	C08		9	0103-0227	522.97	227.72	319	67.36	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			454.4	C08		9	0104-0238	321.22	237.77	481	81.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1194.3	C08		9	0105-0231	741.47	231.83	261	62.87	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			271.2	C08		9	0106-0236	137.63	236.28	389	72.43	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1297.9	C08		9	0107-0237	777.38	237.02	324	69.01	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2090.5	C08		9	0108-0238	853.32	238.03	340	72.08	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3066.0	C08		9	0109-0238	916.87	238.35	294	65.70	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			274.7	C08		9	0110-0240	623.11	240.28	311	65.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			496.0	C08		9	0111-0243	71.18	243.47	298	66.77	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			335.6	C08		9	0112-0247	451.64	247.20	263	59.36	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			191.9	C08		9	0113-0247	227.38	246.53	271	60.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			275.4	C08		9	0114-0252	290.88	251.22	323	68.08	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			7457.8	C08		9	0115-0251	178.20	251.43	263	58.53	0.965
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			332.9	C08		9	0116-0252	539.18	251.95	102	77.98	0.211
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			586.8	C08		9	0117-0259	21.87	259.08	306	69.01	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			928.1	C08		9	0118-0257	148.94	257.02	237	57.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1256.8	C08		9	0119-0257	338.39	257.67	235	56.53	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			291.5	C08		9	0120-0259	806.27	259.06	291	63.11	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			267.1	C08		9	0121-0263	711.79	263.00	343	70.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			240.6	C08		9	0122-0264	280.54	265.02	288	64.08	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1350.3	C08		9	0123-0260	430.89	259.94	241	60.53	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			227.6	C08		9	0124-0264	683.93	264.17	260	60.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			248.6	C08		9	0125-0264	875.82	264.11	313	68.18	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1192.1	C08		9	0126-0271	96.00	269.37	542	99.15	0.693
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			293.8	C08		9	0127-0266	851.68	266.28	250	60.18	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			475.2	C08		9	0128-0268	651.45	267.92	241	61.01	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			417.2	C08		9	0129-0269	616.96	268.57	313	66.77	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			967.5	C08		9	0130-0270	215.06	270.05	331	70.18	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			219.3	C08		9	0131-0275	124.19	275.22	276	64.18	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			272.9	C08		9	0132-0276	434.10	275.58	263	61.11	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1238.5	C08		9	0133-0277	320.08	277.26	241	59.36	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			198.4	C08		9	0134-0281	232.65	281.28	261	61.11	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			257.2	C08		9	0135-0284	345.92	284.36	258	59.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			489.0	C08		9	0136-0289	67.16	289.77	297	68.18	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			222.5	C08		9	0137-0288	931.47	288.01	293	65.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			780.3	C08		9	0138-0291	169.84	291.45	302	65.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			10668.4	C08		9	0139-0293	132.68	292.15	267	64.53	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1234.2	C08		9	0140-0292	731.38	291.66	311	69.60	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			891.5	C08		9	0141-0299	107.70	299.35	444	81.84	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			214.8	C08		9	0142-0298	434.80	298.10	239	56.53	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1868.2	C08		9	0143-0303	239.39	302.15	539	92.91	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1051.3	C08		9	0144-0300	377.66	300.14	294	64.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			264.4	C08		9	0145-0302	549.83	302.46	337	66.77	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			877.1	C08		9	0146-0301	764.47	301.35	306	65.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			753.4	C08		9	0147-0309	392.37	309.45	358	77.36	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			242.3	C08		9	0148-0309	347.42	309.38	218	60.28	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			198.0	C08		9	0149-0310	896.98	310.50	288	62.18	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			332.8	C08		9	0150-0311	577.44	310.83	300	63.36	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			787.9	C08		9	0151-0312	216.08	312.50	255	60.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5938.0	C08		9	0152-0314	494.42	314.03	302	69.26	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			17667.4	C08		9	0153-0316	284.47	316.16	255	61.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			405.5	C08		9	0154-0318	168.21	318.26	221	53.94	0.954
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			887.8	C08		9	0155-0317	772.86	317.30	215	55.11	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			251.1	C08		9	0156-0326	316.42	327.16	303	68.43	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			354.2	C08		9	0157-0329	100.11	329.05	280	63.01	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1936.7	C08		9	0158-0328	399.84	329.06	255	61.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2446.1	C08		9	0159-0331	473.65	331.97	309	69.94	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			324.0	C08		9	0160-0335	827.11	334.40	269	65.01	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			312.1	C08		9	0161-0334	653.21	334.08	294	63.94	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			515.2	C08		9	0162-0337	158.65	337.24	315	66.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			204.6	C08		9	0163-0339	906.65	338.05	301	66.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			259.6	C08		9	0164-0341	280.12	341.05	159	46.87	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1812.2	C08		9	0165-0346	405.37	345.82	260	64.53	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			410.9	C08		9	0166-0346	501.49	346.23	253	57.94	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1434.6	C08		9	0167-0349	610.54	349.77	277	61.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			417.9	C08		9	0168-0351	141.79	350.62	239	59.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			373.5	C08		9	0169-0351	658.83	350.93	212	54.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			242.5	C08		9	0170-0350	285.21	350.41	164	53.70	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			214.6	C08		9	0171-0356	820.54	356.82	457	79.50	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			216.4	C08		9	0172-0356	448.40	356.50	293	63.26	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			422.9	C08		9	0173-0355	476.70	354.62	261	60.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			302.3	C08		9	0174-0357	577.40	356.95	299	68.77	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1257.4	C08		9	0175-0358	238.80	359.38	238	58.18	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			298.5	C08		9	0176-0357	419.39	357.22	250	59.70	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			263.0	C08		9	0177-0361	555.88	361.12	311	71.01	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			508.3	C08		9	0178-0361	65.88	360.72	247	58.18	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			326.0	C08		9	0179-0361	19.97	360.70	264	61.11	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			517.0	C08		9	0180-0361	132.83	362.58	260	61.84	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1797.9	C08		9	0181-0364	345.75	364.55	320	67.84	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			975.5	C08		9	0182-0362	689.31	362.03	220	55.11	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			470.4	C08		9	0183-0365	192.24	365.31	356	69.60	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			385.8	C08		9	0184-0369	298.99	368.75	288	61.36	0.961
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			650.1	C08		9	0185-0376	361.42	376.48	319	71.11	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			299.9	C08		9	0186-0374	649.12	373.54	234	59.11	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			400.8	C08		9	0187-0380	597.95	380.23	274	64.18	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			277.5	C08		9	0188-0380	707.53	380.45	241	58.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			923.1	C08		9	0189-0381	678.68	381.16	240	57.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			873.9	C08		9	0190-0381	225.76	381.28	250	57.94	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			484.6	C08		9	0191-0383	756.09	383.91	241	59.94	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			334.2	C08		9	0192-0391	779.07	391.01	340	72.67	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			697.8	C08		9	0193-0390	799.10	391.04	245	59.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2012.2	C08		9	0194-0392	89.33	392.36	270	62.18	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1262.0	C08		9	0195-0391	43.24	392.06	257	60.53	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			311.9	C08		9	0196-0395	609.25	395.53	320	67.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			262.9	C08		9	0197-0393	699.56	393.71	208	55.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1694.2	C08		9	0198-0400	15.94	400.42	270	60.18	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			510.0	C08		9	0199-0400	309.65	400.91	265	59.36	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			843.4	C08		9	0200-0400	833.98	400.08	295	62.53	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			588.2	C08		9	0201-0407	902.30	406.64	274	62.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2288.5	C08		9	0202-0412	521.72	412.19	305	67.94	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1576.0	C08		9	0203-0408	697.46	408.03	236	57.11	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			206.5	C08		9	0204-0421	330.18	420.87	469	82.57	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			773.0	C08		9	0205-0416	730.08	415.55	217	55.36	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1168.4	C08		9	0206-0421	857.42	421.28	284	64.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			885.8	C08		9	0207-0424	657.84	423.98	250	59.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			257.0	C08		9	0208-0430	96.02	429.79	282	62.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			377.4	C08		9	0209-0430	53.43	430.31	184	59.36	0.656
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			231.2	C08		9	0210-0429	272.80	429.35	252	63.70	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			297.5	C08		9	0211-0436	937.67	435.69	355	72.18	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1963.8	C08		9	0212-0434	404.28	434.71	268	60.53	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			303.2	C08		9	0213-0434	221.85	434.00	235	56.53	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			232.6	C08		9	0214-0437	835.72	437.04	437	77.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			673.0	C08		9	0215-0433	741.32	433.53	271	64.28	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			492.6	C08		9	0216-0441	183.31	440.67	278	63.36	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			230.7	C08		9	0217-0445	118.89	445.84	253	59.94	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			468.1	C08		9	0218-0445	276.34	444.55	334	71.01	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			557.3	C08		9	0219-0446	568.93	446.43	359	69.60	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			236.9	C08		9	0220-0450	509.86	450.39	295	67.26	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1368.1	C08		9	0221-0451	20.54	450.78	221	57.11	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			315.3	C08		9	0222-0451	92.12	451.47	252	58.53	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			220.7	C08		9	0223-0455	199.91	454.64	259	58.87	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			862.5	C08		9	0224-0457	140.99	457.34	266	61.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			546.4	C08		9	0225-0458	292.70	459.22	301	65.50	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1586.4	C08		9	0226-0464	16.19	464.87	249	61.70	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			271.9	C08		9	0227-0466	246.15	466.00	365	69.84	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			224.7	C08		9	0228-0465	774.80	465.10	224	57.11	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			230.1	C08		9	0229-0473	845.32	474.29	456	80.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			419.6	C08		9	0230-0473	943.11	472.67	290	64.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			437.4	C08		9	0231-0474	586.90	473.65	236	56.77	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			360.1	C08		9	0232-0477	117.41	476.98	231	56.53	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			409.7	C08		9	0233-0479	533.86	479.51	256	61.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			263.0	C08		9	0234-0477	780.99	477.30	204	56.87	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			239.4	C08		9	0235-0486	732.95	485.44	478	90.33	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			407.5	C08		9	0236-0484	35.89	484.22	231	57.36	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			12545.0	C08		9	0237-0489	799.12	490.26	263	62.53	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			292.7	C08		9	0238-0492	865.20	491.40	373	74.08	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			331.4	C08		9	0239-0491	170.18	491.71	244	57.70	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3710.3	C08		9	0240-0494	360.13	494.65	280	61.11	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			267.0	C08		9	0241-0496	397.72	496.43	237	57.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			220.9	C08		9	0242-0497	709.02	498.02	186	53.36	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4601.6	C08		9	0243-0501	889.82	500.72	276	63.01	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			311.1	C08		9	0244-0501	745.35	500.87	258	59.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			752.2	C08		9	0245-0509	25.61	509.50	411	76.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1024.9	C08		9	0246-0506	187.12	506.63	263	64.18	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2172.9	C08		9	0247-0508	630.19	507.52	302	65.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			12163.0	C08		9	0248-0509	793.51	508.92	295	66.53	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			319.5	C08		9	0249-0513	765.22	513.46	253	60.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			317.4	C08		9	0250-0515	427.69	515.11	257	60.53	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2124.7	C08		9	0251-0520	600.81	520.37	291	64.43	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			219.9	C08		9	0252-0521	190.24	520.79	236	61.94	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			231.8	C08		9	0253-0526	312.34	526.57	272	63.26	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			223.6	C08		9	0254-0523	382.37	523.68	259	60.87	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			472.9	C08		9	0255-0532	900.91	532.53	282	61.60	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1071.7	C08		9	0256-0534	743.07	534.31	283	63.60	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			471.8	C08		9	0257-0536	72.15	535.68	229	58.18	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			277.4	C08		9	0258-0536	345.34	536.25	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1066.6	C08		9	0259-0541	115.02	540.89	231	57.11	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			194.8	C08		9	0260-0541	388.16	540.96	250	62.04	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1231.8	C08		9	0261-0544	146.31	544.72	261	59.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			471.8	C08		9	0262-0550	208.62	549.77	372	71.01	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4824.4	C08		9	0263-0549	530.58	548.82	256	59.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5979.9	C08		9	0264-0552	65.45	553.53	305	69.74	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			12203.0	C08		9	0265-0551	462.86	551.05	255	61.36	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4845.6	C08		9	0266-0558	187.19	558.95	291	65.11	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1443.1	C08		9	0267-0560	131.96	560.28	266	60.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			313.8	C08		9	0268-0560	300.81	559.95	236	57.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1050.9	C08		9	0269-0562	939.43	562.66	339	69.60	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4642.8	C08		9	0270-0563	49.26	563.13	288	64.18	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			228.2	C08		9	0271-0564	85.36	565.00	271	66.43	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			430.1	C08		9	0272-0566	339.62	565.46	310	65.36	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2012.8	C08		9	0273-0569	464.96	569.44	300	63.36	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			674.8	C08		9	0274-0575	736.81	575.78	288	64.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1376.2	C08		9	0275-0577	412.79	577.08	301	67.36	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			275.8	C08		9	0276-0584	694.25	583.79	271	64.53	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			8349.5	C08		9	0277-0583	193.20	583.45	294	65.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			218.0	C08		9	0278-0588	385.14	587.73	347	73.36	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1340.5	C08		9	0279-0589	72.04	589.28	271	63.70	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			228.9	C08		9	0280-0593	212.91	593.17	300	64.53	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			277.7	C08		9	0281-0595	369.24	595.55	270	63.94	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			195.8	C08		9	0282-0597	146.27	597.00	301	64.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			968.9	C08		9	0283-0600	756.21	600.54	250	60.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			798.3	C08		9	0284-0609	524.75	609.24	263	60.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			174.8	C08		9	0285-0616	38.28	615.69	283	63.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			257.4	C08		9	0286-0619	933.03	619.84	281	62.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			279.2	C08		9	0287-0622	196.88	622.44	282	62.87	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			832.1	C08		9	0288-0623	881.73	623.66	287	62.77	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2017.9	C08		9	0289-0627	467.98	627.32	335	68.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1635.9	C08		9	0290-0632	89.86	632.14	284	64.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			248.2	C08		9	0291-0637	150.45	637.26	292	63.36	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3483.2	C08		9	0292-0649	202.97	648.00	683	104.33	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			191.6	C08		9	0293-0648	124.90	648.49	260	61.36	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			232.7	C08		9	0294-0651	511.67	651.43	319	67.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			180.3	C08		9	0295-0651	69.79	650.22	248	61.36	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1016.2	C08		9	0296-0650	744.16	649.99	267	60.53	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4792.8	C08		9	0297-0650	263.16	650.76	250	60.53	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			167.0	C08		9	0298-0659	19.67	658.90	268	63.60	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			159.0	C08		9	0299-0665	66.46	665.98	267	64.77	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			625.7	C08		9	0300-0668	184.98	667.40	248	60.77	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3983.8	C08		9	0301-0666	264.82	665.46	286	72.77	0.679
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5683.7	C08		9	0302-0671	207.75	671.46	339	71.94	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			210.7	C08		9	0303-0668	387.01	668.37	303	66.43	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1602.3	C08		9	0304-0669	475.83	669.81	291	64.77	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			347.8	C08		9	0305-0673	781.40	673.09	311	67.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1163.3	C08		9	0306-0675	172.35	675.41	223	57.70	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			249.6	C08		9	0307-0677	111.57	677.69	283	61.36	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			268.0	C08		9	0308-0683	936.29	683.92	458	86.43	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			330.8	C08		9	0309-0678	251.31	678.44	264	60.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			200.1	C08		9	0310-0684	140.58	684.18	241	63.11	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			242.3	C08		9	0311-0690	321.34	691.53	581	89.74	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			175.7	C08		9	0312-0689	360.96	689.61	257	60.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			196.1	C08		9	0313-0693	31.45	693.71	260	61.70	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			475.5	C08		9	0314-0695	888.76	694.75	257	61.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1413.8	C08		9	0315-0695	57.33	695.07	272	64.18	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			261.4	C08		9	0316-0699	199.59	698.64	226	56.67	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			701.5	C08		9	0317-0702	750.25	702.11	297	63.60	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			232.6	C08		9	0318-0703	950.13	704.06	183	53.70	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			232.4	C08		9	0319-0704	937.61	703.39	120	41.56	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			749.5	C08		9	0320-0707	214.24	708.02	262	62.18	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			663.0	D08		1	0001-0031	502.05	32.10	433	78.91	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1160.4	D08		1	0002-0035	683.37	35.30	402	74.43	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			225.6	D08		1	0003-0039	168.05	39.26	489	82.67	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			790.1	D08		1	0004-0037	106.24	37.36	378	72.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			348.4	D08		1	0005-0049	326.88	48.58	751	107.30	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			6019.7	D08		1	0006-0044	231.54	43.76	386	72.67	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			821.0	D08		1	0007-0053	916.42	53.65	703	101.50	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			327.0	D08		1	0008-0051	573.73	51.36	507	86.18	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1555.4	D08		1	0009-0051	450.99	50.66	464	82.91	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			651.4	D08		1	0010-0054	799.48	53.77	390	77.26	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			289.9	D08		1	0011-0059	633.85	59.36	412	77.50	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			853.5	D08		1	0012-0069	747.78	68.50	777	107.05	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1362.7	D08		1	0013-0069	470.40	69.42	494	89.26	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1168.5	D08		1	0014-0072	394.62	72.16	441	76.43	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3322.0	D08		1	0015-0074	600.83	74.82	443	84.08	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			318.8	D08		1	0016-0076	493.85	76.67	503	87.60	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1421.3	D08		1	0017-0075	232.83	75.37	381	73.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4770.2	D08		1	0018-0075	574.54	74.86	434	79.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			918.1	D08		1	0019-0079	724.21	79.27	424	78.08	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1461.5	D08		1	0020-0082	109.11	82.07	363	71.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			303.7	D08		1	0021-0086	26.13	85.99	531	87.50	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3193.8	D08		1	0022-0086	935.26	86.56	381	73.50	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			297.9	D08		1	0023-0096	306.50	96.09	417	79.36	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			765.2	D08		1	0024-0106	533.49	106.01	807	108.23	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			478.7	D08		1	0025-0101	285.13	101.97	407	79.01	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1164.7	D08		1	0026-0103	635.68	103.29	852	117.54	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1852.6	D08		1	0027-0105	186.52	104.86	373	75.26	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1277.1	D08		1	0028-0108	789.69	108.23	359	73.60	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2204.7	D08		1	0029-0112	834.07	111.51	371	73.01	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			851.3	D08		1	0030-0113	391.56	113.78	401	74.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1267.0	D08		1	0031-0115	699.70	115.21	399	75.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			298.7	D08		1	0032-0123	159.83	123.97	830	116.37	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			352.0	D08		1	0033-0117	446.57	117.74	434	79.50	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			275.3	D08		1	0034-0120	612.49	120.72	422	79.15	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1991.9	D08		1	0035-0121	926.26	121.01	392	72.18	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			495.6	D08		1	0036-0123	73.44	123.49	376	71.01	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			253.3	D08		1	0037-0126	735.15	126.18	452	81.26	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			814.6	D08		1	0038-0134	420.57	133.51	950	125.88	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1576.7	D08		1	0039-0128	783.39	127.59	449	85.26	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			307.3	D08		1	0040-0144	506.95	143.84	677	95.50	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2387.5	D08		1	0041-0143	905.12	143.51	392	73.60	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			284.2	D08		1	0042-0142	824.88	142.30	383	75.26	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			918.5	D08		1	0043-0146	297.25	145.43	396	74.08	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			399.6	D08		1	0044-0158	642.35	158.75	393	74.67	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1466.7	D08		1	0045-0159	714.83	158.98	388	76.67	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			331.8	D08		1	0046-0164	277.35	164.21	729	105.05	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			681.5	D08		1	0047-0160	227.30	159.90	390	76.08	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			428.3	D08		1	0048-0166	117.67	165.95	373	72.67	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			503.8	D08		1	0049-0166	578.16	166.33	390	74.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1560.2	D08		1	0050-0180	678.45	180.31	399	78.33	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			703.0	D08		1	0051-0179	809.52	179.24	398	73.84	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			659.7	D08		1	0052-0180	338.38	179.91	418	81.01	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			309.8	D08		1	0053-0181	167.78	181.14	400	75.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			272.0	D08		1	0054-0182	444.35	182.31	382	73.84	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			282.8	D08		1	0055-0187	316.80	187.46	409	78.77	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			320.8	D08		1	0056-0187	207.94	187.03	397	77.50	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1779.0	D08		1	0057-0194	513.29	194.35	400	73.26	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			447.7	D08		1	0058-0197	940.92	197.02	399	76.43	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			259.2	D08		1	0059-0199	37.04	199.58	382	73.84	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			295.5	D08		1	0060-0209	253.78	208.26	925	123.78	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			701.5	D08		1	0061-0198	887.77	198.92	427	75.84	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			805.9	D08		1	0062-0199	798.35	199.86	390	73.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			698.5	D08		1	0063-0201	719.56	201.34	398	76.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			337.1	D08		1	0064-0206	71.18	205.95	602	90.91	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			832.9	D08		1	0065-0204	764.36	204.33	390	73.26	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			717.1	D08		1	0066-0207	562.41	208.31	379	75.94	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			862.2	D08		1	0067-0213	135.78	212.78	380	75.50	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1213.2	D08		1	0068-0221	927.57	220.99	385	72.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			356.4	D08		1	0069-0227	202.54	226.91	603	97.98	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1269.2	D08		1	0070-0224	615.97	224.41	409	76.67	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			474.8	D08		1	0071-0224	851.76	224.07	404	75.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			260.2	D08		1	0072-0232	271.35	234.30	725	103.78	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1240.9	D08		1	0073-0227	357.51	227.54	399	78.33	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			348.2	D08		1	0074-0229	482.77	228.83	357	74.18	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			637.6	D08		1	0075-0229	563.89	228.90	504	88.77	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1214.9	D08		1	0076-0238	890.09	239.12	727	104.13	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			271.5	D08		1	0077-0237	506.66	236.92	730	101.50	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			270.1	D08		1	0078-0240	540.09	240.67	552	94.91	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			422.6	D08		1	0079-0236	136.86	236.60	377	74.18	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			401.4	D08		1	0080-0242	58.13	242.18	440	77.84	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			255.9	D08		1	0081-0256	20.39	256.84	381	76.08	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			608.3	D08		1	0082-0258	459.44	258.25	392	73.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			912.6	D08		1	0083-0259	112.01	259.70	374	75.26	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			243.0	D08		1	0084-0271	746.54	271.87	414	75.60	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4730.1	D08		1	0085-0273	854.96	273.67	395	74.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1565.6	D08		1	0086-0279	180.41	278.30	384	73.01	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			663.0	D08		1	0087-0280	697.87	280.13	419	78.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			669.0	D08		1	0088-0281	315.70	280.31	405	76.67	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1457.9	D08		1	0089-0282	813.95	282.55	410	77.26	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			586.2	D08		1	0090-0287	936.07	287.70	382	73.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1062.7	D08		1	0091-0289	296.01	290.63	412	80.67	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			254.4	D08		1	0092-0294	641.46	293.41	420	77.26	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			345.6	D08		1	0093-0299	840.45	299.21	344	68.18	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			360.6	D08		1	0094-0300	899.82	300.36	385	72.43	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			328.3	D08		1	0095-0304	436.31	304.50	925	116.23	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			364.6	D08		1	0096-0303	219.20	302.97	382	71.60	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			233.3	D08		1	0097-0306	109.51	306.11	396	77.26	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1294.2	D08		1	0098-0310	175.48	310.67	613	96.81	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2031.5	D08		1	0099-0305	37.12	304.96	376	74.08	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1465.3	D08		1	0100-0309	549.31	309.07	383	71.60	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1448.6	D08		1	0101-0319	681.97	319.46	401	75.01	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			719.6	D08		1	0102-0319	393.65	319.13	386	73.84	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1817.8	D08		1	0103-0327	934.12	327.39	370	71.26	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			372.0	D08		1	0104-0333	774.77	333.03	392	73.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			244.7	D08		1	0105-0333	582.47	333.28	913	135.05	0.629
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			358.4	D08		1	0106-0336	729.96	335.83	392	73.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			566.3	D08		1	0107-0340	823.92	339.51	324	70.33	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			197.4	D08		1	0108-0344	144.33	344.39	395	74.08	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1489.8	D08		1	0109-0345	180.49	344.57	405	77.50	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			578.1	D08		1	0110-0347	37.82	347.41	374	73.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			571.9	D08		1	0111-0354	298.60	353.98	743	108.13	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			267.4	D08		1	0112-0351	352.83	351.52	398	74.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1157.4	D08		1	0113-0354	106.35	354.35	382	73.84	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			259.8	D08		1	0114-0357	622.14	357.04	652	97.98	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			202.1	D08		1	0115-0365	201.37	366.55	896	121.98	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3381.2	D08		1	0116-0370	707.79	370.13	433	79.50	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			284.3	D08		1	0117-0373	644.17	373.30	598	93.74	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			317.8	D08		1	0118-0373	567.86	374.36	591	92.18	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			243.4	D08		1	0119-0382	920.26	382.67	916	122.23	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			243.7	D08		1	0120-0375	771.27	375.83	427	77.50	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1435.5	D08		1	0121-0381	879.09	380.59	377	71.84	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1354.0	D08		1	0122-0383	134.35	382.33	377	72.91	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			890.1	D08		1	0123-0388	404.24	388.60	396	75.26	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2259.7	D08		1	0124-0397	151.05	397.56	433	81.15	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1205.4	D08		1	0125-0400	578.04	398.64	909	124.47	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			487.7	D08		1	0126-0397	686.35	397.94	414	75.84	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			244.1	D08		1	0127-0402	757.16	401.49	427	78.67	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			691.3	D08		1	0128-0407	603.82	407.99	414	77.74	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1100.9	D08		1	0129-0416	320.94	415.48	832	111.64	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1047.3	D08		1	0130-0412	201.41	411.91	398	75.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			417.4	D08		1	0131-0412	876.19	412.31	396	74.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			879.5	D08		1	0132-0420	769.40	420.86	452	86.91	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			309.7	D08		1	0133-0428	492.31	428.55	399	75.84	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			505.4	D08		1	0134-0433	432.61	433.37	389	73.84	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			550.4	D08		1	0135-0433	655.07	433.40	396	74.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			746.1	D08		1	0136-0446	370.45	445.64	871	123.88	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			236.2	D08		1	0137-0443	99.12	443.74	373	70.43	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			466.8	D08		1	0138-0446	931.58	445.38	330	72.77	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			331.1	D08		1	0139-0446	464.85	446.15	392	73.26	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			453.7	D08		1	0140-0449	914.46	449.53	412	80.18	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			343.3	D08		1	0141-0450	293.65	450.79	391	75.50	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			284.2	D08		1	0142-0453	562.54	453.36	701	99.64	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			257.2	D08		1	0143-0449	715.45	448.99	390	76.08	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2255.0	D08		1	0144-0454	142.77	454.03	401	77.50	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1425.2	D08		1	0145-0455	946.44	455.06	407	78.08	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1505.4	D08		1	0146-0465	186.09	465.22	378	73.50	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			191.6	D08		1	0147-0473	48.87	472.73	757	108.81	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			311.4	D08		1	0148-0468	763.11	467.65	373	73.26	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			282.8	D08		1	0149-0479	695.70	479.85	998	122.81	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			625.3	D08		1	0150-0476	640.27	476.07	384	73.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			412.6	D08		1	0151-0480	336.26	480.21	402	76.77	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			248.9	D08		1	0152-0483	393.22	482.93	564	89.98	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			339.1	D08		1	0153-0480	849.69	480.79	391	74.77	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			246.2	D08		1	0154-0484	443.37	484.11	426	77.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1466.0	D08		1	0155-0484	213.28	483.94	379	71.60	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1359.4	D08		1	0156-0487	770.70	487.97	410	79.15	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			885.6	D08		1	0157-0490	533.71	490.14	403	78.08	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			524.6	D08		1	0158-0489	573.51	488.99	384	74.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			288.4	D08		1	0159-0488	313.19	488.37	428	79.60	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			237.9	D08		1	0160-0497	87.71	497.66	366	71.84	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			225.0	D08		1	0161-0499	866.23	499.79	410	78.08	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2127.4	D08		1	0162-0499	922.02	498.94	359	69.60	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			719.6	D08		1	0163-0506	45.32	507.06	382	78.91	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			471.7	D08		1	0164-0508	817.58	507.77	374	72.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			951.0	D08		1	0165-0509	17.93	509.60	362	72.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			220.5	D08		1	0166-0510	188.53	509.87	383	71.84	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			738.6	D08		1	0167-0512	606.62	511.74	393	76.08	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1905.3	D08		1	0168-0513	745.60	513.60	376	73.01	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2877.0	D08		1	0169-0513	487.28	512.82	395	76.08	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			843.6	D08		1	0170-0517	895.51	516.63	393	75.50	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			278.5	D08		1	0171-0521	326.02	521.07	373	71.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1954.9	D08		1	0172-0523	118.03	523.23	386	72.18	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			728.0	D08		1	0173-0525	289.17	524.87	410	76.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3034.5	D08		1	0174-0525	420.66	525.54	395	76.08	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			847.4	D08		1	0175-0528	648.78	528.16	396	74.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			297.2	D08		1	0176-0530	163.13	530.49	391	74.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1456.9	D08		1	0177-0530	771.34	530.25	390	73.01	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			225.0	D08		1	0178-0533	199.57	533.05	381	73.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			240.1	D08		1	0179-0540	385.59	540.73	417	78.91	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			892.0	D08		1	0180-0539	543.36	539.82	398	75.84	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			757.6	D08		1	0181-0547	897.72	547.42	433	85.40	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1321.9	D08		1	0182-0544	40.20	544.43	338	70.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1126.2	D08		1	0183-0548	473.27	547.35	620	101.40	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5527.2	D08		1	0184-0562	275.66	562.66	620	92.91	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			926.6	D08		1	0185-0571	557.83	571.47	817	113.78	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			783.9	D08		1	0186-0565	658.42	565.82	393	73.84	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2465.5	D08		1	0187-0570	94.36	570.37	340	68.18	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1348.0	D08		1	0188-0570	756.96	569.72	404	76.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1314.8	D08		1	0189-0573	890.54	574.05	415	78.43	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2957.7	D08		1	0190-0575	718.87	575.35	418	79.15	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			232.2	D08		1	0191-0584	443.06	584.72	994	128.02	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2962.7	D08		1	0192-0581	202.82	581.40	407	77.84	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1954.0	D08		1	0193-0584	360.11	584.44	373	73.26	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			421.6	D08		1	0194-0585	610.58	584.79	382	73.26	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			907.6	D08		1	0195-0583	861.48	583.27	393	78.33	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1515.7	D08		1	0196-0591	809.80	591.24	406	78.91	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			952.1	D08		1	0197-0602	194.05	601.73	235	60.77	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			199.9	D08		1	0198-0606	401.04	605.93	421	77.26	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			353.1	D08		1	0199-0607	249.23	606.40	392	78.67	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1707.6	D08		1	0200-0607	715.39	607.94	388	76.67	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			607.6	D08		1	0201-0609	886.12	609.68	379	75.84	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2435.6	D08		1	0202-0613	662.08	613.08	400	74.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			392.4	D08		1	0203-0613	81.87	613.13	432	82.81	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			500.1	D08		1	0204-0619	359.78	619.40	408	77.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			557.5	D08		1	0205-0623	500.22	622.62	416	77.50	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			636.1	D08		1	0206-0632	54.26	631.53	380	72.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			271.1	D08		1	0207-0634	156.18	634.61	438	77.84	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3816.5	D08		1	0208-0632	314.53	632.31	371	75.60	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2741.4	D08		1	0209-0635	337.73	634.71	468	90.18	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			809.5	D08		1	0210-0639	845.81	638.80	759	104.33	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			183.4	D08		1	0211-0637	182.83	636.98	452	85.40	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			791.0	D08		1	0212-0638	479.84	638.61	466	84.91	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			416.6	D08		1	0213-0643	360.80	643.00	528	91.84	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			341.8	D08		1	0214-0643	403.72	643.53	391	72.43	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1660.2	D08		1	0215-0644	797.68	644.62	380	74.43	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1023.7	D08		1	0216-0648	23.17	647.57	369	76.18	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			451.7	D08		1	0217-0653	447.13	653.51	845	118.02	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3348.8	D08		1	0218-0650	266.50	650.23	286	67.60	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			215.7	D08		1	0219-0650	606.93	650.53	444	79.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2724.4	D08		1	0220-0654	76.29	654.09	364	70.43	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			188.5	D08		1	0221-0657	213.13	657.27	388	76.08	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			603.2	D08		1	0222-0660	914.73	660.25	368	72.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			503.0	D08		1	0223-0665	714.94	664.98	405	77.01	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			185.1	D08		1	0224-0666	743.38	666.07	459	82.91	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			331.0	D08		1	0225-0666	648.30	666.58	374	70.43	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			378.2	D08		1	0226-0675	326.89	674.93	673	97.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			853.7	D08		1	0227-0680	772.33	679.99	356	70.43	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			423.8	D08		1	0228-0688	812.57	689.08	726	108.43	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			598.3	D08		1	0229-0686	489.12	685.84	367	75.74	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			196.3	D08		1	0230-0687	143.02	687.83	440	78.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1558.3	D08		1	0231-0690	871.85	690.33	358	72.43	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			442.9	D08		1	0232-0690	191.96	690.27	398	77.50	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			934.3	D08		1	0233-0696	352.59	695.18	460	83.50	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			751.8	D08		1	0234-0700	530.30	700.74	818	111.88	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			967.1	D08		1	0235-0700	579.33	700.33	362	73.50	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			339.8	D08		1	0236-0705	67.56	705.01	383	74.08	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			254.9	D08		3	0001-0032	610.87	32.70	388	77.15	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			427.9	D08		3	0002-0038	761.28	37.99	356	70.43	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			237.7	D08		3	0003-0042	860.23	42.15	366	72.18	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			459.3	D08		3	0004-0041	227.10	41.65	345	72.67	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			462.4	D08		3	0005-0043	410.65	43.52	431	78.67	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1036.7	D08		3	0006-0044	45.88	44.22	373	79.60	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			815.5	D08		3	0007-0047	258.54	47.53	359	75.98	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1092.8	D08		3	0008-0045	550.76	44.87	362	72.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			294.2	D08		3	0009-0049	839.59	49.01	381	77.50	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			549.2	D08		3	0010-0051	694.22	51.36	349	70.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1196.9	D08		3	0011-0053	23.37	52.47	350	73.01	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2055.1	D08		3	0012-0055	131.62	55.52	364	76.67	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			959.1	D08		3	0013-0058	54.92	58.96	377	80.43	0.732
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			255.4	D08		3	0014-0064	74.21	63.65	384	77.26	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			369.8	D08		3	0015-0063	927.38	63.53	352	71.26	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			530.8	D08		3	0016-0065	350.14	65.53	386	73.84	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			817.0	D08		3	0017-0069	250.38	69.79	363	77.26	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3845.1	D08		3	0018-0067	904.78	67.76	366	72.33	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1122.6	D08		3	0019-0072	180.20	72.28	368	75.74	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			7028.2	D08		3	0020-0072	231.46	72.41	371	74.87	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3623.6	D08		3	0021-0073	787.16	73.24	361	74.08	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			515.8	D08		3	0022-0080	733.46	80.24	325	113.64	0.316
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1153.2	D08		3	0023-0086	89.85	85.99	341	71.84	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4108.2	D08		3	0024-0091	165.10	92.46	712	105.40	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			269.4	D08		3	0025-0088	659.30	87.84	389	77.50	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1095.5	D08		3	0026-0087	685.00	87.49	373	74.33	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			6449.4	D08		3	0027-0089	473.46	89.44	376	74.91	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1197.2	D08		3	0028-0091	502.43	91.20	384	76.91	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1700.0	D08		3	0029-0090	753.67	90.95	380	74.08	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			327.4	D08		3	0030-0093	429.24	93.02	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2085.5	D08		3	0031-0093	230.83	92.37	369	72.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			681.6	D08		3	0032-0097	546.64	97.18	360	72.67	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			732.4	D08		3	0033-0098	833.39	98.43	356	70.18	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			217.8	D08		3	0034-0105	125.31	106.25	731	109.54	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			556.7	D08		3	0035-0102	376.54	102.10	373	73.84	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			368.7	D08		3	0036-0106	904.74	106.07	302	66.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			440.7	D08		3	0037-0110	488.71	110.65	412	86.57	0.691
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			909.0	D08		3	0038-0113	641.59	113.02	367	75.84	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1494.8	D08		3	0039-0114	312.85	115.19	368	72.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			264.4	D08		3	0040-0116	69.56	116.39	359	76.33	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			559.5	D08		3	0041-0123	31.77	123.36	329	69.01	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5026.4	D08		3	0042-0121	723.76	121.05	350	73.84	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			334.9	D08		3	0043-0132	913.74	132.69	582	92.81	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			493.1	D08		3	0044-0129	456.50	128.80	387	75.50	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			656.0	D08		3	0045-0131	273.44	130.78	321	67.94	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1777.7	D08		3	0046-0132	293.91	132.21	440	84.67	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			599.5	D08		3	0047-0136	627.21	136.50	365	74.33	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1073.2	D08		3	0048-0138	384.28	138.48	386	75.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1670.4	D08		3	0049-0139	491.76	139.37	370	75.26	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			229.9	D08		3	0050-0142	83.52	141.45	354	71.01	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			469.3	D08		3	0051-0142	173.87	142.35	347	72.08	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1202.8	D08		3	0052-0141	810.52	140.67	331	69.84	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			293.6	D08		3	0053-0148	544.92	147.95	411	76.91	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			328.2	D08		3	0054-0150	859.07	149.48	299	66.18	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			285.7	D08		3	0055-0153	243.01	153.61	398	76.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1419.0	D08		3	0056-0154	761.70	154.94	330	68.28	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			386.2	D08		3	0057-0158	219.30	157.52	385	77.50	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			264.6	D08		3	0058-0163	139.16	162.74	404	77.26	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			271.9	D08		3	0059-0165	43.97	164.94	345	69.84	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1319.6	D08		3	0060-0169	414.27	168.40	409	78.91	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			332.5	D08		3	0061-0166	592.25	165.95	388	77.50	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			246.1	D08		3	0062-0171	912.62	171.55	375	73.50	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1181.6	D08		3	0063-0179	646.07	177.21	720	110.61	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			307.3	D08		3	0064-0173	850.67	172.97	350	69.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			289.8	D08		3	0065-0181	434.16	179.91	762	118.51	0.682
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			350.0	D08		3	0066-0175	759.81	175.04	560	90.18	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			969.6	D08		3	0067-0178	879.52	178.93	356	73.01	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			681.0	D08		3	0068-0178	341.98	177.70	347	70.43	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			891.3	D08		3	0069-0196	97.38	195.27	747	118.95	0.663
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			492.6	D08		3	0070-0195	488.00	194.77	353	72.67	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			370.4	D08		3	0071-0195	523.35	194.58	307	65.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1521.5	D08		3	0072-0197	687.05	197.04	347	73.26	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1169.3	D08		3	0073-0198	557.78	198.27	394	76.18	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			777.0	D08		3	0074-0202	742.04	202.12	370	73.26	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1808.4	D08		3	0075-0205	147.56	205.28	333	70.43	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1549.9	D08		3	0076-0206	387.38	207.07	366	76.33	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1445.5	D08		3	0077-0207	296.40	206.55	341	72.91	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1662.9	D08		3	0078-0210	650.95	210.77	392	76.43	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			429.0	D08		3	0079-0213	252.24	212.90	344	70.67	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			287.6	D08		3	0080-0212	787.19	212.30	356	70.18	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			474.9	D08		3	0081-0215	82.89	215.35	335	72.43	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			573.9	D08		3	0082-0215	903.13	215.44	324	71.26	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			611.5	D08		3	0083-0214	361.40	214.09	349	74.57	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			739.4	D08		3	0084-0220	196.70	219.96	359	72.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1285.1	D08		3	0085-0221	607.95	221.25	364	73.36	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			450.5	D08		3	0086-0224	414.68	224.53	323	67.01	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			848.8	D08		3	0087-0234	477.37	234.22	752	114.95	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			492.9	D08		3	0088-0233	941.28	233.09	368	71.01	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			576.5	D08		3	0089-0234	649.87	234.42	381	79.50	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1333.0	D08		3	0090-0235	41.27	235.00	329	71.74	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1255.6	D08		3	0091-0238	109.05	238.19	359	74.91	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			786.5	D08		3	0092-0244	607.29	243.39	370	77.36	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			936.9	D08		3	0093-0246	299.57	245.76	362	86.81	0.604
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			358.0	D08		3	0094-0245	164.28	245.60	361	72.43	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1672.8	D08		3	0095-0246	673.03	245.73	328	69.70	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			524.0	D08		3	0096-0247	762.15	246.68	347	68.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			238.8	D08		3	0097-0248	868.88	248.01	373	73.26	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2788.0	D08		3	0098-0249	373.11	248.75	358	76.33	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3741.9	D08		3	0099-0249	552.28	249.29	371	75.74	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			394.4	D08		3	0100-0251	693.24	251.37	374	76.18	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			265.7	D08		3	0101-0252	811.85	252.49	441	81.84	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			546.9	D08		3	0102-0258	249.65	258.22	341	71.84	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			329.0	D08		3	0103-0259	944.24	258.82	301	67.60	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4332.3	D08		3	0104-0265	587.53	265.22	377	73.26	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			233.1	D08		3	0105-0267	341.59	266.56	373	74.67	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			826.2	D08		3	0106-0268	312.72	268.76	348	77.50	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1187.6	D08		3	0107-0267	24.76	267.70	326	69.84	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2531.5	D08		3	0108-0283	649.13	284.09	965	130.61	0.711
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1231.7	D08		3	0109-0273	627.87	274.18	281	66.28	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			240.1	D08		3	0110-0277	156.82	276.89	359	72.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			359.2	D08		3	0111-0276	609.90	276.26	304	65.11	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			214.5	D08		3	0112-0282	79.15	282.69	371	75.50	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			408.7	D08		3	0113-0280	897.30	280.57	260	86.23	0.439
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			278.8	D08		3	0114-0281	410.64	281.07	378	75.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			246.0	D08		3	0115-0283	207.48	282.75	296	63.60	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			400.6	D08		3	0116-0280	688.08	279.99	198	53.60	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			224.8	D08		3	0117-0285	118.58	285.09	470	87.50	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			841.0	D08		3	0118-0288	850.70	288.52	361	72.08	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			353.7	D08		3	0119-0290	251.86	290.01	326	69.26	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1359.6	D08		3	0120-0295	573.61	295.23	352	70.67	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1783.7	D08		3	0121-0308	528.74	309.81	752	114.71	0.718
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			255.7	D08		3	0122-0303	354.73	302.37	387	81.74	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			308.3	D08		3	0123-0314	395.21	313.95	362	76.57	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			254.9	D08		3	0124-0313	466.54	313.88	394	77.50	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			905.6	D08		3	0125-0313	915.48	313.75	355	73.84	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2321.3	D08		3	0126-0316	28.55	315.24	376	77.98	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			339.3	D08		3	0127-0317	283.02	317.11	315	65.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			845.7	D08		3	0128-0319	102.04	319.05	333	71.01	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			294.4	D08		3	0129-0328	423.72	328.52	377	75.50	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1006.0	D08		3	0130-0330	854.33	329.72	363	74.91	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			274.1	D08		3	0131-0330	592.86	329.42	402	81.84	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			263.2	D08		3	0132-0332	142.97	332.76	382	76.08	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2083.8	D08		3	0133-0336	321.90	335.75	386	81.98	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			294.6	D08		3	0134-0338	833.06	338.06	514	88.67	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			812.4	D08		3	0135-0338	236.53	338.87	364	74.91	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			735.9	D08		3	0136-0339	675.27	339.86	348	71.84	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			239.4	D08		3	0137-0341	539.42	341.78	376	73.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			216.4	D08		3	0138-0342	45.16	342.09	343	72.67	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			216.9	D08		3	0139-0341	360.98	341.59	365	71.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			278.3	D08		3	0140-0342	741.96	343.01	367	72.43	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1005.4	D08		3	0141-0343	814.07	343.20	311	71.01	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			315.6	D08		3	0142-0352	180.69	352.91	376	80.91	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			665.8	D08		3	0143-0351	911.96	351.27	378	74.91	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3354.1	D08		3	0144-0354	313.52	354.52	377	78.33	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1119.3	D08		3	0145-0355	79.89	355.22	324	72.57	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1067.7	D08		3	0146-0364	113.88	364.88	334	72.91	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1224.9	D08		3	0147-0368	472.96	368.59	712	106.57	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			327.3	D08		3	0148-0373	521.62	372.76	374	76.33	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1219.7	D08		3	0149-0376	665.34	376.52	366	74.91	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1076.5	D08		3	0150-0376	394.46	376.46	359	71.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			236.1	D08		3	0151-0374	711.16	374.31	395	76.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1579.8	D08		3	0152-0378	147.07	378.11	334	78.57	0.680
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1717.6	D08		3	0153-0378	329.62	377.69	360	78.33	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			650.2	D08		3	0154-0382	866.90	381.25	375	76.91	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			274.9	D08		3	0155-0381	32.21	381.87	321	68.43	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			645.2	D08		3	0156-0381	919.31	381.04	350	70.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1392.1	D08		3	0157-0384	258.75	383.93	340	71.26	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			922.3	D08		3	0158-0388	195.57	388.17	350	74.33	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			343.2	D08		3	0159-0387	732.51	386.63	311	66.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			774.0	D08		3	0160-0389	547.02	389.11	374	74.91	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1707.0	D08		3	0161-0395	231.76	395.64	345	74.91	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			977.2	D08		3	0162-0395	819.43	395.72	362	71.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			398.3	D08		3	0163-0396	119.41	396.33	326	69.26	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			286.1	D08		3	0164-0398	477.43	398.21	310	64.77	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			232.8	D08		3	0165-0399	751.44	398.79	398	77.74	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			261.4	D08		3	0166-0402	304.30	401.92	380	73.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1558.4	D08		3	0167-0410	371.75	410.15	720	105.88	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1972.6	D08		3	0168-0403	438.20	403.57	370	74.08	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1380.0	D08		3	0169-0421	593.76	420.87	363	78.91	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			223.2	D08		3	0170-0421	718.80	421.57	380	77.15	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2087.8	D08		3	0171-0423	774.90	423.59	361	75.84	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2340.0	D08		3	0172-0428	33.62	428.69	325	72.91	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1574.3	D08		3	0173-0431	269.61	431.74	353	76.91	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1234.9	D08		3	0174-0431	528.13	432.17	372	77.94	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			309.8	D08		3	0175-0436	693.67	436.44	627	99.64	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			266.2	D08		3	0176-0447	421.89	446.54	748	106.95	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			228.5	D08		3	0177-0440	641.30	440.64	368	74.57	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1104.3	D08		3	0178-0446	162.63	445.35	712	105.88	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			400.9	D08		3	0179-0443	218.47	442.01	246	66.18	0.706
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			334.0	D08		3	0180-0444	231.04	446.37	219	63.70	0.678
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1757.8	D08		3	0181-0448	196.51	448.67	338	72.43	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			640.9	D08		3	0182-0447	315.10	447.79	367	74.91	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1158.1	D08		3	0183-0452	248.41	451.51	349	71.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			643.8	D08		3	0184-0455	527.89	453.68	409	81.84	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			262.8	D08		3	0185-0461	105.25	461.70	375	81.15	0.716
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			216.9	D08		3	0186-0463	71.14	463.23	353	73.26	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			226.1	D08		3	0187-0465	761.22	465.32	369	71.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1135.1	D08		3	0188-0473	624.44	473.31	375	72.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			588.6	D08		3	0189-0476	471.95	476.54	334	72.91	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			750.0	D08		3	0190-0475	851.66	474.90	353	71.01	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			665.6	D08		3	0191-0476	125.82	475.90	352	77.98	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			446.7	D08		3	0192-0482	929.08	482.82	380	78.33	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1979.0	D08		3	0193-0481	238.90	481.00	375	78.57	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			828.6	D08		3	0194-0484	565.52	484.47	368	73.26	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			208.8	D08		3	0195-0488	798.10	488.09	378	76.43	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4078.1	D08		3	0196-0490	720.05	490.02	371	72.67	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			387.6	D08		3	0197-0495	687.56	495.55	364	71.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			705.9	D08		3	0198-0502	601.36	502.21	361	73.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2682.5	D08		3	0199-0504	491.17	503.98	359	76.08	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			384.3	D08		3	0200-0507	230.55	507.90	370	78.33	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2486.3	D08		3	0201-0504	441.48	503.77	353	71.26	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1569.2	D08		3	0202-0506	356.38	506.34	353	72.43	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			547.5	D08		3	0203-0506	76.00	505.92	340	70.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			575.3	D08		3	0204-0510	806.46	509.69	392	81.40	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1467.4	D08		3	0205-0523	274.92	522.77	728	119.78	0.638
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			323.0	D08		3	0206-0520	851.06	520.43	723	112.13	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			223.4	D08		3	0207-0523	183.08	523.49	582	96.81	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			340.5	D08		3	0208-0520	757.32	519.80	372	73.60	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1088.2	D08		3	0209-0522	314.99	522.71	377	72.67	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1782.2	D08		3	0210-0522	481.03	522.56	359	72.67	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			387.8	D08		3	0211-0527	637.44	527.40	373	76.33	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			236.1	D08		3	0212-0525	673.36	524.83	333	68.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			211.8	D08		3	0213-0538	359.97	537.89	341	72.91	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			879.9	D08		3	0214-0537	580.54	536.99	352	72.67	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			505.0	D08		3	0215-0541	941.09	541.53	352	74.57	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			820.6	D08		3	0216-0542	537.15	541.76	363	72.67	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			299.6	D08		3	0217-0557	213.58	557.20	748	119.92	0.654
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1457.3	D08		3	0218-0553	484.31	553.43	396	77.26	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2123.1	D08		3	0219-0554	506.06	554.20	357	72.53	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			957.8	D08		3	0220-0556	736.72	556.00	352	72.91	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			243.5	D08		3	0221-0560	682.76	559.13	385	76.67	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			266.4	D08		3	0222-0561	74.33	561.65	327	68.67	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			776.6	D08		3	0223-0565	910.29	565.48	745	106.57	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4138.4	D08		3	0224-0565	782.87	565.60	625	96.57	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1245.6	D08		3	0225-0567	301.69	568.06	352	79.74	0.696
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			226.0	D08		3	0226-0569	343.30	569.80	330	68.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			822.5	D08		3	0227-0571	427.05	571.92	349	71.84	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			316.4	D08		3	0228-0587	52.37	586.47	695	104.57	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			231.7	D08		3	0229-0589	257.48	589.00	357	73.60	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			673.6	D08		3	0230-0588	216.44	588.13	373	76.08	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1506.1	D08		3	0231-0588	675.96	588.21	372	74.08	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			414.5	D08		3	0232-0589	132.62	588.97	371	74.91	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1823.2	D08		3	0233-0596	504.56	596.61	816	112.13	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			955.8	D08		3	0234-0590	747.04	590.11	349	71.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			392.9	D08		3	0235-0598	541.23	597.72	647	103.40	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			617.9	D08		3	0236-0596	632.60	596.40	377	78.57	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1085.9	D08		3	0237-0603	585.14	603.71	378	75.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			370.1	D08		3	0238-0600	373.07	600.30	254	59.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			223.6	D08		3	0239-0603	923.84	602.96	310	66.43	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			425.1	D08		3	0240-0604	114.56	604.19	360	79.15	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			732.9	D08		3	0241-0621	767.20	622.36	953	139.78	0.613
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			629.8	D08		3	0242-0608	873.87	607.69	343	75.15	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1101.6	D08		3	0243-0619	887.26	619.02	411	81.15	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1278.9	D08		3	0244-0617	824.32	617.02	347	70.67	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			226.5	D08		3	0245-0621	358.11	621.50	605	95.40	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			817.0	D08		3	0246-0620	736.77	620.01	369	81.98	0.690
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			374.0	D08		3	0247-0619	389.04	619.47	348	72.08	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1030.6	D08		3	0248-0626	210.28	626.97	308	71.36	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			536.6	D08		3	0249-0631	692.35	631.02	357	79.98	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			382.0	D08		3	0250-0632	846.96	632.32	249	57.36	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			223.4	D08		3	0251-0636	620.94	636.44	368	73.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			260.5	D08		3	0252-0638	328.05	638.02	417	85.15	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			238.9	D08		3	0253-0642	35.07	642.13	314	71.01	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1796.2	D08		3	0254-0643	168.48	643.62	337	71.50	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1046.4	D08		3	0255-0645	212.27	643.20	363	77.60	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			239.6	D08		3	0256-0650	129.25	650.17	437	81.74	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			334.8	D08		3	0257-0649	798.87	649.68	206	73.50	0.479
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			238.1	D08		3	0258-0654	92.12	653.99	352	70.67	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			244.2	D08		3	0259-0653	558.56	653.05	375	73.84	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			225.3	D08		3	0260-0653	675.92	653.29	342	73.84	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			838.5	D08		3	0261-0659	342.21	659.10	369	83.98	0.657
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			257.3	D08		3	0262-0660	203.39	661.36	396	79.98	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			284.6	D08		3	0263-0663	904.83	662.51	330	69.26	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1273.7	D08		3	0264-0667	947.34	667.52	341	73.84	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			219.7	D08		3	0265-0669	683.59	669.86	372	78.43	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			210.1	D08		3	0266-0674	610.07	674.02	369	74.91	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3133.3	D08		3	0267-0672	488.26	672.92	362	72.67	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			820.6	D08		3	0268-0675	720.71	675.02	357	74.67	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			322.0	D08		3	0269-0685	89.67	685.35	313	65.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			919.7	D08		3	0270-0684	138.76	684.98	315	66.43	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			433.4	D08		3	0271-0688	179.16	688.67	338	71.50	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			389.9	D08		3	0272-0690	896.32	690.52	318	72.33	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			532.1	D08		3	0273-0700	25.13	699.98	615	97.40	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			248.3	D08		3	0274-0697	699.75	697.18	375	76.08	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			346.2	D08		3	0275-0693	363.48	693.79	196	72.77	0.465
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1766.5	D08		3	0276-0707	831.30	707.12	348	71.70	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			251.7	D08		4	0001-0039	733.93	39.86	628	95.74	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			327.5	D08		4	0002-0049	816.27	48.21	984	128.23	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4450.9	D08		4	0003-0047	340.50	45.67	547	92.47	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			947.7	D08		4	0004-0045	603.98	44.77	467	82.91	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1003.7	D08		4	0005-0048	902.79	48.58	451	79.50	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			273.0	D08		4	0006-0049	366.86	49.04	475	82.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			693.7	D08		4	0007-0053	759.08	52.52	483	88.67	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			272.9	D08		4	0008-0055	249.77	55.49	442	78.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2363.5	D08		4	0009-0056	945.82	56.49	406	75.26	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			463.5	D08		4	0010-0056	99.02	56.17	435	83.50	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			305.5	D08		4	0011-0061	322.34	62.53	456	81.98	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1679.5	D08		4	0012-0064	75.47	64.64	501	87.94	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			626.9	D08		4	0013-0066	620.14	67.05	499	85.98	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			364.3	D08		4	0014-0071	446.82	70.23	938	125.44	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			340.5	D08		4	0015-0073	669.51	73.09	432	76.43	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			272.1	D08		4	0016-0077	835.66	77.03	516	88.71	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			536.2	D08		4	0017-0077	744.64	78.29	438	80.43	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			498.1	D08		4	0018-0080	545.97	80.59	922	121.30	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			309.2	D08		4	0019-0086	80.39	85.76	433	82.08	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			246.0	D08		4	0020-0090	179.51	90.53	727	103.64	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			765.4	D08		4	0021-0096	849.52	96.88	428	81.15	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			282.8	D08		4	0022-0097	118.83	97.58	763	103.40	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			959.0	D08		4	0023-0100	519.10	99.71	481	85.74	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4031.9	D08		4	0024-0100	348.91	100.90	383	75.50	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			767.6	D08		4	0025-0102	889.05	102.48	431	77.26	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			221.5	D08		4	0026-0105	706.22	105.50	424	76.67	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			303.0	D08		4	0027-0114	78.30	115.10	429	85.26	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			273.8	D08		4	0028-0113	624.49	113.53	484	84.33	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1084.7	D08		4	0029-0115	801.67	114.62	416	77.50	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			266.5	D08		4	0030-0116	387.80	116.12	561	90.08	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			371.1	D08		4	0031-0123	266.03	123.08	434	78.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1420.2	D08		4	0032-0124	770.35	123.97	438	80.91	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			247.8	D08		4	0033-0124	676.92	124.50	422	76.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			243.9	D08		4	0034-0142	319.72	142.15	433	79.74	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3429.4	D08		4	0035-0148	217.28	148.11	423	76.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			982.2	D08		4	0036-0153	718.54	153.51	431	82.77	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1610.1	D08		4	0037-0159	843.33	158.44	853	112.71	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			255.2	D08		4	0038-0158	145.77	159.32	864	116.23	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			691.8	D08		4	0039-0168	270.56	168.62	924	119.88	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			318.6	D08		4	0040-0168	358.99	168.27	488	84.33	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1218.2	D08		4	0041-0166	664.94	166.66	434	79.50	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			275.3	D08		4	0042-0172	406.55	172.28	479	82.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1148.6	D08		4	0043-0173	716.05	172.21	435	79.11	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			300.8	D08		4	0044-0175	24.26	175.99	395	75.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			235.8	D08		4	0045-0180	572.58	180.40	513	88.91	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			842.1	D08		4	0046-0181	609.93	180.72	439	78.08	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			276.0	D08		4	0047-0184	543.08	183.36	499	87.40	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1466.8	D08		4	0048-0185	883.86	185.73	451	79.26	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			328.3	D08		4	0049-0195	792.79	195.10	446	78.91	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			339.1	D08		4	0050-0195	215.19	194.82	391	71.60	0.958
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			329.3	D08		4	0051-0196	183.93	196.02	391	72.18	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			413.6	D08		4	0052-0198	266.48	198.05	625	94.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			397.3	D08		4	0053-0197	858.04	196.41	430	79.50	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			702.3	D08		4	0054-0201	452.45	201.56	438	79.50	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1575.2	D08		4	0055-0201	145.36	200.44	437	79.26	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			873.1	D08		4	0056-0202	916.56	202.45	431	77.26	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			265.4	D08		4	0057-0213	537.22	213.14	511	91.40	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1484.1	D08		4	0058-0212	735.76	212.22	435	81.50	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			395.1	D08		4	0059-0225	336.76	224.68	832	114.81	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			281.0	D08		4	0060-0227	206.08	226.23	399	79.15	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			753.4	D08		4	0061-0226	418.21	226.03	428	79.50	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			331.8	D08		4	0062-0227	890.19	227.21	818	116.67	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1096.5	D08		4	0063-0245	648.73	245.57	889	123.05	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1420.7	D08		4	0064-0239	554.99	239.38	488	86.33	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			290.8	D08		4	0065-0248	196.20	249.17	476	90.81	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			237.2	D08		4	0066-0249	602.93	249.45	434	78.33	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			466.7	D08		4	0067-0255	723.00	255.13	440	78.67	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			632.1	D08		4	0068-0258	391.21	258.14	441	77.26	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			697.0	D08		4	0069-0263	692.44	264.22	439	79.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			283.2	D08		4	0070-0268	225.86	267.89	430	78.91	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2076.0	D08		4	0071-0267	259.01	267.57	426	79.50	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			551.9	D08		4	0072-0273	54.20	273.66	414	80.33	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1348.7	D08		4	0073-0275	426.18	274.91	483	83.50	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			275.8	D08		4	0074-0282	565.08	282.42	965	129.78	0.720
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			857.6	D08		4	0075-0274	917.38	275.01	446	79.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			479.7	D08		4	0076-0276	842.17	276.79	446	82.91	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			198.3	D08		4	0077-0286	325.72	285.68	477	84.91	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1258.3	D08		4	0078-0291	690.26	290.59	484	87.01	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			306.1	D08		4	0079-0289	163.66	288.76	423	75.26	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			292.3	D08		4	0080-0295	69.01	296.21	555	93.01	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			335.6	D08		4	0081-0298	631.28	298.98	823	111.30	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			937.2	D08		4	0082-0297	92.75	297.45	410	76.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			397.9	D08		4	0083-0298	486.50	297.74	444	79.50	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			410.8	D08		4	0084-0296	730.71	296.02	421	77.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			252.3	D08		4	0085-0309	336.67	309.13	741	102.91	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			292.9	D08		4	0086-0310	792.80	310.62	440	79.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			438.9	D08		4	0087-0314	583.95	314.44	503	91.84	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			423.6	D08		4	0088-0319	915.92	319.07	927	119.20	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1599.5	D08		4	0089-0323	526.57	322.61	442	78.08	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			768.3	D08		4	0090-0329	369.87	328.39	447	80.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1128.7	D08		4	0091-0333	741.86	333.44	431	77.26	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1096.6	D08		4	0092-0335	405.26	335.05	449	79.50	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			276.9	D08		4	0093-0338	442.23	337.84	665	97.64	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			292.9	D08		4	0094-0339	696.49	338.86	459	81.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			355.6	D08		4	0095-0341	573.65	341.09	457	84.91	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			219.1	D08		4	0096-0341	279.50	340.56	475	82.91	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1168.6	D08		4	0097-0345	217.15	344.72	442	78.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			244.5	D08		4	0098-0350	353.90	350.58	483	87.74	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1077.8	D08		4	0099-0350	829.44	351.06	433	78.33	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			467.5	D08		4	0100-0357	882.34	358.36	885	117.54	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			688.2	D08		4	0101-0353	512.95	353.82	454	80.08	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			642.0	D08		4	0102-0357	263.78	357.96	479	86.23	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			302.8	D08		4	0103-0361	645.71	361.63	519	88.67	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			272.0	D08		4	0104-0364	616.45	364.48	490	86.57	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			219.4	D08		4	0105-0365	788.10	365.64	480	81.84	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1016.0	D08		4	0106-0369	420.08	369.56	434	79.26	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			197.5	D08		4	0107-0378	935.44	378.34	450	80.67	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			197.6	D08		4	0108-0378	149.62	378.56	429	75.84	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			275.2	D08		4	0109-0384	640.88	384.35	489	87.60	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			628.8	D08		4	0110-0384	307.53	384.07	449	79.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			706.4	D08		4	0111-0390	83.47	390.26	414	78.33	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			247.4	D08		4	0112-0398	358.78	397.74	826	108.47	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1000.2	D08		4	0113-0398	798.87	397.96	445	84.33	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			298.2	D08		4	0114-0402	595.24	401.63	512	86.23	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			251.3	D08		4	0115-0405	654.01	406.06	567	92.57	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			388.3	D08		4	0116-0405	260.98	405.31	536	88.57	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			662.0	D08		4	0117-0411	535.96	411.71	918	120.23	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			231.9	D08		4	0118-0415	484.12	415.53	806	109.74	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1667.7	D08		4	0119-0415	210.19	414.84	911	116.23	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			225.6	D08		4	0120-0419	869.62	418.01	472	82.08	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			199.3	D08		4	0121-0420	459.39	420.85	457	85.01	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			224.3	D08		4	0122-0423	568.03	423.12	489	85.01	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			295.0	D08		4	0123-0427	783.26	427.75	947	124.47	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			876.3	D08		4	0124-0426	125.16	426.22	419	76.91	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			329.1	D08		4	0125-0431	755.86	431.24	422	80.77	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			661.1	D08		4	0126-0432	385.87	432.72	436	78.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1277.7	D08		4	0127-0435	285.51	435.86	415	75.01	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1119.6	D08		4	0128-0441	66.09	440.53	406	76.43	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			313.5	D08		4	0129-0448	28.71	448.46	574	88.67	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1125.9	D08		4	0130-0449	849.09	449.39	468	81.26	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1737.1	D08		4	0131-0449	896.40	449.15	435	81.15	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			267.3	D08		4	0132-0455	176.90	455.44	435	78.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			798.6	D08		4	0133-0461	630.96	461.45	461	83.74	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			278.0	D08		4	0134-0465	564.54	465.61	437	78.08	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			247.2	D08		4	0135-0465	763.23	465.37	464	82.43	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			907.7	D08		4	0136-0472	232.27	472.22	487	86.57	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			359.3	D08		4	0137-0470	509.73	470.31	422	79.36	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			851.9	D08		4	0138-0469	699.93	469.21	469	81.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			652.3	D08		4	0139-0472	734.89	472.71	504	85.15	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			485.4	D08		4	0140-0473	528.11	473.56	367	75.94	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			256.0	D08		4	0141-0478	96.54	477.90	456	84.08	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			752.5	D08		4	0142-0476	414.40	476.81	439	79.50	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			976.8	D08		4	0143-0484	252.34	484.70	460	84.57	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			273.5	D08		4	0144-0488	937.61	487.58	406	76.08	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			335.8	D08		4	0145-0487	820.13	486.87	287	65.84	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			226.2	D08		4	0146-0491	902.85	490.85	434	78.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			857.8	D08		4	0147-0493	703.55	492.97	483	86.43	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			276.0	D08		4	0148-0496	143.65	496.51	421	78.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			957.8	D08		4	0149-0501	304.77	501.57	431	77.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			263.4	D08		4	0150-0506	60.78	505.86	443	79.26	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			785.4	D08		4	0151-0510	915.79	510.77	476	84.33	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			307.1	D08		4	0152-0512	522.77	512.19	463	82.57	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1436.9	D08		4	0153-0518	459.30	518.98	448	80.08	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			245.7	D08		4	0154-0525	620.07	525.23	571	92.33	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			790.5	D08		4	0155-0527	836.57	527.33	282	64.18	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1140.7	D08		4	0156-0529	360.05	529.94	429	79.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			6327.0	D08		4	0157-0536	213.40	535.85	972	125.30	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			303.7	D08		4	0158-0534	407.41	533.57	504	85.74	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			250.5	D08		4	0159-0535	579.10	535.16	529	91.40	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			236.3	D08		4	0160-0534	23.69	534.42	407	75.26	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			620.7	D08		4	0161-0535	718.74	534.88	466	81.26	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			777.2	D08		4	0162-0550	73.80	550.34	433	80.08	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1283.7	D08		4	0163-0551	781.30	551.45	459	79.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4000.0	D08		4	0164-0552	361.37	551.17	526	89.60	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3473.6	D08		4	0165-0554	444.12	555.08	426	78.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1479.8	D08		4	0166-0560	496.05	559.90	449	79.26	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			277.7	D08		4	0167-0561	717.51	561.75	514	86.33	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			525.0	D08		4	0168-0562	409.60	562.68	472	82.33	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1236.8	D08		4	0169-0567	933.70	566.31	553	96.13	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			249.4	D08		4	0170-0565	628.41	565.59	465	80.67	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			802.9	D08		4	0171-0568	32.00	567.88	411	75.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			365.7	D08		4	0172-0573	259.57	571.93	451	81.40	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1475.9	D08		4	0173-0574	546.75	574.82	461	81.26	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1220.9	D08		4	0174-0577	109.77	577.72	423	75.26	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			244.9	D08		4	0175-0581	316.05	581.14	554	88.08	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			780.2	D08		4	0176-0584	909.84	584.85	803	114.95	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			666.0	D08		4	0177-0579	803.61	578.83	480	81.50	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			543.4	D08		4	0178-0581	649.40	580.88	509	88.81	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			364.9	D08		4	0179-0590	244.16	591.10	457	84.23	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			534.4	D08		4	0180-0594	470.06	594.13	422	77.01	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			657.7	D08		4	0181-0595	357.99	594.48	437	77.84	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4673.4	D08		4	0182-0601	707.62	600.99	472	81.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			339.7	D08		4	0183-0603	861.60	603.94	748	106.91	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			671.3	D08		4	0184-0602	593.70	602.36	432	78.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			320.5	D08		4	0185-0605	803.17	605.81	480	84.53	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			227.5	D08		4	0186-0605	189.40	604.80	467	80.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1068.6	D08		4	0187-0605	682.74	605.51	455	78.67	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1529.7	D08		4	0188-0608	829.34	608.71	803	110.53	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			280.8	D08		4	0189-0609	407.77	609.26	430	77.84	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			498.1	D08		4	0190-0617	48.28	617.11	419	76.08	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			322.7	D08		4	0191-0618	73.94	618.25	435	80.33	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			820.7	D08		4	0192-0620	534.59	620.39	454	83.15	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			247.0	D08		4	0193-0629	652.35	629.74	426	76.43	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			509.2	D08		4	0194-0630	464.45	630.65	459	81.50	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1630.1	D08		4	0195-0631	347.40	631.22	432	76.43	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			262.5	D08		4	0196-0637	166.84	637.00	673	98.81	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			255.2	D08		4	0197-0633	766.19	633.25	448	77.84	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			569.7	D08		4	0198-0637	824.14	634.50	444	83.50	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1421.9	D08		4	0199-0647	616.31	647.51	434	80.08	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			800.1	D08		4	0200-0648	893.26	647.73	452	83.74	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			425.4	D08		4	0201-0647	413.25	647.58	436	79.74	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1615.5	D08		4	0202-0649	811.68	650.31	462	82.47	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			11988.8	D08		4	0203-0655	284.65	655.64	972	129.68	0.726
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1775.0	D08		4	0204-0650	16.51	650.72	409	75.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			702.1	D08		4	0205-0652	564.80	652.91	437	77.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3284.4	D08		4	0206-0655	245.76	654.93	477	87.40	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			482.9	D08		4	0207-0654	60.03	654.59	350	73.36	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			212.7	D08		4	0208-0664	490.73	665.09	551	88.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1003.3	D08		4	0209-0666	107.18	667.24	437	78.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			345.8	D08		4	0210-0670	130.35	670.03	437	81.01	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			423.6	D08		4	0211-0673	66.05	672.95	487	87.01	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			213.8	D08		4	0212-0675	315.43	675.38	458	79.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1924.9	D08		4	0213-0674	384.40	674.78	439	78.91	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1237.9	D08		4	0214-0676	671.90	676.16	437	77.84	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5271.5	D08		4	0215-0677	806.78	677.74	428	79.98	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			415.3	D08		4	0216-0678	219.18	677.65	431	79.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1107.0	D08		4	0217-0680	741.32	680.44	490	87.40	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			240.1	D08		4	0218-0687	521.67	686.81	448	80.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			831.3	D08		4	0219-0690	185.53	690.11	483	87.15	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1660.0	D08		4	0220-0691	426.22	691.59	414	78.18	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			275.0	D08		4	0221-0698	66.48	698.47	483	87.01	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			318.5	D08		4	0222-0697	210.17	697.67	479	90.91	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1481.9	D08		4	0223-0698	848.47	697.67	448	77.84	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			330.9	D08		4	0224-0707	801.44	707.13	338	68.77	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			488.1	D08		5	0001-0033	823.63	32.06	394	74.57	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1026.3	D08		5	0002-0040	391.44	40.78	457	81.84	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			930.8	D08		5	0003-0045	808.53	46.12	380	75.15	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			437.8	D08		5	0004-0045	921.84	46.04	389	78.18	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1484.0	D08		5	0005-0057	318.33	57.37	778	114.23	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			320.4	D08		5	0006-0057	470.15	57.03	421	78.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2610.6	D08		5	0007-0059	50.54	59.00	386	73.84	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			324.6	D08		5	0008-0059	875.92	59.73	269	82.67	0.495
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			247.5	D08		5	0009-0064	397.42	64.22	486	85.84	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1948.5	D08		5	0010-0072	670.92	70.92	819	114.67	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			586.6	D08		5	0011-0071	701.38	70.53	485	87.26	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			608.3	D08		5	0012-0078	543.90	78.14	825	118.71	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			336.2	D08		5	0013-0079	388.66	79.65	130	44.87	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			252.0	D08		5	0014-0085	382.58	87.38	154	58.53	0.565
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			308.1	D08		5	0015-0088	516.98	88.31	354	71.94	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			812.7	D08		5	0016-0093	277.12	93.36	398	75.50	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			430.6	D08		5	0017-0096	633.80	96.06	425	79.26	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			230.5	D08		5	0018-0092	945.00	92.43	416	78.43	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			270.0	D08		5	0019-0099	599.93	98.67	415	77.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1387.5	D08		5	0020-0098	798.67	98.19	423	77.84	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			477.3	D08		5	0021-0100	350.48	100.44	400	75.84	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1629.4	D08		5	0022-0103	71.65	102.95	395	74.67	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			286.4	D08		5	0023-0108	561.28	107.76	640	93.74	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			220.5	D08		5	0024-0112	237.80	112.01	503	85.60	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1145.6	D08		5	0025-0115	454.33	115.52	438	81.74	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1290.4	D08		5	0026-0117	179.42	116.83	392	74.67	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			461.6	D08		5	0027-0118	842.12	118.62	387	73.84	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			484.2	D08		5	0028-0128	945.20	127.33	658	98.67	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			470.9	D08		5	0029-0147	230.98	146.68	883	128.37	0.673
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			454.6	D08		5	0030-0139	417.82	138.92	432	76.43	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			486.8	D08		5	0031-0140	799.39	139.77	419	79.01	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			467.4	D08		5	0032-0143	72.31	143.04	380	72.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2497.3	D08		5	0033-0146	778.08	146.59	408	77.01	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			246.5	D08		5	0034-0149	501.54	148.63	457	80.08	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			862.4	D08		5	0035-0147	714.83	147.15	405	76.08	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			484.2	D08		5	0036-0160	304.21	160.53	837	111.54	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			240.2	D08		5	0037-0160	551.40	160.00	437	81.26	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			435.9	D08		5	0038-0159	625.81	159.03	413	75.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1926.8	D08		5	0039-0163	379.49	163.25	810	111.15	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			326.5	D08		5	0040-0174	218.07	175.08	417	82.33	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1497.6	D08		5	0041-0179	124.30	179.69	857	121.40	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2627.6	D08		5	0042-0182	593.02	181.99	397	76.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			373.5	D08		5	0043-0184	800.09	184.08	393	76.33	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			879.9	D08		5	0044-0195	190.64	195.14	411	81.74	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			803.0	D08		5	0045-0200	860.90	200.69	769	107.64	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1477.4	D08		5	0046-0195	714.01	195.36	418	78.43	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			931.2	D08		5	0047-0204	21.44	204.91	378	76.08	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			609.5	D08		5	0048-0205	71.47	204.85	372	72.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			489.6	D08		5	0049-0211	769.60	211.45	384	74.43	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			968.3	D08		5	0050-0211	468.68	211.28	418	76.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1282.7	D08		5	0051-0214	390.48	213.72	396	75.26	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			657.4	D08		5	0052-0214	734.86	213.37	442	81.01	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			333.0	D08		5	0053-0216	210.48	216.18	445	86.91	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			272.2	D08		5	0054-0212	116.41	212.94	148	51.70	0.696
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			412.2	D08		5	0055-0217	343.50	217.58	399	75.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1109.3	D08		5	0056-0219	649.48	218.86	377	75.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			343.1	D08		5	0057-0225	668.86	226.35	406	82.08	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			860.8	D08		5	0058-0233	554.22	233.81	778	108.23	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			457.4	D08		5	0059-0240	133.89	240.37	385	76.08	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			222.2	D08		5	0060-0248	172.10	248.69	390	74.08	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			920.3	D08		5	0061-0249	56.46	249.02	394	76.08	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			260.3	D08		5	0062-0252	262.48	252.37	426	77.01	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			260.7	D08		5	0063-0252	522.43	252.74	411	80.91	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1024.4	D08		5	0064-0259	941.70	259.65	758	108.71	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1082.3	D08		5	0065-0263	621.63	263.24	862	124.51	0.699
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1378.3	D08		5	0066-0268	474.24	267.82	820	112.81	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			237.1	D08		5	0067-0265	748.25	265.65	425	76.67	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			697.8	D08		5	0068-0268	784.21	268.90	423	82.57	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2037.3	D08		5	0069-0274	346.42	275.00	450	80.43	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2081.2	D08		5	0070-0280	397.61	280.07	764	105.54	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			931.5	D08		5	0071-0274	865.76	273.84	395	74.08	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1042.8	D08		5	0072-0278	121.12	277.83	379	73.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			956.0	D08		5	0073-0277	22.55	277.44	368	73.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			779.7	D08		5	0074-0285	547.62	284.98	407	77.74	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			702.2	D08		5	0075-0285	323.56	284.72	457	81.26	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2139.2	D08		5	0076-0287	260.67	287.23	413	79.50	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1018.2	D08		5	0077-0301	806.06	301.60	896	117.40	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			863.0	D08		5	0078-0301	685.93	301.04	293	63.94	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2566.7	D08		5	0079-0310	430.22	310.43	398	80.33	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			334.2	D08		5	0080-0316	97.58	316.25	428	80.33	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			231.9	D08		5	0081-0314	859.62	313.58	405	78.57	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			428.9	D08		5	0082-0321	21.04	321.60	824	115.68	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1353.8	D08		5	0083-0314	518.69	314.61	381	77.84	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			844.6	D08		5	0084-0323	283.64	323.05	405	78.08	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			544.7	D08		5	0085-0327	344.62	327.27	406	78.33	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			247.8	D08		5	0086-0328	873.27	329.35	403	77.50	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			374.3	D08		5	0087-0330	907.98	329.91	310	64.77	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1915.8	D08		5	0088-0333	223.33	333.96	410	75.26	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			274.2	D08		5	0089-0337	410.57	337.30	756	107.74	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			360.8	D08		5	0090-0338	169.04	337.99	379	77.50	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			225.9	D08		5	0091-0336	660.17	336.80	610	97.15	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			875.9	D08		5	0092-0343	929.00	343.31	782	113.88	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			727.6	D08		5	0093-0344	722.89	344.38	405	76.67	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			336.1	D08		5	0094-0351	438.25	351.57	739	106.57	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2445.9	D08		5	0095-0346	552.67	346.48	413	77.26	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			586.8	D08		5	0096-0347	786.35	346.22	441	83.60	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			398.0	D08		5	0097-0354	761.47	354.39	397	77.84	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			571.0	D08		5	0098-0359	854.76	359.24	407	77.50	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			670.7	D08		5	0099-0360	135.44	360.45	392	76.91	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3018.7	D08		5	0100-0363	589.18	362.90	402	74.43	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1101.6	D08		5	0101-0367	273.26	367.66	450	81.74	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			724.6	D08		5	0102-0365	897.87	364.97	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1421.3	D08		5	0103-0376	484.26	375.96	819	108.71	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1246.1	D08		5	0104-0375	377.85	374.63	416	78.08	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			860.5	D08		5	0105-0378	304.46	378.42	424	78.67	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			282.3	D08		5	0106-0380	40.49	380.98	425	78.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			600.2	D08		5	0107-0386	833.52	386.16	399	75.84	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			222.3	D08		5	0108-0388	630.64	387.98	450	82.33	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			387.6	D08		5	0109-0396	411.42	396.40	397	76.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			295.7	D08		5	0110-0401	740.54	401.57	418	77.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			255.4	D08		5	0111-0404	366.68	404.38	414	76.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			582.6	D08		5	0112-0406	217.90	406.82	369	74.67	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3159.8	D08		5	0113-0408	175.02	408.75	399	76.91	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			711.2	D08		5	0114-0411	715.24	410.60	451	84.33	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1160.5	D08		5	0115-0412	535.17	412.48	466	85.15	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			817.6	D08		5	0116-0418	907.23	417.81	194	52.53	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			277.6	D08		5	0117-0426	802.16	426.03	435	81.74	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1115.9	D08		5	0118-0427	257.71	426.72	386	73.84	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			447.3	D08		5	0119-0427	610.99	426.01	452	86.57	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			258.7	D08		5	0120-0427	511.47	427.34	436	80.91	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			399.8	D08		5	0121-0426	869.44	427.90	301	66.28	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			251.1	D08		5	0122-0430	942.75	429.56	334	72.77	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5592.0	D08		5	0123-0433	475.18	432.91	417	79.50	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			384.0	D08		5	0124-0438	60.42	438.38	370	77.50	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			847.9	D08		5	0125-0443	929.10	443.80	381	72.91	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1099.2	D08		5	0126-0447	231.28	446.57	418	88.08	0.677
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			412.0	D08		5	0127-0447	869.40	446.16	338	70.87	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1362.7	D08		5	0128-0455	318.95	455.36	393	78.33	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			271.9	D08		5	0129-0462	835.61	462.47	606	91.50	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			270.9	D08		5	0130-0461	121.51	461.01	426	79.50	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			252.0	D08		5	0131-0460	443.24	460.54	409	77.50	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			235.0	D08		5	0132-0462	254.37	461.53	431	78.43	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4373.9	D08		5	0133-0466	215.21	467.13	426	78.91	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			301.1	D08		5	0134-0467	783.67	467.61	406	76.67	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			319.7	D08		5	0135-0472	525.52	471.82	416	76.91	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			273.5	D08		5	0136-0482	99.73	482.31	414	75.26	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			204.9	D08		5	0137-0485	143.43	484.89	386	75.26	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			269.6	D08		5	0138-0485	294.49	485.32	292	62.77	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			263.9	D08		5	0139-0490	42.99	490.22	383	74.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1599.0	D08		5	0140-0493	370.45	493.36	377	74.91	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			489.5	D08		5	0141-0496	644.54	496.59	415	76.91	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			6081.1	D08		5	0142-0498	489.71	498.57	453	82.33	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4321.8	D08		5	0143-0502	831.89	502.01	368	72.67	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			238.6	D08		5	0144-0505	939.56	504.88	436	78.08	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			783.3	D08		5	0145-0508	68.46	508.47	432	79.94	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			248.8	D08		5	0146-0511	887.28	511.66	578	90.08	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			916.1	D08		5	0147-0513	20.77	513.26	404	82.08	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			934.3	D08		5	0148-0521	754.52	520.67	409	79.50	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			307.8	D08		5	0149-0523	586.44	523.30	406	78.57	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			527.0	D08		5	0150-0524	298.76	524.83	424	77.26	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			249.9	D08		5	0151-0525	442.76	524.94	407	78.67	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			448.4	D08		5	0152-0528	529.27	528.32	415	77.50	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			383.2	D08		5	0153-0532	108.82	532.31	738	105.64	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			292.1	D08		5	0154-0531	148.05	531.10	448	80.57	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			748.5	D08		5	0155-0529	482.41	529.37	398	74.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			725.2	D08		5	0156-0530	666.31	530.21	407	77.50	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			549.8	D08		5	0157-0531	67.98	529.96	405	77.36	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			998.6	D08		5	0158-0535	709.02	534.75	398	76.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1370.9	D08		5	0159-0550	905.81	549.96	845	121.64	0.718
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			308.5	D08		5	0160-0541	804.22	541.10	367	73.26	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3953.9	D08		5	0161-0543	390.29	543.81	425	79.01	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			223.3	D08		5	0162-0553	412.75	553.04	430	81.26	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1943.5	D08		5	0163-0559	149.09	559.16	557	89.98	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			736.2	D08		5	0164-0560	464.84	560.33	400	78.33	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1453.1	D08		5	0165-0569	757.35	568.12	809	107.88	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			742.5	D08		5	0166-0564	348.33	564.29	444	81.98	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1466.7	D08		5	0167-0569	39.10	568.04	453	84.47	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			402.9	D08		5	0168-0567	599.41	567.21	398	75.84	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3891.1	D08		5	0169-0582	279.61	582.60	861	126.71	0.674
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1156.3	D08		5	0170-0581	25.58	580.97	352	75.15	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2075.1	D08		5	0171-0579	110.23	579.37	378	73.84	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4064.2	D08		5	0172-0581	667.06	581.06	445	80.57	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1167.5	D08		5	0173-0584	58.54	584.46	433	79.15	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5226.2	D08		5	0174-0598	387.24	598.06	913	122.51	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3986.4	D08		5	0175-0592	848.30	591.58	355	69.01	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			187.3	D08		5	0176-0601	452.23	600.94	405	78.57	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			286.0	D08		5	0177-0604	636.33	604.11	417	77.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			603.2	D08		5	0178-0605	707.85	604.88	396	75.84	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			367.7	D08		5	0179-0603	894.34	602.57	424	80.67	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			348.8	D08		5	0180-0611	815.51	611.80	316	65.60	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			872.8	D08		5	0181-0617	749.57	616.84	418	75.84	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1076.7	D08		5	0182-0619	670.03	619.32	407	77.50	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			462.3	D08		5	0183-0627	85.01	627.41	849	117.20	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1607.9	D08		5	0184-0623	380.27	623.57	412	79.98	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			342.6	D08		5	0185-0624	486.57	623.68	408	75.50	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			706.1	D08		5	0186-0636	229.62	636.89	400	80.23	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1464.9	D08		5	0187-0637	896.43	636.89	386	74.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			202.4	D08		5	0188-0639	432.10	639.78	760	107.01	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			217.1	D08		5	0189-0641	399.89	641.34	684	104.91	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			246.2	D08		5	0190-0639	702.72	639.73	363	71.70	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			242.2	D08		5	0191-0641	684.59	641.16	340	70.04	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1425.5	D08		5	0192-0641	833.67	641.18	407	77.26	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			503.9	D08		5	0193-0641	578.90	641.25	386	74.67	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			690.4	D08		5	0194-0644	503.10	644.83	399	75.84	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			974.4	D08		5	0195-0646	792.39	647.04	771	113.05	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			517.9	D08		5	0196-0651	154.62	650.94	391	77.84	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			220.9	D08		5	0197-0653	362.74	653.67	433	81.50	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			908.7	D08		5	0198-0669	557.75	669.58	859	118.02	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			255.0	D08		5	0199-0667	730.14	666.77	409	76.33	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			212.0	D08		5	0200-0669	620.03	669.13	394	76.33	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			198.3	D08		5	0201-0668	678.40	668.34	407	77.26	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3083.8	D08		5	0202-0675	431.90	674.98	414	76.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			217.9	D08		5	0203-0674	318.41	674.03	391	77.01	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			265.1	D08		5	0204-0680	259.83	680.16	394	74.67	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			748.7	D08		5	0205-0682	774.12	682.45	378	72.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			232.1	D08		5	0206-0694	727.59	694.73	419	81.15	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			297.4	D08		5	0207-0694	519.50	694.35	396	74.67	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			265.2	D08		5	0208-0699	210.55	699.05	729	105.88	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			275.4	D08		5	0209-0698	806.63	698.16	371	73.26	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1563.6	D08		5	0210-0704	886.47	704.50	369	71.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			275.9	D08		5	0211-0706	606.42	706.48	384	75.50	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1917.0	D08		6	0001-0031	828.76	31.67	370	71.94	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			958.8	D08		6	0002-0037	847.51	38.12	368	77.60	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			531.6	D08		6	0003-0036	327.60	35.24	339	72.43	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2133.1	D08		6	0004-0042	302.39	41.52	863	121.78	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			548.5	D08		6	0005-0040	923.26	40.40	314	67.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1012.5	D08		6	0006-0048	798.39	47.76	768	107.98	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			352.0	D08		6	0007-0042	130.25	42.06	351	69.60	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			329.9	D08		6	0008-0045	391.38	45.09	404	77.50	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			234.3	D08		6	0009-0049	556.89	49.61	411	80.43	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			241.5	D08		6	0010-0048	597.94	48.65	393	75.50	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			488.8	D08		6	0011-0048	16.62	48.20	323	75.01	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			310.9	D08		6	0012-0053	446.87	53.50	949	121.15	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			301.4	D08		6	0013-0051	666.15	50.88	389	74.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1039.3	D08		6	0014-0065	197.75	64.91	752	110.71	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			306.2	D08		6	0015-0066	900.72	66.61	403	75.84	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1584.7	D08		6	0016-0075	285.42	75.45	803	119.44	0.707
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1222.9	D08		6	0017-0073	628.35	74.13	785	115.64	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1265.0	D08		6	0018-0074	434.92	74.70	330	70.77	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			365.9	D08		6	0019-0078	746.11	77.93	391	73.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			558.7	D08		6	0020-0087	113.81	87.17	714	109.40	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			382.8	D08		6	0021-0082	859.99	81.94	372	74.91	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			254.1	D08		6	0022-0085	374.04	84.87	392	73.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1200.0	D08		6	0023-0094	723.11	93.67	421	78.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1000.3	D08		6	0024-0093	487.55	92.71	394	76.43	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			707.2	D08		6	0025-0094	774.76	94.30	418	78.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			291.1	D08		6	0026-0095	39.55	95.36	380	73.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			653.4	D08		6	0027-0102	836.77	101.45	590	115.05	0.560
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			236.8	D08		6	0028-0099	255.89	99.19	382	75.50	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2833.3	D08		6	0029-0100	595.90	99.78	365	72.67	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			227.7	D08		6	0030-0109	422.07	109.20	401	74.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1580.0	D08		6	0031-0126	484.81	126.11	881	126.71	0.690
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			675.6	D08		6	0032-0131	39.36	130.44	645	96.08	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			897.5	D08		6	0033-0131	549.78	131.58	381	73.84	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1536.4	D08		6	0034-0131	623.75	131.32	378	73.01	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			275.6	D08		6	0035-0132	172.95	132.44	376	77.26	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			460.1	D08		6	0036-0138	663.74	138.16	402	76.08	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			274.9	D08		6	0037-0140	893.42	140.11	365	71.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			409.2	D08		6	0038-0141	808.06	140.48	388	75.84	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			206.2	D08		6	0039-0144	271.47	144.83	389	76.57	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2802.1	D08		6	0040-0146	420.14	146.29	720	105.98	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			261.0	D08		6	0041-0145	457.69	145.41	336	70.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			903.3	D08		6	0042-0145	731.89	144.61	357	71.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			371.1	D08		6	0043-0147	106.08	147.62	398	74.67	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1123.6	D08		6	0044-0146	132.63	146.74	389	80.57	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			334.0	D08		6	0045-0148	301.61	148.60	373	73.50	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			605.4	D08		6	0046-0148	505.48	148.16	399	77.01	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			276.1	D08		6	0047-0149	838.37	149.10	369	72.67	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1064.7	D08		6	0048-0153	190.42	152.90	356	80.43	0.692
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1140.3	D08		6	0049-0159	767.90	159.50	381	75.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			901.8	D08		6	0050-0159	605.24	159.53	411	76.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			326.5	D08		6	0051-0163	326.95	162.93	371	72.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			215.0	D08		6	0052-0162	560.70	162.97	397	76.67	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			556.3	D08		6	0053-0165	928.56	164.82	391	73.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			732.9	D08		6	0054-0167	685.73	167.59	399	73.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			628.9	D08		6	0055-0167	474.63	166.86	391	76.18	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			330.4	D08		6	0056-0171	364.60	171.26	369	73.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1910.1	D08		6	0057-0177	70.64	177.11	396	78.18	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			296.3	D08		6	0058-0178	578.94	178.43	399	75.84	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			391.7	D08		6	0059-0178	93.26	177.67	356	71.94	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			366.8	D08		6	0060-0180	519.28	180.24	369	71.26	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3192.2	D08		6	0061-0188	811.84	187.98	356	71.60	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			532.0	D08		6	0062-0188	732.47	188.22	376	73.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			640.6	D08		6	0063-0188	398.67	187.91	374	72.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			886.8	D08		6	0064-0188	459.42	188.42	391	75.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			655.4	D08		6	0065-0192	707.38	192.26	387	74.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			405.6	D08		6	0066-0194	832.11	193.10	379	75.84	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			855.0	D08		6	0067-0201	129.67	201.14	384	77.26	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			780.6	D08		6	0068-0203	551.30	203.08	376	73.50	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			502.9	D08		6	0069-0204	902.38	204.65	333	66.77	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			214.2	D08		6	0070-0206	355.13	206.40	358	74.43	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			294.0	D08		6	0071-0212	635.35	212.48	399	75.01	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			433.4	D08		6	0072-0214	848.73	215.28	377	77.60	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			458.2	D08		6	0073-0218	932.27	216.97	345	69.26	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			228.9	D08		6	0074-0220	522.35	220.95	391	73.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			182.2	D08		6	0075-0221	324.97	222.47	425	81.01	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			640.1	D08		6	0076-0230	353.42	229.76	822	112.23	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			462.3	D08		6	0077-0233	441.72	232.72	428	80.91	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1304.0	D08		6	0078-0234	887.17	234.36	369	71.36	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			964.4	D08		6	0079-0237	83.22	237.34	399	76.67	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			263.9	D08		6	0080-0240	933.40	241.20	378	72.08	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			453.2	D08		6	0081-0243	854.49	242.67	365	73.84	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			299.3	D08		6	0082-0245	401.20	245.71	365	71.84	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			496.6	D08		6	0083-0244	460.99	244.95	355	75.60	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			473.4	D08		6	0084-0250	217.98	250.08	357	76.33	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			483.9	D08		6	0085-0253	628.92	252.95	378	72.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			456.4	D08		6	0086-0253	263.39	253.75	360	73.26	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1113.4	D08		6	0087-0262	36.17	262.36	722	103.05	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			222.8	D08		6	0088-0260	310.00	260.65	362	73.50	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			455.1	D08		6	0089-0260	102.18	261.17	346	70.43	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			864.5	D08		6	0090-0268	185.69	268.48	884	146.51	0.518
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1363.9	D08		6	0091-0263	454.94	263.11	449	84.67	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			333.5	D08		6	0092-0262	553.62	262.03	325	66.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			339.1	D08		6	0093-0270	678.00	270.01	375	72.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			838.0	D08		6	0094-0273	586.06	273.25	364	72.08	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1660.3	D08		6	0095-0275	369.55	275.52	397	75.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2268.8	D08		6	0096-0276	849.51	275.27	363	72.91	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			664.7	D08		6	0097-0278	235.02	278.33	349	72.43	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			282.4	D08		6	0098-0284	128.71	284.50	355	74.08	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			542.4	D08		6	0099-0287	632.49	287.12	274	61.84	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1001.8	D08		6	0100-0292	864.52	292.16	407	77.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			887.8	D08		6	0101-0296	383.05	296.44	374	73.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			278.2	D08		6	0102-0297	407.90	296.89	387	73.01	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			334.3	D08		6	0103-0297	509.90	297.42	392	72.43	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1536.6	D08		6	0104-0298	44.09	298.72	352	72.08	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1944.5	D08		6	0105-0303	766.26	302.90	352	73.26	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			253.8	D08		6	0106-0310	276.35	310.18	394	75.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1233.8	D08		6	0107-0310	593.44	310.26	370	72.67	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1767.6	D08		6	0108-0310	548.75	310.52	382	74.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2281.2	D08		6	0109-0311	832.11	310.47	382	73.26	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			305.6	D08		6	0110-0315	475.27	315.03	395	74.18	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			354.6	D08		6	0111-0319	683.10	318.92	642	100.47	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			202.2	D08		6	0112-0319	301.13	319.45	382	73.84	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			437.7	D08		6	0113-0327	211.18	328.27	839	117.88	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1355.3	D08		6	0114-0320	566.22	320.72	385	75.50	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			573.3	D08		6	0115-0320	898.68	319.64	306	67.84	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			237.2	D08		6	0116-0322	354.69	321.99	394	75.50	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			627.2	D08		6	0117-0322	717.14	322.36	564	101.26	0.691
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2078.0	D08		6	0118-0328	640.59	328.33	362	75.26	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			893.4	D08		6	0119-0334	269.16	334.69	433	86.08	0.734
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3607.1	D08		6	0120-0332	495.27	331.52	399	74.18	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1349.8	D08		6	0121-0337	817.75	337.00	419	78.33	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			502.8	D08		6	0122-0339	909.62	339.16	468	81.74	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			250.4	D08		6	0123-0340	792.67	339.73	461	82.33	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			955.8	D08		6	0124-0346	23.77	346.14	733	109.64	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1977.8	D08		6	0125-0347	629.09	348.15	482	91.15	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			347.7	D08		6	0126-0349	772.87	349.59	347	73.74	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			832.7	D08		6	0127-0350	932.91	350.68	699	110.81	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			277.1	D08		6	0128-0353	876.46	352.96	385	73.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			247.4	D08		6	0129-0358	727.31	358.52	378	72.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1222.0	D08		6	0130-0371	408.14	370.44	795	118.02	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			321.0	D08		6	0131-0366	226.35	365.77	908	116.33	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			394.7	D08		6	0132-0372	118.56	372.22	342	68.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1609.3	D08		6	0133-0380	171.75	380.43	359	71.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			260.2	D08		6	0134-0381	686.19	380.93	378	72.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			412.8	D08		6	0135-0386	356.86	385.91	362	71.84	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			491.1	D08		6	0136-0386	898.63	385.61	350	70.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4329.0	D08		6	0137-0389	582.02	388.69	403	77.26	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			963.4	D08		6	0138-0393	465.08	393.73	397	76.33	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			434.1	D08		6	0139-0396	531.89	396.65	383	73.60	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2269.0	D08		6	0140-0398	404.18	398.80	397	75.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			331.7	D08		6	0141-0399	263.14	398.89	376	72.43	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			268.1	D08		6	0142-0406	755.66	406.81	828	112.81	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			246.1	D08		6	0143-0400	846.75	399.69	373	72.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			240.2	D08		6	0144-0404	713.06	404.11	418	78.91	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1258.2	D08		6	0145-0406	671.17	405.85	361	71.26	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			608.7	D08		6	0146-0413	138.98	413.47	371	79.74	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1050.3	D08		6	0147-0418	488.43	418.69	409	76.08	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			587.2	D08		6	0148-0420	205.89	419.93	366	72.67	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			257.2	D08		6	0149-0430	813.04	431.09	381	73.26	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			289.8	D08		6	0150-0431	347.02	431.33	380	73.01	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			597.0	D08		6	0151-0432	434.56	432.26	372	75.26	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			323.6	D08		6	0152-0433	386.89	433.27	332	67.01	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2116.4	D08		6	0153-0436	534.23	436.43	387	74.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			430.6	D08		6	0154-0436	566.83	435.94	392	77.50	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			272.6	D08		6	0155-0448	223.60	447.98	776	111.20	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			832.1	D08		6	0156-0444	25.13	445.46	410	79.64	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			214.8	D08		6	0157-0442	879.80	442.45	368	73.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2031.8	D08		6	0158-0453	629.25	451.93	805	122.61	0.673
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			994.7	D08		6	0159-0450	286.83	449.76	498	109.40	0.523
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1536.8	D08		6	0160-0455	546.95	455.76	440	81.26	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			180.6	D08		6	0161-0473	695.65	471.41	849	123.44	0.700
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			194.1	D08		6	0162-0463	767.08	463.73	453	79.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			292.1	D08		6	0163-0470	934.85	469.19	674	102.33	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			466.2	D08		6	0164-0464	910.91	463.51	355	70.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1087.9	D08		6	0165-0469	376.31	469.53	372	70.18	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2764.5	D08		6	0166-0471	177.58	471.75	413	78.67	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			419.7	D08		6	0167-0472	54.05	472.63	343	69.01	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			244.1	D08		6	0168-0475	592.81	474.91	415	75.26	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			245.6	D08		6	0169-0480	324.79	480.81	759	105.74	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1501.2	D08		6	0170-0479	435.04	479.50	376	72.18	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			227.5	D08		6	0171-0483	813.03	483.23	375	74.43	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			240.5	D08		6	0172-0490	770.88	489.39	662	102.91	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			415.5	D08		6	0173-0486	201.54	486.03	380	75.60	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			658.1	D08		6	0174-0487	278.85	487.89	358	69.84	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			437.3	D08		6	0175-0490	245.27	490.50	362	71.84	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			867.7	D08		6	0176-0491	477.77	491.04	428	78.08	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			391.7	D08		6	0177-0498	678.58	499.23	426	79.74	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			252.2	D08		6	0178-0503	118.99	502.66	441	82.57	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			215.9	D08		6	0179-0501	369.40	501.07	369	71.01	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1264.7	D08		6	0180-0503	572.50	503.11	376	74.08	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			266.2	D08		6	0181-0507	34.40	507.78	383	74.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1036.4	D08		6	0182-0509	934.67	508.54	372	73.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			192.3	D08		6	0183-0515	705.36	514.46	392	76.08	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			233.8	D08		6	0184-0512	735.76	512.62	377	75.26	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			833.4	D08		6	0185-0515	198.35	514.67	343	69.60	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			354.8	D08		6	0186-0516	403.12	516.95	377	75.50	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			341.1	D08		6	0187-0528	142.35	527.67	783	122.61	0.655
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			953.5	D08		6	0188-0521	640.20	521.47	403	76.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			444.3	D08		6	0189-0526	248.39	526.31	355	74.91	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			694.9	D08		6	0190-0528	434.65	528.06	364	72.08	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			281.4	D08		6	0191-0539	888.16	539.47	358	68.43	0.961
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			204.3	D08		6	0192-0542	349.12	542.31	386	77.74	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			700.3	D08		6	0193-0550	301.34	550.65	719	105.05	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			354.5	D08		6	0194-0551	111.29	551.67	350	72.91	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			171.0	D08		6	0195-0554	594.03	554.14	397	74.43	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			173.9	D08		6	0196-0555	943.52	555.19	380	73.50	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			778.7	D08		6	0197-0560	443.60	560.66	366	71.84	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			374.9	D08		6	0198-0565	548.38	565.67	372	72.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1581.8	D08		6	0199-0566	171.46	566.61	359	71.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			208.1	D08		6	0200-0571	341.12	571.02	415	82.57	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			487.8	D08		6	0201-0577	784.16	577.07	769	108.81	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2378.6	D08		6	0202-0572	251.05	572.93	407	78.67	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			213.8	D08		6	0203-0572	619.51	572.04	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			317.4	D08		6	0204-0579	74.03	580.39	662	103.40	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			427.4	D08		6	0205-0580	287.78	580.05	376	74.43	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			197.0	D08		6	0206-0579	367.26	578.81	401	77.74	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			433.7	D08		6	0207-0580	819.65	579.49	354	70.43	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1517.1	D08		6	0208-0580	416.10	580.75	378	72.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			561.5	D08		6	0209-0590	474.71	590.58	792	118.47	0.709
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			231.9	D08		6	0210-0582	229.54	582.17	384	74.43	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			833.8	D08		6	0211-0584	716.08	583.65	355	71.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1399.8	D08		6	0212-0590	110.68	589.95	361	72.91	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			191.1	D08		6	0213-0593	326.52	594.57	419	80.91	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			249.3	D08		6	0214-0597	508.27	597.88	502	83.50	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			755.8	D08		6	0215-0598	50.21	597.98	354	72.43	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1240.5	D08		6	0216-0597	558.93	597.18	395	77.01	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			585.0	D08		6	0217-0607	748.76	606.91	688	100.23	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1114.9	D08		6	0218-0603	376.33	604.40	395	79.74	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			551.3	D08		6	0219-0605	166.55	604.53	415	78.18	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			247.0	D08		6	0220-0611	220.68	610.92	370	74.67	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1404.0	D08		6	0221-0613	581.72	612.72	410	78.18	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			475.0	D08		6	0222-0616	412.19	617.09	369	73.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			282.4	D08		6	0223-0624	98.62	624.57	714	100.81	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			451.1	D08		6	0224-0625	180.36	625.83	398	80.43	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			475.1	D08		6	0225-0623	537.52	622.87	384	75.26	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1037.9	D08		6	0226-0635	454.28	635.05	378	73.01	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			219.1	D08		6	0227-0640	821.88	639.14	554	88.57	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1039.1	D08		6	0228-0644	624.45	644.80	425	77.26	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			868.3	D08		6	0229-0645	276.57	645.18	379	74.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			713.2	D08		6	0230-0648	571.47	648.92	714	103.40	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			464.2	D08		6	0231-0647	189.76	646.38	378	79.26	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5922.8	D08		6	0232-0654	371.70	653.98	762	108.47	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			899.3	D08		6	0233-0654	804.65	654.82	380	74.91	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			660.8	D08		6	0234-0650	679.35	650.37	197	55.11	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			318.4	D08		6	0235-0661	46.26	661.50	326	70.18	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2119.8	D08		6	0236-0663	320.64	663.16	378	72.67	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			764.3	D08		6	0237-0666	492.29	665.81	354	70.43	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			525.9	D08		6	0238-0670	135.52	670.49	346	73.26	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			500.8	D08		6	0239-0671	107.79	671.25	366	74.91	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1930.5	D08		6	0240-0676	444.57	675.86	391	73.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1838.3	D08		6	0241-0677	193.75	677.33	365	71.84	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1518.5	D08		6	0242-0680	830.19	680.26	357	70.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			268.6	D08		6	0243-0683	520.86	683.19	371	75.74	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			692.7	D08		6	0244-0686	287.13	685.70	375	73.26	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			251.5	D08		6	0245-0693	909.27	692.95	359	69.84	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1311.5	D08		6	0246-0696	601.90	695.47	367	73.98	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			716.5	D08		6	0247-0703	803.69	703.90	373	74.43	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			208.1	D08		6	0248-0703	212.96	703.48	341	67.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2354.1	D08		6	0249-0708	315.46	708.28	363	75.01	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1146.8	D08		7	0001-0038	138.70	38.64	783	109.88	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			324.6	D08		7	0002-0034	800.14	34.58	338	69.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			231.6	D08		7	0003-0039	895.20	39.35	401	77.26	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2700.4	D08		7	0004-0038	601.43	38.88	500	84.91	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			872.0	D08		7	0005-0042	281.00	42.21	836	111.64	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1307.2	D08		7	0006-0049	348.32	49.45	926	126.02	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			295.4	D08		7	0007-0044	702.80	44.53	423	77.26	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			267.5	D08		7	0008-0059	821.65	58.95	463	82.91	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5362.8	D08		7	0009-0066	79.13	65.78	449	81.15	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			245.2	D08		7	0010-0071	851.75	70.91	773	109.64	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1600.0	D08		7	0011-0070	394.91	69.33	475	86.91	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2133.8	D08		7	0012-0068	431.23	68.86	349	75.84	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1390.3	D08		7	0013-0078	251.23	76.72	434	79.74	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			231.9	D08		7	0014-0081	185.35	81.82	462	82.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			311.3	D08		7	0015-0087	704.28	87.06	423	77.26	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2490.7	D08		7	0016-0086	911.36	85.55	459	81.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2492.1	D08		7	0017-0090	439.34	90.38	570	96.67	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			274.8	D08		7	0018-0090	387.39	89.99	430	83.01	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			334.5	D08		7	0019-0089	534.01	89.23	451	81.50	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			457.8	D08		7	0020-0091	755.54	92.27	522	89.74	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1019.9	D08		7	0021-0091	938.49	90.77	487	85.50	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			430.1	D08		7	0022-0092	650.55	92.57	472	82.08	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1044.5	D08		7	0023-0093	237.84	94.47	446	80.57	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4201.5	D08		7	0024-0094	319.02	94.51	414	78.91	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			852.7	D08		7	0025-0096	815.37	96.64	456	87.40	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1119.8	D08		7	0026-0095	69.91	95.59	424	79.74	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			9561.5	D08		7	0027-0098	845.18	97.93	502	87.15	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			238.5	D08		7	0028-0105	118.84	105.54	422	79.26	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1318.4	D08		7	0029-0106	732.48	106.57	433	80.91	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			379.4	D08		7	0030-0121	299.24	120.12	332	71.50	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3545.8	D08		7	0031-0124	358.14	124.35	404	76.67	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			878.5	D08		7	0032-0127	686.23	126.65	419	77.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			259.7	D08		7	0033-0126	894.96	126.18	404	76.67	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			521.6	D08		7	0034-0127	281.81	128.32	393	78.08	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			758.7	D08		7	0035-0134	17.37	135.18	431	82.91	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			265.1	D08		7	0036-0135	649.93	135.03	457	80.33	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			669.2	D08		7	0037-0137	769.78	137.10	439	82.91	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3091.2	D08		7	0038-0140	523.99	140.31	478	84.33	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			786.0	D08		7	0039-0142	721.43	141.48	426	78.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			332.0	D08		7	0040-0146	451.98	146.47	778	109.74	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			462.7	D08		7	0041-0146	107.97	146.29	445	79.26	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1526.7	D08		7	0042-0148	135.96	147.29	444	84.33	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1029.3	D08		7	0043-0149	316.88	149.62	395	74.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4564.3	D08		7	0044-0154	781.79	154.36	461	87.15	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1913.5	D08		7	0045-0156	845.85	156.05	488	85.74	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			924.6	D08		7	0046-0162	363.17	161.47	444	84.67	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			734.4	D08		7	0047-0166	385.36	167.21	434	82.77	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			563.1	D08		7	0048-0172	184.53	172.77	562	92.81	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5223.9	D08		7	0049-0173	454.80	171.96	385	78.18	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			8482.4	D08		7	0050-0177	288.22	177.19	491	92.81	0.716
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			259.9	D08		7	0051-0178	528.37	178.22	462	85.15	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			563.3	D08		7	0052-0182	51.09	181.36	409	81.05	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1001.3	D08		7	0053-0194	217.97	194.61	776	108.47	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			683.8	D08		7	0054-0197	36.31	198.74	416	81.15	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			771.5	D08		7	0055-0194	138.10	194.57	402	78.08	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			293.2	D08		7	0056-0201	825.33	201.22	458	81.50	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			438.4	D08		7	0057-0208	730.55	207.85	446	88.57	0.714
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			250.0	D08		7	0058-0208	651.04	208.27	465	82.33	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			294.7	D08		7	0059-0209	931.10	209.15	402	78.18	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			286.5	D08		7	0060-0210	274.48	209.99	433	78.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2824.0	D08		7	0061-0213	760.79	212.74	447	80.91	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			201.0	D08		7	0062-0214	792.02	214.30	410	78.33	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			377.2	D08		7	0063-0221	335.11	221.41	436	81.50	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			228.9	D08		7	0064-0221	686.85	220.76	434	77.26	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			274.0	D08		7	0065-0226	873.19	225.05	349	72.33	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			242.2	D08		7	0066-0235	496.90	234.92	499	86.57	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1278.8	D08		7	0067-0239	853.50	238.86	887	116.37	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			252.5	D08		7	0068-0242	232.59	242.28	472	86.57	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			968.4	D08		7	0069-0250	596.44	249.54	397	76.81	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			395.1	D08		7	0070-0250	392.33	250.19	439	78.08	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			586.7	D08		7	0071-0253	203.63	253.94	172	82.91	0.314
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			608.8	D08		7	0072-0262	582.42	264.15	519	91.64	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			667.9	D08		7	0073-0274	91.69	274.93	849	123.54	0.699
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			547.8	D08		7	0074-0270	456.40	270.98	443	81.50	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4031.0	D08		7	0075-0276	191.03	275.28	408	79.40	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			237.6	D08		7	0076-0275	698.99	275.48	495	84.91	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			945.6	D08		7	0077-0279	151.50	279.75	427	83.40	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			709.8	D08		7	0078-0280	370.65	281.07	732	107.64	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4424.4	D08		7	0079-0279	493.68	278.87	455	82.33	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			286.8	D08		7	0080-0284	593.04	284.29	489	89.26	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			545.7	D08		7	0081-0295	181.32	296.34	462	87.15	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4104.8	D08		7	0082-0293	287.27	293.14	439	78.08	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2721.5	D08		7	0083-0293	398.40	293.43	479	89.15	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1517.4	D08		7	0084-0295	218.71	295.12	453	81.84	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			6365.4	D08		7	0085-0315	421.37	315.20	835	113.88	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			452.0	D08		7	0086-0310	316.18	309.58	428	79.74	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1106.3	D08		7	0087-0314	523.18	314.28	453	82.91	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1434.1	D08		7	0088-0316	619.29	316.35	441	79.26	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			903.0	D08		7	0089-0316	210.40	316.01	418	82.43	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			726.3	D08		7	0090-0329	749.51	328.37	902	121.64	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1104.0	D08		7	0091-0324	675.43	324.14	441	81.60	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			242.2	D08		7	0092-0324	697.35	323.76	542	89.01	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			210.6	D08		7	0093-0330	923.70	330.27	449	81.74	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			346.5	D08		7	0094-0333	865.05	333.11	417	79.50	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			796.2	D08		7	0095-0334	184.98	334.20	426	78.08	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			6381.1	D08		7	0096-0340	353.74	339.76	780	111.88	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			256.7	D08		7	0097-0337	503.83	337.39	471	87.98	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			264.2	D08		7	0098-0342	475.99	341.85	503	87.40	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			254.2	D08		7	0099-0352	433.49	352.00	279	62.18	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			355.9	D08		7	0100-0355	632.91	355.63	454	79.26	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			195.9	D08		7	0101-0357	886.90	357.71	400	75.01	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			236.2	D08		7	0102-0365	831.24	365.48	778	105.64	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			319.0	D08		7	0103-0372	28.17	372.53	757	109.84	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			818.1	D08		7	0104-0379	122.49	379.22	502	90.18	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4334.9	D08		7	0105-0383	142.26	381.40	342	74.43	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			203.4	D08		7	0106-0384	326.48	383.91	537	91.15	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			472.4	D08		7	0107-0385	592.79	385.21	478	82.91	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2131.5	D08		7	0108-0390	198.62	390.20	396	77.26	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1037.4	D08		7	0109-0390	648.07	390.05	430	79.26	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			212.1	D08		7	0110-0392	353.79	391.83	524	97.64	0.691
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			743.6	D08		7	0111-0395	155.03	396.14	484	86.81	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			221.3	D08		7	0112-0393	388.35	393.40	457	80.91	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			676.7	D08		7	0113-0401	715.27	400.99	439	83.74	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1654.7	D08		7	0114-0401	910.08	400.87	410	77.26	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			977.6	D08		7	0115-0402	80.39	401.50	410	78.08	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			202.4	D08		7	0116-0408	115.91	409.20	851	116.95	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1149.7	D08		7	0117-0406	47.71	407.15	428	79.60	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			199.9	D08		7	0118-0417	672.49	417.03	472	85.50	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2909.4	D08		7	0119-0419	258.24	419.29	418	75.26	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3029.0	D08		7	0120-0419	852.42	418.87	438	77.84	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1188.5	D08		7	0121-0422	462.95	422.00	463	84.57	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			245.7	D08		7	0122-0428	737.20	428.53	799	106.23	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1283.5	D08		7	0123-0426	357.00	426.46	420	78.91	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1403.0	D08		7	0124-0433	207.82	432.94	401	76.67	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1032.1	D08		7	0125-0439	548.38	439.23	853	114.71	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			478.8	D08		7	0126-0445	130.87	445.13	436	81.15	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			241.7	D08		7	0127-0446	872.69	446.15	435	79.50	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			366.6	D08		7	0128-0450	177.60	449.89	471	86.57	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			667.0	D08		7	0129-0458	504.55	457.94	831	112.13	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			646.2	D08		7	0130-0453	617.91	452.19	430	79.98	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			561.0	D08		7	0131-0460	330.60	460.23	433	78.08	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1624.6	D08		7	0132-0469	633.26	470.21	488	85.40	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			441.2	D08		7	0133-0468	685.96	468.34	437	78.91	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			685.3	D08		7	0134-0469	439.37	469.24	443	79.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			271.3	D08		7	0135-0469	568.45	470.06	280	84.08	0.498
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			265.3	D08		7	0136-0482	928.02	481.95	894	116.95	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			355.5	D08		7	0137-0483	224.25	482.98	421	78.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			264.1	D08		7	0138-0488	77.97	488.45	444	86.23	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2375.7	D08		7	0139-0489	119.46	489.20	400	77.74	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1128.6	D08		7	0140-0503	605.96	503.79	865	116.95	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			390.7	D08		7	0141-0497	448.54	497.80	458	85.15	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1479.8	D08		7	0142-0497	732.17	496.51	436	82.33	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			240.9	D08		7	0143-0497	846.56	496.51	448	80.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			455.4	D08		7	0144-0503	791.27	504.05	818	111.40	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			856.5	D08		7	0145-0504	534.13	504.29	423	77.26	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1575.3	D08		7	0146-0515	397.56	515.35	711	101.40	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1131.8	D08		7	0147-0514	492.38	514.36	432	78.08	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1133.6	D08		7	0148-0520	198.34	520.33	422	77.84	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			451.8	D08		7	0149-0530	560.96	529.57	474	82.57	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			260.0	D08		7	0150-0531	79.84	531.52	448	83.74	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			509.3	D08		7	0151-0534	692.82	534.27	465	85.74	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			288.1	D08		7	0152-0535	859.44	536.14	554	92.47	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			313.5	D08		7	0153-0539	427.78	539.12	414	80.67	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			359.1	D08		7	0154-0547	781.55	547.27	855	118.27	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			793.7	D08		7	0155-0543	216.52	543.56	474	84.33	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			665.6	D08		7	0156-0545	16.05	545.35	394	75.60	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1326.5	D08		7	0157-0546	129.51	546.04	410	80.81	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1868.5	D08		7	0158-0546	542.56	547.35	493	85.98	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			259.0	D08		7	0159-0548	312.37	548.53	846	119.05	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			644.4	D08		7	0160-0556	876.68	556.26	486	84.33	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5744.8	D08		7	0161-0559	421.15	559.94	631	96.91	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			547.1	D08		7	0162-0558	643.98	558.24	421	78.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1107.4	D08		7	0163-0559	697.13	559.46	444	83.50	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			886.1	D08		7	0164-0570	241.67	569.63	417	77.50	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3276.0	D08		7	0165-0574	335.74	574.52	423	81.98	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			544.0	D08		7	0166-0582	939.06	582.12	412	79.60	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			202.7	D08		7	0167-0585	53.65	585.14	766	105.64	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1560.7	D08		7	0168-0583	619.72	583.61	431	76.43	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			834.0	D08		7	0169-0585	567.84	585.96	426	78.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			740.3	D08		7	0170-0587	200.56	587.01	459	81.50	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			884.9	D08		7	0171-0586	381.16	586.27	433	80.91	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			722.6	D08		7	0172-0602	84.26	601.97	412	79.98	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1611.7	D08		7	0173-0608	779.71	607.96	426	77.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			700.1	D08		7	0174-0610	934.27	610.47	448	84.91	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			835.6	D08		7	0175-0612	143.13	612.04	417	84.57	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			979.2	D08		7	0176-0613	692.71	612.59	428	79.26	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			766.5	D08		7	0177-0615	439.99	614.55	437	80.08	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			442.3	D08		7	0178-0622	309.28	622.42	452	80.91	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5637.0	D08		7	0179-0623	216.34	623.50	469	83.26	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1695.1	D08		7	0180-0634	512.13	633.38	446	82.33	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			598.3	D08		7	0181-0636	62.85	636.45	401	76.67	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1548.3	D08		7	0182-0643	332.89	641.98	838	120.13	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			728.3	D08		7	0183-0645	399.66	644.48	449	81.84	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			244.2	D08		7	0184-0647	279.46	648.02	378	80.33	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			521.6	D08		7	0185-0651	639.67	650.98	435	79.01	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1395.2	D08		7	0186-0651	360.99	651.61	463	84.08	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			432.5	D08		7	0187-0655	250.20	654.26	469	86.57	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			544.0	D08		7	0188-0659	500.84	660.70	463	85.74	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			443.0	D08		7	0189-0655	433.42	656.14	379	75.70	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			208.5	D08		7	0190-0660	835.93	660.18	449	80.91	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2808.2	D08		7	0191-0669	391.30	670.27	462	88.81	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			164.1	D08		7	0192-0667	17.13	667.33	458	80.91	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			485.8	D08		7	0193-0667	193.70	667.19	437	79.50	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			287.6	D08		7	0194-0664	222.97	664.04	250	64.43	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			686.6	D08		7	0195-0669	130.34	669.31	415	83.15	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			243.4	D08		7	0196-0671	563.62	671.83	434	80.33	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			545.0	D08		7	0197-0674	744.60	674.36	401	75.50	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			319.5	D08		7	0198-0675	434.96	673.95	430	80.53	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			603.2	D08		7	0199-0680	247.12	680.98	481	89.15	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			987.0	D08		7	0200-0680	297.85	680.08	407	76.43	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			941.4	D08		7	0201-0679	881.66	679.17	397	75.01	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			668.4	D08		7	0202-0683	463.49	683.36	413	78.33	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			622.8	D08		7	0203-0689	910.76	689.07	428	78.67	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			186.9	D08		7	0204-0690	55.66	689.63	424	76.67	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			446.5	D08		7	0205-0698	689.45	697.40	443	86.23	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1106.9	D08		7	0206-0698	656.88	697.85	407	79.15	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1629.9	D08		7	0207-0703	605.62	703.64	412	76.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			290.9	D08		7	0208-0704	351.70	704.08	420	77.26	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			643.4	D08		7	0209-0704	531.98	704.73	484	84.67	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1096.9	D08		7	0210-0704	215.33	704.39	385	72.43	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			963.4	D08		7	0211-0709	508.12	709.51	296	69.84	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1795.6	D08		8	0001-0032	884.95	31.78	381	72.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			194.6	D08		8	0002-0036	369.69	35.91	465	82.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			355.9	D08		8	0003-0034	604.87	34.26	413	78.08	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			845.7	D08		8	0004-0039	695.81	39.74	434	85.64	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			997.8	D08		8	0005-0039	424.75	39.71	513	90.57	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5375.1	D08		8	0006-0042	59.13	41.84	406	76.67	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			216.7	D08		8	0007-0042	116.37	41.58	475	85.40	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			201.8	D08		8	0008-0053	446.51	51.28	509	86.23	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			321.4	D08		8	0009-0060	500.17	59.63	448	81.74	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			274.6	D08		8	0010-0061	133.24	61.79	472	84.33	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			637.7	D08		8	0011-0062	572.17	62.39	818	115.78	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			568.9	D08		8	0012-0065	460.15	66.11	402	78.23	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			540.5	D08		8	0013-0063	918.16	63.17	393	76.33	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1216.3	D08		8	0014-0066	744.30	66.04	400	75.01	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			707.5	D08		8	0015-0073	691.30	73.55	412	75.01	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			327.6	D08		8	0016-0073	860.83	73.44	448	82.57	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2157.8	D08		8	0017-0075	834.89	75.31	412	77.26	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1552.5	D08		8	0018-0078	776.98	78.13	421	78.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1246.1	D08		8	0019-0082	174.03	82.31	390	78.08	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			249.5	D08		8	0020-0083	273.25	83.30	414	77.26	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3068.0	D08		8	0021-0092	219.98	92.53	851	121.05	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			326.9	D08		8	0022-0085	109.71	85.02	386	72.43	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2582.0	D08		8	0023-0088	17.17	87.83	451	82.08	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1158.6	D08		8	0024-0093	44.18	92.84	455	81.50	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			344.4	D08		8	0025-0094	894.42	94.34	407	76.43	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			442.4	D08		8	0026-0098	431.25	98.10	437	83.15	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			874.5	D08		8	0027-0100	366.00	100.19	409	76.67	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2386.7	D08		8	0028-0110	622.43	110.49	865	119.98	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			511.0	D08		8	0029-0107	652.75	107.06	446	81.01	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			636.6	D08		8	0030-0111	703.55	110.95	404	76.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			232.4	D08		8	0031-0113	73.92	113.83	409	77.84	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			406.5	D08		8	0032-0114	142.14	114.63	404	78.91	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			386.7	D08		8	0033-0116	682.50	115.95	406	75.36	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			260.0	D08		8	0034-0119	820.27	119.15	422	77.26	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			982.6	D08		8	0035-0132	728.98	132.30	480	86.57	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			686.6	D08		8	0036-0131	552.04	130.76	407	76.67	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			197.0	D08		8	0037-0141	469.46	141.36	908	135.68	0.620
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1552.3	D08		8	0038-0132	614.30	132.68	390	79.36	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			324.3	D08		8	0039-0144	279.56	144.71	608	95.64	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1289.7	D08		8	0040-0143	414.75	143.33	406	77.50	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			341.8	D08		8	0041-0154	61.26	154.33	437	80.33	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			479.9	D08		8	0042-0153	869.81	153.09	405	77.26	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			552.6	D08		8	0043-0157	138.42	157.09	429	82.08	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2005.3	D08		8	0044-0157	562.84	158.13	412	80.33	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			267.3	D08		8	0045-0159	165.70	159.40	498	90.81	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1771.8	D08		8	0046-0165	521.33	164.82	413	76.67	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			390.7	D08		8	0047-0167	739.78	167.56	428	78.08	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1223.2	D08		8	0048-0168	624.74	168.55	454	80.77	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			421.3	D08		8	0049-0183	567.41	184.60	849	121.78	0.719
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			441.9	D08		8	0050-0183	384.62	183.38	418	79.50	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			478.3	D08		8	0051-0184	277.53	185.34	517	86.53	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1369.7	D08		8	0052-0184	694.35	183.56	388	75.26	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			854.4	D08		8	0053-0186	890.52	186.22	434	79.84	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1737.5	D08		8	0054-0195	913.07	195.23	848	119.15	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			371.1	D08		8	0055-0198	206.93	198.85	984	120.71	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			10818.9	D08		8	0056-0192	625.24	191.31	474	84.18	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			335.8	D08		8	0057-0200	484.87	201.08	671	104.37	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			264.2	D08		8	0058-0199	359.06	199.18	446	83.15	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			218.8	D08		8	0059-0200	527.88	200.43	408	79.15	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			661.3	D08		8	0060-0204	711.12	205.37	848	118.13	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			303.7	D08		8	0061-0205	666.68	205.58	439	80.67	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1060.3	D08		8	0062-0206	779.10	206.07	414	77.26	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			371.4	D08		8	0063-0214	276.88	213.77	792	116.43	0.734
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			304.7	D08		8	0064-0211	35.92	211.97	421	83.01	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			315.8	D08		8	0065-0211	447.74	211.02	441	84.23	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1348.5	D08		8	0066-0216	96.43	217.15	848	116.71	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			919.7	D08		8	0067-0217	253.06	216.84	436	81.01	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			258.9	D08		8	0068-0224	158.37	224.36	418	77.50	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1152.1	D08		8	0069-0228	583.30	228.46	464	85.15	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			794.6	D08		8	0070-0226	851.41	226.38	407	75.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			924.4	D08		8	0071-0237	309.49	237.76	822	113.40	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2487.2	D08		8	0072-0241	284.94	240.54	473	87.36	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1231.9	D08		8	0073-0242	529.69	242.68	413	77.26	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2190.2	D08		8	0074-0240	630.78	239.82	350	72.67	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1759.5	D08		8	0075-0244	789.97	244.51	403	78.33	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1391.0	D08		8	0076-0247	607.99	247.34	445	82.91	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			302.9	D08		8	0077-0260	332.57	260.05	459	82.67	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			307.1	D08		8	0078-0259	477.08	259.25	378	72.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			343.9	D08		8	0079-0260	692.38	261.20	452	80.53	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1481.0	D08		8	0080-0277	257.21	277.66	846	112.37	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3115.5	D08		8	0081-0276	832.37	276.41	609	96.33	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1123.7	D08		8	0082-0274	77.86	273.62	372	74.33	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2740.4	D08		8	0083-0277	649.69	277.28	452	78.67	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1320.6	D08		8	0084-0279	438.27	278.77	417	77.26	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			781.1	D08		8	0085-0284	185.71	284.27	400	77.74	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			235.7	D08		8	0086-0282	884.17	282.00	325	67.01	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			887.9	D08		8	0087-0284	913.06	284.55	406	75.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			284.3	D08		8	0088-0285	118.78	285.70	421	81.40	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			566.1	D08		8	0089-0284	691.85	283.76	461	83.36	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			767.1	D08		8	0090-0286	590.33	286.02	441	83.40	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			375.5	D08		8	0091-0289	62.19	290.24	495	87.05	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			249.6	D08		8	0092-0289	215.23	288.87	428	76.67	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			249.0	D08		8	0093-0292	545.64	292.36	775	106.23	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1104.0	D08		8	0094-0292	733.36	292.72	814	108.57	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			786.4	D08		8	0095-0292	385.56	292.55	865	120.81	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1252.0	D08		8	0096-0294	505.09	292.74	453	88.47	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			365.7	D08		8	0097-0301	945.77	302.32	413	79.26	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			737.7	D08		8	0098-0321	99.54	320.91	400	76.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			912.6	D08		8	0099-0321	502.87	321.41	431	77.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1656.9	D08		8	0100-0319	659.31	318.85	429	79.26	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			654.6	D08		8	0101-0336	890.29	336.90	826	119.68	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			411.5	D08		8	0102-0329	912.12	328.16	412	82.33	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			194.4	D08		8	0103-0332	28.83	332.23	415	79.15	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			909.6	D08		8	0104-0336	249.69	335.89	411	79.74	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			945.7	D08		8	0105-0334	844.38	334.08	456	79.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			773.3	D08		8	0106-0339	425.15	339.81	395	77.60	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			199.0	D08		8	0107-0340	652.93	341.37	469	84.91	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			275.0	D08		8	0108-0342	342.76	342.06	413	78.67	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			244.0	D08		8	0109-0341	386.82	341.56	467	83.50	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1403.3	D08		8	0110-0342	786.67	342.22	406	76.67	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			222.5	D08		8	0111-0348	449.67	347.65	724	104.91	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1786.4	D08		8	0112-0347	166.15	347.14	412	77.50	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			381.1	D08		8	0113-0358	547.03	358.86	868	122.85	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3806.7	D08		8	0114-0349	211.63	349.20	437	79.50	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1423.5	D08		8	0115-0357	711.60	357.80	419	78.91	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			799.1	D08		8	0116-0363	399.47	362.29	445	81.84	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			466.4	D08		8	0117-0372	497.55	372.35	460	81.84	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1936.7	D08		8	0118-0374	757.54	374.67	449	80.91	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			498.6	D08		8	0119-0376	601.74	376.51	426	79.74	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4540.7	D08		8	0120-0378	784.90	377.44	438	79.50	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			823.7	D08		8	0121-0381	304.43	382.27	420	80.18	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1033.5	D08		8	0122-0389	60.15	389.85	389	76.33	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			225.9	D08		8	0123-0393	428.91	394.39	864	118.37	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			206.9	D08		8	0124-0400	117.36	399.99	841	114.13	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			788.4	D08		8	0125-0391	520.05	391.20	456	84.91	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1697.7	D08		8	0126-0394	689.93	393.77	429	76.43	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			766.4	D08		8	0127-0396	907.28	396.73	421	79.84	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			226.1	D08		8	0128-0401	177.10	400.90	434	80.08	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1666.5	D08		8	0129-0403	15.32	402.92	373	72.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			229.4	D08		8	0130-0407	308.11	406.08	476	84.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			788.0	D08		8	0131-0405	651.10	405.55	421	78.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			597.4	D08		8	0132-0411	850.74	411.27	371	71.60	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1588.0	D08		8	0133-0413	581.10	413.40	417	79.74	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			374.0	D08		8	0134-0426	901.74	426.81	747	111.15	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			726.9	D08		8	0135-0421	543.54	421.25	415	78.08	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1745.7	D08		8	0136-0426	135.22	426.07	471	82.91	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			810.2	D08		8	0137-0427	707.94	427.17	405	75.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4162.5	D08		8	0138-0427	750.29	427.15	422	75.84	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			321.6	D08		8	0139-0434	360.23	432.85	438	79.40	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			251.3	D08		8	0140-0443	91.35	443.73	610	94.33	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			364.3	D08		8	0141-0443	856.02	443.55	415	77.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1701.6	D08		8	0142-0443	661.35	442.96	454	83.26	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1829.1	D08		8	0143-0444	808.91	444.31	394	76.08	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			258.0	D08		8	0144-0453	345.48	453.66	469	86.81	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			798.9	D08		8	0145-0451	637.49	450.89	417	77.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			259.4	D08		8	0146-0454	399.22	454.11	446	81.01	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			416.2	D08		8	0147-0455	420.93	455.57	486	86.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2163.4	D08		8	0148-0465	921.78	465.12	432	78.43	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1110.2	D08		8	0149-0465	558.52	464.69	343	71.26	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			742.7	D08		8	0150-0471	252.94	470.44	407	78.77	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3253.8	D08		8	0151-0477	732.29	477.24	423	78.91	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			580.3	D08		8	0152-0476	882.86	476.52	399	73.84	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			261.4	D08		8	0153-0485	32.98	484.12	857	113.54	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			849.8	D08		8	0154-0480	451.55	479.73	419	78.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			237.4	D08		8	0155-0481	500.13	481.23	432	84.33	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1904.2	D08		8	0156-0483	808.31	482.90	444	80.08	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1388.8	D08		8	0157-0482	830.66	481.79	391	81.01	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			663.2	D08		8	0158-0482	622.88	482.80	407	76.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2727.0	D08		8	0159-0485	145.41	485.34	387	77.50	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			202.9	D08		8	0160-0486	206.87	486.52	415	77.50	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1825.0	D08		8	0161-0488	778.91	488.46	406	77.50	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			513.7	D08		8	0162-0493	848.55	493.51	516	89.50	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			283.1	D08		8	0163-0488	409.37	488.78	298	66.08	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			228.0	D08		8	0164-0493	365.42	493.59	435	79.50	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1334.3	D08		8	0165-0496	569.92	495.85	422	79.50	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			722.5	D08		8	0166-0505	741.58	505.90	442	83.60	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			768.7	D08		8	0167-0506	480.71	505.89	443	81.84	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			222.5	D08		8	0168-0518	915.18	518.32	720	110.57	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1243.3	D08		8	0169-0515	647.73	514.94	420	78.08	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			210.8	D08		8	0170-0518	256.99	518.51	433	79.50	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			937.8	D08		8	0171-0523	135.34	522.72	392	76.08	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			794.5	D08		8	0172-0526	814.97	525.92	410	80.33	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			264.0	D08		8	0173-0526	194.48	526.48	394	76.08	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			179.9	D08		8	0174-0525	931.41	524.85	175	53.11	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			531.5	D08		8	0175-0535	746.35	535.25	891	126.47	0.700
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			307.1	D08		8	0176-0527	460.85	527.21	391	72.77	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			353.3	D08		8	0177-0528	366.17	528.27	407	78.67	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			333.8	D08		8	0178-0533	545.31	532.49	555	92.57	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			228.3	D08		8	0179-0544	226.15	544.19	422	78.08	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1265.9	D08		8	0180-0546	793.33	547.02	405	80.91	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			784.8	D08		8	0181-0552	696.30	551.94	410	78.67	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1732.4	D08		8	0182-0560	85.58	559.71	859	121.54	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2159.3	D08		8	0183-0556	404.04	556.74	407	75.50	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4289.8	D08		8	0184-0562	515.01	562.26	465	81.50	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			866.7	D08		8	0185-0564	800.48	565.21	445	86.08	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			869.3	D08		8	0186-0569	173.02	569.09	399	75.50	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			856.3	D08		8	0187-0573	556.41	572.86	403	75.60	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1924.0	D08		8	0188-0578	641.51	577.83	422	78.08	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1024.2	D08		8	0189-0579	740.58	578.80	406	75.50	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			235.3	D08		8	0190-0580	875.42	580.14	437	78.67	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			545.9	D08		8	0191-0585	44.22	584.44	406	84.81	0.709
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			996.9	D08		8	0192-0581	586.30	581.20	404	75.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			217.9	D08		8	0193-0583	324.64	583.53	438	79.50	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			213.0	D08		8	0194-0589	212.22	589.69	435	82.08	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			552.5	D08		8	0195-0595	263.91	595.35	398	77.50	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1983.7	D08		8	0196-0598	426.67	598.42	443	82.08	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			760.6	D08		8	0197-0612	39.00	612.44	432	80.57	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1162.1	D08		8	0198-0611	929.51	611.62	403	79.26	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			403.5	D08		8	0199-0621	82.16	621.05	720	100.57	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			246.9	D08		8	0200-0621	208.06	621.77	573	90.33	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			702.1	D08		8	0201-0619	718.53	619.30	403	74.67	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1200.5	D08		8	0202-0622	429.32	621.30	451	81.26	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			413.6	D08		8	0203-0624	604.82	624.31	425	79.98	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			856.4	D08		8	0204-0627	514.44	626.81	430	80.33	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1150.3	D08		8	0205-0639	318.06	638.75	414	76.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			789.2	D08		8	0206-0639	773.47	638.91	418	77.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1064.7	D08		8	0207-0641	142.44	641.40	392	76.57	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1174.7	D08		8	0208-0646	177.28	646.96	409	76.67	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			224.2	D08		8	0209-0650	67.26	650.15	436	79.26	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			211.1	D08		8	0210-0654	406.54	654.12	430	80.33	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			218.3	D08		8	0211-0660	226.56	660.44	421	78.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			292.0	D08		8	0212-0678	607.91	679.11	851	119.88	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			973.6	D08		8	0213-0674	926.64	673.75	396	75.26	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			450.7	D08		8	0214-0684	414.35	684.91	457	82.67	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			324.8	D08		8	0215-0693	180.42	693.41	765	108.13	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			622.3	D08		8	0216-0691	15.47	691.18	411	78.57	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			735.2	D08		8	0217-0695	389.16	695.35	428	82.57	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			485.9	D08		8	0218-0706	316.19	706.84	392	73.26	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			810.3	D08		9	0001-0031	802.21	31.36	377	73.60	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			224.0	D08		9	0002-0031	211.44	31.27	365	70.43	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			513.1	D08		9	0003-0036	582.69	37.25	373	73.74	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2377.5	D08		9	0004-0037	315.18	36.46	417	77.94	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			340.7	D08		9	0005-0040	243.56	39.76	391	75.26	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			649.4	D08		9	0006-0040	69.25	40.63	358	71.26	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			599.5	D08		9	0007-0043	158.62	42.87	383	74.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1284.9	D08		9	0008-0044	549.39	44.18	431	78.67	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			237.5	D08		9	0009-0044	838.91	44.74	396	74.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			232.2	D08		9	0010-0049	433.97	48.43	422	76.43	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			560.2	D08		9	0011-0056	108.85	56.12	370	71.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			678.0	D08		9	0012-0061	197.89	61.33	371	70.18	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1153.7	D08		9	0013-0063	232.85	63.48	376	74.77	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			518.1	D08		9	0014-0066	12.61	65.95	363	72.67	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			200.4	D08		9	0015-0074	412.99	73.90	420	78.18	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			251.6	D08		9	0016-0073	311.53	73.06	398	75.60	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1660.3	D08		9	0017-0078	615.73	77.56	424	77.84	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			518.7	D08		9	0018-0078	693.87	78.19	421	80.91	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			219.7	D08		9	0019-0081	174.00	80.92	364	74.43	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2271.5	D08		9	0020-0082	740.74	81.87	394	75.26	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1635.7	D08		9	0021-0084	358.91	84.33	395	74.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1573.5	D08		9	0022-0085	480.27	85.05	398	73.60	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1780.5	D08		9	0023-0091	867.98	90.87	374	72.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			680.2	D08		9	0024-0095	909.04	95.92	425	77.84	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			474.2	D08		9	0025-0095	122.55	94.82	359	70.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			277.5	D08		9	0026-0096	307.62	95.97	396	75.84	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			231.5	D08		9	0027-0100	709.31	100.82	473	83.26	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			259.0	D08		9	0028-0104	165.47	104.90	558	90.91	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			251.8	D08		9	0029-0102	609.70	102.70	415	76.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2675.4	D08		9	0030-0104	250.84	103.66	451	81.64	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			325.9	D08		9	0031-0101	932.48	101.56	414	79.11	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			361.1	D08		9	0032-0111	651.76	110.71	396	74.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2402.8	D08		9	0033-0117	265.59	118.91	350	71.15	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			501.1	D08		9	0034-0120	94.20	120.25	375	72.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			417.1	D08		9	0035-0127	711.28	125.36	426	82.33	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			253.2	D08		9	0036-0130	208.51	130.00	397	76.67	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1133.5	D08		9	0037-0134	141.97	134.27	378	75.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			670.9	D08		9	0038-0135	693.09	136.57	410	78.08	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1910.8	D08		9	0039-0138	866.97	137.64	357	70.43	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			538.0	D08		9	0040-0139	51.12	140.05	347	69.01	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			203.5	D08		9	0041-0140	353.61	139.65	376	72.18	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			875.1	D08		9	0042-0139	414.94	138.93	402	79.60	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1537.8	D08		9	0043-0140	286.49	139.79	389	74.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			228.7	D08		9	0044-0140	439.97	140.48	424	77.94	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1590.5	D08		9	0045-0145	914.10	145.16	386	72.43	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1268.1	D08		9	0046-0149	481.63	148.96	445	79.26	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			597.2	D08		9	0047-0159	553.86	159.17	840	114.91	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			430.4	D08		9	0048-0153	211.82	153.04	407	76.43	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			289.3	D08		9	0049-0159	99.45	159.36	413	77.74	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			243.5	D08		9	0050-0159	341.79	159.62	373	73.84	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			317.9	D08		9	0051-0159	277.39	159.59	351	69.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			894.0	D08		9	0052-0163	636.04	163.74	429	78.77	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1712.7	D08		9	0053-0163	660.28	162.67	412	76.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			239.0	D08		9	0054-0169	602.12	169.55	466	80.18	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			717.6	D08		9	0055-0169	465.80	168.72	422	78.67	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1007.1	D08		9	0056-0173	48.26	174.07	357	72.43	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			227.6	D08		9	0057-0179	376.57	178.90	426	79.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1709.7	D08		9	0058-0180	860.74	180.33	366	70.77	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2035.5	D08		9	0059-0187	683.04	187.15	393	76.43	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2104.4	D08		9	0060-0186	178.54	186.46	374	72.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2695.9	D08		9	0061-0196	298.97	196.05	817	112.91	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1838.3	D08		9	0062-0196	783.01	196.00	386	74.91	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			230.4	D08		9	0063-0204	102.44	205.02	417	78.91	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			249.2	D08		9	0064-0206	210.89	206.94	381	77.60	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			619.0	D08		9	0065-0209	412.21	209.50	459	80.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			239.0	D08		9	0066-0212	241.57	212.44	368	74.43	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			500.8	D08		9	0067-0210	391.73	210.62	391	73.70	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			291.6	D08		9	0068-0214	460.20	214.19	731	100.81	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1276.3	D08		9	0069-0212	681.99	212.12	440	80.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			381.0	D08		9	0070-0211	641.53	211.36	385	75.26	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1112.1	D08		9	0071-0215	571.82	215.76	385	74.67	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			333.8	D08		9	0072-0221	357.76	220.80	429	79.26	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1481.5	D08		9	0073-0222	309.49	222.98	389	78.18	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1228.9	D08		9	0074-0223	739.20	223.72	392	76.08	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1201.2	D08		9	0075-0227	205.50	226.76	434	80.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			276.5	D08		9	0076-0233	522.04	232.65	722	103.40	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			375.7	D08		9	0077-0233	717.89	233.06	548	93.40	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1658.7	D08		9	0078-0232	882.86	231.82	374	71.60	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			805.8	D08		9	0079-0242	370.93	242.04	567	91.74	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			285.6	D08		9	0080-0244	793.57	244.69	404	75.26	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1187.1	D08		9	0081-0247	296.20	247.12	377	73.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			864.0	D08		9	0082-0251	259.12	251.10	369	72.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			284.4	D08		9	0083-0251	549.31	251.59	444	78.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			373.1	D08		9	0084-0250	180.46	250.07	376	73.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1158.8	D08		9	0085-0252	587.08	251.82	386	75.84	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			709.3	D08		9	0086-0255	153.26	255.91	388	75.50	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1053.8	D08		9	0087-0256	77.61	256.50	386	74.43	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2925.0	D08		9	0088-0258	514.86	258.37	395	75.84	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			389.6	D08		9	0089-0258	846.26	258.51	396	73.01	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			318.1	D08		9	0090-0264	324.38	263.88	658	94.91	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			413.9	D08		9	0091-0262	671.84	262.19	432	80.91	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			672.4	D08		9	0092-0257	915.92	257.74	364	71.94	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			502.2	D08		9	0093-0264	887.34	264.27	349	75.36	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			10702.0	D08		9	0094-0273	410.97	273.28	409	75.01	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			384.4	D08		9	0095-0274	472.81	274.16	308	64.77	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1011.5	D08		9	0096-0280	581.72	280.94	420	76.08	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5334.0	D08		9	0097-0281	658.64	281.64	406	74.67	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			469.1	D08		9	0098-0283	791.94	282.76	373	73.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			544.8	D08		9	0099-0282	893.76	282.59	393	79.70	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1118.1	D08		9	0100-0289	208.49	288.97	393	76.08	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			873.9	D08		9	0101-0297	517.43	296.76	791	111.40	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			579.1	D08		9	0102-0291	73.87	291.40	377	71.84	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			187.5	D08		9	0103-0295	920.34	294.67	394	75.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			390.4	D08		9	0104-0296	719.32	296.25	389	76.08	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			329.8	D08		9	0105-0297	820.86	296.95	387	73.84	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			341.8	D08		9	0106-0304	162.89	304.23	724	104.57	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1859.8	D08		9	0107-0296	383.18	295.94	379	73.01	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1200.5	D08		9	0108-0298	261.09	298.23	391	73.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			183.6	D08		9	0109-0301	126.12	301.54	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1170.4	D08		9	0110-0301	900.33	301.91	402	82.18	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			324.2	D08		9	0111-0305	40.73	305.65	391	77.01	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1274.7	D08		9	0112-0306	200.21	307.44	419	82.91	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1616.1	D08		9	0113-0312	434.13	312.14	409	75.26	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1841.4	D08		9	0114-0316	880.46	315.48	381	73.50	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			765.4	D08		9	0115-0323	60.64	322.66	395	77.84	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			422.6	D08		9	0116-0324	317.09	323.94	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			315.8	D08		9	0117-0326	248.09	326.70	408	73.60	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			487.4	D08		9	0118-0325	635.30	324.89	385	73.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1649.8	D08		9	0119-0328	373.64	328.69	414	76.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1846.8	D08		9	0120-0333	478.24	333.17	391	73.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2085.9	D08		9	0121-0334	518.50	334.38	419	77.01	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1377.3	D08		9	0122-0340	574.93	340.26	413	75.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			170.5	D08		9	0123-0342	132.05	341.66	397	74.08	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			210.8	D08		9	0124-0346	929.21	345.80	380	75.94	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			234.6	D08		9	0125-0351	225.07	350.96	642	95.74	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			357.9	D08		9	0126-0349	846.02	349.50	381	73.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1041.7	D08		9	0127-0354	682.81	354.31	438	83.98	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			536.5	D08		9	0128-0358	520.07	357.55	423	78.18	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			284.4	D08		9	0129-0361	313.84	360.59	408	78.18	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1012.6	D08		9	0130-0361	810.32	360.87	426	77.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			747.1	D08		9	0131-0368	888.14	368.11	827	118.81	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			286.5	D08		9	0132-0365	295.33	366.12	359	75.21	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			537.5	D08		9	0133-0368	275.28	367.58	453	82.04	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			261.8	D08		9	0134-0369	122.11	369.40	389	76.43	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			421.1	D08		9	0135-0373	189.40	373.03	404	79.15	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			543.6	D08		9	0136-0384	71.53	384.19	382	74.43	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			697.9	D08		9	0137-0388	237.86	388.08	742	104.23	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			228.4	D08		9	0138-0391	207.08	391.67	461	83.84	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			795.8	D08		9	0139-0390	590.14	390.31	388	74.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			977.1	D08		9	0140-0391	753.46	391.08	394	74.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			368.1	D08		9	0141-0405	506.02	405.02	627	95.64	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			315.3	D08		9	0142-0409	630.87	409.11	412	75.60	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			793.3	D08		9	0143-0415	912.32	415.15	681	102.81	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			618.2	D08		9	0144-0413	410.62	413.37	395	73.84	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			246.0	D08		9	0145-0416	296.49	416.09	609	92.91	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			240.0	D08		9	0146-0415	210.30	414.22	360	72.53	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			307.0	D08		9	0147-0421	943.69	422.81	390	94.57	0.548
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			320.4	D08		9	0148-0424	144.14	422.40	940	120.95	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			735.6	D08		9	0149-0418	568.80	418.83	391	73.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			348.5	D08		9	0150-0426	458.36	426.56	387	71.60	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			784.5	D08		9	0151-0433	80.54	432.57	370	74.91	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1115.9	D08		9	0152-0439	352.40	439.52	386	74.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			229.8	D08		9	0153-0447	256.37	447.18	381	78.67	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			258.8	D08		9	0154-0450	757.46	449.77	377	73.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			206.7	D08		9	0155-0454	560.48	453.62	385	73.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			251.8	D08		9	0156-0458	870.25	458.05	663	95.74	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			556.8	D08		9	0157-0458	205.69	458.53	371	71.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			286.0	D08		9	0158-0458	329.27	458.74	406	75.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			237.2	D08		9	0159-0458	650.51	458.66	398	75.26	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			412.8	D08		9	0160-0462	520.47	462.25	402	75.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			259.3	D08		9	0161-0467	263.57	467.17	452	83.26	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2388.0	D08		9	0162-0468	16.54	467.93	374	71.84	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1728.6	D08		9	0163-0472	403.79	472.47	402	76.18	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			207.5	D08		9	0164-0477	903.92	477.48	517	86.33	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			425.9	D08		9	0165-0492	90.84	491.39	786	115.40	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			206.4	D08		9	0166-0487	942.99	487.59	362	71.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			234.6	D08		9	0167-0499	186.12	500.16	391	75.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			634.8	D08		9	0168-0502	514.94	502.30	403	74.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			265.7	D08		9	0169-0509	862.02	509.84	373	71.84	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			284.8	D08		9	0170-0512	468.13	511.72	397	75.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			259.0	D08		9	0171-0513	775.33	513.07	380	74.67	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			229.9	D08		9	0172-0517	556.44	516.30	415	79.50	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			231.9	D08		9	0173-0520	270.30	519.66	642	94.33	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			197.3	D08		9	0174-0520	181.41	520.11	444	82.18	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1242.7	D08		9	0175-0532	226.41	531.71	396	73.84	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			486.5	D08		9	0176-0537	542.74	538.48	362	74.77	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			210.0	D08		9	0177-0540	403.69	540.32	346	69.94	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			451.3	D08		9	0178-0545	561.00	545.00	297	67.60	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			645.9	D08		9	0179-0544	944.64	544.28	384	73.26	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1248.9	D08		9	0180-0546	841.98	546.34	389	72.43	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1085.6	D08		9	0181-0550	301.68	550.16	392	73.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			228.9	D08		9	0182-0561	415.75	561.58	694	106.23	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			493.5	D08		9	0183-0555	544.47	555.11	252	61.46	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			372.5	D08		9	0184-0562	514.95	562.28	417	76.67	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			248.7	D08		9	0185-0569	793.03	569.10	400	75.84	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2252.0	D08		9	0186-0572	258.47	571.14	339	70.91	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			226.5	D08		9	0187-0582	210.17	582.11	368	73.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1331.4	D08		9	0188-0584	273.44	585.56	492	85.88	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			318.0	D08		9	0189-0583	903.29	582.47	449	79.50	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1018.7	D08		9	0190-0586	660.06	585.62	380	73.84	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			536.4	D08		9	0191-0595	175.90	595.08	377	73.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			236.6	D08		9	0192-0601	327.94	601.43	383	73.01	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1381.5	D08		9	0193-0602	461.92	602.65	373	71.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1083.9	D08		9	0194-0611	659.43	611.53	398	74.67	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			472.8	D08		9	0195-0611	904.60	611.52	385	73.26	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1158.8	D08		9	0196-0615	23.70	614.59	387	75.01	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			203.4	D08		9	0197-0621	489.54	621.59	400	74.43	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			380.8	D08		9	0198-0623	814.69	623.36	394	74.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			701.6	D08		9	0199-0627	281.70	626.41	385	73.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1466.4	D08		9	0200-0631	862.18	631.39	385	73.60	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			417.5	D08		9	0201-0634	165.99	634.41	427	77.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			985.4	D08		9	0202-0648	628.33	646.60	406	78.33	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2372.7	D08		9	0203-0647	399.11	647.27	413	76.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			229.2	D08		9	0204-0647	522.59	648.08	369	73.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			228.0	D08		9	0205-0652	900.01	652.45	351	69.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			748.1	D08		9	0206-0655	100.16	655.09	375	76.33	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			211.1	D08		9	0207-0663	616.05	664.54	508	86.57	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			198.1	D08		9	0208-0667	123.12	666.61	455	80.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			656.1	D08		9	0209-0669	561.54	668.87	382	72.43	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			907.2	D08		9	0210-0676	20.62	676.36	402	73.84	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			835.2	D08		9	0211-0678	512.28	677.79	408	75.50	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			201.9	D08		9	0212-0678	676.22	677.75	470	82.08	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			211.2	D08		9	0213-0694	165.23	693.52	415	76.91	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			270.9	D08		9	0214-0699	536.83	699.76	921	117.30	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			258.0	D08		9	0215-0693	258.74	693.52	405	75.26	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			859.4	D08		9	0216-0696	605.92	696.41	379	73.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			182.3	D08		9	0217-0700	784.99	699.49	381	74.67	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			567.1	E08		1	0001-0030	45.07	30.65	419	80.67	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			447.7	E08		1	0002-0042	167.76	42.28	443	77.60	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			904.9	E08		1	0003-0041	625.93	41.06	415	75.01	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			320.7	E08		1	0004-0042	714.23	42.07	387	73.01	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1671.4	E08		1	0005-0046	412.33	45.77	490	84.57	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			884.6	E08		1	0006-0048	453.57	48.42	492	82.08	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1256.9	E08		1	0007-0053	567.12	53.63	471	82.08	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			522.8	E08		1	0008-0063	182.59	62.93	485	84.33	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			224.2	E08		1	0009-0067	34.57	67.11	550	86.91	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			218.3	E08		1	0010-0075	78.32	74.79	442	77.84	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			593.4	E08		1	0011-0073	829.94	73.27	221	56.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1119.2	E08		1	0012-0088	611.67	88.17	454	79.26	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			290.1	E08		1	0013-0088	502.07	88.60	548	90.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1335.2	E08		1	0014-0086	852.50	87.02	282	66.53	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			283.9	E08		1	0015-0091	719.29	91.65	462	80.08	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			623.0	E08		1	0016-0091	524.71	92.67	373	76.53	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			322.3	E08		1	0017-0098	47.05	98.76	435	77.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2733.8	E08		1	0018-0100	168.02	100.31	424	76.43	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			306.8	E08		1	0019-0100	281.75	99.91	402	73.60	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			450.5	E08		1	0020-0101	804.02	101.06	404	76.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			229.9	E08		1	0021-0101	759.55	101.44	445	79.84	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1132.5	E08		1	0022-0107	241.68	107.62	782	109.05	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			678.6	E08		1	0023-0107	355.42	107.05	439	76.43	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2202.7	E08		1	0024-0114	690.88	114.24	486	81.84	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			201.4	E08		1	0025-0121	127.38	120.85	508	89.74	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			484.3	E08		1	0026-0128	900.25	128.11	430	79.60	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1090.8	E08		1	0027-0133	881.34	132.98	363	74.18	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			305.9	E08		1	0028-0136	456.29	136.38	497	86.77	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			936.2	E08		1	0029-0143	481.89	143.29	489	88.67	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			805.1	E08		1	0030-0146	52.86	146.04	428	76.43	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			249.1	E08		1	0031-0149	733.33	148.93	470	84.08	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			785.2	E08		1	0032-0152	636.15	151.24	411	81.50	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1104.9	E08		1	0033-0156	179.65	155.98	413	75.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1704.8	E08		1	0034-0158	695.52	158.70	454	79.26	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3212.0	E08		1	0035-0163	356.63	163.51	438	80.67	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			7341.6	E08		1	0036-0167	538.52	166.59	422	77.26	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			774.4	E08		1	0037-0167	625.67	168.24	495	85.74	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			845.6	E08		1	0038-0181	256.69	180.51	798	105.40	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			838.4	E08		1	0039-0177	940.24	176.77	643	113.98	0.622
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			614.2	E08		1	0040-0182	919.56	184.38	246	70.43	0.623
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			250.1	E08		1	0041-0188	417.75	187.91	483	82.91	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1261.5	E08		1	0042-0193	890.39	193.06	442	76.67	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1313.2	E08		1	0043-0198	114.34	198.34	433	77.84	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1034.1	E08		1	0044-0197	159.98	196.69	427	75.84	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			842.6	E08		1	0045-0199	194.67	198.65	454	80.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2255.7	E08		1	0046-0201	473.12	201.79	429	77.26	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			474.7	E08		1	0047-0203	52.74	203.81	405	75.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			387.9	E08		1	0048-0205	90.17	204.94	458	80.91	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			705.5	E08		1	0049-0205	597.63	204.93	433	76.43	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			410.3	E08		1	0050-0207	801.58	207.66	443	78.67	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			970.1	E08		1	0051-0216	416.35	216.78	451	79.50	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			505.2	E08		1	0052-0222	646.65	223.11	432	79.50	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			273.6	E08		1	0053-0228	871.80	227.91	434	78.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1999.2	E08		1	0054-0226	549.57	226.53	449	78.43	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1068.8	E08		1	0055-0228	840.53	228.39	456	82.33	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			477.9	E08		1	0056-0230	38.92	230.56	395	73.26	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			524.8	E08		1	0057-0245	203.72	245.39	997	129.78	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			333.0	E08		1	0058-0242	477.31	241.90	432	77.26	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			208.5	E08		1	0059-0243	328.76	243.39	580	90.08	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			258.7	E08		1	0060-0251	898.82	251.02	446	77.84	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1235.4	E08		1	0061-0252	519.77	252.54	428	77.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2186.5	E08		1	0062-0253	294.10	253.48	444	77.84	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			236.0	E08		1	0063-0253	767.58	253.20	426	77.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1119.6	E08		1	0064-0262	151.82	262.30	429	77.01	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			428.4	E08		1	0065-0269	833.89	269.22	638	92.91	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			243.6	E08		1	0066-0272	70.77	270.22	706	105.30	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			745.8	E08		1	0067-0269	232.72	268.95	431	77.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1138.3	E08		1	0068-0269	364.87	269.58	436	79.50	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1380.2	E08		1	0069-0270	581.58	269.89	455	79.26	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			723.5	E08		1	0070-0281	485.61	280.87	432	78.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			330.8	E08		1	0071-0289	84.53	290.53	682	104.71	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			317.2	E08		1	0072-0289	194.45	288.69	460	80.67	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			550.8	E08		1	0073-0288	264.75	288.32	431	77.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			216.4	E08		1	0074-0293	797.62	293.31	481	84.08	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			367.9	E08		1	0075-0305	755.92	305.48	433	77.26	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1037.7	E08		1	0076-0304	24.11	305.07	407	77.26	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			873.2	E08		1	0077-0304	106.05	305.36	391	74.08	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			367.1	E08		1	0078-0311	708.14	311.30	480	83.74	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			248.1	E08		1	0079-0324	426.88	324.06	459	80.67	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2096.9	E08		1	0080-0325	155.70	324.92	410	75.26	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2267.7	E08		1	0081-0325	510.81	325.96	429	79.50	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			707.7	E08		1	0082-0328	277.00	327.76	413	75.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2102.4	E08		1	0083-0342	555.08	342.00	894	117.64	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			312.4	E08		1	0084-0345	354.40	344.76	908	122.57	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			212.7	E08		1	0085-0336	328.34	336.14	460	79.60	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1477.5	E08		1	0086-0337	189.42	337.44	426	77.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			337.4	E08		1	0087-0339	465.96	338.48	395	75.70	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			295.8	E08		1	0088-0339	801.06	339.25	480	81.26	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			291.9	E08		1	0089-0341	484.56	340.81	352	70.87	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			941.7	E08		1	0090-0351	904.71	350.58	428	78.08	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			682.6	E08		1	0091-0352	928.99	351.53	454	80.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			201.0	E08		1	0092-0351	95.71	351.12	406	75.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			490.5	E08		1	0093-0357	647.60	356.77	433	78.91	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			548.6	E08		1	0094-0370	457.83	370.44	943	123.64	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			682.5	E08		1	0095-0361	501.42	360.90	351	71.94	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			658.6	E08		1	0096-0371	663.63	371.45	456	84.57	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			418.9	E08		1	0097-0368	188.22	368.04	436	79.50	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			702.0	E08		1	0098-0371	596.97	371.40	448	79.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			530.6	E08		1	0099-0370	63.32	370.48	412	78.08	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			491.2	E08		1	0100-0369	275.88	369.77	423	76.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1357.3	E08		1	0101-0379	508.26	379.37	483	86.67	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			919.9	E08		1	0102-0380	816.50	380.84	437	79.50	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2597.7	E08		1	0103-0392	674.25	392.50	491	83.26	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			741.3	E08		1	0104-0392	134.34	392.60	425	76.43	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2472.4	E08		1	0105-0395	787.89	394.74	460	80.08	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3205.2	E08		1	0106-0397	710.62	397.69	428	77.84	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			398.5	E08		1	0107-0404	622.35	404.81	425	77.26	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			239.4	E08		1	0108-0408	927.12	408.71	622	92.91	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2562.7	E08		1	0109-0408	202.68	407.87	460	82.08	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			390.2	E08		1	0110-0410	447.45	410.02	447	79.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			726.1	E08		1	0111-0410	524.60	409.87	428	77.26	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2110.2	E08		1	0112-0412	230.55	412.57	450	80.08	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			931.1	E08		1	0113-0421	62.27	421.92	824	114.71	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			269.1	E08		1	0114-0414	389.83	414.33	420	76.91	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			890.3	E08		1	0115-0418	264.20	418.41	416	76.67	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1331.0	E08		1	0116-0419	884.01	419.03	418	77.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			190.6	E08		1	0117-0420	149.68	421.22	460	85.50	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			295.9	E08		1	0118-0424	786.24	424.27	462	82.18	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			281.9	E08		1	0119-0424	585.75	424.81	484	82.08	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			230.3	E08		1	0120-0424	113.98	424.14	456	78.67	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3868.8	E08		1	0121-0430	738.05	430.83	419	75.84	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			372.6	E08		1	0122-0437	548.25	437.22	430	77.26	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1096.8	E08		1	0123-0443	679.62	443.50	452	78.43	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1604.2	E08		1	0124-0452	452.68	451.69	956	125.68	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			891.9	E08		1	0125-0455	21.35	455.63	811	114.33	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			392.5	E08		1	0126-0448	861.22	449.47	388	74.04	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			410.6	E08		1	0127-0452	942.36	452.57	419	78.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			603.2	E08		1	0128-0455	97.13	455.50	413	79.84	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			444.6	E08		1	0129-0458	378.27	458.43	435	76.67	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			605.5	E08		1	0130-0461	192.39	459.84	436	78.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2152.3	E08		1	0131-0460	249.49	459.97	406	74.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1114.8	E08		1	0132-0463	493.64	462.81	434	78.08	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			210.4	E08		1	0133-0462	739.66	462.49	417	77.26	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			246.4	E08		1	0134-0470	301.00	469.97	456	82.08	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2954.3	E08		1	0135-0469	532.78	469.25	421	78.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			562.6	E08		1	0136-0467	582.60	466.82	405	74.18	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1005.9	E08		1	0137-0473	855.50	471.79	473	91.84	0.705
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1007.3	E08		1	0138-0475	110.41	475.53	551	93.60	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			901.4	E08		1	0139-0477	875.10	477.05	463	83.15	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			453.1	E08		1	0140-0476	680.21	476.62	444	77.84	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1350.9	E08		1	0141-0480	136.78	480.05	414	77.36	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			609.9	E08		1	0142-0490	209.33	490.94	904	124.23	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			584.5	E08		1	0143-0486	620.14	486.40	460	80.67	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			931.7	E08		1	0144-0485	752.77	484.45	423	76.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			226.2	E08		1	0145-0495	165.67	495.01	458	79.26	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			595.5	E08		1	0146-0498	885.52	498.56	448	80.33	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1023.1	E08		1	0147-0496	358.26	496.12	412	75.84	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1827.3	E08		1	0148-0502	272.90	501.84	428	78.08	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1257.5	E08		1	0149-0503	538.56	503.36	440	79.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			333.8	E08		1	0150-0504	591.68	504.75	436	77.84	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			376.6	E08		1	0151-0508	54.27	507.66	446	82.33	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			214.8	E08		1	0152-0510	455.95	510.37	437	78.91	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			285.0	E08		1	0153-0520	219.13	519.44	450	81.36	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			202.9	E08		1	0154-0522	187.38	522.40	432	83.50	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			441.1	E08		1	0155-0523	792.97	523.36	427	78.67	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			278.2	E08		1	0156-0527	307.68	528.11	430	80.53	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			615.3	E08		1	0157-0531	68.21	531.31	459	82.08	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1204.8	E08		1	0158-0529	624.88	529.41	418	77.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2722.9	E08		1	0159-0530	716.03	530.46	419	75.84	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			337.5	E08		1	0160-0529	850.33	529.04	149	80.57	0.288
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			705.6	E08		1	0161-0537	112.53	537.02	423	76.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			569.6	E08		1	0162-0543	18.86	543.23	388	76.08	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			315.7	E08		1	0163-0545	650.13	545.60	446	80.33	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			195.0	E08		1	0164-0546	936.83	546.77	456	82.43	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			211.2	E08		1	0165-0547	407.42	546.67	432	77.26	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			192.2	E08		1	0166-0549	307.82	547.82	469	84.53	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			490.4	E08		1	0167-0550	162.08	550.18	396	76.43	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			229.5	E08		1	0168-0550	588.08	550.21	436	76.43	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			373.8	E08		1	0169-0558	202.67	558.45	848	115.54	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			643.6	E08		1	0170-0555	49.17	555.21	173	51.11	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			365.7	E08		1	0171-0559	264.46	558.77	440	77.60	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			320.7	E08		1	0172-0567	884.03	567.85	446	79.84	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			472.3	E08		1	0173-0568	916.26	568.48	440	81.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			612.5	E08		1	0174-0569	340.67	568.74	461	80.91	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			264.4	E08		1	0175-0575	375.94	575.06	717	100.57	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1146.3	E08		1	0176-0572	492.05	571.93	452	79.26	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			896.4	E08		1	0177-0584	120.96	583.77	855	117.50	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			295.1	E08		1	0178-0588	729.45	587.53	442	78.67	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			216.4	E08		1	0179-0600	777.15	599.75	450	80.67	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			173.3	E08		1	0180-0601	931.97	601.38	424	78.91	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			229.4	E08		1	0181-0604	627.24	604.09	475	82.91	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			223.2	E08		1	0182-0606	347.15	606.58	459	81.26	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			306.3	E08		1	0183-0618	391.24	618.44	390	73.84	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2720.7	E08		1	0184-0620	797.93	620.38	546	91.60	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			477.8	E08		1	0185-0637	64.60	637.63	890	119.30	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			235.9	E08		1	0186-0631	719.70	631.93	467	81.60	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			490.7	E08		1	0187-0631	176.97	631.35	403	76.67	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			284.5	E08		1	0188-0631	697.91	631.62	408	74.53	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3790.8	E08		1	0189-0632	215.71	632.05	430	79.50	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			185.9	E08		1	0190-0637	18.73	637.73	398	78.91	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			230.0	E08		1	0191-0635	553.23	634.85	420	77.26	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			474.6	E08		1	0192-0640	93.70	640.64	451	79.74	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			324.0	E08		1	0193-0639	869.53	638.74	414	76.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			824.9	E08		1	0194-0643	330.43	643.90	423	76.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1753.9	E08		1	0195-0655	426.54	655.75	880	119.05	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			343.7	E08		1	0196-0651	773.20	651.09	440	77.84	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			290.8	E08		1	0197-0655	649.45	655.53	469	82.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			724.5	E08		1	0198-0655	388.48	654.75	422	78.67	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			294.4	E08		1	0199-0654	481.44	654.30	409	75.01	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			230.8	E08		1	0200-0660	517.44	660.08	452	80.91	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			557.4	E08		1	0201-0661	932.46	661.06	366	71.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			476.7	E08		1	0202-0662	256.71	662.73	437	83.60	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			250.4	E08		1	0203-0666	826.30	664.91	413	79.15	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			449.0	E08		1	0204-0678	175.43	678.36	407	77.11	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			281.3	E08		1	0205-0678	554.22	678.45	450	81.26	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			219.0	E08		1	0206-0678	633.42	677.98	463	82.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			189.6	E08		1	0207-0678	841.42	678.77	388	74.33	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			362.3	E08		1	0208-0682	195.20	682.98	450	81.11	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1405.6	E08		1	0209-0683	262.51	682.34	435	82.18	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			332.9	E08		1	0210-0688	499.60	687.89	420	78.43	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			439.3	E08		1	0211-0690	890.26	690.34	383	71.60	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			460.4	E08		1	0212-0693	757.85	693.38	439	78.08	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			211.7	E08		1	0213-0695	110.13	695.18	404	77.50	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			204.6	E08		1	0214-0702	565.03	701.68	495	86.08	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1099.1	E08		1	0215-0707	378.50	706.73	399	75.84	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			271.2	E08		1	0216-0708	471.87	707.00	351	73.26	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1366.4	E08		2	0001-0027	890.67	26.94	374	73.01	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			247.1	E08		2	0002-0034	802.74	33.78	411	77.26	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			914.5	E08		2	0003-0044	398.89	44.05	408	77.50	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1308.0	E08		2	0004-0045	267.59	45.26	384	75.01	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2105.4	E08		2	0005-0060	539.47	60.49	420	77.26	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			269.1	E08		2	0006-0061	333.18	61.84	459	82.67	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1971.0	E08		2	0007-0062	725.90	61.80	405	76.67	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1278.9	E08		2	0008-0070	697.13	69.59	751	109.40	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			241.0	E08		2	0009-0064	854.95	64.08	402	74.43	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			285.4	E08		2	0010-0068	564.60	67.98	393	74.43	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4322.9	E08		2	0011-0069	311.70	68.45	377	75.60	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1703.8	E08		2	0012-0074	139.75	73.75	380	73.26	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			912.8	E08		2	0013-0079	623.33	79.13	403	75.84	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			269.4	E08		2	0014-0080	806.89	80.21	477	87.26	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1117.5	E08		2	0015-0080	193.12	80.01	410	78.33	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			448.4	E08		2	0016-0080	243.00	80.22	382	75.26	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1272.4	E08		2	0017-0079	410.94	79.08	423	77.60	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			17053.2	E08		2	0018-0084	785.43	83.93	358	70.53	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			527.4	E08		2	0019-0093	67.94	93.43	387	76.08	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			302.7	E08		2	0020-0097	274.93	97.74	306	64.77	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2698.5	E08		2	0021-0104	136.10	104.59	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			846.0	E08		2	0022-0108	442.80	108.17	426	76.43	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			300.9	E08		2	0023-0111	362.97	110.55	364	71.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1414.9	E08		2	0024-0121	683.13	121.47	785	109.88	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			252.6	E08		2	0025-0123	483.35	123.12	381	73.26	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5591.7	E08		2	0026-0127	775.47	127.33	423	78.67	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			217.2	E08		2	0027-0130	354.62	131.04	437	81.50	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			798.1	E08		2	0028-0133	175.78	133.20	395	76.08	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1172.0	E08		2	0029-0133	850.39	133.45	427	78.67	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			805.7	E08		2	0030-0135	378.24	135.97	430	77.26	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			382.8	E08		2	0031-0140	234.73	139.82	400	76.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			937.7	E08		2	0032-0138	422.68	138.62	400	76.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			259.6	E08		2	0033-0147	100.48	147.50	491	83.50	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4521.9	E08		2	0034-0148	724.33	148.39	411	77.50	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1591.5	E08		2	0035-0149	909.00	149.21	391	75.60	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			216.3	E08		2	0036-0161	572.53	161.61	429	78.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			548.7	E08		2	0037-0166	805.96	164.76	428	77.98	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			273.6	E08		2	0038-0167	461.77	167.52	388	73.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1418.5	E08		2	0039-0169	138.99	169.37	396	73.01	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1500.1	E08		2	0040-0176	668.51	175.77	408	76.08	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			470.4	E08		2	0041-0170	27.63	170.20	115	43.11	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1595.7	E08		2	0042-0177	314.08	177.40	384	74.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			917.8	E08		2	0043-0179	46.42	178.70	548	92.57	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			697.2	E08		2	0044-0178	790.37	179.08	372	73.74	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1823.5	E08		2	0045-0182	402.87	182.10	409	75.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2053.8	E08		2	0046-0193	513.15	193.35	924	119.05	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			569.8	E08		2	0047-0184	24.07	185.47	235	66.43	0.669
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1083.2	E08		2	0048-0187	77.70	186.86	377	72.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			194.5	E08		2	0049-0187	877.36	186.70	392	74.08	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1012.7	E08		2	0050-0195	621.74	195.76	405	75.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			184.8	E08		2	0051-0193	258.36	193.62	382	75.60	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1700.9	E08		2	0052-0194	724.88	193.94	428	82.08	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1207.1	E08		2	0053-0203	168.99	203.55	395	76.67	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			709.6	E08		2	0054-0206	420.38	205.55	442	79.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1836.9	E08		2	0055-0207	827.80	207.35	418	75.01	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			845.7	E08		2	0056-0210	51.74	209.85	399	75.50	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			873.5	E08		2	0057-0222	369.13	222.56	396	74.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			360.4	E08		2	0058-0220	809.97	219.30	252	61.84	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			439.5	E08		2	0059-0225	138.35	225.82	377	76.33	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			297.5	E08		2	0060-0225	744.58	224.81	387	72.43	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			208.6	E08		2	0061-0227	215.53	227.48	439	82.67	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			890.9	E08		2	0062-0227	794.99	228.06	380	80.18	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			281.7	E08		2	0063-0238	563.83	238.32	597	91.26	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			880.6	E08		2	0064-0234	268.82	234.46	438	79.01	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			281.0	E08		2	0065-0248	329.53	248.37	391	74.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1085.2	E08		2	0066-0248	76.01	248.58	386	72.43	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			839.2	E08		2	0067-0258	791.77	257.78	926	128.23	0.708
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1544.5	E08		2	0068-0251	221.60	250.53	395	78.67	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			614.4	E08		2	0069-0251	679.71	251.58	412	75.01	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			222.2	E08		2	0070-0256	913.82	256.63	581	89.50	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1511.1	E08		2	0071-0260	634.98	259.87	382	72.77	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			219.8	E08		2	0072-0266	169.77	266.61	555	96.23	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			679.2	E08		2	0073-0264	451.20	264.72	414	76.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			702.3	E08		2	0074-0266	525.51	266.37	435	83.74	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1310.3	E08		2	0075-0274	371.77	274.85	796	111.64	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			281.8	E08		2	0076-0271	411.01	271.76	403	74.67	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1187.6	E08		2	0077-0270	500.82	269.96	400	77.01	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			244.7	E08		2	0078-0293	308.49	292.92	419	77.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1503.4	E08		2	0079-0294	470.07	294.22	400	77.50	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			291.0	E08		2	0080-0297	67.35	297.65	383	73.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			757.1	E08		2	0081-0302	901.77	302.16	369	72.87	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			283.5	E08		2	0082-0302	923.60	301.95	389	74.28	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			284.5	E08		2	0083-0305	581.73	305.14	373	71.84	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			204.2	E08		2	0084-0310	171.84	310.52	381	72.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			199.4	E08		2	0085-0312	544.73	312.04	408	74.18	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			368.5	E08		2	0086-0313	622.31	313.79	659	123.98	0.539
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1004.1	E08		2	0087-0318	272.44	318.88	401	73.36	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			646.1	E08		2	0088-0327	478.15	327.67	419	81.50	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			373.5	E08		2	0089-0329	142.75	328.87	383	71.60	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			630.9	E08		2	0090-0336	451.27	335.94	416	79.50	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			259.0	E08		2	0091-0339	252.17	339.52	404	75.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			374.9	E08		2	0092-0342	303.53	342.63	382	73.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			462.6	E08		2	0093-0344	403.85	343.81	406	78.91	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			723.6	E08		2	0094-0347	823.72	347.14	383	72.43	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1474.5	E08		2	0095-0348	69.00	348.26	383	74.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			219.9	E08		2	0096-0348	226.00	348.72	398	75.84	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			710.6	E08		2	0097-0352	33.51	352.30	399	76.91	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			288.4	E08		2	0098-0351	882.76	350.71	322	69.70	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1102.5	E08		2	0099-0362	151.49	362.52	394	74.67	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			905.8	E08		2	0100-0367	622.50	367.96	417	75.84	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			363.9	E08		2	0101-0371	347.12	371.36	439	78.67	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2618.8	E08		2	0102-0372	879.45	371.13	475	87.50	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2161.6	E08		2	0103-0380	574.82	380.03	402	76.08	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			619.6	E08		2	0104-0390	709.91	389.84	825	113.88	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1723.5	E08		2	0105-0388	95.79	388.54	386	75.50	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			503.0	E08		2	0106-0388	199.33	387.52	442	82.33	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2018.1	E08		2	0107-0390	526.13	389.65	420	80.57	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			217.5	E08		2	0108-0401	820.21	401.50	419	77.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			368.6	E08		2	0109-0402	510.01	403.04	445	80.08	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			871.3	E08		2	0110-0402	654.01	401.98	422	76.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			227.9	E08		2	0111-0406	219.36	406.64	536	89.64	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			678.6	E08		2	0112-0404	292.52	404.38	753	105.50	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			206.4	E08		2	0113-0409	30.77	409.53	628	93.15	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			206.9	E08		2	0114-0406	173.15	406.25	382	73.84	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			338.6	E08		2	0115-0408	120.03	408.10	388	75.26	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1203.6	E08		2	0116-0410	779.56	411.26	437	84.43	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1302.6	E08		2	0117-0413	750.21	412.69	398	75.60	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1164.8	E08		2	0118-0441	495.53	441.66	922	128.81	0.698
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			410.5	E08		2	0119-0435	202.35	435.47	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1900.8	E08		2	0120-0436	438.90	436.64	395	75.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			277.0	E08		2	0121-0439	144.52	438.62	374	72.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			238.8	E08		2	0122-0444	560.08	444.52	417	76.43	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			379.3	E08		2	0123-0453	46.63	453.32	389	75.84	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1776.8	E08		2	0124-0451	476.99	452.07	314	69.94	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			189.0	E08		2	0125-0449	761.44	448.87	161	77.50	0.337
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			907.5	E08		2	0126-0454	380.38	454.11	412	76.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			445.0	E08		2	0127-0457	649.09	457.94	398	76.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			556.2	E08		2	0128-0460	248.91	459.73	375	74.91	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			354.7	E08		2	0129-0471	91.12	471.08	805	114.47	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			194.0	E08		2	0130-0466	923.56	466.10	402	74.67	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5243.7	E08		2	0131-0477	221.96	477.90	722	103.05	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1760.6	E08		2	0132-0473	126.82	472.96	380	72.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			253.6	E08		2	0133-0472	870.35	472.08	319	66.18	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			246.9	E08		2	0134-0475	296.63	475.43	382	75.50	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4596.4	E08		2	0135-0477	173.58	476.81	382	73.84	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			302.8	E08		2	0136-0481	602.06	481.41	489	82.67	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			462.2	E08		2	0137-0490	676.30	490.47	392	75.26	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			214.7	E08		2	0138-0500	890.82	500.70	374	72.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			223.9	E08		2	0139-0501	940.01	500.65	370	73.01	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1598.6	E08		2	0140-0499	617.99	499.08	269	64.43	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			233.7	E08		2	0141-0506	302.68	506.09	559	89.40	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			210.9	E08		2	0142-0504	163.22	503.63	432	81.40	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			209.9	E08		2	0143-0504	847.40	504.03	393	74.43	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			393.5	E08		2	0144-0513	603.02	513.03	283	82.08	0.528
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			274.7	E08		2	0145-0527	375.90	526.51	730	103.05	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			152.6	E08		2	0146-0531	777.66	531.02	435	78.67	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			380.4	E08		2	0147-0540	145.54	540.61	745	109.15	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3053.1	E08		2	0148-0533	531.60	533.96	399	77.50	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1636.0	E08		2	0149-0534	666.34	534.51	401	74.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			307.8	E08		2	0150-0541	707.75	541.05	253	77.84	0.525
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			180.8	E08		2	0151-0547	41.41	547.08	409	78.67	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			206.5	E08		2	0152-0548	73.99	548.39	407	75.26	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			266.6	E08		2	0153-0555	105.27	555.72	398	75.84	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			274.1	E08		2	0154-0551	653.87	551.61	207	52.53	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			254.5	E08		2	0155-0558	832.33	558.28	416	79.26	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1612.6	E08		2	0156-0559	572.73	560.47	817	118.57	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1734.9	E08		2	0157-0560	929.68	559.82	380	74.43	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			468.5	E08		2	0158-0569	20.54	569.14	412	80.33	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			228.7	E08		2	0159-0566	270.34	566.66	420	77.26	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			925.3	E08		2	0160-0576	633.39	576.43	400	73.60	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			220.7	E08		2	0161-0581	471.44	581.79	526	85.50	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			415.3	E08		2	0162-0580	347.13	580.43	396	75.84	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			229.5	E08		2	0163-0582	505.16	581.77	399	73.84	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1514.6	E08		2	0164-0589	591.50	589.08	371	71.26	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			998.2	E08		2	0165-0591	682.30	591.53	370	71.84	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1621.0	E08		2	0166-0600	105.82	600.27	371	71.60	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			356.2	E08		2	0167-0601	285.15	601.69	377	71.84	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			220.4	E08		2	0168-0600	717.83	600.31	422	77.84	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			210.9	E08		2	0169-0602	35.81	602.43	398	73.84	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			676.7	E08		2	0170-0604	200.19	604.23	457	82.08	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1165.2	E08		2	0171-0604	540.79	603.75	393	73.84	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			327.7	E08		2	0172-0609	327.17	609.00	407	77.26	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			568.8	E08		2	0173-0609	774.63	609.18	414	75.36	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			322.8	E08		2	0174-0613	797.36	612.87	461	80.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			745.1	E08		2	0175-0626	196.09	626.48	437	81.60	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1247.3	E08		2	0176-0632	421.06	632.33	407	77.26	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			250.9	E08		2	0177-0646	106.32	646.56	414	76.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			201.0	E08		2	0178-0660	737.33	659.93	429	84.47	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			898.6	E08		2	0179-0657	466.58	656.53	399	79.26	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			453.3	E08		2	0180-0660	350.58	660.47	385	73.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			280.5	E08		2	0181-0661	524.65	661.60	401	74.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			598.8	E08		2	0182-0661	774.24	662.08	435	81.74	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			537.2	E08		2	0183-0662	36.19	661.90	361	71.84	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1224.7	E08		2	0184-0671	157.97	671.75	818	111.40	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			787.6	E08		2	0185-0662	872.90	662.01	666	128.61	0.506
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			743.2	E08		2	0186-0666	289.22	666.21	380	74.08	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1214.4	E08		2	0187-0674	70.95	674.70	366	75.01	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1024.9	E08		2	0188-0677	235.00	676.63	377	73.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			228.6	E08		2	0189-0684	563.26	684.31	396	73.84	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			383.4	E08		2	0190-0691	449.32	690.88	405	76.91	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			174.3	E08		2	0191-0696	716.43	696.13	248	75.50	0.547
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			198.3	E08		2	0192-0702	342.18	702.41	490	87.40	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			471.0	E08		2	0193-0702	591.30	701.65	379	73.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			448.2	E08		3	0001-0028	415.24	28.39	399	76.08	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4588.8	E08		3	0002-0036	582.81	36.50	835	114.95	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1115.7	E08		3	0003-0047	790.25	47.08	573	92.81	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			259.7	E08		3	0004-0047	632.71	47.54	348	69.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1550.5	E08		3	0005-0049	842.21	49.68	380	74.08	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1230.2	E08		3	0006-0059	49.64	58.78	679	99.98	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			738.1	E08		3	0007-0060	451.37	60.22	416	75.84	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			309.8	E08		3	0008-0064	479.63	62.90	740	108.81	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			215.6	E08		3	0009-0067	192.44	67.96	397	75.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			233.2	E08		3	0010-0067	523.81	67.54	485	83.26	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			407.3	E08		3	0011-0073	252.22	73.24	390	75.50	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1594.0	E08		3	0012-0076	425.67	75.91	395	75.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			420.8	E08		3	0013-0076	760.09	75.86	341	69.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1768.9	E08		3	0014-0076	803.99	77.07	365	72.18	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			305.8	E08		3	0015-0079	104.63	79.58	364	71.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			216.6	E08		3	0016-0081	144.10	81.90	430	80.08	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1028.9	E08		3	0017-0087	231.50	86.77	441	82.91	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			395.7	E08		3	0018-0093	904.56	92.91	288	64.18	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2284.6	E08		3	0019-0099	632.40	98.90	380	75.50	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1280.7	E08		3	0020-0099	801.64	99.31	406	77.36	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			296.6	E08		3	0021-0101	606.85	101.13	443	82.33	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			890.0	E08		3	0022-0104	69.86	104.40	367	71.60	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			7455.5	E08		3	0023-0109	554.71	109.17	424	76.67	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1087.8	E08		3	0024-0111	520.13	111.51	384	73.01	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			671.1	E08		3	0025-0117	491.15	117.00	391	73.36	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1369.7	E08		3	0026-0121	454.17	121.55	394	75.94	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5505.7	E08		3	0027-0120	664.67	120.27	349	68.77	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			208.5	E08		3	0028-0125	605.34	126.10	451	82.43	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			479.7	E08		3	0029-0128	760.48	127.64	369	73.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			400.6	E08		3	0030-0133	283.91	133.14	379	77.74	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2170.5	E08		3	0031-0139	43.87	140.08	647	96.33	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			525.1	E08		3	0032-0141	838.44	141.63	356	70.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1147.9	E08		3	0033-0144	462.69	143.91	345	71.60	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			210.6	E08		3	0034-0147	403.48	147.68	423	79.74	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			908.9	E08		3	0035-0145	556.73	145.56	373	72.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			730.3	E08		3	0036-0148	936.63	147.82	359	70.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			292.5	E08		3	0037-0161	105.56	160.15	819	113.74	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			404.0	E08		3	0038-0161	159.37	161.40	377	74.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			218.0	E08		3	0039-0164	694.96	163.46	415	78.57	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			736.2	E08		3	0040-0165	620.89	164.85	366	71.84	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3187.3	E08		3	0041-0168	542.45	167.59	374	70.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1556.4	E08		3	0042-0172	861.79	172.65	398	74.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			475.6	E08		3	0043-0174	581.78	175.04	388	72.43	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			670.9	E08		3	0044-0177	683.05	178.30	328	70.91	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			201.4	E08		3	0045-0180	195.44	180.37	403	77.84	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			273.9	E08		3	0046-0181	308.26	180.58	310	72.53	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			256.8	E08		3	0047-0192	761.51	191.65	599	91.26	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			686.7	E08		3	0048-0194	31.71	193.70	709	107.74	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			252.8	E08		3	0049-0193	307.19	192.85	192	57.11	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			506.4	E08		3	0050-0210	253.54	209.53	363	71.26	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1664.2	E08		3	0051-0214	662.03	214.98	374	73.84	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			356.9	E08		3	0052-0225	202.17	225.33	359	70.67	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			502.8	E08		3	0053-0233	894.48	232.88	741	113.20	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			369.4	E08		3	0054-0226	681.37	224.84	416	77.74	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			700.2	E08		3	0055-0226	622.13	226.02	368	72.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			223.5	E08		3	0056-0230	231.70	229.44	406	77.50	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3552.5	E08		3	0057-0229	432.85	229.64	372	71.84	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3102.4	E08		3	0058-0233	377.23	232.95	380	72.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			890.5	E08		3	0059-0238	698.28	238.85	444	79.15	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1122.5	E08		3	0060-0239	113.51	238.68	366	72.67	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5722.8	E08		3	0061-0248	500.11	247.44	356	70.67	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			246.4	E08		3	0062-0251	752.47	251.41	385	75.26	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			388.3	E08		3	0063-0256	162.63	255.61	376	76.91	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3033.9	E08		3	0064-0276	640.98	276.20	848	126.02	0.671
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			653.2	E08		3	0065-0267	864.53	267.31	398	74.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			202.0	E08		3	0066-0277	682.08	277.03	520	85.50	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			898.2	E08		3	0067-0280	937.73	280.03	369	72.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3288.4	E08		3	0068-0282	619.21	283.03	418	80.67	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			343.3	E08		3	0069-0283	243.07	283.34	402	77.50	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			239.4	E08		3	0070-0286	502.83	286.56	398	75.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			203.1	E08		3	0071-0297	168.63	296.89	692	98.33	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1095.1	E08		3	0072-0293	818.20	293.63	379	73.01	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			727.7	E08		3	0073-0295	365.72	296.06	381	73.26	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			527.9	E08		3	0074-0299	700.88	298.65	369	72.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			966.9	E08		3	0075-0304	116.70	303.98	384	75.26	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			235.2	E08		3	0076-0316	211.94	316.42	415	75.01	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			684.6	E08		3	0077-0329	802.76	329.64	374	71.01	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			987.0	E08		3	0078-0326	851.75	326.91	277	65.60	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			838.5	E08		3	0079-0340	682.57	340.35	401	76.67	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			279.5	E08		3	0080-0346	414.42	345.62	377	70.77	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4862.5	E08		3	0081-0351	596.96	351.22	418	77.60	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			343.8	E08		3	0082-0353	446.26	353.58	383	73.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1110.2	E08		3	0083-0355	895.73	355.83	370	72.67	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			457.2	E08		3	0084-0363	202.60	363.08	387	74.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			640.7	E08		3	0085-0368	142.99	367.77	372	77.84	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1508.5	E08		3	0086-0368	796.25	368.49	398	75.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			976.1	E08		3	0087-0370	633.01	370.73	390	73.84	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			629.9	E08		3	0088-0373	817.02	373.12	337	67.11	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2790.0	E08		3	0089-0376	858.96	376.34	183	53.94	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			926.0	E08		3	0090-0381	323.92	381.41	369	71.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1188.4	E08		3	0091-0384	710.82	384.50	772	107.74	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			273.5	E08		3	0092-0392	230.06	392.60	411	78.91	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			879.7	E08		3	0093-0389	667.16	389.10	379	75.01	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			447.3	E08		3	0094-0390	911.86	389.80	341	71.60	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			967.6	E08		3	0095-0393	139.73	394.28	338	68.18	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			542.5	E08		3	0096-0397	444.60	396.62	591	99.84	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1125.2	E08		3	0097-0399	533.28	399.79	365	72.67	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			241.3	E08		3	0098-0402	246.58	402.44	379	75.26	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			402.9	E08		3	0099-0404	357.90	403.92	369	72.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			405.5	E08		3	0100-0415	486.20	414.77	845	118.61	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			197.0	E08		3	0101-0421	164.73	421.37	387	76.43	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			509.8	E08		3	0102-0421	285.05	421.10	395	73.84	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1072.4	E08		3	0103-0427	465.41	427.88	436	79.98	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			869.3	E08		3	0104-0427	322.12	427.69	395	73.26	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			655.7	E08		3	0105-0430	638.37	430.24	746	107.05	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1603.8	E08		3	0106-0430	686.73	430.73	378	73.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			298.0	E08		3	0107-0434	108.10	433.85	387	73.84	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1170.5	E08		3	0108-0437	59.84	437.40	376	72.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			281.3	E08		3	0109-0439	611.79	439.72	327	67.26	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			286.4	E08		3	0110-0452	856.28	453.15	186	66.77	0.524
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1181.4	E08		3	0111-0462	894.04	461.91	377	72.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			266.3	E08		3	0112-0469	598.73	470.62	823	111.54	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			187.8	E08		3	0113-0466	199.40	465.88	395	76.43	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			226.1	E08		3	0114-0463	864.99	464.80	169	61.11	0.569
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			197.9	E08		3	0115-0468	18.62	468.60	375	72.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			828.0	E08		3	0116-0477	537.51	477.00	395	73.84	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1051.1	E08		3	0117-0480	53.51	480.49	349	71.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			608.6	E08		3	0118-0489	512.63	489.10	419	78.33	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			345.4	E08		3	0119-0487	713.79	487.75	393	75.01	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1071.5	E08		3	0120-0488	757.30	487.96	396	76.43	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			325.9	E08		3	0121-0496	472.71	496.72	389	73.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			278.9	E08		3	0122-0498	409.66	497.78	366	71.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			250.5	E08		3	0123-0503	35.08	503.00	328	68.77	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			184.8	E08		3	0124-0506	169.29	506.84	401	77.60	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			332.7	E08		3	0125-0503	870.94	502.71	369	74.43	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			648.8	E08		3	0126-0513	109.46	513.19	361	72.43	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			269.2	E08		3	0127-0525	449.52	527.03	799	124.81	0.645
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			857.4	E08		3	0128-0515	252.53	515.56	362	73.84	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			756.7	E08		3	0129-0517	190.70	517.05	390	76.33	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			975.3	E08		3	0130-0517	776.83	517.42	340	68.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			758.6	E08		3	0131-0515	808.51	515.00	361	70.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			210.7	E08		3	0132-0521	742.37	520.71	393	75.26	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			189.7	E08		3	0133-0523	296.24	523.06	380	73.26	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			257.3	E08		3	0134-0527	339.69	527.96	523	127.30	0.406
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1679.1	E08		3	0135-0526	587.22	526.52	410	75.36	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1067.4	E08		3	0136-0530	680.35	529.55	417	77.26	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			338.3	E08		3	0137-0531	419.13	531.53	366	72.43	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1159.4	E08		3	0138-0534	548.07	534.35	414	78.08	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			667.1	E08		3	0139-0540	362.14	540.66	391	77.50	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			232.9	E08		3	0140-0545	139.63	544.61	373	77.50	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			790.0	E08		3	0141-0549	525.84	548.52	465	82.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1116.0	E08		3	0142-0556	83.76	556.33	752	107.40	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			236.2	E08		3	0143-0545	688.86	545.38	210	58.77	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			280.3	E08		3	0144-0552	271.47	551.69	372	76.08	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			790.7	E08		3	0145-0557	400.75	557.74	400	75.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			927.5	E08		3	0146-0558	57.64	557.53	415	78.67	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			400.0	E08		3	0147-0557	669.21	557.34	312	65.36	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1813.2	E08		3	0148-0562	24.51	562.19	357	71.60	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			200.7	E08		3	0149-0563	135.43	563.83	398	77.84	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			203.5	E08		3	0150-0563	342.88	563.66	410	79.01	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1249.8	E08		3	0151-0571	182.53	571.83	359	72.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			964.0	E08		3	0152-0581	582.33	580.93	438	79.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1089.8	E08		3	0153-0590	358.55	589.37	813	117.40	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			988.9	E08		3	0154-0586	902.42	586.52	384	73.26	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1687.8	E08		3	0155-0589	448.82	589.10	400	76.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			658.5	E08		3	0156-0593	768.02	593.82	407	74.08	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			975.9	E08		3	0157-0595	502.68	596.04	364	71.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			320.8	E08		3	0158-0604	831.40	603.98	362	73.60	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2242.6	E08		3	0159-0609	640.19	610.11	432	80.33	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1478.6	E08		3	0160-0611	850.23	611.63	370	74.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1446.7	E08		3	0161-0615	610.75	615.08	382	74.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			178.7	E08		3	0162-0628	536.77	627.71	417	78.08	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1211.2	E08		3	0163-0629	888.03	629.44	361	69.84	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1086.4	E08		3	0164-0638	173.63	638.96	773	108.23	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			941.0	E08		3	0165-0632	368.35	632.47	374	72.18	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			228.8	E08		3	0166-0635	289.51	635.13	365	72.43	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			197.8	E08		3	0167-0635	466.65	635.64	364	71.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			199.6	E08		3	0168-0640	241.54	639.77	373	75.01	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			225.9	E08		3	0169-0646	811.99	645.99	397	76.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			333.8	E08		3	0170-0653	50.79	652.78	721	100.23	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			179.6	E08		3	0171-0657	403.07	657.42	389	75.94	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1005.0	E08		3	0172-0669	131.11	669.24	419	79.74	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			870.5	E08		3	0173-0666	790.26	666.03	364	71.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			969.4	E08		3	0174-0669	769.70	669.44	437	82.67	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			580.2	E08		3	0175-0670	282.60	669.71	408	77.50	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			773.8	E08		3	0176-0670	336.02	669.89	373	72.67	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			437.8	E08		3	0177-0676	711.71	675.45	327	70.67	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			453.0	E08		3	0178-0675	902.93	675.77	440	80.57	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1283.7	E08		3	0179-0678	399.08	677.28	461	83.26	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			284.9	E08		3	0180-0679	461.52	678.85	335	71.70	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			328.0	E08		3	0181-0681	480.11	681.06	401	74.87	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			422.7	E08		3	0182-0683	883.11	684.29	410	76.33	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			706.1	E08		3	0183-0686	522.20	685.85	368	71.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			266.6	E08		3	0184-0687	119.99	686.81	247	61.26	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			176.2	E08		3	0185-0690	171.31	690.63	386	73.84	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			583.1	E08		3	0186-0692	290.70	692.65	416	78.67	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			219.2	E08		3	0187-0693	698.95	693.60	331	68.43	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			286.2	E08		3	0188-0696	753.16	696.63	394	74.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2479.1	E08		3	0189-0702	238.41	702.66	741	105.40	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1183.8	E08		4	0001-0029	376.31	29.33	422	79.50	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			243.3	E08		4	0002-0030	469.53	29.71	401	77.50	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			208.9	E08		4	0003-0032	326.73	31.62	416	76.67	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1304.0	E08		4	0004-0035	166.80	35.50	385	74.67	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			510.6	E08		4	0005-0034	539.01	34.48	445	82.43	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			742.7	E08		4	0006-0034	38.45	34.57	375	74.33	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			275.8	E08		4	0007-0036	206.75	36.76	415	80.57	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2399.9	E08		4	0008-0042	639.40	41.71	375	73.50	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			559.2	E08		4	0009-0047	481.05	47.22	481	85.98	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			304.3	E08		4	0010-0051	403.40	51.21	468	82.33	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			810.8	E08		4	0011-0061	606.13	61.23	465	82.08	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2043.1	E08		4	0012-0061	870.01	62.05	423	76.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2875.4	E08		4	0013-0064	814.30	64.40	384	72.77	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			230.9	E08		4	0014-0070	776.89	69.91	432	80.08	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			924.5	E08		4	0015-0069	362.99	69.22	421	80.33	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			493.0	E08		4	0016-0075	690.51	75.10	436	78.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1235.1	E08		4	0017-0076	236.77	76.65	410	77.50	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1341.4	E08		4	0018-0077	538.56	77.41	475	87.15	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			280.7	E08		4	0019-0084	839.75	83.66	374	72.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1581.6	E08		4	0020-0087	511.66	87.27	484	87.15	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1231.2	E08		4	0021-0100	67.65	99.83	411	77.26	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			519.0	E08		4	0022-0102	191.26	101.85	442	80.67	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			229.1	E08		4	0023-0106	411.29	105.96	766	104.91	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			389.7	E08		4	0024-0103	436.90	103.15	459	81.36	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			549.9	E08		4	0025-0103	24.48	103.70	398	75.84	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1644.7	E08		4	0026-0108	564.96	108.42	928	128.95	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1195.7	E08		4	0027-0110	667.55	110.64	870	122.95	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			451.1	E08		4	0028-0108	915.24	107.70	423	78.43	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2166.2	E08		4	0029-0119	369.86	119.71	872	117.64	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			263.5	E08		4	0030-0117	483.56	116.96	693	99.98	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1699.2	E08		4	0031-0133	735.08	133.36	872	128.51	0.664
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			299.5	E08		4	0032-0132	793.21	132.41	434	79.50	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2883.9	E08		4	0033-0135	590.91	134.99	441	78.91	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			780.5	E08		4	0034-0138	284.81	138.69	455	83.15	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1304.0	E08		4	0035-0141	624.33	140.81	426	82.57	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			6866.6	E08		4	0036-0140	258.61	140.15	317	69.50	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			266.2	E08		4	0037-0144	195.41	144.54	413	77.50	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			199.1	E08		4	0038-0144	893.43	144.56	395	74.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1648.2	E08		4	0039-0148	364.65	148.27	417	80.33	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1395.5	E08		4	0040-0164	122.86	165.55	853	117.78	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			588.2	E08		4	0041-0158	345.00	157.93	466	85.15	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			419.5	E08		4	0042-0158	658.78	158.60	415	76.67	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			363.7	E08		4	0043-0162	39.75	161.75	398	74.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			262.3	E08		4	0044-0163	477.58	162.65	392	73.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			282.9	E08		4	0045-0171	757.86	171.71	411	81.50	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			172.7	E08		4	0046-0179	690.09	179.95	451	82.91	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1288.9	E08		4	0047-0181	509.76	179.71	436	82.47	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1755.0	E08		4	0048-0180	423.86	179.86	449	82.91	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			182.0	E08		4	0049-0188	634.58	188.58	481	83.74	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1237.9	E08		4	0050-0191	491.16	193.10	435	82.33	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1324.5	E08		4	0051-0192	794.75	192.31	428	78.08	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			233.7	E08		4	0052-0197	550.39	197.01	414	79.26	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2802.1	E08		4	0053-0197	831.67	197.45	401	76.08	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			396.6	E08		4	0054-0202	411.77	202.14	485	90.33	0.747
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			936.0	E08		4	0055-0211	606.56	211.27	947	125.44	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			293.8	E08		4	0056-0206	385.02	206.39	456	82.67	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			491.9	E08		4	0057-0209	242.02	207.81	446	81.88	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1731.1	E08		4	0058-0212	67.31	211.81	423	79.26	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1575.7	E08		4	0059-0210	286.99	210.26	423	78.08	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1067.8	E08		4	0060-0216	726.80	215.88	427	77.50	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			611.4	E08		4	0061-0221	226.57	222.17	395	78.23	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2018.3	E08		4	0062-0222	544.15	222.08	490	86.18	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			816.7	E08		4	0063-0220	777.29	220.48	419	76.67	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			379.0	E08		4	0064-0230	350.24	230.09	407	76.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			182.2	E08		4	0065-0235	698.65	235.23	431	82.81	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3101.7	E08		4	0066-0235	390.33	235.47	392	75.50	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			719.9	E08		4	0067-0243	108.57	243.69	401	77.50	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			217.9	E08		4	0068-0246	838.49	246.20	452	80.91	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1836.3	E08		4	0069-0248	543.64	247.86	431	78.43	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			969.0	E08		4	0070-0248	753.37	248.95	404	77.50	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			296.0	E08		4	0071-0248	451.53	248.74	468	84.77	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			197.3	E08		4	0072-0252	323.73	252.20	406	77.26	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			249.5	E08		4	0073-0254	473.20	254.32	420	80.18	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			217.3	E08		4	0074-0255	912.05	255.95	362	71.26	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			208.0	E08		4	0075-0258	640.31	258.51	486	85.50	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			573.8	E08		4	0076-0260	665.44	259.77	452	83.50	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			224.7	E08		4	0077-0263	872.41	263.11	474	83.50	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			224.2	E08		4	0078-0266	367.06	265.64	415	76.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			369.6	E08		4	0079-0268	780.52	268.02	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			170.5	E08		4	0080-0274	179.37	274.15	430	77.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2228.7	E08		4	0081-0280	251.34	280.48	399	75.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			238.0	E08		4	0082-0286	526.38	286.29	418	77.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			273.1	E08		4	0083-0291	805.27	290.90	691	98.57	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			216.6	E08		4	0084-0289	415.43	289.20	429	80.08	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			193.2	E08		4	0085-0303	165.61	303.77	430	77.84	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			218.4	E08		4	0086-0308	709.10	308.30	472	83.26	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			172.0	E08		4	0087-0311	288.03	311.72	406	79.50	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			622.3	E08		4	0088-0312	901.72	311.94	422	76.43	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4511.9	E08		4	0089-0318	685.82	317.83	441	80.67	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			230.9	E08		4	0090-0323	249.96	323.02	742	104.47	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2989.1	E08		4	0091-0322	624.79	322.52	399	76.08	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			170.6	E08		4	0092-0322	943.40	322.65	381	73.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2088.1	E08		4	0093-0347	676.81	348.17	412	76.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1168.1	E08		4	0094-0349	750.47	349.19	842	119.64	0.739
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			407.5	E08		4	0095-0349	136.05	348.74	396	76.91	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			264.7	E08		4	0096-0353	704.85	353.22	416	78.91	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			573.2	E08		4	0097-0361	338.63	362.11	810	111.88	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			665.3	E08		4	0098-0357	564.43	357.09	460	82.77	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			312.9	E08		4	0099-0359	203.75	359.23	427	80.33	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			347.6	E08		4	0100-0362	531.38	361.51	870	114.57	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			192.3	E08		4	0101-0364	616.58	364.28	423	75.84	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1059.3	E08		4	0102-0370	180.75	369.39	448	80.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			316.5	E08		4	0103-0375	83.23	375.25	391	78.33	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			494.1	E08		4	0104-0377	425.81	377.11	425	78.91	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			263.4	E08		4	0105-0386	288.74	385.59	897	123.88	0.734
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			369.3	E08		4	0106-0384	871.17	383.61	342	68.18	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			409.8	E08		4	0107-0389	24.18	389.00	376	74.67	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			321.7	E08		4	0108-0387	258.24	387.51	410	78.53	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			723.6	E08		4	0109-0393	491.32	393.10	437	83.15	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			719.2	E08		4	0110-0396	552.04	394.76	415	80.23	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1261.0	E08		4	0111-0398	738.64	397.49	397	74.43	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2656.5	E08		4	0112-0399	684.04	398.75	412	76.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			395.2	E08		4	0113-0407	389.42	406.76	529	94.91	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			723.4	E08		4	0114-0407	589.34	406.88	420	78.67	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			206.3	E08		4	0115-0406	920.59	406.58	440	77.26	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			230.1	E08		4	0116-0413	532.50	414.86	753	104.47	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1192.4	E08		4	0117-0413	233.92	412.73	412	77.26	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			358.0	E08		4	0118-0411	359.40	410.70	415	78.08	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1593.9	E08		4	0119-0413	630.06	411.74	381	77.64	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			713.5	E08		4	0120-0419	285.91	418.45	839	108.81	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1212.9	E08		4	0121-0421	695.14	420.42	479	90.81	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			720.2	E08		4	0122-0419	436.31	419.40	407	76.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			228.9	E08		4	0123-0425	110.14	425.64	562	94.81	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2921.3	E08		4	0124-0426	645.96	426.73	455	80.57	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			826.4	E08		4	0125-0425	866.84	425.04	392	76.91	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			213.2	E08		4	0126-0426	382.97	426.70	214	60.77	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			379.1	E08		4	0127-0431	777.43	430.82	454	83.15	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			772.6	E08		4	0128-0436	705.74	437.07	413	81.98	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			604.0	E08		4	0129-0435	319.58	435.80	410	76.08	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			817.0	E08		4	0130-0446	599.20	446.02	744	100.81	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			309.8	E08		4	0131-0448	163.99	448.51	430	78.08	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			324.2	E08		4	0132-0456	276.89	456.42	424	78.08	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			262.1	E08		4	0133-0459	905.75	457.52	380	75.98	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			352.1	E08		4	0134-0468	888.60	469.74	418	79.74	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2512.5	E08		4	0135-0474	695.70	474.53	764	106.23	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			595.7	E08		4	0136-0477	370.65	476.79	426	80.81	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			716.1	E08		4	0137-0481	112.68	481.24	401	78.33	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1392.8	E08		4	0138-0488	213.74	488.34	406	78.67	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			888.6	E08		4	0139-0486	603.59	485.86	424	78.91	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			523.1	E08		4	0140-0492	76.49	492.01	442	82.33	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			186.0	E08		4	0141-0490	307.38	490.29	448	81.50	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			299.9	E08		4	0142-0495	355.80	495.48	508	86.57	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			551.0	E08		4	0143-0498	530.91	497.54	426	78.43	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			290.7	E08		4	0144-0508	936.11	508.18	411	76.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1290.7	E08		4	0145-0516	640.42	515.71	391	73.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			551.0	E08		4	0146-0518	385.44	518.92	445	83.98	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			967.8	E08		4	0147-0526	569.04	526.32	431	80.33	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			872.7	E08		4	0148-0525	428.94	525.80	418	80.33	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1145.9	E08		4	0149-0528	701.21	528.02	431	79.50	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			287.0	E08		4	0150-0535	118.78	535.26	432	80.91	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			620.1	E08		4	0151-0535	367.11	534.85	449	81.74	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			407.6	E08		4	0152-0538	154.87	538.00	401	75.74	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			331.1	E08		4	0153-0542	403.90	541.72	447	84.33	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1727.8	E08		4	0154-0546	617.77	545.48	421	78.67	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1412.4	E08		4	0155-0553	247.29	552.85	707	100.23	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			395.2	E08		4	0156-0546	851.67	546.21	400	76.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			466.5	E08		4	0157-0551	755.90	550.92	400	75.01	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			195.8	E08		4	0158-0555	509.69	555.50	513	86.33	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			668.7	E08		4	0159-0566	449.55	566.71	846	114.47	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			215.6	E08		4	0160-0565	325.54	565.58	446	78.91	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1289.0	E08		4	0161-0565	718.66	565.16	417	77.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			535.0	E08		4	0162-0578	581.05	578.21	405	77.26	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			686.0	E08		4	0163-0584	352.77	585.09	409	78.91	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			583.4	E08		4	0164-0586	644.49	587.18	809	110.81	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			859.8	E08		4	0165-0599	386.32	598.68	902	122.02	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			241.0	E08		4	0166-0597	820.30	597.28	403	79.50	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			204.2	E08		4	0167-0597	902.14	597.37	399	74.43	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			235.4	E08		4	0168-0601	522.22	601.39	413	77.84	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			243.0	E08		4	0169-0610	858.65	610.57	427	79.50	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			243.3	E08		4	0170-0611	197.02	610.95	439	80.91	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2020.7	E08		4	0171-0610	713.64	610.13	416	77.84	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			267.3	E08		4	0172-0612	777.81	612.44	373	70.77	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			250.4	E08		4	0173-0617	442.56	617.16	390	75.50	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1385.5	E08		4	0174-0620	300.22	620.31	408	74.43	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			242.1	E08		4	0175-0623	818.13	622.92	476	84.08	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			819.6	E08		4	0176-0632	66.66	631.38	777	109.05	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			211.6	E08		4	0177-0638	333.96	638.20	438	79.74	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			244.9	E08		4	0178-0639	645.90	638.83	415	75.84	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			263.3	E08		4	0179-0644	254.30	643.97	410	75.84	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			192.4	E08		4	0180-0644	766.71	644.46	248	87.50	0.407
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			941.5	E08		4	0181-0649	475.70	648.79	796	111.64	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			533.3	E08		4	0182-0654	885.78	655.00	352	69.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1254.1	E08		4	0183-0656	36.38	656.07	390	73.26	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			739.7	E08		4	0184-0658	820.16	658.20	417	75.84	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			921.4	E08		4	0185-0666	109.47	665.99	445	80.91	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			416.8	E08		4	0186-0668	931.79	667.74	379	73.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2117.9	E08		4	0187-0670	764.69	670.90	426	79.74	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			349.6	E08		4	0188-0670	515.22	671.01	430	81.40	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			244.0	E08		4	0189-0672	228.59	672.38	446	80.67	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			741.6	E08		4	0190-0677	711.19	677.12	407	78.33	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			662.1	E08		4	0191-0680	362.66	680.49	407	74.18	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			550.9	E08		4	0192-0682	674.03	681.82	403	75.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1654.9	E08		4	0193-0688	31.90	688.55	387	75.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			200.0	E08		4	0194-0700	913.09	698.64	422	81.15	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2122.5	E08		4	0195-0699	177.40	699.16	425	77.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2808.8	E08		4	0196-0706	896.96	706.45	370	76.67	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			593.1	E08		4	0197-0705	451.24	705.04	393	73.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			231.4	E08		4	0198-0706	841.19	706.47	391	73.84	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			208.5	E08		5	0001-0036	912.92	36.08	697	97.74	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			315.8	E08		5	0002-0037	400.71	36.02	190	56.53	0.747
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			614.6	E08		5	0003-0042	383.54	44.47	533	95.15	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			222.2	E08		5	0004-0043	672.96	42.74	427	77.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			233.5	E08		5	0005-0047	55.66	46.50	612	93.98	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			561.9	E08		5	0006-0047	87.28	46.68	387	97.15	0.515
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			299.6	E08		5	0007-0044	186.17	44.47	395	73.84	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1013.6	E08		5	0008-0047	226.42	47.21	458	83.15	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1237.2	E08		5	0009-0048	129.84	47.85	425	77.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4413.8	E08		5	0010-0050	790.39	50.36	408	77.74	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			139.5	E08		5	0011-0051	101.71	52.26	139	54.53	0.587
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			235.5	E08		5	0012-0057	312.17	57.19	430	79.26	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2869.7	E08		5	0013-0068	489.97	68.32	441	79.50	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			240.5	E08		5	0014-0073	372.57	73.36	407	74.43	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			281.3	E08		5	0015-0074	412.97	74.21	406	77.50	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1867.7	E08		5	0016-0082	710.92	82.13	436	77.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			916.7	E08		5	0017-0089	155.98	89.08	370	72.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			428.4	E08		5	0018-0098	744.01	98.60	365	71.26	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			228.0	E08		5	0019-0101	112.51	100.66	349	70.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3357.6	E08		5	0020-0107	189.04	107.38	386	77.50	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			274.9	E08		5	0021-0106	912.13	105.94	263	75.50	0.580
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			438.6	E08		5	0022-0110	20.05	109.88	419	79.74	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1598.6	E08		5	0023-0113	684.55	113.61	430	78.08	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1762.8	E08		5	0024-0134	634.63	132.56	822	126.37	0.647
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2312.2	E08		5	0025-0135	217.50	135.58	433	79.84	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			415.4	E08		5	0026-0138	151.19	137.96	392	74.67	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			471.9	E08		5	0027-0139	694.30	139.48	432	78.91	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			252.9	E08		5	0028-0138	506.42	138.97	366	71.26	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			222.7	E08		5	0029-0153	739.43	153.21	377	71.01	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			243.2	E08		5	0030-0155	266.99	155.23	390	74.08	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			348.6	E08		5	0031-0158	364.21	158.24	390	74.43	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			585.8	E08		5	0032-0157	789.19	157.46	339	69.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1583.2	E08		5	0033-0161	428.45	161.27	415	79.15	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			293.8	E08		5	0034-0162	606.91	162.23	471	85.98	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			281.3	E08		5	0035-0164	102.21	164.37	385	74.91	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			546.2	E08		5	0036-0170	393.74	169.85	402	75.84	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			946.6	E08		5	0037-0173	45.29	173.71	724	105.50	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			369.6	E08		5	0038-0176	559.97	176.57	534	125.44	0.426
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			450.3	E08		5	0039-0182	182.79	182.45	382	74.33	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1254.3	E08		5	0040-0184	824.00	184.55	431	79.84	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			641.7	E08		5	0041-0189	630.02	190.57	822	113.54	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1904.7	E08		5	0042-0185	228.36	183.91	443	87.05	0.735
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2013.0	E08		5	0043-0202	452.20	201.93	838	110.57	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2194.7	E08		5	0044-0195	279.94	195.23	410	77.01	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			261.4	E08		5	0045-0202	155.62	202.56	473	86.08	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			283.9	E08		5	0046-0201	527.69	201.62	461	81.84	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			842.3	E08		5	0047-0203	752.82	203.24	401	76.08	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3485.5	E08		5	0048-0210	326.39	209.37	856	119.20	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			192.5	E08		5	0049-0207	228.68	207.78	408	82.23	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			309.1	E08		5	0050-0218	126.09	217.93	392	77.74	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			260.8	E08		5	0051-0219	938.78	219.02	391	74.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			201.4	E08		5	0052-0223	167.61	222.46	356	76.43	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1022.6	E08		5	0053-0229	91.30	229.29	380	74.67	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1826.8	E08		5	0054-0229	780.61	229.64	408	76.67	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			232.8	E08		5	0055-0233	833.52	233.37	660	96.57	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			185.7	E08		5	0056-0232	898.40	232.45	416	76.67	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			217.0	E08		5	0057-0241	397.59	241.52	526	87.74	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			840.3	E08		5	0058-0244	649.02	244.50	374	70.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			480.6	E08		5	0059-0248	294.41	247.83	388	74.67	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			284.1	E08		5	0060-0250	614.43	250.41	465	83.74	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1373.3	E08		5	0061-0253	247.78	252.38	415	81.40	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			470.3	E08		5	0062-0253	514.90	252.80	430	80.91	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			226.1	E08		5	0063-0254	738.72	254.37	418	79.01	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			236.2	E08		5	0064-0258	16.81	258.04	373	73.26	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			223.9	E08		5	0065-0260	71.67	260.48	388	73.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			535.8	E08		5	0066-0260	337.57	260.69	413	76.67	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			275.5	E08		5	0067-0261	717.98	261.28	407	79.26	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			335.2	E08		5	0068-0261	359.63	260.89	371	71.70	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			198.8	E08		5	0069-0268	867.65	268.12	368	72.08	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1285.4	E08		5	0070-0271	812.16	270.97	430	79.50	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			455.2	E08		5	0071-0274	164.80	274.49	398	76.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			252.8	E08		5	0072-0282	833.97	281.78	441	82.91	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			185.3	E08		5	0073-0285	930.92	285.11	411	75.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			510.5	E08		5	0074-0291	91.17	291.53	396	75.26	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5955.7	E08		5	0075-0291	480.15	291.94	443	80.33	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			704.6	E08		5	0076-0290	541.98	289.68	413	80.33	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			416.8	E08		5	0077-0297	744.79	296.42	423	79.74	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			426.7	E08		5	0078-0298	638.64	298.19	436	79.50	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			789.6	E08		5	0079-0299	696.64	299.44	421	77.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			380.6	E08		5	0080-0310	859.34	310.60	433	79.26	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1278.9	E08		5	0081-0311	211.24	311.25	384	73.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			239.8	E08		5	0082-0317	458.01	318.23	597	94.81	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			968.0	E08		5	0083-0316	756.38	317.12	453	82.08	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			425.0	E08		5	0084-0320	547.00	320.09	475	92.23	0.702
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			533.2	E08		5	0085-0322	522.21	322.03	409	79.84	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			230.8	E08		5	0086-0325	48.41	324.90	371	73.50	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			361.6	E08		5	0087-0325	111.70	324.44	389	75.01	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			557.2	E08		5	0088-0329	314.40	328.83	415	76.08	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			528.9	E08		5	0089-0331	582.08	332.17	403	76.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			396.8	E08		5	0090-0333	673.06	333.28	435	80.08	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			454.8	E08		5	0091-0331	899.74	331.41	398	77.26	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			239.0	E08		5	0092-0338	172.43	338.13	383	74.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1659.5	E08		5	0093-0339	223.79	339.76	383	74.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			602.2	E08		5	0094-0347	779.18	347.30	388	76.33	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			243.7	E08		5	0095-0349	689.37	349.18	454	81.74	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			692.7	E08		5	0096-0349	144.38	349.49	383	74.08	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1093.3	E08		5	0097-0351	272.80	350.88	394	76.08	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1282.9	E08		5	0098-0356	645.18	355.75	398	76.67	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1158.4	E08		5	0099-0371	89.56	371.12	398	75.26	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			616.1	E08		5	0100-0371	750.34	370.95	394	79.15	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1319.7	E08		5	0101-0375	859.09	374.62	419	77.50	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			675.5	E08		5	0102-0377	235.32	377.50	785	116.95	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			419.8	E08		5	0103-0385	597.11	385.01	934	125.68	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			222.6	E08		5	0104-0389	304.30	388.70	858	119.68	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1639.0	E08		5	0105-0383	122.06	383.52	392	76.57	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			277.5	E08		5	0106-0388	549.09	386.78	494	88.57	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1913.1	E08		5	0107-0388	493.48	388.54	448	86.57	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1787.8	E08		5	0108-0392	464.63	392.49	458	82.91	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3664.4	E08		5	0109-0398	361.87	397.81	415	76.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			793.4	E08		5	0110-0397	729.47	397.47	422	77.50	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1215.3	E08		5	0111-0402	644.21	402.75	401	75.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			206.5	E08		5	0112-0408	25.84	408.78	427	77.50	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1610.4	E08		5	0113-0412	687.08	412.42	423	78.67	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			223.5	E08		5	0114-0420	131.98	419.92	301	71.11	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			273.2	E08		5	0115-0420	149.08	419.68	190	53.21	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1762.6	E08		5	0116-0426	598.50	426.01	414	77.50	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			883.2	E08		5	0117-0428	881.31	428.51	431	80.33	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			510.6	E08		5	0118-0433	743.77	432.91	402	76.67	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			330.6	E08		5	0119-0436	519.01	436.38	420	78.08	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			306.8	E08		5	0120-0440	203.93	440.29	462	83.84	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			774.1	E08		5	0121-0442	226.39	442.23	462	81.60	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			297.5	E08		5	0122-0442	259.99	441.96	399	75.50	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			198.7	E08		5	0123-0442	396.28	441.63	404	77.26	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			250.8	E08		5	0124-0452	828.09	451.93	481	81.01	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			437.3	E08		5	0125-0454	567.20	454.24	407	76.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			221.1	E08		5	0126-0458	60.38	458.16	396	77.26	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			432.4	E08		5	0127-0464	462.94	463.98	444	82.91	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			631.8	E08		5	0128-0462	682.87	461.98	412	76.91	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			187.9	E08		5	0129-0466	727.81	466.33	689	100.47	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2174.3	E08		5	0130-0462	939.93	462.33	386	73.01	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			411.6	E08		5	0131-0480	545.63	480.82	800	118.71	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			591.6	E08		5	0132-0475	595.64	476.17	420	82.33	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			283.3	E08		5	0133-0486	337.27	486.65	436	83.40	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			467.2	E08		5	0134-0487	654.85	487.16	421	78.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			925.0	E08		5	0135-0498	312.01	498.08	791	114.95	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1090.2	E08		5	0136-0500	732.05	500.30	421	78.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			299.6	E08		5	0137-0510	41.05	510.31	392	74.67	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			193.2	E08		5	0138-0511	901.81	511.56	447	79.50	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			321.3	E08		5	0139-0514	171.32	513.56	408	78.57	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			211.9	E08		5	0140-0515	814.29	515.03	404	77.26	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			255.0	E08		5	0141-0517	762.03	517.57	409	75.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			451.8	E08		5	0142-0518	524.67	518.08	411	77.26	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			710.0	E08		5	0143-0530	669.23	530.32	405	76.67	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			300.6	E08		5	0144-0535	381.83	535.94	398	75.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			516.0	E08		5	0145-0537	450.65	536.69	413	79.26	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			194.9	E08		5	0146-0540	496.57	540.79	433	77.01	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1063.4	E08		5	0147-0543	575.29	542.93	427	80.33	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			612.6	E08		5	0148-0551	803.26	551.15	813	113.05	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			255.5	E08		5	0149-0551	922.87	550.54	310	66.18	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			292.2	E08		5	0150-0562	119.28	562.25	412	78.33	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1300.3	E08		5	0151-0565	243.17	565.20	397	74.91	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			240.3	E08		5	0152-0565	856.86	565.48	401	73.84	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			638.6	E08		5	0153-0572	309.73	571.73	409	79.50	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			232.1	E08		5	0154-0576	918.68	577.10	561	89.15	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			253.1	E08		5	0155-0579	350.68	579.12	403	75.50	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			519.5	E08		5	0156-0580	58.30	579.86	385	74.67	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			694.3	E08		5	0157-0584	284.01	584.18	751	105.64	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1898.2	E08		5	0158-0590	578.60	590.09	424	82.08	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			245.0	E08		5	0159-0593	777.12	593.57	371	75.74	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			294.0	E08		5	0160-0595	468.12	594.79	435	77.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			192.0	E08		5	0161-0607	390.67	607.42	853	115.88	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			202.0	E08		5	0162-0605	848.16	605.02	340	68.18	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			220.3	E08		5	0163-0609	726.45	609.57	390	73.26	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2006.3	E08		5	0164-0611	150.33	610.49	400	76.33	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			456.1	E08		5	0165-0614	112.83	614.69	392	74.08	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1712.9	E08		5	0166-0619	311.78	619.52	400	77.74	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			172.4	E08		5	0167-0620	53.42	619.82	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			283.2	E08		5	0168-0621	536.05	620.32	336	70.43	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			221.8	E08		5	0169-0626	822.73	625.75	397	76.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			718.9	E08		5	0170-0623	269.05	623.42	417	77.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			194.1	E08		5	0171-0630	552.07	630.35	420	83.50	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1217.5	E08		5	0172-0631	442.94	631.56	409	77.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1185.9	E08		5	0173-0635	917.01	635.15	376	74.08	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			246.7	E08		5	0174-0635	859.67	635.02	418	77.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			380.8	E08		5	0175-0649	331.63	649.34	432	80.33	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			248.1	E08		5	0176-0651	801.96	651.19	436	82.33	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			231.2	E08		5	0177-0648	142.89	648.94	365	74.43	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1074.7	E08		5	0178-0653	87.19	652.94	379	76.33	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			246.1	E08		5	0179-0654	490.62	655.31	427	97.40	0.566
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1915.7	E08		5	0180-0654	290.92	654.14	391	75.26	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			286.3	E08		5	0181-0658	122.51	658.29	430	78.08	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			189.3	E08		5	0182-0660	943.92	659.79	269	61.36	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1472.2	E08		5	0183-0665	450.32	665.15	408	76.67	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			223.3	E08		5	0184-0666	711.38	665.77	407	78.08	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			650.9	E08		5	0185-0665	388.66	665.79	387	76.08	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			180.3	E08		5	0186-0667	530.37	666.86	408	77.74	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			506.4	E08		5	0187-0670	36.41	670.08	383	75.50	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1041.5	E08		5	0188-0670	867.56	669.86	372	72.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			289.1	E08		5	0189-0687	601.90	686.94	404	75.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			195.9	E08		5	0190-0689	805.54	688.90	400	76.67	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1575.2	E08		5	0191-0691	754.41	691.52	398	75.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			190.5	E08		5	0192-0694	706.03	694.46	414	77.50	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1073.9	E08		5	0193-0695	182.32	695.39	392	74.67	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			931.9	E08		5	0194-0698	408.47	698.36	394	76.08	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			132.3	E08		5	0195-0701	18.07	700.07	363	77.40	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1608.7	E08		5	0196-0700	311.11	700.68	390	74.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			180.2	E08		5	0197-0707	882.43	706.19	366	72.81	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1271.4	E08		6	0001-0039	609.10	39.78	429	78.67	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			288.0	E08		6	0002-0037	360.26	37.48	370	71.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			208.5	E08		6	0003-0043	130.87	43.35	415	76.67	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			290.6	E08		6	0004-0044	937.28	43.85	447	83.26	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1129.2	E08		6	0005-0046	666.80	46.34	393	73.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1047.1	E08		6	0006-0051	182.30	50.93	439	79.84	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			197.8	E08		6	0007-0052	403.43	51.91	456	80.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			208.0	E08		6	0008-0056	835.63	55.83	437	82.67	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			225.2	E08		6	0009-0054	547.64	54.10	424	77.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			239.0	E08		6	0010-0056	445.92	56.36	434	79.26	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			207.4	E08		6	0011-0055	865.44	55.01	398	73.84	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			197.5	E08		6	0012-0056	99.44	56.56	204	59.36	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			578.1	E08		6	0013-0056	709.53	56.49	394	73.84	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1544.2	E08		6	0014-0057	56.19	57.15	276	62.77	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			851.6	E08		6	0015-0061	291.50	60.35	420	80.23	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			369.6	E08		6	0016-0071	649.24	69.38	188	65.01	0.559
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			700.7	E08		6	0017-0075	273.94	76.36	420	78.33	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			177.8	E08		6	0018-0082	865.23	82.94	421	76.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1352.3	E08		6	0019-0087	100.68	87.47	401	75.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			202.9	E08		6	0020-0085	790.76	85.89	405	77.01	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1503.4	E08		6	0021-0099	595.58	98.77	410	75.84	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			200.3	E08		6	0022-0100	401.27	100.66	401	75.26	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			252.9	E08		6	0023-0104	359.67	103.66	639	92.91	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1079.3	E08		6	0024-0101	917.18	101.30	370	71.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			316.6	E08		6	0025-0102	147.44	102.15	426	79.01	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1503.3	E08		6	0026-0104	203.96	103.60	391	73.84	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			683.0	E08		6	0027-0111	687.18	111.25	425	77.26	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			311.5	E08		6	0028-0114	311.62	114.67	409	76.67	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			280.5	E08		6	0029-0126	567.48	126.76	529	119.88	0.463
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			485.6	E08		6	0030-0124	514.48	124.06	399	73.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			255.5	E08		6	0031-0134	874.24	134.51	416	75.26	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			224.4	E08		6	0032-0136	443.35	136.30	428	77.26	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1323.6	E08		6	0033-0137	221.07	136.76	398	74.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			614.9	E08		6	0034-0138	802.41	138.59	416	75.01	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			960.7	E08		6	0035-0141	845.01	141.60	424	79.50	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			214.9	E08		6	0036-0145	932.34	145.11	411	78.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			219.7	E08		6	0037-0156	316.95	156.18	405	75.26	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			380.1	E08		6	0038-0173	180.35	172.98	600	120.37	0.520
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			219.1	E08		6	0039-0171	928.07	170.09	399	76.53	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			458.4	E08		6	0040-0176	889.94	176.64	383	76.67	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			832.9	E08		6	0041-0180	641.53	180.47	408	74.43	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			730.4	E08		6	0042-0181	254.12	181.22	431	79.84	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1690.9	E08		6	0043-0180	575.01	180.53	356	69.01	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			566.5	E08		6	0044-0185	769.00	185.35	487	85.84	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			184.9	E08		6	0045-0201	840.71	200.64	409	78.91	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			435.6	E08		6	0046-0201	402.79	201.96	404	75.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			844.6	E08		6	0047-0217	557.64	217.97	437	78.18	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			210.6	E08		6	0048-0222	65.75	222.55	402	75.84	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			257.7	E08		6	0049-0222	33.66	222.01	378	71.84	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			923.6	E08		6	0050-0230	461.89	228.95	884	118.71	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			672.6	E08		6	0051-0224	894.28	224.40	424	78.08	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			207.2	E08		6	0052-0235	146.72	235.75	423	77.26	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			837.0	E08		6	0053-0238	241.90	238.00	383	73.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1146.1	E08		6	0054-0237	315.12	237.17	411	77.01	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			242.9	E08		6	0055-0243	565.44	243.58	481	82.43	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			167.5	E08		6	0056-0246	675.69	246.47	385	73.26	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			887.3	E08		6	0057-0251	200.63	251.72	394	73.84	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			206.5	E08		6	0058-0254	390.06	254.58	396	73.01	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			256.2	E08		6	0059-0256	274.78	255.92	404	76.28	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			379.3	E08		6	0060-0258	297.14	258.14	451	81.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			384.8	E08		6	0061-0258	122.38	258.27	395	76.67	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2018.0	E08		6	0062-0262	826.81	262.42	397	77.74	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			774.5	E08		6	0063-0265	364.08	265.39	397	75.50	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			195.9	E08		6	0064-0266	66.07	266.07	380	73.01	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2278.8	E08		6	0065-0268	780.41	269.04	384	78.91	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			689.3	E08		6	0066-0276	942.40	276.55	414	77.26	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2176.5	E08		6	0067-0284	864.62	284.60	393	75.01	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			558.3	E08		6	0068-0288	919.98	288.51	425	80.67	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			198.7	E08		6	0069-0287	25.72	287.87	402	74.18	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3933.1	E08		6	0070-0291	794.39	291.48	427	84.91	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1056.3	E08		6	0071-0291	340.77	290.88	388	74.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1820.5	E08		6	0072-0292	733.23	292.36	414	78.08	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			331.2	E08		6	0073-0302	700.29	302.29	365	70.18	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			436.0	E08		6	0074-0307	593.62	308.24	459	83.98	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1562.9	E08		6	0075-0308	389.89	307.90	416	75.60	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			199.2	E08		6	0076-0316	97.64	316.85	772	105.98	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			196.7	E08		6	0077-0322	160.15	322.59	425	78.08	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			399.6	E08		6	0078-0323	429.71	323.83	412	76.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			354.9	E08		6	0079-0325	620.50	325.40	390	74.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			290.7	E08		6	0080-0324	673.88	324.71	368	71.01	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			242.5	E08		6	0081-0326	298.88	326.11	431	79.50	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2066.7	E08		6	0082-0338	840.47	338.66	399	74.43	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			876.9	E08		6	0083-0343	945.96	343.78	423	76.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			357.4	E08		6	0084-0348	94.01	348.05	361	75.26	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			183.1	E08		6	0085-0349	192.31	348.83	427	79.26	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2519.0	E08		6	0086-0355	743.75	355.90	402	75.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4964.7	E08		6	0087-0359	863.28	359.07	375	71.01	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1756.1	E08		6	0088-0361	410.56	360.93	417	76.91	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1402.0	E08		6	0089-0362	549.72	362.11	395	73.60	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1434.7	E08		6	0090-0366	86.07	366.13	430	81.84	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			718.3	E08		6	0091-0368	605.95	368.15	466	81.26	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			622.0	E08		6	0092-0368	461.92	368.59	404	75.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			248.5	E08		6	0093-0369	503.73	369.03	421	75.84	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			360.1	E08		6	0094-0388	126.33	388.29	676	96.33	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			510.3	E08		6	0095-0389	272.93	389.65	406	78.08	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			705.3	E08		6	0096-0397	897.17	397.47	378	76.08	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2173.4	E08		6	0097-0399	741.89	399.01	357	69.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5496.3	E08		6	0098-0401	489.83	401.65	393	73.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			435.2	E08		6	0099-0415	558.39	414.76	891	120.47	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2429.8	E08		6	0100-0418	759.37	417.69	385	73.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1192.1	E08		6	0101-0419	131.28	419.56	412	75.01	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			782.0	E08		6	0102-0428	222.85	428.22	398	75.84	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1081.3	E08		6	0103-0438	440.00	437.97	811	112.57	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			837.4	E08		6	0104-0429	888.69	429.98	388	77.26	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			247.3	E08		6	0105-0432	604.99	432.84	420	76.43	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			620.7	E08		6	0106-0431	803.92	430.66	397	75.01	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			745.0	E08		6	0107-0445	845.80	445.48	452	81.74	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			213.7	E08		6	0108-0449	472.86	450.16	419	76.43	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			941.0	E08		6	0109-0451	399.60	450.90	407	74.43	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			233.5	E08		6	0110-0452	901.77	451.81	344	68.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2839.1	E08		6	0111-0457	510.59	457.67	365	71.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			583.1	E08		6	0112-0458	271.58	458.37	398	75.26	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			689.5	E08		6	0113-0464	362.29	463.93	415	76.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2314.9	E08		6	0114-0465	34.79	465.26	372	71.01	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			198.6	E08		6	0115-0468	319.64	468.73	386	75.50	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			681.5	E08		6	0116-0468	204.85	468.31	403	74.43	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			577.3	E08		6	0117-0472	589.04	472.62	410	77.84	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			831.6	E08		6	0118-0485	130.94	485.17	784	114.57	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1362.3	E08		6	0119-0480	559.70	480.70	401	74.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			280.7	E08		6	0120-0485	765.12	485.12	414	75.01	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			775.3	E08		6	0121-0488	817.96	488.82	421	77.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			202.7	E08		6	0122-0487	700.13	487.33	456	79.60	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1072.0	E08		6	0123-0494	467.40	493.91	413	75.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1017.3	E08		6	0124-0497	519.65	497.45	378	73.01	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1707.2	E08		6	0125-0503	71.84	502.98	397	73.60	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2056.0	E08		6	0126-0510	312.54	510.67	394	76.91	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			915.0	E08		6	0127-0525	839.74	525.65	437	78.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			420.9	E08		6	0128-0527	540.65	527.67	412	75.26	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			569.7	E08		6	0129-0528	685.34	528.07	370	72.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			939.4	E08		6	0130-0531	408.66	531.66	427	82.91	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			231.6	E08		6	0131-0545	184.59	545.56	423	77.26	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			213.3	E08		6	0132-0550	783.64	550.56	434	78.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			230.0	E08		6	0133-0554	16.21	553.55	343	69.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			647.3	E08		6	0134-0558	889.37	558.36	399	75.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			196.5	E08		6	0135-0563	292.95	563.04	416	75.01	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			209.7	E08		6	0136-0566	246.05	566.66	403	75.26	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			807.3	E08		6	0137-0574	207.12	574.39	383	73.01	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			326.7	E08		6	0138-0580	407.06	580.07	744	102.91	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			910.9	E08		6	0139-0579	123.64	579.43	381	73.84	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			418.4	E08		6	0140-0584	648.20	584.41	298	79.26	0.596
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			242.8	E08		6	0141-0588	340.02	588.45	389	76.08	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			644.4	E08		6	0142-0591	512.96	591.21	414	76.08	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3615.2	E08		6	0143-0592	930.00	592.72	460	79.84	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			177.8	E08		6	0144-0600	604.74	599.99	396	74.67	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3202.7	E08		6	0145-0610	674.51	609.31	411	75.26	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			253.0	E08		6	0146-0613	833.51	613.41	434	77.26	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			176.6	E08		6	0147-0616	47.33	616.58	414	76.08	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			964.0	E08		6	0148-0615	120.49	615.56	390	73.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			202.1	E08		6	0149-0618	286.91	617.98	407	78.08	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			732.0	E08		6	0150-0621	579.64	621.75	407	74.43	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			195.7	E08		6	0151-0630	264.54	630.19	456	79.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			246.3	E08		6	0152-0633	530.57	633.89	542	86.91	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			190.2	E08		6	0153-0633	175.78	633.64	416	77.01	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			227.2	E08		6	0154-0644	342.89	645.15	398	75.50	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1165.8	E08		6	0155-0643	423.03	642.72	391	74.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2494.3	E08		6	0156-0649	707.56	648.55	332	71.60	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1160.2	E08		6	0157-0651	879.79	651.82	403	75.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			233.0	E08		6	0158-0654	830.07	653.96	335	68.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			986.1	E08		6	0159-0659	73.10	659.24	383	74.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			229.2	E08		6	0160-0662	37.75	662.74	306	64.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3320.6	E08		6	0161-0664	699.20	664.39	367	72.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			177.3	E08		6	0162-0669	294.23	669.17	425	77.84	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			273.4	E08		6	0163-0672	755.14	671.70	314	65.01	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			369.1	E08		6	0164-0685	651.76	685.15	402	76.43	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1407.4	E08		6	0165-0690	191.80	689.38	504	90.08	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			814.9	E08		6	0166-0688	241.93	688.34	391	75.26	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			518.1	E08		6	0167-0688	860.00	687.87	391	76.67	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			436.5	E08		6	0168-0695	394.10	695.29	375	75.84	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			557.2	E08		6	0169-0692	684.52	691.77	372	73.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1312.2	E08		6	0170-0698	175.02	699.26	445	82.67	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			278.6	E08		6	0171-0696	775.38	696.07	302	63.36	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			881.1	E08		6	0172-0701	605.07	701.16	380	72.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			556.2	E08		6	0173-0702	95.54	701.63	451	85.60	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			643.6	E08		6	0174-0704	120.66	703.75	188	52.63	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			188.8	E08		6	0175-0709	319.30	709.24	414	81.01	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			611.9	E08		7	0001-0031	448.84	30.88	428	78.08	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			230.1	E08		7	0002-0032	838.72	31.96	384	75.50	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			347.5	E08		7	0003-0036	597.08	35.70	508	86.43	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1471.0	E08		7	0004-0040	660.75	40.02	389	73.26	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			214.6	E08		7	0005-0043	46.37	43.18	436	80.08	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			309.9	E08		7	0006-0046	171.75	45.61	395	76.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			297.1	E08		7	0007-0056	779.49	56.58	762	105.40	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			493.7	E08		7	0008-0053	366.46	52.98	413	77.84	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			438.4	E08		7	0009-0061	736.50	60.83	821	110.33	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			201.1	E08		7	0010-0059	514.63	59.64	469	80.67	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1601.5	E08		7	0011-0060	622.88	60.55	447	81.01	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1365.8	E08		7	0012-0062	112.13	62.35	400	73.84	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			835.1	E08		7	0013-0064	827.38	64.14	397	73.01	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			631.5	E08		7	0014-0065	209.40	65.33	397	75.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			905.6	E08		7	0015-0068	474.31	68.46	445	77.84	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			149.4	E08		7	0016-0073	759.50	73.09	441	82.33	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			832.9	E08		7	0017-0071	25.96	71.16	395	74.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			373.0	E08		7	0018-0075	168.45	75.59	400	75.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1201.3	E08		7	0019-0076	649.96	75.19	460	84.91	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2859.8	E08		7	0020-0076	914.47	76.08	389	74.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			464.5	E08		7	0021-0081	412.73	81.20	410	77.01	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			340.2	E08		7	0022-0081	855.73	80.86	331	68.67	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			216.0	E08		7	0023-0090	806.94	90.08	426	77.50	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			693.9	E08		7	0024-0097	123.66	96.62	861	120.47	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2754.5	E08		7	0025-0100	724.72	101.48	808	111.30	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			810.6	E08		7	0026-0096	869.09	97.42	428	79.74	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			206.2	E08		7	0027-0096	384.45	96.22	436	77.26	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1977.7	E08		7	0028-0096	561.68	96.12	419	76.08	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			220.5	E08		7	0029-0103	764.31	103.27	401	74.08	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			302.1	E08		7	0030-0109	829.68	109.22	415	77.74	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2165.1	E08		7	0031-0108	325.77	108.69	389	74.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			263.7	E08		7	0032-0109	935.60	108.20	397	76.91	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			377.8	E08		7	0033-0115	706.49	115.81	360	73.50	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1188.7	E08		7	0034-0122	118.91	122.52	429	82.18	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2844.4	E08		7	0035-0124	923.18	123.79	412	82.23	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			296.4	E08		7	0036-0135	292.88	135.00	383	73.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			318.0	E08		7	0037-0135	354.72	135.33	404	75.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2775.1	E08		7	0038-0139	914.80	139.85	373	76.91	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			648.5	E08		7	0039-0143	59.89	143.01	419	81.84	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1181.8	E08		7	0040-0142	508.69	142.10	427	75.84	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			7868.4	E08		7	0041-0140	651.23	140.11	271	60.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			575.6	E08		7	0042-0143	114.36	144.08	452	82.77	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			799.6	E08		7	0043-0145	174.82	145.47	397	74.43	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			425.0	E08		7	0044-0150	430.95	150.59	605	95.36	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			980.0	E08		7	0045-0151	682.39	151.18	397	75.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			288.6	E08		7	0046-0151	472.56	151.08	281	60.53	0.964
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			808.4	E08		7	0047-0153	408.79	153.93	304	67.94	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			222.8	E08		7	0048-0155	769.28	154.23	416	77.01	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1425.9	E08		7	0049-0160	729.61	159.76	426	78.91	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			210.7	E08		7	0050-0171	710.91	171.77	471	83.15	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1174.9	E08		7	0051-0176	84.38	176.01	398	74.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1225.2	E08		7	0052-0179	757.95	179.10	405	74.67	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			318.2	E08		7	0053-0183	829.21	183.92	409	76.18	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			728.8	E08		7	0054-0182	399.69	182.76	395	74.67	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			331.1	E08		7	0055-0190	561.34	189.93	399	74.43	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			791.7	E08		7	0056-0202	470.42	202.54	999	119.88	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			180.5	E08		7	0057-0196	663.68	196.18	453	79.26	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1111.6	E08		7	0058-0195	880.66	195.17	430	79.50	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1678.2	E08		7	0059-0196	922.97	196.10	429	78.67	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			695.6	E08		7	0060-0202	796.04	201.96	411	75.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			789.1	E08		7	0061-0206	348.07	206.46	389	73.01	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			986.6	E08		7	0062-0209	516.77	208.98	444	83.01	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			246.7	E08		7	0063-0220	186.65	219.98	420	76.33	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			657.1	E08		7	0064-0229	52.67	230.01	832	116.71	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			333.5	E08		7	0065-0221	413.57	222.10	437	84.18	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1448.0	E08		7	0066-0223	154.97	223.16	415	76.67	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			188.1	E08		7	0067-0225	212.81	225.04	416	76.67	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			317.9	E08		7	0068-0236	277.65	236.50	804	114.33	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			267.9	E08		7	0069-0230	717.96	230.20	468	83.26	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			408.2	E08		7	0070-0231	512.52	230.88	408	78.18	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3036.0	E08		7	0071-0231	660.78	231.47	409	76.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			327.3	E08		7	0072-0234	552.17	234.52	465	80.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			227.7	E08		7	0073-0235	743.94	234.70	468	82.91	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			484.9	E08		7	0074-0240	921.31	240.17	436	78.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1494.0	E08		7	0075-0244	349.58	244.76	421	79.50	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			626.2	E08		7	0076-0242	419.81	240.95	462	91.01	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			486.5	E08		7	0077-0245	587.43	245.28	446	79.26	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			288.5	E08		7	0078-0245	616.80	245.35	467	82.33	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			177.5	E08		7	0079-0256	244.72	256.65	411	74.43	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			224.0	E08		7	0080-0256	165.72	256.33	403	75.26	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			563.8	E08		7	0081-0256	546.41	255.98	391	77.36	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			384.7	E08		7	0082-0260	401.71	260.65	446	79.84	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			6590.7	E08		7	0083-0261	770.98	261.39	409	76.08	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			222.6	E08		7	0084-0275	859.66	275.10	420	81.50	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			316.5	E08		7	0085-0280	15.81	280.22	382	76.08	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1017.6	E08		7	0086-0283	911.46	282.82	394	77.84	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			928.6	E08		7	0087-0287	812.91	286.93	384	75.26	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			251.8	E08		7	0088-0291	361.58	290.96	385	73.26	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			623.0	E08		7	0089-0296	449.18	296.56	453	80.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			491.9	E08		7	0090-0299	207.78	299.43	414	77.74	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1554.3	E08		7	0091-0300	615.41	300.01	425	79.26	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1060.5	E08		7	0092-0302	783.03	301.18	396	76.33	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			430.0	E08		7	0093-0305	287.31	304.99	408	75.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1333.1	E08		7	0094-0308	523.05	306.75	406	77.74	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1114.3	E08		7	0095-0304	581.87	304.39	434	78.08	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			554.7	E08		7	0096-0313	940.51	313.37	444	82.43	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3180.3	E08		7	0097-0310	418.35	310.49	410	75.84	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			233.9	E08		7	0098-0313	352.30	313.57	476	86.08	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			482.6	E08		7	0099-0311	766.95	312.50	385	76.33	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			845.5	E08		7	0100-0326	514.28	327.72	504	86.57	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			772.2	E08		7	0101-0333	365.09	333.64	458	82.67	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			996.6	E08		7	0102-0336	262.15	336.27	411	78.08	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			394.7	E08		7	0103-0346	486.60	346.09	878	119.64	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1155.4	E08		7	0104-0339	795.17	339.92	407	75.26	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1142.5	E08		7	0105-0340	576.51	340.22	421	76.67	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1089.8	E08		7	0106-0349	751.18	349.39	815	118.37	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			283.5	E08		7	0107-0342	176.49	342.38	406	75.26	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			526.4	E08		7	0108-0352	838.85	352.49	419	77.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1034.6	E08		7	0109-0353	37.15	353.91	411	77.26	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			15671.6	E08		7	0110-0354	196.64	354.38	249	64.18	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			490.9	E08		7	0111-0357	911.74	356.92	410	77.50	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			487.0	E08		7	0112-0362	721.35	361.82	401	73.60	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1439.1	E08		7	0113-0375	307.67	373.54	822	118.37	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1752.7	E08		7	0114-0372	576.22	372.32	426	78.08	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			209.5	E08		7	0115-0379	255.42	379.49	555	88.33	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			512.8	E08		7	0116-0379	104.36	379.35	412	75.84	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			968.8	E08		7	0117-0383	353.55	383.66	403	78.08	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			672.1	E08		7	0118-0393	729.49	393.01	419	76.43	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			514.9	E08		7	0119-0399	411.40	399.13	422	78.67	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			256.3	E08		7	0120-0400	896.04	400.17	430	77.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3278.9	E08		7	0121-0412	547.67	412.36	432	77.26	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1679.4	E08		7	0122-0417	477.90	416.96	424	78.43	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			355.8	E08		7	0123-0421	798.64	421.39	816	108.13	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			852.1	E08		7	0124-0418	288.39	418.77	420	76.67	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			779.4	E08		7	0125-0422	221.78	422.33	394	75.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1366.1	E08		7	0126-0427	674.72	427.78	474	84.57	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2435.6	E08		7	0127-0435	647.25	434.77	971	126.37	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			755.8	E08		7	0128-0432	22.64	432.45	395	74.67	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5572.6	E08		7	0129-0428	852.61	427.21	311	66.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			314.5	E08		7	0130-0436	442.88	436.49	421	78.67	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1550.9	E08		7	0131-0438	413.29	438.11	427	78.91	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1011.5	E08		7	0132-0448	594.07	448.69	427	78.67	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			225.1	E08		7	0133-0449	916.60	449.00	410	75.84	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1220.1	E08		7	0134-0458	778.28	457.50	871	115.05	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			604.6	E08		7	0135-0453	284.13	453.88	402	74.67	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			241.2	E08		7	0136-0456	158.85	455.93	521	84.33	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			427.7	E08		7	0137-0458	703.47	458.41	431	80.91	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1138.3	E08		7	0138-0460	527.10	460.81	427	79.50	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			308.9	E08		7	0139-0461	851.90	460.82	426	77.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2262.1	E08		7	0140-0471	339.98	470.78	775	109.98	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			308.3	E08		7	0141-0483	82.00	482.90	404	76.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			195.8	E08		7	0142-0491	574.07	490.87	423	76.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			620.7	E08		7	0143-0493	110.84	492.98	414	76.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			240.7	E08		7	0144-0496	268.05	496.37	397	73.60	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			224.3	E08		7	0145-0497	225.62	496.98	383	72.43	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			383.9	E08		7	0146-0502	948.73	502.04	404	79.26	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1269.7	E08		7	0147-0507	728.18	506.57	400	77.60	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			389.9	E08		7	0148-0507	897.43	506.76	385	73.26	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1578.1	E08		7	0149-0515	409.47	515.53	400	75.84	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1273.1	E08		7	0150-0519	585.04	519.69	406	75.26	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			753.2	E08		7	0151-0524	723.90	525.32	292	66.18	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			321.2	E08		7	0152-0526	646.35	526.17	363	72.67	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			265.5	E08		7	0153-0530	160.90	531.09	418	77.11	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4154.6	E08		7	0154-0528	794.84	527.92	437	84.43	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			209.9	E08		7	0155-0538	62.81	537.91	537	87.26	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			431.1	E08		7	0156-0539	94.34	539.64	421	75.84	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1814.5	E08		7	0157-0537	526.23	537.55	407	76.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			198.5	E08		7	0158-0547	636.52	547.51	481	86.33	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			467.6	E08		7	0159-0546	361.37	546.65	416	76.67	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			321.4	E08		7	0160-0556	161.11	554.96	470	83.36	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			458.4	E08		7	0161-0556	830.91	556.71	355	72.08	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			774.8	E08		7	0162-0562	286.89	562.71	427	76.67	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			720.3	E08		7	0163-0563	565.56	563.25	427	76.43	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			399.3	E08		7	0164-0562	879.38	562.67	401	76.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			586.8	E08		7	0165-0563	239.98	563.72	432	77.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1437.0	E08		7	0166-0566	456.03	566.66	814	114.23	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2048.7	E08		7	0167-0578	40.49	578.42	753	104.81	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			628.3	E08		7	0168-0576	380.31	576.15	402	73.60	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1099.5	E08		7	0169-0594	904.98	594.13	711	103.64	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			627.6	E08		7	0170-0596	88.73	596.10	376	73.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			831.5	E08		7	0171-0605	117.62	605.11	407	76.67	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			264.7	E08		7	0172-0608	251.39	608.26	407	75.26	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			353.2	E08		7	0173-0609	171.24	609.16	393	73.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			178.0	E08		7	0174-0609	623.41	609.05	462	82.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1200.9	E08		7	0175-0622	508.45	622.39	442	79.26	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2144.7	E08		7	0176-0622	537.13	621.59	421	76.08	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			216.7	E08		7	0177-0629	839.20	629.32	388	73.60	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1883.1	E08		7	0178-0630	458.46	629.99	392	73.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1375.4	E08		7	0179-0630	375.06	630.96	424	77.84	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1008.7	E08		7	0180-0634	120.29	634.40	434	83.15	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			218.0	E08		7	0181-0638	566.69	638.48	419	78.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			857.5	E08		7	0182-0643	82.73	643.20	390	75.50	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			433.0	E08		7	0183-0641	31.35	641.60	353	68.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1020.5	E08		7	0184-0645	289.37	645.10	406	73.60	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			251.4	E08		7	0185-0644	599.43	644.18	456	81.50	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			235.3	E08		7	0186-0648	147.44	647.92	408	74.18	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			243.2	E08		7	0187-0651	710.26	650.69	404	75.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			423.6	E08		7	0188-0653	250.53	653.75	401	76.08	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			319.3	E08		7	0189-0657	392.64	657.16	439	78.43	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			586.2	E08		7	0190-0667	804.84	668.45	855	117.30	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			458.9	E08		7	0191-0664	204.68	664.59	410	75.01	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			260.0	E08		7	0192-0667	461.60	667.58	383	72.43	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			254.4	E08		7	0193-0668	870.91	668.58	360	70.43	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1916.8	E08		7	0194-0671	620.80	671.53	382	72.43	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			182.1	E08		7	0195-0682	727.61	681.81	759	105.74	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			250.6	E08		7	0196-0689	30.58	689.00	400	74.43	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			492.8	E08		7	0197-0698	843.13	698.26	329	72.43	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			239.3	E08		7	0198-0696	915.86	696.39	333	68.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			206.5	E08		7	0199-0702	286.34	702.25	615	92.91	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			197.2	E08		7	0200-0701	588.98	700.78	613	93.26	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			274.9	E08		7	0201-0703	676.76	703.24	449	80.08	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			422.6	E08		7	0202-0705	860.74	704.81	415	78.77	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1254.2	E08		7	0203-0706	339.00	705.36	365	71.01	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			242.8	E08		8	0001-0027	12.86	26.76	131	43.70	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			222.5	E08		8	0002-0034	878.19	33.39	456	81.98	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1112.6	E08		8	0003-0038	137.55	38.18	360	70.18	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			449.3	E08		8	0004-0036	208.64	36.46	369	71.26	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			206.7	E08		8	0005-0037	928.11	37.23	403	75.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1210.5	E08		8	0006-0039	338.64	39.54	422	77.50	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			211.4	E08		8	0007-0043	830.27	43.72	342	67.60	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			181.6	E08		8	0008-0044	858.88	44.83	369	73.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1800.4	E08		8	0009-0049	252.72	49.24	380	73.84	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			221.4	E08		8	0010-0052	703.68	51.91	725	99.74	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			673.0	E08		8	0011-0054	106.15	53.85	358	70.18	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			656.8	E08		8	0012-0056	435.56	56.02	435	77.26	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			634.7	E08		8	0013-0068	387.24	68.15	402	73.84	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			277.6	E08		8	0014-0072	502.28	72.23	432	79.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			683.0	E08		8	0015-0075	198.47	75.77	388	72.77	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1195.4	E08		8	0016-0076	825.57	76.69	447	78.67	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1899.7	E08		8	0017-0075	916.38	76.13	387	74.67	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3062.0	E08		8	0018-0078	19.55	78.07	365	71.01	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			806.1	E08		8	0019-0081	710.84	81.37	413	75.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2751.7	E08		8	0020-0090	169.84	90.08	388	74.67	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			425.6	E08		8	0021-0089	279.57	89.50	379	73.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2018.4	E08		8	0022-0093	359.40	92.93	391	73.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			778.8	E08		8	0023-0101	97.26	101.04	385	71.84	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			818.1	E08		8	0024-0106	129.43	105.80	377	72.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2217.0	E08		8	0025-0107	912.97	106.51	390	73.01	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			310.0	E08		8	0026-0111	40.25	110.23	367	75.40	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3770.5	E08		8	0027-0114	536.93	113.63	388	72.18	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			236.6	E08		8	0028-0121	790.30	121.16	840	112.08	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			219.0	E08		8	0029-0118	182.89	118.63	396	76.77	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			573.8	E08		8	0030-0117	426.66	117.08	409	75.26	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2853.9	E08		8	0031-0132	24.01	133.27	791	113.54	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			357.1	E08		8	0032-0129	510.23	128.96	385	73.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			573.3	E08		8	0033-0134	659.27	134.22	381	75.84	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			554.5	E08		8	0034-0142	147.05	142.44	399	74.18	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			414.3	E08		8	0035-0142	349.62	142.04	399	76.43	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			201.8	E08		8	0036-0143	184.85	143.18	431	79.94	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5301.0	E08		8	0037-0147	561.04	146.72	400	73.60	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			294.0	E08		8	0038-0152	592.10	151.51	558	98.57	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			741.0	E08		8	0039-0146	775.62	146.78	412	75.01	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			729.6	E08		8	0040-0154	270.66	154.46	398	73.01	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2103.7	E08		8	0041-0154	708.75	154.15	387	71.60	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2508.7	E08		8	0042-0155	221.46	155.64	376	71.01	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			217.3	E08		8	0043-0156	921.65	156.62	398	74.67	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1056.5	E08		8	0044-0157	303.73	157.44	396	73.60	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2735.7	E08		8	0045-0159	833.62	159.60	351	69.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3069.3	E08		8	0046-0166	471.01	165.99	897	114.81	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			307.2	E08		8	0047-0162	890.05	161.56	396	74.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1228.1	E08		8	0048-0161	61.84	161.17	363	71.60	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3229.4	E08		8	0049-0166	187.42	165.14	380	74.53	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2517.9	E08		8	0050-0166	341.97	166.42	401	75.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			569.9	E08		8	0051-0169	377.65	169.22	399	77.26	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			226.9	E08		8	0052-0167	102.73	166.88	363	71.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			960.1	E08		8	0053-0187	938.78	187.67	341	68.18	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			194.8	E08		8	0054-0188	676.21	188.44	420	76.67	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			883.8	E08		8	0055-0187	778.88	187.08	345	69.01	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			440.7	E08		8	0056-0189	823.38	189.83	386	71.60	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			200.9	E08		8	0057-0191	643.60	191.60	416	76.67	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1846.9	E08		8	0058-0194	529.74	194.47	406	75.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			194.3	E08		8	0059-0197	390.61	197.85	434	81.01	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1760.9	E08		8	0060-0198	28.08	198.47	395	78.67	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			513.9	E08		8	0061-0207	234.56	207.06	394	73.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1036.6	E08		8	0062-0210	98.04	210.49	783	110.81	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			470.4	E08		8	0063-0205	730.77	205.93	405	76.87	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			208.4	E08		8	0064-0210	51.96	209.98	417	77.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			485.5	E08		8	0065-0226	150.93	226.45	882	119.20	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1009.4	E08		8	0066-0227	766.45	227.43	385	74.43	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			524.8	E08		8	0067-0225	732.13	224.55	379	74.28	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1015.6	E08		8	0068-0230	517.07	230.49	396	75.26	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			305.3	E08		8	0069-0229	455.43	228.84	391	72.43	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			233.4	E08		8	0070-0234	704.14	234.14	436	77.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			222.1	E08		8	0071-0233	801.86	233.75	412	77.74	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			545.4	E08		8	0072-0235	280.81	235.53	442	79.50	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			472.3	E08		8	0073-0242	26.40	242.17	397	75.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			232.3	E08		8	0074-0239	883.39	239.10	387	73.26	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			727.1	E08		8	0075-0243	827.50	243.32	380	73.01	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			252.4	E08		8	0076-0245	304.28	244.81	430	84.08	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			967.3	E08		8	0077-0248	207.90	247.89	429	77.26	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			300.4	E08		8	0078-0247	338.34	247.62	403	76.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			624.9	E08		8	0079-0253	364.00	253.03	387	73.60	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1322.9	E08		8	0080-0269	645.93	267.39	970	133.05	0.689
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1596.9	E08		8	0081-0258	123.48	258.55	377	72.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			546.4	E08		8	0082-0263	453.70	263.14	404	75.26	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			866.1	E08		8	0083-0264	317.89	264.40	448	82.08	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			814.5	E08		8	0084-0266	75.47	265.97	413	76.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			661.3	E08		8	0085-0265	503.36	265.50	404	74.67	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			358.8	E08		8	0086-0267	273.87	266.82	456	81.15	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1864.2	E08		8	0087-0282	253.98	282.02	486	84.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1072.9	E08		8	0088-0285	16.72	284.89	358	71.60	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			753.9	E08		8	0089-0283	874.71	283.66	396	74.67	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			541.9	E08		8	0090-0301	365.86	301.03	389	73.01	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1101.9	E08		8	0091-0303	85.07	303.28	374	71.60	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			422.7	E08		8	0092-0305	493.41	304.96	634	98.57	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			398.9	E08		8	0093-0304	646.32	304.07	373	70.18	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			189.1	E08		8	0094-0307	801.56	307.47	422	76.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			220.4	E08		8	0095-0313	152.47	313.01	416	78.43	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			611.3	E08		8	0096-0315	45.71	315.47	403	79.01	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			243.1	E08		8	0097-0317	107.42	316.99	421	77.26	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			319.0	E08		8	0098-0324	435.57	323.86	409	76.08	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			594.3	E08		8	0099-0329	225.64	330.02	805	109.54	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			286.7	E08		8	0100-0323	884.08	323.71	276	59.94	0.965
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			308.4	E08		8	0101-0331	923.08	331.31	395	75.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			226.7	E08		8	0102-0334	353.64	334.44	365	71.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1191.7	E08		8	0103-0337	170.74	336.54	362	73.94	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			255.4	E08		8	0104-0338	558.10	338.35	477	80.67	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			274.6	E08		8	0105-0339	149.93	340.00	471	84.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			211.3	E08		8	0106-0341	811.52	341.33	405	75.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			959.2	E08		8	0107-0351	410.83	350.90	374	71.60	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			165.5	E08		8	0108-0353	298.83	353.05	332	67.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			545.4	E08		8	0109-0354	493.00	354.82	371	70.18	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			217.6	E08		8	0110-0358	665.66	358.28	390	74.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			513.0	E08		8	0111-0359	17.15	358.98	363	71.60	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			283.1	E08		8	0112-0357	346.39	357.41	317	65.36	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			900.1	E08		8	0113-0358	901.62	358.35	389	74.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			263.7	E08		8	0114-0371	862.43	370.96	842	117.15	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			795.3	E08		8	0115-0374	738.95	374.20	390	73.84	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			203.2	E08		8	0116-0377	785.88	377.58	417	77.84	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			442.7	E08		8	0117-0382	335.79	382.26	393	73.26	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			197.0	E08		8	0118-0394	112.36	393.65	782	110.37	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1493.5	E08		8	0119-0387	274.56	387.16	394	74.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			701.7	E08		8	0120-0390	208.40	390.43	381	74.91	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			436.8	E08		8	0121-0389	479.21	388.90	386	72.43	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1087.6	E08		8	0122-0401	168.44	400.19	458	87.26	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			204.1	E08		8	0123-0402	565.48	401.81	380	72.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			211.9	E08		8	0124-0406	362.72	406.66	424	79.84	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1927.2	E08		8	0125-0409	434.57	409.45	394	75.60	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			230.4	E08		8	0126-0412	476.60	412.46	404	75.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			283.2	E08		8	0127-0421	609.03	421.87	466	80.91	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			226.6	E08		8	0128-0421	828.47	421.78	413	76.67	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			730.9	E08		8	0129-0422	193.23	422.30	385	71.60	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			733.4	E08		8	0130-0421	261.09	421.26	380	73.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			190.5	E08		8	0131-0421	928.44	421.32	423	79.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			196.1	E08		8	0132-0431	84.88	431.14	373	73.26	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			214.6	E08		8	0133-0429	901.87	428.91	391	76.18	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			486.9	E08		8	0134-0434	390.13	434.87	380	73.01	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			656.5	E08		8	0135-0439	573.78	438.71	432	77.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1457.1	E08		8	0136-0443	677.38	443.35	419	75.01	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			213.9	E08		8	0137-0443	127.46	443.00	401	75.50	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			470.7	E08		8	0138-0443	298.30	442.84	387	74.67	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			885.3	E08		8	0139-0445	250.82	443.39	360	72.91	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			179.1	E08		8	0140-0451	21.71	450.93	367	71.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			480.1	E08		8	0141-0451	57.31	451.96	366	71.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			267.8	E08		8	0142-0456	266.57	457.00	385	74.57	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			935.2	E08		8	0143-0456	757.54	456.78	401	73.84	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			286.2	E08		8	0144-0465	695.31	464.74	333	66.77	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			317.6	E08		8	0145-0475	624.02	474.88	775	109.64	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3987.7	E08		8	0146-0472	545.34	472.55	230	55.94	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			199.7	E08		8	0147-0479	826.55	478.30	624	92.33	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1081.5	E08		8	0148-0480	103.11	480.20	386	73.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2577.9	E08		8	0149-0482	470.82	480.83	343	70.91	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1819.5	E08		8	0150-0483	257.38	482.81	373	70.77	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			262.6	E08		8	0151-0487	382.59	487.61	326	65.94	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			581.1	E08		8	0152-0497	88.68	497.40	427	77.50	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			756.2	E08		8	0153-0501	942.80	501.31	378	74.77	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			393.1	E08		8	0154-0504	53.78	503.94	355	73.60	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			375.1	E08		8	0155-0502	837.74	503.28	408	79.26	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			180.9	E08		8	0156-0506	117.26	506.08	442	81.01	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1769.2	E08		8	0157-0508	692.35	507.93	420	76.08	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			232.9	E08		8	0158-0510	631.74	509.82	395	73.84	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			256.6	E08		8	0159-0518	344.60	518.30	623	92.33	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1224.4	E08		8	0160-0520	502.68	521.89	473	97.40	0.627
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			183.9	E08		8	0161-0519	179.67	519.43	392	73.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			237.9	E08		8	0162-0531	133.80	531.30	437	83.50	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			953.6	E08		8	0163-0530	683.66	531.47	424	77.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			730.3	E08		8	0164-0535	109.15	534.66	422	78.08	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			901.2	E08		8	0165-0538	262.29	538.48	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			302.6	E08		8	0166-0546	422.62	547.19	423	78.43	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			368.3	E08		8	0167-0548	772.56	547.66	381	73.84	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			724.4	E08		8	0168-0549	741.84	549.81	294	64.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			652.1	E08		8	0169-0552	689.00	552.49	408	78.18	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			354.5	E08		8	0170-0554	612.03	554.10	392	73.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3338.0	E08		8	0171-0558	572.27	558.01	387	73.01	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			350.0	E08		8	0172-0558	818.49	558.24	379	72.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			182.7	E08		8	0173-0559	239.19	559.34	388	74.08	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			201.2	E08		8	0174-0567	401.42	566.65	432	77.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			203.7	E08		8	0175-0569	72.52	568.92	371	71.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			282.7	E08		8	0176-0568	115.15	567.72	380	74.08	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			843.7	E08		8	0177-0571	928.14	571.53	366	71.01	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			428.3	E08		8	0178-0573	894.54	573.35	385	73.26	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			430.2	E08		8	0179-0573	472.87	572.73	373	71.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			279.2	E08		8	0180-0578	365.59	578.38	422	77.94	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1001.1	E08		8	0181-0577	620.21	577.65	398	74.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			505.8	E08		8	0182-0579	657.58	579.15	397	75.50	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			231.9	E08		8	0183-0579	130.71	579.51	295	63.84	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			525.1	E08		8	0184-0586	870.14	586.32	352	70.43	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			782.9	E08		8	0185-0593	306.08	592.85	380	72.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1133.5	E08		8	0186-0591	574.66	591.46	375	72.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			341.0	E08		8	0187-0600	798.09	600.44	796	109.88	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			889.7	E08		8	0188-0598	344.16	598.08	407	76.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1466.6	E08		8	0189-0598	649.17	599.12	377	74.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			477.5	E08		8	0190-0606	189.49	605.77	406	77.11	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			480.9	E08		8	0191-0611	212.45	611.06	398	76.77	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1237.3	E08		8	0192-0609	498.57	609.64	381	75.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			959.6	E08		8	0193-0620	745.01	619.76	770	112.47	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			736.4	E08		8	0194-0615	622.23	614.51	375	72.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			322.9	E08		8	0195-0619	247.53	619.43	377	71.01	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			184.8	E08		8	0196-0623	315.00	623.18	422	76.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1337.8	E08		8	0197-0630	449.89	629.80	367	71.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			625.6	E08		8	0198-0630	117.57	630.45	386	73.01	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			178.6	E08		8	0199-0634	145.21	633.58	394	75.50	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			215.5	E08		8	0200-0633	650.83	633.13	404	76.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			804.4	E08		8	0201-0634	411.77	634.57	416	76.18	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			615.0	E08		8	0202-0633	940.43	632.74	121	41.80	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			370.6	E08		8	0203-0642	389.05	641.84	422	77.84	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			305.7	E08		8	0204-0644	535.73	644.60	394	73.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			227.6	E08		8	0205-0650	577.45	650.84	386	72.18	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			179.2	E08		8	0206-0655	104.11	655.06	400	79.01	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			748.3	E08		8	0207-0656	784.90	656.57	391	73.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			799.4	E08		8	0208-0657	274.18	656.98	365	71.01	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			186.0	E08		8	0209-0660	515.41	660.89	414	75.84	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			520.3	E08		8	0210-0662	465.97	662.53	397	74.18	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			203.1	E08		8	0211-0663	862.67	663.21	420	76.43	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			178.3	E08		8	0212-0675	611.14	675.90	404	78.91	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1076.1	E08		8	0213-0687	236.25	687.72	410	77.01	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			827.7	E08		8	0214-0688	937.61	688.35	351	72.18	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1118.5	E08		8	0215-0687	135.56	687.26	385	73.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			496.7	E08		8	0216-0690	767.50	688.49	390	77.98	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			418.0	E08		8	0217-0695	630.66	695.62	404	78.43	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			189.9	E08		8	0218-0698	20.54	698.45	342	67.84	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			203.4	E08		8	0219-0705	876.06	705.52	417	76.91	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			174.6	E08		9	0001-0035	446.94	35.52	381	76.53	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			696.8	E08		9	0002-0030	118.26	29.91	194	54.53	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1234.4	E08		9	0003-0037	467.14	37.29	461	81.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			218.4	E08		9	0004-0035	317.27	34.86	407	80.43	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			199.4	E08		9	0005-0039	22.73	39.90	388	76.91	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			807.5	E08		9	0006-0041	859.08	41.53	402	77.74	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			649.7	E08		9	0007-0048	501.51	48.32	417	77.26	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1909.5	E08		9	0008-0052	92.29	52.34	375	72.67	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1089.3	E08		9	0009-0051	682.41	51.08	408	75.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1201.1	E08		9	0010-0056	198.24	54.50	521	106.81	0.574
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			582.4	E08		9	0011-0053	750.74	53.84	362	71.60	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			465.4	E08		9	0012-0058	180.23	60.22	233	72.08	0.564
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1471.3	E08		9	0013-0059	124.69	58.76	368	74.67	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			887.5	E08		9	0014-0065	905.51	65.74	347	70.43	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			212.6	E08		9	0015-0067	424.89	67.01	396	75.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			221.3	E08		9	0016-0068	807.95	68.14	355	68.77	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			281.0	E08		9	0017-0080	716.35	80.08	379	75.36	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			520.7	E08		9	0018-0076	289.50	76.64	363	72.43	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			821.2	E08		9	0019-0079	840.09	78.86	418	77.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			296.8	E08		9	0020-0082	469.22	81.80	358	71.60	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			591.2	E08		9	0021-0086	533.45	85.87	390	75.84	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			433.6	E08		9	0022-0091	923.79	90.75	578	92.57	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			696.0	E08		9	0023-0090	79.93	89.86	378	73.50	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			562.8	E08		9	0024-0097	361.02	97.13	367	73.26	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			382.0	E08		9	0025-0100	832.20	99.85	407	77.84	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			214.1	E08		9	0026-0104	944.59	104.47	361	71.84	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1751.9	E08		9	0027-0114	400.72	115.10	887	115.98	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			235.3	E08		9	0028-0113	501.62	112.70	613	91.74	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1159.5	E08		9	0029-0124	118.68	124.31	366	71.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1080.6	E08		9	0030-0133	74.11	134.00	385	77.60	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			648.5	E08		9	0031-0136	215.57	136.49	367	71.60	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1096.0	E08		9	0032-0137	304.29	137.25	382	75.26	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			321.1	E08		9	0033-0142	849.97	142.28	397	76.67	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			8181.8	E08		9	0034-0153	773.45	152.25	340	70.33	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			723.3	E08		9	0035-0155	71.06	153.87	405	76.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			815.5	E08		9	0036-0157	644.08	156.94	390	76.08	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			192.3	E08		9	0037-0159	16.79	159.26	372	72.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			7123.2	E08		9	0038-0164	786.81	165.90	382	73.74	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3251.9	E08		9	0039-0170	711.99	170.25	341	68.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			261.7	E08		9	0040-0179	734.38	179.20	399	77.26	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4275.3	E08		9	0041-0182	557.51	181.49	421	78.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			349.6	E08		9	0042-0181	472.02	180.70	441	80.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			261.4	E08		9	0043-0183	320.29	182.67	391	75.26	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1027.9	E08		9	0044-0190	33.68	190.27	339	69.01	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2681.0	E08		9	0045-0190	662.58	189.98	368	74.43	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			496.8	E08		9	0046-0201	870.57	199.09	990	127.54	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			436.3	E08		9	0047-0198	642.58	198.23	392	75.60	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			745.8	E08		9	0048-0198	62.31	198.18	337	69.26	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			381.8	E08		9	0049-0204	137.30	204.06	380	75.84	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1855.9	E08		9	0050-0204	931.35	203.84	337	68.18	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			214.4	E08		9	0051-0207	116.09	206.71	381	75.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1399.7	E08		9	0052-0218	365.71	218.11	398	77.50	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			235.0	E08		9	0053-0223	202.20	223.22	396	76.08	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1244.2	E08		9	0054-0235	446.43	235.83	404	77.74	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			748.7	E08		9	0055-0234	300.74	233.79	385	75.26	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1445.7	E08		9	0056-0237	852.00	237.08	388	73.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			496.9	E08		9	0057-0246	898.77	247.10	689	110.37	0.711
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1024.6	E08		9	0058-0245	510.67	246.13	412	75.26	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1264.5	E08		9	0059-0250	571.60	249.66	391	73.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2192.2	E08		9	0060-0254	95.42	254.05	353	68.18	0.954
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			488.5	E08		9	0061-0261	257.36	261.65	412	80.43	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1431.6	E08		9	0062-0264	925.97	264.27	369	71.01	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			275.0	E08		9	0063-0267	276.08	268.10	156	48.87	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5828.4	E08		9	0064-0295	116.10	293.14	552	94.23	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1180.5	E08		9	0065-0296	865.27	296.47	330	67.94	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			885.6	E08		9	0066-0308	601.08	308.01	785	119.10	0.695
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			269.4	E08		9	0067-0312	311.36	313.08	807	110.37	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			242.3	E08		9	0068-0306	62.59	305.93	393	78.33	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1824.6	E08		9	0069-0310	160.91	310.08	362	74.91	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			196.3	E08		9	0070-0311	534.74	311.75	392	75.01	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			203.3	E08		9	0071-0312	103.15	311.94	275	61.36	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			264.9	E08		9	0072-0316	463.24	315.59	409	77.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			230.3	E08		9	0073-0318	253.19	318.38	397	76.33	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			205.8	E08		9	0074-0321	48.06	322.47	448	79.50	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2781.9	E08		9	0075-0322	843.07	321.93	318	66.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			345.1	E08		9	0076-0329	410.85	329.14	331	68.43	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			281.9	E08		9	0077-0334	18.36	333.96	364	73.50	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1571.5	E08		9	0078-0336	359.49	336.39	397	73.84	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			207.6	E08		9	0079-0361	46.64	361.56	375	76.18	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			513.4	E08		9	0080-0363	143.77	363.02	715	101.05	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1916.9	E08		9	0081-0357	942.03	357.06	341	68.18	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			324.7	E08		9	0082-0367	914.25	366.85	224	76.43	0.482
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2060.6	E08		9	0083-0371	291.66	371.35	368	72.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1943.1	E08		9	0084-0386	92.84	386.67	367	72.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2086.4	E08		9	0085-0400	243.83	400.34	375	73.26	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			259.1	E08		9	0086-0401	306.84	401.24	393	74.67	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			513.0	E08		9	0087-0409	193.29	408.93	388	73.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1031.6	E08		9	0088-0412	70.60	412.71	370	71.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1885.0	E08		9	0089-0421	506.18	420.74	402	75.50	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			163.6	E08		9	0090-0424	23.89	424.00	390	75.60	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1298.8	E08		9	0091-0438	122.48	438.09	377	74.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			220.3	E08		9	0092-0457	67.82	457.34	362	71.60	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			960.4	E08		9	0093-0460	378.98	459.94	408	74.43	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			273.6	E08		9	0094-0472	844.58	471.93	371	74.43	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3972.5	E08		9	0095-0493	233.99	494.65	661	106.23	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			490.6	E08		9	0096-0496	541.76	496.72	360	71.84	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			733.8	E08		9	0097-0502	57.45	502.91	432	82.28	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			750.1	E08		9	0098-0504	37.64	504.09	357	72.53	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			240.8	E08		9	0099-0505	610.27	505.12	422	75.26	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			448.7	E08		9	0100-0519	323.28	519.04	444	79.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1137.0	E08		9	0101-0523	206.62	522.81	376	73.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2029.3	E08		9	0102-0523	59.79	522.94	350	71.70	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			257.2	E08		9	0103-0540	338.97	540.23	445	79.26	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1841.7	E08		9	0104-0545	381.48	545.16	362	70.53	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			236.4	E08		9	0105-0545	571.83	544.20	311	67.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1158.9	E08		9	0106-0559	562.79	560.54	389	75.26	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			888.0	E08		9	0107-0574	22.91	574.25	342	69.60	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			239.4	E08		9	0108-0576	608.85	576.94	389	74.91	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1215.8	E08		9	0109-0587	590.60	587.81	393	75.26	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			307.1	E08		9	0110-0594	360.80	594.71	372	72.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1774.4	E08		9	0111-0597	50.96	597.50	346	71.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			240.8	E08		9	0112-0619	538.40	618.84	271	59.94	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			572.4	E08		9	0113-0632	114.79	632.78	368	71.84	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			388.0	E08		9	0114-0633	916.89	632.73	349	70.77	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			673.1	E08		9	0115-0637	723.10	636.85	398	76.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			755.5	E08		9	0116-0635	35.78	635.56	114	43.46	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			230.0	E08		9	0117-0647	330.91	646.43	963	121.30	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			528.9	E08		9	0118-0643	95.21	643.10	364	74.08	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			265.1	E08		9	0119-0646	831.47	646.01	365	71.84	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			221.1	E08		9	0120-0664	884.80	664.40	591	92.33	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			554.8	E08		9	0121-0688	282.03	688.56	384	75.84	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			901.9	E08		9	0122-0691	32.07	691.03	364	72.43	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			608.3	E08		9	0123-0696	492.71	697.00	914	118.23	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			571.7	E08		9	0124-0692	101.63	692.07	400	76.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2872.5	E08		9	0125-0695	371.28	694.61	380	75.50	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			225.0	E08		9	0126-0700	602.27	699.55	456	83.74	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1227.5	E08		9	0127-0701	453.77	701.32	370	71.84	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			734.5	F08		1	0001-0030	110.32	30.57	334	66.77	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			528.6	F08		1	0002-0030	292.69	29.76	335	69.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			644.3	F08		1	0003-0033	788.07	32.87	308	63.94	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			855.2	F08		1	0004-0036	632.11	35.77	388	76.67	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1295.9	F08		1	0005-0039	856.44	39.34	340	71.26	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1495.9	F08		1	0006-0046	812.65	45.96	342	69.60	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1007.1	F08		1	0007-0045	447.90	44.91	293	63.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			574.5	F08		1	0008-0050	42.39	51.20	369	72.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			406.4	F08		1	0009-0052	596.09	52.45	328	69.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			575.0	F08		1	0010-0056	175.27	55.94	409	77.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			224.4	F08		1	0011-0064	115.82	64.58	333	67.26	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			214.1	F08		1	0012-0066	924.28	65.51	402	78.08	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			707.7	F08		1	0013-0084	473.86	84.49	348	69.60	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			386.1	F08		1	0014-0088	249.65	88.08	246	61.84	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1499.6	F08		1	0015-0090	298.93	89.70	343	71.01	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			257.4	F08		1	0016-0097	626.12	97.82	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4433.0	F08		1	0017-0100	812.67	99.51	412	75.26	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			324.9	F08		1	0018-0101	37.70	101.14	322	67.01	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			248.4	F08		1	0019-0109	158.33	109.14	367	74.67	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3546.4	F08		1	0020-0110	918.49	110.83	230	55.70	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			536.7	F08		1	0021-0117	383.49	117.08	301	63.60	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			209.4	F08		1	0022-0120	224.09	120.30	352	71.84	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			238.2	F08		1	0023-0128	92.30	128.42	330	68.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			482.6	F08		1	0024-0129	304.76	129.88	332	69.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			211.1	F08		1	0025-0132	888.55	131.89	382	74.67	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			318.5	F08		1	0026-0133	624.07	132.24	400	75.84	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			239.1	F08		1	0027-0136	189.70	136.50	377	71.84	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			487.7	F08		1	0028-0139	38.80	139.33	355	71.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			224.5	F08		1	0029-0156	502.25	156.41	361	72.77	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1224.4	F08		1	0030-0159	245.97	159.58	262	60.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			269.8	F08		1	0031-0162	542.47	162.08	305	66.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			227.6	F08		1	0032-0170	856.80	169.98	448	81.26	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			226.2	F08		1	0033-0175	32.65	174.76	287	62.77	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			301.0	F08		1	0034-0180	296.19	180.25	357	70.67	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			367.4	F08		1	0035-0181	102.62	181.53	348	70.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			608.5	F08		1	0036-0191	622.34	191.15	356	70.53	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1285.8	F08		1	0037-0209	549.09	209.23	362	71.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2422.8	F08		1	0038-0216	173.16	216.49	298	64.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			305.2	F08		1	0039-0214	415.90	214.79	279	65.70	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2207.0	F08		1	0040-0218	132.55	218.67	313	65.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			185.2	F08		1	0041-0222	910.76	222.53	352	71.36	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1584.2	F08		1	0042-0227	265.38	226.89	346	70.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			892.9	F08		1	0043-0236	190.99	236.66	350	69.01	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1449.5	F08		1	0044-0238	460.98	238.44	327	74.08	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1355.8	F08		1	0045-0242	620.41	241.77	371	73.26	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			235.9	F08		1	0046-0241	540.92	241.27	310	65.11	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			439.7	F08		1	0047-0241	410.05	241.48	113	37.80	0.994
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			280.3	F08		1	0048-0250	839.25	249.93	357	73.26	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2136.4	F08		1	0049-0261	137.07	261.05	352	71.26	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			634.1	F08		1	0050-0262	571.15	261.52	381	73.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			663.7	F08		1	0051-0266	475.39	266.69	348	70.77	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1462.9	F08		1	0052-0270	530.89	271.01	334	69.84	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			928.6	F08		1	0053-0273	75.30	273.01	386	72.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3188.2	F08		1	0054-0279	210.55	279.03	249	60.43	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			615.8	F08		1	0055-0279	382.62	278.80	308	67.36	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			217.2	F08		1	0056-0282	904.38	282.65	390	74.43	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			589.7	F08		1	0057-0287	15.18	287.71	332	67.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			281.9	F08		1	0058-0300	517.08	299.90	373	73.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			240.6	F08		1	0059-0329	669.56	330.57	345	70.43	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1084.5	F08		1	0060-0329	210.55	329.94	319	64.77	0.956
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			273.9	F08		1	0061-0342	802.79	343.15	334	72.67	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1566.8	F08		1	0062-0344	183.62	344.44	354	70.43	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			783.9	F08		1	0063-0346	343.07	345.89	306	64.77	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2049.3	F08		1	0064-0343	518.02	343.86	284	64.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			215.2	F08		1	0065-0349	610.56	349.57	361	71.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			325.0	F08		1	0066-0349	313.63	348.58	294	67.26	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			816.0	F08		1	0067-0352	260.23	352.27	281	67.11	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			309.0	F08		1	0068-0354	442.75	354.67	287	63.94	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			244.8	F08		1	0069-0363	480.92	363.36	340	69.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1254.9	F08		1	0070-0367	299.40	366.87	304	65.36	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			215.5	F08		1	0071-0365	834.10	365.25	322	69.01	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1892.1	F08		1	0072-0368	527.07	367.61	294	64.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1274.9	F08		1	0073-0382	713.27	382.72	345	71.50	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			213.1	F08		1	0074-0384	173.41	384.36	362	72.77	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1104.9	F08		1	0075-0391	638.78	392.22	333	68.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			228.0	F08		1	0076-0405	573.29	404.87	344	69.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			482.3	F08		1	0077-0406	83.10	406.45	337	72.08	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2967.6	F08		1	0078-0409	594.00	410.00	382	76.43	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1455.4	F08		1	0079-0416	504.68	415.87	285	67.01	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1743.4	F08		1	0080-0418	699.52	417.20	307	69.50	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			447.8	F08		1	0081-0418	203.10	417.77	265	61.36	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			209.9	F08		1	0082-0428	690.61	428.69	321	68.91	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			195.9	F08		1	0083-0435	651.67	435.56	372	72.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			233.9	F08		1	0084-0437	450.85	437.17	367	70.77	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			523.9	F08		1	0085-0435	195.15	435.23	264	61.36	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			672.0	F08		1	0086-0441	111.14	440.70	368	73.84	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			225.4	F08		1	0087-0436	937.32	436.53	267	61.70	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1158.3	F08		1	0088-0444	253.50	444.16	346	118.71	0.309
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			772.3	F08		1	0089-0455	397.40	455.25	368	71.01	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2239.8	F08		1	0090-0464	825.17	463.78	237	57.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			904.2	F08		1	0091-0485	605.91	485.29	412	87.15	0.682
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			240.3	F08		1	0092-0484	359.10	485.15	381	72.18	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			237.8	F08		1	0093-0490	141.87	490.27	500	83.26	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			810.8	F08		1	0094-0485	304.73	485.23	290	63.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2314.1	F08		1	0095-0491	754.70	490.13	391	73.84	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			994.7	F08		1	0096-0498	265.06	497.74	288	63.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			373.8	F08		1	0097-0502	612.95	502.59	117	44.87	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			342.0	F08		1	0098-0527	10.59	527.92	305	65.70	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			653.3	F08		1	0099-0529	57.86	529.03	358	73.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			227.8	F08		1	0100-0535	452.49	535.43	640	112.47	0.636
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			955.9	F08		1	0101-0544	105.27	544.43	300	68.18	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			784.2	F08		1	0102-0546	231.84	545.25	339	71.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			843.9	F08		1	0103-0553	623.75	553.28	268	62.43	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1558.5	F08		1	0104-0555	850.95	555.28	286	62.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			253.6	F08		1	0105-0568	48.18	568.35	360	72.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			355.6	F08		1	0106-0574	819.63	574.22	350	69.11	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1344.5	F08		1	0107-0583	783.20	583.27	312	66.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			211.5	F08		1	0108-0584	710.81	582.51	423	89.50	0.664
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1040.0	F08		1	0109-0601	38.32	600.89	321	67.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			444.7	F08		1	0110-0600	607.81	600.05	367	76.08	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			241.0	F08		1	0111-0606	660.58	605.85	371	69.60	0.962
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			605.6	F08		1	0112-0610	748.21	610.84	319	68.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1405.6	F08		1	0113-0613	409.35	613.53	265	61.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1956.2	F08		1	0114-0617	366.01	617.49	295	65.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			885.9	F08		1	0115-0636	47.83	636.91	302	65.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2894.4	F08		1	0116-0637	228.92	636.45	239	59.84	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			550.9	F08		1	0117-0641	105.73	640.57	304	66.43	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1243.0	F08		1	0118-0640	623.25	640.90	283	65.50	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			787.5	F08		1	0119-0647	682.37	646.90	347	69.36	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			616.2	F08		1	0120-0655	768.36	655.13	297	65.11	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			477.9	F08		1	0121-0662	135.28	662.55	313	68.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			576.2	F08		1	0122-0666	210.92	665.60	261	60.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			546.5	F08		1	0123-0671	801.92	670.94	284	69.94	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			296.4	F08		1	0124-0667	75.29	666.23	255	61.01	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			494.6	F08		1	0125-0677	59.44	677.46	367	73.74	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2267.4	F08		1	0126-0683	690.93	683.68	237	57.11	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			449.5	F08		1	0127-0686	20.18	685.76	352	73.26	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			512.5	F08		1	0128-0684	273.91	684.26	249	60.87	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			231.0	F08		1	0129-0693	915.46	693.02	290	65.36	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			345.4	F08		1	0130-0701	579.21	702.80	368	72.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			228.5	F08		2	0001-0044	402.32	43.52	252	60.87	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			211.8	F08		2	0002-0047	546.79	46.75	377	74.43	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2082.4	F08		2	0003-0045	673.20	45.53	381	73.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			238.3	F08		2	0004-0049	443.67	49.45	286	65.01	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			772.8	F08		2	0005-0054	106.51	53.86	348	73.26	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			397.6	F08		2	0006-0052	743.31	52.03	279	62.43	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			269.0	F08		2	0007-0054	139.17	54.86	280	64.43	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			227.8	F08		2	0008-0067	28.86	65.71	380	74.67	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			807.7	F08		2	0009-0077	470.04	76.71	312	68.18	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2340.0	F08		2	0010-0072	721.48	72.01	287	65.94	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			238.2	F08		2	0011-0074	183.67	73.87	277	62.28	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2237.0	F08		2	0012-0080	815.81	78.97	283	65.50	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			795.6	F08		2	0013-0082	518.19	82.42	330	77.50	0.690
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1113.0	F08		2	0014-0083	889.92	82.14	281	62.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1121.1	F08		2	0015-0093	931.34	92.92	316	69.26	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			245.6	F08		2	0016-0102	144.94	102.35	374	75.50	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1457.6	F08		2	0017-0105	565.73	104.91	454	81.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3600.5	F08		2	0018-0111	22.99	111.27	235	56.53	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1397.9	F08		2	0019-0113	657.25	112.56	319	68.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4366.7	F08		2	0020-0117	207.77	117.49	239	59.70	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2713.1	F08		2	0021-0119	230.19	119.39	242	60.53	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			250.8	F08		2	0022-0134	856.86	133.97	276	62.43	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1650.9	F08		2	0023-0138	939.43	137.65	329	70.43	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			639.6	F08		2	0024-0143	330.89	143.01	345	68.77	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1360.9	F08		2	0025-0151	69.43	151.02	317	67.84	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4057.5	F08		2	0026-0156	215.70	157.45	411	85.50	0.707
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1253.1	F08		2	0027-0157	165.99	157.66	306	66.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3171.7	F08		2	0028-0162	411.80	162.46	265	61.36	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			328.8	F08		2	0029-0166	749.08	166.72	255	59.36	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			608.8	F08		2	0030-0170	119.40	169.22	339	71.01	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			257.8	F08		2	0031-0169	139.86	169.16	344	68.53	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			515.8	F08		2	0032-0176	510.70	176.42	377	72.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			274.4	F08		2	0033-0172	635.63	171.65	154	45.94	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			299.8	F08		2	0034-0178	457.29	178.32	334	68.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			274.9	F08		2	0035-0181	626.08	181.30	201	55.01	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			263.2	F08		2	0036-0187	645.35	186.92	276	63.60	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			487.1	F08		2	0037-0189	845.17	189.53	216	59.60	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			724.2	F08		2	0038-0193	325.10	193.61	304	64.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			649.6	F08		2	0039-0198	409.45	197.88	339	70.18	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			479.5	F08		2	0040-0209	535.17	208.71	386	73.26	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			208.6	F08		2	0041-0222	15.25	222.86	325	68.53	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			424.3	F08		2	0042-0224	616.40	224.46	300	65.01	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			269.2	F08		2	0043-0226	843.78	226.33	273	63.60	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			217.2	F08		2	0044-0230	121.18	229.88	332	68.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			375.0	F08		2	0045-0228	239.63	228.40	268	65.01	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			664.1	F08		2	0046-0230	652.00	230.29	317	67.84	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			6871.2	F08		2	0047-0233	715.12	232.41	190	55.11	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			352.2	F08		2	0048-0235	323.12	235.58	304	71.11	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			330.8	F08		2	0049-0245	404.92	245.37	349	71.84	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			635.1	F08		2	0050-0250	276.28	249.47	274	63.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			225.2	F08		2	0051-0264	929.92	263.21	249	63.01	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			991.5	F08		2	0052-0261	191.74	262.17	309	69.36	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2596.4	F08		2	0053-0261	360.66	261.16	226	56.04	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			536.7	F08		2	0054-0268	54.40	268.60	344	69.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			262.0	F08		2	0055-0269	887.42	269.70	221	56.87	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1117.7	F08		2	0056-0270	341.91	269.66	282	63.94	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			681.2	F08		2	0057-0270	377.36	269.33	302	67.01	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			403.7	F08		2	0058-0280	724.41	279.94	346	72.18	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			432.0	F08		2	0059-0287	837.58	288.01	278	63.36	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			393.4	F08		2	0060-0297	127.28	297.86	214	57.94	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			242.7	F08		2	0061-0310	855.99	310.23	349	72.77	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			446.7	F08		2	0062-0317	259.32	317.68	288	65.70	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			271.5	F08		2	0063-0316	721.99	316.46	335	70.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			397.3	F08		2	0064-0321	376.65	320.95	305	66.67	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			635.5	F08		2	0065-0326	445.77	327.05	286	61.36	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			219.1	F08		2	0066-0330	180.19	329.23	325	67.36	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			201.1	F08		2	0067-0342	868.58	341.35	293	64.18	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3160.4	F08		2	0068-0348	366.56	348.52	336	68.18	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2160.2	F08		2	0069-0351	922.88	351.54	356	73.01	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2024.2	F08		2	0070-0356	941.20	356.11	350	71.60	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			605.0	F08		2	0071-0357	153.69	357.39	612	108.23	0.657
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			246.2	F08		2	0072-0374	406.60	374.81	483	84.43	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			240.5	F08		2	0073-0383	289.40	383.00	313	67.94	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			479.3	F08		2	0074-0383	102.55	383.68	245	59.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			233.8	F08		2	0075-0385	593.84	385.36	304	67.84	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1277.6	F08		2	0076-0387	356.28	387.46	294	66.43	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			576.6	F08		2	0077-0393	141.79	393.65	318	69.26	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			430.4	F08		2	0078-0397	212.63	398.04	322	65.60	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			674.0	F08		2	0079-0404	652.55	404.88	359	70.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			641.1	F08		2	0080-0409	431.96	408.57	379	72.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			224.4	F08		2	0081-0430	485.77	430.66	314	68.18	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			212.4	F08		2	0082-0436	193.76	436.75	316	68.43	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1554.4	F08		2	0083-0436	587.81	435.82	323	69.01	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			240.0	F08		2	0084-0437	42.06	436.96	271	61.11	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2893.3	F08		2	0085-0437	821.66	437.77	223	56.77	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1703.5	F08		2	0086-0448	660.63	448.83	239	58.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			581.2	F08		2	0087-0453	54.39	453.00	355	70.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			396.1	F08		2	0088-0459	340.67	458.85	249	61.84	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			472.0	F08		2	0089-0458	740.67	458.64	236	59.70	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1241.6	F08		2	0090-0467	519.60	467.21	345	69.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			278.9	F08		2	0091-0479	573.14	478.52	194	66.43	0.552
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			987.4	F08		2	0092-0489	169.47	489.35	315	70.77	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			217.4	F08		2	0093-0519	590.31	518.90	428	82.08	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1272.5	F08		2	0094-0517	202.43	517.49	317	67.36	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			272.4	F08		2	0095-0523	87.21	522.84	469	81.50	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			310.1	F08		2	0096-0521	771.81	521.83	313	68.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			217.1	F08		2	0097-0538	125.28	538.27	288	62.53	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1626.0	F08		2	0098-0537	646.98	536.44	248	62.18	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			375.3	F08		2	0099-0545	186.16	545.47	349	70.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1328.3	F08		2	0100-0562	460.22	561.46	366	74.43	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1367.9	F08		2	0101-0559	846.47	559.65	280	61.60	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			871.4	F08		2	0102-0581	830.65	580.36	296	64.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			236.0	F08		2	0103-0584	729.87	584.27	309	67.94	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			273.2	F08		2	0104-0583	136.86	584.11	355	70.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			370.2	F08		2	0105-0593	204.94	592.65	333	67.84	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1296.6	F08		2	0106-0599	657.62	599.28	352	72.77	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			210.0	F08		2	0107-0612	401.82	612.35	416	77.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1224.8	F08		2	0108-0613	282.94	613.38	336	69.60	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			611.9	F08		2	0109-0617	794.31	617.48	364	74.43	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1097.3	F08		2	0110-0627	564.76	627.74	304	68.33	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1759.3	F08		2	0111-0628	503.68	628.54	265	60.43	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1341.9	F08		2	0112-0640	468.48	639.76	358	74.77	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			247.3	F08		2	0113-0637	533.36	637.27	300	64.43	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			223.1	F08		2	0114-0638	142.53	638.49	284	62.28	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2168.5	F08		2	0115-0642	923.09	642.55	259	61.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			221.1	F08		2	0116-0649	490.89	649.79	358	75.60	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1866.3	F08		2	0117-0649	649.70	649.95	364	70.43	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1542.9	F08		2	0118-0651	340.95	651.50	256	60.53	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3928.7	F08		2	0119-0655	74.76	655.35	333	67.01	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			739.6	F08		2	0120-0656	384.32	656.20	315	68.43	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			395.1	F08		2	0121-0657	846.70	657.62	241	65.01	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			317.4	F08		2	0122-0664	526.49	664.41	282	62.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1534.2	F08		2	0123-0666	164.78	666.26	272	63.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			246.2	F08		2	0124-0667	290.75	666.98	342	68.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			243.5	F08		2	0125-0682	731.33	682.52	336	69.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			310.6	F08		2	0126-0684	931.88	683.94	264	62.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			233.3	F08		2	0127-0694	19.90	693.98	297	67.60	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			219.8	F08		2	0128-0705	744.81	704.87	312	65.84	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			231.6	F08		2	0129-0706	272.33	705.97	274	61.70	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			233.5	F08		2	0130-0704	664.77	704.13	313	65.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			196.0	F08		3	0001-0050	476.08	49.13	337	67.70	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			759.6	F08		3	0002-0055	782.98	55.56	261	61.11	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2656.2	F08		3	0003-0061	427.72	60.68	259	63.26	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			207.3	F08		3	0004-0062	393.22	62.02	308	63.36	0.964
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			735.4	F08		3	0005-0065	594.31	65.58	268	65.11	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			184.1	F08		3	0006-0068	325.54	68.02	284	62.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1353.7	F08		3	0007-0074	358.23	74.13	275	61.94	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3270.4	F08		3	0008-0089	435.52	89.44	268	60.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1144.0	F08		3	0009-0095	26.42	95.35	307	67.84	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			727.9	F08		3	0010-0109	138.49	108.04	205	67.26	0.570
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			308.8	F08		3	0011-0121	338.26	120.75	128	83.98	0.228
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1210.2	F08		3	0012-0130	591.11	130.17	181	52.87	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2321.8	F08		3	0013-0135	62.32	134.57	325	67.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			366.1	F08		3	0014-0142	436.10	142.21	309	66.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			529.1	F08		3	0015-0139	714.84	139.16	329	69.84	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1922.1	F08		3	0016-0141	34.55	140.24	322	71.01	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			234.7	F08		3	0017-0151	362.17	151.19	344	69.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1996.9	F08		3	0018-0146	686.46	146.15	203	58.28	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			221.8	F08		3	0019-0162	798.40	161.54	373	72.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			637.5	F08		3	0020-0164	305.82	164.51	279	61.94	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1126.0	F08		3	0021-0169	524.17	169.68	355	70.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2435.7	F08		3	0022-0176	41.37	176.90	331	73.50	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			684.2	F08		3	0023-0177	832.00	178.04	298	65.26	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			292.5	F08		3	0024-0180	761.07	179.65	319	70.18	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2271.6	F08		3	0025-0177	491.67	177.39	215	55.11	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			234.3	F08		3	0026-0188	796.60	188.30	334	69.36	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2937.6	F08		3	0027-0192	111.65	192.79	198	51.11	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			517.9	F08		3	0028-0201	382.46	201.75	271	63.26	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			891.6	F08		3	0029-0205	201.11	204.61	346	71.11	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			232.9	F08		3	0030-0209	706.89	208.43	356	71.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			364.6	F08		3	0031-0212	450.10	211.48	257	58.77	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			429.5	F08		3	0032-0220	833.52	220.04	327	70.67	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1230.5	F08		3	0033-0220	134.00	220.04	250	59.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3351.1	F08		3	0034-0227	404.98	227.52	305	64.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			548.9	F08		3	0035-0230	513.44	230.31	226	62.77	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			584.1	F08		3	0036-0234	547.93	234.56	240	58.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1811.6	F08		3	0037-0237	281.30	237.36	268	63.11	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2137.2	F08		3	0038-0255	675.34	254.68	236	58.53	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			545.5	F08		3	0039-0258	799.14	258.45	311	66.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			371.7	F08		3	0040-0262	553.47	262.69	241	58.53	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			237.6	F08		3	0041-0266	25.16	265.73	251	63.01	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			352.3	F08		3	0042-0265	863.12	265.41	274	63.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			363.8	F08		3	0043-0265	141.87	264.90	244	59.94	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2164.8	F08		3	0044-0269	487.64	268.24	132	54.77	0.553
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			263.1	F08		3	0045-0276	280.84	276.59	386	73.26	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5407.9	F08		3	0046-0283	412.01	282.93	270	61.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3074.6	F08		3	0047-0287	480.67	286.13	285	76.33	0.615
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			382.0	F08		3	0048-0285	614.69	285.54	353	71.01	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			215.1	F08		3	0049-0296	198.32	296.29	316	68.77	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1798.2	F08		3	0050-0294	808.99	294.66	306	65.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			245.9	F08		3	0051-0300	332.45	299.79	423	75.84	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			354.1	F08		3	0052-0300	512.00	299.74	300	64.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			316.3	F08		3	0053-0297	560.29	297.60	266	59.70	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1355.2	F08		3	0054-0305	631.55	304.42	320	68.18	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3477.6	F08		3	0055-0306	733.69	306.77	268	63.26	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5594.9	F08		3	0056-0305	416.53	305.25	160	48.63	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			353.0	F08		3	0057-0317	101.43	316.75	262	61.60	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			480.8	F08		3	0058-0318	58.86	318.20	366	72.08	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1553.6	F08		3	0059-0321	912.88	321.82	329	68.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3449.4	F08		3	0060-0321	412.84	321.14	247	64.77	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			313.3	F08		3	0061-0347	476.90	347.05	328	68.67	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			619.1	F08		3	0062-0349	536.15	349.97	293	67.11	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			215.5	F08		3	0063-0352	322.80	351.71	344	72.43	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			244.0	F08		3	0064-0354	218.01	354.14	410	78.43	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			675.7	F08		3	0065-0351	905.20	351.25	201	57.36	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2105.1	F08		3	0066-0354	18.49	354.18	350	72.18	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2124.0	F08		3	0067-0359	36.63	358.66	327	71.60	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1434.0	F08		3	0068-0361	443.07	361.30	317	74.77	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			293.3	F08		3	0069-0364	167.12	363.84	301	66.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			551.2	F08		3	0070-0375	797.76	374.43	377	74.43	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			343.5	F08		3	0071-0376	407.77	376.33	403	74.43	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			300.7	F08		3	0072-0383	548.09	383.47	271	61.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			351.0	F08		3	0073-0386	55.28	386.66	263	61.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			285.2	F08		3	0074-0389	468.20	389.24	355	71.01	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1607.6	F08		3	0075-0397	757.28	397.31	318	66.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			476.2	F08		3	0076-0407	593.49	407.72	303	65.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			193.5	F08		3	0077-0411	77.32	411.36	338	74.53	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			220.7	F08		3	0078-0415	667.54	414.74	411	79.26	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			410.9	F08		3	0079-0419	610.37	419.36	314	70.53	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			230.8	F08		3	0080-0418	171.29	417.35	336	70.67	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1015.3	F08		3	0081-0420	436.94	420.27	281	66.43	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			659.0	F08		3	0082-0432	899.32	432.10	265	65.60	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1657.6	F08		3	0083-0438	699.89	438.70	296	63.11	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			357.4	F08		3	0084-0444	43.31	444.10	338	70.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			303.9	F08		3	0085-0456	495.79	456.18	406	77.50	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			202.6	F08		3	0086-0460	909.25	460.74	187	53.94	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1274.6	F08		3	0087-0465	185.70	465.70	314	67.94	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1264.2	F08		3	0088-0474	639.22	474.30	345	69.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1658.1	F08		3	0089-0477	108.91	477.06	326	70.43	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			232.2	F08		3	0090-0483	496.72	482.98	270	66.43	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1151.6	F08		3	0091-0489	136.73	489.56	356	70.18	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			745.0	F08		3	0092-0490	780.75	490.99	267	61.36	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			315.0	F08		3	0093-0495	49.45	494.62	325	71.01	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4104.8	F08		3	0094-0500	347.91	499.38	295	64.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2119.2	F08		3	0095-0505	919.44	505.45	336	70.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			230.5	F08		3	0096-0508	250.88	507.89	557	95.74	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1565.4	F08		3	0097-0510	377.92	509.40	309	65.01	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1078.3	F08		3	0098-0527	730.49	527.19	370	73.60	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			213.8	F08		3	0099-0528	126.47	527.79	363	75.26	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			231.5	F08		3	0100-0534	225.35	534.16	299	67.01	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			364.5	F08		3	0101-0536	332.81	536.80	270	62.18	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			166.7	F08		3	0102-0543	554.02	544.15	343	69.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			224.8	F08		3	0103-0559	286.52	558.77	368	74.18	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			352.1	F08		3	0104-0566	404.65	567.19	357	75.60	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3227.8	F08		3	0105-0571	119.84	570.90	342	68.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2227.1	F08		3	0106-0577	154.39	576.28	301	68.43	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1404.4	F08		3	0107-0591	260.04	590.74	287	68.67	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			822.2	F08		3	0108-0616	365.65	616.72	298	71.50	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			261.4	F08		3	0109-0615	867.81	615.37	216	57.36	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			218.9	F08		3	0110-0619	937.72	619.86	247	60.53	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			221.2	F08		3	0111-0617	586.76	617.38	390	76.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			183.0	F08		3	0112-0630	903.23	629.42	344	73.50	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			698.3	F08		3	0113-0631	686.81	631.00	315	66.43	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			626.1	F08		3	0114-0638	664.80	638.76	311	67.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			240.5	F08		3	0115-0642	347.01	643.02	393	73.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2260.2	F08		3	0116-0644	17.93	645.04	252	59.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			409.0	F08		3	0117-0648	121.67	648.11	346	72.18	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2738.8	F08		3	0118-0651	291.92	651.05	242	62.77	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			834.5	F08		3	0119-0654	805.48	654.07	367	80.57	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			634.5	F08		3	0120-0652	309.59	653.07	239	60.77	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			218.6	F08		3	0121-0658	176.52	658.47	307	64.77	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			143.8	F08		3	0122-0658	839.55	658.18	315	69.84	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			464.9	F08		3	0123-0665	557.91	665.19	318	65.60	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1013.0	F08		3	0124-0672	147.01	672.49	294	63.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			412.2	F08		3	0125-0682	690.56	682.16	287	63.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			273.3	F08		3	0126-0686	535.26	685.35	203	55.21	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			287.0	F08		3	0127-0686	26.79	686.38	256	61.11	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			189.6	F08		3	0128-0694	675.48	694.25	328	67.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			276.4	F08		3	0129-0694	879.58	694.71	250	59.94	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1249.6	F08		3	0130-0704	182.73	704.55	273	61.60	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1416.0	F08		3	0131-0705	571.76	705.50	261	61.94	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1968.2	F08		4	0001-0029	171.82	29.32	261	60.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			701.5	F08		4	0002-0029	195.04	28.79	276	62.28	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			963.3	F08		4	0003-0032	144.75	32.73	257	61.70	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1075.0	F08		4	0004-0037	371.19	36.91	404	78.43	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1004.2	F08		4	0005-0064	872.22	63.25	356	72.43	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			458.2	F08		4	0006-0066	791.10	66.43	289	63.84	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			267.2	F08		4	0007-0069	51.72	68.97	255	61.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3676.6	F08		4	0008-0073	575.33	73.58	383	72.18	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			236.4	F08		4	0009-0076	110.78	76.17	321	67.94	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			688.8	F08		4	0010-0081	129.33	81.01	329	68.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			418.8	F08		4	0011-0096	634.11	95.81	337	70.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			485.8	F08		4	0012-0099	658.30	99.12	333	67.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2164.9	F08		4	0013-0106	475.01	106.70	414	83.26	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			316.8	F08		4	0014-0113	291.14	113.27	168	62.18	0.546
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2050.2	F08		4	0015-0121	83.65	120.58	291	65.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			302.4	F08		4	0016-0123	752.18	123.22	242	61.94	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1994.1	F08		4	0017-0121	785.98	121.79	202	51.94	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			276.7	F08		4	0018-0130	765.98	129.70	307	67.60	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			653.7	F08		4	0019-0132	574.14	131.92	314	67.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			310.1	F08		4	0020-0134	331.23	133.99	233	59.60	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			8608.4	F08		4	0021-0136	432.75	135.71	287	64.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1110.6	F08		4	0022-0159	807.45	159.14	211	57.11	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			431.8	F08		4	0023-0161	233.88	160.59	280	61.94	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			888.6	F08		4	0024-0161	49.25	161.54	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1386.3	F08		4	0025-0164	601.52	164.49	295	64.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			511.7	F08		4	0026-0206	90.26	206.84	298	64.53	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			299.2	F08		4	0027-0209	531.51	209.16	307	68.18	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			368.9	F08		4	0028-0216	759.32	217.08	373	77.01	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			458.0	F08		4	0029-0212	912.03	211.82	314	67.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			336.8	F08		4	0030-0220	638.13	219.53	359	73.84	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1010.3	F08		4	0031-0225	408.56	225.08	339	71.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			720.3	F08		4	0032-0233	179.43	233.32	244	59.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			514.6	F08		4	0033-0240	333.77	239.81	310	66.43	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			988.0	F08		4	0034-0248	851.08	248.98	214	56.04	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1064.2	F08		4	0035-0257	43.47	257.21	343	70.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			655.2	F08		4	0036-0259	664.07	259.11	241	61.36	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			242.6	F08		4	0037-0270	424.07	270.27	299	66.18	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			448.7	F08		4	0038-0273	376.22	273.53	333	67.36	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1588.9	F08		4	0039-0272	180.26	272.05	242	58.77	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			407.3	F08		4	0040-0293	717.39	293.01	452	78.67	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			234.8	F08		4	0041-0297	20.10	297.46	353	70.18	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			893.9	F08		4	0042-0306	120.00	305.13	301	67.26	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1089.8	F08		4	0043-0306	917.57	306.35	266	63.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1492.9	F08		4	0044-0307	538.95	307.10	280	61.60	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3520.3	F08		4	0045-0309	667.97	309.75	240	61.60	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			288.4	F08		4	0046-0306	58.29	305.81	108	71.26	0.267
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			528.9	F08		4	0047-0311	377.59	311.42	323	68.77	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1400.4	F08		4	0048-0325	400.90	325.45	277	65.60	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			769.5	F08		4	0049-0329	359.73	329.52	366	72.43	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			531.8	F08		4	0050-0341	175.33	341.14	295	67.36	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1278.8	F08		4	0051-0338	296.96	338.14	314	68.43	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			969.8	F08		4	0052-0335	911.15	335.22	279	63.36	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			262.4	F08		4	0053-0339	454.32	339.21	317	67.60	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			586.0	F08		4	0054-0340	751.27	340.20	239	56.53	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			932.9	F08		4	0055-0347	199.86	347.24	232	57.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1039.0	F08		4	0056-0348	898.53	348.06	261	62.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			194.2	F08		4	0057-0353	925.53	352.89	270	61.94	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4499.6	F08		4	0058-0370	645.70	369.78	240	56.53	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			306.5	F08		4	0059-0374	765.64	375.08	305	63.60	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			319.7	F08		4	0060-0377	230.62	377.83	321	67.84	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2480.0	F08		4	0061-0375	75.09	374.82	228	58.87	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2960.5	F08		4	0062-0397	347.58	396.96	251	61.01	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1145.5	F08		4	0063-0400	196.29	400.36	253	59.11	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3496.8	F08		4	0064-0399	845.43	399.14	274	61.11	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			417.3	F08		4	0065-0405	765.45	405.15	309	65.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			508.8	F08		4	0066-0407	710.17	407.47	313	64.43	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			798.5	F08		4	0067-0411	327.72	411.45	279	64.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			233.7	F08		4	0068-0425	935.39	425.27	246	64.28	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			301.5	F08		4	0069-0426	227.43	425.84	276	63.60	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			238.0	F08		4	0070-0433	826.67	433.62	366	73.01	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			985.5	F08		4	0071-0433	792.34	434.04	296	65.26	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			203.2	F08		4	0072-0439	880.69	439.79	390	75.84	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1118.1	F08		4	0073-0458	342.98	457.95	303	68.53	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			795.6	F08		4	0074-0466	560.47	466.09	336	71.01	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			259.9	F08		4	0075-0477	753.31	477.02	509	85.50	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2368.7	F08		4	0076-0487	519.08	487.44	347	70.43	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			269.6	F08		4	0077-0489	901.11	489.35	224	59.70	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			210.5	F08		4	0078-0497	148.51	496.66	310	65.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			697.4	F08		4	0079-0504	288.85	504.09	327	67.26	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			747.1	F08		4	0080-0502	21.26	502.29	265	65.60	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			502.0	F08		4	0081-0502	230.11	502.30	295	68.43	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			258.7	F08		4	0082-0507	702.74	507.36	250	59.94	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			444.3	F08		4	0083-0518	434.28	517.40	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1814.3	F08		4	0084-0517	327.21	518.02	295	65.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			279.6	F08		4	0085-0532	654.71	531.73	370	71.36	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			636.3	F08		4	0086-0535	143.11	534.87	285	64.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			769.9	F08		4	0087-0536	197.18	535.93	334	68.18	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			888.7	F08		4	0088-0538	519.41	538.85	295	65.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2654.2	F08		4	0089-0547	598.89	547.62	236	57.11	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			281.2	F08		4	0090-0553	770.22	549.80	273	100.71	0.338
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1210.6	F08		4	0091-0553	308.70	552.52	334	68.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			201.0	F08		4	0092-0554	236.15	553.92	325	72.18	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			936.9	F08		4	0093-0553	374.13	553.74	227	60.43	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			309.3	F08		4	0094-0561	844.19	562.12	348	72.67	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			275.1	F08		4	0095-0561	791.09	560.82	264	83.50	0.476
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			229.6	F08		4	0096-0566	270.03	566.14	283	65.84	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			142.3	F08		4	0097-0565	19.85	565.60	260	60.53	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1544.4	F08		4	0098-0581	691.35	581.50	300	65.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2118.5	F08		4	0099-0583	767.19	583.34	293	65.11	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			290.7	F08		4	0100-0587	159.33	587.68	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			296.4	F08		4	0101-0593	844.08	593.08	290	64.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			284.2	F08		4	0102-0608	700.30	608.59	351	72.18	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			945.0	F08		4	0103-0611	330.70	610.79	260	62.18	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			196.1	F08		4	0104-0612	306.01	612.01	306	65.11	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			321.1	F08		4	0105-0615	576.64	615.24	375	74.67	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4564.3	F08		4	0106-0617	891.27	617.43	316	67.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2121.8	F08		4	0107-0628	95.11	628.12	255	61.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			514.8	F08		4	0108-0631	374.02	631.06	239	59.11	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			383.9	F08		4	0109-0636	235.67	635.97	293	68.77	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1842.5	F08		4	0110-0634	316.13	633.75	228	58.87	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			310.4	F08		4	0111-0647	665.33	646.45	365	72.18	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1085.1	F08		4	0112-0653	495.85	653.47	310	65.36	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1997.5	F08		4	0113-0659	788.18	658.88	344	69.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2269.9	F08		4	0114-0659	552.10	659.61	283	67.50	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			299.5	F08		4	0115-0666	282.01	665.44	321	67.60	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			633.2	F08		4	0116-0668	727.49	667.81	322	67.60	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1169.5	F08		4	0117-0680	397.53	679.43	239	57.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			290.3	F08		4	0118-0686	292.84	686.66	270	61.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			252.2	F08		4	0119-0695	861.38	694.59	324	73.50	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1141.8	F08		4	0120-0698	161.50	698.70	379	76.53	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			806.9	F08		4	0121-0700	903.67	700.99	382	111.88	0.383
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1209.4	F08		4	0122-0702	144.98	702.79	376	75.94	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			251.7	F08		4	0123-0699	828.87	699.10	217	57.60	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			246.8	F08		4	0124-0700	594.34	699.65	244	60.43	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			201.6	F08		4	0125-0701	642.94	700.49	282	62.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			727.9	F08		5	0001-0034	395.08	34.47	406	75.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1724.4	F08		5	0002-0038	646.42	38.21	370	70.77	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			420.7	F08		5	0003-0036	895.51	36.62	132	44.87	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1124.5	F08		5	0004-0053	63.91	53.11	294	64.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			249.6	F08		5	0005-0056	130.66	56.10	288	64.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			237.9	F08		5	0006-0053	176.55	53.72	267	61.94	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1149.7	F08		5	0007-0057	930.89	57.41	309	65.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			10499.1	F08		5	0008-0059	214.33	59.15	311	67.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			547.8	F08		5	0009-0059	820.16	60.31	321	68.43	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			306.4	F08		5	0010-0064	611.99	63.41	263	61.11	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			665.9	F08		5	0011-0067	82.12	67.22	330	67.60	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			225.6	F08		5	0012-0070	116.97	70.49	285	65.60	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			220.5	F08		5	0013-0071	460.49	70.35	324	68.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			959.0	F08		5	0014-0076	867.42	76.30	428	91.40	0.644
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1198.3	F08		5	0015-0075	301.28	74.78	281	63.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			201.6	F08		5	0016-0074	439.08	73.56	341	70.18	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1119.3	F08		5	0017-0079	544.63	79.97	407	77.26	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			889.4	F08		5	0018-0077	652.81	76.34	386	75.60	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2427.5	F08		5	0019-0082	157.42	81.90	300	66.77	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			201.7	F08		5	0020-0085	343.85	86.51	368	83.84	0.658
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2622.7	F08		5	0021-0089	282.47	89.26	281	61.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			212.6	F08		5	0022-0092	892.22	92.42	341	70.18	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			192.1	F08		5	0023-0095	483.90	95.58	329	71.01	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			7680.9	F08		5	0024-0109	219.92	109.22	269	61.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			213.7	F08		5	0025-0113	338.05	113.44	337	68.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1884.6	F08		5	0026-0111	115.25	110.85	245	61.94	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			225.4	F08		5	0027-0114	386.41	114.78	323	70.08	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			314.7	F08		5	0028-0114	427.91	114.12	383	73.60	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			690.9	F08		5	0029-0121	903.82	121.33	326	67.84	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			711.8	F08		5	0030-0131	793.61	131.16	271	63.84	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			684.8	F08		5	0031-0133	734.79	133.74	301	66.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			371.4	F08		5	0032-0134	751.30	133.33	292	63.70	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1750.2	F08		5	0033-0132	385.79	132.09	222	55.70	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1712.8	F08		5	0034-0138	86.64	137.47	341	69.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1309.8	F08		5	0035-0139	163.72	139.59	258	66.77	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			925.8	F08		5	0036-0145	476.49	144.75	396	74.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1451.4	F08		5	0037-0157	213.74	156.88	316	68.43	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			694.8	F08		5	0038-0169	274.16	168.88	351	71.01	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			235.8	F08		5	0039-0173	609.16	173.16	404	76.08	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			503.6	F08		5	0040-0175	653.57	175.14	222	66.43	0.632
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			266.8	F08		5	0041-0186	692.54	186.11	259	61.84	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			225.0	F08		5	0042-0189	790.81	189.35	316	66.18	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1761.4	F08		5	0043-0194	433.89	195.30	340	69.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			254.2	F08		5	0044-0192	569.76	192.11	337	69.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			245.0	F08		5	0045-0194	511.55	194.18	281	67.60	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			211.4	F08		5	0046-0198	605.20	198.50	312	67.01	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1009.1	F08		5	0047-0206	138.63	206.49	216	56.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			280.8	F08		5	0048-0211	405.29	211.43	319	71.36	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			279.7	F08		5	0049-0209	751.75	209.63	284	63.01	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3059.6	F08		5	0050-0211	70.94	211.56	255	59.36	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			329.5	F08		5	0051-0213	693.64	213.26	347	68.43	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			392.5	F08		5	0052-0213	17.38	213.79	300	66.18	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			314.7	F08		5	0053-0213	227.18	213.03	327	71.60	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3171.0	F08		5	0054-0215	509.11	214.86	203	52.53	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			299.0	F08		5	0055-0227	876.19	227.30	204	55.11	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			211.5	F08		5	0056-0234	567.51	233.40	287	68.08	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			445.8	F08		5	0057-0240	663.89	240.33	359	72.67	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2252.9	F08		5	0058-0241	438.76	241.98	335	68.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1531.3	F08		5	0059-0243	527.92	243.78	266	63.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			260.0	F08		5	0060-0247	706.19	247.96	330	70.77	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			274.3	F08		5	0061-0249	754.11	249.02	234	57.36	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			600.2	F08		5	0062-0254	389.43	254.59	364	70.67	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1762.8	F08		5	0063-0261	206.44	260.22	459	86.33	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			239.9	F08		5	0064-0270	895.35	270.24	417	76.67	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			845.0	F08		5	0065-0270	599.22	270.41	322	66.77	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2646.4	F08		5	0066-0273	348.28	273.69	299	66.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			978.1	F08		5	0067-0276	448.25	276.64	239	58.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1066.9	F08		5	0068-0278	835.77	278.27	321	71.01	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			319.6	F08		5	0069-0279	292.09	279.55	344	68.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			404.0	F08		5	0070-0281	537.85	281.40	333	68.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			532.6	F08		5	0071-0280	677.23	279.89	332	75.26	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2801.6	F08		5	0072-0296	347.47	296.08	330	69.11	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			284.3	F08		5	0073-0299	635.45	299.89	346	73.94	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			731.3	F08		5	0074-0297	788.73	297.15	291	66.43	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1710.6	F08		5	0075-0304	875.72	303.01	289	70.18	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1409.1	F08		5	0076-0304	729.81	304.02	340	68.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1072.0	F08		5	0077-0308	23.08	308.11	265	63.01	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2292.4	F08		5	0078-0305	939.78	305.35	304	67.11	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			393.9	F08		5	0079-0310	179.55	310.39	294	64.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			299.8	F08		5	0080-0311	598.75	311.32	354	71.84	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2430.9	F08		5	0081-0313	143.45	313.92	286	64.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			912.0	F08		5	0082-0313	690.74	313.03	348	77.26	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			234.9	F08		5	0083-0319	850.96	319.47	303	65.01	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			884.4	F08		5	0084-0322	104.40	321.87	295	62.77	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			799.5	F08		5	0085-0336	533.22	336.35	305	64.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			911.9	F08		5	0086-0337	16.83	337.26	281	63.70	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			630.6	F08		5	0087-0351	708.97	350.24	940	130.02	0.699
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			324.5	F08		5	0088-0353	484.07	354.05	355	77.60	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			204.5	F08		5	0089-0355	30.81	354.84	268	61.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1249.3	F08		5	0090-0368	604.98	368.12	312	65.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3895.3	F08		5	0091-0375	822.27	374.97	333	69.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1418.2	F08		5	0092-0381	723.88	381.54	231	58.77	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			215.7	F08		5	0093-0387	124.99	387.97	340	73.01	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			333.9	F08		5	0094-0394	576.29	394.42	289	63.11	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			538.6	F08		5	0095-0397	186.52	397.07	209	54.28	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			503.6	F08		5	0096-0402	650.80	402.61	306	65.01	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			287.8	F08		5	0097-0403	301.55	402.35	283	62.77	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			217.6	F08		5	0098-0407	729.66	406.83	335	68.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			228.7	F08		5	0099-0411	271.43	411.55	382	72.77	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			325.6	F08		5	0100-0411	806.69	411.17	317	66.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			660.5	F08		5	0101-0410	931.79	410.06	268	63.01	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			211.3	F08		5	0102-0416	163.49	417.53	505	84.33	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			296.6	F08		5	0103-0412	488.23	411.26	280	63.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			399.5	F08		5	0104-0415	603.65	415.15	316	68.18	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			323.0	F08		5	0105-0423	356.28	423.04	348	72.43	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			259.1	F08		5	0106-0427	40.59	427.14	247	64.53	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1451.6	F08		5	0107-0430	435.55	429.89	458	82.33	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			240.2	F08		5	0108-0440	211.05	440.67	269	62.77	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			287.4	F08		5	0109-0439	640.00	439.36	249	57.94	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			363.8	F08		5	0110-0442	417.16	442.94	262	61.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			222.1	F08		5	0111-0443	899.55	443.27	301	64.18	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1471.9	F08		5	0112-0447	476.08	447.55	363	70.67	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			231.7	F08		5	0113-0451	734.64	451.15	297	66.18	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			278.2	F08		5	0114-0456	242.30	455.90	332	69.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			221.7	F08		5	0115-0451	578.34	451.24	303	68.77	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1795.3	F08		5	0116-0469	58.94	469.69	252	61.60	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			271.6	F08		5	0117-0471	351.25	471.21	327	70.43	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			273.4	F08		5	0118-0472	551.99	471.88	329	67.11	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			622.4	F08		5	0119-0472	203.72	471.30	258	61.94	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			285.0	F08		5	0120-0478	503.26	478.79	262	67.11	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			222.5	F08		5	0121-0485	856.17	484.58	358	83.15	0.651
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			228.1	F08		5	0122-0485	677.69	485.26	282	61.36	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1002.0	F08		5	0123-0487	399.87	488.02	359	73.50	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			392.3	F08		5	0124-0490	440.42	490.09	294	65.01	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			230.2	F08		5	0125-0498	773.48	496.68	378	75.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			887.3	F08		5	0126-0496	309.69	496.05	294	69.84	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1262.5	F08		5	0127-0509	643.66	509.29	335	73.94	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			525.4	F08		5	0128-0509	589.08	509.68	338	69.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			234.2	F08		5	0129-0513	89.09	513.87	285	64.77	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			594.5	F08		5	0130-0514	719.54	514.93	320	72.91	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			914.8	F08		5	0131-0519	469.01	520.32	309	67.60	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1016.2	F08		5	0132-0523	618.72	522.90	329	77.36	0.691
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1975.8	F08		5	0133-0522	938.32	521.96	292	66.77	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1550.2	F08		5	0134-0534	72.21	534.62	230	59.60	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			549.7	F08		5	0135-0544	644.19	544.29	316	68.18	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			269.9	F08		5	0136-0567	420.55	567.04	430	77.84	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			216.9	F08		5	0137-0566	673.03	565.57	335	73.26	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			288.9	F08		5	0138-0565	870.81	565.19	320	72.18	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			479.2	F08		5	0139-0575	833.54	575.28	278	69.11	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			297.9	F08		5	0140-0590	131.65	590.88	210	55.11	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			408.2	F08		5	0141-0611	130.17	611.79	263	59.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			565.0	F08		5	0142-0617	860.75	617.22	361	73.26	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			472.8	F08		5	0143-0636	322.12	636.25	311	65.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			600.9	F08		5	0144-0638	552.97	637.55	285	63.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			282.1	F08		5	0145-0636	143.55	636.61	256	67.94	0.697
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1162.9	F08		5	0146-0646	243.79	646.06	331	70.53	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			627.5	F08		5	0147-0645	569.15	644.80	289	64.53	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			370.3	F08		5	0148-0656	209.72	658.89	589	110.33	0.608
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			962.9	F08		5	0149-0649	392.44	648.81	314	67.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			266.4	F08		5	0150-0651	477.69	651.41	393	74.43	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2298.0	F08		5	0151-0651	648.86	650.78	265	63.26	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			456.1	F08		5	0152-0656	839.71	656.03	262	65.60	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			254.6	F08		5	0153-0652	916.58	652.30	326	69.94	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			306.4	F08		5	0154-0660	61.87	660.43	318	67.84	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			268.8	F08		5	0155-0669	717.31	668.92	367	74.33	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1734.8	F08		5	0156-0675	309.34	674.77	300	67.01	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1201.8	F08		5	0157-0674	400.17	675.66	347	73.84	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			708.9	F08		5	0158-0679	451.47	679.38	325	69.84	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			343.3	F08		5	0159-0684	636.39	684.58	320	66.18	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			206.7	F08		5	0160-0696	906.66	696.33	348	73.01	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3856.0	F08		6	0001-0040	323.34	40.63	347	73.01	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1656.7	F08		6	0002-0047	782.00	47.24	273	67.26	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			680.4	F08		6	0003-0053	426.76	53.37	270	66.67	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2197.5	F08		6	0004-0055	149.57	55.43	286	63.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1164.1	F08		6	0005-0060	25.83	60.11	304	64.77	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			624.8	F08		6	0006-0061	823.37	60.79	253	65.84	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			917.9	F08		6	0007-0067	247.36	66.94	265	65.60	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			269.7	F08		6	0008-0077	673.88	77.38	377	71.84	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2226.0	F08		6	0009-0084	318.86	83.55	340	71.26	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			625.4	F08		6	0010-0082	527.49	83.00	305	64.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			817.7	F08		6	0011-0087	691.40	87.25	305	68.43	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			513.2	F08		6	0012-0093	196.33	91.42	299	70.18	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3201.7	F08		6	0013-0093	411.70	93.66	250	59.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1928.4	F08		6	0014-0104	612.42	106.23	346	102.23	0.416
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1047.8	F08		6	0015-0107	853.40	107.97	367	72.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			189.2	F08		6	0016-0113	298.91	113.41	347	71.84	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1118.5	F08		6	0017-0113	172.37	112.80	285	62.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1214.9	F08		6	0018-0114	334.39	113.57	226	58.53	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			639.3	F08		6	0019-0121	811.87	120.64	294	66.77	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1227.0	F08		6	0020-0128	489.88	127.29	314	69.50	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			255.1	F08		6	0021-0127	261.73	127.59	320	69.01	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			411.6	F08		6	0022-0130	584.41	129.80	379	79.50	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5429.6	F08		6	0023-0141	433.17	141.59	228	55.36	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			883.7	F08		6	0024-0149	770.71	149.75	427	77.26	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			537.6	F08		6	0025-0149	541.38	150.44	409	76.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1615.1	F08		6	0026-0155	854.32	156.19	321	72.18	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			220.3	F08		6	0027-0161	680.29	160.66	346	72.43	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2760.8	F08		6	0028-0164	506.03	165.14	481	90.91	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			220.2	F08		6	0029-0162	369.59	161.90	232	59.36	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			712.4	F08		6	0030-0164	279.54	163.75	252	61.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1957.1	F08		6	0031-0172	236.80	172.17	301	64.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1710.7	F08		6	0032-0176	320.72	175.64	352	72.18	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			303.0	F08		6	0033-0175	898.76	174.31	325	73.01	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			204.5	F08		6	0034-0174	375.98	174.89	226	57.46	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			229.5	F08		6	0035-0181	405.96	181.83	347	77.84	0.720
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			582.9	F08		6	0036-0184	582.05	185.12	389	76.43	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			885.8	F08		6	0037-0189	183.13	190.35	103	56.77	0.402
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			477.9	F08		6	0038-0195	864.81	196.10	382	72.43	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			458.1	F08		6	0039-0206	939.73	206.24	363	72.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			290.1	F08		6	0040-0212	24.77	212.32	133	93.78	0.190
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			443.7	F08		6	0041-0211	247.08	211.41	342	71.84	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1768.0	F08		6	0042-0228	579.14	227.70	277	62.53	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1116.7	F08		6	0043-0232	258.80	231.53	298	66.43	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			782.6	F08		6	0044-0238	813.54	237.94	339	80.43	0.659
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			639.9	F08		6	0045-0241	724.82	241.12	241	61.01	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1010.7	F08		6	0046-0251	149.32	251.35	290	64.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4642.3	F08		6	0047-0255	441.49	255.10	296	63.94	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			661.2	F08		6	0048-0257	311.88	256.26	359	71.84	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			548.0	F08		6	0049-0262	774.37	261.17	308	71.01	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			833.8	F08		6	0050-0263	807.80	263.63	324	69.84	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			204.9	F08		6	0051-0265	748.05	265.21	392	77.26	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			834.8	F08		6	0052-0271	841.51	269.91	483	88.81	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			289.3	F08		6	0053-0273	604.82	273.45	298	69.01	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1109.7	F08		6	0054-0275	192.07	275.02	310	67.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			816.0	F08		6	0055-0285	273.81	284.59	342	71.11	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			950.2	F08		6	0056-0288	315.97	287.75	255	58.53	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			438.6	F08		6	0057-0288	238.03	289.05	118	69.84	0.304
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			202.6	F08		6	0058-0297	110.60	297.43	375	74.77	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			365.3	F08		6	0059-0300	402.45	299.81	395	73.01	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			254.0	F08		6	0060-0300	332.60	301.04	309	66.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			311.3	F08		6	0061-0304	919.18	304.82	341	79.26	0.682
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			728.6	F08		6	0062-0303	872.22	303.19	317	67.01	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			353.5	F08		6	0063-0307	380.17	306.95	348	69.84	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2265.8	F08		6	0064-0308	34.85	308.19	303	66.53	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			391.3	F08		6	0065-0314	529.80	314.65	360	71.84	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			477.3	F08		6	0066-0312	737.90	311.53	283	61.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			942.2	F08		6	0067-0319	460.36	319.32	245	57.94	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			591.7	F08		6	0068-0327	176.31	327.19	334	67.84	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			178.7	F08		6	0069-0327	267.39	326.87	358	72.43	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			192.6	F08		6	0070-0345	345.65	345.61	399	78.08	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			220.5	F08		6	0071-0349	652.12	348.88	388	74.67	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			219.0	F08		6	0072-0351	229.47	350.89	306	67.26	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			431.0	F08		6	0073-0357	860.37	356.93	306	69.01	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			230.6	F08		6	0074-0364	724.31	363.77	340	68.18	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1283.5	F08		6	0075-0367	220.38	367.40	249	61.60	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			184.9	F08		6	0076-0375	307.06	375.11	344	72.77	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			215.0	F08		6	0077-0374	379.82	374.77	371	73.84	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			235.4	F08		6	0078-0378	523.40	378.00	387	76.43	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			430.1	F08		6	0079-0372	777.01	372.70	209	54.28	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			348.7	F08		6	0080-0374	795.86	374.76	239	57.11	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			201.3	F08		6	0081-0390	896.09	390.31	343	70.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			990.7	F08		6	0082-0396	270.34	396.79	301	66.43	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			6479.5	F08		6	0083-0400	75.64	400.55	294	63.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			395.1	F08		6	0084-0408	198.73	407.56	319	69.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			571.8	F08		6	0085-0407	558.86	406.76	351	70.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			218.4	F08		6	0086-0411	830.09	410.68	323	70.28	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			613.6	F08		6	0087-0413	26.87	412.80	273	63.01	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			418.5	F08		6	0088-0420	388.43	419.57	320	67.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			653.7	F08		6	0089-0420	699.00	419.51	331	69.01	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			193.2	F08		6	0090-0426	929.04	426.58	303	74.77	0.681
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5428.1	F08		6	0091-0422	80.11	422.33	281	63.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			184.6	F08		6	0092-0422	269.24	422.52	297	65.60	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2315.2	F08		6	0093-0425	495.24	425.58	231	61.70	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			194.2	F08		6	0094-0426	942.53	425.21	293	70.18	0.747
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			511.3	F08		6	0095-0427	654.26	427.01	298	65.01	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			252.8	F08		6	0096-0434	732.15	434.32	345	70.28	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			279.4	F08		6	0097-0434	899.88	434.35	368	72.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			186.3	F08		6	0098-0440	787.04	439.64	350	71.26	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1867.1	F08		6	0099-0444	313.51	444.25	248	63.70	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1163.2	F08		6	0100-0457	612.48	456.44	301	65.60	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1103.2	F08		6	0101-0466	541.75	465.82	314	67.84	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			257.3	F08		6	0102-0469	457.06	467.95	300	69.84	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			404.2	F08		6	0103-0472	899.47	472.04	331	68.43	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			256.9	F08		6	0104-0472	158.56	471.82	129	71.26	0.319
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			190.7	F08		6	0105-0483	421.15	482.38	284	65.01	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			198.7	F08		6	0106-0490	252.39	489.66	277	68.18	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			224.2	F08		6	0107-0488	290.18	488.41	322	68.43	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2976.5	F08		6	0108-0490	467.28	490.61	295	65.70	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			877.2	F08		6	0109-0495	132.47	495.84	269	67.70	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1784.0	F08		6	0110-0491	408.30	491.61	275	63.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1675.8	F08		6	0111-0497	182.57	498.42	305	67.94	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			728.8	F08		6	0112-0499	660.07	499.59	318	69.01	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			177.2	F08		6	0113-0502	370.65	502.53	343	74.43	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			908.4	F08		6	0114-0509	588.39	509.07	310	67.84	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			795.6	F08		6	0115-0515	827.71	515.63	344	68.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			251.0	F08		6	0116-0520	888.52	520.32	253	60.53	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			563.8	F08		6	0117-0522	753.11	521.82	355	70.08	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2024.8	F08		6	0118-0525	33.42	524.89	304	68.43	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			198.7	F08		6	0119-0523	315.91	522.86	302	65.94	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			984.4	F08		6	0120-0530	921.48	530.74	210	53.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			195.4	F08		6	0121-0538	399.98	537.73	342	69.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			612.4	F08		6	0122-0541	48.54	540.58	328	68.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2059.7	F08		6	0123-0546	728.83	546.54	317	66.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1100.9	F08		6	0124-0550	442.78	549.81	360	71.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1396.3	F08		6	0125-0555	695.22	557.17	392	118.13	0.353
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			868.0	F08		6	0126-0558	273.97	559.61	375	88.33	0.604
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			180.6	F08		6	0127-0558	504.41	558.87	368	73.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			183.8	F08		6	0128-0560	633.43	560.60	357	74.43	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1787.2	F08		6	0129-0564	806.22	564.04	342	73.60	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			208.0	F08		6	0130-0572	573.03	573.00	363	76.08	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			367.2	F08		6	0131-0570	899.87	570.25	219	55.70	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2360.2	F08		6	0132-0581	58.91	581.53	285	62.18	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			203.7	F08		6	0133-0585	191.91	585.57	308	69.26	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			561.7	F08		6	0134-0581	760.19	580.73	169	51.36	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			480.2	F08		6	0135-0586	779.09	586.58	318	73.70	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			844.3	F08		6	0136-0593	393.16	593.77	325	68.77	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			221.4	F08		6	0137-0598	524.28	598.86	360	74.43	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1558.4	F08		6	0138-0604	407.96	603.66	268	60.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			918.5	F08		6	0139-0606	719.80	606.67	342	71.60	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			325.0	F08		6	0140-0610	668.02	609.38	332	71.60	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2196.4	F08		6	0141-0610	944.17	610.24	325	67.36	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			206.4	F08		6	0142-0624	254.48	624.73	435	81.36	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4505.5	F08		6	0143-0620	473.85	620.29	254	59.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			927.5	F08		6	0144-0625	498.09	624.46	322	69.60	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			203.7	F08		6	0145-0621	588.56	622.24	126	47.11	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			194.5	F08		6	0146-0626	604.38	625.56	306	69.36	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1454.4	F08		6	0147-0631	399.30	631.24	270	60.18	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			692.0	F08		6	0148-0643	820.36	643.79	331	69.60	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			478.0	F08		6	0149-0647	762.95	647.48	391	74.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			999.5	F08		6	0150-0647	185.53	647.15	314	69.01	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			6344.1	F08		6	0151-0650	467.28	649.78	254	58.53	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			569.8	F08		6	0152-0655	654.47	655.82	408	83.15	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			880.8	F08		6	0153-0657	227.78	657.24	307	67.36	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			700.0	F08		6	0154-0663	678.83	662.86	420	78.08	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			330.3	F08		6	0155-0660	152.33	659.97	228	56.28	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			932.2	F08		6	0156-0664	317.48	664.23	379	78.43	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			325.0	F08		6	0157-0667	131.53	667.22	214	54.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			204.8	F08		6	0158-0685	754.34	685.71	364	73.26	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			183.6	F08		6	0159-0683	214.80	683.17	312	65.01	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			182.7	F08		6	0160-0691	383.37	691.24	545	87.15	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			609.2	F08		6	0161-0691	921.86	691.84	327	67.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1525.9	F08		6	0162-0695	699.02	694.81	134	44.04	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			187.5	F08		6	0163-0703	335.59	703.62	544	86.91	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1428.7	F08		6	0164-0697	712.80	697.08	155	46.39	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			368.6	F08		6	0165-0703	115.04	703.15	344	69.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			208.8	F08		6	0166-0708	252.76	707.97	278	62.53	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			236.1	F08		7	0001-0033	92.68	32.93	251	60.18	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1890.3	F08		7	0002-0044	386.80	44.51	294	62.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1280.4	F08		7	0003-0048	477.35	48.14	278	66.67	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1131.2	F08		7	0004-0060	407.20	59.76	285	63.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			302.4	F08		7	0005-0062	678.12	62.81	233	55.36	0.956
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			335.2	F08		7	0006-0083	498.41	83.94	245	59.11	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			221.3	F08		7	0007-0088	102.28	88.41	272	64.28	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1438.2	F08		7	0008-0090	312.19	90.06	243	58.28	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2265.6	F08		7	0009-0088	857.80	88.23	243	58.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			285.0	F08		7	0010-0091	568.14	91.09	249	59.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			267.7	F08		7	0011-0090	922.36	90.77	285	69.36	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1025.8	F08		7	0012-0096	804.71	96.45	347	71.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			270.9	F08		7	0013-0099	159.09	99.23	396	76.91	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			280.8	F08		7	0014-0101	457.94	101.78	288	63.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			230.2	F08		7	0015-0105	635.09	105.00	234	59.36	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			775.5	F08		7	0016-0119	523.81	119.55	222	58.18	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4399.7	F08		7	0017-0126	686.97	125.86	193	53.94	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			223.8	F08		7	0018-0126	88.93	126.97	301	67.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2320.8	F08		7	0019-0132	641.72	132.74	273	63.60	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			710.2	F08		7	0020-0131	188.37	132.20	306	72.77	0.726
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			222.2	F08		7	0021-0135	281.43	134.70	262	61.60	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			324.8	F08		7	0022-0140	900.77	139.76	353	73.26	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			244.6	F08		7	0023-0140	559.10	140.54	300	64.43	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			468.8	F08		7	0024-0146	372.83	146.27	317	70.18	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1322.9	F08		7	0025-0153	132.29	153.66	301	66.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1646.5	F08		7	0026-0155	245.36	155.87	315	67.84	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			739.4	F08		7	0027-0154	331.26	154.32	290	63.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			172.7	F08		7	0028-0159	830.05	159.13	536	87.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1732.5	F08		7	0029-0163	779.09	162.97	296	65.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1106.9	F08		7	0030-0173	445.86	172.75	269	62.87	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			534.3	F08		7	0031-0180	31.92	180.27	332	72.43	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1979.6	F08		7	0032-0182	770.41	182.44	294	64.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			264.4	F08		7	0033-0201	821.36	201.88	239	57.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			10043.3	F08		7	0034-0203	154.35	202.98	230	56.53	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5050.4	F08		7	0035-0230	658.69	229.95	258	61.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			199.7	F08		7	0036-0236	902.31	237.44	323	75.50	0.712
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			315.4	F08		7	0037-0240	807.18	241.35	115	44.53	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			216.6	F08		7	0038-0265	518.79	264.69	312	69.26	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			404.0	F08		7	0039-0265	544.89	264.71	246	64.18	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2978.7	F08		7	0040-0268	690.63	268.72	226	56.87	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			263.2	F08		7	0041-0273	36.28	273.02	267	65.01	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			382.9	F08		7	0042-0272	803.84	272.63	286	72.08	0.692
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1917.2	F08		7	0043-0279	430.76	279.79	262	60.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1336.2	F08		7	0044-0284	235.60	284.60	328	67.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			246.8	F08		7	0045-0288	629.87	288.63	303	65.01	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			404.6	F08		7	0046-0291	776.86	291.35	339	74.67	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			473.5	F08		7	0047-0299	663.58	299.86	310	67.94	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			864.4	F08		7	0048-0307	180.09	307.59	328	67.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2955.9	F08		7	0049-0307	322.57	307.02	304	65.36	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			477.3	F08		7	0050-0317	748.57	316.98	227	58.18	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			245.4	F08		7	0051-0317	637.80	317.35	248	58.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			647.6	F08		7	0052-0333	847.17	332.72	343	70.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			291.1	F08		7	0053-0334	147.60	333.67	253	61.70	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1178.5	F08		7	0054-0339	491.89	339.39	291	66.53	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			225.7	F08		7	0055-0352	133.12	352.78	247	64.43	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			206.5	F08		7	0056-0355	729.67	355.23	293	63.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3349.0	F08		7	0057-0366	284.61	366.61	267	59.70	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			8886.7	F08		7	0058-0377	900.04	377.04	305	72.18	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			216.9	F08		7	0059-0377	130.33	376.64	342	70.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			192.3	F08		7	0060-0382	614.20	382.79	380	73.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			219.1	F08		7	0061-0386	419.80	385.79	329	69.84	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			217.4	F08		7	0062-0384	562.34	383.61	317	66.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			794.7	F08		7	0063-0392	845.59	392.78	308	67.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			413.0	F08		7	0064-0396	676.19	396.86	321	68.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			208.7	F08		7	0065-0397	781.94	396.61	342	69.84	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4161.1	F08		7	0066-0399	58.99	398.31	273	63.60	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			997.8	F08		7	0067-0409	352.76	410.17	340	72.67	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			859.4	F08		7	0068-0417	292.67	417.10	285	67.84	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5544.4	F08		7	0069-0423	37.19	423.02	275	69.26	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			262.9	F08		7	0070-0419	533.04	419.50	266	63.70	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			228.1	F08		7	0071-0426	229.90	425.89	293	66.43	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2994.6	F08		7	0072-0438	885.79	438.02	319	70.77	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			246.6	F08		7	0073-0437	138.79	436.51	217	59.94	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			375.1	F08		7	0074-0443	717.99	443.46	337	69.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			216.9	F08		7	0075-0448	449.95	447.65	306	67.84	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			6586.7	F08		7	0076-0447	484.62	447.15	225	58.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1208.8	F08		7	0077-0453	631.77	455.68	387	93.98	0.551
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			901.7	F08		7	0078-0449	298.81	448.89	269	66.43	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			706.2	F08		7	0079-0468	104.09	467.16	106	44.53	0.672
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			210.8	F08		7	0080-0479	201.56	479.53	320	69.60	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			800.6	F08		7	0081-0481	581.58	480.98	335	68.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1391.0	F08		7	0082-0486	529.78	486.59	233	58.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1286.6	F08		7	0083-0494	302.87	494.27	285	62.43	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1048.2	F08		7	0084-0495	229.49	495.57	325	68.77	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			766.5	F08		7	0085-0499	904.47	499.00	292	65.60	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			274.5	F08		7	0086-0504	28.67	504.31	308	66.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			244.4	F08		7	0087-0508	444.17	508.44	343	70.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			532.7	F08		7	0088-0525	890.82	525.58	277	65.70	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1023.4	F08		7	0089-0535	193.24	534.84	316	68.77	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2322.1	F08		7	0090-0539	300.64	539.10	270	63.01	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			660.1	F08		7	0091-0539	379.44	538.81	304	65.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			240.2	F08		7	0092-0542	25.51	542.80	256	64.43	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			277.6	F08		7	0093-0549	343.44	548.80	214	55.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1501.0	F08		7	0094-0552	637.08	552.27	261	60.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			195.1	F08		7	0095-0574	164.62	573.41	429	86.08	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2053.8	F08		7	0096-0571	672.22	571.83	228	55.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			922.1	F08		7	0097-0573	507.45	573.46	280	63.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			618.4	F08		7	0098-0581	822.58	581.20	290	67.26	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2972.1	F08		7	0099-0592	714.37	592.57	393	83.74	0.704
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			878.0	F08		7	0100-0604	631.20	604.27	236	60.18	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			368.0	F08		7	0101-0615	95.84	614.75	325	69.36	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			228.8	F08		7	0102-0617	583.01	617.18	308	67.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			497.3	F08		7	0103-0632	208.27	633.24	340	68.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			588.7	F08		7	0104-0635	394.14	634.30	172	52.53	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			281.2	F08		7	0105-0642	602.53	640.54	365	120.71	0.315
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			476.9	F08		7	0106-0646	152.95	645.38	213	59.94	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			486.3	F08		7	0107-0649	403.03	649.67	189	54.53	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			273.9	F08		7	0108-0646	479.26	645.61	195	67.60	0.536
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1593.5	F08		7	0109-0654	434.14	654.28	282	62.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			900.5	F08		7	0110-0661	551.17	661.16	255	58.53	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			468.3	F08		7	0111-0676	429.53	676.20	341	69.50	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			265.7	F08		7	0112-0674	830.80	674.11	271	65.60	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			773.4	F08		7	0113-0679	201.81	678.48	306	66.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1481.5	F08		7	0114-0686	459.50	686.25	297	67.01	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			199.4	F08		7	0115-0687	594.89	687.09	301	69.36	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1773.1	F08		7	0116-0700	860.31	700.06	228	58.77	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4357.4	F08		7	0117-0712	829.75	712.75	159	50.04	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3857.3	F08		8	0001-0033	547.49	33.04	276	63.36	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			217.5	F08		8	0002-0039	390.98	39.49	312	68.87	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			899.1	F08		8	0003-0040	117.38	39.09	364	73.84	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			858.3	F08		8	0004-0043	468.83	43.14	273	63.60	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1003.4	F08		8	0005-0051	61.97	51.24	324	67.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			256.3	F08		8	0006-0057	813.53	56.57	270	65.60	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			228.9	F08		8	0007-0061	423.49	62.30	351	70.67	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			199.1	F08		8	0008-0063	351.36	64.01	288	63.94	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			271.6	F08		8	0009-0073	188.66	73.62	234	58.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			221.0	F08		8	0010-0078	534.60	77.39	546	85.74	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			223.5	F08		8	0011-0090	591.13	91.05	359	73.84	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			293.1	F08		8	0012-0093	27.34	92.73	300	71.60	0.735
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			218.3	F08		8	0013-0098	151.25	98.63	321	70.18	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1049.0	F08		8	0014-0094	862.10	94.33	251	58.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			201.3	F08		8	0015-0107	399.16	107.89	351	69.60	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			235.8	F08		8	0016-0116	77.68	116.31	300	65.60	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			221.6	F08		8	0017-0119	94.58	118.73	270	66.18	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			230.2	F08		8	0018-0117	144.91	118.43	327	67.94	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			227.8	F08		8	0019-0126	297.21	126.26	313	66.77	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4681.0	F08		8	0020-0127	571.17	127.19	260	64.67	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			213.7	F08		8	0021-0132	461.59	131.56	320	67.60	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			325.4	F08		8	0022-0137	524.65	137.50	266	61.46	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1232.2	F08		8	0023-0143	182.96	143.82	360	72.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			876.3	F08		8	0024-0144	858.72	143.84	286	62.53	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			989.0	F08		8	0025-0148	116.34	148.61	341	68.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			542.3	F08		8	0026-0148	631.03	147.91	212	54.53	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			248.9	F08		8	0027-0163	384.92	163.20	349	70.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			234.4	F08		8	0028-0162	498.33	161.44	241	60.77	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			395.2	F08		8	0029-0179	255.75	179.69	303	66.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			342.2	F08		8	0030-0193	903.86	192.59	363	77.60	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1000.0	F08		8	0031-0192	128.31	192.14	319	68.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3422.6	F08		8	0032-0198	834.68	198.26	273	61.36	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			778.8	F08		8	0033-0199	509.73	199.88	314	73.60	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1185.6	F08		8	0034-0200	934.39	200.06	339	68.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			310.0	F08		8	0035-0203	451.50	203.05	309	66.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			716.3	F08		8	0036-0212	809.27	211.52	260	59.94	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			201.5	F08		8	0037-0212	298.17	211.31	305	67.36	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			308.6	F08		8	0038-0219	171.70	218.50	349	70.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			227.0	F08		8	0039-0233	637.45	233.56	392	80.67	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1195.9	F08		8	0040-0231	389.44	231.39	302	67.36	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			221.0	F08		8	0041-0237	69.26	237.61	245	60.43	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			212.0	F08		8	0042-0246	216.23	246.26	271	64.43	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2007.4	F08		8	0043-0252	368.24	252.48	258	60.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			603.8	F08		8	0044-0255	555.78	254.76	308	67.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			6825.8	F08		8	0045-0255	786.48	254.80	372	71.60	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1340.7	F08		8	0046-0255	269.76	254.60	284	66.43	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			200.7	F08		8	0047-0254	91.96	254.52	319	73.70	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2172.9	F08		8	0048-0259	345.30	258.91	262	60.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			203.3	F08		8	0049-0267	175.50	267.03	342	69.60	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			741.2	F08		8	0050-0268	413.70	268.21	323	71.50	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1674.5	F08		8	0051-0269	476.36	269.60	262	62.87	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			239.8	F08		8	0052-0267	608.28	266.91	333	69.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			270.6	F08		8	0053-0276	824.72	276.05	241	71.26	0.596
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			363.0	F08		8	0054-0280	327.52	280.38	308	69.94	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			221.0	F08		8	0055-0286	908.01	285.70	313	68.53	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			641.6	F08		8	0056-0287	257.30	287.08	289	64.18	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			273.9	F08		8	0057-0296	114.24	295.98	271	60.28	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			244.8	F08		8	0058-0301	527.71	301.18	325	70.43	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			406.6	F08		8	0059-0303	773.32	302.44	372	73.26	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1422.6	F08		8	0060-0301	67.03	300.89	265	60.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			325.2	F08		8	0061-0306	726.59	306.20	334	67.60	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			7235.6	F08		8	0062-0307	454.46	307.65	280	64.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			312.4	F08		8	0063-0312	484.66	310.84	355	71.01	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			473.2	F08		8	0064-0309	802.16	310.13	312	67.01	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			299.1	F08		8	0065-0309	596.25	308.86	334	68.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			221.1	F08		8	0066-0316	693.21	316.50	327	69.94	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			300.3	F08		8	0067-0314	860.26	314.34	217	55.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2065.4	F08		8	0068-0321	66.27	321.41	288	64.18	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			243.9	F08		8	0069-0340	518.16	340.62	344	70.18	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			276.5	F08		8	0070-0341	265.73	342.16	331	68.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			371.2	F08		8	0071-0351	434.28	351.13	305	66.53	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1702.6	F08		8	0072-0351	157.55	350.65	335	67.60	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1861.8	F08		8	0073-0357	716.82	357.73	333	68.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			294.6	F08		8	0074-0359	201.87	358.41	290	62.18	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			215.9	F08		8	0075-0364	109.18	363.74	280	62.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1192.5	F08		8	0076-0362	599.31	361.65	263	64.53	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			890.7	F08		8	0077-0367	693.55	366.93	294	66.18	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1773.6	F08		8	0078-0368	311.75	368.05	298	66.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1027.6	F08		8	0079-0377	779.65	376.56	371	72.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			253.2	F08		8	0080-0388	69.99	388.89	308	67.60	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2492.2	F08		8	0081-0390	343.64	390.06	371	73.84	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			515.7	F08		8	0082-0386	263.47	386.26	253	61.11	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			523.9	F08		8	0083-0391	908.93	390.40	404	73.60	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			642.4	F08		8	0084-0391	611.42	391.77	274	69.50	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			243.8	F08		8	0085-0394	117.33	393.86	319	67.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			906.0	F08		8	0086-0399	228.50	398.65	247	60.53	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			297.3	F08		8	0087-0408	842.54	408.45	219	54.63	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1099.2	F08		8	0088-0416	556.27	416.95	354	69.60	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4797.3	F08		8	0089-0420	159.54	420.41	357	71.50	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1396.7	F08		8	0090-0423	731.25	422.91	279	63.01	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1054.5	F08		8	0091-0428	804.60	428.93	253	61.36	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			940.1	F08		8	0092-0436	487.98	436.01	325	66.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			220.8	F08		8	0093-0438	450.52	438.13	320	69.84	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1425.3	F08		8	0094-0441	747.09	440.58	241	61.11	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			234.6	F08		8	0095-0449	897.52	449.38	338	69.84	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			275.2	F08		8	0096-0449	761.52	449.23	256	62.53	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5274.0	F08		8	0097-0454	127.49	454.78	354	70.18	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			260.5	F08		8	0098-0459	837.61	458.78	342	69.84	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			461.0	F08		8	0099-0464	52.51	464.29	258	63.01	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			350.8	F08		8	0100-0475	743.13	475.27	277	63.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			384.2	F08		8	0101-0501	414.64	501.00	335	69.60	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			725.0	F08		8	0102-0507	566.44	507.64	333	69.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			303.5	F08		8	0103-0514	374.99	514.14	306	65.94	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1342.2	F08		8	0104-0513	334.32	513.20	159	48.53	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1370.9	F08		8	0105-0524	327.91	524.49	200	53.94	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			224.8	F08		8	0106-0524	268.31	524.45	261	62.53	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			962.6	F08		8	0107-0531	853.53	531.31	273	60.77	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			345.7	F08		8	0108-0535	604.96	534.87	366	72.18	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1838.1	F08		8	0109-0571	800.98	571.40	335	71.01	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			290.1	F08		8	0110-0569	210.82	568.62	319	65.60	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1431.4	F08		8	0111-0577	472.98	576.95	286	63.60	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1662.8	F08		8	0112-0581	98.85	581.31	272	62.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			9375.1	F08		8	0113-0580	145.09	579.96	365	73.01	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			842.7	F08		8	0114-0590	882.83	590.92	326	71.26	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			586.2	F08		8	0115-0597	725.29	596.96	315	68.18	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			184.5	F08		8	0116-0597	624.95	597.75	362	73.26	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1411.8	F08		8	0117-0611	935.55	610.24	234	62.43	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			518.8	F08		8	0118-0618	164.12	619.05	342	69.84	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1077.6	F08		8	0119-0619	390.63	619.56	358	72.18	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			201.8	F08		8	0120-0624	311.05	624.35	393	74.53	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			228.8	F08		8	0121-0633	257.00	633.60	354	72.18	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			379.5	F08		8	0122-0629	887.85	629.27	229	59.36	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			817.0	F08		8	0123-0631	485.97	631.58	369	71.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			594.0	F08		8	0124-0644	205.67	643.32	267	76.91	0.567
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			329.3	F08		8	0125-0646	113.81	646.09	315	68.28	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			593.3	F08		8	0126-0648	646.66	648.33	311	64.77	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1758.5	F08		8	0127-0652	188.70	652.10	313	72.77	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			282.4	F08		8	0128-0662	807.99	662.37	371	72.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1462.1	F08		8	0129-0679	279.00	679.25	308	66.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			921.9	F08		8	0130-0681	511.91	681.69	286	62.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1000.2	F08		8	0131-0683	818.41	683.45	254	62.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			686.6	F08		8	0132-0700	318.53	700.43	351	71.84	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			258.2	F08		8	0133-0700	869.85	700.89	257	62.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			494.9	F08		8	0134-0703	138.26	703.54	301	64.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			310.7	F08		8	0135-0707	51.06	707.80	312	67.60	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			394.7	F08		9	0001-0027	112.91	26.93	344	68.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			186.4	F08		9	0002-0032	250.70	31.94	275	63.11	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			822.4	F08		9	0003-0037	590.02	36.73	360	76.08	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			217.3	F08		9	0004-0035	182.72	34.71	298	68.18	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1256.0	F08		9	0005-0039	511.18	38.74	272	60.53	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			216.4	F08		9	0006-0052	462.31	52.06	326	68.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			334.4	F08		9	0007-0061	289.42	61.34	340	69.84	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			307.3	F08		9	0008-0060	744.10	60.15	375	75.84	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			941.9	F08		9	0009-0059	539.40	60.03	288	63.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			195.1	F08		9	0010-0067	666.69	67.26	265	60.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1022.3	F08		9	0011-0067	106.69	66.90	298	65.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1971.5	F08		9	0012-0074	577.54	74.11	328	69.36	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			359.3	F08		9	0013-0085	351.37	85.44	320	68.77	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			771.6	F08		9	0014-0091	628.73	91.14	393	77.01	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			576.3	F08		9	0015-0103	150.33	103.48	271	69.26	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1665.9	F08		9	0016-0108	400.39	108.07	454	80.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			926.0	F08		9	0017-0105	858.93	105.72	285	66.53	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			491.5	F08		9	0018-0113	289.82	113.21	327	67.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			225.9	F08		9	0019-0109	606.04	109.78	240	56.53	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			318.9	F08		9	0020-0117	768.48	117.04	247	62.77	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			233.0	F08		9	0021-0125	539.18	124.32	438	80.67	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			331.1	F08		9	0022-0121	873.87	121.45	166	52.53	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			217.2	F08		9	0023-0127	260.01	127.38	302	67.01	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1211.4	F08		9	0024-0138	476.79	138.03	340	71.60	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			427.3	F08		9	0025-0149	319.13	148.94	327	67.11	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			203.8	F08		9	0026-0148	749.13	148.30	298	66.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			208.7	F08		9	0027-0158	503.51	157.38	320	73.60	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2703.4	F08		9	0028-0161	88.66	161.07	266	64.91	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2226.5	F08		9	0029-0159	241.91	159.07	237	59.01	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1783.3	F08		9	0030-0167	191.21	167.88	216	55.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2436.9	F08		9	0031-0175	444.89	175.23	302	65.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			377.5	F08		9	0032-0173	811.23	174.00	102	37.46	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			437.0	F08		9	0033-0186	771.64	186.50	258	63.36	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			612.0	F08		9	0034-0192	90.66	192.61	247	62.18	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			330.7	F08		9	0035-0195	168.87	195.46	266	68.77	0.707
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			399.2	F08		9	0036-0192	373.20	191.67	246	60.77	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			934.0	F08		9	0037-0199	632.74	199.12	474	83.26	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			214.7	F08		9	0038-0200	943.12	200.57	395	77.50	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			192.5	F08		9	0039-0204	909.33	203.92	372	77.84	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1203.7	F08		9	0040-0203	29.78	202.97	327	68.18	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			212.5	F08		9	0041-0216	678.42	216.04	314	73.01	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			229.5	F08		9	0042-0214	529.80	214.47	277	61.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2970.7	F08		9	0043-0235	813.79	235.09	281	65.01	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1313.9	F08		9	0044-0237	767.12	236.64	289	67.84	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1429.4	F08		9	0045-0242	731.53	242.09	337	71.36	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			222.2	F08		9	0046-0239	229.65	240.27	253	58.87	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2713.8	F08		9	0047-0249	661.57	249.17	263	64.77	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			279.4	F08		9	0048-0252	46.14	252.59	303	63.94	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2113.0	F08		9	0049-0253	277.61	253.04	272	61.36	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			228.2	F08		9	0050-0260	938.09	260.43	364	71.50	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			286.3	F08		9	0051-0257	230.00	257.15	285	65.70	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3372.3	F08		9	0052-0266	426.54	266.69	295	65.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			227.3	F08		9	0053-0266	532.37	266.41	288	62.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			539.4	F08		9	0054-0275	141.22	275.50	320	67.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			180.1	F08		9	0055-0280	890.30	279.55	407	79.26	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			792.0	F08		9	0056-0282	381.39	281.55	283	62.18	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2271.9	F08		9	0057-0285	623.90	284.88	302	67.84	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			222.6	F08		9	0058-0298	223.21	298.43	264	59.60	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4053.2	F08		9	0059-0308	484.54	308.19	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			221.2	F08		9	0060-0313	56.31	313.12	372	74.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			212.7	F08		9	0061-0322	259.07	322.01	308	67.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			280.2	F08		9	0062-0327	728.12	326.58	310	69.36	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			207.5	F08		9	0063-0334	925.85	333.62	351	70.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1416.5	F08		9	0064-0333	831.25	333.40	333	69.26	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			939.2	F08		9	0065-0341	545.88	341.42	289	63.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4043.6	F08		9	0066-0341	871.51	341.54	301	64.43	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			769.5	F08		9	0067-0346	43.39	345.92	356	69.01	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1596.8	F08		9	0068-0350	225.43	350.33	358	73.26	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			516.0	F08		9	0069-0364	425.99	364.39	291	69.36	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			251.4	F08		9	0070-0363	784.03	363.41	333	68.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			349.2	F08		9	0071-0368	75.81	368.43	329	66.77	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			686.6	F08		9	0072-0370	728.14	370.19	368	71.84	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			217.4	F08		9	0073-0377	675.67	377.52	431	94.81	0.603
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			241.0	F08		9	0074-0384	562.15	380.29	405	96.47	0.547
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			524.9	F08		9	0075-0380	839.73	380.27	381	72.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1887.4	F08		9	0076-0395	607.01	394.57	312	70.67	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1441.9	F08		9	0077-0401	333.46	400.98	249	60.53	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1219.2	F08		9	0078-0401	429.53	401.57	283	62.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			338.2	F08		9	0079-0413	477.40	413.11	239	58.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			951.2	F08		9	0080-0418	752.22	417.97	326	67.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			775.5	F08		9	0081-0423	108.15	423.49	312	66.77	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			355.0	F08		9	0082-0422	136.76	422.43	323	67.84	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1945.6	F08		9	0083-0431	926.94	431.35	264	63.70	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1137.0	F08		9	0084-0436	663.61	435.45	326	68.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			287.0	F08		9	0085-0441	846.39	442.19	308	68.67	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2137.6	F08		9	0086-0453	788.02	452.55	346	70.43	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			693.4	F08		9	0087-0457	627.33	457.38	328	68.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1165.1	F08		9	0088-0460	250.17	459.58	271	62.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			256.1	F08		9	0089-0460	360.06	459.62	272	61.36	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1488.1	F08		9	0090-0466	762.09	465.46	350	71.01	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1212.2	F08		9	0091-0473	583.58	473.73	297	64.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			472.5	F08		9	0092-0483	354.63	482.60	295	64.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			229.2	F08		9	0093-0490	838.00	490.06	300	64.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			222.1	F08		9	0094-0496	656.41	496.27	342	72.53	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2063.1	F08		9	0095-0495	418.64	495.14	284	62.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			194.7	F08		9	0096-0498	792.53	497.76	331	69.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2156.5	F08		9	0097-0496	774.17	495.84	350	71.94	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			245.8	F08		9	0098-0499	52.74	498.30	283	62.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			553.4	F08		9	0099-0501	727.06	500.76	271	61.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1018.0	F08		9	0100-0505	207.71	504.91	249	58.18	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			559.5	F08		9	0101-0521	78.62	521.30	261	65.01	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			545.0	F08		9	0102-0521	614.23	521.50	371	70.18	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			936.9	F08		9	0103-0525	681.54	525.40	290	65.36	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2019.9	F08		9	0104-0524	710.85	524.45	293	63.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3486.7	F08		9	0105-0536	359.76	536.61	335	68.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			650.8	F08		9	0106-0539	624.88	539.71	358	72.08	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			230.1	F08		9	0107-0545	414.30	545.05	278	68.08	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			281.9	F08		9	0108-0543	740.94	544.00	305	65.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			208.6	F08		9	0109-0551	127.64	551.73	323	70.67	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			394.0	F08		9	0110-0555	376.56	555.19	274	60.77	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			355.1	F08		9	0111-0559	311.67	559.17	348	69.60	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			190.3	F08		9	0112-0570	464.67	570.15	303	67.60	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			293.5	F08		9	0113-0577	227.99	580.26	291	83.15	0.529
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			358.4	F08		9	0114-0584	723.59	584.53	331	68.67	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			222.4	F08		9	0115-0592	144.52	592.32	318	69.26	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			656.5	F08		9	0116-0591	674.89	590.99	317	66.53	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1378.0	F08		9	0117-0600	594.64	600.11	339	70.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1395.9	F08		9	0118-0599	296.56	598.65	303	67.84	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1234.7	F08		9	0119-0597	805.83	597.68	333	75.84	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			447.1	F08		9	0120-0602	928.18	602.38	277	62.77	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			252.9	F08		9	0121-0606	412.90	606.62	306	66.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			207.3	F08		9	0122-0607	466.79	607.03	331	67.84	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1486.5	F08		9	0123-0613	30.57	613.25	236	60.77	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			671.8	F08		9	0124-0615	239.99	615.89	244	63.94	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			311.3	F08		9	0125-0617	908.56	617.47	303	66.53	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1723.3	F08		9	0126-0625	671.13	625.54	417	79.26	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4262.5	F08		9	0127-0638	544.10	637.32	277	67.01	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1577.7	F08		9	0128-0648	205.49	647.63	330	67.60	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			181.9	F08		9	0129-0652	501.09	652.73	310	66.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1627.2	F08		9	0130-0658	185.37	657.89	315	67.84	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			178.8	F08		9	0131-0664	921.81	663.93	269	61.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			367.7	F08		9	0132-0667	677.49	666.70	275	62.18	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			560.9	F08		9	0133-0671	770.94	672.08	269	66.18	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			872.0	F08		9	0134-0674	398.05	674.25	276	63.36	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			240.7	F08		9	0135-0680	852.31	679.91	486	84.67	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			281.1	F08		9	0136-0682	319.34	683.00	307	65.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1761.0	F08		9	0137-0685	378.24	685.79	273	61.36	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			312.5	G08		1	0001-0032	204.59	33.10	257	63.01	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			230.6	G08		1	0002-0042	496.41	42.05	229	59.11	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			291.1	G08		1	0003-0056	98.31	56.55	335	72.08	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			232.3	G08		1	0004-0065	935.15	65.24	324	68.43	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			378.8	G08		1	0005-0075	282.41	75.08	268	64.04	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			385.6	G08		1	0006-0076	711.31	75.89	364	71.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			297.1	G08		1	0007-0083	664.99	83.53	405	80.57	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			308.5	G08		1	0008-0092	730.56	92.42	348	71.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			290.9	G08		1	0009-0092	567.38	92.61	154	68.43	0.413
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			411.5	G08		1	0010-0096	262.76	96.42	254	69.26	0.665
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			317.5	G08		1	0011-0100	77.40	101.22	295	66.18	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			222.1	G08		1	0012-0106	712.96	105.19	322	72.33	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			300.2	G08		1	0013-0107	844.87	105.02	171	73.50	0.398
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			275.0	G08		1	0014-0122	896.06	121.71	302	66.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1443.8	G08		1	0015-0194	835.35	194.66	279	62.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			220.8	G08		1	0016-0199	185.62	199.26	102	39.21	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			692.6	G08		1	0017-0225	584.08	224.71	214	58.04	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			296.7	G08		1	0018-0242	806.26	241.74	215	62.04	0.702
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			293.3	G08		1	0019-0268	829.39	268.12	262	59.36	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			379.7	G08		1	0020-0280	887.64	280.48	237	60.28	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			376.0	G08		1	0021-0288	639.34	288.26	221	57.94	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1443.2	G08		1	0022-0302	32.27	302.53	235	64.18	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			324.1	G08		1	0023-0306	478.27	306.20	195	58.18	0.724
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			460.4	G08		1	0024-0323	657.51	324.42	284	64.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			242.5	G08		1	0025-0343	280.32	343.85	258	62.53	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			300.8	G08		1	0026-0365	47.51	365.09	214	54.87	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			323.2	G08		1	0027-0369	350.54	368.34	227	62.87	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			800.4	G08		1	0028-0364	510.31	363.63	226	58.77	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			816.4	G08		1	0029-0367	623.42	366.98	274	63.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			366.1	G08		1	0030-0365	742.98	365.12	193	57.36	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			158.7	G08		1	0031-0368	147.46	368.35	242	61.36	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			259.4	G08		1	0032-0373	306.88	373.44	229	61.11	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1726.0	G08		1	0033-0383	675.69	383.47	240	63.11	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			273.3	G08		1	0034-0389	935.70	389.37	282	67.60	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			501.5	G08		1	0035-0407	210.27	407.15	209	58.77	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			272.2	G08		1	0036-0414	70.13	414.26	215	57.70	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2277.5	G08		1	0037-0416	890.73	415.95	225	57.70	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			610.1	G08		1	0038-0438	666.57	438.67	262	64.53	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			416.6	G08		1	0039-0444	858.60	443.31	109	75.98	0.237
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			956.1	G08		1	0040-0457	419.20	458.00	233	57.36	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			897.5	G08		1	0041-0462	730.98	462.08	237	61.94	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3338.9	G08		1	0042-0498	314.58	498.27	227	59.60	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			654.6	G08		1	0043-0524	563.97	524.23	303	66.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1036.2	G08		1	0044-0527	829.85	527.56	240	62.77	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1098.2	G08		1	0045-0536	719.53	536.54	205	58.18	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			732.7	G08		1	0046-0539	360.16	539.84	277	72.43	0.664
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			647.4	G08		1	0047-0539	688.61	539.21	272	60.77	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			828.6	G08		1	0048-0541	636.49	541.13	202	54.18	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			431.8	G08		1	0049-0548	12.47	547.60	261	61.36	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			725.9	G08		1	0050-0558	95.67	558.64	212	58.18	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			258.7	G08		1	0051-0568	648.28	568.31	304	68.18	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			932.6	G08		1	0052-0569	834.65	569.67	293	66.43	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			636.7	G08		1	0053-0605	697.52	605.52	252	58.77	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			903.8	G08		1	0054-0610	547.24	610.47	328	69.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			345.4	G08		1	0055-0610	598.30	610.74	166	53.94	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			547.1	G08		1	0056-0639	326.67	638.87	198	53.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1164.7	G08		1	0057-0697	329.28	697.00	230	59.84	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			269.3	G08		1	0058-0706	735.74	705.51	250	73.60	0.580
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			468.7	G08		2	0001-0033	490.85	32.69	260	66.28	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			249.2	G08		2	0002-0065	39.68	65.16	334	70.43	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			253.5	G08		2	0003-0071	263.62	70.95	321	73.26	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			560.0	G08		2	0004-0104	246.65	104.64	292	75.50	0.644
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			398.5	G08		2	0005-0207	403.66	206.99	276	68.18	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			297.3	G08		2	0006-0218	447.01	218.02	223	66.43	0.635
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			359.9	G08		2	0007-0233	670.79	232.76	279	104.81	0.319
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			363.2	G08		2	0008-0248	396.52	248.61	314	69.84	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			320.5	G08		2	0009-0248	449.88	249.51	100	47.46	0.558
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2702.0	G08		2	0010-0282	915.46	282.98	120	50.77	0.585
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			278.3	G08		2	0011-0354	665.79	353.71	302	68.18	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			289.9	G08		2	0012-0389	40.48	389.26	286	68.18	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5317.3	G08		2	0013-0396	667.73	395.75	228	57.01	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1078.0	G08		2	0014-0408	655.79	407.55	276	66.08	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1325.0	G08		2	0015-0409	559.15	408.44	277	64.18	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1012.4	G08		2	0016-0459	258.19	459.85	306	66.18	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3137.5	G08		2	0017-0511	49.96	511.64	225	57.70	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2465.2	G08		2	0018-0515	114.80	515.24	268	63.60	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			837.5	G08		2	0019-0613	133.89	613.28	223	60.53	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			948.9	G08		2	0020-0618	504.01	618.58	259	63.36	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			735.6	G08		2	0021-0635	637.25	635.23	302	66.53	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1307.6	G08		2	0022-0639	285.94	639.91	297	66.18	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			582.6	G08		2	0023-0644	591.27	644.02	278	63.70	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1000.4	G08		2	0024-0650	538.77	650.29	296	64.53	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			243.9	G08		2	0025-0654	224.91	653.80	279	63.70	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			271.8	G08		2	0026-0669	100.45	669.38	299	65.36	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2121.2	G08		2	0027-0672	582.47	672.12	374	76.08	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			989.5	G08		2	0028-0672	305.14	673.35	281	64.53	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			445.0	G08		2	0029-0686	316.60	686.53	125	45.11	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1632.8	G08		2	0030-0691	559.22	690.33	333	73.01	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1591.4	G08		2	0031-0697	615.07	697.26	277	62.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			453.1	G08		2	0032-0703	912.12	702.79	115	40.28	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1980.2	G08		3	0001-0051	392.71	51.40	201	55.36	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			262.7	G08		3	0002-0075	222.13	75.24	244	59.36	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			899.5	G08		3	0003-0084	824.96	84.25	264	61.94	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			275.7	G08		3	0004-0098	283.01	98.19	236	61.26	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			420.9	G08		3	0005-0107	865.02	107.68	209	59.26	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1271.2	G08		3	0006-0109	428.96	108.97	213	54.53	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			729.0	G08		3	0007-0117	337.10	117.22	177	52.18	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4435.9	G08		3	0008-0120	858.06	120.25	224	55.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			374.9	G08		3	0009-0140	463.15	140.84	127	57.60	0.481
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1794.9	G08		3	0010-0154	925.91	153.92	225	57.36	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			246.6	G08		3	0011-0159	132.00	159.59	256	62.53	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			247.3	G08		3	0012-0161	248.69	161.09	118	40.28	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			232.9	G08		3	0013-0170	238.79	170.81	151	46.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3003.1	G08		3	0014-0176	428.50	176.01	204	58.18	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			239.5	G08		3	0015-0181	503.87	181.33	291	66.77	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			440.6	G08		3	0016-0180	529.81	180.56	171	50.53	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			337.1	G08		3	0017-0197	582.62	198.37	177	56.18	0.705
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			609.7	G08		3	0018-0200	927.92	200.57	216	59.60	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			929.3	G08		3	0019-0218	416.36	218.30	165	50.04	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			314.1	G08		3	0020-0225	645.39	226.73	372	80.08	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			550.0	G08		3	0021-0230	534.48	231.10	267	63.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			281.9	G08		3	0022-0244	246.67	242.06	190	58.87	0.689
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1015.7	G08		3	0023-0252	396.23	252.19	223	54.53	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			575.1	G08		3	0024-0254	528.93	254.27	270	65.01	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			273.9	G08		3	0025-0258	249.56	257.64	117	41.70	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			558.5	G08		3	0026-0275	172.46	274.70	276	67.84	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			653.1	G08		3	0027-0281	631.58	281.17	262	59.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2569.3	G08		3	0028-0283	13.67	282.64	191	56.77	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			636.7	G08		3	0029-0291	854.26	290.53	224	59.60	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			345.6	G08		3	0030-0303	103.18	303.57	207	57.36	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			445.4	G08		3	0031-0312	777.94	311.63	151	51.46	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			617.6	G08		3	0032-0322	487.29	322.50	214	56.77	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1252.6	G08		3	0033-0343	170.81	343.65	233	58.28	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			784.9	G08		3	0034-0384	852.19	384.44	220	55.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			902.7	G08		3	0035-0385	203.48	384.96	224	61.70	0.739
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			280.8	G08		3	0036-0396	810.66	396.52	284	63.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2347.0	G08		3	0037-0402	50.40	402.63	241	60.77	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			271.2	G08		3	0038-0407	742.68	408.20	266	64.18	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1846.8	G08		3	0039-0408	893.26	407.85	285	67.26	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2410.9	G08		3	0040-0454	910.50	453.38	237	58.77	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			231.2	G08		3	0041-0486	783.43	486.83	257	62.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			924.5	G08		3	0042-0489	453.81	489.03	234	57.36	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			477.9	G08		3	0043-0499	369.03	498.82	247	60.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			844.5	G08		3	0044-0535	663.85	535.40	257	62.87	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2278.9	G08		3	0045-0539	343.31	539.41	471	89.74	0.735
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1784.9	G08		3	0046-0531	785.86	531.44	177	51.11	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			319.3	G08		3	0047-0549	945.50	548.90	266	68.63	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			191.9	G08		3	0048-0558	808.51	557.74	322	68.18	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			554.6	G08		3	0049-0560	315.90	559.69	220	93.40	0.317
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1787.4	G08		3	0050-0565	444.93	564.88	283	66.18	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			233.2	G08		3	0051-0575	624.95	575.22	373	72.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1343.5	G08		3	0052-0581	325.62	582.28	262	61.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			238.4	G08		3	0053-0609	835.51	610.13	302	66.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			309.9	G08		3	0054-0645	276.97	644.96	208	56.87	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1103.6	G08		3	0055-0663	699.65	662.76	264	65.36	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2084.2	G08		3	0056-0664	832.78	663.96	216	59.84	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1798.5	G08		3	0057-0666	97.42	666.26	212	53.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1019.8	G08		3	0058-0670	618.50	669.36	259	66.43	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1836.0	G08		4	0001-0035	57.39	34.95	202	56.77	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			844.2	G08		4	0002-0036	140.39	36.89	263	67.26	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			271.7	G08		4	0003-0065	897.16	64.19	268	63.26	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			234.4	G08		4	0004-0069	704.73	69.69	260	63.70	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			730.5	G08		4	0005-0087	675.87	87.02	277	61.70	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			322.6	G08		4	0006-0092	168.03	92.02	326	72.91	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1020.1	G08		4	0007-0097	488.16	97.07	264	62.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			302.4	G08		4	0008-0106	695.79	107.02	267	67.26	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3285.7	G08		4	0009-0129	134.25	130.00	186	56.87	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			300.1	G08		4	0010-0144	683.46	144.16	250	68.77	0.664
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2358.5	G08		4	0011-0184	270.60	185.09	156	47.46	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2324.8	G08		4	0012-0184	258.83	184.32	117	42.63	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2587.2	G08		4	0013-0198	252.47	198.14	271	61.60	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2583.7	G08		4	0014-0202	271.16	202.46	228	62.77	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			317.8	G08		4	0015-0222	683.17	222.21	211	63.60	0.656
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			263.7	G08		4	0016-0223	626.05	223.64	268	61.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			359.4	G08		4	0017-0230	296.16	230.32	363	80.67	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			755.1	G08		4	0018-0236	870.80	235.72	251	60.53	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			429.5	G08		4	0019-0248	297.88	248.35	171	67.84	0.467
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			469.7	G08		4	0020-0251	61.22	251.90	222	54.77	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			194.8	G08		4	0021-0252	929.07	252.31	258	60.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			246.3	G08		4	0022-0261	757.81	261.64	281	65.01	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1442.0	G08		4	0023-0260	858.20	260.13	218	61.70	0.720
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1271.5	G08		4	0024-0273	154.52	273.23	239	64.53	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			306.3	G08		4	0025-0274	848.11	274.54	288	65.94	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			311.1	G08		4	0026-0278	57.57	278.85	196	52.53	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			225.6	G08		4	0027-0290	821.95	289.82	232	58.53	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			662.6	G08		4	0028-0297	30.71	296.88	302	66.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			367.4	G08		4	0029-0300	383.48	300.35	174	49.11	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			276.6	G08		4	0030-0308	258.64	308.85	209	57.60	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			798.2	G08		4	0031-0310	101.43	310.42	257	62.53	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			267.6	G08		4	0032-0312	542.78	311.58	301	68.77	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			266.9	G08		4	0033-0325	554.36	324.38	243	67.01	0.680
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			371.1	G08		4	0034-0343	635.95	342.84	195	59.01	0.704
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			530.1	G08		4	0035-0351	370.80	351.24	187	53.70	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1027.5	G08		4	0036-0350	928.55	349.11	162	51.94	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			854.7	G08		4	0037-0355	938.44	356.34	139	44.28	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2122.9	G08		4	0038-0361	218.64	361.70	202	57.11	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			267.3	G08		4	0039-0373	278.48	373.34	189	51.46	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			375.3	G08		4	0040-0382	801.04	382.03	194	55.70	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			867.1	G08		4	0041-0388	284.57	388.10	256	62.53	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1643.6	G08		4	0042-0391	415.82	392.06	295	67.36	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			397.0	G08		4	0043-0390	53.66	390.17	240	60.18	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1155.6	G08		4	0044-0393	267.09	393.23	290	67.26	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			558.0	G08		4	0045-0401	830.60	401.78	210	53.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2170.3	G08		4	0046-0420	198.06	419.82	219	57.46	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			645.1	G08		4	0047-0424	944.84	423.39	270	62.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1787.9	G08		4	0048-0440	392.04	441.07	265	65.84	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1724.1	G08		4	0049-0447	554.05	446.96	215	56.18	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1890.1	G08		4	0050-0446	249.81	446.92	191	53.11	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			244.8	G08		4	0051-0477	904.87	477.53	234	57.70	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			261.7	G08		4	0052-0487	80.59	487.68	262	62.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1525.2	G08		4	0053-0502	230.11	501.89	197	53.46	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			362.3	G08		4	0054-0517	391.63	517.07	253	75.60	0.556
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			379.8	G08		4	0055-0521	120.17	521.56	214	55.36	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			6482.6	G08		4	0056-0523	287.43	523.01	270	63.60	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			389.4	G08		4	0057-0530	144.08	530.84	219	55.46	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2032.8	G08		4	0058-0560	596.96	558.50	392	91.74	0.585
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			301.8	G08		4	0059-0564	877.39	564.54	192	51.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			223.8	G08		4	0060-0577	810.69	577.11	389	74.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1560.9	G08		4	0061-0591	113.98	591.55	247	59.94	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			388.6	G08		4	0062-0606	659.17	606.68	297	78.57	0.605
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			897.9	G08		4	0063-0617	452.28	617.65	211	56.77	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			683.2	G08		4	0064-0621	193.27	621.27	221	60.43	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			400.3	G08		4	0065-0637	190.91	637.47	228	60.18	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			589.6	G08		4	0066-0644	397.00	643.71	282	63.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1068.6	G08		4	0067-0653	92.97	652.55	189	56.53	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			656.1	G08		4	0068-0654	106.20	654.06	160	50.04	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			697.1	G08		4	0069-0663	678.63	663.18	247	64.43	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			241.9	G08		4	0070-0690	349.11	690.26	383	72.67	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			487.1	G08		4	0071-0691	367.79	690.82	276	66.18	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1036.3	G08		4	0072-0704	542.80	703.81	309	68.43	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			430.3	G08		4	0073-0703	589.98	703.36	281	69.11	0.739
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			276.1	G08		4	0074-0703	739.02	703.26	199	52.77	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2926.0	G08		4	0075-0707	196.86	706.90	154	46.53	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			277.5	G08		5	0001-0032	541.11	31.09	192	60.18	0.666
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			294.4	G08		5	0002-0042	152.37	43.12	227	64.53	0.685
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			679.8	G08		5	0003-0068	371.04	67.99	204	61.46	0.679
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			210.8	G08		5	0004-0094	130.78	94.41	220	57.70	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			989.4	G08		5	0005-0108	685.92	107.88	189	51.94	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			728.8	G08		5	0006-0108	655.21	107.84	265	63.36	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			455.0	G08		5	0007-0126	291.19	126.62	202	56.18	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			592.7	G08		5	0008-0163	606.40	162.70	224	68.43	0.601
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			269.5	G08		5	0009-0165	343.14	165.05	250	63.50	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			303.0	G08		5	0010-0175	940.52	174.15	253	63.11	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			585.9	G08		5	0011-0181	825.03	181.58	243	58.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			314.0	G08		5	0012-0189	442.10	189.27	227	64.18	0.692
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			281.3	G08		5	0013-0195	722.38	195.82	185	73.50	0.430
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2782.6	G08		5	0014-0222	93.53	222.62	278	65.94	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			659.8	G08		5	0015-0237	567.80	237.45	194	55.46	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			226.4	G08		5	0016-0239	139.04	239.55	271	62.77	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			272.8	G08		5	0017-0241	470.04	240.31	223	57.46	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			568.0	G08		5	0018-0240	624.42	240.17	185	53.36	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			410.3	G08		5	0019-0248	823.85	247.79	175	69.26	0.459
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			213.2	G08		5	0020-0253	34.52	253.68	252	59.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			848.2	G08		5	0021-0263	132.45	263.34	299	67.84	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			807.0	G08		5	0022-0282	865.29	281.23	145	48.53	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1025.7	G08		5	0023-0292	260.85	292.40	275	62.18	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			791.1	G08		5	0024-0289	871.90	290.19	120	44.28	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			709.7	G08		5	0025-0292	905.12	292.44	265	63.01	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			904.7	G08		5	0026-0292	213.98	291.51	103	49.46	0.529
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			188.8	G08		5	0027-0316	61.57	315.91	259	68.53	0.693
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			604.7	G08		5	0028-0324	909.41	324.06	225	55.11	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1011.1	G08		5	0029-0351	34.16	350.35	160	51.11	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			436.3	G08		5	0030-0356	852.99	356.90	319	68.18	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			938.6	G08		5	0031-0357	43.91	357.60	134	43.46	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			898.7	G08		5	0032-0370	916.33	370.90	242	64.53	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			382.8	G08		5	0033-0388	478.45	387.91	263	61.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			779.5	G08		5	0034-0396	394.79	396.25	187	51.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2038.0	G08		5	0035-0412	692.19	411.81	233	56.28	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			622.3	G08		5	0036-0419	429.87	419.08	156	58.77	0.568
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			700.5	G08		5	0037-0425	50.46	424.75	261	63.60	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			219.5	G08		5	0038-0484	95.58	484.30	269	62.18	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			582.5	G08		5	0039-0483	930.96	483.42	201	53.70	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			424.9	G08		5	0040-0494	633.21	493.73	212	62.28	0.687
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2360.3	G08		5	0041-0497	769.80	497.55	253	61.70	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			756.5	G08		5	0042-0508	329.53	508.48	329	72.43	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2690.6	G08		5	0043-0527	286.51	526.75	220	61.01	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			541.4	G08		5	0044-0535	622.69	534.63	187	56.28	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			239.5	G08		5	0045-0550	220.89	550.54	202	57.94	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			265.6	G08		5	0046-0548	249.45	548.43	172	52.28	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			430.6	G08		5	0047-0563	153.70	562.95	110	53.36	0.486
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			676.1	G08		5	0048-0583	634.62	583.75	264	63.84	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3019.3	G08		5	0049-0594	129.69	594.89	191	54.18	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1483.8	G08		5	0050-0606	526.68	606.72	254	62.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			439.0	G08		5	0051-0621	548.39	620.38	261	60.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3306.8	G08		5	0052-0633	394.79	633.43	175	57.94	0.655
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			201.1	G08		5	0053-0649	879.38	648.46	267	62.77	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			884.8	G08		5	0054-0658	86.40	658.34	208	66.04	0.599
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1489.1	G08		5	0055-0659	146.43	658.61	215	57.11	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1378.8	G08		5	0056-0676	660.44	675.54	242	63.36	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			287.1	G08		5	0057-0680	392.72	679.46	237	61.94	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2287.2	G08		5	0058-0686	413.76	685.86	186	51.70	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2324.7	G08		5	0059-0701	377.39	701.40	197	55.70	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			302.2	G08		5	0060-0703	482.30	702.70	182	64.67	0.547
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1424.6	G08		6	0001-0056	930.28	56.78	245	59.11	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			619.5	G08		6	0002-0062	146.01	62.35	215	56.77	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			228.6	G08		6	0003-0073	880.87	72.50	278	64.43	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			359.0	G08		6	0004-0082	78.92	81.60	182	51.94	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			712.0	G08		6	0005-0093	752.88	94.14	288	67.01	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1458.7	G08		6	0006-0112	641.80	112.21	197	57.60	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			778.6	G08		6	0007-0120	317.19	120.41	213	53.11	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			292.4	G08		6	0008-0124	828.85	124.44	232	71.98	0.563
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1865.3	G08		6	0009-0133	761.87	133.64	241	61.01	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			237.9	G08		6	0010-0139	111.89	138.66	274	63.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			499.0	G08		6	0011-0145	96.13	144.50	281	64.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2140.3	G08		6	0012-0150	731.23	150.14	297	66.18	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			432.6	G08		6	0013-0153	946.07	153.21	217	55.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			394.0	G08		6	0014-0157	818.91	157.09	266	65.01	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			330.2	G08		6	0015-0177	35.63	176.53	252	61.11	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			485.1	G08		6	0016-0179	810.78	179.02	141	59.60	0.499
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			378.9	G08		6	0017-0183	491.89	183.08	192	56.43	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1725.2	G08		6	0018-0187	116.46	188.41	137	46.63	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1675.6	G08		6	0019-0200	117.38	199.99	117	41.80	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2181.8	G08		6	0020-0220	67.60	220.10	243	57.70	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			885.9	G08		6	0021-0225	588.78	225.28	263	64.43	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			253.0	G08		6	0022-0261	649.15	261.19	225	59.70	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			301.8	G08		6	0023-0323	648.24	322.86	229	59.94	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			832.9	G08		6	0024-0328	763.41	329.02	193	57.11	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1414.2	G08		6	0025-0339	100.89	339.06	230	57.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1290.3	G08		6	0026-0347	418.78	347.62	272	65.60	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			279.1	G08		6	0027-0369	308.09	369.43	309	66.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			945.3	G08		6	0028-0373	11.55	373.61	238	63.11	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			664.7	G08		6	0029-0373	577.93	372.96	231	62.63	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			485.0	G08		6	0030-0403	351.02	403.11	335	70.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1933.3	G08		6	0031-0413	837.42	412.60	249	59.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			282.5	G08		6	0032-0418	255.47	418.73	301	69.01	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			819.9	G08		6	0033-0426	394.41	426.17	186	53.46	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1951.1	G08		6	0034-0432	873.70	432.07	251	60.53	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1227.7	G08		6	0035-0454	596.99	454.12	299	82.91	0.547
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			587.9	G08		6	0036-0486	26.23	486.05	202	55.11	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			561.1	G08		6	0037-0513	579.88	512.79	289	64.53	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			367.6	G08		6	0038-0542	313.65	541.48	130	43.94	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			355.1	G08		6	0039-0546	303.22	547.24	144	45.11	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1175.8	G08		6	0040-0554	190.36	554.58	209	53.36	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			282.6	G08		6	0041-0567	183.14	566.73	172	51.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			213.9	G08		6	0042-0568	321.68	568.31	295	65.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			794.1	G08		6	0043-0582	382.57	582.43	275	67.70	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			249.9	G08		6	0044-0604	753.16	604.08	233	58.53	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1584.1	G08		6	0045-0611	859.18	611.21	210	59.36	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			304.1	G08		6	0046-0612	890.31	612.54	187	57.94	0.700
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1110.4	G08		6	0047-0614	613.01	614.72	215	56.87	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			241.5	G08		6	0048-0640	352.25	639.51	291	66.43	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			257.5	G08		6	0049-0646	575.91	645.49	232	59.60	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			303.0	G08		6	0050-0650	617.75	651.14	208	57.84	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			385.0	G08		6	0051-0653	123.89	653.61	205	60.53	0.703
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			263.0	G08		6	0052-0677	466.12	677.74	244	59.94	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			279.7	G08		6	0053-0686	593.53	685.73	205	59.94	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			264.8	G08		6	0054-0691	513.60	691.38	248	61.60	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			202.9	G08		6	0055-0700	351.11	699.46	279	62.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			486.1	G08		6	0056-0709	218.08	709.28	259	60.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			4026.7	G08		6	0057-0709	832.68	709.43	206	58.28	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1169.9	G08		7	0001-0053	156.06	53.48	189	52.87	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1646.9	G08		7	0002-0055	530.23	55.22	234	56.87	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			214.8	G08		7	0003-0059	856.52	59.19	222	59.46	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			365.8	G08		7	0004-0066	818.80	66.19	139	61.60	0.460
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			280.4	G08		7	0005-0108	391.66	108.22	211	60.04	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			193.0	G08		7	0006-0106	876.52	106.30	260	62.77	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			315.2	G08		7	0007-0126	468.55	126.58	207	53.11	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			898.9	G08		7	0008-0146	857.50	145.91	227	61.60	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			325.9	G08		7	0009-0151	424.38	151.78	184	51.46	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2667.7	G08		7	0010-0155	165.33	155.02	235	60.53	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			887.3	G08		7	0011-0169	384.99	168.53	333	77.26	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			245.3	G08		7	0012-0218	214.01	218.13	266	65.01	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			272.2	G08		7	0013-0232	844.78	232.79	244	59.94	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2693.9	G08		7	0014-0246	70.36	245.62	187	57.01	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			334.3	G08		7	0015-0269	254.98	267.70	124	52.87	0.557
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			514.1	G08		7	0016-0278	542.09	277.90	194	55.01	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1111.9	G08		7	0017-0285	589.69	285.54	227	55.70	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			875.3	G08		7	0018-0295	792.60	296.21	261	62.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			272.8	G08		7	0019-0312	44.10	311.83	284	64.53	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1137.7	G08		7	0020-0310	581.07	310.05	230	59.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1062.0	G08		7	0021-0318	797.42	318.62	355	71.01	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1356.0	G08		7	0022-0320	20.50	319.46	217	56.28	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			467.9	G08		7	0023-0342	903.18	342.01	285	63.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2023.0	G08		7	0024-0346	432.50	346.92	216	56.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			223.3	G08		7	0025-0359	304.40	359.04	277	66.18	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			404.0	G08		7	0026-0385	226.98	385.39	107	39.46	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			192.6	G08		7	0027-0408	323.36	408.03	298	66.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			226.4	G08		7	0028-0414	130.61	414.08	313	71.50	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1630.3	G08		7	0029-0412	876.71	411.44	249	59.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			396.2	G08		7	0030-0415	227.08	415.55	205	57.01	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			258.6	G08		7	0031-0458	218.58	458.05	226	59.84	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			780.8	G08		7	0032-0465	900.13	464.79	272	63.01	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			387.7	G08		7	0033-0480	673.05	480.64	163	60.18	0.566
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			237.8	G08		7	0034-0483	154.74	483.15	141	46.87	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1069.3	G08		7	0035-0492	825.90	492.18	214	57.36	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			212.2	G08		7	0036-0494	159.32	495.01	131	49.46	0.673
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1369.3	G08		7	0037-0540	317.29	539.62	261	62.53	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			371.4	G08		7	0038-0537	118.17	537.42	196	57.36	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			724.3	G08		7	0039-0548	749.08	548.28	132	45.36	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			666.7	G08		7	0040-0555	541.81	554.98	291	65.26	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			221.3	G08		7	0041-0557	214.72	557.44	222	57.36	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			736.0	G08		7	0042-0555	735.78	555.98	120	42.28	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			461.4	G08		7	0043-0571	865.45	571.98	235	59.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1415.8	G08		7	0044-0581	458.87	581.32	299	65.26	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1776.0	G08		7	0045-0580	338.24	579.59	201	56.04	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			354.4	G08		7	0046-0584	557.07	584.80	257	61.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			352.2	G08		7	0047-0590	146.42	590.52	220	59.21	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			846.3	G08		7	0048-0590	379.40	589.54	316	66.67	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			973.6	G08		7	0049-0587	725.42	587.60	147	45.11	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1051.4	G08		7	0050-0596	715.02	597.07	151	46.87	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			901.2	G08		7	0051-0647	709.92	647.29	279	62.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1070.2	G08		7	0052-0649	283.27	650.15	195	53.94	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1310.3	G08		7	0053-0663	760.22	663.21	252	61.60	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			889.5	G08		7	0054-0665	58.61	665.53	298	63.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			238.7	G08		7	0055-0677	779.19	677.03	238	61.60	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			384.9	G08		7	0056-0692	383.49	691.93	179	49.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			244.8	G08		7	0057-0691	471.18	691.53	195	56.87	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			305.0	G08		8	0001-0031	936.98	31.62	278	65.60	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1840.4	G08		8	0002-0054	801.15	53.88	209	56.87	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			239.6	G08		8	0003-0061	843.75	61.43	216	66.04	0.622
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			818.2	G08		8	0004-0072	744.01	72.77	201	59.70	0.709
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			445.8	G08		8	0005-0110	290.92	109.83	264	63.01	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1159.6	G08		8	0006-0124	868.05	124.44	204	55.36	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			295.1	G08		8	0007-0136	397.97	136.22	279	62.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2142.3	G08		8	0008-0157	297.33	157.19	199	51.11	0.957
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			514.5	G08		8	0009-0177	236.55	176.67	260	64.53	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1281.8	G08		8	0010-0177	353.95	177.55	204	52.28	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			861.8	G08		8	0011-0182	141.63	182.29	215	60.43	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3694.7	G08		8	0012-0184	417.53	184.50	266	63.84	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			608.2	G08		8	0013-0195	580.65	195.20	189	53.11	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			729.1	G08		8	0014-0207	918.96	206.97	220	55.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			865.1	G08		8	0015-0214	236.87	214.53	211	59.01	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1578.7	G08		8	0016-0241	897.47	241.14	199	55.36	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			578.0	G08		8	0017-0260	527.98	260.45	217	56.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3230.7	G08		8	0018-0264	450.21	263.65	272	63.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1279.5	G08		8	0019-0297	861.92	297.03	274	63.94	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			254.9	G08		8	0020-0298	714.96	298.45	291	64.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			469.9	G08		8	0021-0330	699.62	330.32	173	47.46	0.965
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			310.9	G08		8	0022-0334	721.44	334.50	230	69.26	0.603
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			334.8	G08		8	0023-0343	708.13	343.65	123	45.11	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			790.2	G08		8	0024-0356	95.62	357.04	246	59.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			434.9	G08		8	0025-0358	770.82	358.20	230	63.60	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			273.1	G08		8	0026-0376	353.60	378.03	264	77.26	0.556
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			773.1	G08		8	0027-0378	259.72	378.03	213	55.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			758.3	G08		8	0028-0380	688.59	380.85	231	62.77	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			200.8	G08		8	0029-0388	424.72	387.92	305	67.84	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			296.7	G08		8	0030-0393	795.82	392.83	329	69.36	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			499.8	G08		8	0031-0421	214.39	421.11	189	56.53	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2155.4	G08		8	0032-0423	584.17	423.57	283	64.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1411.8	G08		8	0033-0426	527.98	426.91	228	57.70	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2236.3	G08		8	0034-0431	469.27	430.90	295	64.53	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			760.7	G08		8	0035-0446	174.24	446.17	205	59.26	0.734
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			297.1	G08		8	0036-0465	93.35	465.85	268	64.18	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			327.9	G08		8	0037-0478	172.46	478.59	190	52.77	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			672.2	G08		8	0038-0478	451.26	478.26	172	50.18	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			296.4	G08		8	0039-0485	204.35	484.39	245	61.60	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			230.9	G08		8	0040-0493	109.12	493.18	278	65.94	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			200.1	G08		8	0041-0514	550.29	513.57	307	69.94	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1534.1	G08		8	0042-0513	707.35	513.93	288	62.18	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			212.8	G08		8	0043-0518	868.54	518.43	202	61.01	0.682
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1583.8	G08		8	0044-0518	406.70	519.39	142	45.21	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			311.1	G08		8	0045-0536	565.66	536.59	212	64.04	0.650
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1519.6	G08		8	0046-0533	407.92	532.20	168	48.63	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			860.4	G08		8	0047-0534	301.31	534.72	230	59.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2562.0	G08		8	0048-0548	192.92	547.90	260	61.36	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1069.0	G08		8	0049-0556	511.92	556.09	302	66.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			314.1	G08		8	0050-0566	299.97	566.75	193	53.60	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			236.2	G08		8	0051-0580	924.69	579.23	294	65.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			577.8	G08		8	0052-0589	270.62	588.33	268	63.11	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			230.6	G08		8	0053-0595	880.07	594.80	355	73.36	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1141.0	G08		8	0054-0610	218.90	609.47	260	67.84	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			9762.5	G08		8	0055-0621	146.69	622.02	198	57.11	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			343.2	G08		8	0056-0621	290.70	621.09	249	60.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1161.3	G08		8	0057-0639	577.61	640.06	225	62.53	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			317.8	G08		8	0058-0657	135.73	657.10	210	61.70	0.693
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			497.7	G08		8	0059-0652	674.40	652.07	277	69.36	0.724
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1865.7	G08		8	0060-0666	415.93	666.00	171	55.11	0.707
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1387.4	G08		8	0061-0699	370.97	699.10	183	51.70	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5847.6	G08		8	0062-0701	133.33	701.42	195	51.70	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			153.5	G08		8	0063-0709	842.07	709.27	198	51.70	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			278.9	G08		9	0001-0034	31.77	34.33	273	65.01	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			268.0	G08		9	0002-0034	411.40	35.09	286	64.77	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			623.2	G08		9	0003-0040	489.21	39.94	280	65.84	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			470.5	G08		9	0004-0049	727.83	49.69	258	61.11	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			246.5	G08		9	0005-0071	43.56	71.40	286	64.28	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1943.1	G08		9	0006-0103	476.99	103.18	279	61.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			268.7	G08		9	0007-0106	354.74	106.26	246	59.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			617.2	G08		9	0008-0118	570.68	118.15	240	60.53	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3387.0	G08		9	0009-0145	347.01	145.15	199	53.11	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1040.2	G08		9	0010-0148	694.70	149.05	194	59.36	0.692
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1278.2	G08		9	0011-0150	125.25	150.20	225	59.46	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3180.5	G08		9	0012-0157	97.26	157.47	266	59.11	0.957
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			243.7	G08		9	0013-0183	323.97	183.54	246	61.60	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1859.2	G08		9	0014-0194	251.35	194.46	224	57.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			301.9	G08		9	0015-0206	858.14	205.90	261	62.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			742.6	G08		9	0016-0210	14.17	209.59	216	55.60	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2732.8	G08		9	0017-0211	377.37	210.79	172	54.04	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			5134.7	G08		9	0018-0224	388.18	223.96	199	56.53	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2499.7	G08		9	0019-0235	80.57	235.54	201	56.18	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			501.3	G08		9	0020-0244	687.08	243.72	274	63.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			274.0	G08		9	0021-0246	299.45	245.54	343	72.43	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			321.9	G08		9	0022-0255	445.90	255.26	242	57.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1972.4	G08		9	0023-0268	478.14	267.59	245	58.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2155.1	G08		9	0024-0306	621.04	306.21	306	65.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			292.7	G08		9	0025-0336	263.52	336.65	255	77.50	0.534
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1454.6	G08		9	0026-0338	565.15	337.78	294	65.60	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3469.3	G08		9	0027-0352	423.01	352.32	230	57.36	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			487.4	G08		9	0028-0359	647.64	359.30	201	52.04	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1770.1	G08		9	0029-0366	121.04	366.56	347	72.08	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			354.5	G08		9	0030-0371	599.07	371.81	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1472.3	G08		9	0031-0392	112.90	392.27	302	70.18	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			417.4	G08		9	0032-0394	544.89	393.62	265	87.64	0.434
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			357.3	G08		9	0033-0396	427.88	397.25	206	56.77	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			492.4	G08		9	0034-0412	642.60	412.11	280	69.26	0.734
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			3343.2	G08		9	0035-0416	462.97	416.38	197	60.28	0.681
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			243.7	G08		9	0036-0419	369.72	418.83	238	60.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			319.9	G08		9	0037-0428	443.00	427.25	275	64.77	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			293.7	G08		9	0038-0429	515.38	429.72	271	61.70	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			448.2	G08		9	0039-0440	364.69	440.16	252	61.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1208.3	G08		9	0040-0502	687.24	501.40	247	61.36	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1196.8	G08		9	0041-0505	670.84	506.14	206	54.63	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			342.7	G08		9	0042-0526	480.04	525.65	299	66.77	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			206.6	G08		9	0043-0560	241.00	560.24	284	66.77	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			209.6	G08		9	0044-0582	19.55	581.95	287	64.53	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1805.5	G08		9	0045-0581	306.88	581.25	226	58.18	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			1094.4	G08		9	0046-0596	783.57	595.75	266	63.84	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			2256.6	G08		9	0047-0601	698.86	601.44	250	62.53	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			187.4	G08		9	0048-0605	942.34	604.53	260	67.01	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			597.7	G08		9	0049-0613	300.09	612.81	325	66.43	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80002	p21 / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201295	p21			191.8	G08		9	0050-0664	878.63	665.31	280	63.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			860.0	B08		1	0001-0030	113.89	29.84	299	67.60	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1016.0	B08		1	0002-0029	168.91	28.72	294	66.18	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4844.9	B08		1	0003-0033	263.30	34.12	210	55.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			943.3	B08		1	0004-0039	463.46	39.70	310	65.36	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			845.7	B08		1	0005-0040	504.82	41.10	293	68.67	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			629.8	B08		1	0006-0040	720.01	40.44	289	75.74	0.633
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5499.9	B08		1	0007-0041	803.55	41.85	444	87.50	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1974.6	B08		1	0008-0042	418.82	41.04	267	61.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			9060.0	B08		1	0009-0042	87.75	42.02	158	48.63	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1894.1	B08		1	0010-0045	289.33	45.56	376	71.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3595.0	B08		1	0011-0044	589.42	44.68	234	56.28	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2224.2	B08		1	0012-0045	693.34	45.35	223	54.87	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3540.5	B08		1	0013-0042	652.67	42.21	177	52.63	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1268.2	B08		1	0014-0047	771.72	47.09	254	59.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2072.6	B08		1	0015-0051	172.16	51.15	276	61.94	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			995.0	B08		1	0016-0050	534.61	50.03	323	66.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1340.8	B08		1	0017-0053	219.63	53.47	374	71.60	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1896.9	B08		1	0018-0052	134.85	52.43	234	56.53	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3738.9	B08		1	0019-0058	657.13	57.83	342	70.77	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1480.4	B08		1	0020-0061	258.75	61.24	390	73.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1183.2	B08		1	0021-0063	335.34	62.34	338	68.43	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2568.1	B08		1	0022-0062	630.45	62.65	266	64.28	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2808.2	B08		1	0023-0061	68.12	60.80	231	55.11	0.956
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3301.4	B08		1	0024-0069	569.59	69.83	433	81.26	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1278.0	B08		1	0025-0071	383.06	70.47	307	65.36	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4448.8	B08		1	0026-0072	533.10	71.85	285	67.60	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4007.7	B08		1	0027-0075	85.61	75.59	300	66.18	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			749.2	B08		1	0028-0072	179.49	71.47	229	60.28	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			574.8	B08		1	0029-0075	115.54	75.69	250	60.53	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4131.0	B08		1	0030-0081	364.92	80.88	146	47.46	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3705.3	B08		1	0031-0080	619.08	80.64	222	57.94	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2536.0	B08		1	0032-0081	759.36	80.85	245	58.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1779.5	B08		1	0033-0081	321.95	81.50	130	42.63	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1947.2	B08		1	0034-0088	460.95	87.74	314	66.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1400.7	B08		1	0035-0084	310.93	84.24	113	39.80	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2384.2	B08		1	0036-0090	175.85	90.55	267	61.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1798.6	B08		1	0037-0090	214.71	89.20	254	62.77	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1051.7	B08		1	0038-0092	424.90	91.91	289	65.01	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1175.6	B08		1	0039-0091	680.90	91.72	234	58.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2269.5	B08		1	0040-0094	944.76	95.13	265	65.01	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2831.2	B08		1	0041-0095	625.03	94.75	328	69.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3530.3	B08		1	0042-0103	829.16	103.44	270	62.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2516.5	B08		1	0043-0104	239.83	104.03	255	65.26	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5162.0	B08		1	0044-0104	882.82	104.11	328	67.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1871.2	B08		1	0045-0110	922.35	110.33	335	73.84	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			682.3	B08		1	0046-0109	293.74	110.26	248	62.77	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1106.3	B08		1	0047-0112	493.79	112.96	362	71.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1257.1	B08		1	0048-0114	778.16	114.52	464	84.43	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			636.8	B08		1	0049-0116	112.41	116.63	359	88.08	0.581
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2232.1	B08		1	0050-0116	259.31	115.12	221	56.77	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2614.2	B08		1	0051-0116	647.23	117.24	258	60.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3086.0	B08		1	0052-0117	677.05	116.66	246	60.77	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2799.9	B08		1	0053-0121	836.66	121.20	367	74.18	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1686.7	B08		1	0054-0122	164.49	121.49	263	63.01	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1411.6	B08		1	0055-0120	281.99	120.20	154	46.53	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3616.1	B08		1	0056-0125	949.09	125.05	224	54.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2013.1	B08		1	0057-0128	199.33	128.54	327	68.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1970.4	B08		1	0058-0126	268.66	127.47	256	63.50	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1274.1	B08		1	0059-0129	408.85	128.58	321	73.50	0.747
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2944.8	B08		1	0060-0132	426.69	132.76	233	57.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1750.3	B08		1	0061-0136	630.94	135.58	383	73.94	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3015.4	B08		1	0062-0137	26.05	136.99	233	57.60	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			797.2	B08		1	0063-0137	373.17	137.60	319	72.91	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2466.4	B08		1	0064-0139	329.68	138.96	328	66.18	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3903.2	B08		1	0065-0140	731.73	139.63	294	63.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1947.4	B08		1	0066-0148	178.70	148.16	375	71.84	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3240.4	B08		1	0067-0146	940.07	145.73	218	55.36	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1128.5	B08		1	0068-0149	527.48	149.03	352	71.60	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2120.8	B08		1	0069-0149	37.87	149.11	235	57.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1344.9	B08		1	0070-0150	469.38	149.40	312	67.11	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2339.7	B08		1	0071-0150	596.87	150.27	252	60.53	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			848.2	B08		1	0072-0152	796.78	151.98	299	66.18	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2180.6	B08		1	0073-0159	225.58	157.45	570	99.74	0.720
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1001.5	B08		1	0074-0155	282.20	154.87	260	62.18	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			10558.2	B08		1	0075-0157	632.64	157.02	313	76.43	0.673
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2126.0	B08		1	0076-0158	153.69	157.45	204	55.70	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4175.8	B08		1	0077-0163	328.00	163.42	260	61.01	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1906.6	B08		1	0078-0163	125.94	162.81	221	58.77	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1974.0	B08		1	0079-0165	582.66	164.81	259	59.01	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2080.2	B08		1	0080-0168	806.15	168.59	186	50.28	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1251.4	B08		1	0081-0173	353.97	173.37	375	73.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3007.7	B08		1	0082-0176	393.44	175.46	308	66.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5605.3	B08		1	0083-0181	81.01	179.70	679	108.81	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1552.7	B08		1	0084-0181	37.82	180.94	317	68.67	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2171.0	B08		1	0085-0183	495.13	183.84	242	61.11	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2197.1	B08		1	0086-0186	183.20	185.11	281	70.77	0.705
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1274.1	B08		1	0087-0183	529.17	183.34	292	66.77	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			11532.6	B08		1	0088-0188	592.87	187.56	324	71.26	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1727.4	B08		1	0089-0188	151.31	188.09	239	63.01	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1119.8	B08		1	0090-0186	472.32	186.20	273	62.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6821.3	B08		1	0091-0190	645.42	190.40	355	72.77	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2650.6	B08		1	0092-0189	740.53	189.40	262	61.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3994.8	B08		1	0093-0189	916.61	189.99	213	55.94	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3928.0	B08		1	0094-0199	661.63	199.51	212	54.53	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1270.0	B08		1	0095-0202	325.65	202.00	219	55.36	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1606.1	B08		1	0096-0203	781.21	202.87	198	52.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1971.6	B08		1	0097-0207	126.70	206.94	259	64.43	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2412.8	B08		1	0098-0208	842.96	208.21	277	62.53	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3585.9	B08		1	0099-0207	893.22	207.79	217	56.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2758.1	B08		1	0100-0211	47.78	209.92	245	71.84	0.597
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2365.1	B08		1	0101-0214	541.25	215.01	299	63.94	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1383.3	B08		1	0102-0214	757.81	214.78	388	73.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2406.4	B08		1	0103-0216	410.24	216.66	161	46.77	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			637.9	B08		1	0104-0223	491.65	222.90	275	63.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3754.9	B08		1	0105-0224	660.52	224.84	193	55.70	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4030.7	B08		1	0106-0227	19.25	227.66	223	54.77	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1929.2	B08		1	0107-0228	641.43	228.26	277	63.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1790.4	B08		1	0108-0230	932.04	229.58	285	68.67	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1413.2	B08		1	0109-0231	142.62	231.60	386	74.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2550.5	B08		1	0110-0230	561.73	229.80	229	55.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2172.5	B08		1	0111-0232	381.62	230.95	268	61.11	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2616.4	B08		1	0112-0230	462.01	230.23	249	61.11	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3809.2	B08		1	0113-0233	211.55	233.28	153	48.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1407.5	B08		1	0114-0243	589.35	243.57	309	68.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4748.6	B08		1	0115-0246	199.44	247.53	276	74.43	0.626
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3668.8	B08		1	0116-0244	317.01	244.90	203	53.11	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2286.9	B08		1	0117-0248	76.81	248.53	326	67.01	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2779.6	B08		1	0118-0247	524.13	246.74	325	66.18	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1500.8	B08		1	0119-0247	711.89	247.02	255	60.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2513.9	B08		1	0120-0248	409.52	248.96	336	67.60	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1988.6	B08		1	0121-0249	739.54	249.33	291	62.18	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2220.4	B08		1	0122-0250	840.18	251.21	283	64.43	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1911.6	B08		1	0123-0247	102.44	248.22	225	58.28	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4438.3	B08		1	0124-0252	47.31	252.01	327	67.26	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1842.5	B08		1	0125-0251	779.24	251.24	413	77.84	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2425.1	B08		1	0126-0257	151.50	256.98	248	61.36	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1532.7	B08		1	0127-0260	804.47	259.44	328	74.18	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3241.9	B08		1	0128-0261	359.21	260.93	227	57.94	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2412.9	B08		1	0129-0264	229.84	263.90	281	63.94	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2364.7	B08		1	0130-0263	576.99	262.76	251	59.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			10807.1	B08		1	0131-0263	342.33	262.78	170	48.28	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1010.8	B08		1	0132-0265	453.23	264.74	269	63.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1485.1	B08		1	0133-0267	184.02	266.99	243	60.53	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5115.4	B08		1	0134-0271	400.65	271.07	303	64.43	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			9842.4	B08		1	0135-0282	715.90	282.51	614	104.57	0.706
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1295.6	B08		1	0136-0278	136.40	278.88	316	67.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			706.6	B08		1	0137-0276	499.36	276.36	316	67.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3984.1	B08		1	0138-0278	325.49	278.13	242	57.11	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2908.0	B08		1	0139-0279	115.90	278.85	204	52.53	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5093.2	B08		1	0140-0280	248.03	279.94	274	63.70	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6592.9	B08		1	0141-0280	233.47	280.45	153	47.56	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2845.6	B08		1	0142-0283	831.39	284.12	232	58.77	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3055.3	B08		1	0143-0289	784.07	289.05	364	71.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2715.9	B08		1	0144-0285	871.41	284.96	211	56.04	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1345.3	B08		1	0145-0290	63.79	289.94	259	61.94	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3892.3	B08		1	0146-0294	198.94	293.80	275	68.77	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2737.6	B08		1	0147-0295	251.29	295.72	194	54.53	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1614.0	B08		1	0148-0293	442.69	293.36	247	58.28	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3181.3	B08		1	0149-0295	947.72	294.55	176	50.18	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1712.0	B08		1	0150-0299	539.19	299.01	298	64.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1214.0	B08		1	0151-0299	361.35	299.51	251	57.70	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1047.1	B08		1	0152-0298	577.27	297.82	248	60.53	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1896.6	B08		1	0153-0300	153.20	300.76	218	54.53	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1403.3	B08		1	0154-0304	861.89	303.83	366	74.53	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3140.0	B08		1	0155-0308	69.46	309.04	291	69.60	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2206.3	B08		1	0156-0307	940.82	307.36	244	61.60	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6433.7	B08		1	0157-0306	775.28	306.47	235	57.60	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2744.4	B08		1	0158-0309	925.21	309.35	226	56.28	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1155.3	B08		1	0159-0309	318.39	309.17	272	61.36	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1611.4	B08		1	0160-0314	651.65	313.60	420	79.50	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2084.6	B08		1	0161-0312	467.93	312.35	213	54.28	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			911.9	B08		1	0162-0317	437.95	317.77	267	64.53	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1557.6	B08		1	0163-0318	698.19	319.21	278	66.53	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1681.9	B08		1	0164-0322	42.02	322.21	328	67.94	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			7071.4	B08		1	0165-0320	770.32	320.36	168	53.36	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4415.0	B08		1	0166-0327	754.43	327.63	324	66.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2833.0	B08		1	0167-0326	246.13	326.12	244	58.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1849.5	B08		1	0168-0330	596.47	330.76	289	65.60	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2841.1	B08		1	0169-0330	195.74	329.79	222	56.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2411.1	B08		1	0170-0331	512.72	332.12	223	57.11	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6765.8	B08		1	0171-0336	874.34	337.08	218	56.77	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1321.3	B08		1	0172-0340	922.60	340.37	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3564.1	B08		1	0173-0341	99.15	341.72	292	64.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1705.8	B08		1	0174-0341	120.32	340.55	219	53.11	0.976
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1203.9	B08		1	0175-0342	317.87	341.87	240	57.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2079.7	B08		1	0176-0344	477.32	345.31	233	58.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			943.8	B08		1	0177-0343	360.24	343.09	266	60.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1814.0	B08		1	0178-0348	187.38	348.07	297	64.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1244.7	B08		1	0179-0347	401.52	347.12	252	62.18	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1863.7	B08		1	0180-0348	451.21	348.03	240	59.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2057.4	B08		1	0181-0350	819.68	350.80	359	70.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			962.4	B08		1	0182-0357	235.83	357.38	253	60.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4019.7	B08		1	0183-0356	496.35	355.69	222	57.36	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3402.3	B08		1	0184-0358	158.02	357.54	284	62.43	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			932.3	B08		1	0185-0357	671.00	357.74	234	55.94	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3634.8	B08		1	0186-0359	721.04	359.92	342	71.84	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			662.7	B08		1	0187-0360	752.93	360.36	252	59.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2094.8	B08		1	0188-0365	470.68	365.36	211	57.36	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3252.0	B08		1	0189-0369	836.38	369.52	373	72.53	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5221.7	B08		1	0190-0368	510.44	367.95	374	72.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1729.3	B08		1	0191-0368	29.10	368.35	287	63.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3020.5	B08		1	0192-0368	85.72	368.45	306	65.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1128.3	B08		1	0193-0369	285.20	368.86	294	63.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4023.9	B08		1	0194-0369	644.13	368.90	224	53.70	0.976
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5603.4	B08		1	0195-0371	882.48	372.11	301	84.08	0.535
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6799.2	B08		1	0196-0372	342.42	372.83	297	62.43	0.958
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2966.6	B08		1	0197-0377	903.49	377.77	282	62.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2242.6	B08		1	0198-0382	236.02	382.05	232	61.01	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			736.8	B08		1	0199-0381	465.07	380.93	279	62.18	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1381.8	B08		1	0200-0382	422.53	381.58	245	57.01	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1095.6	B08		1	0201-0384	59.38	384.08	255	60.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2292.5	B08		1	0202-0382	204.75	382.54	279	65.60	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2122.6	B08		1	0203-0384	656.24	384.72	261	60.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1136.1	B08		1	0204-0387	568.05	386.72	328	69.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2345.2	B08		1	0205-0391	518.32	391.39	283	61.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2114.5	B08		1	0206-0390	169.49	389.75	206	54.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			546.6	B08		1	0207-0395	261.77	395.35	279	63.60	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1362.6	B08		1	0208-0395	803.93	394.56	282	63.94	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1338.1	B08		1	0209-0397	83.60	397.43	279	63.36	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2784.6	B08		1	0210-0404	36.94	403.87	278	63.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2297.2	B08		1	0211-0407	730.02	407.84	315	66.18	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1365.3	B08		1	0212-0408	843.73	407.57	293	64.18	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			919.7	B08		1	0213-0410	440.38	410.24	296	63.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1662.1	B08		1	0214-0410	550.82	411.36	275	66.43	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3840.7	B08		1	0215-0413	243.15	413.15	243	60.18	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1894.5	B08		1	0216-0413	516.77	413.09	281	62.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2311.1	B08		1	0217-0413	808.27	412.54	221	53.94	0.954
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			924.9	B08		1	0218-0414	919.87	414.30	185	55.60	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1833.1	B08		1	0219-0416	79.17	416.04	377	71.94	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1978.3	B08		1	0220-0418	163.55	418.03	252	61.36	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1728.0	B08		1	0221-0421	785.55	421.04	344	69.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1866.1	B08		1	0222-0422	409.14	422.85	249	63.01	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2057.3	B08		1	0223-0423	497.98	423.57	253	59.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3035.6	B08		1	0224-0424	532.48	424.18	237	58.04	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1722.5	B08		1	0225-0424	26.41	423.48	304	69.01	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4351.1	B08		1	0226-0426	354.97	425.99	314	67.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2980.5	B08		1	0227-0423	871.09	422.31	179	50.87	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3514.6	B08		1	0228-0427	250.22	427.44	230	57.70	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2666.5	B08		1	0229-0430	206.78	429.65	150	48.28	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3620.2	B08		1	0230-0433	719.33	433.69	222	55.70	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4786.5	B08		1	0231-0434	267.33	434.36	214	54.28	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2703.6	B08		1	0232-0437	480.58	437.58	240	60.18	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5837.8	B08		1	0233-0440	939.21	439.67	353	68.18	0.954
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6206.4	B08		1	0234-0439	609.39	439.19	305	65.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1305.3	B08		1	0235-0441	87.56	441.59	397	78.77	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3933.1	B08		1	0236-0444	313.31	444.10	226	55.60	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			840.6	B08		1	0237-0449	566.89	449.14	471	87.74	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1743.0	B08		1	0238-0447	895.02	446.89	305	64.18	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4475.6	B08		1	0239-0451	447.93	451.30	249	59.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2905.9	B08		1	0240-0452	203.76	451.83	338	69.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			695.5	B08		1	0241-0452	707.34	452.53	248	58.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			574.9	B08		1	0242-0455	138.82	455.82	272	61.11	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1372.1	B08		1	0243-0455	169.80	454.52	249	57.94	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			805.6	B08		1	0244-0455	764.11	454.42	229	57.60	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2089.6	B08		1	0245-0460	338.08	460.12	261	59.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1926.2	B08		1	0246-0458	522.70	457.57	260	71.36	0.642
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2186.8	B08		1	0247-0462	684.36	462.23	245	58.53	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			15284.1	B08		1	0248-0461	929.63	463.41	105	54.28	0.448
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2067.5	B08		1	0249-0463	266.08	463.29	234	56.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1590.6	B08		1	0250-0462	371.30	462.35	222	54.28	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			912.7	B08		1	0251-0465	192.92	465.25	236	56.77	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1263.9	B08		1	0252-0469	19.74	469.00	232	58.18	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			749.9	B08		1	0253-0468	56.76	468.68	245	59.70	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			8215.6	B08		1	0254-0473	454.50	473.71	359	71.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			825.2	B08		1	0255-0471	784.17	470.63	284	63.01	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1245.2	B08		1	0256-0471	889.75	471.18	283	62.28	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			12146.3	B08		1	0257-0476	110.21	476.73	284	80.67	0.548
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2663.9	B08		1	0258-0477	231.35	477.52	324	67.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2272.5	B08		1	0259-0477	939.35	477.30	305	64.18	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			11421.1	B08		1	0260-0489	638.05	489.37	596	101.64	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1236.7	B08		1	0261-0485	756.79	486.02	376	71.84	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1008.2	B08		1	0262-0487	288.53	487.51	264	65.01	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2549.0	B08		1	0263-0486	314.59	485.45	245	59.94	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			655.9	B08		1	0264-0485	553.80	484.53	283	67.36	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1789.0	B08		1	0265-0484	369.54	483.67	268	64.28	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1016.4	B08		1	0266-0491	519.97	491.55	338	72.67	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2433.6	B08		1	0267-0497	99.83	497.16	370	71.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1300.2	B08		1	0268-0498	409.74	499.31	354	71.01	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1449.3	B08		1	0269-0498	872.62	499.24	184	54.18	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1725.8	B08		1	0270-0500	148.78	500.06	228	57.36	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1168.9	B08		1	0271-0503	468.71	503.63	320	68.43	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3082.6	B08		1	0272-0503	77.11	502.93	272	61.11	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			690.4	B08		1	0273-0505	268.93	504.90	270	68.43	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3656.8	B08		1	0274-0509	305.30	509.88	233	57.94	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4988.6	B08		1	0275-0517	207.07	517.49	344	71.01	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1731.7	B08		1	0276-0519	598.46	519.13	290	66.43	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1841.4	B08		1	0277-0518	854.85	517.24	228	61.11	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2397.6	B08		1	0278-0521	933.70	520.66	393	76.43	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2777.3	B08		1	0279-0520	166.61	520.71	241	58.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2392.4	B08		1	0280-0521	238.19	521.80	373	71.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			891.3	B08		1	0281-0521	411.27	521.04	435	79.26	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			965.0	B08		1	0282-0526	563.97	525.63	293	69.01	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1234.6	B08		1	0283-0522	34.32	522.15	220	58.77	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3494.1	B08		1	0284-0523	332.36	523.14	263	59.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1495.6	B08		1	0285-0523	894.77	523.05	222	57.94	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1231.6	B08		1	0286-0527	122.79	526.75	271	60.53	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			411.7	B08		1	0287-0530	535.34	531.28	286	74.67	0.645
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4621.3	B08		1	0288-0525	792.52	525.08	151	48.53	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3329.6	B08		1	0289-0529	377.36	529.29	221	54.53	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1258.3	B08		1	0290-0532	22.59	531.68	118	40.63	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4695.5	B08		1	0291-0534	849.54	533.57	281	64.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			988.1	B08		1	0292-0538	758.80	536.71	288	66.18	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5583.1	B08		1	0293-0538	190.19	539.06	304	68.43	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1497.0	B08		1	0294-0538	155.18	538.33	266	59.94	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			946.3	B08		1	0295-0540	274.52	540.55	302	67.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2432.8	B08		1	0296-0539	584.34	539.26	237	58.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1496.5	B08		1	0297-0541	34.95	541.02	186	53.11	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5115.5	B08		1	0298-0540	246.64	540.12	226	56.28	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1486.7	B08		1	0299-0540	619.66	540.31	228	56.28	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6319.9	B08		1	0300-0546	430.62	546.55	216	53.70	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2292.7	B08		1	0301-0550	48.08	551.22	273	61.11	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2255.7	B08		1	0302-0555	646.66	554.99	394	76.43	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1636.6	B08		1	0303-0551	880.94	551.27	291	63.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5782.9	B08		1	0304-0553	813.38	553.13	188	52.53	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6828.8	B08		1	0305-0557	216.26	557.91	246	60.53	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2316.1	B08		1	0306-0557	115.55	556.04	350	73.01	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1330.2	B08		1	0307-0557	241.89	557.57	344	69.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2041.5	B08		1	0308-0559	407.13	559.18	323	69.01	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3199.0	B08		1	0309-0560	168.93	559.78	333	71.50	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1859.3	B08		1	0310-0556	922.23	556.72	246	58.87	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3865.0	B08		1	0311-0559	458.31	559.38	200	54.53	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2766.6	B08		1	0312-0561	942.12	561.30	280	61.70	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			675.5	B08		1	0313-0565	523.32	564.27	301	67.94	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			845.8	B08		1	0314-0566	762.34	565.33	293	71.50	0.720
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5413.0	B08		1	0315-0564	798.47	565.28	374	85.84	0.638
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3256.6	B08		1	0316-0567	437.78	566.43	249	59.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3379.7	B08		1	0317-0573	192.43	574.30	411	84.33	0.726
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1217.4	B08		1	0318-0569	601.57	568.93	289	69.26	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2126.6	B08		1	0319-0570	381.08	570.75	320	65.60	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2944.0	B08		1	0320-0576	233.09	576.66	252	63.36	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2663.2	B08		1	0321-0575	697.19	575.95	224	56.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1583.9	B08		1	0322-0580	545.77	580.03	344	71.60	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1247.4	B08		1	0323-0577	251.94	576.50	225	55.36	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1659.6	B08		1	0324-0581	58.38	582.52	240	63.60	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			906.4	B08		1	0325-0583	630.98	583.13	273	65.01	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1087.3	B08		1	0326-0585	565.54	585.96	451	83.01	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1845.3	B08		1	0327-0581	463.23	580.17	265	65.11	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5231.0	B08		1	0328-0585	265.66	585.19	263	65.01	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1973.6	B08		1	0329-0588	28.86	587.78	250	61.26	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4236.6	B08		1	0330-0593	115.61	594.13	357	70.18	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			990.5	B08		1	0331-0591	593.95	590.81	268	66.67	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2227.4	B08		1	0332-0591	143.19	591.45	241	57.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1312.7	B08		1	0333-0592	225.25	592.21	260	62.53	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1702.7	B08		1	0334-0594	384.87	594.79	297	66.18	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6540.7	B08		1	0335-0597	284.93	597.01	365	71.26	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2859.3	B08		1	0336-0594	674.84	594.10	229	56.53	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5003.7	B08		1	0337-0592	712.12	592.96	178	51.21	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1747.0	B08		1	0338-0605	414.43	604.17	293	66.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1146.3	B08		1	0339-0605	806.30	605.10	223	55.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3410.7	B08		1	0340-0607	592.13	607.88	231	55.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2022.3	B08		1	0341-0609	744.09	608.82	287	62.77	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			870.4	B08		1	0342-0611	273.89	611.90	251	60.77	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1922.4	B08		1	0343-0612	849.76	611.86	288	65.01	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3268.5	B08		1	0344-0613	153.75	612.82	195	55.36	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2056.6	B08		1	0345-0614	302.75	614.32	232	55.70	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2955.8	B08		1	0346-0616	76.07	616.27	260	59.94	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3008.3	B08		1	0347-0618	198.86	617.72	200	57.60	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2506.0	B08		1	0348-0616	901.75	616.17	251	59.94	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1824.8	B08		1	0349-0620	479.57	620.33	262	63.01	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4489.5	B08		1	0350-0619	681.57	619.71	274	61.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5297.7	B08		1	0351-0623	362.48	623.47	330	71.36	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1548.9	B08		1	0352-0630	892.17	629.37	254	61.01	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2498.9	B08		1	0353-0630	162.83	629.67	272	62.53	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			941.8	B08		1	0354-0629	806.37	629.13	187	53.70	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5705.0	B08		1	0355-0635	848.75	635.77	360	72.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1273.4	B08		1	0356-0634	489.75	634.91	317	71.84	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2418.4	B08		1	0357-0634	93.78	634.92	259	59.60	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2618.4	B08		1	0358-0636	243.32	636.51	374	72.67	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1560.7	B08		1	0359-0638	562.17	638.24	302	63.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1754.4	B08		1	0360-0642	508.02	640.75	239	59.60	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1154.6	B08		1	0361-0644	63.05	643.58	112	40.28	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1653.5	B08		1	0362-0644	693.93	644.85	228	56.87	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1330.3	B08		1	0363-0647	734.79	647.28	278	62.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1145.0	B08		1	0364-0650	783.99	651.00	192	58.53	0.704
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1790.3	B08		1	0365-0650	313.67	650.57	254	60.77	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			852.6	B08		1	0366-0649	401.23	648.55	262	61.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3560.6	B08		1	0367-0653	199.09	653.50	315	65.60	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			795.0	B08		1	0368-0653	447.88	652.57	345	68.77	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1619.7	B08		1	0369-0651	74.63	651.70	142	47.11	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5536.1	B08		1	0370-0663	237.20	663.32	593	97.98	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1648.9	B08		1	0371-0654	359.27	653.72	266	61.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1169.7	B08		1	0372-0659	46.25	659.41	273	61.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2694.1	B08		1	0373-0661	180.10	661.22	361	70.43	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1643.5	B08		1	0374-0661	327.81	660.85	284	63.01	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1723.9	B08		1	0375-0662	546.66	662.74	419	79.01	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1174.6	B08		1	0376-0664	121.03	664.38	276	64.18	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2672.4	B08		1	0377-0664	659.96	664.11	233	56.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2472.0	B08		1	0378-0665	939.18	664.58	280	64.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1461.7	B08		1	0379-0673	144.32	672.28	278	65.01	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			12071.2	B08		1	0380-0675	705.98	673.83	168	59.94	0.588
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1697.7	B08		1	0381-0680	166.68	679.72	399	75.84	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2289.0	B08		1	0382-0679	285.98	678.49	255	61.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1367.4	B08		1	0383-0685	536.72	684.90	266	62.53	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3878.0	B08		1	0384-0684	365.64	683.42	216	57.36	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4277.5	B08		1	0385-0685	615.32	684.80	227	56.28	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2559.6	B08		1	0386-0686	309.17	686.79	228	56.28	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1418.5	B08		1	0387-0688	428.60	688.45	236	58.53	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4895.0	B08		1	0388-0688	264.40	688.51	320	67.11	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6150.1	B08		1	0389-0693	352.59	693.35	387	80.91	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			8619.9	B08		1	0390-0688	916.93	687.99	140	47.11	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1528.4	B08		1	0391-0691	104.52	691.01	261	62.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1380.3	B08		1	0392-0693	133.18	692.16	261	63.70	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1086.8	B08		1	0393-0693	653.79	693.70	266	61.60	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5539.1	B08		1	0394-0693	720.47	693.60	320	65.84	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1594.1	B08		1	0395-0697	50.81	697.15	422	77.26	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1545.2	B08		1	0396-0697	878.17	697.43	330	67.01	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			11829.1	B08		1	0397-0697	926.54	697.25	159	47.70	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3256.3	B08		1	0398-0698	944.56	697.57	170	51.11	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			472.4	B08		1	0399-0703	691.43	704.31	281	67.26	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1577.1	B08		1	0400-0706	315.64	706.08	250	63.01	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2267.9	B08		1	0401-0708	492.58	708.06	259	65.01	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1552.7	B08		1	0402-0710	415.79	710.17	212	52.87	0.953
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1790.9	B08		1	0403-0710	233.22	710.48	313	67.11	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4711.9	B08		2	0001-0029	259.68	29.83	527	96.57	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1934.8	B08		2	0002-0033	541.09	33.64	296	71.01	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3289.7	B08		2	0003-0034	151.54	34.40	223	55.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			7028.5	B08		2	0004-0036	220.81	37.59	352	74.67	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1994.5	B08		2	0005-0036	793.54	36.16	268	61.11	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			815.2	B08		2	0006-0036	936.35	36.88	247	59.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1217.7	B08		2	0007-0038	126.12	39.14	253	58.53	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3383.1	B08		2	0008-0039	584.93	39.38	349	71.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5261.2	B08		2	0009-0042	767.09	42.65	281	62.53	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1962.2	B08		2	0010-0042	828.89	42.74	279	65.60	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1589.5	B08		2	0011-0049	53.05	49.74	437	85.26	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3629.9	B08		2	0012-0047	919.83	46.92	347	72.08	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1697.6	B08		2	0013-0046	639.79	45.79	330	68.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			889.6	B08		2	0014-0047	96.27	48.60	394	79.26	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			11816.2	B08		2	0015-0048	735.18	48.81	336	69.01	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1971.0	B08		2	0016-0061	412.86	62.80	586	130.95	0.429
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3299.5	B08		2	0017-0052	199.96	51.48	256	60.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4810.4	B08		2	0018-0058	900.74	58.85	226	57.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2618.5	B08		2	0019-0060	248.56	59.83	237	58.87	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1926.1	B08		2	0020-0067	388.09	66.98	509	92.33	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2953.6	B08		2	0021-0062	828.67	62.91	291	70.18	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1418.1	B08		2	0022-0068	511.07	68.64	316	64.53	0.954
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2141.6	B08		2	0023-0071	734.71	70.64	328	67.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3789.3	B08		2	0024-0068	932.37	68.17	302	64.53	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4309.8	B08		2	0025-0072	673.71	72.26	200	52.53	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2108.7	B08		2	0026-0078	847.67	78.25	315	66.18	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2702.5	B08		2	0027-0081	341.98	81.08	352	81.84	0.660
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1490.2	B08		2	0028-0086	225.89	85.71	231	56.53	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1190.0	B08		2	0029-0093	68.18	93.30	308	80.08	0.603
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1709.5	B08		2	0030-0090	920.38	89.70	417	77.50	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3439.9	B08		2	0031-0089	162.29	89.72	246	60.43	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3946.1	B08		2	0032-0093	563.27	93.05	241	57.70	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			11730.2	B08		2	0033-0096	697.39	95.95	324	66.43	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2321.4	B08		2	0034-0098	37.60	98.62	268	66.18	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1857.6	B08		2	0035-0097	782.11	98.03	395	73.26	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1442.5	B08		2	0036-0095	830.61	94.67	292	64.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2155.1	B08		2	0037-0095	141.99	95.57	298	73.26	0.698
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2565.8	B08		2	0038-0097	604.69	97.28	212	55.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			734.2	B08		2	0039-0102	647.74	101.72	272	61.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3506.9	B08		2	0040-0105	174.15	103.92	313	73.50	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2955.4	B08		2	0041-0104	294.08	103.98	338	70.18	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2085.1	B08		2	0042-0104	885.71	105.02	275	63.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4200.1	B08		2	0043-0114	713.14	113.75	286	61.94	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			948.2	B08		2	0044-0114	828.93	114.14	248	58.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1074.7	B08		2	0045-0119	450.89	118.43	288	67.01	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2141.9	B08		2	0046-0122	931.96	121.35	274	80.57	0.530
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2521.7	B08		2	0047-0123	516.32	123.01	286	63.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2993.6	B08		2	0048-0122	563.25	122.04	263	59.11	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			742.6	B08		2	0049-0128	97.77	128.00	262	60.53	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3549.9	B08		2	0050-0129	42.10	128.79	231	55.36	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1707.5	B08		2	0051-0128	207.62	128.42	259	59.60	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1693.0	B08		2	0052-0133	604.70	133.19	360	70.43	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1351.7	B08		2	0053-0130	759.25	130.71	251	58.18	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1952.3	B08		2	0054-0136	72.94	136.44	208	54.28	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3850.8	B08		2	0055-0137	550.32	136.78	274	61.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			7825.2	B08		2	0056-0137	777.44	137.14	222	55.11	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			8595.0	B08		2	0057-0137	794.18	136.40	218	53.70	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1589.3	B08		2	0058-0145	727.37	145.32	444	78.18	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4541.8	B08		2	0059-0142	874.27	142.34	224	55.36	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2891.9	B08		2	0060-0144	934.42	143.85	249	58.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			802.5	B08		2	0061-0148	155.76	148.52	292	65.84	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2825.7	B08		2	0062-0149	33.25	149.15	222	54.77	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1321.6	B08		2	0063-0150	106.39	149.81	237	57.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1638.6	B08		2	0064-0155	200.80	155.72	393	73.60	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2878.9	B08		2	0065-0155	471.21	154.30	254	59.01	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3852.0	B08		2	0066-0154	558.32	154.44	292	63.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5371.5	B08		2	0067-0154	254.47	153.92	308	67.36	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1253.7	B08		2	0068-0160	620.04	160.01	404	74.43	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3113.2	B08		2	0069-0164	917.28	164.36	356	70.43	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2703.4	B08		2	0070-0164	175.67	164.23	215	55.36	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			985.1	B08		2	0071-0167	665.68	166.85	405	73.94	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			956.7	B08		2	0072-0167	497.26	168.27	252	60.53	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2253.1	B08		2	0073-0168	67.29	167.45	226	57.70	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2338.1	B08		2	0074-0170	262.45	170.60	324	66.18	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1914.0	B08		2	0075-0172	753.94	172.38	431	78.91	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1056.7	B08		2	0076-0173	146.52	173.59	272	67.01	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1572.6	B08		2	0077-0178	596.57	178.25	306	65.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			10775.5	B08		2	0078-0182	240.50	181.00	298	71.26	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1398.1	B08		2	0079-0182	734.11	182.39	234	58.53	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3481.7	B08		2	0080-0185	187.08	185.78	241	57.70	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			829.5	B08		2	0081-0186	122.92	186.07	343	74.67	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			8148.8	B08		2	0082-0188	225.70	188.67	261	62.53	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1022.2	B08		2	0083-0191	677.56	192.15	364	71.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1226.5	B08		2	0084-0189	840.43	189.39	214	53.94	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1674.7	B08		2	0085-0194	563.06	194.27	385	72.18	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			8643.8	B08		2	0086-0199	890.42	197.48	769	109.64	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3540.7	B08		2	0087-0193	258.30	193.27	200	52.77	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1850.5	B08		2	0088-0195	501.35	195.42	397	73.84	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3116.6	B08		2	0089-0203	329.23	203.08	327	67.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1715.0	B08		2	0090-0201	414.67	201.15	261	61.11	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2363.4	B08		2	0091-0203	943.10	202.94	298	63.36	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1205.9	B08		2	0092-0208	723.00	207.81	312	66.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1330.2	B08		2	0093-0208	386.86	207.98	248	58.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			9035.2	B08		2	0094-0215	917.90	216.26	350	78.43	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1650.3	B08		2	0095-0213	164.52	213.57	360	71.01	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			9445.7	B08		2	0096-0210	456.56	209.86	212	53.60	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3971.6	B08		2	0097-0211	269.62	210.63	212	55.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			595.6	B08		2	0098-0211	832.42	210.58	239	59.70	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2945.7	B08		2	0099-0217	693.56	217.43	398	75.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2456.6	B08		2	0100-0214	756.57	214.54	358	71.01	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4374.0	B08		2	0101-0219	443.84	218.95	289	65.60	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1315.3	B08		2	0102-0222	496.94	222.16	260	62.77	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1964.4	B08		2	0103-0228	869.43	228.89	429	80.91	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1535.8	B08		2	0104-0228	674.85	228.32	255	59.94	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1826.6	B08		2	0105-0234	25.12	233.33	292	68.43	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			7872.0	B08		2	0106-0234	179.97	233.59	273	62.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			8552.8	B08		2	0107-0231	759.55	230.71	145	45.56	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			7632.8	B08		2	0108-0232	746.58	232.09	152	44.63	0.959
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1764.9	B08		2	0109-0240	201.34	240.69	354	69.60	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2061.4	B08		2	0110-0242	934.14	243.11	233	57.70	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1145.4	B08		2	0111-0246	816.39	245.60	275	63.84	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2315.9	B08		2	0112-0247	365.66	247.19	372	74.91	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			878.9	B08		2	0113-0249	780.40	249.74	260	63.01	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3218.5	B08		2	0114-0249	297.44	249.34	298	63.36	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1770.2	B08		2	0115-0256	481.04	256.10	403	83.74	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2105.8	B08		2	0116-0254	250.33	253.89	294	62.18	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1926.1	B08		2	0117-0253	66.16	253.85	295	64.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5038.7	B08		2	0118-0252	126.71	252.34	209	53.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4922.8	B08		2	0119-0259	149.90	258.96	393	73.60	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			8153.2	B08		2	0120-0256	537.78	256.26	177	50.28	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6880.7	B08		2	0121-0260	519.45	260.14	348	75.84	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2110.2	B08		2	0122-0259	871.05	259.54	336	67.94	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1090.0	B08		2	0123-0261	412.65	261.32	297	64.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3000.2	B08		2	0124-0260	934.80	260.40	352	73.94	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3513.2	B08		2	0125-0264	282.78	263.77	217	55.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1766.9	B08		2	0126-0264	376.20	263.74	338	74.08	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5045.0	B08		2	0127-0265	343.44	265.30	320	66.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1831.2	B08		2	0128-0269	75.62	269.45	217	57.36	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4822.6	B08		2	0129-0270	241.05	269.89	292	63.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1321.4	B08		2	0130-0273	432.94	273.97	335	74.43	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			722.3	B08		2	0131-0274	761.98	273.08	264	64.53	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1720.4	B08		2	0132-0271	195.98	272.06	227	57.11	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1323.7	B08		2	0133-0274	687.54	274.55	410	79.60	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4525.5	B08		2	0134-0275	830.69	275.44	266	59.94	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			953.2	B08		2	0135-0277	718.89	277.48	276	60.77	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3272.1	B08		2	0136-0281	935.66	281.24	230	56.28	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1326.1	B08		2	0137-0286	67.07	286.17	261	64.18	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5296.6	B08		2	0138-0280	280.48	280.84	127	40.97	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3012.6	B08		2	0139-0289	85.91	287.86	217	55.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6193.8	B08		2	0140-0289	152.32	289.26	336	71.84	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1520.3	B08		2	0141-0293	537.38	292.84	374	74.18	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2200.7	B08		2	0142-0292	678.60	291.79	270	61.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2625.3	B08		2	0143-0296	882.82	296.27	234	59.11	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5981.0	B08		2	0144-0293	280.31	292.82	140	42.63	0.968
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3395.6	B08		2	0145-0298	40.65	298.33	181	49.94	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			7351.0	B08		2	0146-0298	168.05	298.25	178	50.04	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1445.4	B08		2	0147-0303	768.05	302.95	314	67.84	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1141.4	B08		2	0148-0306	818.96	306.25	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1827.1	B08		2	0149-0306	550.67	305.06	341	76.67	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1565.4	B08		2	0150-0306	208.60	307.31	266	62.53	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1815.7	B08		2	0151-0311	33.99	311.18	233	60.18	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1091.9	B08		2	0152-0309	289.20	309.28	199	53.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2478.0	B08		2	0153-0312	18.54	312.73	229	55.70	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1766.8	B08		2	0154-0314	258.62	313.18	237	56.77	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3423.3	B08		2	0155-0313	347.76	313.31	209	54.04	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4822.2	B08		2	0156-0312	363.62	311.97	194	53.46	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4179.2	B08		2	0157-0321	490.22	320.56	399	77.84	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3243.8	B08		2	0158-0323	747.11	323.03	315	69.60	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1942.1	B08		2	0159-0324	590.58	323.80	257	62.28	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2353.5	B08		2	0160-0325	105.60	325.09	308	65.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4130.3	B08		2	0161-0327	604.71	327.85	195	52.63	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1901.5	B08		2	0162-0330	370.30	330.08	241	59.36	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1738.6	B08		2	0163-0331	246.12	331.06	328	68.77	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2523.1	B08		2	0164-0335	620.25	335.80	228	57.94	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			9693.9	B08		2	0165-0338	914.11	337.65	337	69.26	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1861.7	B08		2	0166-0335	393.51	335.78	105	38.63	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1703.3	B08		2	0167-0337	227.09	336.83	153	45.11	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2343.3	B08		2	0168-0339	382.31	339.19	161	47.46	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1846.5	B08		2	0169-0342	57.86	342.30	285	70.77	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1663.3	B08		2	0170-0343	99.70	343.97	255	59.94	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1549.4	B08		2	0171-0346	464.96	346.86	304	68.77	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1297.1	B08		2	0172-0350	422.90	350.26	367	74.43	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1197.3	B08		2	0173-0355	124.11	355.02	258	62.67	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3171.5	B08		2	0174-0361	929.03	360.97	564	97.98	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1270.9	B08		2	0175-0356	543.50	355.84	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2085.7	B08		2	0176-0356	230.26	356.87	241	58.28	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			986.9	B08		2	0177-0359	656.85	359.38	304	65.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2092.8	B08		2	0178-0360	177.76	360.20	279	62.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6251.5	B08		2	0179-0359	626.60	359.51	217	54.28	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			998.5	B08		2	0180-0362	749.40	362.25	293	65.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3402.6	B08		2	0181-0365	65.16	364.96	220	57.94	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			806.5	B08		2	0182-0361	295.52	360.80	227	58.87	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3913.7	B08		2	0183-0367	321.79	367.32	204	54.53	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1379.9	B08		2	0184-0372	494.01	372.56	361	73.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1204.4	B08		2	0185-0380	438.30	380.98	434	80.33	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			626.9	B08		2	0186-0377	680.65	377.04	328	67.70	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			958.1	B08		2	0187-0378	885.68	377.64	448	79.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3664.6	B08		2	0188-0377	155.27	378.24	193	51.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6213.9	B08		2	0189-0382	203.77	382.92	217	64.08	0.664
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2361.0	B08		2	0190-0383	47.43	383.61	293	65.84	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			844.7	B08		2	0191-0389	360.18	390.60	317	79.84	0.625
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2353.4	B08		2	0192-0383	725.92	383.52	256	62.28	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4285.1	B08		2	0193-0393	183.07	392.87	351	71.84	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6724.6	B08		2	0194-0395	779.94	395.27	248	57.36	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2661.4	B08		2	0195-0398	88.89	398.15	280	63.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3583.7	B08		2	0196-0404	140.56	404.60	305	65.36	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3081.0	B08		2	0197-0408	229.43	408.85	175	51.70	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			665.5	B08		2	0198-0413	464.92	411.27	358	79.84	0.706
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			765.3	B08		2	0199-0413	926.13	412.15	263	61.70	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3113.5	B08		2	0200-0412	870.18	412.74	200	51.70	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1503.2	B08		2	0201-0419	156.19	419.70	250	65.36	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1581.7	B08		2	0202-0419	668.32	417.98	380	76.67	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4429.4	B08		2	0203-0421	113.25	420.36	310	69.84	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			8495.6	B08		2	0204-0421	619.70	420.79	195	53.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			669.8	B08		2	0205-0422	731.26	421.55	354	80.91	0.680
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4249.9	B08		2	0206-0422	58.16	422.39	308	66.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1051.1	B08		2	0207-0424	694.88	425.02	328	69.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1661.5	B08		2	0208-0430	509.50	430.00	397	78.67	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1968.9	B08		2	0209-0430	238.31	430.70	262	64.43	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5188.2	B08		2	0210-0434	99.29	433.29	399	81.74	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2196.5	B08		2	0211-0432	192.14	432.66	306	64.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5176.9	B08		2	0212-0433	630.83	432.85	278	61.60	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1171.6	B08		2	0213-0434	768.89	433.81	220	57.46	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1597.8	B08		2	0214-0435	782.32	434.83	214	54.63	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1380.7	B08		2	0215-0442	809.55	442.16	233	61.11	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5561.4	B08		2	0216-0443	32.31	443.20	349	69.01	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			949.1	B08		2	0217-0446	937.21	447.18	437	81.26	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2173.8	B08		2	0218-0440	881.26	440.24	239	59.11	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1479.7	B08		2	0219-0442	399.14	441.87	294	65.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			9353.7	B08		2	0220-0443	117.82	442.56	192	53.11	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1333.6	B08		2	0221-0451	573.60	451.88	375	84.08	0.667
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2107.5	B08		2	0222-0455	172.70	455.66	538	97.15	0.716
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2264.7	B08		2	0223-0447	159.35	447.29	107	39.11	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1882.3	B08		2	0224-0452	504.40	453.06	294	70.43	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3043.1	B08		2	0225-0451	248.87	451.17	219	59.70	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1391.1	B08		2	0226-0460	434.28	461.51	361	74.91	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1311.7	B08		2	0227-0453	465.39	453.60	198	58.63	0.724
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2501.8	B08		2	0228-0457	762.01	457.02	269	63.36	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1973.3	B08		2	0229-0458	127.88	457.68	242	60.18	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2843.1	B08		2	0230-0458	310.68	458.39	250	59.11	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1495.1	B08		2	0231-0464	534.43	464.78	362	73.84	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			14373.6	B08		2	0232-0465	15.86	463.09	121	65.11	0.359
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			922.3	B08		2	0233-0469	221.42	470.41	351	69.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4317.1	B08		2	0234-0470	858.17	471.00	295	63.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6378.6	B08		2	0235-0474	776.93	473.51	149	46.87	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2680.6	B08		2	0236-0481	32.34	481.04	295	63.36	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1715.2	B08		2	0237-0480	596.84	479.91	259	59.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2220.8	B08		2	0238-0481	712.94	481.18	237	56.28	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4003.5	B08		2	0239-0481	811.78	481.81	243	57.36	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			646.3	B08		2	0240-0482	346.62	482.36	157	46.87	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			759.8	B08		2	0241-0485	334.30	485.46	209	58.04	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			992.6	B08		2	0242-0487	401.77	486.60	330	85.98	0.561
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6391.2	B08		2	0243-0484	794.52	484.85	134	44.04	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1417.5	B08		2	0244-0490	268.59	489.77	219	55.70	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			713.4	B08		2	0245-0495	739.34	495.18	514	90.91	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1106.0	B08		2	0246-0489	873.21	488.82	152	47.70	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1522.2	B08		2	0247-0496	912.94	496.14	442	88.57	0.708
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1303.4	B08		2	0248-0498	569.45	497.41	356	72.77	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			767.8	B08		2	0249-0496	153.46	496.54	305	63.36	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1734.6	B08		2	0250-0496	181.71	495.69	317	65.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1750.3	B08		2	0251-0495	689.16	495.01	254	63.36	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1317.6	B08		2	0252-0495	883.61	495.94	150	46.28	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2302.5	B08		2	0253-0508	654.92	508.22	408	73.94	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1998.2	B08		2	0254-0509	417.01	509.34	242	57.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1031.3	B08		2	0255-0512	221.16	512.13	295	65.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2504.9	B08		2	0256-0512	503.00	512.88	347	68.18	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			682.3	B08		2	0257-0517	108.91	517.87	304	71.26	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1785.5	B08		2	0258-0518	598.24	518.38	446	79.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2784.6	B08		2	0259-0519	266.95	518.57	261	62.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			954.5	B08		2	0260-0516	810.10	516.24	257	60.53	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2353.2	B08		2	0261-0516	901.90	515.64	216	56.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1199.9	B08		2	0262-0520	54.58	519.61	347	69.26	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3588.1	B08		2	0263-0517	693.80	518.29	260	60.28	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1699.3	B08		2	0264-0524	26.70	524.17	391	76.77	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1962.9	B08		2	0265-0524	292.11	523.96	313	66.18	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			474.0	B08		2	0266-0527	129.44	527.45	284	64.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3604.6	B08		2	0267-0528	464.51	528.09	334	68.08	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2983.3	B08		2	0268-0527	331.11	526.84	215	55.94	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1065.2	B08		2	0269-0529	767.18	529.22	288	65.11	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1845.8	B08		2	0270-0535	741.89	534.71	357	70.08	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			768.5	B08		2	0271-0534	170.99	534.05	301	68.77	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3212.2	B08		2	0272-0534	898.09	534.73	223	54.77	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2346.8	B08		2	0273-0537	371.82	537.32	366	71.01	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3409.5	B08		2	0274-0537	692.61	537.02	392	78.18	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3188.0	B08		2	0275-0539	311.64	538.90	281	63.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1041.2	B08		2	0276-0540	807.08	541.01	261	62.53	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1648.2	B08		2	0277-0547	92.38	547.24	225	55.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2678.0	B08		2	0278-0551	216.53	551.61	221	54.28	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2617.5	B08		2	0279-0554	258.15	553.87	246	59.11	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1522.5	B08		2	0280-0553	701.75	552.83	276	66.43	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2426.2	B08		2	0281-0560	189.67	560.55	376	75.36	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1767.1	B08		2	0282-0556	419.16	556.52	241	76.67	0.515
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1906.1	B08		2	0283-0557	573.40	556.84	232	56.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4416.5	B08		2	0284-0561	395.29	560.88	517	89.84	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1699.4	B08		2	0285-0557	489.28	557.20	298	73.60	0.691
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5140.8	B08		2	0286-0561	684.81	560.97	284	62.53	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2229.2	B08		2	0287-0563	53.34	564.04	254	64.77	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2753.5	B08		2	0288-0564	34.75	564.91	277	61.11	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1013.8	B08		2	0289-0564	800.42	563.66	262	62.43	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1063.8	B08		2	0290-0565	132.69	565.45	282	60.77	0.960
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3354.7	B08		2	0291-0569	298.45	569.75	305	66.77	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1209.3	B08		2	0292-0566	734.45	566.03	160	46.63	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1862.3	B08		2	0293-0572	546.80	572.13	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			686.5	B08		2	0294-0567	721.99	567.97	117	40.39	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3406.1	B08		2	0295-0569	337.10	569.57	268	62.77	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1702.6	B08		2	0296-0578	823.42	578.32	245	60.18	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1747.0	B08		2	0297-0576	861.26	576.46	224	58.77	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1448.9	B08		2	0298-0582	740.73	581.99	369	77.26	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1212.0	B08		2	0299-0583	563.98	583.98	248	59.46	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1741.4	B08		2	0300-0586	173.73	586.22	307	65.36	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2401.6	B08		2	0301-0583	658.97	583.84	245	57.11	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1177.9	B08		2	0302-0585	793.90	585.11	248	58.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			823.0	B08		2	0303-0590	227.90	590.27	281	63.11	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3697.2	B08		2	0304-0591	99.57	591.34	294	62.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1927.4	B08		2	0305-0593	505.03	593.37	339	69.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2150.0	B08		2	0306-0592	593.21	591.77	223	56.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1065.1	B08		2	0307-0597	133.78	597.69	338	71.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2944.1	B08		2	0308-0597	75.00	597.76	377	73.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1273.8	B08		2	0309-0598	764.49	598.03	268	61.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			784.5	B08		2	0310-0602	262.69	602.14	245	58.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1204.0	B08		2	0311-0603	370.78	603.27	328	68.53	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6418.0	B08		2	0312-0610	883.28	609.88	539	91.15	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3731.4	B08		2	0313-0609	585.95	609.56	224	57.01	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1258.9	B08		2	0314-0613	841.15	613.76	411	79.26	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3884.2	B08		2	0315-0612	936.63	612.62	227	55.94	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1398.8	B08		2	0316-0617	288.69	617.92	377	74.77	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1664.4	B08		2	0317-0614	609.59	615.13	257	63.60	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1180.1	B08		2	0318-0620	799.21	619.85	258	64.28	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1543.2	B08		2	0319-0620	96.60	619.31	283	61.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2497.9	B08		2	0320-0622	162.75	622.53	248	60.28	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			10247.1	B08		2	0321-0633	664.99	632.93	460	84.43	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			8838.6	B08		2	0322-0636	342.57	636.72	552	91.50	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3560.1	B08		2	0323-0632	681.91	632.43	285	65.94	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1573.9	B08		2	0324-0636	909.48	635.73	392	75.84	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1124.7	B08		2	0325-0637	212.47	637.09	316	74.08	0.724
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1240.2	B08		2	0326-0639	419.96	639.41	505	90.57	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5595.8	B08		2	0327-0635	300.04	635.24	160	46.87	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6591.0	B08		2	0328-0634	311.80	633.78	111	39.56	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2256.0	B08		2	0329-0639	774.09	638.73	357	70.43	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1371.6	B08		2	0330-0640	47.64	639.90	268	61.01	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1377.4	B08		2	0331-0644	575.29	645.64	468	86.33	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			933.1	B08		2	0332-0637	497.09	637.30	111	40.04	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5567.1	B08		2	0333-0645	364.75	645.34	289	61.94	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1540.1	B08		2	0334-0652	503.38	652.97	353	73.01	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1113.2	B08		2	0335-0651	433.80	651.83	219	56.77	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2371.5	B08		2	0336-0656	474.14	655.54	417	82.91	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4952.2	B08		2	0337-0653	132.62	653.87	156	47.21	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2562.1	B08		2	0338-0660	148.53	660.75	228	58.53	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1734.5	B08		2	0339-0665	873.42	665.35	320	67.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2259.0	B08		2	0340-0664	794.21	664.84	230	54.77	0.964
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2113.5	B08		2	0341-0664	345.09	664.25	223	59.70	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2158.6	B08		2	0342-0668	31.79	668.05	280	65.60	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3953.8	B08		2	0343-0666	133.65	665.65	163	48.04	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2114.9	B08		2	0344-0673	488.29	673.97	375	76.77	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1894.6	B08		2	0345-0677	471.11	677.26	388	79.26	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1722.9	B08		2	0346-0674	676.26	675.27	352	69.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			339.9	B08		2	0347-0682	833.49	682.02	319	71.60	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			711.1	B08		2	0348-0681	177.91	682.12	282	64.43	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1481.9	B08		2	0349-0684	536.57	684.33	210	54.28	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3548.3	B08		2	0350-0684	270.18	683.97	243	59.11	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3864.8	B08		2	0351-0692	297.50	692.96	233	58.53	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2005.2	B08		2	0352-0688	897.09	688.15	191	53.94	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2823.8	B08		2	0353-0692	388.37	692.13	236	57.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1450.6	B08		2	0354-0695	559.28	695.50	349	71.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			497.4	B08		2	0355-0695	83.03	695.50	268	60.53	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1098.8	B08		2	0356-0697	649.23	697.13	455	80.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2329.0	B08		2	0357-0696	766.83	695.63	319	67.01	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			10582.2	B08		2	0358-0700	19.22	700.80	156	47.46	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			974.7	B08		2	0359-0704	105.76	704.14	283	68.08	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1386.3	B08		2	0360-0701	846.09	700.80	249	58.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2761.8	B08		2	0361-0702	620.75	701.43	199	53.11	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4090.6	B08		2	0362-0702	37.15	701.76	192	53.11	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1396.8	B08		2	0363-0704	937.46	703.67	299	63.84	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1421.8	B08		2	0364-0708	355.31	708.03	272	62.53	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3057.0	B08		2	0365-0708	207.17	708.01	325	66.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2150.2	B08		2	0366-0708	440.81	708.12	253	58.77	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2069.1	B08		2	0367-0710	121.34	709.93	207	56.53	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1722.5	B08		3	0001-0032	174.22	32.04	249	67.01	0.697
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1273.1	B08		3	0002-0031	771.20	30.98	281	63.11	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2695.4	B08		3	0003-0035	76.25	35.00	272	62.53	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			882.5	B08		3	0004-0037	608.80	37.00	478	85.15	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4609.7	B08		3	0005-0036	648.22	35.64	324	66.18	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			693.1	B08		3	0006-0041	489.76	40.64	488	83.98	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			544.2	B08		3	0007-0040	30.61	40.30	250	60.18	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1840.1	B08		3	0008-0043	704.69	44.35	231	60.87	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4176.4	B08		3	0009-0047	530.33	47.51	250	59.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3238.8	B08		3	0010-0054	456.56	54.71	277	61.36	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4296.8	B08		3	0011-0058	476.96	59.41	445	79.50	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6056.1	B08		3	0012-0058	93.16	59.16	330	67.36	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1498.5	B08		3	0013-0055	207.76	54.54	245	60.77	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1887.6	B08		3	0014-0057	753.82	57.12	256	65.70	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2161.3	B08		3	0015-0060	911.18	59.84	358	69.01	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2237.6	B08		3	0016-0062	426.79	61.94	262	59.84	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1022.7	B08		3	0017-0064	817.54	63.85	291	69.60	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2771.8	B08		3	0018-0062	151.02	62.27	218	57.36	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2306.5	B08		3	0019-0063	563.29	63.40	270	65.01	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5370.7	B08		3	0020-0064	397.98	64.32	303	69.70	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6011.7	B08		3	0021-0069	373.29	69.18	358	74.43	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2755.5	B08		3	0022-0070	444.27	70.30	315	71.01	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1666.1	B08		3	0023-0071	685.11	71.36	324	67.36	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3226.8	B08		3	0024-0071	26.79	71.61	292	63.94	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2429.2	B08		3	0025-0078	63.72	77.41	368	76.08	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1913.5	B08		3	0026-0077	152.86	78.01	324	68.18	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1168.9	B08		3	0027-0076	180.82	77.29	251	61.01	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1868.9	B08		3	0028-0084	869.55	83.92	383	84.18	0.679
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5155.4	B08		3	0029-0081	349.15	80.59	353	70.18	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3299.5	B08		3	0030-0079	97.96	78.72	198	53.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1180.5	B08		3	0031-0081	595.59	80.53	323	70.18	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2699.2	B08		3	0032-0080	291.88	80.04	261	59.60	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			390.2	B08		3	0033-0079	750.97	79.77	269	64.43	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4624.3	B08		3	0034-0082	330.41	82.15	181	54.63	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2612.3	B08		3	0035-0087	940.87	86.52	272	61.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2797.9	B08		3	0036-0088	373.60	88.65	217	53.36	0.958
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1541.6	B08		3	0037-0092	638.43	92.74	241	59.60	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4577.9	B08		3	0038-0091	398.46	91.50	215	55.36	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3681.9	B08		3	0039-0093	565.31	92.96	263	62.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1282.2	B08		3	0040-0098	497.76	98.43	517	84.08	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2839.1	B08		3	0041-0094	191.15	94.77	294	63.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1881.6	B08		3	0042-0099	838.70	99.71	305	67.36	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1295.4	B08		3	0043-0098	448.56	98.24	272	63.01	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3886.3	B08		3	0044-0099	241.85	98.73	246	58.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			869.4	B08		3	0045-0103	791.31	103.40	351	70.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2025.5	B08		3	0046-0107	332.07	106.69	355	72.18	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4216.4	B08		3	0047-0105	545.14	104.91	297	63.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1878.1	B08		3	0048-0109	816.08	108.63	189	55.36	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3804.6	B08		3	0049-0110	101.79	110.50	272	61.60	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3374.9	B08		3	0050-0111	216.70	110.96	304	65.01	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			898.4	B08		3	0051-0111	413.08	111.64	277	62.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4499.8	B08		3	0052-0114	920.64	114.63	335	66.77	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6007.3	B08		3	0053-0117	699.14	116.59	301	64.18	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1753.6	B08		3	0054-0123	493.78	122.81	262	60.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1390.4	B08		3	0055-0125	27.26	124.27	249	74.91	0.558
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2143.4	B08		3	0056-0124	546.77	125.24	276	65.01	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1359.0	B08		3	0057-0125	448.58	125.20	208	55.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6431.0	B08		3	0058-0133	739.38	133.47	362	84.67	0.635
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1803.1	B08		3	0059-0131	145.90	131.35	332	68.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5964.5	B08		3	0060-0134	207.45	132.73	501	95.74	0.687
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2042.0	B08		3	0061-0135	350.90	134.26	255	58.77	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2058.0	B08		3	0062-0136	872.25	136.23	326	66.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2368.5	B08		3	0063-0136	625.52	136.69	299	63.11	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4939.6	B08		3	0064-0147	169.60	147.13	413	77.50	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1859.5	B08		3	0065-0144	487.88	143.45	271	61.60	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4320.4	B08		3	0066-0143	536.82	142.94	241	59.36	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4310.1	B08		3	0067-0146	275.38	145.38	227	58.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2493.1	B08		3	0068-0147	28.95	147.38	243	58.18	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1842.5	B08		3	0069-0153	309.34	153.10	345	69.84	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			13314.0	B08		3	0070-0156	204.86	155.46	204	92.81	0.298
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2372.2	B08		3	0071-0156	387.05	156.20	257	60.53	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3699.3	B08		3	0072-0155	469.56	155.29	230	58.77	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1350.1	B08		3	0073-0154	646.67	152.89	117	43.11	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			792.7	B08		3	0074-0160	722.52	160.55	319	75.50	0.703
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1973.0	B08		3	0075-0159	637.21	159.56	218	57.60	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4143.3	B08		3	0076-0159	779.82	159.08	225	56.28	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1662.2	B08		3	0077-0162	914.86	162.86	346	71.84	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4376.6	B08		3	0078-0167	815.28	167.59	368	75.60	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4366.0	B08		3	0079-0169	271.03	171.52	394	86.33	0.664
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2187.7	B08		3	0080-0168	751.03	167.95	468	85.15	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3552.2	B08		3	0081-0169	186.94	169.00	201	54.53	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2932.9	B08		3	0082-0167	695.55	166.22	183	51.94	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2204.2	B08		3	0083-0170	509.31	169.78	270	61.94	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4509.1	B08		3	0084-0175	838.62	175.55	367	82.08	0.684
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2867.1	B08		3	0085-0171	483.51	171.08	214	55.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3170.4	B08		3	0086-0172	684.74	173.33	136	44.53	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1984.1	B08		3	0087-0178	314.28	178.44	403	76.33	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4615.1	B08		3	0088-0177	66.17	177.18	206	53.70	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4280.0	B08		3	0089-0177	102.73	176.82	203	53.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1615.7	B08		3	0090-0179	253.70	178.90	239	63.60	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1425.2	B08		3	0091-0179	554.12	179.02	349	69.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3460.3	B08		3	0092-0179	444.19	179.66	221	53.11	0.984
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3192.6	B08		3	0093-0183	621.51	182.60	365	70.18	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2049.5	B08		3	0094-0185	210.48	185.09	250	60.18	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2129.2	B08		3	0095-0190	876.28	190.12	404	75.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4054.7	B08		3	0096-0188	297.16	188.57	244	58.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			7132.2	B08		3	0097-0188	370.51	188.18	292	67.60	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			8695.7	B08		3	0098-0188	48.45	188.21	160	46.87	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4284.6	B08		3	0099-0191	339.92	191.37	276	61.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1908.8	B08		3	0100-0196	594.81	196.46	314	68.18	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1243.6	B08		3	0101-0199	914.47	198.34	298	66.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1337.8	B08		3	0102-0199	146.75	199.92	273	65.84	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1496.0	B08		3	0103-0202	173.10	202.21	303	65.84	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5774.3	B08		3	0104-0201	280.82	200.74	205	55.11	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2678.0	B08		3	0105-0203	402.51	203.32	287	61.94	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			8594.4	B08		3	0106-0203	628.31	203.10	297	63.01	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4331.1	B08		3	0107-0204	366.33	204.23	184	51.11	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2218.7	B08		3	0108-0207	37.62	206.55	290	63.70	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2330.1	B08		3	0109-0207	893.74	207.76	249	60.43	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1470.2	B08		3	0110-0207	239.23	207.31	240	58.77	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1354.6	B08		3	0111-0208	948.07	208.67	267	60.43	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1176.5	B08		3	0112-0208	75.39	208.20	233	55.94	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			931.8	B08		3	0113-0209	551.99	209.65	257	59.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3600.3	B08		3	0114-0215	332.77	214.78	256	62.18	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2387.1	B08		3	0115-0220	115.19	220.15	386	74.43	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1881.1	B08		3	0116-0222	660.54	222.51	396	76.43	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1807.6	B08		3	0117-0219	850.80	219.39	168	53.36	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1923.0	B08		3	0118-0219	712.14	219.64	223	54.28	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2266.3	B08		3	0119-0221	286.32	222.07	258	61.01	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1590.3	B08		3	0120-0221	794.26	222.20	231	66.43	0.658
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5065.2	B08		3	0121-0224	354.14	224.73	337	69.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6563.9	B08		3	0122-0224	369.58	223.65	158	48.87	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1476.2	B08		3	0123-0227	613.88	227.23	233	58.28	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3018.3	B08		3	0124-0231	675.39	231.75	274	66.77	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6893.2	B08		3	0125-0237	219.89	236.54	310	68.18	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2591.2	B08		3	0126-0234	892.81	234.08	245	57.94	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2104.4	B08		3	0127-0238	828.42	238.70	314	66.18	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1612.9	B08		3	0128-0240	750.33	241.09	427	77.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1459.4	B08		3	0129-0243	411.02	244.58	306	68.18	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3449.3	B08		3	0130-0240	546.09	240.52	318	66.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			7536.7	B08		3	0131-0244	566.82	244.27	300	64.18	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1644.7	B08		3	0132-0242	609.87	242.66	240	57.11	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1798.4	B08		3	0133-0246	923.15	246.57	256	64.18	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1686.9	B08		3	0134-0246	28.55	246.73	236	58.04	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3022.3	B08		3	0135-0247	204.55	247.05	275	63.94	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			849.0	B08		3	0136-0246	363.41	246.31	316	80.08	0.619
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1308.4	B08		3	0137-0249	494.35	248.84	250	59.26	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2839.7	B08		3	0138-0250	706.94	250.18	191	58.77	0.695
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1987.4	B08		3	0139-0256	100.15	256.98	240	66.53	0.681
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4678.1	B08		3	0140-0254	524.48	253.29	231	58.77	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			10769.6	B08		3	0141-0252	723.12	252.69	191	51.11	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3245.2	B08		3	0142-0256	140.11	256.38	229	57.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2675.5	B08		3	0143-0257	158.04	257.32	212	57.36	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1182.9	B08		3	0144-0254	74.64	253.97	230	58.28	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2453.4	B08		3	0145-0256	307.56	255.86	206	54.28	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1686.4	B08		3	0146-0258	260.05	258.96	250	60.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2080.9	B08		3	0147-0265	589.80	263.58	278	65.94	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2521.2	B08		3	0148-0264	29.42	263.98	343	71.94	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1743.8	B08		3	0149-0269	464.95	269.24	284	64.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5161.1	B08		3	0150-0269	534.17	268.97	227	55.94	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3629.4	B08		3	0151-0271	775.21	271.35	302	65.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3903.0	B08		3	0152-0270	794.95	271.04	250	58.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			879.0	B08		3	0153-0275	631.78	274.75	307	69.60	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1099.9	B08		3	0154-0278	240.09	278.70	298	65.01	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3440.6	B08		3	0155-0278	841.64	278.32	175	52.18	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1838.8	B08		3	0156-0281	88.55	280.69	227	57.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2730.4	B08		3	0157-0279	735.63	279.66	312	67.01	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4578.4	B08		3	0158-0283	395.38	282.92	275	65.01	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1807.5	B08		3	0159-0286	274.36	287.66	322	67.60	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3472.8	B08		3	0160-0284	30.22	284.54	225	56.53	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1151.8	B08		3	0161-0286	122.17	287.01	279	63.60	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4069.9	B08		3	0162-0291	459.86	291.26	412	79.26	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4160.3	B08		3	0163-0287	941.61	287.60	362	71.60	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2828.0	B08		3	0164-0287	359.90	286.65	248	65.26	0.732
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3260.9	B08		3	0165-0289	160.78	289.29	255	58.53	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2994.4	B08		3	0166-0289	181.17	289.44	248	59.36	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2567.8	B08		3	0167-0292	833.48	292.34	404	76.67	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1814.4	B08		3	0168-0290	660.97	290.34	213	55.11	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3138.7	B08		3	0169-0292	813.19	291.83	258	64.18	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			829.6	B08		3	0170-0296	420.18	296.51	238	58.28	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2000.7	B08		3	0171-0295	676.56	294.96	235	58.28	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2038.4	B08		3	0172-0301	925.83	300.69	304	66.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1522.5	B08		3	0173-0301	883.05	301.44	343	68.43	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1722.8	B08		3	0174-0301	219.00	301.60	201	56.18	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2942.7	B08		3	0175-0309	106.17	309.78	331	67.84	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1949.6	B08		3	0176-0311	136.06	311.08	235	57.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			989.7	B08		3	0177-0315	459.87	315.36	306	67.84	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3516.6	B08		3	0178-0315	584.40	314.75	368	70.53	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2479.5	B08		3	0179-0316	734.41	316.36	369	73.84	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			977.9	B08		3	0180-0316	187.10	316.32	224	54.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1926.0	B08		3	0181-0318	254.15	318.24	231	57.94	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1922.5	B08		3	0182-0318	651.34	318.24	294	63.94	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2135.1	B08		3	0183-0323	410.89	322.62	364	73.84	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5341.7	B08		3	0184-0329	875.26	329.64	266	60.18	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1069.9	B08		3	0185-0328	286.92	328.69	215	53.70	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1026.1	B08		3	0186-0335	804.34	336.40	317	70.67	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			11809.9	B08		3	0187-0334	360.46	334.07	193	51.11	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			806.5	B08		3	0188-0335	387.43	335.21	269	61.36	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			898.0	B08		3	0189-0335	536.82	335.92	294	64.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1868.2	B08		3	0190-0335	204.81	335.14	228	55.11	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3481.2	B08		3	0191-0338	650.73	337.72	323	67.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4849.8	B08		3	0192-0339	346.72	339.63	174	52.28	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5202.6	B08		3	0193-0341	725.24	341.64	215	54.28	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4520.4	B08		3	0194-0346	243.63	345.99	277	63.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2446.5	B08		3	0195-0345	317.67	345.39	210	58.77	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1402.4	B08		3	0196-0343	107.28	343.76	273	64.18	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1060.7	B08		3	0197-0344	608.80	343.82	285	64.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3520.5	B08		3	0198-0353	291.95	352.69	379	72.43	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4107.8	B08		3	0199-0354	331.61	354.07	229	56.87	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3386.2	B08		3	0200-0355	425.40	355.58	273	62.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			985.5	B08		3	0201-0355	828.37	355.45	372	72.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5919.6	B08		3	0202-0356	19.52	356.46	186	52.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1699.6	B08		3	0203-0358	179.96	357.71	224	55.70	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4598.2	B08		3	0204-0356	347.30	355.98	226	56.87	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2389.3	B08		3	0205-0356	452.60	356.90	253	59.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2369.3	B08		3	0206-0359	402.75	359.21	322	65.94	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2204.2	B08		3	0207-0355	684.95	355.37	203	55.70	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			715.0	B08		3	0208-0357	483.80	358.09	169	51.11	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5349.9	B08		3	0209-0358	112.39	358.32	148	45.46	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2219.2	B08		3	0210-0367	589.51	368.23	600	167.82	0.268
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3514.5	B08		3	0211-0365	513.79	364.74	343	70.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2111.5	B08		3	0212-0362	928.13	361.92	149	49.70	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1380.4	B08		3	0213-0365	165.18	365.39	230	59.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1236.3	B08		3	0214-0369	26.07	370.68	286	71.01	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3739.4	B08		3	0215-0367	315.45	367.37	307	66.43	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4338.1	B08		3	0216-0367	651.27	367.38	319	68.18	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1939.2	B08		3	0217-0371	910.25	370.76	309	70.43	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2441.0	B08		3	0218-0371	875.06	370.77	305	66.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1434.9	B08		3	0219-0371	374.83	371.79	255	60.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3046.6	B08		3	0220-0374	263.29	374.75	348	71.26	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2417.0	B08		3	0221-0377	712.73	377.14	273	63.36	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			988.8	B08		3	0222-0379	762.43	379.09	281	65.01	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2005.1	B08		3	0223-0379	841.85	379.72	226	58.77	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2320.2	B08		3	0224-0379	147.84	379.00	276	64.77	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1575.3	B08		3	0225-0383	54.65	383.69	298	68.18	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2859.0	B08		3	0226-0382	546.20	382.45	304	65.36	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4753.5	B08		3	0227-0383	352.41	382.21	226	57.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1537.3	B08		3	0228-0382	503.03	382.35	258	60.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1865.5	B08		3	0229-0382	89.21	382.66	219	53.70	0.954
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2178.5	B08		3	0230-0384	103.89	384.05	200	57.11	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			7488.5	B08		3	0231-0384	685.58	384.47	259	60.28	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4689.2	B08		3	0232-0389	133.82	389.88	204	54.18	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2959.8	B08		3	0233-0392	335.87	392.05	229	61.11	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2467.1	B08		3	0234-0397	943.98	397.69	349	70.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1148.1	B08		3	0235-0396	248.74	396.06	266	64.77	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3925.3	B08		3	0236-0399	358.81	399.31	264	63.01	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1257.7	B08		3	0237-0396	400.64	395.69	284	70.77	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1319.0	B08		3	0238-0401	869.31	401.46	353	70.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2322.9	B08		3	0239-0399	477.95	398.80	152	47.46	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			10793.7	B08		3	0240-0400	688.60	398.59	162	49.70	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1321.7	B08		3	0241-0409	450.59	409.76	472	81.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			8185.7	B08		3	0242-0406	677.98	406.95	201	54.43	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1305.5	B08		3	0243-0410	59.30	410.76	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2329.3	B08		3	0244-0410	326.43	410.31	290	64.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2088.5	B08		3	0245-0411	187.48	411.62	229	59.01	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1594.1	B08		3	0246-0411	814.94	410.92	258	64.18	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1907.4	B08		3	0247-0413	918.78	412.65	255	61.01	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3938.3	B08		3	0248-0420	645.90	419.43	683	107.30	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2045.3	B08		3	0249-0418	594.22	418.68	419	80.33	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1301.8	B08		3	0250-0418	709.45	418.12	500	89.98	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			428.0	B08		3	0251-0416	20.37	415.64	244	59.36	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1707.4	B08		3	0252-0418	237.53	417.22	230	59.01	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1752.8	B08		3	0253-0418	369.35	417.47	296	64.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1139.0	B08		3	0254-0418	210.59	417.84	204	54.77	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1730.8	B08		3	0255-0419	164.81	418.96	326	69.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3395.2	B08		3	0256-0421	283.97	421.68	294	63.01	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3051.0	B08		3	0257-0425	308.25	424.38	257	60.53	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2280.2	B08		3	0258-0428	786.09	428.42	228	56.77	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2205.2	B08		3	0259-0425	862.34	425.22	116	41.21	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2040.8	B08		3	0260-0432	503.87	432.37	225	59.60	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1469.5	B08		3	0261-0435	408.07	435.04	291	69.60	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2502.5	B08		3	0262-0437	862.54	437.07	128	41.80	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1601.8	B08		3	0263-0442	807.62	442.76	329	75.26	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2371.7	B08		3	0264-0443	888.83	442.33	332	69.26	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3364.7	B08		3	0265-0443	531.39	443.83	328	67.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			913.4	B08		3	0266-0450	31.80	450.55	432	79.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			606.0	B08		3	0267-0449	933.81	450.02	256	61.11	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1340.0	B08		3	0268-0451	72.30	451.27	263	62.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3910.7	B08		3	0269-0453	371.01	453.85	319	68.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2502.6	B08		3	0270-0451	699.44	451.53	254	59.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			838.1	B08		3	0271-0455	185.28	455.49	283	65.01	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			459.6	B08		3	0272-0453	247.81	453.68	216	55.11	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1506.9	B08		3	0273-0455	748.33	454.75	174	50.63	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1443.3	B08		3	0274-0454	759.92	453.92	166	49.80	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4306.1	B08		3	0275-0454	508.66	454.74	219	59.36	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			12921.0	B08		3	0276-0459	681.14	458.94	406	74.67	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1400.2	B08		3	0277-0458	140.86	458.00	306	64.77	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1739.2	B08		3	0278-0458	447.06	457.61	270	62.18	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2101.5	B08		3	0279-0458	311.78	458.48	236	58.18	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3760.9	B08		3	0280-0461	92.82	461.21	289	63.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3053.0	B08		3	0281-0466	276.12	465.89	268	62.77	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1650.3	B08		3	0282-0466	422.12	466.59	247	57.94	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1561.0	B08		3	0283-0469	324.75	469.28	258	60.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2411.6	B08		3	0284-0469	295.54	469.85	274	61.94	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4583.3	B08		3	0285-0473	383.72	473.38	260	61.01	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1108.2	B08		3	0286-0472	836.60	472.36	236	57.11	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2181.9	B08		3	0287-0476	177.39	476.77	357	72.33	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3566.5	B08		3	0288-0474	697.65	474.06	246	57.94	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4734.0	B08		3	0289-0476	722.76	476.66	332	68.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2271.9	B08		3	0290-0475	259.18	475.33	251	59.70	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1856.3	B08		3	0291-0478	204.42	479.05	212	56.77	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1315.4	B08		3	0292-0480	771.22	479.94	365	75.01	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2903.1	B08		3	0293-0480	363.30	480.13	231	56.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2786.8	B08		3	0294-0480	560.68	479.96	209	59.46	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3077.4	B08		3	0295-0484	501.01	484.07	285	62.53	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1143.4	B08		3	0296-0487	51.52	486.82	251	61.70	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2235.3	B08		3	0297-0486	616.39	487.05	226	56.53	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6980.6	B08		3	0298-0487	342.67	487.35	238	57.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1558.4	B08		3	0299-0488	826.68	488.29	293	62.77	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2265.3	B08		3	0300-0490	596.29	489.20	265	63.60	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3257.4	B08		3	0301-0495	558.65	494.36	331	69.94	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5531.0	B08		3	0302-0502	582.49	500.85	221	60.77	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1912.6	B08		3	0303-0500	808.99	500.75	139	45.70	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1304.1	B08		3	0304-0506	271.95	507.29	292	65.36	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4943.3	B08		3	0305-0506	197.87	506.15	325	67.94	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5053.7	B08		3	0306-0504	326.24	504.30	201	54.53	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2721.3	B08		3	0307-0506	749.41	506.57	218	54.87	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3383.3	B08		3	0308-0512	233.99	511.86	404	77.84	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3829.5	B08		3	0309-0508	309.33	507.70	254	59.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2941.8	B08		3	0310-0512	409.95	512.07	328	68.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1869.8	B08		3	0311-0512	920.21	511.04	368	74.43	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			632.4	B08		3	0312-0511	945.71	510.79	299	69.01	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1779.3	B08		3	0313-0513	162.91	512.93	234	55.70	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			503.2	B08		3	0314-0519	641.88	518.69	471	82.08	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1298.9	B08		3	0315-0518	433.87	518.13	300	65.60	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1417.9	B08		3	0316-0515	807.92	515.37	204	53.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2145.9	B08		3	0317-0516	879.29	515.82	275	62.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1975.3	B08		3	0318-0520	468.34	519.83	387	74.18	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1475.1	B08		3	0319-0525	92.32	525.27	242	61.94	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1879.5	B08		3	0320-0528	892.42	527.57	242	59.94	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2335.7	B08		3	0321-0534	563.20	534.52	290	64.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1259.1	B08		3	0322-0538	930.82	537.99	358	70.43	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			973.3	B08		3	0323-0544	338.86	544.18	447	80.08	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2280.5	B08		3	0324-0543	615.93	543.94	313	68.87	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1790.1	B08		3	0325-0545	291.44	545.26	385	74.91	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4562.9	B08		3	0326-0543	687.91	543.10	258	62.43	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2270.8	B08		3	0327-0542	802.99	542.92	224	57.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2194.1	B08		3	0328-0547	65.80	547.79	283	70.53	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1616.4	B08		3	0329-0545	519.42	545.54	393	73.26	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1207.0	B08		3	0330-0548	752.79	547.78	327	67.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2603.8	B08		3	0331-0547	817.45	547.43	200	54.28	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2161.0	B08		3	0332-0555	168.11	555.12	253	58.53	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3142.6	B08		3	0333-0554	206.92	554.21	165	48.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2938.1	B08		3	0334-0557	241.60	557.24	219	55.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			7341.0	B08		3	0335-0558	680.32	558.84	172	50.04	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3455.0	B08		3	0336-0560	260.65	560.75	258	60.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1029.1	B08		3	0337-0560	437.42	560.49	282	66.18	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5585.4	B08		3	0338-0561	383.72	561.24	199	52.28	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			794.3	B08		3	0339-0564	908.31	563.81	257	60.77	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3744.3	B08		3	0340-0563	362.71	562.57	209	53.11	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1418.3	B08		3	0341-0565	113.81	566.31	220	55.70	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1143.7	B08		3	0342-0563	560.33	563.84	161	49.21	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2119.1	B08		3	0343-0574	707.12	574.45	382	76.18	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3705.9	B08		3	0344-0567	729.32	567.42	211	56.87	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			794.9	B08		3	0345-0577	307.82	577.16	266	66.18	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2380.6	B08		3	0346-0574	484.36	573.74	284	64.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2054.4	B08		3	0347-0578	839.35	579.04	248	60.53	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1012.5	B08		3	0348-0574	557.43	574.80	134	51.70	0.630
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3349.8	B08		3	0349-0579	81.38	579.01	225	56.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2088.4	B08		3	0350-0583	166.37	583.62	332	67.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1446.7	B08		3	0351-0583	187.26	583.22	278	61.46	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1591.9	B08		3	0352-0587	388.61	587.01	346	70.91	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1224.4	B08		3	0353-0587	584.27	587.10	318	81.50	0.602
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			7605.8	B08		3	0354-0584	877.49	584.68	133	42.87	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1433.1	B08		3	0355-0588	898.46	588.43	311	67.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2216.3	B08		3	0356-0589	350.30	589.33	209	55.94	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6209.7	B08		3	0357-0588	862.60	588.17	134	44.28	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1064.5	B08		3	0358-0597	844.23	597.76	370	74.67	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6607.8	B08		3	0359-0594	253.57	593.03	169	49.36	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2725.6	B08		3	0360-0595	633.32	595.37	269	61.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1771.8	B08		3	0361-0598	524.68	598.04	293	62.77	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2281.0	B08		3	0362-0599	764.00	599.49	279	73.50	0.649
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1642.7	B08		3	0363-0604	126.58	605.15	339	68.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			7438.4	B08		3	0364-0601	263.36	601.01	180	52.77	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			800.2	B08		3	0365-0605	322.60	606.03	261	62.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			668.6	B08		3	0366-0602	426.77	602.43	267	62.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2904.6	B08		3	0367-0605	554.18	605.19	350	68.18	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4303.0	B08		3	0368-0603	687.74	604.19	132	42.39	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2307.4	B08		3	0369-0607	616.33	606.87	234	59.84	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1676.2	B08		3	0370-0609	487.93	608.84	297	66.43	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1491.5	B08		3	0371-0608	936.57	607.73	257	64.77	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			758.6	B08		3	0372-0614	411.37	614.44	324	66.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			560.8	B08		3	0373-0613	439.78	613.99	280	63.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3087.0	B08		3	0374-0611	721.30	611.18	193	58.77	0.702
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3710.7	B08		3	0375-0615	30.94	616.00	225	55.36	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1661.5	B08		3	0376-0618	339.28	617.59	279	61.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2374.3	B08		3	0377-0620	63.06	620.52	228	58.53	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4772.0	B08		3	0378-0621	692.34	620.81	285	66.53	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3194.1	B08		3	0379-0621	883.29	620.36	279	63.11	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1721.1	B08		3	0380-0623	179.48	623.20	323	67.01	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2133.0	B08		3	0381-0621	232.61	622.39	272	61.11	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1007.9	B08		3	0382-0622	299.86	622.00	314	67.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			8140.3	B08		3	0383-0621	263.45	621.84	183	52.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3187.9	B08		3	0384-0624	603.64	624.42	363	71.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2090.3	B08		3	0385-0625	751.75	625.19	266	63.11	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2247.3	B08		3	0386-0628	812.46	628.17	378	73.01	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2676.1	B08		3	0387-0628	276.37	628.67	229	57.70	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			12243.8	B08		3	0388-0628	556.75	628.93	195	53.46	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1704.0	B08		3	0389-0637	876.35	637.96	295	68.43	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2221.5	B08		3	0390-0637	771.26	636.84	209	55.70	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2738.7	B08		3	0391-0639	114.14	640.11	204	52.87	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1955.4	B08		3	0392-0642	350.54	642.19	281	64.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3387.6	B08		3	0393-0640	514.81	640.74	269	61.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1249.9	B08		3	0394-0643	895.73	643.48	375	73.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1301.5	B08		3	0395-0642	204.93	642.22	248	60.18	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2931.7	B08		3	0396-0640	164.94	640.47	181	51.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			9866.0	B08		3	0397-0642	556.40	641.47	162	48.63	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1338.8	B08		3	0398-0648	659.03	648.60	327	66.18	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5293.5	B08		3	0399-0653	247.53	653.51	371	75.01	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1004.4	B08		3	0400-0654	388.11	654.36	401	76.43	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2120.6	B08		3	0401-0651	946.17	650.54	275	62.53	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			668.0	B08		3	0402-0656	425.26	656.70	372	71.60	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2596.3	B08		3	0403-0657	713.38	657.91	343	69.26	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1405.2	B08		3	0404-0661	108.19	660.40	327	71.36	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2689.1	B08		3	0405-0660	620.19	659.78	295	64.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3689.9	B08		3	0406-0660	553.77	659.85	269	60.53	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1729.1	B08		3	0407-0660	898.74	660.46	275	66.18	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1386.1	B08		3	0408-0661	175.78	660.96	239	61.60	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1638.1	B08		3	0409-0663	830.21	663.20	256	62.18	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1429.2	B08		3	0410-0663	806.27	663.94	252	60.53	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1650.5	B08		3	0411-0669	321.28	668.18	225	57.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1936.5	B08		3	0412-0674	687.29	674.80	384	75.50	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			678.1	B08		3	0413-0673	473.43	673.39	270	61.11	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2787.9	B08		3	0414-0674	732.78	674.35	260	59.11	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1682.5	B08		3	0415-0675	339.94	674.90	231	57.36	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			547.9	B08		3	0416-0680	911.95	680.09	390	111.88	0.392
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3143.4	B08		3	0417-0678	44.44	677.83	235	60.43	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1017.8	B08		3	0418-0681	448.52	681.25	260	61.36	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2779.8	B08		3	0419-0681	250.43	681.15	231	56.53	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1306.6	B08		3	0420-0682	310.84	682.87	248	58.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2920.3	B08		3	0421-0681	600.75	681.92	187	55.46	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3915.7	B08		3	0422-0682	392.98	682.79	147	46.63	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			626.5	B08		3	0423-0691	70.94	690.67	280	73.84	0.645
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			698.4	B08		3	0424-0686	842.30	686.28	245	59.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2019.0	B08		3	0425-0688	171.82	688.70	240	58.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1063.7	B08		3	0426-0691	568.47	691.37	235	62.77	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2805.8	B08		3	0427-0690	817.05	690.09	266	62.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			919.2	B08		3	0428-0693	204.94	693.32	427	79.84	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3004.6	B08		3	0429-0690	520.23	689.89	241	58.53	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1134.1	B08		3	0430-0695	880.75	694.32	235	59.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1167.7	B08		3	0431-0696	240.36	695.66	237	57.60	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2414.3	B08		3	0432-0695	294.42	694.86	346	69.94	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			10768.7	B08		3	0433-0699	599.55	698.54	340	85.01	0.591
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1199.7	B08		3	0434-0697	389.64	697.22	344	71.84	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			899.8	B08		3	0435-0698	119.26	699.23	252	61.26	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1286.1	B08		3	0436-0707	31.70	707.18	300	66.08	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1839.4	B08		3	0437-0708	278.88	708.13	245	57.94	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4959.8	B08		4	0001-0025	601.39	24.22	237	57.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2019.0	B08		4	0002-0026	295.33	26.23	228	57.11	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1473.2	B08		4	0003-0028	414.67	27.91	247	60.53	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5347.6	B08		4	0004-0028	250.53	27.82	319	67.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6907.4	B08		4	0005-0032	338.83	32.81	380	77.84	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1046.8	B08		4	0006-0030	90.85	30.14	263	62.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1073.8	B08		4	0007-0032	119.56	31.29	266	64.53	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1064.2	B08		4	0008-0032	639.87	33.10	275	62.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5859.9	B08		4	0009-0033	706.63	33.30	326	67.26	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			8969.0	B08		4	0010-0027	902.79	26.86	134	46.28	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1619.4	B08		4	0011-0036	37.02	36.05	423	77.26	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1724.5	B08		4	0012-0036	864.18	36.52	334	67.01	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			12876.2	B08		4	0013-0036	912.23	36.29	173	49.46	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3612.3	B08		4	0014-0037	930.80	36.59	178	52.28	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			526.4	B08		4	0015-0043	677.40	43.66	298	68.08	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1771.1	B08		4	0016-0045	301.85	45.54	255	63.01	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1290.4	B08		4	0017-0051	613.77	48.86	342	82.91	0.625
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1005.3	B08		4	0018-0051	75.69	51.44	486	82.08	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2861.0	B08		4	0019-0048	478.80	47.48	271	66.18	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2259.7	B08		4	0020-0047	936.14	47.06	211	59.36	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1862.7	B08		4	0021-0050	401.86	49.78	218	54.53	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2152.7	B08		4	0022-0050	219.40	49.85	318	68.18	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1134.6	B08		4	0023-0058	740.53	58.83	424	78.57	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3915.8	B08		4	0024-0055	14.62	55.08	250	63.36	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1475.9	B08		4	0025-0056	524.41	56.31	353	71.26	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1161.8	B08		4	0026-0058	888.84	59.06	392	75.01	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			9297.8	B08		4	0027-0060	161.25	60.71	268	70.18	0.684
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1727.3	B08		4	0028-0058	312.75	57.64	272	62.53	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1789.5	B08		4	0029-0060	712.81	59.97	208	60.18	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1315.8	B08		4	0030-0062	766.83	63.27	211	54.87	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2291.0	B08		4	0031-0067	475.75	67.22	283	62.28	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1049.5	B08		4	0032-0069	538.58	69.33	492	86.33	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			929.7	B08		4	0033-0067	812.44	67.35	244	59.01	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1149.0	B08		4	0034-0078	318.23	77.48	282	65.01	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4097.4	B08		4	0035-0080	447.27	80.88	269	61.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1681.5	B08		4	0036-0083	227.30	83.62	238	57.70	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2524.9	B08		4	0037-0088	414.50	87.90	319	68.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1242.8	B08		4	0038-0090	269.16	90.06	247	59.70	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1382.1	B08		4	0039-0091	381.61	91.52	302	64.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			760.8	B08		4	0040-0094	159.26	95.10	397	74.08	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			827.9	B08		4	0041-0092	54.99	92.34	244	59.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			11720.3	B08		4	0042-0093	914.93	93.62	295	64.53	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2311.8	B08		4	0043-0097	678.35	97.15	251	59.94	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1673.7	B08		4	0044-0100	209.86	100.34	241	57.11	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1016.7	B08		4	0045-0106	848.60	106.41	340	68.77	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			942.9	B08		4	0046-0104	798.65	103.91	138	47.21	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1017.7	B08		4	0047-0104	810.06	105.10	155	47.21	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1324.0	B08		4	0048-0109	245.63	109.06	236	56.53	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1637.2	B08		4	0049-0113	274.94	112.69	293	69.26	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1292.1	B08		4	0050-0111	326.72	110.87	297	65.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1704.5	B08		4	0051-0119	62.82	119.71	273	61.60	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1442.2	B08		4	0052-0123	742.79	123.25	327	67.94	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2308.0	B08		4	0053-0130	181.11	130.31	271	64.77	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1356.6	B08		4	0054-0129	601.27	129.58	255	63.60	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			13888.0	B08		4	0055-0131	483.49	131.95	328	116.47	0.304
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1093.8	B08		4	0056-0131	714.45	131.62	301	67.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1663.7	B08		4	0057-0133	237.78	133.58	318	66.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1208.9	B08		4	0058-0134	84.87	133.92	219	55.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2136.3	B08		4	0059-0139	381.43	139.74	258	60.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1436.0	B08		4	0060-0141	350.79	140.88	431	83.84	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6773.6	B08		4	0061-0143	205.07	142.99	327	77.50	0.684
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			960.0	B08		4	0062-0141	302.22	141.46	315	73.60	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1099.4	B08		4	0063-0146	540.29	146.95	291	68.77	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1555.5	B08		4	0064-0146	578.61	146.38	219	60.53	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1901.2	B08		4	0065-0146	858.94	145.96	342	69.26	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2374.5	B08		4	0066-0146	610.35	145.78	215	53.46	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3525.0	B08		4	0067-0146	690.83	146.41	168	48.63	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1494.4	B08		4	0068-0154	145.03	154.58	440	78.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3698.0	B08		4	0069-0150	766.39	150.31	307	64.18	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2510.7	B08		4	0070-0149	434.55	149.47	229	58.28	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1287.0	B08		4	0071-0150	941.52	150.18	274	63.11	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1417.6	B08		4	0072-0152	63.41	152.90	231	58.43	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1774.4	B08		4	0073-0154	235.64	154.02	260	59.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1151.3	B08		4	0074-0156	501.76	155.35	336	70.67	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1693.9	B08		4	0075-0157	85.02	157.84	241	57.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5742.3	B08		4	0076-0158	632.22	157.63	165	47.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2273.5	B08		4	0077-0159	100.79	159.94	187	50.63	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2565.6	B08		4	0078-0160	656.24	160.82	256	62.77	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			665.3	B08		4	0079-0170	22.33	169.11	241	60.28	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1201.7	B08		4	0080-0178	791.21	178.94	515	84.91	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1666.0	B08		4	0081-0181	448.03	180.50	247	63.26	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2072.8	B08		4	0082-0182	233.32	181.46	300	68.18	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			997.4	B08		4	0083-0180	310.78	180.92	232	56.28	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1545.5	B08		4	0084-0185	70.87	183.78	239	60.77	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1896.8	B08		4	0085-0186	549.29	186.57	365	70.67	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			888.5	B08		4	0086-0189	897.78	188.80	401	76.08	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1883.7	B08		4	0087-0189	670.54	188.33	240	58.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2583.8	B08		4	0088-0192	286.83	192.36	336	70.08	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4681.0	B08		4	0089-0193	616.47	193.71	205	55.11	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1790.0	B08		4	0090-0199	343.20	198.44	387	74.91	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			725.6	B08		4	0091-0197	474.47	197.98	279	62.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4309.7	B08		4	0092-0200	270.94	200.21	198	54.53	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2683.9	B08		4	0093-0201	515.72	200.27	291	64.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			532.5	B08		4	0094-0203	936.46	203.12	246	60.43	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			392.7	B08		4	0095-0209	22.00	209.14	321	76.18	0.695
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			10827.7	B08		4	0096-0205	578.42	204.94	380	71.36	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2776.6	B08		4	0097-0203	380.38	202.68	222	56.28	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2359.7	B08		4	0098-0204	131.18	204.17	215	55.94	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1890.0	B08		4	0099-0207	617.57	207.58	247	61.70	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3371.0	B08		4	0100-0214	706.96	213.52	297	64.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5124.5	B08		4	0101-0217	272.55	216.54	216	59.36	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1137.6	B08		4	0102-0218	120.50	218.74	275	64.53	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3092.0	B08		4	0103-0223	558.63	223.58	465	84.08	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2610.1	B08		4	0104-0220	86.17	220.59	199	52.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4225.5	B08		4	0105-0222	632.34	222.35	268	62.43	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1935.0	B08		4	0106-0223	422.80	223.32	251	59.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1290.4	B08		4	0107-0228	60.11	227.98	256	60.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1809.5	B08		4	0108-0226	587.53	226.41	257	59.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2943.8	B08		4	0109-0228	479.79	228.88	256	63.01	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1551.7	B08		4	0110-0231	242.52	231.78	371	74.18	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3534.8	B08		4	0111-0231	454.26	230.39	231	55.70	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2400.5	B08		4	0112-0240	795.06	239.85	337	68.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2815.5	B08		4	0113-0239	370.73	238.64	297	64.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6504.6	B08		4	0114-0238	395.07	237.47	198	53.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2740.9	B08		4	0115-0238	31.13	238.21	231	57.36	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1617.0	B08		4	0116-0243	163.34	243.94	364	71.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5071.7	B08		4	0117-0242	542.80	242.93	185	55.46	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3805.4	B08		4	0118-0243	855.25	243.75	187	51.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1736.8	B08		4	0119-0246	261.20	246.46	213	54.53	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2619.8	B08		4	0120-0247	506.41	247.48	233	56.28	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2046.2	B08		4	0121-0253	424.23	252.69	261	61.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2691.4	B08		4	0122-0257	16.82	256.93	287	63.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2307.6	B08		4	0123-0259	587.93	260.00	252	65.01	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			11895.0	B08		4	0124-0255	869.18	255.90	154	73.74	0.356
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4231.3	B08		4	0125-0257	549.07	256.53	179	52.53	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1865.7	B08		4	0126-0259	820.99	259.13	215	56.53	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1141.0	B08		4	0127-0263	896.26	264.51	303	67.60	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3480.5	B08		4	0128-0265	370.12	264.64	226	55.70	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1080.0	B08		4	0129-0272	749.01	271.91	526	86.91	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1398.8	B08		4	0130-0270	108.85	270.49	342	69.60	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1844.3	B08		4	0131-0264	258.33	264.53	181	49.46	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			12703.5	B08		4	0132-0268	199.78	268.16	272	61.36	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6843.8	B08		4	0133-0266	434.03	266.36	181	50.04	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6549.2	B08		4	0134-0270	132.52	270.68	237	57.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			8686.6	B08		4	0135-0272	383.11	270.73	158	51.11	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3161.9	B08		4	0136-0275	601.91	274.79	252	59.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2039.8	B08		4	0137-0278	569.84	278.36	308	65.26	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2593.0	B08		4	0138-0278	50.14	278.38	250	59.11	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2078.8	B08		4	0139-0278	214.25	278.96	272	61.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6065.8	B08		4	0140-0278	396.04	277.77	240	59.60	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2933.0	B08		4	0141-0279	414.23	279.20	221	57.36	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1576.4	B08		4	0142-0287	479.47	286.64	258	61.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2460.3	B08		4	0143-0291	253.75	291.05	235	60.53	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3927.4	B08		4	0144-0290	556.80	290.27	231	61.01	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1008.6	B08		4	0145-0292	804.57	291.33	267	67.94	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1253.9	B08		4	0146-0293	833.47	292.81	236	57.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6780.8	B08		4	0147-0290	116.51	290.99	150	46.87	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5781.0	B08		4	0148-0291	134.88	291.50	224	54.28	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			815.3	B08		4	0149-0295	170.41	295.48	256	59.36	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5495.3	B08		4	0150-0300	79.90	299.71	377	73.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3223.0	B08		4	0151-0297	340.36	297.42	224	65.01	0.666
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2044.8	B08		4	0152-0306	848.96	306.04	363	70.43	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5414.2	B08		4	0153-0305	580.13	305.85	263	61.60	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2092.4	B08		4	0154-0306	266.38	306.65	255	63.70	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2385.6	B08		4	0155-0304	426.22	304.47	293	70.28	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2131.8	B08		4	0156-0308	771.97	308.78	268	61.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1175.6	B08		4	0157-0310	701.07	310.10	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1302.0	B08		4	0158-0314	241.79	314.07	223	55.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2514.7	B08		4	0159-0318	864.87	318.80	329	69.84	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3316.7	B08		4	0160-0316	426.73	316.36	194	54.87	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1509.1	B08		4	0161-0320	304.77	321.14	227	56.28	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3117.0	B08		4	0162-0327	383.06	326.66	361	74.53	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5049.1	B08		4	0163-0332	509.64	331.99	402	77.50	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			602.1	B08		4	0164-0335	204.03	334.75	270	60.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6538.3	B08		4	0165-0344	355.36	343.79	402	75.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1094.6	B08		4	0166-0339	57.70	339.44	229	57.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2337.3	B08		4	0167-0345	257.77	345.48	367	71.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2961.0	B08		4	0168-0348	683.97	347.91	269	62.18	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1187.9	B08		4	0169-0349	923.36	349.53	318	67.01	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1119.3	B08		4	0170-0350	306.71	349.98	262	60.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1821.9	B08		4	0171-0349	798.73	349.42	249	64.18	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4662.7	B08		4	0172-0354	856.66	353.38	287	62.43	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1779.7	B08		4	0173-0354	27.62	354.81	251	69.84	0.647
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1162.5	B08		4	0174-0361	69.30	360.62	363	70.77	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1602.9	B08		4	0175-0361	794.64	361.10	169	49.70	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4278.4	B08		4	0176-0366	871.02	366.20	355	72.18	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1244.0	B08		4	0177-0369	145.55	369.24	223	55.11	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			796.6	B08		4	0178-0381	287.82	381.21	479	88.33	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			634.8	B08		4	0179-0378	334.49	378.08	223	57.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1443.6	B08		4	0180-0384	670.09	383.67	289	64.18	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2500.7	B08		4	0181-0383	851.40	383.37	236	57.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2016.5	B08		4	0182-0383	917.72	383.24	299	64.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4413.4	B08		4	0183-0386	576.32	386.15	240	59.84	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3409.9	B08		4	0184-0387	418.73	387.11	311	64.18	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2805.8	B08		4	0185-0390	124.30	390.25	186	53.36	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			836.9	B08		4	0186-0394	365.20	394.49	281	66.67	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1294.3	B08		4	0187-0391	494.81	391.49	250	62.18	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1625.2	B08		4	0188-0398	183.49	398.08	301	66.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5737.1	B08		4	0189-0400	98.22	399.80	254	77.84	0.527
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3444.9	B08		4	0190-0400	135.37	401.02	223	54.77	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2009.8	B08		4	0191-0405	156.03	405.04	308	66.43	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5055.8	B08		4	0192-0408	821.50	408.19	249	62.77	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5064.0	B08		4	0193-0411	614.01	410.08	287	65.01	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5178.3	B08		4	0194-0410	649.13	410.07	302	67.01	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4610.3	B08		4	0195-0417	395.36	417.62	367	72.67	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			876.7	B08		4	0196-0415	479.20	415.09	240	58.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2375.5	B08		4	0197-0416	556.77	415.96	302	66.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2741.5	B08		4	0198-0417	942.83	416.70	256	59.11	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			974.6	B08		4	0199-0419	913.28	418.81	232	57.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2234.6	B08		4	0200-0427	43.01	427.15	337	67.36	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2330.1	B08		4	0201-0426	245.01	425.35	253	63.36	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5861.8	B08		4	0202-0432	322.69	431.90	417	78.08	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2247.1	B08		4	0203-0430	351.01	431.03	219	58.53	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1854.4	B08		4	0204-0437	619.88	438.32	364	82.43	0.673
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			914.5	B08		4	0205-0437	93.59	437.36	451	82.08	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			787.0	B08		4	0206-0436	698.93	436.19	371	71.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1801.1	B08		4	0207-0440	172.17	439.91	341	68.18	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			953.2	B08		4	0208-0441	829.11	440.75	250	61.11	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2541.6	B08		4	0209-0443	796.47	444.09	188	50.53	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1792.6	B08		4	0210-0449	400.15	449.28	231	57.11	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1967.8	B08		4	0211-0454	763.35	453.28	232	57.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			784.8	B08		4	0212-0458	906.67	457.70	363	71.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5853.4	B08		4	0213-0460	423.06	460.13	251	60.28	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1709.3	B08		4	0214-0461	634.10	461.13	243	57.11	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			792.5	B08		4	0215-0463	862.53	463.11	269	61.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2322.4	B08		4	0216-0465	240.80	466.18	243	59.60	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1281.6	B08		4	0217-0464	500.68	464.47	268	60.87	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6297.5	B08		4	0218-0465	736.76	464.94	140	46.04	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1292.8	B08		4	0219-0467	924.68	467.49	402	74.18	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2138.0	B08		4	0220-0465	106.92	465.57	237	58.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			557.0	B08		4	0221-0473	551.33	473.05	269	63.94	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			8694.2	B08		4	0222-0466	748.72	466.50	110	38.63	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3456.9	B08		4	0223-0472	41.64	471.90	337	70.43	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4878.9	B08		4	0224-0474	434.46	474.20	297	66.77	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4928.6	B08		4	0225-0476	573.17	476.07	272	62.53	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1845.1	B08		4	0226-0478	296.05	477.74	264	63.26	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4300.8	B08		4	0227-0477	587.41	477.46	213	54.63	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2255.2	B08		4	0228-0477	624.85	477.87	249	57.36	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			942.6	B08		4	0229-0478	773.47	478.74	248	62.43	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5456.7	B08		4	0230-0479	751.17	479.18	167	47.11	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1149.3	B08		4	0231-0481	825.06	480.57	285	64.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1899.3	B08		4	0232-0485	189.56	485.76	327	69.60	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1875.5	B08		4	0233-0485	165.66	485.49	220	53.94	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3052.4	B08		4	0234-0487	331.71	486.88	242	60.28	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2421.3	B08		4	0235-0487	404.26	487.00	244	60.53	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			660.3	B08		4	0236-0489	876.92	489.21	241	57.11	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2037.5	B08		4	0237-0487	97.63	488.05	206	58.53	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			650.3	B08		4	0238-0491	603.73	490.85	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1712.5	B08		4	0239-0491	674.89	490.66	282	62.43	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2434.1	B08		4	0240-0491	378.68	492.19	243	59.11	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3615.3	B08		4	0241-0496	123.05	495.88	287	63.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5162.3	B08		4	0242-0494	814.64	495.00	192	53.11	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1072.6	B08		4	0243-0502	713.55	501.65	378	75.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			7720.8	B08		4	0244-0499	510.71	499.10	178	50.87	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			9027.2	B08		4	0245-0502	247.12	501.64	313	66.77	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			695.5	B08		4	0246-0503	465.57	503.07	296	69.36	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5252.0	B08		4	0247-0504	207.05	503.81	213	55.46	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4054.1	B08		4	0248-0505	317.37	506.23	205	58.87	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6584.1	B08		4	0249-0505	526.72	504.67	133	44.04	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1268.2	B08		4	0250-0509	893.48	509.56	256	58.53	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			503.9	B08		4	0251-0510	769.85	509.88	229	57.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1944.7	B08		4	0252-0515	912.53	515.34	272	63.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2316.4	B08		4	0253-0516	166.09	516.56	195	52.53	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3715.0	B08		4	0254-0519	324.07	518.57	206	56.53	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1450.9	B08		4	0255-0523	62.95	523.51	283	62.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4214.9	B08		4	0256-0521	408.93	520.60	252	59.01	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3165.1	B08		4	0257-0523	632.41	523.01	299	65.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2796.9	B08		4	0258-0524	349.28	523.74	255	61.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			7688.3	B08		4	0259-0525	35.65	525.09	254	65.84	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			751.8	B08		4	0260-0525	667.34	525.91	286	66.43	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2331.4	B08		4	0261-0529	219.15	529.19	279	66.43	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4160.2	B08		4	0262-0527	823.19	526.28	182	51.11	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4140.9	B08		4	0263-0529	189.07	529.13	203	53.11	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1141.1	B08		4	0264-0535	305.67	536.40	353	71.94	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1302.4	B08		4	0265-0536	271.64	534.96	247	62.87	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			421.3	B08		4	0266-0538	853.41	538.09	256	62.43	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1339.9	B08		4	0267-0543	519.43	543.96	379	74.67	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2430.3	B08		4	0268-0543	462.46	543.84	146	47.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			955.7	B08		4	0269-0545	612.72	545.77	302	66.67	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2726.4	B08		4	0270-0546	483.70	546.75	285	67.60	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1104.7	B08		4	0271-0546	120.03	546.11	297	64.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			986.8	B08		4	0272-0551	386.36	551.34	382	75.50	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1906.4	B08		4	0273-0545	452.01	545.29	113	39.21	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4037.5	B08		4	0274-0549	826.28	549.64	208	55.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2613.1	B08		4	0275-0553	769.54	553.39	208	57.01	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			516.8	B08		4	0276-0553	896.29	553.02	252	59.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1177.7	B08		4	0277-0556	169.22	558.38	335	78.18	0.689
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			918.6	B08		4	0278-0552	257.75	552.29	134	46.04	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2574.9	B08		4	0279-0555	927.66	554.65	218	53.70	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1075.7	B08		4	0280-0562	695.36	561.59	340	69.84	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2024.0	B08		4	0281-0560	39.92	559.67	217	54.28	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			581.3	B08		4	0282-0559	792.50	558.57	225	55.94	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1419.7	B08		4	0283-0562	661.76	562.49	244	58.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1645.8	B08		4	0284-0566	442.11	565.66	250	59.11	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			10753.4	B08		4	0285-0571	626.34	571.54	350	72.91	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1364.4	B08		4	0286-0573	745.64	573.60	268	64.28	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3880.1	B08		4	0287-0579	202.08	578.90	254	59.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2141.1	B08		4	0288-0580	355.71	580.32	261	71.26	0.646
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1261.0	B08		4	0289-0578	55.91	579.20	240	59.11	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2681.8	B08		4	0290-0584	101.22	583.64	271	62.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1158.4	B08		4	0291-0587	896.46	587.20	239	57.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2429.5	B08		4	0292-0590	503.77	590.15	227	55.70	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			811.2	B08		4	0293-0593	414.11	594.58	329	71.01	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			389.6	B08		4	0294-0594	466.09	594.47	170	48.63	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3185.1	B08		4	0295-0595	631.79	594.98	228	56.28	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1601.7	B08		4	0296-0599	330.30	599.10	240	58.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1441.7	B08		4	0297-0600	878.35	600.18	225	56.87	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2017.8	B08		4	0298-0604	265.33	603.70	313	65.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1248.9	B08		4	0299-0605	521.43	604.79	295	64.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			12071.6	B08		4	0300-0603	612.33	602.58	160	46.87	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1614.5	B08		4	0301-0605	933.74	605.18	223	55.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			417.2	B08		4	0302-0606	483.26	606.68	184	53.36	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3611.5	B08		4	0303-0607	792.06	607.40	263	59.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1724.9	B08		4	0304-0610	238.36	610.41	227	56.28	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2271.0	B08		4	0305-0612	213.73	611.44	215	55.70	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			10321.7	B08		4	0306-0615	619.13	615.35	176	49.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			937.0	B08		4	0307-0622	857.02	622.48	252	59.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2928.1	B08		4	0308-0620	180.51	620.54	198	53.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			816.5	B08		4	0309-0621	647.58	621.74	256	60.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1022.6	B08		4	0310-0626	931.96	626.09	277	71.60	0.679
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2965.2	B08		4	0311-0627	369.29	627.77	272	62.18	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4936.5	B08		4	0312-0628	240.10	627.52	191	51.11	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1901.9	B08		4	0313-0631	112.43	631.22	295	62.77	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3469.1	B08		4	0314-0631	594.04	631.05	250	59.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1326.8	B08		4	0315-0634	396.37	634.05	245	61.60	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1856.3	B08		4	0316-0636	439.91	636.09	375	71.60	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1635.6	B08		4	0317-0638	518.47	638.36	294	65.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			13262.6	B08		4	0318-0638	851.28	638.87	219	54.87	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1752.0	B08		4	0319-0639	71.19	639.60	175	49.80	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3206.6	B08		4	0320-0643	355.90	642.50	300	67.50	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1753.9	B08		4	0321-0643	720.20	643.02	246	59.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1591.9	B08		4	0322-0650	276.52	648.14	493	95.50	0.679
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1883.7	B08		4	0323-0648	471.83	647.96	344	69.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1651.3	B08		4	0324-0643	623.44	642.89	206	61.36	0.688
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			583.8	B08		4	0325-0651	550.39	650.86	460	82.33	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4088.0	B08		4	0326-0649	751.38	649.17	248	62.53	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1103.1	B08		4	0327-0655	677.54	656.14	307	64.18	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1835.3	B08		4	0328-0657	92.49	656.86	234	56.28	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1222.9	B08		4	0329-0665	419.08	665.94	283	62.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3097.6	B08		4	0330-0665	464.09	665.02	258	60.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2535.0	B08		4	0331-0668	138.91	668.35	265	62.18	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3086.6	B08		4	0332-0670	579.98	670.48	218	55.70	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2264.2	B08		4	0333-0669	157.98	669.52	183	52.53	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2013.6	B08		4	0334-0677	304.96	677.31	383	75.01	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3350.7	B08		4	0335-0676	369.06	676.55	337	71.84	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2875.7	B08		4	0336-0676	106.14	676.43	226	57.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2532.4	B08		4	0337-0681	489.96	681.89	293	70.53	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1851.2	B08		4	0338-0679	219.54	679.54	244	57.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			13433.8	B08		4	0339-0682	439.59	681.45	316	65.60	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5312.7	B08		4	0340-0682	341.94	682.00	147	49.11	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3532.5	B08		4	0341-0686	771.81	686.37	246	59.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5783.0	B08		4	0342-0687	352.74	686.86	160	48.87	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			959.9	B08		4	0343-0689	66.90	688.40	228	58.28	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1344.1	B08		4	0344-0695	584.28	694.25	440	78.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1164.0	B08		4	0345-0693	190.14	693.68	257	58.77	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1918.1	B08		4	0346-0694	508.55	695.05	278	66.18	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4544.9	B08		4	0347-0699	91.54	698.54	186	51.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			601.7	B08		4	0348-0701	321.09	700.57	259	61.94	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1459.1	B08		4	0349-0701	852.08	700.68	243	63.01	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1355.3	B08		4	0350-0704	139.10	703.95	232	56.18	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			8313.7	B08		4	0351-0707	82.78	707.84	131	43.11	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3888.6	B08		4	0352-0709	249.40	709.38	245	58.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3455.4	B08		4	0353-0708	826.55	707.85	222	55.36	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4406.4	B08		5	0001-0030	295.53	30.88	233	58.53	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2140.0	B08		5	0002-0025	894.81	25.66	191	53.70	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			481.9	B08		5	0003-0032	81.20	32.85	281	64.43	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3032.4	B08		5	0004-0030	386.33	30.11	243	57.36	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1549.0	B08		5	0005-0033	557.30	33.38	357	71.01	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1242.0	B08		5	0006-0035	647.06	35.19	464	81.50	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2411.6	B08		5	0007-0034	764.63	33.50	320	66.43	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			11994.4	B08		5	0008-0038	17.47	38.56	167	48.28	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1418.8	B08		5	0009-0038	843.73	38.50	257	60.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1122.6	B08		5	0010-0042	103.70	41.70	286	67.01	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3497.0	B08		5	0011-0044	38.23	44.27	412	80.67	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2913.1	B08		5	0012-0040	618.67	39.46	201	53.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1281.7	B08		5	0013-0041	935.18	41.15	306	66.08	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3110.6	B08		5	0014-0045	205.15	45.67	328	68.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1581.8	B08		5	0015-0046	353.28	45.99	285	63.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2516.7	B08		5	0016-0046	438.62	46.09	260	60.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2294.4	B08		5	0017-0047	119.53	46.85	227	64.53	0.685
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3185.1	B08		5	0018-0053	699.81	51.11	402	85.50	0.691
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1592.5	B08		5	0019-0054	728.32	54.59	354	69.26	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2362.0	B08		5	0020-0053	890.76	53.19	218	61.84	0.716
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2633.9	B08		5	0021-0058	502.59	57.05	187	55.01	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1669.6	B08		5	0022-0061	125.53	61.72	186	57.60	0.705
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1920.8	B08		5	0023-0061	392.17	61.28	300	68.77	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2249.9	B08		5	0024-0063	865.42	63.69	284	63.36	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			7572.6	B08		5	0025-0063	445.32	62.52	211	55.11	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1607.2	B08		5	0026-0068	600.83	67.82	454	81.74	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2556.1	B08		5	0027-0065	641.80	65.14	294	62.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2330.7	B08		5	0028-0072	240.01	71.95	365	82.33	0.677
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3623.6	B08		5	0029-0078	458.41	79.37	349	74.67	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1024.2	B08		5	0030-0074	786.62	75.24	278	64.53	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1137.3	B08		5	0031-0083	537.97	83.52	521	87.84	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2904.8	B08		5	0032-0080	179.82	80.24	229	56.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1394.0	B08		5	0033-0081	307.41	81.64	241	59.36	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1442.3	B08		5	0034-0088	583.99	88.43	520	87.50	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1582.0	B08		5	0035-0088	146.95	87.66	229	58.53	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1947.5	B08		5	0036-0087	849.53	86.85	227	55.94	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			717.4	B08		5	0037-0091	693.33	91.22	257	63.60	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1093.9	B08		5	0038-0093	756.68	92.98	318	65.84	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			937.3	B08		5	0039-0093	325.58	92.74	406	75.60	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			11213.7	B08		5	0040-0095	19.60	95.63	297	63.70	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			777.4	B08		5	0041-0096	621.58	96.99	278	64.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1549.0	B08		5	0042-0096	919.57	96.30	211	53.11	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1701.4	B08		5	0043-0099	829.40	98.50	296	63.94	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1915.7	B08		5	0044-0098	366.33	98.06	223	56.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3827.3	B08		5	0045-0102	285.85	102.24	239	58.77	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			957.8	B08		5	0046-0102	477.28	102.34	344	72.43	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2109.6	B08		5	0047-0105	179.89	105.00	227	57.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3897.2	B08		5	0048-0104	387.49	104.30	273	63.36	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2049.4	B08		5	0049-0110	219.10	111.22	376	75.01	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1468.4	B08		5	0050-0115	432.47	114.86	232	56.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1092.0	B08		5	0051-0122	262.18	122.33	412	75.26	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2414.1	B08		5	0052-0121	613.89	121.83	356	69.60	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2410.4	B08		5	0053-0123	124.96	123.50	317	64.77	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1656.0	B08		5	0054-0127	499.69	125.98	329	73.01	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2411.7	B08		5	0055-0125	317.65	125.28	227	55.94	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1365.4	B08		5	0056-0131	934.50	130.73	378	75.50	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1712.4	B08		5	0057-0128	671.91	127.74	201	52.53	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2369.2	B08		5	0058-0129	98.76	129.47	303	69.36	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4136.2	B08		5	0059-0132	181.45	131.89	279	62.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1635.7	B08		5	0060-0135	445.04	135.96	391	73.26	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			961.7	B08		5	0061-0134	731.47	134.75	276	64.18	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1041.3	B08		5	0062-0138	792.76	138.55	261	59.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2717.7	B08		5	0063-0135	814.56	134.93	256	61.70	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2126.6	B08		5	0064-0142	529.19	142.32	257	60.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1613.8	B08		5	0065-0141	863.11	141.44	233	57.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			778.5	B08		5	0066-0142	911.83	142.77	267	63.60	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2845.8	B08		5	0067-0154	221.83	153.34	667	103.64	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3555.5	B08		5	0068-0147	339.76	146.34	344	69.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1421.4	B08		5	0069-0146	572.14	145.82	248	57.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1697.0	B08		5	0070-0147	654.58	147.15	297	64.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1996.3	B08		5	0071-0147	817.26	148.11	194	56.04	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2693.8	B08		5	0072-0149	362.62	149.64	258	63.11	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1479.1	B08		5	0073-0153	468.98	152.96	303	65.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1053.9	B08		5	0074-0152	46.23	152.22	276	62.53	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3141.0	B08		5	0075-0155	326.26	154.69	198	53.60	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4536.6	B08		5	0076-0158	131.27	157.77	294	64.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			813.8	B08		5	0077-0160	412.59	160.42	281	64.53	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1359.3	B08		5	0078-0159	860.83	159.21	240	58.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2448.0	B08		5	0079-0168	300.99	166.56	212	59.11	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1195.3	B08		5	0080-0169	563.53	168.26	300	72.43	0.719
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6480.1	B08		5	0081-0169	283.17	169.11	340	70.77	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1008.9	B08		5	0082-0170	520.66	170.02	368	70.43	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1114.6	B08		5	0083-0173	714.30	172.85	300	76.43	0.645
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1808.9	B08		5	0084-0176	599.34	175.96	280	65.94	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1736.7	B08		5	0085-0177	767.45	177.37	261	62.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6508.8	B08		5	0086-0183	297.78	183.35	207	53.70	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2047.9	B08		5	0087-0188	458.13	187.82	262	61.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6301.5	B08		5	0088-0186	827.90	186.74	189	55.36	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3355.4	B08		5	0089-0190	123.16	189.82	298	64.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3786.6	B08		5	0090-0189	743.36	189.75	238	57.70	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1897.4	B08		5	0091-0191	435.58	190.96	270	59.94	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			864.8	B08		5	0092-0192	688.43	191.92	324	67.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2464.8	B08		5	0093-0195	802.67	195.07	270	67.26	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1911.1	B08		5	0094-0197	379.86	197.12	323	66.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1383.6	B08		5	0095-0200	532.69	199.42	324	68.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5444.7	B08		5	0096-0199	294.42	199.07	185	53.11	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4559.0	B08		5	0097-0201	256.90	201.30	177	48.87	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3733.6	B08		5	0098-0202	489.30	202.45	295	62.77	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			743.3	B08		5	0099-0205	89.56	204.45	266	63.60	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1403.5	B08		5	0100-0202	599.49	200.85	172	53.70	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3216.3	B08		5	0101-0203	855.77	204.11	257	60.28	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			563.3	B08		5	0102-0205	41.27	205.25	244	59.60	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2384.5	B08		5	0103-0209	559.41	208.92	460	83.26	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6062.5	B08		5	0104-0209	818.71	209.27	352	69.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1891.5	B08		5	0105-0212	363.48	212.07	256	61.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2160.1	B08		5	0106-0207	608.13	207.61	120	42.28	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4121.4	B08		5	0107-0213	243.40	213.91	322	69.26	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2073.4	B08		5	0108-0216	625.16	216.59	319	66.18	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1525.9	B08		5	0109-0223	312.51	224.14	373	80.33	0.726
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3340.8	B08		5	0110-0221	154.93	221.42	238	57.70	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1586.8	B08		5	0111-0222	388.83	221.77	269	61.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2498.9	B08		5	0112-0224	462.43	223.48	257	59.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1558.6	B08		5	0113-0227	527.41	227.24	242	57.46	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5724.0	B08		5	0114-0231	138.45	230.97	229	55.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3158.9	B08		5	0115-0231	354.39	231.96	211	54.53	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3978.6	B08		5	0116-0235	717.67	234.91	391	75.01	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2484.3	B08		5	0117-0232	327.87	231.96	209	53.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1553.3	B08		5	0118-0233	485.95	233.10	274	61.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2033.1	B08		5	0119-0234	549.68	234.97	201	53.36	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1421.5	B08		5	0120-0236	920.16	237.33	301	67.84	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2704.8	B08		5	0121-0238	698.47	238.19	231	56.53	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1007.9	B08		5	0122-0243	786.65	243.09	305	70.43	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1223.9	B08		5	0123-0243	182.01	242.88	185	52.53	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			784.4	B08		5	0124-0247	806.30	247.73	346	69.01	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1621.9	B08		5	0125-0248	342.03	248.20	243	61.60	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2007.2	B08		5	0126-0246	747.93	245.72	211	53.70	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			717.0	B08		5	0127-0251	627.61	251.69	278	63.70	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2674.9	B08		5	0128-0251	839.54	251.41	302	67.01	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			993.3	B08		5	0129-0253	672.20	253.35	290	66.67	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1454.6	B08		5	0130-0255	416.23	254.89	359	69.60	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3152.2	B08		5	0131-0257	234.72	258.05	280	62.18	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2298.3	B08		5	0132-0258	926.87	258.22	304	65.01	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3898.0	B08		5	0133-0259	529.60	259.62	179	50.28	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1294.6	B08		5	0134-0263	370.21	262.63	206	54.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1284.6	B08		5	0135-0265	886.90	264.94	301	63.94	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1047.0	B08		5	0136-0267	603.02	266.82	234	57.94	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1527.8	B08		5	0137-0271	722.33	270.70	281	65.26	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			784.0	B08		5	0138-0274	788.48	273.86	302	64.67	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1388.5	B08		5	0139-0274	286.41	274.47	246	58.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1423.4	B08		5	0140-0275	578.73	274.92	399	75.84	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1331.5	B08		5	0141-0278	471.49	278.13	376	72.43	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			824.7	B08		5	0142-0279	763.35	279.52	327	70.77	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6439.3	B08		5	0143-0285	683.06	284.72	557	96.81	0.747
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1700.1	B08		5	0144-0283	157.84	283.31	270	62.28	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3270.2	B08		5	0145-0282	931.41	282.99	332	68.77	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1411.9	B08		5	0146-0285	305.08	285.40	281	66.43	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1597.5	B08		5	0147-0289	855.11	291.27	292	73.26	0.684
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1085.2	B08		5	0148-0292	652.58	292.68	293	64.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1152.4	B08		5	0149-0293	254.65	293.39	363	72.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3353.9	B08		5	0150-0292	351.44	291.95	169	50.53	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1528.5	B08		5	0151-0296	832.99	296.12	326	66.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1427.0	B08		5	0152-0301	386.36	301.03	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1810.3	B08		5	0153-0297	621.94	297.75	232	59.46	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1205.1	B08		5	0154-0306	946.53	306.29	208	58.53	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1054.9	B08		5	0155-0305	480.20	305.32	257	61.94	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2517.9	B08		5	0156-0306	344.77	306.66	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			7104.5	B08		5	0157-0310	929.56	310.24	264	59.36	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1107.0	B08		5	0158-0311	743.22	311.03	377	73.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2755.5	B08		5	0159-0312	518.81	312.77	358	71.01	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1560.9	B08		5	0160-0319	431.69	319.49	278	62.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2379.0	B08		5	0161-0321	867.44	320.62	300	65.01	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3609.8	B08		5	0162-0322	603.54	321.53	290	64.77	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2745.6	B08		5	0163-0324	762.76	324.64	284	64.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1201.5	B08		5	0164-0324	697.15	324.25	312	65.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3604.2	B08		5	0165-0328	256.84	329.58	236	62.77	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2263.7	B08		5	0166-0330	903.78	330.83	318	65.94	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1443.2	B08		5	0167-0332	640.93	332.77	255	59.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			637.5	B08		5	0168-0334	385.47	335.14	313	70.43	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1572.3	B08		5	0169-0339	199.53	339.86	402	79.26	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4240.3	B08		5	0170-0337	336.46	336.80	347	68.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			513.0	B08		5	0171-0337	109.22	337.39	234	55.70	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3066.6	B08		5	0172-0341	728.54	341.60	301	64.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2461.2	B08		5	0173-0348	247.30	348.39	312	73.01	0.735
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1351.4	B08		5	0174-0347	518.90	347.95	266	61.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1436.0	B08		5	0175-0350	550.53	349.87	304	66.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			976.9	B08		5	0176-0351	28.14	351.54	308	65.01	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1777.0	B08		5	0177-0351	671.10	352.07	300	66.43	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1124.8	B08		5	0178-0351	288.63	351.57	242	57.36	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1669.9	B08		5	0179-0353	605.08	353.64	328	67.84	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1323.7	B08		5	0180-0350	388.40	350.64	213	55.70	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2261.7	B08		5	0181-0355	313.02	354.74	290	68.67	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			973.6	B08		5	0182-0363	367.52	363.21	367	73.74	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2710.9	B08		5	0183-0361	868.51	361.52	228	55.70	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1635.2	B08		5	0184-0364	481.68	364.53	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1271.9	B08		5	0185-0366	744.53	366.18	361	73.84	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1487.0	B08		5	0186-0370	155.81	369.80	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1926.6	B08		5	0187-0368	583.87	367.91	293	63.01	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1275.8	B08		5	0188-0369	793.88	369.56	267	62.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1463.8	B08		5	0189-0374	425.48	374.39	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			934.9	B08		5	0190-0376	815.09	375.59	267	71.01	0.665
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5212.7	B08		5	0191-0377	708.52	377.08	346	67.60	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1752.3	B08		5	0192-0379	228.04	379.25	321	67.60	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5391.2	B08		5	0193-0382	762.06	381.50	344	70.18	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1909.9	B08		5	0194-0384	331.51	384.50	264	59.94	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1117.4	B08		5	0195-0383	57.91	383.42	245	60.18	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			953.8	B08		5	0196-0384	638.43	383.82	173	55.36	0.709
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1684.1	B08		5	0197-0385	22.61	385.34	298	64.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			918.1	B08		5	0198-0387	437.65	386.44	260	61.70	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1360.7	B08		5	0199-0387	264.16	387.60	220	54.87	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			649.4	B08		5	0200-0388	941.49	389.46	247	73.26	0.578
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1230.1	B08		5	0201-0387	298.35	387.32	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4431.2	B08		5	0202-0388	545.48	388.10	243	57.70	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5520.6	B08		5	0203-0390	123.06	389.49	212	55.36	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3110.4	B08		5	0204-0390	474.10	389.95	175	51.36	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			453.5	B08		5	0205-0398	374.06	400.10	337	75.60	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1523.9	B08		5	0206-0399	415.64	399.44	436	78.33	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3072.4	B08		5	0207-0397	845.35	396.76	330	67.36	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			856.8	B08		5	0208-0396	924.48	396.26	284	64.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1668.2	B08		5	0209-0400	96.75	399.85	268	60.53	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2614.9	B08		5	0210-0400	184.98	400.23	329	68.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1419.3	B08		5	0211-0402	596.83	402.10	318	65.94	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4737.1	B08		5	0212-0400	767.01	400.97	234	57.11	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1563.5	B08		5	0213-0402	234.24	403.18	236	57.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1035.2	B08		5	0214-0405	880.80	404.72	302	65.84	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1155.4	B08		5	0215-0408	503.17	407.93	387	73.84	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4834.1	B08		5	0216-0412	850.68	411.78	215	55.70	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			754.8	B08		5	0217-0418	295.11	418.75	263	60.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1863.8	B08		5	0218-0417	753.99	417.39	295	65.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2327.7	B08		5	0219-0419	47.72	418.73	257	58.53	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1222.5	B08		5	0220-0418	264.96	418.82	253	58.77	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2431.8	B08		5	0221-0420	553.94	420.70	336	68.08	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			604.4	B08		5	0222-0421	18.23	420.86	230	57.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1232.6	B08		5	0223-0423	649.21	422.77	326	67.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2660.6	B08		5	0224-0419	716.50	418.66	237	59.36	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1958.3	B08		5	0225-0423	159.47	423.16	268	60.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2183.3	B08		5	0226-0425	207.15	424.76	172	50.63	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1545.9	B08		5	0227-0427	249.84	426.62	227	60.18	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			8344.4	B08		5	0228-0427	107.31	427.34	224	63.70	0.694
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			8052.6	B08		5	0229-0429	93.76	430.11	133	48.53	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2393.1	B08		5	0230-0431	771.38	430.11	262	61.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1259.3	B08		5	0231-0434	318.65	433.86	279	61.60	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1701.2	B08		5	0232-0436	825.71	436.90	333	77.26	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2089.7	B08		5	0233-0434	357.52	434.58	213	55.11	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2872.3	B08		5	0234-0436	338.58	436.41	238	56.77	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2429.8	B08		5	0235-0440	453.24	439.97	251	59.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5163.1	B08		5	0236-0440	716.10	440.61	294	67.01	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1407.2	B08		5	0237-0446	893.39	445.58	305	64.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1203.2	B08		5	0238-0446	397.03	446.42	252	59.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3939.2	B08		5	0239-0446	759.84	446.37	329	66.53	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2347.8	B08		5	0240-0453	613.76	454.39	375	73.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			869.7	B08		5	0241-0451	254.41	451.25	265	60.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3470.6	B08		5	0242-0449	646.18	449.41	106	40.04	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			857.9	B08		5	0243-0454	851.35	454.92	285	66.18	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3201.0	B08		5	0244-0454	459.56	455.29	210	58.53	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1500.5	B08		5	0245-0457	416.62	458.31	258	66.28	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1980.4	B08		5	0246-0459	474.40	458.61	271	62.04	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1958.5	B08		5	0247-0463	580.88	463.68	282	64.53	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3678.4	B08		5	0248-0462	679.75	461.14	229	58.77	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2368.3	B08		5	0249-0466	315.02	467.28	416	85.15	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5037.0	B08		5	0250-0466	340.97	464.47	322	79.84	0.635
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3008.2	B08		5	0251-0467	388.98	466.28	351	71.01	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6387.1	B08		5	0252-0464	512.97	464.52	247	58.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			960.7	B08		5	0253-0468	540.87	467.65	321	68.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3336.9	B08		5	0254-0468	712.10	468.59	270	61.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1052.1	B08		5	0255-0469	29.72	469.57	398	73.60	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1389.9	B08		5	0256-0469	164.99	469.79	233	57.94	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2185.0	B08		5	0257-0469	362.12	469.38	203	53.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2591.8	B08		5	0258-0469	881.30	468.81	265	61.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3200.4	B08		5	0259-0476	686.25	474.81	263	66.67	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3933.3	B08		5	0260-0473	210.69	474.10	179	51.11	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3665.2	B08		5	0261-0474	566.06	474.60	193	54.18	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2484.5	B08		5	0262-0477	259.90	477.08	208	61.01	0.702
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1125.8	B08		5	0263-0478	916.21	478.80	260	64.18	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6566.4	B08		5	0264-0484	226.41	484.79	327	75.50	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3470.6	B08		5	0265-0486	669.26	486.42	312	65.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1771.9	B08		5	0266-0487	312.59	487.82	276	63.01	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1328.2	B08		5	0267-0486	388.91	486.62	233	59.36	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3700.8	B08		5	0268-0486	560.86	485.82	117	40.28	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6870.5	B08		5	0269-0495	621.80	496.89	534	92.91	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6894.9	B08		5	0270-0491	782.00	491.75	311	66.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2678.8	B08		5	0271-0491	816.80	492.21	224	56.53	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2958.9	B08		5	0272-0493	248.22	493.46	176	48.87	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1774.2	B08		5	0273-0500	654.32	501.07	277	63.94	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2669.7	B08		5	0274-0503	300.62	504.45	260	62.77	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			8307.7	B08		5	0275-0506	798.25	505.60	326	70.53	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1230.6	B08		5	0276-0505	82.77	505.79	367	73.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3532.7	B08		5	0277-0504	208.16	504.19	201	51.94	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3594.6	B08		5	0278-0509	168.81	509.67	238	62.77	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1886.1	B08		5	0279-0509	454.85	508.90	311	65.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2141.6	B08		5	0280-0510	567.98	510.19	257	60.28	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3439.3	B08		5	0281-0508	251.51	507.81	140	46.39	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2124.8	B08		5	0282-0514	580.97	514.25	225	62.28	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1080.9	B08		5	0283-0513	947.71	513.22	271	60.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5531.8	B08		5	0284-0514	814.93	514.00	223	58.87	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2639.4	B08		5	0285-0515	766.65	516.13	269	60.28	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1746.6	B08		5	0286-0517	17.14	517.56	263	61.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4508.8	B08		5	0287-0518	185.06	519.87	257	64.77	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2054.3	B08		5	0288-0515	907.14	515.25	189	53.36	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1583.8	B08		5	0289-0520	851.89	519.62	257	59.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3204.3	B08		5	0290-0525	152.92	525.78	265	64.53	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3576.5	B08		5	0291-0523	500.45	522.77	313	65.01	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4085.2	B08		5	0292-0521	247.66	521.15	148	44.87	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1966.9	B08		5	0293-0526	310.58	526.06	250	61.36	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3863.4	B08		5	0294-0530	232.78	529.58	310	66.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4816.1	B08		5	0295-0528	699.51	528.23	219	54.87	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3735.4	B08		5	0296-0529	807.78	529.93	285	66.18	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2992.5	B08		5	0297-0529	602.50	528.81	243	57.36	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1770.3	B08		5	0298-0530	464.02	530.85	276	63.94	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3142.9	B08		5	0299-0535	526.23	535.26	278	62.53	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5145.4	B08		5	0300-0534	194.17	534.36	146	49.46	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1147.3	B08		5	0301-0537	631.59	536.87	273	62.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3585.0	B08		5	0302-0538	203.78	538.71	112	38.39	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1646.6	B08		5	0303-0541	943.14	542.26	251	61.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3184.5	B08		5	0304-0544	285.41	544.89	227	58.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3092.1	B08		5	0305-0542	66.73	542.40	222	54.53	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			935.5	B08		5	0306-0545	394.84	545.45	237	57.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2693.3	B08		5	0307-0547	416.32	546.55	299	65.60	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2743.1	B08		5	0308-0549	501.07	550.03	257	67.01	0.719
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1335.5	B08		5	0309-0548	914.84	547.20	322	67.60	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			898.2	B08		5	0310-0547	861.68	547.45	240	58.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1207.4	B08		5	0311-0550	333.81	549.73	238	60.43	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3516.8	B08		5	0312-0552	96.40	551.94	339	71.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2511.8	B08		5	0313-0550	271.40	550.14	145	47.70	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2966.4	B08		5	0314-0558	159.75	557.98	250	57.94	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2565.4	B08		5	0315-0557	32.26	556.67	214	53.70	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3069.0	B08		5	0316-0560	226.45	559.89	257	66.77	0.724
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1298.5	B08		5	0317-0563	884.68	563.30	252	60.53	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1749.9	B08		5	0318-0563	187.93	563.47	259	60.18	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1000.7	B08		5	0319-0566	488.24	566.76	425	80.43	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			855.7	B08		5	0320-0567	726.77	566.37	288	65.01	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4678.3	B08		5	0321-0570	782.32	570.74	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			788.6	B08		5	0322-0572	138.28	572.28	266	60.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1021.5	B08		5	0323-0577	605.38	577.36	304	65.01	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2845.9	B08		5	0324-0577	257.41	577.32	212	53.36	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1518.4	B08		5	0325-0584	826.31	584.13	267	61.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2050.9	B08		5	0326-0589	905.56	588.89	251	63.60	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2322.9	B08		5	0327-0591	303.02	590.39	204	53.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1103.9	B08		5	0328-0592	671.11	592.34	289	61.94	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1440.4	B08		5	0329-0594	218.77	593.42	285	65.01	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1874.2	B08		5	0330-0593	842.59	593.52	206	53.94	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2406.3	B08		5	0331-0597	890.09	598.13	215	55.70	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3423.5	B08		5	0332-0601	172.79	601.25	348	76.67	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3056.6	B08		5	0333-0602	495.55	601.80	263	59.60	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1674.0	B08		5	0334-0602	698.64	601.29	225	56.53	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1940.4	B08		5	0335-0605	348.19	605.29	285	67.50	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1234.2	B08		5	0336-0606	585.00	606.28	382	74.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1650.9	B08		5	0337-0607	38.14	607.31	229	58.18	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3278.8	B08		5	0338-0610	540.02	609.60	234	59.01	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1987.5	B08		5	0339-0610	417.90	610.62	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1299.8	B08		5	0340-0612	509.01	612.46	249	59.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2053.7	B08		5	0341-0611	793.96	611.55	308	64.77	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			7538.0	B08		5	0342-0614	923.70	614.42	241	56.77	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2906.0	B08		5	0343-0616	320.44	616.36	299	65.26	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2019.6	B08		5	0344-0619	712.48	618.24	295	63.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4277.9	B08		5	0345-0621	215.75	620.77	456	88.91	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1518.1	B08		5	0346-0620	757.65	620.59	258	61.94	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3367.0	B08		5	0347-0622	453.10	622.06	232	56.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2478.1	B08		5	0348-0624	546.22	624.36	285	65.01	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3876.1	B08		5	0349-0623	174.39	622.87	236	56.53	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1058.9	B08		5	0350-0622	870.83	622.71	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1923.6	B08		5	0351-0628	605.87	627.99	397	76.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3178.2	B08		5	0352-0624	946.97	624.84	281	62.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1084.9	B08		5	0353-0628	36.42	628.14	277	72.43	0.664
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3655.9	B08		5	0354-0627	248.60	627.74	260	59.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3925.5	B08		5	0355-0629	830.24	628.84	222	63.26	0.697
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1496.8	B08		5	0356-0633	370.33	632.80	275	64.77	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1569.5	B08		5	0357-0636	408.74	635.45	333	70.18	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1915.7	B08		5	0358-0634	559.32	634.44	189	51.46	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1605.4	B08		5	0359-0638	768.63	638.12	249	61.11	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			445.0	B08		5	0360-0644	477.73	644.58	285	65.60	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2853.1	B08		5	0361-0646	141.04	646.00	238	58.53	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2432.9	B08		5	0362-0645	624.71	644.66	226	55.70	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1733.6	B08		5	0363-0648	565.94	648.44	244	60.53	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			992.0	B08		5	0364-0655	923.94	655.47	386	75.60	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2696.7	B08		5	0365-0654	227.52	653.58	294	63.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1146.1	B08		5	0366-0653	685.29	652.45	228	58.77	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1365.2	B08		5	0367-0655	855.20	655.65	287	62.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1690.1	B08		5	0368-0656	278.26	655.64	249	62.53	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2644.6	B08		5	0369-0655	514.61	654.75	228	56.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2811.8	B08		5	0370-0656	649.18	656.57	234	57.94	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1176.2	B08		5	0371-0656	726.71	655.54	244	57.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2481.9	B08		5	0372-0663	819.55	663.14	272	61.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1648.1	B08		5	0373-0663	156.97	663.83	233	57.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1184.4	B08		5	0374-0668	103.57	668.66	288	64.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2218.0	B08		5	0375-0668	297.00	668.30	230	56.77	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6507.2	B08		5	0376-0676	637.78	676.57	328	67.94	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			8127.5	B08		5	0377-0675	746.61	675.50	218	56.28	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1416.3	B08		5	0378-0673	784.03	672.98	198	54.53	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2143.6	B08		5	0379-0680	130.23	679.86	225	55.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			779.4	B08		5	0380-0681	352.98	681.85	262	60.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			906.4	B08		5	0381-0678	400.87	678.35	219	56.53	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1417.9	B08		5	0382-0680	564.26	680.36	266	60.18	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3489.3	B08		5	0383-0681	809.99	680.69	259	58.53	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1014.1	B08		5	0384-0681	260.11	680.66	242	61.11	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1355.5	B08		5	0385-0682	443.93	681.27	251	58.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			983.7	B08		5	0386-0681	518.84	681.30	267	61.94	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1633.8	B08		5	0387-0689	851.09	689.63	349	71.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			910.3	B08		5	0388-0685	944.31	685.34	228	57.11	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4619.1	B08		5	0389-0689	331.92	689.08	240	58.28	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4040.1	B08		5	0390-0688	175.30	688.12	233	61.60	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3045.3	B08		5	0391-0697	481.88	696.74	235	59.11	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2327.1	B08		5	0392-0696	499.67	696.24	222	59.36	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4251.1	B08		5	0393-0699	454.71	698.92	176	50.28	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1397.9	B08		5	0394-0702	763.55	701.67	360	71.84	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4462.6	B08		5	0395-0702	181.65	702.87	251	59.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2298.4	B08		5	0396-0704	832.21	704.19	334	67.60	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1015.8	B08		5	0397-0706	628.57	706.03	292	65.36	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1478.0	B08		5	0398-0707	607.56	708.06	218	56.28	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3565.6	B08		5	0399-0710	334.25	709.85	209	53.11	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1668.4	B08		5	0400-0711	275.53	711.28	216	59.70	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1163.4	B08		6	0001-0028	566.76	28.73	247	61.36	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			887.3	B08		6	0002-0030	203.14	30.57	437	79.26	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3114.5	B08		6	0003-0027	815.03	27.38	269	60.53	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3092.7	B08		6	0004-0028	518.48	27.57	250	59.94	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1104.7	B08		6	0005-0032	878.67	31.47	241	60.18	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1273.9	B08		6	0006-0034	238.40	33.37	239	58.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2194.7	B08		6	0007-0032	292.61	32.32	341	69.11	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			8282.1	B08		6	0008-0042	603.48	42.80	661	124.71	0.534
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1470.0	B08		6	0009-0035	387.87	34.87	352	71.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			934.2	B08		6	0010-0036	117.52	36.42	257	60.77	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1163.5	B08		6	0011-0044	29.89	44.06	304	66.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2951.1	B08		6	0012-0047	136.17	48.47	208	63.36	0.651
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2534.0	B08		6	0013-0046	277.18	45.73	246	58.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1485.7	B08		6	0014-0048	920.08	48.74	236	58.53	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2016.4	B08		6	0015-0053	47.84	53.09	219	56.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			962.6	B08		6	0016-0057	391.41	57.27	229	56.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3365.8	B08		6	0017-0059	692.75	59.01	218	55.94	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3258.5	B08		6	0018-0062	852.91	61.86	412	77.50	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1442.0	B08		6	0019-0057	351.17	57.35	167	50.28	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2384.3	B08		6	0020-0061	204.10	61.84	226	55.94	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4595.4	B08		6	0021-0063	730.17	63.45	233	59.11	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1054.6	B08		6	0022-0064	498.72	63.16	245	69.01	0.646
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2299.8	B08		6	0023-0063	678.46	63.79	253	60.53	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2964.8	B08		6	0024-0062	800.33	61.85	244	58.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			558.0	B08		6	0025-0068	226.95	67.53	270	62.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3321.9	B08		6	0026-0066	278.84	66.39	246	60.18	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3105.6	B08		6	0027-0072	181.60	72.64	259	59.60	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4360.5	B08		6	0028-0073	303.97	72.75	142	50.87	0.690
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4686.9	B08		6	0029-0075	873.16	74.78	181	55.46	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			775.9	B08		6	0030-0077	137.57	77.45	281	70.77	0.705
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5361.8	B08		6	0031-0072	369.31	71.86	216	56.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3521.7	B08		6	0032-0074	93.35	74.42	277	66.18	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3773.1	B08		6	0033-0076	749.60	75.53	247	60.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2733.3	B08		6	0034-0074	828.53	75.12	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			648.5	B08		6	0035-0074	468.50	73.93	140	53.60	0.612
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5835.5	B08		6	0036-0075	887.21	74.53	157	46.28	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6646.6	B08		6	0037-0076	291.02	76.96	172	51.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2527.7	B08		6	0038-0078	326.11	77.87	206	53.11	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3027.7	B08		6	0039-0081	945.11	81.27	264	61.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			885.5	B08		6	0040-0083	475.33	83.97	171	69.50	0.445
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3754.0	B08		6	0041-0084	646.17	83.21	217	57.01	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2297.9	B08		6	0042-0084	782.09	84.02	216	62.43	0.697
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5652.2	B08		6	0043-0090	621.04	89.96	363	79.50	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2559.3	B08		6	0044-0090	264.22	90.64	234	58.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2268.5	B08		6	0045-0094	656.83	94.92	306	66.08	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			7649.7	B08		6	0046-0095	382.88	95.30	152	47.46	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2197.7	B08		6	0047-0096	915.08	96.39	207	53.70	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3446.2	B08		6	0048-0101	758.37	101.39	211	57.46	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5904.3	B08		6	0049-0100	845.38	100.20	293	63.94	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1496.8	B08		6	0050-0102	96.53	102.95	297	64.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1625.5	B08		6	0051-0101	298.56	101.23	244	58.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1938.6	B08		6	0052-0100	798.87	100.66	225	56.28	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1465.3	B08		6	0053-0104	198.14	103.63	280	61.60	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1246.6	B08		6	0054-0103	877.50	103.52	247	58.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2356.0	B08		6	0055-0102	942.13	102.05	251	59.70	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			7102.9	B08		6	0056-0107	744.36	107.67	162	47.21	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			11316.1	B08		6	0057-0108	391.85	108.59	153	45.46	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2644.0	B08		6	0058-0113	78.79	113.28	277	65.36	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2239.7	B08		6	0059-0113	242.98	113.41	218	53.70	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1922.7	B08		6	0060-0116	766.18	115.78	150	48.04	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3590.8	B08		6	0061-0116	804.17	116.51	207	54.28	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4448.1	B08		6	0062-0119	279.97	119.87	232	56.28	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2286.5	B08		6	0063-0123	914.69	123.08	259	61.01	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1121.9	B08		6	0064-0122	429.92	122.38	403	79.60	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3387.6	B08		6	0065-0128	842.71	127.97	474	112.37	0.472
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			7035.3	B08		6	0066-0127	889.58	127.61	385	73.50	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3742.9	B08		6	0067-0125	389.34	124.73	336	69.36	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1293.2	B08		6	0068-0127	691.92	126.57	245	71.84	0.597
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1894.7	B08		6	0069-0127	175.41	127.89	218	53.36	0.962
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3288.8	B08		6	0070-0132	125.98	132.86	282	62.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1370.0	B08		6	0071-0134	29.09	133.61	376	76.08	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1875.7	B08		6	0072-0130	208.92	130.13	164	48.28	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6742.6	B08		6	0073-0131	813.04	132.02	186	52.87	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1242.7	B08		6	0074-0133	355.82	133.13	343	67.94	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1701.6	B08		6	0075-0138	732.48	138.25	276	61.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1059.0	B08		6	0076-0144	149.47	145.45	274	73.60	0.636
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2190.0	B08		6	0077-0140	309.01	139.24	216	55.94	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1722.5	B08		6	0078-0143	196.39	143.48	203	56.28	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1350.2	B08		6	0079-0149	786.60	150.31	291	65.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1466.9	B08		6	0080-0150	386.37	149.85	275	60.77	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4141.0	B08		6	0081-0148	817.30	148.22	250	75.01	0.558
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3961.4	B08		6	0082-0150	946.96	149.91	242	58.18	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2887.1	B08		6	0083-0153	273.24	154.02	289	65.01	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1616.5	B08		6	0084-0155	131.09	155.52	247	59.01	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4690.4	B08		6	0085-0157	246.98	157.73	337	69.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1149.1	B08		6	0086-0158	457.24	158.53	339	68.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1737.3	B08		6	0087-0158	208.77	158.21	242	58.18	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1874.5	B08		6	0088-0166	49.73	166.25	354	70.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1748.7	B08		6	0089-0166	287.54	166.76	248	58.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			692.0	B08		6	0090-0175	870.84	175.38	381	75.26	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			960.3	B08		6	0091-0172	735.60	172.28	234	59.36	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1668.7	B08		6	0092-0175	835.95	175.10	250	57.94	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1562.0	B08		6	0093-0179	464.94	179.35	215	56.28	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1617.7	B08		6	0094-0179	190.45	179.29	343	71.36	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			429.9	B08		6	0095-0182	76.79	183.02	272	67.01	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			10770.1	B08		6	0096-0182	373.99	181.65	227	79.98	0.446
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2422.1	B08		6	0097-0181	690.04	180.83	277	62.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1563.9	B08		6	0098-0181	231.23	181.50	233	55.94	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2441.2	B08		6	0099-0183	917.64	183.66	167	53.60	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1917.8	B08		6	0100-0184	776.85	184.50	201	52.53	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1968.8	B08		6	0101-0185	758.74	184.56	217	53.36	0.958
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			797.5	B08		6	0102-0188	800.20	188.71	333	70.43	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1897.5	B08		6	0103-0190	397.97	190.57	256	61.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3371.5	B08		6	0104-0192	899.37	192.46	295	64.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4207.0	B08		6	0105-0200	108.71	200.14	359	70.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3273.7	B08		6	0106-0201	56.29	200.70	237	57.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2973.2	B08		6	0107-0200	681.99	201.10	237	62.18	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2024.8	B08		6	0108-0201	834.80	200.47	355	73.26	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1745.6	B08		6	0109-0203	176.64	202.27	263	66.18	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			902.0	B08		6	0110-0209	310.51	208.53	366	75.94	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3196.5	B08		6	0111-0209	472.29	209.39	215	55.94	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6358.7	B08		6	0112-0214	606.09	213.84	242	58.53	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2889.4	B08		6	0113-0214	818.32	214.27	239	57.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			994.2	B08		6	0114-0217	248.87	217.11	332	67.01	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3965.7	B08		6	0115-0217	500.00	216.60	186	49.94	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2993.3	B08		6	0116-0220	568.92	220.19	257	58.77	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2439.7	B08		6	0117-0224	726.78	223.78	320	67.60	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1024.8	B08		6	0118-0225	142.72	225.23	246	57.60	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1341.9	B08		6	0119-0226	234.60	227.06	200	53.70	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2975.6	B08		6	0120-0230	948.80	230.29	228	56.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4952.5	B08		6	0121-0228	659.39	227.78	153	49.80	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6192.4	B08		6	0122-0236	910.61	235.65	274	68.43	0.735
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			8655.1	B08		6	0123-0235	375.34	234.72	210	54.04	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2808.3	B08		6	0124-0234	790.33	235.13	163	49.36	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			8518.5	B08		6	0125-0238	896.97	238.66	203	60.77	0.691
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1221.1	B08		6	0126-0240	625.02	239.52	279	64.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			916.9	B08		6	0127-0246	178.90	245.48	428	85.50	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2368.8	B08		6	0128-0245	438.35	245.28	355	72.77	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2029.2	B08		6	0129-0245	646.48	243.67	266	67.60	0.732
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5558.2	B08		6	0130-0239	663.76	238.35	168	49.21	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2167.1	B08		6	0131-0243	67.63	243.52	213	56.28	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4459.2	B08		6	0132-0247	486.91	246.95	253	64.18	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1195.8	B08		6	0133-0248	531.09	248.44	249	61.01	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			608.8	B08		6	0134-0251	417.01	250.38	212	58.77	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1548.2	B08		6	0135-0253	118.79	252.54	264	60.43	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2165.7	B08		6	0136-0252	675.65	252.20	285	64.53	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1914.5	B08		6	0137-0256	749.14	256.19	300	66.18	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6798.1	B08		6	0138-0253	368.01	252.98	164	51.11	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1386.0	B08		6	0139-0259	598.98	259.20	285	64.87	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4109.4	B08		6	0140-0256	824.76	255.95	217	56.77	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5421.4	B08		6	0141-0259	797.20	259.04	239	58.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1693.8	B08		6	0142-0261	21.52	261.09	298	65.01	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1481.1	B08		6	0143-0259	875.37	259.08	221	56.77	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			964.0	B08		6	0144-0261	553.37	260.39	166	60.18	0.576
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2428.7	B08		6	0145-0263	328.58	263.39	305	65.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3690.1	B08		6	0146-0265	465.15	265.36	291	63.11	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			7516.9	B08		6	0147-0271	68.92	272.53	363	108.23	0.389
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1956.2	B08		6	0148-0272	378.93	270.94	392	79.84	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5453.6	B08		6	0149-0267	850.10	267.54	159	47.70	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			7511.8	B08		6	0150-0267	833.39	268.08	242	59.70	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2079.5	B08		6	0151-0270	502.39	270.25	255	61.11	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1355.8	B08		6	0152-0269	695.23	268.96	241	59.46	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			666.0	B08		6	0153-0274	150.00	273.10	270	66.43	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3512.6	B08		6	0154-0274	212.56	275.08	217	53.94	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			741.4	B08		6	0155-0272	548.82	271.76	128	44.87	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1869.0	B08		6	0156-0279	749.96	279.48	346	77.60	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2816.0	B08		6	0157-0284	596.70	283.79	306	64.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2539.1	B08		6	0158-0285	26.16	285.99	324	68.18	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3033.9	B08		6	0159-0287	859.77	287.10	212	55.36	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2493.1	B08		6	0160-0289	272.88	290.40	237	58.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5086.2	B08		6	0161-0300	476.24	299.32	489	97.88	0.641
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2850.8	B08		6	0162-0294	791.90	294.98	252	59.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1774.6	B08		6	0163-0297	932.42	297.09	289	64.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1366.4	B08		6	0164-0296	306.06	296.08	262	61.60	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2783.0	B08		6	0165-0298	403.47	297.49	312	65.60	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5754.1	B08		6	0166-0296	349.69	295.43	248	58.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2164.6	B08		6	0167-0295	433.52	295.30	274	64.77	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			7791.3	B08		6	0168-0305	645.39	304.40	304	64.18	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3132.8	B08		6	0169-0305	706.26	305.14	243	59.11	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6299.2	B08		6	0170-0313	93.83	312.17	329	85.50	0.566
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1364.8	B08		6	0171-0309	41.27	308.98	197	57.11	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5594.8	B08		6	0172-0306	730.39	305.71	220	55.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			646.4	B08		6	0173-0312	150.84	313.41	276	66.77	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5921.8	B08		6	0174-0313	24.52	313.16	261	59.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6016.2	B08		6	0175-0313	793.17	313.02	264	59.70	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1424.3	B08		6	0176-0315	439.81	316.01	212	55.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1678.6	B08		6	0177-0317	396.13	317.87	407	81.01	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2700.8	B08		6	0178-0318	545.03	318.51	318	65.01	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2957.1	B08		6	0179-0327	754.74	327.17	263	61.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			9146.6	B08		6	0180-0331	645.40	330.50	297	62.77	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5312.2	B08		6	0181-0334	491.61	334.18	219	55.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1186.0	B08		6	0182-0342	301.32	342.68	475	83.50	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2188.2	B08		6	0183-0340	61.74	339.55	158	51.11	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4289.0	B08		6	0184-0339	792.04	339.66	201	52.53	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2134.5	B08		6	0185-0342	72.89	343.66	231	63.11	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3604.0	B08		6	0186-0341	550.94	341.55	258	58.53	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2223.0	B08		6	0187-0345	938.04	345.64	413	76.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2788.4	B08		6	0188-0345	247.62	345.92	257	62.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2480.3	B08		6	0189-0345	736.76	345.12	222	56.18	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			10801.9	B08		6	0190-0352	915.67	352.18	387	81.01	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1505.4	B08		6	0191-0352	377.14	351.79	219	57.70	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3352.0	B08		6	0192-0351	498.07	351.01	213	53.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2850.5	B08		6	0193-0353	692.35	352.74	324	67.36	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2653.8	B08		6	0194-0357	364.46	357.85	224	56.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1853.1	B08		6	0195-0360	461.11	360.46	289	67.84	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5902.4	B08		6	0196-0361	649.92	360.91	230	56.53	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3329.8	B08		6	0197-0363	727.33	363.16	361	72.08	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2877.9	B08		6	0198-0362	812.22	361.84	247	58.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5588.2	B08		6	0199-0362	324.84	362.43	285	62.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2027.8	B08		6	0200-0364	433.33	364.31	205	53.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4513.3	B08		6	0201-0369	678.26	369.38	217	56.77	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6394.0	B08		6	0202-0376	638.40	376.92	207	56.18	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			9150.9	B08		6	0203-0372	911.90	372.84	164	47.21	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1610.1	B08		6	0204-0379	717.08	380.18	358	71.26	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1116.8	B08		6	0205-0383	151.22	382.57	305	66.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			7002.4	B08		6	0206-0382	289.74	381.60	226	57.36	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1165.9	B08		6	0207-0386	890.49	386.72	261	61.84	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2817.2	B08		6	0208-0387	834.65	386.96	213	56.87	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1208.8	B08		6	0209-0390	82.98	390.33	240	58.77	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			693.0	B08		6	0210-0392	36.05	392.71	211	67.01	0.590
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			575.8	B08		6	0211-0392	183.93	392.40	256	60.53	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			9852.0	B08		6	0212-0392	298.98	391.86	144	51.01	0.695
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			481.6	B08		6	0213-0394	114.07	394.56	296	64.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2809.0	B08		6	0214-0394	281.33	394.54	232	57.11	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5817.6	B08		6	0215-0394	412.94	394.12	236	58.18	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2871.0	B08		6	0216-0397	433.84	396.77	302	64.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1900.9	B08		6	0217-0397	808.95	397.53	287	63.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			592.0	B08		6	0218-0399	16.41	398.13	187	55.36	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			10973.9	B08		6	0219-0397	306.38	397.19	106	41.46	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1586.4	B08		6	0220-0401	566.73	401.12	273	61.60	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2865.2	B08		6	0221-0400	702.01	399.92	259	60.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			640.1	B08		6	0222-0402	262.75	402.44	261	59.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1506.6	B08		6	0223-0402	896.29	402.41	262	64.28	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			9082.3	B08		6	0224-0402	917.05	402.60	176	50.53	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1154.5	B08		6	0225-0402	210.70	402.36	213	55.46	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4638.7	B08		6	0226-0406	634.54	405.98	182	52.53	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3615.7	B08		6	0227-0407	617.53	407.50	242	58.04	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3320.1	B08		6	0228-0410	844.46	410.10	232	59.11	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2967.0	B08		6	0229-0414	863.80	414.11	264	61.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3194.4	B08		6	0230-0419	316.94	419.35	384	73.50	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2359.7	B08		6	0231-0416	247.34	416.66	321	66.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3102.1	B08		6	0232-0418	543.53	418.25	242	59.36	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1331.0	B08		6	0233-0420	160.59	420.35	351	71.84	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1805.3	B08		6	0234-0420	689.89	420.40	331	71.01	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			7249.7	B08		6	0235-0417	919.49	417.35	174	48.04	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3272.4	B08		6	0236-0420	650.08	420.06	260	61.36	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1926.7	B08		6	0237-0424	349.77	424.67	239	59.84	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2792.0	B08		6	0238-0422	529.94	422.92	197	54.28	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1625.0	B08		6	0239-0422	766.88	421.56	159	53.94	0.687
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3152.9	B08		6	0240-0430	842.47	430.45	339	69.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1232.9	B08		6	0241-0430	118.40	430.35	258	61.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2185.1	B08		6	0242-0431	611.93	431.41	318	67.01	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4353.9	B08		6	0243-0431	914.42	431.01	211	57.36	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5281.8	B08		6	0244-0432	934.62	432.12	214	58.53	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1325.3	B08		6	0245-0435	49.57	435.67	253	58.28	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1347.3	B08		6	0246-0432	771.14	431.83	128	51.70	0.602
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4253.5	B08		6	0247-0434	896.37	433.69	188	51.94	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5329.0	B08		6	0248-0443	875.29	443.91	144	50.53	0.709
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1098.4	B08		6	0249-0443	261.47	443.67	254	59.11	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2182.5	B08		6	0250-0444	558.68	443.73	283	64.53	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1675.7	B08		6	0251-0449	448.25	449.72	290	66.77	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2723.8	B08		6	0252-0448	228.27	448.43	318	67.94	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6149.6	B08		6	0253-0454	590.24	454.84	417	75.01	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2070.5	B08		6	0254-0455	50.24	454.70	312	65.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3901.6	B08		6	0255-0452	174.21	452.40	213	55.80	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			626.0	B08		6	0256-0455	701.19	455.85	283	66.67	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2597.5	B08		6	0257-0452	853.43	452.66	186	53.70	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4133.3	B08		6	0258-0457	671.01	456.28	211	57.94	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2226.1	B08		6	0259-0458	464.15	458.21	320	68.18	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3953.2	B08		6	0260-0458	747.26	458.97	233	64.43	0.705
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1668.2	B08		6	0261-0462	420.15	463.25	341	75.50	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2627.3	B08		6	0262-0459	85.49	459.20	238	57.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1700.5	B08		6	0263-0459	507.37	459.32	214	54.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5385.9	B08		6	0264-0465	314.66	465.76	333	71.01	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4093.4	B08		6	0265-0466	136.07	466.13	354	71.11	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2203.9	B08		6	0266-0468	172.72	467.77	250	63.70	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1654.7	B08		6	0267-0473	491.59	472.88	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1503.1	B08		6	0268-0473	815.16	473.17	253	59.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1125.9	B08		6	0269-0478	780.69	477.91	325	68.77	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2811.9	B08		6	0270-0475	227.97	475.28	214	57.11	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3062.9	B08		6	0271-0480	211.70	481.35	251	62.18	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3066.2	B08		6	0272-0483	859.42	482.86	271	64.18	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2311.7	B08		6	0273-0485	752.35	484.85	237	60.87	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2515.7	B08		6	0274-0483	585.53	483.73	243	63.36	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2838.3	B08		6	0275-0484	385.51	485.19	164	50.87	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			836.1	B08		6	0276-0488	89.40	489.15	395	75.01	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3179.1	B08		6	0277-0489	296.69	488.85	244	58.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1860.7	B08		6	0278-0492	143.08	492.32	228	55.36	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2005.3	B08		6	0279-0491	336.64	491.70	220	56.28	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			810.6	B08		6	0280-0492	513.77	492.88	252	59.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1753.1	B08		6	0281-0498	48.00	498.20	251	59.94	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3057.6	B08		6	0282-0498	852.36	498.53	283	65.60	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1706.4	B08		6	0283-0500	111.63	500.19	240	58.77	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1574.9	B08		6	0284-0500	478.43	499.97	207	51.46	0.982
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4081.1	B08		6	0285-0501	795.41	501.71	210	53.70	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1280.3	B08		6	0286-0503	443.46	502.86	393	76.67	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2841.7	B08		6	0287-0504	559.57	504.46	323	67.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2208.0	B08		6	0288-0504	831.86	504.47	290	62.53	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1977.5	B08		6	0289-0505	333.16	504.68	199	54.87	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4330.7	B08		6	0290-0509	934.43	509.12	471	88.57	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			758.7	B08		6	0291-0510	601.38	510.61	350	70.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2606.5	B08		6	0292-0512	911.09	511.98	298	68.18	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1530.8	B08		6	0293-0514	516.97	514.15	236	57.70	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1289.3	B08		6	0294-0515	42.43	515.91	283	62.18	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1372.0	B08		6	0295-0516	653.99	516.16	302	66.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1227.0	B08		6	0296-0518	896.99	517.89	228	60.77	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4036.4	B08		6	0297-0518	64.81	518.39	236	56.77	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1093.1	B08		6	0298-0521	259.18	521.20	288	64.43	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2260.6	B08		6	0299-0522	759.26	522.01	321	66.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1027.9	B08		6	0300-0521	695.19	521.83	316	67.84	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1114.3	B08		6	0301-0524	307.39	524.49	237	63.60	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2971.1	B08		6	0302-0524	537.36	523.04	202	57.36	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3229.7	B08		6	0303-0526	738.26	525.71	335	67.11	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2737.9	B08		6	0304-0530	442.40	529.89	215	53.94	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1617.6	B08		6	0305-0529	222.70	529.77	259	62.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1409.1	B08		6	0306-0533	148.88	533.45	266	64.77	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1953.9	B08		6	0307-0537	520.57	536.09	307	66.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			835.6	B08		6	0308-0540	795.24	540.18	237	62.77	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			898.1	B08		6	0309-0541	927.11	540.64	263	61.36	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1672.2	B08		6	0310-0541	111.28	540.83	251	61.94	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3387.3	B08		6	0311-0538	356.39	538.08	144	45.36	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2178.0	B08		6	0312-0542	430.57	542.86	238	62.43	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1991.4	B08		6	0313-0544	37.62	545.15	245	60.18	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1734.2	B08		6	0314-0547	665.59	548.67	353	72.67	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2996.7	B08		6	0315-0546	456.52	545.84	221	57.36	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			780.7	B08		6	0316-0549	376.55	548.79	276	62.87	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1290.3	B08		6	0317-0551	228.15	552.09	280	66.77	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1484.9	B08		6	0318-0547	558.15	547.60	267	61.94	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2597.0	B08		6	0319-0549	84.88	549.15	205	52.28	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6203.2	B08		6	0320-0548	343.66	548.44	170	50.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1304.3	B08		6	0321-0550	623.33	550.48	234	56.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2308.6	B08		6	0322-0553	852.44	553.40	224	58.53	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1533.1	B08		6	0323-0552	702.41	551.60	300	63.36	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2126.2	B08		6	0324-0555	65.46	554.14	214	59.70	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			10552.4	B08		6	0325-0559	412.48	559.15	240	58.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5299.1	B08		6	0326-0556	466.53	556.84	195	54.53	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3353.3	B08		6	0327-0560	785.46	559.58	267	62.43	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1403.0	B08		6	0328-0560	950.45	560.92	238	60.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			936.7	B08		6	0329-0566	215.30	565.75	257	61.70	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3234.6	B08		6	0330-0569	328.41	568.40	269	61.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1836.3	B08		6	0331-0574	461.56	575.67	264	67.36	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3426.8	B08		6	0332-0573	871.02	573.07	373	70.18	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1672.8	B08		6	0333-0572	501.78	572.33	159	49.11	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1439.6	B08		6	0334-0578	44.25	578.31	327	75.01	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3280.8	B08		6	0335-0576	831.51	575.40	184	50.87	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5205.3	B08		6	0336-0579	405.43	579.94	296	65.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1469.2	B08		6	0337-0580	940.14	579.77	260	61.94	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2550.5	B08		6	0338-0582	118.12	582.44	355	70.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1113.2	B08		6	0339-0581	545.71	581.43	267	62.43	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2072.4	B08		6	0340-0583	758.34	583.80	270	60.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2476.8	B08		6	0341-0590	861.76	590.73	212	56.28	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			744.0	B08		6	0342-0593	897.40	593.24	281	63.60	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1337.7	B08		6	0343-0595	503.64	594.99	153	46.28	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3133.0	B08		6	0344-0598	186.48	597.91	353	69.84	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			714.3	B08		6	0345-0598	925.56	598.86	254	59.11	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1372.3	B08		6	0346-0594	793.86	594.85	119	44.28	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1452.1	B08		6	0347-0601	45.57	601.17	270	62.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1377.8	B08		6	0348-0604	674.21	604.94	328	70.77	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			899.2	B08		6	0349-0605	300.47	604.75	327	68.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1526.7	B08		6	0350-0604	797.84	604.85	204	61.94	0.668
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			565.4	B08		6	0351-0610	121.59	610.26	241	58.53	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3993.7	B08		6	0352-0614	419.35	614.52	331	67.60	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			7698.1	B08		6	0353-0617	18.20	617.26	228	54.53	0.964
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2827.4	B08		6	0354-0620	371.00	620.02	395	78.08	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2579.3	B08		6	0355-0618	818.54	619.07	286	63.11	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2118.9	B08		6	0356-0621	886.62	621.92	270	61.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			734.6	B08		6	0357-0624	540.31	624.49	305	65.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3026.2	B08		6	0358-0624	108.75	623.92	311	66.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1019.4	B08		6	0359-0624	238.42	623.48	277	64.53	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3063.2	B08		6	0360-0627	41.31	627.73	283	63.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1911.0	B08		6	0361-0632	771.16	631.75	395	74.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1353.6	B08		6	0362-0638	948.41	638.14	366	72.43	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6064.6	B08		6	0363-0639	381.42	638.47	293	64.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4255.6	B08		6	0364-0642	841.54	642.68	274	63.84	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1721.2	B08		6	0365-0646	214.06	645.66	254	63.11	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1134.3	B08		6	0366-0646	912.19	645.78	237	57.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2537.3	B08		6	0367-0648	64.54	648.32	224	56.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			797.3	B08		6	0368-0650	489.58	649.78	282	63.01	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1040.5	B08		6	0369-0653	422.26	652.20	405	76.67	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2776.5	B08		6	0370-0648	826.17	648.23	215	54.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2047.2	B08		6	0371-0653	113.86	652.70	231	58.87	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1645.7	B08		6	0372-0653	602.39	653.01	329	69.01	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			781.6	B08		6	0373-0658	18.30	658.28	370	72.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			703.7	B08		6	0374-0655	712.94	655.48	293	65.36	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4956.4	B08		6	0375-0658	328.43	658.02	305	64.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2491.5	B08		6	0376-0664	781.20	663.74	247	59.36	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			775.3	B08		6	0377-0662	900.70	662.82	224	56.53	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1329.3	B08		6	0378-0664	148.61	664.67	220	53.94	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1703.3	B08		6	0379-0663	524.35	662.59	272	61.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2517.9	B08		6	0380-0665	835.11	664.12	225	61.01	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3794.7	B08		6	0381-0673	210.21	673.07	188	52.87	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1908.7	B08		6	0382-0672	430.67	672.77	245	58.87	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2842.8	B08		6	0383-0673	822.78	674.69	235	58.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1207.5	B08		6	0384-0675	614.54	674.84	272	63.01	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3085.2	B08		6	0385-0674	859.84	673.39	222	57.01	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1179.4	B08		6	0386-0675	663.73	675.40	406	77.01	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1860.9	B08		6	0387-0677	744.93	677.07	237	59.11	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1417.1	B08		6	0388-0683	78.83	682.69	354	73.26	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4062.3	B08		6	0389-0681	930.27	681.12	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5614.2	B08		6	0390-0686	260.52	686.06	309	64.18	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2158.3	B08		6	0391-0684	802.37	683.50	206	53.11	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2009.6	B08		6	0392-0686	126.55	686.41	213	56.28	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4202.6	B08		6	0393-0687	406.24	687.58	300	63.60	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			998.7	B08		6	0394-0688	38.48	688.08	219	55.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3590.1	B08		6	0395-0692	336.61	691.64	260	61.01	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1391.6	B08		6	0396-0693	377.30	693.73	143	47.80	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			718.4	B08		6	0397-0694	473.18	694.78	246	59.94	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1422.0	B08		6	0398-0700	708.19	700.42	393	75.01	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2582.5	B08		6	0399-0699	725.25	699.07	256	59.70	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5895.3	B08		6	0400-0703	517.50	703.30	205	54.53	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2940.0	B08		6	0401-0706	576.37	706.19	196	53.94	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4171.9	B08		6	0402-0707	116.69	707.16	302	66.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1647.9	B08		6	0403-0709	376.77	708.80	241	61.70	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			8207.3	B08		7	0001-0026	81.39	26.79	137	43.94	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4452.6	B08		7	0002-0029	247.78	28.87	248	59.11	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3776.9	B08		7	0003-0028	824.82	27.21	222	55.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2822.2	B08		7	0004-0033	560.84	33.13	299	64.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2194.6	B08		7	0005-0031	711.12	31.85	252	59.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1430.9	B08		7	0006-0036	632.02	36.41	452	80.08	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3367.4	B08		7	0007-0036	390.73	36.07	154	54.28	0.657
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			496.8	B08		7	0008-0040	52.67	39.62	298	66.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2519.2	B08		7	0009-0037	403.64	36.79	145	43.80	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4274.5	B08		7	0010-0043	16.80	44.41	162	53.70	0.706
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2880.5	B08		7	0011-0040	381.00	39.87	117	42.87	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4689.6	B08		7	0012-0047	30.32	48.28	217	59.94	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1073.5	B08		7	0013-0047	435.38	48.08	253	60.53	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3156.4	B08		7	0014-0046	920.57	45.84	220	55.11	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1506.9	B08		7	0015-0051	272.52	52.16	262	67.50	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2253.8	B08		7	0016-0050	486.01	50.03	449	81.26	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5617.1	B08		7	0017-0057	78.11	57.33	229	56.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1401.2	B08		7	0018-0063	120.28	62.76	458	79.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1180.6	B08		7	0019-0063	57.27	62.60	233	62.77	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4087.2	B08		7	0020-0064	310.19	63.67	254	74.08	0.582
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1870.6	B08		7	0021-0067	750.66	66.50	391	72.67	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2288.4	B08		7	0022-0066	821.45	66.51	304	65.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1871.5	B08		7	0023-0066	167.52	66.48	242	59.94	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2426.2	B08		7	0024-0067	451.50	67.38	306	67.84	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			7736.9	B08		7	0025-0073	68.84	72.68	197	51.70	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1694.1	B08		7	0026-0078	911.74	78.18	401	74.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2939.1	B08		7	0027-0081	195.65	81.18	335	69.26	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2156.6	B08		7	0028-0083	493.62	83.30	468	86.91	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1812.5	B08		7	0029-0081	336.24	81.83	194	56.18	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1033.6	B08		7	0030-0084	688.64	84.51	298	66.67	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3333.7	B08		7	0031-0084	776.67	84.47	260	60.18	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1076.5	B08		7	0032-0087	403.82	87.15	260	59.60	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2161.8	B08		7	0033-0092	240.65	92.13	310	64.77	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			892.6	B08		7	0034-0096	739.27	96.03	240	58.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2249.1	B08		7	0035-0102	295.43	101.57	365	80.43	0.709
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1664.4	B08		7	0036-0106	440.25	106.12	284	64.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2496.5	B08		7	0037-0112	414.56	114.02	365	86.91	0.607
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			905.4	B08		7	0038-0113	24.04	114.25	259	58.77	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1028.0	B08		7	0039-0115	912.85	115.08	264	62.43	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3748.9	B08		7	0040-0112	91.25	111.96	205	54.28	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			714.4	B08		7	0041-0116	861.89	116.11	264	61.36	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3506.4	B08		7	0042-0122	319.98	122.32	317	69.60	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1079.6	B08		7	0043-0121	338.52	120.85	147	52.63	0.667
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1331.4	B08		7	0044-0123	389.16	122.64	301	66.43	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1485.9	B08		7	0045-0121	188.05	120.87	238	64.77	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2940.5	B08		7	0046-0130	584.23	129.68	444	82.08	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			898.4	B08		7	0047-0127	632.15	126.73	300	77.26	0.632
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2818.5	B08		7	0048-0128	236.19	127.72	257	57.70	0.970
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2507.4	B08		7	0049-0132	83.70	132.95	279	65.36	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2673.8	B08		7	0050-0132	157.49	131.97	151	45.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5888.9	B08		7	0051-0132	199.98	133.12	219	57.94	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2155.2	B08		7	0052-0135	440.86	136.01	267	62.77	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2932.1	B08		7	0053-0138	378.41	138.40	250	61.94	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			743.4	B08		7	0054-0143	802.02	142.93	505	87.84	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			11921.2	B08		7	0055-0140	183.23	140.29	197	52.28	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			7514.6	B08		7	0056-0141	168.37	141.83	204	53.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5244.4	B08		7	0057-0146	272.79	146.49	375	76.18	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5082.7	B08		7	0058-0143	290.74	142.61	123	42.28	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1291.3	B08		7	0059-0147	689.43	148.17	378	74.08	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1442.4	B08		7	0060-0151	888.71	150.40	366	70.77	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1565.5	B08		7	0061-0155	242.33	155.57	246	59.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1309.5	B08		7	0062-0159	495.41	159.53	476	81.26	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5015.7	B08		7	0063-0154	140.59	153.43	151	49.36	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			7012.4	B08		7	0064-0161	339.70	161.13	531	97.40	0.703
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			11336.6	B08		7	0065-0159	361.14	158.65	346	75.01	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1815.4	B08		7	0066-0159	674.90	159.46	220	57.60	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1046.4	B08		7	0067-0164	634.54	165.00	233	63.84	0.718
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4550.7	B08		7	0068-0163	134.49	163.21	162	51.60	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1693.9	B08		7	0069-0164	415.04	164.40	351	71.01	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1190.0	B08		7	0070-0164	465.84	164.38	268	60.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3236.3	B08		7	0071-0165	88.45	165.93	207	53.70	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1608.1	B08		7	0072-0167	43.25	167.63	240	56.28	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1229.8	B08		7	0073-0169	215.15	169.30	400	75.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			644.3	B08		7	0074-0174	818.62	173.99	505	87.26	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			588.4	B08		7	0075-0171	853.97	170.66	361	72.08	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1188.7	B08		7	0076-0171	607.12	171.03	221	55.70	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5619.5	B08		7	0077-0176	307.71	176.43	399	76.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2113.6	B08		7	0078-0174	773.89	174.10	219	53.94	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			17429.2	B08		7	0079-0173	920.75	174.10	151	66.43	0.430
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			991.5	B08		7	0080-0179	627.32	179.07	275	68.77	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4328.5	B08		7	0081-0183	92.24	182.24	227	58.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2012.4	B08		7	0082-0186	412.67	186.07	258	59.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			946.4	B08		7	0083-0191	529.97	191.30	400	74.91	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2814.7	B08		7	0084-0193	162.74	193.94	271	72.33	0.651
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5358.2	B08		7	0085-0194	571.70	194.47	302	64.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2844.2	B08		7	0086-0193	719.20	193.39	188	53.94	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3200.5	B08		7	0087-0196	899.44	197.36	350	72.18	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2172.7	B08		7	0088-0195	686.08	194.73	240	57.94	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1799.7	B08		7	0089-0197	218.70	197.96	244	59.36	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1488.7	B08		7	0090-0198	314.70	198.25	251	58.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4590.0	B08		7	0091-0196	613.26	196.59	204	56.87	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3136.5	B08		7	0092-0201	946.42	201.19	274	66.08	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1111.6	B08		7	0093-0206	58.01	206.48	258	61.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1001.5	B08		7	0094-0211	177.98	211.36	360	69.60	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3982.2	B08		7	0095-0216	397.84	216.51	337	69.26	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1178.9	B08		7	0096-0218	339.99	218.35	273	60.77	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4668.4	B08		7	0097-0221	569.60	222.01	391	87.50	0.642
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1093.3	B08		7	0098-0219	89.92	218.98	242	57.11	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1032.6	B08		7	0099-0225	446.62	225.98	396	76.43	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1528.1	B08		7	0100-0228	126.72	228.49	240	56.77	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2853.3	B08		7	0101-0228	413.78	228.49	276	61.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1132.2	B08		7	0102-0231	907.18	231.20	289	63.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2816.6	B08		7	0103-0232	720.98	231.94	236	62.67	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6944.5	B08		7	0104-0233	264.91	234.22	194	56.53	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2744.5	B08		7	0105-0234	283.80	234.69	332	68.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1328.6	B08		7	0106-0237	521.36	236.40	382	73.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4306.9	B08		7	0107-0236	947.56	236.18	340	68.77	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1212.5	B08		7	0108-0237	872.17	237.48	266	63.84	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6071.4	B08		7	0109-0245	843.77	243.71	350	102.57	0.418
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4426.6	B08		7	0110-0243	51.98	243.74	182	49.70	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3392.0	B08		7	0111-0243	604.19	243.46	216	59.36	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1492.5	B08		7	0112-0246	378.93	246.46	256	59.36	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			944.2	B08		7	0113-0249	463.00	249.54	233	56.53	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2525.7	B08		7	0114-0249	587.12	249.49	180	50.87	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1112.6	B08		7	0115-0254	128.47	254.68	307	80.57	0.594
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1746.5	B08		7	0116-0254	247.69	254.10	326	66.43	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2411.6	B08		7	0117-0256	397.74	256.62	240	57.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1229.6	B08		7	0118-0259	553.97	259.30	371	73.01	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			912.8	B08		7	0119-0257	323.31	257.59	255	59.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			683.5	B08		7	0120-0264	877.21	264.15	243	65.94	0.702
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2172.7	B08		7	0121-0264	429.23	263.74	193	51.11	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2661.3	B08		7	0122-0265	682.52	264.78	242	60.18	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1266.5	B08		7	0123-0268	23.52	267.27	312	68.67	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			983.5	B08		7	0124-0273	942.28	273.29	228	55.11	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			820.5	B08		7	0125-0277	472.77	276.83	285	65.36	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			857.1	B08		7	0126-0279	591.93	279.81	335	67.60	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			827.1	B08		7	0127-0280	373.41	281.31	303	65.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			860.7	B08		7	0128-0281	97.96	280.43	287	68.18	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3315.1	B08		7	0129-0289	160.03	289.59	504	84.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2360.4	B08		7	0130-0286	717.44	286.35	251	59.94	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3644.8	B08		7	0131-0285	226.22	284.88	147	47.46	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2307.2	B08		7	0132-0287	884.60	287.66	261	63.01	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2457.5	B08		7	0133-0287	266.28	286.81	204	54.28	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1614.8	B08		7	0134-0295	42.73	293.97	470	84.67	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2195.7	B08		7	0135-0290	409.83	289.56	218	55.11	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			967.4	B08		7	0136-0296	638.34	296.98	357	70.43	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3224.3	B08		7	0137-0296	95.19	296.13	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			927.5	B08		7	0138-0300	300.90	299.53	352	70.18	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1675.7	B08		7	0139-0299	441.91	299.04	285	62.53	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2084.7	B08		7	0140-0303	747.06	302.21	284	64.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			9591.1	B08		7	0141-0300	226.96	300.39	100	38.04	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			890.6	B08		7	0142-0307	921.16	307.62	285	79.50	0.567
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1623.3	B08		7	0143-0304	356.23	304.27	278	65.01	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4912.9	B08		7	0144-0303	621.62	304.04	199	53.11	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2204.0	B08		7	0145-0309	250.39	309.05	279	69.01	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1148.6	B08		7	0146-0312	495.72	311.78	412	83.98	0.734
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1647.2	B08		7	0147-0310	729.52	310.80	232	57.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2179.1	B08		7	0148-0311	762.11	310.96	229	57.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3013.2	B08		7	0149-0310	528.20	310.63	234	58.28	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1811.0	B08		7	0150-0312	795.82	311.91	291	64.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3575.6	B08		7	0151-0316	235.32	316.79	240	70.43	0.608
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4978.9	B08		7	0152-0312	410.34	312.51	248	58.63	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1074.7	B08		7	0153-0317	371.38	316.56	293	65.94	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3465.4	B08		7	0154-0316	266.32	316.82	171	48.87	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2331.3	B08		7	0155-0319	546.92	318.83	210	54.18	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3934.3	B08		7	0156-0321	27.86	321.46	191	51.36	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2976.7	B08		7	0157-0328	430.10	328.68	339	67.94	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2608.9	B08		7	0158-0327	847.85	326.72	221	54.28	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			12193.8	B08		7	0159-0326	410.89	326.20	166	48.39	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2422.4	B08		7	0160-0331	450.98	331.32	320	66.53	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2027.0	B08		7	0161-0334	292.22	334.82	267	65.94	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2237.8	B08		7	0162-0336	930.56	336.09	198	53.60	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3538.2	B08		7	0163-0336	162.68	335.79	175	49.94	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2413.8	B08		7	0164-0338	896.94	338.98	324	67.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2863.1	B08		7	0165-0338	660.25	337.98	156	50.87	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3536.7	B08		7	0166-0341	646.64	340.59	261	61.11	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1803.6	B08		7	0167-0340	675.12	339.91	190	52.77	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1106.7	B08		7	0168-0342	707.87	342.91	276	69.84	0.711
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			16552.2	B08		7	0169-0342	784.65	342.46	217	55.36	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1902.3	B08		7	0170-0343	309.89	343.09	258	60.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			8379.0	B08		7	0171-0346	481.88	346.11	316	72.77	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1563.0	B08		7	0172-0349	217.80	349.32	361	71.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3727.0	B08		7	0173-0347	153.24	347.05	227	56.18	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1828.8	B08		7	0174-0350	859.26	351.10	336	68.53	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			12510.6	B08		7	0175-0349	800.64	349.33	177	49.70	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			808.7	B08		7	0176-0353	338.93	352.34	261	60.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4439.3	B08		7	0177-0358	71.12	358.95	447	91.74	0.667
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6258.1	B08		7	0178-0353	817.46	353.46	233	59.70	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			11881.0	B08		7	0179-0362	371.36	361.56	494	93.05	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1631.8	B08		7	0180-0367	99.04	367.18	454	85.74	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			8090.9	B08		7	0181-0359	462.03	360.16	146	45.21	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1491.3	B08		7	0182-0369	691.26	369.39	264	64.08	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2149.3	B08		7	0183-0370	447.16	369.83	216	55.11	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2900.1	B08		7	0184-0370	843.94	370.61	319	66.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1239.0	B08		7	0185-0371	278.60	372.16	262	63.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2191.0	B08		7	0186-0375	503.14	375.57	260	65.36	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1655.4	B08		7	0187-0374	307.18	373.51	277	65.36	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			11422.7	B08		7	0188-0373	354.76	374.48	147	49.36	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			11188.4	B08		7	0189-0376	381.94	376.76	278	67.01	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			989.4	B08		7	0190-0380	727.75	380.71	335	69.84	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1466.6	B08		7	0191-0380	526.81	381.04	221	57.36	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1422.7	B08		7	0192-0384	684.62	383.73	275	63.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1597.1	B08		7	0193-0390	164.13	389.70	472	83.36	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3857.9	B08		7	0194-0387	798.47	387.55	357	70.43	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2569.2	B08		7	0195-0388	927.26	388.88	312	65.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1830.7	B08		7	0196-0394	185.85	393.76	261	63.01	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			7130.8	B08		7	0197-0395	116.26	395.13	255	58.77	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2512.5	B08		7	0198-0393	840.15	393.95	241	57.70	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1480.3	B08		7	0199-0399	899.11	399.12	309	65.36	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3844.4	B08		7	0200-0400	555.73	400.33	333	71.01	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2304.1	B08		7	0201-0402	94.97	402.82	390	74.43	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1764.7	B08		7	0202-0403	503.44	403.91	240	59.70	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5653.8	B08		7	0203-0402	782.10	402.91	155	50.87	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			565.3	B08		7	0204-0406	870.45	407.13	285	71.01	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1466.5	B08		7	0205-0405	281.16	404.51	254	62.77	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1456.3	B08		7	0206-0408	439.39	407.70	223	57.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3592.5	B08		7	0207-0407	677.66	407.11	250	57.94	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1118.5	B08		7	0208-0409	946.76	409.94	278	67.01	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2225.8	B08		7	0209-0408	50.70	408.74	253	61.70	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1658.4	B08		7	0210-0408	329.76	408.12	319	72.43	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5416.0	B08		7	0211-0412	228.68	412.13	306	65.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2951.6	B08		7	0212-0413	582.83	413.25	313	67.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2991.5	B08		7	0213-0409	753.48	408.41	161	49.70	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2677.4	B08		7	0214-0416	308.23	416.71	224	61.36	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4801.1	B08		7	0215-0419	544.64	418.65	204	51.94	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			937.4	B08		7	0216-0420	627.16	420.38	308	67.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1646.0	B08		7	0217-0423	938.35	422.78	276	65.26	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2512.6	B08		7	0218-0427	816.11	427.07	261	61.70	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2195.5	B08		7	0219-0428	330.82	429.26	299	66.43	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1376.0	B08		7	0220-0429	710.81	428.85	298	66.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1888.0	B08		7	0221-0431	199.59	430.66	279	63.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			869.2	B08		7	0222-0432	784.78	431.99	288	65.60	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2430.3	B08		7	0223-0436	80.45	436.11	367	73.11	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3198.2	B08		7	0224-0434	530.11	433.20	296	67.60	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2884.5	B08		7	0225-0437	547.31	438.14	267	65.26	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2668.6	B08		7	0226-0438	24.77	437.88	236	59.70	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4991.3	B08		7	0227-0437	102.70	437.10	222	58.18	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5177.6	B08		7	0228-0438	689.99	437.92	218	56.28	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1271.0	B08		7	0229-0444	644.17	443.89	414	80.67	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1410.1	B08		7	0230-0445	349.35	444.63	254	62.18	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3328.1	B08		7	0231-0448	673.60	448.71	311	67.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2215.0	B08		7	0232-0451	760.98	450.72	222	61.94	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			670.4	B08		7	0233-0451	577.59	451.76	277	63.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			9257.7	B08		7	0234-0454	817.04	453.79	324	68.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1490.3	B08		7	0235-0456	455.98	456.45	269	64.18	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4695.6	B08		7	0236-0460	63.98	460.09	299	63.94	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1330.8	B08		7	0237-0466	864.93	466.05	302	80.91	0.580
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2825.2	B08		7	0238-0464	356.84	463.88	256	60.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			767.7	B08		7	0239-0466	513.38	466.70	281	63.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5227.1	B08		7	0240-0467	328.45	467.72	371	83.84	0.663
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3386.0	B08		7	0241-0468	849.84	468.20	184	53.46	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4591.4	B08		7	0242-0472	906.09	471.68	340	76.67	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1719.8	B08		7	0243-0470	203.00	469.81	222	58.18	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1318.0	B08		7	0244-0472	236.38	472.69	220	59.01	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1267.7	B08		7	0245-0477	934.34	478.49	318	72.43	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3064.0	B08		7	0246-0481	651.26	482.10	510	106.57	0.564
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5134.6	B08		7	0247-0486	129.79	486.75	499	86.67	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3875.7	B08		7	0248-0482	398.08	481.83	240	57.60	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2054.9	B08		7	0249-0484	782.53	484.13	397	75.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2356.1	B08		7	0250-0491	555.13	492.15	336	68.43	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1515.0	B08		7	0251-0493	488.53	493.04	280	65.01	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2817.2	B08		7	0252-0496	630.32	496.96	275	61.01	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2061.4	B08		7	0253-0504	76.36	503.82	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1687.7	B08		7	0254-0512	563.18	512.38	275	61.11	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2909.4	B08		7	0255-0515	929.60	515.28	331	67.84	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2609.2	B08		7	0256-0515	303.66	514.76	221	56.18	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2855.6	B08		7	0257-0517	419.55	516.60	219	54.87	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1106.1	B08		7	0258-0520	523.11	521.12	339	71.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2309.4	B08		7	0259-0523	102.70	523.12	267	67.94	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2859.9	B08		7	0260-0520	194.12	520.44	217	55.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1549.6	B08		7	0261-0521	781.22	521.50	240	62.18	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3447.2	B08		7	0262-0522	715.60	522.41	182	49.11	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2259.3	B08		7	0263-0529	225.10	528.94	309	65.11	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2999.4	B08		7	0264-0527	285.61	527.28	236	57.70	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2173.1	B08		7	0265-0530	149.38	529.94	288	65.94	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2553.8	B08		7	0266-0534	429.34	534.91	260	62.43	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3276.1	B08		7	0267-0536	770.17	537.07	227	56.18	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			801.9	B08		7	0268-0540	906.22	540.02	407	76.43	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4276.9	B08		7	0269-0540	335.32	539.97	212	55.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1250.4	B08		7	0270-0545	548.09	545.33	251	59.94	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3251.8	B08		7	0271-0545	270.40	544.99	189	51.94	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1114.2	B08		7	0272-0546	447.50	545.93	228	58.43	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3391.9	B08		7	0273-0553	804.74	553.28	232	58.77	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3062.7	B08		7	0274-0549	859.05	549.05	126	43.46	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			950.6	B08		7	0275-0551	482.79	550.94	212	53.70	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1324.8	B08		7	0276-0552	392.00	551.27	300	69.60	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2944.6	B08		7	0277-0553	821.00	553.94	198	56.18	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2202.7	B08		7	0278-0555	301.57	555.59	283	65.94	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2433.9	B08		7	0279-0558	776.62	558.39	269	62.53	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5895.6	B08		7	0280-0559	689.71	560.15	226	62.77	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2412.1	B08		7	0281-0560	339.19	559.53	187	51.36	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3655.7	B08		7	0282-0564	852.72	564.30	217	55.84	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1212.3	B08		7	0283-0565	273.27	565.52	251	61.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1806.8	B08		7	0284-0566	215.27	567.71	321	73.01	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1670.1	B08		7	0285-0568	794.53	567.90	241	58.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1118.7	B08		7	0286-0568	574.60	568.25	313	68.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1761.9	B08		7	0287-0571	97.09	571.01	324	68.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1625.0	B08		7	0288-0572	358.39	571.60	225	57.70	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1733.0	B08		7	0289-0568	451.12	568.59	194	50.87	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			799.9	B08		7	0290-0571	514.70	571.55	238	57.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4338.7	B08		7	0291-0575	818.21	576.01	261	63.11	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2113.9	B08		7	0292-0573	627.10	573.01	252	58.87	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			10998.5	B08		7	0293-0587	161.52	585.95	593	107.05	0.650
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1885.2	B08		7	0294-0580	382.48	581.18	206	56.04	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1721.0	B08		7	0295-0582	856.68	582.60	241	59.84	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5474.8	B08		7	0296-0581	454.66	581.62	195	53.21	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1751.0	B08		7	0297-0584	20.47	584.14	229	57.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2247.6	B08		7	0298-0589	65.54	589.46	360	71.36	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1093.8	B08		7	0299-0589	202.30	589.49	276	69.01	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1248.3	B08		7	0300-0586	306.59	585.47	227	56.53	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1916.0	B08		7	0301-0587	540.11	586.99	191	51.36	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2083.0	B08		7	0302-0589	419.81	589.22	243	57.11	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			781.1	B08		7	0303-0589	641.78	589.13	208	54.28	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1470.5	B08		7	0304-0591	870.52	591.42	226	55.11	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5276.3	B08		7	0305-0592	401.35	592.08	206	54.28	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			7505.8	B08		7	0306-0595	386.10	595.23	181	51.80	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1039.3	B08		7	0307-0599	934.08	598.75	396	74.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2437.5	B08		7	0308-0597	468.94	597.78	296	63.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4662.0	B08		7	0309-0599	531.68	600.05	232	55.36	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			770.8	B08		7	0310-0600	586.68	599.78	239	57.70	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2258.5	B08		7	0311-0603	237.89	602.51	256	58.53	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5617.6	B08		7	0312-0603	747.56	603.22	140	46.28	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1593.1	B08		7	0313-0607	275.96	606.98	234	56.53	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1337.6	B08		7	0314-0618	761.53	616.65	395	87.26	0.652
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1539.7	B08		7	0315-0618	317.58	618.43	245	59.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2265.4	B08		7	0316-0620	798.63	619.75	372	73.60	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			951.8	B08		7	0317-0619	184.08	618.67	255	59.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3227.8	B08		7	0318-0619	536.33	619.55	203	52.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			8113.4	B08		7	0319-0619	732.67	618.91	225	58.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1455.7	B08		7	0320-0624	75.32	624.49	297	67.26	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			990.5	B08		7	0321-0626	149.52	625.62	378	74.18	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1281.8	B08		7	0322-0624	587.75	624.19	255	60.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			855.3	B08		7	0323-0628	266.79	628.79	272	64.77	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			989.7	B08		7	0324-0626	224.98	625.70	269	60.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3195.6	B08		7	0325-0631	33.55	631.63	372	75.84	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1278.8	B08		7	0326-0630	380.71	630.34	182	50.28	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4510.9	B08		7	0327-0632	742.45	633.18	264	63.60	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4988.5	B08		7	0328-0632	870.00	633.29	240	62.77	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2244.1	B08		7	0329-0638	418.93	637.29	242	58.18	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1524.6	B08		7	0330-0635	486.04	635.24	265	64.53	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			9589.0	B08		7	0331-0636	884.42	636.28	183	50.63	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1555.1	B08		7	0332-0640	652.10	639.58	235	59.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1856.1	B08		7	0333-0642	303.25	642.62	278	63.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4128.9	B08		7	0334-0643	369.37	643.58	193	51.70	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1914.5	B08		7	0335-0647	536.33	647.18	228	57.01	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3296.2	B08		7	0336-0648	701.14	648.33	301	63.60	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1414.8	B08		7	0337-0655	825.26	654.58	343	71.50	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4438.6	B08		7	0338-0652	905.80	652.94	180	51.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1189.0	B08		7	0339-0656	494.86	656.41	261	60.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1922.1	B08		7	0340-0655	647.89	656.23	214	54.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			802.0	B08		7	0341-0660	619.43	660.42	307	68.53	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1083.7	B08		7	0342-0660	103.73	660.38	202	60.18	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3452.4	B08		7	0343-0661	331.53	661.26	282	62.28	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4588.4	B08		7	0344-0658	369.54	658.31	227	57.11	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5893.2	B08		7	0345-0659	935.36	658.91	181	52.43	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2366.0	B08		7	0346-0660	447.04	660.05	247	59.11	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1276.9	B08		7	0347-0665	250.08	665.56	256	60.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			879.6	B08		7	0348-0662	37.36	662.14	140	45.94	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			846.6	B08		7	0349-0668	273.05	667.94	244	60.18	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1697.5	B08		7	0350-0671	564.20	671.06	415	79.50	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2531.7	B08		7	0351-0668	724.95	667.73	304	64.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3146.2	B08		7	0352-0666	922.79	665.38	205	57.36	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2411.5	B08		7	0353-0670	193.80	670.59	269	61.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3576.9	B08		7	0354-0673	768.30	672.51	256	59.60	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1836.3	B08		7	0355-0672	377.96	672.48	212	55.46	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2323.2	B08		7	0356-0674	861.90	673.49	332	68.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1706.5	B08		7	0357-0676	85.23	676.00	223	57.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			596.4	B08		7	0358-0677	797.05	677.26	267	63.01	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1092.1	B08		7	0359-0675	34.76	675.73	175	50.28	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5285.7	B08		7	0360-0676	703.10	676.08	198	57.60	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1032.6	B08		7	0361-0678	52.72	679.35	218	59.36	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			7602.0	B08		7	0362-0683	685.57	684.28	648	111.05	0.660
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4151.1	B08		7	0363-0680	448.23	679.47	224	55.36	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1048.4	B08		7	0364-0685	843.10	686.08	260	61.36	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			922.1	B08		7	0365-0688	618.11	687.90	248	63.84	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2894.8	B08		7	0366-0686	340.20	686.29	226	55.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2949.9	B08		7	0367-0692	413.83	691.73	372	73.26	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			8388.9	B08		7	0368-0691	714.85	690.45	150	46.87	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2226.0	B08		7	0369-0694	912.92	694.90	229	57.94	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2605.2	B08		7	0370-0696	937.38	695.64	291	61.94	0.953
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1410.1	B08		7	0371-0697	52.33	696.50	224	55.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1538.1	B08		7	0372-0697	136.01	696.68	215	53.94	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			992.8	B08		7	0373-0702	234.35	703.26	290	67.36	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3963.9	B08		7	0374-0703	882.83	702.70	269	63.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1320.3	B08		7	0375-0704	371.40	704.40	237	58.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2511.5	B08		7	0376-0703	539.66	702.93	202	52.28	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			8749.7	B08		7	0377-0700	690.84	700.22	159	45.70	0.957
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3230.9	B08		7	0378-0706	464.63	706.59	227	57.94	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			627.4	B08		7	0379-0706	646.96	706.78	211	53.11	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			992.9	B08		7	0380-0708	161.23	708.82	276	64.53	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1097.6	B08		8	0001-0027	605.94	27.87	215	56.28	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			887.8	B08		8	0002-0030	678.63	29.96	293	63.01	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4271.2	B08		8	0003-0030	332.84	29.76	212	53.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1102.2	B08		8	0004-0034	100.59	34.63	237	58.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1902.9	B08		8	0005-0030	274.05	30.58	219	59.70	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3110.2	B08		8	0006-0039	437.09	39.00	204	53.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3035.8	B08		8	0007-0041	321.69	41.81	212	54.28	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4005.5	B08		8	0008-0040	928.24	40.30	223	54.28	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1358.3	B08		8	0009-0043	461.70	44.14	285	63.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1183.0	B08		8	0010-0044	809.55	44.14	285	61.36	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			756.2	B08		8	0011-0045	569.92	43.93	174	54.43	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1208.0	B08		8	0012-0045	358.74	45.50	219	55.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4779.5	B08		8	0013-0045	633.25	45.14	254	60.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1023.4	B08		8	0014-0047	122.29	46.71	280	66.18	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2962.0	B08		8	0015-0048	25.24	47.86	211	53.11	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2464.9	B08		8	0016-0048	185.64	48.59	289	64.18	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3307.4	B08		8	0017-0049	384.18	48.78	310	66.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2811.7	B08		8	0018-0049	307.42	48.87	215	54.87	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			809.6	B08		8	0019-0050	580.11	51.04	112	44.87	0.699
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1019.4	B08		8	0020-0053	753.84	52.66	215	54.28	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6785.3	B08		8	0021-0053	254.99	53.81	251	60.53	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1429.4	B08		8	0022-0056	493.18	56.48	338	69.01	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2004.5	B08		8	0023-0054	940.44	54.25	205	52.28	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4341.2	B08		8	0024-0061	241.09	61.83	193	56.77	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4926.0	B08		8	0025-0056	768.83	55.64	147	45.80	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4280.0	B08		8	0026-0060	866.08	60.35	250	59.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1999.9	B08		8	0027-0063	559.18	62.41	294	67.60	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2751.1	B08		8	0028-0063	642.81	63.02	178	48.28	0.959
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1562.3	B08		8	0029-0064	701.82	64.72	262	60.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1059.4	B08		8	0030-0068	91.77	68.89	240	59.11	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2784.1	B08		8	0031-0070	346.19	69.91	273	61.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2505.1	B08		8	0032-0069	838.43	68.84	215	56.18	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3840.6	B08		8	0033-0070	765.62	69.56	157	46.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3973.6	B08		8	0034-0071	878.70	71.36	219	55.70	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4253.3	B08		8	0035-0075	248.18	76.27	218	55.36	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5729.2	B08		8	0036-0076	753.87	77.01	208	55.01	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1354.7	B08		8	0037-0078	789.59	77.65	266	62.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3424.4	B08		8	0038-0080	204.05	79.65	217	54.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2385.2	B08		8	0039-0082	535.30	81.33	202	55.46	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1047.2	B08		8	0040-0086	684.70	86.65	407	78.67	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2673.6	B08		8	0041-0081	911.11	81.40	246	57.70	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2400.8	B08		8	0042-0083	278.01	82.10	183	51.36	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4368.1	B08		8	0043-0083	422.56	82.95	209	52.87	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3152.9	B08		8	0044-0092	521.47	91.87	335	73.11	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			802.3	B08		8	0045-0087	654.93	87.18	272	62.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1221.7	B08		8	0046-0088	803.61	88.22	262	60.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1111.0	B08		8	0047-0085	312.89	85.51	156	48.04	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1819.2	B08		8	0048-0091	506.89	91.64	231	61.11	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3724.7	B08		8	0049-0093	265.32	92.69	347	69.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			16497.3	B08		8	0050-0089	466.44	89.42	126	64.67	0.379
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			8650.2	B08		8	0051-0091	485.54	91.39	178	51.70	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1328.0	B08		8	0052-0095	578.56	94.28	158	52.53	0.720
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			14414.4	B08		8	0053-0098	235.72	97.49	144	47.60	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1054.5	B08		8	0054-0097	312.79	96.29	117	40.63	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1843.4	B08		8	0055-0101	196.52	101.22	216	55.70	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4587.3	B08		8	0056-0109	168.10	109.50	416	84.08	0.739
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1689.5	B08		8	0057-0109	61.26	110.18	302	65.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1364.7	B08		8	0058-0109	325.70	109.43	285	64.53	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			11611.9	B08		8	0059-0105	492.19	104.94	158	46.63	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			16737.2	B08		8	0060-0109	225.69	109.46	155	46.53	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1056.9	B08		8	0061-0110	418.68	110.04	266	61.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3956.2	B08		8	0062-0110	740.53	109.96	202	53.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1532.7	B08		8	0063-0116	365.54	115.83	258	59.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			837.9	B08		8	0064-0117	17.34	117.17	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1679.7	B08		8	0065-0117	710.91	117.16	339	67.60	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3257.4	B08		8	0066-0114	692.08	114.01	112	40.04	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			985.4	B08		8	0067-0116	945.56	116.40	143	45.11	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2986.5	B08		8	0068-0119	476.58	119.53	226	55.94	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4264.3	B08		8	0069-0120	214.16	121.08	218	57.84	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3287.1	B08		8	0070-0123	458.80	122.27	270	66.18	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			902.7	B08		8	0071-0128	621.93	128.49	282	65.11	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			746.2	B08		8	0072-0126	810.83	124.99	255	63.36	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3641.1	B08		8	0073-0129	254.02	128.83	222	57.36	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1286.3	B08		8	0074-0126	312.43	126.66	288	67.94	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1795.1	B08		8	0075-0127	651.45	127.21	274	62.53	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3358.9	B08		8	0076-0124	693.52	124.41	100	38.63	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2574.0	B08		8	0077-0134	544.06	133.88	328	69.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3698.8	B08		8	0078-0131	834.06	131.69	238	57.36	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2838.2	B08		8	0079-0134	916.21	133.84	333	69.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1829.8	B08		8	0080-0139	433.99	140.31	312	67.60	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5490.0	B08		8	0081-0141	742.85	142.35	182	53.36	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1723.0	B08		8	0082-0142	371.39	142.67	287	66.18	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3455.6	B08		8	0083-0142	691.60	143.08	137	49.70	0.697
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4132.2	B08		8	0084-0147	102.87	147.30	221	58.28	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2675.0	B08		8	0085-0146	870.70	146.58	274	63.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			301.6	B08		8	0086-0145	813.59	145.20	244	62.53	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3507.9	B08		8	0087-0147	260.69	146.47	195	52.53	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1384.9	B08		8	0088-0151	610.95	151.63	257	69.60	0.667
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2143.8	B08		8	0089-0151	508.14	151.35	210	54.77	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4162.1	B08		8	0090-0152	201.67	152.39	324	67.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3165.8	B08		8	0091-0153	752.90	153.76	193	51.70	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2805.8	B08		8	0092-0154	646.52	153.18	233	58.53	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			480.8	B08		8	0093-0163	790.71	165.01	286	78.43	0.584
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			440.7	B08		8	0094-0160	115.51	160.99	260	59.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1016.8	B08		8	0095-0163	155.98	162.80	258	62.43	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1045.2	B08		8	0096-0167	638.49	167.91	284	66.67	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1095.0	B08		8	0097-0169	319.81	169.39	287	62.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2296.5	B08		8	0098-0170	387.76	170.51	216	54.53	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1125.0	B08		8	0099-0172	718.99	171.98	280	64.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1569.5	B08		8	0100-0174	444.36	173.61	393	78.43	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2538.1	B08		8	0101-0173	363.23	173.68	207	54.53	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3448.1	B08		8	0102-0172	824.23	172.48	190	52.14	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			7674.1	B08		8	0103-0173	839.23	173.39	161	48.63	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3464.0	B08		8	0104-0174	855.85	173.78	202	54.53	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			14714.9	B08		8	0105-0176	472.06	176.28	277	61.11	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3448.7	B08		8	0106-0176	589.15	176.50	204	53.11	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			17690.1	B08		8	0107-0174	24.47	175.02	132	43.46	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			16338.9	B08		8	0108-0181	916.02	180.69	140	89.98	0.217
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1464.9	B08		8	0109-0191	416.31	190.75	393	73.60	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3423.7	B08		8	0110-0190	557.40	189.97	233	57.36	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2836.6	B08		8	0111-0194	503.96	194.47	352	71.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			8793.4	B08		8	0112-0193	528.14	193.10	302	65.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2737.6	B08		8	0113-0191	576.48	190.90	248	57.70	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			660.6	B08		8	0114-0196	82.44	197.40	250	59.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2235.4	B08		8	0115-0199	731.41	199.55	326	71.84	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			9974.7	B08		8	0116-0206	797.58	204.88	608	103.98	0.707
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2934.2	B08		8	0117-0200	600.24	198.90	321	67.84	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1763.4	B08		8	0118-0201	706.38	200.68	275	65.60	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			652.0	B08		8	0119-0200	105.70	199.53	251	60.77	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3512.2	B08		8	0120-0203	51.33	203.14	263	64.67	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			645.2	B08		8	0121-0201	945.35	201.25	242	64.77	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2638.0	B08		8	0122-0202	841.47	202.21	265	59.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1898.9	B08		8	0123-0204	360.88	204.41	293	66.18	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1431.9	B08		8	0124-0203	473.99	203.12	291	67.36	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			8430.7	B08		8	0125-0209	540.26	210.14	315	74.18	0.719
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4126.5	B08		8	0126-0207	210.90	207.35	301	65.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1039.4	B08		8	0127-0209	653.64	209.25	285	64.77	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2130.1	B08		8	0128-0216	905.41	216.77	342	71.60	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2593.9	B08		8	0129-0217	238.79	216.72	356	70.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3885.2	B08		8	0130-0219	326.08	218.78	230	67.11	0.642
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1001.5	B08		8	0131-0219	404.45	220.29	295	63.11	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1461.3	B08		8	0132-0222	573.44	222.43	240	57.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2212.1	B08		8	0133-0223	825.07	222.16	159	55.11	0.658
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1398.7	B08		8	0134-0228	177.37	228.44	252	65.60	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3025.5	B08		8	0135-0226	444.15	225.99	249	59.70	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2331.2	B08		8	0136-0226	297.91	225.97	241	57.01	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2992.3	B08		8	0137-0226	338.15	227.24	232	60.18	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			10113.4	B08		8	0138-0225	836.01	225.90	134	47.94	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2642.8	B08		8	0139-0231	760.15	231.06	226	56.04	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2615.9	B08		8	0140-0233	362.12	232.89	237	60.18	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			878.0	B08		8	0141-0236	884.11	237.24	290	67.11	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4210.7	B08		8	0142-0238	52.62	238.34	342	68.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3884.9	B08		8	0143-0234	514.13	234.63	207	57.46	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3168.2	B08		8	0144-0239	844.35	239.44	239	58.77	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			931.4	B08		8	0145-0242	131.43	242.42	205	54.53	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			13746.5	B08		8	0146-0241	497.89	242.11	176	49.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1289.4	B08		8	0147-0244	785.63	245.13	262	59.36	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1333.9	B08		8	0148-0244	401.72	243.93	213	54.53	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3313.7	B08		8	0149-0248	624.08	247.94	209	54.53	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2834.6	B08		8	0150-0249	726.50	248.48	254	59.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6001.2	B08		8	0151-0250	757.15	250.54	325	72.18	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3455.4	B08		8	0152-0249	644.05	249.45	254	60.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6530.9	B08		8	0153-0252	104.77	251.94	312	65.11	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3607.4	B08		8	0154-0252	445.78	252.74	217	60.53	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			8619.4	B08		8	0155-0256	571.64	257.18	211	59.70	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4304.9	B08		8	0156-0266	348.79	266.57	640	110.47	0.659
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1371.9	B08		8	0157-0258	883.69	257.58	273	61.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1590.0	B08		8	0158-0256	905.81	256.66	277	63.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			579.4	B08		8	0159-0260	833.84	260.57	489	90.08	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1917.6	B08		8	0160-0260	689.87	260.20	232	57.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3668.8	B08		8	0161-0262	492.09	262.56	290	63.60	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1382.0	B08		8	0162-0267	518.42	267.31	439	80.08	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1103.7	B08		8	0163-0265	186.17	265.60	250	78.91	0.505
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			941.2	B08		8	0164-0265	247.92	265.49	261	59.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1427.6	B08		8	0165-0270	618.28	270.58	224	61.94	0.734
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4120.9	B08		8	0166-0265	797.52	264.67	151	49.11	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2771.6	B08		8	0167-0269	923.08	268.60	250	58.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3044.0	B08		8	0168-0275	409.94	274.74	383	74.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4535.7	B08		8	0169-0276	133.40	275.48	241	61.01	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1040.9	B08		8	0170-0275	47.24	275.34	223	55.11	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1437.3	B08		8	0171-0280	278.01	279.85	388	77.50	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3617.5	B08		8	0172-0279	562.46	279.94	194	57.36	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5375.9	B08		8	0173-0278	458.98	277.90	219	55.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3157.5	B08		8	0174-0278	715.69	277.13	240	59.94	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3232.6	B08		8	0175-0282	119.51	282.12	188	54.53	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2679.8	B08		8	0176-0280	332.96	280.84	132	43.56	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			7251.2	B08		8	0177-0290	891.19	289.75	238	58.18	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4409.8	B08		8	0178-0292	298.21	292.89	218	54.53	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1145.2	B08		8	0179-0295	95.73	294.43	249	61.36	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2805.2	B08		8	0180-0294	330.03	293.71	196	53.46	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2804.6	B08		8	0181-0297	860.98	297.75	317	65.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4036.2	B08		8	0182-0297	512.10	296.55	221	56.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1318.7	B08		8	0183-0303	430.37	303.46	354	71.60	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2939.6	B08		8	0184-0303	479.32	302.65	346	68.18	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3611.2	B08		8	0185-0302	497.46	302.33	187	51.11	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1494.0	B08		8	0186-0303	716.93	302.65	222	57.11	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4623.4	B08		8	0187-0305	830.82	305.53	256	57.94	0.958
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			750.6	B08		8	0188-0310	25.65	309.68	263	66.77	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1256.3	B08		8	0189-0309	198.99	308.92	288	70.67	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1536.0	B08		8	0190-0310	787.30	310.84	332	70.18	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			8363.6	B08		8	0191-0309	934.28	309.96	218	56.28	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			535.2	B08		8	0192-0313	234.95	313.59	264	67.01	0.739
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3532.9	B08		8	0193-0313	297.10	313.57	317	67.01	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1593.7	B08		8	0194-0316	613.92	317.18	222	57.70	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4269.1	B08		8	0195-0319	126.34	319.24	196	63.26	0.616
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			7864.8	B08		8	0196-0320	567.44	319.73	136	47.11	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			11687.0	B08		8	0197-0323	279.05	323.73	192	51.46	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1922.0	B08		8	0198-0328	673.08	328.40	224	62.18	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3955.8	B08		8	0199-0326	330.82	326.80	227	55.94	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3480.3	B08		8	0200-0329	94.74	329.33	229	57.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1795.9	B08		8	0201-0330	718.20	329.79	235	56.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1479.0	B08		8	0202-0331	696.05	331.99	248	57.70	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2028.8	B08		8	0203-0328	485.85	327.96	134	46.87	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2804.5	B08		8	0204-0333	831.68	332.64	270	60.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3016.7	B08		8	0205-0335	182.20	335.61	329	67.36	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1797.7	B08		8	0206-0338	35.69	338.17	193	52.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			8803.9	B08		8	0207-0338	283.63	337.80	194	52.28	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6566.9	B08		8	0208-0341	442.74	341.90	307	66.43	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1611.0	B08		8	0209-0343	495.31	344.36	429	88.67	0.686
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			819.8	B08		8	0210-0341	749.53	341.13	261	59.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5890.3	B08		8	0211-0342	409.14	342.94	258	59.70	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2962.5	B08		8	0212-0344	786.04	343.56	228	55.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2182.3	B08		8	0213-0343	223.49	343.69	205	53.11	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1411.9	B08		8	0214-0345	72.07	344.02	253	60.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1029.9	B08		8	0215-0347	615.45	347.13	290	64.53	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2658.6	B08		8	0216-0349	847.39	348.96	278	64.08	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2520.0	B08		8	0217-0349	162.16	349.02	209	53.94	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1430.3	B08		8	0218-0352	904.73	351.46	230	59.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4208.0	B08		8	0219-0358	239.48	358.57	276	61.01	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3044.0	B08		8	0220-0361	372.20	361.46	328	68.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2268.9	B08		8	0221-0364	732.60	364.38	212	56.53	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			788.3	B08		8	0222-0365	669.58	364.77	308	69.94	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4245.5	B08		8	0223-0363	542.40	363.96	167	48.63	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1335.7	B08		8	0224-0367	825.59	367.27	264	63.01	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1235.6	B08		8	0225-0368	69.91	368.36	423	77.60	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4318.3	B08		8	0226-0367	509.82	366.75	165	49.11	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2941.0	B08		8	0227-0370	842.54	368.99	221	57.36	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3992.1	B08		8	0228-0370	904.68	370.38	299	63.94	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1688.4	B08		8	0229-0374	705.18	375.56	291	65.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			15858.1	B08		8	0230-0380	229.26	379.63	336	69.01	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2072.3	B08		8	0231-0381	625.58	381.14	261	59.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5109.6	B08		8	0232-0380	538.41	379.26	186	52.28	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3664.6	B08		8	0233-0380	122.53	380.11	176	49.46	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4123.5	B08		8	0234-0390	459.42	389.07	472	94.81	0.660
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1669.3	B08		8	0235-0385	174.02	384.99	229	55.11	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2654.6	B08		8	0236-0390	32.31	390.91	315	65.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1107.4	B08		8	0237-0390	476.96	389.92	250	59.46	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5369.3	B08		8	0238-0389	563.53	389.04	227	56.04	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1658.0	B08		8	0239-0392	96.37	392.44	221	54.53	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3003.3	B08		8	0240-0392	140.30	393.04	241	60.53	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3047.2	B08		8	0241-0394	517.34	394.43	226	57.36	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1611.7	B08		8	0242-0393	205.01	393.33	193	53.11	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3545.6	B08		8	0243-0396	357.48	395.76	326	68.43	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1227.1	B08		8	0244-0396	798.26	395.72	268	59.60	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3310.6	B08		8	0245-0393	115.88	393.18	177	49.70	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2011.8	B08		8	0246-0401	285.34	401.61	298	68.67	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2858.1	B08		8	0247-0403	854.48	404.25	271	62.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3240.9	B08		8	0248-0409	874.03	409.15	215	59.36	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			9865.0	B08		8	0249-0410	535.95	410.12	210	57.21	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1682.3	B08		8	0250-0409	757.81	409.18	241	57.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4173.0	B08		8	0251-0408	385.95	408.25	148	47.36	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1336.7	B08		8	0252-0412	51.60	411.98	247	62.43	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1843.2	B08		8	0253-0413	306.91	413.24	351	68.77	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3191.3	B08		8	0254-0411	617.11	411.83	213	54.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4484.5	B08		8	0255-0413	920.61	413.25	248	59.11	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1690.9	B08		8	0256-0425	43.38	424.45	270	64.08	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2170.8	B08		8	0257-0424	197.36	424.82	291	65.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3362.0	B08		8	0258-0426	840.62	426.82	249	59.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1133.2	B08		8	0259-0425	90.69	425.05	252	59.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6881.0	B08		8	0260-0426	395.24	426.38	188	54.18	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			892.0	B08		8	0261-0430	798.43	429.42	316	67.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			963.7	B08		8	0262-0428	429.05	427.54	272	61.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2861.4	B08		8	0263-0430	685.11	429.79	228	59.11	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2626.7	B08		8	0264-0430	536.49	429.89	224	59.21	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4330.2	B08		8	0265-0433	292.44	431.71	270	62.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			848.9	B08		8	0266-0433	463.81	433.41	344	70.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1274.2	B08		8	0267-0440	612.69	440.34	286	66.18	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2429.5	B08		8	0268-0440	376.98	439.41	296	67.36	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3042.6	B08		8	0269-0441	917.64	440.86	239	59.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5444.9	B08		8	0270-0441	571.71	441.23	324	67.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			855.0	B08		8	0271-0448	119.36	447.66	377	73.60	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1675.2	B08		8	0272-0444	709.38	444.02	214	53.70	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3341.1	B08		8	0273-0446	210.10	445.78	171	49.70	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3912.1	B08		8	0274-0450	251.93	449.17	467	84.33	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3259.2	B08		8	0275-0445	284.42	445.95	125	42.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1695.0	B08		8	0276-0447	758.43	447.39	273	63.36	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			586.4	B08		8	0277-0447	510.30	448.26	285	65.60	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5014.0	B08		8	0278-0451	197.74	451.73	214	54.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3362.7	B08		8	0279-0452	679.58	452.71	229	56.53	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			857.5	B08		8	0280-0455	414.52	455.68	259	65.26	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3105.1	B08		8	0281-0458	645.04	457.69	235	57.70	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			946.3	B08		8	0282-0461	893.09	460.31	237	61.11	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1878.1	B08		8	0283-0461	806.05	461.06	265	61.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1408.2	B08		8	0284-0460	849.37	459.94	300	73.26	0.703
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4198.2	B08		8	0285-0467	482.18	466.42	278	65.36	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6599.5	B08		8	0286-0467	502.80	466.67	202	52.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			7404.8	B08		8	0287-0468	175.68	468.11	131	44.39	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4877.1	B08		8	0288-0469	188.14	470.18	220	55.46	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			7677.1	B08		8	0289-0470	164.58	470.70	133	44.87	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1403.6	B08		8	0290-0473	445.19	473.32	256	60.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3675.0	B08		8	0291-0476	340.33	476.43	305	64.43	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3600.4	B08		8	0292-0475	146.13	474.35	224	54.53	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1941.7	B08		8	0293-0476	594.06	476.63	181	50.28	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1790.7	B08		8	0294-0475	282.54	475.44	216	54.53	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1015.6	B08		8	0295-0480	38.72	480.74	281	66.67	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2116.0	B08		8	0296-0475	863.09	475.58	237	58.28	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2983.0	B08		8	0297-0476	670.54	476.17	223	56.28	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5263.4	B08		8	0298-0483	521.14	482.66	460	89.98	0.714
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			888.0	B08		8	0299-0486	72.47	487.20	271	64.77	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3738.9	B08		8	0300-0491	98.43	491.48	476	90.33	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1586.9	B08		8	0301-0489	681.87	489.05	240	57.94	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2910.9	B08		8	0302-0495	317.38	494.84	179	53.36	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3899.3	B08		8	0303-0498	424.53	498.54	275	61.60	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2857.3	B08		8	0304-0496	801.89	496.68	186	52.53	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1034.2	B08		8	0305-0496	568.46	496.21	140	45.46	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1139.9	B08		8	0306-0500	925.96	500.83	237	59.36	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2596.1	B08		8	0307-0506	409.35	506.26	265	71.36	0.654
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2135.0	B08		8	0308-0503	162.81	503.82	231	57.94	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3247.3	B08		8	0309-0502	252.53	502.28	254	61.11	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2266.3	B08		8	0310-0502	720.89	503.30	199	55.11	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3762.5	B08		8	0311-0506	118.28	506.07	213	55.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1489.1	B08		8	0312-0506	213.48	506.27	246	58.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1018.3	B08		8	0313-0505	513.95	505.20	270	61.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			915.7	B08		8	0314-0512	391.39	512.53	273	65.26	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1607.9	B08		8	0315-0508	573.78	508.38	197	52.63	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2661.6	B08		8	0316-0513	459.25	513.30	269	62.77	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			7929.9	B08		8	0317-0516	279.40	515.67	340	72.91	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2243.9	B08		8	0318-0517	34.47	517.38	330	67.01	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2340.4	B08		8	0319-0519	191.56	519.29	327	67.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1620.8	B08		8	0320-0520	598.95	520.02	222	58.43	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			762.7	B08		8	0321-0521	490.02	521.05	227	55.70	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1396.2	B08		8	0322-0523	544.13	524.15	269	79.01	0.541
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			920.5	B08		8	0323-0524	373.61	524.93	246	58.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3766.3	B08		8	0324-0524	249.55	524.74	219	54.87	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1629.4	B08		8	0325-0528	587.81	528.57	220	57.26	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1621.0	B08		8	0326-0528	661.83	528.57	227	57.11	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2861.0	B08		8	0327-0529	741.26	528.96	331	66.18	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			7060.8	B08		8	0328-0529	265.76	529.33	168	49.11	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4095.7	B08		8	0329-0530	886.67	530.57	195	53.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3896.1	B08		8	0330-0536	475.34	535.73	334	73.36	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1722.3	B08		8	0331-0532	693.26	532.27	262	62.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2151.4	B08		8	0332-0535	904.34	535.08	217	57.11	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1288.6	B08		8	0333-0540	503.66	539.29	356	73.01	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3262.1	B08		8	0334-0536	837.33	536.46	168	51.11	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			519.4	B08		8	0335-0540	618.73	540.15	265	63.60	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1631.9	B08		8	0336-0545	108.17	545.82	246	60.77	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			12044.9	B08		8	0337-0540	310.74	540.38	112	45.11	0.692
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			827.7	B08		8	0338-0544	540.04	543.04	278	84.91	0.485
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1170.3	B08		8	0339-0543	647.59	542.83	260	59.94	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2564.1	B08		8	0340-0543	228.87	543.02	213	53.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3643.6	B08		8	0341-0547	440.74	547.05	393	74.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			760.3	B08		8	0342-0547	294.62	547.99	340	68.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1278.4	B08		8	0343-0549	63.74	548.50	494	85.84	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1468.5	B08		8	0344-0547	405.03	547.38	199	53.94	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1263.7	B08		8	0345-0553	720.38	553.08	424	78.91	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1067.5	B08		8	0346-0555	585.25	555.47	238	57.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1229.2	B08		8	0347-0557	930.45	557.56	203	53.94	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2296.6	B08		8	0348-0561	829.71	561.23	214	54.53	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5435.6	B08		8	0349-0561	149.59	561.09	177	51.11	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			792.4	B08		8	0350-0565	359.49	565.73	275	60.28	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1802.9	B08		8	0351-0567	899.27	567.38	262	59.60	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4569.5	B08		8	0352-0583	151.66	583.78	549	92.33	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2478.8	B08		8	0353-0575	301.99	574.27	211	54.53	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2037.9	B08		8	0354-0579	446.16	578.94	247	60.43	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1067.2	B08		8	0355-0580	653.80	579.80	251	60.77	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2407.3	B08		8	0356-0578	881.69	578.52	187	50.28	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			469.9	B08		8	0357-0582	591.28	583.00	268	61.26	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			941.7	B08		8	0358-0586	635.36	586.45	320	72.43	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1448.1	B08		8	0359-0585	522.96	585.30	305	67.36	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1931.1	B08		8	0360-0587	364.23	587.18	323	67.01	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			11998.7	B08		8	0361-0584	292.96	585.51	169	49.11	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1035.1	B08		8	0362-0586	710.05	586.60	261	61.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1305.5	B08		8	0363-0588	546.84	587.82	378	76.18	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			576.4	B08		8	0364-0585	746.54	585.66	197	52.28	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1831.9	B08		8	0365-0594	428.50	594.90	260	61.36	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5993.7	B08		8	0366-0591	791.24	591.44	157	44.87	0.980
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2331.5	B08		8	0367-0594	106.89	593.63	301	67.36	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2937.8	B08		8	0368-0597	409.77	597.79	382	73.26	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1043.8	B08		8	0369-0601	38.88	600.70	394	73.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1732.8	B08		8	0370-0599	245.03	599.26	215	57.11	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			9307.6	B08		8	0371-0603	294.83	602.94	352	87.26	0.581
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1943.7	B08		8	0372-0603	122.93	603.29	228	56.77	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1161.0	B08		8	0373-0602	745.82	602.88	254	59.70	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3179.9	B08		8	0374-0608	772.61	607.70	396	82.08	0.739
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3886.9	B08		8	0375-0611	588.28	610.98	281	61.11	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1366.6	B08		8	0376-0612	691.92	612.85	280	65.36	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			883.1	B08		8	0377-0611	621.03	610.64	266	65.11	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1723.1	B08		8	0378-0615	660.18	615.09	219	54.77	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			500.6	B08		8	0379-0615	91.00	615.30	225	55.11	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			678.8	B08		8	0380-0622	353.66	621.48	274	67.60	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			324.9	B08		8	0381-0617	484.70	617.51	235	57.46	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2646.4	B08		8	0382-0619	283.71	620.14	193	51.46	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1297.9	B08		8	0383-0624	540.61	624.20	286	64.43	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1909.8	B08		8	0384-0623	809.43	623.21	223	55.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1782.8	B08		8	0385-0626	369.46	626.27	240	59.11	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			506.6	B08		8	0386-0628	750.05	628.17	455	80.08	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5540.0	B08		8	0387-0626	315.90	625.91	218	54.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1187.8	B08		8	0388-0630	400.01	630.46	315	65.01	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			549.9	B08		8	0389-0634	103.08	633.11	250	61.60	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			15233.3	B08		8	0390-0633	301.76	632.85	182	52.77	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			729.0	B08		8	0391-0634	920.99	635.17	270	65.01	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5392.3	B08		8	0392-0641	826.35	642.57	525	91.01	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			893.8	B08		8	0393-0636	250.17	635.64	243	57.11	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			14870.2	B08		8	0394-0636	286.29	635.91	299	67.11	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2377.0	B08		8	0395-0640	56.08	640.78	309	64.18	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4983.3	B08		8	0396-0645	176.16	644.35	531	89.74	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3944.4	B08		8	0397-0642	149.11	641.65	448	83.26	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3547.0	B08		8	0398-0641	548.88	641.16	219	57.01	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2308.1	B08		8	0399-0644	331.95	643.38	244	59.60	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1913.2	B08		8	0400-0644	615.31	644.31	242	60.53	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1813.8	B08		8	0401-0653	518.96	653.04	290	69.36	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3155.1	B08		8	0402-0654	562.67	654.67	315	66.18	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1816.4	B08		8	0403-0658	878.27	658.10	486	88.33	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			872.3	B08		8	0404-0659	685.60	660.49	274	65.60	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			7576.2	B08		8	0405-0660	134.72	659.99	277	61.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3427.4	B08		8	0406-0659	651.26	658.94	214	56.18	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			9169.1	B08		8	0407-0662	215.01	661.71	477	97.64	0.629
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2412.0	B08		8	0408-0660	432.11	659.62	345	68.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1425.3	B08		8	0409-0661	746.57	660.93	266	60.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			623.9	B08		8	0410-0660	941.90	660.60	248	60.28	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			11266.2	B08		8	0411-0660	189.48	661.10	161	49.11	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5893.7	B08		8	0412-0661	39.92	660.81	174	50.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3501.3	B08		8	0413-0664	81.31	663.61	225	57.70	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3193.6	B08		8	0414-0668	27.47	667.37	212	59.36	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1441.6	B08		8	0415-0670	173.32	670.15	233	58.53	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1856.8	B08		8	0416-0671	593.71	671.10	209	53.94	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1901.4	B08		8	0417-0679	567.36	678.71	242	59.84	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			856.4	B08		8	0418-0680	633.95	680.76	292	63.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			763.5	B08		8	0419-0685	777.50	685.49	371	71.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2145.4	B08		8	0420-0687	429.91	687.24	392	75.01	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			781.7	B08		8	0421-0684	263.38	684.17	218	56.53	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1349.7	B08		8	0422-0686	584.10	686.88	285	67.01	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2623.2	B08		8	0423-0680	903.82	679.87	100	37.21	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1740.3	B08		8	0424-0688	864.67	688.04	231	55.36	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2947.7	B08		8	0425-0688	80.75	689.10	232	57.11	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2845.6	B08		8	0426-0690	240.48	690.82	319	66.43	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1180.3	B08		8	0427-0693	719.10	693.26	270	60.53	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1963.6	B08		8	0428-0691	901.19	691.00	113	40.63	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1949.3	B08		8	0429-0697	17.33	697.09	223	56.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2527.3	B08		8	0430-0698	42.08	697.67	293	61.94	0.960
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2424.8	B08		8	0431-0699	548.17	698.83	224	56.28	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2677.4	B08		8	0432-0702	522.67	703.01	282	71.01	0.703
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4432.9	B08		8	0433-0703	351.47	703.31	310	65.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2708.4	B08		8	0434-0703	796.34	702.67	220	56.18	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1263.2	B08		8	0435-0702	574.57	702.78	210	54.28	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			588.1	B08		8	0436-0706	669.98	705.58	287	71.60	0.704
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1360.1	B08		9	0001-0029	375.41	28.74	246	63.11	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3714.2	B08		9	0002-0035	296.66	35.80	264	59.94	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1536.5	B08		9	0003-0036	644.36	36.42	315	66.53	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2951.5	B08		9	0004-0038	498.11	37.25	198	56.28	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2646.5	B08		9	0005-0041	524.43	41.73	478	87.74	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1928.2	B08		9	0006-0036	419.86	35.88	237	57.11	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			760.8	B08		9	0007-0037	916.03	37.79	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5994.4	B08		9	0008-0038	140.82	38.08	237	56.53	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1403.5	B08		9	0009-0041	868.08	40.29	256	63.26	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2223.9	B08		9	0010-0042	802.53	43.08	239	57.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1144.9	B08		9	0011-0045	752.63	45.65	300	67.94	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3708.9	B08		9	0012-0043	77.15	42.42	188	50.53	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3873.6	B08		9	0013-0043	22.75	43.23	221	55.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4669.9	B08		9	0014-0048	195.35	48.09	125	41.11	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5059.0	B08		9	0015-0057	182.56	57.31	447	82.91	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			988.9	B08		9	0016-0059	157.91	60.02	233	61.01	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2222.9	B08		9	0017-0057	34.87	57.15	199	51.70	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			665.8	B08		9	0018-0056	285.96	56.48	248	60.77	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2561.4	B08		9	0019-0062	107.83	62.92	258	61.94	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1197.7	B08		9	0020-0064	915.19	64.42	323	65.60	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			9359.4	B08		9	0021-0069	346.07	69.89	504	96.57	0.679
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4543.9	B08		9	0022-0063	704.13	62.44	191	53.70	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1088.1	B08		9	0023-0066	436.04	66.09	338	70.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1567.1	B08		9	0024-0068	580.73	68.94	270	62.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2237.0	B08		9	0025-0070	725.46	70.06	223	58.77	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			830.8	B08		9	0026-0072	284.31	72.25	291	63.36	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1104.2	B08		9	0027-0075	862.66	75.75	196	53.11	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			349.9	B08		9	0028-0081	662.91	82.52	347	71.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1218.3	B08		9	0029-0080	395.44	80.30	251	58.87	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1562.0	B08		9	0030-0082	932.73	81.71	281	61.60	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2580.5	B08		9	0031-0086	835.57	86.40	322	67.01	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1028.2	B08		9	0032-0088	176.88	88.51	268	61.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			963.8	B08		9	0033-0089	413.59	90.14	246	62.77	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			363.5	B08		9	0034-0092	612.75	92.05	284	68.08	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1670.9	B08		9	0035-0089	761.59	88.86	231	57.70	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1246.1	B08		9	0036-0095	240.04	95.34	359	70.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			8026.8	B08		9	0037-0092	365.95	91.80	166	51.70	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3391.2	B08		9	0038-0097	107.13	96.97	346	69.01	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5612.3	B08		9	0039-0095	479.40	93.97	208	55.01	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6826.2	B08		9	0040-0095	395.91	94.90	126	44.28	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			8522.8	B08		9	0041-0100	384.59	100.22	192	62.67	0.614
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			852.7	B08		9	0042-0101	710.55	101.66	287	74.08	0.657
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			9991.5	B08		9	0043-0110	644.32	111.09	321	72.18	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			7027.2	B08		9	0044-0106	372.78	107.06	198	52.77	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5917.4	B08		9	0045-0110	466.14	110.96	338	70.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			906.0	B08		9	0046-0112	75.69	112.16	235	56.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			897.1	B08		9	0047-0116	36.68	116.61	256	63.01	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1498.8	B08		9	0048-0118	294.42	117.84	409	74.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3113.9	B08		9	0049-0119	431.62	119.28	337	71.84	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1705.5	B08		9	0050-0120	677.17	120.32	449	78.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2488.3	B08		9	0051-0121	411.39	121.23	277	62.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			871.2	B08		9	0052-0128	190.63	128.16	380	73.36	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1339.0	B08		9	0053-0126	224.06	125.99	270	63.94	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1328.7	B08		9	0054-0128	144.88	128.15	231	56.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1173.1	B08		9	0055-0133	746.35	133.64	381	73.26	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1120.3	B08		9	0056-0134	835.53	133.85	352	78.33	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1556.4	B08		9	0057-0139	253.74	138.75	396	74.67	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3989.9	B08		9	0058-0141	818.10	141.83	228	57.11	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			826.8	B08		9	0059-0144	47.69	143.22	250	61.36	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1257.3	B08		9	0060-0146	541.50	146.66	220	58.77	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3229.4	B08		9	0061-0150	866.35	150.41	235	57.60	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2957.7	B08		9	0062-0149	219.61	150.24	257	61.11	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1324.5	B08		9	0063-0153	936.51	153.32	219	56.53	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1073.6	B08		9	0064-0152	631.80	151.95	274	63.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			697.2	B08		9	0065-0156	715.63	156.14	264	59.94	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3824.3	B08		9	0066-0159	132.93	160.15	351	80.08	0.688
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1863.2	B08		9	0067-0159	577.05	159.47	210	55.70	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1644.7	B08		9	0068-0161	523.25	160.27	245	71.60	0.601
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1004.0	B08		9	0069-0166	589.08	166.62	279	68.18	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4756.7	B08		9	0070-0168	857.63	168.79	337	69.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2315.1	B08		9	0071-0168	163.28	168.37	218	58.77	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			750.3	B08		9	0072-0167	753.10	167.95	345	77.36	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1240.4	B08		9	0073-0170	813.41	169.51	207	59.11	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1740.8	B08		9	0074-0173	337.38	173.65	437	79.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1815.0	B08		9	0075-0173	53.07	173.78	231	57.94	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			735.0	B08		9	0076-0177	659.41	177.28	409	77.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1502.2	B08		9	0077-0177	903.32	177.17	420	77.26	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			8709.4	B08		9	0078-0177	119.07	177.60	157	47.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			9229.4	B08		9	0079-0179	279.29	179.71	293	63.94	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1012.0	B08		9	0080-0180	544.45	179.49	254	59.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1281.4	B08		9	0081-0186	495.05	186.44	413	75.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1761.2	B08		9	0082-0189	700.98	189.95	318	74.67	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1556.7	B08		9	0083-0200	82.82	200.43	296	66.18	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			694.5	B08		9	0084-0201	898.68	200.80	261	61.84	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			718.8	B08		9	0085-0203	39.87	204.14	236	65.01	0.702
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2053.3	B08		9	0086-0210	142.72	209.61	345	69.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1284.2	B08		9	0087-0210	815.25	209.94	406	75.60	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4392.0	B08		9	0088-0215	585.72	215.59	294	65.60	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2889.3	B08		9	0089-0220	316.80	220.33	296	63.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2074.1	B08		9	0090-0225	761.42	225.12	457	83.26	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2215.2	B08		9	0091-0221	68.78	221.25	223	57.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5925.2	B08		9	0092-0222	712.47	222.20	219	55.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1660.8	B08		9	0093-0229	444.65	229.37	286	62.53	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2629.4	B08		9	0094-0229	257.22	228.54	248	60.77	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1023.9	B08		9	0095-0230	419.36	229.52	313	66.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3829.5	B08		9	0096-0228	934.52	228.45	208	55.11	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			7749.9	B08		9	0097-0233	696.55	233.45	214	54.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2625.7	B08		9	0098-0232	866.73	232.18	273	61.60	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5521.9	B08		9	0099-0240	469.31	240.67	512	91.50	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5172.4	B08		9	0100-0231	583.41	230.91	168	48.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			850.9	B08		9	0101-0237	641.00	236.87	303	71.01	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1316.4	B08		9	0102-0237	786.48	236.79	348	67.60	0.957
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2860.6	B08		9	0103-0238	568.60	238.28	246	62.18	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2707.6	B08		9	0104-0243	188.18	242.63	287	63.94	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1226.1	B08		9	0105-0245	37.25	244.38	184	53.70	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3653.6	B08		9	0106-0247	51.01	246.24	250	65.36	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1919.8	B08		9	0107-0246	387.87	246.42	235	58.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1942.9	B08		9	0108-0247	668.56	246.78	218	58.53	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2683.7	B08		9	0109-0246	67.09	246.25	134	44.04	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2658.1	B08		9	0110-0249	757.96	250.41	242	59.84	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2382.4	B08		9	0111-0251	114.69	250.68	376	73.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3306.1	B08		9	0112-0249	731.62	249.28	190	51.70	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2682.9	B08		9	0113-0256	95.29	255.88	233	57.46	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2454.7	B08		9	0114-0264	314.31	264.28	268	63.11	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3574.0	B08		9	0115-0263	73.71	263.86	225	61.36	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1889.7	B08		9	0116-0262	474.21	262.79	286	65.94	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2120.2	B08		9	0117-0270	339.27	270.00	284	63.36	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6027.4	B08		9	0118-0269	535.85	268.73	309	66.18	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5183.0	B08		9	0119-0269	182.69	270.82	188	52.63	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2370.9	B08		9	0120-0272	17.79	271.66	249	58.53	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2099.8	B08		9	0121-0275	763.22	275.32	256	58.53	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5791.6	B08		9	0122-0277	555.54	277.08	261	60.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2903.1	B08		9	0123-0284	50.90	284.12	340	70.53	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1705.3	B08		9	0124-0281	99.05	281.25	217	54.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			911.1	B08		9	0125-0287	246.12	287.94	272	67.84	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4318.8	B08		9	0126-0292	726.80	291.74	517	93.15	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3182.9	B08		9	0127-0290	183.49	289.35	416	76.18	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			9456.9	B08		9	0128-0289	334.17	289.12	270	59.94	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6420.2	B08		9	0129-0291	540.49	291.77	368	70.43	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3835.7	B08		9	0130-0292	449.98	292.00	252	57.11	0.971
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2361.5	B08		9	0131-0295	589.40	296.33	240	59.94	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2225.2	B08		9	0132-0294	801.72	294.94	278	69.84	0.716
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2385.2	B08		9	0133-0295	493.60	294.97	291	63.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1136.5	B08		9	0134-0300	260.29	300.34	263	68.77	0.699
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3575.4	B08		9	0135-0306	171.30	306.21	233	57.94	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			8319.7	B08		9	0136-0312	29.03	312.93	218	56.53	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2466.1	B08		9	0137-0311	895.81	310.71	243	58.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			568.8	B08		9	0138-0318	53.27	318.60	345	82.08	0.643
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2237.6	B08		9	0139-0316	771.09	315.11	296	64.53	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4255.9	B08		9	0140-0318	229.24	318.55	191	51.70	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1159.5	B08		9	0141-0320	438.45	319.63	210	55.70	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2472.3	B08		9	0142-0321	467.78	320.33	229	56.28	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3586.8	B08		9	0143-0321	317.76	321.39	263	67.36	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1024.1	B08		9	0144-0328	922.76	328.97	281	67.11	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2048.1	B08		9	0145-0327	186.14	327.13	204	54.53	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2524.7	B08		9	0146-0334	85.06	333.61	377	76.18	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			714.1	B08		9	0147-0328	528.84	327.56	216	57.70	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1713.8	B08		9	0148-0337	300.90	337.37	226	68.91	0.598
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1663.2	B08		9	0149-0338	407.57	338.42	370	72.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1528.9	B08		9	0150-0340	108.35	340.54	212	56.28	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1730.2	B08		9	0151-0341	495.40	341.38	246	59.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3292.4	B08		9	0152-0341	755.99	340.88	209	54.28	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2684.6	B08		9	0153-0343	626.36	343.83	258	58.77	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1749.3	B08		9	0154-0344	427.02	344.31	229	57.46	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2170.2	B08		9	0155-0345	682.42	345.77	237	57.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1298.4	B08		9	0156-0352	877.69	351.77	267	62.87	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			515.3	B08		9	0157-0354	511.28	354.98	227	59.94	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1385.6	B08		9	0158-0355	359.05	355.36	404	74.18	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1074.9	B08		9	0159-0357	108.57	356.48	250	58.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4075.6	B08		9	0160-0362	712.63	362.15	219	55.36	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1049.0	B08		9	0161-0364	854.69	363.71	235	58.77	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3030.3	B08		9	0162-0374	762.71	374.69	251	58.53	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5598.3	B08		9	0163-0382	541.62	381.84	369	69.84	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2528.2	B08		9	0164-0384	836.72	385.18	259	62.53	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1309.0	B08		9	0165-0388	132.56	388.06	423	79.84	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3423.3	B08		9	0166-0383	443.86	383.52	208	54.53	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2900.1	B08		9	0167-0385	591.05	385.30	269	63.36	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3829.5	B08		9	0168-0383	795.38	383.11	199	51.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1748.1	B08		9	0169-0386	880.30	385.53	249	63.84	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2446.6	B08		9	0170-0388	609.83	388.72	299	68.18	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2424.4	B08		9	0171-0392	751.60	392.00	346	68.18	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2581.1	B08		9	0172-0392	61.36	392.33	283	61.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6406.2	B08		9	0173-0398	557.28	397.94	324	66.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			696.8	B08		9	0174-0397	499.20	396.92	252	61.11	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2127.3	B08		9	0175-0403	283.02	403.64	278	66.53	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			786.4	B08		9	0176-0402	205.79	402.27	267	61.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			721.3	B08		9	0177-0403	233.59	403.91	230	58.28	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1690.8	B08		9	0178-0405	473.13	404.50	404	75.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2347.3	B08		9	0179-0406	83.40	406.15	256	65.60	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3465.2	B08		9	0180-0413	789.67	413.15	247	57.36	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2974.4	B08		9	0181-0416	426.35	416.54	220	56.53	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			885.9	B08		9	0182-0423	837.61	424.02	364	74.91	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1500.3	B08		9	0183-0421	305.15	420.27	213	56.53	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1268.4	B08		9	0184-0422	494.32	422.69	230	56.43	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			874.4	B08		9	0185-0426	371.17	426.66	319	67.01	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1292.2	B08		9	0186-0427	537.70	427.27	339	69.01	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4654.6	B08		9	0187-0432	685.33	431.98	231	59.36	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			500.5	B08		9	0188-0431	97.98	430.39	188	56.39	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1881.4	B08		9	0189-0433	54.32	433.29	233	60.53	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4495.6	B08		9	0190-0436	449.92	436.02	269	60.53	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			475.2	B08		9	0191-0442	519.64	442.54	258	64.87	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1122.8	B08		9	0192-0439	203.08	439.76	261	62.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			14026.3	B08		9	0193-0437	789.12	437.27	116	40.63	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5793.1	B08		9	0194-0440	878.12	440.65	189	52.77	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			474.6	B08		9	0195-0443	98.41	442.84	227	59.11	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			992.3	B08		9	0196-0447	570.66	447.10	432	77.26	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3380.5	B08		9	0197-0448	170.09	448.37	247	57.94	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1305.5	B08		9	0198-0446	269.82	445.98	162	47.70	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1372.9	B08		9	0199-0446	254.95	446.32	123	39.70	0.981
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3980.1	B08		9	0200-0452	673.57	452.65	230	79.15	0.461
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3001.4	B08		9	0201-0452	307.23	451.83	314	65.60	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3277.8	B08		9	0202-0455	458.89	454.01	262	61.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4469.4	B08		9	0203-0454	867.79	454.33	272	60.77	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2342.5	B08		9	0204-0457	197.88	457.55	260	59.94	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3528.8	B08		9	0205-0458	886.30	458.69	261	59.11	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1414.4	B08		9	0206-0461	116.98	460.20	312	66.77	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			988.0	B08		9	0207-0457	382.26	457.42	169	48.87	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1365.6	B08		9	0208-0462	262.87	461.81	282	64.18	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2354.5	B08		9	0209-0462	492.45	462.02	229	58.77	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			8725.5	B08		9	0210-0465	652.17	465.62	167	52.53	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1318.7	B08		9	0211-0467	447.34	467.17	217	56.53	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1233.7	B08		9	0212-0471	237.87	471.44	203	54.53	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1359.5	B08		9	0213-0475	615.13	476.07	237	61.94	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4576.5	B08		9	0214-0474	890.92	474.25	224	58.77	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			715.1	B08		9	0215-0477	410.11	477.40	250	60.28	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1867.3	B08		9	0216-0481	835.88	480.63	245	68.43	0.658
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1522.6	B08		9	0217-0482	131.20	482.57	312	67.36	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1505.2	B08		9	0218-0485	789.47	484.56	241	57.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3539.7	B08		9	0219-0488	293.83	487.81	344	69.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			845.1	B08		9	0220-0493	57.35	493.06	480	85.50	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1771.7	B08		9	0221-0491	203.22	491.41	302	64.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			900.9	B08		9	0222-0490	177.03	490.29	235	56.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1658.7	B08		9	0223-0495	751.21	495.28	280	66.77	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			754.6	B08		9	0224-0498	80.23	499.11	399	74.43	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3406.8	B08		9	0225-0497	922.77	497.48	204	57.70	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1166.7	B08		9	0226-0502	236.73	501.88	415	75.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3435.9	B08		9	0227-0498	573.39	498.78	297	62.53	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2867.9	B08		9	0228-0500	322.76	499.64	277	61.60	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1246.5	B08		9	0229-0502	506.79	501.80	248	58.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1063.6	B08		9	0230-0503	20.49	503.65	227	58.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3434.1	B08		9	0231-0503	613.53	503.98	219	57.60	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2730.8	B08		9	0232-0506	148.19	505.77	242	59.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2160.2	B08		9	0233-0507	431.14	506.84	291	62.53	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2149.5	B08		9	0234-0507	638.99	507.50	240	56.53	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2659.5	B08		9	0235-0513	402.86	513.41	325	66.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			918.9	B08		9	0236-0514	539.86	512.74	302	67.84	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1580.4	B08		9	0237-0515	869.62	515.16	264	61.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			823.7	B08		9	0238-0516	369.98	516.93	269	64.18	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1360.8	B08		9	0239-0519	104.22	518.97	321	67.26	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3253.7	B08		9	0240-0525	570.22	526.36	302	65.94	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2357.0	B08		9	0241-0528	304.28	527.73	282	63.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			411.7	B08		9	0242-0532	817.06	532.15	301	66.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1728.9	B08		9	0243-0529	424.39	528.53	175	47.94	0.957
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2162.8	B08		9	0244-0536	692.32	536.35	300	71.01	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1565.3	B08		9	0245-0535	203.65	535.32	324	70.77	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			730.8	B08		9	0246-0534	332.49	534.09	240	59.60	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2631.8	B08		9	0247-0535	479.98	535.04	241	57.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3431.0	B08		9	0248-0535	624.18	535.37	228	54.53	0.964
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1359.1	B08		9	0249-0541	520.93	541.71	289	66.08	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1240.5	B08		9	0250-0540	436.99	540.78	196	51.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1153.3	B08		9	0251-0542	849.90	542.58	274	61.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2692.2	B08		9	0252-0547	578.88	546.35	334	73.26	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2613.2	B08		9	0253-0547	64.50	546.90	227	56.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1938.0	B08		9	0254-0548	272.23	548.62	433	82.67	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2338.3	B08		9	0255-0549	125.58	549.29	309	65.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2470.1	B08		9	0256-0552	634.80	553.72	295	69.01	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1374.2	B08		9	0257-0554	757.50	554.76	286	61.94	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1373.8	B08		9	0258-0558	555.44	558.53	254	60.77	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1235.5	B08		9	0259-0560	24.96	560.43	200	53.70	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2854.9	B08		9	0260-0562	697.90	561.96	263	64.77	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1164.2	B08		9	0261-0563	849.83	563.63	267	62.77	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3580.2	B08		9	0262-0566	598.76	565.95	287	64.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2032.7	B08		9	0263-0565	51.84	565.11	217	53.94	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			579.8	B08		9	0264-0568	888.61	568.11	289	68.43	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			492.3	B08		9	0265-0572	386.02	571.90	243	58.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			918.0	B08		9	0266-0575	514.40	575.95	281	61.70	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1985.7	B08		9	0267-0581	532.87	581.25	353	71.94	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1312.8	B08		9	0268-0579	287.29	578.41	257	65.84	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			708.9	B08		9	0269-0584	864.73	583.81	303	73.26	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3313.0	B08		9	0270-0584	646.24	584.16	276	63.01	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1762.9	B08		9	0271-0585	50.25	586.00	238	56.53	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2260.0	B08		9	0272-0588	179.41	588.74	349	70.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1526.3	B08		9	0273-0590	332.10	590.35	315	67.36	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2972.8	B08		9	0274-0586	763.04	585.73	159	46.28	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2360.6	B08		9	0275-0592	716.93	591.83	260	62.43	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1808.1	B08		9	0276-0596	84.07	595.42	314	70.43	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			350.5	B08		9	0277-0596	569.57	597.08	525	102.57	0.627
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2146.9	B08		9	0278-0595	813.75	595.63	252	65.36	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2978.1	B08		9	0279-0592	473.14	591.49	225	56.87	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1351.1	B08		9	0280-0596	369.67	596.03	280	62.18	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3498.8	B08		9	0281-0596	774.53	596.67	295	65.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2071.0	B08		9	0282-0601	122.68	601.11	241	61.84	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			573.6	B08		9	0283-0598	437.42	599.28	254	61.94	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1678.8	B08		9	0284-0604	937.38	603.42	278	62.53	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5402.6	B08		9	0285-0604	397.84	603.82	232	55.36	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3734.7	B08		9	0286-0609	894.82	608.75	206	54.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1183.2	B08		9	0287-0616	115.39	616.74	322	71.60	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2151.5	B08		9	0288-0614	727.58	614.63	374	73.01	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1408.0	B08		9	0289-0615	291.21	615.32	234	60.18	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4113.1	B08		9	0290-0611	909.17	611.05	147	46.04	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2020.2	B08		9	0291-0616	59.21	615.88	279	62.18	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2152.7	B08		9	0292-0616	645.44	616.87	345	73.26	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3297.0	B08		9	0293-0617	868.69	617.47	490	92.81	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			726.8	B08		9	0294-0618	309.51	618.88	216	61.84	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1437.9	B08		9	0295-0618	274.72	618.27	204	54.53	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1450.6	B08		9	0296-0622	927.25	621.70	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2020.0	B08		9	0297-0624	218.76	623.81	309	63.60	0.960
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4167.1	B08		9	0298-0628	473.80	627.67	178	52.53	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2908.5	B08		9	0299-0629	88.26	629.56	283	62.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2176.8	B08		9	0300-0629	777.02	628.82	261	61.01	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1347.5	B08		9	0301-0635	568.32	635.08	290	73.84	0.668
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1994.9	B08		9	0302-0631	810.05	630.69	249	63.26	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2488.7	B08		9	0303-0630	383.60	630.36	218	53.36	0.962
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2487.0	B08		9	0304-0632	640.10	632.53	232	59.70	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2145.9	B08		9	0305-0633	902.89	632.87	350	68.18	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2191.7	B08		9	0306-0631	325.68	632.39	263	60.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4141.1	B08		9	0307-0633	688.22	633.46	306	63.94	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1249.0	B08		9	0308-0640	182.52	640.32	330	69.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1571.3	B08		9	0309-0639	110.84	638.95	229	56.53	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3285.7	B08		9	0310-0642	264.97	641.97	190	53.36	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1097.8	B08		9	0311-0642	946.31	642.26	211	55.94	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6973.4	B08		9	0312-0653	717.73	653.94	494	85.15	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1579.7	B08		9	0313-0650	429.31	649.95	196	52.28	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1257.7	B08		9	0314-0655	504.15	656.17	268	64.18	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1420.9	B08		9	0315-0652	657.70	652.90	261	59.11	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5012.9	B08		9	0316-0654	70.78	654.67	174	51.11	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			879.8	B08		9	0317-0657	339.71	657.78	226	56.53	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			442.8	B08		9	0318-0655	383.03	655.64	149	48.87	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			823.1	B08		9	0319-0657	200.29	656.11	247	59.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3625.5	B08		9	0320-0658	839.59	659.58	154	49.70	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1407.6	B08		9	0321-0657	444.85	658.14	127	47.11	0.719
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4998.3	B08		9	0322-0661	623.12	662.42	258	63.60	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			7102.4	B08		9	0323-0658	568.08	658.62	172	49.70	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4618.2	B08		9	0324-0659	790.18	659.37	206	54.28	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			535.9	B08		9	0325-0663	35.78	663.64	240	57.94	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2189.2	B08		9	0326-0662	404.60	661.96	211	57.36	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			966.3	B08		9	0327-0664	162.23	664.66	252	61.94	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1051.6	B08		9	0328-0670	140.52	670.03	284	64.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1194.8	B08		9	0329-0672	297.72	672.30	288	66.43	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2266.8	B08		9	0330-0674	875.21	673.40	244	60.53	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1677.2	B08		9	0331-0676	380.69	676.33	270	67.84	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3161.8	B08		9	0332-0675	91.03	674.87	253	59.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5256.7	B08		9	0333-0676	937.72	675.75	245	59.11	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4398.9	B08		9	0334-0674	786.59	674.75	198	50.87	0.962
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1531.8	B08		9	0335-0684	887.77	684.20	229	60.77	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			779.7	B08		9	0336-0686	264.85	686.00	246	60.53	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1664.5	B08		9	0337-0692	837.75	693.34	241	64.43	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1288.8	B08		9	0338-0695	451.42	695.09	247	59.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			723.1	B08		9	0339-0698	629.42	698.59	368	72.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1317.5	B08		9	0340-0696	691.70	698.16	252	70.43	0.638
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2761.3	B08		9	0341-0695	937.50	695.64	242	57.11	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1228.1	B08		9	0342-0697	110.29	698.24	232	66.18	0.666
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1484.2	B08		9	0343-0703	749.84	702.22	218	59.11	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4067.0	B08		9	0344-0703	45.50	703.45	308	66.43	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1351.3	B08		9	0345-0708	150.33	708.96	334	70.43	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			306.3	B08		9	0346-0706	185.63	705.56	275	66.43	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1655.9	B08		9	0347-0703	907.57	703.18	102	37.80	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1760.1	B08		9	0348-0708	216.50	709.43	226	57.36	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			872.7	C08		1	0001-0025	822.14	25.96	373	78.43	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1232.0	C08		1	0002-0032	681.57	32.38	336	70.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			412.7	C08		1	0003-0031	209.13	31.38	259	59.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			261.6	C08		1	0004-0035	598.48	35.02	291	65.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			278.7	C08		1	0005-0033	294.09	33.97	277	61.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			463.5	C08		1	0006-0037	95.05	37.30	267	59.36	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1614.8	C08		1	0007-0038	133.57	38.49	299	64.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			349.8	C08		1	0008-0040	943.98	40.01	322	66.77	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			499.1	C08		1	0009-0040	72.15	41.03	262	61.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			626.6	C08		1	0010-0039	525.47	39.38	257	59.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			579.0	C08		1	0011-0041	554.92	42.34	237	63.60	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			311.2	C08		1	0012-0041	925.52	41.93	290	61.94	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			299.6	C08		1	0013-0045	740.21	45.84	288	63.84	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			469.0	C08		1	0014-0050	351.70	51.05	330	68.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2388.2	C08		1	0015-0054	703.39	54.41	393	100.57	0.488
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			589.0	C08		1	0016-0050	831.85	50.06	209	52.28	0.961
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			298.7	C08		1	0017-0054	308.76	53.84	288	64.43	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			252.9	C08		1	0018-0058	877.05	57.46	291	64.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			386.8	C08		1	0019-0061	784.13	62.60	326	70.18	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			642.1	C08		1	0020-0061	248.09	60.88	258	61.01	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1481.3	C08		1	0021-0063	901.93	63.40	246	58.18	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			392.3	C08		1	0022-0065	450.72	64.22	288	63.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			308.9	C08		1	0023-0070	278.90	71.24	278	66.18	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			374.9	C08		1	0024-0072	603.94	72.36	320	66.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			310.2	C08		1	0025-0072	740.78	71.77	255	64.43	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2738.5	C08		1	0026-0072	691.94	72.87	204	67.26	0.567
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			294.5	C08		1	0027-0072	50.25	71.85	260	59.94	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			321.0	C08		1	0028-0074	438.92	74.68	303	65.26	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1971.6	C08		1	0029-0079	190.55	76.48	356	97.64	0.469
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			277.9	C08		1	0030-0075	870.05	76.04	277	65.36	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			263.0	C08		1	0031-0085	158.34	84.95	308	67.60	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1946.6	C08		1	0032-0085	93.65	85.12	246	58.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			524.2	C08		1	0033-0086	125.51	86.38	303	68.08	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			267.9	C08		1	0034-0086	411.37	86.47	305	64.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			356.9	C08		1	0035-0086	333.45	86.21	307	67.36	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			362.9	C08		1	0036-0095	644.36	95.56	264	61.94	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			419.4	C08		1	0037-0095	520.50	94.48	257	62.77	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			295.3	C08		1	0038-0096	764.15	95.07	320	71.01	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			534.1	C08		1	0039-0100	537.98	100.04	222	57.94	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1251.8	C08		1	0040-0101	506.98	101.49	188	52.53	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			589.0	C08		1	0041-0103	259.99	103.05	262	59.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			876.9	C08		1	0042-0105	493.19	105.07	201	53.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			397.7	C08		1	0043-0106	37.63	106.01	252	59.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			374.4	C08		1	0044-0109	240.13	108.48	280	63.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			341.0	C08		1	0045-0108	558.40	108.86	306	65.36	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			319.4	C08		1	0046-0108	577.01	108.07	250	57.36	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			255.1	C08		1	0047-0107	811.47	107.51	328	67.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.2	C08		1	0048-0110	851.09	110.29	317	67.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			392.0	C08		1	0049-0108	445.47	107.83	261	66.77	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			502.0	C08		1	0050-0117	119.82	117.36	249	60.53	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			582.8	C08		1	0051-0119	649.82	119.59	358	69.60	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			803.6	C08		1	0052-0120	103.19	120.90	254	61.11	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			876.4	C08		1	0053-0119	946.75	118.29	260	63.60	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			368.8	C08		1	0054-0118	743.02	118.79	290	64.53	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			276.9	C08		1	0055-0121	58.32	121.55	260	60.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			400.2	C08		1	0056-0131	85.34	132.15	262	61.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			266.3	C08		1	0057-0131	452.43	130.72	300	64.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			202.4	C08		1	0058-0138	487.67	137.96	255	65.84	0.739
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			245.9	C08		1	0059-0137	502.83	137.54	193	57.01	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1030.1	C08		1	0060-0139	210.02	137.63	516	101.40	0.631
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1101.6	C08		1	0061-0138	670.61	138.33	241	56.53	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.5	C08		1	0062-0143	149.45	143.21	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			313.5	C08		1	0063-0140	372.06	140.09	251	59.01	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1167.2	C08		1	0064-0145	749.21	144.31	314	68.18	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			296.2	C08		1	0065-0145	920.96	145.33	331	71.50	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			383.7	C08		1	0066-0146	39.71	146.68	341	69.94	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			329.3	C08		1	0067-0147	173.79	147.27	267	61.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			283.2	C08		1	0068-0153	551.00	153.54	283	63.26	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			264.6	C08		1	0069-0151	813.05	150.94	259	59.36	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			391.1	C08		1	0070-0158	513.00	157.99	546	99.15	0.698
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			284.3	C08		1	0071-0153	446.25	153.63	170	52.77	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			195.4	C08		1	0072-0155	845.90	155.03	319	67.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			849.0	C08		1	0073-0154	334.70	154.51	259	60.18	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			378.6	C08		1	0074-0152	624.74	152.68	246	59.11	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			914.9	C08		1	0075-0156	784.87	156.36	297	65.60	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			244.0	C08		1	0076-0159	884.42	159.25	315	70.43	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.9	C08		1	0077-0160	127.31	160.31	303	65.36	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1114.8	C08		1	0078-0162	305.18	162.32	272	63.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			468.6	C08		1	0079-0168	288.46	168.54	311	67.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			240.1	C08		1	0080-0171	832.81	171.77	291	68.18	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			376.9	C08		1	0081-0174	42.34	174.21	262	63.36	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			629.4	C08		1	0082-0170	729.21	170.50	271	61.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			368.9	C08		1	0083-0173	590.40	173.08	296	63.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			770.8	C08		1	0084-0178	83.14	178.73	315	65.01	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			572.9	C08		1	0085-0177	171.65	177.29	246	57.36	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			366.2	C08		1	0086-0182	691.21	182.38	284	63.36	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			319.2	C08		1	0087-0186	447.87	186.68	253	59.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			888.4	C08		1	0088-0188	242.39	187.62	194	51.94	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6783.7	C08		1	0089-0193	516.56	193.62	611	101.98	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			287.2	C08		1	0090-0190	635.08	190.19	316	70.43	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			271.6	C08		1	0091-0192	872.76	192.02	284	61.36	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			887.8	C08		1	0092-0193	736.41	192.47	313	65.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			359.8	C08		1	0093-0194	386.17	193.83	254	58.53	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			240.2	C08		1	0094-0194	823.62	193.96	316	67.84	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			261.3	C08		1	0095-0196	920.81	196.20	290	64.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			298.9	C08		1	0096-0196	427.88	196.19	297	65.01	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.5	C08		1	0097-0201	117.09	201.51	288	64.28	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			413.5	C08		1	0098-0201	53.21	201.78	281	60.77	0.956
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3740.8	C08		1	0099-0200	257.81	199.94	205	56.77	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			563.5	C08		1	0100-0203	208.24	203.37	234	55.94	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			267.1	C08		1	0101-0206	669.23	206.07	274	62.53	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1021.9	C08		1	0102-0208	574.16	208.16	397	73.84	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			276.5	C08		1	0103-0204	331.29	205.07	268	64.28	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			469.5	C08		1	0104-0211	807.63	211.72	465	80.08	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1165.0	C08		1	0105-0211	246.49	212.01	282	62.43	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			311.4	C08		1	0106-0213	766.71	214.14	272	61.60	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			341.9	C08		1	0107-0227	200.15	227.05	513	92.08	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			441.4	C08		1	0108-0228	722.25	228.10	375	72.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			437.4	C08		1	0109-0230	145.31	230.74	242	58.77	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1427.3	C08		1	0110-0231	695.49	230.67	231	55.36	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			853.9	C08		1	0111-0231	567.25	231.61	293	66.53	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			323.2	C08		1	0112-0236	127.92	236.17	260	61.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1487.2	C08		1	0113-0237	501.37	237.45	245	57.94	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			338.3	C08		1	0114-0236	799.39	236.30	397	79.70	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			339.9	C08		1	0115-0240	324.51	240.08	251	58.53	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			346.6	C08		1	0116-0244	296.32	243.88	305	66.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			289.8	C08		1	0117-0248	90.39	247.75	310	65.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5159.5	C08		1	0118-0248	683.41	248.56	344	67.60	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			716.2	C08		1	0119-0245	744.24	245.15	204	53.11	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			583.7	C08		1	0120-0245	763.73	245.53	199	51.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4560.3	C08		1	0121-0250	345.88	250.19	248	57.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1011.6	C08		1	0122-0255	833.72	255.63	376	75.26	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			321.8	C08		1	0123-0253	578.67	252.77	255	61.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.8	C08		1	0124-0257	141.20	256.83	286	63.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			286.5	C08		1	0125-0262	225.24	261.63	430	78.67	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			265.1	C08		1	0126-0259	74.74	259.19	315	66.53	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1322.8	C08		1	0127-0259	284.48	259.09	366	71.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			9731.0	C08		1	0128-0259	366.80	258.66	326	67.01	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3965.3	C08		1	0129-0257	851.64	258.33	235	58.87	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1008.6	C08		1	0130-0267	526.09	266.69	533	94.57	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			250.4	C08		1	0131-0263	590.14	263.95	263	61.11	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			827.3	C08		1	0132-0266	877.93	266.67	240	58.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1347.3	C08		1	0133-0265	920.94	265.46	218	53.70	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			340.2	C08		1	0134-0271	614.64	271.53	413	74.67	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1020.3	C08		1	0135-0272	765.04	272.49	301	63.36	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4401.6	C08		1	0136-0272	934.67	272.12	175	51.36	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			367.5	C08		1	0137-0276	167.43	277.02	253	61.70	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			292.7	C08		1	0138-0276	674.37	275.96	323	67.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			259.6	C08		1	0139-0278	456.40	277.71	282	63.60	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2665.9	C08		1	0140-0279	829.32	278.74	284	64.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2724.1	C08		1	0141-0279	328.50	279.91	245	56.77	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			620.1	C08		1	0142-0287	283.61	286.97	406	75.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			288.9	C08		1	0143-0290	212.32	290.79	292	66.18	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			284.7	C08		1	0144-0287	406.95	287.56	318	70.77	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			681.2	C08		1	0145-0287	877.73	287.64	261	59.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3776.4	C08		1	0146-0284	940.74	284.64	148	44.28	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			275.6	C08		1	0147-0290	350.24	290.23	304	68.08	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			226.4	C08		1	0148-0293	88.23	293.47	271	63.36	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			311.3	C08		1	0149-0298	478.74	297.61	288	67.11	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			528.6	C08		1	0150-0299	30.29	299.17	312	65.11	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			537.6	C08		1	0151-0297	769.35	297.25	237	56.18	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			268.1	C08		1	0152-0298	577.12	298.30	242	62.18	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			303.7	C08		1	0153-0301	850.21	301.23	325	67.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			358.2	C08		1	0154-0301	793.81	300.67	249	59.60	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			234.9	C08		1	0155-0305	134.72	305.10	300	65.01	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			277.5	C08		1	0156-0305	415.61	306.08	322	69.60	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			308.2	C08		1	0157-0308	177.86	307.75	226	57.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			310.6	C08		1	0158-0311	161.71	310.71	226	56.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			284.6	C08		1	0159-0311	441.45	311.15	283	62.77	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			281.0	C08		1	0160-0310	572.11	310.90	264	63.70	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			325.1	C08		1	0161-0317	258.06	316.84	309	68.77	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			258.0	C08		1	0162-0320	664.01	318.99	331	66.77	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			278.2	C08		1	0163-0324	615.82	324.26	326	70.43	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			346.3	C08		1	0164-0324	23.47	324.39	299	63.60	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			314.4	C08		1	0165-0325	243.62	325.36	286	63.84	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2327.6	C08		1	0166-0325	394.36	325.64	297	64.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			398.9	C08		1	0167-0328	874.08	327.59	234	56.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			688.7	C08		1	0168-0328	899.15	329.03	260	61.94	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			570.1	C08		1	0169-0333	90.84	332.85	266	62.43	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			607.7	C08		1	0170-0333	126.02	332.87	298	67.60	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			392.0	C08		1	0171-0337	818.17	337.25	353	68.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			828.8	C08		1	0172-0336	529.02	336.98	248	59.94	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			281.2	C08		1	0173-0335	936.43	335.59	267	61.36	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1170.8	C08		1	0174-0342	377.70	341.70	254	63.60	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			374.9	C08		1	0175-0341	751.57	340.97	254	61.60	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			577.4	C08		1	0176-0344	76.38	343.86	228	55.36	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			387.2	C08		1	0177-0345	460.57	344.62	193	52.53	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			403.5	C08		1	0178-0351	681.74	350.99	338	69.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			300.7	C08		1	0179-0349	577.92	349.82	294	64.43	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			769.9	C08		1	0180-0351	291.85	350.98	292	63.84	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			365.8	C08		1	0181-0352	489.82	352.37	300	65.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			375.6	C08		1	0182-0352	327.35	351.69	252	61.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			348.2	C08		1	0183-0353	446.60	353.32	231	56.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			469.9	C08		1	0184-0354	805.06	354.07	247	59.70	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			497.9	C08		1	0185-0359	872.13	359.11	311	67.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			987.2	C08		1	0186-0363	132.70	363.09	329	68.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			246.1	C08		1	0187-0365	336.31	364.68	263	59.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			536.7	C08		1	0188-0364	410.22	363.79	327	69.01	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			746.9	C08		1	0189-0367	502.64	368.11	257	61.84	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			246.9	C08		1	0190-0376	921.44	376.79	551	108.95	0.583
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			485.1	C08		1	0191-0369	593.60	369.66	279	63.70	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1206.8	C08		1	0192-0375	268.02	375.42	298	69.36	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			484.9	C08		1	0193-0372	752.98	371.61	257	60.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			246.2	C08		1	0194-0377	634.41	376.32	349	72.43	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			258.7	C08		1	0195-0379	880.14	379.02	319	70.43	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			477.9	C08		1	0196-0377	119.73	376.80	305	72.77	0.724
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			607.8	C08		1	0197-0382	700.82	381.97	292	65.60	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			203.7	C08		1	0198-0382	220.40	381.71	287	64.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1215.5	C08		1	0199-0382	446.89	381.74	234	56.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			413.6	C08		1	0200-0384	428.95	384.84	299	64.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			614.9	C08		1	0201-0387	282.57	387.37	421	76.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			326.2	C08		1	0202-0387	25.30	387.85	243	61.94	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3579.8	C08		1	0203-0393	364.86	393.85	475	94.23	0.672
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			307.0	C08		1	0204-0386	840.01	386.59	291	66.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			276.9	C08		1	0205-0392	728.70	393.05	303	68.18	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			633.7	C08		1	0206-0395	87.04	395.30	245	57.94	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			262.5	C08		1	0207-0395	516.66	395.19	277	61.36	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			427.3	C08		1	0208-0404	108.05	404.45	252	58.18	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1264.5	C08		1	0209-0408	417.91	407.79	261	63.01	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			278.4	C08		1	0210-0413	504.12	413.06	284	62.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			321.7	C08		1	0211-0413	684.04	412.94	283	62.18	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			336.7	C08		1	0212-0418	45.73	418.54	308	64.18	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			831.1	C08		1	0213-0420	133.94	419.89	318	65.84	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.5	C08		1	0214-0424	879.01	423.32	332	79.74	0.656
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			263.3	C08		1	0215-0420	815.78	420.19	308	63.36	0.964
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1249.7	C08		1	0216-0420	439.51	420.26	208	54.04	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			367.8	C08		1	0217-0422	290.62	422.02	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			824.4	C08		1	0218-0426	192.46	426.07	432	78.43	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1016.5	C08		1	0219-0425	457.42	425.06	257	61.70	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			281.2	C08		1	0220-0425	908.76	426.11	267	63.94	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			717.5	C08		1	0221-0430	759.47	429.63	435	88.67	0.695
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			541.0	C08		1	0222-0428	253.32	428.39	295	66.18	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			371.9	C08		1	0223-0431	555.02	431.98	323	95.15	0.448
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			274.6	C08		1	0224-0430	599.73	430.23	285	65.60	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			279.7	C08		1	0225-0433	317.04	433.41	275	62.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			378.8	C08		1	0226-0433	103.24	433.39	402	75.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			270.1	C08		1	0227-0438	640.55	438.85	580	100.57	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			280.8	C08		1	0228-0435	845.96	435.40	258	62.28	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			254.5	C08		1	0229-0438	720.28	437.38	302	67.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			519.8	C08		1	0230-0439	18.11	439.59	340	68.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.8	C08		1	0231-0441	169.96	442.00	318	66.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			415.3	C08		1	0232-0444	771.12	444.45	230	57.36	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			242.0	C08		1	0233-0447	477.66	447.79	262	61.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			670.6	C08		1	0234-0456	438.10	457.77	540	95.40	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.5	C08		1	0235-0456	881.35	455.43	335	78.57	0.682
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			967.9	C08		1	0236-0456	265.11	456.45	313	65.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			765.6	C08		1	0237-0460	511.98	459.79	454	81.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2108.7	C08		1	0238-0456	409.18	456.62	214	53.36	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			409.2	C08		1	0239-0461	38.50	461.65	307	66.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			274.4	C08		1	0240-0462	165.64	462.71	309	71.60	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1038.9	C08		1	0241-0468	330.38	467.02	250	58.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			449.6	C08		1	0242-0470	569.44	470.56	357	69.84	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			332.9	C08		1	0243-0470	930.07	470.50	260	59.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			263.3	C08		1	0244-0471	789.81	471.64	322	67.01	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3149.8	C08		1	0245-0474	229.06	473.77	379	73.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			972.5	C08		1	0246-0471	387.85	471.68	248	58.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			295.9	C08		1	0247-0472	706.29	472.14	277	63.11	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1398.0	C08		1	0248-0481	321.87	481.24	242	58.77	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			786.3	C08		1	0249-0485	380.17	485.37	224	55.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			218.8	C08		1	0250-0486	625.83	486.05	324	66.18	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			193.1	C08		1	0251-0487	260.40	486.47	279	63.01	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2015.2	C08		1	0252-0488	501.49	489.01	313	66.77	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			270.4	C08		1	0253-0492	911.58	492.21	260	59.70	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3088.1	C08		1	0254-0494	593.95	494.04	348	70.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			258.5	C08		1	0255-0495	665.13	495.70	312	69.11	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			694.1	C08		1	0256-0494	159.72	493.86	232	57.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2527.9	C08		1	0257-0496	474.83	495.59	304	64.77	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			335.9	C08		1	0258-0500	942.76	500.59	410	78.43	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			263.4	C08		1	0259-0499	73.34	499.05	270	61.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			294.9	C08		1	0260-0501	746.05	501.11	444	77.26	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			270.2	C08		1	0261-0500	189.28	499.86	272	61.11	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			465.4	C08		1	0262-0505	546.03	505.10	455	80.91	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			247.5	C08		1	0263-0503	299.59	503.95	272	63.01	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			358.5	C08		1	0264-0501	110.04	501.73	271	61.70	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			13105.4	C08		1	0265-0505	789.60	505.62	115	92.43	0.169
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			247.5	C08		1	0266-0510	829.21	510.02	266	60.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			268.2	C08		1	0267-0509	37.93	509.58	271	61.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1373.2	C08		1	0268-0511	426.05	511.33	325	66.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			564.6	C08		1	0269-0514	270.46	514.21	363	71.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			251.7	C08		1	0270-0511	672.74	511.00	271	68.28	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2869.2	C08		1	0271-0516	129.22	517.00	317	67.36	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			587.2	C08		1	0272-0516	194.76	516.95	280	64.53	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			331.5	C08		1	0273-0521	857.97	520.82	269	61.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1430.4	C08		1	0274-0520	584.05	520.77	274	60.77	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			649.9	C08		1	0275-0522	441.51	522.16	302	64.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			310.8	C08		1	0276-0522	713.75	522.25	263	61.70	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			339.2	C08		1	0277-0526	530.57	526.08	301	64.43	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			400.9	C08		1	0278-0533	763.47	532.72	242	59.36	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			330.1	C08		1	0279-0534	795.61	533.70	277	61.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			246.8	C08		1	0280-0533	83.50	533.87	305	73.01	0.719
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1500.9	C08		1	0281-0535	213.46	535.24	213	53.11	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.2	C08		1	0282-0539	273.70	539.14	294	68.67	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			259.3	C08		1	0283-0537	619.01	536.78	268	61.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			459.8	C08		1	0284-0544	727.47	543.99	343	68.43	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			469.3	C08		1	0285-0547	679.63	546.69	355	71.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			357.4	C08		1	0286-0547	351.77	547.50	250	59.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			230.6	C08		1	0287-0549	43.38	549.11	280	63.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			277.0	C08		1	0288-0548	164.29	548.21	254	59.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3731.8	C08		1	0289-0548	540.05	548.03	188	49.70	0.956
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.3	C08		1	0290-0550	835.32	549.74	270	61.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			265.4	C08		1	0291-0549	145.49	549.09	265	62.04	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			282.8	C08		1	0292-0552	920.15	551.59	294	63.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			243.0	C08		1	0293-0553	312.34	553.07	308	65.01	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			390.9	C08		1	0294-0553	786.10	553.31	341	71.84	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1976.6	C08		1	0295-0556	560.59	557.44	266	59.60	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			321.0	C08		1	0296-0559	390.52	558.51	297	64.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1104.9	C08		1	0297-0563	482.05	562.86	252	58.18	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			283.2	C08		1	0298-0563	675.45	563.22	272	63.11	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			208.5	C08		1	0299-0564	92.34	564.16	140	51.11	0.673
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			296.0	C08		1	0300-0569	793.86	569.65	318	66.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1045.7	C08		1	0301-0567	268.09	568.13	164	47.21	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			395.3	C08		1	0302-0571	593.86	571.40	272	60.53	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			202.2	C08		1	0303-0572	205.22	572.62	276	67.60	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5213.9	C08		1	0304-0571	518.31	570.42	129	68.53	0.345
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			265.0	C08		1	0305-0579	898.28	579.25	364	71.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			521.0	C08		1	0306-0575	245.48	575.14	169	47.46	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1391.8	C08		1	0307-0576	559.64	575.69	245	58.53	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			281.5	C08		1	0308-0578	732.89	578.70	294	64.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			222.4	C08		1	0309-0580	875.88	579.73	285	62.18	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			237.3	C08		1	0310-0581	82.77	581.36	293	63.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			912.7	C08		1	0311-0587	262.45	585.43	422	83.60	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1022.1	C08		1	0312-0584	449.27	583.89	246	57.11	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			624.5	C08		1	0313-0585	537.45	585.66	219	55.36	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			231.0	C08		1	0314-0588	301.52	587.94	322	67.60	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4020.4	C08		1	0315-0589	927.47	589.16	304	65.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			271.7	C08		1	0316-0589	150.69	589.40	378	72.77	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.1	C08		1	0317-0592	810.14	592.40	297	64.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			253.1	C08		1	0318-0595	27.14	595.40	266	63.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3331.8	C08		1	0319-0597	944.27	597.18	229	55.70	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			936.5	C08		1	0320-0605	525.30	604.34	263	62.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			329.9	C08		1	0321-0603	766.04	603.99	261	61.70	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			264.9	C08		1	0322-0607	199.34	607.04	248	62.77	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			884.3	C08		1	0323-0608	393.01	608.28	288	63.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			245.7	C08		1	0324-0609	74.76	609.25	262	59.60	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			222.8	C08		1	0325-0612	704.10	611.88	297	64.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			201.0	C08		1	0326-0614	844.13	613.52	296	63.60	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			319.8	C08		1	0327-0612	482.55	611.88	271	62.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			465.8	C08		1	0328-0621	28.06	620.90	218	54.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			300.1	C08		1	0329-0619	763.88	618.42	260	63.11	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.3	C08		1	0330-0624	650.46	623.74	294	66.43	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1128.1	C08		1	0331-0625	262.52	625.35	205	51.70	0.964
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			418.1	C08		1	0332-0633	595.61	632.78	244	57.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			299.5	C08		1	0333-0634	879.26	634.12	249	57.94	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1113.2	C08		1	0334-0638	623.32	638.35	297	62.77	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			317.5	C08		1	0335-0643	419.35	643.64	263	62.53	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			282.2	C08		1	0336-0646	176.89	645.51	593	98.57	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			288.6	C08		1	0337-0645	219.75	645.23	306	69.60	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			288.6	C08		1	0338-0648	126.69	647.81	281	64.77	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			360.6	C08		1	0339-0646	727.56	646.82	268	61.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			368.5	C08		1	0340-0650	88.89	650.61	376	73.01	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			280.9	C08		1	0341-0649	316.53	648.68	283	62.77	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			264.5	C08		1	0342-0650	522.00	651.01	317	68.43	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			338.0	C08		1	0343-0651	570.73	650.76	211	55.11	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			301.5	C08		1	0344-0651	800.58	651.10	287	63.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			217.5	C08		1	0345-0648	909.49	648.45	257	60.53	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			272.3	C08		1	0346-0654	254.61	654.82	304	67.36	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			276.7	C08		1	0347-0653	445.55	652.66	256	59.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			301.1	C08		1	0348-0654	367.50	653.95	286	62.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			254.1	C08		1	0349-0656	762.40	655.48	294	64.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1098.8	C08		1	0350-0664	667.52	664.31	302	63.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			470.9	C08		1	0351-0671	601.16	671.67	341	67.60	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1421.0	C08		1	0352-0672	812.39	672.34	244	58.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4853.2	C08		1	0353-0676	939.29	676.50	264	61.11	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			815.9	C08		1	0354-0678	275.20	678.07	250	57.70	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			283.0	C08		1	0355-0681	711.96	681.31	295	64.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1011.4	C08		1	0356-0682	315.97	682.29	268	61.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			242.6	C08		1	0357-0681	863.81	681.07	227	57.11	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4084.8	C08		1	0358-0683	583.00	683.42	165	46.87	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1290.5	C08		1	0359-0688	917.00	688.43	243	58.18	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			267.8	C08		1	0360-0688	653.24	687.57	269	60.28	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			809.1	C08		1	0361-0693	825.13	693.11	264	63.26	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			236.2	C08		1	0362-0692	465.12	692.45	299	67.60	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			276.6	C08		1	0363-0695	164.66	695.52	270	60.53	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.7	C08		1	0364-0697	406.64	696.45	298	62.77	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			259.3	C08		1	0365-0696	862.07	696.93	302	67.94	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			318.2	C08		1	0366-0699	197.60	698.93	257	59.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			420.5	C08		1	0367-0697	564.69	698.02	245	58.87	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1093.1	C08		1	0368-0700	335.60	700.91	255	58.77	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			222.1	C08		1	0369-0702	19.92	703.24	288	63.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.2	C08		1	0370-0705	367.96	704.81	288	66.67	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			776.2	C08		1	0371-0705	91.70	705.53	250	60.53	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			243.6	C08		2	0001-0024	128.41	23.60	288	63.84	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			676.4	C08		2	0002-0025	174.92	24.72	270	61.94	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			316.0	C08		2	0003-0032	871.75	31.68	248	60.77	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			391.9	C08		2	0004-0033	68.62	32.87	192	51.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			251.9	C08		2	0005-0040	397.91	40.47	375	72.18	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			370.0	C08		2	0006-0037	551.14	37.65	274	62.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			604.4	C08		2	0007-0038	680.72	39.05	242	56.77	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			348.8	C08		2	0008-0042	48.52	41.52	316	66.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			283.3	C08		2	0009-0043	30.09	43.27	294	62.53	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			692.8	C08		2	0010-0043	231.80	43.46	334	67.60	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			798.6	C08		2	0011-0044	186.15	45.23	269	63.26	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.4	C08		2	0012-0048	487.71	49.18	332	70.77	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.2	C08		2	0013-0047	649.05	47.26	310	64.53	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			285.4	C08		2	0014-0048	797.12	49.02	408	78.08	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			321.6	C08		2	0015-0052	99.99	52.40	411	74.67	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2215.7	C08		2	0016-0049	205.02	49.46	206	53.46	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			296.7	C08		2	0017-0052	737.79	51.91	283	62.18	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			313.2	C08		2	0018-0055	716.07	54.90	288	63.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			393.7	C08		2	0019-0055	576.86	55.80	420	81.60	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1270.3	C08		2	0020-0062	153.35	62.35	313	65.01	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			478.7	C08		2	0021-0066	837.30	66.55	305	69.26	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			324.0	C08		2	0022-0064	854.66	63.94	218	55.11	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			257.8	C08		2	0023-0066	291.41	66.74	292	65.60	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			324.6	C08		2	0024-0068	355.25	67.73	270	61.94	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			261.6	C08		2	0025-0071	448.16	70.63	285	63.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			322.7	C08		2	0026-0075	427.60	74.95	326	66.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			346.8	C08		2	0027-0075	776.54	75.29	255	58.28	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			435.0	C08		2	0028-0082	244.28	81.66	317	68.43	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			386.8	C08		2	0029-0084	285.37	84.39	339	73.60	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			298.8	C08		2	0030-0082	659.88	82.54	285	63.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1508.3	C08		2	0031-0087	605.90	89.87	370	80.18	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3270.9	C08		2	0032-0082	618.92	81.58	168	50.87	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			346.6	C08		2	0033-0085	328.68	85.58	227	56.28	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			380.5	C08		2	0034-0084	576.11	84.68	291	63.01	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			329.4	C08		2	0035-0088	830.95	88.00	311	65.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			977.1	C08		2	0036-0087	550.38	87.01	216	53.94	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			325.3	C08		2	0037-0091	72.87	91.06	245	65.84	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			674.8	C08		2	0038-0092	485.02	92.27	221	54.87	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			818.1	C08		2	0039-0092	774.10	91.27	225	57.36	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			288.0	C08		2	0040-0098	696.24	97.15	290	63.60	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			292.7	C08		2	0041-0102	296.21	101.87	305	65.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			212.6	C08		2	0042-0104	886.08	103.99	341	68.18	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			583.4	C08		2	0043-0106	204.77	105.73	293	64.18	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			710.4	C08		2	0044-0107	99.82	106.94	343	68.77	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			526.5	C08		2	0045-0110	741.92	109.44	252	62.28	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2498.2	C08		2	0046-0111	628.60	111.41	280	60.77	0.953
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			240.5	C08		2	0047-0113	944.04	114.24	441	81.50	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			277.4	C08		2	0048-0112	424.05	112.01	281	62.18	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			255.6	C08		2	0049-0115	340.36	115.59	316	65.60	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2077.8	C08		2	0050-0115	524.22	116.08	258	60.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			263.1	C08		2	0051-0116	404.44	116.68	286	62.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			897.0	C08		2	0052-0120	51.63	119.87	261	61.94	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			305.8	C08		2	0053-0122	257.66	121.89	391	76.08	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			253.6	C08		2	0054-0122	784.64	122.43	214	53.94	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			226.0	C08		2	0055-0124	572.99	124.69	321	66.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			313.8	C08		2	0056-0126	892.41	125.50	423	81.26	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			270.8	C08		2	0057-0128	359.94	128.35	310	65.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			329.1	C08		2	0058-0128	127.19	128.48	284	65.84	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			358.1	C08		2	0059-0130	172.43	130.44	391	73.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3393.9	C08		2	0060-0127	67.80	127.03	189	50.87	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			725.3	C08		2	0061-0131	621.82	131.00	285	64.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			290.1	C08		2	0062-0132	711.18	132.55	340	68.18	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			547.4	C08		2	0063-0137	516.40	137.02	356	72.91	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			281.7	C08		2	0064-0137	775.48	136.06	200	57.26	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			424.8	C08		2	0065-0140	460.31	140.21	426	77.01	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2420.2	C08		2	0066-0139	81.33	139.65	215	52.77	0.970
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			305.3	C08		2	0067-0140	823.51	140.83	256	60.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			261.9	C08		2	0068-0147	25.40	146.81	324	69.50	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			258.5	C08		2	0069-0150	221.02	149.90	439	80.43	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			575.8	C08		2	0070-0148	661.59	147.75	298	66.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			512.9	C08		2	0071-0151	277.86	151.60	306	64.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			377.2	C08		2	0072-0150	620.04	149.78	315	67.60	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			268.4	C08		2	0073-0156	748.99	155.98	202	55.70	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			344.3	C08		2	0074-0162	485.58	162.08	325	69.36	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4023.1	C08		2	0075-0159	562.03	159.43	209	54.28	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			683.4	C08		2	0076-0160	681.59	160.78	171	51.36	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			271.8	C08		2	0077-0171	363.75	171.30	328	69.26	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			379.6	C08		2	0078-0170	929.17	169.79	323	68.18	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2789.7	C08		2	0079-0170	58.63	170.19	217	53.11	0.967
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			295.5	C08		2	0080-0171	155.29	171.07	270	63.60	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			289.5	C08		2	0081-0172	587.56	172.32	252	59.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			275.2	C08		2	0082-0174	416.12	173.89	277	60.77	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5306.8	C08		2	0083-0178	456.76	175.89	289	74.18	0.660
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.3	C08		2	0084-0175	280.35	175.27	341	71.01	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			425.6	C08		2	0085-0176	136.98	176.47	272	63.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			366.3	C08		2	0086-0179	526.31	179.88	250	58.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			250.5	C08		2	0087-0181	242.03	181.06	335	69.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			288.7	C08		2	0088-0183	781.58	182.81	340	69.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2980.0	C08		2	0089-0184	103.01	184.47	203	54.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			240.5	C08		2	0090-0188	599.94	188.31	310	66.18	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			299.3	C08		2	0091-0192	481.83	192.42	247	63.70	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			246.7	C08		2	0092-0195	425.92	194.89	295	66.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.2	C08		2	0093-0198	25.57	197.78	289	63.60	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			573.4	C08		2	0094-0197	114.02	196.94	260	63.60	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			522.6	C08		2	0095-0200	525.18	199.68	315	65.94	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			559.0	C08		2	0096-0207	650.18	206.99	239	59.11	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			301.4	C08		2	0097-0204	722.48	204.95	239	56.18	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			248.4	C08		2	0098-0205	182.25	204.45	297	67.36	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			254.4	C08		2	0099-0211	436.75	211.44	299	67.94	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			259.4	C08		2	0100-0209	55.77	209.90	260	61.36	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			267.9	C08		2	0101-0212	318.78	212.16	308	66.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			395.1	C08		2	0102-0220	586.21	220.27	445	81.26	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			262.6	C08		2	0103-0223	186.02	223.61	263	59.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.0	C08		2	0104-0225	229.36	225.31	286	63.70	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			287.6	C08		2	0105-0225	923.17	225.16	242	57.11	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			276.2	C08		2	0106-0227	610.82	226.84	275	60.77	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			218.5	C08		2	0107-0227	100.50	227.54	284	64.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			274.5	C08		2	0108-0230	790.69	229.96	292	65.01	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			321.5	C08		2	0109-0230	383.79	229.79	303	63.94	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			272.3	C08		2	0110-0232	505.35	232.95	268	61.94	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			226.4	C08		2	0111-0231	64.38	230.32	272	61.11	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1167.7	C08		2	0112-0233	469.77	232.81	290	63.36	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2338.0	C08		2	0113-0233	823.19	232.39	260	61.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1054.2	C08		2	0114-0235	667.08	235.64	249	59.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			274.2	C08		2	0115-0241	271.81	241.68	289	65.84	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			244.4	C08		2	0116-0245	139.28	244.70	550	87.74	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			226.4	C08		2	0117-0245	190.45	245.11	306	64.77	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			463.0	C08		2	0118-0244	426.11	244.68	265	60.53	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			361.9	C08		2	0119-0250	256.58	250.75	311	67.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			312.6	C08		2	0120-0254	553.92	254.42	325	66.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1741.4	C08		2	0121-0253	727.06	253.50	243	57.94	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			460.5	C08		2	0122-0254	885.66	254.38	199	53.36	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			545.4	C08		2	0123-0259	302.12	259.35	329	68.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			731.3	C08		2	0124-0260	748.76	259.74	392	74.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			396.2	C08		2	0125-0261	432.64	261.36	196	53.21	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			705.4	C08		2	0126-0268	343.10	268.18	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			874.5	C08		2	0127-0267	25.78	266.73	231	56.18	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5410.8	C08		2	0128-0266	78.02	266.30	192	51.70	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			212.4	C08		2	0129-0267	114.11	267.03	287	64.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1003.0	C08		2	0130-0266	815.10	266.10	269	61.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4754.7	C08		2	0131-0272	91.72	271.87	183	50.28	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			833.3	C08		2	0132-0273	203.04	273.31	316	68.77	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			365.8	C08		2	0133-0275	569.95	274.68	442	79.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4441.1	C08		2	0134-0274	39.33	273.68	180	51.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3266.0	C08		2	0135-0277	672.47	276.66	294	65.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			315.7	C08		2	0136-0278	287.66	278.62	311	77.74	0.647
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			884.7	C08		2	0137-0281	688.77	281.41	190	52.28	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			553.7	C08		2	0138-0284	222.82	283.66	313	66.53	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			558.2	C08		2	0139-0286	317.64	285.56	222	55.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3745.5	C08		2	0140-0286	45.41	286.24	160	46.28	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			288.9	C08		2	0141-0290	149.01	291.47	268	60.53	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			370.4	C08		2	0142-0293	422.51	293.81	423	75.84	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2527.6	C08		2	0143-0291	677.08	291.79	126	44.04	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			360.1	C08		2	0144-0296	375.86	295.72	231	56.53	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			729.1	C08		2	0145-0297	89.16	296.62	270	61.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			307.6	C08		2	0146-0295	125.55	295.30	340	70.43	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			794.7	C08		2	0147-0295	480.48	294.97	101	38.97	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			283.3	C08		2	0148-0305	868.84	305.13	300	65.60	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			320.3	C08		2	0149-0310	390.61	310.17	246	60.28	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			267.9	C08		2	0150-0308	254.84	307.98	242	58.28	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			619.6	C08		2	0151-0313	171.36	313.64	405	74.18	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			280.0	C08		2	0152-0317	189.73	317.29	313	71.36	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1046.2	C08		2	0153-0316	589.99	315.67	255	61.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			254.0	C08		2	0154-0319	724.22	320.00	324	67.36	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			255.8	C08		2	0155-0321	260.97	321.64	282	68.77	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			384.7	C08		2	0156-0322	782.33	322.48	265	61.11	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			439.0	C08		2	0157-0322	765.53	321.86	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			318.3	C08		2	0158-0324	91.62	324.21	284	63.01	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2069.7	C08		2	0159-0324	203.04	324.48	204	54.04	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2651.7	C08		2	0160-0324	219.56	324.07	184	49.70	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			258.3	C08		2	0161-0326	319.77	326.20	239	59.60	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			354.6	C08		2	0162-0326	445.11	325.63	279	63.60	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			313.8	C08		2	0163-0328	745.68	327.32	292	63.36	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			322.8	C08		2	0164-0326	375.73	326.79	238	56.87	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			313.5	C08		2	0165-0328	799.72	328.72	283	62.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			901.9	C08		2	0166-0329	69.68	329.37	267	62.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			314.5	C08		2	0167-0332	828.95	332.49	265	59.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			492.8	C08		2	0168-0333	137.34	333.96	297	63.36	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			250.5	C08		2	0169-0337	333.87	337.33	476	82.67	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			724.8	C08		2	0170-0339	655.25	338.63	375	71.60	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			264.6	C08		2	0171-0337	41.30	337.01	267	59.94	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			368.5	C08		2	0172-0341	449.37	341.53	237	57.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			692.8	C08		2	0173-0344	578.50	344.16	261	59.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2574.9	C08		2	0174-0345	271.53	344.95	333	70.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.2	C08		2	0175-0362	199.91	361.99	283	62.18	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.7	C08		2	0176-0362	744.59	362.13	297	63.36	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			477.5	C08		2	0177-0367	844.22	367.25	476	86.67	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			204.5	C08		2	0178-0367	31.63	367.08	200	55.01	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			248.0	C08		2	0179-0368	356.06	368.90	286	63.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			335.4	C08		2	0180-0371	425.28	370.81	245	58.28	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			469.1	C08		2	0181-0373	472.93	373.74	266	60.18	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			468.0	C08		2	0182-0374	894.56	374.92	213	56.87	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			260.3	C08		2	0183-0377	113.54	377.52	265	61.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			257.7	C08		2	0184-0383	23.22	384.93	341	76.67	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			255.4	C08		2	0185-0378	156.27	377.70	268	60.53	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1329.2	C08		2	0186-0387	229.76	388.44	416	82.08	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			247.6	C08		2	0187-0383	267.30	383.62	237	57.60	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			275.2	C08		2	0188-0384	394.23	383.70	325	67.01	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			264.1	C08		2	0189-0383	521.82	382.94	130	43.46	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			240.6	C08		2	0190-0395	516.46	396.09	209	58.77	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			603.1	C08		2	0191-0398	438.54	398.30	245	57.60	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			242.6	C08		2	0192-0393	534.58	393.96	160	49.80	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			551.6	C08		2	0193-0400	62.70	399.55	259	61.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			298.9	C08		2	0194-0404	289.85	404.07	638	93.84	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			289.7	C08		2	0195-0400	365.27	399.62	250	59.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			318.4	C08		2	0196-0405	724.18	405.92	363	72.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			268.7	C08		2	0197-0409	829.94	409.26	358	70.43	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			344.1	C08		2	0198-0409	463.33	409.72	301	66.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.4	C08		2	0199-0405	535.33	405.06	151	46.04	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			335.6	C08		2	0200-0409	700.43	408.69	295	64.53	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			310.2	C08		2	0201-0409	380.18	410.01	304	65.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			282.9	C08		2	0202-0415	154.53	415.43	294	73.50	0.684
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.3	C08		2	0203-0416	884.62	415.94	289	64.53	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1970.4	C08		2	0204-0415	56.75	416.08	327	67.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			250.3	C08		2	0205-0416	925.04	416.90	278	64.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			978.5	C08		2	0206-0419	663.17	419.11	335	67.36	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			828.8	C08		2	0207-0420	264.27	421.78	251	59.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			681.3	C08		2	0208-0420	498.43	420.59	204	55.11	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			259.2	C08		2	0209-0422	133.84	422.17	248	58.28	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			323.0	C08		2	0210-0424	724.51	424.08	312	66.53	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			242.9	C08		2	0211-0427	13.61	427.56	258	62.53	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			255.8	C08		2	0212-0429	945.19	429.48	286	65.36	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			308.3	C08		2	0213-0428	701.23	428.05	270	62.53	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2317.5	C08		2	0214-0433	190.90	433.18	238	58.53	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			592.8	C08		2	0215-0434	225.32	434.19	271	61.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			263.2	C08		2	0216-0437	87.04	437.77	287	62.77	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2130.7	C08		2	0217-0435	173.26	435.41	244	58.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4311.0	C08		2	0218-0436	260.95	436.35	185	49.80	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			272.9	C08		2	0219-0441	873.85	440.57	308	64.28	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			332.6	C08		2	0220-0444	375.81	444.45	323	66.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			511.7	C08		2	0221-0446	566.04	446.26	348	69.84	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			599.9	C08		2	0222-0449	332.26	449.77	560	94.33	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			419.7	C08		2	0223-0447	424.52	447.61	335	67.94	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			336.4	C08		2	0224-0448	922.18	447.91	265	61.60	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			276.6	C08		2	0225-0449	462.86	449.06	289	65.01	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			304.4	C08		2	0226-0451	604.85	451.48	265	63.60	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2224.6	C08		2	0227-0459	549.21	459.53	351	69.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			472.9	C08		2	0228-0458	143.34	458.86	324	68.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2255.1	C08		2	0229-0459	261.60	459.85	248	57.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			302.1	C08		2	0230-0458	400.63	459.11	238	59.46	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			673.2	C08		2	0231-0466	491.10	466.15	301	69.60	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			302.9	C08		2	0232-0462	632.32	462.23	266	60.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			305.0	C08		2	0233-0472	34.89	471.98	262	59.11	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			689.2	C08		2	0234-0469	119.89	468.96	262	61.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			427.0	C08		2	0235-0477	405.92	477.24	489	96.67	0.658
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			269.0	C08		2	0236-0480	815.69	480.06	304	75.01	0.679
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1249.2	C08		2	0237-0479	914.13	478.71	270	61.11	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			283.0	C08		2	0238-0480	225.31	480.10	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			569.8	C08		2	0239-0477	326.87	477.58	241	59.94	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			353.8	C08		2	0240-0481	871.99	481.61	262	60.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			316.7	C08		2	0241-0484	568.43	484.08	272	61.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			768.2	C08		2	0242-0489	750.74	489.51	488	84.33	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			323.6	C08		2	0243-0488	169.56	487.86	284	62.18	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			414.3	C08		2	0244-0488	679.30	488.67	269	61.70	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1456.2	C08		2	0245-0488	307.68	487.95	359	71.60	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			245.6	C08		2	0246-0489	630.43	488.96	323	68.18	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			202.0	C08		2	0247-0493	16.24	493.55	254	59.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			218.8	C08		2	0248-0493	507.23	493.06	269	63.60	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			344.0	C08		2	0249-0502	47.73	502.09	427	77.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			658.6	C08		2	0250-0500	246.57	500.67	312	66.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1715.8	C08		2	0251-0500	533.77	500.29	219	54.53	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			310.8	C08		2	0252-0504	66.26	503.58	297	64.53	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			779.6	C08		2	0253-0505	699.10	505.70	368	73.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			265.5	C08		2	0254-0501	204.12	501.50	231	59.11	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			386.6	C08		2	0255-0502	433.05	502.56	215	54.87	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			246.8	C08		2	0256-0507	619.58	507.08	300	67.94	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			296.0	C08		2	0257-0511	948.45	510.67	280	67.26	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			327.2	C08		2	0258-0512	475.01	511.55	298	65.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			415.3	C08		2	0259-0513	867.81	513.90	265	61.36	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			370.5	C08		2	0260-0516	850.85	516.77	257	59.60	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			238.1	C08		2	0261-0516	146.95	516.06	263	59.36	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			651.9	C08		2	0262-0523	580.94	523.79	157	47.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			242.2	C08		2	0263-0524	902.61	524.32	334	71.01	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			294.5	C08		2	0264-0524	171.12	524.21	247	58.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1168.0	C08		2	0265-0529	743.25	528.55	460	81.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			287.8	C08		2	0266-0529	338.24	529.73	255	61.36	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			243.4	C08		2	0267-0531	547.18	530.79	348	70.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			516.2	C08		2	0268-0532	520.09	532.34	249	59.60	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			331.9	C08		2	0269-0534	822.04	534.95	290	65.36	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.4	C08		2	0270-0536	121.32	535.69	443	79.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.5	C08		2	0271-0536	253.91	537.11	303	64.77	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.1	C08		2	0272-0540	73.04	539.97	266	60.43	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			249.8	C08		2	0273-0540	438.67	540.09	274	60.53	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			299.4	C08		2	0274-0543	474.92	543.22	497	82.43	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			392.5	C08		2	0275-0543	495.38	542.73	251	57.94	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			230.9	C08		2	0276-0545	179.70	545.24	306	69.94	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			356.8	C08		2	0277-0548	795.48	548.99	303	64.43	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			878.2	C08		2	0278-0551	945.99	550.84	288	62.53	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			237.4	C08		2	0279-0553	24.96	553.10	285	62.18	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			647.6	C08		2	0280-0557	618.00	556.84	266	63.11	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1233.3	C08		2	0281-0561	641.94	560.82	711	101.98	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			455.8	C08		2	0282-0560	291.60	560.59	518	83.01	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			261.8	C08		2	0283-0562	86.27	562.76	232	58.18	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			289.0	C08		2	0284-0563	339.83	563.42	303	64.43	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			684.4	C08		2	0285-0564	707.60	563.60	155	50.53	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.1	C08		2	0286-0567	555.67	567.57	297	65.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			482.0	C08		2	0287-0568	213.50	569.92	207	64.43	0.627
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			899.0	C08		2	0288-0569	583.10	568.94	301	64.28	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			337.4	C08		2	0289-0573	171.22	574.28	290	66.77	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			354.0	C08		2	0290-0573	882.89	572.56	272	63.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			443.2	C08		2	0291-0573	241.29	573.36	271	60.53	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			696.3	C08		2	0292-0577	185.71	576.57	160	48.63	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			269.6	C08		2	0293-0579	907.88	578.08	277	63.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			780.4	C08		2	0294-0581	57.33	580.98	258	59.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			211.8	C08		2	0295-0587	724.98	587.15	316	67.60	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			616.0	C08		2	0296-0587	134.80	587.12	175	50.53	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			260.9	C08		2	0297-0588	505.48	588.00	251	57.60	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			307.4	C08		2	0298-0590	87.90	590.70	192	53.70	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4013.4	C08		2	0299-0591	31.88	590.68	317	65.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.6	C08		2	0300-0591	764.21	591.57	269	61.36	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.5	C08		2	0301-0596	797.64	596.34	275	64.18	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3660.9	C08		2	0302-0598	49.01	598.53	246	58.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			772.4	C08		2	0303-0601	207.24	601.43	355	70.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			207.7	C08		2	0304-0599	600.60	599.30	324	68.18	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.1	C08		2	0305-0602	438.82	602.72	334	68.18	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			205.5	C08		2	0306-0603	746.91	602.13	251	59.84	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			293.7	C08		2	0307-0606	543.49	606.34	266	60.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			191.5	C08		2	0308-0604	250.39	605.09	296	66.18	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			255.8	C08		2	0309-0609	387.02	608.81	269	63.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			502.7	C08		2	0310-0608	335.62	607.84	280	64.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			572.0	C08		2	0311-0610	944.87	609.75	210	53.11	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			599.7	C08		2	0312-0613	119.39	614.07	255	64.77	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3486.7	C08		2	0313-0615	291.31	615.17	248	60.18	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			283.2	C08		2	0314-0621	566.88	622.06	251	60.77	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			366.4	C08		2	0315-0625	840.51	624.99	239	57.36	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2036.3	C08		2	0316-0628	67.91	628.06	236	55.70	0.956
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1838.3	C08		2	0317-0627	266.18	626.84	274	63.94	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2867.1	C08		2	0318-0632	346.98	632.17	263	60.43	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			290.4	C08		2	0319-0634	393.30	633.93	334	75.01	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			762.6	C08		2	0320-0634	670.15	633.03	101	41.70	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			258.4	C08		2	0321-0638	851.24	638.19	292	64.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2828.8	C08		2	0322-0639	445.95	639.26	253	59.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			348.0	C08		2	0323-0642	157.39	640.87	253	62.28	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			310.6	C08		2	0324-0640	174.32	640.06	262	61.46	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			425.3	C08		2	0325-0644	425.47	643.95	353	70.77	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			266.4	C08		2	0326-0644	307.30	643.62	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			186.3	C08		2	0327-0645	630.33	645.35	309	65.01	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.1	C08		2	0328-0648	727.88	648.50	296	64.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			495.8	C08		2	0329-0647	119.09	647.07	268	60.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			297.8	C08		2	0330-0650	679.59	650.26	310	68.77	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			197.7	C08		2	0331-0650	246.41	650.38	298	69.36	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.3	C08		2	0332-0650	13.97	649.82	250	58.87	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1937.9	C08		2	0333-0650	470.51	649.83	248	60.87	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.5	C08		2	0334-0653	588.67	652.30	269	62.77	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			245.1	C08		2	0335-0655	563.64	655.36	249	59.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			199.3	C08		2	0336-0655	263.18	654.92	281	64.77	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			226.4	C08		2	0337-0669	407.40	670.15	329	70.43	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1978.3	C08		2	0338-0669	371.39	669.49	271	61.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3482.1	C08		2	0339-0674	544.22	674.03	278	64.53	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			190.1	C08		2	0340-0674	283.60	674.11	316	67.60	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3622.9	C08		2	0341-0677	50.74	676.48	504	93.74	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			663.4	C08		2	0342-0677	529.26	677.28	241	57.70	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			603.1	C08		2	0343-0679	637.19	678.71	458	80.43	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			393.7	C08		2	0344-0684	829.52	684.32	312	64.77	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			246.2	C08		2	0345-0685	100.70	685.98	251	58.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			428.5	C08		2	0346-0687	352.25	686.86	227	58.28	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			346.1	C08		2	0347-0686	391.95	685.78	302	65.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			331.8	C08		2	0348-0689	565.33	688.86	432	79.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1353.4	C08		2	0349-0687	806.47	688.39	341	72.43	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1151.6	C08		2	0350-0690	21.42	689.99	247	57.36	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			193.6	C08		2	0351-0690	142.77	690.36	295	65.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			405.9	C08		2	0352-0694	479.41	694.54	338	67.60	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			218.5	C08		2	0353-0700	209.29	699.63	276	63.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			247.4	C08		2	0354-0697	630.69	697.57	233	57.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.4	C08		2	0355-0699	247.97	699.45	266	60.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2720.1	C08		2	0356-0702	759.80	701.69	264	60.43	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.7	C08		2	0357-0710	176.17	709.98	264	60.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			328.8	C08		3	0001-0023	532.57	23.39	244	57.60	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2204.9	C08		3	0002-0028	327.48	30.03	247	65.36	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2069.9	C08		3	0003-0029	465.12	29.36	299	67.01	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			314.8	C08		3	0004-0029	685.49	28.96	237	60.63	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			403.5	C08		3	0005-0029	253.25	28.93	221	54.53	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			243.4	C08		3	0006-0032	58.32	32.64	327	66.43	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			300.0	C08		3	0007-0031	771.33	31.27	277	60.77	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			436.0	C08		3	0008-0032	938.39	31.96	323	66.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			294.5	C08		3	0009-0032	428.60	32.82	242	58.28	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			302.7	C08		3	0010-0041	489.88	41.38	564	96.57	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			302.7	C08		3	0011-0034	658.31	34.47	313	66.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			238.1	C08		3	0012-0040	199.61	39.73	314	70.18	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			412.9	C08		3	0013-0039	448.67	39.33	289	63.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			334.8	C08		3	0014-0037	547.08	37.85	227	57.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			524.4	C08		3	0015-0041	721.42	40.98	365	73.01	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			308.2	C08		3	0016-0039	566.60	40.06	313	69.01	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			327.2	C08		3	0017-0040	922.00	40.34	223	66.67	0.630
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			252.1	C08		3	0018-0044	596.63	44.21	304	66.43	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2162.9	C08		3	0019-0041	813.20	41.28	179	51.46	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			495.3	C08		3	0020-0049	113.44	49.20	334	67.84	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2314.2	C08		3	0021-0053	359.25	53.25	278	65.01	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			245.0	C08		3	0022-0049	430.55	48.90	263	61.11	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			331.1	C08		3	0023-0055	223.57	55.22	314	66.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			375.1	C08		3	0024-0053	396.70	52.83	352	69.01	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1779.4	C08		3	0025-0055	809.25	55.67	224	55.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			294.6	C08		3	0026-0059	148.23	58.99	225	59.60	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			481.0	C08		3	0027-0064	280.55	64.35	314	67.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			515.3	C08		3	0028-0063	544.03	63.30	254	57.70	0.959
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			463.5	C08		3	0029-0064	884.27	64.14	186	51.70	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			517.2	C08		3	0030-0066	516.31	65.67	264	63.36	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			288.7	C08		3	0031-0066	137.84	67.13	100	36.87	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			300.6	C08		3	0032-0073	467.13	73.35	280	67.84	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			507.7	C08		3	0033-0082	290.55	82.99	431	79.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			467.5	C08		3	0034-0081	885.37	80.56	222	56.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3247.6	C08		3	0035-0084	53.08	83.10	310	65.84	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			264.1	C08		3	0036-0084	137.48	84.03	298	65.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			434.5	C08		3	0037-0082	269.27	81.66	220	57.46	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			350.4	C08		3	0038-0085	905.06	84.63	292	63.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			641.6	C08		3	0039-0088	663.25	88.70	423	77.50	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			212.3	C08		3	0040-0087	397.19	87.20	335	70.08	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1618.6	C08		3	0041-0091	639.02	90.74	485	81.01	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			664.7	C08		3	0042-0087	769.24	87.52	258	59.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			369.9	C08		3	0043-0090	219.09	90.97	283	63.01	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			399.7	C08		3	0044-0097	238.14	97.34	325	69.60	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			144.9	C08		3	0045-0100	948.51	100.66	304	64.18	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			315.0	C08		3	0046-0106	703.27	106.15	301	71.01	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			260.6	C08		3	0047-0104	412.83	104.58	343	69.36	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			535.9	C08		3	0048-0106	858.33	105.98	240	57.94	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			331.1	C08		3	0049-0114	169.00	114.22	297	65.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			538.8	C08		3	0050-0112	786.67	113.07	223	55.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			257.2	C08		3	0051-0116	38.58	116.93	429	80.08	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			330.7	C08		3	0052-0116	528.84	115.97	313	66.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2830.0	C08		3	0053-0119	387.92	119.01	319	66.18	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			617.2	C08		3	0054-0132	365.36	135.16	821	132.47	0.588
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			401.2	C08		3	0055-0129	748.67	130.15	442	92.23	0.653
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			638.4	C08		3	0056-0128	920.91	127.37	349	69.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			360.5	C08		3	0057-0125	566.78	124.73	293	63.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			282.3	C08		3	0058-0127	626.53	128.10	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			277.2	C08		3	0059-0130	770.46	128.58	300	69.01	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			414.4	C08		3	0060-0135	789.23	134.60	222	61.60	0.735
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			342.8	C08		3	0061-0134	817.31	134.17	319	68.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1906.3	C08		3	0062-0142	89.03	141.16	280	67.11	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1694.4	C08		3	0063-0141	165.57	141.85	330	68.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			872.8	C08		3	0064-0138	224.78	138.64	223	55.70	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			634.0	C08		3	0065-0141	396.66	141.25	271	61.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			300.0	C08		3	0066-0141	497.15	141.74	275	63.11	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			413.0	C08		3	0067-0142	861.03	142.03	262	59.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			636.9	C08		3	0068-0142	337.85	142.39	270	65.11	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			360.9	C08		3	0069-0145	703.67	145.81	261	61.36	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			327.1	C08		3	0070-0148	266.12	148.80	285	65.60	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			268.2	C08		3	0071-0155	897.36	154.70	365	73.26	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			284.9	C08		3	0072-0152	653.92	152.55	284	64.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			507.8	C08		3	0073-0161	237.53	161.53	297	65.01	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			452.8	C08		3	0074-0164	69.27	165.07	267	63.60	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			310.4	C08		3	0075-0164	520.53	163.95	253	61.01	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			584.8	C08		3	0076-0166	620.29	165.68	383	73.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			337.1	C08		3	0077-0164	465.07	164.49	227	57.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			513.7	C08		3	0078-0165	749.54	165.08	432	77.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			253.1	C08		3	0079-0172	869.02	171.91	382	74.33	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			303.7	C08		3	0080-0173	23.84	172.42	302	65.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			561.8	C08		3	0081-0174	592.35	173.61	452	83.84	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.3	C08		3	0082-0174	274.69	173.21	288	67.36	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			372.2	C08		3	0083-0178	545.77	178.99	262	66.53	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			267.0	C08		3	0084-0178	148.43	178.01	338	73.84	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			345.7	C08		3	0085-0176	514.15	177.00	189	52.77	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3947.5	C08		3	0086-0177	679.31	177.37	240	58.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4099.6	C08		3	0087-0181	696.46	181.97	249	59.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			307.8	C08		3	0088-0180	794.34	180.45	254	60.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1502.9	C08		3	0089-0181	108.76	180.88	230	55.11	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			250.4	C08		3	0090-0193	414.72	192.56	330	68.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1300.8	C08		3	0091-0190	64.99	189.93	227	55.11	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2209.8	C08		3	0092-0195	99.27	195.98	234	56.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			691.3	C08		3	0093-0196	202.97	195.97	316	69.01	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			255.8	C08		3	0094-0198	831.79	197.32	370	75.60	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2223.0	C08		3	0095-0197	49.38	196.72	237	58.18	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			452.5	C08		3	0096-0197	513.77	197.29	315	65.01	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			302.6	C08		3	0097-0204	457.17	203.08	271	61.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			497.4	C08		3	0098-0203	704.26	203.91	332	73.01	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			280.4	C08		3	0099-0204	354.49	204.48	347	73.01	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1037.5	C08		3	0100-0208	569.50	207.85	443	78.67	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			297.0	C08		3	0101-0210	948.56	209.54	264	63.11	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			295.8	C08		3	0102-0214	469.57	213.88	255	59.94	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			344.9	C08		3	0103-0225	924.52	225.67	367	87.15	0.607
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			271.7	C08		3	0104-0228	644.11	227.88	315	70.77	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			290.5	C08		3	0105-0225	61.98	224.71	299	70.67	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			249.0	C08		3	0106-0225	160.87	224.84	322	69.84	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			481.2	C08		3	0107-0229	862.41	228.41	317	68.67	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			266.9	C08		3	0108-0228	18.02	227.83	235	55.94	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			341.2	C08		3	0109-0234	751.08	233.32	289	64.18	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			914.0	C08		3	0110-0236	782.55	236.23	246	57.36	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.0	C08		3	0111-0240	93.05	240.20	308	66.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			318.4	C08		3	0112-0238	892.29	239.00	287	65.01	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			617.0	C08		3	0113-0240	235.55	240.11	332	67.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			283.9	C08		3	0114-0237	585.30	237.86	152	46.87	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			422.7	C08		3	0115-0241	269.32	240.96	307	66.77	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			455.8	C08		3	0116-0248	610.00	249.03	258	62.28	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			695.4	C08		3	0117-0246	373.04	246.03	343	76.43	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			529.0	C08		3	0118-0248	765.67	248.01	239	67.01	0.669
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1175.2	C08		3	0119-0248	806.76	248.02	239	55.70	0.968
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4325.8	C08		3	0120-0251	678.80	251.79	260	59.94	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			528.4	C08		3	0121-0250	583.42	250.39	234	68.04	0.635
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			352.1	C08		3	0122-0258	131.40	259.27	494	84.33	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			395.5	C08		3	0123-0256	150.97	255.71	274	63.84	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			297.4	C08		3	0124-0260	490.75	261.11	264	64.18	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			547.9	C08		3	0125-0261	49.17	260.94	240	58.77	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			264.5	C08		3	0126-0261	447.80	260.90	268	65.01	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			440.0	C08		3	0127-0266	406.69	265.92	281	63.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			396.2	C08		3	0128-0263	942.26	262.18	227	57.70	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1052.5	C08		3	0129-0266	729.09	265.65	222	54.53	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			386.6	C08		3	0130-0271	632.23	271.21	387	98.47	0.502
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1003.8	C08		3	0131-0276	877.95	276.41	209	53.46	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			632.9	C08		3	0132-0280	532.20	280.58	357	69.01	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			419.0	C08		3	0133-0283	898.83	283.28	321	65.60	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			255.0	C08		3	0134-0287	309.24	286.78	291	63.60	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			347.2	C08		3	0135-0290	800.71	289.32	280	63.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1666.2	C08		3	0136-0289	858.29	289.80	228	56.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			397.5	C08		3	0137-0293	677.33	293.41	287	63.94	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			427.2	C08		3	0138-0291	459.36	291.79	320	66.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			333.7	C08		3	0139-0297	354.38	297.64	401	79.50	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			755.9	C08		3	0140-0294	757.01	294.27	198	55.11	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			322.1	C08		3	0141-0299	576.94	298.66	443	79.60	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			265.4	C08		3	0142-0298	265.74	298.65	267	61.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			330.6	C08		3	0143-0299	72.18	299.74	253	58.77	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1164.6	C08		3	0144-0304	788.08	303.48	234	59.01	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			424.0	C08		3	0145-0311	518.79	311.58	293	63.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			369.8	C08		3	0146-0311	866.10	311.35	321	66.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			348.5	C08		3	0147-0313	114.14	313.03	312	67.84	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			242.5	C08		3	0148-0316	281.76	314.32	322	72.77	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			367.9	C08		3	0149-0314	216.74	314.24	240	57.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			357.5	C08		3	0150-0316	462.68	315.95	374	71.84	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			337.8	C08		3	0151-0312	671.78	312.33	293	66.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			301.2	C08		3	0152-0319	404.30	319.33	365	90.33	0.562
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			260.4	C08		3	0153-0317	916.73	316.91	325	68.43	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			260.6	C08		3	0154-0321	486.15	320.62	376	90.91	0.572
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			398.8	C08		3	0155-0321	749.58	321.63	264	61.94	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			932.8	C08		3	0156-0320	800.65	320.44	228	56.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			409.1	C08		3	0157-0322	187.82	322.48	247	57.11	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			501.8	C08		3	0158-0325	595.66	325.86	278	63.70	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			218.3	C08		3	0159-0330	310.51	329.78	303	69.60	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			615.5	C08		3	0160-0335	57.67	335.14	295	64.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			360.2	C08		3	0161-0340	769.12	339.27	267	65.36	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			278.7	C08		3	0162-0337	643.36	337.38	259	60.28	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			521.7	C08		3	0163-0342	782.81	341.49	203	57.11	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1153.3	C08		3	0164-0342	707.27	341.53	243	57.94	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			330.2	C08		3	0165-0347	686.39	347.35	273	61.11	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			365.4	C08		3	0166-0349	864.22	349.06	308	67.60	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			384.4	C08		3	0167-0353	197.73	352.76	262	66.18	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			467.8	C08		3	0168-0356	948.80	356.74	354	73.50	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			291.7	C08		3	0169-0351	635.22	351.36	265	63.94	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			337.1	C08		3	0170-0352	215.58	351.55	130	45.36	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			360.6	C08		3	0171-0355	559.53	355.31	290	65.60	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			335.7	C08		3	0172-0358	54.25	359.06	261	61.01	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			465.4	C08		3	0173-0363	341.37	363.34	449	81.01	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			540.1	C08		3	0174-0359	778.66	359.31	223	55.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			506.2	C08		3	0175-0363	359.28	363.10	324	70.53	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			256.4	C08		3	0176-0367	464.46	366.77	345	71.01	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			428.9	C08		3	0177-0367	727.94	367.19	277	61.36	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			372.1	C08		3	0178-0368	906.35	368.80	281	62.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			396.6	C08		3	0179-0368	189.77	367.86	245	57.36	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			398.9	C08		3	0180-0369	213.15	368.99	220	53.94	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			282.1	C08		3	0181-0372	857.11	373.24	323	71.60	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1061.1	C08		3	0182-0374	698.26	374.09	239	60.18	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			274.3	C08		3	0183-0377	303.40	376.96	313	67.01	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			911.8	C08		3	0184-0377	544.99	377.60	241	59.36	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			8430.3	C08		3	0185-0383	44.56	382.58	380	73.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2485.2	C08		3	0186-0389	434.90	390.02	536	103.40	0.630
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			248.7	C08		3	0187-0382	792.69	380.81	322	71.84	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			278.9	C08		3	0188-0387	381.32	386.98	316	72.77	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			581.5	C08		3	0189-0390	610.76	389.98	481	86.33	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			630.9	C08		3	0190-0389	695.86	388.97	303	68.43	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			238.1	C08		3	0191-0392	841.59	392.05	299	65.94	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			754.6	C08		3	0192-0394	134.16	394.28	212	54.53	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1403.0	C08		3	0193-0398	670.63	398.30	256	59.11	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.9	C08		3	0194-0402	272.23	402.84	428	76.91	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			292.5	C08		3	0195-0408	507.87	407.51	311	66.53	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			278.3	C08		3	0196-0410	807.87	410.34	346	69.84	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			289.7	C08		3	0197-0409	472.96	409.63	281	61.60	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			258.3	C08		3	0198-0411	322.05	410.94	282	63.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			520.4	C08		3	0199-0413	571.30	413.44	318	66.53	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.1	C08		3	0200-0414	759.60	414.30	348	71.84	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			282.1	C08		3	0201-0414	89.37	414.72	261	60.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			333.3	C08		3	0202-0417	190.24	417.81	315	66.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.4	C08		3	0203-0419	20.26	419.74	274	65.36	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			240.3	C08		3	0204-0425	422.94	424.10	347	74.43	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			297.0	C08		3	0205-0422	719.69	422.40	292	65.36	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			198.6	C08		3	0206-0425	354.68	425.44	306	65.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			234.4	C08		3	0207-0429	315.29	430.42	404	77.50	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			267.0	C08		3	0208-0427	212.29	427.79	284	63.94	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			578.1	C08		3	0209-0429	585.97	429.94	328	67.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			234.6	C08		3	0210-0432	39.94	432.05	266	62.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			450.7	C08		3	0211-0433	109.61	432.71	202	55.11	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1441.1	C08		3	0212-0438	716.99	437.68	332	76.43	0.714
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2328.1	C08		3	0213-0443	151.37	443.99	239	57.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1285.3	C08		3	0214-0441	866.29	441.56	144	48.04	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			275.6	C08		3	0215-0448	705.39	449.09	366	71.84	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			412.5	C08		3	0216-0445	115.33	445.73	189	51.94	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			814.2	C08		3	0217-0444	904.95	445.08	292	66.53	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2444.1	C08		3	0218-0450	642.85	450.12	331	87.74	0.540
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			289.9	C08		3	0219-0449	247.18	448.68	163	52.18	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			278.4	C08		3	0220-0450	17.02	450.61	255	60.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			770.6	C08		3	0221-0451	528.31	450.92	220	56.87	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			961.7	C08		3	0222-0450	169.22	450.25	225	55.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			269.2	C08		3	0223-0451	232.54	451.54	225	62.28	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			471.5	C08		3	0224-0452	283.27	452.69	218	63.01	0.690
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1597.2	C08		3	0225-0452	833.38	452.54	187	51.46	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1127.2	C08		3	0226-0454	884.15	454.05	199	53.11	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1505.0	C08		3	0227-0451	868.05	451.00	108	41.80	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			329.4	C08		3	0228-0460	783.55	460.00	397	73.60	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1216.1	C08		3	0229-0457	81.69	456.53	160	48.53	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			375.3	C08		3	0230-0459	599.55	459.37	223	55.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			959.7	C08		3	0231-0467	409.14	467.44	277	63.94	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2264.4	C08		3	0232-0463	896.21	463.67	180	50.53	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			642.1	C08		3	0233-0471	73.92	471.13	260	60.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			366.8	C08		3	0234-0470	370.62	469.91	330	66.77	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1944.8	C08		3	0235-0470	909.28	470.32	193	54.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1237.6	C08		3	0236-0474	658.09	474.07	236	108.47	0.252
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			471.8	C08		3	0237-0477	757.68	477.45	310	68.18	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.1	C08		3	0238-0483	861.58	482.86	294	67.36	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.8	C08		3	0239-0482	135.99	482.81	302	65.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			265.3	C08		3	0240-0481	782.06	481.84	320	70.18	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			696.2	C08		3	0241-0484	619.12	484.95	307	67.60	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			473.7	C08		3	0242-0487	230.78	487.27	221	56.77	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3384.0	C08		3	0243-0488	501.96	488.48	303	95.15	0.421
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			234.5	C08		3	0244-0492	845.54	492.39	295	67.01	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			821.0	C08		3	0245-0496	592.35	495.95	308	67.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			192.9	C08		3	0246-0494	948.35	494.15	209	56.28	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			322.6	C08		3	0247-0495	927.22	495.11	272	63.11	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.4	C08		3	0248-0497	887.16	497.36	310	68.43	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			307.2	C08		3	0249-0508	730.86	507.47	308	68.18	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			305.6	C08		3	0250-0510	714.33	510.41	265	63.11	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			198.7	C08		3	0251-0505	944.95	505.82	128	46.63	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			299.7	C08		3	0252-0511	456.37	510.33	310	65.94	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			291.5	C08		3	0253-0513	43.13	513.37	269	63.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			361.5	C08		3	0254-0516	514.45	515.97	247	62.18	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.9	C08		3	0255-0520	646.15	520.03	381	72.67	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			315.9	C08		3	0256-0519	399.86	519.23	316	67.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			238.6	C08		3	0257-0522	197.60	521.91	304	64.77	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			330.3	C08		3	0258-0524	879.76	523.49	273	63.36	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			237.6	C08		3	0259-0526	159.70	527.09	306	67.94	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			308.0	C08		3	0260-0523	483.04	523.55	269	63.94	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			253.4	C08		3	0261-0531	810.81	531.43	365	72.18	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1915.2	C08		3	0262-0528	565.57	527.76	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			282.6	C08		3	0263-0530	782.86	529.80	316	67.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			293.2	C08		3	0264-0530	756.84	529.87	273	60.77	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			537.0	C08		3	0265-0531	367.86	531.22	203	54.04	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			225.5	C08		3	0266-0534	608.04	534.55	326	68.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			207.9	C08		3	0267-0537	119.51	536.59	320	66.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			967.5	C08		3	0268-0538	740.19	538.23	288	63.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			389.8	C08		3	0269-0546	675.65	545.16	234	61.70	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1135.6	C08		3	0270-0549	529.42	550.06	285	65.60	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			331.9	C08		3	0271-0551	426.59	551.08	333	68.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			264.1	C08		3	0272-0551	267.71	551.18	295	63.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			872.4	C08		3	0273-0550	703.60	550.46	250	58.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			852.6	C08		3	0274-0554	40.63	553.53	281	62.53	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			310.5	C08		3	0275-0553	861.92	552.97	283	63.11	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			268.2	C08		3	0276-0552	904.61	552.64	264	62.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			429.3	C08		3	0277-0562	81.73	563.11	229	57.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			237.8	C08		3	0278-0560	180.90	560.41	289	65.11	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			540.2	C08		3	0279-0564	689.94	564.74	395	73.60	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1161.0	C08		3	0280-0566	65.60	566.35	283	61.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			271.8	C08		3	0281-0566	890.89	566.66	302	64.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			308.2	C08		3	0282-0568	447.87	568.48	399	73.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			249.7	C08		3	0283-0567	848.99	567.07	160	48.04	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			881.9	C08		3	0284-0568	726.85	569.11	263	59.46	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.0	C08		3	0285-0574	501.01	573.94	304	68.18	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			205.7	C08		3	0286-0576	103.26	576.46	271	63.11	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			251.8	C08		3	0287-0577	288.58	576.72	309	67.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1910.8	C08		3	0288-0571	588.60	571.12	203	56.28	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			277.8	C08		3	0289-0580	322.17	580.19	286	62.18	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			260.8	C08		3	0290-0582	304.21	582.90	279	63.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5429.7	C08		3	0291-0587	610.80	586.71	430	81.26	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			210.6	C08		3	0292-0583	908.91	583.67	336	71.60	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			293.1	C08		3	0293-0587	357.14	587.71	211	54.87	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1059.9	C08		3	0294-0583	584.48	583.09	206	56.28	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			372.5	C08		3	0295-0584	760.43	583.31	202	53.11	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1264.3	C08		3	0296-0586	839.51	587.03	244	59.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			355.2	C08		3	0297-0588	726.94	587.22	223	56.28	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.9	C08		3	0298-0592	227.26	591.41	284	62.43	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			314.7	C08		3	0299-0596	537.39	596.63	274	62.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1421.6	C08		3	0300-0596	628.00	596.63	204	54.53	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			294.1	C08		3	0301-0598	53.36	598.16	263	59.36	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			245.6	C08		3	0302-0601	490.88	601.10	323	68.18	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.0	C08		3	0303-0598	800.23	598.26	318	66.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.7	C08		3	0304-0606	86.25	606.24	265	59.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			464.0	C08		3	0305-0606	873.17	605.88	286	63.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			306.5	C08		3	0306-0605	758.47	605.61	197	56.18	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			325.2	C08		3	0307-0612	193.94	611.97	326	68.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			216.5	C08		3	0308-0612	153.56	612.34	281	63.36	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			614.7	C08		3	0309-0612	39.38	612.41	207	52.87	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			271.6	C08		3	0310-0617	654.98	617.44	437	77.26	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2147.6	C08		3	0311-0620	691.40	620.80	264	62.77	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			249.4	C08		3	0312-0622	316.84	621.70	292	62.77	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			750.5	C08		3	0313-0628	613.04	628.45	215	54.87	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			278.1	C08		3	0314-0632	119.71	632.15	422	75.36	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			268.9	C08		3	0315-0630	340.94	629.63	275	65.60	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1557.9	C08		3	0316-0635	406.97	634.37	580	95.98	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			444.4	C08		3	0317-0634	44.10	633.95	263	62.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			310.4	C08		3	0318-0637	939.48	637.54	249	58.53	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			656.6	C08		3	0319-0643	596.50	643.24	346	69.60	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			257.6	C08		3	0320-0642	345.82	643.74	326	71.01	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1324.5	C08		3	0321-0643	892.99	643.52	199	54.87	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			375.9	C08		3	0322-0645	755.67	644.84	283	62.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			231.6	C08		3	0323-0647	849.47	645.85	284	66.43	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2066.8	C08		3	0324-0645	915.19	645.36	189	50.53	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			639.9	C08		3	0325-0648	719.79	648.20	266	63.60	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			290.2	C08		3	0326-0650	46.59	649.98	241	58.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			265.1	C08		3	0327-0654	672.21	654.89	277	62.77	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			324.6	C08		3	0328-0659	482.69	658.41	319	68.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			349.6	C08		3	0329-0656	415.05	657.27	273	64.18	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			290.8	C08		3	0330-0661	817.85	661.10	226	55.11	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.4	C08		3	0331-0662	381.27	662.38	254	60.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			275.4	C08		3	0332-0664	602.31	664.16	276	61.94	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			424.0	C08		3	0333-0665	260.71	665.53	161	46.87	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			203.4	C08		3	0334-0669	166.07	669.08	291	63.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.4	C08		3	0335-0673	211.95	673.34	288	68.53	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			416.5	C08		3	0336-0672	244.53	673.82	262	64.53	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			768.3	C08		3	0337-0678	779.05	677.79	266	59.36	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			472.3	C08		3	0338-0679	734.95	678.14	297	63.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			445.9	C08		3	0339-0681	865.04	680.29	300	66.77	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			331.6	C08		3	0340-0682	910.16	681.82	303	65.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1086.2	C08		3	0341-0682	754.15	682.31	293	63.01	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			341.7	C08		3	0342-0681	883.02	681.72	260	61.01	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			464.9	C08		3	0343-0681	559.94	681.50	269	63.36	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			410.3	C08		3	0344-0687	817.17	687.40	326	67.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			265.1	C08		3	0345-0688	615.97	687.25	257	61.11	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			238.5	C08		3	0346-0694	384.31	694.38	318	68.53	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.1	C08		3	0347-0697	418.34	698.00	305	66.77	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			256.6	C08		3	0348-0701	679.16	701.08	282	67.36	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1717.5	C08		3	0349-0701	229.03	700.26	253	67.84	0.691
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			299.5	C08		3	0350-0705	619.82	705.13	278	63.94	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			671.6	C08		3	0351-0702	848.61	702.61	245	59.94	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			272.2	C08		3	0352-0709	943.83	708.13	287	64.77	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			178.2	C08		3	0353-0709	56.23	709.62	258	61.70	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			260.7	C08		3	0354-0711	333.46	711.20	309	69.11	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			297.9	C08		4	0001-0023	195.30	23.30	268	61.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			440.9	C08		4	0002-0022	562.22	22.54	257	61.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			656.5	C08		4	0003-0021	820.66	21.45	146	46.04	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			157.2	C08		4	0004-0026	17.68	27.12	282	63.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1258.7	C08		4	0005-0025	333.33	25.35	262	59.36	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.0	C08		4	0006-0029	365.76	29.28	324	70.67	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			910.4	C08		4	0007-0029	89.76	29.68	255	61.36	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			499.5	C08		4	0008-0033	621.79	33.53	356	70.43	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			295.3	C08		4	0009-0038	108.79	38.32	321	66.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			261.6	C08		4	0010-0042	214.26	42.85	281	64.77	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			253.7	C08		4	0011-0045	786.35	45.55	257	61.11	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			506.1	C08		4	0012-0046	321.66	46.11	241	57.11	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			412.4	C08		4	0013-0046	703.80	46.36	280	65.11	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			299.9	C08		4	0014-0048	943.16	49.11	232	56.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2717.1	C08		4	0015-0055	52.27	55.75	711	116.13	0.663
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.0	C08		4	0016-0052	448.90	51.61	395	72.77	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			274.3	C08		4	0017-0056	116.59	56.15	287	64.77	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			330.3	C08		4	0018-0057	857.49	56.52	218	55.11	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			268.2	C08		4	0019-0062	138.71	62.85	301	69.26	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.3	C08		4	0020-0063	660.87	63.64	333	68.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			362.4	C08		4	0021-0063	268.62	63.38	243	59.60	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			262.3	C08		4	0022-0067	498.94	66.82	322	70.18	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			485.5	C08		4	0023-0063	541.75	63.22	257	60.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			243.5	C08		4	0024-0062	762.42	62.81	263	60.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			208.0	C08		4	0025-0065	921.79	64.05	293	66.43	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			562.4	C08		4	0026-0072	306.40	72.35	280	63.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			737.4	C08		4	0027-0072	555.04	71.69	231	57.94	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			253.7	C08		4	0028-0077	228.36	77.22	311	66.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			517.8	C08		4	0029-0080	255.87	80.63	419	76.08	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			291.5	C08		4	0030-0080	861.20	80.08	233	56.87	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			238.9	C08		4	0031-0080	902.41	80.33	276	62.77	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			699.6	C08		4	0032-0083	625.71	83.44	278	63.94	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			946.2	C08		4	0033-0083	563.68	83.38	211	54.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			493.2	C08		4	0034-0086	418.74	86.24	264	60.43	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			398.1	C08		4	0035-0087	108.03	87.68	255	60.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			340.3	C08		4	0036-0093	591.99	93.38	413	82.08	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			324.8	C08		4	0037-0086	761.03	86.31	272	63.94	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			265.2	C08		4	0038-0087	185.57	87.49	289	61.94	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			217.1	C08		4	0039-0093	461.42	93.14	342	73.74	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			230.4	C08		4	0040-0092	701.97	91.78	300	66.18	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			273.5	C08		4	0041-0100	738.97	99.96	308	65.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			352.7	C08		4	0042-0102	52.13	101.74	260	59.94	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			847.1	C08		4	0043-0110	367.52	110.02	740	103.30	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2500.3	C08		4	0044-0103	837.97	102.66	133	98.13	0.174
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			279.6	C08		4	0045-0104	544.63	104.79	309	65.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.4	C08		4	0046-0107	942.98	106.80	304	64.77	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			359.7	C08		4	0047-0107	89.01	106.82	202	55.11	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			272.9	C08		4	0048-0112	288.36	112.59	289	63.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			291.5	C08		4	0049-0118	163.66	118.71	229	59.70	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			522.8	C08		4	0050-0121	427.35	120.78	283	63.26	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			8303.1	C08		4	0051-0128	672.34	128.38	325	67.01	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			597.9	C08		4	0052-0132	440.24	131.62	293	65.26	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1459.1	C08		4	0053-0132	641.24	132.40	265	63.01	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			444.0	C08		4	0054-0135	321.50	135.13	286	69.11	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			616.9	C08		4	0055-0133	195.76	132.94	243	58.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			521.7	C08		4	0056-0141	832.51	140.76	395	73.01	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1190.1	C08		4	0057-0141	698.12	140.93	279	61.94	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			275.0	C08		4	0058-0144	401.87	144.67	298	65.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			518.7	C08		4	0059-0141	608.51	141.51	293	63.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			692.9	C08		4	0060-0143	890.55	143.94	350	69.01	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			271.1	C08		4	0061-0147	281.89	147.32	272	62.53	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1648.1	C08		4	0062-0155	211.91	154.96	244	59.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			280.2	C08		4	0063-0155	546.55	155.53	283	63.70	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1762.9	C08		4	0064-0157	650.36	156.76	250	58.18	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			425.6	C08		4	0065-0162	471.64	161.79	460	83.98	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			480.7	C08		4	0066-0162	875.55	162.57	335	67.01	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3884.8	C08		4	0067-0165	392.06	164.70	252	60.87	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			341.8	C08		4	0068-0162	908.00	162.89	262	59.11	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			323.1	C08		4	0069-0166	15.51	165.91	257	61.01	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			840.1	C08		4	0070-0165	626.78	165.37	265	61.36	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			370.6	C08		4	0071-0169	55.25	169.81	268	63.94	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			210.9	C08		4	0072-0173	930.06	173.44	334	73.60	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			804.3	C08		4	0073-0171	572.45	171.06	277	65.01	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			320.4	C08		4	0074-0175	117.62	175.02	347	70.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3472.2	C08		4	0075-0174	608.69	174.77	343	72.67	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2971.0	C08		4	0076-0176	709.60	175.55	246	58.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			375.3	C08		4	0077-0182	743.35	181.60	249	57.94	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			226.6	C08		4	0078-0187	260.34	187.52	305	68.43	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2287.5	C08		4	0079-0187	396.30	186.68	288	65.01	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			433.6	C08		4	0080-0189	524.11	189.77	271	62.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			414.3	C08		4	0081-0192	303.68	191.71	332	70.77	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			456.6	C08		4	0082-0193	77.16	194.14	250	58.87	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			774.1	C08		4	0083-0204	189.14	203.70	711	106.91	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			607.5	C08		4	0084-0195	564.72	195.48	236	56.53	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4118.9	C08		4	0085-0197	603.83	197.14	195	51.70	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			317.7	C08		4	0086-0201	361.27	201.37	278	62.18	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			788.9	C08		4	0087-0203	910.95	203.03	256	64.53	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2067.6	C08		4	0088-0200	621.21	201.45	183	52.53	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			848.3	C08		4	0089-0208	451.61	208.79	227	59.94	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1256.3	C08		4	0090-0205	142.26	204.59	219	54.53	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			376.5	C08		4	0091-0211	77.12	210.81	245	58.63	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			885.3	C08		4	0092-0214	212.55	213.45	279	62.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			287.3	C08		4	0093-0215	882.23	215.37	291	63.36	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			510.4	C08		4	0094-0218	788.07	218.22	272	63.94	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			194.7	C08		4	0095-0220	822.27	219.43	310	65.36	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			374.7	C08		4	0096-0221	236.96	221.31	270	60.18	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			261.7	C08		4	0097-0223	700.20	224.18	270	61.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			479.7	C08		4	0098-0225	11.64	225.33	233	56.28	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1832.6	C08		4	0099-0224	907.71	224.45	290	74.43	0.658
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.5	C08		4	0100-0231	46.45	231.41	275	62.18	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2383.9	C08		4	0101-0231	289.29	231.64	353	70.18	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			554.2	C08		4	0102-0233	398.28	233.18	267	64.18	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			781.9	C08		4	0103-0237	156.70	237.75	481	90.57	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			356.6	C08		4	0104-0241	555.48	240.85	356	74.91	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			425.7	C08		4	0105-0241	479.61	240.40	254	60.28	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			623.1	C08		4	0106-0245	716.17	245.07	436	77.60	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			265.7	C08		4	0107-0247	327.17	247.13	466	82.43	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1924.5	C08		4	0108-0246	134.48	245.89	176	49.36	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			275.0	C08		4	0109-0253	433.59	253.15	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1050.5	C08		4	0110-0253	587.73	252.99	305	65.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			292.1	C08		4	0111-0256	80.26	256.04	257	61.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1661.3	C08		4	0112-0257	247.39	255.62	261	61.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			789.8	C08		4	0113-0256	364.30	256.01	292	63.94	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			302.0	C08		4	0114-0254	936.70	254.54	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			382.0	C08		4	0115-0257	755.30	256.76	273	62.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			248.6	C08		4	0116-0257	864.11	257.95	306	66.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			470.0	C08		4	0117-0258	384.05	257.99	249	58.28	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			562.3	C08		4	0118-0260	777.97	259.88	263	59.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			400.9	C08		4	0119-0265	223.78	265.45	272	63.94	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1214.5	C08		4	0120-0264	502.47	264.27	314	66.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			631.0	C08		4	0121-0265	114.70	264.56	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			442.3	C08		4	0122-0271	280.71	271.29	271	61.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			740.0	C08		4	0123-0271	834.78	271.50	274	61.01	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			290.5	C08		4	0124-0274	894.80	274.10	305	65.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.7	C08		4	0125-0278	522.30	279.48	304	69.01	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			303.2	C08		4	0126-0276	602.65	276.21	294	62.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			620.6	C08		4	0127-0284	128.97	286.07	617	101.40	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1440.0	C08		4	0128-0277	254.08	276.78	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			500.5	C08		4	0129-0286	42.86	285.69	296	64.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			813.4	C08		4	0130-0286	158.65	286.05	218	55.70	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			782.3	C08		4	0131-0288	942.68	288.02	330	69.01	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			281.5	C08		4	0132-0289	406.39	289.20	301	67.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			302.0	C08		4	0133-0289	695.37	289.37	262	62.18	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			428.1	C08		4	0134-0294	340.79	295.23	513	90.91	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			409.1	C08		4	0135-0293	917.77	293.73	271	61.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1572.9	C08		4	0136-0296	250.70	296.90	422	77.84	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			412.7	C08		4	0137-0293	712.56	293.65	264	63.36	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			247.9	C08		4	0138-0294	560.23	293.96	274	64.43	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1351.0	C08		4	0139-0299	471.38	299.56	304	65.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			211.1	C08		4	0140-0301	392.38	301.52	280	64.18	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			184.2	C08		4	0141-0307	13.11	307.38	287	63.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6171.1	C08		4	0142-0306	80.29	306.31	181	50.87	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			234.2	C08		4	0143-0307	523.17	306.77	252	59.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			379.9	C08		4	0144-0306	612.94	307.01	227	54.77	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			261.3	C08		4	0145-0309	816.53	308.49	292	66.77	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2920.5	C08		4	0146-0315	425.75	315.11	295	63.01	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.0	C08		4	0147-0319	940.38	319.78	301	64.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			202.5	C08		4	0148-0318	803.67	318.62	290	69.84	0.747
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			792.1	C08		4	0149-0317	849.12	317.73	271	60.18	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			909.8	C08		4	0150-0323	559.21	322.24	321	73.26	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			7077.2	C08		4	0151-0321	87.18	321.12	225	56.28	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			652.6	C08		4	0152-0322	452.39	323.15	367	71.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			279.2	C08		4	0153-0327	162.06	328.11	249	59.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1823.9	C08		4	0154-0330	710.27	330.78	319	65.36	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			330.1	C08		4	0155-0328	886.53	328.26	263	60.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			249.6	C08		4	0156-0338	594.01	337.91	595	97.98	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			222.3	C08		4	0157-0337	646.17	337.01	297	63.60	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			717.3	C08		4	0158-0337	116.88	337.20	284	63.36	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			495.7	C08		4	0159-0341	39.77	340.92	273	63.60	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			327.3	C08		4	0160-0341	454.84	340.21	289	67.11	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			775.7	C08		4	0161-0346	304.57	345.75	260	61.36	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			354.6	C08		4	0162-0346	271.11	346.10	266	59.11	0.957
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.7	C08		4	0163-0350	752.50	350.43	324	67.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			248.3	C08		4	0164-0350	384.43	350.60	255	57.94	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			600.9	C08		4	0165-0356	74.61	354.29	497	93.74	0.711
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			234.6	C08		4	0166-0357	29.79	358.18	297	66.18	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			600.2	C08		4	0167-0358	176.42	358.89	387	72.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			237.2	C08		4	0168-0359	793.52	358.98	294	63.84	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			276.6	C08		4	0169-0361	514.26	361.31	283	61.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			279.2	C08		4	0170-0360	594.36	360.58	300	66.43	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			292.4	C08		4	0171-0361	685.12	361.13	274	61.11	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			238.4	C08		4	0172-0365	840.24	364.88	336	71.26	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			696.4	C08		4	0173-0368	155.00	368.36	278	62.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			226.8	C08		4	0174-0368	933.68	367.98	277	63.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.0	C08		4	0175-0368	547.58	368.08	268	61.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			404.2	C08		4	0176-0373	905.43	372.43	254	62.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			263.2	C08		4	0177-0378	76.68	377.50	293	64.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			522.7	C08		4	0178-0379	403.55	378.78	400	75.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			647.6	C08		4	0179-0381	916.77	381.15	265	65.11	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			607.5	C08		4	0180-0380	783.74	380.76	267	61.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			185.5	C08		4	0181-0381	868.36	381.50	273	62.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			210.1	C08		4	0182-0380	582.62	380.44	267	62.77	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			414.0	C08		4	0183-0387	197.99	387.76	271	62.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			425.3	C08		4	0184-0388	386.37	388.18	276	63.60	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			428.6	C08		4	0185-0393	451.71	392.80	425	77.50	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			363.3	C08		4	0186-0392	327.20	391.44	230	59.01	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			292.5	C08		4	0187-0391	646.40	391.28	327	69.60	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3833.2	C08		4	0188-0393	265.53	394.10	264	71.60	0.647
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			574.0	C08		4	0189-0398	487.40	398.43	243	57.94	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			437.0	C08		4	0190-0407	338.35	406.82	452	79.26	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.8	C08		4	0191-0407	428.75	406.70	308	67.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.6	C08		4	0192-0406	835.29	405.58	284	63.36	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1147.1	C08		4	0193-0406	219.83	405.82	314	75.01	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1748.2	C08		4	0194-0412	39.19	412.53	379	73.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			291.3	C08		4	0195-0414	718.29	413.31	316	70.67	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			546.5	C08		4	0196-0415	616.94	415.67	305	71.11	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			385.2	C08		4	0197-0418	537.24	418.53	261	60.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			310.0	C08		4	0198-0419	314.66	418.81	257	60.77	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			642.0	C08		4	0199-0423	23.37	424.02	327	68.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.4	C08		4	0200-0426	443.84	426.38	435	78.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.2	C08		4	0201-0422	497.94	422.24	234	59.94	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			291.4	C08		4	0202-0421	782.63	422.18	227	57.46	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			372.2	C08		4	0203-0428	102.54	428.54	257	59.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			507.7	C08		4	0204-0428	353.63	428.13	233	58.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			310.2	C08		4	0205-0431	175.61	431.06	260	61.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			606.7	C08		4	0206-0436	869.49	435.52	344	69.26	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			210.8	C08		4	0207-0437	399.03	437.24	300	65.84	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			275.0	C08		4	0208-0435	785.70	435.21	299	67.46	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			249.5	C08		4	0209-0442	844.50	442.06	300	68.08	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			247.4	C08		4	0210-0439	899.85	439.43	274	63.94	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.7	C08		4	0211-0444	533.74	444.45	275	63.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			188.3	C08		4	0212-0451	210.14	451.51	293	67.01	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			389.9	C08		4	0213-0452	160.79	452.29	236	59.70	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			287.8	C08		4	0214-0454	600.75	454.31	294	65.60	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.0	C08		4	0215-0451	736.90	451.79	266	61.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			990.2	C08		4	0216-0454	895.33	454.25	259	61.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.3	C08		4	0217-0458	478.62	458.38	287	65.84	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			380.5	C08		4	0218-0461	694.69	460.92	532	86.91	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			246.8	C08		4	0219-0459	44.19	459.42	281	64.43	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			218.3	C08		4	0220-0459	342.19	460.03	284	62.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			879.1	C08		4	0221-0462	933.42	462.17	236	57.70	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			650.4	C08		4	0222-0465	256.68	465.55	257	60.77	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			734.3	C08		4	0223-0471	643.70	471.56	319	67.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.9	C08		4	0224-0473	375.99	473.75	283	64.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			306.1	C08		4	0225-0478	95.76	477.80	297	67.94	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			258.3	C08		4	0226-0480	226.39	480.27	289	68.53	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			361.5	C08		4	0227-0482	578.29	482.37	597	107.88	0.645
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.1	C08		4	0228-0482	355.23	481.80	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			253.5	C08		4	0229-0483	515.35	483.79	278	63.70	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			257.3	C08		4	0230-0487	464.61	487.29	316	68.67	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			331.5	C08		4	0231-0486	656.31	486.55	381	76.18	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			299.1	C08		4	0232-0489	306.55	488.32	222	57.60	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			247.6	C08		4	0233-0491	261.19	491.53	318	66.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			722.9	C08		4	0234-0492	900.56	491.75	258	62.43	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5210.9	C08		4	0235-0493	119.60	493.37	322	66.43	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			265.4	C08		4	0236-0493	532.25	493.24	329	67.36	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			348.7	C08		4	0237-0496	152.27	496.95	290	63.60	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.2	C08		4	0238-0498	496.09	498.57	275	61.36	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			846.2	C08		4	0239-0506	296.91	506.63	510	89.40	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1182.3	C08		4	0240-0503	747.65	501.76	382	82.77	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.0	C08		4	0241-0505	190.44	504.87	303	66.43	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			925.2	C08		4	0242-0506	585.31	506.50	368	79.01	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1454.0	C08		4	0243-0506	914.71	505.80	385	72.08	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			452.3	C08		4	0244-0507	75.06	506.49	407	77.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			287.4	C08		4	0245-0508	940.54	508.37	248	59.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			270.6	C08		4	0246-0514	460.98	514.37	282	66.18	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.0	C08		4	0247-0515	344.87	515.17	256	58.77	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1345.3	C08		4	0248-0513	752.20	513.18	104	37.56	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			314.8	C08		4	0249-0519	797.87	519.53	305	66.77	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1280.0	C08		4	0250-0523	21.03	522.78	367	71.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			518.9	C08		4	0251-0524	677.56	524.40	267	63.11	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			225.4	C08		4	0252-0525	857.33	525.76	293	63.60	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			263.4	C08		4	0253-0528	605.21	528.13	260	60.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			240.2	C08		4	0254-0530	81.41	530.67	265	59.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.0	C08		4	0255-0532	425.71	531.58	294	64.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1474.0	C08		4	0256-0534	143.33	533.49	348	69.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.3	C08		4	0257-0536	337.79	536.17	304	64.77	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			307.4	C08		4	0258-0540	705.37	540.44	283	67.60	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			225.2	C08		4	0259-0540	375.55	540.29	282	61.36	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			341.4	C08		4	0260-0542	264.94	543.10	283	64.18	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			309.6	C08		4	0261-0540	769.06	541.00	227	55.70	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			522.4	C08		4	0262-0546	504.88	544.75	144	58.18	0.535
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			308.7	C08		4	0263-0545	786.77	545.17	241	58.28	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			319.4	C08		4	0264-0548	466.92	548.01	289	65.60	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			313.0	C08		4	0265-0551	193.95	551.35	335	75.36	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			266.1	C08		4	0266-0551	210.43	550.77	270	61.70	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			509.6	C08		4	0267-0553	564.18	553.75	284	62.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			200.4	C08		4	0268-0551	918.25	551.13	317	66.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			551.7	C08		4	0269-0550	498.75	550.63	113	46.04	0.670
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			326.7	C08		4	0270-0553	125.79	553.98	155	46.87	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5654.3	C08		4	0271-0563	41.40	563.91	377	82.43	0.697
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			222.2	C08		4	0272-0562	294.63	562.32	316	67.60	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			986.7	C08		4	0273-0561	645.15	561.41	241	61.36	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			515.7	C08		4	0274-0566	848.78	566.92	594	97.40	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			216.4	C08		4	0275-0565	518.57	564.82	266	61.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.0	C08		4	0276-0565	593.65	565.42	274	60.77	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			272.8	C08		4	0277-0568	97.71	568.65	271	62.77	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			653.3	C08		4	0278-0566	436.79	566.91	284	68.43	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			257.9	C08		4	0279-0583	385.93	583.07	254	58.53	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.2	C08		4	0280-0582	551.56	582.54	274	61.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			291.7	C08		4	0281-0586	588.04	585.62	294	67.60	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			222.2	C08		4	0282-0585	806.99	584.50	330	70.43	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.1	C08		4	0283-0588	656.39	587.82	317	68.67	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2532.6	C08		4	0284-0585	915.70	585.09	232	55.94	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1960.9	C08		4	0285-0586	752.14	586.11	259	59.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			715.5	C08		4	0286-0589	453.57	588.43	297	65.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			226.0	C08		4	0287-0596	680.62	596.36	294	65.01	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			238.7	C08		4	0288-0597	370.78	597.13	269	60.87	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3707.7	C08		4	0289-0598	906.51	598.67	284	67.01	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1272.5	C08		4	0290-0602	472.15	602.78	265	62.77	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			236.6	C08		4	0291-0606	407.31	605.77	311	66.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			310.9	C08		4	0292-0610	596.24	611.18	339	74.43	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			494.6	C08		4	0293-0606	124.51	606.33	248	59.11	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			265.1	C08		4	0294-0604	150.87	603.91	160	48.87	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			913.1	C08		4	0295-0608	221.37	608.45	282	67.01	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			244.4	C08		4	0296-0611	107.12	611.29	310	67.60	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			7057.9	C08		4	0297-0608	891.26	607.66	201	53.36	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			226.1	C08		4	0298-0617	251.36	617.11	262	63.26	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			218.0	C08		4	0299-0617	546.69	617.58	314	66.18	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			250.5	C08		4	0300-0621	164.67	621.23	270	65.70	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			333.6	C08		4	0301-0617	298.05	616.51	243	57.36	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			549.9	C08		4	0302-0623	508.75	622.51	536	104.13	0.621
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			211.5	C08		4	0303-0621	860.48	620.95	301	66.53	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			557.6	C08		4	0304-0621	89.78	621.50	220	54.18	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			242.9	C08		4	0305-0626	363.21	626.25	240	63.84	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			154.7	C08		4	0306-0623	19.85	623.15	257	57.94	0.962
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			261.1	C08		4	0307-0626	446.30	626.23	296	65.84	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			217.0	C08		4	0308-0628	276.95	627.68	296	65.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.2	C08		4	0309-0632	393.23	631.71	281	63.60	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			249.2	C08		4	0310-0629	712.87	629.97	259	61.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1135.5	C08		4	0311-0633	197.52	634.07	279	62.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			899.0	C08		4	0312-0642	488.06	641.33	754	112.47	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			298.1	C08		4	0313-0637	829.47	636.54	263	61.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			394.6	C08		4	0314-0644	345.03	644.26	229	55.70	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			265.5	C08		4	0315-0641	608.85	641.57	282	65.36	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			317.5	C08		4	0316-0647	814.22	647.40	352	70.67	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			261.7	C08		4	0317-0648	411.99	648.90	283	67.84	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			312.0	C08		4	0318-0654	217.20	652.52	594	101.74	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			564.6	C08		4	0319-0647	372.52	646.90	117	54.67	0.492
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			532.5	C08		4	0320-0651	366.21	653.00	129	56.43	0.509
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			238.9	C08		4	0321-0657	751.75	656.75	276	64.77	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1220.4	C08		4	0322-0661	29.53	660.50	527	89.26	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			191.1	C08		4	0323-0658	948.14	657.79	286	63.60	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			194.7	C08		4	0324-0664	526.90	664.58	255	62.53	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			284.5	C08		4	0325-0661	625.34	660.88	249	57.94	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.3	C08		4	0326-0664	562.53	664.41	309	68.43	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			199.4	C08		4	0327-0667	784.11	667.20	269	63.36	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			252.1	C08		4	0328-0665	139.16	664.90	285	63.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			779.3	C08		4	0329-0670	586.29	670.21	256	59.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1939.6	C08		4	0330-0670	914.77	670.05	225	54.87	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			637.1	C08		4	0331-0674	415.34	674.71	314	66.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			325.8	C08		4	0332-0677	471.76	677.87	291	65.94	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			226.7	C08		4	0333-0679	539.42	678.57	287	67.36	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			603.9	C08		4	0334-0682	65.29	680.87	252	65.36	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			423.4	C08		4	0335-0683	495.42	683.29	294	66.53	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			505.0	C08		4	0336-0681	348.32	681.31	250	58.18	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			183.8	C08		4	0337-0682	512.00	682.29	273	61.21	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2859.3	C08		4	0338-0685	29.24	685.85	265	61.36	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.4	C08		4	0339-0687	261.52	686.48	285	65.36	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2005.9	C08		4	0340-0687	845.32	687.10	233	56.18	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			185.0	C08		4	0341-0692	717.19	692.78	251	61.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			522.9	C08		4	0342-0691	292.89	692.24	199	53.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.3	C08		4	0343-0694	754.00	694.29	290	65.60	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			286.8	C08		4	0344-0696	193.12	695.75	276	62.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1272.6	C08		4	0345-0697	54.64	698.43	341	70.43	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			841.2	C08		4	0346-0696	135.31	695.85	323	66.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			204.7	C08		4	0347-0699	793.59	700.20	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			272.0	C08		4	0348-0699	474.12	699.64	273	62.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			179.9	C08		4	0349-0701	733.39	701.49	303	67.36	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.9	C08		4	0350-0705	877.22	705.20	108	42.04	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			195.7	C08		4	0351-0707	930.89	707.77	266	65.01	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			744.0	C08		4	0352-0710	358.48	709.73	291	63.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			172.7	C08		5	0001-0025	207.22	24.73	281	63.36	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			257.3	C08		5	0002-0023	628.36	23.18	228	56.28	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2735.8	C08		5	0003-0027	757.57	26.69	263	60.43	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			192.8	C08		5	0004-0025	245.80	25.00	263	60.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			194.8	C08		5	0005-0035	174.04	35.25	268	60.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1528.2	C08		5	0006-0036	402.63	35.76	271	61.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			261.6	C08		5	0007-0037	66.40	37.22	253	59.11	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			569.2	C08		5	0008-0039	746.47	39.01	243	59.84	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			195.0	C08		5	0009-0041	937.37	41.10	272	64.18	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1036.1	C08		5	0010-0045	583.63	46.23	377	80.18	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1772.3	C08		5	0011-0041	602.48	40.47	210	54.87	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			335.4	C08		5	0012-0046	510.44	45.61	319	65.01	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			425.4	C08		5	0013-0047	417.06	47.14	262	70.67	0.659
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			260.3	C08		5	0014-0048	325.88	48.14	252	59.70	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			311.5	C08		5	0015-0048	864.11	48.79	362	71.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			748.6	C08		5	0016-0051	538.31	51.75	284	63.94	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			267.6	C08		5	0017-0049	663.18	49.26	245	56.77	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			370.7	C08		5	0018-0051	47.74	51.33	240	58.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			319.3	C08		5	0019-0051	887.77	51.56	252	57.94	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			346.2	C08		5	0020-0056	264.29	55.56	497	91.74	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			446.9	C08		5	0021-0055	482.62	55.53	232	56.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			185.3	C08		5	0022-0063	305.30	62.56	282	66.67	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			187.8	C08		5	0023-0062	186.19	63.10	290	65.60	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			379.3	C08		5	0024-0064	806.78	64.54	201	56.43	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			182.4	C08		5	0025-0067	26.26	66.14	274	64.43	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			261.3	C08		5	0026-0066	117.58	65.66	227	59.60	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			255.6	C08		5	0027-0071	231.30	71.55	281	65.60	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			592.3	C08		5	0028-0071	753.60	71.94	276	61.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			305.4	C08		5	0029-0072	559.09	72.36	265	60.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			249.5	C08		5	0030-0076	379.29	75.97	313	67.01	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			368.5	C08		5	0031-0080	123.83	80.49	366	76.18	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.2	C08		5	0032-0075	165.25	74.41	288	65.70	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			216.8	C08		5	0033-0078	613.99	77.76	256	58.53	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			200.8	C08		5	0034-0079	923.97	79.38	259	59.70	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			249.0	C08		5	0035-0081	60.39	81.99	265	64.18	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			266.0	C08		5	0036-0084	505.04	84.26	310	65.94	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.4	C08		5	0037-0090	693.12	90.15	316	68.18	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			274.8	C08		5	0038-0088	724.22	87.61	299	63.60	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1103.7	C08		5	0039-0087	254.08	87.36	238	58.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			249.5	C08		5	0040-0089	87.63	89.57	252	58.53	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			260.3	C08		5	0041-0090	184.69	90.96	419	81.26	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			312.0	C08		5	0042-0094	281.23	94.20	346	70.18	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			266.5	C08		5	0043-0093	162.46	93.63	217	59.70	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			192.4	C08		5	0044-0097	316.17	98.03	272	60.77	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			242.1	C08		5	0045-0105	858.99	106.45	309	76.77	0.659
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			204.6	C08		5	0046-0101	651.89	101.10	345	69.84	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			202.4	C08		5	0047-0102	503.46	101.78	273	62.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.7	C08		5	0048-0105	894.66	104.84	302	69.84	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			217.7	C08		5	0049-0105	342.24	105.07	235	55.94	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.0	C08		5	0050-0107	788.00	107.40	286	64.77	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.3	C08		5	0051-0109	47.58	108.98	289	62.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4152.5	C08		5	0052-0108	208.12	107.97	321	66.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			417.3	C08		5	0053-0109	829.80	108.41	263	60.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1230.6	C08		5	0054-0110	550.61	109.80	235	57.46	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			513.0	C08		5	0055-0114	939.47	113.65	286	65.94	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			917.6	C08		5	0056-0114	535.56	114.61	220	58.18	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			285.1	C08		5	0057-0115	814.85	115.25	248	61.60	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			234.0	C08		5	0058-0116	125.20	116.96	275	64.67	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			263.7	C08		5	0059-0116	583.58	116.19	253	57.94	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			240.2	C08		5	0060-0117	451.18	117.39	235	63.01	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			377.2	C08		5	0061-0130	293.94	130.74	532	96.57	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			657.7	C08		5	0062-0127	763.95	126.43	390	74.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			237.2	C08		5	0063-0129	241.70	129.15	279	63.01	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.9	C08		5	0064-0128	945.76	129.18	307	67.60	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			288.7	C08		5	0065-0130	709.15	129.47	285	63.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			240.1	C08		5	0066-0132	205.96	132.26	302	67.01	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			182.5	C08		5	0067-0131	83.68	131.34	282	64.77	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			305.9	C08		5	0068-0132	462.85	132.67	223	56.63	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			485.3	C08		5	0069-0142	511.66	141.97	346	70.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			496.7	C08		5	0070-0142	779.76	142.04	281	64.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			196.6	C08		5	0071-0146	124.86	145.69	304	69.01	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			253.4	C08		5	0072-0147	401.83	145.94	226	60.53	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.2	C08		5	0073-0149	538.49	149.60	263	65.01	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			207.8	C08		5	0074-0148	704.63	148.28	295	65.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			337.7	C08		5	0075-0148	826.93	148.52	278	62.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1664.3	C08		5	0076-0150	644.94	149.72	309	65.36	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			630.2	C08		5	0077-0148	467.80	148.00	227	55.70	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			192.9	C08		5	0078-0154	206.08	154.12	273	60.77	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			251.0	C08		5	0079-0155	564.25	155.96	469	80.08	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.9	C08		5	0080-0153	71.19	152.62	267	62.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			198.6	C08		5	0081-0156	224.25	156.24	260	59.70	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			918.5	C08		5	0082-0159	918.75	158.85	309	71.36	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			362.9	C08		5	0083-0161	670.33	161.54	283	65.26	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1099.9	C08		5	0084-0159	901.80	159.44	190	52.28	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			349.3	C08		5	0085-0161	411.74	160.23	259	61.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			282.4	C08		5	0086-0164	12.84	165.13	248	57.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1453.2	C08		5	0087-0167	149.27	167.38	232	56.18	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			326.5	C08		5	0088-0168	837.22	167.15	248	61.94	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.2	C08		5	0089-0175	34.74	175.89	304	70.77	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			230.6	C08		5	0090-0176	348.13	175.84	308	67.60	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			263.4	C08		5	0091-0176	595.11	176.03	445	77.26	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			980.6	C08		5	0092-0177	174.77	177.75	256	58.18	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			249.0	C08		5	0093-0179	752.26	178.85	297	65.60	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			565.3	C08		5	0094-0182	139.86	182.31	239	57.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			382.5	C08		5	0095-0179	480.19	178.89	257	60.53	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			226.8	C08		5	0096-0180	773.20	180.22	253	59.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			351.7	C08		5	0097-0178	819.77	178.06	127	42.97	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			432.6	C08		5	0098-0181	830.53	181.19	108	38.39	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			170.6	C08		5	0099-0189	195.63	189.09	273	62.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			355.2	C08		5	0100-0194	94.39	194.00	361	74.43	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			207.9	C08		5	0101-0192	356.51	192.32	250	61.60	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			198.4	C08		5	0102-0193	111.20	192.63	270	61.70	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			311.3	C08		5	0103-0196	316.62	195.93	423	74.43	0.960
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			9387.0	C08		5	0104-0192	277.15	191.83	127	62.43	0.410
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			254.0	C08		5	0105-0197	255.39	196.94	291	65.11	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			269.0	C08		5	0106-0199	238.00	199.22	270	60.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.0	C08		5	0107-0197	755.16	197.21	333	73.84	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			382.5	C08		5	0108-0203	377.95	202.93	389	73.84	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			352.5	C08		5	0109-0202	729.24	202.66	282	62.28	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			664.8	C08		5	0110-0205	15.79	205.08	242	62.53	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			327.8	C08		5	0111-0201	152.68	200.91	278	65.11	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			278.7	C08		5	0112-0213	531.46	212.95	638	109.64	0.667
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			795.9	C08		5	0113-0208	451.28	209.15	386	77.60	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			774.0	C08		5	0114-0207	707.83	207.15	275	61.70	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			285.6	C08		5	0115-0208	417.03	208.07	264	60.77	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1658.9	C08		5	0116-0212	806.62	212.34	352	71.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			556.9	C08		5	0117-0213	468.08	213.85	235	59.11	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			175.8	C08		5	0118-0215	79.24	215.03	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			916.4	C08		5	0119-0216	916.03	216.05	260	60.18	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			318.2	C08		5	0120-0216	754.19	217.04	271	60.53	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			441.2	C08		5	0121-0220	861.49	220.57	261	61.46	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			383.9	C08		5	0122-0220	846.92	220.50	226	56.53	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1688.6	C08		5	0123-0220	155.45	219.99	235	58.53	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			394.6	C08		5	0124-0227	305.10	227.85	461	79.84	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			240.2	C08		5	0125-0230	209.14	229.56	465	82.18	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			698.1	C08		5	0126-0228	629.67	228.20	214	54.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			201.1	C08		5	0127-0234	566.31	234.22	319	71.60	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1060.5	C08		5	0128-0234	179.64	233.99	323	67.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2756.0	C08		5	0129-0235	160.19	235.37	256	64.18	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			400.1	C08		5	0130-0236	282.88	236.18	299	64.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1005.8	C08		5	0131-0236	649.81	235.52	223	55.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			251.8	C08		5	0132-0237	120.78	237.25	243	58.18	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1657.0	C08		5	0133-0245	368.24	245.87	246	57.60	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.7	C08		5	0134-0246	583.97	245.73	309	67.70	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			423.7	C08		5	0135-0246	746.79	246.21	272	67.01	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			503.9	C08		5	0136-0251	154.83	251.42	213	57.36	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			302.5	C08		5	0137-0257	41.66	256.83	302	66.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1770.7	C08		5	0138-0261	915.84	261.05	264	62.77	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			857.7	C08		5	0139-0268	672.13	267.50	285	65.01	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1030.5	C08		5	0140-0270	701.57	270.34	435	77.26	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.4	C08		5	0141-0268	165.69	268.34	279	64.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			364.4	C08		5	0142-0271	272.79	270.58	228	59.01	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			236.6	C08		5	0143-0272	781.36	271.85	315	68.18	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			473.2	C08		5	0144-0274	218.26	274.24	234	58.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			386.5	C08		5	0145-0274	336.63	274.33	263	61.36	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1528.4	C08		5	0146-0275	403.63	274.97	100	53.94	0.432
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			245.0	C08		5	0147-0277	614.54	277.62	293	63.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			692.8	C08		5	0148-0282	637.91	282.17	280	62.18	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			264.1	C08		5	0149-0285	826.66	284.99	417	75.84	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			754.8	C08		5	0150-0283	727.36	283.45	236	57.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2376.6	C08		5	0151-0284	368.25	284.96	238	57.36	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			234.3	C08		5	0152-0286	122.52	286.93	271	62.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			320.2	C08		5	0153-0288	523.62	287.86	321	69.26	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			719.8	C08		5	0154-0290	47.31	290.37	349	69.01	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			320.5	C08		5	0155-0288	145.49	288.97	279	64.43	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			189.4	C08		5	0156-0293	892.36	293.38	289	65.60	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			500.4	C08		5	0157-0292	100.14	291.43	254	61.94	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			306.4	C08		5	0158-0290	326.27	290.42	232	60.18	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			437.2	C08		5	0159-0294	83.86	294.02	274	62.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.5	C08		5	0160-0293	484.95	293.15	340	72.18	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			285.7	C08		5	0161-0296	22.78	295.96	261	59.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			481.3	C08		5	0162-0297	451.94	296.90	263	62.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2510.6	C08		5	0163-0298	240.29	298.78	366	71.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			10341.7	C08		5	0164-0302	652.45	303.48	138	61.94	0.452
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			247.6	C08		5	0165-0304	280.60	304.06	270	61.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			675.0	C08		5	0166-0305	217.05	305.63	289	63.84	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			173.8	C08		5	0167-0307	930.59	307.42	323	67.01	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.3	C08		5	0168-0310	729.44	309.48	269	62.18	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			274.3	C08		5	0169-0312	158.18	312.84	271	59.94	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			167.1	C08		5	0170-0316	189.03	316.58	267	63.36	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			242.5	C08		5	0171-0316	69.13	316.27	257	58.53	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			181.4	C08		5	0172-0318	89.27	318.53	265	59.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.8	C08		5	0173-0317	799.68	316.63	286	63.60	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			175.2	C08		5	0174-0321	45.21	322.00	284	63.36	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			446.6	C08		5	0175-0320	845.17	320.63	253	58.18	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			378.1	C08		5	0176-0320	136.44	320.06	267	61.70	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			571.1	C08		5	0177-0322	397.22	323.48	278	62.87	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2653.8	C08		5	0178-0322	870.34	322.03	266	60.18	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3503.4	C08		5	0179-0331	461.27	330.50	403	123.30	0.333
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			256.0	C08		5	0180-0327	348.68	327.24	254	59.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			288.6	C08		5	0181-0336	635.50	336.28	311	67.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			442.6	C08		5	0182-0339	704.62	340.13	296	69.01	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5071.6	C08		5	0183-0339	450.08	339.58	202	57.36	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			521.9	C08		5	0184-0341	684.57	341.42	259	59.11	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			207.1	C08		5	0185-0342	157.89	341.75	248	58.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			518.3	C08		5	0186-0341	401.12	341.19	280	63.11	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			188.3	C08		5	0187-0342	227.55	343.12	260	58.53	0.954
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			195.8	C08		5	0188-0349	287.08	348.91	530	90.08	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.0	C08		5	0189-0348	528.05	348.36	309	64.77	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1323.5	C08		5	0190-0349	862.51	349.51	310	65.70	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			567.1	C08		5	0191-0350	111.55	349.91	286	63.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			187.5	C08		5	0192-0351	185.97	351.54	249	59.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			391.2	C08		5	0193-0351	484.60	351.12	260	59.46	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			236.9	C08		5	0194-0351	626.22	351.50	270	60.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			212.1	C08		5	0195-0355	259.67	355.61	272	62.43	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			475.0	C08		5	0196-0355	379.09	355.60	217	55.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			203.1	C08		5	0197-0357	925.07	357.27	292	67.01	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			302.3	C08		5	0198-0359	132.19	358.49	242	57.36	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			780.4	C08		5	0199-0358	402.98	357.83	219	56.53	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			217.0	C08		5	0200-0360	231.80	360.52	300	66.53	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			193.0	C08		5	0201-0363	330.82	363.80	293	67.84	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3491.2	C08		5	0202-0362	570.58	361.86	347	68.43	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			576.3	C08		5	0203-0363	801.77	362.94	302	65.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			453.5	C08		5	0204-0362	692.19	362.38	273	62.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			497.6	C08		5	0205-0362	455.04	362.52	265	59.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			321.9	C08		5	0206-0367	753.07	367.37	195	53.70	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			201.6	C08		5	0207-0370	250.40	370.10	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			418.4	C08		5	0208-0367	489.65	367.26	252	61.70	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			247.4	C08		5	0209-0370	38.62	370.24	269	61.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			203.7	C08		5	0210-0371	65.11	370.95	267	63.60	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			446.3	C08		5	0211-0379	16.47	379.21	528	92.33	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1200.8	C08		5	0212-0374	897.56	373.81	358	70.43	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3235.1	C08		5	0213-0374	392.69	373.41	227	57.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			284.6	C08		5	0214-0372	607.12	372.07	244	59.70	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1048.7	C08		5	0215-0377	715.45	377.60	258	60.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			199.8	C08		5	0216-0380	170.63	380.29	261	60.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			210.8	C08		5	0217-0380	79.57	380.62	269	65.94	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			404.3	C08		5	0218-0380	826.62	380.14	234	67.94	0.637
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			594.5	C08		5	0219-0385	845.60	385.45	276	64.77	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			886.4	C08		5	0220-0393	409.82	393.55	669	106.13	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			367.8	C08		5	0221-0388	931.71	388.88	307	65.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			348.4	C08		5	0222-0389	620.66	388.59	300	65.94	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.5	C08		5	0223-0391	280.28	391.24	286	63.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.6	C08		5	0224-0394	742.34	394.65	218	56.28	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			635.3	C08		5	0225-0397	576.47	397.02	193	53.11	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			518.0	C08		5	0226-0408	234.72	408.22	478	85.98	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			620.9	C08		5	0227-0401	128.22	400.74	230	57.70	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			236.0	C08		5	0228-0403	640.40	402.75	245	59.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			400.4	C08		5	0229-0402	674.17	402.64	236	56.87	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			350.0	C08		5	0230-0407	256.61	407.32	259	58.53	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.8	C08		5	0231-0408	197.58	408.15	263	62.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			259.3	C08		5	0232-0408	809.21	408.51	286	65.11	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			338.5	C08		5	0233-0413	653.05	413.47	257	58.53	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			608.0	C08		5	0234-0413	121.53	413.71	248	60.53	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			933.6	C08		5	0235-0415	880.15	415.33	325	70.18	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			672.0	C08		5	0236-0415	332.75	415.60	283	61.36	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			499.4	C08		5	0237-0420	699.61	420.50	272	61.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			365.4	C08		5	0238-0421	179.91	421.12	203	53.36	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			9532.1	C08		5	0239-0422	547.27	421.79	185	51.94	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			453.9	C08		5	0240-0423	604.43	422.81	241	56.53	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			171.9	C08		5	0241-0425	750.67	425.26	311	67.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			425.7	C08		5	0242-0428	861.17	428.79	347	72.43	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1263.4	C08		5	0243-0429	357.07	429.49	449	79.01	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			270.2	C08		5	0244-0427	425.56	426.68	266	62.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			327.8	C08		5	0245-0428	813.06	427.42	298	67.36	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1312.1	C08		5	0246-0429	910.70	428.36	341	67.60	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5654.2	C08		5	0247-0432	534.22	431.66	315	71.01	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			225.4	C08		5	0248-0432	446.12	431.85	275	61.36	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			240.8	C08		5	0249-0435	62.73	435.07	267	60.53	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			534.6	C08		5	0250-0437	691.92	437.49	220	55.11	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1028.2	C08		5	0251-0441	127.60	441.77	461	86.33	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2225.7	C08		5	0252-0442	555.58	441.73	334	74.43	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			930.9	C08		5	0253-0442	168.94	442.03	258	60.87	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			273.8	C08		5	0254-0445	236.30	444.92	500	88.91	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			237.8	C08		5	0255-0445	612.34	445.07	298	64.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			779.5	C08		5	0256-0447	719.95	447.96	315	72.43	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1949.6	C08		5	0257-0445	380.07	445.62	201	53.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			175.2	C08		5	0258-0449	909.18	450.90	311	69.84	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.4	C08		5	0259-0453	469.88	453.62	288	63.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			343.0	C08		5	0260-0452	66.84	451.78	252	60.18	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			207.1	C08		5	0261-0456	201.00	456.33	242	58.53	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4044.5	C08		5	0262-0458	181.80	458.11	142	57.01	0.549
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1158.1	C08		5	0263-0464	794.80	464.01	517	83.26	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			425.0	C08		5	0264-0460	504.68	460.60	232	55.36	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			231.2	C08		5	0265-0463	416.40	463.13	287	63.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			355.8	C08		5	0266-0463	661.43	462.91	449	82.43	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.3	C08		5	0267-0465	556.12	465.52	281	61.84	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			860.3	C08		5	0268-0464	38.15	464.42	234	57.11	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			351.6	C08		5	0269-0468	577.43	468.57	287	61.94	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1270.6	C08		5	0270-0473	300.85	472.61	357	71.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			244.5	C08		5	0271-0468	741.95	468.06	257	59.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.6	C08		5	0272-0472	885.89	472.06	331	67.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			201.1	C08		5	0273-0473	402.60	473.38	290	65.26	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			199.4	C08		5	0274-0479	229.15	479.36	269	63.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1104.3	C08		5	0275-0484	122.14	484.11	446	81.01	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			260.5	C08		5	0276-0489	271.42	487.98	509	94.57	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			453.0	C08		5	0277-0482	846.77	481.46	271	61.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			186.5	C08		5	0278-0484	334.88	483.78	279	63.36	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			298.1	C08		5	0279-0495	616.96	495.63	262	61.60	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			379.5	C08		5	0280-0493	792.78	494.13	275	65.60	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			338.4	C08		5	0281-0496	452.03	495.40	259	59.36	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			207.5	C08		5	0282-0497	717.65	497.06	232	59.36	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			328.5	C08		5	0283-0501	197.27	500.70	468	85.74	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			452.6	C08		5	0284-0499	473.75	499.76	257	61.94	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			371.9	C08		5	0285-0501	96.90	501.47	294	65.01	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			574.9	C08		5	0286-0501	901.81	501.38	250	58.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			210.6	C08		5	0287-0502	370.13	501.78	271	62.77	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			518.3	C08		5	0288-0503	936.65	503.74	242	57.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			539.3	C08		5	0289-0504	493.62	504.39	252	59.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			299.7	C08		5	0290-0506	631.65	505.45	265	64.18	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1347.7	C08		5	0291-0507	19.27	507.99	386	74.33	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			217.8	C08		5	0292-0509	249.77	508.81	512	95.40	0.707
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.4	C08		5	0293-0509	557.64	509.71	257	65.01	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			706.8	C08		5	0294-0511	442.12	511.25	301	66.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			272.4	C08		5	0295-0510	45.20	510.71	245	58.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			174.1	C08		5	0296-0513	334.12	513.95	289	62.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			257.6	C08		5	0297-0514	286.74	514.68	251	57.94	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			120.9	C08		5	0298-0515	832.59	515.15	339	71.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3514.9	C08		5	0299-0515	468.55	515.56	195	53.70	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			351.5	C08		5	0300-0519	138.33	518.67	241	59.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			261.8	C08		5	0301-0519	526.25	519.51	272	60.53	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			208.4	C08		5	0302-0520	92.26	520.68	300	70.18	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			294.2	C08		5	0303-0523	624.45	523.58	297	65.01	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			994.5	C08		5	0304-0525	394.75	525.32	283	66.43	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			193.2	C08		5	0305-0528	769.98	528.55	280	67.50	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			271.9	C08		5	0306-0532	425.08	531.78	268	63.11	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.2	C08		5	0307-0533	151.14	533.56	258	63.01	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			453.6	C08		5	0308-0534	197.35	533.64	319	73.84	0.735
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.6	C08		5	0309-0539	534.98	538.32	273	65.60	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			366.9	C08		5	0310-0537	607.50	537.37	220	54.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			599.2	C08		5	0311-0541	382.06	542.72	366	75.01	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			151.8	C08		5	0312-0541	832.18	541.50	310	67.36	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3054.7	C08		5	0313-0543	470.35	543.09	177	48.53	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			505.5	C08		5	0314-0551	946.10	550.58	385	77.36	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			681.5	C08		5	0315-0546	321.13	546.71	242	57.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			616.9	C08		5	0316-0548	678.45	548.70	313	65.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			253.8	C08		5	0317-0546	741.53	546.09	268	60.18	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.3	C08		5	0318-0551	553.24	551.57	308	68.43	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			303.6	C08		5	0319-0551	99.70	551.78	270	60.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			473.6	C08		5	0320-0553	231.82	553.69	305	70.08	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			174.3	C08		5	0321-0553	22.92	553.49	287	63.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			184.9	C08		5	0322-0559	495.91	559.76	300	70.28	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			326.9	C08		5	0323-0559	389.91	558.86	287	63.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			356.3	C08		5	0324-0559	821.93	559.31	314	67.36	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			382.5	C08		5	0325-0559	248.37	560.21	257	63.36	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			286.0	C08		5	0326-0562	168.02	561.67	248	62.77	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			242.4	C08		5	0327-0564	702.70	564.62	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			226.8	C08		5	0328-0567	510.91	566.78	301	69.11	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			920.5	C08		5	0329-0564	315.06	563.80	239	59.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.5	C08		5	0330-0566	736.12	565.92	242	57.36	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			204.3	C08		5	0331-0569	150.59	569.48	302	65.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			738.8	C08		5	0332-0567	677.72	567.46	254	60.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			141.7	C08		5	0333-0571	274.35	571.63	273	66.67	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.6	C08		5	0334-0576	918.32	576.50	354	70.18	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			771.0	C08		5	0335-0575	342.32	575.76	263	64.28	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			966.1	C08		5	0336-0577	429.97	576.35	383	73.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.1	C08		5	0337-0578	632.34	578.02	292	65.94	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			188.6	C08		5	0338-0575	859.79	575.79	290	71.36	0.716
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			777.0	C08		5	0339-0580	67.90	580.53	477	87.74	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			240.1	C08		5	0340-0581	898.80	581.22	331	68.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			277.3	C08		5	0341-0583	574.86	583.16	299	66.77	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1186.6	C08		5	0342-0579	91.81	578.80	240	58.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			474.4	C08		5	0343-0582	313.75	583.24	272	64.28	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			825.8	C08		5	0344-0581	391.81	581.10	270	60.18	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			259.9	C08		5	0345-0581	716.10	581.79	223	55.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			375.7	C08		5	0346-0582	362.15	581.71	266	62.28	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			248.5	C08		5	0347-0580	790.21	579.80	287	68.53	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			399.9	C08		5	0348-0584	229.14	583.82	241	58.28	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2585.5	C08		5	0349-0587	20.24	587.47	224	55.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			661.7	C08		5	0350-0596	595.37	596.05	322	69.84	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			201.0	C08		5	0351-0600	354.65	600.31	282	62.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.3	C08		5	0352-0608	474.80	606.92	607	102.57	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			194.1	C08		5	0353-0601	167.12	600.87	304	66.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			306.1	C08		5	0354-0609	148.91	609.45	253	61.11	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			226.3	C08		5	0355-0610	719.24	610.32	321	66.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			340.5	C08		5	0356-0610	533.40	608.97	311	69.26	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			783.6	C08		5	0357-0610	187.17	610.71	253	59.70	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			684.2	C08		5	0358-0611	258.04	611.58	267	61.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.3	C08		5	0359-0613	805.81	613.19	270	61.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			177.7	C08		5	0360-0613	940.84	612.97	258	63.01	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			279.4	C08		5	0361-0617	413.46	616.96	307	68.08	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1850.2	C08		5	0362-0616	61.84	615.87	222	55.11	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			243.1	C08		5	0363-0614	320.99	615.05	262	61.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			257.4	C08		5	0364-0616	295.85	616.52	265	59.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			150.0	C08		5	0365-0619	385.46	618.83	296	65.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			600.5	C08		5	0366-0620	207.44	620.08	266	60.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			578.1	C08		5	0367-0623	671.13	622.99	256	59.36	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			363.3	C08		5	0368-0624	137.19	624.25	240	57.70	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			212.0	C08		5	0369-0629	444.51	629.51	296	65.94	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			848.3	C08		5	0370-0629	186.09	628.77	271	62.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			263.7	C08		5	0371-0634	897.40	633.89	524	91.64	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1681.2	C08		5	0372-0633	864.86	633.43	286	63.60	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			183.2	C08		5	0373-0634	497.57	633.42	289	62.53	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			204.7	C08		5	0374-0647	794.04	647.11	321	69.50	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			359.3	C08		5	0375-0647	539.38	647.38	241	57.70	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			474.7	C08		5	0376-0649	154.97	648.54	220	54.53	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			481.9	C08		5	0377-0647	646.40	647.40	204	53.11	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			287.3	C08		5	0378-0651	195.60	651.23	248	57.70	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			194.6	C08		5	0379-0652	247.90	652.79	293	63.94	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			207.6	C08		5	0380-0650	817.91	650.42	277	63.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.1	C08		5	0381-0648	335.51	648.81	154	48.63	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			321.1	C08		5	0382-0654	433.37	654.60	247	57.94	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			259.0	C08		5	0383-0655	686.50	654.73	395	73.84	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			230.5	C08		5	0384-0656	555.80	656.01	283	64.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			254.0	C08		5	0385-0660	52.60	659.90	289	62.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			278.7	C08		5	0386-0661	313.70	661.95	212	55.70	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			458.3	C08		5	0387-0662	629.58	661.88	213	56.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			264.6	C08		5	0388-0664	337.75	662.55	268	63.01	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			176.1	C08		5	0389-0668	589.42	667.54	275	63.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			290.1	C08		5	0390-0666	147.08	666.75	252	61.60	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.8	C08		5	0391-0666	671.76	667.21	262	63.01	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			271.7	C08		5	0392-0669	739.67	669.43	297	65.01	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			340.8	C08		5	0393-0679	330.09	679.10	404	84.57	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1996.7	C08		5	0394-0672	19.02	672.27	225	57.94	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			837.4	C08		5	0395-0674	160.45	674.70	206	54.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			201.0	C08		5	0396-0676	930.18	676.57	245	64.18	0.747
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			392.8	C08		5	0397-0683	405.39	682.87	637	109.54	0.667
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			194.3	C08		5	0398-0675	547.03	675.66	282	63.94	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			611.0	C08		5	0399-0678	284.16	677.62	271	60.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			363.6	C08		5	0400-0680	625.14	680.18	214	55.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			180.2	C08		5	0401-0684	804.27	684.54	262	59.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			476.2	C08		5	0402-0687	751.15	687.58	259	61.94	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			138.7	C08		5	0403-0688	348.96	687.26	159	58.43	0.585
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			208.8	C08		5	0404-0688	897.14	688.21	252	60.77	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2279.0	C08		5	0405-0691	869.78	690.90	275	78.67	0.558
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			267.6	C08		5	0406-0690	205.49	690.05	230	56.53	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			369.6	C08		5	0407-0690	683.30	690.68	230	56.77	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			319.0	C08		5	0408-0693	612.16	693.49	247	58.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			217.5	C08		5	0409-0706	467.36	706.23	279	61.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.8	C08		5	0410-0706	549.06	706.22	255	59.01	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			189.0	C08		5	0411-0709	35.80	710.01	288	66.77	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			364.7	C08		5	0412-0708	182.19	708.34	229	56.53	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			208.7	C08		5	0413-0709	233.40	709.62	261	59.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			181.9	C08		5	0414-0710	56.38	709.78	280	65.94	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			191.5	C08		6	0001-0023	416.28	23.63	327	71.01	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			282.7	C08		6	0002-0027	676.92	26.76	287	65.94	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1796.7	C08		6	0003-0027	227.08	26.02	257	69.60	0.667
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			295.0	C08		6	0004-0031	617.58	31.04	275	63.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			675.4	C08		6	0005-0028	846.42	28.00	237	59.94	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			263.3	C08		6	0006-0034	941.60	33.31	301	65.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			194.0	C08		6	0007-0035	54.36	34.91	270	63.70	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.0	C08		6	0008-0036	331.47	37.01	311	69.36	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			601.2	C08		6	0009-0047	440.88	47.58	646	109.88	0.672
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			366.2	C08		6	0010-0041	515.00	41.24	407	74.08	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			183.7	C08		6	0011-0044	31.94	44.26	257	62.77	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			225.4	C08		6	0012-0042	91.51	42.05	298	65.26	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.5	C08		6	0013-0043	788.36	43.35	291	63.11	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			271.8	C08		6	0014-0043	641.23	43.00	272	64.53	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			710.5	C08		6	0015-0043	838.81	43.77	348	70.77	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			262.4	C08		6	0016-0048	351.26	47.98	345	68.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1552.8	C08		6	0017-0050	557.36	49.98	316	65.84	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			508.8	C08		6	0018-0056	256.61	56.18	262	60.53	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2047.0	C08		6	0019-0060	857.26	60.45	424	84.91	0.739
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			423.9	C08		6	0020-0058	283.61	58.25	216	55.60	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			463.7	C08		6	0021-0057	302.72	56.67	194	53.11	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			351.0	C08		6	0022-0056	466.92	56.20	294	66.18	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1163.8	C08		6	0023-0058	170.81	57.00	285	73.84	0.657
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1410.3	C08		6	0024-0060	224.81	58.82	486	99.40	0.618
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			698.0	C08		6	0025-0071	610.72	70.65	290	64.53	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			269.1	C08		6	0026-0071	707.96	71.26	316	65.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			933.8	C08		6	0027-0070	53.10	70.92	267	65.60	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			200.8	C08		6	0028-0075	520.80	74.96	302	64.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1122.5	C08		6	0029-0075	161.24	74.69	204	55.94	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			643.7	C08		6	0030-0081	905.91	81.12	542	88.57	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			433.3	C08		6	0031-0077	134.01	77.10	233	58.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			149.2	C08		6	0032-0082	18.69	82.46	248	60.18	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			211.5	C08		6	0033-0086	284.39	86.76	297	64.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1568.1	C08		6	0034-0086	173.60	86.45	261	65.36	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			749.5	C08		6	0035-0090	927.11	89.89	390	78.18	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1123.1	C08		6	0036-0092	722.25	92.38	341	69.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.7	C08		6	0037-0095	346.33	95.23	319	67.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			276.0	C08		6	0038-0098	391.71	98.21	293	65.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			7471.2	C08		6	0039-0096	766.53	96.92	175	49.46	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1231.3	C08		6	0040-0101	64.36	100.97	241	64.28	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			256.7	C08		6	0041-0101	96.92	101.23	221	56.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			265.8	C08		6	0042-0104	835.92	104.70	279	63.60	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			760.3	C08		6	0043-0106	601.66	106.72	274	63.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1144.2	C08		6	0044-0104	916.53	104.14	224	58.18	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			243.5	C08		6	0045-0106	799.62	106.51	315	68.77	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			246.0	C08		6	0046-0108	535.89	108.15	327	66.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1443.1	C08		6	0047-0111	651.77	112.71	282	62.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			523.9	C08		6	0048-0117	34.30	117.20	284	65.60	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1530.9	C08		6	0049-0115	577.40	115.08	245	58.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1198.6	C08		6	0050-0120	617.95	120.33	382	73.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			393.4	C08		6	0051-0118	135.04	118.42	287	70.18	0.732
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			211.4	C08		6	0052-0121	491.85	120.78	273	62.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			734.5	C08		6	0053-0119	376.22	120.22	193	50.87	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.7	C08		6	0054-0123	462.38	123.29	262	58.77	0.953
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			237.7	C08		6	0055-0125	853.84	124.76	210	57.60	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			574.5	C08		6	0056-0126	235.33	125.45	140	50.53	0.689
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1103.0	C08		6	0057-0128	680.24	129.14	265	60.18	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			293.9	C08		6	0058-0127	904.54	127.02	257	59.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			242.4	C08		6	0059-0131	40.69	132.16	280	65.60	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			280.9	C08		6	0060-0135	423.61	135.31	289	63.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			281.5	C08		6	0061-0133	716.97	133.81	268	63.70	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			910.1	C08		6	0062-0135	377.72	135.14	202	53.46	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			321.8	C08		6	0063-0142	340.72	141.79	264	63.01	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			608.6	C08		6	0064-0142	817.92	142.04	234	58.43	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.0	C08		6	0065-0144	514.97	144.61	291	63.36	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			602.6	C08		6	0066-0144	251.74	145.29	181	56.53	0.712
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1053.2	C08		6	0067-0144	594.22	144.32	242	58.53	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			202.9	C08		6	0068-0147	159.52	146.71	303	67.01	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1886.8	C08		6	0069-0150	764.60	150.14	234	56.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			305.9	C08		6	0070-0158	303.10	158.52	238	57.70	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			327.2	C08		6	0071-0157	888.64	157.38	362	71.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			750.4	C08		6	0072-0157	825.04	157.14	224	57.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			751.0	C08		6	0073-0163	537.54	161.94	332	68.77	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3743.7	C08		6	0074-0157	588.91	158.29	128	42.39	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1131.8	C08		6	0075-0161	614.35	161.31	263	60.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1742.3	C08		6	0076-0162	747.17	161.79	249	58.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			313.1	C08		6	0077-0163	676.84	163.38	424	77.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			408.8	C08		6	0078-0166	166.00	166.54	242	59.11	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1138.0	C08		6	0079-0166	400.03	166.05	225	57.70	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.0	C08		6	0080-0169	487.03	168.76	277	62.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			185.0	C08		6	0081-0171	109.83	171.44	282	64.77	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4941.7	C08		6	0082-0172	591.26	172.29	241	63.70	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			255.9	C08		6	0083-0182	835.67	182.33	328	69.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.8	C08		6	0084-0184	172.45	184.33	281	65.94	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2492.5	C08		6	0085-0186	705.00	185.93	345	68.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1563.2	C08		6	0086-0187	75.88	187.63	216	56.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			236.2	C08		6	0087-0187	859.67	187.16	303	68.43	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1243.9	C08		6	0088-0188	60.61	188.80	270	61.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			511.7	C08		6	0089-0187	803.04	186.83	178	60.18	0.618
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			278.9	C08		6	0090-0191	672.91	190.78	309	70.18	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			370.8	C08		6	0091-0193	940.32	193.32	259	59.70	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			303.8	C08		6	0092-0198	822.87	198.48	341	74.67	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.1	C08		6	0093-0203	625.45	203.38	295	65.84	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			449.3	C08		6	0094-0202	909.82	202.56	250	58.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			495.5	C08		6	0095-0201	807.76	202.00	102	63.01	0.323
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			242.8	C08		6	0096-0206	129.34	206.23	298	64.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			363.6	C08		6	0097-0209	397.85	209.34	257	61.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			399.0	C08		6	0098-0211	432.42	211.02	231	61.11	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			262.7	C08		6	0099-0210	500.04	211.04	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			251.7	C08		6	0100-0210	568.93	209.67	290	63.60	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			260.0	C08		6	0101-0215	215.75	215.14	308	65.01	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			375.6	C08		6	0102-0218	279.31	219.19	265	61.46	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			248.5	C08		6	0103-0222	723.31	222.66	271	62.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			252.0	C08		6	0104-0225	618.20	224.48	300	63.60	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1212.8	C08		6	0105-0229	887.94	229.13	329	68.18	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2247.4	C08		6	0106-0231	59.71	230.72	334	66.77	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			251.2	C08		6	0107-0236	91.16	236.34	285	63.26	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2937.1	C08		6	0108-0237	773.38	237.52	324	67.36	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			499.4	C08		6	0109-0236	279.03	236.04	389	74.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			247.1	C08		6	0110-0236	669.75	236.45	282	62.43	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			272.3	C08		6	0111-0238	343.16	238.63	321	67.84	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			266.1	C08		6	0112-0242	573.88	243.29	297	69.84	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			360.8	C08		6	0113-0244	756.21	244.60	290	66.18	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			268.9	C08		6	0114-0240	940.51	240.31	252	60.77	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			431.9	C08		6	0115-0247	198.46	246.56	301	67.84	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			290.9	C08		6	0116-0247	874.65	247.80	241	57.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.9	C08		6	0117-0251	833.26	251.71	322	76.91	0.684
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1274.6	C08		6	0118-0254	386.96	253.92	280	66.67	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1368.0	C08		6	0119-0254	542.86	253.92	303	64.77	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2590.0	C08		6	0120-0252	181.83	252.52	254	61.36	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			675.4	C08		6	0121-0253	560.66	254.21	262	62.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			238.6	C08		6	0122-0256	469.07	255.36	254	64.53	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			340.3	C08		6	0123-0259	334.87	258.49	264	63.70	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			686.9	C08		6	0124-0263	605.14	262.77	302	65.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2162.2	C08		6	0125-0261	147.85	260.95	217	53.46	0.954
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			309.1	C08		6	0126-0264	729.34	264.18	365	74.08	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			297.7	C08		6	0127-0274	797.83	272.58	730	118.71	0.651
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			310.1	C08		6	0128-0265	913.08	265.02	285	63.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			564.5	C08		6	0129-0268	368.30	267.57	260	61.01	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			261.1	C08		6	0130-0271	50.84	271.45	275	64.18	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			247.7	C08		6	0131-0275	466.40	274.78	474	81.26	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.0	C08		6	0132-0271	683.27	271.56	311	66.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			991.0	C08		6	0133-0272	566.82	272.48	293	64.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.2	C08		6	0134-0285	173.94	285.56	273	63.11	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			271.8	C08		6	0135-0291	636.52	291.53	287	61.36	0.958
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1689.7	C08		6	0136-0297	351.39	296.39	280	67.84	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			461.4	C08		6	0137-0295	554.38	295.52	265	61.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			240.5	C08		6	0138-0295	254.50	295.29	293	65.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			268.3	C08		6	0139-0296	850.40	297.06	334	67.01	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			299.9	C08		6	0140-0298	712.21	299.02	442	94.08	0.627
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			267.6	C08		6	0141-0302	901.12	301.88	321	69.60	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			263.1	C08		6	0142-0301	666.58	301.64	262	59.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			838.9	C08		6	0143-0307	917.49	306.26	335	71.01	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			700.4	C08		6	0144-0311	771.61	312.57	588	94.81	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			353.1	C08		6	0145-0307	375.36	307.73	255	58.77	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			198.6	C08		6	0146-0310	25.03	310.38	279	61.94	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			247.6	C08		6	0147-0312	509.64	311.64	257	60.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			537.1	C08		6	0148-0317	462.42	314.77	271	76.33	0.585
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1666.3	C08		6	0149-0313	945.18	313.34	263	62.87	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			289.4	C08		6	0150-0327	581.53	327.68	325	69.36	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			319.3	C08		6	0151-0323	859.49	323.86	256	63.94	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2774.2	C08		6	0152-0328	930.26	328.02	378	71.36	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			192.8	C08		6	0153-0332	300.21	332.99	315	73.01	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			250.9	C08		6	0154-0332	136.47	332.64	402	73.84	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1143.9	C08		6	0155-0331	741.68	331.35	299	63.36	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.8	C08		6	0156-0334	415.15	333.75	322	69.26	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			443.0	C08		6	0157-0336	57.05	335.97	361	70.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			199.1	C08		6	0158-0336	705.21	336.45	327	70.18	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			604.6	C08		6	0159-0337	247.85	337.10	231	57.94	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			281.5	C08		6	0160-0338	873.94	339.03	219	55.80	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			382.8	C08		6	0161-0346	319.24	345.76	246	62.28	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			854.0	C08		6	0162-0347	649.01	347.45	361	70.43	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			632.1	C08		6	0163-0346	262.33	345.89	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1788.5	C08		6	0164-0346	195.54	347.46	207	57.94	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			817.1	C08		6	0165-0349	751.50	349.29	219	55.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			562.4	C08		6	0166-0351	433.65	351.56	202	55.94	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			697.3	C08		6	0167-0355	275.20	356.19	224	54.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			621.4	C08		6	0168-0358	330.88	357.70	234	60.18	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			610.7	C08		6	0169-0358	510.68	358.42	247	66.67	0.698
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			335.2	C08		6	0170-0353	874.29	352.74	227	58.28	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			260.5	C08		6	0171-0360	458.55	360.08	306	69.94	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			242.4	C08		6	0172-0356	782.57	356.41	305	64.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			890.2	C08		6	0173-0359	612.70	359.17	310	65.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			192.3	C08		6	0174-0360	19.86	360.13	273	65.84	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			902.6	C08		6	0175-0362	759.16	362.11	203	55.94	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			200.5	C08		6	0176-0365	107.78	365.12	297	67.36	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			699.7	C08		6	0177-0369	650.63	368.91	309	65.36	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			773.8	C08		6	0178-0368	427.61	368.25	236	56.87	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			289.0	C08		6	0179-0370	895.90	370.77	278	63.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			315.2	C08		6	0180-0371	917.35	371.10	266	62.43	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			724.2	C08		6	0181-0378	630.45	378.26	301	65.60	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1665.8	C08		6	0182-0380	518.18	380.51	214	56.53	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			231.7	C08		6	0183-0380	806.29	380.14	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			163.1	C08		6	0184-0387	132.88	387.35	285	63.94	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			275.6	C08		6	0185-0388	874.32	387.72	253	62.77	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			377.7	C08		6	0186-0391	26.53	391.88	312	65.01	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1391.9	C08		6	0187-0392	680.81	391.79	302	64.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			254.2	C08		6	0188-0400	718.10	399.93	292	65.36	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			684.0	C08		6	0189-0398	935.14	397.83	207	54.53	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			262.4	C08		6	0190-0401	766.60	400.19	271	62.43	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			292.6	C08		6	0191-0399	913.54	399.39	284	62.53	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			331.3	C08		6	0192-0405	563.90	405.58	300	64.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			218.9	C08		6	0193-0411	271.86	410.40	553	103.30	0.651
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			262.2	C08		6	0194-0408	529.67	408.35	277	62.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.9	C08		6	0195-0409	753.00	409.86	266	63.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			205.3	C08		6	0196-0412	855.78	412.42	248	60.43	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			438.9	C08		6	0197-0413	71.26	413.34	383	73.36	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			293.8	C08		6	0198-0418	106.82	418.53	319	68.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.2	C08		6	0199-0423	452.60	421.94	336	71.01	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			465.1	C08		6	0200-0425	791.00	425.65	290	64.53	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1259.3	C08		6	0201-0424	807.62	423.86	267	62.53	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			275.1	C08		6	0202-0429	398.58	429.08	509	89.74	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			217.3	C08		6	0203-0426	839.61	426.67	230	58.18	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			231.1	C08		6	0204-0424	125.23	424.74	219	57.70	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			411.0	C08		6	0205-0430	238.86	429.93	284	65.01	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			279.6	C08		6	0206-0431	597.16	431.73	291	64.43	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3968.6	C08		6	0207-0432	349.09	432.09	224	57.11	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			207.6	C08		6	0208-0441	207.55	440.41	573	90.33	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			197.9	C08		6	0209-0439	417.80	439.51	276	63.94	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			468.9	C08		6	0210-0442	168.49	442.08	272	60.77	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			516.2	C08		6	0211-0442	623.74	441.87	263	58.53	0.965
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1855.1	C08		6	0212-0442	651.19	442.34	231	56.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			258.8	C08		6	0213-0445	705.41	445.49	224	61.84	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			180.7	C08		6	0214-0443	85.27	443.29	281	64.77	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			211.6	C08		6	0215-0449	263.69	449.21	290	65.84	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			431.5	C08		6	0216-0455	601.71	455.23	403	75.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			485.8	C08		6	0217-0454	928.96	453.89	209	55.11	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2883.8	C08		6	0218-0456	369.96	456.02	224	55.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			196.0	C08		6	0219-0458	284.97	458.20	295	63.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1143.5	C08		6	0220-0459	943.71	459.04	258	60.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.4	C08		6	0221-0461	875.56	460.42	304	63.94	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			200.7	C08		6	0222-0459	82.57	458.98	243	58.53	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.4	C08		6	0223-0462	308.85	462.86	247	59.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			357.9	C08		6	0224-0467	636.12	467.79	262	65.01	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			174.0	C08		6	0225-0464	133.52	463.37	241	63.36	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			585.7	C08		6	0226-0466	799.00	466.29	240	57.46	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1507.2	C08		6	0227-0467	814.53	466.96	274	63.11	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			275.4	C08		6	0228-0471	698.92	470.94	320	67.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			259.6	C08		6	0229-0472	764.64	471.85	388	74.08	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			568.3	C08		6	0230-0471	216.16	471.88	246	59.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			252.7	C08		6	0231-0474	430.19	473.76	325	70.43	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			486.0	C08		6	0232-0475	125.39	475.45	271	64.77	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			479.1	C08		6	0233-0477	601.43	476.81	257	59.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			282.3	C08		6	0234-0480	543.61	480.42	248	58.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			242.1	C08		6	0235-0485	754.39	485.62	321	69.01	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			332.2	C08		6	0236-0487	833.43	487.54	169	51.94	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2088.9	C08		6	0237-0489	147.26	489.54	262	60.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			272.1	C08		6	0238-0488	520.89	488.47	281	62.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			762.4	C08		6	0239-0489	211.36	489.19	253	59.11	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			397.9	C08		6	0240-0488	260.82	488.71	235	57.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			344.3	C08		6	0241-0491	897.82	492.01	384	73.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			157.6	C08		6	0242-0496	108.89	496.36	258	60.53	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2170.1	C08		6	0243-0498	794.85	497.72	251	66.53	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			191.5	C08		6	0244-0502	61.85	502.04	264	61.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			150.6	C08		6	0245-0501	431.48	500.98	254	61.60	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			246.8	C08		6	0246-0503	937.07	503.41	305	65.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			391.0	C08		6	0247-0505	703.45	504.80	339	68.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2360.3	C08		6	0248-0503	810.14	503.90	196	54.04	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			544.3	C08		6	0249-0506	31.37	506.93	235	57.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			412.3	C08		6	0250-0507	586.64	507.21	243	58.53	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			179.9	C08		6	0251-0508	414.86	507.96	281	63.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			372.4	C08		6	0252-0508	345.69	507.83	243	59.11	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1423.4	C08		6	0253-0512	150.39	512.45	210	52.87	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6634.0	C08		6	0254-0514	456.22	515.05	348	70.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			569.6	C08		6	0255-0516	164.03	515.62	232	59.46	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			345.8	C08		6	0256-0521	826.80	521.72	313	71.01	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			347.4	C08		6	0257-0523	945.53	522.89	229	56.53	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			222.4	C08		6	0258-0526	105.07	526.30	388	72.43	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.0	C08		6	0259-0522	268.65	522.06	172	50.87	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			781.8	C08		6	0260-0526	664.33	526.56	233	57.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			212.0	C08		6	0261-0527	250.42	526.89	188	53.11	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			195.1	C08		6	0262-0527	381.97	527.90	304	66.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			277.8	C08		6	0263-0528	611.87	528.20	324	68.43	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			367.8	C08		6	0264-0529	437.19	529.34	264	59.94	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.4	C08		6	0265-0535	483.76	535.17	268	63.36	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			736.5	C08		6	0266-0537	901.00	537.63	246	57.60	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			244.5	C08		6	0267-0541	269.74	541.75	257	61.01	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			366.2	C08		6	0268-0544	829.03	543.72	294	66.18	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			486.0	C08		6	0269-0554	41.10	553.69	394	79.60	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			246.9	C08		6	0270-0551	571.25	551.38	298	63.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			522.0	C08		6	0271-0551	62.85	551.76	261	61.26	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.5	C08		6	0272-0551	931.25	551.41	306	67.60	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			696.9	C08		6	0273-0553	753.50	553.00	266	60.18	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			343.7	C08		6	0274-0553	869.76	553.40	256	61.11	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			658.5	C08		6	0275-0557	389.14	557.68	305	66.77	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			652.5	C08		6	0276-0558	694.81	558.28	271	61.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			308.3	C08		6	0277-0564	160.05	564.71	337	67.01	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1818.0	C08		6	0278-0566	80.09	565.96	235	59.36	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1231.2	C08		6	0279-0572	425.35	572.97	289	64.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			336.0	C08		6	0280-0571	641.61	572.09	266	60.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			236.4	C08		6	0281-0573	137.07	573.98	236	59.36	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1468.3	C08		6	0282-0573	444.69	573.46	262	61.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			655.6	C08		6	0283-0579	51.66	578.45	330	70.53	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.3	C08		6	0284-0579	325.79	579.36	274	62.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			266.6	C08		6	0285-0578	843.81	579.39	334	69.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			619.4	C08		6	0286-0581	120.36	580.63	248	58.28	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			199.9	C08		6	0287-0584	914.41	584.32	316	66.18	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			237.1	C08		6	0288-0586	224.69	586.27	267	61.70	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			803.2	C08		6	0289-0591	744.26	590.33	323	68.18	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			426.4	C08		6	0290-0592	357.62	591.89	378	71.84	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1399.3	C08		6	0291-0589	447.52	589.20	262	62.53	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			819.3	C08		6	0292-0594	397.81	594.55	286	64.77	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			405.9	C08		6	0293-0596	478.63	597.04	265	60.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			475.8	C08		6	0294-0600	548.72	600.30	269	59.70	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1147.2	C08		6	0295-0606	768.79	606.37	348	75.50	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2209.6	C08		6	0296-0608	453.66	607.22	275	63.46	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.6	C08		6	0297-0611	871.03	611.29	313	65.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			268.7	C08		6	0298-0613	608.91	612.29	306	66.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			538.8	C08		6	0299-0612	155.25	612.80	258	66.77	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			175.6	C08		6	0300-0616	281.60	616.02	269	61.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			325.3	C08		6	0301-0621	101.66	620.83	457	83.26	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			256.0	C08		6	0302-0616	242.90	616.27	280	64.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			202.8	C08		6	0303-0619	793.31	619.27	289	65.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			156.2	C08		6	0304-0616	35.45	615.89	238	60.18	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			319.1	C08		6	0305-0619	934.38	618.80	234	59.70	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			493.2	C08		6	0306-0622	715.31	622.01	232	56.18	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.2	C08		6	0307-0623	490.18	623.40	266	61.60	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			389.1	C08		6	0308-0625	892.09	625.63	320	68.18	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			385.2	C08		6	0309-0627	922.07	627.14	220	57.94	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.8	C08		6	0310-0633	652.51	633.11	316	65.84	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			287.1	C08		6	0311-0633	318.81	632.76	239	59.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4127.1	C08		6	0312-0636	362.01	636.69	341	69.84	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			971.5	C08		6	0313-0638	466.43	637.42	320	68.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			145.8	C08		6	0314-0642	67.30	642.39	465	81.84	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.3	C08		6	0315-0639	244.92	639.76	419	78.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			499.5	C08		6	0316-0639	559.40	639.37	227	59.01	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			259.4	C08		6	0317-0639	817.75	639.85	284	61.60	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			343.8	C08		6	0318-0646	718.33	646.71	316	71.60	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1564.4	C08		6	0319-0647	754.67	646.84	230	57.60	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			444.4	C08		6	0320-0649	447.54	648.81	246	57.94	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			251.1	C08		6	0321-0652	950.46	652.40	258	59.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2128.5	C08		6	0322-0653	368.94	653.00	209	56.53	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			268.3	C08		6	0323-0657	286.04	657.54	398	75.84	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			162.1	C08		6	0324-0657	420.01	656.43	218	56.77	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1441.7	C08		6	0325-0659	874.28	659.13	245	58.53	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			234.2	C08		6	0326-0659	245.72	659.02	300	66.77	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			200.3	C08		6	0327-0665	617.34	666.04	321	69.84	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			428.4	C08		6	0328-0666	734.34	665.61	289	65.01	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.9	C08		6	0329-0670	799.68	670.44	295	71.50	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			349.8	C08		6	0330-0676	165.38	676.19	237	56.77	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			172.1	C08		6	0331-0679	24.32	679.38	222	60.18	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			188.8	C08		6	0332-0679	281.96	678.70	245	63.94	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			404.7	C08		6	0333-0681	852.07	682.12	305	65.36	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			193.6	C08		6	0334-0684	480.38	683.80	293	67.36	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1676.4	C08		6	0335-0683	870.51	683.10	248	62.18	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			332.3	C08		6	0336-0686	518.61	686.26	352	68.77	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			923.2	C08		6	0337-0683	715.86	683.20	246	59.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.4	C08		6	0338-0688	230.41	688.88	253	60.18	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			186.8	C08		6	0339-0689	103.32	689.98	231	58.53	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			364.5	C08		6	0340-0693	583.34	693.72	373	76.08	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			242.8	C08		6	0341-0701	163.75	701.44	242	58.28	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1387.1	C08		7	0001-0023	51.83	23.84	298	69.84	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			138.8	C08		7	0002-0026	872.40	25.70	203	61.60	0.672
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			184.3	C08		7	0003-0025	731.35	25.70	305	67.94	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.1	C08		7	0004-0031	928.55	31.22	283	66.18	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			172.5	C08		7	0005-0034	824.17	35.30	298	65.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			195.7	C08		7	0006-0035	617.33	35.30	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			865.1	C08		7	0007-0034	356.66	33.84	315	65.94	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			423.6	C08		7	0008-0037	580.19	36.57	282	63.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			207.1	C08		7	0009-0037	316.66	36.54	320	71.60	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			328.5	C08		7	0010-0036	32.18	36.12	266	61.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1236.6	C08		7	0011-0037	90.78	38.03	232	57.70	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			216.2	C08		7	0012-0043	840.82	43.08	252	58.28	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			194.9	C08		7	0013-0044	643.67	43.90	303	65.94	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			211.6	C08		7	0014-0048	19.83	48.94	291	63.60	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			248.7	C08		7	0015-0053	249.97	53.20	305	64.53	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4072.1	C08		7	0016-0055	90.75	55.31	288	65.94	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			341.2	C08		7	0017-0057	556.33	57.88	320	67.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.3	C08		7	0018-0057	409.54	57.82	326	68.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.4	C08		7	0019-0062	520.71	62.39	288	63.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			581.3	C08		7	0020-0064	837.98	65.31	438	89.84	0.682
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			466.5	C08		7	0021-0061	944.96	60.36	110	42.04	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			636.0	C08		7	0022-0063	177.25	63.58	268	62.18	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			236.1	C08		7	0023-0067	871.06	67.00	240	61.84	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			466.2	C08		7	0024-0064	113.77	64.84	266	63.94	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			253.9	C08		7	0025-0073	730.13	72.18	431	81.01	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1198.2	C08		7	0026-0077	24.61	76.57	208	54.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			199.4	C08		7	0027-0087	684.99	87.09	311	67.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			216.4	C08		7	0028-0087	251.91	87.09	337	69.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			222.9	C08		7	0029-0087	288.99	87.22	286	62.53	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			271.1	C08		7	0030-0097	586.15	96.15	584	110.23	0.604
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.9	C08		7	0031-0088	132.75	87.65	315	69.01	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			363.3	C08		7	0032-0087	200.86	87.04	298	64.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			266.1	C08		7	0033-0087	361.81	87.33	303	64.77	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			302.3	C08		7	0034-0091	448.08	91.39	393	77.01	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1288.3	C08		7	0035-0092	17.29	92.61	173	49.94	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			383.4	C08		7	0036-0095	722.59	94.21	265	63.60	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			202.0	C08		7	0037-0100	638.36	99.46	299	66.18	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			643.6	C08		7	0038-0102	816.65	102.78	353	74.08	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			309.1	C08		7	0039-0102	694.93	102.80	276	65.94	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			258.5	C08		7	0040-0106	621.07	106.28	316	67.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			238.0	C08		7	0041-0106	787.14	105.81	284	65.01	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			303.4	C08		7	0042-0108	440.48	108.24	311	67.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			218.0	C08		7	0043-0110	510.10	110.55	295	64.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.9	C08		7	0044-0109	766.18	108.84	275	62.53	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			202.4	C08		7	0045-0113	314.83	112.82	264	59.94	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			187.2	C08		7	0046-0115	914.68	115.50	288	63.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			226.0	C08		7	0047-0116	91.75	116.26	293	62.77	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			238.7	C08		7	0048-0117	563.72	117.16	314	65.60	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			211.2	C08		7	0049-0116	351.44	116.42	305	66.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			196.5	C08		7	0050-0123	180.27	122.55	320	70.18	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1174.7	C08		7	0051-0128	251.79	127.33	470	88.57	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			271.5	C08		7	0052-0120	404.21	120.23	270	62.53	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			357.1	C08		7	0053-0122	67.75	122.10	269	60.28	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			358.6	C08		7	0054-0128	728.23	127.56	314	68.43	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			336.5	C08		7	0055-0129	226.70	128.77	264	60.77	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1257.2	C08		7	0056-0130	853.09	130.34	358	69.60	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			304.1	C08		7	0057-0131	893.96	131.48	307	65.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			326.2	C08		7	0058-0133	668.02	134.08	273	64.18	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			476.9	C08		7	0059-0136	10.94	136.29	264	59.11	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			192.5	C08		7	0060-0141	311.82	141.79	298	65.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.8	C08		7	0061-0143	141.61	143.51	294	65.01	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			275.1	C08		7	0062-0143	722.81	144.64	318	71.26	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1450.9	C08		7	0063-0147	212.29	146.48	286	63.70	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			347.8	C08		7	0064-0152	192.31	151.77	275	66.18	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			226.6	C08		7	0065-0151	635.38	151.20	336	69.11	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			263.6	C08		7	0066-0160	561.54	160.14	535	98.57	0.692
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.6	C08		7	0067-0153	791.77	152.66	322	67.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			315.0	C08		7	0068-0157	417.30	157.18	496	84.08	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			247.6	C08		7	0069-0160	95.47	160.60	301	64.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.6	C08		7	0070-0162	816.09	162.44	317	67.01	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			778.6	C08		7	0071-0162	354.78	162.27	283	68.43	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			560.3	C08		7	0072-0166	235.28	166.37	452	78.43	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			247.2	C08		7	0073-0169	947.12	169.62	436	77.50	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			328.8	C08		7	0074-0168	27.73	168.95	257	59.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			588.6	C08		7	0075-0167	650.18	167.83	282	63.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			247.8	C08		7	0076-0170	492.83	170.51	237	58.77	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1371.8	C08		7	0077-0173	187.93	172.95	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.6	C08		7	0078-0171	706.65	171.49	311	68.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			328.2	C08		7	0079-0173	366.75	173.55	297	67.01	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			260.1	C08		7	0080-0173	479.10	174.12	130	47.46	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			303.5	C08		7	0081-0174	47.24	175.03	264	60.77	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			335.5	C08		7	0082-0176	425.03	175.77	300	65.60	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1879.8	C08		7	0083-0181	306.37	181.78	380	72.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			872.3	C08		7	0084-0184	131.58	183.79	278	62.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			246.8	C08		7	0085-0185	518.78	185.64	312	65.60	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			250.1	C08		7	0086-0186	549.39	185.57	270	66.08	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			210.6	C08		7	0087-0185	848.61	185.47	297	64.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			269.9	C08		7	0088-0189	673.09	189.38	273	60.53	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			785.2	C08		7	0089-0190	380.05	189.97	274	61.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			697.7	C08		7	0090-0193	99.98	191.93	164	69.26	0.430
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			258.3	C08		7	0091-0192	702.90	192.63	273	60.77	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			276.0	C08		7	0092-0194	628.35	194.17	269	62.18	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2028.5	C08		7	0093-0198	586.04	197.99	258	59.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			226.9	C08		7	0094-0201	417.61	201.11	287	64.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.9	C08		7	0095-0201	42.76	201.33	298	66.08	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.4	C08		7	0096-0201	872.92	201.31	246	58.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			461.0	C08		7	0097-0202	306.87	201.56	294	63.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3809.6	C08		7	0098-0204	754.31	203.36	420	82.43	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			932.2	C08		7	0099-0203	239.40	202.95	291	63.60	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			204.6	C08		7	0100-0205	436.00	204.90	300	67.01	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			236.2	C08		7	0101-0207	892.77	207.98	246	57.36	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			815.2	C08		7	0102-0213	353.83	213.62	279	61.94	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			218.4	C08		7	0103-0214	850.75	214.10	297	67.01	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			273.3	C08		7	0104-0213	925.26	213.62	261	59.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			579.4	C08		7	0105-0216	140.33	216.11	277	61.60	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			197.7	C08		7	0106-0218	448.62	218.90	296	65.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2106.0	C08		7	0107-0217	547.32	216.90	235	56.53	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			741.0	C08		7	0108-0216	734.27	216.55	278	63.94	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			196.8	C08		7	0109-0222	203.83	221.45	318	67.36	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			176.2	C08		7	0110-0221	314.48	220.98	295	66.67	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			201.6	C08		7	0111-0222	394.80	221.93	308	66.18	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.5	C08		7	0112-0220	493.45	219.93	292	65.60	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1826.1	C08		7	0113-0225	124.54	226.17	266	61.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			338.3	C08		7	0114-0229	825.06	229.84	372	72.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			226.5	C08		7	0115-0228	613.49	228.12	286	63.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			709.5	C08		7	0116-0232	560.43	232.21	247	58.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			436.6	C08		7	0117-0229	686.19	229.62	305	68.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			577.5	C08		7	0118-0238	248.32	238.50	299	65.60	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1076.2	C08		7	0119-0243	123.31	242.39	241	58.87	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			625.1	C08		7	0120-0245	676.71	245.31	306	72.77	0.726
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			201.1	C08		7	0121-0250	341.73	250.33	328	67.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			189.5	C08		7	0122-0257	274.37	257.90	311	68.43	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			200.3	C08		7	0123-0259	512.98	259.48	298	67.94	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			273.5	C08		7	0124-0255	86.50	255.95	260	59.11	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			201.1	C08		7	0125-0257	381.59	257.67	288	62.53	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			306.4	C08		7	0126-0261	157.63	261.08	323	67.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			205.1	C08		7	0127-0261	480.12	261.93	293	64.18	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.6	C08		7	0128-0261	434.67	261.82	291	64.53	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			230.1	C08		7	0129-0267	177.11	266.96	476	83.84	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			198.4	C08		7	0130-0262	319.73	262.56	312	65.60	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			230.8	C08		7	0131-0262	908.50	262.01	260	61.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			522.9	C08		7	0132-0264	610.11	263.52	277	63.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			796.2	C08		7	0133-0266	633.45	266.54	293	63.94	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1269.2	C08		7	0134-0270	225.67	270.95	303	71.26	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			226.1	C08		7	0135-0275	848.09	274.96	591	103.05	0.699
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			294.6	C08		7	0136-0270	563.50	270.12	245	56.53	0.964
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.8	C08		7	0137-0273	923.56	272.85	264	62.28	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			332.5	C08		7	0138-0275	36.30	275.45	296	66.18	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			245.1	C08		7	0139-0276	74.24	275.93	249	65.46	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			270.7	C08		7	0140-0272	710.08	272.03	295	68.18	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1052.3	C08		7	0141-0279	875.73	278.69	210	55.94	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.5	C08		7	0142-0280	436.92	279.64	319	66.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			207.9	C08		7	0143-0283	376.15	283.21	297	65.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			202.2	C08		7	0144-0283	791.94	283.20	287	64.77	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			193.6	C08		7	0145-0284	394.43	284.19	285	62.53	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			240.0	C08		7	0146-0287	280.72	287.25	263	60.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			659.0	C08		7	0147-0290	884.23	291.40	239	57.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.1	C08		7	0148-0293	518.71	293.39	317	68.08	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.1	C08		7	0149-0291	610.49	291.17	303	66.53	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			602.7	C08		7	0150-0292	686.06	292.11	296	68.18	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			516.8	C08		7	0151-0296	263.56	296.73	307	108.71	0.326
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2024.5	C08		7	0152-0297	142.76	296.77	247	58.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			310.7	C08		7	0153-0298	700.97	298.74	265	63.36	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			283.9	C08		7	0154-0299	754.67	298.77	304	65.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			935.6	C08		7	0155-0304	472.50	304.34	414	76.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			211.6	C08		7	0156-0301	564.05	301.27	298	64.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			396.3	C08		7	0157-0305	335.27	304.40	377	72.67	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			274.0	C08		7	0158-0305	293.40	305.22	296	63.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			169.6	C08		7	0159-0303	409.14	303.46	295	64.28	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			251.8	C08		7	0160-0309	742.48	309.82	249	59.84	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			217.3	C08		7	0161-0313	442.94	313.73	318	65.60	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.0	C08		7	0162-0318	942.53	318.48	418	76.08	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			234.9	C08		7	0163-0322	870.12	321.84	473	82.43	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			205.8	C08		7	0164-0320	325.90	321.12	282	65.01	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1142.6	C08		7	0165-0318	74.38	317.81	250	58.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			374.3	C08		7	0166-0319	776.38	318.80	223	55.11	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			685.1	C08		7	0167-0321	384.45	321.54	317	67.01	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			267.4	C08		7	0168-0326	801.22	326.23	276	62.53	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1712.7	C08		7	0169-0326	100.75	325.66	233	55.94	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.4	C08		7	0170-0328	540.33	328.26	275	61.94	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			216.2	C08		7	0171-0325	618.90	325.47	308	69.11	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			279.2	C08		7	0172-0332	355.64	332.73	326	66.43	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.7	C08		7	0173-0333	827.91	332.60	260	61.94	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			571.7	C08		7	0174-0333	59.54	333.52	229	57.94	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			262.4	C08		7	0175-0340	679.98	340.54	324	70.28	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			409.7	C08		7	0176-0341	182.75	341.17	277	67.60	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			346.3	C08		7	0177-0337	234.22	337.39	279	65.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			796.7	C08		7	0178-0341	393.39	341.51	322	67.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			564.9	C08		7	0179-0344	273.12	344.76	273	60.53	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1542.9	C08		7	0180-0347	443.34	347.29	297	69.50	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			242.1	C08		7	0181-0345	903.28	345.78	250	58.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1891.9	C08		7	0182-0349	511.96	349.53	294	97.64	0.388
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			197.7	C08		7	0183-0352	834.55	351.67	322	68.18	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			813.8	C08		7	0184-0351	480.64	350.76	450	82.43	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			244.7	C08		7	0185-0349	596.52	349.28	272	61.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			242.5	C08		7	0186-0351	734.48	350.94	281	62.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			988.3	C08		7	0187-0354	21.01	354.39	300	63.36	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1110.8	C08		7	0188-0357	136.51	357.68	257	62.77	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1404.9	C08		7	0189-0363	277.83	363.11	282	65.36	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			190.5	C08		7	0190-0369	804.38	370.02	353	76.91	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			406.9	C08		7	0191-0370	623.76	369.67	290	63.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			218.9	C08		7	0192-0371	729.37	370.37	299	70.43	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			201.0	C08		7	0193-0371	883.25	370.76	286	62.18	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			696.4	C08		7	0194-0370	421.52	370.61	212	52.87	0.953
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			612.1	C08		7	0195-0373	440.77	372.81	369	71.94	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			580.1	C08		7	0196-0375	244.52	375.02	278	61.36	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.5	C08		7	0197-0386	779.94	386.38	519	100.33	0.648
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			252.7	C08		7	0198-0377	71.45	377.30	298	66.53	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			511.8	C08		7	0199-0381	358.69	381.63	304	67.26	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1558.7	C08		7	0200-0384	480.38	383.90	280	62.53	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.4	C08		7	0201-0383	594.58	383.38	302	67.36	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			752.0	C08		7	0202-0387	497.35	387.35	255	59.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1551.0	C08		7	0203-0388	159.68	388.14	279	64.18	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			393.0	C08		7	0204-0387	211.60	387.59	296	66.43	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			366.6	C08		7	0205-0389	307.95	388.57	241	57.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			465.1	C08		7	0206-0391	538.00	391.84	277	63.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			539.4	C08		7	0207-0391	340.85	392.48	347	75.50	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			222.1	C08		7	0208-0391	895.57	390.50	309	67.60	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			197.6	C08		7	0209-0392	273.69	392.24	311	66.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.8	C08		7	0210-0392	731.74	391.93	291	66.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			254.7	C08		7	0211-0394	685.93	394.07	333	70.43	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			429.2	C08		7	0212-0397	667.40	397.52	258	63.94	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			274.1	C08		7	0213-0399	588.90	399.42	299	66.77	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			189.3	C08		7	0214-0400	944.59	400.47	310	69.01	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3808.1	C08		7	0215-0405	62.74	405.46	318	72.28	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			340.0	C08		7	0216-0403	315.97	403.96	284	64.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2185.9	C08		7	0217-0403	136.00	402.95	262	59.36	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			291.8	C08		7	0218-0405	648.86	405.48	283	64.18	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			602.6	C08		7	0219-0408	242.85	408.79	298	64.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			839.5	C08		7	0220-0407	454.24	407.57	291	63.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.2	C08		7	0221-0408	727.38	408.60	319	67.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			202.8	C08		7	0222-0413	806.08	413.94	299	65.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1277.2	C08		7	0223-0413	848.18	413.71	226	57.70	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			298.1	C08		7	0224-0424	158.66	424.24	430	77.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2776.0	C08		7	0225-0426	575.46	425.45	392	95.88	0.536
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1277.9	C08		7	0226-0424	443.56	423.89	283	62.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1196.5	C08		7	0227-0428	70.13	428.66	468	82.77	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			520.0	C08		7	0228-0429	302.95	428.77	307	67.84	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3032.0	C08		7	0229-0433	604.50	433.16	423	82.33	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			207.1	C08		7	0230-0432	651.00	431.62	293	64.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			303.9	C08		7	0231-0429	917.79	429.61	133	42.87	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			306.6	C08		7	0232-0435	902.21	434.55	192	52.18	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			272.9	C08		7	0233-0439	201.66	439.00	288	64.18	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			290.7	C08		7	0234-0441	136.25	440.56	313	66.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			290.4	C08		7	0235-0451	551.08	451.54	738	125.30	0.591
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1019.6	C08		7	0236-0447	733.50	447.24	319	66.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1320.7	C08		7	0237-0448	237.40	448.75	413	75.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			182.9	C08		7	0238-0451	171.67	451.56	290	65.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			292.5	C08		7	0239-0452	50.62	451.91	266	63.94	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			266.2	C08		7	0240-0449	372.36	448.99	256	62.53	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			276.9	C08		7	0241-0451	479.06	451.16	238	58.18	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			778.9	C08		7	0242-0467	133.33	469.17	904	137.10	0.604
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			325.2	C08		7	0243-0458	493.89	458.38	335	69.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.2	C08		7	0244-0458	332.53	458.42	279	63.01	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			278.4	C08		7	0245-0460	632.80	460.02	261	66.43	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			288.0	C08		7	0246-0456	274.08	455.57	268	61.70	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1105.5	C08		7	0247-0458	414.12	457.91	197	52.28	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			243.4	C08		7	0248-0463	79.81	463.03	259	62.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.0	C08		7	0249-0468	822.05	468.25	531	87.15	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1054.8	C08		7	0250-0465	393.47	464.98	215	54.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			517.7	C08		7	0251-0465	800.97	465.27	182	52.04	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			283.3	C08		7	0252-0466	695.06	466.10	242	59.36	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			184.9	C08		7	0253-0468	778.09	468.76	311	67.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			324.7	C08		7	0254-0471	731.50	470.88	306	65.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			793.6	C08		7	0255-0481	682.59	481.48	527	94.08	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			250.3	C08		7	0256-0475	432.38	475.66	298	63.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			348.7	C08		7	0257-0476	888.40	476.51	278	63.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1278.8	C08		7	0258-0476	863.53	476.24	285	64.77	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			189.0	C08		7	0259-0479	615.49	479.10	308	65.84	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.7	C08		7	0260-0480	758.16	480.43	318	69.60	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			290.7	C08		7	0261-0489	489.59	489.12	471	81.26	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1538.1	C08		7	0262-0486	905.96	486.58	296	64.18	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			386.6	C08		7	0263-0490	579.07	489.41	186	57.60	0.705
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			359.3	C08		7	0264-0493	259.07	493.34	275	60.77	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			183.8	C08		7	0265-0497	773.89	497.11	282	64.77	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			396.0	C08		7	0266-0497	234.03	496.95	259	58.53	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			276.1	C08		7	0267-0502	658.63	502.20	266	60.18	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			447.7	C08		7	0268-0503	846.58	503.79	333	68.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			943.5	C08		7	0269-0506	122.20	506.82	276	62.53	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.0	C08		7	0270-0508	532.58	508.24	317	65.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5796.6	C08		7	0271-0513	340.54	511.95	653	107.40	0.711
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			201.9	C08		7	0272-0511	201.18	511.35	298	66.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			255.7	C08		7	0273-0509	374.99	510.00	260	58.77	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			201.9	C08		7	0274-0514	779.70	514.47	297	65.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			205.1	C08		7	0275-0514	163.92	514.24	276	63.60	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.6	C08		7	0276-0515	474.02	515.23	306	64.43	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			212.5	C08		7	0277-0520	285.23	519.48	281	66.43	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			321.9	C08		7	0278-0523	554.66	522.46	299	65.60	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			200.3	C08		7	0279-0527	595.61	527.94	333	69.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			243.8	C08		7	0280-0530	462.19	530.53	273	65.26	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.8	C08		7	0281-0531	50.04	531.24	281	65.01	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			204.2	C08		7	0282-0532	83.20	532.26	287	62.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			337.6	C08		7	0283-0538	235.20	538.13	469	80.08	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			217.8	C08		7	0284-0537	720.99	537.06	278	66.43	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			289.6	C08		7	0285-0537	643.63	536.71	328	67.84	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.5	C08		7	0286-0536	769.83	536.82	260	64.67	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			324.7	C08		7	0287-0539	187.08	539.05	290	69.50	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			245.4	C08		7	0288-0536	390.77	535.62	261	61.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			251.5	C08		7	0289-0539	914.20	540.18	320	67.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			268.1	C08		7	0290-0544	701.47	543.96	434	77.74	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			210.0	C08		7	0291-0544	12.36	544.12	314	67.84	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			593.3	C08		7	0292-0543	264.67	542.86	258	59.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			509.3	C08		7	0293-0551	298.73	551.61	248	58.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			778.7	C08		7	0294-0551	213.99	551.36	300	65.70	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			266.6	C08		7	0295-0553	929.54	553.86	299	66.18	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			432.5	C08		7	0296-0558	801.50	557.38	377	72.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			324.5	C08		7	0297-0559	382.14	558.96	278	63.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.1	C08		7	0298-0561	350.08	560.94	292	64.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			285.0	C08		7	0299-0562	322.63	561.88	258	59.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			429.9	C08		7	0300-0563	518.11	563.04	271	61.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			759.5	C08		7	0301-0564	133.95	564.75	242	57.11	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.6	C08		7	0302-0569	241.13	569.70	307	67.01	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			370.4	C08		7	0303-0571	696.96	572.13	336	72.43	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			959.3	C08		7	0304-0571	588.57	571.12	288	63.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1283.1	C08		7	0305-0579	282.97	579.38	397	73.60	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			513.7	C08		7	0306-0585	763.47	587.36	746	117.64	0.677
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.5	C08		7	0307-0579	94.84	579.64	289	64.43	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3178.0	C08		7	0308-0576	649.55	576.07	254	59.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			190.2	C08		7	0309-0583	415.09	583.38	302	67.94	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			282.2	C08		7	0310-0583	893.16	583.45	375	71.60	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.7	C08		7	0311-0584	615.58	583.79	264	60.77	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			242.9	C08		7	0312-0588	460.21	588.56	306	64.53	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			964.9	C08		7	0313-0591	583.80	591.02	473	82.18	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			274.5	C08		7	0314-0595	538.06	595.67	433	77.01	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			380.1	C08		7	0315-0592	700.27	592.00	281	62.87	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			257.4	C08		7	0316-0599	945.31	598.79	258	64.43	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			828.0	C08		7	0317-0599	353.56	599.04	283	64.04	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1298.3	C08		7	0318-0605	336.14	604.94	412	78.18	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			882.5	C08		7	0319-0602	56.90	602.87	252	59.70	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			296.0	C08		7	0320-0606	399.11	607.57	277	63.11	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			309.6	C08		7	0321-0609	855.32	609.79	272	62.53	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			197.0	C08		7	0322-0613	636.26	612.94	273	64.77	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			167.1	C08		7	0323-0613	936.53	613.28	315	67.84	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			218.9	C08		7	0324-0612	678.10	613.04	256	60.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			515.9	C08		7	0325-0621	104.10	620.20	457	78.43	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			320.3	C08		7	0326-0623	291.51	624.26	627	100.91	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			358.9	C08		7	0327-0629	395.95	629.48	448	79.60	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			192.4	C08		7	0328-0628	572.60	628.89	290	62.77	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			210.0	C08		7	0329-0632	748.01	632.18	289	64.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2632.4	C08		7	0330-0636	776.79	636.68	256	60.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			202.8	C08		7	0331-0640	373.08	640.16	281	62.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			826.5	C08		7	0332-0647	710.25	648.24	283	65.60	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			237.2	C08		7	0333-0651	822.58	651.72	261	61.94	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			339.6	C08		7	0334-0652	204.53	653.05	300	64.18	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.8	C08		7	0335-0655	48.52	654.60	298	66.77	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			788.4	C08		7	0336-0658	138.48	657.73	287	62.77	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			201.6	C08		7	0337-0660	500.08	659.81	310	69.36	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			242.7	C08		7	0338-0659	631.58	659.79	261	60.87	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.3	C08		7	0339-0663	91.38	663.46	295	63.36	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			560.0	C08		7	0340-0661	302.24	661.91	258	61.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			207.2	C08		7	0341-0665	867.73	665.18	310	67.60	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			245.3	C08		7	0342-0670	424.56	670.17	396	75.84	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			577.1	C08		7	0343-0666	665.60	666.59	260	59.11	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			387.6	C08		7	0344-0668	699.28	668.58	267	61.94	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.8	C08		7	0345-0667	566.92	667.45	265	64.53	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.8	C08		7	0346-0674	186.53	673.98	438	80.18	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1154.7	C08		7	0347-0677	313.68	677.71	433	78.43	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			649.5	C08		7	0348-0676	807.34	676.26	246	58.18	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			250.8	C08		7	0349-0677	628.99	676.79	257	63.21	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.4	C08		7	0350-0679	645.06	678.65	325	71.94	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1660.8	C08		7	0351-0682	946.39	682.20	232	58.53	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			485.5	C08		7	0352-0684	666.11	684.21	246	57.70	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			702.6	C08		7	0353-0687	759.57	688.18	370	71.84	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1343.3	C08		7	0354-0687	736.92	686.21	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			238.7	C08		7	0355-0688	24.13	688.30	298	65.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2672.8	C08		7	0356-0691	252.88	690.83	430	77.26	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			933.0	C08		7	0357-0688	713.65	688.11	263	63.36	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			205.1	C08		7	0358-0693	469.47	692.93	302	67.70	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			230.7	C08		7	0359-0691	123.37	691.78	285	63.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			236.5	C08		7	0360-0698	43.62	698.59	290	65.60	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1700.4	C08		7	0361-0698	939.07	698.25	235	59.36	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			204.0	C08		7	0362-0700	533.23	700.56	301	65.60	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1314.6	C08		7	0363-0702	438.97	702.40	410	75.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			560.7	C08		7	0364-0702	374.62	702.30	278	61.36	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			800.4	C08		7	0365-0705	762.74	705.83	240	58.87	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2288.0	C08		7	0366-0710	613.25	710.49	186	53.36	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			211.3	C08		8	0001-0030	465.68	30.42	295	61.94	0.966
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			169.1	C08		8	0002-0031	547.19	30.38	278	62.18	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			195.2	C08		8	0003-0033	709.44	32.90	255	63.84	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			190.7	C08		8	0004-0033	33.60	33.54	273	64.77	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			360.8	C08		8	0005-0032	180.29	32.17	229	56.53	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1339.2	C08		8	0006-0032	778.32	31.86	180	51.11	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.4	C08		8	0007-0033	54.01	33.46	295	67.70	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			179.4	C08		8	0008-0033	231.55	33.54	264	59.11	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			269.0	C08		8	0009-0037	693.47	37.68	251	59.94	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			300.7	C08		8	0010-0039	522.67	38.53	294	65.94	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2071.6	C08		8	0011-0040	792.13	40.86	333	76.91	0.707
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			170.0	C08		8	0012-0042	311.06	41.33	294	65.26	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			717.2	C08		8	0013-0048	380.46	46.13	438	89.84	0.682
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1221.8	C08		8	0014-0045	501.66	45.04	449	78.67	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2639.9	C08		8	0015-0044	660.94	45.37	156	80.91	0.299
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			218.3	C08		8	0016-0054	712.35	54.21	264	66.18	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			290.0	C08		8	0017-0053	742.37	52.85	277	63.84	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			295.6	C08		8	0018-0056	837.09	55.92	164	55.11	0.679
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			270.4	C08		8	0019-0057	860.26	57.03	272	62.18	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			412.4	C08		8	0020-0059	448.63	59.29	134	60.18	0.465
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1076.9	C08		8	0021-0068	67.82	67.59	498	87.50	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			210.1	C08		8	0022-0064	909.20	64.16	300	67.36	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1441.1	C08		8	0023-0062	790.69	61.81	207	52.28	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4636.6	C08		8	0024-0063	121.72	63.89	242	57.36	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			257.8	C08		8	0025-0067	286.68	66.55	297	76.57	0.637
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			195.7	C08		8	0026-0067	591.04	66.94	314	70.77	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			489.5	C08		8	0027-0063	50.38	63.06	108	40.63	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3061.8	C08		8	0028-0074	188.81	72.64	695	116.23	0.647
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			281.9	C08		8	0029-0069	345.83	69.59	243	57.11	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			270.2	C08		8	0030-0071	848.67	70.96	252	61.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4227.8	C08		8	0031-0073	106.00	73.30	218	58.77	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1343.2	C08		8	0032-0080	165.89	77.84	532	95.36	0.735
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			212.5	C08		8	0033-0075	629.52	75.54	309	69.26	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			176.5	C08		8	0034-0073	932.67	73.63	278	64.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			316.3	C08		8	0035-0074	236.53	74.59	247	59.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			694.6	C08		8	0036-0081	544.67	81.33	299	68.43	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			144.9	C08		8	0037-0087	824.73	86.97	303	67.84	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			212.6	C08		8	0038-0086	481.64	86.30	296	64.67	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			286.4	C08		8	0039-0086	319.20	85.87	282	62.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			276.8	C08		8	0040-0089	665.56	89.80	432	80.67	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2601.9	C08		8	0041-0100	83.83	100.10	294	64.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.7	C08		8	0042-0100	227.32	99.74	258	63.36	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1741.7	C08		8	0043-0099	773.95	99.27	234	56.87	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.2	C08		8	0044-0100	367.51	100.60	291	65.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2612.0	C08		8	0045-0100	757.50	100.78	259	58.87	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			932.5	C08		8	0046-0108	581.33	108.58	288	65.01	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			200.5	C08		8	0047-0110	902.90	110.16	303	64.18	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.4	C08		8	0048-0110	821.66	109.99	266	61.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			527.9	C08		8	0049-0111	720.99	110.99	228	55.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			195.7	C08		8	0050-0117	19.36	117.48	250	58.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			671.1	C08		8	0051-0122	401.85	120.99	617	103.15	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			248.5	C08		8	0052-0117	602.92	117.43	243	58.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			222.0	C08		8	0053-0117	536.09	116.93	268	61.94	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			320.8	C08		8	0054-0123	645.10	123.14	239	57.36	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			253.9	C08		8	0055-0126	433.22	126.58	256	59.36	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			244.5	C08		8	0056-0125	475.67	125.87	307	65.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1839.8	C08		8	0057-0131	104.76	131.71	320	68.43	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			429.4	C08		8	0058-0129	288.05	129.53	218	55.11	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			645.9	C08		8	0059-0135	847.79	134.33	444	84.91	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2740.0	C08		8	0060-0132	811.21	132.13	224	56.63	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.1	C08		8	0061-0135	207.21	134.94	252	61.36	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			666.4	C08		8	0062-0138	798.43	138.91	261	64.28	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			196.0	C08		8	0063-0140	527.91	140.89	280	63.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.3	C08		8	0064-0142	711.25	142.30	314	70.43	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			396.3	C08		8	0065-0142	375.28	142.34	231	56.28	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			247.4	C08		8	0066-0143	476.59	142.54	270	62.53	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			185.4	C08		8	0067-0148	775.29	148.00	280	62.18	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.5	C08		8	0068-0152	124.19	152.91	275	63.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.0	C08		8	0069-0148	299.03	147.82	247	59.70	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4112.2	C08		8	0070-0152	814.13	152.03	197	51.70	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.9	C08		8	0071-0155	675.60	155.47	270	63.60	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			190.6	C08		8	0072-0155	741.61	154.87	253	59.94	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			211.3	C08		8	0073-0159	614.15	159.31	289	65.70	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			318.6	C08		8	0074-0158	355.70	157.95	353	69.01	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			234.2	C08		8	0075-0158	72.97	157.87	271	61.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			297.4	C08		8	0076-0166	468.52	166.65	303	69.60	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			276.0	C08		8	0077-0171	52.32	171.42	447	79.50	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			236.5	C08		8	0078-0173	161.92	173.06	261	61.36	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			243.8	C08		8	0079-0173	222.76	173.00	257	59.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			940.2	C08		8	0080-0169	397.95	169.91	274	67.94	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			351.6	C08		8	0081-0172	449.89	172.11	212	55.70	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			277.3	C08		8	0082-0176	674.84	176.11	285	66.18	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			302.0	C08		8	0083-0184	538.83	184.41	214	56.53	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.7	C08		8	0084-0186	105.76	186.28	271	60.18	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			253.2	C08		8	0085-0190	896.93	190.67	512	89.74	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			248.0	C08		8	0086-0197	328.77	196.94	376	71.60	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			295.7	C08		8	0087-0194	398.31	194.01	237	58.18	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			494.4	C08		8	0088-0198	481.48	198.28	282	64.53	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			253.7	C08		8	0089-0200	669.44	199.84	309	70.18	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			399.1	C08		8	0090-0199	286.00	199.11	279	63.36	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			636.1	C08		8	0091-0199	513.10	198.22	311	69.11	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			175.1	C08		8	0092-0203	773.71	202.19	159	50.18	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			266.4	C08		8	0093-0208	848.75	208.73	304	70.91	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			280.6	C08		8	0094-0208	385.94	208.71	392	80.33	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			283.7	C08		8	0095-0210	762.42	209.98	316	75.74	0.692
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			172.4	C08		8	0096-0210	784.83	210.44	120	41.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			249.5	C08		8	0097-0214	718.57	214.37	222	59.36	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			267.3	C08		8	0098-0215	30.22	215.69	254	59.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			303.5	C08		8	0099-0214	509.59	215.05	284	65.36	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			236.6	C08		8	0100-0221	901.61	221.67	392	74.67	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			265.6	C08		8	0101-0219	401.57	219.53	273	63.01	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			300.8	C08		8	0102-0227	600.21	227.79	229	56.53	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			328.1	C08		8	0103-0228	180.24	228.63	265	62.77	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.6	C08		8	0104-0232	123.88	234.13	341	79.26	0.682
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			262.2	C08		8	0105-0230	684.46	229.47	250	59.70	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1056.0	C08		8	0106-0230	821.39	229.68	262	60.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1181.4	C08		8	0107-0228	846.38	228.77	224	55.36	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			392.7	C08		8	0108-0235	216.03	234.74	373	71.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			357.4	C08		8	0109-0233	263.29	233.49	159	47.46	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			268.3	C08		8	0110-0241	702.98	240.60	210	55.94	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.0	C08		8	0111-0244	483.81	244.58	343	71.01	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			263.5	C08		8	0112-0247	651.99	247.34	454	81.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.2	C08		8	0113-0246	183.27	246.76	242	59.46	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			635.7	C08		8	0114-0247	567.50	246.42	307	65.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			185.1	C08		8	0115-0248	622.51	248.87	293	63.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			262.4	C08		8	0116-0251	64.62	250.71	270	66.67	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			352.1	C08		8	0117-0252	339.09	252.28	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			546.9	C08		8	0118-0252	746.86	252.39	370	71.26	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			217.8	C08		8	0119-0253	909.42	252.76	302	68.18	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			193.3	C08		8	0120-0256	927.02	256.12	338	72.18	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			403.4	C08		8	0121-0257	507.86	257.96	460	79.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			211.4	C08		8	0122-0257	775.18	257.04	242	57.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			163.5	C08		8	0123-0263	113.49	262.03	264	61.26	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.8	C08		8	0124-0265	13.44	264.14	247	61.60	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2494.3	C08		8	0125-0266	570.91	266.69	224	54.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			684.4	C08		8	0126-0270	431.50	270.56	276	63.36	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			684.5	C08		8	0127-0271	642.41	271.75	266	63.11	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.6	C08		8	0128-0275	28.09	274.67	247	61.36	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			211.0	C08		8	0129-0273	96.59	273.71	293	71.15	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			225.2	C08		8	0130-0278	177.48	278.78	258	61.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			582.1	C08		8	0131-0275	348.47	275.37	282	62.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.6	C08		8	0132-0282	790.68	282.00	280	63.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3721.9	C08		8	0133-0280	616.38	280.19	218	54.53	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1206.6	C08		8	0134-0286	411.59	286.65	516	86.43	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			935.8	C08		8	0135-0289	593.91	290.18	522	96.33	0.707
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			236.7	C08		8	0136-0291	657.83	291.43	401	77.60	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			231.0	C08		8	0137-0292	198.52	292.19	254	62.77	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			282.1	C08		8	0138-0291	503.11	291.22	264	61.36	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			208.8	C08		8	0139-0293	169.12	293.03	223	57.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.2	C08		8	0140-0296	858.63	296.66	278	65.70	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			275.7	C08		8	0141-0296	473.07	295.39	310	66.43	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			868.1	C08		8	0142-0296	631.22	296.87	243	59.94	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			373.1	C08		8	0143-0300	872.90	300.22	285	64.87	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			178.7	C08		8	0144-0300	97.94	300.00	282	66.18	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			699.2	C08		8	0145-0308	702.25	308.18	503	88.43	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			276.7	C08		8	0146-0309	152.79	309.85	475	88.57	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			261.2	C08		8	0147-0310	280.31	309.79	416	77.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			632.5	C08		8	0148-0310	386.42	309.73	244	58.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.7	C08		8	0149-0309	745.08	308.93	281	62.18	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			724.3	C08		8	0150-0315	216.42	314.77	287	65.60	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			190.2	C08		8	0151-0320	47.35	320.46	420	75.26	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			248.6	C08		8	0152-0320	593.64	319.21	252	59.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			300.5	C08		8	0153-0325	528.95	325.66	304	66.77	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			189.7	C08		8	0154-0325	422.95	324.32	285	64.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			225.5	C08		8	0155-0325	910.94	325.64	306	67.84	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			198.5	C08		8	0156-0327	98.64	326.80	373	76.08	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			750.0	C08		8	0157-0326	326.66	326.76	238	58.18	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			217.1	C08		8	0158-0337	772.26	337.59	305	66.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			301.1	C08		8	0159-0341	818.10	341.48	280	65.01	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			496.0	C08		8	0160-0339	871.33	338.94	242	59.11	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			230.2	C08		8	0161-0345	115.39	344.75	275	62.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			839.9	C08		8	0162-0348	525.87	348.58	366	73.84	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			644.1	C08		8	0163-0345	711.92	344.44	249	59.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.1	C08		8	0164-0352	559.11	352.20	276	61.94	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			245.8	C08		8	0165-0351	597.71	351.17	268	60.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			473.5	C08		8	0166-0352	682.45	351.91	255	62.77	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.9	C08		8	0167-0352	731.46	352.60	283	62.18	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			635.7	C08		8	0168-0359	263.84	359.46	487	88.91	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			291.2	C08		8	0169-0354	210.23	354.93	263	59.60	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			246.0	C08		8	0170-0356	631.68	356.32	268	61.11	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			234.0	C08		8	0171-0356	355.10	356.18	258	59.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			218.4	C08		8	0172-0357	416.89	357.57	307	70.43	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			194.6	C08		8	0173-0357	925.03	357.68	273	61.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			212.4	C08		8	0174-0361	468.53	360.83	292	64.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			236.1	C08		8	0175-0362	649.11	362.38	323	69.60	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			336.6	C08		8	0176-0365	171.66	365.70	227	55.70	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			285.4	C08		8	0177-0365	288.04	365.90	287	67.60	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1124.0	C08		8	0178-0366	59.86	366.56	248	58.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			291.5	C08		8	0179-0380	760.61	380.58	357	70.18	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1247.3	C08		8	0180-0380	811.00	379.21	217	55.01	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			218.2	C08		8	0181-0383	196.62	383.55	280	62.18	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			200.7	C08		8	0182-0384	217.55	384.18	269	61.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			394.1	C08		8	0183-0383	334.32	383.75	119	50.04	0.597
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			338.5	C08		8	0184-0389	824.12	389.42	309	65.11	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			168.6	C08		8	0185-0388	948.43	389.19	264	59.70	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3477.8	C08		8	0186-0396	578.23	395.14	311	67.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.1	C08		8	0187-0396	492.26	397.89	297	69.84	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			240.0	C08		8	0188-0398	874.23	398.40	276	62.77	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			863.4	C08		8	0189-0402	378.12	401.83	338	72.67	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			244.0	C08		8	0190-0397	921.02	397.62	284	63.01	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			199.7	C08		8	0191-0401	295.72	402.10	276	61.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			203.5	C08		8	0192-0402	49.43	402.45	275	65.60	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			613.5	C08		8	0193-0404	558.15	404.14	249	59.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1712.9	C08		8	0194-0404	725.10	404.57	103	63.50	0.321
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1567.2	C08		8	0195-0418	319.07	417.56	255	60.28	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			389.9	C08		8	0196-0418	390.15	417.76	412	76.08	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			205.9	C08		8	0197-0420	245.09	420.66	268	64.43	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			328.8	C08		8	0198-0420	684.61	420.01	187	50.53	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			247.4	C08		8	0199-0423	613.93	423.00	244	58.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			360.5	C08		8	0200-0424	562.83	424.34	275	60.77	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			226.5	C08		8	0201-0426	180.00	427.29	275	63.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1602.1	C08		8	0202-0426	827.92	426.59	247	57.70	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			296.5	C08		8	0203-0432	147.17	431.93	238	57.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			212.3	C08		8	0204-0434	261.57	433.98	293	67.94	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			272.4	C08		8	0205-0437	846.62	437.04	304	67.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			429.2	C08		8	0206-0442	340.32	442.00	273	63.36	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			393.6	C08		8	0207-0440	699.29	439.71	234	55.94	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			382.4	C08		8	0208-0442	417.13	442.32	230	56.28	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			346.8	C08		8	0209-0444	718.59	444.25	348	69.60	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			268.3	C08		8	0210-0444	545.86	444.24	272	61.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			353.6	C08		8	0211-0445	458.64	445.50	258	59.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4285.0	C08		8	0212-0448	868.82	448.96	248	59.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			319.0	C08		8	0213-0449	925.97	448.03	219	57.11	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			249.2	C08		8	0214-0453	372.89	453.38	318	70.67	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			326.4	C08		8	0215-0453	608.77	452.64	278	62.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			707.5	C08		8	0216-0458	565.00	458.24	488	82.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			940.0	C08		8	0217-0461	64.26	460.83	476	83.74	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			199.4	C08		8	0218-0461	387.49	461.48	279	63.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2068.9	C08		8	0219-0460	837.21	459.77	248	58.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			341.8	C08		8	0220-0461	921.28	462.13	248	62.77	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			533.4	C08		8	0221-0462	256.23	461.92	220	54.53	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			707.1	C08		8	0222-0461	282.52	461.62	206	54.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1138.8	C08		8	0223-0463	668.71	463.60	263	64.18	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			270.8	C08		8	0224-0467	319.69	467.01	282	63.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1794.5	C08		8	0225-0464	804.55	463.14	229	56.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			781.6	C08		8	0226-0471	787.93	471.14	285	63.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			234.6	C08		8	0227-0477	149.23	477.60	560	102.57	0.669
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			468.4	C08		8	0228-0474	640.90	473.26	224	54.53	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			198.8	C08		8	0229-0477	425.01	478.02	269	62.18	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1674.5	C08		8	0230-0478	292.01	479.06	271	64.53	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1014.5	C08		8	0231-0481	678.51	481.71	247	59.11	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			433.4	C08		8	0232-0479	711.23	479.80	241	57.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.5	C08		8	0233-0479	902.02	479.72	270	60.53	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			242.2	C08		8	0234-0481	941.03	481.25	232	57.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1707.6	C08		8	0235-0484	211.36	483.62	105	43.11	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1735.3	C08		8	0236-0487	201.58	488.12	131	48.53	0.699
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1114.8	C08		8	0237-0487	269.16	487.87	231	58.53	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			708.1	C08		8	0238-0489	620.16	488.89	288	65.11	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			299.5	C08		8	0239-0492	554.03	492.40	349	70.67	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1220.2	C08		8	0240-0491	365.53	491.03	225	56.18	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			447.8	C08		8	0241-0500	171.28	499.87	344	68.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			258.6	C08		8	0242-0498	716.02	498.20	226	60.43	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			194.9	C08		8	0243-0497	109.61	497.63	238	59.60	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			197.3	C08		8	0244-0500	238.91	501.10	239	58.87	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1711.4	C08		8	0245-0502	380.62	502.20	268	63.01	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1349.7	C08		8	0246-0507	930.95	506.66	409	77.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			324.2	C08		8	0247-0504	625.16	504.98	238	60.28	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			853.5	C08		8	0248-0503	273.40	503.05	238	58.28	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			198.9	C08		8	0249-0514	89.34	515.12	507	91.15	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			318.0	C08		8	0250-0509	438.00	509.74	255	58.53	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1790.3	C08		8	0251-0510	696.79	510.30	311	66.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			363.5	C08		8	0252-0512	878.28	512.44	244	59.46	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4518.3	C08		8	0253-0514	310.30	513.18	186	51.70	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			335.5	C08		8	0254-0515	201.80	515.64	228	56.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			322.4	C08		8	0255-0517	759.40	516.79	294	64.67	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			280.3	C08		8	0256-0519	811.58	519.44	486	87.98	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			704.8	C08		8	0257-0516	596.04	516.40	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			196.9	C08		8	0258-0520	237.04	519.50	330	71.11	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			196.8	C08		8	0259-0522	253.68	522.36	228	59.11	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			325.8	C08		8	0260-0523	488.73	522.70	295	62.77	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			270.5	C08		8	0261-0524	661.48	523.87	227	55.70	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			453.5	C08		8	0262-0527	742.40	526.95	260	60.43	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			253.4	C08		8	0263-0530	876.58	529.37	283	62.77	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			234.3	C08		8	0264-0532	356.26	532.79	284	62.53	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			648.3	C08		8	0265-0533	279.96	532.58	250	58.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			301.9	C08		8	0266-0533	631.26	533.79	257	59.60	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			313.6	C08		8	0267-0540	312.82	539.80	275	63.11	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			468.6	C08		8	0268-0544	136.31	544.19	542	91.15	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.9	C08		8	0269-0542	19.31	542.57	283	65.01	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			390.9	C08		8	0270-0541	710.78	541.56	213	55.11	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			194.2	C08		8	0271-0547	528.35	547.46	266	63.60	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			608.1	C08		8	0272-0547	659.37	547.28	221	55.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			352.1	C08		8	0273-0548	340.98	548.12	299	66.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			431.4	C08		8	0274-0551	158.34	550.80	237	57.70	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1147.1	C08		8	0275-0558	593.14	559.17	376	84.43	0.663
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			250.3	C08		8	0276-0557	882.02	557.74	446	77.60	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			269.4	C08		8	0277-0555	34.35	555.92	277	66.43	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1055.3	C08		8	0278-0558	212.69	558.00	294	64.53	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			457.5	C08		8	0279-0556	618.51	556.04	242	56.53	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			288.7	C08		8	0280-0557	686.65	556.60	238	59.60	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			210.3	C08		8	0281-0560	179.36	560.21	253	62.77	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			754.3	C08		8	0282-0558	246.73	557.92	240	58.77	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			545.8	C08		8	0283-0562	830.98	562.33	447	79.26	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			271.3	C08		8	0284-0566	803.90	565.85	314	66.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			208.4	C08		8	0285-0569	497.77	569.36	276	64.53	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.0	C08		8	0286-0567	759.84	567.25	272	63.01	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			604.4	C08		8	0287-0569	119.71	570.06	268	63.94	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			277.5	C08		8	0288-0571	461.61	571.35	266	61.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1293.8	C08		8	0289-0580	59.92	580.69	231	56.87	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			517.2	C08		8	0290-0579	303.55	579.25	251	58.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			374.1	C08		8	0291-0579	624.67	579.37	252	58.53	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.5	C08		8	0292-0583	361.19	583.79	256	61.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			355.9	C08		8	0293-0587	654.64	588.15	349	74.33	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			225.8	C08		8	0294-0589	456.73	589.69	307	70.18	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.1	C08		8	0295-0586	529.34	586.84	286	61.94	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			811.6	C08		8	0296-0586	117.58	586.24	206	54.97	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			247.9	C08		8	0297-0596	295.90	596.50	237	62.77	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			409.5	C08		8	0298-0593	868.74	593.33	202	51.70	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			304.2	C08		8	0299-0601	50.38	600.85	254	64.43	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			290.7	C08		8	0300-0599	701.52	599.57	413	75.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			181.0	C08		8	0301-0598	843.25	598.26	291	64.67	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1248.1	C08		8	0302-0600	63.45	600.21	210	57.46	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			197.4	C08		8	0303-0602	559.38	602.13	283	63.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			175.3	C08		8	0304-0602	185.08	602.33	240	61.01	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.9	C08		8	0305-0601	405.74	600.46	280	65.70	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			482.8	C08		8	0306-0605	120.49	605.06	281	62.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			373.4	C08		8	0307-0607	825.57	607.00	248	58.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			295.5	C08		8	0308-0611	359.21	612.16	250	61.94	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.0	C08		8	0309-0610	721.85	609.54	302	65.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			207.0	C08		8	0310-0613	943.88	612.85	291	65.60	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			207.7	C08		8	0311-0615	41.12	614.97	308	69.50	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			450.7	C08		8	0312-0615	239.39	614.86	257	61.70	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.9	C08		8	0313-0616	916.21	616.39	283	64.08	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			200.8	C08		8	0314-0618	207.71	618.12	223	60.77	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			181.4	C08		8	0315-0617	761.84	618.20	286	63.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			355.0	C08		8	0316-0618	306.06	618.28	239	56.53	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			296.6	C08		8	0317-0620	588.43	620.73	279	62.43	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			784.3	C08		8	0318-0622	404.32	622.59	304	64.18	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			187.3	C08		8	0319-0629	517.58	629.12	284	63.84	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			629.3	C08		8	0320-0632	459.52	631.89	370	71.84	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			374.2	C08		8	0321-0636	76.39	636.01	364	70.18	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			281.3	C08		8	0322-0637	110.24	637.03	317	65.36	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			615.5	C08		8	0323-0640	879.84	640.53	526	93.74	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			259.2	C08		8	0324-0639	391.61	638.97	319	68.18	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			588.5	C08		8	0325-0643	248.85	643.59	323	70.43	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			183.0	C08		8	0326-0645	505.10	645.84	306	66.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			246.6	C08		8	0327-0645	768.94	645.84	266	62.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			295.1	C08		8	0328-0651	671.28	651.61	246	60.18	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.2	C08		8	0329-0653	706.64	652.08	543	92.91	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			210.7	C08		8	0330-0654	300.37	654.17	247	58.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			187.5	C08		8	0331-0656	925.47	655.80	301	68.08	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			583.7	C08		8	0332-0656	362.05	656.09	299	64.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			204.6	C08		8	0333-0658	141.52	658.42	252	70.67	0.634
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			211.4	C08		8	0334-0658	97.64	658.60	267	61.94	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			210.9	C08		8	0335-0662	326.33	662.00	309	69.01	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			182.0	C08		8	0336-0664	412.07	664.33	320	67.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.5	C08		8	0337-0663	542.20	662.74	269	62.53	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			364.7	C08		8	0338-0671	679.72	670.55	583	99.98	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			990.1	C08		8	0339-0670	559.96	669.94	306	65.94	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			328.1	C08		8	0340-0671	522.06	670.94	257	60.53	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			236.5	C08		8	0341-0676	839.62	675.96	277	64.43	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			275.5	C08		8	0342-0677	592.10	676.95	301	64.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			208.8	C08		8	0343-0681	426.87	681.11	257	61.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			290.1	C08		8	0344-0680	825.91	680.22	200	55.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			293.2	C08		8	0345-0681	496.51	681.74	226	55.94	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1663.5	C08		8	0346-0684	50.65	684.36	234	58.53	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			278.1	C08		8	0347-0689	254.18	690.21	283	64.43	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			308.9	C08		8	0348-0688	868.57	687.80	244	57.70	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			260.7	C08		8	0349-0690	188.82	689.63	237	57.70	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			328.0	C08		8	0350-0690	937.26	690.82	252	61.11	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			237.2	C08		8	0351-0694	901.66	693.47	276	65.60	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			304.1	C08		8	0352-0701	762.65	700.30	321	72.77	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1648.7	C08		8	0353-0700	43.43	700.32	233	61.01	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			222.5	C08		8	0354-0703	119.57	703.64	249	58.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			288.3	C08		8	0355-0705	520.70	705.43	283	62.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			204.3	C08		8	0356-0706	389.73	707.25	207	55.94	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			212.6	C08		8	0357-0707	328.37	707.55	294	67.70	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			280.4	C08		9	0001-0024	161.85	25.29	246	59.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2428.4	C08		9	0002-0035	665.72	35.66	214	57.11	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			840.3	C08		9	0003-0039	312.75	39.43	433	76.67	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			191.8	C08		9	0004-0037	420.03	37.46	346	69.01	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			181.9	C08		9	0005-0040	374.47	40.18	320	66.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			199.7	C08		9	0006-0045	820.05	45.39	381	73.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			231.2	C08		9	0007-0047	72.02	46.73	268	64.18	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1768.2	C08		9	0008-0049	676.39	49.76	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3222.3	C08		9	0009-0050	207.06	50.12	309	65.01	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			252.5	C08		9	0010-0052	170.76	52.19	245	58.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			242.8	C08		9	0011-0055	511.16	55.20	391	73.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			317.8	C08		9	0012-0055	553.62	56.11	265	61.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.7	C08		9	0013-0056	84.67	55.33	253	63.60	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			198.1	C08		9	0014-0060	764.20	59.77	410	76.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			171.2	C08		9	0015-0057	111.31	57.22	247	63.94	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			195.3	C08		9	0016-0063	641.28	63.47	291	67.11	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			211.4	C08		9	0017-0063	618.58	62.86	295	65.70	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			565.8	C08		9	0018-0066	660.27	66.16	281	62.18	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1236.1	C08		9	0019-0065	260.89	65.33	267	59.94	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			514.9	C08		9	0020-0065	919.29	65.62	278	62.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			441.8	C08		9	0021-0068	834.44	67.84	321	68.43	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			980.2	C08		9	0022-0074	466.68	74.75	307	65.11	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			159.8	C08		9	0023-0076	27.12	76.64	262	61.60	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			177.8	C08		9	0024-0077	188.25	77.36	293	67.01	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			191.8	C08		9	0025-0078	237.21	78.41	255	61.01	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.2	C08		9	0026-0083	329.86	83.01	316	70.08	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.9	C08		9	0027-0090	387.72	90.27	630	94.81	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			383.9	C08		9	0028-0084	822.71	84.46	238	56.77	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			150.8	C08		9	0029-0087	949.16	87.00	283	63.01	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1292.1	C08		9	0030-0088	499.50	88.20	272	61.36	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3292.7	C08		9	0031-0095	273.32	94.68	232	57.60	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			254.3	C08		9	0032-0099	837.52	99.21	297	64.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			649.4	C08		9	0033-0103	732.27	102.56	218	57.36	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			787.1	C08		9	0034-0103	439.24	102.90	295	65.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			549.1	C08		9	0035-0104	717.93	103.97	242	57.70	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3418.0	C08		9	0036-0107	610.82	107.38	251	58.28	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			483.1	C08		9	0037-0108	762.14	108.40	290	63.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2443.5	C08		9	0038-0114	213.27	114.06	257	59.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			308.3	C08		9	0039-0119	68.38	119.09	248	64.87	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			265.5	C08		9	0040-0120	50.66	120.43	362	73.36	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			376.5	C08		9	0041-0121	287.36	120.29	279	61.11	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			989.3	C08		9	0042-0121	647.54	121.67	265	61.11	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			192.8	C08		9	0043-0121	943.79	120.02	245	59.94	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4825.5	C08		9	0044-0122	243.16	121.57	263	83.50	0.474
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			275.1	C08		9	0045-0124	862.97	124.53	312	66.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			313.8	C08		9	0046-0126	496.69	125.44	297	64.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			656.6	C08		9	0047-0131	422.92	130.66	210	55.01	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			506.5	C08		9	0048-0130	383.67	130.77	198	53.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			533.1	C08		9	0049-0133	667.11	133.29	248	58.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			231.3	C08		9	0050-0138	68.40	138.48	334	74.77	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			263.2	C08		9	0051-0142	113.99	141.80	371	73.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.9	C08		9	0052-0142	192.16	141.80	284	66.67	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			387.6	C08		9	0053-0140	302.18	140.57	275	62.04	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			491.2	C08		9	0054-0143	433.34	143.34	286	62.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			404.8	C08		9	0055-0141	733.55	141.16	244	57.36	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			330.5	C08		9	0056-0142	885.59	142.48	299	63.84	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			369.8	C08		9	0057-0139	772.04	139.76	219	54.87	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			478.0	C08		9	0058-0145	230.77	145.19	399	73.01	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			671.0	C08		9	0059-0147	345.61	146.60	335	67.84	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			238.0	C08		9	0060-0146	132.54	146.26	261	61.94	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1639.1	C08		9	0061-0159	616.86	156.80	390	84.91	0.680
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			726.6	C08		9	0062-0152	166.12	151.85	223	57.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1967.9	C08		9	0063-0153	634.50	153.00	116	38.97	0.960
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.0	C08		9	0064-0156	770.74	155.75	343	68.87	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			695.7	C08		9	0065-0156	449.47	155.91	231	55.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			366.3	C08		9	0066-0156	302.96	155.49	244	60.28	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			274.5	C08		9	0067-0162	490.83	162.58	358	71.26	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			243.8	C08		9	0068-0165	572.41	165.15	422	76.18	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			632.4	C08		9	0069-0166	807.34	166.84	302	69.60	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			479.1	C08		9	0070-0170	532.91	170.34	246	59.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			354.8	C08		9	0071-0173	140.65	173.84	242	57.70	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			255.8	C08		9	0072-0177	414.21	176.85	464	80.67	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			258.6	C08		9	0073-0177	251.09	177.59	287	62.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			903.8	C08		9	0074-0177	660.80	177.44	227	56.53	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.4	C08		9	0075-0182	827.81	182.46	333	68.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1077.9	C08		9	0076-0186	396.07	188.05	451	86.67	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			682.0	C08		9	0077-0185	750.71	185.11	320	66.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			355.3	C08		9	0078-0184	456.37	184.52	346	75.84	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			193.6	C08		9	0079-0186	559.50	186.39	310	65.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			448.1	C08		9	0080-0189	116.64	189.13	234	55.94	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			174.4	C08		9	0081-0188	167.35	187.41	309	70.53	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.4	C08		9	0082-0191	520.39	190.47	422	77.84	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			167.1	C08		9	0083-0192	77.49	191.97	280	63.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			207.7	C08		9	0084-0193	187.40	192.97	270	61.94	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			193.9	C08		9	0085-0191	902.35	191.72	342	71.11	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			258.0	C08		9	0086-0196	324.22	196.80	336	67.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			805.7	C08		9	0087-0199	842.93	200.02	236	57.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			566.2	C08		9	0088-0210	372.57	210.16	458	81.84	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			207.1	C08		9	0089-0206	233.49	206.79	240	58.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			269.7	C08		9	0090-0207	900.41	206.94	299	67.70	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			304.6	C08		9	0091-0211	734.28	211.95	285	63.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			187.5	C08		9	0092-0214	251.54	213.93	326	72.77	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			850.3	C08		9	0093-0211	773.03	210.77	302	64.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3782.1	C08		9	0094-0219	463.37	219.42	274	64.53	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3092.7	C08		9	0095-0217	682.78	217.22	230	57.36	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			291.1	C08		9	0096-0219	500.76	219.35	234	57.70	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			511.4	C08		9	0097-0222	127.39	221.66	282	63.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			291.5	C08		9	0098-0220	637.31	220.35	277	61.36	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			186.8	C08		9	0099-0221	78.75	221.20	239	62.18	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			181.6	C08		9	0100-0222	206.90	222.08	262	62.18	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1160.0	C08		9	0101-0227	722.82	226.89	261	63.36	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			711.4	C08		9	0102-0224	928.66	223.68	354	71.01	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			384.1	C08		9	0103-0227	522.97	227.72	319	67.36	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			270.7	C08		9	0104-0238	321.22	237.77	481	81.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			775.3	C08		9	0105-0231	741.47	231.83	261	62.87	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			268.2	C08		9	0106-0236	137.63	236.28	389	72.43	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			178.1	C08		9	0107-0237	777.38	237.02	324	69.01	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			199.3	C08		9	0108-0238	853.32	238.03	340	72.08	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			385.2	C08		9	0109-0238	916.87	238.35	294	65.70	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			786.0	C08		9	0110-0240	623.11	240.28	311	65.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			142.4	C08		9	0111-0243	71.18	243.47	298	66.77	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			359.7	C08		9	0112-0247	451.64	247.20	263	59.36	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			653.4	C08		9	0113-0247	227.38	246.53	271	60.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			475.2	C08		9	0114-0252	290.88	251.22	323	68.08	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			171.7	C08		9	0115-0251	178.20	251.43	263	58.53	0.965
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			10226.1	C08		9	0116-0252	539.18	251.95	102	77.98	0.211
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			172.8	C08		9	0117-0259	21.87	259.08	306	69.01	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			180.6	C08		9	0118-0257	148.94	257.02	237	57.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3406.6	C08		9	0119-0257	338.39	257.67	235	56.53	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2710.0	C08		9	0120-0259	806.27	259.06	291	63.11	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.5	C08		9	0121-0263	711.79	263.00	343	70.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			599.3	C08		9	0122-0264	280.54	265.02	288	64.08	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			280.7	C08		9	0123-0260	430.89	259.94	241	60.53	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			395.9	C08		9	0124-0264	683.93	264.17	260	60.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			260.7	C08		9	0125-0264	875.82	264.11	313	68.18	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			382.3	C08		9	0126-0271	96.00	269.37	542	99.15	0.693
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			465.1	C08		9	0127-0266	851.68	266.28	250	60.18	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			778.2	C08		9	0128-0268	651.45	267.92	241	61.01	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			274.9	C08		9	0129-0269	616.96	268.57	313	66.77	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			172.8	C08		9	0130-0270	215.06	270.05	331	70.18	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			518.0	C08		9	0131-0275	124.19	275.22	276	64.18	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			353.8	C08		9	0132-0276	434.10	275.58	263	61.11	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1034.2	C08		9	0133-0277	320.08	277.26	241	59.36	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			335.0	C08		9	0134-0281	232.65	281.28	261	61.11	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			639.6	C08		9	0135-0284	345.92	284.36	258	59.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			187.8	C08		9	0136-0289	67.16	289.77	297	68.18	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1460.1	C08		9	0137-0288	931.47	288.01	293	65.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			616.2	C08		9	0138-0291	169.84	291.45	302	65.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2823.8	C08		9	0139-0293	132.68	292.15	267	64.53	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			231.0	C08		9	0140-0292	731.38	291.66	311	69.60	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			492.0	C08		9	0141-0299	107.70	299.35	444	81.84	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			254.9	C08		9	0142-0298	434.80	298.10	239	56.53	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			405.2	C08		9	0143-0303	239.39	302.15	539	92.91	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			216.1	C08		9	0144-0300	377.66	300.14	294	64.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			593.1	C08		9	0145-0302	549.83	302.46	337	66.77	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.7	C08		9	0146-0301	764.47	301.35	306	65.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			225.0	C08		9	0147-0309	392.37	309.45	358	77.36	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1005.2	C08		9	0148-0309	347.42	309.38	218	60.28	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			196.3	C08		9	0149-0310	896.98	310.50	288	62.18	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1842.2	C08		9	0150-0311	577.44	310.83	300	63.36	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1034.7	C08		9	0151-0312	216.08	312.50	255	60.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			199.9	C08		9	0152-0314	494.42	314.03	302	69.26	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			637.0	C08		9	0153-0316	284.47	316.16	255	61.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			622.7	C08		9	0154-0318	168.21	318.26	221	53.94	0.954
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			283.7	C08		9	0155-0317	772.86	317.30	215	55.11	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			290.6	C08		9	0156-0326	316.42	327.16	303	68.43	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			172.7	C08		9	0157-0329	100.11	329.05	280	63.01	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			321.1	C08		9	0158-0328	399.84	329.06	255	61.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			258.3	C08		9	0159-0331	473.65	331.97	309	69.94	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			238.6	C08		9	0160-0335	827.11	334.40	269	65.01	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			361.7	C08		9	0161-0334	653.21	334.08	294	63.94	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			970.5	C08		9	0162-0337	158.65	337.24	315	66.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			231.5	C08		9	0163-0339	906.65	338.05	301	66.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			464.3	C08		9	0164-0341	280.12	341.05	159	46.87	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			306.5	C08		9	0165-0346	405.37	345.82	260	64.53	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.0	C08		9	0166-0346	501.49	346.23	253	57.94	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			524.5	C08		9	0167-0349	610.54	349.77	277	61.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			202.0	C08		9	0168-0351	141.79	350.62	239	59.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			505.3	C08		9	0169-0351	658.83	350.93	212	54.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			399.8	C08		9	0170-0350	285.21	350.41	164	53.70	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			265.8	C08		9	0171-0356	820.54	356.82	457	79.50	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.2	C08		9	0172-0356	448.40	356.50	293	63.26	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.4	C08		9	0173-0355	476.70	354.62	261	60.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			258.4	C08		9	0174-0357	577.40	356.95	299	68.77	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			727.4	C08		9	0175-0358	238.80	359.38	238	58.18	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			210.5	C08		9	0176-0357	419.39	357.22	250	59.70	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			486.1	C08		9	0177-0361	555.88	361.12	311	71.01	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			267.7	C08		9	0178-0361	65.88	360.72	247	58.18	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.6	C08		9	0179-0361	19.97	360.70	264	61.11	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			204.5	C08		9	0180-0361	132.83	362.58	260	61.84	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			176.4	C08		9	0181-0364	345.75	364.55	320	67.84	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			5103.6	C08		9	0182-0362	689.31	362.03	220	55.11	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			631.6	C08		9	0183-0365	192.24	365.31	356	69.60	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			838.9	C08		9	0184-0369	298.99	368.75	288	61.36	0.961
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.9	C08		9	0185-0376	361.42	376.48	319	71.11	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			549.2	C08		9	0186-0374	649.12	373.54	234	59.11	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			329.1	C08		9	0187-0380	597.95	380.23	274	64.18	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			356.5	C08		9	0188-0380	707.53	380.45	241	58.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2923.7	C08		9	0189-0381	678.68	381.16	240	57.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			486.5	C08		9	0190-0381	225.76	381.28	250	57.94	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			631.3	C08		9	0191-0383	756.09	383.91	241	59.94	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			296.7	C08		9	0192-0391	779.07	391.01	340	72.67	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			255.4	C08		9	0193-0390	799.10	391.04	245	59.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			299.2	C08		9	0194-0392	89.33	392.36	270	62.18	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.7	C08		9	0195-0391	43.24	392.06	257	60.53	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			568.5	C08		9	0196-0395	609.25	395.53	320	67.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			328.9	C08		9	0197-0393	699.56	393.71	208	55.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			237.6	C08		9	0198-0400	15.94	400.42	270	60.18	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			255.8	C08		9	0199-0400	309.65	400.91	265	59.36	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.0	C08		9	0200-0400	833.98	400.08	295	62.53	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			234.4	C08		9	0201-0407	902.30	406.64	274	62.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			231.5	C08		9	0202-0412	521.72	412.19	305	67.94	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			272.9	C08		9	0203-0408	697.46	408.03	236	57.11	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			279.5	C08		9	0204-0421	330.18	420.87	469	82.57	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			266.8	C08		9	0205-0416	730.08	415.55	217	55.36	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			231.3	C08		9	0206-0421	857.42	421.28	284	64.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			301.7	C08		9	0207-0424	657.84	423.98	250	59.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			403.7	C08		9	0208-0430	96.02	429.79	282	62.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4591.1	C08		9	0209-0430	53.43	430.31	184	59.36	0.656
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			289.4	C08		9	0210-0429	272.80	429.35	252	63.70	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			476.2	C08		9	0211-0436	937.67	435.69	355	72.18	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			333.1	C08		9	0212-0434	404.28	434.71	268	60.53	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2145.0	C08		9	0213-0434	221.85	434.00	235	56.53	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			482.3	C08		9	0214-0437	835.72	437.04	437	77.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			254.7	C08		9	0215-0433	741.32	433.53	271	64.28	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			275.0	C08		9	0216-0441	183.31	440.67	278	63.36	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			799.0	C08		9	0217-0445	118.89	445.84	253	59.94	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			234.6	C08		9	0218-0445	276.34	444.55	334	71.01	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2275.5	C08		9	0219-0446	568.93	446.43	359	69.60	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			291.5	C08		9	0220-0450	509.86	450.39	295	67.26	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			264.1	C08		9	0221-0451	20.54	450.78	221	57.11	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			262.4	C08		9	0222-0451	92.12	451.47	252	58.53	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			245.9	C08		9	0223-0455	199.91	454.64	259	58.87	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			248.5	C08		9	0224-0457	140.99	457.34	266	61.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.1	C08		9	0225-0458	292.70	459.22	301	65.50	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			273.0	C08		9	0226-0464	16.19	464.87	249	61.70	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1841.8	C08		9	0227-0466	246.15	466.00	365	69.84	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			435.5	C08		9	0228-0465	774.80	465.10	224	57.11	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			351.1	C08		9	0229-0473	845.32	474.29	456	80.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			193.4	C08		9	0230-0473	943.11	472.67	290	64.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			249.8	C08		9	0231-0474	586.90	473.65	236	56.77	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			284.4	C08		9	0232-0477	117.41	476.98	231	56.53	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			337.4	C08		9	0233-0479	533.86	479.51	256	61.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			605.9	C08		9	0234-0477	780.99	477.30	204	56.87	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			709.4	C08		9	0235-0486	732.95	485.44	478	90.33	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			264.3	C08		9	0236-0484	35.89	484.22	231	57.36	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			394.6	C08		9	0237-0489	799.12	490.26	263	62.53	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			522.2	C08		9	0238-0492	865.20	491.40	373	74.08	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3535.4	C08		9	0239-0491	170.18	491.71	244	57.70	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			269.1	C08		9	0240-0494	360.13	494.65	280	61.11	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			300.8	C08		9	0241-0496	397.72	496.43	237	57.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			534.7	C08		9	0242-0497	709.02	498.02	186	53.36	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			263.0	C08		9	0243-0501	889.82	500.72	276	63.01	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			578.6	C08		9	0244-0501	745.35	500.87	258	59.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1428.5	C08		9	0245-0509	25.61	509.50	411	76.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.0	C08		9	0246-0506	187.12	506.63	263	64.18	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			472.4	C08		9	0247-0508	630.19	507.52	302	65.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			343.3	C08		9	0248-0509	793.51	508.92	295	66.53	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			354.5	C08		9	0249-0513	765.22	513.46	253	60.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			662.1	C08		9	0250-0515	427.69	515.11	257	60.53	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			247.2	C08		9	0251-0520	600.81	520.37	291	64.43	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.4	C08		9	0252-0521	190.24	520.79	236	61.94	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			234.5	C08		9	0253-0526	312.34	526.57	272	63.26	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			368.0	C08		9	0254-0523	382.37	523.68	259	60.87	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			242.7	C08		9	0255-0532	900.91	532.53	282	61.60	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			240.5	C08		9	0256-0534	743.07	534.31	283	63.60	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			340.8	C08		9	0257-0536	72.15	535.68	229	58.18	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1488.9	C08		9	0258-0536	345.34	536.25	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			397.7	C08		9	0259-0541	115.02	540.89	231	57.11	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			351.1	C08		9	0260-0541	388.16	540.96	250	62.04	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			276.3	C08		9	0261-0544	146.31	544.72	261	59.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1909.5	C08		9	0262-0550	208.62	549.77	372	71.01	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			292.3	C08		9	0263-0549	530.58	548.82	256	59.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			505.4	C08		9	0264-0552	65.45	553.53	305	69.74	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1704.1	C08		9	0265-0551	462.86	551.05	255	61.36	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1347.9	C08		9	0266-0558	187.19	558.95	291	65.11	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1278.7	C08		9	0267-0560	131.96	560.28	266	60.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			327.3	C08		9	0268-0560	300.81	559.95	236	57.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.0	C08		9	0269-0562	939.43	562.66	339	69.60	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			397.1	C08		9	0270-0563	49.26	563.13	288	64.18	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			832.6	C08		9	0271-0564	85.36	565.00	271	66.43	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			559.7	C08		9	0272-0566	339.62	565.46	310	65.36	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			598.2	C08		9	0273-0569	464.96	569.44	300	63.36	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			236.1	C08		9	0274-0575	736.81	575.78	288	64.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.7	C08		9	0275-0577	412.79	577.08	301	67.36	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			255.3	C08		9	0276-0584	694.25	583.79	271	64.53	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			532.0	C08		9	0277-0583	193.20	583.45	294	65.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1206.7	C08		9	0278-0588	385.14	587.73	347	73.36	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			182.8	C08		9	0279-0589	72.04	589.28	271	63.70	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.9	C08		9	0280-0593	212.91	593.17	300	64.53	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			532.9	C08		9	0281-0595	369.24	595.55	270	63.94	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			798.2	C08		9	0282-0597	146.27	597.00	301	64.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.5	C08		9	0283-0600	756.21	600.54	250	60.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			281.4	C08		9	0284-0609	524.75	609.24	263	60.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.7	C08		9	0285-0616	38.28	615.69	283	63.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			205.9	C08		9	0286-0619	933.03	619.84	281	62.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			288.6	C08		9	0287-0622	196.88	622.44	282	62.87	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			216.4	C08		9	0288-0623	881.73	623.66	287	62.77	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			319.9	C08		9	0289-0627	467.98	627.32	335	68.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			321.6	C08		9	0290-0632	89.86	632.14	284	64.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			249.4	C08		9	0291-0637	150.45	637.26	292	63.36	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			266.9	C08		9	0292-0649	202.97	648.00	683	104.33	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			400.6	C08		9	0293-0648	124.90	648.49	260	61.36	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			231.0	C08		9	0294-0651	511.67	651.43	319	67.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			244.5	C08		9	0295-0651	69.79	650.22	248	61.36	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			246.3	C08		9	0296-0650	744.16	649.99	267	60.53	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			675.6	C08		9	0297-0650	263.16	650.76	250	60.53	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			173.3	C08		9	0298-0659	19.67	658.90	268	63.60	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			193.1	C08		9	0299-0665	66.46	665.98	267	64.77	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			387.6	C08		9	0300-0668	184.98	667.40	248	60.77	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			648.6	C08		9	0301-0666	264.82	665.46	286	72.77	0.679
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			263.8	C08		9	0302-0671	207.75	671.46	339	71.94	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1443.6	C08		9	0303-0668	387.01	668.37	303	66.43	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			199.7	C08		9	0304-0669	475.83	669.81	291	64.77	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			226.3	C08		9	0305-0673	781.40	673.09	311	67.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			306.8	C08		9	0306-0675	172.35	675.41	223	57.70	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			832.5	C08		9	0307-0677	111.57	677.69	283	61.36	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.3	C08		9	0308-0683	936.29	683.92	458	86.43	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			712.0	C08		9	0309-0678	251.31	678.44	264	60.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			398.0	C08		9	0310-0684	140.58	684.18	241	63.11	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			262.1	C08		9	0311-0690	321.34	691.53	581	89.74	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			271.5	C08		9	0312-0689	360.96	689.61	257	60.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			364.4	C08		9	0313-0693	31.45	693.71	260	61.70	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			674.9	C08		9	0314-0695	888.76	694.75	257	61.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			255.5	C08		9	0315-0695	57.33	695.07	272	64.18	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			304.3	C08		9	0316-0699	199.59	698.64	226	56.67	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.7	C08		9	0317-0702	750.25	702.11	297	63.60	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			152.6	C08		9	0318-0703	950.13	704.06	183	53.70	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			168.9	C08		9	0319-0704	937.61	703.39	120	41.56	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			362.1	C08		9	0320-0707	214.24	708.02	262	62.18	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			346.4	D08		1	0001-0031	502.05	32.10	433	78.91	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			248.3	D08		1	0002-0035	683.37	35.30	402	74.43	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			201.3	D08		1	0003-0039	168.05	39.26	489	82.67	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			247.4	D08		1	0004-0037	106.24	37.36	378	72.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			349.2	D08		1	0005-0049	326.88	48.58	751	107.30	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			860.6	D08		1	0006-0044	231.54	43.76	386	72.67	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			293.9	D08		1	0007-0053	916.42	53.65	703	101.50	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			306.8	D08		1	0008-0051	573.73	51.36	507	86.18	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			416.1	D08		1	0009-0051	450.99	50.66	464	82.91	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			238.0	D08		1	0010-0054	799.48	53.77	390	77.26	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			287.0	D08		1	0011-0059	633.85	59.36	412	77.50	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			240.7	D08		1	0012-0069	747.78	68.50	777	107.05	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			434.8	D08		1	0013-0069	470.40	69.42	494	89.26	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			316.1	D08		1	0014-0072	394.62	72.16	441	76.43	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			332.7	D08		1	0015-0074	600.83	74.82	443	84.08	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			323.5	D08		1	0016-0076	493.85	76.67	503	87.60	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			277.2	D08		1	0017-0075	232.83	75.37	381	73.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			333.8	D08		1	0018-0075	574.54	74.86	434	79.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			286.8	D08		1	0019-0079	724.21	79.27	424	78.08	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.0	D08		1	0020-0082	109.11	82.07	363	71.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			571.1	D08		1	0021-0086	26.13	85.99	531	87.50	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			325.9	D08		1	0022-0086	935.26	86.56	381	73.50	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			313.6	D08		1	0023-0096	306.50	96.09	417	79.36	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			306.6	D08		1	0024-0106	533.49	106.01	807	108.23	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			288.4	D08		1	0025-0101	285.13	101.97	407	79.01	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			284.5	D08		1	0026-0103	635.68	103.29	852	117.54	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.6	D08		1	0027-0105	186.52	104.86	373	75.26	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			261.7	D08		1	0028-0108	789.69	108.23	359	73.60	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			380.2	D08		1	0029-0112	834.07	111.51	371	73.01	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			290.6	D08		1	0030-0113	391.56	113.78	401	74.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			338.7	D08		1	0031-0115	699.70	115.21	399	75.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			243.4	D08		1	0032-0123	159.83	123.97	830	116.37	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1145.3	D08		1	0033-0117	446.57	117.74	434	79.50	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			306.7	D08		1	0034-0120	612.49	120.72	422	79.15	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			234.3	D08		1	0035-0121	926.26	121.01	392	72.18	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			301.2	D08		1	0036-0123	73.44	123.49	376	71.01	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			483.8	D08		1	0037-0126	735.15	126.18	452	81.26	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2473.3	D08		1	0038-0134	420.57	133.51	950	125.88	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			262.3	D08		1	0039-0128	783.39	127.59	449	85.26	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			397.1	D08		1	0040-0144	506.95	143.84	677	95.50	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			276.6	D08		1	0041-0143	905.12	143.51	392	73.60	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			187.1	D08		1	0042-0142	824.88	142.30	383	75.26	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			295.8	D08		1	0043-0146	297.25	145.43	396	74.08	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			267.1	D08		1	0044-0158	642.35	158.75	393	74.67	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			264.3	D08		1	0045-0159	714.83	158.98	388	76.67	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			316.0	D08		1	0046-0164	277.35	164.21	729	105.05	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			349.0	D08		1	0047-0160	227.30	159.90	390	76.08	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			273.3	D08		1	0048-0166	117.67	165.95	373	72.67	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			254.3	D08		1	0049-0166	578.16	166.33	390	74.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			323.9	D08		1	0050-0180	678.45	180.31	399	78.33	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.8	D08		1	0051-0179	809.52	179.24	398	73.84	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			292.5	D08		1	0052-0180	338.38	179.91	418	81.01	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			560.3	D08		1	0053-0181	167.78	181.14	400	75.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			282.0	D08		1	0054-0182	444.35	182.31	382	73.84	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			310.4	D08		1	0055-0187	316.80	187.46	409	78.77	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			291.8	D08		1	0056-0187	207.94	187.03	397	77.50	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			297.8	D08		1	0057-0194	513.29	194.35	400	73.26	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			184.6	D08		1	0058-0197	940.92	197.02	399	76.43	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			255.2	D08		1	0059-0199	37.04	199.58	382	73.84	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			278.5	D08		1	0060-0209	253.78	208.26	925	123.78	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			170.3	D08		1	0061-0198	887.77	198.92	427	75.84	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			260.4	D08		1	0062-0199	798.35	199.86	390	73.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			263.8	D08		1	0063-0201	719.56	201.34	398	76.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			380.1	D08		1	0064-0206	71.18	205.95	602	90.91	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			237.3	D08		1	0065-0204	764.36	204.33	390	73.26	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1776.8	D08		1	0066-0207	562.41	208.31	379	75.94	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			205.2	D08		1	0067-0213	135.78	212.78	380	75.50	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			244.1	D08		1	0068-0221	927.57	220.99	385	72.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4220.7	D08		1	0069-0227	202.54	226.91	603	97.98	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			254.1	D08		1	0070-0224	615.97	224.41	409	76.67	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1143.8	D08		1	0071-0224	851.76	224.07	404	75.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			296.5	D08		1	0072-0232	271.35	234.30	725	103.78	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			280.2	D08		1	0073-0227	357.51	227.54	399	78.33	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.2	D08		1	0074-0229	482.77	228.83	357	74.18	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2226.0	D08		1	0075-0229	563.89	228.90	504	88.77	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			847.1	D08		1	0076-0238	890.09	239.12	727	104.13	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			282.1	D08		1	0077-0237	506.66	236.92	730	101.50	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			956.0	D08		1	0078-0240	540.09	240.67	552	94.91	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1822.6	D08		1	0079-0236	136.86	236.60	377	74.18	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			535.7	D08		1	0080-0242	58.13	242.18	440	77.84	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			639.5	D08		1	0081-0256	20.39	256.84	381	76.08	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			268.5	D08		1	0082-0258	459.44	258.25	392	73.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			250.5	D08		1	0083-0259	112.01	259.70	374	75.26	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			272.3	D08		1	0084-0271	746.54	271.87	414	75.60	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			472.2	D08		1	0085-0273	854.96	273.67	395	74.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			368.1	D08		1	0086-0279	180.41	278.30	384	73.01	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			291.3	D08		1	0087-0280	697.87	280.13	419	78.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			522.0	D08		1	0088-0281	315.70	280.31	405	76.67	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			251.2	D08		1	0089-0282	813.95	282.55	410	77.26	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			204.2	D08		1	0090-0287	936.07	287.70	382	73.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1377.1	D08		1	0091-0289	296.01	290.63	412	80.67	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			281.5	D08		1	0092-0294	641.46	293.41	420	77.26	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3478.5	D08		1	0093-0299	840.45	299.21	344	68.18	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			290.5	D08		1	0094-0300	899.82	300.36	385	72.43	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			294.1	D08		1	0095-0304	436.31	304.50	925	116.23	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1067.9	D08		1	0096-0303	219.20	302.97	382	71.60	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			296.0	D08		1	0097-0306	109.51	306.11	396	77.26	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2367.9	D08		1	0098-0310	175.48	310.67	613	96.81	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			287.6	D08		1	0099-0305	37.12	304.96	376	74.08	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			454.7	D08		1	0100-0309	549.31	309.07	383	71.60	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			291.0	D08		1	0101-0319	681.97	319.46	401	75.01	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			317.0	D08		1	0102-0319	393.65	319.13	386	73.84	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			188.6	D08		1	0103-0327	934.12	327.39	370	71.26	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			406.8	D08		1	0104-0333	774.77	333.03	392	73.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			272.1	D08		1	0105-0333	582.47	333.28	913	135.05	0.629
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			323.7	D08		1	0106-0336	729.96	335.83	392	73.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			194.2	D08		1	0107-0340	823.92	339.51	324	70.33	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			204.2	D08		1	0108-0344	144.33	344.39	395	74.08	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.6	D08		1	0109-0345	180.49	344.57	405	77.50	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			296.4	D08		1	0110-0347	37.82	347.41	374	73.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			341.1	D08		1	0111-0354	298.60	353.98	743	108.13	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			509.1	D08		1	0112-0351	352.83	351.52	398	74.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			208.7	D08		1	0113-0354	106.35	354.35	382	73.84	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			257.7	D08		1	0114-0357	622.14	357.04	652	97.98	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			256.4	D08		1	0115-0365	201.37	366.55	896	121.98	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			315.2	D08		1	0116-0370	707.79	370.13	433	79.50	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			286.4	D08		1	0117-0373	644.17	373.30	598	93.74	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			462.0	D08		1	0118-0373	567.86	374.36	591	92.18	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1012.0	D08		1	0119-0382	920.26	382.67	916	122.23	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.5	D08		1	0120-0375	771.27	375.83	427	77.50	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			327.5	D08		1	0121-0381	879.09	380.59	377	71.84	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			253.3	D08		1	0122-0383	134.35	382.33	377	72.91	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			308.8	D08		1	0123-0388	404.24	388.60	396	75.26	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			254.3	D08		1	0124-0397	151.05	397.56	433	81.15	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			645.2	D08		1	0125-0400	578.04	398.64	909	124.47	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			273.6	D08		1	0126-0397	686.35	397.94	414	75.84	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			271.8	D08		1	0127-0402	757.16	401.49	427	78.67	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			261.0	D08		1	0128-0407	603.82	407.99	414	77.74	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			265.4	D08		1	0129-0416	320.94	415.48	832	111.64	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			234.8	D08		1	0130-0412	201.41	411.91	398	75.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			295.7	D08		1	0131-0412	876.19	412.31	396	74.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.8	D08		1	0132-0420	769.40	420.86	452	86.91	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			290.3	D08		1	0133-0428	492.31	428.55	399	75.84	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			274.9	D08		1	0134-0433	432.61	433.37	389	73.84	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			312.5	D08		1	0135-0433	655.07	433.40	396	74.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			273.0	D08		1	0136-0446	370.45	445.64	871	123.88	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			192.6	D08		1	0137-0443	99.12	443.74	373	70.43	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			253.7	D08		1	0138-0446	931.58	445.38	330	72.77	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			283.9	D08		1	0139-0446	464.85	446.15	392	73.26	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			207.2	D08		1	0140-0449	914.46	449.53	412	80.18	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			282.1	D08		1	0141-0450	293.65	450.79	391	75.50	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			297.9	D08		1	0142-0453	562.54	453.36	701	99.64	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.3	D08		1	0143-0449	715.45	448.99	390	76.08	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			576.7	D08		1	0144-0454	142.77	454.03	401	77.50	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			216.6	D08		1	0145-0455	946.44	455.06	407	78.08	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			490.0	D08		1	0146-0465	186.09	465.22	378	73.50	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.5	D08		1	0147-0473	48.87	472.73	757	108.81	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			218.6	D08		1	0148-0468	763.11	467.65	373	73.26	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			333.5	D08		1	0149-0479	695.70	479.85	998	122.81	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.9	D08		1	0150-0476	640.27	476.07	384	73.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			204.3	D08		1	0151-0480	336.26	480.21	402	76.77	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			250.9	D08		1	0152-0483	393.22	482.93	564	89.98	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.1	D08		1	0153-0480	849.69	480.79	391	74.77	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			272.6	D08		1	0154-0484	443.37	484.11	426	77.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			268.5	D08		1	0155-0484	213.28	483.94	379	71.60	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.6	D08		1	0156-0487	770.70	487.97	410	79.15	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			254.4	D08		1	0157-0490	533.71	490.14	403	78.08	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			264.7	D08		1	0158-0489	573.51	488.99	384	74.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.7	D08		1	0159-0488	313.19	488.37	428	79.60	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			187.9	D08		1	0160-0497	87.71	497.66	366	71.84	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			247.5	D08		1	0161-0499	866.23	499.79	410	78.08	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			207.5	D08		1	0162-0499	922.02	498.94	359	69.60	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			162.0	D08		1	0163-0506	45.32	507.06	382	78.91	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			248.1	D08		1	0164-0508	817.58	507.77	374	72.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			175.8	D08		1	0165-0509	17.93	509.60	362	72.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2463.9	D08		1	0166-0510	188.53	509.87	383	71.84	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			422.3	D08		1	0167-0512	606.62	511.74	393	76.08	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			273.2	D08		1	0168-0513	745.60	513.60	376	73.01	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			329.3	D08		1	0169-0513	487.28	512.82	395	76.08	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			191.8	D08		1	0170-0517	895.51	516.63	393	75.50	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			201.6	D08		1	0171-0521	326.02	521.07	373	71.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			202.9	D08		1	0172-0523	118.03	523.23	386	72.18	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			265.7	D08		1	0173-0525	289.17	524.87	410	76.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			242.2	D08		1	0174-0525	420.66	525.54	395	76.08	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			246.3	D08		1	0175-0528	648.78	528.16	396	74.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			189.9	D08		1	0176-0530	163.13	530.49	391	74.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			342.1	D08		1	0177-0530	771.34	530.25	390	73.01	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			216.5	D08		1	0178-0533	199.57	533.05	381	73.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			207.3	D08		1	0179-0540	385.59	540.73	417	78.91	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.4	D08		1	0180-0539	543.36	539.82	398	75.84	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			172.1	D08		1	0181-0547	897.72	547.42	433	85.40	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.1	D08		1	0182-0544	40.20	544.43	338	70.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			750.8	D08		1	0183-0548	473.27	547.35	620	101.40	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			338.4	D08		1	0184-0562	275.66	562.66	620	92.91	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			262.0	D08		1	0185-0571	557.83	571.47	817	113.78	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			287.8	D08		1	0186-0565	658.42	565.82	393	73.84	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			259.4	D08		1	0187-0570	94.36	570.37	340	68.18	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			254.7	D08		1	0188-0570	756.96	569.72	404	76.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			165.6	D08		1	0189-0573	890.54	574.05	415	78.43	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			321.9	D08		1	0190-0575	718.87	575.35	418	79.15	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			231.0	D08		1	0191-0584	443.06	584.72	994	128.02	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			199.9	D08		1	0192-0581	202.82	581.40	407	77.84	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			230.8	D08		1	0193-0584	360.11	584.44	373	73.26	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			264.1	D08		1	0194-0585	610.58	584.79	382	73.26	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			196.9	D08		1	0195-0583	861.48	583.27	393	78.33	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			211.9	D08		1	0196-0591	809.80	591.24	406	78.91	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			161.4	D08		1	0197-0602	194.05	601.73	235	60.77	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			191.2	D08		1	0198-0606	401.04	605.93	421	77.26	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			166.8	D08		1	0199-0607	249.23	606.40	392	78.67	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			236.9	D08		1	0200-0607	715.39	607.94	388	76.67	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			179.4	D08		1	0201-0609	886.12	609.68	379	75.84	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			256.2	D08		1	0202-0613	662.08	613.08	400	74.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.1	D08		1	0203-0613	81.87	613.13	432	82.81	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.9	D08		1	0204-0619	359.78	619.40	408	77.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			253.9	D08		1	0205-0623	500.22	622.62	416	77.50	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			238.0	D08		1	0206-0632	54.26	631.53	380	72.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			208.9	D08		1	0207-0634	156.18	634.61	438	77.84	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			266.8	D08		1	0208-0632	314.53	632.31	371	75.60	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			252.2	D08		1	0209-0635	337.73	634.71	468	90.18	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			189.2	D08		1	0210-0639	845.81	638.80	759	104.33	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.7	D08		1	0211-0637	182.83	636.98	452	85.40	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			250.5	D08		1	0212-0638	479.84	638.61	466	84.91	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.9	D08		1	0213-0643	360.80	643.00	528	91.84	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.5	D08		1	0214-0643	403.72	643.53	391	72.43	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			211.5	D08		1	0215-0644	797.68	644.62	380	74.43	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			299.9	D08		1	0216-0648	23.17	647.57	369	76.18	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			260.3	D08		1	0217-0653	447.13	653.51	845	118.02	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			172.2	D08		1	0218-0650	266.50	650.23	286	67.60	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			336.8	D08		1	0219-0650	606.93	650.53	444	79.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			196.7	D08		1	0220-0654	76.29	654.09	364	70.43	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.3	D08		1	0221-0657	213.13	657.27	388	76.08	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			266.7	D08		1	0222-0660	914.73	660.25	368	72.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.6	D08		1	0223-0665	714.94	664.98	405	77.01	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			202.5	D08		1	0224-0666	743.38	666.07	459	82.91	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.4	D08		1	0225-0666	648.30	666.58	374	70.43	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			656.7	D08		1	0226-0675	326.89	674.93	673	97.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			216.0	D08		1	0227-0680	772.33	679.99	356	70.43	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.8	D08		1	0228-0688	812.57	689.08	726	108.43	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			201.8	D08		1	0229-0686	489.12	685.84	367	75.74	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			342.9	D08		1	0230-0687	143.02	687.83	440	78.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			211.5	D08		1	0231-0690	871.85	690.33	358	72.43	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			252.8	D08		1	0232-0690	191.96	690.27	398	77.50	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			199.3	D08		1	0233-0696	352.59	695.18	460	83.50	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			251.6	D08		1	0234-0700	530.30	700.74	818	111.88	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			188.6	D08		1	0235-0700	579.33	700.33	362	73.50	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.7	D08		1	0236-0705	67.56	705.01	383	74.08	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			270.0	D08		3	0001-0032	610.87	32.70	388	77.15	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.8	D08		3	0002-0038	761.28	37.99	356	70.43	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			255.9	D08		3	0003-0042	860.23	42.15	366	72.18	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.9	D08		3	0004-0041	227.10	41.65	345	72.67	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			290.6	D08		3	0005-0043	410.65	43.52	431	78.67	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			311.2	D08		3	0006-0044	45.88	44.22	373	79.60	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			234.5	D08		3	0007-0047	258.54	47.53	359	75.98	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			257.6	D08		3	0008-0045	550.76	44.87	362	72.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			231.9	D08		3	0009-0049	839.59	49.01	381	77.50	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			323.9	D08		3	0010-0051	694.22	51.36	349	70.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			199.7	D08		3	0011-0053	23.37	52.47	350	73.01	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			248.9	D08		3	0012-0055	131.62	55.52	364	76.67	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			472.5	D08		3	0013-0058	54.92	58.96	377	80.43	0.732
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			315.4	D08		3	0014-0064	74.21	63.65	384	77.26	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			542.3	D08		3	0015-0063	927.38	63.53	352	71.26	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			255.7	D08		3	0016-0065	350.14	65.53	386	73.84	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1309.1	D08		3	0017-0069	250.38	69.79	363	77.26	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.7	D08		3	0018-0067	904.78	67.76	366	72.33	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			440.6	D08		3	0019-0072	180.20	72.28	368	75.74	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1482.6	D08		3	0020-0072	231.46	72.41	371	74.87	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			207.8	D08		3	0021-0073	787.16	73.24	361	74.08	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			580.9	D08		3	0022-0080	733.46	80.24	325	113.64	0.316
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.7	D08		3	0023-0086	89.85	85.99	341	71.84	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			873.6	D08		3	0024-0091	165.10	92.46	712	105.40	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			237.0	D08		3	0025-0088	659.30	87.84	389	77.50	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			259.9	D08		3	0026-0087	685.00	87.49	373	74.33	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			551.8	D08		3	0027-0089	473.46	89.44	376	74.91	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			296.1	D08		3	0028-0091	502.43	91.20	384	76.91	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.4	D08		3	0029-0090	753.67	90.95	380	74.08	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			269.5	D08		3	0030-0093	429.24	93.02	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			442.0	D08		3	0031-0093	230.83	92.37	369	72.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			290.5	D08		3	0032-0097	546.64	97.18	360	72.67	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			250.1	D08		3	0033-0098	833.39	98.43	356	70.18	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			255.0	D08		3	0034-0105	125.31	106.25	731	109.54	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			282.7	D08		3	0035-0102	376.54	102.10	373	73.84	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			401.9	D08		3	0036-0106	904.74	106.07	302	66.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			316.7	D08		3	0037-0110	488.71	110.65	412	86.57	0.691
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			243.1	D08		3	0038-0113	641.59	113.02	367	75.84	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			274.7	D08		3	0039-0114	312.85	115.19	368	72.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.6	D08		3	0040-0116	69.56	116.39	359	76.33	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.2	D08		3	0041-0123	31.77	123.36	329	69.01	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			543.7	D08		3	0042-0121	723.76	121.05	350	73.84	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			293.2	D08		3	0043-0132	913.74	132.69	582	92.81	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			294.4	D08		3	0044-0129	456.50	128.80	387	75.50	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			236.8	D08		3	0045-0131	273.44	130.78	321	67.94	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			263.6	D08		3	0046-0132	293.91	132.21	440	84.67	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			245.8	D08		3	0047-0136	627.21	136.50	365	74.33	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			286.3	D08		3	0048-0138	384.28	138.48	386	75.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			272.0	D08		3	0049-0139	491.76	139.37	370	75.26	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			230.7	D08		3	0050-0142	83.52	141.45	354	71.01	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			275.8	D08		3	0051-0142	173.87	142.35	347	72.08	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			257.2	D08		3	0052-0141	810.52	140.67	331	69.84	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			383.5	D08		3	0053-0148	544.92	147.95	411	76.91	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			545.1	D08		3	0054-0150	859.07	149.48	299	66.18	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			269.9	D08		3	0055-0153	243.01	153.61	398	76.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.3	D08		3	0056-0154	761.70	154.94	330	68.28	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			245.7	D08		3	0057-0158	219.30	157.52	385	77.50	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			273.6	D08		3	0058-0163	139.16	162.74	404	77.26	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			627.3	D08		3	0059-0165	43.97	164.94	345	69.84	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			307.6	D08		3	0060-0169	414.27	168.40	409	78.91	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			306.7	D08		3	0061-0166	592.25	165.95	388	77.50	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			338.4	D08		3	0062-0171	912.62	171.55	375	73.50	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			315.6	D08		3	0063-0179	646.07	177.21	720	110.61	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			700.9	D08		3	0064-0173	850.67	172.97	350	69.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			326.0	D08		3	0065-0181	434.16	179.91	762	118.51	0.682
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			301.9	D08		3	0066-0175	759.81	175.04	560	90.18	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			273.3	D08		3	0067-0178	879.52	178.93	356	73.01	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			269.7	D08		3	0068-0178	341.98	177.70	347	70.43	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			254.1	D08		3	0069-0196	97.38	195.27	747	118.95	0.663
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			294.5	D08		3	0070-0195	488.00	194.77	353	72.67	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3141.8	D08		3	0071-0195	523.35	194.58	307	65.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			265.8	D08		3	0072-0197	687.05	197.04	347	73.26	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			496.3	D08		3	0073-0198	557.78	198.27	394	76.18	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			267.7	D08		3	0074-0202	742.04	202.12	370	73.26	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			264.6	D08		3	0075-0205	147.56	205.28	333	70.43	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			281.2	D08		3	0076-0206	387.38	207.07	366	76.33	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			280.5	D08		3	0077-0207	296.40	206.55	341	72.91	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			250.6	D08		3	0078-0210	650.95	210.77	392	76.43	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			302.4	D08		3	0079-0213	252.24	212.90	344	70.67	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			260.8	D08		3	0080-0212	787.19	212.30	356	70.18	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.1	D08		3	0081-0215	82.89	215.35	335	72.43	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			262.5	D08		3	0082-0215	903.13	215.44	324	71.26	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			280.9	D08		3	0083-0214	361.40	214.09	349	74.57	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			267.4	D08		3	0084-0220	196.70	219.96	359	72.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			250.2	D08		3	0085-0221	607.95	221.25	364	73.36	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			481.5	D08		3	0086-0224	414.68	224.53	323	67.01	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			330.2	D08		3	0087-0234	477.37	234.22	752	114.95	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.2	D08		3	0088-0233	941.28	233.09	368	71.01	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			257.9	D08		3	0089-0234	649.87	234.42	381	79.50	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			236.1	D08		3	0090-0235	41.27	235.00	329	71.74	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			583.9	D08		3	0091-0238	109.05	238.19	359	74.91	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.0	D08		3	0092-0244	607.29	243.39	370	77.36	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			264.1	D08		3	0093-0246	299.57	245.76	362	86.81	0.604
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			260.9	D08		3	0094-0245	164.28	245.60	361	72.43	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			274.1	D08		3	0095-0246	673.03	245.73	328	69.70	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			274.1	D08		3	0096-0247	762.15	246.68	347	68.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			307.7	D08		3	0097-0248	868.88	248.01	373	73.26	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			290.8	D08		3	0098-0249	373.11	248.75	358	76.33	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			291.8	D08		3	0099-0249	552.28	249.29	371	75.74	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			270.2	D08		3	0100-0251	693.24	251.37	374	76.18	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			399.3	D08		3	0101-0252	811.85	252.49	441	81.84	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1151.4	D08		3	0102-0258	249.65	258.22	341	71.84	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			249.2	D08		3	0103-0259	944.24	258.82	301	67.60	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			366.0	D08		3	0104-0265	587.53	265.22	377	73.26	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			263.5	D08		3	0105-0267	341.59	266.56	373	74.67	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			277.1	D08		3	0106-0268	312.72	268.76	348	77.50	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			197.3	D08		3	0107-0267	24.76	267.70	326	69.84	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			311.5	D08		3	0108-0283	649.13	284.09	965	130.61	0.711
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			268.2	D08		3	0109-0273	627.87	274.18	281	66.28	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			267.3	D08		3	0110-0277	156.82	276.89	359	72.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1182.7	D08		3	0111-0276	609.90	276.26	304	65.11	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			237.6	D08		3	0112-0282	79.15	282.69	371	75.50	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6822.8	D08		3	0113-0280	897.30	280.57	260	86.23	0.439
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			286.0	D08		3	0114-0281	410.64	281.07	378	75.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			609.0	D08		3	0115-0283	207.48	282.75	296	63.60	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			262.2	D08		3	0116-0280	688.08	279.99	198	53.60	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			226.5	D08		3	0117-0285	118.58	285.09	470	87.50	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			252.5	D08		3	0118-0288	850.70	288.52	361	72.08	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1729.4	D08		3	0119-0290	251.86	290.01	326	69.26	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			280.5	D08		3	0120-0295	573.61	295.23	352	70.67	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			387.4	D08		3	0121-0308	528.74	309.81	752	114.71	0.718
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.9	D08		3	0122-0303	354.73	302.37	387	81.74	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			261.4	D08		3	0123-0314	395.21	313.95	362	76.57	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			277.4	D08		3	0124-0313	466.54	313.88	394	77.50	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.6	D08		3	0125-0313	915.48	313.75	355	73.84	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			177.3	D08		3	0126-0316	28.55	315.24	376	77.98	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3538.2	D08		3	0127-0317	283.02	317.11	315	65.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			194.1	D08		3	0128-0319	102.04	319.05	333	71.01	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			267.8	D08		3	0129-0328	423.72	328.52	377	75.50	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.6	D08		3	0130-0330	854.33	329.72	363	74.91	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			731.1	D08		3	0131-0330	592.86	329.42	402	81.84	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			322.9	D08		3	0132-0332	142.97	332.76	382	76.08	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1007.7	D08		3	0133-0336	321.90	335.75	386	81.98	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			293.4	D08		3	0134-0338	833.06	338.06	514	88.67	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			304.0	D08		3	0135-0338	236.53	338.87	364	74.91	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			257.1	D08		3	0136-0339	675.27	339.86	348	71.84	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			278.9	D08		3	0137-0341	539.42	341.78	376	73.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			188.1	D08		3	0138-0342	45.16	342.09	343	72.67	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.9	D08		3	0139-0341	360.98	341.59	365	71.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			276.2	D08		3	0140-0342	741.96	343.01	367	72.43	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			302.0	D08		3	0141-0343	814.07	343.20	311	71.01	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.6	D08		3	0142-0352	180.69	352.91	376	80.91	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			238.5	D08		3	0143-0351	911.96	351.27	378	74.91	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			667.4	D08		3	0144-0354	313.52	354.52	377	78.33	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			210.6	D08		3	0145-0355	79.89	355.22	324	72.57	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			347.0	D08		3	0146-0364	113.88	364.88	334	72.91	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			226.7	D08		3	0147-0368	472.96	368.59	712	106.57	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			285.5	D08		3	0148-0373	521.62	372.76	374	76.33	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.0	D08		3	0149-0376	665.34	376.52	366	74.91	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			212.2	D08		3	0150-0376	394.46	376.46	359	71.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			433.8	D08		3	0151-0374	711.16	374.31	395	76.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			489.5	D08		3	0152-0378	147.07	378.11	334	78.57	0.680
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			225.4	D08		3	0153-0378	329.62	377.69	360	78.33	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.6	D08		3	0154-0382	866.90	381.25	375	76.91	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			273.7	D08		3	0155-0381	32.21	381.87	321	68.43	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.4	D08		3	0156-0381	919.31	381.04	350	70.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.7	D08		3	0157-0384	258.75	383.93	340	71.26	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			208.0	D08		3	0158-0388	195.57	388.17	350	74.33	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1431.8	D08		3	0159-0387	732.51	386.63	311	66.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			258.9	D08		3	0160-0389	547.02	389.11	374	74.91	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			207.0	D08		3	0161-0395	231.76	395.64	345	74.91	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			208.7	D08		3	0162-0395	819.43	395.72	362	71.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1025.5	D08		3	0163-0396	119.41	396.33	326	69.26	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			313.0	D08		3	0164-0398	477.43	398.21	310	64.77	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			267.7	D08		3	0165-0399	751.44	398.79	398	77.74	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			240.1	D08		3	0166-0402	304.30	401.92	380	73.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.0	D08		3	0167-0410	371.75	410.15	720	105.88	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			263.8	D08		3	0168-0403	438.20	403.57	370	74.08	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			275.3	D08		3	0169-0421	593.76	420.87	363	78.91	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.1	D08		3	0170-0421	718.80	421.57	380	77.15	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			201.3	D08		3	0171-0423	774.90	423.59	361	75.84	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			153.3	D08		3	0172-0428	33.62	428.69	325	72.91	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.3	D08		3	0173-0431	269.61	431.74	353	76.91	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			458.2	D08		3	0174-0431	528.13	432.17	372	77.94	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			293.0	D08		3	0175-0436	693.67	436.44	627	99.64	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			202.6	D08		3	0176-0447	421.89	446.54	748	106.95	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			250.9	D08		3	0177-0440	641.30	440.64	368	74.57	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			865.2	D08		3	0178-0446	162.63	445.35	712	105.88	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			431.5	D08		3	0179-0443	218.47	442.01	246	66.18	0.706
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			383.6	D08		3	0180-0444	231.04	446.37	219	63.70	0.678
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			182.9	D08		3	0181-0448	196.51	448.67	338	72.43	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			200.5	D08		3	0182-0447	315.10	447.79	367	74.91	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.2	D08		3	0183-0452	248.41	451.51	349	71.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			348.8	D08		3	0184-0455	527.89	453.68	409	81.84	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			323.0	D08		3	0185-0461	105.25	461.70	375	81.15	0.716
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			205.5	D08		3	0186-0463	71.14	463.23	353	73.26	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			212.6	D08		3	0187-0465	761.22	465.32	369	71.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			236.5	D08		3	0188-0473	624.44	473.31	375	72.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			236.3	D08		3	0189-0476	471.95	476.54	334	72.91	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.5	D08		3	0190-0475	851.66	474.90	353	71.01	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			806.9	D08		3	0191-0476	125.82	475.90	352	77.98	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			205.4	D08		3	0192-0482	929.08	482.82	380	78.33	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			187.5	D08		3	0193-0481	238.90	481.00	375	78.57	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			237.4	D08		3	0194-0484	565.52	484.47	368	73.26	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			243.1	D08		3	0195-0488	798.10	488.09	378	76.43	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.8	D08		3	0196-0490	720.05	490.02	371	72.67	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			204.6	D08		3	0197-0495	687.56	495.55	364	71.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			236.7	D08		3	0198-0502	601.36	502.21	361	73.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			216.1	D08		3	0199-0504	491.17	503.98	359	76.08	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.8	D08		3	0200-0507	230.55	507.90	370	78.33	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.0	D08		3	0201-0504	441.48	503.77	353	71.26	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.4	D08		3	0202-0506	356.38	506.34	353	72.43	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			630.8	D08		3	0203-0506	76.00	505.92	340	70.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			210.1	D08		3	0204-0510	806.46	509.69	392	81.40	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			202.1	D08		3	0205-0523	274.92	522.77	728	119.78	0.638
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			595.3	D08		3	0206-0520	851.06	520.43	723	112.13	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			190.2	D08		3	0207-0523	183.08	523.49	582	96.81	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			210.6	D08		3	0208-0520	757.32	519.80	372	73.60	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.2	D08		3	0209-0522	314.99	522.71	377	72.67	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.3	D08		3	0210-0522	481.03	522.56	359	72.67	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			218.0	D08		3	0211-0527	637.44	527.40	373	76.33	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			275.5	D08		3	0212-0525	673.36	524.83	333	68.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			197.6	D08		3	0213-0538	359.97	537.89	341	72.91	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.3	D08		3	0214-0537	580.54	536.99	352	72.67	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			190.1	D08		3	0215-0541	941.09	541.53	352	74.57	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			199.8	D08		3	0216-0542	537.15	541.76	363	72.67	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			182.9	D08		3	0217-0557	213.58	557.20	748	119.92	0.654
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.4	D08		3	0218-0553	484.31	553.43	396	77.26	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			231.8	D08		3	0219-0554	506.06	554.20	357	72.53	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			446.0	D08		3	0220-0556	736.72	556.00	352	72.91	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			238.8	D08		3	0221-0560	682.76	559.13	385	76.67	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			328.2	D08		3	0222-0561	74.33	561.65	327	68.67	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			254.5	D08		3	0223-0565	910.29	565.48	745	106.57	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1103.9	D08		3	0224-0565	782.87	565.60	625	96.57	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			222.7	D08		3	0225-0567	301.69	568.06	352	79.74	0.696
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.7	D08		3	0226-0569	343.30	569.80	330	68.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			259.0	D08		3	0227-0571	427.05	571.92	349	71.84	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			257.0	D08		3	0228-0587	52.37	586.47	695	104.57	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			225.9	D08		3	0229-0589	257.48	589.00	357	73.60	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			177.9	D08		3	0230-0588	216.44	588.13	373	76.08	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.8	D08		3	0231-0588	675.96	588.21	372	74.08	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.9	D08		3	0232-0589	132.62	588.97	371	74.91	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1387.5	D08		3	0233-0596	504.56	596.61	816	112.13	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			234.4	D08		3	0234-0590	747.04	590.11	349	71.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			248.7	D08		3	0235-0598	541.23	597.72	647	103.40	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			237.2	D08		3	0236-0596	632.60	596.40	377	78.57	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			242.1	D08		3	0237-0603	585.14	603.71	378	75.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4864.8	D08		3	0238-0600	373.07	600.30	254	59.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.6	D08		3	0239-0603	923.84	602.96	310	66.43	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			287.9	D08		3	0240-0604	114.56	604.19	360	79.15	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			379.9	D08		3	0241-0621	767.20	622.36	953	139.78	0.613
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.9	D08		3	0242-0608	873.87	607.69	343	75.15	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.4	D08		3	0243-0619	887.26	619.02	411	81.15	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.6	D08		3	0244-0617	824.32	617.02	347	70.67	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			225.2	D08		3	0245-0621	358.11	621.50	605	95.40	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			207.1	D08		3	0246-0620	736.77	620.01	369	81.98	0.690
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4639.3	D08		3	0247-0619	389.04	619.47	348	72.08	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			377.1	D08		3	0248-0626	210.28	626.97	308	71.36	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			282.4	D08		3	0249-0631	692.35	631.02	357	79.98	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			430.5	D08		3	0250-0632	846.96	632.32	249	57.36	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			244.9	D08		3	0251-0636	620.94	636.44	368	73.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			253.6	D08		3	0252-0638	328.05	638.02	417	85.15	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.8	D08		3	0253-0642	35.07	642.13	314	71.01	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			198.5	D08		3	0254-0643	168.48	643.62	337	71.50	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			310.9	D08		3	0255-0645	212.27	643.20	363	77.60	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.6	D08		3	0256-0650	129.25	650.17	437	81.74	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4989.9	D08		3	0257-0649	798.87	649.68	206	73.50	0.479
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			218.1	D08		3	0258-0654	92.12	653.99	352	70.67	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			362.3	D08		3	0259-0653	558.56	653.05	375	73.84	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			335.6	D08		3	0260-0653	675.92	653.29	342	73.84	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			319.6	D08		3	0261-0659	342.21	659.10	369	83.98	0.657
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			529.6	D08		3	0262-0660	203.39	661.36	396	79.98	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.3	D08		3	0263-0663	904.83	662.51	330	69.26	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.7	D08		3	0264-0667	947.34	667.52	341	73.84	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			412.7	D08		3	0265-0669	683.59	669.86	372	78.43	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.0	D08		3	0266-0674	610.07	674.02	369	74.91	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			268.5	D08		3	0267-0672	488.26	672.92	362	72.67	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2398.4	D08		3	0268-0675	720.71	675.02	357	74.67	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			274.7	D08		3	0269-0685	89.67	685.35	313	65.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			184.9	D08		3	0270-0684	138.76	684.98	315	66.43	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			852.2	D08		3	0271-0688	179.16	688.67	338	71.50	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.3	D08		3	0272-0690	896.32	690.52	318	72.33	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.5	D08		3	0273-0700	25.13	699.98	615	97.40	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			247.9	D08		3	0274-0697	699.75	697.18	375	76.08	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			972.3	D08		3	0275-0693	363.48	693.79	196	72.77	0.465
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			222.3	D08		3	0276-0707	831.30	707.12	348	71.70	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			210.8	D08		4	0001-0039	733.93	39.86	628	95.74	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.2	D08		4	0002-0049	816.27	48.21	984	128.23	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			222.8	D08		4	0003-0047	340.50	45.67	547	92.47	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			205.1	D08		4	0004-0045	603.98	44.77	467	82.91	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.4	D08		4	0005-0048	902.79	48.58	451	79.50	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			581.3	D08		4	0006-0049	366.86	49.04	475	82.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			160.9	D08		4	0007-0053	759.08	52.52	483	88.67	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			269.4	D08		4	0008-0055	249.77	55.49	442	78.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			198.0	D08		4	0009-0056	945.82	56.49	406	75.26	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			264.0	D08		4	0010-0056	99.02	56.17	435	83.50	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.1	D08		4	0011-0061	322.34	62.53	456	81.98	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			276.7	D08		4	0012-0064	75.47	64.64	501	87.94	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			225.8	D08		4	0013-0066	620.14	67.05	499	85.98	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			310.5	D08		4	0014-0071	446.82	70.23	938	125.44	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			207.4	D08		4	0015-0073	669.51	73.09	432	76.43	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			205.8	D08		4	0016-0077	835.66	77.03	516	88.71	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			266.8	D08		4	0017-0077	744.64	78.29	438	80.43	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.3	D08		4	0018-0080	545.97	80.59	922	121.30	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.7	D08		4	0019-0086	80.39	85.76	433	82.08	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			295.7	D08		4	0020-0090	179.51	90.53	727	103.64	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.2	D08		4	0021-0096	849.52	96.88	428	81.15	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			268.0	D08		4	0022-0097	118.83	97.58	763	103.40	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.4	D08		4	0023-0100	519.10	99.71	481	85.74	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			234.4	D08		4	0024-0100	348.91	100.90	383	75.50	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			188.4	D08		4	0025-0102	889.05	102.48	431	77.26	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			249.5	D08		4	0026-0105	706.22	105.50	424	76.67	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			266.6	D08		4	0027-0114	78.30	115.10	429	85.26	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			305.5	D08		4	0028-0113	624.49	113.53	484	84.33	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			193.0	D08		4	0029-0115	801.67	114.62	416	77.50	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			273.3	D08		4	0030-0116	387.80	116.12	561	90.08	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			208.5	D08		4	0031-0123	266.03	123.08	434	78.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			192.1	D08		4	0032-0124	770.35	123.97	438	80.91	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			240.0	D08		4	0033-0124	676.92	124.50	422	76.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			230.1	D08		4	0034-0142	319.72	142.15	433	79.74	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.9	D08		4	0035-0148	217.28	148.11	423	76.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			211.9	D08		4	0036-0153	718.54	153.51	431	82.77	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.1	D08		4	0037-0159	843.33	158.44	853	112.71	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.2	D08		4	0038-0158	145.77	159.32	864	116.23	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			293.5	D08		4	0039-0168	270.56	168.62	924	119.88	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			308.8	D08		4	0040-0168	358.99	168.27	488	84.33	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			207.1	D08		4	0041-0166	664.94	166.66	434	79.50	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			275.4	D08		4	0042-0172	406.55	172.28	479	82.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			203.8	D08		4	0043-0173	716.05	172.21	435	79.11	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.6	D08		4	0044-0175	24.26	175.99	395	75.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			236.0	D08		4	0045-0180	572.58	180.40	513	88.91	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			247.8	D08		4	0046-0181	609.93	180.72	439	78.08	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			262.9	D08		4	0047-0184	543.08	183.36	499	87.40	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			177.0	D08		4	0048-0185	883.86	185.73	451	79.26	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			354.6	D08		4	0049-0195	792.79	195.10	446	78.91	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			361.9	D08		4	0050-0195	215.19	194.82	391	71.60	0.958
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			593.8	D08		4	0051-0196	183.93	196.02	391	72.18	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			389.9	D08		4	0052-0198	266.48	198.05	625	94.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			186.9	D08		4	0053-0197	858.04	196.41	430	79.50	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.2	D08		4	0054-0201	452.45	201.56	438	79.50	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			247.2	D08		4	0055-0201	145.36	200.44	437	79.26	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			168.1	D08		4	0056-0202	916.56	202.45	431	77.26	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			248.8	D08		4	0057-0213	537.22	213.14	511	91.40	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.2	D08		4	0058-0212	735.76	212.22	435	81.50	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			262.3	D08		4	0059-0225	336.76	224.68	832	114.81	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			313.9	D08		4	0060-0227	206.08	226.23	399	79.15	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.5	D08		4	0061-0226	418.21	226.03	428	79.50	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			734.4	D08		4	0062-0227	890.19	227.21	818	116.67	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			240.2	D08		4	0063-0245	648.73	245.57	889	123.05	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			289.4	D08		4	0064-0239	554.99	239.38	488	86.33	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			259.2	D08		4	0065-0248	196.20	249.17	476	90.81	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			251.5	D08		4	0066-0249	602.93	249.45	434	78.33	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			185.7	D08		4	0067-0255	723.00	255.13	440	78.67	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			226.5	D08		4	0068-0258	391.21	258.14	441	77.26	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			184.8	D08		4	0069-0263	692.44	264.22	439	79.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.8	D08		4	0070-0268	225.86	267.89	430	78.91	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			236.9	D08		4	0071-0267	259.01	267.57	426	79.50	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			290.4	D08		4	0072-0273	54.20	273.66	414	80.33	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			284.0	D08		4	0073-0275	426.18	274.91	483	83.50	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			285.2	D08		4	0074-0282	565.08	282.42	965	129.78	0.720
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.0	D08		4	0075-0274	917.38	275.01	446	79.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			524.9	D08		4	0076-0276	842.17	276.79	446	82.91	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			193.4	D08		4	0077-0286	325.72	285.68	477	84.91	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.0	D08		4	0078-0291	690.26	290.59	484	87.01	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			312.4	D08		4	0079-0289	163.66	288.76	423	75.26	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			396.0	D08		4	0080-0295	69.01	296.21	555	93.01	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			230.1	D08		4	0081-0298	631.28	298.98	823	111.30	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			319.1	D08		4	0082-0297	92.75	297.45	410	76.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			544.5	D08		4	0083-0298	486.50	297.74	444	79.50	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			191.5	D08		4	0084-0296	730.71	296.02	421	77.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			250.3	D08		4	0085-0309	336.67	309.13	741	102.91	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			216.7	D08		4	0086-0310	792.80	310.62	440	79.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			237.5	D08		4	0087-0314	583.95	314.44	503	91.84	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			202.2	D08		4	0088-0319	915.92	319.07	927	119.20	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			262.0	D08		4	0089-0323	526.57	322.61	442	78.08	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			254.4	D08		4	0090-0329	369.87	328.39	447	80.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			271.7	D08		4	0091-0333	741.86	333.44	431	77.26	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.0	D08		4	0092-0335	405.26	335.05	449	79.50	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			276.7	D08		4	0093-0338	442.23	337.84	665	97.64	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			313.0	D08		4	0094-0339	696.49	338.86	459	81.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			246.8	D08		4	0095-0341	573.65	341.09	457	84.91	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			248.8	D08		4	0096-0341	279.50	340.56	475	82.91	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			256.6	D08		4	0097-0345	217.15	344.72	442	78.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.0	D08		4	0098-0350	353.90	350.58	483	87.74	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.7	D08		4	0099-0350	829.44	351.06	433	78.33	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			212.4	D08		4	0100-0357	882.34	358.36	885	117.54	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			242.2	D08		4	0101-0353	512.95	353.82	454	80.08	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			248.1	D08		4	0102-0357	263.78	357.96	479	86.23	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			259.9	D08		4	0103-0361	645.71	361.63	519	88.67	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			330.2	D08		4	0104-0364	616.45	364.48	490	86.57	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			341.0	D08		4	0105-0365	788.10	365.64	480	81.84	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			225.9	D08		4	0106-0369	420.08	369.56	434	79.26	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			589.2	D08		4	0107-0378	935.44	378.34	450	80.67	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1241.9	D08		4	0108-0378	149.62	378.56	429	75.84	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			274.4	D08		4	0109-0384	640.88	384.35	489	87.60	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			272.5	D08		4	0110-0384	307.53	384.07	449	79.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			419.8	D08		4	0111-0390	83.47	390.26	414	78.33	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			306.0	D08		4	0112-0398	358.78	397.74	826	108.47	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.2	D08		4	0113-0398	798.87	397.96	445	84.33	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3358.9	D08		4	0114-0402	595.24	401.63	512	86.23	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			243.1	D08		4	0115-0405	654.01	406.06	567	92.57	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			394.2	D08		4	0116-0405	260.98	405.31	536	88.57	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			272.3	D08		4	0117-0411	535.96	411.71	918	120.23	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			261.7	D08		4	0118-0415	484.12	415.53	806	109.74	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			792.3	D08		4	0119-0415	210.19	414.84	911	116.23	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			280.5	D08		4	0120-0419	869.62	418.01	472	82.08	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			292.9	D08		4	0121-0420	459.39	420.85	457	85.01	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			238.8	D08		4	0122-0423	568.03	423.12	489	85.01	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			257.1	D08		4	0123-0427	783.26	427.75	947	124.47	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			283.6	D08		4	0124-0426	125.16	426.22	419	76.91	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			282.6	D08		4	0125-0431	755.86	431.24	422	80.77	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.2	D08		4	0126-0432	385.87	432.72	436	78.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			251.1	D08		4	0127-0435	285.51	435.86	415	75.01	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			294.0	D08		4	0128-0441	66.09	440.53	406	76.43	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			339.0	D08		4	0129-0448	28.71	448.46	574	88.67	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			254.5	D08		4	0130-0449	849.09	449.39	468	81.26	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			283.2	D08		4	0131-0449	896.40	449.15	435	81.15	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			330.0	D08		4	0132-0455	176.90	455.44	435	78.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			286.4	D08		4	0133-0461	630.96	461.45	461	83.74	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1973.6	D08		4	0134-0465	564.54	465.61	437	78.08	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.2	D08		4	0135-0465	763.23	465.37	464	82.43	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			273.5	D08		4	0136-0472	232.27	472.22	487	86.57	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			309.8	D08		4	0137-0470	509.73	470.31	422	79.36	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			292.9	D08		4	0138-0469	699.93	469.21	469	81.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			261.3	D08		4	0139-0472	734.89	472.71	504	85.15	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			372.7	D08		4	0140-0473	528.11	473.56	367	75.94	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			474.8	D08		4	0141-0478	96.54	477.90	456	84.08	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.2	D08		4	0142-0476	414.40	476.81	439	79.50	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			302.3	D08		4	0143-0484	252.34	484.70	460	84.57	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			240.8	D08		4	0144-0488	937.61	487.58	406	76.08	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			248.1	D08		4	0145-0487	820.13	486.87	287	65.84	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			325.4	D08		4	0146-0491	902.85	490.85	434	78.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			257.4	D08		4	0147-0493	703.55	492.97	483	86.43	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			257.6	D08		4	0148-0496	143.65	496.51	421	78.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			308.8	D08		4	0149-0501	304.77	501.57	431	77.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.4	D08		4	0150-0506	60.78	505.86	443	79.26	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			250.2	D08		4	0151-0510	915.79	510.77	476	84.33	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			581.1	D08		4	0152-0512	522.77	512.19	463	82.57	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			212.4	D08		4	0153-0518	459.30	518.98	448	80.08	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			192.8	D08		4	0154-0525	620.07	525.23	571	92.33	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			254.5	D08		4	0155-0527	836.57	527.33	282	64.18	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			992.6	D08		4	0156-0529	360.05	529.94	429	79.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			387.8	D08		4	0157-0536	213.40	535.85	972	125.30	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			237.9	D08		4	0158-0534	407.41	533.57	504	85.74	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			431.0	D08		4	0159-0535	579.10	535.16	529	91.40	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			343.7	D08		4	0160-0534	23.69	534.42	407	75.26	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			251.7	D08		4	0161-0535	718.74	534.88	466	81.26	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1193.4	D08		4	0162-0550	73.80	550.34	433	80.08	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			275.6	D08		4	0163-0551	781.30	551.45	459	79.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1910.8	D08		4	0164-0552	361.37	551.17	526	89.60	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			251.1	D08		4	0165-0554	444.12	555.08	426	78.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			190.7	D08		4	0166-0560	496.05	559.90	449	79.26	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			245.8	D08		4	0167-0561	717.51	561.75	514	86.33	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			295.4	D08		4	0168-0562	409.60	562.68	472	82.33	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			187.0	D08		4	0169-0567	933.70	566.31	553	96.13	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			216.7	D08		4	0170-0565	628.41	565.59	465	80.67	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			197.1	D08		4	0171-0568	32.00	567.88	411	75.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			258.3	D08		4	0172-0573	259.57	571.93	451	81.40	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			217.5	D08		4	0173-0574	546.75	574.82	461	81.26	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			258.5	D08		4	0174-0577	109.77	577.72	423	75.26	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			326.4	D08		4	0175-0581	316.05	581.14	554	88.08	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			331.1	D08		4	0176-0584	909.84	584.85	803	114.95	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			203.1	D08		4	0177-0579	803.61	578.83	480	81.50	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			247.1	D08		4	0178-0581	649.40	580.88	509	88.81	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			258.3	D08		4	0179-0590	244.16	591.10	457	84.23	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.3	D08		4	0180-0594	470.06	594.13	422	77.01	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			198.6	D08		4	0181-0595	357.99	594.48	437	77.84	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			348.6	D08		4	0182-0601	707.62	600.99	472	81.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			231.3	D08		4	0183-0603	861.60	603.94	748	106.91	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.6	D08		4	0184-0602	593.70	602.36	432	78.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			222.6	D08		4	0185-0605	803.17	605.81	480	84.53	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			259.8	D08		4	0186-0605	189.40	604.80	467	80.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.8	D08		4	0187-0605	682.74	605.51	455	78.67	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.8	D08		4	0188-0608	829.34	608.71	803	110.53	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.5	D08		4	0189-0609	407.77	609.26	430	77.84	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			230.4	D08		4	0190-0617	48.28	617.11	419	76.08	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			297.6	D08		4	0191-0618	73.94	618.25	435	80.33	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			226.9	D08		4	0192-0620	534.59	620.39	454	83.15	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			314.7	D08		4	0193-0629	652.35	629.74	426	76.43	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.4	D08		4	0194-0630	464.45	630.65	459	81.50	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			196.2	D08		4	0195-0631	347.40	631.22	432	76.43	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			527.0	D08		4	0196-0637	166.84	637.00	673	98.81	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			912.1	D08		4	0197-0633	766.19	633.25	448	77.84	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			225.8	D08		4	0198-0637	824.14	634.50	444	83.50	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			208.9	D08		4	0199-0647	616.31	647.51	434	80.08	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			189.7	D08		4	0200-0648	893.26	647.73	452	83.74	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.1	D08		4	0201-0647	413.25	647.58	436	79.74	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			409.8	D08		4	0202-0649	811.68	650.31	462	82.47	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			843.9	D08		4	0203-0655	284.65	655.64	972	129.68	0.726
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			262.0	D08		4	0204-0650	16.51	650.72	409	75.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			272.5	D08		4	0205-0652	564.80	652.91	437	77.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			256.7	D08		4	0206-0655	245.76	654.93	477	87.40	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			243.9	D08		4	0207-0654	60.03	654.59	350	73.36	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.6	D08		4	0208-0664	490.73	665.09	551	88.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			276.6	D08		4	0209-0666	107.18	667.24	437	78.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			372.3	D08		4	0210-0670	130.35	670.03	437	81.01	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			264.2	D08		4	0211-0673	66.05	672.95	487	87.01	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			249.1	D08		4	0212-0675	315.43	675.38	458	79.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			212.5	D08		4	0213-0674	384.40	674.78	439	78.91	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			192.2	D08		4	0214-0676	671.90	676.16	437	77.84	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			274.4	D08		4	0215-0677	806.78	677.74	428	79.98	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			292.7	D08		4	0216-0678	219.18	677.65	431	79.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.3	D08		4	0217-0680	741.32	680.44	490	87.40	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			267.5	D08		4	0218-0687	521.67	686.81	448	80.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			414.4	D08		4	0219-0690	185.53	690.11	483	87.15	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			201.8	D08		4	0220-0691	426.22	691.59	414	78.18	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			256.1	D08		4	0221-0698	66.48	698.47	483	87.01	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			237.6	D08		4	0222-0697	210.17	697.67	479	90.91	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			197.0	D08		4	0223-0698	848.47	697.67	448	77.84	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3501.1	D08		4	0224-0707	801.44	707.13	338	68.77	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			226.4	D08		5	0001-0033	823.63	32.06	394	74.57	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			281.8	D08		5	0002-0040	391.44	40.78	457	81.84	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			216.9	D08		5	0003-0045	808.53	46.12	380	75.15	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			178.0	D08		5	0004-0045	921.84	46.04	389	78.18	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			906.4	D08		5	0005-0057	318.33	57.37	778	114.23	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			472.5	D08		5	0006-0057	470.15	57.03	421	78.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			264.4	D08		5	0007-0059	50.54	59.00	386	73.84	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3103.8	D08		5	0008-0059	875.92	59.73	269	82.67	0.495
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			592.1	D08		5	0009-0064	397.42	64.22	486	85.84	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			256.1	D08		5	0010-0072	670.92	70.92	819	114.67	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			284.5	D08		5	0011-0071	701.38	70.53	485	87.26	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			666.8	D08		5	0012-0078	543.90	78.14	825	118.71	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6721.1	D08		5	0013-0079	388.66	79.65	130	44.87	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6044.1	D08		5	0014-0085	382.58	87.38	154	58.53	0.565
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			369.4	D08		5	0015-0088	516.98	88.31	354	71.94	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			212.8	D08		5	0016-0093	277.12	93.36	398	75.50	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.0	D08		5	0017-0096	633.80	96.06	425	79.26	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			196.9	D08		5	0018-0092	945.00	92.43	416	78.43	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			210.7	D08		5	0019-0099	599.93	98.67	415	77.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			642.3	D08		5	0020-0098	798.67	98.19	423	77.84	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.5	D08		5	0021-0100	350.48	100.44	400	75.84	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1113.4	D08		5	0022-0103	71.65	102.95	395	74.67	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			293.6	D08		5	0023-0108	561.28	107.76	640	93.74	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			295.8	D08		5	0024-0112	237.80	112.01	503	85.60	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			331.4	D08		5	0025-0115	454.33	115.52	438	81.74	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1245.6	D08		5	0026-0117	179.42	116.83	392	74.67	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			283.6	D08		5	0027-0118	842.12	118.62	387	73.84	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			403.1	D08		5	0028-0128	945.20	127.33	658	98.67	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.1	D08		5	0029-0147	230.98	146.68	883	128.37	0.673
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.0	D08		5	0030-0139	417.82	138.92	432	76.43	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			222.5	D08		5	0031-0140	799.39	139.77	419	79.01	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.1	D08		5	0032-0143	72.31	143.04	380	72.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			251.5	D08		5	0033-0146	778.08	146.59	408	77.01	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			202.3	D08		5	0034-0149	501.54	148.63	457	80.08	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.4	D08		5	0035-0147	714.83	147.15	405	76.08	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			286.8	D08		5	0036-0160	304.21	160.53	837	111.54	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			208.0	D08		5	0037-0160	551.40	160.00	437	81.26	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			222.4	D08		5	0038-0159	625.81	159.03	413	75.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			372.1	D08		5	0039-0163	379.49	163.25	810	111.15	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.1	D08		5	0040-0174	218.07	175.08	417	82.33	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.8	D08		5	0041-0179	124.30	179.69	857	121.40	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			248.4	D08		5	0042-0182	593.02	181.99	397	76.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.1	D08		5	0043-0184	800.09	184.08	393	76.33	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.8	D08		5	0044-0195	190.64	195.14	411	81.74	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			230.8	D08		5	0045-0200	860.90	200.69	769	107.64	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			210.7	D08		5	0046-0195	714.01	195.36	418	78.43	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			188.2	D08		5	0047-0204	21.44	204.91	378	76.08	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			210.1	D08		5	0048-0205	71.47	204.85	372	72.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			216.4	D08		5	0049-0211	769.60	211.45	384	74.43	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			273.5	D08		5	0050-0211	468.68	211.28	418	76.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.5	D08		5	0051-0214	390.48	213.72	396	75.26	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.0	D08		5	0052-0214	734.86	213.37	442	81.01	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			255.3	D08		5	0053-0216	210.48	216.18	445	86.91	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3473.2	D08		5	0054-0212	116.41	212.94	148	51.70	0.696
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			258.1	D08		5	0055-0217	343.50	217.58	399	75.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			658.1	D08		5	0056-0219	649.48	218.86	377	75.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			744.5	D08		5	0057-0225	668.86	226.35	406	82.08	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			268.4	D08		5	0058-0233	554.22	233.81	778	108.23	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			212.5	D08		5	0059-0240	133.89	240.37	385	76.08	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			205.8	D08		5	0060-0248	172.10	248.69	390	74.08	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			236.9	D08		5	0061-0249	56.46	249.02	394	76.08	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			568.1	D08		5	0062-0252	262.48	252.37	426	77.01	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			218.1	D08		5	0063-0252	522.43	252.74	411	80.91	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			194.2	D08		5	0064-0259	941.70	259.65	758	108.71	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.8	D08		5	0065-0263	621.63	263.24	862	124.51	0.699
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			243.4	D08		5	0066-0268	474.24	267.82	820	112.81	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			242.6	D08		5	0067-0265	748.25	265.65	425	76.67	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.3	D08		5	0068-0268	784.21	268.90	423	82.57	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			406.6	D08		5	0069-0274	346.42	275.00	450	80.43	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			341.2	D08		5	0070-0280	397.61	280.07	764	105.54	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			282.3	D08		5	0071-0274	865.76	273.84	395	74.08	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.2	D08		5	0072-0278	121.12	277.83	379	73.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			194.7	D08		5	0073-0277	22.55	277.44	368	73.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.7	D08		5	0074-0285	547.62	284.98	407	77.74	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			313.5	D08		5	0075-0285	323.56	284.72	457	81.26	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			255.3	D08		5	0076-0287	260.67	287.23	413	79.50	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			254.6	D08		5	0077-0301	806.06	301.60	896	117.40	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			253.5	D08		5	0078-0301	685.93	301.04	293	63.94	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.8	D08		5	0079-0310	430.22	310.43	398	80.33	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			602.0	D08		5	0080-0316	97.58	316.25	428	80.33	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			245.7	D08		5	0081-0314	859.62	313.58	405	78.57	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			207.7	D08		5	0082-0321	21.04	321.60	824	115.68	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			257.4	D08		5	0083-0314	518.69	314.61	381	77.84	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			342.2	D08		5	0084-0323	283.64	323.05	405	78.08	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.6	D08		5	0085-0327	344.62	327.27	406	78.33	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.9	D08		5	0086-0328	873.27	329.35	403	77.50	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1112.3	D08		5	0087-0330	907.98	329.91	310	64.77	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			289.9	D08		5	0088-0333	223.33	333.96	410	75.26	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			242.2	D08		5	0089-0337	410.57	337.30	756	107.74	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			205.7	D08		5	0090-0338	169.04	337.99	379	77.50	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			538.0	D08		5	0091-0336	660.17	336.80	610	97.15	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			212.3	D08		5	0092-0343	929.00	343.31	782	113.88	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.3	D08		5	0093-0344	722.89	344.38	405	76.67	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			246.4	D08		5	0094-0351	438.25	351.57	739	106.57	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			218.9	D08		5	0095-0346	552.67	346.48	413	77.26	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			268.8	D08		5	0096-0347	786.35	346.22	441	83.60	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			263.5	D08		5	0097-0354	761.47	354.39	397	77.84	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			230.4	D08		5	0098-0359	854.76	359.24	407	77.50	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			216.1	D08		5	0099-0360	135.44	360.45	392	76.91	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			293.8	D08		5	0100-0363	589.18	362.90	402	74.43	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			862.9	D08		5	0101-0367	273.26	367.66	450	81.74	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			262.5	D08		5	0102-0365	897.87	364.97	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			291.0	D08		5	0103-0376	484.26	375.96	819	108.71	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			289.4	D08		5	0104-0375	377.85	374.63	416	78.08	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			350.6	D08		5	0105-0378	304.46	378.42	424	78.67	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			624.6	D08		5	0106-0380	40.49	380.98	425	78.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			277.1	D08		5	0107-0386	833.52	386.16	399	75.84	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.2	D08		5	0108-0388	630.64	387.98	450	82.33	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.5	D08		5	0109-0396	411.42	396.40	397	76.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			243.0	D08		5	0110-0401	740.54	401.57	418	77.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			238.0	D08		5	0111-0404	366.68	404.38	414	76.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			240.2	D08		5	0112-0406	217.90	406.82	369	74.67	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			222.2	D08		5	0113-0408	175.02	408.75	399	76.91	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			294.7	D08		5	0114-0411	715.24	410.60	451	84.33	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			225.7	D08		5	0115-0412	535.17	412.48	466	85.15	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.1	D08		5	0116-0418	907.23	417.81	194	52.53	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			315.8	D08		5	0117-0426	802.16	426.03	435	81.74	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			226.7	D08		5	0118-0427	257.71	426.72	386	73.84	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.8	D08		5	0119-0427	610.99	426.01	452	86.57	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			266.3	D08		5	0120-0427	511.47	427.34	436	80.91	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			303.6	D08		5	0121-0426	869.44	427.90	301	66.28	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			204.4	D08		5	0122-0430	942.75	429.56	334	72.77	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			286.6	D08		5	0123-0433	475.18	432.91	417	79.50	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			274.0	D08		5	0124-0438	60.42	438.38	370	77.50	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.9	D08		5	0125-0443	929.10	443.80	381	72.91	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			230.7	D08		5	0126-0447	231.28	446.57	418	88.08	0.677
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			335.1	D08		5	0127-0447	869.40	446.16	338	70.87	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			193.5	D08		5	0128-0455	318.95	455.36	393	78.33	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			265.9	D08		5	0129-0462	835.61	462.47	606	91.50	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			244.2	D08		5	0130-0461	121.51	461.01	426	79.50	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			314.9	D08		5	0131-0460	443.24	460.54	409	77.50	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			242.9	D08		5	0132-0462	254.37	461.53	431	78.43	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			283.7	D08		5	0133-0466	215.21	467.13	426	78.91	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			296.2	D08		5	0134-0467	783.67	467.61	406	76.67	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			252.7	D08		5	0135-0472	525.52	471.82	416	76.91	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			273.9	D08		5	0136-0482	99.73	482.31	414	75.26	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			322.7	D08		5	0137-0485	143.43	484.89	386	75.26	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2369.1	D08		5	0138-0485	294.49	485.32	292	62.77	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			292.2	D08		5	0139-0490	42.99	490.22	383	74.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			270.2	D08		5	0140-0493	370.45	493.36	377	74.91	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			230.6	D08		5	0141-0496	644.54	496.59	415	76.91	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.0	D08		5	0142-0498	489.71	498.57	453	82.33	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			278.8	D08		5	0143-0502	831.89	502.01	368	72.67	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			207.3	D08		5	0144-0505	939.56	504.88	436	78.08	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			337.5	D08		5	0145-0508	68.46	508.47	432	79.94	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			246.9	D08		5	0146-0511	887.28	511.66	578	90.08	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			200.2	D08		5	0147-0513	20.77	513.26	404	82.08	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.7	D08		5	0148-0521	754.52	520.67	409	79.50	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			226.7	D08		5	0149-0523	586.44	523.30	406	78.57	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.9	D08		5	0150-0524	298.76	524.83	424	77.26	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			234.3	D08		5	0151-0525	442.76	524.94	407	78.67	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			242.6	D08		5	0152-0528	529.27	528.32	415	77.50	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			253.2	D08		5	0153-0532	108.82	532.31	738	105.64	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			713.1	D08		5	0154-0531	148.05	531.10	448	80.57	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			204.9	D08		5	0155-0529	482.41	529.37	398	74.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			202.3	D08		5	0156-0530	666.31	530.21	407	77.50	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			267.3	D08		5	0157-0531	67.98	529.96	405	77.36	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.4	D08		5	0158-0535	709.02	534.75	398	76.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.4	D08		5	0159-0550	905.81	549.96	845	121.64	0.718
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			447.5	D08		5	0160-0541	804.22	541.10	367	73.26	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			268.5	D08		5	0161-0543	390.29	543.81	425	79.01	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.0	D08		5	0162-0553	412.75	553.04	430	81.26	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			266.8	D08		5	0163-0559	149.09	559.16	557	89.98	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.7	D08		5	0164-0560	464.84	560.33	400	78.33	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.6	D08		5	0165-0569	757.35	568.12	809	107.88	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			291.4	D08		5	0166-0564	348.33	564.29	444	81.98	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.0	D08		5	0167-0569	39.10	568.04	453	84.47	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.1	D08		5	0168-0567	599.41	567.21	398	75.84	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			547.6	D08		5	0169-0582	279.61	582.60	861	126.71	0.674
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			217.8	D08		5	0170-0581	25.58	580.97	352	75.15	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.8	D08		5	0171-0579	110.23	579.37	378	73.84	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			315.1	D08		5	0172-0581	667.06	581.06	445	80.57	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			208.5	D08		5	0173-0584	58.54	584.46	433	79.15	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			208.2	D08		5	0174-0598	387.24	598.06	913	122.51	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			288.8	D08		5	0175-0592	848.30	591.58	355	69.01	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			191.5	D08		5	0176-0601	452.23	600.94	405	78.57	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			369.1	D08		5	0177-0604	636.33	604.11	417	77.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			196.8	D08		5	0178-0605	707.85	604.88	396	75.84	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.9	D08		5	0179-0603	894.34	602.57	424	80.67	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2344.9	D08		5	0180-0611	815.51	611.80	316	65.60	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			329.6	D08		5	0181-0617	749.57	616.84	418	75.84	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			173.5	D08		5	0182-0619	670.03	619.32	407	77.50	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			211.1	D08		5	0183-0627	85.01	627.41	849	117.20	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			245.3	D08		5	0184-0623	380.27	623.57	412	79.98	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			553.0	D08		5	0185-0624	486.57	623.68	408	75.50	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.0	D08		5	0186-0636	229.62	636.89	400	80.23	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			230.3	D08		5	0187-0637	896.43	636.89	386	74.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			420.4	D08		5	0188-0639	432.10	639.78	760	107.01	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			246.9	D08		5	0189-0641	399.89	641.34	684	104.91	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			236.2	D08		5	0190-0639	702.72	639.73	363	71.70	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.1	D08		5	0191-0641	684.59	641.16	340	70.04	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			307.4	D08		5	0192-0641	833.67	641.18	407	77.26	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			331.7	D08		5	0193-0641	578.90	641.25	386	74.67	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			162.8	D08		5	0194-0644	503.10	644.83	399	75.84	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			263.6	D08		5	0195-0646	792.39	647.04	771	113.05	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.1	D08		5	0196-0651	154.62	650.94	391	77.84	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			203.5	D08		5	0197-0653	362.74	653.67	433	81.50	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			186.1	D08		5	0198-0669	557.75	669.58	859	118.02	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.9	D08		5	0199-0667	730.14	666.77	409	76.33	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			191.2	D08		5	0200-0669	620.03	669.13	394	76.33	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			189.7	D08		5	0201-0668	678.40	668.34	407	77.26	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			222.1	D08		5	0202-0675	431.90	674.98	414	76.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			187.2	D08		5	0203-0674	318.41	674.03	391	77.01	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			222.0	D08		5	0204-0680	259.83	680.16	394	74.67	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.0	D08		5	0205-0682	774.12	682.45	378	72.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			192.7	D08		5	0206-0694	727.59	694.73	419	81.15	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			200.9	D08		5	0207-0694	519.50	694.35	396	74.67	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			222.3	D08		5	0208-0699	210.55	699.05	729	105.88	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			198.9	D08		5	0209-0698	806.63	698.16	371	73.26	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			207.5	D08		5	0210-0704	886.47	704.50	369	71.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			216.1	D08		5	0211-0706	606.42	706.48	384	75.50	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			210.2	D08		6	0001-0031	828.76	31.67	370	71.94	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			198.5	D08		6	0002-0037	847.51	38.12	368	77.60	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			212.1	D08		6	0003-0036	327.60	35.24	339	72.43	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.3	D08		6	0004-0042	302.39	41.52	863	121.78	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			338.7	D08		6	0005-0040	923.26	40.40	314	67.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			248.0	D08		6	0006-0048	798.39	47.76	768	107.98	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			205.8	D08		6	0007-0042	130.25	42.06	351	69.60	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			287.1	D08		6	0008-0045	391.38	45.09	404	77.50	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			308.3	D08		6	0009-0049	556.89	49.61	411	80.43	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			192.5	D08		6	0010-0048	597.94	48.65	393	75.50	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			205.3	D08		6	0011-0048	16.62	48.20	323	75.01	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			438.9	D08		6	0012-0053	446.87	53.50	949	121.15	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			198.7	D08		6	0013-0051	666.15	50.88	389	74.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			278.6	D08		6	0014-0065	197.75	64.91	752	110.71	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			194.7	D08		6	0015-0066	900.72	66.61	403	75.84	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.2	D08		6	0016-0075	285.42	75.45	803	119.44	0.707
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.4	D08		6	0017-0073	628.35	74.13	785	115.64	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			591.1	D08		6	0018-0074	434.92	74.70	330	70.77	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			205.3	D08		6	0019-0078	746.11	77.93	391	73.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			296.3	D08		6	0020-0087	113.81	87.17	714	109.40	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			248.6	D08		6	0021-0082	859.99	81.94	372	74.91	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			222.8	D08		6	0022-0085	374.04	84.87	392	73.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.5	D08		6	0023-0094	723.11	93.67	421	78.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			191.1	D08		6	0024-0093	487.55	92.71	394	76.43	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.0	D08		6	0025-0094	774.76	94.30	418	78.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.8	D08		6	0026-0095	39.55	95.36	380	73.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			551.9	D08		6	0027-0102	836.77	101.45	590	115.05	0.560
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			244.6	D08		6	0028-0099	255.89	99.19	382	75.50	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			257.7	D08		6	0029-0100	595.90	99.78	365	72.67	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.2	D08		6	0030-0109	422.07	109.20	401	74.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			335.8	D08		6	0031-0126	484.81	126.11	881	126.71	0.690
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			458.3	D08		6	0032-0131	39.36	130.44	645	96.08	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			179.0	D08		6	0033-0131	549.78	131.58	381	73.84	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			198.3	D08		6	0034-0131	623.75	131.32	378	73.01	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			204.1	D08		6	0035-0132	172.95	132.44	376	77.26	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			456.1	D08		6	0036-0138	663.74	138.16	402	76.08	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			231.4	D08		6	0037-0140	893.42	140.11	365	71.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			268.2	D08		6	0038-0141	808.06	140.48	388	75.84	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			159.6	D08		6	0039-0144	271.47	144.83	389	76.57	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.4	D08		6	0040-0146	420.14	146.29	720	105.98	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1344.0	D08		6	0041-0145	457.69	145.41	336	70.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			303.6	D08		6	0042-0145	731.89	144.61	357	71.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.9	D08		6	0043-0147	106.08	147.62	398	74.67	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			205.5	D08		6	0044-0146	132.63	146.74	389	80.57	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			280.8	D08		6	0045-0148	301.61	148.60	373	73.50	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			191.7	D08		6	0046-0148	505.48	148.16	399	77.01	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			271.3	D08		6	0047-0149	838.37	149.10	369	72.67	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			217.9	D08		6	0048-0153	190.42	152.90	356	80.43	0.692
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.1	D08		6	0049-0159	767.90	159.50	381	75.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			286.8	D08		6	0050-0159	605.24	159.53	411	76.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			378.8	D08		6	0051-0163	326.95	162.93	371	72.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			262.5	D08		6	0052-0162	560.70	162.97	397	76.67	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			289.5	D08		6	0053-0165	928.56	164.82	391	73.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			252.3	D08		6	0054-0167	685.73	167.59	399	73.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			243.4	D08		6	0055-0167	474.63	166.86	391	76.18	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			184.3	D08		6	0056-0171	364.60	171.26	369	73.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			617.2	D08		6	0057-0177	70.64	177.11	396	78.18	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			996.5	D08		6	0058-0178	578.94	178.43	399	75.84	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			871.6	D08		6	0059-0178	93.26	177.67	356	71.94	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.0	D08		6	0060-0180	519.28	180.24	369	71.26	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			544.9	D08		6	0061-0188	811.84	187.98	356	71.60	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			269.8	D08		6	0062-0188	732.47	188.22	376	73.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			211.2	D08		6	0063-0188	398.67	187.91	374	72.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			238.5	D08		6	0064-0188	459.42	188.42	391	75.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			307.2	D08		6	0065-0192	707.38	192.26	387	74.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			313.0	D08		6	0066-0194	832.11	193.10	379	75.84	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			259.2	D08		6	0067-0201	129.67	201.14	384	77.26	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.3	D08		6	0068-0203	551.30	203.08	376	73.50	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			310.2	D08		6	0069-0204	902.38	204.65	333	66.77	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			192.5	D08		6	0070-0206	355.13	206.40	358	74.43	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			691.4	D08		6	0071-0212	635.35	212.48	399	75.01	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			261.1	D08		6	0072-0214	848.73	215.28	377	77.60	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			306.1	D08		6	0073-0218	932.27	216.97	345	69.26	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			270.6	D08		6	0074-0220	522.35	220.95	391	73.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			185.9	D08		6	0075-0221	324.97	222.47	425	81.01	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			248.2	D08		6	0076-0230	353.42	229.76	822	112.23	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.2	D08		6	0077-0233	441.72	232.72	428	80.91	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			242.1	D08		6	0078-0234	887.17	234.36	369	71.36	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			327.4	D08		6	0079-0237	83.22	237.34	399	76.67	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.4	D08		6	0080-0240	933.40	241.20	378	72.08	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			284.5	D08		6	0081-0243	854.49	242.67	365	73.84	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			204.1	D08		6	0082-0245	401.20	245.71	365	71.84	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.7	D08		6	0083-0244	460.99	244.95	355	75.60	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			203.0	D08		6	0084-0250	217.98	250.08	357	76.33	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			246.7	D08		6	0085-0253	628.92	252.95	378	72.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			207.7	D08		6	0086-0253	263.39	253.75	360	73.26	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.7	D08		6	0087-0262	36.17	262.36	722	103.05	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			198.0	D08		6	0088-0260	310.00	260.65	362	73.50	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			196.5	D08		6	0089-0260	102.18	261.17	346	70.43	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			290.7	D08		6	0090-0268	185.69	268.48	884	146.51	0.518
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.4	D08		6	0091-0263	454.94	263.11	449	84.67	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3477.1	D08		6	0092-0262	553.62	262.03	325	66.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			409.0	D08		6	0093-0270	678.00	270.01	375	72.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			275.3	D08		6	0094-0273	586.06	273.25	364	72.08	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			230.1	D08		6	0095-0275	369.55	275.52	397	75.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			412.4	D08		6	0096-0276	849.51	275.27	363	72.91	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.3	D08		6	0097-0278	235.02	278.33	349	72.43	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			211.3	D08		6	0098-0284	128.71	284.50	355	74.08	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1923.1	D08		6	0099-0287	632.49	287.12	274	61.84	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			320.7	D08		6	0100-0292	864.52	292.16	407	77.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			286.6	D08		6	0101-0296	383.05	296.44	374	73.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1215.6	D08		6	0102-0297	407.90	296.89	387	73.01	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			253.6	D08		6	0103-0297	509.90	297.42	392	72.43	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			287.6	D08		6	0104-0298	44.09	298.72	352	72.08	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.6	D08		6	0105-0303	766.26	302.90	352	73.26	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			211.0	D08		6	0106-0310	276.35	310.18	394	75.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.5	D08		6	0107-0310	593.44	310.26	370	72.67	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			260.7	D08		6	0108-0310	548.75	310.52	382	74.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			324.2	D08		6	0109-0311	832.11	310.47	382	73.26	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			292.6	D08		6	0110-0315	475.27	315.03	395	74.18	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			405.3	D08		6	0111-0319	683.10	318.92	642	100.47	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			222.6	D08		6	0112-0319	301.13	319.45	382	73.84	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			248.1	D08		6	0113-0327	211.18	328.27	839	117.88	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			265.1	D08		6	0114-0320	566.22	320.72	385	75.50	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			301.9	D08		6	0115-0320	898.68	319.64	306	67.84	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			247.1	D08		6	0116-0322	354.69	321.99	394	75.50	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			388.8	D08		6	0117-0322	717.14	322.36	564	101.26	0.691
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			912.5	D08		6	0118-0328	640.59	328.33	362	75.26	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			230.3	D08		6	0119-0334	269.16	334.69	433	86.08	0.734
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			299.3	D08		6	0120-0332	495.27	331.52	399	74.18	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			260.0	D08		6	0121-0337	817.75	337.00	419	78.33	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			351.4	D08		6	0122-0339	909.62	339.16	468	81.74	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			585.8	D08		6	0123-0340	792.67	339.73	461	82.33	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			216.4	D08		6	0124-0346	23.77	346.14	733	109.64	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			788.8	D08		6	0125-0347	629.09	348.15	482	91.15	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			625.3	D08		6	0126-0349	772.87	349.59	347	73.74	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			267.7	D08		6	0127-0350	932.91	350.68	699	110.81	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			803.9	D08		6	0128-0353	876.46	352.96	385	73.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			277.7	D08		6	0129-0358	727.31	358.52	378	72.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			248.7	D08		6	0130-0371	408.14	370.44	795	118.02	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			258.8	D08		6	0131-0366	226.35	365.77	908	116.33	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			265.6	D08		6	0132-0372	118.56	372.22	342	68.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			236.2	D08		6	0133-0380	171.75	380.43	359	71.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			589.3	D08		6	0134-0381	686.19	380.93	378	72.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.1	D08		6	0135-0386	356.86	385.91	362	71.84	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			252.6	D08		6	0136-0386	898.63	385.61	350	70.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			771.6	D08		6	0137-0389	582.02	388.69	403	77.26	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			247.7	D08		6	0138-0393	465.08	393.73	397	76.33	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.6	D08		6	0139-0396	531.89	396.65	383	73.60	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			314.0	D08		6	0140-0398	404.18	398.80	397	75.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			278.1	D08		6	0141-0399	263.14	398.89	376	72.43	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			226.5	D08		6	0142-0406	755.66	406.81	828	112.81	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			343.8	D08		6	0143-0400	846.75	399.69	373	72.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			194.3	D08		6	0144-0404	713.06	404.11	418	78.91	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.6	D08		6	0145-0406	671.17	405.85	361	71.26	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.6	D08		6	0146-0413	138.98	413.47	371	79.74	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			487.0	D08		6	0147-0418	488.43	418.69	409	76.08	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			250.0	D08		6	0148-0420	205.89	419.93	366	72.67	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			245.0	D08		6	0149-0430	813.04	431.09	381	73.26	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			291.7	D08		6	0150-0431	347.02	431.33	380	73.01	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.4	D08		6	0151-0432	434.56	432.26	372	75.26	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			289.0	D08		6	0152-0433	386.89	433.27	332	67.01	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.8	D08		6	0153-0436	534.23	436.43	387	74.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			216.6	D08		6	0154-0436	566.83	435.94	392	77.50	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			368.8	D08		6	0155-0448	223.60	447.98	776	111.20	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.0	D08		6	0156-0444	25.13	445.46	410	79.64	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			236.3	D08		6	0157-0442	879.80	442.45	368	73.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			592.7	D08		6	0158-0453	629.25	451.93	805	122.61	0.673
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			354.7	D08		6	0159-0450	286.83	449.76	498	109.40	0.523
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			281.7	D08		6	0160-0455	546.95	455.76	440	81.26	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			191.9	D08		6	0161-0473	695.65	471.41	849	123.44	0.700
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			225.2	D08		6	0162-0463	767.08	463.73	453	79.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.7	D08		6	0163-0470	934.85	469.19	674	102.33	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.3	D08		6	0164-0464	910.91	463.51	355	70.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			245.9	D08		6	0165-0469	376.31	469.53	372	70.18	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			299.8	D08		6	0166-0471	177.58	471.75	413	78.67	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			316.3	D08		6	0167-0472	54.05	472.63	343	69.01	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			182.7	D08		6	0168-0475	592.81	474.91	415	75.26	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			256.3	D08		6	0169-0480	324.79	480.81	759	105.74	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			437.6	D08		6	0170-0479	435.04	479.50	376	72.18	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			202.2	D08		6	0171-0483	813.03	483.23	375	74.43	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			389.5	D08		6	0172-0490	770.88	489.39	662	102.91	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			279.5	D08		6	0173-0486	201.54	486.03	380	75.60	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			383.8	D08		6	0174-0487	278.85	487.89	358	69.84	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.9	D08		6	0175-0490	245.27	490.50	362	71.84	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1952.0	D08		6	0176-0491	477.77	491.04	428	78.08	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			178.3	D08		6	0177-0498	678.58	499.23	426	79.74	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			285.1	D08		6	0178-0503	118.99	502.66	441	82.57	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			234.7	D08		6	0179-0501	369.40	501.07	369	71.01	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			196.1	D08		6	0180-0503	572.50	503.11	376	74.08	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			254.9	D08		6	0181-0507	34.40	507.78	383	74.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.3	D08		6	0182-0509	934.67	508.54	372	73.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			212.5	D08		6	0183-0515	705.36	514.46	392	76.08	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			173.3	D08		6	0184-0512	735.76	512.62	377	75.26	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			313.5	D08		6	0185-0515	198.35	514.67	343	69.60	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			196.5	D08		6	0186-0516	403.12	516.95	377	75.50	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			246.9	D08		6	0187-0528	142.35	527.67	783	122.61	0.655
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			226.7	D08		6	0188-0521	640.20	521.47	403	76.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			231.3	D08		6	0189-0526	248.39	526.31	355	74.91	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			189.2	D08		6	0190-0528	434.65	528.06	364	72.08	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.6	D08		6	0191-0539	888.16	539.47	358	68.43	0.961
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.2	D08		6	0192-0542	349.12	542.31	386	77.74	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			254.3	D08		6	0193-0550	301.34	550.65	719	105.05	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.2	D08		6	0194-0551	111.29	551.67	350	72.91	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			186.8	D08		6	0195-0554	594.03	554.14	397	74.43	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			194.4	D08		6	0196-0555	943.52	555.19	380	73.50	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.5	D08		6	0197-0560	443.60	560.66	366	71.84	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			270.9	D08		6	0198-0565	548.38	565.67	372	72.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			305.1	D08		6	0199-0566	171.46	566.61	359	71.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.9	D08		6	0200-0571	341.12	571.02	415	82.57	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			399.3	D08		6	0201-0577	784.16	577.07	769	108.81	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			299.4	D08		6	0202-0572	251.05	572.93	407	78.67	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			194.2	D08		6	0203-0572	619.51	572.04	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2445.6	D08		6	0204-0579	74.03	580.39	662	103.40	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.6	D08		6	0205-0580	287.78	580.05	376	74.43	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			185.3	D08		6	0206-0579	367.26	578.81	401	77.74	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			216.9	D08		6	0207-0580	819.65	579.49	354	70.43	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			217.7	D08		6	0208-0580	416.10	580.75	378	72.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			234.1	D08		6	0209-0590	474.71	590.58	792	118.47	0.709
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.9	D08		6	0210-0582	229.54	582.17	384	74.43	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			189.5	D08		6	0211-0584	716.08	583.65	355	71.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			549.5	D08		6	0212-0590	110.68	589.95	361	72.91	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			194.7	D08		6	0213-0593	326.52	594.57	419	80.91	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.2	D08		6	0214-0597	508.27	597.88	502	83.50	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.8	D08		6	0215-0598	50.21	597.98	354	72.43	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			198.4	D08		6	0216-0597	558.93	597.18	395	77.01	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.3	D08		6	0217-0607	748.76	606.91	688	100.23	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.8	D08		6	0218-0603	376.33	604.40	395	79.74	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			321.3	D08		6	0219-0605	166.55	604.53	415	78.18	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.4	D08		6	0220-0611	220.68	610.92	370	74.67	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			204.7	D08		6	0221-0613	581.72	612.72	410	78.18	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			190.2	D08		6	0222-0616	412.19	617.09	369	73.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			252.5	D08		6	0223-0624	98.62	624.57	714	100.81	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			283.5	D08		6	0224-0625	180.36	625.83	398	80.43	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			462.9	D08		6	0225-0623	537.52	622.87	384	75.26	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.4	D08		6	0226-0635	454.28	635.05	378	73.01	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			258.0	D08		6	0227-0640	821.88	639.14	554	88.57	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			226.6	D08		6	0228-0644	624.45	644.80	425	77.26	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			218.4	D08		6	0229-0645	276.57	645.18	379	74.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			186.6	D08		6	0230-0648	571.47	648.92	714	103.40	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.1	D08		6	0231-0647	189.76	646.38	378	79.26	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			200.9	D08		6	0232-0654	371.70	653.98	762	108.47	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.6	D08		6	0233-0654	804.65	654.82	380	74.91	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			176.4	D08		6	0234-0650	679.35	650.37	197	55.11	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.9	D08		6	0235-0661	46.26	661.50	326	70.18	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			199.4	D08		6	0236-0663	320.64	663.16	378	72.67	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			186.4	D08		6	0237-0666	492.29	665.81	354	70.43	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.1	D08		6	0238-0670	135.52	670.49	346	73.26	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			257.0	D08		6	0239-0671	107.79	671.25	366	74.91	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.1	D08		6	0240-0676	444.57	675.86	391	73.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			265.2	D08		6	0241-0677	193.75	677.33	365	71.84	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			231.0	D08		6	0242-0680	830.19	680.26	357	70.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			199.2	D08		6	0243-0683	520.86	683.19	371	75.74	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			210.7	D08		6	0244-0686	287.13	685.70	375	73.26	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.5	D08		6	0245-0693	909.27	692.95	359	69.84	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			234.5	D08		6	0246-0696	601.90	695.47	367	73.98	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			240.8	D08		6	0247-0703	803.69	703.90	373	74.43	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			200.4	D08		6	0248-0703	212.96	703.48	341	67.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.2	D08		6	0249-0708	315.46	708.28	363	75.01	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1193.4	D08		7	0001-0038	138.70	38.64	783	109.88	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4253.0	D08		7	0002-0034	800.14	34.58	338	69.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			187.4	D08		7	0003-0039	895.20	39.35	401	77.26	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			187.0	D08		7	0004-0038	601.43	38.88	500	84.91	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.5	D08		7	0005-0042	281.00	42.21	836	111.64	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			211.4	D08		7	0006-0049	348.32	49.45	926	126.02	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			721.9	D08		7	0007-0044	702.80	44.53	423	77.26	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.0	D08		7	0008-0059	821.65	58.95	463	82.91	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			930.3	D08		7	0009-0066	79.13	65.78	449	81.15	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			184.5	D08		7	0010-0071	851.75	70.91	773	109.64	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			194.0	D08		7	0011-0070	394.91	69.33	475	86.91	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			251.7	D08		7	0012-0068	431.23	68.86	349	75.84	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.0	D08		7	0013-0078	251.23	76.72	434	79.74	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			282.4	D08		7	0014-0081	185.35	81.82	462	82.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			289.1	D08		7	0015-0087	704.28	87.06	423	77.26	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.5	D08		7	0016-0086	911.36	85.55	459	81.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.4	D08		7	0017-0090	439.34	90.38	570	96.67	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.6	D08		7	0018-0090	387.39	89.99	430	83.01	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			268.3	D08		7	0019-0089	534.01	89.23	451	81.50	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.6	D08		7	0020-0091	755.54	92.27	522	89.74	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			177.4	D08		7	0021-0091	938.49	90.77	487	85.50	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			295.9	D08		7	0022-0092	650.55	92.57	472	82.08	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.7	D08		7	0023-0093	237.84	94.47	446	80.57	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			253.7	D08		7	0024-0094	319.02	94.51	414	78.91	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			262.8	D08		7	0025-0096	815.37	96.64	456	87.40	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			351.7	D08		7	0026-0095	69.91	95.59	424	79.74	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			274.0	D08		7	0027-0098	845.18	97.93	502	87.15	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			718.0	D08		7	0028-0105	118.84	105.54	422	79.26	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			294.4	D08		7	0029-0106	732.48	106.57	433	80.91	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			7278.0	D08		7	0030-0121	299.24	120.12	332	71.50	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.7	D08		7	0031-0124	358.14	124.35	404	76.67	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			261.8	D08		7	0032-0127	686.23	126.65	419	77.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			198.9	D08		7	0033-0126	894.96	126.18	404	76.67	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			712.8	D08		7	0034-0127	281.81	128.32	393	78.08	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.1	D08		7	0035-0134	17.37	135.18	431	82.91	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			274.9	D08		7	0036-0135	649.93	135.03	457	80.33	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			248.5	D08		7	0037-0137	769.78	137.10	439	82.91	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			319.5	D08		7	0038-0140	523.99	140.31	478	84.33	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			270.7	D08		7	0039-0142	721.43	141.48	426	78.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			283.5	D08		7	0040-0146	451.98	146.47	778	109.74	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.0	D08		7	0041-0146	107.97	146.29	445	79.26	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			222.8	D08		7	0042-0148	135.96	147.29	444	84.33	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			264.1	D08		7	0043-0149	316.88	149.62	395	74.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			244.4	D08		7	0044-0154	781.79	154.36	461	87.15	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			230.4	D08		7	0045-0156	845.85	156.05	488	85.74	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			289.0	D08		7	0046-0162	363.17	161.47	444	84.67	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			270.5	D08		7	0047-0166	385.36	167.21	434	82.77	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2148.1	D08		7	0048-0172	184.53	172.77	562	92.81	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			265.2	D08		7	0049-0173	454.80	171.96	385	78.18	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			282.0	D08		7	0050-0177	288.22	177.19	491	92.81	0.716
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			264.5	D08		7	0051-0178	528.37	178.22	462	85.15	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			309.5	D08		7	0052-0182	51.09	181.36	409	81.05	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			319.5	D08		7	0053-0194	217.97	194.61	776	108.47	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			357.6	D08		7	0054-0197	36.31	198.74	416	81.15	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.3	D08		7	0055-0194	138.10	194.57	402	78.08	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			207.8	D08		7	0056-0201	825.33	201.22	458	81.50	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.2	D08		7	0057-0208	730.55	207.85	446	88.57	0.714
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.3	D08		7	0058-0208	651.04	208.27	465	82.33	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			310.0	D08		7	0059-0209	931.10	209.15	402	78.18	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			234.1	D08		7	0060-0210	274.48	209.99	433	78.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			247.4	D08		7	0061-0213	760.79	212.74	447	80.91	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			196.0	D08		7	0062-0214	792.02	214.30	410	78.33	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			218.8	D08		7	0063-0221	335.11	221.41	436	81.50	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			246.6	D08		7	0064-0221	686.85	220.76	434	77.26	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			256.8	D08		7	0065-0226	873.19	225.05	349	72.33	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			424.0	D08		7	0066-0235	496.90	234.92	499	86.57	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			315.2	D08		7	0067-0239	853.50	238.86	887	116.37	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			212.5	D08		7	0068-0242	232.59	242.28	472	86.57	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			283.3	D08		7	0069-0250	596.44	249.54	397	76.81	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			274.9	D08		7	0070-0250	392.33	250.19	439	78.08	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			407.6	D08		7	0071-0253	203.63	253.94	172	82.91	0.314
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			312.5	D08		7	0072-0262	582.42	264.15	519	91.64	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			199.1	D08		7	0073-0274	91.69	274.93	849	123.54	0.699
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.3	D08		7	0074-0270	456.40	270.98	443	81.50	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			298.4	D08		7	0075-0276	191.03	275.28	408	79.40	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			353.9	D08		7	0076-0275	698.99	275.48	495	84.91	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			197.7	D08		7	0077-0279	151.50	279.75	427	83.40	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.7	D08		7	0078-0280	370.65	281.07	732	107.64	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			185.9	D08		7	0079-0279	493.68	278.87	455	82.33	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			248.6	D08		7	0080-0284	593.04	284.29	489	89.26	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.4	D08		7	0081-0295	181.32	296.34	462	87.15	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.9	D08		7	0082-0293	287.27	293.14	439	78.08	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			248.1	D08		7	0083-0293	398.40	293.43	479	89.15	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			356.8	D08		7	0084-0295	218.71	295.12	453	81.84	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.9	D08		7	0085-0315	421.37	315.20	835	113.88	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			204.4	D08		7	0086-0310	316.18	309.58	428	79.74	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			207.7	D08		7	0087-0314	523.18	314.28	453	82.91	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			259.9	D08		7	0088-0316	619.29	316.35	441	79.26	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			361.7	D08		7	0089-0316	210.40	316.01	418	82.43	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			278.8	D08		7	0090-0329	749.51	328.37	902	121.64	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			218.2	D08		7	0091-0324	675.43	324.14	441	81.60	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.7	D08		7	0092-0324	697.35	323.76	542	89.01	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.6	D08		7	0093-0330	923.70	330.27	449	81.74	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			266.6	D08		7	0094-0333	865.05	333.11	417	79.50	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.3	D08		7	0095-0334	184.98	334.20	426	78.08	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			200.5	D08		7	0096-0340	353.74	339.76	780	111.88	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			302.8	D08		7	0097-0337	503.83	337.39	471	87.98	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			182.0	D08		7	0098-0342	475.99	341.85	503	87.40	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			394.3	D08		7	0099-0352	433.49	352.00	279	62.18	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			265.8	D08		7	0100-0355	632.91	355.63	454	79.26	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			178.6	D08		7	0101-0357	886.90	357.71	400	75.01	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.6	D08		7	0102-0365	831.24	365.48	778	105.64	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			186.0	D08		7	0103-0372	28.17	372.53	757	109.84	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			319.1	D08		7	0104-0379	122.49	379.22	502	90.18	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			284.0	D08		7	0105-0383	142.26	381.40	342	74.43	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			212.0	D08		7	0106-0384	326.48	383.91	537	91.15	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			312.2	D08		7	0107-0385	592.79	385.21	478	82.91	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			187.1	D08		7	0108-0390	198.62	390.20	396	77.26	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			207.4	D08		7	0109-0390	648.07	390.05	430	79.26	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			208.9	D08		7	0110-0392	353.79	391.83	524	97.64	0.691
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			194.5	D08		7	0111-0395	155.03	396.14	484	86.81	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			205.7	D08		7	0112-0393	388.35	393.40	457	80.91	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			286.6	D08		7	0113-0401	715.27	400.99	439	83.74	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			208.9	D08		7	0114-0401	910.08	400.87	410	77.26	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			217.0	D08		7	0115-0402	80.39	401.50	410	78.08	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.6	D08		7	0116-0408	115.91	409.20	851	116.95	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			236.2	D08		7	0117-0406	47.71	407.15	428	79.60	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			192.2	D08		7	0118-0417	672.49	417.03	472	85.50	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			861.1	D08		7	0119-0419	258.24	419.29	418	75.26	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.5	D08		7	0120-0419	852.42	418.87	438	77.84	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.7	D08		7	0121-0422	462.95	422.00	463	84.57	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.7	D08		7	0122-0428	737.20	428.53	799	106.23	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			199.9	D08		7	0123-0426	357.00	426.46	420	78.91	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			167.8	D08		7	0124-0433	207.82	432.94	401	76.67	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			289.5	D08		7	0125-0439	548.38	439.23	853	114.71	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			204.6	D08		7	0126-0445	130.87	445.13	436	81.15	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			242.4	D08		7	0127-0446	872.69	446.15	435	79.50	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			231.4	D08		7	0128-0450	177.60	449.89	471	86.57	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			287.8	D08		7	0129-0458	504.55	457.94	831	112.13	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			201.5	D08		7	0130-0453	617.91	452.19	430	79.98	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			525.9	D08		7	0131-0460	330.60	460.23	433	78.08	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.3	D08		7	0132-0469	633.26	470.21	488	85.40	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			250.9	D08		7	0133-0468	685.96	468.34	437	78.91	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			238.8	D08		7	0134-0469	439.37	469.24	443	79.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2448.2	D08		7	0135-0469	568.45	470.06	280	84.08	0.498
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			451.4	D08		7	0136-0482	928.02	481.95	894	116.95	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			230.8	D08		7	0137-0483	224.25	482.98	421	78.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			315.9	D08		7	0138-0488	77.97	488.45	444	86.23	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			207.0	D08		7	0139-0489	119.46	489.20	400	77.74	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			238.5	D08		7	0140-0503	605.96	503.79	865	116.95	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			222.9	D08		7	0141-0497	448.54	497.80	458	85.15	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			212.3	D08		7	0142-0497	732.17	496.51	436	82.33	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			261.0	D08		7	0143-0497	846.56	496.51	448	80.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			276.8	D08		7	0144-0503	791.27	504.05	818	111.40	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			246.7	D08		7	0145-0504	534.13	504.29	423	77.26	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2046.1	D08		7	0146-0515	397.56	515.35	711	101.40	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			236.6	D08		7	0147-0514	492.38	514.36	432	78.08	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.7	D08		7	0148-0520	198.34	520.33	422	77.84	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			277.7	D08		7	0149-0530	560.96	529.57	474	82.57	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			301.6	D08		7	0150-0531	79.84	531.52	448	83.74	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			294.1	D08		7	0151-0534	692.82	534.27	465	85.74	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			253.9	D08		7	0152-0535	859.44	536.14	554	92.47	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			362.1	D08		7	0153-0539	427.78	539.12	414	80.67	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			310.4	D08		7	0154-0547	781.55	547.27	855	118.27	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			429.4	D08		7	0155-0543	216.52	543.56	474	84.33	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			188.8	D08		7	0156-0545	16.05	545.35	394	75.60	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			243.9	D08		7	0157-0546	129.51	546.04	410	80.81	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			258.2	D08		7	0158-0546	542.56	547.35	493	85.98	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			255.8	D08		7	0159-0548	312.37	548.53	846	119.05	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			301.6	D08		7	0160-0556	876.68	556.26	486	84.33	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			380.0	D08		7	0161-0559	421.15	559.94	631	96.91	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			262.4	D08		7	0162-0558	643.98	558.24	421	78.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			701.7	D08		7	0163-0559	697.13	559.46	444	83.50	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.8	D08		7	0164-0570	241.67	569.63	417	77.50	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.9	D08		7	0165-0574	335.74	574.52	423	81.98	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			322.0	D08		7	0166-0582	939.06	582.12	412	79.60	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			265.2	D08		7	0167-0585	53.65	585.14	766	105.64	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			256.1	D08		7	0168-0583	619.72	583.61	431	76.43	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.5	D08		7	0169-0585	567.84	585.96	426	78.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.3	D08		7	0170-0587	200.56	587.01	459	81.50	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			231.8	D08		7	0171-0586	381.16	586.27	433	80.91	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			300.6	D08		7	0172-0602	84.26	601.97	412	79.98	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.5	D08		7	0173-0608	779.71	607.96	426	77.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			325.8	D08		7	0174-0610	934.27	610.47	448	84.91	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			276.2	D08		7	0175-0612	143.13	612.04	417	84.57	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			269.8	D08		7	0176-0613	692.71	612.59	428	79.26	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			249.0	D08		7	0177-0615	439.99	614.55	437	80.08	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			240.4	D08		7	0178-0622	309.28	622.42	452	80.91	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			482.8	D08		7	0179-0623	216.34	623.50	469	83.26	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			238.0	D08		7	0180-0634	512.13	633.38	446	82.33	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.9	D08		7	0181-0636	62.85	636.45	401	76.67	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			524.8	D08		7	0182-0643	332.89	641.98	838	120.13	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			234.2	D08		7	0183-0645	399.66	644.48	449	81.84	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			256.0	D08		7	0184-0647	279.46	648.02	378	80.33	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			248.7	D08		7	0185-0651	639.67	650.98	435	79.01	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			338.9	D08		7	0186-0651	360.99	651.61	463	84.08	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			252.0	D08		7	0187-0655	250.20	654.26	469	86.57	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.8	D08		7	0188-0659	500.84	660.70	463	85.74	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			546.1	D08		7	0189-0655	433.42	656.14	379	75.70	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			266.8	D08		7	0190-0660	835.93	660.18	449	80.91	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			245.8	D08		7	0191-0669	391.30	670.27	462	88.81	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.5	D08		7	0192-0667	17.13	667.33	458	80.91	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			282.9	D08		7	0193-0667	193.70	667.19	437	79.50	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			422.7	D08		7	0194-0664	222.97	664.04	250	64.43	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.7	D08		7	0195-0669	130.34	669.31	415	83.15	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			299.8	D08		7	0196-0671	563.62	671.83	434	80.33	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			290.3	D08		7	0197-0674	744.60	674.36	401	75.50	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2988.9	D08		7	0198-0675	434.96	673.95	430	80.53	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			238.7	D08		7	0199-0680	247.12	680.98	481	89.15	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.1	D08		7	0200-0680	297.85	680.08	407	76.43	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.7	D08		7	0201-0679	881.66	679.17	397	75.01	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.8	D08		7	0202-0683	463.49	683.36	413	78.33	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			624.9	D08		7	0203-0689	910.76	689.07	428	78.67	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			203.5	D08		7	0204-0690	55.66	689.63	424	76.67	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			230.7	D08		7	0205-0698	689.45	697.40	443	86.23	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.1	D08		7	0206-0698	656.88	697.85	407	79.15	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			205.4	D08		7	0207-0703	605.62	703.64	412	76.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			196.9	D08		7	0208-0704	351.70	704.08	420	77.26	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			367.4	D08		7	0209-0704	531.98	704.73	484	84.67	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			252.6	D08		7	0210-0704	215.33	704.39	385	72.43	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			217.4	D08		7	0211-0709	508.12	709.51	296	69.84	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.5	D08		8	0001-0032	884.95	31.78	381	72.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			211.1	D08		8	0002-0036	369.69	35.91	465	82.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			230.2	D08		8	0003-0034	604.87	34.26	413	78.08	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			181.5	D08		8	0004-0039	695.81	39.74	434	85.64	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			196.1	D08		8	0005-0039	424.75	39.71	513	90.57	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			200.4	D08		8	0006-0042	59.13	41.84	406	76.67	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			268.3	D08		8	0007-0042	116.37	41.58	475	85.40	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			322.2	D08		8	0008-0053	446.51	51.28	509	86.23	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			171.0	D08		8	0009-0060	500.17	59.63	448	81.74	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			322.5	D08		8	0010-0061	133.24	61.79	472	84.33	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			244.1	D08		8	0011-0062	572.17	62.39	818	115.78	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			631.5	D08		8	0012-0065	460.15	66.11	402	78.23	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			306.1	D08		8	0013-0063	918.16	63.17	393	76.33	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			275.8	D08		8	0014-0066	744.30	66.04	400	75.01	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			252.4	D08		8	0015-0073	691.30	73.55	412	75.01	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			295.4	D08		8	0016-0073	860.83	73.44	448	82.57	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			263.7	D08		8	0017-0075	834.89	75.31	412	77.26	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			212.3	D08		8	0018-0078	776.98	78.13	421	78.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.7	D08		8	0019-0082	174.03	82.31	390	78.08	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			572.4	D08		8	0020-0083	273.25	83.30	414	77.26	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.1	D08		8	0021-0092	219.98	92.53	851	121.05	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4121.2	D08		8	0022-0085	109.71	85.02	386	72.43	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			238.5	D08		8	0023-0088	17.17	87.83	451	82.08	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.8	D08		8	0024-0093	44.18	92.84	455	81.50	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			350.0	D08		8	0025-0094	894.42	94.34	407	76.43	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			358.4	D08		8	0026-0098	431.25	98.10	437	83.15	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			208.6	D08		8	0027-0100	366.00	100.19	409	76.67	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			285.7	D08		8	0028-0110	622.43	110.49	865	119.98	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.9	D08		8	0029-0107	652.75	107.06	446	81.01	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			271.1	D08		8	0030-0111	703.55	110.95	404	76.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			237.8	D08		8	0031-0113	73.92	113.83	409	77.84	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			338.3	D08		8	0032-0114	142.14	114.63	404	78.91	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3033.6	D08		8	0033-0116	682.50	115.95	406	75.36	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.3	D08		8	0034-0119	820.27	119.15	422	77.26	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			271.0	D08		8	0035-0132	728.98	132.30	480	86.57	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.0	D08		8	0036-0131	552.04	130.76	407	76.67	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			175.5	D08		8	0037-0141	469.46	141.36	908	135.68	0.620
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			318.5	D08		8	0038-0132	614.30	132.68	390	79.36	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			253.6	D08		8	0039-0144	279.56	144.71	608	95.64	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			217.7	D08		8	0040-0143	414.75	143.33	406	77.50	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			375.6	D08		8	0041-0154	61.26	154.33	437	80.33	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			231.7	D08		8	0042-0153	869.81	153.09	405	77.26	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			258.0	D08		8	0043-0157	138.42	157.09	429	82.08	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			256.9	D08		8	0044-0157	562.84	158.13	412	80.33	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			252.9	D08		8	0045-0159	165.70	159.40	498	90.81	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			179.7	D08		8	0046-0165	521.33	164.82	413	76.67	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			247.4	D08		8	0047-0167	739.78	167.56	428	78.08	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			659.9	D08		8	0048-0168	624.74	168.55	454	80.77	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			251.6	D08		8	0049-0183	567.41	184.60	849	121.78	0.719
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			199.0	D08		8	0050-0183	384.62	183.38	418	79.50	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			272.4	D08		8	0051-0184	277.53	185.34	517	86.53	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			280.0	D08		8	0052-0184	694.35	183.56	388	75.26	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			243.5	D08		8	0053-0186	890.52	186.22	434	79.84	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			276.9	D08		8	0054-0195	913.07	195.23	848	119.15	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			320.1	D08		8	0055-0198	206.93	198.85	984	120.71	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			601.3	D08		8	0056-0192	625.24	191.31	474	84.18	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4839.1	D08		8	0057-0200	484.87	201.08	671	104.37	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			710.0	D08		8	0058-0199	359.06	199.18	446	83.15	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			187.9	D08		8	0059-0200	527.88	200.43	408	79.15	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.3	D08		8	0060-0204	711.12	205.37	848	118.13	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.0	D08		8	0061-0205	666.68	205.58	439	80.67	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			238.2	D08		8	0062-0206	779.10	206.07	414	77.26	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			276.5	D08		8	0063-0214	276.88	213.77	792	116.43	0.734
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			301.0	D08		8	0064-0211	35.92	211.97	421	83.01	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			255.0	D08		8	0065-0211	447.74	211.02	441	84.23	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.8	D08		8	0066-0216	96.43	217.15	848	116.71	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			254.9	D08		8	0067-0217	253.06	216.84	436	81.01	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			287.7	D08		8	0068-0224	158.37	224.36	418	77.50	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			267.3	D08		8	0069-0228	583.30	228.46	464	85.15	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			423.5	D08		8	0070-0226	851.41	226.38	407	75.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			272.9	D08		8	0071-0237	309.49	237.76	822	113.40	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			268.2	D08		8	0072-0241	284.94	240.54	473	87.36	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.6	D08		8	0073-0242	529.69	242.68	413	77.26	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			202.0	D08		8	0074-0240	630.78	239.82	350	72.67	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			277.3	D08		8	0075-0244	789.97	244.51	403	78.33	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			250.1	D08		8	0076-0247	607.99	247.34	445	82.91	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			278.8	D08		8	0077-0260	332.57	260.05	459	82.67	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			727.9	D08		8	0078-0259	477.08	259.25	378	72.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			270.3	D08		8	0079-0260	692.38	261.20	452	80.53	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			245.0	D08		8	0080-0277	257.21	277.66	846	112.37	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1546.5	D08		8	0081-0276	832.37	276.41	609	96.33	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			199.6	D08		8	0082-0274	77.86	273.62	372	74.33	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.7	D08		8	0083-0277	649.69	277.28	452	78.67	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.5	D08		8	0084-0279	438.27	278.77	417	77.26	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			193.0	D08		8	0085-0284	185.71	284.27	400	77.74	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			953.3	D08		8	0086-0282	884.17	282.00	325	67.01	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.1	D08		8	0087-0284	913.06	284.55	406	75.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.4	D08		8	0088-0285	118.78	285.70	421	81.40	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			281.5	D08		8	0089-0284	691.85	283.76	461	83.36	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			240.8	D08		8	0090-0286	590.33	286.02	441	83.40	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			311.5	D08		8	0091-0289	62.19	290.24	495	87.05	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			275.8	D08		8	0092-0289	215.23	288.87	428	76.67	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.8	D08		8	0093-0292	545.64	292.36	775	106.23	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			278.3	D08		8	0094-0292	733.36	292.72	814	108.57	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			457.1	D08		8	0095-0292	385.56	292.55	865	120.81	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.5	D08		8	0096-0294	505.09	292.74	453	88.47	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			236.9	D08		8	0097-0301	945.77	302.32	413	79.26	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			243.2	D08		8	0098-0321	99.54	320.91	400	76.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			251.1	D08		8	0099-0321	502.87	321.41	431	77.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.1	D08		8	0100-0319	659.31	318.85	429	79.26	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			264.3	D08		8	0101-0336	890.29	336.90	826	119.68	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			238.4	D08		8	0102-0329	912.12	328.16	412	82.33	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			202.5	D08		8	0103-0332	28.83	332.23	415	79.15	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			329.0	D08		8	0104-0336	249.69	335.89	411	79.74	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.6	D08		8	0105-0334	844.38	334.08	456	79.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			217.8	D08		8	0106-0339	425.15	339.81	395	77.60	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.1	D08		8	0107-0340	652.93	341.37	469	84.91	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			769.2	D08		8	0108-0342	342.76	342.06	413	78.67	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			331.1	D08		8	0109-0341	386.82	341.56	467	83.50	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.4	D08		8	0110-0342	786.67	342.22	406	76.67	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.8	D08		8	0111-0348	449.67	347.65	724	104.91	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			175.1	D08		8	0112-0347	166.15	347.14	412	77.50	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			562.2	D08		8	0113-0358	547.03	358.86	868	122.85	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			561.5	D08		8	0114-0349	211.63	349.20	437	79.50	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			225.1	D08		8	0115-0357	711.60	357.80	419	78.91	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.4	D08		8	0116-0363	399.47	362.29	445	81.84	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			272.0	D08		8	0117-0372	497.55	372.35	460	81.84	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			195.7	D08		8	0118-0374	757.54	374.67	449	80.91	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.2	D08		8	0119-0376	601.74	376.51	426	79.74	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			230.9	D08		8	0120-0378	784.90	377.44	438	79.50	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			171.2	D08		8	0121-0381	304.43	382.27	420	80.18	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			181.5	D08		8	0122-0389	60.15	389.85	389	76.33	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			466.0	D08		8	0123-0393	428.91	394.39	864	118.37	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			244.9	D08		8	0124-0400	117.36	399.99	841	114.13	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			192.0	D08		8	0125-0391	520.05	391.20	456	84.91	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.6	D08		8	0126-0394	689.93	393.77	429	76.43	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			255.0	D08		8	0127-0396	907.28	396.73	421	79.84	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			269.1	D08		8	0128-0401	177.10	400.90	434	80.08	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			205.7	D08		8	0129-0403	15.32	402.92	373	72.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			194.3	D08		8	0130-0407	308.11	406.08	476	84.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.8	D08		8	0131-0405	651.10	405.55	421	78.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			245.5	D08		8	0132-0411	850.74	411.27	371	71.60	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			248.4	D08		8	0133-0413	581.10	413.40	417	79.74	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			267.4	D08		8	0134-0426	901.74	426.81	747	111.15	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			211.9	D08		8	0135-0421	543.54	421.25	415	78.08	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.5	D08		8	0136-0426	135.22	426.07	471	82.91	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			175.0	D08		8	0137-0427	707.94	427.17	405	75.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			247.1	D08		8	0138-0427	750.29	427.15	422	75.84	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			890.0	D08		8	0139-0434	360.23	432.85	438	79.40	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			244.3	D08		8	0140-0443	91.35	443.73	610	94.33	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			256.9	D08		8	0141-0443	856.02	443.55	415	77.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			212.2	D08		8	0142-0443	661.35	442.96	454	83.26	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			194.3	D08		8	0143-0444	808.91	444.31	394	76.08	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			713.2	D08		8	0144-0453	345.48	453.66	469	86.81	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.4	D08		8	0145-0451	637.49	450.89	417	77.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			236.3	D08		8	0146-0454	399.22	454.11	446	81.01	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			182.7	D08		8	0147-0455	420.93	455.57	486	86.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.3	D08		8	0148-0465	921.78	465.12	432	78.43	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			288.2	D08		8	0149-0465	558.52	464.69	343	71.26	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			216.2	D08		8	0150-0471	252.94	470.44	407	78.77	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			212.0	D08		8	0151-0477	732.29	477.24	423	78.91	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			179.5	D08		8	0152-0476	882.86	476.52	399	73.84	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			451.9	D08		8	0153-0485	32.98	484.12	857	113.54	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			225.8	D08		8	0154-0480	451.55	479.73	419	78.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			190.3	D08		8	0155-0481	500.13	481.23	432	84.33	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			167.6	D08		8	0156-0483	808.31	482.90	444	80.08	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.0	D08		8	0157-0482	830.66	481.79	391	81.01	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			208.9	D08		8	0158-0482	622.88	482.80	407	76.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			252.2	D08		8	0159-0485	145.41	485.34	387	77.50	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			236.5	D08		8	0160-0486	206.87	486.52	415	77.50	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.8	D08		8	0161-0488	778.91	488.46	406	77.50	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.9	D08		8	0162-0493	848.55	493.51	516	89.50	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2330.7	D08		8	0163-0488	409.37	488.78	298	66.08	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			246.3	D08		8	0164-0493	365.42	493.59	435	79.50	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			203.7	D08		8	0165-0496	569.92	495.85	422	79.50	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.5	D08		8	0166-0505	741.58	505.90	442	83.60	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.8	D08		8	0167-0506	480.71	505.89	443	81.84	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			274.8	D08		8	0168-0518	915.18	518.32	720	110.57	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			231.2	D08		8	0169-0515	647.73	514.94	420	78.08	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			225.8	D08		8	0170-0518	256.99	518.51	433	79.50	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.2	D08		8	0171-0523	135.34	522.72	392	76.08	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			208.3	D08		8	0172-0526	814.97	525.92	410	80.33	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			176.4	D08		8	0173-0526	194.48	526.48	394	76.08	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			265.0	D08		8	0174-0525	931.41	524.85	175	53.11	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			200.3	D08		8	0175-0535	746.35	535.25	891	126.47	0.700
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2204.1	D08		8	0176-0527	460.85	527.21	391	72.77	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			258.1	D08		8	0177-0528	366.17	528.27	407	78.67	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.4	D08		8	0178-0533	545.31	532.49	555	92.57	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			361.0	D08		8	0179-0544	226.15	544.19	422	78.08	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			199.4	D08		8	0180-0546	793.33	547.02	405	80.91	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.0	D08		8	0181-0552	696.30	551.94	410	78.67	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.3	D08		8	0182-0560	85.58	559.71	859	121.54	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			225.9	D08		8	0183-0556	404.04	556.74	407	75.50	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			333.6	D08		8	0184-0562	515.01	562.26	465	81.50	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			193.9	D08		8	0185-0564	800.48	565.21	445	86.08	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			212.0	D08		8	0186-0569	173.02	569.09	399	75.50	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			183.2	D08		8	0187-0573	556.41	572.86	403	75.60	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.4	D08		8	0188-0578	641.51	577.83	422	78.08	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			198.4	D08		8	0189-0579	740.58	578.80	406	75.50	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			268.3	D08		8	0190-0580	875.42	580.14	437	78.67	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			291.1	D08		8	0191-0585	44.22	584.44	406	84.81	0.709
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			203.2	D08		8	0192-0581	586.30	581.20	404	75.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			353.9	D08		8	0193-0583	324.64	583.53	438	79.50	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			245.0	D08		8	0194-0589	212.22	589.69	435	82.08	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			212.6	D08		8	0195-0595	263.91	595.35	398	77.50	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.5	D08		8	0196-0598	426.67	598.42	443	82.08	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			302.4	D08		8	0197-0612	39.00	612.44	432	80.57	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.9	D08		8	0198-0611	929.51	611.62	403	79.26	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1921.9	D08		8	0199-0621	82.16	621.05	720	100.57	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			240.6	D08		8	0200-0621	208.06	621.77	573	90.33	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			208.0	D08		8	0201-0619	718.53	619.30	403	74.67	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			254.5	D08		8	0202-0622	429.32	621.30	451	81.26	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			202.8	D08		8	0203-0624	604.82	624.31	425	79.98	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			280.1	D08		8	0204-0627	514.44	626.81	430	80.33	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			321.6	D08		8	0205-0639	318.06	638.75	414	76.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			204.0	D08		8	0206-0639	773.47	638.91	418	77.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			212.8	D08		8	0207-0641	142.44	641.40	392	76.57	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			242.7	D08		8	0208-0646	177.28	646.96	409	76.67	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			684.8	D08		8	0209-0650	67.26	650.15	436	79.26	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.2	D08		8	0210-0654	406.54	654.12	430	80.33	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			245.3	D08		8	0211-0660	226.56	660.44	421	78.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			231.2	D08		8	0212-0678	607.91	679.11	851	119.88	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.3	D08		8	0213-0674	926.64	673.75	396	75.26	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			238.3	D08		8	0214-0684	414.35	684.91	457	82.67	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1016.3	D08		8	0215-0693	180.42	693.41	765	108.13	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			570.3	D08		8	0216-0691	15.47	691.18	411	78.57	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.7	D08		8	0217-0695	389.16	695.35	428	82.57	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			182.5	D08		8	0218-0706	316.19	706.84	392	73.26	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			182.1	D08		9	0001-0031	802.21	31.36	377	73.60	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			198.4	D08		9	0002-0031	211.44	31.27	365	70.43	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			243.0	D08		9	0003-0036	582.69	37.25	373	73.74	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.3	D08		9	0004-0037	315.18	36.46	417	77.94	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			183.1	D08		9	0005-0040	243.56	39.76	391	75.26	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			194.8	D08		9	0006-0040	69.25	40.63	358	71.26	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.8	D08		9	0007-0043	158.62	42.87	383	74.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			204.7	D08		9	0008-0044	549.39	44.18	431	78.67	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			230.5	D08		9	0009-0044	838.91	44.74	396	74.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			185.2	D08		9	0010-0049	433.97	48.43	422	76.43	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			262.0	D08		9	0011-0056	108.85	56.12	370	71.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			180.1	D08		9	0012-0061	197.89	61.33	371	70.18	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			196.2	D08		9	0013-0063	232.85	63.48	376	74.77	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			225.0	D08		9	0014-0066	12.61	65.95	363	72.67	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			510.1	D08		9	0015-0074	412.99	73.90	420	78.18	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			189.2	D08		9	0016-0073	311.53	73.06	398	75.60	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			237.1	D08		9	0017-0078	615.73	77.56	424	77.84	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			226.1	D08		9	0018-0078	693.87	78.19	421	80.91	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			218.0	D08		9	0019-0081	174.00	80.92	364	74.43	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			179.1	D08		9	0020-0082	740.74	81.87	394	75.26	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			198.9	D08		9	0021-0084	358.91	84.33	395	74.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			253.8	D08		9	0022-0085	480.27	85.05	398	73.60	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.9	D08		9	0023-0091	867.98	90.87	374	72.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			189.8	D08		9	0024-0095	909.04	95.92	425	77.84	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.9	D08		9	0025-0095	122.55	94.82	359	70.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			204.2	D08		9	0026-0096	307.62	95.97	396	75.84	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.2	D08		9	0027-0100	709.31	100.82	473	83.26	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			272.2	D08		9	0028-0104	165.47	104.90	558	90.91	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			267.9	D08		9	0029-0102	609.70	102.70	415	76.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			252.8	D08		9	0030-0104	250.84	103.66	451	81.64	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			198.7	D08		9	0031-0101	932.48	101.56	414	79.11	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			207.9	D08		9	0032-0111	651.76	110.71	396	74.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			234.5	D08		9	0033-0117	265.59	118.91	350	71.15	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			237.5	D08		9	0034-0120	94.20	120.25	375	72.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.8	D08		9	0035-0127	711.28	125.36	426	82.33	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			251.6	D08		9	0036-0130	208.51	130.00	397	76.67	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			316.1	D08		9	0037-0134	141.97	134.27	378	75.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.0	D08		9	0038-0135	693.09	136.57	410	78.08	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			263.8	D08		9	0039-0138	866.97	137.64	357	70.43	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			356.9	D08		9	0040-0139	51.12	140.05	347	69.01	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.9	D08		9	0041-0140	353.61	139.65	376	72.18	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.5	D08		9	0042-0139	414.94	138.93	402	79.60	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			237.7	D08		9	0043-0140	286.49	139.79	389	74.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			245.9	D08		9	0044-0140	439.97	140.48	424	77.94	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			234.4	D08		9	0045-0145	914.10	145.16	386	72.43	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			341.0	D08		9	0046-0149	481.63	148.96	445	79.26	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.9	D08		9	0047-0159	553.86	159.17	840	114.91	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			286.9	D08		9	0048-0153	211.82	153.04	407	76.43	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			420.4	D08		9	0049-0159	99.45	159.36	413	77.74	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			246.5	D08		9	0050-0159	341.79	159.62	373	73.84	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2917.8	D08		9	0051-0159	277.39	159.59	351	69.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.6	D08		9	0052-0163	636.04	163.74	429	78.77	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			191.1	D08		9	0053-0163	660.28	162.67	412	76.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			362.4	D08		9	0054-0169	602.12	169.55	466	80.18	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.3	D08		9	0055-0169	465.80	168.72	422	78.67	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			517.9	D08		9	0056-0173	48.26	174.07	357	72.43	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			256.9	D08		9	0057-0179	376.57	178.90	426	79.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			288.0	D08		9	0058-0180	860.74	180.33	366	70.77	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.0	D08		9	0059-0187	683.04	187.15	393	76.43	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			340.0	D08		9	0060-0186	178.54	186.46	374	72.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			258.5	D08		9	0061-0196	298.97	196.05	817	112.91	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			259.2	D08		9	0062-0196	783.01	196.00	386	74.91	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			261.6	D08		9	0063-0204	102.44	205.02	417	78.91	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			294.6	D08		9	0064-0206	210.89	206.94	381	77.60	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			261.5	D08		9	0065-0209	412.21	209.50	459	80.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			251.4	D08		9	0066-0212	241.57	212.44	368	74.43	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.8	D08		9	0067-0210	391.73	210.62	391	73.70	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			318.2	D08		9	0068-0214	460.20	214.19	731	100.81	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			270.5	D08		9	0069-0212	681.99	212.12	440	80.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			265.7	D08		9	0070-0211	641.53	211.36	385	75.26	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			234.4	D08		9	0071-0215	571.82	215.76	385	74.67	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			285.9	D08		9	0072-0221	357.76	220.80	429	79.26	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			246.2	D08		9	0073-0222	309.49	222.98	389	78.18	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			292.0	D08		9	0074-0223	739.20	223.72	392	76.08	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			277.2	D08		9	0075-0227	205.50	226.76	434	80.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			252.6	D08		9	0076-0233	522.04	232.65	722	103.40	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			350.6	D08		9	0077-0233	717.89	233.06	548	93.40	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			374.7	D08		9	0078-0232	882.86	231.82	374	71.60	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.5	D08		9	0079-0242	370.93	242.04	567	91.74	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			305.9	D08		9	0080-0244	793.57	244.69	404	75.26	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			238.0	D08		9	0081-0247	296.20	247.12	377	73.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			234.8	D08		9	0082-0251	259.12	251.10	369	72.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			261.9	D08		9	0083-0251	549.31	251.59	444	78.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			240.1	D08		9	0084-0250	180.46	250.07	376	73.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			253.1	D08		9	0085-0252	587.08	251.82	386	75.84	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			208.2	D08		9	0086-0255	153.26	255.91	388	75.50	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			181.7	D08		9	0087-0256	77.61	256.50	386	74.43	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.9	D08		9	0088-0258	514.86	258.37	395	75.84	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			371.3	D08		9	0089-0258	846.26	258.51	396	73.01	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			256.5	D08		9	0090-0264	324.38	263.88	658	94.91	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			411.0	D08		9	0091-0262	671.84	262.19	432	80.91	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			237.8	D08		9	0092-0257	915.92	257.74	364	71.94	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			251.9	D08		9	0093-0264	887.34	264.27	349	75.36	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			255.0	D08		9	0094-0273	410.97	273.28	409	75.01	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4139.7	D08		9	0095-0274	472.81	274.16	308	64.77	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			211.1	D08		9	0096-0280	581.72	280.94	420	76.08	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			647.3	D08		9	0097-0281	658.64	281.64	406	74.67	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.4	D08		9	0098-0283	791.94	282.76	373	73.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.4	D08		9	0099-0282	893.76	282.59	393	79.70	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			211.0	D08		9	0100-0289	208.49	288.97	393	76.08	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.6	D08		9	0101-0297	517.43	296.76	791	111.40	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			185.4	D08		9	0102-0291	73.87	291.40	377	71.84	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			264.4	D08		9	0103-0295	920.34	294.67	394	75.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.9	D08		9	0104-0296	719.32	296.25	389	76.08	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			257.1	D08		9	0105-0297	820.86	296.95	387	73.84	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			179.8	D08		9	0106-0304	162.89	304.23	724	104.57	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.8	D08		9	0107-0296	383.18	295.94	379	73.01	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			260.6	D08		9	0108-0298	261.09	298.23	391	73.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			192.7	D08		9	0109-0301	126.12	301.54	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			222.9	D08		9	0110-0301	900.33	301.91	402	82.18	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			176.1	D08		9	0111-0305	40.73	305.65	391	77.01	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.4	D08		9	0112-0306	200.21	307.44	419	82.91	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			249.1	D08		9	0113-0312	434.13	312.14	409	75.26	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			211.9	D08		9	0114-0316	880.46	315.48	381	73.50	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			184.1	D08		9	0115-0323	60.64	322.66	395	77.84	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			238.4	D08		9	0116-0324	317.09	323.94	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			277.2	D08		9	0117-0326	248.09	326.70	408	73.60	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			253.6	D08		9	0118-0325	635.30	324.89	385	73.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			298.9	D08		9	0119-0328	373.64	328.69	414	76.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			288.5	D08		9	0120-0333	478.24	333.17	391	73.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			226.8	D08		9	0121-0334	518.50	334.38	419	77.01	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			252.6	D08		9	0122-0340	574.93	340.26	413	75.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			187.1	D08		9	0123-0342	132.05	341.66	397	74.08	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.4	D08		9	0124-0346	929.21	345.80	380	75.94	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			236.9	D08		9	0125-0351	225.07	350.96	642	95.74	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.7	D08		9	0126-0349	846.02	349.50	381	73.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			271.7	D08		9	0127-0354	682.81	354.31	438	83.98	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			276.9	D08		9	0128-0358	520.07	357.55	423	78.18	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.4	D08		9	0129-0361	313.84	360.59	408	78.18	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			309.1	D08		9	0130-0361	810.32	360.87	426	77.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			240.7	D08		9	0131-0368	888.14	368.11	827	118.81	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.9	D08		9	0132-0365	295.33	366.12	359	75.21	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.8	D08		9	0133-0368	275.28	367.58	453	82.04	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			188.0	D08		9	0134-0369	122.11	369.40	389	76.43	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			188.7	D08		9	0135-0373	189.40	373.03	404	79.15	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			205.0	D08		9	0136-0384	71.53	384.19	382	74.43	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			207.1	D08		9	0137-0388	237.86	388.08	742	104.23	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			281.7	D08		9	0138-0391	207.08	391.67	461	83.84	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			286.1	D08		9	0139-0390	590.14	390.31	388	74.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.6	D08		9	0140-0391	753.46	391.08	394	74.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			528.8	D08		9	0141-0405	506.02	405.02	627	95.64	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			504.8	D08		9	0142-0409	630.87	409.11	412	75.60	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			244.1	D08		9	0143-0415	912.32	415.15	681	102.81	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			377.1	D08		9	0144-0413	410.62	413.37	395	73.84	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.8	D08		9	0145-0416	296.49	416.09	609	92.91	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			291.1	D08		9	0146-0415	210.30	414.22	360	72.53	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.7	D08		9	0147-0421	943.69	422.81	390	94.57	0.548
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.0	D08		9	0148-0424	144.14	422.40	940	120.95	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			249.6	D08		9	0149-0418	568.80	418.83	391	73.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			254.2	D08		9	0150-0426	458.36	426.56	387	71.60	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			334.4	D08		9	0151-0433	80.54	432.57	370	74.91	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			254.6	D08		9	0152-0439	352.40	439.52	386	74.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.5	D08		9	0153-0447	256.37	447.18	381	78.67	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			225.3	D08		9	0154-0450	757.46	449.77	377	73.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			242.6	D08		9	0155-0454	560.48	453.62	385	73.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			278.8	D08		9	0156-0458	870.25	458.05	663	95.74	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			181.0	D08		9	0157-0458	205.69	458.53	371	71.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			331.9	D08		9	0158-0458	329.27	458.74	406	75.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.3	D08		9	0159-0458	650.51	458.66	398	75.26	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.3	D08		9	0160-0462	520.47	462.25	402	75.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			210.7	D08		9	0161-0467	263.57	467.17	452	83.26	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			175.8	D08		9	0162-0468	16.54	467.93	374	71.84	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			282.1	D08		9	0163-0472	403.79	472.47	402	76.18	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.1	D08		9	0164-0477	903.92	477.48	517	86.33	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			185.3	D08		9	0165-0492	90.84	491.39	786	115.40	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.1	D08		9	0166-0487	942.99	487.59	362	71.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.2	D08		9	0167-0499	186.12	500.16	391	75.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.4	D08		9	0168-0502	514.94	502.30	403	74.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			356.4	D08		9	0169-0509	862.02	509.84	373	71.84	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			254.8	D08		9	0170-0512	468.13	511.72	397	75.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			238.3	D08		9	0171-0513	775.33	513.07	380	74.67	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			218.8	D08		9	0172-0517	556.44	516.30	415	79.50	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			238.5	D08		9	0173-0520	270.30	519.66	642	94.33	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			193.8	D08		9	0174-0520	181.41	520.11	444	82.18	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.9	D08		9	0175-0532	226.41	531.71	396	73.84	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1674.1	D08		9	0176-0537	542.74	538.48	362	74.77	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			245.9	D08		9	0177-0540	403.69	540.32	346	69.94	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1201.3	D08		9	0178-0545	561.00	545.00	297	67.60	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			202.1	D08		9	0179-0544	944.64	544.28	384	73.26	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1980.1	D08		9	0180-0546	841.98	546.34	389	72.43	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			264.8	D08		9	0181-0550	301.68	550.16	392	73.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.1	D08		9	0182-0561	415.75	561.58	694	106.23	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1397.8	D08		9	0183-0555	544.47	555.11	252	61.46	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			288.6	D08		9	0184-0562	514.95	562.28	417	76.67	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			311.1	D08		9	0185-0569	793.03	569.10	400	75.84	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			265.5	D08		9	0186-0572	258.47	571.14	339	70.91	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.1	D08		9	0187-0582	210.17	582.11	368	73.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			287.5	D08		9	0188-0584	273.44	585.56	492	85.88	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			485.9	D08		9	0189-0583	903.29	582.47	449	79.50	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			263.4	D08		9	0190-0586	660.06	585.62	380	73.84	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			365.3	D08		9	0191-0595	175.90	595.08	377	73.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.5	D08		9	0192-0601	327.94	601.43	383	73.01	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.8	D08		9	0193-0602	461.92	602.65	373	71.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.7	D08		9	0194-0611	659.43	611.53	398	74.67	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			187.9	D08		9	0195-0611	904.60	611.52	385	73.26	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			173.1	D08		9	0196-0615	23.70	614.59	387	75.01	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			193.8	D08		9	0197-0621	489.54	621.59	400	74.43	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.0	D08		9	0198-0623	814.69	623.36	394	74.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			207.0	D08		9	0199-0627	281.70	626.41	385	73.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			176.6	D08		9	0200-0631	862.18	631.39	385	73.60	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			182.5	D08		9	0201-0634	165.99	634.41	427	77.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.9	D08		9	0202-0648	628.33	646.60	406	78.33	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			225.9	D08		9	0203-0647	399.11	647.27	413	76.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			701.4	D08		9	0204-0647	522.59	648.08	369	73.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			196.0	D08		9	0205-0652	900.01	652.45	351	69.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			173.3	D08		9	0206-0655	100.16	655.09	375	76.33	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			277.7	D08		9	0207-0663	616.05	664.54	508	86.57	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			201.0	D08		9	0208-0667	123.12	666.61	455	80.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			179.0	D08		9	0209-0669	561.54	668.87	382	72.43	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			177.2	D08		9	0210-0676	20.62	676.36	402	73.84	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.8	D08		9	0211-0678	512.28	677.79	408	75.50	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			196.7	D08		9	0212-0678	676.22	677.75	470	82.08	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.5	D08		9	0213-0694	165.23	693.52	415	76.91	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			205.3	D08		9	0214-0699	536.83	699.76	921	117.30	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			226.0	D08		9	0215-0693	258.74	693.52	405	75.26	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.6	D08		9	0216-0696	605.92	696.41	379	73.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			177.5	D08		9	0217-0700	784.99	699.49	381	74.67	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			166.1	E08		1	0001-0030	45.07	30.65	419	80.67	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			257.1	E08		1	0002-0042	167.76	42.28	443	77.60	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			252.5	E08		1	0003-0041	625.93	41.06	415	75.01	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			373.6	E08		1	0004-0042	714.23	42.07	387	73.01	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			583.6	E08		1	0005-0046	412.33	45.77	490	84.57	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			189.3	E08		1	0006-0048	453.57	48.42	492	82.08	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			248.2	E08		1	0007-0053	567.12	53.63	471	82.08	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			315.4	E08		1	0008-0063	182.59	62.93	485	84.33	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.0	E08		1	0009-0067	34.57	67.11	550	86.91	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			237.6	E08		1	0010-0075	78.32	74.79	442	77.84	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			263.3	E08		1	0011-0073	829.94	73.27	221	56.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			278.3	E08		1	0012-0088	611.67	88.17	454	79.26	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			260.7	E08		1	0013-0088	502.07	88.60	548	90.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			205.1	E08		1	0014-0086	852.50	87.02	282	66.53	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			287.1	E08		1	0015-0091	719.29	91.65	462	80.08	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			252.1	E08		1	0016-0091	524.71	92.67	373	76.53	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			267.4	E08		1	0017-0098	47.05	98.76	435	77.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			336.6	E08		1	0018-0100	168.02	100.31	424	76.43	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			230.8	E08		1	0019-0100	281.75	99.91	402	73.60	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			230.6	E08		1	0020-0101	804.02	101.06	404	76.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			248.8	E08		1	0021-0101	759.55	101.44	445	79.84	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			316.6	E08		1	0022-0107	241.68	107.62	782	109.05	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			245.1	E08		1	0023-0107	355.42	107.05	439	76.43	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			303.9	E08		1	0024-0114	690.88	114.24	486	81.84	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			230.9	E08		1	0025-0121	127.38	120.85	508	89.74	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			251.0	E08		1	0026-0128	900.25	128.11	430	79.60	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			249.9	E08		1	0027-0133	881.34	132.98	363	74.18	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			273.5	E08		1	0028-0136	456.29	136.38	497	86.77	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			293.7	E08		1	0029-0143	481.89	143.29	489	88.67	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			212.8	E08		1	0030-0146	52.86	146.04	428	76.43	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			723.0	E08		1	0031-0149	733.33	148.93	470	84.08	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			212.0	E08		1	0032-0152	636.15	151.24	411	81.50	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.4	E08		1	0033-0156	179.65	155.98	413	75.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			250.1	E08		1	0034-0158	695.52	158.70	454	79.26	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			243.6	E08		1	0035-0163	356.63	163.51	438	80.67	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2551.7	E08		1	0036-0167	538.52	166.59	422	77.26	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			225.2	E08		1	0037-0167	625.67	168.24	495	85.74	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			471.2	E08		1	0038-0181	256.69	180.51	798	105.40	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			277.2	E08		1	0039-0177	940.24	176.77	643	113.98	0.622
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			363.2	E08		1	0040-0182	919.56	184.38	246	70.43	0.623
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			253.8	E08		1	0041-0188	417.75	187.91	483	82.91	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.5	E08		1	0042-0193	890.39	193.06	442	76.67	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			258.6	E08		1	0043-0198	114.34	198.34	433	77.84	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.3	E08		1	0044-0197	159.98	196.69	427	75.84	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			244.0	E08		1	0045-0199	194.67	198.65	454	80.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			240.8	E08		1	0046-0201	473.12	201.79	429	77.26	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			190.0	E08		1	0047-0203	52.74	203.81	405	75.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			237.0	E08		1	0048-0205	90.17	204.94	458	80.91	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			245.0	E08		1	0049-0205	597.63	204.93	433	76.43	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			323.3	E08		1	0050-0207	801.58	207.66	443	78.67	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			259.1	E08		1	0051-0216	416.35	216.78	451	79.50	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			225.9	E08		1	0052-0222	646.65	223.11	432	79.50	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			387.6	E08		1	0053-0228	871.80	227.91	434	78.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			279.0	E08		1	0054-0226	549.57	226.53	449	78.43	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			640.6	E08		1	0055-0228	840.53	228.39	456	82.33	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			189.3	E08		1	0056-0230	38.92	230.56	395	73.26	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			247.7	E08		1	0057-0245	203.72	245.39	997	129.78	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			217.4	E08		1	0058-0242	477.31	241.90	432	77.26	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			258.7	E08		1	0059-0243	328.76	243.39	580	90.08	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			297.8	E08		1	0060-0251	898.82	251.02	446	77.84	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			211.9	E08		1	0061-0252	519.77	252.54	428	77.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			258.4	E08		1	0062-0253	294.10	253.48	444	77.84	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			316.6	E08		1	0063-0253	767.58	253.20	426	77.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			311.2	E08		1	0064-0262	151.82	262.30	429	77.01	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			489.0	E08		1	0065-0269	833.89	269.22	638	92.91	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			246.9	E08		1	0066-0272	70.77	270.22	706	105.30	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			410.3	E08		1	0067-0269	232.72	268.95	431	77.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.2	E08		1	0068-0269	364.87	269.58	436	79.50	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			240.1	E08		1	0069-0270	581.58	269.89	455	79.26	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			198.6	E08		1	0070-0281	485.61	280.87	432	78.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.7	E08		1	0071-0289	84.53	290.53	682	104.71	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			253.3	E08		1	0072-0289	194.45	288.69	460	80.67	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			230.4	E08		1	0073-0288	264.75	288.32	431	77.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			265.9	E08		1	0074-0293	797.62	293.31	481	84.08	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			240.5	E08		1	0075-0305	755.92	305.48	433	77.26	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.3	E08		1	0076-0304	24.11	305.07	407	77.26	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.9	E08		1	0077-0304	106.05	305.36	391	74.08	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.9	E08		1	0078-0311	708.14	311.30	480	83.74	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			210.7	E08		1	0079-0324	426.88	324.06	459	80.67	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			217.3	E08		1	0080-0325	155.70	324.92	410	75.26	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.3	E08		1	0081-0325	510.81	325.96	429	79.50	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			247.8	E08		1	0082-0328	277.00	327.76	413	75.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			428.7	E08		1	0083-0342	555.08	342.00	894	117.64	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			279.0	E08		1	0084-0345	354.40	344.76	908	122.57	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			276.3	E08		1	0085-0336	328.34	336.14	460	79.60	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			264.0	E08		1	0086-0337	189.42	337.44	426	77.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1452.1	E08		1	0087-0339	465.96	338.48	395	75.70	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			193.5	E08		1	0088-0339	801.06	339.25	480	81.26	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1519.3	E08		1	0089-0341	484.56	340.81	352	70.87	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			203.1	E08		1	0090-0351	904.71	350.58	428	78.08	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.1	E08		1	0091-0352	928.99	351.53	454	80.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			216.5	E08		1	0092-0351	95.71	351.12	406	75.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			275.6	E08		1	0093-0357	647.60	356.77	433	78.91	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			267.5	E08		1	0094-0370	457.83	370.44	943	123.64	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.9	E08		1	0095-0361	501.42	360.90	351	71.94	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			331.6	E08		1	0096-0371	663.63	371.45	456	84.57	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			245.3	E08		1	0097-0368	188.22	368.04	436	79.50	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			252.1	E08		1	0098-0371	596.97	371.40	448	79.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.7	E08		1	0099-0370	63.32	370.48	412	78.08	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.2	E08		1	0100-0369	275.88	369.77	423	76.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			237.8	E08		1	0101-0379	508.26	379.37	483	86.67	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			289.6	E08		1	0102-0380	816.50	380.84	437	79.50	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			338.3	E08		1	0103-0392	674.25	392.50	491	83.26	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.8	E08		1	0104-0392	134.34	392.60	425	76.43	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			262.0	E08		1	0105-0395	787.89	394.74	460	80.08	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			270.6	E08		1	0106-0397	710.62	397.69	428	77.84	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.9	E08		1	0107-0404	622.35	404.81	425	77.26	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			252.8	E08		1	0108-0408	927.12	408.71	622	92.91	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.8	E08		1	0109-0408	202.68	407.87	460	82.08	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			226.6	E08		1	0110-0410	447.45	410.02	447	79.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			190.0	E08		1	0111-0410	524.60	409.87	428	77.26	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.2	E08		1	0112-0412	230.55	412.57	450	80.08	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			201.8	E08		1	0113-0421	62.27	421.92	824	114.71	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			328.2	E08		1	0114-0414	389.83	414.33	420	76.91	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.9	E08		1	0115-0418	264.20	418.41	416	76.67	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			248.7	E08		1	0116-0419	884.01	419.03	418	77.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			195.8	E08		1	0117-0420	149.68	421.22	460	85.50	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			216.8	E08		1	0118-0424	786.24	424.27	462	82.18	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			285.8	E08		1	0119-0424	585.75	424.81	484	82.08	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.4	E08		1	0120-0424	113.98	424.14	456	78.67	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.6	E08		1	0121-0430	738.05	430.83	419	75.84	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.5	E08		1	0122-0437	548.25	437.22	430	77.26	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			247.3	E08		1	0123-0443	679.62	443.50	452	78.43	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			249.2	E08		1	0124-0452	452.68	451.69	956	125.68	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			211.9	E08		1	0125-0455	21.35	455.63	811	114.33	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			383.4	E08		1	0126-0448	861.22	449.47	388	74.04	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			216.8	E08		1	0127-0452	942.36	452.57	419	78.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			182.5	E08		1	0128-0455	97.13	455.50	413	79.84	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			248.4	E08		1	0129-0458	378.27	458.43	435	76.67	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			210.6	E08		1	0130-0461	192.39	459.84	436	78.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			200.7	E08		1	0131-0460	249.49	459.97	406	74.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.5	E08		1	0132-0463	493.64	462.81	434	78.08	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			242.8	E08		1	0133-0462	739.66	462.49	417	77.26	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.2	E08		1	0134-0470	301.00	469.97	456	82.08	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			225.5	E08		1	0135-0469	532.78	469.25	421	78.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			258.7	E08		1	0136-0467	582.60	466.82	405	74.18	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			305.0	E08		1	0137-0473	855.50	471.79	473	91.84	0.705
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			247.7	E08		1	0138-0475	110.41	475.53	551	93.60	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			250.3	E08		1	0139-0477	875.10	477.05	463	83.15	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			210.8	E08		1	0140-0476	680.21	476.62	444	77.84	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			194.3	E08		1	0141-0480	136.78	480.05	414	77.36	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.7	E08		1	0142-0490	209.33	490.94	904	124.23	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			217.9	E08		1	0143-0486	620.14	486.40	460	80.67	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			238.3	E08		1	0144-0485	752.77	484.45	423	76.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.1	E08		1	0145-0495	165.67	495.01	458	79.26	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			254.6	E08		1	0146-0498	885.52	498.56	448	80.33	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			252.9	E08		1	0147-0496	358.26	496.12	412	75.84	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			212.4	E08		1	0148-0502	272.90	501.84	428	78.08	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.8	E08		1	0149-0503	538.56	503.36	440	79.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			212.6	E08		1	0150-0504	591.68	504.75	436	77.84	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.4	E08		1	0151-0508	54.27	507.66	446	82.33	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.8	E08		1	0152-0510	455.95	510.37	437	78.91	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			274.4	E08		1	0153-0520	219.13	519.44	450	81.36	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			271.2	E08		1	0154-0522	187.38	522.40	432	83.50	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			253.5	E08		1	0155-0523	792.97	523.36	427	78.67	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			226.4	E08		1	0156-0527	307.68	528.11	430	80.53	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			311.3	E08		1	0157-0531	68.21	531.31	459	82.08	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			231.3	E08		1	0158-0529	624.88	529.41	418	77.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			197.9	E08		1	0159-0530	716.03	530.46	419	75.84	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2237.5	E08		1	0160-0529	850.33	529.04	149	80.57	0.288
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			321.7	E08		1	0161-0537	112.53	537.02	423	76.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			184.0	E08		1	0162-0543	18.86	543.23	388	76.08	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.1	E08		1	0163-0545	650.13	545.60	446	80.33	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			352.8	E08		1	0164-0546	936.83	546.77	456	82.43	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.9	E08		1	0165-0547	407.42	546.67	432	77.26	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.0	E08		1	0166-0549	307.82	547.82	469	84.53	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.5	E08		1	0167-0550	162.08	550.18	396	76.43	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			211.6	E08		1	0168-0550	588.08	550.21	436	76.43	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.3	E08		1	0169-0558	202.67	558.45	848	115.54	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			184.8	E08		1	0170-0555	49.17	555.21	173	51.11	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			242.8	E08		1	0171-0559	264.46	558.77	440	77.60	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			363.7	E08		1	0172-0567	884.03	567.85	446	79.84	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			202.8	E08		1	0173-0568	916.26	568.48	440	81.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			291.2	E08		1	0174-0569	340.67	568.74	461	80.91	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.6	E08		1	0175-0575	375.94	575.06	717	100.57	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			244.3	E08		1	0176-0572	492.05	571.93	452	79.26	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			247.6	E08		1	0177-0584	120.96	583.77	855	117.50	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.0	E08		1	0178-0588	729.45	587.53	442	78.67	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.1	E08		1	0179-0600	777.15	599.75	450	80.67	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			157.1	E08		1	0180-0601	931.97	601.38	424	78.91	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			255.4	E08		1	0181-0604	627.24	604.09	475	82.91	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			250.9	E08		1	0182-0606	347.15	606.58	459	81.26	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			266.6	E08		1	0183-0618	391.24	618.44	390	73.84	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			193.8	E08		1	0184-0620	797.93	620.38	546	91.60	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			217.4	E08		1	0185-0637	64.60	637.63	890	119.30	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			236.4	E08		1	0186-0631	719.70	631.93	467	81.60	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			258.7	E08		1	0187-0631	176.97	631.35	403	76.67	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			259.5	E08		1	0188-0631	697.91	631.62	408	74.53	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			244.3	E08		1	0189-0632	215.71	632.05	430	79.50	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.3	E08		1	0190-0637	18.73	637.73	398	78.91	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			238.5	E08		1	0191-0635	553.23	634.85	420	77.26	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			259.7	E08		1	0192-0640	93.70	640.64	451	79.74	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			236.9	E08		1	0193-0639	869.53	638.74	414	76.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			270.8	E08		1	0194-0643	330.43	643.90	423	76.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			247.9	E08		1	0195-0655	426.54	655.75	880	119.05	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.7	E08		1	0196-0651	773.20	651.09	440	77.84	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.5	E08		1	0197-0655	649.45	655.53	469	82.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			322.9	E08		1	0198-0655	388.48	654.75	422	78.67	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			711.0	E08		1	0199-0654	481.44	654.30	409	75.01	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.6	E08		1	0200-0660	517.44	660.08	452	80.91	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			193.3	E08		1	0201-0661	932.46	661.06	366	71.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			284.2	E08		1	0202-0662	256.71	662.73	437	83.60	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			302.8	E08		1	0203-0666	826.30	664.91	413	79.15	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			314.3	E08		1	0204-0678	175.43	678.36	407	77.11	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			202.1	E08		1	0205-0678	554.22	678.45	450	81.26	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			246.8	E08		1	0206-0678	633.42	677.98	463	82.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			187.6	E08		1	0207-0678	841.42	678.77	388	74.33	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			378.1	E08		1	0208-0682	195.20	682.98	450	81.11	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			348.5	E08		1	0209-0683	262.51	682.34	435	82.18	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			193.3	E08		1	0210-0688	499.60	687.89	420	78.43	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			234.6	E08		1	0211-0690	890.26	690.34	383	71.60	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			231.0	E08		1	0212-0693	757.85	693.38	439	78.08	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			267.4	E08		1	0213-0695	110.13	695.18	404	77.50	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			191.3	E08		1	0214-0702	565.03	701.68	495	86.08	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			208.4	E08		1	0215-0707	378.50	706.73	399	75.84	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1118.9	E08		1	0216-0708	471.87	707.00	351	73.26	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			198.0	E08		2	0001-0027	890.67	26.94	374	73.01	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.6	E08		2	0002-0034	802.74	33.78	411	77.26	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			210.4	E08		2	0003-0044	398.89	44.05	408	77.50	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.1	E08		2	0004-0045	267.59	45.26	384	75.01	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.6	E08		2	0005-0060	539.47	60.49	420	77.26	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			247.5	E08		2	0006-0061	333.18	61.84	459	82.67	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			249.0	E08		2	0007-0062	725.90	61.80	405	76.67	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			275.3	E08		2	0008-0070	697.13	69.59	751	109.40	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.4	E08		2	0009-0064	854.95	64.08	402	74.43	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			288.5	E08		2	0010-0068	564.60	67.98	393	74.43	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			271.6	E08		2	0011-0069	311.70	68.45	377	75.60	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			207.5	E08		2	0012-0074	139.75	73.75	380	73.26	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			260.6	E08		2	0013-0079	623.33	79.13	403	75.84	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			363.6	E08		2	0014-0080	806.89	80.21	477	87.26	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			661.8	E08		2	0015-0080	193.12	80.01	410	78.33	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.0	E08		2	0016-0080	243.00	80.22	382	75.26	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			237.4	E08		2	0017-0079	410.94	79.08	423	77.60	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1761.1	E08		2	0018-0084	785.43	83.93	358	70.53	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			218.0	E08		2	0019-0093	67.94	93.43	387	76.08	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			847.6	E08		2	0020-0097	274.93	97.74	306	64.77	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			294.3	E08		2	0021-0104	136.10	104.59	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			207.1	E08		2	0022-0108	442.80	108.17	426	76.43	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			663.8	E08		2	0023-0111	362.97	110.55	364	71.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.7	E08		2	0024-0121	683.13	121.47	785	109.88	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			267.3	E08		2	0025-0123	483.35	123.12	381	73.26	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.9	E08		2	0026-0127	775.47	127.33	423	78.67	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			207.8	E08		2	0027-0130	354.62	131.04	437	81.50	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			308.4	E08		2	0028-0133	175.78	133.20	395	76.08	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			176.3	E08		2	0029-0133	850.39	133.45	427	78.67	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			236.1	E08		2	0030-0135	378.24	135.97	430	77.26	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.5	E08		2	0031-0140	234.73	139.82	400	76.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			231.1	E08		2	0032-0138	422.68	138.62	400	76.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			577.6	E08		2	0033-0147	100.48	147.50	491	83.50	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			869.7	E08		2	0034-0148	724.33	148.39	411	77.50	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			212.4	E08		2	0035-0149	909.00	149.21	391	75.60	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			256.7	E08		2	0036-0161	572.53	161.61	429	78.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.5	E08		2	0037-0166	805.96	164.76	428	77.98	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			358.1	E08		2	0038-0167	461.77	167.52	388	73.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			330.1	E08		2	0039-0169	138.99	169.37	396	73.01	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.8	E08		2	0040-0176	668.51	175.77	408	76.08	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			565.7	E08		2	0041-0170	27.63	170.20	115	43.11	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			217.1	E08		2	0042-0177	314.08	177.40	384	74.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			300.3	E08		2	0043-0179	46.42	178.70	548	92.57	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			256.4	E08		2	0044-0178	790.37	179.08	372	73.74	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			257.1	E08		2	0045-0182	402.87	182.10	409	75.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.1	E08		2	0046-0193	513.15	193.35	924	119.05	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			354.4	E08		2	0047-0184	24.07	185.47	235	66.43	0.669
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			284.3	E08		2	0048-0187	77.70	186.86	377	72.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			193.2	E08		2	0049-0187	877.36	186.70	392	74.08	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.9	E08		2	0050-0195	621.74	195.76	405	75.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			225.3	E08		2	0051-0193	258.36	193.62	382	75.60	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			231.7	E08		2	0052-0194	724.88	193.94	428	82.08	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.0	E08		2	0053-0203	168.99	203.55	395	76.67	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			322.6	E08		2	0054-0206	420.38	205.55	442	79.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			197.8	E08		2	0055-0207	827.80	207.35	418	75.01	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			194.5	E08		2	0056-0210	51.74	209.85	399	75.50	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			216.4	E08		2	0057-0222	369.13	222.56	396	74.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			341.2	E08		2	0058-0220	809.97	219.30	252	61.84	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.9	E08		2	0059-0225	138.35	225.82	377	76.33	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.8	E08		2	0060-0225	744.58	224.81	387	72.43	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			457.0	E08		2	0061-0227	215.53	227.48	439	82.67	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			254.7	E08		2	0062-0227	794.99	228.06	380	80.18	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			296.6	E08		2	0063-0238	563.83	238.32	597	91.26	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			268.6	E08		2	0064-0234	268.82	234.46	438	79.01	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.9	E08		2	0065-0248	329.53	248.37	391	74.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			193.3	E08		2	0066-0248	76.01	248.58	386	72.43	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.1	E08		2	0067-0258	791.77	257.78	926	128.23	0.708
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			872.2	E08		2	0068-0251	221.60	250.53	395	78.67	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			216.3	E08		2	0069-0251	679.71	251.58	412	75.01	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			242.1	E08		2	0070-0256	913.82	256.63	581	89.50	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.4	E08		2	0071-0260	634.98	259.87	382	72.77	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.1	E08		2	0072-0266	169.77	266.61	555	96.23	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			198.4	E08		2	0073-0264	451.20	264.72	414	76.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			290.1	E08		2	0074-0266	525.51	266.37	435	83.74	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.2	E08		2	0075-0274	371.77	274.85	796	111.64	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			242.8	E08		2	0076-0271	411.01	271.76	403	74.67	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			290.1	E08		2	0077-0270	500.82	269.96	400	77.01	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			254.8	E08		2	0078-0293	308.49	292.92	419	77.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			222.8	E08		2	0079-0294	470.07	294.22	400	77.50	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.2	E08		2	0080-0297	67.35	297.65	383	73.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			240.9	E08		2	0081-0302	901.77	302.16	369	72.87	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			293.3	E08		2	0082-0302	923.60	301.95	389	74.28	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			263.2	E08		2	0083-0305	581.73	305.14	373	71.84	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			204.7	E08		2	0084-0310	171.84	310.52	381	72.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			331.0	E08		2	0085-0312	544.73	312.04	408	74.18	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			307.7	E08		2	0086-0313	622.31	313.79	659	123.98	0.539
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			201.2	E08		2	0087-0318	272.44	318.88	401	73.36	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			330.8	E08		2	0088-0327	478.15	327.67	419	81.50	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			355.0	E08		2	0089-0329	142.75	328.87	383	71.60	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			272.4	E08		2	0090-0336	451.27	335.94	416	79.50	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.3	E08		2	0091-0339	252.17	339.52	404	75.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			251.5	E08		2	0092-0342	303.53	342.63	382	73.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			567.4	E08		2	0093-0344	403.85	343.81	406	78.91	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.3	E08		2	0094-0347	823.72	347.14	383	72.43	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.5	E08		2	0095-0348	69.00	348.26	383	74.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			194.7	E08		2	0096-0348	226.00	348.72	398	75.84	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			189.7	E08		2	0097-0352	33.51	352.30	399	76.91	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			270.7	E08		2	0098-0351	882.76	350.71	322	69.70	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.2	E08		2	0099-0362	151.49	362.52	394	74.67	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.7	E08		2	0100-0367	622.50	367.96	417	75.84	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			374.4	E08		2	0101-0371	347.12	371.36	439	78.67	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			200.0	E08		2	0102-0372	879.45	371.13	475	87.50	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.5	E08		2	0103-0380	574.82	380.03	402	76.08	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.2	E08		2	0104-0390	709.91	389.84	825	113.88	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			218.4	E08		2	0105-0388	95.79	388.54	386	75.50	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.5	E08		2	0106-0388	199.33	387.52	442	82.33	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			250.6	E08		2	0107-0390	526.13	389.65	420	80.57	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			200.3	E08		2	0108-0401	820.21	401.50	419	77.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.0	E08		2	0109-0402	510.01	403.04	445	80.08	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.0	E08		2	0110-0402	654.01	401.98	422	76.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			210.8	E08		2	0111-0406	219.36	406.64	536	89.64	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.6	E08		2	0112-0404	292.52	404.38	753	105.50	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.5	E08		2	0113-0409	30.77	409.53	628	93.15	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			207.5	E08		2	0114-0406	173.15	406.25	382	73.84	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			179.3	E08		2	0115-0408	120.03	408.10	388	75.26	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			203.6	E08		2	0116-0410	779.56	411.26	437	84.43	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.1	E08		2	0117-0413	750.21	412.69	398	75.60	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			261.9	E08		2	0118-0441	495.53	441.66	922	128.81	0.698
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			203.1	E08		2	0119-0435	202.35	435.47	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			253.0	E08		2	0120-0436	438.90	436.64	395	75.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			210.0	E08		2	0121-0439	144.52	438.62	374	72.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.6	E08		2	0122-0444	560.08	444.52	417	76.43	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.4	E08		2	0123-0453	46.63	453.32	389	75.84	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			245.6	E08		2	0124-0451	476.99	452.07	314	69.94	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			6736.8	E08		2	0125-0449	761.44	448.87	161	77.50	0.337
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			226.0	E08		2	0126-0454	380.38	454.11	412	76.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			247.0	E08		2	0127-0457	649.09	457.94	398	76.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			222.1	E08		2	0128-0460	248.91	459.73	375	74.91	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			202.7	E08		2	0129-0471	91.12	471.08	805	114.47	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			207.2	E08		2	0130-0466	923.56	466.10	402	74.67	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.1	E08		2	0131-0477	221.96	477.90	722	103.05	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.0	E08		2	0132-0473	126.82	472.96	380	72.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			277.2	E08		2	0133-0472	870.35	472.08	319	66.18	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			199.5	E08		2	0134-0475	296.63	475.43	382	75.50	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			205.9	E08		2	0135-0477	173.58	476.81	382	73.84	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1666.1	E08		2	0136-0481	602.06	481.41	489	82.67	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			251.8	E08		2	0137-0490	676.30	490.47	392	75.26	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.6	E08		2	0138-0500	890.82	500.70	374	72.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			169.9	E08		2	0139-0501	940.01	500.65	370	73.01	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			287.8	E08		2	0140-0499	617.99	499.08	269	64.43	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.5	E08		2	0141-0506	302.68	506.09	559	89.40	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.0	E08		2	0142-0504	163.22	503.63	432	81.40	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.3	E08		2	0143-0504	847.40	504.03	393	74.43	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			4593.3	E08		2	0144-0513	603.02	513.03	283	82.08	0.528
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1897.7	E08		2	0145-0527	375.90	526.51	730	103.05	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			529.2	E08		2	0146-0531	777.66	531.02	435	78.67	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			205.3	E08		2	0147-0540	145.54	540.61	745	109.15	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			211.9	E08		2	0148-0533	531.60	533.96	399	77.50	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			246.9	E08		2	0149-0534	666.34	534.51	401	74.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			345.4	E08		2	0150-0541	707.75	541.05	253	77.84	0.525
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			393.9	E08		2	0151-0547	41.41	547.08	409	78.67	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			350.1	E08		2	0152-0548	73.99	548.39	407	75.26	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			230.7	E08		2	0153-0555	105.27	555.72	398	75.84	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			924.4	E08		2	0154-0551	653.87	551.61	207	52.53	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			182.1	E08		2	0155-0558	832.33	558.28	416	79.26	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.7	E08		2	0156-0559	572.73	560.47	817	118.57	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			203.3	E08		2	0157-0560	929.68	559.82	380	74.43	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			167.0	E08		2	0158-0569	20.54	569.14	412	80.33	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			263.8	E08		2	0159-0566	270.34	566.66	420	77.26	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			288.6	E08		2	0160-0576	633.39	576.43	400	73.60	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			267.2	E08		2	0161-0581	471.44	581.79	526	85.50	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			177.7	E08		2	0162-0580	347.13	580.43	396	75.84	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			203.8	E08		2	0163-0582	505.16	581.77	399	73.84	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			231.9	E08		2	0164-0589	591.50	589.08	371	71.26	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			373.7	E08		2	0165-0591	682.30	591.53	370	71.84	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			202.5	E08		2	0166-0600	105.82	600.27	371	71.60	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			210.4	E08		2	0167-0601	285.15	601.69	377	71.84	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			222.8	E08		2	0168-0600	717.83	600.31	422	77.84	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.2	E08		2	0169-0602	35.81	602.43	398	73.84	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			258.6	E08		2	0170-0604	200.19	604.23	457	82.08	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.7	E08		2	0171-0604	540.79	603.75	393	73.84	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			207.4	E08		2	0172-0609	327.17	609.00	407	77.26	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.5	E08		2	0173-0609	774.63	609.18	414	75.36	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			178.9	E08		2	0174-0613	797.36	612.87	461	80.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			212.5	E08		2	0175-0626	196.09	626.48	437	81.60	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			216.5	E08		2	0176-0632	421.06	632.33	407	77.26	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			243.5	E08		2	0177-0646	106.32	646.56	414	76.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			226.0	E08		2	0178-0660	737.33	659.93	429	84.47	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			204.4	E08		2	0179-0657	466.58	656.53	399	79.26	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.8	E08		2	0180-0660	350.58	660.47	385	73.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			202.6	E08		2	0181-0661	524.65	661.60	401	74.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.4	E08		2	0182-0661	774.24	662.08	435	81.74	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			234.3	E08		2	0183-0662	36.19	661.90	361	71.84	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			211.6	E08		2	0184-0671	157.97	671.75	818	111.40	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			426.8	E08		2	0185-0662	872.90	662.01	666	128.61	0.506
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			210.7	E08		2	0186-0666	289.22	666.21	380	74.08	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			205.9	E08		2	0187-0674	70.95	674.70	366	75.01	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			212.6	E08		2	0188-0677	235.00	676.63	377	73.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			222.3	E08		2	0189-0684	563.26	684.31	396	73.84	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			198.6	E08		2	0190-0691	449.32	690.88	405	76.91	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			320.9	E08		2	0191-0696	716.43	696.13	248	75.50	0.547
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			321.2	E08		2	0192-0702	342.18	702.41	490	87.40	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.6	E08		2	0193-0702	591.30	701.65	379	73.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			166.8	E08		3	0001-0028	415.24	28.39	399	76.08	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			347.9	E08		3	0002-0036	582.81	36.50	835	114.95	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			300.4	E08		3	0003-0047	790.25	47.08	573	92.81	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			245.2	E08		3	0004-0047	632.71	47.54	348	69.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			248.8	E08		3	0005-0049	842.21	49.68	380	74.08	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			299.3	E08		3	0006-0059	49.64	58.78	679	99.98	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.2	E08		3	0007-0060	451.37	60.22	416	75.84	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			466.7	E08		3	0008-0064	479.63	62.90	740	108.81	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.0	E08		3	0009-0067	192.44	67.96	397	75.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			249.3	E08		3	0010-0067	523.81	67.54	485	83.26	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			357.8	E08		3	0011-0073	252.22	73.24	390	75.50	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			193.2	E08		3	0012-0076	425.67	75.91	395	75.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			296.0	E08		3	0013-0076	760.09	75.86	341	69.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			285.7	E08		3	0014-0076	803.99	77.07	365	72.18	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.4	E08		3	0015-0079	104.63	79.58	364	71.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			499.9	E08		3	0016-0081	144.10	81.90	430	80.08	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			350.0	E08		3	0017-0087	231.50	86.77	441	82.91	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			249.1	E08		3	0018-0093	904.56	92.91	288	64.18	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.4	E08		3	0019-0099	632.40	98.90	380	75.50	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			245.7	E08		3	0020-0099	801.64	99.31	406	77.36	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			208.2	E08		3	0021-0101	606.85	101.13	443	82.33	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.3	E08		3	0022-0104	69.86	104.40	367	71.60	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			290.5	E08		3	0023-0109	554.71	109.17	424	76.67	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.0	E08		3	0024-0111	520.13	111.51	384	73.01	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			243.3	E08		3	0025-0117	491.15	117.00	391	73.36	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.7	E08		3	0026-0121	454.17	121.55	394	75.94	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			282.6	E08		3	0027-0120	664.67	120.27	349	68.77	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.1	E08		3	0028-0125	605.34	126.10	451	82.43	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.8	E08		3	0029-0128	760.48	127.64	369	73.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			210.5	E08		3	0030-0133	283.91	133.14	379	77.74	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			250.7	E08		3	0031-0139	43.87	140.08	647	96.33	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.5	E08		3	0032-0141	838.44	141.63	356	70.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.7	E08		3	0033-0144	462.69	143.91	345	71.60	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.0	E08		3	0034-0147	403.48	147.68	423	79.74	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.3	E08		3	0035-0145	556.73	145.56	373	72.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.0	E08		3	0036-0148	936.63	147.82	359	70.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			242.4	E08		3	0037-0161	105.56	160.15	819	113.74	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.9	E08		3	0038-0161	159.37	161.40	377	74.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			303.3	E08		3	0039-0164	694.96	163.46	415	78.57	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			212.8	E08		3	0040-0165	620.89	164.85	366	71.84	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			267.3	E08		3	0041-0168	542.45	167.59	374	70.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			312.6	E08		3	0042-0172	861.79	172.65	398	74.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			244.1	E08		3	0043-0174	581.78	175.04	388	72.43	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			256.7	E08		3	0044-0177	683.05	178.30	328	70.91	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.1	E08		3	0045-0180	195.44	180.37	403	77.84	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			402.5	E08		3	0046-0181	308.26	180.58	310	72.53	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			291.6	E08		3	0047-0192	761.51	191.65	599	91.26	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.0	E08		3	0048-0194	31.71	193.70	709	107.74	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			353.9	E08		3	0049-0193	307.19	192.85	192	57.11	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.7	E08		3	0050-0210	253.54	209.53	363	71.26	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			211.7	E08		3	0051-0214	662.03	214.98	374	73.84	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			264.2	E08		3	0052-0225	202.17	225.33	359	70.67	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			399.0	E08		3	0053-0233	894.48	232.88	741	113.20	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			195.5	E08		3	0054-0226	681.37	224.84	416	77.74	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			251.1	E08		3	0055-0226	622.13	226.02	368	72.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.4	E08		3	0056-0230	231.70	229.44	406	77.50	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			257.2	E08		3	0057-0229	432.85	229.64	372	71.84	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			247.2	E08		3	0058-0233	377.23	232.95	380	72.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.3	E08		3	0059-0238	698.28	238.85	444	79.15	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			226.1	E08		3	0060-0239	113.51	238.68	366	72.67	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			260.0	E08		3	0061-0248	500.11	247.44	356	70.67	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			301.5	E08		3	0062-0251	752.47	251.41	385	75.26	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.0	E08		3	0063-0256	162.63	255.61	376	76.91	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			231.2	E08		3	0064-0276	640.98	276.20	848	126.02	0.671
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			318.1	E08		3	0065-0267	864.53	267.31	398	74.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			244.3	E08		3	0066-0277	682.08	277.03	520	85.50	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			383.6	E08		3	0067-0280	937.73	280.03	369	72.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.9	E08		3	0068-0282	619.21	283.03	418	80.67	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			347.5	E08		3	0069-0283	243.07	283.34	402	77.50	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			280.3	E08		3	0070-0286	502.83	286.56	398	75.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			234.9	E08		3	0071-0297	168.63	296.89	692	98.33	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			251.8	E08		3	0072-0293	818.20	293.63	379	73.01	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.5	E08		3	0073-0295	365.72	296.06	381	73.26	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			207.7	E08		3	0074-0299	700.88	298.65	369	72.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			226.4	E08		3	0075-0304	116.70	303.98	384	75.26	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			237.9	E08		3	0076-0316	211.94	316.42	415	75.01	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			305.3	E08		3	0077-0329	802.76	329.64	374	71.01	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			234.5	E08		3	0078-0326	851.75	326.91	277	65.60	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.3	E08		3	0079-0340	682.57	340.35	401	76.67	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			304.2	E08		3	0080-0346	414.42	345.62	377	70.77	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			222.5	E08		3	0081-0351	596.96	351.22	418	77.60	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.1	E08		3	0082-0353	446.26	353.58	383	73.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.8	E08		3	0083-0355	895.73	355.83	370	72.67	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			383.8	E08		3	0084-0363	202.60	363.08	387	74.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			176.6	E08		3	0085-0368	142.99	367.77	372	77.84	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			263.4	E08		3	0086-0368	796.25	368.49	398	75.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.0	E08		3	0087-0370	633.01	370.73	390	73.84	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			300.2	E08		3	0088-0373	817.02	373.12	337	67.11	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			249.0	E08		3	0089-0376	858.96	376.34	183	53.94	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			210.4	E08		3	0090-0381	323.92	381.41	369	71.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			237.5	E08		3	0091-0384	710.82	384.50	772	107.74	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			195.3	E08		3	0092-0392	230.06	392.60	411	78.91	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			217.4	E08		3	0093-0389	667.16	389.10	379	75.01	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			203.0	E08		3	0094-0390	911.86	389.80	341	71.60	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			237.8	E08		3	0095-0393	139.73	394.28	338	68.18	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			237.5	E08		3	0096-0397	444.60	396.62	591	99.84	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			253.6	E08		3	0097-0399	533.28	399.79	365	72.67	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			204.9	E08		3	0098-0402	246.58	402.44	379	75.26	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			216.7	E08		3	0099-0404	357.90	403.92	369	72.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.0	E08		3	0100-0415	486.20	414.77	845	118.61	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			216.6	E08		3	0101-0421	164.73	421.37	387	76.43	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			255.3	E08		3	0102-0421	285.05	421.10	395	73.84	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			316.3	E08		3	0103-0427	465.41	427.88	436	79.98	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			201.7	E08		3	0104-0427	322.12	427.69	395	73.26	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.6	E08		3	0105-0430	638.37	430.24	746	107.05	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.0	E08		3	0106-0430	686.73	430.73	378	73.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			200.5	E08		3	0107-0434	108.10	433.85	387	73.84	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			196.1	E08		3	0108-0437	59.84	437.40	376	72.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			308.0	E08		3	0109-0439	611.79	439.72	327	67.26	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			328.0	E08		3	0110-0452	856.28	453.15	186	66.77	0.524
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			248.3	E08		3	0111-0462	894.04	461.91	377	72.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			198.2	E08		3	0112-0469	598.73	470.62	823	111.54	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			207.4	E08		3	0113-0466	199.40	465.88	395	76.43	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			254.0	E08		3	0114-0463	864.99	464.80	169	61.11	0.569
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			195.9	E08		3	0115-0468	18.62	468.60	375	72.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			186.7	E08		3	0116-0477	537.51	477.00	395	73.84	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			180.5	E08		3	0117-0480	53.51	480.49	349	71.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			201.6	E08		3	0118-0489	512.63	489.10	419	78.33	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.7	E08		3	0119-0487	713.79	487.75	393	75.01	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.3	E08		3	0120-0488	757.30	487.96	396	76.43	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			207.6	E08		3	0121-0496	472.71	496.72	389	73.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			205.8	E08		3	0122-0498	409.66	497.78	366	71.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			190.5	E08		3	0123-0503	35.08	503.00	328	68.77	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			195.5	E08		3	0124-0506	169.29	506.84	401	77.60	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			322.9	E08		3	0125-0503	870.94	502.71	369	74.43	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			177.0	E08		3	0126-0513	109.46	513.19	361	72.43	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			218.2	E08		3	0127-0525	449.52	527.03	799	124.81	0.645
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			210.1	E08		3	0128-0515	252.53	515.56	362	73.84	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.5	E08		3	0129-0517	190.70	517.05	390	76.33	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.0	E08		3	0130-0517	776.83	517.42	340	68.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			240.7	E08		3	0131-0515	808.51	515.00	361	70.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			188.0	E08		3	0132-0521	742.37	520.71	393	75.26	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			225.4	E08		3	0133-0523	296.24	523.06	380	73.26	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2515.0	E08		3	0134-0527	339.69	527.96	523	127.30	0.406
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			193.0	E08		3	0135-0526	587.22	526.52	410	75.36	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			251.4	E08		3	0136-0530	680.35	529.55	417	77.26	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			197.4	E08		3	0137-0531	419.13	531.53	366	72.43	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			180.9	E08		3	0138-0534	548.07	534.35	414	78.08	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			294.4	E08		3	0139-0540	362.14	540.66	391	77.50	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.5	E08		3	0140-0545	139.63	544.61	373	77.50	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			204.2	E08		3	0141-0549	525.84	548.52	465	82.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			178.7	E08		3	0142-0556	83.76	556.33	752	107.40	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			282.8	E08		3	0143-0545	688.86	545.38	210	58.77	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			204.5	E08		3	0144-0552	271.47	551.69	372	76.08	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			193.7	E08		3	0145-0557	400.75	557.74	400	75.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			188.4	E08		3	0146-0558	57.64	557.53	415	78.67	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			307.5	E08		3	0147-0557	669.21	557.34	312	65.36	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			205.8	E08		3	0148-0562	24.51	562.19	357	71.60	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.9	E08		3	0149-0563	135.43	563.83	398	77.84	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			597.9	E08		3	0150-0563	342.88	563.66	410	79.01	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			189.5	E08		3	0151-0571	182.53	571.83	359	72.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			217.2	E08		3	0152-0581	582.33	580.93	438	79.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			546.2	E08		3	0153-0590	358.55	589.37	813	117.40	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			230.7	E08		3	0154-0586	902.42	586.52	384	73.26	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			244.5	E08		3	0155-0589	448.82	589.10	400	76.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			211.0	E08		3	0156-0593	768.02	593.82	407	74.08	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.1	E08		3	0157-0595	502.68	596.04	364	71.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			271.6	E08		3	0158-0604	831.40	603.98	362	73.60	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			248.9	E08		3	0159-0609	640.19	610.11	432	80.33	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			226.0	E08		3	0160-0611	850.23	611.63	370	74.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			244.7	E08		3	0161-0615	610.75	615.08	382	74.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			240.0	E08		3	0162-0628	536.77	627.71	417	78.08	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			208.2	E08		3	0163-0629	888.03	629.44	361	69.84	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			205.5	E08		3	0164-0638	173.63	638.96	773	108.23	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			275.2	E08		3	0165-0632	368.35	632.47	374	72.18	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			218.0	E08		3	0166-0635	289.51	635.13	365	72.43	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.6	E08		3	0167-0635	466.65	635.64	364	71.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			204.6	E08		3	0168-0640	241.54	639.77	373	75.01	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			216.9	E08		3	0169-0646	811.99	645.99	397	76.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			336.1	E08		3	0170-0653	50.79	652.78	721	100.23	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			217.0	E08		3	0171-0657	403.07	657.42	389	75.94	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			248.9	E08		3	0172-0669	131.11	669.24	419	79.74	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			188.8	E08		3	0173-0666	790.26	666.03	364	71.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			194.0	E08		3	0174-0669	769.70	669.44	437	82.67	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			195.2	E08		3	0175-0670	282.60	669.71	408	77.50	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			184.1	E08		3	0176-0670	336.02	669.89	373	72.67	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.0	E08		3	0177-0676	711.71	675.45	327	70.67	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.0	E08		3	0178-0675	902.93	675.77	440	80.57	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			236.6	E08		3	0179-0678	399.08	677.28	461	83.26	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			242.1	E08		3	0180-0679	461.52	678.85	335	71.70	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			193.3	E08		3	0181-0681	480.11	681.06	401	74.87	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.6	E08		3	0182-0683	883.11	684.29	410	76.33	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			188.7	E08		3	0183-0686	522.20	685.85	368	71.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			174.9	E08		3	0184-0687	119.99	686.81	247	61.26	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			200.5	E08		3	0185-0690	171.31	690.63	386	73.84	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			171.5	E08		3	0186-0692	290.70	692.65	416	78.67	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.0	E08		3	0187-0693	698.95	693.60	331	68.43	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			320.2	E08		3	0188-0696	753.16	696.63	394	74.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			211.4	E08		3	0189-0702	238.41	702.66	741	105.40	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			188.4	E08		4	0001-0029	376.31	29.33	422	79.50	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1172.2	E08		4	0002-0030	469.53	29.71	401	77.50	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			199.8	E08		4	0003-0032	326.73	31.62	416	76.67	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			166.2	E08		4	0004-0035	166.80	35.50	385	74.67	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			201.3	E08		4	0005-0034	539.01	34.48	445	82.43	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			240.7	E08		4	0006-0034	38.45	34.57	375	74.33	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			231.7	E08		4	0007-0036	206.75	36.76	415	80.57	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			199.3	E08		4	0008-0042	639.40	41.71	375	73.50	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			286.9	E08		4	0009-0047	481.05	47.22	481	85.98	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			222.8	E08		4	0010-0051	403.40	51.21	468	82.33	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			179.0	E08		4	0011-0061	606.13	61.23	465	82.08	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.2	E08		4	0012-0061	870.01	62.05	423	76.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			237.9	E08		4	0013-0064	814.30	64.40	384	72.77	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			216.0	E08		4	0014-0070	776.89	69.91	432	80.08	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.6	E08		4	0015-0069	362.99	69.22	421	80.33	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			400.2	E08		4	0016-0075	690.51	75.10	436	78.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			245.3	E08		4	0017-0076	236.77	76.65	410	77.50	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.4	E08		4	0018-0077	538.56	77.41	475	87.15	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			469.3	E08		4	0019-0084	839.75	83.66	374	72.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			207.5	E08		4	0020-0087	511.66	87.27	484	87.15	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			216.2	E08		4	0021-0100	67.65	99.83	411	77.26	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.6	E08		4	0022-0102	191.26	101.85	442	80.67	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.3	E08		4	0023-0106	411.29	105.96	766	104.91	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			262.9	E08		4	0024-0103	436.90	103.15	459	81.36	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			236.6	E08		4	0025-0103	24.48	103.70	398	75.84	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.9	E08		4	0026-0108	564.96	108.42	928	128.95	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			234.4	E08		4	0027-0110	667.55	110.64	870	122.95	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			208.3	E08		4	0028-0108	915.24	107.70	423	78.43	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			277.5	E08		4	0029-0119	369.86	119.71	872	117.64	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			252.2	E08		4	0030-0117	483.56	116.96	693	99.98	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.2	E08		4	0031-0133	735.08	133.36	872	128.51	0.664
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			205.7	E08		4	0032-0132	793.21	132.41	434	79.50	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			245.5	E08		4	0033-0135	590.91	134.99	441	78.91	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			282.0	E08		4	0034-0138	284.81	138.69	455	83.15	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			231.8	E08		4	0035-0141	624.33	140.81	426	82.57	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			304.3	E08		4	0036-0140	258.61	140.15	317	69.50	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			274.8	E08		4	0037-0144	195.41	144.54	413	77.50	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			202.7	E08		4	0038-0144	893.43	144.56	395	74.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			269.7	E08		4	0039-0148	364.65	148.27	417	80.33	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			542.5	E08		4	0040-0164	122.86	165.55	853	117.78	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			248.6	E08		4	0041-0158	345.00	157.93	466	85.15	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.8	E08		4	0042-0158	658.78	158.60	415	76.67	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			542.1	E08		4	0043-0162	39.75	161.75	398	74.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			300.0	E08		4	0044-0163	477.58	162.65	392	73.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			177.5	E08		4	0045-0171	757.86	171.71	411	81.50	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			202.9	E08		4	0046-0179	690.09	179.95	451	82.91	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			207.0	E08		4	0047-0181	509.76	179.71	436	82.47	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			244.8	E08		4	0048-0180	423.86	179.86	449	82.91	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			253.0	E08		4	0049-0188	634.58	188.58	481	83.74	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			207.9	E08		4	0050-0191	491.16	193.10	435	82.33	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			191.0	E08		4	0051-0192	794.75	192.31	428	78.08	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			275.9	E08		4	0052-0197	550.39	197.01	414	79.26	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			185.8	E08		4	0053-0197	831.67	197.45	401	76.08	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			212.7	E08		4	0054-0202	411.77	202.14	485	90.33	0.747
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			199.8	E08		4	0055-0211	606.56	211.27	947	125.44	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			217.5	E08		4	0056-0206	385.02	206.39	456	82.67	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			199.8	E08		4	0057-0209	242.02	207.81	446	81.88	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			198.6	E08		4	0058-0212	67.31	211.81	423	79.26	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.6	E08		4	0059-0210	286.99	210.26	423	78.08	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.7	E08		4	0060-0216	726.80	215.88	427	77.50	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			208.9	E08		4	0061-0221	226.57	222.17	395	78.23	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			284.3	E08		4	0062-0222	544.15	222.08	490	86.18	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			544.4	E08		4	0063-0220	777.29	220.48	419	76.67	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			198.5	E08		4	0064-0230	350.24	230.09	407	76.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			335.4	E08		4	0065-0235	698.65	235.23	431	82.81	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.4	E08		4	0066-0235	390.33	235.47	392	75.50	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			174.1	E08		4	0067-0243	108.57	243.69	401	77.50	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			169.4	E08		4	0068-0246	838.49	246.20	452	80.91	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			190.7	E08		4	0069-0248	543.64	247.86	431	78.43	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			204.2	E08		4	0070-0248	753.37	248.95	404	77.50	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			199.9	E08		4	0071-0248	451.53	248.74	468	84.77	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			175.1	E08		4	0072-0252	323.73	252.20	406	77.26	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			202.0	E08		4	0073-0254	473.20	254.32	420	80.18	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.7	E08		4	0074-0255	912.05	255.95	362	71.26	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			323.7	E08		4	0075-0258	640.31	258.51	486	85.50	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			172.1	E08		4	0076-0260	665.44	259.77	452	83.50	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.5	E08		4	0077-0263	872.41	263.11	474	83.50	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			217.3	E08		4	0078-0266	367.06	265.64	415	76.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.4	E08		4	0079-0268	780.52	268.02	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			191.5	E08		4	0080-0274	179.37	274.15	430	77.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			180.5	E08		4	0081-0280	251.34	280.48	399	75.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.1	E08		4	0082-0286	526.38	286.29	418	77.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.8	E08		4	0083-0291	805.27	290.90	691	98.57	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			191.1	E08		4	0084-0289	415.43	289.20	429	80.08	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.4	E08		4	0085-0303	165.61	303.77	430	77.84	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			183.6	E08		4	0086-0308	709.10	308.30	472	83.26	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			168.3	E08		4	0087-0311	288.03	311.72	406	79.50	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			184.3	E08		4	0088-0312	901.72	311.94	422	76.43	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.3	E08		4	0089-0318	685.82	317.83	441	80.67	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			231.1	E08		4	0090-0323	249.96	323.02	742	104.47	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			195.1	E08		4	0091-0322	624.79	322.52	399	76.08	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			186.5	E08		4	0092-0322	943.40	322.65	381	73.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.8	E08		4	0093-0347	676.81	348.17	412	76.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			191.5	E08		4	0094-0349	750.47	349.19	842	119.64	0.739
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			189.4	E08		4	0095-0349	136.05	348.74	396	76.91	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.2	E08		4	0096-0353	704.85	353.22	416	78.91	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.0	E08		4	0097-0361	338.63	362.11	810	111.88	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			195.7	E08		4	0098-0357	564.43	357.09	460	82.77	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			187.0	E08		4	0099-0359	203.75	359.23	427	80.33	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.0	E08		4	0100-0362	531.38	361.51	870	114.57	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			191.1	E08		4	0101-0364	616.58	364.28	423	75.84	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			166.2	E08		4	0102-0370	180.75	369.39	448	80.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			197.2	E08		4	0103-0375	83.23	375.25	391	78.33	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			225.6	E08		4	0104-0377	425.81	377.11	425	78.91	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.7	E08		4	0105-0386	288.74	385.59	897	123.88	0.734
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1786.9	E08		4	0106-0384	871.17	383.61	342	68.18	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			205.8	E08		4	0107-0389	24.18	389.00	376	74.67	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			211.4	E08		4	0108-0387	258.24	387.51	410	78.53	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			196.8	E08		4	0109-0393	491.32	393.10	437	83.15	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			200.4	E08		4	0110-0396	552.04	394.76	415	80.23	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			186.3	E08		4	0111-0398	738.64	397.49	397	74.43	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.8	E08		4	0112-0399	684.04	398.75	412	76.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			251.7	E08		4	0113-0407	389.42	406.76	529	94.91	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			176.0	E08		4	0114-0407	589.34	406.88	420	78.67	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			383.1	E08		4	0115-0406	920.59	406.58	440	77.26	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			273.7	E08		4	0116-0413	532.50	414.86	753	104.47	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			180.5	E08		4	0117-0413	233.92	412.73	412	77.26	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.9	E08		4	0118-0411	359.40	410.70	415	78.08	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			190.3	E08		4	0119-0413	630.06	411.74	381	77.64	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			186.9	E08		4	0120-0419	285.91	418.45	839	108.81	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			242.1	E08		4	0121-0421	695.14	420.42	479	90.81	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.1	E08		4	0122-0419	436.31	419.40	407	76.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			284.0	E08		4	0123-0425	110.14	425.64	562	94.81	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.4	E08		4	0124-0426	645.96	426.73	455	80.57	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			198.0	E08		4	0125-0425	866.84	425.04	392	76.91	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			292.6	E08		4	0126-0426	382.97	426.70	214	60.77	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.5	E08		4	0127-0431	777.43	430.82	454	83.15	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.6	E08		4	0128-0436	705.74	437.07	413	81.98	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			203.7	E08		4	0129-0435	319.58	435.80	410	76.08	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			198.5	E08		4	0130-0446	599.20	446.02	744	100.81	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.7	E08		4	0131-0448	163.99	448.51	430	78.08	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			183.9	E08		4	0132-0456	276.89	456.42	424	78.08	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			821.5	E08		4	0133-0459	905.75	457.52	380	75.98	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			744.2	E08		4	0134-0468	888.60	469.74	418	79.74	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			760.3	E08		4	0135-0474	695.70	474.53	764	106.23	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.2	E08		4	0136-0477	370.65	476.79	426	80.81	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			160.5	E08		4	0137-0481	112.68	481.24	401	78.33	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.5	E08		4	0138-0488	213.74	488.34	406	78.67	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			183.1	E08		4	0139-0486	603.59	485.86	424	78.91	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			195.2	E08		4	0140-0492	76.49	492.01	442	82.33	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.6	E08		4	0141-0490	307.38	490.29	448	81.50	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			291.7	E08		4	0142-0495	355.80	495.48	508	86.57	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			201.2	E08		4	0143-0498	530.91	497.54	426	78.43	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			164.6	E08		4	0144-0508	936.11	508.18	411	76.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			238.0	E08		4	0145-0516	640.42	515.71	391	73.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			188.6	E08		4	0146-0518	385.44	518.92	445	83.98	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			200.2	E08		4	0147-0526	569.04	526.32	431	80.33	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			169.3	E08		4	0148-0525	428.94	525.80	418	80.33	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			185.1	E08		4	0149-0528	701.21	528.02	431	79.50	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			222.8	E08		4	0150-0535	118.78	535.26	432	80.91	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.0	E08		4	0151-0535	367.11	534.85	449	81.74	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.6	E08		4	0152-0538	154.87	538.00	401	75.74	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			170.7	E08		4	0153-0542	403.90	541.72	447	84.33	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.0	E08		4	0154-0546	617.77	545.48	421	78.67	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			262.2	E08		4	0155-0553	247.29	552.85	707	100.23	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			218.6	E08		4	0156-0546	851.67	546.21	400	76.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.6	E08		4	0157-0551	755.90	550.92	400	75.01	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			288.5	E08		4	0158-0555	509.69	555.50	513	86.33	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			164.3	E08		4	0159-0566	449.55	566.71	846	114.47	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.3	E08		4	0160-0565	325.54	565.58	446	78.91	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.6	E08		4	0161-0565	718.66	565.16	417	77.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			243.0	E08		4	0162-0578	581.05	578.21	405	77.26	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.9	E08		4	0163-0584	352.77	585.09	409	78.91	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.7	E08		4	0164-0586	644.49	587.18	809	110.81	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			617.8	E08		4	0165-0599	386.32	598.68	902	122.02	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			304.4	E08		4	0166-0597	820.30	597.28	403	79.50	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			203.1	E08		4	0167-0597	902.14	597.37	399	74.43	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.4	E08		4	0168-0601	522.22	601.39	413	77.84	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.0	E08		4	0169-0610	858.65	610.57	427	79.50	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			253.7	E08		4	0170-0611	197.02	610.95	439	80.91	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			192.6	E08		4	0171-0610	713.64	610.13	416	77.84	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			756.2	E08		4	0172-0612	777.81	612.44	373	70.77	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			273.5	E08		4	0173-0617	442.56	617.16	390	75.50	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.7	E08		4	0174-0620	300.22	620.31	408	74.43	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			497.1	E08		4	0175-0623	818.13	622.92	476	84.08	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			202.1	E08		4	0176-0632	66.66	631.38	777	109.05	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			197.0	E08		4	0177-0638	333.96	638.20	438	79.74	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			293.6	E08		4	0178-0639	645.90	638.83	415	75.84	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			187.4	E08		4	0179-0644	254.30	643.97	410	75.84	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1435.2	E08		4	0180-0644	766.71	644.46	248	87.50	0.407
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.3	E08		4	0181-0649	475.70	648.79	796	111.64	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			216.0	E08		4	0182-0654	885.78	655.00	352	69.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			187.6	E08		4	0183-0656	36.38	656.07	390	73.26	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			157.3	E08		4	0184-0658	820.16	658.20	417	75.84	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			451.3	E08		4	0185-0666	109.47	665.99	445	80.91	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			198.1	E08		4	0186-0668	931.79	667.74	379	73.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			357.8	E08		4	0187-0670	764.69	670.90	426	79.74	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			195.3	E08		4	0188-0670	515.22	671.01	430	81.40	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			400.8	E08		4	0189-0672	228.59	672.38	446	80.67	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			200.0	E08		4	0190-0677	711.19	677.12	407	78.33	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.1	E08		4	0191-0680	362.66	680.49	407	74.18	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			182.2	E08		4	0192-0682	674.03	681.82	403	75.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			176.2	E08		4	0193-0688	31.90	688.55	387	75.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			216.1	E08		4	0194-0700	913.09	698.64	422	81.15	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			958.9	E08		4	0195-0699	177.40	699.16	425	77.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			211.7	E08		4	0196-0706	896.96	706.45	370	76.67	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.5	E08		4	0197-0705	451.24	705.04	393	73.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			247.5	E08		4	0198-0706	841.19	706.47	391	73.84	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			204.7	E08		5	0001-0036	912.92	36.08	697	97.74	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1402.6	E08		5	0002-0037	400.71	36.02	190	56.53	0.747
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			375.3	E08		5	0003-0042	383.54	44.47	533	95.15	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.9	E08		5	0004-0043	672.96	42.74	427	77.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			256.4	E08		5	0005-0047	55.66	46.50	612	93.98	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			285.0	E08		5	0006-0047	87.28	46.68	387	97.15	0.515
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			210.6	E08		5	0007-0044	186.17	44.47	395	73.84	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			205.7	E08		5	0008-0047	226.42	47.21	458	83.15	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			402.8	E08		5	0009-0048	129.84	47.85	425	77.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			234.9	E08		5	0010-0050	790.39	50.36	408	77.74	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			346.0	E08		5	0011-0051	101.71	52.26	139	54.53	0.587
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			204.7	E08		5	0012-0057	312.17	57.19	430	79.26	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			208.6	E08		5	0013-0068	489.97	68.32	441	79.50	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			187.2	E08		5	0014-0073	372.57	73.36	407	74.43	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			208.4	E08		5	0015-0074	412.97	74.21	406	77.50	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			186.1	E08		5	0016-0082	710.92	82.13	436	77.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			236.8	E08		5	0017-0089	155.98	89.08	370	72.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.6	E08		5	0018-0098	744.01	98.60	365	71.26	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			270.3	E08		5	0019-0101	112.51	100.66	349	70.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			184.6	E08		5	0020-0107	189.04	107.38	386	77.50	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			500.9	E08		5	0021-0106	912.13	105.94	263	75.50	0.580
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			201.2	E08		5	0022-0110	20.05	109.88	419	79.74	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			355.1	E08		5	0023-0113	684.55	113.61	430	78.08	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1126.6	E08		5	0024-0134	634.63	132.56	822	126.37	0.647
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			197.1	E08		5	0025-0135	217.50	135.58	433	79.84	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			203.6	E08		5	0026-0138	151.19	137.96	392	74.67	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			299.0	E08		5	0027-0139	694.30	139.48	432	78.91	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1953.2	E08		5	0028-0138	506.42	138.97	366	71.26	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			288.0	E08		5	0029-0153	739.43	153.21	377	71.01	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			315.7	E08		5	0030-0155	266.99	155.23	390	74.08	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			181.7	E08		5	0031-0158	364.21	158.24	390	74.43	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.9	E08		5	0032-0157	789.19	157.46	339	69.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			258.5	E08		5	0033-0161	428.45	161.27	415	79.15	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			486.9	E08		5	0034-0162	606.91	162.23	471	85.98	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			189.9	E08		5	0035-0164	102.21	164.37	385	74.91	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			188.4	E08		5	0036-0170	393.74	169.85	402	75.84	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			420.7	E08		5	0037-0173	45.29	173.71	724	105.50	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			445.1	E08		5	0038-0176	559.97	176.57	534	125.44	0.426
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			190.7	E08		5	0039-0182	182.79	182.45	382	74.33	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			203.3	E08		5	0040-0184	824.00	184.55	431	79.84	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.4	E08		5	0041-0189	630.02	190.57	822	113.54	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			194.2	E08		5	0042-0185	228.36	183.91	443	87.05	0.735
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			419.0	E08		5	0043-0202	452.20	201.93	838	110.57	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			230.5	E08		5	0044-0195	279.94	195.23	410	77.01	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.5	E08		5	0045-0202	155.62	202.56	473	86.08	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			598.6	E08		5	0046-0201	527.69	201.62	461	81.84	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			204.8	E08		5	0047-0203	752.82	203.24	401	76.08	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			542.6	E08		5	0048-0210	326.39	209.37	856	119.20	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			203.5	E08		5	0049-0207	228.68	207.78	408	82.23	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.5	E08		5	0050-0218	126.09	217.93	392	77.74	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			174.0	E08		5	0051-0219	938.78	219.02	391	74.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			182.1	E08		5	0052-0223	167.61	222.46	356	76.43	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.1	E08		5	0053-0229	91.30	229.29	380	74.67	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			236.0	E08		5	0054-0229	780.61	229.64	408	76.67	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			210.7	E08		5	0055-0233	833.52	233.37	660	96.57	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			298.1	E08		5	0056-0232	898.40	232.45	416	76.67	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			204.0	E08		5	0057-0241	397.59	241.52	526	87.74	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			230.1	E08		5	0058-0244	649.02	244.50	374	70.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			170.0	E08		5	0059-0248	294.41	247.83	388	74.67	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			319.4	E08		5	0060-0250	614.43	250.41	465	83.74	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			192.9	E08		5	0061-0253	247.78	252.38	415	81.40	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			202.0	E08		5	0062-0253	514.90	252.80	430	80.91	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.0	E08		5	0063-0254	738.72	254.37	418	79.01	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			222.2	E08		5	0064-0258	16.81	258.04	373	73.26	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			205.7	E08		5	0065-0260	71.67	260.48	388	73.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			207.3	E08		5	0066-0260	337.57	260.69	413	76.67	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.7	E08		5	0067-0261	717.98	261.28	407	79.26	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2839.2	E08		5	0068-0261	359.63	260.89	371	71.70	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			225.0	E08		5	0069-0268	867.65	268.12	368	72.08	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			225.4	E08		5	0070-0271	812.16	270.97	430	79.50	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			186.4	E08		5	0071-0274	164.80	274.49	398	76.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			502.9	E08		5	0072-0282	833.97	281.78	441	82.91	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			201.3	E08		5	0073-0285	930.92	285.11	411	75.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			187.2	E08		5	0074-0291	91.17	291.53	396	75.26	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.6	E08		5	0075-0291	480.15	291.94	443	80.33	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			195.6	E08		5	0076-0290	541.98	289.68	413	80.33	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			177.5	E08		5	0077-0297	744.79	296.42	423	79.74	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.1	E08		5	0078-0298	638.64	298.19	436	79.50	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			203.6	E08		5	0079-0299	696.64	299.44	421	77.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.0	E08		5	0080-0310	859.34	310.60	433	79.26	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			194.6	E08		5	0081-0311	211.24	311.25	384	73.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.5	E08		5	0082-0317	458.01	318.23	597	94.81	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			184.5	E08		5	0083-0316	756.38	317.12	453	82.08	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.7	E08		5	0084-0320	547.00	320.09	475	92.23	0.702
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			203.7	E08		5	0085-0322	522.21	322.03	409	79.84	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			186.1	E08		5	0086-0325	48.41	324.90	371	73.50	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			186.4	E08		5	0087-0325	111.70	324.44	389	75.01	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			230.7	E08		5	0088-0329	314.40	328.83	415	76.08	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.2	E08		5	0089-0331	582.08	332.17	403	76.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			194.8	E08		5	0090-0333	673.06	333.28	435	80.08	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.8	E08		5	0091-0331	899.74	331.41	398	77.26	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			203.5	E08		5	0092-0338	172.43	338.13	383	74.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			184.2	E08		5	0093-0339	223.79	339.76	383	74.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			188.1	E08		5	0094-0347	779.18	347.30	388	76.33	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			316.1	E08		5	0095-0349	689.37	349.18	454	81.74	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			201.5	E08		5	0096-0349	144.38	349.49	383	74.08	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			181.0	E08		5	0097-0351	272.80	350.88	394	76.08	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.6	E08		5	0098-0356	645.18	355.75	398	76.67	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.8	E08		5	0099-0371	89.56	371.12	398	75.26	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			180.4	E08		5	0100-0371	750.34	370.95	394	79.15	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			202.4	E08		5	0101-0375	859.09	374.62	419	77.50	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			211.1	E08		5	0102-0377	235.32	377.50	785	116.95	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			237.8	E08		5	0103-0385	597.11	385.01	934	125.68	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			255.0	E08		5	0104-0389	304.30	388.70	858	119.68	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			199.1	E08		5	0105-0383	122.06	383.52	392	76.57	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			217.8	E08		5	0106-0388	549.09	386.78	494	88.57	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			234.5	E08		5	0107-0388	493.48	388.54	448	86.57	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.3	E08		5	0108-0392	464.63	392.49	458	82.91	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			207.9	E08		5	0109-0398	361.87	397.81	415	76.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			204.3	E08		5	0110-0397	729.47	397.47	422	77.50	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			246.6	E08		5	0111-0402	644.21	402.75	401	75.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			358.3	E08		5	0112-0408	25.84	408.78	427	77.50	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			191.3	E08		5	0113-0412	687.08	412.42	423	78.67	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.0	E08		5	0114-0420	131.98	419.92	301	71.11	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			208.0	E08		5	0115-0420	149.08	419.68	190	53.21	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			249.4	E08		5	0116-0426	598.50	426.01	414	77.50	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			211.0	E08		5	0117-0428	881.31	428.51	431	80.33	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			180.8	E08		5	0118-0433	743.77	432.91	402	76.67	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			200.0	E08		5	0119-0436	519.01	436.38	420	78.08	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			192.1	E08		5	0120-0440	203.93	440.29	462	83.84	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			198.2	E08		5	0121-0442	226.39	442.23	462	81.60	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			208.6	E08		5	0122-0442	259.99	441.96	399	75.50	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			195.4	E08		5	0123-0442	396.28	441.63	404	77.26	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			216.4	E08		5	0124-0452	828.09	451.93	481	81.01	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			199.1	E08		5	0125-0454	567.20	454.24	407	76.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			208.0	E08		5	0126-0458	60.38	458.16	396	77.26	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.6	E08		5	0127-0464	462.94	463.98	444	82.91	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			199.9	E08		5	0128-0462	682.87	461.98	412	76.91	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			205.8	E08		5	0129-0466	727.81	466.33	689	100.47	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			240.6	E08		5	0130-0462	939.93	462.33	386	73.01	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			208.1	E08		5	0131-0480	545.63	480.82	800	118.71	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			167.7	E08		5	0132-0475	595.64	476.17	420	82.33	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			196.9	E08		5	0133-0486	337.27	486.65	436	83.40	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			199.5	E08		5	0134-0487	654.85	487.16	421	78.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			211.2	E08		5	0135-0498	312.01	498.08	791	114.95	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			176.2	E08		5	0136-0500	732.05	500.30	421	78.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			184.0	E08		5	0137-0510	41.05	510.31	392	74.67	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			211.7	E08		5	0138-0511	901.81	511.56	447	79.50	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			194.3	E08		5	0139-0514	171.32	513.56	408	78.57	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			212.7	E08		5	0140-0515	814.29	515.03	404	77.26	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			196.7	E08		5	0141-0517	762.03	517.57	409	75.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			198.7	E08		5	0142-0518	524.67	518.08	411	77.26	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			175.0	E08		5	0143-0530	669.23	530.32	405	76.67	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			230.3	E08		5	0144-0535	381.83	535.94	398	75.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			184.8	E08		5	0145-0537	450.65	536.69	413	79.26	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			182.6	E08		5	0146-0540	496.57	540.79	433	77.01	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			192.6	E08		5	0147-0543	575.29	542.93	427	80.33	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			194.8	E08		5	0148-0551	803.26	551.15	813	113.05	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			856.3	E08		5	0149-0551	922.87	550.54	310	66.18	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			181.7	E08		5	0150-0562	119.28	562.25	412	78.33	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			312.5	E08		5	0151-0565	243.17	565.20	397	74.91	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.4	E08		5	0152-0565	856.86	565.48	401	73.84	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			193.8	E08		5	0153-0572	309.73	571.73	409	79.50	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			234.0	E08		5	0154-0576	918.68	577.10	561	89.15	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			222.7	E08		5	0155-0579	350.68	579.12	403	75.50	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			193.6	E08		5	0156-0580	58.30	579.86	385	74.67	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			255.2	E08		5	0157-0584	284.01	584.18	751	105.64	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			176.1	E08		5	0158-0590	578.60	590.09	424	82.08	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			273.1	E08		5	0159-0593	777.12	593.57	371	75.74	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			216.5	E08		5	0160-0595	468.12	594.79	435	77.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			211.5	E08		5	0161-0607	390.67	607.42	853	115.88	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			439.8	E08		5	0162-0605	848.16	605.02	340	68.18	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			208.5	E08		5	0163-0609	726.45	609.57	390	73.26	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			304.2	E08		5	0164-0611	150.33	610.49	400	76.33	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			187.0	E08		5	0165-0614	112.83	614.69	392	74.08	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			198.7	E08		5	0166-0619	311.78	619.52	400	77.74	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.5	E08		5	0167-0620	53.42	619.82	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2644.6	E08		5	0168-0621	536.05	620.32	336	70.43	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			193.8	E08		5	0169-0626	822.73	625.75	397	76.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			197.7	E08		5	0170-0623	269.05	623.42	417	77.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			612.3	E08		5	0171-0630	552.07	630.35	420	83.50	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			185.1	E08		5	0172-0631	442.94	631.56	409	77.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.3	E08		5	0173-0635	917.01	635.15	376	74.08	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			412.9	E08		5	0174-0635	859.67	635.02	418	77.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.7	E08		5	0175-0649	331.63	649.34	432	80.33	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			186.2	E08		5	0176-0651	801.96	651.19	436	82.33	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			257.7	E08		5	0177-0648	142.89	648.94	365	74.43	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			160.9	E08		5	0178-0653	87.19	652.94	379	76.33	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			456.4	E08		5	0179-0654	490.62	655.31	427	97.40	0.566
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			168.7	E08		5	0180-0654	290.92	654.14	391	75.26	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			193.1	E08		5	0181-0658	122.51	658.29	430	78.08	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.6	E08		5	0182-0660	943.92	659.79	269	61.36	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			182.4	E08		5	0183-0665	450.32	665.15	408	76.67	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			185.6	E08		5	0184-0666	711.38	665.77	407	78.08	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			222.2	E08		5	0185-0665	388.66	665.79	387	76.08	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			197.5	E08		5	0186-0667	530.37	666.86	408	77.74	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			183.9	E08		5	0187-0670	36.41	670.08	383	75.50	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			186.7	E08		5	0188-0670	867.56	669.86	372	72.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			187.6	E08		5	0189-0687	601.90	686.94	404	75.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			195.5	E08		5	0190-0689	805.54	688.90	400	76.67	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			207.6	E08		5	0191-0691	754.41	691.52	398	75.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			192.4	E08		5	0192-0694	706.03	694.46	414	77.50	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			199.5	E08		5	0193-0695	182.32	695.39	392	74.67	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			187.1	E08		5	0194-0698	408.47	698.36	394	76.08	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			191.1	E08		5	0195-0701	18.07	700.07	363	77.40	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			185.3	E08		5	0196-0700	311.11	700.68	390	74.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			201.0	E08		5	0197-0707	882.43	706.19	366	72.81	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			195.7	E08		6	0001-0039	609.10	39.78	429	78.67	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			238.5	E08		6	0002-0037	360.26	37.48	370	71.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			195.6	E08		6	0003-0043	130.87	43.35	415	76.67	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			548.4	E08		6	0004-0044	937.28	43.85	447	83.26	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			182.2	E08		6	0005-0046	666.80	46.34	393	73.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			201.4	E08		6	0006-0051	182.30	50.93	439	79.84	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			212.4	E08		6	0007-0052	403.43	51.91	456	80.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			202.7	E08		6	0008-0056	835.63	55.83	437	82.67	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			230.4	E08		6	0009-0054	547.64	54.10	424	77.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			339.8	E08		6	0010-0056	445.92	56.36	434	79.26	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.3	E08		6	0011-0055	865.44	55.01	398	73.84	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			188.0	E08		6	0012-0056	99.44	56.56	204	59.36	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			196.8	E08		6	0013-0056	709.53	56.49	394	73.84	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			195.7	E08		6	0014-0057	56.19	57.15	276	62.77	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			193.2	E08		6	0015-0061	291.50	60.35	420	80.23	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3821.8	E08		6	0016-0071	649.24	69.38	188	65.01	0.559
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			201.0	E08		6	0017-0075	273.94	76.36	420	78.33	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.6	E08		6	0018-0082	865.23	82.94	421	76.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			211.7	E08		6	0019-0087	100.68	87.47	401	75.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			236.8	E08		6	0020-0085	790.76	85.89	405	77.01	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			252.4	E08		6	0021-0099	595.58	98.77	410	75.84	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			238.7	E08		6	0022-0100	401.27	100.66	401	75.26	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			249.2	E08		6	0023-0104	359.67	103.66	639	92.91	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			196.4	E08		6	0024-0101	917.18	101.30	370	71.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			254.2	E08		6	0025-0102	147.44	102.15	426	79.01	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			193.8	E08		6	0026-0104	203.96	103.60	391	73.84	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.1	E08		6	0027-0111	687.18	111.25	425	77.26	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.7	E08		6	0028-0114	311.62	114.67	409	76.67	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			631.9	E08		6	0029-0126	567.48	126.76	529	119.88	0.463
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			253.3	E08		6	0030-0124	514.48	124.06	399	73.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			187.0	E08		6	0031-0134	874.24	134.51	416	75.26	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			216.7	E08		6	0032-0136	443.35	136.30	428	77.26	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			199.6	E08		6	0033-0137	221.07	136.76	398	74.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.4	E08		6	0034-0138	802.41	138.59	416	75.01	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			190.6	E08		6	0035-0141	845.01	141.60	424	79.50	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.4	E08		6	0036-0145	932.34	145.11	411	78.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.5	E08		6	0037-0156	316.95	156.18	405	75.26	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			404.6	E08		6	0038-0173	180.35	172.98	600	120.37	0.520
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.8	E08		6	0039-0171	928.07	170.09	399	76.53	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.7	E08		6	0040-0176	889.94	176.64	383	76.67	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			216.0	E08		6	0041-0180	641.53	180.47	408	74.43	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			211.6	E08		6	0042-0181	254.12	181.22	431	79.84	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			292.2	E08		6	0043-0180	575.01	180.53	356	69.01	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			197.0	E08		6	0044-0185	769.00	185.35	487	85.84	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			242.4	E08		6	0045-0201	840.71	200.64	409	78.91	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.5	E08		6	0046-0201	402.79	201.96	404	75.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.8	E08		6	0047-0217	557.64	217.97	437	78.18	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			204.8	E08		6	0048-0222	65.75	222.55	402	75.84	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.7	E08		6	0049-0222	33.66	222.01	378	71.84	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			217.8	E08		6	0050-0230	461.89	228.95	884	118.71	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.4	E08		6	0051-0224	894.28	224.40	424	78.08	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			201.8	E08		6	0052-0235	146.72	235.75	423	77.26	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			176.8	E08		6	0053-0238	241.90	238.00	383	73.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.7	E08		6	0054-0237	315.12	237.17	411	77.01	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			479.4	E08		6	0055-0243	565.44	243.58	481	82.43	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			273.9	E08		6	0056-0246	675.69	246.47	385	73.26	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			200.6	E08		6	0057-0251	200.63	251.72	394	73.84	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			247.8	E08		6	0058-0254	390.06	254.58	396	73.01	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			242.4	E08		6	0059-0256	274.78	255.92	404	76.28	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.3	E08		6	0060-0258	297.14	258.14	451	81.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			185.3	E08		6	0061-0258	122.38	258.27	395	76.67	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			487.9	E08		6	0062-0262	826.81	262.42	397	77.74	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.5	E08		6	0063-0265	364.08	265.39	397	75.50	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			196.5	E08		6	0064-0266	66.07	266.07	380	73.01	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			217.7	E08		6	0065-0268	780.41	269.04	384	78.91	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			192.0	E08		6	0066-0276	942.40	276.55	414	77.26	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			248.2	E08		6	0067-0284	864.62	284.60	393	75.01	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.2	E08		6	0068-0288	919.98	288.51	425	80.67	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.3	E08		6	0069-0287	25.72	287.87	402	74.18	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			237.5	E08		6	0070-0291	794.39	291.48	427	84.91	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			189.8	E08		6	0071-0291	340.77	290.88	388	74.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			200.5	E08		6	0072-0292	733.23	292.36	414	78.08	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			190.3	E08		6	0073-0302	700.29	302.29	365	70.18	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.0	E08		6	0074-0307	593.62	308.24	459	83.98	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			174.4	E08		6	0075-0308	389.89	307.90	416	75.60	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			199.8	E08		6	0076-0316	97.64	316.85	772	105.98	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			263.3	E08		6	0077-0322	160.15	322.59	425	78.08	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			384.3	E08		6	0078-0323	429.71	323.83	412	76.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			222.2	E08		6	0079-0325	620.50	325.40	390	74.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			225.8	E08		6	0080-0324	673.88	324.71	368	71.01	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			188.1	E08		6	0081-0326	298.88	326.11	431	79.50	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			259.1	E08		6	0082-0338	840.47	338.66	399	74.43	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			236.5	E08		6	0083-0343	945.96	343.78	423	76.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.3	E08		6	0084-0348	94.01	348.05	361	75.26	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			226.7	E08		6	0085-0349	192.31	348.83	427	79.26	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			246.1	E08		6	0086-0355	743.75	355.90	402	75.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			301.7	E08		6	0087-0359	863.28	359.07	375	71.01	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			200.3	E08		6	0088-0361	410.56	360.93	417	76.91	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.7	E08		6	0089-0362	549.72	362.11	395	73.60	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			194.4	E08		6	0090-0366	86.07	366.13	430	81.84	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			211.5	E08		6	0091-0368	605.95	368.15	466	81.26	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			197.3	E08		6	0092-0368	461.92	368.59	404	75.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			242.4	E08		6	0093-0369	503.73	369.03	421	75.84	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.3	E08		6	0094-0388	126.33	388.29	676	96.33	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			222.0	E08		6	0095-0389	272.93	389.65	406	78.08	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			192.4	E08		6	0096-0397	897.17	397.47	378	76.08	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			265.7	E08		6	0097-0399	741.89	399.01	357	69.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			212.8	E08		6	0098-0401	489.83	401.65	393	73.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			216.9	E08		6	0099-0415	558.39	414.76	891	120.47	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			265.7	E08		6	0100-0418	759.37	417.69	385	73.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.1	E08		6	0101-0419	131.28	419.56	412	75.01	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			200.5	E08		6	0102-0428	222.85	428.22	398	75.84	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			187.2	E08		6	0103-0438	440.00	437.97	811	112.57	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			202.4	E08		6	0104-0429	888.69	429.98	388	77.26	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			536.2	E08		6	0105-0432	604.99	432.84	420	76.43	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			196.0	E08		6	0106-0431	803.92	430.66	397	75.01	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			200.2	E08		6	0107-0445	845.80	445.48	452	81.74	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			287.6	E08		6	0108-0449	472.86	450.16	419	76.43	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			185.0	E08		6	0109-0451	399.60	450.90	407	74.43	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			210.7	E08		6	0110-0452	901.77	451.81	344	68.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			250.1	E08		6	0111-0457	510.59	457.67	365	71.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			188.1	E08		6	0112-0458	271.58	458.37	398	75.26	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			199.9	E08		6	0113-0464	362.29	463.93	415	76.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.1	E08		6	0114-0465	34.79	465.26	372	71.01	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			185.2	E08		6	0115-0468	319.64	468.73	386	75.50	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.7	E08		6	0116-0468	204.85	468.31	403	74.43	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			236.3	E08		6	0117-0472	589.04	472.62	410	77.84	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.4	E08		6	0118-0485	130.94	485.17	784	114.57	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.4	E08		6	0119-0480	559.70	480.70	401	74.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			289.6	E08		6	0120-0485	765.12	485.12	414	75.01	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			210.7	E08		6	0121-0488	817.96	488.82	421	77.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			270.8	E08		6	0122-0487	700.13	487.33	456	79.60	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			211.3	E08		6	0123-0494	467.40	493.91	413	75.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			211.5	E08		6	0124-0497	519.65	497.45	378	73.01	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			279.1	E08		6	0125-0503	71.84	502.98	397	73.60	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			194.0	E08		6	0126-0510	312.54	510.67	394	76.91	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			195.0	E08		6	0127-0525	839.74	525.65	437	78.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			207.1	E08		6	0128-0527	540.65	527.67	412	75.26	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			225.2	E08		6	0129-0528	685.34	528.07	370	72.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.0	E08		6	0130-0531	408.66	531.66	427	82.91	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			218.7	E08		6	0131-0545	184.59	545.56	423	77.26	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			230.5	E08		6	0132-0550	783.64	550.56	434	78.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			745.1	E08		6	0133-0554	16.21	553.55	343	69.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.6	E08		6	0134-0558	889.37	558.36	399	75.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			216.1	E08		6	0135-0563	292.95	563.04	416	75.01	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			210.8	E08		6	0136-0566	246.05	566.66	403	75.26	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.9	E08		6	0137-0574	207.12	574.39	383	73.01	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.1	E08		6	0138-0580	407.06	580.07	744	102.91	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			222.2	E08		6	0139-0579	123.64	579.43	381	73.84	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1568.5	E08		6	0140-0584	648.20	584.41	298	79.26	0.596
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			198.1	E08		6	0141-0588	340.02	588.45	389	76.08	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			208.7	E08		6	0142-0591	512.96	591.21	414	76.08	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			622.0	E08		6	0143-0592	930.00	592.72	460	79.84	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			205.7	E08		6	0144-0600	604.74	599.99	396	74.67	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			270.1	E08		6	0145-0610	674.51	609.31	411	75.26	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			391.8	E08		6	0146-0613	833.51	613.41	434	77.26	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			218.1	E08		6	0147-0616	47.33	616.58	414	76.08	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.7	E08		6	0148-0615	120.49	615.56	390	73.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.7	E08		6	0149-0618	286.91	617.98	407	78.08	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			217.1	E08		6	0150-0621	579.64	621.75	407	74.43	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.9	E08		6	0151-0630	264.54	630.19	456	79.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			205.2	E08		6	0152-0633	530.57	633.89	542	86.91	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			208.6	E08		6	0153-0633	175.78	633.64	416	77.01	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			205.9	E08		6	0154-0644	342.89	645.15	398	75.50	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.3	E08		6	0155-0643	423.03	642.72	391	74.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			192.1	E08		6	0156-0649	707.56	648.55	332	71.60	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.2	E08		6	0157-0651	879.79	651.82	403	75.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			246.9	E08		6	0158-0654	830.07	653.96	335	68.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			190.8	E08		6	0159-0659	73.10	659.24	383	74.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			217.9	E08		6	0160-0662	37.75	662.74	306	64.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			197.7	E08		6	0161-0664	699.20	664.39	367	72.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.8	E08		6	0162-0669	294.23	669.17	425	77.84	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			248.2	E08		6	0163-0672	755.14	671.70	314	65.01	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			184.3	E08		6	0164-0685	651.76	685.15	402	76.43	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			204.4	E08		6	0165-0690	191.80	689.38	504	90.08	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.5	E08		6	0166-0688	241.93	688.34	391	75.26	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.8	E08		6	0167-0688	860.00	687.87	391	76.67	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.4	E08		6	0168-0695	394.10	695.29	375	75.84	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			185.2	E08		6	0169-0692	684.52	691.77	372	73.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			183.3	E08		6	0170-0698	175.02	699.26	445	82.67	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			260.4	E08		6	0171-0696	775.38	696.07	302	63.36	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			348.3	E08		6	0172-0701	605.07	701.16	380	72.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			202.6	E08		6	0173-0702	95.54	701.63	451	85.60	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.9	E08		6	0174-0704	120.66	703.75	188	52.63	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			188.4	E08		6	0175-0709	319.30	709.24	414	81.01	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			226.5	E08		7	0001-0031	448.84	30.88	428	78.08	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			205.6	E08		7	0002-0032	838.72	31.96	384	75.50	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2728.4	E08		7	0003-0036	597.08	35.70	508	86.43	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			174.5	E08		7	0004-0040	660.75	40.02	389	73.26	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			203.2	E08		7	0005-0043	46.37	43.18	436	80.08	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			3173.5	E08		7	0006-0046	171.75	45.61	395	76.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			174.0	E08		7	0007-0056	779.49	56.58	762	105.40	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.3	E08		7	0008-0053	366.46	52.98	413	77.84	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			178.7	E08		7	0009-0061	736.50	60.83	821	110.33	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			181.6	E08		7	0010-0059	514.63	59.64	469	80.67	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			202.6	E08		7	0011-0060	622.88	60.55	447	81.01	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			212.5	E08		7	0012-0062	112.13	62.35	400	73.84	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.4	E08		7	0013-0064	827.38	64.14	397	73.01	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.6	E08		7	0014-0065	209.40	65.33	397	75.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			192.6	E08		7	0015-0068	474.31	68.46	445	77.84	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			193.5	E08		7	0016-0073	759.50	73.09	441	82.33	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			194.6	E08		7	0017-0071	25.96	71.16	395	74.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			189.3	E08		7	0018-0075	168.45	75.59	400	75.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.6	E08		7	0019-0076	649.96	75.19	460	84.91	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			200.2	E08		7	0020-0076	914.47	76.08	389	74.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.4	E08		7	0021-0081	412.73	81.20	410	77.01	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.9	E08		7	0022-0081	855.73	80.86	331	68.67	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			218.7	E08		7	0023-0090	806.94	90.08	426	77.50	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.6	E08		7	0024-0097	123.66	96.62	861	120.47	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			202.2	E08		7	0025-0100	724.72	101.48	808	111.30	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			195.6	E08		7	0026-0096	869.09	97.42	428	79.74	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			190.2	E08		7	0027-0096	384.45	96.22	436	77.26	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			189.1	E08		7	0028-0096	561.68	96.12	419	76.08	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			192.6	E08		7	0029-0103	764.31	103.27	401	74.08	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			205.5	E08		7	0030-0109	829.68	109.22	415	77.74	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			245.1	E08		7	0031-0108	325.77	108.69	389	74.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			174.4	E08		7	0032-0109	935.60	108.20	397	76.91	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			179.5	E08		7	0033-0115	706.49	115.81	360	73.50	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			197.8	E08		7	0034-0122	118.91	122.52	429	82.18	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.6	E08		7	0035-0124	923.18	123.79	412	82.23	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.1	E08		7	0036-0135	292.88	135.00	383	73.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			485.0	E08		7	0037-0135	354.72	135.33	404	75.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			193.2	E08		7	0038-0139	914.80	139.85	373	76.91	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			175.5	E08		7	0039-0143	59.89	143.01	419	81.84	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.8	E08		7	0040-0142	508.69	142.10	427	75.84	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.5	E08		7	0041-0140	651.23	140.11	271	60.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.4	E08		7	0042-0143	114.36	144.08	452	82.77	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			207.8	E08		7	0043-0145	174.82	145.47	397	74.43	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			271.2	E08		7	0044-0150	430.95	150.59	605	95.36	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			187.4	E08		7	0045-0151	682.39	151.18	397	75.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			292.8	E08		7	0046-0151	472.56	151.08	281	60.53	0.964
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.7	E08		7	0047-0153	408.79	153.93	304	67.94	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			234.1	E08		7	0048-0155	769.28	154.23	416	77.01	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			190.2	E08		7	0049-0160	729.61	159.76	426	78.91	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			207.6	E08		7	0050-0171	710.91	171.77	471	83.15	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.5	E08		7	0051-0176	84.38	176.01	398	74.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			203.6	E08		7	0052-0179	757.95	179.10	405	74.67	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.9	E08		7	0053-0183	829.21	183.92	409	76.18	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			246.6	E08		7	0054-0182	399.69	182.76	395	74.67	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			183.2	E08		7	0055-0190	561.34	189.93	399	74.43	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			230.3	E08		7	0056-0202	470.42	202.54	999	119.88	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			196.6	E08		7	0057-0196	663.68	196.18	453	79.26	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.3	E08		7	0058-0195	880.66	195.17	430	79.50	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			181.2	E08		7	0059-0196	922.97	196.10	429	78.67	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			200.3	E08		7	0060-0202	796.04	201.96	411	75.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.7	E08		7	0061-0206	348.07	206.46	389	73.01	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			183.5	E08		7	0062-0209	516.77	208.98	444	83.01	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			559.7	E08		7	0063-0220	186.65	219.98	420	76.33	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			256.4	E08		7	0064-0229	52.67	230.01	832	116.71	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			479.7	E08		7	0065-0221	413.57	222.10	437	84.18	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			417.3	E08		7	0066-0223	154.97	223.16	415	76.67	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.3	E08		7	0067-0225	212.81	225.04	416	76.67	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.2	E08		7	0068-0236	277.65	236.50	804	114.33	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			198.1	E08		7	0069-0230	717.96	230.20	468	83.26	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			204.8	E08		7	0070-0231	512.52	230.88	408	78.18	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			216.6	E08		7	0071-0231	660.78	231.47	409	76.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			188.6	E08		7	0072-0234	552.17	234.52	465	80.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.1	E08		7	0073-0235	743.94	234.70	468	82.91	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			202.0	E08		7	0074-0240	921.31	240.17	436	78.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			207.4	E08		7	0075-0244	349.58	244.76	421	79.50	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			263.5	E08		7	0076-0242	419.81	240.95	462	91.01	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			182.1	E08		7	0077-0245	587.43	245.28	446	79.26	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.4	E08		7	0078-0245	616.80	245.35	467	82.33	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			275.8	E08		7	0079-0256	244.72	256.65	411	74.43	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			234.9	E08		7	0080-0256	165.72	256.33	403	75.26	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			185.2	E08		7	0081-0256	546.41	255.98	391	77.36	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			212.1	E08		7	0082-0260	401.71	260.65	446	79.84	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.2	E08		7	0083-0261	770.98	261.39	409	76.08	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			222.5	E08		7	0084-0275	859.66	275.10	420	81.50	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			193.8	E08		7	0085-0280	15.81	280.22	382	76.08	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			203.3	E08		7	0086-0283	911.46	282.82	394	77.84	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			199.6	E08		7	0087-0287	812.91	286.93	384	75.26	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			459.5	E08		7	0088-0291	361.58	290.96	385	73.26	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.6	E08		7	0089-0296	449.18	296.56	453	80.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.2	E08		7	0090-0299	207.78	299.43	414	77.74	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			205.8	E08		7	0091-0300	615.41	300.01	425	79.26	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			205.9	E08		7	0092-0302	783.03	301.18	396	76.33	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			289.8	E08		7	0093-0305	287.31	304.99	408	75.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.7	E08		7	0094-0308	523.05	306.75	406	77.74	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			186.2	E08		7	0095-0304	581.87	304.39	434	78.08	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			181.5	E08		7	0096-0313	940.51	313.37	444	82.43	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			263.2	E08		7	0097-0310	418.35	310.49	410	75.84	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			296.8	E08		7	0098-0313	352.30	313.57	476	86.08	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.0	E08		7	0099-0311	766.95	312.50	385	76.33	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.0	E08		7	0100-0326	514.28	327.72	504	86.57	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			200.5	E08		7	0101-0333	365.09	333.64	458	82.67	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.9	E08		7	0102-0336	262.15	336.27	411	78.08	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			247.7	E08		7	0103-0346	486.60	346.09	878	119.64	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			174.4	E08		7	0104-0339	795.17	339.92	407	75.26	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			208.3	E08		7	0105-0340	576.51	340.22	421	76.67	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			202.0	E08		7	0106-0349	751.18	349.39	815	118.37	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			338.0	E08		7	0107-0342	176.49	342.38	406	75.26	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			183.0	E08		7	0108-0352	838.85	352.49	419	77.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.0	E08		7	0109-0353	37.15	353.91	411	77.26	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			249.6	E08		7	0110-0354	196.64	354.38	249	64.18	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			202.1	E08		7	0111-0357	911.74	356.92	410	77.50	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			222.1	E08		7	0112-0362	721.35	361.82	401	73.60	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.3	E08		7	0113-0375	307.67	373.54	822	118.37	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.6	E08		7	0114-0372	576.22	372.32	426	78.08	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			243.8	E08		7	0115-0379	255.42	379.49	555	88.33	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.5	E08		7	0116-0379	104.36	379.35	412	75.84	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			211.2	E08		7	0117-0383	353.55	383.66	403	78.08	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			203.1	E08		7	0118-0393	729.49	393.01	419	76.43	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			901.4	E08		7	0119-0399	411.40	399.13	422	78.67	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			176.8	E08		7	0120-0400	896.04	400.17	430	77.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			251.1	E08		7	0121-0412	547.67	412.36	432	77.26	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			191.2	E08		7	0122-0417	477.90	416.96	424	78.43	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			201.7	E08		7	0123-0421	798.64	421.39	816	108.13	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.0	E08		7	0124-0418	288.39	418.77	420	76.67	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			212.9	E08		7	0125-0422	221.78	422.33	394	75.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			601.2	E08		7	0126-0427	674.72	427.78	474	84.57	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			234.3	E08		7	0127-0435	647.25	434.77	971	126.37	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			191.3	E08		7	0128-0432	22.64	432.45	395	74.67	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1030.2	E08		7	0129-0428	852.61	427.21	311	66.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.3	E08		7	0130-0436	442.88	436.49	421	78.67	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			236.7	E08		7	0131-0438	413.29	438.11	427	78.91	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.6	E08		7	0132-0448	594.07	448.69	427	78.67	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			216.3	E08		7	0133-0449	916.60	449.00	410	75.84	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			226.0	E08		7	0134-0458	778.28	457.50	871	115.05	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.3	E08		7	0135-0453	284.13	453.88	402	74.67	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.7	E08		7	0136-0456	158.85	455.93	521	84.33	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			663.0	E08		7	0137-0458	703.47	458.41	431	80.91	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.0	E08		7	0138-0460	527.10	460.81	427	79.50	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			270.8	E08		7	0139-0461	851.90	460.82	426	77.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1220.9	E08		7	0140-0471	339.98	470.78	775	109.98	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.8	E08		7	0141-0483	82.00	482.90	404	76.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.3	E08		7	0142-0491	574.07	490.87	423	76.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			253.0	E08		7	0143-0493	110.84	492.98	414	76.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			244.9	E08		7	0144-0496	268.05	496.37	397	73.60	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.3	E08		7	0145-0497	225.62	496.98	383	72.43	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			187.6	E08		7	0146-0502	948.73	502.04	404	79.26	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			278.3	E08		7	0147-0507	728.18	506.57	400	77.60	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.7	E08		7	0148-0507	897.43	506.76	385	73.26	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.9	E08		7	0149-0515	409.47	515.53	400	75.84	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			222.2	E08		7	0150-0519	585.04	519.69	406	75.26	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			180.1	E08		7	0151-0524	723.90	525.32	292	66.18	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.6	E08		7	0152-0526	646.35	526.17	363	72.67	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			265.1	E08		7	0153-0530	160.90	531.09	418	77.11	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			244.4	E08		7	0154-0528	794.84	527.92	437	84.43	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			225.7	E08		7	0155-0538	62.81	537.91	537	87.26	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			261.3	E08		7	0156-0539	94.34	539.64	421	75.84	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			222.5	E08		7	0157-0537	526.23	537.55	407	76.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			225.7	E08		7	0158-0547	636.52	547.51	481	86.33	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.1	E08		7	0159-0546	361.37	546.65	416	76.67	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.3	E08		7	0160-0556	161.11	554.96	470	83.36	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			276.5	E08		7	0161-0556	830.91	556.71	355	72.08	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			256.4	E08		7	0162-0562	286.89	562.71	427	76.67	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			218.6	E08		7	0163-0563	565.56	563.25	427	76.43	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			217.4	E08		7	0164-0562	879.38	562.67	401	76.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			231.3	E08		7	0165-0563	239.98	563.72	432	77.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			296.7	E08		7	0166-0566	456.03	566.66	814	114.23	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			285.2	E08		7	0167-0578	40.49	578.42	753	104.81	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.9	E08		7	0168-0576	380.31	576.15	402	73.60	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			251.7	E08		7	0169-0594	904.98	594.13	711	103.64	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			188.5	E08		7	0170-0596	88.73	596.10	376	73.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			180.1	E08		7	0171-0605	117.62	605.11	407	76.67	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			205.8	E08		7	0172-0608	251.39	608.26	407	75.26	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.6	E08		7	0173-0609	171.24	609.16	393	73.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			184.6	E08		7	0174-0609	623.41	609.05	462	82.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			236.6	E08		7	0175-0622	508.45	622.39	442	79.26	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			255.1	E08		7	0176-0622	537.13	621.59	421	76.08	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			198.9	E08		7	0177-0629	839.20	629.32	388	73.60	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			246.5	E08		7	0178-0630	458.46	629.99	392	73.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			502.9	E08		7	0179-0630	375.06	630.96	424	77.84	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			174.5	E08		7	0180-0634	120.29	634.40	434	83.15	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.3	E08		7	0181-0638	566.69	638.48	419	78.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			178.5	E08		7	0182-0643	82.73	643.20	390	75.50	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			264.6	E08		7	0183-0641	31.35	641.60	353	68.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			201.3	E08		7	0184-0645	289.37	645.10	406	73.60	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			204.3	E08		7	0185-0644	599.43	644.18	456	81.50	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			200.8	E08		7	0186-0648	147.44	647.92	408	74.18	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			480.2	E08		7	0187-0651	710.26	650.69	404	75.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			187.6	E08		7	0188-0653	250.53	653.75	401	76.08	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			348.3	E08		7	0189-0657	392.64	657.16	439	78.43	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.0	E08		7	0190-0667	804.84	668.45	855	117.30	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			260.3	E08		7	0191-0664	204.68	664.59	410	75.01	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			234.9	E08		7	0192-0667	461.60	667.58	383	72.43	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			192.3	E08		7	0193-0668	870.91	668.58	360	70.43	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			192.5	E08		7	0194-0671	620.80	671.53	382	72.43	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			231.2	E08		7	0195-0682	727.61	681.81	759	105.74	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			308.2	E08		7	0196-0689	30.58	689.00	400	74.43	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			194.6	E08		7	0197-0698	843.13	698.26	329	72.43	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.3	E08		7	0198-0696	915.86	696.39	333	68.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			244.0	E08		7	0199-0702	286.34	702.25	615	92.91	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			189.0	E08		7	0200-0701	588.98	700.78	613	93.26	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			222.6	E08		7	0201-0703	676.76	703.24	449	80.08	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			201.9	E08		7	0202-0705	860.74	704.81	415	78.77	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.5	E08		7	0203-0706	339.00	705.36	365	71.01	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			131.9	E08		8	0001-0027	12.86	26.76	131	43.70	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			165.2	E08		8	0002-0034	878.19	33.39	456	81.98	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			173.1	E08		8	0003-0038	137.55	38.18	360	70.18	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			166.9	E08		8	0004-0036	208.64	36.46	369	71.26	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			150.2	E08		8	0005-0037	928.11	37.23	403	75.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			186.6	E08		8	0006-0039	338.64	39.54	422	77.50	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.2	E08		8	0007-0043	830.27	43.72	342	67.60	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			176.1	E08		8	0008-0044	858.88	44.83	369	73.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			192.2	E08		8	0009-0049	252.72	49.24	380	73.84	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			199.2	E08		8	0010-0052	703.68	51.91	725	99.74	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			180.7	E08		8	0011-0054	106.15	53.85	358	70.18	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			199.0	E08		8	0012-0056	435.56	56.02	435	77.26	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			170.4	E08		8	0013-0068	387.24	68.15	402	73.84	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			177.7	E08		8	0014-0072	502.28	72.23	432	79.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			249.5	E08		8	0015-0075	198.47	75.77	388	72.77	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			203.0	E08		8	0016-0076	825.57	76.69	447	78.67	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			193.2	E08		8	0017-0075	916.38	76.13	387	74.67	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			172.2	E08		8	0018-0078	19.55	78.07	365	71.01	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			210.3	E08		8	0019-0081	710.84	81.37	413	75.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			189.1	E08		8	0020-0090	169.84	90.08	388	74.67	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			186.4	E08		8	0021-0089	279.57	89.50	379	73.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			217.8	E08		8	0022-0093	359.40	92.93	391	73.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.1	E08		8	0023-0101	97.26	101.04	385	71.84	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			178.7	E08		8	0024-0106	129.43	105.80	377	72.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			200.8	E08		8	0025-0107	912.97	106.51	390	73.01	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			191.5	E08		8	0026-0111	40.25	110.23	367	75.40	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			222.9	E08		8	0027-0114	536.93	113.63	388	72.18	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			247.2	E08		8	0028-0121	790.30	121.16	840	112.08	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			694.5	E08		8	0029-0118	182.89	118.63	396	76.77	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			266.2	E08		8	0030-0117	426.66	117.08	409	75.26	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			191.0	E08		8	0031-0132	24.01	133.27	791	113.54	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			178.6	E08		8	0032-0129	510.23	128.96	385	73.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			164.7	E08		8	0033-0134	659.27	134.22	381	75.84	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			197.1	E08		8	0034-0142	147.05	142.44	399	74.18	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			194.3	E08		8	0035-0142	349.62	142.04	399	76.43	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			444.9	E08		8	0036-0143	184.85	143.18	431	79.94	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			258.0	E08		8	0037-0147	561.04	146.72	400	73.60	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			202.0	E08		8	0038-0152	592.10	151.51	558	98.57	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.6	E08		8	0039-0146	775.62	146.78	412	75.01	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			184.5	E08		8	0040-0154	270.66	154.46	398	73.01	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			187.0	E08		8	0041-0154	708.75	154.15	387	71.60	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			218.4	E08		8	0042-0155	221.46	155.64	376	71.01	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			208.0	E08		8	0043-0156	921.65	156.62	398	74.67	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			250.1	E08		8	0044-0157	303.73	157.44	396	73.60	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			266.3	E08		8	0045-0159	833.62	159.60	351	69.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			288.8	E08		8	0046-0166	471.01	165.99	897	114.81	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			191.4	E08		8	0047-0162	890.05	161.56	396	74.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			183.1	E08		8	0048-0161	61.84	161.17	363	71.60	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			207.1	E08		8	0049-0166	187.42	165.14	380	74.53	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			207.2	E08		8	0050-0166	341.97	166.42	401	75.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			200.5	E08		8	0051-0169	377.65	169.22	399	77.26	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			172.3	E08		8	0052-0167	102.73	166.88	363	71.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			194.2	E08		8	0053-0187	938.78	187.67	341	68.18	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			183.0	E08		8	0054-0188	676.21	188.44	420	76.67	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			200.7	E08		8	0055-0187	778.88	187.08	345	69.01	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			208.4	E08		8	0056-0189	823.38	189.83	386	71.60	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.5	E08		8	0057-0191	643.60	191.60	416	76.67	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			203.7	E08		8	0058-0194	529.74	194.47	406	75.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			181.3	E08		8	0059-0197	390.61	197.85	434	81.01	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			196.7	E08		8	0060-0198	28.08	198.47	395	78.67	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			180.4	E08		8	0061-0207	234.56	207.06	394	73.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			182.8	E08		8	0062-0210	98.04	210.49	783	110.81	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			275.5	E08		8	0063-0205	730.77	205.93	405	76.87	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			190.6	E08		8	0064-0210	51.96	209.98	417	77.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			300.0	E08		8	0065-0226	150.93	226.45	882	119.20	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			193.4	E08		8	0066-0227	766.45	227.43	385	74.43	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			302.2	E08		8	0067-0225	732.13	224.55	379	74.28	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			201.1	E08		8	0068-0230	517.07	230.49	396	75.26	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.2	E08		8	0069-0229	455.43	228.84	391	72.43	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			256.8	E08		8	0070-0234	704.14	234.14	436	77.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			180.9	E08		8	0071-0233	801.86	233.75	412	77.74	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			620.4	E08		8	0072-0235	280.81	235.53	442	79.50	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			155.7	E08		8	0073-0242	26.40	242.17	397	75.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			369.0	E08		8	0074-0239	883.39	239.10	387	73.26	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			212.2	E08		8	0075-0243	827.50	243.32	380	73.01	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			336.8	E08		8	0076-0245	304.28	244.81	430	84.08	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1436.7	E08		8	0077-0248	207.90	247.89	429	77.26	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.8	E08		8	0078-0247	338.34	247.62	403	76.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			193.9	E08		8	0079-0253	364.00	253.03	387	73.60	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			934.2	E08		8	0080-0269	645.93	267.39	970	133.05	0.689
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			186.2	E08		8	0081-0258	123.48	258.55	377	72.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			186.2	E08		8	0082-0263	453.70	263.14	404	75.26	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			335.7	E08		8	0083-0264	317.89	264.40	448	82.08	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			225.3	E08		8	0084-0266	75.47	265.97	413	76.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.9	E08		8	0085-0265	503.36	265.50	404	74.67	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			355.5	E08		8	0086-0267	273.87	266.82	456	81.15	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			418.5	E08		8	0087-0282	253.98	282.02	486	84.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			160.1	E08		8	0088-0285	16.72	284.89	358	71.60	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.0	E08		8	0089-0283	874.71	283.66	396	74.67	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.1	E08		8	0090-0301	365.86	301.03	389	73.01	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			181.5	E08		8	0091-0303	85.07	303.28	374	71.60	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.6	E08		8	0092-0305	493.41	304.96	634	98.57	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			280.6	E08		8	0093-0304	646.32	304.07	373	70.18	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			201.2	E08		8	0094-0307	801.56	307.47	422	76.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.4	E08		8	0095-0313	152.47	313.01	416	78.43	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			190.2	E08		8	0096-0315	45.71	315.47	403	79.01	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			200.6	E08		8	0097-0317	107.42	316.99	421	77.26	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			216.7	E08		8	0098-0324	435.57	323.86	409	76.08	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			187.0	E08		8	0099-0329	225.64	330.02	805	109.54	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2753.3	E08		8	0100-0323	884.08	323.71	276	59.94	0.965
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			194.8	E08		8	0101-0331	923.08	331.31	395	75.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			418.2	E08		8	0102-0334	353.64	334.44	365	71.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			187.9	E08		8	0103-0337	170.74	336.54	362	73.94	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			266.2	E08		8	0104-0338	558.10	338.35	477	80.67	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			207.4	E08		8	0105-0339	149.93	340.00	471	84.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			198.8	E08		8	0106-0341	811.52	341.33	405	75.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			258.2	E08		8	0107-0351	410.83	350.90	374	71.60	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.6	E08		8	0108-0353	298.83	353.05	332	67.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2705.1	E08		8	0109-0354	493.00	354.82	371	70.18	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			202.6	E08		8	0110-0358	665.66	358.28	390	74.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			183.7	E08		8	0111-0359	17.15	358.98	363	71.60	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			721.2	E08		8	0112-0357	346.39	357.41	317	65.36	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			197.8	E08		8	0113-0358	901.62	358.35	389	74.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			180.0	E08		8	0114-0371	862.43	370.96	842	117.15	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			198.2	E08		8	0115-0374	738.95	374.20	390	73.84	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			197.7	E08		8	0116-0377	785.88	377.58	417	77.84	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			374.5	E08		8	0117-0382	335.79	382.26	393	73.26	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			289.3	E08		8	0118-0394	112.36	393.65	782	110.37	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.7	E08		8	0119-0387	274.56	387.16	394	74.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.1	E08		8	0120-0390	208.40	390.43	381	74.91	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.0	E08		8	0121-0389	479.21	388.90	386	72.43	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			179.3	E08		8	0122-0401	168.44	400.19	458	87.26	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			247.6	E08		8	0123-0402	565.48	401.81	380	72.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			204.6	E08		8	0124-0406	362.72	406.66	424	79.84	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.1	E08		8	0125-0409	434.57	409.45	394	75.60	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			267.5	E08		8	0126-0412	476.60	412.46	404	75.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.2	E08		8	0127-0421	609.03	421.87	466	80.91	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			636.1	E08		8	0128-0421	828.47	421.78	413	76.67	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			193.0	E08		8	0129-0422	193.23	422.30	385	71.60	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			201.2	E08		8	0130-0421	261.09	421.26	380	73.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			553.9	E08		8	0131-0421	928.44	421.32	423	79.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			163.1	E08		8	0132-0431	84.88	431.14	373	73.26	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			672.4	E08		8	0133-0429	901.87	428.91	391	76.18	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.9	E08		8	0134-0434	390.13	434.87	380	73.01	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			275.1	E08		8	0135-0439	573.78	438.71	432	77.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			231.2	E08		8	0136-0443	677.38	443.35	419	75.01	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			509.7	E08		8	0137-0443	127.46	443.00	401	75.50	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			173.4	E08		8	0138-0443	298.30	442.84	387	74.67	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.9	E08		8	0139-0445	250.82	443.39	360	72.91	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			167.0	E08		8	0140-0451	21.71	450.93	367	71.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			200.4	E08		8	0141-0451	57.31	451.96	366	71.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			313.7	E08		8	0142-0456	266.57	457.00	385	74.57	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			190.4	E08		8	0143-0456	757.54	456.78	401	73.84	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			458.1	E08		8	0144-0465	695.31	464.74	333	66.77	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			188.7	E08		8	0145-0475	624.02	474.88	775	109.64	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.9	E08		8	0146-0472	545.34	472.55	230	55.94	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			212.7	E08		8	0147-0479	826.55	478.30	624	92.33	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			268.0	E08		8	0148-0480	103.11	480.20	386	73.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			199.0	E08		8	0149-0482	470.82	480.83	343	70.91	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.0	E08		8	0150-0483	257.38	482.81	373	70.77	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1874.7	E08		8	0151-0487	382.59	487.61	326	65.94	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			272.6	E08		8	0152-0497	88.68	497.40	427	77.50	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			200.2	E08		8	0153-0501	942.80	501.31	378	74.77	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			151.7	E08		8	0154-0504	53.78	503.94	355	73.60	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			204.9	E08		8	0155-0502	837.74	503.28	408	79.26	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			498.3	E08		8	0156-0506	117.26	506.08	442	81.01	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			185.5	E08		8	0157-0508	692.35	507.93	420	76.08	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			308.7	E08		8	0158-0510	631.74	509.82	395	73.84	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			212.6	E08		8	0159-0518	344.60	518.30	623	92.33	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1030.8	E08		8	0160-0520	502.68	521.89	473	97.40	0.627
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			450.1	E08		8	0161-0519	179.67	519.43	392	73.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			240.2	E08		8	0162-0531	133.80	531.30	437	83.50	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			205.8	E08		8	0163-0530	683.66	531.47	424	77.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			169.3	E08		8	0164-0535	109.15	534.66	422	78.08	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			191.3	E08		8	0165-0538	262.29	538.48	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.9	E08		8	0166-0546	422.62	547.19	423	78.43	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			204.8	E08		8	0167-0548	772.56	547.66	381	73.84	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.6	E08		8	0168-0549	741.84	549.81	294	64.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.3	E08		8	0169-0552	689.00	552.49	408	78.18	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			201.8	E08		8	0170-0554	612.03	554.10	392	73.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			194.5	E08		8	0171-0558	572.27	558.01	387	73.01	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			217.9	E08		8	0172-0558	818.49	558.24	379	72.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			203.4	E08		8	0173-0559	239.19	559.34	388	74.08	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			192.3	E08		8	0174-0567	401.42	566.65	432	77.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			198.0	E08		8	0175-0569	72.52	568.92	371	71.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			185.6	E08		8	0176-0568	115.15	567.72	380	74.08	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			181.7	E08		8	0177-0571	928.14	571.53	366	71.01	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.0	E08		8	0178-0573	894.54	573.35	385	73.26	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			216.7	E08		8	0179-0573	472.87	572.73	373	71.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.9	E08		8	0180-0578	365.59	578.38	422	77.94	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			187.9	E08		8	0181-0577	620.21	577.65	398	74.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			202.9	E08		8	0182-0579	657.58	579.15	397	75.50	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			207.0	E08		8	0183-0579	130.71	579.51	295	63.84	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			191.7	E08		8	0184-0586	870.14	586.32	352	70.43	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			222.3	E08		8	0185-0593	306.08	592.85	380	72.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			188.1	E08		8	0186-0591	574.66	591.46	375	72.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			204.4	E08		8	0187-0600	798.09	600.44	796	109.88	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			208.8	E08		8	0188-0598	344.16	598.08	407	76.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			202.1	E08		8	0189-0598	649.17	599.12	377	74.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.6	E08		8	0190-0606	189.49	605.77	406	77.11	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.8	E08		8	0191-0611	212.45	611.06	398	76.77	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			182.8	E08		8	0192-0609	498.57	609.64	381	75.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.0	E08		8	0193-0620	745.01	619.76	770	112.47	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.9	E08		8	0194-0615	622.23	614.51	375	72.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			193.4	E08		8	0195-0619	247.53	619.43	377	71.01	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			202.0	E08		8	0196-0623	315.00	623.18	422	76.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			278.5	E08		8	0197-0630	449.89	629.80	367	71.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			194.6	E08		8	0198-0630	117.57	630.45	386	73.01	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			387.7	E08		8	0199-0634	145.21	633.58	394	75.50	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.6	E08		8	0200-0633	650.83	633.13	404	76.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			175.1	E08		8	0201-0634	411.77	634.57	416	76.18	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			246.2	E08		8	0202-0633	940.43	632.74	121	41.80	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			172.6	E08		8	0203-0642	389.05	641.84	422	77.84	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			212.0	E08		8	0204-0644	535.73	644.60	394	73.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			195.9	E08		8	0205-0650	577.45	650.84	386	72.18	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			178.1	E08		8	0206-0655	104.11	655.06	400	79.01	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			203.8	E08		8	0207-0656	784.90	656.57	391	73.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.6	E08		8	0208-0657	274.18	656.98	365	71.01	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.9	E08		8	0209-0660	515.41	660.89	414	75.84	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.1	E08		8	0210-0662	465.97	662.53	397	74.18	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.3	E08		8	0211-0663	862.67	663.21	420	76.43	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.2	E08		8	0212-0675	611.14	675.90	404	78.91	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			208.3	E08		8	0213-0687	236.25	687.72	410	77.01	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			197.7	E08		8	0214-0688	937.61	688.35	351	72.18	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			192.1	E08		8	0215-0687	135.56	687.26	385	73.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			324.7	E08		8	0216-0690	767.50	688.49	390	77.98	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.7	E08		8	0217-0695	630.66	695.62	404	78.43	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			201.3	E08		8	0218-0698	20.54	698.45	342	67.84	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			202.0	E08		8	0219-0705	876.06	705.52	417	76.91	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			195.3	E08		9	0001-0035	446.94	35.52	381	76.53	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			191.1	E08		9	0002-0030	118.26	29.91	194	54.53	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			196.3	E08		9	0003-0037	467.14	37.29	461	81.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			183.2	E08		9	0004-0035	317.27	34.86	407	80.43	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			177.3	E08		9	0005-0039	22.73	39.90	388	76.91	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			198.5	E08		9	0006-0041	859.08	41.53	402	77.74	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			145.6	E08		9	0007-0048	501.51	48.32	417	77.26	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			167.6	E08		9	0008-0052	92.29	52.34	375	72.67	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.5	E08		9	0009-0051	682.41	51.08	408	75.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			255.6	E08		9	0010-0056	198.24	54.50	521	106.81	0.574
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			196.5	E08		9	0011-0053	750.74	53.84	362	71.60	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			263.1	E08		9	0012-0058	180.23	60.22	233	72.08	0.564
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			189.9	E08		9	0013-0059	124.69	58.76	368	74.67	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			230.5	E08		9	0014-0065	905.51	65.74	347	70.43	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			200.8	E08		9	0015-0067	424.89	67.01	396	75.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			238.1	E08		9	0016-0068	807.95	68.14	355	68.77	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			244.0	E08		9	0017-0080	716.35	80.08	379	75.36	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			208.6	E08		9	0018-0076	289.50	76.64	363	72.43	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			210.8	E08		9	0019-0079	840.09	78.86	418	77.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			578.4	E08		9	0020-0082	469.22	81.80	358	71.60	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.3	E08		9	0021-0086	533.45	85.87	390	75.84	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			292.0	E08		9	0022-0091	923.79	90.75	578	92.57	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			187.4	E08		9	0023-0090	79.93	89.86	378	73.50	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			248.1	E08		9	0024-0097	361.02	97.13	367	73.26	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			308.4	E08		9	0025-0100	832.20	99.85	407	77.84	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.2	E08		9	0026-0104	944.59	104.47	361	71.84	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1144.3	E08		9	0027-0114	400.72	115.10	887	115.98	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			193.9	E08		9	0028-0113	501.62	112.70	613	91.74	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			203.6	E08		9	0029-0124	118.68	124.31	366	71.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.8	E08		9	0030-0133	74.11	134.00	385	77.60	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			199.8	E08		9	0031-0136	215.57	136.49	367	71.60	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			423.6	E08		9	0032-0137	304.29	137.25	382	75.26	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			338.7	E08		9	0033-0142	849.97	142.28	397	76.67	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			231.7	E08		9	0034-0153	773.45	152.25	340	70.33	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			230.7	E08		9	0035-0155	71.06	153.87	405	76.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			201.9	E08		9	0036-0157	644.08	156.94	390	76.08	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			230.3	E08		9	0037-0159	16.79	159.26	372	72.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.3	E08		9	0038-0164	786.81	165.90	382	73.74	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			280.6	E08		9	0039-0170	711.99	170.25	341	68.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.8	E08		9	0040-0179	734.38	179.20	399	77.26	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			245.7	E08		9	0041-0182	557.51	181.49	421	78.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			200.2	E08		9	0042-0181	472.02	180.70	441	80.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			211.8	E08		9	0043-0183	320.29	182.67	391	75.26	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			212.4	E08		9	0044-0190	33.68	190.27	339	69.01	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			286.9	E08		9	0045-0190	662.58	189.98	368	74.43	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			222.3	E08		9	0046-0201	870.57	199.09	990	127.54	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.8	E08		9	0047-0198	642.58	198.23	392	75.60	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			199.5	E08		9	0048-0198	62.31	198.18	337	69.26	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			196.2	E08		9	0049-0204	137.30	204.06	380	75.84	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.4	E08		9	0050-0204	931.35	203.84	337	68.18	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			185.2	E08		9	0051-0207	116.09	206.71	381	75.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			258.5	E08		9	0052-0218	365.71	218.11	398	77.50	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.3	E08		9	0053-0223	202.20	223.22	396	76.08	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.7	E08		9	0054-0235	446.43	235.83	404	77.74	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.4	E08		9	0055-0234	300.74	233.79	385	75.26	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			195.8	E08		9	0056-0237	852.00	237.08	388	73.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			192.7	E08		9	0057-0246	898.77	247.10	689	110.37	0.711
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			242.2	E08		9	0058-0245	510.67	246.13	412	75.26	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.5	E08		9	0059-0250	571.60	249.66	391	73.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			196.9	E08		9	0060-0254	95.42	254.05	353	68.18	0.954
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			302.9	E08		9	0061-0261	257.36	261.65	412	80.43	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.0	E08		9	0062-0264	925.97	264.27	369	71.01	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			2254.4	E08		9	0063-0267	276.08	268.10	156	48.87	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			364.8	E08		9	0064-0295	116.10	293.14	552	94.23	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			299.3	E08		9	0065-0296	865.27	296.47	330	67.94	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			204.8	E08		9	0066-0308	601.08	308.01	785	119.10	0.695
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.5	E08		9	0067-0312	311.36	313.08	807	110.37	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			257.6	E08		9	0068-0306	62.59	305.93	393	78.33	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			225.7	E08		9	0069-0310	160.91	310.08	362	74.91	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			345.0	E08		9	0070-0311	534.74	311.75	392	75.01	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			592.0	E08		9	0071-0312	103.15	311.94	275	61.36	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.3	E08		9	0072-0316	463.24	315.59	409	77.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.5	E08		9	0073-0318	253.19	318.38	397	76.33	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.6	E08		9	0074-0321	48.06	322.47	448	79.50	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			279.5	E08		9	0075-0322	843.07	321.93	318	66.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			280.0	E08		9	0076-0329	410.85	329.14	331	68.43	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			180.0	E08		9	0077-0334	18.36	333.96	364	73.50	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			259.8	E08		9	0078-0336	359.49	336.39	397	73.84	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.1	E08		9	0079-0361	46.64	361.56	375	76.18	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.9	E08		9	0080-0363	143.77	363.02	715	101.05	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			268.9	E08		9	0081-0357	942.03	357.06	341	68.18	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			419.7	E08		9	0082-0367	914.25	366.85	224	76.43	0.482
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.5	E08		9	0083-0371	291.66	371.35	368	72.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			187.0	E08		9	0084-0386	92.84	386.67	367	72.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			231.5	E08		9	0085-0400	243.83	400.34	375	73.26	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.2	E08		9	0086-0401	306.84	401.24	393	74.67	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			237.6	E08		9	0087-0409	193.29	408.93	388	73.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.2	E08		9	0088-0412	70.60	412.71	370	71.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.3	E08		9	0089-0421	506.18	420.74	402	75.50	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			533.1	E08		9	0090-0424	23.89	424.00	390	75.60	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			203.3	E08		9	0091-0438	122.48	438.09	377	74.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			798.8	E08		9	0092-0457	67.82	457.34	362	71.60	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.5	E08		9	0093-0460	378.98	459.94	408	74.43	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			201.7	E08		9	0094-0472	844.58	471.93	371	74.43	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			208.6	E08		9	0095-0493	233.99	494.65	661	106.23	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.1	E08		9	0096-0496	541.76	496.72	360	71.84	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			216.6	E08		9	0097-0502	57.45	502.91	432	82.28	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			177.1	E08		9	0098-0504	37.64	504.09	357	72.53	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			210.8	E08		9	0099-0505	610.27	505.12	422	75.26	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.3	E08		9	0100-0519	323.28	519.04	444	79.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			196.4	E08		9	0101-0523	206.62	522.81	376	73.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.4	E08		9	0102-0523	59.79	522.94	350	71.70	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			207.4	E08		9	0103-0540	338.97	540.23	445	79.26	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			178.9	E08		9	0104-0545	381.48	545.16	362	70.53	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			301.3	E08		9	0105-0545	571.83	544.20	311	67.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			240.7	E08		9	0106-0559	562.79	560.54	389	75.26	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			178.6	E08		9	0107-0574	22.91	574.25	342	69.60	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			191.9	E08		9	0108-0576	608.85	576.94	389	74.91	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			216.8	E08		9	0109-0587	590.60	587.81	393	75.26	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			193.2	E08		9	0110-0594	360.80	594.71	372	72.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			175.0	E08		9	0111-0597	50.96	597.50	346	71.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1845.5	E08		9	0112-0619	538.40	618.84	271	59.94	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			247.6	E08		9	0113-0632	114.79	632.78	368	71.84	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			199.1	E08		9	0114-0633	916.89	632.73	349	70.77	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.5	E08		9	0115-0637	723.10	636.85	398	76.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.7	E08		9	0116-0635	35.78	635.56	114	43.46	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			226.4	E08		9	0117-0647	330.91	646.43	963	121.30	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			238.3	E08		9	0118-0643	95.21	643.10	364	74.08	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			249.0	E08		9	0119-0646	831.47	646.01	365	71.84	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			243.2	E08		9	0120-0664	884.80	664.40	591	92.33	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			605.2	E08		9	0121-0688	282.03	688.56	384	75.84	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			183.8	E08		9	0122-0691	32.07	691.03	364	72.43	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.3	E08		9	0123-0696	492.71	697.00	914	118.23	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			199.2	E08		9	0124-0692	101.63	692.07	400	76.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			254.1	E08		9	0125-0695	371.28	694.61	380	75.50	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			457.7	E08		9	0126-0700	602.27	699.55	456	83.74	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			203.4	E08		9	0127-0701	453.77	701.32	370	71.84	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.3	F08		1	0001-0030	110.32	30.57	334	66.77	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			530.3	F08		1	0002-0030	292.69	29.76	335	69.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			212.8	F08		1	0003-0033	788.07	32.87	308	63.94	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.9	F08		1	0004-0036	632.11	35.77	388	76.67	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.9	F08		1	0005-0039	856.44	39.34	340	71.26	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.1	F08		1	0006-0046	812.65	45.96	342	69.60	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			247.7	F08		1	0007-0045	447.90	44.91	293	63.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			250.0	F08		1	0008-0050	42.39	51.20	369	72.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			272.4	F08		1	0009-0052	596.09	52.45	328	69.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.7	F08		1	0010-0056	175.27	55.94	409	77.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.7	F08		1	0011-0064	115.82	64.58	333	67.26	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			390.2	F08		1	0012-0066	924.28	65.51	402	78.08	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			244.5	F08		1	0013-0084	473.86	84.49	348	69.60	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			285.9	F08		1	0014-0088	249.65	88.08	246	61.84	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.5	F08		1	0015-0090	298.93	89.70	343	71.01	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			234.9	F08		1	0016-0097	626.12	97.82	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.2	F08		1	0017-0100	812.67	99.51	412	75.26	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.8	F08		1	0018-0101	37.70	101.14	322	67.01	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			531.9	F08		1	0019-0109	158.33	109.14	367	74.67	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			327.0	F08		1	0020-0110	918.49	110.83	230	55.70	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			267.8	F08		1	0021-0117	383.49	117.08	301	63.60	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			210.3	F08		1	0022-0120	224.09	120.30	352	71.84	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.9	F08		1	0023-0128	92.30	128.42	330	68.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.3	F08		1	0024-0129	304.76	129.88	332	69.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			225.0	F08		1	0025-0132	888.55	131.89	382	74.67	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			596.7	F08		1	0026-0133	624.07	132.24	400	75.84	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.5	F08		1	0027-0136	189.70	136.50	377	71.84	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.4	F08		1	0028-0139	38.80	139.33	355	71.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			268.1	F08		1	0029-0156	502.25	156.41	361	72.77	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			312.9	F08		1	0030-0159	245.97	159.58	262	60.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			266.7	F08		1	0031-0162	542.47	162.08	305	66.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			230.7	F08		1	0032-0170	856.80	169.98	448	81.26	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			300.7	F08		1	0033-0175	32.65	174.76	287	62.77	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			257.6	F08		1	0034-0180	296.19	180.25	357	70.67	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.0	F08		1	0035-0181	102.62	181.53	348	70.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			244.5	F08		1	0036-0191	622.34	191.15	356	70.53	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.5	F08		1	0037-0209	549.09	209.23	362	71.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			245.0	F08		1	0038-0216	173.16	216.49	298	64.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			330.6	F08		1	0039-0214	415.90	214.79	279	65.70	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			315.5	F08		1	0040-0218	132.55	218.67	313	65.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			250.3	F08		1	0041-0222	910.76	222.53	352	71.36	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			257.7	F08		1	0042-0227	265.38	226.89	346	70.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			240.6	F08		1	0043-0236	190.99	236.66	350	69.01	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			255.3	F08		1	0044-0238	460.98	238.44	327	74.08	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			264.5	F08		1	0045-0242	620.41	241.77	371	73.26	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			257.2	F08		1	0046-0241	540.92	241.27	310	65.11	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			498.3	F08		1	0047-0241	410.05	241.48	113	37.80	0.994
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			217.8	F08		1	0048-0250	839.25	249.93	357	73.26	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			302.5	F08		1	0049-0261	137.07	261.05	352	71.26	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			263.7	F08		1	0050-0262	571.15	261.52	381	73.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.2	F08		1	0051-0266	475.39	266.69	348	70.77	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			238.6	F08		1	0052-0270	530.89	271.01	334	69.84	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			274.3	F08		1	0053-0273	75.30	273.01	386	72.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.9	F08		1	0054-0279	210.55	279.03	249	60.43	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			266.9	F08		1	0055-0279	382.62	278.80	308	67.36	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			464.9	F08		1	0056-0282	904.38	282.65	390	74.43	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.0	F08		1	0057-0287	15.18	287.71	332	67.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.4	F08		1	0058-0300	517.08	299.90	373	73.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			287.9	F08		1	0059-0329	669.56	330.57	345	70.43	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			250.3	F08		1	0060-0329	210.55	329.94	319	64.77	0.956
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			225.9	F08		1	0061-0342	802.79	343.15	334	72.67	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			238.6	F08		1	0062-0344	183.62	344.44	354	70.43	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			250.3	F08		1	0063-0346	343.07	345.89	306	64.77	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			252.5	F08		1	0064-0343	518.02	343.86	284	64.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			251.7	F08		1	0065-0349	610.56	349.57	361	71.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			225.7	F08		1	0066-0349	313.63	348.58	294	67.26	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			255.5	F08		1	0067-0352	260.23	352.27	281	67.11	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			283.8	F08		1	0068-0354	442.75	354.67	287	63.94	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			253.6	F08		1	0069-0363	480.92	363.36	340	69.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.7	F08		1	0070-0367	299.40	366.87	304	65.36	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.9	F08		1	0071-0365	834.10	365.25	322	69.01	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			260.3	F08		1	0072-0368	527.07	367.61	294	64.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.2	F08		1	0073-0382	713.27	382.72	345	71.50	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.7	F08		1	0074-0384	173.41	384.36	362	72.77	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			197.5	F08		1	0075-0391	638.78	392.22	333	68.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			260.6	F08		1	0076-0405	573.29	404.87	344	69.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			212.8	F08		1	0077-0406	83.10	406.45	337	72.08	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			234.6	F08		1	0078-0409	594.00	410.00	382	76.43	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			292.2	F08		1	0079-0416	504.68	415.87	285	67.01	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			290.0	F08		1	0080-0418	699.52	417.20	307	69.50	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			250.4	F08		1	0081-0418	203.10	417.77	265	61.36	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			240.8	F08		1	0082-0428	690.61	428.69	321	68.91	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.6	F08		1	0083-0435	651.67	435.56	372	72.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			245.9	F08		1	0084-0437	450.85	437.17	367	70.77	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			246.5	F08		1	0085-0435	195.15	435.23	264	61.36	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			234.6	F08		1	0086-0441	111.14	440.70	368	73.84	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			290.9	F08		1	0087-0436	937.32	436.53	267	61.70	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			343.1	F08		1	0088-0444	253.50	444.16	346	118.71	0.309
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.0	F08		1	0089-0455	397.40	455.25	368	71.01	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			292.6	F08		1	0090-0464	825.17	463.78	237	57.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			273.7	F08		1	0091-0485	605.91	485.29	412	87.15	0.682
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.6	F08		1	0092-0484	359.10	485.15	381	72.18	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			282.1	F08		1	0093-0490	141.87	490.27	500	83.26	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			252.1	F08		1	0094-0485	304.73	485.23	290	63.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1142.9	F08		1	0095-0491	754.70	490.13	391	73.84	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			277.0	F08		1	0096-0498	265.06	497.74	288	63.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			319.6	F08		1	0097-0502	612.95	502.59	117	44.87	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			244.3	F08		1	0098-0527	10.59	527.92	305	65.70	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.6	F08		1	0099-0529	57.86	529.03	358	73.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.7	F08		1	0100-0535	452.49	535.43	640	112.47	0.636
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			257.7	F08		1	0101-0544	105.27	544.43	300	68.18	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.8	F08		1	0102-0546	231.84	545.25	339	71.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			252.4	F08		1	0103-0553	623.75	553.28	268	62.43	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.6	F08		1	0104-0555	850.95	555.28	286	62.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			238.1	F08		1	0105-0568	48.18	568.35	360	72.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			242.8	F08		1	0106-0574	819.63	574.22	350	69.11	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			218.9	F08		1	0107-0583	783.20	583.27	312	66.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			225.9	F08		1	0108-0584	710.81	582.51	423	89.50	0.664
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			222.7	F08		1	0109-0601	38.32	600.89	321	67.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			189.3	F08		1	0110-0600	607.81	600.05	367	76.08	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			203.2	F08		1	0111-0606	660.58	605.85	371	69.60	0.962
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			185.5	F08		1	0112-0610	748.21	610.84	319	68.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			294.8	F08		1	0113-0613	409.35	613.53	265	61.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			288.2	F08		1	0114-0617	366.01	617.49	295	65.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.1	F08		1	0115-0636	47.83	636.91	302	65.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			307.5	F08		1	0116-0637	228.92	636.45	239	59.84	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			255.6	F08		1	0117-0641	105.73	640.57	304	66.43	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.2	F08		1	0118-0640	623.25	640.90	283	65.50	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.3	F08		1	0119-0647	682.37	646.90	347	69.36	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			236.0	F08		1	0120-0655	768.36	655.13	297	65.11	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.0	F08		1	0121-0662	135.28	662.55	313	68.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			292.9	F08		1	0122-0666	210.92	665.60	261	60.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			243.4	F08		1	0123-0671	801.92	670.94	284	69.94	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			300.4	F08		1	0124-0667	75.29	666.23	255	61.01	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			202.9	F08		1	0125-0677	59.44	677.46	367	73.74	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			273.4	F08		1	0126-0683	690.93	683.68	237	57.11	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.4	F08		1	0127-0686	20.18	685.76	352	73.26	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.8	F08		1	0128-0684	273.91	684.26	249	60.87	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			238.9	F08		1	0129-0693	915.46	693.02	290	65.36	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			200.2	F08		1	0130-0701	579.21	702.80	368	72.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.6	F08		2	0001-0044	402.32	43.52	252	60.87	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			248.1	F08		2	0002-0047	546.79	46.75	377	74.43	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			205.8	F08		2	0003-0045	673.20	45.53	381	73.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			252.2	F08		2	0004-0049	443.67	49.45	286	65.01	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			204.6	F08		2	0005-0054	106.51	53.86	348	73.26	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.2	F08		2	0006-0052	743.31	52.03	279	62.43	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			250.3	F08		2	0007-0054	139.17	54.86	280	64.43	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			334.3	F08		2	0008-0067	28.86	65.71	380	74.67	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			256.3	F08		2	0009-0077	470.04	76.71	312	68.18	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			248.1	F08		2	0010-0072	721.48	72.01	287	65.94	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			274.6	F08		2	0011-0074	183.67	73.87	277	62.28	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			317.4	F08		2	0012-0080	815.81	78.97	283	65.50	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			240.6	F08		2	0013-0082	518.19	82.42	330	77.50	0.690
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			242.0	F08		2	0014-0083	889.92	82.14	281	62.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			218.8	F08		2	0015-0093	931.34	92.92	316	69.26	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			226.3	F08		2	0016-0102	144.94	102.35	374	75.50	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			288.3	F08		2	0017-0105	565.73	104.91	454	81.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			247.0	F08		2	0018-0111	22.99	111.27	235	56.53	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			259.6	F08		2	0019-0113	657.25	112.56	319	68.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			292.0	F08		2	0020-0117	207.77	117.49	239	59.70	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			296.0	F08		2	0021-0119	230.19	119.39	242	60.53	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			276.7	F08		2	0022-0134	856.86	133.97	276	62.43	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			218.5	F08		2	0023-0138	939.43	137.65	329	70.43	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			243.3	F08		2	0024-0143	330.89	143.01	345	68.77	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.7	F08		2	0025-0151	69.43	151.02	317	67.84	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			405.4	F08		2	0026-0156	215.70	157.45	411	85.50	0.707
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			247.5	F08		2	0027-0157	165.99	157.66	306	66.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			266.8	F08		2	0028-0162	411.80	162.46	265	61.36	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			318.5	F08		2	0029-0166	749.08	166.72	255	59.36	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			924.1	F08		2	0030-0170	119.40	169.22	339	71.01	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			361.3	F08		2	0031-0169	139.86	169.16	344	68.53	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			231.0	F08		2	0032-0176	510.70	176.42	377	72.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			281.6	F08		2	0033-0172	635.63	171.65	154	45.94	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			249.3	F08		2	0034-0178	457.29	178.32	334	68.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			286.7	F08		2	0035-0181	626.08	181.30	201	55.01	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			280.8	F08		2	0036-0187	645.35	186.92	276	63.60	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			353.2	F08		2	0037-0189	845.17	189.53	216	59.60	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.6	F08		2	0038-0193	325.10	193.61	304	64.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.4	F08		2	0039-0198	409.45	197.88	339	70.18	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			234.8	F08		2	0040-0209	535.17	208.71	386	73.26	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.6	F08		2	0041-0222	15.25	222.86	325	68.53	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.8	F08		2	0042-0224	616.40	224.46	300	65.01	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			317.2	F08		2	0043-0226	843.78	226.33	273	63.60	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			246.5	F08		2	0044-0230	121.18	229.88	332	68.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			247.1	F08		2	0045-0228	239.63	228.40	268	65.01	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			205.2	F08		2	0046-0230	652.00	230.29	317	67.84	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.8	F08		2	0047-0233	715.12	232.41	190	55.11	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			306.9	F08		2	0048-0235	323.12	235.58	304	71.11	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			258.0	F08		2	0049-0245	404.92	245.37	349	71.84	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			247.8	F08		2	0050-0250	276.28	249.47	274	63.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			288.0	F08		2	0051-0264	929.92	263.21	249	63.01	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.2	F08		2	0052-0261	191.74	262.17	309	69.36	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			409.0	F08		2	0053-0261	360.66	261.16	226	56.04	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.7	F08		2	0054-0268	54.40	268.60	344	69.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			323.6	F08		2	0055-0269	887.42	269.70	221	56.87	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			271.3	F08		2	0056-0270	341.91	269.66	282	63.94	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			257.7	F08		2	0057-0270	377.36	269.33	302	67.01	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.1	F08		2	0058-0280	724.41	279.94	346	72.18	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			376.7	F08		2	0059-0287	837.58	288.01	278	63.36	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			284.4	F08		2	0060-0297	127.28	297.86	214	57.94	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			256.3	F08		2	0061-0310	855.99	310.23	349	72.77	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			217.9	F08		2	0062-0317	259.32	317.68	288	65.70	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.6	F08		2	0063-0316	721.99	316.46	335	70.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			253.7	F08		2	0064-0321	376.65	320.95	305	66.67	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			256.7	F08		2	0065-0326	445.77	327.05	286	61.36	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			237.4	F08		2	0066-0330	180.19	329.23	325	67.36	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			274.0	F08		2	0067-0342	868.58	341.35	293	64.18	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.1	F08		2	0068-0348	366.56	348.52	336	68.18	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			217.7	F08		2	0069-0351	922.88	351.54	356	73.01	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			202.1	F08		2	0070-0356	941.20	356.11	350	71.60	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.6	F08		2	0071-0357	153.69	357.39	612	108.23	0.657
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.8	F08		2	0072-0374	406.60	374.81	483	84.43	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			216.6	F08		2	0073-0383	289.40	383.00	313	67.94	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			275.6	F08		2	0074-0383	102.55	383.68	245	59.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			273.3	F08		2	0075-0385	593.84	385.36	304	67.84	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.3	F08		2	0076-0387	356.28	387.46	294	66.43	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.1	F08		2	0077-0393	141.79	393.65	318	69.26	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			225.6	F08		2	0078-0397	212.63	398.04	322	65.60	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			240.4	F08		2	0079-0404	652.55	404.88	359	70.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			197.5	F08		2	0080-0409	431.96	408.57	379	72.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			279.0	F08		2	0081-0430	485.77	430.66	314	68.18	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.3	F08		2	0082-0436	193.76	436.75	316	68.43	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			254.8	F08		2	0083-0436	587.81	435.82	323	69.01	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			296.1	F08		2	0084-0437	42.06	436.96	271	61.11	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			561.6	F08		2	0085-0437	821.66	437.77	223	56.77	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			372.0	F08		2	0086-0448	660.63	448.83	239	58.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			234.0	F08		2	0087-0453	54.39	453.00	355	70.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			237.0	F08		2	0088-0459	340.67	458.85	249	61.84	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			329.6	F08		2	0089-0458	740.67	458.64	236	59.70	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.0	F08		2	0090-0467	519.60	467.21	345	69.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			294.8	F08		2	0091-0479	573.14	478.52	194	66.43	0.552
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.0	F08		2	0092-0489	169.47	489.35	315	70.77	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.5	F08		2	0093-0519	590.31	518.90	428	82.08	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			260.1	F08		2	0094-0517	202.43	517.49	317	67.36	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.2	F08		2	0095-0523	87.21	522.84	469	81.50	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			286.6	F08		2	0096-0521	771.81	521.83	313	68.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.7	F08		2	0097-0538	125.28	538.27	288	62.53	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			243.6	F08		2	0098-0537	646.98	536.44	248	62.18	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.8	F08		2	0099-0545	186.16	545.47	349	70.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			248.5	F08		2	0100-0562	460.22	561.46	366	74.43	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.8	F08		2	0101-0559	846.47	559.65	280	61.60	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			242.4	F08		2	0102-0581	830.65	580.36	296	64.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			412.7	F08		2	0103-0584	729.87	584.27	309	67.94	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			204.8	F08		2	0104-0583	136.86	584.11	355	70.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.9	F08		2	0105-0593	204.94	592.65	333	67.84	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.1	F08		2	0106-0599	657.62	599.28	352	72.77	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			582.3	F08		2	0107-0612	401.82	612.35	416	77.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			216.0	F08		2	0108-0613	282.94	613.38	336	69.60	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			208.9	F08		2	0109-0617	794.31	617.48	364	74.43	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.6	F08		2	0110-0627	564.76	627.74	304	68.33	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			260.9	F08		2	0111-0628	503.68	628.54	265	60.43	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.2	F08		2	0112-0640	468.48	639.76	358	74.77	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			271.0	F08		2	0113-0637	533.36	637.27	300	64.43	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			343.9	F08		2	0114-0638	142.53	638.49	284	62.28	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			284.3	F08		2	0115-0642	923.09	642.55	259	61.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			264.5	F08		2	0116-0649	490.89	649.79	358	75.60	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			193.1	F08		2	0117-0649	649.70	649.95	364	70.43	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			321.0	F08		2	0118-0651	340.95	651.50	256	60.53	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			263.2	F08		2	0119-0655	74.76	655.35	333	67.01	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			186.6	F08		2	0120-0656	384.32	656.20	315	68.43	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.3	F08		2	0121-0657	846.70	657.62	241	65.01	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			250.5	F08		2	0122-0664	526.49	664.41	282	62.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			251.7	F08		2	0123-0666	164.78	666.26	272	63.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.7	F08		2	0124-0667	290.75	666.98	342	68.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			230.5	F08		2	0125-0682	731.33	682.52	336	69.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			243.4	F08		2	0126-0684	931.88	683.94	264	62.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			252.3	F08		2	0127-0694	19.90	693.98	297	67.60	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.6	F08		2	0128-0705	744.81	704.87	312	65.84	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			254.0	F08		2	0129-0706	272.33	705.97	274	61.70	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			302.7	F08		2	0130-0704	664.77	704.13	313	65.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			260.4	F08		3	0001-0050	476.08	49.13	337	67.70	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			283.5	F08		3	0002-0055	782.98	55.56	261	61.11	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			336.4	F08		3	0003-0061	427.72	60.68	259	63.26	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			268.1	F08		3	0004-0062	393.22	62.02	308	63.36	0.964
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			267.0	F08		3	0005-0065	594.31	65.58	268	65.11	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			247.0	F08		3	0006-0068	325.54	68.02	284	62.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			278.1	F08		3	0007-0074	358.23	74.13	275	61.94	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			322.4	F08		3	0008-0089	435.52	89.44	268	60.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			202.2	F08		3	0009-0095	26.42	95.35	307	67.84	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			785.1	F08		3	0010-0109	138.49	108.04	205	67.26	0.570
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			364.5	F08		3	0011-0121	338.26	120.75	128	83.98	0.228
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			326.3	F08		3	0012-0130	591.11	130.17	181	52.87	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.9	F08		3	0013-0135	62.32	134.57	325	67.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			299.9	F08		3	0014-0142	436.10	142.21	309	66.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			263.5	F08		3	0015-0139	714.84	139.16	329	69.84	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.4	F08		3	0016-0141	34.55	140.24	322	71.01	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			398.4	F08		3	0017-0151	362.17	151.19	344	69.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			408.6	F08		3	0018-0146	686.46	146.15	203	58.28	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			268.1	F08		3	0019-0162	798.40	161.54	373	72.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			257.2	F08		3	0020-0164	305.82	164.51	279	61.94	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.6	F08		3	0021-0169	524.17	169.68	355	70.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			486.2	F08		3	0022-0176	41.37	176.90	331	73.50	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			275.0	F08		3	0023-0177	832.00	178.04	298	65.26	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			200.5	F08		3	0024-0180	761.07	179.65	319	70.18	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			306.2	F08		3	0025-0177	491.67	177.39	215	55.11	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			203.6	F08		3	0026-0188	796.60	188.30	334	69.36	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			513.8	F08		3	0027-0192	111.65	192.79	198	51.11	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			336.2	F08		3	0028-0201	382.46	201.75	271	63.26	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			247.7	F08		3	0029-0205	201.11	204.61	346	71.11	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.5	F08		3	0030-0209	706.89	208.43	356	71.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			314.3	F08		3	0031-0212	450.10	211.48	257	58.77	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			242.6	F08		3	0032-0220	833.52	220.04	327	70.67	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			294.0	F08		3	0033-0220	134.00	220.04	250	59.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			282.6	F08		3	0034-0227	404.98	227.52	305	64.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			329.3	F08		3	0035-0230	513.44	230.31	226	62.77	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			389.0	F08		3	0036-0234	547.93	234.56	240	58.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			245.9	F08		3	0037-0237	281.30	237.36	268	63.11	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			279.1	F08		3	0038-0255	675.34	254.68	236	58.53	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.9	F08		3	0039-0258	799.14	258.45	311	66.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			426.1	F08		3	0040-0262	553.47	262.69	241	58.53	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			244.4	F08		3	0041-0266	25.16	265.73	251	63.01	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			275.4	F08		3	0042-0265	863.12	265.41	274	63.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			291.5	F08		3	0043-0265	141.87	264.90	244	59.94	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			429.7	F08		3	0044-0269	487.64	268.24	132	54.77	0.553
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			261.2	F08		3	0045-0276	280.84	276.59	386	73.26	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			285.4	F08		3	0046-0283	412.01	282.93	270	61.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			387.8	F08		3	0047-0287	480.67	286.13	285	76.33	0.615
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			242.3	F08		3	0048-0285	614.69	285.54	353	71.01	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			238.5	F08		3	0049-0296	198.32	296.29	316	68.77	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			252.4	F08		3	0050-0294	808.99	294.66	306	65.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			314.7	F08		3	0051-0300	332.45	299.79	423	75.84	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			304.8	F08		3	0052-0300	512.00	299.74	300	64.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			350.0	F08		3	0053-0297	560.29	297.60	266	59.70	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			193.1	F08		3	0054-0305	631.55	304.42	320	68.18	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			231.8	F08		3	0055-0306	733.69	306.77	268	63.26	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			479.8	F08		3	0056-0305	416.53	305.25	160	48.63	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			344.3	F08		3	0057-0317	101.43	316.75	262	61.60	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			197.3	F08		3	0058-0318	58.86	318.20	366	72.08	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			260.9	F08		3	0059-0321	912.88	321.82	329	68.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			322.2	F08		3	0060-0321	412.84	321.14	247	64.77	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			262.5	F08		3	0061-0347	476.90	347.05	328	68.67	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			253.7	F08		3	0062-0349	536.15	349.97	293	67.11	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.2	F08		3	0063-0352	322.80	351.71	344	72.43	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			277.2	F08		3	0064-0354	218.01	354.14	410	78.43	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.7	F08		3	0065-0351	905.20	351.25	201	57.36	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			184.5	F08		3	0066-0354	18.49	354.18	350	72.18	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			205.0	F08		3	0067-0359	36.63	358.66	327	71.60	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			251.7	F08		3	0068-0361	443.07	361.30	317	74.77	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			222.0	F08		3	0069-0364	167.12	363.84	301	66.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			270.0	F08		3	0070-0375	797.76	374.43	377	74.43	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			358.2	F08		3	0071-0376	407.77	376.33	403	74.43	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			370.7	F08		3	0072-0383	548.09	383.47	271	61.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			293.4	F08		3	0073-0386	55.28	386.66	263	61.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.6	F08		3	0074-0389	468.20	389.24	355	71.01	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			238.0	F08		3	0075-0397	757.28	397.31	318	66.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			210.2	F08		3	0076-0407	593.49	407.72	303	65.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.9	F08		3	0077-0411	77.32	411.36	338	74.53	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			444.7	F08		3	0078-0415	667.54	414.74	411	79.26	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			216.2	F08		3	0079-0419	610.37	419.36	314	70.53	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			237.1	F08		3	0080-0418	171.29	417.35	336	70.67	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			250.6	F08		3	0081-0420	436.94	420.27	281	66.43	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			314.7	F08		3	0082-0432	899.32	432.10	265	65.60	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.1	F08		3	0083-0438	699.89	438.70	296	63.11	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			195.8	F08		3	0084-0444	43.31	444.10	338	70.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			306.5	F08		3	0085-0456	495.79	456.18	406	77.50	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			247.6	F08		3	0086-0460	909.25	460.74	187	53.94	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.9	F08		3	0087-0465	185.70	465.70	314	67.94	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			217.2	F08		3	0088-0474	639.22	474.30	345	69.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			199.2	F08		3	0089-0477	108.91	477.06	326	70.43	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			236.3	F08		3	0090-0483	496.72	482.98	270	66.43	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.5	F08		3	0091-0489	136.73	489.56	356	70.18	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			311.5	F08		3	0092-0490	780.75	490.99	267	61.36	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.0	F08		3	0093-0495	49.45	494.62	325	71.01	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			238.9	F08		3	0094-0500	347.91	499.38	295	64.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			240.8	F08		3	0095-0505	919.44	505.45	336	70.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.0	F08		3	0096-0508	250.88	507.89	557	95.74	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			244.9	F08		3	0097-0510	377.92	509.40	309	65.01	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.7	F08		3	0098-0527	730.49	527.19	370	73.60	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			254.3	F08		3	0099-0528	126.47	527.79	363	75.26	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			245.0	F08		3	0100-0534	225.35	534.16	299	67.01	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			256.7	F08		3	0101-0536	332.81	536.80	270	62.18	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			193.0	F08		3	0102-0543	554.02	544.15	343	69.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.3	F08		3	0103-0559	286.52	558.77	368	74.18	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			204.0	F08		3	0104-0566	404.65	567.19	357	75.60	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			197.0	F08		3	0105-0571	119.84	570.90	342	68.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.6	F08		3	0106-0577	154.39	576.28	301	68.43	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			243.0	F08		3	0107-0591	260.04	590.74	287	68.67	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			263.2	F08		3	0108-0616	365.65	616.72	298	71.50	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			284.0	F08		3	0109-0615	867.81	615.37	216	57.36	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			563.9	F08		3	0110-0619	937.72	619.86	247	60.53	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			196.0	F08		3	0111-0617	586.76	617.38	390	76.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			196.6	F08		3	0112-0630	903.23	629.42	344	73.50	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			247.6	F08		3	0113-0631	686.81	631.00	315	66.43	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			240.5	F08		3	0114-0638	664.80	638.76	311	67.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			476.0	F08		3	0115-0642	347.01	643.02	393	73.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.5	F08		3	0116-0644	17.93	645.04	252	59.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			236.4	F08		3	0117-0648	121.67	648.11	346	72.18	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			273.6	F08		3	0118-0651	291.92	651.05	242	62.77	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.4	F08		3	0119-0654	805.48	654.07	367	80.57	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			261.9	F08		3	0120-0652	309.59	653.07	239	60.77	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			238.2	F08		3	0121-0658	176.52	658.47	307	64.77	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			205.3	F08		3	0122-0658	839.55	658.18	315	69.84	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			191.9	F08		3	0123-0665	557.91	665.19	318	65.60	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			203.2	F08		3	0124-0672	147.01	672.49	294	63.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.9	F08		3	0125-0682	690.56	682.16	287	63.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			306.1	F08		3	0126-0686	535.26	685.35	203	55.21	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			202.3	F08		3	0127-0686	26.79	686.38	256	61.11	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.9	F08		3	0128-0694	675.48	694.25	328	67.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			218.3	F08		3	0129-0694	879.58	694.71	250	59.94	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.1	F08		3	0130-0704	182.73	704.55	273	61.60	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.4	F08		3	0131-0705	571.76	705.50	261	61.94	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			216.4	F08		4	0001-0029	171.82	29.32	261	60.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			298.1	F08		4	0002-0029	195.04	28.79	276	62.28	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			191.6	F08		4	0003-0032	144.75	32.73	257	61.70	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.4	F08		4	0004-0037	371.19	36.91	404	78.43	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.9	F08		4	0005-0064	872.22	63.25	356	72.43	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			216.7	F08		4	0006-0066	791.10	66.43	289	63.84	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			347.4	F08		4	0007-0069	51.72	68.97	255	61.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.2	F08		4	0008-0073	575.33	73.58	383	72.18	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			231.6	F08		4	0009-0076	110.78	76.17	321	67.94	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.8	F08		4	0010-0081	129.33	81.01	329	68.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			217.4	F08		4	0011-0096	634.11	95.81	337	70.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			216.7	F08		4	0012-0099	658.30	99.12	333	67.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			242.2	F08		4	0013-0106	475.01	106.70	414	83.26	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			323.1	F08		4	0014-0113	291.14	113.27	168	62.18	0.546
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			262.7	F08		4	0015-0121	83.65	120.58	291	65.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			267.2	F08		4	0016-0123	752.18	123.22	242	61.94	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			321.7	F08		4	0017-0121	785.98	121.79	202	51.94	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.1	F08		4	0018-0130	765.98	129.70	307	67.60	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			264.2	F08		4	0019-0132	574.14	131.92	314	67.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			248.2	F08		4	0020-0134	331.23	133.99	233	59.60	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			260.6	F08		4	0021-0136	432.75	135.71	287	64.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			362.3	F08		4	0022-0159	807.45	159.14	211	57.11	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1052.2	F08		4	0023-0161	233.88	160.59	280	61.94	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			489.4	F08		4	0024-0161	49.25	161.54	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			247.3	F08		4	0025-0164	601.52	164.49	295	64.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.1	F08		4	0026-0206	90.26	206.84	298	64.53	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			468.5	F08		4	0027-0209	531.51	209.16	307	68.18	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			305.6	F08		4	0028-0216	759.32	217.08	373	77.01	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			252.2	F08		4	0029-0212	912.03	211.82	314	67.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.8	F08		4	0030-0220	638.13	219.53	359	73.84	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			258.5	F08		4	0031-0225	408.56	225.08	339	71.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			273.5	F08		4	0032-0233	179.43	233.32	244	59.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.7	F08		4	0033-0240	333.77	239.81	310	66.43	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			280.5	F08		4	0034-0248	851.08	248.98	214	56.04	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			198.2	F08		4	0035-0257	43.47	257.21	343	70.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			270.5	F08		4	0036-0259	664.07	259.11	241	61.36	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.0	F08		4	0037-0270	424.07	270.27	299	66.18	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			226.7	F08		4	0038-0273	376.22	273.53	333	67.36	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			278.1	F08		4	0039-0272	180.26	272.05	242	58.77	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			261.0	F08		4	0040-0293	717.39	293.01	452	78.67	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			252.9	F08		4	0041-0297	20.10	297.46	353	70.18	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.2	F08		4	0042-0306	120.00	305.13	301	67.26	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.6	F08		4	0043-0306	917.57	306.35	266	63.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			271.6	F08		4	0044-0307	538.95	307.10	280	61.60	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			279.6	F08		4	0045-0309	667.97	309.75	240	61.60	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			809.1	F08		4	0046-0306	58.29	305.81	108	71.26	0.267
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.7	F08		4	0047-0311	377.59	311.42	323	68.77	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			261.2	F08		4	0048-0325	400.90	325.45	277	65.60	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.1	F08		4	0049-0329	359.73	329.52	366	72.43	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			217.8	F08		4	0050-0341	175.33	341.14	295	67.36	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			222.7	F08		4	0051-0338	296.96	338.14	314	68.43	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			210.8	F08		4	0052-0335	911.15	335.22	279	63.36	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			255.5	F08		4	0053-0339	454.32	339.21	317	67.60	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			313.1	F08		4	0054-0340	751.27	340.20	239	56.53	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			276.1	F08		4	0055-0347	199.86	347.24	232	57.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			217.9	F08		4	0056-0348	898.53	348.06	261	62.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			208.2	F08		4	0057-0353	925.53	352.89	270	61.94	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			268.8	F08		4	0058-0370	645.70	369.78	240	56.53	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			246.5	F08		4	0059-0374	765.64	375.08	305	63.60	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			264.4	F08		4	0060-0377	230.62	377.83	321	67.84	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			246.0	F08		4	0061-0375	75.09	374.82	228	58.87	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			321.5	F08		4	0062-0397	347.58	396.96	251	61.01	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			268.2	F08		4	0063-0400	196.29	400.36	253	59.11	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			237.3	F08		4	0064-0399	845.43	399.14	274	61.11	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			217.6	F08		4	0065-0405	765.45	405.15	309	65.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.2	F08		4	0066-0407	710.17	407.47	313	64.43	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			279.1	F08		4	0067-0411	327.72	411.45	279	64.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			234.6	F08		4	0068-0425	935.39	425.27	246	64.28	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			251.1	F08		4	0069-0426	227.43	425.84	276	63.60	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			240.7	F08		4	0070-0433	826.67	433.62	366	73.01	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.1	F08		4	0071-0433	792.34	434.04	296	65.26	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			217.2	F08		4	0072-0439	880.69	439.79	390	75.84	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.3	F08		4	0073-0458	342.98	457.95	303	68.53	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.9	F08		4	0074-0466	560.47	466.09	336	71.01	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			260.8	F08		4	0075-0477	753.31	477.02	509	85.50	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			236.3	F08		4	0076-0487	519.08	487.44	347	70.43	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			269.8	F08		4	0077-0489	901.11	489.35	224	59.70	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			238.2	F08		4	0078-0497	148.51	496.66	310	65.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.9	F08		4	0079-0504	288.85	504.09	327	67.26	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			272.6	F08		4	0080-0502	21.26	502.29	265	65.60	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			217.2	F08		4	0081-0502	230.11	502.30	295	68.43	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			218.2	F08		4	0082-0507	702.74	507.36	250	59.94	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			231.1	F08		4	0083-0518	434.28	517.40	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			252.9	F08		4	0084-0517	327.21	518.02	295	65.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			237.2	F08		4	0085-0532	654.71	531.73	370	71.36	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			222.0	F08		4	0086-0535	143.11	534.87	285	64.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.4	F08		4	0087-0536	197.18	535.93	334	68.18	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			263.4	F08		4	0088-0538	519.41	538.85	295	65.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			225.6	F08		4	0089-0547	598.89	547.62	236	57.11	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			263.8	F08		4	0090-0553	770.22	549.80	273	100.71	0.338
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.5	F08		4	0091-0553	308.70	552.52	334	68.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			243.5	F08		4	0092-0554	236.15	553.92	325	72.18	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			267.5	F08		4	0093-0553	374.13	553.74	227	60.43	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			171.9	F08		4	0094-0561	844.19	562.12	348	72.67	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			269.7	F08		4	0095-0561	791.09	560.82	264	83.50	0.476
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			217.8	F08		4	0096-0566	270.03	566.14	283	65.84	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			293.8	F08		4	0097-0565	19.85	565.60	260	60.53	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.1	F08		4	0098-0581	691.35	581.50	300	65.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			126.6	F08		4	0099-0583	767.19	583.34	293	65.11	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			217.3	F08		4	0100-0587	159.33	587.68	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			295.4	F08		4	0101-0593	844.08	593.08	290	64.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			160.7	F08		4	0102-0608	700.30	608.59	351	72.18	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.5	F08		4	0103-0611	330.70	610.79	260	62.18	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			204.9	F08		4	0104-0612	306.01	612.01	306	65.11	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			222.4	F08		4	0105-0615	576.64	615.24	375	74.67	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			559.2	F08		4	0106-0617	891.27	617.43	316	67.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			326.6	F08		4	0107-0628	95.11	628.12	255	61.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			509.5	F08		4	0108-0631	374.02	631.06	239	59.11	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			210.1	F08		4	0109-0636	235.67	635.97	293	68.77	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			285.9	F08		4	0110-0634	316.13	633.75	228	58.87	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			157.0	F08		4	0111-0647	665.33	646.45	365	72.18	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			202.7	F08		4	0112-0653	495.85	653.47	310	65.36	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			272.3	F08		4	0113-0659	788.18	658.88	344	69.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			236.5	F08		4	0114-0659	552.10	659.61	283	67.50	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			205.7	F08		4	0115-0666	282.01	665.44	321	67.60	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			211.9	F08		4	0116-0668	727.49	667.81	322	67.60	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			304.4	F08		4	0117-0680	397.53	679.43	239	57.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			226.1	F08		4	0118-0686	292.84	686.66	270	61.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.7	F08		4	0119-0695	861.38	694.59	324	73.50	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.1	F08		4	0120-0698	161.50	698.70	379	76.53	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			301.2	F08		4	0121-0700	903.67	700.99	382	111.88	0.383
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.4	F08		4	0122-0702	144.98	702.79	376	75.94	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			317.2	F08		4	0123-0699	828.87	699.10	217	57.60	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			237.5	F08		4	0124-0700	594.34	699.65	244	60.43	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			199.6	F08		4	0125-0701	642.94	700.49	282	62.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			192.6	F08		5	0001-0034	395.08	34.47	406	75.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			203.8	F08		5	0002-0038	646.42	38.21	370	70.77	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			200.0	F08		5	0003-0036	895.51	36.62	132	44.87	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			190.3	F08		5	0004-0053	63.91	53.11	294	64.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			273.1	F08		5	0005-0056	130.66	56.10	288	64.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			256.0	F08		5	0006-0053	176.55	53.72	267	61.94	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			208.3	F08		5	0007-0057	930.89	57.41	309	65.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.4	F08		5	0008-0059	214.33	59.15	311	67.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			198.4	F08		5	0009-0059	820.16	60.31	321	68.43	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			287.7	F08		5	0010-0064	611.99	63.41	263	61.11	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			191.1	F08		5	0011-0067	82.12	67.22	330	67.60	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			254.2	F08		5	0012-0070	116.97	70.49	285	65.60	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.4	F08		5	0013-0071	460.49	70.35	324	68.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			210.6	F08		5	0014-0076	867.42	76.30	428	91.40	0.644
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			276.8	F08		5	0015-0075	301.28	74.78	281	63.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			242.5	F08		5	0016-0074	439.08	73.56	341	70.18	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			673.4	F08		5	0017-0079	544.63	79.97	407	77.26	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			191.0	F08		5	0018-0077	652.81	76.34	386	75.60	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.5	F08		5	0019-0082	157.42	81.90	300	66.77	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			217.4	F08		5	0020-0085	343.85	86.51	368	83.84	0.658
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			237.0	F08		5	0021-0089	282.47	89.26	281	61.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.0	F08		5	0022-0092	892.22	92.42	341	70.18	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			200.3	F08		5	0023-0095	483.90	95.58	329	71.01	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			267.4	F08		5	0024-0109	219.92	109.22	269	61.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			198.1	F08		5	0025-0113	338.05	113.44	337	68.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.7	F08		5	0026-0111	115.25	110.85	245	61.94	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.3	F08		5	0027-0114	386.41	114.78	323	70.08	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			204.7	F08		5	0028-0114	427.91	114.12	383	73.60	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			236.1	F08		5	0029-0121	903.82	121.33	326	67.84	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			230.5	F08		5	0030-0131	793.61	131.16	271	63.84	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			898.6	F08		5	0031-0133	734.79	133.74	301	66.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			909.5	F08		5	0032-0134	751.30	133.33	292	63.70	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			337.6	F08		5	0033-0132	385.79	132.09	222	55.70	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			208.1	F08		5	0034-0138	86.64	137.47	341	69.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			240.7	F08		5	0035-0139	163.72	139.59	258	66.77	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			932.4	F08		5	0036-0145	476.49	144.75	396	74.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			253.5	F08		5	0037-0157	213.74	156.88	316	68.43	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			267.7	F08		5	0038-0169	274.16	168.88	351	71.01	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			259.1	F08		5	0039-0173	609.16	173.16	404	76.08	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			415.4	F08		5	0040-0175	653.57	175.14	222	66.43	0.632
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			271.0	F08		5	0041-0186	692.54	186.11	259	61.84	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			274.7	F08		5	0042-0189	790.81	189.35	316	66.18	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			211.2	F08		5	0043-0194	433.89	195.30	340	69.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.7	F08		5	0044-0192	569.76	192.11	337	69.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			300.9	F08		5	0045-0194	511.55	194.18	281	67.60	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			237.6	F08		5	0046-0198	605.20	198.50	312	67.01	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			260.3	F08		5	0047-0206	138.63	206.49	216	56.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.2	F08		5	0048-0211	405.29	211.43	319	71.36	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			274.7	F08		5	0049-0209	751.75	209.63	284	63.01	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.3	F08		5	0050-0211	70.94	211.56	255	59.36	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			346.5	F08		5	0051-0213	693.64	213.26	347	68.43	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			193.1	F08		5	0052-0213	17.38	213.79	300	66.18	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			259.8	F08		5	0053-0213	227.18	213.03	327	71.60	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			292.3	F08		5	0054-0215	509.11	214.86	203	52.53	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			314.2	F08		5	0055-0227	876.19	227.30	204	55.11	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			257.5	F08		5	0056-0234	567.51	233.40	287	68.08	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			254.3	F08		5	0057-0240	663.89	240.33	359	72.67	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			237.0	F08		5	0058-0241	438.76	241.98	335	68.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			272.6	F08		5	0059-0243	527.92	243.78	266	63.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			262.7	F08		5	0060-0247	706.19	247.96	330	70.77	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			283.8	F08		5	0061-0249	754.11	249.02	234	57.36	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			225.6	F08		5	0062-0254	389.43	254.59	364	70.67	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			290.9	F08		5	0063-0261	206.44	260.22	459	86.33	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			263.7	F08		5	0064-0270	895.35	270.24	417	76.67	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.1	F08		5	0065-0270	599.22	270.41	322	66.77	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.7	F08		5	0066-0273	348.28	273.69	299	66.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			314.6	F08		5	0067-0276	448.25	276.64	239	58.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			563.7	F08		5	0068-0278	835.77	278.27	321	71.01	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.3	F08		5	0069-0279	292.09	279.55	344	68.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			218.6	F08		5	0070-0281	537.85	281.40	333	68.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			205.3	F08		5	0071-0280	677.23	279.89	332	75.26	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			250.8	F08		5	0072-0296	347.47	296.08	330	69.11	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			270.3	F08		5	0073-0299	635.45	299.89	346	73.94	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			290.0	F08		5	0074-0297	788.73	297.15	291	66.43	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.8	F08		5	0075-0304	875.72	303.01	289	70.18	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			254.0	F08		5	0076-0304	729.81	304.02	340	68.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			211.1	F08		5	0077-0308	23.08	308.11	265	63.01	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.2	F08		5	0078-0305	939.78	305.35	304	67.11	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			217.0	F08		5	0079-0310	179.55	310.39	294	64.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.4	F08		5	0080-0311	598.75	311.32	354	71.84	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			222.6	F08		5	0081-0313	143.45	313.92	286	64.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			218.5	F08		5	0082-0313	690.74	313.03	348	77.26	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			267.2	F08		5	0083-0319	850.96	319.47	303	65.01	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			212.8	F08		5	0084-0322	104.40	321.87	295	62.77	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			267.7	F08		5	0085-0336	533.22	336.35	305	64.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			194.7	F08		5	0086-0337	16.83	337.26	281	63.70	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			268.8	F08		5	0087-0351	708.97	350.24	940	130.02	0.699
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.0	F08		5	0088-0353	484.07	354.05	355	77.60	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.4	F08		5	0089-0355	30.81	354.84	268	61.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			246.6	F08		5	0090-0368	604.98	368.12	312	65.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			267.7	F08		5	0091-0375	822.27	374.97	333	69.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			262.0	F08		5	0092-0381	723.88	381.54	231	58.77	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.9	F08		5	0093-0387	124.99	387.97	340	73.01	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			237.3	F08		5	0094-0394	576.29	394.42	289	63.11	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			282.4	F08		5	0095-0397	186.52	397.07	209	54.28	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.0	F08		5	0096-0402	650.80	402.61	306	65.01	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			238.4	F08		5	0097-0403	301.55	402.35	283	62.77	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.7	F08		5	0098-0407	729.66	406.83	335	68.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			246.3	F08		5	0099-0411	271.43	411.55	382	72.77	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			237.1	F08		5	0100-0411	806.69	411.17	317	66.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			192.2	F08		5	0101-0410	931.79	410.06	268	63.01	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			181.5	F08		5	0102-0416	163.49	417.53	505	84.33	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			202.0	F08		5	0103-0412	488.23	411.26	280	63.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.1	F08		5	0104-0415	603.65	415.15	316	68.18	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.6	F08		5	0105-0423	356.28	423.04	348	72.43	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			243.3	F08		5	0106-0427	40.59	427.14	247	64.53	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			250.9	F08		5	0107-0430	435.55	429.89	458	82.33	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			197.7	F08		5	0108-0440	211.05	440.67	269	62.77	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.8	F08		5	0109-0439	640.00	439.36	249	57.94	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			263.9	F08		5	0110-0442	417.16	442.94	262	61.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			231.6	F08		5	0111-0443	899.55	443.27	301	64.18	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			217.0	F08		5	0112-0447	476.08	447.55	363	70.67	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.4	F08		5	0113-0451	734.64	451.15	297	66.18	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.6	F08		5	0114-0456	242.30	455.90	332	69.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.4	F08		5	0115-0451	578.34	451.24	303	68.77	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			222.6	F08		5	0116-0469	58.94	469.69	252	61.60	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.1	F08		5	0117-0471	351.25	471.21	327	70.43	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			265.3	F08		5	0118-0472	551.99	471.88	329	67.11	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			222.4	F08		5	0119-0472	203.72	471.30	258	61.94	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.8	F08		5	0120-0478	503.26	478.79	262	67.11	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			230.3	F08		5	0121-0485	856.17	484.58	358	83.15	0.651
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.7	F08		5	0122-0485	677.69	485.26	282	61.36	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			208.4	F08		5	0123-0487	399.87	488.02	359	73.50	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.6	F08		5	0124-0490	440.42	490.09	294	65.01	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.4	F08		5	0125-0498	773.48	496.68	378	75.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.7	F08		5	0126-0496	309.69	496.05	294	69.84	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.7	F08		5	0127-0509	643.66	509.29	335	73.94	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			204.4	F08		5	0128-0509	589.08	509.68	338	69.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			275.4	F08		5	0129-0513	89.09	513.87	285	64.77	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			212.7	F08		5	0130-0514	719.54	514.93	320	72.91	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.2	F08		5	0131-0519	469.01	520.32	309	67.60	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			210.3	F08		5	0132-0523	618.72	522.90	329	77.36	0.691
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			582.3	F08		5	0133-0522	938.32	521.96	292	66.77	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.1	F08		5	0134-0534	72.21	534.62	230	59.60	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			218.3	F08		5	0135-0544	644.19	544.29	316	68.18	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			231.7	F08		5	0136-0567	420.55	567.04	430	77.84	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.7	F08		5	0137-0566	673.03	565.57	335	73.26	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			203.9	F08		5	0138-0565	870.81	565.19	320	72.18	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			280.2	F08		5	0139-0575	833.54	575.28	278	69.11	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			322.7	F08		5	0140-0590	131.65	590.88	210	55.11	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.0	F08		5	0141-0611	130.17	611.79	263	59.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			183.2	F08		5	0142-0617	860.75	617.22	361	73.26	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			194.4	F08		5	0143-0636	322.12	636.25	311	65.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			226.0	F08		5	0144-0638	552.97	637.55	285	63.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			225.6	F08		5	0145-0636	143.55	636.61	256	67.94	0.697
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.4	F08		5	0146-0646	243.79	646.06	331	70.53	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.3	F08		5	0147-0645	569.15	644.80	289	64.53	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			466.5	F08		5	0148-0656	209.72	658.89	589	110.33	0.608
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.6	F08		5	0149-0649	392.44	648.81	314	67.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			260.3	F08		5	0150-0651	477.69	651.41	393	74.43	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.4	F08		5	0151-0651	648.86	650.78	265	63.26	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			253.4	F08		5	0152-0656	839.71	656.03	262	65.60	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.7	F08		5	0153-0652	916.58	652.30	326	69.94	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			135.9	F08		5	0154-0660	61.87	660.43	318	67.84	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			208.7	F08		5	0155-0669	717.31	668.92	367	74.33	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.0	F08		5	0156-0675	309.34	674.77	300	67.01	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			231.5	F08		5	0157-0674	400.17	675.66	347	73.84	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.8	F08		5	0158-0679	451.47	679.38	325	69.84	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			333.4	F08		5	0159-0684	636.39	684.58	320	66.18	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			242.2	F08		5	0160-0696	906.66	696.33	348	73.01	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			204.7	F08		6	0001-0040	323.34	40.63	347	73.01	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			261.9	F08		6	0002-0047	782.00	47.24	273	67.26	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			243.7	F08		6	0003-0053	426.76	53.37	270	66.67	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			602.9	F08		6	0004-0055	149.57	55.43	286	63.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			217.6	F08		6	0005-0060	25.83	60.11	304	64.77	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			262.3	F08		6	0006-0061	823.37	60.79	253	65.84	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			331.6	F08		6	0007-0067	247.36	66.94	265	65.60	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			203.5	F08		6	0008-0077	673.88	77.38	377	71.84	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.3	F08		6	0009-0084	318.86	83.55	340	71.26	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			290.8	F08		6	0010-0082	527.49	83.00	305	64.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			255.4	F08		6	0011-0087	691.40	87.25	305	68.43	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			256.6	F08		6	0012-0093	196.33	91.42	299	70.18	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			269.1	F08		6	0013-0093	411.70	93.66	250	59.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			523.3	F08		6	0014-0104	612.42	106.23	346	102.23	0.416
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.2	F08		6	0015-0107	853.40	107.97	367	72.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			231.8	F08		6	0016-0113	298.91	113.41	347	71.84	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			244.2	F08		6	0017-0113	172.37	112.80	285	62.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			290.9	F08		6	0018-0114	334.39	113.57	226	58.53	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			248.4	F08		6	0019-0121	811.87	120.64	294	66.77	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.4	F08		6	0020-0128	489.88	127.29	314	69.50	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.0	F08		6	0021-0127	261.73	127.59	320	69.01	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			242.6	F08		6	0022-0130	584.41	129.80	379	79.50	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			311.0	F08		6	0023-0141	433.17	141.59	228	55.36	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			216.3	F08		6	0024-0149	770.71	149.75	427	77.26	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.2	F08		6	0025-0149	541.38	150.44	409	76.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			208.0	F08		6	0026-0155	854.32	156.19	321	72.18	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.7	F08		6	0027-0161	680.29	160.66	346	72.43	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			289.7	F08		6	0028-0164	506.03	165.14	481	90.91	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			278.2	F08		6	0029-0162	369.59	161.90	232	59.36	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			258.1	F08		6	0030-0164	279.54	163.75	252	61.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			277.4	F08		6	0031-0172	236.80	172.17	301	64.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.2	F08		6	0032-0176	320.72	175.64	352	72.18	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			237.9	F08		6	0033-0175	898.76	174.31	325	73.01	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			285.1	F08		6	0034-0174	375.98	174.89	226	57.46	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			234.7	F08		6	0035-0181	405.96	181.83	347	77.84	0.720
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			231.9	F08		6	0036-0184	582.05	185.12	389	76.43	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			608.9	F08		6	0037-0189	183.13	190.35	103	56.77	0.402
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			189.9	F08		6	0038-0195	864.81	196.10	382	72.43	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.5	F08		6	0039-0206	939.73	206.24	363	72.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			351.3	F08		6	0040-0212	24.77	212.32	133	93.78	0.190
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			231.0	F08		6	0041-0211	247.08	211.41	342	71.84	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			336.2	F08		6	0042-0228	579.14	227.70	277	62.53	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			225.7	F08		6	0043-0232	258.80	231.53	298	66.43	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.0	F08		6	0044-0238	813.54	237.94	339	80.43	0.659
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			253.2	F08		6	0045-0241	724.82	241.12	241	61.01	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.1	F08		6	0046-0251	149.32	251.35	290	64.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			266.1	F08		6	0047-0255	441.49	255.10	296	63.94	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			204.6	F08		6	0048-0257	311.88	256.26	359	71.84	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.3	F08		6	0049-0262	774.37	261.17	308	71.01	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.1	F08		6	0050-0263	807.80	263.63	324	69.84	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			226.5	F08		6	0051-0265	748.05	265.21	392	77.26	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			297.2	F08		6	0052-0271	841.51	269.91	483	88.81	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			320.3	F08		6	0053-0273	604.82	273.45	298	69.01	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			248.1	F08		6	0054-0275	192.07	275.02	310	67.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.8	F08		6	0055-0285	273.81	284.59	342	71.11	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			247.4	F08		6	0056-0288	315.97	287.75	255	58.53	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			396.9	F08		6	0057-0288	238.03	289.05	118	69.84	0.304
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			301.9	F08		6	0058-0297	110.60	297.43	375	74.77	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			240.0	F08		6	0059-0300	402.45	299.81	395	73.01	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			201.3	F08		6	0060-0300	332.60	301.04	309	66.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			259.6	F08		6	0061-0304	919.18	304.82	341	79.26	0.682
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.9	F08		6	0062-0303	872.22	303.19	317	67.01	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			216.1	F08		6	0063-0307	380.17	306.95	348	69.84	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.8	F08		6	0064-0308	34.85	308.19	303	66.53	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			245.3	F08		6	0065-0314	529.80	314.65	360	71.84	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.7	F08		6	0066-0312	737.90	311.53	283	61.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			296.1	F08		6	0067-0319	460.36	319.32	245	57.94	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			234.2	F08		6	0068-0327	176.31	327.19	334	67.84	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			189.9	F08		6	0069-0327	267.39	326.87	358	72.43	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.6	F08		6	0070-0345	345.65	345.61	399	78.08	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.7	F08		6	0071-0349	652.12	348.88	388	74.67	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.9	F08		6	0072-0351	229.47	350.89	306	67.26	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			230.8	F08		6	0073-0357	860.37	356.93	306	69.01	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.8	F08		6	0074-0364	724.31	363.77	340	68.18	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			299.2	F08		6	0075-0367	220.38	367.40	249	61.60	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			184.8	F08		6	0076-0375	307.06	375.11	344	72.77	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.6	F08		6	0077-0374	379.82	374.77	371	73.84	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			276.9	F08		6	0078-0378	523.40	378.00	387	76.43	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			254.5	F08		6	0079-0372	777.01	372.70	209	54.28	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			266.1	F08		6	0080-0374	795.86	374.76	239	57.11	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			222.0	F08		6	0081-0390	896.09	390.31	343	70.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			236.9	F08		6	0082-0396	270.34	396.79	301	66.43	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			291.2	F08		6	0083-0400	75.64	400.55	294	63.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			288.4	F08		6	0084-0408	198.73	407.56	319	69.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.4	F08		6	0085-0407	558.86	406.76	351	70.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			212.3	F08		6	0086-0411	830.09	410.68	323	70.28	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			247.7	F08		6	0087-0413	26.87	412.80	273	63.01	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			291.3	F08		6	0088-0420	388.43	419.57	320	67.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			231.4	F08		6	0089-0420	699.00	419.51	331	69.01	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			236.4	F08		6	0090-0426	929.04	426.58	303	74.77	0.681
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			270.0	F08		6	0091-0422	80.11	422.33	281	63.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			202.1	F08		6	0092-0422	269.24	422.52	297	65.60	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			244.8	F08		6	0093-0425	495.24	425.58	231	61.70	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			218.5	F08		6	0094-0426	942.53	425.21	293	70.18	0.747
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			217.6	F08		6	0095-0427	654.26	427.01	298	65.01	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			238.6	F08		6	0096-0434	732.15	434.32	345	70.28	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			240.9	F08		6	0097-0434	899.88	434.35	368	72.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.9	F08		6	0098-0440	787.04	439.64	350	71.26	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.4	F08		6	0099-0444	313.51	444.25	248	63.70	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			207.0	F08		6	0100-0457	612.48	456.44	301	65.60	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.3	F08		6	0101-0466	541.75	465.82	314	67.84	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			249.1	F08		6	0102-0469	457.06	467.95	300	69.84	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.9	F08		6	0103-0472	899.47	472.04	331	68.43	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			251.5	F08		6	0104-0472	158.56	471.82	129	71.26	0.319
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			217.1	F08		6	0105-0483	421.15	482.38	284	65.01	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.3	F08		6	0106-0490	252.39	489.66	277	68.18	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			193.0	F08		6	0107-0488	290.18	488.41	322	68.43	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			238.0	F08		6	0108-0490	467.28	490.61	295	65.70	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			222.9	F08		6	0109-0495	132.47	495.84	269	67.70	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.1	F08		6	0110-0491	408.30	491.61	275	63.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			205.7	F08		6	0111-0497	182.57	498.42	305	67.94	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			194.7	F08		6	0112-0499	660.07	499.59	318	69.01	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.0	F08		6	0113-0502	370.65	502.53	343	74.43	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.2	F08		6	0114-0509	588.39	509.07	310	67.84	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.9	F08		6	0115-0515	827.71	515.63	344	68.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.2	F08		6	0116-0520	888.52	520.32	253	60.53	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			192.9	F08		6	0117-0522	753.11	521.82	355	70.08	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			646.7	F08		6	0118-0525	33.42	524.89	304	68.43	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			202.9	F08		6	0119-0523	315.91	522.86	302	65.94	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			281.0	F08		6	0120-0530	921.48	530.74	210	53.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			193.8	F08		6	0121-0538	399.98	537.73	342	69.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			217.1	F08		6	0122-0541	48.54	540.58	328	68.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			211.4	F08		6	0123-0546	728.83	546.54	317	66.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			288.8	F08		6	0124-0550	442.78	549.81	360	71.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			211.3	F08		6	0125-0555	695.22	557.17	392	118.13	0.353
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			271.0	F08		6	0126-0558	273.97	559.61	375	88.33	0.604
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			195.8	F08		6	0127-0558	504.41	558.87	368	73.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.7	F08		6	0128-0560	633.43	560.60	357	74.43	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			262.6	F08		6	0129-0564	806.22	564.04	342	73.60	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.0	F08		6	0130-0572	573.03	573.00	363	76.08	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			269.9	F08		6	0131-0570	899.87	570.25	219	55.70	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			248.1	F08		6	0132-0581	58.91	581.53	285	62.18	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			211.1	F08		6	0133-0585	191.91	585.57	308	69.26	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			211.8	F08		6	0134-0581	760.19	580.73	169	51.36	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			244.6	F08		6	0135-0586	779.09	586.58	318	73.70	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			190.8	F08		6	0136-0593	393.16	593.77	325	68.77	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			196.9	F08		6	0137-0598	524.28	598.86	360	74.43	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.1	F08		6	0138-0604	407.96	603.66	268	60.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			197.0	F08		6	0139-0606	719.80	606.67	342	71.60	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.0	F08		6	0140-0610	668.02	609.38	332	71.60	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			167.0	F08		6	0141-0610	944.17	610.24	325	67.36	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.7	F08		6	0142-0624	254.48	624.73	435	81.36	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			311.7	F08		6	0143-0620	473.85	620.29	254	59.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.3	F08		6	0144-0625	498.09	624.46	322	69.60	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			726.8	F08		6	0145-0621	588.56	622.24	126	47.11	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			440.1	F08		6	0146-0626	604.38	625.56	306	69.36	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			217.1	F08		6	0147-0631	399.30	631.24	270	60.18	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			225.2	F08		6	0148-0643	820.36	643.79	331	69.60	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.4	F08		6	0149-0647	762.95	647.48	391	74.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.1	F08		6	0150-0647	185.53	647.15	314	69.01	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			312.5	F08		6	0151-0650	467.28	649.78	254	58.53	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			201.0	F08		6	0152-0655	654.47	655.82	408	83.15	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			197.2	F08		6	0153-0657	227.78	657.24	307	67.36	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			182.2	F08		6	0154-0663	678.83	662.86	420	78.08	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			315.9	F08		6	0155-0660	152.33	659.97	228	56.28	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			275.9	F08		6	0156-0664	317.48	664.23	379	78.43	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			301.7	F08		6	0157-0667	131.53	667.22	214	54.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			196.6	F08		6	0158-0685	754.34	685.71	364	73.26	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.6	F08		6	0159-0683	214.80	683.17	312	65.01	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			225.9	F08		6	0160-0691	383.37	691.24	545	87.15	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			185.7	F08		6	0161-0691	921.86	691.84	327	67.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			230.7	F08		6	0162-0695	699.02	694.81	134	44.04	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.5	F08		6	0163-0703	335.59	703.62	544	86.91	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.8	F08		6	0164-0697	712.80	697.08	155	46.39	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			222.7	F08		6	0165-0703	115.04	703.15	344	69.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.9	F08		6	0166-0708	252.76	707.97	278	62.53	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			240.0	F08		7	0001-0033	92.68	32.93	251	60.18	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			203.5	F08		7	0002-0044	386.80	44.51	294	62.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.4	F08		7	0003-0048	477.35	48.14	278	66.67	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.8	F08		7	0004-0060	407.20	59.76	285	63.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			305.8	F08		7	0005-0062	678.12	62.81	233	55.36	0.956
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			247.8	F08		7	0006-0083	498.41	83.94	245	59.11	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			217.5	F08		7	0007-0088	102.28	88.41	272	64.28	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			320.7	F08		7	0008-0090	312.19	90.06	243	58.28	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			287.4	F08		7	0009-0088	857.80	88.23	243	58.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			282.5	F08		7	0010-0091	568.14	91.09	249	59.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			264.3	F08		7	0011-0090	922.36	90.77	285	69.36	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			283.5	F08		7	0012-0096	804.71	96.45	347	71.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			238.8	F08		7	0013-0099	159.09	99.23	396	76.91	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			251.1	F08		7	0014-0101	457.94	101.78	288	63.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			236.9	F08		7	0015-0105	635.09	105.00	234	59.36	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			268.3	F08		7	0016-0119	523.81	119.55	222	58.18	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			277.1	F08		7	0017-0126	686.97	125.86	193	53.94	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.1	F08		7	0018-0126	88.93	126.97	301	67.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			257.0	F08		7	0019-0132	641.72	132.74	273	63.60	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			237.0	F08		7	0020-0131	188.37	132.20	306	72.77	0.726
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			254.3	F08		7	0021-0135	281.43	134.70	262	61.60	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			207.2	F08		7	0022-0140	900.77	139.76	353	73.26	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.7	F08		7	0023-0140	559.10	140.54	300	64.43	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			258.1	F08		7	0024-0146	372.83	146.27	317	70.18	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.3	F08		7	0025-0153	132.29	153.66	301	66.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.1	F08		7	0026-0155	245.36	155.87	315	67.84	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			262.7	F08		7	0027-0154	331.26	154.32	290	63.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			211.2	F08		7	0028-0159	830.05	159.13	536	87.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			260.8	F08		7	0029-0163	779.09	162.97	296	65.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			243.7	F08		7	0030-0173	445.86	172.75	269	62.87	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			238.0	F08		7	0031-0180	31.92	180.27	332	72.43	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			274.7	F08		7	0032-0182	770.41	182.44	294	64.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			344.7	F08		7	0033-0201	821.36	201.88	239	57.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			292.2	F08		7	0034-0203	154.35	202.98	230	56.53	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			281.9	F08		7	0035-0230	658.69	229.95	258	61.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			190.4	F08		7	0036-0236	902.31	237.44	323	75.50	0.712
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			285.9	F08		7	0037-0240	807.18	241.35	115	44.53	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			257.2	F08		7	0038-0265	518.79	264.69	312	69.26	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			318.9	F08		7	0039-0265	544.89	264.71	246	64.18	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			259.4	F08		7	0040-0268	690.63	268.72	226	56.87	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			277.2	F08		7	0041-0273	36.28	273.02	267	65.01	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			199.7	F08		7	0042-0272	803.84	272.63	286	72.08	0.692
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			254.1	F08		7	0043-0279	430.76	279.79	262	60.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			222.2	F08		7	0044-0284	235.60	284.60	328	67.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			264.5	F08		7	0045-0288	629.87	288.63	303	65.01	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			200.1	F08		7	0046-0291	776.86	291.35	339	74.67	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			247.6	F08		7	0047-0299	663.58	299.86	310	67.94	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.3	F08		7	0048-0307	180.09	307.59	328	67.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			238.7	F08		7	0049-0307	322.57	307.02	304	65.36	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			242.3	F08		7	0050-0317	748.57	316.98	227	58.18	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			258.3	F08		7	0051-0317	637.80	317.35	248	58.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			201.4	F08		7	0052-0333	847.17	332.72	343	70.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			246.6	F08		7	0053-0334	147.60	333.67	253	61.70	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.8	F08		7	0054-0339	491.89	339.39	291	66.53	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			277.4	F08		7	0055-0352	133.12	352.78	247	64.43	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.8	F08		7	0056-0355	729.67	355.23	293	63.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			226.5	F08		7	0057-0366	284.61	366.61	267	59.70	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			190.7	F08		7	0058-0377	900.04	377.04	305	72.18	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			251.1	F08		7	0059-0377	130.33	376.64	342	70.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.9	F08		7	0060-0382	614.20	382.79	380	73.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			256.3	F08		7	0061-0386	419.80	385.79	329	69.84	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			243.4	F08		7	0062-0384	562.34	383.61	317	66.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			197.3	F08		7	0063-0392	845.59	392.78	308	67.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			203.4	F08		7	0064-0396	676.19	396.86	321	68.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.8	F08		7	0065-0397	781.94	396.61	342	69.84	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			300.7	F08		7	0066-0399	58.99	398.31	273	63.60	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			268.0	F08		7	0067-0409	352.76	410.17	340	72.67	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			243.7	F08		7	0068-0417	292.67	417.10	285	67.84	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.3	F08		7	0069-0423	37.19	423.02	275	69.26	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			328.1	F08		7	0070-0419	533.04	419.50	266	63.70	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.8	F08		7	0071-0426	229.90	425.89	293	66.43	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			218.0	F08		7	0072-0438	885.79	438.02	319	70.77	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.5	F08		7	0073-0437	138.79	436.51	217	59.94	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			222.3	F08		7	0074-0443	717.99	443.46	337	69.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			290.6	F08		7	0075-0448	449.95	447.65	306	67.84	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			307.5	F08		7	0076-0447	484.62	447.15	225	58.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			477.5	F08		7	0077-0453	631.77	455.68	387	93.98	0.551
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			292.9	F08		7	0078-0449	298.81	448.89	269	66.43	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			275.7	F08		7	0079-0468	104.09	467.16	106	44.53	0.672
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			372.9	F08		7	0080-0479	201.56	479.53	320	69.60	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.6	F08		7	0081-0481	581.58	480.98	335	68.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			259.5	F08		7	0082-0486	529.78	486.59	233	58.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			242.5	F08		7	0083-0494	302.87	494.27	285	62.43	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			244.9	F08		7	0084-0495	229.49	495.57	325	68.77	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.9	F08		7	0085-0499	904.47	499.00	292	65.60	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			237.5	F08		7	0086-0504	28.67	504.31	308	66.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			830.1	F08		7	0087-0508	444.17	508.44	343	70.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.5	F08		7	0088-0525	890.82	525.58	277	65.70	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			238.9	F08		7	0089-0535	193.24	534.84	316	68.77	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			277.0	F08		7	0090-0539	300.64	539.10	270	63.01	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.5	F08		7	0091-0539	379.44	538.81	304	65.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.5	F08		7	0092-0542	25.51	542.80	256	64.43	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			264.9	F08		7	0093-0549	343.44	548.80	214	55.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			253.9	F08		7	0094-0552	637.08	552.27	261	60.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			245.3	F08		7	0095-0574	164.62	573.41	429	86.08	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			268.9	F08		7	0096-0571	672.22	571.83	228	55.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			275.4	F08		7	0097-0573	507.45	573.46	280	63.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			236.1	F08		7	0098-0581	822.58	581.20	290	67.26	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			193.5	F08		7	0099-0592	714.37	592.57	393	83.74	0.704
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			230.5	F08		7	0100-0604	631.20	604.27	236	60.18	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			237.0	F08		7	0101-0615	95.84	614.75	325	69.36	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			218.8	F08		7	0102-0617	583.01	617.18	308	67.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			252.5	F08		7	0103-0632	208.27	633.24	340	68.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.3	F08		7	0104-0635	394.14	634.30	172	52.53	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			477.7	F08		7	0105-0642	602.53	640.54	365	120.71	0.315
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			252.3	F08		7	0106-0646	152.95	645.38	213	59.94	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			250.1	F08		7	0107-0649	403.03	649.67	189	54.53	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			284.8	F08		7	0108-0646	479.26	645.61	195	67.60	0.536
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			226.1	F08		7	0109-0654	434.14	654.28	282	62.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			222.7	F08		7	0110-0661	551.17	661.16	255	58.53	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.6	F08		7	0111-0676	429.53	676.20	341	69.50	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			362.3	F08		7	0112-0674	830.80	674.11	271	65.60	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			204.3	F08		7	0113-0679	201.81	678.48	306	66.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.3	F08		7	0114-0686	459.50	686.25	297	67.01	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.6	F08		7	0115-0687	594.89	687.09	301	69.36	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			321.9	F08		7	0116-0700	860.31	700.06	228	58.77	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			212.1	F08		7	0117-0712	829.75	712.75	159	50.04	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.7	F08		8	0001-0033	547.49	33.04	276	63.36	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.9	F08		8	0002-0039	390.98	39.49	312	68.87	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.1	F08		8	0003-0040	117.38	39.09	364	73.84	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.0	F08		8	0004-0043	468.83	43.14	273	63.60	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			249.9	F08		8	0005-0051	61.97	51.24	324	67.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			238.7	F08		8	0006-0057	813.53	56.57	270	65.60	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.2	F08		8	0007-0061	423.49	62.30	351	70.67	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.7	F08		8	0008-0063	351.36	64.01	288	63.94	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			290.3	F08		8	0009-0073	188.66	73.62	234	58.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			250.3	F08		8	0010-0078	534.60	77.39	546	85.74	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			243.0	F08		8	0011-0090	591.13	91.05	359	73.84	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			326.8	F08		8	0012-0093	27.34	92.73	300	71.60	0.735
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			175.0	F08		8	0013-0098	151.25	98.63	321	70.18	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			242.7	F08		8	0014-0094	862.10	94.33	251	58.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			240.9	F08		8	0015-0107	399.16	107.89	351	69.60	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			166.2	F08		8	0016-0116	77.68	116.31	300	65.60	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			269.7	F08		8	0017-0119	94.58	118.73	270	66.18	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			196.5	F08		8	0018-0117	144.91	118.43	327	67.94	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			492.7	F08		8	0019-0126	297.21	126.26	313	66.77	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			296.8	F08		8	0020-0127	571.17	127.19	260	64.67	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			230.0	F08		8	0021-0132	461.59	131.56	320	67.60	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			588.3	F08		8	0022-0137	524.65	137.50	266	61.46	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			188.8	F08		8	0023-0143	182.96	143.82	360	72.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			210.3	F08		8	0024-0144	858.72	143.84	286	62.53	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			201.3	F08		8	0025-0148	116.34	148.61	341	68.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			387.9	F08		8	0026-0148	631.03	147.91	212	54.53	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.9	F08		8	0027-0163	384.92	163.20	349	70.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			230.0	F08		8	0028-0162	498.33	161.44	241	60.77	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			204.4	F08		8	0029-0179	255.75	179.69	303	66.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			343.6	F08		8	0030-0193	903.86	192.59	363	77.60	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			207.8	F08		8	0031-0192	128.31	192.14	319	68.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			190.3	F08		8	0032-0198	834.68	198.26	273	61.36	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			273.2	F08		8	0033-0199	509.73	199.88	314	73.60	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			176.4	F08		8	0034-0200	934.39	200.06	339	68.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			250.8	F08		8	0035-0203	451.50	203.05	309	66.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			237.5	F08		8	0036-0212	809.27	211.52	260	59.94	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.8	F08		8	0037-0212	298.17	211.31	305	67.36	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			290.6	F08		8	0038-0219	171.70	218.50	349	70.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.1	F08		8	0039-0233	637.45	233.56	392	80.67	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			330.6	F08		8	0040-0231	389.44	231.39	302	67.36	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			237.1	F08		8	0041-0237	69.26	237.61	245	60.43	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			210.4	F08		8	0042-0246	216.23	246.26	271	64.43	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			447.2	F08		8	0043-0252	368.24	252.48	258	60.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.7	F08		8	0044-0255	555.78	254.76	308	67.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			387.3	F08		8	0045-0255	786.48	254.80	372	71.60	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			205.7	F08		8	0046-0255	269.76	254.60	284	66.43	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			212.3	F08		8	0047-0254	91.96	254.52	319	73.70	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			341.8	F08		8	0048-0259	345.30	258.91	262	60.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			186.6	F08		8	0049-0267	175.50	267.03	342	69.60	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.1	F08		8	0050-0268	413.70	268.21	323	71.50	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			226.6	F08		8	0051-0269	476.36	269.60	262	62.87	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			248.2	F08		8	0052-0267	608.28	266.91	333	69.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			543.7	F08		8	0053-0276	824.72	276.05	241	71.26	0.596
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			309.3	F08		8	0054-0280	327.52	280.38	308	69.94	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			226.7	F08		8	0055-0286	908.01	285.70	313	68.53	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.8	F08		8	0056-0287	257.30	287.08	289	64.18	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			199.7	F08		8	0057-0296	114.24	295.98	271	60.28	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			230.9	F08		8	0058-0301	527.71	301.18	325	70.43	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			305.8	F08		8	0059-0303	773.32	302.44	372	73.26	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			249.5	F08		8	0060-0301	67.03	300.89	265	60.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			202.2	F08		8	0061-0306	726.59	306.20	334	67.60	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.8	F08		8	0062-0307	454.46	307.65	280	64.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.3	F08		8	0063-0312	484.66	310.84	355	71.01	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.8	F08		8	0064-0309	802.16	310.13	312	67.01	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			270.1	F08		8	0065-0309	596.25	308.86	334	68.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.2	F08		8	0066-0316	693.21	316.50	327	69.94	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			406.1	F08		8	0067-0314	860.26	314.34	217	55.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			244.2	F08		8	0068-0321	66.27	321.41	288	64.18	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			208.2	F08		8	0069-0340	518.16	340.62	344	70.18	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			218.9	F08		8	0070-0341	265.73	342.16	331	68.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.5	F08		8	0071-0351	434.28	351.13	305	66.53	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			194.7	F08		8	0072-0351	157.55	350.65	335	67.60	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.1	F08		8	0073-0357	716.82	357.73	333	68.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			286.5	F08		8	0074-0359	201.87	358.41	290	62.18	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			203.3	F08		8	0075-0364	109.18	363.74	280	62.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			255.1	F08		8	0076-0362	599.31	361.65	263	64.53	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			208.7	F08		8	0077-0367	693.55	366.93	294	66.18	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.3	F08		8	0078-0368	311.75	368.05	298	66.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			211.8	F08		8	0079-0377	779.65	376.56	371	72.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			179.1	F08		8	0080-0388	69.99	388.89	308	67.60	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.2	F08		8	0081-0390	343.64	390.06	371	73.84	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			429.7	F08		8	0082-0386	263.47	386.26	253	61.11	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			190.8	F08		8	0083-0391	908.93	390.40	404	73.60	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			267.2	F08		8	0084-0391	611.42	391.77	274	69.50	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.9	F08		8	0085-0394	117.33	393.86	319	67.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			270.9	F08		8	0086-0399	228.50	398.65	247	60.53	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			357.5	F08		8	0087-0408	842.54	408.45	219	54.63	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.6	F08		8	0088-0416	556.27	416.95	354	69.60	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			644.1	F08		8	0089-0420	159.54	420.41	357	71.50	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			263.4	F08		8	0090-0423	731.25	422.91	279	63.01	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			360.5	F08		8	0091-0428	804.60	428.93	253	61.36	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.0	F08		8	0092-0436	487.98	436.01	325	66.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			212.8	F08		8	0093-0438	450.52	438.13	320	69.84	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			275.6	F08		8	0094-0441	747.09	440.58	241	61.11	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.6	F08		8	0095-0449	897.52	449.38	338	69.84	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			247.9	F08		8	0096-0449	761.52	449.23	256	62.53	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			406.5	F08		8	0097-0454	127.49	454.78	354	70.18	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			166.1	F08		8	0098-0459	837.61	458.78	342	69.84	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			195.9	F08		8	0099-0464	52.51	464.29	258	63.01	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.4	F08		8	0100-0475	743.13	475.27	277	63.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.9	F08		8	0101-0501	414.64	501.00	335	69.60	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			255.9	F08		8	0102-0507	566.44	507.64	333	69.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.8	F08		8	0103-0514	374.99	514.14	306	65.94	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			197.9	F08		8	0104-0513	334.32	513.20	159	48.53	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			210.9	F08		8	0105-0524	327.91	524.49	200	53.94	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			317.3	F08		8	0106-0524	268.31	524.45	261	62.53	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			255.9	F08		8	0107-0531	853.53	531.31	273	60.77	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			202.4	F08		8	0108-0535	604.96	534.87	366	72.18	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			201.0	F08		8	0109-0571	800.98	571.40	335	71.01	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			270.6	F08		8	0110-0569	210.82	568.62	319	65.60	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			261.7	F08		8	0111-0577	472.98	576.95	286	63.60	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			181.5	F08		8	0112-0581	98.85	581.31	272	62.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.6	F08		8	0113-0580	145.09	579.96	365	73.01	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			177.0	F08		8	0114-0590	882.83	590.92	326	71.26	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			201.6	F08		8	0115-0597	725.29	596.96	315	68.18	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			198.2	F08		8	0116-0597	624.95	597.75	362	73.26	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			263.0	F08		8	0117-0611	935.55	610.24	234	62.43	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			205.3	F08		8	0118-0618	164.12	619.05	342	69.84	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			242.8	F08		8	0119-0619	390.63	619.56	358	72.18	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			217.0	F08		8	0120-0624	311.05	624.35	393	74.53	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.6	F08		8	0121-0633	257.00	633.60	354	72.18	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			270.6	F08		8	0122-0629	887.85	629.27	229	59.36	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			908.1	F08		8	0123-0631	485.97	631.58	369	71.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			212.5	F08		8	0124-0644	205.67	643.32	267	76.91	0.567
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			369.0	F08		8	0125-0646	113.81	646.09	315	68.28	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			225.7	F08		8	0126-0648	646.66	648.33	311	64.77	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			306.5	F08		8	0127-0652	188.70	652.10	313	72.77	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			246.0	F08		8	0128-0662	807.99	662.37	371	72.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			222.1	F08		8	0129-0679	279.00	679.25	308	66.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.0	F08		8	0130-0681	511.91	681.69	286	62.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			254.6	F08		8	0131-0683	818.41	683.45	254	62.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			185.0	F08		8	0132-0700	318.53	700.43	351	71.84	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			407.1	F08		8	0133-0700	869.85	700.89	257	62.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			212.0	F08		8	0134-0703	138.26	703.54	301	64.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			212.6	F08		8	0135-0707	51.06	707.80	312	67.60	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			173.6	F08		9	0001-0027	112.91	26.93	344	68.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.9	F08		9	0002-0032	250.70	31.94	275	63.11	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.9	F08		9	0003-0037	590.02	36.73	360	76.08	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			196.2	F08		9	0004-0035	182.72	34.71	298	68.18	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			253.1	F08		9	0005-0039	511.18	38.74	272	60.53	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			265.6	F08		9	0006-0052	462.31	52.06	326	68.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			237.4	F08		9	0007-0061	289.42	61.34	340	69.84	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			198.0	F08		9	0008-0060	744.10	60.15	375	75.84	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.0	F08		9	0009-0059	539.40	60.03	288	63.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			237.8	F08		9	0010-0067	666.69	67.26	265	60.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			231.1	F08		9	0011-0067	106.69	66.90	298	65.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.6	F08		9	0012-0074	577.54	74.11	328	69.36	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.8	F08		9	0013-0085	351.37	85.44	320	68.77	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			177.0	F08		9	0014-0091	628.73	91.14	393	77.01	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.0	F08		9	0015-0103	150.33	103.48	271	69.26	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.9	F08		9	0016-0108	400.39	108.07	454	80.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.8	F08		9	0017-0105	858.93	105.72	285	66.53	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			207.6	F08		9	0018-0113	289.82	113.21	327	67.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			247.0	F08		9	0019-0109	606.04	109.78	240	56.53	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			318.9	F08		9	0020-0117	768.48	117.04	247	62.77	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.8	F08		9	0021-0125	539.18	124.32	438	80.67	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			275.0	F08		9	0022-0121	873.87	121.45	166	52.53	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.5	F08		9	0023-0127	260.01	127.38	302	67.01	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.6	F08		9	0024-0138	476.79	138.03	340	71.60	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			198.6	F08		9	0025-0149	319.13	148.94	327	67.11	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			226.6	F08		9	0026-0148	749.13	148.30	298	66.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			225.1	F08		9	0027-0158	503.51	157.38	320	73.60	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			259.4	F08		9	0028-0161	88.66	161.07	266	64.91	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			257.9	F08		9	0029-0159	241.91	159.07	237	59.01	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			278.5	F08		9	0030-0167	191.21	167.88	216	55.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			274.0	F08		9	0031-0175	444.89	175.23	302	65.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			345.7	F08		9	0032-0173	811.23	174.00	102	37.46	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			245.1	F08		9	0033-0186	771.64	186.50	258	63.36	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			246.0	F08		9	0034-0192	90.66	192.61	247	62.18	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			226.0	F08		9	0035-0195	168.87	195.46	266	68.77	0.707
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			443.7	F08		9	0036-0192	373.20	191.67	246	60.77	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			396.4	F08		9	0037-0199	632.74	199.12	474	83.26	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			165.5	F08		9	0038-0200	943.12	200.57	395	77.50	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			195.1	F08		9	0039-0204	909.33	203.92	372	77.84	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.6	F08		9	0040-0203	29.78	202.97	327	68.18	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.7	F08		9	0041-0216	678.42	216.04	314	73.01	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			243.0	F08		9	0042-0214	529.80	214.47	277	61.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			247.0	F08		9	0043-0235	813.79	235.09	281	65.01	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			247.8	F08		9	0044-0237	767.12	236.64	289	67.84	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			225.3	F08		9	0045-0242	731.53	242.09	337	71.36	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			242.9	F08		9	0046-0239	229.65	240.27	253	58.87	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			217.8	F08		9	0047-0249	661.57	249.17	263	64.77	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			204.6	F08		9	0048-0252	46.14	252.59	303	63.94	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			278.9	F08		9	0049-0253	277.61	253.04	272	61.36	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			187.5	F08		9	0050-0260	938.09	260.43	364	71.50	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			231.0	F08		9	0051-0257	230.00	257.15	285	65.70	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			210.3	F08		9	0052-0266	426.54	266.69	295	65.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			234.1	F08		9	0053-0266	532.37	266.41	288	62.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			196.4	F08		9	0054-0275	141.22	275.50	320	67.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			197.4	F08		9	0055-0280	890.30	279.55	407	79.26	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			210.6	F08		9	0056-0282	381.39	281.55	283	62.18	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.6	F08		9	0057-0285	623.90	284.88	302	67.84	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			253.9	F08		9	0058-0298	223.21	298.43	264	59.60	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.4	F08		9	0059-0308	484.54	308.19	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			243.4	F08		9	0060-0313	56.31	313.12	372	74.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			210.1	F08		9	0061-0322	259.07	322.01	308	67.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.6	F08		9	0062-0327	728.12	326.58	310	69.36	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			192.3	F08		9	0063-0334	925.85	333.62	351	70.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			234.7	F08		9	0064-0333	831.25	333.40	333	69.26	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			230.5	F08		9	0065-0341	545.88	341.42	289	63.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			200.8	F08		9	0066-0341	871.51	341.54	301	64.43	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			192.2	F08		9	0067-0346	43.39	345.92	356	69.01	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			311.1	F08		9	0068-0350	225.43	350.33	358	73.26	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			245.5	F08		9	0069-0364	425.99	364.39	291	69.36	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			249.9	F08		9	0070-0363	784.03	363.41	333	68.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			199.5	F08		9	0071-0368	75.81	368.43	329	66.77	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			247.5	F08		9	0072-0370	728.14	370.19	368	71.84	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.2	F08		9	0073-0377	675.67	377.52	431	94.81	0.603
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			308.6	F08		9	0074-0384	562.15	380.29	405	96.47	0.547
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.2	F08		9	0075-0380	839.73	380.27	381	72.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.4	F08		9	0076-0395	607.01	394.57	312	70.67	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			236.4	F08		9	0077-0401	333.46	400.98	249	60.53	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			217.7	F08		9	0078-0401	429.53	401.57	283	62.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			260.6	F08		9	0079-0413	477.40	413.11	239	58.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.2	F08		9	0080-0418	752.22	417.97	326	67.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			189.4	F08		9	0081-0423	108.15	423.49	312	66.77	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.6	F08		9	0082-0422	136.76	422.43	323	67.84	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			260.8	F08		9	0083-0431	926.94	431.35	264	63.70	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			244.6	F08		9	0084-0436	663.61	435.45	326	68.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			197.5	F08		9	0085-0441	846.39	442.19	308	68.67	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			203.7	F08		9	0086-0453	788.02	452.55	346	70.43	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			210.4	F08		9	0087-0457	627.33	457.38	328	68.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			260.3	F08		9	0088-0460	250.17	459.58	271	62.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			327.2	F08		9	0089-0460	360.06	459.62	272	61.36	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			192.7	F08		9	0090-0466	762.09	465.46	350	71.01	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			225.3	F08		9	0091-0473	583.58	473.73	297	64.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			284.6	F08		9	0092-0483	354.63	482.60	295	64.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.1	F08		9	0093-0490	838.00	490.06	300	64.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			210.2	F08		9	0094-0496	656.41	496.27	342	72.53	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.3	F08		9	0095-0495	418.64	495.14	284	62.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			189.7	F08		9	0096-0498	792.53	497.76	331	69.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			187.1	F08		9	0097-0496	774.17	495.84	350	71.94	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			208.7	F08		9	0098-0499	52.74	498.30	283	62.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			218.3	F08		9	0099-0501	727.06	500.76	271	61.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.2	F08		9	0100-0505	207.71	504.91	249	58.18	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.4	F08		9	0101-0521	78.62	521.30	261	65.01	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			225.2	F08		9	0102-0521	614.23	521.50	371	70.18	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			242.3	F08		9	0103-0525	681.54	525.40	290	65.36	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			234.3	F08		9	0104-0524	710.85	524.45	293	63.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			253.1	F08		9	0105-0536	359.76	536.61	335	68.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			212.6	F08		9	0106-0539	624.88	539.71	358	72.08	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			238.9	F08		9	0107-0545	414.30	545.05	278	68.08	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.7	F08		9	0108-0543	740.94	544.00	305	65.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			211.6	F08		9	0109-0551	127.64	551.73	323	70.67	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			208.6	F08		9	0110-0555	376.56	555.19	274	60.77	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			222.7	F08		9	0111-0559	311.67	559.17	348	69.60	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			240.4	F08		9	0112-0570	464.67	570.15	303	67.60	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			237.8	F08		9	0113-0577	227.99	580.26	291	83.15	0.529
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			216.6	F08		9	0114-0584	723.59	584.53	331	68.67	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			375.4	F08		9	0115-0592	144.52	592.32	318	69.26	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			206.9	F08		9	0116-0591	674.89	590.99	317	66.53	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			225.3	F08		9	0117-0600	594.64	600.11	339	70.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.3	F08		9	0118-0599	296.56	598.65	303	67.84	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.9	F08		9	0119-0597	805.83	597.68	333	75.84	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			189.0	F08		9	0120-0602	928.18	602.38	277	62.77	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			211.9	F08		9	0121-0606	412.90	606.62	306	66.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.8	F08		9	0122-0607	466.79	607.03	331	67.84	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			259.8	F08		9	0123-0613	30.57	613.25	236	60.77	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			531.1	F08		9	0124-0615	239.99	615.89	244	63.94	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			212.8	F08		9	0125-0617	908.56	617.47	303	66.53	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			194.4	F08		9	0126-0625	671.13	625.54	417	79.26	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			216.9	F08		9	0127-0638	544.10	637.32	277	67.01	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.2	F08		9	0128-0648	205.49	647.63	330	67.60	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.6	F08		9	0129-0652	501.09	652.73	310	66.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			205.9	F08		9	0130-0658	185.37	657.89	315	67.84	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.3	F08		9	0131-0664	921.81	663.93	269	61.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.2	F08		9	0132-0667	677.49	666.70	275	62.18	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.3	F08		9	0133-0671	770.94	672.08	269	66.18	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.8	F08		9	0134-0674	398.05	674.25	276	63.36	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.0	F08		9	0135-0680	852.31	679.91	486	84.67	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.4	F08		9	0136-0682	319.34	683.00	307	65.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.6	F08		9	0137-0685	378.24	685.79	273	61.36	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.6	G08		1	0001-0032	204.59	33.10	257	63.01	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			266.3	G08		1	0002-0042	496.41	42.05	229	59.11	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			225.6	G08		1	0003-0056	98.31	56.55	335	72.08	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			272.8	G08		1	0004-0065	935.15	65.24	324	68.43	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			330.1	G08		1	0005-0075	282.41	75.08	268	64.04	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			243.1	G08		1	0006-0076	711.31	75.89	364	71.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			285.0	G08		1	0007-0083	664.99	83.53	405	80.57	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			415.1	G08		1	0008-0092	730.56	92.42	348	71.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			328.2	G08		1	0009-0092	567.38	92.61	154	68.43	0.413
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			275.2	G08		1	0010-0096	262.76	96.42	254	69.26	0.665
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.9	G08		1	0011-0100	77.40	101.22	295	66.18	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			250.5	G08		1	0012-0106	712.96	105.19	322	72.33	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			421.4	G08		1	0013-0107	844.87	105.02	171	73.50	0.398
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			253.6	G08		1	0014-0122	896.06	121.71	302	66.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			251.5	G08		1	0015-0194	835.35	194.66	279	62.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			316.5	G08		1	0016-0199	185.62	199.26	102	39.21	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			308.3	G08		1	0017-0225	584.08	224.71	214	58.04	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			328.5	G08		1	0018-0242	806.26	241.74	215	62.04	0.702
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			714.4	G08		1	0019-0268	829.39	268.12	262	59.36	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			271.1	G08		1	0020-0280	887.64	280.48	237	60.28	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			282.3	G08		1	0021-0288	639.34	288.26	221	57.94	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			282.8	G08		1	0022-0302	32.27	302.53	235	64.18	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			284.8	G08		1	0023-0306	478.27	306.20	195	58.18	0.724
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			255.1	G08		1	0024-0323	657.51	324.42	284	64.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			277.0	G08		1	0025-0343	280.32	343.85	258	62.53	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			281.6	G08		1	0026-0365	47.51	365.09	214	54.87	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			294.3	G08		1	0027-0369	350.54	368.34	227	62.87	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			285.8	G08		1	0028-0364	510.31	363.63	226	58.77	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			245.5	G08		1	0029-0367	623.42	366.98	274	63.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			309.2	G08		1	0030-0365	742.98	365.12	193	57.36	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			317.0	G08		1	0031-0368	147.46	368.35	242	61.36	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			258.8	G08		1	0032-0373	306.88	373.44	229	61.11	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			274.2	G08		1	0033-0383	675.69	383.47	240	63.11	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.7	G08		1	0034-0389	935.70	389.37	282	67.60	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			320.1	G08		1	0035-0407	210.27	407.15	209	58.77	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			307.0	G08		1	0036-0414	70.13	414.26	215	57.70	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			304.9	G08		1	0037-0416	890.73	415.95	225	57.70	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.3	G08		1	0038-0438	666.57	438.67	262	64.53	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			426.3	G08		1	0039-0444	858.60	443.31	109	75.98	0.237
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			327.5	G08		1	0040-0457	419.20	458.00	233	57.36	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			265.5	G08		1	0041-0462	730.98	462.08	237	61.94	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			304.3	G08		1	0042-0498	314.58	498.27	227	59.60	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			254.3	G08		1	0043-0524	563.97	524.23	303	66.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			280.2	G08		1	0044-0527	829.85	527.56	240	62.77	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			268.6	G08		1	0045-0536	719.53	536.54	205	58.18	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			264.5	G08		1	0046-0539	360.16	539.84	277	72.43	0.664
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			268.0	G08		1	0047-0539	688.61	539.21	272	60.77	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			320.2	G08		1	0048-0541	636.49	541.13	202	54.18	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			226.9	G08		1	0049-0548	12.47	547.60	261	61.36	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			273.9	G08		1	0050-0558	95.67	558.64	212	58.18	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			217.2	G08		1	0051-0568	648.28	568.31	304	68.18	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			230.2	G08		1	0052-0569	834.65	569.67	293	66.43	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			248.9	G08		1	0053-0605	697.52	605.52	252	58.77	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			234.9	G08		1	0054-0610	547.24	610.47	328	69.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			285.7	G08		1	0055-0610	598.30	610.74	166	53.94	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			279.5	G08		1	0056-0639	326.67	638.87	198	53.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			273.8	G08		1	0057-0697	329.28	697.00	230	59.84	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			243.0	G08		1	0058-0706	735.74	705.51	250	73.60	0.580
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			267.2	G08		2	0001-0033	490.85	32.69	260	66.28	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.8	G08		2	0002-0065	39.68	65.16	334	70.43	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.1	G08		2	0003-0071	263.62	70.95	321	73.26	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			263.9	G08		2	0004-0104	246.65	104.64	292	75.50	0.644
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			266.5	G08		2	0005-0207	403.66	206.99	276	68.18	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			322.5	G08		2	0006-0218	447.01	218.02	223	66.43	0.635
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			320.9	G08		2	0007-0233	670.79	232.76	279	104.81	0.319
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.9	G08		2	0008-0248	396.52	248.61	314	69.84	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			283.9	G08		2	0009-0248	449.88	249.51	100	47.46	0.558
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			302.9	G08		2	0010-0282	915.46	282.98	120	50.77	0.585
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			252.8	G08		2	0011-0354	665.79	353.71	302	68.18	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			225.4	G08		2	0012-0389	40.48	389.26	286	68.18	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			663.0	G08		2	0013-0396	667.73	395.75	228	57.01	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			540.8	G08		2	0014-0408	655.79	407.55	276	66.08	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			319.3	G08		2	0015-0409	559.15	408.44	277	64.18	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			240.6	G08		2	0016-0459	258.19	459.85	306	66.18	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			280.2	G08		2	0017-0511	49.96	511.64	225	57.70	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			243.2	G08		2	0018-0515	114.80	515.24	268	63.60	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			292.3	G08		2	0019-0613	133.89	613.28	223	60.53	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			300.0	G08		2	0020-0618	504.01	618.58	259	63.36	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			246.3	G08		2	0021-0635	637.25	635.23	302	66.53	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.7	G08		2	0022-0639	285.94	639.91	297	66.18	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			248.1	G08		2	0023-0644	591.27	644.02	278	63.70	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.0	G08		2	0024-0650	538.77	650.29	296	64.53	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.2	G08		2	0025-0654	224.91	653.80	279	63.70	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			231.0	G08		2	0026-0669	100.45	669.38	299	65.36	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			245.3	G08		2	0027-0672	582.47	672.12	374	76.08	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			245.7	G08		2	0028-0672	305.14	673.35	281	64.53	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			482.0	G08		2	0029-0686	316.60	686.53	125	45.11	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			237.6	G08		2	0030-0691	559.22	690.33	333	73.01	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			222.5	G08		2	0031-0697	615.07	697.26	277	62.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1260.8	G08		2	0032-0703	912.12	702.79	115	40.28	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			306.7	G08		3	0001-0051	392.71	51.40	201	55.36	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			290.7	G08		3	0002-0075	222.13	75.24	244	59.36	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			327.1	G08		3	0003-0084	824.96	84.25	264	61.94	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			257.0	G08		3	0004-0098	283.01	98.19	236	61.26	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			287.8	G08		3	0005-0107	865.02	107.68	209	59.26	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			291.9	G08		3	0006-0109	428.96	108.97	213	54.53	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			298.3	G08		3	0007-0117	337.10	117.22	177	52.18	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			303.2	G08		3	0008-0120	858.06	120.25	224	55.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			391.7	G08		3	0009-0140	463.15	140.84	127	57.60	0.481
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			271.7	G08		3	0010-0154	925.91	153.92	225	57.36	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			276.5	G08		3	0011-0159	132.00	159.59	256	62.53	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			296.7	G08		3	0012-0161	248.69	161.09	118	40.28	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			230.0	G08		3	0013-0170	238.79	170.81	151	46.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			353.0	G08		3	0014-0176	428.50	176.01	204	58.18	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			243.6	G08		3	0015-0181	503.87	181.33	291	66.77	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			593.8	G08		3	0016-0180	529.81	180.56	171	50.53	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			377.8	G08		3	0017-0197	582.62	198.37	177	56.18	0.705
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			301.5	G08		3	0018-0200	927.92	200.57	216	59.60	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			372.7	G08		3	0019-0218	416.36	218.30	165	50.04	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			349.5	G08		3	0020-0225	645.39	226.73	372	80.08	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			258.5	G08		3	0021-0230	534.48	231.10	267	63.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			244.6	G08		3	0022-0244	246.67	242.06	190	58.87	0.689
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			316.7	G08		3	0023-0252	396.23	252.19	223	54.53	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			252.2	G08		3	0024-0254	528.93	254.27	270	65.01	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			240.2	G08		3	0025-0258	249.56	257.64	117	41.70	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			249.8	G08		3	0026-0275	172.46	274.70	276	67.84	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			254.3	G08		3	0027-0281	631.58	281.17	262	59.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			298.0	G08		3	0028-0283	13.67	282.64	191	56.77	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			317.6	G08		3	0029-0291	854.26	290.53	224	59.60	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			295.9	G08		3	0030-0303	103.18	303.57	207	57.36	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			898.8	G08		3	0031-0312	777.94	311.63	151	51.46	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			314.1	G08		3	0032-0322	487.29	322.50	214	56.77	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			238.3	G08		3	0033-0343	170.81	343.65	233	58.28	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			345.6	G08		3	0034-0384	852.19	384.44	220	55.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			249.5	G08		3	0035-0385	203.48	384.96	224	61.70	0.739
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			245.3	G08		3	0036-0396	810.66	396.52	284	63.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			252.2	G08		3	0037-0402	50.40	402.63	241	60.77	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			268.1	G08		3	0038-0407	742.68	408.20	266	64.18	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			229.1	G08		3	0039-0408	893.26	407.85	285	67.26	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			299.4	G08		3	0040-0454	910.50	453.38	237	58.77	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.2	G08		3	0041-0486	783.43	486.83	257	62.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			282.3	G08		3	0042-0489	453.81	489.03	234	57.36	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			252.1	G08		3	0043-0499	369.03	498.82	247	60.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			236.6	G08		3	0044-0535	663.85	535.40	257	62.87	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			261.6	G08		3	0045-0539	343.31	539.41	471	89.74	0.735
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			404.8	G08		3	0046-0531	785.86	531.44	177	51.11	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			485.2	G08		3	0047-0549	945.50	548.90	266	68.63	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			238.7	G08		3	0048-0558	808.51	557.74	322	68.18	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			398.6	G08		3	0049-0560	315.90	559.69	220	93.40	0.317
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			234.2	G08		3	0050-0565	444.93	564.88	283	66.18	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			252.6	G08		3	0051-0575	624.95	575.22	373	72.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.0	G08		3	0052-0581	325.62	582.28	262	61.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.8	G08		3	0053-0609	835.51	610.13	302	66.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			318.4	G08		3	0054-0645	276.97	644.96	208	56.87	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			208.8	G08		3	0055-0663	699.65	662.76	264	65.36	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			251.2	G08		3	0056-0664	832.78	663.96	216	59.84	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			336.0	G08		3	0057-0666	97.42	666.26	212	53.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.4	G08		3	0058-0670	618.50	669.36	259	66.43	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			250.0	G08		4	0001-0035	57.39	34.95	202	56.77	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.3	G08		4	0002-0036	140.39	36.89	263	67.26	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			193.6	G08		4	0003-0065	897.16	64.19	268	63.26	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.0	G08		4	0004-0069	704.73	69.69	260	63.70	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			260.8	G08		4	0005-0087	675.87	87.02	277	61.70	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			276.3	G08		4	0006-0092	168.03	92.02	326	72.91	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.7	G08		4	0007-0097	488.16	97.07	264	62.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			264.8	G08		4	0008-0106	695.79	107.02	267	67.26	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			270.0	G08		4	0009-0129	134.25	130.00	186	56.87	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			284.4	G08		4	0010-0144	683.46	144.16	250	68.77	0.664
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			257.9	G08		4	0011-0184	270.60	185.09	156	47.46	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.7	G08		4	0012-0184	258.83	184.32	117	42.63	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			237.1	G08		4	0013-0198	252.47	198.14	271	61.60	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			231.7	G08		4	0014-0202	271.16	202.46	228	62.77	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			291.6	G08		4	0015-0222	683.17	222.21	211	63.60	0.656
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.7	G08		4	0016-0223	626.05	223.64	268	61.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			248.2	G08		4	0017-0230	296.16	230.32	363	80.67	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			217.7	G08		4	0018-0236	870.80	235.72	251	60.53	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1308.8	G08		4	0019-0248	297.88	248.35	171	67.84	0.467
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			242.4	G08		4	0020-0251	61.22	251.90	222	54.77	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.4	G08		4	0021-0252	929.07	252.31	258	60.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			234.7	G08		4	0022-0261	757.81	261.64	281	65.01	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			264.4	G08		4	0023-0260	858.20	260.13	218	61.70	0.720
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			267.0	G08		4	0024-0273	154.52	273.23	239	64.53	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			257.1	G08		4	0025-0274	848.11	274.54	288	65.94	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			285.2	G08		4	0026-0278	57.57	278.85	196	52.53	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			290.1	G08		4	0027-0290	821.95	289.82	232	58.53	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.8	G08		4	0028-0297	30.71	296.88	302	66.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			268.5	G08		4	0029-0300	383.48	300.35	174	49.11	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			284.5	G08		4	0030-0308	258.64	308.85	209	57.60	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			250.1	G08		4	0031-0310	101.43	310.42	257	62.53	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			234.5	G08		4	0032-0312	542.78	311.58	301	68.77	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			267.2	G08		4	0033-0325	554.36	324.38	243	67.01	0.680
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			261.4	G08		4	0034-0343	635.95	342.84	195	59.01	0.704
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			288.3	G08		4	0035-0351	370.80	351.24	187	53.70	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			225.5	G08		4	0036-0350	928.55	349.11	162	51.94	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			193.6	G08		4	0037-0355	938.44	356.34	139	44.28	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			309.7	G08		4	0038-0361	218.64	361.70	202	57.11	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			315.6	G08		4	0039-0373	278.48	373.34	189	51.46	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			417.5	G08		4	0040-0382	801.04	382.03	194	55.70	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			272.3	G08		4	0041-0388	284.57	388.10	256	62.53	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			265.9	G08		4	0042-0391	415.82	392.06	295	67.36	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			276.6	G08		4	0043-0390	53.66	390.17	240	60.18	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			234.3	G08		4	0044-0393	267.09	393.23	290	67.26	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			256.6	G08		4	0045-0401	830.60	401.78	210	53.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			296.3	G08		4	0046-0420	198.06	419.82	219	57.46	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.6	G08		4	0047-0424	944.84	423.39	270	62.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			256.0	G08		4	0048-0440	392.04	441.07	265	65.84	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			312.0	G08		4	0049-0447	554.05	446.96	215	56.18	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			313.6	G08		4	0050-0446	249.81	446.92	191	53.11	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			244.9	G08		4	0051-0477	904.87	477.53	234	57.70	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			258.7	G08		4	0052-0487	80.59	487.68	262	62.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			310.4	G08		4	0053-0502	230.11	501.89	197	53.46	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			302.8	G08		4	0054-0517	391.63	517.07	253	75.60	0.556
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			275.3	G08		4	0055-0521	120.17	521.56	214	55.36	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			490.8	G08		4	0056-0523	287.43	523.01	270	63.60	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			277.1	G08		4	0057-0530	144.08	530.84	219	55.46	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			268.0	G08		4	0058-0560	596.96	558.50	392	91.74	0.585
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			290.3	G08		4	0059-0564	877.39	564.54	192	51.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.0	G08		4	0060-0577	810.69	577.11	389	74.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			266.7	G08		4	0061-0591	113.98	591.55	247	59.94	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.9	G08		4	0062-0606	659.17	606.68	297	78.57	0.605
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			285.0	G08		4	0063-0617	452.28	617.65	211	56.77	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			274.3	G08		4	0064-0621	193.27	621.27	221	60.43	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			251.9	G08		4	0065-0637	190.91	637.47	228	60.18	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			504.1	G08		4	0066-0644	397.00	643.71	282	63.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			291.7	G08		4	0067-0653	92.97	652.55	189	56.53	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			356.9	G08		4	0068-0654	106.20	654.06	160	50.04	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			226.3	G08		4	0069-0663	678.63	663.18	247	64.43	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			272.7	G08		4	0070-0690	349.11	690.26	383	72.67	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.1	G08		4	0071-0691	367.79	690.82	276	66.18	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			196.6	G08		4	0072-0704	542.80	703.81	309	68.43	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			167.4	G08		4	0073-0703	589.98	703.36	281	69.11	0.739
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			306.0	G08		4	0074-0703	739.02	703.26	199	52.77	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			236.8	G08		4	0075-0707	196.86	706.90	154	46.53	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.5	G08		5	0001-0032	541.11	31.09	192	60.18	0.666
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			280.5	G08		5	0002-0042	152.37	43.12	227	64.53	0.685
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			302.1	G08		5	0003-0068	371.04	67.99	204	61.46	0.679
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			197.6	G08		5	0004-0094	130.78	94.41	220	57.70	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			365.2	G08		5	0005-0108	685.92	107.88	189	51.94	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			264.3	G08		5	0006-0108	655.21	107.84	265	63.36	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			279.3	G08		5	0007-0126	291.19	126.62	202	56.18	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			244.2	G08		5	0008-0163	606.40	162.70	224	68.43	0.601
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			255.5	G08		5	0009-0165	343.14	165.05	250	63.50	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			212.5	G08		5	0010-0175	940.52	174.15	253	63.11	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			273.5	G08		5	0011-0181	825.03	181.58	243	58.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			297.3	G08		5	0012-0189	442.10	189.27	227	64.18	0.692
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			287.7	G08		5	0013-0195	722.38	195.82	185	73.50	0.430
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			211.4	G08		5	0014-0222	93.53	222.62	278	65.94	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			254.7	G08		5	0015-0237	567.80	237.45	194	55.46	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			207.5	G08		5	0016-0239	139.04	239.55	271	62.77	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			258.4	G08		5	0017-0241	470.04	240.31	223	57.46	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			282.0	G08		5	0018-0240	624.42	240.17	185	53.36	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			487.2	G08		5	0019-0248	823.85	247.79	175	69.26	0.459
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			216.1	G08		5	0020-0253	34.52	253.68	252	59.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			217.4	G08		5	0021-0263	132.45	263.34	299	67.84	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.8	G08		5	0022-0282	865.29	281.23	145	48.53	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.9	G08		5	0023-0292	260.85	292.40	275	62.18	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			198.4	G08		5	0024-0289	871.90	290.19	120	44.28	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			196.1	G08		5	0025-0292	905.12	292.44	265	63.01	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			439.7	G08		5	0026-0292	213.98	291.51	103	49.46	0.529
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			222.1	G08		5	0027-0316	61.57	315.91	259	68.53	0.693
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			240.4	G08		5	0028-0324	909.41	324.06	225	55.11	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			208.0	G08		5	0029-0351	34.16	350.35	160	51.11	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			203.4	G08		5	0030-0356	852.99	356.90	319	68.18	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.5	G08		5	0031-0357	43.91	357.60	134	43.46	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			218.2	G08		5	0032-0370	916.33	370.90	242	64.53	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			240.4	G08		5	0033-0388	478.45	387.91	263	61.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			340.5	G08		5	0034-0396	394.79	396.25	187	51.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			276.9	G08		5	0035-0412	692.19	411.81	233	56.28	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			263.6	G08		5	0036-0419	429.87	419.08	156	58.77	0.568
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.1	G08		5	0037-0425	50.46	424.75	261	63.60	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			250.7	G08		5	0038-0484	95.58	484.30	269	62.18	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			324.2	G08		5	0039-0483	930.96	483.42	201	53.70	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			259.5	G08		5	0040-0494	633.21	493.73	212	62.28	0.687
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			265.2	G08		5	0041-0497	769.80	497.55	253	61.70	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.2	G08		5	0042-0508	329.53	508.48	329	72.43	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			248.2	G08		5	0043-0527	286.51	526.75	220	61.01	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			267.0	G08		5	0044-0535	622.69	534.63	187	56.28	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.7	G08		5	0045-0550	220.89	550.54	202	57.94	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			222.8	G08		5	0046-0548	249.45	548.43	172	52.28	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			306.2	G08		5	0047-0563	153.70	562.95	110	53.36	0.486
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			247.5	G08		5	0048-0583	634.62	583.75	264	63.84	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			286.2	G08		5	0049-0594	129.69	594.89	191	54.18	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.3	G08		5	0050-0606	526.68	606.72	254	62.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.1	G08		5	0051-0621	548.39	620.38	261	60.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			315.7	G08		5	0052-0633	394.79	633.43	175	57.94	0.655
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			197.8	G08		5	0053-0649	879.38	648.46	267	62.77	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.9	G08		5	0054-0658	86.40	658.34	208	66.04	0.599
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			240.5	G08		5	0055-0659	146.43	658.61	215	57.11	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.3	G08		5	0056-0676	660.44	675.54	242	63.36	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			316.0	G08		5	0057-0680	392.72	679.46	237	61.94	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			308.1	G08		5	0058-0686	413.76	685.86	186	51.70	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			311.7	G08		5	0059-0701	377.39	701.40	197	55.70	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			279.0	G08		5	0060-0703	482.30	702.70	182	64.67	0.547
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			329.2	G08		6	0001-0056	930.28	56.78	245	59.11	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.5	G08		6	0002-0062	146.01	62.35	215	56.77	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			249.5	G08		6	0003-0073	880.87	72.50	278	64.43	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			649.9	G08		6	0004-0082	78.92	81.60	182	51.94	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.4	G08		6	0005-0093	752.88	94.14	288	67.01	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			266.9	G08		6	0006-0112	641.80	112.21	197	57.60	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			411.2	G08		6	0007-0120	317.19	120.41	213	53.11	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			258.1	G08		6	0008-0124	828.85	124.44	232	71.98	0.563
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			244.6	G08		6	0009-0133	761.87	133.64	241	61.01	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			197.4	G08		6	0010-0139	111.89	138.66	274	63.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			204.5	G08		6	0011-0145	96.13	144.50	281	64.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			250.5	G08		6	0012-0150	731.23	150.14	297	66.18	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			326.9	G08		6	0013-0153	946.07	153.21	217	55.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			258.3	G08		6	0014-0157	818.91	157.09	266	65.01	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			259.4	G08		6	0015-0177	35.63	176.53	252	61.11	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			405.3	G08		6	0016-0179	810.78	179.02	141	59.60	0.499
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			246.7	G08		6	0017-0183	491.89	183.08	192	56.43	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			303.5	G08		6	0018-0187	116.46	188.41	137	46.63	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.6	G08		6	0019-0200	117.38	199.99	117	41.80	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			208.1	G08		6	0020-0220	67.60	220.10	243	57.70	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			274.7	G08		6	0021-0225	588.78	225.28	263	64.43	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			269.8	G08		6	0022-0261	649.15	261.19	225	59.70	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			298.3	G08		6	0023-0323	648.24	322.86	229	59.94	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			304.3	G08		6	0024-0328	763.41	329.02	193	57.11	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.3	G08		6	0025-0339	100.89	339.06	230	57.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			234.3	G08		6	0026-0347	418.78	347.62	272	65.60	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.6	G08		6	0027-0369	308.09	369.43	309	66.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.0	G08		6	0028-0373	11.55	373.61	238	63.11	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.4	G08		6	0029-0373	577.93	372.96	231	62.63	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			238.9	G08		6	0030-0403	351.02	403.11	335	70.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			231.6	G08		6	0031-0413	837.42	412.60	249	59.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			258.1	G08		6	0032-0418	255.47	418.73	301	69.01	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			270.7	G08		6	0033-0426	394.41	426.17	186	53.46	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.5	G08		6	0034-0432	873.70	432.07	251	60.53	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			334.2	G08		6	0035-0454	596.99	454.12	299	82.91	0.547
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			293.9	G08		6	0036-0486	26.23	486.05	202	55.11	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			258.1	G08		6	0037-0513	579.88	512.79	289	64.53	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			243.1	G08		6	0038-0542	313.65	541.48	130	43.94	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			246.9	G08		6	0039-0546	303.22	547.24	144	45.11	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			325.8	G08		6	0040-0554	190.36	554.58	209	53.36	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			272.8	G08		6	0041-0567	183.14	566.73	172	51.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			234.0	G08		6	0042-0568	321.68	568.31	295	65.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			203.8	G08		6	0043-0582	382.57	582.43	275	67.70	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			249.0	G08		6	0044-0604	753.16	604.08	233	58.53	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			316.4	G08		6	0045-0611	859.18	611.21	210	59.36	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			257.1	G08		6	0046-0612	890.31	612.54	187	57.94	0.700
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			323.1	G08		6	0047-0614	613.01	614.72	215	56.87	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			215.9	G08		6	0048-0640	352.25	639.51	291	66.43	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			306.3	G08		6	0049-0646	575.91	645.49	232	59.60	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			285.1	G08		6	0050-0650	617.75	651.14	208	57.84	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			245.2	G08		6	0051-0653	123.89	653.61	205	60.53	0.703
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			279.6	G08		6	0052-0677	466.12	677.74	244	59.94	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			240.8	G08		6	0053-0686	593.53	685.73	205	59.94	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			262.1	G08		6	0054-0691	513.60	691.38	248	61.60	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			196.9	G08		6	0055-0700	351.11	699.46	279	62.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.8	G08		6	0056-0709	218.08	709.28	259	60.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			330.7	G08		6	0057-0709	832.68	709.43	206	58.28	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			328.4	G08		7	0001-0053	156.06	53.48	189	52.87	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			271.7	G08		7	0002-0055	530.23	55.22	234	56.87	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.9	G08		7	0003-0059	856.52	59.19	222	59.46	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			284.6	G08		7	0004-0066	818.80	66.19	139	61.60	0.460
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			287.9	G08		7	0005-0108	391.66	108.22	211	60.04	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			231.9	G08		7	0006-0106	876.52	106.30	260	62.77	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			350.7	G08		7	0007-0126	468.55	126.58	207	53.11	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			290.3	G08		7	0008-0146	857.50	145.91	227	61.60	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			338.2	G08		7	0009-0151	424.38	151.78	184	51.46	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			238.3	G08		7	0010-0155	165.33	155.02	235	60.53	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			246.2	G08		7	0011-0169	384.99	168.53	333	77.26	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			283.3	G08		7	0012-0218	214.01	218.13	266	65.01	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			238.4	G08		7	0013-0232	844.78	232.79	244	59.94	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			263.7	G08		7	0014-0246	70.36	245.62	187	57.01	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			389.7	G08		7	0015-0269	254.98	267.70	124	52.87	0.557
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			269.7	G08		7	0016-0278	542.09	277.90	194	55.01	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.3	G08		7	0017-0285	589.69	285.54	227	55.70	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			711.0	G08		7	0018-0295	792.60	296.21	261	62.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			228.6	G08		7	0019-0312	44.10	311.83	284	64.53	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			273.2	G08		7	0020-0310	581.07	310.05	230	59.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1468.2	G08		7	0021-0318	797.42	318.62	355	71.01	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			242.3	G08		7	0022-0320	20.50	319.46	217	56.28	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			243.1	G08		7	0023-0342	903.18	342.01	285	63.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			313.2	G08		7	0024-0346	432.50	346.92	216	56.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.7	G08		7	0025-0359	304.40	359.04	277	66.18	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			385.6	G08		7	0026-0385	226.98	385.39	107	39.46	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			230.9	G08		7	0027-0408	323.36	408.03	298	66.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			205.1	G08		7	0028-0414	130.61	414.08	313	71.50	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			266.2	G08		7	0029-0412	876.71	411.44	249	59.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			321.8	G08		7	0030-0415	227.08	415.55	205	57.01	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			318.8	G08		7	0031-0458	218.58	458.05	226	59.84	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			254.8	G08		7	0032-0465	900.13	464.79	272	63.01	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			357.7	G08		7	0033-0480	673.05	480.64	163	60.18	0.566
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			236.9	G08		7	0034-0483	154.74	483.15	141	46.87	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			290.0	G08		7	0035-0492	825.90	492.18	214	57.36	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			225.2	G08		7	0036-0494	159.32	495.01	131	49.46	0.673
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			380.3	G08		7	0037-0540	317.29	539.62	261	62.53	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			284.5	G08		7	0038-0537	118.17	537.42	196	57.36	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			281.4	G08		7	0039-0548	749.08	548.28	132	45.36	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.9	G08		7	0040-0555	541.81	554.98	291	65.26	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			247.5	G08		7	0041-0557	214.72	557.44	222	57.36	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			269.8	G08		7	0042-0555	735.78	555.98	120	42.28	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			244.0	G08		7	0043-0571	865.45	571.98	235	59.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			244.6	G08		7	0044-0581	458.87	581.32	299	65.26	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			265.4	G08		7	0045-0580	338.24	579.59	201	56.04	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			187.2	G08		7	0046-0584	557.07	584.80	257	61.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			253.9	G08		7	0047-0590	146.42	590.52	220	59.21	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			238.4	G08		7	0048-0590	379.40	589.54	316	66.67	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.4	G08		7	0049-0587	725.42	587.60	147	45.11	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			246.4	G08		7	0050-0596	715.02	597.07	151	46.87	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			446.9	G08		7	0051-0647	709.92	647.29	279	62.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.1	G08		7	0052-0649	283.27	650.15	195	53.94	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			267.2	G08		7	0053-0663	760.22	663.21	252	61.60	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			243.0	G08		7	0054-0665	58.61	665.53	298	63.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			264.9	G08		7	0055-0677	779.19	677.03	238	61.60	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			328.2	G08		7	0056-0692	383.49	691.93	179	49.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			253.1	G08		7	0057-0691	471.18	691.53	195	56.87	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			175.7	G08		8	0001-0031	936.98	31.62	278	65.60	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			242.7	G08		8	0002-0054	801.15	53.88	209	56.87	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.7	G08		8	0003-0061	843.75	61.43	216	66.04	0.622
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			230.1	G08		8	0004-0072	744.01	72.77	201	59.70	0.709
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			1476.0	G08		8	0005-0110	290.92	109.83	264	63.01	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			298.4	G08		8	0006-0124	868.05	124.44	204	55.36	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.0	G08		8	0007-0136	397.97	136.22	279	62.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			324.9	G08		8	0008-0157	297.33	157.19	199	51.11	0.957
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			246.6	G08		8	0009-0177	236.55	176.67	260	64.53	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			315.3	G08		8	0010-0177	353.95	177.55	204	52.28	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			236.8	G08		8	0011-0182	141.63	182.29	215	60.43	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			290.3	G08		8	0012-0184	417.53	184.50	266	63.84	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			326.1	G08		8	0013-0195	580.65	195.20	189	53.11	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			234.9	G08		8	0014-0207	918.96	206.97	220	55.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			263.3	G08		8	0015-0214	236.87	214.53	211	59.01	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			271.8	G08		8	0016-0241	897.47	241.14	199	55.36	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			270.2	G08		8	0017-0260	527.98	260.45	217	56.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			273.3	G08		8	0018-0264	450.21	263.65	272	63.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			241.7	G08		8	0019-0297	861.92	297.03	274	63.94	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			235.3	G08		8	0020-0298	714.96	298.45	291	64.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.9	G08		8	0021-0330	699.62	330.32	173	47.46	0.965
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			256.5	G08		8	0022-0334	721.44	334.50	230	69.26	0.603
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.0	G08		8	0023-0343	708.13	343.65	123	45.11	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.1	G08		8	0024-0356	95.62	357.04	246	59.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			205.3	G08		8	0025-0358	770.82	358.20	230	63.60	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			283.3	G08		8	0026-0376	353.60	378.03	264	77.26	0.556
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			262.5	G08		8	0027-0378	259.72	378.03	213	55.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			242.2	G08		8	0028-0380	688.59	380.85	231	62.77	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			218.5	G08		8	0029-0388	424.72	387.92	305	67.84	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			313.6	G08		8	0030-0393	795.82	392.83	329	69.36	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			265.3	G08		8	0031-0421	214.39	421.11	189	56.53	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			299.0	G08		8	0032-0423	584.17	423.57	283	64.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			272.4	G08		8	0033-0426	527.98	426.91	228	57.70	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			248.1	G08		8	0034-0431	469.27	430.90	295	64.53	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			279.4	G08		8	0035-0446	174.24	446.17	205	59.26	0.734
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			208.5	G08		8	0036-0465	93.35	465.85	268	64.18	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			304.0	G08		8	0037-0478	172.46	478.59	190	52.77	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			245.1	G08		8	0038-0478	451.26	478.26	172	50.18	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			277.0	G08		8	0039-0485	204.35	484.39	245	61.60	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			243.7	G08		8	0040-0493	109.12	493.18	278	65.94	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			240.9	G08		8	0041-0514	550.29	513.57	307	69.94	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			197.5	G08		8	0042-0513	707.35	513.93	288	62.18	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			214.7	G08		8	0043-0518	868.54	518.43	202	61.01	0.682
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			230.9	G08		8	0044-0518	406.70	519.39	142	45.21	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			249.8	G08		8	0045-0536	565.66	536.59	212	64.04	0.650
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			221.4	G08		8	0046-0533	407.92	532.20	168	48.63	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			268.5	G08		8	0047-0534	301.31	534.72	230	59.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			277.1	G08		8	0048-0548	192.92	547.90	260	61.36	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			197.1	G08		8	0049-0556	511.92	556.09	302	66.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			315.5	G08		8	0050-0566	299.97	566.75	193	53.60	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			203.5	G08		8	0051-0580	924.69	579.23	294	65.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			238.0	G08		8	0052-0589	270.62	588.33	268	63.11	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			236.4	G08		8	0053-0595	880.07	594.80	355	73.36	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			227.6	G08		8	0054-0610	218.90	609.47	260	67.84	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			279.9	G08		8	0055-0621	146.69	622.02	198	57.11	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			326.0	G08		8	0056-0621	290.70	621.09	249	60.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			242.5	G08		8	0057-0639	577.61	640.06	225	62.53	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			246.2	G08		8	0058-0657	135.73	657.10	210	61.70	0.693
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.5	G08		8	0059-0652	674.40	652.07	277	69.36	0.724
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			299.0	G08		8	0060-0666	415.93	666.00	171	55.11	0.707
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			278.9	G08		8	0061-0699	370.97	699.10	183	51.70	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			280.4	G08		8	0062-0701	133.33	701.42	195	51.70	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			285.2	G08		8	0063-0709	842.07	709.27	198	51.70	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			169.6	G08		9	0001-0034	31.77	34.33	273	65.01	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.7	G08		9	0002-0034	411.40	35.09	286	64.77	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			183.1	G08		9	0003-0040	489.21	39.94	280	65.84	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			232.6	G08		9	0004-0049	727.83	49.69	258	61.11	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			492.8	G08		9	0005-0071	43.56	71.40	286	64.28	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			364.4	G08		9	0006-0103	476.99	103.18	279	61.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			248.5	G08		9	0007-0106	354.74	106.26	246	59.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			239.9	G08		9	0008-0118	570.68	118.15	240	60.53	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			270.8	G08		9	0009-0145	347.01	145.15	199	53.11	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			303.7	G08		9	0010-0148	694.70	149.05	194	59.36	0.692
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			288.4	G08		9	0011-0150	125.25	150.20	225	59.46	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			257.5	G08		9	0012-0157	97.26	157.47	266	59.11	0.957
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			233.1	G08		9	0013-0183	323.97	183.54	246	61.60	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			242.6	G08		9	0014-0194	251.35	194.46	224	57.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			218.3	G08		9	0015-0206	858.14	205.90	261	62.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			237.9	G08		9	0016-0210	14.17	209.59	216	55.60	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			273.6	G08		9	0017-0211	377.37	210.79	172	54.04	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			287.9	G08		9	0018-0224	388.18	223.96	199	56.53	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			237.8	G08		9	0019-0235	80.57	235.54	201	56.18	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			288.1	G08		9	0020-0244	687.08	243.72	274	63.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			302.6	G08		9	0021-0246	299.45	245.54	343	72.43	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			258.5	G08		9	0022-0255	445.90	255.26	242	57.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			309.9	G08		9	0023-0268	478.14	267.59	245	58.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			262.9	G08		9	0024-0306	621.04	306.21	306	65.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			213.7	G08		9	0025-0336	263.52	336.65	255	77.50	0.534
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			220.5	G08		9	0026-0338	565.15	337.78	294	65.60	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			312.9	G08		9	0027-0352	423.01	352.32	230	57.36	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			304.3	G08		9	0028-0359	647.64	359.30	201	52.04	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			216.7	G08		9	0029-0366	121.04	366.56	347	72.08	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			246.1	G08		9	0030-0371	599.07	371.81	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.3	G08		9	0031-0392	112.90	392.27	302	70.18	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			347.2	G08		9	0032-0394	544.89	393.62	265	87.64	0.434
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			246.6	G08		9	0033-0396	427.88	397.25	206	56.77	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			212.7	G08		9	0034-0412	642.60	412.11	280	69.26	0.734
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			268.1	G08		9	0035-0416	462.97	416.38	197	60.28	0.681
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			260.9	G08		9	0036-0419	369.72	418.83	238	60.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			275.0	G08		9	0037-0428	443.00	427.25	275	64.77	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.0	G08		9	0038-0429	515.38	429.72	271	61.70	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			245.6	G08		9	0039-0440	364.69	440.16	252	61.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			291.1	G08		9	0040-0502	687.24	501.40	247	61.36	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			276.4	G08		9	0041-0505	670.84	506.14	206	54.63	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			223.7	G08		9	0042-0526	480.04	525.65	299	66.77	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			218.6	G08		9	0043-0560	241.00	560.24	284	66.77	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			179.1	G08		9	0044-0582	19.55	581.95	287	64.53	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			267.1	G08		9	0045-0581	306.88	581.25	226	58.18	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			219.8	G08		9	0046-0596	783.57	595.75	266	63.84	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			208.3	G08		9	0047-0601	698.86	601.44	250	62.53	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			186.9	G08		9	0048-0605	942.34	604.53	260	67.01	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			209.3	G08		9	0049-0613	300.09	612.81	325	66.43	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80005	S6 (pS235; pS236) / Alexa Fluor 647	80007	rabbit IgG(H+L) / goat / cross-adsorbed	Cy5	201298	S6 (pS235; pS236)			224.3	G08		9	0050-0664	878.63	665.31	280	63.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			547.5	B08		1	0001-0030	113.89	29.84	299	67.60	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			652.4	B08		1	0002-0029	168.91	28.72	294	66.18	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3702.7	B08		1	0003-0033	263.30	34.12	210	55.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1118.1	B08		1	0004-0039	463.46	39.70	310	65.36	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			932.0	B08		1	0005-0040	504.82	41.10	293	68.67	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			749.5	B08		1	0006-0040	720.01	40.44	289	75.74	0.633
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2189.5	B08		1	0007-0041	803.55	41.85	444	87.50	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1018.6	B08		1	0008-0042	418.82	41.04	267	61.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7159.1	B08		1	0009-0042	87.75	42.02	158	48.63	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1801.6	B08		1	0010-0045	289.33	45.56	376	71.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1042.6	B08		1	0011-0044	589.42	44.68	234	56.28	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3113.0	B08		1	0012-0045	693.34	45.35	223	54.87	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1074.3	B08		1	0013-0042	652.67	42.21	177	52.63	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1883.5	B08		1	0014-0047	771.72	47.09	254	59.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2048.6	B08		1	0015-0051	172.16	51.15	276	61.94	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1724.3	B08		1	0016-0050	534.61	50.03	323	66.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1695.7	B08		1	0017-0053	219.63	53.47	374	71.60	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2647.6	B08		1	0018-0052	134.85	52.43	234	56.53	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2660.7	B08		1	0019-0058	657.13	57.83	342	70.77	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2440.5	B08		1	0020-0061	258.75	61.24	390	73.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1591.7	B08		1	0021-0063	335.34	62.34	338	68.43	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1063.8	B08		1	0022-0062	630.45	62.65	266	64.28	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1019.8	B08		1	0023-0061	68.12	60.80	231	55.11	0.956
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2568.8	B08		1	0024-0069	569.59	69.83	433	81.26	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1414.1	B08		1	0025-0071	383.06	70.47	307	65.36	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1710.3	B08		1	0026-0072	533.10	71.85	285	67.60	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1216.3	B08		1	0027-0075	85.61	75.59	300	66.18	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			826.7	B08		1	0028-0072	179.49	71.47	229	60.28	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2411.2	B08		1	0029-0075	115.54	75.69	250	60.53	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			793.7	B08		1	0030-0081	364.92	80.88	146	47.46	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1332.5	B08		1	0031-0080	619.08	80.64	222	57.94	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1189.4	B08		1	0032-0081	759.36	80.85	245	58.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1156.9	B08		1	0033-0081	321.95	81.50	130	42.63	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1392.3	B08		1	0034-0088	460.95	87.74	314	66.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1235.2	B08		1	0035-0084	310.93	84.24	113	39.80	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			913.1	B08		1	0036-0090	175.85	90.55	267	61.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1379.3	B08		1	0037-0090	214.71	89.20	254	62.77	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2148.5	B08		1	0038-0092	424.90	91.91	289	65.01	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3129.7	B08		1	0039-0091	680.90	91.72	234	58.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			752.4	B08		1	0040-0094	944.76	95.13	265	65.01	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2453.5	B08		1	0041-0095	625.03	94.75	328	69.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1904.8	B08		1	0042-0103	829.16	103.44	270	62.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3527.8	B08		1	0043-0104	239.83	104.03	255	65.26	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3192.4	B08		1	0044-0104	882.82	104.11	328	67.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1378.7	B08		1	0045-0110	922.35	110.33	335	73.84	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			872.6	B08		1	0046-0109	293.74	110.26	248	62.77	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2257.3	B08		1	0047-0112	493.79	112.96	362	71.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3341.4	B08		1	0048-0114	778.16	114.52	464	84.43	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			835.4	B08		1	0049-0116	112.41	116.63	359	88.08	0.581
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			966.9	B08		1	0050-0116	259.31	115.12	221	56.77	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			653.7	B08		1	0051-0116	647.23	117.24	258	60.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			934.4	B08		1	0052-0117	677.05	116.66	246	60.77	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3808.8	B08		1	0053-0121	836.66	121.20	367	74.18	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2548.3	B08		1	0054-0122	164.49	121.49	263	63.01	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			836.0	B08		1	0055-0120	281.99	120.20	154	46.53	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2483.1	B08		1	0056-0125	949.09	125.05	224	54.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2507.9	B08		1	0057-0128	199.33	128.54	327	68.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2280.6	B08		1	0058-0126	268.66	127.47	256	63.50	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			853.7	B08		1	0059-0129	408.85	128.58	321	73.50	0.747
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2198.9	B08		1	0060-0132	426.69	132.76	233	57.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1228.0	B08		1	0061-0136	630.94	135.58	383	73.94	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1755.3	B08		1	0062-0137	26.05	136.99	233	57.60	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			598.9	B08		1	0063-0137	373.17	137.60	319	72.91	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2918.8	B08		1	0064-0139	329.68	138.96	328	66.18	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4024.0	B08		1	0065-0140	731.73	139.63	294	63.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1869.4	B08		1	0066-0148	178.70	148.16	375	71.84	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1733.1	B08		1	0067-0146	940.07	145.73	218	55.36	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1285.2	B08		1	0068-0149	527.48	149.03	352	71.60	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1827.3	B08		1	0069-0149	37.87	149.11	235	57.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1734.2	B08		1	0070-0150	469.38	149.40	312	67.11	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1080.1	B08		1	0071-0150	596.87	150.27	252	60.53	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			747.9	B08		1	0072-0152	796.78	151.98	299	66.18	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2016.6	B08		1	0073-0159	225.58	157.45	570	99.74	0.720
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1122.0	B08		1	0074-0155	282.20	154.87	260	62.18	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4274.6	B08		1	0075-0157	632.64	157.02	313	76.43	0.673
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2874.3	B08		1	0076-0158	153.69	157.45	204	55.70	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1660.6	B08		1	0077-0163	328.00	163.42	260	61.01	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2043.0	B08		1	0078-0163	125.94	162.81	221	58.77	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			966.7	B08		1	0079-0165	582.66	164.81	259	59.01	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3966.8	B08		1	0080-0168	806.15	168.59	186	50.28	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2400.5	B08		1	0081-0173	353.97	173.37	375	73.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2817.1	B08		1	0082-0176	393.44	175.46	308	66.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2240.8	B08		1	0083-0181	81.01	179.70	679	108.81	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1622.3	B08		1	0084-0181	37.82	180.94	317	68.67	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			589.9	B08		1	0085-0183	495.13	183.84	242	61.11	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3250.5	B08		1	0086-0186	183.20	185.11	281	70.77	0.705
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2560.4	B08		1	0087-0183	529.17	183.34	292	66.77	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5776.7	B08		1	0088-0188	592.87	187.56	324	71.26	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1288.3	B08		1	0089-0188	151.31	188.09	239	63.01	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1281.8	B08		1	0090-0186	472.32	186.20	273	62.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3369.8	B08		1	0091-0190	645.42	190.40	355	72.77	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1888.0	B08		1	0092-0189	740.53	189.40	262	61.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3805.3	B08		1	0093-0189	916.61	189.99	213	55.94	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5976.5	B08		1	0094-0199	661.63	199.51	212	54.53	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1650.0	B08		1	0095-0202	325.65	202.00	219	55.36	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3630.4	B08		1	0096-0203	781.21	202.87	198	52.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2448.5	B08		1	0097-0207	126.70	206.94	259	64.43	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1027.7	B08		1	0098-0208	842.96	208.21	277	62.53	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4378.7	B08		1	0099-0207	893.22	207.79	217	56.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1508.3	B08		1	0100-0211	47.78	209.92	245	71.84	0.597
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2317.8	B08		1	0101-0214	541.25	215.01	299	63.94	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3010.7	B08		1	0102-0214	757.81	214.78	388	73.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2287.3	B08		1	0103-0216	410.24	216.66	161	46.77	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			585.3	B08		1	0104-0223	491.65	222.90	275	63.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6316.1	B08		1	0105-0224	660.52	224.84	193	55.70	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			945.1	B08		1	0106-0227	19.25	227.66	223	54.77	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1408.3	B08		1	0107-0228	641.43	228.26	277	63.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			913.8	B08		1	0108-0230	932.04	229.58	285	68.67	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2671.0	B08		1	0109-0231	142.62	231.60	386	74.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1832.8	B08		1	0110-0230	561.73	229.80	229	55.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1118.3	B08		1	0111-0232	381.62	230.95	268	61.11	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2256.0	B08		1	0112-0230	462.01	230.23	249	61.11	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5147.8	B08		1	0113-0233	211.55	233.28	153	48.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4520.6	B08		1	0114-0243	589.35	243.57	309	68.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4294.9	B08		1	0115-0246	199.44	247.53	276	74.43	0.626
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2318.6	B08		1	0116-0244	317.01	244.90	203	53.11	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1369.3	B08		1	0117-0248	76.81	248.53	326	67.01	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1937.3	B08		1	0118-0247	524.13	246.74	325	66.18	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			987.5	B08		1	0119-0247	711.89	247.02	255	60.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2328.6	B08		1	0120-0248	409.52	248.96	336	67.60	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2242.9	B08		1	0121-0249	739.54	249.33	291	62.18	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			707.3	B08		1	0122-0250	840.18	251.21	283	64.43	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			805.8	B08		1	0123-0247	102.44	248.22	225	58.28	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3034.2	B08		1	0124-0252	47.31	252.01	327	67.26	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1864.1	B08		1	0125-0251	779.24	251.24	413	77.84	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1701.3	B08		1	0126-0257	151.50	256.98	248	61.36	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2041.0	B08		1	0127-0260	804.47	259.44	328	74.18	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3332.7	B08		1	0128-0261	359.21	260.93	227	57.94	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1103.7	B08		1	0129-0264	229.84	263.90	281	63.94	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1060.1	B08		1	0130-0263	576.99	262.76	251	59.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4928.3	B08		1	0131-0263	342.33	262.78	170	48.28	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1881.9	B08		1	0132-0265	453.23	264.74	269	63.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1030.9	B08		1	0133-0267	184.02	266.99	243	60.53	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2078.7	B08		1	0134-0271	400.65	271.07	303	64.43	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4356.9	B08		1	0135-0282	715.90	282.51	614	104.57	0.706
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			868.9	B08		1	0136-0278	136.40	278.88	316	67.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1704.1	B08		1	0137-0276	499.36	276.36	316	67.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			720.0	B08		1	0138-0278	325.49	278.13	242	57.11	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2771.3	B08		1	0139-0279	115.90	278.85	204	52.53	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			944.8	B08		1	0140-0280	248.03	279.94	274	63.70	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2981.2	B08		1	0141-0280	233.47	280.45	153	47.56	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1388.3	B08		1	0142-0283	831.39	284.12	232	58.77	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1343.1	B08		1	0143-0289	784.07	289.05	364	71.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1140.0	B08		1	0144-0285	871.41	284.96	211	56.04	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			589.3	B08		1	0145-0290	63.79	289.94	259	61.94	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			803.7	B08		1	0146-0294	198.94	293.80	275	68.77	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2593.6	B08		1	0147-0295	251.29	295.72	194	54.53	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1310.8	B08		1	0148-0293	442.69	293.36	247	58.28	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2724.2	B08		1	0149-0295	947.72	294.55	176	50.18	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1862.0	B08		1	0150-0299	539.19	299.01	298	64.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4060.0	B08		1	0151-0299	361.35	299.51	251	57.70	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			952.7	B08		1	0152-0298	577.27	297.82	248	60.53	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2987.9	B08		1	0153-0300	153.20	300.76	218	54.53	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2036.5	B08		1	0154-0304	861.89	303.83	366	74.53	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2941.5	B08		1	0155-0308	69.46	309.04	291	69.60	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1835.9	B08		1	0156-0307	940.82	307.36	244	61.60	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6007.8	B08		1	0157-0306	775.28	306.47	235	57.60	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2351.7	B08		1	0158-0309	925.21	309.35	226	56.28	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1325.3	B08		1	0159-0309	318.39	309.17	272	61.36	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3847.9	B08		1	0160-0314	651.65	313.60	420	79.50	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1390.8	B08		1	0161-0312	467.93	312.35	213	54.28	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2243.7	B08		1	0162-0317	437.95	317.77	267	64.53	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			849.5	B08		1	0163-0318	698.19	319.21	278	66.53	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2514.1	B08		1	0164-0322	42.02	322.21	328	67.94	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7325.6	B08		1	0165-0320	770.32	320.36	168	53.36	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1903.6	B08		1	0166-0327	754.43	327.63	324	66.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			697.6	B08		1	0167-0326	246.13	326.12	244	58.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1782.2	B08		1	0168-0330	596.47	330.76	289	65.60	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2237.4	B08		1	0169-0330	195.74	329.79	222	56.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4075.0	B08		1	0170-0331	512.72	332.12	223	57.11	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			652.8	B08		1	0171-0336	874.34	337.08	218	56.77	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1949.7	B08		1	0172-0340	922.60	340.37	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2634.6	B08		1	0173-0341	99.15	341.72	292	64.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2440.8	B08		1	0174-0341	120.32	340.55	219	53.11	0.976
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1027.0	B08		1	0175-0342	317.87	341.87	240	57.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3088.7	B08		1	0176-0344	477.32	345.31	233	58.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3392.0	B08		1	0177-0343	360.24	343.09	266	60.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1696.1	B08		1	0178-0348	187.38	348.07	297	64.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1272.5	B08		1	0179-0347	401.52	347.12	252	62.18	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2407.6	B08		1	0180-0348	451.21	348.03	240	59.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3030.9	B08		1	0181-0350	819.68	350.80	359	70.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			847.9	B08		1	0182-0357	235.83	357.38	253	60.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2131.3	B08		1	0183-0356	496.35	355.69	222	57.36	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1895.6	B08		1	0184-0358	158.02	357.54	284	62.43	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			420.6	B08		1	0185-0357	671.00	357.74	234	55.94	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2474.5	B08		1	0186-0359	721.04	359.92	342	71.84	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			870.8	B08		1	0187-0360	752.93	360.36	252	59.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3025.3	B08		1	0188-0365	470.68	365.36	211	57.36	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2661.6	B08		1	0189-0369	836.38	369.52	373	72.53	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1729.1	B08		1	0190-0368	510.44	367.95	374	72.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			904.2	B08		1	0191-0368	29.10	368.35	287	63.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2172.6	B08		1	0192-0368	85.72	368.45	306	65.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1207.0	B08		1	0193-0369	285.20	368.86	294	63.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5094.3	B08		1	0194-0369	644.13	368.90	224	53.70	0.976
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			647.3	B08		1	0195-0371	882.48	372.11	301	84.08	0.535
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4530.2	B08		1	0196-0372	342.42	372.83	297	62.43	0.958
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1055.1	B08		1	0197-0377	903.49	377.77	282	62.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2331.5	B08		1	0198-0382	236.02	382.05	232	61.01	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1469.5	B08		1	0199-0381	465.07	380.93	279	62.18	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1312.8	B08		1	0200-0382	422.53	381.58	245	57.01	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			851.5	B08		1	0201-0384	59.38	384.08	255	60.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			798.6	B08		1	0202-0382	204.75	382.54	279	65.60	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4676.5	B08		1	0203-0384	656.24	384.72	261	60.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1452.4	B08		1	0204-0387	568.05	386.72	328	69.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1384.5	B08		1	0205-0391	518.32	391.39	283	61.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2376.6	B08		1	0206-0390	169.49	389.75	206	54.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			902.4	B08		1	0207-0395	261.77	395.35	279	63.60	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3583.2	B08		1	0208-0395	803.93	394.56	282	63.94	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			825.3	B08		1	0209-0397	83.60	397.43	279	63.36	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1668.6	B08		1	0210-0404	36.94	403.87	278	63.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1278.8	B08		1	0211-0407	730.02	407.84	315	66.18	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			567.8	B08		1	0212-0408	843.73	407.57	293	64.18	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			785.6	B08		1	0213-0410	440.38	410.24	296	63.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			427.4	B08		1	0214-0410	550.82	411.36	275	66.43	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1628.4	B08		1	0215-0413	243.15	413.15	243	60.18	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1067.4	B08		1	0216-0413	516.77	413.09	281	62.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1295.7	B08		1	0217-0413	808.27	412.54	221	53.94	0.954
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1254.5	B08		1	0218-0414	919.87	414.30	185	55.60	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1068.0	B08		1	0219-0416	79.17	416.04	377	71.94	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			762.2	B08		1	0220-0418	163.55	418.03	252	61.36	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1792.9	B08		1	0221-0421	785.55	421.04	344	69.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			895.8	B08		1	0222-0422	409.14	422.85	249	63.01	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3240.4	B08		1	0223-0423	497.98	423.57	253	59.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2391.3	B08		1	0224-0424	532.48	424.18	237	58.04	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1834.5	B08		1	0225-0424	26.41	423.48	304	69.01	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5827.4	B08		1	0226-0426	354.97	425.99	314	67.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1060.7	B08		1	0227-0423	871.09	422.31	179	50.87	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			810.1	B08		1	0228-0427	250.22	427.44	230	57.70	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			479.3	B08		1	0229-0430	206.78	429.65	150	48.28	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1292.3	B08		1	0230-0433	719.33	433.69	222	55.70	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3073.6	B08		1	0231-0434	267.33	434.36	214	54.28	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3446.8	B08		1	0232-0437	480.58	437.58	240	60.18	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1050.8	B08		1	0233-0440	939.21	439.67	353	68.18	0.954
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4395.3	B08		1	0234-0439	609.39	439.19	305	65.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2140.0	B08		1	0235-0441	87.56	441.59	397	78.77	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2301.0	B08		1	0236-0444	313.31	444.10	226	55.60	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5254.0	B08		1	0237-0449	566.89	449.14	471	87.74	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2054.5	B08		1	0238-0447	895.02	446.89	305	64.18	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1716.4	B08		1	0239-0451	447.93	451.30	249	59.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1914.2	B08		1	0240-0452	203.76	451.83	338	69.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2647.3	B08		1	0241-0452	707.34	452.53	248	58.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1714.6	B08		1	0242-0455	138.82	455.82	272	61.11	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			785.1	B08		1	0243-0455	169.80	454.52	249	57.94	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2830.7	B08		1	0244-0455	764.11	454.42	229	57.60	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2279.4	B08		1	0245-0460	338.08	460.12	261	59.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2374.3	B08		1	0246-0458	522.70	457.57	260	71.36	0.642
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1369.7	B08		1	0247-0462	684.36	462.23	245	58.53	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			8285.6	B08		1	0248-0461	929.63	463.41	105	54.28	0.448
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3919.9	B08		1	0249-0463	266.08	463.29	234	56.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2040.0	B08		1	0250-0462	371.30	462.35	222	54.28	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1296.7	B08		1	0251-0465	192.92	465.25	236	56.77	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1004.9	B08		1	0252-0469	19.74	469.00	232	58.18	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1007.3	B08		1	0253-0468	56.76	468.68	245	59.70	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2798.7	B08		1	0254-0473	454.50	473.71	359	71.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			599.6	B08		1	0255-0471	784.17	470.63	284	63.01	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1988.2	B08		1	0256-0471	889.75	471.18	283	62.28	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			8197.6	B08		1	0257-0476	110.21	476.73	284	80.67	0.548
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2420.6	B08		1	0258-0477	231.35	477.52	324	67.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1141.0	B08		1	0259-0477	939.35	477.30	305	64.18	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4043.3	B08		1	0260-0489	638.05	489.37	596	101.64	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3649.8	B08		1	0261-0485	756.79	486.02	376	71.84	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1120.4	B08		1	0262-0487	288.53	487.51	264	65.01	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			468.3	B08		1	0263-0486	314.59	485.45	245	59.94	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			855.7	B08		1	0264-0485	553.80	484.53	283	67.36	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1400.7	B08		1	0265-0484	369.54	483.67	268	64.28	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2386.2	B08		1	0266-0491	519.97	491.55	338	72.67	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2580.3	B08		1	0267-0497	99.83	497.16	370	71.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2333.5	B08		1	0268-0498	409.74	499.31	354	71.01	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			745.0	B08		1	0269-0498	872.62	499.24	184	54.18	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			580.4	B08		1	0270-0500	148.78	500.06	228	57.36	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1366.5	B08		1	0271-0503	468.71	503.63	320	68.43	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1336.4	B08		1	0272-0503	77.11	502.93	272	61.11	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1042.1	B08		1	0273-0505	268.93	504.90	270	68.43	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1959.5	B08		1	0274-0509	305.30	509.88	233	57.94	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1645.9	B08		1	0275-0517	207.07	517.49	344	71.01	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1079.9	B08		1	0276-0519	598.46	519.13	290	66.43	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			725.4	B08		1	0277-0518	854.85	517.24	228	61.11	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2035.5	B08		1	0278-0521	933.70	520.66	393	76.43	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			802.5	B08		1	0279-0520	166.61	520.71	241	58.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1681.2	B08		1	0280-0521	238.19	521.80	373	71.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1729.0	B08		1	0281-0521	411.27	521.04	435	79.26	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			776.1	B08		1	0282-0526	563.97	525.63	293	69.01	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			727.1	B08		1	0283-0522	34.32	522.15	220	58.77	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			449.1	B08		1	0284-0523	332.36	523.14	263	59.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1114.6	B08		1	0285-0523	894.77	523.05	222	57.94	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1650.9	B08		1	0286-0527	122.79	526.75	271	60.53	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2442.0	B08		1	0287-0530	535.34	531.28	286	74.67	0.645
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1899.7	B08		1	0288-0525	792.52	525.08	151	48.53	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1033.7	B08		1	0289-0529	377.36	529.29	221	54.53	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			624.6	B08		1	0290-0532	22.59	531.68	118	40.63	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4814.5	B08		1	0291-0534	849.54	533.57	281	64.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1712.0	B08		1	0292-0538	758.80	536.71	288	66.18	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2053.6	B08		1	0293-0538	190.19	539.06	304	68.43	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1125.0	B08		1	0294-0538	155.18	538.33	266	59.94	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1406.2	B08		1	0295-0540	274.52	540.55	302	67.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2048.8	B08		1	0296-0539	584.34	539.26	237	58.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			609.1	B08		1	0297-0541	34.95	541.02	186	53.11	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1577.9	B08		1	0298-0540	246.64	540.12	226	56.28	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1752.5	B08		1	0299-0540	619.66	540.31	228	56.28	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1996.2	B08		1	0300-0546	430.62	546.55	216	53.70	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			942.9	B08		1	0301-0550	48.08	551.22	273	61.11	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4278.2	B08		1	0302-0555	646.66	554.99	394	76.43	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1945.8	B08		1	0303-0551	880.94	551.27	291	63.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5666.7	B08		1	0304-0553	813.38	553.13	188	52.53	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1773.1	B08		1	0305-0557	216.26	557.91	246	60.53	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2018.0	B08		1	0306-0557	115.55	556.04	350	73.01	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			512.6	B08		1	0307-0557	241.89	557.57	344	69.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1862.6	B08		1	0308-0559	407.13	559.18	323	69.01	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1539.6	B08		1	0309-0560	168.93	559.78	333	71.50	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			562.6	B08		1	0310-0556	922.23	556.72	246	58.87	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1178.2	B08		1	0311-0559	458.31	559.38	200	54.53	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2655.7	B08		1	0312-0561	942.12	561.30	280	61.70	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2785.0	B08		1	0313-0565	523.32	564.27	301	67.94	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1595.5	B08		1	0314-0566	762.34	565.33	293	71.50	0.720
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3487.3	B08		1	0315-0564	798.47	565.28	374	85.84	0.638
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1856.9	B08		1	0316-0567	437.78	566.43	249	59.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1916.9	B08		1	0317-0573	192.43	574.30	411	84.33	0.726
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1367.8	B08		1	0318-0569	601.57	568.93	289	69.26	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			736.4	B08		1	0319-0570	381.08	570.75	320	65.60	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1357.0	B08		1	0320-0576	233.09	576.66	252	63.36	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3112.0	B08		1	0321-0575	697.19	575.95	224	56.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2508.3	B08		1	0322-0580	545.77	580.03	344	71.60	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2066.4	B08		1	0323-0577	251.94	576.50	225	55.36	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			688.0	B08		1	0324-0581	58.38	582.52	240	63.60	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			585.2	B08		1	0325-0583	630.98	583.13	273	65.01	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2857.5	B08		1	0326-0585	565.54	585.96	451	83.01	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			385.9	B08		1	0327-0581	463.23	580.17	265	65.11	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2271.8	B08		1	0328-0585	265.66	585.19	263	65.01	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1341.3	B08		1	0329-0588	28.86	587.78	250	61.26	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2370.4	B08		1	0330-0593	115.61	594.13	357	70.18	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1404.7	B08		1	0331-0591	593.95	590.81	268	66.67	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2791.6	B08		1	0332-0591	143.19	591.45	241	57.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1397.2	B08		1	0333-0592	225.25	592.21	260	62.53	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1062.2	B08		1	0334-0594	384.87	594.79	297	66.18	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3239.5	B08		1	0335-0597	284.93	597.01	365	71.26	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			945.0	B08		1	0336-0594	674.84	594.10	229	56.53	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1774.9	B08		1	0337-0592	712.12	592.96	178	51.21	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			785.9	B08		1	0338-0605	414.43	604.17	293	66.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1623.9	B08		1	0339-0605	806.30	605.10	223	55.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1007.0	B08		1	0340-0607	592.13	607.88	231	55.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2429.6	B08		1	0341-0609	744.09	608.82	287	62.77	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			424.5	B08		1	0342-0611	273.89	611.90	251	60.77	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1164.0	B08		1	0343-0612	849.76	611.86	288	65.01	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3778.3	B08		1	0344-0613	153.75	612.82	195	55.36	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1221.8	B08		1	0345-0614	302.75	614.32	232	55.70	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			899.0	B08		1	0346-0616	76.07	616.27	260	59.94	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3831.2	B08		1	0347-0618	198.86	617.72	200	57.60	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3238.3	B08		1	0348-0616	901.75	616.17	251	59.94	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			924.8	B08		1	0349-0620	479.57	620.33	262	63.01	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2861.6	B08		1	0350-0619	681.57	619.71	274	61.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1446.4	B08		1	0351-0623	362.48	623.47	330	71.36	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2045.7	B08		1	0352-0630	892.17	629.37	254	61.01	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			637.4	B08		1	0353-0630	162.83	629.67	272	62.53	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1048.1	B08		1	0354-0629	806.37	629.13	187	53.70	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			9584.2	B08		1	0355-0635	848.75	635.77	360	72.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1448.6	B08		1	0356-0634	489.75	634.91	317	71.84	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2139.7	B08		1	0357-0634	93.78	634.92	259	59.60	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2374.3	B08		1	0358-0636	243.32	636.51	374	72.67	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1737.1	B08		1	0359-0638	562.17	638.24	302	63.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			972.1	B08		1	0360-0642	508.02	640.75	239	59.60	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1949.3	B08		1	0361-0644	63.05	643.58	112	40.28	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1111.7	B08		1	0362-0644	693.93	644.85	228	56.87	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2681.2	B08		1	0363-0647	734.79	647.28	278	62.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3143.7	B08		1	0364-0650	783.99	651.00	192	58.53	0.704
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			660.0	B08		1	0365-0650	313.67	650.57	254	60.77	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			710.1	B08		1	0366-0649	401.23	648.55	262	61.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1778.1	B08		1	0367-0653	199.09	653.50	315	65.60	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1663.4	B08		1	0368-0653	447.88	652.57	345	68.77	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1789.0	B08		1	0369-0651	74.63	651.70	142	47.11	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1500.9	B08		1	0370-0663	237.20	663.32	593	97.98	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			843.1	B08		1	0371-0654	359.27	653.72	266	61.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			936.2	B08		1	0372-0659	46.25	659.41	273	61.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1814.1	B08		1	0373-0661	180.10	661.22	361	70.43	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2018.1	B08		1	0374-0661	327.81	660.85	284	63.01	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2056.7	B08		1	0375-0662	546.66	662.74	419	79.01	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1927.4	B08		1	0376-0664	121.03	664.38	276	64.18	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1606.5	B08		1	0377-0664	659.96	664.11	233	56.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3640.8	B08		1	0378-0665	939.18	664.58	280	64.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2357.9	B08		1	0379-0673	144.32	672.28	278	65.01	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3968.7	B08		1	0380-0675	705.98	673.83	168	59.94	0.588
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2093.7	B08		1	0381-0680	166.68	679.72	399	75.84	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1572.9	B08		1	0382-0679	285.98	678.49	255	61.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			753.1	B08		1	0383-0685	536.72	684.90	266	62.53	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2845.3	B08		1	0384-0684	365.64	683.42	216	57.36	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1209.1	B08		1	0385-0685	615.32	684.80	227	56.28	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			725.9	B08		1	0386-0686	309.17	686.79	228	56.28	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4064.2	B08		1	0387-0688	428.60	688.45	236	58.53	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5235.2	B08		1	0388-0688	264.40	688.51	320	67.11	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4227.3	B08		1	0389-0693	352.59	693.35	387	80.91	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5571.5	B08		1	0390-0688	916.93	687.99	140	47.11	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3745.8	B08		1	0391-0691	104.52	691.01	261	62.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3654.1	B08		1	0392-0693	133.18	692.16	261	63.70	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2672.5	B08		1	0393-0693	653.79	693.70	266	61.60	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5685.1	B08		1	0394-0693	720.47	693.60	320	65.84	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2309.0	B08		1	0395-0697	50.81	697.15	422	77.26	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3550.1	B08		1	0396-0697	878.17	697.43	330	67.01	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4416.7	B08		1	0397-0697	926.54	697.25	159	47.70	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1705.3	B08		1	0398-0698	944.56	697.57	170	51.11	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			953.6	B08		1	0399-0703	691.43	704.31	281	67.26	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1109.8	B08		1	0400-0706	315.64	706.08	250	63.01	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			779.9	B08		1	0401-0708	492.58	708.06	259	65.01	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4136.1	B08		1	0402-0710	415.79	710.17	212	52.87	0.953
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1416.2	B08		1	0403-0710	233.22	710.48	313	67.11	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2049.7	B08		2	0001-0029	259.68	29.83	527	96.57	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1849.4	B08		2	0002-0033	541.09	33.64	296	71.01	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			757.2	B08		2	0003-0034	151.54	34.40	223	55.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3672.6	B08		2	0004-0036	220.81	37.59	352	74.67	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1566.1	B08		2	0005-0036	793.54	36.16	268	61.11	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			613.6	B08		2	0006-0036	936.35	36.88	247	59.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2483.0	B08		2	0007-0038	126.12	39.14	253	58.53	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6057.0	B08		2	0008-0039	584.93	39.38	349	71.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			695.9	B08		2	0009-0042	767.09	42.65	281	62.53	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			675.2	B08		2	0010-0042	828.89	42.74	279	65.60	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			775.0	B08		2	0011-0049	53.05	49.74	437	85.26	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3322.0	B08		2	0012-0047	919.83	46.92	347	72.08	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3486.2	B08		2	0013-0046	639.79	45.79	330	68.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2333.7	B08		2	0014-0047	96.27	48.60	394	79.26	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3203.5	B08		2	0015-0048	735.18	48.81	336	69.01	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1890.8	B08		2	0016-0061	412.86	62.80	586	130.95	0.429
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			653.2	B08		2	0017-0052	199.96	51.48	256	60.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1051.2	B08		2	0018-0058	900.74	58.85	226	57.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			712.8	B08		2	0019-0060	248.56	59.83	237	58.87	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1714.7	B08		2	0020-0067	388.09	66.98	509	92.33	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			872.0	B08		2	0021-0062	828.67	62.91	291	70.18	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2522.4	B08		2	0022-0068	511.07	68.64	316	64.53	0.954
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3068.1	B08		2	0023-0071	734.71	70.64	328	67.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2050.6	B08		2	0024-0068	932.37	68.17	302	64.53	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1766.3	B08		2	0025-0072	673.71	72.26	200	52.53	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2200.0	B08		2	0026-0078	847.67	78.25	315	66.18	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1740.1	B08		2	0027-0081	341.98	81.08	352	81.84	0.660
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2170.6	B08		2	0028-0086	225.89	85.71	231	56.53	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1223.3	B08		2	0029-0093	68.18	93.30	308	80.08	0.603
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3265.6	B08		2	0030-0090	920.38	89.70	417	77.50	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1368.9	B08		2	0031-0089	162.29	89.72	246	60.43	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3323.9	B08		2	0032-0093	563.27	93.05	241	57.70	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4160.3	B08		2	0033-0096	697.39	95.95	324	66.43	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			738.2	B08		2	0034-0098	37.60	98.62	268	66.18	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2529.1	B08		2	0035-0097	782.11	98.03	395	73.26	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1160.8	B08		2	0036-0095	830.61	94.67	292	64.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			376.0	B08		2	0037-0095	141.99	95.57	298	73.26	0.698
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2082.5	B08		2	0038-0097	604.69	97.28	212	55.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			299.9	B08		2	0039-0102	647.74	101.72	272	61.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1935.0	B08		2	0040-0105	174.15	103.92	313	73.50	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1078.4	B08		2	0041-0104	294.08	103.98	338	70.18	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1178.6	B08		2	0042-0104	885.71	105.02	275	63.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2206.4	B08		2	0043-0114	713.14	113.75	286	61.94	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1126.9	B08		2	0044-0114	828.93	114.14	248	58.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1789.5	B08		2	0045-0119	450.89	118.43	288	67.01	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			369.6	B08		2	0046-0122	931.96	121.35	274	80.57	0.530
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2205.9	B08		2	0047-0123	516.32	123.01	286	63.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1683.1	B08		2	0048-0122	563.25	122.04	263	59.11	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1817.4	B08		2	0049-0128	97.77	128.00	262	60.53	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2555.6	B08		2	0050-0129	42.10	128.79	231	55.36	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			912.9	B08		2	0051-0128	207.62	128.42	259	59.60	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2600.1	B08		2	0052-0133	604.70	133.19	360	70.43	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			930.9	B08		2	0053-0130	759.25	130.71	251	58.18	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3405.6	B08		2	0054-0136	72.94	136.44	208	54.28	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2013.5	B08		2	0055-0137	550.32	136.78	274	61.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5624.2	B08		2	0056-0137	777.44	137.14	222	55.11	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5988.7	B08		2	0057-0137	794.18	136.40	218	53.70	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3908.5	B08		2	0058-0145	727.37	145.32	444	78.18	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1683.0	B08		2	0059-0142	874.27	142.34	224	55.36	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1232.1	B08		2	0060-0144	934.42	143.85	249	58.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2104.4	B08		2	0061-0148	155.76	148.52	292	65.84	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1809.2	B08		2	0062-0149	33.25	149.15	222	54.77	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			932.0	B08		2	0063-0150	106.39	149.81	237	57.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1249.5	B08		2	0064-0155	200.80	155.72	393	73.60	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1773.6	B08		2	0065-0155	471.21	154.30	254	59.01	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2159.4	B08		2	0066-0154	558.32	154.44	292	63.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2929.4	B08		2	0067-0154	254.47	153.92	308	67.36	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2639.6	B08		2	0068-0160	620.04	160.01	404	74.43	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3583.6	B08		2	0069-0164	917.28	164.36	356	70.43	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2294.4	B08		2	0070-0164	175.67	164.23	215	55.36	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3785.7	B08		2	0071-0167	665.68	166.85	405	73.94	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2375.5	B08		2	0072-0167	497.26	168.27	252	60.53	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4130.7	B08		2	0073-0168	67.29	167.45	226	57.70	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1910.9	B08		2	0074-0170	262.45	170.60	324	66.18	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5714.5	B08		2	0075-0172	753.94	172.38	431	78.91	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1132.3	B08		2	0076-0173	146.52	173.59	272	67.01	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3053.7	B08		2	0077-0178	596.57	178.25	306	65.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3934.8	B08		2	0078-0182	240.50	181.00	298	71.26	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1023.6	B08		2	0079-0182	734.11	182.39	234	58.53	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1783.4	B08		2	0080-0185	187.08	185.78	241	57.70	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1071.3	B08		2	0081-0186	122.92	186.07	343	74.67	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2499.1	B08		2	0082-0188	225.70	188.67	261	62.53	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2419.1	B08		2	0083-0191	677.56	192.15	364	71.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2333.3	B08		2	0084-0189	840.43	189.39	214	53.94	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4274.0	B08		2	0085-0194	563.06	194.27	385	72.18	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5110.5	B08		2	0086-0199	890.42	197.48	769	109.64	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3077.9	B08		2	0087-0193	258.30	193.27	200	52.77	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2911.1	B08		2	0088-0195	501.35	195.42	397	73.84	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3330.2	B08		2	0089-0203	329.23	203.08	327	67.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1182.4	B08		2	0090-0201	414.67	201.15	261	61.11	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1363.0	B08		2	0091-0203	943.10	202.94	298	63.36	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1690.7	B08		2	0092-0208	723.00	207.81	312	66.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			730.2	B08		2	0093-0208	386.86	207.98	248	58.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			8324.9	B08		2	0094-0215	917.90	216.26	350	78.43	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2399.6	B08		2	0095-0213	164.52	213.57	360	71.01	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3100.2	B08		2	0096-0210	456.56	209.86	212	53.60	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3132.3	B08		2	0097-0211	269.62	210.63	212	55.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1565.5	B08		2	0098-0211	832.42	210.58	239	59.70	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4079.5	B08		2	0099-0217	693.56	217.43	398	75.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2829.0	B08		2	0100-0214	756.57	214.54	358	71.01	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1978.2	B08		2	0101-0219	443.84	218.95	289	65.60	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2339.1	B08		2	0102-0222	496.94	222.16	260	62.77	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3732.9	B08		2	0103-0228	869.43	228.89	429	80.91	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			920.6	B08		2	0104-0228	674.85	228.32	255	59.94	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			839.6	B08		2	0105-0234	25.12	233.33	292	68.43	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4729.1	B08		2	0106-0234	179.97	233.59	273	62.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			8695.7	B08		2	0107-0231	759.55	230.71	145	45.56	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			9101.2	B08		2	0108-0232	746.58	232.09	152	44.63	0.959
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1819.0	B08		2	0109-0240	201.34	240.69	354	69.60	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1234.5	B08		2	0110-0242	934.14	243.11	233	57.70	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			743.9	B08		2	0111-0246	816.39	245.60	275	63.84	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4116.8	B08		2	0112-0247	365.66	247.19	372	74.91	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1694.9	B08		2	0113-0249	780.40	249.74	260	63.01	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2862.5	B08		2	0114-0249	297.44	249.34	298	63.36	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3004.7	B08		2	0115-0256	481.04	256.10	403	83.74	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1067.4	B08		2	0116-0254	250.33	253.89	294	62.18	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2627.3	B08		2	0117-0253	66.16	253.85	295	64.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2459.3	B08		2	0118-0252	126.71	252.34	209	53.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3388.6	B08		2	0119-0259	149.90	258.96	393	73.60	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4967.0	B08		2	0120-0256	537.78	256.26	177	50.28	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4134.2	B08		2	0121-0260	519.45	260.14	348	75.84	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6096.3	B08		2	0122-0259	871.05	259.54	336	67.94	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2453.9	B08		2	0123-0261	412.65	261.32	297	64.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2650.8	B08		2	0124-0260	934.80	260.40	352	73.94	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			894.8	B08		2	0125-0264	282.78	263.77	217	55.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2535.8	B08		2	0126-0264	376.20	263.74	338	74.08	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4901.5	B08		2	0127-0265	343.44	265.30	320	66.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2793.6	B08		2	0128-0269	75.62	269.45	217	57.36	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1231.9	B08		2	0129-0270	241.05	269.89	292	63.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1168.9	B08		2	0130-0273	432.94	273.97	335	74.43	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1582.6	B08		2	0131-0274	761.98	273.08	264	64.53	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1786.8	B08		2	0132-0271	195.98	272.06	227	57.11	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1487.0	B08		2	0133-0274	687.54	274.55	410	79.60	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3855.3	B08		2	0134-0275	830.69	275.44	266	59.94	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1476.6	B08		2	0135-0277	718.89	277.48	276	60.77	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1217.1	B08		2	0136-0281	935.66	281.24	230	56.28	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1257.3	B08		2	0137-0286	67.07	286.17	261	64.18	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1683.1	B08		2	0138-0280	280.48	280.84	127	40.97	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2910.5	B08		2	0139-0289	85.91	287.86	217	55.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3190.6	B08		2	0140-0289	152.32	289.26	336	71.84	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1825.0	B08		2	0141-0293	537.38	292.84	374	74.18	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1904.8	B08		2	0142-0292	678.60	291.79	270	61.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1022.8	B08		2	0143-0296	882.82	296.27	234	59.11	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1617.9	B08		2	0144-0293	280.31	292.82	140	42.63	0.968
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2802.5	B08		2	0145-0298	40.65	298.33	181	49.94	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1924.6	B08		2	0146-0298	168.05	298.25	178	50.04	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1981.0	B08		2	0147-0303	768.05	302.95	314	67.84	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			743.5	B08		2	0148-0306	818.96	306.25	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1929.5	B08		2	0149-0306	550.67	305.06	341	76.67	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2443.9	B08		2	0150-0306	208.60	307.31	266	62.53	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1904.4	B08		2	0151-0311	33.99	311.18	233	60.18	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			930.5	B08		2	0152-0309	289.20	309.28	199	53.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2321.2	B08		2	0153-0312	18.54	312.73	229	55.70	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1201.3	B08		2	0154-0314	258.62	313.18	237	56.77	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2758.9	B08		2	0155-0313	347.76	313.31	209	54.04	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1407.4	B08		2	0156-0312	363.62	311.97	194	53.46	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2659.6	B08		2	0157-0321	490.22	320.56	399	77.84	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2179.0	B08		2	0158-0323	747.11	323.03	315	69.60	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			999.0	B08		2	0159-0324	590.58	323.80	257	62.28	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2333.9	B08		2	0160-0325	105.60	325.09	308	65.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1398.8	B08		2	0161-0327	604.71	327.85	195	52.63	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			669.1	B08		2	0162-0330	370.30	330.08	241	59.36	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1465.9	B08		2	0163-0331	246.12	331.06	328	68.77	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2797.0	B08		2	0164-0335	620.25	335.80	228	57.94	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3136.6	B08		2	0165-0338	914.11	337.65	337	69.26	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1095.2	B08		2	0166-0335	393.51	335.78	105	38.63	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2830.1	B08		2	0167-0337	227.09	336.83	153	45.11	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1118.6	B08		2	0168-0339	382.31	339.19	161	47.46	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1435.3	B08		2	0169-0342	57.86	342.30	285	70.77	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1567.9	B08		2	0170-0343	99.70	343.97	255	59.94	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2292.1	B08		2	0171-0346	464.96	346.86	304	68.77	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1980.2	B08		2	0172-0350	422.90	350.26	367	74.43	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			961.0	B08		2	0173-0355	124.11	355.02	258	62.67	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2211.4	B08		2	0174-0361	929.03	360.97	564	97.98	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2396.1	B08		2	0175-0356	543.50	355.84	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1502.6	B08		2	0176-0356	230.26	356.87	241	58.28	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1323.1	B08		2	0177-0359	656.85	359.38	304	65.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1604.3	B08		2	0178-0360	177.76	360.20	279	62.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1571.5	B08		2	0179-0359	626.60	359.51	217	54.28	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1229.6	B08		2	0180-0362	749.40	362.25	293	65.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			820.1	B08		2	0181-0365	65.16	364.96	220	57.94	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			853.8	B08		2	0182-0361	295.52	360.80	227	58.87	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1585.5	B08		2	0183-0367	321.79	367.32	204	54.53	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3475.2	B08		2	0184-0372	494.01	372.56	361	73.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2855.1	B08		2	0185-0380	438.30	380.98	434	80.33	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2105.0	B08		2	0186-0377	680.65	377.04	328	67.70	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4497.8	B08		2	0187-0378	885.68	377.64	448	79.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1558.5	B08		2	0188-0377	155.27	378.24	193	51.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1050.6	B08		2	0189-0382	203.77	382.92	217	64.08	0.664
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1030.2	B08		2	0190-0383	47.43	383.61	293	65.84	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1929.2	B08		2	0191-0389	360.18	390.60	317	79.84	0.625
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1805.3	B08		2	0192-0383	725.92	383.52	256	62.28	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2907.6	B08		2	0193-0393	183.07	392.87	351	71.84	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3253.2	B08		2	0194-0395	779.94	395.27	248	57.36	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2124.3	B08		2	0195-0398	88.89	398.15	280	63.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			690.1	B08		2	0196-0404	140.56	404.60	305	65.36	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1205.0	B08		2	0197-0408	229.43	408.85	175	51.70	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			563.4	B08		2	0198-0413	464.92	411.27	358	79.84	0.706
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			985.6	B08		2	0199-0413	926.13	412.15	263	61.70	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3593.4	B08		2	0200-0412	870.18	412.74	200	51.70	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			950.9	B08		2	0201-0419	156.19	419.70	250	65.36	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3683.4	B08		2	0202-0419	668.32	417.98	380	76.67	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3325.0	B08		2	0203-0421	113.25	420.36	310	69.84	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			297.6	B08		2	0204-0421	619.70	420.79	195	53.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			573.4	B08		2	0205-0422	731.26	421.55	354	80.91	0.680
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2985.1	B08		2	0206-0422	58.16	422.39	308	66.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			959.6	B08		2	0207-0424	694.88	425.02	328	69.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1313.7	B08		2	0208-0430	509.50	430.00	397	78.67	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1273.1	B08		2	0209-0430	238.31	430.70	262	64.43	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1409.1	B08		2	0210-0434	99.29	433.29	399	81.74	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2272.2	B08		2	0211-0432	192.14	432.66	306	64.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1285.9	B08		2	0212-0433	630.83	432.85	278	61.60	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3301.5	B08		2	0213-0434	768.89	433.81	220	57.46	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2839.6	B08		2	0214-0435	782.32	434.83	214	54.63	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			994.1	B08		2	0215-0442	809.55	442.16	233	61.11	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1006.0	B08		2	0216-0443	32.31	443.20	349	69.01	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2369.8	B08		2	0217-0446	937.21	447.18	437	81.26	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1069.8	B08		2	0218-0440	881.26	440.24	239	59.11	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1651.5	B08		2	0219-0442	399.14	441.87	294	65.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1743.5	B08		2	0220-0443	117.82	442.56	192	53.11	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3897.8	B08		2	0221-0451	573.60	451.88	375	84.08	0.667
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2593.7	B08		2	0222-0455	172.70	455.66	538	97.15	0.716
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2850.6	B08		2	0223-0447	159.35	447.29	107	39.11	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2640.2	B08		2	0224-0452	504.40	453.06	294	70.43	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1696.3	B08		2	0225-0451	248.87	451.17	219	59.70	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1999.4	B08		2	0226-0460	434.28	461.51	361	74.91	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1644.2	B08		2	0227-0453	465.39	453.60	198	58.63	0.724
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1409.6	B08		2	0228-0457	762.01	457.02	269	63.36	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1279.6	B08		2	0229-0458	127.88	457.68	242	60.18	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1721.9	B08		2	0230-0458	310.68	458.39	250	59.11	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3319.5	B08		2	0231-0464	534.43	464.78	362	73.84	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			10430.2	B08		2	0232-0465	15.86	463.09	121	65.11	0.359
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2312.4	B08		2	0233-0469	221.42	470.41	351	69.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4787.8	B08		2	0234-0470	858.17	471.00	295	63.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7277.8	B08		2	0235-0474	776.93	473.51	149	46.87	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1164.7	B08		2	0236-0481	32.34	481.04	295	63.36	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1507.6	B08		2	0237-0480	596.84	479.91	259	59.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4536.6	B08		2	0238-0481	712.94	481.18	237	56.28	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3494.1	B08		2	0239-0481	811.78	481.81	243	57.36	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1924.5	B08		2	0240-0482	346.62	482.36	157	46.87	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1958.3	B08		2	0241-0485	334.30	485.46	209	58.04	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			456.3	B08		2	0242-0487	401.77	486.60	330	85.98	0.561
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			8065.9	B08		2	0243-0484	794.52	484.85	134	44.04	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			785.9	B08		2	0244-0490	268.59	489.77	219	55.70	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2362.3	B08		2	0245-0495	739.34	495.18	514	90.91	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			371.4	B08		2	0246-0489	873.21	488.82	152	47.70	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3839.7	B08		2	0247-0496	912.94	496.14	442	88.57	0.708
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2736.6	B08		2	0248-0498	569.45	497.41	356	72.77	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1204.8	B08		2	0249-0496	153.46	496.54	305	63.36	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2057.1	B08		2	0250-0496	181.71	495.69	317	65.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			773.2	B08		2	0251-0495	689.16	495.01	254	63.36	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			386.7	B08		2	0252-0495	883.61	495.94	150	46.28	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2755.7	B08		2	0253-0508	654.92	508.22	408	73.94	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1278.7	B08		2	0254-0509	417.01	509.34	242	57.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1130.6	B08		2	0255-0512	221.16	512.13	295	65.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2241.5	B08		2	0256-0512	503.00	512.88	347	68.18	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			683.6	B08		2	0257-0517	108.91	517.87	304	71.26	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4789.3	B08		2	0258-0518	598.24	518.38	446	79.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			839.8	B08		2	0259-0519	266.95	518.57	261	62.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1929.2	B08		2	0260-0516	810.10	516.24	257	60.53	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2949.6	B08		2	0261-0516	901.90	515.64	216	56.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1680.0	B08		2	0262-0520	54.58	519.61	347	69.26	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2270.3	B08		2	0263-0517	693.80	518.29	260	60.28	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2033.5	B08		2	0264-0524	26.70	524.17	391	76.77	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			666.8	B08		2	0265-0524	292.11	523.96	313	66.18	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			683.7	B08		2	0266-0527	129.44	527.45	284	64.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4108.2	B08		2	0267-0528	464.51	528.09	334	68.08	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			632.3	B08		2	0268-0527	331.11	526.84	215	55.94	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1758.9	B08		2	0269-0529	767.18	529.22	288	65.11	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3315.0	B08		2	0270-0535	741.89	534.71	357	70.08	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			649.2	B08		2	0271-0534	170.99	534.05	301	68.77	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3498.5	B08		2	0272-0534	898.09	534.73	223	54.77	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5096.6	B08		2	0273-0537	371.82	537.32	366	71.01	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5907.7	B08		2	0274-0537	692.61	537.02	392	78.18	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4144.9	B08		2	0275-0539	311.64	538.90	281	63.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			968.6	B08		2	0276-0540	807.08	541.01	261	62.53	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			378.2	B08		2	0277-0547	92.38	547.24	225	55.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4286.4	B08		2	0278-0551	216.53	551.61	221	54.28	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2797.4	B08		2	0279-0554	258.15	553.87	246	59.11	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2664.5	B08		2	0280-0553	701.75	552.83	276	66.43	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4734.6	B08		2	0281-0560	189.67	560.55	376	75.36	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			664.9	B08		2	0282-0556	419.16	556.52	241	76.67	0.515
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1103.0	B08		2	0283-0557	573.40	556.84	232	56.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4575.8	B08		2	0284-0561	395.29	560.88	517	89.84	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1356.7	B08		2	0285-0557	489.28	557.20	298	73.60	0.691
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4008.8	B08		2	0286-0561	684.81	560.97	284	62.53	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2841.5	B08		2	0287-0563	53.34	564.04	254	64.77	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2765.5	B08		2	0288-0564	34.75	564.91	277	61.11	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2086.1	B08		2	0289-0564	800.42	563.66	262	62.43	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1043.2	B08		2	0290-0565	132.69	565.45	282	60.77	0.960
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2067.8	B08		2	0291-0569	298.45	569.75	305	66.77	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2002.2	B08		2	0292-0566	734.45	566.03	160	46.63	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1028.8	B08		2	0293-0572	546.80	572.13	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1657.2	B08		2	0294-0567	721.99	567.97	117	40.39	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2106.4	B08		2	0295-0569	337.10	569.57	268	62.77	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3678.1	B08		2	0296-0578	823.42	578.32	245	60.18	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3645.5	B08		2	0297-0576	861.26	576.46	224	58.77	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3737.8	B08		2	0298-0582	740.73	581.99	369	77.26	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1697.6	B08		2	0299-0583	563.98	583.98	248	59.46	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2625.4	B08		2	0300-0586	173.73	586.22	307	65.36	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1456.7	B08		2	0301-0583	658.97	583.84	245	57.11	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1005.8	B08		2	0302-0585	793.90	585.11	248	58.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			601.3	B08		2	0303-0590	227.90	590.27	281	63.11	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5356.1	B08		2	0304-0591	99.57	591.34	294	62.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4376.9	B08		2	0305-0593	505.03	593.37	339	69.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1892.8	B08		2	0306-0592	593.21	591.77	223	56.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3526.7	B08		2	0307-0597	133.78	597.69	338	71.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3542.2	B08		2	0308-0597	75.00	597.76	377	73.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1055.7	B08		2	0309-0598	764.49	598.03	268	61.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1902.1	B08		2	0310-0602	262.69	602.14	245	58.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1090.1	B08		2	0311-0603	370.78	603.27	328	68.53	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2940.7	B08		2	0312-0610	883.28	609.88	539	91.15	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4129.2	B08		2	0313-0609	585.95	609.56	224	57.01	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3282.7	B08		2	0314-0613	841.15	613.76	411	79.26	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1812.8	B08		2	0315-0612	936.63	612.62	227	55.94	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2434.8	B08		2	0316-0617	288.69	617.92	377	74.77	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1264.5	B08		2	0317-0614	609.59	615.13	257	63.60	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1281.2	B08		2	0318-0620	799.21	619.85	258	64.28	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2284.6	B08		2	0319-0620	96.60	619.31	283	61.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1565.5	B08		2	0320-0622	162.75	622.53	248	60.28	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5066.6	B08		2	0321-0633	664.99	632.93	460	84.43	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7446.7	B08		2	0322-0636	342.57	636.72	552	91.50	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5048.8	B08		2	0323-0632	681.91	632.43	285	65.94	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3373.2	B08		2	0324-0636	909.48	635.73	392	75.84	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			700.1	B08		2	0325-0637	212.47	637.09	316	74.08	0.724
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2962.1	B08		2	0326-0639	419.96	639.41	505	90.57	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5276.3	B08		2	0327-0635	300.04	635.24	160	46.87	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4748.1	B08		2	0328-0634	311.80	633.78	111	39.56	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5080.9	B08		2	0329-0639	774.09	638.73	357	70.43	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2326.9	B08		2	0330-0640	47.64	639.90	268	61.01	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3573.4	B08		2	0331-0644	575.29	645.64	468	86.33	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3868.0	B08		2	0332-0637	497.09	637.30	111	40.04	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2398.6	B08		2	0333-0645	364.75	645.34	289	61.94	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3387.3	B08		2	0334-0652	503.38	652.97	353	73.01	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1087.7	B08		2	0335-0651	433.80	651.83	219	56.77	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4495.8	B08		2	0336-0656	474.14	655.54	417	82.91	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1287.7	B08		2	0337-0653	132.62	653.87	156	47.21	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1042.0	B08		2	0338-0660	148.53	660.75	228	58.53	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2551.8	B08		2	0339-0665	873.42	665.35	320	67.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			914.8	B08		2	0340-0664	794.21	664.84	230	54.77	0.964
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1617.9	B08		2	0341-0664	345.09	664.25	223	59.70	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3778.4	B08		2	0342-0668	31.79	668.05	280	65.60	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1131.9	B08		2	0343-0666	133.65	665.65	163	48.04	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6820.6	B08		2	0344-0673	488.29	673.97	375	76.77	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4030.6	B08		2	0345-0677	471.11	677.26	388	79.26	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2425.1	B08		2	0346-0674	676.26	675.27	352	69.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			471.9	B08		2	0347-0682	833.49	682.02	319	71.60	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1029.4	B08		2	0348-0681	177.91	682.12	282	64.43	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1338.0	B08		2	0349-0684	536.57	684.33	210	54.28	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4027.4	B08		2	0350-0684	270.18	683.97	243	59.11	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2275.3	B08		2	0351-0692	297.50	692.96	233	58.53	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4358.2	B08		2	0352-0688	897.09	688.15	191	53.94	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			915.2	B08		2	0353-0692	388.37	692.13	236	57.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2222.2	B08		2	0354-0695	559.28	695.50	349	71.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2870.2	B08		2	0355-0695	83.03	695.50	268	60.53	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3134.6	B08		2	0356-0697	649.23	697.13	455	80.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2965.7	B08		2	0357-0696	766.83	695.63	319	67.01	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4799.8	B08		2	0358-0700	19.22	700.80	156	47.46	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3062.7	B08		2	0359-0704	105.76	704.14	283	68.08	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			852.2	B08		2	0360-0701	846.09	700.80	249	58.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2287.5	B08		2	0361-0702	620.75	701.43	199	53.11	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1665.8	B08		2	0362-0702	37.15	701.76	192	53.11	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1913.6	B08		2	0363-0704	937.46	703.67	299	63.84	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			799.7	B08		2	0364-0708	355.31	708.03	272	62.53	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4358.0	B08		2	0365-0708	207.17	708.01	325	66.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1236.0	B08		2	0366-0708	440.81	708.12	253	58.77	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1433.6	B08		2	0367-0710	121.34	709.93	207	56.53	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1063.6	B08		3	0001-0032	174.22	32.04	249	67.01	0.697
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			717.9	B08		3	0002-0031	771.20	30.98	281	63.11	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			789.3	B08		3	0003-0035	76.25	35.00	272	62.53	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3771.5	B08		3	0004-0037	608.80	37.00	478	85.15	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4885.3	B08		3	0005-0036	648.22	35.64	324	66.18	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3402.7	B08		3	0006-0041	489.76	40.64	488	83.98	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			634.6	B08		3	0007-0040	30.61	40.30	250	60.18	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1295.2	B08		3	0008-0043	704.69	44.35	231	60.87	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2325.1	B08		3	0009-0047	530.33	47.51	250	59.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1631.1	B08		3	0010-0054	456.56	54.71	277	61.36	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			9431.9	B08		3	0011-0058	476.96	59.41	445	79.50	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6353.1	B08		3	0012-0058	93.16	59.16	330	67.36	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			900.5	B08		3	0013-0055	207.76	54.54	245	60.77	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4236.6	B08		3	0014-0057	753.82	57.12	256	65.70	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4343.9	B08		3	0015-0060	911.18	59.84	358	69.01	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2180.0	B08		3	0016-0062	426.79	61.94	262	59.84	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1324.6	B08		3	0017-0064	817.54	63.85	291	69.60	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3726.0	B08		3	0018-0062	151.02	62.27	218	57.36	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1441.5	B08		3	0019-0063	563.29	63.40	270	65.01	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6625.3	B08		3	0020-0064	397.98	64.32	303	69.70	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7515.3	B08		3	0021-0069	373.29	69.18	358	74.43	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5610.4	B08		3	0022-0070	444.27	70.30	315	71.01	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1641.2	B08		3	0023-0071	685.11	71.36	324	67.36	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2157.5	B08		3	0024-0071	26.79	71.61	292	63.94	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4083.5	B08		3	0025-0078	63.72	77.41	368	76.08	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2177.0	B08		3	0026-0077	152.86	78.01	324	68.18	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1988.4	B08		3	0027-0076	180.82	77.29	251	61.01	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2999.2	B08		3	0028-0084	869.55	83.92	383	84.18	0.679
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3178.6	B08		3	0029-0081	349.15	80.59	353	70.18	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2081.7	B08		3	0030-0079	97.96	78.72	198	53.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1095.0	B08		3	0031-0081	595.59	80.53	323	70.18	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			671.4	B08		3	0032-0080	291.88	80.04	261	59.60	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			440.4	B08		3	0033-0079	750.97	79.77	269	64.43	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1200.7	B08		3	0034-0082	330.41	82.15	181	54.63	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2443.8	B08		3	0035-0087	940.87	86.52	272	61.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3757.3	B08		3	0036-0088	373.60	88.65	217	53.36	0.958
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1931.5	B08		3	0037-0092	638.43	92.74	241	59.60	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1199.8	B08		3	0038-0091	398.46	91.50	215	55.36	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2213.4	B08		3	0039-0093	565.31	92.96	263	62.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4301.9	B08		3	0040-0098	497.76	98.43	517	84.08	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			568.4	B08		3	0041-0094	191.15	94.77	294	63.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2219.0	B08		3	0042-0099	838.70	99.71	305	67.36	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1125.3	B08		3	0043-0098	448.56	98.24	272	63.01	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2716.7	B08		3	0044-0099	241.85	98.73	246	58.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			657.9	B08		3	0045-0103	791.31	103.40	351	70.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2492.6	B08		3	0046-0107	332.07	106.69	355	72.18	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			746.3	B08		3	0047-0105	545.14	104.91	297	63.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4928.5	B08		3	0048-0109	816.08	108.63	189	55.36	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3055.1	B08		3	0049-0110	101.79	110.50	272	61.60	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2296.7	B08		3	0050-0111	216.70	110.96	304	65.01	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1068.1	B08		3	0051-0111	413.08	111.64	277	62.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5430.0	B08		3	0052-0114	920.64	114.63	335	66.77	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5028.6	B08		3	0053-0117	699.14	116.59	301	64.18	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2640.4	B08		3	0054-0123	493.78	122.81	262	60.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			337.4	B08		3	0055-0125	27.26	124.27	249	74.91	0.558
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2038.6	B08		3	0056-0124	546.77	125.24	276	65.01	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1599.1	B08		3	0057-0125	448.58	125.20	208	55.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			644.7	B08		3	0058-0133	739.38	133.47	362	84.67	0.635
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2605.6	B08		3	0059-0131	145.90	131.35	332	68.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1993.9	B08		3	0060-0134	207.45	132.73	501	95.74	0.687
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			944.4	B08		3	0061-0135	350.90	134.26	255	58.77	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1988.2	B08		3	0062-0136	872.25	136.23	326	66.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1428.5	B08		3	0063-0136	625.52	136.69	299	63.11	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4506.3	B08		3	0064-0147	169.60	147.13	413	77.50	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2560.9	B08		3	0065-0144	487.88	143.45	271	61.60	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1991.0	B08		3	0066-0143	536.82	142.94	241	59.36	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3458.0	B08		3	0067-0146	275.38	145.38	227	58.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1281.1	B08		3	0068-0147	28.95	147.38	243	58.18	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3179.8	B08		3	0069-0153	309.34	153.10	345	69.84	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			10631.9	B08		3	0070-0156	204.86	155.46	204	92.81	0.298
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1571.4	B08		3	0071-0156	387.05	156.20	257	60.53	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2216.1	B08		3	0072-0155	469.56	155.29	230	58.77	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1258.8	B08		3	0073-0154	646.67	152.89	117	43.11	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			505.4	B08		3	0074-0160	722.52	160.55	319	75.50	0.703
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1276.0	B08		3	0075-0159	637.21	159.56	218	57.60	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1736.7	B08		3	0076-0159	779.82	159.08	225	56.28	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2732.4	B08		3	0077-0162	914.86	162.86	346	71.84	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5097.7	B08		3	0078-0167	815.28	167.59	368	75.60	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2154.8	B08		3	0079-0169	271.03	171.52	394	86.33	0.664
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4358.7	B08		3	0080-0168	751.03	167.95	468	85.15	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3733.1	B08		3	0081-0169	186.94	169.00	201	54.53	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1962.0	B08		3	0082-0167	695.55	166.22	183	51.94	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			951.6	B08		3	0083-0170	509.31	169.78	270	61.94	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5573.7	B08		3	0084-0175	838.62	175.55	367	82.08	0.684
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			543.0	B08		3	0085-0171	483.51	171.08	214	55.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2071.1	B08		3	0086-0172	684.74	173.33	136	44.53	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6201.9	B08		3	0087-0178	314.28	178.44	403	76.33	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5043.2	B08		3	0088-0177	66.17	177.18	206	53.70	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1645.9	B08		3	0089-0177	102.73	176.82	203	53.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1001.1	B08		3	0090-0179	253.70	178.90	239	63.60	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1975.4	B08		3	0091-0179	554.12	179.02	349	69.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3069.4	B08		3	0092-0179	444.19	179.66	221	53.11	0.984
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4778.6	B08		3	0093-0183	621.51	182.60	365	70.18	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1073.0	B08		3	0094-0185	210.48	185.09	250	60.18	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4427.6	B08		3	0095-0190	876.28	190.12	404	75.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1214.5	B08		3	0096-0188	297.16	188.57	244	58.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1813.2	B08		3	0097-0188	370.51	188.18	292	67.60	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6128.9	B08		3	0098-0188	48.45	188.21	160	46.87	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2403.7	B08		3	0099-0191	339.92	191.37	276	61.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3019.2	B08		3	0100-0196	594.81	196.46	314	68.18	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2380.3	B08		3	0101-0199	914.47	198.34	298	66.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			682.2	B08		3	0102-0199	146.75	199.92	273	65.84	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1989.4	B08		3	0103-0202	173.10	202.21	303	65.84	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			573.0	B08		3	0104-0201	280.82	200.74	205	55.11	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1872.7	B08		3	0105-0203	402.51	203.32	287	61.94	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7287.0	B08		3	0106-0203	628.31	203.10	297	63.01	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4532.8	B08		3	0107-0204	366.33	204.23	184	51.11	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1411.2	B08		3	0108-0207	37.62	206.55	290	63.70	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1934.0	B08		3	0109-0207	893.74	207.76	249	60.43	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1444.2	B08		3	0110-0207	239.23	207.31	240	58.77	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1639.2	B08		3	0111-0208	948.07	208.67	267	60.43	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1437.6	B08		3	0112-0208	75.39	208.20	233	55.94	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			562.8	B08		3	0113-0209	551.99	209.65	257	59.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1121.7	B08		3	0114-0215	332.77	214.78	256	62.18	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6351.0	B08		3	0115-0220	115.19	220.15	386	74.43	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5062.3	B08		3	0116-0222	660.54	222.51	396	76.43	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			833.6	B08		3	0117-0219	850.80	219.39	168	53.36	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4946.7	B08		3	0118-0219	712.14	219.64	223	54.28	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1819.0	B08		3	0119-0221	286.32	222.07	258	61.01	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1710.1	B08		3	0120-0221	794.26	222.20	231	66.43	0.658
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4600.6	B08		3	0121-0224	354.14	224.73	337	69.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5128.9	B08		3	0122-0224	369.58	223.65	158	48.87	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3240.0	B08		3	0123-0227	613.88	227.23	233	58.28	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6419.2	B08		3	0124-0231	675.39	231.75	274	66.77	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			9653.6	B08		3	0125-0237	219.89	236.54	310	68.18	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1939.0	B08		3	0126-0234	892.81	234.08	245	57.94	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6436.9	B08		3	0127-0238	828.42	238.70	314	66.18	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4374.8	B08		3	0128-0240	750.33	241.09	427	77.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1604.0	B08		3	0129-0243	411.02	244.58	306	68.18	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3198.5	B08		3	0130-0240	546.09	240.52	318	66.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7618.1	B08		3	0131-0244	566.82	244.27	300	64.18	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3093.2	B08		3	0132-0242	609.87	242.66	240	57.11	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1426.3	B08		3	0133-0246	923.15	246.57	256	64.18	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1215.7	B08		3	0134-0246	28.55	246.73	236	58.04	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1437.7	B08		3	0135-0247	204.55	247.05	275	63.94	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			423.8	B08		3	0136-0246	363.41	246.31	316	80.08	0.619
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1705.5	B08		3	0137-0249	494.35	248.84	250	59.26	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			660.5	B08		3	0138-0250	706.94	250.18	191	58.77	0.695
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			518.8	B08		3	0139-0256	100.15	256.98	240	66.53	0.681
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1055.0	B08		3	0140-0254	524.48	253.29	231	58.77	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			265.8	B08		3	0141-0252	723.12	252.69	191	51.11	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3349.9	B08		3	0142-0256	140.11	256.38	229	57.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3517.4	B08		3	0143-0257	158.04	257.32	212	57.36	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			607.7	B08		3	0144-0254	74.64	253.97	230	58.28	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			737.6	B08		3	0145-0256	307.56	255.86	206	54.28	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1702.7	B08		3	0146-0258	260.05	258.96	250	60.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			747.5	B08		3	0147-0265	589.80	263.58	278	65.94	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2685.1	B08		3	0148-0264	29.42	263.98	343	71.94	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1006.9	B08		3	0149-0269	464.95	269.24	284	64.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			836.0	B08		3	0150-0269	534.17	268.97	227	55.94	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3068.0	B08		3	0151-0271	775.21	271.35	302	65.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			915.2	B08		3	0152-0270	794.95	271.04	250	58.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			548.2	B08		3	0153-0275	631.78	274.75	307	69.60	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1411.8	B08		3	0154-0278	240.09	278.70	298	65.01	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2363.0	B08		3	0155-0278	841.64	278.32	175	52.18	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			599.7	B08		3	0156-0281	88.55	280.69	227	57.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2387.2	B08		3	0157-0279	735.63	279.66	312	67.01	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1980.3	B08		3	0158-0283	395.38	282.92	275	65.01	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1329.8	B08		3	0159-0286	274.36	287.66	322	67.60	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1211.4	B08		3	0160-0284	30.22	284.54	225	56.53	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			472.0	B08		3	0161-0286	122.17	287.01	279	63.60	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4053.3	B08		3	0162-0291	459.86	291.26	412	79.26	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5691.3	B08		3	0163-0287	941.61	287.60	362	71.60	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2090.3	B08		3	0164-0287	359.90	286.65	248	65.26	0.732
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2568.2	B08		3	0165-0289	160.78	289.29	255	58.53	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2006.5	B08		3	0166-0289	181.17	289.44	248	59.36	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5468.1	B08		3	0167-0292	833.48	292.34	404	76.67	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2864.6	B08		3	0168-0290	660.97	290.34	213	55.11	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1733.4	B08		3	0169-0292	813.19	291.83	258	64.18	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			852.9	B08		3	0170-0296	420.18	296.51	238	58.28	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2397.2	B08		3	0171-0295	676.56	294.96	235	58.28	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			946.3	B08		3	0172-0301	925.83	300.69	304	66.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2744.4	B08		3	0173-0301	883.05	301.44	343	68.43	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1550.3	B08		3	0174-0301	219.00	301.60	201	56.18	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6927.3	B08		3	0175-0309	106.17	309.78	331	67.84	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			992.7	B08		3	0176-0311	136.06	311.08	235	57.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			308.4	B08		3	0177-0315	459.87	315.36	306	67.84	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6250.9	B08		3	0178-0315	584.40	314.75	368	70.53	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5486.6	B08		3	0179-0316	734.41	316.36	369	73.84	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			580.2	B08		3	0180-0316	187.10	316.32	224	54.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2282.7	B08		3	0181-0318	254.15	318.24	231	57.94	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2134.2	B08		3	0182-0318	651.34	318.24	294	63.94	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2962.4	B08		3	0183-0323	410.89	322.62	364	73.84	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6176.5	B08		3	0184-0329	875.26	329.64	266	60.18	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1054.7	B08		3	0185-0328	286.92	328.69	215	53.70	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			750.1	B08		3	0186-0335	804.34	336.40	317	70.67	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7262.6	B08		3	0187-0334	360.46	334.07	193	51.11	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2512.8	B08		3	0188-0335	387.43	335.21	269	61.36	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			441.9	B08		3	0189-0335	536.82	335.92	294	64.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2288.3	B08		3	0190-0335	204.81	335.14	228	55.11	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3423.7	B08		3	0191-0338	650.73	337.72	323	67.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7796.5	B08		3	0192-0339	346.72	339.63	174	52.28	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2287.8	B08		3	0193-0341	725.24	341.64	215	54.28	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1352.3	B08		3	0194-0346	243.63	345.99	277	63.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1452.7	B08		3	0195-0345	317.67	345.39	210	58.77	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1298.5	B08		3	0196-0343	107.28	343.76	273	64.18	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			542.3	B08		3	0197-0344	608.80	343.82	285	64.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4784.7	B08		3	0198-0353	291.95	352.69	379	72.43	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1262.8	B08		3	0199-0354	331.61	354.07	229	56.87	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1398.8	B08		3	0200-0355	425.40	355.58	273	62.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2627.3	B08		3	0201-0355	828.37	355.45	372	72.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2650.2	B08		3	0202-0356	19.52	356.46	186	52.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1787.9	B08		3	0203-0358	179.96	357.71	224	55.70	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3230.6	B08		3	0204-0356	347.30	355.98	226	56.87	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			920.8	B08		3	0205-0356	452.60	356.90	253	59.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2490.7	B08		3	0206-0359	402.75	359.21	322	65.94	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1902.5	B08		3	0207-0355	684.95	355.37	203	55.70	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			830.4	B08		3	0208-0357	483.80	358.09	169	51.11	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5092.5	B08		3	0209-0358	112.39	358.32	148	45.46	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1731.5	B08		3	0210-0367	589.51	368.23	600	167.82	0.268
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3955.7	B08		3	0211-0365	513.79	364.74	343	70.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1143.4	B08		3	0212-0362	928.13	361.92	149	49.70	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1304.3	B08		3	0213-0365	165.18	365.39	230	59.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1988.1	B08		3	0214-0369	26.07	370.68	286	71.01	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3548.7	B08		3	0215-0367	315.45	367.37	307	66.43	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5068.4	B08		3	0216-0367	651.27	367.38	319	68.18	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2050.5	B08		3	0217-0371	910.25	370.76	309	70.43	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1978.8	B08		3	0218-0371	875.06	370.77	305	66.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2584.8	B08		3	0219-0371	374.83	371.79	255	60.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4774.9	B08		3	0220-0374	263.29	374.75	348	71.26	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			662.1	B08		3	0221-0377	712.73	377.14	273	63.36	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1235.4	B08		3	0222-0379	762.43	379.09	281	65.01	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1632.4	B08		3	0223-0379	841.85	379.72	226	58.77	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			601.2	B08		3	0224-0379	147.84	379.00	276	64.77	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1109.4	B08		3	0225-0383	54.65	383.69	298	68.18	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2767.7	B08		3	0226-0382	546.20	382.45	304	65.36	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2765.5	B08		3	0227-0383	352.41	382.21	226	57.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1375.4	B08		3	0228-0382	503.03	382.35	258	60.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			951.5	B08		3	0229-0382	89.21	382.66	219	53.70	0.954
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3706.0	B08		3	0230-0384	103.89	384.05	200	57.11	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2137.0	B08		3	0231-0384	685.58	384.47	259	60.28	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1381.1	B08		3	0232-0389	133.82	389.88	204	54.18	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1441.3	B08		3	0233-0392	335.87	392.05	229	61.11	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3480.2	B08		3	0234-0397	943.98	397.69	349	70.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			474.7	B08		3	0235-0396	248.74	396.06	266	64.77	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2318.4	B08		3	0236-0399	358.81	399.31	264	63.01	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2265.3	B08		3	0237-0396	400.64	395.69	284	70.77	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3115.9	B08		3	0238-0401	869.31	401.46	353	70.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			848.9	B08		3	0239-0399	477.95	398.80	152	47.46	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4017.2	B08		3	0240-0400	688.60	398.59	162	49.70	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4239.0	B08		3	0241-0409	450.59	409.76	472	81.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3548.8	B08		3	0242-0406	677.98	406.95	201	54.43	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			848.5	B08		3	0243-0410	59.30	410.76	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2434.6	B08		3	0244-0410	326.43	410.31	290	64.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			444.1	B08		3	0245-0411	187.48	411.62	229	59.01	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4530.5	B08		3	0246-0411	814.94	410.92	258	64.18	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1664.9	B08		3	0247-0413	918.78	412.65	255	61.01	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5283.9	B08		3	0248-0420	645.90	419.43	683	107.30	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3936.5	B08		3	0249-0418	594.22	418.68	419	80.33	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3665.7	B08		3	0250-0418	709.45	418.12	500	89.98	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			971.6	B08		3	0251-0416	20.37	415.64	244	59.36	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			694.7	B08		3	0252-0418	237.53	417.22	230	59.01	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3098.8	B08		3	0253-0418	369.35	417.47	296	64.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1514.9	B08		3	0254-0418	210.59	417.84	204	54.77	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4433.1	B08		3	0255-0419	164.81	418.96	326	69.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3090.3	B08		3	0256-0421	283.97	421.68	294	63.01	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1160.7	B08		3	0257-0425	308.25	424.38	257	60.53	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5369.8	B08		3	0258-0428	786.09	428.42	228	56.77	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			893.2	B08		3	0259-0425	862.34	425.22	116	41.21	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			620.7	B08		3	0260-0432	503.87	432.37	225	59.60	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2068.4	B08		3	0261-0435	408.07	435.04	291	69.60	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			939.6	B08		3	0262-0437	862.54	437.07	128	41.80	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1408.1	B08		3	0263-0442	807.62	442.76	329	75.26	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3036.4	B08		3	0264-0443	888.83	442.33	332	69.26	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3511.2	B08		3	0265-0443	531.39	443.83	328	67.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2304.6	B08		3	0266-0450	31.80	450.55	432	79.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			415.5	B08		3	0267-0449	933.81	450.02	256	61.11	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3425.4	B08		3	0268-0451	72.30	451.27	263	62.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			471.9	B08		3	0269-0453	371.01	453.85	319	68.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			797.5	B08		3	0270-0451	699.44	451.53	254	59.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			457.3	B08		3	0271-0455	185.28	455.49	283	65.01	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1151.0	B08		3	0272-0453	247.81	453.68	216	55.11	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1857.8	B08		3	0273-0455	748.33	454.75	174	50.63	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1615.3	B08		3	0274-0454	759.92	453.92	166	49.80	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			742.0	B08		3	0275-0454	508.66	454.74	219	59.36	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4355.5	B08		3	0276-0459	681.14	458.94	406	74.67	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			395.4	B08		3	0277-0458	140.86	458.00	306	64.77	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1925.1	B08		3	0278-0458	447.06	457.61	270	62.18	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			989.5	B08		3	0279-0458	311.78	458.48	236	58.18	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2583.4	B08		3	0280-0461	92.82	461.21	289	63.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5705.7	B08		3	0281-0466	276.12	465.89	268	62.77	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			627.8	B08		3	0282-0466	422.12	466.59	247	57.94	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			980.2	B08		3	0283-0469	324.75	469.28	258	60.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1866.2	B08		3	0284-0469	295.54	469.85	274	61.94	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1561.0	B08		3	0285-0473	383.72	473.38	260	61.01	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			546.9	B08		3	0286-0472	836.60	472.36	236	57.11	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4240.8	B08		3	0287-0476	177.39	476.77	357	72.33	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1288.6	B08		3	0288-0474	697.65	474.06	246	57.94	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3557.9	B08		3	0289-0476	722.76	476.66	332	68.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1120.4	B08		3	0290-0475	259.18	475.33	251	59.70	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1094.7	B08		3	0291-0478	204.42	479.05	212	56.77	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2317.8	B08		3	0292-0480	771.22	479.94	365	75.01	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1217.2	B08		3	0293-0480	363.30	480.13	231	56.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			717.2	B08		3	0294-0480	560.68	479.96	209	59.46	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			756.9	B08		3	0295-0484	501.01	484.07	285	62.53	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2686.6	B08		3	0296-0487	51.52	486.82	251	61.70	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1248.0	B08		3	0297-0486	616.39	487.05	226	56.53	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1357.9	B08		3	0298-0487	342.67	487.35	238	57.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			618.1	B08		3	0299-0488	826.68	488.29	293	62.77	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1815.3	B08		3	0300-0490	596.29	489.20	265	63.60	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2938.5	B08		3	0301-0495	558.65	494.36	331	69.94	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			594.1	B08		3	0302-0502	582.49	500.85	221	60.77	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2317.7	B08		3	0303-0500	808.99	500.75	139	45.70	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			903.4	B08		3	0304-0506	271.95	507.29	292	65.36	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5213.4	B08		3	0305-0506	197.87	506.15	325	67.94	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6060.3	B08		3	0306-0504	326.24	504.30	201	54.53	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			918.7	B08		3	0307-0506	749.41	506.57	218	54.87	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5578.5	B08		3	0308-0512	233.99	511.86	404	77.84	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2149.3	B08		3	0309-0508	309.33	507.70	254	59.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5069.7	B08		3	0310-0512	409.95	512.07	328	68.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2406.4	B08		3	0311-0512	920.21	511.04	368	74.43	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			723.9	B08		3	0312-0511	945.71	510.79	299	69.01	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2293.6	B08		3	0313-0513	162.91	512.93	234	55.70	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2410.0	B08		3	0314-0519	641.88	518.69	471	82.08	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			665.7	B08		3	0315-0518	433.87	518.13	300	65.60	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1923.9	B08		3	0316-0515	807.92	515.37	204	53.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2821.9	B08		3	0317-0516	879.29	515.82	275	62.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4297.2	B08		3	0318-0520	468.34	519.83	387	74.18	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			838.2	B08		3	0319-0525	92.32	525.27	242	61.94	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			924.4	B08		3	0320-0528	892.42	527.57	242	59.94	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2277.4	B08		3	0321-0534	563.20	534.52	290	64.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3302.6	B08		3	0322-0538	930.82	537.99	358	70.43	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3370.3	B08		3	0323-0544	338.86	544.18	447	80.08	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3038.4	B08		3	0324-0543	615.93	543.94	313	68.87	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2333.2	B08		3	0325-0545	291.44	545.26	385	74.91	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2018.7	B08		3	0326-0543	687.91	543.10	258	62.43	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4036.2	B08		3	0327-0542	802.99	542.92	224	57.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1419.7	B08		3	0328-0547	65.80	547.79	283	70.53	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2965.2	B08		3	0329-0545	519.42	545.54	393	73.26	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1113.7	B08		3	0330-0548	752.79	547.78	327	67.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4399.3	B08		3	0331-0547	817.45	547.43	200	54.28	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1212.8	B08		3	0332-0555	168.11	555.12	253	58.53	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3249.2	B08		3	0333-0554	206.92	554.21	165	48.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1646.5	B08		3	0334-0557	241.60	557.24	219	55.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3777.9	B08		3	0335-0558	680.32	558.84	172	50.04	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4739.3	B08		3	0336-0560	260.65	560.75	258	60.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			395.3	B08		3	0337-0560	437.42	560.49	282	66.18	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			902.6	B08		3	0338-0561	383.72	561.24	199	52.28	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			838.4	B08		3	0339-0564	908.31	563.81	257	60.77	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			955.6	B08		3	0340-0563	362.71	562.57	209	53.11	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1368.3	B08		3	0341-0565	113.81	566.31	220	55.70	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1947.8	B08		3	0342-0563	560.33	563.84	161	49.21	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3863.0	B08		3	0343-0574	707.12	574.45	382	76.18	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1619.1	B08		3	0344-0567	729.32	567.42	211	56.87	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			371.8	B08		3	0345-0577	307.82	577.16	266	66.18	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1055.2	B08		3	0346-0574	484.36	573.74	284	64.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			379.8	B08		3	0347-0578	839.35	579.04	248	60.53	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1242.1	B08		3	0348-0574	557.43	574.80	134	51.70	0.630
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			615.6	B08		3	0349-0579	81.38	579.01	225	56.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2954.0	B08		3	0350-0583	166.37	583.62	332	67.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2238.9	B08		3	0351-0583	187.26	583.22	278	61.46	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2404.9	B08		3	0352-0587	388.61	587.01	346	70.91	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2725.0	B08		3	0353-0587	584.27	587.10	318	81.50	0.602
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7165.2	B08		3	0354-0584	877.49	584.68	133	42.87	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1896.7	B08		3	0355-0588	898.46	588.43	311	67.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1196.1	B08		3	0356-0589	350.30	589.33	209	55.94	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6981.3	B08		3	0357-0588	862.60	588.17	134	44.28	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1845.7	B08		3	0358-0597	844.23	597.76	370	74.67	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5830.2	B08		3	0359-0594	253.57	593.03	169	49.36	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1728.5	B08		3	0360-0595	633.32	595.37	269	61.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			805.8	B08		3	0361-0598	524.68	598.04	293	62.77	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2530.2	B08		3	0362-0599	764.00	599.49	279	73.50	0.649
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1714.3	B08		3	0363-0604	126.58	605.15	339	68.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5489.1	B08		3	0364-0601	263.36	601.01	180	52.77	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2077.7	B08		3	0365-0605	322.60	606.03	261	62.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2831.3	B08		3	0366-0602	426.77	602.43	267	62.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5231.1	B08		3	0367-0605	554.18	605.19	350	68.18	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4472.2	B08		3	0368-0603	687.74	604.19	132	42.39	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1921.2	B08		3	0369-0607	616.33	606.87	234	59.84	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1284.8	B08		3	0370-0609	487.93	608.84	297	66.43	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1707.4	B08		3	0371-0608	936.57	607.73	257	64.77	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			975.7	B08		3	0372-0614	411.37	614.44	324	66.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2579.3	B08		3	0373-0613	439.78	613.99	280	63.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			538.5	B08		3	0374-0611	721.30	611.18	193	58.77	0.702
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1844.0	B08		3	0375-0615	30.94	616.00	225	55.36	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			503.1	B08		3	0376-0618	339.28	617.59	279	61.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1477.3	B08		3	0377-0620	63.06	620.52	228	58.53	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1357.1	B08		3	0378-0621	692.34	620.81	285	66.53	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4261.6	B08		3	0379-0621	883.29	620.36	279	63.11	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1599.9	B08		3	0380-0623	179.48	623.20	323	67.01	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			981.3	B08		3	0381-0621	232.61	622.39	272	61.11	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2965.1	B08		3	0382-0622	299.86	622.00	314	67.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1207.6	B08		3	0383-0621	263.45	621.84	183	52.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4052.8	B08		3	0384-0624	603.64	624.42	363	71.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3914.1	B08		3	0385-0625	751.75	625.19	266	63.11	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3600.3	B08		3	0386-0628	812.46	628.17	378	73.01	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2209.9	B08		3	0387-0628	276.37	628.67	229	57.70	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7253.0	B08		3	0388-0628	556.75	628.93	195	53.46	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			521.9	B08		3	0389-0637	876.35	637.96	295	68.43	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1500.1	B08		3	0390-0637	771.26	636.84	209	55.70	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			604.5	B08		3	0391-0639	114.14	640.11	204	52.87	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1573.2	B08		3	0392-0642	350.54	642.19	281	64.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1718.1	B08		3	0393-0640	514.81	640.74	269	61.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2163.7	B08		3	0394-0643	895.73	643.48	375	73.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4247.8	B08		3	0395-0642	204.93	642.22	248	60.18	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			823.0	B08		3	0396-0640	164.94	640.47	181	51.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			8527.8	B08		3	0397-0642	556.40	641.47	162	48.63	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1471.4	B08		3	0398-0648	659.03	648.60	327	66.18	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			10017.8	B08		3	0399-0653	247.53	653.51	371	75.01	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3149.4	B08		3	0400-0654	388.11	654.36	401	76.43	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3316.6	B08		3	0401-0651	946.17	650.54	275	62.53	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1373.6	B08		3	0402-0656	425.26	656.70	372	71.60	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2666.0	B08		3	0403-0657	713.38	657.91	343	69.26	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2142.4	B08		3	0404-0661	108.19	660.40	327	71.36	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1554.0	B08		3	0405-0660	620.19	659.78	295	64.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3976.9	B08		3	0406-0660	553.77	659.85	269	60.53	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1081.5	B08		3	0407-0660	898.74	660.46	275	66.18	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4995.0	B08		3	0408-0661	175.78	660.96	239	61.60	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2171.1	B08		3	0409-0663	830.21	663.20	256	62.18	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3473.5	B08		3	0410-0663	806.27	663.94	252	60.53	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4201.6	B08		3	0411-0669	321.28	668.18	225	57.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3790.7	B08		3	0412-0674	687.29	674.80	384	75.50	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			325.8	B08		3	0413-0673	473.43	673.39	270	61.11	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4590.9	B08		3	0414-0674	732.78	674.35	260	59.11	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1422.7	B08		3	0415-0675	339.94	674.90	231	57.36	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1375.8	B08		3	0416-0680	911.95	680.09	390	111.88	0.392
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1587.8	B08		3	0417-0678	44.44	677.83	235	60.43	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			620.2	B08		3	0418-0681	448.52	681.25	260	61.36	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1296.8	B08		3	0419-0681	250.43	681.15	231	56.53	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3820.6	B08		3	0420-0682	310.84	682.87	248	58.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7986.8	B08		3	0421-0681	600.75	681.92	187	55.46	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4102.1	B08		3	0422-0682	392.98	682.79	147	46.63	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			761.6	B08		3	0423-0691	70.94	690.67	280	73.84	0.645
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1513.2	B08		3	0424-0686	842.30	686.28	245	59.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2124.1	B08		3	0425-0688	171.82	688.70	240	58.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4386.0	B08		3	0426-0691	568.47	691.37	235	62.77	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2862.4	B08		3	0427-0690	817.05	690.09	266	62.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2211.8	B08		3	0428-0693	204.94	693.32	427	79.84	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			659.9	B08		3	0429-0690	520.23	689.89	241	58.53	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1463.3	B08		3	0430-0695	880.75	694.32	235	59.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1015.8	B08		3	0431-0696	240.36	695.66	237	57.60	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2686.6	B08		3	0432-0695	294.42	694.86	346	69.94	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			10314.5	B08		3	0433-0699	599.55	698.54	340	85.01	0.591
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1134.7	B08		3	0434-0697	389.64	697.22	344	71.84	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			898.8	B08		3	0435-0698	119.26	699.23	252	61.26	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2077.9	B08		3	0436-0707	31.70	707.18	300	66.08	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2126.9	B08		3	0437-0708	278.88	708.13	245	57.94	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1395.1	B08		4	0001-0025	601.39	24.22	237	57.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			855.0	B08		4	0002-0026	295.33	26.23	228	57.11	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4656.8	B08		4	0003-0028	414.67	27.91	247	60.53	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5930.5	B08		4	0004-0028	250.53	27.82	319	67.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5039.6	B08		4	0005-0032	338.83	32.81	380	77.84	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4028.8	B08		4	0006-0030	90.85	30.14	263	62.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3979.2	B08		4	0007-0032	119.56	31.29	266	64.53	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3185.3	B08		4	0008-0032	639.87	33.10	275	62.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6226.1	B08		4	0009-0033	706.63	33.30	326	67.26	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6083.0	B08		4	0010-0027	902.79	26.86	134	46.28	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2551.5	B08		4	0011-0036	37.02	36.05	423	77.26	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3866.7	B08		4	0012-0036	864.18	36.52	334	67.01	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4472.8	B08		4	0013-0036	912.23	36.29	173	49.46	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1837.5	B08		4	0014-0037	930.80	36.59	178	52.28	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1154.2	B08		4	0015-0043	677.40	43.66	298	68.08	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1318.5	B08		4	0016-0045	301.85	45.54	255	63.01	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2120.0	B08		4	0017-0051	613.77	48.86	342	82.91	0.625
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4169.3	B08		4	0018-0051	75.69	51.44	486	82.08	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			923.2	B08		4	0019-0048	478.80	47.48	271	66.18	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1684.4	B08		4	0020-0047	936.14	47.06	211	59.36	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4954.5	B08		4	0021-0050	401.86	49.78	218	54.53	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1599.6	B08		4	0022-0050	219.40	49.85	318	68.18	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2547.7	B08		4	0023-0058	740.53	58.83	424	78.57	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2281.3	B08		4	0024-0055	14.62	55.08	250	63.36	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2747.1	B08		4	0025-0056	524.41	56.31	353	71.26	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3277.9	B08		4	0026-0058	888.84	59.06	392	75.01	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7809.8	B08		4	0027-0060	161.25	60.71	268	70.18	0.684
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1376.6	B08		4	0028-0058	312.75	57.64	272	62.53	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			677.3	B08		4	0029-0060	712.81	59.97	208	60.18	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3284.6	B08		4	0030-0062	766.83	63.27	211	54.87	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1182.0	B08		4	0031-0067	475.75	67.22	283	62.28	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3994.3	B08		4	0032-0069	538.58	69.33	492	86.33	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			954.4	B08		4	0033-0067	812.44	67.35	244	59.01	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1352.7	B08		4	0034-0078	318.23	77.48	282	65.01	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1419.7	B08		4	0035-0080	447.27	80.88	269	61.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2752.0	B08		4	0036-0083	227.30	83.62	238	57.70	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1057.2	B08		4	0037-0088	414.50	87.90	319	68.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			339.5	B08		4	0038-0090	269.16	90.06	247	59.70	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1321.8	B08		4	0039-0091	381.61	91.52	302	64.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2075.3	B08		4	0040-0094	159.26	95.10	397	74.08	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1324.2	B08		4	0041-0092	54.99	92.34	244	59.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			12970.8	B08		4	0042-0093	914.93	93.62	295	64.53	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1419.3	B08		4	0043-0097	678.35	97.15	251	59.94	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2846.0	B08		4	0044-0100	209.86	100.34	241	57.11	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2260.7	B08		4	0045-0106	848.60	106.41	340	68.77	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			485.9	B08		4	0046-0104	798.65	103.91	138	47.21	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			510.5	B08		4	0047-0104	810.06	105.10	155	47.21	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2044.9	B08		4	0048-0109	245.63	109.06	236	56.53	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2521.9	B08		4	0049-0113	274.94	112.69	293	69.26	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1545.6	B08		4	0050-0111	326.72	110.87	297	65.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			774.9	B08		4	0051-0119	62.82	119.71	273	61.60	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1918.2	B08		4	0052-0123	742.79	123.25	327	67.94	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1012.4	B08		4	0053-0130	181.11	130.31	271	64.77	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2766.8	B08		4	0054-0129	601.27	129.58	255	63.60	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7277.2	B08		4	0055-0131	483.49	131.95	328	116.47	0.304
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1040.0	B08		4	0056-0131	714.45	131.62	301	67.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2304.1	B08		4	0057-0133	237.78	133.58	318	66.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2608.3	B08		4	0058-0134	84.87	133.92	219	55.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1681.6	B08		4	0059-0139	381.43	139.74	258	60.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3832.1	B08		4	0060-0141	350.79	140.88	431	83.84	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7279.0	B08		4	0061-0143	205.07	142.99	327	77.50	0.684
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1449.9	B08		4	0062-0141	302.22	141.46	315	73.60	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2390.0	B08		4	0063-0146	540.29	146.95	291	68.77	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1836.9	B08		4	0064-0146	578.61	146.38	219	60.53	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3626.4	B08		4	0065-0146	858.94	145.96	342	69.26	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2323.5	B08		4	0066-0146	610.35	145.78	215	53.46	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2277.3	B08		4	0067-0146	690.83	146.41	168	48.63	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3245.4	B08		4	0068-0154	145.03	154.58	440	78.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3716.2	B08		4	0069-0150	766.39	150.31	307	64.18	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2753.2	B08		4	0070-0149	434.55	149.47	229	58.28	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			631.3	B08		4	0071-0150	941.52	150.18	274	63.11	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2269.6	B08		4	0072-0152	63.41	152.90	231	58.43	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2356.7	B08		4	0073-0154	235.64	154.02	260	59.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2051.8	B08		4	0074-0156	501.76	155.35	336	70.67	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1877.2	B08		4	0075-0157	85.02	157.84	241	57.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			8033.8	B08		4	0076-0158	632.22	157.63	165	47.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			390.8	B08		4	0077-0159	100.79	159.94	187	50.63	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3713.4	B08		4	0078-0160	656.24	160.82	256	62.77	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3494.8	B08		4	0079-0170	22.33	169.11	241	60.28	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5152.4	B08		4	0080-0178	791.21	178.94	515	84.91	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3294.5	B08		4	0081-0181	448.03	180.50	247	63.26	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1470.2	B08		4	0082-0182	233.32	181.46	300	68.18	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3210.4	B08		4	0083-0180	310.78	180.92	232	56.28	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3878.7	B08		4	0084-0185	70.87	183.78	239	60.77	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4451.6	B08		4	0085-0186	549.29	186.57	365	70.67	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1541.7	B08		4	0086-0189	897.78	188.80	401	76.08	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2535.6	B08		4	0087-0189	670.54	188.33	240	58.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3084.5	B08		4	0088-0192	286.83	192.36	336	70.08	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6982.6	B08		4	0089-0193	616.47	193.71	205	55.11	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2912.9	B08		4	0090-0199	343.20	198.44	387	74.91	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			731.4	B08		4	0091-0197	474.47	197.98	279	62.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1717.5	B08		4	0092-0200	270.94	200.21	198	54.53	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2100.4	B08		4	0093-0201	515.72	200.27	291	64.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1022.5	B08		4	0094-0203	936.46	203.12	246	60.43	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1204.4	B08		4	0095-0209	22.00	209.14	321	76.18	0.695
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5319.4	B08		4	0096-0205	578.42	204.94	380	71.36	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1355.8	B08		4	0097-0203	380.38	202.68	222	56.28	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			776.2	B08		4	0098-0204	131.18	204.17	215	55.94	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2351.5	B08		4	0099-0207	617.57	207.58	247	61.70	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3445.3	B08		4	0100-0214	706.96	213.52	297	64.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			778.9	B08		4	0101-0217	272.55	216.54	216	59.36	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1312.3	B08		4	0102-0218	120.50	218.74	275	64.53	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4269.7	B08		4	0103-0223	558.63	223.58	465	84.08	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1394.9	B08		4	0104-0220	86.17	220.59	199	52.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3485.4	B08		4	0105-0222	632.34	222.35	268	62.43	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3317.1	B08		4	0106-0223	422.80	223.32	251	59.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2107.9	B08		4	0107-0228	60.11	227.98	256	60.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1072.7	B08		4	0108-0226	587.53	226.41	257	59.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4696.6	B08		4	0109-0228	479.79	228.88	256	63.01	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2409.4	B08		4	0110-0231	242.52	231.78	371	74.18	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4429.9	B08		4	0111-0231	454.26	230.39	231	55.70	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3038.5	B08		4	0112-0240	795.06	239.85	337	68.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2790.7	B08		4	0113-0239	370.73	238.64	297	64.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1904.9	B08		4	0114-0238	395.07	237.47	198	53.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1158.6	B08		4	0115-0238	31.13	238.21	231	57.36	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3750.1	B08		4	0116-0243	163.34	243.94	364	71.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7386.4	B08		4	0117-0242	542.80	242.93	185	55.46	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5477.9	B08		4	0118-0243	855.25	243.75	187	51.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4841.5	B08		4	0119-0246	261.20	246.46	213	54.53	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1332.3	B08		4	0120-0247	506.41	247.48	233	56.28	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			962.8	B08		4	0121-0253	424.23	252.69	261	61.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2531.4	B08		4	0122-0257	16.82	256.93	287	63.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1680.6	B08		4	0123-0259	587.93	260.00	252	65.01	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			9095.8	B08		4	0124-0255	869.18	255.90	154	73.74	0.356
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7090.1	B08		4	0125-0257	549.07	256.53	179	52.53	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4219.4	B08		4	0126-0259	820.99	259.13	215	56.53	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			476.4	B08		4	0127-0263	896.26	264.51	303	67.60	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			566.1	B08		4	0128-0265	370.12	264.64	226	55.70	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1947.9	B08		4	0129-0272	749.01	271.91	526	86.91	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2024.3	B08		4	0130-0270	108.85	270.49	342	69.60	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5582.1	B08		4	0131-0264	258.33	264.53	181	49.46	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			10693.1	B08		4	0132-0268	199.78	268.16	272	61.36	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4895.6	B08		4	0133-0266	434.03	266.36	181	50.04	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2545.6	B08		4	0134-0270	132.52	270.68	237	57.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2821.6	B08		4	0135-0272	383.11	270.73	158	51.11	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1093.7	B08		4	0136-0275	601.91	274.79	252	59.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2285.5	B08		4	0137-0278	569.84	278.36	308	65.26	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2313.1	B08		4	0138-0278	50.14	278.38	250	59.11	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2009.2	B08		4	0139-0278	214.25	278.96	272	61.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1446.2	B08		4	0140-0278	396.04	277.77	240	59.60	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1634.2	B08		4	0141-0279	414.23	279.20	221	57.36	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4721.4	B08		4	0142-0287	479.47	286.64	258	61.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1378.0	B08		4	0143-0291	253.75	291.05	235	60.53	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1878.9	B08		4	0144-0290	556.80	290.27	231	61.01	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2280.1	B08		4	0145-0292	804.57	291.33	267	67.94	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2128.7	B08		4	0146-0293	833.47	292.81	236	57.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6164.2	B08		4	0147-0290	116.51	290.99	150	46.87	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3952.4	B08		4	0148-0291	134.88	291.50	224	54.28	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1010.2	B08		4	0149-0295	170.41	295.48	256	59.36	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5693.3	B08		4	0150-0300	79.90	299.71	377	73.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1846.4	B08		4	0151-0297	340.36	297.42	224	65.01	0.666
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4133.7	B08		4	0152-0306	848.96	306.04	363	70.43	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			871.4	B08		4	0153-0305	580.13	305.85	263	61.60	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2275.5	B08		4	0154-0306	266.38	306.65	255	63.70	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2701.8	B08		4	0155-0304	426.22	304.47	293	70.28	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2145.7	B08		4	0156-0308	771.97	308.78	268	61.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1110.2	B08		4	0157-0310	701.07	310.10	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1575.1	B08		4	0158-0314	241.79	314.07	223	55.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3035.2	B08		4	0159-0318	864.87	318.80	329	69.84	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1620.3	B08		4	0160-0316	426.73	316.36	194	54.87	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			700.9	B08		4	0161-0320	304.77	321.14	227	56.28	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2002.7	B08		4	0162-0327	383.06	326.66	361	74.53	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4416.1	B08		4	0163-0332	509.64	331.99	402	77.50	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			671.3	B08		4	0164-0335	204.03	334.75	270	60.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			860.8	B08		4	0165-0344	355.36	343.79	402	75.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			771.6	B08		4	0166-0339	57.70	339.44	229	57.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4143.0	B08		4	0167-0345	257.77	345.48	367	71.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			371.8	B08		4	0168-0348	683.97	347.91	269	62.18	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1663.9	B08		4	0169-0349	923.36	349.53	318	67.01	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1205.3	B08		4	0170-0350	306.71	349.98	262	60.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2596.8	B08		4	0171-0349	798.73	349.42	249	64.18	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4300.0	B08		4	0172-0354	856.66	353.38	287	62.43	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			934.3	B08		4	0173-0354	27.62	354.81	251	69.84	0.647
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3434.6	B08		4	0174-0361	69.30	360.62	363	70.77	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2280.2	B08		4	0175-0361	794.64	361.10	169	49.70	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5849.3	B08		4	0176-0366	871.02	366.20	355	72.18	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5555.8	B08		4	0177-0369	145.55	369.24	223	55.11	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2533.7	B08		4	0178-0381	287.82	381.21	479	88.33	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1055.9	B08		4	0179-0378	334.49	378.08	223	57.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1496.7	B08		4	0180-0384	670.09	383.67	289	64.18	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1289.3	B08		4	0181-0383	851.40	383.37	236	57.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2451.8	B08		4	0182-0383	917.72	383.24	299	64.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1030.9	B08		4	0183-0386	576.32	386.15	240	59.84	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3742.4	B08		4	0184-0387	418.73	387.11	311	64.18	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6165.9	B08		4	0185-0390	124.30	390.25	186	53.36	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			389.1	B08		4	0186-0394	365.20	394.49	281	66.67	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1219.3	B08		4	0187-0391	494.81	391.49	250	62.18	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			489.7	B08		4	0188-0398	183.49	398.08	301	66.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1004.4	B08		4	0189-0400	98.22	399.80	254	77.84	0.527
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1805.0	B08		4	0190-0400	135.37	401.02	223	54.77	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1787.9	B08		4	0191-0405	156.03	405.04	308	66.43	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			737.7	B08		4	0192-0408	821.50	408.19	249	62.77	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4005.6	B08		4	0193-0411	614.01	410.08	287	65.01	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6891.4	B08		4	0194-0410	649.13	410.07	302	67.01	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			8468.9	B08		4	0195-0417	395.36	417.62	367	72.67	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			890.6	B08		4	0196-0415	479.20	415.09	240	58.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1947.0	B08		4	0197-0416	556.77	415.96	302	66.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1713.3	B08		4	0198-0417	942.83	416.70	256	59.11	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			513.1	B08		4	0199-0419	913.28	418.81	232	57.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2221.6	B08		4	0200-0427	43.01	427.15	337	67.36	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1895.9	B08		4	0201-0426	245.01	425.35	253	63.36	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6171.7	B08		4	0202-0432	322.69	431.90	417	78.08	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6256.1	B08		4	0203-0430	351.01	431.03	219	58.53	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2490.9	B08		4	0204-0437	619.88	438.32	364	82.43	0.673
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2537.2	B08		4	0205-0437	93.59	437.36	451	82.08	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1929.0	B08		4	0206-0436	698.93	436.19	371	71.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3381.0	B08		4	0207-0440	172.17	439.91	341	68.18	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1370.7	B08		4	0208-0441	829.11	440.75	250	61.11	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2272.3	B08		4	0209-0443	796.47	444.09	188	50.53	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			775.1	B08		4	0210-0449	400.15	449.28	231	57.11	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			892.3	B08		4	0211-0454	763.35	453.28	232	57.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3240.3	B08		4	0212-0458	906.67	457.70	363	71.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3814.3	B08		4	0213-0460	423.06	460.13	251	60.28	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4532.0	B08		4	0214-0461	634.10	461.13	243	57.11	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			529.2	B08		4	0215-0463	862.53	463.11	269	61.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			849.0	B08		4	0216-0465	240.80	466.18	243	59.60	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			789.3	B08		4	0217-0464	500.68	464.47	268	60.87	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			8482.9	B08		4	0218-0465	736.76	464.94	140	46.04	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4162.8	B08		4	0219-0467	924.68	467.49	402	74.18	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			647.8	B08		4	0220-0465	106.92	465.57	237	58.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1060.1	B08		4	0221-0473	551.33	473.05	269	63.94	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			11011.8	B08		4	0222-0466	748.72	466.50	110	38.63	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1561.6	B08		4	0223-0472	41.64	471.90	337	70.43	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2385.1	B08		4	0224-0474	434.46	474.20	297	66.77	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3823.9	B08		4	0225-0476	573.17	476.07	272	62.53	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1606.3	B08		4	0226-0478	296.05	477.74	264	63.26	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1897.0	B08		4	0227-0477	587.41	477.46	213	54.63	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3897.8	B08		4	0228-0477	624.85	477.87	249	57.36	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2216.6	B08		4	0229-0478	773.47	478.74	248	62.43	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			8656.2	B08		4	0230-0479	751.17	479.18	167	47.11	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			673.4	B08		4	0231-0481	825.06	480.57	285	64.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4079.3	B08		4	0232-0485	189.56	485.76	327	69.60	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2611.5	B08		4	0233-0485	165.66	485.49	220	53.94	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2886.7	B08		4	0234-0487	331.71	486.88	242	60.28	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1364.2	B08		4	0235-0487	404.26	487.00	244	60.53	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2110.4	B08		4	0236-0489	876.92	489.21	241	57.11	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			527.7	B08		4	0237-0487	97.63	488.05	206	58.53	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1030.4	B08		4	0238-0491	603.73	490.85	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2090.3	B08		4	0239-0491	674.89	490.66	282	62.43	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			832.4	B08		4	0240-0491	378.68	492.19	243	59.11	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2197.9	B08		4	0241-0496	123.05	495.88	287	63.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2159.2	B08		4	0242-0494	814.64	495.00	192	53.11	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2958.1	B08		4	0243-0502	713.55	501.65	378	75.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			151.7	B08		4	0244-0499	510.71	499.10	178	50.87	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3482.2	B08		4	0245-0502	247.12	501.64	313	66.77	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			521.3	B08		4	0246-0503	465.57	503.07	296	69.36	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2505.1	B08		4	0247-0504	207.05	503.81	213	55.46	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6576.0	B08		4	0248-0505	317.37	506.23	205	58.87	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			153.7	B08		4	0249-0505	526.72	504.67	133	44.04	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2023.0	B08		4	0250-0509	893.48	509.56	256	58.53	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			761.9	B08		4	0251-0510	769.85	509.88	229	57.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			976.3	B08		4	0252-0515	912.53	515.34	272	63.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4331.7	B08		4	0253-0516	166.09	516.56	195	52.53	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6356.2	B08		4	0254-0519	324.07	518.57	206	56.53	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1548.7	B08		4	0255-0523	62.95	523.51	283	62.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3389.5	B08		4	0256-0521	408.93	520.60	252	59.01	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3229.5	B08		4	0257-0523	632.41	523.01	299	65.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			666.5	B08		4	0258-0524	349.28	523.74	255	61.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7243.0	B08		4	0259-0525	35.65	525.09	254	65.84	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1043.9	B08		4	0260-0525	667.34	525.91	286	66.43	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1645.3	B08		4	0261-0529	219.15	529.19	279	66.43	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6899.7	B08		4	0262-0527	823.19	526.28	182	51.11	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3905.6	B08		4	0263-0529	189.07	529.13	203	53.11	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2378.6	B08		4	0264-0535	305.67	536.40	353	71.94	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			706.8	B08		4	0265-0536	271.64	534.96	247	62.87	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2171.9	B08		4	0266-0538	853.41	538.09	256	62.43	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3307.3	B08		4	0267-0543	519.43	543.96	379	74.67	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4904.8	B08		4	0268-0543	462.46	543.84	146	47.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			895.6	B08		4	0269-0545	612.72	545.77	302	66.67	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4418.1	B08		4	0270-0546	483.70	546.75	285	67.60	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1042.3	B08		4	0271-0546	120.03	546.11	297	64.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3548.2	B08		4	0272-0551	386.36	551.34	382	75.50	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4140.1	B08		4	0273-0545	452.01	545.29	113	39.21	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5878.1	B08		4	0274-0549	826.28	549.64	208	55.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			703.2	B08		4	0275-0553	769.54	553.39	208	57.01	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1230.0	B08		4	0276-0553	896.29	553.02	252	59.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2976.0	B08		4	0277-0556	169.22	558.38	335	78.18	0.689
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4472.9	B08		4	0278-0552	257.75	552.29	134	46.04	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4205.8	B08		4	0279-0555	927.66	554.65	218	53.70	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2230.1	B08		4	0280-0562	695.36	561.59	340	69.84	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3443.0	B08		4	0281-0560	39.92	559.67	217	54.28	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			684.2	B08		4	0282-0559	792.50	558.57	225	55.94	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			584.4	B08		4	0283-0562	661.76	562.49	244	58.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			907.2	B08		4	0284-0566	442.11	565.66	250	59.11	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5764.8	B08		4	0285-0571	626.34	571.54	350	72.91	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			596.6	B08		4	0286-0573	745.64	573.60	268	64.28	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1313.9	B08		4	0287-0579	202.08	578.90	254	59.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1948.0	B08		4	0288-0580	355.71	580.32	261	71.26	0.646
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			595.3	B08		4	0289-0578	55.91	579.20	240	59.11	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2093.0	B08		4	0290-0584	101.22	583.64	271	62.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			767.8	B08		4	0291-0587	896.46	587.20	239	57.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1038.1	B08		4	0292-0590	503.77	590.15	227	55.70	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			703.5	B08		4	0293-0593	414.11	594.58	329	71.01	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2176.4	B08		4	0294-0594	466.09	594.47	170	48.63	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			723.9	B08		4	0295-0595	631.79	594.98	228	56.28	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			584.7	B08		4	0296-0599	330.30	599.10	240	58.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1382.4	B08		4	0297-0600	878.35	600.18	225	56.87	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2699.4	B08		4	0298-0604	265.33	603.70	313	65.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1366.7	B08		4	0299-0605	521.43	604.79	295	64.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7764.0	B08		4	0300-0603	612.33	602.58	160	46.87	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3025.7	B08		4	0301-0605	933.74	605.18	223	55.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1426.6	B08		4	0302-0606	483.26	606.68	184	53.36	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3359.3	B08		4	0303-0607	792.06	607.40	263	59.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4142.9	B08		4	0304-0610	238.36	610.41	227	56.28	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2134.1	B08		4	0305-0612	213.73	611.44	215	55.70	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7176.5	B08		4	0306-0615	619.13	615.35	176	49.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2687.4	B08		4	0307-0622	857.02	622.48	252	59.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2076.7	B08		4	0308-0620	180.51	620.54	198	53.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			873.5	B08		4	0309-0621	647.58	621.74	256	60.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			494.8	B08		4	0310-0626	931.96	626.09	277	71.60	0.679
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1240.6	B08		4	0311-0627	369.29	627.77	272	62.18	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2308.6	B08		4	0312-0628	240.10	627.52	191	51.11	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2211.4	B08		4	0313-0631	112.43	631.22	295	62.77	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			414.8	B08		4	0314-0631	594.04	631.05	250	59.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2945.2	B08		4	0315-0634	396.37	634.05	245	61.60	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5378.7	B08		4	0316-0636	439.91	636.09	375	71.60	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2029.1	B08		4	0317-0638	518.47	638.36	294	65.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			942.6	B08		4	0318-0638	851.28	638.87	219	54.87	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3090.6	B08		4	0319-0639	71.19	639.60	175	49.80	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2296.8	B08		4	0320-0643	355.90	642.50	300	67.50	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1718.9	B08		4	0321-0643	720.20	643.02	246	59.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4127.9	B08		4	0322-0650	276.52	648.14	493	95.50	0.679
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2905.9	B08		4	0323-0648	471.83	647.96	344	69.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			691.9	B08		4	0324-0643	623.44	642.89	206	61.36	0.688
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3971.2	B08		4	0325-0651	550.39	650.86	460	82.33	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			437.3	B08		4	0326-0649	751.38	649.17	248	62.53	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1905.2	B08		4	0327-0655	677.54	656.14	307	64.18	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1274.6	B08		4	0328-0657	92.49	656.86	234	56.28	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1431.6	B08		4	0329-0665	419.08	665.94	283	62.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2866.2	B08		4	0330-0665	464.09	665.02	258	60.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4315.9	B08		4	0331-0668	138.91	668.35	265	62.18	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			972.9	B08		4	0332-0670	579.98	670.48	218	55.70	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5215.5	B08		4	0333-0669	157.98	669.52	183	52.53	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4419.4	B08		4	0334-0677	304.96	677.31	383	75.01	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5892.8	B08		4	0335-0676	369.06	676.55	337	71.84	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1858.4	B08		4	0336-0676	106.14	676.43	226	57.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3177.7	B08		4	0337-0681	489.96	681.89	293	70.53	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2989.2	B08		4	0338-0679	219.54	679.54	244	57.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7991.3	B08		4	0339-0682	439.59	681.45	316	65.60	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6257.6	B08		4	0340-0682	341.94	682.00	147	49.11	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2445.9	B08		4	0341-0686	771.81	686.37	246	59.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5961.9	B08		4	0342-0687	352.74	686.86	160	48.87	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2842.9	B08		4	0343-0689	66.90	688.40	228	58.28	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3644.8	B08		4	0344-0695	584.28	694.25	440	78.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			568.6	B08		4	0345-0693	190.14	693.68	257	58.77	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1336.3	B08		4	0346-0694	508.55	695.05	278	66.18	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3219.4	B08		4	0347-0699	91.54	698.54	186	51.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			548.5	B08		4	0348-0701	321.09	700.57	259	61.94	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			301.9	B08		4	0349-0701	852.08	700.68	243	63.01	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1698.4	B08		4	0350-0704	139.10	703.95	232	56.18	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1013.3	B08		4	0351-0707	82.78	707.84	131	43.11	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3347.4	B08		4	0352-0709	249.40	709.38	245	58.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4413.1	B08		4	0353-0708	826.55	707.85	222	55.36	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2645.7	B08		5	0001-0030	295.53	30.88	233	58.53	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4733.8	B08		5	0002-0025	894.81	25.66	191	53.70	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3077.7	B08		5	0003-0032	81.20	32.85	281	64.43	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1070.1	B08		5	0004-0030	386.33	30.11	243	57.36	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2592.0	B08		5	0005-0033	557.30	33.38	357	71.01	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3634.8	B08		5	0006-0035	647.06	35.19	464	81.50	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3261.5	B08		5	0007-0034	764.63	33.50	320	66.43	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4640.2	B08		5	0008-0038	17.47	38.56	167	48.28	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			957.1	B08		5	0009-0038	843.73	38.50	257	60.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3395.4	B08		5	0010-0042	103.70	41.70	286	67.01	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1733.1	B08		5	0011-0044	38.23	44.27	412	80.67	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2716.1	B08		5	0012-0040	618.67	39.46	201	53.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2274.1	B08		5	0013-0041	935.18	41.15	306	66.08	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4771.5	B08		5	0014-0045	205.15	45.67	328	68.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			998.0	B08		5	0015-0046	353.28	45.99	285	63.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1506.7	B08		5	0016-0046	438.62	46.09	260	60.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1599.7	B08		5	0017-0047	119.53	46.85	227	64.53	0.685
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5941.5	B08		5	0018-0053	699.81	51.11	402	85.50	0.691
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2187.6	B08		5	0019-0054	728.32	54.59	354	69.26	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5445.2	B08		5	0020-0053	890.76	53.19	218	61.84	0.716
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3641.4	B08		5	0021-0058	502.59	57.05	187	55.01	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1498.0	B08		5	0022-0061	125.53	61.72	186	57.60	0.705
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1837.0	B08		5	0023-0061	392.17	61.28	300	68.77	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1671.6	B08		5	0024-0063	865.42	63.69	284	63.36	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1607.1	B08		5	0025-0063	445.32	62.52	211	55.11	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3466.4	B08		5	0026-0068	600.83	67.82	454	81.74	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5835.1	B08		5	0027-0065	641.80	65.14	294	62.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			10011.4	B08		5	0028-0072	240.01	71.95	365	82.33	0.677
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2383.0	B08		5	0029-0078	458.41	79.37	349	74.67	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			855.0	B08		5	0030-0074	786.62	75.24	278	64.53	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5814.6	B08		5	0031-0083	537.97	83.52	521	87.84	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			857.8	B08		5	0032-0080	179.82	80.24	229	56.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2057.4	B08		5	0033-0081	307.41	81.64	241	59.36	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4129.7	B08		5	0034-0088	583.99	88.43	520	87.50	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2611.1	B08		5	0035-0088	146.95	87.66	229	58.53	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			673.1	B08		5	0036-0087	849.53	86.85	227	55.94	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1261.1	B08		5	0037-0091	693.33	91.22	257	63.60	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2496.7	B08		5	0038-0093	756.68	92.98	318	65.84	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2659.8	B08		5	0039-0093	325.58	92.74	406	75.60	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			13225.2	B08		5	0040-0095	19.60	95.63	297	63.70	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			659.5	B08		5	0041-0096	621.58	96.99	278	64.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			920.7	B08		5	0042-0096	919.57	96.30	211	53.11	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1128.7	B08		5	0043-0099	829.40	98.50	296	63.94	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1145.5	B08		5	0044-0098	366.33	98.06	223	56.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3024.3	B08		5	0045-0102	285.85	102.24	239	58.77	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1229.0	B08		5	0046-0102	477.28	102.34	344	72.43	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2591.7	B08		5	0047-0105	179.89	105.00	227	57.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5778.2	B08		5	0048-0104	387.49	104.30	273	63.36	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5191.3	B08		5	0049-0110	219.10	111.22	376	75.01	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			967.7	B08		5	0050-0115	432.47	114.86	232	56.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5094.0	B08		5	0051-0122	262.18	122.33	412	75.26	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2952.5	B08		5	0052-0121	613.89	121.83	356	69.60	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2031.9	B08		5	0053-0123	124.96	123.50	317	64.77	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4813.1	B08		5	0054-0127	499.69	125.98	329	73.01	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1655.6	B08		5	0055-0125	317.65	125.28	227	55.94	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4143.8	B08		5	0056-0131	934.50	130.73	378	75.50	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2350.7	B08		5	0057-0128	671.91	127.74	201	52.53	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1382.0	B08		5	0058-0129	98.76	129.47	303	69.36	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2301.7	B08		5	0059-0132	181.45	131.89	279	62.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2779.9	B08		5	0060-0135	445.04	135.96	391	73.26	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			565.4	B08		5	0061-0134	731.47	134.75	276	64.18	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			856.0	B08		5	0062-0138	792.76	138.55	261	59.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2168.8	B08		5	0063-0135	814.56	134.93	256	61.70	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1529.9	B08		5	0064-0142	529.19	142.32	257	60.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			779.0	B08		5	0065-0141	863.11	141.44	233	57.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			493.2	B08		5	0066-0142	911.83	142.77	267	63.60	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3470.7	B08		5	0067-0154	221.83	153.34	667	103.64	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5642.1	B08		5	0068-0147	339.76	146.34	344	69.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1109.9	B08		5	0069-0146	572.14	145.82	248	57.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1662.6	B08		5	0070-0147	654.58	147.15	297	64.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2762.1	B08		5	0071-0147	817.26	148.11	194	56.04	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6290.8	B08		5	0072-0149	362.62	149.64	258	63.11	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1548.1	B08		5	0073-0153	468.98	152.96	303	65.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			865.5	B08		5	0074-0152	46.23	152.22	276	62.53	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2129.9	B08		5	0075-0155	326.26	154.69	198	53.60	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2692.2	B08		5	0076-0158	131.27	157.77	294	64.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1006.4	B08		5	0077-0160	412.59	160.42	281	64.53	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1340.6	B08		5	0078-0159	860.83	159.21	240	58.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			917.3	B08		5	0079-0168	300.99	166.56	212	59.11	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			658.9	B08		5	0080-0169	563.53	168.26	300	72.43	0.719
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6983.0	B08		5	0081-0169	283.17	169.11	340	70.77	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2430.8	B08		5	0082-0170	520.66	170.02	368	70.43	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1888.0	B08		5	0083-0173	714.30	172.85	300	76.43	0.645
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2533.9	B08		5	0084-0176	599.34	175.96	280	65.94	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			485.4	B08		5	0085-0177	767.45	177.37	261	62.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7170.6	B08		5	0086-0183	297.78	183.35	207	53.70	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1361.7	B08		5	0087-0188	458.13	187.82	262	61.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1673.6	B08		5	0088-0186	827.90	186.74	189	55.36	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3072.1	B08		5	0089-0190	123.16	189.82	298	64.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1161.5	B08		5	0090-0189	743.36	189.75	238	57.70	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1863.0	B08		5	0091-0191	435.58	190.96	270	59.94	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1075.5	B08		5	0092-0192	688.43	191.92	324	67.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			569.1	B08		5	0093-0195	802.67	195.07	270	67.26	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2323.2	B08		5	0094-0197	379.86	197.12	323	66.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1531.7	B08		5	0095-0200	532.69	199.42	324	68.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			8078.6	B08		5	0096-0199	294.42	199.07	185	53.11	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1396.7	B08		5	0097-0201	256.90	201.30	177	48.87	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2467.5	B08		5	0098-0202	489.30	202.45	295	62.77	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1005.5	B08		5	0099-0205	89.56	204.45	266	63.60	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			701.9	B08		5	0100-0202	599.49	200.85	172	53.70	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1662.3	B08		5	0101-0203	855.77	204.11	257	60.28	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1017.2	B08		5	0102-0205	41.27	205.25	244	59.60	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4609.2	B08		5	0103-0209	559.41	208.92	460	83.26	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5796.9	B08		5	0104-0209	818.71	209.27	352	69.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			638.7	B08		5	0105-0212	363.48	212.07	256	61.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			944.2	B08		5	0106-0207	608.13	207.61	120	42.28	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7945.8	B08		5	0107-0213	243.40	213.91	322	69.26	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1875.4	B08		5	0108-0216	625.16	216.59	319	66.18	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3815.7	B08		5	0109-0223	312.51	224.14	373	80.33	0.726
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			683.4	B08		5	0110-0221	154.93	221.42	238	57.70	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			711.2	B08		5	0111-0222	388.83	221.77	269	61.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			753.7	B08		5	0112-0224	462.43	223.48	257	59.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4277.5	B08		5	0113-0227	527.41	227.24	242	57.46	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1003.1	B08		5	0114-0231	138.45	230.97	229	55.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1517.9	B08		5	0115-0231	354.39	231.96	211	54.53	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3416.9	B08		5	0116-0235	717.67	234.91	391	75.01	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5089.6	B08		5	0117-0232	327.87	231.96	209	53.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			692.1	B08		5	0118-0233	485.95	233.10	274	61.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4530.1	B08		5	0119-0234	549.68	234.97	201	53.36	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			486.6	B08		5	0120-0236	920.16	237.33	301	67.84	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3955.0	B08		5	0121-0238	698.47	238.19	231	56.53	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1373.1	B08		5	0122-0243	786.65	243.09	305	70.43	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1175.8	B08		5	0123-0243	182.01	242.88	185	52.53	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2132.9	B08		5	0124-0247	806.30	247.73	346	69.01	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4539.6	B08		5	0125-0248	342.03	248.20	243	61.60	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2980.9	B08		5	0126-0246	747.93	245.72	211	53.70	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1115.3	B08		5	0127-0251	627.61	251.69	278	63.70	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1305.9	B08		5	0128-0251	839.54	251.41	302	67.01	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1009.7	B08		5	0129-0253	672.20	253.35	290	66.67	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1970.8	B08		5	0130-0255	416.23	254.89	359	69.60	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1869.9	B08		5	0131-0257	234.72	258.05	280	62.18	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1594.2	B08		5	0132-0258	926.87	258.22	304	65.01	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2375.5	B08		5	0133-0259	529.60	259.62	179	50.28	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1325.0	B08		5	0134-0263	370.21	262.63	206	54.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2743.4	B08		5	0135-0265	886.90	264.94	301	63.94	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			944.6	B08		5	0136-0267	603.02	266.82	234	57.94	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3613.9	B08		5	0137-0271	722.33	270.70	281	65.26	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1045.4	B08		5	0138-0274	788.48	273.86	302	64.67	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			743.0	B08		5	0139-0274	286.41	274.47	246	58.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5187.5	B08		5	0140-0275	578.73	274.92	399	75.84	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2669.0	B08		5	0141-0278	471.49	278.13	376	72.43	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			643.5	B08		5	0142-0279	763.35	279.52	327	70.77	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4688.0	B08		5	0143-0285	683.06	284.72	557	96.81	0.747
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			741.4	B08		5	0144-0283	157.84	283.31	270	62.28	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1127.2	B08		5	0145-0282	931.41	282.99	332	68.77	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2621.0	B08		5	0146-0285	305.08	285.40	281	66.43	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1005.6	B08		5	0147-0289	855.11	291.27	292	73.26	0.684
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1174.5	B08		5	0148-0292	652.58	292.68	293	64.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3356.2	B08		5	0149-0293	254.65	293.39	363	72.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1892.5	B08		5	0150-0292	351.44	291.95	169	50.53	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1570.0	B08		5	0151-0296	832.99	296.12	326	66.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1270.2	B08		5	0152-0301	386.36	301.03	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1277.5	B08		5	0153-0297	621.94	297.75	232	59.46	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			447.2	B08		5	0154-0306	946.53	306.29	208	58.53	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2633.3	B08		5	0155-0305	480.20	305.32	257	61.94	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2945.4	B08		5	0156-0306	344.77	306.66	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			561.7	B08		5	0157-0310	929.56	310.24	264	59.36	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3226.6	B08		5	0158-0311	743.22	311.03	377	73.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3918.9	B08		5	0159-0312	518.81	312.77	358	71.01	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1141.0	B08		5	0160-0319	431.69	319.49	278	62.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2606.0	B08		5	0161-0321	867.44	320.62	300	65.01	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5142.3	B08		5	0162-0322	603.54	321.53	290	64.77	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3403.2	B08		5	0163-0324	762.76	324.64	284	64.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1285.9	B08		5	0164-0324	697.15	324.25	312	65.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4234.4	B08		5	0165-0328	256.84	329.58	236	62.77	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1826.7	B08		5	0166-0330	903.78	330.83	318	65.94	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2138.5	B08		5	0167-0332	640.93	332.77	255	59.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4579.6	B08		5	0168-0334	385.47	335.14	313	70.43	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3708.3	B08		5	0169-0339	199.53	339.86	402	79.26	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3862.3	B08		5	0170-0337	336.46	336.80	347	68.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			930.1	B08		5	0171-0337	109.22	337.39	234	55.70	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3719.2	B08		5	0172-0341	728.54	341.60	301	64.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4496.3	B08		5	0173-0348	247.30	348.39	312	73.01	0.735
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3107.0	B08		5	0174-0347	518.90	347.95	266	61.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3235.2	B08		5	0175-0350	550.53	349.87	304	66.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1655.9	B08		5	0176-0351	28.14	351.54	308	65.01	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			950.6	B08		5	0177-0351	671.10	352.07	300	66.43	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2660.6	B08		5	0178-0351	288.63	351.57	242	57.36	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2836.5	B08		5	0179-0353	605.08	353.64	328	67.84	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1103.4	B08		5	0180-0350	388.40	350.64	213	55.70	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3783.4	B08		5	0181-0355	313.02	354.74	290	68.67	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1148.6	B08		5	0182-0363	367.52	363.21	367	73.74	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2903.3	B08		5	0183-0361	868.51	361.52	228	55.70	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3699.2	B08		5	0184-0364	481.68	364.53	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2210.6	B08		5	0185-0366	744.53	366.18	361	73.84	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2136.1	B08		5	0186-0370	155.81	369.80	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1656.0	B08		5	0187-0368	583.87	367.91	293	63.01	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1144.6	B08		5	0188-0369	793.88	369.56	267	62.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			554.5	B08		5	0189-0374	425.48	374.39	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			998.3	B08		5	0190-0376	815.09	375.59	267	71.01	0.665
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7701.2	B08		5	0191-0377	708.52	377.08	346	67.60	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1235.0	B08		5	0192-0379	228.04	379.25	321	67.60	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5924.9	B08		5	0193-0382	762.06	381.50	344	70.18	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2385.4	B08		5	0194-0384	331.51	384.50	264	59.94	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1769.4	B08		5	0195-0383	57.91	383.42	245	60.18	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			674.3	B08		5	0196-0384	638.43	383.82	173	55.36	0.709
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2424.7	B08		5	0197-0385	22.61	385.34	298	64.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1471.5	B08		5	0198-0387	437.65	386.44	260	61.70	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1171.8	B08		5	0199-0387	264.16	387.60	220	54.87	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			308.0	B08		5	0200-0388	941.49	389.46	247	73.26	0.578
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1099.6	B08		5	0201-0387	298.35	387.32	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3637.8	B08		5	0202-0388	545.48	388.10	243	57.70	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1578.3	B08		5	0203-0390	123.06	389.49	212	55.36	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5343.9	B08		5	0204-0390	474.10	389.95	175	51.36	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1091.1	B08		5	0205-0398	374.06	400.10	337	75.60	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3620.0	B08		5	0206-0399	415.64	399.44	436	78.33	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1148.5	B08		5	0207-0397	845.35	396.76	330	67.36	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			509.3	B08		5	0208-0396	924.48	396.26	284	64.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			852.6	B08		5	0209-0400	96.75	399.85	268	60.53	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2940.4	B08		5	0210-0400	184.98	400.23	329	68.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1412.4	B08		5	0211-0402	596.83	402.10	318	65.94	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5230.0	B08		5	0212-0400	767.01	400.97	234	57.11	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3112.1	B08		5	0213-0402	234.24	403.18	236	57.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3782.4	B08		5	0214-0405	880.80	404.72	302	65.84	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4627.8	B08		5	0215-0408	503.17	407.93	387	73.84	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3139.1	B08		5	0216-0412	850.68	411.78	215	55.70	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1826.2	B08		5	0217-0418	295.11	418.75	263	60.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			858.7	B08		5	0218-0417	753.99	417.39	295	65.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1763.2	B08		5	0219-0419	47.72	418.73	257	58.53	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3990.1	B08		5	0220-0418	264.96	418.82	253	58.77	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2818.8	B08		5	0221-0420	553.94	420.70	336	68.08	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			507.2	B08		5	0222-0421	18.23	420.86	230	57.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2527.0	B08		5	0223-0423	649.21	422.77	326	67.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2546.4	B08		5	0224-0419	716.50	418.66	237	59.36	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1379.5	B08		5	0225-0423	159.47	423.16	268	60.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3025.2	B08		5	0226-0425	207.15	424.76	172	50.63	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			894.2	B08		5	0227-0427	249.84	426.62	227	60.18	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1325.9	B08		5	0228-0427	107.31	427.34	224	63.70	0.694
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			443.4	B08		5	0229-0429	93.76	430.11	133	48.53	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1814.1	B08		5	0230-0431	771.38	430.11	262	61.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1846.0	B08		5	0231-0434	318.65	433.86	279	61.60	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1081.1	B08		5	0232-0436	825.71	436.90	333	77.26	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1659.5	B08		5	0233-0434	357.52	434.58	213	55.11	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			968.2	B08		5	0234-0436	338.58	436.41	238	56.77	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3002.6	B08		5	0235-0440	453.24	439.97	251	59.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2182.8	B08		5	0236-0440	716.10	440.61	294	67.01	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			762.5	B08		5	0237-0446	893.39	445.58	305	64.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2669.4	B08		5	0238-0446	397.03	446.42	252	59.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3646.9	B08		5	0239-0446	759.84	446.37	329	66.53	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2570.9	B08		5	0240-0453	613.76	454.39	375	73.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3485.0	B08		5	0241-0451	254.41	451.25	265	60.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			765.0	B08		5	0242-0449	646.18	449.41	106	40.04	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1389.6	B08		5	0243-0454	851.35	454.92	285	66.18	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			839.7	B08		5	0244-0454	459.56	455.29	210	58.53	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			888.7	B08		5	0245-0457	416.62	458.31	258	66.28	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1732.0	B08		5	0246-0459	474.40	458.61	271	62.04	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			797.7	B08		5	0247-0463	580.88	463.68	282	64.53	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6808.0	B08		5	0248-0462	679.75	461.14	229	58.77	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4456.1	B08		5	0249-0466	315.02	467.28	416	85.15	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7818.4	B08		5	0250-0466	340.97	464.47	322	79.84	0.635
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3339.2	B08		5	0251-0467	388.98	466.28	351	71.01	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3663.3	B08		5	0252-0464	512.97	464.52	247	58.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1072.1	B08		5	0253-0468	540.87	467.65	321	68.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3437.5	B08		5	0254-0468	712.10	468.59	270	61.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4218.6	B08		5	0255-0469	29.72	469.57	398	73.60	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			846.2	B08		5	0256-0469	164.99	469.79	233	57.94	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1750.9	B08		5	0257-0469	362.12	469.38	203	53.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			958.6	B08		5	0258-0469	881.30	468.81	265	61.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2022.9	B08		5	0259-0476	686.25	474.81	263	66.67	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1619.4	B08		5	0260-0473	210.69	474.10	179	51.11	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5117.8	B08		5	0261-0474	566.06	474.60	193	54.18	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1084.2	B08		5	0262-0477	259.90	477.08	208	61.01	0.702
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1127.1	B08		5	0263-0478	916.21	478.80	260	64.18	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5922.3	B08		5	0264-0484	226.41	484.79	327	75.50	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4684.7	B08		5	0265-0486	669.26	486.42	312	65.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			720.3	B08		5	0266-0487	312.59	487.82	276	63.01	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			998.6	B08		5	0267-0486	388.91	486.62	233	59.36	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4426.3	B08		5	0268-0486	560.86	485.82	117	40.28	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2584.5	B08		5	0269-0495	621.80	496.89	534	92.91	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4444.4	B08		5	0270-0491	782.00	491.75	311	66.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			991.3	B08		5	0271-0491	816.80	492.21	224	56.53	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3736.6	B08		5	0272-0493	248.22	493.46	176	48.87	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			949.2	B08		5	0273-0500	654.32	501.07	277	63.94	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			926.2	B08		5	0274-0503	300.62	504.45	260	62.77	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4284.6	B08		5	0275-0506	798.25	505.60	326	70.53	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1967.0	B08		5	0276-0505	82.77	505.79	367	73.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2521.6	B08		5	0277-0504	208.16	504.19	201	51.94	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3517.2	B08		5	0278-0509	168.81	509.67	238	62.77	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3627.3	B08		5	0279-0509	454.85	508.90	311	65.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2307.6	B08		5	0280-0510	567.98	510.19	257	60.28	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3934.6	B08		5	0281-0508	251.51	507.81	140	46.39	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			419.8	B08		5	0282-0514	580.97	514.25	225	62.28	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1658.6	B08		5	0283-0513	947.71	513.22	271	60.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5288.6	B08		5	0284-0514	814.93	514.00	223	58.87	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			475.0	B08		5	0285-0515	766.65	516.13	269	60.28	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			940.8	B08		5	0286-0517	17.14	517.56	263	61.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1224.4	B08		5	0287-0518	185.06	519.87	257	64.77	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1519.2	B08		5	0288-0515	907.14	515.25	189	53.36	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1982.9	B08		5	0289-0520	851.89	519.62	257	59.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			817.4	B08		5	0290-0525	152.92	525.78	265	64.53	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4344.1	B08		5	0291-0523	500.45	522.77	313	65.01	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1751.1	B08		5	0292-0521	247.66	521.15	148	44.87	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1027.9	B08		5	0293-0526	310.58	526.06	250	61.36	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5784.5	B08		5	0294-0530	232.78	529.58	310	66.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2976.5	B08		5	0295-0528	699.51	528.23	219	54.87	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3088.5	B08		5	0296-0529	807.78	529.93	285	66.18	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1610.0	B08		5	0297-0529	602.50	528.81	243	57.36	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1060.0	B08		5	0298-0530	464.02	530.85	276	63.94	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4895.9	B08		5	0299-0535	526.23	535.26	278	62.53	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			446.1	B08		5	0300-0534	194.17	534.36	146	49.46	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			593.4	B08		5	0301-0537	631.59	536.87	273	62.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			376.4	B08		5	0302-0538	203.78	538.71	112	38.39	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4342.3	B08		5	0303-0541	943.14	542.26	251	61.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4053.8	B08		5	0304-0544	285.41	544.89	227	58.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			983.6	B08		5	0305-0542	66.73	542.40	222	54.53	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1628.5	B08		5	0306-0545	394.84	545.45	237	57.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4304.4	B08		5	0307-0547	416.32	546.55	299	65.60	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1259.8	B08		5	0308-0549	501.07	550.03	257	67.01	0.719
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2693.4	B08		5	0309-0548	914.84	547.20	322	67.60	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1049.2	B08		5	0310-0547	861.68	547.45	240	58.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1168.5	B08		5	0311-0550	333.81	549.73	238	60.43	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2899.3	B08		5	0312-0552	96.40	551.94	339	71.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5540.8	B08		5	0313-0550	271.40	550.14	145	47.70	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2334.2	B08		5	0314-0558	159.75	557.98	250	57.94	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4360.2	B08		5	0315-0557	32.26	556.67	214	53.70	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2482.1	B08		5	0316-0560	226.45	559.89	257	66.77	0.724
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2273.3	B08		5	0317-0563	884.68	563.30	252	60.53	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			927.1	B08		5	0318-0563	187.93	563.47	259	60.18	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4400.2	B08		5	0319-0566	488.24	566.76	425	80.43	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			658.8	B08		5	0320-0567	726.77	566.37	288	65.01	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3895.1	B08		5	0321-0570	782.32	570.74	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1073.1	B08		5	0322-0572	138.28	572.28	266	60.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			980.7	B08		5	0323-0577	605.38	577.36	304	65.01	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			942.2	B08		5	0324-0577	257.41	577.32	212	53.36	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			495.0	B08		5	0325-0584	826.31	584.13	267	61.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2359.6	B08		5	0326-0589	905.56	588.89	251	63.60	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			831.8	B08		5	0327-0591	303.02	590.39	204	53.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			759.0	B08		5	0328-0592	671.11	592.34	289	61.94	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2016.4	B08		5	0329-0594	218.77	593.42	285	65.01	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3235.2	B08		5	0330-0593	842.59	593.52	206	53.94	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2906.9	B08		5	0331-0597	890.09	598.13	215	55.70	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4692.5	B08		5	0332-0601	172.79	601.25	348	76.67	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1794.6	B08		5	0333-0602	495.55	601.80	263	59.60	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3279.7	B08		5	0334-0602	698.64	601.29	225	56.53	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2006.6	B08		5	0335-0605	348.19	605.29	285	67.50	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3598.2	B08		5	0336-0606	585.00	606.28	382	74.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3045.3	B08		5	0337-0607	38.14	607.31	229	58.18	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4979.0	B08		5	0338-0610	540.02	609.60	234	59.01	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3326.5	B08		5	0339-0610	417.90	610.62	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			954.3	B08		5	0340-0612	509.01	612.46	249	59.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2269.1	B08		5	0341-0611	793.96	611.55	308	64.77	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2140.8	B08		5	0342-0614	923.70	614.42	241	56.77	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1981.2	B08		5	0343-0616	320.44	616.36	299	65.26	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2045.3	B08		5	0344-0619	712.48	618.24	295	63.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2944.5	B08		5	0345-0621	215.75	620.77	456	88.91	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1192.4	B08		5	0346-0620	757.65	620.59	258	61.94	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3615.6	B08		5	0347-0622	453.10	622.06	232	56.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2427.8	B08		5	0348-0624	546.22	624.36	285	65.01	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1190.6	B08		5	0349-0623	174.39	622.87	236	56.53	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2484.2	B08		5	0350-0622	870.83	622.71	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4104.8	B08		5	0351-0628	605.87	627.99	397	76.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2515.9	B08		5	0352-0624	946.97	624.84	281	62.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			552.5	B08		5	0353-0628	36.42	628.14	277	72.43	0.664
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1765.6	B08		5	0354-0627	248.60	627.74	260	59.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1019.9	B08		5	0355-0629	830.24	628.84	222	63.26	0.697
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1579.9	B08		5	0356-0633	370.33	632.80	275	64.77	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2212.6	B08		5	0357-0636	408.74	635.45	333	70.18	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4378.2	B08		5	0358-0634	559.32	634.44	189	51.46	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1231.0	B08		5	0359-0638	768.63	638.12	249	61.11	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			572.8	B08		5	0360-0644	477.73	644.58	285	65.60	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1974.8	B08		5	0361-0646	141.04	646.00	238	58.53	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3120.9	B08		5	0362-0645	624.71	644.66	226	55.70	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3484.4	B08		5	0363-0648	565.94	648.44	244	60.53	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2367.7	B08		5	0364-0655	923.94	655.47	386	75.60	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2410.8	B08		5	0365-0654	227.52	653.58	294	63.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2239.1	B08		5	0366-0653	685.29	652.45	228	58.77	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			763.0	B08		5	0367-0655	855.20	655.65	287	62.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1708.8	B08		5	0368-0656	278.26	655.64	249	62.53	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1238.8	B08		5	0369-0655	514.61	654.75	228	56.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			917.4	B08		5	0370-0656	649.18	656.57	234	57.94	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2001.9	B08		5	0371-0656	726.71	655.54	244	57.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			932.5	B08		5	0372-0663	819.55	663.14	272	61.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1264.1	B08		5	0373-0663	156.97	663.83	233	57.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2658.0	B08		5	0374-0668	103.57	668.66	288	64.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1107.3	B08		5	0375-0668	297.00	668.30	230	56.77	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5273.5	B08		5	0376-0676	637.78	676.57	328	67.94	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			634.5	B08		5	0377-0675	746.61	675.50	218	56.28	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1730.8	B08		5	0378-0673	784.03	672.98	198	54.53	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4794.3	B08		5	0379-0680	130.23	679.86	225	55.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1373.9	B08		5	0380-0681	352.98	681.85	262	60.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			912.2	B08		5	0381-0678	400.87	678.35	219	56.53	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2432.5	B08		5	0382-0680	564.26	680.36	266	60.18	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			923.7	B08		5	0383-0681	809.99	680.69	259	58.53	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1167.6	B08		5	0384-0681	260.11	680.66	242	61.11	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1069.3	B08		5	0385-0682	443.93	681.27	251	58.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2090.0	B08		5	0386-0681	518.84	681.30	267	61.94	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1709.3	B08		5	0387-0689	851.09	689.63	349	71.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1246.1	B08		5	0388-0685	944.31	685.34	228	57.11	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1934.8	B08		5	0389-0689	331.92	689.08	240	58.28	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5134.1	B08		5	0390-0688	175.30	688.12	233	61.60	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			845.0	B08		5	0391-0697	481.88	696.74	235	59.11	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1015.4	B08		5	0392-0696	499.67	696.24	222	59.36	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4209.0	B08		5	0393-0699	454.71	698.92	176	50.28	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2934.6	B08		5	0394-0702	763.55	701.67	360	71.84	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3335.9	B08		5	0395-0702	181.65	702.87	251	59.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6928.0	B08		5	0396-0704	832.21	704.19	334	67.60	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1631.9	B08		5	0397-0706	628.57	706.03	292	65.36	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1443.2	B08		5	0398-0707	607.56	708.06	218	56.28	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1320.0	B08		5	0399-0710	334.25	709.85	209	53.11	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			388.8	B08		5	0400-0711	275.53	711.28	216	59.70	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5045.5	B08		6	0001-0028	566.76	28.73	247	61.36	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2528.3	B08		6	0002-0030	203.14	30.57	437	79.26	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3064.0	B08		6	0003-0027	815.03	27.38	269	60.53	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			723.7	B08		6	0004-0028	518.48	27.57	250	59.94	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1636.5	B08		6	0005-0032	878.67	31.47	241	60.18	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1163.0	B08		6	0006-0034	238.40	33.37	239	58.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3230.7	B08		6	0007-0032	292.61	32.32	341	69.11	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			8383.2	B08		6	0008-0042	603.48	42.80	661	124.71	0.534
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1438.0	B08		6	0009-0035	387.87	34.87	352	71.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1046.9	B08		6	0010-0036	117.52	36.42	257	60.77	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2321.4	B08		6	0011-0044	29.89	44.06	304	66.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5240.8	B08		6	0012-0047	136.17	48.47	208	63.36	0.651
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2496.7	B08		6	0013-0046	277.18	45.73	246	58.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1543.3	B08		6	0014-0048	920.08	48.74	236	58.53	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4638.2	B08		6	0015-0053	47.84	53.09	219	56.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			637.4	B08		6	0016-0057	391.41	57.27	229	56.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2947.7	B08		6	0017-0059	692.75	59.01	218	55.94	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4763.3	B08		6	0018-0062	852.91	61.86	412	77.50	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1307.9	B08		6	0019-0057	351.17	57.35	167	50.28	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1418.4	B08		6	0020-0061	204.10	61.84	226	55.94	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2362.7	B08		6	0021-0063	730.17	63.45	233	59.11	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			727.0	B08		6	0022-0064	498.72	63.16	245	69.01	0.646
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3619.1	B08		6	0023-0063	678.46	63.79	253	60.53	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2074.3	B08		6	0024-0062	800.33	61.85	244	58.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			416.0	B08		6	0025-0068	226.95	67.53	270	62.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1110.7	B08		6	0026-0066	278.84	66.39	246	60.18	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1887.7	B08		6	0027-0072	181.60	72.64	259	59.60	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7131.4	B08		6	0028-0073	303.97	72.75	142	50.87	0.690
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6718.2	B08		6	0029-0075	873.16	74.78	181	55.46	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1279.8	B08		6	0030-0077	137.57	77.45	281	70.77	0.705
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3368.0	B08		6	0031-0072	369.31	71.86	216	56.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1499.8	B08		6	0032-0074	93.35	74.42	277	66.18	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3211.7	B08		6	0033-0076	749.60	75.53	247	60.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			794.8	B08		6	0034-0074	828.53	75.12	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			608.2	B08		6	0035-0074	468.50	73.93	140	53.60	0.612
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7449.9	B08		6	0036-0075	887.21	74.53	157	46.28	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5829.4	B08		6	0037-0076	291.02	76.96	172	51.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3528.7	B08		6	0038-0078	326.11	77.87	206	53.11	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3769.3	B08		6	0039-0081	945.11	81.27	264	61.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			558.4	B08		6	0040-0083	475.33	83.97	171	69.50	0.445
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4085.7	B08		6	0041-0084	646.17	83.21	217	57.01	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2707.9	B08		6	0042-0084	782.09	84.02	216	62.43	0.697
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5821.3	B08		6	0043-0090	621.04	89.96	363	79.50	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2795.6	B08		6	0044-0090	264.22	90.64	234	58.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5462.4	B08		6	0045-0094	656.83	94.92	306	66.08	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7073.1	B08		6	0046-0095	382.88	95.30	152	47.46	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2682.1	B08		6	0047-0096	915.08	96.39	207	53.70	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1968.4	B08		6	0048-0101	758.37	101.39	211	57.46	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6127.0	B08		6	0049-0100	845.38	100.20	293	63.94	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4462.9	B08		6	0050-0102	96.53	102.95	297	64.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1830.0	B08		6	0051-0101	298.56	101.23	244	58.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2636.8	B08		6	0052-0100	798.87	100.66	225	56.28	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2617.2	B08		6	0053-0104	198.14	103.63	280	61.60	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4399.4	B08		6	0054-0103	877.50	103.52	247	58.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4750.2	B08		6	0055-0102	942.13	102.05	251	59.70	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			10181.5	B08		6	0056-0107	744.36	107.67	162	47.21	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7232.8	B08		6	0057-0108	391.85	108.59	153	45.46	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1499.9	B08		6	0058-0113	78.79	113.28	277	65.36	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			748.5	B08		6	0059-0113	242.98	113.41	218	53.70	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6989.3	B08		6	0060-0116	766.18	115.78	150	48.04	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5892.1	B08		6	0061-0116	804.17	116.51	207	54.28	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1913.5	B08		6	0062-0119	279.97	119.87	232	56.28	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1448.6	B08		6	0063-0123	914.69	123.08	259	61.01	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1936.6	B08		6	0064-0122	429.92	122.38	403	79.60	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3894.2	B08		6	0065-0128	842.71	127.97	474	112.37	0.472
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			13370.2	B08		6	0066-0127	889.58	127.61	385	73.50	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3765.5	B08		6	0067-0125	389.34	124.73	336	69.36	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			641.9	B08		6	0068-0127	691.92	126.57	245	71.84	0.597
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			866.0	B08		6	0069-0127	175.41	127.89	218	53.36	0.962
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5146.9	B08		6	0070-0132	125.98	132.86	282	62.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4245.7	B08		6	0071-0134	29.09	133.61	376	76.08	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1295.4	B08		6	0072-0130	208.92	130.13	164	48.28	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6523.8	B08		6	0073-0131	813.04	132.02	186	52.87	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1859.5	B08		6	0074-0133	355.82	133.13	343	67.94	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3055.7	B08		6	0075-0138	732.48	138.25	276	61.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1282.7	B08		6	0076-0144	149.47	145.45	274	73.60	0.636
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3006.8	B08		6	0077-0140	309.01	139.24	216	55.94	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1158.6	B08		6	0078-0143	196.39	143.48	203	56.28	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1963.5	B08		6	0079-0149	786.60	150.31	291	65.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2273.2	B08		6	0080-0150	386.37	149.85	275	60.77	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3944.5	B08		6	0081-0148	817.30	148.22	250	75.01	0.558
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			903.8	B08		6	0082-0150	946.96	149.91	242	58.18	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4131.5	B08		6	0083-0153	273.24	154.02	289	65.01	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			882.4	B08		6	0084-0155	131.09	155.52	247	59.01	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4842.2	B08		6	0085-0157	246.98	157.73	337	69.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2029.6	B08		6	0086-0158	457.24	158.53	339	68.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			867.7	B08		6	0087-0158	208.77	158.21	242	58.18	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3062.7	B08		6	0088-0166	49.73	166.25	354	70.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1816.5	B08		6	0089-0166	287.54	166.76	248	58.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2768.8	B08		6	0090-0175	870.84	175.38	381	75.26	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			712.1	B08		6	0091-0172	735.60	172.28	234	59.36	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1235.3	B08		6	0092-0175	835.95	175.10	250	57.94	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			645.1	B08		6	0093-0179	464.94	179.35	215	56.28	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4558.5	B08		6	0094-0179	190.45	179.29	343	71.36	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			411.3	B08		6	0095-0182	76.79	183.02	272	67.01	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			9835.5	B08		6	0096-0182	373.99	181.65	227	79.98	0.446
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2975.8	B08		6	0097-0181	690.04	180.83	277	62.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1285.0	B08		6	0098-0181	231.23	181.50	233	55.94	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			510.6	B08		6	0099-0183	917.64	183.66	167	53.60	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1325.5	B08		6	0100-0184	776.85	184.50	201	52.53	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1270.1	B08		6	0101-0185	758.74	184.56	217	53.36	0.958
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2229.1	B08		6	0102-0188	800.20	188.71	333	70.43	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			694.3	B08		6	0103-0190	397.97	190.57	256	61.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2667.3	B08		6	0104-0192	899.37	192.46	295	64.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5927.2	B08		6	0105-0200	108.71	200.14	359	70.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			920.5	B08		6	0106-0201	56.29	200.70	237	57.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4628.2	B08		6	0107-0200	681.99	201.10	237	62.18	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3667.2	B08		6	0108-0201	834.80	200.47	355	73.26	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1437.8	B08		6	0109-0203	176.64	202.27	263	66.18	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1423.9	B08		6	0110-0209	310.51	208.53	366	75.94	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4823.1	B08		6	0111-0209	472.29	209.39	215	55.94	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1373.4	B08		6	0112-0214	606.09	213.84	242	58.53	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1841.6	B08		6	0113-0214	818.32	214.27	239	57.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3300.5	B08		6	0114-0217	248.87	217.11	332	67.01	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5638.2	B08		6	0115-0217	500.00	216.60	186	49.94	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2836.2	B08		6	0116-0220	568.92	220.19	257	58.77	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5590.4	B08		6	0117-0224	726.78	223.78	320	67.60	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2781.3	B08		6	0118-0225	142.72	225.23	246	57.60	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3125.1	B08		6	0119-0226	234.60	227.06	200	53.70	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			932.9	B08		6	0120-0230	948.80	230.29	228	56.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			8720.7	B08		6	0121-0228	659.39	227.78	153	49.80	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2935.4	B08		6	0122-0236	910.61	235.65	274	68.43	0.735
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5879.6	B08		6	0123-0235	375.34	234.72	210	54.04	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2478.4	B08		6	0124-0234	790.33	235.13	163	49.36	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			390.6	B08		6	0125-0238	896.97	238.66	203	60.77	0.691
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1027.6	B08		6	0126-0240	625.02	239.52	279	64.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3190.7	B08		6	0127-0246	178.90	245.48	428	85.50	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3785.2	B08		6	0128-0245	438.35	245.28	355	72.77	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1130.9	B08		6	0129-0245	646.48	243.67	266	67.60	0.732
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7500.3	B08		6	0130-0239	663.76	238.35	168	49.21	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1332.2	B08		6	0131-0243	67.63	243.52	213	56.28	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			9359.8	B08		6	0132-0247	486.91	246.95	253	64.18	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4376.8	B08		6	0133-0248	531.09	248.44	249	61.01	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2645.7	B08		6	0134-0251	417.01	250.38	212	58.77	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4325.8	B08		6	0135-0253	118.79	252.54	264	60.43	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2505.2	B08		6	0136-0252	675.65	252.20	285	64.53	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2627.9	B08		6	0137-0256	749.14	256.19	300	66.18	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6720.0	B08		6	0138-0253	368.01	252.98	164	51.11	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1485.6	B08		6	0139-0259	598.98	259.20	285	64.87	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1827.8	B08		6	0140-0256	824.76	255.95	217	56.77	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1193.2	B08		6	0141-0259	797.20	259.04	239	58.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1578.9	B08		6	0142-0261	21.52	261.09	298	65.01	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1175.8	B08		6	0143-0259	875.37	259.08	221	56.77	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			280.2	B08		6	0144-0261	553.37	260.39	166	60.18	0.576
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3569.5	B08		6	0145-0263	328.58	263.39	305	65.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3623.2	B08		6	0146-0265	465.15	265.36	291	63.11	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2886.1	B08		6	0147-0271	68.92	272.53	363	108.23	0.389
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3444.4	B08		6	0148-0272	378.93	270.94	392	79.84	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2102.3	B08		6	0149-0267	850.10	267.54	159	47.70	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1988.7	B08		6	0150-0267	833.39	268.08	242	59.70	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4410.5	B08		6	0151-0270	502.39	270.25	255	61.11	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1084.7	B08		6	0152-0269	695.23	268.96	241	59.46	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			721.0	B08		6	0153-0274	150.00	273.10	270	66.43	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1632.1	B08		6	0154-0274	212.56	275.08	217	53.94	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			290.1	B08		6	0155-0272	548.82	271.76	128	44.87	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1012.1	B08		6	0156-0279	749.96	279.48	346	77.60	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3210.6	B08		6	0157-0284	596.70	283.79	306	64.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1124.0	B08		6	0158-0285	26.16	285.99	324	68.18	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			407.6	B08		6	0159-0287	859.77	287.10	212	55.36	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3639.8	B08		6	0160-0289	272.88	290.40	237	58.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2857.0	B08		6	0161-0300	476.24	299.32	489	97.88	0.641
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1572.7	B08		6	0162-0294	791.90	294.98	252	59.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2789.5	B08		6	0163-0297	932.42	297.09	289	64.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1377.9	B08		6	0164-0296	306.06	296.08	262	61.60	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1134.6	B08		6	0165-0298	403.47	297.49	312	65.60	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6032.3	B08		6	0166-0296	349.69	295.43	248	58.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1221.1	B08		6	0167-0295	433.52	295.30	274	64.77	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7724.4	B08		6	0168-0305	645.39	304.40	304	64.18	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2314.1	B08		6	0169-0305	706.26	305.14	243	59.11	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5986.0	B08		6	0170-0313	93.83	312.17	329	85.50	0.566
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			467.4	B08		6	0171-0309	41.27	308.98	197	57.11	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1574.0	B08		6	0172-0306	730.39	305.71	220	55.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			754.2	B08		6	0173-0312	150.84	313.41	276	66.77	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			540.2	B08		6	0174-0313	24.52	313.16	261	59.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1741.7	B08		6	0175-0313	793.17	313.02	264	59.70	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3590.5	B08		6	0176-0315	439.81	316.01	212	55.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1497.0	B08		6	0177-0317	396.13	317.87	407	81.01	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5253.5	B08		6	0178-0318	545.03	318.51	318	65.01	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1235.3	B08		6	0179-0327	754.74	327.17	263	61.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5193.8	B08		6	0180-0331	645.40	330.50	297	62.77	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2198.7	B08		6	0181-0334	491.61	334.18	219	55.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1877.0	B08		6	0182-0342	301.32	342.68	475	83.50	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2181.2	B08		6	0183-0340	61.74	339.55	158	51.11	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1381.6	B08		6	0184-0339	792.04	339.66	201	52.53	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2170.2	B08		6	0185-0342	72.89	343.66	231	63.11	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5671.8	B08		6	0186-0341	550.94	341.55	258	58.53	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5727.1	B08		6	0187-0345	938.04	345.64	413	76.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2279.5	B08		6	0188-0345	247.62	345.92	257	62.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1850.2	B08		6	0189-0345	736.76	345.12	222	56.18	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1802.4	B08		6	0190-0352	915.67	352.18	387	81.01	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			753.4	B08		6	0191-0352	377.14	351.79	219	57.70	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2972.7	B08		6	0192-0351	498.07	351.01	213	53.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6803.6	B08		6	0193-0353	692.35	352.74	324	67.36	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4355.8	B08		6	0194-0357	364.46	357.85	224	56.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			542.8	B08		6	0195-0360	461.11	360.46	289	67.84	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1451.5	B08		6	0196-0361	649.92	360.91	230	56.53	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3923.4	B08		6	0197-0363	727.33	363.16	361	72.08	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1822.5	B08		6	0198-0362	812.22	361.84	247	58.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6967.2	B08		6	0199-0362	324.84	362.43	285	62.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2164.8	B08		6	0200-0364	433.33	364.31	205	53.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2107.9	B08		6	0201-0369	678.26	369.38	217	56.77	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3027.4	B08		6	0202-0376	638.40	376.92	207	56.18	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1168.6	B08		6	0203-0372	911.90	372.84	164	47.21	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2681.8	B08		6	0204-0379	717.08	380.18	358	71.26	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1059.1	B08		6	0205-0383	151.22	382.57	305	66.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2931.1	B08		6	0206-0382	289.74	381.60	226	57.36	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2445.9	B08		6	0207-0386	890.49	386.72	261	61.84	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1576.1	B08		6	0208-0387	834.65	386.96	213	56.87	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			532.1	B08		6	0209-0390	82.98	390.33	240	58.77	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			305.5	B08		6	0210-0392	36.05	392.71	211	67.01	0.590
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1206.2	B08		6	0211-0392	183.93	392.40	256	60.53	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			8654.7	B08		6	0212-0392	298.98	391.86	144	51.01	0.695
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1464.9	B08		6	0213-0394	114.07	394.56	296	64.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2409.1	B08		6	0214-0394	281.33	394.54	232	57.11	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5230.9	B08		6	0215-0394	412.94	394.12	236	58.18	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5600.2	B08		6	0216-0397	433.84	396.77	302	64.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2162.4	B08		6	0217-0397	808.95	397.53	287	63.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			444.8	B08		6	0218-0399	16.41	398.13	187	55.36	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7009.5	B08		6	0219-0397	306.38	397.19	106	41.46	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			693.0	B08		6	0220-0401	566.73	401.12	273	61.60	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2675.7	B08		6	0221-0400	702.01	399.92	259	60.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1417.5	B08		6	0222-0402	262.75	402.44	261	59.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1279.3	B08		6	0223-0402	896.29	402.41	262	64.28	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5967.0	B08		6	0224-0402	917.05	402.60	176	50.53	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1097.5	B08		6	0225-0402	210.70	402.36	213	55.46	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1629.3	B08		6	0226-0406	634.54	405.98	182	52.53	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1449.6	B08		6	0227-0407	617.53	407.50	242	58.04	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2198.7	B08		6	0228-0410	844.46	410.10	232	59.11	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1388.4	B08		6	0229-0414	863.80	414.11	264	61.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3829.2	B08		6	0230-0419	316.94	419.35	384	73.50	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1778.7	B08		6	0231-0416	247.34	416.66	321	66.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2889.8	B08		6	0232-0418	543.53	418.25	242	59.36	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2465.0	B08		6	0233-0420	160.59	420.35	351	71.84	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1259.4	B08		6	0234-0420	689.89	420.40	331	71.01	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			8516.1	B08		6	0235-0417	919.49	417.35	174	48.04	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2824.8	B08		6	0236-0420	650.08	420.06	260	61.36	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2639.3	B08		6	0237-0424	349.77	424.67	239	59.84	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3453.3	B08		6	0238-0422	529.94	422.92	197	54.28	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			541.0	B08		6	0239-0422	766.88	421.56	159	53.94	0.687
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4401.1	B08		6	0240-0430	842.47	430.45	339	69.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1443.3	B08		6	0241-0430	118.40	430.35	258	61.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3371.7	B08		6	0242-0431	611.93	431.41	318	67.01	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1039.7	B08		6	0243-0431	914.42	431.01	211	57.36	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6535.9	B08		6	0244-0432	934.62	432.12	214	58.53	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1018.1	B08		6	0245-0435	49.57	435.67	253	58.28	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			565.5	B08		6	0246-0432	771.14	431.83	128	51.70	0.602
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1457.6	B08		6	0247-0434	896.37	433.69	188	51.94	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6317.7	B08		6	0248-0443	875.29	443.91	144	50.53	0.709
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2066.8	B08		6	0249-0443	261.47	443.67	254	59.11	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1937.7	B08		6	0250-0444	558.68	443.73	283	64.53	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6823.6	B08		6	0251-0449	448.25	449.72	290	66.77	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1079.6	B08		6	0252-0448	228.27	448.43	318	67.94	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7765.1	B08		6	0253-0454	590.24	454.84	417	75.01	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			403.9	B08		6	0254-0455	50.24	454.70	312	65.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2458.4	B08		6	0255-0452	174.21	452.40	213	55.80	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5544.2	B08		6	0256-0455	701.19	455.85	283	66.67	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1378.3	B08		6	0257-0452	853.43	452.66	186	53.70	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4403.8	B08		6	0258-0457	671.01	456.28	211	57.94	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2635.4	B08		6	0259-0458	464.15	458.21	320	68.18	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5038.2	B08		6	0260-0458	747.26	458.97	233	64.43	0.705
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6565.0	B08		6	0261-0462	420.15	463.25	341	75.50	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1071.2	B08		6	0262-0459	85.49	459.20	238	57.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1138.5	B08		6	0263-0459	507.37	459.32	214	54.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4645.2	B08		6	0264-0465	314.66	465.76	333	71.01	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2640.9	B08		6	0265-0466	136.07	466.13	354	71.11	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			986.8	B08		6	0266-0468	172.72	467.77	250	63.70	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1188.7	B08		6	0267-0473	491.59	472.88	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			704.3	B08		6	0268-0473	815.16	473.17	253	59.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2629.8	B08		6	0269-0478	780.69	477.91	325	68.77	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5054.6	B08		6	0270-0475	227.97	475.28	214	57.11	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1769.3	B08		6	0271-0480	211.70	481.35	251	62.18	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3522.7	B08		6	0272-0483	859.42	482.86	271	64.18	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5216.1	B08		6	0273-0485	752.35	484.85	237	60.87	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2285.3	B08		6	0274-0483	585.53	483.73	243	63.36	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			673.0	B08		6	0275-0484	385.51	485.19	164	50.87	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2033.0	B08		6	0276-0488	89.40	489.15	395	75.01	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4398.7	B08		6	0277-0489	296.69	488.85	244	58.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			825.6	B08		6	0278-0492	143.08	492.32	228	55.36	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3013.4	B08		6	0279-0491	336.64	491.70	220	56.28	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1379.2	B08		6	0280-0492	513.77	492.88	252	59.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1305.6	B08		6	0281-0498	48.00	498.20	251	59.94	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3437.6	B08		6	0282-0498	852.36	498.53	283	65.60	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			542.5	B08		6	0283-0500	111.63	500.19	240	58.77	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1321.9	B08		6	0284-0500	478.43	499.97	207	51.46	0.982
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2666.3	B08		6	0285-0501	795.41	501.71	210	53.70	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3717.1	B08		6	0286-0503	443.46	502.86	393	76.67	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4055.6	B08		6	0287-0504	559.57	504.46	323	67.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2928.1	B08		6	0288-0504	831.86	504.47	290	62.53	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			854.9	B08		6	0289-0505	333.16	504.68	199	54.87	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1170.0	B08		6	0290-0509	934.43	509.12	471	88.57	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1672.7	B08		6	0291-0510	601.38	510.61	350	70.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			806.1	B08		6	0292-0512	911.09	511.98	298	68.18	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4534.0	B08		6	0293-0514	516.97	514.15	236	57.70	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1674.3	B08		6	0294-0515	42.43	515.91	283	62.18	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			598.8	B08		6	0295-0516	653.99	516.16	302	66.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			958.1	B08		6	0296-0518	896.99	517.89	228	60.77	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1344.6	B08		6	0297-0518	64.81	518.39	236	56.77	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1324.1	B08		6	0298-0521	259.18	521.20	288	64.43	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3253.7	B08		6	0299-0522	759.26	522.01	321	66.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			515.1	B08		6	0300-0521	695.19	521.83	316	67.84	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			991.3	B08		6	0301-0524	307.39	524.49	237	63.60	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5426.6	B08		6	0302-0524	537.36	523.04	202	57.36	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6111.0	B08		6	0303-0526	738.26	525.71	335	67.11	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			922.9	B08		6	0304-0530	442.40	529.89	215	53.94	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			782.7	B08		6	0305-0529	222.70	529.77	259	62.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1054.2	B08		6	0306-0533	148.88	533.45	266	64.77	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1153.1	B08		6	0307-0537	520.57	536.09	307	66.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			877.3	B08		6	0308-0540	795.24	540.18	237	62.77	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1242.4	B08		6	0309-0541	927.11	540.64	263	61.36	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1223.5	B08		6	0310-0541	111.28	540.83	251	61.94	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6173.8	B08		6	0311-0538	356.39	538.08	144	45.36	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			820.4	B08		6	0312-0542	430.57	542.86	238	62.43	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4505.8	B08		6	0313-0544	37.62	545.15	245	60.18	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3245.8	B08		6	0314-0547	665.59	548.67	353	72.67	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2356.6	B08		6	0315-0546	456.52	545.84	221	57.36	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			988.5	B08		6	0316-0549	376.55	548.79	276	62.87	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			729.4	B08		6	0317-0551	228.15	552.09	280	66.77	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			604.3	B08		6	0318-0547	558.15	547.60	267	61.94	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			787.6	B08		6	0319-0549	84.88	549.15	205	52.28	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6140.1	B08		6	0320-0548	343.66	548.44	170	50.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3557.2	B08		6	0321-0550	623.33	550.48	234	56.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2185.6	B08		6	0322-0553	852.44	553.40	224	58.53	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1818.8	B08		6	0323-0552	702.41	551.60	300	63.36	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			823.7	B08		6	0324-0555	65.46	554.14	214	59.70	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7491.8	B08		6	0325-0559	412.48	559.15	240	58.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3111.0	B08		6	0326-0556	466.53	556.84	195	54.53	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1176.0	B08		6	0327-0560	785.46	559.58	267	62.43	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1983.0	B08		6	0328-0560	950.45	560.92	238	60.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			320.0	B08		6	0329-0566	215.30	565.75	257	61.70	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1415.3	B08		6	0330-0569	328.41	568.40	269	61.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			984.9	B08		6	0331-0574	461.56	575.67	264	67.36	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6864.9	B08		6	0332-0573	871.02	573.07	373	70.18	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3696.0	B08		6	0333-0572	501.78	572.33	159	49.11	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4383.9	B08		6	0334-0578	44.25	578.31	327	75.01	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2396.4	B08		6	0335-0576	831.51	575.40	184	50.87	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6892.3	B08		6	0336-0579	405.43	579.94	296	65.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1953.4	B08		6	0337-0580	940.14	579.77	260	61.94	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6705.0	B08		6	0338-0582	118.12	582.44	355	70.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1708.7	B08		6	0339-0581	545.71	581.43	267	62.43	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1339.7	B08		6	0340-0583	758.34	583.80	270	60.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2457.0	B08		6	0341-0590	861.76	590.73	212	56.28	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1278.4	B08		6	0342-0593	897.40	593.24	281	63.60	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3533.5	B08		6	0343-0595	503.64	594.99	153	46.28	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2165.6	B08		6	0344-0598	186.48	597.91	353	69.84	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			304.1	B08		6	0345-0598	925.56	598.86	254	59.11	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1426.1	B08		6	0346-0594	793.86	594.85	119	44.28	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			723.9	B08		6	0347-0601	45.57	601.17	270	62.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4851.5	B08		6	0348-0604	674.21	604.94	328	70.77	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1458.6	B08		6	0349-0605	300.47	604.75	327	68.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1529.7	B08		6	0350-0604	797.84	604.85	204	61.94	0.668
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1135.3	B08		6	0351-0610	121.59	610.26	241	58.53	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5016.4	B08		6	0352-0614	419.35	614.52	331	67.60	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2239.6	B08		6	0353-0617	18.20	617.26	228	54.53	0.964
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			688.8	B08		6	0354-0620	371.00	620.02	395	78.08	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			869.0	B08		6	0355-0618	818.54	619.07	286	63.11	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1001.7	B08		6	0356-0621	886.62	621.92	270	61.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1432.1	B08		6	0357-0624	540.31	624.49	305	65.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2375.2	B08		6	0358-0624	108.75	623.92	311	66.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			918.8	B08		6	0359-0624	238.42	623.48	277	64.53	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2669.2	B08		6	0360-0627	41.31	627.73	283	63.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3593.5	B08		6	0361-0632	771.16	631.75	395	74.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2284.8	B08		6	0362-0638	948.41	638.14	366	72.43	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7755.4	B08		6	0363-0639	381.42	638.47	293	64.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1670.4	B08		6	0364-0642	841.54	642.68	274	63.84	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			742.2	B08		6	0365-0646	214.06	645.66	254	63.11	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			496.8	B08		6	0366-0646	912.19	645.78	237	57.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2054.5	B08		6	0367-0648	64.54	648.32	224	56.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1271.5	B08		6	0368-0650	489.58	649.78	282	63.01	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2337.7	B08		6	0369-0653	422.26	652.20	405	76.67	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5506.4	B08		6	0370-0648	826.17	648.23	215	54.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1672.5	B08		6	0371-0653	113.86	652.70	231	58.87	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4971.2	B08		6	0372-0653	602.39	653.01	329	69.01	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2425.7	B08		6	0373-0658	18.30	658.28	370	72.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			553.3	B08		6	0374-0655	712.94	655.48	293	65.36	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5639.8	B08		6	0375-0658	328.43	658.02	305	64.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			802.9	B08		6	0376-0664	781.20	663.74	247	59.36	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2412.1	B08		6	0377-0662	900.70	662.82	224	56.53	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1571.4	B08		6	0378-0664	148.61	664.67	220	53.94	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			924.4	B08		6	0379-0663	524.35	662.59	272	61.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2305.0	B08		6	0380-0665	835.11	664.12	225	61.01	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1573.7	B08		6	0381-0673	210.21	673.07	188	52.87	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2261.0	B08		6	0382-0672	430.67	672.77	245	58.87	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			988.0	B08		6	0383-0673	822.78	674.69	235	58.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1720.3	B08		6	0384-0675	614.54	674.84	272	63.01	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4697.0	B08		6	0385-0674	859.84	673.39	222	57.01	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3371.2	B08		6	0386-0675	663.73	675.40	406	77.01	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			455.4	B08		6	0387-0677	744.93	677.07	237	59.11	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2962.3	B08		6	0388-0683	78.83	682.69	354	73.26	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2166.0	B08		6	0389-0681	930.27	681.12	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5805.7	B08		6	0390-0686	260.52	686.06	309	64.18	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1727.2	B08		6	0391-0684	802.37	683.50	206	53.11	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			939.6	B08		6	0392-0686	126.55	686.41	213	56.28	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3953.7	B08		6	0393-0687	406.24	687.58	300	63.60	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1323.2	B08		6	0394-0688	38.48	688.08	219	55.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1289.1	B08		6	0395-0692	336.61	691.64	260	61.01	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1633.1	B08		6	0396-0693	377.30	693.73	143	47.80	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			753.0	B08		6	0397-0694	473.18	694.78	246	59.94	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2697.1	B08		6	0398-0700	708.19	700.42	393	75.01	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1093.3	B08		6	0399-0699	725.25	699.07	256	59.70	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5550.4	B08		6	0400-0703	517.50	703.30	205	54.53	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4005.3	B08		6	0401-0706	576.37	706.19	196	53.94	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3376.6	B08		6	0402-0707	116.69	707.16	302	66.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1486.1	B08		6	0403-0709	376.77	708.80	241	61.70	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1123.6	B08		7	0001-0026	81.39	26.79	137	43.94	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3730.8	B08		7	0002-0029	247.78	28.87	248	59.11	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4797.4	B08		7	0003-0028	824.82	27.21	222	55.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2890.9	B08		7	0004-0033	560.84	33.13	299	64.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1530.5	B08		7	0005-0031	711.12	31.85	252	59.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5299.3	B08		7	0006-0036	632.02	36.41	452	80.08	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4620.2	B08		7	0007-0036	390.73	36.07	154	54.28	0.657
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3129.6	B08		7	0008-0040	52.67	39.62	298	66.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6176.1	B08		7	0009-0037	403.64	36.79	145	43.80	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7253.5	B08		7	0010-0043	16.80	44.41	162	53.70	0.706
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4855.5	B08		7	0011-0040	381.00	39.87	117	42.87	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5786.8	B08		7	0012-0047	30.32	48.28	217	59.94	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2100.0	B08		7	0013-0047	435.38	48.08	253	60.53	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1295.4	B08		7	0014-0046	920.57	45.84	220	55.11	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			647.9	B08		7	0015-0051	272.52	52.16	262	67.50	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7404.4	B08		7	0016-0050	486.01	50.03	449	81.26	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1092.9	B08		7	0017-0057	78.11	57.33	229	56.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6413.1	B08		7	0018-0063	120.28	62.76	458	79.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1497.2	B08		7	0019-0063	57.27	62.60	233	62.77	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3561.4	B08		7	0020-0064	310.19	63.67	254	74.08	0.582
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5374.0	B08		7	0021-0067	750.66	66.50	391	72.67	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3092.1	B08		7	0022-0066	821.45	66.51	304	65.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1164.8	B08		7	0023-0066	167.52	66.48	242	59.94	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1953.5	B08		7	0024-0067	451.50	67.38	306	67.84	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1152.5	B08		7	0025-0073	68.84	72.68	197	51.70	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4063.7	B08		7	0026-0078	911.74	78.18	401	74.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1460.8	B08		7	0027-0081	195.65	81.18	335	69.26	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5098.1	B08		7	0028-0083	493.62	83.30	468	86.91	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1995.1	B08		7	0029-0081	336.24	81.83	194	56.18	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			545.6	B08		7	0030-0084	688.64	84.51	298	66.67	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4537.4	B08		7	0031-0084	776.67	84.47	260	60.18	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1744.0	B08		7	0032-0087	403.82	87.15	260	59.60	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3958.1	B08		7	0033-0092	240.65	92.13	310	64.77	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3662.6	B08		7	0034-0096	739.27	96.03	240	58.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3662.5	B08		7	0035-0102	295.43	101.57	365	80.43	0.709
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			925.6	B08		7	0036-0106	440.25	106.12	284	64.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4733.8	B08		7	0037-0112	414.56	114.02	365	86.91	0.607
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			823.1	B08		7	0038-0113	24.04	114.25	259	58.77	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1995.5	B08		7	0039-0115	912.85	115.08	264	62.43	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1918.5	B08		7	0040-0112	91.25	111.96	205	54.28	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1540.0	B08		7	0041-0116	861.89	116.11	264	61.36	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1137.5	B08		7	0042-0122	319.98	122.32	317	69.60	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1052.4	B08		7	0043-0121	338.52	120.85	147	52.63	0.667
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2172.6	B08		7	0044-0123	389.16	122.64	301	66.43	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			812.0	B08		7	0045-0121	188.05	120.87	238	64.77	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2499.3	B08		7	0046-0130	584.23	129.68	444	82.08	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			528.1	B08		7	0047-0127	632.15	126.73	300	77.26	0.632
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2030.5	B08		7	0048-0128	236.19	127.72	257	57.70	0.970
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1852.5	B08		7	0049-0132	83.70	132.95	279	65.36	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3948.1	B08		7	0050-0132	157.49	131.97	151	45.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3837.4	B08		7	0051-0132	199.98	133.12	219	57.94	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2656.8	B08		7	0052-0135	440.86	136.01	267	62.77	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1841.5	B08		7	0053-0138	378.41	138.40	250	61.94	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1917.3	B08		7	0054-0143	802.02	142.93	505	87.84	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6487.4	B08		7	0055-0140	183.23	140.29	197	52.28	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6625.8	B08		7	0056-0141	168.37	141.83	204	53.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4940.1	B08		7	0057-0146	272.79	146.49	375	76.18	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1167.5	B08		7	0058-0143	290.74	142.61	123	42.28	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2232.5	B08		7	0059-0147	689.43	148.17	378	74.08	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2634.1	B08		7	0060-0151	888.71	150.40	366	70.77	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			997.5	B08		7	0061-0155	242.33	155.57	246	59.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7288.6	B08		7	0062-0159	495.41	159.53	476	81.26	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5856.2	B08		7	0063-0154	140.59	153.43	151	49.36	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4494.8	B08		7	0064-0161	339.70	161.13	531	97.40	0.703
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7611.7	B08		7	0065-0159	361.14	158.65	346	75.01	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3581.4	B08		7	0066-0159	674.90	159.46	220	57.60	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2080.9	B08		7	0067-0164	634.54	165.00	233	63.84	0.718
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5079.7	B08		7	0068-0163	134.49	163.21	162	51.60	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1514.4	B08		7	0069-0164	415.04	164.40	351	71.01	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1520.6	B08		7	0070-0164	465.84	164.38	268	60.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1591.5	B08		7	0071-0165	88.45	165.93	207	53.70	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6382.0	B08		7	0072-0167	43.25	167.63	240	56.28	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3731.3	B08		7	0073-0169	215.15	169.30	400	75.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1652.4	B08		7	0074-0174	818.62	173.99	505	87.26	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1161.6	B08		7	0075-0171	853.97	170.66	361	72.08	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2219.1	B08		7	0076-0171	607.12	171.03	221	55.70	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3273.3	B08		7	0077-0176	307.71	176.43	399	76.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3870.0	B08		7	0078-0174	773.89	174.10	219	53.94	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			16217.6	B08		7	0079-0173	920.75	174.10	151	66.43	0.430
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1751.2	B08		7	0080-0179	627.32	179.07	275	68.77	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			573.8	B08		7	0081-0183	92.24	182.24	227	58.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1108.7	B08		7	0082-0186	412.67	186.07	258	59.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1932.5	B08		7	0083-0191	529.97	191.30	400	74.91	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			560.3	B08		7	0084-0193	162.74	193.94	271	72.33	0.651
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4068.3	B08		7	0085-0194	571.70	194.47	302	64.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4515.0	B08		7	0086-0193	719.20	193.39	188	53.94	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6427.2	B08		7	0087-0196	899.44	197.36	350	72.18	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			597.2	B08		7	0088-0195	686.08	194.73	240	57.94	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1431.7	B08		7	0089-0197	218.70	197.96	244	59.36	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			768.0	B08		7	0090-0198	314.70	198.25	251	58.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			806.4	B08		7	0091-0196	613.26	196.59	204	56.87	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1350.7	B08		7	0092-0201	946.42	201.19	274	66.08	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2645.4	B08		7	0093-0206	58.01	206.48	258	61.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2039.9	B08		7	0094-0211	177.98	211.36	360	69.60	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4740.7	B08		7	0095-0216	397.84	216.51	337	69.26	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			656.6	B08		7	0096-0218	339.99	218.35	273	60.77	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5512.6	B08		7	0097-0221	569.60	222.01	391	87.50	0.642
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1170.6	B08		7	0098-0219	89.92	218.98	242	57.11	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2077.1	B08		7	0099-0225	446.62	225.98	396	76.43	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1482.7	B08		7	0100-0228	126.72	228.49	240	56.77	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2641.7	B08		7	0101-0228	413.78	228.49	276	61.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			583.3	B08		7	0102-0231	907.18	231.20	289	63.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			616.8	B08		7	0103-0232	720.98	231.94	236	62.67	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5684.5	B08		7	0104-0233	264.91	234.22	194	56.53	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2725.2	B08		7	0105-0234	283.80	234.69	332	68.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2676.3	B08		7	0106-0237	521.36	236.40	382	73.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3886.4	B08		7	0107-0236	947.56	236.18	340	68.77	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			851.9	B08		7	0108-0237	872.17	237.48	266	63.84	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5961.3	B08		7	0109-0245	843.77	243.71	350	102.57	0.418
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2293.0	B08		7	0110-0243	51.98	243.74	182	49.70	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5561.6	B08		7	0111-0243	604.19	243.46	216	59.36	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1031.2	B08		7	0112-0246	378.93	246.46	256	59.36	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			647.0	B08		7	0113-0249	463.00	249.54	233	56.53	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6069.7	B08		7	0114-0249	587.12	249.49	180	50.87	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			725.7	B08		7	0115-0254	128.47	254.68	307	80.57	0.594
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2897.0	B08		7	0116-0254	247.69	254.10	326	66.43	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1649.1	B08		7	0117-0256	397.74	256.62	240	57.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2109.5	B08		7	0118-0259	553.97	259.30	371	73.01	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			519.0	B08		7	0119-0257	323.31	257.59	255	59.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			775.1	B08		7	0120-0264	877.21	264.15	243	65.94	0.702
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			731.8	B08		7	0121-0264	429.23	263.74	193	51.11	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			637.3	B08		7	0122-0265	682.52	264.78	242	60.18	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2073.6	B08		7	0123-0268	23.52	267.27	312	68.67	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1821.4	B08		7	0124-0273	942.28	273.29	228	55.11	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			896.6	B08		7	0125-0277	472.77	276.83	285	65.36	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2075.1	B08		7	0126-0279	591.93	279.81	335	67.60	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1831.1	B08		7	0127-0280	373.41	281.31	303	65.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			493.0	B08		7	0128-0281	97.96	280.43	287	68.18	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3700.6	B08		7	0129-0289	160.03	289.59	504	84.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2287.7	B08		7	0130-0286	717.44	286.35	251	59.94	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3212.4	B08		7	0131-0285	226.22	284.88	147	47.46	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			599.4	B08		7	0132-0287	884.60	287.66	261	63.01	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4344.7	B08		7	0133-0287	266.28	286.81	204	54.28	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3536.4	B08		7	0134-0295	42.73	293.97	470	84.67	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			540.8	B08		7	0135-0290	409.83	289.56	218	55.11	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2556.5	B08		7	0136-0296	638.34	296.98	357	70.43	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1438.1	B08		7	0137-0296	95.19	296.13	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2529.5	B08		7	0138-0300	300.90	299.53	352	70.18	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1816.2	B08		7	0139-0299	441.91	299.04	285	62.53	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2139.2	B08		7	0140-0303	747.06	302.21	284	64.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3839.8	B08		7	0141-0300	226.96	300.39	100	38.04	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			314.8	B08		7	0142-0307	921.16	307.62	285	79.50	0.567
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			977.3	B08		7	0143-0304	356.23	304.27	278	65.01	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1754.1	B08		7	0144-0303	621.62	304.04	199	53.11	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			910.9	B08		7	0145-0309	250.39	309.05	279	69.01	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2236.7	B08		7	0146-0312	495.72	311.78	412	83.98	0.734
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1060.4	B08		7	0147-0310	729.52	310.80	232	57.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1081.5	B08		7	0148-0311	762.11	310.96	229	57.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1897.3	B08		7	0149-0310	528.20	310.63	234	58.28	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3186.2	B08		7	0150-0312	795.82	311.91	291	64.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3319.9	B08		7	0151-0316	235.32	316.79	240	70.43	0.608
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7306.0	B08		7	0152-0312	410.34	312.51	248	58.63	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1179.9	B08		7	0153-0317	371.38	316.56	293	65.94	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4995.7	B08		7	0154-0316	266.32	316.82	171	48.87	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1593.1	B08		7	0155-0319	546.92	318.83	210	54.18	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4582.2	B08		7	0156-0321	27.86	321.46	191	51.36	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3506.1	B08		7	0157-0328	430.10	328.68	339	67.94	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1229.1	B08		7	0158-0327	847.85	326.72	221	54.28	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7446.8	B08		7	0159-0326	410.89	326.20	166	48.39	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4153.4	B08		7	0160-0331	450.98	331.32	320	66.53	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			426.9	B08		7	0161-0334	292.22	334.82	267	65.94	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3144.0	B08		7	0162-0336	930.56	336.09	198	53.60	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2668.7	B08		7	0163-0336	162.68	335.79	175	49.94	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1882.7	B08		7	0164-0338	896.94	338.98	324	67.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7041.4	B08		7	0165-0338	660.25	337.98	156	50.87	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1908.2	B08		7	0166-0341	646.64	340.59	261	61.11	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5748.2	B08		7	0167-0340	675.12	339.91	190	52.77	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1027.8	B08		7	0168-0342	707.87	342.91	276	69.84	0.711
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5410.5	B08		7	0169-0342	784.65	342.46	217	55.36	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3540.9	B08		7	0170-0343	309.89	343.09	258	60.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6755.9	B08		7	0171-0346	481.88	346.11	316	72.77	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3558.7	B08		7	0172-0349	217.80	349.32	361	71.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			996.8	B08		7	0173-0347	153.24	347.05	227	56.18	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3296.4	B08		7	0174-0350	859.26	351.10	336	68.53	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6539.9	B08		7	0175-0349	800.64	349.33	177	49.70	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2708.3	B08		7	0176-0353	338.93	352.34	261	60.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2720.9	B08		7	0177-0358	71.12	358.95	447	91.74	0.667
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2081.6	B08		7	0178-0353	817.46	353.46	233	59.70	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2690.1	B08		7	0179-0362	371.36	361.56	494	93.05	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4521.4	B08		7	0180-0367	99.04	367.18	454	85.74	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			10518.1	B08		7	0181-0359	462.03	360.16	146	45.21	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1745.6	B08		7	0182-0369	691.26	369.39	264	64.08	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			857.2	B08		7	0183-0370	447.16	369.83	216	55.11	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1882.0	B08		7	0184-0370	843.94	370.61	319	66.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			647.0	B08		7	0185-0371	278.60	372.16	262	63.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			846.1	B08		7	0186-0375	503.14	375.57	260	65.36	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1201.5	B08		7	0187-0374	307.18	373.51	277	65.36	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4141.4	B08		7	0188-0373	354.76	374.48	147	49.36	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3815.6	B08		7	0189-0376	381.94	376.76	278	67.01	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1338.4	B08		7	0190-0380	727.75	380.71	335	69.84	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1144.9	B08		7	0191-0380	526.81	381.04	221	57.36	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1452.3	B08		7	0192-0384	684.62	383.73	275	63.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5265.4	B08		7	0193-0390	164.13	389.70	472	83.36	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5658.5	B08		7	0194-0387	798.47	387.55	357	70.43	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4498.6	B08		7	0195-0388	927.26	388.88	312	65.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1416.2	B08		7	0196-0394	185.85	393.76	261	63.01	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1982.0	B08		7	0197-0395	116.26	395.13	255	58.77	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1100.6	B08		7	0198-0393	840.15	393.95	241	57.70	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2310.3	B08		7	0199-0399	899.11	399.12	309	65.36	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4127.0	B08		7	0200-0400	555.73	400.33	333	71.01	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3272.7	B08		7	0201-0402	94.97	402.82	390	74.43	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1393.3	B08		7	0202-0403	503.44	403.91	240	59.70	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6157.0	B08		7	0203-0402	782.10	402.91	155	50.87	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1083.9	B08		7	0204-0406	870.45	407.13	285	71.01	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			452.9	B08		7	0205-0405	281.16	404.51	254	62.77	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2637.3	B08		7	0206-0408	439.39	407.70	223	57.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2172.9	B08		7	0207-0407	677.66	407.11	250	57.94	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1573.1	B08		7	0208-0409	946.76	409.94	278	67.01	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3317.6	B08		7	0209-0408	50.70	408.74	253	61.70	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			528.9	B08		7	0210-0408	329.76	408.12	319	72.43	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			168.2	B08		7	0211-0412	228.68	412.13	306	65.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6995.4	B08		7	0212-0413	582.83	413.25	313	67.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5834.2	B08		7	0213-0409	753.48	408.41	161	49.70	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			758.0	B08		7	0214-0416	308.23	416.71	224	61.36	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3574.9	B08		7	0215-0419	544.64	418.65	204	51.94	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1410.3	B08		7	0216-0420	627.16	420.38	308	67.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			679.2	B08		7	0217-0423	938.35	422.78	276	65.26	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1168.6	B08		7	0218-0427	816.11	427.07	261	61.70	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3087.2	B08		7	0219-0428	330.82	429.26	299	66.43	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1443.2	B08		7	0220-0429	710.81	428.85	298	66.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			610.1	B08		7	0221-0431	199.59	430.66	279	63.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			540.3	B08		7	0222-0432	784.78	431.99	288	65.60	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2556.8	B08		7	0223-0436	80.45	436.11	367	73.11	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2554.2	B08		7	0224-0434	530.11	433.20	296	67.60	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3424.0	B08		7	0225-0437	547.31	438.14	267	65.26	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2667.0	B08		7	0226-0438	24.77	437.88	236	59.70	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3261.0	B08		7	0227-0437	102.70	437.10	222	58.18	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1659.9	B08		7	0228-0438	689.99	437.92	218	56.28	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3258.5	B08		7	0229-0444	644.17	443.89	414	80.67	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			748.9	B08		7	0230-0445	349.35	444.63	254	62.18	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1019.2	B08		7	0231-0448	673.60	448.71	311	67.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1419.9	B08		7	0232-0451	760.98	450.72	222	61.94	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1364.8	B08		7	0233-0451	577.59	451.76	277	63.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			8089.5	B08		7	0234-0454	817.04	453.79	324	68.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			698.6	B08		7	0235-0456	455.98	456.45	269	64.18	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4577.6	B08		7	0236-0460	63.98	460.09	299	63.94	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			885.8	B08		7	0237-0466	864.93	466.05	302	80.91	0.580
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			712.1	B08		7	0238-0464	356.84	463.88	256	60.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1610.4	B08		7	0239-0466	513.38	466.70	281	63.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4268.5	B08		7	0240-0467	328.45	467.72	371	83.84	0.663
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			615.6	B08		7	0241-0468	849.84	468.20	184	53.46	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3817.3	B08		7	0242-0472	906.09	471.68	340	76.67	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			891.4	B08		7	0243-0470	203.00	469.81	222	58.18	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1463.0	B08		7	0244-0472	236.38	472.69	220	59.01	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			878.7	B08		7	0245-0477	934.34	478.49	318	72.43	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			638.8	B08		7	0246-0481	651.26	482.10	510	106.57	0.564
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4661.1	B08		7	0247-0486	129.79	486.75	499	86.67	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1757.0	B08		7	0248-0482	398.08	481.83	240	57.60	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3720.7	B08		7	0249-0484	782.53	484.13	397	75.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3424.9	B08		7	0250-0491	555.13	492.15	336	68.43	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			630.5	B08		7	0251-0493	488.53	493.04	280	65.01	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1783.8	B08		7	0252-0496	630.32	496.96	275	61.01	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2163.9	B08		7	0253-0504	76.36	503.82	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1327.1	B08		7	0254-0512	563.18	512.38	275	61.11	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4265.2	B08		7	0255-0515	929.60	515.28	331	67.84	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2363.1	B08		7	0256-0515	303.66	514.76	221	56.18	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1267.3	B08		7	0257-0517	419.55	516.60	219	54.87	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1652.6	B08		7	0258-0520	523.11	521.12	339	71.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1338.5	B08		7	0259-0523	102.70	523.12	267	67.94	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1811.3	B08		7	0260-0520	194.12	520.44	217	55.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1120.9	B08		7	0261-0521	781.22	521.50	240	62.18	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1426.7	B08		7	0262-0522	715.60	522.41	182	49.11	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2184.8	B08		7	0263-0529	225.10	528.94	309	65.11	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2224.0	B08		7	0264-0527	285.61	527.28	236	57.70	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1479.6	B08		7	0265-0530	149.38	529.94	288	65.94	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1305.3	B08		7	0266-0534	429.34	534.91	260	62.43	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1212.2	B08		7	0267-0536	770.17	537.07	227	56.18	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4687.7	B08		7	0268-0540	906.22	540.02	407	76.43	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2265.0	B08		7	0269-0540	335.32	539.97	212	55.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1331.3	B08		7	0270-0545	548.09	545.33	251	59.94	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1459.4	B08		7	0271-0545	270.40	544.99	189	51.94	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			961.6	B08		7	0272-0546	447.50	545.93	228	58.43	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3938.6	B08		7	0273-0553	804.74	553.28	232	58.77	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3615.7	B08		7	0274-0549	859.05	549.05	126	43.46	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			834.7	B08		7	0275-0551	482.79	550.94	212	53.70	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			792.4	B08		7	0276-0552	392.00	551.27	300	69.60	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1261.9	B08		7	0277-0553	821.00	553.94	198	56.18	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			459.3	B08		7	0278-0555	301.57	555.59	283	65.94	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1186.8	B08		7	0279-0558	776.62	558.39	269	62.53	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1712.1	B08		7	0280-0559	689.71	560.15	226	62.77	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1368.4	B08		7	0281-0560	339.19	559.53	187	51.36	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4843.4	B08		7	0282-0564	852.72	564.30	217	55.84	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			466.9	B08		7	0283-0565	273.27	565.52	251	61.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1635.8	B08		7	0284-0566	215.27	567.71	321	73.01	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1130.9	B08		7	0285-0568	794.53	567.90	241	58.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3246.4	B08		7	0286-0568	574.60	568.25	313	68.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1285.2	B08		7	0287-0571	97.09	571.01	324	68.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			573.3	B08		7	0288-0572	358.39	571.60	225	57.70	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			803.0	B08		7	0289-0568	451.12	568.59	194	50.87	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			460.1	B08		7	0290-0571	514.70	571.55	238	57.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2295.9	B08		7	0291-0575	818.21	576.01	261	63.11	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			774.2	B08		7	0292-0573	627.10	573.01	252	58.87	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4996.9	B08		7	0293-0587	161.52	585.95	593	107.05	0.650
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1556.2	B08		7	0294-0580	382.48	581.18	206	56.04	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3753.4	B08		7	0295-0582	856.68	582.60	241	59.84	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			819.3	B08		7	0296-0581	454.66	581.62	195	53.21	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2076.4	B08		7	0297-0584	20.47	584.14	229	57.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3325.9	B08		7	0298-0589	65.54	589.46	360	71.36	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1269.9	B08		7	0299-0589	202.30	589.49	276	69.01	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			988.3	B08		7	0300-0586	306.59	585.47	227	56.53	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1648.8	B08		7	0301-0587	540.11	586.99	191	51.36	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1012.7	B08		7	0302-0589	419.81	589.22	243	57.11	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1698.6	B08		7	0303-0589	641.78	589.13	208	54.28	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1138.6	B08		7	0304-0591	870.52	591.42	226	55.11	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5141.6	B08		7	0305-0592	401.35	592.08	206	54.28	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5134.7	B08		7	0306-0595	386.10	595.23	181	51.80	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2618.6	B08		7	0307-0599	934.08	598.75	396	74.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			643.5	B08		7	0308-0597	468.94	597.78	296	63.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1052.9	B08		7	0309-0599	531.68	600.05	232	55.36	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1442.5	B08		7	0310-0600	586.68	599.78	239	57.70	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1025.6	B08		7	0311-0603	237.89	602.51	256	58.53	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			831.7	B08		7	0312-0603	747.56	603.22	140	46.28	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1149.4	B08		7	0313-0607	275.96	606.98	234	56.53	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3694.3	B08		7	0314-0618	761.53	616.65	395	87.26	0.652
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			829.4	B08		7	0315-0618	317.58	618.43	245	59.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4241.9	B08		7	0316-0620	798.63	619.75	372	73.60	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			828.5	B08		7	0317-0619	184.08	618.67	255	59.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			762.8	B08		7	0318-0619	536.33	619.55	203	52.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1245.8	B08		7	0319-0619	732.67	618.91	225	58.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			971.1	B08		7	0320-0624	75.32	624.49	297	67.26	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5888.1	B08		7	0321-0626	149.52	625.62	378	74.18	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1048.2	B08		7	0322-0624	587.75	624.19	255	60.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1221.6	B08		7	0323-0628	266.79	628.79	272	64.77	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1451.1	B08		7	0324-0626	224.98	625.70	269	60.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3551.4	B08		7	0325-0631	33.55	631.63	372	75.84	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3128.3	B08		7	0326-0630	380.71	630.34	182	50.28	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5713.7	B08		7	0327-0632	742.45	633.18	264	63.60	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2759.9	B08		7	0328-0632	870.00	633.29	240	62.77	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1538.3	B08		7	0329-0638	418.93	637.29	242	58.18	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1369.1	B08		7	0330-0635	486.04	635.24	265	64.53	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3680.8	B08		7	0331-0636	884.42	636.28	183	50.63	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2872.7	B08		7	0332-0640	652.10	639.58	235	59.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2462.0	B08		7	0333-0642	303.25	642.62	278	63.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1770.8	B08		7	0334-0643	369.37	643.58	193	51.70	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3789.0	B08		7	0335-0647	536.33	647.18	228	57.01	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4696.3	B08		7	0336-0648	701.14	648.33	301	63.60	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1701.8	B08		7	0337-0655	825.26	654.58	343	71.50	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3560.1	B08		7	0338-0652	905.80	652.94	180	51.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4002.2	B08		7	0339-0656	494.86	656.41	261	60.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			731.8	B08		7	0340-0655	647.89	656.23	214	54.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2898.9	B08		7	0341-0660	619.43	660.42	307	68.53	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			309.1	B08		7	0342-0660	103.73	660.38	202	60.18	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3574.0	B08		7	0343-0661	331.53	661.26	282	62.28	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1648.0	B08		7	0344-0658	369.54	658.31	227	57.11	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1619.2	B08		7	0345-0659	935.36	658.91	181	52.43	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1293.7	B08		7	0346-0660	447.04	660.05	247	59.11	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1486.9	B08		7	0347-0665	250.08	665.56	256	60.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			554.4	B08		7	0348-0662	37.36	662.14	140	45.94	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1221.5	B08		7	0349-0668	273.05	667.94	244	60.18	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4373.1	B08		7	0350-0671	564.20	671.06	415	79.50	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3145.3	B08		7	0351-0668	724.95	667.73	304	64.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2303.0	B08		7	0352-0666	922.79	665.38	205	57.36	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1171.0	B08		7	0353-0670	193.80	670.59	269	61.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			908.3	B08		7	0354-0673	768.30	672.51	256	59.60	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2836.9	B08		7	0355-0672	377.96	672.48	212	55.46	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4175.7	B08		7	0356-0674	861.90	673.49	332	68.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2815.5	B08		7	0357-0676	85.23	676.00	223	57.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1054.7	B08		7	0358-0677	797.05	677.26	267	63.01	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			526.6	B08		7	0359-0675	34.76	675.73	175	50.28	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1359.1	B08		7	0360-0676	703.10	676.08	198	57.60	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			508.6	B08		7	0361-0678	52.72	679.35	218	59.36	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3477.2	B08		7	0362-0683	685.57	684.28	648	111.05	0.660
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1523.2	B08		7	0363-0680	448.23	679.47	224	55.36	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1010.3	B08		7	0364-0685	843.10	686.08	260	61.36	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			361.2	B08		7	0365-0688	618.11	687.90	248	63.84	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2837.3	B08		7	0366-0686	340.20	686.29	226	55.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6123.7	B08		7	0367-0692	413.83	691.73	372	73.26	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5839.4	B08		7	0368-0691	714.85	690.45	150	46.87	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1193.2	B08		7	0369-0694	912.92	694.90	229	57.94	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1870.7	B08		7	0370-0696	937.38	695.64	291	61.94	0.953
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1328.1	B08		7	0371-0697	52.33	696.50	224	55.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1717.0	B08		7	0372-0697	136.01	696.68	215	53.94	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			420.0	B08		7	0373-0702	234.35	703.26	290	67.36	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3001.2	B08		7	0374-0703	882.83	702.70	269	63.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2894.0	B08		7	0375-0704	371.40	704.40	237	58.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4754.8	B08		7	0376-0703	539.66	702.93	202	52.28	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4293.3	B08		7	0377-0700	690.84	700.22	159	45.70	0.957
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2436.1	B08		7	0378-0706	464.63	706.59	227	57.94	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1065.0	B08		7	0379-0706	646.96	706.78	211	53.11	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			357.7	B08		7	0380-0708	161.23	708.82	276	64.53	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1726.9	B08		8	0001-0027	605.94	27.87	215	56.28	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			894.1	B08		8	0002-0030	678.63	29.96	293	63.01	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1617.5	B08		8	0003-0030	332.84	29.76	212	53.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1358.4	B08		8	0004-0034	100.59	34.63	237	58.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			487.9	B08		8	0005-0030	274.05	30.58	219	59.70	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4296.5	B08		8	0006-0039	437.09	39.00	204	53.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5223.9	B08		8	0007-0041	321.69	41.81	212	54.28	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1418.9	B08		8	0008-0040	928.24	40.30	223	54.28	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1007.0	B08		8	0009-0043	461.70	44.14	285	63.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2268.7	B08		8	0010-0044	809.55	44.14	285	61.36	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1418.8	B08		8	0011-0045	569.92	43.93	174	54.43	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4034.7	B08		8	0012-0045	358.74	45.50	219	55.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4296.0	B08		8	0013-0045	633.25	45.14	254	60.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			566.4	B08		8	0014-0047	122.29	46.71	280	66.18	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1311.7	B08		8	0015-0048	25.24	47.86	211	53.11	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3274.6	B08		8	0016-0048	185.64	48.59	289	64.18	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4374.6	B08		8	0017-0049	384.18	48.78	310	66.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4960.5	B08		8	0018-0049	307.42	48.87	215	54.87	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1759.0	B08		8	0019-0050	580.11	51.04	112	44.87	0.699
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2096.7	B08		8	0020-0053	753.84	52.66	215	54.28	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2261.4	B08		8	0021-0053	254.99	53.81	251	60.53	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2738.3	B08		8	0022-0056	493.18	56.48	338	69.01	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			950.8	B08		8	0023-0054	940.44	54.25	205	52.28	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1740.2	B08		8	0024-0061	241.09	61.83	193	56.77	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			10071.7	B08		8	0025-0056	768.83	55.64	147	45.80	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1089.0	B08		8	0026-0060	866.08	60.35	250	59.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1228.9	B08		8	0027-0063	559.18	62.41	294	67.60	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			462.2	B08		8	0028-0063	642.81	63.02	178	48.28	0.959
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3219.1	B08		8	0029-0064	701.82	64.72	262	60.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1237.7	B08		8	0030-0068	91.77	68.89	240	59.11	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2011.8	B08		8	0031-0070	346.19	69.91	273	61.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2663.1	B08		8	0032-0069	838.43	68.84	215	56.18	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			8813.5	B08		8	0033-0070	765.62	69.56	157	46.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			974.7	B08		8	0034-0071	878.70	71.36	219	55.70	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1210.5	B08		8	0035-0075	248.18	76.27	218	55.36	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2102.6	B08		8	0036-0076	753.87	77.01	208	55.01	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2255.1	B08		8	0037-0078	789.59	77.65	266	62.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5190.1	B08		8	0038-0080	204.05	79.65	217	54.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			569.1	B08		8	0039-0082	535.30	81.33	202	55.46	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3155.6	B08		8	0040-0086	684.70	86.65	407	78.67	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2489.3	B08		8	0041-0081	911.11	81.40	246	57.70	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3861.0	B08		8	0042-0083	278.01	82.10	183	51.36	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3446.9	B08		8	0043-0083	422.56	82.95	209	52.87	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3539.0	B08		8	0044-0092	521.47	91.87	335	73.11	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1105.0	B08		8	0045-0087	654.93	87.18	272	62.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2190.9	B08		8	0046-0088	803.61	88.22	262	60.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1412.1	B08		8	0047-0085	312.89	85.51	156	48.04	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1459.9	B08		8	0048-0091	506.89	91.64	231	61.11	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6246.6	B08		8	0049-0093	265.32	92.69	347	69.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			13854.6	B08		8	0050-0089	466.44	89.42	126	64.67	0.379
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6383.8	B08		8	0051-0091	485.54	91.39	178	51.70	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1958.9	B08		8	0052-0095	578.56	94.28	158	52.53	0.720
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			8648.5	B08		8	0053-0098	235.72	97.49	144	47.60	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1219.4	B08		8	0054-0097	312.79	96.29	117	40.63	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			817.8	B08		8	0055-0101	196.52	101.22	216	55.70	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3880.7	B08		8	0056-0109	168.10	109.50	416	84.08	0.739
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1608.1	B08		8	0057-0109	61.26	110.18	302	65.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			766.5	B08		8	0058-0109	325.70	109.43	285	64.53	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7517.2	B08		8	0059-0105	492.19	104.94	158	46.63	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7681.0	B08		8	0060-0109	225.69	109.46	155	46.53	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			790.2	B08		8	0061-0110	418.68	110.04	266	61.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1827.7	B08		8	0062-0110	740.53	109.96	202	53.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1011.8	B08		8	0063-0116	365.54	115.83	258	59.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2082.5	B08		8	0064-0117	17.34	117.17	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2508.2	B08		8	0065-0117	710.91	117.16	339	67.60	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2000.3	B08		8	0066-0114	692.08	114.01	112	40.04	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1338.9	B08		8	0067-0116	945.56	116.40	143	45.11	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2938.6	B08		8	0068-0119	476.58	119.53	226	55.94	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			963.7	B08		8	0069-0120	214.16	121.08	218	57.84	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1352.7	B08		8	0070-0123	458.80	122.27	270	66.18	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1373.2	B08		8	0071-0128	621.93	128.49	282	65.11	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2582.3	B08		8	0072-0126	810.83	124.99	255	63.36	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1187.8	B08		8	0073-0129	254.02	128.83	222	57.36	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1311.7	B08		8	0074-0126	312.43	126.66	288	67.94	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1500.7	B08		8	0075-0127	651.45	127.21	274	62.53	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1954.5	B08		8	0076-0124	693.52	124.41	100	38.63	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			458.0	B08		8	0077-0134	544.06	133.88	328	69.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2174.5	B08		8	0078-0131	834.06	131.69	238	57.36	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3646.4	B08		8	0079-0134	916.21	133.84	333	69.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3011.4	B08		8	0080-0139	433.99	140.31	312	67.60	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2026.4	B08		8	0081-0141	742.85	142.35	182	53.36	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1614.9	B08		8	0082-0142	371.39	142.67	287	66.18	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2380.8	B08		8	0083-0142	691.60	143.08	137	49.70	0.697
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1267.4	B08		8	0084-0147	102.87	147.30	221	58.28	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1808.6	B08		8	0085-0146	870.70	146.58	274	63.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2266.7	B08		8	0086-0145	813.59	145.20	244	62.53	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1248.8	B08		8	0087-0147	260.69	146.47	195	52.53	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3368.4	B08		8	0088-0151	610.95	151.63	257	69.60	0.667
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1752.9	B08		8	0089-0151	508.14	151.35	210	54.77	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5021.7	B08		8	0090-0152	201.67	152.39	324	67.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1739.9	B08		8	0091-0153	752.90	153.76	193	51.70	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3755.2	B08		8	0092-0154	646.52	153.18	233	58.53	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2537.9	B08		8	0093-0163	790.71	165.01	286	78.43	0.584
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2493.2	B08		8	0094-0160	115.51	160.99	260	59.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			887.0	B08		8	0095-0163	155.98	162.80	258	62.43	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1720.6	B08		8	0096-0167	638.49	167.91	284	66.67	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			856.5	B08		8	0097-0169	319.81	169.39	287	62.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3610.9	B08		8	0098-0170	387.76	170.51	216	54.53	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			877.1	B08		8	0099-0172	718.99	171.98	280	64.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1966.9	B08		8	0100-0174	444.36	173.61	393	78.43	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1056.0	B08		8	0101-0173	363.23	173.68	207	54.53	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2002.5	B08		8	0102-0172	824.23	172.48	190	52.14	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3903.6	B08		8	0103-0173	839.23	173.39	161	48.63	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3767.5	B08		8	0104-0174	855.85	173.78	202	54.53	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7908.6	B08		8	0105-0176	472.06	176.28	277	61.11	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1092.8	B08		8	0106-0176	589.15	176.50	204	53.11	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			18264.3	B08		8	0107-0174	24.47	175.02	132	43.46	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			11292.0	B08		8	0108-0181	916.02	180.69	140	89.98	0.217
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3516.3	B08		8	0109-0191	416.31	190.75	393	73.60	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1929.0	B08		8	0110-0190	557.40	189.97	233	57.36	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7079.1	B08		8	0111-0194	503.96	194.47	352	71.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5167.3	B08		8	0112-0193	528.14	193.10	302	65.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1189.8	B08		8	0113-0191	576.48	190.90	248	57.70	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1815.2	B08		8	0114-0196	82.44	197.40	250	59.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4665.0	B08		8	0115-0199	731.41	199.55	326	71.84	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5158.3	B08		8	0116-0206	797.58	204.88	608	103.98	0.707
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2424.4	B08		8	0117-0200	600.24	198.90	321	67.84	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			926.6	B08		8	0118-0201	706.38	200.68	275	65.60	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1507.0	B08		8	0119-0200	105.70	199.53	251	60.77	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1364.3	B08		8	0120-0203	51.33	203.14	263	64.67	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			886.3	B08		8	0121-0201	945.35	201.25	242	64.77	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1409.2	B08		8	0122-0202	841.47	202.21	265	59.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1117.8	B08		8	0123-0204	360.88	204.41	293	66.18	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1026.3	B08		8	0124-0203	473.99	203.12	291	67.36	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5048.3	B08		8	0125-0209	540.26	210.14	315	74.18	0.719
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4791.8	B08		8	0126-0207	210.90	207.35	301	65.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			804.3	B08		8	0127-0209	653.64	209.25	285	64.77	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4180.0	B08		8	0128-0216	905.41	216.77	342	71.60	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4727.5	B08		8	0129-0217	238.79	216.72	356	70.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3330.6	B08		8	0130-0219	326.08	218.78	230	67.11	0.642
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			952.4	B08		8	0131-0219	404.45	220.29	295	63.11	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1894.6	B08		8	0132-0222	573.44	222.43	240	57.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4312.4	B08		8	0133-0223	825.07	222.16	159	55.11	0.658
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			382.3	B08		8	0134-0228	177.37	228.44	252	65.60	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1224.0	B08		8	0135-0226	444.15	225.99	249	59.70	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1293.9	B08		8	0136-0226	297.91	225.97	241	57.01	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2313.0	B08		8	0137-0226	338.15	227.24	232	60.18	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3517.2	B08		8	0138-0225	836.01	225.90	134	47.94	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1537.6	B08		8	0139-0231	760.15	231.06	226	56.04	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2947.6	B08		8	0140-0233	362.12	232.89	237	60.18	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			985.6	B08		8	0141-0236	884.11	237.24	290	67.11	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3873.0	B08		8	0142-0238	52.62	238.34	342	68.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4683.8	B08		8	0143-0234	514.13	234.63	207	57.46	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1687.6	B08		8	0144-0239	844.35	239.44	239	58.77	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			607.7	B08		8	0145-0242	131.43	242.42	205	54.53	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6182.7	B08		8	0146-0241	497.89	242.11	176	49.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1462.3	B08		8	0147-0244	785.63	245.13	262	59.36	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3479.9	B08		8	0148-0244	401.72	243.93	213	54.53	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1525.6	B08		8	0149-0248	624.08	247.94	209	54.53	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1241.3	B08		8	0150-0249	726.50	248.48	254	59.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7247.8	B08		8	0151-0250	757.15	250.54	325	72.18	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1534.1	B08		8	0152-0249	644.05	249.45	254	60.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			8612.3	B08		8	0153-0252	104.77	251.94	312	65.11	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2314.5	B08		8	0154-0252	445.78	252.74	217	60.53	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5393.9	B08		8	0155-0256	571.64	257.18	211	59.70	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5939.0	B08		8	0156-0266	348.79	266.57	640	110.47	0.659
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1263.2	B08		8	0157-0258	883.69	257.58	273	61.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1314.5	B08		8	0158-0256	905.81	256.66	277	63.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2866.0	B08		8	0159-0260	833.84	260.57	489	90.08	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1024.9	B08		8	0160-0260	689.87	260.20	232	57.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3363.9	B08		8	0161-0262	492.09	262.56	290	63.60	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2480.8	B08		8	0162-0267	518.42	267.31	439	80.08	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1044.5	B08		8	0163-0265	186.17	265.60	250	78.91	0.505
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			833.8	B08		8	0164-0265	247.92	265.49	261	59.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			591.9	B08		8	0165-0270	618.28	270.58	224	61.94	0.734
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			760.5	B08		8	0166-0265	797.52	264.67	151	49.11	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1837.9	B08		8	0167-0269	923.08	268.60	250	58.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3256.2	B08		8	0168-0275	409.94	274.74	383	74.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5092.7	B08		8	0169-0276	133.40	275.48	241	61.01	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1819.1	B08		8	0170-0275	47.24	275.34	223	55.11	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3983.3	B08		8	0171-0280	278.01	279.85	388	77.50	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5740.3	B08		8	0172-0279	562.46	279.94	194	57.36	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2332.9	B08		8	0173-0278	458.98	277.90	219	55.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1615.3	B08		8	0174-0278	715.69	277.13	240	59.94	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6204.1	B08		8	0175-0282	119.51	282.12	188	54.53	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3735.9	B08		8	0176-0280	332.96	280.84	132	43.56	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2666.0	B08		8	0177-0290	891.19	289.75	238	58.18	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			881.6	B08		8	0178-0292	298.21	292.89	218	54.53	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2258.0	B08		8	0179-0295	95.73	294.43	249	61.36	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3575.0	B08		8	0180-0294	330.03	293.71	196	53.46	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5902.8	B08		8	0181-0297	860.98	297.75	317	65.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1796.2	B08		8	0182-0297	512.10	296.55	221	56.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1965.9	B08		8	0183-0303	430.37	303.46	354	71.60	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3109.8	B08		8	0184-0303	479.32	302.65	346	68.18	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2208.6	B08		8	0185-0302	497.46	302.33	187	51.11	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1315.1	B08		8	0186-0303	716.93	302.65	222	57.11	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4734.6	B08		8	0187-0305	830.82	305.53	256	57.94	0.958
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			305.5	B08		8	0188-0310	25.65	309.68	263	66.77	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1270.2	B08		8	0189-0309	198.99	308.92	288	70.67	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4454.7	B08		8	0190-0310	787.30	310.84	332	70.18	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			888.0	B08		8	0191-0309	934.28	309.96	218	56.28	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			507.3	B08		8	0192-0313	234.95	313.59	264	67.01	0.739
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3291.3	B08		8	0193-0313	297.10	313.57	317	67.01	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2566.6	B08		8	0194-0316	613.92	317.18	222	57.70	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			667.1	B08		8	0195-0319	126.34	319.24	196	63.26	0.616
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			10835.6	B08		8	0196-0320	567.44	319.73	136	47.11	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6222.8	B08		8	0197-0323	279.05	323.73	192	51.46	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			687.7	B08		8	0198-0328	673.08	328.40	224	62.18	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1825.4	B08		8	0199-0326	330.82	326.80	227	55.94	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6262.3	B08		8	0200-0329	94.74	329.33	229	57.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1888.7	B08		8	0201-0330	718.20	329.79	235	56.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2007.6	B08		8	0202-0331	696.05	331.99	248	57.70	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2208.6	B08		8	0203-0328	485.85	327.96	134	46.87	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2902.9	B08		8	0204-0333	831.68	332.64	270	60.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3264.7	B08		8	0205-0335	182.20	335.61	329	67.36	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3193.4	B08		8	0206-0338	35.69	338.17	193	52.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5572.9	B08		8	0207-0338	283.63	337.80	194	52.28	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4533.2	B08		8	0208-0341	442.74	341.90	307	66.43	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1989.1	B08		8	0209-0343	495.31	344.36	429	88.67	0.686
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2240.9	B08		8	0210-0341	749.53	341.13	261	59.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5250.6	B08		8	0211-0342	409.14	342.94	258	59.70	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1340.7	B08		8	0212-0344	786.04	343.56	228	55.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2728.2	B08		8	0213-0343	223.49	343.69	205	53.11	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5178.5	B08		8	0214-0345	72.07	344.02	253	60.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			497.1	B08		8	0215-0347	615.45	347.13	290	64.53	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			395.5	B08		8	0216-0349	847.39	348.96	278	64.08	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1534.5	B08		8	0217-0349	162.16	349.02	209	53.94	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1278.6	B08		8	0218-0352	904.73	351.46	230	59.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2691.9	B08		8	0219-0358	239.48	358.57	276	61.01	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6731.6	B08		8	0220-0361	372.20	361.46	328	68.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2250.7	B08		8	0221-0364	732.60	364.38	212	56.53	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			690.5	B08		8	0222-0365	669.58	364.77	308	69.94	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3063.3	B08		8	0223-0363	542.40	363.96	167	48.63	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1221.9	B08		8	0224-0367	825.59	367.27	264	63.01	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4446.3	B08		8	0225-0368	69.91	368.36	423	77.60	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			588.0	B08		8	0226-0367	509.82	366.75	165	49.11	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1270.0	B08		8	0227-0370	842.54	368.99	221	57.36	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2491.3	B08		8	0228-0370	904.68	370.38	299	63.94	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1856.4	B08		8	0229-0374	705.18	375.56	291	65.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			11284.0	B08		8	0230-0380	229.26	379.63	336	69.01	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1217.0	B08		8	0231-0381	625.58	381.14	261	59.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3115.2	B08		8	0232-0380	538.41	379.26	186	52.28	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4191.2	B08		8	0233-0380	122.53	380.11	176	49.46	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3236.3	B08		8	0234-0390	459.42	389.07	472	94.81	0.660
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1289.2	B08		8	0235-0385	174.02	384.99	229	55.11	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4423.9	B08		8	0236-0390	32.31	390.91	315	65.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1761.9	B08		8	0237-0390	476.96	389.92	250	59.46	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4531.5	B08		8	0238-0389	563.53	389.04	227	56.04	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1748.9	B08		8	0239-0392	96.37	392.44	221	54.53	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			856.1	B08		8	0240-0392	140.30	393.04	241	60.53	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			917.1	B08		8	0241-0394	517.34	394.43	226	57.36	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3914.7	B08		8	0242-0393	205.01	393.33	193	53.11	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4860.5	B08		8	0243-0396	357.48	395.76	326	68.43	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1050.5	B08		8	0244-0396	798.26	395.72	268	59.60	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4331.4	B08		8	0245-0393	115.88	393.18	177	49.70	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1384.0	B08		8	0246-0401	285.34	401.61	298	68.67	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			667.5	B08		8	0247-0403	854.48	404.25	271	62.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2019.4	B08		8	0248-0409	874.03	409.15	215	59.36	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1852.9	B08		8	0249-0410	535.95	410.12	210	57.21	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3282.5	B08		8	0250-0409	757.81	409.18	241	57.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			558.3	B08		8	0251-0408	385.95	408.25	148	47.36	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1654.4	B08		8	0252-0412	51.60	411.98	247	62.43	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3218.4	B08		8	0253-0413	306.91	413.24	351	68.77	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1149.0	B08		8	0254-0411	617.11	411.83	213	54.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3063.8	B08		8	0255-0413	920.61	413.25	248	59.11	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			645.3	B08		8	0256-0425	43.38	424.45	270	64.08	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1964.4	B08		8	0257-0424	197.36	424.82	291	65.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6873.8	B08		8	0258-0426	840.62	426.82	249	59.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2033.9	B08		8	0259-0425	90.69	425.05	252	59.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			464.0	B08		8	0260-0426	395.24	426.38	188	54.18	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2621.3	B08		8	0261-0430	798.43	429.42	316	67.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1340.0	B08		8	0262-0428	429.05	427.54	272	61.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2611.9	B08		8	0263-0430	685.11	429.79	228	59.11	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			944.5	B08		8	0264-0430	536.49	429.89	224	59.21	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2747.5	B08		8	0265-0433	292.44	431.71	270	62.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3067.4	B08		8	0266-0433	463.81	433.41	344	70.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			977.3	B08		8	0267-0440	612.69	440.34	286	66.18	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2867.4	B08		8	0268-0440	376.98	439.41	296	67.36	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1085.0	B08		8	0269-0441	917.64	440.86	239	59.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4798.1	B08		8	0270-0441	571.71	441.23	324	67.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3877.8	B08		8	0271-0448	119.36	447.66	377	73.60	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1006.2	B08		8	0272-0444	709.38	444.02	214	53.70	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3387.0	B08		8	0273-0446	210.10	445.78	171	49.70	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1564.7	B08		8	0274-0450	251.93	449.17	467	84.33	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			970.2	B08		8	0275-0445	284.42	445.95	125	42.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1078.8	B08		8	0276-0447	758.43	447.39	273	63.36	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			538.7	B08		8	0277-0447	510.30	448.26	285	65.60	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3145.2	B08		8	0278-0451	197.74	451.73	214	54.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5304.2	B08		8	0279-0452	679.58	452.71	229	56.53	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1782.5	B08		8	0280-0455	414.52	455.68	259	65.26	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5064.2	B08		8	0281-0458	645.04	457.69	235	57.70	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			631.3	B08		8	0282-0461	893.09	460.31	237	61.11	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1294.1	B08		8	0283-0461	806.05	461.06	265	61.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1399.6	B08		8	0284-0460	849.37	459.94	300	73.26	0.703
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3984.0	B08		8	0285-0467	482.18	466.42	278	65.36	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3456.6	B08		8	0286-0467	502.80	466.67	202	52.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7347.5	B08		8	0287-0468	175.68	468.11	131	44.39	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5142.7	B08		8	0288-0469	188.14	470.18	220	55.46	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6865.1	B08		8	0289-0470	164.58	470.70	133	44.87	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1261.4	B08		8	0290-0473	445.19	473.32	256	60.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3718.4	B08		8	0291-0476	340.33	476.43	305	64.43	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4799.3	B08		8	0292-0475	146.13	474.35	224	54.53	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			430.6	B08		8	0293-0476	594.06	476.63	181	50.28	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2996.0	B08		8	0294-0475	282.54	475.44	216	54.53	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			928.9	B08		8	0295-0480	38.72	480.74	281	66.67	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			447.2	B08		8	0296-0475	863.09	475.58	237	58.28	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			890.0	B08		8	0297-0476	670.54	476.17	223	56.28	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4150.3	B08		8	0298-0483	521.14	482.66	460	89.98	0.714
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1327.6	B08		8	0299-0486	72.47	487.20	271	64.77	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1934.4	B08		8	0300-0491	98.43	491.48	476	90.33	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			542.4	B08		8	0301-0489	681.87	489.05	240	57.94	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1389.6	B08		8	0302-0495	317.38	494.84	179	53.36	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1391.9	B08		8	0303-0498	424.53	498.54	275	61.60	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4460.0	B08		8	0304-0496	801.89	496.68	186	52.53	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1843.3	B08		8	0305-0496	568.46	496.21	140	45.46	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4446.8	B08		8	0306-0500	925.96	500.83	237	59.36	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1738.6	B08		8	0307-0506	409.35	506.26	265	71.36	0.654
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			876.2	B08		8	0308-0503	162.81	503.82	231	57.94	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			856.5	B08		8	0309-0502	252.53	502.28	254	61.11	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			494.3	B08		8	0310-0502	720.89	503.30	199	55.11	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2569.1	B08		8	0311-0506	118.28	506.07	213	55.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1437.0	B08		8	0312-0506	213.48	506.27	246	58.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			684.2	B08		8	0313-0505	513.95	505.20	270	61.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1429.9	B08		8	0314-0512	391.39	512.53	273	65.26	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2186.8	B08		8	0315-0508	573.78	508.38	197	52.63	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			375.8	B08		8	0316-0513	459.25	513.30	269	62.77	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2228.8	B08		8	0317-0516	279.40	515.67	340	72.91	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4296.8	B08		8	0318-0517	34.47	517.38	330	67.01	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2766.2	B08		8	0319-0519	191.56	519.29	327	67.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1452.1	B08		8	0320-0520	598.95	520.02	222	58.43	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			766.8	B08		8	0321-0521	490.02	521.05	227	55.70	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2253.8	B08		8	0322-0523	544.13	524.15	269	79.01	0.541
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1133.7	B08		8	0323-0524	373.61	524.93	246	58.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1634.1	B08		8	0324-0524	249.55	524.74	219	54.87	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1492.3	B08		8	0325-0528	587.81	528.57	220	57.26	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1441.8	B08		8	0326-0528	661.83	528.57	227	57.11	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4605.5	B08		8	0327-0529	741.26	528.96	331	66.18	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4055.2	B08		8	0328-0529	265.76	529.33	168	49.11	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4487.1	B08		8	0329-0530	886.67	530.57	195	53.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3195.9	B08		8	0330-0536	475.34	535.73	334	73.36	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			805.5	B08		8	0331-0532	693.26	532.27	262	62.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2044.0	B08		8	0332-0535	904.34	535.08	217	57.11	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2059.1	B08		8	0333-0540	503.66	539.29	356	73.01	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4571.1	B08		8	0334-0536	837.33	536.46	168	51.11	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			785.9	B08		8	0335-0540	618.73	540.15	265	63.60	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			334.1	B08		8	0336-0545	108.17	545.82	246	60.77	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			10435.3	B08		8	0337-0540	310.74	540.38	112	45.11	0.692
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2334.4	B08		8	0338-0544	540.04	543.04	278	84.91	0.485
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1392.3	B08		8	0339-0543	647.59	542.83	260	59.94	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2215.7	B08		8	0340-0543	228.87	543.02	213	53.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7958.4	B08		8	0341-0547	440.74	547.05	393	74.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2330.6	B08		8	0342-0547	294.62	547.99	340	68.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4708.7	B08		8	0343-0549	63.74	548.50	494	85.84	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1814.0	B08		8	0344-0547	405.03	547.38	199	53.94	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2285.2	B08		8	0345-0553	720.38	553.08	424	78.91	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1302.6	B08		8	0346-0555	585.25	555.47	238	57.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1921.7	B08		8	0347-0557	930.45	557.56	203	53.94	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4617.0	B08		8	0348-0561	829.71	561.23	214	54.53	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5171.6	B08		8	0349-0561	149.59	561.09	177	51.11	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			886.3	B08		8	0350-0565	359.49	565.73	275	60.28	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			538.5	B08		8	0351-0567	899.27	567.38	262	59.60	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3876.4	B08		8	0352-0583	151.66	583.78	549	92.33	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7216.7	B08		8	0353-0575	301.99	574.27	211	54.53	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			522.0	B08		8	0354-0579	446.16	578.94	247	60.43	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			763.8	B08		8	0355-0580	653.80	579.80	251	60.77	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2306.3	B08		8	0356-0578	881.69	578.52	187	50.28	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1027.7	B08		8	0357-0582	591.28	583.00	268	61.26	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1867.6	B08		8	0358-0586	635.36	586.45	320	72.43	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			490.2	B08		8	0359-0585	522.96	585.30	305	67.36	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2754.6	B08		8	0360-0587	364.23	587.18	323	67.01	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1125.9	B08		8	0361-0584	292.96	585.51	169	49.11	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2025.1	B08		8	0362-0586	710.05	586.60	261	61.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2382.6	B08		8	0363-0588	546.84	587.82	378	76.18	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3289.8	B08		8	0364-0585	746.54	585.66	197	52.28	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			761.9	B08		8	0365-0594	428.50	594.90	260	61.36	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			771.3	B08		8	0366-0591	791.24	591.44	157	44.87	0.980
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1522.4	B08		8	0367-0594	106.89	593.63	301	67.36	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3543.6	B08		8	0368-0597	409.77	597.79	382	73.26	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2643.5	B08		8	0369-0601	38.88	600.70	394	73.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6196.9	B08		8	0370-0599	245.03	599.26	215	57.11	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3943.6	B08		8	0371-0603	294.83	602.94	352	87.26	0.581
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2656.8	B08		8	0372-0603	122.93	603.29	228	56.77	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2922.7	B08		8	0373-0602	745.82	602.88	254	59.70	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3515.8	B08		8	0374-0608	772.61	607.70	396	82.08	0.739
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			823.3	B08		8	0375-0611	588.28	610.98	281	61.11	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1570.7	B08		8	0376-0612	691.92	612.85	280	65.36	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1610.4	B08		8	0377-0611	621.03	610.64	266	65.11	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1038.1	B08		8	0378-0615	660.18	615.09	219	54.77	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3343.9	B08		8	0379-0615	91.00	615.30	225	55.11	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			706.7	B08		8	0380-0622	353.66	621.48	274	67.60	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2053.0	B08		8	0381-0617	484.70	617.51	235	57.46	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2426.7	B08		8	0382-0619	283.71	620.14	193	51.46	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2701.4	B08		8	0383-0624	540.61	624.20	286	64.43	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2692.3	B08		8	0384-0623	809.43	623.21	223	55.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3356.0	B08		8	0385-0626	369.46	626.27	240	59.11	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2948.7	B08		8	0386-0628	750.05	628.17	455	80.08	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1912.5	B08		8	0387-0626	315.90	625.91	218	54.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1347.7	B08		8	0388-0630	400.01	630.46	315	65.01	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2716.9	B08		8	0389-0634	103.08	633.11	250	61.60	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7335.3	B08		8	0390-0633	301.76	632.85	182	52.77	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			340.8	B08		8	0391-0634	920.99	635.17	270	65.01	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2729.5	B08		8	0392-0641	826.35	642.57	525	91.01	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			862.6	B08		8	0393-0636	250.17	635.64	243	57.11	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			9657.2	B08		8	0394-0636	286.29	635.91	299	67.11	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2176.2	B08		8	0395-0640	56.08	640.78	309	64.18	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3867.5	B08		8	0396-0645	176.16	644.35	531	89.74	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3235.4	B08		8	0397-0642	149.11	641.65	448	83.26	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1454.0	B08		8	0398-0641	548.88	641.16	219	57.01	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1710.1	B08		8	0399-0644	331.95	643.38	244	59.60	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1945.2	B08		8	0400-0644	615.31	644.31	242	60.53	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			450.2	B08		8	0401-0653	518.96	653.04	290	69.36	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3483.5	B08		8	0402-0654	562.67	654.67	315	66.18	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3557.2	B08		8	0403-0658	878.27	658.10	486	88.33	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2159.4	B08		8	0404-0659	685.60	660.49	274	65.60	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			13372.7	B08		8	0405-0660	134.72	659.99	277	61.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2458.1	B08		8	0406-0659	651.26	658.94	214	56.18	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6050.5	B08		8	0407-0662	215.01	661.71	477	97.64	0.629
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3425.2	B08		8	0408-0660	432.11	659.62	345	68.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			865.0	B08		8	0409-0661	746.57	660.93	266	60.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1100.7	B08		8	0410-0660	941.90	660.60	248	60.28	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6108.3	B08		8	0411-0660	189.48	661.10	161	49.11	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1723.1	B08		8	0412-0661	39.92	660.81	174	50.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2771.3	B08		8	0413-0664	81.31	663.61	225	57.70	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2236.2	B08		8	0414-0668	27.47	667.37	212	59.36	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1668.6	B08		8	0415-0670	173.32	670.15	233	58.53	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2898.3	B08		8	0416-0671	593.71	671.10	209	53.94	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1558.7	B08		8	0417-0679	567.36	678.71	242	59.84	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1350.0	B08		8	0418-0680	633.95	680.76	292	63.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2688.2	B08		8	0419-0685	777.50	685.49	371	71.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7436.4	B08		8	0420-0687	429.91	687.24	392	75.01	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2025.5	B08		8	0421-0684	263.38	684.17	218	56.53	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			415.0	B08		8	0422-0686	584.10	686.88	285	67.01	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2674.4	B08		8	0423-0680	903.82	679.87	100	37.21	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2272.6	B08		8	0424-0688	864.67	688.04	231	55.36	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1042.1	B08		8	0425-0688	80.75	689.10	232	57.11	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1799.1	B08		8	0426-0690	240.48	690.82	319	66.43	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			763.7	B08		8	0427-0693	719.10	693.26	270	60.53	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2392.5	B08		8	0428-0691	901.19	691.00	113	40.63	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1212.0	B08		8	0429-0697	17.33	697.09	223	56.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1919.7	B08		8	0430-0698	42.08	697.67	293	61.94	0.960
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1433.3	B08		8	0431-0699	548.17	698.83	224	56.28	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			917.4	B08		8	0432-0702	522.67	703.01	282	71.01	0.703
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2908.8	B08		8	0433-0703	351.47	703.31	310	65.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2775.9	B08		8	0434-0703	796.34	702.67	220	56.18	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			946.9	B08		8	0435-0702	574.57	702.78	210	54.28	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1002.2	B08		8	0436-0706	669.98	705.58	287	71.60	0.704
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1798.9	B08		9	0001-0029	375.41	28.74	246	63.11	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3591.3	B08		9	0002-0035	296.66	35.80	264	59.94	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2297.8	B08		9	0003-0036	644.36	36.42	315	66.53	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			749.9	B08		9	0004-0038	498.11	37.25	198	56.28	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2914.8	B08		9	0005-0041	524.43	41.73	478	87.74	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			526.2	B08		9	0006-0036	419.86	35.88	237	57.11	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1513.8	B08		9	0007-0037	916.03	37.79	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2014.9	B08		9	0008-0038	140.82	38.08	237	56.53	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1644.3	B08		9	0009-0041	868.08	40.29	256	63.26	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1496.8	B08		9	0010-0042	802.53	43.08	239	57.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			480.4	B08		9	0011-0045	752.63	45.65	300	67.94	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2547.9	B08		9	0012-0043	77.15	42.42	188	50.53	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1418.0	B08		9	0013-0043	22.75	43.23	221	55.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			9126.6	B08		9	0014-0048	195.35	48.09	125	41.11	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4885.2	B08		9	0015-0057	182.56	57.31	447	82.91	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			637.3	B08		9	0016-0059	157.91	60.02	233	61.01	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			981.6	B08		9	0017-0057	34.87	57.15	199	51.70	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1292.8	B08		9	0018-0056	285.96	56.48	248	60.77	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1352.4	B08		9	0019-0062	107.83	62.92	258	61.94	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2528.3	B08		9	0020-0064	915.19	64.42	323	65.60	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5134.4	B08		9	0021-0069	346.07	69.89	504	96.57	0.679
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4237.7	B08		9	0022-0063	704.13	62.44	191	53.70	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1774.5	B08		9	0023-0066	436.04	66.09	338	70.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			614.9	B08		9	0024-0068	580.73	68.94	270	62.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1715.9	B08		9	0025-0070	725.46	70.06	223	58.77	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1343.5	B08		9	0026-0072	284.31	72.25	291	63.36	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3581.2	B08		9	0027-0075	862.66	75.75	196	53.11	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2108.9	B08		9	0028-0081	662.91	82.52	347	71.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2166.2	B08		9	0029-0080	395.44	80.30	251	58.87	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			890.6	B08		9	0030-0082	932.73	81.71	281	61.60	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6950.0	B08		9	0031-0086	835.57	86.40	322	67.01	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			535.3	B08		9	0032-0088	176.88	88.51	268	61.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1341.5	B08		9	0033-0089	413.59	90.14	246	62.77	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			361.2	B08		9	0034-0092	612.75	92.05	284	68.08	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			814.4	B08		9	0035-0089	761.59	88.86	231	57.70	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3536.4	B08		9	0036-0095	240.04	95.34	359	70.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7451.0	B08		9	0037-0092	365.95	91.80	166	51.70	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			9862.9	B08		9	0038-0097	107.13	96.97	346	69.01	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2733.0	B08		9	0039-0095	479.40	93.97	208	55.01	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			23076.7	B08		9	0040-0095	395.91	94.90	126	44.28	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			9303.7	B08		9	0041-0100	384.59	100.22	192	62.67	0.614
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1567.7	B08		9	0042-0101	710.55	101.66	287	74.08	0.657
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			10738.2	B08		9	0043-0110	644.32	111.09	321	72.18	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1347.3	B08		9	0044-0106	372.78	107.06	198	52.77	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5266.9	B08		9	0045-0110	466.14	110.96	338	70.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1543.9	B08		9	0046-0112	75.69	112.16	235	56.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1353.7	B08		9	0047-0116	36.68	116.61	256	63.01	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5637.3	B08		9	0048-0118	294.42	117.84	409	74.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			869.4	B08		9	0049-0119	431.62	119.28	337	71.84	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			8941.0	B08		9	0050-0120	677.17	120.32	449	78.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1205.1	B08		9	0051-0121	411.39	121.23	277	62.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2916.3	B08		9	0052-0128	190.63	128.16	380	73.36	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1382.1	B08		9	0053-0126	224.06	125.99	270	63.94	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3845.3	B08		9	0054-0128	144.88	128.15	231	56.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3569.5	B08		9	0055-0133	746.35	133.64	381	73.26	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			579.7	B08		9	0056-0134	835.53	133.85	352	78.33	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4230.9	B08		9	0057-0139	253.74	138.75	396	74.67	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6418.5	B08		9	0058-0141	818.10	141.83	228	57.11	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1241.3	B08		9	0059-0144	47.69	143.22	250	61.36	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2344.7	B08		9	0060-0146	541.50	146.66	220	58.77	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2792.1	B08		9	0061-0150	866.35	150.41	235	57.60	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1454.8	B08		9	0062-0149	219.61	150.24	257	61.11	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3569.8	B08		9	0063-0153	936.51	153.32	219	56.53	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1226.9	B08		9	0064-0152	631.80	151.95	274	63.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1220.9	B08		9	0065-0156	715.63	156.14	264	59.94	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3977.4	B08		9	0066-0159	132.93	160.15	351	80.08	0.688
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1556.9	B08		9	0067-0159	577.05	159.47	210	55.70	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			881.3	B08		9	0068-0161	523.25	160.27	245	71.60	0.601
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			390.8	B08		9	0069-0166	589.08	166.62	279	68.18	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			8673.8	B08		9	0070-0168	857.63	168.79	337	69.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4037.8	B08		9	0071-0168	163.28	168.37	218	58.77	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			524.9	B08		9	0072-0167	753.10	167.95	345	77.36	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6841.2	B08		9	0073-0170	813.41	169.51	207	59.11	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4879.3	B08		9	0074-0173	337.38	173.65	437	79.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1059.0	B08		9	0075-0173	53.07	173.78	231	57.94	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1931.8	B08		9	0076-0177	659.41	177.28	409	77.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3372.9	B08		9	0077-0177	903.32	177.17	420	77.26	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6880.4	B08		9	0078-0177	119.07	177.60	157	47.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			10344.0	B08		9	0079-0179	279.29	179.71	293	63.94	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2012.4	B08		9	0080-0180	544.45	179.49	254	59.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3333.6	B08		9	0081-0186	495.05	186.44	413	75.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1202.6	B08		9	0082-0189	700.98	189.95	318	74.67	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1800.4	B08		9	0083-0200	82.82	200.43	296	66.18	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			596.2	B08		9	0084-0201	898.68	200.80	261	61.84	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			865.6	B08		9	0085-0203	39.87	204.14	236	65.01	0.702
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4079.5	B08		9	0086-0210	142.72	209.61	345	69.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2775.2	B08		9	0087-0210	815.25	209.94	406	75.60	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3661.6	B08		9	0088-0215	585.72	215.59	294	65.60	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4157.2	B08		9	0089-0220	316.80	220.33	296	63.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2822.7	B08		9	0090-0225	761.42	225.12	457	83.26	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2229.7	B08		9	0091-0221	68.78	221.25	223	57.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2825.8	B08		9	0092-0222	712.47	222.20	219	55.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2214.3	B08		9	0093-0229	444.65	229.37	286	62.53	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1394.8	B08		9	0094-0229	257.22	228.54	248	60.77	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2707.4	B08		9	0095-0230	419.36	229.52	313	66.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1749.4	B08		9	0096-0228	934.52	228.45	208	55.11	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2721.8	B08		9	0097-0233	696.55	233.45	214	54.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4443.8	B08		9	0098-0232	866.73	232.18	273	61.60	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5818.4	B08		9	0099-0240	469.31	240.67	512	91.50	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5683.9	B08		9	0100-0231	583.41	230.91	168	48.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			952.0	B08		9	0101-0237	641.00	236.87	303	71.01	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2694.2	B08		9	0102-0237	786.48	236.79	348	67.60	0.957
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			951.7	B08		9	0103-0238	568.60	238.28	246	62.18	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1393.5	B08		9	0104-0243	188.18	242.63	287	63.94	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3079.4	B08		9	0105-0245	37.25	244.38	184	53.70	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4189.7	B08		9	0106-0247	51.01	246.24	250	65.36	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1314.2	B08		9	0107-0246	387.87	246.42	235	58.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4815.4	B08		9	0108-0247	668.56	246.78	218	58.53	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4696.4	B08		9	0109-0246	67.09	246.25	134	44.04	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			656.4	B08		9	0110-0249	757.96	250.41	242	59.84	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2928.1	B08		9	0111-0251	114.69	250.68	376	73.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5589.7	B08		9	0112-0249	731.62	249.28	190	51.70	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3644.1	B08		9	0113-0256	95.29	255.88	233	57.46	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1660.1	B08		9	0114-0264	314.31	264.28	268	63.11	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1544.6	B08		9	0115-0263	73.71	263.86	225	61.36	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1054.0	B08		9	0116-0262	474.21	262.79	286	65.94	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1893.5	B08		9	0117-0270	339.27	270.00	284	63.36	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3499.0	B08		9	0118-0269	535.85	268.73	309	66.18	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1124.4	B08		9	0119-0269	182.69	270.82	188	52.63	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1807.1	B08		9	0120-0272	17.79	271.66	249	58.53	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2326.1	B08		9	0121-0275	763.22	275.32	256	58.53	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2446.1	B08		9	0122-0277	555.54	277.08	261	60.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2900.5	B08		9	0123-0284	50.90	284.12	340	70.53	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2273.0	B08		9	0124-0281	99.05	281.25	217	54.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			494.2	B08		9	0125-0287	246.12	287.94	272	67.84	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2694.5	B08		9	0126-0292	726.80	291.74	517	93.15	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4834.8	B08		9	0127-0290	183.49	289.35	416	76.18	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			8203.6	B08		9	0128-0289	334.17	289.12	270	59.94	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5276.1	B08		9	0129-0291	540.49	291.77	368	70.43	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1229.6	B08		9	0130-0292	449.98	292.00	252	57.11	0.971
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1077.4	B08		9	0131-0295	589.40	296.33	240	59.94	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1275.2	B08		9	0132-0294	801.72	294.94	278	69.84	0.716
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3358.1	B08		9	0133-0295	493.60	294.97	291	63.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1295.8	B08		9	0134-0300	260.29	300.34	263	68.77	0.699
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3502.9	B08		9	0135-0306	171.30	306.21	233	57.94	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			878.7	B08		9	0136-0312	29.03	312.93	218	56.53	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			533.3	B08		9	0137-0311	895.81	310.71	243	58.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			865.3	B08		9	0138-0318	53.27	318.60	345	82.08	0.643
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2629.4	B08		9	0139-0316	771.09	315.11	296	64.53	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2051.9	B08		9	0140-0318	229.24	318.55	191	51.70	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3309.5	B08		9	0141-0320	438.45	319.63	210	55.70	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3531.0	B08		9	0142-0321	467.78	320.33	229	56.28	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			458.6	B08		9	0143-0321	317.76	321.39	263	67.36	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			579.8	B08		9	0144-0328	922.76	328.97	281	67.11	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2212.9	B08		9	0145-0327	186.14	327.13	204	54.53	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4165.5	B08		9	0146-0334	85.06	333.61	377	76.18	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1515.7	B08		9	0147-0328	528.84	327.56	216	57.70	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			502.7	B08		9	0148-0337	300.90	337.37	226	68.91	0.598
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3519.5	B08		9	0149-0338	407.57	338.42	370	72.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2206.7	B08		9	0150-0340	108.35	340.54	212	56.28	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1853.4	B08		9	0151-0341	495.40	341.38	246	59.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3574.6	B08		9	0152-0341	755.99	340.88	209	54.28	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2578.4	B08		9	0153-0343	626.36	343.83	258	58.77	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3101.5	B08		9	0154-0344	427.02	344.31	229	57.46	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2215.9	B08		9	0155-0345	682.42	345.77	237	57.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			850.9	B08		9	0156-0352	877.69	351.77	267	62.87	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			963.7	B08		9	0157-0354	511.28	354.98	227	59.94	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3569.2	B08		9	0158-0355	359.05	355.36	404	74.18	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1780.3	B08		9	0159-0357	108.57	356.48	250	58.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3376.9	B08		9	0160-0362	712.63	362.15	219	55.36	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1691.0	B08		9	0161-0364	854.69	363.71	235	58.77	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1437.6	B08		9	0162-0374	762.71	374.69	251	58.53	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			10709.1	B08		9	0163-0382	541.62	381.84	369	69.84	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1637.5	B08		9	0164-0384	836.72	385.18	259	62.53	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4434.5	B08		9	0165-0388	132.56	388.06	423	79.84	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4758.8	B08		9	0166-0383	443.86	383.52	208	54.53	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			776.8	B08		9	0167-0385	591.05	385.30	269	63.36	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6380.8	B08		9	0168-0383	795.38	383.11	199	51.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1345.8	B08		9	0169-0386	880.30	385.53	249	63.84	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			685.7	B08		9	0170-0388	609.83	388.72	299	68.18	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1817.0	B08		9	0171-0392	751.60	392.00	346	68.18	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2101.3	B08		9	0172-0392	61.36	392.33	283	61.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5216.5	B08		9	0173-0398	557.28	397.94	324	66.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1354.8	B08		9	0174-0397	499.20	396.92	252	61.11	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1955.8	B08		9	0175-0403	283.02	403.64	278	66.53	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1931.5	B08		9	0176-0402	205.79	402.27	267	61.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2176.2	B08		9	0177-0403	233.59	403.91	230	58.28	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3011.6	B08		9	0178-0405	473.13	404.50	404	75.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			745.0	B08		9	0179-0406	83.40	406.15	256	65.60	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5187.1	B08		9	0180-0413	789.67	413.15	247	57.36	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4980.5	B08		9	0181-0416	426.35	416.54	220	56.53	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1600.1	B08		9	0182-0423	837.61	424.02	364	74.91	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1512.4	B08		9	0183-0421	305.15	420.27	213	56.53	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2425.9	B08		9	0184-0422	494.32	422.69	230	56.43	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1983.0	B08		9	0185-0426	371.17	426.66	319	67.01	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4203.4	B08		9	0186-0427	537.70	427.27	339	69.01	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4853.0	B08		9	0187-0432	685.33	431.98	231	59.36	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1780.2	B08		9	0188-0431	97.98	430.39	188	56.39	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4642.1	B08		9	0189-0433	54.32	433.29	233	60.53	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4041.4	B08		9	0190-0436	449.92	436.02	269	60.53	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1192.3	B08		9	0191-0442	519.64	442.54	258	64.87	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2116.1	B08		9	0192-0439	203.08	439.76	261	62.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			8953.8	B08		9	0193-0437	789.12	437.27	116	40.63	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2970.4	B08		9	0194-0440	878.12	440.65	189	52.77	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1852.6	B08		9	0195-0443	98.41	442.84	227	59.11	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4396.0	B08		9	0196-0447	570.66	447.10	432	77.26	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			885.2	B08		9	0197-0448	170.09	448.37	247	57.94	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3322.7	B08		9	0198-0446	269.82	445.98	162	47.70	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3484.0	B08		9	0199-0446	254.95	446.32	123	39.70	0.981
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			851.4	B08		9	0200-0452	673.57	452.65	230	79.15	0.461
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3107.1	B08		9	0201-0452	307.23	451.83	314	65.60	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1463.9	B08		9	0202-0455	458.89	454.01	262	61.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3303.8	B08		9	0203-0454	867.79	454.33	272	60.77	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			812.5	B08		9	0204-0457	197.88	457.55	260	59.94	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2764.3	B08		9	0205-0458	886.30	458.69	261	59.11	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1178.2	B08		9	0206-0461	116.98	460.20	312	66.77	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			761.1	B08		9	0207-0457	382.26	457.42	169	48.87	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3888.9	B08		9	0208-0462	262.87	461.81	282	64.18	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2097.2	B08		9	0209-0462	492.45	462.02	229	58.77	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3420.8	B08		9	0210-0465	652.17	465.62	167	52.53	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4533.7	B08		9	0211-0467	447.34	467.17	217	56.53	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1835.0	B08		9	0212-0471	237.87	471.44	203	54.53	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			810.7	B08		9	0213-0475	615.13	476.07	237	61.94	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1780.0	B08		9	0214-0474	890.92	474.25	224	58.77	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1323.3	B08		9	0215-0477	410.11	477.40	250	60.28	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5201.3	B08		9	0216-0481	835.88	480.63	245	68.43	0.658
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1550.9	B08		9	0217-0482	131.20	482.57	312	67.36	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1138.8	B08		9	0218-0485	789.47	484.56	241	57.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4285.0	B08		9	0219-0488	293.83	487.81	344	69.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3978.5	B08		9	0220-0493	57.35	493.06	480	85.50	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1508.9	B08		9	0221-0491	203.22	491.41	302	64.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			570.5	B08		9	0222-0490	177.03	490.29	235	56.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2278.8	B08		9	0223-0495	751.21	495.28	280	66.77	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1979.2	B08		9	0224-0498	80.23	499.11	399	74.43	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2000.2	B08		9	0225-0497	922.77	497.48	204	57.70	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3272.0	B08		9	0226-0502	236.73	501.88	415	75.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2340.9	B08		9	0227-0498	573.39	498.78	297	62.53	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5114.1	B08		9	0228-0500	322.76	499.64	277	61.60	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2823.1	B08		9	0229-0502	506.79	501.80	248	58.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4497.0	B08		9	0230-0503	20.49	503.65	227	58.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2514.4	B08		9	0231-0503	613.53	503.98	219	57.60	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			928.4	B08		9	0232-0506	148.19	505.77	242	59.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3436.5	B08		9	0233-0507	431.14	506.84	291	62.53	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1709.2	B08		9	0234-0507	638.99	507.50	240	56.53	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2519.6	B08		9	0235-0513	402.86	513.41	325	66.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			755.9	B08		9	0236-0514	539.86	512.74	302	67.84	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			861.0	B08		9	0237-0515	869.62	515.16	264	61.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1613.5	B08		9	0238-0516	369.98	516.93	269	64.18	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2429.1	B08		9	0239-0519	104.22	518.97	321	67.26	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2568.3	B08		9	0240-0525	570.22	526.36	302	65.94	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2229.3	B08		9	0241-0528	304.28	527.73	282	63.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2604.7	B08		9	0242-0532	817.06	532.15	301	66.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3071.8	B08		9	0243-0529	424.39	528.53	175	47.94	0.957
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			773.1	B08		9	0244-0536	692.32	536.35	300	71.01	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			318.8	B08		9	0245-0535	203.65	535.32	324	70.77	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1318.9	B08		9	0246-0534	332.49	534.09	240	59.60	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1056.3	B08		9	0247-0535	479.98	535.04	241	57.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1577.0	B08		9	0248-0535	624.18	535.37	228	54.53	0.964
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			866.1	B08		9	0249-0541	520.93	541.71	289	66.08	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2474.6	B08		9	0250-0540	436.99	540.78	196	51.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1011.7	B08		9	0251-0542	849.90	542.58	274	61.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3444.3	B08		9	0252-0547	578.88	546.35	334	73.26	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1003.2	B08		9	0253-0547	64.50	546.90	227	56.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4318.9	B08		9	0254-0548	272.23	548.62	433	82.67	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2411.9	B08		9	0255-0549	125.58	549.29	309	65.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1367.6	B08		9	0256-0552	634.80	553.72	295	69.01	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2960.7	B08		9	0257-0554	757.50	554.76	286	61.94	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1903.6	B08		9	0258-0558	555.44	558.53	254	60.77	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1942.2	B08		9	0259-0560	24.96	560.43	200	53.70	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3014.9	B08		9	0260-0562	697.90	561.96	263	64.77	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			689.0	B08		9	0261-0563	849.83	563.63	267	62.77	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4040.2	B08		9	0262-0566	598.76	565.95	287	64.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1012.6	B08		9	0263-0565	51.84	565.11	217	53.94	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			869.4	B08		9	0264-0568	888.61	568.11	289	68.43	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1020.3	B08		9	0265-0572	386.02	571.90	243	58.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			638.5	B08		9	0266-0575	514.40	575.95	281	61.70	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4296.6	B08		9	0267-0581	532.87	581.25	353	71.94	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4538.5	B08		9	0268-0579	287.29	578.41	257	65.84	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2294.6	B08		9	0269-0584	864.73	583.81	303	73.26	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3009.8	B08		9	0270-0584	646.24	584.16	276	63.01	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1330.9	B08		9	0271-0585	50.25	586.00	238	56.53	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2152.3	B08		9	0272-0588	179.41	588.74	349	70.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2918.6	B08		9	0273-0590	332.10	590.35	315	67.36	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2598.7	B08		9	0274-0586	763.04	585.73	159	46.28	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			433.1	B08		9	0275-0592	716.93	591.83	260	62.43	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2009.3	B08		9	0276-0596	84.07	595.42	314	70.43	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2482.3	B08		9	0277-0596	569.57	597.08	525	102.57	0.627
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3035.8	B08		9	0278-0595	813.75	595.63	252	65.36	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			921.9	B08		9	0279-0592	473.14	591.49	225	56.87	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1533.7	B08		9	0280-0596	369.67	596.03	280	62.18	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2712.3	B08		9	0281-0596	774.53	596.67	295	65.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1794.8	B08		9	0282-0601	122.68	601.11	241	61.84	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1524.7	B08		9	0283-0598	437.42	599.28	254	61.94	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2828.0	B08		9	0284-0604	937.38	603.42	278	62.53	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1024.3	B08		9	0285-0604	397.84	603.82	232	55.36	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6339.5	B08		9	0286-0609	894.82	608.75	206	54.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1748.2	B08		9	0287-0616	115.39	616.74	322	71.60	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3789.5	B08		9	0288-0614	727.58	614.63	374	73.01	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1923.8	B08		9	0289-0615	291.21	615.32	234	60.18	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7083.2	B08		9	0290-0611	909.17	611.05	147	46.04	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4056.8	B08		9	0291-0616	59.21	615.88	279	62.18	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5831.1	B08		9	0292-0616	645.44	616.87	345	73.26	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1667.0	B08		9	0293-0617	868.69	617.47	490	92.81	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			723.1	B08		9	0294-0618	309.51	618.88	216	61.84	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2541.3	B08		9	0295-0618	274.72	618.27	204	54.53	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1339.9	B08		9	0296-0622	927.25	621.70	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2955.2	B08		9	0297-0624	218.76	623.81	309	63.60	0.960
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7837.7	B08		9	0298-0628	473.80	627.67	178	52.53	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2379.8	B08		9	0299-0629	88.26	629.56	283	62.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1625.7	B08		9	0300-0629	777.02	628.82	261	61.01	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1453.1	B08		9	0301-0635	568.32	635.08	290	73.84	0.668
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3026.5	B08		9	0302-0631	810.05	630.69	249	63.26	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			952.0	B08		9	0303-0630	383.60	630.36	218	53.36	0.962
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2241.9	B08		9	0304-0632	640.10	632.53	232	59.70	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3112.9	B08		9	0305-0633	902.89	632.87	350	68.18	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1897.9	B08		9	0306-0631	325.68	632.39	263	60.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4169.3	B08		9	0307-0633	688.22	633.46	306	63.94	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1850.8	B08		9	0308-0640	182.52	640.32	330	69.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3809.3	B08		9	0309-0639	110.84	638.95	229	56.53	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2508.5	B08		9	0310-0642	264.97	641.97	190	53.36	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2229.3	B08		9	0311-0642	946.31	642.26	211	55.94	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4543.4	B08		9	0312-0653	717.73	653.94	494	85.15	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			560.1	B08		9	0313-0650	429.31	649.95	196	52.28	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			731.9	B08		9	0314-0655	504.15	656.17	268	64.18	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1309.3	B08		9	0315-0652	657.70	652.90	261	59.11	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6669.4	B08		9	0316-0654	70.78	654.67	174	51.11	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2488.2	B08		9	0317-0657	339.71	657.78	226	56.53	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			855.5	B08		9	0318-0655	383.03	655.64	149	48.87	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1049.4	B08		9	0319-0657	200.29	656.11	247	59.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			847.8	B08		9	0320-0658	839.59	659.58	154	49.70	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			496.1	B08		9	0321-0657	444.85	658.14	127	47.11	0.719
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3437.8	B08		9	0322-0661	623.12	662.42	258	63.60	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2568.2	B08		9	0323-0658	568.08	658.62	172	49.70	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3043.0	B08		9	0324-0659	790.18	659.37	206	54.28	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1144.8	B08		9	0325-0663	35.78	663.64	240	57.94	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1221.8	B08		9	0326-0662	404.60	661.96	211	57.36	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4091.4	B08		9	0327-0664	162.23	664.66	252	61.94	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1277.7	B08		9	0328-0670	140.52	670.03	284	64.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4087.9	B08		9	0329-0672	297.72	672.30	288	66.43	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1549.7	B08		9	0330-0674	875.21	673.40	244	60.53	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2025.4	B08		9	0331-0676	380.69	676.33	270	67.84	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1589.9	B08		9	0332-0675	91.03	674.87	253	59.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1229.8	B08		9	0333-0676	937.72	675.75	245	59.11	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3248.5	B08		9	0334-0674	786.59	674.75	198	50.87	0.962
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			489.2	B08		9	0335-0684	887.77	684.20	229	60.77	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			950.9	B08		9	0336-0686	264.85	686.00	246	60.53	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			913.9	B08		9	0337-0692	837.75	693.34	241	64.43	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			628.1	B08		9	0338-0695	451.42	695.09	247	59.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2558.9	B08		9	0339-0698	629.42	698.59	368	72.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			668.3	B08		9	0340-0696	691.70	698.16	252	70.43	0.638
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1536.1	B08		9	0341-0695	937.50	695.64	242	57.11	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			564.8	B08		9	0342-0697	110.29	698.24	232	66.18	0.666
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2718.3	B08		9	0343-0703	749.84	702.22	218	59.11	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4049.8	B08		9	0344-0703	45.50	703.45	308	66.43	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2353.5	B08		9	0345-0708	150.33	708.96	334	70.43	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			316.7	B08		9	0346-0706	185.63	705.56	275	66.43	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2116.5	B08		9	0347-0703	907.57	703.18	102	37.80	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			595.4	B08		9	0348-0708	216.50	709.43	226	57.36	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1406.9	C08		1	0001-0025	822.14	25.96	373	78.43	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			769.2	C08		1	0002-0032	681.57	32.38	336	70.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1297.3	C08		1	0003-0031	209.13	31.38	259	59.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1177.3	C08		1	0004-0035	598.48	35.02	291	65.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1216.5	C08		1	0005-0033	294.09	33.97	277	61.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			431.0	C08		1	0006-0037	95.05	37.30	267	59.36	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			486.3	C08		1	0007-0038	133.57	38.49	299	64.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			512.1	C08		1	0008-0040	943.98	40.01	322	66.77	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			545.4	C08		1	0009-0040	72.15	41.03	262	61.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2109.8	C08		1	0010-0039	525.47	39.38	257	59.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1411.6	C08		1	0011-0041	554.92	42.34	237	63.60	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			415.8	C08		1	0012-0041	925.52	41.93	290	61.94	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			506.6	C08		1	0013-0045	740.21	45.84	288	63.84	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2869.3	C08		1	0014-0050	351.70	51.05	330	68.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1879.8	C08		1	0015-0054	703.39	54.41	393	100.57	0.488
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1261.0	C08		1	0016-0050	831.85	50.06	209	52.28	0.961
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1169.6	C08		1	0017-0054	308.76	53.84	288	64.43	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			376.4	C08		1	0018-0058	877.05	57.46	291	64.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1106.9	C08		1	0019-0061	784.13	62.60	326	70.18	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1740.8	C08		1	0020-0061	248.09	60.88	258	61.01	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			462.3	C08		1	0021-0063	901.93	63.40	246	58.18	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			518.9	C08		1	0022-0065	450.72	64.22	288	63.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1314.3	C08		1	0023-0070	278.90	71.24	278	66.18	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			538.8	C08		1	0024-0072	603.94	72.36	320	66.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			381.2	C08		1	0025-0072	740.78	71.77	255	64.43	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4014.9	C08		1	0026-0072	691.94	72.87	204	67.26	0.567
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1120.5	C08		1	0027-0072	50.25	71.85	260	59.94	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			481.4	C08		1	0028-0074	438.92	74.68	303	65.26	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1867.2	C08		1	0029-0079	190.55	76.48	356	97.64	0.469
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			892.8	C08		1	0030-0075	870.05	76.04	277	65.36	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			417.5	C08		1	0031-0085	158.34	84.95	308	67.60	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			934.8	C08		1	0032-0085	93.65	85.12	246	58.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			808.7	C08		1	0033-0086	125.51	86.38	303	68.08	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			600.2	C08		1	0034-0086	411.37	86.47	305	64.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1573.8	C08		1	0035-0086	333.45	86.21	307	67.36	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			495.1	C08		1	0036-0095	644.36	95.56	264	61.94	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1175.4	C08		1	0037-0095	520.50	94.48	257	62.77	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1030.6	C08		1	0038-0096	764.15	95.07	320	71.01	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1621.2	C08		1	0039-0100	537.98	100.04	222	57.94	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3639.6	C08		1	0040-0101	506.98	101.49	188	52.53	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1410.5	C08		1	0041-0103	259.99	103.05	262	59.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4017.0	C08		1	0042-0105	493.19	105.07	201	53.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			520.8	C08		1	0043-0106	37.63	106.01	252	59.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1115.3	C08		1	0044-0109	240.13	108.48	280	63.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			621.2	C08		1	0045-0108	558.40	108.86	306	65.36	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			656.3	C08		1	0046-0108	577.01	108.07	250	57.36	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			749.7	C08		1	0047-0107	811.47	107.51	328	67.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			365.0	C08		1	0048-0110	851.09	110.29	317	67.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			625.3	C08		1	0049-0108	445.47	107.83	261	66.77	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1156.7	C08		1	0050-0117	119.82	117.36	249	60.53	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			610.2	C08		1	0051-0119	649.82	119.59	358	69.60	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2039.0	C08		1	0052-0120	103.19	120.90	254	61.11	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			709.9	C08		1	0053-0119	946.75	118.29	260	63.60	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			544.5	C08		1	0054-0118	743.02	118.79	290	64.53	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			564.7	C08		1	0055-0121	58.32	121.55	260	60.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			762.3	C08		1	0056-0131	85.34	132.15	262	61.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			722.9	C08		1	0057-0131	452.43	130.72	300	64.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			515.4	C08		1	0058-0138	487.67	137.96	255	65.84	0.739
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			579.6	C08		1	0059-0137	502.83	137.54	193	57.01	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1234.0	C08		1	0060-0139	210.02	137.63	516	101.40	0.631
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			622.8	C08		1	0061-0138	670.61	138.33	241	56.53	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			533.7	C08		1	0062-0143	149.45	143.21	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			831.5	C08		1	0063-0140	372.06	140.09	251	59.01	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			402.7	C08		1	0064-0145	749.21	144.31	314	68.18	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			373.3	C08		1	0065-0145	920.96	145.33	331	71.50	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			995.7	C08		1	0066-0146	39.71	146.68	341	69.94	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			747.1	C08		1	0067-0147	173.79	147.27	267	61.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			445.5	C08		1	0068-0153	551.00	153.54	283	63.26	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			580.6	C08		1	0069-0151	813.05	150.94	259	59.36	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			455.4	C08		1	0070-0158	513.00	157.99	546	99.15	0.698
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			589.9	C08		1	0071-0153	446.25	153.63	170	52.77	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			659.4	C08		1	0072-0155	845.90	155.03	319	67.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1243.5	C08		1	0073-0154	334.70	154.51	259	60.18	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			527.8	C08		1	0074-0152	624.74	152.68	246	59.11	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			337.0	C08		1	0075-0156	784.87	156.36	297	65.60	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			301.3	C08		1	0076-0159	884.42	159.25	315	70.43	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			460.6	C08		1	0077-0160	127.31	160.31	303	65.36	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			848.3	C08		1	0078-0162	305.18	162.32	272	63.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			500.1	C08		1	0079-0168	288.46	168.54	311	67.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			278.2	C08		1	0080-0171	832.81	171.77	291	68.18	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			454.5	C08		1	0081-0174	42.34	174.21	262	63.36	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			830.2	C08		1	0082-0170	729.21	170.50	271	61.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			392.6	C08		1	0083-0173	590.40	173.08	296	63.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			458.4	C08		1	0084-0178	83.14	178.73	315	65.01	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			771.8	C08		1	0085-0177	171.65	177.29	246	57.36	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			627.3	C08		1	0086-0182	691.21	182.38	284	63.36	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			688.8	C08		1	0087-0186	447.87	186.68	253	59.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			748.4	C08		1	0088-0188	242.39	187.62	194	51.94	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			691.7	C08		1	0089-0193	516.56	193.62	611	101.98	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			349.1	C08		1	0090-0190	635.08	190.19	316	70.43	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			594.6	C08		1	0091-0192	872.76	192.02	284	61.36	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			906.1	C08		1	0092-0193	736.41	192.47	313	65.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			627.9	C08		1	0093-0194	386.17	193.83	254	58.53	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			474.7	C08		1	0094-0194	823.62	193.96	316	67.84	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			418.1	C08		1	0095-0196	920.81	196.20	290	64.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			394.6	C08		1	0096-0196	427.88	196.19	297	65.01	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			569.9	C08		1	0097-0201	117.09	201.51	288	64.28	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			502.2	C08		1	0098-0201	53.21	201.78	281	60.77	0.956
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1826.0	C08		1	0099-0200	257.81	199.94	205	56.77	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			873.4	C08		1	0100-0203	208.24	203.37	234	55.94	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			370.6	C08		1	0101-0206	669.23	206.07	274	62.53	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			513.3	C08		1	0102-0208	574.16	208.16	397	73.84	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			512.1	C08		1	0103-0204	331.29	205.07	268	64.28	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2311.5	C08		1	0104-0211	807.63	211.72	465	80.08	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1420.8	C08		1	0105-0211	246.49	212.01	282	62.43	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			581.8	C08		1	0106-0213	766.71	214.14	272	61.60	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			683.9	C08		1	0107-0227	200.15	227.05	513	92.08	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			548.1	C08		1	0108-0228	722.25	228.10	375	72.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			903.8	C08		1	0109-0230	145.31	230.74	242	58.77	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			738.8	C08		1	0110-0231	695.49	230.67	231	55.36	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			443.2	C08		1	0111-0231	567.25	231.61	293	66.53	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			445.9	C08		1	0112-0236	127.92	236.17	260	61.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			922.8	C08		1	0113-0237	501.37	237.45	245	57.94	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1041.4	C08		1	0114-0236	799.39	236.30	397	79.70	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			497.7	C08		1	0115-0240	324.51	240.08	251	58.53	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			356.4	C08		1	0116-0244	296.32	243.88	305	66.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1507.1	C08		1	0117-0248	90.39	247.75	310	65.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1269.0	C08		1	0118-0248	683.41	248.56	344	67.60	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3715.1	C08		1	0119-0245	744.24	245.15	204	53.11	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2099.6	C08		1	0120-0245	763.73	245.53	199	51.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1708.0	C08		1	0121-0250	345.88	250.19	248	57.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			714.9	C08		1	0122-0255	833.72	255.63	376	75.26	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1262.2	C08		1	0123-0253	578.67	252.77	255	61.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			337.0	C08		1	0124-0257	141.20	256.83	286	63.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			731.3	C08		1	0125-0262	225.24	261.63	430	78.67	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			493.3	C08		1	0126-0259	74.74	259.19	315	66.53	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			566.5	C08		1	0127-0259	284.48	259.09	366	71.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7681.0	C08		1	0128-0259	366.80	258.66	326	67.01	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			770.4	C08		1	0129-0257	851.64	258.33	235	58.87	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			479.8	C08		1	0130-0267	526.09	266.69	533	94.57	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			810.9	C08		1	0131-0263	590.14	263.95	263	61.11	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			851.9	C08		1	0132-0266	877.93	266.67	240	58.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			583.3	C08		1	0133-0265	920.94	265.46	218	53.70	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1051.7	C08		1	0134-0271	614.64	271.53	413	74.67	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			400.8	C08		1	0135-0272	765.04	272.49	301	63.36	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2871.7	C08		1	0136-0272	934.67	272.12	175	51.36	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			493.8	C08		1	0137-0276	167.43	277.02	253	61.70	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			344.0	C08		1	0138-0276	674.37	275.96	323	67.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			384.4	C08		1	0139-0278	456.40	277.71	282	63.60	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			888.8	C08		1	0140-0279	829.32	278.74	284	64.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			556.6	C08		1	0141-0279	328.50	279.91	245	56.77	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			428.7	C08		1	0142-0287	283.61	286.97	406	75.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			446.2	C08		1	0143-0290	212.32	290.79	292	66.18	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			413.8	C08		1	0144-0287	406.95	287.56	318	70.77	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			594.6	C08		1	0145-0287	877.73	287.64	261	59.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3875.7	C08		1	0146-0284	940.74	284.64	148	44.28	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			375.1	C08		1	0147-0290	350.24	290.23	304	68.08	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			374.4	C08		1	0148-0293	88.23	293.47	271	63.36	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			338.9	C08		1	0149-0298	478.74	297.61	288	67.11	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			522.9	C08		1	0150-0299	30.29	299.17	312	65.11	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			598.3	C08		1	0151-0297	769.35	297.25	237	56.18	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1167.6	C08		1	0152-0298	577.12	298.30	242	62.18	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			330.4	C08		1	0153-0301	850.21	301.23	325	67.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			790.3	C08		1	0154-0301	793.81	300.67	249	59.60	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			353.0	C08		1	0155-0305	134.72	305.10	300	65.01	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			438.7	C08		1	0156-0305	415.61	306.08	322	69.60	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1643.7	C08		1	0157-0308	177.86	307.75	226	57.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1529.7	C08		1	0158-0311	161.71	310.71	226	56.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			437.4	C08		1	0159-0311	441.45	311.15	283	62.77	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			986.0	C08		1	0160-0310	572.11	310.90	264	63.70	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			354.0	C08		1	0161-0317	258.06	316.84	309	68.77	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			361.2	C08		1	0162-0320	664.01	318.99	331	66.77	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			382.6	C08		1	0163-0324	615.82	324.26	326	70.43	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			415.7	C08		1	0164-0324	23.47	324.39	299	63.60	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			341.9	C08		1	0165-0325	243.62	325.36	286	63.84	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			575.1	C08		1	0166-0325	394.36	325.64	297	64.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			889.1	C08		1	0167-0328	874.08	327.59	234	56.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1751.5	C08		1	0168-0328	899.15	329.03	260	61.94	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			941.5	C08		1	0169-0333	90.84	332.85	266	62.43	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			417.3	C08		1	0170-0333	126.02	332.87	298	67.60	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			490.6	C08		1	0171-0337	818.17	337.25	353	68.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1155.0	C08		1	0172-0336	529.02	336.98	248	59.94	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			485.2	C08		1	0173-0335	936.43	335.59	267	61.36	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			613.2	C08		1	0174-0342	377.70	341.70	254	63.60	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			433.1	C08		1	0175-0341	751.57	340.97	254	61.60	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3895.4	C08		1	0176-0344	76.38	343.86	228	55.36	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2159.5	C08		1	0177-0345	460.57	344.62	193	52.53	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1012.6	C08		1	0178-0351	681.74	350.99	338	69.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			514.0	C08		1	0179-0349	577.92	349.82	294	64.43	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			631.8	C08		1	0180-0351	291.85	350.98	292	63.84	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			361.5	C08		1	0181-0352	489.82	352.37	300	65.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			461.7	C08		1	0182-0352	327.35	351.69	252	61.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2809.2	C08		1	0183-0353	446.60	353.32	231	56.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			539.7	C08		1	0184-0354	805.06	354.07	247	59.70	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			592.6	C08		1	0185-0359	872.13	359.11	311	67.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1036.1	C08		1	0186-0363	132.70	363.09	329	68.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			486.2	C08		1	0187-0365	336.31	364.68	263	59.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			392.8	C08		1	0188-0364	410.22	363.79	327	69.01	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			406.6	C08		1	0189-0367	502.64	368.11	257	61.84	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			762.7	C08		1	0190-0376	921.44	376.79	551	108.95	0.583
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			463.1	C08		1	0191-0369	593.60	369.66	279	63.70	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			505.3	C08		1	0192-0375	268.02	375.42	298	69.36	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			714.3	C08		1	0193-0372	752.98	371.61	257	60.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			295.7	C08		1	0194-0377	634.41	376.32	349	72.43	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			435.7	C08		1	0195-0379	880.14	379.02	319	70.43	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			455.8	C08		1	0196-0377	119.73	376.80	305	72.77	0.724
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			405.5	C08		1	0197-0382	700.82	381.97	292	65.60	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			916.3	C08		1	0198-0382	220.40	381.71	287	64.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2668.1	C08		1	0199-0382	446.89	381.74	234	56.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			424.4	C08		1	0200-0384	428.95	384.84	299	64.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			767.2	C08		1	0201-0387	282.57	387.37	421	76.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			284.5	C08		1	0202-0387	25.30	387.85	243	61.94	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			618.1	C08		1	0203-0393	364.86	393.85	475	94.23	0.672
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			568.0	C08		1	0204-0386	840.01	386.59	291	66.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			542.7	C08		1	0205-0392	728.70	393.05	303	68.18	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			716.8	C08		1	0206-0395	87.04	395.30	245	57.94	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			470.8	C08		1	0207-0395	516.66	395.19	277	61.36	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			634.4	C08		1	0208-0404	108.05	404.45	252	58.18	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			739.0	C08		1	0209-0408	417.91	407.79	261	63.01	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			450.9	C08		1	0210-0413	504.12	413.06	284	62.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			458.7	C08		1	0211-0413	684.04	412.94	283	62.18	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			305.9	C08		1	0212-0418	45.73	418.54	308	64.18	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1365.6	C08		1	0213-0420	133.94	419.89	318	65.84	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			938.4	C08		1	0214-0424	879.01	423.32	332	79.74	0.656
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			391.1	C08		1	0215-0420	815.78	420.19	308	63.36	0.964
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			608.4	C08		1	0216-0420	439.51	420.26	208	54.04	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			918.7	C08		1	0217-0422	290.62	422.02	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			739.3	C08		1	0218-0426	192.46	426.07	432	78.43	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2519.2	C08		1	0219-0425	457.42	425.06	257	61.70	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			402.1	C08		1	0220-0425	908.76	426.11	267	63.94	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1406.4	C08		1	0221-0430	759.47	429.63	435	88.67	0.695
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			827.2	C08		1	0222-0428	253.32	428.39	295	66.18	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			274.3	C08		1	0223-0431	555.02	431.98	323	95.15	0.448
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			817.5	C08		1	0224-0430	599.73	430.23	285	65.60	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			509.2	C08		1	0225-0433	317.04	433.41	275	62.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			696.8	C08		1	0226-0433	103.24	433.39	402	75.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			872.8	C08		1	0227-0438	640.55	438.85	580	100.57	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			494.0	C08		1	0228-0435	845.96	435.40	258	62.28	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			579.0	C08		1	0229-0438	720.28	437.38	302	67.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			453.0	C08		1	0230-0439	18.11	439.59	340	68.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			261.5	C08		1	0231-0441	169.96	442.00	318	66.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			767.7	C08		1	0232-0444	771.12	444.45	230	57.36	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			463.3	C08		1	0233-0447	477.66	447.79	262	61.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			797.3	C08		1	0234-0456	438.10	457.77	540	95.40	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			983.6	C08		1	0235-0456	881.35	455.43	335	78.57	0.682
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			450.3	C08		1	0236-0456	265.11	456.45	313	65.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			868.0	C08		1	0237-0460	511.98	459.79	454	81.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			648.6	C08		1	0238-0456	409.18	456.62	214	53.36	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			294.1	C08		1	0239-0461	38.50	461.65	307	66.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			371.0	C08		1	0240-0462	165.64	462.71	309	71.60	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2485.6	C08		1	0241-0468	330.38	467.02	250	58.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			628.9	C08		1	0242-0470	569.44	470.56	357	69.84	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			635.3	C08		1	0243-0470	930.07	470.50	260	59.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			381.7	C08		1	0244-0471	789.81	471.64	322	67.01	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1347.2	C08		1	0245-0474	229.06	473.77	379	73.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1549.1	C08		1	0246-0471	387.85	471.68	248	58.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1703.4	C08		1	0247-0472	706.29	472.14	277	63.11	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1518.0	C08		1	0248-0481	321.87	481.24	242	58.77	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4612.0	C08		1	0249-0485	380.17	485.37	224	55.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			804.4	C08		1	0250-0486	625.83	486.05	324	66.18	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			423.5	C08		1	0251-0487	260.40	486.47	279	63.01	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			450.3	C08		1	0252-0488	501.49	489.01	313	66.77	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			322.5	C08		1	0253-0492	911.58	492.21	260	59.70	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1136.9	C08		1	0254-0494	593.95	494.04	348	70.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			662.1	C08		1	0255-0495	665.13	495.70	312	69.11	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			435.5	C08		1	0256-0494	159.72	493.86	232	57.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			916.0	C08		1	0257-0496	474.83	495.59	304	64.77	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2925.2	C08		1	0258-0500	942.76	500.59	410	78.43	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			452.9	C08		1	0259-0499	73.34	499.05	270	61.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2146.1	C08		1	0260-0501	746.05	501.11	444	77.26	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			648.2	C08		1	0261-0500	189.28	499.86	272	61.11	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2586.4	C08		1	0262-0505	546.03	505.10	455	80.91	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			968.9	C08		1	0263-0503	299.59	503.95	272	63.01	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			465.2	C08		1	0264-0501	110.04	501.73	271	61.70	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			8598.0	C08		1	0265-0505	789.60	505.62	115	92.43	0.169
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			366.9	C08		1	0266-0510	829.21	510.02	266	60.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			664.5	C08		1	0267-0509	37.93	509.58	271	61.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			568.5	C08		1	0268-0511	426.05	511.33	325	66.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			510.1	C08		1	0269-0514	270.46	514.21	363	71.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			729.3	C08		1	0270-0511	672.74	511.00	271	68.28	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			426.1	C08		1	0271-0516	129.22	517.00	317	67.36	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			389.6	C08		1	0272-0516	194.76	516.95	280	64.53	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			376.6	C08		1	0273-0521	857.97	520.82	269	61.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1586.3	C08		1	0274-0520	584.05	520.77	274	60.77	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			457.9	C08		1	0275-0522	441.51	522.16	302	64.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2864.7	C08		1	0276-0522	713.75	522.25	263	61.70	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			768.6	C08		1	0277-0526	530.57	526.08	301	64.43	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			927.1	C08		1	0278-0533	763.47	532.72	242	59.36	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			433.4	C08		1	0279-0534	795.61	533.70	277	61.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			668.6	C08		1	0280-0533	83.50	533.87	305	73.01	0.719
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			375.3	C08		1	0281-0535	213.46	535.24	213	53.11	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			477.2	C08		1	0282-0539	273.70	539.14	294	68.67	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			643.0	C08		1	0283-0537	619.01	536.78	268	61.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6086.1	C08		1	0284-0544	727.47	543.99	343	68.43	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1662.5	C08		1	0285-0547	679.63	546.69	355	71.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			479.2	C08		1	0286-0547	351.77	547.50	250	59.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			637.6	C08		1	0287-0549	43.38	549.11	280	63.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			624.1	C08		1	0288-0548	164.29	548.21	254	59.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			748.0	C08		1	0289-0548	540.05	548.03	188	49.70	0.956
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			718.8	C08		1	0290-0550	835.32	549.74	270	61.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			405.4	C08		1	0291-0549	145.49	549.09	265	62.04	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			428.4	C08		1	0292-0552	920.15	551.59	294	63.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			337.1	C08		1	0293-0553	312.34	553.07	308	65.01	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2032.9	C08		1	0294-0553	786.10	553.31	341	71.84	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1481.0	C08		1	0295-0556	560.59	557.44	266	59.60	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1208.3	C08		1	0296-0559	390.52	558.51	297	64.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1783.3	C08		1	0297-0563	482.05	562.86	252	58.18	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			378.0	C08		1	0298-0563	675.45	563.22	272	63.11	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			277.1	C08		1	0299-0564	92.34	564.16	140	51.11	0.673
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			821.0	C08		1	0300-0569	793.86	569.65	318	66.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5592.9	C08		1	0301-0567	268.09	568.13	164	47.21	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			536.4	C08		1	0302-0571	593.86	571.40	272	60.53	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			618.3	C08		1	0303-0572	205.22	572.62	276	67.60	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			10936.3	C08		1	0304-0571	518.31	570.42	129	68.53	0.345
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2273.1	C08		1	0305-0579	898.28	579.25	364	71.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			316.0	C08		1	0306-0575	245.48	575.14	169	47.46	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			610.7	C08		1	0307-0576	559.64	575.69	245	58.53	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			588.2	C08		1	0308-0578	732.89	578.70	294	64.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			405.9	C08		1	0309-0580	875.88	579.73	285	62.18	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			676.2	C08		1	0310-0581	82.77	581.36	293	63.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2245.8	C08		1	0311-0587	262.45	585.43	422	83.60	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1179.8	C08		1	0312-0584	449.27	583.89	246	57.11	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			991.7	C08		1	0313-0585	537.45	585.66	219	55.36	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			265.1	C08		1	0314-0588	301.52	587.94	322	67.60	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5682.5	C08		1	0315-0589	927.47	589.16	304	65.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			381.4	C08		1	0316-0589	150.69	589.40	378	72.77	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			556.5	C08		1	0317-0592	810.14	592.40	297	64.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			297.1	C08		1	0318-0595	27.14	595.40	266	63.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2661.7	C08		1	0319-0597	944.27	597.18	229	55.70	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			508.4	C08		1	0320-0605	525.30	604.34	263	62.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			777.9	C08		1	0321-0603	766.04	603.99	261	61.70	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			659.9	C08		1	0322-0607	199.34	607.04	248	62.77	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			963.5	C08		1	0323-0608	393.01	608.28	288	63.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			332.3	C08		1	0324-0609	74.76	609.25	262	59.60	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			480.0	C08		1	0325-0612	704.10	611.88	297	64.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			634.9	C08		1	0326-0614	844.13	613.52	296	63.60	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1578.2	C08		1	0327-0612	482.55	611.88	271	62.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2100.5	C08		1	0328-0621	28.06	620.90	218	54.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			702.6	C08		1	0329-0619	763.88	618.42	260	63.11	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			464.5	C08		1	0330-0624	650.46	623.74	294	66.43	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2040.9	C08		1	0331-0625	262.52	625.35	205	51.70	0.964
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			545.9	C08		1	0332-0633	595.61	632.78	244	57.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			641.0	C08		1	0333-0634	879.26	634.12	249	57.94	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3394.9	C08		1	0334-0638	623.32	638.35	297	62.77	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			474.7	C08		1	0335-0643	419.35	643.64	263	62.53	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			439.8	C08		1	0336-0646	176.89	645.51	593	98.57	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			649.1	C08		1	0337-0645	219.75	645.23	306	69.60	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			353.3	C08		1	0338-0648	126.69	647.81	281	64.77	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			725.6	C08		1	0339-0646	727.56	646.82	268	61.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1398.8	C08		1	0340-0650	88.89	650.61	376	73.01	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			373.0	C08		1	0341-0649	316.53	648.68	283	62.77	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			326.1	C08		1	0342-0650	522.00	651.01	317	68.43	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1300.0	C08		1	0343-0651	570.73	650.76	211	55.11	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			542.4	C08		1	0344-0651	800.58	651.10	287	63.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			630.1	C08		1	0345-0648	909.49	648.45	257	60.53	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			380.9	C08		1	0346-0654	254.61	654.82	304	67.36	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2105.5	C08		1	0347-0653	445.55	652.66	256	59.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1066.4	C08		1	0348-0654	367.50	653.95	286	62.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			398.6	C08		1	0349-0656	762.40	655.48	294	64.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3553.1	C08		1	0350-0664	667.52	664.31	302	63.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2860.0	C08		1	0351-0671	601.16	671.67	341	67.60	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2257.5	C08		1	0352-0672	812.39	672.34	244	58.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			900.8	C08		1	0353-0676	939.29	676.50	264	61.11	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1607.4	C08		1	0354-0678	275.20	678.07	250	57.70	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			563.9	C08		1	0355-0681	711.96	681.31	295	64.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1018.0	C08		1	0356-0682	315.97	682.29	268	61.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			880.3	C08		1	0357-0681	863.81	681.07	227	57.11	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			909.3	C08		1	0358-0683	583.00	683.42	165	46.87	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			887.3	C08		1	0359-0688	917.00	688.43	243	58.18	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			602.7	C08		1	0360-0688	653.24	687.57	269	60.28	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			477.0	C08		1	0361-0693	825.13	693.11	264	63.26	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			343.4	C08		1	0362-0692	465.12	692.45	299	67.60	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			343.6	C08		1	0363-0695	164.66	695.52	270	60.53	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			646.6	C08		1	0364-0697	406.64	696.45	298	62.77	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			283.2	C08		1	0365-0696	862.07	696.93	302	67.94	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			803.1	C08		1	0366-0699	197.60	698.93	257	59.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1292.0	C08		1	0367-0697	564.69	698.02	245	58.87	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1191.8	C08		1	0368-0700	335.60	700.91	255	58.77	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			303.1	C08		1	0369-0702	19.92	703.24	288	63.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			283.7	C08		1	0370-0705	367.96	704.81	288	66.67	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			713.6	C08		1	0371-0705	91.70	705.53	250	60.53	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			346.0	C08		2	0001-0024	128.41	23.60	288	63.84	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			944.1	C08		2	0002-0025	174.92	24.72	270	61.94	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			699.8	C08		2	0003-0032	871.75	31.68	248	60.77	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1109.9	C08		2	0004-0033	68.62	32.87	192	51.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			841.3	C08		2	0005-0040	397.91	40.47	375	72.18	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			572.5	C08		2	0006-0037	551.14	37.65	274	62.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			508.7	C08		2	0007-0038	680.72	39.05	242	56.77	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			559.3	C08		2	0008-0042	48.52	41.52	316	66.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			466.9	C08		2	0009-0043	30.09	43.27	294	62.53	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			266.9	C08		2	0010-0043	231.80	43.46	334	67.60	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			657.6	C08		2	0011-0044	186.15	45.23	269	63.26	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			344.1	C08		2	0012-0048	487.71	49.18	332	70.77	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			448.2	C08		2	0013-0047	649.05	47.26	310	64.53	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1079.0	C08		2	0014-0048	797.12	49.02	408	78.08	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			570.2	C08		2	0015-0052	99.99	52.40	411	74.67	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1085.8	C08		2	0016-0049	205.02	49.46	206	53.46	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			570.2	C08		2	0017-0052	737.79	51.91	283	62.18	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			581.3	C08		2	0018-0055	716.07	54.90	288	63.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			846.5	C08		2	0019-0055	576.86	55.80	420	81.60	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			584.6	C08		2	0020-0062	153.35	62.35	313	65.01	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			518.1	C08		2	0021-0066	837.30	66.55	305	69.26	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			825.7	C08		2	0022-0064	854.66	63.94	218	55.11	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			330.8	C08		2	0023-0066	291.41	66.74	292	65.60	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			720.4	C08		2	0024-0068	355.25	67.73	270	61.94	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			874.7	C08		2	0025-0071	448.16	70.63	285	63.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			479.7	C08		2	0026-0075	427.60	74.95	326	66.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			573.3	C08		2	0027-0075	776.54	75.29	255	58.28	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			302.7	C08		2	0028-0082	244.28	81.66	317	68.43	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			560.5	C08		2	0029-0084	285.37	84.39	339	73.60	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			827.3	C08		2	0030-0082	659.88	82.54	285	63.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			814.8	C08		2	0031-0087	605.90	89.87	370	80.18	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1119.0	C08		2	0032-0082	618.92	81.58	168	50.87	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			673.7	C08		2	0033-0085	328.68	85.58	227	56.28	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			529.4	C08		2	0034-0084	576.11	84.68	291	63.01	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			365.7	C08		2	0035-0088	830.95	88.00	311	65.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			779.5	C08		2	0036-0087	550.38	87.01	216	53.94	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			909.2	C08		2	0037-0091	72.87	91.06	245	65.84	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2105.4	C08		2	0038-0092	485.02	92.27	221	54.87	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			884.0	C08		2	0039-0092	774.10	91.27	225	57.36	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			479.8	C08		2	0040-0098	696.24	97.15	290	63.60	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			344.0	C08		2	0041-0102	296.21	101.87	305	65.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			490.0	C08		2	0042-0104	886.08	103.99	341	68.18	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			524.3	C08		2	0043-0106	204.77	105.73	293	64.18	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3968.3	C08		2	0044-0107	99.82	106.94	343	68.77	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1038.8	C08		2	0045-0110	741.92	109.44	252	62.28	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			985.5	C08		2	0046-0111	628.60	111.41	280	60.77	0.953
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1611.5	C08		2	0047-0113	944.04	114.24	441	81.50	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2066.5	C08		2	0048-0112	424.05	112.01	281	62.18	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			338.5	C08		2	0049-0115	340.36	115.59	316	65.60	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2908.2	C08		2	0050-0115	524.22	116.08	258	60.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			897.3	C08		2	0051-0116	404.44	116.68	286	62.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			732.4	C08		2	0052-0120	51.63	119.87	261	61.94	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			609.1	C08		2	0053-0122	257.66	121.89	391	76.08	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			671.4	C08		2	0054-0122	784.64	122.43	214	53.94	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			525.8	C08		2	0055-0124	572.99	124.69	321	66.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			910.1	C08		2	0056-0126	892.41	125.50	423	81.26	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			432.0	C08		2	0057-0128	359.94	128.35	310	65.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			429.9	C08		2	0058-0128	127.19	128.48	284	65.84	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			401.3	C08		2	0059-0130	172.43	130.44	391	73.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2265.4	C08		2	0060-0127	67.80	127.03	189	50.87	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			411.3	C08		2	0061-0131	621.82	131.00	285	64.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1400.5	C08		2	0062-0132	711.18	132.55	340	68.18	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			611.2	C08		2	0063-0137	516.40	137.02	356	72.91	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			699.4	C08		2	0064-0137	775.48	136.06	200	57.26	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			772.5	C08		2	0065-0140	460.31	140.21	426	77.01	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1183.6	C08		2	0066-0139	81.33	139.65	215	52.77	0.970
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			678.7	C08		2	0067-0140	823.51	140.83	256	60.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			425.2	C08		2	0068-0147	25.40	146.81	324	69.50	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1256.6	C08		2	0069-0150	221.02	149.90	439	80.43	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			574.9	C08		2	0070-0148	661.59	147.75	298	66.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			659.1	C08		2	0071-0151	277.86	151.60	306	64.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			666.3	C08		2	0072-0150	620.04	149.78	315	67.60	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			654.7	C08		2	0073-0156	748.99	155.98	202	55.70	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			473.0	C08		2	0074-0162	485.58	162.08	325	69.36	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2021.7	C08		2	0075-0159	562.03	159.43	209	54.28	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3881.0	C08		2	0076-0160	681.59	160.78	171	51.36	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			295.7	C08		2	0077-0171	363.75	171.30	328	69.26	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			438.2	C08		2	0078-0170	929.17	169.79	323	68.18	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1745.9	C08		2	0079-0170	58.63	170.19	217	53.11	0.967
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			936.1	C08		2	0080-0171	155.29	171.07	270	63.60	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1429.5	C08		2	0081-0172	587.56	172.32	252	59.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1089.6	C08		2	0082-0174	416.12	173.89	277	60.77	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			644.1	C08		2	0083-0178	456.76	175.89	289	74.18	0.660
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			743.2	C08		2	0084-0175	280.35	175.27	341	71.01	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2258.8	C08		2	0085-0176	136.98	176.47	272	63.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			408.7	C08		2	0086-0179	526.31	179.88	250	58.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			918.4	C08		2	0087-0181	242.03	181.06	335	69.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			340.8	C08		2	0088-0183	781.58	182.81	340	69.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1214.1	C08		2	0089-0184	103.01	184.47	203	54.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			643.0	C08		2	0090-0188	599.94	188.31	310	66.18	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			469.4	C08		2	0091-0192	481.83	192.42	247	63.70	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			694.2	C08		2	0092-0195	425.92	194.89	295	66.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			412.0	C08		2	0093-0198	25.57	197.78	289	63.60	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1002.4	C08		2	0094-0197	114.02	196.94	260	63.60	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			403.5	C08		2	0095-0200	525.18	199.68	315	65.94	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			475.2	C08		2	0096-0207	650.18	206.99	239	59.11	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			564.3	C08		2	0097-0204	722.48	204.95	239	56.18	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			958.6	C08		2	0098-0205	182.25	204.45	297	67.36	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			442.7	C08		2	0099-0211	436.75	211.44	299	67.94	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			312.3	C08		2	0100-0209	55.77	209.90	260	61.36	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			446.7	C08		2	0101-0212	318.78	212.16	308	66.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1747.5	C08		2	0102-0220	586.21	220.27	445	81.26	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			456.0	C08		2	0103-0223	186.02	223.61	263	59.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1037.2	C08		2	0104-0225	229.36	225.31	286	63.70	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1934.4	C08		2	0105-0225	923.17	225.16	242	57.11	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			758.2	C08		2	0106-0227	610.82	226.84	275	60.77	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			406.5	C08		2	0107-0227	100.50	227.54	284	64.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			475.4	C08		2	0108-0230	790.69	229.96	292	65.01	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			769.0	C08		2	0109-0230	383.79	229.79	303	63.94	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			429.9	C08		2	0110-0232	505.35	232.95	268	61.94	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			388.5	C08		2	0111-0231	64.38	230.32	272	61.11	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			616.8	C08		2	0112-0233	469.77	232.81	290	63.36	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			505.0	C08		2	0113-0233	823.19	232.39	260	61.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1098.0	C08		2	0114-0235	667.08	235.64	249	59.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			679.2	C08		2	0115-0241	271.81	241.68	289	65.84	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			631.0	C08		2	0116-0245	139.28	244.70	550	87.74	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			264.9	C08		2	0117-0245	190.45	245.11	306	64.77	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1421.6	C08		2	0118-0244	426.11	244.68	265	60.53	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			708.3	C08		2	0119-0250	256.58	250.75	311	67.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			734.6	C08		2	0120-0254	553.92	254.42	325	66.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			558.9	C08		2	0121-0253	727.06	253.50	243	57.94	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2018.5	C08		2	0122-0254	885.66	254.38	199	53.36	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			759.7	C08		2	0123-0259	302.12	259.35	329	68.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			459.0	C08		2	0124-0260	748.76	259.74	392	74.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1588.1	C08		2	0125-0261	432.64	261.36	196	53.21	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			581.5	C08		2	0126-0268	343.10	268.18	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			518.3	C08		2	0127-0267	25.78	266.73	231	56.18	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1731.9	C08		2	0128-0266	78.02	266.30	192	51.70	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			259.5	C08		2	0129-0267	114.11	267.03	287	64.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			833.7	C08		2	0130-0266	815.10	266.10	269	61.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1575.9	C08		2	0131-0272	91.72	271.87	183	50.28	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			626.2	C08		2	0132-0273	203.04	273.31	316	68.77	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			566.8	C08		2	0133-0275	569.95	274.68	442	79.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2872.9	C08		2	0134-0274	39.33	273.68	180	51.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			907.1	C08		2	0135-0277	672.47	276.66	294	65.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1128.5	C08		2	0136-0278	287.66	278.62	311	77.74	0.647
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			395.1	C08		2	0137-0281	688.77	281.41	190	52.28	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1120.2	C08		2	0138-0284	222.82	283.66	313	66.53	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1086.7	C08		2	0139-0286	317.64	285.56	222	55.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3798.9	C08		2	0140-0286	45.41	286.24	160	46.28	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			537.7	C08		2	0141-0290	149.01	291.47	268	60.53	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			403.8	C08		2	0142-0293	422.51	293.81	423	75.84	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			532.6	C08		2	0143-0291	677.08	291.79	126	44.04	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			803.6	C08		2	0144-0296	375.86	295.72	231	56.53	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			298.6	C08		2	0145-0297	89.16	296.62	270	61.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			383.0	C08		2	0146-0295	125.55	295.30	340	70.43	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			9554.6	C08		2	0147-0295	480.48	294.97	101	38.97	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			494.4	C08		2	0148-0305	868.84	305.13	300	65.60	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			409.7	C08		2	0149-0310	390.61	310.17	246	60.28	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			771.2	C08		2	0150-0308	254.84	307.98	242	58.28	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			440.5	C08		2	0151-0313	171.36	313.64	405	74.18	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			374.4	C08		2	0152-0317	189.73	317.29	313	71.36	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			619.2	C08		2	0153-0316	589.99	315.67	255	61.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			892.5	C08		2	0154-0319	724.22	320.00	324	67.36	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			721.4	C08		2	0155-0321	260.97	321.64	282	68.77	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			783.5	C08		2	0156-0322	782.33	322.48	265	61.11	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			621.6	C08		2	0157-0322	765.53	321.86	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			934.3	C08		2	0158-0324	91.62	324.21	284	63.01	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2379.0	C08		2	0159-0324	203.04	324.48	204	54.04	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3332.1	C08		2	0160-0324	219.56	324.07	184	49.70	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			437.7	C08		2	0161-0326	319.77	326.20	239	59.60	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			460.9	C08		2	0162-0326	445.11	325.63	279	63.60	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			579.0	C08		2	0163-0328	745.68	327.32	292	63.36	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1572.5	C08		2	0164-0326	375.73	326.79	238	56.87	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			788.7	C08		2	0165-0328	799.72	328.72	283	62.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			398.9	C08		2	0166-0329	69.68	329.37	267	62.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			688.9	C08		2	0167-0332	828.95	332.49	265	59.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			304.3	C08		2	0168-0333	137.34	333.96	297	63.36	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1123.8	C08		2	0169-0337	333.87	337.33	476	82.67	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			394.1	C08		2	0170-0339	655.25	338.63	375	71.60	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			474.4	C08		2	0171-0337	41.30	337.01	267	59.94	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			839.4	C08		2	0172-0341	449.37	341.53	237	57.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			727.9	C08		2	0173-0344	578.50	344.16	261	59.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			519.8	C08		2	0174-0345	271.53	344.95	333	70.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			772.0	C08		2	0175-0362	199.91	361.99	283	62.18	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			986.1	C08		2	0176-0362	744.59	362.13	297	63.36	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1310.8	C08		2	0177-0367	844.22	367.25	476	86.67	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			834.0	C08		2	0178-0367	31.63	367.08	200	55.01	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			551.1	C08		2	0179-0368	356.06	368.90	286	63.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1002.9	C08		2	0180-0371	425.28	370.81	245	58.28	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			841.2	C08		2	0181-0373	472.93	373.74	266	60.18	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1759.8	C08		2	0182-0374	894.56	374.92	213	56.87	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			289.8	C08		2	0183-0377	113.54	377.52	265	61.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			668.7	C08		2	0184-0383	23.22	384.93	341	76.67	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			657.5	C08		2	0185-0378	156.27	377.70	268	60.53	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1695.6	C08		2	0186-0387	229.76	388.44	416	82.08	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1645.6	C08		2	0187-0383	267.30	383.62	237	57.60	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			372.2	C08		2	0188-0384	394.23	383.70	325	67.01	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			343.6	C08		2	0189-0383	521.82	382.94	130	43.46	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			328.6	C08		2	0190-0395	516.46	396.09	209	58.77	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			773.3	C08		2	0191-0398	438.54	398.30	245	57.60	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			322.4	C08		2	0192-0393	534.58	393.96	160	49.80	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			490.1	C08		2	0193-0400	62.70	399.55	259	61.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			609.5	C08		2	0194-0404	289.85	404.07	638	93.84	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			592.2	C08		2	0195-0400	365.27	399.62	250	59.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			378.5	C08		2	0196-0405	724.18	405.92	363	72.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			763.9	C08		2	0197-0409	829.94	409.26	358	70.43	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			816.0	C08		2	0198-0409	463.33	409.72	301	66.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			301.2	C08		2	0199-0405	535.33	405.06	151	46.04	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			359.7	C08		2	0200-0409	700.43	408.69	295	64.53	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			444.5	C08		2	0201-0409	380.18	410.01	304	65.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			463.5	C08		2	0202-0415	154.53	415.43	294	73.50	0.684
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			320.7	C08		2	0203-0416	884.62	415.94	289	64.53	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			547.1	C08		2	0204-0415	56.75	416.08	327	67.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			424.3	C08		2	0205-0416	925.04	416.90	278	64.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2346.8	C08		2	0206-0419	663.17	419.11	335	67.36	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2314.4	C08		2	0207-0420	264.27	421.78	251	59.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			461.6	C08		2	0208-0420	498.43	420.59	204	55.11	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			722.1	C08		2	0209-0422	133.84	422.17	248	58.28	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			381.2	C08		2	0210-0424	724.51	424.08	312	66.53	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			338.3	C08		2	0211-0427	13.61	427.56	258	62.53	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			386.4	C08		2	0212-0429	945.19	429.48	286	65.36	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			363.0	C08		2	0213-0428	701.23	428.05	270	62.53	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2499.3	C08		2	0214-0433	190.90	433.18	238	58.53	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1000.7	C08		2	0215-0434	225.32	434.19	271	61.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			852.0	C08		2	0216-0437	87.04	437.77	287	62.77	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2409.5	C08		2	0217-0435	173.26	435.41	244	58.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3690.2	C08		2	0218-0436	260.95	436.35	185	49.80	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			389.1	C08		2	0219-0441	873.85	440.57	308	64.28	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			520.7	C08		2	0220-0444	375.81	444.45	323	66.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2878.8	C08		2	0221-0446	566.04	446.26	348	69.84	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1235.2	C08		2	0222-0449	332.26	449.77	560	94.33	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			637.0	C08		2	0223-0447	424.52	447.61	335	67.94	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1027.4	C08		2	0224-0448	922.18	447.91	265	61.60	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			352.2	C08		2	0225-0449	462.86	449.06	289	65.01	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			714.2	C08		2	0226-0451	604.85	451.48	265	63.60	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3209.8	C08		2	0227-0459	549.21	459.53	351	69.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			342.5	C08		2	0228-0458	143.34	458.86	324	68.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3125.0	C08		2	0229-0459	261.60	459.85	248	57.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			747.8	C08		2	0230-0458	400.63	459.11	238	59.46	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			355.8	C08		2	0231-0466	491.10	466.15	301	69.60	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			661.6	C08		2	0232-0462	632.32	462.23	266	60.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			610.3	C08		2	0233-0472	34.89	471.98	262	59.11	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1959.1	C08		2	0234-0469	119.89	468.96	262	61.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			583.1	C08		2	0235-0477	405.92	477.24	489	96.67	0.658
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			335.0	C08		2	0236-0480	815.69	480.06	304	75.01	0.679
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1230.1	C08		2	0237-0479	914.13	478.71	270	61.11	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			413.9	C08		2	0238-0480	225.31	480.10	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			525.8	C08		2	0239-0477	326.87	477.58	241	59.94	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			600.9	C08		2	0240-0481	871.99	481.61	262	60.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			443.4	C08		2	0241-0484	568.43	484.08	272	61.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3822.7	C08		2	0242-0489	750.74	489.51	488	84.33	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1600.5	C08		2	0243-0488	169.56	487.86	284	62.18	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			833.9	C08		2	0244-0488	679.30	488.67	269	61.70	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2678.7	C08		2	0245-0488	307.68	487.95	359	71.60	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			339.7	C08		2	0246-0489	630.43	488.96	323	68.18	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			304.8	C08		2	0247-0493	16.24	493.55	254	59.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			436.2	C08		2	0248-0493	507.23	493.06	269	63.60	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2945.7	C08		2	0249-0502	47.73	502.09	427	77.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1689.7	C08		2	0250-0500	246.57	500.67	312	66.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2908.3	C08		2	0251-0500	533.77	500.29	219	54.53	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			755.6	C08		2	0252-0504	66.26	503.58	297	64.53	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			474.2	C08		2	0253-0505	699.10	505.70	368	73.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1084.5	C08		2	0254-0501	204.12	501.50	231	59.11	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			953.6	C08		2	0255-0502	433.05	502.56	215	54.87	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			381.2	C08		2	0256-0507	619.58	507.08	300	67.94	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			750.5	C08		2	0257-0511	948.45	510.67	280	67.26	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			686.4	C08		2	0258-0512	475.01	511.55	298	65.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1067.0	C08		2	0259-0513	867.81	513.90	265	61.36	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			534.7	C08		2	0260-0516	850.85	516.77	257	59.60	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			935.4	C08		2	0261-0516	146.95	516.06	263	59.36	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			631.9	C08		2	0262-0523	580.94	523.79	157	47.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			448.0	C08		2	0263-0524	902.61	524.32	334	71.01	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			785.3	C08		2	0264-0524	171.12	524.21	247	58.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3606.3	C08		2	0265-0529	743.25	528.55	460	81.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			910.7	C08		2	0266-0529	338.24	529.73	255	61.36	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			326.2	C08		2	0267-0531	547.18	530.79	348	70.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2590.6	C08		2	0268-0532	520.09	532.34	249	59.60	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			446.8	C08		2	0269-0534	822.04	534.95	290	65.36	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1502.6	C08		2	0270-0536	121.32	535.69	443	79.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			572.1	C08		2	0271-0536	253.91	537.11	303	64.77	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			384.3	C08		2	0272-0540	73.04	539.97	266	60.43	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			521.1	C08		2	0273-0540	438.67	540.09	274	60.53	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1342.8	C08		2	0274-0543	474.92	543.22	497	82.43	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1689.7	C08		2	0275-0543	495.38	542.73	251	57.94	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			355.5	C08		2	0276-0545	179.70	545.24	306	69.94	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1317.3	C08		2	0277-0548	795.48	548.99	303	64.43	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1260.5	C08		2	0278-0551	945.99	550.84	288	62.53	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			376.0	C08		2	0279-0553	24.96	553.10	285	62.18	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			568.1	C08		2	0280-0557	618.00	556.84	266	63.11	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			484.3	C08		2	0281-0561	641.94	560.82	711	101.98	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5723.0	C08		2	0282-0560	291.60	560.59	518	83.01	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2713.8	C08		2	0283-0562	86.27	562.76	232	58.18	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			641.0	C08		2	0284-0563	339.83	563.42	303	64.43	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1109.4	C08		2	0285-0564	707.60	563.60	155	50.53	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			376.7	C08		2	0286-0567	555.67	567.57	297	65.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			483.5	C08		2	0287-0568	213.50	569.92	207	64.43	0.627
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2563.0	C08		2	0288-0569	583.10	568.94	301	64.28	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			373.4	C08		2	0289-0573	171.22	574.28	290	66.77	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1003.8	C08		2	0290-0573	882.89	572.56	272	63.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			792.1	C08		2	0291-0573	241.29	573.36	271	60.53	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			676.8	C08		2	0292-0577	185.71	576.57	160	48.63	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			668.8	C08		2	0293-0579	907.88	578.08	277	63.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			413.1	C08		2	0294-0581	57.33	580.98	258	59.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			321.5	C08		2	0295-0587	724.98	587.15	316	67.60	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			326.8	C08		2	0296-0587	134.80	587.12	175	50.53	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			546.3	C08		2	0297-0588	505.48	588.00	251	57.60	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3241.6	C08		2	0298-0590	87.90	590.70	192	53.70	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5590.3	C08		2	0299-0591	31.88	590.68	317	65.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2054.0	C08		2	0300-0591	764.21	591.57	269	61.36	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1293.9	C08		2	0301-0596	797.64	596.34	275	64.18	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2644.8	C08		2	0302-0598	49.01	598.53	246	58.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2558.0	C08		2	0303-0601	207.24	601.43	355	70.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			259.8	C08		2	0304-0599	600.60	599.30	324	68.18	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			586.5	C08		2	0305-0602	438.82	602.72	334	68.18	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2257.1	C08		2	0306-0603	746.91	602.13	251	59.84	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			454.6	C08		2	0307-0606	543.49	606.34	266	60.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			596.6	C08		2	0308-0604	250.39	605.09	296	66.18	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			415.1	C08		2	0309-0609	387.02	608.81	269	63.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			412.9	C08		2	0310-0608	335.62	607.84	280	64.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			781.2	C08		2	0311-0610	944.87	609.75	210	53.11	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			388.1	C08		2	0312-0613	119.39	614.07	255	64.77	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1745.6	C08		2	0313-0615	291.31	615.17	248	60.18	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2985.3	C08		2	0314-0621	566.88	622.06	251	60.77	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1138.2	C08		2	0315-0625	840.51	624.99	239	57.36	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2946.3	C08		2	0316-0628	67.91	628.06	236	55.70	0.956
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1481.5	C08		2	0317-0627	266.18	626.84	274	63.94	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1583.2	C08		2	0318-0632	346.98	632.17	263	60.43	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1182.5	C08		2	0319-0634	393.30	633.93	334	75.01	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			527.8	C08		2	0320-0634	670.15	633.03	101	41.70	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1197.5	C08		2	0321-0638	851.24	638.19	292	64.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4205.1	C08		2	0322-0639	445.95	639.26	253	59.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1650.0	C08		2	0323-0642	157.39	640.87	253	62.28	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			478.9	C08		2	0324-0640	174.32	640.06	262	61.46	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			386.0	C08		2	0325-0644	425.47	643.95	353	70.77	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			666.4	C08		2	0326-0644	307.30	643.62	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			283.1	C08		2	0327-0645	630.33	645.35	309	65.01	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			692.8	C08		2	0328-0648	727.88	648.50	296	64.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1478.8	C08		2	0329-0647	119.09	647.07	268	60.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			292.8	C08		2	0330-0650	679.59	650.26	310	68.77	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			551.7	C08		2	0331-0650	246.41	650.38	298	69.36	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			604.9	C08		2	0332-0650	13.97	649.82	250	58.87	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3734.7	C08		2	0333-0650	470.51	649.83	248	60.87	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			397.9	C08		2	0334-0653	588.67	652.30	269	62.77	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3012.0	C08		2	0335-0655	563.64	655.36	249	59.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			408.4	C08		2	0336-0655	263.18	654.92	281	64.77	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1355.6	C08		2	0337-0669	407.40	670.15	329	70.43	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1129.6	C08		2	0338-0669	371.39	669.49	271	61.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			609.4	C08		2	0339-0674	544.22	674.03	278	64.53	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			737.1	C08		2	0340-0674	283.60	674.11	316	67.60	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			911.6	C08		2	0341-0677	50.74	676.48	504	93.74	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2028.9	C08		2	0342-0677	529.26	677.28	241	57.70	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4570.9	C08		2	0343-0679	637.19	678.71	458	80.43	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			465.9	C08		2	0344-0684	829.52	684.32	312	64.77	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1836.9	C08		2	0345-0685	100.70	685.98	251	58.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			637.1	C08		2	0346-0687	352.25	686.86	227	58.28	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			371.9	C08		2	0347-0686	391.95	685.78	302	65.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3620.6	C08		2	0348-0689	565.33	688.86	432	79.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6495.1	C08		2	0349-0687	806.47	688.39	341	72.43	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			891.7	C08		2	0350-0690	21.42	689.99	247	57.36	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			297.5	C08		2	0351-0690	142.77	690.36	295	65.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3283.3	C08		2	0352-0694	479.41	694.54	338	67.60	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			995.8	C08		2	0353-0700	209.29	699.63	276	63.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			498.7	C08		2	0354-0697	630.69	697.57	233	57.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			623.7	C08		2	0355-0699	247.97	699.45	266	60.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1422.2	C08		2	0356-0702	759.80	701.69	264	60.43	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			600.0	C08		2	0357-0710	176.17	709.98	264	60.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1297.6	C08		3	0001-0023	532.57	23.39	244	57.60	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3077.0	C08		3	0002-0028	327.48	30.03	247	65.36	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			436.0	C08		3	0003-0029	465.12	29.36	299	67.01	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			680.2	C08		3	0004-0029	685.49	28.96	237	60.63	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			537.8	C08		3	0005-0029	253.25	28.93	221	54.53	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			769.5	C08		3	0006-0032	58.32	32.64	327	66.43	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			742.5	C08		3	0007-0031	771.33	31.27	277	60.77	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			501.3	C08		3	0008-0032	938.39	31.96	323	66.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1120.4	C08		3	0009-0032	428.60	32.82	242	58.28	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			592.6	C08		3	0010-0041	489.88	41.38	564	96.57	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			446.1	C08		3	0011-0034	658.31	34.47	313	66.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			447.7	C08		3	0012-0040	199.61	39.73	314	70.18	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			407.5	C08		3	0013-0039	448.67	39.33	289	63.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1031.8	C08		3	0014-0037	547.08	37.85	227	57.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			520.1	C08		3	0015-0041	721.42	40.98	365	73.01	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			341.6	C08		3	0016-0039	566.60	40.06	313	69.01	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			348.1	C08		3	0017-0040	922.00	40.34	223	66.67	0.630
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			446.7	C08		3	0018-0044	596.63	44.21	304	66.43	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3486.3	C08		3	0019-0041	813.20	41.28	179	51.46	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			280.2	C08		3	0020-0049	113.44	49.20	334	67.84	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			887.3	C08		3	0021-0053	359.25	53.25	278	65.01	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1428.0	C08		3	0022-0049	430.55	48.90	263	61.11	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			250.1	C08		3	0023-0055	223.57	55.22	314	66.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			545.4	C08		3	0024-0053	396.70	52.83	352	69.01	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1814.6	C08		3	0025-0055	809.25	55.67	224	55.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			335.9	C08		3	0026-0059	148.23	58.99	225	59.60	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			329.9	C08		3	0027-0064	280.55	64.35	314	67.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			526.5	C08		3	0028-0063	544.03	63.30	254	57.70	0.959
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			349.1	C08		3	0029-0064	884.27	64.14	186	51.70	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			529.4	C08		3	0030-0066	516.31	65.67	264	63.36	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			317.7	C08		3	0031-0066	137.84	67.13	100	36.87	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			394.6	C08		3	0032-0073	467.13	73.35	280	67.84	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			337.4	C08		3	0033-0082	290.55	82.99	431	79.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			347.4	C08		3	0034-0081	885.37	80.56	222	56.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			788.2	C08		3	0035-0084	53.08	83.10	310	65.84	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			343.2	C08		3	0036-0084	137.48	84.03	298	65.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			484.6	C08		3	0037-0082	269.27	81.66	220	57.46	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			324.7	C08		3	0038-0085	905.06	84.63	292	63.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			393.2	C08		3	0039-0088	663.25	88.70	423	77.50	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			303.6	C08		3	0040-0087	397.19	87.20	335	70.08	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			615.6	C08		3	0041-0091	639.02	90.74	485	81.01	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1400.1	C08		3	0042-0087	769.24	87.52	258	59.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			437.7	C08		3	0043-0090	219.09	90.97	283	63.01	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			362.3	C08		3	0044-0097	238.14	97.34	325	69.60	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			382.5	C08		3	0045-0100	948.51	100.66	304	64.18	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			350.5	C08		3	0046-0106	703.27	106.15	301	71.01	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			319.6	C08		3	0047-0104	412.83	104.58	343	69.36	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1478.6	C08		3	0048-0106	858.33	105.98	240	57.94	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			356.4	C08		3	0049-0114	169.00	114.22	297	65.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3086.5	C08		3	0050-0112	786.67	113.07	223	55.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1648.4	C08		3	0051-0116	38.58	116.93	429	80.08	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			513.1	C08		3	0052-0116	528.84	115.97	313	66.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			865.2	C08		3	0053-0119	387.92	119.01	319	66.18	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			659.0	C08		3	0054-0132	365.36	135.16	821	132.47	0.588
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			351.7	C08		3	0055-0129	748.67	130.15	442	92.23	0.653
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			454.9	C08		3	0056-0128	920.91	127.37	349	69.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			637.1	C08		3	0057-0125	566.78	124.73	293	63.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			494.5	C08		3	0058-0127	626.53	128.10	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			265.7	C08		3	0059-0130	770.46	128.58	300	69.01	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			393.2	C08		3	0060-0135	789.23	134.60	222	61.60	0.735
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			401.4	C08		3	0061-0134	817.31	134.17	319	68.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			437.3	C08		3	0062-0142	89.03	141.16	280	67.11	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1589.3	C08		3	0063-0141	165.57	141.85	330	68.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			576.6	C08		3	0064-0138	224.78	138.64	223	55.70	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			585.9	C08		3	0065-0141	396.66	141.25	271	61.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			406.3	C08		3	0066-0141	497.15	141.74	275	63.11	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1777.9	C08		3	0067-0142	861.03	142.03	262	59.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			705.4	C08		3	0068-0142	337.85	142.39	270	65.11	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			489.2	C08		3	0069-0145	703.67	145.81	261	61.36	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			565.0	C08		3	0070-0148	266.12	148.80	285	65.60	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			816.5	C08		3	0071-0155	897.36	154.70	365	73.26	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			446.0	C08		3	0072-0152	653.92	152.55	284	64.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			437.3	C08		3	0073-0161	237.53	161.53	297	65.01	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			600.7	C08		3	0074-0164	69.27	165.07	267	63.60	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			887.6	C08		3	0075-0164	520.53	163.95	253	61.01	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			607.4	C08		3	0076-0166	620.29	165.68	383	73.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			349.7	C08		3	0077-0164	465.07	164.49	227	57.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1217.1	C08		3	0078-0165	749.54	165.08	432	77.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			299.6	C08		3	0079-0172	869.02	171.91	382	74.33	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			459.0	C08		3	0080-0173	23.84	172.42	302	65.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			311.9	C08		3	0081-0174	592.35	173.61	452	83.84	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			278.4	C08		3	0082-0174	274.69	173.21	288	67.36	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			553.2	C08		3	0083-0178	545.77	178.99	262	66.53	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			285.5	C08		3	0084-0178	148.43	178.01	338	73.84	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1316.6	C08		3	0085-0176	514.15	177.00	189	52.77	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			507.6	C08		3	0086-0177	679.31	177.37	240	58.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			535.4	C08		3	0087-0181	696.46	181.97	249	59.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			331.2	C08		3	0088-0180	794.34	180.45	254	60.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			506.5	C08		3	0089-0181	108.76	180.88	230	55.11	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			289.6	C08		3	0090-0193	414.72	192.56	330	68.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			532.5	C08		3	0091-0190	64.99	189.93	227	55.11	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			538.3	C08		3	0092-0195	99.27	195.98	234	56.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1106.8	C08		3	0093-0196	202.97	195.97	316	69.01	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			275.2	C08		3	0094-0198	831.79	197.32	370	75.60	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1766.6	C08		3	0095-0197	49.38	196.72	237	58.18	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			477.5	C08		3	0096-0197	513.77	197.29	315	65.01	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1052.6	C08		3	0097-0204	457.17	203.08	271	61.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			332.9	C08		3	0098-0203	704.26	203.91	332	73.01	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			256.7	C08		3	0099-0204	354.49	204.48	347	73.01	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1020.6	C08		3	0100-0208	569.50	207.85	443	78.67	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			536.3	C08		3	0101-0210	948.56	209.54	264	63.11	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1088.7	C08		3	0102-0214	469.57	213.88	255	59.94	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			287.3	C08		3	0103-0225	924.52	225.67	367	87.15	0.607
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			301.1	C08		3	0104-0228	644.11	227.88	315	70.77	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			410.7	C08		3	0105-0225	61.98	224.71	299	70.67	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			401.2	C08		3	0106-0225	160.87	224.84	322	69.84	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			341.1	C08		3	0107-0229	862.41	228.41	317	68.67	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1891.7	C08		3	0108-0228	18.02	227.83	235	55.94	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			459.7	C08		3	0109-0234	751.08	233.32	289	64.18	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1046.5	C08		3	0110-0236	782.55	236.23	246	57.36	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			312.7	C08		3	0111-0240	93.05	240.20	308	66.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			313.4	C08		3	0112-0238	892.29	239.00	287	65.01	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			609.3	C08		3	0113-0240	235.55	240.11	332	67.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			476.9	C08		3	0114-0237	585.30	237.86	152	46.87	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			357.1	C08		3	0115-0241	269.32	240.96	307	66.77	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			586.5	C08		3	0116-0248	610.00	249.03	258	62.28	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			335.1	C08		3	0117-0246	373.04	246.03	343	76.43	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			751.2	C08		3	0118-0248	765.67	248.01	239	67.01	0.669
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			689.7	C08		3	0119-0248	806.76	248.02	239	55.70	0.968
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1096.9	C08		3	0120-0251	678.80	251.79	260	59.94	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			399.3	C08		3	0121-0250	583.42	250.39	234	68.04	0.635
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1097.2	C08		3	0122-0258	131.40	259.27	494	84.33	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			455.9	C08		3	0123-0256	150.97	255.71	274	63.84	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			325.7	C08		3	0124-0260	490.75	261.11	264	64.18	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1785.3	C08		3	0125-0261	49.17	260.94	240	58.77	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			354.5	C08		3	0126-0261	447.80	260.90	268	65.01	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			419.2	C08		3	0127-0266	406.69	265.92	281	63.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			362.7	C08		3	0128-0263	942.26	262.18	227	57.70	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			883.7	C08		3	0129-0266	729.09	265.65	222	54.53	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			236.0	C08		3	0130-0271	632.23	271.21	387	98.47	0.502
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			580.3	C08		3	0131-0276	877.95	276.41	209	53.46	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			525.4	C08		3	0132-0280	532.20	280.58	357	69.01	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			313.1	C08		3	0133-0283	898.83	283.28	321	65.60	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			336.3	C08		3	0134-0287	309.24	286.78	291	63.60	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			303.6	C08		3	0135-0290	800.71	289.32	280	63.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			550.1	C08		3	0136-0289	858.29	289.80	228	56.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			310.5	C08		3	0137-0293	677.33	293.41	287	63.94	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			605.0	C08		3	0138-0291	459.36	291.79	320	66.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			560.0	C08		3	0139-0297	354.38	297.64	401	79.50	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			931.1	C08		3	0140-0294	757.01	294.27	198	55.11	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1406.5	C08		3	0141-0299	576.94	298.66	443	79.60	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			374.0	C08		3	0142-0298	265.74	298.65	267	61.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1206.8	C08		3	0143-0299	72.18	299.74	253	58.77	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1240.3	C08		3	0144-0304	788.08	303.48	234	59.01	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			473.2	C08		3	0145-0311	518.79	311.58	293	63.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			423.9	C08		3	0146-0311	866.10	311.35	321	66.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			303.2	C08		3	0147-0313	114.14	313.03	312	67.84	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			575.0	C08		3	0148-0316	281.76	314.32	322	72.77	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1696.9	C08		3	0149-0314	216.74	314.24	240	57.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1131.7	C08		3	0150-0316	462.68	315.95	374	71.84	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			411.8	C08		3	0151-0312	671.78	312.33	293	66.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			388.5	C08		3	0152-0319	404.30	319.33	365	90.33	0.562
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			380.1	C08		3	0153-0317	916.73	316.91	325	68.43	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			915.2	C08		3	0154-0321	486.15	320.62	376	90.91	0.572
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1321.5	C08		3	0155-0321	749.58	321.63	264	61.94	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1573.0	C08		3	0156-0320	800.65	320.44	228	56.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1908.6	C08		3	0157-0322	187.82	322.48	247	57.11	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			420.9	C08		3	0158-0325	595.66	325.86	278	63.70	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			506.7	C08		3	0159-0330	310.51	329.78	303	69.60	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			668.0	C08		3	0160-0335	57.67	335.14	295	64.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1295.2	C08		3	0161-0340	769.12	339.27	267	65.36	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			554.8	C08		3	0162-0337	643.36	337.38	259	60.28	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1621.4	C08		3	0163-0342	782.81	341.49	203	57.11	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			868.8	C08		3	0164-0342	707.27	341.53	243	57.94	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			463.7	C08		3	0165-0347	686.39	347.35	273	61.11	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			448.0	C08		3	0166-0349	864.22	349.06	308	67.60	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			639.9	C08		3	0167-0353	197.73	352.76	262	66.18	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			411.0	C08		3	0168-0356	948.80	356.74	354	73.50	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			461.2	C08		3	0169-0351	635.22	351.36	265	63.94	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			635.7	C08		3	0170-0352	215.58	351.55	130	45.36	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			535.2	C08		3	0171-0355	559.53	355.31	290	65.60	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			393.1	C08		3	0172-0358	54.25	359.06	261	61.01	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4371.5	C08		3	0173-0363	341.37	363.34	449	81.01	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1598.7	C08		3	0174-0359	778.66	359.31	223	55.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			332.9	C08		3	0175-0363	359.28	363.10	324	70.53	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			973.5	C08		3	0176-0367	464.46	366.77	345	71.01	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			519.9	C08		3	0177-0367	727.94	367.19	277	61.36	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			533.5	C08		3	0178-0368	906.35	368.80	281	62.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1803.6	C08		3	0179-0368	189.77	367.86	245	57.36	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			749.8	C08		3	0180-0369	213.15	368.99	220	53.94	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			322.9	C08		3	0181-0372	857.11	373.24	323	71.60	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1081.0	C08		3	0182-0374	698.26	374.09	239	60.18	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			863.9	C08		3	0183-0377	303.40	376.96	313	67.01	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			725.1	C08		3	0184-0377	544.99	377.60	241	59.36	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4048.4	C08		3	0185-0383	44.56	382.58	380	73.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2274.2	C08		3	0186-0389	434.90	390.02	536	103.40	0.630
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			440.1	C08		3	0187-0382	792.69	380.81	322	71.84	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			922.6	C08		3	0188-0387	381.32	386.98	316	72.77	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1795.3	C08		3	0189-0390	610.76	389.98	481	86.33	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			364.7	C08		3	0190-0389	695.86	388.97	303	68.43	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			639.4	C08		3	0191-0392	841.59	392.05	299	65.94	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2076.7	C08		3	0192-0394	134.16	394.28	212	54.53	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2102.5	C08		3	0193-0398	670.63	398.30	256	59.11	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1502.3	C08		3	0194-0402	272.23	402.84	428	76.91	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			497.7	C08		3	0195-0408	507.87	407.51	311	66.53	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			469.7	C08		3	0196-0410	807.87	410.34	346	69.84	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			499.8	C08		3	0197-0409	472.96	409.63	281	61.60	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			872.3	C08		3	0198-0411	322.05	410.94	282	63.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			341.4	C08		3	0199-0413	571.30	413.44	318	66.53	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			306.1	C08		3	0200-0414	759.60	414.30	348	71.84	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			474.8	C08		3	0201-0414	89.37	414.72	261	60.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			392.1	C08		3	0202-0417	190.24	417.81	315	66.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			426.7	C08		3	0203-0419	20.26	419.74	274	65.36	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			537.0	C08		3	0204-0425	422.94	424.10	347	74.43	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			451.2	C08		3	0205-0422	719.69	422.40	292	65.36	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			466.9	C08		3	0206-0425	354.68	425.44	306	65.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2472.2	C08		3	0207-0429	315.29	430.42	404	77.50	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			442.7	C08		3	0208-0427	212.29	427.79	284	63.94	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			315.9	C08		3	0209-0429	585.97	429.94	328	67.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			380.6	C08		3	0210-0432	39.94	432.05	266	62.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3217.8	C08		3	0211-0433	109.61	432.71	202	55.11	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			581.7	C08		3	0212-0438	716.99	437.68	332	76.43	0.714
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2138.8	C08		3	0213-0443	151.37	443.99	239	57.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			937.3	C08		3	0214-0441	866.29	441.56	144	48.04	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			778.5	C08		3	0215-0448	705.39	449.09	366	71.84	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3227.2	C08		3	0216-0445	115.33	445.73	189	51.94	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			472.7	C08		3	0217-0444	904.95	445.08	292	66.53	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			8791.7	C08		3	0218-0450	642.85	450.12	331	87.74	0.540
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			552.9	C08		3	0219-0449	247.18	448.68	163	52.18	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1003.9	C08		3	0220-0450	17.02	450.61	255	60.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2119.4	C08		3	0221-0451	528.31	450.92	220	56.87	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2288.6	C08		3	0222-0450	169.22	450.25	225	55.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			516.5	C08		3	0223-0451	232.54	451.54	225	62.28	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			591.6	C08		3	0224-0452	283.27	452.69	218	63.01	0.690
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1509.7	C08		3	0225-0452	833.38	452.54	187	51.46	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1455.6	C08		3	0226-0454	884.15	454.05	199	53.11	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			924.4	C08		3	0227-0451	868.05	451.00	108	41.80	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			660.7	C08		3	0228-0460	783.55	460.00	397	73.60	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6599.1	C08		3	0229-0457	81.69	456.53	160	48.53	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2361.1	C08		3	0230-0459	599.55	459.37	223	55.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			393.2	C08		3	0231-0467	409.14	467.44	277	63.94	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2362.7	C08		3	0232-0463	896.21	463.67	180	50.53	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3909.4	C08		3	0233-0471	73.92	471.13	260	60.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			387.7	C08		3	0234-0470	370.62	469.91	330	66.77	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1996.8	C08		3	0235-0470	909.28	470.32	193	54.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4020.6	C08		3	0236-0474	658.09	474.07	236	108.47	0.252
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			523.8	C08		3	0237-0477	757.68	477.45	310	68.18	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			575.2	C08		3	0238-0483	861.58	482.86	294	67.36	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			389.6	C08		3	0239-0482	135.99	482.81	302	65.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			715.6	C08		3	0240-0481	782.06	481.84	320	70.18	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5439.2	C08		3	0241-0484	619.12	484.95	307	67.60	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1928.6	C08		3	0242-0487	230.78	487.27	221	56.77	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3089.2	C08		3	0243-0488	501.96	488.48	303	95.15	0.421
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			463.8	C08		3	0244-0492	845.54	492.39	295	67.01	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5794.7	C08		3	0245-0496	592.35	495.95	308	67.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			432.6	C08		3	0246-0494	948.35	494.15	209	56.28	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			976.5	C08		3	0247-0495	927.22	495.11	272	63.11	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			384.5	C08		3	0248-0497	887.16	497.36	310	68.43	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			414.0	C08		3	0249-0508	730.86	507.47	308	68.18	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			526.4	C08		3	0250-0510	714.33	510.41	265	63.11	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			393.0	C08		3	0251-0505	944.95	505.82	128	46.63	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2307.5	C08		3	0252-0511	456.37	510.33	310	65.94	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			757.7	C08		3	0253-0513	43.13	513.37	269	63.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3135.1	C08		3	0254-0516	514.45	515.97	247	62.18	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1326.9	C08		3	0255-0520	646.15	520.03	381	72.67	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			412.0	C08		3	0256-0519	399.86	519.23	316	67.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			355.1	C08		3	0257-0522	197.60	521.91	304	64.77	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1369.1	C08		3	0258-0524	879.76	523.49	273	63.36	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			364.3	C08		3	0259-0526	159.70	527.09	306	67.94	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3116.2	C08		3	0260-0523	483.04	523.55	269	63.94	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			237.9	C08		3	0261-0531	810.81	531.43	365	72.18	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4032.9	C08		3	0262-0528	565.57	527.76	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			437.0	C08		3	0263-0530	782.86	529.80	316	67.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1129.7	C08		3	0264-0530	756.84	529.87	273	60.77	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4037.4	C08		3	0265-0531	367.86	531.22	203	54.04	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			289.3	C08		3	0266-0534	608.04	534.55	326	68.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			335.9	C08		3	0267-0537	119.51	536.59	320	66.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2231.9	C08		3	0268-0538	740.19	538.23	288	63.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2276.8	C08		3	0269-0546	675.65	545.16	234	61.70	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3919.7	C08		3	0270-0549	529.42	550.06	285	65.60	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			350.9	C08		3	0271-0551	426.59	551.08	333	68.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			530.0	C08		3	0272-0551	267.71	551.18	295	63.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2088.3	C08		3	0273-0550	703.60	550.46	250	58.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1303.2	C08		3	0274-0554	40.63	553.53	281	62.53	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1292.1	C08		3	0275-0553	861.92	552.97	283	63.11	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			513.3	C08		3	0276-0552	904.61	552.64	264	62.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			453.2	C08		3	0277-0562	81.73	563.11	229	57.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			382.3	C08		3	0278-0560	180.90	560.41	289	65.11	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2102.9	C08		3	0279-0564	689.94	564.74	395	73.60	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1910.1	C08		3	0280-0566	65.60	566.35	283	61.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			331.5	C08		3	0281-0566	890.89	566.66	302	64.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1594.0	C08		3	0282-0568	447.87	568.48	399	73.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			397.2	C08		3	0283-0567	848.99	567.07	160	48.04	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2066.0	C08		3	0284-0568	726.85	569.11	263	59.46	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			262.6	C08		3	0285-0574	501.01	573.94	304	68.18	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			731.6	C08		3	0286-0576	103.26	576.46	271	63.11	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1118.6	C08		3	0287-0577	288.58	576.72	309	67.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3717.9	C08		3	0288-0571	588.60	571.12	203	56.28	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			602.7	C08		3	0289-0580	322.17	580.19	286	62.18	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			641.4	C08		3	0290-0582	304.21	582.90	279	63.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3032.2	C08		3	0291-0587	610.80	586.71	430	81.26	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			463.1	C08		3	0292-0583	908.91	583.67	336	71.60	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3903.9	C08		3	0293-0587	357.14	587.71	211	54.87	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1368.2	C08		3	0294-0583	584.48	583.09	206	56.28	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			288.0	C08		3	0295-0584	760.43	583.31	202	53.11	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			573.9	C08		3	0296-0586	839.51	587.03	244	59.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			695.6	C08		3	0297-0588	726.94	587.22	223	56.28	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			679.1	C08		3	0298-0592	227.26	591.41	284	62.43	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			981.4	C08		3	0299-0596	537.39	596.63	274	62.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1767.8	C08		3	0300-0596	628.00	596.63	204	54.53	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1092.2	C08		3	0301-0598	53.36	598.16	263	59.36	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			389.4	C08		3	0302-0601	490.88	601.10	323	68.18	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			337.2	C08		3	0303-0598	800.23	598.26	318	66.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1105.2	C08		3	0304-0606	86.25	606.24	265	59.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			547.1	C08		3	0305-0606	873.17	605.88	286	63.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			251.3	C08		3	0306-0605	758.47	605.61	197	56.18	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			415.7	C08		3	0307-0612	193.94	611.97	326	68.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			475.5	C08		3	0308-0612	153.56	612.34	281	63.36	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			842.5	C08		3	0309-0612	39.38	612.41	207	52.87	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2766.1	C08		3	0310-0617	654.98	617.44	437	77.26	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			556.4	C08		3	0311-0620	691.40	620.80	264	62.77	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1048.8	C08		3	0312-0622	316.84	621.70	292	62.77	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1514.4	C08		3	0313-0628	613.04	628.45	215	54.87	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3623.7	C08		3	0314-0632	119.71	632.15	422	75.36	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			408.9	C08		3	0315-0630	340.94	629.63	275	65.60	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			438.1	C08		3	0316-0635	406.97	634.37	580	95.98	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			727.1	C08		3	0317-0634	44.10	633.95	263	62.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1757.4	C08		3	0318-0637	939.48	637.54	249	58.53	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3979.8	C08		3	0319-0643	596.50	643.24	346	69.60	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			301.1	C08		3	0320-0642	345.82	643.74	326	71.01	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2024.8	C08		3	0321-0643	892.99	643.52	199	54.87	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1317.8	C08		3	0322-0645	755.67	644.84	283	62.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1181.7	C08		3	0323-0647	849.47	645.85	284	66.43	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1412.0	C08		3	0324-0645	915.19	645.36	189	50.53	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			468.6	C08		3	0325-0648	719.79	648.20	266	63.60	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			617.9	C08		3	0326-0650	46.59	649.98	241	58.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			832.0	C08		3	0327-0654	672.21	654.89	277	62.77	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			458.7	C08		3	0328-0659	482.69	658.41	319	68.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1827.3	C08		3	0329-0656	415.05	657.27	273	64.18	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1541.1	C08		3	0330-0661	817.85	661.10	226	55.11	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			633.4	C08		3	0331-0662	381.27	662.38	254	60.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			368.7	C08		3	0332-0664	602.31	664.16	276	61.94	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			585.7	C08		3	0333-0665	260.71	665.53	161	46.87	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1297.2	C08		3	0334-0669	166.07	669.08	291	63.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1265.6	C08		3	0335-0673	211.95	673.34	288	68.53	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			593.7	C08		3	0336-0672	244.53	673.82	262	64.53	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			962.2	C08		3	0337-0678	779.05	677.79	266	59.36	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			920.4	C08		3	0338-0679	734.95	678.14	297	63.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			875.5	C08		3	0339-0681	865.04	680.29	300	66.77	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			575.7	C08		3	0340-0682	910.16	681.82	303	65.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			540.2	C08		3	0341-0682	754.15	682.31	293	63.01	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			664.8	C08		3	0342-0681	883.02	681.72	260	61.01	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			439.9	C08		3	0343-0681	559.94	681.50	269	63.36	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1399.3	C08		3	0344-0687	817.17	687.40	326	67.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			396.7	C08		3	0345-0688	615.97	687.25	257	61.11	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			366.8	C08		3	0346-0694	384.31	694.38	318	68.53	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			595.9	C08		3	0347-0697	418.34	698.00	305	66.77	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			542.5	C08		3	0348-0701	679.16	701.08	282	67.36	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1180.1	C08		3	0349-0701	229.03	700.26	253	67.84	0.691
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			575.0	C08		3	0350-0705	619.82	705.13	278	63.94	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			440.0	C08		3	0351-0702	848.61	702.61	245	59.94	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			251.3	C08		3	0352-0709	943.83	708.13	287	64.77	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1707.5	C08		3	0353-0709	56.23	709.62	258	61.70	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			326.3	C08		3	0354-0711	333.46	711.20	309	69.11	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			882.7	C08		4	0001-0023	195.30	23.30	268	61.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1491.2	C08		4	0002-0022	562.22	22.54	257	61.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			423.8	C08		4	0003-0021	820.66	21.45	146	46.04	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			294.2	C08		4	0004-0026	17.68	27.12	282	63.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1351.7	C08		4	0005-0025	333.33	25.35	262	59.36	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			309.9	C08		4	0006-0029	365.76	29.28	324	70.67	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			819.4	C08		4	0007-0029	89.76	29.68	255	61.36	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4556.4	C08		4	0008-0033	621.79	33.53	356	70.43	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			378.6	C08		4	0009-0038	108.79	38.32	321	66.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1275.2	C08		4	0010-0042	214.26	42.85	281	64.77	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1228.8	C08		4	0011-0045	786.35	45.55	257	61.11	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			583.0	C08		4	0012-0046	321.66	46.11	241	57.11	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			612.1	C08		4	0013-0046	703.80	46.36	280	65.11	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1017.0	C08		4	0014-0048	943.16	49.11	232	56.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			456.6	C08		4	0015-0055	52.27	55.75	711	116.13	0.663
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2315.0	C08		4	0016-0052	448.90	51.61	395	72.77	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			465.1	C08		4	0017-0056	116.59	56.15	287	64.77	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1315.5	C08		4	0018-0057	857.49	56.52	218	55.11	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			391.5	C08		4	0019-0062	138.71	62.85	301	69.26	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			527.4	C08		4	0020-0063	660.87	63.64	333	68.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1574.0	C08		4	0021-0063	268.62	63.38	243	59.60	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			366.8	C08		4	0022-0067	498.94	66.82	322	70.18	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1298.0	C08		4	0023-0063	541.75	63.22	257	60.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1147.3	C08		4	0024-0062	762.42	62.81	263	60.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			460.3	C08		4	0025-0065	921.79	64.05	293	66.43	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2635.0	C08		4	0026-0072	306.40	72.35	280	63.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			716.4	C08		4	0027-0072	555.04	71.69	231	57.94	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			825.2	C08		4	0028-0077	228.36	77.22	311	66.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2811.2	C08		4	0029-0080	255.87	80.63	419	76.08	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1405.6	C08		4	0030-0080	861.20	80.08	233	56.87	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			521.6	C08		4	0031-0080	902.41	80.33	276	62.77	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			593.5	C08		4	0032-0083	625.71	83.44	278	63.94	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2048.0	C08		4	0033-0083	563.68	83.38	211	54.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4930.5	C08		4	0034-0086	418.74	86.24	264	60.43	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2290.4	C08		4	0035-0087	108.03	87.68	255	60.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3819.0	C08		4	0036-0093	591.99	93.38	413	82.08	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			374.0	C08		4	0037-0086	761.03	86.31	272	63.94	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			376.7	C08		4	0038-0087	185.57	87.49	289	61.94	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			376.0	C08		4	0039-0093	461.42	93.14	342	73.74	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			312.9	C08		4	0040-0092	701.97	91.78	300	66.18	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			530.9	C08		4	0041-0100	738.97	99.96	308	65.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			332.3	C08		4	0042-0102	52.13	101.74	260	59.94	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			9694.0	C08		4	0043-0110	367.52	110.02	740	103.30	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			8867.4	C08		4	0044-0103	837.97	102.66	133	98.13	0.174
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			365.9	C08		4	0045-0104	544.63	104.79	309	65.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			347.6	C08		4	0046-0107	942.98	106.80	304	64.77	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2364.9	C08		4	0047-0107	89.01	106.82	202	55.11	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			370.8	C08		4	0048-0112	288.36	112.59	289	63.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			469.6	C08		4	0049-0118	163.66	118.71	229	59.70	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1750.5	C08		4	0050-0121	427.35	120.78	283	63.26	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			13283.5	C08		4	0051-0128	672.34	128.38	325	67.01	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1397.4	C08		4	0052-0132	440.24	131.62	293	65.26	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			587.8	C08		4	0053-0132	641.24	132.40	265	63.01	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1331.7	C08		4	0054-0135	321.50	135.13	286	69.11	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1527.6	C08		4	0055-0133	195.76	132.94	243	58.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3145.0	C08		4	0056-0141	832.51	140.76	395	73.01	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			678.3	C08		4	0057-0141	698.12	140.93	279	61.94	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			485.4	C08		4	0058-0144	401.87	144.67	298	65.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2209.0	C08		4	0059-0141	608.51	141.51	293	63.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5266.4	C08		4	0060-0143	890.55	143.94	350	69.01	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			345.3	C08		4	0061-0147	281.89	147.32	272	62.53	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			910.6	C08		4	0062-0155	211.91	154.96	244	59.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			423.0	C08		4	0063-0155	546.55	155.53	283	63.70	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1627.2	C08		4	0064-0157	650.36	156.76	250	58.18	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1479.6	C08		4	0065-0162	471.64	161.79	460	83.98	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4166.4	C08		4	0066-0162	875.55	162.57	335	67.01	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			512.1	C08		4	0067-0165	392.06	164.70	252	60.87	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			670.9	C08		4	0068-0162	908.00	162.89	262	59.11	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			387.4	C08		4	0069-0166	15.51	165.91	257	61.01	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2041.6	C08		4	0070-0165	626.78	165.37	265	61.36	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			415.8	C08		4	0071-0169	55.25	169.81	268	63.94	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			397.2	C08		4	0072-0173	930.06	173.44	334	73.60	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			468.3	C08		4	0073-0171	572.45	171.06	277	65.01	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			353.2	C08		4	0074-0175	117.62	175.02	347	70.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3069.0	C08		4	0075-0174	608.69	174.77	343	72.67	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2281.3	C08		4	0076-0176	709.60	175.55	246	58.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			962.7	C08		4	0077-0182	743.35	181.60	249	57.94	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			274.8	C08		4	0078-0187	260.34	187.52	305	68.43	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2533.3	C08		4	0079-0187	396.30	186.68	288	65.01	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			577.5	C08		4	0080-0189	524.11	189.77	271	62.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			335.1	C08		4	0081-0192	303.68	191.71	332	70.77	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			629.8	C08		4	0082-0193	77.16	194.14	250	58.87	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3087.2	C08		4	0083-0204	189.14	203.70	711	106.91	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1048.6	C08		4	0084-0195	564.72	195.48	236	56.53	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4292.5	C08		4	0085-0197	603.83	197.14	195	51.70	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			619.0	C08		4	0086-0201	361.27	201.37	278	62.18	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			871.3	C08		4	0087-0203	910.95	203.03	256	64.53	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5265.7	C08		4	0088-0200	621.21	201.45	183	52.53	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			470.7	C08		4	0089-0208	451.61	208.79	227	59.94	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3831.2	C08		4	0090-0205	142.26	204.59	219	54.53	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			613.8	C08		4	0091-0211	77.12	210.81	245	58.63	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			387.0	C08		4	0092-0214	212.55	213.45	279	62.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			941.8	C08		4	0093-0215	882.23	215.37	291	63.36	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2548.8	C08		4	0094-0218	788.07	218.22	272	63.94	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			317.0	C08		4	0095-0220	822.27	219.43	310	65.36	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1911.7	C08		4	0096-0221	236.96	221.31	270	60.18	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			455.8	C08		4	0097-0223	700.20	224.18	270	61.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			649.4	C08		4	0098-0225	11.64	225.33	233	56.28	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1782.0	C08		4	0099-0224	907.71	224.45	290	74.43	0.658
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			566.1	C08		4	0100-0231	46.45	231.41	275	62.18	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			8320.2	C08		4	0101-0231	289.29	231.64	353	70.18	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1987.8	C08		4	0102-0233	398.28	233.18	267	64.18	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			978.6	C08		4	0103-0237	156.70	237.75	481	90.57	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1597.3	C08		4	0104-0241	555.48	240.85	356	74.91	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4756.8	C08		4	0105-0241	479.61	240.40	254	60.28	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4472.7	C08		4	0106-0245	716.17	245.07	436	77.60	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3057.8	C08		4	0107-0247	327.17	247.13	466	82.43	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1056.4	C08		4	0108-0246	134.48	245.89	176	49.36	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			499.4	C08		4	0109-0253	433.59	253.15	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1878.8	C08		4	0110-0253	587.73	252.99	305	65.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			379.7	C08		4	0111-0256	80.26	256.04	257	61.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5363.1	C08		4	0112-0257	247.39	255.62	261	61.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2345.7	C08		4	0113-0256	364.30	256.01	292	63.94	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1365.0	C08		4	0114-0254	936.70	254.54	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			626.3	C08		4	0115-0257	755.30	256.76	273	62.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			650.6	C08		4	0116-0257	864.11	257.95	306	66.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4165.6	C08		4	0117-0258	384.05	257.99	249	58.28	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2561.6	C08		4	0118-0260	777.97	259.88	263	59.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			351.5	C08		4	0119-0265	223.78	265.45	272	63.94	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1340.6	C08		4	0120-0264	502.47	264.27	314	66.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3224.2	C08		4	0121-0265	114.70	264.56	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			745.8	C08		4	0122-0271	280.71	271.29	271	61.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			421.2	C08		4	0123-0271	834.78	271.50	274	61.01	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1053.9	C08		4	0124-0274	894.80	274.10	305	65.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3226.6	C08		4	0125-0278	522.30	279.48	304	69.01	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			507.8	C08		4	0126-0276	602.65	276.21	294	62.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3093.4	C08		4	0127-0284	128.97	286.07	617	101.40	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5031.5	C08		4	0128-0277	254.08	276.78	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			336.0	C08		4	0129-0286	42.86	285.69	296	64.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			395.4	C08		4	0130-0286	158.65	286.05	218	55.70	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5318.7	C08		4	0131-0288	942.68	288.02	330	69.01	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			802.8	C08		4	0132-0289	406.39	289.20	301	67.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			396.7	C08		4	0133-0289	695.37	289.37	262	62.18	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2278.0	C08		4	0134-0294	340.79	295.23	513	90.91	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			803.0	C08		4	0135-0293	917.77	293.73	271	61.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6846.5	C08		4	0136-0296	250.70	296.90	422	77.84	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			725.7	C08		4	0137-0293	712.56	293.65	264	63.36	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3527.0	C08		4	0138-0294	560.23	293.96	274	64.43	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1598.1	C08		4	0139-0299	471.38	299.56	304	65.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1180.1	C08		4	0140-0301	392.38	301.52	280	64.18	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			349.2	C08		4	0141-0307	13.11	307.38	287	63.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			8032.3	C08		4	0142-0306	80.29	306.31	181	50.87	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			456.6	C08		4	0143-0307	523.17	306.77	252	59.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2494.6	C08		4	0144-0306	612.94	307.01	227	54.77	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			592.3	C08		4	0145-0309	816.53	308.49	292	66.77	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2935.7	C08		4	0146-0315	425.75	315.11	295	63.01	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			242.2	C08		4	0147-0319	940.38	319.78	301	64.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			360.0	C08		4	0148-0318	803.67	318.62	290	69.84	0.747
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			709.0	C08		4	0149-0317	849.12	317.73	271	60.18	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6935.7	C08		4	0150-0323	559.21	322.24	321	73.26	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7102.7	C08		4	0151-0321	87.18	321.12	225	56.28	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2430.8	C08		4	0152-0322	452.39	323.15	367	71.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			645.4	C08		4	0153-0327	162.06	328.11	249	59.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2602.7	C08		4	0154-0330	710.27	330.78	319	65.36	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			868.5	C08		4	0155-0328	886.53	328.26	263	60.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			394.8	C08		4	0156-0338	594.01	337.91	595	97.98	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1396.1	C08		4	0157-0337	646.17	337.01	297	63.60	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			460.1	C08		4	0158-0337	116.88	337.20	284	63.36	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1009.4	C08		4	0159-0341	39.77	340.92	273	63.60	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			411.0	C08		4	0160-0341	454.84	340.21	289	67.11	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			474.0	C08		4	0161-0346	304.57	345.75	260	61.36	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			382.4	C08		4	0162-0346	271.11	346.10	266	59.11	0.957
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			325.6	C08		4	0163-0350	752.50	350.43	324	67.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1068.5	C08		4	0164-0350	384.43	350.60	255	57.94	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			787.2	C08		4	0165-0356	74.61	354.29	497	93.74	0.711
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			358.7	C08		4	0166-0357	29.79	358.18	297	66.18	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5888.7	C08		4	0167-0358	176.42	358.89	387	72.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			308.8	C08		4	0168-0359	793.52	358.98	294	63.84	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			383.3	C08		4	0169-0361	514.26	361.31	283	61.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1773.8	C08		4	0170-0360	594.36	360.58	300	66.43	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			519.3	C08		4	0171-0361	685.12	361.13	274	61.11	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			317.4	C08		4	0172-0365	840.24	364.88	336	71.26	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			869.9	C08		4	0173-0368	155.00	368.36	278	62.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			602.4	C08		4	0174-0368	933.68	367.98	277	63.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			441.0	C08		4	0175-0368	547.58	368.08	268	61.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			501.3	C08		4	0176-0373	905.43	372.43	254	62.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			369.1	C08		4	0177-0378	76.68	377.50	293	64.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5240.6	C08		4	0178-0379	403.55	378.78	400	75.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			624.1	C08		4	0179-0381	916.77	381.15	265	65.11	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			651.7	C08		4	0180-0380	783.74	380.76	267	61.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			450.2	C08		4	0181-0381	868.36	381.50	273	62.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			484.4	C08		4	0182-0380	582.62	380.44	267	62.77	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1517.2	C08		4	0183-0387	197.99	387.76	271	62.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2796.3	C08		4	0184-0388	386.37	388.18	276	63.60	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3976.2	C08		4	0185-0393	451.71	392.80	425	77.50	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			542.4	C08		4	0186-0392	327.20	391.44	230	59.01	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			272.1	C08		4	0187-0391	646.40	391.28	327	69.60	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1135.0	C08		4	0188-0393	265.53	394.10	264	71.60	0.647
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			542.2	C08		4	0189-0398	487.40	398.43	243	57.94	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1852.0	C08		4	0190-0407	338.35	406.82	452	79.26	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			587.3	C08		4	0191-0407	428.75	406.70	308	67.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			498.8	C08		4	0192-0406	835.29	405.58	284	63.36	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			691.1	C08		4	0193-0406	219.83	405.82	314	75.01	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3345.7	C08		4	0194-0412	39.19	412.53	379	73.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			313.8	C08		4	0195-0414	718.29	413.31	316	70.67	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			369.8	C08		4	0196-0415	616.94	415.67	305	71.11	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1031.9	C08		4	0197-0418	537.24	418.53	261	60.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			482.3	C08		4	0198-0419	314.66	418.81	257	60.77	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2058.4	C08		4	0199-0423	23.37	424.02	327	68.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			941.7	C08		4	0200-0426	443.84	426.38	435	78.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			997.1	C08		4	0201-0422	497.94	422.24	234	59.94	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			479.3	C08		4	0202-0421	782.63	422.18	227	57.46	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			900.2	C08		4	0203-0428	102.54	428.54	257	59.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			807.0	C08		4	0204-0428	353.63	428.13	233	58.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			672.2	C08		4	0205-0431	175.61	431.06	260	61.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4460.1	C08		4	0206-0436	869.49	435.52	344	69.26	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			591.0	C08		4	0207-0437	399.03	437.24	300	65.84	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			380.7	C08		4	0208-0435	785.70	435.21	299	67.46	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			386.1	C08		4	0209-0442	844.50	442.06	300	68.08	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			506.4	C08		4	0210-0439	899.85	439.43	274	63.94	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			965.0	C08		4	0211-0444	533.74	444.45	275	63.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			334.5	C08		4	0212-0451	210.14	451.51	293	67.01	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1895.2	C08		4	0213-0452	160.79	452.29	236	59.70	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			336.9	C08		4	0214-0454	600.75	454.31	294	65.60	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			394.7	C08		4	0215-0451	736.90	451.79	266	61.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3263.4	C08		4	0216-0454	895.33	454.25	259	61.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			372.4	C08		4	0217-0458	478.62	458.38	287	65.84	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4379.9	C08		4	0218-0461	694.69	460.92	532	86.91	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			966.4	C08		4	0219-0459	44.19	459.42	281	64.43	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			462.6	C08		4	0220-0459	342.19	460.03	284	62.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3308.0	C08		4	0221-0462	933.42	462.17	236	57.70	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2758.5	C08		4	0222-0465	256.68	465.55	257	60.77	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			403.4	C08		4	0223-0471	643.70	471.56	319	67.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			528.1	C08		4	0224-0473	375.99	473.75	283	64.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			470.7	C08		4	0225-0478	95.76	477.80	297	67.94	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			376.1	C08		4	0226-0480	226.39	480.27	289	68.53	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2525.8	C08		4	0227-0482	578.29	482.37	597	107.88	0.645
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			482.0	C08		4	0228-0482	355.23	481.80	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1052.1	C08		4	0229-0483	515.35	483.79	278	63.70	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			413.1	C08		4	0230-0487	464.61	487.29	316	68.67	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2303.0	C08		4	0231-0486	656.31	486.55	381	76.18	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			439.9	C08		4	0232-0489	306.55	488.32	222	57.60	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1085.9	C08		4	0233-0491	261.19	491.53	318	66.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			440.5	C08		4	0234-0492	900.56	491.75	258	62.43	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5308.8	C08		4	0235-0493	119.60	493.37	322	66.43	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			364.7	C08		4	0236-0493	532.25	493.24	329	67.36	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			597.9	C08		4	0237-0496	152.27	496.95	290	63.60	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			975.3	C08		4	0238-0498	496.09	498.57	275	61.36	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2458.7	C08		4	0239-0506	296.91	506.63	510	89.40	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3378.0	C08		4	0240-0503	747.65	501.76	382	82.77	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			325.8	C08		4	0241-0505	190.44	504.87	303	66.43	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3408.4	C08		4	0242-0506	585.31	506.50	368	79.01	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5206.6	C08		4	0243-0506	914.71	505.80	385	72.08	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3257.0	C08		4	0244-0507	75.06	506.49	407	77.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1489.5	C08		4	0245-0508	940.54	508.37	248	59.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			699.7	C08		4	0246-0514	460.98	514.37	282	66.18	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2397.1	C08		4	0247-0515	344.87	515.17	256	58.77	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4627.9	C08		4	0248-0513	752.20	513.18	104	37.56	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			499.3	C08		4	0249-0519	797.87	519.53	305	66.77	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3358.6	C08		4	0250-0523	21.03	522.78	367	71.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3674.3	C08		4	0251-0524	677.56	524.40	267	63.11	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			414.3	C08		4	0252-0525	857.33	525.76	293	63.60	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			836.1	C08		4	0253-0528	605.21	528.13	260	60.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			583.3	C08		4	0254-0530	81.41	530.67	265	59.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			413.4	C08		4	0255-0532	425.71	531.58	294	64.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5016.2	C08		4	0256-0534	143.33	533.49	348	69.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			641.9	C08		4	0257-0536	337.79	536.17	304	64.77	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			388.4	C08		4	0258-0540	705.37	540.44	283	67.60	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			417.4	C08		4	0259-0540	375.55	540.29	282	61.36	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1223.1	C08		4	0260-0542	264.94	543.10	283	64.18	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1566.5	C08		4	0261-0540	769.06	541.00	227	55.70	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5271.5	C08		4	0262-0546	504.88	544.75	144	58.18	0.535
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1620.1	C08		4	0263-0545	786.77	545.17	241	58.28	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			721.7	C08		4	0264-0548	466.92	548.01	289	65.60	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			457.1	C08		4	0265-0551	193.95	551.35	335	75.36	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			443.8	C08		4	0266-0551	210.43	550.77	270	61.70	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1830.8	C08		4	0267-0553	564.18	553.75	284	62.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			312.9	C08		4	0268-0551	918.25	551.13	317	66.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5013.4	C08		4	0269-0550	498.75	550.63	113	46.04	0.670
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1918.4	C08		4	0270-0553	125.79	553.98	155	46.87	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5273.9	C08		4	0271-0563	41.40	563.91	377	82.43	0.697
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			386.4	C08		4	0272-0562	294.63	562.32	316	67.60	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4137.4	C08		4	0273-0561	645.15	561.41	241	61.36	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			914.7	C08		4	0274-0566	848.78	566.92	594	97.40	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1432.3	C08		4	0275-0565	518.57	564.82	266	61.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1359.3	C08		4	0276-0565	593.65	565.42	274	60.77	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			689.3	C08		4	0277-0568	97.71	568.65	271	62.77	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			915.4	C08		4	0278-0566	436.79	566.91	284	68.43	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3045.7	C08		4	0279-0583	385.93	583.07	254	58.53	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1314.4	C08		4	0280-0582	551.56	582.54	274	61.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			479.3	C08		4	0281-0586	588.04	585.62	294	67.60	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			388.7	C08		4	0282-0585	806.99	584.50	330	70.43	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			361.0	C08		4	0283-0588	656.39	587.82	317	68.67	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1625.5	C08		4	0284-0585	915.70	585.09	232	55.94	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			600.7	C08		4	0285-0586	752.14	586.11	259	59.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			904.8	C08		4	0286-0589	453.57	588.43	297	65.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			343.3	C08		4	0287-0596	680.62	596.36	294	65.01	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3090.1	C08		4	0288-0597	370.78	597.13	269	60.87	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4400.6	C08		4	0289-0598	906.51	598.67	284	67.01	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3933.8	C08		4	0290-0602	472.15	602.78	265	62.77	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			903.7	C08		4	0291-0606	407.31	605.77	311	66.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1121.7	C08		4	0292-0610	596.24	611.18	339	74.43	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			645.3	C08		4	0293-0606	124.51	606.33	248	59.11	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1776.9	C08		4	0294-0604	150.87	603.91	160	48.87	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3195.4	C08		4	0295-0608	221.37	608.45	282	67.01	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1012.3	C08		4	0296-0611	107.12	611.29	310	67.60	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6092.2	C08		4	0297-0608	891.26	607.66	201	53.36	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2207.3	C08		4	0298-0617	251.36	617.11	262	63.26	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			365.4	C08		4	0299-0617	546.69	617.58	314	66.18	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			472.6	C08		4	0300-0621	164.67	621.23	270	65.70	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1085.0	C08		4	0301-0617	298.05	616.51	243	57.36	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2898.5	C08		4	0302-0623	508.75	622.51	536	104.13	0.621
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			381.5	C08		4	0303-0621	860.48	620.95	301	66.53	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1698.5	C08		4	0304-0621	89.78	621.50	220	54.18	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2241.1	C08		4	0305-0626	363.21	626.25	240	63.84	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			399.6	C08		4	0306-0623	19.85	623.15	257	57.94	0.962
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			780.7	C08		4	0307-0626	446.30	626.23	296	65.84	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			315.4	C08		4	0308-0628	276.95	627.68	296	65.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1556.8	C08		4	0309-0632	393.23	631.71	281	63.60	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1667.2	C08		4	0310-0629	712.87	629.97	259	61.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2841.8	C08		4	0311-0633	197.52	634.07	279	62.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3669.8	C08		4	0312-0642	488.06	641.33	754	112.47	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1260.9	C08		4	0313-0637	829.47	636.54	263	61.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3620.0	C08		4	0314-0644	345.03	644.26	229	55.70	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			391.2	C08		4	0315-0641	608.85	641.57	282	65.36	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4214.9	C08		4	0316-0647	814.22	647.40	352	70.67	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1296.1	C08		4	0317-0648	411.99	648.90	283	67.84	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1117.2	C08		4	0318-0654	217.20	652.52	594	101.74	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7452.4	C08		4	0319-0647	372.52	646.90	117	54.67	0.492
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5743.8	C08		4	0320-0651	366.21	653.00	129	56.43	0.509
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2038.1	C08		4	0321-0657	751.75	656.75	276	64.77	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			687.7	C08		4	0322-0661	29.53	660.50	527	89.26	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			301.3	C08		4	0323-0658	948.14	657.79	286	63.60	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			384.3	C08		4	0324-0664	526.90	664.58	255	62.53	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			963.0	C08		4	0325-0661	625.34	660.88	249	57.94	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			335.7	C08		4	0326-0664	562.53	664.41	309	68.43	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1141.6	C08		4	0327-0667	784.11	667.20	269	63.36	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			323.2	C08		4	0328-0665	139.16	664.90	285	63.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1199.9	C08		4	0329-0670	586.29	670.21	256	59.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5305.8	C08		4	0330-0670	914.77	670.05	225	54.87	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			779.1	C08		4	0331-0674	415.34	674.71	314	66.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			841.8	C08		4	0332-0677	471.76	677.87	291	65.94	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			329.9	C08		4	0333-0679	539.42	678.57	287	67.36	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2533.9	C08		4	0334-0682	65.29	680.87	252	65.36	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			778.8	C08		4	0335-0683	495.42	683.29	294	66.53	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3118.4	C08		4	0336-0681	348.32	681.31	250	58.18	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			387.0	C08		4	0337-0682	512.00	682.29	273	61.21	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			601.9	C08		4	0338-0685	29.24	685.85	265	61.36	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			246.8	C08		4	0339-0687	261.52	686.48	285	65.36	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4679.3	C08		4	0340-0687	845.32	687.10	233	56.18	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1176.2	C08		4	0341-0692	717.19	692.78	251	61.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1165.1	C08		4	0342-0691	292.89	692.24	199	53.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			919.8	C08		4	0343-0694	754.00	694.29	290	65.60	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			454.0	C08		4	0344-0696	193.12	695.75	276	62.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1771.4	C08		4	0345-0697	54.64	698.43	341	70.43	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2504.5	C08		4	0346-0696	135.31	695.85	323	66.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			473.5	C08		4	0347-0699	793.59	700.20	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			614.2	C08		4	0348-0699	474.12	699.64	273	62.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1102.5	C08		4	0349-0701	733.39	701.49	303	67.36	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			509.6	C08		4	0350-0705	877.22	705.20	108	42.04	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			973.6	C08		4	0351-0707	930.89	707.77	266	65.01	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			791.8	C08		4	0352-0710	358.48	709.73	291	63.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1129.7	C08		5	0001-0025	207.22	24.73	281	63.36	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			575.9	C08		5	0002-0023	628.36	23.18	228	56.28	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1512.9	C08		5	0003-0027	757.57	26.69	263	60.43	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			704.6	C08		5	0004-0025	245.80	25.00	263	60.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			668.1	C08		5	0005-0035	174.04	35.25	268	60.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1505.5	C08		5	0006-0036	402.63	35.76	271	61.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1738.9	C08		5	0007-0037	66.40	37.22	253	59.11	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			480.2	C08		5	0008-0039	746.47	39.01	243	59.84	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			595.9	C08		5	0009-0041	937.37	41.10	272	64.18	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			686.9	C08		5	0010-0045	583.63	46.23	377	80.18	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			904.5	C08		5	0011-0041	602.48	40.47	210	54.87	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			416.9	C08		5	0012-0046	510.44	45.61	319	65.01	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			551.1	C08		5	0013-0047	417.06	47.14	262	70.67	0.659
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			628.4	C08		5	0014-0048	325.88	48.14	252	59.70	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2501.4	C08		5	0015-0048	864.11	48.79	362	71.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1282.4	C08		5	0016-0051	538.31	51.75	284	63.94	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			389.1	C08		5	0017-0049	663.18	49.26	245	56.77	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1055.9	C08		5	0018-0051	47.74	51.33	240	58.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1173.8	C08		5	0019-0051	887.77	51.56	252	57.94	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1467.2	C08		5	0020-0056	264.29	55.56	497	91.74	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			624.0	C08		5	0021-0055	482.62	55.53	232	56.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			854.6	C08		5	0022-0063	305.30	62.56	282	66.67	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			988.1	C08		5	0023-0062	186.19	63.10	290	65.60	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1098.7	C08		5	0024-0064	806.78	64.54	201	56.43	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			469.0	C08		5	0025-0067	26.26	66.14	274	64.43	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1827.0	C08		5	0026-0066	117.58	65.66	227	59.60	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			311.5	C08		5	0027-0071	231.30	71.55	281	65.60	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1519.7	C08		5	0028-0071	753.60	71.94	276	61.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			652.1	C08		5	0029-0072	559.09	72.36	265	60.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			370.0	C08		5	0030-0076	379.29	75.97	313	67.01	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2269.4	C08		5	0031-0080	123.83	80.49	366	76.18	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			825.0	C08		5	0032-0075	165.25	74.41	288	65.70	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			558.3	C08		5	0033-0078	613.99	77.76	256	58.53	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1034.9	C08		5	0034-0079	923.97	79.38	259	59.70	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1364.9	C08		5	0035-0081	60.39	81.99	265	64.18	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			461.7	C08		5	0036-0084	505.04	84.26	310	65.94	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			269.4	C08		5	0037-0090	693.12	90.15	316	68.18	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1730.0	C08		5	0038-0088	724.22	87.61	299	63.60	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			521.7	C08		5	0039-0087	254.08	87.36	238	58.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			943.3	C08		5	0040-0089	87.63	89.57	252	58.53	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			680.9	C08		5	0041-0090	184.69	90.96	419	81.26	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4016.1	C08		5	0042-0094	281.23	94.20	346	70.18	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1307.5	C08		5	0043-0093	162.46	93.63	217	59.70	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2322.2	C08		5	0044-0097	316.17	98.03	272	60.77	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			371.0	C08		5	0045-0105	858.99	106.45	309	76.77	0.659
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			330.6	C08		5	0046-0101	651.89	101.10	345	69.84	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1576.1	C08		5	0047-0102	503.46	101.78	273	62.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			309.9	C08		5	0048-0105	894.66	104.84	302	69.84	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2583.2	C08		5	0049-0105	342.24	105.07	235	55.94	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			720.4	C08		5	0050-0107	788.00	107.40	286	64.77	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			332.8	C08		5	0051-0109	47.58	108.98	289	62.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5116.5	C08		5	0052-0108	208.12	107.97	321	66.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1567.7	C08		5	0053-0109	829.80	108.41	263	60.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4406.6	C08		5	0054-0110	550.61	109.80	235	57.46	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			310.2	C08		5	0055-0114	939.47	113.65	286	65.94	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4924.5	C08		5	0056-0114	535.56	114.61	220	58.18	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			764.8	C08		5	0057-0115	814.85	115.25	248	61.60	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1532.1	C08		5	0058-0116	125.20	116.96	275	64.67	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			422.6	C08		5	0059-0116	583.58	116.19	253	57.94	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1530.7	C08		5	0060-0117	451.18	117.39	235	63.01	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			358.8	C08		5	0061-0130	293.94	130.74	532	96.57	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1097.5	C08		5	0062-0127	763.95	126.43	390	74.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			308.4	C08		5	0063-0129	241.70	129.15	279	63.01	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			299.5	C08		5	0064-0128	945.76	129.18	307	67.60	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1610.4	C08		5	0065-0130	709.15	129.47	285	63.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			320.6	C08		5	0066-0132	205.96	132.26	302	67.01	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			876.9	C08		5	0067-0131	83.68	131.34	282	64.77	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			640.3	C08		5	0068-0132	462.85	132.67	223	56.63	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1493.6	C08		5	0069-0142	511.66	141.97	346	70.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1220.0	C08		5	0070-0142	779.76	142.04	281	64.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			323.0	C08		5	0071-0146	124.86	145.69	304	69.01	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			919.3	C08		5	0072-0147	401.83	145.94	226	60.53	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			388.1	C08		5	0073-0149	538.49	149.60	263	65.01	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			916.0	C08		5	0074-0148	704.63	148.28	295	65.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1021.1	C08		5	0075-0148	826.93	148.52	278	62.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3470.8	C08		5	0076-0150	644.94	149.72	309	65.36	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			610.0	C08		5	0077-0148	467.80	148.00	227	55.70	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1057.1	C08		5	0078-0154	206.08	154.12	273	60.77	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4263.6	C08		5	0079-0155	564.25	155.96	469	80.08	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			397.3	C08		5	0080-0153	71.19	152.62	267	62.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1207.8	C08		5	0081-0156	224.25	156.24	260	59.70	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			409.8	C08		5	0082-0159	918.75	158.85	309	71.36	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1234.4	C08		5	0083-0161	670.33	161.54	283	65.26	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1276.4	C08		5	0084-0159	901.80	159.44	190	52.28	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1032.8	C08		5	0085-0161	411.74	160.23	259	61.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			618.3	C08		5	0086-0164	12.84	165.13	248	57.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1764.9	C08		5	0087-0167	149.27	167.38	232	56.18	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			495.1	C08		5	0088-0168	837.22	167.15	248	61.94	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			446.8	C08		5	0089-0175	34.74	175.89	304	70.77	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2115.6	C08		5	0090-0176	348.13	175.84	308	67.60	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4331.9	C08		5	0091-0176	595.11	176.03	445	77.26	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1968.1	C08		5	0092-0177	174.77	177.75	256	58.18	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			517.2	C08		5	0093-0179	752.26	178.85	297	65.60	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			669.2	C08		5	0094-0182	139.86	182.31	239	57.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			800.9	C08		5	0095-0179	480.19	178.89	257	60.53	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			512.9	C08		5	0096-0180	773.20	180.22	253	59.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			594.8	C08		5	0097-0178	819.77	178.06	127	42.97	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			566.3	C08		5	0098-0181	830.53	181.19	108	38.39	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			392.8	C08		5	0099-0189	195.63	189.09	273	62.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			597.0	C08		5	0100-0194	94.39	194.00	361	74.43	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2636.8	C08		5	0101-0192	356.51	192.32	250	61.60	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			922.3	C08		5	0102-0193	111.20	192.63	270	61.70	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3920.2	C08		5	0103-0196	316.62	195.93	423	74.43	0.960
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			500.6	C08		5	0104-0192	277.15	191.83	127	62.43	0.410
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			384.8	C08		5	0105-0197	255.39	196.94	291	65.11	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			575.6	C08		5	0106-0199	238.00	199.22	270	60.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			622.0	C08		5	0107-0197	755.16	197.21	333	73.84	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2481.8	C08		5	0108-0203	377.95	202.93	389	73.84	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1525.9	C08		5	0109-0202	729.24	202.66	282	62.28	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			842.5	C08		5	0110-0205	15.79	205.08	242	62.53	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			940.0	C08		5	0111-0201	152.68	200.91	278	65.11	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2731.0	C08		5	0112-0213	531.46	212.95	638	109.64	0.667
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1227.7	C08		5	0113-0208	451.28	209.15	386	77.60	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3188.2	C08		5	0114-0207	707.83	207.15	275	61.70	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			403.7	C08		5	0115-0208	417.03	208.07	264	60.77	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4206.8	C08		5	0116-0212	806.62	212.34	352	71.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1044.0	C08		5	0117-0213	468.08	213.85	235	59.11	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			371.9	C08		5	0118-0215	79.24	215.03	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1424.8	C08		5	0119-0216	916.03	216.05	260	60.18	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1501.4	C08		5	0120-0216	754.19	217.04	271	60.53	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			403.5	C08		5	0121-0220	861.49	220.57	261	61.46	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1468.3	C08		5	0122-0220	846.92	220.50	226	56.53	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1134.1	C08		5	0123-0220	155.45	219.99	235	58.53	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5129.4	C08		5	0124-0227	305.10	227.85	461	79.84	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1528.2	C08		5	0125-0230	209.14	229.56	465	82.18	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4536.4	C08		5	0126-0228	629.67	228.20	214	54.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			848.8	C08		5	0127-0234	566.31	234.22	319	71.60	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2957.7	C08		5	0128-0234	179.64	233.99	323	67.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1831.9	C08		5	0129-0235	160.19	235.37	256	64.18	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1996.3	C08		5	0130-0236	282.88	236.18	299	64.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4631.3	C08		5	0131-0236	649.81	235.52	223	55.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			583.2	C08		5	0132-0237	120.78	237.25	243	58.18	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4693.2	C08		5	0133-0245	368.24	245.87	246	57.60	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			370.9	C08		5	0134-0246	583.97	245.73	309	67.70	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1367.8	C08		5	0135-0246	746.79	246.21	272	67.01	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			550.8	C08		5	0136-0251	154.83	251.42	213	57.36	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1378.4	C08		5	0137-0257	41.66	256.83	302	66.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			514.1	C08		5	0138-0261	915.84	261.05	264	62.77	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			684.3	C08		5	0139-0268	672.13	267.50	285	65.01	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1490.6	C08		5	0140-0270	701.57	270.34	435	77.26	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			464.3	C08		5	0141-0268	165.69	268.34	279	64.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2783.5	C08		5	0142-0271	272.79	270.58	228	59.01	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			677.4	C08		5	0143-0272	781.36	271.85	315	68.18	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			700.5	C08		5	0144-0274	218.26	274.24	234	58.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1758.8	C08		5	0145-0274	336.63	274.33	263	61.36	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			9998.8	C08		5	0146-0275	403.63	274.97	100	53.94	0.432
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			576.6	C08		5	0147-0277	614.54	277.62	293	63.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			588.8	C08		5	0148-0282	637.91	282.17	280	62.18	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3113.7	C08		5	0149-0285	826.66	284.99	417	75.84	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2717.2	C08		5	0150-0283	727.36	283.45	236	57.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4835.5	C08		5	0151-0284	368.25	284.96	238	57.36	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			644.1	C08		5	0152-0286	122.52	286.93	271	62.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			383.9	C08		5	0153-0288	523.62	287.86	321	69.26	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5179.2	C08		5	0154-0290	47.31	290.37	349	69.01	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			782.4	C08		5	0155-0288	145.49	288.97	279	64.43	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			408.8	C08		5	0156-0293	892.36	293.38	289	65.60	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2341.1	C08		5	0157-0292	100.14	291.43	254	61.94	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			669.9	C08		5	0158-0290	326.27	290.42	232	60.18	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2153.3	C08		5	0159-0294	83.86	294.02	274	62.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			422.8	C08		5	0160-0293	484.95	293.15	340	72.18	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			747.8	C08		5	0161-0296	22.78	295.96	261	59.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			837.0	C08		5	0162-0297	451.94	296.90	263	62.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3933.5	C08		5	0163-0298	240.29	298.78	366	71.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6341.6	C08		5	0164-0302	652.45	303.48	138	61.94	0.452
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			740.4	C08		5	0165-0304	280.60	304.06	270	61.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			450.4	C08		5	0166-0305	217.05	305.63	289	63.84	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			294.5	C08		5	0167-0307	930.59	307.42	323	67.01	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1983.0	C08		5	0168-0310	729.44	309.48	269	62.18	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			852.0	C08		5	0169-0312	158.18	312.84	271	59.94	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			528.6	C08		5	0170-0316	189.03	316.58	267	63.36	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			992.4	C08		5	0171-0316	69.13	316.27	257	58.53	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			648.2	C08		5	0172-0318	89.27	318.53	265	59.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			422.3	C08		5	0173-0317	799.68	316.63	286	63.60	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			271.4	C08		5	0174-0321	45.21	322.00	284	63.36	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1188.4	C08		5	0175-0320	845.17	320.63	253	58.18	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			596.7	C08		5	0176-0320	136.44	320.06	267	61.70	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			460.4	C08		5	0177-0322	397.22	323.48	278	62.87	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1510.2	C08		5	0178-0322	870.34	322.03	266	60.18	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5192.2	C08		5	0179-0331	461.27	330.50	403	123.30	0.333
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1408.7	C08		5	0180-0327	348.68	327.24	254	59.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			458.6	C08		5	0181-0336	635.50	336.28	311	67.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			673.1	C08		5	0182-0339	704.62	340.13	296	69.01	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			8857.8	C08		5	0183-0339	450.08	339.58	202	57.36	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2172.7	C08		5	0184-0341	684.57	341.42	259	59.11	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			343.3	C08		5	0185-0342	157.89	341.75	248	58.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1053.8	C08		5	0186-0341	401.12	341.19	280	63.11	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1260.9	C08		5	0187-0342	227.55	343.12	260	58.53	0.954
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			864.0	C08		5	0188-0349	287.08	348.91	530	90.08	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			336.3	C08		5	0189-0348	528.05	348.36	309	64.77	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2389.1	C08		5	0190-0349	862.51	349.51	310	65.70	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			973.5	C08		5	0191-0350	111.55	349.91	286	63.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			686.9	C08		5	0192-0351	185.97	351.54	249	59.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3035.9	C08		5	0193-0351	484.60	351.12	260	59.46	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1000.3	C08		5	0194-0351	626.22	351.50	270	60.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1200.4	C08		5	0195-0355	259.67	355.61	272	62.43	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1229.9	C08		5	0196-0355	379.09	355.60	217	55.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			396.7	C08		5	0197-0357	925.07	357.27	292	67.01	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			715.9	C08		5	0198-0359	132.19	358.49	242	57.36	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			939.3	C08		5	0199-0358	402.98	357.83	219	56.53	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			563.5	C08		5	0200-0360	231.80	360.52	300	66.53	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			287.0	C08		5	0201-0363	330.82	363.80	293	67.84	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4311.6	C08		5	0202-0362	570.58	361.86	347	68.43	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			611.9	C08		5	0203-0363	801.77	362.94	302	65.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1619.3	C08		5	0204-0362	692.19	362.38	273	62.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			594.9	C08		5	0205-0362	455.04	362.52	265	59.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4108.7	C08		5	0206-0367	753.07	367.37	195	53.70	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			535.1	C08		5	0207-0370	250.40	370.10	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2523.0	C08		5	0208-0367	489.65	367.26	252	61.70	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			647.8	C08		5	0209-0370	38.62	370.24	269	61.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			512.3	C08		5	0210-0371	65.11	370.95	267	63.60	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			534.5	C08		5	0211-0379	16.47	379.21	528	92.33	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4262.8	C08		5	0212-0374	897.56	373.81	358	70.43	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			621.7	C08		5	0213-0374	392.69	373.41	227	57.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1216.0	C08		5	0214-0372	607.12	372.07	244	59.70	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			899.9	C08		5	0215-0377	715.45	377.60	258	60.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			537.1	C08		5	0216-0380	170.63	380.29	261	60.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			470.0	C08		5	0217-0380	79.57	380.62	269	65.94	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			592.1	C08		5	0218-0380	826.62	380.14	234	67.94	0.637
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			428.0	C08		5	0219-0385	845.60	385.45	276	64.77	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			729.4	C08		5	0220-0393	409.82	393.55	669	106.13	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2428.1	C08		5	0221-0388	931.71	388.88	307	65.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			487.3	C08		5	0222-0389	620.66	388.59	300	65.94	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			310.6	C08		5	0223-0391	280.28	391.24	286	63.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3884.4	C08		5	0224-0394	742.34	394.65	218	56.28	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2364.4	C08		5	0225-0397	576.47	397.02	193	53.11	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			706.8	C08		5	0226-0408	234.72	408.22	478	85.98	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			742.2	C08		5	0227-0401	128.22	400.74	230	57.70	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1077.5	C08		5	0228-0403	640.40	402.75	245	59.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2287.6	C08		5	0229-0402	674.17	402.64	236	56.87	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			736.8	C08		5	0230-0407	256.61	407.32	259	58.53	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			372.7	C08		5	0231-0408	197.58	408.15	263	62.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			592.3	C08		5	0232-0408	809.21	408.51	286	65.11	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1849.4	C08		5	0233-0413	653.05	413.47	257	58.53	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1079.9	C08		5	0234-0413	121.53	413.71	248	60.53	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			627.8	C08		5	0235-0415	880.15	415.33	325	70.18	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			374.7	C08		5	0236-0415	332.75	415.60	283	61.36	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1174.9	C08		5	0237-0420	699.61	420.50	272	61.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1273.8	C08		5	0238-0421	179.91	421.12	203	53.36	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			11508.8	C08		5	0239-0422	547.27	421.79	185	51.94	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1698.5	C08		5	0240-0423	604.43	422.81	241	56.53	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			505.7	C08		5	0241-0425	750.67	425.26	311	67.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			240.8	C08		5	0242-0428	861.17	428.79	347	72.43	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1939.3	C08		5	0243-0429	357.07	429.49	449	79.01	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			470.9	C08		5	0244-0427	425.56	426.68	266	62.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			722.0	C08		5	0245-0428	813.06	427.42	298	67.36	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4063.2	C08		5	0246-0429	910.70	428.36	341	67.60	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2570.2	C08		5	0247-0432	534.22	431.66	315	71.01	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			590.2	C08		5	0248-0432	446.12	431.85	275	61.36	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			526.1	C08		5	0249-0435	62.73	435.07	267	60.53	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2227.7	C08		5	0250-0437	691.92	437.49	220	55.11	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3000.9	C08		5	0251-0441	127.60	441.77	461	86.33	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1741.4	C08		5	0252-0442	555.58	441.73	334	74.43	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1266.7	C08		5	0253-0442	168.94	442.03	258	60.87	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			553.2	C08		5	0254-0445	236.30	444.92	500	88.91	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			411.8	C08		5	0255-0445	612.34	445.07	298	64.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			463.3	C08		5	0256-0447	719.95	447.96	315	72.43	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			437.7	C08		5	0257-0445	380.07	445.62	201	53.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			332.9	C08		5	0258-0449	909.18	450.90	311	69.84	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			304.6	C08		5	0259-0453	469.88	453.62	288	63.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			652.1	C08		5	0260-0452	66.84	451.78	252	60.18	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			629.6	C08		5	0261-0456	201.00	456.33	242	58.53	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			458.3	C08		5	0262-0458	181.80	458.11	142	57.01	0.549
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5686.1	C08		5	0263-0464	794.80	464.01	517	83.26	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1377.6	C08		5	0264-0460	504.68	460.60	232	55.36	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			346.0	C08		5	0265-0463	416.40	463.13	287	63.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1599.4	C08		5	0266-0463	661.43	462.91	449	82.43	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1345.3	C08		5	0267-0465	556.12	465.52	281	61.84	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3271.4	C08		5	0268-0464	38.15	464.42	234	57.11	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			774.5	C08		5	0269-0468	577.43	468.57	287	61.94	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4117.8	C08		5	0270-0473	300.85	472.61	357	71.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			872.4	C08		5	0271-0468	741.95	468.06	257	59.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1050.3	C08		5	0272-0472	885.89	472.06	331	67.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			692.2	C08		5	0273-0473	402.60	473.38	290	65.26	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			380.7	C08		5	0274-0479	229.15	479.36	269	63.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2969.1	C08		5	0275-0484	122.14	484.11	446	81.01	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			500.7	C08		5	0276-0489	271.42	487.98	509	94.57	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			550.6	C08		5	0277-0482	846.77	481.46	271	61.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			471.2	C08		5	0278-0484	334.88	483.78	279	63.36	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2125.2	C08		5	0279-0495	616.96	495.63	262	61.60	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			415.3	C08		5	0280-0493	792.78	494.13	275	65.60	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			730.2	C08		5	0281-0496	452.03	495.40	259	59.36	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			697.9	C08		5	0282-0497	717.65	497.06	232	59.36	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			613.7	C08		5	0283-0501	197.27	500.70	468	85.74	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			422.0	C08		5	0284-0499	473.75	499.76	257	61.94	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			341.1	C08		5	0285-0501	96.90	501.47	294	65.01	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1356.4	C08		5	0286-0501	901.81	501.38	250	58.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			389.0	C08		5	0287-0502	370.13	501.78	271	62.77	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1432.0	C08		5	0288-0503	936.65	503.74	242	57.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1572.0	C08		5	0289-0504	493.62	504.39	252	59.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2186.1	C08		5	0290-0506	631.65	505.45	265	64.18	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5095.7	C08		5	0291-0507	19.27	507.99	386	74.33	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2751.2	C08		5	0292-0509	249.77	508.81	512	95.40	0.707
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			499.3	C08		5	0293-0509	557.64	509.71	257	65.01	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			667.6	C08		5	0294-0511	442.12	511.25	301	66.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1506.0	C08		5	0295-0510	45.20	510.71	245	58.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			369.4	C08		5	0296-0513	334.12	513.95	289	62.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			486.2	C08		5	0297-0514	286.74	514.68	251	57.94	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			229.9	C08		5	0298-0515	832.59	515.15	339	71.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3884.1	C08		5	0299-0515	468.55	515.56	195	53.70	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			694.1	C08		5	0300-0519	138.33	518.67	241	59.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			529.9	C08		5	0301-0519	526.25	519.51	272	60.53	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			320.3	C08		5	0302-0520	92.26	520.68	300	70.18	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1624.4	C08		5	0303-0523	624.45	523.58	297	65.01	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			673.6	C08		5	0304-0525	394.75	525.32	283	66.43	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			420.8	C08		5	0305-0528	769.98	528.55	280	67.50	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			365.0	C08		5	0306-0532	425.08	531.78	268	63.11	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			448.5	C08		5	0307-0533	151.14	533.56	258	63.01	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6108.8	C08		5	0308-0534	197.35	533.64	319	73.84	0.735
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			508.6	C08		5	0309-0539	534.98	538.32	273	65.60	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			832.8	C08		5	0310-0537	607.50	537.37	220	54.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			421.9	C08		5	0311-0541	382.06	542.72	366	75.01	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			391.9	C08		5	0312-0541	832.18	541.50	310	67.36	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4400.5	C08		5	0313-0543	470.35	543.09	177	48.53	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2170.4	C08		5	0314-0551	946.10	550.58	385	77.36	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1021.7	C08		5	0315-0546	321.13	546.71	242	57.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1383.0	C08		5	0316-0548	678.45	548.70	313	65.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			583.8	C08		5	0317-0546	741.53	546.09	268	60.18	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			439.3	C08		5	0318-0551	553.24	551.57	308	68.43	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			423.2	C08		5	0319-0551	99.70	551.78	270	60.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			565.7	C08		5	0320-0553	231.82	553.69	305	70.08	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			273.4	C08		5	0321-0553	22.92	553.49	287	63.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			718.0	C08		5	0322-0559	495.91	559.76	300	70.28	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1192.2	C08		5	0323-0559	389.91	558.86	287	63.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			432.3	C08		5	0324-0559	821.93	559.31	314	67.36	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2968.1	C08		5	0325-0559	248.37	560.21	257	63.36	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2470.4	C08		5	0326-0562	168.02	561.67	248	62.77	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			646.3	C08		5	0327-0564	702.70	564.62	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			821.1	C08		5	0328-0567	510.91	566.78	301	69.11	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2330.2	C08		5	0329-0564	315.06	563.80	239	59.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3164.6	C08		5	0330-0566	736.12	565.92	242	57.36	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			357.7	C08		5	0331-0569	150.59	569.48	302	65.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3302.8	C08		5	0332-0567	677.72	567.46	254	60.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			367.0	C08		5	0333-0571	274.35	571.63	273	66.67	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2091.7	C08		5	0334-0576	918.32	576.50	354	70.18	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			758.8	C08		5	0335-0575	342.32	575.76	263	64.28	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3318.5	C08		5	0336-0577	429.97	576.35	383	73.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			763.9	C08		5	0337-0578	632.34	578.02	292	65.94	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			776.4	C08		5	0338-0575	859.79	575.79	290	71.36	0.716
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1041.4	C08		5	0339-0580	67.90	580.53	477	87.74	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1569.5	C08		5	0340-0581	898.80	581.22	331	68.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			584.5	C08		5	0341-0583	574.86	583.16	299	66.77	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1144.4	C08		5	0342-0579	91.81	578.80	240	58.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2532.3	C08		5	0343-0582	313.75	583.24	272	64.28	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1151.6	C08		5	0344-0581	391.81	581.10	270	60.18	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3520.8	C08		5	0345-0581	716.10	581.79	223	55.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1184.3	C08		5	0346-0582	362.15	581.71	266	62.28	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1005.2	C08		5	0347-0580	790.21	579.80	287	68.53	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			814.5	C08		5	0348-0584	229.14	583.82	241	58.28	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1655.7	C08		5	0349-0587	20.24	587.47	224	55.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			393.5	C08		5	0350-0596	595.37	596.05	322	69.84	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			446.3	C08		5	0351-0600	354.65	600.31	282	62.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			674.2	C08		5	0352-0608	474.80	606.92	607	102.57	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			310.8	C08		5	0353-0601	167.12	600.87	304	66.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			982.5	C08		5	0354-0609	148.91	609.45	253	61.11	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			693.2	C08		5	0355-0610	719.24	610.32	321	66.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			688.0	C08		5	0356-0610	533.40	608.97	311	69.26	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			721.9	C08		5	0357-0610	187.17	610.71	253	59.70	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			532.5	C08		5	0358-0611	258.04	611.58	267	61.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			406.3	C08		5	0359-0613	805.81	613.19	270	61.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			302.7	C08		5	0360-0613	940.84	612.97	258	63.01	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			605.2	C08		5	0361-0617	413.46	616.96	307	68.08	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1739.3	C08		5	0362-0616	61.84	615.87	222	55.11	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			445.3	C08		5	0363-0614	320.99	615.05	262	61.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			426.3	C08		5	0364-0616	295.85	616.52	265	59.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			522.1	C08		5	0365-0619	385.46	618.83	296	65.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1113.2	C08		5	0366-0620	207.44	620.08	266	60.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3159.7	C08		5	0367-0623	671.13	622.99	256	59.36	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2362.9	C08		5	0368-0624	137.19	624.25	240	57.70	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			406.9	C08		5	0369-0629	444.51	629.51	296	65.94	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1084.9	C08		5	0370-0629	186.09	628.77	271	62.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			889.7	C08		5	0371-0634	897.40	633.89	524	91.64	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			757.7	C08		5	0372-0633	864.86	633.43	286	63.60	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			275.2	C08		5	0373-0634	497.57	633.42	289	62.53	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			465.9	C08		5	0374-0647	794.04	647.11	321	69.50	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			604.9	C08		5	0375-0647	539.38	647.38	241	57.70	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1118.5	C08		5	0376-0649	154.97	648.54	220	54.53	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4575.3	C08		5	0377-0647	646.40	647.40	204	53.11	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1140.1	C08		5	0378-0651	195.60	651.23	248	57.70	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			312.1	C08		5	0379-0652	247.90	652.79	293	63.94	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			905.0	C08		5	0380-0650	817.91	650.42	277	63.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			653.3	C08		5	0381-0648	335.51	648.81	154	48.63	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			530.5	C08		5	0382-0654	433.37	654.60	247	57.94	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3843.8	C08		5	0383-0655	686.50	654.73	395	73.84	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			445.6	C08		5	0384-0656	555.80	656.01	283	64.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			352.2	C08		5	0385-0660	52.60	659.90	289	62.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			605.0	C08		5	0386-0661	313.70	661.95	212	55.70	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4511.3	C08		5	0387-0662	629.58	661.88	213	56.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			560.6	C08		5	0388-0664	337.75	662.55	268	63.01	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			327.6	C08		5	0389-0668	589.42	667.54	275	63.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			618.9	C08		5	0390-0666	147.08	666.75	252	61.60	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			515.2	C08		5	0391-0666	671.76	667.21	262	63.01	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			553.9	C08		5	0392-0669	739.67	669.43	297	65.01	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			632.7	C08		5	0393-0679	330.09	679.10	404	84.57	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5370.2	C08		5	0394-0672	19.02	672.27	225	57.94	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3062.3	C08		5	0395-0674	160.45	674.70	206	54.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1166.2	C08		5	0396-0676	930.18	676.57	245	64.18	0.747
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3352.9	C08		5	0397-0683	405.39	682.87	637	109.54	0.667
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			338.7	C08		5	0398-0675	547.03	675.66	282	63.94	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			313.5	C08		5	0399-0678	284.16	677.62	271	60.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1555.7	C08		5	0400-0680	625.14	680.18	214	55.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			916.6	C08		5	0401-0684	804.27	684.54	262	59.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1159.1	C08		5	0402-0687	751.15	687.58	259	61.94	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1018.0	C08		5	0403-0688	348.96	687.26	159	58.43	0.585
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			342.0	C08		5	0404-0688	897.14	688.21	252	60.77	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			328.4	C08		5	0405-0691	869.78	690.90	275	78.67	0.558
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			920.0	C08		5	0406-0690	205.49	690.05	230	56.53	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1521.7	C08		5	0407-0690	683.30	690.68	230	56.77	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1663.3	C08		5	0408-0693	612.16	693.49	247	58.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			421.1	C08		5	0409-0706	467.36	706.23	279	61.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			606.0	C08		5	0410-0706	549.06	706.22	255	59.01	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			959.6	C08		5	0411-0709	35.80	710.01	288	66.77	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			937.6	C08		5	0412-0708	182.19	708.34	229	56.53	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			412.7	C08		5	0413-0709	233.40	709.62	261	59.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			326.6	C08		5	0414-0710	56.38	709.78	280	65.94	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			654.5	C08		6	0001-0023	416.28	23.63	327	71.01	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			557.6	C08		6	0002-0027	676.92	26.76	287	65.94	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1298.0	C08		6	0003-0027	227.08	26.02	257	69.60	0.667
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			639.6	C08		6	0004-0031	617.58	31.04	275	63.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			558.9	C08		6	0005-0028	846.42	28.00	237	59.94	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			272.9	C08		6	0006-0034	941.60	33.31	301	65.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1858.0	C08		6	0007-0035	54.36	34.91	270	63.70	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			373.3	C08		6	0008-0036	331.47	37.01	311	69.36	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			652.8	C08		6	0009-0047	440.88	47.58	646	109.88	0.672
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3865.4	C08		6	0010-0041	515.00	41.24	407	74.08	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			607.2	C08		6	0011-0044	31.94	44.26	257	62.77	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			329.5	C08		6	0012-0042	91.51	42.05	298	65.26	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			390.6	C08		6	0013-0043	788.36	43.35	291	63.11	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			921.1	C08		6	0014-0043	641.23	43.00	272	64.53	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5167.9	C08		6	0015-0043	838.81	43.77	348	70.77	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4062.9	C08		6	0016-0048	351.26	47.98	345	68.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3497.1	C08		6	0017-0050	557.36	49.98	316	65.84	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1806.9	C08		6	0018-0056	256.61	56.18	262	60.53	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2027.4	C08		6	0019-0060	857.26	60.45	424	84.91	0.739
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			962.4	C08		6	0020-0058	283.61	58.25	216	55.60	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1667.7	C08		6	0021-0057	302.72	56.67	194	53.11	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			732.4	C08		6	0022-0056	466.92	56.20	294	66.18	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1749.4	C08		6	0023-0058	170.81	57.00	285	73.84	0.657
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1539.1	C08		6	0024-0060	224.81	58.82	486	99.40	0.618
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1415.9	C08		6	0025-0071	610.72	70.65	290	64.53	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			466.6	C08		6	0026-0071	707.96	71.26	316	65.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			917.6	C08		6	0027-0070	53.10	70.92	267	65.60	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			365.5	C08		6	0028-0075	520.80	74.96	302	64.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			747.0	C08		6	0029-0075	161.24	74.69	204	55.94	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2607.7	C08		6	0030-0081	905.91	81.12	542	88.57	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2398.1	C08		6	0031-0077	134.01	77.10	233	58.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			998.7	C08		6	0032-0082	18.69	82.46	248	60.18	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			341.2	C08		6	0033-0086	284.39	86.76	297	64.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2282.5	C08		6	0034-0086	173.60	86.45	261	65.36	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2242.9	C08		6	0035-0090	927.11	89.89	390	78.18	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2960.9	C08		6	0036-0092	722.25	92.38	341	69.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			437.3	C08		6	0037-0095	346.33	95.23	319	67.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			361.5	C08		6	0038-0098	391.71	98.21	293	65.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6569.1	C08		6	0039-0096	766.53	96.92	175	49.46	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1163.2	C08		6	0040-0101	64.36	100.97	241	64.28	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			868.4	C08		6	0041-0101	96.92	101.23	221	56.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1009.2	C08		6	0042-0104	835.92	104.70	279	63.60	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			914.4	C08		6	0043-0106	601.66	106.72	274	63.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4736.7	C08		6	0044-0104	916.53	104.14	224	58.18	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			356.2	C08		6	0045-0106	799.62	106.51	315	68.77	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			285.8	C08		6	0046-0108	535.89	108.15	327	66.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			545.9	C08		6	0047-0111	651.77	112.71	282	62.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			303.7	C08		6	0048-0117	34.30	117.20	284	65.60	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2261.0	C08		6	0049-0115	577.40	115.08	245	58.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4412.1	C08		6	0050-0120	617.95	120.33	382	73.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			349.3	C08		6	0051-0118	135.04	118.42	287	70.18	0.732
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3705.6	C08		6	0052-0121	491.85	120.78	273	62.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5814.1	C08		6	0053-0119	376.22	120.22	193	50.87	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3840.6	C08		6	0054-0123	462.38	123.29	262	58.77	0.953
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			862.5	C08		6	0055-0125	853.84	124.76	210	57.60	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3171.9	C08		6	0056-0126	235.33	125.45	140	50.53	0.689
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			609.3	C08		6	0057-0128	680.24	129.14	265	60.18	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			891.2	C08		6	0058-0127	904.54	127.02	257	59.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			290.2	C08		6	0059-0131	40.69	132.16	280	65.60	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1173.7	C08		6	0060-0135	423.61	135.31	289	63.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			353.2	C08		6	0061-0133	716.97	133.81	268	63.70	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5326.3	C08		6	0062-0135	377.72	135.14	202	53.46	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			962.6	C08		6	0063-0142	340.72	141.79	264	63.01	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1421.4	C08		6	0064-0142	817.92	142.04	234	58.43	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			487.8	C08		6	0065-0144	514.97	144.61	291	63.36	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2509.8	C08		6	0066-0144	251.74	145.29	181	56.53	0.712
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2546.1	C08		6	0067-0144	594.22	144.32	242	58.53	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			537.9	C08		6	0068-0147	159.52	146.71	303	67.01	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1909.7	C08		6	0069-0150	764.60	150.14	234	56.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2255.3	C08		6	0070-0158	303.10	158.52	238	57.70	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3105.6	C08		6	0071-0157	888.64	157.38	362	71.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			888.2	C08		6	0072-0157	825.04	157.14	224	57.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5548.4	C08		6	0073-0163	537.54	161.94	332	68.77	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5836.0	C08		6	0074-0157	588.91	158.29	128	42.39	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2107.2	C08		6	0075-0161	614.35	161.31	263	60.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1190.7	C08		6	0076-0162	747.17	161.79	249	58.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3793.7	C08		6	0077-0163	676.84	163.38	424	77.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2090.8	C08		6	0078-0166	166.00	166.54	242	59.11	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2987.7	C08		6	0079-0166	400.03	166.05	225	57.70	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			430.7	C08		6	0080-0169	487.03	168.76	277	62.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			593.9	C08		6	0081-0171	109.83	171.44	282	64.77	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5490.5	C08		6	0082-0172	591.26	172.29	241	63.70	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			347.8	C08		6	0083-0182	835.67	182.33	328	69.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			280.7	C08		6	0084-0184	172.45	184.33	281	65.94	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2996.8	C08		6	0085-0186	705.00	185.93	345	68.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2201.5	C08		6	0086-0187	75.88	187.63	216	56.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			344.3	C08		6	0087-0187	859.67	187.16	303	68.43	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2484.6	C08		6	0088-0188	60.61	188.80	270	61.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5443.1	C08		6	0089-0187	803.04	186.83	178	60.18	0.618
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3641.6	C08		6	0090-0191	672.91	190.78	309	70.18	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			522.7	C08		6	0091-0193	940.32	193.32	259	59.70	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			830.6	C08		6	0092-0198	822.87	198.48	341	74.67	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3259.5	C08		6	0093-0203	625.45	203.38	295	65.84	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			967.3	C08		6	0094-0202	909.82	202.56	250	58.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5887.3	C08		6	0095-0201	807.76	202.00	102	63.01	0.323
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			530.6	C08		6	0096-0206	129.34	206.23	298	64.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			406.2	C08		6	0097-0209	397.85	209.34	257	61.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2766.2	C08		6	0098-0211	432.42	211.02	231	61.11	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1063.4	C08		6	0099-0210	500.04	211.04	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			436.4	C08		6	0100-0210	568.93	209.67	290	63.60	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			340.5	C08		6	0101-0215	215.75	215.14	308	65.01	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1381.2	C08		6	0102-0218	279.31	219.19	265	61.46	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5006.0	C08		6	0103-0222	723.31	222.66	271	62.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			419.5	C08		6	0104-0225	618.20	224.48	300	63.60	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2363.3	C08		6	0105-0229	887.94	229.13	329	68.18	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5405.3	C08		6	0106-0231	59.71	230.72	334	66.77	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			327.5	C08		6	0107-0236	91.16	236.34	285	63.26	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3340.4	C08		6	0108-0237	773.38	237.52	324	67.36	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1219.2	C08		6	0109-0236	279.03	236.04	389	74.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5018.7	C08		6	0110-0236	669.75	236.45	282	62.43	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			407.8	C08		6	0111-0238	343.16	238.63	321	67.84	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			493.0	C08		6	0112-0242	573.88	243.29	297	69.84	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			442.9	C08		6	0113-0244	756.21	244.60	290	66.18	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			567.4	C08		6	0114-0240	940.51	240.31	252	60.77	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			336.9	C08		6	0115-0247	198.46	246.56	301	67.84	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			628.7	C08		6	0116-0247	874.65	247.80	241	57.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			435.7	C08		6	0117-0251	833.26	251.71	322	76.91	0.684
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			467.3	C08		6	0118-0254	386.96	253.92	280	66.67	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			571.4	C08		6	0119-0254	542.86	253.92	303	64.77	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3447.3	C08		6	0120-0252	181.83	252.52	254	61.36	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			533.4	C08		6	0121-0253	560.66	254.21	262	62.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			929.3	C08		6	0122-0256	469.07	255.36	254	64.53	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1778.7	C08		6	0123-0259	334.87	258.49	264	63.70	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			464.7	C08		6	0124-0263	605.14	262.77	302	65.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3849.4	C08		6	0125-0261	147.85	260.95	217	53.46	0.954
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2855.6	C08		6	0126-0264	729.34	264.18	365	74.08	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1810.3	C08		6	0127-0274	797.83	272.58	730	118.71	0.651
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			460.3	C08		6	0128-0265	913.08	265.02	285	63.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1839.9	C08		6	0129-0268	368.30	267.57	260	61.01	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			446.5	C08		6	0130-0271	50.84	271.45	275	64.18	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2375.7	C08		6	0131-0275	466.40	274.78	474	81.26	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			287.4	C08		6	0132-0271	683.27	271.56	311	66.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			508.1	C08		6	0133-0272	566.82	272.48	293	64.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			298.5	C08		6	0134-0285	173.94	285.56	273	63.11	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			398.9	C08		6	0135-0291	636.52	291.53	287	61.36	0.958
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			593.8	C08		6	0136-0297	351.39	296.39	280	67.84	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			685.2	C08		6	0137-0295	554.38	295.52	265	61.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			309.6	C08		6	0138-0295	254.50	295.29	293	65.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			759.2	C08		6	0139-0296	850.40	297.06	334	67.01	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2012.2	C08		6	0140-0298	712.21	299.02	442	94.08	0.627
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			408.8	C08		6	0141-0302	901.12	301.88	321	69.60	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2609.6	C08		6	0142-0301	666.58	301.64	262	59.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			424.5	C08		6	0143-0307	917.49	306.26	335	71.01	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			443.5	C08		6	0144-0311	771.61	312.57	588	94.81	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			641.3	C08		6	0145-0307	375.36	307.73	255	58.77	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			293.8	C08		6	0146-0310	25.03	310.38	279	61.94	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			633.1	C08		6	0147-0312	509.64	311.64	257	60.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5827.1	C08		6	0148-0317	462.42	314.77	271	76.33	0.585
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			656.5	C08		6	0149-0313	945.18	313.34	263	62.87	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			488.8	C08		6	0150-0327	581.53	327.68	325	69.36	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			417.2	C08		6	0151-0323	859.49	323.86	256	63.94	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6281.1	C08		6	0152-0328	930.26	328.02	378	71.36	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			289.4	C08		6	0153-0332	300.21	332.99	315	73.01	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2399.4	C08		6	0154-0332	136.47	332.64	402	73.84	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3495.0	C08		6	0155-0331	741.68	331.35	299	63.36	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			282.2	C08		6	0156-0334	415.15	333.75	322	69.26	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1499.5	C08		6	0157-0336	57.05	335.97	361	70.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			282.5	C08		6	0158-0336	705.21	336.45	327	70.18	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1758.0	C08		6	0159-0337	247.85	337.10	231	57.94	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2425.4	C08		6	0160-0338	873.94	339.03	219	55.80	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			405.7	C08		6	0161-0346	319.24	345.76	246	62.28	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			368.0	C08		6	0162-0347	649.01	347.45	361	70.43	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1383.9	C08		6	0163-0346	262.33	345.89	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			673.2	C08		6	0164-0346	195.54	347.46	207	57.94	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1833.9	C08		6	0165-0349	751.50	349.29	219	55.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2074.6	C08		6	0166-0351	433.65	351.56	202	55.94	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			591.6	C08		6	0167-0355	275.20	356.19	224	54.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			756.1	C08		6	0168-0358	330.88	357.70	234	60.18	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			558.6	C08		6	0169-0358	510.68	358.42	247	66.67	0.698
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2633.3	C08		6	0170-0353	874.29	352.74	227	58.28	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			456.0	C08		6	0171-0360	458.55	360.08	306	69.94	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			584.1	C08		6	0172-0356	782.57	356.41	305	64.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			416.4	C08		6	0173-0359	612.70	359.17	310	65.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			397.1	C08		6	0174-0360	19.86	360.13	273	65.84	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1521.0	C08		6	0175-0362	759.16	362.11	203	55.94	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			235.6	C08		6	0176-0365	107.78	365.12	297	67.36	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			649.6	C08		6	0177-0369	650.63	368.91	309	65.36	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2282.6	C08		6	0178-0368	427.61	368.25	236	56.87	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			414.1	C08		6	0179-0370	895.90	370.77	278	63.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			410.6	C08		6	0180-0371	917.35	371.10	266	62.43	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			729.4	C08		6	0181-0378	630.45	378.26	301	65.60	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1835.1	C08		6	0182-0380	518.18	380.51	214	56.53	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			275.9	C08		6	0183-0380	806.29	380.14	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			403.2	C08		6	0184-0387	132.88	387.35	285	63.94	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			457.1	C08		6	0185-0388	874.32	387.72	253	62.77	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2348.0	C08		6	0186-0391	26.53	391.88	312	65.01	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			378.4	C08		6	0187-0392	680.81	391.79	302	64.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			473.5	C08		6	0188-0400	718.10	399.93	292	65.36	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1634.7	C08		6	0189-0398	935.14	397.83	207	54.53	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			412.0	C08		6	0190-0401	766.60	400.19	271	62.43	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			545.2	C08		6	0191-0399	913.54	399.39	284	62.53	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			459.2	C08		6	0192-0405	563.90	405.58	300	64.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			340.6	C08		6	0193-0411	271.86	410.40	553	103.30	0.651
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			363.2	C08		6	0194-0408	529.67	408.35	277	62.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			547.8	C08		6	0195-0409	753.00	409.86	266	63.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			333.1	C08		6	0196-0412	855.78	412.42	248	60.43	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3885.5	C08		6	0197-0413	71.26	413.34	383	73.36	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			317.8	C08		6	0198-0418	106.82	418.53	319	68.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			402.1	C08		6	0199-0423	452.60	421.94	336	71.01	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			630.2	C08		6	0200-0425	791.00	425.65	290	64.53	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4565.2	C08		6	0201-0424	807.62	423.86	267	62.53	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			810.0	C08		6	0202-0429	398.58	429.08	509	89.74	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			348.4	C08		6	0203-0426	839.61	426.67	230	58.18	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			766.4	C08		6	0204-0424	125.23	424.74	219	57.70	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1654.9	C08		6	0205-0430	238.86	429.93	284	65.01	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			512.5	C08		6	0206-0431	597.16	431.73	291	64.43	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1968.1	C08		6	0207-0432	349.09	432.09	224	57.11	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			476.3	C08		6	0208-0441	207.55	440.41	573	90.33	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1059.1	C08		6	0209-0439	417.80	439.51	276	63.94	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			725.0	C08		6	0210-0442	168.49	442.08	272	60.77	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1523.7	C08		6	0211-0442	623.74	441.87	263	58.53	0.965
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1333.0	C08		6	0212-0442	651.19	442.34	231	56.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			577.5	C08		6	0213-0445	705.41	445.49	224	61.84	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			369.2	C08		6	0214-0443	85.27	443.29	281	64.77	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			262.7	C08		6	0215-0449	263.69	449.21	290	65.84	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4404.7	C08		6	0216-0455	601.71	455.23	403	75.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			566.5	C08		6	0217-0454	928.96	453.89	209	55.11	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2406.3	C08		6	0218-0456	369.96	456.02	224	55.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			468.8	C08		6	0219-0458	284.97	458.20	295	63.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2652.1	C08		6	0220-0459	943.71	459.04	258	60.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			351.0	C08		6	0221-0461	875.56	460.42	304	63.94	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1605.1	C08		6	0222-0459	82.57	458.98	243	58.53	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			414.8	C08		6	0223-0462	308.85	462.86	247	59.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			590.8	C08		6	0224-0467	636.12	467.79	262	65.01	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			527.8	C08		6	0225-0464	133.52	463.37	241	63.36	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			540.1	C08		6	0226-0466	799.00	466.29	240	57.46	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4322.6	C08		6	0227-0467	814.53	466.96	274	63.11	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			378.2	C08		6	0228-0471	698.92	470.94	320	67.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2955.4	C08		6	0229-0472	764.64	471.85	388	74.08	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2115.0	C08		6	0230-0471	216.16	471.88	246	59.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			517.7	C08		6	0231-0474	430.19	473.76	325	70.43	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			439.5	C08		6	0232-0475	125.39	475.45	271	64.77	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			989.6	C08		6	0233-0477	601.43	476.81	257	59.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1545.9	C08		6	0234-0480	543.61	480.42	248	58.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			387.8	C08		6	0235-0485	754.39	485.62	321	69.01	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			366.7	C08		6	0236-0487	833.43	487.54	169	51.94	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3002.7	C08		6	0237-0489	147.26	489.54	262	60.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1229.7	C08		6	0238-0488	520.89	488.47	281	62.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2386.0	C08		6	0239-0489	211.36	489.19	253	59.11	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2206.9	C08		6	0240-0488	260.82	488.71	235	57.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4528.5	C08		6	0241-0491	897.82	492.01	384	73.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			342.3	C08		6	0242-0496	108.89	496.36	258	60.53	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5576.0	C08		6	0243-0498	794.85	497.72	251	66.53	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			373.7	C08		6	0244-0502	61.85	502.04	264	61.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1349.6	C08		6	0245-0501	431.48	500.98	254	61.60	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			364.4	C08		6	0246-0503	937.07	503.41	305	65.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3712.7	C08		6	0247-0505	703.45	504.80	339	68.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6432.3	C08		6	0248-0503	810.14	503.90	196	54.04	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1397.4	C08		6	0249-0506	31.37	506.93	235	57.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1742.9	C08		6	0250-0507	586.64	507.21	243	58.53	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1913.9	C08		6	0251-0508	414.86	507.96	281	63.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2285.1	C08		6	0252-0508	345.69	507.83	243	59.11	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3763.7	C08		6	0253-0512	150.39	512.45	210	52.87	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6526.2	C08		6	0254-0514	456.22	515.05	348	70.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2011.9	C08		6	0255-0516	164.03	515.62	232	59.46	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			395.2	C08		6	0256-0521	826.80	521.72	313	71.01	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			613.3	C08		6	0257-0523	945.53	522.89	229	56.53	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2118.1	C08		6	0258-0526	105.07	526.30	388	72.43	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			353.8	C08		6	0259-0522	268.65	522.06	172	50.87	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1034.7	C08		6	0260-0526	664.33	526.56	233	57.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			353.2	C08		6	0261-0527	250.42	526.89	188	53.11	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			256.4	C08		6	0262-0527	381.97	527.90	304	66.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			530.5	C08		6	0263-0528	611.87	528.20	324	68.43	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1836.2	C08		6	0264-0529	437.19	529.34	264	59.94	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1383.9	C08		6	0265-0535	483.76	535.17	268	63.36	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2725.2	C08		6	0266-0537	901.00	537.63	246	57.60	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			750.8	C08		6	0267-0541	269.74	541.75	257	61.01	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1369.5	C08		6	0268-0544	829.03	543.72	294	66.18	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2180.7	C08		6	0269-0554	41.10	553.69	394	79.60	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			478.1	C08		6	0270-0551	571.25	551.38	298	63.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			387.0	C08		6	0271-0551	62.85	551.76	261	61.26	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			356.4	C08		6	0272-0551	931.25	551.41	306	67.60	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1152.0	C08		6	0273-0553	753.50	553.00	266	60.18	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1867.4	C08		6	0274-0553	869.76	553.40	256	61.11	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3379.4	C08		6	0275-0557	389.14	557.68	305	66.77	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			885.7	C08		6	0276-0558	694.81	558.28	271	61.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2867.4	C08		6	0277-0564	160.05	564.71	337	67.01	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			819.1	C08		6	0278-0566	80.09	565.96	235	59.36	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			417.2	C08		6	0279-0572	425.35	572.97	289	64.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2523.4	C08		6	0280-0571	641.61	572.09	266	60.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1748.3	C08		6	0281-0573	137.07	573.98	236	59.36	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			348.4	C08		6	0282-0573	444.69	573.46	262	61.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1446.3	C08		6	0283-0579	51.66	578.45	330	70.53	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			319.7	C08		6	0284-0579	325.79	579.36	274	62.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1494.6	C08		6	0285-0578	843.81	579.39	334	69.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			884.1	C08		6	0286-0581	120.36	580.63	248	58.28	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			353.2	C08		6	0287-0584	914.41	584.32	316	66.18	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			425.6	C08		6	0288-0586	224.69	586.27	267	61.70	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			395.4	C08		6	0289-0591	744.26	590.33	323	68.18	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1027.5	C08		6	0290-0592	357.62	591.89	378	71.84	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			411.0	C08		6	0291-0589	447.52	589.20	262	62.53	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3374.2	C08		6	0292-0594	397.81	594.55	286	64.77	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			416.9	C08		6	0293-0596	478.63	597.04	265	60.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2280.7	C08		6	0294-0600	548.72	600.30	269	59.70	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1529.4	C08		6	0295-0606	768.79	606.37	348	75.50	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			429.9	C08		6	0296-0608	453.66	607.22	275	63.46	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			231.9	C08		6	0297-0611	871.03	611.29	313	65.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			863.9	C08		6	0298-0613	608.91	612.29	306	66.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			414.3	C08		6	0299-0612	155.25	612.80	258	66.77	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			887.1	C08		6	0300-0616	281.60	616.02	269	61.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3322.1	C08		6	0301-0621	101.66	620.83	457	83.26	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			338.6	C08		6	0302-0616	242.90	616.27	280	64.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			348.0	C08		6	0303-0619	793.31	619.27	289	65.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			290.9	C08		6	0304-0616	35.45	615.89	238	60.18	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			366.9	C08		6	0305-0619	934.38	618.80	234	59.70	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1125.5	C08		6	0306-0622	715.31	622.01	232	56.18	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1792.8	C08		6	0307-0623	490.18	623.40	266	61.60	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			611.2	C08		6	0308-0625	892.09	625.63	320	68.18	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			599.5	C08		6	0309-0627	922.07	627.14	220	57.94	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			295.8	C08		6	0310-0633	652.51	633.11	316	65.84	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			428.9	C08		6	0311-0633	318.81	632.76	239	59.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3536.3	C08		6	0312-0636	362.01	636.69	341	69.84	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			467.8	C08		6	0313-0638	466.43	637.42	320	68.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1403.3	C08		6	0314-0642	67.30	642.39	465	81.84	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2157.9	C08		6	0315-0639	244.92	639.76	419	78.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2711.6	C08		6	0316-0639	559.40	639.37	227	59.01	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1698.7	C08		6	0317-0639	817.75	639.85	284	61.60	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1136.9	C08		6	0318-0646	718.33	646.71	316	71.60	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			910.6	C08		6	0319-0647	754.67	646.84	230	57.60	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1667.1	C08		6	0320-0649	447.54	648.81	246	57.94	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			476.3	C08		6	0321-0652	950.46	652.40	258	59.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4551.4	C08		6	0322-0653	368.94	653.00	209	56.53	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2709.5	C08		6	0323-0657	286.04	657.54	398	75.84	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			363.5	C08		6	0324-0657	420.01	656.43	218	56.77	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			682.0	C08		6	0325-0659	874.28	659.13	245	58.53	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			335.8	C08		6	0326-0659	245.72	659.02	300	66.77	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			322.7	C08		6	0327-0665	617.34	666.04	321	69.84	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			698.9	C08		6	0328-0666	734.34	665.61	289	65.01	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			343.6	C08		6	0329-0670	799.68	670.44	295	71.50	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2265.9	C08		6	0330-0676	165.38	676.19	237	56.77	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1140.4	C08		6	0331-0679	24.32	679.38	222	60.18	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			711.2	C08		6	0332-0679	281.96	678.70	245	63.94	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			441.3	C08		6	0333-0681	852.07	682.12	305	65.36	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			465.0	C08		6	0334-0684	480.38	683.80	293	67.36	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			691.8	C08		6	0335-0683	870.51	683.10	248	62.18	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2228.0	C08		6	0336-0686	518.61	686.26	352	68.77	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			379.4	C08		6	0337-0683	715.86	683.20	246	59.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			449.5	C08		6	0338-0688	230.41	688.88	253	60.18	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			312.5	C08		6	0339-0689	103.32	689.98	231	58.53	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			417.6	C08		6	0340-0693	583.34	693.72	373	76.08	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1568.5	C08		6	0341-0701	163.75	701.44	242	58.28	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1897.9	C08		7	0001-0023	51.83	23.84	298	69.84	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			536.6	C08		7	0002-0026	872.40	25.70	203	61.60	0.672
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1221.0	C08		7	0003-0025	731.35	25.70	305	67.94	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1075.2	C08		7	0004-0031	928.55	31.22	283	66.18	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			531.7	C08		7	0005-0034	824.17	35.30	298	65.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			484.6	C08		7	0006-0035	617.33	35.30	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			944.3	C08		7	0007-0034	356.66	33.84	315	65.94	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			641.8	C08		7	0008-0037	580.19	36.57	282	63.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			284.3	C08		7	0009-0037	316.66	36.54	320	71.60	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3189.7	C08		7	0010-0036	32.18	36.12	266	61.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1095.7	C08		7	0011-0037	90.78	38.03	232	57.70	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1790.6	C08		7	0012-0043	840.82	43.08	252	58.28	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			533.1	C08		7	0013-0044	643.67	43.90	303	65.94	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			325.2	C08		7	0014-0048	19.83	48.94	291	63.60	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			237.9	C08		7	0015-0053	249.97	53.20	305	64.53	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1770.6	C08		7	0016-0055	90.75	55.31	288	65.94	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			615.5	C08		7	0017-0057	556.33	57.88	320	67.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			418.7	C08		7	0018-0057	409.54	57.82	326	68.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			593.2	C08		7	0019-0062	520.71	62.39	288	63.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1270.1	C08		7	0020-0064	837.98	65.31	438	89.84	0.682
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			498.7	C08		7	0021-0061	944.96	60.36	110	42.04	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2048.2	C08		7	0022-0063	177.25	63.58	268	62.18	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			489.8	C08		7	0023-0067	871.06	67.00	240	61.84	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1161.7	C08		7	0024-0064	113.77	64.84	266	63.94	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5720.7	C08		7	0025-0073	730.13	72.18	431	81.01	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5061.7	C08		7	0026-0077	24.61	76.57	208	54.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			489.1	C08		7	0027-0087	684.99	87.09	311	67.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			810.4	C08		7	0028-0087	251.91	87.09	337	69.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			892.7	C08		7	0029-0087	288.99	87.22	286	62.53	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1271.5	C08		7	0030-0097	586.15	96.15	584	110.23	0.604
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			309.8	C08		7	0031-0088	132.75	87.65	315	69.01	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			426.2	C08		7	0032-0087	200.86	87.04	298	64.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			346.2	C08		7	0033-0087	361.81	87.33	303	64.77	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2386.5	C08		7	0034-0091	448.08	91.39	393	77.01	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5579.5	C08		7	0035-0092	17.29	92.61	173	49.94	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			355.7	C08		7	0036-0095	722.59	94.21	265	63.60	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			442.2	C08		7	0037-0100	638.36	99.46	299	66.18	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			750.9	C08		7	0038-0102	816.65	102.78	353	74.08	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1879.4	C08		7	0039-0102	694.93	102.80	276	65.94	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			535.0	C08		7	0040-0106	621.07	106.28	316	67.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			536.4	C08		7	0041-0106	787.14	105.81	284	65.01	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			426.6	C08		7	0042-0108	440.48	108.24	311	67.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			416.4	C08		7	0043-0110	510.10	110.55	295	64.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			663.3	C08		7	0044-0109	766.18	108.84	275	62.53	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			932.7	C08		7	0045-0113	314.83	112.82	264	59.94	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			803.5	C08		7	0046-0115	914.68	115.50	288	63.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1424.8	C08		7	0047-0116	91.75	116.26	293	62.77	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			437.1	C08		7	0048-0117	563.72	117.16	314	65.60	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			320.3	C08		7	0049-0116	351.44	116.42	305	66.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			327.8	C08		7	0050-0123	180.27	122.55	320	70.18	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5238.3	C08		7	0051-0128	251.79	127.33	470	88.57	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			664.3	C08		7	0052-0120	404.21	120.23	270	62.53	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			954.4	C08		7	0053-0122	67.75	122.10	269	60.28	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			641.3	C08		7	0054-0128	728.23	127.56	314	68.43	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2060.5	C08		7	0055-0129	226.70	128.77	264	60.77	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6554.5	C08		7	0056-0130	853.09	130.34	358	69.60	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			624.0	C08		7	0057-0131	893.96	131.48	307	65.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1543.5	C08		7	0058-0133	668.02	134.08	273	64.18	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			687.6	C08		7	0059-0136	10.94	136.29	264	59.11	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			436.8	C08		7	0060-0141	311.82	141.79	298	65.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1105.3	C08		7	0061-0143	141.61	143.51	294	65.01	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			599.9	C08		7	0062-0143	722.81	144.64	318	71.26	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1296.3	C08		7	0063-0147	212.29	146.48	286	63.70	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2096.4	C08		7	0064-0152	192.31	151.77	275	66.18	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			622.5	C08		7	0065-0151	635.38	151.20	336	69.11	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			749.8	C08		7	0066-0160	561.54	160.14	535	98.57	0.692
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			296.1	C08		7	0067-0153	791.77	152.66	322	67.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2906.5	C08		7	0068-0157	417.30	157.18	496	84.08	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			334.9	C08		7	0069-0160	95.47	160.60	301	64.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			266.0	C08		7	0070-0162	816.09	162.44	317	67.01	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			532.0	C08		7	0071-0162	354.78	162.27	283	68.43	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4178.3	C08		7	0072-0166	235.28	166.37	452	78.43	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4411.1	C08		7	0073-0169	947.12	169.62	436	77.50	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2810.1	C08		7	0074-0168	27.73	168.95	257	59.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			685.3	C08		7	0075-0167	650.18	167.83	282	63.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			425.4	C08		7	0076-0170	492.83	170.51	237	58.77	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1063.6	C08		7	0077-0173	187.93	172.95	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			564.5	C08		7	0078-0171	706.65	171.49	311	68.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			683.1	C08		7	0079-0173	366.75	173.55	297	67.01	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			460.4	C08		7	0080-0173	479.10	174.12	130	47.46	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3092.4	C08		7	0081-0174	47.24	175.03	264	60.77	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1524.8	C08		7	0082-0176	425.03	175.77	300	65.60	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			329.7	C08		7	0083-0181	306.37	181.78	380	72.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1311.9	C08		7	0084-0184	131.58	183.79	278	62.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			742.7	C08		7	0085-0185	518.78	185.64	312	65.60	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			419.2	C08		7	0086-0186	549.39	185.57	270	66.08	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			587.5	C08		7	0087-0185	848.61	185.47	297	64.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1611.8	C08		7	0088-0189	673.09	189.38	273	60.53	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2705.6	C08		7	0089-0190	380.05	189.97	274	61.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7703.4	C08		7	0090-0193	99.98	191.93	164	69.26	0.430
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			581.1	C08		7	0091-0192	702.90	192.63	273	60.77	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1654.2	C08		7	0092-0194	628.35	194.17	269	62.18	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4043.0	C08		7	0093-0198	586.04	197.99	258	59.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			818.8	C08		7	0094-0201	417.61	201.11	287	64.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			267.7	C08		7	0095-0201	42.76	201.33	298	66.08	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1532.3	C08		7	0096-0201	872.92	201.31	246	58.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			783.2	C08		7	0097-0202	306.87	201.56	294	63.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5529.6	C08		7	0098-0204	754.31	203.36	420	82.43	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1269.5	C08		7	0099-0203	239.40	202.95	291	63.60	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			323.9	C08		7	0100-0205	436.00	204.90	300	67.01	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1770.9	C08		7	0101-0207	892.77	207.98	246	57.36	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2316.1	C08		7	0102-0213	353.83	213.62	279	61.94	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			730.9	C08		7	0103-0214	850.75	214.10	297	67.01	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			504.7	C08		7	0104-0213	925.26	213.62	261	59.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1620.8	C08		7	0105-0216	140.33	216.11	277	61.60	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			309.6	C08		7	0106-0218	448.62	218.90	296	65.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4072.4	C08		7	0107-0217	547.32	216.90	235	56.53	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			975.9	C08		7	0108-0216	734.27	216.55	278	63.94	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			310.0	C08		7	0109-0222	203.83	221.45	318	67.36	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			332.0	C08		7	0110-0221	314.48	220.98	295	66.67	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			306.1	C08		7	0111-0222	394.80	221.93	308	66.18	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			321.5	C08		7	0112-0220	493.45	219.93	292	65.60	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1495.9	C08		7	0113-0225	124.54	226.17	266	61.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3011.3	C08		7	0114-0229	825.06	229.84	372	72.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			645.8	C08		7	0115-0228	613.49	228.12	286	63.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3034.3	C08		7	0116-0232	560.43	232.21	247	58.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			677.8	C08		7	0117-0229	686.19	229.62	305	68.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			714.6	C08		7	0118-0238	248.32	238.50	299	65.60	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1773.1	C08		7	0119-0243	123.31	242.39	241	58.87	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2059.0	C08		7	0120-0245	676.71	245.31	306	72.77	0.726
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			506.2	C08		7	0121-0250	341.73	250.33	328	67.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			364.4	C08		7	0122-0257	274.37	257.90	311	68.43	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			314.8	C08		7	0123-0259	512.98	259.48	298	67.94	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			658.1	C08		7	0124-0255	86.50	255.95	260	59.11	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			318.1	C08		7	0125-0257	381.59	257.67	288	62.53	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			677.6	C08		7	0126-0261	157.63	261.08	323	67.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			322.6	C08		7	0127-0261	480.12	261.93	293	64.18	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			454.2	C08		7	0128-0261	434.67	261.82	291	64.53	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1329.0	C08		7	0129-0267	177.11	266.96	476	83.84	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			275.3	C08		7	0130-0262	319.73	262.56	312	65.60	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			685.0	C08		7	0131-0262	908.50	262.01	260	61.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			516.6	C08		7	0132-0264	610.11	263.52	277	63.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1750.0	C08		7	0133-0266	633.45	266.54	293	63.94	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3994.5	C08		7	0134-0270	225.67	270.95	303	71.26	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			533.4	C08		7	0135-0275	848.09	274.96	591	103.05	0.699
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2832.9	C08		7	0136-0270	563.50	270.12	245	56.53	0.964
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			584.3	C08		7	0137-0273	923.56	272.85	264	62.28	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			314.5	C08		7	0138-0275	36.30	275.45	296	66.18	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			414.6	C08		7	0139-0276	74.24	275.93	249	65.46	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			734.1	C08		7	0140-0272	710.08	272.03	295	68.18	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5536.9	C08		7	0141-0279	875.73	278.69	210	55.94	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			450.5	C08		7	0142-0280	436.92	279.64	319	66.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2110.2	C08		7	0143-0283	376.15	283.21	297	65.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			330.8	C08		7	0144-0283	791.94	283.20	287	64.77	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2364.4	C08		7	0145-0284	394.43	284.19	285	62.53	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			536.3	C08		7	0146-0287	280.72	287.25	263	60.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4867.7	C08		7	0147-0290	884.23	291.40	239	57.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			445.6	C08		7	0148-0293	518.71	293.39	317	68.08	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			322.0	C08		7	0149-0291	610.49	291.17	303	66.53	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			577.3	C08		7	0150-0292	686.06	292.11	296	68.18	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2659.6	C08		7	0151-0296	263.56	296.73	307	108.71	0.326
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5345.6	C08		7	0152-0297	142.76	296.77	247	58.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2867.4	C08		7	0153-0298	700.97	298.74	265	63.36	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2393.4	C08		7	0154-0299	754.67	298.77	304	65.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3025.0	C08		7	0155-0304	472.50	304.34	414	76.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			302.4	C08		7	0156-0301	564.05	301.27	298	64.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2287.1	C08		7	0157-0305	335.27	304.40	377	72.67	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			700.9	C08		7	0158-0305	293.40	305.22	296	63.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			309.6	C08		7	0159-0303	409.14	303.46	295	64.28	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1467.8	C08		7	0160-0309	742.48	309.82	249	59.84	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			376.0	C08		7	0161-0313	442.94	313.73	318	65.60	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2955.7	C08		7	0162-0318	942.53	318.48	418	76.08	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1998.2	C08		7	0163-0322	870.12	321.84	473	82.43	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			292.2	C08		7	0164-0320	325.90	321.12	282	65.01	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3681.4	C08		7	0165-0318	74.38	317.81	250	58.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1395.1	C08		7	0166-0319	776.38	318.80	223	55.11	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1283.1	C08		7	0167-0321	384.45	321.54	317	67.01	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1063.0	C08		7	0168-0326	801.22	326.23	276	62.53	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4249.1	C08		7	0169-0326	100.75	325.66	233	55.94	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1286.2	C08		7	0170-0328	540.33	328.26	275	61.94	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			389.6	C08		7	0171-0325	618.90	325.47	308	69.11	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1548.1	C08		7	0172-0332	355.64	332.73	326	66.43	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			737.7	C08		7	0173-0333	827.91	332.60	260	61.94	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1223.1	C08		7	0174-0333	59.54	333.52	229	57.94	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			626.8	C08		7	0175-0340	679.98	340.54	324	70.28	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1928.8	C08		7	0176-0341	182.75	341.17	277	67.60	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2144.6	C08		7	0177-0337	234.22	337.39	279	65.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			920.3	C08		7	0178-0341	393.39	341.51	322	67.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			857.0	C08		7	0179-0344	273.12	344.76	273	60.53	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1429.7	C08		7	0180-0347	443.34	347.29	297	69.50	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			553.6	C08		7	0181-0345	903.28	345.78	250	58.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6414.4	C08		7	0182-0349	511.96	349.53	294	97.64	0.388
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			529.8	C08		7	0183-0352	834.55	351.67	322	68.18	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4040.0	C08		7	0184-0351	480.64	350.76	450	82.43	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			537.6	C08		7	0185-0349	596.52	349.28	272	61.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1485.9	C08		7	0186-0351	734.48	350.94	281	62.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			747.0	C08		7	0187-0354	21.01	354.39	300	63.36	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1823.5	C08		7	0188-0357	136.51	357.68	257	62.77	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3299.1	C08		7	0189-0363	277.83	363.11	282	65.36	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			797.3	C08		7	0190-0369	804.38	370.02	353	76.91	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2063.8	C08		7	0191-0370	623.76	369.67	290	63.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			473.5	C08		7	0192-0371	729.37	370.37	299	70.43	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			438.0	C08		7	0193-0371	883.25	370.76	286	62.18	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			429.4	C08		7	0194-0370	421.52	370.61	212	52.87	0.953
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1684.7	C08		7	0195-0373	440.77	372.81	369	71.94	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			453.6	C08		7	0196-0375	244.52	375.02	278	61.36	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			495.7	C08		7	0197-0386	779.94	386.38	519	100.33	0.648
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			572.3	C08		7	0198-0377	71.45	377.30	298	66.53	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			976.5	C08		7	0199-0381	358.69	381.63	304	67.26	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1517.3	C08		7	0200-0384	480.38	383.90	280	62.53	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			323.9	C08		7	0201-0383	594.58	383.38	302	67.36	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			577.5	C08		7	0202-0387	497.35	387.35	255	59.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1525.1	C08		7	0203-0388	159.68	388.14	279	64.18	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			407.7	C08		7	0204-0387	211.60	387.59	296	66.43	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3981.9	C08		7	0205-0389	307.95	388.57	241	57.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1330.8	C08		7	0206-0391	538.00	391.84	277	63.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6699.5	C08		7	0207-0391	340.85	392.48	347	75.50	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			284.9	C08		7	0208-0391	895.57	390.50	309	67.60	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			395.1	C08		7	0209-0392	273.69	392.24	311	66.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			592.3	C08		7	0210-0392	731.74	391.93	291	66.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			464.0	C08		7	0211-0394	685.93	394.07	333	70.43	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2331.4	C08		7	0212-0397	667.40	397.52	258	63.94	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1152.3	C08		7	0213-0399	588.90	399.42	299	66.77	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			452.1	C08		7	0214-0400	944.59	400.47	310	69.01	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			540.5	C08		7	0215-0405	62.74	405.46	318	72.28	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3538.4	C08		7	0216-0403	315.97	403.96	284	64.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5016.6	C08		7	0217-0403	136.00	402.95	262	59.36	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1919.6	C08		7	0218-0405	648.86	405.48	283	64.18	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2034.0	C08		7	0219-0408	242.85	408.79	298	64.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			580.3	C08		7	0220-0407	454.24	407.57	291	63.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			621.7	C08		7	0221-0408	727.38	408.60	319	67.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			577.8	C08		7	0222-0413	806.08	413.94	299	65.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			489.6	C08		7	0223-0413	848.18	413.71	226	57.70	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2447.3	C08		7	0224-0424	158.66	424.24	430	77.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1729.4	C08		7	0225-0426	575.46	425.45	392	95.88	0.536
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			603.4	C08		7	0226-0424	443.56	423.89	283	62.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4136.5	C08		7	0227-0428	70.13	428.66	468	82.77	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			710.7	C08		7	0228-0429	302.95	428.77	307	67.84	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6223.3	C08		7	0229-0433	604.50	433.16	423	82.33	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			958.7	C08		7	0230-0432	651.00	431.62	293	64.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			495.4	C08		7	0231-0429	917.79	429.61	133	42.87	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			408.9	C08		7	0232-0435	902.21	434.55	192	52.18	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			439.4	C08		7	0233-0439	201.66	439.00	288	64.18	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			541.4	C08		7	0234-0441	136.25	440.56	313	66.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			403.3	C08		7	0235-0451	551.08	451.54	738	125.30	0.591
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			396.8	C08		7	0236-0447	733.50	447.24	319	66.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4838.1	C08		7	0237-0448	237.40	448.75	413	75.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			469.7	C08		7	0238-0451	171.67	451.56	290	65.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1298.9	C08		7	0239-0452	50.62	451.91	266	63.94	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			539.4	C08		7	0240-0449	372.36	448.99	256	62.53	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			545.6	C08		7	0241-0451	479.06	451.16	238	58.18	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2651.9	C08		7	0242-0467	133.33	469.17	904	137.10	0.604
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2656.5	C08		7	0243-0458	493.89	458.38	335	69.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			500.1	C08		7	0244-0458	332.53	458.42	279	63.01	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2922.7	C08		7	0245-0460	632.80	460.02	261	66.43	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			552.6	C08		7	0246-0456	274.08	455.57	268	61.70	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			8717.3	C08		7	0247-0458	414.12	457.91	197	52.28	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1405.6	C08		7	0248-0463	79.81	463.03	259	62.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			504.8	C08		7	0249-0468	822.05	468.25	531	87.15	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			8371.0	C08		7	0250-0465	393.47	464.98	215	54.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			320.2	C08		7	0251-0465	800.97	465.27	182	52.04	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1100.7	C08		7	0252-0466	695.06	466.10	242	59.36	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			478.7	C08		7	0253-0468	778.09	468.76	311	67.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			419.5	C08		7	0254-0471	731.50	470.88	306	65.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1230.2	C08		7	0255-0481	682.59	481.48	527	94.08	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			517.1	C08		7	0256-0475	432.38	475.66	298	63.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			348.2	C08		7	0257-0476	888.40	476.51	278	63.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3680.0	C08		7	0258-0476	863.53	476.24	285	64.77	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			623.1	C08		7	0259-0479	615.49	479.10	308	65.84	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			640.9	C08		7	0260-0480	758.16	480.43	318	69.60	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2941.8	C08		7	0261-0489	489.59	489.12	471	81.26	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3462.6	C08		7	0262-0486	905.96	486.58	296	64.18	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			483.0	C08		7	0263-0490	579.07	489.41	186	57.60	0.705
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2260.2	C08		7	0264-0493	259.07	493.34	275	60.77	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1129.3	C08		7	0265-0497	773.89	497.11	282	64.77	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1410.9	C08		7	0266-0497	234.03	496.95	259	58.53	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3272.7	C08		7	0267-0502	658.63	502.20	266	60.18	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			226.0	C08		7	0268-0503	846.58	503.79	333	68.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			600.2	C08		7	0269-0506	122.20	506.82	276	62.53	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			327.8	C08		7	0270-0508	532.58	508.24	317	65.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4670.7	C08		7	0271-0513	340.54	511.95	653	107.40	0.711
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			450.3	C08		7	0272-0511	201.18	511.35	298	66.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			593.1	C08		7	0273-0509	374.99	510.00	260	58.77	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1258.4	C08		7	0274-0514	779.70	514.47	297	65.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			424.5	C08		7	0275-0514	163.92	514.24	276	63.60	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1286.9	C08		7	0276-0515	474.02	515.23	306	64.43	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			369.3	C08		7	0277-0520	285.23	519.48	281	66.43	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			403.7	C08		7	0278-0523	554.66	522.46	299	65.60	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			470.0	C08		7	0279-0527	595.61	527.94	333	69.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			495.7	C08		7	0280-0530	462.19	530.53	273	65.26	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			270.7	C08		7	0281-0531	50.04	531.24	281	65.01	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			351.1	C08		7	0282-0532	83.20	532.26	287	62.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3460.5	C08		7	0283-0538	235.20	538.13	469	80.08	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1627.0	C08		7	0284-0537	720.99	537.06	278	66.43	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			879.4	C08		7	0285-0537	643.63	536.71	328	67.84	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			622.6	C08		7	0286-0536	769.83	536.82	260	64.67	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			489.7	C08		7	0287-0539	187.08	539.05	290	69.50	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			747.3	C08		7	0288-0536	390.77	535.62	261	61.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			397.5	C08		7	0289-0539	914.20	540.18	320	67.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3734.6	C08		7	0290-0544	701.47	543.96	434	77.74	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			709.4	C08		7	0291-0544	12.36	544.12	314	67.84	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2782.3	C08		7	0292-0543	264.67	542.86	258	59.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			944.6	C08		7	0293-0551	298.73	551.61	248	58.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			618.4	C08		7	0294-0551	213.99	551.36	300	65.70	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1162.6	C08		7	0295-0553	929.54	553.86	299	66.18	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			909.4	C08		7	0296-0558	801.50	557.38	377	72.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1182.1	C08		7	0297-0559	382.14	558.96	278	63.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			535.4	C08		7	0298-0561	350.08	560.94	292	64.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			759.1	C08		7	0299-0562	322.63	561.88	258	59.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			430.3	C08		7	0300-0563	518.11	563.04	271	61.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3333.9	C08		7	0301-0564	133.95	564.75	242	57.11	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			436.6	C08		7	0302-0569	241.13	569.70	307	67.01	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1281.5	C08		7	0303-0571	696.96	572.13	336	72.43	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			895.3	C08		7	0304-0571	588.57	571.12	288	63.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4812.7	C08		7	0305-0579	282.97	579.38	397	73.60	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3892.9	C08		7	0306-0585	763.47	587.36	746	117.64	0.677
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			381.6	C08		7	0307-0579	94.84	579.64	289	64.43	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2841.0	C08		7	0308-0576	649.55	576.07	254	59.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			461.9	C08		7	0309-0583	415.09	583.38	302	67.94	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2961.5	C08		7	0310-0583	893.16	583.45	375	71.60	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			713.4	C08		7	0311-0584	615.58	583.79	264	60.77	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			421.0	C08		7	0312-0588	460.21	588.56	306	64.53	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1059.8	C08		7	0313-0591	583.80	591.02	473	82.18	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			813.5	C08		7	0314-0595	538.06	595.67	433	77.01	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1495.3	C08		7	0315-0592	700.27	592.00	281	62.87	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1156.4	C08		7	0316-0599	945.31	598.79	258	64.43	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			721.5	C08		7	0317-0599	353.56	599.04	283	64.04	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4160.4	C08		7	0318-0605	336.14	604.94	412	78.18	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2729.2	C08		7	0319-0602	56.90	602.87	252	59.70	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			773.8	C08		7	0320-0606	399.11	607.57	277	63.11	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			317.3	C08		7	0321-0609	855.32	609.79	272	62.53	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			790.2	C08		7	0322-0613	636.26	612.94	273	64.77	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			401.4	C08		7	0323-0613	936.53	613.28	315	67.84	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3547.8	C08		7	0324-0612	678.10	613.04	256	60.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4431.2	C08		7	0325-0621	104.10	620.20	457	78.43	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1269.6	C08		7	0326-0623	291.51	624.26	627	100.91	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3995.0	C08		7	0327-0629	395.95	629.48	448	79.60	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			396.6	C08		7	0328-0628	572.60	628.89	290	62.77	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			769.5	C08		7	0329-0632	748.01	632.18	289	64.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			579.1	C08		7	0330-0636	776.79	636.68	256	60.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1089.9	C08		7	0331-0640	373.08	640.16	281	62.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1558.8	C08		7	0332-0647	710.25	648.24	283	65.60	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			394.5	C08		7	0333-0651	822.58	651.72	261	61.94	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			375.8	C08		7	0334-0652	204.53	653.05	300	64.18	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			304.2	C08		7	0335-0655	48.52	654.60	298	66.77	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			542.9	C08		7	0336-0658	138.48	657.73	287	62.77	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			404.6	C08		7	0337-0660	500.08	659.81	310	69.36	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			470.3	C08		7	0338-0659	631.58	659.79	261	60.87	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			315.9	C08		7	0339-0663	91.38	663.46	295	63.36	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1133.9	C08		7	0340-0661	302.24	661.91	258	61.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			290.6	C08		7	0341-0665	867.73	665.18	310	67.60	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1129.8	C08		7	0342-0670	424.56	670.17	396	75.84	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3584.8	C08		7	0343-0666	665.60	666.59	260	59.11	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3145.7	C08		7	0344-0668	699.28	668.58	267	61.94	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			367.9	C08		7	0345-0667	566.92	667.45	265	64.53	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2245.3	C08		7	0346-0674	186.53	673.98	438	80.18	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5025.0	C08		7	0347-0677	313.68	677.71	433	78.43	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2004.7	C08		7	0348-0676	807.34	676.26	246	58.18	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			408.6	C08		7	0349-0677	628.99	676.79	257	63.21	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			395.8	C08		7	0350-0679	645.06	678.65	325	71.94	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1227.5	C08		7	0351-0682	946.39	682.20	232	58.53	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3773.8	C08		7	0352-0684	666.11	684.21	246	57.70	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3093.3	C08		7	0353-0687	759.57	688.18	370	71.84	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2933.2	C08		7	0354-0687	736.92	686.21	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			388.2	C08		7	0355-0688	24.13	688.30	298	65.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7087.3	C08		7	0356-0691	252.88	690.83	430	77.26	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			442.0	C08		7	0357-0688	713.65	688.11	263	63.36	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			379.5	C08		7	0358-0693	469.47	692.93	302	67.70	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			520.5	C08		7	0359-0691	123.37	691.78	285	63.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			449.0	C08		7	0360-0698	43.62	698.59	290	65.60	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1176.9	C08		7	0361-0698	939.07	698.25	235	59.36	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			322.1	C08		7	0362-0700	533.23	700.56	301	65.60	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6533.2	C08		7	0363-0702	438.97	702.40	410	75.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			331.1	C08		7	0364-0702	374.62	702.30	278	61.36	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1913.0	C08		7	0365-0705	762.74	705.83	240	58.87	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			406.5	C08		7	0366-0710	613.25	710.49	186	53.36	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			510.5	C08		8	0001-0030	465.68	30.42	295	61.94	0.966
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			735.5	C08		8	0002-0031	547.19	30.38	278	62.18	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2413.4	C08		8	0003-0033	709.44	32.90	255	63.84	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1098.2	C08		8	0004-0033	33.60	33.54	273	64.77	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1062.2	C08		8	0005-0032	180.29	32.17	229	56.53	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7329.8	C08		8	0006-0032	778.32	31.86	180	51.11	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			388.2	C08		8	0007-0033	54.01	33.46	295	67.70	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			502.3	C08		8	0008-0033	231.55	33.54	264	59.11	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			769.1	C08		8	0009-0037	693.47	37.68	251	59.94	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			401.3	C08		8	0010-0039	522.67	38.53	294	65.94	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3812.0	C08		8	0011-0040	792.13	40.86	333	76.91	0.707
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			604.4	C08		8	0012-0042	311.06	41.33	294	65.26	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5723.5	C08		8	0013-0048	380.46	46.13	438	89.84	0.682
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6182.5	C08		8	0014-0045	501.66	45.04	449	78.67	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			612.1	C08		8	0015-0044	660.94	45.37	156	80.91	0.299
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			660.0	C08		8	0016-0054	712.35	54.21	264	66.18	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			786.0	C08		8	0017-0053	742.37	52.85	277	63.84	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			325.0	C08		8	0018-0056	837.09	55.92	164	55.11	0.679
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			555.5	C08		8	0019-0057	860.26	57.03	272	62.18	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			700.6	C08		8	0020-0059	448.63	59.29	134	60.18	0.465
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			563.8	C08		8	0021-0068	67.82	67.59	498	87.50	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1492.5	C08		8	0022-0064	909.20	64.16	300	67.36	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2435.2	C08		8	0023-0062	790.69	61.81	207	52.28	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7468.6	C08		8	0024-0063	121.72	63.89	242	57.36	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			256.3	C08		8	0025-0067	286.68	66.55	297	76.57	0.637
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			380.0	C08		8	0026-0067	591.04	66.94	314	70.77	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			550.4	C08		8	0027-0063	50.38	63.06	108	40.63	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4124.5	C08		8	0028-0074	188.81	72.64	695	116.23	0.647
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			420.7	C08		8	0029-0069	345.83	69.59	243	57.11	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			811.4	C08		8	0030-0071	848.67	70.96	252	61.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			8422.7	C08		8	0031-0073	106.00	73.30	218	58.77	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			582.3	C08		8	0032-0080	165.89	77.84	532	95.36	0.735
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			413.2	C08		8	0033-0075	629.52	75.54	309	69.26	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			326.0	C08		8	0034-0073	932.67	73.63	278	64.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			553.3	C08		8	0035-0074	236.53	74.59	247	59.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1280.2	C08		8	0036-0081	544.67	81.33	299	68.43	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			376.0	C08		8	0037-0087	824.73	86.97	303	67.84	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			504.0	C08		8	0038-0086	481.64	86.30	296	64.67	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			598.3	C08		8	0039-0086	319.20	85.87	282	62.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2046.7	C08		8	0040-0089	665.56	89.80	432	80.67	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7502.5	C08		8	0041-0100	83.83	100.10	294	64.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1108.7	C08		8	0042-0100	227.32	99.74	258	63.36	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1700.6	C08		8	0043-0099	773.95	99.27	234	56.87	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			416.9	C08		8	0044-0100	367.51	100.60	291	65.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2419.4	C08		8	0045-0100	757.50	100.78	259	58.87	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1484.7	C08		8	0046-0108	581.33	108.58	288	65.01	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			414.0	C08		8	0047-0110	902.90	110.16	303	64.18	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			593.7	C08		8	0048-0110	821.66	109.99	266	61.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1754.8	C08		8	0049-0111	720.99	110.99	228	55.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			854.2	C08		8	0050-0117	19.36	117.48	250	58.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2699.8	C08		8	0051-0122	401.85	120.99	617	103.15	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			637.1	C08		8	0052-0117	602.92	117.43	243	58.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			550.5	C08		8	0053-0117	536.09	116.93	268	61.94	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			820.4	C08		8	0054-0123	645.10	123.14	239	57.36	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			706.0	C08		8	0055-0126	433.22	126.58	256	59.36	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			404.0	C08		8	0056-0125	475.67	125.87	307	65.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6575.6	C08		8	0057-0131	104.76	131.71	320	68.43	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			985.0	C08		8	0058-0129	288.05	129.53	218	55.11	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			617.6	C08		8	0059-0135	847.79	134.33	444	84.91	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1446.1	C08		8	0060-0132	811.21	132.13	224	56.63	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			995.1	C08		8	0061-0135	207.21	134.94	252	61.36	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1402.2	C08		8	0062-0138	798.43	138.91	261	64.28	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			287.6	C08		8	0063-0140	527.91	140.89	280	63.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			338.2	C08		8	0064-0142	711.25	142.30	314	70.43	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1097.6	C08		8	0065-0142	375.28	142.34	231	56.28	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			464.8	C08		8	0066-0143	476.59	142.54	270	62.53	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			442.8	C08		8	0067-0148	775.29	148.00	280	62.18	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			288.9	C08		8	0068-0152	124.19	152.91	275	63.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			634.5	C08		8	0069-0148	299.03	147.82	247	59.70	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1551.6	C08		8	0070-0152	814.13	152.03	197	51.70	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2545.7	C08		8	0071-0155	675.60	155.47	270	63.60	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			521.6	C08		8	0072-0155	741.61	154.87	253	59.94	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			312.7	C08		8	0073-0159	614.15	159.31	289	65.70	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4587.4	C08		8	0074-0158	355.70	157.95	353	69.01	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			557.7	C08		8	0075-0158	72.97	157.87	271	61.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			422.6	C08		8	0076-0166	468.52	166.65	303	69.60	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4405.3	C08		8	0077-0171	52.32	171.42	447	79.50	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1035.2	C08		8	0078-0173	161.92	173.06	261	61.36	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			551.6	C08		8	0079-0173	222.76	173.00	257	59.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			384.7	C08		8	0080-0169	397.95	169.91	274	67.94	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			671.2	C08		8	0081-0172	449.89	172.11	212	55.70	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			885.9	C08		8	0082-0176	674.84	176.11	285	66.18	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			771.7	C08		8	0083-0184	538.83	184.41	214	56.53	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			548.6	C08		8	0084-0186	105.76	186.28	271	60.18	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			437.9	C08		8	0085-0190	896.93	190.67	512	89.74	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2314.2	C08		8	0086-0197	328.77	196.94	376	71.60	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			518.7	C08		8	0087-0194	398.31	194.01	237	58.18	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1750.7	C08		8	0088-0198	481.48	198.28	282	64.53	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			354.9	C08		8	0089-0200	669.44	199.84	309	70.18	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			351.2	C08		8	0090-0199	286.00	199.11	279	63.36	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2054.4	C08		8	0091-0199	513.10	198.22	311	69.11	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			292.9	C08		8	0092-0203	773.71	202.19	159	50.18	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			307.2	C08		8	0093-0208	848.75	208.73	304	70.91	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2733.1	C08		8	0094-0208	385.94	208.71	392	80.33	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			337.5	C08		8	0095-0210	762.42	209.98	316	75.74	0.692
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			271.0	C08		8	0096-0210	784.83	210.44	120	41.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			424.1	C08		8	0097-0214	718.57	214.37	222	59.36	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			471.1	C08		8	0098-0215	30.22	215.69	254	59.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			296.3	C08		8	0099-0214	509.59	215.05	284	65.36	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2490.3	C08		8	0100-0221	901.61	221.67	392	74.67	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			398.9	C08		8	0101-0219	401.57	219.53	273	63.01	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			677.2	C08		8	0102-0227	600.21	227.79	229	56.53	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			410.4	C08		8	0103-0228	180.24	228.63	265	62.77	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			336.3	C08		8	0104-0232	123.88	234.13	341	79.26	0.682
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			868.0	C08		8	0105-0230	684.46	229.47	250	59.70	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1033.0	C08		8	0106-0230	821.39	229.68	262	60.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1790.9	C08		8	0107-0228	846.38	228.77	224	55.36	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5008.3	C08		8	0108-0235	216.03	234.74	373	71.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			473.8	C08		8	0109-0233	263.29	233.49	159	47.46	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			507.5	C08		8	0110-0241	702.98	240.60	210	55.94	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3095.2	C08		8	0111-0244	483.81	244.58	343	71.01	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2761.6	C08		8	0112-0247	651.99	247.34	454	81.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			370.4	C08		8	0113-0246	183.27	246.76	242	59.46	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			431.7	C08		8	0114-0247	567.50	246.42	307	65.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			345.3	C08		8	0115-0248	622.51	248.87	293	63.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			568.2	C08		8	0116-0251	64.62	250.71	270	66.67	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			528.3	C08		8	0117-0252	339.09	252.28	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5621.9	C08		8	0118-0252	746.86	252.39	370	71.26	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			632.7	C08		8	0119-0253	909.42	252.76	302	68.18	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			299.2	C08		8	0120-0256	927.02	256.12	338	72.18	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3581.6	C08		8	0121-0257	507.86	257.96	460	79.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			655.1	C08		8	0122-0257	775.18	257.04	242	57.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			484.5	C08		8	0123-0263	113.49	262.03	264	61.26	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			670.1	C08		8	0124-0265	13.44	264.14	247	61.60	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7265.3	C08		8	0125-0266	570.91	266.69	224	54.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1527.7	C08		8	0126-0270	431.50	270.56	276	63.36	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			856.5	C08		8	0127-0271	642.41	271.75	266	63.11	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			532.9	C08		8	0128-0275	28.09	274.67	247	61.36	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			267.3	C08		8	0129-0273	96.59	273.71	293	71.15	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			373.0	C08		8	0130-0278	177.48	278.78	258	61.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			464.8	C08		8	0131-0275	348.47	275.37	282	62.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			404.0	C08		8	0132-0282	790.68	282.00	280	63.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6415.4	C08		8	0133-0280	616.38	280.19	218	54.53	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3952.5	C08		8	0134-0286	411.59	286.65	516	86.43	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			672.0	C08		8	0135-0289	593.91	290.18	522	96.33	0.707
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2063.3	C08		8	0136-0291	657.83	291.43	401	77.60	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			426.8	C08		8	0137-0292	198.52	292.19	254	62.77	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			520.8	C08		8	0138-0291	503.11	291.22	264	61.36	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			578.0	C08		8	0139-0293	169.12	293.03	223	57.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			506.0	C08		8	0140-0296	858.63	296.66	278	65.70	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			401.1	C08		8	0141-0296	473.07	295.39	310	66.43	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3344.8	C08		8	0142-0296	631.22	296.87	243	59.94	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1316.5	C08		8	0143-0300	872.90	300.22	285	64.87	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			557.4	C08		8	0144-0300	97.94	300.00	282	66.18	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			614.9	C08		8	0145-0308	702.25	308.18	503	88.43	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1779.1	C08		8	0146-0309	152.79	309.85	475	88.57	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1677.0	C08		8	0147-0310	280.31	309.79	416	77.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3109.8	C08		8	0148-0310	386.42	309.73	244	58.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			535.2	C08		8	0149-0309	745.08	308.93	281	62.18	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			336.3	C08		8	0150-0315	216.42	314.77	287	65.60	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2953.0	C08		8	0151-0320	47.35	320.46	420	75.26	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3132.7	C08		8	0152-0320	593.64	319.21	252	59.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			482.3	C08		8	0153-0325	528.95	325.66	304	66.77	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			339.9	C08		8	0154-0325	422.95	324.32	285	64.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			242.4	C08		8	0155-0325	910.94	325.64	306	67.84	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1358.8	C08		8	0156-0327	98.64	326.80	373	76.08	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2857.8	C08		8	0157-0326	326.66	326.76	238	58.18	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			270.5	C08		8	0158-0337	772.26	337.59	305	66.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			545.0	C08		8	0159-0341	818.10	341.48	280	65.01	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1278.8	C08		8	0160-0339	871.33	338.94	242	59.11	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			332.7	C08		8	0161-0345	115.39	344.75	275	62.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5414.7	C08		8	0162-0348	525.87	348.58	366	73.84	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			833.1	C08		8	0163-0345	711.92	344.44	249	59.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			410.0	C08		8	0164-0352	559.11	352.20	276	61.94	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			787.2	C08		8	0165-0351	597.71	351.17	268	60.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			717.9	C08		8	0166-0352	682.45	351.91	255	62.77	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			307.0	C08		8	0167-0352	731.46	352.60	283	62.18	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2954.3	C08		8	0168-0359	263.84	359.46	487	88.91	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			727.9	C08		8	0169-0354	210.23	354.93	263	59.60	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			674.8	C08		8	0170-0356	631.68	356.32	268	61.11	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			386.3	C08		8	0171-0356	355.10	356.18	258	59.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1340.8	C08		8	0172-0357	416.89	357.57	307	70.43	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			497.4	C08		8	0173-0357	925.03	357.68	273	61.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			326.7	C08		8	0174-0361	468.53	360.83	292	64.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			646.2	C08		8	0175-0362	649.11	362.38	323	69.60	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3068.1	C08		8	0176-0365	171.66	365.70	227	55.70	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1296.3	C08		8	0177-0365	288.04	365.90	287	67.60	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			798.9	C08		8	0178-0366	59.86	366.56	248	58.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2817.0	C08		8	0179-0380	760.61	380.58	357	70.18	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1160.9	C08		8	0180-0380	811.00	379.21	217	55.01	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			660.8	C08		8	0181-0383	196.62	383.55	280	62.18	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			822.0	C08		8	0182-0384	217.55	384.18	269	61.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6077.8	C08		8	0183-0383	334.32	383.75	119	50.04	0.597
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			485.4	C08		8	0184-0389	824.12	389.42	309	65.11	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			565.9	C08		8	0185-0388	948.43	389.19	264	59.70	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			8868.7	C08		8	0186-0396	578.23	395.14	311	67.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			360.5	C08		8	0187-0396	492.26	397.89	297	69.84	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			370.7	C08		8	0188-0398	874.23	398.40	276	62.77	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5711.2	C08		8	0189-0402	378.12	401.83	338	72.67	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			423.7	C08		8	0190-0397	921.02	397.62	284	63.01	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1470.4	C08		8	0191-0401	295.72	402.10	276	61.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			476.9	C08		8	0192-0402	49.43	402.45	275	65.60	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			811.0	C08		8	0193-0404	558.15	404.14	249	59.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6688.2	C08		8	0194-0404	725.10	404.57	103	63.50	0.321
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1533.1	C08		8	0195-0418	319.07	417.56	255	60.28	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3518.9	C08		8	0196-0418	390.15	417.76	412	76.08	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			406.1	C08		8	0197-0420	245.09	420.66	268	64.43	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5093.9	C08		8	0198-0420	684.61	420.01	187	50.53	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			467.7	C08		8	0199-0423	613.93	423.00	244	58.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			406.1	C08		8	0200-0424	562.83	424.34	275	60.77	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			342.6	C08		8	0201-0426	180.00	427.29	275	63.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3741.7	C08		8	0202-0426	827.92	426.59	247	57.70	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			432.3	C08		8	0203-0432	147.17	431.93	238	57.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			490.0	C08		8	0204-0434	261.57	433.98	293	67.94	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			338.8	C08		8	0205-0437	846.62	437.04	304	67.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			491.5	C08		8	0206-0442	340.32	442.00	273	63.36	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4103.9	C08		8	0207-0440	699.29	439.71	234	55.94	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			701.5	C08		8	0208-0442	417.13	442.32	230	56.28	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2493.2	C08		8	0209-0444	718.59	444.25	348	69.60	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			419.6	C08		8	0210-0444	545.86	444.24	272	61.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			864.1	C08		8	0211-0445	458.64	445.50	258	59.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1890.1	C08		8	0212-0448	868.82	448.96	248	59.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1051.9	C08		8	0213-0449	925.97	448.03	219	57.11	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2580.1	C08		8	0214-0453	372.89	453.38	318	70.67	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			807.0	C08		8	0215-0453	608.77	452.64	278	62.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2728.4	C08		8	0216-0458	565.00	458.24	488	82.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4796.0	C08		8	0217-0461	64.26	460.83	476	83.74	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			546.5	C08		8	0218-0461	387.49	461.48	279	63.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3798.7	C08		8	0219-0460	837.21	459.77	248	58.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			849.6	C08		8	0220-0461	921.28	462.13	248	62.77	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4643.6	C08		8	0221-0462	256.23	461.92	220	54.53	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5154.7	C08		8	0222-0461	282.52	461.62	206	54.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2136.7	C08		8	0223-0463	668.71	463.60	263	64.18	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1442.8	C08		8	0224-0467	319.69	467.01	282	63.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1439.3	C08		8	0225-0464	804.55	463.14	229	56.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			691.6	C08		8	0226-0471	787.93	471.14	285	63.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			588.7	C08		8	0227-0477	149.23	477.60	560	102.57	0.669
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2693.0	C08		8	0228-0474	640.90	473.26	224	54.53	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			510.2	C08		8	0229-0477	425.01	478.02	269	62.18	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1868.2	C08		8	0230-0478	292.01	479.06	271	64.53	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			737.0	C08		8	0231-0481	678.51	481.71	247	59.11	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3748.0	C08		8	0232-0479	711.23	479.80	241	57.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			677.9	C08		8	0233-0479	902.02	479.72	270	60.53	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			681.8	C08		8	0234-0481	941.03	481.25	232	57.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			11937.0	C08		8	0235-0484	211.36	483.62	105	43.11	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			11493.4	C08		8	0236-0487	201.58	488.12	131	48.53	0.699
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			748.7	C08		8	0237-0487	269.16	487.87	231	58.53	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			596.1	C08		8	0238-0489	620.16	488.89	288	65.11	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2849.6	C08		8	0239-0492	554.03	492.40	349	70.67	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1397.1	C08		8	0240-0491	365.53	491.03	225	56.18	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1858.0	C08		8	0241-0500	171.28	499.87	344	68.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			405.4	C08		8	0242-0498	716.02	498.20	226	60.43	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			737.6	C08		8	0243-0497	109.61	497.63	238	59.60	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1758.7	C08		8	0244-0500	238.91	501.10	239	58.87	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1086.1	C08		8	0245-0502	380.62	502.20	268	63.01	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3652.6	C08		8	0246-0507	930.95	506.66	409	77.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			516.1	C08		8	0247-0504	625.16	504.98	238	60.28	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1328.3	C08		8	0248-0503	273.40	503.05	238	58.28	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2213.3	C08		8	0249-0514	89.34	515.12	507	91.15	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			356.8	C08		8	0250-0509	438.00	509.74	255	58.53	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2595.1	C08		8	0251-0510	696.79	510.30	311	66.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			673.2	C08		8	0252-0512	878.28	512.44	244	59.46	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			538.2	C08		8	0253-0514	310.30	513.18	186	51.70	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			466.4	C08		8	0254-0515	201.80	515.64	228	56.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1796.7	C08		8	0255-0517	759.40	516.79	294	64.67	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1128.4	C08		8	0256-0519	811.58	519.44	486	87.98	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			559.0	C08		8	0257-0516	596.04	516.40	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2523.9	C08		8	0258-0520	237.04	519.50	330	71.11	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3422.1	C08		8	0259-0522	253.68	522.36	228	59.11	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			399.2	C08		8	0260-0523	488.73	522.70	295	62.77	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5251.7	C08		8	0261-0524	661.48	523.87	227	55.70	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1853.1	C08		8	0262-0527	742.40	526.95	260	60.43	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			414.9	C08		8	0263-0530	876.58	529.37	283	62.77	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			444.4	C08		8	0264-0532	356.26	532.79	284	62.53	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			958.0	C08		8	0265-0533	279.96	532.58	250	58.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4704.0	C08		8	0266-0533	631.26	533.79	257	59.60	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1590.6	C08		8	0267-0540	312.82	539.80	275	63.11	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4458.4	C08		8	0268-0544	136.31	544.19	542	91.15	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			400.4	C08		8	0269-0542	19.31	542.57	283	65.01	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2925.4	C08		8	0270-0541	710.78	541.56	213	55.11	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			333.9	C08		8	0271-0547	528.35	547.46	266	63.60	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			745.2	C08		8	0272-0547	659.37	547.28	221	55.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			442.5	C08		8	0273-0548	340.98	548.12	299	66.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			880.0	C08		8	0274-0551	158.34	550.80	237	57.70	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6626.7	C08		8	0275-0558	593.14	559.17	376	84.43	0.663
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2954.6	C08		8	0276-0557	882.02	557.74	446	77.60	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1215.3	C08		8	0277-0555	34.35	555.92	277	66.43	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			626.6	C08		8	0278-0558	212.69	558.00	294	64.53	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			621.6	C08		8	0279-0556	618.51	556.04	242	56.53	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2215.4	C08		8	0280-0557	686.65	556.60	238	59.60	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			684.3	C08		8	0281-0560	179.36	560.21	253	62.77	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			851.4	C08		8	0282-0558	246.73	557.92	240	58.77	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2458.3	C08		8	0283-0562	830.98	562.33	447	79.26	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			388.4	C08		8	0284-0566	803.90	565.85	314	66.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			480.7	C08		8	0285-0569	497.77	569.36	276	64.53	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			358.4	C08		8	0286-0567	759.84	567.25	272	63.01	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4401.2	C08		8	0287-0569	119.71	570.06	268	63.94	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			382.3	C08		8	0288-0571	461.61	571.35	266	61.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2562.2	C08		8	0289-0580	59.92	580.69	231	56.87	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3289.4	C08		8	0290-0579	303.55	579.25	251	58.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			664.6	C08		8	0291-0579	624.67	579.37	252	58.53	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1358.2	C08		8	0292-0583	361.19	583.79	256	61.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3621.1	C08		8	0293-0587	654.64	588.15	349	74.33	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			475.2	C08		8	0294-0589	456.73	589.69	307	70.18	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			608.2	C08		8	0295-0586	529.34	586.84	286	61.94	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5396.0	C08		8	0296-0586	117.58	586.24	206	54.97	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3792.6	C08		8	0297-0596	295.90	596.50	237	62.77	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			825.4	C08		8	0298-0593	868.74	593.33	202	51.70	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1183.2	C08		8	0299-0601	50.38	600.85	254	64.43	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4032.1	C08		8	0300-0599	701.52	599.57	413	75.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			349.9	C08		8	0301-0598	843.25	598.26	291	64.67	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2072.5	C08		8	0302-0600	63.45	600.21	210	57.46	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			491.7	C08		8	0303-0602	559.38	602.13	283	63.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			336.8	C08		8	0304-0602	185.08	602.33	240	61.01	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			425.5	C08		8	0305-0601	405.74	600.46	280	65.70	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			508.6	C08		8	0306-0605	120.49	605.06	281	62.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			471.4	C08		8	0307-0607	825.57	607.00	248	58.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			629.2	C08		8	0308-0611	359.21	612.16	250	61.94	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			387.5	C08		8	0309-0610	721.85	609.54	302	65.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2061.3	C08		8	0310-0613	943.88	612.85	291	65.60	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			417.1	C08		8	0311-0615	41.12	614.97	308	69.50	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1190.6	C08		8	0312-0615	239.39	614.86	257	61.70	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2129.2	C08		8	0313-0616	916.21	616.39	283	64.08	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			335.8	C08		8	0314-0618	207.71	618.12	223	60.77	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			375.3	C08		8	0315-0617	761.84	618.20	286	63.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3596.2	C08		8	0316-0618	306.06	618.28	239	56.53	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			312.3	C08		8	0317-0620	588.43	620.73	279	62.43	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1529.7	C08		8	0318-0622	404.32	622.59	304	64.18	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			337.2	C08		8	0319-0629	517.58	629.12	284	63.84	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2081.5	C08		8	0320-0632	459.52	631.89	370	71.84	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2476.7	C08		8	0321-0636	76.39	636.01	364	70.18	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1997.5	C08		8	0322-0637	110.24	637.03	317	65.36	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3493.7	C08		8	0323-0640	879.84	640.53	526	93.74	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1056.3	C08		8	0324-0639	391.61	638.97	319	68.18	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			791.7	C08		8	0325-0643	248.85	643.59	323	70.43	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			328.7	C08		8	0326-0645	505.10	645.84	306	66.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			418.5	C08		8	0327-0645	768.94	645.84	266	62.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1023.2	C08		8	0328-0651	671.28	651.61	246	60.18	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			358.9	C08		8	0329-0653	706.64	652.08	543	92.91	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3655.3	C08		8	0330-0654	300.37	654.17	247	58.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			278.5	C08		8	0331-0656	925.47	655.80	301	68.08	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			387.1	C08		8	0332-0656	362.05	656.09	299	64.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			307.6	C08		8	0333-0658	141.52	658.42	252	70.67	0.634
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			318.8	C08		8	0334-0658	97.64	658.60	267	61.94	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			304.6	C08		8	0335-0662	326.33	662.00	309	69.01	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			282.2	C08		8	0336-0664	412.07	664.33	320	67.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			493.9	C08		8	0337-0663	542.20	662.74	269	62.53	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			665.9	C08		8	0338-0671	679.72	670.55	583	99.98	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			478.7	C08		8	0339-0670	559.96	669.94	306	65.94	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			966.5	C08		8	0340-0671	522.06	670.94	257	60.53	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			427.0	C08		8	0341-0676	839.62	675.96	277	64.43	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			339.5	C08		8	0342-0677	592.10	676.95	301	64.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			575.2	C08		8	0343-0681	426.87	681.11	257	61.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2628.1	C08		8	0344-0680	825.91	680.22	200	55.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			982.8	C08		8	0345-0681	496.51	681.74	226	55.94	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1359.2	C08		8	0346-0684	50.65	684.36	234	58.53	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			424.7	C08		8	0347-0689	254.18	690.21	283	64.43	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2683.3	C08		8	0348-0688	868.57	687.80	244	57.70	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			744.9	C08		8	0349-0690	188.82	689.63	237	57.70	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			674.6	C08		8	0350-0690	937.26	690.82	252	61.11	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			374.7	C08		8	0351-0694	901.66	693.47	276	65.60	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			368.3	C08		8	0352-0701	762.65	700.30	321	72.77	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1281.3	C08		8	0353-0700	43.43	700.32	233	61.01	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			610.4	C08		8	0354-0703	119.57	703.64	249	58.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			502.9	C08		8	0355-0705	520.70	705.43	283	62.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			336.4	C08		8	0356-0706	389.73	707.25	207	55.94	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			333.6	C08		8	0357-0707	328.37	707.55	294	67.70	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1750.4	C08		9	0001-0024	161.85	25.29	246	59.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4146.3	C08		9	0002-0035	665.72	35.66	214	57.11	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4583.9	C08		9	0003-0039	312.75	39.43	433	76.67	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			316.5	C08		9	0004-0037	420.03	37.46	346	69.01	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			676.4	C08		9	0005-0040	374.47	40.18	320	66.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			809.0	C08		9	0006-0045	820.05	45.39	381	73.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			392.3	C08		9	0007-0047	72.02	46.73	268	64.18	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3592.6	C08		9	0008-0049	676.39	49.76	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6007.7	C08		9	0009-0050	207.06	50.12	309	65.01	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			569.7	C08		9	0010-0052	170.76	52.19	245	58.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3334.5	C08		9	0011-0055	511.16	55.20	391	73.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			952.9	C08		9	0012-0055	553.62	56.11	265	61.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			387.2	C08		9	0013-0056	84.67	55.33	253	63.60	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			927.3	C08		9	0014-0060	764.20	59.77	410	76.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1126.7	C08		9	0015-0057	111.31	57.22	247	63.94	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			434.8	C08		9	0016-0063	641.28	63.47	291	67.11	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			426.1	C08		9	0017-0063	618.58	62.86	295	65.70	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			579.1	C08		9	0018-0066	660.27	66.16	281	62.18	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2870.8	C08		9	0019-0065	260.89	65.33	267	59.94	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			588.8	C08		9	0020-0065	919.29	65.62	278	62.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1578.1	C08		9	0021-0068	834.44	67.84	321	68.43	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			370.5	C08		9	0022-0074	466.68	74.75	307	65.11	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			319.1	C08		9	0023-0076	27.12	76.64	262	61.60	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			554.5	C08		9	0024-0077	188.25	77.36	293	67.01	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			532.3	C08		9	0025-0078	237.21	78.41	255	61.01	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			287.6	C08		9	0026-0083	329.86	83.01	316	70.08	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2322.1	C08		9	0027-0090	387.72	90.27	630	94.81	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2148.2	C08		9	0028-0084	822.71	84.46	238	56.77	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			493.2	C08		9	0029-0087	949.16	87.00	283	63.01	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			628.2	C08		9	0030-0088	499.50	88.20	272	61.36	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2653.9	C08		9	0031-0095	273.32	94.68	232	57.60	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			469.5	C08		9	0032-0099	837.52	99.21	297	64.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2496.5	C08		9	0033-0103	732.27	102.56	218	57.36	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1073.4	C08		9	0034-0103	439.24	102.90	295	65.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2746.8	C08		9	0035-0104	717.93	103.97	242	57.70	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1603.6	C08		9	0036-0107	610.82	107.38	251	58.28	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1317.8	C08		9	0037-0108	762.14	108.40	290	63.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			770.6	C08		9	0038-0114	213.27	114.06	257	59.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			353.8	C08		9	0039-0119	68.38	119.09	248	64.87	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3608.5	C08		9	0040-0120	50.66	120.43	362	73.36	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			493.5	C08		9	0041-0121	287.36	120.29	279	61.11	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1331.2	C08		9	0042-0121	647.54	121.67	265	61.11	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			526.4	C08		9	0043-0121	943.79	120.02	245	59.94	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5208.4	C08		9	0044-0122	243.16	121.57	263	83.50	0.474
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			651.3	C08		9	0045-0124	862.97	124.53	312	66.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			827.9	C08		9	0046-0126	496.69	125.44	297	64.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4676.8	C08		9	0047-0131	422.92	130.66	210	55.01	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1071.6	C08		9	0048-0130	383.67	130.77	198	53.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2546.5	C08		9	0049-0133	667.11	133.29	248	58.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			374.0	C08		9	0050-0138	68.40	138.48	334	74.77	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3184.6	C08		9	0051-0142	113.99	141.80	371	73.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			417.4	C08		9	0052-0142	192.16	141.80	284	66.67	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2460.0	C08		9	0053-0140	302.18	140.57	275	62.04	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1081.9	C08		9	0054-0143	433.34	143.34	286	62.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			501.8	C08		9	0055-0141	733.55	141.16	244	57.36	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			608.6	C08		9	0056-0142	885.59	142.48	299	63.84	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			517.2	C08		9	0057-0139	772.04	139.76	219	54.87	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3375.0	C08		9	0058-0145	230.77	145.19	399	73.01	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1529.2	C08		9	0059-0147	345.61	146.60	335	67.84	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2747.9	C08		9	0060-0146	132.54	146.26	261	61.94	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			696.2	C08		9	0061-0159	616.86	156.80	390	84.91	0.680
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			564.1	C08		9	0062-0152	166.12	151.85	223	57.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			721.6	C08		9	0063-0153	634.50	153.00	116	38.97	0.960
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			289.9	C08		9	0064-0156	770.74	155.75	343	68.87	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4033.6	C08		9	0065-0156	449.47	155.91	231	55.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2580.4	C08		9	0066-0156	302.96	155.49	244	60.28	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2318.2	C08		9	0067-0162	490.83	162.58	358	71.26	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2552.3	C08		9	0068-0165	572.41	165.15	422	76.18	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1161.1	C08		9	0069-0166	807.34	166.84	302	69.60	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			698.8	C08		9	0070-0170	532.91	170.34	246	59.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3345.2	C08		9	0071-0173	140.65	173.84	242	57.70	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2646.5	C08		9	0072-0177	414.21	176.85	464	80.67	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			826.2	C08		9	0073-0177	251.09	177.59	287	62.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1444.5	C08		9	0074-0177	660.80	177.44	227	56.53	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			282.8	C08		9	0075-0182	827.81	182.46	333	68.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1483.9	C08		9	0076-0186	396.07	188.05	451	86.67	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1333.5	C08		9	0077-0185	750.71	185.11	320	66.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			440.0	C08		9	0078-0184	456.37	184.52	346	75.84	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			306.3	C08		9	0079-0186	559.50	186.39	310	65.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3489.9	C08		9	0080-0189	116.64	189.13	234	55.94	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			314.1	C08		9	0081-0188	167.35	187.41	309	70.53	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2676.5	C08		9	0082-0191	520.39	190.47	422	77.84	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			369.3	C08		9	0083-0192	77.49	191.97	280	63.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			416.4	C08		9	0084-0193	187.40	192.97	270	61.94	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			272.8	C08		9	0085-0191	902.35	191.72	342	71.11	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2846.6	C08		9	0086-0196	324.22	196.80	336	67.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			569.8	C08		9	0087-0199	842.93	200.02	236	57.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3577.6	C08		9	0088-0210	372.57	210.16	458	81.84	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1086.5	C08		9	0089-0206	233.49	206.79	240	58.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			434.5	C08		9	0090-0207	900.41	206.94	299	67.70	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			419.0	C08		9	0091-0211	734.28	211.95	285	63.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			294.2	C08		9	0092-0214	251.54	213.93	326	72.77	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1734.1	C08		9	0093-0211	773.03	210.77	302	64.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1687.7	C08		9	0094-0219	463.37	219.42	274	64.53	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1796.7	C08		9	0095-0217	682.78	217.22	230	57.36	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			584.2	C08		9	0096-0219	500.76	219.35	234	57.70	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1588.9	C08		9	0097-0222	127.39	221.66	282	63.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			418.5	C08		9	0098-0220	637.31	220.35	277	61.36	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			333.3	C08		9	0099-0221	78.75	221.20	239	62.18	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			917.0	C08		9	0100-0222	206.90	222.08	262	62.18	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			574.8	C08		9	0101-0227	722.82	226.89	261	63.36	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1623.6	C08		9	0102-0224	928.66	223.68	354	71.01	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2994.8	C08		9	0103-0227	522.97	227.72	319	67.36	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3024.4	C08		9	0104-0238	321.22	237.77	481	81.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4686.1	C08		9	0105-0231	741.47	231.83	261	62.87	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3653.5	C08		9	0106-0236	137.63	236.28	389	72.43	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			244.0	C08		9	0107-0237	777.38	237.02	324	69.01	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			282.0	C08		9	0108-0238	853.32	238.03	340	72.08	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			481.0	C08		9	0109-0238	916.87	238.35	294	65.70	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2680.8	C08		9	0110-0240	623.11	240.28	311	65.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			233.5	C08		9	0111-0243	71.18	243.47	298	66.77	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1804.2	C08		9	0112-0247	451.64	247.20	263	59.36	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			717.0	C08		9	0113-0247	227.38	246.53	271	60.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1992.2	C08		9	0114-0252	290.88	251.22	323	68.08	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			442.5	C08		9	0115-0251	178.20	251.43	263	58.53	0.965
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			558.2	C08		9	0116-0252	539.18	251.95	102	77.98	0.211
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			311.7	C08		9	0117-0259	21.87	259.08	306	69.01	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2013.1	C08		9	0118-0257	148.94	257.02	237	57.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2925.9	C08		9	0119-0257	338.39	257.67	235	56.53	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1682.9	C08		9	0120-0259	806.27	259.06	291	63.11	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1326.5	C08		9	0121-0263	711.79	263.00	343	70.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2073.4	C08		9	0122-0264	280.54	265.02	288	64.08	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			624.8	C08		9	0123-0260	430.89	259.94	241	60.53	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			842.0	C08		9	0124-0264	683.93	264.17	260	60.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1578.4	C08		9	0125-0264	875.82	264.11	313	68.18	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1226.4	C08		9	0126-0271	96.00	269.37	542	99.15	0.693
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			602.2	C08		9	0127-0266	851.68	266.28	250	60.18	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1677.4	C08		9	0128-0268	651.45	267.92	241	61.01	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			468.2	C08		9	0129-0269	616.96	268.57	313	66.77	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			385.0	C08		9	0130-0270	215.06	270.05	331	70.18	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			967.9	C08		9	0131-0275	124.19	275.22	276	64.18	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			741.0	C08		9	0132-0276	434.10	275.58	263	61.11	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3409.7	C08		9	0133-0277	320.08	277.26	241	59.36	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			718.5	C08		9	0134-0281	232.65	281.28	261	61.11	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3869.1	C08		9	0135-0284	345.92	284.36	258	59.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			379.9	C08		9	0136-0289	67.16	289.77	297	68.18	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			709.0	C08		9	0137-0288	931.47	288.01	293	65.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			839.0	C08		9	0138-0291	169.84	291.45	302	65.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			476.6	C08		9	0139-0293	132.68	292.15	267	64.53	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			372.9	C08		9	0140-0292	731.38	291.66	311	69.60	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1805.7	C08		9	0141-0299	107.70	299.35	444	81.84	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1874.0	C08		9	0142-0298	434.80	298.10	239	56.53	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1616.6	C08		9	0143-0303	239.39	302.15	539	92.91	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			474.9	C08		9	0144-0300	377.66	300.14	294	64.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2924.1	C08		9	0145-0302	549.83	302.46	337	66.77	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			382.1	C08		9	0146-0301	764.47	301.35	306	65.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			351.0	C08		9	0147-0309	392.37	309.45	358	77.36	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4823.8	C08		9	0148-0309	347.42	309.38	218	60.28	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			708.3	C08		9	0149-0310	896.98	310.50	288	62.18	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2484.3	C08		9	0150-0311	577.44	310.83	300	63.36	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3195.8	C08		9	0151-0312	216.08	312.50	255	60.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			310.9	C08		9	0152-0314	494.42	314.03	302	69.26	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1207.3	C08		9	0153-0316	284.47	316.16	255	61.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1167.4	C08		9	0154-0318	168.21	318.26	221	53.94	0.954
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4778.6	C08		9	0155-0317	772.86	317.30	215	55.11	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			464.5	C08		9	0156-0326	316.42	327.16	303	68.43	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			813.6	C08		9	0157-0329	100.11	329.05	280	63.01	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			677.5	C08		9	0158-0328	399.84	329.06	255	61.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			385.2	C08		9	0159-0331	473.65	331.97	309	69.94	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			474.0	C08		9	0160-0335	827.11	334.40	269	65.01	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			448.7	C08		9	0161-0334	653.21	334.08	294	63.94	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2460.9	C08		9	0162-0337	158.65	337.24	315	66.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			693.2	C08		9	0163-0339	906.65	338.05	301	66.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6723.8	C08		9	0164-0341	280.12	341.05	159	46.87	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			628.0	C08		9	0165-0346	405.37	345.82	260	64.53	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1859.1	C08		9	0166-0346	501.49	346.23	253	57.94	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1034.9	C08		9	0167-0349	610.54	349.77	277	61.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			575.5	C08		9	0168-0351	141.79	350.62	239	59.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7589.2	C08		9	0169-0351	658.83	350.93	212	54.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6234.4	C08		9	0170-0350	285.21	350.41	164	53.70	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4571.9	C08		9	0171-0356	820.54	356.82	457	79.50	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1199.9	C08		9	0172-0356	448.40	356.50	293	63.26	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1763.8	C08		9	0173-0355	476.70	354.62	261	60.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			362.4	C08		9	0174-0357	577.40	356.95	299	68.77	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3466.5	C08		9	0175-0358	238.80	359.38	238	58.18	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1984.3	C08		9	0176-0357	419.39	357.22	250	59.70	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			369.4	C08		9	0177-0361	555.88	361.12	311	71.01	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			822.8	C08		9	0178-0361	65.88	360.72	247	58.18	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			474.7	C08		9	0179-0361	19.97	360.70	264	61.11	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			480.7	C08		9	0180-0361	132.83	362.58	260	61.84	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			343.2	C08		9	0181-0364	345.75	364.55	320	67.84	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4119.6	C08		9	0182-0362	689.31	362.03	220	55.11	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3942.8	C08		9	0183-0365	192.24	365.31	356	69.60	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1280.3	C08		9	0184-0369	298.99	368.75	288	61.36	0.961
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			316.6	C08		9	0185-0376	361.42	376.48	319	71.11	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6466.0	C08		9	0186-0374	649.12	373.54	234	59.11	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			410.7	C08		9	0187-0380	597.95	380.23	274	64.18	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3583.2	C08		9	0188-0380	707.53	380.45	241	58.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3763.4	C08		9	0189-0381	678.68	381.16	240	57.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			862.3	C08		9	0190-0381	225.76	381.28	250	57.94	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			482.8	C08		9	0191-0383	756.09	383.91	241	59.94	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2925.4	C08		9	0192-0391	779.07	391.01	340	72.67	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2691.6	C08		9	0193-0390	799.10	391.04	245	59.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			330.4	C08		9	0194-0392	89.33	392.36	270	62.18	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			593.9	C08		9	0195-0391	43.24	392.06	257	60.53	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			370.6	C08		9	0196-0395	609.25	395.53	320	67.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4251.8	C08		9	0197-0393	699.56	393.71	208	55.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			383.6	C08		9	0198-0400	15.94	400.42	270	60.18	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			784.2	C08		9	0199-0400	309.65	400.91	265	59.36	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			696.2	C08		9	0200-0400	833.98	400.08	295	62.53	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			441.5	C08		9	0201-0407	902.30	406.64	274	62.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			357.5	C08		9	0202-0412	521.72	412.19	305	67.94	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			690.4	C08		9	0203-0408	697.46	408.03	236	57.11	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3021.8	C08		9	0204-0421	330.18	420.87	469	82.57	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3258.5	C08		9	0205-0416	730.08	415.55	217	55.36	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			572.2	C08		9	0206-0421	857.42	421.28	284	64.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			925.3	C08		9	0207-0424	657.84	423.98	250	59.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			600.4	C08		9	0208-0430	96.02	429.79	282	62.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			452.5	C08		9	0209-0430	53.43	430.31	184	59.36	0.656
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			498.6	C08		9	0210-0429	272.80	429.35	252	63.70	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3210.5	C08		9	0211-0436	937.67	435.69	355	72.18	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			661.9	C08		9	0212-0434	404.28	434.71	268	60.53	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1499.4	C08		9	0213-0434	221.85	434.00	235	56.53	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5070.1	C08		9	0214-0437	835.72	437.04	437	77.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			409.6	C08		9	0215-0433	741.32	433.53	271	64.28	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1349.1	C08		9	0216-0441	183.31	440.67	278	63.36	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			645.8	C08		9	0217-0445	118.89	445.84	253	59.94	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			367.3	C08		9	0218-0445	276.34	444.55	334	71.01	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5285.7	C08		9	0219-0446	568.93	446.43	359	69.60	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1121.6	C08		9	0220-0450	509.86	450.39	295	67.26	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			994.9	C08		9	0221-0451	20.54	450.78	221	57.11	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			635.5	C08		9	0222-0451	92.12	451.47	252	58.53	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			856.0	C08		9	0223-0455	199.91	454.64	259	58.87	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			659.2	C08		9	0224-0457	140.99	457.34	266	61.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			325.9	C08		9	0225-0458	292.70	459.22	301	65.50	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			805.8	C08		9	0226-0464	16.19	464.87	249	61.70	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7423.8	C08		9	0227-0466	246.15	466.00	365	69.84	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2376.9	C08		9	0228-0465	774.80	465.10	224	57.11	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3275.9	C08		9	0229-0473	845.32	474.29	456	80.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2728.7	C08		9	0230-0473	943.11	472.67	290	64.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			630.3	C08		9	0231-0474	586.90	473.65	236	56.77	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			811.1	C08		9	0232-0477	117.41	476.98	231	56.53	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1442.1	C08		9	0233-0479	533.86	479.51	256	61.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1352.8	C08		9	0234-0477	780.99	477.30	204	56.87	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1248.4	C08		9	0235-0486	732.95	485.44	478	90.33	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			702.3	C08		9	0236-0484	35.89	484.22	231	57.36	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			545.3	C08		9	0237-0489	799.12	490.26	263	62.53	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4025.6	C08		9	0238-0492	865.20	491.40	373	74.08	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1787.1	C08		9	0239-0491	170.18	491.71	244	57.70	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			337.5	C08		9	0240-0494	360.13	494.65	280	61.11	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			756.9	C08		9	0241-0496	397.72	496.43	237	57.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			910.0	C08		9	0242-0497	709.02	498.02	186	53.36	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			628.6	C08		9	0243-0501	889.82	500.72	276	63.01	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4327.2	C08		9	0244-0501	745.35	500.87	258	59.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3668.0	C08		9	0245-0509	25.61	509.50	411	76.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1322.7	C08		9	0246-0506	187.12	506.63	263	64.18	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			674.2	C08		9	0247-0508	630.19	507.52	302	65.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			551.3	C08		9	0248-0509	793.51	508.92	295	66.53	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4394.2	C08		9	0249-0513	765.22	513.46	253	60.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1589.5	C08		9	0250-0515	427.69	515.11	257	60.53	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			455.8	C08		9	0251-0520	600.81	520.37	291	64.43	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			688.5	C08		9	0252-0521	190.24	520.79	236	61.94	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1115.7	C08		9	0253-0526	312.34	526.57	272	63.26	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4847.2	C08		9	0254-0523	382.37	523.68	259	60.87	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			357.6	C08		9	0255-0532	900.91	532.53	282	61.60	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			421.3	C08		9	0256-0534	743.07	534.31	283	63.60	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			518.2	C08		9	0257-0536	72.15	535.68	229	58.18	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1302.4	C08		9	0258-0536	345.34	536.25	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			957.2	C08		9	0259-0541	115.02	540.89	231	57.11	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4580.0	C08		9	0260-0541	388.16	540.96	250	62.04	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			870.6	C08		9	0261-0544	146.31	544.72	261	59.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4326.0	C08		9	0262-0550	208.62	549.77	372	71.01	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			413.2	C08		9	0263-0549	530.58	548.82	256	59.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			558.1	C08		9	0264-0552	65.45	553.53	305	69.74	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1073.9	C08		9	0265-0551	462.86	551.05	255	61.36	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			636.2	C08		9	0266-0558	187.19	558.95	291	65.11	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			601.4	C08		9	0267-0560	131.96	560.28	266	60.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1141.8	C08		9	0268-0560	300.81	559.95	236	57.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			316.9	C08		9	0269-0562	939.43	562.66	339	69.60	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			471.1	C08		9	0270-0563	49.26	563.13	288	64.18	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			537.5	C08		9	0271-0564	85.36	565.00	271	66.43	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2511.8	C08		9	0272-0566	339.62	565.46	310	65.36	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			536.6	C08		9	0273-0569	464.96	569.44	300	63.36	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			338.8	C08		9	0274-0575	736.81	575.78	288	64.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			522.7	C08		9	0275-0577	412.79	577.08	301	67.36	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			393.0	C08		9	0276-0584	694.25	583.79	271	64.53	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			505.7	C08		9	0277-0583	193.20	583.45	294	65.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			643.7	C08		9	0278-0588	385.14	587.73	347	73.36	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			243.6	C08		9	0279-0589	72.04	589.28	271	63.70	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2770.0	C08		9	0280-0593	212.91	593.17	300	64.53	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1206.3	C08		9	0281-0595	369.24	595.55	270	63.94	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			354.9	C08		9	0282-0597	146.27	597.00	301	64.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			554.8	C08		9	0283-0600	756.21	600.54	250	60.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			464.4	C08		9	0284-0609	524.75	609.24	263	60.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2190.0	C08		9	0285-0616	38.28	615.69	283	63.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			407.3	C08		9	0286-0619	933.03	619.84	281	62.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3197.8	C08		9	0287-0622	196.88	622.44	282	62.87	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			315.0	C08		9	0288-0623	881.73	623.66	287	62.77	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			423.1	C08		9	0289-0627	467.98	627.32	335	68.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			386.4	C08		9	0290-0632	89.86	632.14	284	64.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1360.2	C08		9	0291-0637	150.45	637.26	292	63.36	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3144.7	C08		9	0292-0649	202.97	648.00	683	104.33	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3539.3	C08		9	0293-0648	124.90	648.49	260	61.36	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			379.0	C08		9	0294-0651	511.67	651.43	319	67.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			550.1	C08		9	0295-0651	69.79	650.22	248	61.36	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			556.5	C08		9	0296-0650	744.16	649.99	267	60.53	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2737.0	C08		9	0297-0650	263.16	650.76	250	60.53	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			241.0	C08		9	0298-0659	19.67	658.90	268	63.60	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			310.0	C08		9	0299-0665	66.46	665.98	267	64.77	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			711.1	C08		9	0300-0668	184.98	667.40	248	60.77	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2854.6	C08		9	0301-0666	264.82	665.46	286	72.77	0.679
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3596.2	C08		9	0302-0671	207.75	671.46	339	71.94	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			423.1	C08		9	0303-0668	387.01	668.37	303	66.43	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			316.1	C08		9	0304-0669	475.83	669.81	291	64.77	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			341.9	C08		9	0305-0673	781.40	673.09	311	67.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4182.9	C08		9	0306-0675	172.35	675.41	223	57.70	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			405.3	C08		9	0307-0677	111.57	677.69	283	61.36	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2265.8	C08		9	0308-0683	936.29	683.92	458	86.43	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1363.7	C08		9	0309-0678	251.31	678.44	264	60.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3839.4	C08		9	0310-0684	140.58	684.18	241	63.11	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4434.5	C08		9	0311-0690	321.34	691.53	581	89.74	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1228.3	C08		9	0312-0689	360.96	689.61	257	60.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			708.0	C08		9	0313-0693	31.45	693.71	260	61.70	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1049.1	C08		9	0314-0695	888.76	694.75	257	61.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			344.9	C08		9	0315-0695	57.33	695.07	272	64.18	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1891.8	C08		9	0316-0699	199.59	698.64	226	56.67	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			331.7	C08		9	0317-0702	750.25	702.11	297	63.60	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2300.7	C08		9	0318-0703	950.13	704.06	183	53.70	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1853.9	C08		9	0319-0704	937.61	703.39	120	41.56	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			996.1	C08		9	0320-0707	214.24	708.02	262	62.18	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			579.5	D08		1	0001-0031	502.05	32.10	433	78.91	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			500.0	D08		1	0002-0035	683.37	35.30	402	74.43	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1243.4	D08		1	0003-0039	168.05	39.26	489	82.67	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			350.3	D08		1	0004-0037	106.24	37.36	378	72.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2190.5	D08		1	0005-0049	326.88	48.58	751	107.30	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1404.7	D08		1	0006-0044	231.54	43.76	386	72.67	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			687.6	D08		1	0007-0053	916.42	53.65	703	101.50	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			458.7	D08		1	0008-0051	573.73	51.36	507	86.18	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			604.1	D08		1	0009-0051	450.99	50.66	464	82.91	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			327.6	D08		1	0010-0054	799.48	53.77	390	77.26	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			467.5	D08		1	0011-0059	633.85	59.36	412	77.50	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			385.0	D08		1	0012-0069	747.78	68.50	777	107.05	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			456.1	D08		1	0013-0069	470.40	69.42	494	89.26	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			839.8	D08		1	0014-0072	394.62	72.16	441	76.43	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			437.6	D08		1	0015-0074	600.83	74.82	443	84.08	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			529.7	D08		1	0016-0076	493.85	76.67	503	87.60	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			379.8	D08		1	0017-0075	232.83	75.37	381	73.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			347.3	D08		1	0018-0075	574.54	74.86	434	79.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			353.1	D08		1	0019-0079	724.21	79.27	424	78.08	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			305.4	D08		1	0020-0082	109.11	82.07	363	71.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1887.2	D08		1	0021-0086	26.13	85.99	531	87.50	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			478.7	D08		1	0022-0086	935.26	86.56	381	73.50	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			326.9	D08		1	0023-0096	306.50	96.09	417	79.36	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			425.6	D08		1	0024-0106	533.49	106.01	807	108.23	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			297.9	D08		1	0025-0101	285.13	101.97	407	79.01	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			385.4	D08		1	0026-0103	635.68	103.29	852	117.54	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			369.5	D08		1	0027-0105	186.52	104.86	373	75.26	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			442.9	D08		1	0028-0108	789.69	108.23	359	73.60	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			873.9	D08		1	0029-0112	834.07	111.51	371	73.01	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			396.2	D08		1	0030-0113	391.56	113.78	401	74.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			498.0	D08		1	0031-0115	699.70	115.21	399	75.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			433.9	D08		1	0032-0123	159.83	123.97	830	116.37	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			457.7	D08		1	0033-0117	446.57	117.74	434	79.50	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			341.7	D08		1	0034-0120	612.49	120.72	422	79.15	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			536.4	D08		1	0035-0121	926.26	121.01	392	72.18	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			626.9	D08		1	0036-0123	73.44	123.49	376	71.01	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			289.1	D08		1	0037-0126	735.15	126.18	452	81.26	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1176.4	D08		1	0038-0134	420.57	133.51	950	125.88	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			300.8	D08		1	0039-0128	783.39	127.59	449	85.26	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5215.1	D08		1	0040-0144	506.95	143.84	677	95.50	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			406.0	D08		1	0041-0143	905.12	143.51	392	73.60	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			735.4	D08		1	0042-0142	824.88	142.30	383	75.26	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			435.1	D08		1	0043-0146	297.25	145.43	396	74.08	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			369.2	D08		1	0044-0158	642.35	158.75	393	74.67	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			458.2	D08		1	0045-0159	714.83	158.98	388	76.67	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2223.2	D08		1	0046-0164	277.35	164.21	729	105.05	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			370.9	D08		1	0047-0160	227.30	159.90	390	76.08	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			548.6	D08		1	0048-0166	117.67	165.95	373	72.67	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			408.8	D08		1	0049-0166	578.16	166.33	390	74.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			352.5	D08		1	0050-0180	678.45	180.31	399	78.33	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			488.5	D08		1	0051-0179	809.52	179.24	398	73.84	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			286.6	D08		1	0052-0180	338.38	179.91	418	81.01	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			311.6	D08		1	0053-0181	167.78	181.14	400	75.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			424.7	D08		1	0054-0182	444.35	182.31	382	73.84	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			259.5	D08		1	0055-0187	316.80	187.46	409	78.77	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			291.1	D08		1	0056-0187	207.94	187.03	397	77.50	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			383.3	D08		1	0057-0194	513.29	194.35	400	73.26	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			675.5	D08		1	0058-0197	940.92	197.02	399	76.43	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			286.1	D08		1	0059-0199	37.04	199.58	382	73.84	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			928.6	D08		1	0060-0209	253.78	208.26	925	123.78	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			304.2	D08		1	0061-0198	887.77	198.92	427	75.84	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			490.9	D08		1	0062-0199	798.35	199.86	390	73.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			341.1	D08		1	0063-0201	719.56	201.34	398	76.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3099.5	D08		1	0064-0206	71.18	205.95	602	90.91	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			440.1	D08		1	0065-0204	764.36	204.33	390	73.26	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6970.4	D08		1	0066-0207	562.41	208.31	379	75.94	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			337.3	D08		1	0067-0213	135.78	212.78	380	75.50	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			289.4	D08		1	0068-0221	927.57	220.99	385	72.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			732.1	D08		1	0069-0227	202.54	226.91	603	97.98	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			404.6	D08		1	0070-0224	615.97	224.41	409	76.67	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			428.7	D08		1	0071-0224	851.76	224.07	404	75.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2224.4	D08		1	0072-0232	271.35	234.30	725	103.78	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			329.1	D08		1	0073-0227	357.51	227.54	399	78.33	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			421.1	D08		1	0074-0229	482.77	228.83	357	74.18	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5738.7	D08		1	0075-0229	563.89	228.90	504	88.77	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			605.9	D08		1	0076-0238	890.09	239.12	727	104.13	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2472.8	D08		1	0077-0237	506.66	236.92	730	101.50	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			456.1	D08		1	0078-0240	540.09	240.67	552	94.91	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			959.4	D08		1	0079-0236	136.86	236.60	377	74.18	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1168.1	D08		1	0080-0242	58.13	242.18	440	77.84	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			323.4	D08		1	0081-0256	20.39	256.84	381	76.08	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			320.7	D08		1	0082-0258	459.44	258.25	392	73.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			367.1	D08		1	0083-0259	112.01	259.70	374	75.26	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			370.4	D08		1	0084-0271	746.54	271.87	414	75.60	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			476.7	D08		1	0085-0273	854.96	273.67	395	74.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			530.8	D08		1	0086-0279	180.41	278.30	384	73.01	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			406.2	D08		1	0087-0280	697.87	280.13	419	78.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			295.9	D08		1	0088-0281	315.70	280.31	405	76.67	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			253.0	D08		1	0089-0282	813.95	282.55	410	77.26	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			236.8	D08		1	0090-0287	936.07	287.70	382	73.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			343.9	D08		1	0091-0289	296.01	290.63	412	80.67	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			479.3	D08		1	0092-0294	641.46	293.41	420	77.26	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			545.7	D08		1	0093-0299	840.45	299.21	344	68.18	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			531.1	D08		1	0094-0300	899.82	300.36	385	72.43	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1342.1	D08		1	0095-0304	436.31	304.50	925	116.23	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			382.6	D08		1	0096-0303	219.20	302.97	382	71.60	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			392.8	D08		1	0097-0306	109.51	306.11	396	77.26	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			616.3	D08		1	0098-0310	175.48	310.67	613	96.81	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			452.4	D08		1	0099-0305	37.12	304.96	376	74.08	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			568.8	D08		1	0100-0309	549.31	309.07	383	71.60	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			350.9	D08		1	0101-0319	681.97	319.46	401	75.01	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			275.6	D08		1	0102-0319	393.65	319.13	386	73.84	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			501.7	D08		1	0103-0327	934.12	327.39	370	71.26	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			381.5	D08		1	0104-0333	774.77	333.03	392	73.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			383.3	D08		1	0105-0333	582.47	333.28	913	135.05	0.629
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			577.2	D08		1	0106-0336	729.96	335.83	392	73.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			387.7	D08		1	0107-0340	823.92	339.51	324	70.33	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			492.2	D08		1	0108-0344	144.33	344.39	395	74.08	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			474.6	D08		1	0109-0345	180.49	344.57	405	77.50	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			295.5	D08		1	0110-0347	37.82	347.41	374	73.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			362.8	D08		1	0111-0354	298.60	353.98	743	108.13	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			316.1	D08		1	0112-0351	352.83	351.52	398	74.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			401.6	D08		1	0113-0354	106.35	354.35	382	73.84	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1424.1	D08		1	0114-0357	622.14	357.04	652	97.98	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			447.7	D08		1	0115-0365	201.37	366.55	896	121.98	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			496.4	D08		1	0116-0370	707.79	370.13	433	79.50	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2022.8	D08		1	0117-0373	644.17	373.30	598	93.74	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5717.7	D08		1	0118-0373	567.86	374.36	591	92.18	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1448.0	D08		1	0119-0382	920.26	382.67	916	122.23	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2516.6	D08		1	0120-0375	771.27	375.83	427	77.50	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			861.1	D08		1	0121-0381	879.09	380.59	377	71.84	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			780.6	D08		1	0122-0383	134.35	382.33	377	72.91	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			307.8	D08		1	0123-0388	404.24	388.60	396	75.26	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			470.8	D08		1	0124-0397	151.05	397.56	433	81.15	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			545.8	D08		1	0125-0400	578.04	398.64	909	124.47	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			306.0	D08		1	0126-0397	686.35	397.94	414	75.84	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2639.8	D08		1	0127-0402	757.16	401.49	427	78.67	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			373.3	D08		1	0128-0407	603.82	407.99	414	77.74	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			317.9	D08		1	0129-0416	320.94	415.48	832	111.64	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			621.9	D08		1	0130-0412	201.41	411.91	398	75.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			534.8	D08		1	0131-0412	876.19	412.31	396	74.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			298.7	D08		1	0132-0420	769.40	420.86	452	86.91	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2313.8	D08		1	0133-0428	492.31	428.55	399	75.84	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			295.3	D08		1	0134-0433	432.61	433.37	389	73.84	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			404.2	D08		1	0135-0433	655.07	433.40	396	74.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			283.5	D08		1	0136-0446	370.45	445.64	871	123.88	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			313.5	D08		1	0137-0443	99.12	443.74	373	70.43	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			323.2	D08		1	0138-0446	931.58	445.38	330	72.77	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2132.3	D08		1	0139-0446	464.85	446.15	392	73.26	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			310.4	D08		1	0140-0449	914.46	449.53	412	80.18	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2497.8	D08		1	0141-0450	293.65	450.79	391	75.50	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2366.1	D08		1	0142-0453	562.54	453.36	701	99.64	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			403.9	D08		1	0143-0449	715.45	448.99	390	76.08	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			313.1	D08		1	0144-0454	142.77	454.03	401	77.50	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			327.5	D08		1	0145-0455	946.44	455.06	407	78.08	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			451.9	D08		1	0146-0465	186.09	465.22	378	73.50	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			387.2	D08		1	0147-0473	48.87	472.73	757	108.81	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			399.4	D08		1	0148-0468	763.11	467.65	373	73.26	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1760.5	D08		1	0149-0479	695.70	479.85	998	122.81	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			432.7	D08		1	0150-0476	640.27	476.07	384	73.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			800.6	D08		1	0151-0480	336.26	480.21	402	76.77	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1351.8	D08		1	0152-0483	393.22	482.93	564	89.98	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			721.1	D08		1	0153-0480	849.69	480.79	391	74.77	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			593.8	D08		1	0154-0484	443.37	484.11	426	77.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			571.6	D08		1	0155-0484	213.28	483.94	379	71.60	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			837.6	D08		1	0156-0487	770.70	487.97	410	79.15	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			305.8	D08		1	0157-0490	533.71	490.14	403	78.08	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			411.8	D08		1	0158-0489	573.51	488.99	384	74.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2357.0	D08		1	0159-0488	313.19	488.37	428	79.60	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			303.3	D08		1	0160-0497	87.71	497.66	366	71.84	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			351.2	D08		1	0161-0499	866.23	499.79	410	78.08	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			506.0	D08		1	0162-0499	922.02	498.94	359	69.60	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			263.9	D08		1	0163-0506	45.32	507.06	382	78.91	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			967.8	D08		1	0164-0508	817.58	507.77	374	72.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			513.1	D08		1	0165-0509	17.93	509.60	362	72.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			356.9	D08		1	0166-0510	188.53	509.87	383	71.84	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			298.9	D08		1	0167-0512	606.62	511.74	393	76.08	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			525.1	D08		1	0168-0513	745.60	513.60	376	73.01	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			394.0	D08		1	0169-0513	487.28	512.82	395	76.08	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			266.5	D08		1	0170-0517	895.51	516.63	393	75.50	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			753.5	D08		1	0171-0521	326.02	521.07	373	71.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			533.8	D08		1	0172-0523	118.03	523.23	386	72.18	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			431.2	D08		1	0173-0525	289.17	524.87	410	76.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			345.5	D08		1	0174-0525	420.66	525.54	395	76.08	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			324.8	D08		1	0175-0528	648.78	528.16	396	74.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			461.2	D08		1	0176-0530	163.13	530.49	391	74.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2731.2	D08		1	0177-0530	771.34	530.25	390	73.01	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			352.3	D08		1	0178-0533	199.57	533.05	381	73.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			601.8	D08		1	0179-0540	385.59	540.73	417	78.91	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			325.3	D08		1	0180-0539	543.36	539.82	398	75.84	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			286.0	D08		1	0181-0547	897.72	547.42	433	85.40	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			468.4	D08		1	0182-0544	40.20	544.43	338	70.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			360.8	D08		1	0183-0548	473.27	547.35	620	101.40	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			487.3	D08		1	0184-0562	275.66	562.66	620	92.91	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1448.6	D08		1	0185-0571	557.83	571.47	817	113.78	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			292.7	D08		1	0186-0565	658.42	565.82	393	73.84	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			498.1	D08		1	0187-0570	94.36	570.37	340	68.18	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			537.6	D08		1	0188-0570	756.96	569.72	404	76.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			397.8	D08		1	0189-0573	890.54	574.05	415	78.43	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			603.5	D08		1	0190-0575	718.87	575.35	418	79.15	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			578.7	D08		1	0191-0584	443.06	584.72	994	128.02	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			458.3	D08		1	0192-0581	202.82	581.40	407	77.84	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			457.5	D08		1	0193-0584	360.11	584.44	373	73.26	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3202.0	D08		1	0194-0585	610.58	584.79	382	73.26	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			546.5	D08		1	0195-0583	861.48	583.27	393	78.33	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			481.9	D08		1	0196-0591	809.80	591.24	406	78.91	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			401.9	D08		1	0197-0602	194.05	601.73	235	60.77	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			262.0	D08		1	0198-0606	401.04	605.93	421	77.26	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			361.7	D08		1	0199-0607	249.23	606.40	392	78.67	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			308.4	D08		1	0200-0607	715.39	607.94	388	76.67	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			341.3	D08		1	0201-0609	886.12	609.68	379	75.84	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			521.3	D08		1	0202-0613	662.08	613.08	400	74.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			292.7	D08		1	0203-0613	81.87	613.13	432	82.81	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			366.9	D08		1	0204-0619	359.78	619.40	408	77.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			412.3	D08		1	0205-0623	500.22	622.62	416	77.50	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			517.1	D08		1	0206-0632	54.26	631.53	380	72.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			368.0	D08		1	0207-0634	156.18	634.61	438	77.84	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			405.8	D08		1	0208-0632	314.53	632.31	371	75.60	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			388.4	D08		1	0209-0635	337.73	634.71	468	90.18	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			469.1	D08		1	0210-0639	845.81	638.80	759	104.33	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			374.2	D08		1	0211-0637	182.83	636.98	452	85.40	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			337.0	D08		1	0212-0638	479.84	638.61	466	84.91	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			309.4	D08		1	0213-0643	360.80	643.00	528	91.84	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			380.8	D08		1	0214-0643	403.72	643.53	391	72.43	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			323.7	D08		1	0215-0644	797.68	644.62	380	74.43	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1547.1	D08		1	0216-0648	23.17	647.57	369	76.18	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			395.5	D08		1	0217-0653	447.13	653.51	845	118.02	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			358.1	D08		1	0218-0650	266.50	650.23	286	67.60	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1031.5	D08		1	0219-0650	606.93	650.53	444	79.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			678.2	D08		1	0220-0654	76.29	654.09	364	70.43	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			729.4	D08		1	0221-0657	213.13	657.27	388	76.08	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			279.0	D08		1	0222-0660	914.73	660.25	368	72.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			405.5	D08		1	0223-0665	714.94	664.98	405	77.01	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			386.6	D08		1	0224-0666	743.38	666.07	459	82.91	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3049.8	D08		1	0225-0666	648.30	666.58	374	70.43	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3108.7	D08		1	0226-0675	326.89	674.93	673	97.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			435.8	D08		1	0227-0680	772.33	679.99	356	70.43	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1376.2	D08		1	0228-0688	812.57	689.08	726	108.43	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			270.2	D08		1	0229-0686	489.12	685.84	367	75.74	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			705.2	D08		1	0230-0687	143.02	687.83	440	78.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			250.3	D08		1	0231-0690	871.85	690.33	358	72.43	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			262.4	D08		1	0232-0690	191.96	690.27	398	77.50	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			336.6	D08		1	0233-0696	352.59	695.18	460	83.50	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			353.1	D08		1	0234-0700	530.30	700.74	818	111.88	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			262.7	D08		1	0235-0700	579.33	700.33	362	73.50	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			420.3	D08		1	0236-0705	67.56	705.01	383	74.08	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			394.8	D08		3	0001-0032	610.87	32.70	388	77.15	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			421.6	D08		3	0002-0038	761.28	37.99	356	70.43	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			422.2	D08		3	0003-0042	860.23	42.15	366	72.18	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			287.5	D08		3	0004-0041	227.10	41.65	345	72.67	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			403.3	D08		3	0005-0043	410.65	43.52	431	78.67	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			495.9	D08		3	0006-0044	45.88	44.22	373	79.60	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1617.7	D08		3	0007-0047	258.54	47.53	359	75.98	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			640.5	D08		3	0008-0045	550.76	44.87	362	72.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			278.3	D08		3	0009-0049	839.59	49.01	381	77.50	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			598.1	D08		3	0010-0051	694.22	51.36	349	70.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			485.1	D08		3	0011-0053	23.37	52.47	350	73.01	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			290.8	D08		3	0012-0055	131.62	55.52	364	76.67	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			466.9	D08		3	0013-0058	54.92	58.96	377	80.43	0.732
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			983.0	D08		3	0014-0064	74.21	63.65	384	77.26	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			515.1	D08		3	0015-0063	927.38	63.53	352	71.26	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			397.6	D08		3	0016-0065	350.14	65.53	386	73.84	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			967.4	D08		3	0017-0069	250.38	69.79	363	77.26	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			306.7	D08		3	0018-0067	904.78	67.76	366	72.33	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			530.9	D08		3	0019-0072	180.20	72.28	368	75.74	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1324.8	D08		3	0020-0072	231.46	72.41	371	74.87	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			467.3	D08		3	0021-0073	787.16	73.24	361	74.08	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4608.8	D08		3	0022-0080	733.46	80.24	325	113.64	0.316
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			398.9	D08		3	0023-0086	89.85	85.99	341	71.84	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2149.4	D08		3	0024-0091	165.10	92.46	712	105.40	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			398.4	D08		3	0025-0088	659.30	87.84	389	77.50	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			401.3	D08		3	0026-0087	685.00	87.49	373	74.33	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			840.3	D08		3	0027-0089	473.46	89.44	376	74.91	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			972.8	D08		3	0028-0091	502.43	91.20	384	76.91	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			473.7	D08		3	0029-0090	753.67	90.95	380	74.08	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			807.2	D08		3	0030-0093	429.24	93.02	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			919.5	D08		3	0031-0093	230.83	92.37	369	72.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			358.8	D08		3	0032-0097	546.64	97.18	360	72.67	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			422.8	D08		3	0033-0098	833.39	98.43	356	70.18	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1823.5	D08		3	0034-0105	125.31	106.25	731	109.54	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			460.2	D08		3	0035-0102	376.54	102.10	373	73.84	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			635.9	D08		3	0036-0106	904.74	106.07	302	66.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			536.3	D08		3	0037-0110	488.71	110.65	412	86.57	0.691
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			514.9	D08		3	0038-0113	641.59	113.02	367	75.84	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			381.1	D08		3	0039-0114	312.85	115.19	368	72.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			328.6	D08		3	0040-0116	69.56	116.39	359	76.33	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1016.9	D08		3	0041-0123	31.77	123.36	329	69.01	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			537.4	D08		3	0042-0121	723.76	121.05	350	73.84	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3408.2	D08		3	0043-0132	913.74	132.69	582	92.81	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			713.1	D08		3	0044-0129	456.50	128.80	387	75.50	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1965.4	D08		3	0045-0131	273.44	130.78	321	67.94	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			638.5	D08		3	0046-0132	293.91	132.21	440	84.67	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			361.3	D08		3	0047-0136	627.21	136.50	365	74.33	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			316.6	D08		3	0048-0138	384.28	138.48	386	75.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			586.2	D08		3	0049-0139	491.76	139.37	370	75.26	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			322.2	D08		3	0050-0142	83.52	141.45	354	71.01	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			893.6	D08		3	0051-0142	173.87	142.35	347	72.08	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			362.6	D08		3	0052-0141	810.52	140.67	331	69.84	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1404.5	D08		3	0053-0148	544.92	147.95	411	76.91	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			514.5	D08		3	0054-0150	859.07	149.48	299	66.18	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			350.6	D08		3	0055-0153	243.01	153.61	398	76.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			394.0	D08		3	0056-0154	761.70	154.94	330	68.28	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			483.3	D08		3	0057-0158	219.30	157.52	385	77.50	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1185.4	D08		3	0058-0163	139.16	162.74	404	77.26	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			341.1	D08		3	0059-0165	43.97	164.94	345	69.84	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			331.1	D08		3	0060-0169	414.27	168.40	409	78.91	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			494.9	D08		3	0061-0166	592.25	165.95	388	77.50	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			833.6	D08		3	0062-0171	912.62	171.55	375	73.50	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1100.3	D08		3	0063-0179	646.07	177.21	720	110.61	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			636.4	D08		3	0064-0173	850.67	172.97	350	69.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			328.8	D08		3	0065-0181	434.16	179.91	762	118.51	0.682
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1876.4	D08		3	0066-0175	759.81	175.04	560	90.18	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			694.5	D08		3	0067-0178	879.52	178.93	356	73.01	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			357.1	D08		3	0068-0178	341.98	177.70	347	70.43	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			346.9	D08		3	0069-0196	97.38	195.27	747	118.95	0.663
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			459.6	D08		3	0070-0195	488.00	194.77	353	72.67	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			464.4	D08		3	0071-0195	523.35	194.58	307	65.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1328.2	D08		3	0072-0197	687.05	197.04	347	73.26	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			452.7	D08		3	0073-0198	557.78	198.27	394	76.18	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			427.6	D08		3	0074-0202	742.04	202.12	370	73.26	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			283.5	D08		3	0075-0205	147.56	205.28	333	70.43	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			477.2	D08		3	0076-0206	387.38	207.07	366	76.33	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			359.2	D08		3	0077-0207	296.40	206.55	341	72.91	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			377.5	D08		3	0078-0210	650.95	210.77	392	76.43	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			352.5	D08		3	0079-0213	252.24	212.90	344	70.67	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			338.9	D08		3	0080-0212	787.19	212.30	356	70.18	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			275.7	D08		3	0081-0215	82.89	215.35	335	72.43	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			643.6	D08		3	0082-0215	903.13	215.44	324	71.26	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			467.9	D08		3	0083-0214	361.40	214.09	349	74.57	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			927.0	D08		3	0084-0220	196.70	219.96	359	72.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			410.4	D08		3	0085-0221	607.95	221.25	364	73.36	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1008.0	D08		3	0086-0224	414.68	224.53	323	67.01	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			337.1	D08		3	0087-0234	477.37	234.22	752	114.95	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			528.9	D08		3	0088-0233	941.28	233.09	368	71.01	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			401.9	D08		3	0089-0234	649.87	234.42	381	79.50	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			266.1	D08		3	0090-0235	41.27	235.00	329	71.74	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			772.6	D08		3	0091-0238	109.05	238.19	359	74.91	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			424.3	D08		3	0092-0244	607.29	243.39	370	77.36	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			291.2	D08		3	0093-0246	299.57	245.76	362	86.81	0.604
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			421.1	D08		3	0094-0245	164.28	245.60	361	72.43	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1309.9	D08		3	0095-0246	673.03	245.73	328	69.70	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			391.3	D08		3	0096-0247	762.15	246.68	347	68.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			452.3	D08		3	0097-0248	868.88	248.01	373	73.26	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			307.4	D08		3	0098-0249	373.11	248.75	358	76.33	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			491.4	D08		3	0099-0249	552.28	249.29	371	75.74	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1500.6	D08		3	0100-0251	693.24	251.37	374	76.18	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			702.4	D08		3	0101-0252	811.85	252.49	441	81.84	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			286.0	D08		3	0102-0258	249.65	258.22	341	71.84	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			422.2	D08		3	0103-0259	944.24	258.82	301	67.60	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			463.8	D08		3	0104-0265	587.53	265.22	377	73.26	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1122.5	D08		3	0105-0267	341.59	266.56	373	74.67	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2295.6	D08		3	0106-0268	312.72	268.76	348	77.50	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			469.4	D08		3	0107-0267	24.76	267.70	326	69.84	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			564.8	D08		3	0108-0283	649.13	284.09	965	130.61	0.711
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			376.6	D08		3	0109-0273	627.87	274.18	281	66.28	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			423.4	D08		3	0110-0277	156.82	276.89	359	72.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			410.0	D08		3	0111-0276	609.90	276.26	304	65.11	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			362.3	D08		3	0112-0282	79.15	282.69	371	75.50	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			580.2	D08		3	0113-0280	897.30	280.57	260	86.23	0.439
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			330.6	D08		3	0114-0281	410.64	281.07	378	75.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			363.3	D08		3	0115-0283	207.48	282.75	296	63.60	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			316.9	D08		3	0116-0280	688.08	279.99	198	53.60	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1766.8	D08		3	0117-0285	118.58	285.09	470	87.50	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			340.2	D08		3	0118-0288	850.70	288.52	361	72.08	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			485.4	D08		3	0119-0290	251.86	290.01	326	69.26	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			530.9	D08		3	0120-0295	573.61	295.23	352	70.67	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			454.1	D08		3	0121-0308	528.74	309.81	752	114.71	0.718
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1109.4	D08		3	0122-0303	354.73	302.37	387	81.74	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			259.0	D08		3	0123-0314	395.21	313.95	362	76.57	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2005.4	D08		3	0124-0313	466.54	313.88	394	77.50	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			466.9	D08		3	0125-0313	915.48	313.75	355	73.84	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			311.5	D08		3	0126-0316	28.55	315.24	376	77.98	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			410.7	D08		3	0127-0317	283.02	317.11	315	65.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			306.3	D08		3	0128-0319	102.04	319.05	333	71.01	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			265.2	D08		3	0129-0328	423.72	328.52	377	75.50	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			490.6	D08		3	0130-0330	854.33	329.72	363	74.91	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1076.9	D08		3	0131-0330	592.86	329.42	402	81.84	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			328.8	D08		3	0132-0332	142.97	332.76	382	76.08	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			823.7	D08		3	0133-0336	321.90	335.75	386	81.98	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1973.8	D08		3	0134-0338	833.06	338.06	514	88.67	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			452.3	D08		3	0135-0338	236.53	338.87	364	74.91	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			324.8	D08		3	0136-0339	675.27	339.86	348	71.84	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2086.2	D08		3	0137-0341	539.42	341.78	376	73.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			311.3	D08		3	0138-0342	45.16	342.09	343	72.67	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			342.7	D08		3	0139-0341	360.98	341.59	365	71.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			395.1	D08		3	0140-0342	741.96	343.01	367	72.43	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			458.8	D08		3	0141-0343	814.07	343.20	311	71.01	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			315.4	D08		3	0142-0352	180.69	352.91	376	80.91	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			260.8	D08		3	0143-0351	911.96	351.27	378	74.91	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			748.4	D08		3	0144-0354	313.52	354.52	377	78.33	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			346.6	D08		3	0145-0355	79.89	355.22	324	72.57	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			320.0	D08		3	0146-0364	113.88	364.88	334	72.91	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			381.9	D08		3	0147-0368	472.96	368.59	712	106.57	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			259.8	D08		3	0148-0373	521.62	372.76	374	76.33	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			406.1	D08		3	0149-0376	665.34	376.52	366	74.91	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			282.9	D08		3	0150-0376	394.46	376.46	359	71.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			335.1	D08		3	0151-0374	711.16	374.31	395	76.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			316.9	D08		3	0152-0378	147.07	378.11	334	78.57	0.680
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			301.1	D08		3	0153-0378	329.62	377.69	360	78.33	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			401.4	D08		3	0154-0382	866.90	381.25	375	76.91	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			608.4	D08		3	0155-0381	32.21	381.87	321	68.43	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			298.4	D08		3	0156-0381	919.31	381.04	350	70.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2266.1	D08		3	0157-0384	258.75	383.93	340	71.26	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			330.5	D08		3	0158-0388	195.57	388.17	350	74.33	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			497.2	D08		3	0159-0387	732.51	386.63	311	66.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			389.7	D08		3	0160-0389	547.02	389.11	374	74.91	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			546.7	D08		3	0161-0395	231.76	395.64	345	74.91	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			325.0	D08		3	0162-0395	819.43	395.72	362	71.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			722.9	D08		3	0163-0396	119.41	396.33	326	69.26	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			431.5	D08		3	0164-0398	477.43	398.21	310	64.77	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			378.9	D08		3	0165-0399	751.44	398.79	398	77.74	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			921.4	D08		3	0166-0402	304.30	401.92	380	73.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			468.3	D08		3	0167-0410	371.75	410.15	720	105.88	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			360.3	D08		3	0168-0403	438.20	403.57	370	74.08	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			313.6	D08		3	0169-0421	593.76	420.87	363	78.91	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2152.6	D08		3	0170-0421	718.80	421.57	380	77.15	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			430.3	D08		3	0171-0423	774.90	423.59	361	75.84	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			318.4	D08		3	0172-0428	33.62	428.69	325	72.91	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			323.4	D08		3	0173-0431	269.61	431.74	353	76.91	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			349.3	D08		3	0174-0431	528.13	432.17	372	77.94	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2100.8	D08		3	0175-0436	693.67	436.44	627	99.64	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			392.3	D08		3	0176-0447	421.89	446.54	748	106.95	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2153.1	D08		3	0177-0440	641.30	440.64	368	74.57	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			822.4	D08		3	0178-0446	162.63	445.35	712	105.88	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7259.8	D08		3	0179-0443	218.47	442.01	246	66.18	0.706
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3872.5	D08		3	0180-0444	231.04	446.37	219	63.70	0.678
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			391.5	D08		3	0181-0448	196.51	448.67	338	72.43	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			396.0	D08		3	0182-0447	315.10	447.79	367	74.91	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			264.4	D08		3	0183-0452	248.41	451.51	349	71.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			322.8	D08		3	0184-0455	527.89	453.68	409	81.84	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			298.4	D08		3	0185-0461	105.25	461.70	375	81.15	0.716
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			258.0	D08		3	0186-0463	71.14	463.23	353	73.26	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			376.4	D08		3	0187-0465	761.22	465.32	369	71.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			391.6	D08		3	0188-0473	624.44	473.31	375	72.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			432.4	D08		3	0189-0476	471.95	476.54	334	72.91	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			284.2	D08		3	0190-0475	851.66	474.90	353	71.01	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			330.3	D08		3	0191-0476	125.82	475.90	352	77.98	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			250.6	D08		3	0192-0482	929.08	482.82	380	78.33	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			384.7	D08		3	0193-0481	238.90	481.00	375	78.57	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			334.4	D08		3	0194-0484	565.52	484.47	368	73.26	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			374.3	D08		3	0195-0488	798.10	488.09	378	76.43	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			871.5	D08		3	0196-0490	720.05	490.02	371	72.67	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			384.9	D08		3	0197-0495	687.56	495.55	364	71.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			380.9	D08		3	0198-0502	601.36	502.21	361	73.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			445.6	D08		3	0199-0504	491.17	503.98	359	76.08	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			354.2	D08		3	0200-0507	230.55	507.90	370	78.33	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			563.4	D08		3	0201-0504	441.48	503.77	353	71.26	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			391.6	D08		3	0202-0506	356.38	506.34	353	72.43	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			309.6	D08		3	0203-0506	76.00	505.92	340	70.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			428.9	D08		3	0204-0510	806.46	509.69	392	81.40	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			280.6	D08		3	0205-0523	274.92	522.77	728	119.78	0.638
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			370.7	D08		3	0206-0520	851.06	520.43	723	112.13	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1679.7	D08		3	0207-0523	183.08	523.49	582	96.81	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			405.3	D08		3	0208-0520	757.32	519.80	372	73.60	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			434.8	D08		3	0209-0522	314.99	522.71	377	72.67	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			421.1	D08		3	0210-0522	481.03	522.56	359	72.67	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			452.7	D08		3	0211-0527	637.44	527.40	373	76.33	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			446.7	D08		3	0212-0525	673.36	524.83	333	68.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1722.9	D08		3	0213-0538	359.97	537.89	341	72.91	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			295.0	D08		3	0214-0537	580.54	536.99	352	72.67	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			512.6	D08		3	0215-0541	941.09	541.53	352	74.57	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			366.4	D08		3	0216-0542	537.15	541.76	363	72.67	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			340.6	D08		3	0217-0557	213.58	557.20	748	119.92	0.654
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			580.2	D08		3	0218-0553	484.31	553.43	396	77.26	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			654.9	D08		3	0219-0554	506.06	554.20	357	72.53	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			712.4	D08		3	0220-0556	736.72	556.00	352	72.91	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			433.3	D08		3	0221-0560	682.76	559.13	385	76.67	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			284.4	D08		3	0222-0561	74.33	561.65	327	68.67	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			379.3	D08		3	0223-0565	910.29	565.48	745	106.57	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1587.6	D08		3	0224-0565	782.87	565.60	625	96.57	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			315.2	D08		3	0225-0567	301.69	568.06	352	79.74	0.696
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1660.9	D08		3	0226-0569	343.30	569.80	330	68.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			598.1	D08		3	0227-0571	427.05	571.92	349	71.84	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			343.3	D08		3	0228-0587	52.37	586.47	695	104.57	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			336.5	D08		3	0229-0589	257.48	589.00	357	73.60	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			326.7	D08		3	0230-0588	216.44	588.13	373	76.08	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			647.3	D08		3	0231-0588	675.96	588.21	372	74.08	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			342.7	D08		3	0232-0589	132.62	588.97	371	74.91	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			536.3	D08		3	0233-0596	504.56	596.61	816	112.13	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2324.5	D08		3	0234-0590	747.04	590.11	349	71.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2319.1	D08		3	0235-0598	541.23	597.72	647	103.40	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			320.1	D08		3	0236-0596	632.60	596.40	377	78.57	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			303.3	D08		3	0237-0603	585.14	603.71	378	75.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			663.1	D08		3	0238-0600	373.07	600.30	254	59.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			532.5	D08		3	0239-0603	923.84	602.96	310	66.43	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			561.9	D08		3	0240-0604	114.56	604.19	360	79.15	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1231.3	D08		3	0241-0621	767.20	622.36	953	139.78	0.613
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			356.8	D08		3	0242-0608	873.87	607.69	343	75.15	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			268.6	D08		3	0243-0619	887.26	619.02	411	81.15	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			507.0	D08		3	0244-0617	824.32	617.02	347	70.67	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1815.0	D08		3	0245-0621	358.11	621.50	605	95.40	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			302.9	D08		3	0246-0620	736.77	620.01	369	81.98	0.690
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			594.2	D08		3	0247-0619	389.04	619.47	348	72.08	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			446.4	D08		3	0248-0626	210.28	626.97	308	71.36	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			316.7	D08		3	0249-0631	692.35	631.02	357	79.98	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			598.2	D08		3	0250-0632	846.96	632.32	249	57.36	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			369.6	D08		3	0251-0636	620.94	636.44	368	73.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			330.7	D08		3	0252-0638	328.05	638.02	417	85.15	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			419.3	D08		3	0253-0642	35.07	642.13	314	71.01	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			410.0	D08		3	0254-0643	168.48	643.62	337	71.50	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			751.8	D08		3	0255-0645	212.27	643.20	363	77.60	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			723.7	D08		3	0256-0650	129.25	650.17	437	81.74	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			570.5	D08		3	0257-0649	798.87	649.68	206	73.50	0.479
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			374.8	D08		3	0258-0654	92.12	653.99	352	70.67	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			355.2	D08		3	0259-0653	558.56	653.05	375	73.84	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2350.3	D08		3	0260-0653	675.92	653.29	342	73.84	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			392.7	D08		3	0261-0659	342.21	659.10	369	83.98	0.657
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			396.3	D08		3	0262-0660	203.39	661.36	396	79.98	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			337.1	D08		3	0263-0663	904.83	662.51	330	69.26	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			297.5	D08		3	0264-0667	947.34	667.52	341	73.84	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2226.5	D08		3	0265-0669	683.59	669.86	372	78.43	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			326.9	D08		3	0266-0674	610.07	674.02	369	74.91	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			637.0	D08		3	0267-0672	488.26	672.92	362	72.67	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			393.3	D08		3	0268-0675	720.71	675.02	357	74.67	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1385.6	D08		3	0269-0685	89.67	685.35	313	65.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			396.7	D08		3	0270-0684	138.76	684.98	315	66.43	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			369.7	D08		3	0271-0688	179.16	688.67	338	71.50	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			605.9	D08		3	0272-0690	896.32	690.52	318	72.33	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			598.1	D08		3	0273-0700	25.13	699.98	615	97.40	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			228.5	D08		3	0274-0697	699.75	697.18	375	76.08	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			467.6	D08		3	0275-0693	363.48	693.79	196	72.77	0.465
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			379.7	D08		3	0276-0707	831.30	707.12	348	71.70	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2466.6	D08		4	0001-0039	733.93	39.86	628	95.74	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2051.7	D08		4	0002-0049	816.27	48.21	984	128.23	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			539.8	D08		4	0003-0047	340.50	45.67	547	92.47	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			441.5	D08		4	0004-0045	603.98	44.77	467	82.91	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			277.0	D08		4	0005-0048	902.79	48.58	451	79.50	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			294.4	D08		4	0006-0049	366.86	49.04	475	82.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			291.9	D08		4	0007-0053	759.08	52.52	483	88.67	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			402.0	D08		4	0008-0055	249.77	55.49	442	78.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			489.8	D08		4	0009-0056	945.82	56.49	406	75.26	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			329.0	D08		4	0010-0056	99.02	56.17	435	83.50	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			417.5	D08		4	0011-0061	322.34	62.53	456	81.98	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			464.8	D08		4	0012-0064	75.47	64.64	501	87.94	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			334.3	D08		4	0013-0066	620.14	67.05	499	85.98	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			358.9	D08		4	0014-0071	446.82	70.23	938	125.44	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			373.2	D08		4	0015-0073	669.51	73.09	432	76.43	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			346.4	D08		4	0016-0077	835.66	77.03	516	88.71	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			564.5	D08		4	0017-0077	744.64	78.29	438	80.43	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			430.3	D08		4	0018-0080	545.97	80.59	922	121.30	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			354.3	D08		4	0019-0086	80.39	85.76	433	82.08	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3254.3	D08		4	0020-0090	179.51	90.53	727	103.64	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			257.8	D08		4	0021-0096	849.52	96.88	428	81.15	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3512.9	D08		4	0022-0097	118.83	97.58	763	103.40	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			358.3	D08		4	0023-0100	519.10	99.71	481	85.74	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			457.0	D08		4	0024-0100	348.91	100.90	383	75.50	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			284.1	D08		4	0025-0102	889.05	102.48	431	77.26	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			549.9	D08		4	0026-0105	706.22	105.50	424	76.67	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			389.1	D08		4	0027-0114	78.30	115.10	429	85.26	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			341.0	D08		4	0028-0113	624.49	113.53	484	84.33	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			598.3	D08		4	0029-0115	801.67	114.62	416	77.50	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2226.9	D08		4	0030-0116	387.80	116.12	561	90.08	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			299.3	D08		4	0031-0123	266.03	123.08	434	78.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			415.0	D08		4	0032-0124	770.35	123.97	438	80.91	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			484.6	D08		4	0033-0124	676.92	124.50	422	76.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			314.3	D08		4	0034-0142	319.72	142.15	433	79.74	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			367.7	D08		4	0035-0148	217.28	148.11	423	76.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			322.2	D08		4	0036-0153	718.54	153.51	431	82.77	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			553.4	D08		4	0037-0159	843.33	158.44	853	112.71	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			788.1	D08		4	0038-0158	145.77	159.32	864	116.23	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			389.2	D08		4	0039-0168	270.56	168.62	924	119.88	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			790.8	D08		4	0040-0168	358.99	168.27	488	84.33	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			295.4	D08		4	0041-0166	664.94	166.66	434	79.50	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			293.9	D08		4	0042-0172	406.55	172.28	479	82.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			391.5	D08		4	0043-0173	716.05	172.21	435	79.11	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			350.4	D08		4	0044-0175	24.26	175.99	395	75.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			394.2	D08		4	0045-0180	572.58	180.40	513	88.91	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			340.3	D08		4	0046-0181	609.93	180.72	439	78.08	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			368.6	D08		4	0047-0184	543.08	183.36	499	87.40	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			435.4	D08		4	0048-0185	883.86	185.73	451	79.26	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			314.0	D08		4	0049-0195	792.79	195.10	446	78.91	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			475.8	D08		4	0050-0195	215.19	194.82	391	71.60	0.958
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			398.1	D08		4	0051-0196	183.93	196.02	391	72.18	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4004.1	D08		4	0052-0198	266.48	198.05	625	94.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			858.7	D08		4	0053-0197	858.04	196.41	430	79.50	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			471.9	D08		4	0054-0201	452.45	201.56	438	79.50	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			386.1	D08		4	0055-0201	145.36	200.44	437	79.26	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			307.0	D08		4	0056-0202	916.56	202.45	431	77.26	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			386.3	D08		4	0057-0213	537.22	213.14	511	91.40	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			355.3	D08		4	0058-0212	735.76	212.22	435	81.50	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1601.6	D08		4	0059-0225	336.76	224.68	832	114.81	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			297.9	D08		4	0060-0227	206.08	226.23	399	79.15	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			429.7	D08		4	0061-0226	418.21	226.03	428	79.50	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			476.8	D08		4	0062-0227	890.19	227.21	818	116.67	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			373.5	D08		4	0063-0245	648.73	245.57	889	123.05	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			298.1	D08		4	0064-0239	554.99	239.38	488	86.33	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			277.5	D08		4	0065-0248	196.20	249.17	476	90.81	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			365.9	D08		4	0066-0249	602.93	249.45	434	78.33	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			282.9	D08		4	0067-0255	723.00	255.13	440	78.67	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			492.8	D08		4	0068-0258	391.21	258.14	441	77.26	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			404.5	D08		4	0069-0263	692.44	264.22	439	79.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			369.0	D08		4	0070-0268	225.86	267.89	430	78.91	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			462.8	D08		4	0071-0267	259.01	267.57	426	79.50	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			304.7	D08		4	0072-0273	54.20	273.66	414	80.33	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			309.9	D08		4	0073-0275	426.18	274.91	483	83.50	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			433.9	D08		4	0074-0282	565.08	282.42	965	129.78	0.720
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			326.3	D08		4	0075-0274	917.38	275.01	446	79.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			332.8	D08		4	0076-0276	842.17	276.79	446	82.91	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			245.8	D08		4	0077-0286	325.72	285.68	477	84.91	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			397.5	D08		4	0078-0291	690.26	290.59	484	87.01	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			456.2	D08		4	0079-0289	163.66	288.76	423	75.26	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			381.2	D08		4	0080-0295	69.01	296.21	555	93.01	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			406.4	D08		4	0081-0298	631.28	298.98	823	111.30	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			520.8	D08		4	0082-0297	92.75	297.45	410	76.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			321.1	D08		4	0083-0298	486.50	297.74	444	79.50	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			241.3	D08		4	0084-0296	730.71	296.02	421	77.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1794.1	D08		4	0085-0309	336.67	309.13	741	102.91	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			304.7	D08		4	0086-0310	792.80	310.62	440	79.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			472.0	D08		4	0087-0314	583.95	314.44	503	91.84	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			310.3	D08		4	0088-0319	915.92	319.07	927	119.20	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			330.4	D08		4	0089-0323	526.57	322.61	442	78.08	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			502.5	D08		4	0090-0329	369.87	328.39	447	80.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			275.3	D08		4	0091-0333	741.86	333.44	431	77.26	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			265.9	D08		4	0092-0335	405.26	335.05	449	79.50	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			779.9	D08		4	0093-0338	442.23	337.84	665	97.64	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			401.8	D08		4	0094-0339	696.49	338.86	459	81.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			481.8	D08		4	0095-0341	573.65	341.09	457	84.91	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			301.1	D08		4	0096-0341	279.50	340.56	475	82.91	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			383.5	D08		4	0097-0345	217.15	344.72	442	78.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			299.3	D08		4	0098-0350	353.90	350.58	483	87.74	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			412.8	D08		4	0099-0350	829.44	351.06	433	78.33	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			396.5	D08		4	0100-0357	882.34	358.36	885	117.54	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			309.4	D08		4	0101-0353	512.95	353.82	454	80.08	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			311.1	D08		4	0102-0357	263.78	357.96	479	86.23	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			344.1	D08		4	0103-0361	645.71	361.63	519	88.67	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			332.5	D08		4	0104-0364	616.45	364.48	490	86.57	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			679.1	D08		4	0105-0365	788.10	365.64	480	81.84	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			283.6	D08		4	0106-0369	420.08	369.56	434	79.26	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			309.2	D08		4	0107-0378	935.44	378.34	450	80.67	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			161.4	D08		4	0108-0378	149.62	378.56	429	75.84	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			307.6	D08		4	0109-0384	640.88	384.35	489	87.60	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			660.0	D08		4	0110-0384	307.53	384.07	449	79.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			300.6	D08		4	0111-0390	83.47	390.26	414	78.33	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2280.5	D08		4	0112-0398	358.78	397.74	826	108.47	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			379.1	D08		4	0113-0398	798.87	397.96	445	84.33	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			354.8	D08		4	0114-0402	595.24	401.63	512	86.23	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1382.9	D08		4	0115-0405	654.01	406.06	567	92.57	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1659.6	D08		4	0116-0405	260.98	405.31	536	88.57	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			278.8	D08		4	0117-0411	535.96	411.71	918	120.23	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2213.9	D08		4	0118-0415	484.12	415.53	806	109.74	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2081.2	D08		4	0119-0415	210.19	414.84	911	116.23	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			313.1	D08		4	0120-0419	869.62	418.01	472	82.08	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			391.3	D08		4	0121-0420	459.39	420.85	457	85.01	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			432.0	D08		4	0122-0423	568.03	423.12	489	85.01	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			774.2	D08		4	0123-0427	783.26	427.75	947	124.47	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			303.7	D08		4	0124-0426	125.16	426.22	419	76.91	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			569.5	D08		4	0125-0431	755.86	431.24	422	80.77	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			392.0	D08		4	0126-0432	385.87	432.72	436	78.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			342.0	D08		4	0127-0435	285.51	435.86	415	75.01	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			257.7	D08		4	0128-0441	66.09	440.53	406	76.43	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1927.9	D08		4	0129-0448	28.71	448.46	574	88.67	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			266.1	D08		4	0130-0449	849.09	449.39	468	81.26	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			416.1	D08		4	0131-0449	896.40	449.15	435	81.15	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			270.7	D08		4	0132-0455	176.90	455.44	435	78.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			311.9	D08		4	0133-0461	630.96	461.45	461	83.74	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			434.6	D08		4	0134-0465	564.54	465.61	437	78.08	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			348.5	D08		4	0135-0465	763.23	465.37	464	82.43	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			295.2	D08		4	0136-0472	232.27	472.22	487	86.57	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2008.8	D08		4	0137-0470	509.73	470.31	422	79.36	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			377.4	D08		4	0138-0469	699.93	469.21	469	81.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			442.9	D08		4	0139-0472	734.89	472.71	504	85.15	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2287.7	D08		4	0140-0473	528.11	473.56	367	75.94	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			404.6	D08		4	0141-0478	96.54	477.90	456	84.08	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			380.9	D08		4	0142-0476	414.40	476.81	439	79.50	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			390.7	D08		4	0143-0484	252.34	484.70	460	84.57	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			444.4	D08		4	0144-0488	937.61	487.58	406	76.08	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			230.7	D08		4	0145-0487	820.13	486.87	287	65.84	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			332.6	D08		4	0146-0491	902.85	490.85	434	78.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			399.4	D08		4	0147-0493	703.55	492.97	483	86.43	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			278.2	D08		4	0148-0496	143.65	496.51	421	78.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			347.4	D08		4	0149-0501	304.77	501.57	431	77.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			275.3	D08		4	0150-0506	60.78	505.86	443	79.26	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			326.9	D08		4	0151-0510	915.79	510.77	476	84.33	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			412.1	D08		4	0152-0512	522.77	512.19	463	82.57	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			297.3	D08		4	0153-0518	459.30	518.98	448	80.08	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1007.4	D08		4	0154-0525	620.07	525.23	571	92.33	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			304.0	D08		4	0155-0527	836.57	527.33	282	64.18	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			448.4	D08		4	0156-0529	360.05	529.94	429	79.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1962.9	D08		4	0157-0536	213.40	535.85	972	125.30	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			387.4	D08		4	0158-0534	407.41	533.57	504	85.74	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			770.9	D08		4	0159-0535	579.10	535.16	529	91.40	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			569.2	D08		4	0160-0534	23.69	534.42	407	75.26	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			275.8	D08		4	0161-0535	718.74	534.88	466	81.26	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			356.6	D08		4	0162-0550	73.80	550.34	433	80.08	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1215.4	D08		4	0163-0551	781.30	551.45	459	79.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			431.9	D08		4	0164-0552	361.37	551.17	526	89.60	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			720.0	D08		4	0165-0554	444.12	555.08	426	78.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			331.7	D08		4	0166-0560	496.05	559.90	449	79.26	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			415.7	D08		4	0167-0561	717.51	561.75	514	86.33	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			272.9	D08		4	0168-0562	409.60	562.68	472	82.33	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			271.8	D08		4	0169-0567	933.70	566.31	553	96.13	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			326.7	D08		4	0170-0565	628.41	565.59	465	80.67	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			367.4	D08		4	0171-0568	32.00	567.88	411	75.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2187.3	D08		4	0172-0573	259.57	571.93	451	81.40	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			298.7	D08		4	0173-0574	546.75	574.82	461	81.26	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			416.9	D08		4	0174-0577	109.77	577.72	423	75.26	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1355.1	D08		4	0175-0581	316.05	581.14	554	88.08	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			815.7	D08		4	0176-0584	909.84	584.85	803	114.95	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			341.6	D08		4	0177-0579	803.61	578.83	480	81.50	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			346.7	D08		4	0178-0581	649.40	580.88	509	88.81	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2065.7	D08		4	0179-0590	244.16	591.10	457	84.23	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			249.4	D08		4	0180-0594	470.06	594.13	422	77.01	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			340.5	D08		4	0181-0595	357.99	594.48	437	77.84	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			709.1	D08		4	0182-0601	707.62	600.99	472	81.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1101.0	D08		4	0183-0603	861.60	603.94	748	106.91	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			340.1	D08		4	0184-0602	593.70	602.36	432	78.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			403.1	D08		4	0185-0605	803.17	605.81	480	84.53	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			313.8	D08		4	0186-0605	189.40	604.80	467	80.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			379.8	D08		4	0187-0605	682.74	605.51	455	78.67	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			441.8	D08		4	0188-0608	829.34	608.71	803	110.53	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			236.2	D08		4	0189-0609	407.77	609.26	430	77.84	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			546.0	D08		4	0190-0617	48.28	617.11	419	76.08	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			600.7	D08		4	0191-0618	73.94	618.25	435	80.33	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			379.7	D08		4	0192-0620	534.59	620.39	454	83.15	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			303.5	D08		4	0193-0629	652.35	629.74	426	76.43	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			286.1	D08		4	0194-0630	464.45	630.65	459	81.50	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			303.3	D08		4	0195-0631	347.40	631.22	432	76.43	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2821.3	D08		4	0196-0637	166.84	637.00	673	98.81	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			511.2	D08		4	0197-0633	766.19	633.25	448	77.84	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2020.3	D08		4	0198-0637	824.14	634.50	444	83.50	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			347.8	D08		4	0199-0647	616.31	647.51	434	80.08	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			170.9	D08		4	0200-0648	893.26	647.73	452	83.74	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			307.0	D08		4	0201-0647	413.25	647.58	436	79.74	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			582.6	D08		4	0202-0649	811.68	650.31	462	82.47	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			348.1	D08		4	0203-0655	284.65	655.64	972	129.68	0.726
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1280.4	D08		4	0204-0650	16.51	650.72	409	75.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			959.6	D08		4	0205-0652	564.80	652.91	437	77.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			342.4	D08		4	0206-0655	245.76	654.93	477	87.40	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			297.0	D08		4	0207-0654	60.03	654.59	350	73.36	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			905.4	D08		4	0208-0664	490.73	665.09	551	88.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			547.8	D08		4	0209-0666	107.18	667.24	437	78.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2339.8	D08		4	0210-0670	130.35	670.03	437	81.01	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			796.9	D08		4	0211-0673	66.05	672.95	487	87.01	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			311.5	D08		4	0212-0675	315.43	675.38	458	79.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			272.9	D08		4	0213-0674	384.40	674.78	439	78.91	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			415.8	D08		4	0214-0676	671.90	676.16	437	77.84	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1191.6	D08		4	0215-0677	806.78	677.74	428	79.98	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			327.1	D08		4	0216-0678	219.18	677.65	431	79.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			302.2	D08		4	0217-0680	741.32	680.44	490	87.40	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			381.0	D08		4	0218-0687	521.67	686.81	448	80.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			344.6	D08		4	0219-0690	185.53	690.11	483	87.15	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			237.2	D08		4	0220-0691	426.22	691.59	414	78.18	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1955.3	D08		4	0221-0698	66.48	698.47	483	87.01	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			370.1	D08		4	0222-0697	210.17	697.67	479	90.91	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			264.1	D08		4	0223-0698	848.47	697.67	448	77.84	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			451.1	D08		4	0224-0707	801.44	707.13	338	68.77	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			703.1	D08		5	0001-0033	823.63	32.06	394	74.57	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2588.7	D08		5	0002-0040	391.44	40.78	457	81.84	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			438.0	D08		5	0003-0045	808.53	46.12	380	75.15	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			403.7	D08		5	0004-0045	921.84	46.04	389	78.18	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			519.2	D08		5	0005-0057	318.33	57.37	778	114.23	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			783.3	D08		5	0006-0057	470.15	57.03	421	78.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			526.2	D08		5	0007-0059	50.54	59.00	386	73.84	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			407.4	D08		5	0008-0059	875.92	59.73	269	82.67	0.495
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			504.6	D08		5	0009-0064	397.42	64.22	486	85.84	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			326.3	D08		5	0010-0072	670.92	70.92	819	114.67	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			362.6	D08		5	0011-0071	701.38	70.53	485	87.26	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2186.2	D08		5	0012-0078	543.90	78.14	825	118.71	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			686.6	D08		5	0013-0079	388.66	79.65	130	44.87	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			421.9	D08		5	0014-0085	382.58	87.38	154	58.53	0.565
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			850.3	D08		5	0015-0088	516.98	88.31	354	71.94	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			491.9	D08		5	0016-0093	277.12	93.36	398	75.50	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			468.5	D08		5	0017-0096	633.80	96.06	425	79.26	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			290.3	D08		5	0018-0092	945.00	92.43	416	78.43	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			463.0	D08		5	0019-0099	599.93	98.67	415	77.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			344.0	D08		5	0020-0098	798.67	98.19	423	77.84	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1089.1	D08		5	0021-0100	350.48	100.44	400	75.84	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			303.0	D08		5	0022-0103	71.65	102.95	395	74.67	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2882.9	D08		5	0023-0108	561.28	107.76	640	93.74	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			686.8	D08		5	0024-0112	237.80	112.01	503	85.60	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			381.4	D08		5	0025-0115	454.33	115.52	438	81.74	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			513.2	D08		5	0026-0117	179.42	116.83	392	74.67	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			301.8	D08		5	0027-0118	842.12	118.62	387	73.84	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			557.6	D08		5	0028-0128	945.20	127.33	658	98.67	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1384.7	D08		5	0029-0147	230.98	146.68	883	128.37	0.673
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			484.3	D08		5	0030-0139	417.82	138.92	432	76.43	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			280.4	D08		5	0031-0140	799.39	139.77	419	79.01	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			380.5	D08		5	0032-0143	72.31	143.04	380	72.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			307.4	D08		5	0033-0146	778.08	146.59	408	77.01	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			394.1	D08		5	0034-0149	501.54	148.63	457	80.08	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			918.3	D08		5	0035-0147	714.83	147.15	405	76.08	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			715.1	D08		5	0036-0160	304.21	160.53	837	111.54	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			354.5	D08		5	0037-0160	551.40	160.00	437	81.26	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			498.4	D08		5	0038-0159	625.81	159.03	413	75.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			360.5	D08		5	0039-0163	379.49	163.25	810	111.15	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			343.9	D08		5	0040-0174	218.07	175.08	417	82.33	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			319.1	D08		5	0041-0179	124.30	179.69	857	121.40	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			435.3	D08		5	0042-0182	593.02	181.99	397	76.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			509.5	D08		5	0043-0184	800.09	184.08	393	76.33	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			702.3	D08		5	0044-0195	190.64	195.14	411	81.74	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			763.1	D08		5	0045-0200	860.90	200.69	769	107.64	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			794.4	D08		5	0046-0195	714.01	195.36	418	78.43	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			307.4	D08		5	0047-0204	21.44	204.91	378	76.08	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			395.0	D08		5	0048-0205	71.47	204.85	372	72.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			496.7	D08		5	0049-0211	769.60	211.45	384	74.43	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			416.0	D08		5	0050-0211	468.68	211.28	418	76.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			468.8	D08		5	0051-0214	390.48	213.72	396	75.26	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			261.7	D08		5	0052-0214	734.86	213.37	442	81.01	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			311.4	D08		5	0053-0216	210.48	216.18	445	86.91	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			432.6	D08		5	0054-0212	116.41	212.94	148	51.70	0.696
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2527.5	D08		5	0055-0217	343.50	217.58	399	75.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			639.9	D08		5	0056-0219	649.48	218.86	377	75.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			468.9	D08		5	0057-0225	668.86	226.35	406	82.08	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			725.7	D08		5	0058-0233	554.22	233.81	778	108.23	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			390.9	D08		5	0059-0240	133.89	240.37	385	76.08	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			493.1	D08		5	0060-0248	172.10	248.69	390	74.08	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			346.0	D08		5	0061-0249	56.46	249.02	394	76.08	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			517.2	D08		5	0062-0252	262.48	252.37	426	77.01	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			478.3	D08		5	0063-0252	522.43	252.74	411	80.91	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			542.5	D08		5	0064-0259	941.70	259.65	758	108.71	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			516.5	D08		5	0065-0263	621.63	263.24	862	124.51	0.699
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			423.3	D08		5	0066-0268	474.24	267.82	820	112.81	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			353.2	D08		5	0067-0265	748.25	265.65	425	76.67	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			275.9	D08		5	0068-0268	784.21	268.90	423	82.57	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			649.3	D08		5	0069-0274	346.42	275.00	450	80.43	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			618.6	D08		5	0070-0280	397.61	280.07	764	105.54	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			673.8	D08		5	0071-0274	865.76	273.84	395	74.08	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			598.1	D08		5	0072-0278	121.12	277.83	379	73.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			291.0	D08		5	0073-0277	22.55	277.44	368	73.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			331.7	D08		5	0074-0285	547.62	284.98	407	77.74	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			565.4	D08		5	0075-0285	323.56	284.72	457	81.26	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			404.3	D08		5	0076-0287	260.67	287.23	413	79.50	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			749.0	D08		5	0077-0301	806.06	301.60	896	117.40	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			391.0	D08		5	0078-0301	685.93	301.04	293	63.94	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			517.6	D08		5	0079-0310	430.22	310.43	398	80.33	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			301.8	D08		5	0080-0316	97.58	316.25	428	80.33	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			356.8	D08		5	0081-0314	859.62	313.58	405	78.57	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			299.1	D08		5	0082-0321	21.04	321.60	824	115.68	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			446.8	D08		5	0083-0314	518.69	314.61	381	77.84	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			355.9	D08		5	0084-0323	283.64	323.05	405	78.08	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			429.1	D08		5	0085-0327	344.62	327.27	406	78.33	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			570.7	D08		5	0086-0328	873.27	329.35	403	77.50	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			922.0	D08		5	0087-0330	907.98	329.91	310	64.77	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			472.3	D08		5	0088-0333	223.33	333.96	410	75.26	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2088.2	D08		5	0089-0337	410.57	337.30	756	107.74	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			427.8	D08		5	0090-0338	169.04	337.99	379	77.50	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			379.6	D08		5	0091-0336	660.17	336.80	610	97.15	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			532.4	D08		5	0092-0343	929.00	343.31	782	113.88	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			289.9	D08		5	0093-0344	722.89	344.38	405	76.67	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2324.1	D08		5	0094-0351	438.25	351.57	739	106.57	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			446.2	D08		5	0095-0346	552.67	346.48	413	77.26	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			487.7	D08		5	0096-0347	786.35	346.22	441	83.60	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			337.8	D08		5	0097-0354	761.47	354.39	397	77.84	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			413.8	D08		5	0098-0359	854.76	359.24	407	77.50	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			307.1	D08		5	0099-0360	135.44	360.45	392	76.91	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			398.0	D08		5	0100-0363	589.18	362.90	402	74.43	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			485.2	D08		5	0101-0367	273.26	367.66	450	81.74	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			590.7	D08		5	0102-0365	897.87	364.97	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			424.0	D08		5	0103-0376	484.26	375.96	819	108.71	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			298.6	D08		5	0104-0375	377.85	374.63	416	78.08	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			282.1	D08		5	0105-0378	304.46	378.42	424	78.67	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			351.9	D08		5	0106-0380	40.49	380.98	425	78.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			427.1	D08		5	0107-0386	833.52	386.16	399	75.84	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			323.1	D08		5	0108-0388	630.64	387.98	450	82.33	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			639.4	D08		5	0109-0396	411.42	396.40	397	76.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			451.8	D08		5	0110-0401	740.54	401.57	418	77.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			611.8	D08		5	0111-0404	366.68	404.38	414	76.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			413.2	D08		5	0112-0406	217.90	406.82	369	74.67	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			321.3	D08		5	0113-0408	175.02	408.75	399	76.91	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			628.9	D08		5	0114-0411	715.24	410.60	451	84.33	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			340.2	D08		5	0115-0412	535.17	412.48	466	85.15	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			397.1	D08		5	0116-0418	907.23	417.81	194	52.53	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			458.7	D08		5	0117-0426	802.16	426.03	435	81.74	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			284.9	D08		5	0118-0427	257.71	426.72	386	73.84	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			288.0	D08		5	0119-0427	610.99	426.01	452	86.57	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			255.8	D08		5	0120-0427	511.47	427.34	436	80.91	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			248.3	D08		5	0121-0426	869.44	427.90	301	66.28	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			827.1	D08		5	0122-0430	942.75	429.56	334	72.77	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			396.9	D08		5	0123-0433	475.18	432.91	417	79.50	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			445.5	D08		5	0124-0438	60.42	438.38	370	77.50	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			303.1	D08		5	0125-0443	929.10	443.80	381	72.91	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			422.1	D08		5	0126-0447	231.28	446.57	418	88.08	0.677
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			224.0	D08		5	0127-0447	869.40	446.16	338	70.87	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			498.3	D08		5	0128-0455	318.95	455.36	393	78.33	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1581.7	D08		5	0129-0462	835.61	462.47	606	91.50	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			516.2	D08		5	0130-0461	121.51	461.01	426	79.50	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			312.0	D08		5	0131-0460	443.24	460.54	409	77.50	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			714.9	D08		5	0132-0462	254.37	461.53	431	78.43	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			406.2	D08		5	0133-0466	215.21	467.13	426	78.91	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			335.7	D08		5	0134-0467	783.67	467.61	406	76.67	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			497.1	D08		5	0135-0472	525.52	471.82	416	76.91	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			655.5	D08		5	0136-0482	99.73	482.31	414	75.26	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			265.4	D08		5	0137-0485	143.43	484.89	386	75.26	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			362.4	D08		5	0138-0485	294.49	485.32	292	62.77	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			444.9	D08		5	0139-0490	42.99	490.22	383	74.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			271.1	D08		5	0140-0493	370.45	493.36	377	74.91	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			281.5	D08		5	0141-0496	644.54	496.59	415	76.91	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			323.6	D08		5	0142-0498	489.71	498.57	453	82.33	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			517.5	D08		5	0143-0502	831.89	502.01	368	72.67	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			227.5	D08		5	0144-0505	939.56	504.88	436	78.08	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			624.8	D08		5	0145-0508	68.46	508.47	432	79.94	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1633.7	D08		5	0146-0511	887.28	511.66	578	90.08	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			334.8	D08		5	0147-0513	20.77	513.26	404	82.08	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			548.9	D08		5	0148-0521	754.52	520.67	409	79.50	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			453.9	D08		5	0149-0523	586.44	523.30	406	78.57	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			455.1	D08		5	0150-0524	298.76	524.83	424	77.26	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			295.1	D08		5	0151-0525	442.76	524.94	407	78.67	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			368.9	D08		5	0152-0528	529.27	528.32	415	77.50	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1779.3	D08		5	0153-0532	108.82	532.31	738	105.64	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			367.3	D08		5	0154-0531	148.05	531.10	448	80.57	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			291.6	D08		5	0155-0529	482.41	529.37	398	74.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			272.0	D08		5	0156-0530	666.31	530.21	407	77.50	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			342.9	D08		5	0157-0531	67.98	529.96	405	77.36	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			810.0	D08		5	0158-0535	709.02	534.75	398	76.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			428.9	D08		5	0159-0550	905.81	549.96	845	121.64	0.718
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			475.7	D08		5	0160-0541	804.22	541.10	367	73.26	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			396.6	D08		5	0161-0543	390.29	543.81	425	79.01	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			298.7	D08		5	0162-0553	412.75	553.04	430	81.26	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			303.7	D08		5	0163-0559	149.09	559.16	557	89.98	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			312.4	D08		5	0164-0560	464.84	560.33	400	78.33	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			499.3	D08		5	0165-0569	757.35	568.12	809	107.88	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			843.5	D08		5	0166-0564	348.33	564.29	444	81.98	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			257.4	D08		5	0167-0569	39.10	568.04	453	84.47	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			300.2	D08		5	0168-0567	599.41	567.21	398	75.84	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			545.8	D08		5	0169-0582	279.61	582.60	861	126.71	0.674
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			573.8	D08		5	0170-0581	25.58	580.97	352	75.15	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			478.6	D08		5	0171-0579	110.23	579.37	378	73.84	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			643.3	D08		5	0172-0581	667.06	581.06	445	80.57	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			474.4	D08		5	0173-0584	58.54	584.46	433	79.15	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			403.6	D08		5	0174-0598	387.24	598.06	913	122.51	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			560.2	D08		5	0175-0592	848.30	591.58	355	69.01	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			288.7	D08		5	0176-0601	452.23	600.94	405	78.57	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			397.5	D08		5	0177-0604	636.33	604.11	417	77.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			596.9	D08		5	0178-0605	707.85	604.88	396	75.84	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			319.6	D08		5	0179-0603	894.34	602.57	424	80.67	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			441.9	D08		5	0180-0611	815.51	611.80	316	65.60	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			702.3	D08		5	0181-0617	749.57	616.84	418	75.84	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			491.0	D08		5	0182-0619	670.03	619.32	407	77.50	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			297.2	D08		5	0183-0627	85.01	627.41	849	117.20	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			458.0	D08		5	0184-0623	380.27	623.57	412	79.98	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2486.6	D08		5	0185-0624	486.57	623.68	408	75.50	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			291.0	D08		5	0186-0636	229.62	636.89	400	80.23	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			395.5	D08		5	0187-0637	896.43	636.89	386	74.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			517.7	D08		5	0188-0639	432.10	639.78	760	107.01	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1323.4	D08		5	0189-0641	399.89	641.34	684	104.91	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2422.5	D08		5	0190-0639	702.72	639.73	363	71.70	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2572.7	D08		5	0191-0641	684.59	641.16	340	70.04	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			568.7	D08		5	0192-0641	833.67	641.18	407	77.26	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2588.9	D08		5	0193-0641	578.90	641.25	386	74.67	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			387.7	D08		5	0194-0644	503.10	644.83	399	75.84	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			571.4	D08		5	0195-0646	792.39	647.04	771	113.05	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			445.7	D08		5	0196-0651	154.62	650.94	391	77.84	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			283.3	D08		5	0197-0653	362.74	653.67	433	81.50	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			246.7	D08		5	0198-0669	557.75	669.58	859	118.02	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1037.5	D08		5	0199-0667	730.14	666.77	409	76.33	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			403.4	D08		5	0200-0669	620.03	669.13	394	76.33	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			403.9	D08		5	0201-0668	678.40	668.34	407	77.26	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			298.4	D08		5	0202-0675	431.90	674.98	414	76.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			252.0	D08		5	0203-0674	318.41	674.03	391	77.01	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			404.1	D08		5	0204-0680	259.83	680.16	394	74.67	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			606.6	D08		5	0205-0682	774.12	682.45	378	72.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			339.9	D08		5	0206-0694	727.59	694.73	419	81.15	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			473.4	D08		5	0207-0694	519.50	694.35	396	74.67	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2328.4	D08		5	0208-0699	210.55	699.05	729	105.88	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1050.5	D08		5	0209-0698	806.63	698.16	371	73.26	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			356.5	D08		5	0210-0704	886.47	704.50	369	71.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			392.6	D08		5	0211-0706	606.42	706.48	384	75.50	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			411.2	D08		6	0001-0031	828.76	31.67	370	71.94	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			294.1	D08		6	0002-0037	847.51	38.12	368	77.60	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			441.9	D08		6	0003-0036	327.60	35.24	339	72.43	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			443.5	D08		6	0004-0042	302.39	41.52	863	121.78	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			746.3	D08		6	0005-0040	923.26	40.40	314	67.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			377.9	D08		6	0006-0048	798.39	47.76	768	107.98	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			540.8	D08		6	0007-0042	130.25	42.06	351	69.60	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			510.6	D08		6	0008-0045	391.38	45.09	404	77.50	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			399.3	D08		6	0009-0049	556.89	49.61	411	80.43	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			359.8	D08		6	0010-0048	597.94	48.65	393	75.50	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			406.9	D08		6	0011-0048	16.62	48.20	323	75.01	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			395.2	D08		6	0012-0053	446.87	53.50	949	121.15	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			345.7	D08		6	0013-0051	666.15	50.88	389	74.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			435.7	D08		6	0014-0065	197.75	64.91	752	110.71	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1059.7	D08		6	0015-0066	900.72	66.61	403	75.84	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			958.9	D08		6	0016-0075	285.42	75.45	803	119.44	0.707
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			385.5	D08		6	0017-0073	628.35	74.13	785	115.64	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			345.7	D08		6	0018-0074	434.92	74.70	330	70.77	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			384.1	D08		6	0019-0078	746.11	77.93	391	73.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			445.2	D08		6	0020-0087	113.81	87.17	714	109.40	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			995.1	D08		6	0021-0082	859.99	81.94	372	74.91	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			614.6	D08		6	0022-0085	374.04	84.87	392	73.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			884.2	D08		6	0023-0094	723.11	93.67	421	78.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			826.7	D08		6	0024-0093	487.55	92.71	394	76.43	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			331.9	D08		6	0025-0094	774.76	94.30	418	78.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			329.4	D08		6	0026-0095	39.55	95.36	380	73.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			345.1	D08		6	0027-0102	836.77	101.45	590	115.05	0.560
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			355.1	D08		6	0028-0099	255.89	99.19	382	75.50	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			545.9	D08		6	0029-0100	595.90	99.78	365	72.67	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			401.1	D08		6	0030-0109	422.07	109.20	401	74.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1573.2	D08		6	0031-0126	484.81	126.11	881	126.71	0.690
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			689.5	D08		6	0032-0131	39.36	130.44	645	96.08	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			370.0	D08		6	0033-0131	549.78	131.58	381	73.84	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			660.2	D08		6	0034-0131	623.75	131.32	378	73.01	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			407.0	D08		6	0035-0132	172.95	132.44	376	77.26	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			333.1	D08		6	0036-0138	663.74	138.16	402	76.08	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1067.2	D08		6	0037-0140	893.42	140.11	365	71.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			300.1	D08		6	0038-0141	808.06	140.48	388	75.84	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			313.2	D08		6	0039-0144	271.47	144.83	389	76.57	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1831.4	D08		6	0040-0146	420.14	146.29	720	105.98	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			420.9	D08		6	0041-0145	457.69	145.41	336	70.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4216.7	D08		6	0042-0145	731.89	144.61	357	71.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			315.1	D08		6	0043-0147	106.08	147.62	398	74.67	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			373.6	D08		6	0044-0146	132.63	146.74	389	80.57	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			263.7	D08		6	0045-0148	301.61	148.60	373	73.50	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			420.6	D08		6	0046-0148	505.48	148.16	399	77.01	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			662.7	D08		6	0047-0149	838.37	149.10	369	72.67	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			300.1	D08		6	0048-0153	190.42	152.90	356	80.43	0.692
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			350.7	D08		6	0049-0159	767.90	159.50	381	75.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			263.1	D08		6	0050-0159	605.24	159.53	411	76.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			274.5	D08		6	0051-0163	326.95	162.93	371	72.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			366.0	D08		6	0052-0162	560.70	162.97	397	76.67	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			318.7	D08		6	0053-0165	928.56	164.82	391	73.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			312.3	D08		6	0054-0167	685.73	167.59	399	73.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			742.3	D08		6	0055-0167	474.63	166.86	391	76.18	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			476.1	D08		6	0056-0171	364.60	171.26	369	73.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			421.6	D08		6	0057-0177	70.64	177.11	396	78.18	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			350.3	D08		6	0058-0178	578.94	178.43	399	75.84	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			647.4	D08		6	0059-0178	93.26	177.67	356	71.94	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			536.5	D08		6	0060-0180	519.28	180.24	369	71.26	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			643.4	D08		6	0061-0188	811.84	187.98	356	71.60	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			418.9	D08		6	0062-0188	732.47	188.22	376	73.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			464.3	D08		6	0063-0188	398.67	187.91	374	72.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			396.8	D08		6	0064-0188	459.42	188.42	391	75.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3887.3	D08		6	0065-0192	707.38	192.26	387	74.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			467.6	D08		6	0066-0194	832.11	193.10	379	75.84	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			578.9	D08		6	0067-0201	129.67	201.14	384	77.26	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			604.8	D08		6	0068-0203	551.30	203.08	376	73.50	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4247.1	D08		6	0069-0204	902.38	204.65	333	66.77	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			378.6	D08		6	0070-0206	355.13	206.40	358	74.43	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			570.3	D08		6	0071-0212	635.35	212.48	399	75.01	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			422.6	D08		6	0072-0214	848.73	215.28	377	77.60	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4236.6	D08		6	0073-0218	932.27	216.97	345	69.26	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			300.6	D08		6	0074-0220	522.35	220.95	391	73.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			428.6	D08		6	0075-0221	324.97	222.47	425	81.01	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			417.2	D08		6	0076-0230	353.42	229.76	822	112.23	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			480.1	D08		6	0077-0233	441.72	232.72	428	80.91	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			359.5	D08		6	0078-0234	887.17	234.36	369	71.36	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			677.2	D08		6	0079-0237	83.22	237.34	399	76.67	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			277.7	D08		6	0080-0240	933.40	241.20	378	72.08	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			647.3	D08		6	0081-0243	854.49	242.67	365	73.84	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			480.7	D08		6	0082-0245	401.20	245.71	365	71.84	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1017.2	D08		6	0083-0244	460.99	244.95	355	75.60	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			286.4	D08		6	0084-0250	217.98	250.08	357	76.33	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			387.4	D08		6	0085-0253	628.92	252.95	378	72.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			288.8	D08		6	0086-0253	263.39	253.75	360	73.26	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			559.5	D08		6	0087-0262	36.17	262.36	722	103.05	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			548.3	D08		6	0088-0260	310.00	260.65	362	73.50	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			940.1	D08		6	0089-0260	102.18	261.17	346	70.43	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			392.6	D08		6	0090-0268	185.69	268.48	884	146.51	0.518
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1022.7	D08		6	0091-0263	454.94	263.11	449	84.67	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			433.3	D08		6	0092-0262	553.62	262.03	325	66.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			376.1	D08		6	0093-0270	678.00	270.01	375	72.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			518.5	D08		6	0094-0273	586.06	273.25	364	72.08	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			554.0	D08		6	0095-0275	369.55	275.52	397	75.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			617.0	D08		6	0096-0276	849.51	275.27	363	72.91	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			267.9	D08		6	0097-0278	235.02	278.33	349	72.43	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			971.3	D08		6	0098-0284	128.71	284.50	355	74.08	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			724.1	D08		6	0099-0287	632.49	287.12	274	61.84	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			391.0	D08		6	0100-0292	864.52	292.16	407	77.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			553.4	D08		6	0101-0296	383.05	296.44	374	73.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			320.8	D08		6	0102-0297	407.90	296.89	387	73.01	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			352.7	D08		6	0103-0297	509.90	297.42	392	72.43	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			869.7	D08		6	0104-0298	44.09	298.72	352	72.08	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			613.8	D08		6	0105-0303	766.26	302.90	352	73.26	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			336.0	D08		6	0106-0310	276.35	310.18	394	75.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			339.2	D08		6	0107-0310	593.44	310.26	370	72.67	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			721.9	D08		6	0108-0310	548.75	310.52	382	74.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			885.6	D08		6	0109-0311	832.11	310.47	382	73.26	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			398.5	D08		6	0110-0315	475.27	315.03	395	74.18	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2973.5	D08		6	0111-0319	683.10	318.92	642	100.47	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			486.7	D08		6	0112-0319	301.13	319.45	382	73.84	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			867.3	D08		6	0113-0327	211.18	328.27	839	117.88	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			353.6	D08		6	0114-0320	566.22	320.72	385	75.50	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3235.8	D08		6	0115-0320	898.68	319.64	306	67.84	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			311.0	D08		6	0116-0322	354.69	321.99	394	75.50	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			798.0	D08		6	0117-0322	717.14	322.36	564	101.26	0.691
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			304.3	D08		6	0118-0328	640.59	328.33	362	75.26	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			445.1	D08		6	0119-0334	269.16	334.69	433	86.08	0.734
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			751.8	D08		6	0120-0332	495.27	331.52	399	74.18	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			968.5	D08		6	0121-0337	817.75	337.00	419	78.33	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3535.1	D08		6	0122-0339	909.62	339.16	468	81.74	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			380.7	D08		6	0123-0340	792.67	339.73	461	82.33	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			551.7	D08		6	0124-0346	23.77	346.14	733	109.64	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			307.0	D08		6	0125-0347	629.09	348.15	482	91.15	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			712.5	D08		6	0126-0349	772.87	349.59	347	73.74	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			602.2	D08		6	0127-0350	932.91	350.68	699	110.81	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			380.5	D08		6	0128-0353	876.46	352.96	385	73.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			365.2	D08		6	0129-0358	727.31	358.52	378	72.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			457.9	D08		6	0130-0371	408.14	370.44	795	118.02	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1618.9	D08		6	0131-0366	226.35	365.77	908	116.33	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			518.6	D08		6	0132-0372	118.56	372.22	342	68.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			553.3	D08		6	0133-0380	171.75	380.43	359	71.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			478.8	D08		6	0134-0381	686.19	380.93	378	72.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			310.6	D08		6	0135-0386	356.86	385.91	362	71.84	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			408.6	D08		6	0136-0386	898.63	385.61	350	70.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			337.2	D08		6	0137-0389	582.02	388.69	403	77.26	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			275.8	D08		6	0138-0393	465.08	393.73	397	76.33	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			366.9	D08		6	0139-0396	531.89	396.65	383	73.60	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			525.5	D08		6	0140-0398	404.18	398.80	397	75.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			414.8	D08		6	0141-0399	263.14	398.89	376	72.43	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			761.6	D08		6	0142-0406	755.66	406.81	828	112.81	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			511.5	D08		6	0143-0400	846.75	399.69	373	72.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			387.3	D08		6	0144-0404	713.06	404.11	418	78.91	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			367.0	D08		6	0145-0406	671.17	405.85	361	71.26	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			317.6	D08		6	0146-0413	138.98	413.47	371	79.74	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			548.8	D08		6	0147-0418	488.43	418.69	409	76.08	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			257.3	D08		6	0148-0420	205.89	419.93	366	72.67	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			539.1	D08		6	0149-0430	813.04	431.09	381	73.26	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			479.6	D08		6	0150-0431	347.02	431.33	380	73.01	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			419.4	D08		6	0151-0432	434.56	432.26	372	75.26	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			476.4	D08		6	0152-0433	386.89	433.27	332	67.01	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			518.5	D08		6	0153-0436	534.23	436.43	387	74.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			567.0	D08		6	0154-0436	566.83	435.94	392	77.50	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			521.4	D08		6	0155-0448	223.60	447.98	776	111.20	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			308.8	D08		6	0156-0444	25.13	445.46	410	79.64	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			483.9	D08		6	0157-0442	879.80	442.45	368	73.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			349.2	D08		6	0158-0453	629.25	451.93	805	122.61	0.673
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			773.9	D08		6	0159-0450	286.83	449.76	498	109.40	0.523
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			590.1	D08		6	0160-0455	546.95	455.76	440	81.26	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			384.8	D08		6	0161-0473	695.65	471.41	849	123.44	0.700
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			473.8	D08		6	0162-0463	767.08	463.73	453	79.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1930.3	D08		6	0163-0470	934.85	469.19	674	102.33	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			931.2	D08		6	0164-0464	910.91	463.51	355	70.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			351.6	D08		6	0165-0469	376.31	469.53	372	70.18	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			669.1	D08		6	0166-0471	177.58	471.75	413	78.67	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			460.2	D08		6	0167-0472	54.05	472.63	343	69.01	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			254.7	D08		6	0168-0475	592.81	474.91	415	75.26	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			364.6	D08		6	0169-0480	324.79	480.81	759	105.74	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			521.8	D08		6	0170-0479	435.04	479.50	376	72.18	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			793.0	D08		6	0171-0483	813.03	483.23	375	74.43	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			263.0	D08		6	0172-0490	770.88	489.39	662	102.91	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2314.9	D08		6	0173-0486	201.54	486.03	380	75.60	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			577.1	D08		6	0174-0487	278.85	487.89	358	69.84	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2478.1	D08		6	0175-0490	245.27	490.50	362	71.84	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			460.0	D08		6	0176-0491	477.77	491.04	428	78.08	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			380.6	D08		6	0177-0498	678.58	499.23	426	79.74	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			386.1	D08		6	0178-0503	118.99	502.66	441	82.57	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2366.4	D08		6	0179-0501	369.40	501.07	369	71.01	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			305.0	D08		6	0180-0503	572.50	503.11	376	74.08	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			250.4	D08		6	0181-0507	34.40	507.78	383	74.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1354.4	D08		6	0182-0509	934.67	508.54	372	73.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			504.3	D08		6	0183-0515	705.36	514.46	392	76.08	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			493.5	D08		6	0184-0512	735.76	512.62	377	75.26	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			741.5	D08		6	0185-0515	198.35	514.67	343	69.60	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			384.7	D08		6	0186-0516	403.12	516.95	377	75.50	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			706.0	D08		6	0187-0528	142.35	527.67	783	122.61	0.655
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			292.8	D08		6	0188-0521	640.20	521.47	403	76.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3513.3	D08		6	0189-0526	248.39	526.31	355	74.91	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			515.5	D08		6	0190-0528	434.65	528.06	364	72.08	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			594.4	D08		6	0191-0539	888.16	539.47	358	68.43	0.961
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			274.6	D08		6	0192-0542	349.12	542.31	386	77.74	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1222.7	D08		6	0193-0550	301.34	550.65	719	105.05	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			369.3	D08		6	0194-0551	111.29	551.67	350	72.91	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			449.9	D08		6	0195-0554	594.03	554.14	397	74.43	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			281.9	D08		6	0196-0555	943.52	555.19	380	73.50	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			470.5	D08		6	0197-0560	443.60	560.66	366	71.84	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			557.5	D08		6	0198-0565	548.38	565.67	372	72.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			401.1	D08		6	0199-0566	171.46	566.61	359	71.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2217.6	D08		6	0200-0571	341.12	571.02	415	82.57	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			467.9	D08		6	0201-0577	784.16	577.07	769	108.81	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			769.0	D08		6	0202-0572	251.05	572.93	407	78.67	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			291.8	D08		6	0203-0572	619.51	572.04	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			424.7	D08		6	0204-0579	74.03	580.39	662	103.40	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3328.7	D08		6	0205-0580	287.78	580.05	376	74.43	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			518.6	D08		6	0206-0579	367.26	578.81	401	77.74	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			314.0	D08		6	0207-0580	819.65	579.49	354	70.43	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			655.5	D08		6	0208-0580	416.10	580.75	378	72.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			394.3	D08		6	0209-0590	474.71	590.58	792	118.47	0.709
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			360.0	D08		6	0210-0582	229.54	582.17	384	74.43	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			629.8	D08		6	0211-0584	716.08	583.65	355	71.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			300.6	D08		6	0212-0590	110.68	589.95	361	72.91	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			564.9	D08		6	0213-0593	326.52	594.57	419	80.91	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1709.1	D08		6	0214-0597	508.27	597.88	502	83.50	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			310.1	D08		6	0215-0598	50.21	597.98	354	72.43	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			309.1	D08		6	0216-0597	558.93	597.18	395	77.01	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			665.4	D08		6	0217-0607	748.76	606.91	688	100.23	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			825.5	D08		6	0218-0603	376.33	604.40	395	79.74	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			396.4	D08		6	0219-0605	166.55	604.53	415	78.18	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			343.2	D08		6	0220-0611	220.68	610.92	370	74.67	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			436.8	D08		6	0221-0613	581.72	612.72	410	78.18	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			267.5	D08		6	0222-0616	412.19	617.09	369	73.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2383.1	D08		6	0223-0624	98.62	624.57	714	100.81	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3206.9	D08		6	0224-0625	180.36	625.83	398	80.43	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			580.3	D08		6	0225-0623	537.52	622.87	384	75.26	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			270.1	D08		6	0226-0635	454.28	635.05	378	73.01	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1560.8	D08		6	0227-0640	821.88	639.14	554	88.57	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			385.4	D08		6	0228-0644	624.45	644.80	425	77.26	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			390.0	D08		6	0229-0645	276.57	645.18	379	74.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1304.4	D08		6	0230-0648	571.47	648.92	714	103.40	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			333.9	D08		6	0231-0647	189.76	646.38	378	79.26	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1171.8	D08		6	0232-0654	371.70	653.98	762	108.47	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			275.8	D08		6	0233-0654	804.65	654.82	380	74.91	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1400.4	D08		6	0234-0650	679.35	650.37	197	55.11	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			255.4	D08		6	0235-0661	46.26	661.50	326	70.18	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			360.6	D08		6	0236-0663	320.64	663.16	378	72.67	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			443.2	D08		6	0237-0666	492.29	665.81	354	70.43	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			252.1	D08		6	0238-0670	135.52	670.49	346	73.26	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			292.2	D08		6	0239-0671	107.79	671.25	366	74.91	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			295.3	D08		6	0240-0676	444.57	675.86	391	73.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			999.2	D08		6	0241-0677	193.75	677.33	365	71.84	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			414.0	D08		6	0242-0680	830.19	680.26	357	70.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			239.4	D08		6	0243-0683	520.86	683.19	371	75.74	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			365.1	D08		6	0244-0686	287.13	685.70	375	73.26	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			483.8	D08		6	0245-0693	909.27	692.95	359	69.84	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			424.5	D08		6	0246-0696	601.90	695.47	367	73.98	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			523.7	D08		6	0247-0703	803.69	703.90	373	74.43	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			373.0	D08		6	0248-0703	212.96	703.48	341	67.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			495.6	D08		6	0249-0708	315.46	708.28	363	75.01	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			355.8	D08		7	0001-0038	138.70	38.64	783	109.88	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			518.3	D08		7	0002-0034	800.14	34.58	338	69.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			667.5	D08		7	0003-0039	895.20	39.35	401	77.26	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			280.7	D08		7	0004-0038	601.43	38.88	500	84.91	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			366.6	D08		7	0005-0042	281.00	42.21	836	111.64	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			273.6	D08		7	0006-0049	348.32	49.45	926	126.02	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			393.1	D08		7	0007-0044	702.80	44.53	423	77.26	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			371.8	D08		7	0008-0059	821.65	58.95	463	82.91	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			304.0	D08		7	0009-0066	79.13	65.78	449	81.15	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2810.4	D08		7	0010-0071	851.75	70.91	773	109.64	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			344.5	D08		7	0011-0070	394.91	69.33	475	86.91	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			368.2	D08		7	0012-0068	431.23	68.86	349	75.84	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			349.4	D08		7	0013-0078	251.23	76.72	434	79.74	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			383.2	D08		7	0014-0081	185.35	81.82	462	82.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			359.1	D08		7	0015-0087	704.28	87.06	423	77.26	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			377.8	D08		7	0016-0086	911.36	85.55	459	81.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			393.3	D08		7	0017-0090	439.34	90.38	570	96.67	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			300.8	D08		7	0018-0090	387.39	89.99	430	83.01	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			418.0	D08		7	0019-0089	534.01	89.23	451	81.50	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			255.7	D08		7	0020-0091	755.54	92.27	522	89.74	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			264.4	D08		7	0021-0091	938.49	90.77	487	85.50	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			453.9	D08		7	0022-0092	650.55	92.57	472	82.08	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			360.7	D08		7	0023-0093	237.84	94.47	446	80.57	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			338.0	D08		7	0024-0094	319.02	94.51	414	78.91	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			382.9	D08		7	0025-0096	815.37	96.64	456	87.40	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			655.1	D08		7	0026-0095	69.91	95.59	424	79.74	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			394.5	D08		7	0027-0098	845.18	97.93	502	87.15	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			296.0	D08		7	0028-0105	118.84	105.54	422	79.26	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			290.8	D08		7	0029-0106	732.48	106.57	433	80.91	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			470.9	D08		7	0030-0121	299.24	120.12	332	71.50	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			436.6	D08		7	0031-0124	358.14	124.35	404	76.67	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			278.7	D08		7	0032-0127	686.23	126.65	419	77.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			640.8	D08		7	0033-0126	894.96	126.18	404	76.67	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			473.6	D08		7	0034-0127	281.81	128.32	393	78.08	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			368.2	D08		7	0035-0134	17.37	135.18	431	82.91	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			415.8	D08		7	0036-0135	649.93	135.03	457	80.33	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			394.3	D08		7	0037-0137	769.78	137.10	439	82.91	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			330.0	D08		7	0038-0140	523.99	140.31	478	84.33	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			413.6	D08		7	0039-0142	721.43	141.48	426	78.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2312.1	D08		7	0040-0146	451.98	146.47	778	109.74	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			387.9	D08		7	0041-0146	107.97	146.29	445	79.26	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			381.6	D08		7	0042-0148	135.96	147.29	444	84.33	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			343.5	D08		7	0043-0149	316.88	149.62	395	74.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			328.1	D08		7	0044-0154	781.79	154.36	461	87.15	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			261.0	D08		7	0045-0156	845.85	156.05	488	85.74	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			349.0	D08		7	0046-0162	363.17	161.47	444	84.67	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			399.7	D08		7	0047-0166	385.36	167.21	434	82.77	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1586.8	D08		7	0048-0172	184.53	172.77	562	92.81	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			440.5	D08		7	0049-0173	454.80	171.96	385	78.18	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			369.9	D08		7	0050-0177	288.22	177.19	491	92.81	0.716
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			328.5	D08		7	0051-0178	528.37	178.22	462	85.15	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			735.0	D08		7	0052-0182	51.09	181.36	409	81.05	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			494.9	D08		7	0053-0194	217.97	194.61	776	108.47	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			640.9	D08		7	0054-0197	36.31	198.74	416	81.15	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			416.5	D08		7	0055-0194	138.10	194.57	402	78.08	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			294.7	D08		7	0056-0201	825.33	201.22	458	81.50	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			271.4	D08		7	0057-0208	730.55	207.85	446	88.57	0.714
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			412.6	D08		7	0058-0208	651.04	208.27	465	82.33	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			491.1	D08		7	0059-0209	931.10	209.15	402	78.18	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			270.3	D08		7	0060-0210	274.48	209.99	433	78.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			313.0	D08		7	0061-0213	760.79	212.74	447	80.91	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			418.2	D08		7	0062-0214	792.02	214.30	410	78.33	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1965.2	D08		7	0063-0221	335.11	221.41	436	81.50	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			329.6	D08		7	0064-0221	686.85	220.76	434	77.26	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			468.8	D08		7	0065-0226	873.19	225.05	349	72.33	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			557.6	D08		7	0066-0235	496.90	234.92	499	86.57	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			532.2	D08		7	0067-0239	853.50	238.86	887	116.37	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1933.8	D08		7	0068-0242	232.59	242.28	472	86.57	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3313.9	D08		7	0069-0250	596.44	249.54	397	76.81	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			318.3	D08		7	0070-0250	392.33	250.19	439	78.08	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1021.9	D08		7	0071-0253	203.63	253.94	172	82.91	0.314
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2746.2	D08		7	0072-0262	582.42	264.15	519	91.64	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			358.8	D08		7	0073-0274	91.69	274.93	849	123.54	0.699
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			304.0	D08		7	0074-0270	456.40	270.98	443	81.50	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			452.1	D08		7	0075-0276	191.03	275.28	408	79.40	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			704.3	D08		7	0076-0275	698.99	275.48	495	84.91	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			415.5	D08		7	0077-0279	151.50	279.75	427	83.40	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			348.5	D08		7	0078-0280	370.65	281.07	732	107.64	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			304.4	D08		7	0079-0279	493.68	278.87	455	82.33	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			458.4	D08		7	0080-0284	593.04	284.29	489	89.26	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			350.8	D08		7	0081-0295	181.32	296.34	462	87.15	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			472.1	D08		7	0082-0293	287.27	293.14	439	78.08	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			476.5	D08		7	0083-0293	398.40	293.43	479	89.15	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3742.6	D08		7	0084-0295	218.71	295.12	453	81.84	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			579.5	D08		7	0085-0315	421.37	315.20	835	113.88	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			244.6	D08		7	0086-0310	316.18	309.58	428	79.74	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			368.8	D08		7	0087-0314	523.18	314.28	453	82.91	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			398.0	D08		7	0088-0316	619.29	316.35	441	79.26	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3480.9	D08		7	0089-0316	210.40	316.01	418	82.43	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			652.4	D08		7	0090-0329	749.51	328.37	902	121.64	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			458.4	D08		7	0091-0324	675.43	324.14	441	81.60	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			565.1	D08		7	0092-0324	697.35	323.76	542	89.01	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			264.6	D08		7	0093-0330	923.70	330.27	449	81.74	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			412.8	D08		7	0094-0333	865.05	333.11	417	79.50	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			647.7	D08		7	0095-0334	184.98	334.20	426	78.08	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			422.2	D08		7	0096-0340	353.74	339.76	780	111.88	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			353.2	D08		7	0097-0337	503.83	337.39	471	87.98	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			294.5	D08		7	0098-0342	475.99	341.85	503	87.40	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			733.7	D08		7	0099-0352	433.49	352.00	279	62.18	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			423.9	D08		7	0100-0355	632.91	355.63	454	79.26	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			412.9	D08		7	0101-0357	886.90	357.71	400	75.01	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1992.8	D08		7	0102-0365	831.24	365.48	778	105.64	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1453.4	D08		7	0103-0372	28.17	372.53	757	109.84	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			514.7	D08		7	0104-0379	122.49	379.22	502	90.18	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			460.0	D08		7	0105-0383	142.26	381.40	342	74.43	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			660.3	D08		7	0106-0384	326.48	383.91	537	91.15	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			389.9	D08		7	0107-0385	592.79	385.21	478	82.91	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			458.0	D08		7	0108-0390	198.62	390.20	396	77.26	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			405.9	D08		7	0109-0390	648.07	390.05	430	79.26	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			408.9	D08		7	0110-0392	353.79	391.83	524	97.64	0.691
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			330.7	D08		7	0111-0395	155.03	396.14	484	86.81	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			334.6	D08		7	0112-0393	388.35	393.40	457	80.91	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			363.6	D08		7	0113-0401	715.27	400.99	439	83.74	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			580.5	D08		7	0114-0401	910.08	400.87	410	77.26	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			778.6	D08		7	0115-0402	80.39	401.50	410	78.08	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1173.5	D08		7	0116-0408	115.91	409.20	851	116.95	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			386.0	D08		7	0117-0406	47.71	407.15	428	79.60	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			616.0	D08		7	0118-0417	672.49	417.03	472	85.50	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			308.5	D08		7	0119-0419	258.24	419.29	418	75.26	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			285.7	D08		7	0120-0419	852.42	418.87	438	77.84	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			321.5	D08		7	0121-0422	462.95	422.00	463	84.57	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2015.2	D08		7	0122-0428	737.20	428.53	799	106.23	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			347.6	D08		7	0123-0426	357.00	426.46	420	78.91	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			322.8	D08		7	0124-0433	207.82	432.94	401	76.67	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			546.9	D08		7	0125-0439	548.38	439.23	853	114.71	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			409.6	D08		7	0126-0445	130.87	445.13	436	81.15	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			496.7	D08		7	0127-0446	872.69	446.15	435	79.50	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			254.9	D08		7	0128-0450	177.60	449.89	471	86.57	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			559.4	D08		7	0129-0458	504.55	457.94	831	112.13	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			361.6	D08		7	0130-0453	617.91	452.19	430	79.98	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			362.2	D08		7	0131-0460	330.60	460.23	433	78.08	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			372.8	D08		7	0132-0469	633.26	470.21	488	85.40	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			432.7	D08		7	0133-0468	685.96	468.34	437	78.91	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			559.8	D08		7	0134-0469	439.37	469.24	443	79.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			350.7	D08		7	0135-0469	568.45	470.06	280	84.08	0.498
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			444.0	D08		7	0136-0482	928.02	481.95	894	116.95	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			301.3	D08		7	0137-0483	224.25	482.98	421	78.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			269.4	D08		7	0138-0488	77.97	488.45	444	86.23	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			457.4	D08		7	0139-0489	119.46	489.20	400	77.74	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			546.3	D08		7	0140-0503	605.96	503.79	865	116.95	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			614.5	D08		7	0141-0497	448.54	497.80	458	85.15	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			411.8	D08		7	0142-0497	732.17	496.51	436	82.33	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			321.7	D08		7	0143-0497	846.56	496.51	448	80.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			513.9	D08		7	0144-0503	791.27	504.05	818	111.40	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			467.0	D08		7	0145-0504	534.13	504.29	423	77.26	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			393.4	D08		7	0146-0515	397.56	515.35	711	101.40	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			445.3	D08		7	0147-0514	492.38	514.36	432	78.08	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			457.7	D08		7	0148-0520	198.34	520.33	422	77.84	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			380.8	D08		7	0149-0530	560.96	529.57	474	82.57	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			283.4	D08		7	0150-0531	79.84	531.52	448	83.74	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			530.8	D08		7	0151-0534	692.82	534.27	465	85.74	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2478.8	D08		7	0152-0535	859.44	536.14	554	92.47	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			872.4	D08		7	0153-0539	427.78	539.12	414	80.67	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			383.5	D08		7	0154-0547	781.55	547.27	855	118.27	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			473.3	D08		7	0155-0543	216.52	543.56	474	84.33	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			238.7	D08		7	0156-0545	16.05	545.35	394	75.60	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			327.6	D08		7	0157-0546	129.51	546.04	410	80.81	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			303.3	D08		7	0158-0546	542.56	547.35	493	85.98	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2126.8	D08		7	0159-0548	312.37	548.53	846	119.05	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			295.2	D08		7	0160-0556	876.68	556.26	486	84.33	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			644.3	D08		7	0161-0559	421.15	559.94	631	96.91	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			424.0	D08		7	0162-0558	643.98	558.24	421	78.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			297.5	D08		7	0163-0559	697.13	559.46	444	83.50	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			345.4	D08		7	0164-0570	241.67	569.63	417	77.50	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			428.7	D08		7	0165-0574	335.74	574.52	423	81.98	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			374.6	D08		7	0166-0582	939.06	582.12	412	79.60	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2781.7	D08		7	0167-0585	53.65	585.14	766	105.64	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			464.5	D08		7	0168-0583	619.72	583.61	431	76.43	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			351.1	D08		7	0169-0585	567.84	585.96	426	78.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			558.5	D08		7	0170-0587	200.56	587.01	459	81.50	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			338.0	D08		7	0171-0586	381.16	586.27	433	80.91	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			313.9	D08		7	0172-0602	84.26	601.97	412	79.98	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			842.5	D08		7	0173-0608	779.71	607.96	426	77.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1775.7	D08		7	0174-0610	934.27	610.47	448	84.91	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			282.1	D08		7	0175-0612	143.13	612.04	417	84.57	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			345.4	D08		7	0176-0613	692.71	612.59	428	79.26	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			443.9	D08		7	0177-0615	439.99	614.55	437	80.08	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			420.9	D08		7	0178-0622	309.28	622.42	452	80.91	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			484.8	D08		7	0179-0623	216.34	623.50	469	83.26	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			465.7	D08		7	0180-0634	512.13	633.38	446	82.33	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			263.4	D08		7	0181-0636	62.85	636.45	401	76.67	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			462.4	D08		7	0182-0643	332.89	641.98	838	120.13	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			374.0	D08		7	0183-0645	399.66	644.48	449	81.84	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			396.4	D08		7	0184-0647	279.46	648.02	378	80.33	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			454.2	D08		7	0185-0651	639.67	650.98	435	79.01	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			378.7	D08		7	0186-0651	360.99	651.61	463	84.08	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			329.2	D08		7	0187-0655	250.20	654.26	469	86.57	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			406.7	D08		7	0188-0659	500.84	660.70	463	85.74	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			511.4	D08		7	0189-0655	433.42	656.14	379	75.70	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			290.8	D08		7	0190-0660	835.93	660.18	449	80.91	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			385.3	D08		7	0191-0669	391.30	670.27	462	88.81	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			975.3	D08		7	0192-0667	17.13	667.33	458	80.91	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			523.2	D08		7	0193-0667	193.70	667.19	437	79.50	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			352.8	D08		7	0194-0664	222.97	664.04	250	64.43	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			307.9	D08		7	0195-0669	130.34	669.31	415	83.15	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			264.1	D08		7	0196-0671	563.62	671.83	434	80.33	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			424.1	D08		7	0197-0674	744.60	674.36	401	75.50	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			498.4	D08		7	0198-0675	434.96	673.95	430	80.53	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			404.1	D08		7	0199-0680	247.12	680.98	481	89.15	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			364.2	D08		7	0200-0680	297.85	680.08	407	76.43	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			419.3	D08		7	0201-0679	881.66	679.17	397	75.01	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			493.1	D08		7	0202-0683	463.49	683.36	413	78.33	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1991.5	D08		7	0203-0689	910.76	689.07	428	78.67	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			313.5	D08		7	0204-0690	55.66	689.63	424	76.67	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			787.8	D08		7	0205-0698	689.45	697.40	443	86.23	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			345.1	D08		7	0206-0698	656.88	697.85	407	79.15	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			444.2	D08		7	0207-0703	605.62	703.64	412	76.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			403.1	D08		7	0208-0704	351.70	704.08	420	77.26	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			336.5	D08		7	0209-0704	531.98	704.73	484	84.67	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			609.2	D08		7	0210-0704	215.33	704.39	385	72.43	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			313.3	D08		7	0211-0709	508.12	709.51	296	69.84	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			404.5	D08		8	0001-0032	884.95	31.78	381	72.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			431.4	D08		8	0002-0036	369.69	35.91	465	82.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			442.7	D08		8	0003-0034	604.87	34.26	413	78.08	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			450.8	D08		8	0004-0039	695.81	39.74	434	85.64	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			273.8	D08		8	0005-0039	424.75	39.71	513	90.57	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			319.8	D08		8	0006-0042	59.13	41.84	406	76.67	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			331.9	D08		8	0007-0042	116.37	41.58	475	85.40	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			381.1	D08		8	0008-0053	446.51	51.28	509	86.23	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			337.2	D08		8	0009-0060	500.17	59.63	448	81.74	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			492.6	D08		8	0010-0061	133.24	61.79	472	84.33	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			514.9	D08		8	0011-0062	572.17	62.39	818	115.78	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			261.9	D08		8	0012-0065	460.15	66.11	402	78.23	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			310.3	D08		8	0013-0063	918.16	63.17	393	76.33	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			388.1	D08		8	0014-0066	744.30	66.04	400	75.01	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			461.4	D08		8	0015-0073	691.30	73.55	412	75.01	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			241.4	D08		8	0016-0073	860.83	73.44	448	82.57	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			457.2	D08		8	0017-0075	834.89	75.31	412	77.26	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			337.5	D08		8	0018-0078	776.98	78.13	421	78.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			292.3	D08		8	0019-0082	174.03	82.31	390	78.08	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			346.0	D08		8	0020-0083	273.25	83.30	414	77.26	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			401.0	D08		8	0021-0092	219.98	92.53	851	121.05	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			436.5	D08		8	0022-0085	109.71	85.02	386	72.43	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			341.0	D08		8	0023-0088	17.17	87.83	451	82.08	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			252.1	D08		8	0024-0093	44.18	92.84	455	81.50	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			273.1	D08		8	0025-0094	894.42	94.34	407	76.43	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			371.7	D08		8	0026-0098	431.25	98.10	437	83.15	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			354.7	D08		8	0027-0100	366.00	100.19	409	76.67	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			455.6	D08		8	0028-0110	622.43	110.49	865	119.98	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			585.4	D08		8	0029-0107	652.75	107.06	446	81.01	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			684.4	D08		8	0030-0111	703.55	110.95	404	76.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			479.9	D08		8	0031-0113	73.92	113.83	409	77.84	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			282.4	D08		8	0032-0114	142.14	114.63	404	78.91	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			498.1	D08		8	0033-0116	682.50	115.95	406	75.36	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			253.7	D08		8	0034-0119	820.27	119.15	422	77.26	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			337.5	D08		8	0035-0132	728.98	132.30	480	86.57	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			499.3	D08		8	0036-0131	552.04	130.76	407	76.67	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			376.7	D08		8	0037-0141	469.46	141.36	908	135.68	0.620
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			544.6	D08		8	0038-0132	614.30	132.68	390	79.36	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2419.2	D08		8	0039-0144	279.56	144.71	608	95.64	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			407.4	D08		8	0040-0143	414.75	143.33	406	77.50	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			325.6	D08		8	0041-0154	61.26	154.33	437	80.33	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			319.0	D08		8	0042-0153	869.81	153.09	405	77.26	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			270.9	D08		8	0043-0157	138.42	157.09	429	82.08	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			396.4	D08		8	0044-0157	562.84	158.13	412	80.33	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			845.2	D08		8	0045-0159	165.70	159.40	498	90.81	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			401.1	D08		8	0046-0165	521.33	164.82	413	76.67	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			363.4	D08		8	0047-0167	739.78	167.56	428	78.08	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			468.9	D08		8	0048-0168	624.74	168.55	454	80.77	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			372.2	D08		8	0049-0183	567.41	184.60	849	121.78	0.719
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			262.2	D08		8	0050-0183	384.62	183.38	418	79.50	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			614.9	D08		8	0051-0184	277.53	185.34	517	86.53	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			386.6	D08		8	0052-0184	694.35	183.56	388	75.26	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			259.3	D08		8	0053-0186	890.52	186.22	434	79.84	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			304.6	D08		8	0054-0195	913.07	195.23	848	119.15	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1797.1	D08		8	0055-0198	206.93	198.85	984	120.71	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			567.2	D08		8	0056-0192	625.24	191.31	474	84.18	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			477.9	D08		8	0057-0200	484.87	201.08	671	104.37	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			284.2	D08		8	0058-0199	359.06	199.18	446	83.15	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			293.1	D08		8	0059-0200	527.88	200.43	408	79.15	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			491.0	D08		8	0060-0204	711.12	205.37	848	118.13	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			259.5	D08		8	0061-0205	666.68	205.58	439	80.67	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			344.1	D08		8	0062-0206	779.10	206.07	414	77.26	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			350.9	D08		8	0063-0214	276.88	213.77	792	116.43	0.734
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			485.6	D08		8	0064-0211	35.92	211.97	421	83.01	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			304.0	D08		8	0065-0211	447.74	211.02	441	84.23	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			343.2	D08		8	0066-0216	96.43	217.15	848	116.71	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			742.3	D08		8	0067-0217	253.06	216.84	436	81.01	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			530.6	D08		8	0068-0224	158.37	224.36	418	77.50	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			340.3	D08		8	0069-0228	583.30	228.46	464	85.15	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			401.2	D08		8	0070-0226	851.41	226.38	407	75.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			527.1	D08		8	0071-0237	309.49	237.76	822	113.40	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			407.4	D08		8	0072-0241	284.94	240.54	473	87.36	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			436.9	D08		8	0073-0242	529.69	242.68	413	77.26	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			350.0	D08		8	0074-0240	630.78	239.82	350	72.67	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			335.3	D08		8	0075-0244	789.97	244.51	403	78.33	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			340.7	D08		8	0076-0247	607.99	247.34	445	82.91	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			645.1	D08		8	0077-0260	332.57	260.05	459	82.67	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			410.9	D08		8	0078-0259	477.08	259.25	378	72.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			353.5	D08		8	0079-0260	692.38	261.20	452	80.53	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			448.5	D08		8	0080-0277	257.21	277.66	846	112.37	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			493.5	D08		8	0081-0276	832.37	276.41	609	96.33	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			338.0	D08		8	0082-0274	77.86	273.62	372	74.33	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			509.4	D08		8	0083-0277	649.69	277.28	452	78.67	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			443.2	D08		8	0084-0279	438.27	278.77	417	77.26	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			809.5	D08		8	0085-0284	185.71	284.27	400	77.74	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			307.2	D08		8	0086-0282	884.17	282.00	325	67.01	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			363.6	D08		8	0087-0284	913.06	284.55	406	75.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			311.0	D08		8	0088-0285	118.78	285.70	421	81.40	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			314.6	D08		8	0089-0284	691.85	283.76	461	83.36	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			408.0	D08		8	0090-0286	590.33	286.02	441	83.40	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			528.7	D08		8	0091-0289	62.19	290.24	495	87.05	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			326.3	D08		8	0092-0289	215.23	288.87	428	76.67	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2206.1	D08		8	0093-0292	545.64	292.36	775	106.23	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			384.7	D08		8	0094-0292	733.36	292.72	814	108.57	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			271.7	D08		8	0095-0292	385.56	292.55	865	120.81	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			340.2	D08		8	0096-0294	505.09	292.74	453	88.47	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			294.4	D08		8	0097-0301	945.77	302.32	413	79.26	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			313.9	D08		8	0098-0321	99.54	320.91	400	76.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			312.0	D08		8	0099-0321	502.87	321.41	431	77.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			418.6	D08		8	0100-0319	659.31	318.85	429	79.26	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			402.5	D08		8	0101-0336	890.29	336.90	826	119.68	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			339.9	D08		8	0102-0329	912.12	328.16	412	82.33	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			282.2	D08		8	0103-0332	28.83	332.23	415	79.15	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			319.9	D08		8	0104-0336	249.69	335.89	411	79.74	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			325.1	D08		8	0105-0334	844.38	334.08	456	79.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			397.3	D08		8	0106-0339	425.15	339.81	395	77.60	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			294.9	D08		8	0107-0340	652.93	341.37	469	84.91	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			282.6	D08		8	0108-0342	342.76	342.06	413	78.67	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			381.5	D08		8	0109-0341	386.82	341.56	467	83.50	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			311.1	D08		8	0110-0342	786.67	342.22	406	76.67	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1898.7	D08		8	0111-0348	449.67	347.65	724	104.91	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			287.5	D08		8	0112-0347	166.15	347.14	412	77.50	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			360.3	D08		8	0113-0358	547.03	358.86	868	122.85	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			380.4	D08		8	0114-0349	211.63	349.20	437	79.50	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			364.6	D08		8	0115-0357	711.60	357.80	419	78.91	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			301.3	D08		8	0116-0363	399.47	362.29	445	81.84	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			369.3	D08		8	0117-0372	497.55	372.35	460	81.84	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			386.4	D08		8	0118-0374	757.54	374.67	449	80.91	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			796.3	D08		8	0119-0376	601.74	376.51	426	79.74	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			476.6	D08		8	0120-0378	784.90	377.44	438	79.50	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			499.3	D08		8	0121-0381	304.43	382.27	420	80.18	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			273.2	D08		8	0122-0389	60.15	389.85	389	76.33	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1790.7	D08		8	0123-0393	428.91	394.39	864	118.37	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2784.0	D08		8	0124-0400	117.36	399.99	841	114.13	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			431.2	D08		8	0125-0391	520.05	391.20	456	84.91	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			404.4	D08		8	0126-0394	689.93	393.77	429	76.43	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			395.6	D08		8	0127-0396	907.28	396.73	421	79.84	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			287.7	D08		8	0128-0401	177.10	400.90	434	80.08	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			592.9	D08		8	0129-0403	15.32	402.92	373	72.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			381.1	D08		8	0130-0407	308.11	406.08	476	84.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			505.4	D08		8	0131-0405	651.10	405.55	421	78.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			435.9	D08		8	0132-0411	850.74	411.27	371	71.60	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			285.2	D08		8	0133-0413	581.10	413.40	417	79.74	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			376.8	D08		8	0134-0426	901.74	426.81	747	111.15	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			748.7	D08		8	0135-0421	543.54	421.25	415	78.08	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			330.4	D08		8	0136-0426	135.22	426.07	471	82.91	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			448.6	D08		8	0137-0427	707.94	427.17	405	75.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			532.4	D08		8	0138-0427	750.29	427.15	422	75.84	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			297.5	D08		8	0139-0434	360.23	432.85	438	79.40	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1983.0	D08		8	0140-0443	91.35	443.73	610	94.33	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			479.6	D08		8	0141-0443	856.02	443.55	415	77.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			296.9	D08		8	0142-0443	661.35	442.96	454	83.26	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			465.0	D08		8	0143-0444	808.91	444.31	394	76.08	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			326.2	D08		8	0144-0453	345.48	453.66	469	86.81	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1829.0	D08		8	0145-0451	637.49	450.89	417	77.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			343.5	D08		8	0146-0454	399.22	454.11	446	81.01	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			526.5	D08		8	0147-0455	420.93	455.57	486	86.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			391.6	D08		8	0148-0465	921.78	465.12	432	78.43	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			395.2	D08		8	0149-0465	558.52	464.69	343	71.26	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			308.0	D08		8	0150-0471	252.94	470.44	407	78.77	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			515.4	D08		8	0151-0477	732.29	477.24	423	78.91	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			320.6	D08		8	0152-0476	882.86	476.52	399	73.84	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			470.3	D08		8	0153-0485	32.98	484.12	857	113.54	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			488.7	D08		8	0154-0480	451.55	479.73	419	78.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			475.7	D08		8	0155-0481	500.13	481.23	432	84.33	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			228.7	D08		8	0156-0483	808.31	482.90	444	80.08	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			368.1	D08		8	0157-0482	830.66	481.79	391	81.01	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2122.4	D08		8	0158-0482	622.88	482.80	407	76.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			446.3	D08		8	0159-0485	145.41	485.34	387	77.50	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			300.9	D08		8	0160-0486	206.87	486.52	415	77.50	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			328.7	D08		8	0161-0488	778.91	488.46	406	77.50	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			316.4	D08		8	0162-0493	848.55	493.51	516	89.50	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			402.4	D08		8	0163-0488	409.37	488.78	298	66.08	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			339.8	D08		8	0164-0493	365.42	493.59	435	79.50	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			326.8	D08		8	0165-0496	569.92	495.85	422	79.50	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			894.0	D08		8	0166-0505	741.58	505.90	442	83.60	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			371.8	D08		8	0167-0506	480.71	505.89	443	81.84	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			672.1	D08		8	0168-0518	915.18	518.32	720	110.57	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			334.3	D08		8	0169-0515	647.73	514.94	420	78.08	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			300.9	D08		8	0170-0518	256.99	518.51	433	79.50	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			311.0	D08		8	0171-0523	135.34	522.72	392	76.08	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			279.5	D08		8	0172-0526	814.97	525.92	410	80.33	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			337.2	D08		8	0173-0526	194.48	526.48	394	76.08	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			151.6	D08		8	0174-0525	931.41	524.85	175	53.11	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			621.2	D08		8	0175-0535	746.35	535.25	891	126.47	0.700
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			456.0	D08		8	0176-0527	460.85	527.21	391	72.77	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			581.2	D08		8	0177-0528	366.17	528.27	407	78.67	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1354.1	D08		8	0178-0533	545.31	532.49	555	92.57	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			969.9	D08		8	0179-0544	226.15	544.19	422	78.08	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			273.5	D08		8	0180-0546	793.33	547.02	405	80.91	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			352.5	D08		8	0181-0552	696.30	551.94	410	78.67	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			358.3	D08		8	0182-0560	85.58	559.71	859	121.54	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			573.4	D08		8	0183-0556	404.04	556.74	407	75.50	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			533.9	D08		8	0184-0562	515.01	562.26	465	81.50	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			240.6	D08		8	0185-0564	800.48	565.21	445	86.08	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			325.2	D08		8	0186-0569	173.02	569.09	399	75.50	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			984.8	D08		8	0187-0573	556.41	572.86	403	75.60	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			280.8	D08		8	0188-0578	641.51	577.83	422	78.08	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			350.7	D08		8	0189-0579	740.58	578.80	406	75.50	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			427.0	D08		8	0190-0580	875.42	580.14	437	78.67	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			382.4	D08		8	0191-0585	44.22	584.44	406	84.81	0.709
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			769.3	D08		8	0192-0581	586.30	581.20	404	75.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			315.3	D08		8	0193-0583	324.64	583.53	438	79.50	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			311.7	D08		8	0194-0589	212.22	589.69	435	82.08	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			287.9	D08		8	0195-0595	263.91	595.35	398	77.50	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			485.6	D08		8	0196-0598	426.67	598.42	443	82.08	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1879.7	D08		8	0197-0612	39.00	612.44	432	80.57	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			257.7	D08		8	0198-0611	929.51	611.62	403	79.26	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5984.8	D08		8	0199-0621	82.16	621.05	720	100.57	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2009.7	D08		8	0200-0621	208.06	621.77	573	90.33	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			475.3	D08		8	0201-0619	718.53	619.30	403	74.67	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			456.2	D08		8	0202-0622	429.32	621.30	451	81.26	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			342.6	D08		8	0203-0624	604.82	624.31	425	79.98	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			662.1	D08		8	0204-0627	514.44	626.81	430	80.33	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1928.7	D08		8	0205-0639	318.06	638.75	414	76.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			474.5	D08		8	0206-0639	773.47	638.91	418	77.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			247.4	D08		8	0207-0641	142.44	641.40	392	76.57	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			246.3	D08		8	0208-0646	177.28	646.96	409	76.67	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			314.1	D08		8	0209-0650	67.26	650.15	436	79.26	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1551.8	D08		8	0210-0654	406.54	654.12	430	80.33	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			752.1	D08		8	0211-0660	226.56	660.44	421	78.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			234.7	D08		8	0212-0678	607.91	679.11	851	119.88	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			611.8	D08		8	0213-0674	926.64	673.75	396	75.26	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			332.1	D08		8	0214-0684	414.35	684.91	457	82.67	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			464.8	D08		8	0215-0693	180.42	693.41	765	108.13	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2115.8	D08		8	0216-0691	15.47	691.18	411	78.57	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			684.7	D08		8	0217-0695	389.16	695.35	428	82.57	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			352.0	D08		8	0218-0706	316.19	706.84	392	73.26	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			579.9	D08		9	0001-0031	802.21	31.36	377	73.60	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			366.3	D08		9	0002-0031	211.44	31.27	365	70.43	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2389.1	D08		9	0003-0036	582.69	37.25	373	73.74	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			607.3	D08		9	0004-0037	315.18	36.46	417	77.94	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3313.5	D08		9	0005-0040	243.56	39.76	391	75.26	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			400.1	D08		9	0006-0040	69.25	40.63	358	71.26	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			353.3	D08		9	0007-0043	158.62	42.87	383	74.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			460.4	D08		9	0008-0044	549.39	44.18	431	78.67	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			429.8	D08		9	0009-0044	838.91	44.74	396	74.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			376.8	D08		9	0010-0049	433.97	48.43	422	76.43	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			336.3	D08		9	0011-0056	108.85	56.12	370	71.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			387.7	D08		9	0012-0061	197.89	61.33	371	70.18	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			384.9	D08		9	0013-0063	232.85	63.48	376	74.77	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			307.7	D08		9	0014-0066	12.61	65.95	363	72.67	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			379.2	D08		9	0015-0074	412.99	73.90	420	78.18	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1256.5	D08		9	0016-0073	311.53	73.06	398	75.60	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			351.2	D08		9	0017-0078	615.73	77.56	424	77.84	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			529.9	D08		9	0018-0078	693.87	78.19	421	80.91	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			404.9	D08		9	0019-0081	174.00	80.92	364	74.43	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			447.4	D08		9	0020-0082	740.74	81.87	394	75.26	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			398.2	D08		9	0021-0084	358.91	84.33	395	74.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			493.4	D08		9	0022-0085	480.27	85.05	398	73.60	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			292.2	D08		9	0023-0091	867.98	90.87	374	72.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			316.4	D08		9	0024-0095	909.04	95.92	425	77.84	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			272.4	D08		9	0025-0095	122.55	94.82	359	70.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			319.2	D08		9	0026-0096	307.62	95.97	396	75.84	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			441.6	D08		9	0027-0100	709.31	100.82	473	83.26	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			958.2	D08		9	0028-0104	165.47	104.90	558	90.91	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			385.2	D08		9	0029-0102	609.70	102.70	415	76.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			439.0	D08		9	0030-0104	250.84	103.66	451	81.64	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			326.8	D08		9	0031-0101	932.48	101.56	414	79.11	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			444.9	D08		9	0032-0111	651.76	110.71	396	74.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			445.4	D08		9	0033-0117	265.59	118.91	350	71.15	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			268.8	D08		9	0034-0120	94.20	120.25	375	72.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			355.0	D08		9	0035-0127	711.28	125.36	426	82.33	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			297.3	D08		9	0036-0130	208.51	130.00	397	76.67	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			384.3	D08		9	0037-0134	141.97	134.27	378	75.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			343.3	D08		9	0038-0135	693.09	136.57	410	78.08	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			569.9	D08		9	0039-0138	866.97	137.64	357	70.43	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			545.0	D08		9	0040-0139	51.12	140.05	347	69.01	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1443.4	D08		9	0041-0140	353.61	139.65	376	72.18	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			325.0	D08		9	0042-0139	414.94	138.93	402	79.60	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			332.8	D08		9	0043-0140	286.49	139.79	389	74.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			629.8	D08		9	0044-0140	439.97	140.48	424	77.94	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			433.7	D08		9	0045-0145	914.10	145.16	386	72.43	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			331.7	D08		9	0046-0149	481.63	148.96	445	79.26	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			422.1	D08		9	0047-0159	553.86	159.17	840	114.91	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			283.7	D08		9	0048-0153	211.82	153.04	407	76.43	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			527.0	D08		9	0049-0159	99.45	159.36	413	77.74	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1415.0	D08		9	0050-0159	341.79	159.62	373	73.84	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			451.6	D08		9	0051-0159	277.39	159.59	351	69.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			306.7	D08		9	0052-0163	636.04	163.74	429	78.77	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			446.6	D08		9	0053-0163	660.28	162.67	412	76.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1021.4	D08		9	0054-0169	602.12	169.55	466	80.18	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			288.3	D08		9	0055-0169	465.80	168.72	422	78.67	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			547.4	D08		9	0056-0173	48.26	174.07	357	72.43	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			252.6	D08		9	0057-0179	376.57	178.90	426	79.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			526.2	D08		9	0058-0180	860.74	180.33	366	70.77	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			493.5	D08		9	0059-0187	683.04	187.15	393	76.43	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			297.1	D08		9	0060-0186	178.54	186.46	374	72.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			364.5	D08		9	0061-0196	298.97	196.05	817	112.91	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			500.9	D08		9	0062-0196	783.01	196.00	386	74.91	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			523.8	D08		9	0063-0204	102.44	205.02	417	78.91	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			392.9	D08		9	0064-0206	210.89	206.94	381	77.60	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			960.3	D08		9	0065-0209	412.21	209.50	459	80.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			298.0	D08		9	0066-0212	241.57	212.44	368	74.43	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			317.0	D08		9	0067-0210	391.73	210.62	391	73.70	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2821.9	D08		9	0068-0214	460.20	214.19	731	100.81	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			351.7	D08		9	0069-0212	681.99	212.12	440	80.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			455.2	D08		9	0070-0211	641.53	211.36	385	75.26	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			498.0	D08		9	0071-0215	571.82	215.76	385	74.67	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			313.1	D08		9	0072-0221	357.76	220.80	429	79.26	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			423.4	D08		9	0073-0222	309.49	222.98	389	78.18	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			517.8	D08		9	0074-0223	739.20	223.72	392	76.08	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			236.6	D08		9	0075-0227	205.50	226.76	434	80.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1882.9	D08		9	0076-0233	522.04	232.65	722	103.40	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2341.0	D08		9	0077-0233	717.89	233.06	548	93.40	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			735.4	D08		9	0078-0232	882.86	231.82	374	71.60	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1872.5	D08		9	0079-0242	370.93	242.04	567	91.74	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			462.3	D08		9	0080-0244	793.57	244.69	404	75.26	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			271.1	D08		9	0081-0247	296.20	247.12	377	73.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			348.1	D08		9	0082-0251	259.12	251.10	369	72.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			646.5	D08		9	0083-0251	549.31	251.59	444	78.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			446.8	D08		9	0084-0250	180.46	250.07	376	73.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			427.2	D08		9	0085-0252	587.08	251.82	386	75.84	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			393.3	D08		9	0086-0255	153.26	255.91	388	75.50	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			531.7	D08		9	0087-0256	77.61	256.50	386	74.43	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1071.0	D08		9	0088-0258	514.86	258.37	395	75.84	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			441.8	D08		9	0089-0258	846.26	258.51	396	73.01	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2779.9	D08		9	0090-0264	324.38	263.88	658	94.91	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			485.3	D08		9	0091-0262	671.84	262.19	432	80.91	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			476.8	D08		9	0092-0257	915.92	257.74	364	71.94	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			688.0	D08		9	0093-0264	887.34	264.27	349	75.36	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			865.9	D08		9	0094-0273	410.97	273.28	409	75.01	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			506.9	D08		9	0095-0274	472.81	274.16	308	64.77	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			304.8	D08		9	0096-0280	581.72	280.94	420	76.08	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4697.7	D08		9	0097-0281	658.64	281.64	406	74.67	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			368.7	D08		9	0098-0283	791.94	282.76	373	73.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			636.0	D08		9	0099-0282	893.76	282.59	393	79.70	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			440.0	D08		9	0100-0289	208.49	288.97	393	76.08	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			379.1	D08		9	0101-0297	517.43	296.76	791	111.40	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			274.8	D08		9	0102-0291	73.87	291.40	377	71.84	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			472.5	D08		9	0103-0295	920.34	294.67	394	75.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1146.4	D08		9	0104-0296	719.32	296.25	389	76.08	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			258.8	D08		9	0105-0297	820.86	296.95	387	73.84	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1412.6	D08		9	0106-0304	162.89	304.23	724	104.57	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			406.4	D08		9	0107-0296	383.18	295.94	379	73.01	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			313.3	D08		9	0108-0298	261.09	298.23	391	73.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			266.9	D08		9	0109-0301	126.12	301.54	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			273.8	D08		9	0110-0301	900.33	301.91	402	82.18	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			284.9	D08		9	0111-0305	40.73	305.65	391	77.01	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			423.1	D08		9	0112-0306	200.21	307.44	419	82.91	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1138.8	D08		9	0113-0312	434.13	312.14	409	75.26	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			440.2	D08		9	0114-0316	880.46	315.48	381	73.50	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			272.1	D08		9	0115-0323	60.64	322.66	395	77.84	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			345.9	D08		9	0116-0324	317.09	323.94	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1488.9	D08		9	0117-0326	248.09	326.70	408	73.60	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			999.7	D08		9	0118-0325	635.30	324.89	385	73.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			502.4	D08		9	0119-0328	373.64	328.69	414	76.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			426.4	D08		9	0120-0333	478.24	333.17	391	73.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			379.4	D08		9	0121-0334	518.50	334.38	419	77.01	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			346.8	D08		9	0122-0340	574.93	340.26	413	75.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			261.7	D08		9	0123-0342	132.05	341.66	397	74.08	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			273.5	D08		9	0124-0346	929.21	345.80	380	75.94	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1747.0	D08		9	0125-0351	225.07	350.96	642	95.74	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			366.8	D08		9	0126-0349	846.02	349.50	381	73.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			370.7	D08		9	0127-0354	682.81	354.31	438	83.98	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			340.2	D08		9	0128-0358	520.07	357.55	423	78.18	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			328.4	D08		9	0129-0361	313.84	360.59	408	78.18	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			387.8	D08		9	0130-0361	810.32	360.87	426	77.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			384.5	D08		9	0131-0368	888.14	368.11	827	118.81	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			374.4	D08		9	0132-0365	295.33	366.12	359	75.21	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1310.8	D08		9	0133-0368	275.28	367.58	453	82.04	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			256.0	D08		9	0134-0369	122.11	369.40	389	76.43	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			267.3	D08		9	0135-0373	189.40	373.03	404	79.15	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			427.2	D08		9	0136-0384	71.53	384.19	382	74.43	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			592.5	D08		9	0137-0388	237.86	388.08	742	104.23	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2303.9	D08		9	0138-0391	207.08	391.67	461	83.84	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			361.3	D08		9	0139-0390	590.14	390.31	388	74.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			380.0	D08		9	0140-0391	753.46	391.08	394	74.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4169.4	D08		9	0141-0405	506.02	405.02	627	95.64	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			371.4	D08		9	0142-0409	630.87	409.11	412	75.60	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			406.6	D08		9	0143-0415	912.32	415.15	681	102.81	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			933.5	D08		9	0144-0413	410.62	413.37	395	73.84	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1960.5	D08		9	0145-0416	296.49	416.09	609	92.91	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2851.1	D08		9	0146-0415	210.30	414.22	360	72.53	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			469.2	D08		9	0147-0421	943.69	422.81	390	94.57	0.548
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			841.5	D08		9	0148-0424	144.14	422.40	940	120.95	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			595.3	D08		9	0149-0418	568.80	418.83	391	73.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			372.8	D08		9	0150-0426	458.36	426.56	387	71.60	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			313.0	D08		9	0151-0433	80.54	432.57	370	74.91	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			733.1	D08		9	0152-0439	352.40	439.52	386	74.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			311.5	D08		9	0153-0447	256.37	447.18	381	78.67	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			288.1	D08		9	0154-0450	757.46	449.77	377	73.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			392.7	D08		9	0155-0454	560.48	453.62	385	73.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2783.5	D08		9	0156-0458	870.25	458.05	663	95.74	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			413.3	D08		9	0157-0458	205.69	458.53	371	71.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1095.6	D08		9	0158-0458	329.27	458.74	406	75.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2455.4	D08		9	0159-0458	650.51	458.66	398	75.26	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2534.3	D08		9	0160-0462	520.47	462.25	402	75.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			293.8	D08		9	0161-0467	263.57	467.17	452	83.26	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			437.4	D08		9	0162-0468	16.54	467.93	374	71.84	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			393.1	D08		9	0163-0472	403.79	472.47	402	76.18	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1951.0	D08		9	0164-0477	903.92	477.48	517	86.33	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			282.6	D08		9	0165-0492	90.84	491.39	786	115.40	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			381.0	D08		9	0166-0487	942.99	487.59	362	71.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			839.1	D08		9	0167-0499	186.12	500.16	391	75.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			445.8	D08		9	0168-0502	514.94	502.30	403	74.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			326.9	D08		9	0169-0509	862.02	509.84	373	71.84	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			428.9	D08		9	0170-0512	468.13	511.72	397	75.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			289.9	D08		9	0171-0513	775.33	513.07	380	74.67	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			322.9	D08		9	0172-0517	556.44	516.30	415	79.50	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2354.9	D08		9	0173-0520	270.30	519.66	642	94.33	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			750.0	D08		9	0174-0520	181.41	520.11	444	82.18	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			929.1	D08		9	0175-0532	226.41	531.71	396	73.84	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2549.7	D08		9	0176-0537	542.74	538.48	362	74.77	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1279.7	D08		9	0177-0540	403.69	540.32	346	69.94	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3154.1	D08		9	0178-0545	561.00	545.00	297	67.60	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			236.7	D08		9	0179-0544	944.64	544.28	384	73.26	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			483.9	D08		9	0180-0546	841.98	546.34	389	72.43	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1046.4	D08		9	0181-0550	301.68	550.16	392	73.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1630.7	D08		9	0182-0561	415.75	561.58	694	106.23	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4430.1	D08		9	0183-0555	544.47	555.11	252	61.46	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			559.1	D08		9	0184-0562	514.95	562.28	417	76.67	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			285.1	D08		9	0185-0569	793.03	569.10	400	75.84	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			345.7	D08		9	0186-0572	258.47	571.14	339	70.91	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			310.1	D08		9	0187-0582	210.17	582.11	368	73.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			732.2	D08		9	0188-0584	273.44	585.56	492	85.88	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			338.1	D08		9	0189-0583	903.29	582.47	449	79.50	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			737.7	D08		9	0190-0586	660.06	585.62	380	73.84	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			303.7	D08		9	0191-0595	175.90	595.08	377	73.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			470.0	D08		9	0192-0601	327.94	601.43	383	73.01	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			381.4	D08		9	0193-0602	461.92	602.65	373	71.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			702.1	D08		9	0194-0611	659.43	611.53	398	74.67	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			261.8	D08		9	0195-0611	904.60	611.52	385	73.26	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			283.4	D08		9	0196-0615	23.70	614.59	387	75.01	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			457.1	D08		9	0197-0621	489.54	621.59	400	74.43	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			301.5	D08		9	0198-0623	814.69	623.36	394	74.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			258.0	D08		9	0199-0627	281.70	626.41	385	73.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			331.3	D08		9	0200-0631	862.18	631.39	385	73.60	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			278.2	D08		9	0201-0634	165.99	634.41	427	77.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			462.3	D08		9	0202-0648	628.33	646.60	406	78.33	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1041.7	D08		9	0203-0647	399.11	647.27	413	76.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			322.6	D08		9	0204-0647	522.59	648.08	369	73.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			306.0	D08		9	0205-0652	900.01	652.45	351	69.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2192.5	D08		9	0206-0655	100.16	655.09	375	76.33	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3146.8	D08		9	0207-0663	616.05	664.54	508	86.57	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			964.9	D08		9	0208-0667	123.12	666.61	455	80.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			379.5	D08		9	0209-0669	561.54	668.87	382	72.43	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			644.0	D08		9	0210-0676	20.62	676.36	402	73.84	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			233.7	D08		9	0211-0678	512.28	677.79	408	75.50	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			443.8	D08		9	0212-0678	676.22	677.75	470	82.08	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			579.5	D08		9	0213-0694	165.23	693.52	415	76.91	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1763.0	D08		9	0214-0699	536.83	699.76	921	117.30	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			369.8	D08		9	0215-0693	258.74	693.52	405	75.26	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			490.3	D08		9	0216-0696	605.92	696.41	379	73.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			325.9	D08		9	0217-0700	784.99	699.49	381	74.67	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			432.3	E08		1	0001-0030	45.07	30.65	419	80.67	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2693.6	E08		1	0002-0042	167.76	42.28	443	77.60	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			716.3	E08		1	0003-0041	625.93	41.06	415	75.01	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			460.1	E08		1	0004-0042	714.23	42.07	387	73.01	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			419.6	E08		1	0005-0046	412.33	45.77	490	84.57	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			497.4	E08		1	0006-0048	453.57	48.42	492	82.08	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			564.1	E08		1	0007-0053	567.12	53.63	471	82.08	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			394.5	E08		1	0008-0063	182.59	62.93	485	84.33	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1959.3	E08		1	0009-0067	34.57	67.11	550	86.91	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			408.3	E08		1	0010-0075	78.32	74.79	442	77.84	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1098.8	E08		1	0011-0073	829.94	73.27	221	56.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			509.7	E08		1	0012-0088	611.67	88.17	454	79.26	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			408.8	E08		1	0013-0088	502.07	88.60	548	90.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			354.9	E08		1	0014-0086	852.50	87.02	282	66.53	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			571.1	E08		1	0015-0091	719.29	91.65	462	80.08	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			384.4	E08		1	0016-0091	524.71	92.67	373	76.53	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			387.7	E08		1	0017-0098	47.05	98.76	435	77.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			526.3	E08		1	0018-0100	168.02	100.31	424	76.43	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			643.4	E08		1	0019-0100	281.75	99.91	402	73.60	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			370.0	E08		1	0020-0101	804.02	101.06	404	76.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			522.9	E08		1	0021-0101	759.55	101.44	445	79.84	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			450.4	E08		1	0022-0107	241.68	107.62	782	109.05	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			401.6	E08		1	0023-0107	355.42	107.05	439	76.43	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			419.8	E08		1	0024-0114	690.88	114.24	486	81.84	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			411.8	E08		1	0025-0121	127.38	120.85	508	89.74	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1159.7	E08		1	0026-0128	900.25	128.11	430	79.60	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1197.2	E08		1	0027-0133	881.34	132.98	363	74.18	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			560.9	E08		1	0028-0136	456.29	136.38	497	86.77	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			370.3	E08		1	0029-0143	481.89	143.29	489	88.67	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			549.5	E08		1	0030-0146	52.86	146.04	428	76.43	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			380.9	E08		1	0031-0149	733.33	148.93	470	84.08	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			353.2	E08		1	0032-0152	636.15	151.24	411	81.50	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			793.2	E08		1	0033-0156	179.65	155.98	413	75.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			472.5	E08		1	0034-0158	695.52	158.70	454	79.26	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			387.0	E08		1	0035-0163	356.63	163.51	438	80.67	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			621.7	E08		1	0036-0167	538.52	166.59	422	77.26	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			396.1	E08		1	0037-0167	625.67	168.24	495	85.74	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			622.6	E08		1	0038-0181	256.69	180.51	798	105.40	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			451.0	E08		1	0039-0177	940.24	176.77	643	113.98	0.622
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			767.2	E08		1	0040-0182	919.56	184.38	246	70.43	0.623
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			430.5	E08		1	0041-0188	417.75	187.91	483	82.91	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			664.0	E08		1	0042-0193	890.39	193.06	442	76.67	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			409.0	E08		1	0043-0198	114.34	198.34	433	77.84	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			334.0	E08		1	0044-0197	159.98	196.69	427	75.84	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			398.6	E08		1	0045-0199	194.67	198.65	454	80.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			433.9	E08		1	0046-0201	473.12	201.79	429	77.26	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			291.5	E08		1	0047-0203	52.74	203.81	405	75.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			320.1	E08		1	0048-0205	90.17	204.94	458	80.91	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			392.3	E08		1	0049-0205	597.63	204.93	433	76.43	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			601.4	E08		1	0050-0207	801.58	207.66	443	78.67	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			402.1	E08		1	0051-0216	416.35	216.78	451	79.50	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			337.4	E08		1	0052-0222	646.65	223.11	432	79.50	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			805.4	E08		1	0053-0228	871.80	227.91	434	78.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			339.6	E08		1	0054-0226	549.57	226.53	449	78.43	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			506.5	E08		1	0055-0228	840.53	228.39	456	82.33	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			700.3	E08		1	0056-0230	38.92	230.56	395	73.26	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1005.8	E08		1	0057-0245	203.72	245.39	997	129.78	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			338.3	E08		1	0058-0242	477.31	241.90	432	77.26	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1476.9	E08		1	0059-0243	328.76	243.39	580	90.08	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1846.1	E08		1	0060-0251	898.82	251.02	446	77.84	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			422.6	E08		1	0061-0252	519.77	252.54	428	77.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			345.5	E08		1	0062-0253	294.10	253.48	444	77.84	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			310.7	E08		1	0063-0253	767.58	253.20	426	77.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			330.0	E08		1	0064-0262	151.82	262.30	429	77.01	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1733.2	E08		1	0065-0269	833.89	269.22	638	92.91	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1650.0	E08		1	0066-0272	70.77	270.22	706	105.30	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			414.8	E08		1	0067-0269	232.72	268.95	431	77.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			523.2	E08		1	0068-0269	364.87	269.58	436	79.50	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			399.6	E08		1	0069-0270	581.58	269.89	455	79.26	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			463.8	E08		1	0070-0281	485.61	280.87	432	78.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2154.3	E08		1	0071-0289	84.53	290.53	682	104.71	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			232.1	E08		1	0072-0289	194.45	288.69	460	80.67	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			381.4	E08		1	0073-0288	264.75	288.32	431	77.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			518.6	E08		1	0074-0293	797.62	293.31	481	84.08	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			335.9	E08		1	0075-0305	755.92	305.48	433	77.26	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			346.6	E08		1	0076-0304	24.11	305.07	407	77.26	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			325.5	E08		1	0077-0304	106.05	305.36	391	74.08	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1913.3	E08		1	0078-0311	708.14	311.30	480	83.74	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			484.1	E08		1	0079-0324	426.88	324.06	459	80.67	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			379.4	E08		1	0080-0325	155.70	324.92	410	75.26	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			331.3	E08		1	0081-0325	510.81	325.96	429	79.50	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			585.8	E08		1	0082-0328	277.00	327.76	413	75.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			450.4	E08		1	0083-0342	555.08	342.00	894	117.64	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1416.7	E08		1	0084-0345	354.40	344.76	908	122.57	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			469.4	E08		1	0085-0336	328.34	336.14	460	79.60	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			495.9	E08		1	0086-0337	189.42	337.44	426	77.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			504.9	E08		1	0087-0339	465.96	338.48	395	75.70	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			307.2	E08		1	0088-0339	801.06	339.25	480	81.26	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			411.8	E08		1	0089-0341	484.56	340.81	352	70.87	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			319.1	E08		1	0090-0351	904.71	350.58	428	78.08	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			311.5	E08		1	0091-0352	928.99	351.53	454	80.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			446.7	E08		1	0092-0351	95.71	351.12	406	75.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			405.7	E08		1	0093-0357	647.60	356.77	433	78.91	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			507.4	E08		1	0094-0370	457.83	370.44	943	123.64	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			520.7	E08		1	0095-0361	501.42	360.90	351	71.94	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			436.6	E08		1	0096-0371	663.63	371.45	456	84.57	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			299.5	E08		1	0097-0368	188.22	368.04	436	79.50	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			350.4	E08		1	0098-0371	596.97	371.40	448	79.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			261.3	E08		1	0099-0370	63.32	370.48	412	78.08	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			269.7	E08		1	0100-0369	275.88	369.77	423	76.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2334.6	E08		1	0101-0379	508.26	379.37	483	86.67	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			629.4	E08		1	0102-0380	816.50	380.84	437	79.50	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1301.4	E08		1	0103-0392	674.25	392.50	491	83.26	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			274.4	E08		1	0104-0392	134.34	392.60	425	76.43	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			452.8	E08		1	0105-0395	787.89	394.74	460	80.08	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1216.3	E08		1	0106-0397	710.62	397.69	428	77.84	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			365.7	E08		1	0107-0404	622.35	404.81	425	77.26	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2089.4	E08		1	0108-0408	927.12	408.71	622	92.91	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			614.2	E08		1	0109-0408	202.68	407.87	460	82.08	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			367.8	E08		1	0110-0410	447.45	410.02	447	79.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			427.9	E08		1	0111-0410	524.60	409.87	428	77.26	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			743.1	E08		1	0112-0412	230.55	412.57	450	80.08	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			506.8	E08		1	0113-0421	62.27	421.92	824	114.71	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			363.6	E08		1	0114-0414	389.83	414.33	420	76.91	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			503.7	E08		1	0115-0418	264.20	418.41	416	76.67	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			363.0	E08		1	0116-0419	884.01	419.03	418	77.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			282.5	E08		1	0117-0420	149.68	421.22	460	85.50	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2067.6	E08		1	0118-0424	786.24	424.27	462	82.18	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			458.1	E08		1	0119-0424	585.75	424.81	484	82.08	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			484.8	E08		1	0120-0424	113.98	424.14	456	78.67	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			316.8	E08		1	0121-0430	738.05	430.83	419	75.84	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			674.4	E08		1	0122-0437	548.25	437.22	430	77.26	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			442.2	E08		1	0123-0443	679.62	443.50	452	78.43	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			372.5	E08		1	0124-0452	452.68	451.69	956	125.68	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			313.3	E08		1	0125-0455	21.35	455.63	811	114.33	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1037.0	E08		1	0126-0448	861.22	449.47	388	74.04	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			383.6	E08		1	0127-0452	942.36	452.57	419	78.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			271.0	E08		1	0128-0455	97.13	455.50	413	79.84	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			850.2	E08		1	0129-0458	378.27	458.43	435	76.67	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			301.0	E08		1	0130-0461	192.39	459.84	436	78.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			400.5	E08		1	0131-0460	249.49	459.97	406	74.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			328.7	E08		1	0132-0463	493.64	462.81	434	78.08	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			620.1	E08		1	0133-0462	739.66	462.49	417	77.26	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			368.2	E08		1	0134-0470	301.00	469.97	456	82.08	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			369.0	E08		1	0135-0469	532.78	469.25	421	78.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			428.2	E08		1	0136-0467	582.60	466.82	405	74.18	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			494.4	E08		1	0137-0473	855.50	471.79	473	91.84	0.705
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			387.4	E08		1	0138-0475	110.41	475.53	551	93.60	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			307.7	E08		1	0139-0477	875.10	477.05	463	83.15	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			432.6	E08		1	0140-0476	680.21	476.62	444	77.84	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			248.5	E08		1	0141-0480	136.78	480.05	414	77.36	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			342.8	E08		1	0142-0490	209.33	490.94	904	124.23	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			589.4	E08		1	0143-0486	620.14	486.40	460	80.67	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			321.1	E08		1	0144-0485	752.77	484.45	423	76.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			448.7	E08		1	0145-0495	165.67	495.01	458	79.26	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			350.9	E08		1	0146-0498	885.52	498.56	448	80.33	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			513.4	E08		1	0147-0496	358.26	496.12	412	75.84	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			341.3	E08		1	0148-0502	272.90	501.84	428	78.08	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			344.6	E08		1	0149-0503	538.56	503.36	440	79.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			422.5	E08		1	0150-0504	591.68	504.75	436	77.84	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			331.5	E08		1	0151-0508	54.27	507.66	446	82.33	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			367.6	E08		1	0152-0510	455.95	510.37	437	78.91	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			373.7	E08		1	0153-0520	219.13	519.44	450	81.36	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			358.4	E08		1	0154-0522	187.38	522.40	432	83.50	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			691.9	E08		1	0155-0523	792.97	523.36	427	78.67	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			320.3	E08		1	0156-0527	307.68	528.11	430	80.53	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3719.3	E08		1	0157-0531	68.21	531.31	459	82.08	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			360.2	E08		1	0158-0529	624.88	529.41	418	77.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			315.1	E08		1	0159-0530	716.03	530.46	419	75.84	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			389.3	E08		1	0160-0529	850.33	529.04	149	80.57	0.288
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4196.3	E08		1	0161-0537	112.53	537.02	423	76.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			262.6	E08		1	0162-0543	18.86	543.23	388	76.08	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			301.4	E08		1	0163-0545	650.13	545.60	446	80.33	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			259.7	E08		1	0164-0546	936.83	546.77	456	82.43	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			366.9	E08		1	0165-0547	407.42	546.67	432	77.26	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			303.8	E08		1	0166-0549	307.82	547.82	469	84.53	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			378.3	E08		1	0167-0550	162.08	550.18	396	76.43	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			361.9	E08		1	0168-0550	588.08	550.21	436	76.43	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			377.9	E08		1	0169-0558	202.67	558.45	848	115.54	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			349.2	E08		1	0170-0555	49.17	555.21	173	51.11	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			830.1	E08		1	0171-0559	264.46	558.77	440	77.60	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			251.6	E08		1	0172-0567	884.03	567.85	446	79.84	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			276.8	E08		1	0173-0568	916.26	568.48	440	81.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1360.7	E08		1	0174-0569	340.67	568.74	461	80.91	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2375.6	E08		1	0175-0575	375.94	575.06	717	100.57	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			630.9	E08		1	0176-0572	492.05	571.93	452	79.26	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			578.2	E08		1	0177-0584	120.96	583.77	855	117.50	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			351.4	E08		1	0178-0588	729.45	587.53	442	78.67	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			371.5	E08		1	0179-0600	777.15	599.75	450	80.67	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			391.3	E08		1	0180-0601	931.97	601.38	424	78.91	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1085.4	E08		1	0181-0604	627.24	604.09	475	82.91	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			811.8	E08		1	0182-0606	347.15	606.58	459	81.26	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			560.9	E08		1	0183-0618	391.24	618.44	390	73.84	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			320.7	E08		1	0184-0620	797.93	620.38	546	91.60	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			317.1	E08		1	0185-0637	64.60	637.63	890	119.30	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			609.2	E08		1	0186-0631	719.70	631.93	467	81.60	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			462.9	E08		1	0187-0631	176.97	631.35	403	76.67	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			454.0	E08		1	0188-0631	697.91	631.62	408	74.53	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			327.1	E08		1	0189-0632	215.71	632.05	430	79.50	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			209.7	E08		1	0190-0637	18.73	637.73	398	78.91	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			252.1	E08		1	0191-0635	553.23	634.85	420	77.26	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			943.7	E08		1	0192-0640	93.70	640.64	451	79.74	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			351.8	E08		1	0193-0639	869.53	638.74	414	76.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2379.8	E08		1	0194-0643	330.43	643.90	423	76.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1007.0	E08		1	0195-0655	426.54	655.75	880	119.05	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			431.0	E08		1	0196-0651	773.20	651.09	440	77.84	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			387.9	E08		1	0197-0655	649.45	655.53	469	82.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1938.6	E08		1	0198-0655	388.48	654.75	422	78.67	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			468.9	E08		1	0199-0654	481.44	654.30	409	75.01	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			330.3	E08		1	0200-0660	517.44	660.08	452	80.91	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			509.9	E08		1	0201-0661	932.46	661.06	366	71.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1142.2	E08		1	0202-0662	256.71	662.73	437	83.60	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			380.7	E08		1	0203-0666	826.30	664.91	413	79.15	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			530.4	E08		1	0204-0678	175.43	678.36	407	77.11	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			398.2	E08		1	0205-0678	554.22	678.45	450	81.26	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			417.1	E08		1	0206-0678	633.42	677.98	463	82.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			262.0	E08		1	0207-0678	841.42	678.77	388	74.33	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			480.8	E08		1	0208-0682	195.20	682.98	450	81.11	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			403.6	E08		1	0209-0683	262.51	682.34	435	82.18	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			261.5	E08		1	0210-0688	499.60	687.89	420	78.43	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			389.9	E08		1	0211-0690	890.26	690.34	383	71.60	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			395.3	E08		1	0212-0693	757.85	693.38	439	78.08	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			281.2	E08		1	0213-0695	110.13	695.18	404	77.50	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			338.8	E08		1	0214-0702	565.03	701.68	495	86.08	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			841.8	E08		1	0215-0707	378.50	706.73	399	75.84	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			406.1	E08		1	0216-0708	471.87	707.00	351	73.26	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			355.3	E08		2	0001-0027	890.67	26.94	374	73.01	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			352.6	E08		2	0002-0034	802.74	33.78	411	77.26	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1331.3	E08		2	0003-0044	398.89	44.05	408	77.50	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			452.9	E08		2	0004-0045	267.59	45.26	384	75.01	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			575.3	E08		2	0005-0060	539.47	60.49	420	77.26	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			529.0	E08		2	0006-0061	333.18	61.84	459	82.67	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			452.5	E08		2	0007-0062	725.90	61.80	405	76.67	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			859.2	E08		2	0008-0070	697.13	69.59	751	109.40	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			309.0	E08		2	0009-0064	854.95	64.08	402	74.43	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			513.6	E08		2	0010-0068	564.60	67.98	393	74.43	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1124.0	E08		2	0011-0069	311.70	68.45	377	75.60	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			298.9	E08		2	0012-0074	139.75	73.75	380	73.26	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1210.8	E08		2	0013-0079	623.33	79.13	403	75.84	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			340.0	E08		2	0014-0080	806.89	80.21	477	87.26	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			485.3	E08		2	0015-0080	193.12	80.01	410	78.33	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			335.0	E08		2	0016-0080	243.00	80.22	382	75.26	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			555.6	E08		2	0017-0079	410.94	79.08	423	77.60	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			374.7	E08		2	0018-0084	785.43	83.93	358	70.53	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			241.9	E08		2	0019-0093	67.94	93.43	387	76.08	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			458.5	E08		2	0020-0097	274.93	97.74	306	64.77	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			613.1	E08		2	0021-0104	136.10	104.59	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			332.9	E08		2	0022-0108	442.80	108.17	426	76.43	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			440.1	E08		2	0023-0111	362.97	110.55	364	71.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			549.0	E08		2	0024-0121	683.13	121.47	785	109.88	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1722.6	E08		2	0025-0123	483.35	123.12	381	73.26	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			486.1	E08		2	0026-0127	775.47	127.33	423	78.67	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			431.1	E08		2	0027-0130	354.62	131.04	437	81.50	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			558.1	E08		2	0028-0133	175.78	133.20	395	76.08	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			655.7	E08		2	0029-0133	850.39	133.45	427	78.67	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			345.7	E08		2	0030-0135	378.24	135.97	430	77.26	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			507.5	E08		2	0031-0140	234.73	139.82	400	76.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			440.4	E08		2	0032-0138	422.68	138.62	400	76.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1555.8	E08		2	0033-0147	100.48	147.50	491	83.50	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			485.9	E08		2	0034-0148	724.33	148.39	411	77.50	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			782.1	E08		2	0035-0149	909.00	149.21	391	75.60	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			641.3	E08		2	0036-0161	572.53	161.61	429	78.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			368.4	E08		2	0037-0166	805.96	164.76	428	77.98	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1861.1	E08		2	0038-0167	461.77	167.52	388	73.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			476.1	E08		2	0039-0169	138.99	169.37	396	73.01	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			387.6	E08		2	0040-0176	668.51	175.77	408	76.08	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			739.5	E08		2	0041-0170	27.63	170.20	115	43.11	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			608.7	E08		2	0042-0177	314.08	177.40	384	74.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			420.7	E08		2	0043-0179	46.42	178.70	548	92.57	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			387.2	E08		2	0044-0178	790.37	179.08	372	73.74	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			575.0	E08		2	0045-0182	402.87	182.10	409	75.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			406.7	E08		2	0046-0193	513.15	193.35	924	119.05	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			686.8	E08		2	0047-0184	24.07	185.47	235	66.43	0.669
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			514.2	E08		2	0048-0187	77.70	186.86	377	72.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			318.2	E08		2	0049-0187	877.36	186.70	392	74.08	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			368.8	E08		2	0050-0195	621.74	195.76	405	75.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			290.5	E08		2	0051-0193	258.36	193.62	382	75.60	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			361.4	E08		2	0052-0194	724.88	193.94	428	82.08	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			249.6	E08		2	0053-0203	168.99	203.55	395	76.67	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2785.2	E08		2	0054-0206	420.38	205.55	442	79.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			368.6	E08		2	0055-0207	827.80	207.35	418	75.01	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			266.0	E08		2	0056-0210	51.74	209.85	399	75.50	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			518.1	E08		2	0057-0222	369.13	222.56	396	74.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			488.7	E08		2	0058-0220	809.97	219.30	252	61.84	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			289.7	E08		2	0059-0225	138.35	225.82	377	76.33	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			322.0	E08		2	0060-0225	744.58	224.81	387	72.43	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			248.0	E08		2	0061-0227	215.53	227.48	439	82.67	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			423.0	E08		2	0062-0227	794.99	228.06	380	80.18	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			250.6	E08		2	0063-0238	563.83	238.32	597	91.26	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			331.3	E08		2	0064-0234	268.82	234.46	438	79.01	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			305.6	E08		2	0065-0248	329.53	248.37	391	74.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			378.2	E08		2	0066-0248	76.01	248.58	386	72.43	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			369.4	E08		2	0067-0258	791.77	257.78	926	128.23	0.708
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			260.8	E08		2	0068-0251	221.60	250.53	395	78.67	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			438.3	E08		2	0069-0251	679.71	251.58	412	75.01	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1516.8	E08		2	0070-0256	913.82	256.63	581	89.50	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			985.8	E08		2	0071-0260	634.98	259.87	382	72.77	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			503.0	E08		2	0072-0266	169.77	266.61	555	96.23	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			428.2	E08		2	0073-0264	451.20	264.72	414	76.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			456.5	E08		2	0074-0266	525.51	266.37	435	83.74	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1806.8	E08		2	0075-0274	371.77	274.85	796	111.64	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			450.7	E08		2	0076-0271	411.01	271.76	403	74.67	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			891.4	E08		2	0077-0270	500.82	269.96	400	77.01	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			323.9	E08		2	0078-0293	308.49	292.92	419	77.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			426.5	E08		2	0079-0294	470.07	294.22	400	77.50	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			262.2	E08		2	0080-0297	67.35	297.65	383	73.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			304.9	E08		2	0081-0302	901.77	302.16	369	72.87	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			483.5	E08		2	0082-0302	923.60	301.95	389	74.28	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			510.2	E08		2	0083-0305	581.73	305.14	373	71.84	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			305.2	E08		2	0084-0310	171.84	310.52	381	72.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			233.1	E08		2	0085-0312	544.73	312.04	408	74.18	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			268.5	E08		2	0086-0313	622.31	313.79	659	123.98	0.539
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			462.0	E08		2	0087-0318	272.44	318.88	401	73.36	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			235.3	E08		2	0088-0327	478.15	327.67	419	81.50	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			269.1	E08		2	0089-0329	142.75	328.87	383	71.60	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			972.1	E08		2	0090-0336	451.27	335.94	416	79.50	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			338.2	E08		2	0091-0339	252.17	339.52	404	75.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			453.5	E08		2	0092-0342	303.53	342.63	382	73.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			252.9	E08		2	0093-0344	403.85	343.81	406	78.91	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			413.7	E08		2	0094-0347	823.72	347.14	383	72.43	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			387.1	E08		2	0095-0348	69.00	348.26	383	74.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			316.7	E08		2	0096-0348	226.00	348.72	398	75.84	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			303.1	E08		2	0097-0352	33.51	352.30	399	76.91	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			375.0	E08		2	0098-0351	882.76	350.71	322	69.70	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			477.0	E08		2	0099-0362	151.49	362.52	394	74.67	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			255.2	E08		2	0100-0367	622.50	367.96	417	75.84	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			389.6	E08		2	0101-0371	347.12	371.36	439	78.67	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			309.5	E08		2	0102-0372	879.45	371.13	475	87.50	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			378.8	E08		2	0103-0380	574.82	380.03	402	76.08	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			283.0	E08		2	0104-0390	709.91	389.84	825	113.88	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			505.6	E08		2	0105-0388	95.79	388.54	386	75.50	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			383.7	E08		2	0106-0388	199.33	387.52	442	82.33	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			378.8	E08		2	0107-0390	526.13	389.65	420	80.57	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			361.7	E08		2	0108-0401	820.21	401.50	419	77.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			510.2	E08		2	0109-0402	510.01	403.04	445	80.08	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			314.3	E08		2	0110-0402	654.01	401.98	422	76.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1115.7	E08		2	0111-0406	219.36	406.64	536	89.64	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			698.1	E08		2	0112-0404	292.52	404.38	753	105.50	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2070.3	E08		2	0113-0409	30.77	409.53	628	93.15	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			267.0	E08		2	0114-0406	173.15	406.25	382	73.84	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			338.9	E08		2	0115-0408	120.03	408.10	388	75.26	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			582.0	E08		2	0116-0410	779.56	411.26	437	84.43	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			317.0	E08		2	0117-0413	750.21	412.69	398	75.60	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			506.0	E08		2	0118-0441	495.53	441.66	922	128.81	0.698
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			723.1	E08		2	0119-0435	202.35	435.47	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			870.0	E08		2	0120-0436	438.90	436.64	395	75.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			732.3	E08		2	0121-0439	144.52	438.62	374	72.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			298.1	E08		2	0122-0444	560.08	444.52	417	76.43	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			400.6	E08		2	0123-0453	46.63	453.32	389	75.84	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1027.6	E08		2	0124-0451	476.99	452.07	314	69.94	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			271.2	E08		2	0125-0449	761.44	448.87	161	77.50	0.337
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			859.1	E08		2	0126-0454	380.38	454.11	412	76.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			328.6	E08		2	0127-0457	649.09	457.94	398	76.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			298.8	E08		2	0128-0460	248.91	459.73	375	74.91	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			649.0	E08		2	0129-0471	91.12	471.08	805	114.47	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			288.3	E08		2	0130-0466	923.56	466.10	402	74.67	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			475.3	E08		2	0131-0477	221.96	477.90	722	103.05	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			555.3	E08		2	0132-0473	126.82	472.96	380	72.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			409.9	E08		2	0133-0472	870.35	472.08	319	66.18	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			346.9	E08		2	0134-0475	296.63	475.43	382	75.50	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			352.9	E08		2	0135-0477	173.58	476.81	382	73.84	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			429.1	E08		2	0136-0481	602.06	481.41	489	82.67	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			565.0	E08		2	0137-0490	676.30	490.47	392	75.26	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			317.4	E08		2	0138-0500	890.82	500.70	374	72.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			257.7	E08		2	0139-0501	940.01	500.65	370	73.01	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			320.1	E08		2	0140-0499	617.99	499.08	269	64.43	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1947.3	E08		2	0141-0506	302.68	506.09	559	89.40	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			250.7	E08		2	0142-0504	163.22	503.63	432	81.40	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			325.4	E08		2	0143-0504	847.40	504.03	393	74.43	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			534.7	E08		2	0144-0513	603.02	513.03	283	82.08	0.528
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			455.2	E08		2	0145-0527	375.90	526.51	730	103.05	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			390.3	E08		2	0146-0531	777.66	531.02	435	78.67	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			336.1	E08		2	0147-0540	145.54	540.61	745	109.15	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			351.9	E08		2	0148-0533	531.60	533.96	399	77.50	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			697.5	E08		2	0149-0534	666.34	534.51	401	74.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			416.0	E08		2	0150-0541	707.75	541.05	253	77.84	0.525
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			320.6	E08		2	0151-0547	41.41	547.08	409	78.67	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			426.1	E08		2	0152-0548	73.99	548.39	407	75.26	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			433.2	E08		2	0153-0555	105.27	555.72	398	75.84	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			281.0	E08		2	0154-0551	653.87	551.61	207	52.53	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			275.3	E08		2	0155-0558	832.33	558.28	416	79.26	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			375.5	E08		2	0156-0559	572.73	560.47	817	118.57	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			312.6	E08		2	0157-0560	929.68	559.82	380	74.43	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			263.9	E08		2	0158-0569	20.54	569.14	412	80.33	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			325.7	E08		2	0159-0566	270.34	566.66	420	77.26	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			420.3	E08		2	0160-0576	633.39	576.43	400	73.60	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3005.1	E08		2	0161-0581	471.44	581.79	526	85.50	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			303.7	E08		2	0162-0580	347.13	580.43	396	75.84	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			321.4	E08		2	0163-0582	505.16	581.77	399	73.84	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			949.1	E08		2	0164-0589	591.50	589.08	371	71.26	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			440.7	E08		2	0165-0591	682.30	591.53	370	71.84	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			313.6	E08		2	0166-0600	105.82	600.27	371	71.60	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			341.9	E08		2	0167-0601	285.15	601.69	377	71.84	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			249.0	E08		2	0168-0600	717.83	600.31	422	77.84	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			442.4	E08		2	0169-0602	35.81	602.43	398	73.84	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			438.6	E08		2	0170-0604	200.19	604.23	457	82.08	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			386.6	E08		2	0171-0604	540.79	603.75	393	73.84	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			295.4	E08		2	0172-0609	327.17	609.00	407	77.26	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			438.7	E08		2	0173-0609	774.63	609.18	414	75.36	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			334.7	E08		2	0174-0613	797.36	612.87	461	80.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			322.3	E08		2	0175-0626	196.09	626.48	437	81.60	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			533.2	E08		2	0176-0632	421.06	632.33	407	77.26	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			395.8	E08		2	0177-0646	106.32	646.56	414	76.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			391.9	E08		2	0178-0660	737.33	659.93	429	84.47	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			524.3	E08		2	0179-0657	466.58	656.53	399	79.26	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			320.9	E08		2	0180-0660	350.58	660.47	385	73.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			375.4	E08		2	0181-0661	524.65	661.60	401	74.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			456.0	E08		2	0182-0661	774.24	662.08	435	81.74	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			519.3	E08		2	0183-0662	36.19	661.90	361	71.84	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			478.1	E08		2	0184-0671	157.97	671.75	818	111.40	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			362.8	E08		2	0185-0662	872.90	662.01	666	128.61	0.506
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			440.0	E08		2	0186-0666	289.22	666.21	380	74.08	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			355.4	E08		2	0187-0674	70.95	674.70	366	75.01	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			527.5	E08		2	0188-0677	235.00	676.63	377	73.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			357.0	E08		2	0189-0684	563.26	684.31	396	73.84	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			287.4	E08		2	0190-0691	449.32	690.88	405	76.91	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			206.1	E08		2	0191-0696	716.43	696.13	248	75.50	0.547
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1023.2	E08		2	0192-0702	342.18	702.41	490	87.40	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			432.4	E08		2	0193-0702	591.30	701.65	379	73.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			488.9	E08		3	0001-0028	415.24	28.39	399	76.08	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			482.5	E08		3	0002-0036	582.81	36.50	835	114.95	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			608.5	E08		3	0003-0047	790.25	47.08	573	92.81	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			482.2	E08		3	0004-0047	632.71	47.54	348	69.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			322.7	E08		3	0005-0049	842.21	49.68	380	74.08	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			782.0	E08		3	0006-0059	49.64	58.78	679	99.98	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			373.6	E08		3	0007-0060	451.37	60.22	416	75.84	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			579.5	E08		3	0008-0064	479.63	62.90	740	108.81	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			295.6	E08		3	0009-0067	192.44	67.96	397	75.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1199.2	E08		3	0010-0067	523.81	67.54	485	83.26	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			402.5	E08		3	0011-0073	252.22	73.24	390	75.50	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			365.0	E08		3	0012-0076	425.67	75.91	395	75.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			429.6	E08		3	0013-0076	760.09	75.86	341	69.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			467.6	E08		3	0014-0076	803.99	77.07	365	72.18	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			512.5	E08		3	0015-0079	104.63	79.58	364	71.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			452.9	E08		3	0016-0081	144.10	81.90	430	80.08	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			468.9	E08		3	0017-0087	231.50	86.77	441	82.91	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			373.2	E08		3	0018-0093	904.56	92.91	288	64.18	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			318.9	E08		3	0019-0099	632.40	98.90	380	75.50	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			337.8	E08		3	0020-0099	801.64	99.31	406	77.36	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			622.0	E08		3	0021-0101	606.85	101.13	443	82.33	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			676.9	E08		3	0022-0104	69.86	104.40	367	71.60	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			412.5	E08		3	0023-0109	554.71	109.17	424	76.67	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			658.7	E08		3	0024-0111	520.13	111.51	384	73.01	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			535.6	E08		3	0025-0117	491.15	117.00	391	73.36	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			294.5	E08		3	0026-0121	454.17	121.55	394	75.94	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1114.0	E08		3	0027-0120	664.67	120.27	349	68.77	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			436.5	E08		3	0028-0125	605.34	126.10	451	82.43	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			346.0	E08		3	0029-0128	760.48	127.64	369	73.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			396.5	E08		3	0030-0133	283.91	133.14	379	77.74	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			679.5	E08		3	0031-0139	43.87	140.08	647	96.33	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			409.8	E08		3	0032-0141	838.44	141.63	356	70.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			283.1	E08		3	0033-0144	462.69	143.91	345	71.60	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			307.3	E08		3	0034-0147	403.48	147.68	423	79.74	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			404.0	E08		3	0035-0145	556.73	145.56	373	72.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			428.4	E08		3	0036-0148	936.63	147.82	359	70.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			291.1	E08		3	0037-0161	105.56	160.15	819	113.74	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			405.7	E08		3	0038-0161	159.37	161.40	377	74.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			552.0	E08		3	0039-0164	694.96	163.46	415	78.57	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			408.7	E08		3	0040-0165	620.89	164.85	366	71.84	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			349.3	E08		3	0041-0168	542.45	167.59	374	70.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			360.3	E08		3	0042-0172	861.79	172.65	398	74.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			305.7	E08		3	0043-0174	581.78	175.04	388	72.43	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1006.5	E08		3	0044-0177	683.05	178.30	328	70.91	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			293.5	E08		3	0045-0180	195.44	180.37	403	77.84	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3725.0	E08		3	0046-0181	308.26	180.58	310	72.53	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2125.4	E08		3	0047-0192	761.51	191.65	599	91.26	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			429.7	E08		3	0048-0194	31.71	193.70	709	107.74	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2680.6	E08		3	0049-0193	307.19	192.85	192	57.11	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			310.7	E08		3	0050-0210	253.54	209.53	363	71.26	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			955.9	E08		3	0051-0214	662.03	214.98	374	73.84	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			363.9	E08		3	0052-0225	202.17	225.33	359	70.67	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			470.2	E08		3	0053-0233	894.48	232.88	741	113.20	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			302.6	E08		3	0054-0226	681.37	224.84	416	77.74	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			373.7	E08		3	0055-0226	622.13	226.02	368	72.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			323.0	E08		3	0056-0230	231.70	229.44	406	77.50	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			650.6	E08		3	0057-0229	432.85	229.64	372	71.84	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			410.6	E08		3	0058-0233	377.23	232.95	380	72.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			281.7	E08		3	0059-0238	698.28	238.85	444	79.15	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			244.4	E08		3	0060-0239	113.51	238.68	366	72.67	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			535.7	E08		3	0061-0248	500.11	247.44	356	70.67	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			450.2	E08		3	0062-0251	752.47	251.41	385	75.26	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			293.3	E08		3	0063-0256	162.63	255.61	376	76.91	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			328.5	E08		3	0064-0276	640.98	276.20	848	126.02	0.671
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			489.5	E08		3	0065-0267	864.53	267.31	398	74.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2118.3	E08		3	0066-0277	682.08	277.03	520	85.50	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			536.2	E08		3	0067-0280	937.73	280.03	369	72.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			316.6	E08		3	0068-0282	619.21	283.03	418	80.67	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			285.3	E08		3	0069-0283	243.07	283.34	402	77.50	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			378.6	E08		3	0070-0286	502.83	286.56	398	75.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1847.2	E08		3	0071-0297	168.63	296.89	692	98.33	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			402.0	E08		3	0072-0293	818.20	293.63	379	73.01	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			388.8	E08		3	0073-0295	365.72	296.06	381	73.26	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			507.0	E08		3	0074-0299	700.88	298.65	369	72.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			250.8	E08		3	0075-0304	116.70	303.98	384	75.26	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			300.1	E08		3	0076-0316	211.94	316.42	415	75.01	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			418.3	E08		3	0077-0329	802.76	329.64	374	71.01	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			645.7	E08		3	0078-0326	851.75	326.91	277	65.60	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			526.5	E08		3	0079-0340	682.57	340.35	401	76.67	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			713.4	E08		3	0080-0346	414.42	345.62	377	70.77	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			344.9	E08		3	0081-0351	596.96	351.22	418	77.60	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			508.0	E08		3	0082-0353	446.26	353.58	383	73.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			480.3	E08		3	0083-0355	895.73	355.83	370	72.67	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			291.6	E08		3	0084-0363	202.60	363.08	387	74.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			235.9	E08		3	0085-0368	142.99	367.77	372	77.84	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			563.3	E08		3	0086-0368	796.25	368.49	398	75.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			489.6	E08		3	0087-0370	633.01	370.73	390	73.84	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			796.3	E08		3	0088-0373	817.02	373.12	337	67.11	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			657.4	E08		3	0089-0376	858.96	376.34	183	53.94	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			418.8	E08		3	0090-0381	323.92	381.41	369	71.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			451.2	E08		3	0091-0384	710.82	384.50	772	107.74	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			333.4	E08		3	0092-0392	230.06	392.60	411	78.91	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			498.5	E08		3	0093-0389	667.16	389.10	379	75.01	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			290.2	E08		3	0094-0390	911.86	389.80	341	71.60	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			420.0	E08		3	0095-0393	139.73	394.28	338	68.18	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			470.8	E08		3	0096-0397	444.60	396.62	591	99.84	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			493.3	E08		3	0097-0399	533.28	399.79	365	72.67	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			332.6	E08		3	0098-0402	246.58	402.44	379	75.26	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			436.6	E08		3	0099-0404	357.90	403.92	369	72.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			345.8	E08		3	0100-0415	486.20	414.77	845	118.61	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			380.1	E08		3	0101-0421	164.73	421.37	387	76.43	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			396.0	E08		3	0102-0421	285.05	421.10	395	73.84	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			327.9	E08		3	0103-0427	465.41	427.88	436	79.98	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			364.2	E08		3	0104-0427	322.12	427.69	395	73.26	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			451.6	E08		3	0105-0430	638.37	430.24	746	107.05	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			467.0	E08		3	0106-0430	686.73	430.73	378	73.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			264.0	E08		3	0107-0434	108.10	433.85	387	73.84	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1224.1	E08		3	0108-0437	59.84	437.40	376	72.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			459.9	E08		3	0109-0439	611.79	439.72	327	67.26	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			467.9	E08		3	0110-0452	856.28	453.15	186	66.77	0.524
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			390.8	E08		3	0111-0462	894.04	461.91	377	72.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			365.6	E08		3	0112-0469	598.73	470.62	823	111.54	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			340.4	E08		3	0113-0466	199.40	465.88	395	76.43	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			238.1	E08		3	0114-0463	864.99	464.80	169	61.11	0.569
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			296.0	E08		3	0115-0468	18.62	468.60	375	72.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			581.7	E08		3	0116-0477	537.51	477.00	395	73.84	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1196.5	E08		3	0117-0480	53.51	480.49	349	71.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			302.2	E08		3	0118-0489	512.63	489.10	419	78.33	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			356.4	E08		3	0119-0487	713.79	487.75	393	75.01	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			426.7	E08		3	0120-0488	757.30	487.96	396	76.43	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			346.3	E08		3	0121-0496	472.71	496.72	389	73.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			317.2	E08		3	0122-0498	409.66	497.78	366	71.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			244.0	E08		3	0123-0503	35.08	503.00	328	68.77	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			471.5	E08		3	0124-0506	169.29	506.84	401	77.60	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			538.8	E08		3	0125-0503	870.94	502.71	369	74.43	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			408.4	E08		3	0126-0513	109.46	513.19	361	72.43	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			766.2	E08		3	0127-0525	449.52	527.03	799	124.81	0.645
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			436.1	E08		3	0128-0515	252.53	515.56	362	73.84	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			556.6	E08		3	0129-0517	190.70	517.05	390	76.33	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			411.7	E08		3	0130-0517	776.83	517.42	340	68.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			370.1	E08		3	0131-0515	808.51	515.00	361	70.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			338.9	E08		3	0132-0521	742.37	520.71	393	75.26	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			330.9	E08		3	0133-0523	296.24	523.06	380	73.26	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			484.1	E08		3	0134-0527	339.69	527.96	523	127.30	0.406
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			331.1	E08		3	0135-0526	587.22	526.52	410	75.36	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			338.1	E08		3	0136-0530	680.35	529.55	417	77.26	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1131.1	E08		3	0137-0531	419.13	531.53	366	72.43	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			469.3	E08		3	0138-0534	548.07	534.35	414	78.08	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			360.1	E08		3	0139-0540	362.14	540.66	391	77.50	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			419.8	E08		3	0140-0545	139.63	544.61	373	77.50	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			306.3	E08		3	0141-0549	525.84	548.52	465	82.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			453.8	E08		3	0142-0556	83.76	556.33	752	107.40	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			311.6	E08		3	0143-0545	688.86	545.38	210	58.77	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			399.2	E08		3	0144-0552	271.47	551.69	372	76.08	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			283.7	E08		3	0145-0557	400.75	557.74	400	75.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			277.1	E08		3	0146-0558	57.64	557.53	415	78.67	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			638.6	E08		3	0147-0557	669.21	557.34	312	65.36	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			290.9	E08		3	0148-0562	24.51	562.19	357	71.60	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			447.2	E08		3	0149-0563	135.43	563.83	398	77.84	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			312.5	E08		3	0150-0563	342.88	563.66	410	79.01	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			394.9	E08		3	0151-0571	182.53	571.83	359	72.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			322.1	E08		3	0152-0581	582.33	580.93	438	79.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			338.7	E08		3	0153-0590	358.55	589.37	813	117.40	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			570.3	E08		3	0154-0586	902.42	586.52	384	73.26	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			358.8	E08		3	0155-0589	448.82	589.10	400	76.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			333.3	E08		3	0156-0593	768.02	593.82	407	74.08	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			297.5	E08		3	0157-0595	502.68	596.04	364	71.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			285.0	E08		3	0158-0604	831.40	603.98	362	73.60	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			446.8	E08		3	0159-0609	640.19	610.11	432	80.33	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			369.0	E08		3	0160-0611	850.23	611.63	370	74.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			463.7	E08		3	0161-0615	610.75	615.08	382	74.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			334.2	E08		3	0162-0628	536.77	627.71	417	78.08	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			447.6	E08		3	0163-0629	888.03	629.44	361	69.84	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			346.9	E08		3	0164-0638	173.63	638.96	773	108.23	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			351.9	E08		3	0165-0632	368.35	632.47	374	72.18	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			313.9	E08		3	0166-0635	289.51	635.13	365	72.43	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			315.7	E08		3	0167-0635	466.65	635.64	364	71.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			277.3	E08		3	0168-0640	241.54	639.77	373	75.01	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			738.1	E08		3	0169-0646	811.99	645.99	397	76.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			466.1	E08		3	0170-0653	50.79	652.78	721	100.23	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			300.0	E08		3	0171-0657	403.07	657.42	389	75.94	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			674.3	E08		3	0172-0669	131.11	669.24	419	79.74	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			337.9	E08		3	0173-0666	790.26	666.03	364	71.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			579.2	E08		3	0174-0669	769.70	669.44	437	82.67	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			285.7	E08		3	0175-0670	282.60	669.71	408	77.50	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			276.7	E08		3	0176-0670	336.02	669.89	373	72.67	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2410.4	E08		3	0177-0676	711.71	675.45	327	70.67	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			247.4	E08		3	0178-0675	902.93	675.77	440	80.57	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			341.1	E08		3	0179-0678	399.08	677.28	461	83.26	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			396.8	E08		3	0180-0679	461.52	678.85	335	71.70	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			306.4	E08		3	0181-0681	480.11	681.06	401	74.87	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			284.1	E08		3	0182-0683	883.11	684.29	410	76.33	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			304.3	E08		3	0183-0686	522.20	685.85	368	71.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			365.5	E08		3	0184-0687	119.99	686.81	247	61.26	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1378.8	E08		3	0185-0690	171.31	690.63	386	73.84	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			252.8	E08		3	0186-0692	290.70	692.65	416	78.67	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			396.6	E08		3	0187-0693	698.95	693.60	331	68.43	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			288.7	E08		3	0188-0696	753.16	696.63	394	74.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			330.7	E08		3	0189-0702	238.41	702.66	741	105.40	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			898.9	E08		4	0001-0029	376.31	29.33	422	79.50	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			406.6	E08		4	0002-0030	469.53	29.71	401	77.50	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			374.7	E08		4	0003-0032	326.73	31.62	416	76.67	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			360.8	E08		4	0004-0035	166.80	35.50	385	74.67	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			429.1	E08		4	0005-0034	539.01	34.48	445	82.43	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			416.0	E08		4	0006-0034	38.45	34.57	375	74.33	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			463.5	E08		4	0007-0036	206.75	36.76	415	80.57	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			310.9	E08		4	0008-0042	639.40	41.71	375	73.50	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			293.6	E08		4	0009-0047	481.05	47.22	481	85.98	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			634.1	E08		4	0010-0051	403.40	51.21	468	82.33	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			397.4	E08		4	0011-0061	606.13	61.23	465	82.08	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			338.8	E08		4	0012-0061	870.01	62.05	423	76.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			409.8	E08		4	0013-0064	814.30	64.40	384	72.77	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			389.0	E08		4	0014-0070	776.89	69.91	432	80.08	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			939.3	E08		4	0015-0069	362.99	69.22	421	80.33	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			341.1	E08		4	0016-0075	690.51	75.10	436	78.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			365.0	E08		4	0017-0076	236.77	76.65	410	77.50	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			271.0	E08		4	0018-0077	538.56	77.41	475	87.15	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			434.7	E08		4	0019-0084	839.75	83.66	374	72.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			404.8	E08		4	0020-0087	511.66	87.27	484	87.15	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			787.3	E08		4	0021-0100	67.65	99.83	411	77.26	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			417.3	E08		4	0022-0102	191.26	101.85	442	80.67	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1514.7	E08		4	0023-0106	411.29	105.96	766	104.91	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			745.8	E08		4	0024-0103	436.90	103.15	459	81.36	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			334.4	E08		4	0025-0103	24.48	103.70	398	75.84	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			480.5	E08		4	0026-0108	564.96	108.42	928	128.95	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			393.6	E08		4	0027-0110	667.55	110.64	870	122.95	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			520.1	E08		4	0028-0108	915.24	107.70	423	78.43	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			786.8	E08		4	0029-0119	369.86	119.71	872	117.64	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1895.0	E08		4	0030-0117	483.56	116.96	693	99.98	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			435.7	E08		4	0031-0133	735.08	133.36	872	128.51	0.664
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			339.1	E08		4	0032-0132	793.21	132.41	434	79.50	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			475.9	E08		4	0033-0135	590.91	134.99	441	78.91	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			399.7	E08		4	0034-0138	284.81	138.69	455	83.15	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			289.1	E08		4	0035-0141	624.33	140.81	426	82.57	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			456.4	E08		4	0036-0140	258.61	140.15	317	69.50	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			403.6	E08		4	0037-0144	195.41	144.54	413	77.50	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			343.1	E08		4	0038-0144	893.43	144.56	395	74.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			435.4	E08		4	0039-0148	364.65	148.27	417	80.33	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			376.1	E08		4	0040-0164	122.86	165.55	853	117.78	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			329.4	E08		4	0041-0158	345.00	157.93	466	85.15	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			330.0	E08		4	0042-0158	658.78	158.60	415	76.67	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			372.0	E08		4	0043-0162	39.75	161.75	398	74.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			398.1	E08		4	0044-0163	477.58	162.65	392	73.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			268.0	E08		4	0045-0171	757.86	171.71	411	81.50	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			291.1	E08		4	0046-0179	690.09	179.95	451	82.91	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			377.9	E08		4	0047-0181	509.76	179.71	436	82.47	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			472.8	E08		4	0048-0180	423.86	179.86	449	82.91	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			335.8	E08		4	0049-0188	634.58	188.58	481	83.74	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1038.7	E08		4	0050-0191	491.16	193.10	435	82.33	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			305.5	E08		4	0051-0192	794.75	192.31	428	78.08	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			441.9	E08		4	0052-0197	550.39	197.01	414	79.26	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			835.8	E08		4	0053-0197	831.67	197.45	401	76.08	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1335.6	E08		4	0054-0202	411.77	202.14	485	90.33	0.747
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			304.8	E08		4	0055-0211	606.56	211.27	947	125.44	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			329.1	E08		4	0056-0206	385.02	206.39	456	82.67	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			351.0	E08		4	0057-0209	242.02	207.81	446	81.88	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			287.5	E08		4	0058-0212	67.31	211.81	423	79.26	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			401.8	E08		4	0059-0210	286.99	210.26	423	78.08	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			687.8	E08		4	0060-0216	726.80	215.88	427	77.50	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			969.0	E08		4	0061-0221	226.57	222.17	395	78.23	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			488.3	E08		4	0062-0222	544.15	222.08	490	86.18	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			311.4	E08		4	0063-0220	777.29	220.48	419	76.67	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			331.2	E08		4	0064-0230	350.24	230.09	407	76.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			373.0	E08		4	0065-0235	698.65	235.23	431	82.81	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			688.2	E08		4	0066-0235	390.33	235.47	392	75.50	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			308.2	E08		4	0067-0243	108.57	243.69	401	77.50	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			315.4	E08		4	0068-0246	838.49	246.20	452	80.91	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			301.4	E08		4	0069-0248	543.64	247.86	431	78.43	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			624.1	E08		4	0070-0248	753.37	248.95	404	77.50	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1277.4	E08		4	0071-0248	451.53	248.74	468	84.77	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			322.6	E08		4	0072-0252	323.73	252.20	406	77.26	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			320.2	E08		4	0073-0254	473.20	254.32	420	80.18	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			396.9	E08		4	0074-0255	912.05	255.95	362	71.26	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			364.3	E08		4	0075-0258	640.31	258.51	486	85.50	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			326.4	E08		4	0076-0260	665.44	259.77	452	83.50	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			566.0	E08		4	0077-0263	872.41	263.11	474	83.50	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			366.9	E08		4	0078-0266	367.06	265.64	415	76.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			444.1	E08		4	0079-0268	780.52	268.02	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			315.0	E08		4	0080-0274	179.37	274.15	430	77.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			597.5	E08		4	0081-0280	251.34	280.48	399	75.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			408.5	E08		4	0082-0286	526.38	286.29	418	77.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2766.6	E08		4	0083-0291	805.27	290.90	691	98.57	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			369.7	E08		4	0084-0289	415.43	289.20	429	80.08	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			318.2	E08		4	0085-0303	165.61	303.77	430	77.84	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			348.1	E08		4	0086-0308	709.10	308.30	472	83.26	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			304.5	E08		4	0087-0311	288.03	311.72	406	79.50	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			279.6	E08		4	0088-0312	901.72	311.94	422	76.43	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			628.0	E08		4	0089-0318	685.82	317.83	441	80.67	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2750.5	E08		4	0090-0323	249.96	323.02	742	104.47	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			619.3	E08		4	0091-0322	624.79	322.52	399	76.08	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			255.4	E08		4	0092-0322	943.40	322.65	381	73.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			384.9	E08		4	0093-0347	676.81	348.17	412	76.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			367.2	E08		4	0094-0349	750.47	349.19	842	119.64	0.739
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			577.8	E08		4	0095-0349	136.05	348.74	396	76.91	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			391.6	E08		4	0096-0353	704.85	353.22	416	78.91	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			730.1	E08		4	0097-0361	338.63	362.11	810	111.88	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1288.3	E08		4	0098-0357	564.43	357.09	460	82.77	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			262.3	E08		4	0099-0359	203.75	359.23	427	80.33	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			895.2	E08		4	0100-0362	531.38	361.51	870	114.57	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			785.4	E08		4	0101-0364	616.58	364.28	423	75.84	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			391.7	E08		4	0102-0370	180.75	369.39	448	80.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			283.3	E08		4	0103-0375	83.23	375.25	391	78.33	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			336.9	E08		4	0104-0377	425.81	377.11	425	78.91	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			998.2	E08		4	0105-0386	288.74	385.59	897	123.88	0.734
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			658.9	E08		4	0106-0384	871.17	383.61	342	68.18	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			312.5	E08		4	0107-0389	24.18	389.00	376	74.67	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1773.3	E08		4	0108-0387	258.24	387.51	410	78.53	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			261.9	E08		4	0109-0393	491.32	393.10	437	83.15	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			281.6	E08		4	0110-0396	552.04	394.76	415	80.23	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			359.4	E08		4	0111-0398	738.64	397.49	397	74.43	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			546.4	E08		4	0112-0399	684.04	398.75	412	76.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			412.4	E08		4	0113-0407	389.42	406.76	529	94.91	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			274.8	E08		4	0114-0407	589.34	406.88	420	78.67	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1030.1	E08		4	0115-0406	920.59	406.58	440	77.26	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2131.2	E08		4	0116-0413	532.50	414.86	753	104.47	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			256.0	E08		4	0117-0413	233.92	412.73	412	77.26	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			275.1	E08		4	0118-0411	359.40	410.70	415	78.08	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			922.9	E08		4	0119-0413	630.06	411.74	381	77.64	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			490.8	E08		4	0120-0419	285.91	418.45	839	108.81	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			310.3	E08		4	0121-0421	695.14	420.42	479	90.81	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			467.2	E08		4	0122-0419	436.31	419.40	407	76.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1452.2	E08		4	0123-0425	110.14	425.64	562	94.81	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			697.7	E08		4	0124-0426	645.96	426.73	455	80.57	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			350.8	E08		4	0125-0425	866.84	425.04	392	76.91	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			249.3	E08		4	0126-0426	382.97	426.70	214	60.77	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			327.5	E08		4	0127-0431	777.43	430.82	454	83.15	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			328.7	E08		4	0128-0436	705.74	437.07	413	81.98	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			749.6	E08		4	0129-0435	319.58	435.80	410	76.08	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			363.6	E08		4	0130-0446	599.20	446.02	744	100.81	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			395.7	E08		4	0131-0448	163.99	448.51	430	78.08	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			430.5	E08		4	0132-0456	276.89	456.42	424	78.08	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			355.4	E08		4	0133-0459	905.75	457.52	380	75.98	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			385.1	E08		4	0134-0468	888.60	469.74	418	79.74	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3668.1	E08		4	0135-0474	695.70	474.53	764	106.23	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			535.3	E08		4	0136-0477	370.65	476.79	426	80.81	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			514.8	E08		4	0137-0481	112.68	481.24	401	78.33	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			351.0	E08		4	0138-0488	213.74	488.34	406	78.67	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			270.7	E08		4	0139-0486	603.59	485.86	424	78.91	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			309.3	E08		4	0140-0492	76.49	492.01	442	82.33	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			447.1	E08		4	0141-0490	307.38	490.29	448	81.50	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			362.2	E08		4	0142-0495	355.80	495.48	508	86.57	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			409.1	E08		4	0143-0498	530.91	497.54	426	78.43	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			262.1	E08		4	0144-0508	936.11	508.18	411	76.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			597.2	E08		4	0145-0516	640.42	515.71	391	73.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			673.8	E08		4	0146-0518	385.44	518.92	445	83.98	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			263.5	E08		4	0147-0526	569.04	526.32	431	80.33	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			341.2	E08		4	0148-0525	428.94	525.80	418	80.33	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			274.2	E08		4	0149-0528	701.21	528.02	431	79.50	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			367.9	E08		4	0150-0535	118.78	535.26	432	80.91	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			408.1	E08		4	0151-0535	367.11	534.85	449	81.74	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			328.1	E08		4	0152-0538	154.87	538.00	401	75.74	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			616.5	E08		4	0153-0542	403.90	541.72	447	84.33	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			495.5	E08		4	0154-0546	617.77	545.48	421	78.67	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1367.7	E08		4	0155-0553	247.29	552.85	707	100.23	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			314.0	E08		4	0156-0546	851.67	546.21	400	76.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			476.5	E08		4	0157-0551	755.90	550.92	400	75.01	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			789.4	E08		4	0158-0555	509.69	555.50	513	86.33	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			397.3	E08		4	0159-0566	449.55	566.71	846	114.47	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			303.0	E08		4	0160-0565	325.54	565.58	446	78.91	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			305.0	E08		4	0161-0565	718.66	565.16	417	77.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1077.1	E08		4	0162-0578	581.05	578.21	405	77.26	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			475.9	E08		4	0163-0584	352.77	585.09	409	78.91	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			489.5	E08		4	0164-0586	644.49	587.18	809	110.81	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			319.1	E08		4	0165-0599	386.32	598.68	902	122.02	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			355.2	E08		4	0166-0597	820.30	597.28	403	79.50	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			363.7	E08		4	0167-0597	902.14	597.37	399	74.43	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			262.0	E08		4	0168-0601	522.22	601.39	413	77.84	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2021.9	E08		4	0169-0610	858.65	610.57	427	79.50	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			326.5	E08		4	0170-0611	197.02	610.95	439	80.91	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			346.2	E08		4	0171-0610	713.64	610.13	416	77.84	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4835.6	E08		4	0172-0612	777.81	612.44	373	70.77	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			365.4	E08		4	0173-0617	442.56	617.16	390	75.50	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			512.6	E08		4	0174-0620	300.22	620.31	408	74.43	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1393.9	E08		4	0175-0623	818.13	622.92	476	84.08	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			401.7	E08		4	0176-0632	66.66	631.38	777	109.05	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			262.7	E08		4	0177-0638	333.96	638.20	438	79.74	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			336.9	E08		4	0178-0639	645.90	638.83	415	75.84	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			472.6	E08		4	0179-0644	254.30	643.97	410	75.84	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			276.7	E08		4	0180-0644	766.71	644.46	248	87.50	0.407
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			333.4	E08		4	0181-0649	475.70	648.79	796	111.64	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			608.5	E08		4	0182-0654	885.78	655.00	352	69.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			639.8	E08		4	0183-0656	36.38	656.07	390	73.26	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			254.5	E08		4	0184-0658	820.16	658.20	417	75.84	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			311.3	E08		4	0185-0666	109.47	665.99	445	80.91	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			253.3	E08		4	0186-0668	931.79	667.74	379	73.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			282.9	E08		4	0187-0670	764.69	670.90	426	79.74	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			287.8	E08		4	0188-0670	515.22	671.01	430	81.40	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			369.2	E08		4	0189-0672	228.59	672.38	446	80.67	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			335.5	E08		4	0190-0677	711.19	677.12	407	78.33	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			382.5	E08		4	0191-0680	362.66	680.49	407	74.18	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			343.3	E08		4	0192-0682	674.03	681.82	403	75.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			602.3	E08		4	0193-0688	31.90	688.55	387	75.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			244.4	E08		4	0194-0700	913.09	698.64	422	81.15	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			361.0	E08		4	0195-0699	177.40	699.16	425	77.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			763.2	E08		4	0196-0706	896.96	706.45	370	76.67	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			386.5	E08		4	0197-0705	451.24	705.04	393	73.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1808.1	E08		4	0198-0706	841.19	706.47	391	73.84	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2889.5	E08		5	0001-0036	912.92	36.08	697	97.74	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			451.6	E08		5	0002-0037	400.71	36.02	190	56.53	0.747
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			366.8	E08		5	0003-0042	383.54	44.47	533	95.15	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			359.1	E08		5	0004-0043	672.96	42.74	427	77.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			447.1	E08		5	0005-0047	55.66	46.50	612	93.98	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			340.5	E08		5	0006-0047	87.28	46.68	387	97.15	0.515
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			299.2	E08		5	0007-0044	186.17	44.47	395	73.84	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			304.8	E08		5	0008-0047	226.42	47.21	458	83.15	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			422.4	E08		5	0009-0048	129.84	47.85	425	77.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1321.2	E08		5	0010-0050	790.39	50.36	408	77.74	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			197.1	E08		5	0011-0051	101.71	52.26	139	54.53	0.587
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			352.4	E08		5	0012-0057	312.17	57.19	430	79.26	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			412.4	E08		5	0013-0068	489.97	68.32	441	79.50	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			402.9	E08		5	0014-0073	372.57	73.36	407	74.43	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			437.1	E08		5	0015-0074	412.97	74.21	406	77.50	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1405.5	E08		5	0016-0082	710.92	82.13	436	77.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			429.0	E08		5	0017-0089	155.98	89.08	370	72.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3430.7	E08		5	0018-0098	744.01	98.60	365	71.26	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			578.5	E08		5	0019-0101	112.51	100.66	349	70.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			526.3	E08		5	0020-0107	189.04	107.38	386	77.50	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			400.3	E08		5	0021-0106	912.13	105.94	263	75.50	0.580
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			488.9	E08		5	0022-0110	20.05	109.88	419	79.74	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			532.6	E08		5	0023-0113	684.55	113.61	430	78.08	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			595.3	E08		5	0024-0134	634.63	132.56	822	126.37	0.647
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			478.0	E08		5	0025-0135	217.50	135.58	433	79.84	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			321.6	E08		5	0026-0138	151.19	137.96	392	74.67	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			406.0	E08		5	0027-0139	694.30	139.48	432	78.91	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			416.3	E08		5	0028-0138	506.42	138.97	366	71.26	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			389.8	E08		5	0029-0153	739.43	153.21	377	71.01	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			486.5	E08		5	0030-0155	266.99	155.23	390	74.08	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2089.1	E08		5	0031-0158	364.21	158.24	390	74.43	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3521.6	E08		5	0032-0157	789.19	157.46	339	69.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			871.1	E08		5	0033-0161	428.45	161.27	415	79.15	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			395.9	E08		5	0034-0162	606.91	162.23	471	85.98	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			339.1	E08		5	0035-0164	102.21	164.37	385	74.91	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2256.0	E08		5	0036-0170	393.74	169.85	402	75.84	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			509.2	E08		5	0037-0173	45.29	173.71	724	105.50	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			514.5	E08		5	0038-0176	559.97	176.57	534	125.44	0.426
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			663.5	E08		5	0039-0182	182.79	182.45	382	74.33	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			405.2	E08		5	0040-0184	824.00	184.55	431	79.84	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			461.5	E08		5	0041-0189	630.02	190.57	822	113.54	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			326.9	E08		5	0042-0185	228.36	183.91	443	87.05	0.735
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			560.5	E08		5	0043-0202	452.20	201.93	838	110.57	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			437.2	E08		5	0044-0195	279.94	195.23	410	77.01	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			856.6	E08		5	0045-0202	155.62	202.56	473	86.08	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1067.1	E08		5	0046-0201	527.69	201.62	461	81.84	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			343.5	E08		5	0047-0203	752.82	203.24	401	76.08	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			588.1	E08		5	0048-0210	326.39	209.37	856	119.20	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			285.3	E08		5	0049-0207	228.68	207.78	408	82.23	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			288.3	E08		5	0050-0218	126.09	217.93	392	77.74	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			346.5	E08		5	0051-0219	938.78	219.02	391	74.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			318.5	E08		5	0052-0223	167.61	222.46	356	76.43	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			396.6	E08		5	0053-0229	91.30	229.29	380	74.67	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			512.3	E08		5	0054-0229	780.61	229.64	408	76.67	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2132.5	E08		5	0055-0233	833.52	233.37	660	96.57	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			330.2	E08		5	0056-0232	898.40	232.45	416	76.67	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			995.4	E08		5	0057-0241	397.59	241.52	526	87.74	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			463.2	E08		5	0058-0244	649.02	244.50	374	70.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			496.6	E08		5	0059-0248	294.41	247.83	388	74.67	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2086.8	E08		5	0060-0250	614.43	250.41	465	83.74	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			286.4	E08		5	0061-0253	247.78	252.38	415	81.40	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			343.0	E08		5	0062-0253	514.90	252.80	430	80.91	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			335.6	E08		5	0063-0254	738.72	254.37	418	79.01	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			367.7	E08		5	0064-0258	16.81	258.04	373	73.26	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			292.0	E08		5	0065-0260	71.67	260.48	388	73.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			264.2	E08		5	0066-0260	337.57	260.69	413	76.67	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			328.6	E08		5	0067-0261	717.98	261.28	407	79.26	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			355.7	E08		5	0068-0261	359.63	260.89	371	71.70	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			483.4	E08		5	0069-0268	867.65	268.12	368	72.08	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			300.4	E08		5	0070-0271	812.16	270.97	430	79.50	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			552.2	E08		5	0071-0274	164.80	274.49	398	76.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			292.7	E08		5	0072-0282	833.97	281.78	441	82.91	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			585.4	E08		5	0073-0285	930.92	285.11	411	75.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			303.4	E08		5	0074-0291	91.17	291.53	396	75.26	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			408.4	E08		5	0075-0291	480.15	291.94	443	80.33	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			343.8	E08		5	0076-0290	541.98	289.68	413	80.33	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			299.9	E08		5	0077-0297	744.79	296.42	423	79.74	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			370.2	E08		5	0078-0298	638.64	298.19	436	79.50	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			307.2	E08		5	0079-0299	696.64	299.44	421	77.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			238.7	E08		5	0080-0310	859.34	310.60	433	79.26	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			474.8	E08		5	0081-0311	211.24	311.25	384	73.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1620.8	E08		5	0082-0317	458.01	318.23	597	94.81	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			279.3	E08		5	0083-0316	756.38	317.12	453	82.08	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			313.9	E08		5	0084-0320	547.00	320.09	475	92.23	0.702
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			359.9	E08		5	0085-0322	522.21	322.03	409	79.84	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			240.6	E08		5	0086-0325	48.41	324.90	371	73.50	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			277.6	E08		5	0087-0325	111.70	324.44	389	75.01	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			653.4	E08		5	0088-0329	314.40	328.83	415	76.08	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			396.4	E08		5	0089-0331	582.08	332.17	403	76.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			280.2	E08		5	0090-0333	673.06	333.28	435	80.08	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			267.4	E08		5	0091-0331	899.74	331.41	398	77.26	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			323.3	E08		5	0092-0338	172.43	338.13	383	74.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			394.8	E08		5	0093-0339	223.79	339.76	383	74.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			388.7	E08		5	0094-0347	779.18	347.30	388	76.33	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			317.1	E08		5	0095-0349	689.37	349.18	454	81.74	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			304.5	E08		5	0096-0349	144.38	349.49	383	74.08	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			305.7	E08		5	0097-0351	272.80	350.88	394	76.08	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			571.9	E08		5	0098-0356	645.18	355.75	398	76.67	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			353.5	E08		5	0099-0371	89.56	371.12	398	75.26	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			387.4	E08		5	0100-0371	750.34	370.95	394	79.15	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			388.5	E08		5	0101-0375	859.09	374.62	419	77.50	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			598.7	E08		5	0102-0377	235.32	377.50	785	116.95	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			550.5	E08		5	0103-0385	597.11	385.01	934	125.68	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			685.1	E08		5	0104-0389	304.30	388.70	858	119.68	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			356.8	E08		5	0105-0383	122.06	383.52	392	76.57	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			389.9	E08		5	0106-0388	549.09	386.78	494	88.57	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			385.7	E08		5	0107-0388	493.48	388.54	448	86.57	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			314.3	E08		5	0108-0392	464.63	392.49	458	82.91	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			691.3	E08		5	0109-0398	361.87	397.81	415	76.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			269.0	E08		5	0110-0397	729.47	397.47	422	77.50	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			671.3	E08		5	0111-0402	644.21	402.75	401	75.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1029.1	E08		5	0112-0408	25.84	408.78	427	77.50	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			699.0	E08		5	0113-0412	687.08	412.42	423	78.67	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			268.5	E08		5	0114-0420	131.98	419.92	301	71.11	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			304.4	E08		5	0115-0420	149.08	419.68	190	53.21	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			400.9	E08		5	0116-0426	598.50	426.01	414	77.50	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			900.5	E08		5	0117-0428	881.31	428.51	431	80.33	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			306.3	E08		5	0118-0433	743.77	432.91	402	76.67	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			470.2	E08		5	0119-0436	519.01	436.38	420	78.08	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			235.0	E08		5	0120-0440	203.93	440.29	462	83.84	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			256.0	E08		5	0121-0442	226.39	442.23	462	81.60	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			808.2	E08		5	0122-0442	259.99	441.96	399	75.50	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1302.7	E08		5	0123-0442	396.28	441.63	404	77.26	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			689.9	E08		5	0124-0452	828.09	451.93	481	81.01	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			305.7	E08		5	0125-0454	567.20	454.24	407	76.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			271.1	E08		5	0126-0458	60.38	458.16	396	77.26	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			276.7	E08		5	0127-0464	462.94	463.98	444	82.91	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			283.6	E08		5	0128-0462	682.87	461.98	412	76.91	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1622.5	E08		5	0129-0466	727.81	466.33	689	100.47	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			755.8	E08		5	0130-0462	939.93	462.33	386	73.01	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			945.7	E08		5	0131-0480	545.63	480.82	800	118.71	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			273.7	E08		5	0132-0475	595.64	476.17	420	82.33	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			519.6	E08		5	0133-0486	337.27	486.65	436	83.40	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			456.6	E08		5	0134-0487	654.85	487.16	421	78.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			513.7	E08		5	0135-0498	312.01	498.08	791	114.95	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			247.2	E08		5	0136-0500	732.05	500.30	421	78.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			288.1	E08		5	0137-0510	41.05	510.31	392	74.67	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			262.9	E08		5	0138-0511	901.81	511.56	447	79.50	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			471.7	E08		5	0139-0514	171.32	513.56	408	78.57	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			252.5	E08		5	0140-0515	814.29	515.03	404	77.26	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			612.7	E08		5	0141-0517	762.03	517.57	409	75.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			477.3	E08		5	0142-0518	524.67	518.08	411	77.26	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			485.6	E08		5	0143-0530	669.23	530.32	405	76.67	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			382.7	E08		5	0144-0535	381.83	535.94	398	75.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			443.9	E08		5	0145-0537	450.65	536.69	413	79.26	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2331.7	E08		5	0146-0540	496.57	540.79	433	77.01	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			287.1	E08		5	0147-0543	575.29	542.93	427	80.33	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			313.7	E08		5	0148-0551	803.26	551.15	813	113.05	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			362.2	E08		5	0149-0551	922.87	550.54	310	66.18	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			371.8	E08		5	0150-0562	119.28	562.25	412	78.33	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			864.8	E08		5	0151-0565	243.17	565.20	397	74.91	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			208.6	E08		5	0152-0565	856.86	565.48	401	73.84	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			309.9	E08		5	0153-0572	309.73	571.73	409	79.50	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1670.7	E08		5	0154-0576	918.68	577.10	561	89.15	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			414.2	E08		5	0155-0579	350.68	579.12	403	75.50	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			300.2	E08		5	0156-0580	58.30	579.86	385	74.67	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			622.6	E08		5	0157-0584	284.01	584.18	751	105.64	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			262.9	E08		5	0158-0590	578.60	590.09	424	82.08	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			358.0	E08		5	0159-0593	777.12	593.57	371	75.74	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2364.2	E08		5	0160-0595	468.12	594.79	435	77.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3106.6	E08		5	0161-0607	390.67	607.42	853	115.88	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			324.2	E08		5	0162-0605	848.16	605.02	340	68.18	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1755.8	E08		5	0163-0609	726.45	609.57	390	73.26	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			881.8	E08		5	0164-0611	150.33	610.49	400	76.33	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			312.8	E08		5	0165-0614	112.83	614.69	392	74.08	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			300.9	E08		5	0166-0619	311.78	619.52	400	77.74	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			380.9	E08		5	0167-0620	53.42	619.82	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			455.2	E08		5	0168-0621	536.05	620.32	336	70.43	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			667.7	E08		5	0169-0626	822.73	625.75	397	76.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			433.3	E08		5	0170-0623	269.05	623.42	417	77.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			355.7	E08		5	0171-0630	552.07	630.35	420	83.50	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			360.1	E08		5	0172-0631	442.94	631.56	409	77.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1209.1	E08		5	0173-0635	917.01	635.15	376	74.08	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			266.8	E08		5	0174-0635	859.67	635.02	418	77.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			302.2	E08		5	0175-0649	331.63	649.34	432	80.33	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			289.3	E08		5	0176-0651	801.96	651.19	436	82.33	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			294.1	E08		5	0177-0648	142.89	648.94	365	74.43	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			326.4	E08		5	0178-0653	87.19	652.94	379	76.33	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1888.5	E08		5	0179-0654	490.62	655.31	427	97.40	0.566
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			384.6	E08		5	0180-0654	290.92	654.14	391	75.26	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			471.1	E08		5	0181-0658	122.51	658.29	430	78.08	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			307.8	E08		5	0182-0660	943.92	659.79	269	61.36	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			398.6	E08		5	0183-0665	450.32	665.15	408	76.67	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1542.8	E08		5	0184-0666	711.38	665.77	407	78.08	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			360.2	E08		5	0185-0665	388.66	665.79	387	76.08	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			362.9	E08		5	0186-0667	530.37	666.86	408	77.74	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			272.8	E08		5	0187-0670	36.41	670.08	383	75.50	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1135.2	E08		5	0188-0670	867.56	669.86	372	72.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			254.9	E08		5	0189-0687	601.90	686.94	404	75.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			303.0	E08		5	0190-0689	805.54	688.90	400	76.67	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			369.5	E08		5	0191-0691	754.41	691.52	398	75.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			336.5	E08		5	0192-0694	706.03	694.46	414	77.50	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			284.4	E08		5	0193-0695	182.32	695.39	392	74.67	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			382.6	E08		5	0194-0698	408.47	698.36	394	76.08	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			195.7	E08		5	0195-0701	18.07	700.07	363	77.40	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			320.8	E08		5	0196-0700	311.11	700.68	390	74.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			365.3	E08		5	0197-0707	882.43	706.19	366	72.81	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			296.4	E08		6	0001-0039	609.10	39.78	429	78.67	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			458.2	E08		6	0002-0037	360.26	37.48	370	71.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1553.1	E08		6	0003-0043	130.87	43.35	415	76.67	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			322.5	E08		6	0004-0044	937.28	43.85	447	83.26	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			496.7	E08		6	0005-0046	666.80	46.34	393	73.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			365.9	E08		6	0006-0051	182.30	50.93	439	79.84	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			355.9	E08		6	0007-0052	403.43	51.91	456	80.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			325.4	E08		6	0008-0056	835.63	55.83	437	82.67	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			341.0	E08		6	0009-0054	547.64	54.10	424	77.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			378.9	E08		6	0010-0056	445.92	56.36	434	79.26	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			284.4	E08		6	0011-0055	865.44	55.01	398	73.84	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			411.8	E08		6	0012-0056	99.44	56.56	204	59.36	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2300.8	E08		6	0013-0056	709.53	56.49	394	73.84	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			331.6	E08		6	0014-0057	56.19	57.15	276	62.77	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			306.7	E08		6	0015-0061	291.50	60.35	420	80.23	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			725.3	E08		6	0016-0071	649.24	69.38	188	65.01	0.559
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			357.6	E08		6	0017-0075	273.94	76.36	420	78.33	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			287.3	E08		6	0018-0082	865.23	82.94	421	76.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			618.2	E08		6	0019-0087	100.68	87.47	401	75.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			330.6	E08		6	0020-0085	790.76	85.89	405	77.01	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			718.8	E08		6	0021-0099	595.58	98.77	410	75.84	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			306.0	E08		6	0022-0100	401.27	100.66	401	75.26	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2940.8	E08		6	0023-0104	359.67	103.66	639	92.91	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			305.6	E08		6	0024-0101	917.18	101.30	370	71.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			330.8	E08		6	0025-0102	147.44	102.15	426	79.01	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			323.0	E08		6	0026-0104	203.96	103.60	391	73.84	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			325.0	E08		6	0027-0111	687.18	111.25	425	77.26	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			416.1	E08		6	0028-0114	311.62	114.67	409	76.67	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			390.8	E08		6	0029-0126	567.48	126.76	529	119.88	0.463
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			361.6	E08		6	0030-0124	514.48	124.06	399	73.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			535.4	E08		6	0031-0134	874.24	134.51	416	75.26	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			417.4	E08		6	0032-0136	443.35	136.30	428	77.26	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			321.3	E08		6	0033-0137	221.07	136.76	398	74.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			285.5	E08		6	0034-0138	802.41	138.59	416	75.01	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			463.1	E08		6	0035-0141	845.01	141.60	424	79.50	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			311.9	E08		6	0036-0145	932.34	145.11	411	78.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			366.3	E08		6	0037-0156	316.95	156.18	405	75.26	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			626.9	E08		6	0038-0173	180.35	172.98	600	120.37	0.520
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			320.5	E08		6	0039-0171	928.07	170.09	399	76.53	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			484.4	E08		6	0040-0176	889.94	176.64	383	76.67	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			310.4	E08		6	0041-0180	641.53	180.47	408	74.43	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			420.5	E08		6	0042-0181	254.12	181.22	431	79.84	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			352.5	E08		6	0043-0180	575.01	180.53	356	69.01	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			270.5	E08		6	0044-0185	769.00	185.35	487	85.84	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			354.5	E08		6	0045-0201	840.71	200.64	409	78.91	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			363.0	E08		6	0046-0201	402.79	201.96	404	75.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			321.3	E08		6	0047-0217	557.64	217.97	437	78.18	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			528.3	E08		6	0048-0222	65.75	222.55	402	75.84	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			357.1	E08		6	0049-0222	33.66	222.01	378	71.84	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			336.2	E08		6	0050-0230	461.89	228.95	884	118.71	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			301.6	E08		6	0051-0224	894.28	224.40	424	78.08	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			423.4	E08		6	0052-0235	146.72	235.75	423	77.26	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			440.3	E08		6	0053-0238	241.90	238.00	383	73.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			470.0	E08		6	0054-0237	315.12	237.17	411	77.01	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1445.7	E08		6	0055-0243	565.44	243.58	481	82.43	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			154.9	E08		6	0056-0246	675.69	246.47	385	73.26	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			449.9	E08		6	0057-0251	200.63	251.72	394	73.84	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			488.9	E08		6	0058-0254	390.06	254.58	396	73.01	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			327.1	E08		6	0059-0256	274.78	255.92	404	76.28	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			361.6	E08		6	0060-0258	297.14	258.14	451	81.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			292.1	E08		6	0061-0258	122.38	258.27	395	76.67	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			581.2	E08		6	0062-0262	826.81	262.42	397	77.74	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			374.0	E08		6	0063-0265	364.08	265.39	397	75.50	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			494.8	E08		6	0064-0266	66.07	266.07	380	73.01	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			310.4	E08		6	0065-0268	780.41	269.04	384	78.91	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			360.5	E08		6	0066-0276	942.40	276.55	414	77.26	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			321.3	E08		6	0067-0284	864.62	284.60	393	75.01	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			351.6	E08		6	0068-0288	919.98	288.51	425	80.67	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			563.5	E08		6	0069-0287	25.72	287.87	402	74.18	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			890.4	E08		6	0070-0291	794.39	291.48	427	84.91	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			492.8	E08		6	0071-0291	340.77	290.88	388	74.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			297.6	E08		6	0072-0292	733.23	292.36	414	78.08	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1875.9	E08		6	0073-0302	700.29	302.29	365	70.18	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			514.4	E08		6	0074-0307	593.62	308.24	459	83.98	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			327.1	E08		6	0075-0308	389.89	307.90	416	75.60	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1657.8	E08		6	0076-0316	97.64	316.85	772	105.98	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			533.2	E08		6	0077-0322	160.15	322.59	425	78.08	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			296.7	E08		6	0078-0323	429.71	323.83	412	76.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			271.2	E08		6	0079-0325	620.50	325.40	390	74.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1920.8	E08		6	0080-0324	673.88	324.71	368	71.01	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			330.9	E08		6	0081-0326	298.88	326.11	431	79.50	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			299.1	E08		6	0082-0338	840.47	338.66	399	74.43	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			292.1	E08		6	0083-0343	945.96	343.78	423	76.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			562.5	E08		6	0084-0348	94.01	348.05	361	75.26	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			558.8	E08		6	0085-0349	192.31	348.83	427	79.26	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			740.5	E08		6	0086-0355	743.75	355.90	402	75.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			561.9	E08		6	0087-0359	863.28	359.07	375	71.01	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			337.1	E08		6	0088-0361	410.56	360.93	417	76.91	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			410.2	E08		6	0089-0362	549.72	362.11	395	73.60	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			302.3	E08		6	0090-0366	86.07	366.13	430	81.84	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			454.8	E08		6	0091-0368	605.95	368.15	466	81.26	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			295.2	E08		6	0092-0368	461.92	368.59	404	75.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			304.1	E08		6	0093-0369	503.73	369.03	421	75.84	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1486.3	E08		6	0094-0388	126.33	388.29	676	96.33	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			314.4	E08		6	0095-0389	272.93	389.65	406	78.08	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			550.8	E08		6	0096-0397	897.17	397.47	378	76.08	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			591.0	E08		6	0097-0399	741.89	399.01	357	69.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			434.1	E08		6	0098-0401	489.83	401.65	393	73.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			495.5	E08		6	0099-0415	558.39	414.76	891	120.47	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			566.7	E08		6	0100-0418	759.37	417.69	385	73.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			318.9	E08		6	0101-0419	131.28	419.56	412	75.01	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			322.8	E08		6	0102-0428	222.85	428.22	398	75.84	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			353.2	E08		6	0103-0438	440.00	437.97	811	112.57	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			579.6	E08		6	0104-0429	888.69	429.98	388	77.26	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			254.7	E08		6	0105-0432	604.99	432.84	420	76.43	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			347.8	E08		6	0106-0431	803.92	430.66	397	75.01	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			284.2	E08		6	0107-0445	845.80	445.48	452	81.74	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			281.4	E08		6	0108-0449	472.86	450.16	419	76.43	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			352.5	E08		6	0109-0451	399.60	450.90	407	74.43	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			759.0	E08		6	0110-0452	901.77	451.81	344	68.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			495.1	E08		6	0111-0457	510.59	457.67	365	71.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			276.8	E08		6	0112-0458	271.58	458.37	398	75.26	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			244.6	E08		6	0113-0464	362.29	463.93	415	76.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			782.2	E08		6	0114-0465	34.79	465.26	372	71.01	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			250.9	E08		6	0115-0468	319.64	468.73	386	75.50	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			480.2	E08		6	0116-0468	204.85	468.31	403	74.43	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			253.6	E08		6	0117-0472	589.04	472.62	410	77.84	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			546.9	E08		6	0118-0485	130.94	485.17	784	114.57	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			343.6	E08		6	0119-0480	559.70	480.70	401	74.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			299.0	E08		6	0120-0485	765.12	485.12	414	75.01	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			342.2	E08		6	0121-0488	817.96	488.82	421	77.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			337.1	E08		6	0122-0487	700.13	487.33	456	79.60	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			417.0	E08		6	0123-0494	467.40	493.91	413	75.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			391.5	E08		6	0124-0497	519.65	497.45	378	73.01	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1082.4	E08		6	0125-0503	71.84	502.98	397	73.60	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			331.4	E08		6	0126-0510	312.54	510.67	394	76.91	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			310.6	E08		6	0127-0525	839.74	525.65	437	78.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			308.3	E08		6	0128-0527	540.65	527.67	412	75.26	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			390.9	E08		6	0129-0528	685.34	528.07	370	72.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			356.5	E08		6	0130-0531	408.66	531.66	427	82.91	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			275.0	E08		6	0131-0545	184.59	545.56	423	77.26	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			334.1	E08		6	0132-0550	783.64	550.56	434	78.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			313.7	E08		6	0133-0554	16.21	553.55	343	69.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			244.0	E08		6	0134-0558	889.37	558.36	399	75.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			344.6	E08		6	0135-0563	292.95	563.04	416	75.01	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			326.0	E08		6	0136-0566	246.05	566.66	403	75.26	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			293.4	E08		6	0137-0574	207.12	574.39	383	73.01	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			498.5	E08		6	0138-0580	407.06	580.07	744	102.91	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			808.4	E08		6	0139-0579	123.64	579.43	381	73.84	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			719.0	E08		6	0140-0584	648.20	584.41	298	79.26	0.596
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			303.1	E08		6	0141-0588	340.02	588.45	389	76.08	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			294.8	E08		6	0142-0591	512.96	591.21	414	76.08	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			315.7	E08		6	0143-0592	930.00	592.72	460	79.84	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			279.2	E08		6	0144-0600	604.74	599.99	396	74.67	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			422.3	E08		6	0145-0610	674.51	609.31	411	75.26	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			321.4	E08		6	0146-0613	833.51	613.41	434	77.26	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			299.3	E08		6	0147-0616	47.33	616.58	414	76.08	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			288.9	E08		6	0148-0615	120.49	615.56	390	73.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			351.6	E08		6	0149-0618	286.91	617.98	407	78.08	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			281.9	E08		6	0150-0621	579.64	621.75	407	74.43	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			310.0	E08		6	0151-0630	264.54	630.19	456	79.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1743.1	E08		6	0152-0633	530.57	633.89	542	86.91	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			285.8	E08		6	0153-0633	175.78	633.64	416	77.01	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			348.1	E08		6	0154-0644	342.89	645.15	398	75.50	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			354.0	E08		6	0155-0643	423.03	642.72	391	74.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			465.5	E08		6	0156-0649	707.56	648.55	332	71.60	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			236.0	E08		6	0157-0651	879.79	651.82	403	75.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			540.7	E08		6	0158-0654	830.07	653.96	335	68.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			358.2	E08		6	0159-0659	73.10	659.24	383	74.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			336.5	E08		6	0160-0662	37.75	662.74	306	64.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			474.6	E08		6	0161-0664	699.20	664.39	367	72.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			308.2	E08		6	0162-0669	294.23	669.17	425	77.84	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1439.7	E08		6	0163-0672	755.14	671.70	314	65.01	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			242.7	E08		6	0164-0685	651.76	685.15	402	76.43	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			339.6	E08		6	0165-0690	191.80	689.38	504	90.08	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			334.3	E08		6	0166-0688	241.93	688.34	391	75.26	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			331.5	E08		6	0167-0688	860.00	687.87	391	76.67	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			418.7	E08		6	0168-0695	394.10	695.29	375	75.84	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			288.6	E08		6	0169-0692	684.52	691.77	372	73.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			341.0	E08		6	0170-0698	175.02	699.26	445	82.67	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1335.7	E08		6	0171-0696	775.38	696.07	302	63.36	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			382.2	E08		6	0172-0701	605.07	701.16	380	72.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			377.3	E08		6	0173-0702	95.54	701.63	451	85.60	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			541.4	E08		6	0174-0704	120.66	703.75	188	52.63	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			279.4	E08		6	0175-0709	319.30	709.24	414	81.01	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			416.0	E08		7	0001-0031	448.84	30.88	428	78.08	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1965.5	E08		7	0002-0032	838.72	31.96	384	75.50	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			505.6	E08		7	0003-0036	597.08	35.70	508	86.43	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1093.9	E08		7	0004-0040	660.75	40.02	389	73.26	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			351.6	E08		7	0005-0043	46.37	43.18	436	80.08	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			461.4	E08		7	0006-0046	171.75	45.61	395	76.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1304.3	E08		7	0007-0056	779.49	56.58	762	105.40	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			690.2	E08		7	0008-0053	366.46	52.98	413	77.84	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			931.9	E08		7	0009-0061	736.50	60.83	821	110.33	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			333.0	E08		7	0010-0059	514.63	59.64	469	80.67	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			841.0	E08		7	0011-0060	622.88	60.55	447	81.01	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			628.8	E08		7	0012-0062	112.13	62.35	400	73.84	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			371.8	E08		7	0013-0064	827.38	64.14	397	73.01	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			544.2	E08		7	0014-0065	209.40	65.33	397	75.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			396.5	E08		7	0015-0068	474.31	68.46	445	77.84	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			492.8	E08		7	0016-0073	759.50	73.09	441	82.33	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			505.1	E08		7	0017-0071	25.96	71.16	395	74.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			486.2	E08		7	0018-0075	168.45	75.59	400	75.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			337.3	E08		7	0019-0076	649.96	75.19	460	84.91	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			842.5	E08		7	0020-0076	914.47	76.08	389	74.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			643.7	E08		7	0021-0081	412.73	81.20	410	77.01	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2176.7	E08		7	0022-0081	855.73	80.86	331	68.67	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			726.6	E08		7	0023-0090	806.94	90.08	426	77.50	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			583.5	E08		7	0024-0097	123.66	96.62	861	120.47	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			397.3	E08		7	0025-0100	724.72	101.48	808	111.30	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			344.9	E08		7	0026-0096	869.09	97.42	428	79.74	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			291.6	E08		7	0027-0096	384.45	96.22	436	77.26	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			995.5	E08		7	0028-0096	561.68	96.12	419	76.08	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1488.0	E08		7	0029-0103	764.31	103.27	401	74.08	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			485.5	E08		7	0030-0109	829.68	109.22	415	77.74	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			443.3	E08		7	0031-0108	325.77	108.69	389	74.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			259.6	E08		7	0032-0109	935.60	108.20	397	76.91	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			293.9	E08		7	0033-0115	706.49	115.81	360	73.50	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			872.7	E08		7	0034-0122	118.91	122.52	429	82.18	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			440.7	E08		7	0035-0124	923.18	123.79	412	82.23	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			314.4	E08		7	0036-0135	292.88	135.00	383	73.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			362.4	E08		7	0037-0135	354.72	135.33	404	75.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			425.3	E08		7	0038-0139	914.80	139.85	373	76.91	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			370.8	E08		7	0039-0143	59.89	143.01	419	81.84	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			399.1	E08		7	0040-0142	508.69	142.10	427	75.84	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1625.3	E08		7	0041-0140	651.23	140.11	271	60.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			453.5	E08		7	0042-0143	114.36	144.08	452	82.77	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			883.4	E08		7	0043-0145	174.82	145.47	397	74.43	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			451.6	E08		7	0044-0150	430.95	150.59	605	95.36	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			293.7	E08		7	0045-0151	682.39	151.18	397	75.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			411.9	E08		7	0046-0151	472.56	151.08	281	60.53	0.964
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			373.4	E08		7	0047-0153	408.79	153.93	304	67.94	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1323.5	E08		7	0048-0155	769.28	154.23	416	77.01	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			391.5	E08		7	0049-0160	729.61	159.76	426	78.91	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1096.3	E08		7	0050-0171	710.91	171.77	471	83.15	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			679.8	E08		7	0051-0176	84.38	176.01	398	74.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			464.0	E08		7	0052-0179	757.95	179.10	405	74.67	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			642.4	E08		7	0053-0183	829.21	183.92	409	76.18	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3270.7	E08		7	0054-0182	399.69	182.76	395	74.67	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			339.7	E08		7	0055-0190	561.34	189.93	399	74.43	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1184.3	E08		7	0056-0202	470.42	202.54	999	119.88	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			289.4	E08		7	0057-0196	663.68	196.18	453	79.26	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			373.8	E08		7	0058-0195	880.66	195.17	430	79.50	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			334.8	E08		7	0059-0196	922.97	196.10	429	78.67	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			280.1	E08		7	0060-0202	796.04	201.96	411	75.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3113.2	E08		7	0061-0206	348.07	206.46	389	73.01	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			451.6	E08		7	0062-0209	516.77	208.98	444	83.01	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			290.7	E08		7	0063-0220	186.65	219.98	420	76.33	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			393.7	E08		7	0064-0229	52.67	230.01	832	116.71	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			283.5	E08		7	0065-0221	413.57	222.10	437	84.18	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			440.3	E08		7	0066-0223	154.97	223.16	415	76.67	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			287.2	E08		7	0067-0225	212.81	225.04	416	76.67	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			393.1	E08		7	0068-0236	277.65	236.50	804	114.33	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			403.4	E08		7	0069-0230	717.96	230.20	468	83.26	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			401.3	E08		7	0070-0231	512.52	230.88	408	78.18	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			363.0	E08		7	0071-0231	660.78	231.47	409	76.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			310.3	E08		7	0072-0234	552.17	234.52	465	80.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1112.3	E08		7	0073-0235	743.94	234.70	468	82.91	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			799.8	E08		7	0074-0240	921.31	240.17	436	78.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			419.4	E08		7	0075-0244	349.58	244.76	421	79.50	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			392.7	E08		7	0076-0242	419.81	240.95	462	91.01	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			737.7	E08		7	0077-0245	587.43	245.28	446	79.26	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			332.8	E08		7	0078-0245	616.80	245.35	467	82.33	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			269.5	E08		7	0079-0256	244.72	256.65	411	74.43	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			275.2	E08		7	0080-0256	165.72	256.33	403	75.26	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			425.9	E08		7	0081-0256	546.41	255.98	391	77.36	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			397.2	E08		7	0082-0260	401.71	260.65	446	79.84	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			441.5	E08		7	0083-0261	770.98	261.39	409	76.08	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			354.6	E08		7	0084-0275	859.66	275.10	420	81.50	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			344.4	E08		7	0085-0280	15.81	280.22	382	76.08	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			423.1	E08		7	0086-0283	911.46	282.82	394	77.84	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			439.9	E08		7	0087-0287	812.91	286.93	384	75.26	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			355.9	E08		7	0088-0291	361.58	290.96	385	73.26	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			459.4	E08		7	0089-0296	449.18	296.56	453	80.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			335.8	E08		7	0090-0299	207.78	299.43	414	77.74	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			347.7	E08		7	0091-0300	615.41	300.01	425	79.26	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			331.2	E08		7	0092-0302	783.03	301.18	396	76.33	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			592.1	E08		7	0093-0305	287.31	304.99	408	75.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			387.7	E08		7	0094-0308	523.05	306.75	406	77.74	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			670.2	E08		7	0095-0304	581.87	304.39	434	78.08	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			268.8	E08		7	0096-0313	940.51	313.37	444	82.43	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			440.9	E08		7	0097-0310	418.35	310.49	410	75.84	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			314.2	E08		7	0098-0313	352.30	313.57	476	86.08	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			451.5	E08		7	0099-0311	766.95	312.50	385	76.33	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			310.5	E08		7	0100-0326	514.28	327.72	504	86.57	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			367.3	E08		7	0101-0333	365.09	333.64	458	82.67	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			508.4	E08		7	0102-0336	262.15	336.27	411	78.08	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			349.0	E08		7	0103-0346	486.60	346.09	878	119.64	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			390.3	E08		7	0104-0339	795.17	339.92	407	75.26	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			357.1	E08		7	0105-0340	576.51	340.22	421	76.67	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			282.8	E08		7	0106-0349	751.18	349.39	815	118.37	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			544.1	E08		7	0107-0342	176.49	342.38	406	75.26	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			301.4	E08		7	0108-0352	838.85	352.49	419	77.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			283.7	E08		7	0109-0353	37.15	353.91	411	77.26	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			381.3	E08		7	0110-0354	196.64	354.38	249	64.18	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			395.5	E08		7	0111-0357	911.74	356.92	410	77.50	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			405.6	E08		7	0112-0362	721.35	361.82	401	73.60	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			476.5	E08		7	0113-0375	307.67	373.54	822	118.37	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			354.9	E08		7	0114-0372	576.22	372.32	426	78.08	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1976.3	E08		7	0115-0379	255.42	379.49	555	88.33	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			307.2	E08		7	0116-0379	104.36	379.35	412	75.84	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			475.3	E08		7	0117-0383	353.55	383.66	403	78.08	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			309.1	E08		7	0118-0393	729.49	393.01	419	76.43	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			350.1	E08		7	0119-0399	411.40	399.13	422	78.67	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			333.2	E08		7	0120-0400	896.04	400.17	430	77.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			501.5	E08		7	0121-0412	547.67	412.36	432	77.26	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			350.9	E08		7	0122-0417	477.90	416.96	424	78.43	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			389.1	E08		7	0123-0421	798.64	421.39	816	108.13	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			242.0	E08		7	0124-0418	288.39	418.77	420	76.67	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			836.2	E08		7	0125-0422	221.78	422.33	394	75.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			275.2	E08		7	0126-0427	674.72	427.78	474	84.57	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			540.0	E08		7	0127-0435	647.25	434.77	971	126.37	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			301.6	E08		7	0128-0432	22.64	432.45	395	74.67	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			282.1	E08		7	0129-0428	852.61	427.21	311	66.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			533.5	E08		7	0130-0436	442.88	436.49	421	78.67	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			509.4	E08		7	0131-0438	413.29	438.11	427	78.91	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			329.1	E08		7	0132-0448	594.07	448.69	427	78.67	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			265.2	E08		7	0133-0449	916.60	449.00	410	75.84	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			317.2	E08		7	0134-0458	778.28	457.50	871	115.05	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			884.3	E08		7	0135-0453	284.13	453.88	402	74.67	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1675.8	E08		7	0136-0456	158.85	455.93	521	84.33	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			252.0	E08		7	0137-0458	703.47	458.41	431	80.91	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			396.7	E08		7	0138-0460	527.10	460.81	427	79.50	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			296.4	E08		7	0139-0461	851.90	460.82	426	77.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			488.7	E08		7	0140-0471	339.98	470.78	775	109.98	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			262.6	E08		7	0141-0483	82.00	482.90	404	76.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			392.0	E08		7	0142-0491	574.07	490.87	423	76.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1747.4	E08		7	0143-0493	110.84	492.98	414	76.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			311.7	E08		7	0144-0496	268.05	496.37	397	73.60	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			558.4	E08		7	0145-0497	225.62	496.98	383	72.43	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			189.5	E08		7	0146-0502	948.73	502.04	404	79.26	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			584.4	E08		7	0147-0507	728.18	506.57	400	77.60	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			674.4	E08		7	0148-0507	897.43	506.76	385	73.26	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			517.2	E08		7	0149-0515	409.47	515.53	400	75.84	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			370.8	E08		7	0150-0519	585.04	519.69	406	75.26	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			350.5	E08		7	0151-0524	723.90	525.32	292	66.18	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			505.8	E08		7	0152-0526	646.35	526.17	363	72.67	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			346.1	E08		7	0153-0530	160.90	531.09	418	77.11	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			999.8	E08		7	0154-0528	794.84	527.92	437	84.43	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1984.6	E08		7	0155-0538	62.81	537.91	537	87.26	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1772.9	E08		7	0156-0539	94.34	539.64	421	75.84	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			629.3	E08		7	0157-0537	526.23	537.55	407	76.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			345.3	E08		7	0158-0547	636.52	547.51	481	86.33	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			429.4	E08		7	0159-0546	361.37	546.65	416	76.67	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			314.9	E08		7	0160-0556	161.11	554.96	470	83.36	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			703.5	E08		7	0161-0556	830.91	556.71	355	72.08	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			330.5	E08		7	0162-0562	286.89	562.71	427	76.67	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			417.0	E08		7	0163-0563	565.56	563.25	427	76.43	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			355.7	E08		7	0164-0562	879.38	562.67	401	76.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			277.8	E08		7	0165-0563	239.98	563.72	432	77.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			475.0	E08		7	0166-0566	456.03	566.66	814	114.23	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			297.9	E08		7	0167-0578	40.49	578.42	753	104.81	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			373.4	E08		7	0168-0576	380.31	576.15	402	73.60	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			375.7	E08		7	0169-0594	904.98	594.13	711	103.64	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			528.8	E08		7	0170-0596	88.73	596.10	376	73.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			612.7	E08		7	0171-0605	117.62	605.11	407	76.67	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			381.4	E08		7	0172-0608	251.39	608.26	407	75.26	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			539.6	E08		7	0173-0609	171.24	609.16	393	73.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			284.9	E08		7	0174-0609	623.41	609.05	462	82.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			282.3	E08		7	0175-0622	508.45	622.39	442	79.26	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			753.8	E08		7	0176-0622	537.13	621.59	421	76.08	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			242.1	E08		7	0177-0629	839.20	629.32	388	73.60	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			435.1	E08		7	0178-0630	458.46	629.99	392	73.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			612.8	E08		7	0179-0630	375.06	630.96	424	77.84	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			366.1	E08		7	0180-0634	120.29	634.40	434	83.15	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			381.2	E08		7	0181-0638	566.69	638.48	419	78.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			599.1	E08		7	0182-0643	82.73	643.20	390	75.50	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			305.8	E08		7	0183-0641	31.35	641.60	353	68.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			393.9	E08		7	0184-0645	289.37	645.10	406	73.60	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			304.5	E08		7	0185-0644	599.43	644.18	456	81.50	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			454.1	E08		7	0186-0648	147.44	647.92	408	74.18	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			327.3	E08		7	0187-0651	710.26	650.69	404	75.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			367.2	E08		7	0188-0653	250.53	653.75	401	76.08	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			482.4	E08		7	0189-0657	392.64	657.16	439	78.43	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			445.7	E08		7	0190-0667	804.84	668.45	855	117.30	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			364.7	E08		7	0191-0664	204.68	664.59	410	75.01	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			410.4	E08		7	0192-0667	461.60	667.58	383	72.43	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1039.2	E08		7	0193-0668	870.91	668.58	360	70.43	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			508.1	E08		7	0194-0671	620.80	671.53	382	72.43	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			453.7	E08		7	0195-0682	727.61	681.81	759	105.74	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			388.8	E08		7	0196-0689	30.58	689.00	400	74.43	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			378.9	E08		7	0197-0698	843.13	698.26	329	72.43	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			481.8	E08		7	0198-0696	915.86	696.39	333	68.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2252.0	E08		7	0199-0702	286.34	702.25	615	92.91	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1205.9	E08		7	0200-0701	588.98	700.78	613	93.26	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			301.1	E08		7	0201-0703	676.76	703.24	449	80.08	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			940.7	E08		7	0202-0705	860.74	704.81	415	78.77	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			463.6	E08		7	0203-0706	339.00	705.36	365	71.01	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			274.7	E08		8	0001-0027	12.86	26.76	131	43.70	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			444.9	E08		8	0002-0034	878.19	33.39	456	81.98	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			377.2	E08		8	0003-0038	137.55	38.18	360	70.18	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			316.7	E08		8	0004-0036	208.64	36.46	369	71.26	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			209.2	E08		8	0005-0037	928.11	37.23	403	75.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			411.8	E08		8	0006-0039	338.64	39.54	422	77.50	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			488.9	E08		8	0007-0043	830.27	43.72	342	67.60	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			463.1	E08		8	0008-0044	858.88	44.83	369	73.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			435.9	E08		8	0009-0049	252.72	49.24	380	73.84	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3967.9	E08		8	0010-0052	703.68	51.91	725	99.74	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			465.3	E08		8	0011-0054	106.15	53.85	358	70.18	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			392.7	E08		8	0012-0056	435.56	56.02	435	77.26	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			289.4	E08		8	0013-0068	387.24	68.15	402	73.84	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			526.0	E08		8	0014-0072	502.28	72.23	432	79.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			488.7	E08		8	0015-0075	198.47	75.77	388	72.77	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			349.2	E08		8	0016-0076	825.57	76.69	447	78.67	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			642.8	E08		8	0017-0075	916.38	76.13	387	74.67	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			871.0	E08		8	0018-0078	19.55	78.07	365	71.01	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			273.6	E08		8	0019-0081	710.84	81.37	413	75.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			415.3	E08		8	0020-0090	169.84	90.08	388	74.67	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			480.9	E08		8	0021-0089	279.57	89.50	379	73.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			481.7	E08		8	0022-0093	359.40	92.93	391	73.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			329.5	E08		8	0023-0101	97.26	101.04	385	71.84	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			379.6	E08		8	0024-0106	129.43	105.80	377	72.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			541.9	E08		8	0025-0107	912.97	106.51	390	73.01	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			276.9	E08		8	0026-0111	40.25	110.23	367	75.40	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			907.6	E08		8	0027-0114	536.93	113.63	388	72.18	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1073.1	E08		8	0028-0121	790.30	121.16	840	112.08	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			278.8	E08		8	0029-0118	182.89	118.63	396	76.77	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			287.2	E08		8	0030-0117	426.66	117.08	409	75.26	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			442.5	E08		8	0031-0132	24.01	133.27	791	113.54	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			336.0	E08		8	0032-0129	510.23	128.96	385	73.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			407.2	E08		8	0033-0134	659.27	134.22	381	75.84	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			609.1	E08		8	0034-0142	147.05	142.44	399	74.18	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			514.3	E08		8	0035-0142	349.62	142.04	399	76.43	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			489.8	E08		8	0036-0143	184.85	143.18	431	79.94	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			845.1	E08		8	0037-0147	561.04	146.72	400	73.60	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			279.9	E08		8	0038-0152	592.10	151.51	558	98.57	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			288.3	E08		8	0039-0146	775.62	146.78	412	75.01	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			494.1	E08		8	0040-0154	270.66	154.46	398	73.01	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			352.8	E08		8	0041-0154	708.75	154.15	387	71.60	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			503.5	E08		8	0042-0155	221.46	155.64	376	71.01	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			512.1	E08		8	0043-0156	921.65	156.62	398	74.67	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			395.4	E08		8	0044-0157	303.73	157.44	396	73.60	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			853.7	E08		8	0045-0159	833.62	159.60	351	69.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			326.8	E08		8	0046-0166	471.01	165.99	897	114.81	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			568.0	E08		8	0047-0162	890.05	161.56	396	74.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			282.7	E08		8	0048-0161	61.84	161.17	363	71.60	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			466.4	E08		8	0049-0166	187.42	165.14	380	74.53	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			440.3	E08		8	0050-0166	341.97	166.42	401	75.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			513.6	E08		8	0051-0169	377.65	169.22	399	77.26	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			455.1	E08		8	0052-0167	102.73	166.88	363	71.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			515.1	E08		8	0053-0187	938.78	187.67	341	68.18	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1280.0	E08		8	0054-0188	676.21	188.44	420	76.67	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			737.4	E08		8	0055-0187	778.88	187.08	345	69.01	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			264.7	E08		8	0056-0189	823.38	189.83	386	71.60	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1352.3	E08		8	0057-0191	643.60	191.60	416	76.67	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			935.1	E08		8	0058-0194	529.74	194.47	406	75.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			297.7	E08		8	0059-0197	390.61	197.85	434	81.01	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			333.8	E08		8	0060-0198	28.08	198.47	395	78.67	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			250.4	E08		8	0061-0207	234.56	207.06	394	73.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			373.0	E08		8	0062-0210	98.04	210.49	783	110.81	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			304.1	E08		8	0063-0205	730.77	205.93	405	76.87	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			660.3	E08		8	0064-0210	51.96	209.98	417	77.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			565.2	E08		8	0065-0226	150.93	226.45	882	119.20	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			269.1	E08		8	0066-0227	766.45	227.43	385	74.43	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			306.1	E08		8	0067-0225	732.13	224.55	379	74.28	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			311.6	E08		8	0068-0230	517.07	230.49	396	75.26	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			477.1	E08		8	0069-0229	455.43	228.84	391	72.43	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			328.9	E08		8	0070-0234	704.14	234.14	436	77.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			260.4	E08		8	0071-0233	801.86	233.75	412	77.74	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1053.9	E08		8	0072-0235	280.81	235.53	442	79.50	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			831.0	E08		8	0073-0242	26.40	242.17	397	75.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			392.0	E08		8	0074-0239	883.39	239.10	387	73.26	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			461.5	E08		8	0075-0243	827.50	243.32	380	73.01	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			374.4	E08		8	0076-0245	304.28	244.81	430	84.08	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			735.8	E08		8	0077-0248	207.90	247.89	429	77.26	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			414.5	E08		8	0078-0247	338.34	247.62	403	76.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			365.9	E08		8	0079-0253	364.00	253.03	387	73.60	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1554.1	E08		8	0080-0269	645.93	267.39	970	133.05	0.689
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			314.1	E08		8	0081-0258	123.48	258.55	377	72.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			258.1	E08		8	0082-0263	453.70	263.14	404	75.26	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			479.7	E08		8	0083-0264	317.89	264.40	448	82.08	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			377.1	E08		8	0084-0266	75.47	265.97	413	76.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			289.4	E08		8	0085-0265	503.36	265.50	404	74.67	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1039.1	E08		8	0086-0267	273.87	266.82	456	81.15	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1382.5	E08		8	0087-0282	253.98	282.02	486	84.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			424.3	E08		8	0088-0285	16.72	284.89	358	71.60	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			459.1	E08		8	0089-0283	874.71	283.66	396	74.67	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			378.9	E08		8	0090-0301	365.86	301.03	389	73.01	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			476.4	E08		8	0091-0303	85.07	303.28	374	71.60	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			301.4	E08		8	0092-0305	493.41	304.96	634	98.57	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			688.9	E08		8	0093-0304	646.32	304.07	373	70.18	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			375.1	E08		8	0094-0307	801.56	307.47	422	76.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			424.4	E08		8	0095-0313	152.47	313.01	416	78.43	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			313.3	E08		8	0096-0315	45.71	315.47	403	79.01	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			582.1	E08		8	0097-0317	107.42	316.99	421	77.26	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			270.2	E08		8	0098-0324	435.57	323.86	409	76.08	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			373.9	E08		8	0099-0329	225.64	330.02	805	109.54	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			487.6	E08		8	0100-0323	884.08	323.71	276	59.94	0.965
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			261.2	E08		8	0101-0331	923.08	331.31	395	75.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			298.2	E08		8	0102-0334	353.64	334.44	365	71.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			438.8	E08		8	0103-0337	170.74	336.54	362	73.94	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1713.9	E08		8	0104-0338	558.10	338.35	477	80.67	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			271.8	E08		8	0105-0339	149.93	340.00	471	84.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			613.7	E08		8	0106-0341	811.52	341.33	405	75.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			689.2	E08		8	0107-0351	410.83	350.90	374	71.60	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			165.8	E08		8	0108-0353	298.83	353.05	332	67.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5262.2	E08		8	0109-0354	493.00	354.82	371	70.18	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1828.6	E08		8	0110-0358	665.66	358.28	390	74.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			401.6	E08		8	0111-0359	17.15	358.98	363	71.60	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			770.3	E08		8	0112-0357	346.39	357.41	317	65.36	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			296.2	E08		8	0113-0358	901.62	358.35	389	74.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			499.9	E08		8	0114-0371	862.43	370.96	842	117.15	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			542.8	E08		8	0115-0374	738.95	374.20	390	73.84	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			653.1	E08		8	0116-0377	785.88	377.58	417	77.84	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			551.2	E08		8	0117-0382	335.79	382.26	393	73.26	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			372.9	E08		8	0118-0394	112.36	393.65	782	110.37	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			321.6	E08		8	0119-0387	274.56	387.16	394	74.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			467.8	E08		8	0120-0390	208.40	390.43	381	74.91	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			792.9	E08		8	0121-0389	479.21	388.90	386	72.43	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			308.2	E08		8	0122-0401	168.44	400.19	458	87.26	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			384.6	E08		8	0123-0402	565.48	401.81	380	72.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			314.6	E08		8	0124-0406	362.72	406.66	424	79.84	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			326.8	E08		8	0125-0409	434.57	409.45	394	75.60	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			359.5	E08		8	0126-0412	476.60	412.46	404	75.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			693.5	E08		8	0127-0421	609.03	421.87	466	80.91	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			378.7	E08		8	0128-0421	828.47	421.78	413	76.67	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			325.1	E08		8	0129-0422	193.23	422.30	385	71.60	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			359.0	E08		8	0130-0421	261.09	421.26	380	73.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			549.8	E08		8	0131-0421	928.44	421.32	423	79.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			281.9	E08		8	0132-0431	84.88	431.14	373	73.26	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			286.9	E08		8	0133-0429	901.87	428.91	391	76.18	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			407.0	E08		8	0134-0434	390.13	434.87	380	73.01	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			290.9	E08		8	0135-0439	573.78	438.71	432	77.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			316.1	E08		8	0136-0443	677.38	443.35	419	75.01	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			302.3	E08		8	0137-0443	127.46	443.00	401	75.50	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			386.7	E08		8	0138-0443	298.30	442.84	387	74.67	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			344.4	E08		8	0139-0445	250.82	443.39	360	72.91	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			260.8	E08		8	0140-0451	21.71	450.93	367	71.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			238.7	E08		8	0141-0451	57.31	451.96	366	71.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			714.6	E08		8	0142-0456	266.57	457.00	385	74.57	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			774.2	E08		8	0143-0456	757.54	456.78	401	73.84	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			388.7	E08		8	0144-0465	695.31	464.74	333	66.77	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			561.4	E08		8	0145-0475	624.02	474.88	775	109.64	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1295.0	E08		8	0146-0472	545.34	472.55	230	55.94	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1255.6	E08		8	0147-0479	826.55	478.30	624	92.33	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			415.7	E08		8	0148-0480	103.11	480.20	386	73.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			328.2	E08		8	0149-0482	470.82	480.83	343	70.91	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			398.2	E08		8	0150-0483	257.38	482.81	373	70.77	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			355.8	E08		8	0151-0487	382.59	487.61	326	65.94	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			303.1	E08		8	0152-0497	88.68	497.40	427	77.50	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			272.2	E08		8	0153-0501	942.80	501.31	378	74.77	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			232.1	E08		8	0154-0504	53.78	503.94	355	73.60	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			650.5	E08		8	0155-0502	837.74	503.28	408	79.26	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			323.0	E08		8	0156-0506	117.26	506.08	442	81.01	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			414.3	E08		8	0157-0508	692.35	507.93	420	76.08	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			318.3	E08		8	0158-0510	631.74	509.82	395	73.84	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2078.2	E08		8	0159-0518	344.60	518.30	623	92.33	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			496.3	E08		8	0160-0520	502.68	521.89	473	97.40	0.627
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			276.9	E08		8	0161-0519	179.67	519.43	392	73.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			397.1	E08		8	0162-0531	133.80	531.30	437	83.50	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			425.4	E08		8	0163-0530	683.66	531.47	424	77.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			263.2	E08		8	0164-0535	109.15	534.66	422	78.08	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			371.8	E08		8	0165-0538	262.29	538.48	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			446.0	E08		8	0166-0546	422.62	547.19	423	78.43	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			409.9	E08		8	0167-0548	772.56	547.66	381	73.84	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			8298.4	E08		8	0168-0549	741.84	549.81	294	64.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4037.1	E08		8	0169-0552	689.00	552.49	408	78.18	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			682.6	E08		8	0170-0554	612.03	554.10	392	73.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			787.0	E08		8	0171-0558	572.27	558.01	387	73.01	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			265.0	E08		8	0172-0558	818.49	558.24	379	72.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			270.4	E08		8	0173-0559	239.19	559.34	388	74.08	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			341.4	E08		8	0174-0567	401.42	566.65	432	77.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			267.1	E08		8	0175-0569	72.52	568.92	371	71.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			255.0	E08		8	0176-0568	115.15	567.72	380	74.08	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			286.5	E08		8	0177-0571	928.14	571.53	366	71.01	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			305.6	E08		8	0178-0573	894.54	573.35	385	73.26	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			421.1	E08		8	0179-0573	472.87	572.73	373	71.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			413.4	E08		8	0180-0578	365.59	578.38	422	77.94	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			660.4	E08		8	0181-0577	620.21	577.65	398	74.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			254.4	E08		8	0182-0579	657.58	579.15	397	75.50	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			284.9	E08		8	0183-0579	130.71	579.51	295	63.84	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			367.3	E08		8	0184-0586	870.14	586.32	352	70.43	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			350.5	E08		8	0185-0593	306.08	592.85	380	72.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			279.1	E08		8	0186-0591	574.66	591.46	375	72.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			244.5	E08		8	0187-0600	798.09	600.44	796	109.88	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			371.3	E08		8	0188-0598	344.16	598.08	407	76.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			380.5	E08		8	0189-0598	649.17	599.12	377	74.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			777.9	E08		8	0190-0606	189.49	605.77	406	77.11	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			727.7	E08		8	0191-0611	212.45	611.06	398	76.77	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			415.0	E08		8	0192-0609	498.57	609.64	381	75.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			446.9	E08		8	0193-0620	745.01	619.76	770	112.47	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			590.6	E08		8	0194-0615	622.23	614.51	375	72.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			450.2	E08		8	0195-0619	247.53	619.43	377	71.01	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			355.0	E08		8	0196-0623	315.00	623.18	422	76.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			655.7	E08		8	0197-0630	449.89	629.80	367	71.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			514.3	E08		8	0198-0630	117.57	630.45	386	73.01	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			275.2	E08		8	0199-0634	145.21	633.58	394	75.50	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			281.9	E08		8	0200-0633	650.83	633.13	404	76.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			319.5	E08		8	0201-0634	411.77	634.57	416	76.18	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			356.9	E08		8	0202-0633	940.43	632.74	121	41.80	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			354.3	E08		8	0203-0642	389.05	641.84	422	77.84	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			353.5	E08		8	0204-0644	535.73	644.60	394	73.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			282.9	E08		8	0205-0650	577.45	650.84	386	72.18	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			248.2	E08		8	0206-0655	104.11	655.06	400	79.01	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			697.9	E08		8	0207-0656	784.90	656.57	391	73.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			343.4	E08		8	0208-0657	274.18	656.98	365	71.01	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			331.4	E08		8	0209-0660	515.41	660.89	414	75.84	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			414.9	E08		8	0210-0662	465.97	662.53	397	74.18	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			259.7	E08		8	0211-0663	862.67	663.21	420	76.43	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			257.7	E08		8	0212-0675	611.14	675.90	404	78.91	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			340.3	E08		8	0213-0687	236.25	687.72	410	77.01	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			388.4	E08		8	0214-0688	937.61	688.35	351	72.18	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			264.9	E08		8	0215-0687	135.56	687.26	385	73.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			251.6	E08		8	0216-0690	767.50	688.49	390	77.98	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			255.7	E08		8	0217-0695	630.66	695.62	404	78.43	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			423.2	E08		8	0218-0698	20.54	698.45	342	67.84	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			312.4	E08		8	0219-0705	876.06	705.52	417	76.91	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			357.9	E08		9	0001-0035	446.94	35.52	381	76.53	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			590.5	E08		9	0002-0030	118.26	29.91	194	54.53	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			508.1	E08		9	0003-0037	467.14	37.29	461	81.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			316.4	E08		9	0004-0035	317.27	34.86	407	80.43	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			219.3	E08		9	0005-0039	22.73	39.90	388	76.91	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			331.3	E08		9	0006-0041	859.08	41.53	402	77.74	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			320.2	E08		9	0007-0048	501.51	48.32	417	77.26	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			327.5	E08		9	0008-0052	92.29	52.34	375	72.67	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			357.8	E08		9	0009-0051	682.41	51.08	408	75.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			502.8	E08		9	0010-0056	198.24	54.50	521	106.81	0.574
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			398.4	E08		9	0011-0053	750.74	53.84	362	71.60	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			375.7	E08		9	0012-0058	180.23	60.22	233	72.08	0.564
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			329.2	E08		9	0013-0059	124.69	58.76	368	74.67	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			482.4	E08		9	0014-0065	905.51	65.74	347	70.43	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			487.2	E08		9	0015-0067	424.89	67.01	396	75.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			739.3	E08		9	0016-0068	807.95	68.14	355	68.77	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4704.5	E08		9	0017-0080	716.35	80.08	379	75.36	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			412.3	E08		9	0018-0076	289.50	76.64	363	72.43	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			289.2	E08		9	0019-0079	840.09	78.86	418	77.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			598.8	E08		9	0020-0082	469.22	81.80	358	71.60	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			615.2	E08		9	0021-0086	533.45	85.87	390	75.84	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1630.2	E08		9	0022-0091	923.79	90.75	578	92.57	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			250.1	E08		9	0023-0090	79.93	89.86	378	73.50	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			537.8	E08		9	0024-0097	361.02	97.13	367	73.26	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			333.8	E08		9	0025-0100	832.20	99.85	407	77.84	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			301.9	E08		9	0026-0104	944.59	104.47	361	71.84	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			637.9	E08		9	0027-0114	400.72	115.10	887	115.98	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2147.6	E08		9	0028-0113	501.62	112.70	613	91.74	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1489.6	E08		9	0029-0124	118.68	124.31	366	71.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1278.2	E08		9	0030-0133	74.11	134.00	385	77.60	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			457.1	E08		9	0031-0136	215.57	136.49	367	71.60	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			304.5	E08		9	0032-0137	304.29	137.25	382	75.26	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			298.6	E08		9	0033-0142	849.97	142.28	397	76.67	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			809.8	E08		9	0034-0153	773.45	152.25	340	70.33	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			328.4	E08		9	0035-0155	71.06	153.87	405	76.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			552.0	E08		9	0036-0157	644.08	156.94	390	76.08	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			527.5	E08		9	0037-0159	16.79	159.26	372	72.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			608.5	E08		9	0038-0164	786.81	165.90	382	73.74	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3453.9	E08		9	0039-0170	711.99	170.25	341	68.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4376.0	E08		9	0040-0179	734.38	179.20	399	77.26	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			389.3	E08		9	0041-0182	557.51	181.49	421	78.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			312.9	E08		9	0042-0181	472.02	180.70	441	80.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			356.6	E08		9	0043-0183	320.29	182.67	391	75.26	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			558.8	E08		9	0044-0190	33.68	190.27	339	69.01	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3062.9	E08		9	0045-0190	662.58	189.98	368	74.43	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1378.2	E08		9	0046-0201	870.57	199.09	990	127.54	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			328.8	E08		9	0047-0198	642.58	198.23	392	75.60	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			498.4	E08		9	0048-0198	62.31	198.18	337	69.26	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			637.7	E08		9	0049-0204	137.30	204.06	380	75.84	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			466.8	E08		9	0050-0204	931.35	203.84	337	68.18	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			554.1	E08		9	0051-0207	116.09	206.71	381	75.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			472.4	E08		9	0052-0218	365.71	218.11	398	77.50	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			516.3	E08		9	0053-0223	202.20	223.22	396	76.08	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			355.3	E08		9	0054-0235	446.43	235.83	404	77.74	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			502.3	E08		9	0055-0234	300.74	233.79	385	75.26	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			358.2	E08		9	0056-0237	852.00	237.08	388	73.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			937.0	E08		9	0057-0246	898.77	247.10	689	110.37	0.711
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			411.0	E08		9	0058-0245	510.67	246.13	412	75.26	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			440.3	E08		9	0059-0250	571.60	249.66	391	73.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			386.9	E08		9	0060-0254	95.42	254.05	353	68.18	0.954
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			339.1	E08		9	0061-0261	257.36	261.65	412	80.43	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			390.5	E08		9	0062-0264	925.97	264.27	369	71.01	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			480.5	E08		9	0063-0267	276.08	268.10	156	48.87	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			492.9	E08		9	0064-0295	116.10	293.14	552	94.23	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			759.3	E08		9	0065-0296	865.27	296.47	330	67.94	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			352.0	E08		9	0066-0308	601.08	308.01	785	119.10	0.695
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			361.9	E08		9	0067-0312	311.36	313.08	807	110.37	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			413.0	E08		9	0068-0306	62.59	305.93	393	78.33	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			449.2	E08		9	0069-0310	160.91	310.08	362	74.91	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			306.0	E08		9	0070-0311	534.74	311.75	392	75.01	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			473.5	E08		9	0071-0312	103.15	311.94	275	61.36	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			628.4	E08		9	0072-0316	463.24	315.59	409	77.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			345.7	E08		9	0073-0318	253.19	318.38	397	76.33	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			358.1	E08		9	0074-0321	48.06	322.47	448	79.50	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			654.0	E08		9	0075-0322	843.07	321.93	318	66.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			541.0	E08		9	0076-0329	410.85	329.14	331	68.43	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			225.7	E08		9	0077-0334	18.36	333.96	364	73.50	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1389.1	E08		9	0078-0336	359.49	336.39	397	73.84	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			249.4	E08		9	0079-0361	46.64	361.56	375	76.18	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			303.8	E08		9	0080-0363	143.77	363.02	715	101.05	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5036.4	E08		9	0081-0357	942.03	357.06	341	68.18	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			473.9	E08		9	0082-0367	914.25	366.85	224	76.43	0.482
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			478.2	E08		9	0083-0371	291.66	371.35	368	72.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			318.4	E08		9	0084-0386	92.84	386.67	367	72.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			530.1	E08		9	0085-0400	243.83	400.34	375	73.26	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			507.6	E08		9	0086-0401	306.84	401.24	393	74.67	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			299.5	E08		9	0087-0409	193.29	408.93	388	73.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			224.5	E08		9	0088-0412	70.60	412.71	370	71.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			360.4	E08		9	0089-0421	506.18	420.74	402	75.50	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			536.9	E08		9	0090-0424	23.89	424.00	390	75.60	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			350.4	E08		9	0091-0438	122.48	438.09	377	74.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			260.5	E08		9	0092-0457	67.82	457.34	362	71.60	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			404.3	E08		9	0093-0460	378.98	459.94	408	74.43	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			283.6	E08		9	0094-0472	844.58	471.93	371	74.43	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			466.3	E08		9	0095-0493	233.99	494.65	661	106.23	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			549.1	E08		9	0096-0496	541.76	496.72	360	71.84	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			298.2	E08		9	0097-0502	57.45	502.91	432	82.28	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			272.6	E08		9	0098-0504	37.64	504.09	357	72.53	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			358.5	E08		9	0099-0505	610.27	505.12	422	75.26	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			380.2	E08		9	0100-0519	323.28	519.04	444	79.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1031.1	E08		9	0101-0523	206.62	522.81	376	73.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			673.6	E08		9	0102-0523	59.79	522.94	350	71.70	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			304.4	E08		9	0103-0540	338.97	540.23	445	79.26	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			469.2	E08		9	0104-0545	381.48	545.16	362	70.53	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			403.9	E08		9	0105-0545	571.83	544.20	311	67.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1042.1	E08		9	0106-0559	562.79	560.54	389	75.26	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			304.7	E08		9	0107-0574	22.91	574.25	342	69.60	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			340.0	E08		9	0108-0576	608.85	576.94	389	74.91	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			797.1	E08		9	0109-0587	590.60	587.81	393	75.26	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1115.3	E08		9	0110-0594	360.80	594.71	372	72.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			504.2	E08		9	0111-0597	50.96	597.50	346	71.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			306.6	E08		9	0112-0619	538.40	618.84	271	59.94	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			350.6	E08		9	0113-0632	114.79	632.78	368	71.84	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			250.6	E08		9	0114-0633	916.89	632.73	349	70.77	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			478.7	E08		9	0115-0637	723.10	636.85	398	76.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			426.2	E08		9	0116-0635	35.78	635.56	114	43.46	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1488.3	E08		9	0117-0647	330.91	646.43	963	121.30	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			429.5	E08		9	0118-0643	95.21	643.10	364	74.08	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			737.2	E08		9	0119-0646	831.47	646.01	365	71.84	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3825.8	E08		9	0120-0664	884.80	664.40	591	92.33	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			311.0	E08		9	0121-0688	282.03	688.56	384	75.84	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			400.0	E08		9	0122-0691	32.07	691.03	364	72.43	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			947.9	E08		9	0123-0696	492.71	697.00	914	118.23	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			286.4	E08		9	0124-0692	101.63	692.07	400	76.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			360.0	E08		9	0125-0695	371.28	694.61	380	75.50	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1500.7	E08		9	0126-0700	602.27	699.55	456	83.74	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			290.1	E08		9	0127-0701	453.77	701.32	370	71.84	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			634.9	F08		1	0001-0030	110.32	30.57	334	66.77	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			348.7	F08		1	0002-0030	292.69	29.76	335	69.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			381.1	F08		1	0003-0033	788.07	32.87	308	63.94	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			536.0	F08		1	0004-0036	632.11	35.77	388	76.67	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1059.1	F08		1	0005-0039	856.44	39.34	340	71.26	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1063.2	F08		1	0006-0046	812.65	45.96	342	69.60	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			430.8	F08		1	0007-0045	447.90	44.91	293	63.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			674.4	F08		1	0008-0050	42.39	51.20	369	72.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			863.8	F08		1	0009-0052	596.09	52.45	328	69.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			277.2	F08		1	0010-0056	175.27	55.94	409	77.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			616.9	F08		1	0011-0064	115.82	64.58	333	67.26	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			305.7	F08		1	0012-0066	924.28	65.51	402	78.08	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			465.7	F08		1	0013-0084	473.86	84.49	348	69.60	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			582.7	F08		1	0014-0088	249.65	88.08	246	61.84	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			637.0	F08		1	0015-0090	298.93	89.70	343	71.01	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			472.4	F08		1	0016-0097	626.12	97.82	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			295.5	F08		1	0017-0100	812.67	99.51	412	75.26	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1141.9	F08		1	0018-0101	37.70	101.14	322	67.01	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			322.7	F08		1	0019-0109	158.33	109.14	367	74.67	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			497.8	F08		1	0020-0110	918.49	110.83	230	55.70	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			619.7	F08		1	0021-0117	383.49	117.08	301	63.60	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			276.9	F08		1	0022-0120	224.09	120.30	352	71.84	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			636.1	F08		1	0023-0128	92.30	128.42	330	68.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			645.6	F08		1	0024-0129	304.76	129.88	332	69.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			318.8	F08		1	0025-0132	888.55	131.89	382	74.67	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			299.3	F08		1	0026-0133	624.07	132.24	400	75.84	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			304.4	F08		1	0027-0136	189.70	136.50	377	71.84	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			570.0	F08		1	0028-0139	38.80	139.33	355	71.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			386.0	F08		1	0029-0156	502.25	156.41	361	72.77	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			922.9	F08		1	0030-0159	245.97	159.58	262	60.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			518.1	F08		1	0031-0162	542.47	162.08	305	66.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			319.4	F08		1	0032-0170	856.80	169.98	448	81.26	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			312.8	F08		1	0033-0175	32.65	174.76	287	62.77	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			328.8	F08		1	0034-0180	296.19	180.25	357	70.67	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			333.0	F08		1	0035-0181	102.62	181.53	348	70.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			335.0	F08		1	0036-0191	622.34	191.15	356	70.53	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			312.1	F08		1	0037-0209	549.09	209.23	362	71.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			483.7	F08		1	0038-0216	173.16	216.49	298	64.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			511.6	F08		1	0039-0214	415.90	214.79	279	65.70	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			452.2	F08		1	0040-0218	132.55	218.67	313	65.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			343.9	F08		1	0041-0222	910.76	222.53	352	71.36	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			295.8	F08		1	0042-0227	265.38	226.89	346	70.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			316.8	F08		1	0043-0236	190.99	236.66	350	69.01	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			663.8	F08		1	0044-0238	460.98	238.44	327	74.08	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			437.2	F08		1	0045-0242	620.41	241.77	371	73.26	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			635.1	F08		1	0046-0241	540.92	241.27	310	65.11	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			566.7	F08		1	0047-0241	410.05	241.48	113	37.80	0.994
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1125.1	F08		1	0048-0250	839.25	249.93	357	73.26	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			338.1	F08		1	0049-0261	137.07	261.05	352	71.26	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			587.2	F08		1	0050-0262	571.15	261.52	381	73.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			341.2	F08		1	0051-0266	475.39	266.69	348	70.77	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			325.9	F08		1	0052-0270	530.89	271.01	334	69.84	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			283.8	F08		1	0053-0273	75.30	273.01	386	72.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			334.2	F08		1	0054-0279	210.55	279.03	249	60.43	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			435.2	F08		1	0055-0279	382.62	278.80	308	67.36	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1083.4	F08		1	0056-0282	904.38	282.65	390	74.43	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			348.5	F08		1	0057-0287	15.18	287.71	332	67.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			416.3	F08		1	0058-0300	517.08	299.90	373	73.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			530.9	F08		1	0059-0329	669.56	330.57	345	70.43	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			639.7	F08		1	0060-0329	210.55	329.94	319	64.77	0.956
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1248.8	F08		1	0061-0342	802.79	343.15	334	72.67	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			315.9	F08		1	0062-0344	183.62	344.44	354	70.43	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			720.7	F08		1	0063-0346	343.07	345.89	306	64.77	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1471.8	F08		1	0064-0343	518.02	343.86	284	64.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			581.5	F08		1	0065-0349	610.56	349.57	361	71.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			710.3	F08		1	0066-0349	313.63	348.58	294	67.26	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			827.9	F08		1	0067-0352	260.23	352.27	281	67.11	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			529.0	F08		1	0068-0354	442.75	354.67	287	63.94	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			382.7	F08		1	0069-0363	480.92	363.36	340	69.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			536.8	F08		1	0070-0367	299.40	366.87	304	65.36	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			294.2	F08		1	0071-0365	834.10	365.25	322	69.01	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1268.3	F08		1	0072-0368	527.07	367.61	294	64.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			925.6	F08		1	0073-0382	713.27	382.72	345	71.50	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			326.2	F08		1	0074-0384	173.41	384.36	362	72.77	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			961.8	F08		1	0075-0391	638.78	392.22	333	68.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			361.7	F08		1	0076-0405	573.29	404.87	344	69.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			299.8	F08		1	0077-0406	83.10	406.45	337	72.08	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1139.2	F08		1	0078-0409	594.00	410.00	382	76.43	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			537.6	F08		1	0079-0416	504.68	415.87	285	67.01	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			526.3	F08		1	0080-0418	699.52	417.20	307	69.50	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			431.6	F08		1	0081-0418	203.10	417.77	265	61.36	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			280.1	F08		1	0082-0428	690.61	428.69	321	68.91	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			283.5	F08		1	0083-0435	651.67	435.56	372	72.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			400.8	F08		1	0084-0437	450.85	437.17	367	70.77	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			390.7	F08		1	0085-0435	195.15	435.23	264	61.36	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			400.5	F08		1	0086-0441	111.14	440.70	368	73.84	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			462.3	F08		1	0087-0436	937.32	436.53	267	61.70	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			602.3	F08		1	0088-0444	253.50	444.16	346	118.71	0.309
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			306.6	F08		1	0089-0455	397.40	455.25	368	71.01	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			631.6	F08		1	0090-0464	825.17	463.78	237	57.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			665.0	F08		1	0091-0485	605.91	485.29	412	87.15	0.682
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			435.6	F08		1	0092-0484	359.10	485.15	381	72.18	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1613.8	F08		1	0093-0490	141.87	490.27	500	83.26	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			494.7	F08		1	0094-0485	304.73	485.23	290	63.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			369.4	F08		1	0095-0491	754.70	490.13	391	73.84	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			527.7	F08		1	0096-0498	265.06	497.74	288	63.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1356.1	F08		1	0097-0502	612.95	502.59	117	44.87	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			569.6	F08		1	0098-0527	10.59	527.92	305	65.70	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			431.0	F08		1	0099-0529	57.86	529.03	358	73.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1314.2	F08		1	0100-0535	452.49	535.43	640	112.47	0.636
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			306.3	F08		1	0101-0544	105.27	544.43	300	68.18	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			336.5	F08		1	0102-0546	231.84	545.25	339	71.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			518.4	F08		1	0103-0553	623.75	553.28	268	62.43	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			475.2	F08		1	0104-0555	850.95	555.28	286	62.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			519.0	F08		1	0105-0568	48.18	568.35	360	72.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			544.1	F08		1	0106-0574	819.63	574.22	350	69.11	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			521.2	F08		1	0107-0583	783.20	583.27	312	66.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			326.1	F08		1	0108-0584	710.81	582.51	423	89.50	0.664
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			340.5	F08		1	0109-0601	38.32	600.89	321	67.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			395.9	F08		1	0110-0600	607.81	600.05	367	76.08	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			359.9	F08		1	0111-0606	660.58	605.85	371	69.60	0.962
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			524.7	F08		1	0112-0610	748.21	610.84	319	68.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			447.3	F08		1	0113-0613	409.35	613.53	265	61.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1059.2	F08		1	0114-0617	366.01	617.49	295	65.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			347.7	F08		1	0115-0636	47.83	636.91	302	65.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			460.3	F08		1	0116-0637	228.92	636.45	239	59.84	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			409.7	F08		1	0117-0641	105.73	640.57	304	66.43	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			685.9	F08		1	0118-0640	623.25	640.90	283	65.50	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			278.4	F08		1	0119-0647	682.37	646.90	347	69.36	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1052.5	F08		1	0120-0655	768.36	655.13	297	65.11	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			407.4	F08		1	0121-0662	135.28	662.55	313	68.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			549.1	F08		1	0122-0666	210.92	665.60	261	60.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			443.0	F08		1	0123-0671	801.92	670.94	284	69.94	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3568.7	F08		1	0124-0667	75.29	666.23	255	61.01	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			296.9	F08		1	0125-0677	59.44	677.46	367	73.74	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1034.1	F08		1	0126-0683	690.93	683.68	237	57.11	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			289.7	F08		1	0127-0686	20.18	685.76	352	73.26	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			506.5	F08		1	0128-0684	273.91	684.26	249	60.87	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			401.9	F08		1	0129-0693	915.46	693.02	290	65.36	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			317.0	F08		1	0130-0701	579.21	702.80	368	72.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			344.8	F08		2	0001-0044	402.32	43.52	252	60.87	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			292.0	F08		2	0002-0047	546.79	46.75	377	74.43	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			402.1	F08		2	0003-0045	673.20	45.53	381	73.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			372.0	F08		2	0004-0049	443.67	49.45	286	65.01	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			330.5	F08		2	0005-0054	106.51	53.86	348	73.26	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			467.3	F08		2	0006-0052	743.31	52.03	279	62.43	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2391.8	F08		2	0007-0054	139.17	54.86	280	64.43	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			306.4	F08		2	0008-0067	28.86	65.71	380	74.67	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			443.2	F08		2	0009-0077	470.04	76.71	312	68.18	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			455.0	F08		2	0010-0072	721.48	72.01	287	65.94	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2325.0	F08		2	0011-0074	183.67	73.87	277	62.28	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			533.1	F08		2	0012-0080	815.81	78.97	283	65.50	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			760.1	F08		2	0013-0082	518.19	82.42	330	77.50	0.690
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			453.7	F08		2	0014-0083	889.92	82.14	281	62.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			355.6	F08		2	0015-0093	931.34	92.92	316	69.26	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			276.2	F08		2	0016-0102	144.94	102.35	374	75.50	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			690.5	F08		2	0017-0105	565.73	104.91	454	81.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			475.4	F08		2	0018-0111	22.99	111.27	235	56.53	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			408.2	F08		2	0019-0113	657.25	112.56	319	68.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			738.3	F08		2	0020-0117	207.77	117.49	239	59.70	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			790.5	F08		2	0021-0119	230.19	119.39	242	60.53	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			382.7	F08		2	0022-0134	856.86	133.97	276	62.43	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			278.5	F08		2	0023-0138	939.43	137.65	329	70.43	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			892.0	F08		2	0024-0143	330.89	143.01	345	68.77	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			385.5	F08		2	0025-0151	69.43	151.02	317	67.84	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			877.8	F08		2	0026-0156	215.70	157.45	411	85.50	0.707
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			381.0	F08		2	0027-0157	165.99	157.66	306	66.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			508.1	F08		2	0028-0162	411.80	162.46	265	61.36	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			427.9	F08		2	0029-0166	749.08	166.72	255	59.36	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			399.0	F08		2	0030-0170	119.40	169.22	339	71.01	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5304.4	F08		2	0031-0169	139.86	169.16	344	68.53	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			343.5	F08		2	0032-0176	510.70	176.42	377	72.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3226.1	F08		2	0033-0172	635.63	171.65	154	45.94	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			574.9	F08		2	0034-0178	457.29	178.32	334	68.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3380.4	F08		2	0035-0181	626.08	181.30	201	55.01	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3029.2	F08		2	0036-0187	645.35	186.92	276	63.60	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			544.7	F08		2	0037-0189	845.17	189.53	216	59.60	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			846.1	F08		2	0038-0193	325.10	193.61	304	64.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			362.1	F08		2	0039-0198	409.45	197.88	339	70.18	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			364.4	F08		2	0040-0209	535.17	208.71	386	73.26	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			310.5	F08		2	0041-0222	15.25	222.86	325	68.53	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			513.9	F08		2	0042-0224	616.40	224.46	300	65.01	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			388.8	F08		2	0043-0226	843.78	226.33	273	63.60	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			324.6	F08		2	0044-0230	121.18	229.88	332	68.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			399.2	F08		2	0045-0228	239.63	228.40	268	65.01	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			477.2	F08		2	0046-0230	652.00	230.29	317	67.84	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			400.6	F08		2	0047-0233	715.12	232.41	190	55.11	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			402.8	F08		2	0048-0235	323.12	235.58	304	71.11	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			378.7	F08		2	0049-0245	404.92	245.37	349	71.84	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			606.1	F08		2	0050-0250	276.28	249.47	274	63.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			854.8	F08		2	0051-0264	929.92	263.21	249	63.01	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			332.8	F08		2	0052-0261	191.74	262.17	309	69.36	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			677.1	F08		2	0053-0261	360.66	261.16	226	56.04	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			424.4	F08		2	0054-0268	54.40	268.60	344	69.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			525.2	F08		2	0055-0269	887.42	269.70	221	56.87	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			452.5	F08		2	0056-0270	341.91	269.66	282	63.94	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			387.6	F08		2	0057-0270	377.36	269.33	302	67.01	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			304.6	F08		2	0058-0280	724.41	279.94	346	72.18	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			448.1	F08		2	0059-0287	837.58	288.01	278	63.36	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			386.4	F08		2	0060-0297	127.28	297.86	214	57.94	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			261.7	F08		2	0061-0310	855.99	310.23	349	72.77	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1456.4	F08		2	0062-0317	259.32	317.68	288	65.70	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			336.1	F08		2	0063-0316	721.99	316.46	335	70.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			430.1	F08		2	0064-0321	376.65	320.95	305	66.67	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			411.3	F08		2	0065-0326	445.77	327.05	286	61.36	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			414.2	F08		2	0066-0330	180.19	329.23	325	67.36	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			664.4	F08		2	0067-0342	868.58	341.35	293	64.18	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			359.2	F08		2	0068-0348	366.56	348.52	336	68.18	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			437.7	F08		2	0069-0351	922.88	351.54	356	73.01	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			427.9	F08		2	0070-0356	941.20	356.11	350	71.60	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			661.7	F08		2	0071-0357	153.69	357.39	612	108.23	0.657
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1322.2	F08		2	0072-0374	406.60	374.81	483	84.43	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1233.3	F08		2	0073-0383	289.40	383.00	313	67.94	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			638.9	F08		2	0074-0383	102.55	383.68	245	59.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			561.1	F08		2	0075-0385	593.84	385.36	304	67.84	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			585.2	F08		2	0076-0387	356.28	387.46	294	66.43	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			661.5	F08		2	0077-0393	141.79	393.65	318	69.26	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			866.2	F08		2	0078-0397	212.63	398.04	322	65.60	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			326.6	F08		2	0079-0404	652.55	404.88	359	70.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			385.1	F08		2	0080-0409	431.96	408.57	379	72.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			642.9	F08		2	0081-0430	485.77	430.66	314	68.18	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			896.7	F08		2	0082-0436	193.76	436.75	316	68.43	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			634.1	F08		2	0083-0436	587.81	435.82	323	69.01	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			422.0	F08		2	0084-0437	42.06	436.96	271	61.11	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1660.3	F08		2	0085-0437	821.66	437.77	223	56.77	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1448.4	F08		2	0086-0448	660.63	448.83	239	58.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			311.0	F08		2	0087-0453	54.39	453.00	355	70.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			442.7	F08		2	0088-0459	340.67	458.85	249	61.84	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1225.2	F08		2	0089-0458	740.67	458.64	236	59.70	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			383.8	F08		2	0090-0467	519.60	467.21	345	69.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			566.4	F08		2	0091-0479	573.14	478.52	194	66.43	0.552
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			527.4	F08		2	0092-0489	169.47	489.35	315	70.77	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			387.3	F08		2	0093-0519	590.31	518.90	428	82.08	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			305.8	F08		2	0094-0517	202.43	517.49	317	67.36	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3584.9	F08		2	0095-0523	87.21	522.84	469	81.50	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			477.6	F08		2	0096-0521	771.81	521.83	313	68.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			364.1	F08		2	0097-0538	125.28	538.27	288	62.53	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			505.5	F08		2	0098-0537	646.98	536.44	248	62.18	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			290.8	F08		2	0099-0545	186.16	545.47	349	70.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			388.4	F08		2	0100-0562	460.22	561.46	366	74.43	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			363.1	F08		2	0101-0559	846.47	559.65	280	61.60	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			711.6	F08		2	0102-0581	830.65	580.36	296	64.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			376.7	F08		2	0103-0584	729.87	584.27	309	67.94	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			340.6	F08		2	0104-0583	136.86	584.11	355	70.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			281.8	F08		2	0105-0593	204.94	592.65	333	67.84	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			418.6	F08		2	0106-0599	657.62	599.28	352	72.77	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			316.6	F08		2	0107-0612	401.82	612.35	416	77.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			273.7	F08		2	0108-0613	282.94	613.38	336	69.60	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			382.0	F08		2	0109-0617	794.31	617.48	364	74.43	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			373.1	F08		2	0110-0627	564.76	627.74	304	68.33	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1345.1	F08		2	0111-0628	503.68	628.54	265	60.43	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			395.2	F08		2	0112-0640	468.48	639.76	358	74.77	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			537.1	F08		2	0113-0637	533.36	637.27	300	64.43	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			370.4	F08		2	0114-0638	142.53	638.49	284	62.28	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			765.0	F08		2	0115-0642	923.09	642.55	259	61.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2088.8	F08		2	0116-0649	490.89	649.79	358	75.60	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			329.5	F08		2	0117-0649	649.70	649.95	364	70.43	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			495.8	F08		2	0118-0651	340.95	651.50	256	60.53	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1625.4	F08		2	0119-0655	74.76	655.35	333	67.01	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			354.3	F08		2	0120-0656	384.32	656.20	315	68.43	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2347.4	F08		2	0121-0657	846.70	657.62	241	65.01	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1096.8	F08		2	0122-0664	526.49	664.41	282	62.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			467.5	F08		2	0123-0666	164.78	666.26	272	63.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			317.4	F08		2	0124-0667	290.75	666.98	342	68.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			282.0	F08		2	0125-0682	731.33	682.52	336	69.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2119.8	F08		2	0126-0684	931.88	683.94	264	62.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			401.7	F08		2	0127-0694	19.90	693.98	297	67.60	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			283.9	F08		2	0128-0705	744.81	704.87	312	65.84	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			543.0	F08		2	0129-0706	272.33	705.97	274	61.70	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1123.8	F08		2	0130-0704	664.77	704.13	313	65.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			471.7	F08		3	0001-0050	476.08	49.13	337	67.70	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1075.5	F08		3	0002-0055	782.98	55.56	261	61.11	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2935.4	F08		3	0003-0061	427.72	60.68	259	63.26	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			494.1	F08		3	0004-0062	393.22	62.02	308	63.36	0.964
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			631.1	F08		3	0005-0065	594.31	65.58	268	65.11	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			470.4	F08		3	0006-0068	325.54	68.02	284	62.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			778.6	F08		3	0007-0074	358.23	74.13	275	61.94	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2286.8	F08		3	0008-0089	435.52	89.44	268	60.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			372.7	F08		3	0009-0095	26.42	95.35	307	67.84	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6603.6	F08		3	0010-0109	138.49	108.04	205	67.26	0.570
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			496.8	F08		3	0011-0121	338.26	120.75	128	83.98	0.228
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			789.6	F08		3	0012-0130	591.11	130.17	181	52.87	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			415.2	F08		3	0013-0135	62.32	134.57	325	67.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			387.2	F08		3	0014-0142	436.10	142.21	309	66.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			481.4	F08		3	0015-0139	714.84	139.16	329	69.84	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			575.4	F08		3	0016-0141	34.55	140.24	322	71.01	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1306.0	F08		3	0017-0151	362.17	151.19	344	69.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			704.9	F08		3	0018-0146	686.46	146.15	203	58.28	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2690.8	F08		3	0019-0162	798.40	161.54	373	72.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			780.2	F08		3	0020-0164	305.82	164.51	279	61.94	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			284.8	F08		3	0021-0169	524.17	169.68	355	70.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			340.0	F08		3	0022-0176	41.37	176.90	331	73.50	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			443.3	F08		3	0023-0177	832.00	178.04	298	65.26	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			333.1	F08		3	0024-0180	761.07	179.65	319	70.18	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			897.7	F08		3	0025-0177	491.67	177.39	215	55.11	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			606.2	F08		3	0026-0188	796.60	188.30	334	69.36	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1218.7	F08		3	0027-0192	111.65	192.79	198	51.11	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			756.8	F08		3	0028-0201	382.46	201.75	271	63.26	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			445.9	F08		3	0029-0205	201.11	204.61	346	71.11	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			353.4	F08		3	0030-0209	706.89	208.43	356	71.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			784.4	F08		3	0031-0212	450.10	211.48	257	58.77	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			792.8	F08		3	0032-0220	833.52	220.04	327	70.67	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			550.0	F08		3	0033-0220	134.00	220.04	250	59.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			699.5	F08		3	0034-0227	404.98	227.52	305	64.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2376.9	F08		3	0035-0230	513.44	230.31	226	62.77	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			665.9	F08		3	0036-0234	547.93	234.56	240	58.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			633.5	F08		3	0037-0237	281.30	237.36	268	63.11	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			413.9	F08		3	0038-0255	675.34	254.68	236	58.53	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			737.4	F08		3	0039-0258	799.14	258.45	311	66.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4445.2	F08		3	0040-0262	553.47	262.69	241	58.53	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			781.9	F08		3	0041-0266	25.16	265.73	251	63.01	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			831.3	F08		3	0042-0265	863.12	265.41	274	63.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			516.8	F08		3	0043-0265	141.87	264.90	244	59.94	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2927.4	F08		3	0044-0269	487.64	268.24	132	54.77	0.553
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3471.0	F08		3	0045-0276	280.84	276.59	386	73.26	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			969.1	F08		3	0046-0283	412.01	282.93	270	61.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1072.1	F08		3	0047-0287	480.67	286.13	285	76.33	0.615
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			459.5	F08		3	0048-0285	614.69	285.54	353	71.01	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			307.0	F08		3	0049-0296	198.32	296.29	316	68.77	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			545.3	F08		3	0050-0294	808.99	294.66	306	65.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4600.1	F08		3	0051-0300	332.45	299.79	423	75.84	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			337.3	F08		3	0052-0300	512.00	299.74	300	64.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4138.1	F08		3	0053-0297	560.29	297.60	266	59.70	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			509.5	F08		3	0054-0305	631.55	304.42	320	68.18	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			416.1	F08		3	0055-0306	733.69	306.77	268	63.26	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			628.6	F08		3	0056-0305	416.53	305.25	160	48.63	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3457.1	F08		3	0057-0317	101.43	316.75	262	61.60	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			256.6	F08		3	0058-0318	58.86	318.20	366	72.08	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			359.3	F08		3	0059-0321	912.88	321.82	329	68.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			775.6	F08		3	0060-0321	412.84	321.14	247	64.77	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			338.5	F08		3	0061-0347	476.90	347.05	328	68.67	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			416.9	F08		3	0062-0349	536.15	349.97	293	67.11	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2475.8	F08		3	0063-0352	322.80	351.71	344	72.43	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3534.4	F08		3	0064-0354	218.01	354.14	410	78.43	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			326.7	F08		3	0065-0351	905.20	351.25	201	57.36	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			414.8	F08		3	0066-0354	18.49	354.18	350	72.18	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			441.4	F08		3	0067-0359	36.63	358.66	327	71.60	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			454.1	F08		3	0068-0361	443.07	361.30	317	74.77	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			379.0	F08		3	0069-0364	167.12	363.84	301	66.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			311.6	F08		3	0070-0375	797.76	374.43	377	74.43	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3376.4	F08		3	0071-0376	407.77	376.33	403	74.43	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			518.8	F08		3	0072-0383	548.09	383.47	271	61.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			400.9	F08		3	0073-0386	55.28	386.66	263	61.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			454.6	F08		3	0074-0389	468.20	389.24	355	71.01	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			517.3	F08		3	0075-0397	757.28	397.31	318	66.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			476.0	F08		3	0076-0407	593.49	407.72	303	65.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			316.2	F08		3	0077-0411	77.32	411.36	338	74.53	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			387.0	F08		3	0078-0415	667.54	414.74	411	79.26	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			469.7	F08		3	0079-0419	610.37	419.36	314	70.53	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			417.4	F08		3	0080-0418	171.29	417.35	336	70.67	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			329.8	F08		3	0081-0420	436.94	420.27	281	66.43	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			535.5	F08		3	0082-0432	899.32	432.10	265	65.60	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			518.0	F08		3	0083-0438	699.89	438.70	296	63.11	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			494.4	F08		3	0084-0444	43.31	444.10	338	70.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			278.1	F08		3	0085-0456	495.79	456.18	406	77.50	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			506.1	F08		3	0086-0460	909.25	460.74	187	53.94	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			327.7	F08		3	0087-0465	185.70	465.70	314	67.94	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			345.1	F08		3	0088-0474	639.22	474.30	345	69.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			363.6	F08		3	0089-0477	108.91	477.06	326	70.43	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			444.1	F08		3	0090-0483	496.72	482.98	270	66.43	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			322.4	F08		3	0091-0489	136.73	489.56	356	70.18	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			810.9	F08		3	0092-0490	780.75	490.99	267	61.36	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			273.0	F08		3	0093-0495	49.45	494.62	325	71.01	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			481.3	F08		3	0094-0500	347.91	499.38	295	64.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			336.6	F08		3	0095-0505	919.44	505.45	336	70.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1108.4	F08		3	0096-0508	250.88	507.89	557	95.74	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			420.6	F08		3	0097-0510	377.92	509.40	309	65.01	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			319.7	F08		3	0098-0527	730.49	527.19	370	73.60	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			956.4	F08		3	0099-0528	126.47	527.79	363	75.26	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			286.8	F08		3	0100-0534	225.35	534.16	299	67.01	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			608.2	F08		3	0101-0536	332.81	536.80	270	62.18	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			602.5	F08		3	0102-0543	554.02	544.15	343	69.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			279.0	F08		3	0103-0559	286.52	558.77	368	74.18	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			317.7	F08		3	0104-0566	404.65	567.19	357	75.60	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			331.6	F08		3	0105-0571	119.84	570.90	342	68.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			379.0	F08		3	0106-0577	154.39	576.28	301	68.43	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			489.7	F08		3	0107-0591	260.04	590.74	287	68.67	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			397.9	F08		3	0108-0616	365.65	616.72	298	71.50	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			508.6	F08		3	0109-0615	867.81	615.37	216	57.36	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2010.5	F08		3	0110-0619	937.72	619.86	247	60.53	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			546.9	F08		3	0111-0617	586.76	617.38	390	76.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			287.7	F08		3	0112-0630	903.23	629.42	344	73.50	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			343.1	F08		3	0113-0631	686.81	631.00	315	66.43	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			346.5	F08		3	0114-0638	664.80	638.76	311	67.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			286.8	F08		3	0115-0642	347.01	643.02	393	73.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			786.3	F08		3	0116-0644	17.93	645.04	252	59.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			300.5	F08		3	0117-0648	121.67	648.11	346	72.18	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			676.8	F08		3	0118-0651	291.92	651.05	242	62.77	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			315.0	F08		3	0119-0654	805.48	654.07	367	80.57	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1350.7	F08		3	0120-0652	309.59	653.07	239	60.77	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			306.2	F08		3	0121-0658	176.52	658.47	307	64.77	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			314.9	F08		3	0122-0658	839.55	658.18	315	69.84	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			658.8	F08		3	0123-0665	557.91	665.19	318	65.60	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			403.2	F08		3	0124-0672	147.01	672.49	294	63.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			333.4	F08		3	0125-0682	690.56	682.16	287	63.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			837.2	F08		3	0126-0686	535.26	685.35	203	55.21	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2162.5	F08		3	0127-0686	26.79	686.38	256	61.11	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			366.7	F08		3	0128-0694	675.48	694.25	328	67.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			411.7	F08		3	0129-0694	879.58	694.71	250	59.94	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			469.5	F08		3	0130-0704	182.73	704.55	273	61.60	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			566.7	F08		3	0131-0705	571.76	705.50	261	61.94	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			484.9	F08		4	0001-0029	171.82	29.32	261	60.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			529.3	F08		4	0002-0029	195.04	28.79	276	62.28	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			382.6	F08		4	0003-0032	144.75	32.73	257	61.70	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			389.3	F08		4	0004-0037	371.19	36.91	404	78.43	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			442.0	F08		4	0005-0064	872.22	63.25	356	72.43	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			475.2	F08		4	0006-0066	791.10	66.43	289	63.84	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3150.1	F08		4	0007-0069	51.72	68.97	255	61.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			453.4	F08		4	0008-0073	575.33	73.58	383	72.18	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			464.3	F08		4	0009-0076	110.78	76.17	321	67.94	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			387.7	F08		4	0010-0081	129.33	81.01	329	68.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			370.9	F08		4	0011-0096	634.11	95.81	337	70.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			366.9	F08		4	0012-0099	658.30	99.12	333	67.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			447.7	F08		4	0013-0106	475.01	106.70	414	83.26	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			514.4	F08		4	0014-0113	291.14	113.27	168	62.18	0.546
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			372.6	F08		4	0015-0121	83.65	120.58	291	65.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			601.6	F08		4	0016-0123	752.18	123.22	242	61.94	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1422.3	F08		4	0017-0121	785.98	121.79	202	51.94	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			337.4	F08		4	0018-0130	765.98	129.70	307	67.60	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			371.5	F08		4	0019-0132	574.14	131.92	314	67.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			650.1	F08		4	0020-0134	331.23	133.99	233	59.60	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			702.9	F08		4	0021-0136	432.75	135.71	287	64.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			614.9	F08		4	0022-0159	807.45	159.14	211	57.11	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			582.8	F08		4	0023-0161	233.88	160.59	280	61.94	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			379.5	F08		4	0024-0161	49.25	161.54	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			381.4	F08		4	0025-0164	601.52	164.49	295	64.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			420.7	F08		4	0026-0206	90.26	206.84	298	64.53	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			520.4	F08		4	0027-0209	531.51	209.16	307	68.18	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			278.7	F08		4	0028-0216	759.32	217.08	373	77.01	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			581.1	F08		4	0029-0212	912.03	211.82	314	67.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			344.8	F08		4	0030-0220	638.13	219.53	359	73.84	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			359.4	F08		4	0031-0225	408.56	225.08	339	71.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			422.3	F08		4	0032-0233	179.43	233.32	244	59.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			442.4	F08		4	0033-0240	333.77	239.81	310	66.43	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			756.6	F08		4	0034-0248	851.08	248.98	214	56.04	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			290.7	F08		4	0035-0257	43.47	257.21	343	70.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			999.5	F08		4	0036-0259	664.07	259.11	241	61.36	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2378.4	F08		4	0037-0270	424.07	270.27	299	66.18	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			449.7	F08		4	0038-0273	376.22	273.53	333	67.36	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			443.4	F08		4	0039-0272	180.26	272.05	242	58.77	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2558.8	F08		4	0040-0293	717.39	293.01	452	78.67	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			354.2	F08		4	0041-0297	20.10	297.46	353	70.18	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			542.5	F08		4	0042-0306	120.00	305.13	301	67.26	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			510.7	F08		4	0043-0306	917.57	306.35	266	63.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1704.3	F08		4	0044-0307	538.95	307.10	280	61.60	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			470.0	F08		4	0045-0309	667.97	309.75	240	61.60	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			459.3	F08		4	0046-0306	58.29	305.81	108	71.26	0.267
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2004.2	F08		4	0047-0311	377.59	311.42	323	68.77	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			387.3	F08		4	0048-0325	400.90	325.45	277	65.60	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			785.2	F08		4	0049-0329	359.73	329.52	366	72.43	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			599.1	F08		4	0050-0341	175.33	341.14	295	67.36	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1045.6	F08		4	0051-0338	296.96	338.14	314	68.43	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			528.9	F08		4	0052-0335	911.15	335.22	279	63.36	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			376.3	F08		4	0053-0339	454.32	339.21	317	67.60	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			990.9	F08		4	0054-0340	751.27	340.20	239	56.53	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			698.0	F08		4	0055-0347	199.86	347.24	232	57.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			605.9	F08		4	0056-0348	898.53	348.06	261	62.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3530.5	F08		4	0057-0353	925.53	352.89	270	61.94	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			525.3	F08		4	0058-0370	645.70	369.78	240	56.53	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			352.9	F08		4	0059-0374	765.64	375.08	305	63.60	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			340.0	F08		4	0060-0377	230.62	377.83	321	67.84	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1143.7	F08		4	0061-0375	75.09	374.82	228	58.87	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			803.9	F08		4	0062-0397	347.58	396.96	251	61.01	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			603.4	F08		4	0063-0400	196.29	400.36	253	59.11	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			456.7	F08		4	0064-0399	845.43	399.14	274	61.11	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			321.4	F08		4	0065-0405	765.45	405.15	309	65.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			332.9	F08		4	0066-0407	710.17	407.47	313	64.43	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			386.0	F08		4	0067-0411	327.72	411.45	279	64.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4327.5	F08		4	0068-0425	935.39	425.27	246	64.28	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			463.8	F08		4	0069-0426	227.43	425.84	276	63.60	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2326.3	F08		4	0070-0433	826.67	433.62	366	73.01	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			631.2	F08		4	0071-0433	792.34	434.04	296	65.26	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			334.2	F08		4	0072-0439	880.69	439.79	390	75.84	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			409.3	F08		4	0073-0458	342.98	457.95	303	68.53	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			435.7	F08		4	0074-0466	560.47	466.09	336	71.01	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3696.1	F08		4	0075-0477	753.31	477.02	509	85.50	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			629.2	F08		4	0076-0487	519.08	487.44	347	70.43	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			735.1	F08		4	0077-0489	901.11	489.35	224	59.70	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			611.1	F08		4	0078-0497	148.51	496.66	310	65.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			518.4	F08		4	0079-0504	288.85	504.09	327	67.26	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			670.4	F08		4	0080-0502	21.26	502.29	265	65.60	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			639.2	F08		4	0081-0502	230.11	502.30	295	68.43	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			604.2	F08		4	0082-0507	702.74	507.36	250	59.94	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			932.3	F08		4	0083-0518	434.28	517.40	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			619.2	F08		4	0084-0517	327.21	518.02	295	65.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2384.9	F08		4	0085-0532	654.71	531.73	370	71.36	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			525.8	F08		4	0086-0535	143.11	534.87	285	64.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			297.6	F08		4	0087-0536	197.18	535.93	334	68.18	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			437.0	F08		4	0088-0538	519.41	538.85	295	65.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			771.7	F08		4	0089-0547	598.89	547.62	236	57.11	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			638.2	F08		4	0090-0553	770.22	549.80	273	100.71	0.338
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			463.8	F08		4	0091-0553	308.70	552.52	334	68.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			294.4	F08		4	0092-0554	236.15	553.92	325	72.18	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1285.9	F08		4	0093-0553	374.13	553.74	227	60.43	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			352.6	F08		4	0094-0561	844.19	562.12	348	72.67	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			438.1	F08		4	0095-0561	791.09	560.82	264	83.50	0.476
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			465.1	F08		4	0096-0566	270.03	566.14	283	65.84	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			124.6	F08		4	0097-0565	19.85	565.60	260	60.53	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			417.4	F08		4	0098-0581	691.35	581.50	300	65.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			382.9	F08		4	0099-0583	767.19	583.34	293	65.11	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			627.5	F08		4	0100-0587	159.33	587.68	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			512.4	F08		4	0101-0593	844.08	593.08	290	64.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2942.4	F08		4	0102-0608	700.30	608.59	351	72.18	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			636.3	F08		4	0103-0611	330.70	610.79	260	62.18	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			502.3	F08		4	0104-0612	306.01	612.01	306	65.11	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			259.4	F08		4	0105-0615	576.64	615.24	375	74.67	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			461.2	F08		4	0106-0617	891.27	617.43	316	67.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1007.8	F08		4	0107-0628	95.11	628.12	255	61.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			742.4	F08		4	0108-0631	374.02	631.06	239	59.11	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			560.7	F08		4	0109-0636	235.67	635.97	293	68.77	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			445.3	F08		4	0110-0634	316.13	633.75	228	58.87	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			250.7	F08		4	0111-0647	665.33	646.45	365	72.18	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			345.0	F08		4	0112-0653	495.85	653.47	310	65.36	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			455.3	F08		4	0113-0659	788.18	658.88	344	69.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			262.2	F08		4	0114-0659	552.10	659.61	283	67.50	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			452.0	F08		4	0115-0666	282.01	665.44	321	67.60	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			433.6	F08		4	0116-0668	727.49	667.81	322	67.60	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			453.6	F08		4	0117-0680	397.53	679.43	239	57.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			432.9	F08		4	0118-0686	292.84	686.66	270	61.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			356.4	F08		4	0119-0695	861.38	694.59	324	73.50	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			865.7	F08		4	0120-0698	161.50	698.70	379	76.53	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			476.4	F08		4	0121-0700	903.67	700.99	382	111.88	0.383
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1002.6	F08		4	0122-0702	144.98	702.79	376	75.94	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			743.9	F08		4	0123-0699	828.87	699.10	217	57.60	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			585.6	F08		4	0124-0700	594.34	699.65	244	60.43	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			301.2	F08		4	0125-0701	642.94	700.49	282	62.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			331.1	F08		5	0001-0034	395.08	34.47	406	75.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			361.1	F08		5	0002-0038	646.42	38.21	370	70.77	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			379.9	F08		5	0003-0036	895.51	36.62	132	44.87	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			456.1	F08		5	0004-0053	63.91	53.11	294	64.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			396.1	F08		5	0005-0056	130.66	56.10	288	64.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			516.4	F08		5	0006-0053	176.55	53.72	267	61.94	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			346.3	F08		5	0007-0057	930.89	57.41	309	65.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			694.6	F08		5	0008-0059	214.33	59.15	311	67.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			354.5	F08		5	0009-0059	820.16	60.31	321	68.43	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			582.0	F08		5	0010-0064	611.99	63.41	263	61.11	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			415.3	F08		5	0011-0067	82.12	67.22	330	67.60	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			511.7	F08		5	0012-0070	116.97	70.49	285	65.60	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			846.0	F08		5	0013-0071	460.49	70.35	324	68.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			301.3	F08		5	0014-0076	867.42	76.30	428	91.40	0.644
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2246.7	F08		5	0015-0075	301.28	74.78	281	63.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			433.6	F08		5	0016-0074	439.08	73.56	341	70.18	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			369.3	F08		5	0017-0079	544.63	79.97	407	77.26	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			268.5	F08		5	0018-0077	652.81	76.34	386	75.60	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			378.2	F08		5	0019-0082	157.42	81.90	300	66.77	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			370.6	F08		5	0020-0085	343.85	86.51	368	83.84	0.658
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1944.4	F08		5	0021-0089	282.47	89.26	281	61.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			289.0	F08		5	0022-0092	892.22	92.42	341	70.18	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			830.9	F08		5	0023-0095	483.90	95.58	329	71.01	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			370.7	F08		5	0024-0109	219.92	109.22	269	61.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			477.9	F08		5	0025-0113	338.05	113.44	337	68.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			361.3	F08		5	0026-0111	115.25	110.85	245	61.94	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			377.0	F08		5	0027-0114	386.41	114.78	323	70.08	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			429.0	F08		5	0028-0114	427.91	114.12	383	73.60	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			316.6	F08		5	0029-0121	903.82	121.33	326	67.84	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			425.7	F08		5	0030-0131	793.61	131.16	271	63.84	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			541.0	F08		5	0031-0133	734.79	133.74	301	66.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			458.8	F08		5	0032-0134	751.30	133.33	292	63.70	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			629.9	F08		5	0033-0132	385.79	132.09	222	55.70	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			303.0	F08		5	0034-0138	86.64	137.47	341	69.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			388.9	F08		5	0035-0139	163.72	139.59	258	66.77	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			420.8	F08		5	0036-0145	476.49	144.75	396	74.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			328.2	F08		5	0037-0157	213.74	156.88	316	68.43	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			323.2	F08		5	0038-0169	274.16	168.88	351	71.01	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3793.5	F08		5	0039-0173	609.16	173.16	404	76.08	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6392.6	F08		5	0040-0175	653.57	175.14	222	66.43	0.632
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			376.9	F08		5	0041-0186	692.54	186.11	259	61.84	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			349.1	F08		5	0042-0189	790.81	189.35	316	66.18	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1008.3	F08		5	0043-0194	433.89	195.30	340	69.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			409.8	F08		5	0044-0192	569.76	192.11	337	69.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			821.1	F08		5	0045-0194	511.55	194.18	281	67.60	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			406.1	F08		5	0046-0198	605.20	198.50	312	67.01	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1180.8	F08		5	0047-0206	138.63	206.49	216	56.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			428.4	F08		5	0048-0211	405.29	211.43	319	71.36	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			387.1	F08		5	0049-0209	751.75	209.63	284	63.01	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			682.0	F08		5	0050-0211	70.94	211.56	255	59.36	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4131.5	F08		5	0051-0213	693.64	213.26	347	68.43	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			581.2	F08		5	0052-0213	17.38	213.79	300	66.18	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			367.5	F08		5	0053-0213	227.18	213.03	327	71.60	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			558.7	F08		5	0054-0215	509.11	214.86	203	52.53	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			591.1	F08		5	0055-0227	876.19	227.30	204	55.11	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			799.6	F08		5	0056-0234	567.51	233.40	287	68.08	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			229.9	F08		5	0057-0240	663.89	240.33	359	72.67	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			910.4	F08		5	0058-0241	438.76	241.98	335	68.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			350.8	F08		5	0059-0243	527.92	243.78	266	63.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			333.2	F08		5	0060-0247	706.19	247.96	330	70.77	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			379.6	F08		5	0061-0249	754.11	249.02	234	57.36	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			422.9	F08		5	0062-0254	389.43	254.59	364	70.67	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			399.1	F08		5	0063-0261	206.44	260.22	459	86.33	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2984.5	F08		5	0064-0270	895.35	270.24	417	76.67	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			397.3	F08		5	0065-0270	599.22	270.41	322	66.77	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			484.9	F08		5	0066-0273	348.28	273.69	299	66.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			554.7	F08		5	0067-0276	448.25	276.64	239	58.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			530.2	F08		5	0068-0278	835.77	278.27	321	71.01	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			338.5	F08		5	0069-0279	292.09	279.55	344	68.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			501.6	F08		5	0070-0281	537.85	281.40	333	68.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			248.6	F08		5	0071-0280	677.23	279.89	332	75.26	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			480.8	F08		5	0072-0296	347.47	296.08	330	69.11	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			354.3	F08		5	0073-0299	635.45	299.89	346	73.94	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			406.3	F08		5	0074-0297	788.73	297.15	291	66.43	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2127.6	F08		5	0075-0304	875.72	303.01	289	70.18	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			357.4	F08		5	0076-0304	729.81	304.02	340	68.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			491.1	F08		5	0077-0308	23.08	308.11	265	63.01	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1829.5	F08		5	0078-0305	939.78	305.35	304	67.11	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			449.1	F08		5	0079-0310	179.55	310.39	294	64.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			272.1	F08		5	0080-0311	598.75	311.32	354	71.84	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			701.4	F08		5	0081-0313	143.45	313.92	286	64.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			299.0	F08		5	0082-0313	690.74	313.03	348	77.26	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			355.3	F08		5	0083-0319	850.96	319.47	303	65.01	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			645.5	F08		5	0084-0322	104.40	321.87	295	62.77	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			346.9	F08		5	0085-0336	533.22	336.35	305	64.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			521.9	F08		5	0086-0337	16.83	337.26	281	63.70	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3832.9	F08		5	0087-0351	708.97	350.24	940	130.02	0.699
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			269.2	F08		5	0088-0353	484.07	354.05	355	77.60	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3542.1	F08		5	0089-0355	30.81	354.84	268	61.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			346.8	F08		5	0090-0368	604.98	368.12	312	65.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			297.0	F08		5	0091-0375	822.27	374.97	333	69.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			388.8	F08		5	0092-0381	723.88	381.54	231	58.77	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			293.7	F08		5	0093-0387	124.99	387.97	340	73.01	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			366.1	F08		5	0094-0394	576.29	394.42	289	63.11	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			583.5	F08		5	0095-0397	186.52	397.07	209	54.28	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			386.4	F08		5	0096-0402	650.80	402.61	306	65.01	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			329.9	F08		5	0097-0403	301.55	402.35	283	62.77	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			279.8	F08		5	0098-0407	729.66	406.83	335	68.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1285.3	F08		5	0099-0411	271.43	411.55	382	72.77	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			262.6	F08		5	0100-0411	806.69	411.17	317	66.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			327.1	F08		5	0101-0410	931.79	410.06	268	63.01	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2836.0	F08		5	0102-0416	163.49	417.53	505	84.33	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1603.9	F08		5	0103-0412	488.23	411.26	280	63.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			362.9	F08		5	0104-0415	603.65	415.15	316	68.18	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			352.6	F08		5	0105-0423	356.28	423.04	348	72.43	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4258.7	F08		5	0106-0427	40.59	427.14	247	64.53	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1078.8	F08		5	0107-0430	435.55	429.89	458	82.33	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1735.2	F08		5	0108-0440	211.05	440.67	269	62.77	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			343.0	F08		5	0109-0439	640.00	439.36	249	57.94	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1458.0	F08		5	0110-0442	417.16	442.94	262	61.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			320.7	F08		5	0111-0443	899.55	443.27	301	64.18	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			236.6	F08		5	0112-0447	476.08	447.55	363	70.67	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			555.9	F08		5	0113-0451	734.64	451.15	297	66.18	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			266.9	F08		5	0114-0456	242.30	455.90	332	69.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			331.5	F08		5	0115-0451	578.34	451.24	303	68.77	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			729.5	F08		5	0116-0469	58.94	469.69	252	61.60	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			354.9	F08		5	0117-0471	351.25	471.21	327	70.43	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3208.0	F08		5	0118-0472	551.99	471.88	329	67.11	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2007.3	F08		5	0119-0472	203.72	471.30	258	61.94	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1657.9	F08		5	0120-0478	503.26	478.79	262	67.11	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			274.5	F08		5	0121-0485	856.17	484.58	358	83.15	0.651
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			341.3	F08		5	0122-0485	677.69	485.26	282	61.36	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			295.6	F08		5	0123-0487	399.87	488.02	359	73.50	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			292.5	F08		5	0124-0490	440.42	490.09	294	65.01	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			460.8	F08		5	0125-0498	773.48	496.68	378	75.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			418.7	F08		5	0126-0496	309.69	496.05	294	69.84	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			624.8	F08		5	0127-0509	643.66	509.29	335	73.94	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			346.9	F08		5	0128-0509	589.08	509.68	338	69.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			940.9	F08		5	0129-0513	89.09	513.87	285	64.77	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			358.1	F08		5	0130-0514	719.54	514.93	320	72.91	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			300.8	F08		5	0131-0519	469.01	520.32	309	67.60	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			664.6	F08		5	0132-0523	618.72	522.90	329	77.36	0.691
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			303.7	F08		5	0133-0522	938.32	521.96	292	66.77	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			478.5	F08		5	0134-0534	72.21	534.62	230	59.60	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			459.0	F08		5	0135-0544	644.19	544.29	316	68.18	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2426.1	F08		5	0136-0567	420.55	567.04	430	77.84	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			492.5	F08		5	0137-0566	673.03	565.57	335	73.26	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			432.2	F08		5	0138-0565	870.81	565.19	320	72.18	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			540.0	F08		5	0139-0575	833.54	575.28	278	69.11	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			471.4	F08		5	0140-0590	131.65	590.88	210	55.11	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1798.1	F08		5	0141-0611	130.17	611.79	263	59.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			241.6	F08		5	0142-0617	860.75	617.22	361	73.26	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			343.6	F08		5	0143-0636	322.12	636.25	311	65.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			386.3	F08		5	0144-0638	552.97	637.55	285	63.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1923.8	F08		5	0145-0636	143.55	636.61	256	67.94	0.697
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			386.6	F08		5	0146-0646	243.79	646.06	331	70.53	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			355.8	F08		5	0147-0645	569.15	644.80	289	64.53	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			525.0	F08		5	0148-0656	209.72	658.89	589	110.33	0.608
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			354.9	F08		5	0149-0649	392.44	648.81	314	67.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1841.0	F08		5	0150-0651	477.69	651.41	393	74.43	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			568.9	F08		5	0151-0651	648.86	650.78	265	63.26	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			361.8	F08		5	0152-0656	839.71	656.03	262	65.60	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			252.9	F08		5	0153-0652	916.58	652.30	326	69.94	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			247.3	F08		5	0154-0660	61.87	660.43	318	67.84	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			447.4	F08		5	0155-0669	717.31	668.92	367	74.33	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1235.1	F08		5	0156-0675	309.34	674.77	300	67.01	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			309.8	F08		5	0157-0674	400.17	675.66	347	73.84	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			270.9	F08		5	0158-0679	451.47	679.38	325	69.84	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4526.1	F08		5	0159-0684	636.39	684.58	320	66.18	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			295.1	F08		5	0160-0696	906.66	696.33	348	73.01	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			689.0	F08		6	0001-0040	323.34	40.63	347	73.01	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			429.8	F08		6	0002-0047	782.00	47.24	273	67.26	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			478.3	F08		6	0003-0053	426.76	53.37	270	66.67	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			531.3	F08		6	0004-0055	149.57	55.43	286	63.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			371.6	F08		6	0005-0060	25.83	60.11	304	64.77	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			413.9	F08		6	0006-0061	823.37	60.79	253	65.84	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			657.9	F08		6	0007-0067	247.36	66.94	265	65.60	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			381.5	F08		6	0008-0077	673.88	77.38	377	71.84	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			761.4	F08		6	0009-0084	318.86	83.55	340	71.26	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			460.2	F08		6	0010-0082	527.49	83.00	305	64.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			296.0	F08		6	0011-0087	691.40	87.25	305	68.43	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1476.4	F08		6	0012-0093	196.33	91.42	299	70.18	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1705.4	F08		6	0013-0093	411.70	93.66	250	59.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			759.8	F08		6	0014-0104	612.42	106.23	346	102.23	0.416
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			430.1	F08		6	0015-0107	853.40	107.97	367	72.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			268.7	F08		6	0016-0113	298.91	113.41	347	71.84	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			373.2	F08		6	0017-0113	172.37	112.80	285	62.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1154.7	F08		6	0018-0114	334.39	113.57	226	58.53	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			542.6	F08		6	0019-0121	811.87	120.64	294	66.77	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			375.6	F08		6	0020-0128	489.88	127.29	314	69.50	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			294.3	F08		6	0021-0127	261.73	127.59	320	69.01	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			302.9	F08		6	0022-0130	584.41	129.80	379	79.50	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			682.9	F08		6	0023-0141	433.17	141.59	228	55.36	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			466.0	F08		6	0024-0149	770.71	149.75	427	77.26	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			300.3	F08		6	0025-0149	541.38	150.44	409	76.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1282.4	F08		6	0026-0155	854.32	156.19	321	72.18	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			381.9	F08		6	0027-0161	680.29	160.66	346	72.43	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1019.9	F08		6	0028-0164	506.03	165.14	481	90.91	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2863.1	F08		6	0029-0162	369.59	161.90	232	59.36	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1190.3	F08		6	0030-0164	279.54	163.75	252	61.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			530.8	F08		6	0031-0172	236.80	172.17	301	64.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			311.5	F08		6	0032-0176	320.72	175.64	352	72.18	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1121.9	F08		6	0033-0175	898.76	174.31	325	73.01	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2898.4	F08		6	0034-0174	375.98	174.89	226	57.46	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			283.1	F08		6	0035-0181	405.96	181.83	347	77.84	0.720
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			236.8	F08		6	0036-0184	582.05	185.12	389	76.43	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1125.7	F08		6	0037-0189	183.13	190.35	103	56.77	0.402
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			389.6	F08		6	0038-0195	864.81	196.10	382	72.43	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			376.8	F08		6	0039-0206	939.73	206.24	363	72.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			486.6	F08		6	0040-0212	24.77	212.32	133	93.78	0.190
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			346.1	F08		6	0041-0211	247.08	211.41	342	71.84	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			879.7	F08		6	0042-0228	579.14	227.70	277	62.53	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			566.0	F08		6	0043-0232	258.80	231.53	298	66.43	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			352.1	F08		6	0044-0238	813.54	237.94	339	80.43	0.659
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			582.9	F08		6	0045-0241	724.82	241.12	241	61.01	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			308.5	F08		6	0046-0251	149.32	251.35	290	64.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			722.8	F08		6	0047-0255	441.49	255.10	296	63.94	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			500.3	F08		6	0048-0257	311.88	256.26	359	71.84	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			519.8	F08		6	0049-0262	774.37	261.17	308	71.01	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			320.6	F08		6	0050-0263	807.80	263.63	324	69.84	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			288.7	F08		6	0051-0265	748.05	265.21	392	77.26	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			545.2	F08		6	0052-0271	841.51	269.91	483	88.81	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			487.9	F08		6	0053-0273	604.82	273.45	298	69.01	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			317.0	F08		6	0054-0275	192.07	275.02	310	67.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			475.1	F08		6	0055-0285	273.81	284.59	342	71.11	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			487.6	F08		6	0056-0288	315.97	287.75	255	58.53	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			718.5	F08		6	0057-0288	238.03	289.05	118	69.84	0.304
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			410.7	F08		6	0058-0297	110.60	297.43	375	74.77	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			549.3	F08		6	0059-0300	402.45	299.81	395	73.01	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			362.0	F08		6	0060-0300	332.60	301.04	309	66.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1245.4	F08		6	0061-0304	919.18	304.82	341	79.26	0.682
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			275.5	F08		6	0062-0303	872.22	303.19	317	67.01	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			524.8	F08		6	0063-0307	380.17	306.95	348	69.84	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1837.7	F08		6	0064-0308	34.85	308.19	303	66.53	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			304.0	F08		6	0065-0314	529.80	314.65	360	71.84	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			288.2	F08		6	0066-0312	737.90	311.53	283	61.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			457.8	F08		6	0067-0319	460.36	319.32	245	57.94	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			444.0	F08		6	0068-0327	176.31	327.19	334	67.84	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			294.7	F08		6	0069-0327	267.39	326.87	358	72.43	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			283.3	F08		6	0070-0345	345.65	345.61	399	78.08	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			304.2	F08		6	0071-0349	652.12	348.88	388	74.67	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			528.4	F08		6	0072-0351	229.47	350.89	306	67.26	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1395.6	F08		6	0073-0357	860.37	356.93	306	69.01	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			291.9	F08		6	0074-0364	724.31	363.77	340	68.18	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			636.3	F08		6	0075-0367	220.38	367.40	249	61.60	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			293.2	F08		6	0076-0375	307.06	375.11	344	72.77	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			295.0	F08		6	0077-0374	379.82	374.77	371	73.84	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			332.9	F08		6	0078-0378	523.40	378.00	387	76.43	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2189.2	F08		6	0079-0372	777.01	372.70	209	54.28	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2139.9	F08		6	0080-0374	795.86	374.76	239	57.11	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			392.9	F08		6	0081-0390	896.09	390.31	343	70.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			434.3	F08		6	0082-0396	270.34	396.79	301	66.43	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			773.9	F08		6	0083-0400	75.64	400.55	294	63.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			345.8	F08		6	0084-0408	198.73	407.56	319	69.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			309.6	F08		6	0085-0407	558.86	406.76	351	70.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			306.8	F08		6	0086-0411	830.09	410.68	323	70.28	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			315.8	F08		6	0087-0413	26.87	412.80	273	63.01	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			410.4	F08		6	0088-0420	388.43	419.57	320	67.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			355.0	F08		6	0089-0420	699.00	419.51	331	69.01	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			567.6	F08		6	0090-0426	929.04	426.58	303	74.77	0.681
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			690.1	F08		6	0091-0422	80.11	422.33	281	63.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			495.9	F08		6	0092-0422	269.24	422.52	297	65.60	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			401.8	F08		6	0093-0425	495.24	425.58	231	61.70	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			472.5	F08		6	0094-0426	942.53	425.21	293	70.18	0.747
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			374.2	F08		6	0095-0427	654.26	427.01	298	65.01	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3822.4	F08		6	0096-0434	732.15	434.32	345	70.28	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			287.8	F08		6	0097-0434	899.88	434.35	368	72.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			399.6	F08		6	0098-0440	787.04	439.64	350	71.26	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			451.3	F08		6	0099-0444	313.51	444.25	248	63.70	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			351.9	F08		6	0100-0457	612.48	456.44	301	65.60	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2172.9	F08		6	0101-0466	541.75	465.82	314	67.84	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			566.2	F08		6	0102-0469	457.06	467.95	300	69.84	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			304.9	F08		6	0103-0472	899.47	472.04	331	68.43	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			317.9	F08		6	0104-0472	158.56	471.82	129	71.26	0.319
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			507.3	F08		6	0105-0483	421.15	482.38	284	65.01	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			476.4	F08		6	0106-0490	252.39	489.66	277	68.18	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			399.9	F08		6	0107-0488	290.18	488.41	322	68.43	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			335.5	F08		6	0108-0490	467.28	490.61	295	65.70	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			600.1	F08		6	0109-0495	132.47	495.84	269	67.70	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			348.4	F08		6	0110-0491	408.30	491.61	275	63.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			527.9	F08		6	0111-0497	182.57	498.42	305	67.94	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			626.2	F08		6	0112-0499	660.07	499.59	318	69.01	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			301.1	F08		6	0113-0502	370.65	502.53	343	74.43	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2080.3	F08		6	0114-0509	588.39	509.07	310	67.84	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			322.3	F08		6	0115-0515	827.71	515.63	344	68.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			496.3	F08		6	0116-0520	888.52	520.32	253	60.53	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			287.8	F08		6	0117-0522	753.11	521.82	355	70.08	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			302.1	F08		6	0118-0525	33.42	524.89	304	68.43	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			822.0	F08		6	0119-0523	315.91	522.86	302	65.94	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			994.9	F08		6	0120-0530	921.48	530.74	210	53.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			675.3	F08		6	0121-0538	399.98	537.73	342	69.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			457.1	F08		6	0122-0541	48.54	540.58	328	68.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			465.4	F08		6	0123-0546	728.83	546.54	317	66.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			302.2	F08		6	0124-0550	442.78	549.81	360	71.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			568.5	F08		6	0125-0555	695.22	557.17	392	118.13	0.353
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			628.5	F08		6	0126-0558	273.97	559.61	375	88.33	0.604
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			471.4	F08		6	0127-0558	504.41	558.87	368	73.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			324.1	F08		6	0128-0560	633.43	560.60	357	74.43	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			401.0	F08		6	0129-0564	806.22	564.04	342	73.60	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			294.6	F08		6	0130-0572	573.03	573.00	363	76.08	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1763.3	F08		6	0131-0570	899.87	570.25	219	55.70	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			422.2	F08		6	0132-0581	58.91	581.53	285	62.18	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			333.0	F08		6	0133-0585	191.91	585.57	308	69.26	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			318.2	F08		6	0134-0581	760.19	580.73	169	51.36	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			328.2	F08		6	0135-0586	779.09	586.58	318	73.70	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			301.8	F08		6	0136-0593	393.16	593.77	325	68.77	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			447.4	F08		6	0137-0598	524.28	598.86	360	74.43	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			820.1	F08		6	0138-0604	407.96	603.66	268	60.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			376.9	F08		6	0139-0606	719.80	606.67	342	71.60	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			544.4	F08		6	0140-0610	668.02	609.38	332	71.60	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			458.2	F08		6	0141-0610	944.17	610.24	325	67.36	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			711.3	F08		6	0142-0624	254.48	624.73	435	81.36	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			627.8	F08		6	0143-0620	473.85	620.29	254	59.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			281.9	F08		6	0144-0625	498.09	624.46	322	69.60	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			308.4	F08		6	0145-0621	588.56	622.24	126	47.11	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			484.6	F08		6	0146-0626	604.38	625.56	306	69.36	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			784.4	F08		6	0147-0631	399.30	631.24	270	60.18	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			612.8	F08		6	0148-0643	820.36	643.79	331	69.60	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			267.1	F08		6	0149-0647	762.95	647.48	391	74.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			401.0	F08		6	0150-0647	185.53	647.15	314	69.01	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			584.6	F08		6	0151-0650	467.28	649.78	254	58.53	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			251.4	F08		6	0152-0655	654.47	655.82	408	83.15	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			295.8	F08		6	0153-0657	227.78	657.24	307	67.36	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			252.8	F08		6	0154-0663	678.83	662.86	420	78.08	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4767.0	F08		6	0155-0660	152.33	659.97	228	56.28	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			283.5	F08		6	0156-0664	317.48	664.23	379	78.43	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5025.3	F08		6	0157-0667	131.53	667.22	214	54.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			485.4	F08		6	0158-0685	754.34	685.71	364	73.26	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			335.1	F08		6	0159-0683	214.80	683.17	312	65.01	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2355.9	F08		6	0160-0691	383.37	691.24	545	87.15	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			301.9	F08		6	0161-0691	921.86	691.84	327	67.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			548.0	F08		6	0162-0695	699.02	694.81	134	44.04	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2082.6	F08		6	0163-0703	335.59	703.62	544	86.91	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			520.4	F08		6	0164-0697	712.80	697.08	155	46.39	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			243.3	F08		6	0165-0703	115.04	703.15	344	69.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			456.9	F08		6	0166-0708	252.76	707.97	278	62.53	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2108.4	F08		7	0001-0033	92.68	32.93	251	60.18	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			536.3	F08		7	0002-0044	386.80	44.51	294	62.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			673.1	F08		7	0003-0048	477.35	48.14	278	66.67	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			593.6	F08		7	0004-0060	407.20	59.76	285	63.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1020.3	F08		7	0005-0062	678.12	62.81	233	55.36	0.956
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			935.3	F08		7	0006-0083	498.41	83.94	245	59.11	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			498.2	F08		7	0007-0088	102.28	88.41	272	64.28	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			929.9	F08		7	0008-0090	312.19	90.06	243	58.28	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			842.4	F08		7	0009-0088	857.80	88.23	243	58.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1309.6	F08		7	0010-0091	568.14	91.09	249	59.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			432.3	F08		7	0011-0090	922.36	90.77	285	69.36	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			274.9	F08		7	0012-0096	804.71	96.45	347	71.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2095.6	F08		7	0013-0099	159.09	99.23	396	76.91	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			825.4	F08		7	0014-0101	457.94	101.78	288	63.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1293.7	F08		7	0015-0105	635.09	105.00	234	59.36	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3178.5	F08		7	0016-0119	523.81	119.55	222	58.18	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1066.9	F08		7	0017-0126	686.97	125.86	193	53.94	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			457.9	F08		7	0018-0126	88.93	126.97	301	67.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			621.0	F08		7	0019-0132	641.72	132.74	273	63.60	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			328.1	F08		7	0020-0131	188.37	132.20	306	72.77	0.726
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			469.3	F08		7	0021-0135	281.43	134.70	262	61.60	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			275.3	F08		7	0022-0140	900.77	139.76	353	73.26	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			376.5	F08		7	0023-0140	559.10	140.54	300	64.43	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			372.6	F08		7	0024-0146	372.83	146.27	317	70.18	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			358.2	F08		7	0025-0153	132.29	153.66	301	66.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			592.8	F08		7	0026-0155	245.36	155.87	315	67.84	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			341.4	F08		7	0027-0154	331.26	154.32	290	63.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3035.0	F08		7	0028-0159	830.05	159.13	536	87.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			549.1	F08		7	0029-0163	779.09	162.97	296	65.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			529.1	F08		7	0030-0173	445.86	172.75	269	62.87	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			392.8	F08		7	0031-0180	31.92	180.27	332	72.43	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			630.7	F08		7	0032-0182	770.41	182.44	294	64.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4380.1	F08		7	0033-0201	821.36	201.88	239	57.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1148.6	F08		7	0034-0203	154.35	202.98	230	56.53	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			518.4	F08		7	0035-0230	658.69	229.95	258	61.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			727.5	F08		7	0036-0236	902.31	237.44	323	75.50	0.712
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5307.2	F08		7	0037-0240	807.18	241.35	115	44.53	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			440.4	F08		7	0038-0265	518.79	264.69	312	69.26	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			686.7	F08		7	0039-0265	544.89	264.71	246	64.18	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			868.6	F08		7	0040-0268	690.63	268.72	226	56.87	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			367.2	F08		7	0041-0273	36.28	273.02	267	65.01	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			671.7	F08		7	0042-0272	803.84	272.63	286	72.08	0.692
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			716.9	F08		7	0043-0279	430.76	279.79	262	60.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			448.1	F08		7	0044-0284	235.60	284.60	328	67.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			351.7	F08		7	0045-0288	629.87	288.63	303	65.01	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			637.6	F08		7	0046-0291	776.86	291.35	339	74.67	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			348.4	F08		7	0047-0299	663.58	299.86	310	67.94	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			439.3	F08		7	0048-0307	180.09	307.59	328	67.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			434.1	F08		7	0049-0307	322.57	307.02	304	65.36	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			553.8	F08		7	0050-0317	748.57	316.98	227	58.18	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1285.9	F08		7	0051-0317	637.80	317.35	248	58.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			291.7	F08		7	0052-0333	847.17	332.72	343	70.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			297.7	F08		7	0053-0334	147.60	333.67	253	61.70	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			345.8	F08		7	0054-0339	491.89	339.39	291	66.53	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			616.7	F08		7	0055-0352	133.12	352.78	247	64.43	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			320.9	F08		7	0056-0355	729.67	355.23	293	63.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			603.3	F08		7	0057-0366	284.61	366.61	267	59.70	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			530.0	F08		7	0058-0377	900.04	377.04	305	72.18	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			377.8	F08		7	0059-0377	130.33	376.64	342	70.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			636.9	F08		7	0060-0382	614.20	382.79	380	73.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			375.8	F08		7	0061-0386	419.80	385.79	329	69.84	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			375.9	F08		7	0062-0384	562.34	383.61	317	66.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			291.5	F08		7	0063-0392	845.59	392.78	308	67.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			910.7	F08		7	0064-0396	676.19	396.86	321	68.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			321.5	F08		7	0065-0397	781.94	396.61	342	69.84	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			397.9	F08		7	0066-0399	58.99	398.31	273	63.60	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			295.9	F08		7	0067-0409	352.76	410.17	340	72.67	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			462.9	F08		7	0068-0417	292.67	417.10	285	67.84	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			320.6	F08		7	0069-0423	37.19	423.02	275	69.26	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			517.6	F08		7	0070-0419	533.04	419.50	266	63.70	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			493.0	F08		7	0071-0426	229.90	425.89	293	66.43	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			487.7	F08		7	0072-0438	885.79	438.02	319	70.77	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			638.6	F08		7	0073-0437	138.79	436.51	217	59.94	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			328.8	F08		7	0074-0443	717.99	443.46	337	69.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			370.8	F08		7	0075-0448	449.95	447.65	306	67.84	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			889.5	F08		7	0076-0447	484.62	447.15	225	58.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			555.0	F08		7	0077-0453	631.77	455.68	387	93.98	0.551
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			473.7	F08		7	0078-0449	298.81	448.89	269	66.43	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			753.6	F08		7	0079-0468	104.09	467.16	106	44.53	0.672
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			411.9	F08		7	0080-0479	201.56	479.53	320	69.60	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			363.1	F08		7	0081-0481	581.58	480.98	335	68.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1027.2	F08		7	0082-0486	529.78	486.59	233	58.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			452.1	F08		7	0083-0494	302.87	494.27	285	62.43	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			388.6	F08		7	0084-0495	229.49	495.57	325	68.77	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			312.3	F08		7	0085-0499	904.47	499.00	292	65.60	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			384.3	F08		7	0086-0504	28.67	504.31	308	66.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			312.1	F08		7	0087-0508	444.17	508.44	343	70.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			296.8	F08		7	0088-0525	890.82	525.58	277	65.70	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			335.3	F08		7	0089-0535	193.24	534.84	316	68.77	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			826.8	F08		7	0090-0539	300.64	539.10	270	63.01	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			408.8	F08		7	0091-0539	379.44	538.81	304	65.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			329.4	F08		7	0092-0542	25.51	542.80	256	64.43	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			602.3	F08		7	0093-0549	343.44	548.80	214	55.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1127.1	F08		7	0094-0552	637.08	552.27	261	60.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1565.4	F08		7	0095-0574	164.62	573.41	429	86.08	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1484.7	F08		7	0096-0571	672.22	571.83	228	55.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			568.6	F08		7	0097-0573	507.45	573.46	280	63.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			299.3	F08		7	0098-0581	822.58	581.20	290	67.26	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			249.6	F08		7	0099-0592	714.37	592.57	393	83.74	0.704
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			895.2	F08		7	0100-0604	631.20	604.27	236	60.18	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			387.7	F08		7	0101-0615	95.84	614.75	325	69.36	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			522.0	F08		7	0102-0617	583.01	617.18	308	67.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			964.9	F08		7	0103-0632	208.27	633.24	340	68.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3668.4	F08		7	0104-0635	394.14	634.30	172	52.53	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			487.2	F08		7	0105-0642	602.53	640.54	365	120.71	0.315
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			481.4	F08		7	0106-0646	152.95	645.38	213	59.94	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2630.5	F08		7	0107-0649	403.03	649.67	189	54.53	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			498.2	F08		7	0108-0646	479.26	645.61	195	67.60	0.536
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			875.6	F08		7	0109-0654	434.14	654.28	282	62.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			497.7	F08		7	0110-0661	551.17	661.16	255	58.53	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			552.8	F08		7	0111-0676	429.53	676.20	341	69.50	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			440.5	F08		7	0112-0674	830.80	674.11	271	65.60	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			775.4	F08		7	0113-0679	201.81	678.48	306	66.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			529.5	F08		7	0114-0686	459.50	686.25	297	67.01	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			393.4	F08		7	0115-0687	594.89	687.09	301	69.36	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			852.1	F08		7	0116-0700	860.31	700.06	228	58.77	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			271.8	F08		7	0117-0712	829.75	712.75	159	50.04	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			603.7	F08		8	0001-0033	547.49	33.04	276	63.36	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			676.5	F08		8	0002-0039	390.98	39.49	312	68.87	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			284.6	F08		8	0003-0040	117.38	39.09	364	73.84	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			324.1	F08		8	0004-0043	468.83	43.14	273	63.60	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			290.2	F08		8	0005-0051	61.97	51.24	324	67.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			389.3	F08		8	0006-0057	813.53	56.57	270	65.60	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			384.2	F08		8	0007-0061	423.49	62.30	351	70.67	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			640.7	F08		8	0008-0063	351.36	64.01	288	63.94	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			471.6	F08		8	0009-0073	188.66	73.62	234	58.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4946.5	F08		8	0010-0078	534.60	77.39	546	85.74	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			346.0	F08		8	0011-0090	591.13	91.05	359	73.84	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			440.8	F08		8	0012-0093	27.34	92.73	300	71.60	0.735
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2017.9	F08		8	0013-0098	151.25	98.63	321	70.18	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			336.3	F08		8	0014-0094	862.10	94.33	251	58.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1551.4	F08		8	0015-0107	399.16	107.89	351	69.60	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			310.2	F08		8	0016-0116	77.68	116.31	300	65.60	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			359.0	F08		8	0017-0119	94.58	118.73	270	66.18	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2116.0	F08		8	0018-0117	144.91	118.43	327	67.94	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			313.6	F08		8	0019-0126	297.21	126.26	313	66.77	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2934.5	F08		8	0020-0127	571.17	127.19	260	64.67	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			431.0	F08		8	0021-0132	461.59	131.56	320	67.60	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3398.3	F08		8	0022-0137	524.65	137.50	266	61.46	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			292.3	F08		8	0023-0143	182.96	143.82	360	72.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			588.4	F08		8	0024-0144	858.72	143.84	286	62.53	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			436.7	F08		8	0025-0148	116.34	148.61	341	68.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			511.0	F08		8	0026-0148	631.03	147.91	212	54.53	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			341.3	F08		8	0027-0163	384.92	163.20	349	70.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			753.9	F08		8	0028-0162	498.33	161.44	241	60.77	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			372.2	F08		8	0029-0179	255.75	179.69	303	66.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			461.4	F08		8	0030-0193	903.86	192.59	363	77.60	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			405.5	F08		8	0031-0192	128.31	192.14	319	68.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1028.0	F08		8	0032-0198	834.68	198.26	273	61.36	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			737.8	F08		8	0033-0199	509.73	199.88	314	73.60	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			426.0	F08		8	0034-0200	934.39	200.06	339	68.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			569.6	F08		8	0035-0203	451.50	203.05	309	66.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			548.7	F08		8	0036-0212	809.27	211.52	260	59.94	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			337.1	F08		8	0037-0212	298.17	211.31	305	67.36	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			265.7	F08		8	0038-0219	171.70	218.50	349	70.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			307.5	F08		8	0039-0233	637.45	233.56	392	80.67	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			768.4	F08		8	0040-0231	389.44	231.39	302	67.36	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1188.3	F08		8	0041-0237	69.26	237.61	245	60.43	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			366.3	F08		8	0042-0246	216.23	246.26	271	64.43	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			9216.1	F08		8	0043-0252	368.24	252.48	258	60.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			330.8	F08		8	0044-0255	555.78	254.76	308	67.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			334.4	F08		8	0045-0255	786.48	254.80	372	71.60	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			396.8	F08		8	0046-0255	269.76	254.60	284	66.43	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			729.5	F08		8	0047-0254	91.96	254.52	319	73.70	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			9419.3	F08		8	0048-0259	345.30	258.91	262	60.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			250.4	F08		8	0049-0267	175.50	267.03	342	69.60	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			651.6	F08		8	0050-0268	413.70	268.21	323	71.50	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1072.4	F08		8	0051-0269	476.36	269.60	262	62.87	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			468.1	F08		8	0052-0267	608.28	266.91	333	69.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			450.7	F08		8	0053-0276	824.72	276.05	241	71.26	0.596
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			428.2	F08		8	0054-0280	327.52	280.38	308	69.94	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			573.7	F08		8	0055-0286	908.01	285.70	313	68.53	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			304.1	F08		8	0056-0287	257.30	287.08	289	64.18	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			273.1	F08		8	0057-0296	114.24	295.98	271	60.28	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			388.5	F08		8	0058-0301	527.71	301.18	325	70.43	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			294.9	F08		8	0059-0303	773.32	302.44	372	73.26	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			408.7	F08		8	0060-0301	67.03	300.89	265	60.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			234.0	F08		8	0061-0306	726.59	306.20	334	67.60	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1091.1	F08		8	0062-0307	454.46	307.65	280	64.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			383.3	F08		8	0063-0312	484.66	310.84	355	71.01	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			436.7	F08		8	0064-0309	802.16	310.13	312	67.01	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			316.9	F08		8	0065-0309	596.25	308.86	334	68.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			293.9	F08		8	0066-0316	693.21	316.50	327	69.94	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3136.1	F08		8	0067-0314	860.26	314.34	217	55.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			929.8	F08		8	0068-0321	66.27	321.41	288	64.18	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			411.4	F08		8	0069-0340	518.16	340.62	344	70.18	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			334.1	F08		8	0070-0341	265.73	342.16	331	68.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			445.7	F08		8	0071-0351	434.28	351.13	305	66.53	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			321.0	F08		8	0072-0351	157.55	350.65	335	67.60	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			450.2	F08		8	0073-0357	716.82	357.73	333	68.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2464.7	F08		8	0074-0359	201.87	358.41	290	62.18	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			325.6	F08		8	0075-0364	109.18	363.74	280	62.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			569.8	F08		8	0076-0362	599.31	361.65	263	64.53	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			518.2	F08		8	0077-0367	693.55	366.93	294	66.18	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			523.7	F08		8	0078-0368	311.75	368.05	298	66.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			341.3	F08		8	0079-0377	779.65	376.56	371	72.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			795.9	F08		8	0080-0388	69.99	388.89	308	67.60	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			355.0	F08		8	0081-0390	343.64	390.06	371	73.84	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			556.4	F08		8	0082-0386	263.47	386.26	253	61.11	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			260.4	F08		8	0083-0391	908.93	390.40	404	73.60	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1989.4	F08		8	0084-0391	611.42	391.77	274	69.50	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			320.0	F08		8	0085-0394	117.33	393.86	319	67.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			764.9	F08		8	0086-0399	228.50	398.65	247	60.53	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3328.8	F08		8	0087-0408	842.54	408.45	219	54.63	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			482.9	F08		8	0088-0416	556.27	416.95	354	69.60	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2339.7	F08		8	0089-0420	159.54	420.41	357	71.50	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			397.2	F08		8	0090-0423	731.25	422.91	279	63.01	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			350.2	F08		8	0091-0428	804.60	428.93	253	61.36	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			470.2	F08		8	0092-0436	487.98	436.01	325	66.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			381.2	F08		8	0093-0438	450.52	438.13	320	69.84	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			760.5	F08		8	0094-0441	747.09	440.58	241	61.11	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			336.2	F08		8	0095-0449	897.52	449.38	338	69.84	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			344.8	F08		8	0096-0449	761.52	449.23	256	62.53	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2392.0	F08		8	0097-0454	127.49	454.78	354	70.18	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			344.3	F08		8	0098-0459	837.61	458.78	342	69.84	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			929.1	F08		8	0099-0464	52.51	464.29	258	63.01	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			602.9	F08		8	0100-0475	743.13	475.27	277	63.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			392.1	F08		8	0101-0501	414.64	501.00	335	69.60	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			463.8	F08		8	0102-0507	566.44	507.64	333	69.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			312.7	F08		8	0103-0514	374.99	514.14	306	65.94	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			254.3	F08		8	0104-0513	334.32	513.20	159	48.53	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			258.4	F08		8	0105-0524	327.91	524.49	200	53.94	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			440.3	F08		8	0106-0524	268.31	524.45	261	62.53	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			368.0	F08		8	0107-0531	853.53	531.31	273	60.77	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			425.7	F08		8	0108-0535	604.96	534.87	366	72.18	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			346.6	F08		8	0109-0571	800.98	571.40	335	71.01	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1129.2	F08		8	0110-0569	210.82	568.62	319	65.60	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			713.8	F08		8	0111-0577	472.98	576.95	286	63.60	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			545.4	F08		8	0112-0581	98.85	581.31	272	62.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			284.5	F08		8	0113-0580	145.09	579.96	365	73.01	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			312.8	F08		8	0114-0590	882.83	590.92	326	71.26	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			401.5	F08		8	0115-0597	725.29	596.96	315	68.18	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			263.5	F08		8	0116-0597	624.95	597.75	362	73.26	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			335.9	F08		8	0117-0611	935.55	610.24	234	62.43	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			264.3	F08		8	0118-0618	164.12	619.05	342	69.84	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			526.7	F08		8	0119-0619	390.63	619.56	358	72.18	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			250.3	F08		8	0120-0624	311.05	624.35	393	74.53	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			262.1	F08		8	0121-0633	257.00	633.60	354	72.18	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5036.4	F08		8	0122-0629	887.85	629.27	229	59.36	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			505.6	F08		8	0123-0631	485.97	631.58	369	71.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			282.8	F08		8	0124-0644	205.67	643.32	267	76.91	0.567
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			477.1	F08		8	0125-0646	113.81	646.09	315	68.28	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			289.1	F08		8	0126-0648	646.66	648.33	311	64.77	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			534.1	F08		8	0127-0652	188.70	652.10	313	72.77	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2736.7	F08		8	0128-0662	807.99	662.37	371	72.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			305.6	F08		8	0129-0679	279.00	679.25	308	66.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			494.7	F08		8	0130-0681	511.91	681.69	286	62.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			597.7	F08		8	0131-0683	818.41	683.45	254	62.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			965.3	F08		8	0132-0700	318.53	700.43	351	71.84	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			548.1	F08		8	0133-0700	869.85	700.89	257	62.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			405.3	F08		8	0134-0703	138.26	703.54	301	64.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			286.9	F08		8	0135-0707	51.06	707.80	312	67.60	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			238.0	F08		9	0001-0027	112.91	26.93	344	68.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			517.2	F08		9	0002-0032	250.70	31.94	275	63.11	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			307.3	F08		9	0003-0037	590.02	36.73	360	76.08	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			390.5	F08		9	0004-0035	182.72	34.71	298	68.18	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1592.1	F08		9	0005-0039	511.18	38.74	272	60.53	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1374.4	F08		9	0006-0052	462.31	52.06	326	68.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			399.2	F08		9	0007-0061	289.42	61.34	340	69.84	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			325.8	F08		9	0008-0060	744.10	60.15	375	75.84	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1380.1	F08		9	0009-0059	539.40	60.03	288	63.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			364.7	F08		9	0010-0067	666.69	67.26	265	60.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			419.0	F08		9	0011-0067	106.69	66.90	298	65.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			626.7	F08		9	0012-0074	577.54	74.11	328	69.36	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			321.9	F08		9	0013-0085	351.37	85.44	320	68.77	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			287.4	F08		9	0014-0091	628.73	91.14	393	77.01	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			515.8	F08		9	0015-0103	150.33	103.48	271	69.26	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			329.8	F08		9	0016-0108	400.39	108.07	454	80.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			412.6	F08		9	0017-0105	858.93	105.72	285	66.53	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			444.9	F08		9	0018-0113	289.82	113.21	327	67.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			415.2	F08		9	0019-0109	606.04	109.78	240	56.53	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			555.7	F08		9	0020-0117	768.48	117.04	247	62.77	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			609.9	F08		9	0021-0125	539.18	124.32	438	80.67	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			555.4	F08		9	0022-0121	873.87	121.45	166	52.53	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			422.0	F08		9	0023-0127	260.01	127.38	302	67.01	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			312.9	F08		9	0024-0138	476.79	138.03	340	71.60	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			286.5	F08		9	0025-0149	319.13	148.94	327	67.11	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			440.1	F08		9	0026-0148	749.13	148.30	298	66.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			467.1	F08		9	0027-0158	503.51	157.38	320	73.60	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			488.8	F08		9	0028-0161	88.66	161.07	266	64.91	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1295.1	F08		9	0029-0159	241.91	159.07	237	59.01	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1718.4	F08		9	0030-0167	191.21	167.88	216	55.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			527.0	F08		9	0031-0175	444.89	175.23	302	65.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			473.4	F08		9	0032-0173	811.23	174.00	102	37.46	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			658.4	F08		9	0033-0186	771.64	186.50	258	63.36	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			704.9	F08		9	0034-0192	90.66	192.61	247	62.18	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			672.8	F08		9	0035-0195	168.87	195.46	266	68.77	0.707
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			465.1	F08		9	0036-0192	373.20	191.67	246	60.77	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2029.8	F08		9	0037-0199	632.74	199.12	474	83.26	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			245.6	F08		9	0038-0200	943.12	200.57	395	77.50	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			317.1	F08		9	0039-0204	909.33	203.92	372	77.84	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			441.4	F08		9	0040-0203	29.78	202.97	327	68.18	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			285.3	F08		9	0041-0216	678.42	216.04	314	73.01	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			426.7	F08		9	0042-0214	529.80	214.47	277	61.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5317.3	F08		9	0043-0235	813.79	235.09	281	65.01	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			698.4	F08		9	0044-0237	767.12	236.64	289	67.84	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			388.0	F08		9	0045-0242	731.53	242.09	337	71.36	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			521.4	F08		9	0046-0239	229.65	240.27	253	58.87	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			474.3	F08		9	0047-0249	661.57	249.17	263	64.77	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			299.0	F08		9	0048-0252	46.14	252.59	303	63.94	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			511.8	F08		9	0049-0253	277.61	253.04	272	61.36	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			269.3	F08		9	0050-0260	938.09	260.43	364	71.50	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			368.5	F08		9	0051-0257	230.00	257.15	285	65.70	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			450.3	F08		9	0052-0266	426.54	266.69	295	65.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			413.3	F08		9	0053-0266	532.37	266.41	288	62.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			340.3	F08		9	0054-0275	141.22	275.50	320	67.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			316.6	F08		9	0055-0280	890.30	279.55	407	79.26	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			501.7	F08		9	0056-0282	381.39	281.55	283	62.18	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			416.6	F08		9	0057-0285	623.90	284.88	302	67.84	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			395.1	F08		9	0058-0298	223.21	298.43	264	59.60	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			478.1	F08		9	0059-0308	484.54	308.19	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			908.3	F08		9	0060-0313	56.31	313.12	372	74.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			395.5	F08		9	0061-0322	259.07	322.01	308	67.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			334.7	F08		9	0062-0327	728.12	326.58	310	69.36	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			262.8	F08		9	0063-0334	925.85	333.62	351	70.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			395.2	F08		9	0064-0333	831.25	333.40	333	69.26	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			496.5	F08		9	0065-0341	545.88	341.42	289	63.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			410.2	F08		9	0066-0341	871.51	341.54	301	64.43	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			343.9	F08		9	0067-0346	43.39	345.92	356	69.01	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			414.9	F08		9	0068-0350	225.43	350.33	358	73.26	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			365.1	F08		9	0069-0364	425.99	364.39	291	69.36	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			288.0	F08		9	0070-0363	784.03	363.41	333	68.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			353.7	F08		9	0071-0368	75.81	368.43	329	66.77	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			344.2	F08		9	0072-0370	728.14	370.19	368	71.84	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			537.1	F08		9	0073-0377	675.67	377.52	431	94.81	0.603
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1320.6	F08		9	0074-0384	562.15	380.29	405	96.47	0.547
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			331.6	F08		9	0075-0380	839.73	380.27	381	72.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			356.9	F08		9	0076-0395	607.01	394.57	312	70.67	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			470.0	F08		9	0077-0401	333.46	400.98	249	60.53	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			605.1	F08		9	0078-0401	429.53	401.57	283	62.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			537.1	F08		9	0079-0413	477.40	413.11	239	58.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			371.7	F08		9	0080-0418	752.22	417.97	326	67.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1149.1	F08		9	0081-0423	108.15	423.49	312	66.77	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			296.8	F08		9	0082-0422	136.76	422.43	323	67.84	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			428.3	F08		9	0083-0431	926.94	431.35	264	63.70	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			393.5	F08		9	0084-0436	663.61	435.45	326	68.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			389.3	F08		9	0085-0441	846.39	442.19	308	68.67	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			712.9	F08		9	0086-0453	788.02	452.55	346	70.43	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			329.6	F08		9	0087-0457	627.33	457.38	328	68.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			669.0	F08		9	0088-0460	250.17	459.58	271	62.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			749.0	F08		9	0089-0460	360.06	459.62	272	61.36	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			850.4	F08		9	0090-0466	762.09	465.46	350	71.01	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			461.6	F08		9	0091-0473	583.58	473.73	297	64.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			589.2	F08		9	0092-0483	354.63	482.60	295	64.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			440.4	F08		9	0093-0490	838.00	490.06	300	64.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			295.0	F08		9	0094-0496	656.41	496.27	342	72.53	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			484.6	F08		9	0095-0495	418.64	495.14	284	62.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			317.0	F08		9	0096-0498	792.53	497.76	331	69.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			654.4	F08		9	0097-0496	774.17	495.84	350	71.94	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			374.7	F08		9	0098-0499	52.74	498.30	283	62.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1723.0	F08		9	0099-0501	727.06	500.76	271	61.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			759.5	F08		9	0100-0505	207.71	504.91	249	58.18	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1619.8	F08		9	0101-0521	78.62	521.30	261	65.01	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			298.5	F08		9	0102-0521	614.23	521.50	371	70.18	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1289.0	F08		9	0103-0525	681.54	525.40	290	65.36	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			823.3	F08		9	0104-0524	710.85	524.45	293	63.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			539.3	F08		9	0105-0536	359.76	536.61	335	68.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			309.9	F08		9	0106-0539	624.88	539.71	358	72.08	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			331.0	F08		9	0107-0545	414.30	545.05	278	68.08	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2371.6	F08		9	0108-0543	740.94	544.00	305	65.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			457.9	F08		9	0109-0551	127.64	551.73	323	70.67	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			531.3	F08		9	0110-0555	376.56	555.19	274	60.77	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			343.0	F08		9	0111-0559	311.67	559.17	348	69.60	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			371.3	F08		9	0112-0570	464.67	570.15	303	67.60	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			341.2	F08		9	0113-0577	227.99	580.26	291	83.15	0.529
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2884.6	F08		9	0114-0584	723.59	584.53	331	68.67	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			391.9	F08		9	0115-0592	144.52	592.32	318	69.26	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			446.9	F08		9	0116-0591	674.89	590.99	317	66.53	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			297.2	F08		9	0117-0600	594.64	600.11	339	70.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			336.4	F08		9	0118-0599	296.56	598.65	303	67.84	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			274.2	F08		9	0119-0597	805.83	597.68	333	75.84	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			676.5	F08		9	0120-0602	928.18	602.38	277	62.77	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			385.4	F08		9	0121-0606	412.90	606.62	306	66.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			381.8	F08		9	0122-0607	466.79	607.03	331	67.84	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			372.0	F08		9	0123-0613	30.57	613.25	236	60.77	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			433.8	F08		9	0124-0615	239.99	615.89	244	63.94	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			661.4	F08		9	0125-0617	908.56	617.47	303	66.53	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			252.3	F08		9	0126-0625	671.13	625.54	417	79.26	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			320.5	F08		9	0127-0638	544.10	637.32	277	67.01	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			352.6	F08		9	0128-0648	205.49	647.63	330	67.60	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			334.1	F08		9	0129-0652	501.09	652.73	310	66.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			353.3	F08		9	0130-0658	185.37	657.89	315	67.84	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			487.6	F08		9	0131-0664	921.81	663.93	269	61.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			473.6	F08		9	0132-0667	677.49	666.70	275	62.18	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			833.5	F08		9	0133-0671	770.94	672.08	269	66.18	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			504.7	F08		9	0134-0674	398.05	674.25	276	63.36	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1565.7	F08		9	0135-0680	852.31	679.91	486	84.67	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			287.9	F08		9	0136-0682	319.34	683.00	307	65.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			492.5	F08		9	0137-0685	378.24	685.79	273	61.36	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			864.9	G08		1	0001-0032	204.59	33.10	257	63.01	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3268.0	G08		1	0002-0042	496.41	42.05	229	59.11	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			390.1	G08		1	0003-0056	98.31	56.55	335	72.08	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			386.3	G08		1	0004-0065	935.15	65.24	324	68.43	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			505.5	G08		1	0005-0075	282.41	75.08	268	64.04	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			429.2	G08		1	0006-0076	711.31	75.89	364	71.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3407.9	G08		1	0007-0083	664.99	83.53	405	80.57	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			368.5	G08		1	0008-0092	730.56	92.42	348	71.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			378.7	G08		1	0009-0092	567.38	92.61	154	68.43	0.413
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			490.1	G08		1	0010-0096	262.76	96.42	254	69.26	0.665
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			434.3	G08		1	0011-0100	77.40	101.22	295	66.18	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			402.7	G08		1	0012-0106	712.96	105.19	322	72.33	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			5507.9	G08		1	0013-0107	844.87	105.02	171	73.50	0.398
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			381.5	G08		1	0014-0122	896.06	121.71	302	66.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			478.5	G08		1	0015-0194	835.35	194.66	279	62.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			354.1	G08		1	0016-0199	185.62	199.26	102	39.21	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			541.3	G08		1	0017-0225	584.08	224.71	214	58.04	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			513.5	G08		1	0018-0242	806.26	241.74	215	62.04	0.702
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			429.1	G08		1	0019-0268	829.39	268.12	262	59.36	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			468.1	G08		1	0020-0280	887.64	280.48	237	60.28	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1004.2	G08		1	0021-0288	639.34	288.26	221	57.94	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			370.9	G08		1	0022-0302	32.27	302.53	235	64.18	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			700.4	G08		1	0023-0306	478.27	306.20	195	58.18	0.724
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			342.9	G08		1	0024-0323	657.51	324.42	284	64.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			400.3	G08		1	0025-0343	280.32	343.85	258	62.53	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			643.1	G08		1	0026-0365	47.51	365.09	214	54.87	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1447.6	G08		1	0027-0369	350.54	368.34	227	62.87	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			622.0	G08		1	0028-0364	510.31	363.63	226	58.77	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			404.6	G08		1	0029-0367	623.42	366.98	274	63.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1145.3	G08		1	0030-0365	742.98	365.12	193	57.36	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			160.9	G08		1	0031-0368	147.46	368.35	242	61.36	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			443.4	G08		1	0032-0373	306.88	373.44	229	61.11	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			524.2	G08		1	0033-0383	675.69	383.47	240	63.11	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			307.7	G08		1	0034-0389	935.70	389.37	282	67.60	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			479.5	G08		1	0035-0407	210.27	407.15	209	58.77	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			561.0	G08		1	0036-0414	70.13	414.26	215	57.70	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			967.8	G08		1	0037-0416	890.73	415.95	225	57.70	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			576.2	G08		1	0038-0438	666.57	438.67	262	64.53	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			610.6	G08		1	0039-0444	858.60	443.31	109	75.98	0.237
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7288.7	G08		1	0040-0457	419.20	458.00	233	57.36	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			758.9	G08		1	0041-0462	730.98	462.08	237	61.94	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			716.5	G08		1	0042-0498	314.58	498.27	227	59.60	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			546.6	G08		1	0043-0524	563.97	524.23	303	66.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			555.7	G08		1	0044-0527	829.85	527.56	240	62.77	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			788.6	G08		1	0045-0536	719.53	536.54	205	58.18	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			491.6	G08		1	0046-0539	360.16	539.84	277	72.43	0.664
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			421.7	G08		1	0047-0539	688.61	539.21	272	60.77	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			519.7	G08		1	0048-0541	636.49	541.13	202	54.18	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			629.2	G08		1	0049-0548	12.47	547.60	261	61.36	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			879.4	G08		1	0050-0558	95.67	558.64	212	58.18	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			353.8	G08		1	0051-0568	648.28	568.31	304	68.18	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			431.4	G08		1	0052-0569	834.65	569.67	293	66.43	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			435.2	G08		1	0053-0605	697.52	605.52	252	58.77	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			571.0	G08		1	0054-0610	547.24	610.47	328	69.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			727.7	G08		1	0055-0610	598.30	610.74	166	53.94	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			617.6	G08		1	0056-0639	326.67	638.87	198	53.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			927.0	G08		1	0057-0697	329.28	697.00	230	59.84	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			471.2	G08		1	0058-0706	735.74	705.51	250	73.60	0.580
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			472.7	G08		2	0001-0033	490.85	32.69	260	66.28	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			349.7	G08		2	0002-0065	39.68	65.16	334	70.43	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			422.4	G08		2	0003-0071	263.62	70.95	321	73.26	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			421.4	G08		2	0004-0104	246.65	104.64	292	75.50	0.644
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			370.2	G08		2	0005-0207	403.66	206.99	276	68.18	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			518.7	G08		2	0006-0218	447.01	218.02	223	66.43	0.635
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4380.3	G08		2	0007-0233	670.79	232.76	279	104.81	0.319
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			323.3	G08		2	0008-0248	396.52	248.61	314	69.84	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			524.1	G08		2	0009-0248	449.88	249.51	100	47.46	0.558
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			555.1	G08		2	0010-0282	915.46	282.98	120	50.77	0.585
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			392.1	G08		2	0011-0354	665.79	353.71	302	68.18	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			317.5	G08		2	0012-0389	40.48	389.26	286	68.18	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			794.2	G08		2	0013-0396	667.73	395.75	228	57.01	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			430.0	G08		2	0014-0408	655.79	407.55	276	66.08	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			521.9	G08		2	0015-0409	559.15	408.44	277	64.18	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			345.3	G08		2	0016-0459	258.19	459.85	306	66.18	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			933.6	G08		2	0017-0511	49.96	511.64	225	57.70	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			834.0	G08		2	0018-0515	114.80	515.24	268	63.60	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			538.5	G08		2	0019-0613	133.89	613.28	223	60.53	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			450.8	G08		2	0020-0618	504.01	618.58	259	63.36	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			423.5	G08		2	0021-0635	637.25	635.23	302	66.53	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			420.3	G08		2	0022-0639	285.94	639.91	297	66.18	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			447.1	G08		2	0023-0644	591.27	644.02	278	63.70	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			412.8	G08		2	0024-0650	538.77	650.29	296	64.53	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			354.6	G08		2	0025-0654	224.91	653.80	279	63.70	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			338.4	G08		2	0026-0669	100.45	669.38	299	65.36	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			659.6	G08		2	0027-0672	582.47	672.12	374	76.08	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			474.4	G08		2	0028-0672	305.14	673.35	281	64.53	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			673.2	G08		2	0029-0686	316.60	686.53	125	45.11	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			768.0	G08		2	0030-0691	559.22	690.33	333	73.01	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			371.9	G08		2	0031-0697	615.07	697.26	277	62.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			685.7	G08		2	0032-0703	912.12	702.79	115	40.28	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1209.3	G08		3	0001-0051	392.71	51.40	201	55.36	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1061.4	G08		3	0002-0075	222.13	75.24	244	59.36	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			631.8	G08		3	0003-0084	824.96	84.25	264	61.94	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1157.3	G08		3	0004-0098	283.01	98.19	236	61.26	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			933.7	G08		3	0005-0107	865.02	107.68	209	59.26	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			655.3	G08		3	0006-0109	428.96	108.97	213	54.53	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			7265.5	G08		3	0007-0117	337.10	117.22	177	52.18	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			692.4	G08		3	0008-0120	858.06	120.25	224	55.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			487.3	G08		3	0009-0140	463.15	140.84	127	57.60	0.481
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			683.7	G08		3	0010-0154	925.91	153.92	225	57.36	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			328.6	G08		3	0011-0159	132.00	159.59	256	62.53	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			569.4	G08		3	0012-0161	248.69	161.09	118	40.28	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			567.7	G08		3	0013-0170	238.79	170.81	151	46.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1166.7	G08		3	0014-0176	428.50	176.01	204	58.18	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			816.2	G08		3	0015-0181	503.87	181.33	291	66.77	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3429.3	G08		3	0016-0180	529.81	180.56	171	50.53	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3268.7	G08		3	0017-0197	582.62	198.37	177	56.18	0.705
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			869.5	G08		3	0018-0200	927.92	200.57	216	59.60	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			8576.7	G08		3	0019-0218	416.36	218.30	165	50.04	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1065.7	G08		3	0020-0225	645.39	226.73	372	80.08	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			413.6	G08		3	0021-0230	534.48	231.10	267	63.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			467.7	G08		3	0022-0244	246.67	242.06	190	58.87	0.689
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			505.1	G08		3	0023-0252	396.23	252.19	223	54.53	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			448.5	G08		3	0024-0254	528.93	254.27	270	65.01	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			426.8	G08		3	0025-0258	249.56	257.64	117	41.70	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			388.5	G08		3	0026-0275	172.46	274.70	276	67.84	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			435.5	G08		3	0027-0281	631.58	281.17	262	59.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			465.5	G08		3	0028-0283	13.67	282.64	191	56.77	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			546.4	G08		3	0029-0291	854.26	290.53	224	59.60	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			584.5	G08		3	0030-0303	103.18	303.57	207	57.36	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			741.7	G08		3	0031-0312	777.94	311.63	151	51.46	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			583.3	G08		3	0032-0322	487.29	322.50	214	56.77	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			437.8	G08		3	0033-0343	170.81	343.65	233	58.28	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			769.7	G08		3	0034-0384	852.19	384.44	220	55.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			513.5	G08		3	0035-0385	203.48	384.96	224	61.70	0.739
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			432.1	G08		3	0036-0396	810.66	396.52	284	63.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			662.0	G08		3	0037-0402	50.40	402.63	241	60.77	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			530.8	G08		3	0038-0407	742.68	408.20	266	64.18	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			450.9	G08		3	0039-0408	893.26	407.85	285	67.26	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			567.5	G08		3	0040-0454	910.50	453.38	237	58.77	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1604.1	G08		3	0041-0486	783.43	486.83	257	62.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			689.4	G08		3	0042-0489	453.81	489.03	234	57.36	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1140.6	G08		3	0043-0499	369.03	498.82	247	60.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1645.8	G08		3	0044-0535	663.85	535.40	257	62.87	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			682.1	G08		3	0045-0539	343.31	539.41	471	89.74	0.735
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			497.9	G08		3	0046-0531	785.86	531.44	177	51.11	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			401.5	G08		3	0047-0549	945.50	548.90	266	68.63	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			323.8	G08		3	0048-0558	808.51	557.74	322	68.18	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1593.6	G08		3	0049-0560	315.90	559.69	220	93.40	0.317
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			525.9	G08		3	0050-0565	444.93	564.88	283	66.18	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1821.9	G08		3	0051-0575	624.95	575.22	373	72.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			579.4	G08		3	0052-0581	325.62	582.28	262	61.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			301.7	G08		3	0053-0609	835.51	610.13	302	66.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			551.7	G08		3	0054-0645	276.97	644.96	208	56.87	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			572.5	G08		3	0055-0663	699.65	662.76	264	65.36	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1279.0	G08		3	0056-0664	832.78	663.96	216	59.84	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3883.9	G08		3	0057-0666	97.42	666.26	212	53.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			512.9	G08		3	0058-0670	618.50	669.36	259	66.43	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			938.8	G08		4	0001-0035	57.39	34.95	202	56.77	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1021.4	G08		4	0002-0036	140.39	36.89	263	67.26	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			429.1	G08		4	0003-0065	897.16	64.19	268	63.26	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			502.6	G08		4	0004-0069	704.73	69.69	260	63.70	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			672.2	G08		4	0005-0087	675.87	87.02	277	61.70	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1446.4	G08		4	0006-0092	168.03	92.02	326	72.91	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			457.3	G08		4	0007-0097	488.16	97.07	264	62.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			465.7	G08		4	0008-0106	695.79	107.02	267	67.26	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			868.8	G08		4	0009-0129	134.25	130.00	186	56.87	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			477.2	G08		4	0010-0144	683.46	144.16	250	68.77	0.664
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			894.4	G08		4	0011-0184	270.60	185.09	156	47.46	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			995.2	G08		4	0012-0184	258.83	184.32	117	42.63	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			884.5	G08		4	0013-0198	252.47	198.14	271	61.60	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			825.4	G08		4	0014-0202	271.16	202.46	228	62.77	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			629.5	G08		4	0015-0222	683.17	222.21	211	63.60	0.656
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			534.4	G08		4	0016-0223	626.05	223.64	268	61.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			386.2	G08		4	0017-0230	296.16	230.32	363	80.67	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			487.6	G08		4	0018-0236	870.80	235.72	251	60.53	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			574.4	G08		4	0019-0248	297.88	248.35	171	67.84	0.467
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2566.4	G08		4	0020-0251	61.22	251.90	222	54.77	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			308.3	G08		4	0021-0252	929.07	252.31	258	60.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			550.5	G08		4	0022-0261	757.81	261.64	281	65.01	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			456.4	G08		4	0023-0260	858.20	260.13	218	61.70	0.720
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			535.3	G08		4	0024-0273	154.52	273.23	239	64.53	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			431.3	G08		4	0025-0274	848.11	274.54	288	65.94	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			666.7	G08		4	0026-0278	57.57	278.85	196	52.53	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			902.3	G08		4	0027-0290	821.95	289.82	232	58.53	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			290.8	G08		4	0028-0297	30.71	296.88	302	66.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1975.4	G08		4	0029-0300	383.48	300.35	174	49.11	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1763.1	G08		4	0030-0308	258.64	308.85	209	57.60	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			494.0	G08		4	0031-0310	101.43	310.42	257	62.53	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			954.4	G08		4	0032-0312	542.78	311.58	301	68.77	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			947.8	G08		4	0033-0325	554.36	324.38	243	67.01	0.680
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			537.0	G08		4	0034-0343	635.95	342.84	195	59.01	0.704
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1797.6	G08		4	0035-0351	370.80	351.24	187	53.70	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			320.1	G08		4	0036-0350	928.55	349.11	162	51.94	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			312.0	G08		4	0037-0355	938.44	356.34	139	44.28	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3530.4	G08		4	0038-0361	218.64	361.70	202	57.11	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			480.4	G08		4	0039-0373	278.48	373.34	189	51.46	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			502.6	G08		4	0040-0382	801.04	382.03	194	55.70	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			447.7	G08		4	0041-0388	284.57	388.10	256	62.53	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			395.7	G08		4	0042-0391	415.82	392.06	295	67.36	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			335.6	G08		4	0043-0390	53.66	390.17	240	60.18	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			432.3	G08		4	0044-0393	267.09	393.23	290	67.26	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			454.3	G08		4	0045-0401	830.60	401.78	210	53.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3132.5	G08		4	0046-0420	198.06	419.82	219	57.46	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			687.7	G08		4	0047-0424	944.84	423.39	270	62.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			379.4	G08		4	0048-0440	392.04	441.07	265	65.84	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			569.2	G08		4	0049-0447	554.05	446.96	215	56.18	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2646.2	G08		4	0050-0446	249.81	446.92	191	53.11	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			381.4	G08		4	0051-0477	904.87	477.53	234	57.70	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			381.9	G08		4	0052-0487	80.59	487.68	262	62.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2920.6	G08		4	0053-0502	230.11	501.89	197	53.46	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4371.7	G08		4	0054-0517	391.63	517.07	253	75.60	0.556
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3159.8	G08		4	0055-0521	120.17	521.56	214	55.36	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			396.6	G08		4	0056-0523	287.43	523.01	270	63.60	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3098.6	G08		4	0057-0530	144.08	530.84	219	55.46	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			750.0	G08		4	0058-0560	596.96	558.50	392	91.74	0.585
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			690.1	G08		4	0059-0564	877.39	564.54	192	51.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2212.9	G08		4	0060-0577	810.69	577.11	389	74.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			509.0	G08		4	0061-0591	113.98	591.55	247	59.94	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			441.5	G08		4	0062-0606	659.17	606.68	297	78.57	0.605
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			464.7	G08		4	0063-0617	452.28	617.65	211	56.77	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			698.1	G08		4	0064-0621	193.27	621.27	221	60.43	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			684.2	G08		4	0065-0637	190.91	637.47	228	60.18	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			806.6	G08		4	0066-0644	397.00	643.71	282	63.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			703.2	G08		4	0067-0653	92.97	652.55	189	56.53	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			848.8	G08		4	0068-0654	106.20	654.06	160	50.04	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			429.2	G08		4	0069-0663	678.63	663.18	247	64.43	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			4460.0	G08		4	0070-0690	349.11	690.26	383	72.67	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			791.5	G08		4	0071-0691	367.79	690.82	276	66.18	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			342.9	G08		4	0072-0704	542.80	703.81	309	68.43	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			331.8	G08		4	0073-0703	589.98	703.36	281	69.11	0.739
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			720.0	G08		4	0074-0703	739.02	703.26	199	52.77	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1248.3	G08		4	0075-0707	196.86	706.90	154	46.53	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			418.4	G08		5	0001-0032	541.11	31.09	192	60.18	0.666
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			505.9	G08		5	0002-0042	152.37	43.12	227	64.53	0.685
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			560.5	G08		5	0003-0068	371.04	67.99	204	61.46	0.679
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			356.4	G08		5	0004-0094	130.78	94.41	220	57.70	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1985.9	G08		5	0005-0108	685.92	107.88	189	51.94	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			454.9	G08		5	0006-0108	655.21	107.84	265	63.36	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			483.2	G08		5	0007-0126	291.19	126.62	202	56.18	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			401.0	G08		5	0008-0163	606.40	162.70	224	68.43	0.601
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			390.0	G08		5	0009-0165	343.14	165.05	250	63.50	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			329.6	G08		5	0010-0175	940.52	174.15	253	63.11	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			493.7	G08		5	0011-0181	825.03	181.58	243	58.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			508.9	G08		5	0012-0189	442.10	189.27	227	64.18	0.692
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			377.7	G08		5	0013-0195	722.38	195.82	185	73.50	0.430
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			350.4	G08		5	0014-0222	93.53	222.62	278	65.94	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			681.5	G08		5	0015-0237	567.80	237.45	194	55.46	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			459.9	G08		5	0016-0239	139.04	239.55	271	62.77	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			425.1	G08		5	0017-0241	470.04	240.31	223	57.46	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			508.5	G08		5	0018-0240	624.42	240.17	185	53.36	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			506.3	G08		5	0019-0248	823.85	247.79	175	69.26	0.459
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			333.0	G08		5	0020-0253	34.52	253.68	252	59.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			900.1	G08		5	0021-0263	132.45	263.34	299	67.84	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			719.8	G08		5	0022-0282	865.29	281.23	145	48.53	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			350.1	G08		5	0023-0292	260.85	292.40	275	62.18	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			652.6	G08		5	0024-0289	871.90	290.19	120	44.28	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			813.9	G08		5	0025-0292	905.12	292.44	265	63.01	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			889.5	G08		5	0026-0292	213.98	291.51	103	49.46	0.529
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			381.1	G08		5	0027-0316	61.57	315.91	259	68.53	0.693
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2889.8	G08		5	0028-0324	909.41	324.06	225	55.11	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			307.7	G08		5	0029-0351	34.16	350.35	160	51.11	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			270.7	G08		5	0030-0356	852.99	356.90	319	68.18	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			362.0	G08		5	0031-0357	43.91	357.60	134	43.46	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3367.4	G08		5	0032-0370	916.33	370.90	242	64.53	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			343.7	G08		5	0033-0388	478.45	387.91	263	61.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3066.9	G08		5	0034-0396	394.79	396.25	187	51.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			389.8	G08		5	0035-0412	692.19	411.81	233	56.28	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3126.4	G08		5	0036-0419	429.87	419.08	156	58.77	0.568
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			701.2	G08		5	0037-0425	50.46	424.75	261	63.60	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			341.9	G08		5	0038-0484	95.58	484.30	269	62.18	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			672.6	G08		5	0039-0483	930.96	483.42	201	53.70	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			558.1	G08		5	0040-0494	633.21	493.73	212	62.28	0.687
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			381.2	G08		5	0041-0497	769.80	497.55	253	61.70	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			449.7	G08		5	0042-0508	329.53	508.48	329	72.43	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			405.6	G08		5	0043-0527	286.51	526.75	220	61.01	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			608.6	G08		5	0044-0535	622.69	534.63	187	56.28	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			500.3	G08		5	0045-0550	220.89	550.54	202	57.94	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			580.0	G08		5	0046-0548	249.45	548.43	172	52.28	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			606.7	G08		5	0047-0563	153.70	562.95	110	53.36	0.486
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			370.8	G08		5	0048-0583	634.62	583.75	264	63.84	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			893.8	G08		5	0049-0594	129.69	594.89	191	54.18	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			803.9	G08		5	0050-0606	526.68	606.72	254	62.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			487.3	G08		5	0051-0621	548.39	620.38	261	60.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1153.7	G08		5	0052-0633	394.79	633.43	175	57.94	0.655
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			813.9	G08		5	0053-0649	879.38	648.46	267	62.77	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			404.9	G08		5	0054-0658	86.40	658.34	208	66.04	0.599
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			478.3	G08		5	0055-0659	146.43	658.61	215	57.11	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1079.3	G08		5	0056-0676	660.44	675.54	242	63.36	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			358.0	G08		5	0057-0680	392.72	679.46	237	61.94	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1012.7	G08		5	0058-0686	413.76	685.86	186	51.70	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1191.0	G08		5	0059-0701	377.39	701.40	197	55.70	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			783.7	G08		5	0060-0703	482.30	702.70	182	64.67	0.547
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			557.2	G08		6	0001-0056	930.28	56.78	245	59.11	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1577.4	G08		6	0002-0062	146.01	62.35	215	56.77	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			380.3	G08		6	0003-0073	880.87	72.50	278	64.43	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			501.9	G08		6	0004-0082	78.92	81.60	182	51.94	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			438.3	G08		6	0005-0093	752.88	94.14	288	67.01	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1371.5	G08		6	0006-0112	641.80	112.21	197	57.60	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			675.4	G08		6	0007-0120	317.19	120.41	213	53.11	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			557.5	G08		6	0008-0124	828.85	124.44	232	71.98	0.563
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			929.1	G08		6	0009-0133	761.87	133.64	241	61.01	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			529.4	G08		6	0010-0139	111.89	138.66	274	63.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			572.1	G08		6	0011-0145	96.13	144.50	281	64.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			685.3	G08		6	0012-0150	731.23	150.14	297	66.18	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1064.3	G08		6	0013-0153	946.07	153.21	217	55.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			853.8	G08		6	0014-0157	818.91	157.09	266	65.01	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			319.8	G08		6	0015-0177	35.63	176.53	252	61.11	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			762.9	G08		6	0016-0179	810.78	179.02	141	59.60	0.499
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			374.6	G08		6	0017-0183	491.89	183.08	192	56.43	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			607.5	G08		6	0018-0187	116.46	188.41	137	46.63	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			499.8	G08		6	0019-0200	117.38	199.99	117	41.80	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			603.0	G08		6	0020-0220	67.60	220.10	243	57.70	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			461.5	G08		6	0021-0225	588.78	225.28	263	64.43	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			458.2	G08		6	0022-0261	649.15	261.19	225	59.70	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			537.6	G08		6	0023-0323	648.24	322.86	229	59.94	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1130.5	G08		6	0024-0328	763.41	329.02	193	57.11	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			862.5	G08		6	0025-0339	100.89	339.06	230	57.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			406.5	G08		6	0026-0347	418.78	347.62	272	65.60	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			343.6	G08		6	0027-0369	308.09	369.43	309	66.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			3273.2	G08		6	0028-0373	11.55	373.61	238	63.11	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			954.8	G08		6	0029-0373	577.93	372.96	231	62.63	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			364.8	G08		6	0030-0403	351.02	403.11	335	70.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			643.1	G08		6	0031-0413	837.42	412.60	249	59.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			505.4	G08		6	0032-0418	255.47	418.73	301	69.01	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			812.2	G08		6	0033-0426	394.41	426.17	186	53.46	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			935.7	G08		6	0034-0432	873.70	432.07	251	60.53	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2233.0	G08		6	0035-0454	596.99	454.12	299	82.91	0.547
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			649.4	G08		6	0036-0486	26.23	486.05	202	55.11	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2181.6	G08		6	0037-0513	579.88	512.79	289	64.53	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			342.3	G08		6	0038-0542	313.65	541.48	130	43.94	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			361.5	G08		6	0039-0546	303.22	547.24	144	45.11	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			611.4	G08		6	0040-0554	190.36	554.58	209	53.36	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			811.2	G08		6	0041-0567	183.14	566.73	172	51.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			338.0	G08		6	0042-0568	321.68	568.31	295	65.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			389.5	G08		6	0043-0582	382.57	582.43	275	67.70	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			436.6	G08		6	0044-0604	753.16	604.08	233	58.53	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1505.9	G08		6	0045-0611	859.18	611.21	210	59.36	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			570.8	G08		6	0046-0612	890.31	612.54	187	57.94	0.700
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			807.8	G08		6	0047-0614	613.01	614.72	215	56.87	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			338.6	G08		6	0048-0640	352.25	639.51	291	66.43	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			457.6	G08		6	0049-0646	575.91	645.49	232	59.60	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			498.9	G08		6	0050-0650	617.75	651.14	208	57.84	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			484.5	G08		6	0051-0653	123.89	653.61	205	60.53	0.703
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			476.2	G08		6	0052-0677	466.12	677.74	244	59.94	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			500.5	G08		6	0053-0686	593.53	685.73	205	59.94	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			467.9	G08		6	0054-0691	513.60	691.38	248	61.60	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			348.4	G08		6	0055-0700	351.11	699.46	279	62.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			387.9	G08		6	0056-0709	218.08	709.28	259	60.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1559.8	G08		6	0057-0709	832.68	709.43	206	58.28	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			526.7	G08		7	0001-0053	156.06	53.48	189	52.87	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			475.9	G08		7	0002-0055	530.23	55.22	234	56.87	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			940.1	G08		7	0003-0059	856.52	59.19	222	59.46	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			681.3	G08		7	0004-0066	818.80	66.19	139	61.60	0.460
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			496.5	G08		7	0005-0108	391.66	108.22	211	60.04	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			559.4	G08		7	0006-0106	876.52	106.30	260	62.77	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			939.4	G08		7	0007-0126	468.55	126.58	207	53.11	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			429.9	G08		7	0008-0146	857.50	145.91	227	61.60	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			984.3	G08		7	0009-0151	424.38	151.78	184	51.46	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			640.1	G08		7	0010-0155	165.33	155.02	235	60.53	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			345.2	G08		7	0011-0169	384.99	168.53	333	77.26	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			386.6	G08		7	0012-0218	214.01	218.13	266	65.01	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			668.9	G08		7	0013-0232	844.78	232.79	244	59.94	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			581.0	G08		7	0014-0246	70.36	245.62	187	57.01	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			489.1	G08		7	0015-0269	254.98	267.70	124	52.87	0.557
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1625.2	G08		7	0016-0278	542.09	277.90	194	55.01	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1386.9	G08		7	0017-0285	589.69	285.54	227	55.70	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			705.3	G08		7	0018-0295	792.60	296.21	261	62.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			379.1	G08		7	0019-0312	44.10	311.83	284	64.53	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			531.5	G08		7	0020-0310	581.07	310.05	230	59.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2974.4	G08		7	0021-0318	797.42	318.62	355	71.01	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			579.9	G08		7	0022-0320	20.50	319.46	217	56.28	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			313.4	G08		7	0023-0342	903.18	342.01	285	63.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2622.4	G08		7	0024-0346	432.50	346.92	216	56.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			645.7	G08		7	0025-0359	304.40	359.04	277	66.18	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			550.0	G08		7	0026-0385	226.98	385.39	107	39.46	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			695.4	G08		7	0027-0408	323.36	408.03	298	66.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			640.7	G08		7	0028-0414	130.61	414.08	313	71.50	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			924.9	G08		7	0029-0412	876.71	411.44	249	59.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			569.4	G08		7	0030-0415	227.08	415.55	205	57.01	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			500.7	G08		7	0031-0458	218.58	458.05	226	59.84	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			404.5	G08		7	0032-0465	900.13	464.79	272	63.01	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			552.5	G08		7	0033-0480	673.05	480.64	163	60.18	0.566
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			618.4	G08		7	0034-0483	154.74	483.15	141	46.87	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			540.5	G08		7	0035-0492	825.90	492.18	214	57.36	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			553.8	G08		7	0036-0494	159.32	495.01	131	49.46	0.673
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			502.9	G08		7	0037-0540	317.29	539.62	261	62.53	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			815.3	G08		7	0038-0537	118.17	537.42	196	57.36	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			375.7	G08		7	0039-0548	749.08	548.28	132	45.36	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			345.3	G08		7	0040-0555	541.81	554.98	291	65.26	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			409.0	G08		7	0041-0557	214.72	557.44	222	57.36	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			386.8	G08		7	0042-0555	735.78	555.98	120	42.28	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			533.3	G08		7	0043-0571	865.45	571.98	235	59.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			361.2	G08		7	0044-0581	458.87	581.32	299	65.26	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			552.8	G08		7	0045-0580	338.24	579.59	201	56.04	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			367.1	G08		7	0046-0584	557.07	584.80	257	61.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			706.2	G08		7	0047-0590	146.42	590.52	220	59.21	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			298.5	G08		7	0048-0590	379.40	589.54	316	66.67	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			291.7	G08		7	0049-0587	725.42	587.60	147	45.11	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			262.7	G08		7	0050-0596	715.02	597.07	151	46.87	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			475.5	G08		7	0051-0647	709.92	647.29	279	62.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1276.2	G08		7	0052-0649	283.27	650.15	195	53.94	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			847.1	G08		7	0053-0663	760.22	663.21	252	61.60	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			423.2	G08		7	0054-0665	58.61	665.53	298	63.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			353.4	G08		7	0055-0677	779.19	677.03	238	61.60	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1199.1	G08		7	0056-0692	383.49	691.93	179	49.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1146.8	G08		7	0057-0691	471.18	691.53	195	56.87	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			363.1	G08		8	0001-0031	936.98	31.62	278	65.60	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			992.5	G08		8	0002-0054	801.15	53.88	209	56.87	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			774.9	G08		8	0003-0061	843.75	61.43	216	66.04	0.622
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1536.1	G08		8	0004-0072	744.01	72.77	201	59.70	0.709
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			684.7	G08		8	0005-0110	290.92	109.83	264	63.01	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			651.4	G08		8	0006-0124	868.05	124.44	204	55.36	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			455.3	G08		8	0007-0136	397.97	136.22	279	62.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1139.3	G08		8	0008-0157	297.33	157.19	199	51.11	0.957
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			421.3	G08		8	0009-0177	236.55	176.67	260	64.53	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1091.9	G08		8	0010-0177	353.95	177.55	204	52.28	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			595.8	G08		8	0011-0182	141.63	182.29	215	60.43	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			778.3	G08		8	0012-0184	417.53	184.50	266	63.84	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			778.2	G08		8	0013-0195	580.65	195.20	189	53.11	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			954.6	G08		8	0014-0207	918.96	206.97	220	55.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			507.7	G08		8	0015-0214	236.87	214.53	211	59.01	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			483.7	G08		8	0016-0241	897.47	241.14	199	55.36	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			656.5	G08		8	0017-0260	527.98	260.45	217	56.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			840.5	G08		8	0018-0264	450.21	263.65	272	63.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			451.6	G08		8	0019-0297	861.92	297.03	274	63.94	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			358.2	G08		8	0020-0298	714.96	298.45	291	64.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			483.4	G08		8	0021-0330	699.62	330.32	173	47.46	0.965
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			443.6	G08		8	0022-0334	721.44	334.50	230	69.26	0.603
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			366.0	G08		8	0023-0343	708.13	343.65	123	45.11	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1417.0	G08		8	0024-0356	95.62	357.04	246	59.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			369.8	G08		8	0025-0358	770.82	358.20	230	63.60	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			437.3	G08		8	0026-0376	353.60	378.03	264	77.26	0.556
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			483.3	G08		8	0027-0378	259.72	378.03	213	55.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			452.2	G08		8	0028-0380	688.59	380.85	231	62.77	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			287.3	G08		8	0029-0388	424.72	387.92	305	67.84	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			349.6	G08		8	0030-0393	795.82	392.83	329	69.36	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			637.9	G08		8	0031-0421	214.39	421.11	189	56.53	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			506.5	G08		8	0032-0423	584.17	423.57	283	64.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1351.7	G08		8	0033-0426	527.98	426.91	228	57.70	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			412.5	G08		8	0034-0431	469.27	430.90	295	64.53	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			475.7	G08		8	0035-0446	174.24	446.17	205	59.26	0.734
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			288.8	G08		8	0036-0465	93.35	465.85	268	64.18	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			489.6	G08		8	0037-0478	172.46	478.59	190	52.77	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			800.1	G08		8	0038-0478	451.26	478.26	172	50.18	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2124.9	G08		8	0039-0485	204.35	484.39	245	61.60	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1803.5	G08		8	0040-0493	109.12	493.18	278	65.94	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			386.1	G08		8	0041-0514	550.29	513.57	307	69.94	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			413.0	G08		8	0042-0513	707.35	513.93	288	62.18	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1218.1	G08		8	0043-0518	868.54	518.43	202	61.01	0.682
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			339.9	G08		8	0044-0518	406.70	519.39	142	45.21	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			534.7	G08		8	0045-0536	565.66	536.59	212	64.04	0.650
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			347.3	G08		8	0046-0533	407.92	532.20	168	48.63	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			366.4	G08		8	0047-0534	301.31	534.72	230	59.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1038.0	G08		8	0048-0548	192.92	547.90	260	61.36	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			576.4	G08		8	0049-0556	511.92	556.09	302	66.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			837.0	G08		8	0050-0566	299.97	566.75	193	53.60	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1088.6	G08		8	0051-0580	924.69	579.23	294	65.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			419.3	G08		8	0052-0589	270.62	588.33	268	63.11	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			8418.0	G08		8	0053-0595	880.07	594.80	355	73.36	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			353.8	G08		8	0054-0610	218.90	609.47	260	67.84	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			676.1	G08		8	0055-0621	146.69	622.02	198	57.11	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			471.8	G08		8	0056-0621	290.70	621.09	249	60.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			728.4	G08		8	0057-0639	577.61	640.06	225	62.53	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			446.0	G08		8	0058-0657	135.73	657.10	210	61.70	0.693
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			350.9	G08		8	0059-0652	674.40	652.07	277	69.36	0.724
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1000.7	G08		8	0060-0666	415.93	666.00	171	55.11	0.707
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			830.5	G08		8	0061-0699	370.97	699.10	183	51.70	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			572.6	G08		8	0062-0701	133.33	701.42	195	51.70	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			137.7	G08		8	0063-0709	842.07	709.27	198	51.70	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			336.5	G08		9	0001-0034	31.77	34.33	273	65.01	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			443.5	G08		9	0002-0034	411.40	35.09	286	64.77	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			349.6	G08		9	0003-0040	489.21	39.94	280	65.84	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			492.6	G08		9	0004-0049	727.83	49.69	258	61.11	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			6972.7	G08		9	0005-0071	43.56	71.40	286	64.28	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1051.8	G08		9	0006-0103	476.99	103.18	279	61.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			447.8	G08		9	0007-0106	354.74	106.26	246	59.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			481.3	G08		9	0008-0118	570.68	118.15	240	60.53	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1198.2	G08		9	0009-0145	347.01	145.15	199	53.11	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			867.3	G08		9	0010-0148	694.70	149.05	194	59.36	0.692
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			427.6	G08		9	0011-0150	125.25	150.20	225	59.46	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			401.5	G08		9	0012-0157	97.26	157.47	266	59.11	0.957
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			397.6	G08		9	0013-0183	323.97	183.54	246	61.60	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1362.3	G08		9	0014-0194	251.35	194.46	224	57.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			387.1	G08		9	0015-0206	858.14	205.90	261	62.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			931.9	G08		9	0016-0210	14.17	209.59	216	55.60	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1275.8	G08		9	0017-0211	377.37	210.79	172	54.04	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1107.9	G08		9	0018-0224	388.18	223.96	199	56.53	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1033.3	G08		9	0019-0235	80.57	235.54	201	56.18	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			513.5	G08		9	0020-0244	687.08	243.72	274	63.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			2411.2	G08		9	0021-0246	299.45	245.54	343	72.43	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			441.6	G08		9	0022-0255	445.90	255.26	242	57.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			566.5	G08		9	0023-0268	478.14	267.59	245	58.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			373.2	G08		9	0024-0306	621.04	306.21	306	65.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			351.4	G08		9	0025-0336	263.52	336.65	255	77.50	0.534
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			498.3	G08		9	0026-0338	565.15	337.78	294	65.60	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			556.3	G08		9	0027-0352	423.01	352.32	230	57.36	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			480.2	G08		9	0028-0359	647.64	359.30	201	52.04	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			664.7	G08		9	0029-0366	121.04	366.56	347	72.08	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			436.6	G08		9	0030-0371	599.07	371.81	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			619.1	G08		9	0031-0392	112.90	392.27	302	70.18	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			499.7	G08		9	0032-0394	544.89	393.62	265	87.64	0.434
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			430.0	G08		9	0033-0396	427.88	397.25	206	56.77	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			517.6	G08		9	0034-0412	642.60	412.11	280	69.26	0.734
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			886.4	G08		9	0035-0416	462.97	416.38	197	60.28	0.681
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			800.5	G08		9	0036-0419	369.72	418.83	238	60.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			390.5	G08		9	0037-0428	443.00	427.25	275	64.77	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			415.9	G08		9	0038-0429	515.38	429.72	271	61.70	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			355.0	G08		9	0039-0440	364.69	440.16	252	61.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			412.5	G08		9	0040-0502	687.24	501.40	247	61.36	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			408.2	G08		9	0041-0505	670.84	506.14	206	54.63	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			555.1	G08		9	0042-0526	480.04	525.65	299	66.77	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			455.3	G08		9	0043-0560	241.00	560.24	284	66.77	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			1091.7	G08		9	0044-0582	19.55	581.95	287	64.53	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			784.5	G08		9	0045-0581	306.88	581.25	226	58.18	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			429.1	G08		9	0046-0596	783.57	595.75	266	63.84	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			814.9	G08		9	0047-0601	698.86	601.44	250	62.53	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			340.9	G08		9	0048-0605	942.34	604.53	260	67.01	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			333.8	G08		9	0049-0613	300.09	612.81	325	66.43	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1	80003	KI-67 / clone D3B5	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201296	KI-67			303.3	G08		9	0050-0664	878.63	665.31	280	63.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1039.4	B08		1	0001-0030	113.89	29.84	299	67.60	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1501.2	B08		1	0002-0029	168.91	28.72	294	66.18	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5638.9	B08		1	0003-0033	263.30	34.12	210	55.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1428.6	B08		1	0004-0039	463.46	39.70	310	65.36	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1043.9	B08		1	0005-0040	504.82	41.10	293	68.67	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1359.5	B08		1	0006-0040	720.01	40.44	289	75.74	0.633
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8478.0	B08		1	0007-0041	803.55	41.85	444	87.50	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3323.9	B08		1	0008-0042	418.82	41.04	267	61.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8195.8	B08		1	0009-0042	87.75	42.02	158	48.63	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2633.6	B08		1	0010-0045	289.33	45.56	376	71.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4157.4	B08		1	0011-0044	589.42	44.68	234	56.28	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3109.6	B08		1	0012-0045	693.34	45.35	223	54.87	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7283.0	B08		1	0013-0042	652.67	42.21	177	52.63	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2877.2	B08		1	0014-0047	771.72	47.09	254	59.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2290.4	B08		1	0015-0051	172.16	51.15	276	61.94	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1705.6	B08		1	0016-0050	534.61	50.03	323	66.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1949.7	B08		1	0017-0053	219.63	53.47	374	71.60	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2462.6	B08		1	0018-0052	134.85	52.43	234	56.53	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5693.7	B08		1	0019-0058	657.13	57.83	342	70.77	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1746.0	B08		1	0020-0061	258.75	61.24	390	73.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1660.1	B08		1	0021-0063	335.34	62.34	338	68.43	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4225.7	B08		1	0022-0062	630.45	62.65	266	64.28	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4179.4	B08		1	0023-0061	68.12	60.80	231	55.11	0.956
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4268.1	B08		1	0024-0069	569.59	69.83	433	81.26	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1869.0	B08		1	0025-0071	383.06	70.47	307	65.36	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5475.7	B08		1	0026-0072	533.10	71.85	285	67.60	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3994.0	B08		1	0027-0075	85.61	75.59	300	66.18	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1631.0	B08		1	0028-0072	179.49	71.47	229	60.28	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1069.1	B08		1	0029-0075	115.54	75.69	250	60.53	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5011.0	B08		1	0030-0081	364.92	80.88	146	47.46	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4817.9	B08		1	0031-0080	619.08	80.64	222	57.94	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3570.6	B08		1	0032-0081	759.36	80.85	245	58.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3709.9	B08		1	0033-0081	321.95	81.50	130	42.63	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2996.9	B08		1	0034-0088	460.95	87.74	314	66.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2530.6	B08		1	0035-0084	310.93	84.24	113	39.80	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2970.3	B08		1	0036-0090	175.85	90.55	267	61.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2451.6	B08		1	0037-0090	214.71	89.20	254	62.77	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1731.2	B08		1	0038-0092	424.90	91.91	289	65.01	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1938.8	B08		1	0039-0091	680.90	91.72	234	58.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2697.0	B08		1	0040-0094	944.76	95.13	265	65.01	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3545.7	B08		1	0041-0095	625.03	94.75	328	69.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4880.2	B08		1	0042-0103	829.16	103.44	270	62.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2892.4	B08		1	0043-0104	239.83	104.03	255	65.26	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6596.1	B08		1	0044-0104	882.82	104.11	328	67.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2274.9	B08		1	0045-0110	922.35	110.33	335	73.84	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1551.6	B08		1	0046-0109	293.74	110.26	248	62.77	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2029.6	B08		1	0047-0112	493.79	112.96	362	71.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1818.1	B08		1	0048-0114	778.16	114.52	464	84.43	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1574.3	B08		1	0049-0116	112.41	116.63	359	88.08	0.581
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3068.3	B08		1	0050-0116	259.31	115.12	221	56.77	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3132.0	B08		1	0051-0116	647.23	117.24	258	60.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3655.5	B08		1	0052-0117	677.05	116.66	246	60.77	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3902.4	B08		1	0053-0121	836.66	121.20	367	74.18	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2165.1	B08		1	0054-0122	164.49	121.49	263	63.01	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2214.9	B08		1	0055-0120	281.99	120.20	154	46.53	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4279.5	B08		1	0056-0125	949.09	125.05	224	54.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2325.1	B08		1	0057-0128	199.33	128.54	327	68.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3479.2	B08		1	0058-0126	268.66	127.47	256	63.50	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1888.2	B08		1	0059-0129	408.85	128.58	321	73.50	0.747
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3875.1	B08		1	0060-0132	426.69	132.76	233	57.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2261.2	B08		1	0061-0136	630.94	135.58	383	73.94	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4563.8	B08		1	0062-0137	26.05	136.99	233	57.60	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			998.7	B08		1	0063-0137	373.17	137.60	319	72.91	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3009.3	B08		1	0064-0139	329.68	138.96	328	66.18	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5310.2	B08		1	0065-0140	731.73	139.63	294	63.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2473.9	B08		1	0066-0148	178.70	148.16	375	71.84	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5048.7	B08		1	0067-0146	940.07	145.73	218	55.36	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1806.8	B08		1	0068-0149	527.48	149.03	352	71.60	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2696.4	B08		1	0069-0149	37.87	149.11	235	57.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1667.9	B08		1	0070-0150	469.38	149.40	312	67.11	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2754.7	B08		1	0071-0150	596.87	150.27	252	60.53	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1610.2	B08		1	0072-0152	796.78	151.98	299	66.18	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3672.1	B08		1	0073-0159	225.58	157.45	570	99.74	0.720
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1635.8	B08		1	0074-0155	282.20	154.87	260	62.18	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			9056.9	B08		1	0075-0157	632.64	157.02	313	76.43	0.673
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2830.7	B08		1	0076-0158	153.69	157.45	204	55.70	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6262.5	B08		1	0077-0163	328.00	163.42	260	61.01	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2415.3	B08		1	0078-0163	125.94	162.81	221	58.77	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2470.5	B08		1	0079-0165	582.66	164.81	259	59.01	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3358.4	B08		1	0080-0168	806.15	168.59	186	50.28	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1646.3	B08		1	0081-0173	353.97	173.37	375	73.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3333.3	B08		1	0082-0176	393.44	175.46	308	66.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6745.7	B08		1	0083-0181	81.01	179.70	679	108.81	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2375.2	B08		1	0084-0181	37.82	180.94	317	68.67	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3073.4	B08		1	0085-0183	495.13	183.84	242	61.11	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3358.8	B08		1	0086-0186	183.20	185.11	281	70.77	0.705
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1441.4	B08		1	0087-0183	529.17	183.34	292	66.77	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			10481.0	B08		1	0088-0188	592.87	187.56	324	71.26	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2341.9	B08		1	0089-0188	151.31	188.09	239	63.01	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1356.3	B08		1	0090-0186	472.32	186.20	273	62.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7018.0	B08		1	0091-0190	645.42	190.40	355	72.77	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4307.9	B08		1	0092-0189	740.53	189.40	262	61.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5811.4	B08		1	0093-0189	916.61	189.99	213	55.94	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3889.0	B08		1	0094-0199	661.63	199.51	212	54.53	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2832.8	B08		1	0095-0202	325.65	202.00	219	55.36	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3190.1	B08		1	0096-0203	781.21	202.87	198	52.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2546.1	B08		1	0097-0207	126.70	206.94	259	64.43	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3022.0	B08		1	0098-0208	842.96	208.21	277	62.53	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4203.0	B08		1	0099-0207	893.22	207.79	217	56.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4021.5	B08		1	0100-0211	47.78	209.92	245	71.84	0.597
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3148.4	B08		1	0101-0214	541.25	215.01	299	63.94	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1934.4	B08		1	0102-0214	757.81	214.78	388	73.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5939.5	B08		1	0103-0216	410.24	216.66	161	46.77	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1113.0	B08		1	0104-0223	491.65	222.90	275	63.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3757.1	B08		1	0105-0224	660.52	224.84	193	55.70	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6080.2	B08		1	0106-0227	19.25	227.66	223	54.77	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2960.9	B08		1	0107-0228	641.43	228.26	277	63.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2613.2	B08		1	0108-0230	932.04	229.58	285	68.67	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1900.3	B08		1	0109-0231	142.62	231.60	386	74.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2965.9	B08		1	0110-0230	561.73	229.80	229	55.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3073.8	B08		1	0111-0232	381.62	230.95	268	61.11	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3963.6	B08		1	0112-0230	462.01	230.23	249	61.11	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4013.8	B08		1	0113-0233	211.55	233.28	153	48.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2686.2	B08		1	0114-0243	589.35	243.57	309	68.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4258.7	B08		1	0115-0246	199.44	247.53	276	74.43	0.626
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5066.6	B08		1	0116-0244	317.01	244.90	203	53.11	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2700.5	B08		1	0117-0248	76.81	248.53	326	67.01	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3368.2	B08		1	0118-0247	524.13	246.74	325	66.18	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3111.3	B08		1	0119-0247	711.89	247.02	255	60.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3889.8	B08		1	0120-0248	409.52	248.96	336	67.60	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2839.2	B08		1	0121-0249	739.54	249.33	291	62.18	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2877.1	B08		1	0122-0250	840.18	251.21	283	64.43	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3348.0	B08		1	0123-0247	102.44	248.22	225	58.28	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5868.9	B08		1	0124-0252	47.31	252.01	327	67.26	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2522.6	B08		1	0125-0251	779.24	251.24	413	77.84	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3282.3	B08		1	0126-0257	151.50	256.98	248	61.36	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2079.2	B08		1	0127-0260	804.47	259.44	328	74.18	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3086.1	B08		1	0128-0261	359.21	260.93	227	57.94	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4077.8	B08		1	0129-0264	229.84	263.90	281	63.94	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3286.5	B08		1	0130-0263	576.99	262.76	251	59.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			10679.5	B08		1	0131-0263	342.33	262.78	170	48.28	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1526.1	B08		1	0132-0265	453.23	264.74	269	63.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2076.7	B08		1	0133-0267	184.02	266.99	243	60.53	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6433.9	B08		1	0134-0271	400.65	271.07	303	64.43	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			9897.1	B08		1	0135-0282	715.90	282.51	614	104.57	0.706
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1759.0	B08		1	0136-0278	136.40	278.88	316	67.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1347.4	B08		1	0137-0276	499.36	276.36	316	67.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4467.0	B08		1	0138-0278	325.49	278.13	242	57.11	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3821.6	B08		1	0139-0279	115.90	278.85	204	52.53	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6030.1	B08		1	0140-0280	248.03	279.94	274	63.70	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7741.9	B08		1	0141-0280	233.47	280.45	153	47.56	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4065.5	B08		1	0142-0283	831.39	284.12	232	58.77	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3622.3	B08		1	0143-0289	784.07	289.05	364	71.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3405.1	B08		1	0144-0285	871.41	284.96	211	56.04	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2524.1	B08		1	0145-0290	63.79	289.94	259	61.94	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4513.3	B08		1	0146-0294	198.94	293.80	275	68.77	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2995.3	B08		1	0147-0295	251.29	295.72	194	54.53	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2217.6	B08		1	0148-0293	442.69	293.36	247	58.28	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4735.5	B08		1	0149-0295	947.72	294.55	176	50.18	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2656.3	B08		1	0150-0299	539.19	299.01	298	64.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1925.8	B08		1	0151-0299	361.35	299.51	251	57.70	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1945.6	B08		1	0152-0298	577.27	297.82	248	60.53	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2958.5	B08		1	0153-0300	153.20	300.76	218	54.53	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2102.9	B08		1	0154-0304	861.89	303.83	366	74.53	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3877.8	B08		1	0155-0308	69.46	309.04	291	69.60	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3600.0	B08		1	0156-0307	940.82	307.36	244	61.60	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7081.5	B08		1	0157-0306	775.28	306.47	235	57.60	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3648.1	B08		1	0158-0309	925.21	309.35	226	56.28	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2859.0	B08		1	0159-0309	318.39	309.17	272	61.36	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3003.4	B08		1	0160-0314	651.65	313.60	420	79.50	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2980.1	B08		1	0161-0312	467.93	312.35	213	54.28	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1689.2	B08		1	0162-0317	437.95	317.77	267	64.53	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2302.2	B08		1	0163-0318	698.19	319.21	278	66.53	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3207.9	B08		1	0164-0322	42.02	322.21	328	67.94	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7321.4	B08		1	0165-0320	770.32	320.36	168	53.36	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4562.7	B08		1	0166-0327	754.43	327.63	324	66.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3378.8	B08		1	0167-0326	246.13	326.12	244	58.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2355.3	B08		1	0168-0330	596.47	330.76	289	65.60	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5694.7	B08		1	0169-0330	195.74	329.79	222	56.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2773.9	B08		1	0170-0331	512.72	332.12	223	57.11	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7582.5	B08		1	0171-0336	874.34	337.08	218	56.77	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2339.0	B08		1	0172-0340	922.60	340.37	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5822.3	B08		1	0173-0341	99.15	341.72	292	64.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3728.7	B08		1	0174-0341	120.32	340.55	219	53.11	0.976
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2408.1	B08		1	0175-0342	317.87	341.87	240	57.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3683.6	B08		1	0176-0344	477.32	345.31	233	58.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1497.1	B08		1	0177-0343	360.24	343.09	266	60.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3349.4	B08		1	0178-0348	187.38	348.07	297	64.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2370.1	B08		1	0179-0347	401.52	347.12	252	62.18	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3815.7	B08		1	0180-0348	451.21	348.03	240	59.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2861.5	B08		1	0181-0350	819.68	350.80	359	70.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1777.7	B08		1	0182-0357	235.83	357.38	253	60.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4276.6	B08		1	0183-0356	496.35	355.69	222	57.36	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5966.6	B08		1	0184-0358	158.02	357.54	284	62.43	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1718.9	B08		1	0185-0357	671.00	357.74	234	55.94	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4531.1	B08		1	0186-0359	721.04	359.92	342	71.84	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1597.6	B08		1	0187-0360	752.93	360.36	252	59.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3248.7	B08		1	0188-0365	470.68	365.36	211	57.36	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3897.5	B08		1	0189-0369	836.38	369.52	373	72.53	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6574.8	B08		1	0190-0368	510.44	367.95	374	72.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2898.2	B08		1	0191-0368	29.10	368.35	287	63.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3804.0	B08		1	0192-0368	85.72	368.45	306	65.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1971.6	B08		1	0193-0369	285.20	368.86	294	63.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4125.6	B08		1	0194-0369	644.13	368.90	224	53.70	0.976
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6092.5	B08		1	0195-0371	882.48	372.11	301	84.08	0.535
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			10676.1	B08		1	0196-0372	342.42	372.83	297	62.43	0.958
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3801.5	B08		1	0197-0377	903.49	377.77	282	62.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3222.3	B08		1	0198-0382	236.02	382.05	232	61.01	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1341.9	B08		1	0199-0381	465.07	380.93	279	62.18	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2175.0	B08		1	0200-0382	422.53	381.58	245	57.01	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2339.3	B08		1	0201-0384	59.38	384.08	255	60.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2744.8	B08		1	0202-0382	204.75	382.54	279	65.60	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2310.7	B08		1	0203-0384	656.24	384.72	261	60.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1454.2	B08		1	0204-0387	568.05	386.72	328	69.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3396.4	B08		1	0205-0391	518.32	391.39	283	61.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3320.2	B08		1	0206-0390	169.49	389.75	206	54.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1109.3	B08		1	0207-0395	261.77	395.35	279	63.60	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1705.8	B08		1	0208-0395	803.93	394.56	282	63.94	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1984.4	B08		1	0209-0397	83.60	397.43	279	63.36	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3798.6	B08		1	0210-0404	36.94	403.87	278	63.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3029.8	B08		1	0211-0407	730.02	407.84	315	66.18	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1852.9	B08		1	0212-0408	843.73	407.57	293	64.18	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1187.7	B08		1	0213-0410	440.38	410.24	296	63.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1956.6	B08		1	0214-0410	550.82	411.36	275	66.43	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6855.0	B08		1	0215-0413	243.15	413.15	243	60.18	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3147.0	B08		1	0216-0413	516.77	413.09	281	62.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3330.8	B08		1	0217-0413	808.27	412.54	221	53.94	0.954
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1841.4	B08		1	0218-0414	919.87	414.30	185	55.60	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2401.0	B08		1	0219-0416	79.17	416.04	377	71.94	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2722.6	B08		1	0220-0418	163.55	418.03	252	61.36	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2161.2	B08		1	0221-0421	785.55	421.04	344	69.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2444.6	B08		1	0222-0422	409.14	422.85	249	63.01	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2699.4	B08		1	0223-0423	497.98	423.57	253	59.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4086.2	B08		1	0224-0424	532.48	424.18	237	58.04	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2428.0	B08		1	0225-0424	26.41	423.48	304	69.01	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5676.6	B08		1	0226-0426	354.97	425.99	314	67.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6443.0	B08		1	0227-0423	871.09	422.31	179	50.87	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5250.3	B08		1	0228-0427	250.22	427.44	230	57.70	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3497.1	B08		1	0229-0430	206.78	429.65	150	48.28	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5486.9	B08		1	0230-0433	719.33	433.69	222	55.70	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7452.4	B08		1	0231-0434	267.33	434.36	214	54.28	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3341.2	B08		1	0232-0437	480.58	437.58	240	60.18	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6974.4	B08		1	0233-0440	939.21	439.67	353	68.18	0.954
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6379.1	B08		1	0234-0439	609.39	439.19	305	65.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2209.5	B08		1	0235-0441	87.56	441.59	397	78.77	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5427.2	B08		1	0236-0444	313.31	444.10	226	55.60	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1152.2	B08		1	0237-0449	566.89	449.14	471	87.74	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2134.1	B08		1	0238-0447	895.02	446.89	305	64.18	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5464.6	B08		1	0239-0451	447.93	451.30	249	59.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4518.3	B08		1	0240-0452	203.76	451.83	338	69.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1397.8	B08		1	0241-0452	707.34	452.53	248	58.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			907.8	B08		1	0242-0455	138.82	455.82	272	61.11	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2239.2	B08		1	0243-0455	169.80	454.52	249	57.94	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1449.4	B08		1	0244-0455	764.11	454.42	229	57.60	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2915.7	B08		1	0245-0460	338.08	460.12	261	59.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2801.0	B08		1	0246-0458	522.70	457.57	260	71.36	0.642
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3127.7	B08		1	0247-0462	684.36	462.23	245	58.53	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			16866.4	B08		1	0248-0461	929.63	463.41	105	54.28	0.448
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3198.6	B08		1	0249-0463	266.08	463.29	234	56.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2068.8	B08		1	0250-0462	371.30	462.35	222	54.28	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2149.5	B08		1	0251-0465	192.92	465.25	236	56.77	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2266.2	B08		1	0252-0469	19.74	469.00	232	58.18	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2365.1	B08		1	0253-0468	56.76	468.68	245	59.70	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8821.6	B08		1	0254-0473	454.50	473.71	359	71.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1391.1	B08		1	0255-0471	784.17	470.63	284	63.01	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1662.3	B08		1	0256-0471	889.75	471.18	283	62.28	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			13604.0	B08		1	0257-0476	110.21	476.73	284	80.67	0.548
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4103.0	B08		1	0258-0477	231.35	477.52	324	67.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3041.3	B08		1	0259-0477	939.35	477.30	305	64.18	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			12655.0	B08		1	0260-0489	638.05	489.37	596	101.64	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2151.1	B08		1	0261-0485	756.79	486.02	376	71.84	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1481.1	B08		1	0262-0487	288.53	487.51	264	65.01	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3460.5	B08		1	0263-0486	314.59	485.45	245	59.94	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1346.0	B08		1	0264-0485	553.80	484.53	283	67.36	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2256.5	B08		1	0265-0484	369.54	483.67	268	64.28	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1610.2	B08		1	0266-0491	519.97	491.55	338	72.67	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3544.5	B08		1	0267-0497	99.83	497.16	370	71.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1639.7	B08		1	0268-0498	409.74	499.31	354	71.01	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1831.9	B08		1	0269-0498	872.62	499.24	184	54.18	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2389.1	B08		1	0270-0500	148.78	500.06	228	57.36	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1480.7	B08		1	0271-0503	468.71	503.63	320	68.43	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3825.0	B08		1	0272-0503	77.11	502.93	272	61.11	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1095.3	B08		1	0273-0505	268.93	504.90	270	68.43	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5056.9	B08		1	0274-0509	305.30	509.88	233	57.94	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5830.8	B08		1	0275-0517	207.07	517.49	344	71.01	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3983.7	B08		1	0276-0519	598.46	519.13	290	66.43	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3411.4	B08		1	0277-0518	854.85	517.24	228	61.11	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2576.3	B08		1	0278-0521	933.70	520.66	393	76.43	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3445.0	B08		1	0279-0520	166.61	520.71	241	58.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3105.8	B08		1	0280-0521	238.19	521.80	373	71.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1748.2	B08		1	0281-0521	411.27	521.04	435	79.26	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1559.2	B08		1	0282-0526	563.97	525.63	293	69.01	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2837.9	B08		1	0283-0522	34.32	522.15	220	58.77	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4244.2	B08		1	0284-0523	332.36	523.14	263	59.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2232.9	B08		1	0285-0523	894.77	523.05	222	57.94	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1773.3	B08		1	0286-0527	122.79	526.75	271	60.53	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			510.9	B08		1	0287-0530	535.34	531.28	286	74.67	0.645
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5562.3	B08		1	0288-0525	792.52	525.08	151	48.53	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4614.7	B08		1	0289-0529	377.36	529.29	221	54.53	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3069.8	B08		1	0290-0532	22.59	531.68	118	40.63	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6180.6	B08		1	0291-0534	849.54	533.57	281	64.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1384.8	B08		1	0292-0538	758.80	536.71	288	66.18	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6472.4	B08		1	0293-0538	190.19	539.06	304	68.43	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2196.0	B08		1	0294-0538	155.18	538.33	266	59.94	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1225.0	B08		1	0295-0540	274.52	540.55	302	67.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3485.4	B08		1	0296-0539	584.34	539.26	237	58.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3234.2	B08		1	0297-0541	34.95	541.02	186	53.11	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6771.3	B08		1	0298-0540	246.64	540.12	226	56.28	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2355.3	B08		1	0299-0540	619.66	540.31	228	56.28	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			9662.1	B08		1	0300-0546	430.62	546.55	216	53.70	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2956.1	B08		1	0301-0550	48.08	551.22	273	61.11	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2697.8	B08		1	0302-0555	646.66	554.99	394	76.43	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2095.2	B08		1	0303-0551	880.94	551.27	291	63.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6512.5	B08		1	0304-0553	813.38	553.13	188	52.53	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7682.6	B08		1	0305-0557	216.26	557.91	246	60.53	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5438.8	B08		1	0306-0557	115.55	556.04	350	73.01	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2249.7	B08		1	0307-0557	241.89	557.57	344	69.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2988.8	B08		1	0308-0559	407.13	559.18	323	69.01	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4343.6	B08		1	0309-0560	168.93	559.78	333	71.50	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2096.8	B08		1	0310-0556	922.23	556.72	246	58.87	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4912.1	B08		1	0311-0559	458.31	559.38	200	54.53	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3285.0	B08		1	0312-0561	942.12	561.30	280	61.70	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			877.9	B08		1	0313-0565	523.32	564.27	301	67.94	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1187.2	B08		1	0314-0566	762.34	565.33	293	71.50	0.720
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6978.8	B08		1	0315-0564	798.47	565.28	374	85.84	0.638
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4682.2	B08		1	0316-0567	437.78	566.43	249	59.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5519.1	B08		1	0317-0573	192.43	574.30	411	84.33	0.726
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1638.3	B08		1	0318-0569	601.57	568.93	289	69.26	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3376.9	B08		1	0319-0570	381.08	570.75	320	65.60	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4202.3	B08		1	0320-0576	233.09	576.66	252	63.36	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4740.3	B08		1	0321-0575	697.19	575.95	224	56.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2129.0	B08		1	0322-0580	545.77	580.03	344	71.60	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1842.8	B08		1	0323-0577	251.94	576.50	225	55.36	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2771.4	B08		1	0324-0581	58.38	582.52	240	63.60	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1338.3	B08		1	0325-0583	630.98	583.13	273	65.01	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1466.6	B08		1	0326-0585	565.54	585.96	451	83.01	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2313.3	B08		1	0327-0581	463.23	580.17	265	65.11	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6930.6	B08		1	0328-0585	265.66	585.19	263	65.01	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2472.8	B08		1	0329-0588	28.86	587.78	250	61.26	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5081.4	B08		1	0330-0593	115.61	594.13	357	70.18	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1354.6	B08		1	0331-0591	593.95	590.81	268	66.67	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3909.9	B08		1	0332-0591	143.19	591.45	241	57.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1884.7	B08		1	0333-0592	225.25	592.21	260	62.53	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1911.7	B08		1	0334-0594	384.87	594.79	297	66.18	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7431.2	B08		1	0335-0597	284.93	597.01	365	71.26	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4955.4	B08		1	0336-0594	674.84	594.10	229	56.53	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7870.7	B08		1	0337-0592	712.12	592.96	178	51.21	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2643.2	B08		1	0338-0605	414.43	604.17	293	66.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3090.9	B08		1	0339-0605	806.30	605.10	223	55.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4789.8	B08		1	0340-0607	592.13	607.88	231	55.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2631.8	B08		1	0341-0609	744.09	608.82	287	62.77	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1767.4	B08		1	0342-0611	273.89	611.90	251	60.77	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3399.0	B08		1	0343-0612	849.76	611.86	288	65.01	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3735.1	B08		1	0344-0613	153.75	612.82	195	55.36	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2861.1	B08		1	0345-0614	302.75	614.32	232	55.70	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4672.0	B08		1	0346-0616	76.07	616.27	260	59.94	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3678.3	B08		1	0347-0618	198.86	617.72	200	57.60	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4035.6	B08		1	0348-0616	901.75	616.17	251	59.94	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2489.2	B08		1	0349-0620	479.57	620.33	262	63.01	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5579.8	B08		1	0350-0619	681.57	619.71	274	61.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6166.3	B08		1	0351-0623	362.48	623.47	330	71.36	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1892.2	B08		1	0352-0630	892.17	629.37	254	61.01	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2941.4	B08		1	0353-0630	162.83	629.67	272	62.53	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2570.7	B08		1	0354-0629	806.37	629.13	187	53.70	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6974.5	B08		1	0355-0635	848.75	635.77	360	72.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1909.5	B08		1	0356-0634	489.75	634.91	317	71.84	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3174.7	B08		1	0357-0634	93.78	634.92	259	59.60	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3931.9	B08		1	0358-0636	243.32	636.51	374	72.67	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2564.5	B08		1	0359-0638	562.17	638.24	302	63.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2306.6	B08		1	0360-0642	508.02	640.75	239	59.60	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1745.5	B08		1	0361-0644	63.05	643.58	112	40.28	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2820.6	B08		1	0362-0644	693.93	644.85	228	56.87	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1857.5	B08		1	0363-0647	734.79	647.28	278	62.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2249.8	B08		1	0364-0650	783.99	651.00	192	58.53	0.704
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2368.5	B08		1	0365-0650	313.67	650.57	254	60.77	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1863.3	B08		1	0366-0649	401.23	648.55	262	61.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4346.5	B08		1	0367-0653	199.09	653.50	315	65.60	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1327.0	B08		1	0368-0653	447.88	652.57	345	68.77	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2327.7	B08		1	0369-0651	74.63	651.70	142	47.11	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7688.6	B08		1	0370-0663	237.20	663.32	593	97.98	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2680.0	B08		1	0371-0654	359.27	653.72	266	61.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1967.3	B08		1	0372-0659	46.25	659.41	273	61.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3678.5	B08		1	0373-0661	180.10	661.22	361	70.43	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2054.3	B08		1	0374-0661	327.81	660.85	284	63.01	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2223.8	B08		1	0375-0662	546.66	662.74	419	79.01	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1619.4	B08		1	0376-0664	121.03	664.38	276	64.18	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3210.7	B08		1	0377-0664	659.96	664.11	233	56.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3055.6	B08		1	0378-0665	939.18	664.58	280	64.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1999.9	B08		1	0379-0673	144.32	672.28	278	65.01	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			12718.7	B08		1	0380-0675	705.98	673.83	168	59.94	0.588
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2154.6	B08		1	0381-0680	166.68	679.72	399	75.84	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2884.7	B08		1	0382-0679	285.98	678.49	255	61.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1666.6	B08		1	0383-0685	536.72	684.90	266	62.53	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4774.4	B08		1	0384-0684	365.64	683.42	216	57.36	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5322.3	B08		1	0385-0685	615.32	684.80	227	56.28	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3494.7	B08		1	0386-0686	309.17	686.79	228	56.28	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1512.8	B08		1	0387-0688	428.60	688.45	236	58.53	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6223.5	B08		1	0388-0688	264.40	688.51	320	67.11	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			10042.6	B08		1	0389-0693	352.59	693.35	387	80.91	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7641.9	B08		1	0390-0688	916.93	687.99	140	47.11	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1719.5	B08		1	0391-0691	104.52	691.01	261	62.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1448.2	B08		1	0392-0693	133.18	692.16	261	63.70	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1318.8	B08		1	0393-0693	653.79	693.70	266	61.60	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			10207.8	B08		1	0394-0693	720.47	693.60	320	65.84	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2059.8	B08		1	0395-0697	50.81	697.15	422	77.26	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2109.5	B08		1	0396-0697	878.17	697.43	330	67.01	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			10549.6	B08		1	0397-0697	926.54	697.25	159	47.70	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4701.4	B08		1	0398-0698	944.56	697.57	170	51.11	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			790.6	B08		1	0399-0703	691.43	704.31	281	67.26	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2066.3	B08		1	0400-0706	315.64	706.08	250	63.01	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2939.1	B08		1	0401-0708	492.58	708.06	259	65.01	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1770.1	B08		1	0402-0710	415.79	710.17	212	52.87	0.953
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2197.6	B08		1	0403-0710	233.22	710.48	313	67.11	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5763.2	B08		2	0001-0029	259.68	29.83	527	96.57	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2602.4	B08		2	0002-0033	541.09	33.64	296	71.01	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5563.4	B08		2	0003-0034	151.54	34.40	223	55.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8167.3	B08		2	0004-0036	220.81	37.59	352	74.67	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3442.1	B08		2	0005-0036	793.54	36.16	268	61.11	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1272.0	B08		2	0006-0036	936.35	36.88	247	59.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3046.8	B08		2	0007-0038	126.12	39.14	253	58.53	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3774.4	B08		2	0008-0039	584.93	39.38	349	71.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6506.7	B08		2	0009-0042	767.09	42.65	281	62.53	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2475.3	B08		2	0010-0042	828.89	42.74	279	65.60	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1802.7	B08		2	0011-0049	53.05	49.74	437	85.26	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5562.2	B08		2	0012-0047	919.83	46.92	347	72.08	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2913.3	B08		2	0013-0046	639.79	45.79	330	68.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1372.4	B08		2	0014-0047	96.27	48.60	394	79.26	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			12111.3	B08		2	0015-0048	735.18	48.81	336	69.01	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2602.7	B08		2	0016-0061	412.86	62.80	586	130.95	0.429
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4352.5	B08		2	0017-0052	199.96	51.48	256	60.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5228.4	B08		2	0018-0058	900.74	58.85	226	57.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5119.8	B08		2	0019-0060	248.56	59.83	237	58.87	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2416.1	B08		2	0020-0067	388.09	66.98	509	92.33	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3116.4	B08		2	0021-0062	828.67	62.91	291	70.18	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1877.6	B08		2	0022-0068	511.07	68.64	316	64.53	0.954
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2959.0	B08		2	0023-0071	734.71	70.64	328	67.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4752.1	B08		2	0024-0068	932.37	68.17	302	64.53	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5548.7	B08		2	0025-0072	673.71	72.26	200	52.53	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3477.2	B08		2	0026-0078	847.67	78.25	315	66.18	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3109.2	B08		2	0027-0081	341.98	81.08	352	81.84	0.660
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2785.4	B08		2	0028-0086	225.89	85.71	231	56.53	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1595.2	B08		2	0029-0093	68.18	93.30	308	80.08	0.603
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2067.7	B08		2	0030-0090	920.38	89.70	417	77.50	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4565.0	B08		2	0031-0089	162.29	89.72	246	60.43	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5330.7	B08		2	0032-0093	563.27	93.05	241	57.70	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			13578.1	B08		2	0033-0096	697.39	95.95	324	66.43	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2848.2	B08		2	0034-0098	37.60	98.62	268	66.18	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2337.0	B08		2	0035-0097	782.11	98.03	395	73.26	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1834.7	B08		2	0036-0095	830.61	94.67	292	64.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2600.6	B08		2	0037-0095	141.99	95.57	298	73.26	0.698
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4458.9	B08		2	0038-0097	604.69	97.28	212	55.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1111.1	B08		2	0039-0102	647.74	101.72	272	61.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3657.0	B08		2	0040-0105	174.15	103.92	313	73.50	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3009.7	B08		2	0041-0104	294.08	103.98	338	70.18	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2668.2	B08		2	0042-0104	885.71	105.02	275	63.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4799.8	B08		2	0043-0114	713.14	113.75	286	61.94	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1497.3	B08		2	0044-0114	828.93	114.14	248	58.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2259.3	B08		2	0045-0119	450.89	118.43	288	67.01	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2454.5	B08		2	0046-0122	931.96	121.35	274	80.57	0.530
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3813.1	B08		2	0047-0123	516.32	123.01	286	63.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4172.3	B08		2	0048-0122	563.25	122.04	263	59.11	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1574.8	B08		2	0049-0128	97.77	128.00	262	60.53	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4432.9	B08		2	0050-0129	42.10	128.79	231	55.36	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2079.8	B08		2	0051-0128	207.62	128.42	259	59.60	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2243.3	B08		2	0052-0133	604.70	133.19	360	70.43	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1759.3	B08		2	0053-0130	759.25	130.71	251	58.18	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2714.5	B08		2	0054-0136	72.94	136.44	208	54.28	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4316.5	B08		2	0055-0137	550.32	136.78	274	61.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8864.9	B08		2	0056-0137	777.44	137.14	222	55.11	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			9602.6	B08		2	0057-0137	794.18	136.40	218	53.70	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1983.5	B08		2	0058-0145	727.37	145.32	444	78.18	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4765.2	B08		2	0059-0142	874.27	142.34	224	55.36	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3642.0	B08		2	0060-0144	934.42	143.85	249	58.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1388.3	B08		2	0061-0148	155.76	148.52	292	65.84	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4977.6	B08		2	0062-0149	33.25	149.15	222	54.77	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1833.6	B08		2	0063-0150	106.39	149.81	237	57.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2200.5	B08		2	0064-0155	200.80	155.72	393	73.60	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3449.8	B08		2	0065-0155	471.21	154.30	254	59.01	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4128.2	B08		2	0066-0154	558.32	154.44	292	63.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5686.9	B08		2	0067-0154	254.47	153.92	308	67.36	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1692.4	B08		2	0068-0160	620.04	160.01	404	74.43	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3890.2	B08		2	0069-0164	917.28	164.36	356	70.43	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4273.7	B08		2	0070-0164	175.67	164.23	215	55.36	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1324.5	B08		2	0071-0167	665.68	166.85	405	73.94	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1764.0	B08		2	0072-0167	497.26	168.27	252	60.53	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3264.6	B08		2	0073-0168	67.29	167.45	226	57.70	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3167.0	B08		2	0074-0170	262.45	170.60	324	66.18	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2825.2	B08		2	0075-0172	753.94	172.38	431	78.91	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1635.0	B08		2	0076-0173	146.52	173.59	272	67.01	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2294.9	B08		2	0077-0178	596.57	178.25	306	65.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			10128.7	B08		2	0078-0182	240.50	181.00	298	71.26	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2099.9	B08		2	0079-0182	734.11	182.39	234	58.53	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4503.6	B08		2	0080-0185	187.08	185.78	241	57.70	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1659.7	B08		2	0081-0186	122.92	186.07	343	74.67	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8073.2	B08		2	0082-0188	225.70	188.67	261	62.53	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1942.8	B08		2	0083-0191	677.56	192.15	364	71.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3126.4	B08		2	0084-0189	840.43	189.39	214	53.94	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2066.9	B08		2	0085-0194	563.06	194.27	385	72.18	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8371.0	B08		2	0086-0199	890.42	197.48	769	109.64	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4740.5	B08		2	0087-0193	258.30	193.27	200	52.77	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2196.3	B08		2	0088-0195	501.35	195.42	397	73.84	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4453.6	B08		2	0089-0203	329.23	203.08	327	67.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2455.8	B08		2	0090-0201	414.67	201.15	261	61.11	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3208.1	B08		2	0091-0203	943.10	202.94	298	63.36	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1691.2	B08		2	0092-0208	723.00	207.81	312	66.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1841.2	B08		2	0093-0208	386.86	207.98	248	58.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6976.6	B08		2	0094-0215	917.90	216.26	350	78.43	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2142.0	B08		2	0095-0213	164.52	213.57	360	71.01	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			12287.7	B08		2	0096-0210	456.56	209.86	212	53.60	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5080.9	B08		2	0097-0211	269.62	210.63	212	55.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1346.8	B08		2	0098-0211	832.42	210.58	239	59.70	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4213.8	B08		2	0099-0217	693.56	217.43	398	75.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2623.4	B08		2	0100-0214	756.57	214.54	358	71.01	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5520.8	B08		2	0101-0219	443.84	218.95	289	65.60	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2629.6	B08		2	0102-0222	496.94	222.16	260	62.77	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2460.4	B08		2	0103-0228	869.43	228.89	429	80.91	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1970.4	B08		2	0104-0228	674.85	228.32	255	59.94	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2637.9	B08		2	0105-0234	25.12	233.33	292	68.43	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8563.0	B08		2	0106-0234	179.97	233.59	273	62.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7514.7	B08		2	0107-0231	759.55	230.71	145	45.56	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7500.5	B08		2	0108-0232	746.58	232.09	152	44.63	0.959
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2737.1	B08		2	0109-0240	201.34	240.69	354	69.60	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3320.3	B08		2	0110-0242	934.14	243.11	233	57.70	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1514.5	B08		2	0111-0246	816.39	245.60	275	63.84	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3051.7	B08		2	0112-0247	365.66	247.19	372	74.91	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1311.6	B08		2	0113-0249	780.40	249.74	260	63.01	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3956.1	B08		2	0114-0249	297.44	249.34	298	63.36	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2339.7	B08		2	0115-0256	481.04	256.10	403	83.74	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4973.9	B08		2	0116-0254	250.33	253.89	294	62.18	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4032.0	B08		2	0117-0253	66.16	253.85	295	64.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5596.8	B08		2	0118-0252	126.71	252.34	209	53.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6988.0	B08		2	0119-0259	149.90	258.96	393	73.60	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			10857.6	B08		2	0120-0256	537.78	256.26	177	50.28	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			9050.3	B08		2	0121-0260	519.45	260.14	348	75.84	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3698.3	B08		2	0122-0259	871.05	259.54	336	67.94	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1639.1	B08		2	0123-0261	412.65	261.32	297	64.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3506.8	B08		2	0124-0260	934.80	260.40	352	73.94	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4480.7	B08		2	0125-0264	282.78	263.77	217	55.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1886.1	B08		2	0126-0264	376.20	263.74	338	74.08	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6105.9	B08		2	0127-0265	343.44	265.30	320	66.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3247.8	B08		2	0128-0269	75.62	269.45	217	57.36	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5953.4	B08		2	0129-0270	241.05	269.89	292	63.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1595.5	B08		2	0130-0273	432.94	273.97	335	74.43	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1284.8	B08		2	0131-0274	761.98	273.08	264	64.53	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2252.2	B08		2	0132-0271	195.98	272.06	227	57.11	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2159.8	B08		2	0133-0274	687.54	274.55	410	79.60	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5498.8	B08		2	0134-0275	830.69	275.44	266	59.94	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1762.2	B08		2	0135-0277	718.89	277.48	276	60.77	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3903.2	B08		2	0136-0281	935.66	281.24	230	56.28	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2212.9	B08		2	0137-0286	67.07	286.17	261	64.18	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6756.7	B08		2	0138-0280	280.48	280.84	127	40.97	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5011.6	B08		2	0139-0289	85.91	287.86	217	55.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8112.3	B08		2	0140-0289	152.32	289.26	336	71.84	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2390.4	B08		2	0141-0293	537.38	292.84	374	74.18	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3338.1	B08		2	0142-0292	678.60	291.79	270	61.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3075.3	B08		2	0143-0296	882.82	296.27	234	59.11	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7678.9	B08		2	0144-0293	280.31	292.82	140	42.63	0.968
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4826.7	B08		2	0145-0298	40.65	298.33	181	49.94	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8588.8	B08		2	0146-0298	168.05	298.25	178	50.04	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2124.5	B08		2	0147-0303	768.05	302.95	314	67.84	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1454.9	B08		2	0148-0306	818.96	306.25	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2578.1	B08		2	0149-0306	550.67	305.06	341	76.67	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2061.7	B08		2	0150-0306	208.60	307.31	266	62.53	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3470.1	B08		2	0151-0311	33.99	311.18	233	60.18	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3371.4	B08		2	0152-0309	289.20	309.28	199	53.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3552.6	B08		2	0153-0312	18.54	312.73	229	55.70	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3342.9	B08		2	0154-0314	258.62	313.18	237	56.77	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5961.3	B08		2	0155-0313	347.76	313.31	209	54.04	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7227.3	B08		2	0156-0312	363.62	311.97	194	53.46	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6113.0	B08		2	0157-0321	490.22	320.56	399	77.84	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3698.8	B08		2	0158-0323	747.11	323.03	315	69.60	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2931.6	B08		2	0159-0324	590.58	323.80	257	62.28	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3829.0	B08		2	0160-0325	105.60	325.09	308	65.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5612.4	B08		2	0161-0327	604.71	327.85	195	52.63	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2775.1	B08		2	0162-0330	370.30	330.08	241	59.36	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2411.6	B08		2	0163-0331	246.12	331.06	328	68.77	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3402.7	B08		2	0164-0335	620.25	335.80	228	57.94	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			11609.7	B08		2	0165-0338	914.11	337.65	337	69.26	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2215.2	B08		2	0166-0335	393.51	335.78	105	38.63	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6012.9	B08		2	0167-0337	227.09	336.83	153	45.11	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2712.3	B08		2	0168-0339	382.31	339.19	161	47.46	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2657.3	B08		2	0169-0342	57.86	342.30	285	70.77	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2237.8	B08		2	0170-0343	99.70	343.97	255	59.94	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2105.4	B08		2	0171-0346	464.96	346.86	304	68.77	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1708.9	B08		2	0172-0350	422.90	350.26	367	74.43	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1721.2	B08		2	0173-0355	124.11	355.02	258	62.67	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5063.4	B08		2	0174-0361	929.03	360.97	564	97.98	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1886.5	B08		2	0175-0356	543.50	355.84	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3844.5	B08		2	0176-0356	230.26	356.87	241	58.28	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2022.2	B08		2	0177-0359	656.85	359.38	304	65.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2906.2	B08		2	0178-0360	177.76	360.20	279	62.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			9240.1	B08		2	0179-0359	626.60	359.51	217	54.28	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1446.1	B08		2	0180-0362	749.40	362.25	293	65.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4545.6	B08		2	0181-0365	65.16	364.96	220	57.94	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1369.3	B08		2	0182-0361	295.52	360.80	227	58.87	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6713.7	B08		2	0183-0367	321.79	367.32	204	54.53	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2019.1	B08		2	0184-0372	494.01	372.56	361	73.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2685.1	B08		2	0185-0380	438.30	380.98	434	80.33	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1594.3	B08		2	0186-0377	680.65	377.04	328	67.70	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1245.1	B08		2	0187-0378	885.68	377.64	448	79.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4701.1	B08		2	0188-0377	155.27	378.24	193	51.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7815.6	B08		2	0189-0382	203.77	382.92	217	64.08	0.664
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3981.8	B08		2	0190-0383	47.43	383.61	293	65.84	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1210.5	B08		2	0191-0389	360.18	390.60	317	79.84	0.625
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2743.4	B08		2	0192-0383	725.92	383.52	256	62.28	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5529.9	B08		2	0193-0393	183.07	392.87	351	71.84	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8019.2	B08		2	0194-0395	779.94	395.27	248	57.36	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3374.9	B08		2	0195-0398	88.89	398.15	280	63.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5451.0	B08		2	0196-0404	140.56	404.60	305	65.36	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4528.8	B08		2	0197-0408	229.43	408.85	175	51.70	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			999.0	B08		2	0198-0413	464.92	411.27	358	79.84	0.706
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1046.0	B08		2	0199-0413	926.13	412.15	263	61.70	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5785.4	B08		2	0200-0412	870.18	412.74	200	51.70	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2183.9	B08		2	0201-0419	156.19	419.70	250	65.36	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2024.6	B08		2	0202-0419	668.32	417.98	380	76.67	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5037.8	B08		2	0203-0421	113.25	420.36	310	69.84	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			13385.7	B08		2	0204-0421	619.70	420.79	195	53.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1061.0	B08		2	0205-0422	731.26	421.55	354	80.91	0.680
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5812.2	B08		2	0206-0422	58.16	422.39	308	66.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1418.6	B08		2	0207-0424	694.88	425.02	328	69.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2264.5	B08		2	0208-0430	509.50	430.00	397	78.67	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2958.0	B08		2	0209-0430	238.31	430.70	262	64.43	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8095.2	B08		2	0210-0434	99.29	433.29	399	81.74	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3916.3	B08		2	0211-0432	192.14	432.66	306	64.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7549.5	B08		2	0212-0433	630.83	432.85	278	61.60	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1659.9	B08		2	0213-0434	768.89	433.81	220	57.46	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2053.8	B08		2	0214-0435	782.32	434.83	214	54.63	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2249.4	B08		2	0215-0442	809.55	442.16	233	61.11	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6862.8	B08		2	0216-0443	32.31	443.20	349	69.01	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1909.4	B08		2	0217-0446	937.21	447.18	437	81.26	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2991.4	B08		2	0218-0440	881.26	440.24	239	59.11	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1908.9	B08		2	0219-0442	399.14	441.87	294	65.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			13705.9	B08		2	0220-0443	117.82	442.56	192	53.11	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1952.5	B08		2	0221-0451	573.60	451.88	375	84.08	0.667
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2551.4	B08		2	0222-0455	172.70	455.66	538	97.15	0.716
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2900.2	B08		2	0223-0447	159.35	447.29	107	39.11	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2379.7	B08		2	0224-0452	504.40	453.06	294	70.43	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5360.7	B08		2	0225-0451	248.87	451.17	219	59.70	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2094.0	B08		2	0226-0460	434.28	461.51	361	74.91	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1911.2	B08		2	0227-0453	465.39	453.60	198	58.63	0.724
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3036.0	B08		2	0228-0457	762.01	457.02	269	63.36	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3613.4	B08		2	0229-0458	127.88	457.68	242	60.18	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4297.2	B08		2	0230-0458	310.68	458.39	250	59.11	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1761.7	B08		2	0231-0464	534.43	464.78	362	73.84	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			15934.3	B08		2	0232-0465	15.86	463.09	121	65.11	0.359
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1374.9	B08		2	0233-0469	221.42	470.41	351	69.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5159.7	B08		2	0234-0470	858.17	471.00	295	63.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6642.0	B08		2	0235-0474	776.93	473.51	149	46.87	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3062.7	B08		2	0236-0481	32.34	481.04	295	63.36	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2794.3	B08		2	0237-0480	596.84	479.91	259	59.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2682.7	B08		2	0238-0481	712.94	481.18	237	56.28	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5355.1	B08		2	0239-0481	811.78	481.81	243	57.36	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1812.1	B08		2	0240-0482	346.62	482.36	157	46.87	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2221.6	B08		2	0241-0485	334.30	485.46	209	58.04	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1238.1	B08		2	0242-0487	401.77	486.60	330	85.98	0.561
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6393.8	B08		2	0243-0484	794.52	484.85	134	44.04	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2339.6	B08		2	0244-0490	268.59	489.77	219	55.70	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1386.6	B08		2	0245-0495	739.34	495.18	514	90.91	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1586.7	B08		2	0246-0489	873.21	488.82	152	47.70	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2279.4	B08		2	0247-0496	912.94	496.14	442	88.57	0.708
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2297.4	B08		2	0248-0498	569.45	497.41	356	72.77	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1776.2	B08		2	0249-0496	153.46	496.54	305	63.36	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2377.4	B08		2	0250-0496	181.71	495.69	317	65.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3354.0	B08		2	0251-0495	689.16	495.01	254	63.36	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1723.1	B08		2	0252-0495	883.61	495.94	150	46.28	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2718.2	B08		2	0253-0508	654.92	508.22	408	73.94	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3521.6	B08		2	0254-0509	417.01	509.34	242	57.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1335.9	B08		2	0255-0512	221.16	512.13	295	65.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3683.1	B08		2	0256-0512	503.00	512.88	347	68.18	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1068.4	B08		2	0257-0517	108.91	517.87	304	71.26	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2181.1	B08		2	0258-0518	598.24	518.38	446	79.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4310.2	B08		2	0259-0519	266.95	518.57	261	62.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1791.4	B08		2	0260-0516	810.10	516.24	257	60.53	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3450.4	B08		2	0261-0516	901.90	515.64	216	56.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1642.9	B08		2	0262-0520	54.58	519.61	347	69.26	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4216.9	B08		2	0263-0517	693.80	518.29	260	60.28	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2417.4	B08		2	0264-0524	26.70	524.17	391	76.77	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3948.7	B08		2	0265-0524	292.11	523.96	313	66.18	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			841.0	B08		2	0266-0527	129.44	527.45	284	64.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4700.3	B08		2	0267-0528	464.51	528.09	334	68.08	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4233.5	B08		2	0268-0527	331.11	526.84	215	55.94	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1621.7	B08		2	0269-0529	767.18	529.22	288	65.11	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2116.1	B08		2	0270-0535	741.89	534.71	357	70.08	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1110.6	B08		2	0271-0534	170.99	534.05	301	68.77	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4641.8	B08		2	0272-0534	898.09	534.73	223	54.77	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3368.9	B08		2	0273-0537	371.82	537.32	366	71.01	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3643.4	B08		2	0274-0537	692.61	537.02	392	78.18	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4314.9	B08		2	0275-0539	311.64	538.90	281	63.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1775.1	B08		2	0276-0540	807.08	541.01	261	62.53	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2034.0	B08		2	0277-0547	92.38	547.24	225	55.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3813.6	B08		2	0278-0551	216.53	551.61	221	54.28	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4457.0	B08		2	0279-0554	258.15	553.87	246	59.11	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2065.2	B08		2	0280-0553	701.75	552.83	276	66.43	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3039.7	B08		2	0281-0560	189.67	560.55	376	75.36	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3070.1	B08		2	0282-0556	419.16	556.52	241	76.67	0.515
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3606.8	B08		2	0283-0557	573.40	556.84	232	56.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7215.6	B08		2	0284-0561	395.29	560.88	517	89.84	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2482.4	B08		2	0285-0557	489.28	557.20	298	73.60	0.691
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6589.2	B08		2	0286-0561	684.81	560.97	284	62.53	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2901.3	B08		2	0287-0563	53.34	564.04	254	64.77	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3421.7	B08		2	0288-0564	34.75	564.91	277	61.11	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1676.6	B08		2	0289-0564	800.42	563.66	262	62.43	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1737.1	B08		2	0290-0565	132.69	565.45	282	60.77	0.960
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5071.6	B08		2	0291-0569	298.45	569.75	305	66.77	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1495.2	B08		2	0292-0566	734.45	566.03	160	46.63	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2460.9	B08		2	0293-0572	546.80	572.13	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1033.9	B08		2	0294-0567	721.99	567.97	117	40.39	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4410.9	B08		2	0295-0569	337.10	569.57	268	62.77	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2169.4	B08		2	0296-0578	823.42	578.32	245	60.18	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2153.4	B08		2	0297-0576	861.26	576.46	224	58.77	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1855.5	B08		2	0298-0582	740.73	581.99	369	77.26	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1978.0	B08		2	0299-0583	563.98	583.98	248	59.46	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2344.0	B08		2	0300-0586	173.73	586.22	307	65.36	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3356.5	B08		2	0301-0583	658.97	583.84	245	57.11	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2178.7	B08		2	0302-0585	793.90	585.11	248	58.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1558.4	B08		2	0303-0590	227.90	590.27	281	63.11	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4678.2	B08		2	0304-0591	99.57	591.34	294	62.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2479.4	B08		2	0305-0593	505.03	593.37	339	69.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3380.0	B08		2	0306-0592	593.21	591.77	223	56.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2165.5	B08		2	0307-0597	133.78	597.69	338	71.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4238.1	B08		2	0308-0597	75.00	597.76	377	73.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1902.2	B08		2	0309-0598	764.49	598.03	268	61.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1728.6	B08		2	0310-0602	262.69	602.14	245	58.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1766.0	B08		2	0311-0603	370.78	603.27	328	68.53	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			9333.6	B08		2	0312-0610	883.28	609.88	539	91.15	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6602.6	B08		2	0313-0609	585.95	609.56	224	57.01	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1843.0	B08		2	0314-0613	841.15	613.76	411	79.26	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4790.0	B08		2	0315-0612	936.63	612.62	227	55.94	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1781.1	B08		2	0316-0617	288.69	617.92	377	74.77	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2704.7	B08		2	0317-0614	609.59	615.13	257	63.60	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2430.1	B08		2	0318-0620	799.21	619.85	258	64.28	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2363.7	B08		2	0319-0620	96.60	619.31	283	61.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3270.2	B08		2	0320-0622	162.75	622.53	248	60.28	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			11835.6	B08		2	0321-0633	664.99	632.93	460	84.43	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			10622.4	B08		2	0322-0636	342.57	636.72	552	91.50	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4926.5	B08		2	0323-0632	681.91	632.43	285	65.94	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2479.4	B08		2	0324-0636	909.48	635.73	392	75.84	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1699.5	B08		2	0325-0637	212.47	637.09	316	74.08	0.724
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1967.4	B08		2	0326-0639	419.96	639.41	505	90.57	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6291.2	B08		2	0327-0635	300.04	635.24	160	46.87	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7348.6	B08		2	0328-0634	311.80	633.78	111	39.56	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2794.1	B08		2	0329-0639	774.09	638.73	357	70.43	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1864.5	B08		2	0330-0640	47.64	639.90	268	61.01	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1766.2	B08		2	0331-0644	575.29	645.64	468	86.33	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1165.1	B08		2	0332-0637	497.09	637.30	111	40.04	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7186.1	B08		2	0333-0645	364.75	645.34	289	61.94	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1780.1	B08		2	0334-0652	503.38	652.97	353	73.01	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2105.4	B08		2	0335-0651	433.80	651.83	219	56.77	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3091.3	B08		2	0336-0656	474.14	655.54	417	82.91	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8191.9	B08		2	0337-0653	132.62	653.87	156	47.21	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4524.4	B08		2	0338-0660	148.53	660.75	228	58.53	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3041.4	B08		2	0339-0665	873.42	665.35	320	67.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3245.4	B08		2	0340-0664	794.21	664.84	230	54.77	0.964
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2937.0	B08		2	0341-0664	345.09	664.25	223	59.70	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3092.8	B08		2	0342-0668	31.79	668.05	280	65.60	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6655.7	B08		2	0343-0666	133.65	665.65	163	48.04	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2836.1	B08		2	0344-0673	488.29	673.97	375	76.77	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2483.0	B08		2	0345-0677	471.11	677.26	388	79.26	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2827.5	B08		2	0346-0674	676.26	675.27	352	69.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			567.1	B08		2	0347-0682	833.49	682.02	319	71.60	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1213.1	B08		2	0348-0681	177.91	682.12	282	64.43	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3102.9	B08		2	0349-0684	536.57	684.33	210	54.28	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6497.4	B08		2	0350-0684	270.18	683.97	243	59.11	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5097.1	B08		2	0351-0692	297.50	692.96	233	58.53	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3143.0	B08		2	0352-0688	897.09	688.15	191	53.94	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3539.1	B08		2	0353-0692	388.37	692.13	236	57.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2445.5	B08		2	0354-0695	559.28	695.50	349	71.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			994.1	B08		2	0355-0695	83.03	695.50	268	60.53	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2006.9	B08		2	0356-0697	649.23	697.13	455	80.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3088.0	B08		2	0357-0696	766.83	695.63	319	67.01	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			10316.9	B08		2	0358-0700	19.22	700.80	156	47.46	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1722.4	B08		2	0359-0704	105.76	704.14	283	68.08	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1854.6	B08		2	0360-0701	846.09	700.80	249	58.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3810.2	B08		2	0361-0702	620.75	701.43	199	53.11	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5079.7	B08		2	0362-0702	37.15	701.76	192	53.11	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1925.0	B08		2	0363-0704	937.46	703.67	299	63.84	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2014.1	B08		2	0364-0708	355.31	708.03	272	62.53	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5023.0	B08		2	0365-0708	207.17	708.01	325	66.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2947.9	B08		2	0366-0708	440.81	708.12	253	58.77	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2997.2	B08		2	0367-0710	121.34	709.93	207	56.53	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2398.6	B08		3	0001-0032	174.22	32.04	249	67.01	0.697
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1641.1	B08		3	0002-0031	771.20	30.98	281	63.11	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3337.0	B08		3	0003-0035	76.25	35.00	272	62.53	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1310.4	B08		3	0004-0037	608.80	37.00	478	85.15	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5209.4	B08		3	0005-0036	648.22	35.64	324	66.18	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1050.4	B08		3	0006-0041	489.76	40.64	488	83.98	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1022.7	B08		3	0007-0040	30.61	40.30	250	60.18	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2654.4	B08		3	0008-0043	704.69	44.35	231	60.87	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5230.0	B08		3	0009-0047	530.33	47.51	250	59.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4376.8	B08		3	0010-0054	456.56	54.71	277	61.36	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4745.1	B08		3	0011-0058	476.96	59.41	445	79.50	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6997.4	B08		3	0012-0058	93.16	59.16	330	67.36	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2812.0	B08		3	0013-0055	207.76	54.54	245	60.77	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1749.2	B08		3	0014-0057	753.82	57.12	256	65.70	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2694.0	B08		3	0015-0060	911.18	59.84	358	69.01	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3746.7	B08		3	0016-0062	426.79	61.94	262	59.84	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1294.7	B08		3	0017-0064	817.54	63.85	291	69.60	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3823.1	B08		3	0018-0062	151.02	62.27	218	57.36	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3963.7	B08		3	0019-0063	563.29	63.40	270	65.01	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5951.7	B08		3	0020-0064	397.98	64.32	303	69.70	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8010.4	B08		3	0021-0069	373.29	69.18	358	74.43	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4498.3	B08		3	0022-0070	444.27	70.30	315	71.01	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2033.9	B08		3	0023-0071	685.11	71.36	324	67.36	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4187.0	B08		3	0024-0071	26.79	71.61	292	63.94	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2731.5	B08		3	0025-0078	63.72	77.41	368	76.08	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2306.4	B08		3	0026-0077	152.86	78.01	324	68.18	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2263.7	B08		3	0027-0076	180.82	77.29	251	61.01	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2129.4	B08		3	0028-0084	869.55	83.92	383	84.18	0.679
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6149.6	B08		3	0029-0081	349.15	80.59	353	70.18	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3951.1	B08		3	0030-0079	97.96	78.72	198	53.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1681.2	B08		3	0031-0081	595.59	80.53	323	70.18	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4298.4	B08		3	0032-0080	291.88	80.04	261	59.60	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			673.5	B08		3	0033-0079	750.97	79.77	269	64.43	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5497.3	B08		3	0034-0082	330.41	82.15	181	54.63	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2444.3	B08		3	0035-0087	940.87	86.52	272	61.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6224.1	B08		3	0036-0088	373.60	88.65	217	53.36	0.958
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2741.5	B08		3	0037-0092	638.43	92.74	241	59.60	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6569.7	B08		3	0038-0091	398.46	91.50	215	55.36	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4542.6	B08		3	0039-0093	565.31	92.96	263	62.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1857.5	B08		3	0040-0098	497.76	98.43	517	84.08	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4040.3	B08		3	0041-0094	191.15	94.77	294	63.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2311.0	B08		3	0042-0099	838.70	99.71	305	67.36	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2408.9	B08		3	0043-0098	448.56	98.24	272	63.01	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4833.6	B08		3	0044-0099	241.85	98.73	246	58.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1264.7	B08		3	0045-0103	791.31	103.40	351	70.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3529.6	B08		3	0046-0107	332.07	106.69	355	72.18	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6073.7	B08		3	0047-0105	545.14	104.91	297	63.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2557.3	B08		3	0048-0109	816.08	108.63	189	55.36	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5003.2	B08		3	0049-0110	101.79	110.50	272	61.60	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4769.5	B08		3	0050-0111	216.70	110.96	304	65.01	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1812.9	B08		3	0051-0111	413.08	111.64	277	62.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5041.9	B08		3	0052-0114	920.64	114.63	335	66.77	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6764.3	B08		3	0053-0117	699.14	116.59	301	64.18	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3227.9	B08		3	0054-0123	493.78	122.81	262	60.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1854.0	B08		3	0055-0125	27.26	124.27	249	74.91	0.558
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2891.4	B08		3	0056-0124	546.77	125.24	276	65.01	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4601.9	B08		3	0057-0125	448.58	125.20	208	55.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7410.0	B08		3	0058-0133	739.38	133.47	362	84.67	0.635
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2331.0	B08		3	0059-0131	145.90	131.35	332	68.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6702.9	B08		3	0060-0134	207.45	132.73	501	95.74	0.687
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3082.3	B08		3	0061-0135	350.90	134.26	255	58.77	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2349.0	B08		3	0062-0136	872.25	136.23	326	66.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2470.9	B08		3	0063-0136	625.52	136.69	299	63.11	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			9631.8	B08		3	0064-0147	169.60	147.13	413	77.50	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3213.6	B08		3	0065-0144	487.88	143.45	271	61.60	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5149.9	B08		3	0066-0143	536.82	142.94	241	59.36	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			9244.2	B08		3	0067-0146	275.38	145.38	227	58.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3511.2	B08		3	0068-0147	28.95	147.38	243	58.18	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2377.3	B08		3	0069-0153	309.34	153.10	345	69.84	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			15181.3	B08		3	0070-0156	204.86	155.46	204	92.81	0.298
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2981.1	B08		3	0071-0156	387.05	156.20	257	60.53	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5286.0	B08		3	0072-0155	469.56	155.29	230	58.77	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1756.4	B08		3	0073-0154	646.67	152.89	117	43.11	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1128.8	B08		3	0074-0160	722.52	160.55	319	75.50	0.703
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2564.4	B08		3	0075-0159	637.21	159.56	218	57.60	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5041.5	B08		3	0076-0159	779.82	159.08	225	56.28	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1823.8	B08		3	0077-0162	914.86	162.86	346	71.84	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7346.4	B08		3	0078-0167	815.28	167.59	368	75.60	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5330.4	B08		3	0079-0169	271.03	171.52	394	86.33	0.664
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2743.4	B08		3	0080-0168	751.03	167.95	468	85.15	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4821.5	B08		3	0081-0169	186.94	169.00	201	54.53	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3202.3	B08		3	0082-0167	695.55	166.22	183	51.94	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2400.2	B08		3	0083-0170	509.31	169.78	270	61.94	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4738.7	B08		3	0084-0175	838.62	175.55	367	82.08	0.684
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5593.5	B08		3	0085-0171	483.51	171.08	214	55.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4348.5	B08		3	0086-0172	684.74	173.33	136	44.53	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2132.1	B08		3	0087-0178	314.28	178.44	403	76.33	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5666.9	B08		3	0088-0177	66.17	177.18	206	53.70	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6069.3	B08		3	0089-0177	102.73	176.82	203	53.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2520.7	B08		3	0090-0179	253.70	178.90	239	63.60	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2105.8	B08		3	0091-0179	554.12	179.02	349	69.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8117.0	B08		3	0092-0179	444.19	179.66	221	53.11	0.984
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3873.3	B08		3	0093-0183	621.51	182.60	365	70.18	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3017.1	B08		3	0094-0185	210.48	185.09	250	60.18	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2578.4	B08		3	0095-0190	876.28	190.12	404	75.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4690.1	B08		3	0096-0188	297.16	188.57	244	58.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6953.4	B08		3	0097-0188	370.51	188.18	292	67.60	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			11336.2	B08		3	0098-0188	48.45	188.21	160	46.87	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5547.2	B08		3	0099-0191	339.92	191.37	276	61.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3162.4	B08		3	0100-0196	594.81	196.46	314	68.18	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2463.3	B08		3	0101-0199	914.47	198.34	298	66.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2264.6	B08		3	0102-0199	146.75	199.92	273	65.84	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1992.1	B08		3	0103-0202	173.10	202.21	303	65.84	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7126.0	B08		3	0104-0201	280.82	200.74	205	55.11	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2973.8	B08		3	0105-0203	402.51	203.32	287	61.94	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			9107.0	B08		3	0106-0203	628.31	203.10	297	63.01	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5095.8	B08		3	0107-0204	366.33	204.23	184	51.11	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3235.1	B08		3	0108-0207	37.62	206.55	290	63.70	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3158.8	B08		3	0109-0207	893.74	207.76	249	60.43	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2425.1	B08		3	0110-0207	239.23	207.31	240	58.77	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1649.6	B08		3	0111-0208	948.07	208.67	267	60.43	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3171.4	B08		3	0112-0208	75.39	208.20	233	55.94	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1643.1	B08		3	0113-0209	551.99	209.65	257	59.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4427.5	B08		3	0114-0215	332.77	214.78	256	62.18	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3528.3	B08		3	0115-0220	115.19	220.15	386	74.43	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1953.4	B08		3	0116-0222	660.54	222.51	396	76.43	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2399.6	B08		3	0117-0219	850.80	219.39	168	53.36	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2989.4	B08		3	0118-0219	712.14	219.64	223	54.28	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2673.7	B08		3	0119-0221	286.32	222.07	258	61.01	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2422.7	B08		3	0120-0221	794.26	222.20	231	66.43	0.658
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6296.2	B08		3	0121-0224	354.14	224.73	337	69.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8315.5	B08		3	0122-0224	369.58	223.65	158	48.87	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3510.5	B08		3	0123-0227	613.88	227.23	233	58.28	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3838.1	B08		3	0124-0231	675.39	231.75	274	66.77	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7878.0	B08		3	0125-0237	219.89	236.54	310	68.18	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2777.7	B08		3	0126-0234	892.81	234.08	245	57.94	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2789.5	B08		3	0127-0238	828.42	238.70	314	66.18	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2042.2	B08		3	0128-0240	750.33	241.09	427	77.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2216.8	B08		3	0129-0243	411.02	244.58	306	68.18	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4074.2	B08		3	0130-0240	546.09	240.52	318	66.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			9360.7	B08		3	0131-0244	566.82	244.27	300	64.18	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3634.0	B08		3	0132-0242	609.87	242.66	240	57.11	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2494.1	B08		3	0133-0246	923.15	246.57	256	64.18	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3184.6	B08		3	0134-0246	28.55	246.73	236	58.04	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4054.5	B08		3	0135-0247	204.55	247.05	275	63.94	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1268.9	B08		3	0136-0246	363.41	246.31	316	80.08	0.619
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2308.9	B08		3	0137-0249	494.35	248.84	250	59.26	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3491.2	B08		3	0138-0250	706.94	250.18	191	58.77	0.695
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2446.6	B08		3	0139-0256	100.15	256.98	240	66.53	0.681
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6632.7	B08		3	0140-0254	524.48	253.29	231	58.77	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			12812.0	B08		3	0141-0252	723.12	252.69	191	51.11	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4502.8	B08		3	0142-0256	140.11	256.38	229	57.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3123.3	B08		3	0143-0257	158.04	257.32	212	57.36	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2501.5	B08		3	0144-0254	74.64	253.97	230	58.28	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3151.7	B08		3	0145-0256	307.56	255.86	206	54.28	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2449.2	B08		3	0146-0258	260.05	258.96	250	60.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2552.7	B08		3	0147-0265	589.80	263.58	278	65.94	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3472.7	B08		3	0148-0264	29.42	263.98	343	71.94	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2662.0	B08		3	0149-0269	464.95	269.24	284	64.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5346.9	B08		3	0150-0269	534.17	268.97	227	55.94	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4948.6	B08		3	0151-0271	775.21	271.35	302	65.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4309.0	B08		3	0152-0270	794.95	271.04	250	58.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1686.1	B08		3	0153-0275	631.78	274.75	307	69.60	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1634.8	B08		3	0154-0278	240.09	278.70	298	65.01	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5157.3	B08		3	0155-0278	841.64	278.32	175	52.18	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2173.4	B08		3	0156-0281	88.55	280.69	227	57.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3913.2	B08		3	0157-0279	735.63	279.66	312	67.01	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6136.3	B08		3	0158-0283	395.38	282.92	275	65.01	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2319.0	B08		3	0159-0286	274.36	287.66	322	67.60	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3894.7	B08		3	0160-0284	30.22	284.54	225	56.53	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2045.6	B08		3	0161-0286	122.17	287.01	279	63.60	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7980.2	B08		3	0162-0291	459.86	291.26	412	79.26	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5452.7	B08		3	0163-0287	941.61	287.60	362	71.60	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4014.9	B08		3	0164-0287	359.90	286.65	248	65.26	0.732
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3831.3	B08		3	0165-0289	160.78	289.29	255	58.53	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3593.9	B08		3	0166-0289	181.17	289.44	248	59.36	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3406.0	B08		3	0167-0292	833.48	292.34	404	76.67	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2958.1	B08		3	0168-0290	660.97	290.34	213	55.11	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3360.5	B08		3	0169-0292	813.19	291.83	258	64.18	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2418.0	B08		3	0170-0296	420.18	296.51	238	58.28	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2634.6	B08		3	0171-0295	676.56	294.96	235	58.28	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2550.0	B08		3	0172-0301	925.83	300.69	304	66.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2733.6	B08		3	0173-0301	883.05	301.44	343	68.43	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4124.5	B08		3	0174-0301	219.00	301.60	201	56.18	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3511.2	B08		3	0175-0309	106.17	309.78	331	67.84	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2745.0	B08		3	0176-0311	136.06	311.08	235	57.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1112.7	B08		3	0177-0315	459.87	315.36	306	67.84	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3987.2	B08		3	0178-0315	584.40	314.75	368	70.53	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3306.9	B08		3	0179-0316	734.41	316.36	369	73.84	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1635.5	B08		3	0180-0316	187.10	316.32	224	54.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3434.3	B08		3	0181-0318	254.15	318.24	231	57.94	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2526.0	B08		3	0182-0318	651.34	318.24	294	63.94	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2704.5	B08		3	0183-0323	410.89	322.62	364	73.84	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6183.5	B08		3	0184-0329	875.26	329.64	266	60.18	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3042.7	B08		3	0185-0328	286.92	328.69	215	53.70	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1187.4	B08		3	0186-0335	804.34	336.40	317	70.67	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			10469.7	B08		3	0187-0334	360.46	334.07	193	51.11	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2111.3	B08		3	0188-0335	387.43	335.21	269	61.36	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1197.8	B08		3	0189-0335	536.82	335.92	294	64.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4994.8	B08		3	0190-0335	204.81	335.14	228	55.11	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4113.3	B08		3	0191-0338	650.73	337.72	323	67.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4165.6	B08		3	0192-0339	346.72	339.63	174	52.28	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6384.6	B08		3	0193-0341	725.24	341.64	215	54.28	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6492.9	B08		3	0194-0346	243.63	345.99	277	63.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3340.9	B08		3	0195-0345	317.67	345.39	210	58.77	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2842.0	B08		3	0196-0343	107.28	343.76	273	64.18	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1463.2	B08		3	0197-0344	608.80	343.82	285	64.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3998.2	B08		3	0198-0353	291.95	352.69	379	72.43	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4731.2	B08		3	0199-0354	331.61	354.07	229	56.87	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4319.4	B08		3	0200-0355	425.40	355.58	273	62.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1735.6	B08		3	0201-0355	828.37	355.45	372	72.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			10025.3	B08		3	0202-0356	19.52	356.46	186	52.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2892.8	B08		3	0203-0358	179.96	357.71	224	55.70	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4968.7	B08		3	0204-0356	347.30	355.98	226	56.87	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4192.9	B08		3	0205-0356	452.60	356.90	253	59.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3548.1	B08		3	0206-0359	402.75	359.21	322	65.94	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3949.4	B08		3	0207-0355	684.95	355.37	203	55.70	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1628.6	B08		3	0208-0357	483.80	358.09	169	51.11	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8497.7	B08		3	0209-0358	112.39	358.32	148	45.46	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2553.1	B08		3	0210-0367	589.51	368.23	600	167.82	0.268
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4251.8	B08		3	0211-0365	513.79	364.74	343	70.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2956.5	B08		3	0212-0362	928.13	361.92	149	49.70	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2060.3	B08		3	0213-0365	165.18	365.39	230	59.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1658.8	B08		3	0214-0369	26.07	370.68	286	71.01	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4582.9	B08		3	0215-0367	315.45	367.37	307	66.43	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5514.4	B08		3	0216-0367	651.27	367.38	319	68.18	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3529.7	B08		3	0217-0371	910.25	370.76	309	70.43	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3495.7	B08		3	0218-0371	875.06	370.77	305	66.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2720.1	B08		3	0219-0371	374.83	371.79	255	60.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3374.4	B08		3	0220-0374	263.29	374.75	348	71.26	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3325.1	B08		3	0221-0377	712.73	377.14	273	63.36	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1607.7	B08		3	0222-0379	762.43	379.09	281	65.01	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2608.5	B08		3	0223-0379	841.85	379.72	226	58.77	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3403.4	B08		3	0224-0379	147.84	379.00	276	64.77	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2578.6	B08		3	0225-0383	54.65	383.69	298	68.18	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3466.6	B08		3	0226-0382	546.20	382.45	304	65.36	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5510.7	B08		3	0227-0383	352.41	382.21	226	57.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3232.2	B08		3	0228-0382	503.03	382.35	258	60.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2520.4	B08		3	0229-0382	89.21	382.66	219	53.70	0.954
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3476.5	B08		3	0230-0384	103.89	384.05	200	57.11	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8310.1	B08		3	0231-0384	685.58	384.47	259	60.28	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5591.4	B08		3	0232-0389	133.82	389.88	204	54.18	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4082.9	B08		3	0233-0392	335.87	392.05	229	61.11	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3013.1	B08		3	0234-0397	943.98	397.69	349	70.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1613.2	B08		3	0235-0396	248.74	396.06	266	64.77	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4803.4	B08		3	0236-0399	358.81	399.31	264	63.01	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1578.5	B08		3	0237-0396	400.64	395.69	284	70.77	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1863.7	B08		3	0238-0401	869.31	401.46	353	70.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4598.4	B08		3	0239-0399	477.95	398.80	152	47.46	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			12388.6	B08		3	0240-0400	688.60	398.59	162	49.70	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1716.3	B08		3	0241-0409	450.59	409.76	472	81.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			10853.3	B08		3	0242-0406	677.98	406.95	201	54.43	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1800.1	B08		3	0243-0410	59.30	410.76	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3761.4	B08		3	0244-0410	326.43	410.31	290	64.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2976.9	B08		3	0245-0411	187.48	411.62	229	59.01	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2619.1	B08		3	0246-0411	814.94	410.92	258	64.18	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2716.2	B08		3	0247-0413	918.78	412.65	255	61.01	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4611.7	B08		3	0248-0420	645.90	419.43	683	107.30	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2393.9	B08		3	0249-0418	594.22	418.68	419	80.33	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1578.4	B08		3	0250-0418	709.45	418.12	500	89.98	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			887.4	B08		3	0251-0416	20.37	415.64	244	59.36	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3278.8	B08		3	0252-0418	237.53	417.22	230	59.01	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2693.3	B08		3	0253-0418	369.35	417.47	296	64.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2818.2	B08		3	0254-0418	210.59	417.84	204	54.77	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2530.2	B08		3	0255-0419	164.81	418.96	326	69.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5171.6	B08		3	0256-0421	283.97	421.68	294	63.01	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4270.0	B08		3	0257-0425	308.25	424.38	257	60.53	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3335.1	B08		3	0258-0428	786.09	428.42	228	56.77	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2452.5	B08		3	0259-0425	862.34	425.22	116	41.21	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3314.7	B08		3	0260-0432	503.87	432.37	225	59.60	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1920.9	B08		3	0261-0435	408.07	435.04	291	69.60	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2592.3	B08		3	0262-0437	862.54	437.07	128	41.80	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2209.2	B08		3	0263-0442	807.62	442.76	329	75.26	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2672.3	B08		3	0264-0443	888.83	442.33	332	69.26	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4309.8	B08		3	0265-0443	531.39	443.83	328	67.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1950.1	B08		3	0266-0450	31.80	450.55	432	79.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1030.2	B08		3	0267-0449	933.81	450.02	256	61.11	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1817.8	B08		3	0268-0451	72.30	451.27	263	62.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4729.9	B08		3	0269-0453	371.01	453.85	319	68.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3272.1	B08		3	0270-0451	699.44	451.53	254	59.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1368.5	B08		3	0271-0455	185.28	455.49	283	65.01	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1074.2	B08		3	0272-0453	247.81	453.68	216	55.11	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1967.8	B08		3	0273-0455	748.33	454.75	174	50.63	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1945.7	B08		3	0274-0454	759.92	453.92	166	49.80	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5857.5	B08		3	0275-0454	508.66	454.74	219	59.36	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			14648.6	B08		3	0276-0459	681.14	458.94	406	74.67	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1950.4	B08		3	0277-0458	140.86	458.00	306	64.77	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2374.6	B08		3	0278-0458	447.06	457.61	270	62.18	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3129.7	B08		3	0279-0458	311.78	458.48	236	58.18	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4443.8	B08		3	0280-0461	92.82	461.21	289	63.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3702.5	B08		3	0281-0466	276.12	465.89	268	62.77	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2615.7	B08		3	0282-0466	422.12	466.59	247	57.94	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2373.0	B08		3	0283-0469	324.75	469.28	258	60.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3347.5	B08		3	0284-0469	295.54	469.85	274	61.94	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5262.3	B08		3	0285-0473	383.72	473.38	260	61.01	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2091.0	B08		3	0286-0472	836.60	472.36	236	57.11	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2926.8	B08		3	0287-0476	177.39	476.77	357	72.33	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4119.8	B08		3	0288-0474	697.65	474.06	246	57.94	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5223.6	B08		3	0289-0476	722.76	476.66	332	68.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3217.7	B08		3	0290-0475	259.18	475.33	251	59.70	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2971.8	B08		3	0291-0478	204.42	479.05	212	56.77	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1759.4	B08		3	0292-0480	771.22	479.94	365	75.01	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3641.2	B08		3	0293-0480	363.30	480.13	231	56.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3194.6	B08		3	0294-0480	560.68	479.96	209	59.46	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3483.3	B08		3	0295-0484	501.01	484.07	285	62.53	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1819.1	B08		3	0296-0487	51.52	486.82	251	61.70	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3572.1	B08		3	0297-0486	616.39	487.05	226	56.53	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8518.1	B08		3	0298-0487	342.67	487.35	238	57.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1808.8	B08		3	0299-0488	826.68	488.29	293	62.77	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3734.1	B08		3	0300-0490	596.29	489.20	265	63.60	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3813.1	B08		3	0301-0495	558.65	494.36	331	69.94	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6121.8	B08		3	0302-0502	582.49	500.85	221	60.77	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2057.0	B08		3	0303-0500	808.99	500.75	139	45.70	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1757.8	B08		3	0304-0506	271.95	507.29	292	65.36	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6111.1	B08		3	0305-0506	197.87	506.15	325	67.94	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5920.6	B08		3	0306-0504	326.24	504.30	201	54.53	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4965.2	B08		3	0307-0506	749.41	506.57	218	54.87	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4099.3	B08		3	0308-0512	233.99	511.86	404	77.84	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4524.6	B08		3	0309-0508	309.33	507.70	254	59.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3334.6	B08		3	0310-0512	409.95	512.07	328	68.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3325.5	B08		3	0311-0512	920.21	511.04	368	74.43	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1046.5	B08		3	0312-0511	945.71	510.79	299	69.01	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2520.3	B08		3	0313-0513	162.91	512.93	234	55.70	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			914.3	B08		3	0314-0519	641.88	518.69	471	82.08	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1738.7	B08		3	0315-0518	433.87	518.13	300	65.60	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1747.6	B08		3	0316-0515	807.92	515.37	204	53.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2162.7	B08		3	0317-0516	879.29	515.82	275	62.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2560.4	B08		3	0318-0520	468.34	519.83	387	74.18	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1948.9	B08		3	0319-0525	92.32	525.27	242	61.94	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2195.6	B08		3	0320-0528	892.42	527.57	242	59.94	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3078.2	B08		3	0321-0534	563.20	534.52	290	64.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2543.5	B08		3	0322-0538	930.82	537.99	358	70.43	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1497.1	B08		3	0323-0544	338.86	544.18	447	80.08	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3033.8	B08		3	0324-0543	615.93	543.94	313	68.87	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3005.3	B08		3	0325-0545	291.44	545.26	385	74.91	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5290.7	B08		3	0326-0543	687.91	543.10	258	62.43	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2479.0	B08		3	0327-0542	802.99	542.92	224	57.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3718.7	B08		3	0328-0547	65.80	547.79	283	70.53	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2256.7	B08		3	0329-0545	519.42	545.54	393	73.26	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1441.7	B08		3	0330-0548	752.79	547.78	327	67.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2958.0	B08		3	0331-0547	817.45	547.43	200	54.28	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2908.5	B08		3	0332-0555	168.11	555.12	253	58.53	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4817.8	B08		3	0333-0554	206.92	554.21	165	48.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4280.2	B08		3	0334-0557	241.60	557.24	219	55.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7810.2	B08		3	0335-0558	680.32	558.84	172	50.04	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4469.4	B08		3	0336-0560	260.65	560.75	258	60.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1508.3	B08		3	0337-0560	437.42	560.49	282	66.18	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6237.5	B08		3	0338-0561	383.72	561.24	199	52.28	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1602.9	B08		3	0339-0564	908.31	563.81	257	60.77	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5643.0	B08		3	0340-0563	362.71	562.57	209	53.11	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2616.7	B08		3	0341-0565	113.81	566.31	220	55.70	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1364.7	B08		3	0342-0563	560.33	563.84	161	49.21	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3107.2	B08		3	0343-0574	707.12	574.45	382	76.18	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5064.6	B08		3	0344-0567	729.32	567.42	211	56.87	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1373.7	B08		3	0345-0577	307.82	577.16	266	66.18	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3287.7	B08		3	0346-0574	484.36	573.74	284	64.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2374.7	B08		3	0347-0578	839.35	579.04	248	60.53	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1184.0	B08		3	0348-0574	557.43	574.80	134	51.70	0.630
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4505.3	B08		3	0349-0579	81.38	579.01	225	56.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2797.8	B08		3	0350-0583	166.37	583.62	332	67.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3319.7	B08		3	0351-0583	187.26	583.22	278	61.46	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2067.9	B08		3	0352-0587	388.61	587.01	346	70.91	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1490.6	B08		3	0353-0587	584.27	587.10	318	81.50	0.602
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7272.0	B08		3	0354-0584	877.49	584.68	133	42.87	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1878.7	B08		3	0355-0588	898.46	588.43	311	67.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3197.3	B08		3	0356-0589	350.30	589.33	209	55.94	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6286.8	B08		3	0357-0588	862.60	588.17	134	44.28	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1563.9	B08		3	0358-0597	844.23	597.76	370	74.67	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6676.4	B08		3	0359-0594	253.57	593.03	169	49.36	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3953.6	B08		3	0360-0595	633.32	595.37	269	61.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2333.8	B08		3	0361-0598	524.68	598.04	293	62.77	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2831.4	B08		3	0362-0599	764.00	599.49	279	73.50	0.649
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2300.3	B08		3	0363-0604	126.58	605.15	339	68.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7287.1	B08		3	0364-0601	263.36	601.01	180	52.77	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1530.2	B08		3	0365-0605	322.60	606.03	261	62.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1131.5	B08		3	0366-0602	426.77	602.43	267	62.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3262.5	B08		3	0367-0605	554.18	605.19	350	68.18	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6041.9	B08		3	0368-0603	687.74	604.19	132	42.39	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4127.0	B08		3	0369-0607	616.33	606.87	234	59.84	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2457.6	B08		3	0370-0609	487.93	608.84	297	66.43	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2468.8	B08		3	0371-0608	936.57	607.73	257	64.77	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1273.4	B08		3	0372-0614	411.37	614.44	324	66.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			923.2	B08		3	0373-0613	439.78	613.99	280	63.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3518.5	B08		3	0374-0611	721.30	611.18	193	58.77	0.702
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5034.0	B08		3	0375-0615	30.94	616.00	225	55.36	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2646.5	B08		3	0376-0618	339.28	617.59	279	61.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3484.3	B08		3	0377-0620	63.06	620.52	228	58.53	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6625.1	B08		3	0378-0621	692.34	620.81	285	66.53	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3734.8	B08		3	0379-0621	883.29	620.36	279	63.11	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2556.0	B08		3	0380-0623	179.48	623.20	323	67.01	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2938.8	B08		3	0381-0621	232.61	622.39	272	61.11	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1888.3	B08		3	0382-0622	299.86	622.00	314	67.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			10010.3	B08		3	0383-0621	263.45	621.84	183	52.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3748.3	B08		3	0384-0624	603.64	624.42	363	71.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2571.7	B08		3	0385-0625	751.75	625.19	266	63.11	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2607.9	B08		3	0386-0628	812.46	628.17	378	73.01	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4111.5	B08		3	0387-0628	276.37	628.67	229	57.70	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			11383.3	B08		3	0388-0628	556.75	628.93	195	53.46	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2006.1	B08		3	0389-0637	876.35	637.96	295	68.43	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3873.4	B08		3	0390-0637	771.26	636.84	209	55.70	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3905.6	B08		3	0391-0639	114.14	640.11	204	52.87	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2727.2	B08		3	0392-0642	350.54	642.19	281	64.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4096.3	B08		3	0393-0640	514.81	640.74	269	61.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2266.6	B08		3	0394-0643	895.73	643.48	375	73.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2129.1	B08		3	0395-0642	204.93	642.22	248	60.18	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4520.4	B08		3	0396-0640	164.94	640.47	181	51.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			9497.3	B08		3	0397-0642	556.40	641.47	162	48.63	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1725.9	B08		3	0398-0648	659.03	648.60	327	66.18	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5850.6	B08		3	0399-0653	247.53	653.51	371	75.01	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1350.3	B08		3	0400-0654	388.11	654.36	401	76.43	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3664.9	B08		3	0401-0651	946.17	650.54	275	62.53	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1161.0	B08		3	0402-0656	425.26	656.70	372	71.60	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3242.8	B08		3	0403-0657	713.38	657.91	343	69.26	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2143.5	B08		3	0404-0661	108.19	660.40	327	71.36	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3369.4	B08		3	0405-0660	620.19	659.78	295	64.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3825.1	B08		3	0406-0660	553.77	659.85	269	60.53	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2804.7	B08		3	0407-0660	898.74	660.46	275	66.18	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2069.7	B08		3	0408-0661	175.78	660.96	239	61.60	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2255.6	B08		3	0409-0663	830.21	663.20	256	62.18	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1830.5	B08		3	0410-0663	806.27	663.94	252	60.53	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2500.8	B08		3	0411-0669	321.28	668.18	225	57.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2397.7	B08		3	0412-0674	687.29	674.80	384	75.50	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1169.9	B08		3	0413-0673	473.43	673.39	270	61.11	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3175.0	B08		3	0414-0674	732.78	674.35	260	59.11	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2838.4	B08		3	0415-0675	339.94	674.90	231	57.36	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1064.7	B08		3	0416-0680	911.95	680.09	390	111.88	0.392
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4601.0	B08		3	0417-0678	44.44	677.83	235	60.43	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2187.4	B08		3	0418-0681	448.52	681.25	260	61.36	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4096.7	B08		3	0419-0681	250.43	681.15	231	56.53	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1884.0	B08		3	0420-0682	310.84	682.87	248	58.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3410.6	B08		3	0421-0681	600.75	681.92	187	55.46	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6580.5	B08		3	0422-0682	392.98	682.79	147	46.63	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1123.9	B08		3	0423-0691	70.94	690.67	280	73.84	0.645
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1412.9	B08		3	0424-0686	842.30	686.28	245	59.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3142.5	B08		3	0425-0688	171.82	688.70	240	58.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1635.1	B08		3	0426-0691	568.47	691.37	235	62.77	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4289.0	B08		3	0427-0690	817.05	690.09	266	62.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1138.5	B08		3	0428-0693	204.94	693.32	427	79.84	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5204.9	B08		3	0429-0690	520.23	689.89	241	58.53	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1803.3	B08		3	0430-0695	880.75	694.32	235	59.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2457.5	B08		3	0431-0696	240.36	695.66	237	57.60	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3263.6	B08		3	0432-0695	294.42	694.86	346	69.94	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			11148.8	B08		3	0433-0699	599.55	698.54	340	85.01	0.591
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1738.5	B08		3	0434-0697	389.64	697.22	344	71.84	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1656.2	B08		3	0435-0698	119.26	699.23	252	61.26	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2133.1	B08		3	0436-0707	31.70	707.18	300	66.08	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2510.3	B08		3	0437-0708	278.88	708.13	245	57.94	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5874.5	B08		4	0001-0025	601.39	24.22	237	57.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3200.1	B08		4	0002-0026	295.33	26.23	228	57.11	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1687.8	B08		4	0003-0028	414.67	27.91	247	60.53	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6392.5	B08		4	0004-0028	250.53	27.82	319	67.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			10932.1	B08		4	0005-0032	338.83	32.81	380	77.84	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1303.8	B08		4	0006-0030	90.85	30.14	263	62.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1036.6	B08		4	0007-0032	119.56	31.29	266	64.53	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1401.7	B08		4	0008-0032	639.87	33.10	275	62.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			10675.4	B08		4	0009-0033	706.63	33.30	326	67.26	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7582.8	B08		4	0010-0027	902.79	26.86	134	46.28	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2134.1	B08		4	0011-0036	37.02	36.05	423	77.26	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2319.8	B08		4	0012-0036	864.18	36.52	334	67.01	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			10858.2	B08		4	0013-0036	912.23	36.29	173	49.46	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5014.4	B08		4	0014-0037	930.80	36.59	178	52.28	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			858.2	B08		4	0015-0043	677.40	43.66	298	68.08	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2177.8	B08		4	0016-0045	301.85	45.54	255	63.01	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3283.8	B08		4	0017-0051	613.77	48.86	342	82.91	0.625
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1273.8	B08		4	0018-0051	75.69	51.44	486	82.08	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3619.8	B08		4	0019-0048	478.80	47.48	271	66.18	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3382.3	B08		4	0020-0047	936.14	47.06	211	59.36	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2142.3	B08		4	0021-0050	401.86	49.78	218	54.53	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2448.0	B08		4	0022-0050	219.40	49.85	318	68.18	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1821.0	B08		4	0023-0058	740.53	58.83	424	78.57	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5048.4	B08		4	0024-0055	14.62	55.08	250	63.36	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1901.7	B08		4	0025-0056	524.41	56.31	353	71.26	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1576.5	B08		4	0026-0058	888.84	59.06	392	75.01	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			11244.9	B08		4	0027-0060	161.25	60.71	268	70.18	0.684
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2938.6	B08		4	0028-0058	312.75	57.64	272	62.53	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2203.9	B08		4	0029-0060	712.81	59.97	208	60.18	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2301.0	B08		4	0030-0062	766.83	63.27	211	54.87	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2988.7	B08		4	0031-0067	475.75	67.22	283	62.28	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1608.4	B08		4	0032-0069	538.58	69.33	492	86.33	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1975.0	B08		4	0033-0067	812.44	67.35	244	59.01	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1585.1	B08		4	0034-0078	318.23	77.48	282	65.01	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5497.0	B08		4	0035-0080	447.27	80.88	269	61.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2257.2	B08		4	0036-0083	227.30	83.62	238	57.70	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3305.5	B08		4	0037-0088	414.50	87.90	319	68.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1616.0	B08		4	0038-0090	269.16	90.06	247	59.70	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2551.2	B08		4	0039-0091	381.61	91.52	302	64.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1200.8	B08		4	0040-0094	159.26	95.10	397	74.08	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1197.3	B08		4	0041-0092	54.99	92.34	244	59.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			12556.2	B08		4	0042-0093	914.93	93.62	295	64.53	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3155.9	B08		4	0043-0097	678.35	97.15	251	59.94	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2372.6	B08		4	0044-0100	209.86	100.34	241	57.11	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1711.3	B08		4	0045-0106	848.60	106.41	340	68.77	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1272.9	B08		4	0046-0104	798.65	103.91	138	47.21	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1219.0	B08		4	0047-0104	810.06	105.10	155	47.21	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2124.5	B08		4	0048-0109	245.63	109.06	236	56.53	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2071.5	B08		4	0049-0113	274.94	112.69	293	69.26	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1801.3	B08		4	0050-0111	326.72	110.87	297	65.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2784.6	B08		4	0051-0119	62.82	119.71	273	61.60	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1949.9	B08		4	0052-0123	742.79	123.25	327	67.94	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2790.1	B08		4	0053-0130	181.11	130.31	271	64.77	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2547.8	B08		4	0054-0129	601.27	129.58	255	63.60	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			13630.0	B08		4	0055-0131	483.49	131.95	328	116.47	0.304
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1640.7	B08		4	0056-0131	714.45	131.62	301	67.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2115.6	B08		4	0057-0133	237.78	133.58	318	66.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1964.1	B08		4	0058-0134	84.87	133.92	219	55.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3267.8	B08		4	0059-0139	381.43	139.74	258	60.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2244.4	B08		4	0060-0141	350.79	140.88	431	83.84	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6371.7	B08		4	0061-0143	205.07	142.99	327	77.50	0.684
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1186.1	B08		4	0062-0141	302.22	141.46	315	73.60	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2129.2	B08		4	0063-0146	540.29	146.95	291	68.77	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2228.1	B08		4	0064-0146	578.61	146.38	219	60.53	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2579.8	B08		4	0065-0146	858.94	145.96	342	69.26	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4367.6	B08		4	0066-0146	610.35	145.78	215	53.46	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4779.4	B08		4	0067-0146	690.83	146.41	168	48.63	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1838.7	B08		4	0068-0154	145.03	154.58	440	78.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4654.6	B08		4	0069-0150	766.39	150.31	307	64.18	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3157.9	B08		4	0070-0149	434.55	149.47	229	58.28	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2056.1	B08		4	0071-0150	941.52	150.18	274	63.11	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2161.0	B08		4	0072-0152	63.41	152.90	231	58.43	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2204.8	B08		4	0073-0154	235.64	154.02	260	59.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1415.4	B08		4	0074-0156	501.76	155.35	336	70.67	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2732.9	B08		4	0075-0157	85.02	157.84	241	57.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5511.5	B08		4	0076-0158	632.22	157.63	165	47.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2814.4	B08		4	0077-0159	100.79	159.94	187	50.63	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3448.2	B08		4	0078-0160	656.24	160.82	256	62.77	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1052.9	B08		4	0079-0170	22.33	169.11	241	60.28	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1845.0	B08		4	0080-0178	791.21	178.94	515	84.91	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2155.1	B08		4	0081-0181	448.03	180.50	247	63.26	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2328.2	B08		4	0082-0182	233.32	181.46	300	68.18	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1495.6	B08		4	0083-0180	310.78	180.92	232	56.28	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1995.5	B08		4	0084-0185	70.87	183.78	239	60.77	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2377.3	B08		4	0085-0186	549.29	186.57	365	70.67	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1189.5	B08		4	0086-0189	897.78	188.80	401	76.08	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3075.4	B08		4	0087-0189	670.54	188.33	240	58.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3897.2	B08		4	0088-0192	286.83	192.36	336	70.08	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4773.4	B08		4	0089-0193	616.47	193.71	205	55.11	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2387.0	B08		4	0090-0199	343.20	198.44	387	74.91	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1457.0	B08		4	0091-0197	474.47	197.98	279	62.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5964.8	B08		4	0092-0200	270.94	200.21	198	54.53	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3898.2	B08		4	0093-0201	515.72	200.27	291	64.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			957.0	B08		4	0094-0203	936.46	203.12	246	60.43	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			889.8	B08		4	0095-0209	22.00	209.14	321	76.18	0.695
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			13874.3	B08		4	0096-0205	578.42	204.94	380	71.36	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3420.9	B08		4	0097-0203	380.38	202.68	222	56.28	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4282.8	B08		4	0098-0204	131.18	204.17	215	55.94	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2382.4	B08		4	0099-0207	617.57	207.58	247	61.70	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5875.9	B08		4	0100-0214	706.96	213.52	297	64.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7153.2	B08		4	0101-0217	272.55	216.54	216	59.36	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1680.0	B08		4	0102-0218	120.50	218.74	275	64.53	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3628.1	B08		4	0103-0223	558.63	223.58	465	84.08	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4053.6	B08		4	0104-0220	86.17	220.59	199	52.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5349.8	B08		4	0105-0222	632.34	222.35	268	62.43	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2194.5	B08		4	0106-0223	422.80	223.32	251	59.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1889.1	B08		4	0107-0228	60.11	227.98	256	60.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3562.7	B08		4	0108-0226	587.53	226.41	257	59.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3789.5	B08		4	0109-0228	479.79	228.88	256	63.01	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2294.7	B08		4	0110-0231	242.52	231.78	371	74.18	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4642.0	B08		4	0111-0231	454.26	230.39	231	55.70	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2911.8	B08		4	0112-0240	795.06	239.85	337	68.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3777.4	B08		4	0113-0239	370.73	238.64	297	64.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			10079.9	B08		4	0114-0238	395.07	237.47	198	53.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3559.0	B08		4	0115-0238	31.13	238.21	231	57.36	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2159.5	B08		4	0116-0243	163.34	243.94	364	71.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4443.5	B08		4	0117-0242	542.80	242.93	185	55.46	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4753.3	B08		4	0118-0243	855.25	243.75	187	51.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4528.4	B08		4	0119-0246	261.20	246.46	213	54.53	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3924.8	B08		4	0120-0247	506.41	247.48	233	56.28	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3292.3	B08		4	0121-0253	424.23	252.69	261	61.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3325.7	B08		4	0122-0257	16.82	256.93	287	63.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3359.6	B08		4	0123-0259	587.93	260.00	252	65.01	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			12029.8	B08		4	0124-0255	869.18	255.90	154	73.74	0.356
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3878.1	B08		4	0125-0257	549.07	256.53	179	52.53	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2738.6	B08		4	0126-0259	820.99	259.13	215	56.53	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1749.9	B08		4	0127-0263	896.26	264.51	303	67.60	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5374.4	B08		4	0128-0265	370.12	264.64	226	55.70	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1475.6	B08		4	0129-0272	749.01	271.91	526	86.91	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2353.7	B08		4	0130-0270	108.85	270.49	342	69.60	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3647.2	B08		4	0131-0264	258.33	264.53	181	49.46	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			11619.0	B08		4	0132-0268	199.78	268.16	272	61.36	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8056.0	B08		4	0133-0266	434.03	266.36	181	50.04	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7570.2	B08		4	0134-0270	132.52	270.68	237	57.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			12152.1	B08		4	0135-0272	383.11	270.73	158	51.11	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3772.7	B08		4	0136-0275	601.91	274.79	252	59.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3984.5	B08		4	0137-0278	569.84	278.36	308	65.26	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3229.6	B08		4	0138-0278	50.14	278.38	250	59.11	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1948.6	B08		4	0139-0278	214.25	278.96	272	61.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7984.9	B08		4	0140-0278	396.04	277.77	240	59.60	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3757.7	B08		4	0141-0279	414.23	279.20	221	57.36	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2329.4	B08		4	0142-0287	479.47	286.64	258	61.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3615.9	B08		4	0143-0291	253.75	291.05	235	60.53	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4218.7	B08		4	0144-0290	556.80	290.27	231	61.01	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1591.5	B08		4	0145-0292	804.57	291.33	267	67.94	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2188.3	B08		4	0146-0293	833.47	292.81	236	57.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8016.6	B08		4	0147-0290	116.51	290.99	150	46.87	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6127.0	B08		4	0148-0291	134.88	291.50	224	54.28	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1721.2	B08		4	0149-0295	170.41	295.48	256	59.36	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6651.1	B08		4	0150-0300	79.90	299.71	377	73.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4402.2	B08		4	0151-0297	340.36	297.42	224	65.01	0.666
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2499.2	B08		4	0152-0306	848.96	306.04	363	70.43	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5770.1	B08		4	0153-0305	580.13	305.85	263	61.60	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2541.1	B08		4	0154-0306	266.38	306.65	255	63.70	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3280.7	B08		4	0155-0304	426.22	304.47	293	70.28	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2478.5	B08		4	0156-0308	771.97	308.78	268	61.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1863.8	B08		4	0157-0310	701.07	310.10	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2952.0	B08		4	0158-0314	241.79	314.07	223	55.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3197.4	B08		4	0159-0318	864.87	318.80	329	69.84	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4372.1	B08		4	0160-0316	426.73	316.36	194	54.87	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2278.0	B08		4	0161-0320	304.77	321.14	227	56.28	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4654.8	B08		4	0162-0327	383.06	326.66	361	74.53	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5753.7	B08		4	0163-0332	509.64	331.99	402	77.50	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1537.1	B08		4	0164-0335	204.03	334.75	270	60.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8005.0	B08		4	0165-0344	355.36	343.79	402	75.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2967.6	B08		4	0166-0339	57.70	339.44	229	57.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3464.9	B08		4	0167-0345	257.77	345.48	367	71.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3464.0	B08		4	0168-0348	683.97	347.91	269	62.18	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1468.9	B08		4	0169-0349	923.36	349.53	318	67.01	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1960.9	B08		4	0170-0350	306.71	349.98	262	60.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3824.4	B08		4	0171-0349	798.73	349.42	249	64.18	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5767.6	B08		4	0172-0354	856.66	353.38	287	62.43	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3358.9	B08		4	0173-0354	27.62	354.81	251	69.84	0.647
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2129.2	B08		4	0174-0361	69.30	360.62	363	70.77	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3386.7	B08		4	0175-0361	794.64	361.10	169	49.70	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5601.8	B08		4	0176-0366	871.02	366.20	355	72.18	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3080.7	B08		4	0177-0369	145.55	369.24	223	55.11	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1498.4	B08		4	0178-0381	287.82	381.21	479	88.33	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1384.8	B08		4	0179-0378	334.49	378.08	223	57.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1737.1	B08		4	0180-0384	670.09	383.67	289	64.18	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3565.9	B08		4	0181-0383	851.40	383.37	236	57.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2900.7	B08		4	0182-0383	917.72	383.24	299	64.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6269.1	B08		4	0183-0386	576.32	386.15	240	59.84	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7358.1	B08		4	0184-0387	418.73	387.11	311	64.18	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6556.3	B08		4	0185-0390	124.30	390.25	186	53.36	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1333.5	B08		4	0186-0394	365.20	394.49	281	66.67	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3635.5	B08		4	0187-0391	494.81	391.49	250	62.18	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3343.2	B08		4	0188-0398	183.49	398.08	301	66.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7214.3	B08		4	0189-0400	98.22	399.80	254	77.84	0.527
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5041.8	B08		4	0190-0400	135.37	401.02	223	54.77	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3051.3	B08		4	0191-0405	156.03	405.04	308	66.43	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6081.9	B08		4	0192-0408	821.50	408.19	249	62.77	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7408.4	B08		4	0193-0411	614.01	410.08	287	65.01	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7026.1	B08		4	0194-0410	649.13	410.07	302	67.01	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5490.9	B08		4	0195-0417	395.36	417.62	367	72.67	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1807.4	B08		4	0196-0415	479.20	415.09	240	58.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3861.7	B08		4	0197-0416	556.77	415.96	302	66.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3823.2	B08		4	0198-0417	942.83	416.70	256	59.11	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1816.9	B08		4	0199-0419	913.28	418.81	232	57.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3132.2	B08		4	0200-0427	43.01	427.15	337	67.36	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3193.4	B08		4	0201-0426	245.01	425.35	253	63.36	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8219.5	B08		4	0202-0432	322.69	431.90	417	78.08	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3052.9	B08		4	0203-0430	351.01	431.03	219	58.53	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2440.3	B08		4	0204-0437	619.88	438.32	364	82.43	0.673
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1452.9	B08		4	0205-0437	93.59	437.36	451	82.08	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1703.5	B08		4	0206-0436	698.93	436.19	371	71.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3202.1	B08		4	0207-0440	172.17	439.91	341	68.18	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1783.3	B08		4	0208-0441	829.11	440.75	250	61.11	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5411.2	B08		4	0209-0443	796.47	444.09	188	50.53	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2844.7	B08		4	0210-0449	400.15	449.28	231	57.11	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3341.5	B08		4	0211-0454	763.35	453.28	232	57.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1103.1	B08		4	0212-0458	906.67	457.70	363	71.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7623.2	B08		4	0213-0460	423.06	460.13	251	60.28	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2489.1	B08		4	0214-0461	634.10	461.13	243	57.11	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1573.2	B08		4	0215-0463	862.53	463.11	269	61.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3244.3	B08		4	0216-0465	240.80	466.18	243	59.60	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2126.6	B08		4	0217-0464	500.68	464.47	268	60.87	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6366.3	B08		4	0218-0465	736.76	464.94	140	46.04	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1573.1	B08		4	0219-0467	924.68	467.49	402	74.18	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3368.2	B08		4	0220-0465	106.92	465.57	237	58.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1164.8	B08		4	0221-0473	551.33	473.05	269	63.94	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			9831.6	B08		4	0222-0466	748.72	466.50	110	38.63	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5014.6	B08		4	0223-0472	41.64	471.90	337	70.43	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6450.0	B08		4	0224-0474	434.46	474.20	297	66.77	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6109.8	B08		4	0225-0476	573.17	476.07	272	62.53	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2643.7	B08		4	0226-0478	296.05	477.74	264	63.26	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6652.5	B08		4	0227-0477	587.41	477.46	213	54.63	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4085.7	B08		4	0228-0477	624.85	477.87	249	57.36	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1714.3	B08		4	0229-0478	773.47	478.74	248	62.43	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6189.6	B08		4	0230-0479	751.17	479.18	167	47.11	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1678.4	B08		4	0231-0481	825.06	480.57	285	64.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2258.6	B08		4	0232-0485	189.56	485.76	327	69.60	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2814.7	B08		4	0233-0485	165.66	485.49	220	53.94	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3676.3	B08		4	0234-0487	331.71	486.88	242	60.28	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3301.2	B08		4	0235-0487	404.26	487.00	244	60.53	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1832.0	B08		4	0236-0489	876.92	489.21	241	57.11	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3065.1	B08		4	0237-0487	97.63	488.05	206	58.53	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1322.2	B08		4	0238-0491	603.73	490.85	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2279.8	B08		4	0239-0491	674.89	490.66	282	62.43	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3268.0	B08		4	0240-0491	378.68	492.19	243	59.11	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5633.6	B08		4	0241-0496	123.05	495.88	287	63.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6819.9	B08		4	0242-0494	814.64	495.00	192	53.11	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1614.6	B08		4	0243-0502	713.55	501.65	378	75.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7837.6	B08		4	0244-0499	510.71	499.10	178	50.87	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			12209.5	B08		4	0245-0502	247.12	501.64	313	66.77	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1248.4	B08		4	0246-0503	465.57	503.07	296	69.36	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7465.6	B08		4	0247-0504	207.05	503.81	213	55.46	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4523.5	B08		4	0248-0505	317.37	506.23	205	58.87	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6421.5	B08		4	0249-0505	526.72	504.67	133	44.04	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2691.8	B08		4	0250-0509	893.48	509.56	256	58.53	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1248.0	B08		4	0251-0510	769.85	509.88	229	57.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2902.1	B08		4	0252-0515	912.53	515.34	272	63.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2688.3	B08		4	0253-0516	166.09	516.56	195	52.53	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4184.2	B08		4	0254-0519	324.07	518.57	206	56.53	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2637.5	B08		4	0255-0523	62.95	523.51	283	62.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5776.8	B08		4	0256-0521	408.93	520.60	252	59.01	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3790.1	B08		4	0257-0523	632.41	523.01	299	65.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3589.8	B08		4	0258-0524	349.28	523.74	255	61.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7502.0	B08		4	0259-0525	35.65	525.09	254	65.84	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1157.5	B08		4	0260-0525	667.34	525.91	286	66.43	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3698.7	B08		4	0261-0529	219.15	529.19	279	66.43	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4264.5	B08		4	0262-0527	823.19	526.28	182	51.11	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4390.1	B08		4	0263-0529	189.07	529.13	203	53.11	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1524.3	B08		4	0264-0535	305.67	536.40	353	71.94	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1997.9	B08		4	0265-0536	271.64	534.96	247	62.87	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			931.2	B08		4	0266-0538	853.41	538.09	256	62.43	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2071.8	B08		4	0267-0543	519.43	543.96	379	74.67	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2984.2	B08		4	0268-0543	462.46	543.84	146	47.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1384.9	B08		4	0269-0545	612.72	545.77	302	66.67	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3403.0	B08		4	0270-0546	483.70	546.75	285	67.60	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1447.9	B08		4	0271-0546	120.03	546.11	297	64.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1822.4	B08		4	0272-0551	386.36	551.34	382	75.50	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2450.9	B08		4	0273-0545	452.01	545.29	113	39.21	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4516.0	B08		4	0274-0549	826.28	549.64	208	55.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4651.8	B08		4	0275-0553	769.54	553.39	208	57.01	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1447.3	B08		4	0276-0553	896.29	553.02	252	59.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2415.8	B08		4	0277-0556	169.22	558.38	335	78.18	0.689
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2654.7	B08		4	0278-0552	257.75	552.29	134	46.04	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3417.8	B08		4	0279-0555	927.66	554.65	218	53.70	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2085.0	B08		4	0280-0562	695.36	561.59	340	69.84	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3357.7	B08		4	0281-0560	39.92	559.67	217	54.28	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1597.0	B08		4	0282-0559	792.50	558.57	225	55.94	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1986.1	B08		4	0283-0562	661.76	562.49	244	58.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2192.4	B08		4	0284-0566	442.11	565.66	250	59.11	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			11457.4	B08		4	0285-0571	626.34	571.54	350	72.91	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3100.1	B08		4	0286-0573	745.64	573.60	268	64.28	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6559.1	B08		4	0287-0579	202.08	578.90	254	59.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3256.9	B08		4	0288-0580	355.71	580.32	261	71.26	0.646
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2873.8	B08		4	0289-0578	55.91	579.20	240	59.11	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5126.2	B08		4	0290-0584	101.22	583.64	271	62.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2624.9	B08		4	0291-0587	896.46	587.20	239	57.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2753.2	B08		4	0292-0590	503.77	590.15	227	55.70	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			991.5	B08		4	0293-0593	414.11	594.58	329	71.01	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			896.4	B08		4	0294-0594	466.09	594.47	170	48.63	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5440.1	B08		4	0295-0595	631.79	594.98	228	56.28	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3884.6	B08		4	0296-0599	330.30	599.10	240	58.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2936.7	B08		4	0297-0600	878.35	600.18	225	56.87	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4321.2	B08		4	0298-0604	265.33	603.70	313	65.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1606.3	B08		4	0299-0605	521.43	604.79	295	64.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			12068.7	B08		4	0300-0603	612.33	602.58	160	46.87	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2153.1	B08		4	0301-0605	933.74	605.18	223	55.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1101.1	B08		4	0302-0606	483.26	606.68	184	53.36	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5214.8	B08		4	0303-0607	792.06	607.40	263	59.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3784.5	B08		4	0304-0610	238.36	610.41	227	56.28	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3543.1	B08		4	0305-0612	213.73	611.44	215	55.70	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			10815.7	B08		4	0306-0615	619.13	615.35	176	49.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1816.5	B08		4	0307-0622	857.02	622.48	252	59.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6151.4	B08		4	0308-0620	180.51	620.54	198	53.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1564.6	B08		4	0309-0621	647.58	621.74	256	60.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1746.7	B08		4	0310-0626	931.96	626.09	277	71.60	0.679
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3626.8	B08		4	0311-0627	369.29	627.77	272	62.18	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7325.6	B08		4	0312-0628	240.10	627.52	191	51.11	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2772.9	B08		4	0313-0631	112.43	631.22	295	62.77	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4143.9	B08		4	0314-0631	594.04	631.05	250	59.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2932.0	B08		4	0315-0634	396.37	634.05	245	61.60	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3272.9	B08		4	0316-0636	439.91	636.09	375	71.60	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2092.1	B08		4	0317-0638	518.47	638.36	294	65.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			14654.7	B08		4	0318-0638	851.28	638.87	219	54.87	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3302.4	B08		4	0319-0639	71.19	639.60	175	49.80	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4201.6	B08		4	0320-0643	355.90	642.50	300	67.50	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2551.6	B08		4	0321-0643	720.20	643.02	246	59.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2415.6	B08		4	0322-0650	276.52	648.14	493	95.50	0.679
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2631.4	B08		4	0323-0648	471.83	647.96	344	69.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2601.7	B08		4	0324-0643	623.44	642.89	206	61.36	0.688
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1183.2	B08		4	0325-0651	550.39	650.86	460	82.33	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5137.4	B08		4	0326-0649	751.38	649.17	248	62.53	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1612.7	B08		4	0327-0655	677.54	656.14	307	64.18	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3527.2	B08		4	0328-0657	92.49	656.86	234	56.28	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1786.5	B08		4	0329-0665	419.08	665.94	283	62.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3871.7	B08		4	0330-0665	464.09	665.02	258	60.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3054.8	B08		4	0331-0668	138.91	668.35	265	62.18	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3877.8	B08		4	0332-0670	579.98	670.48	218	55.70	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3139.8	B08		4	0333-0669	157.98	669.52	183	52.53	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3689.2	B08		4	0334-0677	304.96	677.31	383	75.01	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3838.3	B08		4	0335-0676	369.06	676.55	337	71.84	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4608.1	B08		4	0336-0676	106.14	676.43	226	57.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2989.0	B08		4	0337-0681	489.96	681.89	293	70.53	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2845.0	B08		4	0338-0679	219.54	679.54	244	57.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			16565.8	B08		4	0339-0682	439.59	681.45	316	65.60	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5439.4	B08		4	0340-0682	341.94	682.00	147	49.11	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4730.3	B08		4	0341-0686	771.81	686.37	246	59.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6113.9	B08		4	0342-0687	352.74	686.86	160	48.87	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1791.1	B08		4	0343-0689	66.90	688.40	228	58.28	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2013.6	B08		4	0344-0695	584.28	694.25	440	78.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3117.5	B08		4	0345-0693	190.14	693.68	257	58.77	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2493.6	B08		4	0346-0694	508.55	695.05	278	66.18	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6009.6	B08		4	0347-0699	91.54	698.54	186	51.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1094.5	B08		4	0348-0701	321.09	700.57	259	61.94	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2115.4	B08		4	0349-0701	852.08	700.68	243	63.01	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2135.9	B08		4	0350-0704	139.10	703.95	232	56.18	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			9740.9	B08		4	0351-0707	82.78	707.84	131	43.11	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5899.6	B08		4	0352-0709	249.40	709.38	245	58.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4469.5	B08		4	0353-0708	826.55	707.85	222	55.36	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5830.0	B08		5	0001-0030	295.53	30.88	233	58.53	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3069.0	B08		5	0002-0025	894.81	25.66	191	53.70	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			931.2	B08		5	0003-0032	81.20	32.85	281	64.43	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3992.6	B08		5	0004-0030	386.33	30.11	243	57.36	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2739.4	B08		5	0005-0033	557.30	33.38	357	71.01	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2327.4	B08		5	0006-0035	647.06	35.19	464	81.50	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3214.1	B08		5	0007-0034	764.63	33.50	320	66.43	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			11073.1	B08		5	0008-0038	17.47	38.56	167	48.28	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1939.3	B08		5	0009-0038	843.73	38.50	257	60.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1780.0	B08		5	0010-0042	103.70	41.70	286	67.01	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4491.1	B08		5	0011-0044	38.23	44.27	412	80.67	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4298.6	B08		5	0012-0040	618.67	39.46	201	53.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2067.5	B08		5	0013-0041	935.18	41.15	306	66.08	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5417.7	B08		5	0014-0045	205.15	45.67	328	68.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2450.8	B08		5	0015-0046	353.28	45.99	285	63.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3680.1	B08		5	0016-0046	438.62	46.09	260	60.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3208.0	B08		5	0017-0047	119.53	46.85	227	64.53	0.685
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3355.1	B08		5	0018-0053	699.81	51.11	402	85.50	0.691
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2652.3	B08		5	0019-0054	728.32	54.59	354	69.26	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2879.8	B08		5	0020-0053	890.76	53.19	218	61.84	0.716
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7156.9	B08		5	0021-0058	502.59	57.05	187	55.01	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2257.7	B08		5	0022-0061	125.53	61.72	186	57.60	0.705
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2959.9	B08		5	0023-0061	392.17	61.28	300	68.77	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2601.9	B08		5	0024-0063	865.42	63.69	284	63.36	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			10257.2	B08		5	0025-0063	445.32	62.52	211	55.11	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2125.6	B08		5	0026-0068	600.83	67.82	454	81.74	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3553.5	B08		5	0027-0065	641.80	65.14	294	62.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6251.6	B08		5	0028-0072	240.01	71.95	365	82.33	0.677
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4602.8	B08		5	0029-0078	458.41	79.37	349	74.67	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1732.4	B08		5	0030-0074	786.62	75.24	278	64.53	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1790.5	B08		5	0031-0083	537.97	83.52	521	87.84	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3620.6	B08		5	0032-0080	179.82	80.24	229	56.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2699.6	B08		5	0033-0081	307.41	81.64	241	59.36	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2288.9	B08		5	0034-0088	583.99	88.43	520	87.50	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2494.7	B08		5	0035-0088	146.95	87.66	229	58.53	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3273.5	B08		5	0036-0087	849.53	86.85	227	55.94	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1072.2	B08		5	0037-0091	693.33	91.22	257	63.60	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1344.9	B08		5	0038-0093	756.68	92.98	318	65.84	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1929.7	B08		5	0039-0093	325.58	92.74	406	75.60	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			12416.8	B08		5	0040-0095	19.60	95.63	297	63.70	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1534.5	B08		5	0041-0096	621.58	96.99	278	64.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2704.5	B08		5	0042-0096	919.57	96.30	211	53.11	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2939.9	B08		5	0043-0099	829.40	98.50	296	63.94	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3605.4	B08		5	0044-0098	366.33	98.06	223	56.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4944.7	B08		5	0045-0102	285.85	102.24	239	58.77	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1310.0	B08		5	0046-0102	477.28	102.34	344	72.43	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3620.7	B08		5	0047-0105	179.89	105.00	227	57.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4707.2	B08		5	0048-0104	387.49	104.30	273	63.36	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2600.6	B08		5	0049-0110	219.10	111.22	376	75.01	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2925.2	B08		5	0050-0115	432.47	114.86	232	56.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1744.4	B08		5	0051-0122	262.18	122.33	412	75.26	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3319.1	B08		5	0052-0121	613.89	121.83	356	69.60	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3670.3	B08		5	0053-0123	124.96	123.50	317	64.77	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3056.0	B08		5	0054-0127	499.69	125.98	329	73.01	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3124.8	B08		5	0055-0125	317.65	125.28	227	55.94	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2513.7	B08		5	0056-0131	934.50	130.73	378	75.50	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3541.8	B08		5	0057-0128	671.91	127.74	201	52.53	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3354.1	B08		5	0058-0129	98.76	129.47	303	69.36	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5112.0	B08		5	0059-0132	181.45	131.89	279	62.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3049.9	B08		5	0060-0135	445.04	135.96	391	73.26	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1396.2	B08		5	0061-0134	731.47	134.75	276	64.18	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1803.5	B08		5	0062-0138	792.76	138.55	261	59.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3712.7	B08		5	0063-0135	814.56	134.93	256	61.70	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3459.7	B08		5	0064-0142	529.19	142.32	257	60.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2481.6	B08		5	0065-0141	863.11	141.44	233	57.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1212.3	B08		5	0066-0142	911.83	142.77	267	63.60	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6441.6	B08		5	0067-0154	221.83	153.34	667	103.64	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4418.0	B08		5	0068-0147	339.76	146.34	344	69.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2595.2	B08		5	0069-0146	572.14	145.82	248	57.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2739.1	B08		5	0070-0147	654.58	147.15	297	64.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2694.4	B08		5	0071-0147	817.26	148.11	194	56.04	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3291.4	B08		5	0072-0149	362.62	149.64	258	63.11	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2431.4	B08		5	0073-0153	468.98	152.96	303	65.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2160.1	B08		5	0074-0152	46.23	152.22	276	62.53	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3694.5	B08		5	0075-0155	326.26	154.69	198	53.60	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5287.1	B08		5	0076-0158	131.27	157.77	294	64.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1842.1	B08		5	0077-0160	412.59	160.42	281	64.53	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2341.9	B08		5	0078-0159	860.83	159.21	240	58.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3426.4	B08		5	0079-0168	300.99	166.56	212	59.11	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1998.9	B08		5	0080-0169	563.53	168.26	300	72.43	0.719
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6838.7	B08		5	0081-0169	283.17	169.11	340	70.77	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2042.9	B08		5	0082-0170	520.66	170.02	368	70.43	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1615.5	B08		5	0083-0173	714.30	172.85	300	76.43	0.645
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3123.4	B08		5	0084-0176	599.34	175.96	280	65.94	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3433.6	B08		5	0085-0177	767.45	177.37	261	62.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5685.8	B08		5	0086-0183	297.78	183.35	207	53.70	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2903.1	B08		5	0087-0188	458.13	187.82	262	61.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7512.8	B08		5	0088-0186	827.90	186.74	189	55.36	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4930.0	B08		5	0089-0190	123.16	189.82	298	64.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4680.4	B08		5	0090-0189	743.36	189.75	238	57.70	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2743.6	B08		5	0091-0191	435.58	190.96	270	59.94	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1330.9	B08		5	0092-0192	688.43	191.92	324	67.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3064.2	B08		5	0093-0195	802.67	195.07	270	67.26	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2659.0	B08		5	0094-0197	379.86	197.12	323	66.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2343.9	B08		5	0095-0200	532.69	199.42	324	68.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4687.9	B08		5	0096-0199	294.42	199.07	185	53.11	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5557.5	B08		5	0097-0201	256.90	201.30	177	48.87	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4607.7	B08		5	0098-0202	489.30	202.45	295	62.77	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1203.6	B08		5	0099-0205	89.56	204.45	266	63.60	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1888.3	B08		5	0100-0202	599.49	200.85	172	53.70	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4786.7	B08		5	0101-0203	855.77	204.11	257	60.28	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			991.3	B08		5	0102-0205	41.27	205.25	244	59.60	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3309.1	B08		5	0103-0209	559.41	208.92	460	83.26	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6268.7	B08		5	0104-0209	818.71	209.27	352	69.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3103.6	B08		5	0105-0212	363.48	212.07	256	61.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2916.3	B08		5	0106-0207	608.13	207.61	120	42.28	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4499.1	B08		5	0107-0213	243.40	213.91	322	69.26	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2759.4	B08		5	0108-0216	625.16	216.59	319	66.18	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2213.1	B08		5	0109-0223	312.51	224.14	373	80.33	0.726
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4122.1	B08		5	0110-0221	154.93	221.42	238	57.70	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2161.6	B08		5	0111-0222	388.83	221.77	269	61.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3778.8	B08		5	0112-0224	462.43	223.48	257	59.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2018.1	B08		5	0113-0227	527.41	227.24	242	57.46	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8044.9	B08		5	0114-0231	138.45	230.97	229	55.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4809.0	B08		5	0115-0231	354.39	231.96	211	54.53	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7158.4	B08		5	0116-0235	717.67	234.91	391	75.01	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3305.6	B08		5	0117-0232	327.87	231.96	209	53.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1739.4	B08		5	0118-0233	485.95	233.10	274	61.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2819.2	B08		5	0119-0234	549.68	234.97	201	53.36	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1735.4	B08		5	0120-0236	920.16	237.33	301	67.84	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2868.0	B08		5	0121-0238	698.47	238.19	231	56.53	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1292.3	B08		5	0122-0243	786.65	243.09	305	70.43	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3210.4	B08		5	0123-0243	182.01	242.88	185	52.53	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1421.9	B08		5	0124-0247	806.30	247.73	346	69.01	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2174.7	B08		5	0125-0248	342.03	248.20	243	61.60	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3127.0	B08		5	0126-0246	747.93	245.72	211	53.70	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1420.3	B08		5	0127-0251	627.61	251.69	278	63.70	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3088.3	B08		5	0128-0251	839.54	251.41	302	67.01	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1411.5	B08		5	0129-0253	672.20	253.35	290	66.67	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1890.8	B08		5	0130-0255	416.23	254.89	359	69.60	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4123.0	B08		5	0131-0257	234.72	258.05	280	62.18	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3057.1	B08		5	0132-0258	926.87	258.22	304	65.01	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5821.9	B08		5	0133-0259	529.60	259.62	179	50.28	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2718.2	B08		5	0134-0263	370.21	262.63	206	54.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1686.2	B08		5	0135-0265	886.90	264.94	301	63.94	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2163.6	B08		5	0136-0267	603.02	266.82	234	57.94	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1721.0	B08		5	0137-0271	722.33	270.70	281	65.26	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			933.1	B08		5	0138-0274	788.48	273.86	302	64.67	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2337.4	B08		5	0139-0274	286.41	274.47	246	58.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2279.8	B08		5	0140-0275	578.73	274.92	399	75.84	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2026.5	B08		5	0141-0278	471.49	278.13	376	72.43	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1298.2	B08		5	0142-0279	763.35	279.52	327	70.77	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7693.5	B08		5	0143-0285	683.06	284.72	557	96.81	0.747
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2558.0	B08		5	0144-0283	157.84	283.31	270	62.28	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4241.7	B08		5	0145-0282	931.41	282.99	332	68.77	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1821.0	B08		5	0146-0285	305.08	285.40	281	66.43	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2192.4	B08		5	0147-0289	855.11	291.27	292	73.26	0.684
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1721.4	B08		5	0148-0292	652.58	292.68	293	64.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1579.7	B08		5	0149-0293	254.65	293.39	363	72.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4609.7	B08		5	0150-0292	351.44	291.95	169	50.53	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2114.5	B08		5	0151-0296	832.99	296.12	326	66.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2200.8	B08		5	0152-0301	386.36	301.03	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2514.4	B08		5	0153-0297	621.94	297.75	232	59.46	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2981.7	B08		5	0154-0306	946.53	306.29	208	58.53	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1639.7	B08		5	0155-0305	480.20	305.32	257	61.94	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4654.7	B08		5	0156-0306	344.77	306.66	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8395.0	B08		5	0157-0310	929.56	310.24	264	59.36	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1426.5	B08		5	0158-0311	743.22	311.03	377	73.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3454.3	B08		5	0159-0312	518.81	312.77	358	71.01	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2197.9	B08		5	0160-0319	431.69	319.49	278	62.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2570.9	B08		5	0161-0321	867.44	320.62	300	65.01	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4134.8	B08		5	0162-0322	603.54	321.53	290	64.77	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3904.3	B08		5	0163-0324	762.76	324.64	284	64.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1917.9	B08		5	0164-0324	697.15	324.25	312	65.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3941.6	B08		5	0165-0328	256.84	329.58	236	62.77	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2851.4	B08		5	0166-0330	903.78	330.83	318	65.94	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2600.8	B08		5	0167-0332	640.93	332.77	255	59.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2149.9	B08		5	0168-0334	385.47	335.14	313	70.43	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2057.6	B08		5	0169-0339	199.53	339.86	402	79.26	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5081.2	B08		5	0170-0337	336.46	336.80	347	68.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1539.9	B08		5	0171-0337	109.22	337.39	234	55.70	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4328.6	B08		5	0172-0341	728.54	341.60	301	64.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2781.6	B08		5	0173-0348	247.30	348.39	312	73.01	0.735
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2038.7	B08		5	0174-0347	518.90	347.95	266	61.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3337.5	B08		5	0175-0350	550.53	349.87	304	66.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1320.7	B08		5	0176-0351	28.14	351.54	308	65.01	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2380.1	B08		5	0177-0351	671.10	352.07	300	66.43	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2387.0	B08		5	0178-0351	288.63	351.57	242	57.36	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3568.6	B08		5	0179-0353	605.08	353.64	328	67.84	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2583.3	B08		5	0180-0350	388.40	350.64	213	55.70	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2825.7	B08		5	0181-0355	313.02	354.74	290	68.67	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1724.8	B08		5	0182-0363	367.52	363.21	367	73.74	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3292.3	B08		5	0183-0361	868.51	361.52	228	55.70	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1842.2	B08		5	0184-0364	481.68	364.53	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2063.2	B08		5	0185-0366	744.53	366.18	361	73.84	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2326.2	B08		5	0186-0370	155.81	369.80	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2922.2	B08		5	0187-0368	583.87	367.91	293	63.01	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1678.7	B08		5	0188-0369	793.88	369.56	267	62.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2408.9	B08		5	0189-0374	425.48	374.39	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1335.1	B08		5	0190-0376	815.09	375.59	267	71.01	0.665
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5907.5	B08		5	0191-0377	708.52	377.08	346	67.60	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2446.3	B08		5	0192-0379	228.04	379.25	321	67.60	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5977.3	B08		5	0193-0382	762.06	381.50	344	70.18	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2943.8	B08		5	0194-0384	331.51	384.50	264	59.94	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1737.0	B08		5	0195-0383	57.91	383.42	245	60.18	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2637.1	B08		5	0196-0384	638.43	383.82	173	55.36	0.709
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2703.6	B08		5	0197-0385	22.61	385.34	298	64.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1758.2	B08		5	0198-0387	437.65	386.44	260	61.70	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2766.2	B08		5	0199-0387	264.16	387.60	220	54.87	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1088.0	B08		5	0200-0388	941.49	389.46	247	73.26	0.578
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2450.1	B08		5	0201-0387	298.35	387.32	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5796.9	B08		5	0202-0388	545.48	388.10	243	57.70	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7454.2	B08		5	0203-0390	123.06	389.49	212	55.36	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3326.4	B08		5	0204-0390	474.10	389.95	175	51.36	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1289.8	B08		5	0205-0398	374.06	400.10	337	75.60	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2076.7	B08		5	0206-0399	415.64	399.44	436	78.33	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3659.9	B08		5	0207-0397	845.35	396.76	330	67.36	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1477.4	B08		5	0208-0396	924.48	396.26	284	64.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3218.1	B08		5	0209-0400	96.75	399.85	268	60.53	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4347.9	B08		5	0210-0400	184.98	400.23	329	68.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2362.9	B08		5	0211-0402	596.83	402.10	318	65.94	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5285.6	B08		5	0212-0400	767.01	400.97	234	57.11	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3049.7	B08		5	0213-0402	234.24	403.18	236	57.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1558.1	B08		5	0214-0405	880.80	404.72	302	65.84	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2237.3	B08		5	0215-0408	503.17	407.93	387	73.84	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6212.5	B08		5	0216-0412	850.68	411.78	215	55.70	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1428.0	B08		5	0217-0418	295.11	418.75	263	60.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2625.5	B08		5	0218-0417	753.99	417.39	295	65.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3764.2	B08		5	0219-0419	47.72	418.73	257	58.53	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2403.9	B08		5	0220-0418	264.96	418.82	253	58.77	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3247.4	B08		5	0221-0420	553.94	420.70	336	68.08	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1460.8	B08		5	0222-0421	18.23	420.86	230	57.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1643.6	B08		5	0223-0423	649.21	422.77	326	67.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3394.1	B08		5	0224-0419	716.50	418.66	237	59.36	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3062.7	B08		5	0225-0423	159.47	423.16	268	60.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3407.2	B08		5	0226-0425	207.15	424.76	172	50.63	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3505.4	B08		5	0227-0427	249.84	426.62	227	60.18	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			11103.9	B08		5	0228-0427	107.31	427.34	224	63.70	0.694
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			10948.3	B08		5	0229-0429	93.76	430.11	133	48.53	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3145.1	B08		5	0230-0431	771.38	430.11	262	61.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2359.8	B08		5	0231-0434	318.65	433.86	279	61.60	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2224.7	B08		5	0232-0436	825.71	436.90	333	77.26	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4094.5	B08		5	0233-0434	357.52	434.58	213	55.11	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6394.1	B08		5	0234-0436	338.58	436.41	238	56.77	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3136.4	B08		5	0235-0440	453.24	439.97	251	59.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6567.7	B08		5	0236-0440	716.10	440.61	294	67.01	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2578.7	B08		5	0237-0446	893.39	445.58	305	64.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2308.5	B08		5	0238-0446	397.03	446.42	252	59.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4521.8	B08		5	0239-0446	759.84	446.37	329	66.53	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2926.4	B08		5	0240-0453	613.76	454.39	375	73.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2249.0	B08		5	0241-0451	254.41	451.25	265	60.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6932.5	B08		5	0242-0449	646.18	449.41	106	40.04	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1183.1	B08		5	0243-0454	851.35	454.92	285	66.18	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3907.2	B08		5	0244-0454	459.56	455.29	210	58.53	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2480.6	B08		5	0245-0457	416.62	458.31	258	66.28	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2416.8	B08		5	0246-0459	474.40	458.61	271	62.04	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3070.4	B08		5	0247-0463	580.88	463.68	282	64.53	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3733.0	B08		5	0248-0462	679.75	461.14	229	58.77	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2857.0	B08		5	0249-0466	315.02	467.28	416	85.15	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6257.3	B08		5	0250-0466	340.97	464.47	322	79.84	0.635
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4118.5	B08		5	0251-0467	388.98	466.28	351	71.01	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7634.9	B08		5	0252-0464	512.97	464.52	247	58.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1367.5	B08		5	0253-0468	540.87	467.65	321	68.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6001.0	B08		5	0254-0468	712.10	468.59	270	61.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1296.3	B08		5	0255-0469	29.72	469.57	398	73.60	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2914.3	B08		5	0256-0469	164.99	469.79	233	57.94	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4267.4	B08		5	0257-0469	362.12	469.38	203	53.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3660.1	B08		5	0258-0469	881.30	468.81	265	61.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6057.5	B08		5	0259-0476	686.25	474.81	263	66.67	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6892.9	B08		5	0260-0473	210.69	474.10	179	51.11	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4662.8	B08		5	0261-0474	566.06	474.60	193	54.18	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4464.2	B08		5	0262-0477	259.90	477.08	208	61.01	0.702
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1644.7	B08		5	0263-0478	916.21	478.80	260	64.18	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8998.3	B08		5	0264-0484	226.41	484.79	327	75.50	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4808.1	B08		5	0265-0486	669.26	486.42	312	65.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2305.0	B08		5	0266-0487	312.59	487.82	276	63.01	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2302.8	B08		5	0267-0486	388.91	486.62	233	59.36	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4940.8	B08		5	0268-0486	560.86	485.82	117	40.28	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7518.6	B08		5	0269-0495	621.80	496.89	534	92.91	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7798.2	B08		5	0270-0491	782.00	491.75	311	66.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3717.1	B08		5	0271-0491	816.80	492.21	224	56.53	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3560.6	B08		5	0272-0493	248.22	493.46	176	48.87	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2396.3	B08		5	0273-0500	654.32	501.07	277	63.94	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3444.2	B08		5	0274-0503	300.62	504.45	260	62.77	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			9821.8	B08		5	0275-0506	798.25	505.60	326	70.53	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2491.6	B08		5	0276-0505	82.77	505.79	367	73.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5752.4	B08		5	0277-0504	208.16	504.19	201	51.94	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4986.6	B08		5	0278-0509	168.81	509.67	238	62.77	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4025.6	B08		5	0279-0509	454.85	508.90	311	65.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4465.0	B08		5	0280-0510	567.98	510.19	257	60.28	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3927.5	B08		5	0281-0508	251.51	507.81	140	46.39	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3875.2	B08		5	0282-0514	580.97	514.25	225	62.28	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1820.6	B08		5	0283-0513	947.71	513.22	271	60.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8446.5	B08		5	0284-0514	814.93	514.00	223	58.87	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3180.0	B08		5	0285-0515	766.65	516.13	269	60.28	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2875.5	B08		5	0286-0517	17.14	517.56	263	61.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5470.6	B08		5	0287-0518	185.06	519.87	257	64.77	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3685.6	B08		5	0288-0515	907.14	515.25	189	53.36	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2340.9	B08		5	0289-0520	851.89	519.62	257	59.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3736.6	B08		5	0290-0525	152.92	525.78	265	64.53	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4617.5	B08		5	0291-0523	500.45	522.77	313	65.01	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6564.7	B08		5	0292-0521	247.66	521.15	148	44.87	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2724.1	B08		5	0293-0526	310.58	526.06	250	61.36	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6612.0	B08		5	0294-0530	232.78	529.58	310	66.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6516.8	B08		5	0295-0528	699.51	528.23	219	54.87	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4878.8	B08		5	0296-0529	807.78	529.93	285	66.18	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5235.2	B08		5	0297-0529	602.50	528.81	243	57.36	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2768.5	B08		5	0298-0530	464.02	530.85	276	63.94	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4833.9	B08		5	0299-0535	526.23	535.26	278	62.53	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6389.5	B08		5	0300-0534	194.17	534.36	146	49.46	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1790.4	B08		5	0301-0537	631.59	536.87	273	62.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4695.3	B08		5	0302-0538	203.78	538.71	112	38.39	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2285.9	B08		5	0303-0541	943.14	542.26	251	61.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5517.3	B08		5	0304-0544	285.41	544.89	227	58.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4821.9	B08		5	0305-0542	66.73	542.40	222	54.53	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1809.6	B08		5	0306-0545	394.84	545.45	237	57.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5223.5	B08		5	0307-0547	416.32	546.55	299	65.60	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3291.8	B08		5	0308-0549	501.07	550.03	257	67.01	0.719
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2278.8	B08		5	0309-0548	914.84	547.20	322	67.60	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2009.3	B08		5	0310-0547	861.68	547.45	240	58.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2120.4	B08		5	0311-0550	333.81	549.73	238	60.43	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4328.2	B08		5	0312-0552	96.40	551.94	339	71.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6167.3	B08		5	0313-0550	271.40	550.14	145	47.70	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4033.8	B08		5	0314-0558	159.75	557.98	250	57.94	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3430.2	B08		5	0315-0557	32.26	556.67	214	53.70	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4036.4	B08		5	0316-0560	226.45	559.89	257	66.77	0.724
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1841.4	B08		5	0317-0563	884.68	563.30	252	60.53	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2488.8	B08		5	0318-0563	187.93	563.47	259	60.18	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1880.7	B08		5	0319-0566	488.24	566.76	425	80.43	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1594.5	B08		5	0320-0567	726.77	566.37	288	65.01	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5887.5	B08		5	0321-0570	782.32	570.74	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1478.2	B08		5	0322-0572	138.28	572.28	266	60.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1753.9	B08		5	0323-0577	605.38	577.36	304	65.01	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3975.9	B08		5	0324-0577	257.41	577.32	212	53.36	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2949.1	B08		5	0325-0584	826.31	584.13	267	61.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2985.0	B08		5	0326-0589	905.56	588.89	251	63.60	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4550.3	B08		5	0327-0591	303.02	590.39	204	53.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1692.1	B08		5	0328-0592	671.11	592.34	289	61.94	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1956.1	B08		5	0329-0594	218.77	593.42	285	65.01	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3764.3	B08		5	0330-0593	842.59	593.52	206	53.94	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4533.3	B08		5	0331-0597	890.09	598.13	215	55.70	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5530.1	B08		5	0332-0601	172.79	601.25	348	76.67	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3905.8	B08		5	0333-0602	495.55	601.80	263	59.60	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3646.9	B08		5	0334-0602	698.64	601.29	225	56.53	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2483.0	B08		5	0335-0605	348.19	605.29	285	67.50	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2189.0	B08		5	0336-0606	585.00	606.28	382	74.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2404.0	B08		5	0337-0607	38.14	607.31	229	58.18	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4966.9	B08		5	0338-0610	540.02	609.60	234	59.01	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2298.0	B08		5	0339-0610	417.90	610.62	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2075.3	B08		5	0340-0612	509.01	612.46	249	59.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3323.1	B08		5	0341-0611	793.96	611.55	308	64.77	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8468.9	B08		5	0342-0614	923.70	614.42	241	56.77	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5071.3	B08		5	0343-0616	320.44	616.36	299	65.26	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2768.0	B08		5	0344-0619	712.48	618.24	295	63.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6584.1	B08		5	0345-0621	215.75	620.77	456	88.91	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2316.5	B08		5	0346-0620	757.65	620.59	258	61.94	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4221.9	B08		5	0347-0622	453.10	622.06	232	56.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5144.6	B08		5	0348-0624	546.22	624.36	285	65.01	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4674.2	B08		5	0349-0623	174.39	622.87	236	56.53	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3130.6	B08		5	0350-0622	870.83	622.71	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2313.7	B08		5	0351-0628	605.87	627.99	397	76.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4213.6	B08		5	0352-0624	946.97	624.84	281	62.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1810.2	B08		5	0353-0628	36.42	628.14	277	72.43	0.664
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4836.2	B08		5	0354-0627	248.60	627.74	260	59.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6188.2	B08		5	0355-0629	830.24	628.84	222	63.26	0.697
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2705.5	B08		5	0356-0633	370.33	632.80	275	64.77	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2497.4	B08		5	0357-0636	408.74	635.45	333	70.18	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5162.2	B08		5	0358-0634	559.32	634.44	189	51.46	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2472.8	B08		5	0359-0638	768.63	638.12	249	61.11	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1327.1	B08		5	0360-0644	477.73	644.58	285	65.60	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3303.9	B08		5	0361-0646	141.04	646.00	238	58.53	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3500.4	B08		5	0362-0645	624.71	644.66	226	55.70	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2657.5	B08		5	0363-0648	565.94	648.44	244	60.53	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1341.7	B08		5	0364-0655	923.94	655.47	386	75.60	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3627.9	B08		5	0365-0654	227.52	653.58	294	63.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2168.6	B08		5	0366-0653	685.29	652.45	228	58.77	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1797.3	B08		5	0367-0655	855.20	655.65	287	62.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2509.0	B08		5	0368-0656	278.26	655.64	249	62.53	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3642.9	B08		5	0369-0655	514.61	654.75	228	56.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3806.8	B08		5	0370-0656	649.18	656.57	234	57.94	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1644.5	B08		5	0371-0656	726.71	655.54	244	57.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3188.9	B08		5	0372-0663	819.55	663.14	272	61.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2669.6	B08		5	0373-0663	156.97	663.83	233	57.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1949.8	B08		5	0374-0668	103.57	668.66	288	64.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2939.0	B08		5	0375-0668	297.00	668.30	230	56.77	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			9939.8	B08		5	0376-0676	637.78	676.57	328	67.94	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8842.3	B08		5	0377-0675	746.61	675.50	218	56.28	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3349.4	B08		5	0378-0673	784.03	672.98	198	54.53	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2433.2	B08		5	0379-0680	130.23	679.86	225	55.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1309.9	B08		5	0380-0681	352.98	681.85	262	60.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2689.1	B08		5	0381-0678	400.87	678.35	219	56.53	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1786.9	B08		5	0382-0680	564.26	680.36	266	60.18	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4182.9	B08		5	0383-0681	809.99	680.69	259	58.53	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1638.9	B08		5	0384-0681	260.11	680.66	242	61.11	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3112.8	B08		5	0385-0682	443.93	681.27	251	58.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1352.4	B08		5	0386-0681	518.84	681.30	267	61.94	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2025.0	B08		5	0387-0689	851.09	689.63	349	71.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1975.2	B08		5	0388-0685	944.31	685.34	228	57.11	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6095.5	B08		5	0389-0689	331.92	689.08	240	58.28	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4759.7	B08		5	0390-0688	175.30	688.12	233	61.60	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3949.3	B08		5	0391-0697	481.88	696.74	235	59.11	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2983.0	B08		5	0392-0696	499.67	696.24	222	59.36	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5568.9	B08		5	0393-0699	454.71	698.92	176	50.28	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2492.1	B08		5	0394-0702	763.55	701.67	360	71.84	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5746.8	B08		5	0395-0702	181.65	702.87	251	59.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3530.3	B08		5	0396-0704	832.21	704.19	334	67.60	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2108.7	B08		5	0397-0706	628.57	706.03	292	65.36	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2955.7	B08		5	0398-0707	607.56	708.06	218	56.28	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4782.4	B08		5	0399-0710	334.25	709.85	209	53.11	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3359.3	B08		5	0400-0711	275.53	711.28	216	59.70	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1768.8	B08		6	0001-0028	566.76	28.73	247	61.36	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1105.9	B08		6	0002-0030	203.14	30.57	437	79.26	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4591.0	B08		6	0003-0027	815.03	27.38	269	60.53	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5952.8	B08		6	0004-0028	518.48	27.57	250	59.94	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1895.7	B08		6	0005-0032	878.67	31.47	241	60.18	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2217.9	B08		6	0006-0034	238.40	33.37	239	58.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3472.4	B08		6	0007-0032	292.61	32.32	341	69.11	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8811.1	B08		6	0008-0042	603.48	42.80	661	124.71	0.534
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1834.6	B08		6	0009-0035	387.87	34.87	352	71.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1589.7	B08		6	0010-0036	117.52	36.42	257	60.77	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2178.4	B08		6	0011-0044	29.89	44.06	304	66.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3795.4	B08		6	0012-0047	136.17	48.47	208	63.36	0.651
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3423.8	B08		6	0013-0046	277.18	45.73	246	58.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1876.8	B08		6	0014-0048	920.08	48.74	236	58.53	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2377.6	B08		6	0015-0053	47.84	53.09	219	56.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1941.8	B08		6	0016-0057	391.41	57.27	229	56.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4215.8	B08		6	0017-0059	692.75	59.01	218	55.94	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4090.5	B08		6	0018-0062	852.91	61.86	412	77.50	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3362.9	B08		6	0019-0057	351.17	57.35	167	50.28	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4200.7	B08		6	0020-0061	204.10	61.84	226	55.94	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5562.2	B08		6	0021-0063	730.17	63.45	233	59.11	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1504.1	B08		6	0022-0064	498.72	63.16	245	69.01	0.646
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2807.6	B08		6	0023-0063	678.46	63.79	253	60.53	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4146.4	B08		6	0024-0062	800.33	61.85	244	58.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1019.3	B08		6	0025-0068	226.95	67.53	270	62.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5715.8	B08		6	0026-0066	278.84	66.39	246	60.18	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4626.0	B08		6	0027-0072	181.60	72.64	259	59.60	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4885.0	B08		6	0028-0073	303.97	72.75	142	50.87	0.690
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4330.0	B08		6	0029-0075	873.16	74.78	181	55.46	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1071.5	B08		6	0030-0077	137.57	77.45	281	70.77	0.705
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7217.4	B08		6	0031-0072	369.31	71.86	216	56.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4299.0	B08		6	0032-0074	93.35	74.42	277	66.18	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4669.3	B08		6	0033-0076	749.60	75.53	247	60.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3642.1	B08		6	0034-0074	828.53	75.12	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			913.7	B08		6	0035-0074	468.50	73.93	140	53.60	0.612
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6938.2	B08		6	0036-0075	887.21	74.53	157	46.28	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6296.3	B08		6	0037-0076	291.02	76.96	172	51.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3148.4	B08		6	0038-0078	326.11	77.87	206	53.11	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3858.7	B08		6	0039-0081	945.11	81.27	264	61.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1182.5	B08		6	0040-0083	475.33	83.97	171	69.50	0.445
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4665.9	B08		6	0041-0084	646.17	83.21	217	57.01	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3589.4	B08		6	0042-0084	782.09	84.02	216	62.43	0.697
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7834.0	B08		6	0043-0090	621.04	89.96	363	79.50	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3260.0	B08		6	0044-0090	264.22	90.64	234	58.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3062.4	B08		6	0045-0094	656.83	94.92	306	66.08	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8235.9	B08		6	0046-0095	382.88	95.30	152	47.46	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3127.7	B08		6	0047-0096	915.08	96.39	207	53.70	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4398.7	B08		6	0048-0101	758.37	101.39	211	57.46	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7590.7	B08		6	0049-0100	845.38	100.20	293	63.94	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2855.7	B08		6	0050-0102	96.53	102.95	297	64.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3107.8	B08		6	0051-0101	298.56	101.23	244	58.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2749.3	B08		6	0052-0100	798.87	100.66	225	56.28	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3032.3	B08		6	0053-0104	198.14	103.63	280	61.60	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2275.0	B08		6	0054-0103	877.50	103.52	247	58.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3247.2	B08		6	0055-0102	942.13	102.05	251	59.70	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8307.7	B08		6	0056-0107	744.36	107.67	162	47.21	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			13496.0	B08		6	0057-0108	391.85	108.59	153	45.46	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3191.5	B08		6	0058-0113	78.79	113.28	277	65.36	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4041.9	B08		6	0059-0113	242.98	113.41	218	53.70	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4163.4	B08		6	0060-0116	766.18	115.78	150	48.04	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4860.9	B08		6	0061-0116	804.17	116.51	207	54.28	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5241.8	B08		6	0062-0119	279.97	119.87	232	56.28	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4365.5	B08		6	0063-0123	914.69	123.08	259	61.01	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1562.8	B08		6	0064-0122	429.92	122.38	403	79.60	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4490.3	B08		6	0065-0128	842.71	127.97	474	112.37	0.472
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7028.0	B08		6	0066-0127	889.58	127.61	385	73.50	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5046.3	B08		6	0067-0125	389.34	124.73	336	69.36	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1426.1	B08		6	0068-0127	691.92	126.57	245	71.84	0.597
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3997.9	B08		6	0069-0127	175.41	127.89	218	53.36	0.962
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4826.5	B08		6	0070-0132	125.98	132.86	282	62.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2619.7	B08		6	0071-0134	29.09	133.61	376	76.08	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3091.3	B08		6	0072-0130	208.92	130.13	164	48.28	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			9133.7	B08		6	0073-0131	813.04	132.02	186	52.87	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1651.7	B08		6	0074-0133	355.82	133.13	343	67.94	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2095.9	B08		6	0075-0138	732.48	138.25	276	61.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1404.6	B08		6	0076-0144	149.47	145.45	274	73.60	0.636
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4855.1	B08		6	0077-0140	309.01	139.24	216	55.94	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2805.7	B08		6	0078-0143	196.39	143.48	203	56.28	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2742.9	B08		6	0079-0149	786.60	150.31	291	65.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2074.1	B08		6	0080-0150	386.37	149.85	275	60.77	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5972.8	B08		6	0081-0148	817.30	148.22	250	75.01	0.558
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5371.9	B08		6	0082-0150	946.96	149.91	242	58.18	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7443.4	B08		6	0083-0153	273.24	154.02	289	65.01	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2197.5	B08		6	0084-0155	131.09	155.52	247	59.01	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5326.0	B08		6	0085-0157	246.98	157.73	337	69.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2003.2	B08		6	0086-0158	457.24	158.53	339	68.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3015.8	B08		6	0087-0158	208.77	158.21	242	58.18	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2626.5	B08		6	0088-0166	49.73	166.25	354	70.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2545.7	B08		6	0089-0166	287.54	166.76	248	58.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1227.7	B08		6	0090-0175	870.84	175.38	381	75.26	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1399.2	B08		6	0091-0172	735.60	172.28	234	59.36	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2054.7	B08		6	0092-0175	835.95	175.10	250	57.94	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2750.7	B08		6	0093-0179	464.94	179.35	215	56.28	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3252.3	B08		6	0094-0179	190.45	179.29	343	71.36	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			686.5	B08		6	0095-0182	76.79	183.02	272	67.01	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			12960.2	B08		6	0096-0182	373.99	181.65	227	79.98	0.446
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3181.9	B08		6	0097-0181	690.04	180.83	277	62.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2534.9	B08		6	0098-0181	231.23	181.50	233	55.94	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4510.1	B08		6	0099-0183	917.64	183.66	167	53.60	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4867.9	B08		6	0100-0184	776.85	184.50	201	52.53	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3567.3	B08		6	0101-0185	758.74	184.56	217	53.36	0.958
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1391.1	B08		6	0102-0188	800.20	188.71	333	70.43	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2553.2	B08		6	0103-0190	397.97	190.57	256	61.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3305.7	B08		6	0104-0192	899.37	192.46	295	64.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6291.4	B08		6	0105-0200	108.71	200.14	359	70.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4123.4	B08		6	0106-0201	56.29	200.70	237	57.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3782.2	B08		6	0107-0200	681.99	201.10	237	62.18	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3326.9	B08		6	0108-0201	834.80	200.47	355	73.26	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2375.1	B08		6	0109-0203	176.64	202.27	263	66.18	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1385.2	B08		6	0110-0209	310.51	208.53	366	75.94	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3889.4	B08		6	0111-0209	472.29	209.39	215	55.94	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8134.4	B08		6	0112-0214	606.09	213.84	242	58.53	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4623.4	B08		6	0113-0214	818.32	214.27	239	57.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2090.0	B08		6	0114-0217	248.87	217.11	332	67.01	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4713.0	B08		6	0115-0217	500.00	216.60	186	49.94	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4762.0	B08		6	0116-0220	568.92	220.19	257	58.77	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3124.1	B08		6	0117-0224	726.78	223.78	320	67.60	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1669.9	B08		6	0118-0225	142.72	225.23	246	57.60	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2500.1	B08		6	0119-0226	234.60	227.06	200	53.70	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3086.7	B08		6	0120-0230	948.80	230.29	228	56.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4630.2	B08		6	0121-0228	659.39	227.78	153	49.80	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			9942.0	B08		6	0122-0236	910.61	235.65	274	68.43	0.735
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7972.8	B08		6	0123-0235	375.34	234.72	210	54.04	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3604.2	B08		6	0124-0234	790.33	235.13	163	49.36	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			12135.7	B08		6	0125-0238	896.97	238.66	203	60.77	0.691
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1604.4	B08		6	0126-0240	625.02	239.52	279	64.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1234.1	B08		6	0127-0246	178.90	245.48	428	85.50	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3134.5	B08		6	0128-0245	438.35	245.28	355	72.77	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2093.0	B08		6	0129-0245	646.48	243.67	266	67.60	0.732
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5477.0	B08		6	0130-0239	663.76	238.35	168	49.21	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4025.2	B08		6	0131-0243	67.63	243.52	213	56.28	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			9669.9	B08		6	0132-0247	486.91	246.95	253	64.18	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1532.6	B08		6	0133-0248	531.09	248.44	249	61.01	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1570.0	B08		6	0134-0251	417.01	250.38	212	58.77	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2226.3	B08		6	0135-0253	118.79	252.54	264	60.43	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2748.8	B08		6	0136-0252	675.65	252.20	285	64.53	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2355.6	B08		6	0137-0256	749.14	256.19	300	66.18	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6084.1	B08		6	0138-0253	368.01	252.98	164	51.11	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1691.4	B08		6	0139-0259	598.98	259.20	285	64.87	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4516.8	B08		6	0140-0256	824.76	255.95	217	56.77	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6550.3	B08		6	0141-0259	797.20	259.04	239	58.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2125.9	B08		6	0142-0261	21.52	261.09	298	65.01	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3017.3	B08		6	0143-0259	875.37	259.08	221	56.77	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1194.2	B08		6	0144-0261	553.37	260.39	166	60.18	0.576
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3445.1	B08		6	0145-0263	328.58	263.39	305	65.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4129.7	B08		6	0146-0265	465.15	265.36	291	63.11	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			9790.1	B08		6	0147-0271	68.92	272.53	363	108.23	0.389
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2445.5	B08		6	0148-0272	378.93	270.94	392	79.84	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8271.1	B08		6	0149-0267	850.10	267.54	159	47.70	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7729.4	B08		6	0150-0267	833.39	268.08	242	59.70	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2628.4	B08		6	0151-0270	502.39	270.25	255	61.11	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1905.3	B08		6	0152-0269	695.23	268.96	241	59.46	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1156.4	B08		6	0153-0274	150.00	273.10	270	66.43	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4180.0	B08		6	0154-0274	212.56	275.08	217	53.94	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			976.6	B08		6	0155-0272	548.82	271.76	128	44.87	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2068.0	B08		6	0156-0279	749.96	279.48	346	77.60	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3979.0	B08		6	0157-0284	596.70	283.79	306	64.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3383.5	B08		6	0158-0285	26.16	285.99	324	68.18	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4587.0	B08		6	0159-0287	859.77	287.10	212	55.36	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3986.0	B08		6	0160-0289	272.88	290.40	237	58.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5584.3	B08		6	0161-0300	476.24	299.32	489	97.88	0.641
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3961.4	B08		6	0162-0294	791.90	294.98	252	59.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1998.8	B08		6	0163-0297	932.42	297.09	289	64.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2437.4	B08		6	0164-0296	306.06	296.08	262	61.60	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3553.7	B08		6	0165-0298	403.47	297.49	312	65.60	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6381.7	B08		6	0166-0296	349.69	295.43	248	58.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3049.2	B08		6	0167-0295	433.52	295.30	274	64.77	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			9575.5	B08		6	0168-0305	645.39	304.40	304	64.18	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5113.6	B08		6	0169-0305	706.26	305.14	243	59.11	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6110.2	B08		6	0170-0313	93.83	312.17	329	85.50	0.566
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2394.7	B08		6	0171-0309	41.27	308.98	197	57.11	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8227.6	B08		6	0172-0306	730.39	305.71	220	55.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1004.4	B08		6	0173-0312	150.84	313.41	276	66.77	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7460.8	B08		6	0174-0313	24.52	313.16	261	59.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7060.2	B08		6	0175-0313	793.17	313.02	264	59.70	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2532.3	B08		6	0176-0315	439.81	316.01	212	55.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2572.5	B08		6	0177-0317	396.13	317.87	407	81.01	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3867.5	B08		6	0178-0318	545.03	318.51	318	65.01	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4475.6	B08		6	0179-0327	754.74	327.17	263	61.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			11471.6	B08		6	0180-0331	645.40	330.50	297	62.77	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6198.5	B08		6	0181-0334	491.61	334.18	219	55.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1899.2	B08		6	0182-0342	301.32	342.68	475	83.50	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3073.3	B08		6	0183-0340	61.74	339.55	158	51.11	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5828.0	B08		6	0184-0339	792.04	339.66	201	52.53	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2954.1	B08		6	0185-0342	72.89	343.66	231	63.11	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6254.5	B08		6	0186-0341	550.94	341.55	258	58.53	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2647.0	B08		6	0187-0345	938.04	345.64	413	76.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3847.4	B08		6	0188-0345	247.62	345.92	257	62.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4170.4	B08		6	0189-0345	736.76	345.12	222	56.18	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			11761.5	B08		6	0190-0352	915.67	352.18	387	81.01	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3735.5	B08		6	0191-0352	377.14	351.79	219	57.70	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5077.1	B08		6	0192-0351	498.07	351.01	213	53.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5861.9	B08		6	0193-0353	692.35	352.74	324	67.36	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4207.6	B08		6	0194-0357	364.46	357.85	224	56.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2812.3	B08		6	0195-0360	461.11	360.46	289	67.84	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7659.5	B08		6	0196-0361	649.92	360.91	230	56.53	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3865.6	B08		6	0197-0363	727.33	363.16	361	72.08	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4918.6	B08		6	0198-0362	812.22	361.84	247	58.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7461.3	B08		6	0199-0362	324.84	362.43	285	62.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3515.1	B08		6	0200-0364	433.33	364.31	205	53.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5675.4	B08		6	0201-0369	678.26	369.38	217	56.77	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6805.1	B08		6	0202-0376	638.40	376.92	207	56.18	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			9141.3	B08		6	0203-0372	911.90	372.84	164	47.21	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1846.6	B08		6	0204-0379	717.08	380.18	358	71.26	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1514.4	B08		6	0205-0383	151.22	382.57	305	66.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7634.5	B08		6	0206-0382	289.74	381.60	226	57.36	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1598.9	B08		6	0207-0386	890.49	386.72	261	61.84	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4096.2	B08		6	0208-0387	834.65	386.96	213	56.87	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2111.7	B08		6	0209-0390	82.98	390.33	240	58.77	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1214.8	B08		6	0210-0392	36.05	392.71	211	67.01	0.590
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1803.1	B08		6	0211-0392	183.93	392.40	256	60.53	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			9468.7	B08		6	0212-0392	298.98	391.86	144	51.01	0.695
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			889.3	B08		6	0213-0394	114.07	394.56	296	64.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3585.9	B08		6	0214-0394	281.33	394.54	232	57.11	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6776.0	B08		6	0215-0394	412.94	394.12	236	58.18	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3808.9	B08		6	0216-0397	433.84	396.77	302	64.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3137.2	B08		6	0217-0397	808.95	397.53	287	63.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1000.3	B08		6	0218-0399	16.41	398.13	187	55.36	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			10955.8	B08		6	0219-0397	306.38	397.19	106	41.46	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3883.1	B08		6	0220-0401	566.73	401.12	273	61.60	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3369.5	B08		6	0221-0400	702.01	399.92	259	60.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1538.2	B08		6	0222-0402	262.75	402.44	261	59.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1865.0	B08		6	0223-0402	896.29	402.41	262	64.28	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			9775.3	B08		6	0224-0402	917.05	402.60	176	50.53	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2027.9	B08		6	0225-0402	210.70	402.36	213	55.46	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6030.3	B08		6	0226-0406	634.54	405.98	182	52.53	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4274.4	B08		6	0227-0407	617.53	407.50	242	58.04	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6098.5	B08		6	0228-0410	844.46	410.10	232	59.11	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6272.5	B08		6	0229-0414	863.80	414.11	264	61.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4273.0	B08		6	0230-0419	316.94	419.35	384	73.50	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3392.1	B08		6	0231-0416	247.34	416.66	321	66.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4684.6	B08		6	0232-0418	543.53	418.25	242	59.36	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2259.7	B08		6	0233-0420	160.59	420.35	351	71.84	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2149.0	B08		6	0234-0420	689.89	420.40	331	71.01	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7387.9	B08		6	0235-0417	919.49	417.35	174	48.04	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3967.6	B08		6	0236-0420	650.08	420.06	260	61.36	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2492.1	B08		6	0237-0424	349.77	424.67	239	59.84	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4112.9	B08		6	0238-0422	529.94	422.92	197	54.28	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1785.3	B08		6	0239-0422	766.88	421.56	159	53.94	0.687
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4716.1	B08		6	0240-0430	842.47	430.45	339	69.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1639.8	B08		6	0241-0430	118.40	430.35	258	61.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3125.8	B08		6	0242-0431	611.93	431.41	318	67.01	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6940.2	B08		6	0243-0431	914.42	431.01	211	57.36	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5536.6	B08		6	0244-0432	934.62	432.12	214	58.53	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2014.8	B08		6	0245-0435	49.57	435.67	253	58.28	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1496.5	B08		6	0246-0432	771.14	431.83	128	51.70	0.602
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8795.3	B08		6	0247-0434	896.37	433.69	188	51.94	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6437.5	B08		6	0248-0443	875.29	443.91	144	50.53	0.709
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2388.4	B08		6	0249-0443	261.47	443.67	254	59.11	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3302.6	B08		6	0250-0444	558.68	443.73	283	64.53	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2236.4	B08		6	0251-0449	448.25	449.72	290	66.77	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4027.0	B08		6	0252-0448	228.27	448.43	318	67.94	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8291.1	B08		6	0253-0454	590.24	454.84	417	75.01	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2656.0	B08		6	0254-0455	50.24	454.70	312	65.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4497.5	B08		6	0255-0452	174.21	452.40	213	55.80	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1386.9	B08		6	0256-0455	701.19	455.85	283	66.67	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5093.6	B08		6	0257-0452	853.43	452.66	186	53.70	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5056.1	B08		6	0258-0457	671.01	456.28	211	57.94	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3377.6	B08		6	0259-0458	464.15	458.21	320	68.18	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3529.5	B08		6	0260-0458	747.26	458.97	233	64.43	0.705
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2183.7	B08		6	0261-0462	420.15	463.25	341	75.50	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3121.9	B08		6	0262-0459	85.49	459.20	238	57.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2229.4	B08		6	0263-0459	507.37	459.32	214	54.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6201.5	B08		6	0264-0465	314.66	465.76	333	71.01	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6081.9	B08		6	0265-0466	136.07	466.13	354	71.11	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3064.5	B08		6	0266-0468	172.72	467.77	250	63.70	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3198.1	B08		6	0267-0473	491.59	472.88	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3194.1	B08		6	0268-0473	815.16	473.17	253	59.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1567.1	B08		6	0269-0478	780.69	477.91	325	68.77	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4057.1	B08		6	0270-0475	227.97	475.28	214	57.11	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3921.1	B08		6	0271-0480	211.70	481.35	251	62.18	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4069.2	B08		6	0272-0483	859.42	482.86	271	64.18	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2261.9	B08		6	0273-0485	752.35	484.85	237	60.87	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4096.6	B08		6	0274-0483	585.53	483.73	243	63.36	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3801.0	B08		6	0275-0484	385.51	485.19	164	50.87	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1766.6	B08		6	0276-0488	89.40	489.15	395	75.01	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4075.7	B08		6	0277-0489	296.69	488.85	244	58.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2472.6	B08		6	0278-0492	143.08	492.32	228	55.36	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4201.7	B08		6	0279-0491	336.64	491.70	220	56.28	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1301.3	B08		6	0280-0492	513.77	492.88	252	59.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2359.5	B08		6	0281-0498	48.00	498.20	251	59.94	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3808.8	B08		6	0282-0498	852.36	498.53	283	65.60	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2604.1	B08		6	0283-0500	111.63	500.19	240	58.77	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2371.9	B08		6	0284-0500	478.43	499.97	207	51.46	0.982
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5106.8	B08		6	0285-0501	795.41	501.71	210	53.70	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2095.1	B08		6	0286-0503	443.46	502.86	393	76.67	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3762.5	B08		6	0287-0504	559.57	504.46	323	67.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3244.5	B08		6	0288-0504	831.86	504.47	290	62.53	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4269.8	B08		6	0289-0505	333.16	504.68	199	54.87	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5226.6	B08		6	0290-0509	934.43	509.12	471	88.57	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1225.6	B08		6	0291-0510	601.38	510.61	350	70.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3382.2	B08		6	0292-0512	911.09	511.98	298	68.18	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2323.5	B08		6	0293-0514	516.97	514.15	236	57.70	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2342.1	B08		6	0294-0515	42.43	515.91	283	62.18	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1742.9	B08		6	0295-0516	653.99	516.16	302	66.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1964.1	B08		6	0296-0518	896.99	517.89	228	60.77	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5572.0	B08		6	0297-0518	64.81	518.39	236	56.77	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1626.4	B08		6	0298-0521	259.18	521.20	288	64.43	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2663.8	B08		6	0299-0522	759.26	522.01	321	66.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1385.2	B08		6	0300-0521	695.19	521.83	316	67.84	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2889.1	B08		6	0301-0524	307.39	524.49	237	63.60	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3831.6	B08		6	0302-0524	537.36	523.04	202	57.36	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4113.8	B08		6	0303-0526	738.26	525.71	335	67.11	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5254.6	B08		6	0304-0530	442.40	529.89	215	53.94	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3006.6	B08		6	0305-0529	222.70	529.77	259	62.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2158.4	B08		6	0306-0533	148.88	533.45	266	64.77	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2644.6	B08		6	0307-0537	520.57	536.09	307	66.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2599.3	B08		6	0308-0540	795.24	540.18	237	62.77	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2001.3	B08		6	0309-0541	927.11	540.64	263	61.36	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2531.4	B08		6	0310-0541	111.28	540.83	251	61.94	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4647.2	B08		6	0311-0538	356.39	538.08	144	45.36	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3563.4	B08		6	0312-0542	430.57	542.86	238	62.43	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2600.7	B08		6	0313-0544	37.62	545.15	245	60.18	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2643.6	B08		6	0314-0547	665.59	548.67	353	72.67	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4866.7	B08		6	0315-0546	456.52	545.84	221	57.36	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2376.4	B08		6	0316-0549	376.55	548.79	276	62.87	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2773.6	B08		6	0317-0551	228.15	552.09	280	66.77	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2085.6	B08		6	0318-0547	558.15	547.60	267	61.94	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4689.0	B08		6	0319-0549	84.88	549.15	205	52.28	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8206.1	B08		6	0320-0548	343.66	548.44	170	50.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2242.2	B08		6	0321-0550	623.33	550.48	234	56.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3772.9	B08		6	0322-0553	852.44	553.40	224	58.53	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1949.4	B08		6	0323-0552	702.41	551.60	300	63.36	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3556.6	B08		6	0324-0555	65.46	554.14	214	59.70	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			15493.6	B08		6	0325-0559	412.48	559.15	240	58.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7662.6	B08		6	0326-0556	466.53	556.84	195	54.53	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6137.4	B08		6	0327-0560	785.46	559.58	267	62.43	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2468.0	B08		6	0328-0560	950.45	560.92	238	60.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1266.6	B08		6	0329-0566	215.30	565.75	257	61.70	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4238.2	B08		6	0330-0569	328.41	568.40	269	61.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2764.9	B08		6	0331-0574	461.56	575.67	264	67.36	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4195.4	B08		6	0332-0573	871.02	573.07	373	70.18	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2482.2	B08		6	0333-0572	501.78	572.33	159	49.11	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2359.0	B08		6	0334-0578	44.25	578.31	327	75.01	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4318.8	B08		6	0335-0576	831.51	575.40	184	50.87	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6645.3	B08		6	0336-0579	405.43	579.94	296	65.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2457.7	B08		6	0337-0580	940.14	579.77	260	61.94	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3521.0	B08		6	0338-0582	118.12	582.44	355	70.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1527.5	B08		6	0339-0581	545.71	581.43	267	62.43	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2642.7	B08		6	0340-0583	758.34	583.80	270	60.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3895.0	B08		6	0341-0590	861.76	590.73	212	56.28	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1334.8	B08		6	0342-0593	897.40	593.24	281	63.60	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2067.6	B08		6	0343-0595	503.64	594.99	153	46.28	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3785.1	B08		6	0344-0598	186.48	597.91	353	69.84	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1433.7	B08		6	0345-0598	925.56	598.86	254	59.11	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2482.2	B08		6	0346-0594	793.86	594.85	119	44.28	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2000.6	B08		6	0347-0601	45.57	601.17	270	62.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1962.2	B08		6	0348-0604	674.21	604.94	328	70.77	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2012.0	B08		6	0349-0605	300.47	604.75	327	68.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2691.0	B08		6	0350-0604	797.84	604.85	204	61.94	0.668
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			905.4	B08		6	0351-0610	121.59	610.26	241	58.53	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5399.5	B08		6	0352-0614	419.35	614.52	331	67.60	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8334.6	B08		6	0353-0617	18.20	617.26	228	54.53	0.964
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4965.8	B08		6	0354-0620	371.00	620.02	395	78.08	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4238.9	B08		6	0355-0618	818.54	619.07	286	63.11	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3094.2	B08		6	0356-0621	886.62	621.92	270	61.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1139.6	B08		6	0357-0624	540.31	624.49	305	65.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4156.9	B08		6	0358-0624	108.75	623.92	311	66.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2077.5	B08		6	0359-0624	238.42	623.48	277	64.53	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4475.6	B08		6	0360-0627	41.31	627.73	283	63.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2545.9	B08		6	0361-0632	771.16	631.75	395	74.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1919.5	B08		6	0362-0638	948.41	638.14	366	72.43	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7062.5	B08		6	0363-0639	381.42	638.47	293	64.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5396.3	B08		6	0364-0642	841.54	642.68	274	63.84	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2449.6	B08		6	0365-0646	214.06	645.66	254	63.11	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2475.2	B08		6	0366-0646	912.19	645.78	237	57.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3803.8	B08		6	0367-0648	64.54	648.32	224	56.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1119.9	B08		6	0368-0650	489.58	649.78	282	63.01	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1564.1	B08		6	0369-0653	422.26	652.20	405	76.67	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4254.2	B08		6	0370-0648	826.17	648.23	215	54.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3070.4	B08		6	0371-0653	113.86	652.70	231	58.87	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2249.0	B08		6	0372-0653	602.39	653.01	329	69.01	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1181.6	B08		6	0373-0658	18.30	658.28	370	72.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1328.1	B08		6	0374-0655	712.94	655.48	293	65.36	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6677.8	B08		6	0375-0658	328.43	658.02	305	64.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3124.8	B08		6	0376-0664	781.20	663.74	247	59.36	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1814.2	B08		6	0377-0662	900.70	662.82	224	56.53	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1898.5	B08		6	0378-0664	148.61	664.67	220	53.94	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2370.7	B08		6	0379-0663	524.35	662.59	272	61.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3571.6	B08		6	0380-0665	835.11	664.12	225	61.01	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5190.3	B08		6	0381-0673	210.21	673.07	188	52.87	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2573.4	B08		6	0382-0672	430.67	672.77	245	58.87	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4240.8	B08		6	0383-0673	822.78	674.69	235	58.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2104.1	B08		6	0384-0675	614.54	674.84	272	63.01	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4801.0	B08		6	0385-0674	859.84	673.39	222	57.01	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1642.2	B08		6	0386-0675	663.73	675.40	406	77.01	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2438.5	B08		6	0387-0677	744.93	677.07	237	59.11	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2153.0	B08		6	0388-0683	78.83	682.69	354	73.26	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4526.9	B08		6	0389-0681	930.27	681.12	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			9774.3	B08		6	0390-0686	260.52	686.06	309	64.18	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3797.6	B08		6	0391-0684	802.37	683.50	206	53.11	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5328.4	B08		6	0392-0686	126.55	686.41	213	56.28	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5800.2	B08		6	0393-0687	406.24	687.58	300	63.60	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2118.0	B08		6	0394-0688	38.48	688.08	219	55.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5622.7	B08		6	0395-0692	336.61	691.64	260	61.01	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2025.5	B08		6	0396-0693	377.30	693.73	143	47.80	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1875.1	B08		6	0397-0694	473.18	694.78	246	59.94	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2363.6	B08		6	0398-0700	708.19	700.42	393	75.01	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3121.8	B08		6	0399-0699	725.25	699.07	256	59.70	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8700.2	B08		6	0400-0703	517.50	703.30	205	54.53	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3646.5	B08		6	0401-0706	576.37	706.19	196	53.94	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6085.5	B08		6	0402-0707	116.69	707.16	302	66.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2168.3	B08		6	0403-0709	376.77	708.80	241	61.70	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			9627.3	B08		7	0001-0026	81.39	26.79	137	43.94	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6369.9	B08		7	0002-0029	247.78	28.87	248	59.11	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4694.4	B08		7	0003-0028	824.82	27.21	222	55.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5285.6	B08		7	0004-0033	560.84	33.13	299	64.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2710.1	B08		7	0005-0031	711.12	31.85	252	59.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2033.5	B08		7	0006-0036	632.02	36.41	452	80.08	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6509.8	B08		7	0007-0036	390.73	36.07	154	54.28	0.657
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1373.6	B08		7	0008-0040	52.67	39.62	298	66.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4860.1	B08		7	0009-0037	403.64	36.79	145	43.80	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4417.3	B08		7	0010-0043	16.80	44.41	162	53.70	0.706
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5911.4	B08		7	0011-0040	381.00	39.87	117	42.87	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5678.4	B08		7	0012-0047	30.32	48.28	217	59.94	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2450.9	B08		7	0013-0047	435.38	48.08	253	60.53	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3503.5	B08		7	0014-0046	920.57	45.84	220	55.11	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2593.3	B08		7	0015-0051	272.52	52.16	262	67.50	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3098.4	B08		7	0016-0050	486.01	50.03	449	81.26	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7238.5	B08		7	0017-0057	78.11	57.33	229	56.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1803.5	B08		7	0018-0063	120.28	62.76	458	79.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2607.1	B08		7	0019-0063	57.27	62.60	233	62.77	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6542.7	B08		7	0020-0064	310.19	63.67	254	74.08	0.582
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2556.5	B08		7	0021-0067	750.66	66.50	391	72.67	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3070.2	B08		7	0022-0066	821.45	66.51	304	65.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2648.3	B08		7	0023-0066	167.52	66.48	242	59.94	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3155.6	B08		7	0024-0067	451.50	67.38	306	67.84	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			12306.2	B08		7	0025-0073	68.84	72.68	197	51.70	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2881.5	B08		7	0026-0078	911.74	78.18	401	74.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3673.9	B08		7	0027-0081	195.65	81.18	335	69.26	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2837.5	B08		7	0028-0083	493.62	83.30	468	86.91	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3203.4	B08		7	0029-0081	336.24	81.83	194	56.18	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1560.1	B08		7	0030-0084	688.64	84.51	298	66.67	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4079.7	B08		7	0031-0084	776.67	84.47	260	60.18	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2301.5	B08		7	0032-0087	403.82	87.15	260	59.60	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3595.4	B08		7	0033-0092	240.65	92.13	310	64.77	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1724.8	B08		7	0034-0096	739.27	96.03	240	58.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3054.2	B08		7	0035-0102	295.43	101.57	365	80.43	0.709
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2456.6	B08		7	0036-0106	440.25	106.12	284	64.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3142.0	B08		7	0037-0112	414.56	114.02	365	86.91	0.607
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1472.5	B08		7	0038-0113	24.04	114.25	259	58.77	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1496.2	B08		7	0039-0115	912.85	115.08	264	62.43	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5436.6	B08		7	0040-0112	91.25	111.96	205	54.28	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1037.6	B08		7	0041-0116	861.89	116.11	264	61.36	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4466.2	B08		7	0042-0122	319.98	122.32	317	69.60	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2482.8	B08		7	0043-0121	338.52	120.85	147	52.63	0.667
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2214.3	B08		7	0044-0123	389.16	122.64	301	66.43	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3364.6	B08		7	0045-0121	188.05	120.87	238	64.77	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4853.1	B08		7	0046-0130	584.23	129.68	444	82.08	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1250.2	B08		7	0047-0127	632.15	126.73	300	77.26	0.632
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5607.2	B08		7	0048-0128	236.19	127.72	257	57.70	0.970
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4079.3	B08		7	0049-0132	83.70	132.95	279	65.36	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3301.8	B08		7	0050-0132	157.49	131.97	151	45.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6526.2	B08		7	0051-0132	199.98	133.12	219	57.94	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2877.0	B08		7	0052-0135	440.86	136.01	267	62.77	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3514.2	B08		7	0053-0138	378.41	138.40	250	61.94	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1473.2	B08		7	0054-0143	802.02	142.93	505	87.84	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			13796.1	B08		7	0055-0140	183.23	140.29	197	52.28	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			11751.5	B08		7	0056-0141	168.37	141.83	204	53.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7157.6	B08		7	0057-0146	272.79	146.49	375	76.18	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6420.7	B08		7	0058-0143	290.74	142.61	123	42.28	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1674.5	B08		7	0059-0147	689.43	148.17	378	74.08	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2471.6	B08		7	0060-0151	888.71	150.40	366	70.77	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2273.0	B08		7	0061-0155	242.33	155.57	246	59.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1861.0	B08		7	0062-0159	495.41	159.53	476	81.26	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4833.8	B08		7	0063-0154	140.59	153.43	151	49.36	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8658.2	B08		7	0064-0161	339.70	161.13	531	97.40	0.703
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			15227.0	B08		7	0065-0159	361.14	158.65	346	75.01	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2241.2	B08		7	0066-0159	674.90	159.46	220	57.60	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1532.2	B08		7	0067-0164	634.54	165.00	233	63.84	0.718
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4499.2	B08		7	0068-0163	134.49	163.21	162	51.60	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2178.9	B08		7	0069-0164	415.04	164.40	351	71.01	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1706.3	B08		7	0070-0164	465.84	164.38	268	60.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5217.4	B08		7	0071-0165	88.45	165.93	207	53.70	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1748.4	B08		7	0072-0167	43.25	167.63	240	56.28	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2186.5	B08		7	0073-0169	215.15	169.30	400	75.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1235.0	B08		7	0074-0174	818.62	173.99	505	87.26	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1218.3	B08		7	0075-0171	853.97	170.66	361	72.08	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1682.5	B08		7	0076-0171	607.12	171.03	221	55.70	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			9530.7	B08		7	0077-0176	307.71	176.43	399	76.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3544.8	B08		7	0078-0174	773.89	174.10	219	53.94	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			17823.0	B08		7	0079-0173	920.75	174.10	151	66.43	0.430
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1274.8	B08		7	0080-0179	627.32	179.07	275	68.77	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6158.6	B08		7	0081-0183	92.24	182.24	227	58.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2756.1	B08		7	0082-0186	412.67	186.07	258	59.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1282.5	B08		7	0083-0191	529.97	191.30	400	74.91	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4230.0	B08		7	0084-0193	162.74	193.94	271	72.33	0.651
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5989.9	B08		7	0085-0194	571.70	194.47	302	64.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3801.6	B08		7	0086-0193	719.20	193.39	188	53.94	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4291.1	B08		7	0087-0196	899.44	197.36	350	72.18	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2628.2	B08		7	0088-0195	686.08	194.73	240	57.94	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2827.0	B08		7	0089-0197	218.70	197.96	244	59.36	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2272.2	B08		7	0090-0198	314.70	198.25	251	58.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5472.2	B08		7	0091-0196	613.26	196.59	204	56.87	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4292.8	B08		7	0092-0201	946.42	201.19	274	66.08	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1944.1	B08		7	0093-0206	58.01	206.48	258	61.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1532.3	B08		7	0094-0211	177.98	211.36	360	69.60	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4921.6	B08		7	0095-0216	397.84	216.51	337	69.26	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1601.2	B08		7	0096-0218	339.99	218.35	273	60.77	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6527.0	B08		7	0097-0221	569.60	222.01	391	87.50	0.642
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1986.6	B08		7	0098-0219	89.92	218.98	242	57.11	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1577.7	B08		7	0099-0225	446.62	225.98	396	76.43	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2547.1	B08		7	0100-0228	126.72	228.49	240	56.77	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4705.3	B08		7	0101-0228	413.78	228.49	276	61.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1688.1	B08		7	0102-0231	907.18	231.20	289	63.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5892.2	B08		7	0103-0232	720.98	231.94	236	62.67	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6014.0	B08		7	0104-0233	264.91	234.22	194	56.53	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3290.6	B08		7	0105-0234	283.80	234.69	332	68.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1827.2	B08		7	0106-0237	521.36	236.40	382	73.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5120.0	B08		7	0107-0236	947.56	236.18	340	68.77	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1814.2	B08		7	0108-0237	872.17	237.48	266	63.84	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7384.8	B08		7	0109-0245	843.77	243.71	350	102.57	0.418
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6379.7	B08		7	0110-0243	51.98	243.74	182	49.70	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3190.1	B08		7	0111-0243	604.19	243.46	216	59.36	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3417.3	B08		7	0112-0246	378.93	246.46	256	59.36	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2003.6	B08		7	0113-0249	463.00	249.54	233	56.53	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2411.1	B08		7	0114-0249	587.12	249.49	180	50.87	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1398.5	B08		7	0115-0254	128.47	254.68	307	80.57	0.594
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3415.7	B08		7	0116-0254	247.69	254.10	326	66.43	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4501.4	B08		7	0117-0256	397.74	256.62	240	57.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1755.5	B08		7	0118-0259	553.97	259.30	371	73.01	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1335.5	B08		7	0119-0257	323.31	257.59	255	59.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1245.4	B08		7	0120-0264	877.21	264.15	243	65.94	0.702
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5111.2	B08		7	0121-0264	429.23	263.74	193	51.11	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3293.4	B08		7	0122-0265	682.52	264.78	242	60.18	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1768.9	B08		7	0123-0268	23.52	267.27	312	68.67	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1482.7	B08		7	0124-0273	942.28	273.29	228	55.11	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1588.8	B08		7	0125-0277	472.77	276.83	285	65.36	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1304.0	B08		7	0126-0279	591.93	279.81	335	67.60	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1631.6	B08		7	0127-0280	373.41	281.31	303	65.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1245.6	B08		7	0128-0281	97.96	280.43	287	68.18	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4251.2	B08		7	0129-0289	160.03	289.59	504	84.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3601.1	B08		7	0130-0286	717.44	286.35	251	59.94	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4415.8	B08		7	0131-0285	226.22	284.88	147	47.46	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2823.9	B08		7	0132-0287	884.60	287.66	261	63.01	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3095.1	B08		7	0133-0287	266.28	286.81	204	54.28	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2410.4	B08		7	0134-0295	42.73	293.97	470	84.67	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4827.2	B08		7	0135-0290	409.83	289.56	218	55.11	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2393.1	B08		7	0136-0296	638.34	296.98	357	70.43	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4540.7	B08		7	0137-0296	95.19	296.13	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1817.5	B08		7	0138-0300	300.90	299.53	352	70.18	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3543.1	B08		7	0139-0299	441.91	299.04	285	62.53	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2781.2	B08		7	0140-0303	747.06	302.21	284	64.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			10296.5	B08		7	0141-0300	226.96	300.39	100	38.04	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1638.5	B08		7	0142-0307	921.16	307.62	285	79.50	0.567
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2449.2	B08		7	0143-0304	356.23	304.27	278	65.01	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			10911.2	B08		7	0144-0303	621.62	304.04	199	53.11	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2868.0	B08		7	0145-0309	250.39	309.05	279	69.01	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1524.1	B08		7	0146-0312	495.72	311.78	412	83.98	0.734
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2671.6	B08		7	0147-0310	729.52	310.80	232	57.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3123.4	B08		7	0148-0311	762.11	310.96	229	57.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4001.2	B08		7	0149-0310	528.20	310.63	234	58.28	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2634.9	B08		7	0150-0312	795.82	311.91	291	64.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4251.6	B08		7	0151-0316	235.32	316.79	240	70.43	0.608
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5754.5	B08		7	0152-0312	410.34	312.51	248	58.63	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1870.8	B08		7	0153-0317	371.38	316.56	293	65.94	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3707.7	B08		7	0154-0316	266.32	316.82	171	48.87	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4107.7	B08		7	0155-0319	546.92	318.83	210	54.18	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5163.0	B08		7	0156-0321	27.86	321.46	191	51.36	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3734.4	B08		7	0157-0328	430.10	328.68	339	67.94	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3764.7	B08		7	0158-0327	847.85	326.72	221	54.28	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			13512.0	B08		7	0159-0326	410.89	326.20	166	48.39	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3378.0	B08		7	0160-0331	450.98	331.32	320	66.53	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3552.2	B08		7	0161-0334	292.22	334.82	267	65.94	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3673.2	B08		7	0162-0336	930.56	336.09	198	53.60	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6688.9	B08		7	0163-0336	162.68	335.79	175	49.94	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3260.2	B08		7	0164-0338	896.94	338.98	324	67.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6263.2	B08		7	0165-0338	660.25	337.98	156	50.87	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4627.3	B08		7	0166-0341	646.64	340.59	261	61.11	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4872.0	B08		7	0167-0340	675.12	339.91	190	52.77	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1627.4	B08		7	0168-0342	707.87	342.91	276	69.84	0.711
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			16429.1	B08		7	0169-0342	784.65	342.46	217	55.36	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2553.1	B08		7	0170-0343	309.89	343.09	258	60.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8056.5	B08		7	0171-0346	481.88	346.11	316	72.77	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3084.7	B08		7	0172-0349	217.80	349.32	361	71.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5310.3	B08		7	0173-0347	153.24	347.05	227	56.18	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3248.0	B08		7	0174-0350	859.26	351.10	336	68.53	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			11293.8	B08		7	0175-0349	800.64	349.33	177	49.70	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1175.6	B08		7	0176-0353	338.93	352.34	261	60.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5472.8	B08		7	0177-0358	71.12	358.95	447	91.74	0.667
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6816.9	B08		7	0178-0353	817.46	353.46	233	59.70	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			13272.4	B08		7	0179-0362	371.36	361.56	494	93.05	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2649.2	B08		7	0180-0367	99.04	367.18	454	85.74	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8233.8	B08		7	0181-0359	462.03	360.16	146	45.21	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1861.7	B08		7	0182-0369	691.26	369.39	264	64.08	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3630.3	B08		7	0183-0370	447.16	369.83	216	55.11	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3749.5	B08		7	0184-0370	843.94	370.61	319	66.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1998.5	B08		7	0185-0371	278.60	372.16	262	63.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2905.5	B08		7	0186-0375	503.14	375.57	260	65.36	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2521.4	B08		7	0187-0374	307.18	373.51	277	65.36	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			11104.7	B08		7	0188-0373	354.76	374.48	147	49.36	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			12973.5	B08		7	0189-0376	381.94	376.76	278	67.01	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1555.6	B08		7	0190-0380	727.75	380.71	335	69.84	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2849.6	B08		7	0191-0380	526.81	381.04	221	57.36	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1846.0	B08		7	0192-0384	684.62	383.73	275	63.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2123.8	B08		7	0193-0390	164.13	389.70	472	83.36	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4967.0	B08		7	0194-0387	798.47	387.55	357	70.43	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4044.5	B08		7	0195-0388	927.26	388.88	312	65.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2442.7	B08		7	0196-0394	185.85	393.76	261	63.01	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8485.6	B08		7	0197-0395	116.26	395.13	255	58.77	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2944.5	B08		7	0198-0393	840.15	393.95	241	57.70	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2528.4	B08		7	0199-0399	899.11	399.12	309	65.36	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5424.9	B08		7	0200-0400	555.73	400.33	333	71.01	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4642.3	B08		7	0201-0402	94.97	402.82	390	74.43	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3272.6	B08		7	0202-0403	503.44	403.91	240	59.70	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6641.9	B08		7	0203-0402	782.10	402.91	155	50.87	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			915.0	B08		7	0204-0406	870.45	407.13	285	71.01	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1979.6	B08		7	0205-0405	281.16	404.51	254	62.77	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3229.9	B08		7	0206-0408	439.39	407.70	223	57.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4563.2	B08		7	0207-0407	677.66	407.11	250	57.94	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1575.9	B08		7	0208-0409	946.76	409.94	278	67.01	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3035.4	B08		7	0209-0408	50.70	408.74	253	61.70	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2501.9	B08		7	0210-0408	329.76	408.12	319	72.43	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8928.2	B08		7	0211-0412	228.68	412.13	306	65.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5142.2	B08		7	0212-0413	582.83	413.25	313	67.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3707.3	B08		7	0213-0409	753.48	408.41	161	49.70	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3747.8	B08		7	0214-0416	308.23	416.71	224	61.36	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5923.5	B08		7	0215-0419	544.64	418.65	204	51.94	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1568.0	B08		7	0216-0420	627.16	420.38	308	67.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2144.4	B08		7	0217-0423	938.35	422.78	276	65.26	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3049.9	B08		7	0218-0427	816.11	427.07	261	61.70	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2701.7	B08		7	0219-0428	330.82	429.26	299	66.43	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2116.2	B08		7	0220-0429	710.81	428.85	298	66.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3359.0	B08		7	0221-0431	199.59	430.66	279	63.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1306.7	B08		7	0222-0432	784.78	431.99	288	65.60	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3889.2	B08		7	0223-0436	80.45	436.11	367	73.11	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6608.6	B08		7	0224-0434	530.11	433.20	296	67.60	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5230.4	B08		7	0225-0437	547.31	438.14	267	65.26	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3422.7	B08		7	0226-0438	24.77	437.88	236	59.70	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7457.1	B08		7	0227-0437	102.70	437.10	222	58.18	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6722.3	B08		7	0228-0438	689.99	437.92	218	56.28	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1919.5	B08		7	0229-0444	644.17	443.89	414	80.67	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2004.2	B08		7	0230-0445	349.35	444.63	254	62.18	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4159.1	B08		7	0231-0448	673.60	448.71	311	67.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3095.9	B08		7	0232-0451	760.98	450.72	222	61.94	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1115.7	B08		7	0233-0451	577.59	451.76	277	63.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			10063.0	B08		7	0234-0454	817.04	453.79	324	68.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2153.4	B08		7	0235-0456	455.98	456.45	269	64.18	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6174.5	B08		7	0236-0460	63.98	460.09	299	63.94	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1726.9	B08		7	0237-0466	864.93	466.05	302	80.91	0.580
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3962.8	B08		7	0238-0464	356.84	463.88	256	60.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1421.7	B08		7	0239-0466	513.38	466.70	281	63.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6729.3	B08		7	0240-0467	328.45	467.72	371	83.84	0.663
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4080.4	B08		7	0241-0468	849.84	468.20	184	53.46	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5761.3	B08		7	0242-0472	906.09	471.68	340	76.67	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3311.4	B08		7	0243-0470	203.00	469.81	222	58.18	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2803.1	B08		7	0244-0472	236.38	472.69	220	59.01	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1449.5	B08		7	0245-0477	934.34	478.49	318	72.43	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4229.4	B08		7	0246-0481	651.26	482.10	510	106.57	0.564
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5906.9	B08		7	0247-0486	129.79	486.75	499	86.67	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5355.4	B08		7	0248-0482	398.08	481.83	240	57.60	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3300.6	B08		7	0249-0484	782.53	484.13	397	75.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3491.6	B08		7	0250-0491	555.13	492.15	336	68.43	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2401.1	B08		7	0251-0493	488.53	493.04	280	65.01	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3443.7	B08		7	0252-0496	630.32	496.96	275	61.01	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2864.7	B08		7	0253-0504	76.36	503.82	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2454.4	B08		7	0254-0512	563.18	512.38	275	61.11	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3478.4	B08		7	0255-0515	929.60	515.28	331	67.84	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4597.2	B08		7	0256-0515	303.66	514.76	221	56.18	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3904.4	B08		7	0257-0517	419.55	516.60	219	54.87	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2125.2	B08		7	0258-0520	523.11	521.12	339	71.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4170.1	B08		7	0259-0523	102.70	523.12	267	67.94	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4118.0	B08		7	0260-0520	194.12	520.44	217	55.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2660.9	B08		7	0261-0521	781.22	521.50	240	62.18	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4853.6	B08		7	0262-0522	715.60	522.41	182	49.11	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3235.1	B08		7	0263-0529	225.10	528.94	309	65.11	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6124.6	B08		7	0264-0527	285.61	527.28	236	57.70	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2893.0	B08		7	0265-0530	149.38	529.94	288	65.94	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3735.3	B08		7	0266-0534	429.34	534.91	260	62.43	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5038.2	B08		7	0267-0536	770.17	537.07	227	56.18	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1158.8	B08		7	0268-0540	906.22	540.02	407	76.43	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6102.8	B08		7	0269-0540	335.32	539.97	212	55.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2233.2	B08		7	0270-0545	548.09	545.33	251	59.94	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5555.2	B08		7	0271-0545	270.40	544.99	189	51.94	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2611.0	B08		7	0272-0546	447.50	545.93	228	58.43	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4892.6	B08		7	0273-0553	804.74	553.28	232	58.77	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4291.9	B08		7	0274-0549	859.05	549.05	126	43.46	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2059.3	B08		7	0275-0551	482.79	550.94	212	53.70	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1932.6	B08		7	0276-0552	392.00	551.27	300	69.60	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3927.1	B08		7	0277-0553	821.00	553.94	198	56.18	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3589.1	B08		7	0278-0555	301.57	555.59	283	65.94	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3754.3	B08		7	0279-0558	776.62	558.39	269	62.53	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7710.0	B08		7	0280-0559	689.71	560.15	226	62.77	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5058.4	B08		7	0281-0560	339.19	559.53	187	51.36	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4188.8	B08		7	0282-0564	852.72	564.30	217	55.84	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2385.0	B08		7	0283-0565	273.27	565.52	251	61.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2452.3	B08		7	0284-0566	215.27	567.71	321	73.01	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3021.3	B08		7	0285-0568	794.53	567.90	241	58.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1784.8	B08		7	0286-0568	574.60	568.25	313	68.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2294.8	B08		7	0287-0571	97.09	571.01	324	68.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3178.5	B08		7	0288-0572	358.39	571.60	225	57.70	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3467.6	B08		7	0289-0568	451.12	568.59	194	50.87	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1672.5	B08		7	0290-0571	514.70	571.55	238	57.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5660.5	B08		7	0291-0575	818.21	576.01	261	63.11	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3803.5	B08		7	0292-0573	627.10	573.01	252	58.87	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			10945.0	B08		7	0293-0587	161.52	585.95	593	107.05	0.650
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4510.5	B08		7	0294-0580	382.48	581.18	206	56.04	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2692.6	B08		7	0295-0582	856.68	582.60	241	59.84	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6168.8	B08		7	0296-0581	454.66	581.62	195	53.21	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2276.9	B08		7	0297-0584	20.47	584.14	229	57.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2791.6	B08		7	0298-0589	65.54	589.46	360	71.36	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1715.6	B08		7	0299-0589	202.30	589.49	276	69.01	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2118.2	B08		7	0300-0586	306.59	585.47	227	56.53	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4603.6	B08		7	0301-0587	540.11	586.99	191	51.36	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3988.2	B08		7	0302-0589	419.81	589.22	243	57.11	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2043.5	B08		7	0303-0589	641.78	589.13	208	54.28	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3165.7	B08		7	0304-0591	870.52	591.42	226	55.11	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8546.1	B08		7	0305-0592	401.35	592.08	206	54.28	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			12924.4	B08		7	0306-0595	386.10	595.23	181	51.80	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2006.7	B08		7	0307-0599	934.08	598.75	396	74.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3994.1	B08		7	0308-0597	468.94	597.78	296	63.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			9764.5	B08		7	0309-0599	531.68	600.05	232	55.36	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1900.6	B08		7	0310-0600	586.68	599.78	239	57.70	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3962.5	B08		7	0311-0603	237.89	602.51	256	58.53	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7187.2	B08		7	0312-0603	747.56	603.22	140	46.28	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3773.8	B08		7	0313-0607	275.96	606.98	234	56.53	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2200.2	B08		7	0314-0618	761.53	616.65	395	87.26	0.652
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2887.8	B08		7	0315-0618	317.58	618.43	245	59.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3023.8	B08		7	0316-0620	798.63	619.75	372	73.60	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1816.6	B08		7	0317-0619	184.08	618.67	255	59.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4090.3	B08		7	0318-0619	536.33	619.55	203	52.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			13824.7	B08		7	0319-0619	732.67	618.91	225	58.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1996.6	B08		7	0320-0624	75.32	624.49	297	67.26	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2432.3	B08		7	0321-0626	149.52	625.62	378	74.18	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2069.5	B08		7	0322-0624	587.75	624.19	255	60.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2153.4	B08		7	0323-0628	266.79	628.79	272	64.77	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2072.1	B08		7	0324-0626	224.98	625.70	269	60.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5973.5	B08		7	0325-0631	33.55	631.63	372	75.84	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3210.8	B08		7	0326-0630	380.71	630.34	182	50.28	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6041.3	B08		7	0327-0632	742.45	633.18	264	63.60	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4911.0	B08		7	0328-0632	870.00	633.29	240	62.77	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4180.3	B08		7	0329-0638	418.93	637.29	242	58.18	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2424.5	B08		7	0330-0635	486.04	635.24	265	64.53	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			10490.8	B08		7	0331-0636	884.42	636.28	183	50.63	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3046.1	B08		7	0332-0640	652.10	639.58	235	59.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2609.6	B08		7	0333-0642	303.25	642.62	278	63.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6597.8	B08		7	0334-0643	369.37	643.58	193	51.70	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3980.1	B08		7	0335-0647	536.33	647.18	228	57.01	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4364.8	B08		7	0336-0648	701.14	648.33	301	63.60	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1759.0	B08		7	0337-0655	825.26	654.58	343	71.50	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4826.7	B08		7	0338-0652	905.80	652.94	180	51.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2683.4	B08		7	0339-0656	494.86	656.41	261	60.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3564.1	B08		7	0340-0655	647.89	656.23	214	54.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1501.5	B08		7	0341-0660	619.43	660.42	307	68.53	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1506.2	B08		7	0342-0660	103.73	660.38	202	60.18	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5283.8	B08		7	0343-0661	331.53	661.26	282	62.28	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7508.8	B08		7	0344-0658	369.54	658.31	227	57.11	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7120.6	B08		7	0345-0659	935.36	658.91	181	52.43	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3433.1	B08		7	0346-0660	447.04	660.05	247	59.11	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2088.9	B08		7	0347-0665	250.08	665.56	256	60.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1381.6	B08		7	0348-0662	37.36	662.14	140	45.94	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2474.6	B08		7	0349-0668	273.05	667.94	244	60.18	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3006.0	B08		7	0350-0671	564.20	671.06	415	79.50	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5688.3	B08		7	0351-0668	724.95	667.73	304	64.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3741.4	B08		7	0352-0666	922.79	665.38	205	57.36	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3158.1	B08		7	0353-0670	193.80	670.59	269	61.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4617.2	B08		7	0354-0673	768.30	672.51	256	59.60	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4021.9	B08		7	0355-0672	377.96	672.48	212	55.46	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3070.4	B08		7	0356-0674	861.90	673.49	332	68.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3407.0	B08		7	0357-0676	85.23	676.00	223	57.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1055.6	B08		7	0358-0677	797.05	677.26	267	63.01	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1585.2	B08		7	0359-0675	34.76	675.73	175	50.28	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6255.7	B08		7	0360-0676	703.10	676.08	198	57.60	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1564.8	B08		7	0361-0678	52.72	679.35	218	59.36	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			9863.9	B08		7	0362-0683	685.57	684.28	648	111.05	0.660
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6176.4	B08		7	0363-0680	448.23	679.47	224	55.36	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1486.7	B08		7	0364-0685	843.10	686.08	260	61.36	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1658.4	B08		7	0365-0688	618.11	687.90	248	63.84	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4997.5	B08		7	0366-0686	340.20	686.29	226	55.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3733.5	B08		7	0367-0692	413.83	691.73	372	73.26	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			9060.7	B08		7	0368-0691	714.85	690.45	150	46.87	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3979.9	B08		7	0369-0694	912.92	694.90	229	57.94	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3373.9	B08		7	0370-0696	937.38	695.64	291	61.94	0.953
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2119.6	B08		7	0371-0697	52.33	696.50	224	55.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2514.2	B08		7	0372-0697	136.01	696.68	215	53.94	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1527.2	B08		7	0373-0702	234.35	703.26	290	67.36	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4118.1	B08		7	0374-0703	882.83	702.70	269	63.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2449.6	B08		7	0375-0704	371.40	704.40	237	58.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4473.0	B08		7	0376-0703	539.66	702.93	202	52.28	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			12563.2	B08		7	0377-0700	690.84	700.22	159	45.70	0.957
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5302.3	B08		7	0378-0706	464.63	706.59	227	57.94	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1807.8	B08		7	0379-0706	646.96	706.78	211	53.11	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1296.8	B08		7	0380-0708	161.23	708.82	276	64.53	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1952.3	B08		8	0001-0027	605.94	27.87	215	56.28	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1222.5	B08		8	0002-0030	678.63	29.96	293	63.01	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5066.1	B08		8	0003-0030	332.84	29.76	212	53.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2543.2	B08		8	0004-0034	100.59	34.63	237	58.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3781.9	B08		8	0005-0030	274.05	30.58	219	59.70	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3855.6	B08		8	0006-0039	437.09	39.00	204	53.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5596.1	B08		8	0007-0041	321.69	41.81	212	54.28	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6831.3	B08		8	0008-0040	928.24	40.30	223	54.28	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1730.2	B08		8	0009-0043	461.70	44.14	285	63.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2726.0	B08		8	0010-0044	809.55	44.14	285	61.36	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1423.8	B08		8	0011-0045	569.92	43.93	174	54.43	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2301.6	B08		8	0012-0045	358.74	45.50	219	55.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8345.4	B08		8	0013-0045	633.25	45.14	254	60.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1699.9	B08		8	0014-0047	122.29	46.71	280	66.18	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3516.6	B08		8	0015-0048	25.24	47.86	211	53.11	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3475.3	B08		8	0016-0048	185.64	48.59	289	64.18	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4869.5	B08		8	0017-0049	384.18	48.78	310	66.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3698.7	B08		8	0018-0049	307.42	48.87	215	54.87	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1484.0	B08		8	0019-0050	580.11	51.04	112	44.87	0.699
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2481.7	B08		8	0020-0053	753.84	52.66	215	54.28	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			9013.0	B08		8	0021-0053	254.99	53.81	251	60.53	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2575.5	B08		8	0022-0056	493.18	56.48	338	69.01	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4835.9	B08		8	0023-0054	940.44	54.25	205	52.28	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4779.7	B08		8	0024-0061	241.09	61.83	193	56.77	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7901.8	B08		8	0025-0056	768.83	55.64	147	45.80	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6169.1	B08		8	0026-0060	866.08	60.35	250	59.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2602.3	B08		8	0027-0063	559.18	62.41	294	67.60	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3539.1	B08		8	0028-0063	642.81	63.02	178	48.28	0.959
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2548.0	B08		8	0029-0064	701.82	64.72	262	60.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1731.5	B08		8	0030-0068	91.77	68.89	240	59.11	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3707.4	B08		8	0031-0070	346.19	69.91	273	61.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3639.3	B08		8	0032-0069	838.43	68.84	215	56.18	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6147.0	B08		8	0033-0070	765.62	69.56	157	46.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5462.4	B08		8	0034-0071	878.70	71.36	219	55.70	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5637.6	B08		8	0035-0075	248.18	76.27	218	55.36	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7445.7	B08		8	0036-0076	753.87	77.01	208	55.01	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3435.4	B08		8	0037-0078	789.59	77.65	266	62.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4442.1	B08		8	0038-0080	204.05	79.65	217	54.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3363.2	B08		8	0039-0082	535.30	81.33	202	55.46	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2189.9	B08		8	0040-0086	684.70	86.65	407	78.67	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4256.7	B08		8	0041-0081	911.11	81.40	246	57.70	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3637.2	B08		8	0042-0083	278.01	82.10	183	51.36	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5879.1	B08		8	0043-0083	422.56	82.95	209	52.87	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3971.0	B08		8	0044-0092	521.47	91.87	335	73.11	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1660.7	B08		8	0045-0087	654.93	87.18	272	62.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2891.1	B08		8	0046-0088	803.61	88.22	262	60.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1557.9	B08		8	0047-0085	312.89	85.51	156	48.04	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2625.2	B08		8	0048-0091	506.89	91.64	231	61.11	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4382.2	B08		8	0049-0093	265.32	92.69	347	69.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			19985.8	B08		8	0050-0089	466.44	89.42	126	64.67	0.379
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			12479.4	B08		8	0051-0091	485.54	91.39	178	51.70	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2330.1	B08		8	0052-0095	578.56	94.28	158	52.53	0.720
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			13818.1	B08		8	0053-0098	235.72	97.49	144	47.60	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1583.6	B08		8	0054-0097	312.79	96.29	117	40.63	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2773.6	B08		8	0055-0101	196.52	101.22	216	55.70	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5345.4	B08		8	0056-0109	168.10	109.50	416	84.08	0.739
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2453.5	B08		8	0057-0109	61.26	110.18	302	65.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1964.4	B08		8	0058-0109	325.70	109.43	285	64.53	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			15096.7	B08		8	0059-0105	492.19	104.94	158	46.63	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			15562.3	B08		8	0060-0109	225.69	109.46	155	46.53	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1650.9	B08		8	0061-0110	418.68	110.04	266	61.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5173.8	B08		8	0062-0110	740.53	109.96	202	53.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2397.4	B08		8	0063-0116	365.54	115.83	258	59.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1368.9	B08		8	0064-0117	17.34	117.17	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3197.4	B08		8	0065-0117	710.91	117.16	339	67.60	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5330.0	B08		8	0066-0114	692.08	114.01	112	40.04	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1319.9	B08		8	0067-0116	945.56	116.40	143	45.11	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4259.0	B08		8	0068-0119	476.58	119.53	226	55.94	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4387.1	B08		8	0069-0120	214.16	121.08	218	57.84	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3963.5	B08		8	0070-0123	458.80	122.27	270	66.18	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1614.9	B08		8	0071-0128	621.93	128.49	282	65.11	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1227.1	B08		8	0072-0126	810.83	124.99	255	63.36	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4800.3	B08		8	0073-0129	254.02	128.83	222	57.36	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1567.3	B08		8	0074-0126	312.43	126.66	288	67.94	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2671.5	B08		8	0075-0127	651.45	127.21	274	62.53	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5120.0	B08		8	0076-0124	693.52	124.41	100	38.63	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3348.3	B08		8	0077-0134	544.06	133.88	328	69.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5207.3	B08		8	0078-0131	834.06	131.69	238	57.36	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4157.9	B08		8	0079-0134	916.21	133.84	333	69.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2557.6	B08		8	0080-0139	433.99	140.31	312	67.60	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7443.5	B08		8	0081-0141	742.85	142.35	182	53.36	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2323.7	B08		8	0082-0142	371.39	142.67	287	66.18	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6052.2	B08		8	0083-0142	691.60	143.08	137	49.70	0.697
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5037.0	B08		8	0084-0147	102.87	147.30	221	58.28	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3515.8	B08		8	0085-0146	870.70	146.58	274	63.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			629.6	B08		8	0086-0145	813.59	145.20	244	62.53	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4428.3	B08		8	0087-0147	260.69	146.47	195	52.53	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1774.8	B08		8	0088-0151	610.95	151.63	257	69.60	0.667
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3504.0	B08		8	0089-0151	508.14	151.35	210	54.77	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5094.3	B08		8	0090-0152	201.67	152.39	324	67.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5431.2	B08		8	0091-0153	752.90	153.76	193	51.70	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3280.5	B08		8	0092-0154	646.52	153.18	233	58.53	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			893.9	B08		8	0093-0163	790.71	165.01	286	78.43	0.584
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1062.3	B08		8	0094-0160	115.51	160.99	260	59.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1390.9	B08		8	0095-0163	155.98	162.80	258	62.43	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1393.5	B08		8	0096-0167	638.49	167.91	284	66.67	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1414.5	B08		8	0097-0169	319.81	169.39	287	62.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2912.1	B08		8	0098-0170	387.76	170.51	216	54.53	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1687.4	B08		8	0099-0172	718.99	171.98	280	64.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2045.6	B08		8	0100-0174	444.36	173.61	393	78.43	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4369.6	B08		8	0101-0173	363.23	173.68	207	54.53	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4151.2	B08		8	0102-0172	824.23	172.48	190	52.14	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			10817.4	B08		8	0103-0173	839.23	173.39	161	48.63	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5044.2	B08		8	0104-0174	855.85	173.78	202	54.53	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			14253.6	B08		8	0105-0176	472.06	176.28	277	61.11	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4199.5	B08		8	0106-0176	589.15	176.50	204	53.11	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			18301.9	B08		8	0107-0174	24.47	175.02	132	43.46	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			18238.1	B08		8	0108-0181	916.02	180.69	140	89.98	0.217
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2753.2	B08		8	0109-0191	416.31	190.75	393	73.60	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4136.1	B08		8	0110-0190	557.40	189.97	233	57.36	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3967.0	B08		8	0111-0194	503.96	194.47	352	71.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			11852.8	B08		8	0112-0193	528.14	193.10	302	65.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4591.1	B08		8	0113-0191	576.48	190.90	248	57.70	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1539.7	B08		8	0114-0196	82.44	197.40	250	59.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3406.1	B08		8	0115-0199	731.41	199.55	326	71.84	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			11002.6	B08		8	0116-0206	797.58	204.88	608	103.98	0.707
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3932.6	B08		8	0117-0200	600.24	198.90	321	67.84	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2254.7	B08		8	0118-0201	706.38	200.68	275	65.60	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1309.2	B08		8	0119-0200	105.70	199.53	251	60.77	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4388.1	B08		8	0120-0203	51.33	203.14	263	64.67	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			879.0	B08		8	0121-0201	945.35	201.25	242	64.77	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3365.6	B08		8	0122-0202	841.47	202.21	265	59.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2415.1	B08		8	0123-0204	360.88	204.41	293	66.18	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1864.9	B08		8	0124-0203	473.99	203.12	291	67.36	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			9923.7	B08		8	0125-0209	540.26	210.14	315	74.18	0.719
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5072.3	B08		8	0126-0207	210.90	207.35	301	65.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1839.7	B08		8	0127-0209	653.64	209.25	285	64.77	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3126.9	B08		8	0128-0216	905.41	216.77	342	71.60	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3530.1	B08		8	0129-0217	238.79	216.72	356	70.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5104.1	B08		8	0130-0219	326.08	218.78	230	67.11	0.642
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2007.2	B08		8	0131-0219	404.45	220.29	295	63.11	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3165.1	B08		8	0132-0222	573.44	222.43	240	57.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3236.3	B08		8	0133-0223	825.07	222.16	159	55.11	0.658
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2177.4	B08		8	0134-0228	177.37	228.44	252	65.60	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3957.9	B08		8	0135-0226	444.15	225.99	249	59.70	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3888.6	B08		8	0136-0226	297.91	225.97	241	57.01	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4096.8	B08		8	0137-0226	338.15	227.24	232	60.18	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			11982.9	B08		8	0138-0225	836.01	225.90	134	47.94	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3483.9	B08		8	0139-0231	760.15	231.06	226	56.04	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3761.1	B08		8	0140-0233	362.12	232.89	237	60.18	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1304.4	B08		8	0141-0236	884.11	237.24	290	67.11	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5299.7	B08		8	0142-0238	52.62	238.34	342	68.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4457.3	B08		8	0143-0234	514.13	234.63	207	57.46	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4065.4	B08		8	0144-0239	844.35	239.44	239	58.77	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1426.1	B08		8	0145-0242	131.43	242.42	205	54.53	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			13650.7	B08		8	0146-0241	497.89	242.11	176	49.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1844.3	B08		8	0147-0244	785.63	245.13	262	59.36	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2416.5	B08		8	0148-0244	401.72	243.93	213	54.53	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3815.4	B08		8	0149-0248	624.08	247.94	209	54.53	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3596.0	B08		8	0150-0249	726.50	248.48	254	59.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6886.3	B08		8	0151-0250	757.15	250.54	325	72.18	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4065.6	B08		8	0152-0249	644.05	249.45	254	60.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7190.5	B08		8	0153-0252	104.77	251.94	312	65.11	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4015.9	B08		8	0154-0252	445.78	252.74	217	60.53	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8164.7	B08		8	0155-0256	571.64	257.18	211	59.70	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5686.5	B08		8	0156-0266	348.79	266.57	640	110.47	0.659
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1702.7	B08		8	0157-0258	883.69	257.58	273	61.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2009.1	B08		8	0158-0256	905.81	256.66	277	63.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			918.9	B08		8	0159-0260	833.84	260.57	489	90.08	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3085.7	B08		8	0160-0260	689.87	260.20	232	57.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6747.9	B08		8	0161-0262	492.09	262.56	290	63.60	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2121.4	B08		8	0162-0267	518.42	267.31	439	80.08	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1567.2	B08		8	0163-0265	186.17	265.60	250	78.91	0.505
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1410.7	B08		8	0164-0265	247.92	265.49	261	59.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2191.2	B08		8	0165-0270	618.28	270.58	224	61.94	0.734
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6513.2	B08		8	0166-0265	797.52	264.67	151	49.11	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3811.7	B08		8	0167-0269	923.08	268.60	250	58.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3675.4	B08		8	0168-0275	409.94	274.74	383	74.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5249.9	B08		8	0169-0276	133.40	275.48	241	61.01	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1592.8	B08		8	0170-0275	47.24	275.34	223	55.11	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2035.2	B08		8	0171-0280	278.01	279.85	388	77.50	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3716.4	B08		8	0172-0279	562.46	279.94	194	57.36	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6426.7	B08		8	0173-0278	458.98	277.90	219	55.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3917.5	B08		8	0174-0278	715.69	277.13	240	59.94	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3842.0	B08		8	0175-0282	119.51	282.12	188	54.53	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3624.4	B08		8	0176-0280	332.96	280.84	132	43.56	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8169.7	B08		8	0177-0290	891.19	289.75	238	58.18	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5395.5	B08		8	0178-0292	298.21	292.89	218	54.53	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1737.5	B08		8	0179-0295	95.73	294.43	249	61.36	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3770.7	B08		8	0180-0294	330.03	293.71	196	53.46	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3233.1	B08		8	0181-0297	860.98	297.75	317	65.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			10612.8	B08		8	0182-0297	512.10	296.55	221	56.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2251.7	B08		8	0183-0303	430.37	303.46	354	71.60	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3959.4	B08		8	0184-0303	479.32	302.65	346	68.18	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6641.1	B08		8	0185-0302	497.46	302.33	187	51.11	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3030.9	B08		8	0186-0303	716.93	302.65	222	57.11	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5044.6	B08		8	0187-0305	830.82	305.53	256	57.94	0.958
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1564.2	B08		8	0188-0310	25.65	309.68	263	66.77	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1908.6	B08		8	0189-0309	198.99	308.92	288	70.67	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3110.5	B08		8	0190-0310	787.30	310.84	332	70.18	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			9948.3	B08		8	0191-0309	934.28	309.96	218	56.28	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1020.1	B08		8	0192-0313	234.95	313.59	264	67.01	0.739
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4356.4	B08		8	0193-0313	297.10	313.57	317	67.01	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3450.8	B08		8	0194-0316	613.92	317.18	222	57.70	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4664.9	B08		8	0195-0319	126.34	319.24	196	63.26	0.616
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			9830.2	B08		8	0196-0320	567.44	319.73	136	47.11	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			12231.3	B08		8	0197-0323	279.05	323.73	192	51.46	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3488.1	B08		8	0198-0328	673.08	328.40	224	62.18	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6911.4	B08		8	0199-0326	330.82	326.80	227	55.94	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3509.4	B08		8	0200-0329	94.74	329.33	229	57.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3118.1	B08		8	0201-0330	718.20	329.79	235	56.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2245.9	B08		8	0202-0331	696.05	331.99	248	57.70	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2866.7	B08		8	0203-0328	485.85	327.96	134	46.87	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3550.1	B08		8	0204-0333	831.68	332.64	270	60.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4284.0	B08		8	0205-0335	182.20	335.61	329	67.36	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3633.1	B08		8	0206-0338	35.69	338.17	193	52.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8960.3	B08		8	0207-0338	283.63	337.80	194	52.28	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8057.5	B08		8	0208-0341	442.74	341.90	307	66.43	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2202.2	B08		8	0209-0343	495.31	344.36	429	88.67	0.686
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2015.4	B08		8	0210-0341	749.53	341.13	261	59.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7303.2	B08		8	0211-0342	409.14	342.94	258	59.70	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4242.9	B08		8	0212-0344	786.04	343.56	228	55.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3126.7	B08		8	0213-0343	223.49	343.69	205	53.11	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1484.7	B08		8	0214-0345	72.07	344.02	253	60.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1392.7	B08		8	0215-0347	615.45	347.13	290	64.53	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3539.6	B08		8	0216-0349	847.39	348.96	278	64.08	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3514.2	B08		8	0217-0349	162.16	349.02	209	53.94	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2459.4	B08		8	0218-0352	904.73	351.46	230	59.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5337.8	B08		8	0219-0358	239.48	358.57	276	61.01	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5053.3	B08		8	0220-0361	372.20	361.46	328	68.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4116.8	B08		8	0221-0364	732.60	364.38	212	56.53	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1243.4	B08		8	0222-0365	669.58	364.77	308	69.94	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6379.6	B08		8	0223-0363	542.40	363.96	167	48.63	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2197.5	B08		8	0224-0367	825.59	367.27	264	63.01	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1686.5	B08		8	0225-0368	69.91	368.36	423	77.60	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5995.4	B08		8	0226-0367	509.82	366.75	165	49.11	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3663.6	B08		8	0227-0370	842.54	368.99	221	57.36	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5435.7	B08		8	0228-0370	904.68	370.38	299	63.94	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2667.4	B08		8	0229-0374	705.18	375.56	291	65.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			14013.1	B08		8	0230-0380	229.26	379.63	336	69.01	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2953.2	B08		8	0231-0381	625.58	381.14	261	59.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6484.1	B08		8	0232-0380	538.41	379.26	186	52.28	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6011.1	B08		8	0233-0380	122.53	380.11	176	49.46	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5216.3	B08		8	0234-0390	459.42	389.07	472	94.81	0.660
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2559.0	B08		8	0235-0385	174.02	384.99	229	55.11	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4165.3	B08		8	0236-0390	32.31	390.91	315	65.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2416.0	B08		8	0237-0390	476.96	389.92	250	59.46	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8253.2	B08		8	0238-0389	563.53	389.04	227	56.04	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2759.8	B08		8	0239-0392	96.37	392.44	221	54.53	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3800.6	B08		8	0240-0392	140.30	393.04	241	60.53	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4508.6	B08		8	0241-0394	517.34	394.43	226	57.36	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2976.5	B08		8	0242-0393	205.01	393.33	193	53.11	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4746.5	B08		8	0243-0396	357.48	395.76	326	68.43	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1727.7	B08		8	0244-0396	798.26	395.72	268	59.60	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4917.5	B08		8	0245-0393	115.88	393.18	177	49.70	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3112.3	B08		8	0246-0401	285.34	401.61	298	68.67	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3215.6	B08		8	0247-0403	854.48	404.25	271	62.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4365.7	B08		8	0248-0409	874.03	409.15	215	59.36	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			11592.4	B08		8	0249-0410	535.95	410.12	210	57.21	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2889.9	B08		8	0250-0409	757.81	409.18	241	57.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5590.1	B08		8	0251-0408	385.95	408.25	148	47.36	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1945.1	B08		8	0252-0412	51.60	411.98	247	62.43	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3427.1	B08		8	0253-0413	306.91	413.24	351	68.77	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4938.8	B08		8	0254-0411	617.11	411.83	213	54.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7411.7	B08		8	0255-0413	920.61	413.25	248	59.11	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2345.5	B08		8	0256-0425	43.38	424.45	270	64.08	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2808.2	B08		8	0257-0424	197.36	424.82	291	65.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6477.7	B08		8	0258-0426	840.62	426.82	249	59.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1736.5	B08		8	0259-0425	90.69	425.05	252	59.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7999.1	B08		8	0260-0426	395.24	426.38	188	54.18	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2017.7	B08		8	0261-0430	798.43	429.42	316	67.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1375.8	B08		8	0262-0428	429.05	427.54	272	61.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3830.7	B08		8	0263-0430	685.11	429.79	228	59.11	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3410.9	B08		8	0264-0430	536.49	429.89	224	59.21	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5829.1	B08		8	0265-0433	292.44	431.71	270	62.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1584.3	B08		8	0266-0433	463.81	433.41	344	70.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1664.4	B08		8	0267-0440	612.69	440.34	286	66.18	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3231.5	B08		8	0268-0440	376.98	439.41	296	67.36	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4174.7	B08		8	0269-0441	917.64	440.86	239	59.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6497.1	B08		8	0270-0441	571.71	441.23	324	67.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1698.7	B08		8	0271-0448	119.36	447.66	377	73.60	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3077.0	B08		8	0272-0444	709.38	444.02	214	53.70	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4890.0	B08		8	0273-0446	210.10	445.78	171	49.70	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6258.4	B08		8	0274-0450	251.93	449.17	467	84.33	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4000.3	B08		8	0275-0445	284.42	445.95	125	42.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2710.3	B08		8	0276-0447	758.43	447.39	273	63.36	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1537.3	B08		8	0277-0447	510.30	448.26	285	65.60	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7335.1	B08		8	0278-0451	197.74	451.73	214	54.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3591.9	B08		8	0279-0452	679.58	452.71	229	56.53	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1348.6	B08		8	0280-0455	414.52	455.68	259	65.26	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3510.8	B08		8	0281-0458	645.04	457.69	235	57.70	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2242.0	B08		8	0282-0461	893.09	460.31	237	61.11	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2285.7	B08		8	0283-0461	806.05	461.06	265	61.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1927.5	B08		8	0284-0460	849.37	459.94	300	73.26	0.703
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5788.3	B08		8	0285-0467	482.18	466.42	278	65.36	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			11051.9	B08		8	0286-0467	502.80	466.67	202	52.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8627.9	B08		8	0287-0468	175.68	468.11	131	44.39	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5439.3	B08		8	0288-0469	188.14	470.18	220	55.46	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8496.3	B08		8	0289-0470	164.58	470.70	133	44.87	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2160.8	B08		8	0290-0473	445.19	473.32	256	60.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5473.1	B08		8	0291-0476	340.33	476.43	305	64.43	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4335.2	B08		8	0292-0475	146.13	474.35	224	54.53	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2764.3	B08		8	0293-0476	594.06	476.63	181	50.28	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4275.7	B08		8	0294-0475	282.54	475.44	216	54.53	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1229.8	B08		8	0295-0480	38.72	480.74	281	66.67	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2791.9	B08		8	0296-0475	863.09	475.58	237	58.28	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5113.9	B08		8	0297-0476	670.54	476.17	223	56.28	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8112.3	B08		8	0298-0483	521.14	482.66	460	89.98	0.714
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1279.1	B08		8	0299-0486	72.47	487.20	271	64.77	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6138.5	B08		8	0300-0491	98.43	491.48	476	90.33	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2645.1	B08		8	0301-0489	681.87	489.05	240	57.94	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4590.6	B08		8	0302-0495	317.38	494.84	179	53.36	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4469.2	B08		8	0303-0498	424.53	498.54	275	61.60	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4291.9	B08		8	0304-0496	801.89	496.68	186	52.53	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1639.5	B08		8	0305-0496	568.46	496.21	140	45.46	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1729.6	B08		8	0306-0500	925.96	500.83	237	59.36	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3193.7	B08		8	0307-0506	409.35	506.26	265	71.36	0.654
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3393.9	B08		8	0308-0503	162.81	503.82	231	57.94	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4067.9	B08		8	0309-0502	252.53	502.28	254	61.11	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3514.5	B08		8	0310-0502	720.89	503.30	199	55.11	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5773.5	B08		8	0311-0506	118.28	506.07	213	55.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2066.3	B08		8	0312-0506	213.48	506.27	246	58.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1601.6	B08		8	0313-0505	513.95	505.20	270	61.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1340.1	B08		8	0314-0512	391.39	512.53	273	65.26	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2344.5	B08		8	0315-0508	573.78	508.38	197	52.63	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3657.7	B08		8	0316-0513	459.25	513.30	269	62.77	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			10225.9	B08		8	0317-0516	279.40	515.67	340	72.91	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3269.9	B08		8	0318-0517	34.47	517.38	330	67.01	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3286.0	B08		8	0319-0519	191.56	519.29	327	67.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2985.9	B08		8	0320-0520	598.95	520.02	222	58.43	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1587.8	B08		8	0321-0521	490.02	521.05	227	55.70	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1990.9	B08		8	0322-0523	544.13	524.15	269	79.01	0.541
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1613.5	B08		8	0323-0524	373.61	524.93	246	58.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5311.7	B08		8	0324-0524	249.55	524.74	219	54.87	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2903.7	B08		8	0325-0528	587.81	528.57	220	57.26	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3469.7	B08		8	0326-0528	661.83	528.57	227	57.11	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5980.4	B08		8	0327-0529	741.26	528.96	331	66.18	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8217.0	B08		8	0328-0529	265.76	529.33	168	49.11	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5711.0	B08		8	0329-0530	886.67	530.57	195	53.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4569.3	B08		8	0330-0536	475.34	535.73	334	73.36	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3135.6	B08		8	0331-0532	693.26	532.27	262	62.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3113.8	B08		8	0332-0535	904.34	535.08	217	57.11	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2434.7	B08		8	0333-0540	503.66	539.29	356	73.01	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4544.7	B08		8	0334-0536	837.33	536.46	168	51.11	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1081.9	B08		8	0335-0540	618.73	540.15	265	63.60	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2439.7	B08		8	0336-0545	108.17	545.82	246	60.77	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			15637.3	B08		8	0337-0540	310.74	540.38	112	45.11	0.692
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1370.8	B08		8	0338-0544	540.04	543.04	278	84.91	0.485
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3500.6	B08		8	0339-0543	647.59	542.83	260	59.94	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3475.0	B08		8	0340-0543	228.87	543.02	213	53.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4254.5	B08		8	0341-0547	440.74	547.05	393	74.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1778.6	B08		8	0342-0547	294.62	547.99	340	68.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1858.8	B08		8	0343-0549	63.74	548.50	494	85.84	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2206.2	B08		8	0344-0547	405.03	547.38	199	53.94	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1811.0	B08		8	0345-0553	720.38	553.08	424	78.91	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1710.4	B08		8	0346-0555	585.25	555.47	238	57.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2470.2	B08		8	0347-0557	930.45	557.56	203	53.94	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3886.6	B08		8	0348-0561	829.71	561.23	214	54.53	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6355.2	B08		8	0349-0561	149.59	561.09	177	51.11	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1493.1	B08		8	0350-0565	359.49	565.73	275	60.28	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3606.2	B08		8	0351-0567	899.27	567.38	262	59.60	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5137.0	B08		8	0352-0583	151.66	583.78	549	92.33	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2769.1	B08		8	0353-0575	301.99	574.27	211	54.53	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2661.2	B08		8	0354-0579	446.16	578.94	247	60.43	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2329.7	B08		8	0355-0580	653.80	579.80	251	60.77	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3574.8	B08		8	0356-0578	881.69	578.52	187	50.28	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			899.5	B08		8	0357-0582	591.28	583.00	268	61.26	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1297.0	B08		8	0358-0586	635.36	586.45	320	72.43	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1686.3	B08		8	0359-0585	522.96	585.30	305	67.36	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2729.3	B08		8	0360-0587	364.23	587.18	323	67.01	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			13114.6	B08		8	0361-0584	292.96	585.51	169	49.11	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1469.3	B08		8	0362-0586	710.05	586.60	261	61.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1784.3	B08		8	0363-0588	546.84	587.82	378	76.18	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2363.5	B08		8	0364-0585	746.54	585.66	197	52.28	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2834.0	B08		8	0365-0594	428.50	594.90	260	61.36	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			9406.9	B08		8	0366-0591	791.24	591.44	157	44.87	0.980
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3598.9	B08		8	0367-0594	106.89	593.63	301	67.36	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3867.7	B08		8	0368-0597	409.77	597.79	382	73.26	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2010.3	B08		8	0369-0601	38.88	600.70	394	73.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2221.6	B08		8	0370-0599	245.03	599.26	215	57.11	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			12699.4	B08		8	0371-0603	294.83	602.94	352	87.26	0.581
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2656.4	B08		8	0372-0603	122.93	603.29	228	56.77	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2256.9	B08		8	0373-0602	745.82	602.88	254	59.70	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4259.0	B08		8	0374-0608	772.61	607.70	396	82.08	0.739
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4966.1	B08		8	0375-0611	588.28	610.98	281	61.11	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1913.0	B08		8	0376-0612	691.92	612.85	280	65.36	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1323.3	B08		8	0377-0611	621.03	610.64	266	65.11	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2879.5	B08		8	0378-0615	660.18	615.09	219	54.77	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1124.6	B08		8	0379-0615	91.00	615.30	225	55.11	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1072.1	B08		8	0380-0622	353.66	621.48	274	67.60	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			742.9	B08		8	0381-0617	484.70	617.51	235	57.46	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4392.2	B08		8	0382-0619	283.71	620.14	193	51.46	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1679.0	B08		8	0383-0624	540.61	624.20	286	64.43	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2237.2	B08		8	0384-0623	809.43	623.21	223	55.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3782.4	B08		8	0385-0626	369.46	626.27	240	59.11	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1323.6	B08		8	0386-0628	750.05	628.17	455	80.08	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6680.8	B08		8	0387-0626	315.90	625.91	218	54.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1904.7	B08		8	0388-0630	400.01	630.46	315	65.01	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1253.2	B08		8	0389-0634	103.08	633.11	250	61.60	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			15560.7	B08		8	0390-0633	301.76	632.85	182	52.77	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1296.4	B08		8	0391-0634	920.99	635.17	270	65.01	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6667.5	B08		8	0392-0641	826.35	642.57	525	91.01	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1467.1	B08		8	0393-0636	250.17	635.64	243	57.11	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			14521.8	B08		8	0394-0636	286.29	635.91	299	67.11	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3800.2	B08		8	0395-0640	56.08	640.78	309	64.18	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8101.4	B08		8	0396-0645	176.16	644.35	531	89.74	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6138.2	B08		8	0397-0642	149.11	641.65	448	83.26	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4396.4	B08		8	0398-0641	548.88	641.16	219	57.01	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3134.1	B08		8	0399-0644	331.95	643.38	244	59.60	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3149.6	B08		8	0400-0644	615.31	644.31	242	60.53	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2273.6	B08		8	0401-0653	518.96	653.04	290	69.36	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4774.3	B08		8	0402-0654	562.67	654.67	315	66.18	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2367.2	B08		8	0403-0658	878.27	658.10	486	88.33	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1444.5	B08		8	0404-0659	685.60	660.49	274	65.60	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			10041.1	B08		8	0405-0660	134.72	659.99	277	61.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4460.6	B08		8	0406-0659	651.26	658.94	214	56.18	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			10334.0	B08		8	0407-0662	215.01	661.71	477	97.64	0.629
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3511.5	B08		8	0408-0660	432.11	659.62	345	68.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2374.8	B08		8	0409-0661	746.57	660.93	266	60.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1061.4	B08		8	0410-0660	941.90	660.60	248	60.28	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			13163.5	B08		8	0411-0660	189.48	661.10	161	49.11	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7197.6	B08		8	0412-0661	39.92	660.81	174	50.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4701.7	B08		8	0413-0664	81.31	663.61	225	57.70	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3878.8	B08		8	0414-0668	27.47	667.37	212	59.36	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3269.2	B08		8	0415-0670	173.32	670.15	233	58.53	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3631.8	B08		8	0416-0671	593.71	671.10	209	53.94	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2891.4	B08		8	0417-0679	567.36	678.71	242	59.84	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1336.3	B08		8	0418-0680	633.95	680.76	292	63.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1703.5	B08		8	0419-0685	777.50	685.49	371	71.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2862.4	B08		8	0420-0687	429.91	687.24	392	75.01	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1799.9	B08		8	0421-0684	263.38	684.17	218	56.53	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3092.1	B08		8	0422-0686	584.10	686.88	285	67.01	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3445.9	B08		8	0423-0680	903.82	679.87	100	37.21	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2393.8	B08		8	0424-0688	864.67	688.04	231	55.36	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4609.4	B08		8	0425-0688	80.75	689.10	232	57.11	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3902.6	B08		8	0426-0690	240.48	690.82	319	66.43	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1868.0	B08		8	0427-0693	719.10	693.26	270	60.53	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2615.8	B08		8	0428-0691	901.19	691.00	113	40.63	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3716.4	B08		8	0429-0697	17.33	697.09	223	56.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3254.0	B08		8	0430-0698	42.08	697.67	293	61.94	0.960
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4290.1	B08		8	0431-0699	548.17	698.83	224	56.28	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3678.9	B08		8	0432-0702	522.67	703.01	282	71.01	0.703
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7590.8	B08		8	0433-0703	351.47	703.31	310	65.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3421.5	B08		8	0434-0703	796.34	702.67	220	56.18	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2799.0	B08		8	0435-0702	574.57	702.78	210	54.28	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1011.0	B08		8	0436-0706	669.98	705.58	287	71.60	0.704
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2158.8	B08		9	0001-0029	375.41	28.74	246	63.11	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6152.7	B08		9	0002-0035	296.66	35.80	264	59.94	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2162.7	B08		9	0003-0036	644.36	36.42	315	66.53	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5698.8	B08		9	0004-0038	498.11	37.25	198	56.28	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3638.9	B08		9	0005-0041	524.43	41.73	478	87.74	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2953.8	B08		9	0006-0036	419.86	35.88	237	57.11	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1291.2	B08		9	0007-0037	916.03	37.79	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7025.3	B08		9	0008-0038	140.82	38.08	237	56.53	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2150.2	B08		9	0009-0041	868.08	40.29	256	63.26	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2617.9	B08		9	0010-0042	802.53	43.08	239	57.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2057.3	B08		9	0011-0045	752.63	45.65	300	67.94	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5004.1	B08		9	0012-0043	77.15	42.42	188	50.53	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6907.3	B08		9	0013-0043	22.75	43.23	221	55.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5555.7	B08		9	0014-0048	195.35	48.09	125	41.11	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5917.2	B08		9	0015-0057	182.56	57.31	447	82.91	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1834.3	B08		9	0016-0059	157.91	60.02	233	61.01	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5056.3	B08		9	0017-0057	34.87	57.15	199	51.70	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			756.5	B08		9	0018-0056	285.96	56.48	248	60.77	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4463.4	B08		9	0019-0062	107.83	62.92	258	61.94	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2355.1	B08		9	0020-0064	915.19	64.42	323	65.60	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			11264.8	B08		9	0021-0069	346.07	69.89	504	96.57	0.679
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6526.1	B08		9	0022-0063	704.13	62.44	191	53.70	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1810.8	B08		9	0023-0066	436.04	66.09	338	70.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2694.9	B08		9	0024-0068	580.73	68.94	270	62.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2950.5	B08		9	0025-0070	725.46	70.06	223	58.77	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			803.2	B08		9	0026-0072	284.31	72.25	291	63.36	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2476.8	B08		9	0027-0075	862.66	75.75	196	53.11	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			949.9	B08		9	0028-0081	662.91	82.52	347	71.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2572.7	B08		9	0029-0080	395.44	80.30	251	58.87	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2491.5	B08		9	0030-0082	932.73	81.71	281	61.60	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3408.0	B08		9	0031-0086	835.57	86.40	322	67.01	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1410.7	B08		9	0032-0088	176.88	88.51	268	61.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1956.6	B08		9	0033-0089	413.59	90.14	246	62.77	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			760.6	B08		9	0034-0092	612.75	92.05	284	68.08	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2390.8	B08		9	0035-0089	761.59	88.86	231	57.70	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1657.5	B08		9	0036-0095	240.04	95.34	359	70.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			11008.4	B08		9	0037-0092	365.95	91.80	166	51.70	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4091.3	B08		9	0038-0097	107.13	96.97	346	69.01	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8232.5	B08		9	0039-0095	479.40	93.97	208	55.01	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			10899.5	B08		9	0040-0095	395.91	94.90	126	44.28	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			11170.2	B08		9	0041-0100	384.59	100.22	192	62.67	0.614
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1571.5	B08		9	0042-0101	710.55	101.66	287	74.08	0.657
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			10715.9	B08		9	0043-0110	644.32	111.09	321	72.18	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8774.9	B08		9	0044-0106	372.78	107.06	198	52.77	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6873.2	B08		9	0045-0110	466.14	110.96	338	70.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1648.3	B08		9	0046-0112	75.69	112.16	235	56.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1412.8	B08		9	0047-0116	36.68	116.61	256	63.01	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1994.7	B08		9	0048-0118	294.42	117.84	409	74.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4393.9	B08		9	0049-0119	431.62	119.28	337	71.84	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2440.6	B08		9	0050-0120	677.17	120.32	449	78.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4539.7	B08		9	0051-0121	411.39	121.23	277	62.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1213.3	B08		9	0052-0128	190.63	128.16	380	73.36	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1992.7	B08		9	0053-0126	224.06	125.99	270	63.94	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1836.6	B08		9	0054-0128	144.88	128.15	231	56.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1737.4	B08		9	0055-0133	746.35	133.64	381	73.26	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1424.1	B08		9	0056-0134	835.53	133.85	352	78.33	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2464.0	B08		9	0057-0139	253.74	138.75	396	74.67	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4058.2	B08		9	0058-0141	818.10	141.83	228	57.11	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1582.0	B08		9	0059-0144	47.69	143.22	250	61.36	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2526.2	B08		9	0060-0146	541.50	146.66	220	58.77	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4249.9	B08		9	0061-0150	866.35	150.41	235	57.60	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3915.2	B08		9	0062-0149	219.61	150.24	257	61.11	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2197.5	B08		9	0063-0153	936.51	153.32	219	56.53	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2667.9	B08		9	0064-0152	631.80	151.95	274	63.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1424.0	B08		9	0065-0156	715.63	156.14	264	59.94	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4761.4	B08		9	0066-0159	132.93	160.15	351	80.08	0.688
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2543.2	B08		9	0067-0159	577.05	159.47	210	55.70	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2680.0	B08		9	0068-0161	523.25	160.27	245	71.60	0.601
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1371.6	B08		9	0069-0166	589.08	166.62	279	68.18	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4469.3	B08		9	0070-0168	857.63	168.79	337	69.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2863.3	B08		9	0071-0168	163.28	168.37	218	58.77	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1045.6	B08		9	0072-0167	753.10	167.95	345	77.36	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1378.1	B08		9	0073-0170	813.41	169.51	207	59.11	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2151.5	B08		9	0074-0173	337.38	173.65	437	79.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2568.6	B08		9	0075-0173	53.07	173.78	231	57.94	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1048.9	B08		9	0076-0177	659.41	177.28	409	77.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1996.1	B08		9	0077-0177	903.32	177.17	420	77.26	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			10108.3	B08		9	0078-0177	119.07	177.60	157	47.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			9830.8	B08		9	0079-0179	279.29	179.71	293	63.94	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2177.2	B08		9	0080-0180	544.45	179.49	254	59.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1801.9	B08		9	0081-0186	495.05	186.44	413	75.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2288.9	B08		9	0082-0189	700.98	189.95	318	74.67	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2220.1	B08		9	0083-0200	82.82	200.43	296	66.18	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1534.7	B08		9	0084-0201	898.68	200.80	261	61.84	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1007.1	B08		9	0085-0203	39.87	204.14	236	65.01	0.702
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3019.3	B08		9	0086-0210	142.72	209.61	345	69.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1636.0	B08		9	0087-0210	815.25	209.94	406	75.60	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5620.4	B08		9	0088-0215	585.72	215.59	294	65.60	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6121.4	B08		9	0089-0220	316.80	220.33	296	63.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2961.7	B08		9	0090-0225	761.42	225.12	457	83.26	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3332.3	B08		9	0091-0221	68.78	221.25	223	57.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7502.7	B08		9	0092-0222	712.47	222.20	219	55.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2649.6	B08		9	0093-0229	444.65	229.37	286	62.53	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3496.9	B08		9	0094-0229	257.22	228.54	248	60.77	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1420.0	B08		9	0095-0230	419.36	229.52	313	66.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4155.8	B08		9	0096-0228	934.52	228.45	208	55.11	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			9534.9	B08		9	0097-0233	696.55	233.45	214	54.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3603.3	B08		9	0098-0232	866.73	232.18	273	61.60	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6453.4	B08		9	0099-0240	469.31	240.67	512	91.50	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8499.5	B08		9	0100-0231	583.41	230.91	168	48.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1566.3	B08		9	0101-0237	641.00	236.87	303	71.01	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1765.2	B08		9	0102-0237	786.48	236.79	348	67.60	0.957
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3591.2	B08		9	0103-0238	568.60	238.28	246	62.18	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3891.1	B08		9	0104-0243	188.18	242.63	287	63.94	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3006.0	B08		9	0105-0245	37.25	244.38	184	53.70	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8100.5	B08		9	0106-0247	51.01	246.24	250	65.36	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2349.1	B08		9	0107-0246	387.87	246.42	235	58.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2351.9	B08		9	0108-0247	668.56	246.78	218	58.53	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6603.0	B08		9	0109-0246	67.09	246.25	134	44.04	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3113.9	B08		9	0110-0249	757.96	250.41	242	59.84	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3263.1	B08		9	0111-0251	114.69	250.68	376	73.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4094.7	B08		9	0112-0249	731.62	249.28	190	51.70	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3636.3	B08		9	0113-0256	95.29	255.88	233	57.46	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3208.5	B08		9	0114-0264	314.31	264.28	268	63.11	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5531.6	B08		9	0115-0263	73.71	263.86	225	61.36	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2283.3	B08		9	0116-0262	474.21	262.79	286	65.94	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3507.0	B08		9	0117-0270	339.27	270.00	284	63.36	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6847.8	B08		9	0118-0269	535.85	268.73	309	66.18	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7116.6	B08		9	0119-0269	182.69	270.82	188	52.63	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3952.4	B08		9	0120-0272	17.79	271.66	249	58.53	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2363.9	B08		9	0121-0275	763.22	275.32	256	58.53	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6331.4	B08		9	0122-0277	555.54	277.08	261	60.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4467.2	B08		9	0123-0284	50.90	284.12	340	70.53	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2798.9	B08		9	0124-0281	99.05	281.25	217	54.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1553.3	B08		9	0125-0287	246.12	287.94	272	67.84	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5955.9	B08		9	0126-0292	726.80	291.74	517	93.15	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4408.2	B08		9	0127-0290	183.49	289.35	416	76.18	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			10813.3	B08		9	0128-0289	334.17	289.12	270	59.94	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7578.7	B08		9	0129-0291	540.49	291.77	368	70.43	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5759.5	B08		9	0130-0292	449.98	292.00	252	57.11	0.971
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3753.1	B08		9	0131-0295	589.40	296.33	240	59.94	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2978.4	B08		9	0132-0294	801.72	294.94	278	69.84	0.716
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3937.3	B08		9	0133-0295	493.60	294.97	291	63.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1909.4	B08		9	0134-0300	260.29	300.34	263	68.77	0.699
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4069.4	B08		9	0135-0306	171.30	306.21	233	57.94	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			10313.9	B08		9	0136-0312	29.03	312.93	218	56.53	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3811.9	B08		9	0137-0311	895.81	310.71	243	58.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			905.9	B08		9	0138-0318	53.27	318.60	345	82.08	0.643
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2907.3	B08		9	0139-0316	771.09	315.11	296	64.53	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6620.7	B08		9	0140-0318	229.24	318.55	191	51.70	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2221.3	B08		9	0141-0320	438.45	319.63	210	55.70	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4724.2	B08		9	0142-0321	467.78	320.33	229	56.28	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4713.6	B08		9	0143-0321	317.76	321.39	263	67.36	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1267.9	B08		9	0144-0328	922.76	328.97	281	67.11	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2824.6	B08		9	0145-0327	186.14	327.13	204	54.53	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3554.5	B08		9	0146-0334	85.06	333.61	377	76.18	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1899.4	B08		9	0147-0328	528.84	327.56	216	57.70	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2546.2	B08		9	0148-0337	300.90	337.37	226	68.91	0.598
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2194.0	B08		9	0149-0338	407.57	338.42	370	72.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2607.9	B08		9	0150-0340	108.35	340.54	212	56.28	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2960.1	B08		9	0151-0341	495.40	341.38	246	59.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4036.8	B08		9	0152-0341	755.99	340.88	209	54.28	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3513.0	B08		9	0153-0343	626.36	343.83	258	58.77	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2762.4	B08		9	0154-0344	427.02	344.31	229	57.46	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3240.2	B08		9	0155-0345	682.42	345.77	237	57.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2052.4	B08		9	0156-0352	877.69	351.77	267	62.87	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1254.0	B08		9	0157-0354	511.28	354.98	227	59.94	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1843.1	B08		9	0158-0355	359.05	355.36	404	74.18	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1891.7	B08		9	0159-0357	108.57	356.48	250	58.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4550.5	B08		9	0160-0362	712.63	362.15	219	55.36	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1577.0	B08		9	0161-0364	854.69	363.71	235	58.77	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4113.9	B08		9	0162-0374	762.71	374.69	251	58.53	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7012.2	B08		9	0163-0382	541.62	381.84	369	69.84	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3320.8	B08		9	0164-0384	836.72	385.18	259	62.53	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1712.8	B08		9	0165-0388	132.56	388.06	423	79.84	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4756.0	B08		9	0166-0383	443.86	383.52	208	54.53	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7569.2	B08		9	0167-0385	591.05	385.30	269	63.36	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3812.9	B08		9	0168-0383	795.38	383.11	199	51.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2242.2	B08		9	0169-0386	880.30	385.53	249	63.84	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6182.4	B08		9	0170-0388	609.83	388.72	299	68.18	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2711.4	B08		9	0171-0392	751.60	392.00	346	68.18	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3824.3	B08		9	0172-0392	61.36	392.33	283	61.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8180.2	B08		9	0173-0398	557.28	397.94	324	66.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1881.2	B08		9	0174-0397	499.20	396.92	252	61.11	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2959.4	B08		9	0175-0403	283.02	403.64	278	66.53	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1399.6	B08		9	0176-0402	205.79	402.27	267	61.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1515.0	B08		9	0177-0403	233.59	403.91	230	58.28	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2355.4	B08		9	0178-0405	473.13	404.50	404	75.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4136.0	B08		9	0179-0406	83.40	406.15	256	65.60	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4116.5	B08		9	0180-0413	789.67	413.15	247	57.36	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3929.1	B08		9	0181-0416	426.35	416.54	220	56.53	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1504.8	B08		9	0182-0423	837.61	424.02	364	74.91	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2750.1	B08		9	0183-0421	305.15	420.27	213	56.53	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1714.7	B08		9	0184-0422	494.32	422.69	230	56.43	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2098.0	B08		9	0185-0426	371.17	426.66	319	67.01	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2949.5	B08		9	0186-0427	537.70	427.27	339	69.01	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5462.1	B08		9	0187-0432	685.33	431.98	231	59.36	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1366.0	B08		9	0188-0431	97.98	430.39	188	56.39	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2884.9	B08		9	0189-0433	54.32	433.29	233	60.53	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5149.5	B08		9	0190-0436	449.92	436.02	269	60.53	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1556.0	B08		9	0191-0442	519.64	442.54	258	64.87	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1953.8	B08		9	0192-0439	203.08	439.76	261	62.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			14736.7	B08		9	0193-0437	789.12	437.27	116	40.63	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8270.0	B08		9	0194-0440	878.12	440.65	189	52.77	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1268.4	B08		9	0195-0443	98.41	442.84	227	59.11	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1539.1	B08		9	0196-0447	570.66	447.10	432	77.26	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5258.9	B08		9	0197-0448	170.09	448.37	247	57.94	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1765.5	B08		9	0198-0446	269.82	445.98	162	47.70	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1903.8	B08		9	0199-0446	254.95	446.32	123	39.70	0.981
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4688.9	B08		9	0200-0452	673.57	452.65	230	79.15	0.461
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4418.1	B08		9	0201-0452	307.23	451.83	314	65.60	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4585.3	B08		9	0202-0455	458.89	454.01	262	61.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5788.8	B08		9	0203-0454	867.79	454.33	272	60.77	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3104.0	B08		9	0204-0457	197.88	457.55	260	59.94	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5488.1	B08		9	0205-0458	886.30	458.69	261	59.11	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2012.8	B08		9	0206-0461	116.98	460.20	312	66.77	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2524.3	B08		9	0207-0457	382.26	457.42	169	48.87	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1812.9	B08		9	0208-0462	262.87	461.81	282	64.18	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3097.6	B08		9	0209-0462	492.45	462.02	229	58.77	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			11225.1	B08		9	0210-0465	652.17	465.62	167	52.53	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2819.5	B08		9	0211-0467	447.34	467.17	217	56.53	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2552.0	B08		9	0212-0471	237.87	471.44	203	54.53	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2866.3	B08		9	0213-0475	615.13	476.07	237	61.94	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5806.5	B08		9	0214-0474	890.92	474.25	224	58.77	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1878.8	B08		9	0215-0477	410.11	477.40	250	60.28	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2281.1	B08		9	0216-0481	835.88	480.63	245	68.43	0.658
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2116.0	B08		9	0217-0482	131.20	482.57	312	67.36	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2775.2	B08		9	0218-0485	789.47	484.56	241	57.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4254.9	B08		9	0219-0488	293.83	487.81	344	69.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1340.2	B08		9	0220-0493	57.35	493.06	480	85.50	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2879.1	B08		9	0221-0491	203.22	491.41	302	64.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2078.6	B08		9	0222-0490	177.03	490.29	235	56.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2412.2	B08		9	0223-0495	751.21	495.28	280	66.77	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1159.7	B08		9	0224-0498	80.23	499.11	399	74.43	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4683.8	B08		9	0225-0497	922.77	497.48	204	57.70	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1647.2	B08		9	0226-0502	236.73	501.88	415	75.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4901.9	B08		9	0227-0498	573.39	498.78	297	62.53	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5683.5	B08		9	0228-0500	322.76	499.64	277	61.60	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2448.6	B08		9	0229-0502	506.79	501.80	248	58.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1721.7	B08		9	0230-0503	20.49	503.65	227	58.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4619.7	B08		9	0231-0503	613.53	503.98	219	57.60	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3505.9	B08		9	0232-0506	148.19	505.77	242	59.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2572.9	B08		9	0233-0507	431.14	506.84	291	62.53	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3428.0	B08		9	0234-0507	638.99	507.50	240	56.53	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3582.6	B08		9	0235-0513	402.86	513.41	325	66.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1596.8	B08		9	0236-0514	539.86	512.74	302	67.84	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2729.6	B08		9	0237-0515	869.62	515.16	264	61.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2470.7	B08		9	0238-0516	369.98	516.93	269	64.18	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2236.9	B08		9	0239-0519	104.22	518.97	321	67.26	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5266.3	B08		9	0240-0525	570.22	526.36	302	65.94	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2966.9	B08		9	0241-0528	304.28	527.73	282	63.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1061.1	B08		9	0242-0532	817.06	532.15	301	66.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4651.7	B08		9	0243-0529	424.39	528.53	175	47.94	0.957
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2617.3	B08		9	0244-0536	692.32	536.35	300	71.01	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2202.8	B08		9	0245-0535	203.65	535.32	324	70.77	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2457.0	B08		9	0246-0534	332.49	534.09	240	59.60	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3881.2	B08		9	0247-0535	479.98	535.04	241	57.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4533.6	B08		9	0248-0535	624.18	535.37	228	54.53	0.964
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2297.0	B08		9	0249-0541	520.93	541.71	289	66.08	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3362.3	B08		9	0250-0540	436.99	540.78	196	51.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2040.3	B08		9	0251-0542	849.90	542.58	274	61.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3631.2	B08		9	0252-0547	578.88	546.35	334	73.26	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4338.9	B08		9	0253-0547	64.50	546.90	227	56.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3113.7	B08		9	0254-0548	272.23	548.62	433	82.67	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3761.0	B08		9	0255-0549	125.58	549.29	309	65.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3307.8	B08		9	0256-0552	634.80	553.72	295	69.01	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2619.6	B08		9	0257-0554	757.50	554.76	286	61.94	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3328.1	B08		9	0258-0558	555.44	558.53	254	60.77	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2536.6	B08		9	0259-0560	24.96	560.43	200	53.70	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4037.9	B08		9	0260-0562	697.90	561.96	263	64.77	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2839.5	B08		9	0261-0563	849.83	563.63	267	62.77	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4127.1	B08		9	0262-0566	598.76	565.95	287	64.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3504.6	B08		9	0263-0565	51.84	565.11	217	53.94	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1132.4	B08		9	0264-0568	888.61	568.11	289	68.43	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1572.1	B08		9	0265-0572	386.02	571.90	243	58.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2294.2	B08		9	0266-0575	514.40	575.95	281	61.70	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3402.6	B08		9	0267-0581	532.87	581.25	353	71.94	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1863.7	B08		9	0268-0579	287.29	578.41	257	65.84	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1877.9	B08		9	0269-0584	864.73	583.81	303	73.26	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3789.7	B08		9	0270-0584	646.24	584.16	276	63.01	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3632.6	B08		9	0271-0585	50.25	586.00	238	56.53	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3111.6	B08		9	0272-0588	179.41	588.74	349	70.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2066.5	B08		9	0273-0590	332.10	590.35	315	67.36	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4144.6	B08		9	0274-0586	763.04	585.73	159	46.28	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3692.3	B08		9	0275-0592	716.93	591.83	260	62.43	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3013.5	B08		9	0276-0596	84.07	595.42	314	70.43	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			823.7	B08		9	0277-0596	569.57	597.08	525	102.57	0.627
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2926.0	B08		9	0278-0595	813.75	595.63	252	65.36	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4153.6	B08		9	0279-0592	473.14	591.49	225	56.87	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2863.4	B08		9	0280-0596	369.67	596.03	280	62.18	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4311.8	B08		9	0281-0596	774.53	596.67	295	65.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3132.7	B08		9	0282-0601	122.68	601.11	241	61.84	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1785.6	B08		9	0283-0598	437.42	599.28	254	61.94	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3104.8	B08		9	0284-0604	937.38	603.42	278	62.53	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6520.8	B08		9	0285-0604	397.84	603.82	232	55.36	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4514.7	B08		9	0286-0609	894.82	608.75	206	54.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2140.9	B08		9	0287-0616	115.39	616.74	322	71.60	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3419.8	B08		9	0288-0614	727.58	614.63	374	73.01	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2807.5	B08		9	0289-0615	291.21	615.32	234	60.18	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4738.8	B08		9	0290-0611	909.17	611.05	147	46.04	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3187.3	B08		9	0291-0616	59.21	615.88	279	62.18	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3188.4	B08		9	0292-0616	645.44	616.87	345	73.26	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4596.4	B08		9	0293-0617	868.69	617.47	490	92.81	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1882.2	B08		9	0294-0618	309.51	618.88	216	61.84	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2760.0	B08		9	0295-0618	274.72	618.27	204	54.53	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2496.0	B08		9	0296-0622	927.25	621.70	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2678.4	B08		9	0297-0624	218.76	623.81	309	63.60	0.960
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4249.1	B08		9	0298-0628	473.80	627.67	178	52.53	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3625.0	B08		9	0299-0629	88.26	629.56	283	62.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2645.3	B08		9	0300-0629	777.02	628.82	261	61.01	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1794.6	B08		9	0301-0635	568.32	635.08	290	73.84	0.668
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2706.2	B08		9	0302-0631	810.05	630.69	249	63.26	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3052.5	B08		9	0303-0630	383.60	630.36	218	53.36	0.962
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3228.0	B08		9	0304-0632	640.10	632.53	232	59.70	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3347.5	B08		9	0305-0633	902.89	632.87	350	68.18	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3444.5	B08		9	0306-0631	325.68	632.39	263	60.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5144.4	B08		9	0307-0633	688.22	633.46	306	63.94	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1606.8	B08		9	0308-0640	182.52	640.32	330	69.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3526.8	B08		9	0309-0639	110.84	638.95	229	56.53	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4819.6	B08		9	0310-0642	264.97	641.97	190	53.36	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1807.7	B08		9	0311-0642	946.31	642.26	211	55.94	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			9031.2	B08		9	0312-0653	717.73	653.94	494	85.15	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2381.6	B08		9	0313-0650	429.31	649.95	196	52.28	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1731.8	B08		9	0314-0655	504.15	656.17	268	64.18	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2428.4	B08		9	0315-0652	657.70	652.90	261	59.11	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5416.1	B08		9	0316-0654	70.78	654.67	174	51.11	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1866.5	B08		9	0317-0657	339.71	657.78	226	56.53	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1215.1	B08		9	0318-0655	383.03	655.64	149	48.87	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1323.7	B08		9	0319-0657	200.29	656.11	247	59.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4007.0	B08		9	0320-0658	839.59	659.58	154	49.70	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2167.5	B08		9	0321-0657	444.85	658.14	127	47.11	0.719
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5427.7	B08		9	0322-0661	623.12	662.42	258	63.60	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			9250.3	B08		9	0323-0658	568.08	658.62	172	49.70	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5923.6	B08		9	0324-0659	790.18	659.37	206	54.28	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1108.7	B08		9	0325-0663	35.78	663.64	240	57.94	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3625.7	B08		9	0326-0662	404.60	661.96	211	57.36	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2089.0	B08		9	0327-0664	162.23	664.66	252	61.94	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1837.8	B08		9	0328-0670	140.52	670.03	284	64.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1631.1	B08		9	0329-0672	297.72	672.30	288	66.43	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3235.3	B08		9	0330-0674	875.21	673.40	244	60.53	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3197.5	B08		9	0331-0676	380.69	676.33	270	67.84	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4106.6	B08		9	0332-0675	91.03	674.87	253	59.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6059.3	B08		9	0333-0676	937.72	675.75	245	59.11	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6003.3	B08		9	0334-0674	786.59	674.75	198	50.87	0.962
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1952.6	B08		9	0335-0684	887.77	684.20	229	60.77	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1285.3	B08		9	0336-0686	264.85	686.00	246	60.53	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2893.9	B08		9	0337-0692	837.75	693.34	241	64.43	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1815.4	B08		9	0338-0695	451.42	695.09	247	59.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1263.3	B08		9	0339-0698	629.42	698.59	368	72.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2427.0	B08		9	0340-0696	691.70	698.16	252	70.43	0.638
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3972.7	B08		9	0341-0695	937.50	695.64	242	57.11	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1331.0	B08		9	0342-0697	110.29	698.24	232	66.18	0.666
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2171.5	B08		9	0343-0703	749.84	702.22	218	59.11	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5197.2	B08		9	0344-0703	45.50	703.45	308	66.43	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1678.0	B08		9	0345-0708	150.33	708.96	334	70.43	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			584.6	B08		9	0346-0706	185.63	705.56	275	66.43	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2777.5	B08		9	0347-0703	907.57	703.18	102	37.80	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3160.8	B08		9	0348-0708	216.50	709.43	226	57.36	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2659.3	C08		1	0001-0025	822.14	25.96	373	78.43	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3337.1	C08		1	0002-0032	681.57	32.38	336	70.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1347.5	C08		1	0003-0031	209.13	31.38	259	59.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			409.8	C08		1	0004-0035	598.48	35.02	291	65.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			606.6	C08		1	0005-0033	294.09	33.97	277	61.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1354.1	C08		1	0006-0037	95.05	37.30	267	59.36	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3345.5	C08		1	0007-0038	133.57	38.49	299	64.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			891.3	C08		1	0008-0040	943.98	40.01	322	66.77	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1221.4	C08		1	0009-0040	72.15	41.03	262	61.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1694.7	C08		1	0010-0039	525.47	39.38	257	59.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1105.2	C08		1	0011-0041	554.92	42.34	237	63.60	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			410.2	C08		1	0012-0041	925.52	41.93	290	61.94	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			447.6	C08		1	0013-0045	740.21	45.84	288	63.84	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1317.3	C08		1	0014-0050	351.70	51.05	330	68.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4238.8	C08		1	0015-0054	703.39	54.41	393	100.57	0.488
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1464.3	C08		1	0016-0050	831.85	50.06	209	52.28	0.961
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			662.2	C08		1	0017-0054	308.76	53.84	288	64.43	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			349.8	C08		1	0018-0058	877.05	57.46	291	64.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			947.8	C08		1	0019-0061	784.13	62.60	326	70.18	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1690.3	C08		1	0020-0061	248.09	60.88	258	61.01	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3866.8	C08		1	0021-0063	901.93	63.40	246	58.18	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1294.2	C08		1	0022-0065	450.72	64.22	288	63.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			623.6	C08		1	0023-0070	278.90	71.24	278	66.18	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			765.7	C08		1	0024-0072	603.94	72.36	320	66.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			455.5	C08		1	0025-0072	740.78	71.77	255	64.43	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5262.6	C08		1	0026-0072	691.94	72.87	204	67.26	0.567
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			393.3	C08		1	0027-0072	50.25	71.85	260	59.94	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			516.4	C08		1	0028-0074	438.92	74.68	303	65.26	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2928.2	C08		1	0029-0079	190.55	76.48	356	97.64	0.469
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			337.3	C08		1	0030-0075	870.05	76.04	277	65.36	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			365.9	C08		1	0031-0085	158.34	84.95	308	67.60	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3643.0	C08		1	0032-0085	93.65	85.12	246	58.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1696.8	C08		1	0033-0086	125.51	86.38	303	68.08	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			362.9	C08		1	0034-0086	411.37	86.47	305	64.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			739.8	C08		1	0035-0086	333.45	86.21	307	67.36	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			855.9	C08		1	0036-0095	644.36	95.56	264	61.94	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1115.0	C08		1	0037-0095	520.50	94.48	257	62.77	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			639.3	C08		1	0038-0096	764.15	95.07	320	71.01	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1283.5	C08		1	0039-0100	537.98	100.04	222	57.94	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4899.1	C08		1	0040-0101	506.98	101.49	188	52.53	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1721.1	C08		1	0041-0103	259.99	103.05	262	59.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2771.5	C08		1	0042-0105	493.19	105.07	201	53.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1106.4	C08		1	0043-0106	37.63	106.01	252	59.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			981.5	C08		1	0044-0109	240.13	108.48	280	63.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			561.3	C08		1	0045-0108	558.40	108.86	306	65.36	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			503.5	C08		1	0046-0108	577.01	108.07	250	57.36	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			303.5	C08		1	0047-0107	811.47	107.51	328	67.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			328.0	C08		1	0048-0110	851.09	110.29	317	67.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1378.8	C08		1	0049-0108	445.47	107.83	261	66.77	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1817.5	C08		1	0050-0117	119.82	117.36	249	60.53	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1510.3	C08		1	0051-0119	649.82	119.59	358	69.60	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2567.8	C08		1	0052-0120	103.19	120.90	254	61.11	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1809.4	C08		1	0053-0119	946.75	118.29	260	63.60	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			595.5	C08		1	0054-0118	743.02	118.79	290	64.53	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			359.8	C08		1	0055-0121	58.32	121.55	260	60.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1139.5	C08		1	0056-0131	85.34	132.15	262	61.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			418.4	C08		1	0057-0131	452.43	130.72	300	64.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			249.3	C08		1	0058-0138	487.67	137.96	255	65.84	0.739
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			389.6	C08		1	0059-0137	502.83	137.54	193	57.01	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3499.4	C08		1	0060-0139	210.02	137.63	516	101.40	0.631
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4204.0	C08		1	0061-0138	670.61	138.33	241	56.53	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			283.1	C08		1	0062-0143	149.45	143.21	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			644.4	C08		1	0063-0140	372.06	140.09	251	59.01	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1411.6	C08		1	0064-0145	749.21	144.31	314	68.18	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			748.1	C08		1	0065-0145	920.96	145.33	331	71.50	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			876.2	C08		1	0066-0146	39.71	146.68	341	69.94	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			447.8	C08		1	0067-0147	173.79	147.27	267	61.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			546.8	C08		1	0068-0153	551.00	153.54	283	63.26	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			406.8	C08		1	0069-0151	813.05	150.94	259	59.36	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			874.1	C08		1	0070-0158	513.00	157.99	546	99.15	0.698
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			338.3	C08		1	0071-0153	446.25	153.63	170	52.77	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			246.9	C08		1	0072-0155	845.90	155.03	319	67.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2636.6	C08		1	0073-0154	334.70	154.51	259	60.18	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			868.3	C08		1	0074-0152	624.74	152.68	246	59.11	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1883.0	C08		1	0075-0156	784.87	156.36	297	65.60	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			517.2	C08		1	0076-0159	884.42	159.25	315	70.43	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			235.6	C08		1	0077-0160	127.31	160.31	303	65.36	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2211.8	C08		1	0078-0162	305.18	162.32	272	63.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			865.0	C08		1	0079-0168	288.46	168.54	311	67.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			616.8	C08		1	0080-0171	832.81	171.77	291	68.18	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			576.7	C08		1	0081-0174	42.34	174.21	262	63.36	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1018.4	C08		1	0082-0170	729.21	170.50	271	61.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			720.6	C08		1	0083-0173	590.40	173.08	296	63.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2691.9	C08		1	0084-0178	83.14	178.73	315	65.01	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1929.6	C08		1	0085-0177	171.65	177.29	246	57.36	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			918.3	C08		1	0086-0182	691.21	182.38	284	63.36	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			358.2	C08		1	0087-0186	447.87	186.68	253	59.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3066.0	C08		1	0088-0188	242.39	187.62	194	51.94	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8051.1	C08		1	0089-0193	516.56	193.62	611	101.98	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			473.2	C08		1	0090-0190	635.08	190.19	316	70.43	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			390.4	C08		1	0091-0192	872.76	192.02	284	61.36	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1926.2	C08		1	0092-0193	736.41	192.47	313	65.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			781.5	C08		1	0093-0194	386.17	193.83	254	58.53	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			361.3	C08		1	0094-0194	823.62	193.96	316	67.84	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			343.3	C08		1	0095-0196	920.81	196.20	290	64.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			311.0	C08		1	0096-0196	427.88	196.19	297	65.01	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			356.2	C08		1	0097-0201	117.09	201.51	288	64.28	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1069.7	C08		1	0098-0201	53.21	201.78	281	60.77	0.956
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8063.4	C08		1	0099-0200	257.81	199.94	205	56.77	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2091.6	C08		1	0100-0203	208.24	203.37	234	55.94	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			322.8	C08		1	0101-0206	669.23	206.07	274	62.53	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1950.1	C08		1	0102-0208	574.16	208.16	397	73.84	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			364.4	C08		1	0103-0204	331.29	205.07	268	64.28	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1226.8	C08		1	0104-0211	807.63	211.72	465	80.08	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2264.2	C08		1	0105-0211	246.49	212.01	282	62.43	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			702.3	C08		1	0106-0213	766.71	214.14	272	61.60	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			841.9	C08		1	0107-0227	200.15	227.05	513	92.08	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			948.4	C08		1	0108-0228	722.25	228.10	375	72.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1752.0	C08		1	0109-0230	145.31	230.74	242	58.77	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5449.3	C08		1	0110-0231	695.49	230.67	231	55.36	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1421.8	C08		1	0111-0231	567.25	231.61	293	66.53	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			714.8	C08		1	0112-0236	127.92	236.17	260	61.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2879.1	C08		1	0113-0237	501.37	237.45	245	57.94	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			656.0	C08		1	0114-0236	799.39	236.30	397	79.70	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			555.0	C08		1	0115-0240	324.51	240.08	251	58.53	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			531.1	C08		1	0116-0244	296.32	243.88	305	66.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			673.7	C08		1	0117-0248	90.39	247.75	310	65.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8940.7	C08		1	0118-0248	683.41	248.56	344	67.60	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2065.7	C08		1	0119-0245	744.24	245.15	204	53.11	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1371.5	C08		1	0120-0245	763.73	245.53	199	51.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6404.5	C08		1	0121-0250	345.88	250.19	248	57.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1372.7	C08		1	0122-0255	833.72	255.63	376	75.26	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			834.4	C08		1	0123-0253	578.67	252.77	255	61.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			366.1	C08		1	0124-0257	141.20	256.83	286	63.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			417.7	C08		1	0125-0262	225.24	261.63	430	78.67	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			385.7	C08		1	0126-0259	74.74	259.19	315	66.53	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2009.7	C08		1	0127-0259	284.48	259.09	366	71.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			11276.3	C08		1	0128-0259	366.80	258.66	326	67.01	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5771.3	C08		1	0129-0257	851.64	258.33	235	58.87	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1956.9	C08		1	0130-0267	526.09	266.69	533	94.57	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			469.2	C08		1	0131-0263	590.14	263.95	263	61.11	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3120.9	C08		1	0132-0266	877.93	266.67	240	58.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2474.2	C08		1	0133-0265	920.94	265.46	218	53.70	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			448.5	C08		1	0134-0271	614.64	271.53	413	74.67	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2617.8	C08		1	0135-0272	765.04	272.49	301	63.36	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8234.9	C08		1	0136-0272	934.67	272.12	175	51.36	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1027.6	C08		1	0137-0276	167.43	277.02	253	61.70	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			433.2	C08		1	0138-0276	674.37	275.96	323	67.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			356.6	C08		1	0139-0278	456.40	277.71	282	63.60	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3468.9	C08		1	0140-0279	829.32	278.74	284	64.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4423.6	C08		1	0141-0279	328.50	279.91	245	56.77	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			956.6	C08		1	0142-0287	283.61	286.97	406	75.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			578.1	C08		1	0143-0290	212.32	290.79	292	66.18	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			394.4	C08		1	0144-0287	406.95	287.56	318	70.77	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1591.7	C08		1	0145-0287	877.73	287.64	261	59.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7002.5	C08		1	0146-0284	940.74	284.64	148	44.28	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			294.5	C08		1	0147-0290	350.24	290.23	304	68.08	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			318.7	C08		1	0148-0293	88.23	293.47	271	63.36	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			542.8	C08		1	0149-0298	478.74	297.61	288	67.11	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			903.8	C08		1	0150-0299	30.29	299.17	312	65.11	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1702.8	C08		1	0151-0297	769.35	297.25	237	56.18	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			350.1	C08		1	0152-0298	577.12	298.30	242	62.18	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			278.4	C08		1	0153-0301	850.21	301.23	325	67.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			948.0	C08		1	0154-0301	793.81	300.67	249	59.60	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			300.1	C08		1	0155-0305	134.72	305.10	300	65.01	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			349.3	C08		1	0156-0305	415.61	306.08	322	69.60	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			537.5	C08		1	0157-0308	177.86	307.75	226	57.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			554.1	C08		1	0158-0311	161.71	310.71	226	56.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			347.5	C08		1	0159-0311	441.45	311.15	283	62.77	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			369.3	C08		1	0160-0310	572.11	310.90	264	63.70	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			654.7	C08		1	0161-0317	258.06	316.84	309	68.77	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			414.4	C08		1	0162-0320	664.01	318.99	331	66.77	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			358.1	C08		1	0163-0324	615.82	324.26	326	70.43	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			524.4	C08		1	0164-0324	23.47	324.39	299	63.60	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			620.2	C08		1	0165-0325	243.62	325.36	286	63.84	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3564.6	C08		1	0166-0325	394.36	325.64	297	64.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			838.8	C08		1	0167-0328	874.08	327.59	234	56.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1488.6	C08		1	0168-0328	899.15	329.03	260	61.94	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1122.2	C08		1	0169-0333	90.84	332.85	266	62.43	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1530.3	C08		1	0170-0333	126.02	332.87	298	67.60	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			819.9	C08		1	0171-0337	818.17	337.25	353	68.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2911.5	C08		1	0172-0336	529.02	336.98	248	59.94	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			382.5	C08		1	0173-0335	936.43	335.59	267	61.36	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2782.5	C08		1	0174-0342	377.70	341.70	254	63.60	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			530.9	C08		1	0175-0341	751.57	340.97	254	61.60	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1495.8	C08		1	0176-0344	76.38	343.86	228	55.36	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			620.2	C08		1	0177-0345	460.57	344.62	193	52.53	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			789.9	C08		1	0178-0351	681.74	350.99	338	69.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			465.8	C08		1	0179-0349	577.92	349.82	294	64.43	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1397.7	C08		1	0180-0351	291.85	350.98	292	63.84	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			770.2	C08		1	0181-0352	489.82	352.37	300	65.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			675.7	C08		1	0182-0352	327.35	351.69	252	61.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			631.3	C08		1	0183-0353	446.60	353.32	231	56.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1137.0	C08		1	0184-0354	805.06	354.07	247	59.70	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1430.1	C08		1	0185-0359	872.13	359.11	311	67.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3374.9	C08		1	0186-0363	132.70	363.09	329	68.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			353.9	C08		1	0187-0365	336.31	364.68	263	59.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			975.2	C08		1	0188-0364	410.22	363.79	327	69.01	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2212.4	C08		1	0189-0367	502.64	368.11	257	61.84	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			298.5	C08		1	0190-0376	921.44	376.79	551	108.95	0.583
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			917.3	C08		1	0191-0369	593.60	369.66	279	63.70	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1969.7	C08		1	0192-0375	268.02	375.42	298	69.36	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1013.2	C08		1	0193-0372	752.98	371.61	257	60.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			376.2	C08		1	0194-0377	634.41	376.32	349	72.43	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			259.4	C08		1	0195-0379	880.14	379.02	319	70.43	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1312.2	C08		1	0196-0377	119.73	376.80	305	72.77	0.724
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1050.1	C08		1	0197-0382	700.82	381.97	292	65.60	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			424.1	C08		1	0198-0382	220.40	381.71	287	64.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4281.3	C08		1	0199-0382	446.89	381.74	234	56.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1003.3	C08		1	0200-0384	428.95	384.84	299	64.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1719.8	C08		1	0201-0387	282.57	387.37	421	76.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			707.7	C08		1	0202-0387	25.30	387.85	243	61.94	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4801.8	C08		1	0203-0393	364.86	393.85	475	94.23	0.672
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			411.7	C08		1	0204-0386	840.01	386.59	291	66.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			279.2	C08		1	0205-0392	728.70	393.05	303	68.18	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2146.7	C08		1	0206-0395	87.04	395.30	245	57.94	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			336.0	C08		1	0207-0395	516.66	395.19	277	61.36	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1373.4	C08		1	0208-0404	108.05	404.45	252	58.18	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2895.0	C08		1	0209-0408	417.91	407.79	261	63.01	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			325.9	C08		1	0210-0413	504.12	413.06	284	62.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			619.3	C08		1	0211-0413	684.04	412.94	283	62.18	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			734.3	C08		1	0212-0418	45.73	418.54	308	64.18	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4120.9	C08		1	0213-0420	133.94	419.89	318	65.84	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			356.7	C08		1	0214-0424	879.01	423.32	332	79.74	0.656
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			337.4	C08		1	0215-0420	815.78	420.19	308	63.36	0.964
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3141.7	C08		1	0216-0420	439.51	420.26	208	54.04	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1178.2	C08		1	0217-0422	290.62	422.02	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1128.4	C08		1	0218-0426	192.46	426.07	432	78.43	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2346.1	C08		1	0219-0425	457.42	425.06	257	61.70	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			513.7	C08		1	0220-0425	908.76	426.11	267	63.94	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2022.7	C08		1	0221-0430	759.47	429.63	435	88.67	0.695
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			959.0	C08		1	0222-0428	253.32	428.39	295	66.18	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			708.0	C08		1	0223-0431	555.02	431.98	323	95.15	0.448
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			473.0	C08		1	0224-0430	599.73	430.23	285	65.60	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			675.8	C08		1	0225-0433	317.04	433.41	275	62.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			732.7	C08		1	0226-0433	103.24	433.39	402	75.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			336.3	C08		1	0227-0438	640.55	438.85	580	100.57	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			383.0	C08		1	0228-0435	845.96	435.40	258	62.28	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			278.8	C08		1	0229-0438	720.28	437.38	302	67.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1887.4	C08		1	0230-0439	18.11	439.59	340	68.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			233.1	C08		1	0231-0441	169.96	442.00	318	66.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1131.3	C08		1	0232-0444	771.12	444.45	230	57.36	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			354.4	C08		1	0233-0447	477.66	447.79	262	61.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2130.1	C08		1	0234-0456	438.10	457.77	540	95.40	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			408.7	C08		1	0235-0456	881.35	455.43	335	78.57	0.682
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1375.1	C08		1	0236-0456	265.11	456.45	313	65.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1619.7	C08		1	0237-0460	511.98	459.79	454	81.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4875.3	C08		1	0238-0456	409.18	456.62	214	53.36	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			683.5	C08		1	0239-0461	38.50	461.65	307	66.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			620.9	C08		1	0240-0462	165.64	462.71	309	71.60	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1849.8	C08		1	0241-0468	330.38	467.02	250	58.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1139.1	C08		1	0242-0470	569.44	470.56	357	69.84	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			661.6	C08		1	0243-0470	930.07	470.50	260	59.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			293.2	C08		1	0244-0471	789.81	471.64	322	67.01	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5406.1	C08		1	0245-0474	229.06	473.77	379	73.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2269.6	C08		1	0246-0471	387.85	471.68	248	58.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			553.7	C08		1	0247-0472	706.29	472.14	277	63.11	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2725.3	C08		1	0248-0481	321.87	481.24	242	58.77	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2322.0	C08		1	0249-0485	380.17	485.37	224	55.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			506.2	C08		1	0250-0486	625.83	486.05	324	66.18	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			267.4	C08		1	0251-0487	260.40	486.47	279	63.01	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2748.6	C08		1	0252-0488	501.49	489.01	313	66.77	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			274.9	C08		1	0253-0492	911.58	492.21	260	59.70	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5202.7	C08		1	0254-0494	593.95	494.04	348	70.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			291.0	C08		1	0255-0495	665.13	495.70	312	69.11	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			900.2	C08		1	0256-0494	159.72	493.86	232	57.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4817.1	C08		1	0257-0496	474.83	495.59	304	64.77	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			785.9	C08		1	0258-0500	942.76	500.59	410	78.43	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			551.1	C08		1	0259-0499	73.34	499.05	270	61.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			555.3	C08		1	0260-0501	746.05	501.11	444	77.26	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			496.6	C08		1	0261-0500	189.28	499.86	272	61.11	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1436.6	C08		1	0262-0505	546.03	505.10	455	80.91	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			291.8	C08		1	0263-0503	299.59	503.95	272	63.01	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			698.5	C08		1	0264-0501	110.04	501.73	271	61.70	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			14863.3	C08		1	0265-0505	789.60	505.62	115	92.43	0.169
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			304.0	C08		1	0266-0510	829.21	510.02	266	60.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			417.8	C08		1	0267-0509	37.93	509.58	271	61.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4633.3	C08		1	0268-0511	426.05	511.33	325	66.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2130.1	C08		1	0269-0514	270.46	514.21	363	71.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			312.7	C08		1	0270-0511	672.74	511.00	271	68.28	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4296.4	C08		1	0271-0516	129.22	517.00	317	67.36	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2036.9	C08		1	0272-0516	194.76	516.95	280	64.53	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			904.7	C08		1	0273-0521	857.97	520.82	269	61.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3250.6	C08		1	0274-0520	584.05	520.77	274	60.77	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2113.6	C08		1	0275-0522	441.51	522.16	302	64.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			673.1	C08		1	0276-0522	713.75	522.25	263	61.70	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			686.7	C08		1	0277-0526	530.57	526.08	301	64.43	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			723.8	C08		1	0278-0533	763.47	532.72	242	59.36	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			458.2	C08		1	0279-0534	795.61	533.70	277	61.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			462.4	C08		1	0280-0533	83.50	533.87	305	73.01	0.719
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4022.3	C08		1	0281-0535	213.46	535.24	213	53.11	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			370.2	C08		1	0282-0539	273.70	539.14	294	68.67	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			567.8	C08		1	0283-0537	619.01	536.78	268	61.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			946.2	C08		1	0284-0544	727.47	543.99	343	68.43	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1217.8	C08		1	0285-0547	679.63	546.69	355	71.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			722.5	C08		1	0286-0547	351.77	547.50	250	59.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			351.6	C08		1	0287-0549	43.38	549.11	280	63.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			442.9	C08		1	0288-0548	164.29	548.21	254	59.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5702.6	C08		1	0289-0548	540.05	548.03	188	49.70	0.956
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			260.0	C08		1	0290-0550	835.32	549.74	270	61.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			359.7	C08		1	0291-0549	145.49	549.09	265	62.04	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			298.9	C08		1	0292-0552	920.15	551.59	294	63.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			338.3	C08		1	0293-0553	312.34	553.07	308	65.01	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			897.7	C08		1	0294-0553	786.10	553.31	341	71.84	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3608.4	C08		1	0295-0556	560.59	557.44	266	59.60	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			659.2	C08		1	0296-0559	390.52	558.51	297	64.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2370.6	C08		1	0297-0563	482.05	562.86	252	58.18	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			469.1	C08		1	0298-0563	675.45	563.22	272	63.11	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			212.1	C08		1	0299-0564	92.34	564.16	140	51.11	0.673
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			608.0	C08		1	0300-0569	793.86	569.65	318	66.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3388.6	C08		1	0301-0567	268.09	568.13	164	47.21	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1227.6	C08		1	0302-0571	593.86	571.40	272	60.53	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			232.8	C08		1	0303-0572	205.22	572.62	276	67.60	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			10569.9	C08		1	0304-0571	518.31	570.42	129	68.53	0.345
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			480.1	C08		1	0305-0579	898.28	579.25	364	71.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1891.4	C08		1	0306-0575	245.48	575.14	169	47.46	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4117.0	C08		1	0307-0576	559.64	575.69	245	58.53	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			587.9	C08		1	0308-0578	732.89	578.70	294	64.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			396.0	C08		1	0309-0580	875.88	579.73	285	62.18	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			215.4	C08		1	0310-0581	82.77	581.36	293	63.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2714.0	C08		1	0311-0587	262.45	585.43	422	83.60	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2745.4	C08		1	0312-0584	449.27	583.89	246	57.11	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2762.7	C08		1	0313-0585	537.45	585.66	219	55.36	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			322.5	C08		1	0314-0588	301.52	587.94	322	67.60	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8899.4	C08		1	0315-0589	927.47	589.16	304	65.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			559.1	C08		1	0316-0589	150.69	589.40	378	72.77	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			249.3	C08		1	0317-0592	810.14	592.40	297	64.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			450.3	C08		1	0318-0595	27.14	595.40	266	63.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5196.3	C08		1	0319-0597	944.27	597.18	229	55.70	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2735.6	C08		1	0320-0605	525.30	604.34	263	62.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			879.3	C08		1	0321-0603	766.04	603.99	261	61.70	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			363.2	C08		1	0322-0607	199.34	607.04	248	62.77	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1948.4	C08		1	0323-0608	393.01	608.28	288	63.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			328.8	C08		1	0324-0609	74.76	609.25	262	59.60	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			329.1	C08		1	0325-0612	704.10	611.88	297	64.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			353.0	C08		1	0326-0614	844.13	613.52	296	63.60	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			411.2	C08		1	0327-0612	482.55	611.88	271	62.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1252.0	C08		1	0328-0621	28.06	620.90	218	54.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			718.9	C08		1	0329-0619	763.88	618.42	260	63.11	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			325.3	C08		1	0330-0624	650.46	623.74	294	66.43	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5015.9	C08		1	0331-0625	262.52	625.35	205	51.70	0.964
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1407.3	C08		1	0332-0633	595.61	632.78	244	57.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			804.6	C08		1	0333-0634	879.26	634.12	249	57.94	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4264.4	C08		1	0334-0638	623.32	638.35	297	62.77	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			540.7	C08		1	0335-0643	419.35	643.64	263	62.53	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			448.5	C08		1	0336-0646	176.89	645.51	593	98.57	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			326.2	C08		1	0337-0645	219.75	645.23	306	69.60	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			476.4	C08		1	0338-0648	126.69	647.81	281	64.77	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1044.3	C08		1	0339-0646	727.56	646.82	268	61.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			987.9	C08		1	0340-0650	88.89	650.61	376	73.01	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			385.0	C08		1	0341-0649	316.53	648.68	283	62.77	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			438.1	C08		1	0342-0650	522.00	651.01	317	68.43	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1219.9	C08		1	0343-0651	570.73	650.76	211	55.11	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			523.9	C08		1	0344-0651	800.58	651.10	287	63.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			315.0	C08		1	0345-0648	909.49	648.45	257	60.53	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			386.1	C08		1	0346-0654	254.61	654.82	304	67.36	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			464.8	C08		1	0347-0653	445.55	652.66	256	59.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			578.9	C08		1	0348-0654	367.50	653.95	286	62.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			389.1	C08		1	0349-0656	762.40	655.48	294	64.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2548.0	C08		1	0350-0664	667.52	664.31	302	63.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1184.8	C08		1	0351-0671	601.16	671.67	341	67.60	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4416.2	C08		1	0352-0672	812.39	672.34	244	58.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6544.2	C08		1	0353-0676	939.29	676.50	264	61.11	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3093.9	C08		1	0354-0678	275.20	678.07	250	57.70	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			541.3	C08		1	0355-0681	711.96	681.31	295	64.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2053.8	C08		1	0356-0682	315.97	682.29	268	61.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			367.1	C08		1	0357-0681	863.81	681.07	227	57.11	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8479.1	C08		1	0358-0683	583.00	683.42	165	46.87	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1964.2	C08		1	0359-0688	917.00	688.43	243	58.18	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			573.4	C08		1	0360-0688	653.24	687.57	269	60.28	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2745.5	C08		1	0361-0693	825.13	693.11	264	63.26	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			368.7	C08		1	0362-0692	465.12	692.45	299	67.60	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			391.0	C08		1	0363-0695	164.66	695.52	270	60.53	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			302.2	C08		1	0364-0697	406.64	696.45	298	62.77	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			347.9	C08		1	0365-0696	862.07	696.93	302	67.94	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			794.9	C08		1	0366-0699	197.60	698.93	257	59.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			909.1	C08		1	0367-0697	564.69	698.02	245	58.87	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2115.2	C08		1	0368-0700	335.60	700.91	255	58.77	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			265.0	C08		1	0369-0702	19.92	703.24	288	63.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			207.9	C08		1	0370-0705	367.96	704.81	288	66.67	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2185.2	C08		1	0371-0705	91.70	705.53	250	60.53	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			301.0	C08		2	0001-0024	128.41	23.60	288	63.84	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1734.3	C08		2	0002-0025	174.92	24.72	270	61.94	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			503.8	C08		2	0003-0032	871.75	31.68	248	60.77	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			827.1	C08		2	0004-0033	68.62	32.87	192	51.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			526.0	C08		2	0005-0040	397.91	40.47	375	72.18	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1022.3	C08		2	0006-0037	551.14	37.65	274	62.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1719.3	C08		2	0007-0038	680.72	39.05	242	56.77	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			958.9	C08		2	0008-0042	48.52	41.52	316	66.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			397.0	C08		2	0009-0043	30.09	43.27	294	62.53	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1085.1	C08		2	0010-0043	231.80	43.46	334	67.60	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2253.2	C08		2	0011-0044	186.15	45.23	269	63.26	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			364.2	C08		2	0012-0048	487.71	49.18	332	70.77	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			363.4	C08		2	0013-0047	649.05	47.26	310	64.53	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			578.4	C08		2	0014-0048	797.12	49.02	408	78.08	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			526.1	C08		2	0015-0052	99.99	52.40	411	74.67	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3285.7	C08		2	0016-0049	205.02	49.46	206	53.46	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			372.6	C08		2	0017-0052	737.79	51.91	283	62.18	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			463.6	C08		2	0018-0055	716.07	54.90	288	63.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			969.1	C08		2	0019-0055	576.86	55.80	420	81.60	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3677.4	C08		2	0020-0062	153.35	62.35	313	65.01	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1105.4	C08		2	0021-0066	837.30	66.55	305	69.26	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			686.4	C08		2	0022-0064	854.66	63.94	218	55.11	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			655.2	C08		2	0023-0066	291.41	66.74	292	65.60	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			678.0	C08		2	0024-0068	355.25	67.73	270	61.94	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			472.6	C08		2	0025-0071	448.16	70.63	285	63.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			739.0	C08		2	0026-0075	427.60	74.95	326	66.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			835.1	C08		2	0027-0075	776.54	75.29	255	58.28	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			995.7	C08		2	0028-0082	244.28	81.66	317	68.43	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1464.9	C08		2	0029-0084	285.37	84.39	339	73.60	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1013.8	C08		2	0030-0082	659.88	82.54	285	63.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2496.2	C08		2	0031-0087	605.90	89.87	370	80.18	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4539.9	C08		2	0032-0082	618.92	81.58	168	50.87	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			656.7	C08		2	0033-0085	328.68	85.58	227	56.28	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1236.6	C08		2	0034-0084	576.11	84.68	291	63.01	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			555.3	C08		2	0035-0088	830.95	88.00	311	65.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3797.9	C08		2	0036-0087	550.38	87.01	216	53.94	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			570.2	C08		2	0037-0091	72.87	91.06	245	65.84	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2734.2	C08		2	0038-0092	485.02	92.27	221	54.87	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2365.9	C08		2	0039-0092	774.10	91.27	225	57.36	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			377.8	C08		2	0040-0098	696.24	97.15	290	63.60	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			659.3	C08		2	0041-0102	296.21	101.87	305	65.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			260.9	C08		2	0042-0104	886.08	103.99	341	68.18	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1469.8	C08		2	0043-0106	204.77	105.73	293	64.18	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2208.6	C08		2	0044-0107	99.82	106.94	343	68.77	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1269.7	C08		2	0045-0110	741.92	109.44	252	62.28	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3200.6	C08		2	0046-0111	628.60	111.41	280	60.77	0.953
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			513.9	C08		2	0047-0113	944.04	114.24	441	81.50	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			449.3	C08		2	0048-0112	424.05	112.01	281	62.18	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			319.5	C08		2	0049-0115	340.36	115.59	316	65.60	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3284.1	C08		2	0050-0115	524.22	116.08	258	60.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			495.3	C08		2	0051-0116	404.44	116.68	286	62.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1953.1	C08		2	0052-0120	51.63	119.87	261	61.94	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			555.6	C08		2	0053-0122	257.66	121.89	391	76.08	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			400.7	C08		2	0054-0122	784.64	122.43	214	53.94	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			336.2	C08		2	0055-0124	572.99	124.69	321	66.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			705.8	C08		2	0056-0126	892.41	125.50	423	81.26	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			337.6	C08		2	0057-0128	359.94	128.35	310	65.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			545.4	C08		2	0058-0128	127.19	128.48	284	65.84	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			578.8	C08		2	0059-0130	172.43	130.44	391	73.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6976.8	C08		2	0060-0127	67.80	127.03	189	50.87	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			747.4	C08		2	0061-0131	621.82	131.00	285	64.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			500.4	C08		2	0062-0132	711.18	132.55	340	68.18	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1155.9	C08		2	0063-0137	516.40	137.02	356	72.91	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			473.2	C08		2	0064-0137	775.48	136.06	200	57.26	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1006.3	C08		2	0065-0140	460.31	140.21	426	77.01	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3839.1	C08		2	0066-0139	81.33	139.65	215	52.77	0.970
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			382.0	C08		2	0067-0140	823.51	140.83	256	60.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			678.7	C08		2	0068-0147	25.40	146.81	324	69.50	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			389.1	C08		2	0069-0150	221.02	149.90	439	80.43	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1771.5	C08		2	0070-0148	661.59	147.75	298	66.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1108.9	C08		2	0071-0151	277.86	151.60	306	64.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			681.8	C08		2	0072-0150	620.04	149.78	315	67.60	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			404.4	C08		2	0073-0156	748.99	155.98	202	55.70	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			585.2	C08		2	0074-0162	485.58	162.08	325	69.36	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5616.8	C08		2	0075-0159	562.03	159.43	209	54.28	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2110.7	C08		2	0076-0160	681.59	160.78	171	51.36	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			495.7	C08		2	0077-0171	363.75	171.30	328	69.26	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			511.5	C08		2	0078-0170	929.17	169.79	323	68.18	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4227.0	C08		2	0079-0170	58.63	170.19	217	53.11	0.967
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			497.5	C08		2	0080-0171	155.29	171.07	270	63.60	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			502.0	C08		2	0081-0172	587.56	172.32	252	59.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			387.9	C08		2	0082-0174	416.12	173.89	277	60.77	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7670.8	C08		2	0083-0178	456.76	175.89	289	74.18	0.660
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			270.9	C08		2	0084-0175	280.35	175.27	341	71.01	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1036.4	C08		2	0085-0176	136.98	176.47	272	63.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			907.6	C08		2	0086-0179	526.31	179.88	250	58.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			289.9	C08		2	0087-0181	242.03	181.06	335	69.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			485.2	C08		2	0088-0183	781.58	182.81	340	69.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5216.3	C08		2	0089-0184	103.01	184.47	203	54.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			278.7	C08		2	0090-0188	599.94	188.31	310	66.18	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			514.5	C08		2	0091-0192	481.83	192.42	247	63.70	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			240.6	C08		2	0092-0195	425.92	194.89	295	66.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			295.4	C08		2	0093-0198	25.57	197.78	289	63.60	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1240.9	C08		2	0094-0197	114.02	196.94	260	63.60	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1295.4	C08		2	0095-0200	525.18	199.68	315	65.94	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1667.8	C08		2	0096-0207	650.18	206.99	239	59.11	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			474.6	C08		2	0097-0204	722.48	204.95	239	56.18	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			325.1	C08		2	0098-0205	182.25	204.45	297	67.36	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			441.7	C08		2	0099-0211	436.75	211.44	299	67.94	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			269.1	C08		2	0100-0209	55.77	209.90	260	61.36	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			333.8	C08		2	0101-0212	318.78	212.16	308	66.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1574.3	C08		2	0102-0220	586.21	220.27	445	81.26	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			396.1	C08		2	0103-0223	186.02	223.61	263	59.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			320.1	C08		2	0104-0225	229.36	225.31	286	63.70	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			575.1	C08		2	0105-0225	923.17	225.16	242	57.11	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			537.1	C08		2	0106-0227	610.82	226.84	275	60.77	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			272.9	C08		2	0107-0227	100.50	227.54	284	64.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			401.6	C08		2	0108-0230	790.69	229.96	292	65.01	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			615.3	C08		2	0109-0230	383.79	229.79	303	63.94	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			417.7	C08		2	0110-0232	505.35	232.95	268	61.94	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			353.3	C08		2	0111-0231	64.38	230.32	272	61.11	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1551.5	C08		2	0112-0233	469.77	232.81	290	63.36	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3966.0	C08		2	0113-0233	823.19	232.39	260	61.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3399.5	C08		2	0114-0235	667.08	235.64	249	59.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			712.0	C08		2	0115-0241	271.81	241.68	289	65.84	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			444.0	C08		2	0116-0245	139.28	244.70	550	87.74	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			270.8	C08		2	0117-0245	190.45	245.11	306	64.77	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1119.4	C08		2	0118-0244	426.11	244.68	265	60.53	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1026.3	C08		2	0119-0250	256.58	250.75	311	67.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			462.8	C08		2	0120-0254	553.92	254.42	325	66.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3257.7	C08		2	0121-0253	727.06	253.50	243	57.94	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1663.3	C08		2	0122-0254	885.66	254.38	199	53.36	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1166.1	C08		2	0123-0259	302.12	259.35	329	68.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1318.8	C08		2	0124-0260	748.76	259.74	392	74.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			800.8	C08		2	0125-0261	432.64	261.36	196	53.21	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1151.2	C08		2	0126-0268	343.10	268.18	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2460.9	C08		2	0127-0267	25.78	266.73	231	56.18	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5437.5	C08		2	0128-0266	78.02	266.30	192	51.70	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			302.9	C08		2	0129-0267	114.11	267.03	287	64.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2430.3	C08		2	0130-0266	815.10	266.10	269	61.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4788.7	C08		2	0131-0272	91.72	271.87	183	50.28	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2070.0	C08		2	0132-0273	203.04	273.31	316	68.77	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			548.4	C08		2	0133-0275	569.95	274.68	442	79.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8285.9	C08		2	0134-0274	39.33	273.68	180	51.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6327.7	C08		2	0135-0277	672.47	276.66	294	65.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1145.8	C08		2	0136-0278	287.66	278.62	311	77.74	0.647
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2170.5	C08		2	0137-0281	688.77	281.41	190	52.28	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1386.9	C08		2	0138-0284	222.82	283.66	313	66.53	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1774.3	C08		2	0139-0286	317.64	285.56	222	55.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6856.0	C08		2	0140-0286	45.41	286.24	160	46.28	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			360.5	C08		2	0141-0290	149.01	291.47	268	60.53	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			766.9	C08		2	0142-0293	422.51	293.81	423	75.84	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5337.2	C08		2	0143-0291	677.08	291.79	126	44.04	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1267.1	C08		2	0144-0296	375.86	295.72	231	56.53	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			646.5	C08		2	0145-0297	89.16	296.62	270	61.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			293.5	C08		2	0146-0295	125.55	295.30	340	70.43	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1488.0	C08		2	0147-0295	480.48	294.97	101	38.97	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			540.9	C08		2	0148-0305	868.84	305.13	300	65.60	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			672.7	C08		2	0149-0310	390.61	310.17	246	60.28	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			477.6	C08		2	0150-0308	254.84	307.98	242	58.28	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2210.1	C08		2	0151-0313	171.36	313.64	405	74.18	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			471.5	C08		2	0152-0317	189.73	317.29	313	71.36	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2985.4	C08		2	0153-0316	589.99	315.67	255	61.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			494.0	C08		2	0154-0319	724.22	320.00	324	67.36	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			517.5	C08		2	0155-0321	260.97	321.64	282	68.77	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			733.9	C08		2	0156-0322	782.33	322.48	265	61.11	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1041.8	C08		2	0157-0322	765.53	321.86	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			382.2	C08		2	0158-0324	91.62	324.21	284	63.01	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5095.0	C08		2	0159-0324	203.04	324.48	204	54.04	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7081.8	C08		2	0160-0324	219.56	324.07	184	49.70	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			449.1	C08		2	0161-0326	319.77	326.20	239	59.60	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			847.7	C08		2	0162-0326	445.11	325.63	279	63.60	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			684.0	C08		2	0163-0328	745.68	327.32	292	63.36	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			735.5	C08		2	0164-0326	375.73	326.79	238	56.87	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			485.0	C08		2	0165-0328	799.72	328.72	283	62.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1691.9	C08		2	0166-0329	69.68	329.37	267	62.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			489.9	C08		2	0167-0332	828.95	332.49	265	59.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			624.4	C08		2	0168-0333	137.34	333.96	297	63.36	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			494.6	C08		2	0169-0337	333.87	337.33	476	82.67	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1344.7	C08		2	0170-0339	655.25	338.63	375	71.60	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			358.3	C08		2	0171-0337	41.30	337.01	267	59.94	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			757.7	C08		2	0172-0341	449.37	341.53	237	57.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1976.7	C08		2	0173-0344	578.50	344.16	261	59.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3328.0	C08		2	0174-0345	271.53	344.95	333	70.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			347.2	C08		2	0175-0362	199.91	361.99	283	62.18	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			322.4	C08		2	0176-0362	744.59	362.13	297	63.36	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1311.0	C08		2	0177-0367	844.22	367.25	476	86.67	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			328.4	C08		2	0178-0367	31.63	367.08	200	55.01	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			343.0	C08		2	0179-0368	356.06	368.90	286	63.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			680.2	C08		2	0180-0371	425.28	370.81	245	58.28	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1660.5	C08		2	0181-0373	472.93	373.74	266	60.18	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1995.5	C08		2	0182-0374	894.56	374.92	213	56.87	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			361.5	C08		2	0183-0377	113.54	377.52	265	61.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			328.2	C08		2	0184-0383	23.22	384.93	341	76.67	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			461.4	C08		2	0185-0378	156.27	377.70	268	60.53	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2715.9	C08		2	0186-0387	229.76	388.44	416	82.08	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			380.2	C08		2	0187-0383	267.30	383.62	237	57.60	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			318.7	C08		2	0188-0384	394.23	383.70	325	67.01	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			478.0	C08		2	0189-0383	521.82	382.94	130	43.46	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			453.8	C08		2	0190-0395	516.46	396.09	209	58.77	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2083.0	C08		2	0191-0398	438.54	398.30	245	57.60	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			420.7	C08		2	0192-0393	534.58	393.96	160	49.80	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1161.4	C08		2	0193-0400	62.70	399.55	259	61.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			445.9	C08		2	0194-0404	289.85	404.07	638	93.84	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			362.0	C08		2	0195-0400	365.27	399.62	250	59.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			389.7	C08		2	0196-0405	724.18	405.92	363	72.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			493.8	C08		2	0197-0409	829.94	409.26	358	70.43	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			759.0	C08		2	0198-0409	463.33	409.72	301	66.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			408.4	C08		2	0199-0405	535.33	405.06	151	46.04	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			490.5	C08		2	0200-0409	700.43	408.69	295	64.53	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			420.3	C08		2	0201-0409	380.18	410.01	304	65.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			630.0	C08		2	0202-0415	154.53	415.43	294	73.50	0.684
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			341.5	C08		2	0203-0416	884.62	415.94	289	64.53	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3880.3	C08		2	0204-0415	56.75	416.08	327	67.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			388.3	C08		2	0205-0416	925.04	416.90	278	64.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1717.1	C08		2	0206-0419	663.17	419.11	335	67.36	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1524.4	C08		2	0207-0420	264.27	421.78	251	59.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1404.9	C08		2	0208-0420	498.43	420.59	204	55.11	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			517.4	C08		2	0209-0422	133.84	422.17	248	58.28	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			410.1	C08		2	0210-0424	724.51	424.08	312	66.53	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			435.3	C08		2	0211-0427	13.61	427.56	258	62.53	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			478.4	C08		2	0212-0429	945.19	429.48	286	65.36	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			414.6	C08		2	0213-0428	701.23	428.05	270	62.53	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3492.7	C08		2	0214-0433	190.90	433.18	238	58.53	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2342.8	C08		2	0215-0434	225.32	434.19	271	61.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			437.6	C08		2	0216-0437	87.04	437.77	287	62.77	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3068.1	C08		2	0217-0435	173.26	435.41	244	58.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7990.8	C08		2	0218-0436	260.95	436.35	185	49.80	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			457.6	C08		2	0219-0441	873.85	440.57	308	64.28	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			917.6	C08		2	0220-0444	375.81	444.45	323	66.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1992.3	C08		2	0221-0446	566.04	446.26	348	69.84	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2042.2	C08		2	0222-0449	332.26	449.77	560	94.33	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1582.2	C08		2	0223-0447	424.52	447.61	335	67.94	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			587.6	C08		2	0224-0448	922.18	447.91	265	61.60	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			357.1	C08		2	0225-0449	462.86	449.06	289	65.01	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			845.6	C08		2	0226-0451	604.85	451.48	265	63.60	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4370.8	C08		2	0227-0459	549.21	459.53	351	69.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			996.2	C08		2	0228-0458	143.34	458.86	324	68.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4011.0	C08		2	0229-0459	261.60	459.85	248	57.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			582.2	C08		2	0230-0458	400.63	459.11	238	59.46	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1847.6	C08		2	0231-0466	491.10	466.15	301	69.60	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			934.6	C08		2	0232-0462	632.32	462.23	266	60.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			710.6	C08		2	0233-0472	34.89	471.98	262	59.11	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1345.7	C08		2	0234-0469	119.89	468.96	262	61.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			988.7	C08		2	0235-0477	405.92	477.24	489	96.67	0.658
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			579.0	C08		2	0236-0480	815.69	480.06	304	75.01	0.679
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2549.1	C08		2	0237-0479	914.13	478.71	270	61.11	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			543.6	C08		2	0238-0480	225.31	480.10	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1054.8	C08		2	0239-0477	326.87	477.58	241	59.94	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1031.2	C08		2	0240-0481	871.99	481.61	262	60.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1142.1	C08		2	0241-0484	568.43	484.08	272	61.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2473.3	C08		2	0242-0489	750.74	489.51	488	84.33	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			789.1	C08		2	0243-0488	169.56	487.86	284	62.18	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			844.3	C08		2	0244-0488	679.30	488.67	269	61.70	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2810.5	C08		2	0245-0488	307.68	487.95	359	71.60	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			356.1	C08		2	0246-0489	630.43	488.96	323	68.18	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			280.1	C08		2	0247-0493	16.24	493.55	254	59.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			292.5	C08		2	0248-0493	507.23	493.06	269	63.60	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			899.3	C08		2	0249-0502	47.73	502.09	427	77.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2725.1	C08		2	0250-0500	246.57	500.67	312	66.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4939.8	C08		2	0251-0500	533.77	500.29	219	54.53	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			599.1	C08		2	0252-0504	66.26	503.58	297	64.53	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1212.8	C08		2	0253-0505	699.10	505.70	368	73.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			630.9	C08		2	0254-0501	204.12	501.50	231	59.11	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			895.4	C08		2	0255-0502	433.05	502.56	215	54.87	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			318.7	C08		2	0256-0507	619.58	507.08	300	67.94	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			429.3	C08		2	0257-0511	948.45	510.67	280	67.26	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			792.6	C08		2	0258-0512	475.01	511.55	298	65.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1487.4	C08		2	0259-0513	867.81	513.90	265	61.36	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1131.3	C08		2	0260-0516	850.85	516.77	257	59.60	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			592.5	C08		2	0261-0516	146.95	516.06	263	59.36	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1461.6	C08		2	0262-0523	580.94	523.79	157	47.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			378.6	C08		2	0263-0524	902.61	524.32	334	71.01	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			511.0	C08		2	0264-0524	171.12	524.21	247	58.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3611.3	C08		2	0265-0529	743.25	528.55	460	81.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			701.2	C08		2	0266-0529	338.24	529.73	255	61.36	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			435.7	C08		2	0267-0531	547.18	530.79	348	70.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1427.5	C08		2	0268-0532	520.09	532.34	249	59.60	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			930.2	C08		2	0269-0534	822.04	534.95	290	65.36	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			347.4	C08		2	0270-0536	121.32	535.69	443	79.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			387.7	C08		2	0271-0536	253.91	537.11	303	64.77	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			438.3	C08		2	0272-0540	73.04	539.97	266	60.43	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			252.8	C08		2	0273-0540	438.67	540.09	274	60.53	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			620.9	C08		2	0274-0543	474.92	543.22	497	82.43	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			950.8	C08		2	0275-0543	495.38	542.73	251	57.94	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			475.2	C08		2	0276-0545	179.70	545.24	306	69.94	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			786.7	C08		2	0277-0548	795.48	548.99	303	64.43	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1723.4	C08		2	0278-0551	945.99	550.84	288	62.53	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			386.6	C08		2	0279-0553	24.96	553.10	285	62.18	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2108.8	C08		2	0280-0557	618.00	556.84	266	63.11	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2698.2	C08		2	0281-0561	641.94	560.82	711	101.98	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1134.0	C08		2	0282-0560	291.60	560.59	518	83.01	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			626.5	C08		2	0283-0562	86.27	562.76	232	58.18	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			424.3	C08		2	0284-0563	339.83	563.42	303	64.43	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1384.8	C08		2	0285-0564	707.60	563.60	155	50.53	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			273.8	C08		2	0286-0567	555.67	567.57	297	65.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			829.3	C08		2	0287-0568	213.50	569.92	207	64.43	0.627
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3403.4	C08		2	0288-0569	583.10	568.94	301	64.28	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			927.6	C08		2	0289-0573	171.22	574.28	290	66.77	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			973.9	C08		2	0290-0573	882.89	572.56	272	63.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1162.4	C08		2	0291-0573	241.29	573.36	271	60.53	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1914.9	C08		2	0292-0577	185.71	576.57	160	48.63	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			863.5	C08		2	0293-0579	907.88	578.08	277	63.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1108.7	C08		2	0294-0581	57.33	580.98	258	59.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			293.0	C08		2	0295-0587	724.98	587.15	316	67.60	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1036.7	C08		2	0296-0587	134.80	587.12	175	50.53	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			570.3	C08		2	0297-0588	505.48	588.00	251	57.60	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			599.6	C08		2	0298-0590	87.90	590.70	192	53.70	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			9125.7	C08		2	0299-0591	31.88	590.68	317	65.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			419.1	C08		2	0300-0591	764.21	591.57	269	61.36	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			537.9	C08		2	0301-0596	797.64	596.34	275	64.18	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5756.6	C08		2	0302-0598	49.01	598.53	246	58.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1866.9	C08		2	0303-0601	207.24	601.43	355	70.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			243.7	C08		2	0304-0599	600.60	599.30	324	68.18	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			310.4	C08		2	0305-0602	438.82	602.72	334	68.18	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			350.9	C08		2	0306-0603	746.91	602.13	251	59.84	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			760.4	C08		2	0307-0606	543.49	606.34	266	60.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			372.3	C08		2	0308-0604	250.39	605.09	296	66.18	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			280.6	C08		2	0309-0609	387.02	608.81	269	63.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1072.0	C08		2	0310-0608	335.62	607.84	280	64.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2385.1	C08		2	0311-0610	944.87	609.75	210	53.11	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1002.1	C08		2	0312-0613	119.39	614.07	255	64.77	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6495.8	C08		2	0313-0615	291.31	615.17	248	60.18	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			440.7	C08		2	0314-0621	566.88	622.06	251	60.77	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			889.5	C08		2	0315-0625	840.51	624.99	239	57.36	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3728.1	C08		2	0316-0628	67.91	628.06	236	55.70	0.956
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3873.7	C08		2	0317-0627	266.18	626.84	274	63.94	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4982.7	C08		2	0318-0632	346.98	632.17	263	60.43	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			751.6	C08		2	0319-0634	393.30	633.93	334	75.01	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1256.0	C08		2	0320-0634	670.15	633.03	101	41.70	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			511.0	C08		2	0321-0638	851.24	638.19	292	64.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4573.5	C08		2	0322-0639	445.95	639.26	253	59.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			841.7	C08		2	0323-0642	157.39	640.87	253	62.28	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			746.0	C08		2	0324-0640	174.32	640.06	262	61.46	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			661.0	C08		2	0325-0644	425.47	643.95	353	70.77	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			671.0	C08		2	0326-0644	307.30	643.62	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			257.6	C08		2	0327-0645	630.33	645.35	309	65.01	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			296.2	C08		2	0328-0648	727.88	648.50	296	64.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1265.6	C08		2	0329-0647	119.09	647.07	268	60.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			658.8	C08		2	0330-0650	679.59	650.26	310	68.77	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			421.3	C08		2	0331-0650	246.41	650.38	298	69.36	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			246.6	C08		2	0332-0650	13.97	649.82	250	58.87	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4149.9	C08		2	0333-0650	470.51	649.83	248	60.87	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			561.7	C08		2	0334-0653	588.67	652.30	269	62.77	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			383.6	C08		2	0335-0655	563.64	655.36	249	59.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			360.6	C08		2	0336-0655	263.18	654.92	281	64.77	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			463.0	C08		2	0337-0669	407.40	670.15	329	70.43	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3790.6	C08		2	0338-0669	371.39	669.49	271	61.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6138.7	C08		2	0339-0674	544.22	674.03	278	64.53	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			208.5	C08		2	0340-0674	283.60	674.11	316	67.60	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5478.1	C08		2	0341-0677	50.74	676.48	504	93.74	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2313.5	C08		2	0342-0677	529.26	677.28	241	57.70	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1576.4	C08		2	0343-0679	637.19	678.71	458	80.43	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1125.6	C08		2	0344-0684	829.52	684.32	312	64.77	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			611.4	C08		2	0345-0685	100.70	685.98	251	58.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			968.7	C08		2	0346-0687	352.25	686.86	227	58.28	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			579.4	C08		2	0347-0686	391.95	685.78	302	65.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			979.7	C08		2	0348-0689	565.33	688.86	432	79.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4146.8	C08		2	0349-0687	806.47	688.39	341	72.43	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1969.7	C08		2	0350-0690	21.42	689.99	247	57.36	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			267.2	C08		2	0351-0690	142.77	690.36	295	65.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1770.0	C08		2	0352-0694	479.41	694.54	338	67.60	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			215.1	C08		2	0353-0700	209.29	699.63	276	63.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			428.8	C08		2	0354-0697	630.69	697.57	233	57.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			397.2	C08		2	0355-0699	247.97	699.45	266	60.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4624.0	C08		2	0356-0702	759.80	701.69	264	60.43	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			355.5	C08		2	0357-0710	176.17	709.98	264	60.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			444.1	C08		3	0001-0023	532.57	23.39	244	57.60	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3277.5	C08		3	0002-0028	327.48	30.03	247	65.36	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4178.2	C08		3	0003-0029	465.12	29.36	299	67.01	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			483.6	C08		3	0004-0029	685.49	28.96	237	60.63	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1198.6	C08		3	0005-0029	253.25	28.93	221	54.53	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			416.8	C08		3	0006-0032	58.32	32.64	327	66.43	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			526.7	C08		3	0007-0031	771.33	31.27	277	60.77	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1208.1	C08		3	0008-0032	938.39	31.96	323	66.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			450.3	C08		3	0009-0032	428.60	32.82	242	58.28	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			656.6	C08		3	0010-0041	489.88	41.38	564	96.57	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			425.8	C08		3	0011-0034	658.31	34.47	313	66.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			315.5	C08		3	0012-0040	199.61	39.73	314	70.18	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			537.7	C08		3	0013-0039	448.67	39.33	289	63.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			521.0	C08		3	0014-0037	547.08	37.85	227	57.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1408.5	C08		3	0015-0041	721.42	40.98	365	73.01	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			561.4	C08		3	0016-0039	566.60	40.06	313	69.01	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			511.3	C08		3	0017-0040	922.00	40.34	223	66.67	0.630
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			521.4	C08		3	0018-0044	596.63	44.21	304	66.43	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3164.7	C08		3	0019-0041	813.20	41.28	179	51.46	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1085.6	C08		3	0020-0049	113.44	49.20	334	67.84	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2962.3	C08		3	0021-0053	359.25	53.25	278	65.01	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			446.9	C08		3	0022-0049	430.55	48.90	263	61.11	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			884.2	C08		3	0023-0055	223.57	55.22	314	66.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1064.7	C08		3	0024-0053	396.70	52.83	352	69.01	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2641.7	C08		3	0025-0055	809.25	55.67	224	55.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			589.6	C08		3	0026-0059	148.23	58.99	225	59.60	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1372.2	C08		3	0027-0064	280.55	64.35	314	67.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1436.7	C08		3	0028-0063	544.03	63.30	254	57.70	0.959
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1081.3	C08		3	0029-0064	884.27	64.14	186	51.70	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1025.4	C08		3	0030-0066	516.31	65.67	264	63.36	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			591.1	C08		3	0031-0066	137.84	67.13	100	36.87	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			409.9	C08		3	0032-0073	467.13	73.35	280	67.84	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1212.7	C08		3	0033-0082	290.55	82.99	431	79.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1014.2	C08		3	0034-0081	885.37	80.56	222	56.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6872.1	C08		3	0035-0084	53.08	83.10	310	65.84	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			408.5	C08		3	0036-0084	137.48	84.03	298	65.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			719.4	C08		3	0037-0082	269.27	81.66	220	57.46	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			722.3	C08		3	0038-0085	905.06	84.63	292	63.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1187.2	C08		3	0039-0088	663.25	88.70	423	77.50	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			351.9	C08		3	0040-0087	397.19	87.20	335	70.08	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2578.2	C08		3	0041-0091	639.02	90.74	485	81.01	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1576.5	C08		3	0042-0087	769.24	87.52	258	59.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			538.1	C08		3	0043-0090	219.09	90.97	283	63.01	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			863.8	C08		3	0044-0097	238.14	97.34	325	69.60	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			176.9	C08		3	0045-0100	948.51	100.66	304	64.18	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			364.1	C08		3	0046-0106	703.27	106.15	301	71.01	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			462.1	C08		3	0047-0104	412.83	104.58	343	69.36	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1342.7	C08		3	0048-0106	858.33	105.98	240	57.94	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			716.7	C08		3	0049-0114	169.00	114.22	297	65.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1726.9	C08		3	0050-0112	786.67	113.07	223	55.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			535.5	C08		3	0051-0116	38.58	116.93	429	80.08	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			701.4	C08		3	0052-0116	528.84	115.97	313	66.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6359.8	C08		3	0053-0119	387.92	119.01	319	66.18	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1538.4	C08		3	0054-0132	365.36	135.16	821	132.47	0.588
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			831.1	C08		3	0055-0129	748.67	130.15	442	92.23	0.653
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1449.0	C08		3	0056-0128	920.91	127.37	349	69.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			799.0	C08		3	0057-0125	566.78	124.73	293	63.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			448.6	C08		3	0058-0127	626.53	128.10	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			467.4	C08		3	0059-0130	770.46	128.58	300	69.01	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			750.6	C08		3	0060-0135	789.23	134.60	222	61.60	0.735
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			452.7	C08		3	0061-0134	817.31	134.17	319	68.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3228.1	C08		3	0062-0142	89.03	141.16	280	67.11	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2975.0	C08		3	0063-0141	165.57	141.85	330	68.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2645.3	C08		3	0064-0138	224.78	138.64	223	55.70	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1959.7	C08		3	0065-0141	396.66	141.25	271	61.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			432.9	C08		3	0066-0141	497.15	141.74	275	63.11	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			970.9	C08		3	0067-0142	861.03	142.03	262	59.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1417.6	C08		3	0068-0142	337.85	142.39	270	65.11	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			681.9	C08		3	0069-0145	703.67	145.81	261	61.36	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			501.8	C08		3	0070-0148	266.12	148.80	285	65.60	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			384.5	C08		3	0071-0155	897.36	154.70	365	73.26	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			465.5	C08		3	0072-0152	653.92	152.55	284	64.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1160.3	C08		3	0073-0161	237.53	161.53	297	65.01	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1301.6	C08		3	0074-0164	69.27	165.07	267	63.60	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			419.8	C08		3	0075-0164	520.53	163.95	253	61.01	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1752.4	C08		3	0076-0166	620.29	165.68	383	73.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			548.2	C08		3	0077-0164	465.07	164.49	227	57.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1161.8	C08		3	0078-0165	749.54	165.08	432	77.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			542.4	C08		3	0079-0172	869.02	171.91	382	74.33	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			457.0	C08		3	0080-0173	23.84	172.42	302	65.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1185.2	C08		3	0081-0174	592.35	173.61	452	83.84	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			307.3	C08		3	0082-0174	274.69	173.21	288	67.36	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			693.2	C08		3	0083-0178	545.77	178.99	262	66.53	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			545.1	C08		3	0084-0178	148.43	178.01	338	73.84	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			508.4	C08		3	0085-0176	514.15	177.00	189	52.77	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5257.6	C08		3	0086-0177	679.31	177.37	240	58.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5002.7	C08		3	0087-0181	696.46	181.97	249	59.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			375.6	C08		3	0088-0180	794.34	180.45	254	60.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3600.2	C08		3	0089-0181	108.76	180.88	230	55.11	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			303.9	C08		3	0090-0193	414.72	192.56	330	68.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2451.1	C08		3	0091-0190	64.99	189.93	227	55.11	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5083.0	C08		3	0092-0195	99.27	195.98	234	56.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1489.7	C08		3	0093-0196	202.97	195.97	316	69.01	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			378.3	C08		3	0094-0198	831.79	197.32	370	75.60	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3190.4	C08		3	0095-0197	49.38	196.72	237	58.18	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1056.3	C08		3	0096-0197	513.77	197.29	315	65.01	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			402.0	C08		3	0097-0204	457.17	203.08	271	61.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			723.3	C08		3	0098-0203	704.26	203.91	332	73.01	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			639.0	C08		3	0099-0204	354.49	204.48	347	73.01	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1440.2	C08		3	0100-0208	569.50	207.85	443	78.67	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			384.9	C08		3	0101-0210	948.56	209.54	264	63.11	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			337.8	C08		3	0102-0214	469.57	213.88	255	59.94	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			513.1	C08		3	0103-0225	924.52	225.67	367	87.15	0.607
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			440.1	C08		3	0104-0228	644.11	227.88	315	70.77	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			608.3	C08		3	0105-0225	61.98	224.71	299	70.67	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			427.1	C08		3	0106-0225	160.87	224.84	322	69.84	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			859.5	C08		3	0107-0229	862.41	228.41	317	68.67	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			571.7	C08		3	0108-0228	18.02	227.83	235	55.94	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			434.6	C08		3	0109-0234	751.08	233.32	289	64.18	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4467.2	C08		3	0110-0236	782.55	236.23	246	57.36	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			267.3	C08		3	0111-0240	93.05	240.20	308	66.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			589.2	C08		3	0112-0238	892.29	239.00	287	65.01	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1086.6	C08		3	0113-0240	235.55	240.11	332	67.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			513.7	C08		3	0114-0237	585.30	237.86	152	46.87	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			880.4	C08		3	0115-0241	269.32	240.96	307	66.77	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1397.8	C08		3	0116-0248	610.00	249.03	258	62.28	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1059.5	C08		3	0117-0246	373.04	246.03	343	76.43	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1731.5	C08		3	0118-0248	765.67	248.01	239	67.01	0.669
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3418.6	C08		3	0119-0248	806.76	248.02	239	55.70	0.968
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7113.6	C08		3	0120-0251	678.80	251.79	260	59.94	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1348.8	C08		3	0121-0250	583.42	250.39	234	68.04	0.635
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			782.9	C08		3	0122-0258	131.40	259.27	494	84.33	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1071.3	C08		3	0123-0256	150.97	255.71	274	63.84	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			348.4	C08		3	0124-0260	490.75	261.11	264	64.18	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			901.1	C08		3	0125-0261	49.17	260.94	240	58.77	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			343.9	C08		3	0126-0261	447.80	260.90	268	65.01	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1032.5	C08		3	0127-0266	406.69	265.92	281	63.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1064.0	C08		3	0128-0263	942.26	262.18	227	57.70	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2680.0	C08		3	0129-0266	729.09	265.65	222	54.53	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			786.1	C08		3	0130-0271	632.23	271.21	387	98.47	0.502
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2828.1	C08		3	0131-0276	877.95	276.41	209	53.46	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1445.8	C08		3	0132-0280	532.20	280.58	357	69.01	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			910.1	C08		3	0133-0283	898.83	283.28	321	65.60	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			289.4	C08		3	0134-0287	309.24	286.78	291	63.60	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			649.3	C08		3	0135-0290	800.71	289.32	280	63.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4147.2	C08		3	0136-0289	858.29	289.80	228	56.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			612.1	C08		3	0137-0293	677.33	293.41	287	63.94	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			776.0	C08		3	0138-0291	459.36	291.79	320	66.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			711.1	C08		3	0139-0297	354.38	297.64	401	79.50	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3111.9	C08		3	0140-0294	757.01	294.27	198	55.11	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			752.6	C08		3	0141-0299	576.94	298.66	443	79.60	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			365.4	C08		3	0142-0298	265.74	298.65	267	61.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			608.5	C08		3	0143-0299	72.18	299.74	253	58.77	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3321.3	C08		3	0144-0304	788.08	303.48	234	59.01	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			921.1	C08		3	0145-0311	518.79	311.58	293	63.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			546.1	C08		3	0146-0311	866.10	311.35	321	66.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			743.2	C08		3	0147-0313	114.14	313.03	312	67.84	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			259.0	C08		3	0148-0316	281.76	314.32	322	72.77	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1112.9	C08		3	0149-0314	216.74	314.24	240	57.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			586.1	C08		3	0150-0316	462.68	315.95	374	71.84	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			552.2	C08		3	0151-0312	671.78	312.33	293	66.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			460.6	C08		3	0152-0319	404.30	319.33	365	90.33	0.562
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			304.6	C08		3	0153-0317	916.73	316.91	325	68.43	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			325.0	C08		3	0154-0321	486.15	320.62	376	90.91	0.572
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1116.4	C08		3	0155-0321	749.58	321.63	264	61.94	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3208.3	C08		3	0156-0320	800.65	320.44	228	56.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1345.5	C08		3	0157-0322	187.82	322.48	247	57.11	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			942.9	C08		3	0158-0325	595.66	325.86	278	63.70	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			299.9	C08		3	0159-0330	310.51	329.78	303	69.60	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2146.0	C08		3	0160-0335	57.67	335.14	295	64.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1052.5	C08		3	0161-0340	769.12	339.27	267	65.36	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			442.5	C08		3	0162-0337	643.36	337.38	259	60.28	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1741.2	C08		3	0163-0342	782.81	341.49	203	57.11	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3321.7	C08		3	0164-0342	707.27	341.53	243	57.94	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			631.3	C08		3	0165-0347	686.39	347.35	273	61.11	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			731.5	C08		3	0166-0349	864.22	349.06	308	67.60	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1135.7	C08		3	0167-0353	197.73	352.76	262	66.18	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			976.0	C08		3	0168-0356	948.80	356.74	354	73.50	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			550.3	C08		3	0169-0351	635.22	351.36	265	63.94	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			929.2	C08		3	0170-0352	215.58	351.55	130	45.36	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			929.8	C08		3	0171-0355	559.53	355.31	290	65.60	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			709.7	C08		3	0172-0358	54.25	359.06	261	61.01	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1047.2	C08		3	0173-0363	341.37	363.34	449	81.01	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1890.3	C08		3	0174-0359	778.66	359.31	223	55.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			876.4	C08		3	0175-0363	359.28	363.10	324	70.53	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			549.9	C08		3	0176-0367	464.46	366.77	345	71.01	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1014.6	C08		3	0177-0367	727.94	367.19	277	61.36	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			956.9	C08		3	0178-0368	906.35	368.80	281	62.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1228.5	C08		3	0179-0368	189.77	367.86	245	57.36	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1230.7	C08		3	0180-0369	213.15	368.99	220	53.94	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			484.6	C08		3	0181-0372	857.11	373.24	323	71.60	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2647.0	C08		3	0182-0374	698.26	374.09	239	60.18	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			705.4	C08		3	0183-0377	303.40	376.96	313	67.01	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2674.9	C08		3	0184-0377	544.99	377.60	241	59.36	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			13117.9	C08		3	0185-0383	44.56	382.58	380	73.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3552.0	C08		3	0186-0389	434.90	390.02	536	103.40	0.630
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			214.2	C08		3	0187-0382	792.69	380.81	322	71.84	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			293.2	C08		3	0188-0387	381.32	386.98	316	72.77	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1170.4	C08		3	0189-0390	610.76	389.98	481	86.33	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1282.4	C08		3	0190-0389	695.86	388.97	303	68.43	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			339.2	C08		3	0191-0392	841.59	392.05	299	65.94	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3191.8	C08		3	0192-0394	134.16	394.28	212	54.53	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2467.5	C08		3	0193-0398	670.63	398.30	256	59.11	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			417.4	C08		3	0194-0402	272.23	402.84	428	76.91	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			534.1	C08		3	0195-0408	507.87	407.51	311	66.53	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			520.7	C08		3	0196-0410	807.87	410.34	346	69.84	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			483.6	C08		3	0197-0409	472.96	409.63	281	61.60	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			703.7	C08		3	0198-0411	322.05	410.94	282	63.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1156.3	C08		3	0199-0413	571.30	413.44	318	66.53	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			300.4	C08		3	0200-0414	759.60	414.30	348	71.84	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			396.9	C08		3	0201-0414	89.37	414.72	261	60.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			925.4	C08		3	0202-0417	190.24	417.81	315	66.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			370.0	C08		3	0203-0419	20.26	419.74	274	65.36	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			435.1	C08		3	0204-0425	422.94	424.10	347	74.43	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			429.5	C08		3	0205-0422	719.69	422.40	292	65.36	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			400.1	C08		3	0206-0425	354.68	425.44	306	65.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			392.9	C08		3	0207-0429	315.29	430.42	404	77.50	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			537.6	C08		3	0208-0427	212.29	427.79	284	63.94	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1083.2	C08		3	0209-0429	585.97	429.94	328	67.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			471.4	C08		3	0210-0432	39.94	432.05	266	62.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1247.4	C08		3	0211-0433	109.61	432.71	202	55.11	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1791.2	C08		3	0212-0438	716.99	437.68	332	76.43	0.714
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3944.5	C08		3	0213-0443	151.37	443.99	239	57.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3602.7	C08		3	0214-0441	866.29	441.56	144	48.04	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			494.5	C08		3	0215-0448	705.39	449.09	366	71.84	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1107.3	C08		3	0216-0445	115.33	445.73	189	51.94	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1672.3	C08		3	0217-0444	904.95	445.08	292	66.53	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5001.6	C08		3	0218-0450	642.85	450.12	331	87.74	0.540
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			904.4	C08		3	0219-0449	247.18	448.68	163	52.18	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			536.9	C08		3	0220-0450	17.02	450.61	255	60.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1730.2	C08		3	0221-0451	528.31	450.92	220	56.87	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3230.8	C08		3	0222-0450	169.22	450.25	225	55.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			960.1	C08		3	0223-0451	232.54	451.54	225	62.28	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1491.2	C08		3	0224-0452	283.27	452.69	218	63.01	0.690
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5487.8	C08		3	0225-0452	833.38	452.54	187	51.46	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4753.4	C08		3	0226-0454	884.15	454.05	199	53.11	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5250.6	C08		3	0227-0451	868.05	451.00	108	41.80	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			601.9	C08		3	0228-0460	783.55	460.00	397	73.60	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2798.9	C08		3	0229-0457	81.69	456.53	160	48.53	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			606.6	C08		3	0230-0459	599.55	459.37	223	55.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1709.5	C08		3	0231-0467	409.14	467.44	277	63.94	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4324.6	C08		3	0232-0463	896.21	463.67	180	50.53	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1779.0	C08		3	0233-0471	73.92	471.13	260	60.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			457.7	C08		3	0234-0470	370.62	469.91	330	66.77	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3771.8	C08		3	0235-0470	909.28	470.32	193	54.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3827.1	C08		3	0236-0474	658.09	474.07	236	108.47	0.252
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			982.2	C08		3	0237-0477	757.68	477.45	310	68.18	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			418.5	C08		3	0238-0483	861.58	482.86	294	67.36	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			433.5	C08		3	0239-0482	135.99	482.81	302	65.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			538.8	C08		3	0240-0481	782.06	481.84	320	70.18	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1599.1	C08		3	0241-0484	619.12	484.95	307	67.60	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1117.4	C08		3	0242-0487	230.78	487.27	221	56.77	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4350.4	C08		3	0243-0488	501.96	488.48	303	95.15	0.421
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			392.6	C08		3	0244-0492	845.54	492.39	295	67.01	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1452.4	C08		3	0245-0496	592.35	495.95	308	67.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			159.0	C08		3	0246-0494	948.35	494.15	209	56.28	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			959.0	C08		3	0247-0495	927.22	495.11	272	63.11	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			388.2	C08		3	0248-0497	887.16	497.36	310	68.43	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			524.3	C08		3	0249-0508	730.86	507.47	308	68.18	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			541.0	C08		3	0250-0510	714.33	510.41	265	63.11	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			232.5	C08		3	0251-0505	944.95	505.82	128	46.63	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			477.8	C08		3	0252-0511	456.37	510.33	310	65.94	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			498.8	C08		3	0253-0513	43.13	513.37	269	63.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			675.3	C08		3	0254-0516	514.45	515.97	247	62.18	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			447.2	C08		3	0255-0520	646.15	520.03	381	72.67	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			570.8	C08		3	0256-0519	399.86	519.23	316	67.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			459.5	C08		3	0257-0522	197.60	521.91	304	64.77	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1037.0	C08		3	0258-0524	879.76	523.49	273	63.36	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			368.4	C08		3	0259-0526	159.70	527.09	306	67.94	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			726.5	C08		3	0260-0523	483.04	523.55	269	63.94	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			492.1	C08		3	0261-0531	810.81	531.43	365	72.18	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3133.0	C08		3	0262-0528	565.57	527.76	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			562.8	C08		3	0263-0530	782.86	529.80	316	67.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			384.0	C08		3	0264-0530	756.84	529.87	273	60.77	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1174.7	C08		3	0265-0531	367.86	531.22	203	54.04	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			342.4	C08		3	0266-0534	608.04	534.55	326	68.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			368.4	C08		3	0267-0537	119.51	536.59	320	66.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1675.6	C08		3	0268-0538	740.19	538.23	288	63.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			789.6	C08		3	0269-0546	675.65	545.16	234	61.70	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1953.1	C08		3	0270-0549	529.42	550.06	285	65.60	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			881.3	C08		3	0271-0551	426.59	551.08	333	68.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			298.2	C08		3	0272-0551	267.71	551.18	295	63.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2347.5	C08		3	0273-0550	703.60	550.46	250	58.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1836.8	C08		3	0274-0554	40.63	553.53	281	62.53	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			918.3	C08		3	0275-0553	861.92	552.97	283	63.11	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			398.3	C08		3	0276-0552	904.61	552.64	264	62.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			941.9	C08		3	0277-0562	81.73	563.11	229	57.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			484.4	C08		3	0278-0560	180.90	560.41	289	65.11	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1078.4	C08		3	0279-0564	689.94	564.74	395	73.60	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3149.6	C08		3	0280-0566	65.60	566.35	283	61.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			498.8	C08		3	0281-0566	890.89	566.66	302	64.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			773.9	C08		3	0282-0568	447.87	568.48	399	73.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			401.0	C08		3	0283-0567	848.99	567.07	160	48.04	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1885.8	C08		3	0284-0568	726.85	569.11	263	59.46	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			276.1	C08		3	0285-0574	501.01	573.94	304	68.18	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			278.5	C08		3	0286-0576	103.26	576.46	271	63.11	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			332.3	C08		3	0287-0577	288.58	576.72	309	67.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3582.3	C08		3	0288-0571	588.60	571.12	203	56.28	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			438.8	C08		3	0289-0580	322.17	580.19	286	62.18	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			386.6	C08		3	0290-0582	304.21	582.90	279	63.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8260.8	C08		3	0291-0587	610.80	586.71	430	81.26	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			250.1	C08		3	0292-0583	908.91	583.67	336	71.60	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			533.3	C08		3	0293-0587	357.14	587.71	211	54.87	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1732.7	C08		3	0294-0583	584.48	583.09	206	56.28	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			536.4	C08		3	0295-0584	760.43	583.31	202	53.11	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2280.0	C08		3	0296-0586	839.51	587.03	244	59.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			893.1	C08		3	0297-0588	726.94	587.22	223	56.28	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			385.9	C08		3	0298-0592	227.26	591.41	284	62.43	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			674.1	C08		3	0299-0596	537.39	596.63	274	62.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3900.9	C08		3	0300-0596	628.00	596.63	204	54.53	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			661.5	C08		3	0301-0598	53.36	598.16	263	59.36	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			592.9	C08		3	0302-0601	490.88	601.10	323	68.18	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			357.8	C08		3	0303-0598	800.23	598.26	318	66.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			250.2	C08		3	0304-0606	86.25	606.24	265	59.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1249.4	C08		3	0305-0606	873.17	605.88	286	63.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			504.6	C08		3	0306-0605	758.47	605.61	197	56.18	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			807.1	C08		3	0307-0612	193.94	611.97	326	68.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			265.1	C08		3	0308-0612	153.56	612.34	281	63.36	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2509.5	C08		3	0309-0612	39.38	612.41	207	52.87	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			441.3	C08		3	0310-0617	654.98	617.44	437	77.26	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3160.6	C08		3	0311-0620	691.40	620.80	264	62.77	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			366.1	C08		3	0312-0622	316.84	621.70	292	62.77	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2849.4	C08		3	0313-0628	613.04	628.45	215	54.87	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			632.1	C08		3	0314-0632	119.71	632.15	422	75.36	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			582.7	C08		3	0315-0630	340.94	629.63	275	65.60	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2496.3	C08		3	0316-0635	406.97	634.37	580	95.98	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1810.0	C08		3	0317-0634	44.10	633.95	263	62.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			742.9	C08		3	0318-0637	939.48	637.54	249	58.53	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2012.6	C08		3	0319-0643	596.50	643.24	346	69.60	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			508.9	C08		3	0320-0642	345.82	643.74	326	71.01	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4033.1	C08		3	0321-0643	892.99	643.52	199	54.87	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1293.5	C08		3	0322-0645	755.67	644.84	283	62.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			452.1	C08		3	0323-0647	849.47	645.85	284	66.43	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5634.9	C08		3	0324-0645	915.19	645.36	189	50.53	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1215.8	C08		3	0325-0648	719.79	648.20	266	63.60	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			702.9	C08		3	0326-0650	46.59	649.98	241	58.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			405.2	C08		3	0327-0654	672.21	654.89	277	62.77	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			875.3	C08		3	0328-0659	482.69	658.41	319	68.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			963.0	C08		3	0329-0656	415.05	657.27	273	64.18	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			628.5	C08		3	0330-0661	817.85	661.10	226	55.11	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			307.4	C08		3	0331-0662	381.27	662.38	254	60.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			494.5	C08		3	0332-0664	602.31	664.16	276	61.94	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			829.2	C08		3	0333-0665	260.71	665.53	161	46.87	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			333.2	C08		3	0334-0669	166.07	669.08	291	63.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			385.4	C08		3	0335-0673	211.95	673.34	288	68.53	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			717.0	C08		3	0336-0672	244.53	673.82	262	64.53	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3098.1	C08		3	0337-0678	779.05	677.79	266	59.36	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			805.5	C08		3	0338-0679	734.95	678.14	297	63.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1114.9	C08		3	0339-0681	865.04	680.29	300	66.77	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			788.8	C08		3	0340-0682	910.16	681.82	303	65.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2556.1	C08		3	0341-0682	754.15	682.31	293	63.01	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			803.4	C08		3	0342-0681	883.02	681.72	260	61.01	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			556.6	C08		3	0343-0681	559.94	681.50	269	63.36	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1155.9	C08		3	0344-0687	817.17	687.40	326	67.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			537.5	C08		3	0345-0688	615.97	687.25	257	61.11	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			496.7	C08		3	0346-0694	384.31	694.38	318	68.53	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			404.7	C08		3	0347-0697	418.34	698.00	305	66.77	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			375.3	C08		3	0348-0701	679.16	701.08	282	67.36	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3871.9	C08		3	0349-0701	229.03	700.26	253	67.84	0.691
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			806.4	C08		3	0350-0705	619.82	705.13	278	63.94	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2053.2	C08		3	0351-0702	848.61	702.61	245	59.94	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			423.5	C08		3	0352-0709	943.83	708.13	287	64.77	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			183.1	C08		3	0353-0709	56.23	709.62	258	61.70	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			545.9	C08		3	0354-0711	333.46	711.20	309	69.11	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			779.1	C08		4	0001-0023	195.30	23.30	268	61.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			969.0	C08		4	0002-0022	562.22	22.54	257	61.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2320.7	C08		4	0003-0021	820.66	21.45	146	46.04	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			186.3	C08		4	0004-0026	17.68	27.12	282	63.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2517.6	C08		4	0005-0025	333.33	25.35	262	59.36	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			309.3	C08		4	0006-0029	365.76	29.28	324	70.67	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2423.1	C08		4	0007-0029	89.76	29.68	255	61.36	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1802.6	C08		4	0008-0033	621.79	33.53	356	70.43	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			386.9	C08		4	0009-0038	108.79	38.32	321	66.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			383.4	C08		4	0010-0042	214.26	42.85	281	64.77	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			494.7	C08		4	0011-0045	786.35	45.55	257	61.11	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1624.7	C08		4	0012-0046	321.66	46.11	241	57.11	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1302.2	C08		4	0013-0046	703.80	46.36	280	65.11	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1454.4	C08		4	0014-0048	943.16	49.11	232	56.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3673.4	C08		4	0015-0055	52.27	55.75	711	116.13	0.663
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			295.6	C08		4	0016-0052	448.90	51.61	395	72.77	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			338.4	C08		4	0017-0056	116.59	56.15	287	64.77	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1198.2	C08		4	0018-0057	857.49	56.52	218	55.11	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			379.2	C08		4	0019-0062	138.71	62.85	301	69.26	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			579.3	C08		4	0020-0063	660.87	63.64	333	68.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			777.5	C08		4	0021-0063	268.62	63.38	243	59.60	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			653.6	C08		4	0022-0067	498.94	66.82	322	70.18	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1519.2	C08		4	0023-0063	541.75	63.22	257	60.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			523.1	C08		4	0024-0062	762.42	62.81	263	60.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			237.1	C08		4	0025-0065	921.79	64.05	293	66.43	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1791.7	C08		4	0026-0072	306.40	72.35	280	63.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2944.7	C08		4	0027-0072	555.04	71.69	231	57.94	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			394.2	C08		4	0028-0077	228.36	77.22	311	66.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1684.8	C08		4	0029-0080	255.87	80.63	419	76.08	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			674.5	C08		4	0030-0080	861.20	80.08	233	56.87	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			392.5	C08		4	0031-0080	902.41	80.33	276	62.77	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1120.2	C08		4	0032-0083	625.71	83.44	278	63.94	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4237.5	C08		4	0033-0083	563.68	83.38	211	54.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1679.4	C08		4	0034-0086	418.74	86.24	264	60.43	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			984.1	C08		4	0035-0087	108.03	87.68	255	60.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			714.8	C08		4	0036-0093	591.99	93.38	413	82.08	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1102.1	C08		4	0037-0086	761.03	86.31	272	63.94	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			397.2	C08		4	0038-0087	185.57	87.49	289	61.94	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			455.1	C08		4	0039-0093	461.42	93.14	342	73.74	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			327.6	C08		4	0040-0092	701.97	91.78	300	66.18	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			527.7	C08		4	0041-0100	738.97	99.96	308	65.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			492.0	C08		4	0042-0102	52.13	101.74	260	59.94	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1843.1	C08		4	0043-0110	367.52	110.02	740	103.30	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7351.5	C08		4	0044-0103	837.97	102.66	133	98.13	0.174
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			650.9	C08		4	0045-0104	544.63	104.79	309	65.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			290.3	C08		4	0046-0107	942.98	106.80	304	64.77	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			921.1	C08		4	0047-0107	89.01	106.82	202	55.11	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			375.6	C08		4	0048-0112	288.36	112.59	289	63.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			407.4	C08		4	0049-0118	163.66	118.71	229	59.70	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1741.9	C08		4	0050-0121	427.35	120.78	283	63.26	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			10108.1	C08		4	0051-0128	672.34	128.38	325	67.01	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2117.7	C08		4	0052-0132	440.24	131.62	293	65.26	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3653.6	C08		4	0053-0132	641.24	132.40	265	63.01	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1136.4	C08		4	0054-0135	321.50	135.13	286	69.11	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1116.3	C08		4	0055-0133	195.76	132.94	243	58.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1670.7	C08		4	0056-0141	832.51	140.76	395	73.01	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3335.1	C08		4	0057-0141	698.12	140.93	279	61.94	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			446.2	C08		4	0058-0144	401.87	144.67	298	65.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1134.3	C08		4	0059-0141	608.51	141.51	293	63.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2587.7	C08		4	0060-0143	890.55	143.94	350	69.01	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			315.2	C08		4	0061-0147	281.89	147.32	272	62.53	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2900.5	C08		4	0062-0155	211.91	154.96	244	59.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			649.5	C08		4	0063-0155	546.55	155.53	283	63.70	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3925.7	C08		4	0064-0157	650.36	156.76	250	58.18	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			973.6	C08		4	0065-0162	471.64	161.79	460	83.98	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1771.4	C08		4	0066-0162	875.55	162.57	335	67.01	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5956.2	C08		4	0067-0165	392.06	164.70	252	60.87	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			979.8	C08		4	0068-0162	908.00	162.89	262	59.11	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1191.1	C08		4	0069-0166	15.51	165.91	257	61.01	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2009.8	C08		4	0070-0165	626.78	165.37	265	61.36	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1045.7	C08		4	0071-0169	55.25	169.81	268	63.94	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			373.1	C08		4	0072-0173	930.06	173.44	334	73.60	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2251.8	C08		4	0073-0171	572.45	171.06	277	65.01	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			413.1	C08		4	0074-0175	117.62	175.02	347	70.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5887.5	C08		4	0075-0174	608.69	174.77	343	72.67	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6898.0	C08		4	0076-0176	709.60	175.55	246	58.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			753.0	C08		4	0077-0182	743.35	181.60	249	57.94	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			390.4	C08		4	0078-0187	260.34	187.52	305	68.43	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4306.2	C08		4	0079-0187	396.30	186.68	288	65.01	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1256.6	C08		4	0080-0189	524.11	189.77	271	62.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			783.2	C08		4	0081-0192	303.68	191.71	332	70.77	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1035.5	C08		4	0082-0193	77.16	194.14	250	58.87	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1913.1	C08		4	0083-0204	189.14	203.70	711	106.91	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1286.4	C08		4	0084-0195	564.72	195.48	236	56.53	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7990.8	C08		4	0085-0197	603.83	197.14	195	51.70	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			586.0	C08		4	0086-0201	361.27	201.37	278	62.18	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2409.4	C08		4	0087-0203	910.95	203.03	256	64.53	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5957.9	C08		4	0088-0200	621.21	201.45	183	52.53	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2364.1	C08		4	0089-0208	451.61	208.79	227	59.94	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3610.7	C08		4	0090-0205	142.26	204.59	219	54.53	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1028.5	C08		4	0091-0211	77.12	210.81	245	58.63	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1450.7	C08		4	0092-0214	212.55	213.45	279	62.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			531.3	C08		4	0093-0215	882.23	215.37	291	63.36	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1505.2	C08		4	0094-0218	788.07	218.22	272	63.94	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			278.7	C08		4	0095-0220	822.27	219.43	310	65.36	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			861.2	C08		4	0096-0221	236.96	221.31	270	60.18	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			522.7	C08		4	0097-0223	700.20	224.18	270	61.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1309.8	C08		4	0098-0225	11.64	225.33	233	56.28	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5497.4	C08		4	0099-0224	907.71	224.45	290	74.43	0.658
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			429.2	C08		4	0100-0231	46.45	231.41	275	62.18	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4621.0	C08		4	0101-0231	289.29	231.64	353	70.18	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1748.6	C08		4	0102-0233	398.28	233.18	267	64.18	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2048.6	C08		4	0103-0237	156.70	237.75	481	90.57	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			790.2	C08		4	0104-0241	555.48	240.85	356	74.91	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			944.2	C08		4	0105-0241	479.61	240.40	254	60.28	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1954.7	C08		4	0106-0245	716.17	245.07	436	77.60	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			409.1	C08		4	0107-0247	327.17	247.13	466	82.43	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6422.6	C08		4	0108-0246	134.48	245.89	176	49.36	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			382.1	C08		4	0109-0253	433.59	253.15	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3492.3	C08		4	0110-0253	587.73	252.99	305	65.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			631.1	C08		4	0111-0256	80.26	256.04	257	61.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3478.8	C08		4	0112-0257	247.39	255.62	261	61.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2616.4	C08		4	0113-0256	364.30	256.01	292	63.94	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1216.9	C08		4	0114-0254	936.70	254.54	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1169.1	C08		4	0115-0257	755.30	256.76	273	62.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			388.2	C08		4	0116-0257	864.11	257.95	306	66.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1246.1	C08		4	0117-0258	384.05	257.99	249	58.28	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1780.1	C08		4	0118-0260	777.97	259.88	263	59.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			711.6	C08		4	0119-0265	223.78	265.45	272	63.94	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2342.6	C08		4	0120-0264	502.47	264.27	314	66.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1982.4	C08		4	0121-0265	114.70	264.56	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			743.8	C08		4	0122-0271	280.71	271.29	271	61.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1052.8	C08		4	0123-0271	834.78	271.50	274	61.01	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			711.7	C08		4	0124-0274	894.80	274.10	305	65.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			403.1	C08		4	0125-0278	522.30	279.48	304	69.01	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			513.9	C08		4	0126-0276	602.65	276.21	294	62.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1688.4	C08		4	0127-0284	128.97	286.07	617	101.40	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3962.1	C08		4	0128-0277	254.08	276.78	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			915.4	C08		4	0129-0286	42.86	285.69	296	64.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2937.1	C08		4	0130-0286	158.65	286.05	218	55.70	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2958.2	C08		4	0131-0288	942.68	288.02	330	69.01	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			483.2	C08		4	0132-0289	406.39	289.20	301	67.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			728.9	C08		4	0133-0289	695.37	289.37	262	62.18	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1017.4	C08		4	0134-0294	340.79	295.23	513	90.91	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1022.4	C08		4	0135-0293	917.77	293.73	271	61.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3885.4	C08		4	0136-0296	250.70	296.90	422	77.84	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1644.3	C08		4	0137-0293	712.56	293.65	264	63.36	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			506.4	C08		4	0138-0294	560.23	293.96	274	64.43	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2517.3	C08		4	0139-0299	471.38	299.56	304	65.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			374.0	C08		4	0140-0301	392.38	301.52	280	64.18	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			199.4	C08		4	0141-0307	13.11	307.38	287	63.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6783.3	C08		4	0142-0306	80.29	306.31	181	50.87	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			441.1	C08		4	0143-0307	523.17	306.77	252	59.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1560.5	C08		4	0144-0306	612.94	307.01	227	54.77	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			373.8	C08		4	0145-0309	816.53	308.49	292	66.77	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4938.4	C08		4	0146-0315	425.75	315.11	295	63.01	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			236.2	C08		4	0147-0319	940.38	319.78	301	64.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			308.8	C08		4	0148-0318	803.67	318.62	290	69.84	0.747
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2838.4	C08		4	0149-0317	849.12	317.73	271	60.18	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3116.6	C08		4	0150-0323	559.21	322.24	321	73.26	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7823.5	C08		4	0151-0321	87.18	321.12	225	56.28	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1759.4	C08		4	0152-0322	452.39	323.15	367	71.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			563.0	C08		4	0153-0327	162.06	328.11	249	59.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4833.0	C08		4	0154-0330	710.27	330.78	319	65.36	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1168.3	C08		4	0155-0328	886.53	328.26	263	60.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			381.0	C08		4	0156-0338	594.01	337.91	595	97.98	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			402.8	C08		4	0157-0337	646.17	337.01	297	63.60	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1998.5	C08		4	0158-0337	116.88	337.20	284	63.36	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1356.9	C08		4	0159-0341	39.77	340.92	273	63.60	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			715.8	C08		4	0160-0341	454.84	340.21	289	67.11	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2844.1	C08		4	0161-0346	304.57	345.75	260	61.36	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			803.6	C08		4	0162-0346	271.11	346.10	266	59.11	0.957
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			288.3	C08		4	0163-0350	752.50	350.43	324	67.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			336.9	C08		4	0164-0350	384.43	350.60	255	57.94	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1917.4	C08		4	0165-0356	74.61	354.29	497	93.74	0.711
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			344.6	C08		4	0166-0357	29.79	358.18	297	66.18	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2027.7	C08		4	0167-0358	176.42	358.89	387	72.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			479.5	C08		4	0168-0359	793.52	358.98	294	63.84	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			671.2	C08		4	0169-0361	514.26	361.31	283	61.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			872.7	C08		4	0170-0360	594.36	360.58	300	66.43	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			972.8	C08		4	0171-0361	685.12	361.13	274	61.11	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			657.7	C08		4	0172-0365	840.24	364.88	336	71.26	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2815.2	C08		4	0173-0368	155.00	368.36	278	62.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			382.6	C08		4	0174-0368	933.68	367.98	277	63.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			330.8	C08		4	0175-0368	547.58	368.08	268	61.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			853.0	C08		4	0176-0373	905.43	372.43	254	62.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			491.1	C08		4	0177-0378	76.68	377.50	293	64.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1668.7	C08		4	0178-0379	403.55	378.78	400	75.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1910.5	C08		4	0179-0381	916.77	381.15	265	65.11	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2338.0	C08		4	0180-0380	783.74	380.76	267	61.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			307.4	C08		4	0181-0381	868.36	381.50	273	62.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			354.0	C08		4	0182-0380	582.62	380.44	267	62.77	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1620.3	C08		4	0183-0387	197.99	387.76	271	62.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1487.5	C08		4	0184-0388	386.37	388.18	276	63.60	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1056.3	C08		4	0185-0393	451.71	392.80	425	77.50	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1145.7	C08		4	0186-0392	327.20	391.44	230	59.01	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			784.1	C08		4	0187-0391	646.40	391.28	327	69.60	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			9171.8	C08		4	0188-0393	265.53	394.10	264	71.60	0.647
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1990.6	C08		4	0189-0398	487.40	398.43	243	57.94	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1283.0	C08		4	0190-0407	338.35	406.82	452	79.26	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			326.5	C08		4	0191-0407	428.75	406.70	308	67.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			289.5	C08		4	0192-0406	835.29	405.58	284	63.36	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2661.2	C08		4	0193-0406	219.83	405.82	314	75.01	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3706.5	C08		4	0194-0412	39.19	412.53	379	73.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			818.4	C08		4	0195-0414	718.29	413.31	316	70.67	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1375.0	C08		4	0196-0415	616.94	415.67	305	71.11	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1465.9	C08		4	0197-0418	537.24	418.53	261	60.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			687.3	C08		4	0198-0419	314.66	418.81	257	60.77	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2077.0	C08		4	0199-0423	23.37	424.02	327	68.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			403.1	C08		4	0200-0426	443.84	426.38	435	78.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			543.5	C08		4	0201-0422	497.94	422.24	234	59.94	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			668.4	C08		4	0202-0421	782.63	422.18	227	57.46	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1079.8	C08		4	0203-0428	102.54	428.54	257	59.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2020.3	C08		4	0204-0428	353.63	428.13	233	58.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1215.3	C08		4	0205-0431	175.61	431.06	260	61.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2209.3	C08		4	0206-0436	869.49	435.52	344	69.26	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			288.8	C08		4	0207-0437	399.03	437.24	300	65.84	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			489.2	C08		4	0208-0435	785.70	435.21	299	67.46	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			338.5	C08		4	0209-0442	844.50	442.06	300	68.08	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			523.5	C08		4	0210-0439	899.85	439.43	274	63.94	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			286.6	C08		4	0211-0444	533.74	444.45	275	63.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			276.8	C08		4	0212-0451	210.14	451.51	293	67.01	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1708.1	C08		4	0213-0452	160.79	452.29	236	59.70	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			693.8	C08		4	0214-0454	600.75	454.31	294	65.60	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			431.5	C08		4	0215-0451	736.90	451.79	266	61.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2421.1	C08		4	0216-0454	895.33	454.25	259	61.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			182.2	C08		4	0217-0458	478.62	458.38	287	65.84	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1063.6	C08		4	0218-0461	694.69	460.92	532	86.91	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			483.4	C08		4	0219-0459	44.19	459.42	281	64.43	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			280.0	C08		4	0220-0459	342.19	460.03	284	62.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2385.1	C08		4	0221-0462	933.42	462.17	236	57.70	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1813.8	C08		4	0222-0465	256.68	465.55	257	60.77	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1215.0	C08		4	0223-0471	643.70	471.56	319	67.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			303.0	C08		4	0224-0473	375.99	473.75	283	64.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			910.4	C08		4	0225-0478	95.76	477.80	297	67.94	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			340.9	C08		4	0226-0480	226.39	480.27	289	68.53	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1010.9	C08		4	0227-0482	578.29	482.37	597	107.88	0.645
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			237.3	C08		4	0228-0482	355.23	481.80	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			508.8	C08		4	0229-0483	515.35	483.79	278	63.70	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			379.2	C08		4	0230-0487	464.61	487.29	316	68.67	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			596.9	C08		4	0231-0486	656.31	486.55	381	76.18	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			620.7	C08		4	0232-0489	306.55	488.32	222	57.60	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			410.3	C08		4	0233-0491	261.19	491.53	318	66.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1483.9	C08		4	0234-0492	900.56	491.75	258	62.43	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			9665.9	C08		4	0235-0493	119.60	493.37	322	66.43	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			567.6	C08		4	0236-0493	532.25	493.24	329	67.36	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			994.7	C08		4	0237-0496	152.27	496.95	290	63.60	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			376.8	C08		4	0238-0498	496.09	498.57	275	61.36	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1701.8	C08		4	0239-0506	296.91	506.63	510	89.40	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3668.2	C08		4	0240-0503	747.65	501.76	382	82.77	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			366.7	C08		4	0241-0505	190.44	504.87	303	66.43	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2749.5	C08		4	0242-0506	585.31	506.50	368	79.01	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3504.9	C08		4	0243-0506	914.71	505.80	385	72.08	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1251.3	C08		4	0244-0507	75.06	506.49	407	77.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			635.9	C08		4	0245-0508	940.54	508.37	248	59.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			506.2	C08		4	0246-0514	460.98	514.37	282	66.18	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			487.1	C08		4	0247-0515	344.87	515.17	256	58.77	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5255.5	C08		4	0248-0513	752.20	513.18	104	37.56	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			947.2	C08		4	0249-0519	797.87	519.53	305	66.77	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2925.0	C08		4	0250-0523	21.03	522.78	367	71.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1342.8	C08		4	0251-0524	677.56	524.40	267	63.11	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			337.1	C08		4	0252-0525	857.33	525.76	293	63.60	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			527.9	C08		4	0253-0528	605.21	528.13	260	60.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			564.6	C08		4	0254-0530	81.41	530.67	265	59.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			333.0	C08		4	0255-0532	425.71	531.58	294	64.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5103.4	C08		4	0256-0534	143.33	533.49	348	69.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			719.7	C08		4	0257-0536	337.79	536.17	304	64.77	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1080.7	C08		4	0258-0540	705.37	540.44	283	67.60	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			266.4	C08		4	0259-0540	375.55	540.29	282	61.36	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1203.4	C08		4	0260-0542	264.94	543.10	283	64.18	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1378.8	C08		4	0261-0540	769.06	541.00	227	55.70	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1356.7	C08		4	0262-0546	504.88	544.75	144	58.18	0.535
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1395.3	C08		4	0263-0545	786.77	545.17	241	58.28	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1123.0	C08		4	0264-0548	466.92	548.01	289	65.60	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			616.8	C08		4	0265-0551	193.95	551.35	335	75.36	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			484.6	C08		4	0266-0551	210.43	550.77	270	61.70	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1701.1	C08		4	0267-0553	564.18	553.75	284	62.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			291.7	C08		4	0268-0551	918.25	551.13	317	66.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1584.2	C08		4	0269-0550	498.75	550.63	113	46.04	0.670
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			767.8	C08		4	0270-0553	125.79	553.98	155	46.87	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7300.9	C08		4	0271-0563	41.40	563.91	377	82.43	0.697
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			361.8	C08		4	0272-0562	294.63	562.32	316	67.60	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2580.1	C08		4	0273-0561	645.15	561.41	241	61.36	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			985.3	C08		4	0274-0566	848.78	566.92	594	97.40	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			327.6	C08		4	0275-0565	518.57	564.82	266	61.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			348.7	C08		4	0276-0565	593.65	565.42	274	60.77	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			643.7	C08		4	0277-0568	97.71	568.65	271	62.77	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1749.4	C08		4	0278-0566	436.79	566.91	284	68.43	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			482.4	C08		4	0279-0583	385.93	583.07	254	58.53	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			297.0	C08		4	0280-0582	551.56	582.54	274	61.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			652.4	C08		4	0281-0586	588.04	585.62	294	67.60	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			511.3	C08		4	0282-0585	806.99	584.50	330	70.43	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			385.5	C08		4	0283-0588	656.39	587.82	317	68.67	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5125.8	C08		4	0284-0585	915.70	585.09	232	55.94	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3011.6	C08		4	0285-0586	752.14	586.11	259	59.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1914.5	C08		4	0286-0589	453.57	588.43	297	65.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			470.7	C08		4	0287-0596	680.62	596.36	294	65.01	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			402.9	C08		4	0288-0597	370.78	597.13	269	60.87	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4432.8	C08		4	0289-0598	906.51	598.67	284	67.01	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2520.7	C08		4	0290-0602	472.15	602.78	265	62.77	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			324.3	C08		4	0291-0606	407.31	605.77	311	66.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			932.9	C08		4	0292-0610	596.24	611.18	339	74.43	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1655.4	C08		4	0293-0606	124.51	606.33	248	59.11	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			659.1	C08		4	0294-0604	150.87	603.91	160	48.87	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1829.8	C08		4	0295-0608	221.37	608.45	282	67.01	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			521.1	C08		4	0296-0611	107.12	611.29	310	67.60	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8096.5	C08		4	0297-0608	891.26	607.66	201	53.36	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			340.9	C08		4	0298-0617	251.36	617.11	262	63.26	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			420.7	C08		4	0299-0617	546.69	617.58	314	66.18	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			453.8	C08		4	0300-0621	164.67	621.23	270	65.70	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1508.5	C08		4	0301-0617	298.05	616.51	243	57.36	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1190.6	C08		4	0302-0623	508.75	622.51	536	104.13	0.621
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			361.3	C08		4	0303-0621	860.48	620.95	301	66.53	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1088.1	C08		4	0304-0621	89.78	621.50	220	54.18	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			354.6	C08		4	0305-0626	363.21	626.25	240	63.84	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			172.5	C08		4	0306-0623	19.85	623.15	257	57.94	0.962
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			371.3	C08		4	0307-0626	446.30	626.23	296	65.84	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			358.3	C08		4	0308-0628	276.95	627.68	296	65.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			246.1	C08		4	0309-0632	393.23	631.71	281	63.60	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			616.3	C08		4	0310-0629	712.87	629.97	259	61.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2569.6	C08		4	0311-0633	197.52	634.07	279	62.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2150.9	C08		4	0312-0642	488.06	641.33	754	112.47	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			788.7	C08		4	0313-0637	829.47	636.54	263	61.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1643.7	C08		4	0314-0644	345.03	644.26	229	55.70	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			382.2	C08		4	0315-0641	608.85	641.57	282	65.36	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			931.0	C08		4	0316-0647	814.22	647.40	352	70.67	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			374.8	C08		4	0317-0648	411.99	648.90	283	67.84	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			503.2	C08		4	0318-0654	217.20	652.52	594	101.74	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1052.4	C08		4	0319-0647	372.52	646.90	117	54.67	0.492
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1028.4	C08		4	0320-0651	366.21	653.00	129	56.43	0.509
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			422.7	C08		4	0321-0657	751.75	656.75	276	64.77	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3217.9	C08		4	0322-0661	29.53	660.50	527	89.26	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			360.5	C08		4	0323-0658	948.14	657.79	286	63.60	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			395.7	C08		4	0324-0664	526.90	664.58	255	62.53	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1301.6	C08		4	0325-0661	625.34	660.88	249	57.94	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			485.6	C08		4	0326-0664	562.53	664.41	309	68.43	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			316.2	C08		4	0327-0667	784.11	667.20	269	63.36	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			466.7	C08		4	0328-0665	139.16	664.90	285	63.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2065.2	C08		4	0329-0670	586.29	670.21	256	59.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4909.8	C08		4	0330-0670	914.77	670.05	225	54.87	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1529.4	C08		4	0331-0674	415.34	674.71	314	66.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			683.5	C08		4	0332-0677	471.76	677.87	291	65.94	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			575.7	C08		4	0333-0679	539.42	678.57	287	67.36	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1277.7	C08		4	0334-0682	65.29	680.87	252	65.36	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			981.8	C08		4	0335-0683	495.42	683.29	294	66.53	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1440.9	C08		4	0336-0681	348.32	681.31	250	58.18	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			309.0	C08		4	0337-0682	512.00	682.29	273	61.21	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6381.2	C08		4	0338-0685	29.24	685.85	265	61.36	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			199.3	C08		4	0339-0687	261.52	686.48	285	65.36	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3107.2	C08		4	0340-0687	845.32	687.10	233	56.18	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			338.1	C08		4	0341-0692	717.19	692.78	251	61.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2454.7	C08		4	0342-0691	292.89	692.24	199	53.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			587.1	C08		4	0343-0694	754.00	694.29	290	65.60	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			842.4	C08		4	0344-0696	193.12	695.75	276	62.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4413.1	C08		4	0345-0697	54.64	698.43	341	70.43	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1875.6	C08		4	0346-0696	135.31	695.85	323	66.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			269.7	C08		4	0347-0699	793.59	700.20	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			470.4	C08		4	0348-0699	474.12	699.64	273	62.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			387.8	C08		4	0349-0701	733.39	701.49	303	67.36	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			308.8	C08		4	0350-0705	877.22	705.20	108	42.04	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			217.5	C08		4	0351-0707	930.89	707.77	266	65.01	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1553.3	C08		4	0352-0710	358.48	709.73	291	63.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			155.6	C08		5	0001-0025	207.22	24.73	281	63.36	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			360.8	C08		5	0002-0023	628.36	23.18	228	56.28	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5044.6	C08		5	0003-0027	757.57	26.69	263	60.43	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			390.4	C08		5	0004-0025	245.80	25.00	263	60.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			320.0	C08		5	0005-0035	174.04	35.25	268	60.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3955.9	C08		5	0006-0036	402.63	35.76	271	61.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			750.2	C08		5	0007-0037	66.40	37.22	253	59.11	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1523.5	C08		5	0008-0039	746.47	39.01	243	59.84	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			291.5	C08		5	0009-0041	937.37	41.10	272	64.18	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2852.5	C08		5	0010-0045	583.63	46.23	377	80.18	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5011.4	C08		5	0011-0041	602.48	40.47	210	54.87	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1097.1	C08		5	0012-0046	510.44	45.61	319	65.01	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			924.5	C08		5	0013-0047	417.06	47.14	262	70.67	0.659
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			897.7	C08		5	0014-0048	325.88	48.14	252	59.70	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			735.8	C08		5	0015-0048	864.11	48.79	362	71.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2925.5	C08		5	0016-0051	538.31	51.75	284	63.94	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			358.0	C08		5	0017-0049	663.18	49.26	245	56.77	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1769.3	C08		5	0018-0051	47.74	51.33	240	58.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			882.0	C08		5	0019-0051	887.77	51.56	252	57.94	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1701.6	C08		5	0020-0056	264.29	55.56	497	91.74	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2346.4	C08		5	0021-0055	482.62	55.53	232	56.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			367.2	C08		5	0022-0063	305.30	62.56	282	66.67	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			299.2	C08		5	0023-0062	186.19	63.10	290	65.60	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			944.6	C08		5	0024-0064	806.78	64.54	201	56.43	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			244.7	C08		5	0025-0067	26.26	66.14	274	64.43	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			870.2	C08		5	0026-0066	117.58	65.66	227	59.60	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			638.0	C08		5	0027-0071	231.30	71.55	281	65.60	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2000.5	C08		5	0028-0071	753.60	71.94	276	61.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			670.2	C08		5	0029-0072	559.09	72.36	265	60.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			609.4	C08		5	0030-0076	379.29	75.97	313	67.01	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1120.3	C08		5	0031-0080	123.83	80.49	366	76.18	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			420.5	C08		5	0032-0075	165.25	74.41	288	65.70	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			345.0	C08		5	0033-0078	613.99	77.76	256	58.53	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			275.0	C08		5	0034-0079	923.97	79.38	259	59.70	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			779.5	C08		5	0035-0081	60.39	81.99	265	64.18	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			851.6	C08		5	0036-0084	505.04	84.26	310	65.94	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			298.3	C08		5	0037-0090	693.12	90.15	316	68.18	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			742.0	C08		5	0038-0088	724.22	87.61	299	63.60	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3423.6	C08		5	0039-0087	254.08	87.36	238	58.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			971.1	C08		5	0040-0089	87.63	89.57	252	58.53	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			565.1	C08		5	0041-0090	184.69	90.96	419	81.26	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1061.2	C08		5	0042-0094	281.23	94.20	346	70.18	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			584.6	C08		5	0043-0093	162.46	93.63	217	59.70	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			329.2	C08		5	0044-0097	316.17	98.03	272	60.77	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			412.6	C08		5	0045-0105	858.99	106.45	309	76.77	0.659
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			407.6	C08		5	0046-0101	651.89	101.10	345	69.84	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			297.2	C08		5	0047-0102	503.46	101.78	273	62.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			283.9	C08		5	0048-0105	894.66	104.84	302	69.84	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			385.5	C08		5	0049-0105	342.24	105.07	235	55.94	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			290.5	C08		5	0050-0107	788.00	107.40	286	64.77	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			364.4	C08		5	0051-0109	47.58	108.98	289	62.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7767.3	C08		5	0052-0108	208.12	107.97	321	66.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1504.7	C08		5	0053-0109	829.80	108.41	263	60.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3651.1	C08		5	0054-0110	550.61	109.80	235	57.46	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			973.8	C08		5	0055-0114	939.47	113.65	286	65.94	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3535.3	C08		5	0056-0114	535.56	114.61	220	58.18	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			537.8	C08		5	0057-0115	814.85	115.25	248	61.60	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			377.3	C08		5	0058-0116	125.20	116.96	275	64.67	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			998.0	C08		5	0059-0116	583.58	116.19	253	57.94	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			520.4	C08		5	0060-0117	451.18	117.39	235	63.01	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1218.7	C08		5	0061-0130	293.94	130.74	532	96.57	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1926.1	C08		5	0062-0127	763.95	126.43	390	74.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			407.4	C08		5	0063-0129	241.70	129.15	279	63.01	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			298.1	C08		5	0064-0128	945.76	129.18	307	67.60	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			607.9	C08		5	0065-0130	709.15	129.47	285	63.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			294.7	C08		5	0066-0132	205.96	132.26	302	67.01	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			242.0	C08		5	0067-0131	83.68	131.34	282	64.77	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			893.0	C08		5	0068-0132	462.85	132.67	223	56.63	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1322.8	C08		5	0069-0142	511.66	141.97	346	70.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1781.7	C08		5	0070-0142	779.76	142.04	281	64.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			210.8	C08		5	0071-0146	124.86	145.69	304	69.01	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			480.9	C08		5	0072-0147	401.83	145.94	226	60.53	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			334.3	C08		5	0073-0149	538.49	149.60	263	65.01	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			290.6	C08		5	0074-0148	704.63	148.28	295	65.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1146.9	C08		5	0075-0148	826.93	148.52	278	62.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3065.6	C08		5	0076-0150	644.94	149.72	309	65.36	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2494.0	C08		5	0077-0148	467.80	148.00	227	55.70	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			350.8	C08		5	0078-0154	206.08	154.12	273	60.77	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			437.9	C08		5	0079-0155	564.25	155.96	469	80.08	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			376.8	C08		5	0080-0153	71.19	152.62	267	62.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			340.9	C08		5	0081-0156	224.25	156.24	260	59.70	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2932.8	C08		5	0082-0159	918.75	158.85	309	71.36	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			630.7	C08		5	0083-0161	670.33	161.54	283	65.26	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3251.8	C08		5	0084-0159	901.80	159.44	190	52.28	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1089.2	C08		5	0085-0161	411.74	160.23	259	61.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			693.7	C08		5	0086-0164	12.84	165.13	248	57.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3585.3	C08		5	0087-0167	149.27	167.38	232	56.18	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1204.7	C08		5	0088-0168	837.22	167.15	248	61.94	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			357.6	C08		5	0089-0175	34.74	175.89	304	70.77	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			437.7	C08		5	0090-0176	348.13	175.84	308	67.60	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			523.8	C08		5	0091-0176	595.11	176.03	445	77.26	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2345.8	C08		5	0092-0177	174.77	177.75	256	58.18	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			559.3	C08		5	0093-0179	752.26	178.85	297	65.60	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2321.3	C08		5	0094-0182	139.86	182.31	239	57.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			815.6	C08		5	0095-0179	480.19	178.89	257	60.53	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			602.8	C08		5	0096-0180	773.20	180.22	253	59.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1242.3	C08		5	0097-0178	819.77	178.06	127	42.97	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1608.9	C08		5	0098-0181	830.53	181.19	108	38.39	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			190.1	C08		5	0099-0189	195.63	189.09	273	62.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			551.9	C08		5	0100-0194	94.39	194.00	361	74.43	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			315.6	C08		5	0101-0192	356.51	192.32	250	61.60	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			206.1	C08		5	0102-0193	111.20	192.63	270	61.70	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			637.2	C08		5	0103-0196	316.62	195.93	423	74.43	0.960
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4354.9	C08		5	0104-0192	277.15	191.83	127	62.43	0.410
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			355.6	C08		5	0105-0197	255.39	196.94	291	65.11	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			481.8	C08		5	0106-0199	238.00	199.22	270	60.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			396.2	C08		5	0107-0197	755.16	197.21	333	73.84	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1007.4	C08		5	0108-0203	377.95	202.93	389	73.84	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1239.1	C08		5	0109-0202	729.24	202.66	282	62.28	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2027.0	C08		5	0110-0205	15.79	205.08	242	62.53	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			749.7	C08		5	0111-0201	152.68	200.91	278	65.11	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			656.8	C08		5	0112-0213	531.46	212.95	638	109.64	0.667
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2104.1	C08		5	0113-0208	451.28	209.15	386	77.60	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2632.3	C08		5	0114-0207	707.83	207.15	275	61.70	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			757.6	C08		5	0115-0208	417.03	208.07	264	60.77	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3875.1	C08		5	0116-0212	806.62	212.34	352	71.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1554.7	C08		5	0117-0213	468.08	213.85	235	59.11	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			234.4	C08		5	0118-0215	79.24	215.03	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2967.8	C08		5	0119-0216	916.03	216.05	260	60.18	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1142.2	C08		5	0120-0216	754.19	217.04	271	60.53	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1364.4	C08		5	0121-0220	861.49	220.57	261	61.46	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1653.4	C08		5	0122-0220	846.92	220.50	226	56.53	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3847.5	C08		5	0123-0220	155.45	219.99	235	58.53	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1113.8	C08		5	0124-0227	305.10	227.85	461	79.84	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			528.6	C08		5	0125-0230	209.14	229.56	465	82.18	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1517.4	C08		5	0126-0228	629.67	228.20	214	54.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			366.7	C08		5	0127-0234	566.31	234.22	319	71.60	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3982.2	C08		5	0128-0234	179.64	233.99	323	67.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5030.0	C08		5	0129-0235	160.19	235.37	256	64.18	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1680.0	C08		5	0130-0236	282.88	236.18	299	64.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2285.3	C08		5	0131-0236	649.81	235.52	223	55.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			356.7	C08		5	0132-0237	120.78	237.25	243	58.18	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3261.9	C08		5	0133-0245	368.24	245.87	246	57.60	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			345.3	C08		5	0134-0246	583.97	245.73	309	67.70	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1790.2	C08		5	0135-0246	746.79	246.21	272	67.01	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1575.9	C08		5	0136-0251	154.83	251.42	213	57.36	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1229.5	C08		5	0137-0257	41.66	256.83	302	66.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3896.6	C08		5	0138-0261	915.84	261.05	264	62.77	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1264.5	C08		5	0139-0268	672.13	267.50	285	65.01	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1523.9	C08		5	0140-0270	701.57	270.34	435	77.26	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			395.0	C08		5	0141-0268	165.69	268.34	279	64.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1107.0	C08		5	0142-0271	272.79	270.58	228	59.01	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			483.0	C08		5	0143-0272	781.36	271.85	315	68.18	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1736.7	C08		5	0144-0274	218.26	274.24	234	58.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1270.5	C08		5	0145-0274	336.63	274.33	263	61.36	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5243.0	C08		5	0146-0275	403.63	274.97	100	53.94	0.432
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			619.0	C08		5	0147-0277	614.54	277.62	293	63.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2152.1	C08		5	0148-0282	637.91	282.17	280	62.18	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			667.9	C08		5	0149-0285	826.66	284.99	417	75.84	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1374.3	C08		5	0150-0283	727.36	283.45	236	57.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4764.4	C08		5	0151-0284	368.25	284.96	238	57.36	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			514.1	C08		5	0152-0286	122.52	286.93	271	62.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			808.2	C08		5	0153-0288	523.62	287.86	321	69.26	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3079.8	C08		5	0154-0290	47.31	290.37	349	69.01	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			986.5	C08		5	0155-0288	145.49	288.97	279	64.43	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			258.8	C08		5	0156-0293	892.36	293.38	289	65.60	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1886.0	C08		5	0157-0292	100.14	291.43	254	61.94	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			654.5	C08		5	0158-0290	326.27	290.42	232	60.18	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2015.2	C08		5	0159-0294	83.86	294.02	274	62.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			519.9	C08		5	0160-0293	484.95	293.15	340	72.18	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			939.8	C08		5	0161-0296	22.78	295.96	261	59.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1766.9	C08		5	0162-0297	451.94	296.90	263	62.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4956.3	C08		5	0163-0298	240.29	298.78	366	71.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			14916.6	C08		5	0164-0302	652.45	303.48	138	61.94	0.452
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			399.3	C08		5	0165-0304	280.60	304.06	270	61.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1051.2	C08		5	0166-0305	217.05	305.63	289	63.84	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			267.8	C08		5	0167-0307	930.59	307.42	323	67.01	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			517.8	C08		5	0168-0310	729.44	309.48	269	62.18	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			871.7	C08		5	0169-0312	158.18	312.84	271	59.94	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			165.0	C08		5	0170-0316	189.03	316.58	267	63.36	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			628.1	C08		5	0171-0316	69.13	316.27	257	58.53	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			323.2	C08		5	0172-0318	89.27	318.53	265	59.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			329.0	C08		5	0173-0317	799.68	316.63	286	63.60	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			255.6	C08		5	0174-0321	45.21	322.00	284	63.36	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1178.9	C08		5	0175-0320	845.17	320.63	253	58.18	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1183.3	C08		5	0176-0320	136.44	320.06	267	61.70	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1538.5	C08		5	0177-0322	397.22	323.48	278	62.87	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4098.7	C08		5	0178-0322	870.34	322.03	266	60.18	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4570.8	C08		5	0179-0331	461.27	330.50	403	123.30	0.333
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			808.1	C08		5	0180-0327	348.68	327.24	254	59.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			820.5	C08		5	0181-0336	635.50	336.28	311	67.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1761.2	C08		5	0182-0339	704.62	340.13	296	69.01	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6550.7	C08		5	0183-0339	450.08	339.58	202	57.36	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2012.5	C08		5	0184-0341	684.57	341.42	259	59.11	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			340.5	C08		5	0185-0342	157.89	341.75	248	58.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2061.0	C08		5	0186-0341	401.12	341.19	280	63.11	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			218.2	C08		5	0187-0342	227.55	343.12	260	58.53	0.954
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			215.8	C08		5	0188-0349	287.08	348.91	530	90.08	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			352.5	C08		5	0189-0348	528.05	348.36	309	64.77	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4045.9	C08		5	0190-0349	862.51	349.51	310	65.70	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1607.0	C08		5	0191-0350	111.55	349.91	286	63.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			201.9	C08		5	0192-0351	185.97	351.54	249	59.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1262.0	C08		5	0193-0351	484.60	351.12	260	59.46	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			417.5	C08		5	0194-0351	626.22	351.50	270	60.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			232.5	C08		5	0195-0355	259.67	355.61	272	62.43	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1689.9	C08		5	0196-0355	379.09	355.60	217	55.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			392.9	C08		5	0197-0357	925.07	357.27	292	67.01	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1195.6	C08		5	0198-0359	132.19	358.49	242	57.36	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3550.3	C08		5	0199-0358	402.98	357.83	219	56.53	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			179.5	C08		5	0200-0360	231.80	360.52	300	66.53	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			278.2	C08		5	0201-0363	330.82	363.80	293	67.84	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5433.5	C08		5	0202-0362	570.58	361.86	347	68.43	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1482.9	C08		5	0203-0363	801.77	362.94	302	65.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1642.2	C08		5	0204-0362	692.19	362.38	273	62.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			693.0	C08		5	0205-0362	455.04	362.52	265	59.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			790.7	C08		5	0206-0367	753.07	367.37	195	53.70	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			160.1	C08		5	0207-0370	250.40	370.10	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1187.9	C08		5	0208-0367	489.65	367.26	252	61.70	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			360.8	C08		5	0209-0370	38.62	370.24	269	61.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			291.8	C08		5	0210-0371	65.11	370.95	267	63.60	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1238.2	C08		5	0211-0379	16.47	379.21	528	92.33	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3509.8	C08		5	0212-0374	897.56	373.81	358	70.43	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5190.5	C08		5	0213-0374	392.69	373.41	227	57.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			568.5	C08		5	0214-0372	607.12	372.07	244	59.70	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3204.8	C08		5	0215-0377	715.45	377.60	258	60.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			251.0	C08		5	0216-0380	170.63	380.29	261	60.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			262.2	C08		5	0217-0380	79.57	380.62	269	65.94	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1050.3	C08		5	0218-0380	826.62	380.14	234	67.94	0.637
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1720.9	C08		5	0219-0385	845.60	385.45	276	64.77	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1453.9	C08		5	0220-0393	409.82	393.55	669	106.13	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1893.7	C08		5	0221-0388	931.71	388.88	307	65.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1393.4	C08		5	0222-0389	620.66	388.59	300	65.94	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			331.5	C08		5	0223-0391	280.28	391.24	286	63.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			500.7	C08		5	0224-0394	742.34	394.65	218	56.28	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2948.1	C08		5	0225-0397	576.47	397.02	193	53.11	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2011.5	C08		5	0226-0408	234.72	408.22	478	85.98	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3043.9	C08		5	0227-0401	128.22	400.74	230	57.70	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			646.6	C08		5	0228-0403	640.40	402.75	245	59.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1552.1	C08		5	0229-0402	674.17	402.64	236	56.87	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			807.1	C08		5	0230-0407	256.61	407.32	259	58.53	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			549.9	C08		5	0231-0408	197.58	408.15	263	62.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			546.5	C08		5	0232-0408	809.21	408.51	286	65.11	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1425.3	C08		5	0233-0413	653.05	413.47	257	58.53	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2187.1	C08		5	0234-0413	121.53	413.71	248	60.53	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1652.1	C08		5	0235-0415	880.15	415.33	325	70.18	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1521.4	C08		5	0236-0415	332.75	415.60	283	61.36	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1979.9	C08		5	0237-0420	699.61	420.50	272	61.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1380.0	C08		5	0238-0421	179.91	421.12	203	53.36	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			13171.8	C08		5	0239-0422	547.27	421.79	185	51.94	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2098.1	C08		5	0240-0423	604.43	422.81	241	56.53	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			312.4	C08		5	0241-0425	750.67	425.26	311	67.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			874.4	C08		5	0242-0428	861.17	428.79	347	72.43	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2121.4	C08		5	0243-0429	357.07	429.49	449	79.01	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			583.8	C08		5	0244-0427	425.56	426.68	266	62.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1239.9	C08		5	0245-0428	813.06	427.42	298	67.36	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4087.0	C08		5	0246-0429	910.70	428.36	341	67.60	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7743.6	C08		5	0247-0432	534.22	431.66	315	71.01	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			377.4	C08		5	0248-0432	446.12	431.85	275	61.36	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			388.4	C08		5	0249-0435	62.73	435.07	267	60.53	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2371.2	C08		5	0250-0437	691.92	437.49	220	55.11	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2059.5	C08		5	0251-0441	127.60	441.77	461	86.33	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3313.7	C08		5	0252-0442	555.58	441.73	334	74.43	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3294.3	C08		5	0253-0442	168.94	442.03	258	60.87	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1284.5	C08		5	0254-0445	236.30	444.92	500	88.91	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			563.5	C08		5	0255-0445	612.34	445.07	298	64.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1958.8	C08		5	0256-0447	719.95	447.96	315	72.43	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3790.8	C08		5	0257-0445	380.07	445.62	201	53.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			431.5	C08		5	0258-0449	909.18	450.90	311	69.84	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			289.4	C08		5	0259-0453	469.88	453.62	288	63.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1018.4	C08		5	0260-0452	66.84	451.78	252	60.18	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			444.2	C08		5	0261-0456	201.00	456.33	242	58.53	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4079.9	C08		5	0262-0458	181.80	458.11	142	57.01	0.549
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1805.8	C08		5	0263-0464	794.80	464.01	517	83.26	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1891.5	C08		5	0264-0460	504.68	460.60	232	55.36	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			297.8	C08		5	0265-0463	416.40	463.13	287	63.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1408.0	C08		5	0266-0463	661.43	462.91	449	82.43	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			419.2	C08		5	0267-0465	556.12	465.52	281	61.84	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2359.7	C08		5	0268-0464	38.15	464.42	234	57.11	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1191.9	C08		5	0269-0468	577.43	468.57	287	61.94	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3303.9	C08		5	0270-0473	300.85	472.61	357	71.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			693.4	C08		5	0271-0468	741.95	468.06	257	59.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			642.7	C08		5	0272-0472	885.89	472.06	331	67.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			345.6	C08		5	0273-0473	402.60	473.38	290	65.26	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			223.3	C08		5	0274-0479	229.15	479.36	269	63.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2105.2	C08		5	0275-0484	122.14	484.11	446	81.01	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			480.8	C08		5	0276-0489	271.42	487.98	509	94.57	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1407.1	C08		5	0277-0482	846.77	481.46	271	61.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			197.6	C08		5	0278-0484	334.88	483.78	279	63.36	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			765.2	C08		5	0279-0495	616.96	495.63	262	61.60	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			485.8	C08		5	0280-0493	792.78	494.13	275	65.60	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			961.6	C08		5	0281-0496	452.03	495.40	259	59.36	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			309.8	C08		5	0282-0497	717.65	497.06	232	59.36	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1182.4	C08		5	0283-0501	197.27	500.70	468	85.74	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			977.2	C08		5	0284-0499	473.75	499.76	257	61.94	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			862.0	C08		5	0285-0501	96.90	501.47	294	65.01	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2497.4	C08		5	0286-0501	901.81	501.38	250	58.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			243.7	C08		5	0287-0502	370.13	501.78	271	62.77	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3055.2	C08		5	0288-0503	936.65	503.74	242	57.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2076.2	C08		5	0289-0504	493.62	504.39	252	59.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			738.2	C08		5	0290-0506	631.65	505.45	265	64.18	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3259.5	C08		5	0291-0507	19.27	507.99	386	74.33	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			471.1	C08		5	0292-0509	249.77	508.81	512	95.40	0.707
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			462.5	C08		5	0293-0509	557.64	509.71	257	65.01	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1849.4	C08		5	0294-0511	442.12	511.25	301	66.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			659.8	C08		5	0295-0510	45.20	510.71	245	58.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			159.7	C08		5	0296-0513	334.12	513.95	289	62.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			524.9	C08		5	0297-0514	286.74	514.68	251	57.94	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			343.6	C08		5	0298-0515	832.59	515.15	339	71.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7722.1	C08		5	0299-0515	468.55	515.56	195	53.70	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1516.3	C08		5	0300-0519	138.33	518.67	241	59.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			538.1	C08		5	0301-0519	526.25	519.51	272	60.53	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			358.0	C08		5	0302-0520	92.26	520.68	300	70.18	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			809.2	C08		5	0303-0523	624.45	523.58	297	65.01	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2349.8	C08		5	0304-0525	394.75	525.32	283	66.43	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			299.9	C08		5	0305-0528	769.98	528.55	280	67.50	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			416.7	C08		5	0306-0532	425.08	531.78	268	63.11	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			397.1	C08		5	0307-0533	151.14	533.56	258	63.01	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1503.8	C08		5	0308-0534	197.35	533.64	319	73.84	0.735
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			302.6	C08		5	0309-0539	534.98	538.32	273	65.60	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			702.8	C08		5	0310-0537	607.50	537.37	220	54.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1032.8	C08		5	0311-0541	382.06	542.72	366	75.01	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			380.5	C08		5	0312-0541	832.18	541.50	310	67.36	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4937.9	C08		5	0313-0543	470.35	543.09	177	48.53	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1666.8	C08		5	0314-0551	946.10	550.58	385	77.36	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3018.5	C08		5	0315-0546	321.13	546.71	242	57.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2270.7	C08		5	0316-0548	678.45	548.70	313	65.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			577.8	C08		5	0317-0546	741.53	546.09	268	60.18	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			531.1	C08		5	0318-0551	553.24	551.57	308	68.43	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			538.3	C08		5	0319-0551	99.70	551.78	270	60.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			886.6	C08		5	0320-0553	231.82	553.69	305	70.08	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			261.3	C08		5	0321-0553	22.92	553.49	287	63.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			250.3	C08		5	0322-0559	495.91	559.76	300	70.28	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1088.2	C08		5	0323-0559	389.91	558.86	287	63.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			722.6	C08		5	0324-0559	821.93	559.31	314	67.36	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1045.9	C08		5	0325-0559	248.37	560.21	257	63.36	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			992.9	C08		5	0326-0562	168.02	561.67	248	62.77	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			456.6	C08		5	0327-0564	702.70	564.62	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			372.7	C08		5	0328-0567	510.91	566.78	301	69.11	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3470.5	C08		5	0329-0564	315.06	563.80	239	59.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			473.6	C08		5	0330-0566	736.12	565.92	242	57.36	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			366.0	C08		5	0331-0569	150.59	569.48	302	65.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3413.6	C08		5	0332-0567	677.72	567.46	254	60.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			235.9	C08		5	0333-0571	274.35	571.63	273	66.67	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			459.8	C08		5	0334-0576	918.32	576.50	354	70.18	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3302.1	C08		5	0335-0575	342.32	575.76	263	64.28	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2855.9	C08		5	0336-0577	429.97	576.35	383	73.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			485.2	C08		5	0337-0578	632.34	578.02	292	65.94	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			288.4	C08		5	0338-0575	859.79	575.79	290	71.36	0.716
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1928.0	C08		5	0339-0580	67.90	580.53	477	87.74	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			350.7	C08		5	0340-0581	898.80	581.22	331	68.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			744.5	C08		5	0341-0583	574.86	583.16	299	66.77	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2824.3	C08		5	0342-0579	91.81	578.80	240	58.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1929.3	C08		5	0343-0582	313.75	583.24	272	64.28	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4248.4	C08		5	0344-0581	391.81	581.10	270	60.18	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			483.5	C08		5	0345-0581	716.10	581.79	223	55.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1928.2	C08		5	0346-0582	362.15	581.71	266	62.28	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			453.5	C08		5	0347-0580	790.21	579.80	287	68.53	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1473.8	C08		5	0348-0584	229.14	583.82	241	58.28	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5373.6	C08		5	0349-0587	20.24	587.47	224	55.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1358.7	C08		5	0350-0596	595.37	596.05	322	69.84	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			480.1	C08		5	0351-0600	354.65	600.31	282	62.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			376.2	C08		5	0352-0608	474.80	606.92	607	102.57	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			327.7	C08		5	0353-0601	167.12	600.87	304	66.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1009.6	C08		5	0354-0609	148.91	609.45	253	61.11	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			447.9	C08		5	0355-0610	719.24	610.32	321	66.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1055.4	C08		5	0356-0610	533.40	608.97	311	69.26	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2574.3	C08		5	0357-0610	187.17	610.71	253	59.70	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2073.8	C08		5	0358-0611	258.04	611.58	267	61.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			345.2	C08		5	0359-0613	805.81	613.19	270	61.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			126.1	C08		5	0360-0613	940.84	612.97	258	63.01	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			833.0	C08		5	0361-0617	413.46	616.96	307	68.08	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5895.3	C08		5	0362-0616	61.84	615.87	222	55.11	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			637.8	C08		5	0363-0614	320.99	615.05	262	61.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			426.6	C08		5	0364-0616	295.85	616.52	265	59.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			229.8	C08		5	0365-0619	385.46	618.83	296	65.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1506.7	C08		5	0366-0620	207.44	620.08	266	60.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2848.1	C08		5	0367-0623	671.13	622.99	256	59.36	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1553.2	C08		5	0368-0624	137.19	624.25	240	57.70	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			311.7	C08		5	0369-0629	444.51	629.51	296	65.94	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2498.8	C08		5	0370-0629	186.09	628.77	271	62.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			462.7	C08		5	0371-0634	897.40	633.89	524	91.64	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3829.1	C08		5	0372-0633	864.86	633.43	286	63.60	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			228.7	C08		5	0373-0634	497.57	633.42	289	62.53	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			359.9	C08		5	0374-0647	794.04	647.11	321	69.50	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1525.7	C08		5	0375-0647	539.38	647.38	241	57.70	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3153.5	C08		5	0376-0649	154.97	648.54	220	54.53	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1439.0	C08		5	0377-0647	646.40	647.40	204	53.11	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1120.6	C08		5	0378-0651	195.60	651.23	248	57.70	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			478.9	C08		5	0379-0652	247.90	652.79	293	63.94	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			294.9	C08		5	0380-0650	817.91	650.42	277	63.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			440.9	C08		5	0381-0648	335.51	648.81	154	48.63	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1280.6	C08		5	0382-0654	433.37	654.60	247	57.94	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			565.3	C08		5	0383-0655	686.50	654.73	395	73.84	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			588.6	C08		5	0384-0656	555.80	656.01	283	64.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			530.7	C08		5	0385-0660	52.60	659.90	289	62.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			595.8	C08		5	0386-0661	313.70	661.95	212	55.70	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2046.2	C08		5	0387-0662	629.58	661.88	213	56.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			543.3	C08		5	0388-0664	337.75	662.55	268	63.01	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			195.4	C08		5	0389-0668	589.42	667.54	275	63.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			829.9	C08		5	0390-0666	147.08	666.75	252	61.60	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			407.1	C08		5	0391-0666	671.76	667.21	262	63.01	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			738.7	C08		5	0392-0669	739.67	669.43	297	65.01	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			873.9	C08		5	0393-0679	330.09	679.10	404	84.57	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4839.8	C08		5	0394-0672	19.02	672.27	225	57.94	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3717.4	C08		5	0395-0674	160.45	674.70	206	54.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			239.5	C08		5	0396-0676	930.18	676.57	245	64.18	0.747
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1036.3	C08		5	0397-0683	405.39	682.87	637	109.54	0.667
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			287.1	C08		5	0398-0675	547.03	675.66	282	63.94	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			895.6	C08		5	0399-0678	284.16	677.62	271	60.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1594.1	C08		5	0400-0680	625.14	680.18	214	55.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			263.4	C08		5	0401-0684	804.27	684.54	262	59.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1611.7	C08		5	0402-0687	751.15	687.58	259	61.94	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			161.5	C08		5	0403-0688	348.96	687.26	159	58.43	0.585
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			304.4	C08		5	0404-0688	897.14	688.21	252	60.77	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1497.5	C08		5	0405-0691	869.78	690.90	275	78.67	0.558
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1110.3	C08		5	0406-0690	205.49	690.05	230	56.53	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1578.9	C08		5	0407-0690	683.30	690.68	230	56.77	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1244.7	C08		5	0408-0693	612.16	693.49	247	58.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			323.3	C08		5	0409-0706	467.36	706.23	279	61.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			331.5	C08		5	0410-0706	549.06	706.22	255	59.01	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			346.0	C08		5	0411-0709	35.80	710.01	288	66.77	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			527.4	C08		5	0412-0708	182.19	708.34	229	56.53	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			166.0	C08		5	0413-0709	233.40	709.62	261	59.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			328.2	C08		5	0414-0710	56.38	709.78	280	65.94	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			275.9	C08		6	0001-0023	416.28	23.63	327	71.01	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			416.4	C08		6	0002-0027	676.92	26.76	287	65.94	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4296.9	C08		6	0003-0027	227.08	26.02	257	69.60	0.667
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			924.5	C08		6	0004-0031	617.58	31.04	275	63.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2180.5	C08		6	0005-0028	846.42	28.00	237	59.94	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			300.1	C08		6	0006-0034	941.60	33.31	301	65.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			367.1	C08		6	0007-0035	54.36	34.91	270	63.70	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			625.9	C08		6	0008-0036	331.47	37.01	311	69.36	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1087.1	C08		6	0009-0047	440.88	47.58	646	109.88	0.672
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1015.6	C08		6	0010-0041	515.00	41.24	407	74.08	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			402.7	C08		6	0011-0044	31.94	44.26	257	62.77	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			621.5	C08		6	0012-0042	91.51	42.05	298	65.26	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			270.7	C08		6	0013-0043	788.36	43.35	291	63.11	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			541.8	C08		6	0014-0043	641.23	43.00	272	64.53	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1772.9	C08		6	0015-0043	838.81	43.77	348	70.77	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			495.2	C08		6	0016-0048	351.26	47.98	345	68.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2489.8	C08		6	0017-0050	557.36	49.98	316	65.84	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1544.7	C08		6	0018-0056	256.61	56.18	262	60.53	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4004.8	C08		6	0019-0060	857.26	60.45	424	84.91	0.739
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1951.0	C08		6	0020-0058	283.61	58.25	216	55.60	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1072.1	C08		6	0021-0057	302.72	56.67	194	53.11	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			690.2	C08		6	0022-0056	466.92	56.20	294	66.18	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2647.3	C08		6	0023-0058	170.81	57.00	285	73.84	0.657
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2878.5	C08		6	0024-0060	224.81	58.82	486	99.40	0.618
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1888.3	C08		6	0025-0071	610.72	70.65	290	64.53	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			409.4	C08		6	0026-0071	707.96	71.26	316	65.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2047.5	C08		6	0027-0070	53.10	70.92	267	65.60	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			295.1	C08		6	0028-0075	520.80	74.96	302	64.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3645.9	C08		6	0029-0075	161.24	74.69	204	55.94	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1622.8	C08		6	0030-0081	905.91	81.12	542	88.57	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			966.2	C08		6	0031-0077	134.01	77.10	233	58.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			228.1	C08		6	0032-0082	18.69	82.46	248	60.18	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			337.9	C08		6	0033-0086	284.39	86.76	297	64.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3498.7	C08		6	0034-0086	173.60	86.45	261	65.36	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3030.3	C08		6	0035-0090	927.11	89.89	390	78.18	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2208.9	C08		6	0036-0092	722.25	92.38	341	69.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			402.8	C08		6	0037-0095	346.33	95.23	319	67.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			573.9	C08		6	0038-0098	391.71	98.21	293	65.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			9836.7	C08		6	0039-0096	766.53	96.92	175	49.46	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2940.7	C08		6	0040-0101	64.36	100.97	241	64.28	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			544.8	C08		6	0041-0101	96.92	101.23	221	56.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			520.1	C08		6	0042-0104	835.92	104.70	279	63.60	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2789.9	C08		6	0043-0106	601.66	106.72	274	63.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4428.8	C08		6	0044-0104	916.53	104.14	224	58.18	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			362.1	C08		6	0045-0106	799.62	106.51	315	68.77	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			409.9	C08		6	0046-0108	535.89	108.15	327	66.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2369.6	C08		6	0047-0111	651.77	112.71	282	62.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1046.1	C08		6	0048-0117	34.30	117.20	284	65.60	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2640.4	C08		6	0049-0115	577.40	115.08	245	58.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3448.8	C08		6	0050-0120	617.95	120.33	382	73.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			716.9	C08		6	0051-0118	135.04	118.42	287	70.18	0.732
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			429.1	C08		6	0052-0121	491.85	120.78	273	62.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2461.2	C08		6	0053-0119	376.22	120.22	193	50.87	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			422.8	C08		6	0054-0123	462.38	123.29	262	58.77	0.953
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			431.3	C08		6	0055-0125	853.84	124.76	210	57.60	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1815.3	C08		6	0056-0126	235.33	125.45	140	50.53	0.689
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1892.9	C08		6	0057-0128	680.24	129.14	265	60.18	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			678.6	C08		6	0058-0127	904.54	127.02	257	59.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			378.3	C08		6	0059-0131	40.69	132.16	280	65.60	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			568.6	C08		6	0060-0135	423.61	135.31	289	63.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			383.2	C08		6	0061-0133	716.97	133.81	268	63.70	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3128.4	C08		6	0062-0135	377.72	135.14	202	53.46	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1060.2	C08		6	0063-0142	340.72	141.79	264	63.01	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2496.4	C08		6	0064-0142	817.92	142.04	234	58.43	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			419.7	C08		6	0065-0144	514.97	144.61	291	63.36	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1427.8	C08		6	0066-0144	251.74	145.29	181	56.53	0.712
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3401.7	C08		6	0067-0144	594.22	144.32	242	58.53	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			324.3	C08		6	0068-0147	159.52	146.71	303	67.01	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5292.2	C08		6	0069-0150	764.60	150.14	234	56.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			734.5	C08		6	0070-0158	303.10	158.52	238	57.70	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			823.5	C08		6	0071-0157	888.64	157.38	362	71.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2478.2	C08		6	0072-0157	825.04	157.14	224	57.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2414.0	C08		6	0073-0163	537.54	161.94	332	68.77	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4475.8	C08		6	0074-0157	588.91	158.29	128	42.39	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2530.5	C08		6	0075-0161	614.35	161.31	263	60.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4794.8	C08		6	0076-0162	747.17	161.79	249	58.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			531.6	C08		6	0077-0163	676.84	163.38	424	77.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1165.9	C08		6	0078-0166	166.00	166.54	242	59.11	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3237.6	C08		6	0079-0166	400.03	166.05	225	57.70	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			370.6	C08		6	0080-0169	487.03	168.76	277	62.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			219.8	C08		6	0081-0171	109.83	171.44	282	64.77	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5132.9	C08		6	0082-0172	591.26	172.29	241	63.70	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			458.4	C08		6	0083-0182	835.67	182.33	328	69.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			276.1	C08		6	0084-0184	172.45	184.33	281	65.94	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4207.2	C08		6	0085-0186	705.00	185.93	345	68.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2797.5	C08		6	0086-0187	75.88	187.63	216	56.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			390.0	C08		6	0087-0187	859.67	187.16	303	68.43	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2615.2	C08		6	0088-0188	60.61	188.80	270	61.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1285.2	C08		6	0089-0187	803.04	186.83	178	60.18	0.618
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			442.1	C08		6	0090-0191	672.91	190.78	309	70.18	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			909.5	C08		6	0091-0193	940.32	193.32	259	59.70	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			511.3	C08		6	0092-0198	822.87	198.48	341	74.67	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			312.1	C08		6	0093-0203	625.45	203.38	295	65.84	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1385.1	C08		6	0094-0202	909.82	202.56	250	58.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1312.5	C08		6	0095-0201	807.76	202.00	102	63.01	0.323
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			525.8	C08		6	0096-0206	129.34	206.23	298	64.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			532.6	C08		6	0097-0209	397.85	209.34	257	61.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1363.6	C08		6	0098-0211	432.42	211.02	231	61.11	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			446.4	C08		6	0099-0210	500.04	211.04	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			334.7	C08		6	0100-0210	568.93	209.67	290	63.60	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			553.9	C08		6	0101-0215	215.75	215.14	308	65.01	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1504.8	C08		6	0102-0218	279.31	219.19	265	61.46	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			480.2	C08		6	0103-0222	723.31	222.66	271	62.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			331.4	C08		6	0104-0225	618.20	224.48	300	63.60	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2570.8	C08		6	0105-0229	887.94	229.13	329	68.18	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3468.7	C08		6	0106-0231	59.71	230.72	334	66.77	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			332.3	C08		6	0107-0236	91.16	236.34	285	63.26	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5843.5	C08		6	0108-0237	773.38	237.52	324	67.36	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1286.2	C08		6	0109-0236	279.03	236.04	389	74.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			547.3	C08		6	0110-0236	669.75	236.45	282	62.43	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			605.3	C08		6	0111-0238	343.16	238.63	321	67.84	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			485.7	C08		6	0112-0242	573.88	243.29	297	69.84	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			601.1	C08		6	0113-0244	756.21	244.60	290	66.18	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			511.5	C08		6	0114-0240	940.51	240.31	252	60.77	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			918.0	C08		6	0115-0247	198.46	246.56	301	67.84	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			686.9	C08		6	0116-0247	874.65	247.80	241	57.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			349.9	C08		6	0117-0251	833.26	251.71	322	76.91	0.684
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2280.3	C08		6	0118-0254	386.96	253.92	280	66.67	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2210.6	C08		6	0119-0254	542.86	253.92	303	64.77	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4135.8	C08		6	0120-0252	181.83	252.52	254	61.36	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1752.8	C08		6	0121-0253	560.66	254.21	262	62.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			313.4	C08		6	0122-0256	469.07	255.36	254	64.53	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1035.2	C08		6	0123-0259	334.87	258.49	264	63.70	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1333.2	C08		6	0124-0263	605.14	262.77	302	65.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3247.4	C08		6	0125-0261	147.85	260.95	217	53.46	0.954
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			814.3	C08		6	0126-0264	729.34	264.18	365	74.08	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			629.1	C08		6	0127-0274	797.83	272.58	730	118.71	0.651
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			937.4	C08		6	0128-0265	913.08	265.02	285	63.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1607.8	C08		6	0129-0268	368.30	267.57	260	61.01	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			393.2	C08		6	0130-0271	50.84	271.45	275	64.18	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			406.6	C08		6	0131-0275	466.40	274.78	474	81.26	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			432.1	C08		6	0132-0271	683.27	271.56	311	66.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1737.2	C08		6	0133-0272	566.82	272.48	293	64.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			473.9	C08		6	0134-0285	173.94	285.56	273	63.11	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			352.7	C08		6	0135-0291	636.52	291.53	287	61.36	0.958
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3987.5	C08		6	0136-0297	351.39	296.39	280	67.84	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			731.0	C08		6	0137-0295	554.38	295.52	265	61.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			577.2	C08		6	0138-0295	254.50	295.29	293	65.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			571.5	C08		6	0139-0296	850.40	297.06	334	67.01	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			649.2	C08		6	0140-0298	712.21	299.02	442	94.08	0.627
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			414.7	C08		6	0141-0302	901.12	301.88	321	69.60	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			520.6	C08		6	0142-0301	666.58	301.64	262	59.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1168.7	C08		6	0143-0307	917.49	306.26	335	71.01	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1688.0	C08		6	0144-0311	771.61	312.57	588	94.81	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1494.4	C08		6	0145-0307	375.36	307.73	255	58.77	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			325.8	C08		6	0146-0310	25.03	310.38	279	61.94	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			461.7	C08		6	0147-0312	509.64	311.64	257	60.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1691.4	C08		6	0148-0317	462.42	314.77	271	76.33	0.585
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3114.6	C08		6	0149-0313	945.18	313.34	263	62.87	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			934.9	C08		6	0150-0327	581.53	327.68	325	69.36	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			886.2	C08		6	0151-0323	859.49	323.86	256	63.94	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3602.5	C08		6	0152-0328	930.26	328.02	378	71.36	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			272.9	C08		6	0153-0332	300.21	332.99	315	73.01	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			495.2	C08		6	0154-0332	136.47	332.64	402	73.84	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3978.8	C08		6	0155-0331	741.68	331.35	299	63.36	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			272.7	C08		6	0156-0334	415.15	333.75	322	69.26	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1230.5	C08		6	0157-0336	57.05	335.97	361	70.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			362.8	C08		6	0158-0336	705.21	336.45	327	70.18	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3087.9	C08		6	0159-0337	247.85	337.10	231	57.94	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			931.0	C08		6	0160-0338	873.94	339.03	219	55.80	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1123.8	C08		6	0161-0346	319.24	345.76	246	62.28	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1368.0	C08		6	0162-0347	649.01	347.45	361	70.43	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3404.9	C08		6	0163-0346	262.33	345.89	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1576.6	C08		6	0164-0346	195.54	347.46	207	57.94	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3577.1	C08		6	0165-0349	751.50	349.29	219	55.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2435.8	C08		6	0166-0351	433.65	351.56	202	55.94	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3571.2	C08		6	0167-0355	275.20	356.19	224	54.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2202.7	C08		6	0168-0358	330.88	357.70	234	60.18	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1720.8	C08		6	0169-0358	510.68	358.42	247	66.67	0.698
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1049.5	C08		6	0170-0353	874.29	352.74	227	58.28	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			471.0	C08		6	0171-0360	458.55	360.08	306	69.94	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			305.2	C08		6	0172-0356	782.57	356.41	305	64.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1837.9	C08		6	0173-0359	612.70	359.17	310	65.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			336.4	C08		6	0174-0360	19.86	360.13	273	65.84	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3607.5	C08		6	0175-0362	759.16	362.11	203	55.94	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			296.8	C08		6	0176-0365	107.78	365.12	297	67.36	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1323.4	C08		6	0177-0369	650.63	368.91	309	65.36	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3322.1	C08		6	0178-0368	427.61	368.25	236	56.87	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			516.6	C08		6	0179-0370	895.90	370.77	278	63.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			647.3	C08		6	0180-0371	917.35	371.10	266	62.43	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1629.2	C08		6	0181-0378	630.45	378.26	301	65.60	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4764.4	C08		6	0182-0380	518.18	380.51	214	56.53	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			410.1	C08		6	0183-0380	806.29	380.14	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			284.1	C08		6	0184-0387	132.88	387.35	285	63.94	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			496.0	C08		6	0185-0388	874.32	387.72	253	62.77	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1865.7	C08		6	0186-0391	26.53	391.88	312	65.01	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1979.1	C08		6	0187-0392	680.81	391.79	302	64.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			487.5	C08		6	0188-0400	718.10	399.93	292	65.36	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2989.2	C08		6	0189-0398	935.14	397.83	207	54.53	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			919.8	C08		6	0190-0401	766.60	400.19	271	62.43	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			443.0	C08		6	0191-0399	913.54	399.39	284	62.53	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			721.7	C08		6	0192-0405	563.90	405.58	300	64.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			362.7	C08		6	0193-0411	271.86	410.40	553	103.30	0.651
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			455.6	C08		6	0194-0408	529.67	408.35	277	62.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			617.9	C08		6	0195-0409	753.00	409.86	266	63.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			360.2	C08		6	0196-0412	855.78	412.42	248	60.43	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1306.1	C08		6	0197-0413	71.26	413.34	383	73.36	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1200.0	C08		6	0198-0418	106.82	418.53	319	68.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			313.5	C08		6	0199-0423	452.60	421.94	336	71.01	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			707.8	C08		6	0200-0425	791.00	425.65	290	64.53	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1849.9	C08		6	0201-0424	807.62	423.86	267	62.53	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			757.2	C08		6	0202-0429	398.58	429.08	509	89.74	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			430.0	C08		6	0203-0426	839.61	426.67	230	58.18	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1307.1	C08		6	0204-0424	125.23	424.74	219	57.70	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1453.1	C08		6	0205-0430	238.86	429.93	284	65.01	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			833.6	C08		6	0206-0431	597.16	431.73	291	64.43	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7073.3	C08		6	0207-0432	349.09	432.09	224	57.11	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			555.6	C08		6	0208-0441	207.55	440.41	573	90.33	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			572.8	C08		6	0209-0439	417.80	439.51	276	63.94	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1733.1	C08		6	0210-0442	168.49	442.08	272	60.77	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2008.0	C08		6	0211-0442	623.74	441.87	263	58.53	0.965
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6531.1	C08		6	0212-0442	651.19	442.34	231	56.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			394.0	C08		6	0213-0445	705.41	445.49	224	61.84	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			417.4	C08		6	0214-0443	85.27	443.29	281	64.77	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			597.2	C08		6	0215-0449	263.69	449.21	290	65.84	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1455.5	C08		6	0216-0455	601.71	455.23	403	75.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			949.2	C08		6	0217-0454	928.96	453.89	209	55.11	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5780.1	C08		6	0218-0456	369.96	456.02	224	55.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			665.5	C08		6	0219-0458	284.97	458.20	295	63.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2992.8	C08		6	0220-0459	943.71	459.04	258	60.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			463.6	C08		6	0221-0461	875.56	460.42	304	63.94	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			646.1	C08		6	0222-0459	82.57	458.98	243	58.53	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			461.5	C08		6	0223-0462	308.85	462.86	247	59.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			995.4	C08		6	0224-0467	636.12	467.79	262	65.01	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			360.9	C08		6	0225-0464	133.52	463.37	241	63.36	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1802.5	C08		6	0226-0466	799.00	466.29	240	57.46	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2439.0	C08		6	0227-0467	814.53	466.96	274	63.11	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			533.7	C08		6	0228-0471	698.92	470.94	320	67.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			418.5	C08		6	0229-0472	764.64	471.85	388	74.08	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1809.4	C08		6	0230-0471	216.16	471.88	246	59.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			915.8	C08		6	0231-0474	430.19	473.76	325	70.43	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1028.6	C08		6	0232-0475	125.39	475.45	271	64.77	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2165.2	C08		6	0233-0477	601.43	476.81	257	59.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			656.5	C08		6	0234-0480	543.61	480.42	248	58.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			292.8	C08		6	0235-0485	754.39	485.62	321	69.01	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			845.0	C08		6	0236-0487	833.43	487.54	169	51.94	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3939.7	C08		6	0237-0489	147.26	489.54	262	60.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			719.9	C08		6	0238-0488	520.89	488.47	281	62.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2348.6	C08		6	0239-0489	211.36	489.19	253	59.11	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1206.9	C08		6	0240-0488	260.82	488.71	235	57.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			943.4	C08		6	0241-0491	897.82	492.01	384	73.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			200.9	C08		6	0242-0496	108.89	496.36	258	60.53	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3540.2	C08		6	0243-0498	794.85	497.72	251	66.53	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			427.7	C08		6	0244-0502	61.85	502.04	264	61.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			315.4	C08		6	0245-0501	431.48	500.98	254	61.60	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			475.4	C08		6	0246-0503	937.07	503.41	305	65.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1543.9	C08		6	0247-0505	703.45	504.80	339	68.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3817.3	C08		6	0248-0503	810.14	503.90	196	54.04	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3017.6	C08		6	0249-0506	31.37	506.93	235	57.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1550.3	C08		6	0250-0507	586.64	507.21	243	58.53	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			619.5	C08		6	0251-0508	414.86	507.96	281	63.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1271.7	C08		6	0252-0508	345.69	507.83	243	59.11	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3305.3	C08		6	0253-0512	150.39	512.45	210	52.87	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			10050.1	C08		6	0254-0514	456.22	515.05	348	70.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1432.2	C08		6	0255-0516	164.03	515.62	232	59.46	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			613.4	C08		6	0256-0521	826.80	521.72	313	71.01	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1368.7	C08		6	0257-0523	945.53	522.89	229	56.53	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			403.7	C08		6	0258-0526	105.07	526.30	388	72.43	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			320.5	C08		6	0259-0522	268.65	522.06	172	50.87	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3924.4	C08		6	0260-0526	664.33	526.56	233	57.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			283.6	C08		6	0261-0527	250.42	526.89	188	53.11	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			375.9	C08		6	0262-0527	381.97	527.90	304	66.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			854.5	C08		6	0263-0528	611.87	528.20	324	68.43	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			754.1	C08		6	0264-0529	437.19	529.34	264	59.94	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			430.2	C08		6	0265-0535	483.76	535.17	268	63.36	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2277.2	C08		6	0266-0537	901.00	537.63	246	57.60	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			452.1	C08		6	0267-0541	269.74	541.75	257	61.01	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			908.6	C08		6	0268-0544	829.03	543.72	294	66.18	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2022.3	C08		6	0269-0554	41.10	553.69	394	79.60	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			569.0	C08		6	0270-0551	571.25	551.38	298	63.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1058.0	C08		6	0271-0551	62.85	551.76	261	61.26	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			248.7	C08		6	0272-0551	931.25	551.41	306	67.60	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2713.1	C08		6	0273-0553	753.50	553.00	266	60.18	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			936.8	C08		6	0274-0553	869.76	553.40	256	61.11	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1484.7	C08		6	0275-0557	389.14	557.68	305	66.77	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2410.7	C08		6	0276-0558	694.81	558.28	271	61.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1255.5	C08		6	0277-0564	160.05	564.71	337	67.01	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3685.8	C08		6	0278-0566	80.09	565.96	235	59.36	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2060.9	C08		6	0279-0572	425.35	572.97	289	64.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1044.2	C08		6	0280-0571	641.61	572.09	266	60.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			423.4	C08		6	0281-0573	137.07	573.98	236	59.36	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2397.4	C08		6	0282-0573	444.69	573.46	262	61.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1842.8	C08		6	0283-0579	51.66	578.45	330	70.53	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			251.0	C08		6	0284-0579	325.79	579.36	274	62.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			567.0	C08		6	0285-0578	843.81	579.39	334	69.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1575.3	C08		6	0286-0581	120.36	580.63	248	58.28	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			247.5	C08		6	0287-0584	914.41	584.32	316	66.18	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			437.2	C08		6	0288-0586	224.69	586.27	267	61.70	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1346.9	C08		6	0289-0591	744.26	590.33	323	68.18	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			823.8	C08		6	0290-0592	357.62	591.89	378	71.84	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2687.8	C08		6	0291-0589	447.52	589.20	262	62.53	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1525.4	C08		6	0292-0594	397.81	594.55	286	64.77	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1120.0	C08		6	0293-0596	478.63	597.04	265	60.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1483.2	C08		6	0294-0600	548.72	600.30	269	59.70	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2608.4	C08		6	0295-0606	768.79	606.37	348	75.50	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3702.1	C08		6	0296-0608	453.66	607.22	275	63.46	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			322.8	C08		6	0297-0611	871.03	611.29	313	65.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			735.7	C08		6	0298-0613	608.91	612.29	306	66.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1433.5	C08		6	0299-0612	155.25	612.80	258	66.77	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			272.8	C08		6	0300-0616	281.60	616.02	269	61.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			776.7	C08		6	0301-0621	101.66	620.83	457	83.26	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			631.8	C08		6	0302-0616	242.90	616.27	280	64.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			254.3	C08		6	0303-0619	793.31	619.27	289	65.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			162.6	C08		6	0304-0616	35.45	615.89	238	60.18	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			468.5	C08		6	0305-0619	934.38	618.80	234	59.70	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1178.7	C08		6	0306-0622	715.31	622.01	232	56.18	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			497.1	C08		6	0307-0623	490.18	623.40	266	61.60	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1009.2	C08		6	0308-0625	892.09	625.63	320	68.18	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1154.4	C08		6	0309-0627	922.07	627.14	220	57.94	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			508.3	C08		6	0310-0633	652.51	633.11	316	65.84	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			716.8	C08		6	0311-0633	318.81	632.76	239	59.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7014.0	C08		6	0312-0636	362.01	636.69	341	69.84	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2317.0	C08		6	0313-0638	466.43	637.42	320	68.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			397.7	C08		6	0314-0642	67.30	642.39	465	81.84	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			398.5	C08		6	0315-0639	244.92	639.76	419	78.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1844.8	C08		6	0316-0639	559.40	639.37	227	59.01	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			687.9	C08		6	0317-0639	817.75	639.85	284	61.60	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1118.5	C08		6	0318-0646	718.33	646.71	316	71.60	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4015.2	C08		6	0319-0647	754.67	646.84	230	57.60	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1132.9	C08		6	0320-0649	447.54	648.81	246	57.94	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			456.5	C08		6	0321-0652	950.46	652.40	258	59.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3660.2	C08		6	0322-0653	368.94	653.00	209	56.53	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			835.7	C08		6	0323-0657	286.04	657.54	398	75.84	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			332.7	C08		6	0324-0657	420.01	656.43	218	56.77	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2554.7	C08		6	0325-0659	874.28	659.13	245	58.53	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			580.3	C08		6	0326-0659	245.72	659.02	300	66.77	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			363.8	C08		6	0327-0665	617.34	666.04	321	69.84	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			987.2	C08		6	0328-0666	734.34	665.61	289	65.01	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			395.0	C08		6	0329-0670	799.68	670.44	295	71.50	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			860.9	C08		6	0330-0676	165.38	676.19	237	56.77	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			227.5	C08		6	0331-0679	24.32	679.38	222	60.18	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			332.2	C08		6	0332-0679	281.96	678.70	245	63.94	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			621.5	C08		6	0333-0681	852.07	682.12	305	65.36	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			273.7	C08		6	0334-0684	480.38	683.80	293	67.36	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2709.7	C08		6	0335-0683	870.51	683.10	248	62.18	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1149.7	C08		6	0336-0686	518.61	686.26	352	68.77	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2042.3	C08		6	0337-0683	715.86	683.20	246	59.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			679.0	C08		6	0338-0688	230.41	688.88	253	60.18	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			277.5	C08		6	0339-0689	103.32	689.98	231	58.53	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			773.4	C08		6	0340-0693	583.34	693.72	373	76.08	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			545.1	C08		6	0341-0701	163.75	701.44	242	58.28	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4815.7	C08		7	0001-0023	51.83	23.84	298	69.84	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			243.4	C08		7	0002-0026	872.40	25.70	203	61.60	0.672
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			410.0	C08		7	0003-0025	731.35	25.70	305	67.94	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			324.4	C08		7	0004-0031	928.55	31.22	283	66.18	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			255.7	C08		7	0005-0034	824.17	35.30	298	65.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			269.4	C08		7	0006-0035	617.33	35.30	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1915.5	C08		7	0007-0034	356.66	33.84	315	65.94	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1571.6	C08		7	0008-0037	580.19	36.57	282	63.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			241.4	C08		7	0009-0037	316.66	36.54	320	71.60	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			724.2	C08		7	0010-0036	32.18	36.12	266	61.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2974.8	C08		7	0011-0037	90.78	38.03	232	57.70	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			718.6	C08		7	0012-0043	840.82	43.08	252	58.28	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			266.8	C08		7	0013-0044	643.67	43.90	303	65.94	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			324.3	C08		7	0014-0048	19.83	48.94	291	63.60	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			515.8	C08		7	0015-0053	249.97	53.20	305	64.53	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8537.5	C08		7	0016-0055	90.75	55.31	288	65.94	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1409.9	C08		7	0017-0057	556.33	57.88	320	67.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			251.7	C08		7	0018-0057	409.54	57.82	326	68.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			353.7	C08		7	0019-0062	520.71	62.39	288	63.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1769.8	C08		7	0020-0064	837.98	65.31	438	89.84	0.682
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1241.9	C08		7	0021-0061	944.96	60.36	110	42.04	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2626.5	C08		7	0022-0063	177.25	63.58	268	62.18	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			490.6	C08		7	0023-0067	871.06	67.00	240	61.84	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1110.1	C08		7	0024-0064	113.77	64.84	266	63.94	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			436.8	C08		7	0025-0073	730.13	72.18	431	81.01	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4026.9	C08		7	0026-0077	24.61	76.57	208	54.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			334.1	C08		7	0027-0087	684.99	87.09	311	67.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			355.8	C08		7	0028-0087	251.91	87.09	337	69.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			354.9	C08		7	0029-0087	288.99	87.22	286	62.53	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			704.7	C08		7	0030-0097	586.15	96.15	584	110.23	0.604
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			247.5	C08		7	0031-0088	132.75	87.65	315	69.01	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1119.6	C08		7	0032-0087	200.86	87.04	298	64.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			310.1	C08		7	0033-0087	361.81	87.33	303	64.77	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			857.8	C08		7	0034-0091	448.08	91.39	393	77.01	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4276.6	C08		7	0035-0092	17.29	92.61	173	49.94	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1205.2	C08		7	0036-0095	722.59	94.21	265	63.60	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			308.6	C08		7	0037-0100	638.36	99.46	299	66.18	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1608.6	C08		7	0038-0102	816.65	102.78	353	74.08	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1120.6	C08		7	0039-0102	694.93	102.80	276	65.94	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			464.9	C08		7	0040-0106	621.07	106.28	316	67.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			407.6	C08		7	0041-0106	787.14	105.81	284	65.01	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			798.4	C08		7	0042-0108	440.48	108.24	311	67.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			335.0	C08		7	0043-0110	510.10	110.55	295	64.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			410.4	C08		7	0044-0109	766.18	108.84	275	62.53	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			347.3	C08		7	0045-0113	314.83	112.82	264	59.94	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			281.6	C08		7	0046-0115	914.68	115.50	288	63.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			300.1	C08		7	0047-0116	91.75	116.26	293	62.77	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			425.2	C08		7	0048-0117	563.72	117.16	314	65.60	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			478.1	C08		7	0049-0116	351.44	116.42	305	66.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			226.5	C08		7	0050-0123	180.27	122.55	320	70.18	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2597.1	C08		7	0051-0128	251.79	127.33	470	88.57	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			422.4	C08		7	0052-0120	404.21	120.23	270	62.53	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			979.4	C08		7	0053-0122	67.75	122.10	269	60.28	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			828.4	C08		7	0054-0128	728.23	127.56	314	68.43	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			692.1	C08		7	0055-0129	226.70	128.77	264	60.77	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3973.9	C08		7	0056-0130	853.09	130.34	358	69.60	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			911.5	C08		7	0057-0131	893.96	131.48	307	65.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1131.3	C08		7	0058-0133	668.02	134.08	273	64.18	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1402.5	C08		7	0059-0136	10.94	136.29	264	59.11	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			254.5	C08		7	0060-0141	311.82	141.79	298	65.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			223.6	C08		7	0061-0143	141.61	143.51	294	65.01	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			411.9	C08		7	0062-0143	722.81	144.64	318	71.26	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3517.7	C08		7	0063-0147	212.29	146.48	286	63.70	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			690.4	C08		7	0064-0152	192.31	151.77	275	66.18	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			309.2	C08		7	0065-0151	635.38	151.20	336	69.11	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			500.4	C08		7	0066-0160	561.54	160.14	535	98.57	0.692
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			424.7	C08		7	0067-0153	791.77	152.66	322	67.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			815.0	C08		7	0068-0157	417.30	157.18	496	84.08	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			294.1	C08		7	0069-0160	95.47	160.60	301	64.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			274.9	C08		7	0070-0162	816.09	162.44	317	67.01	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1123.3	C08		7	0071-0162	354.78	162.27	283	68.43	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1346.4	C08		7	0072-0166	235.28	166.37	452	78.43	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			552.0	C08		7	0073-0169	947.12	169.62	436	77.50	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1289.8	C08		7	0074-0168	27.73	168.95	257	59.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2363.6	C08		7	0075-0167	650.18	167.83	282	63.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			498.7	C08		7	0076-0170	492.83	170.51	237	58.77	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3198.6	C08		7	0077-0173	187.93	172.95	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			513.2	C08		7	0078-0171	706.65	171.49	311	68.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			591.7	C08		7	0079-0173	366.75	173.55	297	67.01	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			487.9	C08		7	0080-0173	479.10	174.12	130	47.46	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			835.0	C08		7	0081-0174	47.24	175.03	264	60.77	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1063.0	C08		7	0082-0176	425.03	175.77	300	65.60	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2599.5	C08		7	0083-0181	306.37	181.78	380	72.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2427.9	C08		7	0084-0184	131.58	183.79	278	62.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			356.2	C08		7	0085-0185	518.78	185.64	312	65.60	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			320.4	C08		7	0086-0186	549.39	185.57	270	66.08	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			302.0	C08		7	0087-0185	848.61	185.47	297	64.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			740.0	C08		7	0088-0189	673.09	189.38	273	60.53	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2945.4	C08		7	0089-0190	380.05	189.97	274	61.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1429.9	C08		7	0090-0193	99.98	191.93	164	69.26	0.430
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			814.1	C08		7	0091-0192	702.90	192.63	273	60.77	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			891.6	C08		7	0092-0194	628.35	194.17	269	62.18	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4316.8	C08		7	0093-0198	586.04	197.99	258	59.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			443.5	C08		7	0094-0201	417.61	201.11	287	64.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			471.0	C08		7	0095-0201	42.76	201.33	298	66.08	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			449.7	C08		7	0096-0201	872.92	201.31	246	58.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			623.4	C08		7	0097-0202	306.87	201.56	294	63.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7526.2	C08		7	0098-0204	754.31	203.36	420	82.43	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1947.6	C08		7	0099-0203	239.40	202.95	291	63.60	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			207.1	C08		7	0100-0205	436.00	204.90	300	67.01	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			568.2	C08		7	0101-0207	892.77	207.98	246	57.36	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1847.3	C08		7	0102-0213	353.83	213.62	279	61.94	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			459.5	C08		7	0103-0214	850.75	214.10	297	67.01	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			598.2	C08		7	0104-0213	925.26	213.62	261	59.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1477.2	C08		7	0105-0216	140.33	216.11	277	61.60	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			187.5	C08		7	0106-0218	448.62	218.90	296	65.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5561.8	C08		7	0107-0217	547.32	216.90	235	56.53	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1131.0	C08		7	0108-0216	734.27	216.55	278	63.94	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			327.4	C08		7	0109-0222	203.83	221.45	318	67.36	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			213.8	C08		7	0110-0221	314.48	220.98	295	66.67	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			157.4	C08		7	0111-0222	394.80	221.93	308	66.18	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			198.4	C08		7	0112-0220	493.45	219.93	292	65.60	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4253.5	C08		7	0113-0225	124.54	226.17	266	61.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			740.9	C08		7	0114-0229	825.06	229.84	372	72.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			335.8	C08		7	0115-0228	613.49	228.12	286	63.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2034.6	C08		7	0116-0232	560.43	232.21	247	58.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1683.7	C08		7	0117-0229	686.19	229.62	305	68.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1830.9	C08		7	0118-0238	248.32	238.50	299	65.60	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2930.3	C08		7	0119-0243	123.31	242.39	241	58.87	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2043.0	C08		7	0120-0245	676.71	245.31	306	72.77	0.726
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			249.3	C08		7	0121-0250	341.73	250.33	328	67.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			185.4	C08		7	0122-0257	274.37	257.90	311	68.43	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			244.5	C08		7	0123-0259	512.98	259.48	298	67.94	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			668.1	C08		7	0124-0255	86.50	255.95	260	59.11	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			210.7	C08		7	0125-0257	381.59	257.67	288	62.53	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			687.5	C08		7	0126-0261	157.63	261.08	323	67.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			249.4	C08		7	0127-0261	480.12	261.93	293	64.18	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			247.4	C08		7	0128-0261	434.67	261.82	291	64.53	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			340.8	C08		7	0129-0267	177.11	266.96	476	83.84	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			442.0	C08		7	0130-0262	319.73	262.56	312	65.60	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			581.2	C08		7	0131-0262	908.50	262.01	260	61.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1232.6	C08		7	0132-0264	610.11	263.52	277	63.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2118.5	C08		7	0133-0266	633.45	266.54	293	63.94	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1836.4	C08		7	0134-0270	225.67	270.95	303	71.26	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			377.0	C08		7	0135-0275	848.09	274.96	591	103.05	0.699
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			613.0	C08		7	0136-0270	563.50	270.12	245	56.53	0.964
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			462.7	C08		7	0137-0273	923.56	272.85	264	62.28	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1014.7	C08		7	0138-0275	36.30	275.45	296	66.18	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			373.3	C08		7	0139-0276	74.24	275.93	249	65.46	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			586.9	C08		7	0140-0272	710.08	272.03	295	68.18	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3987.7	C08		7	0141-0279	875.73	278.69	210	55.94	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			302.8	C08		7	0142-0280	436.92	279.64	319	66.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			207.2	C08		7	0143-0283	376.15	283.21	297	65.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			302.4	C08		7	0144-0283	791.94	283.20	287	64.77	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			199.6	C08		7	0145-0284	394.43	284.19	285	62.53	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			615.4	C08		7	0146-0287	280.72	287.25	263	60.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2488.8	C08		7	0147-0290	884.23	291.40	239	57.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			485.9	C08		7	0148-0293	518.71	293.39	317	68.08	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			290.4	C08		7	0149-0291	610.49	291.17	303	66.53	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1722.3	C08		7	0150-0292	686.06	292.11	296	68.18	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1067.9	C08		7	0151-0296	263.56	296.73	307	108.71	0.326
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3916.4	C08		7	0152-0297	142.76	296.77	247	58.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			908.5	C08		7	0153-0298	700.97	298.74	265	63.36	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			800.1	C08		7	0154-0299	754.67	298.77	304	65.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1605.8	C08		7	0155-0304	472.50	304.34	414	76.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			235.3	C08		7	0156-0301	564.05	301.27	298	64.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1555.3	C08		7	0157-0305	335.27	304.40	377	72.67	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			919.1	C08		7	0158-0305	293.40	305.22	296	63.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			162.2	C08		7	0159-0303	409.14	303.46	295	64.28	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			424.3	C08		7	0160-0309	742.48	309.82	249	59.84	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			327.5	C08		7	0161-0313	442.94	313.73	318	65.60	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			239.8	C08		7	0162-0318	942.53	318.48	418	76.08	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			409.0	C08		7	0163-0322	870.12	321.84	473	82.43	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			251.3	C08		7	0164-0320	325.90	321.12	282	65.01	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3010.7	C08		7	0165-0318	74.38	317.81	250	58.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1162.7	C08		7	0166-0319	776.38	318.80	223	55.11	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2022.3	C08		7	0167-0321	384.45	321.54	317	67.01	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			865.4	C08		7	0168-0326	801.22	326.23	276	62.53	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4469.3	C08		7	0169-0326	100.75	325.66	233	55.94	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			258.4	C08		7	0170-0328	540.33	328.26	275	61.94	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			328.7	C08		7	0171-0325	618.90	325.47	308	69.11	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			603.0	C08		7	0172-0332	355.64	332.73	326	66.43	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			949.5	C08		7	0173-0333	827.91	332.60	260	61.94	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2053.9	C08		7	0174-0333	59.54	333.52	229	57.94	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			685.8	C08		7	0175-0340	679.98	340.54	324	70.28	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			996.9	C08		7	0176-0341	182.75	341.17	277	67.60	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			841.1	C08		7	0177-0337	234.22	337.39	279	65.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1757.9	C08		7	0178-0341	393.39	341.51	322	67.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1641.3	C08		7	0179-0344	273.12	344.76	273	60.53	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4068.3	C08		7	0180-0347	443.34	347.29	297	69.50	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			483.5	C08		7	0181-0345	903.28	345.78	250	58.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5550.6	C08		7	0182-0349	511.96	349.53	294	97.64	0.388
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			544.2	C08		7	0183-0352	834.55	351.67	322	68.18	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2664.8	C08		7	0184-0351	480.64	350.76	450	82.43	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			378.9	C08		7	0185-0349	596.52	349.28	272	61.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			425.4	C08		7	0186-0351	734.48	350.94	281	62.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1940.0	C08		7	0187-0354	21.01	354.39	300	63.36	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3023.5	C08		7	0188-0357	136.51	357.68	257	62.77	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2372.0	C08		7	0189-0363	277.83	363.11	282	65.36	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			378.2	C08		7	0190-0369	804.38	370.02	353	76.91	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1130.4	C08		7	0191-0370	623.76	369.67	290	63.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			307.8	C08		7	0192-0371	729.37	370.37	299	70.43	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			323.5	C08		7	0193-0371	883.25	370.76	286	62.18	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1086.5	C08		7	0194-0370	421.52	370.61	212	52.87	0.953
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1610.3	C08		7	0195-0373	440.77	372.81	369	71.94	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1577.7	C08		7	0196-0375	244.52	375.02	278	61.36	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			264.5	C08		7	0197-0386	779.94	386.38	519	100.33	0.648
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			378.3	C08		7	0198-0377	71.45	377.30	298	66.53	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2046.5	C08		7	0199-0381	358.69	381.63	304	67.26	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3837.8	C08		7	0200-0384	480.38	383.90	280	62.53	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			290.8	C08		7	0201-0383	594.58	383.38	302	67.36	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1832.5	C08		7	0202-0387	497.35	387.35	255	59.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3929.0	C08		7	0203-0388	159.68	388.14	279	64.18	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			842.7	C08		7	0204-0387	211.60	387.59	296	66.43	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1378.3	C08		7	0205-0389	307.95	388.57	241	57.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1020.9	C08		7	0206-0391	538.00	391.84	277	63.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1766.8	C08		7	0207-0391	340.85	392.48	347	75.50	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			512.8	C08		7	0208-0391	895.57	390.50	309	67.60	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			238.2	C08		7	0209-0392	273.69	392.24	311	66.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			283.8	C08		7	0210-0392	731.74	391.93	291	66.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			669.4	C08		7	0211-0394	685.93	394.07	333	70.43	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1568.1	C08		7	0212-0397	667.40	397.52	258	63.94	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			786.6	C08		7	0213-0399	588.90	399.42	299	66.77	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			410.8	C08		7	0214-0400	944.59	400.47	310	69.01	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5829.0	C08		7	0215-0405	62.74	405.46	318	72.28	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1037.0	C08		7	0216-0403	315.97	403.96	284	64.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4696.3	C08		7	0217-0403	136.00	402.95	262	59.36	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			862.7	C08		7	0218-0405	648.86	405.48	283	64.18	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2752.7	C08		7	0219-0408	242.85	408.79	298	64.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3334.6	C08		7	0220-0407	454.24	407.57	291	63.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			324.2	C08		7	0221-0408	727.38	408.60	319	67.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			258.9	C08		7	0222-0413	806.08	413.94	299	65.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2566.8	C08		7	0223-0413	848.18	413.71	226	57.70	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			690.9	C08		7	0224-0424	158.66	424.24	430	77.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5416.2	C08		7	0225-0426	575.46	425.45	392	95.88	0.536
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4043.7	C08		7	0226-0424	443.56	423.89	283	62.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2977.2	C08		7	0227-0428	70.13	428.66	468	82.77	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1052.7	C08		7	0228-0429	302.95	428.77	307	67.84	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7628.7	C08		7	0229-0433	604.50	433.16	423	82.33	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			416.7	C08		7	0230-0432	651.00	431.62	293	64.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			776.7	C08		7	0231-0429	917.79	429.61	133	42.87	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			954.4	C08		7	0232-0435	902.21	434.55	192	52.18	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			531.2	C08		7	0233-0439	201.66	439.00	288	64.18	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			822.4	C08		7	0234-0441	136.25	440.56	313	66.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			659.9	C08		7	0235-0451	551.08	451.54	738	125.30	0.591
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2321.3	C08		7	0236-0447	733.50	447.24	319	66.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3297.9	C08		7	0237-0448	237.40	448.75	413	75.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			200.6	C08		7	0238-0451	171.67	451.56	290	65.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			628.7	C08		7	0239-0452	50.62	451.91	266	63.94	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			395.7	C08		7	0240-0449	372.36	448.99	256	62.53	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			673.9	C08		7	0241-0451	479.06	451.16	238	58.18	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2268.3	C08		7	0242-0467	133.33	469.17	904	137.10	0.604
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			720.5	C08		7	0243-0458	493.89	458.38	335	69.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			315.1	C08		7	0244-0458	332.53	458.42	279	63.01	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			804.3	C08		7	0245-0460	632.80	460.02	261	66.43	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			496.0	C08		7	0246-0456	274.08	455.57	268	61.70	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3257.6	C08		7	0247-0458	414.12	457.91	197	52.28	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			540.5	C08		7	0248-0463	79.81	463.03	259	62.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			403.8	C08		7	0249-0468	822.05	468.25	531	87.15	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3068.8	C08		7	0250-0465	393.47	464.98	215	54.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			683.5	C08		7	0251-0465	800.97	465.27	182	52.04	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			727.4	C08		7	0252-0466	695.06	466.10	242	59.36	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			227.8	C08		7	0253-0468	778.09	468.76	311	67.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			514.4	C08		7	0254-0471	731.50	470.88	306	65.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1781.2	C08		7	0255-0481	682.59	481.48	527	94.08	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			442.5	C08		7	0256-0475	432.38	475.66	298	63.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			578.9	C08		7	0257-0476	888.40	476.51	278	63.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2521.7	C08		7	0258-0476	863.53	476.24	285	64.77	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			396.2	C08		7	0259-0479	615.49	479.10	308	65.84	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			433.0	C08		7	0260-0480	758.16	480.43	318	69.60	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			664.2	C08		7	0261-0489	489.59	489.12	471	81.26	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2949.6	C08		7	0262-0486	905.96	486.58	296	64.18	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1021.7	C08		7	0263-0490	579.07	489.41	186	57.60	0.705
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1251.4	C08		7	0264-0493	259.07	493.34	275	60.77	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			262.5	C08		7	0265-0497	773.89	497.11	282	64.77	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1139.7	C08		7	0266-0497	234.03	496.95	259	58.53	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			754.4	C08		7	0267-0502	658.63	502.20	266	60.18	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			971.6	C08		7	0268-0503	846.58	503.79	333	68.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1555.2	C08		7	0269-0506	122.20	506.82	276	62.53	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			525.0	C08		7	0270-0508	532.58	508.24	317	65.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7926.3	C08		7	0271-0513	340.54	511.95	653	107.40	0.711
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			208.9	C08		7	0272-0511	201.18	511.35	298	66.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			429.5	C08		7	0273-0509	374.99	510.00	260	58.77	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			319.2	C08		7	0274-0514	779.70	514.47	297	65.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			218.7	C08		7	0275-0514	163.92	514.24	276	63.60	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			287.9	C08		7	0276-0515	474.02	515.23	306	64.43	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			303.5	C08		7	0277-0520	285.23	519.48	281	66.43	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			876.4	C08		7	0278-0523	554.66	522.46	299	65.60	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			296.6	C08		7	0279-0527	595.61	527.94	333	69.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			308.5	C08		7	0280-0530	462.19	530.53	273	65.26	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			302.7	C08		7	0281-0531	50.04	531.24	281	65.01	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			290.3	C08		7	0282-0532	83.20	532.26	287	62.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			744.0	C08		7	0283-0538	235.20	538.13	469	80.08	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			346.8	C08		7	0284-0537	720.99	537.06	278	66.43	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			702.3	C08		7	0285-0537	643.63	536.71	328	67.84	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			316.1	C08		7	0286-0536	769.83	536.82	260	64.67	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			745.3	C08		7	0287-0539	187.08	539.05	290	69.50	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			446.7	C08		7	0288-0536	390.77	535.62	261	61.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			487.2	C08		7	0289-0539	914.20	540.18	320	67.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			444.8	C08		7	0290-0544	701.47	543.96	434	77.74	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			371.9	C08		7	0291-0544	12.36	544.12	314	67.84	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2260.3	C08		7	0292-0543	264.67	542.86	258	59.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2383.2	C08		7	0293-0551	298.73	551.61	248	58.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2309.3	C08		7	0294-0551	213.99	551.36	300	65.70	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			437.8	C08		7	0295-0553	929.54	553.86	299	66.18	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1049.8	C08		7	0296-0558	801.50	557.38	377	72.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1092.3	C08		7	0297-0559	382.14	558.96	278	63.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			351.2	C08		7	0298-0561	350.08	560.94	292	64.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			588.5	C08		7	0299-0562	322.63	561.88	258	59.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1168.9	C08		7	0300-0563	518.11	563.04	271	61.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2514.2	C08		7	0301-0564	133.95	564.75	242	57.11	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			276.1	C08		7	0302-0569	241.13	569.70	307	67.01	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1043.5	C08		7	0303-0571	696.96	572.13	336	72.43	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2893.3	C08		7	0304-0571	588.57	571.12	288	63.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3523.5	C08		7	0305-0579	282.97	579.38	397	73.60	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1676.5	C08		7	0306-0585	763.47	587.36	746	117.64	0.677
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			264.1	C08		7	0307-0579	94.84	579.64	289	64.43	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7503.3	C08		7	0308-0576	649.55	576.07	254	59.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			466.2	C08		7	0309-0583	415.09	583.38	302	67.94	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			738.7	C08		7	0310-0583	893.16	583.45	375	71.60	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			426.8	C08		7	0311-0584	615.58	583.79	264	60.77	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			348.9	C08		7	0312-0588	460.21	588.56	306	64.53	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2871.2	C08		7	0313-0591	583.80	591.02	473	82.18	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			863.0	C08		7	0314-0595	538.06	595.67	433	77.01	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1171.5	C08		7	0315-0592	700.27	592.00	281	62.87	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			452.3	C08		7	0316-0599	945.31	598.79	258	64.43	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2728.2	C08		7	0317-0599	353.56	599.04	283	64.04	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4648.2	C08		7	0318-0605	336.14	604.94	412	78.18	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2747.0	C08		7	0319-0602	56.90	602.87	252	59.70	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1056.8	C08		7	0320-0606	399.11	607.57	277	63.11	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			698.4	C08		7	0321-0609	855.32	609.79	272	62.53	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			407.5	C08		7	0322-0613	636.26	612.94	273	64.77	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			230.8	C08		7	0323-0613	936.53	613.28	315	67.84	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			415.1	C08		7	0324-0612	678.10	613.04	256	60.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1620.8	C08		7	0325-0621	104.10	620.20	457	78.43	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			881.1	C08		7	0326-0623	291.51	624.26	627	100.91	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1276.2	C08		7	0327-0629	395.95	629.48	448	79.60	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			381.9	C08		7	0328-0628	572.60	628.89	290	62.77	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			340.7	C08		7	0329-0632	748.01	632.18	289	64.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4349.5	C08		7	0330-0636	776.79	636.68	256	60.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			428.2	C08		7	0331-0640	373.08	640.16	281	62.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1556.8	C08		7	0332-0647	710.25	648.24	283	65.60	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			530.7	C08		7	0333-0651	822.58	651.72	261	61.94	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			868.5	C08		7	0334-0652	204.53	653.05	300	64.18	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			300.0	C08		7	0335-0655	48.52	654.60	298	66.77	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1245.4	C08		7	0336-0658	138.48	657.73	287	62.77	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			323.0	C08		7	0337-0660	500.08	659.81	310	69.36	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			501.6	C08		7	0338-0659	631.58	659.79	261	60.87	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			383.4	C08		7	0339-0663	91.38	663.46	295	63.36	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1175.2	C08		7	0340-0661	302.24	661.91	258	61.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			270.2	C08		7	0341-0665	867.73	665.18	310	67.60	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			525.9	C08		7	0342-0670	424.56	670.17	396	75.84	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1484.8	C08		7	0343-0666	665.60	666.59	260	59.11	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			661.0	C08		7	0344-0668	699.28	668.58	267	61.94	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			331.9	C08		7	0345-0667	566.92	667.45	265	64.53	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			413.2	C08		7	0346-0674	186.53	673.98	438	80.18	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2772.2	C08		7	0347-0677	313.68	677.71	433	78.43	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2986.6	C08		7	0348-0676	807.34	676.26	246	58.18	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			473.0	C08		7	0349-0677	628.99	676.79	257	63.21	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			361.5	C08		7	0350-0679	645.06	678.65	325	71.94	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3818.5	C08		7	0351-0682	946.39	682.20	232	58.53	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1316.4	C08		7	0352-0684	666.11	684.21	246	57.70	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2624.5	C08		7	0353-0687	759.57	688.18	370	71.84	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4328.3	C08		7	0354-0687	736.92	686.21	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			641.5	C08		7	0355-0688	24.13	688.30	298	65.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4520.7	C08		7	0356-0691	252.88	690.83	430	77.26	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2452.1	C08		7	0357-0688	713.65	688.11	263	63.36	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			328.6	C08		7	0358-0693	469.47	692.93	302	67.70	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			654.4	C08		7	0359-0691	123.37	691.78	285	63.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			675.7	C08		7	0360-0698	43.62	698.59	290	65.60	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3781.5	C08		7	0361-0698	939.07	698.25	235	59.36	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			424.6	C08		7	0362-0700	533.23	700.56	301	65.60	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3641.5	C08		7	0363-0702	438.97	702.40	410	75.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			324.5	C08		7	0364-0702	374.62	702.30	278	61.36	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2432.7	C08		7	0365-0705	762.74	705.83	240	58.87	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1640.8	C08		7	0366-0710	613.25	710.49	186	53.36	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			291.7	C08		8	0001-0030	465.68	30.42	295	61.94	0.966
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			404.5	C08		8	0002-0031	547.19	30.38	278	62.18	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			334.1	C08		8	0003-0033	709.44	32.90	255	63.84	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			270.9	C08		8	0004-0033	33.60	33.54	273	64.77	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			717.7	C08		8	0005-0032	180.29	32.17	229	56.53	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3221.2	C08		8	0006-0032	778.32	31.86	180	51.11	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			305.5	C08		8	0007-0033	54.01	33.46	295	67.70	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			242.5	C08		8	0008-0033	231.55	33.54	264	59.11	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			769.4	C08		8	0009-0037	693.47	37.68	251	59.94	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			609.7	C08		8	0010-0039	522.67	38.53	294	65.94	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5268.3	C08		8	0011-0040	792.13	40.86	333	76.91	0.707
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			394.5	C08		8	0012-0042	311.06	41.33	294	65.26	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2220.0	C08		8	0013-0048	380.46	46.13	438	89.84	0.682
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2619.3	C08		8	0014-0045	501.66	45.04	449	78.67	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3208.5	C08		8	0015-0044	660.94	45.37	156	80.91	0.299
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			306.9	C08		8	0016-0054	712.35	54.21	264	66.18	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1178.4	C08		8	0017-0053	742.37	52.85	277	63.84	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			650.2	C08		8	0018-0056	837.09	55.92	164	55.11	0.679
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			611.5	C08		8	0019-0057	860.26	57.03	272	62.18	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			949.2	C08		8	0020-0059	448.63	59.29	134	60.18	0.465
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2539.4	C08		8	0021-0068	67.82	67.59	498	87.50	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			717.7	C08		8	0022-0064	909.20	64.16	300	67.36	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4878.1	C08		8	0023-0062	790.69	61.81	207	52.28	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7003.0	C08		8	0024-0063	121.72	63.89	242	57.36	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			597.0	C08		8	0025-0067	286.68	66.55	297	76.57	0.637
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			373.7	C08		8	0026-0067	591.04	66.94	314	70.77	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1620.0	C08		8	0027-0063	50.38	63.06	108	40.63	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5641.1	C08		8	0028-0074	188.81	72.64	695	116.23	0.647
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1065.6	C08		8	0029-0069	345.83	69.59	243	57.11	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			817.5	C08		8	0030-0071	848.67	70.96	252	61.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7073.5	C08		8	0031-0073	106.00	73.30	218	58.77	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3763.5	C08		8	0032-0080	165.89	77.84	532	95.36	0.735
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			494.7	C08		8	0033-0075	629.52	75.54	309	69.26	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			346.9	C08		8	0034-0073	932.67	73.63	278	64.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			511.1	C08		8	0035-0074	236.53	74.59	247	59.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2328.6	C08		8	0036-0081	544.67	81.33	299	68.43	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			254.2	C08		8	0037-0087	824.73	86.97	303	67.84	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			294.6	C08		8	0038-0086	481.64	86.30	296	64.67	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1028.8	C08		8	0039-0086	319.20	85.87	282	62.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			863.5	C08		8	0040-0089	665.56	89.80	432	80.67	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8131.0	C08		8	0041-0100	83.83	100.10	294	64.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			293.5	C08		8	0042-0100	227.32	99.74	258	63.36	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4605.4	C08		8	0043-0099	773.95	99.27	234	56.87	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			436.3	C08		8	0044-0100	367.51	100.60	291	65.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7000.6	C08		8	0045-0100	757.50	100.78	259	58.87	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4262.2	C08		8	0046-0108	581.33	108.58	288	65.01	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			391.9	C08		8	0047-0110	902.90	110.16	303	64.18	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			376.5	C08		8	0048-0110	821.66	109.99	266	61.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2731.4	C08		8	0049-0111	720.99	110.99	228	55.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			339.9	C08		8	0050-0117	19.36	117.48	250	58.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3085.0	C08		8	0051-0122	401.85	120.99	617	103.15	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			517.1	C08		8	0052-0117	602.92	117.43	243	58.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			417.6	C08		8	0053-0117	536.09	116.93	268	61.94	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			642.0	C08		8	0054-0123	645.10	123.14	239	57.36	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			705.2	C08		8	0055-0126	433.22	126.58	256	59.36	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			361.9	C08		8	0056-0125	475.67	125.87	307	65.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6320.8	C08		8	0057-0131	104.76	131.71	320	68.43	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1843.2	C08		8	0058-0129	288.05	129.53	218	55.11	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1591.0	C08		8	0059-0135	847.79	134.33	444	84.91	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5753.4	C08		8	0060-0132	811.21	132.13	224	56.63	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			449.4	C08		8	0061-0135	207.21	134.94	252	61.36	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1200.3	C08		8	0062-0138	798.43	138.91	261	64.28	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			215.7	C08		8	0063-0140	527.91	140.89	280	63.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			376.0	C08		8	0064-0142	711.25	142.30	314	70.43	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1747.6	C08		8	0065-0142	375.28	142.34	231	56.28	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			360.3	C08		8	0066-0143	476.59	142.54	270	62.53	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			248.9	C08		8	0067-0148	775.29	148.00	280	62.18	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			474.7	C08		8	0068-0152	124.19	152.91	275	63.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			656.6	C08		8	0069-0148	299.03	147.82	247	59.70	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7716.8	C08		8	0070-0152	814.13	152.03	197	51.70	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			433.2	C08		8	0071-0155	675.60	155.47	270	63.60	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			247.3	C08		8	0072-0155	741.61	154.87	253	59.94	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			492.9	C08		8	0073-0159	614.15	159.31	289	65.70	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1392.6	C08		8	0074-0158	355.70	157.95	353	69.01	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			429.6	C08		8	0075-0158	72.97	157.87	271	61.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			538.4	C08		8	0076-0166	468.52	166.65	303	69.60	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			599.7	C08		8	0077-0171	52.32	171.42	447	79.50	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			473.8	C08		8	0078-0173	161.92	173.06	261	61.36	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			551.3	C08		8	0079-0173	222.76	173.00	257	59.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1510.4	C08		8	0080-0169	397.95	169.91	274	67.94	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1180.1	C08		8	0081-0172	449.89	172.11	212	55.70	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			581.9	C08		8	0082-0176	674.84	176.11	285	66.18	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			835.8	C08		8	0083-0184	538.83	184.41	214	56.53	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			382.9	C08		8	0084-0186	105.76	186.28	271	60.18	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			662.6	C08		8	0085-0190	896.93	190.67	512	89.74	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			366.6	C08		8	0086-0197	328.77	196.94	376	71.60	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			899.4	C08		8	0087-0194	398.31	194.01	237	58.18	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1478.3	C08		8	0088-0198	481.48	198.28	282	64.53	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			454.4	C08		8	0089-0200	669.44	199.84	309	70.18	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			802.7	C08		8	0090-0199	286.00	199.11	279	63.36	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2813.8	C08		8	0091-0199	513.10	198.22	311	69.11	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			268.5	C08		8	0092-0203	773.71	202.19	159	50.18	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			787.5	C08		8	0093-0208	848.75	208.73	304	70.91	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			747.3	C08		8	0094-0208	385.94	208.71	392	80.33	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			716.9	C08		8	0095-0210	762.42	209.98	316	75.74	0.692
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			311.2	C08		8	0096-0210	784.83	210.44	120	41.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			811.7	C08		8	0097-0214	718.57	214.37	222	59.36	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			623.1	C08		8	0098-0215	30.22	215.69	254	59.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			792.2	C08		8	0099-0214	509.59	215.05	284	65.36	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			417.1	C08		8	0100-0221	901.61	221.67	392	74.67	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			533.5	C08		8	0101-0219	401.57	219.53	273	63.01	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			920.0	C08		8	0102-0227	600.21	227.79	229	56.53	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			808.6	C08		8	0103-0228	180.24	228.63	265	62.77	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			166.1	C08		8	0104-0232	123.88	234.13	341	79.26	0.682
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			458.6	C08		8	0105-0230	684.46	229.47	250	59.70	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3253.9	C08		8	0106-0230	821.39	229.68	262	60.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4530.4	C08		8	0107-0228	846.38	228.77	224	55.36	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1165.3	C08		8	0108-0235	216.03	234.74	373	71.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1526.2	C08		8	0109-0233	263.29	233.49	159	47.46	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			633.4	C08		8	0110-0241	702.98	240.60	210	55.94	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			450.0	C08		8	0111-0244	483.81	244.58	343	71.01	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			933.7	C08		8	0112-0247	651.99	247.34	454	81.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			404.8	C08		8	0113-0246	183.27	246.76	242	59.46	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1185.4	C08		8	0114-0247	567.50	246.42	307	65.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			199.2	C08		8	0115-0248	622.51	248.87	293	63.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			804.9	C08		8	0116-0251	64.62	250.71	270	66.67	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1103.1	C08		8	0117-0252	339.09	252.28	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1690.7	C08		8	0118-0252	746.86	252.39	370	71.26	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			342.8	C08		8	0119-0253	909.42	252.76	302	68.18	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			329.8	C08		8	0120-0256	927.02	256.12	338	72.18	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			713.9	C08		8	0121-0257	507.86	257.96	460	79.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			677.1	C08		8	0122-0257	775.18	257.04	242	57.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			166.1	C08		8	0123-0263	113.49	262.03	264	61.26	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			561.2	C08		8	0124-0265	13.44	264.14	247	61.60	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3864.8	C08		8	0125-0266	570.91	266.69	224	54.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1782.0	C08		8	0126-0270	431.50	270.56	276	63.36	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1495.7	C08		8	0127-0271	642.41	271.75	266	63.11	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			473.1	C08		8	0128-0275	28.09	274.67	247	61.36	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			461.0	C08		8	0129-0273	96.59	273.71	293	71.15	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			401.8	C08		8	0130-0278	177.48	278.78	258	61.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1758.8	C08		8	0131-0275	348.47	275.37	282	62.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			305.1	C08		8	0132-0282	790.68	282.00	280	63.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6401.7	C08		8	0133-0280	616.38	280.19	218	54.53	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2250.9	C08		8	0134-0286	411.59	286.65	516	86.43	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2045.1	C08		8	0135-0289	593.91	290.18	522	96.33	0.707
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			529.7	C08		8	0136-0291	657.83	291.43	401	77.60	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			347.5	C08		8	0137-0292	198.52	292.19	254	62.77	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			561.9	C08		8	0138-0291	503.11	291.22	264	61.36	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			327.7	C08		8	0139-0293	169.12	293.03	223	57.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			347.8	C08		8	0140-0296	858.63	296.66	278	65.70	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			769.9	C08		8	0141-0296	473.07	295.39	310	66.43	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1375.5	C08		8	0142-0296	631.22	296.87	243	59.94	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1124.0	C08		8	0143-0300	872.90	300.22	285	64.87	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			259.6	C08		8	0144-0300	97.94	300.00	282	66.18	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1714.0	C08		8	0145-0308	702.25	308.18	503	88.43	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			534.1	C08		8	0146-0309	152.79	309.85	475	88.57	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			525.5	C08		8	0147-0310	280.31	309.79	416	77.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2612.7	C08		8	0148-0310	386.42	309.73	244	58.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			349.8	C08		8	0149-0309	745.08	308.93	281	62.18	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1773.6	C08		8	0150-0315	216.42	314.77	287	65.60	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			272.4	C08		8	0151-0320	47.35	320.46	420	75.26	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			360.8	C08		8	0152-0320	593.64	319.21	252	59.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			682.8	C08		8	0153-0325	528.95	325.66	304	66.77	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			341.2	C08		8	0154-0325	422.95	324.32	285	64.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			416.4	C08		8	0155-0325	910.94	325.64	306	67.84	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			392.2	C08		8	0156-0327	98.64	326.80	373	76.08	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2528.8	C08		8	0157-0326	326.66	326.76	238	58.18	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			275.2	C08		8	0158-0337	772.26	337.59	305	66.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			944.4	C08		8	0159-0341	818.10	341.48	280	65.01	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1998.8	C08		8	0160-0339	871.33	338.94	242	59.11	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			334.4	C08		8	0161-0345	115.39	344.75	275	62.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2722.2	C08		8	0162-0348	525.87	348.58	366	73.84	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2281.2	C08		8	0163-0345	711.92	344.44	249	59.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			281.5	C08		8	0164-0352	559.11	352.20	276	61.94	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			735.7	C08		8	0165-0351	597.71	351.17	268	60.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1450.7	C08		8	0166-0352	682.45	351.91	255	62.77	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			460.1	C08		8	0167-0352	731.46	352.60	283	62.18	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1857.6	C08		8	0168-0359	263.84	359.46	487	88.91	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			769.7	C08		8	0169-0354	210.23	354.93	263	59.60	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			699.8	C08		8	0170-0356	631.68	356.32	268	61.11	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			526.8	C08		8	0171-0356	355.10	356.18	258	59.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			356.1	C08		8	0172-0357	416.89	357.57	307	70.43	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			288.2	C08		8	0173-0357	925.03	357.68	273	61.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			296.7	C08		8	0174-0361	468.53	360.83	292	64.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			553.2	C08		8	0175-0362	649.11	362.38	323	69.60	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			900.0	C08		8	0176-0365	171.66	365.70	227	55.70	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			547.5	C08		8	0177-0365	288.04	365.90	287	67.60	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2775.2	C08		8	0178-0366	59.86	366.56	248	58.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			636.0	C08		8	0179-0380	760.61	380.58	357	70.18	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3458.4	C08		8	0180-0380	811.00	379.21	217	55.01	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			349.7	C08		8	0181-0383	196.62	383.55	280	62.18	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			432.0	C08		8	0182-0384	217.55	384.18	269	61.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			921.4	C08		8	0183-0383	334.32	383.75	119	50.04	0.597
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			833.7	C08		8	0184-0389	824.12	389.42	309	65.11	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			308.7	C08		8	0185-0388	948.43	389.19	264	59.70	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8663.7	C08		8	0186-0396	578.23	395.14	311	67.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			379.2	C08		8	0187-0396	492.26	397.89	297	69.84	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			615.5	C08		8	0188-0398	874.23	398.40	276	62.77	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3321.0	C08		8	0189-0402	378.12	401.83	338	72.67	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			683.5	C08		8	0190-0397	921.02	397.62	284	63.01	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			352.5	C08		8	0191-0401	295.72	402.10	276	61.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			476.9	C08		8	0192-0402	49.43	402.45	275	65.60	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1422.8	C08		8	0193-0404	558.15	404.14	249	59.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4964.8	C08		8	0194-0404	725.10	404.57	103	63.50	0.321
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3388.4	C08		8	0195-0418	319.07	417.56	255	60.28	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2259.0	C08		8	0196-0418	390.15	417.76	412	76.08	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			509.0	C08		8	0197-0420	245.09	420.66	268	64.43	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			707.1	C08		8	0198-0420	684.61	420.01	187	50.53	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			313.2	C08		8	0199-0423	613.93	423.00	244	58.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			612.5	C08		8	0200-0424	562.83	424.34	275	60.77	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			425.8	C08		8	0201-0426	180.00	427.29	275	63.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3477.8	C08		8	0202-0426	827.92	426.59	247	57.70	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1048.8	C08		8	0203-0432	147.17	431.93	238	57.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			506.5	C08		8	0204-0434	261.57	433.98	293	67.94	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			559.9	C08		8	0205-0437	846.62	437.04	304	67.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			710.9	C08		8	0206-0442	340.32	442.00	273	63.36	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1228.0	C08		8	0207-0440	699.29	439.71	234	55.94	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2041.8	C08		8	0208-0442	417.13	442.32	230	56.28	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1079.0	C08		8	0209-0444	718.59	444.25	348	69.60	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			469.0	C08		8	0210-0444	545.86	444.24	272	61.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1018.3	C08		8	0211-0445	458.64	445.50	258	59.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2247.6	C08		8	0212-0448	868.82	448.96	248	59.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1096.1	C08		8	0213-0449	925.97	448.03	219	57.11	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			492.5	C08		8	0214-0453	372.89	453.38	318	70.67	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1209.5	C08		8	0215-0453	608.77	452.64	278	62.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1595.1	C08		8	0216-0458	565.00	458.24	488	82.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1556.5	C08		8	0217-0461	64.26	460.83	476	83.74	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			282.3	C08		8	0218-0461	387.49	461.48	279	63.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3411.5	C08		8	0219-0460	837.21	459.77	248	58.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1529.6	C08		8	0220-0461	921.28	462.13	248	62.77	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1112.1	C08		8	0221-0462	256.23	461.92	220	54.53	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1833.5	C08		8	0222-0461	282.52	461.62	206	54.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3415.8	C08		8	0223-0463	668.71	463.60	263	64.18	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			387.7	C08		8	0224-0467	319.69	467.01	282	63.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6451.2	C08		8	0225-0464	804.55	463.14	229	56.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2242.2	C08		8	0226-0471	787.93	471.14	285	63.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			356.6	C08		8	0227-0477	149.23	477.60	560	102.57	0.669
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2369.1	C08		8	0228-0474	640.90	473.26	224	54.53	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			263.0	C08		8	0229-0477	425.01	478.02	269	62.18	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3399.7	C08		8	0230-0478	292.01	479.06	271	64.53	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3622.5	C08		8	0231-0481	678.51	481.71	247	59.11	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1659.1	C08		8	0232-0479	711.23	479.80	241	57.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			530.1	C08		8	0233-0479	902.02	479.72	270	60.53	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			821.8	C08		8	0234-0481	941.03	481.25	232	57.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4107.8	C08		8	0235-0484	211.36	483.62	105	43.11	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4170.9	C08		8	0236-0487	201.58	488.12	131	48.53	0.699
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2983.5	C08		8	0237-0487	269.16	487.87	231	58.53	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2197.9	C08		8	0238-0489	620.16	488.89	288	65.11	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1136.0	C08		8	0239-0492	554.03	492.40	349	70.67	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2607.5	C08		8	0240-0491	365.53	491.03	225	56.18	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1223.5	C08		8	0241-0500	171.28	499.87	344	68.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			509.6	C08		8	0242-0498	716.02	498.20	226	60.43	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			276.3	C08		8	0243-0497	109.61	497.63	238	59.60	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			277.3	C08		8	0244-0500	238.91	501.10	239	58.87	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3402.5	C08		8	0245-0502	380.62	502.20	268	63.01	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2289.5	C08		8	0246-0507	930.95	506.66	409	77.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			902.3	C08		8	0247-0504	625.16	504.98	238	60.28	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3689.0	C08		8	0248-0503	273.40	503.05	238	58.28	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			296.4	C08		8	0249-0514	89.34	515.12	507	91.15	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			775.4	C08		8	0250-0509	438.00	509.74	255	58.53	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4076.8	C08		8	0251-0510	696.79	510.30	311	66.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			766.8	C08		8	0252-0512	878.28	512.44	244	59.46	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2696.8	C08		8	0253-0514	310.30	513.18	186	51.70	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			934.9	C08		8	0254-0515	201.80	515.64	228	56.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1255.5	C08		8	0255-0517	759.40	516.79	294	64.67	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			780.8	C08		8	0256-0519	811.58	519.44	486	87.98	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2348.6	C08		8	0257-0516	596.04	516.40	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			321.3	C08		8	0258-0520	237.04	519.50	330	71.11	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			316.4	C08		8	0259-0522	253.68	522.36	228	59.11	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			875.7	C08		8	0260-0523	488.73	522.70	295	62.77	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1324.2	C08		8	0261-0524	661.48	523.87	227	55.70	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2011.9	C08		8	0262-0527	742.40	526.95	260	60.43	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			515.5	C08		8	0263-0530	876.58	529.37	283	62.77	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			699.1	C08		8	0264-0532	356.26	532.79	284	62.53	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2279.1	C08		8	0265-0533	279.96	532.58	250	58.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1010.2	C08		8	0266-0533	631.26	533.79	257	59.60	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			669.9	C08		8	0267-0540	312.82	539.80	275	63.11	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1071.9	C08		8	0268-0544	136.31	544.19	542	91.15	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			390.6	C08		8	0269-0542	19.31	542.57	283	65.01	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1808.1	C08		8	0270-0541	710.78	541.56	213	55.11	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			268.1	C08		8	0271-0547	528.35	547.46	266	63.60	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3101.9	C08		8	0272-0547	659.37	547.28	221	55.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1354.1	C08		8	0273-0548	340.98	548.12	299	66.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1084.8	C08		8	0274-0551	158.34	550.80	237	57.70	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4254.1	C08		8	0275-0558	593.14	559.17	376	84.43	0.663
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			579.8	C08		8	0276-0557	882.02	557.74	446	77.60	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			463.3	C08		8	0277-0555	34.35	555.92	277	66.43	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2007.1	C08		8	0278-0558	212.69	558.00	294	64.53	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1699.3	C08		8	0279-0556	618.51	556.04	242	56.53	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1171.9	C08		8	0280-0557	686.65	556.60	238	59.60	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			183.6	C08		8	0281-0560	179.36	560.21	253	62.77	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3138.2	C08		8	0282-0558	246.73	557.92	240	58.77	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1475.4	C08		8	0283-0562	830.98	562.33	447	79.26	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			524.5	C08		8	0284-0566	803.90	565.85	314	66.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			255.9	C08		8	0285-0569	497.77	569.36	276	64.53	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			283.6	C08		8	0286-0567	759.84	567.25	272	63.01	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1234.6	C08		8	0287-0569	119.71	570.06	268	63.94	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			410.0	C08		8	0288-0571	461.61	571.35	266	61.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2989.7	C08		8	0289-0580	59.92	580.69	231	56.87	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2089.0	C08		8	0290-0579	303.55	579.25	251	58.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1576.4	C08		8	0291-0579	624.67	579.37	252	58.53	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			364.8	C08		8	0292-0583	361.19	583.79	256	61.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1309.0	C08		8	0293-0587	654.64	588.15	349	74.33	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			310.4	C08		8	0294-0589	456.73	589.69	307	70.18	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			274.5	C08		8	0295-0586	529.34	586.84	286	61.94	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1697.8	C08		8	0296-0586	117.58	586.24	206	54.97	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			456.4	C08		8	0297-0596	295.90	596.50	237	62.77	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1943.5	C08		8	0298-0593	868.74	593.33	202	51.70	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			634.2	C08		8	0299-0601	50.38	600.85	254	64.43	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			864.5	C08		8	0300-0599	701.52	599.57	413	75.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			343.3	C08		8	0301-0598	843.25	598.26	291	64.67	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3154.4	C08		8	0302-0600	63.45	600.21	210	57.46	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			316.5	C08		8	0303-0602	559.38	602.13	283	63.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			242.5	C08		8	0304-0602	185.08	602.33	240	61.01	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			293.6	C08		8	0305-0601	405.74	600.46	280	65.70	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			897.9	C08		8	0306-0605	120.49	605.06	281	62.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1486.6	C08		8	0307-0607	825.57	607.00	248	58.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1316.6	C08		8	0308-0611	359.21	612.16	250	61.94	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			673.2	C08		8	0309-0610	721.85	609.54	302	65.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			504.6	C08		8	0310-0613	943.88	612.85	291	65.60	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			239.6	C08		8	0311-0615	41.12	614.97	308	69.50	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1623.8	C08		8	0312-0615	239.39	614.86	257	61.70	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			519.4	C08		8	0313-0616	916.21	616.39	283	64.08	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			216.4	C08		8	0314-0618	207.71	618.12	223	60.77	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			277.0	C08		8	0315-0617	761.84	618.20	286	63.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1248.1	C08		8	0316-0618	306.06	618.28	239	56.53	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			678.6	C08		8	0317-0620	588.43	620.73	279	62.43	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4306.0	C08		8	0318-0622	404.32	622.59	304	64.18	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			229.5	C08		8	0319-0629	517.58	629.12	284	63.84	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1952.2	C08		8	0320-0632	459.52	631.89	370	71.84	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			799.0	C08		8	0321-0636	76.39	636.01	364	70.18	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			773.0	C08		8	0322-0637	110.24	637.03	317	65.36	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2887.1	C08		8	0323-0640	879.84	640.53	526	93.74	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			775.1	C08		8	0324-0639	391.61	638.97	319	68.18	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1970.7	C08		8	0325-0643	248.85	643.59	323	70.43	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			217.0	C08		8	0326-0645	505.10	645.84	306	66.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			402.7	C08		8	0327-0645	768.94	645.84	266	62.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			669.4	C08		8	0328-0651	671.28	651.61	246	60.18	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			383.0	C08		8	0329-0653	706.64	652.08	543	92.91	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			409.5	C08		8	0330-0654	300.37	654.17	247	58.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			219.3	C08		8	0331-0656	925.47	655.80	301	68.08	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1521.8	C08		8	0332-0656	362.05	656.09	299	64.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			308.3	C08		8	0333-0658	141.52	658.42	252	70.67	0.634
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			344.8	C08		8	0334-0658	97.64	658.60	267	61.94	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			259.8	C08		8	0335-0662	326.33	662.00	309	69.01	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			358.3	C08		8	0336-0664	412.07	664.33	320	67.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			434.1	C08		8	0337-0663	542.20	662.74	269	62.53	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1148.8	C08		8	0338-0671	679.72	670.55	583	99.98	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1796.9	C08		8	0339-0670	559.96	669.94	306	65.94	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1611.0	C08		8	0340-0671	522.06	670.94	257	60.53	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			542.8	C08		8	0341-0676	839.62	675.96	277	64.43	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			717.4	C08		8	0342-0677	592.10	676.95	301	64.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			419.4	C08		8	0343-0681	426.87	681.11	257	61.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			851.5	C08		8	0344-0680	825.91	680.22	200	55.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1772.9	C08		8	0345-0681	496.51	681.74	226	55.94	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4288.5	C08		8	0346-0684	50.65	684.36	234	58.53	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			737.2	C08		8	0347-0689	254.18	690.21	283	64.43	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			827.8	C08		8	0348-0688	868.57	687.80	244	57.70	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			407.9	C08		8	0349-0690	188.82	689.63	237	57.70	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1343.9	C08		8	0350-0690	937.26	690.82	252	61.11	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			521.7	C08		8	0351-0694	901.66	693.47	276	65.60	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			937.3	C08		8	0352-0701	762.65	700.30	321	72.77	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4173.8	C08		8	0353-0700	43.43	700.32	233	61.01	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			310.0	C08		8	0354-0703	119.57	703.64	249	58.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			635.4	C08		8	0355-0705	520.70	705.43	283	62.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			277.2	C08		8	0356-0706	389.73	707.25	207	55.94	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			201.1	C08		8	0357-0707	328.37	707.55	294	67.70	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			488.6	C08		9	0001-0024	161.85	25.29	246	59.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5432.5	C08		9	0002-0035	665.72	35.66	214	57.11	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2407.7	C08		9	0003-0039	312.75	39.43	433	76.67	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			419.2	C08		9	0004-0037	420.03	37.46	346	69.01	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			265.9	C08		9	0005-0040	374.47	40.18	320	66.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			419.9	C08		9	0006-0045	820.05	45.39	381	73.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			578.4	C08		9	0007-0047	72.02	46.73	268	64.18	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4661.5	C08		9	0008-0049	676.39	49.76	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6067.5	C08		9	0009-0050	207.06	50.12	309	65.01	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			462.7	C08		9	0010-0052	170.76	52.19	245	58.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1169.8	C08		9	0011-0055	511.16	55.20	391	73.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1021.1	C08		9	0012-0055	553.62	56.11	265	61.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			473.7	C08		9	0013-0056	84.67	55.33	253	63.60	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			352.5	C08		9	0014-0060	764.20	59.77	410	76.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			281.9	C08		9	0015-0057	111.31	57.22	247	63.94	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			327.8	C08		9	0016-0063	641.28	63.47	291	67.11	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			340.1	C08		9	0017-0063	618.58	62.86	295	65.70	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1126.9	C08		9	0018-0066	660.27	66.16	281	62.18	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3435.8	C08		9	0019-0065	260.89	65.33	267	59.94	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1357.5	C08		9	0020-0065	919.29	65.62	278	62.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1956.0	C08		9	0021-0068	834.44	67.84	321	68.43	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1819.2	C08		9	0022-0074	466.68	74.75	307	65.11	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			318.3	C08		9	0023-0076	27.12	76.64	262	61.60	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			662.6	C08		9	0024-0077	188.25	77.36	293	67.01	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1075.4	C08		9	0025-0078	237.21	78.41	255	61.01	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			693.7	C08		9	0026-0083	329.86	83.01	316	70.08	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			514.5	C08		9	0027-0090	387.72	90.27	630	94.81	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1170.7	C08		9	0028-0084	822.71	84.46	238	56.77	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			165.0	C08		9	0029-0087	949.16	87.00	283	63.01	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3049.0	C08		9	0030-0088	499.50	88.20	272	61.36	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6251.2	C08		9	0031-0095	273.32	94.68	232	57.60	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			544.9	C08		9	0032-0099	837.52	99.21	297	64.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2560.2	C08		9	0033-0103	732.27	102.56	218	57.36	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2002.4	C08		9	0034-0103	439.24	102.90	295	65.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1680.0	C08		9	0035-0104	717.93	103.97	242	57.70	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			10901.6	C08		9	0036-0107	610.82	107.38	251	58.28	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1486.9	C08		9	0037-0108	762.14	108.40	290	63.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5681.1	C08		9	0038-0114	213.27	114.06	257	59.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			913.4	C08		9	0039-0119	68.38	119.09	248	64.87	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1080.4	C08		9	0040-0120	50.66	120.43	362	73.36	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1259.2	C08		9	0041-0121	287.36	120.29	279	61.11	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2558.9	C08		9	0042-0121	647.54	121.67	265	61.11	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			293.5	C08		9	0043-0121	943.79	120.02	245	59.94	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			8875.1	C08		9	0044-0122	243.16	121.57	263	83.50	0.474
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			396.3	C08		9	0045-0124	862.97	124.53	312	66.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1271.4	C08		9	0046-0126	496.69	125.44	297	64.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2766.6	C08		9	0047-0131	422.92	130.66	210	55.01	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2203.9	C08		9	0048-0130	383.67	130.77	198	53.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1334.7	C08		9	0049-0133	667.11	133.29	248	58.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			626.4	C08		9	0050-0138	68.40	138.48	334	74.77	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			777.0	C08		9	0051-0142	113.99	141.80	371	73.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			335.3	C08		9	0052-0142	192.16	141.80	284	66.67	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1375.4	C08		9	0053-0140	302.18	140.57	275	62.04	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1600.5	C08		9	0054-0143	433.34	143.34	286	62.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1688.8	C08		9	0055-0141	733.55	141.16	244	57.36	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			801.4	C08		9	0056-0142	885.59	142.48	299	63.84	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1356.4	C08		9	0057-0139	772.04	139.76	219	54.87	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1741.1	C08		9	0058-0145	230.77	145.19	399	73.01	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1886.9	C08		9	0059-0147	345.61	146.60	335	67.84	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			865.9	C08		9	0060-0146	132.54	146.26	261	61.94	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4062.6	C08		9	0061-0159	616.86	156.80	390	84.91	0.680
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2884.0	C08		9	0062-0152	166.12	151.85	223	57.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5074.2	C08		9	0063-0153	634.50	153.00	116	38.97	0.960
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			350.7	C08		9	0064-0156	770.74	155.75	343	68.87	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2346.7	C08		9	0065-0156	449.47	155.91	231	55.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1186.6	C08		9	0066-0156	302.96	155.49	244	60.28	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1012.3	C08		9	0067-0162	490.83	162.58	358	71.26	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			496.4	C08		9	0068-0165	572.41	165.15	422	76.18	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2214.1	C08		9	0069-0166	807.34	166.84	302	69.60	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1506.4	C08		9	0070-0170	532.91	170.34	246	59.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1909.8	C08		9	0071-0173	140.65	173.84	242	57.70	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			598.8	C08		9	0072-0177	414.21	176.85	464	80.67	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			558.4	C08		9	0073-0177	251.09	177.59	287	62.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4471.9	C08		9	0074-0177	660.80	177.44	227	56.53	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			414.5	C08		9	0075-0182	827.81	182.46	333	68.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4599.6	C08		9	0076-0186	396.07	188.05	451	86.67	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2013.8	C08		9	0077-0185	750.71	185.11	320	66.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			833.7	C08		9	0078-0184	456.37	184.52	346	75.84	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			304.3	C08		9	0079-0186	559.50	186.39	310	65.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2047.6	C08		9	0080-0189	116.64	189.13	234	55.94	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			325.9	C08		9	0081-0188	167.35	187.41	309	70.53	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			380.3	C08		9	0082-0191	520.39	190.47	422	77.84	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			351.9	C08		9	0083-0192	77.49	191.97	280	63.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			305.1	C08		9	0084-0193	187.40	192.97	270	61.94	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			256.8	C08		9	0085-0191	902.35	191.72	342	71.11	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			657.1	C08		9	0086-0196	324.22	196.80	336	67.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2918.7	C08		9	0087-0199	842.93	200.02	236	57.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1205.3	C08		9	0088-0210	372.57	210.16	458	81.84	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			535.6	C08		9	0089-0206	233.49	206.79	240	58.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			438.6	C08		9	0090-0207	900.41	206.94	299	67.70	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			736.3	C08		9	0091-0211	734.28	211.95	285	63.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			411.5	C08		9	0092-0214	251.54	213.93	326	72.77	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1733.8	C08		9	0093-0211	773.03	210.77	302	64.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5331.7	C08		9	0094-0219	463.37	219.42	274	64.53	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6285.6	C08		9	0095-0217	682.78	217.22	230	57.36	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			500.1	C08		9	0096-0219	500.76	219.35	234	57.70	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2420.9	C08		9	0097-0222	127.39	221.66	282	63.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			804.8	C08		9	0098-0220	637.31	220.35	277	61.36	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			253.8	C08		9	0099-0221	78.75	221.20	239	62.18	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			316.2	C08		9	0100-0222	206.90	222.08	262	62.18	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2902.5	C08		9	0101-0227	722.82	226.89	261	63.36	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1290.1	C08		9	0102-0224	928.66	223.68	354	71.01	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1949.8	C08		9	0103-0227	522.97	227.72	319	67.36	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			587.1	C08		9	0104-0238	321.22	237.77	481	81.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1735.7	C08		9	0105-0231	741.47	231.83	261	62.87	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			691.2	C08		9	0106-0236	137.63	236.28	389	72.43	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			277.7	C08		9	0107-0237	777.38	237.02	324	69.01	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			268.1	C08		9	0108-0238	853.32	238.03	340	72.08	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			480.5	C08		9	0109-0238	916.87	238.35	294	65.70	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2281.5	C08		9	0110-0240	623.11	240.28	311	65.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			152.1	C08		9	0111-0243	71.18	243.47	298	66.77	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1043.0	C08		9	0112-0247	451.64	247.20	263	59.36	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1806.1	C08		9	0113-0247	227.38	246.53	271	60.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1930.3	C08		9	0114-0252	290.88	251.22	323	68.08	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			189.3	C08		9	0115-0251	178.20	251.43	263	58.53	0.965
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4013.4	C08		9	0116-0252	539.18	251.95	102	77.98	0.211
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			228.8	C08		9	0117-0259	21.87	259.08	306	69.01	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			223.4	C08		9	0118-0257	148.94	257.02	237	57.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7635.2	C08		9	0119-0257	338.39	257.67	235	56.53	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4682.8	C08		9	0120-0259	806.27	259.06	291	63.11	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			455.8	C08		9	0121-0263	711.79	263.00	343	70.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1920.2	C08		9	0122-0264	280.54	265.02	288	64.08	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			795.3	C08		9	0123-0260	430.89	259.94	241	60.53	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1768.1	C08		9	0124-0264	683.93	264.17	260	60.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			601.3	C08		9	0125-0264	875.82	264.11	313	68.18	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			919.9	C08		9	0126-0271	96.00	269.37	542	99.15	0.693
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1867.5	C08		9	0127-0266	851.68	266.28	250	60.18	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2338.2	C08		9	0128-0268	651.45	267.92	241	61.01	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			675.0	C08		9	0129-0269	616.96	268.57	313	66.77	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			464.9	C08		9	0130-0270	215.06	270.05	331	70.18	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1939.0	C08		9	0131-0275	124.19	275.22	276	64.18	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1476.7	C08		9	0132-0276	434.10	275.58	263	61.11	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3253.7	C08		9	0133-0277	320.08	277.26	241	59.36	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1603.5	C08		9	0134-0281	232.65	281.28	261	61.11	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1918.0	C08		9	0135-0284	345.92	284.36	258	59.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			324.1	C08		9	0136-0289	67.16	289.77	297	68.18	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2849.7	C08		9	0137-0288	931.47	288.01	293	65.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2279.6	C08		9	0138-0291	169.84	291.45	302	65.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6228.7	C08		9	0139-0293	132.68	292.15	267	64.53	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			332.1	C08		9	0140-0292	731.38	291.66	311	69.60	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1653.4	C08		9	0141-0299	107.70	299.35	444	81.84	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			747.5	C08		9	0142-0298	434.80	298.10	239	56.53	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2097.7	C08		9	0143-0303	239.39	302.15	539	92.91	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			429.8	C08		9	0144-0300	377.66	300.14	294	64.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2394.2	C08		9	0145-0302	549.83	302.46	337	66.77	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			303.3	C08		9	0146-0301	764.47	301.35	306	65.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			329.0	C08		9	0147-0309	392.37	309.45	358	77.36	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3083.5	C08		9	0148-0309	347.42	309.38	218	60.28	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			484.7	C08		9	0149-0310	896.98	310.50	288	62.18	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			6026.6	C08		9	0150-0311	577.44	310.83	300	63.36	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3202.0	C08		9	0151-0312	216.08	312.50	255	60.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			489.5	C08		9	0152-0314	494.42	314.03	302	69.26	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2802.1	C08		9	0153-0316	284.47	316.16	255	61.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3795.4	C08		9	0154-0318	168.21	318.26	221	53.94	0.954
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			391.8	C08		9	0155-0317	772.86	317.30	215	55.11	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			558.5	C08		9	0156-0326	316.42	327.16	303	68.43	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			566.8	C08		9	0157-0329	100.11	329.05	280	63.01	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1299.9	C08		9	0158-0328	399.84	329.06	255	61.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			814.8	C08		9	0159-0331	473.65	331.97	309	69.94	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			356.5	C08		9	0160-0335	827.11	334.40	269	65.01	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1246.9	C08		9	0161-0334	653.21	334.08	294	63.94	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3843.9	C08		9	0162-0337	158.65	337.24	315	66.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			592.9	C08		9	0163-0339	906.65	338.05	301	66.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1046.3	C08		9	0164-0341	280.12	341.05	159	46.87	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1311.9	C08		9	0165-0346	405.37	345.82	260	64.53	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			718.9	C08		9	0166-0346	501.49	346.23	253	57.94	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2174.7	C08		9	0167-0349	610.54	349.77	277	61.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			608.3	C08		9	0168-0351	141.79	350.62	239	59.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1871.8	C08		9	0169-0351	658.83	350.93	212	54.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			856.8	C08		9	0170-0350	285.21	350.41	164	53.70	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			600.6	C08		9	0171-0356	820.54	356.82	457	79.50	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			752.2	C08		9	0172-0356	448.40	356.50	293	63.26	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			572.8	C08		9	0173-0355	476.70	354.62	261	60.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			432.2	C08		9	0174-0357	577.40	356.95	299	68.77	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2219.8	C08		9	0175-0358	238.80	359.38	238	58.18	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			760.6	C08		9	0176-0357	419.39	357.22	250	59.70	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1026.0	C08		9	0177-0361	555.88	361.12	311	71.01	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			729.7	C08		9	0178-0361	65.88	360.72	247	58.18	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			265.7	C08		9	0179-0361	19.97	360.70	264	61.11	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			517.0	C08		9	0180-0361	132.83	362.58	260	61.84	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			210.7	C08		9	0181-0364	345.75	364.55	320	67.84	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			7630.2	C08		9	0182-0362	689.31	362.03	220	55.11	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1946.3	C08		9	0183-0365	192.24	365.31	356	69.60	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2249.9	C08		9	0184-0369	298.99	368.75	288	61.36	0.961
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			468.6	C08		9	0185-0376	361.42	376.48	319	71.11	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1847.2	C08		9	0186-0374	649.12	373.54	234	59.11	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1094.7	C08		9	0187-0380	597.95	380.23	274	64.18	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1223.2	C08		9	0188-0380	707.53	380.45	241	58.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4231.7	C08		9	0189-0381	678.68	381.16	240	57.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2010.9	C08		9	0190-0381	225.76	381.28	250	57.94	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2666.7	C08		9	0191-0383	756.09	383.91	241	59.94	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			629.9	C08		9	0192-0391	779.07	391.01	340	72.67	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			488.0	C08		9	0193-0390	799.10	391.04	245	59.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			918.4	C08		9	0194-0392	89.33	392.36	270	62.18	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			313.3	C08		9	0195-0391	43.24	392.06	257	60.53	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1422.1	C08		9	0196-0395	609.25	395.53	320	67.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1319.4	C08		9	0197-0393	699.56	393.71	208	55.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			612.6	C08		9	0198-0400	15.94	400.42	270	60.18	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			873.6	C08		9	0199-0400	309.65	400.91	265	59.36	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			524.4	C08		9	0200-0400	833.98	400.08	295	62.53	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			353.5	C08		9	0201-0407	902.30	406.64	274	62.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			449.1	C08		9	0202-0412	521.72	412.19	305	67.94	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			656.0	C08		9	0203-0408	697.46	408.03	236	57.11	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1078.1	C08		9	0204-0421	330.18	420.87	469	82.57	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			537.6	C08		9	0205-0416	730.08	415.55	217	55.36	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			613.7	C08		9	0206-0421	857.42	421.28	284	64.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1100.6	C08		9	0207-0424	657.84	423.98	250	59.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1377.9	C08		9	0208-0430	96.02	429.79	282	62.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2058.8	C08		9	0209-0430	53.43	430.31	184	59.36	0.656
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			631.0	C08		9	0210-0429	272.80	429.35	252	63.70	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1206.0	C08		9	0211-0436	937.67	435.69	355	72.18	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1313.7	C08		9	0212-0434	404.28	434.71	268	60.53	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5215.6	C08		9	0213-0434	221.85	434.00	235	56.53	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1462.3	C08		9	0214-0437	835.72	437.04	437	77.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			323.1	C08		9	0215-0433	741.32	433.53	271	64.28	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			483.1	C08		9	0216-0441	183.31	440.67	278	63.36	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2717.8	C08		9	0217-0445	118.89	445.84	253	59.94	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			394.6	C08		9	0218-0445	276.34	444.55	334	71.01	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4788.2	C08		9	0219-0446	568.93	446.43	359	69.60	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1040.5	C08		9	0220-0450	509.86	450.39	295	67.26	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			965.9	C08		9	0221-0451	20.54	450.78	221	57.11	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			676.4	C08		9	0222-0451	92.12	451.47	252	58.53	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			443.4	C08		9	0223-0455	199.91	454.64	259	58.87	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			454.9	C08		9	0224-0457	140.99	457.34	266	61.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			266.5	C08		9	0225-0458	292.70	459.22	301	65.50	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1303.6	C08		9	0226-0464	16.19	464.87	249	61.70	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3856.2	C08		9	0227-0466	246.15	466.00	365	69.84	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1686.5	C08		9	0228-0465	774.80	465.10	224	57.11	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			896.1	C08		9	0229-0473	845.32	474.29	456	80.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			421.4	C08		9	0230-0473	943.11	472.67	290	64.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			444.9	C08		9	0231-0474	586.90	473.65	236	56.77	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			485.1	C08		9	0232-0477	117.41	476.98	231	56.53	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			922.6	C08		9	0233-0479	533.86	479.51	256	61.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2347.8	C08		9	0234-0477	780.99	477.30	204	56.87	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3539.8	C08		9	0235-0486	732.95	485.44	478	90.33	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			828.7	C08		9	0236-0484	35.89	484.22	231	57.36	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1044.4	C08		9	0237-0489	799.12	490.26	263	62.53	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1816.9	C08		9	0238-0492	865.20	491.40	373	74.08	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5557.9	C08		9	0239-0491	170.18	491.71	244	57.70	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			467.9	C08		9	0240-0494	360.13	494.65	280	61.11	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			814.9	C08		9	0241-0496	397.72	496.43	237	57.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2445.2	C08		9	0242-0497	709.02	498.02	186	53.36	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			570.4	C08		9	0243-0501	889.82	500.72	276	63.01	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2306.9	C08		9	0244-0501	745.35	500.87	258	59.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2206.5	C08		9	0245-0509	25.61	509.50	411	76.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			344.8	C08		9	0246-0506	187.12	506.63	263	64.18	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1207.1	C08		9	0247-0508	630.19	507.52	302	65.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			885.2	C08		9	0248-0509	793.51	508.92	295	66.53	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1298.3	C08		9	0249-0513	765.22	513.46	253	60.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1374.7	C08		9	0250-0515	427.69	515.11	257	60.53	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			342.2	C08		9	0251-0520	600.81	520.37	291	64.43	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			394.5	C08		9	0252-0521	190.24	520.79	236	61.94	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			424.0	C08		9	0253-0526	312.34	526.57	272	63.26	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1541.2	C08		9	0254-0523	382.37	523.68	259	60.87	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			494.5	C08		9	0255-0532	900.91	532.53	282	61.60	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			367.0	C08		9	0256-0534	743.07	534.31	283	63.60	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			862.8	C08		9	0257-0536	72.15	535.68	229	58.18	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3775.0	C08		9	0258-0536	345.34	536.25	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1008.7	C08		9	0259-0541	115.02	540.89	231	57.11	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1141.6	C08		9	0260-0541	388.16	540.96	250	62.04	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			492.0	C08		9	0261-0544	146.31	544.72	261	59.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5330.0	C08		9	0262-0550	208.62	549.77	372	71.01	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			524.9	C08		9	0263-0549	530.58	548.82	256	59.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1871.7	C08		9	0264-0552	65.45	553.53	305	69.74	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3032.7	C08		9	0265-0551	462.86	551.05	255	61.36	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2599.6	C08		9	0266-0558	187.19	558.95	291	65.11	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3375.0	C08		9	0267-0560	131.96	560.28	266	60.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1031.5	C08		9	0268-0560	300.81	559.95	236	57.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			517.7	C08		9	0269-0562	939.43	562.66	339	69.60	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1517.8	C08		9	0270-0563	49.26	563.13	288	64.18	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2737.1	C08		9	0271-0564	85.36	565.00	271	66.43	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1760.7	C08		9	0272-0566	339.62	565.46	310	65.36	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			810.7	C08		9	0273-0569	464.96	569.44	300	63.36	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			367.0	C08		9	0274-0575	736.81	575.78	288	64.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			249.8	C08		9	0275-0577	412.79	577.08	301	67.36	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			446.3	C08		9	0276-0584	694.25	583.79	271	64.53	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1280.5	C08		9	0277-0583	193.20	583.45	294	65.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2505.4	C08		9	0278-0588	385.14	587.73	347	73.36	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			245.7	C08		9	0279-0589	72.04	589.28	271	63.70	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			791.1	C08		9	0280-0593	212.91	593.17	300	64.53	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			998.9	C08		9	0281-0595	369.24	595.55	270	63.94	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1612.6	C08		9	0282-0597	146.27	597.00	301	64.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			366.0	C08		9	0283-0600	756.21	600.54	250	60.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			622.3	C08		9	0284-0609	524.75	609.24	263	60.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			430.9	C08		9	0285-0616	38.28	615.69	283	63.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			301.9	C08		9	0286-0619	933.03	619.84	281	62.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			902.6	C08		9	0287-0622	196.88	622.44	282	62.87	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			369.0	C08		9	0288-0623	881.73	623.66	287	62.77	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1049.8	C08		9	0289-0627	467.98	627.32	335	68.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			841.7	C08		9	0290-0632	89.86	632.14	284	64.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			554.0	C08		9	0291-0637	150.45	637.26	292	63.36	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			652.8	C08		9	0292-0649	202.97	648.00	683	104.33	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			864.1	C08		9	0293-0648	124.90	648.49	260	61.36	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			602.5	C08		9	0294-0651	511.67	651.43	319	67.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			856.7	C08		9	0295-0651	69.79	650.22	248	61.36	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			359.2	C08		9	0296-0650	744.16	649.99	267	60.53	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1548.6	C08		9	0297-0650	263.16	650.76	250	60.53	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			202.6	C08		9	0298-0659	19.67	658.90	268	63.60	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			398.3	C08		9	0299-0665	66.46	665.98	267	64.77	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1535.3	C08		9	0300-0668	184.98	667.40	248	60.77	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1504.0	C08		9	0301-0666	264.82	665.46	286	72.77	0.679
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			634.0	C08		9	0302-0671	207.75	671.46	339	71.94	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2920.4	C08		9	0303-0668	387.01	668.37	303	66.43	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			335.3	C08		9	0304-0669	475.83	669.81	291	64.77	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			298.8	C08		9	0305-0673	781.40	673.09	311	67.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			914.8	C08		9	0306-0675	172.35	675.41	223	57.70	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1506.8	C08		9	0307-0677	111.57	677.69	283	61.36	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			388.3	C08		9	0308-0683	936.29	683.92	458	86.43	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1961.2	C08		9	0309-0678	251.31	678.44	264	60.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			971.5	C08		9	0310-0684	140.58	684.18	241	63.11	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			658.8	C08		9	0311-0690	321.34	691.53	581	89.74	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			860.6	C08		9	0312-0689	360.96	689.61	257	60.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1455.0	C08		9	0313-0693	31.45	693.71	260	61.70	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1939.9	C08		9	0314-0695	888.76	694.75	257	61.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			717.5	C08		9	0315-0695	57.33	695.07	272	64.18	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1321.5	C08		9	0316-0699	199.59	698.64	226	56.67	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			295.1	C08		9	0317-0702	750.25	702.11	297	63.60	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			232.4	C08		9	0318-0703	950.13	704.06	183	53.70	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			213.3	C08		9	0319-0704	937.61	703.39	120	41.56	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1687.7	C08		9	0320-0707	214.24	708.02	262	62.18	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			541.6	D08		1	0001-0031	502.05	32.10	433	78.91	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			185.9	D08		1	0002-0035	683.37	35.30	402	74.43	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			176.4	D08		1	0003-0039	168.05	39.26	489	82.67	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			674.5	D08		1	0004-0037	106.24	37.36	378	72.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			888.8	D08		1	0005-0049	326.88	48.58	751	107.30	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2502.1	D08		1	0006-0044	231.54	43.76	386	72.67	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			605.4	D08		1	0007-0053	916.42	53.65	703	101.50	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			388.9	D08		1	0008-0051	573.73	51.36	507	86.18	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			601.4	D08		1	0009-0051	450.99	50.66	464	82.91	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			340.3	D08		1	0010-0054	799.48	53.77	390	77.26	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			222.2	D08		1	0011-0059	633.85	59.36	412	77.50	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			233.6	D08		1	0012-0069	747.78	68.50	777	107.05	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			880.6	D08		1	0013-0069	470.40	69.42	494	89.26	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			581.0	D08		1	0014-0072	394.62	72.16	441	76.43	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			361.7	D08		1	0015-0074	600.83	74.82	443	84.08	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			843.6	D08		1	0016-0076	493.85	76.67	503	87.60	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			329.1	D08		1	0017-0075	232.83	75.37	381	73.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			543.7	D08		1	0018-0075	574.54	74.86	434	79.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			348.6	D08		1	0019-0079	724.21	79.27	424	78.08	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			269.5	D08		1	0020-0082	109.11	82.07	363	71.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1027.1	D08		1	0021-0086	26.13	85.99	531	87.50	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			668.9	D08		1	0022-0086	935.26	86.56	381	73.50	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			406.6	D08		1	0023-0096	306.50	96.09	417	79.36	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			323.0	D08		1	0024-0106	533.49	106.01	807	108.23	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			376.3	D08		1	0025-0101	285.13	101.97	407	79.01	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			252.5	D08		1	0026-0103	635.68	103.29	852	117.54	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			334.8	D08		1	0027-0105	186.52	104.86	373	75.26	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			192.1	D08		1	0028-0108	789.69	108.23	359	73.60	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			570.6	D08		1	0029-0112	834.07	111.51	371	73.01	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			399.0	D08		1	0030-0113	391.56	113.78	401	74.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			443.0	D08		1	0031-0115	699.70	115.21	399	75.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			338.7	D08		1	0032-0123	159.83	123.97	830	116.37	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2317.3	D08		1	0033-0117	446.57	117.74	434	79.50	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			295.5	D08		1	0034-0120	612.49	120.72	422	79.15	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			311.6	D08		1	0035-0121	926.26	121.01	392	72.18	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			645.8	D08		1	0036-0123	73.44	123.49	376	71.01	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1121.4	D08		1	0037-0126	735.15	126.18	452	81.26	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			4031.8	D08		1	0038-0134	420.57	133.51	950	125.88	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			210.9	D08		1	0039-0128	783.39	127.59	449	85.26	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			757.8	D08		1	0040-0144	506.95	143.84	677	95.50	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			423.7	D08		1	0041-0143	905.12	143.51	392	73.60	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			206.3	D08		1	0042-0142	824.88	142.30	383	75.26	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			318.8	D08		1	0043-0146	297.25	145.43	396	74.08	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			215.3	D08		1	0044-0158	642.35	158.75	393	74.67	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			219.2	D08		1	0045-0159	714.83	158.98	388	76.67	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			344.4	D08		1	0046-0164	277.35	164.21	729	105.05	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			358.8	D08		1	0047-0160	227.30	159.90	390	76.08	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			347.7	D08		1	0048-0166	117.67	165.95	373	72.67	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			309.5	D08		1	0049-0166	578.16	166.33	390	74.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			413.8	D08		1	0050-0180	678.45	180.31	399	78.33	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			322.8	D08		1	0051-0179	809.52	179.24	398	73.84	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			272.0	D08		1	0052-0180	338.38	179.91	418	81.01	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1069.7	D08		1	0053-0181	167.78	181.14	400	75.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			299.8	D08		1	0054-0182	444.35	182.31	382	73.84	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			324.6	D08		1	0055-0187	316.80	187.46	409	78.77	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			320.0	D08		1	0056-0187	207.94	187.03	397	77.50	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			402.2	D08		1	0057-0194	513.29	194.35	400	73.26	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			289.3	D08		1	0058-0197	940.92	197.02	399	76.43	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			634.5	D08		1	0059-0199	37.04	199.58	382	73.84	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			307.4	D08		1	0060-0209	253.78	208.26	925	123.78	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			291.0	D08		1	0061-0198	887.77	198.92	427	75.84	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			613.0	D08		1	0062-0199	798.35	199.86	390	73.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			259.5	D08		1	0063-0201	719.56	201.34	398	76.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			659.6	D08		1	0064-0206	71.18	205.95	602	90.91	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			267.7	D08		1	0065-0204	764.36	204.33	390	73.26	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2480.6	D08		1	0066-0207	562.41	208.31	379	75.94	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			270.4	D08		1	0067-0213	135.78	212.78	380	75.50	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			428.3	D08		1	0068-0221	927.57	220.99	385	72.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2162.6	D08		1	0069-0227	202.54	226.91	603	97.98	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			345.0	D08		1	0070-0224	615.97	224.41	409	76.67	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1821.7	D08		1	0071-0224	851.76	224.07	404	75.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			305.6	D08		1	0072-0232	271.35	234.30	725	103.78	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			448.6	D08		1	0073-0227	357.51	227.54	399	78.33	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			255.3	D08		1	0074-0229	482.77	228.83	357	74.18	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3019.5	D08		1	0075-0229	563.89	228.90	504	88.77	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1653.3	D08		1	0076-0238	890.09	239.12	727	104.13	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			409.7	D08		1	0077-0237	506.66	236.92	730	101.50	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1305.6	D08		1	0078-0240	540.09	240.67	552	94.91	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1522.0	D08		1	0079-0236	136.86	236.60	377	74.18	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1114.3	D08		1	0080-0242	58.13	242.18	440	77.84	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1116.2	D08		1	0081-0256	20.39	256.84	381	76.08	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			357.4	D08		1	0082-0258	459.44	258.25	392	73.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			322.1	D08		1	0083-0259	112.01	259.70	374	75.26	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			606.0	D08		1	0084-0271	746.54	271.87	414	75.60	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			611.0	D08		1	0085-0273	854.96	273.67	395	74.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			489.4	D08		1	0086-0279	180.41	278.30	384	73.01	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			366.4	D08		1	0087-0280	697.87	280.13	419	78.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			680.2	D08		1	0088-0281	315.70	280.31	405	76.67	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			905.9	D08		1	0089-0282	813.95	282.55	410	77.26	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			231.7	D08		1	0090-0287	936.07	287.70	382	73.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2190.5	D08		1	0091-0289	296.01	290.63	412	80.67	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			487.5	D08		1	0092-0294	641.46	293.41	420	77.26	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1980.3	D08		1	0093-0299	840.45	299.21	344	68.18	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			357.2	D08		1	0094-0300	899.82	300.36	385	72.43	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			347.3	D08		1	0095-0304	436.31	304.50	925	116.23	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1542.4	D08		1	0096-0303	219.20	302.97	382	71.60	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			360.2	D08		1	0097-0306	109.51	306.11	396	77.26	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1646.7	D08		1	0098-0310	175.48	310.67	613	96.81	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			333.5	D08		1	0099-0305	37.12	304.96	376	74.08	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1159.9	D08		1	0100-0309	549.31	309.07	383	71.60	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			616.7	D08		1	0101-0319	681.97	319.46	401	75.01	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			583.7	D08		1	0102-0319	393.65	319.13	386	73.84	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			260.6	D08		1	0103-0327	934.12	327.39	370	71.26	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			903.2	D08		1	0104-0333	774.77	333.03	392	73.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			785.2	D08		1	0105-0333	582.47	333.28	913	135.05	0.629
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			635.0	D08		1	0106-0336	729.96	335.83	392	73.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			260.5	D08		1	0107-0340	823.92	339.51	324	70.33	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			276.9	D08		1	0108-0344	144.33	344.39	395	74.08	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			295.1	D08		1	0109-0345	180.49	344.57	405	77.50	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			884.7	D08		1	0110-0347	37.82	347.41	374	73.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			469.2	D08		1	0111-0354	298.60	353.98	743	108.13	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			980.8	D08		1	0112-0351	352.83	351.52	398	74.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			543.3	D08		1	0113-0354	106.35	354.35	382	73.84	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			254.4	D08		1	0114-0357	622.14	357.04	652	97.98	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			491.7	D08		1	0115-0365	201.37	366.55	896	121.98	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			463.4	D08		1	0116-0370	707.79	370.13	433	79.50	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			218.7	D08		1	0117-0373	644.17	373.30	598	93.74	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1029.1	D08		1	0118-0373	567.86	374.36	591	92.18	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1956.4	D08		1	0119-0382	920.26	382.67	916	122.23	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			349.9	D08		1	0120-0375	771.27	375.83	427	77.50	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			762.5	D08		1	0121-0381	879.09	380.59	377	71.84	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			680.6	D08		1	0122-0383	134.35	382.33	377	72.91	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			352.0	D08		1	0123-0388	404.24	388.60	396	75.26	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			578.2	D08		1	0124-0397	151.05	397.56	433	81.15	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1028.3	D08		1	0125-0400	578.04	398.64	909	124.47	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			279.0	D08		1	0126-0397	686.35	397.94	414	75.84	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			404.3	D08		1	0127-0402	757.16	401.49	427	78.67	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			269.5	D08		1	0128-0407	603.82	407.99	414	77.74	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			262.1	D08		1	0129-0416	320.94	415.48	832	111.64	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			301.2	D08		1	0130-0412	201.41	411.91	398	75.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1067.4	D08		1	0131-0412	876.19	412.31	396	74.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			287.7	D08		1	0132-0420	769.40	420.86	452	86.91	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			334.4	D08		1	0133-0428	492.31	428.55	399	75.84	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			228.0	D08		1	0134-0433	432.61	433.37	389	73.84	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			721.8	D08		1	0135-0433	655.07	433.40	396	74.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			375.0	D08		1	0136-0446	370.45	445.64	871	123.88	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			274.5	D08		1	0137-0443	99.12	443.74	373	70.43	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			416.6	D08		1	0138-0446	931.58	445.38	330	72.77	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			236.8	D08		1	0139-0446	464.85	446.15	392	73.26	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			441.4	D08		1	0140-0449	914.46	449.53	412	80.18	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			268.0	D08		1	0141-0450	293.65	450.79	391	75.50	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			365.9	D08		1	0142-0453	562.54	453.36	701	99.64	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			356.8	D08		1	0143-0449	715.45	448.99	390	76.08	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1984.4	D08		1	0144-0454	142.77	454.03	401	77.50	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			355.1	D08		1	0145-0455	946.44	455.06	407	78.08	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			422.5	D08		1	0146-0465	186.09	465.22	378	73.50	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			424.9	D08		1	0147-0473	48.87	472.73	757	108.81	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			236.5	D08		1	0148-0468	763.11	467.65	373	73.26	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			602.3	D08		1	0149-0479	695.70	479.85	998	122.81	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			271.2	D08		1	0150-0476	640.27	476.07	384	73.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			223.8	D08		1	0151-0480	336.26	480.21	402	76.77	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			352.8	D08		1	0152-0483	393.22	482.93	564	89.98	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			391.2	D08		1	0153-0480	849.69	480.79	391	74.77	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			370.0	D08		1	0154-0484	443.37	484.11	426	77.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			319.7	D08		1	0155-0484	213.28	483.94	379	71.60	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			535.2	D08		1	0156-0487	770.70	487.97	410	79.15	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			274.5	D08		1	0157-0490	533.71	490.14	403	78.08	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			269.9	D08		1	0158-0489	573.51	488.99	384	74.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			318.7	D08		1	0159-0488	313.19	488.37	428	79.60	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			310.0	D08		1	0160-0497	87.71	497.66	366	71.84	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			436.5	D08		1	0161-0499	866.23	499.79	410	78.08	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			301.9	D08		1	0162-0499	922.02	498.94	359	69.60	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			207.1	D08		1	0163-0506	45.32	507.06	382	78.91	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			365.6	D08		1	0164-0508	817.58	507.77	374	72.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			192.3	D08		1	0165-0509	17.93	509.60	362	72.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1251.3	D08		1	0166-0510	188.53	509.87	383	71.84	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			832.0	D08		1	0167-0512	606.62	511.74	393	76.08	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			339.3	D08		1	0168-0513	745.60	513.60	376	73.01	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			601.8	D08		1	0169-0513	487.28	512.82	395	76.08	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			158.6	D08		1	0170-0517	895.51	516.63	393	75.50	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			237.6	D08		1	0171-0521	326.02	521.07	373	71.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			343.2	D08		1	0172-0523	118.03	523.23	386	72.18	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			538.6	D08		1	0173-0525	289.17	524.87	410	76.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			183.1	D08		1	0174-0525	420.66	525.54	395	76.08	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			279.4	D08		1	0175-0528	648.78	528.16	396	74.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			463.2	D08		1	0176-0530	163.13	530.49	391	74.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			858.4	D08		1	0177-0530	771.34	530.25	390	73.01	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			433.4	D08		1	0178-0533	199.57	533.05	381	73.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			228.9	D08		1	0179-0540	385.59	540.73	417	78.91	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			250.4	D08		1	0180-0539	543.36	539.82	398	75.84	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			254.8	D08		1	0181-0547	897.72	547.42	433	85.40	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			222.9	D08		1	0182-0544	40.20	544.43	338	70.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			607.2	D08		1	0183-0548	473.27	547.35	620	101.40	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			769.3	D08		1	0184-0562	275.66	562.66	620	92.91	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			382.6	D08		1	0185-0571	557.83	571.47	817	113.78	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			648.0	D08		1	0186-0565	658.42	565.82	393	73.84	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			481.8	D08		1	0187-0570	94.36	570.37	340	68.18	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			384.5	D08		1	0188-0570	756.96	569.72	404	76.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			269.9	D08		1	0189-0573	890.54	574.05	415	78.43	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			337.8	D08		1	0190-0575	718.87	575.35	418	79.15	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			317.9	D08		1	0191-0584	443.06	584.72	994	128.02	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			310.6	D08		1	0192-0581	202.82	581.40	407	77.84	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			235.9	D08		1	0193-0584	360.11	584.44	373	73.26	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			342.9	D08		1	0194-0585	610.58	584.79	382	73.26	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			269.3	D08		1	0195-0583	861.48	583.27	393	78.33	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			326.5	D08		1	0196-0591	809.80	591.24	406	78.91	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			345.5	D08		1	0197-0602	194.05	601.73	235	60.77	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			373.9	D08		1	0198-0606	401.04	605.93	421	77.26	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			336.2	D08		1	0199-0607	249.23	606.40	392	78.67	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			340.8	D08		1	0200-0607	715.39	607.94	388	76.67	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			265.8	D08		1	0201-0609	886.12	609.68	379	75.84	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			289.5	D08		1	0202-0613	662.08	613.08	400	74.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			458.0	D08		1	0203-0613	81.87	613.13	432	82.81	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			409.3	D08		1	0204-0619	359.78	619.40	408	77.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			227.6	D08		1	0205-0623	500.22	622.62	416	77.50	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			432.3	D08		1	0206-0632	54.26	631.53	380	72.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			205.4	D08		1	0207-0634	156.18	634.61	438	77.84	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			895.9	D08		1	0208-0632	314.53	632.31	371	75.60	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			811.9	D08		1	0209-0635	337.73	634.71	468	90.18	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			265.1	D08		1	0210-0639	845.81	638.80	759	104.33	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			402.7	D08		1	0211-0637	182.83	636.98	452	85.40	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			268.7	D08		1	0212-0638	479.84	638.61	466	84.91	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			501.4	D08		1	0213-0643	360.80	643.00	528	91.84	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			316.0	D08		1	0214-0643	403.72	643.53	391	72.43	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			327.8	D08		1	0215-0644	797.68	644.62	380	74.43	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			624.4	D08		1	0216-0648	23.17	647.57	369	76.18	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			265.1	D08		1	0217-0653	447.13	653.51	845	118.02	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			191.0	D08		1	0218-0650	266.50	650.23	286	67.60	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			945.9	D08		1	0219-0650	606.93	650.53	444	79.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			192.5	D08		1	0220-0654	76.29	654.09	364	70.43	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			317.9	D08		1	0221-0657	213.13	657.27	388	76.08	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			661.0	D08		1	0222-0660	914.73	660.25	368	72.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			576.3	D08		1	0223-0665	714.94	664.98	405	77.01	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			481.3	D08		1	0224-0666	743.38	666.07	459	82.91	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			461.7	D08		1	0225-0666	648.30	666.58	374	70.43	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2225.2	D08		1	0226-0675	326.89	674.93	673	97.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			394.9	D08		1	0227-0680	772.33	679.99	356	70.43	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			399.4	D08		1	0228-0688	812.57	689.08	726	108.43	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			214.9	D08		1	0229-0686	489.12	685.84	367	75.74	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			829.6	D08		1	0230-0687	143.02	687.83	440	78.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			169.4	D08		1	0231-0690	871.85	690.33	358	72.43	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			577.1	D08		1	0232-0690	191.96	690.27	398	77.50	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			290.1	D08		1	0233-0696	352.59	695.18	460	83.50	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			642.7	D08		1	0234-0700	530.30	700.74	818	111.88	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			242.6	D08		1	0235-0700	579.33	700.33	362	73.50	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			241.5	D08		1	0236-0705	67.56	705.01	383	74.08	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			656.3	D08		3	0001-0032	610.87	32.70	388	77.15	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			325.7	D08		3	0002-0038	761.28	37.99	356	70.43	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			714.3	D08		3	0003-0042	860.23	42.15	366	72.18	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			190.5	D08		3	0004-0041	227.10	41.65	345	72.67	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			628.3	D08		3	0005-0043	410.65	43.52	431	78.67	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			665.0	D08		3	0006-0044	45.88	44.22	373	79.60	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			361.3	D08		3	0007-0047	258.54	47.53	359	75.98	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			489.6	D08		3	0008-0045	550.76	44.87	362	72.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			358.3	D08		3	0009-0049	839.59	49.01	381	77.50	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			737.7	D08		3	0010-0051	694.22	51.36	349	70.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			169.9	D08		3	0011-0053	23.37	52.47	350	73.01	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			228.3	D08		3	0012-0055	131.62	55.52	364	76.67	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1081.4	D08		3	0013-0058	54.92	58.96	377	80.43	0.732
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			428.8	D08		3	0014-0064	74.21	63.65	384	77.26	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1436.7	D08		3	0015-0063	927.38	63.53	352	71.26	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			322.8	D08		3	0016-0065	350.14	65.53	386	73.84	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2650.3	D08		3	0017-0069	250.38	69.79	363	77.26	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			328.0	D08		3	0018-0067	904.78	67.76	366	72.33	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			944.8	D08		3	0019-0072	180.20	72.28	368	75.74	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2889.2	D08		3	0020-0072	231.46	72.41	371	74.87	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			298.8	D08		3	0021-0073	787.16	73.24	361	74.08	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			940.3	D08		3	0022-0080	733.46	80.24	325	113.64	0.316
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			349.2	D08		3	0023-0086	89.85	85.99	341	71.84	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2561.6	D08		3	0024-0091	165.10	92.46	712	105.40	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			436.6	D08		3	0025-0088	659.30	87.84	389	77.50	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			366.5	D08		3	0026-0087	685.00	87.49	373	74.33	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1055.7	D08		3	0027-0089	473.46	89.44	376	74.91	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			452.7	D08		3	0028-0091	502.43	91.20	384	76.91	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			257.2	D08		3	0029-0090	753.67	90.95	380	74.08	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			479.0	D08		3	0030-0093	429.24	93.02	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			727.4	D08		3	0031-0093	230.83	92.37	369	72.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			309.0	D08		3	0032-0097	546.64	97.18	360	72.67	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			382.5	D08		3	0033-0098	833.39	98.43	356	70.18	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			476.0	D08		3	0034-0105	125.31	106.25	731	109.54	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			317.9	D08		3	0035-0102	376.54	102.10	373	73.84	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			791.1	D08		3	0036-0106	904.74	106.07	302	66.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			721.9	D08		3	0037-0110	488.71	110.65	412	86.57	0.691
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			391.7	D08		3	0038-0113	641.59	113.02	367	75.84	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			442.4	D08		3	0039-0114	312.85	115.19	368	72.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			242.4	D08		3	0040-0116	69.56	116.39	359	76.33	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			195.1	D08		3	0041-0123	31.77	123.36	329	69.01	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1091.5	D08		3	0042-0121	723.76	121.05	350	73.84	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			540.1	D08		3	0043-0132	913.74	132.69	582	92.81	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			312.3	D08		3	0044-0129	456.50	128.80	387	75.50	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			273.0	D08		3	0045-0131	273.44	130.78	321	67.94	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			368.2	D08		3	0046-0132	293.91	132.21	440	84.67	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			252.3	D08		3	0047-0136	627.21	136.50	365	74.33	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			316.7	D08		3	0048-0138	384.28	138.48	386	75.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			276.4	D08		3	0049-0139	491.76	139.37	370	75.26	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			338.3	D08		3	0050-0142	83.52	141.45	354	71.01	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			542.1	D08		3	0051-0142	173.87	142.35	347	72.08	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			351.3	D08		3	0052-0141	810.52	140.67	331	69.84	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1126.6	D08		3	0053-0148	544.92	147.95	411	76.91	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1611.6	D08		3	0054-0150	859.07	149.48	299	66.18	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			480.2	D08		3	0055-0153	243.01	153.61	398	76.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			377.3	D08		3	0056-0154	761.70	154.94	330	68.28	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			574.0	D08		3	0057-0158	219.30	157.52	385	77.50	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			422.8	D08		3	0058-0163	139.16	162.74	404	77.26	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			645.3	D08		3	0059-0165	43.97	164.94	345	69.84	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			606.3	D08		3	0060-0169	414.27	168.40	409	78.91	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			668.7	D08		3	0061-0166	592.25	165.95	388	77.50	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			955.2	D08		3	0062-0171	912.62	171.55	375	73.50	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			447.2	D08		3	0063-0179	646.07	177.21	720	110.61	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1561.0	D08		3	0064-0173	850.67	172.97	350	69.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			533.9	D08		3	0065-0181	434.16	179.91	762	118.51	0.682
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			417.2	D08		3	0066-0175	759.81	175.04	560	90.18	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			428.9	D08		3	0067-0178	879.52	178.93	356	73.01	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			406.8	D08		3	0068-0178	341.98	177.70	347	70.43	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			378.0	D08		3	0069-0196	97.38	195.27	747	118.95	0.663
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			306.8	D08		3	0070-0195	488.00	194.77	353	72.67	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2416.3	D08		3	0071-0195	523.35	194.58	307	65.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			254.6	D08		3	0072-0197	687.05	197.04	347	73.26	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1091.2	D08		3	0073-0198	557.78	198.27	394	76.18	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			307.5	D08		3	0074-0202	742.04	202.12	370	73.26	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			229.7	D08		3	0075-0205	147.56	205.28	333	70.43	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			221.3	D08		3	0076-0206	387.38	207.07	366	76.33	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			250.6	D08		3	0077-0207	296.40	206.55	341	72.91	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			198.7	D08		3	0078-0210	650.95	210.77	392	76.43	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			295.2	D08		3	0079-0213	252.24	212.90	344	70.67	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			318.2	D08		3	0080-0212	787.19	212.30	356	70.18	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			210.3	D08		3	0081-0215	82.89	215.35	335	72.43	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			286.4	D08		3	0082-0215	903.13	215.44	324	71.26	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			291.2	D08		3	0083-0214	361.40	214.09	349	74.57	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			392.3	D08		3	0084-0220	196.70	219.96	359	72.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			216.0	D08		3	0085-0221	607.95	221.25	364	73.36	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			717.0	D08		3	0086-0224	414.68	224.53	323	67.01	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			299.3	D08		3	0087-0234	477.37	234.22	752	114.95	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			370.0	D08		3	0088-0233	941.28	233.09	368	71.01	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			212.4	D08		3	0089-0234	649.87	234.42	381	79.50	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			276.2	D08		3	0090-0235	41.27	235.00	329	71.74	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1600.1	D08		3	0091-0238	109.05	238.19	359	74.91	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			180.7	D08		3	0092-0244	607.29	243.39	370	77.36	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			223.1	D08		3	0093-0246	299.57	245.76	362	86.81	0.604
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			428.9	D08		3	0094-0245	164.28	245.60	361	72.43	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			202.6	D08		3	0095-0246	673.03	245.73	328	69.70	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			428.5	D08		3	0096-0247	762.15	246.68	347	68.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			362.0	D08		3	0097-0248	868.88	248.01	373	73.26	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			195.4	D08		3	0098-0249	373.11	248.75	358	76.33	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			263.2	D08		3	0099-0249	552.28	249.29	371	75.74	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			342.0	D08		3	0100-0251	693.24	251.37	374	76.18	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			927.5	D08		3	0101-0252	811.85	252.49	441	81.84	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1979.7	D08		3	0102-0258	249.65	258.22	341	71.84	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			253.1	D08		3	0103-0259	944.24	258.82	301	67.60	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			456.2	D08		3	0104-0265	587.53	265.22	377	73.26	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			220.6	D08		3	0105-0267	341.59	266.56	373	74.67	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			278.6	D08		3	0106-0268	312.72	268.76	348	77.50	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			269.2	D08		3	0107-0267	24.76	267.70	326	69.84	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			403.4	D08		3	0108-0283	649.13	284.09	965	130.61	0.711
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			264.6	D08		3	0109-0273	627.87	274.18	281	66.28	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			420.0	D08		3	0110-0277	156.82	276.89	359	72.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			998.5	D08		3	0111-0276	609.90	276.26	304	65.11	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			268.1	D08		3	0112-0282	79.15	282.69	371	75.50	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3174.6	D08		3	0113-0280	897.30	280.57	260	86.23	0.439
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			319.4	D08		3	0114-0281	410.64	281.07	378	75.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			791.1	D08		3	0115-0283	207.48	282.75	296	63.60	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			241.4	D08		3	0116-0280	688.08	279.99	198	53.60	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			423.2	D08		3	0117-0285	118.58	285.09	470	87.50	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			311.3	D08		3	0118-0288	850.70	288.52	361	72.08	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1332.6	D08		3	0119-0290	251.86	290.01	326	69.26	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			273.3	D08		3	0120-0295	573.61	295.23	352	70.67	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			617.3	D08		3	0121-0308	528.74	309.81	752	114.71	0.718
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			175.0	D08		3	0122-0303	354.73	302.37	387	81.74	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			423.4	D08		3	0123-0314	395.21	313.95	362	76.57	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			351.0	D08		3	0124-0313	466.54	313.88	394	77.50	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			210.1	D08		3	0125-0313	915.48	313.75	355	73.84	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			215.3	D08		3	0126-0316	28.55	315.24	376	77.98	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2064.3	D08		3	0127-0317	283.02	317.11	315	65.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			267.5	D08		3	0128-0319	102.04	319.05	333	71.01	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			466.4	D08		3	0129-0328	423.72	328.52	377	75.50	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			239.5	D08		3	0130-0330	854.33	329.72	363	74.91	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1849.8	D08		3	0131-0330	592.86	329.42	402	81.84	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			772.4	D08		3	0132-0332	142.97	332.76	382	76.08	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2034.0	D08		3	0133-0336	321.90	335.75	386	81.98	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			522.9	D08		3	0134-0338	833.06	338.06	514	88.67	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			772.2	D08		3	0135-0338	236.53	338.87	364	74.91	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			206.4	D08		3	0136-0339	675.27	339.86	348	71.84	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			253.8	D08		3	0137-0341	539.42	341.78	376	73.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			385.0	D08		3	0138-0342	45.16	342.09	343	72.67	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			253.3	D08		3	0139-0341	360.98	341.59	365	71.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			384.6	D08		3	0140-0342	741.96	343.01	367	72.43	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			431.2	D08		3	0141-0343	814.07	343.20	311	71.01	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			528.7	D08		3	0142-0352	180.69	352.91	376	80.91	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			224.5	D08		3	0143-0351	911.96	351.27	378	74.91	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1738.5	D08		3	0144-0354	313.52	354.52	377	78.33	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			274.2	D08		3	0145-0355	79.89	355.22	324	72.57	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			453.4	D08		3	0146-0364	113.88	364.88	334	72.91	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			254.1	D08		3	0147-0368	472.96	368.59	712	106.57	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			442.7	D08		3	0148-0373	521.62	372.76	374	76.33	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			328.3	D08		3	0149-0376	665.34	376.52	366	74.91	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			180.0	D08		3	0150-0376	394.46	376.46	359	71.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			804.1	D08		3	0151-0374	711.16	374.31	395	76.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			604.8	D08		3	0152-0378	147.07	378.11	334	78.57	0.680
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			257.5	D08		3	0153-0378	329.62	377.69	360	78.33	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			502.1	D08		3	0154-0382	866.90	381.25	375	76.91	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			808.6	D08		3	0155-0381	32.21	381.87	321	68.43	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			505.9	D08		3	0156-0381	919.31	381.04	350	70.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			363.1	D08		3	0157-0384	258.75	383.93	340	71.26	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			198.7	D08		3	0158-0388	195.57	388.17	350	74.33	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2092.7	D08		3	0159-0387	732.51	386.63	311	66.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			374.9	D08		3	0160-0389	547.02	389.11	374	74.91	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			266.4	D08		3	0161-0395	231.76	395.64	345	74.91	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			280.5	D08		3	0162-0395	819.43	395.72	362	71.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1718.2	D08		3	0163-0396	119.41	396.33	326	69.26	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			383.3	D08		3	0164-0398	477.43	398.21	310	64.77	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			490.8	D08		3	0165-0399	751.44	398.79	398	77.74	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			415.1	D08		3	0166-0402	304.30	401.92	380	73.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			233.6	D08		3	0167-0410	371.75	410.15	720	105.88	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			411.6	D08		3	0168-0403	438.20	403.57	370	74.08	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			260.7	D08		3	0169-0421	593.76	420.87	363	78.91	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			225.1	D08		3	0170-0421	718.80	421.57	380	77.15	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			278.5	D08		3	0171-0423	774.90	423.59	361	75.84	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			131.9	D08		3	0172-0428	33.62	428.69	325	72.91	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			189.0	D08		3	0173-0431	269.61	431.74	353	76.91	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			872.3	D08		3	0174-0431	528.13	432.17	372	77.94	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			340.9	D08		3	0175-0436	693.67	436.44	627	99.64	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			298.3	D08		3	0176-0447	421.89	446.54	748	106.95	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			299.8	D08		3	0177-0440	641.30	440.64	368	74.57	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1192.7	D08		3	0178-0446	162.63	445.35	712	105.88	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			830.4	D08		3	0179-0443	218.47	442.01	246	66.18	0.706
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			683.0	D08		3	0180-0444	231.04	446.37	219	63.70	0.678
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			159.6	D08		3	0181-0448	196.51	448.67	338	72.43	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			355.4	D08		3	0182-0447	315.10	447.79	367	74.91	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			229.6	D08		3	0183-0452	248.41	451.51	349	71.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			475.0	D08		3	0184-0455	527.89	453.68	409	81.84	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			703.6	D08		3	0185-0461	105.25	461.70	375	81.15	0.716
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			205.8	D08		3	0186-0463	71.14	463.23	353	73.26	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			534.6	D08		3	0187-0465	761.22	465.32	369	71.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			338.4	D08		3	0188-0473	624.44	473.31	375	72.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			324.3	D08		3	0189-0476	471.95	476.54	334	72.91	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			278.1	D08		3	0190-0475	851.66	474.90	353	71.01	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1300.7	D08		3	0191-0476	125.82	475.90	352	77.98	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			285.6	D08		3	0192-0482	929.08	482.82	380	78.33	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			231.4	D08		3	0193-0481	238.90	481.00	375	78.57	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			317.3	D08		3	0194-0484	565.52	484.47	368	73.26	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			345.5	D08		3	0195-0488	798.10	488.09	378	76.43	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			385.8	D08		3	0196-0490	720.05	490.02	371	72.67	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			250.5	D08		3	0197-0495	687.56	495.55	364	71.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			362.0	D08		3	0198-0502	601.36	502.21	361	73.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			223.5	D08		3	0199-0504	491.17	503.98	359	76.08	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			304.5	D08		3	0200-0507	230.55	507.90	370	78.33	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			246.4	D08		3	0201-0504	441.48	503.77	353	71.26	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			433.4	D08		3	0202-0506	356.38	506.34	353	72.43	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1095.5	D08		3	0203-0506	76.00	505.92	340	70.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			245.4	D08		3	0204-0510	806.46	509.69	392	81.40	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			251.2	D08		3	0205-0523	274.92	522.77	728	119.78	0.638
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1397.2	D08		3	0206-0520	851.06	520.43	723	112.13	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			242.8	D08		3	0207-0523	183.08	523.49	582	96.81	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			500.2	D08		3	0208-0520	757.32	519.80	372	73.60	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			326.8	D08		3	0209-0522	314.99	522.71	377	72.67	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			255.5	D08		3	0210-0522	481.03	522.56	359	72.67	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			387.3	D08		3	0211-0527	637.44	527.40	373	76.33	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			363.3	D08		3	0212-0525	673.36	524.83	333	68.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			345.6	D08		3	0213-0538	359.97	537.89	341	72.91	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			201.2	D08		3	0214-0537	580.54	536.99	352	72.67	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			188.0	D08		3	0215-0541	941.09	541.53	352	74.57	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			225.1	D08		3	0216-0542	537.15	541.76	363	72.67	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			215.3	D08		3	0217-0557	213.58	557.20	748	119.92	0.654
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			248.1	D08		3	0218-0553	484.31	553.43	396	77.26	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			226.5	D08		3	0219-0554	506.06	554.20	357	72.53	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			624.3	D08		3	0220-0556	736.72	556.00	352	72.91	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			398.4	D08		3	0221-0560	682.76	559.13	385	76.67	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			683.9	D08		3	0222-0561	74.33	561.65	327	68.67	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			579.9	D08		3	0223-0565	910.29	565.48	745	106.57	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1989.9	D08		3	0224-0565	782.87	565.60	625	96.57	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			434.7	D08		3	0225-0567	301.69	568.06	352	79.74	0.696
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			252.6	D08		3	0226-0569	343.30	569.80	330	68.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			312.0	D08		3	0227-0571	427.05	571.92	349	71.84	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			637.3	D08		3	0228-0587	52.37	586.47	695	104.57	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			386.4	D08		3	0229-0589	257.48	589.00	357	73.60	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			281.3	D08		3	0230-0588	216.44	588.13	373	76.08	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			312.9	D08		3	0231-0588	675.96	588.21	372	74.08	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			309.2	D08		3	0232-0589	132.62	588.97	371	74.91	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2823.8	D08		3	0233-0596	504.56	596.61	816	112.13	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			391.0	D08		3	0234-0590	747.04	590.11	349	71.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			720.4	D08		3	0235-0598	541.23	597.72	647	103.40	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			265.2	D08		3	0236-0596	632.60	596.40	377	78.57	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			259.3	D08		3	0237-0603	585.14	603.71	378	75.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3153.4	D08		3	0238-0600	373.07	600.30	254	59.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			415.5	D08		3	0239-0603	923.84	602.96	310	66.43	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			771.5	D08		3	0240-0604	114.56	604.19	360	79.15	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1698.7	D08		3	0241-0621	767.20	622.36	953	139.78	0.613
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			251.9	D08		3	0242-0608	873.87	607.69	343	75.15	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			270.2	D08		3	0243-0619	887.26	619.02	411	81.15	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			233.9	D08		3	0244-0617	824.32	617.02	347	70.67	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			343.2	D08		3	0245-0621	358.11	621.50	605	95.40	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			252.5	D08		3	0246-0620	736.77	620.01	369	81.98	0.690
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2959.7	D08		3	0247-0619	389.04	619.47	348	72.08	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1206.2	D08		3	0248-0626	210.28	626.97	308	71.36	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			400.6	D08		3	0249-0631	692.35	631.02	357	79.98	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			691.6	D08		3	0250-0632	846.96	632.32	249	57.36	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			457.0	D08		3	0251-0636	620.94	636.44	368	73.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			703.7	D08		3	0252-0638	328.05	638.02	417	85.15	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			329.4	D08		3	0253-0642	35.07	642.13	314	71.01	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			237.3	D08		3	0254-0643	168.48	643.62	337	71.50	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			668.1	D08		3	0255-0645	212.27	643.20	363	77.60	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			235.8	D08		3	0256-0650	129.25	650.17	437	81.74	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3213.8	D08		3	0257-0649	798.87	649.68	206	73.50	0.479
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			381.4	D08		3	0258-0654	92.12	653.99	352	70.67	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			935.1	D08		3	0259-0653	558.56	653.05	375	73.84	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1368.9	D08		3	0260-0653	675.92	653.29	342	73.84	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			606.2	D08		3	0261-0659	342.21	659.10	369	83.98	0.657
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1217.2	D08		3	0262-0660	203.39	661.36	396	79.98	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			315.6	D08		3	0263-0663	904.83	662.51	330	69.26	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			254.9	D08		3	0264-0667	947.34	667.52	341	73.84	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1414.0	D08		3	0265-0669	683.59	669.86	372	78.43	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			543.0	D08		3	0266-0674	610.07	674.02	369	74.91	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			551.9	D08		3	0267-0672	488.26	672.92	362	72.67	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3963.4	D08		3	0268-0675	720.71	675.02	357	74.67	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			388.1	D08		3	0269-0685	89.67	685.35	313	65.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			232.0	D08		3	0270-0684	138.76	684.98	315	66.43	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1713.7	D08		3	0271-0688	179.16	688.67	338	71.50	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			240.6	D08		3	0272-0690	896.32	690.52	318	72.33	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			288.1	D08		3	0273-0700	25.13	699.98	615	97.40	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			317.3	D08		3	0274-0697	699.75	697.18	375	76.08	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1466.4	D08		3	0275-0693	363.48	693.79	196	72.77	0.465
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			190.7	D08		3	0276-0707	831.30	707.12	348	71.70	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			494.1	D08		4	0001-0039	733.93	39.86	628	95.74	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			283.2	D08		4	0002-0049	816.27	48.21	984	128.23	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			405.0	D08		4	0003-0047	340.50	45.67	547	92.47	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			201.3	D08		4	0004-0045	603.98	44.77	467	82.91	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			358.4	D08		4	0005-0048	902.79	48.58	451	79.50	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1019.4	D08		4	0006-0049	366.86	49.04	475	82.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			334.8	D08		4	0007-0053	759.08	52.52	483	88.67	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			829.8	D08		4	0008-0055	249.77	55.49	442	78.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			213.4	D08		4	0009-0056	945.82	56.49	406	75.26	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			547.4	D08		4	0010-0056	99.02	56.17	435	83.50	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			383.9	D08		4	0011-0061	322.34	62.53	456	81.98	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			620.5	D08		4	0012-0064	75.47	64.64	501	87.94	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			362.9	D08		4	0013-0066	620.14	67.05	499	85.98	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			661.2	D08		4	0014-0071	446.82	70.23	938	125.44	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			308.7	D08		4	0015-0073	669.51	73.09	432	76.43	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			260.7	D08		4	0016-0077	835.66	77.03	516	88.71	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			747.3	D08		4	0017-0077	744.64	78.29	438	80.43	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			277.5	D08		4	0018-0080	545.97	80.59	922	121.30	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			283.9	D08		4	0019-0086	80.39	85.76	433	82.08	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			476.1	D08		4	0020-0090	179.51	90.53	727	103.64	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			308.8	D08		4	0021-0096	849.52	96.88	428	81.15	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			724.2	D08		4	0022-0097	118.83	97.58	763	103.40	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			291.9	D08		4	0023-0100	519.10	99.71	481	85.74	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			440.6	D08		4	0024-0100	348.91	100.90	383	75.50	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			424.0	D08		4	0025-0102	889.05	102.48	431	77.26	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			343.9	D08		4	0026-0105	706.22	105.50	424	76.67	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			186.1	D08		4	0027-0114	78.30	115.10	429	85.26	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			911.1	D08		4	0028-0113	624.49	113.53	484	84.33	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			281.2	D08		4	0029-0115	801.67	114.62	416	77.50	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			666.8	D08		4	0030-0116	387.80	116.12	561	90.08	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			223.0	D08		4	0031-0123	266.03	123.08	434	78.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			315.3	D08		4	0032-0124	770.35	123.97	438	80.91	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			222.4	D08		4	0033-0124	676.92	124.50	422	76.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			277.2	D08		4	0034-0142	319.72	142.15	433	79.74	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			243.3	D08		4	0035-0148	217.28	148.11	423	76.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			249.6	D08		4	0036-0153	718.54	153.51	431	82.77	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			235.0	D08		4	0037-0159	843.33	158.44	853	112.71	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			301.9	D08		4	0038-0158	145.77	159.32	864	116.23	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			487.6	D08		4	0039-0168	270.56	168.62	924	119.88	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			695.5	D08		4	0040-0168	358.99	168.27	488	84.33	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			324.9	D08		4	0041-0166	664.94	166.66	434	79.50	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			703.3	D08		4	0042-0172	406.55	172.28	479	82.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			274.1	D08		4	0043-0173	716.05	172.21	435	79.11	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			439.1	D08		4	0044-0175	24.26	175.99	395	75.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			337.5	D08		4	0045-0180	572.58	180.40	513	88.91	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			294.9	D08		4	0046-0181	609.93	180.72	439	78.08	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			443.1	D08		4	0047-0184	543.08	183.36	499	87.40	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			205.6	D08		4	0048-0185	883.86	185.73	451	79.26	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			795.6	D08		4	0049-0195	792.79	195.10	446	78.91	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			587.4	D08		4	0050-0195	215.19	194.82	391	71.60	0.958
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1248.5	D08		4	0051-0196	183.93	196.02	391	72.18	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			716.1	D08		4	0052-0198	266.48	198.05	625	94.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			300.7	D08		4	0053-0197	858.04	196.41	430	79.50	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			255.1	D08		4	0054-0201	452.45	201.56	438	79.50	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			274.5	D08		4	0055-0201	145.36	200.44	437	79.26	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			347.5	D08		4	0056-0202	916.56	202.45	431	77.26	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			215.7	D08		4	0057-0213	537.22	213.14	511	91.40	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			206.3	D08		4	0058-0212	735.76	212.22	435	81.50	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			438.6	D08		4	0059-0225	336.76	224.68	832	114.81	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			494.5	D08		4	0060-0227	206.08	226.23	399	79.15	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			196.6	D08		4	0061-0226	418.21	226.03	428	79.50	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1669.9	D08		4	0062-0227	890.19	227.21	818	116.67	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			312.3	D08		4	0063-0245	648.73	245.57	889	123.05	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			256.0	D08		4	0064-0239	554.99	239.38	488	86.33	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			448.8	D08		4	0065-0248	196.20	249.17	476	90.81	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			516.5	D08		4	0066-0249	602.93	249.45	434	78.33	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			202.2	D08		4	0067-0255	723.00	255.13	440	78.67	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			205.1	D08		4	0068-0258	391.21	258.14	441	77.26	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			282.8	D08		4	0069-0263	692.44	264.22	439	79.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			269.6	D08		4	0070-0268	225.86	267.89	430	78.91	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			286.3	D08		4	0071-0267	259.01	267.57	426	79.50	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			565.8	D08		4	0072-0273	54.20	273.66	414	80.33	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			404.3	D08		4	0073-0275	426.18	274.91	483	83.50	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			290.1	D08		4	0074-0282	565.08	282.42	965	129.78	0.720
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			366.0	D08		4	0075-0274	917.38	275.01	446	79.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			547.1	D08		4	0076-0276	842.17	276.79	446	82.91	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			260.7	D08		4	0077-0286	325.72	285.68	477	84.91	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			266.9	D08		4	0078-0291	690.26	290.59	484	87.01	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			588.3	D08		4	0079-0289	163.66	288.76	423	75.26	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1464.6	D08		4	0080-0295	69.01	296.21	555	93.01	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			306.4	D08		4	0081-0298	631.28	298.98	823	111.30	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			748.1	D08		4	0082-0297	92.75	297.45	410	76.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1125.9	D08		4	0083-0298	486.50	297.74	444	79.50	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			178.3	D08		4	0084-0296	730.71	296.02	421	77.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			235.9	D08		4	0085-0309	336.67	309.13	741	102.91	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			451.7	D08		4	0086-0310	792.80	310.62	440	79.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			192.6	D08		4	0087-0314	583.95	314.44	503	91.84	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			283.0	D08		4	0088-0319	915.92	319.07	927	119.20	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			293.1	D08		4	0089-0323	526.57	322.61	442	78.08	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			172.3	D08		4	0090-0329	369.87	328.39	447	80.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			475.8	D08		4	0091-0333	741.86	333.44	431	77.26	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			256.5	D08		4	0092-0335	405.26	335.05	449	79.50	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			472.3	D08		4	0093-0338	442.23	337.84	665	97.64	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			640.8	D08		4	0094-0339	696.49	338.86	459	81.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			244.8	D08		4	0095-0341	573.65	341.09	457	84.91	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			563.8	D08		4	0096-0341	279.50	340.56	475	82.91	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			232.1	D08		4	0097-0345	217.15	344.72	442	78.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			302.3	D08		4	0098-0350	353.90	350.58	483	87.74	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			267.3	D08		4	0099-0350	829.44	351.06	433	78.33	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			323.0	D08		4	0100-0357	882.34	358.36	885	117.54	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			242.0	D08		4	0101-0353	512.95	353.82	454	80.08	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			279.7	D08		4	0102-0357	263.78	357.96	479	86.23	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			534.7	D08		4	0103-0361	645.71	361.63	519	88.67	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			751.1	D08		4	0104-0364	616.45	364.48	490	86.57	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			946.8	D08		4	0105-0365	788.10	365.64	480	81.84	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			178.3	D08		4	0106-0369	420.08	369.56	434	79.26	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1308.1	D08		4	0107-0378	935.44	378.34	450	80.67	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1277.0	D08		4	0108-0378	149.62	378.56	429	75.84	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			536.3	D08		4	0109-0384	640.88	384.35	489	87.60	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			344.3	D08		4	0110-0384	307.53	384.07	449	79.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			969.8	D08		4	0111-0390	83.47	390.26	414	78.33	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			556.8	D08		4	0112-0398	358.78	397.74	826	108.47	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			236.2	D08		4	0113-0398	798.87	397.96	445	84.33	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1510.1	D08		4	0114-0402	595.24	401.63	512	86.23	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			458.8	D08		4	0115-0405	654.01	406.06	567	92.57	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1030.4	D08		4	0116-0405	260.98	405.31	536	88.57	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			266.0	D08		4	0117-0411	535.96	411.71	918	120.23	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			323.2	D08		4	0118-0415	484.12	415.53	806	109.74	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1937.6	D08		4	0119-0415	210.19	414.84	911	116.23	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			514.6	D08		4	0120-0419	869.62	418.01	472	82.08	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			639.4	D08		4	0121-0420	459.39	420.85	457	85.01	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			207.7	D08		4	0122-0423	568.03	423.12	489	85.01	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			306.7	D08		4	0123-0427	783.26	427.75	947	124.47	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			367.5	D08		4	0124-0426	125.16	426.22	419	76.91	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			590.5	D08		4	0125-0431	755.86	431.24	422	80.77	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			307.6	D08		4	0126-0432	385.87	432.72	436	78.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			248.9	D08		4	0127-0435	285.51	435.86	415	75.01	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			426.5	D08		4	0128-0441	66.09	440.53	406	76.43	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			572.7	D08		4	0129-0448	28.71	448.46	574	88.67	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			274.2	D08		4	0130-0449	849.09	449.39	468	81.26	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			372.0	D08		4	0131-0449	896.40	449.15	435	81.15	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			783.8	D08		4	0132-0455	176.90	455.44	435	78.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			546.1	D08		4	0133-0461	630.96	461.45	461	83.74	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1408.2	D08		4	0134-0465	564.54	465.61	437	78.08	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			287.2	D08		4	0135-0465	763.23	465.37	464	82.43	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			265.3	D08		4	0136-0472	232.27	472.22	487	86.57	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			337.7	D08		4	0137-0470	509.73	470.31	422	79.36	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			402.3	D08		4	0138-0469	699.93	469.21	469	81.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			385.0	D08		4	0139-0472	734.89	472.71	504	85.15	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			537.8	D08		4	0140-0473	528.11	473.56	367	75.94	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			871.2	D08		4	0141-0478	96.54	477.90	456	84.08	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			241.8	D08		4	0142-0476	414.40	476.81	439	79.50	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			310.1	D08		4	0143-0484	252.34	484.70	460	84.57	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			284.4	D08		4	0144-0488	937.61	487.58	406	76.08	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			254.6	D08		4	0145-0487	820.13	486.87	287	65.84	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			732.3	D08		4	0146-0491	902.85	490.85	434	78.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			283.2	D08		4	0147-0493	703.55	492.97	483	86.43	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			494.4	D08		4	0148-0496	143.65	496.51	421	78.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			549.7	D08		4	0149-0501	304.77	501.57	431	77.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			244.4	D08		4	0150-0506	60.78	505.86	443	79.26	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			423.9	D08		4	0151-0510	915.79	510.77	476	84.33	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1401.7	D08		4	0152-0512	522.77	512.19	463	82.57	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			238.2	D08		4	0153-0518	459.30	518.98	448	80.08	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			303.5	D08		4	0154-0525	620.07	525.23	571	92.33	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			580.2	D08		4	0155-0527	836.57	527.33	282	64.18	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1785.2	D08		4	0156-0529	360.05	529.94	429	79.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			966.3	D08		4	0157-0536	213.40	535.85	972	125.30	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			590.6	D08		4	0158-0534	407.41	533.57	504	85.74	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			919.8	D08		4	0159-0535	579.10	535.16	529	91.40	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			973.9	D08		4	0160-0534	23.69	534.42	407	75.26	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			270.9	D08		4	0161-0535	718.74	534.88	466	81.26	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2120.5	D08		4	0162-0550	73.80	550.34	433	80.08	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			552.9	D08		4	0163-0551	781.30	551.45	459	79.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3475.9	D08		4	0164-0552	361.37	551.17	526	89.60	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			581.5	D08		4	0165-0554	444.12	555.08	426	78.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			297.3	D08		4	0166-0560	496.05	559.90	449	79.26	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			313.7	D08		4	0167-0561	717.51	561.75	514	86.33	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			492.9	D08		4	0168-0562	409.60	562.68	472	82.33	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			304.9	D08		4	0169-0567	933.70	566.31	553	96.13	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			191.3	D08		4	0170-0565	628.41	565.59	465	80.67	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			285.8	D08		4	0171-0568	32.00	567.88	411	75.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			610.6	D08		4	0172-0573	259.57	571.93	451	81.40	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			517.0	D08		4	0173-0574	546.75	574.82	461	81.26	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			558.7	D08		4	0174-0577	109.77	577.72	423	75.26	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			798.7	D08		4	0175-0581	316.05	581.14	554	88.08	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1035.9	D08		4	0176-0584	909.84	584.85	803	114.95	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			273.8	D08		4	0177-0579	803.61	578.83	480	81.50	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			275.1	D08		4	0178-0581	649.40	580.88	509	88.81	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			561.8	D08		4	0179-0590	244.16	591.10	457	84.23	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			190.8	D08		4	0180-0594	470.06	594.13	422	77.01	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			245.4	D08		4	0181-0595	357.99	594.48	437	77.84	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			452.2	D08		4	0182-0601	707.62	600.99	472	81.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			321.2	D08		4	0183-0603	861.60	603.94	748	106.91	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			236.2	D08		4	0184-0602	593.70	602.36	432	78.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			444.0	D08		4	0185-0605	803.17	605.81	480	84.53	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			473.0	D08		4	0186-0605	189.40	604.80	467	80.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			241.1	D08		4	0187-0605	682.74	605.51	455	78.67	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			280.1	D08		4	0188-0608	829.34	608.71	803	110.53	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			171.7	D08		4	0189-0609	407.77	609.26	430	77.84	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			226.8	D08		4	0190-0617	48.28	617.11	419	76.08	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			481.4	D08		4	0191-0618	73.94	618.25	435	80.33	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			359.4	D08		4	0192-0620	534.59	620.39	454	83.15	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			503.6	D08		4	0193-0629	652.35	629.74	426	76.43	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			234.1	D08		4	0194-0630	464.45	630.65	459	81.50	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			191.3	D08		4	0195-0631	347.40	631.22	432	76.43	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1646.9	D08		4	0196-0637	166.84	637.00	673	98.81	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1840.9	D08		4	0197-0633	766.19	633.25	448	77.84	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			415.6	D08		4	0198-0637	824.14	634.50	444	83.50	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			286.0	D08		4	0199-0647	616.31	647.51	434	80.08	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			332.8	D08		4	0200-0648	893.26	647.73	452	83.74	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			361.6	D08		4	0201-0647	413.25	647.58	436	79.74	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			744.5	D08		4	0202-0649	811.68	650.31	462	82.47	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2063.4	D08		4	0203-0655	284.65	655.64	972	129.68	0.726
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			565.4	D08		4	0204-0650	16.51	650.72	409	75.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			904.4	D08		4	0205-0652	564.80	652.91	437	77.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			293.1	D08		4	0206-0655	245.76	654.93	477	87.40	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			315.3	D08		4	0207-0654	60.03	654.59	350	73.36	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			326.7	D08		4	0208-0664	490.73	665.09	551	88.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			388.1	D08		4	0209-0666	107.18	667.24	437	78.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			564.3	D08		4	0210-0670	130.35	670.03	437	81.01	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			330.6	D08		4	0211-0673	66.05	672.95	487	87.01	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			538.4	D08		4	0212-0675	315.43	675.38	458	79.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			201.6	D08		4	0213-0674	384.40	674.78	439	78.91	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			340.4	D08		4	0214-0676	671.90	676.16	437	77.84	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			489.6	D08		4	0215-0677	806.78	677.74	428	79.98	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			330.8	D08		4	0216-0678	219.18	677.65	431	79.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			357.3	D08		4	0217-0680	741.32	680.44	490	87.40	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			706.8	D08		4	0218-0687	521.67	686.81	448	80.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			677.0	D08		4	0219-0690	185.53	690.11	483	87.15	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			212.6	D08		4	0220-0691	426.22	691.59	414	78.18	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			153.2	D08		4	0221-0698	66.48	698.47	483	87.01	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			354.6	D08		4	0222-0697	210.17	697.67	479	90.91	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			203.2	D08		4	0223-0698	848.47	697.67	448	77.84	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2032.5	D08		4	0224-0707	801.44	707.13	338	68.77	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			375.3	D08		5	0001-0033	823.63	32.06	394	74.57	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1012.0	D08		5	0002-0040	391.44	40.78	457	81.84	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			350.1	D08		5	0003-0045	808.53	46.12	380	75.15	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			244.3	D08		5	0004-0045	921.84	46.04	389	78.18	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1958.0	D08		5	0005-0057	318.33	57.37	778	114.23	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1438.9	D08		5	0006-0057	470.15	57.03	421	78.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			220.2	D08		5	0007-0059	50.54	59.00	386	73.84	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2712.4	D08		5	0008-0059	875.92	59.73	269	82.67	0.495
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			710.6	D08		5	0009-0064	397.42	64.22	486	85.84	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			376.9	D08		5	0010-0072	670.92	70.92	819	114.67	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			569.3	D08		5	0011-0071	701.38	70.53	485	87.26	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2021.5	D08		5	0012-0078	543.90	78.14	825	118.71	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3406.7	D08		5	0013-0079	388.66	79.65	130	44.87	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2769.7	D08		5	0014-0085	382.58	87.38	154	58.53	0.565
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1647.6	D08		5	0015-0088	516.98	88.31	354	71.94	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			493.6	D08		5	0016-0093	277.12	93.36	398	75.50	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			372.6	D08		5	0017-0096	633.80	96.06	425	79.26	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			297.0	D08		5	0018-0092	945.00	92.43	416	78.43	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			306.2	D08		5	0019-0099	599.93	98.67	415	77.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1332.1	D08		5	0020-0098	798.67	98.19	423	77.84	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			357.9	D08		5	0021-0100	350.48	100.44	400	75.84	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2417.2	D08		5	0022-0103	71.65	102.95	395	74.67	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1107.7	D08		5	0023-0108	561.28	107.76	640	93.74	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1011.0	D08		5	0024-0112	237.80	112.01	503	85.60	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			849.5	D08		5	0025-0115	454.33	115.52	438	81.74	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2153.5	D08		5	0026-0117	179.42	116.83	392	74.67	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			647.0	D08		5	0027-0118	842.12	118.62	387	73.84	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1551.3	D08		5	0028-0128	945.20	127.33	658	98.67	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			529.4	D08		5	0029-0147	230.98	146.68	883	128.37	0.673
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			416.9	D08		5	0030-0139	417.82	138.92	432	76.43	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			258.4	D08		5	0031-0140	799.39	139.77	419	79.01	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			277.2	D08		5	0032-0143	72.31	143.04	380	72.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			340.6	D08		5	0033-0146	778.08	146.59	408	77.01	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			488.9	D08		5	0034-0149	501.54	148.63	457	80.08	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			296.7	D08		5	0035-0147	714.83	147.15	405	76.08	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			822.8	D08		5	0036-0160	304.21	160.53	837	111.54	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			307.3	D08		5	0037-0160	551.40	160.00	437	81.26	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			305.3	D08		5	0038-0159	625.81	159.03	413	75.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1031.8	D08		5	0039-0163	379.49	163.25	810	111.15	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			293.9	D08		5	0040-0174	218.07	175.08	417	82.33	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			341.1	D08		5	0041-0179	124.30	179.69	857	121.40	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			330.6	D08		5	0042-0182	593.02	181.99	397	76.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			193.4	D08		5	0043-0184	800.09	184.08	393	76.33	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			267.9	D08		5	0044-0195	190.64	195.14	411	81.74	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			353.1	D08		5	0045-0200	860.90	200.69	769	107.64	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			268.4	D08		5	0046-0195	714.01	195.36	418	78.43	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			279.4	D08		5	0047-0204	21.44	204.91	378	76.08	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			223.8	D08		5	0048-0205	71.47	204.85	372	72.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			165.6	D08		5	0049-0211	769.60	211.45	384	74.43	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			340.5	D08		5	0050-0211	468.68	211.28	418	76.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			270.5	D08		5	0051-0214	390.48	213.72	396	75.26	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			421.0	D08		5	0052-0214	734.86	213.37	442	81.01	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			542.1	D08		5	0053-0216	210.48	216.18	445	86.91	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2503.3	D08		5	0054-0212	116.41	212.94	148	51.70	0.696
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			353.6	D08		5	0055-0217	343.50	217.58	399	75.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1653.4	D08		5	0056-0219	649.48	218.86	377	75.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1673.3	D08		5	0057-0225	668.86	226.35	406	82.08	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			405.4	D08		5	0058-0233	554.22	233.81	778	108.23	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			364.3	D08		5	0059-0240	133.89	240.37	385	76.08	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			480.4	D08		5	0060-0248	172.10	248.69	390	74.08	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			408.4	D08		5	0061-0249	56.46	249.02	394	76.08	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1576.1	D08		5	0062-0252	262.48	252.37	426	77.01	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			537.3	D08		5	0063-0252	522.43	252.74	411	80.91	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			259.7	D08		5	0064-0259	941.70	259.65	758	108.71	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			281.9	D08		5	0065-0263	621.63	263.24	862	124.51	0.699
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			377.7	D08		5	0066-0268	474.24	267.82	820	112.81	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			448.8	D08		5	0067-0265	748.25	265.65	425	76.67	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			308.3	D08		5	0068-0268	784.21	268.90	423	82.57	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			990.7	D08		5	0069-0274	346.42	275.00	450	80.43	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			644.0	D08		5	0070-0280	397.61	280.07	764	105.54	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			301.1	D08		5	0071-0274	865.76	273.84	395	74.08	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			290.2	D08		5	0072-0278	121.12	277.83	379	73.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			343.3	D08		5	0073-0277	22.55	277.44	368	73.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			300.8	D08		5	0074-0285	547.62	284.98	407	77.74	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			587.1	D08		5	0075-0285	323.56	284.72	457	81.26	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			644.0	D08		5	0076-0287	260.67	287.23	413	79.50	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			281.7	D08		5	0077-0301	806.06	301.60	896	117.40	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			317.3	D08		5	0078-0301	685.93	301.04	293	63.94	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			225.4	D08		5	0079-0310	430.22	310.43	398	80.33	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1159.7	D08		5	0080-0316	97.58	316.25	428	80.33	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			723.5	D08		5	0081-0314	859.62	313.58	405	78.57	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			254.7	D08		5	0082-0321	21.04	321.60	824	115.68	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			352.5	D08		5	0083-0314	518.69	314.61	381	77.84	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			593.6	D08		5	0084-0323	283.64	323.05	405	78.08	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			388.0	D08		5	0085-0327	344.62	327.27	406	78.33	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			513.7	D08		5	0086-0328	873.27	329.35	403	77.50	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1751.2	D08		5	0087-0330	907.98	329.91	310	64.77	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			611.6	D08		5	0088-0333	223.33	333.96	410	75.26	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			307.0	D08		5	0089-0337	410.57	337.30	756	107.74	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			290.6	D08		5	0090-0338	169.04	337.99	379	77.50	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1267.8	D08		5	0091-0336	660.17	336.80	610	97.15	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			279.7	D08		5	0092-0343	929.00	343.31	782	113.88	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			280.8	D08		5	0093-0344	722.89	344.38	405	76.67	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			264.0	D08		5	0094-0351	438.25	351.57	739	106.57	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			265.8	D08		5	0095-0346	552.67	346.48	413	77.26	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			303.7	D08		5	0096-0347	786.35	346.22	441	83.60	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			344.9	D08		5	0097-0354	761.47	354.39	397	77.84	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			360.4	D08		5	0098-0359	854.76	359.24	407	77.50	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			333.3	D08		5	0099-0360	135.44	360.45	392	76.91	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			693.1	D08		5	0100-0363	589.18	362.90	402	74.43	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1637.5	D08		5	0101-0367	273.26	367.66	450	81.74	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			195.2	D08		5	0102-0365	897.87	364.97	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			455.2	D08		5	0103-0376	484.26	375.96	819	108.71	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			681.0	D08		5	0104-0375	377.85	374.63	416	78.08	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			880.1	D08		5	0105-0378	304.46	378.42	424	78.67	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1301.3	D08		5	0106-0380	40.49	380.98	425	78.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			553.8	D08		5	0107-0386	833.52	386.16	399	75.84	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			271.7	D08		5	0108-0388	630.64	387.98	450	82.33	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			337.3	D08		5	0109-0396	411.42	396.40	397	76.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			354.3	D08		5	0110-0401	740.54	401.57	418	77.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			342.7	D08		5	0111-0404	366.68	404.38	414	76.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			218.1	D08		5	0112-0406	217.90	406.82	369	74.67	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			278.8	D08		5	0113-0408	175.02	408.75	399	76.91	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			381.0	D08		5	0114-0411	715.24	410.60	451	84.33	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			244.9	D08		5	0115-0412	535.17	412.48	466	85.15	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			326.6	D08		5	0116-0418	907.23	417.81	194	52.53	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			558.1	D08		5	0117-0426	802.16	426.03	435	81.74	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			267.2	D08		5	0118-0427	257.71	426.72	386	73.84	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			509.0	D08		5	0119-0427	610.99	426.01	452	86.57	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			299.3	D08		5	0120-0427	511.47	427.34	436	80.91	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			765.2	D08		5	0121-0426	869.44	427.90	301	66.28	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			254.0	D08		5	0122-0430	942.75	429.56	334	72.77	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			464.3	D08		5	0123-0433	475.18	432.91	417	79.50	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			327.6	D08		5	0124-0438	60.42	438.38	370	77.50	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			380.4	D08		5	0125-0443	929.10	443.80	381	72.91	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			287.0	D08		5	0126-0447	231.28	446.57	418	88.08	0.677
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			770.8	D08		5	0127-0447	869.40	446.16	338	70.87	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			255.8	D08		5	0128-0455	318.95	455.36	393	78.33	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			395.2	D08		5	0129-0462	835.61	462.47	606	91.50	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			359.0	D08		5	0130-0461	121.51	461.01	426	79.50	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			656.9	D08		5	0131-0460	443.24	460.54	409	77.50	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			367.3	D08		5	0132-0462	254.37	461.53	431	78.43	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			478.5	D08		5	0133-0466	215.21	467.13	426	78.91	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			480.5	D08		5	0134-0467	783.67	467.61	406	76.67	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			449.1	D08		5	0135-0472	525.52	471.82	416	76.91	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			483.1	D08		5	0136-0482	99.73	482.31	414	75.26	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			734.1	D08		5	0137-0485	143.43	484.89	386	75.26	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1417.0	D08		5	0138-0485	294.49	485.32	292	62.77	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			238.7	D08		5	0139-0490	42.99	490.22	383	74.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			238.4	D08		5	0140-0493	370.45	493.36	377	74.91	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			200.1	D08		5	0141-0496	644.54	496.59	415	76.91	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			231.1	D08		5	0142-0498	489.71	498.57	453	82.33	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			338.6	D08		5	0143-0502	831.89	502.01	368	72.67	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			211.9	D08		5	0144-0505	939.56	504.88	436	78.08	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			418.6	D08		5	0145-0508	68.46	508.47	432	79.94	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			283.1	D08		5	0146-0511	887.28	511.66	578	90.08	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			258.8	D08		5	0147-0513	20.77	513.26	404	82.08	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			355.6	D08		5	0148-0521	754.52	520.67	409	79.50	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			454.4	D08		5	0149-0523	586.44	523.30	406	78.57	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			286.9	D08		5	0150-0524	298.76	524.83	424	77.26	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			188.6	D08		5	0151-0525	442.76	524.94	407	78.67	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			286.1	D08		5	0152-0528	529.27	528.32	415	77.50	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			375.3	D08		5	0153-0532	108.82	532.31	738	105.64	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1636.6	D08		5	0154-0531	148.05	531.10	448	80.57	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			235.9	D08		5	0155-0529	482.41	529.37	398	74.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			226.0	D08		5	0156-0530	666.31	530.21	407	77.50	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			250.6	D08		5	0157-0531	67.98	529.96	405	77.36	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			264.8	D08		5	0158-0535	709.02	534.75	398	76.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			277.3	D08		5	0159-0550	905.81	549.96	845	121.64	0.718
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			704.9	D08		5	0160-0541	804.22	541.10	367	73.26	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			547.0	D08		5	0161-0543	390.29	543.81	425	79.01	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			214.5	D08		5	0162-0553	412.75	553.04	430	81.26	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			345.6	D08		5	0163-0559	149.09	559.16	557	89.98	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			312.3	D08		5	0164-0560	464.84	560.33	400	78.33	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			297.6	D08		5	0165-0569	757.35	568.12	809	107.88	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			549.0	D08		5	0166-0564	348.33	564.29	444	81.98	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			294.3	D08		5	0167-0569	39.10	568.04	453	84.47	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			595.8	D08		5	0168-0567	599.41	567.21	398	75.84	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			996.9	D08		5	0169-0582	279.61	582.60	861	126.71	0.674
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			490.2	D08		5	0170-0581	25.58	580.97	352	75.15	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			199.3	D08		5	0171-0579	110.23	579.37	378	73.84	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1012.6	D08		5	0172-0581	667.06	581.06	445	80.57	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			240.8	D08		5	0173-0584	58.54	584.46	433	79.15	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			314.5	D08		5	0174-0598	387.24	598.06	913	122.51	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			477.5	D08		5	0175-0592	848.30	591.58	355	69.01	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			289.7	D08		5	0176-0601	452.23	600.94	405	78.57	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			958.7	D08		5	0177-0604	636.33	604.11	417	77.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			184.7	D08		5	0178-0605	707.85	604.88	396	75.84	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			221.6	D08		5	0179-0603	894.34	602.57	424	80.67	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2066.2	D08		5	0180-0611	815.51	611.80	316	65.60	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			903.7	D08		5	0181-0617	749.57	616.84	418	75.84	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			238.4	D08		5	0182-0619	670.03	619.32	407	77.50	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			463.9	D08		5	0183-0627	85.01	627.41	849	117.20	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			323.3	D08		5	0184-0623	380.27	623.57	412	79.98	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1912.4	D08		5	0185-0624	486.57	623.68	408	75.50	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			390.8	D08		5	0186-0636	229.62	636.89	400	80.23	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			333.4	D08		5	0187-0637	896.43	636.89	386	74.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1283.7	D08		5	0188-0639	432.10	639.78	760	107.01	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			453.3	D08		5	0189-0641	399.89	641.34	684	104.91	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			383.8	D08		5	0190-0639	702.72	639.73	363	71.70	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			432.6	D08		5	0191-0641	684.59	641.16	340	70.04	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			453.7	D08		5	0192-0641	833.67	641.18	407	77.26	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1042.5	D08		5	0193-0641	578.90	641.25	386	74.67	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			518.0	D08		5	0194-0644	503.10	644.83	399	75.84	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			473.1	D08		5	0195-0646	792.39	647.04	771	113.05	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			384.0	D08		5	0196-0651	154.62	650.94	391	77.84	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			218.9	D08		5	0197-0653	362.74	653.67	433	81.50	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			222.4	D08		5	0198-0669	557.75	669.58	859	118.02	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			254.6	D08		5	0199-0667	730.14	666.77	409	76.33	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			331.7	D08		5	0200-0669	620.03	669.13	394	76.33	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			262.1	D08		5	0201-0668	678.40	668.34	407	77.26	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			376.6	D08		5	0202-0675	431.90	674.98	414	76.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			194.5	D08		5	0203-0674	318.41	674.03	391	77.01	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			316.1	D08		5	0204-0680	259.83	680.16	394	74.67	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			490.3	D08		5	0205-0682	774.12	682.45	378	72.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			239.8	D08		5	0206-0694	727.59	694.73	419	81.15	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			255.4	D08		5	0207-0694	519.50	694.35	396	74.67	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			389.7	D08		5	0208-0699	210.55	699.05	729	105.88	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			239.6	D08		5	0209-0698	806.63	698.16	371	73.26	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			315.3	D08		5	0210-0704	886.47	704.50	369	71.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			527.6	D08		5	0211-0706	606.42	706.48	384	75.50	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			190.7	D08		6	0001-0031	828.76	31.67	370	71.94	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			210.5	D08		6	0002-0037	847.51	38.12	368	77.60	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			253.8	D08		6	0003-0036	327.60	35.24	339	72.43	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			212.1	D08		6	0004-0042	302.39	41.52	863	121.78	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			999.5	D08		6	0005-0040	923.26	40.40	314	67.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			296.3	D08		6	0006-0048	798.39	47.76	768	107.98	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			248.7	D08		6	0007-0042	130.25	42.06	351	69.60	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			730.4	D08		6	0008-0045	391.38	45.09	404	77.50	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			725.5	D08		6	0009-0049	556.89	49.61	411	80.43	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			236.7	D08		6	0010-0048	597.94	48.65	393	75.50	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			153.0	D08		6	0011-0048	16.62	48.20	323	75.01	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1481.6	D08		6	0012-0053	446.87	53.50	949	121.15	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			352.3	D08		6	0013-0051	666.15	50.88	389	74.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			434.1	D08		6	0014-0065	197.75	64.91	752	110.71	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			212.0	D08		6	0015-0066	900.72	66.61	403	75.84	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			239.2	D08		6	0016-0075	285.42	75.45	803	119.44	0.707
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			315.9	D08		6	0017-0073	628.35	74.13	785	115.64	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1645.6	D08		6	0018-0074	434.92	74.70	330	70.77	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			431.6	D08		6	0019-0078	746.11	77.93	391	73.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			572.4	D08		6	0020-0087	113.81	87.17	714	109.40	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			274.6	D08		6	0021-0082	859.99	81.94	372	74.91	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			479.8	D08		6	0022-0085	374.04	84.87	392	73.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			411.1	D08		6	0023-0094	723.11	93.67	421	78.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			288.5	D08		6	0024-0093	487.55	92.71	394	76.43	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			327.9	D08		6	0025-0094	774.76	94.30	418	78.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			271.6	D08		6	0026-0095	39.55	95.36	380	73.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1001.7	D08		6	0027-0102	836.77	101.45	590	115.05	0.560
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			494.9	D08		6	0028-0099	255.89	99.19	382	75.50	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			387.8	D08		6	0029-0100	595.90	99.78	365	72.67	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			230.4	D08		6	0030-0109	422.07	109.20	401	74.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			978.3	D08		6	0031-0126	484.81	126.11	881	126.71	0.690
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1484.6	D08		6	0032-0131	39.36	130.44	645	96.08	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			285.7	D08		6	0033-0131	549.78	131.58	381	73.84	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			457.1	D08		6	0034-0131	623.75	131.32	378	73.01	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			247.7	D08		6	0035-0132	172.95	132.44	376	77.26	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			878.6	D08		6	0036-0138	663.74	138.16	402	76.08	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			397.5	D08		6	0037-0140	893.42	140.11	365	71.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			289.0	D08		6	0038-0141	808.06	140.48	388	75.84	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			196.6	D08		6	0039-0144	271.47	144.83	389	76.57	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			861.1	D08		6	0040-0146	420.14	146.29	720	105.98	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1580.5	D08		6	0041-0145	457.69	145.41	336	70.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			512.9	D08		6	0042-0145	731.89	144.61	357	71.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			431.5	D08		6	0043-0147	106.08	147.62	398	74.67	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			258.4	D08		6	0044-0146	132.63	146.74	389	80.57	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			650.4	D08		6	0045-0148	301.61	148.60	373	73.50	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			427.5	D08		6	0046-0148	505.48	148.16	399	77.01	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			377.1	D08		6	0047-0149	838.37	149.10	369	72.67	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			224.8	D08		6	0048-0153	190.42	152.90	356	80.43	0.692
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			208.0	D08		6	0049-0159	767.90	159.50	381	75.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			499.7	D08		6	0050-0159	605.24	159.53	411	76.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			771.2	D08		6	0051-0163	326.95	162.93	371	72.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			605.7	D08		6	0052-0162	560.70	162.97	397	76.67	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			612.5	D08		6	0053-0165	928.56	164.82	391	73.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			204.2	D08		6	0054-0167	685.73	167.59	399	73.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			285.0	D08		6	0055-0167	474.63	166.86	391	76.18	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			223.3	D08		6	0056-0171	364.60	171.26	369	73.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2092.0	D08		6	0057-0177	70.64	177.11	396	78.18	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2008.2	D08		6	0058-0178	578.94	178.43	399	75.84	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2894.4	D08		6	0059-0178	93.26	177.67	356	71.94	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			318.4	D08		6	0060-0180	519.28	180.24	369	71.26	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1453.5	D08		6	0061-0188	811.84	187.98	356	71.60	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			244.9	D08		6	0062-0188	732.47	188.22	376	73.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			291.6	D08		6	0063-0188	398.67	187.91	374	72.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			209.7	D08		6	0064-0188	459.42	188.42	391	75.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			447.9	D08		6	0065-0192	707.38	192.26	387	74.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			423.9	D08		6	0066-0194	832.11	193.10	379	75.84	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			417.7	D08		6	0067-0201	129.67	201.14	384	77.26	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			181.4	D08		6	0068-0203	551.30	203.08	376	73.50	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			523.8	D08		6	0069-0204	902.38	204.65	333	66.77	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			216.2	D08		6	0070-0206	355.13	206.40	358	74.43	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1241.5	D08		6	0071-0212	635.35	212.48	399	75.01	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			236.5	D08		6	0072-0214	848.73	215.28	377	77.60	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			542.8	D08		6	0073-0218	932.27	216.97	345	69.26	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			253.1	D08		6	0074-0220	522.35	220.95	391	73.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			206.5	D08		6	0075-0221	324.97	222.47	425	81.01	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			287.2	D08		6	0076-0230	353.42	229.76	822	112.23	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			274.3	D08		6	0077-0233	441.72	232.72	428	80.91	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			223.5	D08		6	0078-0234	887.17	234.36	369	71.36	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1110.1	D08		6	0079-0237	83.22	237.34	399	76.67	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			237.9	D08		6	0080-0240	933.40	241.20	378	72.08	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			310.8	D08		6	0081-0243	854.49	242.67	365	73.84	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			255.1	D08		6	0082-0245	401.20	245.71	365	71.84	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			274.0	D08		6	0083-0244	460.99	244.95	355	75.60	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			156.8	D08		6	0084-0250	217.98	250.08	357	76.33	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			397.6	D08		6	0085-0253	628.92	252.95	378	72.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			226.9	D08		6	0086-0253	263.39	253.75	360	73.26	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			266.0	D08		6	0087-0262	36.17	262.36	722	103.05	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			224.2	D08		6	0088-0260	310.00	260.65	362	73.50	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			247.6	D08		6	0089-0260	102.18	261.17	346	70.43	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			450.3	D08		6	0090-0268	185.69	268.48	884	146.51	0.518
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			272.1	D08		6	0091-0263	454.94	263.11	449	84.67	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2298.4	D08		6	0092-0262	553.62	262.03	325	66.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			940.8	D08		6	0093-0270	678.00	270.01	375	72.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			420.5	D08		6	0094-0273	586.06	273.25	364	72.08	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			494.3	D08		6	0095-0275	369.55	275.52	397	75.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			865.2	D08		6	0096-0276	849.51	275.27	363	72.91	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			203.1	D08		6	0097-0278	235.02	278.33	349	72.43	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			245.6	D08		6	0098-0284	128.71	284.50	355	74.08	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			5022.8	D08		6	0099-0287	632.49	287.12	274	61.84	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			349.4	D08		6	0100-0292	864.52	292.16	407	77.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			524.1	D08		6	0101-0296	383.05	296.44	374	73.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1134.3	D08		6	0102-0297	407.90	296.89	387	73.01	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			280.7	D08		6	0103-0297	509.90	297.42	392	72.43	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			297.7	D08		6	0104-0298	44.09	298.72	352	72.08	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			194.5	D08		6	0105-0303	766.26	302.90	352	73.26	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			233.4	D08		6	0106-0310	276.35	310.18	394	75.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			320.5	D08		6	0107-0310	593.44	310.26	370	72.67	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			459.2	D08		6	0108-0310	548.75	310.52	382	74.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			477.0	D08		6	0109-0311	832.11	310.47	382	73.26	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			528.4	D08		6	0110-0315	475.27	315.03	395	74.18	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			870.9	D08		6	0111-0319	683.10	318.92	642	100.47	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			207.1	D08		6	0112-0319	301.13	319.45	382	73.84	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			316.6	D08		6	0113-0327	211.18	328.27	839	117.88	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			344.0	D08		6	0114-0320	566.22	320.72	385	75.50	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			460.2	D08		6	0115-0320	898.68	319.64	306	67.84	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			540.8	D08		6	0116-0322	354.69	321.99	394	75.50	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1188.7	D08		6	0117-0322	717.14	322.36	564	101.26	0.691
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1350.0	D08		6	0118-0328	640.59	328.33	362	75.26	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			268.9	D08		6	0119-0334	269.16	334.69	433	86.08	0.734
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			451.0	D08		6	0120-0332	495.27	331.52	399	74.18	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			312.0	D08		6	0121-0337	817.75	337.00	419	78.33	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			571.4	D08		6	0122-0339	909.62	339.16	468	81.74	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1228.5	D08		6	0123-0340	792.67	339.73	461	82.33	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			267.1	D08		6	0124-0346	23.77	346.14	733	109.64	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1219.5	D08		6	0125-0347	629.09	348.15	482	91.15	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1074.6	D08		6	0126-0349	772.87	349.59	347	73.74	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			403.6	D08		6	0127-0350	932.91	350.68	699	110.81	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1901.1	D08		6	0128-0353	876.46	352.96	385	73.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			608.1	D08		6	0129-0358	727.31	358.52	378	72.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			316.3	D08		6	0130-0371	408.14	370.44	795	118.02	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			524.3	D08		6	0131-0366	226.35	365.77	908	116.33	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			614.0	D08		6	0132-0372	118.56	372.22	342	68.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			252.7	D08		6	0133-0380	171.75	380.43	359	71.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1030.9	D08		6	0134-0381	686.19	380.93	378	72.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			248.5	D08		6	0135-0386	356.86	385.91	362	71.84	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			404.7	D08		6	0136-0386	898.63	385.61	350	70.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1465.2	D08		6	0137-0389	582.02	388.69	403	77.26	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			314.2	D08		6	0138-0393	465.08	393.73	397	76.33	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			199.5	D08		6	0139-0396	531.89	396.65	383	73.60	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			407.9	D08		6	0140-0398	404.18	398.80	397	75.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			390.2	D08		6	0141-0399	263.14	398.89	376	72.43	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			191.6	D08		6	0142-0406	755.66	406.81	828	112.81	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			705.1	D08		6	0143-0400	846.75	399.69	373	72.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			183.2	D08		6	0144-0404	713.06	404.11	418	78.91	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			269.2	D08		6	0145-0406	671.17	405.85	361	71.26	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			317.3	D08		6	0146-0413	138.98	413.47	371	79.74	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1146.2	D08		6	0147-0418	488.43	418.69	409	76.08	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			181.9	D08		6	0148-0420	205.89	419.93	366	72.67	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			421.3	D08		6	0149-0430	813.04	431.09	381	73.26	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			401.7	D08		6	0150-0431	347.02	431.33	380	73.01	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			358.8	D08		6	0151-0432	434.56	432.26	372	75.26	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			532.8	D08		6	0152-0433	386.89	433.27	332	67.01	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			186.7	D08		6	0153-0436	534.23	436.43	387	74.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			286.5	D08		6	0154-0436	566.83	435.94	392	77.50	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1011.4	D08		6	0155-0448	223.60	447.98	776	111.20	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			320.4	D08		6	0156-0444	25.13	445.46	410	79.64	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			580.7	D08		6	0157-0442	879.80	442.45	368	73.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1602.8	D08		6	0158-0453	629.25	451.93	805	122.61	0.673
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			783.4	D08		6	0159-0450	286.83	449.76	498	109.40	0.523
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			322.1	D08		6	0160-0455	546.95	455.76	440	81.26	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			192.6	D08		6	0161-0473	695.65	471.41	849	123.44	0.700
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			396.9	D08		6	0162-0463	767.08	463.73	453	79.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			310.7	D08		6	0163-0470	934.85	469.19	674	102.33	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			290.3	D08		6	0164-0464	910.91	463.51	355	70.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			217.9	D08		6	0165-0469	376.31	469.53	372	70.18	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			427.0	D08		6	0166-0471	177.58	471.75	413	78.67	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			518.2	D08		6	0167-0472	54.05	472.63	343	69.01	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			368.8	D08		6	0168-0475	592.81	474.91	415	75.26	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			271.9	D08		6	0169-0480	324.79	480.81	759	105.74	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			921.8	D08		6	0170-0479	435.04	479.50	376	72.18	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			238.0	D08		6	0171-0483	813.03	483.23	375	74.43	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1376.3	D08		6	0172-0490	770.88	489.39	662	102.91	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			352.8	D08		6	0173-0486	201.54	486.03	380	75.60	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1323.2	D08		6	0174-0487	278.85	487.89	358	69.84	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			455.2	D08		6	0175-0490	245.27	490.50	362	71.84	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3408.0	D08		6	0176-0491	477.77	491.04	428	78.08	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			268.6	D08		6	0177-0498	678.58	499.23	426	79.74	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			314.9	D08		6	0178-0503	118.99	502.66	441	82.57	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			200.9	D08		6	0179-0501	369.40	501.07	369	71.01	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			193.3	D08		6	0180-0503	572.50	503.11	376	74.08	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			257.6	D08		6	0181-0507	34.40	507.78	383	74.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			279.2	D08		6	0182-0509	934.67	508.54	372	73.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			293.3	D08		6	0183-0515	705.36	514.46	392	76.08	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			258.5	D08		6	0184-0512	735.76	512.62	377	75.26	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			459.7	D08		6	0185-0515	198.35	514.67	343	69.60	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			222.3	D08		6	0186-0516	403.12	516.95	377	75.50	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			248.8	D08		6	0187-0528	142.35	527.67	783	122.61	0.655
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			265.9	D08		6	0188-0521	640.20	521.47	403	76.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			286.9	D08		6	0189-0526	248.39	526.31	355	74.91	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			236.7	D08		6	0190-0528	434.65	528.06	364	72.08	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			626.3	D08		6	0191-0539	888.16	539.47	358	68.43	0.961
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			243.2	D08		6	0192-0542	349.12	542.31	386	77.74	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			231.5	D08		6	0193-0550	301.34	550.65	719	105.05	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			322.2	D08		6	0194-0551	111.29	551.67	350	72.91	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			273.8	D08		6	0195-0554	594.03	554.14	397	74.43	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			303.6	D08		6	0196-0555	943.52	555.19	380	73.50	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			218.4	D08		6	0197-0560	443.60	560.66	366	71.84	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			596.3	D08		6	0198-0565	548.38	565.67	372	72.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			338.5	D08		6	0199-0566	171.46	566.61	359	71.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			277.0	D08		6	0200-0571	341.12	571.02	415	82.57	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1244.3	D08		6	0201-0577	784.16	577.07	769	108.81	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			380.1	D08		6	0202-0572	251.05	572.93	407	78.67	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			248.0	D08		6	0203-0572	619.51	572.04	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1254.0	D08		6	0204-0579	74.03	580.39	662	103.40	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			213.8	D08		6	0205-0580	287.78	580.05	376	74.43	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			205.3	D08		6	0206-0579	367.26	578.81	401	77.74	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			513.0	D08		6	0207-0580	819.65	579.49	354	70.43	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			227.9	D08		6	0208-0580	416.10	580.75	378	72.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			356.5	D08		6	0209-0590	474.71	590.58	792	118.47	0.709
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			292.5	D08		6	0210-0582	229.54	582.17	384	74.43	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			266.8	D08		6	0211-0584	716.08	583.65	355	71.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			407.0	D08		6	0212-0590	110.68	589.95	361	72.91	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			224.8	D08		6	0213-0593	326.52	594.57	419	80.91	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			249.2	D08		6	0214-0597	508.27	597.88	502	83.50	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			385.1	D08		6	0215-0598	50.21	597.98	354	72.43	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			295.7	D08		6	0216-0597	558.93	597.18	395	77.01	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			474.7	D08		6	0217-0607	748.76	606.91	688	100.23	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			248.8	D08		6	0218-0603	376.33	604.40	395	79.74	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			632.9	D08		6	0219-0605	166.55	604.53	415	78.18	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			251.9	D08		6	0220-0611	220.68	610.92	370	74.67	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			248.4	D08		6	0221-0613	581.72	612.72	410	78.18	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			214.7	D08		6	0222-0616	412.19	617.09	369	73.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			554.5	D08		6	0223-0624	98.62	624.57	714	100.81	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			363.7	D08		6	0224-0625	180.36	625.83	398	80.43	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1245.8	D08		6	0225-0623	537.52	622.87	384	75.26	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			290.7	D08		6	0226-0635	454.28	635.05	378	73.01	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			253.1	D08		6	0227-0640	821.88	639.14	554	88.57	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			259.3	D08		6	0228-0644	624.45	644.80	425	77.26	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			262.0	D08		6	0229-0645	276.57	645.18	379	74.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			235.7	D08		6	0230-0648	571.47	648.92	714	103.40	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			257.5	D08		6	0231-0647	189.76	646.38	378	79.26	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			320.4	D08		6	0232-0654	371.70	653.98	762	108.47	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			366.4	D08		6	0233-0654	804.65	654.82	380	74.91	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			253.1	D08		6	0234-0650	679.35	650.37	197	55.11	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			212.6	D08		6	0235-0661	46.26	661.50	326	70.18	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			220.2	D08		6	0236-0663	320.64	663.16	378	72.67	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			273.9	D08		6	0237-0666	492.29	665.81	354	70.43	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			173.7	D08		6	0238-0670	135.52	670.49	346	73.26	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			199.6	D08		6	0239-0671	107.79	671.25	366	74.91	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			504.1	D08		6	0240-0676	444.57	675.86	391	73.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			295.5	D08		6	0241-0677	193.75	677.33	365	71.84	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			250.3	D08		6	0242-0680	830.19	680.26	357	70.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			512.3	D08		6	0243-0683	520.86	683.19	371	75.74	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			200.5	D08		6	0244-0686	287.13	685.70	375	73.26	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			256.9	D08		6	0245-0693	909.27	692.95	359	69.84	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			210.2	D08		6	0246-0696	601.90	695.47	367	73.98	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			239.8	D08		6	0247-0703	803.69	703.90	373	74.43	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			264.9	D08		6	0248-0703	212.96	703.48	341	67.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			261.0	D08		6	0249-0708	315.46	708.28	363	75.01	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2093.9	D08		7	0001-0038	138.70	38.64	783	109.88	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2316.3	D08		7	0002-0034	800.14	34.58	338	69.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			182.6	D08		7	0003-0039	895.20	39.35	401	77.26	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			287.8	D08		7	0004-0038	601.43	38.88	500	84.91	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			250.5	D08		7	0005-0042	281.00	42.21	836	111.64	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			339.2	D08		7	0006-0049	348.32	49.45	926	126.02	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1890.6	D08		7	0007-0044	702.80	44.53	423	77.26	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			429.9	D08		7	0008-0059	821.65	58.95	463	82.91	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1756.7	D08		7	0009-0066	79.13	65.78	449	81.15	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			244.9	D08		7	0010-0071	851.75	70.91	773	109.64	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			202.6	D08		7	0011-0070	394.91	69.33	475	86.91	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			265.2	D08		7	0012-0068	431.23	68.86	349	75.84	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			237.0	D08		7	0013-0078	251.23	76.72	434	79.74	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			746.3	D08		7	0014-0081	185.35	81.82	462	82.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			454.6	D08		7	0015-0087	704.28	87.06	423	77.26	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			539.0	D08		7	0016-0086	911.36	85.55	459	81.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			309.5	D08		7	0017-0090	439.34	90.38	570	96.67	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			299.8	D08		7	0018-0090	387.39	89.99	430	83.01	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			971.4	D08		7	0019-0089	534.01	89.23	451	81.50	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			232.5	D08		7	0020-0091	755.54	92.27	522	89.74	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			385.5	D08		7	0021-0091	938.49	90.77	487	85.50	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			699.1	D08		7	0022-0092	650.55	92.57	472	82.08	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			308.4	D08		7	0023-0093	237.84	94.47	446	80.57	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			407.6	D08		7	0024-0094	319.02	94.51	414	78.91	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			297.8	D08		7	0025-0096	815.37	96.64	456	87.40	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			350.5	D08		7	0026-0095	69.91	95.59	424	79.74	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			588.7	D08		7	0027-0098	845.18	97.93	502	87.15	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1288.3	D08		7	0028-0105	118.84	105.54	422	79.26	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			205.6	D08		7	0029-0106	732.48	106.57	433	80.91	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3492.1	D08		7	0030-0121	299.24	120.12	332	71.50	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			332.4	D08		7	0031-0124	358.14	124.35	404	76.67	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			169.5	D08		7	0032-0127	686.23	126.65	419	77.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			268.6	D08		7	0033-0126	894.96	126.18	404	76.67	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			628.5	D08		7	0034-0127	281.81	128.32	393	78.08	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			299.2	D08		7	0035-0134	17.37	135.18	431	82.91	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			358.3	D08		7	0036-0135	649.93	135.03	457	80.33	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			194.3	D08		7	0037-0137	769.78	137.10	439	82.91	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			756.7	D08		7	0038-0140	523.99	140.31	478	84.33	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			249.4	D08		7	0039-0142	721.43	141.48	426	78.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			457.0	D08		7	0040-0146	451.98	146.47	778	109.74	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			206.5	D08		7	0041-0146	107.97	146.29	445	79.26	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			250.1	D08		7	0042-0148	135.96	147.29	444	84.33	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			186.4	D08		7	0043-0149	316.88	149.62	395	74.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			202.0	D08		7	0044-0154	781.79	154.36	461	87.15	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			307.6	D08		7	0045-0156	845.85	156.05	488	85.74	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			337.9	D08		7	0046-0162	363.17	161.47	444	84.67	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			404.9	D08		7	0047-0166	385.36	167.21	434	82.77	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3451.3	D08		7	0048-0172	184.53	172.77	562	92.81	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			260.8	D08		7	0049-0173	454.80	171.96	385	78.18	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			260.3	D08		7	0050-0177	288.22	177.19	491	92.81	0.716
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			237.5	D08		7	0051-0178	528.37	178.22	462	85.15	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			387.2	D08		7	0052-0182	51.09	181.36	409	81.05	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			531.9	D08		7	0053-0194	217.97	194.61	776	108.47	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			394.7	D08		7	0054-0197	36.31	198.74	416	81.15	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			256.4	D08		7	0055-0194	138.10	194.57	402	78.08	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			250.9	D08		7	0056-0201	825.33	201.22	458	81.50	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			254.8	D08		7	0057-0208	730.55	207.85	446	88.57	0.714
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			320.7	D08		7	0058-0208	651.04	208.27	465	82.33	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			940.4	D08		7	0059-0209	931.10	209.15	402	78.18	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			269.8	D08		7	0060-0210	274.48	209.99	433	78.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			477.2	D08		7	0061-0213	760.79	212.74	447	80.91	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			294.9	D08		7	0062-0214	792.02	214.30	410	78.33	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			306.1	D08		7	0063-0221	335.11	221.41	436	81.50	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			384.3	D08		7	0064-0221	686.85	220.76	434	77.26	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			532.9	D08		7	0065-0226	873.19	225.05	349	72.33	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			952.1	D08		7	0066-0235	496.90	234.92	499	86.57	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			875.6	D08		7	0067-0239	853.50	238.86	887	116.37	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			291.8	D08		7	0068-0242	232.59	242.28	472	86.57	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			748.8	D08		7	0069-0250	596.44	249.54	397	76.81	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			226.7	D08		7	0070-0250	392.33	250.19	439	78.08	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1008.6	D08		7	0071-0253	203.63	253.94	172	82.91	0.314
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1080.0	D08		7	0072-0262	582.42	264.15	519	91.64	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			248.9	D08		7	0073-0274	91.69	274.93	849	123.54	0.699
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			207.8	D08		7	0074-0270	456.40	270.98	443	81.50	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			378.6	D08		7	0075-0276	191.03	275.28	408	79.40	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			928.7	D08		7	0076-0275	698.99	275.48	495	84.91	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			480.1	D08		7	0077-0279	151.50	279.75	427	83.40	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			431.6	D08		7	0078-0280	370.65	281.07	732	107.64	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			208.8	D08		7	0079-0279	493.68	278.87	455	82.33	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			664.2	D08		7	0080-0284	593.04	284.29	489	89.26	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			321.0	D08		7	0081-0295	181.32	296.34	462	87.15	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			369.4	D08		7	0082-0293	287.27	293.14	439	78.08	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			509.7	D08		7	0083-0293	398.40	293.43	479	89.15	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1118.6	D08		7	0084-0295	218.71	295.12	453	81.84	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			421.7	D08		7	0085-0315	421.37	315.20	835	113.88	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			320.2	D08		7	0086-0310	316.18	309.58	428	79.74	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			502.8	D08		7	0087-0314	523.18	314.28	453	82.91	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			381.7	D08		7	0088-0316	619.29	316.35	441	79.26	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1289.7	D08		7	0089-0316	210.40	316.01	418	82.43	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			414.8	D08		7	0090-0329	749.51	328.37	902	121.64	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			312.0	D08		7	0091-0324	675.43	324.14	441	81.60	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			344.9	D08		7	0092-0324	697.35	323.76	542	89.01	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			436.7	D08		7	0093-0330	923.70	330.27	449	81.74	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			414.4	D08		7	0094-0333	865.05	333.11	417	79.50	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			335.1	D08		7	0095-0334	184.98	334.20	426	78.08	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			282.9	D08		7	0096-0340	353.74	339.76	780	111.88	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			698.2	D08		7	0097-0337	503.83	337.39	471	87.98	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			209.0	D08		7	0098-0342	475.99	341.85	503	87.40	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			570.2	D08		7	0099-0352	433.49	352.00	279	62.18	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			374.8	D08		7	0100-0355	632.91	355.63	454	79.26	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			436.0	D08		7	0101-0357	886.90	357.71	400	75.01	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			488.4	D08		7	0102-0365	831.24	365.48	778	105.64	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			237.6	D08		7	0103-0372	28.17	372.53	757	109.84	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			862.4	D08		7	0104-0379	122.49	379.22	502	90.18	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			301.9	D08		7	0105-0383	142.26	381.40	342	74.43	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			657.8	D08		7	0106-0384	326.48	383.91	537	91.15	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			798.7	D08		7	0107-0385	592.79	385.21	478	82.91	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			164.2	D08		7	0108-0390	198.62	390.20	396	77.26	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			267.6	D08		7	0109-0390	648.07	390.05	430	79.26	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			653.4	D08		7	0110-0392	353.79	391.83	524	97.64	0.691
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			255.0	D08		7	0111-0395	155.03	396.14	484	86.81	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			284.4	D08		7	0112-0393	388.35	393.40	457	80.91	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			463.5	D08		7	0113-0401	715.27	400.99	439	83.74	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			471.2	D08		7	0114-0401	910.08	400.87	410	77.26	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			237.5	D08		7	0115-0402	80.39	401.50	410	78.08	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			418.0	D08		7	0116-0408	115.91	409.20	851	116.95	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			388.1	D08		7	0117-0406	47.71	407.15	428	79.60	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			345.3	D08		7	0118-0417	672.49	417.03	472	85.50	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1655.6	D08		7	0119-0419	258.24	419.29	418	75.26	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			288.2	D08		7	0120-0419	852.42	418.87	438	77.84	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			416.5	D08		7	0121-0422	462.95	422.00	463	84.57	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			368.5	D08		7	0122-0428	737.20	428.53	799	106.23	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			233.4	D08		7	0123-0426	357.00	426.46	420	78.91	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			198.2	D08		7	0124-0433	207.82	432.94	401	76.67	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			348.5	D08		7	0125-0439	548.38	439.23	853	114.71	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			400.7	D08		7	0126-0445	130.87	445.13	436	81.15	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			207.3	D08		7	0127-0446	872.69	446.15	435	79.50	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			304.5	D08		7	0128-0450	177.60	449.89	471	86.57	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			556.8	D08		7	0129-0458	504.55	457.94	831	112.13	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			289.6	D08		7	0130-0453	617.91	452.19	430	79.98	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1046.3	D08		7	0131-0460	330.60	460.23	433	78.08	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			274.8	D08		7	0132-0469	633.26	470.21	488	85.40	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			278.7	D08		7	0133-0468	685.96	468.34	437	78.91	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			239.8	D08		7	0134-0469	439.37	469.24	443	79.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1568.0	D08		7	0135-0469	568.45	470.06	280	84.08	0.498
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1122.9	D08		7	0136-0482	928.02	481.95	894	116.95	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			464.1	D08		7	0137-0483	224.25	482.98	421	78.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			698.1	D08		7	0138-0488	77.97	488.45	444	86.23	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			191.1	D08		7	0139-0489	119.46	489.20	400	77.74	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			336.7	D08		7	0140-0503	605.96	503.79	865	116.95	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			253.5	D08		7	0141-0497	448.54	497.80	458	85.15	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			247.9	D08		7	0142-0497	732.17	496.51	436	82.33	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			289.5	D08		7	0143-0497	846.56	496.51	448	80.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			549.0	D08		7	0144-0503	791.27	504.05	818	111.40	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			263.3	D08		7	0145-0504	534.13	504.29	423	77.26	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1585.0	D08		7	0146-0515	397.56	515.35	711	101.40	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			342.0	D08		7	0147-0514	492.38	514.36	432	78.08	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			256.6	D08		7	0148-0520	198.34	520.33	422	77.84	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			447.2	D08		7	0149-0530	560.96	529.57	474	82.57	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			693.7	D08		7	0150-0531	79.84	531.52	448	83.74	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			524.0	D08		7	0151-0534	692.82	534.27	465	85.74	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			350.0	D08		7	0152-0535	859.44	536.14	554	92.47	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			803.4	D08		7	0153-0539	427.78	539.12	414	80.67	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			689.0	D08		7	0154-0547	781.55	547.27	855	118.27	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			853.3	D08		7	0155-0543	216.52	543.56	474	84.33	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			152.5	D08		7	0156-0545	16.05	545.35	394	75.60	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			308.8	D08		7	0157-0546	129.51	546.04	410	80.81	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			393.8	D08		7	0158-0546	542.56	547.35	493	85.98	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			325.7	D08		7	0159-0548	312.37	548.53	846	119.05	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			695.7	D08		7	0160-0556	876.68	556.26	486	84.33	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			681.8	D08		7	0161-0559	421.15	559.94	631	96.91	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			559.0	D08		7	0162-0558	643.98	558.24	421	78.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1608.9	D08		7	0163-0559	697.13	559.46	444	83.50	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			338.4	D08		7	0164-0570	241.67	569.63	417	77.50	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			360.7	D08		7	0165-0574	335.74	574.52	423	81.98	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			771.6	D08		7	0166-0582	939.06	582.12	412	79.60	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			594.5	D08		7	0167-0585	53.65	585.14	766	105.64	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			312.3	D08		7	0168-0583	619.72	583.61	431	76.43	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			255.4	D08		7	0169-0585	567.84	585.96	426	78.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			334.6	D08		7	0170-0587	200.56	587.01	459	81.50	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			300.1	D08		7	0171-0586	381.16	586.27	433	80.91	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			307.8	D08		7	0172-0602	84.26	601.97	412	79.98	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			356.6	D08		7	0173-0608	779.71	607.96	426	77.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			907.5	D08		7	0174-0610	934.27	610.47	448	84.91	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			298.6	D08		7	0175-0612	143.13	612.04	417	84.57	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			465.4	D08		7	0176-0613	692.71	612.59	428	79.26	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			246.2	D08		7	0177-0615	439.99	614.55	437	80.08	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			425.8	D08		7	0178-0622	309.28	622.42	452	80.91	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1405.8	D08		7	0179-0623	216.34	623.50	469	83.26	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			308.0	D08		7	0180-0634	512.13	633.38	446	82.33	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			200.5	D08		7	0181-0636	62.85	636.45	401	76.67	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1620.3	D08		7	0182-0643	332.89	641.98	838	120.13	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			285.9	D08		7	0183-0645	399.66	644.48	449	81.84	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			390.7	D08		7	0184-0647	279.46	648.02	378	80.33	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			350.0	D08		7	0185-0651	639.67	650.98	435	79.01	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			709.7	D08		7	0186-0651	360.99	651.61	463	84.08	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			305.9	D08		7	0187-0655	250.20	654.26	469	86.57	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			270.7	D08		7	0188-0659	500.84	660.70	463	85.74	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			452.1	D08		7	0189-0655	433.42	656.14	379	75.70	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			609.3	D08		7	0190-0660	835.93	660.18	449	80.91	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			317.8	D08		7	0191-0669	391.30	670.27	462	88.81	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			480.8	D08		7	0192-0667	17.13	667.33	458	80.91	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			444.3	D08		7	0193-0667	193.70	667.19	437	79.50	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1713.6	D08		7	0194-0664	222.97	664.04	250	64.43	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			391.0	D08		7	0195-0669	130.34	669.31	415	83.15	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			635.0	D08		7	0196-0671	563.62	671.83	434	80.33	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			471.0	D08		7	0197-0674	744.60	674.36	401	75.50	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1920.4	D08		7	0198-0675	434.96	673.95	430	80.53	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			440.8	D08		7	0199-0680	247.12	680.98	481	89.15	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			398.9	D08		7	0200-0680	297.85	680.08	407	76.43	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			350.6	D08		7	0201-0679	881.66	679.17	397	75.01	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			252.6	D08		7	0202-0683	463.49	683.36	413	78.33	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1966.3	D08		7	0203-0689	910.76	689.07	428	78.67	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			490.3	D08		7	0204-0690	55.66	689.63	424	76.67	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			167.5	D08		7	0205-0698	689.45	697.40	443	86.23	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			456.2	D08		7	0206-0698	656.88	697.85	407	79.15	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			194.8	D08		7	0207-0703	605.62	703.64	412	76.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			274.9	D08		7	0208-0704	351.70	704.08	420	77.26	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			697.2	D08		7	0209-0704	531.98	704.73	484	84.67	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			472.0	D08		7	0210-0704	215.33	704.39	385	72.43	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			357.9	D08		7	0211-0709	508.12	709.51	296	69.84	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			246.5	D08		8	0001-0032	884.95	31.78	381	72.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			436.1	D08		8	0002-0036	369.69	35.91	465	82.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			582.4	D08		8	0003-0034	604.87	34.26	413	78.08	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			241.9	D08		8	0004-0039	695.81	39.74	434	85.64	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			430.3	D08		8	0005-0039	424.75	39.71	513	90.57	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			250.6	D08		8	0006-0042	59.13	41.84	406	76.67	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			746.4	D08		8	0007-0042	116.37	41.58	475	85.40	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			613.8	D08		8	0008-0053	446.51	51.28	509	86.23	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			238.5	D08		8	0009-0060	500.17	59.63	448	81.74	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			871.8	D08		8	0010-0061	133.24	61.79	472	84.33	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			437.5	D08		8	0011-0062	572.17	62.39	818	115.78	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1439.7	D08		8	0012-0065	460.15	66.11	402	78.23	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			282.8	D08		8	0013-0063	918.16	63.17	393	76.33	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			458.8	D08		8	0014-0066	744.30	66.04	400	75.01	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			307.1	D08		8	0015-0073	691.30	73.55	412	75.01	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			242.7	D08		8	0016-0073	860.83	73.44	448	82.57	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			255.1	D08		8	0017-0075	834.89	75.31	412	77.26	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			251.0	D08		8	0018-0078	776.98	78.13	421	78.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			250.6	D08		8	0019-0082	174.03	82.31	390	78.08	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1484.1	D08		8	0020-0083	273.25	83.30	414	77.26	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			310.0	D08		8	0021-0092	219.98	92.53	851	121.05	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2007.1	D08		8	0022-0085	109.71	85.02	386	72.43	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			496.8	D08		8	0023-0088	17.17	87.83	451	82.08	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			443.1	D08		8	0024-0093	44.18	92.84	455	81.50	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			636.1	D08		8	0025-0094	894.42	94.34	407	76.43	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1040.5	D08		8	0026-0098	431.25	98.10	437	83.15	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			285.6	D08		8	0027-0100	366.00	100.19	409	76.67	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			714.1	D08		8	0028-0110	622.43	110.49	865	119.98	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			287.4	D08		8	0029-0107	652.75	107.06	446	81.01	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			332.1	D08		8	0030-0111	703.55	110.95	404	76.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			313.7	D08		8	0031-0113	73.92	113.83	409	77.84	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			584.0	D08		8	0032-0114	142.14	114.63	404	78.91	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1917.5	D08		8	0033-0116	682.50	115.95	406	75.36	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			337.3	D08		8	0034-0119	820.27	119.15	422	77.26	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			212.7	D08		8	0035-0132	728.98	132.30	480	86.57	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			412.1	D08		8	0036-0131	552.04	130.76	407	76.67	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			240.2	D08		8	0037-0141	469.46	141.36	908	135.68	0.620
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			842.2	D08		8	0038-0132	614.30	132.68	390	79.36	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			343.2	D08		8	0039-0144	279.56	144.71	608	95.64	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			275.7	D08		8	0040-0143	414.75	143.33	406	77.50	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			740.1	D08		8	0041-0154	61.26	154.33	437	80.33	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			442.1	D08		8	0042-0153	869.81	153.09	405	77.26	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			310.4	D08		8	0043-0157	138.42	157.09	429	82.08	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			319.7	D08		8	0044-0157	562.84	158.13	412	80.33	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			392.8	D08		8	0045-0159	165.70	159.40	498	90.81	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			357.8	D08		8	0046-0165	521.33	164.82	413	76.67	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			319.5	D08		8	0047-0167	739.78	167.56	428	78.08	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2082.2	D08		8	0048-0168	624.74	168.55	454	80.77	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			337.0	D08		8	0049-0183	567.41	184.60	849	121.78	0.719
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			343.0	D08		8	0050-0183	384.62	183.38	418	79.50	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			247.0	D08		8	0051-0184	277.53	185.34	517	86.53	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			444.2	D08		8	0052-0184	694.35	183.56	388	75.26	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			216.9	D08		8	0053-0186	890.52	186.22	434	79.84	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			303.1	D08		8	0054-0195	913.07	195.23	848	119.15	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			805.2	D08		8	0055-0198	206.93	198.85	984	120.71	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1836.2	D08		8	0056-0192	625.24	191.31	474	84.18	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2659.1	D08		8	0057-0200	484.87	201.08	671	104.37	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1595.8	D08		8	0058-0199	359.06	199.18	446	83.15	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			200.0	D08		8	0059-0200	527.88	200.43	408	79.15	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			328.1	D08		8	0060-0204	711.12	205.37	848	118.13	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			237.4	D08		8	0061-0205	666.68	205.58	439	80.67	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			325.3	D08		8	0062-0206	779.10	206.07	414	77.26	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			422.5	D08		8	0063-0214	276.88	213.77	792	116.43	0.734
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			927.9	D08		8	0064-0211	35.92	211.97	421	83.01	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			558.2	D08		8	0065-0211	447.74	211.02	441	84.23	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			327.0	D08		8	0066-0216	96.43	217.15	848	116.71	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			334.5	D08		8	0067-0217	253.06	216.84	436	81.01	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			743.4	D08		8	0068-0224	158.37	224.36	418	77.50	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			615.6	D08		8	0069-0228	583.30	228.46	464	85.15	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			876.8	D08		8	0070-0226	851.41	226.38	407	75.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			435.0	D08		8	0071-0237	309.49	237.76	822	113.40	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			376.3	D08		8	0072-0241	284.94	240.54	473	87.36	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			173.8	D08		8	0073-0242	529.69	242.68	413	77.26	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			328.6	D08		8	0074-0240	630.78	239.82	350	72.67	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			558.4	D08		8	0075-0244	789.97	244.51	403	78.33	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			289.1	D08		8	0076-0247	607.99	247.34	445	82.91	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			276.6	D08		8	0077-0260	332.57	260.05	459	82.67	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1207.8	D08		8	0078-0259	477.08	259.25	378	72.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			500.2	D08		8	0079-0260	692.38	261.20	452	80.53	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			342.3	D08		8	0080-0277	257.21	277.66	846	112.37	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2759.5	D08		8	0081-0276	832.37	276.41	609	96.33	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			360.0	D08		8	0082-0274	77.86	273.62	372	74.33	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			357.5	D08		8	0083-0277	649.69	277.28	452	78.67	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			229.0	D08		8	0084-0279	438.27	278.77	417	77.26	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			458.0	D08		8	0085-0284	185.71	284.27	400	77.74	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1475.6	D08		8	0086-0282	884.17	282.00	325	67.01	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			251.8	D08		8	0087-0284	913.06	284.55	406	75.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			389.0	D08		8	0088-0285	118.78	285.70	421	81.40	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			749.2	D08		8	0089-0284	691.85	283.76	461	83.36	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			355.9	D08		8	0090-0286	590.33	286.02	441	83.40	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1029.0	D08		8	0091-0289	62.19	290.24	495	87.05	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			802.0	D08		8	0092-0289	215.23	288.87	428	76.67	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			297.8	D08		8	0093-0292	545.64	292.36	775	106.23	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			869.0	D08		8	0094-0292	733.36	292.72	814	108.57	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			695.4	D08		8	0095-0292	385.56	292.55	865	120.81	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			240.3	D08		8	0096-0294	505.09	292.74	453	88.47	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			207.2	D08		8	0097-0301	945.77	302.32	413	79.26	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			241.3	D08		8	0098-0321	99.54	320.91	400	76.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			255.8	D08		8	0099-0321	502.87	321.41	431	77.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			209.2	D08		8	0100-0319	659.31	318.85	429	79.26	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			392.4	D08		8	0101-0336	890.29	336.90	826	119.68	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			324.3	D08		8	0102-0329	912.12	328.16	412	82.33	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			397.5	D08		8	0103-0332	28.83	332.23	415	79.15	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			684.5	D08		8	0104-0336	249.69	335.89	411	79.74	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			321.9	D08		8	0105-0334	844.38	334.08	456	79.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			188.2	D08		8	0106-0339	425.15	339.81	395	77.60	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			223.1	D08		8	0107-0340	652.93	341.37	469	84.91	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1200.9	D08		8	0108-0342	342.76	342.06	413	78.67	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			964.4	D08		8	0109-0341	386.82	341.56	467	83.50	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			241.9	D08		8	0110-0342	786.67	342.22	406	76.67	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			257.2	D08		8	0111-0348	449.67	347.65	724	104.91	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			286.6	D08		8	0112-0347	166.15	347.14	412	77.50	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1169.7	D08		8	0113-0358	547.03	358.86	868	122.85	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1459.7	D08		8	0114-0349	211.63	349.20	437	79.50	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			320.3	D08		8	0115-0357	711.60	357.80	419	78.91	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			382.1	D08		8	0116-0363	399.47	362.29	445	81.84	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			316.6	D08		8	0117-0372	497.55	372.35	460	81.84	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			246.4	D08		8	0118-0374	757.54	374.67	449	80.91	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			274.5	D08		8	0119-0376	601.74	376.51	426	79.74	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			201.3	D08		8	0120-0378	784.90	377.44	438	79.50	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			160.6	D08		8	0121-0381	304.43	382.27	420	80.18	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			180.6	D08		8	0122-0389	60.15	389.85	389	76.33	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			972.8	D08		8	0123-0393	428.91	394.39	864	118.37	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			599.5	D08		8	0124-0400	117.36	399.99	841	114.13	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			209.6	D08		8	0125-0391	520.05	391.20	456	84.91	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			577.5	D08		8	0126-0394	689.93	393.77	429	76.43	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			387.6	D08		8	0127-0396	907.28	396.73	421	79.84	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			583.9	D08		8	0128-0401	177.10	400.90	434	80.08	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			440.2	D08		8	0129-0403	15.32	402.92	373	72.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			212.7	D08		8	0130-0407	308.11	406.08	476	84.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			256.5	D08		8	0131-0405	651.10	405.55	421	78.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			395.3	D08		8	0132-0411	850.74	411.27	371	71.60	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			292.4	D08		8	0133-0413	581.10	413.40	417	79.74	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			624.6	D08		8	0134-0426	901.74	426.81	747	111.15	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			250.7	D08		8	0135-0421	543.54	421.25	415	78.08	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			428.6	D08		8	0136-0426	135.22	426.07	471	82.91	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			250.2	D08		8	0137-0427	707.94	427.17	405	75.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			279.8	D08		8	0138-0427	750.29	427.15	422	75.84	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1385.6	D08		8	0139-0434	360.23	432.85	438	79.40	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			489.5	D08		8	0140-0443	91.35	443.73	610	94.33	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			385.3	D08		8	0141-0443	856.02	443.55	415	77.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			273.6	D08		8	0142-0443	661.35	442.96	454	83.26	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			252.1	D08		8	0143-0444	808.91	444.31	394	76.08	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1462.1	D08		8	0144-0453	345.48	453.66	469	86.81	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			325.4	D08		8	0145-0451	637.49	450.89	417	77.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			418.8	D08		8	0146-0454	399.22	454.11	446	81.01	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			196.5	D08		8	0147-0455	420.93	455.57	486	86.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			238.9	D08		8	0148-0465	921.78	465.12	432	78.43	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			954.2	D08		8	0149-0465	558.52	464.69	343	71.26	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			218.4	D08		8	0150-0471	252.94	470.44	407	78.77	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			240.3	D08		8	0151-0477	732.29	477.24	423	78.91	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			189.7	D08		8	0152-0476	882.86	476.52	399	73.84	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1077.4	D08		8	0153-0485	32.98	484.12	857	113.54	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			524.0	D08		8	0154-0480	451.55	479.73	419	78.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			308.2	D08		8	0155-0481	500.13	481.23	432	84.33	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			257.9	D08		8	0156-0483	808.31	482.90	444	80.08	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			252.4	D08		8	0157-0482	830.66	481.79	391	81.01	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			276.0	D08		8	0158-0482	622.88	482.80	407	76.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			273.3	D08		8	0159-0485	145.41	485.34	387	77.50	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			447.9	D08		8	0160-0486	206.87	486.52	415	77.50	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			306.4	D08		8	0161-0488	778.91	488.46	406	77.50	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			199.5	D08		8	0162-0493	848.55	493.51	516	89.50	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1042.2	D08		8	0163-0488	409.37	488.78	298	66.08	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			475.2	D08		8	0164-0493	365.42	493.59	435	79.50	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			267.0	D08		8	0165-0496	569.92	495.85	422	79.50	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			251.7	D08		8	0166-0505	741.58	505.90	442	83.60	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			297.8	D08		8	0167-0506	480.71	505.89	443	81.84	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			364.4	D08		8	0168-0518	915.18	518.32	720	110.57	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			301.7	D08		8	0169-0515	647.73	514.94	420	78.08	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			349.8	D08		8	0170-0518	256.99	518.51	433	79.50	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			300.1	D08		8	0171-0523	135.34	522.72	392	76.08	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			221.4	D08		8	0172-0526	814.97	525.92	410	80.33	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			169.5	D08		8	0173-0526	194.48	526.48	394	76.08	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			318.2	D08		8	0174-0525	931.41	524.85	175	53.11	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			271.9	D08		8	0175-0535	746.35	535.25	891	126.47	0.700
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1356.2	D08		8	0176-0527	460.85	527.21	391	72.77	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			536.2	D08		8	0177-0528	366.17	528.27	407	78.67	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			317.6	D08		8	0178-0533	545.31	532.49	555	92.57	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1171.8	D08		8	0179-0544	226.15	544.19	422	78.08	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			205.5	D08		8	0180-0546	793.33	547.02	405	80.91	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			387.9	D08		8	0181-0552	696.30	551.94	410	78.67	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			264.9	D08		8	0182-0560	85.58	559.71	859	121.54	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			270.5	D08		8	0183-0556	404.04	556.74	407	75.50	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			758.7	D08		8	0184-0562	515.01	562.26	465	81.50	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			170.2	D08		8	0185-0564	800.48	565.21	445	86.08	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			234.8	D08		8	0186-0569	173.02	569.09	399	75.50	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			216.1	D08		8	0187-0573	556.41	572.86	403	75.60	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			482.3	D08		8	0188-0578	641.51	577.83	422	78.08	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			221.2	D08		8	0189-0579	740.58	578.80	406	75.50	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			544.8	D08		8	0190-0580	875.42	580.14	437	78.67	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			769.0	D08		8	0191-0585	44.22	584.44	406	84.81	0.709
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			218.9	D08		8	0192-0581	586.30	581.20	404	75.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			884.8	D08		8	0193-0583	324.64	583.53	438	79.50	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			334.6	D08		8	0194-0589	212.22	589.69	435	82.08	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			229.2	D08		8	0195-0595	263.91	595.35	398	77.50	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			320.8	D08		8	0196-0598	426.67	598.42	443	82.08	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			928.3	D08		8	0197-0612	39.00	612.44	432	80.57	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			294.3	D08		8	0198-0611	929.51	611.62	403	79.26	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3124.5	D08		8	0199-0621	82.16	621.05	720	100.57	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			272.6	D08		8	0200-0621	208.06	621.77	573	90.33	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			300.5	D08		8	0201-0619	718.53	619.30	403	74.67	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			312.3	D08		8	0202-0622	429.32	621.30	451	81.26	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			326.3	D08		8	0203-0624	604.82	624.31	425	79.98	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			763.1	D08		8	0204-0627	514.44	626.81	430	80.33	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			847.0	D08		8	0205-0639	318.06	638.75	414	76.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			332.8	D08		8	0206-0639	773.47	638.91	418	77.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			270.3	D08		8	0207-0641	142.44	641.40	392	76.57	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			253.9	D08		8	0208-0646	177.28	646.96	409	76.67	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1253.2	D08		8	0209-0650	67.26	650.15	436	79.26	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			389.0	D08		8	0210-0654	406.54	654.12	430	80.33	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			630.6	D08		8	0211-0660	226.56	660.44	421	78.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			515.8	D08		8	0212-0678	607.91	679.11	851	119.88	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			277.8	D08		8	0213-0674	926.64	673.75	396	75.26	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			398.9	D08		8	0214-0684	414.35	684.91	457	82.67	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1068.1	D08		8	0215-0693	180.42	693.41	765	108.13	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1958.7	D08		8	0216-0691	15.47	691.18	411	78.57	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			251.6	D08		8	0217-0695	389.16	695.35	428	82.57	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			247.8	D08		8	0218-0706	316.19	706.84	392	73.26	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			230.1	D08		9	0001-0031	802.21	31.36	377	73.60	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			233.9	D08		9	0002-0031	211.44	31.27	365	70.43	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			288.9	D08		9	0003-0036	582.69	37.25	373	73.74	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			260.0	D08		9	0004-0037	315.18	36.46	417	77.94	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			311.1	D08		9	0005-0040	243.56	39.76	391	75.26	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			176.9	D08		9	0006-0040	69.25	40.63	358	71.26	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			240.5	D08		9	0007-0043	158.62	42.87	383	74.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			202.7	D08		9	0008-0044	549.39	44.18	431	78.67	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			432.5	D08		9	0009-0044	838.91	44.74	396	74.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			280.9	D08		9	0010-0049	433.97	48.43	422	76.43	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			206.5	D08		9	0011-0056	108.85	56.12	370	71.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			221.7	D08		9	0012-0061	197.89	61.33	371	70.18	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			184.4	D08		9	0013-0063	232.85	63.48	376	74.77	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			250.3	D08		9	0014-0066	12.61	65.95	363	72.67	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1098.8	D08		9	0015-0074	412.99	73.90	420	78.18	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			297.9	D08		9	0016-0073	311.53	73.06	398	75.60	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			375.6	D08		9	0017-0078	615.73	77.56	424	77.84	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			322.4	D08		9	0018-0078	693.87	78.19	421	80.91	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			317.6	D08		9	0019-0081	174.00	80.92	364	74.43	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			202.6	D08		9	0020-0082	740.74	81.87	394	75.26	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			382.2	D08		9	0021-0084	358.91	84.33	395	74.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			385.9	D08		9	0022-0085	480.27	85.05	398	73.60	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			242.2	D08		9	0023-0091	867.98	90.87	374	72.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			372.0	D08		9	0024-0095	909.04	95.92	425	77.84	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			199.0	D08		9	0025-0095	122.55	94.82	359	70.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			577.7	D08		9	0026-0096	307.62	95.97	396	75.84	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			532.4	D08		9	0027-0100	709.31	100.82	473	83.26	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			327.7	D08		9	0028-0104	165.47	104.90	558	90.91	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			425.2	D08		9	0029-0102	609.70	102.70	415	76.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			283.2	D08		9	0030-0104	250.84	103.66	451	81.64	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			315.6	D08		9	0031-0101	932.48	101.56	414	79.11	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			290.2	D08		9	0032-0111	651.76	110.71	396	74.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			209.0	D08		9	0033-0117	265.59	118.91	350	71.15	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			604.6	D08		9	0034-0120	94.20	120.25	375	72.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			274.6	D08		9	0035-0127	711.28	125.36	426	82.33	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			191.9	D08		9	0036-0130	208.51	130.00	397	76.67	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			375.0	D08		9	0037-0134	141.97	134.27	378	75.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			209.9	D08		9	0038-0135	693.09	136.57	410	78.08	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			650.1	D08		9	0039-0138	866.97	137.64	357	70.43	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			517.8	D08		9	0040-0139	51.12	140.05	347	69.01	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			624.1	D08		9	0041-0140	353.61	139.65	376	72.18	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			280.4	D08		9	0042-0139	414.94	138.93	402	79.60	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			281.3	D08		9	0043-0140	286.49	139.79	389	74.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			443.5	D08		9	0044-0140	439.97	140.48	424	77.94	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			264.5	D08		9	0045-0145	914.10	145.16	386	72.43	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			984.7	D08		9	0046-0149	481.63	148.96	445	79.26	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			292.1	D08		9	0047-0159	553.86	159.17	840	114.91	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			225.4	D08		9	0048-0153	211.82	153.04	407	76.43	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			946.6	D08		9	0049-0159	99.45	159.36	413	77.74	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			717.0	D08		9	0050-0159	341.79	159.62	373	73.84	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1980.5	D08		9	0051-0159	277.39	159.59	351	69.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			261.7	D08		9	0052-0163	636.04	163.74	429	78.77	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			207.7	D08		9	0053-0163	660.28	162.67	412	76.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			870.4	D08		9	0054-0169	602.12	169.55	466	80.18	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			405.6	D08		9	0055-0169	465.80	168.72	422	78.67	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			502.6	D08		9	0056-0173	48.26	174.07	357	72.43	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			611.9	D08		9	0057-0179	376.57	178.90	426	79.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			657.0	D08		9	0058-0180	860.74	180.33	366	70.77	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			202.8	D08		9	0059-0187	683.04	187.15	393	76.43	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			348.9	D08		9	0060-0186	178.54	186.46	374	72.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			236.4	D08		9	0061-0196	298.97	196.05	817	112.91	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			372.0	D08		9	0062-0196	783.01	196.00	386	74.91	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			750.3	D08		9	0063-0204	102.44	205.02	417	78.91	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			245.2	D08		9	0064-0206	210.89	206.94	381	77.60	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			238.8	D08		9	0065-0209	412.21	209.50	459	80.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			207.5	D08		9	0066-0212	241.57	212.44	368	74.43	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			241.5	D08		9	0067-0210	391.73	210.62	391	73.70	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			781.2	D08		9	0068-0214	460.20	214.19	731	100.81	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			246.4	D08		9	0069-0212	681.99	212.12	440	80.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			207.7	D08		9	0070-0211	641.53	211.36	385	75.26	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			260.7	D08		9	0071-0215	571.82	215.76	385	74.67	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			604.9	D08		9	0072-0221	357.76	220.80	429	79.26	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			192.1	D08		9	0073-0222	309.49	222.98	389	78.18	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			361.0	D08		9	0074-0223	739.20	223.72	392	76.08	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			291.5	D08		9	0075-0227	205.50	226.76	434	80.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			340.8	D08		9	0076-0233	522.04	232.65	722	103.40	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			479.3	D08		9	0077-0233	717.89	233.06	548	93.40	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			683.4	D08		9	0078-0232	882.86	231.82	374	71.60	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			378.8	D08		9	0079-0242	370.93	242.04	567	91.74	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			520.3	D08		9	0080-0244	793.57	244.69	404	75.26	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			153.2	D08		9	0081-0247	296.20	247.12	377	73.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			239.6	D08		9	0082-0251	259.12	251.10	369	72.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			375.7	D08		9	0083-0251	549.31	251.59	444	78.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			372.5	D08		9	0084-0250	180.46	250.07	376	73.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			241.0	D08		9	0085-0252	587.08	251.82	386	75.84	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			236.5	D08		9	0086-0255	153.26	255.91	388	75.50	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			290.8	D08		9	0087-0256	77.61	256.50	386	74.43	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			294.8	D08		9	0088-0258	514.86	258.37	395	75.84	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			817.8	D08		9	0089-0258	846.26	258.51	396	73.01	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			310.4	D08		9	0090-0264	324.38	263.88	658	94.91	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1100.9	D08		9	0091-0262	671.84	262.19	432	80.91	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			212.9	D08		9	0092-0257	915.92	257.74	364	71.94	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			197.4	D08		9	0093-0264	887.34	264.27	349	75.36	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			360.8	D08		9	0094-0273	410.97	273.28	409	75.01	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2479.5	D08		9	0095-0274	472.81	274.16	308	64.77	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			214.3	D08		9	0096-0280	581.72	280.94	420	76.08	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2029.8	D08		9	0097-0281	658.64	281.64	406	74.67	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			250.4	D08		9	0098-0283	791.94	282.76	373	73.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			188.1	D08		9	0099-0282	893.76	282.59	393	79.70	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			209.4	D08		9	0100-0289	208.49	288.97	393	76.08	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			287.3	D08		9	0101-0297	517.43	296.76	791	111.40	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			410.6	D08		9	0102-0291	73.87	291.40	377	71.84	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			215.0	D08		9	0103-0295	920.34	294.67	394	75.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			250.2	D08		9	0104-0296	719.32	296.25	389	76.08	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			323.5	D08		9	0105-0297	820.86	296.95	387	73.84	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			205.0	D08		9	0106-0304	162.89	304.23	724	104.57	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			232.7	D08		9	0107-0296	383.18	295.94	379	73.01	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			244.5	D08		9	0108-0298	261.09	298.23	391	73.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			315.0	D08		9	0109-0301	126.12	301.54	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			230.3	D08		9	0110-0301	900.33	301.91	402	82.18	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			218.7	D08		9	0111-0305	40.73	305.65	391	77.01	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			227.9	D08		9	0112-0306	200.21	307.44	419	82.91	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			274.6	D08		9	0113-0312	434.13	312.14	409	75.26	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			212.0	D08		9	0114-0316	880.46	315.48	381	73.50	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			228.1	D08		9	0115-0323	60.64	322.66	395	77.84	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			250.0	D08		9	0116-0324	317.09	323.94	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			458.8	D08		9	0117-0326	248.09	326.70	408	73.60	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			261.6	D08		9	0118-0325	635.30	324.89	385	73.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			581.8	D08		9	0119-0328	373.64	328.69	414	76.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			671.4	D08		9	0120-0333	478.24	333.17	391	73.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			346.8	D08		9	0121-0334	518.50	334.38	419	77.01	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			376.2	D08		9	0122-0340	574.93	340.26	413	75.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			319.0	D08		9	0123-0342	132.05	341.66	397	74.08	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			266.5	D08		9	0124-0346	929.21	345.80	380	75.94	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			282.0	D08		9	0125-0351	225.07	350.96	642	95.74	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			265.6	D08		9	0126-0349	846.02	349.50	381	73.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			440.1	D08		9	0127-0354	682.81	354.31	438	83.98	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			602.4	D08		9	0128-0358	520.07	357.55	423	78.18	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			256.1	D08		9	0129-0361	313.84	360.59	408	78.18	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			707.5	D08		9	0130-0361	810.32	360.87	426	77.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			627.0	D08		9	0131-0368	888.14	368.11	827	118.81	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			280.2	D08		9	0132-0365	295.33	366.12	359	75.21	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			367.8	D08		9	0133-0368	275.28	367.58	453	82.04	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			375.8	D08		9	0134-0369	122.11	369.40	389	76.43	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			291.4	D08		9	0135-0373	189.40	373.03	404	79.15	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			269.7	D08		9	0136-0384	71.53	384.19	382	74.43	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			268.5	D08		9	0137-0388	237.86	388.08	742	104.23	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			962.8	D08		9	0138-0391	207.08	391.67	461	83.84	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			305.6	D08		9	0139-0390	590.14	390.31	388	74.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			310.1	D08		9	0140-0391	753.46	391.08	394	74.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1679.3	D08		9	0141-0405	506.02	405.02	627	95.64	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1036.0	D08		9	0142-0409	630.87	409.11	412	75.60	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			435.9	D08		9	0143-0415	912.32	415.15	681	102.81	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1203.8	D08		9	0144-0413	410.62	413.37	395	73.84	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			262.7	D08		9	0145-0416	296.49	416.09	609	92.91	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			780.5	D08		9	0146-0415	210.30	414.22	360	72.53	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			286.9	D08		9	0147-0421	943.69	422.81	390	94.57	0.548
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			425.1	D08		9	0148-0424	144.14	422.40	940	120.95	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			440.3	D08		9	0149-0418	568.80	418.83	391	73.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			343.3	D08		9	0150-0426	458.36	426.56	387	71.60	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			751.8	D08		9	0151-0433	80.54	432.57	370	74.91	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			279.3	D08		9	0152-0439	352.40	439.52	386	74.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			418.3	D08		9	0153-0447	256.37	447.18	381	78.67	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			256.1	D08		9	0154-0450	757.46	449.77	377	73.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			506.6	D08		9	0155-0454	560.48	453.62	385	73.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			411.5	D08		9	0156-0458	870.25	458.05	663	95.74	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			456.2	D08		9	0157-0458	205.69	458.53	371	71.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			979.0	D08		9	0158-0458	329.27	458.74	406	75.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			267.4	D08		9	0159-0458	650.51	458.66	398	75.26	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			301.1	D08		9	0160-0462	520.47	462.25	402	75.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			373.3	D08		9	0161-0467	263.57	467.17	452	83.26	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			243.0	D08		9	0162-0468	16.54	467.93	374	71.84	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			357.7	D08		9	0163-0472	403.79	472.47	402	76.18	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			381.5	D08		9	0164-0477	903.92	477.48	517	86.33	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			189.8	D08		9	0165-0492	90.84	491.39	786	115.40	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			383.0	D08		9	0166-0487	942.99	487.59	362	71.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			520.1	D08		9	0167-0499	186.12	500.16	391	75.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			229.4	D08		9	0168-0502	514.94	502.30	403	74.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			871.7	D08		9	0169-0509	862.02	509.84	373	71.84	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			483.7	D08		9	0170-0512	468.13	511.72	397	75.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			370.0	D08		9	0171-0513	775.33	513.07	380	74.67	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			296.7	D08		9	0172-0517	556.44	516.30	415	79.50	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			312.6	D08		9	0173-0520	270.30	519.66	642	94.33	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			313.0	D08		9	0174-0520	181.41	520.11	444	82.18	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			229.3	D08		9	0175-0532	226.41	531.71	396	73.84	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2329.3	D08		9	0176-0537	542.74	538.48	362	74.77	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			399.9	D08		9	0177-0540	403.69	540.32	346	69.94	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1985.4	D08		9	0178-0545	561.00	545.00	297	67.60	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			508.4	D08		9	0179-0544	944.64	544.28	384	73.26	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3819.7	D08		9	0180-0546	841.98	546.34	389	72.43	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			427.5	D08		9	0181-0550	301.68	550.16	392	73.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			343.9	D08		9	0182-0561	415.75	561.58	694	106.23	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2839.5	D08		9	0183-0555	544.47	555.11	252	61.46	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			383.3	D08		9	0184-0562	514.95	562.28	417	76.67	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			923.5	D08		9	0185-0569	793.03	569.10	400	75.84	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			303.2	D08		9	0186-0572	258.47	571.14	339	70.91	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			308.3	D08		9	0187-0582	210.17	582.11	368	73.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			315.8	D08		9	0188-0584	273.44	585.56	492	85.88	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1089.1	D08		9	0189-0583	903.29	582.47	449	79.50	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			343.4	D08		9	0190-0586	660.06	585.62	380	73.84	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			384.3	D08		9	0191-0595	175.90	595.08	377	73.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			257.7	D08		9	0192-0601	327.94	601.43	383	73.01	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			233.5	D08		9	0193-0602	461.92	602.65	373	71.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			285.7	D08		9	0194-0611	659.43	611.53	398	74.67	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			520.2	D08		9	0195-0611	904.60	611.52	385	73.26	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			261.3	D08		9	0196-0615	23.70	614.59	387	75.01	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			275.3	D08		9	0197-0621	489.54	621.59	400	74.43	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			293.9	D08		9	0198-0623	814.69	623.36	394	74.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			222.8	D08		9	0199-0627	281.70	626.41	385	73.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			303.9	D08		9	0200-0631	862.18	631.39	385	73.60	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			218.5	D08		9	0201-0634	165.99	634.41	427	77.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			486.1	D08		9	0202-0648	628.33	646.60	406	78.33	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			370.1	D08		9	0203-0647	399.11	647.27	413	76.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			950.3	D08		9	0204-0647	522.59	648.08	369	73.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			309.2	D08		9	0205-0652	900.01	652.45	351	69.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			250.9	D08		9	0206-0655	100.16	655.09	375	76.33	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1067.2	D08		9	0207-0663	616.05	664.54	508	86.57	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			467.8	D08		9	0208-0667	123.12	666.61	455	80.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			260.2	D08		9	0209-0669	561.54	668.87	382	72.43	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			243.0	D08		9	0210-0676	20.62	676.36	402	73.84	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			283.1	D08		9	0211-0678	512.28	677.79	408	75.50	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			679.6	D08		9	0212-0678	676.22	677.75	470	82.08	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			412.6	D08		9	0213-0694	165.23	693.52	415	76.91	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			281.6	D08		9	0214-0699	536.83	699.76	921	117.30	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			283.6	D08		9	0215-0693	258.74	693.52	405	75.26	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			632.7	D08		9	0216-0696	605.92	696.41	379	73.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			271.8	D08		9	0217-0700	784.99	699.49	381	74.67	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			168.5	E08		1	0001-0030	45.07	30.65	419	80.67	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			457.1	E08		1	0002-0042	167.76	42.28	443	77.60	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			315.2	E08		1	0003-0041	625.93	41.06	415	75.01	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1168.4	E08		1	0004-0042	714.23	42.07	387	73.01	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1424.7	E08		1	0005-0046	412.33	45.77	490	84.57	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			303.5	E08		1	0006-0048	453.57	48.42	492	82.08	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			299.5	E08		1	0007-0053	567.12	53.63	471	82.08	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			759.8	E08		1	0008-0063	182.59	62.93	485	84.33	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			381.0	E08		1	0009-0067	34.57	67.11	550	86.91	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			377.2	E08		1	0010-0075	78.32	74.79	442	77.84	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			425.2	E08		1	0011-0073	829.94	73.27	221	56.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			488.2	E08		1	0012-0088	611.67	88.17	454	79.26	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			449.5	E08		1	0013-0088	502.07	88.60	548	90.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			337.6	E08		1	0014-0086	852.50	87.02	282	66.53	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			410.2	E08		1	0015-0091	719.29	91.65	462	80.08	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			386.8	E08		1	0016-0091	524.71	92.67	373	76.53	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			682.1	E08		1	0017-0098	47.05	98.76	435	77.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			798.0	E08		1	0018-0100	168.02	100.31	424	76.43	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			285.8	E08		1	0019-0100	281.75	99.91	402	73.60	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			320.0	E08		1	0020-0101	804.02	101.06	404	76.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			327.6	E08		1	0021-0101	759.55	101.44	445	79.84	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			691.5	E08		1	0022-0107	241.68	107.62	782	109.05	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			348.7	E08		1	0023-0107	355.42	107.05	439	76.43	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			529.9	E08		1	0024-0114	690.88	114.24	486	81.84	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			401.0	E08		1	0025-0121	127.38	120.85	508	89.74	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			327.9	E08		1	0026-0128	900.25	128.11	430	79.60	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			376.0	E08		1	0027-0133	881.34	132.98	363	74.18	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			461.0	E08		1	0028-0136	456.29	136.38	497	86.77	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			427.0	E08		1	0029-0143	481.89	143.29	489	88.67	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			250.3	E08		1	0030-0146	52.86	146.04	428	76.43	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1011.2	E08		1	0031-0149	733.33	148.93	470	84.08	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			230.8	E08		1	0032-0152	636.15	151.24	411	81.50	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			257.7	E08		1	0033-0156	179.65	155.98	413	75.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			293.1	E08		1	0034-0158	695.52	158.70	454	79.26	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			310.0	E08		1	0035-0163	356.63	163.51	438	80.67	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3432.0	E08		1	0036-0167	538.52	166.59	422	77.26	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			226.8	E08		1	0037-0167	625.67	168.24	495	85.74	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1287.9	E08		1	0038-0181	256.69	180.51	798	105.40	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			544.5	E08		1	0039-0177	940.24	176.77	643	113.98	0.622
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			711.6	E08		1	0040-0182	919.56	184.38	246	70.43	0.623
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			371.3	E08		1	0041-0188	417.75	187.91	483	82.91	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			237.1	E08		1	0042-0193	890.39	193.06	442	76.67	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			252.9	E08		1	0043-0198	114.34	198.34	433	77.84	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			274.4	E08		1	0044-0197	159.98	196.69	427	75.84	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			411.9	E08		1	0045-0199	194.67	198.65	454	80.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			348.1	E08		1	0046-0201	473.12	201.79	429	77.26	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			276.3	E08		1	0047-0203	52.74	203.81	405	75.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			229.9	E08		1	0048-0205	90.17	204.94	458	80.91	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			326.6	E08		1	0049-0205	597.63	204.93	433	76.43	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			667.5	E08		1	0050-0207	801.58	207.66	443	78.67	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			257.0	E08		1	0051-0216	416.35	216.78	451	79.50	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			276.1	E08		1	0052-0222	646.65	223.11	432	79.50	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			889.3	E08		1	0053-0228	871.80	227.91	434	78.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			425.4	E08		1	0054-0226	549.57	226.53	449	78.43	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1362.7	E08		1	0055-0228	840.53	228.39	456	82.33	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			247.0	E08		1	0056-0230	38.92	230.56	395	73.26	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			254.4	E08		1	0057-0245	203.72	245.39	997	129.78	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			245.4	E08		1	0058-0242	477.31	241.90	432	77.26	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			298.0	E08		1	0059-0243	328.76	243.39	580	90.08	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			618.7	E08		1	0060-0251	898.82	251.02	446	77.84	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			259.9	E08		1	0061-0252	519.77	252.54	428	77.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			274.6	E08		1	0062-0253	294.10	253.48	444	77.84	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			696.3	E08		1	0063-0253	767.58	253.20	426	77.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			559.4	E08		1	0064-0262	151.82	262.30	429	77.01	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			586.6	E08		1	0065-0269	833.89	269.22	638	92.91	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			314.7	E08		1	0066-0272	70.77	270.22	706	105.30	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			375.5	E08		1	0067-0269	232.72	268.95	431	77.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			333.9	E08		1	0068-0269	364.87	269.58	436	79.50	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			357.3	E08		1	0069-0270	581.58	269.89	455	79.26	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			284.3	E08		1	0070-0281	485.61	280.87	432	78.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			266.3	E08		1	0071-0289	84.53	290.53	682	104.71	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			271.0	E08		1	0072-0289	194.45	288.69	460	80.67	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			232.5	E08		1	0073-0288	264.75	288.32	431	77.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			476.3	E08		1	0074-0293	797.62	293.31	481	84.08	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			450.6	E08		1	0075-0305	755.92	305.48	433	77.26	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			264.9	E08		1	0076-0304	24.11	305.07	407	77.26	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			236.0	E08		1	0077-0304	106.05	305.36	391	74.08	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			290.7	E08		1	0078-0311	708.14	311.30	480	83.74	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			252.1	E08		1	0079-0324	426.88	324.06	459	80.67	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			217.7	E08		1	0080-0325	155.70	324.92	410	75.26	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			356.4	E08		1	0081-0325	510.81	325.96	429	79.50	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			276.3	E08		1	0082-0328	277.00	327.76	413	75.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			884.3	E08		1	0083-0342	555.08	342.00	894	117.64	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			459.4	E08		1	0084-0345	354.40	344.76	908	122.57	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			557.9	E08		1	0085-0336	328.34	336.14	460	79.60	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			254.9	E08		1	0086-0337	189.42	337.44	426	77.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1186.9	E08		1	0087-0339	465.96	338.48	395	75.70	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			324.2	E08		1	0088-0339	801.06	339.25	480	81.26	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1164.1	E08		1	0089-0341	484.56	340.81	352	70.87	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			296.2	E08		1	0090-0351	904.71	350.58	428	78.08	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			229.4	E08		1	0091-0352	928.99	351.53	454	80.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			208.3	E08		1	0092-0351	95.71	351.12	406	75.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			385.1	E08		1	0093-0357	647.60	356.77	433	78.91	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			405.0	E08		1	0094-0370	457.83	370.44	943	123.64	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			257.5	E08		1	0095-0361	501.42	360.90	351	71.94	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			703.9	E08		1	0096-0371	663.63	371.45	456	84.57	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			435.0	E08		1	0097-0368	188.22	368.04	436	79.50	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			273.6	E08		1	0098-0371	596.97	371.40	448	79.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			214.8	E08		1	0099-0370	63.32	370.48	412	78.08	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			266.3	E08		1	0100-0369	275.88	369.77	423	76.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			274.0	E08		1	0101-0379	508.26	379.37	483	86.67	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			514.1	E08		1	0102-0380	816.50	380.84	437	79.50	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			599.1	E08		1	0103-0392	674.25	392.50	491	83.26	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			234.6	E08		1	0104-0392	134.34	392.60	425	76.43	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			364.1	E08		1	0105-0395	787.89	394.74	460	80.08	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			427.1	E08		1	0106-0397	710.62	397.69	428	77.84	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			250.7	E08		1	0107-0404	622.35	404.81	425	77.26	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			323.2	E08		1	0108-0408	927.12	408.71	622	92.91	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			239.2	E08		1	0109-0408	202.68	407.87	460	82.08	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			278.9	E08		1	0110-0410	447.45	410.02	447	79.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			282.3	E08		1	0111-0410	524.60	409.87	428	77.26	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			278.5	E08		1	0112-0412	230.55	412.57	450	80.08	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			202.5	E08		1	0113-0421	62.27	421.92	824	114.71	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			648.7	E08		1	0114-0414	389.83	414.33	420	76.91	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			265.5	E08		1	0115-0418	264.20	418.41	416	76.67	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			329.6	E08		1	0116-0419	884.01	419.03	418	77.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			245.7	E08		1	0117-0420	149.68	421.22	460	85.50	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			259.6	E08		1	0118-0424	786.24	424.27	462	82.18	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			486.6	E08		1	0119-0424	585.75	424.81	484	82.08	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			242.6	E08		1	0120-0424	113.98	424.14	456	78.67	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			372.6	E08		1	0121-0430	738.05	430.83	419	75.84	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			257.0	E08		1	0122-0437	548.25	437.22	430	77.26	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			265.6	E08		1	0123-0443	679.62	443.50	452	78.43	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			304.6	E08		1	0124-0452	452.68	451.69	956	125.68	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			212.7	E08		1	0125-0455	21.35	455.63	811	114.33	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			788.7	E08		1	0126-0448	861.22	449.47	388	74.04	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			204.5	E08		1	0127-0452	942.36	452.57	419	78.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			238.3	E08		1	0128-0455	97.13	455.50	413	79.84	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			374.3	E08		1	0129-0458	378.27	458.43	435	76.67	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			216.6	E08		1	0130-0461	192.39	459.84	436	78.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			213.7	E08		1	0131-0460	249.49	459.97	406	74.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			279.1	E08		1	0132-0463	493.64	462.81	434	78.08	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			239.4	E08		1	0133-0462	739.66	462.49	417	77.26	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			301.9	E08		1	0134-0470	301.00	469.97	456	82.08	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			272.2	E08		1	0135-0469	532.78	469.25	421	78.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			449.4	E08		1	0136-0467	582.60	466.82	405	74.18	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			480.2	E08		1	0137-0473	855.50	471.79	473	91.84	0.705
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			278.0	E08		1	0138-0475	110.41	475.53	551	93.60	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			440.3	E08		1	0139-0477	875.10	477.05	463	83.15	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			254.1	E08		1	0140-0476	680.21	476.62	444	77.84	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			254.9	E08		1	0141-0480	136.78	480.05	414	77.36	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			245.1	E08		1	0142-0490	209.33	490.94	904	124.23	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			273.6	E08		1	0143-0486	620.14	486.40	460	80.67	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			238.9	E08		1	0144-0485	752.77	484.45	423	76.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			454.0	E08		1	0145-0495	165.67	495.01	458	79.26	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			271.0	E08		1	0146-0498	885.52	498.56	448	80.33	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			343.0	E08		1	0147-0496	358.26	496.12	412	75.84	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			256.2	E08		1	0148-0502	272.90	501.84	428	78.08	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			283.6	E08		1	0149-0503	538.56	503.36	440	79.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			266.7	E08		1	0150-0504	591.68	504.75	436	77.84	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			340.3	E08		1	0151-0508	54.27	507.66	446	82.33	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			296.1	E08		1	0152-0510	455.95	510.37	437	78.91	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			522.0	E08		1	0153-0520	219.13	519.44	450	81.36	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			495.8	E08		1	0154-0522	187.38	522.40	432	83.50	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			457.1	E08		1	0155-0523	792.97	523.36	427	78.67	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			285.5	E08		1	0156-0527	307.68	528.11	430	80.53	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			685.3	E08		1	0157-0531	68.21	531.31	459	82.08	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			247.7	E08		1	0158-0529	624.88	529.41	418	77.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			275.5	E08		1	0159-0530	716.03	530.46	419	75.84	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1651.7	E08		1	0160-0529	850.33	529.04	149	80.57	0.288
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			743.0	E08		1	0161-0537	112.53	537.02	423	76.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			225.6	E08		1	0162-0543	18.86	543.23	388	76.08	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			281.2	E08		1	0163-0545	650.13	545.60	446	80.33	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			794.2	E08		1	0164-0546	936.83	546.77	456	82.43	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			417.6	E08		1	0165-0547	407.42	546.67	432	77.26	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			273.3	E08		1	0166-0549	307.82	547.82	469	84.53	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			307.1	E08		1	0167-0550	162.08	550.18	396	76.43	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			259.5	E08		1	0168-0550	588.08	550.21	436	76.43	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			224.8	E08		1	0169-0558	202.67	558.45	848	115.54	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			186.9	E08		1	0170-0555	49.17	555.21	173	51.11	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			394.0	E08		1	0171-0559	264.46	558.77	440	77.60	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			738.0	E08		1	0172-0567	884.03	567.85	446	79.84	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			292.6	E08		1	0173-0568	916.26	568.48	440	81.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			505.4	E08		1	0174-0569	340.67	568.74	461	80.91	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			420.3	E08		1	0175-0575	375.94	575.06	717	100.57	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			338.8	E08		1	0176-0572	492.05	571.93	452	79.26	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			248.8	E08		1	0177-0584	120.96	583.77	855	117.50	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			299.7	E08		1	0178-0588	729.45	587.53	442	78.67	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			262.5	E08		1	0179-0600	777.15	599.75	450	80.67	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			199.2	E08		1	0180-0601	931.97	601.38	424	78.91	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			559.3	E08		1	0181-0604	627.24	604.09	475	82.91	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			350.2	E08		1	0182-0606	347.15	606.58	459	81.26	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			439.9	E08		1	0183-0618	391.24	618.44	390	73.84	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			222.9	E08		1	0184-0620	797.93	620.38	546	91.60	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			258.7	E08		1	0185-0637	64.60	637.63	890	119.30	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			317.9	E08		1	0186-0631	719.70	631.93	467	81.60	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			323.1	E08		1	0187-0631	176.97	631.35	403	76.67	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			523.3	E08		1	0188-0631	697.91	631.62	408	74.53	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			327.0	E08		1	0189-0632	215.71	632.05	430	79.50	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			423.8	E08		1	0190-0637	18.73	637.73	398	78.91	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			346.0	E08		1	0191-0635	553.23	634.85	420	77.26	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			325.9	E08		1	0192-0640	93.70	640.64	451	79.74	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			459.5	E08		1	0193-0639	869.53	638.74	414	76.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			373.9	E08		1	0194-0643	330.43	643.90	423	76.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			281.7	E08		1	0195-0655	426.54	655.75	880	119.05	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			240.8	E08		1	0196-0651	773.20	651.09	440	77.84	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			281.7	E08		1	0197-0655	649.45	655.53	469	82.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			534.2	E08		1	0198-0655	388.48	654.75	422	78.67	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			752.9	E08		1	0199-0654	481.44	654.30	409	75.01	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			367.4	E08		1	0200-0660	517.44	660.08	452	80.91	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			257.1	E08		1	0201-0661	932.46	661.06	366	71.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			394.5	E08		1	0202-0662	256.71	662.73	437	83.60	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			427.5	E08		1	0203-0666	826.30	664.91	413	79.15	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			660.2	E08		1	0204-0678	175.43	678.36	407	77.11	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			264.9	E08		1	0205-0678	554.22	678.45	450	81.26	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			453.8	E08		1	0206-0678	633.42	677.98	463	82.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			189.7	E08		1	0207-0678	841.42	678.77	388	74.33	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			904.0	E08		1	0208-0682	195.20	682.98	450	81.11	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			399.3	E08		1	0209-0683	262.51	682.34	435	82.18	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			177.9	E08		1	0210-0688	499.60	687.89	420	78.43	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			309.8	E08		1	0211-0690	890.26	690.34	383	71.60	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			293.6	E08		1	0212-0693	757.85	693.38	439	78.08	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			426.8	E08		1	0213-0695	110.13	695.18	404	77.50	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			215.1	E08		1	0214-0702	565.03	701.68	495	86.08	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			197.8	E08		1	0215-0707	378.50	706.73	399	75.84	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1048.9	E08		1	0216-0708	471.87	707.00	351	73.26	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			225.2	E08		2	0001-0027	890.67	26.94	374	73.01	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			223.6	E08		2	0002-0034	802.74	33.78	411	77.26	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			267.0	E08		2	0003-0044	398.89	44.05	408	77.50	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			251.8	E08		2	0004-0045	267.59	45.26	384	75.01	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			304.9	E08		2	0005-0060	539.47	60.49	420	77.26	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			304.2	E08		2	0006-0061	333.18	61.84	459	82.67	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			359.0	E08		2	0007-0062	725.90	61.80	405	76.67	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			366.0	E08		2	0008-0070	697.13	69.59	751	109.40	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			300.1	E08		2	0009-0064	854.95	64.08	402	74.43	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			385.6	E08		2	0010-0068	564.60	67.98	393	74.43	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			421.4	E08		2	0011-0069	311.70	68.45	377	75.60	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			303.7	E08		2	0012-0074	139.75	73.75	380	73.26	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			544.2	E08		2	0013-0079	623.33	79.13	403	75.84	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			528.0	E08		2	0014-0080	806.89	80.21	477	87.26	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1112.9	E08		2	0015-0080	193.12	80.01	410	78.33	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			279.3	E08		2	0016-0080	243.00	80.22	382	75.26	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			313.6	E08		2	0017-0079	410.94	79.08	423	77.60	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2448.5	E08		2	0018-0084	785.43	83.93	358	70.53	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			345.9	E08		2	0019-0093	67.94	93.43	387	76.08	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1362.0	E08		2	0020-0097	274.93	97.74	306	64.77	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			402.4	E08		2	0021-0104	136.10	104.59	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			293.0	E08		2	0022-0108	442.80	108.17	426	76.43	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1387.1	E08		2	0023-0111	362.97	110.55	364	71.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			297.1	E08		2	0024-0121	683.13	121.47	785	109.88	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			611.1	E08		2	0025-0123	483.35	123.12	381	73.26	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			305.2	E08		2	0026-0127	775.47	127.33	423	78.67	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			348.0	E08		2	0027-0130	354.62	131.04	437	81.50	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			720.7	E08		2	0028-0133	175.78	133.20	395	76.08	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			238.2	E08		2	0029-0133	850.39	133.45	427	78.67	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			361.3	E08		2	0030-0135	378.24	135.97	430	77.26	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			344.8	E08		2	0031-0140	234.73	139.82	400	76.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			317.4	E08		2	0032-0138	422.68	138.62	400	76.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1218.4	E08		2	0033-0147	100.48	147.50	491	83.50	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1384.3	E08		2	0034-0148	724.33	148.39	411	77.50	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			246.2	E08		2	0035-0149	909.00	149.21	391	75.60	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			344.9	E08		2	0036-0161	572.53	161.61	429	78.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			260.7	E08		2	0037-0166	805.96	164.76	428	77.98	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			927.6	E08		2	0038-0167	461.77	167.52	388	73.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			352.5	E08		2	0039-0169	138.99	169.37	396	73.01	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			297.0	E08		2	0040-0176	668.51	175.77	408	76.08	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1466.6	E08		2	0041-0170	27.63	170.20	115	43.11	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			292.5	E08		2	0042-0177	314.08	177.40	384	74.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			444.6	E08		2	0043-0179	46.42	178.70	548	92.57	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			262.1	E08		2	0044-0178	790.37	179.08	372	73.74	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			445.9	E08		2	0045-0182	402.87	182.10	409	75.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			275.5	E08		2	0046-0193	513.15	193.35	924	119.05	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			767.3	E08		2	0047-0184	24.07	185.47	235	66.43	0.669
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			344.0	E08		2	0048-0187	77.70	186.86	377	72.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			347.2	E08		2	0049-0187	877.36	186.70	392	74.08	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			302.4	E08		2	0050-0195	621.74	195.76	405	75.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			354.2	E08		2	0051-0193	258.36	193.62	382	75.60	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			232.9	E08		2	0052-0194	724.88	193.94	428	82.08	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			304.1	E08		2	0053-0203	168.99	203.55	395	76.67	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			564.0	E08		2	0054-0206	420.38	205.55	442	79.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			259.3	E08		2	0055-0207	827.80	207.35	418	75.01	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			223.6	E08		2	0056-0210	51.74	209.85	399	75.50	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			252.0	E08		2	0057-0222	369.13	222.56	396	74.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			388.8	E08		2	0058-0220	809.97	219.30	252	61.84	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			327.6	E08		2	0059-0225	138.35	225.82	377	76.33	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			313.7	E08		2	0060-0225	744.58	224.81	387	72.43	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			741.8	E08		2	0061-0227	215.53	227.48	439	82.67	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			263.4	E08		2	0062-0227	794.99	228.06	380	80.18	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			506.3	E08		2	0063-0238	563.83	238.32	597	91.26	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			391.8	E08		2	0064-0234	268.82	234.46	438	79.01	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			331.1	E08		2	0065-0248	329.53	248.37	391	74.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			211.5	E08		2	0066-0248	76.01	248.58	386	72.43	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			234.8	E08		2	0067-0258	791.77	257.78	926	128.23	0.708
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1400.5	E08		2	0068-0251	221.60	250.53	395	78.67	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			344.0	E08		2	0069-0251	679.71	251.58	412	75.01	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			475.0	E08		2	0070-0256	913.82	256.63	581	89.50	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			316.2	E08		2	0071-0260	634.98	259.87	382	72.77	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			219.6	E08		2	0072-0266	169.77	266.61	555	96.23	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			273.9	E08		2	0073-0264	451.20	264.72	414	76.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			551.8	E08		2	0074-0266	525.51	266.37	435	83.74	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			256.3	E08		2	0075-0274	371.77	274.85	796	111.64	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			332.1	E08		2	0076-0271	411.01	271.76	403	74.67	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			476.0	E08		2	0077-0270	500.82	269.96	400	77.01	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			415.5	E08		2	0078-0293	308.49	292.92	419	77.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			481.5	E08		2	0079-0294	470.07	294.22	400	77.50	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			324.2	E08		2	0080-0297	67.35	297.65	383	73.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			334.3	E08		2	0081-0302	901.77	302.16	369	72.87	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			519.8	E08		2	0082-0302	923.60	301.95	389	74.28	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			391.7	E08		2	0083-0305	581.73	305.14	373	71.84	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			289.2	E08		2	0084-0310	171.84	310.52	381	72.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			899.7	E08		2	0085-0312	544.73	312.04	408	74.18	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			511.8	E08		2	0086-0313	622.31	313.79	659	123.98	0.539
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			260.7	E08		2	0087-0318	272.44	318.88	401	73.36	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			581.4	E08		2	0088-0327	478.15	327.67	419	81.50	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			756.8	E08		2	0089-0329	142.75	328.87	383	71.60	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			349.4	E08		2	0090-0336	451.27	335.94	416	79.50	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			371.9	E08		2	0091-0339	252.17	339.52	404	75.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			474.4	E08		2	0092-0342	303.53	342.63	382	73.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1000.7	E08		2	0093-0344	403.85	343.81	406	78.91	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			456.6	E08		2	0094-0347	823.72	347.14	383	72.43	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			310.8	E08		2	0095-0348	69.00	348.26	383	74.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			274.1	E08		2	0096-0348	226.00	348.72	398	75.84	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			254.4	E08		2	0097-0352	33.51	352.30	399	76.91	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			336.0	E08		2	0098-0351	882.76	350.71	322	69.70	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			265.8	E08		2	0099-0362	151.49	362.52	394	74.67	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			299.5	E08		2	0100-0367	622.50	367.96	417	75.84	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			887.1	E08		2	0101-0371	347.12	371.36	439	78.67	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			286.9	E08		2	0102-0372	879.45	371.13	475	87.50	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			304.5	E08		2	0103-0380	574.82	380.03	402	76.08	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			258.7	E08		2	0104-0390	709.91	389.84	825	113.88	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			274.7	E08		2	0105-0388	95.79	388.54	386	75.50	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			346.5	E08		2	0106-0388	199.33	387.52	442	82.33	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			343.7	E08		2	0107-0390	526.13	389.65	420	80.57	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			307.8	E08		2	0108-0401	820.21	401.50	419	77.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			229.1	E08		2	0109-0402	510.01	403.04	445	80.08	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			349.1	E08		2	0110-0402	654.01	401.98	422	76.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			301.7	E08		2	0111-0406	219.36	406.64	536	89.64	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			247.6	E08		2	0112-0404	292.52	404.38	753	105.50	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			304.8	E08		2	0113-0409	30.77	409.53	628	93.15	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			226.3	E08		2	0114-0406	173.15	406.25	382	73.84	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			206.2	E08		2	0115-0408	120.03	408.10	388	75.26	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			203.3	E08		2	0116-0410	779.56	411.26	437	84.43	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			246.0	E08		2	0117-0413	750.21	412.69	398	75.60	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			365.3	E08		2	0118-0441	495.53	441.66	922	128.81	0.698
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			214.0	E08		2	0119-0435	202.35	435.47	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			292.0	E08		2	0120-0436	438.90	436.64	395	75.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			214.4	E08		2	0121-0439	144.52	438.62	374	72.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			317.6	E08		2	0122-0444	560.08	444.52	417	76.43	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			237.0	E08		2	0123-0453	46.63	453.32	389	75.84	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			331.5	E08		2	0124-0451	476.99	452.07	314	69.94	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3053.1	E08		2	0125-0449	761.44	448.87	161	77.50	0.337
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			342.7	E08		2	0126-0454	380.38	454.11	412	76.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			287.0	E08		2	0127-0457	649.09	457.94	398	76.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			257.9	E08		2	0128-0460	248.91	459.73	375	74.91	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			202.6	E08		2	0129-0471	91.12	471.08	805	114.47	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			297.4	E08		2	0130-0466	923.56	466.10	402	74.67	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			298.7	E08		2	0131-0477	221.96	477.90	722	103.05	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			269.7	E08		2	0132-0473	126.82	472.96	380	72.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			324.7	E08		2	0133-0472	870.35	472.08	319	66.18	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			298.2	E08		2	0134-0475	296.63	475.43	382	75.50	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			217.6	E08		2	0135-0477	173.58	476.81	382	73.84	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1500.6	E08		2	0136-0481	602.06	481.41	489	82.67	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			390.7	E08		2	0137-0490	676.30	490.47	392	75.26	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			472.0	E08		2	0138-0500	890.82	500.70	374	72.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			274.6	E08		2	0139-0501	940.01	500.65	370	73.01	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			262.5	E08		2	0140-0499	617.99	499.08	269	64.43	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			494.3	E08		2	0141-0506	302.68	506.09	559	89.40	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			294.6	E08		2	0142-0504	163.22	503.63	432	81.40	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			435.8	E08		2	0143-0504	847.40	504.03	393	74.43	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1794.3	E08		2	0144-0513	603.02	513.03	283	82.08	0.528
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1414.1	E08		2	0145-0527	375.90	526.51	730	103.05	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			984.3	E08		2	0146-0531	777.66	531.02	435	78.67	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			285.7	E08		2	0147-0540	145.54	540.61	745	109.15	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			287.6	E08		2	0148-0533	531.60	533.96	399	77.50	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			331.3	E08		2	0149-0534	666.34	534.51	401	74.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			622.5	E08		2	0150-0541	707.75	541.05	253	77.84	0.525
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			826.5	E08		2	0151-0547	41.41	547.08	409	78.67	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			864.7	E08		2	0152-0548	73.99	548.39	407	75.26	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			419.6	E08		2	0153-0555	105.27	555.72	398	75.84	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1691.8	E08		2	0154-0551	653.87	551.61	207	52.53	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			394.4	E08		2	0155-0558	832.33	558.28	416	79.26	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			342.3	E08		2	0156-0559	572.73	560.47	817	118.57	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			282.5	E08		2	0157-0560	929.68	559.82	380	74.43	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			311.8	E08		2	0158-0569	20.54	569.14	412	80.33	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			566.6	E08		2	0159-0566	270.34	566.66	420	77.26	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			607.3	E08		2	0160-0576	633.39	576.43	400	73.60	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			762.8	E08		2	0161-0581	471.44	581.79	526	85.50	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			301.2	E08		2	0162-0580	347.13	580.43	396	75.84	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			317.3	E08		2	0163-0582	505.16	581.77	399	73.84	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			382.2	E08		2	0164-0589	591.50	589.08	371	71.26	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			771.0	E08		2	0165-0591	682.30	591.53	370	71.84	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			195.3	E08		2	0166-0600	105.82	600.27	371	71.60	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			240.1	E08		2	0167-0601	285.15	601.69	377	71.84	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			242.5	E08		2	0168-0600	717.83	600.31	422	77.84	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			187.0	E08		2	0169-0602	35.81	602.43	398	73.84	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			453.7	E08		2	0170-0604	200.19	604.23	457	82.08	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			243.9	E08		2	0171-0604	540.79	603.75	393	73.84	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			253.8	E08		2	0172-0609	327.17	609.00	407	77.26	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			316.1	E08		2	0173-0609	774.63	609.18	414	75.36	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			259.9	E08		2	0174-0613	797.36	612.87	461	80.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			308.8	E08		2	0175-0626	196.09	626.48	437	81.60	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			368.3	E08		2	0176-0632	421.06	632.33	407	77.26	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			394.5	E08		2	0177-0646	106.32	646.56	414	76.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			504.3	E08		2	0178-0660	737.33	659.93	429	84.47	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			301.1	E08		2	0179-0657	466.58	656.53	399	79.26	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			303.8	E08		2	0180-0660	350.58	660.47	385	73.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			240.2	E08		2	0181-0661	524.65	661.60	401	74.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			337.2	E08		2	0182-0661	774.24	662.08	435	81.74	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			285.3	E08		2	0183-0662	36.19	661.90	361	71.84	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			240.3	E08		2	0184-0671	157.97	671.75	818	111.40	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1010.8	E08		2	0185-0662	872.90	662.01	666	128.61	0.506
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			287.8	E08		2	0186-0666	289.22	666.21	380	74.08	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			238.6	E08		2	0187-0674	70.95	674.70	366	75.01	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			248.0	E08		2	0188-0677	235.00	676.63	377	73.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			335.6	E08		2	0189-0684	563.26	684.31	396	73.84	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			413.1	E08		2	0190-0691	449.32	690.88	405	76.91	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			519.7	E08		2	0191-0696	716.43	696.13	248	75.50	0.547
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			746.2	E08		2	0192-0702	342.18	702.41	490	87.40	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			339.3	E08		2	0193-0702	591.30	701.65	379	73.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			238.8	E08		3	0001-0028	415.24	28.39	399	76.08	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			680.6	E08		3	0002-0036	582.81	36.50	835	114.95	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			347.6	E08		3	0003-0047	790.25	47.08	573	92.81	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			436.0	E08		3	0004-0047	632.71	47.54	348	69.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			287.7	E08		3	0005-0049	842.21	49.68	380	74.08	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			374.1	E08		3	0006-0059	49.64	58.78	679	99.98	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			194.3	E08		3	0007-0060	451.37	60.22	416	75.84	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1180.5	E08		3	0008-0064	479.63	62.90	740	108.81	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			220.2	E08		3	0009-0067	192.44	67.96	397	75.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			180.5	E08		3	0010-0067	523.81	67.54	485	83.26	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			734.4	E08		3	0011-0073	252.22	73.24	390	75.50	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			252.4	E08		3	0012-0076	425.67	75.91	395	75.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			376.9	E08		3	0013-0076	760.09	75.86	341	69.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			333.3	E08		3	0014-0076	803.99	77.07	365	72.18	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			250.9	E08		3	0015-0079	104.63	79.58	364	71.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			981.1	E08		3	0016-0081	144.10	81.90	430	80.08	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			576.2	E08		3	0017-0087	231.50	86.77	441	82.91	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			508.4	E08		3	0018-0093	904.56	92.91	288	64.18	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			252.9	E08		3	0019-0099	632.40	98.90	380	75.50	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			269.4	E08		3	0020-0099	801.64	99.31	406	77.36	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			280.0	E08		3	0021-0101	606.85	101.13	443	82.33	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			246.6	E08		3	0022-0104	69.86	104.40	367	71.60	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			484.9	E08		3	0023-0109	554.71	109.17	424	76.67	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			374.0	E08		3	0024-0111	520.13	111.51	384	73.01	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			389.2	E08		3	0025-0117	491.15	117.00	391	73.36	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			349.8	E08		3	0026-0121	454.17	121.55	394	75.94	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			333.0	E08		3	0027-0120	664.67	120.27	349	68.77	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			415.6	E08		3	0028-0125	605.34	126.10	451	82.43	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			280.9	E08		3	0029-0128	760.48	127.64	369	73.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			271.4	E08		3	0030-0133	283.91	133.14	379	77.74	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			318.8	E08		3	0031-0139	43.87	140.08	647	96.33	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			289.9	E08		3	0032-0141	838.44	141.63	356	70.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			327.6	E08		3	0033-0144	462.69	143.91	345	71.60	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			455.8	E08		3	0034-0147	403.48	147.68	423	79.74	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			221.7	E08		3	0035-0145	556.73	145.56	373	72.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			326.0	E08		3	0036-0148	936.63	147.82	359	70.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			551.3	E08		3	0037-0161	105.56	160.15	819	113.74	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			489.7	E08		3	0038-0161	159.37	161.40	377	74.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			517.4	E08		3	0039-0164	694.96	163.46	415	78.57	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			259.0	E08		3	0040-0165	620.89	164.85	366	71.84	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			264.4	E08		3	0041-0168	542.45	167.59	374	70.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			599.6	E08		3	0042-0172	861.79	172.65	398	74.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			195.7	E08		3	0043-0174	581.78	175.04	388	72.43	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			370.5	E08		3	0044-0177	683.05	178.30	328	70.91	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			330.3	E08		3	0045-0180	195.44	180.37	403	77.84	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			634.3	E08		3	0046-0181	308.26	180.58	310	72.53	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			683.9	E08		3	0047-0192	761.51	191.65	599	91.26	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			283.7	E08		3	0048-0194	31.71	193.70	709	107.74	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			544.8	E08		3	0049-0193	307.19	192.85	192	57.11	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			266.1	E08		3	0050-0210	253.54	209.53	363	71.26	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			198.3	E08		3	0051-0214	662.03	214.98	374	73.84	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			318.7	E08		3	0052-0225	202.17	225.33	359	70.67	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			627.1	E08		3	0053-0233	894.48	232.88	741	113.20	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			211.5	E08		3	0054-0226	681.37	224.84	416	77.74	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			250.8	E08		3	0055-0226	622.13	226.02	368	72.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			319.7	E08		3	0056-0230	231.70	229.44	406	77.50	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			396.0	E08		3	0057-0229	432.85	229.64	372	71.84	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			259.3	E08		3	0058-0233	377.23	232.95	380	72.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			217.8	E08		3	0059-0238	698.28	238.85	444	79.15	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			340.0	E08		3	0060-0239	113.51	238.68	366	72.67	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			373.3	E08		3	0061-0248	500.11	247.44	356	70.67	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			642.7	E08		3	0062-0251	752.47	251.41	385	75.26	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			528.1	E08		3	0063-0256	162.63	255.61	376	76.91	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			277.3	E08		3	0064-0276	640.98	276.20	848	126.02	0.671
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			619.6	E08		3	0065-0267	864.53	267.31	398	74.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			208.1	E08		3	0066-0277	682.08	277.03	520	85.50	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			792.0	E08		3	0067-0280	937.73	280.03	369	72.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			331.6	E08		3	0068-0282	619.21	283.03	418	80.67	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			720.7	E08		3	0069-0283	243.07	283.34	402	77.50	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			531.3	E08		3	0070-0286	502.83	286.56	398	75.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			253.4	E08		3	0071-0297	168.63	296.89	692	98.33	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			336.2	E08		3	0072-0293	818.20	293.63	379	73.01	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			258.4	E08		3	0073-0295	365.72	296.06	381	73.26	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			175.1	E08		3	0074-0299	700.88	298.65	369	72.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			272.6	E08		3	0075-0304	116.70	303.98	384	75.26	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			502.8	E08		3	0076-0316	211.94	316.42	415	75.01	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			614.8	E08		3	0077-0329	802.76	329.64	374	71.01	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			372.9	E08		3	0078-0326	851.75	326.91	277	65.60	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			260.5	E08		3	0079-0340	682.57	340.35	401	76.67	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			688.6	E08		3	0080-0346	414.42	345.62	377	70.77	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			279.3	E08		3	0081-0351	596.96	351.22	418	77.60	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			423.0	E08		3	0082-0353	446.26	353.58	383	73.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			343.0	E08		3	0083-0355	895.73	355.83	370	72.67	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			673.6	E08		3	0084-0363	202.60	363.08	387	74.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			186.4	E08		3	0085-0368	142.99	367.77	372	77.84	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			401.5	E08		3	0086-0368	796.25	368.49	398	75.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			282.9	E08		3	0087-0370	633.01	370.73	390	73.84	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			544.2	E08		3	0088-0373	817.02	373.12	337	67.11	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			389.3	E08		3	0089-0376	858.96	376.34	183	53.94	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			258.3	E08		3	0090-0381	323.92	381.41	369	71.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			284.7	E08		3	0091-0384	710.82	384.50	772	107.74	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			277.7	E08		3	0092-0392	230.06	392.60	411	78.91	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			262.0	E08		3	0093-0389	667.16	389.10	379	75.01	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			267.3	E08		3	0094-0390	911.86	389.80	341	71.60	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			277.2	E08		3	0095-0393	139.73	394.28	338	68.18	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			396.8	E08		3	0096-0397	444.60	396.62	591	99.84	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			444.4	E08		3	0097-0399	533.28	399.79	365	72.67	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			311.6	E08		3	0098-0402	246.58	402.44	379	75.26	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			275.9	E08		3	0099-0404	357.90	403.92	369	72.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			437.9	E08		3	0100-0415	486.20	414.77	845	118.61	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			251.7	E08		3	0101-0421	164.73	421.37	387	76.43	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			302.1	E08		3	0102-0421	285.05	421.10	395	73.84	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			694.3	E08		3	0103-0427	465.41	427.88	436	79.98	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			219.4	E08		3	0104-0427	322.12	427.69	395	73.26	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			371.7	E08		3	0105-0430	638.37	430.24	746	107.05	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			345.7	E08		3	0106-0430	686.73	430.73	378	73.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			277.9	E08		3	0107-0434	108.10	433.85	387	73.84	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			273.9	E08		3	0108-0437	59.84	437.40	376	72.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			489.4	E08		3	0109-0439	611.79	439.72	327	67.26	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			422.6	E08		3	0110-0452	856.28	453.15	186	66.77	0.524
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			398.1	E08		3	0111-0462	894.04	461.91	377	72.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			244.8	E08		3	0112-0469	598.73	470.62	823	111.54	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			314.5	E08		3	0113-0466	199.40	465.88	395	76.43	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			302.0	E08		3	0114-0463	864.99	464.80	169	61.11	0.569
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			257.4	E08		3	0115-0468	18.62	468.60	375	72.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			204.3	E08		3	0116-0477	537.51	477.00	395	73.84	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			255.5	E08		3	0117-0480	53.51	480.49	349	71.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			230.0	E08		3	0118-0489	512.63	489.10	419	78.33	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			248.1	E08		3	0119-0487	713.79	487.75	393	75.01	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			284.5	E08		3	0120-0488	757.30	487.96	396	76.43	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			269.9	E08		3	0121-0496	472.71	496.72	389	73.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			226.7	E08		3	0122-0498	409.66	497.78	366	71.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			327.0	E08		3	0123-0503	35.08	503.00	328	68.77	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			230.6	E08		3	0124-0506	169.29	506.84	401	77.60	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			543.2	E08		3	0125-0503	870.94	502.71	369	74.43	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			271.8	E08		3	0126-0513	109.46	513.19	361	72.43	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			263.6	E08		3	0127-0525	449.52	527.03	799	124.81	0.645
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			251.4	E08		3	0128-0515	252.53	515.56	362	73.84	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			243.0	E08		3	0129-0517	190.70	517.05	390	76.33	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			337.5	E08		3	0130-0517	776.83	517.42	340	68.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			348.3	E08		3	0131-0515	808.51	515.00	361	70.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			281.1	E08		3	0132-0521	742.37	520.71	393	75.26	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			219.1	E08		3	0133-0523	296.24	523.06	380	73.26	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1688.6	E08		3	0134-0527	339.69	527.96	523	127.30	0.406
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			223.5	E08		3	0135-0526	587.22	526.52	410	75.36	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			477.5	E08		3	0136-0530	680.35	529.55	417	77.26	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			235.1	E08		3	0137-0531	419.13	531.53	366	72.43	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			230.1	E08		3	0138-0534	548.07	534.35	414	78.08	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			879.3	E08		3	0139-0540	362.14	540.66	391	77.50	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			276.6	E08		3	0140-0545	139.63	544.61	373	77.50	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			298.7	E08		3	0141-0549	525.84	548.52	465	82.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			220.4	E08		3	0142-0556	83.76	556.33	752	107.40	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			605.5	E08		3	0143-0545	688.86	545.38	210	58.77	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			229.8	E08		3	0144-0552	271.47	551.69	372	76.08	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			218.3	E08		3	0145-0557	400.75	557.74	400	75.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			366.9	E08		3	0146-0558	57.64	557.53	415	78.67	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			585.5	E08		3	0147-0557	669.21	557.34	312	65.36	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			245.7	E08		3	0148-0562	24.51	562.19	357	71.60	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			307.8	E08		3	0149-0563	135.43	563.83	398	77.84	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1390.9	E08		3	0150-0563	342.88	563.66	410	79.01	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			240.1	E08		3	0151-0571	182.53	571.83	359	72.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			434.7	E08		3	0152-0581	582.33	580.93	438	79.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1261.8	E08		3	0153-0590	358.55	589.37	813	117.40	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			382.7	E08		3	0154-0586	902.42	586.52	384	73.26	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			457.7	E08		3	0155-0589	448.82	589.10	400	76.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			328.7	E08		3	0156-0593	768.02	593.82	407	74.08	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			196.3	E08		3	0157-0595	502.68	596.04	364	71.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			549.6	E08		3	0158-0604	831.40	603.98	362	73.60	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			378.1	E08		3	0159-0609	640.19	610.11	432	80.33	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			342.1	E08		3	0160-0611	850.23	611.63	370	74.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			432.5	E08		3	0161-0615	610.75	615.08	382	74.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			362.3	E08		3	0162-0628	536.77	627.71	417	78.08	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			328.5	E08		3	0163-0629	888.03	629.44	361	69.84	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			262.5	E08		3	0164-0638	173.63	638.96	773	108.23	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			450.6	E08		3	0165-0632	368.35	632.47	374	72.18	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			278.8	E08		3	0166-0635	289.51	635.13	365	72.43	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			312.0	E08		3	0167-0635	466.65	635.64	364	71.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			284.4	E08		3	0168-0640	241.54	639.77	373	75.01	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			261.9	E08		3	0169-0646	811.99	645.99	397	76.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			821.1	E08		3	0170-0653	50.79	652.78	721	100.23	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			518.0	E08		3	0171-0657	403.07	657.42	389	75.94	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			421.4	E08		3	0172-0669	131.11	669.24	419	79.74	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			205.0	E08		3	0173-0666	790.26	666.03	364	71.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			250.9	E08		3	0174-0669	769.70	669.44	437	82.67	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			240.6	E08		3	0175-0670	282.60	669.71	408	77.50	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			186.9	E08		3	0176-0670	336.02	669.89	373	72.67	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			311.3	E08		3	0177-0676	711.71	675.45	327	70.67	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			247.7	E08		3	0178-0675	902.93	675.77	440	80.57	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			329.1	E08		3	0179-0678	399.08	677.28	461	83.26	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			255.4	E08		3	0180-0679	461.52	678.85	335	71.70	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			206.7	E08		3	0181-0681	480.11	681.06	401	74.87	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			282.0	E08		3	0182-0683	883.11	684.29	410	76.33	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			249.1	E08		3	0183-0686	522.20	685.85	368	71.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			273.7	E08		3	0184-0687	119.99	686.81	247	61.26	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			168.0	E08		3	0185-0690	171.31	690.63	386	73.84	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			179.4	E08		3	0186-0692	290.70	692.65	416	78.67	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			394.3	E08		3	0187-0693	698.95	693.60	331	68.43	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			649.4	E08		3	0188-0696	753.16	696.63	394	74.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			249.5	E08		3	0189-0702	238.41	702.66	741	105.40	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			201.2	E08		4	0001-0029	376.31	29.33	422	79.50	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1190.8	E08		4	0002-0030	469.53	29.71	401	77.50	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			297.7	E08		4	0003-0032	326.73	31.62	416	76.67	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			181.1	E08		4	0004-0035	166.80	35.50	385	74.67	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			252.7	E08		4	0005-0034	539.01	34.48	445	82.43	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			299.9	E08		4	0006-0034	38.45	34.57	375	74.33	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			373.9	E08		4	0007-0036	206.75	36.76	415	80.57	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			255.7	E08		4	0008-0042	639.40	41.71	375	73.50	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			298.8	E08		4	0009-0047	481.05	47.22	481	85.98	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			357.3	E08		4	0010-0051	403.40	51.21	468	82.33	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			257.9	E08		4	0011-0061	606.13	61.23	465	82.08	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			398.6	E08		4	0012-0061	870.01	62.05	423	76.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			358.9	E08		4	0013-0064	814.30	64.40	384	72.77	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			508.0	E08		4	0014-0070	776.89	69.91	432	80.08	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			281.9	E08		4	0015-0069	362.99	69.22	421	80.33	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			890.1	E08		4	0016-0075	690.51	75.10	436	78.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			285.4	E08		4	0017-0076	236.77	76.65	410	77.50	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			249.4	E08		4	0018-0077	538.56	77.41	475	87.15	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1335.9	E08		4	0019-0084	839.75	83.66	374	72.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			251.6	E08		4	0020-0087	511.66	87.27	484	87.15	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			267.6	E08		4	0021-0100	67.65	99.83	411	77.26	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			364.6	E08		4	0022-0102	191.26	101.85	442	80.67	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			310.0	E08		4	0023-0106	411.29	105.96	766	104.91	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			399.4	E08		4	0024-0103	436.90	103.15	459	81.36	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			461.8	E08		4	0025-0103	24.48	103.70	398	75.84	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			266.9	E08		4	0026-0108	564.96	108.42	928	128.95	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			242.4	E08		4	0027-0110	667.55	110.64	870	122.95	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			349.6	E08		4	0028-0108	915.24	107.70	423	78.43	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			451.8	E08		4	0029-0119	369.86	119.71	872	117.64	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			466.0	E08		4	0030-0117	483.56	116.96	693	99.98	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			255.7	E08		4	0031-0133	735.08	133.36	872	128.51	0.664
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			286.0	E08		4	0032-0132	793.21	132.41	434	79.50	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			338.2	E08		4	0033-0135	590.91	134.99	441	78.91	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			503.9	E08		4	0034-0138	284.81	138.69	455	83.15	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			243.4	E08		4	0035-0141	624.33	140.81	426	82.57	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			427.2	E08		4	0036-0140	258.61	140.15	317	69.50	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			756.7	E08		4	0037-0144	195.41	144.54	413	77.50	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			229.5	E08		4	0038-0144	893.43	144.56	395	74.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			343.4	E08		4	0039-0148	364.65	148.27	417	80.33	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1363.7	E08		4	0040-0164	122.86	165.55	853	117.78	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			347.5	E08		4	0041-0158	345.00	157.93	466	85.15	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			221.9	E08		4	0042-0158	658.78	158.60	415	76.67	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			889.1	E08		4	0043-0162	39.75	161.75	398	74.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			440.6	E08		4	0044-0163	477.58	162.65	392	73.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			208.9	E08		4	0045-0171	757.86	171.71	411	81.50	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			219.8	E08		4	0046-0179	690.09	179.95	451	82.91	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			290.7	E08		4	0047-0181	509.76	179.71	436	82.47	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			412.0	E08		4	0048-0180	423.86	179.86	449	82.91	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			620.0	E08		4	0049-0188	634.58	188.58	481	83.74	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			352.9	E08		4	0050-0191	491.16	193.10	435	82.33	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			241.7	E08		4	0051-0192	794.75	192.31	428	78.08	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			535.9	E08		4	0052-0197	550.39	197.01	414	79.26	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			247.1	E08		4	0053-0197	831.67	197.45	401	76.08	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			316.3	E08		4	0054-0202	411.77	202.14	485	90.33	0.747
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			294.1	E08		4	0055-0211	606.56	211.27	947	125.44	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			493.8	E08		4	0056-0206	385.02	206.39	456	82.67	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			343.7	E08		4	0057-0209	242.02	207.81	446	81.88	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			360.8	E08		4	0058-0212	67.31	211.81	423	79.26	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			431.8	E08		4	0059-0210	286.99	210.26	423	78.08	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			229.8	E08		4	0060-0216	726.80	215.88	427	77.50	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			300.6	E08		4	0061-0221	226.57	222.17	395	78.23	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			425.4	E08		4	0062-0222	544.15	222.08	490	86.18	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			998.4	E08		4	0063-0220	777.29	220.48	419	76.67	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			248.1	E08		4	0064-0230	350.24	230.09	407	76.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			623.4	E08		4	0065-0235	698.65	235.23	431	82.81	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			339.1	E08		4	0066-0235	390.33	235.47	392	75.50	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			313.2	E08		4	0067-0243	108.57	243.69	401	77.50	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			269.5	E08		4	0068-0246	838.49	246.20	452	80.91	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			218.7	E08		4	0069-0248	543.64	247.86	431	78.43	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			221.9	E08		4	0070-0248	753.37	248.95	404	77.50	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			247.2	E08		4	0071-0248	451.53	248.74	468	84.77	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			225.6	E08		4	0072-0252	323.73	252.20	406	77.26	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			283.1	E08		4	0073-0254	473.20	254.32	420	80.18	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			429.1	E08		4	0074-0255	912.05	255.95	362	71.26	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			684.0	E08		4	0075-0258	640.31	258.51	486	85.50	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			247.1	E08		4	0076-0260	665.44	259.77	452	83.50	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			535.2	E08		4	0077-0263	872.41	263.11	474	83.50	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			433.7	E08		4	0078-0266	367.06	265.64	415	76.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			334.6	E08		4	0079-0268	780.52	268.02	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			309.1	E08		4	0080-0274	179.37	274.15	430	77.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			271.8	E08		4	0081-0280	251.34	280.48	399	75.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			285.3	E08		4	0082-0286	526.38	286.29	418	77.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			554.9	E08		4	0083-0291	805.27	290.90	691	98.57	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			224.2	E08		4	0084-0289	415.43	289.20	429	80.08	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			281.2	E08		4	0085-0303	165.61	303.77	430	77.84	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			274.9	E08		4	0086-0308	709.10	308.30	472	83.26	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			298.8	E08		4	0087-0311	288.03	311.72	406	79.50	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			207.2	E08		4	0088-0312	901.72	311.94	422	76.43	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			276.2	E08		4	0089-0318	685.82	317.83	441	80.67	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			405.2	E08		4	0090-0323	249.96	323.02	742	104.47	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			288.9	E08		4	0091-0322	624.79	322.52	399	76.08	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			233.8	E08		4	0092-0322	943.40	322.65	381	73.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			261.3	E08		4	0093-0347	676.81	348.17	412	76.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			247.7	E08		4	0094-0349	750.47	349.19	842	119.64	0.739
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			249.2	E08		4	0095-0349	136.05	348.74	396	76.91	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			289.2	E08		4	0096-0353	704.85	353.22	416	78.91	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			292.0	E08		4	0097-0361	338.63	362.11	810	111.88	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			278.9	E08		4	0098-0357	564.43	357.09	460	82.77	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			330.2	E08		4	0099-0359	203.75	359.23	427	80.33	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			259.4	E08		4	0100-0362	531.38	361.51	870	114.57	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			271.4	E08		4	0101-0364	616.58	364.28	423	75.84	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			218.4	E08		4	0102-0370	180.75	369.39	448	80.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			240.1	E08		4	0103-0375	83.23	375.25	391	78.33	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			500.0	E08		4	0104-0377	425.81	377.11	425	78.91	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			295.1	E08		4	0105-0386	288.74	385.59	897	123.88	0.734
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1735.6	E08		4	0106-0384	871.17	383.61	342	68.18	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			244.0	E08		4	0107-0389	24.18	389.00	376	74.67	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			306.0	E08		4	0108-0387	258.24	387.51	410	78.53	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			362.5	E08		4	0109-0393	491.32	393.10	437	83.15	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			443.7	E08		4	0110-0396	552.04	394.76	415	80.23	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			210.0	E08		4	0111-0398	738.64	397.49	397	74.43	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			403.1	E08		4	0112-0399	684.04	398.75	412	76.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			314.7	E08		4	0113-0407	389.42	406.76	529	94.91	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			230.4	E08		4	0114-0407	589.34	406.88	420	78.67	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			829.8	E08		4	0115-0406	920.59	406.58	440	77.26	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			707.2	E08		4	0116-0413	532.50	414.86	753	104.47	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			206.0	E08		4	0117-0413	233.92	412.73	412	77.26	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			252.1	E08		4	0118-0411	359.40	410.70	415	78.08	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			272.7	E08		4	0119-0413	630.06	411.74	381	77.64	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			246.8	E08		4	0120-0419	285.91	418.45	839	108.81	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			353.6	E08		4	0121-0421	695.14	420.42	479	90.81	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			243.2	E08		4	0122-0419	436.31	419.40	407	76.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			774.9	E08		4	0123-0425	110.14	425.64	562	94.81	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			312.2	E08		4	0124-0426	645.96	426.73	455	80.57	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			279.0	E08		4	0125-0425	866.84	425.04	392	76.91	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			408.4	E08		4	0126-0426	382.97	426.70	214	60.77	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			379.0	E08		4	0127-0431	777.43	430.82	454	83.15	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			277.6	E08		4	0128-0436	705.74	437.07	413	81.98	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			249.3	E08		4	0129-0435	319.58	435.80	410	76.08	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			273.4	E08		4	0130-0446	599.20	446.02	744	100.81	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			358.1	E08		4	0131-0448	163.99	448.51	430	78.08	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			193.9	E08		4	0132-0456	276.89	456.42	424	78.08	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1414.0	E08		4	0133-0459	905.75	457.52	380	75.98	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1282.1	E08		4	0134-0468	888.60	469.74	418	79.74	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1932.7	E08		4	0135-0474	695.70	474.53	764	106.23	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			418.5	E08		4	0136-0477	370.65	476.79	426	80.81	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			240.9	E08		4	0137-0481	112.68	481.24	401	78.33	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			296.5	E08		4	0138-0488	213.74	488.34	406	78.67	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			322.4	E08		4	0139-0486	603.59	485.86	424	78.91	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			294.2	E08		4	0140-0492	76.49	492.01	442	82.33	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			289.4	E08		4	0141-0490	307.38	490.29	448	81.50	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			715.0	E08		4	0142-0495	355.80	495.48	508	86.57	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			328.1	E08		4	0143-0498	530.91	497.54	426	78.43	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			320.2	E08		4	0144-0508	936.11	508.18	411	76.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			288.8	E08		4	0145-0516	640.42	515.71	391	73.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			262.2	E08		4	0146-0518	385.44	518.92	445	83.98	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			337.3	E08		4	0147-0526	569.04	526.32	431	80.33	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			199.3	E08		4	0148-0525	428.94	525.80	418	80.33	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			237.3	E08		4	0149-0528	701.21	528.02	431	79.50	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			376.8	E08		4	0150-0535	118.78	535.26	432	80.91	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			331.7	E08		4	0151-0535	367.11	534.85	449	81.74	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			341.7	E08		4	0152-0538	154.87	538.00	401	75.74	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			204.1	E08		4	0153-0542	403.90	541.72	447	84.33	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			381.3	E08		4	0154-0546	617.77	545.48	421	78.67	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			413.6	E08		4	0155-0553	247.29	552.85	707	100.23	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			297.5	E08		4	0156-0546	851.67	546.21	400	76.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			311.8	E08		4	0157-0551	755.90	550.92	400	75.01	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			690.6	E08		4	0158-0555	509.69	555.50	513	86.33	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			204.2	E08		4	0159-0566	449.55	566.71	846	114.47	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			269.5	E08		4	0160-0565	325.54	565.58	446	78.91	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			261.8	E08		4	0161-0565	718.66	565.16	417	77.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			334.8	E08		4	0162-0578	581.05	578.21	405	77.26	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			287.7	E08		4	0163-0584	352.77	585.09	409	78.91	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			345.7	E08		4	0164-0586	644.49	587.18	809	110.81	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1028.5	E08		4	0165-0599	386.32	598.68	902	122.02	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			588.1	E08		4	0166-0597	820.30	597.28	403	79.50	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			335.0	E08		4	0167-0597	902.14	597.37	399	74.43	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			266.4	E08		4	0168-0601	522.22	601.39	413	77.84	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			264.9	E08		4	0169-0610	858.65	610.57	427	79.50	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			559.9	E08		4	0170-0611	197.02	610.95	439	80.91	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			256.3	E08		4	0171-0610	713.64	610.13	416	77.84	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1502.6	E08		4	0172-0612	777.81	612.44	373	70.77	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			573.6	E08		4	0173-0617	442.56	617.16	390	75.50	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			237.9	E08		4	0174-0620	300.22	620.31	408	74.43	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			825.7	E08		4	0175-0623	818.13	622.92	476	84.08	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			239.4	E08		4	0176-0632	66.66	631.38	777	109.05	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			315.0	E08		4	0177-0638	333.96	638.20	438	79.74	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			744.7	E08		4	0178-0639	645.90	638.83	415	75.84	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			240.7	E08		4	0179-0644	254.30	643.97	410	75.84	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1525.2	E08		4	0180-0644	766.71	644.46	248	87.50	0.407
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			350.7	E08		4	0181-0649	475.70	648.79	796	111.64	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			278.3	E08		4	0182-0654	885.78	655.00	352	69.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			212.7	E08		4	0183-0656	36.38	656.07	390	73.26	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			295.0	E08		4	0184-0658	820.16	658.20	417	75.84	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			907.2	E08		4	0185-0666	109.47	665.99	445	80.91	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			221.0	E08		4	0186-0668	931.79	667.74	379	73.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			835.7	E08		4	0187-0670	764.69	670.90	426	79.74	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			223.0	E08		4	0188-0670	515.22	671.01	430	81.40	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			749.2	E08		4	0189-0672	228.59	672.38	446	80.67	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			285.8	E08		4	0190-0677	711.19	677.12	407	78.33	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			392.6	E08		4	0191-0680	362.66	680.49	407	74.18	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			224.2	E08		4	0192-0682	674.03	681.82	403	75.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			192.9	E08		4	0193-0688	31.90	688.55	387	75.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			420.8	E08		4	0194-0700	913.09	698.64	422	81.15	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1245.9	E08		4	0195-0699	177.40	699.16	425	77.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			263.7	E08		4	0196-0706	896.96	706.45	370	76.67	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			327.6	E08		4	0197-0705	451.24	705.04	393	73.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			238.6	E08		4	0198-0706	841.19	706.47	391	73.84	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			338.8	E08		5	0001-0036	912.92	36.08	697	97.74	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1108.5	E08		5	0002-0037	400.71	36.02	190	56.53	0.747
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			311.9	E08		5	0003-0042	383.54	44.47	533	95.15	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			339.0	E08		5	0004-0043	672.96	42.74	427	77.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			483.5	E08		5	0005-0047	55.66	46.50	612	93.98	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			651.4	E08		5	0006-0047	87.28	46.68	387	97.15	0.515
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			252.8	E08		5	0007-0044	186.17	44.47	395	73.84	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			232.2	E08		5	0008-0047	226.42	47.21	458	83.15	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			958.8	E08		5	0009-0048	129.84	47.85	425	77.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			641.0	E08		5	0010-0050	790.39	50.36	408	77.74	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			731.0	E08		5	0011-0051	101.71	52.26	139	54.53	0.587
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			231.1	E08		5	0012-0057	312.17	57.19	430	79.26	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			239.9	E08		5	0013-0068	489.97	68.32	441	79.50	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			266.8	E08		5	0014-0073	372.57	73.36	407	74.43	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			269.3	E08		5	0015-0074	412.97	74.21	406	77.50	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			489.1	E08		5	0016-0082	710.92	82.13	436	77.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			257.0	E08		5	0017-0089	155.98	89.08	370	72.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			393.1	E08		5	0018-0098	744.01	98.60	365	71.26	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			393.9	E08		5	0019-0101	112.51	100.66	349	70.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			195.1	E08		5	0020-0107	189.04	107.38	386	77.50	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			584.7	E08		5	0021-0106	912.13	105.94	263	75.50	0.580
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			370.5	E08		5	0022-0110	20.05	109.88	419	79.74	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			813.8	E08		5	0023-0113	684.55	113.61	430	78.08	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2828.8	E08		5	0024-0134	634.63	132.56	822	126.37	0.647
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			235.6	E08		5	0025-0135	217.50	135.58	433	79.84	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			248.0	E08		5	0026-0138	151.19	137.96	392	74.67	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			515.8	E08		5	0027-0139	694.30	139.48	432	78.91	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1378.5	E08		5	0028-0138	506.42	138.97	366	71.26	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			613.5	E08		5	0029-0153	739.43	153.21	377	71.01	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			766.3	E08		5	0030-0155	266.99	155.23	390	74.08	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			316.3	E08		5	0031-0158	364.21	158.24	390	74.43	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			438.2	E08		5	0032-0157	789.19	157.46	339	69.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			476.3	E08		5	0033-0161	428.45	161.27	415	79.15	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1257.0	E08		5	0034-0162	606.91	162.23	471	85.98	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			274.8	E08		5	0035-0164	102.21	164.37	385	74.91	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			296.7	E08		5	0036-0170	393.74	169.85	402	75.84	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			538.3	E08		5	0037-0173	45.29	173.71	724	105.50	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1007.4	E08		5	0038-0176	559.97	176.57	534	125.44	0.426
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			215.4	E08		5	0039-0182	182.79	182.45	382	74.33	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			260.3	E08		5	0040-0184	824.00	184.55	431	79.84	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			254.9	E08		5	0041-0189	630.02	190.57	822	113.54	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			210.8	E08		5	0042-0185	228.36	183.91	443	87.05	0.735
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1203.7	E08		5	0043-0202	452.20	201.93	838	110.57	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			325.9	E08		5	0044-0195	279.94	195.23	410	77.01	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			424.6	E08		5	0045-0202	155.62	202.56	473	86.08	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1130.0	E08		5	0046-0201	527.69	201.62	461	81.84	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			230.4	E08		5	0047-0203	752.82	203.24	401	76.08	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1308.5	E08		5	0048-0210	326.39	209.37	856	119.20	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			169.1	E08		5	0049-0207	228.68	207.78	408	82.23	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			479.8	E08		5	0050-0218	126.09	217.93	392	77.74	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			353.6	E08		5	0051-0219	938.78	219.02	391	74.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			252.9	E08		5	0052-0223	167.61	222.46	356	76.43	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			364.3	E08		5	0053-0229	91.30	229.29	380	74.67	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			425.9	E08		5	0054-0229	780.61	229.64	408	76.67	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			296.3	E08		5	0055-0233	833.52	233.37	660	96.57	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			655.9	E08		5	0056-0232	898.40	232.45	416	76.67	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			285.8	E08		5	0057-0241	397.59	241.52	526	87.74	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			289.8	E08		5	0058-0244	649.02	244.50	374	70.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			194.7	E08		5	0059-0248	294.41	247.83	388	74.67	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			922.7	E08		5	0060-0250	614.43	250.41	465	83.74	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			215.3	E08		5	0061-0253	247.78	252.38	415	81.40	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			268.9	E08		5	0062-0253	514.90	252.80	430	80.91	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			268.8	E08		5	0063-0254	738.72	254.37	418	79.01	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			396.2	E08		5	0064-0258	16.81	258.04	373	73.26	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			333.7	E08		5	0065-0260	71.67	260.48	388	73.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			222.5	E08		5	0066-0260	337.57	260.69	413	76.67	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			348.9	E08		5	0067-0261	717.98	261.28	407	79.26	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1148.6	E08		5	0068-0261	359.63	260.89	371	71.70	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			345.9	E08		5	0069-0268	867.65	268.12	368	72.08	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			241.3	E08		5	0070-0271	812.16	270.97	430	79.50	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			316.5	E08		5	0071-0274	164.80	274.49	398	76.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			704.4	E08		5	0072-0282	833.97	281.78	441	82.91	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			439.4	E08		5	0073-0285	930.92	285.11	411	75.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			219.7	E08		5	0074-0291	91.17	291.53	396	75.26	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			299.3	E08		5	0075-0291	480.15	291.94	443	80.33	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			248.6	E08		5	0076-0290	541.98	289.68	413	80.33	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			271.5	E08		5	0077-0297	744.79	296.42	423	79.74	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			358.4	E08		5	0078-0298	638.64	298.19	436	79.50	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			304.9	E08		5	0079-0299	696.64	299.44	421	77.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			342.7	E08		5	0080-0310	859.34	310.60	433	79.26	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			214.5	E08		5	0081-0311	211.24	311.25	384	73.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			315.8	E08		5	0082-0317	458.01	318.23	597	94.81	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			230.8	E08		5	0083-0316	756.38	317.12	453	82.08	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			299.1	E08		5	0084-0320	547.00	320.09	475	92.23	0.702
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			232.5	E08		5	0085-0322	522.21	322.03	409	79.84	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			219.4	E08		5	0086-0325	48.41	324.90	371	73.50	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			247.0	E08		5	0087-0325	111.70	324.44	389	75.01	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			371.8	E08		5	0088-0329	314.40	328.83	415	76.08	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			519.9	E08		5	0089-0331	582.08	332.17	403	76.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			240.7	E08		5	0090-0333	673.06	333.28	435	80.08	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			218.4	E08		5	0091-0331	899.74	331.41	398	77.26	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			287.6	E08		5	0092-0338	172.43	338.13	383	74.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			196.2	E08		5	0093-0339	223.79	339.76	383	74.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			183.8	E08		5	0094-0347	779.18	347.30	388	76.33	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			517.9	E08		5	0095-0349	689.37	349.18	454	81.74	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			235.0	E08		5	0096-0349	144.38	349.49	383	74.08	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			219.2	E08		5	0097-0351	272.80	350.88	394	76.08	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			407.0	E08		5	0098-0356	645.18	355.75	398	76.67	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			299.2	E08		5	0099-0371	89.56	371.12	398	75.26	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			210.6	E08		5	0100-0371	750.34	370.95	394	79.15	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			337.2	E08		5	0101-0375	859.09	374.62	419	77.50	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			269.4	E08		5	0102-0377	235.32	377.50	785	116.95	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			381.0	E08		5	0103-0385	597.11	385.01	934	125.68	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			557.3	E08		5	0104-0389	304.30	388.70	858	119.68	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			204.0	E08		5	0105-0383	122.06	383.52	392	76.57	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			310.4	E08		5	0106-0388	549.09	386.78	494	88.57	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			412.9	E08		5	0107-0388	493.48	388.54	448	86.57	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			243.1	E08		5	0108-0392	464.63	392.49	458	82.91	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			276.2	E08		5	0109-0398	361.87	397.81	415	76.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			349.7	E08		5	0110-0397	729.47	397.47	422	77.50	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			564.1	E08		5	0111-0402	644.21	402.75	401	75.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			858.2	E08		5	0112-0408	25.84	408.78	427	77.50	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			269.6	E08		5	0113-0412	687.08	412.42	423	78.67	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			242.8	E08		5	0114-0420	131.98	419.92	301	71.11	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			239.4	E08		5	0115-0420	149.08	419.68	190	53.21	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			438.0	E08		5	0116-0426	598.50	426.01	414	77.50	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			363.3	E08		5	0117-0428	881.31	428.51	431	80.33	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			177.0	E08		5	0118-0433	743.77	432.91	402	76.67	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			221.6	E08		5	0119-0436	519.01	436.38	420	78.08	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			261.0	E08		5	0120-0440	203.93	440.29	462	83.84	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			280.5	E08		5	0121-0442	226.39	442.23	462	81.60	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			301.1	E08		5	0122-0442	259.99	441.96	399	75.50	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			255.9	E08		5	0123-0442	396.28	441.63	404	77.26	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			375.0	E08		5	0124-0452	828.09	451.93	481	81.01	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			320.4	E08		5	0125-0454	567.20	454.24	407	76.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			314.5	E08		5	0126-0458	60.38	458.16	396	77.26	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			277.8	E08		5	0127-0464	462.94	463.98	444	82.91	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			224.5	E08		5	0128-0462	682.87	461.98	412	76.91	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			294.2	E08		5	0129-0466	727.81	466.33	689	100.47	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			527.4	E08		5	0130-0462	939.93	462.33	386	73.01	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			319.8	E08		5	0131-0480	545.63	480.82	800	118.71	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			208.5	E08		5	0132-0475	595.64	476.17	420	82.33	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			331.8	E08		5	0133-0486	337.27	486.65	436	83.40	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			346.4	E08		5	0134-0487	654.85	487.16	421	78.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			321.0	E08		5	0135-0498	312.01	498.08	791	114.95	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			232.9	E08		5	0136-0500	732.05	500.30	421	78.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			300.3	E08		5	0137-0510	41.05	510.31	392	74.67	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			259.1	E08		5	0138-0511	901.81	511.56	447	79.50	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			254.2	E08		5	0139-0514	171.32	513.56	408	78.57	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			423.1	E08		5	0140-0515	814.29	515.03	404	77.26	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			254.7	E08		5	0141-0517	762.03	517.57	409	75.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			249.4	E08		5	0142-0518	524.67	518.08	411	77.26	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			268.9	E08		5	0143-0530	669.23	530.32	405	76.67	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			316.4	E08		5	0144-0535	381.83	535.94	398	75.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			264.9	E08		5	0145-0537	450.65	536.69	413	79.26	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			246.2	E08		5	0146-0540	496.57	540.79	433	77.01	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			248.0	E08		5	0147-0543	575.29	542.93	427	80.33	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			194.7	E08		5	0148-0551	803.26	551.15	813	113.05	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1325.0	E08		5	0149-0551	922.87	550.54	310	66.18	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			290.9	E08		5	0150-0562	119.28	562.25	412	78.33	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			783.1	E08		5	0151-0565	243.17	565.20	397	74.91	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			510.2	E08		5	0152-0565	856.86	565.48	401	73.84	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			219.9	E08		5	0153-0572	309.73	571.73	409	79.50	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			333.6	E08		5	0154-0576	918.68	577.10	561	89.15	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			245.1	E08		5	0155-0579	350.68	579.12	403	75.50	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			303.3	E08		5	0156-0580	58.30	579.86	385	74.67	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			304.5	E08		5	0157-0584	284.01	584.18	751	105.64	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			268.6	E08		5	0158-0590	578.60	590.09	424	82.08	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1193.0	E08		5	0159-0593	777.12	593.57	371	75.74	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			265.8	E08		5	0160-0595	468.12	594.79	435	77.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			375.0	E08		5	0161-0607	390.67	607.42	853	115.88	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1186.9	E08		5	0162-0605	848.16	605.02	340	68.18	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			283.7	E08		5	0163-0609	726.45	609.57	390	73.26	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			639.7	E08		5	0164-0611	150.33	610.49	400	76.33	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			291.8	E08		5	0165-0614	112.83	614.69	392	74.08	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			302.0	E08		5	0166-0619	311.78	619.52	400	77.74	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			427.4	E08		5	0167-0620	53.42	619.82	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1508.8	E08		5	0168-0621	536.05	620.32	336	70.43	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			316.6	E08		5	0169-0626	822.73	625.75	397	76.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			219.1	E08		5	0170-0623	269.05	623.42	417	77.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			524.9	E08		5	0171-0630	552.07	630.35	420	83.50	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			215.1	E08		5	0172-0631	442.94	631.56	409	77.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			171.7	E08		5	0173-0635	917.01	635.15	376	74.08	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			853.0	E08		5	0174-0635	859.67	635.02	418	77.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			433.4	E08		5	0175-0649	331.63	649.34	432	80.33	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			318.3	E08		5	0176-0651	801.96	651.19	436	82.33	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			604.9	E08		5	0177-0648	142.89	648.94	365	74.43	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			236.8	E08		5	0178-0653	87.19	652.94	379	76.33	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			934.7	E08		5	0179-0654	490.62	655.31	427	97.40	0.566
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			182.5	E08		5	0180-0654	290.92	654.14	391	75.26	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			267.1	E08		5	0181-0658	122.51	658.29	430	78.08	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			330.4	E08		5	0182-0660	943.92	659.79	269	61.36	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			259.0	E08		5	0183-0665	450.32	665.15	408	76.67	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			316.9	E08		5	0184-0666	711.38	665.77	407	78.08	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			448.7	E08		5	0185-0665	388.66	665.79	387	76.08	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			373.4	E08		5	0186-0667	530.37	666.86	408	77.74	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			238.9	E08		5	0187-0670	36.41	670.08	383	75.50	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			194.4	E08		5	0188-0670	867.56	669.86	372	72.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			384.5	E08		5	0189-0687	601.90	686.94	404	75.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			235.4	E08		5	0190-0689	805.54	688.90	400	76.67	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			288.2	E08		5	0191-0691	754.41	691.52	398	75.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			257.1	E08		5	0192-0694	706.03	694.46	414	77.50	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			209.1	E08		5	0193-0695	182.32	695.39	392	74.67	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			234.5	E08		5	0194-0698	408.47	698.36	394	76.08	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			435.8	E08		5	0195-0701	18.07	700.07	363	77.40	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			236.6	E08		5	0196-0700	311.11	700.68	390	74.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			278.2	E08		5	0197-0707	882.43	706.19	366	72.81	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			295.5	E08		6	0001-0039	609.10	39.78	429	78.67	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			363.6	E08		6	0002-0037	360.26	37.48	370	71.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			302.4	E08		6	0003-0043	130.87	43.35	415	76.67	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			764.2	E08		6	0004-0044	937.28	43.85	447	83.26	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			357.3	E08		6	0005-0046	666.80	46.34	393	73.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			331.0	E08		6	0006-0051	182.30	50.93	439	79.84	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			450.1	E08		6	0007-0052	403.43	51.91	456	80.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			291.3	E08		6	0008-0056	835.63	55.83	437	82.67	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			438.5	E08		6	0009-0054	547.64	54.10	424	77.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			743.0	E08		6	0010-0056	445.92	56.36	434	79.26	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			213.4	E08		6	0011-0055	865.44	55.01	398	73.84	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			218.7	E08		6	0012-0056	99.44	56.56	204	59.36	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			320.6	E08		6	0013-0056	709.53	56.49	394	73.84	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			352.5	E08		6	0014-0057	56.19	57.15	276	62.77	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			271.8	E08		6	0015-0061	291.50	60.35	420	80.23	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2462.7	E08		6	0016-0071	649.24	69.38	188	65.01	0.559
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			275.5	E08		6	0017-0075	273.94	76.36	420	78.33	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			238.2	E08		6	0018-0082	865.23	82.94	421	76.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			307.6	E08		6	0019-0087	100.68	87.47	401	75.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			465.0	E08		6	0020-0085	790.76	85.89	405	77.01	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			360.6	E08		6	0021-0099	595.58	98.77	410	75.84	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			404.4	E08		6	0022-0100	401.27	100.66	401	75.26	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			568.4	E08		6	0023-0104	359.67	103.66	639	92.91	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			227.2	E08		6	0024-0101	917.18	101.30	370	71.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			418.6	E08		6	0025-0102	147.44	102.15	426	79.01	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			247.1	E08		6	0026-0104	203.96	103.60	391	73.84	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			296.3	E08		6	0027-0111	687.18	111.25	425	77.26	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			285.8	E08		6	0028-0114	311.62	114.67	409	76.67	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			854.7	E08		6	0029-0126	567.48	126.76	529	119.88	0.463
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			485.3	E08		6	0030-0124	514.48	124.06	399	73.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			288.5	E08		6	0031-0134	874.24	134.51	416	75.26	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			471.6	E08		6	0032-0136	443.35	136.30	428	77.26	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			395.8	E08		6	0033-0137	221.07	136.76	398	74.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			314.4	E08		6	0034-0138	802.41	138.59	416	75.01	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			250.4	E08		6	0035-0141	845.01	141.60	424	79.50	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			420.6	E08		6	0036-0145	932.34	145.11	411	78.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			286.2	E08		6	0037-0156	316.95	156.18	405	75.26	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			690.6	E08		6	0038-0173	180.35	172.98	600	120.37	0.520
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			376.0	E08		6	0039-0171	928.07	170.09	399	76.53	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			279.4	E08		6	0040-0176	889.94	176.64	383	76.67	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			324.6	E08		6	0041-0180	641.53	180.47	408	74.43	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			282.9	E08		6	0042-0181	254.12	181.22	431	79.84	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			670.8	E08		6	0043-0180	575.01	180.53	356	69.01	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			265.0	E08		6	0044-0185	769.00	185.35	487	85.84	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			507.7	E08		6	0045-0201	840.71	200.64	409	78.91	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			487.9	E08		6	0046-0201	402.79	201.96	404	75.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			273.8	E08		6	0047-0217	557.64	217.97	437	78.18	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			335.7	E08		6	0048-0222	65.75	222.55	402	75.84	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			338.6	E08		6	0049-0222	33.66	222.01	378	71.84	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			269.9	E08		6	0050-0230	461.89	228.95	884	118.71	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			268.3	E08		6	0051-0224	894.28	224.40	424	78.08	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			227.2	E08		6	0052-0235	146.72	235.75	423	77.26	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			230.7	E08		6	0053-0238	241.90	238.00	383	73.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			240.4	E08		6	0054-0237	315.12	237.17	411	77.01	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			984.8	E08		6	0055-0243	565.44	243.58	481	82.43	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			590.0	E08		6	0056-0246	675.69	246.47	385	73.26	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			222.0	E08		6	0057-0251	200.63	251.72	394	73.84	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			538.1	E08		6	0058-0254	390.06	254.58	396	73.01	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			294.8	E08		6	0059-0256	274.78	255.92	404	76.28	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			259.6	E08		6	0060-0258	297.14	258.14	451	81.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			259.6	E08		6	0061-0258	122.38	258.27	395	76.67	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			607.8	E08		6	0062-0262	826.81	262.42	397	77.74	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			283.2	E08		6	0063-0265	364.08	265.39	397	75.50	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			259.2	E08		6	0064-0266	66.07	266.07	380	73.01	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			278.3	E08		6	0065-0268	780.41	269.04	384	78.91	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			204.1	E08		6	0066-0276	942.40	276.55	414	77.26	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			374.6	E08		6	0067-0284	864.62	284.60	393	75.01	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			267.1	E08		6	0068-0288	919.98	288.51	425	80.67	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			405.2	E08		6	0069-0287	25.72	287.87	402	74.18	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			318.5	E08		6	0070-0291	794.39	291.48	427	84.91	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			240.0	E08		6	0071-0291	340.77	290.88	388	74.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			254.3	E08		6	0072-0292	733.23	292.36	414	78.08	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			275.2	E08		6	0073-0302	700.29	302.29	365	70.18	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			299.5	E08		6	0074-0307	593.62	308.24	459	83.98	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			197.7	E08		6	0075-0308	389.89	307.90	416	75.60	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			313.0	E08		6	0076-0316	97.64	316.85	772	105.98	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			570.6	E08		6	0077-0322	160.15	322.59	425	78.08	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			754.3	E08		6	0078-0323	429.71	323.83	412	76.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			233.9	E08		6	0079-0325	620.50	325.40	390	74.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			289.9	E08		6	0080-0324	673.88	324.71	368	71.01	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			273.9	E08		6	0081-0326	298.88	326.11	431	79.50	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			322.6	E08		6	0082-0338	840.47	338.66	399	74.43	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			429.3	E08		6	0083-0343	945.96	343.78	423	76.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			328.0	E08		6	0084-0348	94.01	348.05	361	75.26	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			455.7	E08		6	0085-0349	192.31	348.83	427	79.26	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			373.2	E08		6	0086-0355	743.75	355.90	402	75.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			447.7	E08		6	0087-0359	863.28	359.07	375	71.01	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			355.6	E08		6	0088-0361	410.56	360.93	417	76.91	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			317.1	E08		6	0089-0362	549.72	362.11	395	73.60	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			256.1	E08		6	0090-0366	86.07	366.13	430	81.84	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			354.6	E08		6	0091-0368	605.95	368.15	466	81.26	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			343.9	E08		6	0092-0368	461.92	368.59	404	75.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			643.0	E08		6	0093-0369	503.73	369.03	421	75.84	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			251.3	E08		6	0094-0388	126.33	388.29	676	96.33	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			264.2	E08		6	0095-0389	272.93	389.65	406	78.08	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			256.9	E08		6	0096-0397	897.17	397.47	378	76.08	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			403.1	E08		6	0097-0399	741.89	399.01	357	69.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			270.9	E08		6	0098-0401	489.83	401.65	393	73.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			310.4	E08		6	0099-0415	558.39	414.76	891	120.47	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			436.1	E08		6	0100-0418	759.37	417.69	385	73.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			323.5	E08		6	0101-0419	131.28	419.56	412	75.01	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			343.1	E08		6	0102-0428	222.85	428.22	398	75.84	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			187.7	E08		6	0103-0438	440.00	437.97	811	112.57	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			209.0	E08		6	0104-0429	888.69	429.98	388	77.26	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			957.7	E08		6	0105-0432	604.99	432.84	420	76.43	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			284.6	E08		6	0106-0431	803.92	430.66	397	75.01	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			313.4	E08		6	0107-0445	845.80	445.48	452	81.74	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			607.8	E08		6	0108-0449	472.86	450.16	419	76.43	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			198.3	E08		6	0109-0451	399.60	450.90	407	74.43	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			252.6	E08		6	0110-0452	901.77	451.81	344	68.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			339.7	E08		6	0111-0457	510.59	457.67	365	71.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			197.4	E08		6	0112-0458	271.58	458.37	398	75.26	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			440.7	E08		6	0113-0464	362.29	463.93	415	76.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			487.6	E08		6	0114-0465	34.79	465.26	372	71.01	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			160.2	E08		6	0115-0468	319.64	468.73	386	75.50	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			327.1	E08		6	0116-0468	204.85	468.31	403	74.43	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			416.4	E08		6	0117-0472	589.04	472.62	410	77.84	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			373.1	E08		6	0118-0485	130.94	485.17	784	114.57	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			258.9	E08		6	0119-0480	559.70	480.70	401	74.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			685.7	E08		6	0120-0485	765.12	485.12	414	75.01	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			277.9	E08		6	0121-0488	817.96	488.82	421	77.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			630.2	E08		6	0122-0487	700.13	487.33	456	79.60	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			262.0	E08		6	0123-0494	467.40	493.91	413	75.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			346.3	E08		6	0124-0497	519.65	497.45	378	73.01	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			489.4	E08		6	0125-0503	71.84	502.98	397	73.60	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			277.2	E08		6	0126-0510	312.54	510.67	394	76.91	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			235.2	E08		6	0127-0525	839.74	525.65	437	78.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			266.7	E08		6	0128-0527	540.65	527.67	412	75.26	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			542.7	E08		6	0129-0528	685.34	528.07	370	72.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			396.0	E08		6	0130-0531	408.66	531.66	427	82.91	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			255.5	E08		6	0131-0545	184.59	545.56	423	77.26	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			576.5	E08		6	0132-0550	783.64	550.56	434	78.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1147.8	E08		6	0133-0554	16.21	553.55	343	69.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			307.4	E08		6	0134-0558	889.37	558.36	399	75.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			285.8	E08		6	0135-0563	292.95	563.04	416	75.01	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			264.9	E08		6	0136-0566	246.05	566.66	403	75.26	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			226.1	E08		6	0137-0574	207.12	574.39	383	73.01	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			247.4	E08		6	0138-0580	407.06	580.07	744	102.91	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			255.1	E08		6	0139-0579	123.64	579.43	381	73.84	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1725.3	E08		6	0140-0584	648.20	584.41	298	79.26	0.596
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			257.6	E08		6	0141-0588	340.02	588.45	389	76.08	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			293.6	E08		6	0142-0591	512.96	591.21	414	76.08	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1216.6	E08		6	0143-0592	930.00	592.72	460	79.84	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			333.4	E08		6	0144-0600	604.74	599.99	396	74.67	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			426.0	E08		6	0145-0610	674.51	609.31	411	75.26	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			920.8	E08		6	0146-0613	833.51	613.41	434	77.26	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			249.7	E08		6	0147-0616	47.33	616.58	414	76.08	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			259.1	E08		6	0148-0615	120.49	615.56	390	73.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			280.6	E08		6	0149-0618	286.91	617.98	407	78.08	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			422.9	E08		6	0150-0621	579.64	621.75	407	74.43	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			286.0	E08		6	0151-0630	264.54	630.19	456	79.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			308.2	E08		6	0152-0633	530.57	633.89	542	86.91	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			289.1	E08		6	0153-0633	175.78	633.64	416	77.01	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			280.2	E08		6	0154-0644	342.89	645.15	398	75.50	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			363.4	E08		6	0155-0643	423.03	642.72	391	74.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			332.8	E08		6	0156-0649	707.56	648.55	332	71.60	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			223.7	E08		6	0157-0651	879.79	651.82	403	75.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			599.5	E08		6	0158-0654	830.07	653.96	335	68.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			220.2	E08		6	0159-0659	73.10	659.24	383	74.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			326.2	E08		6	0160-0662	37.75	662.74	306	64.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			401.8	E08		6	0161-0664	699.20	664.39	367	72.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			315.0	E08		6	0162-0669	294.23	669.17	425	77.84	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			393.8	E08		6	0163-0672	755.14	671.70	314	65.01	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			302.2	E08		6	0164-0685	651.76	685.15	402	76.43	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			206.6	E08		6	0165-0690	191.80	689.38	504	90.08	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			305.9	E08		6	0166-0688	241.93	688.34	391	75.26	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			288.0	E08		6	0167-0688	860.00	687.87	391	76.67	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			352.0	E08		6	0168-0695	394.10	695.29	375	75.84	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			240.4	E08		6	0169-0692	684.52	691.77	372	73.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			202.6	E08		6	0170-0698	175.02	699.26	445	82.67	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			515.0	E08		6	0171-0696	775.38	696.07	302	63.36	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			815.4	E08		6	0172-0701	605.07	701.16	380	72.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			241.2	E08		6	0173-0702	95.54	701.63	451	85.60	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			274.8	E08		6	0174-0704	120.66	703.75	188	52.63	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			266.5	E08		6	0175-0709	319.30	709.24	414	81.01	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			312.4	E08		7	0001-0031	448.84	30.88	428	78.08	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			251.4	E08		7	0002-0032	838.72	31.96	384	75.50	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1608.2	E08		7	0003-0036	597.08	35.70	508	86.43	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			233.8	E08		7	0004-0040	660.75	40.02	389	73.26	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			439.4	E08		7	0005-0043	46.37	43.18	436	80.08	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1638.6	E08		7	0006-0046	171.75	45.61	395	76.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			172.9	E08		7	0007-0056	779.49	56.58	762	105.40	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			272.6	E08		7	0008-0053	366.46	52.98	413	77.84	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			229.5	E08		7	0009-0061	736.50	60.83	821	110.33	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			365.9	E08		7	0010-0059	514.63	59.64	469	80.67	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			297.2	E08		7	0011-0060	622.88	60.55	447	81.01	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			263.5	E08		7	0012-0062	112.13	62.35	400	73.84	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			198.3	E08		7	0013-0064	827.38	64.14	397	73.01	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			394.2	E08		7	0014-0065	209.40	65.33	397	75.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			248.3	E08		7	0015-0068	474.31	68.46	445	77.84	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			294.2	E08		7	0016-0073	759.50	73.09	441	82.33	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			303.7	E08		7	0017-0071	25.96	71.16	395	74.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			223.8	E08		7	0018-0075	168.45	75.59	400	75.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			422.8	E08		7	0019-0076	649.96	75.19	460	84.91	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			215.6	E08		7	0020-0076	914.47	76.08	389	74.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			278.6	E08		7	0021-0081	412.73	81.20	410	77.01	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			236.2	E08		7	0022-0081	855.73	80.86	331	68.67	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			228.7	E08		7	0023-0090	806.94	90.08	426	77.50	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			262.7	E08		7	0024-0097	123.66	96.62	861	120.47	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			265.5	E08		7	0025-0100	724.72	101.48	808	111.30	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			230.2	E08		7	0026-0096	869.09	97.42	428	79.74	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			341.7	E08		7	0027-0096	384.45	96.22	436	77.26	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			314.6	E08		7	0028-0096	561.68	96.12	419	76.08	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			339.5	E08		7	0029-0103	764.31	103.27	401	74.08	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			347.6	E08		7	0030-0109	829.68	109.22	415	77.74	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			588.6	E08		7	0031-0108	325.77	108.69	389	74.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			250.7	E08		7	0032-0109	935.60	108.20	397	76.91	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			265.8	E08		7	0033-0115	706.49	115.81	360	73.50	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			270.9	E08		7	0034-0122	118.91	122.52	429	82.18	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			269.6	E08		7	0035-0124	923.18	123.79	412	82.23	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			332.1	E08		7	0036-0135	292.88	135.00	383	73.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			853.8	E08		7	0037-0135	354.72	135.33	404	75.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			290.2	E08		7	0038-0139	914.80	139.85	373	76.91	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			276.3	E08		7	0039-0143	59.89	143.01	419	81.84	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			406.8	E08		7	0040-0142	508.69	142.10	427	75.84	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			331.0	E08		7	0041-0140	651.23	140.11	271	60.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			277.2	E08		7	0042-0143	114.36	144.08	452	82.77	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			338.8	E08		7	0043-0145	174.82	145.47	397	74.43	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			707.0	E08		7	0044-0150	430.95	150.59	605	95.36	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			226.8	E08		7	0045-0151	682.39	151.18	397	75.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			571.8	E08		7	0046-0151	472.56	151.08	281	60.53	0.964
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			453.9	E08		7	0047-0153	408.79	153.93	304	67.94	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			532.0	E08		7	0048-0155	769.28	154.23	416	77.01	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			201.0	E08		7	0049-0160	729.61	159.76	426	78.91	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			231.1	E08		7	0050-0171	710.91	171.77	471	83.15	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			319.8	E08		7	0051-0176	84.38	176.01	398	74.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			187.8	E08		7	0052-0179	757.95	179.10	405	74.67	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			353.2	E08		7	0053-0183	829.21	183.92	409	76.18	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			390.0	E08		7	0054-0182	399.69	182.76	395	74.67	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			232.8	E08		7	0055-0190	561.34	189.93	399	74.43	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			293.6	E08		7	0056-0202	470.42	202.54	999	119.88	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			315.8	E08		7	0057-0196	663.68	196.18	453	79.26	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			267.0	E08		7	0058-0195	880.66	195.17	430	79.50	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			227.5	E08		7	0059-0196	922.97	196.10	429	78.67	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			315.0	E08		7	0060-0202	796.04	201.96	411	75.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			295.6	E08		7	0061-0206	348.07	206.46	389	73.01	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			236.3	E08		7	0062-0209	516.77	208.98	444	83.01	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1043.4	E08		7	0063-0220	186.65	219.98	420	76.33	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			357.8	E08		7	0064-0229	52.67	230.01	832	116.71	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			820.2	E08		7	0065-0221	413.57	222.10	437	84.18	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			863.8	E08		7	0066-0223	154.97	223.16	415	76.67	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			288.8	E08		7	0067-0225	212.81	225.04	416	76.67	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			299.4	E08		7	0068-0236	277.65	236.50	804	114.33	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			218.8	E08		7	0069-0230	717.96	230.20	468	83.26	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			255.8	E08		7	0070-0231	512.52	230.88	408	78.18	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			343.8	E08		7	0071-0231	660.78	231.47	409	76.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			228.4	E08		7	0072-0234	552.17	234.52	465	80.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			265.4	E08		7	0073-0235	743.94	234.70	468	82.91	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			285.3	E08		7	0074-0240	921.31	240.17	436	78.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			299.0	E08		7	0075-0244	349.58	244.76	421	79.50	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			272.1	E08		7	0076-0242	419.81	240.95	462	91.01	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			217.9	E08		7	0077-0245	587.43	245.28	446	79.26	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			352.2	E08		7	0078-0245	616.80	245.35	467	82.33	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			538.9	E08		7	0079-0256	244.72	256.65	411	74.43	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			266.2	E08		7	0080-0256	165.72	256.33	403	75.26	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			194.2	E08		7	0081-0256	546.41	255.98	391	77.36	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			197.6	E08		7	0082-0260	401.71	260.65	446	79.84	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			324.0	E08		7	0083-0261	770.98	261.39	409	76.08	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			278.1	E08		7	0084-0275	859.66	275.10	420	81.50	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			264.4	E08		7	0085-0280	15.81	280.22	382	76.08	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			232.0	E08		7	0086-0283	911.46	282.82	394	77.84	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			288.6	E08		7	0087-0287	812.91	286.93	384	75.26	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			832.7	E08		7	0088-0291	361.58	290.96	385	73.26	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			283.5	E08		7	0089-0296	449.18	296.56	453	80.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			249.7	E08		7	0090-0299	207.78	299.43	414	77.74	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			187.7	E08		7	0091-0300	615.41	300.01	425	79.26	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			282.5	E08		7	0092-0302	783.03	301.18	396	76.33	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			422.3	E08		7	0093-0305	287.31	304.99	408	75.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			311.4	E08		7	0094-0308	523.05	306.75	406	77.74	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			222.3	E08		7	0095-0304	581.87	304.39	434	78.08	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			286.5	E08		7	0096-0313	940.51	313.37	444	82.43	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			342.6	E08		7	0097-0310	418.35	310.49	410	75.84	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			487.2	E08		7	0098-0313	352.30	313.57	476	86.08	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			275.3	E08		7	0099-0311	766.95	312.50	385	76.33	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			294.9	E08		7	0100-0326	514.28	327.72	504	86.57	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			268.5	E08		7	0101-0333	365.09	333.64	458	82.67	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			366.4	E08		7	0102-0336	262.15	336.27	411	78.08	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			459.3	E08		7	0103-0346	486.60	346.09	878	119.64	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			230.5	E08		7	0104-0339	795.17	339.92	407	75.26	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			183.6	E08		7	0105-0340	576.51	340.22	421	76.67	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			222.5	E08		7	0106-0349	751.18	349.39	815	118.37	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			802.3	E08		7	0107-0342	176.49	342.38	406	75.26	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			249.7	E08		7	0108-0352	838.85	352.49	419	77.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			466.9	E08		7	0109-0353	37.15	353.91	411	77.26	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			368.1	E08		7	0110-0354	196.64	354.38	249	64.18	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			258.2	E08		7	0111-0357	911.74	356.92	410	77.50	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			200.0	E08		7	0112-0362	721.35	361.82	401	73.60	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			284.9	E08		7	0113-0375	307.67	373.54	822	118.37	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			242.1	E08		7	0114-0372	576.22	372.32	426	78.08	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			476.9	E08		7	0115-0379	255.42	379.49	555	88.33	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			285.3	E08		7	0116-0379	104.36	379.35	412	75.84	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			238.4	E08		7	0117-0383	353.55	383.66	403	78.08	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			223.7	E08		7	0118-0393	729.49	393.01	419	76.43	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1231.2	E08		7	0119-0399	411.40	399.13	422	78.67	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			318.1	E08		7	0120-0400	896.04	400.17	430	77.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			593.4	E08		7	0121-0412	547.67	412.36	432	77.26	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			241.2	E08		7	0122-0417	477.90	416.96	424	78.43	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			349.0	E08		7	0123-0421	798.64	421.39	816	108.13	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			365.8	E08		7	0124-0418	288.39	418.77	420	76.67	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			256.1	E08		7	0125-0422	221.78	422.33	394	75.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1049.0	E08		7	0126-0427	674.72	427.78	474	84.57	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			298.6	E08		7	0127-0435	647.25	434.77	971	126.37	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			288.0	E08		7	0128-0432	22.64	432.45	395	74.67	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1643.3	E08		7	0129-0428	852.61	427.21	311	66.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			487.2	E08		7	0130-0436	442.88	436.49	421	78.67	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			388.8	E08		7	0131-0438	413.29	438.11	427	78.91	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			409.1	E08		7	0132-0448	594.07	448.69	427	78.67	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			330.9	E08		7	0133-0449	916.60	449.00	410	75.84	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			294.4	E08		7	0134-0458	778.28	457.50	871	115.05	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			250.3	E08		7	0135-0453	284.13	453.88	402	74.67	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			470.9	E08		7	0136-0456	158.85	455.93	521	84.33	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1054.6	E08		7	0137-0458	703.47	458.41	431	80.91	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			303.7	E08		7	0138-0460	527.10	460.81	427	79.50	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			340.6	E08		7	0139-0461	851.90	460.82	426	77.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2259.1	E08		7	0140-0471	339.98	470.78	775	109.98	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			272.9	E08		7	0141-0483	82.00	482.90	404	76.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			365.7	E08		7	0142-0491	574.07	490.87	423	76.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			481.4	E08		7	0143-0493	110.84	492.98	414	76.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			359.4	E08		7	0144-0496	268.05	496.37	397	73.60	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			253.5	E08		7	0145-0497	225.62	496.98	383	72.43	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			174.6	E08		7	0146-0502	948.73	502.04	404	79.26	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			418.6	E08		7	0147-0507	728.18	506.57	400	77.60	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			239.1	E08		7	0148-0507	897.43	506.76	385	73.26	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			296.6	E08		7	0149-0515	409.47	515.53	400	75.84	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			269.1	E08		7	0150-0519	585.04	519.69	406	75.26	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			222.5	E08		7	0151-0524	723.90	525.32	292	66.18	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			334.7	E08		7	0152-0526	646.35	526.17	363	72.67	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			611.8	E08		7	0153-0530	160.90	531.09	418	77.11	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			298.9	E08		7	0154-0528	794.84	527.92	437	84.43	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			388.6	E08		7	0155-0538	62.81	537.91	537	87.26	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			482.3	E08		7	0156-0539	94.34	539.64	421	75.84	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			342.4	E08		7	0157-0537	526.23	537.55	407	76.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			310.5	E08		7	0158-0547	636.52	547.51	481	86.33	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			304.8	E08		7	0159-0546	361.37	546.65	416	76.67	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			464.6	E08		7	0160-0556	161.11	554.96	470	83.36	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			466.9	E08		7	0161-0556	830.91	556.71	355	72.08	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			499.0	E08		7	0162-0562	286.89	562.71	427	76.67	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			360.8	E08		7	0163-0563	565.56	563.25	427	76.43	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			342.4	E08		7	0164-0562	879.38	562.67	401	76.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			352.6	E08		7	0165-0563	239.98	563.72	432	77.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			699.4	E08		7	0166-0566	456.03	566.66	814	114.23	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			690.4	E08		7	0167-0578	40.49	578.42	753	104.81	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			352.3	E08		7	0168-0576	380.31	576.15	402	73.60	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			382.5	E08		7	0169-0594	904.98	594.13	711	103.64	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			189.7	E08		7	0170-0596	88.73	596.10	376	73.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			207.0	E08		7	0171-0605	117.62	605.11	407	76.67	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			254.8	E08		7	0172-0608	251.39	608.26	407	75.26	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			250.0	E08		7	0173-0609	171.24	609.16	393	73.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			272.4	E08		7	0174-0609	623.41	609.05	462	82.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			373.0	E08		7	0175-0622	508.45	622.39	442	79.26	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			539.6	E08		7	0176-0622	537.13	621.59	421	76.08	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			287.2	E08		7	0177-0629	839.20	629.32	388	73.60	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			332.5	E08		7	0178-0630	458.46	629.99	392	73.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1357.6	E08		7	0179-0630	375.06	630.96	424	77.84	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			239.7	E08		7	0180-0634	120.29	634.40	434	83.15	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			326.7	E08		7	0181-0638	566.69	638.48	419	78.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			222.5	E08		7	0182-0643	82.73	643.20	390	75.50	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			475.7	E08		7	0183-0641	31.35	641.60	353	68.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			293.1	E08		7	0184-0645	289.37	645.10	406	73.60	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			248.9	E08		7	0185-0644	599.43	644.18	456	81.50	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			282.2	E08		7	0186-0648	147.44	647.92	408	74.18	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			824.3	E08		7	0187-0651	710.26	650.69	404	75.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			248.7	E08		7	0188-0653	250.53	653.75	401	76.08	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			820.7	E08		7	0189-0657	392.64	657.16	439	78.43	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			311.6	E08		7	0190-0667	804.84	668.45	855	117.30	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			429.6	E08		7	0191-0664	204.68	664.59	410	75.01	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			439.4	E08		7	0192-0667	461.60	667.58	383	72.43	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			240.1	E08		7	0193-0668	870.91	668.58	360	70.43	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			241.8	E08		7	0194-0671	620.80	671.53	382	72.43	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			297.4	E08		7	0195-0682	727.61	681.81	759	105.74	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			594.4	E08		7	0196-0689	30.58	689.00	400	74.43	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			268.0	E08		7	0197-0698	843.13	698.26	329	72.43	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			344.7	E08		7	0198-0696	915.86	696.39	333	68.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			330.5	E08		7	0199-0702	286.34	702.25	615	92.91	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			301.9	E08		7	0200-0701	588.98	700.78	613	93.26	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			416.5	E08		7	0201-0703	676.76	703.24	449	80.08	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			347.0	E08		7	0202-0705	860.74	704.81	415	78.77	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			331.0	E08		7	0203-0706	339.00	705.36	365	71.01	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			142.7	E08		8	0001-0027	12.86	26.76	131	43.70	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			217.8	E08		8	0002-0034	878.19	33.39	456	81.98	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			215.2	E08		8	0003-0038	137.55	38.18	360	70.18	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			216.5	E08		8	0004-0036	208.64	36.46	369	71.26	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			165.3	E08		8	0005-0037	928.11	37.23	403	75.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			247.3	E08		8	0006-0039	338.64	39.54	422	77.50	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			282.2	E08		8	0007-0043	830.27	43.72	342	67.60	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			202.3	E08		8	0008-0044	858.88	44.83	369	73.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			258.5	E08		8	0009-0049	252.72	49.24	380	73.84	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			453.0	E08		8	0010-0052	703.68	51.91	725	99.74	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			207.6	E08		8	0011-0054	106.15	53.85	358	70.18	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			310.9	E08		8	0012-0056	435.56	56.02	435	77.26	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			259.8	E08		8	0013-0068	387.24	68.15	402	73.84	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			371.3	E08		8	0014-0072	502.28	72.23	432	79.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			375.4	E08		8	0015-0075	198.47	75.77	388	72.77	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			231.7	E08		8	0016-0076	825.57	76.69	447	78.67	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			230.2	E08		8	0017-0075	916.38	76.13	387	74.67	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			188.2	E08		8	0018-0078	19.55	78.07	365	71.01	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			351.6	E08		8	0019-0081	710.84	81.37	413	75.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			280.1	E08		8	0020-0090	169.84	90.08	388	74.67	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			250.6	E08		8	0021-0089	279.57	89.50	379	73.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			406.2	E08		8	0022-0093	359.40	92.93	391	73.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			520.4	E08		8	0023-0101	97.26	101.04	385	71.84	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			208.5	E08		8	0024-0106	129.43	105.80	377	72.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			216.7	E08		8	0025-0107	912.97	106.51	390	73.01	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			234.8	E08		8	0026-0111	40.25	110.23	367	75.40	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			426.7	E08		8	0027-0114	536.93	113.63	388	72.18	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			367.8	E08		8	0028-0121	790.30	121.16	840	112.08	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			658.1	E08		8	0029-0118	182.89	118.63	396	76.77	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			669.9	E08		8	0030-0117	426.66	117.08	409	75.26	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			198.2	E08		8	0031-0132	24.01	133.27	791	113.54	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			271.3	E08		8	0032-0129	510.23	128.96	385	73.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			297.6	E08		8	0033-0134	659.27	134.22	381	75.84	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			220.9	E08		8	0034-0142	147.05	142.44	399	74.18	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			223.9	E08		8	0035-0142	349.62	142.04	399	76.43	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			331.8	E08		8	0036-0143	184.85	143.18	431	79.94	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			360.9	E08		8	0037-0147	561.04	146.72	400	73.60	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			302.3	E08		8	0038-0152	592.10	151.51	558	98.57	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			201.5	E08		8	0039-0146	775.62	146.78	412	75.01	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			255.7	E08		8	0040-0154	270.66	154.46	398	73.01	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			275.9	E08		8	0041-0154	708.75	154.15	387	71.60	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			274.9	E08		8	0042-0155	221.46	155.64	376	71.01	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			387.2	E08		8	0043-0156	921.65	156.62	398	74.67	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			524.9	E08		8	0044-0157	303.73	157.44	396	73.60	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			435.7	E08		8	0045-0159	833.62	159.60	351	69.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			958.6	E08		8	0046-0166	471.01	165.99	897	114.81	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			328.2	E08		8	0047-0162	890.05	161.56	396	74.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			172.6	E08		8	0048-0161	61.84	161.17	363	71.60	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			242.0	E08		8	0049-0166	187.42	165.14	380	74.53	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			250.0	E08		8	0050-0166	341.97	166.42	401	75.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			226.9	E08		8	0051-0169	377.65	169.22	399	77.26	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			193.2	E08		8	0052-0167	102.73	166.88	363	71.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			251.0	E08		8	0053-0187	938.78	187.67	341	68.18	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			331.5	E08		8	0054-0188	676.21	188.44	420	76.67	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			242.7	E08		8	0055-0187	778.88	187.08	345	69.01	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			217.8	E08		8	0056-0189	823.38	189.83	386	71.60	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			329.7	E08		8	0057-0191	643.60	191.60	416	76.67	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			299.2	E08		8	0058-0194	529.74	194.47	406	75.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			210.7	E08		8	0059-0197	390.61	197.85	434	81.01	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			221.2	E08		8	0060-0198	28.08	198.47	395	78.67	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			262.0	E08		8	0061-0207	234.56	207.06	394	73.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			219.3	E08		8	0062-0210	98.04	210.49	783	110.81	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			617.8	E08		8	0063-0205	730.77	205.93	405	76.87	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			203.3	E08		8	0064-0210	51.96	209.98	417	77.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			590.2	E08		8	0065-0226	150.93	226.45	882	119.20	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			169.2	E08		8	0066-0227	766.45	227.43	385	74.43	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			815.0	E08		8	0067-0225	732.13	224.55	379	74.28	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			229.0	E08		8	0068-0230	517.07	230.49	396	75.26	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			367.5	E08		8	0069-0229	455.43	228.84	391	72.43	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			518.3	E08		8	0070-0234	704.14	234.14	436	77.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			275.3	E08		8	0071-0233	801.86	233.75	412	77.74	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1356.3	E08		8	0072-0235	280.81	235.53	442	79.50	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			256.7	E08		8	0073-0242	26.40	242.17	397	75.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			777.0	E08		8	0074-0239	883.39	239.10	387	73.26	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			232.8	E08		8	0075-0243	827.50	243.32	380	73.01	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			774.1	E08		8	0076-0245	304.28	244.81	430	84.08	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2119.4	E08		8	0077-0248	207.90	247.89	429	77.26	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			355.8	E08		8	0078-0247	338.34	247.62	403	76.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			212.5	E08		8	0079-0253	364.00	253.03	387	73.60	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2002.7	E08		8	0080-0269	645.93	267.39	970	133.05	0.689
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			170.9	E08		8	0081-0258	123.48	258.55	377	72.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			298.7	E08		8	0082-0263	453.70	263.14	404	75.26	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1015.6	E08		8	0083-0264	317.89	264.40	448	82.08	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			213.5	E08		8	0084-0266	75.47	265.97	413	76.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			214.4	E08		8	0085-0265	503.36	265.50	404	74.67	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			821.3	E08		8	0086-0267	273.87	266.82	456	81.15	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			938.6	E08		8	0087-0282	253.98	282.02	486	84.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			175.5	E08		8	0088-0285	16.72	284.89	358	71.60	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			322.0	E08		8	0089-0283	874.71	283.66	396	74.67	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			218.7	E08		8	0090-0301	365.86	301.03	389	73.01	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			245.2	E08		8	0091-0303	85.07	303.28	374	71.60	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			538.0	E08		8	0092-0305	493.41	304.96	634	98.57	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			392.3	E08		8	0093-0304	646.32	304.07	373	70.18	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			363.0	E08		8	0094-0307	801.56	307.47	422	76.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			412.5	E08		8	0095-0313	152.47	313.01	416	78.43	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			325.9	E08		8	0096-0315	45.71	315.47	403	79.01	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			303.2	E08		8	0097-0317	107.42	316.99	421	77.26	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			488.5	E08		8	0098-0324	435.57	323.86	409	76.08	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			266.7	E08		8	0099-0329	225.64	330.02	805	109.54	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1868.3	E08		8	0100-0323	884.08	323.71	276	59.94	0.965
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			206.1	E08		8	0101-0331	923.08	331.31	395	75.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			607.6	E08		8	0102-0334	353.64	334.44	365	71.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			247.5	E08		8	0103-0337	170.74	336.54	362	73.94	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			700.5	E08		8	0104-0338	558.10	338.35	477	80.67	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			315.6	E08		8	0105-0339	149.93	340.00	471	84.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			236.7	E08		8	0106-0341	811.52	341.33	405	75.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			423.6	E08		8	0107-0351	410.83	350.90	374	71.60	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			244.7	E08		8	0108-0353	298.83	353.05	332	67.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3549.8	E08		8	0109-0354	493.00	354.82	371	70.18	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			298.0	E08		8	0110-0358	665.66	358.28	390	74.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			227.9	E08		8	0111-0359	17.15	358.98	363	71.60	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			869.1	E08		8	0112-0357	346.39	357.41	317	65.36	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			232.7	E08		8	0113-0358	901.62	358.35	389	74.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			296.4	E08		8	0114-0371	862.43	370.96	842	117.15	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			268.0	E08		8	0115-0374	738.95	374.20	390	73.84	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			258.3	E08		8	0116-0377	785.88	377.58	417	77.84	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			943.7	E08		8	0117-0382	335.79	382.26	393	73.26	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			698.3	E08		8	0118-0394	112.36	393.65	782	110.37	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			266.0	E08		8	0119-0387	274.56	387.16	394	74.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			215.0	E08		8	0120-0390	208.40	390.43	381	74.91	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			435.4	E08		8	0121-0389	479.21	388.90	386	72.43	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			246.4	E08		8	0122-0401	168.44	400.19	458	87.26	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			431.3	E08		8	0123-0402	565.48	401.81	380	72.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			225.6	E08		8	0124-0406	362.72	406.66	424	79.84	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			292.2	E08		8	0125-0409	434.57	409.45	394	75.60	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			554.6	E08		8	0126-0412	476.60	412.46	404	75.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			250.6	E08		8	0127-0421	609.03	421.87	466	80.91	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1151.9	E08		8	0128-0421	828.47	421.78	413	76.67	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			230.0	E08		8	0129-0422	193.23	422.30	385	71.60	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			228.7	E08		8	0130-0421	261.09	421.26	380	73.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1222.5	E08		8	0131-0421	928.44	421.32	423	79.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			182.7	E08		8	0132-0431	84.88	431.14	373	73.26	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1080.5	E08		8	0133-0429	901.87	428.91	391	76.18	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			202.9	E08		8	0134-0434	390.13	434.87	380	73.01	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			571.8	E08		8	0135-0439	573.78	438.71	432	77.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			470.7	E08		8	0136-0443	677.38	443.35	419	75.01	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1081.3	E08		8	0137-0443	127.46	443.00	401	75.50	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			210.3	E08		8	0138-0443	298.30	442.84	387	74.67	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			283.7	E08		8	0139-0445	250.82	443.39	360	72.91	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			292.9	E08		8	0140-0451	21.71	450.93	367	71.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			368.7	E08		8	0141-0451	57.31	451.96	366	71.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1102.6	E08		8	0142-0456	266.57	457.00	385	74.57	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			403.7	E08		8	0143-0456	757.54	456.78	401	73.84	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			921.9	E08		8	0144-0465	695.31	464.74	333	66.77	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			281.2	E08		8	0145-0475	624.02	474.88	775	109.64	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			338.1	E08		8	0146-0472	545.34	472.55	230	55.94	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			287.8	E08		8	0147-0479	826.55	478.30	624	92.33	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			481.7	E08		8	0148-0480	103.11	480.20	386	73.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			317.4	E08		8	0149-0482	470.82	480.83	343	70.91	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			325.7	E08		8	0150-0483	257.38	482.81	373	70.77	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1313.8	E08		8	0151-0487	382.59	487.61	326	65.94	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			415.5	E08		8	0152-0497	88.68	497.40	427	77.50	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			243.1	E08		8	0153-0501	942.80	501.31	378	74.77	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			184.0	E08		8	0154-0504	53.78	503.94	355	73.60	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			216.4	E08		8	0155-0502	837.74	503.28	408	79.26	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1194.5	E08		8	0156-0506	117.26	506.08	442	81.01	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			212.9	E08		8	0157-0508	692.35	507.93	420	76.08	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			697.8	E08		8	0158-0510	631.74	509.82	395	73.84	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			292.7	E08		8	0159-0518	344.60	518.30	623	92.33	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1022.0	E08		8	0160-0520	502.68	521.89	473	97.40	0.627
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			776.9	E08		8	0161-0519	179.67	519.43	392	73.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			460.3	E08		8	0162-0531	133.80	531.30	437	83.50	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			247.0	E08		8	0163-0530	683.66	531.47	424	77.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			173.0	E08		8	0164-0535	109.15	534.66	422	78.08	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			302.3	E08		8	0165-0538	262.29	538.48	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			349.0	E08		8	0166-0546	422.62	547.19	423	78.43	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			274.2	E08		8	0167-0548	772.56	547.66	381	73.84	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			368.4	E08		8	0168-0549	741.84	549.81	294	64.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			294.4	E08		8	0169-0552	689.00	552.49	408	78.18	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			271.1	E08		8	0170-0554	612.03	554.10	392	73.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			238.4	E08		8	0171-0558	572.27	558.01	387	73.01	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			348.5	E08		8	0172-0558	818.49	558.24	379	72.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			323.0	E08		8	0173-0559	239.19	559.34	388	74.08	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			265.7	E08		8	0174-0567	401.42	566.65	432	77.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			216.8	E08		8	0175-0569	72.52	568.92	371	71.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			176.5	E08		8	0176-0568	115.15	567.72	380	74.08	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			296.8	E08		8	0177-0571	928.14	571.53	366	71.01	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			432.8	E08		8	0178-0573	894.54	573.35	385	73.26	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			360.2	E08		8	0179-0573	472.87	572.73	373	71.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			260.6	E08		8	0180-0578	365.59	578.38	422	77.94	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			215.2	E08		8	0181-0577	620.21	577.65	398	74.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			208.1	E08		8	0182-0579	657.58	579.15	397	75.50	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			236.0	E08		8	0183-0579	130.71	579.51	295	63.84	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			269.7	E08		8	0184-0586	870.14	586.32	352	70.43	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			299.5	E08		8	0185-0593	306.08	592.85	380	72.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			228.6	E08		8	0186-0591	574.66	591.46	375	72.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			279.9	E08		8	0187-0600	798.09	600.44	796	109.88	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			279.9	E08		8	0188-0598	344.16	598.08	407	76.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			210.3	E08		8	0189-0598	649.17	599.12	377	74.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			363.6	E08		8	0190-0606	189.49	605.77	406	77.11	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			400.9	E08		8	0191-0611	212.45	611.06	398	76.77	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			297.8	E08		8	0192-0609	498.57	609.64	381	75.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			276.9	E08		8	0193-0620	745.01	619.76	770	112.47	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			335.6	E08		8	0194-0615	622.23	614.51	375	72.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			248.9	E08		8	0195-0619	247.53	619.43	377	71.01	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			279.9	E08		8	0196-0623	315.00	623.18	422	76.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			516.0	E08		8	0197-0630	449.89	629.80	367	71.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			314.8	E08		8	0198-0630	117.57	630.45	386	73.01	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			752.7	E08		8	0199-0634	145.21	633.58	394	75.50	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			234.9	E08		8	0200-0633	650.83	633.13	404	76.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			262.3	E08		8	0201-0634	411.77	634.57	416	76.18	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			353.9	E08		8	0202-0633	940.43	632.74	121	41.80	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			289.0	E08		8	0203-0642	389.05	641.84	422	77.84	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			291.0	E08		8	0204-0644	535.73	644.60	394	73.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			309.1	E08		8	0205-0650	577.45	650.84	386	72.18	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			254.6	E08		8	0206-0655	104.11	655.06	400	79.01	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			238.2	E08		8	0207-0656	784.90	656.57	391	73.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			324.1	E08		8	0208-0657	274.18	656.98	365	71.01	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			330.0	E08		8	0209-0660	515.41	660.89	414	75.84	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			308.6	E08		8	0210-0662	465.97	662.53	397	74.18	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			453.9	E08		8	0211-0663	862.67	663.21	420	76.43	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			390.7	E08		8	0212-0675	611.14	675.90	404	78.91	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			390.2	E08		8	0213-0687	236.25	687.72	410	77.01	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			213.5	E08		8	0214-0688	937.61	688.35	351	72.18	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			220.6	E08		8	0215-0687	135.56	687.26	385	73.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			402.5	E08		8	0216-0690	767.50	688.49	390	77.98	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			304.0	E08		8	0217-0695	630.66	695.62	404	78.43	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			320.5	E08		8	0218-0698	20.54	698.45	342	67.84	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			231.3	E08		8	0219-0705	876.06	705.52	417	76.91	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			253.0	E08		9	0001-0035	446.94	35.52	381	76.53	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			206.8	E08		9	0002-0030	118.26	29.91	194	54.53	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			302.8	E08		9	0003-0037	467.14	37.29	461	81.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			289.2	E08		9	0004-0035	317.27	34.86	407	80.43	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			201.8	E08		9	0005-0039	22.73	39.90	388	76.91	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			211.3	E08		9	0006-0041	859.08	41.53	402	77.74	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			227.5	E08		9	0007-0048	501.51	48.32	417	77.26	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			173.6	E08		9	0008-0052	92.29	52.34	375	72.67	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			586.3	E08		9	0009-0051	682.41	51.08	408	75.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			394.2	E08		9	0010-0056	198.24	54.50	521	106.81	0.574
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			322.2	E08		9	0011-0053	750.74	53.84	362	71.60	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			339.1	E08		9	0012-0058	180.23	60.22	233	72.08	0.564
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			231.5	E08		9	0013-0059	124.69	58.76	368	74.67	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			368.5	E08		9	0014-0065	905.51	65.74	347	70.43	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			401.6	E08		9	0015-0067	424.89	67.01	396	75.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			650.9	E08		9	0016-0068	807.95	68.14	355	68.77	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			392.7	E08		9	0017-0080	716.35	80.08	379	75.36	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			239.5	E08		9	0018-0076	289.50	76.64	363	72.43	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			303.3	E08		9	0019-0079	840.09	78.86	418	77.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			715.2	E08		9	0020-0082	469.22	81.80	358	71.60	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			316.5	E08		9	0021-0086	533.45	85.87	390	75.84	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			533.5	E08		9	0022-0091	923.79	90.75	578	92.57	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			252.0	E08		9	0023-0090	79.93	89.86	378	73.50	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			592.3	E08		9	0024-0097	361.02	97.13	367	73.26	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			588.5	E08		9	0025-0100	832.20	99.85	407	77.84	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			245.6	E08		9	0026-0104	944.59	104.47	361	71.84	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3555.0	E08		9	0027-0114	400.72	115.10	887	115.98	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			416.2	E08		9	0028-0113	501.62	112.70	613	91.74	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			203.2	E08		9	0029-0124	118.68	124.31	366	71.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			319.0	E08		9	0030-0133	74.11	134.00	385	77.60	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			335.5	E08		9	0031-0136	215.57	136.49	367	71.60	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			799.5	E08		9	0032-0137	304.29	137.25	382	75.26	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			926.6	E08		9	0033-0142	849.97	142.28	397	76.67	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			334.6	E08		9	0034-0153	773.45	152.25	340	70.33	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			385.0	E08		9	0035-0155	71.06	153.87	405	76.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			294.1	E08		9	0036-0157	644.08	156.94	390	76.08	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			338.9	E08		9	0037-0159	16.79	159.26	372	72.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			342.8	E08		9	0038-0164	786.81	165.90	382	73.74	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			595.5	E08		9	0039-0170	711.99	170.25	341	68.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			401.9	E08		9	0040-0179	734.38	179.20	399	77.26	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			426.8	E08		9	0041-0182	557.51	181.49	421	78.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			477.5	E08		9	0042-0181	472.02	180.70	441	80.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			339.2	E08		9	0043-0183	320.29	182.67	391	75.26	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			288.8	E08		9	0044-0190	33.68	190.27	339	69.01	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			606.2	E08		9	0045-0190	662.58	189.98	368	74.43	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			412.2	E08		9	0046-0201	870.57	199.09	990	127.54	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			329.4	E08		9	0047-0198	642.58	198.23	392	75.60	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			265.9	E08		9	0048-0198	62.31	198.18	337	69.26	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			295.4	E08		9	0049-0204	137.30	204.06	380	75.84	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			302.0	E08		9	0050-0204	931.35	203.84	337	68.18	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			255.4	E08		9	0051-0207	116.09	206.71	381	75.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			353.0	E08		9	0052-0218	365.71	218.11	398	77.50	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			421.6	E08		9	0053-0223	202.20	223.22	396	76.08	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			445.5	E08		9	0054-0235	446.43	235.83	404	77.74	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			375.0	E08		9	0055-0234	300.74	233.79	385	75.26	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			271.7	E08		9	0056-0237	852.00	237.08	388	73.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			252.1	E08		9	0057-0246	898.77	247.10	689	110.37	0.711
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			449.6	E08		9	0058-0245	510.67	246.13	412	75.26	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			333.0	E08		9	0059-0250	571.60	249.66	391	73.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			292.5	E08		9	0060-0254	95.42	254.05	353	68.18	0.954
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			345.6	E08		9	0061-0261	257.36	261.65	412	80.43	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			286.3	E08		9	0062-0264	925.97	264.27	369	71.01	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1399.1	E08		9	0063-0267	276.08	268.10	156	48.87	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			495.0	E08		9	0064-0295	116.10	293.14	552	94.23	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			513.8	E08		9	0065-0296	865.27	296.47	330	67.94	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			321.2	E08		9	0066-0308	601.08	308.01	785	119.10	0.695
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			278.9	E08		9	0067-0312	311.36	313.08	807	110.37	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			564.6	E08		9	0068-0306	62.59	305.93	393	78.33	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			235.2	E08		9	0069-0310	160.91	310.08	362	74.91	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			728.9	E08		9	0070-0311	534.74	311.75	392	75.01	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			702.8	E08		9	0071-0312	103.15	311.94	275	61.36	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			284.9	E08		9	0072-0316	463.24	315.59	409	77.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			322.2	E08		9	0073-0318	253.19	318.38	397	76.33	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			387.9	E08		9	0074-0321	48.06	322.47	448	79.50	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			525.4	E08		9	0075-0322	843.07	321.93	318	66.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			316.4	E08		9	0076-0329	410.85	329.14	331	68.43	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			222.1	E08		9	0077-0334	18.36	333.96	364	73.50	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			249.5	E08		9	0078-0336	359.49	336.39	397	73.84	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			270.6	E08		9	0079-0361	46.64	361.56	375	76.18	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			255.5	E08		9	0080-0363	143.77	363.02	715	101.05	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			453.8	E08		9	0081-0357	942.03	357.06	341	68.18	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			790.3	E08		9	0082-0367	914.25	366.85	224	76.43	0.482
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			257.7	E08		9	0083-0371	291.66	371.35	368	72.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			216.7	E08		9	0084-0386	92.84	386.67	367	72.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			293.9	E08		9	0085-0400	243.83	400.34	375	73.26	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			287.9	E08		9	0086-0401	306.84	401.24	393	74.67	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			468.1	E08		9	0087-0409	193.29	408.93	388	73.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			194.4	E08		9	0088-0412	70.60	412.71	370	71.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			314.2	E08		9	0089-0421	506.18	420.74	402	75.50	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1089.3	E08		9	0090-0424	23.89	424.00	390	75.60	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			217.9	E08		9	0091-0438	122.48	438.09	377	74.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1161.4	E08		9	0092-0457	67.82	457.34	362	71.60	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			335.9	E08		9	0093-0460	378.98	459.94	408	74.43	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			305.4	E08		9	0094-0472	844.58	471.93	371	74.43	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			270.1	E08		9	0095-0493	233.99	494.65	661	106.23	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			258.4	E08		9	0096-0496	541.76	496.72	360	71.84	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			227.5	E08		9	0097-0502	57.45	502.91	432	82.28	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			211.7	E08		9	0098-0504	37.64	504.09	357	72.53	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			334.0	E08		9	0099-0505	610.27	505.12	422	75.26	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			292.5	E08		9	0100-0519	323.28	519.04	444	79.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			259.2	E08		9	0101-0523	206.62	522.81	376	73.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			481.9	E08		9	0102-0523	59.79	522.94	350	71.70	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			401.9	E08		9	0103-0540	338.97	540.23	445	79.26	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			239.2	E08		9	0104-0545	381.48	545.16	362	70.53	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			557.0	E08		9	0105-0545	571.83	544.20	311	67.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			434.6	E08		9	0106-0559	562.79	560.54	389	75.26	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			274.8	E08		9	0107-0574	22.91	574.25	342	69.60	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			303.7	E08		9	0108-0576	608.85	576.94	389	74.91	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			276.8	E08		9	0109-0587	590.60	587.81	393	75.26	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			280.7	E08		9	0110-0594	360.80	594.71	372	72.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			234.6	E08		9	0111-0597	50.96	597.50	346	71.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1169.0	E08		9	0112-0619	538.40	618.84	271	59.94	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			301.1	E08		9	0113-0632	114.79	632.78	368	71.84	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			309.9	E08		9	0114-0633	916.89	632.73	349	70.77	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			287.6	E08		9	0115-0637	723.10	636.85	398	76.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			297.4	E08		9	0116-0635	35.78	635.56	114	43.46	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			315.9	E08		9	0117-0647	330.91	646.43	963	121.30	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			303.2	E08		9	0118-0643	95.21	643.10	364	74.08	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			604.9	E08		9	0119-0646	831.47	646.01	365	71.84	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			380.9	E08		9	0120-0664	884.80	664.40	591	92.33	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			847.9	E08		9	0121-0688	282.03	688.56	384	75.84	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			218.9	E08		9	0122-0691	32.07	691.03	364	72.43	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			285.6	E08		9	0123-0696	492.71	697.00	914	118.23	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			253.3	E08		9	0124-0692	101.63	692.07	400	76.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			604.0	E08		9	0125-0695	371.28	694.61	380	75.50	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			926.7	E08		9	0126-0700	602.27	699.55	456	83.74	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			289.0	E08		9	0127-0701	453.77	701.32	370	71.84	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			306.7	F08		1	0001-0030	110.32	30.57	334	66.77	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1400.3	F08		1	0002-0030	292.69	29.76	335	69.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			318.9	F08		1	0003-0033	788.07	32.87	308	63.94	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			342.0	F08		1	0004-0036	632.11	35.77	388	76.67	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			259.0	F08		1	0005-0039	856.44	39.34	340	71.26	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			287.7	F08		1	0006-0046	812.65	45.96	342	69.60	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			390.7	F08		1	0007-0045	447.90	44.91	293	63.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			433.8	F08		1	0008-0050	42.39	51.20	369	72.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			399.2	F08		1	0009-0052	596.09	52.45	328	69.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			293.5	F08		1	0010-0056	175.27	55.94	409	77.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			342.2	F08		1	0011-0064	115.82	64.58	333	67.26	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			726.3	F08		1	0012-0066	924.28	65.51	402	78.08	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			485.4	F08		1	0013-0084	473.86	84.49	348	69.60	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			404.7	F08		1	0014-0088	249.65	88.08	246	61.84	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			371.6	F08		1	0015-0090	298.93	89.70	343	71.01	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			377.5	F08		1	0016-0097	626.12	97.82	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			321.4	F08		1	0017-0100	812.67	99.51	412	75.26	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			451.8	F08		1	0018-0101	37.70	101.14	322	67.01	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1273.2	F08		1	0019-0109	158.33	109.14	367	74.67	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			433.6	F08		1	0020-0110	918.49	110.83	230	55.70	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			466.8	F08		1	0021-0117	383.49	117.08	301	63.60	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			336.2	F08		1	0022-0120	224.09	120.30	352	71.84	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			350.9	F08		1	0023-0128	92.30	128.42	330	68.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			384.8	F08		1	0024-0129	304.76	129.88	332	69.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			363.3	F08		1	0025-0132	888.55	131.89	382	74.67	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			981.1	F08		1	0026-0133	624.07	132.24	400	75.84	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			274.6	F08		1	0027-0136	189.70	136.50	377	71.84	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			321.1	F08		1	0028-0139	38.80	139.33	355	71.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			446.2	F08		1	0029-0156	502.25	156.41	361	72.77	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			485.1	F08		1	0030-0159	245.97	159.58	262	60.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			447.9	F08		1	0031-0162	542.47	162.08	305	66.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			330.1	F08		1	0032-0170	856.80	169.98	448	81.26	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			452.4	F08		1	0033-0175	32.65	174.76	287	62.77	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			332.0	F08		1	0034-0180	296.19	180.25	357	70.67	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			335.0	F08		1	0035-0181	102.62	181.53	348	70.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			323.4	F08		1	0036-0191	622.34	191.15	356	70.53	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			305.2	F08		1	0037-0209	549.09	209.23	362	71.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			364.1	F08		1	0038-0216	173.16	216.49	298	64.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			496.8	F08		1	0039-0214	415.90	214.79	279	65.70	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			565.1	F08		1	0040-0218	132.55	218.67	313	65.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			361.2	F08		1	0041-0222	910.76	222.53	352	71.36	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			346.3	F08		1	0042-0227	265.38	226.89	346	70.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			353.1	F08		1	0043-0236	190.99	236.66	350	69.01	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			306.0	F08		1	0044-0238	460.98	238.44	327	74.08	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			373.8	F08		1	0045-0242	620.41	241.77	371	73.26	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			299.4	F08		1	0046-0241	540.92	241.27	310	65.11	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			675.2	F08		1	0047-0241	410.05	241.48	113	37.80	0.994
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			309.1	F08		1	0048-0250	839.25	249.93	357	73.26	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			455.2	F08		1	0049-0261	137.07	261.05	352	71.26	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			322.7	F08		1	0050-0262	571.15	261.52	381	73.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			335.6	F08		1	0051-0266	475.39	266.69	348	70.77	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			315.2	F08		1	0052-0270	530.89	271.01	334	69.84	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			413.4	F08		1	0053-0273	75.30	273.01	386	72.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			335.0	F08		1	0054-0279	210.55	279.03	249	60.43	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			345.2	F08		1	0055-0279	382.62	278.80	308	67.36	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1017.4	F08		1	0056-0282	904.38	282.65	390	74.43	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			330.6	F08		1	0057-0287	15.18	287.71	332	67.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			346.1	F08		1	0058-0300	517.08	299.90	373	73.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			618.3	F08		1	0059-0329	669.56	330.57	345	70.43	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			331.3	F08		1	0060-0329	210.55	329.94	319	64.77	0.956
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			309.8	F08		1	0061-0342	802.79	343.15	334	72.67	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			329.3	F08		1	0062-0344	183.62	344.44	354	70.43	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			307.1	F08		1	0063-0346	343.07	345.89	306	64.77	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			408.3	F08		1	0064-0343	518.02	343.86	284	64.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			309.8	F08		1	0065-0349	610.56	349.57	361	71.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			353.7	F08		1	0066-0349	313.63	348.58	294	67.26	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			354.6	F08		1	0067-0352	260.23	352.27	281	67.11	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			483.3	F08		1	0068-0354	442.75	354.67	287	63.94	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			401.7	F08		1	0069-0363	480.92	363.36	340	69.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			345.0	F08		1	0070-0367	299.40	366.87	304	65.36	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			318.8	F08		1	0071-0365	834.10	365.25	322	69.01	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			358.1	F08		1	0072-0368	527.07	367.61	294	64.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			300.0	F08		1	0073-0382	713.27	382.72	345	71.50	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			387.4	F08		1	0074-0384	173.41	384.36	362	72.77	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			271.8	F08		1	0075-0391	638.78	392.22	333	68.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			325.5	F08		1	0076-0405	573.29	404.87	344	69.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			371.4	F08		1	0077-0406	83.10	406.45	337	72.08	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			301.6	F08		1	0078-0409	594.00	410.00	382	76.43	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			473.5	F08		1	0079-0416	504.68	415.87	285	67.01	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			527.2	F08		1	0080-0418	699.52	417.20	307	69.50	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			346.9	F08		1	0081-0418	203.10	417.77	265	61.36	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			354.8	F08		1	0082-0428	690.61	428.69	321	68.91	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			366.3	F08		1	0083-0435	651.67	435.56	372	72.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			350.5	F08		1	0084-0437	450.85	437.17	367	70.77	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			378.5	F08		1	0085-0435	195.15	435.23	264	61.36	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			301.2	F08		1	0086-0441	111.14	440.70	368	73.84	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			549.0	F08		1	0087-0436	937.32	436.53	267	61.70	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			593.5	F08		1	0088-0444	253.50	444.16	346	118.71	0.309
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			340.4	F08		1	0089-0455	397.40	455.25	368	71.01	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			525.9	F08		1	0090-0464	825.17	463.78	237	57.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			438.1	F08		1	0091-0485	605.91	485.29	412	87.15	0.682
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			330.0	F08		1	0092-0484	359.10	485.15	381	72.18	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			534.9	F08		1	0093-0490	141.87	490.27	500	83.26	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			341.0	F08		1	0094-0485	304.73	485.23	290	63.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1564.6	F08		1	0095-0491	754.70	490.13	391	73.84	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			371.6	F08		1	0096-0498	265.06	497.74	288	63.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			759.5	F08		1	0097-0502	612.95	502.59	117	44.87	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			388.5	F08		1	0098-0527	10.59	527.92	305	65.70	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			303.7	F08		1	0099-0529	57.86	529.03	358	73.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			340.0	F08		1	0100-0535	452.49	535.43	640	112.47	0.636
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			347.1	F08		1	0101-0544	105.27	544.43	300	68.18	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			354.3	F08		1	0102-0546	231.84	545.25	339	71.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			432.0	F08		1	0103-0553	623.75	553.28	268	62.43	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			296.8	F08		1	0104-0555	850.95	555.28	286	62.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			291.4	F08		1	0105-0568	48.18	568.35	360	72.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			555.9	F08		1	0106-0574	819.63	574.22	350	69.11	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			309.1	F08		1	0107-0583	783.20	583.27	312	66.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			340.9	F08		1	0108-0584	710.81	582.51	423	89.50	0.664
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			282.9	F08		1	0109-0601	38.32	600.89	321	67.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			409.4	F08		1	0110-0600	607.81	600.05	367	76.08	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			380.8	F08		1	0111-0606	660.58	605.85	371	69.60	0.962
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			275.0	F08		1	0112-0610	748.21	610.84	319	68.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			420.8	F08		1	0113-0613	409.35	613.53	265	61.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			421.8	F08		1	0114-0617	366.01	617.49	295	65.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			281.6	F08		1	0115-0636	47.83	636.91	302	65.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			561.9	F08		1	0116-0637	228.92	636.45	239	59.84	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			389.2	F08		1	0117-0641	105.73	640.57	304	66.43	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			329.8	F08		1	0118-0640	623.25	640.90	283	65.50	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			333.2	F08		1	0119-0647	682.37	646.90	347	69.36	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			350.1	F08		1	0120-0655	768.36	655.13	297	65.11	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			319.3	F08		1	0121-0662	135.28	662.55	313	68.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			401.4	F08		1	0122-0666	210.92	665.60	261	60.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			374.1	F08		1	0123-0671	801.92	670.94	284	69.94	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			725.9	F08		1	0124-0667	75.29	666.23	255	61.01	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			329.8	F08		1	0125-0677	59.44	677.46	367	73.74	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			414.7	F08		1	0126-0683	690.93	683.68	237	57.11	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			313.7	F08		1	0127-0686	20.18	685.76	352	73.26	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			348.8	F08		1	0128-0684	273.91	684.26	249	60.87	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			403.2	F08		1	0129-0693	915.46	693.02	290	65.36	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			288.1	F08		1	0130-0701	579.21	702.80	368	72.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			412.6	F08		2	0001-0044	402.32	43.52	252	60.87	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			439.7	F08		2	0002-0047	546.79	46.75	377	74.43	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			299.2	F08		2	0003-0045	673.20	45.53	381	73.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			393.9	F08		2	0004-0049	443.67	49.45	286	65.01	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			308.8	F08		2	0005-0054	106.51	53.86	348	73.26	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			323.7	F08		2	0006-0052	743.31	52.03	279	62.43	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			308.9	F08		2	0007-0054	139.17	54.86	280	64.43	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			806.2	F08		2	0008-0067	28.86	65.71	380	74.67	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			457.7	F08		2	0009-0077	470.04	76.71	312	68.18	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			375.7	F08		2	0010-0072	721.48	72.01	287	65.94	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			355.2	F08		2	0011-0074	183.67	73.87	277	62.28	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			512.0	F08		2	0012-0080	815.81	78.97	283	65.50	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			347.6	F08		2	0013-0082	518.19	82.42	330	77.50	0.690
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			402.8	F08		2	0014-0083	889.92	82.14	281	62.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			263.8	F08		2	0015-0093	931.34	92.92	316	69.26	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			252.7	F08		2	0016-0102	144.94	102.35	374	75.50	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			438.5	F08		2	0017-0105	565.73	104.91	454	81.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			397.7	F08		2	0018-0111	22.99	111.27	235	56.53	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			373.4	F08		2	0019-0113	657.25	112.56	319	68.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			410.1	F08		2	0020-0117	207.77	117.49	239	59.70	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			420.7	F08		2	0021-0119	230.19	119.39	242	60.53	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			406.0	F08		2	0022-0134	856.86	133.97	276	62.43	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			304.8	F08		2	0023-0138	939.43	137.65	329	70.43	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			414.4	F08		2	0024-0143	330.89	143.01	345	68.77	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			319.0	F08		2	0025-0151	69.43	151.02	317	67.84	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			806.4	F08		2	0026-0156	215.70	157.45	411	85.50	0.707
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			290.8	F08		2	0027-0157	165.99	157.66	306	66.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			422.6	F08		2	0028-0162	411.80	162.46	265	61.36	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			678.2	F08		2	0029-0166	749.08	166.72	255	59.36	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1333.3	F08		2	0030-0170	119.40	169.22	339	71.01	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			523.5	F08		2	0031-0169	139.86	169.16	344	68.53	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			332.9	F08		2	0032-0176	510.70	176.42	377	72.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			367.4	F08		2	0033-0172	635.63	171.65	154	45.94	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			347.1	F08		2	0034-0178	457.29	178.32	334	68.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			394.3	F08		2	0035-0181	626.08	181.30	201	55.01	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			379.8	F08		2	0036-0187	645.35	186.92	276	63.60	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			443.0	F08		2	0037-0189	845.17	189.53	216	59.60	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			287.7	F08		2	0038-0193	325.10	193.61	304	64.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			310.6	F08		2	0039-0198	409.45	197.88	339	70.18	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			306.4	F08		2	0040-0209	535.17	208.71	386	73.26	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			310.7	F08		2	0041-0222	15.25	222.86	325	68.53	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			295.8	F08		2	0042-0224	616.40	224.46	300	65.01	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			603.4	F08		2	0043-0226	843.78	226.33	273	63.60	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			341.1	F08		2	0044-0230	121.18	229.88	332	68.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			299.3	F08		2	0045-0228	239.63	228.40	268	65.01	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			252.4	F08		2	0046-0230	652.00	230.29	317	67.84	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			357.6	F08		2	0047-0233	715.12	232.41	190	55.11	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			444.0	F08		2	0048-0235	323.12	235.58	304	71.11	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			324.5	F08		2	0049-0245	404.92	245.37	349	71.84	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			296.0	F08		2	0050-0250	276.28	249.47	274	63.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			335.2	F08		2	0051-0264	929.92	263.21	249	63.01	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			285.3	F08		2	0052-0261	191.74	262.17	309	69.36	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			524.5	F08		2	0053-0261	360.66	261.16	226	56.04	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			338.2	F08		2	0054-0268	54.40	268.60	344	69.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			471.9	F08		2	0055-0269	887.42	269.70	221	56.87	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			344.2	F08		2	0056-0270	341.91	269.66	282	63.94	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			275.6	F08		2	0057-0270	377.36	269.33	302	67.01	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			347.3	F08		2	0058-0280	724.41	279.94	346	72.18	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			765.3	F08		2	0059-0287	837.58	288.01	278	63.36	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			545.0	F08		2	0060-0297	127.28	297.86	214	57.94	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			321.6	F08		2	0061-0310	855.99	310.23	349	72.77	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			376.0	F08		2	0062-0317	259.32	317.68	288	65.70	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			345.9	F08		2	0063-0316	721.99	316.46	335	70.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			342.6	F08		2	0064-0321	376.65	320.95	305	66.67	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			360.9	F08		2	0065-0326	445.77	327.05	286	61.36	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			395.6	F08		2	0066-0330	180.19	329.23	325	67.36	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			376.7	F08		2	0067-0342	868.58	341.35	293	64.18	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			335.0	F08		2	0068-0348	366.56	348.52	336	68.18	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			309.1	F08		2	0069-0351	922.88	351.54	356	73.01	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			236.9	F08		2	0070-0356	941.20	356.11	350	71.60	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			288.4	F08		2	0071-0357	153.69	357.39	612	108.23	0.657
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			311.4	F08		2	0072-0374	406.60	374.81	483	84.43	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			329.4	F08		2	0073-0383	289.40	383.00	313	67.94	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			358.9	F08		2	0074-0383	102.55	383.68	245	59.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			605.5	F08		2	0075-0385	593.84	385.36	304	67.84	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			288.9	F08		2	0076-0387	356.28	387.46	294	66.43	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			274.3	F08		2	0077-0393	141.79	393.65	318	69.26	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			364.4	F08		2	0078-0397	212.63	398.04	322	65.60	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			333.0	F08		2	0079-0404	652.55	404.88	359	70.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			275.7	F08		2	0080-0409	431.96	408.57	379	72.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			514.1	F08		2	0081-0430	485.77	430.66	314	68.18	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			349.7	F08		2	0082-0436	193.76	436.75	316	68.43	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			508.9	F08		2	0083-0436	587.81	435.82	323	69.01	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			517.2	F08		2	0084-0437	42.06	436.96	271	61.11	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			976.2	F08		2	0085-0437	821.66	437.77	223	56.77	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			721.1	F08		2	0086-0448	660.63	448.83	239	58.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			277.1	F08		2	0087-0453	54.39	453.00	355	70.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			324.0	F08		2	0088-0459	340.67	458.85	249	61.84	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			561.3	F08		2	0089-0458	740.67	458.64	236	59.70	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			305.2	F08		2	0090-0467	519.60	467.21	345	69.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			519.1	F08		2	0091-0479	573.14	478.52	194	66.43	0.552
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			278.5	F08		2	0092-0489	169.47	489.35	315	70.77	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			390.6	F08		2	0093-0519	590.31	518.90	428	82.08	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			321.1	F08		2	0094-0517	202.43	517.49	317	67.36	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			459.0	F08		2	0095-0523	87.21	522.84	469	81.50	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			502.2	F08		2	0096-0521	771.81	521.83	313	68.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			351.8	F08		2	0097-0538	125.28	538.27	288	62.53	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			363.5	F08		2	0098-0537	646.98	536.44	248	62.18	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			384.4	F08		2	0099-0545	186.16	545.47	349	70.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			441.7	F08		2	0100-0562	460.22	561.46	366	74.43	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			314.1	F08		2	0101-0559	846.47	559.65	280	61.60	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			332.4	F08		2	0102-0581	830.65	580.36	296	64.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			817.2	F08		2	0103-0584	729.87	584.27	309	67.94	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			430.6	F08		2	0104-0583	136.86	584.11	355	70.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			403.2	F08		2	0105-0593	204.94	592.65	333	67.84	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			321.8	F08		2	0106-0599	657.62	599.28	352	72.77	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			870.9	F08		2	0107-0612	401.82	612.35	416	77.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			344.2	F08		2	0108-0613	282.94	613.38	336	69.60	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			324.4	F08		2	0109-0617	794.31	617.48	364	74.43	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			299.1	F08		2	0110-0627	564.76	627.74	304	68.33	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			375.0	F08		2	0111-0628	503.68	628.54	265	60.43	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			328.0	F08		2	0112-0640	468.48	639.76	358	74.77	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			478.2	F08		2	0113-0637	533.36	637.27	300	64.43	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			752.5	F08		2	0114-0638	142.53	638.49	284	62.28	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			304.9	F08		2	0115-0642	923.09	642.55	259	61.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			374.1	F08		2	0116-0649	490.89	649.79	358	75.60	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			282.7	F08		2	0117-0649	649.70	649.95	364	70.43	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			470.4	F08		2	0118-0651	340.95	651.50	256	60.53	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			462.1	F08		2	0119-0655	74.76	655.35	333	67.01	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			281.0	F08		2	0120-0656	384.32	656.20	315	68.43	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			306.9	F08		2	0121-0657	846.70	657.62	241	65.01	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			356.1	F08		2	0122-0664	526.49	664.41	282	62.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			346.9	F08		2	0123-0666	164.78	666.26	272	63.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			384.0	F08		2	0124-0667	290.75	666.98	342	68.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			463.1	F08		2	0125-0682	731.33	682.52	336	69.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			267.8	F08		2	0126-0684	931.88	683.94	264	62.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			389.0	F08		2	0127-0694	19.90	693.98	297	67.60	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			402.8	F08		2	0128-0705	744.81	704.87	312	65.84	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			495.0	F08		2	0129-0706	272.33	705.97	274	61.70	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			735.2	F08		2	0130-0704	664.77	704.13	313	65.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			383.5	F08		3	0001-0050	476.08	49.13	337	67.70	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			394.0	F08		3	0002-0055	782.98	55.56	261	61.11	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			595.4	F08		3	0003-0061	427.72	60.68	259	63.26	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			404.8	F08		3	0004-0062	393.22	62.02	308	63.36	0.964
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			486.3	F08		3	0005-0065	594.31	65.58	268	65.11	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			620.3	F08		3	0006-0068	325.54	68.02	284	62.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			434.0	F08		3	0007-0074	358.23	74.13	275	61.94	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			597.4	F08		3	0008-0089	435.52	89.44	268	60.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			293.7	F08		3	0009-0095	26.42	95.35	307	67.84	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2572.6	F08		3	0010-0109	138.49	108.04	205	67.26	0.570
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1112.0	F08		3	0011-0121	338.26	120.75	128	83.98	0.228
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			572.7	F08		3	0012-0130	591.11	130.17	181	52.87	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			290.2	F08		3	0013-0135	62.32	134.57	325	67.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			548.4	F08		3	0014-0142	436.10	142.21	309	66.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			444.8	F08		3	0015-0139	714.84	139.16	329	69.84	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			302.9	F08		3	0016-0141	34.55	140.24	322	71.01	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			762.7	F08		3	0017-0151	362.17	151.19	344	69.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			742.9	F08		3	0018-0146	686.46	146.15	203	58.28	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			386.6	F08		3	0019-0162	798.40	161.54	373	72.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			327.1	F08		3	0020-0164	305.82	164.51	279	61.94	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			323.9	F08		3	0021-0169	524.17	169.68	355	70.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			552.9	F08		3	0022-0176	41.37	176.90	331	73.50	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			299.3	F08		3	0023-0177	832.00	178.04	298	65.26	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			370.6	F08		3	0024-0180	761.07	179.65	319	70.18	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			518.4	F08		3	0025-0177	491.67	177.39	215	55.11	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			283.8	F08		3	0026-0188	796.60	188.30	334	69.36	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			940.6	F08		3	0027-0192	111.65	192.79	198	51.11	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			393.0	F08		3	0028-0201	382.46	201.75	271	63.26	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			310.4	F08		3	0029-0205	201.11	204.61	346	71.11	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			386.2	F08		3	0030-0209	706.89	208.43	356	71.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			379.5	F08		3	0031-0212	450.10	211.48	257	58.77	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			267.0	F08		3	0032-0220	833.52	220.04	327	70.67	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			423.6	F08		3	0033-0220	134.00	220.04	250	59.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			327.7	F08		3	0034-0227	404.98	227.52	305	64.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			397.8	F08		3	0035-0230	513.44	230.31	226	62.77	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			703.2	F08		3	0036-0234	547.93	234.56	240	58.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			342.5	F08		3	0037-0237	281.30	237.36	268	63.11	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			436.0	F08		3	0038-0255	675.34	254.68	236	58.53	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			330.2	F08		3	0039-0258	799.14	258.45	311	66.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			883.0	F08		3	0040-0262	553.47	262.69	241	58.53	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			330.3	F08		3	0041-0266	25.16	265.73	251	63.01	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			301.4	F08		3	0042-0265	863.12	265.41	274	63.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			719.7	F08		3	0043-0265	141.87	264.90	244	59.94	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			641.7	F08		3	0044-0269	487.64	268.24	132	54.77	0.553
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			432.2	F08		3	0045-0276	280.84	276.59	386	73.26	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			372.9	F08		3	0046-0283	412.01	282.93	270	61.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			525.0	F08		3	0047-0287	480.67	286.13	285	76.33	0.615
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			389.1	F08		3	0048-0285	614.69	285.54	353	71.01	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			506.8	F08		3	0049-0296	198.32	296.29	316	68.77	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			328.2	F08		3	0050-0294	808.99	294.66	306	65.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			534.2	F08		3	0051-0300	332.45	299.79	423	75.84	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			326.7	F08		3	0052-0300	512.00	299.74	300	64.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			725.0	F08		3	0053-0297	560.29	297.60	266	59.70	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			284.0	F08		3	0054-0305	631.55	304.42	320	68.18	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			353.4	F08		3	0055-0306	733.69	306.77	268	63.26	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			700.1	F08		3	0056-0305	416.53	305.25	160	48.63	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			734.0	F08		3	0057-0317	101.43	316.75	262	61.60	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			294.4	F08		3	0058-0318	58.86	318.20	366	72.08	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			381.6	F08		3	0059-0321	912.88	321.82	329	68.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			352.6	F08		3	0060-0321	412.84	321.14	247	64.77	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			339.1	F08		3	0061-0347	476.90	347.05	328	68.67	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			469.6	F08		3	0062-0349	536.15	349.97	293	67.11	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			406.7	F08		3	0063-0352	322.80	351.71	344	72.43	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			431.9	F08		3	0064-0354	218.01	354.14	410	78.43	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			255.4	F08		3	0065-0351	905.20	351.25	201	57.36	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			259.5	F08		3	0066-0354	18.49	354.18	350	72.18	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			257.9	F08		3	0067-0359	36.63	358.66	327	71.60	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			306.3	F08		3	0068-0361	443.07	361.30	317	74.77	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			298.6	F08		3	0069-0364	167.12	363.84	301	66.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			556.6	F08		3	0070-0375	797.76	374.43	377	74.43	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			397.1	F08		3	0071-0376	407.77	376.33	403	74.43	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			892.2	F08		3	0072-0383	548.09	383.47	271	61.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			694.9	F08		3	0073-0386	55.28	386.66	263	61.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			288.8	F08		3	0074-0389	468.20	389.24	355	71.01	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			332.4	F08		3	0075-0397	757.28	397.31	318	66.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			271.5	F08		3	0076-0407	593.49	407.72	303	65.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			289.4	F08		3	0077-0411	77.32	411.36	338	74.53	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			682.0	F08		3	0078-0415	667.54	414.74	411	79.26	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			311.3	F08		3	0079-0419	610.37	419.36	314	70.53	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			351.5	F08		3	0080-0418	171.29	417.35	336	70.67	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			340.9	F08		3	0081-0420	436.94	420.27	281	66.43	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			490.5	F08		3	0082-0432	899.32	432.10	265	65.60	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			311.4	F08		3	0083-0438	699.89	438.70	296	63.11	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			271.1	F08		3	0084-0444	43.31	444.10	338	70.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			703.0	F08		3	0085-0456	495.79	456.18	406	77.50	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			369.3	F08		3	0086-0460	909.25	460.74	187	53.94	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			373.1	F08		3	0087-0465	185.70	465.70	314	67.94	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			329.7	F08		3	0088-0474	639.22	474.30	345	69.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			330.1	F08		3	0089-0477	108.91	477.06	326	70.43	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			357.3	F08		3	0090-0483	496.72	482.98	270	66.43	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			298.9	F08		3	0091-0489	136.73	489.56	356	70.18	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			455.0	F08		3	0092-0490	780.75	490.99	267	61.36	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			277.3	F08		3	0093-0495	49.45	494.62	325	71.01	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			305.7	F08		3	0094-0500	347.91	499.38	295	64.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			331.2	F08		3	0095-0505	919.44	505.45	336	70.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			315.8	F08		3	0096-0508	250.88	507.89	557	95.74	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			304.0	F08		3	0097-0510	377.92	509.40	309	65.01	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			326.1	F08		3	0098-0527	730.49	527.19	370	73.60	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			557.9	F08		3	0099-0528	126.47	527.79	363	75.26	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			499.9	F08		3	0100-0534	225.35	534.16	299	67.01	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			324.9	F08		3	0101-0536	332.81	536.80	270	62.18	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			401.7	F08		3	0102-0543	554.02	544.15	343	69.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			275.0	F08		3	0103-0559	286.52	558.77	368	74.18	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			315.1	F08		3	0104-0566	404.65	567.19	357	75.60	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			274.2	F08		3	0105-0571	119.84	570.90	342	68.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			318.9	F08		3	0106-0577	154.39	576.28	301	68.43	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			336.1	F08		3	0107-0591	260.04	590.74	287	68.67	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			382.3	F08		3	0108-0616	365.65	616.72	298	71.50	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			391.6	F08		3	0109-0615	867.81	615.37	216	57.36	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1792.5	F08		3	0110-0619	937.72	619.86	247	60.53	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			367.9	F08		3	0111-0617	586.76	617.38	390	76.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			356.4	F08		3	0112-0630	903.23	629.42	344	73.50	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			385.3	F08		3	0113-0631	686.81	631.00	315	66.43	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			379.6	F08		3	0114-0638	664.80	638.76	311	67.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			829.9	F08		3	0115-0642	347.01	643.02	393	73.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			343.1	F08		3	0116-0644	17.93	645.04	252	59.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			420.9	F08		3	0117-0648	121.67	648.11	346	72.18	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			403.1	F08		3	0118-0651	291.92	651.05	242	62.77	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			438.9	F08		3	0119-0654	805.48	654.07	367	80.57	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			464.5	F08		3	0120-0652	309.59	653.07	239	60.77	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			308.0	F08		3	0121-0658	176.52	658.47	307	64.77	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			272.7	F08		3	0122-0658	839.55	658.18	315	69.84	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			272.1	F08		3	0123-0665	557.91	665.19	318	65.60	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			264.2	F08		3	0124-0672	147.01	672.49	294	63.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			312.8	F08		3	0125-0682	690.56	682.16	287	63.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			550.7	F08		3	0126-0686	535.26	685.35	203	55.21	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			309.7	F08		3	0127-0686	26.79	686.38	256	61.11	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			287.9	F08		3	0128-0694	675.48	694.25	328	67.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			305.6	F08		3	0129-0694	879.58	694.71	250	59.94	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			288.4	F08		3	0130-0704	182.73	704.55	273	61.60	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			316.7	F08		3	0131-0705	571.76	705.50	261	61.94	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			405.5	F08		4	0001-0029	171.82	29.32	261	60.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			486.0	F08		4	0002-0029	195.04	28.79	276	62.28	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			303.7	F08		4	0003-0032	144.75	32.73	257	61.70	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			487.7	F08		4	0004-0037	371.19	36.91	404	78.43	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			309.6	F08		4	0005-0064	872.22	63.25	356	72.43	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			353.8	F08		4	0006-0066	791.10	66.43	289	63.84	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1037.9	F08		4	0007-0069	51.72	68.97	255	61.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			342.5	F08		4	0008-0073	575.33	73.58	383	72.18	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			309.4	F08		4	0009-0076	110.78	76.17	321	67.94	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			339.7	F08		4	0010-0081	129.33	81.01	329	68.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			299.8	F08		4	0011-0096	634.11	95.81	337	70.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			363.7	F08		4	0012-0099	658.30	99.12	333	67.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			402.7	F08		4	0013-0106	475.01	106.70	414	83.26	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			606.5	F08		4	0014-0113	291.14	113.27	168	62.18	0.546
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			397.4	F08		4	0015-0121	83.65	120.58	291	65.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			456.5	F08		4	0016-0123	752.18	123.22	242	61.94	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			564.1	F08		4	0017-0121	785.98	121.79	202	51.94	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			335.6	F08		4	0018-0130	765.98	129.70	307	67.60	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			355.1	F08		4	0019-0132	574.14	131.92	314	67.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			435.5	F08		4	0020-0134	331.23	133.99	233	59.60	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			436.8	F08		4	0021-0136	432.75	135.71	287	64.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			799.2	F08		4	0022-0159	807.45	159.14	211	57.11	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2384.1	F08		4	0023-0161	233.88	160.59	280	61.94	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			616.4	F08		4	0024-0161	49.25	161.54	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			329.3	F08		4	0025-0164	601.52	164.49	295	64.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			336.7	F08		4	0026-0206	90.26	206.84	298	64.53	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1477.5	F08		4	0027-0209	531.51	209.16	307	68.18	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			605.0	F08		4	0028-0216	759.32	217.08	373	77.01	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			395.1	F08		4	0029-0212	912.03	211.82	314	67.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			277.9	F08		4	0030-0220	638.13	219.53	359	73.84	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			393.5	F08		4	0031-0225	408.56	225.08	339	71.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			374.8	F08		4	0032-0233	179.43	233.32	244	59.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			306.7	F08		4	0033-0240	333.77	239.81	310	66.43	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			455.9	F08		4	0034-0248	851.08	248.98	214	56.04	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			280.4	F08		4	0035-0257	43.47	257.21	343	70.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			385.3	F08		4	0036-0259	664.07	259.11	241	61.36	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			313.4	F08		4	0037-0270	424.07	270.27	299	66.18	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			328.9	F08		4	0038-0273	376.22	273.53	333	67.36	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			427.5	F08		4	0039-0272	180.26	272.05	242	58.77	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			381.4	F08		4	0040-0293	717.39	293.01	452	78.67	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			477.3	F08		4	0041-0297	20.10	297.46	353	70.18	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			347.3	F08		4	0042-0306	120.00	305.13	301	67.26	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			352.6	F08		4	0043-0306	917.57	306.35	266	63.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			571.9	F08		4	0044-0307	538.95	307.10	280	61.60	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			387.3	F08		4	0045-0309	667.97	309.75	240	61.60	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1227.5	F08		4	0046-0306	58.29	305.81	108	71.26	0.267
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			289.4	F08		4	0047-0311	377.59	311.42	323	68.77	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			334.5	F08		4	0048-0325	400.90	325.45	277	65.60	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			266.8	F08		4	0049-0329	359.73	329.52	366	72.43	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			297.4	F08		4	0050-0341	175.33	341.14	295	67.36	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			285.5	F08		4	0051-0338	296.96	338.14	314	68.43	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			267.8	F08		4	0052-0335	911.15	335.22	279	63.36	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			499.1	F08		4	0053-0339	454.32	339.21	317	67.60	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			492.8	F08		4	0054-0340	751.27	340.20	239	56.53	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			419.5	F08		4	0055-0347	199.86	347.24	232	57.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			299.9	F08		4	0056-0348	898.53	348.06	261	62.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			317.4	F08		4	0057-0353	925.53	352.89	270	61.94	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			496.8	F08		4	0058-0370	645.70	369.78	240	56.53	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			293.0	F08		4	0059-0374	765.64	375.08	305	63.60	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			352.1	F08		4	0060-0377	230.62	377.83	321	67.84	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			455.3	F08		4	0061-0375	75.09	374.82	228	58.87	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			313.0	F08		4	0062-0397	347.58	396.96	251	61.01	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			328.7	F08		4	0063-0400	196.29	400.36	253	59.11	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			411.8	F08		4	0064-0399	845.43	399.14	274	61.11	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			322.1	F08		4	0065-0405	765.45	405.15	309	65.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			369.6	F08		4	0066-0407	710.17	407.47	313	64.43	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			333.3	F08		4	0067-0411	327.72	411.45	279	64.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			374.5	F08		4	0068-0425	935.39	425.27	246	64.28	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			325.3	F08		4	0069-0426	227.43	425.84	276	63.60	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			336.7	F08		4	0070-0433	826.67	433.62	366	73.01	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			279.0	F08		4	0071-0433	792.34	434.04	296	65.26	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			305.8	F08		4	0072-0439	880.69	439.79	390	75.84	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			334.0	F08		4	0073-0458	342.98	457.95	303	68.53	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			305.4	F08		4	0074-0466	560.47	466.09	336	71.01	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			465.0	F08		4	0075-0477	753.31	477.02	509	85.50	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			403.5	F08		4	0076-0487	519.08	487.44	347	70.43	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			385.4	F08		4	0077-0489	901.11	489.35	224	59.70	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			417.7	F08		4	0078-0497	148.51	496.66	310	65.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			317.6	F08		4	0079-0504	288.85	504.09	327	67.26	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			401.0	F08		4	0080-0502	21.26	502.29	265	65.60	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			347.3	F08		4	0081-0502	230.11	502.30	295	68.43	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			462.8	F08		4	0082-0507	702.74	507.36	250	59.94	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			343.8	F08		4	0083-0518	434.28	517.40	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			332.2	F08		4	0084-0517	327.21	518.02	295	65.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			369.4	F08		4	0085-0532	654.71	531.73	370	71.36	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			273.1	F08		4	0086-0535	143.11	534.87	285	64.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			376.0	F08		4	0087-0536	197.18	535.93	334	68.18	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			485.8	F08		4	0088-0538	519.41	538.85	295	65.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			417.0	F08		4	0089-0547	598.89	547.62	236	57.11	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			529.7	F08		4	0090-0553	770.22	549.80	273	100.71	0.338
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			411.4	F08		4	0091-0553	308.70	552.52	334	68.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			459.1	F08		4	0092-0554	236.15	553.92	325	72.18	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			396.8	F08		4	0093-0553	374.13	553.74	227	60.43	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			297.0	F08		4	0094-0561	844.19	562.12	348	72.67	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			466.0	F08		4	0095-0561	791.09	560.82	264	83.50	0.476
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			283.6	F08		4	0096-0566	270.03	566.14	283	65.84	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			448.6	F08		4	0097-0565	19.85	565.60	260	60.53	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			305.0	F08		4	0098-0581	691.35	581.50	300	65.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			292.0	F08		4	0099-0583	767.19	583.34	293	65.11	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			309.7	F08		4	0100-0587	159.33	587.68	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			404.9	F08		4	0101-0593	844.08	593.08	290	64.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			429.5	F08		4	0102-0608	700.30	608.59	351	72.18	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			308.5	F08		4	0103-0611	330.70	610.79	260	62.18	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			292.8	F08		4	0104-0612	306.01	612.01	306	65.11	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			490.9	F08		4	0105-0615	576.64	615.24	375	74.67	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1430.6	F08		4	0106-0617	891.27	617.43	316	67.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			547.8	F08		4	0107-0628	95.11	628.12	255	61.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			673.5	F08		4	0108-0631	374.02	631.06	239	59.11	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			373.3	F08		4	0109-0636	235.67	635.97	293	68.77	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			585.9	F08		4	0110-0634	316.13	633.75	228	58.87	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			286.7	F08		4	0111-0647	665.33	646.45	365	72.18	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			411.5	F08		4	0112-0653	495.85	653.47	310	65.36	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			273.8	F08		4	0113-0659	788.18	658.88	344	69.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			485.7	F08		4	0114-0659	552.10	659.61	283	67.50	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			263.3	F08		4	0115-0666	282.01	665.44	321	67.60	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			307.9	F08		4	0116-0668	727.49	667.81	322	67.60	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			451.7	F08		4	0117-0680	397.53	679.43	239	57.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			294.5	F08		4	0118-0686	292.84	686.66	270	61.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			251.8	F08		4	0119-0695	861.38	694.59	324	73.50	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			285.7	F08		4	0120-0698	161.50	698.70	379	76.53	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			576.7	F08		4	0121-0700	903.67	700.99	382	111.88	0.383
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			284.3	F08		4	0122-0702	144.98	702.79	376	75.94	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			382.0	F08		4	0123-0699	828.87	699.10	217	57.60	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			542.8	F08		4	0124-0700	594.34	699.65	244	60.43	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			368.2	F08		4	0125-0701	642.94	700.49	282	62.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			288.9	F08		5	0001-0034	395.08	34.47	406	75.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			326.1	F08		5	0002-0038	646.42	38.21	370	70.77	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			256.1	F08		5	0003-0036	895.51	36.62	132	44.87	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			259.2	F08		5	0004-0053	63.91	53.11	294	64.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			400.1	F08		5	0005-0056	130.66	56.10	288	64.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			390.2	F08		5	0006-0053	176.55	53.72	267	61.94	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			291.5	F08		5	0007-0057	930.89	57.41	309	65.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			286.7	F08		5	0008-0059	214.33	59.15	311	67.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			319.7	F08		5	0009-0059	820.16	60.31	321	68.43	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			593.2	F08		5	0010-0064	611.99	63.41	263	61.11	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			258.0	F08		5	0011-0067	82.12	67.22	330	67.60	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			462.0	F08		5	0012-0070	116.97	70.49	285	65.60	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			274.6	F08		5	0013-0071	460.49	70.35	324	68.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			261.9	F08		5	0014-0076	867.42	76.30	428	91.40	0.644
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			404.2	F08		5	0015-0075	301.28	74.78	281	63.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			300.2	F08		5	0016-0074	439.08	73.56	341	70.18	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1116.4	F08		5	0017-0079	544.63	79.97	407	77.26	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			325.7	F08		5	0018-0077	652.81	76.34	386	75.60	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			271.0	F08		5	0019-0082	157.42	81.90	300	66.77	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			411.7	F08		5	0020-0085	343.85	86.51	368	83.84	0.658
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			341.4	F08		5	0021-0089	282.47	89.26	281	61.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			224.4	F08		5	0022-0092	892.22	92.42	341	70.18	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			284.8	F08		5	0023-0095	483.90	95.58	329	71.01	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			294.3	F08		5	0024-0109	219.92	109.22	269	61.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			334.0	F08		5	0025-0113	338.05	113.44	337	68.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			298.7	F08		5	0026-0111	115.25	110.85	245	61.94	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			373.3	F08		5	0027-0114	386.41	114.78	323	70.08	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			361.9	F08		5	0028-0114	427.91	114.12	383	73.60	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			350.9	F08		5	0029-0121	903.82	121.33	326	67.84	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			370.3	F08		5	0030-0131	793.61	131.16	271	63.84	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2632.3	F08		5	0031-0133	734.79	133.74	301	66.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2304.3	F08		5	0032-0134	751.30	133.33	292	63.70	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			532.0	F08		5	0033-0132	385.79	132.09	222	55.70	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			240.9	F08		5	0034-0138	86.64	137.47	341	69.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			310.3	F08		5	0035-0139	163.72	139.59	258	66.77	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1535.2	F08		5	0036-0145	476.49	144.75	396	74.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			292.4	F08		5	0037-0157	213.74	156.88	316	68.43	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			358.3	F08		5	0038-0169	274.16	168.88	351	71.01	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			387.6	F08		5	0039-0173	609.16	173.16	404	76.08	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			672.7	F08		5	0040-0175	653.57	175.14	222	66.43	0.632
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			329.6	F08		5	0041-0186	692.54	186.11	259	61.84	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			335.4	F08		5	0042-0189	790.81	189.35	316	66.18	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			305.3	F08		5	0043-0194	433.89	195.30	340	69.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			265.9	F08		5	0044-0192	569.76	192.11	337	69.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			589.6	F08		5	0045-0194	511.55	194.18	281	67.60	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			242.1	F08		5	0046-0198	605.20	198.50	312	67.01	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			423.2	F08		5	0047-0206	138.63	206.49	216	56.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			407.9	F08		5	0048-0211	405.29	211.43	319	71.36	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			379.3	F08		5	0049-0209	751.75	209.63	284	63.01	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			415.1	F08		5	0050-0211	70.94	211.56	255	59.36	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			614.3	F08		5	0051-0213	693.64	213.26	347	68.43	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			355.7	F08		5	0052-0213	17.38	213.79	300	66.18	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			299.3	F08		5	0053-0213	227.18	213.03	327	71.60	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			467.7	F08		5	0054-0215	509.11	214.86	203	52.53	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			497.1	F08		5	0055-0227	876.19	227.30	204	55.11	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			334.2	F08		5	0056-0234	567.51	233.40	287	68.08	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			235.5	F08		5	0057-0240	663.89	240.33	359	72.67	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			251.8	F08		5	0058-0241	438.76	241.98	335	68.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			357.7	F08		5	0059-0243	527.92	243.78	266	63.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			302.7	F08		5	0060-0247	706.19	247.96	330	70.77	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			414.8	F08		5	0061-0249	754.11	249.02	234	57.36	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			255.9	F08		5	0062-0254	389.43	254.59	364	70.67	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			369.1	F08		5	0063-0261	206.44	260.22	459	86.33	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			371.3	F08		5	0064-0270	895.35	270.24	417	76.67	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			332.6	F08		5	0065-0270	599.22	270.41	322	66.77	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			346.6	F08		5	0066-0273	348.28	273.69	299	66.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			571.6	F08		5	0067-0276	448.25	276.64	239	58.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			652.3	F08		5	0068-0278	835.77	278.27	321	71.01	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			456.4	F08		5	0069-0279	292.09	279.55	344	68.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			298.6	F08		5	0070-0281	537.85	281.40	333	68.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			287.9	F08		5	0071-0280	677.23	279.89	332	75.26	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			324.9	F08		5	0072-0296	347.47	296.08	330	69.11	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			411.4	F08		5	0073-0299	635.45	299.89	346	73.94	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			382.9	F08		5	0074-0297	788.73	297.15	291	66.43	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			323.8	F08		5	0075-0304	875.72	303.01	289	70.18	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			422.0	F08		5	0076-0304	729.81	304.02	340	68.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			330.0	F08		5	0077-0308	23.08	308.11	265	63.01	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			301.9	F08		5	0078-0305	939.78	305.35	304	67.11	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			313.3	F08		5	0079-0310	179.55	310.39	294	64.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			329.9	F08		5	0080-0311	598.75	311.32	354	71.84	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			321.0	F08		5	0081-0313	143.45	313.92	286	64.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			282.8	F08		5	0082-0313	690.74	313.03	348	77.26	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			333.1	F08		5	0083-0319	850.96	319.47	303	65.01	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			336.7	F08		5	0084-0322	104.40	321.87	295	62.77	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			399.0	F08		5	0085-0336	533.22	336.35	305	64.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			252.2	F08		5	0086-0337	16.83	337.26	281	63.70	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			402.0	F08		5	0087-0351	708.97	350.24	940	130.02	0.699
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			379.0	F08		5	0088-0353	484.07	354.05	355	77.60	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			302.5	F08		5	0089-0355	30.81	354.84	268	61.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			298.8	F08		5	0090-0368	604.98	368.12	312	65.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			339.6	F08		5	0091-0375	822.27	374.97	333	69.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			357.8	F08		5	0092-0381	723.88	381.54	231	58.77	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			347.2	F08		5	0093-0387	124.99	387.97	340	73.01	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			283.5	F08		5	0094-0394	576.29	394.42	289	63.11	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			565.1	F08		5	0095-0397	186.52	397.07	209	54.28	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			275.6	F08		5	0096-0402	650.80	402.61	306	65.01	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			296.7	F08		5	0097-0403	301.55	402.35	283	62.77	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			264.1	F08		5	0098-0407	729.66	406.83	335	68.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			304.7	F08		5	0099-0411	271.43	411.55	382	72.77	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			258.8	F08		5	0100-0411	806.69	411.17	317	66.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			289.1	F08		5	0101-0410	931.79	410.06	268	63.01	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			306.0	F08		5	0102-0416	163.49	417.53	505	84.33	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			312.2	F08		5	0103-0412	488.23	411.26	280	63.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			265.4	F08		5	0104-0415	603.65	415.15	316	68.18	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			272.8	F08		5	0105-0423	356.28	423.04	348	72.43	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			374.4	F08		5	0106-0427	40.59	427.14	247	64.53	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			367.3	F08		5	0107-0430	435.55	429.89	458	82.33	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			303.4	F08		5	0108-0440	211.05	440.67	269	62.77	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			354.0	F08		5	0109-0439	640.00	439.36	249	57.94	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			329.7	F08		5	0110-0442	417.16	442.94	262	61.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			284.8	F08		5	0111-0443	899.55	443.27	301	64.18	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			327.9	F08		5	0112-0447	476.08	447.55	363	70.67	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			717.2	F08		5	0113-0451	734.64	451.15	297	66.18	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			263.5	F08		5	0114-0456	242.30	455.90	332	69.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			300.6	F08		5	0115-0451	578.34	451.24	303	68.77	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			354.8	F08		5	0116-0469	58.94	469.69	252	61.60	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			448.9	F08		5	0117-0471	351.25	471.21	327	70.43	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			449.6	F08		5	0118-0472	551.99	471.88	329	67.11	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			322.2	F08		5	0119-0472	203.72	471.30	258	61.94	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			331.2	F08		5	0120-0478	503.26	478.79	262	67.11	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			309.2	F08		5	0121-0485	856.17	484.58	358	83.15	0.651
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			268.5	F08		5	0122-0485	677.69	485.26	282	61.36	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			266.5	F08		5	0123-0487	399.87	488.02	359	73.50	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			273.2	F08		5	0124-0490	440.42	490.09	294	65.01	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			269.1	F08		5	0125-0498	773.48	496.68	378	75.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			341.8	F08		5	0126-0496	309.69	496.05	294	69.84	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			255.9	F08		5	0127-0509	643.66	509.29	335	73.94	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			329.7	F08		5	0128-0509	589.08	509.68	338	69.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			559.5	F08		5	0129-0513	89.09	513.87	285	64.77	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			298.7	F08		5	0130-0514	719.54	514.93	320	72.91	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			272.4	F08		5	0131-0519	469.01	520.32	309	67.60	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			275.4	F08		5	0132-0523	618.72	522.90	329	77.36	0.691
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			974.4	F08		5	0133-0522	938.32	521.96	292	66.77	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			319.1	F08		5	0134-0534	72.21	534.62	230	59.60	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			285.1	F08		5	0135-0544	644.19	544.29	316	68.18	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			378.7	F08		5	0136-0567	420.55	567.04	430	77.84	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			263.4	F08		5	0137-0566	673.03	565.57	335	73.26	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			324.1	F08		5	0138-0565	870.81	565.19	320	72.18	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			500.0	F08		5	0139-0575	833.54	575.28	278	69.11	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			774.5	F08		5	0140-0590	131.65	590.88	210	55.11	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			342.1	F08		5	0141-0611	130.17	611.79	263	59.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			263.7	F08		5	0142-0617	860.75	617.22	361	73.26	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			318.0	F08		5	0143-0636	322.12	636.25	311	65.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			331.9	F08		5	0144-0638	552.97	637.55	285	63.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			303.5	F08		5	0145-0636	143.55	636.61	256	67.94	0.697
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			290.8	F08		5	0146-0646	243.79	646.06	331	70.53	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			284.3	F08		5	0147-0645	569.15	644.80	289	64.53	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			817.2	F08		5	0148-0656	209.72	658.89	589	110.33	0.608
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			298.0	F08		5	0149-0649	392.44	648.81	314	67.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			314.0	F08		5	0150-0651	477.69	651.41	393	74.43	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			352.7	F08		5	0151-0651	648.86	650.78	265	63.26	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			467.2	F08		5	0152-0656	839.71	656.03	262	65.60	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			308.9	F08		5	0153-0652	916.58	652.30	326	69.94	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			236.5	F08		5	0154-0660	61.87	660.43	318	67.84	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			320.8	F08		5	0155-0669	717.31	668.92	367	74.33	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			364.9	F08		5	0156-0675	309.34	674.77	300	67.01	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			316.9	F08		5	0157-0674	400.17	675.66	347	73.84	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			336.9	F08		5	0158-0679	451.47	679.38	325	69.84	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1009.1	F08		5	0159-0684	636.39	684.58	320	66.18	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			390.3	F08		5	0160-0696	906.66	696.33	348	73.01	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			268.4	F08		6	0001-0040	323.34	40.63	347	73.01	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			344.1	F08		6	0002-0047	782.00	47.24	273	67.26	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			514.3	F08		6	0003-0053	426.76	53.37	270	66.67	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			583.5	F08		6	0004-0055	149.57	55.43	286	63.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			269.2	F08		6	0005-0060	25.83	60.11	304	64.77	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			368.1	F08		6	0006-0061	823.37	60.79	253	65.84	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			640.9	F08		6	0007-0067	247.36	66.94	265	65.60	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			260.0	F08		6	0008-0077	673.88	77.38	377	71.84	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			269.0	F08		6	0009-0084	318.86	83.55	340	71.26	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			431.6	F08		6	0010-0082	527.49	83.00	305	64.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			365.6	F08		6	0011-0087	691.40	87.25	305	68.43	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			303.9	F08		6	0012-0093	196.33	91.42	299	70.18	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			413.2	F08		6	0013-0093	411.70	93.66	250	59.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1006.0	F08		6	0014-0104	612.42	106.23	346	102.23	0.416
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			390.6	F08		6	0015-0107	853.40	107.97	367	72.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			303.8	F08		6	0016-0113	298.91	113.41	347	71.84	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			387.8	F08		6	0017-0113	172.37	112.80	285	62.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			464.9	F08		6	0018-0114	334.39	113.57	226	58.53	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			341.0	F08		6	0019-0121	811.87	120.64	294	66.77	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			336.7	F08		6	0020-0128	489.88	127.29	314	69.50	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			306.6	F08		6	0021-0127	261.73	127.59	320	69.01	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			429.6	F08		6	0022-0130	584.41	129.80	379	79.50	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			538.1	F08		6	0023-0141	433.17	141.59	228	55.36	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			316.7	F08		6	0024-0149	770.71	149.75	427	77.26	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			281.8	F08		6	0025-0149	541.38	150.44	409	76.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			319.4	F08		6	0026-0155	854.32	156.19	321	72.18	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			290.9	F08		6	0027-0161	680.29	160.66	346	72.43	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			384.2	F08		6	0028-0164	506.03	165.14	481	90.91	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			319.0	F08		6	0029-0162	369.59	161.90	232	59.36	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			360.2	F08		6	0030-0164	279.54	163.75	252	61.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			424.8	F08		6	0031-0172	236.80	172.17	301	64.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			333.6	F08		6	0032-0176	320.72	175.64	352	72.18	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			316.5	F08		6	0033-0175	898.76	174.31	325	73.01	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			307.7	F08		6	0034-0174	375.98	174.89	226	57.46	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			276.7	F08		6	0035-0181	405.96	181.83	347	77.84	0.720
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			255.2	F08		6	0036-0184	582.05	185.12	389	76.43	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			938.9	F08		6	0037-0189	183.13	190.35	103	56.77	0.402
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			316.0	F08		6	0038-0195	864.81	196.10	382	72.43	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			464.7	F08		6	0039-0206	939.73	206.24	363	72.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			552.8	F08		6	0040-0212	24.77	212.32	133	93.78	0.190
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			302.4	F08		6	0041-0211	247.08	211.41	342	71.84	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			395.6	F08		6	0042-0228	579.14	227.70	277	62.53	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			274.8	F08		6	0043-0232	258.80	231.53	298	66.43	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			303.3	F08		6	0044-0238	813.54	237.94	339	80.43	0.659
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			375.6	F08		6	0045-0241	724.82	241.12	241	61.01	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			277.1	F08		6	0046-0251	149.32	251.35	290	64.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			408.4	F08		6	0047-0255	441.49	255.10	296	63.94	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			266.9	F08		6	0048-0257	311.88	256.26	359	71.84	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			378.5	F08		6	0049-0262	774.37	261.17	308	71.01	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			301.0	F08		6	0050-0263	807.80	263.63	324	69.84	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			422.4	F08		6	0051-0265	748.05	265.21	392	77.26	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			386.7	F08		6	0052-0271	841.51	269.91	483	88.81	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			515.8	F08		6	0053-0273	604.82	273.45	298	69.01	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			265.8	F08		6	0054-0275	192.07	275.02	310	67.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			259.5	F08		6	0055-0285	273.81	284.59	342	71.11	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			411.0	F08		6	0056-0288	315.97	287.75	255	58.53	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			866.8	F08		6	0057-0288	238.03	289.05	118	69.84	0.304
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			601.3	F08		6	0058-0297	110.60	297.43	375	74.77	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			267.3	F08		6	0059-0300	402.45	299.81	395	73.01	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			283.0	F08		6	0060-0300	332.60	301.04	309	66.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			316.7	F08		6	0061-0304	919.18	304.82	341	79.26	0.682
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			279.6	F08		6	0062-0303	872.22	303.19	317	67.01	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			245.8	F08		6	0063-0307	380.17	306.95	348	69.84	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			314.5	F08		6	0064-0308	34.85	308.19	303	66.53	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			287.3	F08		6	0065-0314	529.80	314.65	360	71.84	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			335.5	F08		6	0066-0312	737.90	311.53	283	61.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			618.1	F08		6	0067-0319	460.36	319.32	245	57.94	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			344.5	F08		6	0068-0327	176.31	327.19	334	67.84	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			306.8	F08		6	0069-0327	267.39	326.87	358	72.43	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			232.2	F08		6	0070-0345	345.65	345.61	399	78.08	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			314.4	F08		6	0071-0349	652.12	348.88	388	74.67	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			286.2	F08		6	0072-0351	229.47	350.89	306	67.26	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			275.4	F08		6	0073-0357	860.37	356.93	306	69.01	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			349.2	F08		6	0074-0364	724.31	363.77	340	68.18	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			545.4	F08		6	0075-0367	220.38	367.40	249	61.60	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			273.0	F08		6	0076-0375	307.06	375.11	344	72.77	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			271.8	F08		6	0077-0374	379.82	374.77	371	73.84	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			451.5	F08		6	0078-0378	523.40	378.00	387	76.43	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			346.5	F08		6	0079-0372	777.01	372.70	209	54.28	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			440.0	F08		6	0080-0374	795.86	374.76	239	57.11	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			270.9	F08		6	0081-0390	896.09	390.31	343	70.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			292.6	F08		6	0082-0396	270.34	396.79	301	66.43	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			488.7	F08		6	0083-0400	75.64	400.55	294	63.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			722.6	F08		6	0084-0408	198.73	407.56	319	69.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			375.4	F08		6	0085-0407	558.86	406.76	351	70.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			310.6	F08		6	0086-0411	830.09	410.68	323	70.28	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			302.2	F08		6	0087-0413	26.87	412.80	273	63.01	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			567.1	F08		6	0088-0420	388.43	419.57	320	67.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			313.8	F08		6	0089-0420	699.00	419.51	331	69.01	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			257.5	F08		6	0090-0426	929.04	426.58	303	74.77	0.681
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			483.6	F08		6	0091-0422	80.11	422.33	281	63.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			259.9	F08		6	0092-0422	269.24	422.52	297	65.60	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			351.9	F08		6	0093-0425	495.24	425.58	231	61.70	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			250.5	F08		6	0094-0426	942.53	425.21	293	70.18	0.747
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			461.7	F08		6	0095-0427	654.26	427.01	298	65.01	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			440.7	F08		6	0096-0434	732.15	434.32	345	70.28	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			468.6	F08		6	0097-0434	899.88	434.35	368	72.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			369.5	F08		6	0098-0440	787.04	439.64	350	71.26	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			316.7	F08		6	0099-0444	313.51	444.25	248	63.70	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			308.6	F08		6	0100-0457	612.48	456.44	301	65.60	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			358.1	F08		6	0101-0466	541.75	465.82	314	67.84	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			356.5	F08		6	0102-0469	457.06	467.95	300	69.84	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			317.1	F08		6	0103-0472	899.47	472.04	331	68.43	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			431.5	F08		6	0104-0472	158.56	471.82	129	71.26	0.319
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			288.8	F08		6	0105-0483	421.15	482.38	284	65.01	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			295.9	F08		6	0106-0490	252.39	489.66	277	68.18	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			270.7	F08		6	0107-0488	290.18	488.41	322	68.43	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			313.8	F08		6	0108-0490	467.28	490.61	295	65.70	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			325.3	F08		6	0109-0495	132.47	495.84	269	67.70	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			265.4	F08		6	0110-0491	408.30	491.61	275	63.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			357.1	F08		6	0111-0497	182.57	498.42	305	67.94	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			303.8	F08		6	0112-0499	660.07	499.59	318	69.01	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			279.6	F08		6	0113-0502	370.65	502.53	343	74.43	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			314.1	F08		6	0114-0509	588.39	509.07	310	67.84	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			320.2	F08		6	0115-0515	827.71	515.63	344	68.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			346.1	F08		6	0116-0520	888.52	520.32	253	60.53	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			262.6	F08		6	0117-0522	753.11	521.82	355	70.08	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1030.7	F08		6	0118-0525	33.42	524.89	304	68.43	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			287.1	F08		6	0119-0523	315.91	522.86	302	65.94	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			514.1	F08		6	0120-0530	921.48	530.74	210	53.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			278.5	F08		6	0121-0538	399.98	537.73	342	69.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			446.6	F08		6	0122-0541	48.54	540.58	328	68.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			343.5	F08		6	0123-0546	728.83	546.54	317	66.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			630.5	F08		6	0124-0550	442.78	549.81	360	71.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			308.9	F08		6	0125-0555	695.22	557.17	392	118.13	0.353
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			409.4	F08		6	0126-0558	273.97	559.61	375	88.33	0.604
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			308.1	F08		6	0127-0558	504.41	558.87	368	73.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			273.3	F08		6	0128-0560	633.43	560.60	357	74.43	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			566.5	F08		6	0129-0564	806.22	564.04	342	73.60	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			428.8	F08		6	0130-0572	573.03	573.00	363	76.08	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			547.7	F08		6	0131-0570	899.87	570.25	219	55.70	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			431.3	F08		6	0132-0581	58.91	581.53	285	62.18	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			342.6	F08		6	0133-0585	191.91	585.57	308	69.26	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			352.2	F08		6	0134-0581	760.19	580.73	169	51.36	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			357.6	F08		6	0135-0586	779.09	586.58	318	73.70	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			303.4	F08		6	0136-0593	393.16	593.77	325	68.77	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			292.0	F08		6	0137-0598	524.28	598.86	360	74.43	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			318.7	F08		6	0138-0604	407.96	603.66	268	60.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			288.3	F08		6	0139-0606	719.80	606.67	342	71.60	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			268.6	F08		6	0140-0610	668.02	609.38	332	71.60	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			224.2	F08		6	0141-0610	944.17	610.24	325	67.36	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			491.3	F08		6	0142-0624	254.48	624.73	435	81.36	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			716.4	F08		6	0143-0620	473.85	620.29	254	59.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			274.1	F08		6	0144-0625	498.09	624.46	322	69.60	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			701.8	F08		6	0145-0621	588.56	622.24	126	47.11	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			407.8	F08		6	0146-0626	604.38	625.56	306	69.36	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			311.9	F08		6	0147-0631	399.30	631.24	270	60.18	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			276.3	F08		6	0148-0643	820.36	643.79	331	69.60	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			314.5	F08		6	0149-0647	762.95	647.48	391	74.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			272.0	F08		6	0150-0647	185.53	647.15	314	69.01	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			685.3	F08		6	0151-0650	467.28	649.78	254	58.53	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			296.6	F08		6	0152-0655	654.47	655.82	408	83.15	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			253.4	F08		6	0153-0657	227.78	657.24	307	67.36	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			284.8	F08		6	0154-0663	678.83	662.86	420	78.08	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			641.3	F08		6	0155-0660	152.33	659.97	228	56.28	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			532.9	F08		6	0156-0664	317.48	664.23	379	78.43	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			649.0	F08		6	0157-0667	131.53	667.22	214	54.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			260.5	F08		6	0158-0685	754.34	685.71	364	73.26	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			262.2	F08		6	0159-0683	214.80	683.17	312	65.01	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			429.3	F08		6	0160-0691	383.37	691.24	545	87.15	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			283.8	F08		6	0161-0691	921.86	691.84	327	67.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			273.3	F08		6	0162-0695	699.02	694.81	134	44.04	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			256.3	F08		6	0163-0703	335.59	703.62	544	86.91	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			251.9	F08		6	0164-0697	712.80	697.08	155	46.39	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			256.2	F08		6	0165-0703	115.04	703.15	344	69.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			255.6	F08		6	0166-0708	252.76	707.97	278	62.53	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			307.7	F08		7	0001-0033	92.68	32.93	251	60.18	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			268.9	F08		7	0002-0044	386.80	44.51	294	62.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			328.1	F08		7	0003-0048	477.35	48.14	278	66.67	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			331.0	F08		7	0004-0060	407.20	59.76	285	63.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			403.9	F08		7	0005-0062	678.12	62.81	233	55.36	0.956
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			377.8	F08		7	0006-0083	498.41	83.94	245	59.11	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			263.7	F08		7	0007-0088	102.28	88.41	272	64.28	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			715.5	F08		7	0008-0090	312.19	90.06	243	58.28	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			346.1	F08		7	0009-0088	857.80	88.23	243	58.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			616.0	F08		7	0010-0091	568.14	91.09	249	59.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			465.0	F08		7	0011-0090	922.36	90.77	285	69.36	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			271.4	F08		7	0012-0096	804.71	96.45	347	71.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			376.2	F08		7	0013-0099	159.09	99.23	396	76.91	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			406.0	F08		7	0014-0101	457.94	101.78	288	63.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			496.5	F08		7	0015-0105	635.09	105.00	234	59.36	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			784.1	F08		7	0016-0119	523.81	119.55	222	58.18	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			437.1	F08		7	0017-0126	686.97	125.86	193	53.94	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			290.0	F08		7	0018-0126	88.93	126.97	301	67.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			357.4	F08		7	0019-0132	641.72	132.74	273	63.60	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			373.3	F08		7	0020-0131	188.37	132.20	306	72.77	0.726
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			362.5	F08		7	0021-0135	281.43	134.70	262	61.60	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			317.3	F08		7	0022-0140	900.77	139.76	353	73.26	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			337.1	F08		7	0023-0140	559.10	140.54	300	64.43	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			410.0	F08		7	0024-0146	372.83	146.27	317	70.18	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			285.6	F08		7	0025-0153	132.29	153.66	301	66.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			299.7	F08		7	0026-0155	245.36	155.87	315	67.84	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			516.9	F08		7	0027-0154	331.26	154.32	290	63.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			313.7	F08		7	0028-0159	830.05	159.13	536	87.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			294.2	F08		7	0029-0163	779.09	162.97	296	65.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			371.4	F08		7	0030-0173	445.86	172.75	269	62.87	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			371.9	F08		7	0031-0180	31.92	180.27	332	72.43	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			326.9	F08		7	0032-0182	770.41	182.44	294	64.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			419.7	F08		7	0033-0201	821.36	201.88	239	57.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			491.9	F08		7	0034-0203	154.35	202.98	230	56.53	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			462.3	F08		7	0035-0230	658.69	229.95	258	61.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			292.5	F08		7	0036-0236	902.31	237.44	323	75.50	0.712
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			482.7	F08		7	0037-0240	807.18	241.35	115	44.53	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			354.2	F08		7	0038-0265	518.79	264.69	312	69.26	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			480.3	F08		7	0039-0265	544.89	264.71	246	64.18	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			406.0	F08		7	0040-0268	690.63	268.72	226	56.87	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			424.6	F08		7	0041-0273	36.28	273.02	267	65.01	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			316.8	F08		7	0042-0272	803.84	272.63	286	72.08	0.692
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			507.5	F08		7	0043-0279	430.76	279.79	262	60.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			358.0	F08		7	0044-0284	235.60	284.60	328	67.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			335.4	F08		7	0045-0288	629.87	288.63	303	65.01	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			445.9	F08		7	0046-0291	776.86	291.35	339	74.67	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			395.3	F08		7	0047-0299	663.58	299.86	310	67.94	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			294.3	F08		7	0048-0307	180.09	307.59	328	67.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			315.3	F08		7	0049-0307	322.57	307.02	304	65.36	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			444.6	F08		7	0050-0317	748.57	316.98	227	58.18	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			494.7	F08		7	0051-0317	637.80	317.35	248	58.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			448.6	F08		7	0052-0333	847.17	332.72	343	70.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			352.6	F08		7	0053-0334	147.60	333.67	253	61.70	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			382.6	F08		7	0054-0339	491.89	339.39	291	66.53	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			568.6	F08		7	0055-0352	133.12	352.78	247	64.43	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			331.2	F08		7	0056-0355	729.67	355.23	293	63.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			356.3	F08		7	0057-0366	284.61	366.61	267	59.70	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			304.8	F08		7	0058-0377	900.04	377.04	305	72.18	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			655.3	F08		7	0059-0377	130.33	376.64	342	70.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			367.3	F08		7	0060-0382	614.20	382.79	380	73.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			540.5	F08		7	0061-0386	419.80	385.79	329	69.84	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			366.3	F08		7	0062-0384	562.34	383.61	317	66.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			282.7	F08		7	0063-0392	845.59	392.78	308	67.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			356.1	F08		7	0064-0396	676.19	396.86	321	68.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			291.6	F08		7	0065-0397	781.94	396.61	342	69.84	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			426.1	F08		7	0066-0399	58.99	398.31	273	63.60	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			635.8	F08		7	0067-0409	352.76	410.17	340	72.67	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			386.4	F08		7	0068-0417	292.67	417.10	285	67.84	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			310.3	F08		7	0069-0423	37.19	423.02	275	69.26	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			583.8	F08		7	0070-0419	533.04	419.50	266	63.70	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			368.1	F08		7	0071-0426	229.90	425.89	293	66.43	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			323.8	F08		7	0072-0438	885.79	438.02	319	70.77	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			365.1	F08		7	0073-0437	138.79	436.51	217	59.94	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			357.2	F08		7	0074-0443	717.99	443.46	337	69.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			498.3	F08		7	0075-0448	449.95	447.65	306	67.84	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			428.5	F08		7	0076-0447	484.62	447.15	225	58.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1052.9	F08		7	0077-0453	631.77	455.68	387	93.98	0.551
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			481.7	F08		7	0078-0449	298.81	448.89	269	66.43	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			347.0	F08		7	0079-0468	104.09	467.16	106	44.53	0.672
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			709.6	F08		7	0080-0479	201.56	479.53	320	69.60	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			340.5	F08		7	0081-0481	581.58	480.98	335	68.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			359.5	F08		7	0082-0486	529.78	486.59	233	58.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			365.6	F08		7	0083-0494	302.87	494.27	285	62.43	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			393.7	F08		7	0084-0495	229.49	495.57	325	68.77	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			287.7	F08		7	0085-0499	904.47	499.00	292	65.60	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			340.5	F08		7	0086-0504	28.67	504.31	308	66.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1272.2	F08		7	0087-0508	444.17	508.44	343	70.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			358.6	F08		7	0088-0525	890.82	525.58	277	65.70	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			282.5	F08		7	0089-0535	193.24	534.84	316	68.77	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			461.9	F08		7	0090-0539	300.64	539.10	270	63.01	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			361.4	F08		7	0091-0539	379.44	538.81	304	65.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			363.9	F08		7	0092-0542	25.51	542.80	256	64.43	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			401.8	F08		7	0093-0549	343.44	548.80	214	55.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			391.3	F08		7	0094-0552	637.08	552.27	261	60.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			390.5	F08		7	0095-0574	164.62	573.41	429	86.08	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			438.4	F08		7	0096-0571	672.22	571.83	228	55.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			400.3	F08		7	0097-0573	507.45	573.46	280	63.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			553.7	F08		7	0098-0581	822.58	581.20	290	67.26	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			269.7	F08		7	0099-0592	714.37	592.57	393	83.74	0.704
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			373.8	F08		7	0100-0604	631.20	604.27	236	60.18	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			335.4	F08		7	0101-0615	95.84	614.75	325	69.36	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			320.6	F08		7	0102-0617	583.01	617.18	308	67.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			387.7	F08		7	0103-0632	208.27	633.24	340	68.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			465.9	F08		7	0104-0635	394.14	634.30	172	52.53	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			974.0	F08		7	0105-0642	602.53	640.54	365	120.71	0.315
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			332.7	F08		7	0106-0646	152.95	645.38	213	59.94	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			366.1	F08		7	0107-0649	403.03	649.67	189	54.53	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			520.7	F08		7	0108-0646	479.26	645.61	195	67.60	0.536
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			322.0	F08		7	0109-0654	434.14	654.28	282	62.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			322.1	F08		7	0110-0661	551.17	661.16	255	58.53	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			268.3	F08		7	0111-0676	429.53	676.20	341	69.50	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			971.4	F08		7	0112-0674	830.80	674.11	271	65.60	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			275.7	F08		7	0113-0679	201.81	678.48	306	66.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			273.2	F08		7	0114-0686	459.50	686.25	297	67.01	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			291.4	F08		7	0115-0687	594.89	687.09	301	69.36	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			412.8	F08		7	0116-0700	860.31	700.06	228	58.77	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			325.0	F08		7	0117-0712	829.75	712.75	159	50.04	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			362.8	F08		8	0001-0033	547.49	33.04	276	63.36	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			388.2	F08		8	0002-0039	390.98	39.49	312	68.87	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			360.9	F08		8	0003-0040	117.38	39.09	364	73.84	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			310.4	F08		8	0004-0043	468.83	43.14	273	63.60	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			284.7	F08		8	0005-0051	61.97	51.24	324	67.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			365.2	F08		8	0006-0057	813.53	56.57	270	65.60	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			317.9	F08		8	0007-0061	423.49	62.30	351	70.67	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			365.1	F08		8	0008-0063	351.36	64.01	288	63.94	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			664.5	F08		8	0009-0073	188.66	73.62	234	58.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			506.6	F08		8	0010-0078	534.60	77.39	546	85.74	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			369.5	F08		8	0011-0090	591.13	91.05	359	73.84	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			419.6	F08		8	0012-0093	27.34	92.73	300	71.60	0.735
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			274.8	F08		8	0013-0098	151.25	98.63	321	70.18	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			354.1	F08		8	0014-0094	862.10	94.33	251	58.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			465.4	F08		8	0015-0107	399.16	107.89	351	69.60	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			267.9	F08		8	0016-0116	77.68	116.31	300	65.60	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			310.2	F08		8	0017-0119	94.58	118.73	270	66.18	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			274.5	F08		8	0018-0117	144.91	118.43	327	67.94	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1094.8	F08		8	0019-0126	297.21	126.26	313	66.77	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			561.4	F08		8	0020-0127	571.17	127.19	260	64.67	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			361.7	F08		8	0021-0132	461.59	131.56	320	67.60	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1529.1	F08		8	0022-0137	524.65	137.50	266	61.46	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			268.4	F08		8	0023-0143	182.96	143.82	360	72.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			285.9	F08		8	0024-0144	858.72	143.84	286	62.53	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			257.7	F08		8	0025-0148	116.34	148.61	341	68.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			927.7	F08		8	0026-0148	631.03	147.91	212	54.53	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			443.8	F08		8	0027-0163	384.92	163.20	349	70.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			315.1	F08		8	0028-0162	498.33	161.44	241	60.77	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			276.0	F08		8	0029-0179	255.75	179.69	303	66.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			708.6	F08		8	0030-0193	903.86	192.59	363	77.60	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			257.9	F08		8	0031-0192	128.31	192.14	319	68.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			309.2	F08		8	0032-0198	834.68	198.26	273	61.36	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			400.7	F08		8	0033-0199	509.73	199.88	314	73.60	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			268.3	F08		8	0034-0200	934.39	200.06	339	68.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			265.1	F08		8	0035-0203	451.50	203.05	309	66.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			444.4	F08		8	0036-0212	809.27	211.52	260	59.94	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			389.7	F08		8	0037-0212	298.17	211.31	305	67.36	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			596.3	F08		8	0038-0219	171.70	218.50	349	70.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			321.3	F08		8	0039-0233	637.45	233.56	392	80.67	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			881.1	F08		8	0040-0231	389.44	231.39	302	67.36	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			345.0	F08		8	0041-0237	69.26	237.61	245	60.43	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			277.5	F08		8	0042-0246	216.23	246.26	271	64.43	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1194.1	F08		8	0043-0252	368.24	252.48	258	60.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			308.7	F08		8	0044-0255	555.78	254.76	308	67.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			898.9	F08		8	0045-0255	786.48	254.80	372	71.60	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			254.4	F08		8	0046-0255	269.76	254.60	284	66.43	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			266.9	F08		8	0047-0254	91.96	254.52	319	73.70	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			728.4	F08		8	0048-0259	345.30	258.91	262	60.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			288.0	F08		8	0049-0267	175.50	267.03	342	69.60	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			420.6	F08		8	0050-0268	413.70	268.21	323	71.50	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			318.9	F08		8	0051-0269	476.36	269.60	262	62.87	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			302.2	F08		8	0052-0267	608.28	266.91	333	69.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			733.6	F08		8	0053-0276	824.72	276.05	241	71.26	0.596
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			684.6	F08		8	0054-0280	327.52	280.38	308	69.94	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			302.2	F08		8	0055-0286	908.01	285.70	313	68.53	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			310.9	F08		8	0056-0287	257.30	287.08	289	64.18	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			286.4	F08		8	0057-0296	114.24	295.98	271	60.28	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			271.1	F08		8	0058-0301	527.71	301.18	325	70.43	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			726.7	F08		8	0059-0303	773.32	302.44	372	73.26	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			399.6	F08		8	0060-0301	67.03	300.89	265	60.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			316.2	F08		8	0061-0306	726.59	306.20	334	67.60	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			338.8	F08		8	0062-0307	454.46	307.65	280	64.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			276.9	F08		8	0063-0312	484.66	310.84	355	71.01	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			369.3	F08		8	0064-0309	802.16	310.13	312	67.01	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			332.4	F08		8	0065-0309	596.25	308.86	334	68.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			324.2	F08		8	0066-0316	693.21	316.50	327	69.94	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1072.5	F08		8	0067-0314	860.26	314.34	217	55.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			439.9	F08		8	0068-0321	66.27	321.41	288	64.18	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			261.6	F08		8	0069-0340	518.16	340.62	344	70.18	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			336.9	F08		8	0070-0341	265.73	342.16	331	68.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			369.1	F08		8	0071-0351	434.28	351.13	305	66.53	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			286.6	F08		8	0072-0351	157.55	350.65	335	67.60	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			243.7	F08		8	0073-0357	716.82	357.73	333	68.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			429.6	F08		8	0074-0359	201.87	358.41	290	62.18	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			250.8	F08		8	0075-0364	109.18	363.74	280	62.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			290.9	F08		8	0076-0362	599.31	361.65	263	64.53	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			255.9	F08		8	0077-0367	693.55	366.93	294	66.18	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			289.2	F08		8	0078-0368	311.75	368.05	298	66.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			304.7	F08		8	0079-0377	779.65	376.56	371	72.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			273.1	F08		8	0080-0388	69.99	388.89	308	67.60	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			338.9	F08		8	0081-0390	343.64	390.06	371	73.84	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1147.0	F08		8	0082-0386	263.47	386.26	253	61.11	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			267.5	F08		8	0083-0391	908.93	390.40	404	73.60	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			343.8	F08		8	0084-0391	611.42	391.77	274	69.50	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			241.8	F08		8	0085-0394	117.33	393.86	319	67.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			503.0	F08		8	0086-0399	228.50	398.65	247	60.53	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			901.2	F08		8	0087-0408	842.54	408.45	219	54.63	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			281.0	F08		8	0088-0416	556.27	416.95	354	69.60	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1109.4	F08		8	0089-0420	159.54	420.41	357	71.50	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			340.0	F08		8	0090-0423	731.25	422.91	279	63.01	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			868.6	F08		8	0091-0428	804.60	428.93	253	61.36	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			315.6	F08		8	0092-0436	487.98	436.01	325	66.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			367.8	F08		8	0093-0438	450.52	438.13	320	69.84	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			446.6	F08		8	0094-0441	747.09	440.58	241	61.11	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			405.0	F08		8	0095-0449	897.52	449.38	338	69.84	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			313.4	F08		8	0096-0449	761.52	449.23	256	62.53	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			883.9	F08		8	0097-0454	127.49	454.78	354	70.18	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			297.8	F08		8	0098-0459	837.61	458.78	342	69.84	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			289.3	F08		8	0099-0464	52.51	464.29	258	63.01	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			340.0	F08		8	0100-0475	743.13	475.27	277	63.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			326.6	F08		8	0101-0501	414.64	501.00	335	69.60	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			314.7	F08		8	0102-0507	566.44	507.64	333	69.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			403.3	F08		8	0103-0514	374.99	514.14	306	65.94	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			337.7	F08		8	0104-0513	334.32	513.20	159	48.53	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			308.8	F08		8	0105-0524	327.91	524.49	200	53.94	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			533.8	F08		8	0106-0524	268.31	524.45	261	62.53	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			329.7	F08		8	0107-0531	853.53	531.31	273	60.77	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			328.2	F08		8	0108-0535	604.96	534.87	366	72.18	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			324.8	F08		8	0109-0571	800.98	571.40	335	71.01	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			515.1	F08		8	0110-0569	210.82	568.62	319	65.60	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			496.7	F08		8	0111-0577	472.98	576.95	286	63.60	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			279.8	F08		8	0112-0581	98.85	581.31	272	62.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			271.1	F08		8	0113-0580	145.09	579.96	365	73.01	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			286.4	F08		8	0114-0590	882.83	590.92	326	71.26	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			307.0	F08		8	0115-0597	725.29	596.96	315	68.18	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			355.4	F08		8	0116-0597	624.95	597.75	362	73.26	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			484.5	F08		8	0117-0611	935.55	610.24	234	62.43	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			267.1	F08		8	0118-0618	164.12	619.05	342	69.84	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			358.8	F08		8	0119-0619	390.63	619.56	358	72.18	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			262.8	F08		8	0120-0624	311.05	624.35	393	74.53	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			255.1	F08		8	0121-0633	257.00	633.60	354	72.18	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			566.8	F08		8	0122-0629	887.85	629.27	229	59.36	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2026.2	F08		8	0123-0631	485.97	631.58	369	71.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			294.2	F08		8	0124-0644	205.67	643.32	267	76.91	0.567
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			573.1	F08		8	0125-0646	113.81	646.09	315	68.28	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			352.5	F08		8	0126-0648	646.66	648.33	311	64.77	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			450.0	F08		8	0127-0652	188.70	652.10	313	72.77	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			375.6	F08		8	0128-0662	807.99	662.37	371	72.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			294.6	F08		8	0129-0679	279.00	679.25	308	66.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			316.3	F08		8	0130-0681	511.91	681.69	286	62.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			484.0	F08		8	0131-0683	818.41	683.45	254	62.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			285.9	F08		8	0132-0700	318.53	700.43	351	71.84	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			737.5	F08		8	0133-0700	869.85	700.89	257	62.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			283.4	F08		8	0134-0703	138.26	703.54	301	64.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			258.0	F08		8	0135-0707	51.06	707.80	312	67.60	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			266.5	F08		9	0001-0027	112.91	26.93	344	68.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			307.4	F08		9	0002-0032	250.70	31.94	275	63.11	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			313.0	F08		9	0003-0037	590.02	36.73	360	76.08	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			267.7	F08		9	0004-0035	182.72	34.71	298	68.18	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			385.2	F08		9	0005-0039	511.18	38.74	272	60.53	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			344.5	F08		9	0006-0052	462.31	52.06	326	68.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			293.9	F08		9	0007-0061	289.42	61.34	340	69.84	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			320.3	F08		9	0008-0060	744.10	60.15	375	75.84	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			361.4	F08		9	0009-0059	539.40	60.03	288	63.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			456.0	F08		9	0010-0067	666.69	67.26	265	60.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			312.8	F08		9	0011-0067	106.69	66.90	298	65.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			324.0	F08		9	0012-0074	577.54	74.11	328	69.36	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			327.0	F08		9	0013-0085	351.37	85.44	320	68.77	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			342.9	F08		9	0014-0091	628.73	91.14	393	77.01	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			294.8	F08		9	0015-0103	150.33	103.48	271	69.26	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			441.7	F08		9	0016-0108	400.39	108.07	454	80.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			353.9	F08		9	0017-0105	858.93	105.72	285	66.53	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			353.1	F08		9	0018-0113	289.82	113.21	327	67.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			505.2	F08		9	0019-0109	606.04	109.78	240	56.53	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			708.1	F08		9	0020-0117	768.48	117.04	247	62.77	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			458.1	F08		9	0021-0125	539.18	124.32	438	80.67	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			695.7	F08		9	0022-0121	873.87	121.45	166	52.53	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			280.5	F08		9	0023-0127	260.01	127.38	302	67.01	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			391.0	F08		9	0024-0138	476.79	138.03	340	71.60	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			278.0	F08		9	0025-0149	319.13	148.94	327	67.11	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			314.2	F08		9	0026-0148	749.13	148.30	298	66.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			473.4	F08		9	0027-0158	503.51	157.38	320	73.60	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			302.0	F08		9	0028-0161	88.66	161.07	266	64.91	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			304.3	F08		9	0029-0159	241.91	159.07	237	59.01	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			374.3	F08		9	0030-0167	191.21	167.88	216	55.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			337.8	F08		9	0031-0175	444.89	175.23	302	65.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			676.5	F08		9	0032-0173	811.23	174.00	102	37.46	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			387.0	F08		9	0033-0186	771.64	186.50	258	63.36	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			300.3	F08		9	0034-0192	90.66	192.61	247	62.18	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			312.3	F08		9	0035-0195	168.87	195.46	266	68.77	0.707
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			983.1	F08		9	0036-0192	373.20	191.67	246	60.77	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			778.3	F08		9	0037-0199	632.74	199.12	474	83.26	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			247.2	F08		9	0038-0200	943.12	200.57	395	77.50	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			272.9	F08		9	0039-0204	909.33	203.92	372	77.84	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			254.5	F08		9	0040-0203	29.78	202.97	327	68.18	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			293.5	F08		9	0041-0216	678.42	216.04	314	73.01	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			339.5	F08		9	0042-0214	529.80	214.47	277	61.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			320.5	F08		9	0043-0235	813.79	235.09	281	65.01	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			409.7	F08		9	0044-0237	767.12	236.64	289	67.84	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			320.4	F08		9	0045-0242	731.53	242.09	337	71.36	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			289.6	F08		9	0046-0239	229.65	240.27	253	58.87	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			279.0	F08		9	0047-0249	661.57	249.17	263	64.77	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			296.7	F08		9	0048-0252	46.14	252.59	303	63.94	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			376.4	F08		9	0049-0253	277.61	253.04	272	61.36	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			309.3	F08		9	0050-0260	938.09	260.43	364	71.50	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			268.8	F08		9	0051-0257	230.00	257.15	285	65.70	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			331.7	F08		9	0052-0266	426.54	266.69	295	65.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			324.6	F08		9	0053-0266	532.37	266.41	288	62.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			262.7	F08		9	0054-0275	141.22	275.50	320	67.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			262.6	F08		9	0055-0280	890.30	279.55	407	79.26	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			305.1	F08		9	0056-0282	381.39	281.55	283	62.18	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			318.0	F08		9	0057-0285	623.90	284.88	302	67.84	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			412.4	F08		9	0058-0298	223.21	298.43	264	59.60	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			343.0	F08		9	0059-0308	484.54	308.19	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			563.2	F08		9	0060-0313	56.31	313.12	372	74.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			267.0	F08		9	0061-0322	259.07	322.01	308	67.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			349.6	F08		9	0062-0327	728.12	326.58	310	69.36	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			307.3	F08		9	0063-0334	925.85	333.62	351	70.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			302.5	F08		9	0064-0333	831.25	333.40	333	69.26	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			359.5	F08		9	0065-0341	545.88	341.42	289	63.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			325.5	F08		9	0066-0341	871.51	341.54	301	64.43	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			240.6	F08		9	0067-0346	43.39	345.92	356	69.01	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			562.4	F08		9	0068-0350	225.43	350.33	358	73.26	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			392.2	F08		9	0069-0364	425.99	364.39	291	69.36	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			352.0	F08		9	0070-0363	784.03	363.41	333	68.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			277.9	F08		9	0071-0368	75.81	368.43	329	66.77	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			309.6	F08		9	0072-0370	728.14	370.19	368	71.84	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			324.2	F08		9	0073-0377	675.67	377.52	431	94.81	0.603
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			538.3	F08		9	0074-0384	562.15	380.29	405	96.47	0.547
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			305.1	F08		9	0075-0380	839.73	380.27	381	72.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			295.7	F08		9	0076-0395	607.01	394.57	312	70.67	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			336.5	F08		9	0077-0401	333.46	400.98	249	60.53	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			363.7	F08		9	0078-0401	429.53	401.57	283	62.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			361.0	F08		9	0079-0413	477.40	413.11	239	58.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			285.7	F08		9	0080-0418	752.22	417.97	326	67.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			257.0	F08		9	0081-0423	108.15	423.49	312	66.77	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			313.9	F08		9	0082-0422	136.76	422.43	323	67.84	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			364.7	F08		9	0083-0431	926.94	431.35	264	63.70	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			323.1	F08		9	0084-0436	663.61	435.45	326	68.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			291.4	F08		9	0085-0441	846.39	442.19	308	68.67	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			245.3	F08		9	0086-0453	788.02	452.55	346	70.43	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			287.0	F08		9	0087-0457	627.33	457.38	328	68.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			358.0	F08		9	0088-0460	250.17	459.58	271	62.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			984.2	F08		9	0089-0460	360.06	459.62	272	61.36	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			283.6	F08		9	0090-0466	762.09	465.46	350	71.01	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			288.9	F08		9	0091-0473	583.58	473.73	297	64.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			661.8	F08		9	0092-0483	354.63	482.60	295	64.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			380.6	F08		9	0093-0490	838.00	490.06	300	64.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			297.0	F08		9	0094-0496	656.41	496.27	342	72.53	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			354.7	F08		9	0095-0495	418.64	495.14	284	62.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			253.0	F08		9	0096-0498	792.53	497.76	331	69.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			236.9	F08		9	0097-0496	774.17	495.84	350	71.94	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			315.3	F08		9	0098-0499	52.74	498.30	283	62.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			355.0	F08		9	0099-0501	727.06	500.76	271	61.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			351.6	F08		9	0100-0505	207.71	504.91	249	58.18	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			314.9	F08		9	0101-0521	78.62	521.30	261	65.01	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			405.2	F08		9	0102-0521	614.23	521.50	371	70.18	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			375.6	F08		9	0103-0525	681.54	525.40	290	65.36	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			290.4	F08		9	0104-0524	710.85	524.45	293	63.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			360.2	F08		9	0105-0536	359.76	536.61	335	68.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			412.5	F08		9	0106-0539	624.88	539.71	358	72.08	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			297.4	F08		9	0107-0545	414.30	545.05	278	68.08	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			303.9	F08		9	0108-0543	740.94	544.00	305	65.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			293.0	F08		9	0109-0551	127.64	551.73	323	70.67	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			319.0	F08		9	0110-0555	376.56	555.19	274	60.77	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			491.7	F08		9	0111-0559	311.67	559.17	348	69.60	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			472.3	F08		9	0112-0570	464.67	570.15	303	67.60	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			397.8	F08		9	0113-0577	227.99	580.26	291	83.15	0.529
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			393.3	F08		9	0114-0584	723.59	584.53	331	68.67	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			752.9	F08		9	0115-0592	144.52	592.32	318	69.26	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			270.6	F08		9	0116-0591	674.89	590.99	317	66.53	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			329.8	F08		9	0117-0600	594.64	600.11	339	70.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			311.4	F08		9	0118-0599	296.56	598.65	303	67.84	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			334.1	F08		9	0119-0597	805.83	597.68	333	75.84	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			260.6	F08		9	0120-0602	928.18	602.38	277	62.77	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			387.6	F08		9	0121-0606	412.90	606.62	306	66.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			346.1	F08		9	0122-0607	466.79	607.03	331	67.84	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			523.3	F08		9	0123-0613	30.57	613.25	236	60.77	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			905.0	F08		9	0124-0615	239.99	615.89	244	63.94	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			219.1	F08		9	0125-0617	908.56	617.47	303	66.53	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			246.3	F08		9	0126-0625	671.13	625.54	417	79.26	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			353.3	F08		9	0127-0638	544.10	637.32	277	67.01	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			337.1	F08		9	0128-0648	205.49	647.63	330	67.60	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			405.9	F08		9	0129-0652	501.09	652.73	310	66.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			335.1	F08		9	0130-0658	185.37	657.89	315	67.84	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			313.0	F08		9	0131-0664	921.81	663.93	269	61.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			335.9	F08		9	0132-0667	677.49	666.70	275	62.18	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			294.0	F08		9	0133-0671	770.94	672.08	269	66.18	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			310.9	F08		9	0134-0674	398.05	674.25	276	63.36	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			319.5	F08		9	0135-0680	852.31	679.91	486	84.67	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			289.3	F08		9	0136-0682	319.34	683.00	307	65.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			304.1	F08		9	0137-0685	378.24	685.79	273	61.36	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			373.4	G08		1	0001-0032	204.59	33.10	257	63.01	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			394.7	G08		1	0002-0042	496.41	42.05	229	59.11	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			328.9	G08		1	0003-0056	98.31	56.55	335	72.08	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			362.1	G08		1	0004-0065	935.15	65.24	324	68.43	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			725.1	G08		1	0005-0075	282.41	75.08	268	64.04	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			309.2	G08		1	0006-0076	711.31	75.89	364	71.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			424.8	G08		1	0007-0083	664.99	83.53	405	80.57	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			772.8	G08		1	0008-0092	730.56	92.42	348	71.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			608.9	G08		1	0009-0092	567.38	92.61	154	68.43	0.413
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			542.6	G08		1	0010-0096	262.76	96.42	254	69.26	0.665
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			282.8	G08		1	0011-0100	77.40	101.22	295	66.18	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			296.8	G08		1	0012-0106	712.96	105.19	322	72.33	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			730.2	G08		1	0013-0107	844.87	105.02	171	73.50	0.398
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			406.0	G08		1	0014-0122	896.06	121.71	302	66.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			359.9	G08		1	0015-0194	835.35	194.66	279	62.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			591.9	G08		1	0016-0199	185.62	199.26	102	39.21	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			452.8	G08		1	0017-0225	584.08	224.71	214	58.04	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			427.4	G08		1	0018-0242	806.26	241.74	215	62.04	0.702
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			844.5	G08		1	0019-0268	829.39	268.12	262	59.36	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			448.3	G08		1	0020-0280	887.64	280.48	237	60.28	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			411.3	G08		1	0021-0288	639.34	288.26	221	57.94	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			398.9	G08		1	0022-0302	32.27	302.53	235	64.18	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			408.0	G08		1	0023-0306	478.27	306.20	195	58.18	0.724
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			386.8	G08		1	0024-0323	657.51	324.42	284	64.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			357.5	G08		1	0025-0343	280.32	343.85	258	62.53	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			457.6	G08		1	0026-0365	47.51	365.09	214	54.87	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			557.9	G08		1	0027-0369	350.54	368.34	227	62.87	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			406.7	G08		1	0028-0364	510.31	363.63	226	58.77	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			373.8	G08		1	0029-0367	623.42	366.98	274	63.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			472.2	G08		1	0030-0365	742.98	365.12	193	57.36	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			555.1	G08		1	0031-0368	147.46	368.35	242	61.36	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			372.3	G08		1	0032-0373	306.88	373.44	229	61.11	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			478.5	G08		1	0033-0383	675.69	383.47	240	63.11	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			357.6	G08		1	0034-0389	935.70	389.37	282	67.60	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			471.3	G08		1	0035-0407	210.27	407.15	209	58.77	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			615.4	G08		1	0036-0414	70.13	414.26	215	57.70	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			512.2	G08		1	0037-0416	890.73	415.95	225	57.70	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			385.1	G08		1	0038-0438	666.57	438.67	262	64.53	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			860.2	G08		1	0039-0444	858.60	443.31	109	75.98	0.237
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			791.5	G08		1	0040-0457	419.20	458.00	233	57.36	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			453.5	G08		1	0041-0462	730.98	462.08	237	61.94	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			554.9	G08		1	0042-0498	314.58	498.27	227	59.60	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			342.4	G08		1	0043-0524	563.97	524.23	303	66.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			440.1	G08		1	0044-0527	829.85	527.56	240	62.77	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			479.8	G08		1	0045-0536	719.53	536.54	205	58.18	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			388.1	G08		1	0046-0539	360.16	539.84	277	72.43	0.664
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			323.7	G08		1	0047-0539	688.61	539.21	272	60.77	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			527.6	G08		1	0048-0541	636.49	541.13	202	54.18	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			405.2	G08		1	0049-0548	12.47	547.60	261	61.36	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			434.6	G08		1	0050-0558	95.67	558.64	212	58.18	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			344.4	G08		1	0051-0568	648.28	568.31	304	68.18	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			371.9	G08		1	0052-0569	834.65	569.67	293	66.43	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			375.1	G08		1	0053-0605	697.52	605.52	252	58.77	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			328.6	G08		1	0054-0610	547.24	610.47	328	69.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			624.7	G08		1	0055-0610	598.30	610.74	166	53.94	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			521.3	G08		1	0056-0639	326.67	638.87	198	53.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			433.7	G08		1	0057-0697	329.28	697.00	230	59.84	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			369.4	G08		1	0058-0706	735.74	705.51	250	73.60	0.580
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			511.3	G08		2	0001-0033	490.85	32.69	260	66.28	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			392.6	G08		2	0002-0065	39.68	65.16	334	70.43	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			410.4	G08		2	0003-0071	263.62	70.95	321	73.26	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			397.9	G08		2	0004-0104	246.65	104.64	292	75.50	0.644
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			362.5	G08		2	0005-0207	403.66	206.99	276	68.18	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			521.9	G08		2	0006-0218	447.01	218.02	223	66.43	0.635
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			619.3	G08		2	0007-0233	670.79	232.76	279	104.81	0.319
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			310.6	G08		2	0008-0248	396.52	248.61	314	69.84	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			561.7	G08		2	0009-0248	449.88	249.51	100	47.46	0.558
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			556.3	G08		2	0010-0282	915.46	282.98	120	50.77	0.585
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			471.6	G08		2	0011-0354	665.79	353.71	302	68.18	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			370.7	G08		2	0012-0389	40.48	389.26	286	68.18	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2023.1	G08		2	0013-0396	667.73	395.75	228	57.01	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1965.0	G08		2	0014-0408	655.79	407.55	276	66.08	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			609.5	G08		2	0015-0409	559.15	408.44	277	64.18	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			375.6	G08		2	0016-0459	258.19	459.85	306	66.18	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			484.9	G08		2	0017-0511	49.96	511.64	225	57.70	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			382.3	G08		2	0018-0515	114.80	515.24	268	63.60	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			420.6	G08		2	0019-0613	133.89	613.28	223	60.53	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			478.9	G08		2	0020-0618	504.01	618.58	259	63.36	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			364.6	G08		2	0021-0635	637.25	635.23	302	66.53	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			310.5	G08		2	0022-0639	285.94	639.91	297	66.18	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			315.3	G08		2	0023-0644	591.27	644.02	278	63.70	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			310.8	G08		2	0024-0650	538.77	650.29	296	64.53	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			369.1	G08		2	0025-0654	224.91	653.80	279	63.70	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			333.3	G08		2	0026-0669	100.45	669.38	299	65.36	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			313.8	G08		2	0027-0672	582.47	672.12	374	76.08	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			379.5	G08		2	0028-0672	305.14	673.35	281	64.53	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1208.3	G08		2	0029-0686	316.60	686.53	125	45.11	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			336.8	G08		2	0030-0691	559.22	690.33	333	73.01	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			323.5	G08		2	0031-0697	615.07	697.26	277	62.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2094.3	G08		2	0032-0703	912.12	702.79	115	40.28	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			613.6	G08		3	0001-0051	392.71	51.40	201	55.36	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			407.0	G08		3	0002-0075	222.13	75.24	244	59.36	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			505.9	G08		3	0003-0084	824.96	84.25	264	61.94	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			459.3	G08		3	0004-0098	283.01	98.19	236	61.26	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			481.2	G08		3	0005-0107	865.02	107.68	209	59.26	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			500.2	G08		3	0006-0109	428.96	108.97	213	54.53	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			589.7	G08		3	0007-0117	337.10	117.22	177	52.18	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			478.0	G08		3	0008-0120	858.06	120.25	224	55.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1167.8	G08		3	0009-0140	463.15	140.84	127	57.60	0.481
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			431.8	G08		3	0010-0154	925.91	153.92	225	57.36	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			437.5	G08		3	0011-0159	132.00	159.59	256	62.53	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			393.9	G08		3	0012-0161	248.69	161.09	118	40.28	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			366.9	G08		3	0013-0170	238.79	170.81	151	46.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			572.1	G08		3	0014-0176	428.50	176.01	204	58.18	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			353.9	G08		3	0015-0181	503.87	181.33	291	66.77	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1674.5	G08		3	0016-0180	529.81	180.56	171	50.53	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			797.7	G08		3	0017-0197	582.62	198.37	177	56.18	0.705
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			458.1	G08		3	0018-0200	927.92	200.57	216	59.60	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			653.9	G08		3	0019-0218	416.36	218.30	165	50.04	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			707.1	G08		3	0020-0225	645.39	226.73	372	80.08	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			349.4	G08		3	0021-0230	534.48	231.10	267	63.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			443.8	G08		3	0022-0244	246.67	242.06	190	58.87	0.689
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			442.0	G08		3	0023-0252	396.23	252.19	223	54.53	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			330.0	G08		3	0024-0254	528.93	254.27	270	65.01	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			393.1	G08		3	0025-0258	249.56	257.64	117	41.70	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			330.4	G08		3	0026-0275	172.46	274.70	276	67.84	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			336.3	G08		3	0027-0281	631.58	281.17	262	59.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			465.8	G08		3	0028-0283	13.67	282.64	191	56.77	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			600.8	G08		3	0029-0291	854.26	290.53	224	59.60	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			475.3	G08		3	0030-0303	103.18	303.57	207	57.36	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1227.8	G08		3	0031-0312	777.94	311.63	151	51.46	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			553.2	G08		3	0032-0322	487.29	322.50	214	56.77	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			364.1	G08		3	0033-0343	170.81	343.65	233	58.28	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			644.9	G08		3	0034-0384	852.19	384.44	220	55.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			384.0	G08		3	0035-0385	203.48	384.96	224	61.70	0.739
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			445.7	G08		3	0036-0396	810.66	396.52	284	63.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			435.8	G08		3	0037-0402	50.40	402.63	241	60.77	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			423.2	G08		3	0038-0407	742.68	408.20	266	64.18	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			341.1	G08		3	0039-0408	893.26	407.85	285	67.26	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			430.4	G08		3	0040-0454	910.50	453.38	237	58.77	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			333.9	G08		3	0041-0486	783.43	486.83	257	62.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			510.4	G08		3	0042-0489	453.81	489.03	234	57.36	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			411.6	G08		3	0043-0499	369.03	498.82	247	60.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			381.1	G08		3	0044-0535	663.85	535.40	257	62.87	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			425.3	G08		3	0045-0539	343.31	539.41	471	89.74	0.735
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1094.6	G08		3	0046-0531	785.86	531.44	177	51.11	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1289.3	G08		3	0047-0549	945.50	548.90	266	68.63	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			335.4	G08		3	0048-0558	808.51	557.74	322	68.18	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1066.0	G08		3	0049-0560	315.90	559.69	220	93.40	0.317
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			339.8	G08		3	0050-0565	444.93	564.88	283	66.18	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			367.2	G08		3	0051-0575	624.95	575.22	373	72.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			373.6	G08		3	0052-0581	325.62	582.28	262	61.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			340.5	G08		3	0053-0609	835.51	610.13	302	66.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			605.5	G08		3	0054-0645	276.97	644.96	208	56.87	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			344.0	G08		3	0055-0663	699.65	662.76	264	65.36	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			409.6	G08		3	0056-0664	832.78	663.96	216	59.84	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			553.1	G08		3	0057-0666	97.42	666.26	212	53.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			323.9	G08		3	0058-0670	618.50	669.36	259	66.43	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			376.6	G08		4	0001-0035	57.39	34.95	202	56.77	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			373.5	G08		4	0002-0036	140.39	36.89	263	67.26	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			314.4	G08		4	0003-0065	897.16	64.19	268	63.26	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			351.5	G08		4	0004-0069	704.73	69.69	260	63.70	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			345.4	G08		4	0005-0087	675.87	87.02	277	61.70	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			449.7	G08		4	0006-0092	168.03	92.02	326	72.91	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			389.0	G08		4	0007-0097	488.16	97.07	264	62.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			405.8	G08		4	0008-0106	695.79	107.02	267	67.26	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			427.1	G08		4	0009-0129	134.25	130.00	186	56.87	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			472.3	G08		4	0010-0144	683.46	144.16	250	68.77	0.664
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			350.7	G08		4	0011-0184	270.60	185.09	156	47.46	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			315.1	G08		4	0012-0184	258.83	184.32	117	42.63	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			334.9	G08		4	0013-0198	252.47	198.14	271	61.60	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			339.0	G08		4	0014-0202	271.16	202.46	228	62.77	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			393.7	G08		4	0015-0222	683.17	222.21	211	63.60	0.656
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			372.4	G08		4	0016-0223	626.05	223.64	268	61.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			346.8	G08		4	0017-0230	296.16	230.32	363	80.67	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			366.8	G08		4	0018-0236	870.80	235.72	251	60.53	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2409.6	G08		4	0019-0248	297.88	248.35	171	67.84	0.467
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			353.6	G08		4	0020-0251	61.22	251.90	222	54.77	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			314.6	G08		4	0021-0252	929.07	252.31	258	60.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			332.6	G08		4	0022-0261	757.81	261.64	281	65.01	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			361.3	G08		4	0023-0260	858.20	260.13	218	61.70	0.720
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			399.3	G08		4	0024-0273	154.52	273.23	239	64.53	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			380.6	G08		4	0025-0274	848.11	274.54	288	65.94	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			496.4	G08		4	0026-0278	57.57	278.85	196	52.53	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			447.7	G08		4	0027-0290	821.95	289.82	232	58.53	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			301.3	G08		4	0028-0297	30.71	296.88	302	66.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			457.4	G08		4	0029-0300	383.48	300.35	174	49.11	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			394.1	G08		4	0030-0308	258.64	308.85	209	57.60	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			381.4	G08		4	0031-0310	101.43	310.42	257	62.53	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			425.4	G08		4	0032-0312	542.78	311.58	301	68.77	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			492.6	G08		4	0033-0325	554.36	324.38	243	67.01	0.680
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			405.2	G08		4	0034-0343	635.95	342.84	195	59.01	0.704
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			517.0	G08		4	0035-0351	370.80	351.24	187	53.70	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			337.5	G08		4	0036-0350	928.55	349.11	162	51.94	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			347.3	G08		4	0037-0355	938.44	356.34	139	44.28	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			555.6	G08		4	0038-0361	218.64	361.70	202	57.11	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			485.1	G08		4	0039-0373	278.48	373.34	189	51.46	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1217.8	G08		4	0040-0382	801.04	382.03	194	55.70	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			343.6	G08		4	0041-0388	284.57	388.10	256	62.53	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			359.9	G08		4	0042-0391	415.82	392.06	295	67.36	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			591.7	G08		4	0043-0390	53.66	390.17	240	60.18	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			317.4	G08		4	0044-0393	267.09	393.23	290	67.26	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			432.7	G08		4	0045-0401	830.60	401.78	210	53.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			487.2	G08		4	0046-0420	198.06	419.82	219	57.46	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			390.8	G08		4	0047-0424	944.84	423.39	270	62.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			309.1	G08		4	0048-0440	392.04	441.07	265	65.84	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			550.1	G08		4	0049-0447	554.05	446.96	215	56.18	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			473.9	G08		4	0050-0446	249.81	446.92	191	53.11	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			313.1	G08		4	0051-0477	904.87	477.53	234	57.70	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			480.2	G08		4	0052-0487	80.59	487.68	262	62.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			410.2	G08		4	0053-0502	230.11	501.89	197	53.46	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			539.5	G08		4	0054-0517	391.63	517.07	253	75.60	0.556
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			523.2	G08		4	0055-0521	120.17	521.56	214	55.36	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1302.1	G08		4	0056-0523	287.43	523.01	270	63.60	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			422.4	G08		4	0057-0530	144.08	530.84	219	55.46	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			483.0	G08		4	0058-0560	596.96	558.50	392	91.74	0.585
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			629.2	G08		4	0059-0564	877.39	564.54	192	51.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			373.8	G08		4	0060-0577	810.69	577.11	389	74.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			360.1	G08		4	0061-0591	113.98	591.55	247	59.94	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			385.1	G08		4	0062-0606	659.17	606.68	297	78.57	0.605
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			433.0	G08		4	0063-0617	452.28	617.65	211	56.77	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			420.2	G08		4	0064-0621	193.27	621.27	221	60.43	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			383.9	G08		4	0065-0637	190.91	637.47	228	60.18	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			821.0	G08		4	0066-0644	397.00	643.71	282	63.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			446.1	G08		4	0067-0653	92.97	652.55	189	56.53	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1033.6	G08		4	0068-0654	106.20	654.06	160	50.04	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			385.4	G08		4	0069-0663	678.63	663.18	247	64.43	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			459.2	G08		4	0070-0690	349.11	690.26	383	72.67	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			331.5	G08		4	0071-0691	367.79	690.82	276	66.18	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			343.5	G08		4	0072-0704	542.80	703.81	309	68.43	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			283.5	G08		4	0073-0703	589.98	703.36	281	69.11	0.739
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			875.6	G08		4	0074-0703	739.02	703.26	199	52.77	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			506.4	G08		4	0075-0707	196.86	706.90	154	46.53	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			391.1	G08		5	0001-0032	541.11	31.09	192	60.18	0.666
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			586.0	G08		5	0002-0042	152.37	43.12	227	64.53	0.685
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			554.3	G08		5	0003-0068	371.04	67.99	204	61.46	0.679
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			352.6	G08		5	0004-0094	130.78	94.41	220	57.70	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			737.6	G08		5	0005-0108	685.92	107.88	189	51.94	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			414.0	G08		5	0006-0108	655.21	107.84	265	63.36	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			499.0	G08		5	0007-0126	291.19	126.62	202	56.18	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			429.5	G08		5	0008-0163	606.40	162.70	224	68.43	0.601
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			382.1	G08		5	0009-0165	343.14	165.05	250	63.50	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			325.4	G08		5	0010-0175	940.52	174.15	253	63.11	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			513.9	G08		5	0011-0181	825.03	181.58	243	58.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			483.4	G08		5	0012-0189	442.10	189.27	227	64.18	0.692
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			905.3	G08		5	0013-0195	722.38	195.82	185	73.50	0.430
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			397.6	G08		5	0014-0222	93.53	222.62	278	65.94	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			390.7	G08		5	0015-0237	567.80	237.45	194	55.46	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			332.4	G08		5	0016-0239	139.04	239.55	271	62.77	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			383.4	G08		5	0017-0241	470.04	240.31	223	57.46	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			482.0	G08		5	0018-0240	624.42	240.17	185	53.36	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			757.4	G08		5	0019-0248	823.85	247.79	175	69.26	0.459
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			324.3	G08		5	0020-0253	34.52	253.68	252	59.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			335.0	G08		5	0021-0263	132.45	263.34	299	67.84	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			317.4	G08		5	0022-0282	865.29	281.23	145	48.53	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			332.9	G08		5	0023-0292	260.85	292.40	275	62.18	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			311.0	G08		5	0024-0289	871.90	290.19	120	44.28	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			299.9	G08		5	0025-0292	905.12	292.44	265	63.01	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1263.8	G08		5	0026-0292	213.98	291.51	103	49.46	0.529
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			348.4	G08		5	0027-0316	61.57	315.91	259	68.53	0.693
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			529.0	G08		5	0028-0324	909.41	324.06	225	55.11	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			337.7	G08		5	0029-0351	34.16	350.35	160	51.11	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			370.9	G08		5	0030-0356	852.99	356.90	319	68.18	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			302.0	G08		5	0031-0357	43.91	357.60	134	43.46	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			425.0	G08		5	0032-0370	916.33	370.90	242	64.53	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			353.2	G08		5	0033-0388	478.45	387.91	263	61.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			580.3	G08		5	0034-0396	394.79	396.25	187	51.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			443.3	G08		5	0035-0412	692.19	411.81	233	56.28	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			477.4	G08		5	0036-0419	429.87	419.08	156	58.77	0.568
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			410.2	G08		5	0037-0425	50.46	424.75	261	63.60	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			377.8	G08		5	0038-0484	95.58	484.30	269	62.18	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			639.1	G08		5	0039-0483	930.96	483.42	201	53.70	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			460.1	G08		5	0040-0494	633.21	493.73	212	62.28	0.687
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			382.2	G08		5	0041-0497	769.80	497.55	253	61.70	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			302.5	G08		5	0042-0508	329.53	508.48	329	72.43	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			386.0	G08		5	0043-0527	286.51	526.75	220	61.01	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			460.7	G08		5	0044-0535	622.69	534.63	187	56.28	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			293.6	G08		5	0045-0550	220.89	550.54	202	57.94	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			382.9	G08		5	0046-0548	249.45	548.43	172	52.28	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1109.9	G08		5	0047-0563	153.70	562.95	110	53.36	0.486
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			359.0	G08		5	0048-0583	634.62	583.75	264	63.84	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			457.3	G08		5	0049-0594	129.69	594.89	191	54.18	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			414.8	G08		5	0050-0606	526.68	606.72	254	62.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			443.4	G08		5	0051-0621	548.39	620.38	261	60.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			603.0	G08		5	0052-0633	394.79	633.43	175	57.94	0.655
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			299.3	G08		5	0053-0649	879.38	648.46	267	62.77	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			473.3	G08		5	0054-0658	86.40	658.34	208	66.04	0.599
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			423.0	G08		5	0055-0659	146.43	658.61	215	57.11	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			408.6	G08		5	0056-0676	660.44	675.54	242	63.36	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			711.4	G08		5	0057-0680	392.72	679.46	237	61.94	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			596.6	G08		5	0058-0686	413.76	685.86	186	51.70	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			561.5	G08		5	0059-0701	377.39	701.40	197	55.70	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			722.3	G08		5	0060-0703	482.30	702.70	182	64.67	0.547
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			572.7	G08		6	0001-0056	930.28	56.78	245	59.11	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			382.2	G08		6	0002-0062	146.01	62.35	215	56.77	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			351.7	G08		6	0003-0073	880.87	72.50	278	64.43	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1735.0	G08		6	0004-0082	78.92	81.60	182	51.94	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			332.9	G08		6	0005-0093	752.88	94.14	288	67.01	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			418.5	G08		6	0006-0112	641.80	112.21	197	57.60	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			759.4	G08		6	0007-0120	317.19	120.41	213	53.11	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			444.3	G08		6	0008-0124	828.85	124.44	232	71.98	0.563
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			355.2	G08		6	0009-0133	761.87	133.64	241	61.01	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			280.6	G08		6	0010-0139	111.89	138.66	274	63.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			281.6	G08		6	0011-0145	96.13	144.50	281	64.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			349.4	G08		6	0012-0150	731.23	150.14	297	66.18	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			498.3	G08		6	0013-0153	946.07	153.21	217	55.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			490.2	G08		6	0014-0157	818.91	157.09	266	65.01	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			471.0	G08		6	0015-0177	35.63	176.53	252	61.11	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1025.0	G08		6	0016-0179	810.78	179.02	141	59.60	0.499
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			360.9	G08		6	0017-0183	491.89	183.08	192	56.43	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			518.1	G08		6	0018-0187	116.46	188.41	137	46.63	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			307.5	G08		6	0019-0200	117.38	199.99	117	41.80	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			329.4	G08		6	0020-0220	67.60	220.10	243	57.70	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			379.2	G08		6	0021-0225	588.78	225.28	263	64.43	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			515.5	G08		6	0022-0261	649.15	261.19	225	59.70	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			482.6	G08		6	0023-0323	648.24	322.86	229	59.94	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			398.3	G08		6	0024-0328	763.41	329.02	193	57.11	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			355.2	G08		6	0025-0339	100.89	339.06	230	57.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			357.5	G08		6	0026-0347	418.78	347.62	272	65.60	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			366.4	G08		6	0027-0369	308.09	369.43	309	66.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			365.0	G08		6	0028-0373	11.55	373.61	238	63.11	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			378.9	G08		6	0029-0373	577.93	372.96	231	62.63	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			344.7	G08		6	0030-0403	351.02	403.11	335	70.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			413.6	G08		6	0031-0413	837.42	412.60	249	59.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			397.6	G08		6	0032-0418	255.47	418.73	301	69.01	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			417.8	G08		6	0033-0426	394.41	426.17	186	53.46	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			385.6	G08		6	0034-0432	873.70	432.07	251	60.53	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			720.4	G08		6	0035-0454	596.99	454.12	299	82.91	0.547
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			592.0	G08		6	0036-0486	26.23	486.05	202	55.11	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			477.4	G08		6	0037-0513	579.88	512.79	289	64.53	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			365.9	G08		6	0038-0542	313.65	541.48	130	43.94	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			333.0	G08		6	0039-0546	303.22	547.24	144	45.11	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			551.4	G08		6	0040-0554	190.36	554.58	209	53.36	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			495.3	G08		6	0041-0567	183.14	566.73	172	51.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			331.8	G08		6	0042-0568	321.68	568.31	295	65.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			342.1	G08		6	0043-0582	382.57	582.43	275	67.70	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			436.5	G08		6	0044-0604	753.16	604.08	233	58.53	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			832.2	G08		6	0045-0611	859.18	611.21	210	59.36	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			503.2	G08		6	0046-0612	890.31	612.54	187	57.94	0.700
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			563.4	G08		6	0047-0614	613.01	614.72	215	56.87	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			314.9	G08		6	0048-0640	352.25	639.51	291	66.43	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			436.0	G08		6	0049-0646	575.91	645.49	232	59.60	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			458.1	G08		6	0050-0650	617.75	651.14	208	57.84	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			401.1	G08		6	0051-0653	123.89	653.61	205	60.53	0.703
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			494.3	G08		6	0052-0677	466.12	677.74	244	59.94	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			473.3	G08		6	0053-0686	593.53	685.73	205	59.94	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			416.5	G08		6	0054-0691	513.60	691.38	248	61.60	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			316.6	G08		6	0055-0700	351.11	699.46	279	62.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			397.7	G08		6	0056-0709	218.08	709.28	259	60.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			854.5	G08		6	0057-0709	832.68	709.43	206	58.28	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			534.6	G08		7	0001-0053	156.06	53.48	189	52.87	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			455.3	G08		7	0002-0055	530.23	55.22	234	56.87	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			373.9	G08		7	0003-0059	856.52	59.19	222	59.46	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			829.9	G08		7	0004-0066	818.80	66.19	139	61.60	0.460
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			424.6	G08		7	0005-0108	391.66	108.22	211	60.04	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			299.6	G08		7	0006-0106	876.52	106.30	260	62.77	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			618.5	G08		7	0007-0126	468.55	126.58	207	53.11	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			411.7	G08		7	0008-0146	857.50	145.91	227	61.60	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			666.5	G08		7	0009-0151	424.38	151.78	184	51.46	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			408.7	G08		7	0010-0155	165.33	155.02	235	60.53	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			334.4	G08		7	0011-0169	384.99	168.53	333	77.26	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			433.9	G08		7	0012-0218	214.01	218.13	266	65.01	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			344.7	G08		7	0013-0232	844.78	232.79	244	59.94	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			504.0	G08		7	0014-0246	70.36	245.62	187	57.01	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			614.4	G08		7	0015-0269	254.98	267.70	124	52.87	0.557
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			461.6	G08		7	0016-0278	542.09	277.90	194	55.01	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			326.5	G08		7	0017-0285	589.69	285.54	227	55.70	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2215.6	G08		7	0018-0295	792.60	296.21	261	62.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			334.2	G08		7	0019-0312	44.10	311.83	284	64.53	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			421.6	G08		7	0020-0310	581.07	310.05	230	59.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			2910.2	G08		7	0021-0318	797.42	318.62	355	71.01	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			420.7	G08		7	0022-0320	20.50	319.46	217	56.28	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			443.2	G08		7	0023-0342	903.18	342.01	285	63.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			517.2	G08		7	0024-0346	432.50	346.92	216	56.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			350.6	G08		7	0025-0359	304.40	359.04	277	66.18	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1383.7	G08		7	0026-0385	226.98	385.39	107	39.46	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			329.5	G08		7	0027-0408	323.36	408.03	298	66.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			344.9	G08		7	0028-0414	130.61	414.08	313	71.50	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			426.9	G08		7	0029-0412	876.71	411.44	249	59.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			559.0	G08		7	0030-0415	227.08	415.55	205	57.01	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			502.7	G08		7	0031-0458	218.58	458.05	226	59.84	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			428.8	G08		7	0032-0465	900.13	464.79	272	63.01	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			974.3	G08		7	0033-0480	673.05	480.64	163	60.18	0.566
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			364.1	G08		7	0034-0483	154.74	483.15	141	46.87	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			457.4	G08		7	0035-0492	825.90	492.18	214	57.36	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			355.0	G08		7	0036-0494	159.32	495.01	131	49.46	0.673
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1004.5	G08		7	0037-0540	317.29	539.62	261	62.53	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			444.8	G08		7	0038-0537	118.17	537.42	196	57.36	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			416.6	G08		7	0039-0548	749.08	548.28	132	45.36	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			320.9	G08		7	0040-0555	541.81	554.98	291	65.26	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			411.2	G08		7	0041-0557	214.72	557.44	222	57.36	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			395.0	G08		7	0042-0555	735.78	555.98	120	42.28	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			432.3	G08		7	0043-0571	865.45	571.98	235	59.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			300.5	G08		7	0044-0581	458.87	581.32	299	65.26	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			453.6	G08		7	0045-0580	338.24	579.59	201	56.04	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			316.7	G08		7	0046-0584	557.07	584.80	257	61.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			407.0	G08		7	0047-0590	146.42	590.52	220	59.21	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			309.4	G08		7	0048-0590	379.40	589.54	316	66.67	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			311.7	G08		7	0049-0587	725.42	587.60	147	45.11	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			312.4	G08		7	0050-0596	715.02	597.07	151	46.87	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			948.4	G08		7	0051-0647	709.92	647.29	279	62.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			445.1	G08		7	0052-0649	283.27	650.15	195	53.94	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			392.1	G08		7	0053-0663	760.22	663.21	252	61.60	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			345.3	G08		7	0054-0665	58.61	665.53	298	63.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			331.3	G08		7	0055-0677	779.19	677.03	238	61.60	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			562.0	G08		7	0056-0692	383.49	691.93	179	49.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			406.7	G08		7	0057-0691	471.18	691.53	195	56.87	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			299.9	G08		8	0001-0031	936.98	31.62	278	65.60	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			430.7	G08		8	0002-0054	801.15	53.88	209	56.87	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			375.3	G08		8	0003-0061	843.75	61.43	216	66.04	0.622
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			473.3	G08		8	0004-0072	744.01	72.77	201	59.70	0.709
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			3949.4	G08		8	0005-0110	290.92	109.83	264	63.01	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			757.9	G08		8	0006-0124	868.05	124.44	204	55.36	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			491.1	G08		8	0007-0136	397.97	136.22	279	62.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			501.6	G08		8	0008-0157	297.33	157.19	199	51.11	0.957
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			360.7	G08		8	0009-0177	236.55	176.67	260	64.53	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			558.8	G08		8	0010-0177	353.95	177.55	204	52.28	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			407.7	G08		8	0011-0182	141.63	182.29	215	60.43	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			414.8	G08		8	0012-0184	417.53	184.50	266	63.84	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			659.5	G08		8	0013-0195	580.65	195.20	189	53.11	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			435.8	G08		8	0014-0207	918.96	206.97	220	55.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			415.4	G08		8	0015-0214	236.87	214.53	211	59.01	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			466.3	G08		8	0016-0241	897.47	241.14	199	55.36	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			467.0	G08		8	0017-0260	527.98	260.45	217	56.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			464.2	G08		8	0018-0264	450.21	263.65	272	63.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			371.5	G08		8	0019-0297	861.92	297.03	274	63.94	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			360.3	G08		8	0020-0298	714.96	298.45	291	64.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			355.7	G08		8	0021-0330	699.62	330.32	173	47.46	0.965
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			388.0	G08		8	0022-0334	721.44	334.50	230	69.26	0.603
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			342.4	G08		8	0023-0343	708.13	343.65	123	45.11	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			318.1	G08		8	0024-0356	95.62	357.04	246	59.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			317.4	G08		8	0025-0358	770.82	358.20	230	63.60	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			447.0	G08		8	0026-0376	353.60	378.03	264	77.26	0.556
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			499.9	G08		8	0027-0378	259.72	378.03	213	55.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			400.5	G08		8	0028-0380	688.59	380.85	231	62.77	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			355.5	G08		8	0029-0388	424.72	387.92	305	67.84	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1037.8	G08		8	0030-0393	795.82	392.83	329	69.36	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			389.6	G08		8	0031-0421	214.39	421.11	189	56.53	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			600.3	G08		8	0032-0423	584.17	423.57	283	64.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			421.3	G08		8	0033-0426	527.98	426.91	228	57.70	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			358.4	G08		8	0034-0431	469.27	430.90	295	64.53	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			421.3	G08		8	0035-0446	174.24	446.17	205	59.26	0.734
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			284.7	G08		8	0036-0465	93.35	465.85	268	64.18	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			509.2	G08		8	0037-0478	172.46	478.59	190	52.77	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			449.3	G08		8	0038-0478	451.26	478.26	172	50.18	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			562.6	G08		8	0039-0485	204.35	484.39	245	61.60	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			396.8	G08		8	0040-0493	109.12	493.18	278	65.94	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			341.8	G08		8	0041-0514	550.29	513.57	307	69.94	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			342.0	G08		8	0042-0513	707.35	513.93	288	62.18	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			325.7	G08		8	0043-0518	868.54	518.43	202	61.01	0.682
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			361.1	G08		8	0044-0518	406.70	519.39	142	45.21	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			415.2	G08		8	0045-0536	565.66	536.59	212	64.04	0.650
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			415.8	G08		8	0046-0533	407.92	532.20	168	48.63	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			351.7	G08		8	0047-0534	301.31	534.72	230	59.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			421.7	G08		8	0048-0548	192.92	547.90	260	61.36	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			328.5	G08		8	0049-0556	511.92	556.09	302	66.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			428.9	G08		8	0050-0566	299.97	566.75	193	53.60	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			295.5	G08		8	0051-0580	924.69	579.23	294	65.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			320.6	G08		8	0052-0589	270.62	588.33	268	63.11	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			429.6	G08		8	0053-0595	880.07	594.80	355	73.36	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			303.9	G08		8	0054-0610	218.90	609.47	260	67.84	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			539.5	G08		8	0055-0621	146.69	622.02	198	57.11	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			943.5	G08		8	0056-0621	290.70	621.09	249	60.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			428.7	G08		8	0057-0639	577.61	640.06	225	62.53	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			409.5	G08		8	0058-0657	135.73	657.10	210	61.70	0.693
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			365.0	G08		8	0059-0652	674.40	652.07	277	69.36	0.724
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			586.9	G08		8	0060-0666	415.93	666.00	171	55.11	0.707
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			687.6	G08		8	0061-0699	370.97	699.10	183	51.70	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			377.2	G08		8	0062-0701	133.33	701.42	195	51.70	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			540.3	G08		8	0063-0709	842.07	709.27	198	51.70	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			271.1	G08		9	0001-0034	31.77	34.33	273	65.01	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			398.3	G08		9	0002-0034	411.40	35.09	286	64.77	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			290.0	G08		9	0003-0040	489.21	39.94	280	65.84	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			370.1	G08		9	0004-0049	727.83	49.69	258	61.11	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1232.6	G08		9	0005-0071	43.56	71.40	286	64.28	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			680.1	G08		9	0006-0103	476.99	103.18	279	61.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			378.2	G08		9	0007-0106	354.74	106.26	246	59.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			490.6	G08		9	0008-0118	570.68	118.15	240	60.53	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			397.2	G08		9	0009-0145	347.01	145.15	199	53.11	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			613.8	G08		9	0010-0148	694.70	149.05	194	59.36	0.692
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			377.6	G08		9	0011-0150	125.25	150.20	225	59.46	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			414.1	G08		9	0012-0157	97.26	157.47	266	59.11	0.957
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			334.8	G08		9	0013-0183	323.97	183.54	246	61.60	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			421.5	G08		9	0014-0194	251.35	194.46	224	57.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			370.5	G08		9	0015-0206	858.14	205.90	261	62.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			390.9	G08		9	0016-0210	14.17	209.59	216	55.60	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			474.9	G08		9	0017-0211	377.37	210.79	172	54.04	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			507.6	G08		9	0018-0224	388.18	223.96	199	56.53	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			384.1	G08		9	0019-0235	80.57	235.54	201	56.18	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			555.2	G08		9	0020-0244	687.08	243.72	274	63.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			473.6	G08		9	0021-0246	299.45	245.54	343	72.43	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			465.5	G08		9	0022-0255	445.90	255.26	242	57.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			571.7	G08		9	0023-0268	478.14	267.59	245	58.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			391.9	G08		9	0024-0306	621.04	306.21	306	65.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			373.8	G08		9	0025-0336	263.52	336.65	255	77.50	0.534
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			322.4	G08		9	0026-0338	565.15	337.78	294	65.60	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			645.0	G08		9	0027-0352	423.01	352.32	230	57.36	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			1065.9	G08		9	0028-0359	647.64	359.30	201	52.04	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			307.5	G08		9	0029-0366	121.04	366.56	347	72.08	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			353.9	G08		9	0030-0371	599.07	371.81	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			314.9	G08		9	0031-0392	112.90	392.27	302	70.18	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			751.3	G08		9	0032-0394	544.89	393.62	265	87.64	0.434
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			448.3	G08		9	0033-0396	427.88	397.25	206	56.77	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			345.4	G08		9	0034-0412	642.60	412.11	280	69.26	0.734
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			378.2	G08		9	0035-0416	462.97	416.38	197	60.28	0.681
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			373.1	G08		9	0036-0419	369.72	418.83	238	60.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			367.1	G08		9	0037-0428	443.00	427.25	275	64.77	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			346.7	G08		9	0038-0429	515.38	429.72	271	61.70	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			351.6	G08		9	0039-0440	364.69	440.16	252	61.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			825.1	G08		9	0040-0502	687.24	501.40	247	61.36	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			591.7	G08		9	0041-0505	670.84	506.14	206	54.63	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			336.1	G08		9	0042-0526	480.04	525.65	299	66.77	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			334.6	G08		9	0043-0560	241.00	560.24	284	66.77	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			299.5	G08		9	0044-0582	19.55	581.95	287	64.53	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			428.0	G08		9	0045-0581	306.88	581.25	226	58.18	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			369.3	G08		9	0046-0596	783.57	595.75	266	63.84	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			388.8	G08		9	0047-0601	698.86	601.44	250	62.53	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			284.5	G08		9	0048-0605	942.34	604.53	260	67.01	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			317.8	G08		9	0049-0613	300.09	612.81	325	66.43	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2	80006	S6 (pS240; pS244) / Alexa Fluor 488	80007	rabbit IgG(H+L) / goat / cross-adsorbed	FITC	201299	S6 (pS240; pS244)			325.0	G08		9	0050-0664	878.63	665.31	280	63.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12474.8	B08		1	0001-0030	113.89	29.84	299	67.60	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12932.8	B08		1	0002-0029	168.91	28.72	294	66.18	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17289.6	B08		1	0003-0033	263.30	34.12	210	55.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13285.8	B08		1	0004-0039	463.46	39.70	310	65.36	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14023.9	B08		1	0005-0040	504.82	41.10	293	68.67	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13992.3	B08		1	0006-0040	720.01	40.44	289	75.74	0.633
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19964.7	B08		1	0007-0041	803.55	41.85	444	87.50	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14890.2	B08		1	0008-0042	418.82	41.04	267	61.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21955.9	B08		1	0009-0042	87.75	42.02	158	48.63	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18846.0	B08		1	0010-0045	289.33	45.56	376	71.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16852.0	B08		1	0011-0044	589.42	44.68	234	56.28	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16978.5	B08		1	0012-0045	693.34	45.35	223	54.87	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21624.8	B08		1	0013-0042	652.67	42.21	177	52.63	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21155.6	B08		1	0014-0047	771.72	47.09	254	59.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13303.6	B08		1	0015-0051	172.16	51.15	276	61.94	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14638.5	B08		1	0016-0050	534.61	50.03	323	66.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19415.6	B08		1	0017-0053	219.63	53.47	374	71.60	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15445.6	B08		1	0018-0052	134.85	52.43	234	56.53	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22592.7	B08		1	0019-0058	657.13	57.83	342	70.77	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16977.9	B08		1	0020-0061	258.75	61.24	390	73.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14471.2	B08		1	0021-0063	335.34	62.34	338	68.43	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15532.0	B08		1	0022-0062	630.45	62.65	266	64.28	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15727.5	B08		1	0023-0061	68.12	60.80	231	55.11	0.956
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18490.5	B08		1	0024-0069	569.59	69.83	433	81.26	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14335.9	B08		1	0025-0071	383.06	70.47	307	65.36	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15772.6	B08		1	0026-0072	533.10	71.85	285	67.60	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12621.1	B08		1	0027-0075	85.61	75.59	300	66.18	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15188.7	B08		1	0028-0072	179.49	71.47	229	60.28	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14593.6	B08		1	0029-0075	115.54	75.69	250	60.53	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16090.9	B08		1	0030-0081	364.92	80.88	146	47.46	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16051.3	B08		1	0031-0080	619.08	80.64	222	57.94	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15489.9	B08		1	0032-0081	759.36	80.85	245	58.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15662.9	B08		1	0033-0081	321.95	81.50	130	42.63	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18829.4	B08		1	0034-0088	460.95	87.74	314	66.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15594.9	B08		1	0035-0084	310.93	84.24	113	39.80	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13603.7	B08		1	0036-0090	175.85	90.55	267	61.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14488.5	B08		1	0037-0090	214.71	89.20	254	62.77	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13611.7	B08		1	0038-0092	424.90	91.91	289	65.01	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16417.1	B08		1	0039-0091	680.90	91.72	234	58.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13916.5	B08		1	0040-0094	944.76	95.13	265	65.01	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21219.0	B08		1	0041-0095	625.03	94.75	328	69.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16503.9	B08		1	0042-0103	829.16	103.44	270	62.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14571.9	B08		1	0043-0104	239.83	104.03	255	65.26	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18545.9	B08		1	0044-0104	882.82	104.11	328	67.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14096.2	B08		1	0045-0110	922.35	110.33	335	73.84	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15500.7	B08		1	0046-0109	293.74	110.26	248	62.77	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18635.7	B08		1	0047-0112	493.79	112.96	362	71.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17797.6	B08		1	0048-0114	778.16	114.52	464	84.43	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14043.1	B08		1	0049-0116	112.41	116.63	359	88.08	0.581
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16298.4	B08		1	0050-0116	259.31	115.12	221	56.77	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15109.4	B08		1	0051-0116	647.23	117.24	258	60.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16295.5	B08		1	0052-0117	677.05	116.66	246	60.77	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20625.1	B08		1	0053-0121	836.66	121.20	367	74.18	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13278.2	B08		1	0054-0122	164.49	121.49	263	63.01	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14970.2	B08		1	0055-0120	281.99	120.20	154	46.53	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15265.9	B08		1	0056-0125	949.09	125.05	224	54.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14373.1	B08		1	0057-0128	199.33	128.54	327	68.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19194.0	B08		1	0058-0126	268.66	127.47	256	63.50	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11743.7	B08		1	0059-0129	408.85	128.58	321	73.50	0.747
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16250.3	B08		1	0060-0132	426.69	132.76	233	57.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14567.5	B08		1	0061-0136	630.94	135.58	383	73.94	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15160.4	B08		1	0062-0137	26.05	136.99	233	57.60	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12324.0	B08		1	0063-0137	373.17	137.60	319	72.91	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	25393.0	B08		1	0064-0139	329.68	138.96	328	66.18	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	24664.3	B08		1	0065-0140	731.73	139.63	294	63.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19508.5	B08		1	0066-0148	178.70	148.16	375	71.84	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15813.0	B08		1	0067-0146	940.07	145.73	218	55.36	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14633.7	B08		1	0068-0149	527.48	149.03	352	71.60	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15618.2	B08		1	0069-0149	37.87	149.11	235	57.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15370.0	B08		1	0070-0150	469.38	149.40	312	67.11	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17011.1	B08		1	0071-0150	596.87	150.27	252	60.53	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13432.6	B08		1	0072-0152	796.78	151.98	299	66.18	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19988.0	B08		1	0073-0159	225.58	157.45	570	99.74	0.720
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14063.7	B08		1	0074-0155	282.20	154.87	260	62.18	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	24158.1	B08		1	0075-0157	632.64	157.02	313	76.43	0.673
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16729.7	B08		1	0076-0158	153.69	157.45	204	55.70	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17858.3	B08		1	0077-0163	328.00	163.42	260	61.01	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15571.7	B08		1	0078-0163	125.94	162.81	221	58.77	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14869.8	B08		1	0079-0165	582.66	164.81	259	59.01	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19547.4	B08		1	0080-0168	806.15	168.59	186	50.28	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15535.2	B08		1	0081-0173	353.97	173.37	375	73.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18724.1	B08		1	0082-0176	393.44	175.46	308	66.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16067.6	B08		1	0083-0181	81.01	179.70	679	108.81	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17011.4	B08		1	0084-0181	37.82	180.94	317	68.67	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15828.8	B08		1	0085-0183	495.13	183.84	242	61.11	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13732.0	B08		1	0086-0186	183.20	185.11	281	70.77	0.705
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13421.4	B08		1	0087-0183	529.17	183.34	292	66.77	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23098.8	B08		1	0088-0188	592.87	187.56	324	71.26	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13816.6	B08		1	0089-0188	151.31	188.09	239	63.01	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14343.7	B08		1	0090-0186	472.32	186.20	273	62.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21924.4	B08		1	0091-0190	645.42	190.40	355	72.77	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14516.8	B08		1	0092-0189	740.53	189.40	262	61.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16779.3	B08		1	0093-0189	916.61	189.99	213	55.94	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17282.3	B08		1	0094-0199	661.63	199.51	212	54.53	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17046.5	B08		1	0095-0202	325.65	202.00	219	55.36	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19068.3	B08		1	0096-0203	781.21	202.87	198	52.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13626.8	B08		1	0097-0207	126.70	206.94	259	64.43	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15447.2	B08		1	0098-0208	842.96	208.21	277	62.53	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16777.5	B08		1	0099-0207	893.22	207.79	217	56.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14120.1	B08		1	0100-0211	47.78	209.92	245	71.84	0.597
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18191.2	B08		1	0101-0214	541.25	215.01	299	63.94	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20479.2	B08		1	0102-0214	757.81	214.78	388	73.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22210.6	B08		1	0103-0216	410.24	216.66	161	46.77	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14438.7	B08		1	0104-0223	491.65	222.90	275	63.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18712.7	B08		1	0105-0224	660.52	224.84	193	55.70	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16979.4	B08		1	0106-0227	19.25	227.66	223	54.77	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16173.8	B08		1	0107-0228	641.43	228.26	277	63.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14874.2	B08		1	0108-0230	932.04	229.58	285	68.67	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18465.5	B08		1	0109-0231	142.62	231.60	386	74.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16481.1	B08		1	0110-0230	561.73	229.80	229	55.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15567.6	B08		1	0111-0232	381.62	230.95	268	61.11	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14620.1	B08		1	0112-0230	462.01	230.23	249	61.11	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19475.3	B08		1	0113-0233	211.55	233.28	153	48.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23574.0	B08		1	0114-0243	589.35	243.57	309	68.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17040.4	B08		1	0115-0246	199.44	247.53	276	74.43	0.626
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20929.1	B08		1	0116-0244	317.01	244.90	203	53.11	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19596.3	B08		1	0117-0248	76.81	248.53	326	67.01	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20806.3	B08		1	0118-0247	524.13	246.74	325	66.18	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15233.3	B08		1	0119-0247	711.89	247.02	255	60.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19608.3	B08		1	0120-0248	409.52	248.96	336	67.60	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18941.1	B08		1	0121-0249	739.54	249.33	291	62.18	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13958.2	B08		1	0122-0250	840.18	251.21	283	64.43	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15826.1	B08		1	0123-0247	102.44	248.22	225	58.28	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22410.7	B08		1	0124-0252	47.31	252.01	327	67.26	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18692.2	B08		1	0125-0251	779.24	251.24	413	77.84	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13751.3	B08		1	0126-0257	151.50	256.98	248	61.36	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18115.3	B08		1	0127-0260	804.47	259.44	328	74.18	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17082.4	B08		1	0128-0261	359.21	260.93	227	57.94	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18485.7	B08		1	0129-0264	229.84	263.90	281	63.94	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15468.2	B08		1	0130-0263	576.99	262.76	251	59.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22691.4	B08		1	0131-0263	342.33	262.78	170	48.28	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14061.1	B08		1	0132-0265	453.23	264.74	269	63.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13972.0	B08		1	0133-0267	184.02	266.99	243	60.53	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	24141.5	B08		1	0134-0271	400.65	271.07	303	64.43	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21385.4	B08		1	0135-0282	715.90	282.51	614	104.57	0.706
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14444.5	B08		1	0136-0278	136.40	278.88	316	67.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16018.3	B08		1	0137-0276	499.36	276.36	316	67.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16840.5	B08		1	0138-0278	325.49	278.13	242	57.11	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17738.9	B08		1	0139-0279	115.90	278.85	204	52.53	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18407.1	B08		1	0140-0280	248.03	279.94	274	63.70	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22811.9	B08		1	0141-0280	233.47	280.45	153	47.56	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18410.7	B08		1	0142-0283	831.39	284.12	232	58.77	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20412.4	B08		1	0143-0289	784.07	289.05	364	71.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17271.5	B08		1	0144-0285	871.41	284.96	211	56.04	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14755.5	B08		1	0145-0290	63.79	289.94	259	61.94	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14814.3	B08		1	0146-0294	198.94	293.80	275	68.77	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18956.3	B08		1	0147-0295	251.29	295.72	194	54.53	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15412.4	B08		1	0148-0293	442.69	293.36	247	58.28	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18395.7	B08		1	0149-0295	947.72	294.55	176	50.18	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15610.4	B08		1	0150-0299	539.19	299.01	298	64.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14922.5	B08		1	0151-0299	361.35	299.51	251	57.70	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15414.9	B08		1	0152-0298	577.27	297.82	248	60.53	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16622.9	B08		1	0153-0300	153.20	300.76	218	54.53	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17064.2	B08		1	0154-0304	861.89	303.83	366	74.53	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18457.1	B08		1	0155-0308	69.46	309.04	291	69.60	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16275.0	B08		1	0156-0307	940.82	307.36	244	61.60	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16329.1	B08		1	0157-0306	775.28	306.47	235	57.60	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16015.2	B08		1	0158-0309	925.21	309.35	226	56.28	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16754.5	B08		1	0159-0309	318.39	309.17	272	61.36	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18816.2	B08		1	0160-0314	651.65	313.60	420	79.50	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17702.3	B08		1	0161-0312	467.93	312.35	213	54.28	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13854.5	B08		1	0162-0317	437.95	317.77	267	64.53	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15018.6	B08		1	0163-0318	698.19	319.21	278	66.53	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18354.8	B08		1	0164-0322	42.02	322.21	328	67.94	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21426.9	B08		1	0165-0320	770.32	320.36	168	53.36	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19195.1	B08		1	0166-0327	754.43	327.63	324	66.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14988.3	B08		1	0167-0326	246.13	326.12	244	58.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14923.6	B08		1	0168-0330	596.47	330.76	289	65.60	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17074.8	B08		1	0169-0330	195.74	329.79	222	56.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17574.0	B08		1	0170-0331	512.72	332.12	223	57.11	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18418.4	B08		1	0171-0336	874.34	337.08	218	56.77	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19086.0	B08		1	0172-0340	922.60	340.37	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19312.0	B08		1	0173-0341	99.15	341.72	292	64.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16949.3	B08		1	0174-0341	120.32	340.55	219	53.11	0.976
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16664.4	B08		1	0175-0342	317.87	341.87	240	57.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17172.1	B08		1	0176-0344	477.32	345.31	233	58.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13981.4	B08		1	0177-0343	360.24	343.09	266	60.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20824.2	B08		1	0178-0348	187.38	348.07	297	64.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14961.4	B08		1	0179-0347	401.52	347.12	252	62.18	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15881.0	B08		1	0180-0348	451.21	348.03	240	59.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20715.6	B08		1	0181-0350	819.68	350.80	359	70.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14340.3	B08		1	0182-0357	235.83	357.38	253	60.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17721.2	B08		1	0183-0356	496.35	355.69	222	57.36	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19154.0	B08		1	0184-0358	158.02	357.54	284	62.43	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13685.2	B08		1	0185-0357	671.00	357.74	234	55.94	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19086.3	B08		1	0186-0359	721.04	359.92	342	71.84	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14549.9	B08		1	0187-0360	752.93	360.36	252	59.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18788.5	B08		1	0188-0365	470.68	365.36	211	57.36	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20172.2	B08		1	0189-0369	836.38	369.52	373	72.53	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19547.8	B08		1	0190-0368	510.44	367.95	374	72.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13608.8	B08		1	0191-0368	29.10	368.35	287	63.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22687.2	B08		1	0192-0368	85.72	368.45	306	65.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16261.0	B08		1	0193-0369	285.20	368.86	294	63.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17233.1	B08		1	0194-0369	644.13	368.90	224	53.70	0.976
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12593.3	B08		1	0195-0371	882.48	372.11	301	84.08	0.535
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	24654.0	B08		1	0196-0372	342.42	372.83	297	62.43	0.958
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18168.5	B08		1	0197-0377	903.49	377.77	282	62.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16739.7	B08		1	0198-0382	236.02	382.05	232	61.01	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13832.8	B08		1	0199-0381	465.07	380.93	279	62.18	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14969.2	B08		1	0200-0382	422.53	381.58	245	57.01	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14436.4	B08		1	0201-0384	59.38	384.08	255	60.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14166.0	B08		1	0202-0382	204.75	382.54	279	65.60	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14757.4	B08		1	0203-0384	656.24	384.72	261	60.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12358.2	B08		1	0204-0387	568.05	386.72	328	69.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13826.8	B08		1	0205-0391	518.32	391.39	283	61.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18268.9	B08		1	0206-0390	169.49	389.75	206	54.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13065.1	B08		1	0207-0395	261.77	395.35	279	63.60	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14446.6	B08		1	0208-0395	803.93	394.56	282	63.94	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13518.7	B08		1	0209-0397	83.60	397.43	279	63.36	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18914.2	B08		1	0210-0404	36.94	403.87	278	63.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14926.2	B08		1	0211-0407	730.02	407.84	315	66.18	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12452.8	B08		1	0212-0408	843.73	407.57	293	64.18	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13267.5	B08		1	0213-0410	440.38	410.24	296	63.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11787.0	B08		1	0214-0410	550.82	411.36	275	66.43	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18797.6	B08		1	0215-0413	243.15	413.15	243	60.18	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14242.7	B08		1	0216-0413	516.77	413.09	281	62.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17124.8	B08		1	0217-0413	808.27	412.54	221	53.94	0.954
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19105.9	B08		1	0218-0414	919.87	414.30	185	55.60	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18672.3	B08		1	0219-0416	79.17	416.04	377	71.94	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15384.0	B08		1	0220-0418	163.55	418.03	252	61.36	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16927.9	B08		1	0221-0421	785.55	421.04	344	69.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15737.7	B08		1	0222-0422	409.14	422.85	249	63.01	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15469.3	B08		1	0223-0423	497.98	423.57	253	59.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16761.5	B08		1	0224-0424	532.48	424.18	237	58.04	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17582.2	B08		1	0225-0424	26.41	423.48	304	69.01	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	28042.8	B08		1	0226-0426	354.97	425.99	314	67.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21612.6	B08		1	0227-0423	871.09	422.31	179	50.87	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17374.1	B08		1	0228-0427	250.22	427.44	230	57.70	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15779.0	B08		1	0229-0430	206.78	429.65	150	48.28	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18320.1	B08		1	0230-0433	719.33	433.69	222	55.70	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18358.3	B08		1	0231-0434	267.33	434.36	214	54.28	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16244.1	B08		1	0232-0437	480.58	437.58	240	60.18	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21245.4	B08		1	0233-0440	939.21	439.67	353	68.18	0.954
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	24321.3	B08		1	0234-0439	609.39	439.19	305	65.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19752.4	B08		1	0235-0441	87.56	441.59	397	78.77	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20698.8	B08		1	0236-0444	313.31	444.10	226	55.60	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18994.5	B08		1	0237-0449	566.89	449.14	471	87.74	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15190.5	B08		1	0238-0447	895.02	446.89	305	64.18	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16150.3	B08		1	0239-0451	447.93	451.30	249	59.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19076.0	B08		1	0240-0452	203.76	451.83	338	69.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15615.3	B08		1	0241-0452	707.34	452.53	248	58.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12984.5	B08		1	0242-0455	138.82	455.82	272	61.11	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15280.1	B08		1	0243-0455	169.80	454.52	249	57.94	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16523.5	B08		1	0244-0455	764.11	454.42	229	57.60	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19017.2	B08		1	0245-0460	338.08	460.12	261	59.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15574.2	B08		1	0246-0458	522.70	457.57	260	71.36	0.642
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15944.3	B08		1	0247-0462	684.36	462.23	245	58.53	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23950.6	B08		1	0248-0461	929.63	463.41	105	54.28	0.448
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16339.8	B08		1	0249-0463	266.08	463.29	234	56.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16985.2	B08		1	0250-0462	371.30	462.35	222	54.28	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15348.9	B08		1	0251-0465	192.92	465.25	236	56.77	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16330.2	B08		1	0252-0469	19.74	469.00	232	58.18	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15202.9	B08		1	0253-0468	56.76	468.68	245	59.70	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22840.0	B08		1	0254-0473	454.50	473.71	359	71.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13849.1	B08		1	0255-0471	784.17	470.63	284	63.01	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13462.2	B08		1	0256-0471	889.75	471.18	283	62.28	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	25629.3	B08		1	0257-0476	110.21	476.73	284	80.67	0.548
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18244.7	B08		1	0258-0477	231.35	477.52	324	67.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19945.3	B08		1	0259-0477	939.35	477.30	305	64.18	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19960.2	B08		1	0260-0489	638.05	489.37	596	101.64	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18069.1	B08		1	0261-0485	756.79	486.02	376	71.84	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14079.9	B08		1	0262-0487	288.53	487.51	264	65.01	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15355.2	B08		1	0263-0486	314.59	485.45	245	59.94	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13521.7	B08		1	0264-0485	553.80	484.53	283	67.36	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14578.5	B08		1	0265-0484	369.54	483.67	268	64.28	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19023.0	B08		1	0266-0491	519.97	491.55	338	72.67	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18131.2	B08		1	0267-0497	99.83	497.16	370	71.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13410.5	B08		1	0268-0498	409.74	499.31	354	71.01	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12951.3	B08		1	0269-0498	872.62	499.24	184	54.18	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16416.2	B08		1	0270-0500	148.78	500.06	228	57.36	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14659.0	B08		1	0271-0503	468.71	503.63	320	68.43	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19255.2	B08		1	0272-0503	77.11	502.93	272	61.11	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13427.3	B08		1	0273-0505	268.93	504.90	270	68.43	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16628.5	B08		1	0274-0509	305.30	509.88	233	57.94	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23118.5	B08		1	0275-0517	207.07	517.49	344	71.01	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12460.4	B08		1	0276-0519	598.46	519.13	290	66.43	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16681.3	B08		1	0277-0518	854.85	517.24	228	61.11	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15524.8	B08		1	0278-0521	933.70	520.66	393	76.43	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15485.1	B08		1	0279-0520	166.61	520.71	241	58.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20259.8	B08		1	0280-0521	238.19	521.80	373	71.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18219.4	B08		1	0281-0521	411.27	521.04	435	79.26	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13262.9	B08		1	0282-0526	563.97	525.63	293	69.01	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15183.2	B08		1	0283-0522	34.32	522.15	220	58.77	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15144.4	B08		1	0284-0523	332.36	523.14	263	59.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16419.9	B08		1	0285-0523	894.77	523.05	222	57.94	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13364.4	B08		1	0286-0527	122.79	526.75	271	60.53	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11610.6	B08		1	0287-0530	535.34	531.28	286	74.67	0.645
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17060.1	B08		1	0288-0525	792.52	525.08	151	48.53	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17773.7	B08		1	0289-0529	377.36	529.29	221	54.53	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17187.0	B08		1	0290-0532	22.59	531.68	118	40.63	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23017.8	B08		1	0291-0534	849.54	533.57	281	64.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12523.5	B08		1	0292-0538	758.80	536.71	288	66.18	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15959.9	B08		1	0293-0538	190.19	539.06	304	68.43	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13636.3	B08		1	0294-0538	155.18	538.33	266	59.94	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12152.6	B08		1	0295-0540	274.52	540.55	302	67.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16249.2	B08		1	0296-0539	584.34	539.26	237	58.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16426.3	B08		1	0297-0541	34.95	541.02	186	53.11	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18994.6	B08		1	0298-0540	246.64	540.12	226	56.28	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16764.9	B08		1	0299-0540	619.66	540.31	228	56.28	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19159.0	B08		1	0300-0546	430.62	546.55	216	53.70	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15018.9	B08		1	0301-0550	48.08	551.22	273	61.11	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19977.4	B08		1	0302-0555	646.66	554.99	394	76.43	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13589.0	B08		1	0303-0551	880.94	551.27	291	63.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20506.7	B08		1	0304-0553	813.38	553.13	188	52.53	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17750.9	B08		1	0305-0557	216.26	557.91	246	60.53	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20803.0	B08		1	0306-0557	115.55	556.04	350	73.01	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17077.2	B08		1	0307-0557	241.89	557.57	344	69.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22400.9	B08		1	0308-0559	407.13	559.18	323	69.01	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16758.6	B08		1	0309-0560	168.93	559.78	333	71.50	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15090.6	B08		1	0310-0556	922.23	556.72	246	58.87	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19809.3	B08		1	0311-0559	458.31	559.38	200	54.53	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15759.7	B08		1	0312-0561	942.12	561.30	280	61.70	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12391.5	B08		1	0313-0565	523.32	564.27	301	67.94	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12611.9	B08		1	0314-0566	762.34	565.33	293	71.50	0.720
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20300.4	B08		1	0315-0564	798.47	565.28	374	85.84	0.638
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16707.8	B08		1	0316-0567	437.78	566.43	249	59.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19271.2	B08		1	0317-0573	192.43	574.30	411	84.33	0.726
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13871.5	B08		1	0318-0569	601.57	568.93	289	69.26	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21419.5	B08		1	0319-0570	381.08	570.75	320	65.60	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16278.5	B08		1	0320-0576	233.09	576.66	252	63.36	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	25802.4	B08		1	0321-0575	697.19	575.95	224	56.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21586.7	B08		1	0322-0580	545.77	580.03	344	71.60	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12790.2	B08		1	0323-0577	251.94	576.50	225	55.36	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16040.6	B08		1	0324-0581	58.38	582.52	240	63.60	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13750.5	B08		1	0325-0583	630.98	583.13	273	65.01	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16190.9	B08		1	0326-0585	565.54	585.96	451	83.01	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13883.4	B08		1	0327-0581	463.23	580.17	265	65.11	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17930.3	B08		1	0328-0585	265.66	585.19	263	65.01	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15820.6	B08		1	0329-0588	28.86	587.78	250	61.26	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20990.6	B08		1	0330-0593	115.61	594.13	357	70.18	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14600.8	B08		1	0331-0591	593.95	590.81	268	66.67	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18762.6	B08		1	0332-0591	143.19	591.45	241	57.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15028.1	B08		1	0333-0592	225.25	592.21	260	62.53	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13828.2	B08		1	0334-0594	384.87	594.79	297	66.18	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20549.0	B08		1	0335-0597	284.93	597.01	365	71.26	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16834.2	B08		1	0336-0594	674.84	594.10	229	56.53	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22337.1	B08		1	0337-0592	712.12	592.96	178	51.21	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13542.4	B08		1	0338-0605	414.43	604.17	293	66.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17267.1	B08		1	0339-0605	806.30	605.10	223	55.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16963.7	B08		1	0340-0607	592.13	607.88	231	55.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16223.0	B08		1	0341-0609	744.09	608.82	287	62.77	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15142.2	B08		1	0342-0611	273.89	611.90	251	60.77	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15034.0	B08		1	0343-0612	849.76	611.86	288	65.01	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19958.3	B08		1	0344-0613	153.75	612.82	195	55.36	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16641.3	B08		1	0345-0614	302.75	614.32	232	55.70	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14700.3	B08		1	0346-0616	76.07	616.27	260	59.94	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19453.7	B08		1	0347-0618	198.86	617.72	200	57.60	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22083.8	B08		1	0348-0616	901.75	616.17	251	59.94	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15127.3	B08		1	0349-0620	479.57	620.33	262	63.01	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22641.1	B08		1	0350-0619	681.57	619.71	274	61.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23283.1	B08		1	0351-0623	362.48	623.47	330	71.36	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15620.2	B08		1	0352-0630	892.17	629.37	254	61.01	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14358.7	B08		1	0353-0630	162.83	629.67	272	62.53	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19597.2	B08		1	0354-0629	806.37	629.13	187	53.70	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22483.9	B08		1	0355-0635	848.75	635.77	360	72.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13374.6	B08		1	0356-0634	489.75	634.91	317	71.84	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15548.2	B08		1	0357-0634	93.78	634.92	259	59.60	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19435.5	B08		1	0358-0636	243.32	636.51	374	72.67	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18832.7	B08		1	0359-0638	562.17	638.24	302	63.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16127.3	B08		1	0360-0642	508.02	640.75	239	59.60	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13917.0	B08		1	0361-0644	63.05	643.58	112	40.28	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16896.6	B08		1	0362-0644	693.93	644.85	228	56.87	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14488.2	B08		1	0363-0647	734.79	647.28	278	62.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17231.9	B08		1	0364-0650	783.99	651.00	192	58.53	0.704
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15104.1	B08		1	0365-0650	313.67	650.57	254	60.77	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14663.5	B08		1	0366-0649	401.23	648.55	262	61.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	24347.7	B08		1	0367-0653	199.09	653.50	315	65.60	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17104.1	B08		1	0368-0653	447.88	652.57	345	68.77	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14991.2	B08		1	0369-0651	74.63	651.70	142	47.11	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	25665.0	B08		1	0370-0663	237.20	663.32	593	97.98	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14265.2	B08		1	0371-0654	359.27	653.72	266	61.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14774.7	B08		1	0372-0659	46.25	659.41	273	61.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20884.2	B08		1	0373-0661	180.10	661.22	361	70.43	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14152.1	B08		1	0374-0661	327.81	660.85	284	63.01	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16802.5	B08		1	0375-0662	546.66	662.74	419	79.01	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13866.8	B08		1	0376-0664	121.03	664.38	276	64.18	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16353.6	B08		1	0377-0664	659.96	664.11	233	56.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15265.9	B08		1	0378-0665	939.18	664.58	280	64.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14202.9	B08		1	0379-0673	144.32	672.28	278	65.01	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18604.0	B08		1	0380-0675	705.98	673.83	168	59.94	0.588
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18748.7	B08		1	0381-0680	166.68	679.72	399	75.84	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15516.7	B08		1	0382-0679	285.98	678.49	255	61.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14693.8	B08		1	0383-0685	536.72	684.90	266	62.53	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16809.4	B08		1	0384-0684	365.64	683.42	216	57.36	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16494.2	B08		1	0385-0685	615.32	684.80	227	56.28	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16522.9	B08		1	0386-0686	309.17	686.79	228	56.28	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15614.0	B08		1	0387-0688	428.60	688.45	236	58.53	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	24804.8	B08		1	0388-0688	264.40	688.51	320	67.11	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21189.2	B08		1	0389-0693	352.59	693.35	387	80.91	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	24636.8	B08		1	0390-0688	916.93	687.99	140	47.11	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14946.9	B08		1	0391-0691	104.52	691.01	261	62.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14909.3	B08		1	0392-0693	133.18	692.16	261	63.70	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14437.8	B08		1	0393-0693	653.79	693.70	266	61.60	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13774.5	B08		1	0394-0693	720.47	693.60	320	65.84	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17518.4	B08		1	0395-0697	50.81	697.15	422	77.26	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16571.3	B08		1	0396-0697	878.17	697.43	330	67.01	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20002.7	B08		1	0397-0697	926.54	697.25	159	47.70	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16052.0	B08		1	0398-0698	944.56	697.57	170	51.11	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12483.9	B08		1	0399-0703	691.43	704.31	281	67.26	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14814.7	B08		1	0400-0706	315.64	706.08	250	63.01	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15432.1	B08		1	0401-0708	492.58	708.06	259	65.01	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17266.7	B08		1	0402-0710	415.79	710.17	212	52.87	0.953
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184810	1375309	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14924.8	B08		1	0403-0710	233.22	710.48	313	67.11	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18046.8	B08		2	0001-0029	259.68	29.83	527	96.57	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17196.9	B08		2	0002-0033	541.09	33.64	296	71.01	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16520.9	B08		2	0003-0034	151.54	34.40	223	55.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20823.5	B08		2	0004-0036	220.81	37.59	352	74.67	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17693.4	B08		2	0005-0036	793.54	36.16	268	61.11	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14064.7	B08		2	0006-0036	936.35	36.88	247	59.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15683.2	B08		2	0007-0038	126.12	39.14	253	58.53	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21962.3	B08		2	0008-0039	584.93	39.38	349	71.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13178.7	B08		2	0009-0042	767.09	42.65	281	62.53	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14077.7	B08		2	0010-0042	828.89	42.74	279	65.60	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17234.2	B08		2	0011-0049	53.05	49.74	437	85.26	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20130.7	B08		2	0012-0047	919.83	46.92	347	72.08	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19685.9	B08		2	0013-0046	639.79	45.79	330	68.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16552.0	B08		2	0014-0047	96.27	48.60	394	79.26	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21664.5	B08		2	0015-0048	735.18	48.81	336	69.01	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13870.4	B08		2	0016-0061	412.86	62.80	586	130.95	0.429
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14648.5	B08		2	0017-0052	199.96	51.48	256	60.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15901.5	B08		2	0018-0058	900.74	58.85	226	57.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16087.8	B08		2	0019-0060	248.56	59.83	237	58.87	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13188.5	B08		2	0020-0067	388.09	66.98	509	92.33	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13778.2	B08		2	0021-0062	828.67	62.91	291	70.18	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17557.1	B08		2	0022-0068	511.07	68.64	316	64.53	0.954
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19351.4	B08		2	0023-0071	734.71	70.64	328	67.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18706.7	B08		2	0024-0068	932.37	68.17	302	64.53	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17949.6	B08		2	0025-0072	673.71	72.26	200	52.53	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19299.1	B08		2	0026-0078	847.67	78.25	315	66.18	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11664.9	B08		2	0027-0081	341.98	81.08	352	81.84	0.660
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17316.0	B08		2	0028-0086	225.89	85.71	231	56.53	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11750.7	B08		2	0029-0093	68.18	93.30	308	80.08	0.603
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17711.5	B08		2	0030-0090	920.38	89.70	417	77.50	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15538.6	B08		2	0031-0089	162.29	89.72	246	60.43	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19855.7	B08		2	0032-0093	563.27	93.05	241	57.70	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23269.4	B08		2	0033-0096	697.39	95.95	324	66.43	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14083.3	B08		2	0034-0098	37.60	98.62	268	66.18	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16330.3	B08		2	0035-0097	782.11	98.03	395	73.26	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15588.6	B08		2	0036-0095	830.61	94.67	292	64.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11465.0	B08		2	0037-0095	141.99	95.57	298	73.26	0.698
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17430.8	B08		2	0038-0097	604.69	97.28	212	55.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13034.1	B08		2	0039-0102	647.74	101.72	272	61.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16961.9	B08		2	0040-0105	174.15	103.92	313	73.50	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16314.3	B08		2	0041-0104	294.08	103.98	338	70.18	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15519.6	B08		2	0042-0104	885.71	105.02	275	63.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16339.0	B08		2	0043-0114	713.14	113.75	286	61.94	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14627.5	B08		2	0044-0114	828.93	114.14	248	58.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13134.8	B08		2	0045-0119	450.89	118.43	288	67.01	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11043.8	B08		2	0046-0122	931.96	121.35	274	80.57	0.530
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16381.4	B08		2	0047-0123	516.32	123.01	286	63.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16855.6	B08		2	0048-0122	563.25	122.04	263	59.11	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13907.4	B08		2	0049-0128	97.77	128.00	262	60.53	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15448.4	B08		2	0050-0129	42.10	128.79	231	55.36	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15040.7	B08		2	0051-0128	207.62	128.42	259	59.60	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17368.8	B08		2	0052-0133	604.70	133.19	360	70.43	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14977.5	B08		2	0053-0130	759.25	130.71	251	58.18	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17430.2	B08		2	0054-0136	72.94	136.44	208	54.28	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15343.9	B08		2	0055-0137	550.32	136.78	274	61.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17391.1	B08		2	0056-0137	777.44	137.14	222	55.11	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17553.6	B08		2	0057-0137	794.18	136.40	218	53.70	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16980.6	B08		2	0058-0145	727.37	145.32	444	78.18	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16140.9	B08		2	0059-0142	874.27	142.34	224	55.36	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14667.3	B08		2	0060-0144	934.42	143.85	249	58.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12261.7	B08		2	0061-0148	155.76	148.52	292	65.84	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15941.7	B08		2	0062-0149	33.25	149.15	222	54.77	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15082.3	B08		2	0063-0150	106.39	149.81	237	57.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18289.7	B08		2	0064-0155	200.80	155.72	393	73.60	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15112.5	B08		2	0065-0155	471.21	154.30	254	59.01	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14562.3	B08		2	0066-0154	558.32	154.44	292	63.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23756.3	B08		2	0067-0154	254.47	153.92	308	67.36	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18178.5	B08		2	0068-0160	620.04	160.01	404	74.43	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20902.8	B08		2	0069-0164	917.28	164.36	356	70.43	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16737.4	B08		2	0070-0164	175.67	164.23	215	55.36	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18463.5	B08		2	0071-0167	665.68	166.85	405	73.94	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14818.2	B08		2	0072-0167	497.26	168.27	252	60.53	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16290.9	B08		2	0073-0168	67.29	167.45	226	57.70	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18661.3	B08		2	0074-0170	262.45	170.60	324	66.18	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18966.7	B08		2	0075-0172	753.94	172.38	431	78.91	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13130.8	B08		2	0076-0173	146.52	173.59	272	67.01	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21968.5	B08		2	0077-0178	596.57	178.25	306	65.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21896.8	B08		2	0078-0182	240.50	181.00	298	71.26	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15804.8	B08		2	0079-0182	734.11	182.39	234	58.53	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14683.3	B08		2	0080-0185	187.08	185.78	241	57.70	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13588.6	B08		2	0081-0186	122.92	186.07	343	74.67	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17546.1	B08		2	0082-0188	225.70	188.67	261	62.53	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19533.4	B08		2	0083-0191	677.56	192.15	364	71.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15151.5	B08		2	0084-0189	840.43	189.39	214	53.94	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18265.2	B08		2	0085-0194	563.06	194.27	385	72.18	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19303.4	B08		2	0086-0199	890.42	197.48	769	109.64	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18159.0	B08		2	0087-0193	258.30	193.27	200	52.77	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19344.4	B08		2	0088-0195	501.35	195.42	397	73.84	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22013.7	B08		2	0089-0203	329.23	203.08	327	67.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15296.9	B08		2	0090-0201	414.67	201.15	261	61.11	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16157.8	B08		2	0091-0203	943.10	202.94	298	63.36	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20013.3	B08		2	0092-0208	723.00	207.81	312	66.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14816.9	B08		2	0093-0208	386.86	207.98	248	58.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21684.9	B08		2	0094-0215	917.90	216.26	350	78.43	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17656.4	B08		2	0095-0213	164.52	213.57	360	71.01	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21300.6	B08		2	0096-0210	456.56	209.86	212	53.60	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16965.4	B08		2	0097-0211	269.62	210.63	212	55.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13154.8	B08		2	0098-0211	832.42	210.58	239	59.70	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19147.6	B08		2	0099-0217	693.56	217.43	398	75.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16830.5	B08		2	0100-0214	756.57	214.54	358	71.01	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16278.7	B08		2	0101-0219	443.84	218.95	289	65.60	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14286.8	B08		2	0102-0222	496.94	222.16	260	62.77	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17214.3	B08		2	0103-0228	869.43	228.89	429	80.91	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14645.9	B08		2	0104-0228	674.85	228.32	255	59.94	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14550.7	B08		2	0105-0234	25.12	233.33	292	68.43	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	26163.0	B08		2	0106-0234	179.97	233.59	273	62.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	24599.5	B08		2	0107-0231	759.55	230.71	145	45.56	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	24471.6	B08		2	0108-0232	746.58	232.09	152	44.63	0.959
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17818.9	B08		2	0109-0240	201.34	240.69	354	69.60	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14369.7	B08		2	0110-0242	934.14	243.11	233	57.70	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13612.6	B08		2	0111-0246	816.39	245.60	275	63.84	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19517.4	B08		2	0112-0247	365.66	247.19	372	74.91	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14908.1	B08		2	0113-0249	780.40	249.74	260	63.01	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20398.0	B08		2	0114-0249	297.44	249.34	298	63.36	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19184.8	B08		2	0115-0256	481.04	256.10	403	83.74	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18850.7	B08		2	0116-0254	250.33	253.89	294	62.18	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19876.0	B08		2	0117-0253	66.16	253.85	295	64.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17114.1	B08		2	0118-0252	126.71	252.34	209	53.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19781.9	B08		2	0119-0259	149.90	258.96	393	73.60	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22041.8	B08		2	0120-0256	537.78	256.26	177	50.28	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22174.6	B08		2	0121-0260	519.45	260.14	348	75.84	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21534.8	B08		2	0122-0259	871.05	259.54	336	67.94	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17759.3	B08		2	0123-0261	412.65	261.32	297	64.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19309.9	B08		2	0124-0260	934.80	260.40	352	73.94	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17354.3	B08		2	0125-0264	282.78	263.77	217	55.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15843.7	B08		2	0126-0264	376.20	263.74	338	74.08	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23243.4	B08		2	0127-0265	343.44	265.30	320	66.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17157.2	B08		2	0128-0269	75.62	269.45	217	57.36	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21714.2	B08		2	0129-0270	241.05	269.89	292	63.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13755.1	B08		2	0130-0273	432.94	273.97	335	74.43	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14888.9	B08		2	0131-0274	761.98	273.08	264	64.53	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16636.9	B08		2	0132-0271	195.98	272.06	227	57.11	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14663.7	B08		2	0133-0274	687.54	274.55	410	79.60	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20158.5	B08		2	0134-0275	830.69	275.44	266	59.94	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15686.5	B08		2	0135-0277	718.89	277.48	276	60.77	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15976.0	B08		2	0136-0281	935.66	281.24	230	56.28	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14118.4	B08		2	0137-0286	67.07	286.17	261	64.18	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17442.4	B08		2	0138-0280	280.48	280.84	127	40.97	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17179.6	B08		2	0139-0289	85.91	287.86	217	55.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20732.7	B08		2	0140-0289	152.32	289.26	336	71.84	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16912.1	B08		2	0141-0293	537.38	292.84	374	74.18	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13398.4	B08		2	0142-0292	678.60	291.79	270	61.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15526.3	B08		2	0143-0296	882.82	296.27	234	59.11	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16407.2	B08		2	0144-0293	280.31	292.82	140	42.63	0.968
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18738.4	B08		2	0145-0298	40.65	298.33	181	49.94	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20163.1	B08		2	0146-0298	168.05	298.25	178	50.04	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17550.3	B08		2	0147-0303	768.05	302.95	314	67.84	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13552.3	B08		2	0148-0306	818.96	306.25	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17970.9	B08		2	0149-0306	550.67	305.06	341	76.67	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14354.4	B08		2	0150-0306	208.60	307.31	266	62.53	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16182.2	B08		2	0151-0311	33.99	311.18	233	60.18	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18866.5	B08		2	0152-0309	289.20	309.28	199	53.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15948.7	B08		2	0153-0312	18.54	312.73	229	55.70	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18199.4	B08		2	0154-0314	258.62	313.18	237	56.77	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19668.6	B08		2	0155-0313	347.76	313.31	209	54.04	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19260.9	B08		2	0156-0312	363.62	311.97	194	53.46	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15502.0	B08		2	0157-0321	490.22	320.56	399	77.84	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17096.4	B08		2	0158-0323	747.11	323.03	315	69.60	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14359.1	B08		2	0159-0324	590.58	323.80	257	62.28	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20566.5	B08		2	0160-0325	105.60	325.09	308	65.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18907.1	B08		2	0161-0327	604.71	327.85	195	52.63	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15579.7	B08		2	0162-0330	370.30	330.08	241	59.36	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13874.3	B08		2	0163-0331	246.12	331.06	328	68.77	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17059.4	B08		2	0164-0335	620.25	335.80	228	57.94	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12537.4	B08		2	0165-0338	914.11	337.65	337	69.26	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15150.2	B08		2	0166-0335	393.51	335.78	105	38.63	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23747.8	B08		2	0167-0337	227.09	336.83	153	45.11	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15709.4	B08		2	0168-0339	382.31	339.19	161	47.46	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13184.7	B08		2	0169-0342	57.86	342.30	285	70.77	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14368.4	B08		2	0170-0343	99.70	343.97	255	59.94	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13655.4	B08		2	0171-0346	464.96	346.86	304	68.77	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15613.4	B08		2	0172-0350	422.90	350.26	367	74.43	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14418.4	B08		2	0173-0355	124.11	355.02	258	62.67	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15699.7	B08		2	0174-0361	929.03	360.97	564	97.98	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15024.9	B08		2	0175-0356	543.50	355.84	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19079.5	B08		2	0176-0356	230.26	356.87	241	58.28	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15823.4	B08		2	0177-0359	656.85	359.38	304	65.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13625.9	B08		2	0178-0360	177.76	360.20	279	62.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18009.9	B08		2	0179-0359	626.60	359.51	217	54.28	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13141.9	B08		2	0180-0362	749.40	362.25	293	65.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16467.0	B08		2	0181-0365	65.16	364.96	220	57.94	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16475.0	B08		2	0182-0361	295.52	360.80	227	58.87	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19673.9	B08		2	0183-0367	321.79	367.32	204	54.53	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20915.7	B08		2	0184-0372	494.01	372.56	361	73.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17605.7	B08		2	0185-0380	438.30	380.98	434	80.33	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16339.7	B08		2	0186-0377	680.65	377.04	328	67.70	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18112.6	B08		2	0187-0378	885.68	377.64	448	79.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18844.5	B08		2	0188-0377	155.27	378.24	193	51.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17131.7	B08		2	0189-0382	203.77	382.92	217	64.08	0.664
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14447.8	B08		2	0190-0383	47.43	383.61	293	65.84	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11960.8	B08		2	0191-0389	360.18	390.60	317	79.84	0.625
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15862.6	B08		2	0192-0383	725.92	383.52	256	62.28	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22404.4	B08		2	0193-0393	183.07	392.87	351	71.84	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20880.2	B08		2	0194-0395	779.94	395.27	248	57.36	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16984.7	B08		2	0195-0398	88.89	398.15	280	63.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13656.1	B08		2	0196-0404	140.56	404.60	305	65.36	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21247.8	B08		2	0197-0408	229.43	408.85	175	51.70	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11924.1	B08		2	0198-0413	464.92	411.27	358	79.84	0.706
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13912.4	B08		2	0199-0413	926.13	412.15	263	61.70	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18851.4	B08		2	0200-0412	870.18	412.74	200	51.70	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15313.6	B08		2	0201-0419	156.19	419.70	250	65.36	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19049.0	B08		2	0202-0419	668.32	417.98	380	76.67	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14647.2	B08		2	0203-0421	113.25	420.36	310	69.84	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	466.7	B08		2	0204-0421	619.70	420.79	195	53.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11824.0	B08		2	0205-0422	731.26	421.55	354	80.91	0.680
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23613.4	B08		2	0206-0422	58.16	422.39	308	66.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12696.0	B08		2	0207-0424	694.88	425.02	328	69.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14868.8	B08		2	0208-0430	509.50	430.00	397	78.67	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17387.2	B08		2	0209-0430	238.31	430.70	262	64.43	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20221.9	B08		2	0210-0434	99.29	433.29	399	81.74	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23345.1	B08		2	0211-0432	192.14	432.66	306	64.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10280.3	B08		2	0212-0433	630.83	432.85	278	61.60	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16567.9	B08		2	0213-0434	768.89	433.81	220	57.46	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17313.9	B08		2	0214-0435	782.32	434.83	214	54.63	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16043.5	B08		2	0215-0442	809.55	442.16	233	61.11	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21123.4	B08		2	0216-0443	32.31	443.20	349	69.01	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16688.7	B08		2	0217-0446	937.21	447.18	437	81.26	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16127.2	B08		2	0218-0440	881.26	440.24	239	59.11	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13882.9	B08		2	0219-0442	399.14	441.87	294	65.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18267.1	B08		2	0220-0443	117.82	442.56	192	53.11	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18013.8	B08		2	0221-0451	573.60	451.88	375	84.08	0.667
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15360.5	B08		2	0222-0455	172.70	455.66	538	97.15	0.716
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15791.9	B08		2	0223-0447	159.35	447.29	107	39.11	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13883.6	B08		2	0224-0452	504.40	453.06	294	70.43	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17358.2	B08		2	0225-0451	248.87	451.17	219	59.70	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14236.4	B08		2	0226-0460	434.28	461.51	361	74.91	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14358.4	B08		2	0227-0453	465.39	453.60	198	58.63	0.724
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15206.9	B08		2	0228-0457	762.01	457.02	269	63.36	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16642.6	B08		2	0229-0458	127.88	457.68	242	60.18	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17715.8	B08		2	0230-0458	310.68	458.39	250	59.11	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18964.6	B08		2	0231-0464	534.43	464.78	362	73.84	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	26660.1	B08		2	0232-0465	15.86	463.09	121	65.11	0.359
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15133.8	B08		2	0233-0469	221.42	470.41	351	69.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22218.1	B08		2	0234-0470	858.17	471.00	295	63.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	24522.6	B08		2	0235-0474	776.93	473.51	149	46.87	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20068.0	B08		2	0236-0481	32.34	481.04	295	63.36	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15313.4	B08		2	0237-0480	596.84	479.91	259	59.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21071.6	B08		2	0238-0481	712.94	481.18	237	56.28	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15996.8	B08		2	0239-0481	811.78	481.81	243	57.36	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17279.7	B08		2	0240-0482	346.62	482.36	157	46.87	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17168.1	B08		2	0241-0485	334.30	485.46	209	58.04	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11135.9	B08		2	0242-0487	401.77	486.60	330	85.98	0.561
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	27048.1	B08		2	0243-0484	794.52	484.85	134	44.04	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16860.4	B08		2	0244-0490	268.59	489.77	219	55.70	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14728.1	B08		2	0245-0495	739.34	495.18	514	90.91	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12583.8	B08		2	0246-0489	873.21	488.82	152	47.70	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18260.0	B08		2	0247-0496	912.94	496.14	442	88.57	0.708
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14906.3	B08		2	0248-0498	569.45	497.41	356	72.77	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14302.5	B08		2	0249-0496	153.46	496.54	305	63.36	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18379.6	B08		2	0250-0496	181.71	495.69	317	65.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15382.2	B08		2	0251-0495	689.16	495.01	254	63.36	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12511.5	B08		2	0252-0495	883.61	495.94	150	46.28	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16996.8	B08		2	0253-0508	654.92	508.22	408	73.94	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15913.3	B08		2	0254-0509	417.01	509.34	242	57.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13097.3	B08		2	0255-0512	221.16	512.13	295	65.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18975.2	B08		2	0256-0512	503.00	512.88	347	68.18	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12654.7	B08		2	0257-0517	108.91	517.87	304	71.26	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17215.1	B08		2	0258-0518	598.24	518.38	446	79.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15695.6	B08		2	0259-0519	266.95	518.57	261	62.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14944.3	B08		2	0260-0516	810.10	516.24	257	60.53	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17530.8	B08		2	0261-0516	901.90	515.64	216	56.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16960.4	B08		2	0262-0520	54.58	519.61	347	69.26	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19344.4	B08		2	0263-0517	693.80	518.29	260	60.28	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15217.1	B08		2	0264-0524	26.70	524.17	391	76.77	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12972.8	B08		2	0265-0524	292.11	523.96	313	66.18	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13236.2	B08		2	0266-0527	129.44	527.45	284	64.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19120.1	B08		2	0267-0528	464.51	528.09	334	68.08	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17389.8	B08		2	0268-0527	331.11	526.84	215	55.94	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13567.1	B08		2	0269-0529	767.18	529.22	288	65.11	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18930.8	B08		2	0270-0535	741.89	534.71	357	70.08	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12305.1	B08		2	0271-0534	170.99	534.05	301	68.77	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17147.6	B08		2	0272-0534	898.09	534.73	223	54.77	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20272.7	B08		2	0273-0537	371.82	537.32	366	71.01	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19507.1	B08		2	0274-0537	692.61	537.02	392	78.18	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14289.9	B08		2	0275-0539	311.64	538.90	281	63.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14209.9	B08		2	0276-0540	807.08	541.01	261	62.53	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15926.2	B08		2	0277-0547	92.38	547.24	225	55.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17025.5	B08		2	0278-0551	216.53	551.61	221	54.28	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22192.4	B08		2	0279-0554	258.15	553.87	246	59.11	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15011.7	B08		2	0280-0553	701.75	552.83	276	66.43	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17091.4	B08		2	0281-0560	189.67	560.55	376	75.36	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10784.2	B08		2	0282-0556	419.16	556.52	241	76.67	0.515
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17296.3	B08		2	0283-0557	573.40	556.84	232	56.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	28362.2	B08		2	0284-0561	395.29	560.88	517	89.84	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16386.4	B08		2	0285-0557	489.28	557.20	298	73.60	0.691
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21304.8	B08		2	0286-0561	684.81	560.97	284	62.53	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14719.7	B08		2	0287-0563	53.34	564.04	254	64.77	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15691.2	B08		2	0288-0564	34.75	564.91	277	61.11	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14361.0	B08		2	0289-0564	800.42	563.66	262	62.43	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14907.5	B08		2	0290-0565	132.69	565.45	282	60.77	0.960
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14641.6	B08		2	0291-0569	298.45	569.75	305	66.77	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14304.8	B08		2	0292-0566	734.45	566.03	160	46.63	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13628.9	B08		2	0293-0572	546.80	572.13	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13612.5	B08		2	0294-0567	721.99	567.97	117	40.39	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14817.3	B08		2	0295-0569	337.10	569.57	268	62.77	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15520.4	B08		2	0296-0578	823.42	578.32	245	60.18	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16701.6	B08		2	0297-0576	861.26	576.46	224	58.77	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18210.0	B08		2	0298-0582	740.73	581.99	369	77.26	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15730.4	B08		2	0299-0583	563.98	583.98	248	59.46	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17368.1	B08		2	0300-0586	173.73	586.22	307	65.36	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15894.1	B08		2	0301-0583	658.97	583.84	245	57.11	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15413.0	B08		2	0302-0585	793.90	585.11	248	58.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12915.4	B08		2	0303-0590	227.90	590.27	281	63.11	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21476.3	B08		2	0304-0591	99.57	591.34	294	62.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18754.9	B08		2	0305-0593	505.03	593.37	339	69.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16867.7	B08		2	0306-0592	593.21	591.77	223	56.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18086.5	B08		2	0307-0597	133.78	597.69	338	71.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19141.2	B08		2	0308-0597	75.00	597.76	377	73.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14301.4	B08		2	0309-0598	764.49	598.03	268	61.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18650.2	B08		2	0310-0602	262.69	602.14	245	58.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13058.1	B08		2	0311-0603	370.78	603.27	328	68.53	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15839.4	B08		2	0312-0610	883.28	609.88	539	91.15	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22389.2	B08		2	0313-0609	585.95	609.56	224	57.01	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17310.0	B08		2	0314-0613	841.15	613.76	411	79.26	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17302.8	B08		2	0315-0612	936.63	612.62	227	55.94	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14545.3	B08		2	0316-0617	288.69	617.92	377	74.77	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15445.8	B08		2	0317-0614	609.59	615.13	257	63.60	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14638.3	B08		2	0318-0620	799.21	619.85	258	64.28	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13851.9	B08		2	0319-0620	96.60	619.31	283	61.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17645.5	B08		2	0320-0622	162.75	622.53	248	60.28	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22849.4	B08		2	0321-0633	664.99	632.93	460	84.43	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	26636.2	B08		2	0322-0636	342.57	636.72	552	91.50	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	26014.3	B08		2	0323-0632	681.91	632.43	285	65.94	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18569.7	B08		2	0324-0636	909.48	635.73	392	75.84	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14084.4	B08		2	0325-0637	212.47	637.09	316	74.08	0.724
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17790.5	B08		2	0326-0639	419.96	639.41	505	90.57	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22523.7	B08		2	0327-0635	300.04	635.24	160	46.87	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22729.2	B08		2	0328-0634	311.80	633.78	111	39.56	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19301.4	B08		2	0329-0639	774.09	638.73	357	70.43	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13527.6	B08		2	0330-0640	47.64	639.90	268	61.01	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16647.0	B08		2	0331-0644	575.29	645.64	468	86.33	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14111.5	B08		2	0332-0637	497.09	637.30	111	40.04	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17589.2	B08		2	0333-0645	364.75	645.34	289	61.94	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16608.7	B08		2	0334-0652	503.38	652.97	353	73.01	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16302.1	B08		2	0335-0651	433.80	651.83	219	56.77	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21872.6	B08		2	0336-0656	474.14	655.54	417	82.91	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17154.1	B08		2	0337-0653	132.62	653.87	156	47.21	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18611.1	B08		2	0338-0660	148.53	660.75	228	58.53	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18516.8	B08		2	0339-0665	873.42	665.35	320	67.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15969.5	B08		2	0340-0664	794.21	664.84	230	54.77	0.964
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17293.2	B08		2	0341-0664	345.09	664.25	223	59.70	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15540.3	B08		2	0342-0668	31.79	668.05	280	65.60	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17460.5	B08		2	0343-0666	133.65	665.65	163	48.04	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16981.5	B08		2	0344-0673	488.29	673.97	375	76.77	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19210.0	B08		2	0345-0677	471.11	677.26	388	79.26	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19092.9	B08		2	0346-0674	676.26	675.27	352	69.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12566.6	B08		2	0347-0682	833.49	682.02	319	71.60	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14416.3	B08		2	0348-0681	177.91	682.12	282	64.43	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17923.8	B08		2	0349-0684	536.57	684.33	210	54.28	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23615.6	B08		2	0350-0684	270.18	683.97	243	59.11	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16582.7	B08		2	0351-0692	297.50	692.96	233	58.53	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19296.7	B08		2	0352-0688	897.09	688.15	191	53.94	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15874.4	B08		2	0353-0692	388.37	692.13	236	57.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19010.1	B08		2	0354-0695	559.28	695.50	349	71.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12044.8	B08		2	0355-0695	83.03	695.50	268	60.53	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16293.7	B08		2	0356-0697	649.23	697.13	455	80.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16919.0	B08		2	0357-0696	766.83	695.63	319	67.01	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21054.4	B08		2	0358-0700	19.22	700.80	156	47.46	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12691.7	B08		2	0359-0704	105.76	704.14	283	68.08	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14405.9	B08		2	0360-0701	846.09	700.80	249	58.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20680.1	B08		2	0361-0702	620.75	701.43	199	53.11	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16207.0	B08		2	0362-0702	37.15	701.76	192	53.11	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16744.9	B08		2	0363-0704	937.46	703.67	299	63.84	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13011.7	B08		2	0364-0708	355.31	708.03	272	62.53	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22491.0	B08		2	0365-0708	207.17	708.01	325	66.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15101.5	B08		2	0366-0708	440.81	708.12	253	58.77	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184811	1375310	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12102.6	B08		2	0367-0710	121.34	709.93	207	56.53	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15238.0	B08		3	0001-0032	174.22	32.04	249	67.01	0.697
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13907.8	B08		3	0002-0031	771.20	30.98	281	63.11	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14241.0	B08		3	0003-0035	76.25	35.00	272	62.53	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15491.6	B08		3	0004-0037	608.80	37.00	478	85.15	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22608.5	B08		3	0005-0036	648.22	35.64	324	66.18	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17157.4	B08		3	0006-0041	489.76	40.64	488	83.98	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14240.8	B08		3	0007-0040	30.61	40.30	250	60.18	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17167.1	B08		3	0008-0043	704.69	44.35	231	60.87	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15993.7	B08		3	0009-0047	530.33	47.51	250	59.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17278.2	B08		3	0010-0054	456.56	54.71	277	61.36	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19829.2	B08		3	0011-0058	476.96	59.41	445	79.50	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21778.8	B08		3	0012-0058	93.16	59.16	330	67.36	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15268.9	B08		3	0013-0055	207.76	54.54	245	60.77	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15077.6	B08		3	0014-0057	753.82	57.12	256	65.70	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20628.2	B08		3	0015-0060	911.18	59.84	358	69.01	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17127.8	B08		3	0016-0062	426.79	61.94	262	59.84	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13232.7	B08		3	0017-0064	817.54	63.85	291	69.60	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17171.6	B08		3	0018-0062	151.02	62.27	218	57.36	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16636.3	B08		3	0019-0063	563.29	63.40	270	65.01	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	26402.5	B08		3	0020-0064	397.98	64.32	303	69.70	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23235.6	B08		3	0021-0069	373.29	69.18	358	74.43	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	24121.5	B08		3	0022-0070	444.27	70.30	315	71.01	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14602.8	B08		3	0023-0071	685.11	71.36	324	67.36	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19100.3	B08		3	0024-0071	26.79	71.61	292	63.94	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19108.2	B08		3	0025-0078	63.72	77.41	368	76.08	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17390.9	B08		3	0026-0077	152.86	78.01	324	68.18	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14740.8	B08		3	0027-0076	180.82	77.29	251	61.01	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16423.2	B08		3	0028-0084	869.55	83.92	383	84.18	0.679
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17518.5	B08		3	0029-0081	349.15	80.59	353	70.18	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18421.5	B08		3	0030-0079	97.96	78.72	198	53.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14470.1	B08		3	0031-0081	595.59	80.53	323	70.18	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14571.1	B08		3	0032-0080	291.88	80.04	261	59.60	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14501.8	B08		3	0033-0079	750.97	79.77	269	64.43	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20198.8	B08		3	0034-0082	330.41	82.15	181	54.63	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14638.5	B08		3	0035-0087	940.87	86.52	272	61.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21331.4	B08		3	0036-0088	373.60	88.65	217	53.36	0.958
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16080.8	B08		3	0037-0092	638.43	92.74	241	59.60	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18319.8	B08		3	0038-0091	398.46	91.50	215	55.36	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15380.3	B08		3	0039-0093	565.31	92.96	263	62.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15157.4	B08		3	0040-0098	497.76	98.43	517	84.08	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13458.7	B08		3	0041-0094	191.15	94.77	294	63.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17888.7	B08		3	0042-0099	838.70	99.71	305	67.36	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14260.4	B08		3	0043-0098	448.56	98.24	272	63.01	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15307.3	B08		3	0044-0099	241.85	98.73	246	58.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12453.8	B08		3	0045-0103	791.31	103.40	351	70.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18278.6	B08		3	0046-0107	332.07	106.69	355	72.18	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13691.0	B08		3	0047-0105	545.14	104.91	297	63.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20100.3	B08		3	0048-0109	816.08	108.63	189	55.36	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21772.6	B08		3	0049-0110	101.79	110.50	272	61.60	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19084.7	B08		3	0050-0111	216.70	110.96	304	65.01	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13762.8	B08		3	0051-0111	413.08	111.64	277	62.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21890.6	B08		3	0052-0114	920.64	114.63	335	66.77	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	24413.1	B08		3	0053-0117	699.14	116.59	301	64.18	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14828.5	B08		3	0054-0123	493.78	122.81	262	60.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11109.2	B08		3	0055-0125	27.26	124.27	249	74.91	0.558
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13756.6	B08		3	0056-0124	546.77	125.24	276	65.01	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18964.5	B08		3	0057-0125	448.58	125.20	208	55.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17450.7	B08		3	0058-0133	739.38	133.47	362	84.67	0.635
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15167.4	B08		3	0059-0131	145.90	131.35	332	68.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17204.7	B08		3	0060-0134	207.45	132.73	501	95.74	0.687
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16072.7	B08		3	0061-0135	350.90	134.26	255	58.77	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17108.9	B08		3	0062-0136	872.25	136.23	326	66.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16862.3	B08		3	0063-0136	625.52	136.69	299	63.11	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	24610.1	B08		3	0064-0147	169.60	147.13	413	77.50	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14128.6	B08		3	0065-0144	487.88	143.45	271	61.60	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16614.6	B08		3	0066-0143	536.82	142.94	241	59.36	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	24727.2	B08		3	0067-0146	275.38	145.38	227	58.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14852.5	B08		3	0068-0147	28.95	147.38	243	58.18	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18462.6	B08		3	0069-0153	309.34	153.10	345	69.84	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22427.1	B08		3	0070-0156	204.86	155.46	204	92.81	0.298
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15003.4	B08		3	0071-0156	387.05	156.20	257	60.53	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16896.5	B08		3	0072-0155	469.56	155.29	230	58.77	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13863.8	B08		3	0073-0154	646.67	152.89	117	43.11	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11184.3	B08		3	0074-0160	722.52	160.55	319	75.50	0.703
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15040.5	B08		3	0075-0159	637.21	159.56	218	57.60	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16929.6	B08		3	0076-0159	779.82	159.08	225	56.28	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19760.0	B08		3	0077-0162	914.86	162.86	346	71.84	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19014.2	B08		3	0078-0167	815.28	167.59	368	75.60	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19396.7	B08		3	0079-0169	271.03	171.52	394	86.33	0.664
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17691.0	B08		3	0080-0168	751.03	167.95	468	85.15	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17965.4	B08		3	0081-0169	186.94	169.00	201	54.53	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17753.5	B08		3	0082-0167	695.55	166.22	183	51.94	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15223.7	B08		3	0083-0170	509.31	169.78	270	61.94	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20664.8	B08		3	0084-0175	838.62	175.55	367	82.08	0.684
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18083.1	B08		3	0085-0171	483.51	171.08	214	55.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16911.6	B08		3	0086-0172	684.74	173.33	136	44.53	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19049.1	B08		3	0087-0178	314.28	178.44	403	76.33	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17475.2	B08		3	0088-0177	66.17	177.18	206	53.70	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17956.4	B08		3	0089-0177	102.73	176.82	203	53.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15207.6	B08		3	0090-0179	253.70	178.90	239	63.60	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16913.5	B08		3	0091-0179	554.12	179.02	349	69.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23745.2	B08		3	0092-0179	444.19	179.66	221	53.11	0.984
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21238.2	B08		3	0093-0183	621.51	182.60	365	70.18	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16010.8	B08		3	0094-0185	210.48	185.09	250	60.18	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18325.8	B08		3	0095-0190	876.28	190.12	404	75.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16936.8	B08		3	0096-0188	297.16	188.57	244	58.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19846.6	B08		3	0097-0188	370.51	188.18	292	67.60	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22187.7	B08		3	0098-0188	48.45	188.21	160	46.87	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18234.9	B08		3	0099-0191	339.92	191.37	276	61.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16624.6	B08		3	0100-0196	594.81	196.46	314	68.18	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19313.9	B08		3	0101-0199	914.47	198.34	298	66.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13437.7	B08		3	0102-0199	146.75	199.92	273	65.84	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17856.4	B08		3	0103-0202	173.10	202.21	303	65.84	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18277.5	B08		3	0104-0201	280.82	200.74	205	55.11	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17277.8	B08		3	0105-0203	402.51	203.32	287	61.94	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	25438.4	B08		3	0106-0203	628.31	203.10	297	63.01	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20255.9	B08		3	0107-0204	366.33	204.23	184	51.11	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16302.9	B08		3	0108-0207	37.62	206.55	290	63.70	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15257.0	B08		3	0109-0207	893.74	207.76	249	60.43	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15740.6	B08		3	0110-0207	239.23	207.31	240	58.77	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14090.1	B08		3	0111-0208	948.07	208.67	267	60.43	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15902.2	B08		3	0112-0208	75.39	208.20	233	55.94	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15039.4	B08		3	0113-0209	551.99	209.65	257	59.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15994.4	B08		3	0114-0215	332.77	214.78	256	62.18	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19216.0	B08		3	0115-0220	115.19	220.15	386	74.43	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19630.2	B08		3	0116-0222	660.54	222.51	396	76.43	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13507.1	B08		3	0117-0219	850.80	219.39	168	53.36	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17051.6	B08		3	0118-0219	712.14	219.64	223	54.28	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15560.1	B08		3	0119-0221	286.32	222.07	258	61.01	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16744.4	B08		3	0120-0221	794.26	222.20	231	66.43	0.658
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21995.3	B08		3	0121-0224	354.14	224.73	337	69.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	24259.0	B08		3	0122-0224	369.58	223.65	158	48.87	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20491.9	B08		3	0123-0227	613.88	227.23	233	58.28	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	25980.6	B08		3	0124-0231	675.39	231.75	274	66.77	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23464.5	B08		3	0125-0237	219.89	236.54	310	68.18	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15715.4	B08		3	0126-0234	892.81	234.08	245	57.94	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22595.4	B08		3	0127-0238	828.42	238.70	314	66.18	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17783.0	B08		3	0128-0240	750.33	241.09	427	77.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14475.9	B08		3	0129-0243	411.02	244.58	306	68.18	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20811.9	B08		3	0130-0240	546.09	240.52	318	66.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	24978.3	B08		3	0131-0244	566.82	244.27	300	64.18	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20533.3	B08		3	0132-0242	609.87	242.66	240	57.11	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14986.8	B08		3	0133-0246	923.15	246.57	256	64.18	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14437.3	B08		3	0134-0246	28.55	246.73	236	58.04	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15109.6	B08		3	0135-0247	204.55	247.05	275	63.94	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11763.6	B08		3	0136-0246	363.41	246.31	316	80.08	0.619
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15152.8	B08		3	0137-0249	494.35	248.84	250	59.26	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12031.4	B08		3	0138-0250	706.94	250.18	191	58.77	0.695
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14935.5	B08		3	0139-0256	100.15	256.98	240	66.53	0.681
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16521.7	B08		3	0140-0254	524.48	253.29	231	58.77	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	507.5	B08		3	0141-0252	723.12	252.69	191	51.11	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16566.6	B08		3	0142-0256	140.11	256.38	229	57.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17675.5	B08		3	0143-0257	158.04	257.32	212	57.36	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15248.7	B08		3	0144-0254	74.64	253.97	230	58.28	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18689.1	B08		3	0145-0256	307.56	255.86	206	54.28	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15004.9	B08		3	0146-0258	260.05	258.96	250	60.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14271.0	B08		3	0147-0265	589.80	263.58	278	65.94	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19229.8	B08		3	0148-0264	29.42	263.98	343	71.94	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14594.2	B08		3	0149-0269	464.95	269.24	284	64.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18003.0	B08		3	0150-0269	534.17	268.97	227	55.94	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20325.9	B08		3	0151-0271	775.21	271.35	302	65.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16053.4	B08		3	0152-0270	794.95	271.04	250	58.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11865.2	B08		3	0153-0275	631.78	274.75	307	69.60	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13617.5	B08		3	0154-0278	240.09	278.70	298	65.01	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20541.9	B08		3	0155-0278	841.64	278.32	175	52.18	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15594.5	B08		3	0156-0281	88.55	280.69	227	57.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17247.1	B08		3	0157-0279	735.63	279.66	312	67.01	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14332.1	B08		3	0158-0283	395.38	282.92	275	65.01	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15426.2	B08		3	0159-0286	274.36	287.66	322	67.60	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16170.7	B08		3	0160-0284	30.22	284.54	225	56.53	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12989.8	B08		3	0161-0286	122.17	287.01	279	63.60	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20698.9	B08		3	0162-0291	459.86	291.26	412	79.26	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21119.4	B08		3	0163-0287	941.61	287.60	362	71.60	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15176.3	B08		3	0164-0287	359.90	286.65	248	65.26	0.732
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14615.7	B08		3	0165-0289	160.78	289.29	255	58.53	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15153.5	B08		3	0166-0289	181.17	289.44	248	59.36	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19654.5	B08		3	0167-0292	833.48	292.34	404	76.67	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17745.0	B08		3	0168-0290	660.97	290.34	213	55.11	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14680.6	B08		3	0169-0292	813.19	291.83	258	64.18	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16124.7	B08		3	0170-0296	420.18	296.51	238	58.28	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16008.9	B08		3	0171-0295	676.56	294.96	235	58.28	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14122.4	B08		3	0172-0301	925.83	300.69	304	66.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18461.7	B08		3	0173-0301	883.05	301.44	343	68.43	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18180.4	B08		3	0174-0301	219.00	301.60	201	56.18	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21153.4	B08		3	0175-0309	106.17	309.78	331	67.84	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15609.2	B08		3	0176-0311	136.06	311.08	235	57.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12142.2	B08		3	0177-0315	459.87	315.36	306	67.84	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21002.8	B08		3	0178-0315	584.40	314.75	368	70.53	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19995.8	B08		3	0179-0316	734.41	316.36	369	73.84	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16056.4	B08		3	0180-0316	187.10	316.32	224	54.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16270.1	B08		3	0181-0318	254.15	318.24	231	57.94	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15169.6	B08		3	0182-0318	651.34	318.24	294	63.94	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17746.7	B08		3	0183-0323	410.89	322.62	364	73.84	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	26126.0	B08		3	0184-0329	875.26	329.64	266	60.18	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17690.6	B08		3	0185-0328	286.92	328.69	215	53.70	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12140.1	B08		3	0186-0335	804.34	336.40	317	70.67	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21422.7	B08		3	0187-0334	360.46	334.07	193	51.11	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19331.2	B08		3	0188-0335	387.43	335.21	269	61.36	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12537.0	B08		3	0189-0335	536.82	335.92	294	64.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22054.8	B08		3	0190-0335	204.81	335.14	228	55.11	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22598.5	B08		3	0191-0338	650.73	337.72	323	67.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21505.5	B08		3	0192-0339	346.72	339.63	174	52.28	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17289.5	B08		3	0193-0341	725.24	341.64	215	54.28	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15401.9	B08		3	0194-0346	243.63	345.99	277	63.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17185.1	B08		3	0195-0345	317.67	345.39	210	58.77	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16042.1	B08		3	0196-0343	107.28	343.76	273	64.18	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13874.3	B08		3	0197-0344	608.80	343.82	285	64.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20154.5	B08		3	0198-0353	291.95	352.69	379	72.43	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16607.0	B08		3	0199-0354	331.61	354.07	229	56.87	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18564.8	B08		3	0200-0355	425.40	355.58	273	62.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18080.2	B08		3	0201-0355	828.37	355.45	372	72.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17723.9	B08		3	0202-0356	19.52	356.46	186	52.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16463.1	B08		3	0203-0358	179.96	357.71	224	55.70	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17669.5	B08		3	0204-0356	347.30	355.98	226	56.87	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16945.5	B08		3	0205-0356	452.60	356.90	253	59.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19299.3	B08		3	0206-0359	402.75	359.21	322	65.94	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17064.4	B08		3	0207-0355	684.95	355.37	203	55.70	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14204.7	B08		3	0208-0357	483.80	358.09	169	51.11	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	24106.7	B08		3	0209-0358	112.39	358.32	148	45.46	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12250.6	B08		3	0210-0367	589.51	368.23	600	167.82	0.268
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22460.0	B08		3	0211-0365	513.79	364.74	343	70.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12773.6	B08		3	0212-0362	928.13	361.92	149	49.70	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15959.9	B08		3	0213-0365	165.18	365.39	230	59.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14498.3	B08		3	0214-0369	26.07	370.68	286	71.01	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19846.8	B08		3	0215-0367	315.45	367.37	307	66.43	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23684.0	B08		3	0216-0367	651.27	367.38	319	68.18	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17714.8	B08		3	0217-0371	910.25	370.76	309	70.43	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18939.6	B08		3	0218-0371	875.06	370.77	305	66.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17456.9	B08		3	0219-0371	374.83	371.79	255	60.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22020.8	B08		3	0220-0374	263.29	374.75	348	71.26	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13542.7	B08		3	0221-0377	712.73	377.14	273	63.36	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13820.8	B08		3	0222-0379	762.43	379.09	281	65.01	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17013.3	B08		3	0223-0379	841.85	379.72	226	58.77	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13648.2	B08		3	0224-0379	147.84	379.00	276	64.77	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14308.7	B08		3	0225-0383	54.65	383.69	298	68.18	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14589.9	B08		3	0226-0382	546.20	382.45	304	65.36	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16998.9	B08		3	0227-0383	352.41	382.21	226	57.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15628.1	B08		3	0228-0382	503.03	382.35	258	60.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16655.3	B08		3	0229-0382	89.21	382.66	219	53.70	0.954
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17866.1	B08		3	0230-0384	103.89	384.05	200	57.11	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16582.6	B08		3	0231-0384	685.58	384.47	259	60.28	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18517.8	B08		3	0232-0389	133.82	389.88	204	54.18	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16577.2	B08		3	0233-0392	335.87	392.05	229	61.11	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20478.7	B08		3	0234-0397	943.98	397.69	349	70.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12957.2	B08		3	0235-0396	248.74	396.06	266	64.77	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16572.2	B08		3	0236-0399	358.81	399.31	264	63.01	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12445.6	B08		3	0237-0396	400.64	395.69	284	70.77	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21190.1	B08		3	0238-0401	869.31	401.46	353	70.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21716.5	B08		3	0239-0399	477.95	398.80	152	47.46	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18335.3	B08		3	0240-0400	688.60	398.59	162	49.70	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17573.4	B08		3	0241-0409	450.59	409.76	472	81.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17008.6	B08		3	0242-0406	677.98	406.95	201	54.43	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13765.8	B08		3	0243-0410	59.30	410.76	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17737.2	B08		3	0244-0410	326.43	410.31	290	64.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16027.4	B08		3	0245-0411	187.48	411.62	229	59.01	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15233.1	B08		3	0246-0411	814.94	410.92	258	64.18	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15063.7	B08		3	0247-0413	918.78	412.65	255	61.01	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23310.0	B08		3	0248-0420	645.90	419.43	683	107.30	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18898.0	B08		3	0249-0418	594.22	418.68	419	80.33	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15464.5	B08		3	0250-0418	709.45	418.12	500	89.98	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13473.9	B08		3	0251-0416	20.37	415.64	244	59.36	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16368.6	B08		3	0252-0418	237.53	417.22	230	59.01	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16375.1	B08		3	0253-0418	369.35	417.47	296	64.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17566.7	B08		3	0254-0418	210.59	417.84	204	54.77	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20007.6	B08		3	0255-0419	164.81	418.96	326	69.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19893.5	B08		3	0256-0421	283.97	421.68	294	63.01	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15078.3	B08		3	0257-0425	308.25	424.38	257	60.53	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17274.0	B08		3	0258-0428	786.09	428.42	228	56.77	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14726.7	B08		3	0259-0425	862.34	425.22	116	41.21	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16844.7	B08		3	0260-0432	503.87	432.37	225	59.60	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12819.0	B08		3	0261-0435	408.07	435.04	291	69.60	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15514.7	B08		3	0262-0437	862.54	437.07	128	41.80	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15710.2	B08		3	0263-0442	807.62	442.76	329	75.26	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14152.4	B08		3	0264-0443	888.83	442.33	332	69.26	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19332.5	B08		3	0265-0443	531.39	443.83	328	67.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16042.0	B08		3	0266-0450	31.80	450.55	432	79.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14101.6	B08		3	0267-0449	933.81	450.02	256	61.11	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13342.5	B08		3	0268-0451	72.30	451.27	263	62.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13427.3	B08		3	0269-0453	371.01	453.85	319	68.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16345.1	B08		3	0270-0451	699.44	451.53	254	59.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12370.8	B08		3	0271-0455	185.28	455.49	283	65.01	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16257.3	B08		3	0272-0453	247.81	453.68	216	55.11	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15854.9	B08		3	0273-0455	748.33	454.75	174	50.63	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15890.0	B08		3	0274-0454	759.92	453.92	166	49.80	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18035.9	B08		3	0275-0454	508.66	454.74	219	59.36	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17626.6	B08		3	0276-0459	681.14	458.94	406	74.67	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12120.4	B08		3	0277-0458	140.86	458.00	306	64.77	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18560.6	B08		3	0278-0458	447.06	457.61	270	62.18	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14762.1	B08		3	0279-0458	311.78	458.48	236	58.18	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17378.9	B08		3	0280-0461	92.82	461.21	289	63.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15327.8	B08		3	0281-0466	276.12	465.89	268	62.77	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15383.1	B08		3	0282-0466	422.12	466.59	247	57.94	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14781.9	B08		3	0283-0469	324.75	469.28	258	60.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16667.9	B08		3	0284-0469	295.54	469.85	274	61.94	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16496.2	B08		3	0285-0473	383.72	473.38	260	61.01	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15841.1	B08		3	0286-0472	836.60	472.36	236	57.11	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18843.7	B08		3	0287-0476	177.39	476.77	357	72.33	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15838.2	B08		3	0288-0474	697.65	474.06	246	57.94	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22080.6	B08		3	0289-0476	722.76	476.66	332	68.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16094.4	B08		3	0290-0475	259.18	475.33	251	59.70	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16745.3	B08		3	0291-0478	204.42	479.05	212	56.77	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15447.4	B08		3	0292-0480	771.22	479.94	365	75.01	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16156.9	B08		3	0293-0480	363.30	480.13	231	56.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18011.9	B08		3	0294-0480	560.68	479.96	209	59.46	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15420.3	B08		3	0295-0484	501.01	484.07	285	62.53	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13482.8	B08		3	0296-0487	51.52	486.82	251	61.70	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17298.2	B08		3	0297-0486	616.39	487.05	226	56.53	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18520.8	B08		3	0298-0487	342.67	487.35	238	57.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14312.4	B08		3	0299-0488	826.68	488.29	293	62.77	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19899.9	B08		3	0300-0490	596.29	489.20	265	63.60	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19823.7	B08		3	0301-0495	558.65	494.36	331	69.94	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18677.7	B08		3	0302-0502	582.49	500.85	221	60.77	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12328.9	B08		3	0303-0500	808.99	500.75	139	45.70	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14664.0	B08		3	0304-0506	271.95	507.29	292	65.36	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22063.4	B08		3	0305-0506	197.87	506.15	325	67.94	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19873.1	B08		3	0306-0504	326.24	504.30	201	54.53	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18529.7	B08		3	0307-0506	749.41	506.57	218	54.87	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19884.6	B08		3	0308-0512	233.99	511.86	404	77.84	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14930.3	B08		3	0309-0508	309.33	507.70	254	59.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20871.4	B08		3	0310-0512	409.95	512.07	328	68.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20443.8	B08		3	0311-0512	920.21	511.04	368	74.43	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13824.4	B08		3	0312-0511	945.71	510.79	299	69.01	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15361.2	B08		3	0313-0513	162.91	512.93	234	55.70	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14944.5	B08		3	0314-0519	641.88	518.69	471	82.08	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14421.0	B08		3	0315-0518	433.87	518.13	300	65.60	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12366.6	B08		3	0316-0515	807.92	515.37	204	53.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17075.1	B08		3	0317-0516	879.29	515.82	275	62.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19055.4	B08		3	0318-0520	468.34	519.83	387	74.18	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15012.9	B08		3	0319-0525	92.32	525.27	242	61.94	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15802.0	B08		3	0320-0528	892.42	527.57	242	59.94	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13964.5	B08		3	0321-0534	563.20	534.52	290	64.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19595.9	B08		3	0322-0538	930.82	537.99	358	70.43	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16255.9	B08		3	0323-0544	338.86	544.18	447	80.08	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20548.1	B08		3	0324-0543	615.93	543.94	313	68.87	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18244.8	B08		3	0325-0545	291.44	545.26	385	74.91	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17990.7	B08		3	0326-0543	687.91	543.10	258	62.43	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17638.5	B08		3	0327-0542	802.99	542.92	224	57.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15736.2	B08		3	0328-0547	65.80	547.79	283	70.53	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18941.2	B08		3	0329-0545	519.42	545.54	393	73.26	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13971.7	B08		3	0330-0548	752.79	547.78	327	67.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19316.2	B08		3	0331-0547	817.45	547.43	200	54.28	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15719.3	B08		3	0332-0555	168.11	555.12	253	58.53	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21794.8	B08		3	0333-0554	206.92	554.21	165	48.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16136.3	B08		3	0334-0557	241.60	557.24	219	55.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19088.8	B08		3	0335-0558	680.32	558.84	172	50.04	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14734.6	B08		3	0336-0560	260.65	560.75	258	60.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12694.9	B08		3	0337-0560	437.42	560.49	282	66.18	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19180.3	B08		3	0338-0561	383.72	561.24	199	52.28	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14262.5	B08		3	0339-0564	908.31	563.81	257	60.77	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18836.0	B08		3	0340-0563	362.71	562.57	209	53.11	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16733.6	B08		3	0341-0565	113.81	566.31	220	55.70	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11910.2	B08		3	0342-0563	560.33	563.84	161	49.21	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20406.6	B08		3	0343-0574	707.12	574.45	382	76.18	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17611.4	B08		3	0344-0567	729.32	567.42	211	56.87	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12867.4	B08		3	0345-0577	307.82	577.16	266	66.18	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15409.5	B08		3	0346-0574	484.36	573.74	284	64.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15639.5	B08		3	0347-0578	839.35	579.04	248	60.53	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11179.4	B08		3	0348-0574	557.43	574.80	134	51.70	0.630
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16150.8	B08		3	0349-0579	81.38	579.01	225	56.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18219.0	B08		3	0350-0583	166.37	583.62	332	67.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18915.6	B08		3	0351-0583	187.26	583.22	278	61.46	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16539.2	B08		3	0352-0587	388.61	587.01	346	70.91	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12550.6	B08		3	0353-0587	584.27	587.10	318	81.50	0.602
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	26997.3	B08		3	0354-0584	877.49	584.68	133	42.87	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15826.0	B08		3	0355-0588	898.46	588.43	311	67.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16803.7	B08		3	0356-0589	350.30	589.33	209	55.94	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	26240.7	B08		3	0357-0588	862.60	588.17	134	44.28	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16361.7	B08		3	0358-0597	844.23	597.76	370	74.67	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21952.5	B08		3	0359-0594	253.57	593.03	169	49.36	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16707.8	B08		3	0360-0595	633.32	595.37	269	61.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13617.9	B08		3	0361-0598	524.68	598.04	293	62.77	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15550.1	B08		3	0362-0599	764.00	599.49	279	73.50	0.649
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15949.9	B08		3	0363-0604	126.58	605.15	339	68.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20854.5	B08		3	0364-0601	263.36	601.01	180	52.77	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13211.1	B08		3	0365-0605	322.60	606.03	261	62.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14333.9	B08		3	0366-0602	426.77	602.43	267	62.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20848.2	B08		3	0367-0605	554.18	605.19	350	68.18	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18207.0	B08		3	0368-0603	687.74	604.19	132	42.39	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18542.0	B08		3	0369-0607	616.33	606.87	234	59.84	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15460.2	B08		3	0370-0609	487.93	608.84	297	66.43	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13886.1	B08		3	0371-0608	936.57	607.73	257	64.77	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15207.0	B08		3	0372-0614	411.37	614.44	324	66.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13917.9	B08		3	0373-0613	439.78	613.99	280	63.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19075.6	B08		3	0374-0611	721.30	611.18	193	58.77	0.702
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17272.2	B08		3	0375-0615	30.94	616.00	225	55.36	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12917.6	B08		3	0376-0618	339.28	617.59	279	61.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15210.8	B08		3	0377-0620	63.06	620.52	228	58.53	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18188.1	B08		3	0378-0621	692.34	620.81	285	66.53	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23342.0	B08		3	0379-0621	883.29	620.36	279	63.11	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16689.7	B08		3	0380-0623	179.48	623.20	323	67.01	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15066.9	B08		3	0381-0621	232.61	622.39	272	61.11	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16007.3	B08		3	0382-0622	299.86	622.00	314	67.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19090.3	B08		3	0383-0621	263.45	621.84	183	52.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20193.2	B08		3	0384-0624	603.64	624.42	363	71.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14848.0	B08		3	0385-0625	751.75	625.19	266	63.11	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18654.5	B08		3	0386-0628	812.46	628.17	378	73.01	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16709.4	B08		3	0387-0628	276.37	628.67	229	57.70	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19672.4	B08		3	0388-0628	556.75	628.93	195	53.46	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12677.0	B08		3	0389-0637	876.35	637.96	295	68.43	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17868.5	B08		3	0390-0637	771.26	636.84	209	55.70	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17295.9	B08		3	0391-0639	114.14	640.11	204	52.87	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16883.4	B08		3	0392-0642	350.54	642.19	281	64.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16498.2	B08		3	0393-0640	514.81	640.74	269	61.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17328.2	B08		3	0394-0643	895.73	643.48	375	73.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14440.5	B08		3	0395-0642	204.93	642.22	248	60.18	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19771.3	B08		3	0396-0640	164.94	640.47	181	51.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	24958.3	B08		3	0397-0642	556.40	641.47	162	48.63	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15877.2	B08		3	0398-0648	659.03	648.60	327	66.18	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21555.6	B08		3	0399-0653	247.53	653.51	371	75.01	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16145.4	B08		3	0400-0654	388.11	654.36	401	76.43	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21142.6	B08		3	0401-0651	946.17	650.54	275	62.53	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16020.5	B08		3	0402-0656	425.26	656.70	372	71.60	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19061.8	B08		3	0403-0657	713.38	657.91	343	69.26	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15795.9	B08		3	0404-0661	108.19	660.40	327	71.36	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18249.1	B08		3	0405-0660	620.19	659.78	295	64.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14359.9	B08		3	0406-0660	553.77	659.85	269	60.53	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13242.6	B08		3	0407-0660	898.74	660.46	275	66.18	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14503.5	B08		3	0408-0661	175.78	660.96	239	61.60	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14189.1	B08		3	0409-0663	830.21	663.20	256	62.18	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14786.7	B08		3	0410-0663	806.27	663.94	252	60.53	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16067.9	B08		3	0411-0669	321.28	668.18	225	57.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16228.2	B08		3	0412-0674	687.29	674.80	384	75.50	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12579.7	B08		3	0413-0673	473.43	673.39	270	61.11	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15064.7	B08		3	0414-0674	732.78	674.35	260	59.11	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15839.1	B08		3	0415-0675	339.94	674.90	231	57.36	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13268.1	B08		3	0416-0680	911.95	680.09	390	111.88	0.392
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14931.8	B08		3	0417-0678	44.44	677.83	235	60.43	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14622.8	B08		3	0418-0681	448.52	681.25	260	61.36	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15727.3	B08		3	0419-0681	250.43	681.15	231	56.53	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16162.1	B08		3	0420-0682	310.84	682.87	248	58.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23269.1	B08		3	0421-0681	600.75	681.92	187	55.46	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23616.1	B08		3	0422-0682	392.98	682.79	147	46.63	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13223.8	B08		3	0423-0691	70.94	690.67	280	73.84	0.645
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14577.1	B08		3	0424-0686	842.30	686.28	245	59.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14402.1	B08		3	0425-0688	171.82	688.70	240	58.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15595.8	B08		3	0426-0691	568.47	691.37	235	62.77	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22943.5	B08		3	0427-0690	817.05	690.09	266	62.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14753.2	B08		3	0428-0693	204.94	693.32	427	79.84	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15822.8	B08		3	0429-0690	520.23	689.89	241	58.53	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14762.7	B08		3	0430-0695	880.75	694.32	235	59.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15432.6	B08		3	0431-0696	240.36	695.66	237	57.60	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17517.6	B08		3	0432-0695	294.42	694.86	346	69.94	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	26967.9	B08		3	0433-0699	599.55	698.54	340	85.01	0.591
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13735.2	B08		3	0434-0697	389.64	697.22	344	71.84	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13906.3	B08		3	0435-0698	119.26	699.23	252	61.26	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16982.9	B08		3	0436-0707	31.70	707.18	300	66.08	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184812	1375311	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15630.2	B08		3	0437-0708	278.88	708.13	245	57.94	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16296.1	B08		4	0001-0025	601.39	24.22	237	57.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16256.0	B08		4	0002-0026	295.33	26.23	228	57.11	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16586.5	B08		4	0003-0028	414.67	27.91	247	60.53	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	24678.0	B08		4	0004-0028	250.53	27.82	319	67.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20743.5	B08		4	0005-0032	338.83	32.81	380	77.84	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15184.8	B08		4	0006-0030	90.85	30.14	263	62.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14871.1	B08		4	0007-0032	119.56	31.29	266	64.53	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14869.6	B08		4	0008-0032	639.87	33.10	275	62.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14654.3	B08		4	0009-0033	706.63	33.30	326	67.26	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	24469.2	B08		4	0010-0027	902.79	26.86	134	46.28	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18224.1	B08		4	0011-0036	37.02	36.05	423	77.26	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16817.0	B08		4	0012-0036	864.18	36.52	334	67.01	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18809.2	B08		4	0013-0036	912.23	36.29	173	49.46	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16643.4	B08		4	0014-0037	930.80	36.59	178	52.28	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12892.8	B08		4	0015-0043	677.40	43.66	298	68.08	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14773.7	B08		4	0016-0045	301.85	45.54	255	63.01	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16163.3	B08		4	0017-0051	613.77	48.86	342	82.91	0.625
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16663.3	B08		4	0018-0051	75.69	51.44	486	82.08	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16402.1	B08		4	0019-0048	478.80	47.48	271	66.18	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15306.1	B08		4	0020-0047	936.14	47.06	211	59.36	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17788.0	B08		4	0021-0050	401.86	49.78	218	54.53	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14953.6	B08		4	0022-0050	219.40	49.85	318	68.18	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17880.2	B08		4	0023-0058	740.53	58.83	424	78.57	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15347.1	B08		4	0024-0055	14.62	55.08	250	63.36	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16995.1	B08		4	0025-0056	524.41	56.31	353	71.26	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18390.2	B08		4	0026-0058	888.84	59.06	392	75.01	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	25839.8	B08		4	0027-0060	161.25	60.71	268	70.18	0.684
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13982.8	B08		4	0028-0058	312.75	57.64	272	62.53	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13201.1	B08		4	0029-0060	712.81	59.97	208	60.18	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16019.6	B08		4	0030-0062	766.83	63.27	211	54.87	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14461.5	B08		4	0031-0067	475.75	67.22	283	62.28	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17069.0	B08		4	0032-0069	538.58	69.33	492	86.33	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15207.3	B08		4	0033-0067	812.44	67.35	244	59.01	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13212.0	B08		4	0034-0078	318.23	77.48	282	65.01	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15010.9	B08		4	0035-0080	447.27	80.88	269	61.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15674.1	B08		4	0036-0083	227.30	83.62	238	57.70	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13395.3	B08		4	0037-0088	414.50	87.90	319	68.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14718.7	B08		4	0038-0090	269.16	90.06	247	59.70	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12769.9	B08		4	0039-0091	381.61	91.52	302	64.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15182.0	B08		4	0040-0094	159.26	95.10	397	74.08	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15096.2	B08		4	0041-0092	54.99	92.34	244	59.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	24918.5	B08		4	0042-0093	914.93	93.62	295	64.53	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15562.9	B08		4	0043-0097	678.35	97.15	251	59.94	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15209.5	B08		4	0044-0100	209.86	100.34	241	57.11	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16459.8	B08		4	0045-0106	848.60	106.41	340	68.77	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12093.5	B08		4	0046-0104	798.65	103.91	138	47.21	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11869.3	B08		4	0047-0104	810.06	105.10	155	47.21	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15816.5	B08		4	0048-0109	245.63	109.06	236	56.53	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13598.2	B08		4	0049-0113	274.94	112.69	293	69.26	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12743.4	B08		4	0050-0111	326.72	110.87	297	65.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13420.6	B08		4	0051-0119	62.82	119.71	273	61.60	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16945.6	B08		4	0052-0123	742.79	123.25	327	67.94	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14440.9	B08		4	0053-0130	181.11	130.31	271	64.77	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14357.9	B08		4	0054-0129	601.27	129.58	255	63.60	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	24056.4	B08		4	0055-0131	483.49	131.95	328	116.47	0.304
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13242.8	B08		4	0056-0131	714.45	131.62	301	67.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15172.4	B08		4	0057-0133	237.78	133.58	318	66.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16497.9	B08		4	0058-0134	84.87	133.92	219	55.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14613.6	B08		4	0059-0139	381.43	139.74	258	60.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18221.3	B08		4	0060-0141	350.79	140.88	431	83.84	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23025.7	B08		4	0061-0143	205.07	142.99	327	77.50	0.684
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12233.1	B08		4	0062-0141	302.22	141.46	315	73.60	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13039.5	B08		4	0063-0146	540.29	146.95	291	68.77	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16277.3	B08		4	0064-0146	578.61	146.38	219	60.53	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19267.4	B08		4	0065-0146	858.94	145.96	342	69.26	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17737.3	B08		4	0066-0146	610.35	145.78	215	53.46	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21520.8	B08		4	0067-0146	690.83	146.41	168	48.63	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15376.7	B08		4	0068-0154	145.03	154.58	440	78.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22025.5	B08		4	0069-0150	766.39	150.31	307	64.18	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16438.2	B08		4	0070-0149	434.55	149.47	229	58.28	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13008.1	B08		4	0071-0150	941.52	150.18	274	63.11	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15732.3	B08		4	0072-0152	63.41	152.90	231	58.43	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14406.9	B08		4	0073-0154	235.64	154.02	260	59.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11901.7	B08		4	0074-0156	501.76	155.35	336	70.67	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15309.6	B08		4	0075-0157	85.02	157.84	241	57.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22568.4	B08		4	0076-0158	632.22	157.63	165	47.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16477.1	B08		4	0077-0159	100.79	159.94	187	50.63	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15792.3	B08		4	0078-0160	656.24	160.82	256	62.77	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15030.1	B08		4	0079-0170	22.33	169.11	241	60.28	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16128.0	B08		4	0080-0178	791.21	178.94	515	84.91	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15356.0	B08		4	0081-0181	448.03	180.50	247	63.26	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13040.9	B08		4	0082-0182	233.32	181.46	300	68.18	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14650.4	B08		4	0083-0180	310.78	180.92	232	56.28	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15425.6	B08		4	0084-0185	70.87	183.78	239	60.77	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20802.5	B08		4	0085-0186	549.29	186.57	365	70.67	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12739.3	B08		4	0086-0189	897.78	188.80	401	76.08	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15872.6	B08		4	0087-0189	670.54	188.33	240	58.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21055.5	B08		4	0088-0192	286.83	192.36	336	70.08	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18831.4	B08		4	0089-0193	616.47	193.71	205	55.11	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17428.9	B08		4	0090-0199	343.20	198.44	387	74.91	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13118.7	B08		4	0091-0197	474.47	197.98	279	62.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20924.2	B08		4	0092-0200	270.94	200.21	198	54.53	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16909.0	B08		4	0093-0201	515.72	200.27	291	64.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14046.1	B08		4	0094-0203	936.46	203.12	246	60.43	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13542.2	B08		4	0095-0209	22.00	209.14	321	76.18	0.695
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20778.1	B08		4	0096-0205	578.42	204.94	380	71.36	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17223.6	B08		4	0097-0203	380.38	202.68	222	56.28	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17129.8	B08		4	0098-0204	131.18	204.17	215	55.94	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15901.2	B08		4	0099-0207	617.57	207.58	247	61.70	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20132.1	B08		4	0100-0214	706.96	213.52	297	64.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17005.7	B08		4	0101-0217	272.55	216.54	216	59.36	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13869.6	B08		4	0102-0218	120.50	218.74	275	64.53	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18139.5	B08		4	0103-0223	558.63	223.58	465	84.08	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10743.3	B08		4	0104-0220	86.17	220.59	199	52.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15066.6	B08		4	0105-0222	632.34	222.35	268	62.43	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15262.0	B08		4	0106-0223	422.80	223.32	251	59.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14836.4	B08		4	0107-0228	60.11	227.98	256	60.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14668.5	B08		4	0108-0226	587.53	226.41	257	59.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16049.5	B08		4	0109-0228	479.79	228.88	256	63.01	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15694.4	B08		4	0110-0231	242.52	231.78	371	74.18	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16578.0	B08		4	0111-0231	454.26	230.39	231	55.70	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17944.2	B08		4	0112-0240	795.06	239.85	337	68.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16826.3	B08		4	0113-0239	370.73	238.64	297	64.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19804.9	B08		4	0114-0238	395.07	237.47	198	53.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17825.5	B08		4	0115-0238	31.13	238.21	231	57.36	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19200.6	B08		4	0116-0243	163.34	243.94	364	71.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20728.6	B08		4	0117-0242	542.80	242.93	185	55.46	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20623.7	B08		4	0118-0243	855.25	243.75	187	51.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17789.2	B08		4	0119-0246	261.20	246.46	213	54.53	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16059.7	B08		4	0120-0247	506.41	247.48	233	56.28	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14387.0	B08		4	0121-0253	424.23	252.69	261	61.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13839.3	B08		4	0122-0257	16.82	256.93	287	63.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15322.5	B08		4	0123-0259	587.93	260.00	252	65.01	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	24189.6	B08		4	0124-0255	869.18	255.90	154	73.74	0.356
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22013.4	B08		4	0125-0257	549.07	256.53	179	52.53	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18384.1	B08		4	0126-0259	820.99	259.13	215	56.53	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12790.1	B08		4	0127-0263	896.26	264.51	303	67.60	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14019.9	B08		4	0128-0265	370.12	264.64	226	55.70	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14368.8	B08		4	0129-0272	749.01	271.91	526	86.91	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16373.7	B08		4	0130-0270	108.85	270.49	342	69.60	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20439.1	B08		4	0131-0264	258.33	264.53	181	49.46	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	29641.0	B08		4	0132-0268	199.78	268.16	272	61.36	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20422.8	B08		4	0133-0266	434.03	266.36	181	50.04	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16299.7	B08		4	0134-0270	132.52	270.68	237	57.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19166.7	B08		4	0135-0272	383.11	270.73	158	51.11	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16239.5	B08		4	0136-0275	601.91	274.79	252	59.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18328.6	B08		4	0137-0278	569.84	278.36	308	65.26	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15705.9	B08		4	0138-0278	50.14	278.38	250	59.11	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14395.2	B08		4	0139-0278	214.25	278.96	272	61.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20762.3	B08		4	0140-0278	396.04	277.77	240	59.60	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18526.4	B08		4	0141-0279	414.23	279.20	221	57.36	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15712.0	B08		4	0142-0287	479.47	286.64	258	61.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15317.8	B08		4	0143-0291	253.75	291.05	235	60.53	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16840.1	B08		4	0144-0290	556.80	290.27	231	61.01	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13445.6	B08		4	0145-0292	804.57	291.33	267	67.94	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15484.3	B08		4	0146-0293	833.47	292.81	236	57.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23085.4	B08		4	0147-0290	116.51	290.99	150	46.87	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17268.3	B08		4	0148-0291	134.88	291.50	224	54.28	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14498.1	B08		4	0149-0295	170.41	295.48	256	59.36	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22019.4	B08		4	0150-0300	79.90	299.71	377	73.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13422.9	B08		4	0151-0297	340.36	297.42	224	65.01	0.666
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20659.9	B08		4	0152-0306	848.96	306.04	363	70.43	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15120.4	B08		4	0153-0305	580.13	305.85	263	61.60	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15686.2	B08		4	0154-0306	266.38	306.65	255	63.70	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18941.1	B08		4	0155-0304	426.22	304.47	293	70.28	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17897.2	B08		4	0156-0308	771.97	308.78	268	61.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15613.3	B08		4	0157-0310	701.07	310.10	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16312.4	B08		4	0158-0314	241.79	314.07	223	55.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18346.2	B08		4	0159-0318	864.87	318.80	329	69.84	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20412.1	B08		4	0160-0316	426.73	316.36	194	54.87	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13573.8	B08		4	0161-0320	304.77	321.14	227	56.28	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19905.0	B08		4	0162-0327	383.06	326.66	361	74.53	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19569.3	B08		4	0163-0332	509.64	331.99	402	77.50	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13371.8	B08		4	0164-0335	204.03	334.75	270	60.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8419.5	B08		4	0165-0344	355.36	343.79	402	75.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16714.1	B08		4	0166-0339	57.70	339.44	229	57.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20442.5	B08		4	0167-0345	257.77	345.48	367	71.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13898.3	B08		4	0168-0348	683.97	347.91	269	62.18	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13574.7	B08		4	0169-0349	923.36	349.53	318	67.01	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13176.5	B08		4	0170-0350	306.71	349.98	262	60.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18522.2	B08		4	0171-0349	798.73	349.42	249	64.18	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23917.2	B08		4	0172-0354	856.66	353.38	287	62.43	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14983.9	B08		4	0173-0354	27.62	354.81	251	69.84	0.647
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19407.4	B08		4	0174-0361	69.30	360.62	363	70.77	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17019.3	B08		4	0175-0361	794.64	361.10	169	49.70	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22198.5	B08		4	0176-0366	871.02	366.20	355	72.18	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17907.4	B08		4	0177-0369	145.55	369.24	223	55.11	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15747.6	B08		4	0178-0381	287.82	381.21	479	88.33	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15736.8	B08		4	0179-0378	334.49	378.08	223	57.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13628.3	B08		4	0180-0384	670.09	383.67	289	64.18	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15978.9	B08		4	0181-0383	851.40	383.37	236	57.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14814.9	B08		4	0182-0383	917.72	383.24	299	64.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16947.2	B08		4	0183-0386	576.32	386.15	240	59.84	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20739.1	B08		4	0184-0387	418.73	387.11	311	64.18	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20829.9	B08		4	0185-0390	124.30	390.25	186	53.36	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12045.0	B08		4	0186-0394	365.20	394.49	281	66.67	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16575.7	B08		4	0187-0391	494.81	391.49	250	62.18	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12800.3	B08		4	0188-0398	183.49	398.08	301	66.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14987.9	B08		4	0189-0400	98.22	399.80	254	77.84	0.527
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19849.9	B08		4	0190-0400	135.37	401.02	223	54.77	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16348.4	B08		4	0191-0405	156.03	405.04	308	66.43	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15019.8	B08		4	0192-0408	821.50	408.19	249	62.77	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	24270.8	B08		4	0193-0411	614.01	410.08	287	65.01	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	25506.5	B08		4	0194-0410	649.13	410.07	302	67.01	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21781.9	B08		4	0195-0417	395.36	417.62	367	72.67	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15747.5	B08		4	0196-0415	479.20	415.09	240	58.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17893.1	B08		4	0197-0416	556.77	415.96	302	66.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17098.1	B08		4	0198-0417	942.83	416.70	256	59.11	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15908.2	B08		4	0199-0419	913.28	418.81	232	57.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15825.9	B08		4	0200-0427	43.01	427.15	337	67.36	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14812.7	B08		4	0201-0426	245.01	425.35	253	63.36	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	26033.6	B08		4	0202-0432	322.69	431.90	417	78.08	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17485.9	B08		4	0203-0430	351.01	431.03	219	58.53	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15300.9	B08		4	0204-0437	619.88	438.32	364	82.43	0.673
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16404.0	B08		4	0205-0437	93.59	437.36	451	82.08	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16922.8	B08		4	0206-0436	698.93	436.19	371	71.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19543.1	B08		4	0207-0440	172.17	439.91	341	68.18	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15036.4	B08		4	0208-0441	829.11	440.75	250	61.11	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20134.7	B08		4	0209-0443	796.47	444.09	188	50.53	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16623.9	B08		4	0210-0449	400.15	449.28	231	57.11	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16165.6	B08		4	0211-0454	763.35	453.28	232	57.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18121.7	B08		4	0212-0458	906.67	457.70	363	71.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23687.3	B08		4	0213-0460	423.06	460.13	251	60.28	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16075.0	B08		4	0214-0461	634.10	461.13	243	57.11	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14134.1	B08		4	0215-0463	862.53	463.11	269	61.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15650.2	B08		4	0216-0465	240.80	466.18	243	59.60	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14513.5	B08		4	0217-0464	500.68	464.47	268	60.87	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17399.9	B08		4	0218-0465	736.76	464.94	140	46.04	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18286.6	B08		4	0219-0467	924.68	467.49	402	74.18	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15551.4	B08		4	0220-0465	106.92	465.57	237	58.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15065.9	B08		4	0221-0473	551.33	473.05	269	63.94	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21637.8	B08		4	0222-0466	748.72	466.50	110	38.63	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17247.4	B08		4	0223-0472	41.64	471.90	337	70.43	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17033.9	B08		4	0224-0474	434.46	474.20	297	66.77	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23161.9	B08		4	0225-0476	573.17	476.07	272	62.53	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14138.5	B08		4	0226-0478	296.05	477.74	264	63.26	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22633.2	B08		4	0227-0477	587.41	477.46	213	54.63	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15914.9	B08		4	0228-0477	624.85	477.87	249	57.36	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14853.5	B08		4	0229-0478	773.47	478.74	248	62.43	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18257.3	B08		4	0230-0479	751.17	479.18	167	47.11	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14135.9	B08		4	0231-0481	825.06	480.57	285	64.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16661.7	B08		4	0232-0485	189.56	485.76	327	69.60	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16941.0	B08		4	0233-0485	165.66	485.49	220	53.94	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15687.4	B08		4	0234-0487	331.71	486.88	242	60.28	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16354.5	B08		4	0235-0487	404.26	487.00	244	60.53	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15797.7	B08		4	0236-0489	876.92	489.21	241	57.11	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17570.6	B08		4	0237-0487	97.63	488.05	206	58.53	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14638.8	B08		4	0238-0491	603.73	490.85	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18559.6	B08		4	0239-0491	674.89	490.66	282	62.43	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15984.0	B08		4	0240-0491	378.68	492.19	243	59.11	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18710.1	B08		4	0241-0496	123.05	495.88	287	63.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19716.8	B08		4	0242-0494	814.64	495.00	192	53.11	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14630.5	B08		4	0243-0502	713.55	501.65	378	75.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	177.4	B08		4	0244-0499	510.71	499.10	178	50.87	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	25423.9	B08		4	0245-0502	247.12	501.64	313	66.77	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12444.6	B08		4	0246-0503	465.57	503.07	296	69.36	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17944.6	B08		4	0247-0504	207.05	503.81	213	55.46	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17847.9	B08		4	0248-0505	317.37	506.23	205	58.87	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	208.9	B08		4	0249-0505	526.72	504.67	133	44.04	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17887.2	B08		4	0250-0509	893.48	509.56	256	58.53	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17073.3	B08		4	0251-0510	769.85	509.88	229	57.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14316.4	B08		4	0252-0515	912.53	515.34	272	63.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19134.3	B08		4	0253-0516	166.09	516.56	195	52.53	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18936.4	B08		4	0254-0519	324.07	518.57	206	56.53	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16454.2	B08		4	0255-0523	62.95	523.51	283	62.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15982.5	B08		4	0256-0521	408.93	520.60	252	59.01	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19877.5	B08		4	0257-0523	632.41	523.01	299	65.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15100.5	B08		4	0258-0524	349.28	523.74	255	61.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	28027.3	B08		4	0259-0525	35.65	525.09	254	65.84	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12916.5	B08		4	0260-0525	667.34	525.91	286	66.43	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16962.4	B08		4	0261-0529	219.15	529.19	279	66.43	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21571.4	B08		4	0262-0527	823.19	526.28	182	51.11	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18792.7	B08		4	0263-0529	189.07	529.13	203	53.11	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14300.3	B08		4	0264-0535	305.67	536.40	353	71.94	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15237.0	B08		4	0265-0536	271.64	534.96	247	62.87	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14376.7	B08		4	0266-0538	853.41	538.09	256	62.43	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18162.4	B08		4	0267-0543	519.43	543.96	379	74.67	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15191.0	B08		4	0268-0543	462.46	543.84	146	47.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12545.6	B08		4	0269-0545	612.72	545.77	302	66.67	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14609.0	B08		4	0270-0546	483.70	546.75	285	67.60	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14994.8	B08		4	0271-0546	120.03	546.11	297	64.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18952.3	B08		4	0272-0551	386.36	551.34	382	75.50	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14709.7	B08		4	0273-0545	452.01	545.29	113	39.21	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19166.0	B08		4	0274-0549	826.28	549.64	208	55.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17567.6	B08		4	0275-0553	769.54	553.39	208	57.01	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14812.1	B08		4	0276-0553	896.29	553.02	252	59.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16714.1	B08		4	0277-0556	169.22	558.38	335	78.18	0.689
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19108.1	B08		4	0278-0552	257.75	552.29	134	46.04	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16430.8	B08		4	0279-0555	927.66	554.65	218	53.70	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17041.5	B08		4	0280-0562	695.36	561.59	340	69.84	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15706.4	B08		4	0281-0560	39.92	559.67	217	54.28	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17741.2	B08		4	0282-0559	792.50	558.57	225	55.94	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15020.4	B08		4	0283-0562	661.76	562.49	244	58.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15777.2	B08		4	0284-0566	442.11	565.66	250	59.11	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23230.1	B08		4	0285-0571	626.34	571.54	350	72.91	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14743.2	B08		4	0286-0573	745.64	573.60	268	64.28	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17467.0	B08		4	0287-0579	202.08	578.90	254	59.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15501.2	B08		4	0288-0580	355.71	580.32	261	71.26	0.646
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14933.5	B08		4	0289-0578	55.91	579.20	240	59.11	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17902.6	B08		4	0290-0584	101.22	583.64	271	62.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12740.0	B08		4	0291-0587	896.46	587.20	239	57.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17438.6	B08		4	0292-0590	503.77	590.15	227	55.70	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12709.9	B08		4	0293-0593	414.11	594.58	329	71.01	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12865.0	B08		4	0294-0594	466.09	594.47	170	48.63	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17569.9	B08		4	0295-0595	631.79	594.98	228	56.28	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16262.9	B08		4	0296-0599	330.30	599.10	240	58.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16345.4	B08		4	0297-0600	878.35	600.18	225	56.87	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22970.5	B08		4	0298-0604	265.33	603.70	313	65.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15999.5	B08		4	0299-0605	521.43	604.79	295	64.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23308.6	B08		4	0300-0603	612.33	602.58	160	46.87	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15494.4	B08		4	0301-0605	933.74	605.18	223	55.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14474.9	B08		4	0302-0606	483.26	606.68	184	53.36	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22243.9	B08		4	0303-0607	792.06	607.40	263	59.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17182.1	B08		4	0304-0610	238.36	610.41	227	56.28	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17831.4	B08		4	0305-0612	213.73	611.44	215	55.70	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21524.2	B08		4	0306-0615	619.13	615.35	176	49.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15512.8	B08		4	0307-0622	857.02	622.48	252	59.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19072.2	B08		4	0308-0620	180.51	620.54	198	53.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15317.4	B08		4	0309-0621	647.58	621.74	256	60.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13390.9	B08		4	0310-0626	931.96	626.09	277	71.60	0.679
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14889.8	B08		4	0311-0627	369.29	627.77	272	62.18	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19929.2	B08		4	0312-0628	240.10	627.52	191	51.11	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17412.0	B08		4	0313-0631	112.43	631.22	295	62.77	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15322.4	B08		4	0314-0631	594.04	631.05	250	59.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16792.3	B08		4	0315-0634	396.37	634.05	245	61.60	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20564.4	B08		4	0316-0636	439.91	636.09	375	71.60	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16035.2	B08		4	0317-0638	518.47	638.36	294	65.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16130.8	B08		4	0318-0638	851.28	638.87	219	54.87	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19295.6	B08		4	0319-0639	71.19	639.60	175	49.80	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16415.7	B08		4	0320-0643	355.90	642.50	300	67.50	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19291.2	B08		4	0321-0643	720.20	643.02	246	59.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16583.7	B08		4	0322-0650	276.52	648.14	493	95.50	0.679
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20213.7	B08		4	0323-0648	471.83	647.96	344	69.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13846.5	B08		4	0324-0643	623.44	642.89	206	61.36	0.688
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17596.6	B08		4	0325-0651	550.39	650.86	460	82.33	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18291.7	B08		4	0326-0649	751.38	649.17	248	62.53	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15457.6	B08		4	0327-0655	677.54	656.14	307	64.18	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15852.4	B08		4	0328-0657	92.49	656.86	234	56.28	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15884.7	B08		4	0329-0665	419.08	665.94	283	62.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20582.6	B08		4	0330-0665	464.09	665.02	258	60.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19946.4	B08		4	0331-0668	138.91	668.35	265	62.18	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16708.7	B08		4	0332-0670	579.98	670.48	218	55.70	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	24866.5	B08		4	0333-0669	157.98	669.52	183	52.53	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19949.7	B08		4	0334-0677	304.96	677.31	383	75.01	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23059.0	B08		4	0335-0676	369.06	676.55	337	71.84	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16893.8	B08		4	0336-0676	106.14	676.43	226	57.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13552.5	B08		4	0337-0681	489.96	681.89	293	70.53	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15095.8	B08		4	0338-0679	219.54	679.54	244	57.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22914.8	B08		4	0339-0682	439.59	681.45	316	65.60	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	24511.5	B08		4	0340-0682	341.94	682.00	147	49.11	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21170.1	B08		4	0341-0686	771.81	686.37	246	59.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23489.8	B08		4	0342-0687	352.74	686.86	160	48.87	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16015.3	B08		4	0343-0689	66.90	688.40	228	58.28	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17699.7	B08		4	0344-0695	584.28	694.25	440	78.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14474.4	B08		4	0345-0693	190.14	693.68	257	58.77	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13741.5	B08		4	0346-0694	508.55	695.05	278	66.18	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17608.6	B08		4	0347-0699	91.54	698.54	186	51.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13879.9	B08		4	0348-0701	321.09	700.57	259	61.94	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12367.3	B08		4	0349-0701	852.08	700.68	243	63.01	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16488.5	B08		4	0350-0704	139.10	703.95	232	56.18	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10549.3	B08		4	0351-0707	82.78	707.84	131	43.11	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15828.0	B08		4	0352-0709	249.40	709.38	245	58.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184813	1375312	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15955.3	B08		4	0353-0708	826.55	707.85	222	55.36	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16026.5	B08		5	0001-0030	295.53	30.88	233	58.53	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19198.1	B08		5	0002-0025	894.81	25.66	191	53.70	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12254.2	B08		5	0003-0032	81.20	32.85	281	64.43	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16559.5	B08		5	0004-0030	386.33	30.11	243	57.36	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19902.2	B08		5	0005-0033	557.30	33.38	357	71.01	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16548.1	B08		5	0006-0035	647.06	35.19	464	81.50	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17111.0	B08		5	0007-0034	764.63	33.50	320	66.43	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19201.3	B08		5	0008-0038	17.47	38.56	167	48.28	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14418.8	B08		5	0009-0038	843.73	38.50	257	60.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12925.2	B08		5	0010-0042	103.70	41.70	286	67.01	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15858.1	B08		5	0011-0044	38.23	44.27	412	80.67	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20666.8	B08		5	0012-0040	618.67	39.46	201	53.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17644.8	B08		5	0013-0041	935.18	41.15	306	66.08	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22406.2	B08		5	0014-0045	205.15	45.67	328	68.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13256.9	B08		5	0015-0046	353.28	45.99	285	63.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15872.8	B08		5	0016-0046	438.62	46.09	260	60.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12075.5	B08		5	0017-0047	119.53	46.85	227	64.53	0.685
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18571.4	B08		5	0018-0053	699.81	51.11	402	85.50	0.691
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17647.8	B08		5	0019-0054	728.32	54.59	354	69.26	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17224.5	B08		5	0020-0053	890.76	53.19	218	61.84	0.716
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23264.9	B08		5	0021-0058	502.59	57.05	187	55.01	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11596.9	B08		5	0022-0061	125.53	61.72	186	57.60	0.705
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17115.8	B08		5	0023-0061	392.17	61.28	300	68.77	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16209.3	B08		5	0024-0063	865.42	63.69	284	63.36	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18311.6	B08		5	0025-0063	445.32	62.52	211	55.11	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16708.3	B08		5	0026-0068	600.83	67.82	454	81.74	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20556.7	B08		5	0027-0065	641.80	65.14	294	62.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	24493.8	B08		5	0028-0072	240.01	71.95	365	82.33	0.677
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14315.4	B08		5	0029-0078	458.41	79.37	349	74.67	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13353.0	B08		5	0030-0074	786.62	75.24	278	64.53	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16413.0	B08		5	0031-0083	537.97	83.52	521	87.84	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15943.8	B08		5	0032-0080	179.82	80.24	229	56.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15291.1	B08		5	0033-0081	307.41	81.64	241	59.36	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16250.2	B08		5	0034-0088	583.99	88.43	520	87.50	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15926.7	B08		5	0035-0088	146.95	87.66	229	58.53	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16490.0	B08		5	0036-0087	849.53	86.85	227	55.94	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14508.4	B08		5	0037-0091	693.33	91.22	257	63.60	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12398.2	B08		5	0038-0093	756.68	92.98	318	65.84	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16148.1	B08		5	0039-0093	325.58	92.74	406	75.60	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	25075.6	B08		5	0040-0095	19.60	95.63	297	63.70	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14067.6	B08		5	0041-0096	621.58	96.99	278	64.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16484.9	B08		5	0042-0096	919.57	96.30	211	53.11	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15034.7	B08		5	0043-0099	829.40	98.50	296	63.94	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16536.0	B08		5	0044-0098	366.33	98.06	223	56.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23460.7	B08		5	0045-0102	285.85	102.24	239	58.77	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12643.6	B08		5	0046-0102	477.28	102.34	344	72.43	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16025.4	B08		5	0047-0105	179.89	105.00	227	57.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14757.3	B08		5	0048-0104	387.49	104.30	273	63.36	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19463.9	B08		5	0049-0110	219.10	111.22	376	75.01	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16688.8	B08		5	0050-0115	432.47	114.86	232	56.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17971.3	B08		5	0051-0122	262.18	122.33	412	75.26	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21139.2	B08		5	0052-0121	613.89	121.83	356	69.60	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20592.0	B08		5	0053-0123	124.96	123.50	317	64.77	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22318.9	B08		5	0054-0127	499.69	125.98	329	73.01	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16679.9	B08		5	0055-0125	317.65	125.28	227	55.94	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18661.7	B08		5	0056-0131	934.50	130.73	378	75.50	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17814.8	B08		5	0057-0128	671.91	127.74	201	52.53	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16094.6	B08		5	0058-0129	98.76	129.47	303	69.36	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18907.6	B08		5	0059-0132	181.45	131.89	279	62.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18084.3	B08		5	0060-0135	445.04	135.96	391	73.26	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13593.0	B08		5	0061-0134	731.47	134.75	276	64.18	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14237.5	B08		5	0062-0138	792.76	138.55	261	59.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16050.0	B08		5	0063-0135	814.56	134.93	256	61.70	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16502.5	B08		5	0064-0142	529.19	142.32	257	60.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15432.3	B08		5	0065-0141	863.11	141.44	233	57.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14072.4	B08		5	0066-0142	911.83	142.77	267	63.60	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20394.1	B08		5	0067-0154	221.83	153.34	667	103.64	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18150.7	B08		5	0068-0147	339.76	146.34	344	69.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15689.2	B08		5	0069-0146	572.14	145.82	248	57.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17702.7	B08		5	0070-0147	654.58	147.15	297	64.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18786.2	B08		5	0071-0147	817.26	148.11	194	56.04	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15110.9	B08		5	0072-0149	362.62	149.64	258	63.11	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15695.8	B08		5	0073-0153	468.98	152.96	303	65.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13089.9	B08		5	0074-0152	46.23	152.22	276	62.53	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18401.6	B08		5	0075-0155	326.26	154.69	198	53.60	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18015.0	B08		5	0076-0158	131.27	157.77	294	64.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13488.7	B08		5	0077-0160	412.59	160.42	281	64.53	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16335.6	B08		5	0078-0159	860.83	159.21	240	58.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16471.9	B08		5	0079-0168	300.99	166.56	212	59.11	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12885.5	B08		5	0080-0169	563.53	168.26	300	72.43	0.719
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20158.9	B08		5	0081-0169	283.17	169.11	340	70.77	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18861.8	B08		5	0082-0170	520.66	170.02	368	70.43	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11683.3	B08		5	0083-0173	714.30	172.85	300	76.43	0.645
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17831.5	B08		5	0084-0176	599.34	175.96	280	65.94	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14509.5	B08		5	0085-0177	767.45	177.37	261	62.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18697.8	B08		5	0086-0183	297.78	183.35	207	53.70	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15039.3	B08		5	0087-0188	458.13	187.82	262	61.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19463.6	B08		5	0088-0186	827.90	186.74	189	55.36	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21625.2	B08		5	0089-0190	123.16	189.82	298	64.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15756.2	B08		5	0090-0189	743.36	189.75	238	57.70	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16817.1	B08		5	0091-0191	435.58	190.96	270	59.94	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11290.2	B08		5	0092-0192	688.43	191.92	324	67.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14990.3	B08		5	0093-0195	802.67	195.07	270	67.26	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15570.3	B08		5	0094-0197	379.86	197.12	323	66.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15325.2	B08		5	0095-0200	532.69	199.42	324	68.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20590.4	B08		5	0096-0199	294.42	199.07	185	53.11	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20095.9	B08		5	0097-0201	256.90	201.30	177	48.87	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20673.6	B08		5	0098-0202	489.30	202.45	295	62.77	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13366.3	B08		5	0099-0205	89.56	204.45	266	63.60	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12039.3	B08		5	0100-0202	599.49	200.85	172	53.70	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17362.9	B08		5	0101-0203	855.77	204.11	257	60.28	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14054.2	B08		5	0102-0205	41.27	205.25	244	59.60	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18182.7	B08		5	0103-0209	559.41	208.92	460	83.26	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20734.4	B08		5	0104-0209	818.71	209.27	352	69.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15557.5	B08		5	0105-0212	363.48	212.07	256	61.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13101.9	B08		5	0106-0207	608.13	207.61	120	42.28	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22395.8	B08		5	0107-0213	243.40	213.91	322	69.26	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17338.9	B08		5	0108-0216	625.16	216.59	319	66.18	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16603.4	B08		5	0109-0223	312.51	224.14	373	80.33	0.726
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16081.2	B08		5	0110-0221	154.93	221.42	238	57.70	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14514.2	B08		5	0111-0222	388.83	221.77	269	61.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15585.1	B08		5	0112-0224	462.43	223.48	257	59.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15635.7	B08		5	0113-0227	527.41	227.24	242	57.46	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16333.0	B08		5	0114-0231	138.45	230.97	229	55.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17854.6	B08		5	0115-0231	354.39	231.96	211	54.53	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21030.9	B08		5	0116-0235	717.67	234.91	391	75.01	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18192.5	B08		5	0117-0232	327.87	231.96	209	53.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15024.6	B08		5	0118-0233	485.95	233.10	274	61.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18560.7	B08		5	0119-0234	549.68	234.97	201	53.36	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12238.4	B08		5	0120-0236	920.16	237.33	301	67.84	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17066.4	B08		5	0121-0238	698.47	238.19	231	56.53	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12385.2	B08		5	0122-0243	786.65	243.09	305	70.43	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20171.2	B08		5	0123-0243	182.01	242.88	185	52.53	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19873.1	B08		5	0124-0247	806.30	247.73	346	69.01	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15695.7	B08		5	0125-0248	342.03	248.20	243	61.60	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17362.7	B08		5	0126-0246	747.93	245.72	211	53.70	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13786.5	B08		5	0127-0251	627.61	251.69	278	63.70	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14684.6	B08		5	0128-0251	839.54	251.41	302	67.01	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12656.7	B08		5	0129-0253	672.20	253.35	290	66.67	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17879.4	B08		5	0130-0255	416.23	254.89	359	69.60	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13601.7	B08		5	0131-0257	234.72	258.05	280	62.18	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15362.2	B08		5	0132-0258	926.87	258.22	304	65.01	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20520.2	B08		5	0133-0259	529.60	259.62	179	50.28	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18504.2	B08		5	0134-0263	370.21	262.63	206	54.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14038.0	B08		5	0135-0265	886.90	264.94	301	63.94	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15848.2	B08		5	0136-0267	603.02	266.82	234	57.94	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14216.5	B08		5	0137-0271	722.33	270.70	281	65.26	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13028.7	B08		5	0138-0274	788.48	273.86	302	64.67	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14933.3	B08		5	0139-0274	286.41	274.47	246	58.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19502.0	B08		5	0140-0275	578.73	274.92	399	75.84	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19666.3	B08		5	0141-0278	471.49	278.13	376	72.43	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11970.3	B08		5	0142-0279	763.35	279.52	327	70.77	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20643.5	B08		5	0143-0285	683.06	284.72	557	96.81	0.747
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14797.0	B08		5	0144-0283	157.84	283.31	270	62.28	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14681.9	B08		5	0145-0282	931.41	282.99	332	68.77	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14141.2	B08		5	0146-0285	305.08	285.40	281	66.43	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13630.2	B08		5	0147-0289	855.11	291.27	292	73.26	0.684
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12982.9	B08		5	0148-0292	652.58	292.68	293	64.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15407.3	B08		5	0149-0293	254.65	293.39	363	72.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22175.6	B08		5	0150-0292	351.44	291.95	169	50.53	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16628.1	B08		5	0151-0296	832.99	296.12	326	66.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16360.4	B08		5	0152-0301	386.36	301.03	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16308.9	B08		5	0153-0297	621.94	297.75	232	59.46	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17151.3	B08		5	0154-0306	946.53	306.29	208	58.53	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14999.3	B08		5	0155-0305	480.20	305.32	257	61.94	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20791.2	B08		5	0156-0306	344.77	306.66	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14092.0	B08		5	0157-0310	929.56	310.24	264	59.36	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16468.1	B08		5	0158-0311	743.22	311.03	377	73.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20717.5	B08		5	0159-0312	518.81	312.77	358	71.01	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15033.1	B08		5	0160-0319	431.69	319.49	278	62.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13560.0	B08		5	0161-0321	867.44	320.62	300	65.01	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20727.1	B08		5	0162-0322	603.54	321.53	290	64.77	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20479.8	B08		5	0163-0324	762.76	324.64	284	64.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16522.6	B08		5	0164-0324	697.15	324.25	312	65.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16424.5	B08		5	0165-0328	256.84	329.58	236	62.77	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17093.0	B08		5	0166-0330	903.78	330.83	318	65.94	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15094.5	B08		5	0167-0332	640.93	332.77	255	59.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21785.2	B08		5	0168-0334	385.47	335.14	313	70.43	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17251.5	B08		5	0169-0339	199.53	339.86	402	79.26	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20684.7	B08		5	0170-0337	336.46	336.80	347	68.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16204.2	B08		5	0171-0337	109.22	337.39	234	55.70	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20188.5	B08		5	0172-0341	728.54	341.60	301	64.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12590.0	B08		5	0173-0348	247.30	348.39	312	73.01	0.735
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14656.7	B08		5	0174-0347	518.90	347.95	266	61.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	24032.5	B08		5	0175-0350	550.53	349.87	304	66.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13465.3	B08		5	0176-0351	28.14	351.54	308	65.01	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14859.6	B08		5	0177-0351	671.10	352.07	300	66.43	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15257.3	B08		5	0178-0351	288.63	351.57	242	57.36	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21909.5	B08		5	0179-0353	605.08	353.64	328	67.84	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17488.4	B08		5	0180-0350	388.40	350.64	213	55.70	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13729.8	B08		5	0181-0355	313.02	354.74	290	68.67	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13541.6	B08		5	0182-0363	367.52	363.21	367	73.74	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16063.4	B08		5	0183-0361	868.51	361.52	228	55.70	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16010.0	B08		5	0184-0364	481.68	364.53	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18000.4	B08		5	0185-0366	744.53	366.18	361	73.84	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15203.8	B08		5	0186-0370	155.81	369.80	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17403.7	B08		5	0187-0368	583.87	367.91	293	63.01	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14210.2	B08		5	0188-0369	793.88	369.56	267	62.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13532.4	B08		5	0189-0374	425.48	374.39	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11894.6	B08		5	0190-0376	815.09	375.59	267	71.01	0.665
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22017.7	B08		5	0191-0377	708.52	377.08	346	67.60	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16034.9	B08		5	0192-0379	228.04	379.25	321	67.60	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21218.3	B08		5	0193-0382	762.06	381.50	344	70.18	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14701.9	B08		5	0194-0384	331.51	384.50	264	59.94	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14083.2	B08		5	0195-0383	57.91	383.42	245	60.18	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13057.6	B08		5	0196-0384	638.43	383.82	173	55.36	0.709
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14558.2	B08		5	0197-0385	22.61	385.34	298	64.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15919.5	B08		5	0198-0387	437.65	386.44	260	61.70	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17206.6	B08		5	0199-0387	264.16	387.60	220	54.87	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11578.2	B08		5	0200-0388	941.49	389.46	247	73.26	0.578
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14243.2	B08		5	0201-0387	298.35	387.32	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	25111.5	B08		5	0202-0388	545.48	388.10	243	57.70	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17045.7	B08		5	0203-0390	123.06	389.49	212	55.36	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21602.2	B08		5	0204-0390	474.10	389.95	175	51.36	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13481.3	B08		5	0205-0398	374.06	400.10	337	75.60	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16613.1	B08		5	0206-0399	415.64	399.44	436	78.33	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14384.1	B08		5	0207-0397	845.35	396.76	330	67.36	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11012.0	B08		5	0208-0396	924.48	396.26	284	64.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13836.8	B08		5	0209-0400	96.75	399.85	268	60.53	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18668.3	B08		5	0210-0400	184.98	400.23	329	68.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16848.8	B08		5	0211-0402	596.83	402.10	318	65.94	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17500.9	B08		5	0212-0400	767.01	400.97	234	57.11	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16012.4	B08		5	0213-0402	234.24	403.18	236	57.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13556.8	B08		5	0214-0405	880.80	404.72	302	65.84	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20421.2	B08		5	0215-0408	503.17	407.93	387	73.84	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17610.6	B08		5	0216-0412	850.68	411.78	215	55.70	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14246.7	B08		5	0217-0418	295.11	418.75	263	60.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13042.3	B08		5	0218-0417	753.99	417.39	295	65.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16980.6	B08		5	0219-0419	47.72	418.73	257	58.53	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15224.2	B08		5	0220-0418	264.96	418.82	253	58.77	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21347.9	B08		5	0221-0420	553.94	420.70	336	68.08	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15651.5	B08		5	0222-0421	18.23	420.86	230	57.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20142.0	B08		5	0223-0423	649.21	422.77	326	67.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16613.5	B08		5	0224-0419	716.50	418.66	237	59.36	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14246.5	B08		5	0225-0423	159.47	423.16	268	60.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22416.1	B08		5	0226-0425	207.15	424.76	172	50.63	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17217.5	B08		5	0227-0427	249.84	426.62	227	60.18	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14418.6	B08		5	0228-0427	107.31	427.34	224	63.70	0.694
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4407.3	B08		5	0229-0429	93.76	430.11	133	48.53	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14827.5	B08		5	0230-0431	771.38	430.11	262	61.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13823.2	B08		5	0231-0434	318.65	433.86	279	61.60	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12982.9	B08		5	0232-0436	825.71	436.90	333	77.26	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17679.4	B08		5	0233-0434	357.52	434.58	213	55.11	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17025.8	B08		5	0234-0436	338.58	436.41	238	56.77	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16036.1	B08		5	0235-0440	453.24	439.97	251	59.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17495.9	B08		5	0236-0440	716.10	440.61	294	67.01	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12679.7	B08		5	0237-0446	893.39	445.58	305	64.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15605.4	B08		5	0238-0446	397.03	446.42	252	59.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20471.7	B08		5	0239-0446	759.84	446.37	329	66.53	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16142.7	B08		5	0240-0453	613.76	454.39	375	73.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14681.5	B08		5	0241-0451	254.41	451.25	265	60.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18909.6	B08		5	0242-0449	646.18	449.41	106	40.04	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13094.5	B08		5	0243-0454	851.35	454.92	285	66.18	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19392.4	B08		5	0244-0454	459.56	455.29	210	58.53	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15842.6	B08		5	0245-0457	416.62	458.31	258	66.28	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17130.0	B08		5	0246-0459	474.40	458.61	271	62.04	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14089.2	B08		5	0247-0463	580.88	463.68	282	64.53	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18074.5	B08		5	0248-0462	679.75	461.14	229	58.77	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16636.8	B08		5	0249-0466	315.02	467.28	416	85.15	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22978.8	B08		5	0250-0466	340.97	464.47	322	79.84	0.635
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19621.5	B08		5	0251-0467	388.98	466.28	351	71.01	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17523.4	B08		5	0252-0464	512.97	464.52	247	58.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13893.3	B08		5	0253-0468	540.87	467.65	321	68.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	24051.6	B08		5	0254-0468	712.10	468.59	270	61.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17833.3	B08		5	0255-0469	29.72	469.57	398	73.60	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13715.0	B08		5	0256-0469	164.99	469.79	233	57.94	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19493.2	B08		5	0257-0469	362.12	469.38	203	53.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13636.4	B08		5	0258-0469	881.30	468.81	265	61.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19119.3	B08		5	0259-0476	686.25	474.81	263	66.67	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12239.6	B08		5	0260-0473	210.69	474.10	179	51.11	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16647.4	B08		5	0261-0474	566.06	474.60	193	54.18	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18479.1	B08		5	0262-0477	259.90	477.08	208	61.01	0.702
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14777.1	B08		5	0263-0478	916.21	478.80	260	64.18	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18992.2	B08		5	0264-0484	226.41	484.79	327	75.50	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23062.4	B08		5	0265-0486	669.26	486.42	312	65.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14355.6	B08		5	0266-0487	312.59	487.82	276	63.01	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17318.5	B08		5	0267-0486	388.91	486.62	233	59.36	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17964.5	B08		5	0268-0486	560.86	485.82	117	40.28	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20794.0	B08		5	0269-0495	621.80	496.89	534	92.91	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23206.3	B08		5	0270-0491	782.00	491.75	311	66.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16709.9	B08		5	0271-0491	816.80	492.21	224	56.53	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17196.8	B08		5	0272-0493	248.22	493.46	176	48.87	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14977.3	B08		5	0273-0500	654.32	501.07	277	63.94	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15692.0	B08		5	0274-0503	300.62	504.45	260	62.77	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21465.0	B08		5	0275-0506	798.25	505.60	326	70.53	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16340.2	B08		5	0276-0505	82.77	505.79	367	73.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18467.3	B08		5	0277-0504	208.16	504.19	201	51.94	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17798.3	B08		5	0278-0509	168.81	509.67	238	62.77	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21486.1	B08		5	0279-0509	454.85	508.90	311	65.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19929.0	B08		5	0280-0510	567.98	510.19	257	60.28	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18841.7	B08		5	0281-0508	251.51	507.81	140	46.39	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16962.3	B08		5	0282-0514	580.97	514.25	225	62.28	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17787.9	B08		5	0283-0513	947.71	513.22	271	60.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	28132.1	B08		5	0284-0514	814.93	514.00	223	58.87	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15016.3	B08		5	0285-0515	766.65	516.13	269	60.28	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14132.8	B08		5	0286-0517	17.14	517.56	263	61.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17997.6	B08		5	0287-0518	185.06	519.87	257	64.77	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19194.1	B08		5	0288-0515	907.14	515.25	189	53.36	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15332.7	B08		5	0289-0520	851.89	519.62	257	59.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14107.1	B08		5	0290-0525	152.92	525.78	265	64.53	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18493.9	B08		5	0291-0523	500.45	522.77	313	65.01	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	24772.9	B08		5	0292-0521	247.66	521.15	148	44.87	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16009.6	B08		5	0293-0526	310.58	526.06	250	61.36	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	25393.2	B08		5	0294-0530	232.78	529.58	310	66.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19677.3	B08		5	0295-0528	699.51	528.23	219	54.87	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22176.6	B08		5	0296-0529	807.78	529.93	285	66.18	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16496.0	B08		5	0297-0529	602.50	528.81	243	57.36	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15734.4	B08		5	0298-0530	464.02	530.85	276	63.94	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20312.7	B08		5	0299-0535	526.23	535.26	278	62.53	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13898.6	B08		5	0300-0534	194.17	534.36	146	49.46	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15118.3	B08		5	0301-0537	631.59	536.87	273	62.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13567.6	B08		5	0302-0538	203.78	538.71	112	38.39	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16107.1	B08		5	0303-0541	943.14	542.26	251	61.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18446.7	B08		5	0304-0544	285.41	544.89	227	58.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16490.4	B08		5	0305-0542	66.73	542.40	222	54.53	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16057.2	B08		5	0306-0545	394.84	545.45	237	57.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22385.2	B08		5	0307-0547	416.32	546.55	299	65.60	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15740.5	B08		5	0308-0549	501.07	550.03	257	67.01	0.719
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18210.8	B08		5	0309-0548	914.84	547.20	322	67.60	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15644.9	B08		5	0310-0547	861.68	547.45	240	58.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15540.9	B08		5	0311-0550	333.81	549.73	238	60.43	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15453.5	B08		5	0312-0552	96.40	551.94	339	71.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	26286.8	B08		5	0313-0550	271.40	550.14	145	47.70	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15553.9	B08		5	0314-0558	159.75	557.98	250	57.94	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16514.2	B08		5	0315-0557	32.26	556.67	214	53.70	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14276.5	B08		5	0316-0560	226.45	559.89	257	66.77	0.724
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14435.3	B08		5	0317-0563	884.68	563.30	252	60.53	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14146.7	B08		5	0318-0563	187.93	563.47	259	60.18	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18461.4	B08		5	0319-0566	488.24	566.76	425	80.43	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12762.3	B08		5	0320-0567	726.77	566.37	288	65.01	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23508.2	B08		5	0321-0570	782.32	570.74	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13785.0	B08		5	0322-0572	138.28	572.28	266	60.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14487.9	B08		5	0323-0577	605.38	577.36	304	65.01	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18047.8	B08		5	0324-0577	257.41	577.32	212	53.36	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14726.0	B08		5	0325-0584	826.31	584.13	267	61.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14418.0	B08		5	0326-0589	905.56	588.89	251	63.60	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18242.0	B08		5	0327-0591	303.02	590.39	204	53.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14789.7	B08		5	0328-0592	671.11	592.34	289	61.94	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13023.0	B08		5	0329-0594	218.77	593.42	285	65.01	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17949.7	B08		5	0330-0593	842.59	593.52	206	53.94	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16921.3	B08		5	0331-0597	890.09	598.13	215	55.70	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21460.8	B08		5	0332-0601	172.79	601.25	348	76.67	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14993.7	B08		5	0333-0602	495.55	601.80	263	59.60	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16745.1	B08		5	0334-0602	698.64	601.29	225	56.53	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14362.8	B08		5	0335-0605	348.19	605.29	285	67.50	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19279.4	B08		5	0336-0606	585.00	606.28	382	74.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15609.0	B08		5	0337-0607	38.14	607.31	229	58.18	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20531.4	B08		5	0338-0610	540.02	609.60	234	59.01	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14639.7	B08		5	0339-0610	417.90	610.62	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15707.6	B08		5	0340-0612	509.01	612.46	249	59.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18935.5	B08		5	0341-0611	793.96	611.55	308	64.77	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19472.7	B08		5	0342-0614	923.70	614.42	241	56.77	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16494.3	B08		5	0343-0616	320.44	616.36	299	65.26	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19674.1	B08		5	0344-0619	712.48	618.24	295	63.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16593.4	B08		5	0345-0621	215.75	620.77	456	88.91	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14791.5	B08		5	0346-0620	757.65	620.59	258	61.94	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17004.5	B08		5	0347-0622	453.10	622.06	232	56.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21556.1	B08		5	0348-0624	546.22	624.36	285	65.01	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16109.9	B08		5	0349-0623	174.39	622.87	236	56.53	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20301.1	B08		5	0350-0622	870.83	622.71	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18224.2	B08		5	0351-0628	605.87	627.99	397	76.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18754.5	B08		5	0352-0624	946.97	624.84	281	62.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13689.9	B08		5	0353-0628	36.42	628.14	277	72.43	0.664
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17002.2	B08		5	0354-0627	248.60	627.74	260	59.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17046.0	B08		5	0355-0629	830.24	628.84	222	63.26	0.697
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14270.1	B08		5	0356-0633	370.33	632.80	275	64.77	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18325.1	B08		5	0357-0636	408.74	635.45	333	70.18	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19989.5	B08		5	0358-0634	559.32	634.44	189	51.46	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15116.8	B08		5	0359-0638	768.63	638.12	249	61.11	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13115.3	B08		5	0360-0644	477.73	644.58	285	65.60	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16785.2	B08		5	0361-0646	141.04	646.00	238	58.53	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16581.7	B08		5	0362-0645	624.71	644.66	226	55.70	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15766.1	B08		5	0363-0648	565.94	648.44	244	60.53	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15165.8	B08		5	0364-0655	923.94	655.47	386	75.60	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19597.4	B08		5	0365-0654	227.52	653.58	294	63.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15929.8	B08		5	0366-0653	685.29	652.45	228	58.77	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13870.6	B08		5	0367-0655	855.20	655.65	287	62.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14959.8	B08		5	0368-0656	278.26	655.64	249	62.53	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16271.6	B08		5	0369-0655	514.61	654.75	228	56.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16425.3	B08		5	0370-0656	649.18	656.57	234	57.94	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14704.2	B08		5	0371-0656	726.71	655.54	244	57.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14042.7	B08		5	0372-0663	819.55	663.14	272	61.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15748.0	B08		5	0373-0663	156.97	663.83	233	57.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15852.6	B08		5	0374-0668	103.57	668.66	288	64.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16670.0	B08		5	0375-0668	297.00	668.30	230	56.77	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21987.1	B08		5	0376-0676	637.78	676.57	328	67.94	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18350.2	B08		5	0377-0675	746.61	675.50	218	56.28	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18883.3	B08		5	0378-0673	784.03	672.98	198	54.53	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17567.6	B08		5	0379-0680	130.23	679.86	225	55.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14246.5	B08		5	0380-0681	352.98	681.85	262	60.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18125.0	B08		5	0381-0678	400.87	678.35	219	56.53	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13795.5	B08		5	0382-0680	564.26	680.36	266	60.18	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14512.7	B08		5	0383-0681	809.99	680.69	259	58.53	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15120.8	B08		5	0384-0681	260.11	680.66	242	61.11	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15054.3	B08		5	0385-0682	443.93	681.27	251	58.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13755.3	B08		5	0386-0681	518.84	681.30	267	61.94	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16957.2	B08		5	0387-0689	851.09	689.63	349	71.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14322.4	B08		5	0388-0685	944.31	685.34	228	57.11	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15699.7	B08		5	0389-0689	331.92	689.08	240	58.28	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17305.9	B08		5	0390-0688	175.30	688.12	233	61.60	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16861.1	B08		5	0391-0697	481.88	696.74	235	59.11	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17656.5	B08		5	0392-0696	499.67	696.24	222	59.36	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20319.9	B08		5	0393-0699	454.71	698.92	176	50.28	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19182.5	B08		5	0394-0702	763.55	701.67	360	71.84	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14798.3	B08		5	0395-0702	181.65	702.87	251	59.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21899.3	B08		5	0396-0704	832.21	704.19	334	67.60	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14061.1	B08		5	0397-0706	628.57	706.03	292	65.36	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17325.4	B08		5	0398-0707	607.56	708.06	218	56.28	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17812.5	B08		5	0399-0710	334.25	709.85	209	53.11	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184814	1375313	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16764.4	B08		5	0400-0711	275.53	711.28	216	59.70	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16100.4	B08		6	0001-0028	566.76	28.73	247	61.36	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15444.6	B08		6	0002-0030	203.14	30.57	437	79.26	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22535.1	B08		6	0003-0027	815.03	27.38	269	60.53	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15978.6	B08		6	0004-0028	518.48	27.57	250	59.94	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14975.2	B08		6	0005-0032	878.67	31.47	241	60.18	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15809.0	B08		6	0006-0034	238.40	33.37	239	58.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18169.9	B08		6	0007-0032	292.61	32.32	341	69.11	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22726.7	B08		6	0008-0042	603.48	42.80	661	124.71	0.534
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14797.9	B08		6	0009-0035	387.87	34.87	352	71.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14687.8	B08		6	0010-0036	117.52	36.42	257	60.77	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18309.3	B08		6	0011-0044	29.89	44.06	304	66.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18557.7	B08		6	0012-0047	136.17	48.47	208	63.36	0.651
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15676.1	B08		6	0013-0046	277.18	45.73	246	58.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15139.9	B08		6	0014-0048	920.08	48.74	236	58.53	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17655.7	B08		6	0015-0053	47.84	53.09	219	56.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16705.3	B08		6	0016-0057	391.41	57.27	229	56.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16430.5	B08		6	0017-0059	692.75	59.01	218	55.94	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19357.4	B08		6	0018-0062	852.91	61.86	412	77.50	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12562.1	B08		6	0019-0057	351.17	57.35	167	50.28	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16017.0	B08		6	0020-0061	204.10	61.84	226	55.94	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16246.5	B08		6	0021-0063	730.17	63.45	233	59.11	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10972.8	B08		6	0022-0064	498.72	63.16	245	69.01	0.646
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15554.6	B08		6	0023-0063	678.46	63.79	253	60.53	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14920.5	B08		6	0024-0062	800.33	61.85	244	58.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13173.9	B08		6	0025-0068	226.95	67.53	270	62.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15667.8	B08		6	0026-0066	278.84	66.39	246	60.18	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19102.5	B08		6	0027-0072	181.60	72.64	259	59.60	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	24134.9	B08		6	0028-0073	303.97	72.75	142	50.87	0.690
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19602.9	B08		6	0029-0075	873.16	74.78	181	55.46	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12741.2	B08		6	0030-0077	137.57	77.45	281	70.77	0.705
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18502.6	B08		6	0031-0072	369.31	71.86	216	56.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14507.2	B08		6	0032-0074	93.35	74.42	277	66.18	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15961.9	B08		6	0033-0076	749.60	75.53	247	60.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15172.2	B08		6	0034-0074	828.53	75.12	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10163.6	B08		6	0035-0074	468.50	73.93	140	53.60	0.612
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22000.5	B08		6	0036-0075	887.21	74.53	157	46.28	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21199.8	B08		6	0037-0076	291.02	76.96	172	51.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17245.5	B08		6	0038-0078	326.11	77.87	206	53.11	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14691.6	B08		6	0039-0081	945.11	81.27	264	61.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10338.0	B08		6	0040-0083	475.33	83.97	171	69.50	0.445
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17294.6	B08		6	0041-0084	646.17	83.21	217	57.01	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17181.1	B08		6	0042-0084	782.09	84.02	216	62.43	0.697
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20758.7	B08		6	0043-0090	621.04	89.96	363	79.50	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15531.6	B08		6	0044-0090	264.22	90.64	234	58.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23330.4	B08		6	0045-0094	656.83	94.92	306	66.08	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23985.0	B08		6	0046-0095	382.88	95.30	152	47.46	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17154.0	B08		6	0047-0096	915.08	96.39	207	53.70	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17689.6	B08		6	0048-0101	758.37	101.39	211	57.46	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23353.0	B08		6	0049-0100	845.38	100.20	293	63.94	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22532.1	B08		6	0050-0102	96.53	102.95	297	64.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16443.6	B08		6	0051-0101	298.56	101.23	244	58.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17076.3	B08		6	0052-0100	798.87	100.66	225	56.28	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21353.1	B08		6	0053-0104	198.14	103.63	280	61.60	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14855.5	B08		6	0054-0103	877.50	103.52	247	58.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14361.5	B08		6	0055-0102	942.13	102.05	251	59.70	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23970.4	B08		6	0056-0107	744.36	107.67	162	47.21	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23553.3	B08		6	0057-0108	391.85	108.59	153	45.46	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13927.8	B08		6	0058-0113	78.79	113.28	277	65.36	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16879.9	B08		6	0059-0113	242.98	113.41	218	53.70	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	24473.5	B08		6	0060-0116	766.18	115.78	150	48.04	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18313.5	B08		6	0061-0116	804.17	116.51	207	54.28	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17069.3	B08		6	0062-0119	279.97	119.87	232	56.28	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16805.3	B08		6	0063-0123	914.69	123.08	259	61.01	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14630.0	B08		6	0064-0122	429.92	122.38	403	79.60	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16413.1	B08		6	0065-0128	842.71	127.97	474	112.37	0.472
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20461.1	B08		6	0066-0127	889.58	127.61	385	73.50	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21887.3	B08		6	0067-0125	389.34	124.73	336	69.36	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10702.4	B08		6	0068-0127	691.92	126.57	245	71.84	0.597
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16911.9	B08		6	0069-0127	175.41	127.89	218	53.36	0.962
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21830.6	B08		6	0070-0132	125.98	132.86	282	62.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18898.8	B08		6	0071-0134	29.09	133.61	376	76.08	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13176.8	B08		6	0072-0130	208.92	130.13	164	48.28	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18121.6	B08		6	0073-0131	813.04	132.02	186	52.87	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14026.2	B08		6	0074-0133	355.82	133.13	343	67.94	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13938.8	B08		6	0075-0138	732.48	138.25	276	61.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13348.3	B08		6	0076-0144	149.47	145.45	274	73.60	0.636
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17714.4	B08		6	0077-0140	309.01	139.24	216	55.94	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14369.0	B08		6	0078-0143	196.39	143.48	203	56.28	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13371.5	B08		6	0079-0149	786.60	150.31	291	65.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16195.4	B08		6	0080-0150	386.37	149.85	275	60.77	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16449.2	B08		6	0081-0148	817.30	148.22	250	75.01	0.558
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14694.2	B08		6	0082-0150	946.96	149.91	242	58.18	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	24277.4	B08		6	0083-0153	273.24	154.02	289	65.01	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14680.3	B08		6	0084-0155	131.09	155.52	247	59.01	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21801.0	B08		6	0085-0157	246.98	157.73	337	69.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18240.7	B08		6	0086-0158	457.24	158.53	339	68.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15394.3	B08		6	0087-0158	208.77	158.21	242	58.18	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20389.6	B08		6	0088-0166	49.73	166.25	354	70.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15062.2	B08		6	0089-0166	287.54	166.76	248	58.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15124.9	B08		6	0090-0175	870.84	175.38	381	75.26	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13221.3	B08		6	0091-0172	735.60	172.28	234	59.36	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14992.3	B08		6	0092-0175	835.95	175.10	250	57.94	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17381.8	B08		6	0093-0179	464.94	179.35	215	56.28	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21714.4	B08		6	0094-0179	190.45	179.29	343	71.36	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17531.9	B08		6	0095-0182	76.79	183.02	272	67.01	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23028.3	B08		6	0096-0182	373.99	181.65	227	79.98	0.446
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13888.2	B08		6	0097-0181	690.04	180.83	277	62.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15582.7	B08		6	0098-0181	231.23	181.50	233	55.94	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19758.6	B08		6	0099-0183	917.64	183.66	167	53.60	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19423.9	B08		6	0100-0184	776.85	184.50	201	52.53	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18074.9	B08		6	0101-0185	758.74	184.56	217	53.36	0.958
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17316.0	B08		6	0102-0188	800.20	188.71	333	70.43	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14505.1	B08		6	0103-0190	397.97	190.57	256	61.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13173.3	B08		6	0104-0192	899.37	192.46	295	64.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20480.0	B08		6	0105-0200	108.71	200.14	359	70.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16580.5	B08		6	0106-0201	56.29	200.70	237	57.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16368.5	B08		6	0107-0200	681.99	201.10	237	62.18	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16678.8	B08		6	0108-0201	834.80	200.47	355	73.26	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15277.8	B08		6	0109-0203	176.64	202.27	263	66.18	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14386.6	B08		6	0110-0209	310.51	208.53	366	75.94	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17858.1	B08		6	0111-0209	472.29	209.39	215	55.94	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16498.2	B08		6	0112-0214	606.09	213.84	242	58.53	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17034.3	B08		6	0113-0214	818.32	214.27	239	57.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21729.5	B08		6	0114-0217	248.87	217.11	332	67.01	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20656.4	B08		6	0115-0217	500.00	216.60	186	49.94	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15641.4	B08		6	0116-0220	568.92	220.19	257	58.77	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23642.7	B08		6	0117-0224	726.78	223.78	320	67.60	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14593.5	B08		6	0118-0225	142.72	225.23	246	57.60	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17160.5	B08		6	0119-0226	234.60	227.06	200	53.70	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16698.3	B08		6	0120-0230	948.80	230.29	228	56.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23519.4	B08		6	0121-0228	659.39	227.78	153	49.80	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20176.3	B08		6	0122-0236	910.61	235.65	274	68.43	0.735
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18384.0	B08		6	0123-0235	375.34	234.72	210	54.04	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16864.5	B08		6	0124-0234	790.33	235.13	163	49.36	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	2487.7	B08		6	0125-0238	896.97	238.66	203	60.77	0.691
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13293.8	B08		6	0126-0240	625.02	239.52	279	64.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16484.3	B08		6	0127-0246	178.90	245.48	428	85.50	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21006.3	B08		6	0128-0245	438.35	245.28	355	72.77	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13489.7	B08		6	0129-0245	646.48	243.67	266	67.60	0.732
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22186.9	B08		6	0130-0239	663.76	238.35	168	49.21	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16875.8	B08		6	0131-0243	67.63	243.52	213	56.28	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	28713.9	B08		6	0132-0247	486.91	246.95	253	64.18	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15414.6	B08		6	0133-0248	531.09	248.44	249	61.01	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16760.4	B08		6	0134-0251	417.01	250.38	212	58.77	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13562.5	B08		6	0135-0253	118.79	252.54	264	60.43	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15176.8	B08		6	0136-0252	675.65	252.20	285	64.53	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14849.2	B08		6	0137-0256	749.14	256.19	300	66.18	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22297.0	B08		6	0138-0253	368.01	252.98	164	51.11	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13023.9	B08		6	0139-0259	598.98	259.20	285	64.87	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17333.4	B08		6	0140-0256	824.76	255.95	217	56.77	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15828.5	B08		6	0141-0259	797.20	259.04	239	58.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15735.8	B08		6	0142-0261	21.52	261.09	298	65.01	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16526.5	B08		6	0143-0259	875.37	259.08	221	56.77	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11082.3	B08		6	0144-0261	553.37	260.39	166	60.18	0.576
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19122.7	B08		6	0145-0263	328.58	263.39	305	65.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16324.7	B08		6	0146-0265	465.15	265.36	291	63.11	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19879.2	B08		6	0147-0271	68.92	272.53	363	108.23	0.389
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19648.1	B08		6	0148-0272	378.93	270.94	392	79.84	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18606.3	B08		6	0149-0267	850.10	267.54	159	47.70	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16371.7	B08		6	0150-0267	833.39	268.08	242	59.70	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15161.1	B08		6	0151-0270	502.39	270.25	255	61.11	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16378.9	B08		6	0152-0269	695.23	268.96	241	59.46	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12038.6	B08		6	0153-0274	150.00	273.10	270	66.43	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16801.3	B08		6	0154-0274	212.56	275.08	217	53.94	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11020.4	B08		6	0155-0272	548.82	271.76	128	44.87	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14117.7	B08		6	0156-0279	749.96	279.48	346	77.60	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19944.9	B08		6	0157-0284	596.70	283.79	306	64.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15049.3	B08		6	0158-0285	26.16	285.99	324	68.18	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	3620.1	B08		6	0159-0287	859.77	287.10	212	55.36	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15617.7	B08		6	0160-0289	272.88	290.40	237	58.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17861.2	B08		6	0161-0300	476.24	299.32	489	97.88	0.641
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14955.9	B08		6	0162-0294	791.90	294.98	252	59.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14902.1	B08		6	0163-0297	932.42	297.09	289	64.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13635.5	B08		6	0164-0296	306.06	296.08	262	61.60	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15637.0	B08		6	0165-0298	403.47	297.49	312	65.60	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20351.6	B08		6	0166-0296	349.69	295.43	248	58.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14267.1	B08		6	0167-0295	433.52	295.30	274	64.77	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20701.0	B08		6	0168-0305	645.39	304.40	304	64.18	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21624.8	B08		6	0169-0305	706.26	305.14	243	59.11	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22080.8	B08		6	0170-0313	93.83	312.17	329	85.50	0.566
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17905.1	B08		6	0171-0309	41.27	308.98	197	57.11	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18796.5	B08		6	0172-0306	730.39	305.71	220	55.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12565.8	B08		6	0173-0312	150.84	313.41	276	66.77	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14666.7	B08		6	0174-0313	24.52	313.16	261	59.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16268.2	B08		6	0175-0313	793.17	313.02	264	59.70	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17015.6	B08		6	0176-0315	439.81	316.01	212	55.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17252.9	B08		6	0177-0317	396.13	317.87	407	81.01	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22586.6	B08		6	0178-0318	545.03	318.51	318	65.01	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15063.7	B08		6	0179-0327	754.74	327.17	263	61.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17166.6	B08		6	0180-0331	645.40	330.50	297	62.77	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17756.6	B08		6	0181-0334	491.61	334.18	219	55.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14956.2	B08		6	0182-0342	301.32	342.68	475	83.50	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17645.0	B08		6	0183-0340	61.74	339.55	158	51.11	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18446.4	B08		6	0184-0339	792.04	339.66	201	52.53	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17535.6	B08		6	0185-0342	72.89	343.66	231	63.11	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	28404.3	B08		6	0186-0341	550.94	341.55	258	58.53	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19308.1	B08		6	0187-0345	938.04	345.64	413	76.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14393.8	B08		6	0188-0345	247.62	345.92	257	62.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17425.2	B08		6	0189-0345	736.76	345.12	222	56.18	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13552.8	B08		6	0190-0352	915.67	352.18	387	81.01	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16688.2	B08		6	0191-0352	377.14	351.79	219	57.70	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18739.3	B08		6	0192-0351	498.07	351.01	213	53.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	24548.1	B08		6	0193-0353	692.35	352.74	324	67.36	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17142.3	B08		6	0194-0357	364.46	357.85	224	56.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16364.3	B08		6	0195-0360	461.11	360.46	289	67.84	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17278.9	B08		6	0196-0361	649.92	360.91	230	56.53	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18011.0	B08		6	0197-0363	727.33	363.16	361	72.08	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18883.5	B08		6	0198-0362	812.22	361.84	247	58.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	25951.4	B08		6	0199-0362	324.84	362.43	285	62.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18755.1	B08		6	0200-0364	433.33	364.31	205	53.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18048.3	B08		6	0201-0369	678.26	369.38	217	56.77	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19079.5	B08		6	0202-0376	638.40	376.92	207	56.18	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5587.4	B08		6	0203-0372	911.90	372.84	164	47.21	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15461.1	B08		6	0204-0379	717.08	380.18	358	71.26	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13183.2	B08		6	0205-0383	151.22	382.57	305	66.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17907.9	B08		6	0206-0382	289.74	381.60	226	57.36	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17426.8	B08		6	0207-0386	890.49	386.72	261	61.84	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17444.7	B08		6	0208-0387	834.65	386.96	213	56.87	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16146.3	B08		6	0209-0390	82.98	390.33	240	58.77	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11775.4	B08		6	0210-0392	36.05	392.71	211	67.01	0.590
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15918.8	B08		6	0211-0392	183.93	392.40	256	60.53	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	24339.4	B08		6	0212-0392	298.98	391.86	144	51.01	0.695
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13764.0	B08		6	0213-0394	114.07	394.56	296	64.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17762.7	B08		6	0214-0394	281.33	394.54	232	57.11	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18479.4	B08		6	0215-0394	412.94	394.12	236	58.18	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23814.5	B08		6	0216-0397	433.84	396.77	302	64.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16425.7	B08		6	0217-0397	808.95	397.53	287	63.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11246.6	B08		6	0218-0399	16.41	398.13	187	55.36	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	24661.7	B08		6	0219-0397	306.38	397.19	106	41.46	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14558.9	B08		6	0220-0401	566.73	401.12	273	61.60	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17172.1	B08		6	0221-0400	702.01	399.92	259	60.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14398.0	B08		6	0222-0402	262.75	402.44	261	59.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14858.6	B08		6	0223-0402	896.29	402.41	262	64.28	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14356.9	B08		6	0224-0402	917.05	402.60	176	50.53	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22116.9	B08		6	0225-0402	210.70	402.36	213	55.46	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21691.6	B08		6	0226-0406	634.54	405.98	182	52.53	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16315.0	B08		6	0227-0407	617.53	407.50	242	58.04	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16713.1	B08		6	0228-0410	844.46	410.10	232	59.11	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14853.4	B08		6	0229-0414	863.80	414.11	264	61.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19099.1	B08		6	0230-0419	316.94	419.35	384	73.50	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15803.4	B08		6	0231-0416	247.34	416.66	321	66.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15394.5	B08		6	0232-0418	543.53	418.25	242	59.36	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18141.7	B08		6	0233-0420	160.59	420.35	351	71.84	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16116.2	B08		6	0234-0420	689.89	420.40	331	71.01	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21152.1	B08		6	0235-0417	919.49	417.35	174	48.04	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16953.0	B08		6	0236-0420	650.08	420.06	260	61.36	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15665.4	B08		6	0237-0424	349.77	424.67	239	59.84	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18654.3	B08		6	0238-0422	529.94	422.92	197	54.28	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11398.9	B08		6	0239-0422	766.88	421.56	159	53.94	0.687
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22330.3	B08		6	0240-0430	842.47	430.45	339	69.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13086.0	B08		6	0241-0430	118.40	430.35	258	61.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20701.4	B08		6	0242-0431	611.93	431.41	318	67.01	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16797.0	B08		6	0243-0431	914.42	431.01	211	57.36	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18509.9	B08		6	0244-0432	934.62	432.12	214	58.53	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12822.6	B08		6	0245-0435	49.57	435.67	253	58.28	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10917.1	B08		6	0246-0432	771.14	431.83	128	51.70	0.602
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19209.6	B08		6	0247-0434	896.37	433.69	188	51.94	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17927.2	B08		6	0248-0443	875.29	443.91	144	50.53	0.709
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14461.4	B08		6	0249-0443	261.47	443.67	254	59.11	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20019.5	B08		6	0250-0444	558.68	443.73	283	64.53	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13542.3	B08		6	0251-0449	448.25	449.72	290	66.77	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14965.3	B08		6	0252-0448	228.27	448.43	318	67.94	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18796.8	B08		6	0253-0454	590.24	454.84	417	75.01	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12284.4	B08		6	0254-0455	50.24	454.70	312	65.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20282.3	B08		6	0255-0452	174.21	452.40	213	55.80	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15683.2	B08		6	0256-0455	701.19	455.85	283	66.67	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19630.0	B08		6	0257-0452	853.43	452.66	186	53.70	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18291.0	B08		6	0258-0457	671.01	456.28	211	57.94	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18207.9	B08		6	0259-0458	464.15	458.21	320	68.18	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17234.6	B08		6	0260-0458	747.26	458.97	233	64.43	0.705
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11975.0	B08		6	0261-0462	420.15	463.25	341	75.50	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15796.8	B08		6	0262-0459	85.49	459.20	238	57.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18084.9	B08		6	0263-0459	507.37	459.32	214	54.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20759.1	B08		6	0264-0465	314.66	465.76	333	71.01	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19620.7	B08		6	0265-0466	136.07	466.13	354	71.11	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16991.1	B08		6	0266-0468	172.72	467.77	250	63.70	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16053.9	B08		6	0267-0473	491.59	472.88	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15315.1	B08		6	0268-0473	815.16	473.17	253	59.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14555.5	B08		6	0269-0478	780.69	477.91	325	68.77	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17342.3	B08		6	0270-0475	227.97	475.28	214	57.11	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16127.1	B08		6	0271-0480	211.70	481.35	251	62.18	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23233.7	B08		6	0272-0483	859.42	482.86	271	64.18	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17273.8	B08		6	0273-0485	752.35	484.85	237	60.87	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17219.1	B08		6	0274-0483	585.53	483.73	243	63.36	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16424.1	B08		6	0275-0484	385.51	485.19	164	50.87	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16873.5	B08		6	0276-0488	89.40	489.15	395	75.01	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16743.8	B08		6	0277-0489	296.69	488.85	244	58.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16960.5	B08		6	0278-0492	143.08	492.32	228	55.36	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16517.9	B08		6	0279-0491	336.64	491.70	220	56.28	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15995.4	B08		6	0280-0492	513.77	492.88	252	59.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13938.1	B08		6	0281-0498	48.00	498.20	251	59.94	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21905.4	B08		6	0282-0498	852.36	498.53	283	65.60	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14830.8	B08		6	0283-0500	111.63	500.19	240	58.77	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18468.0	B08		6	0284-0500	478.43	499.97	207	51.46	0.982
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18064.0	B08		6	0285-0501	795.41	501.71	210	53.70	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17138.1	B08		6	0286-0503	443.46	502.86	393	76.67	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22880.2	B08		6	0287-0504	559.57	504.46	323	67.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18962.6	B08		6	0288-0504	831.86	504.47	290	62.53	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19452.7	B08		6	0289-0505	333.16	504.68	199	54.87	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17299.0	B08		6	0290-0509	934.43	509.12	471	88.57	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17666.7	B08		6	0291-0510	601.38	510.61	350	70.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14211.7	B08		6	0292-0512	911.09	511.98	298	68.18	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16966.2	B08		6	0293-0514	516.97	514.15	236	57.70	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17557.5	B08		6	0294-0515	42.43	515.91	283	62.18	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13553.2	B08		6	0295-0516	653.99	516.16	302	66.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15861.4	B08		6	0296-0518	896.99	517.89	228	60.77	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17366.2	B08		6	0297-0518	64.81	518.39	236	56.77	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12612.6	B08		6	0298-0521	259.18	521.20	288	64.43	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19094.9	B08		6	0299-0522	759.26	522.01	321	66.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13014.7	B08		6	0300-0521	695.19	521.83	316	67.84	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17149.2	B08		6	0301-0524	307.39	524.49	237	63.60	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19194.9	B08		6	0302-0524	537.36	523.04	202	57.36	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22482.5	B08		6	0303-0526	738.26	525.71	335	67.11	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18155.0	B08		6	0304-0530	442.40	529.89	215	53.94	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14821.4	B08		6	0305-0529	222.70	529.77	259	62.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13363.3	B08		6	0306-0533	148.88	533.45	266	64.77	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15988.0	B08		6	0307-0537	520.57	536.09	307	66.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16568.9	B08		6	0308-0540	795.24	540.18	237	62.77	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14946.1	B08		6	0309-0541	927.11	540.64	263	61.36	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14422.6	B08		6	0310-0541	111.28	540.83	251	61.94	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22936.7	B08		6	0311-0538	356.39	538.08	144	45.36	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16165.4	B08		6	0312-0542	430.57	542.86	238	62.43	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16264.2	B08		6	0313-0544	37.62	545.15	245	60.18	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18092.9	B08		6	0314-0547	665.59	548.67	353	72.67	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17727.8	B08		6	0315-0546	456.52	545.84	221	57.36	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14600.7	B08		6	0316-0549	376.55	548.79	276	62.87	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13632.4	B08		6	0317-0551	228.15	552.09	280	66.77	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15277.8	B08		6	0318-0547	558.15	547.60	267	61.94	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18137.2	B08		6	0319-0549	84.88	549.15	205	52.28	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22918.2	B08		6	0320-0548	343.66	548.44	170	50.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16472.9	B08		6	0321-0550	623.33	550.48	234	56.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17721.4	B08		6	0322-0553	852.44	553.40	224	58.53	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15767.5	B08		6	0323-0552	702.41	551.60	300	63.36	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16785.4	B08		6	0324-0555	65.46	554.14	214	59.70	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	30049.1	B08		6	0325-0559	412.48	559.15	240	58.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19123.6	B08		6	0326-0556	466.53	556.84	195	54.53	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15830.2	B08		6	0327-0560	785.46	559.58	267	62.43	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15582.1	B08		6	0328-0560	950.45	560.92	238	60.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12859.7	B08		6	0329-0566	215.30	565.75	257	61.70	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18737.9	B08		6	0330-0569	328.41	568.40	269	61.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14707.2	B08		6	0331-0574	461.56	575.67	264	67.36	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19812.1	B08		6	0332-0573	871.02	573.07	373	70.18	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15727.8	B08		6	0333-0572	501.78	572.33	159	49.11	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17458.2	B08		6	0334-0578	44.25	578.31	327	75.01	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20509.9	B08		6	0335-0576	831.51	575.40	184	50.87	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	26820.9	B08		6	0336-0579	405.43	579.94	296	65.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14521.8	B08		6	0337-0580	940.14	579.77	260	61.94	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20249.0	B08		6	0338-0582	118.12	582.44	355	70.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14469.5	B08		6	0339-0581	545.71	581.43	267	62.43	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14538.3	B08		6	0340-0583	758.34	583.80	270	60.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18403.3	B08		6	0341-0590	861.76	590.73	212	56.28	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12951.7	B08		6	0342-0593	897.40	593.24	281	63.60	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14214.0	B08		6	0343-0595	503.64	594.99	153	46.28	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18658.8	B08		6	0344-0598	186.48	597.91	353	69.84	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13904.9	B08		6	0345-0598	925.56	598.86	254	59.11	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15445.4	B08		6	0346-0594	793.86	594.85	119	44.28	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13154.0	B08		6	0347-0601	45.57	601.17	270	62.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15932.9	B08		6	0348-0604	674.21	604.94	328	70.77	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16841.1	B08		6	0349-0605	300.47	604.75	327	68.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15975.7	B08		6	0350-0604	797.84	604.85	204	61.94	0.668
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13897.1	B08		6	0351-0610	121.59	610.26	241	58.53	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22932.1	B08		6	0352-0614	419.35	614.52	331	67.60	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20772.6	B08		6	0353-0617	18.20	617.26	228	54.53	0.964
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18890.9	B08		6	0354-0620	371.00	620.02	395	78.08	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15256.5	B08		6	0355-0618	818.54	619.07	286	63.11	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15502.5	B08		6	0356-0621	886.62	621.92	270	61.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13077.5	B08		6	0357-0624	540.31	624.49	305	65.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19086.7	B08		6	0358-0624	108.75	623.92	311	66.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14299.3	B08		6	0359-0624	238.42	623.48	277	64.53	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19614.9	B08		6	0360-0627	41.31	627.73	283	63.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17730.6	B08		6	0361-0632	771.16	631.75	395	74.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17303.3	B08		6	0362-0638	948.41	638.14	366	72.43	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	25665.0	B08		6	0363-0639	381.42	638.47	293	64.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16812.4	B08		6	0364-0642	841.54	642.68	274	63.84	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15484.7	B08		6	0365-0646	214.06	645.66	254	63.11	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15850.8	B08		6	0366-0646	912.19	645.78	237	57.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16229.0	B08		6	0367-0648	64.54	648.32	224	56.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12486.3	B08		6	0368-0650	489.58	649.78	282	63.01	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15703.8	B08		6	0369-0653	422.26	652.20	405	76.67	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17647.4	B08		6	0370-0648	826.17	648.23	215	54.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15161.0	B08		6	0371-0653	113.86	652.70	231	58.87	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15619.2	B08		6	0372-0653	602.39	653.01	329	69.01	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15283.2	B08		6	0373-0658	18.30	658.28	370	72.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12218.2	B08		6	0374-0655	712.94	655.48	293	65.36	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	24244.3	B08		6	0375-0658	328.43	658.02	305	64.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15398.9	B08		6	0376-0664	781.20	663.74	247	59.36	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15242.0	B08		6	0377-0662	900.70	662.82	224	56.53	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15574.9	B08		6	0378-0664	148.61	664.67	220	53.94	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16263.8	B08		6	0379-0663	524.35	662.59	272	61.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15725.7	B08		6	0380-0665	835.11	664.12	225	61.01	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19443.5	B08		6	0381-0673	210.21	673.07	188	52.87	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15780.4	B08		6	0382-0672	430.67	672.77	245	58.87	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16663.2	B08		6	0383-0673	822.78	674.69	235	58.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12872.5	B08		6	0384-0675	614.54	674.84	272	63.01	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16274.5	B08		6	0385-0674	859.84	673.39	222	57.01	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17871.0	B08		6	0386-0675	663.73	675.40	406	77.01	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15978.2	B08		6	0387-0677	744.93	677.07	237	59.11	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16808.8	B08		6	0388-0683	78.83	682.69	354	73.26	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14002.3	B08		6	0389-0681	930.27	681.12	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23938.3	B08		6	0390-0686	260.52	686.06	309	64.18	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17354.9	B08		6	0391-0684	802.37	683.50	206	53.11	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18487.7	B08		6	0392-0686	126.55	686.41	213	56.28	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23301.2	B08		6	0393-0687	406.24	687.58	300	63.60	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15093.8	B08		6	0394-0688	38.48	688.08	219	55.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16143.0	B08		6	0395-0692	336.61	691.64	260	61.01	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15504.4	B08		6	0396-0693	377.30	693.73	143	47.80	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16096.4	B08		6	0397-0694	473.18	694.78	246	59.94	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18111.0	B08		6	0398-0700	708.19	700.42	393	75.01	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15151.3	B08		6	0399-0699	725.25	699.07	256	59.70	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16542.3	B08		6	0400-0703	517.50	703.30	205	54.53	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19318.0	B08		6	0401-0706	576.37	706.19	196	53.94	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20671.7	B08		6	0402-0707	116.69	707.16	302	66.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184815	1375314	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15753.4	B08		6	0403-0709	376.77	708.80	241	61.70	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10986.3	B08		7	0001-0026	81.39	26.79	137	43.94	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15863.0	B08		7	0002-0029	247.78	28.87	248	59.11	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16489.4	B08		7	0003-0028	824.82	27.21	222	55.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20452.9	B08		7	0004-0033	560.84	33.13	299	64.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15161.8	B08		7	0005-0031	711.12	31.85	252	59.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17512.6	B08		7	0006-0036	632.02	36.41	452	80.08	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17159.8	B08		7	0007-0036	390.73	36.07	154	54.28	0.657
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16863.0	B08		7	0008-0040	52.67	39.62	298	66.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20296.6	B08		7	0009-0037	403.64	36.79	145	43.80	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21633.3	B08		7	0010-0043	16.80	44.41	162	53.70	0.706
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18488.4	B08		7	0011-0040	381.00	39.87	117	42.87	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17616.1	B08		7	0012-0047	30.32	48.28	217	59.94	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16063.6	B08		7	0013-0047	435.38	48.08	253	60.53	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16707.7	B08		7	0014-0046	920.57	45.84	220	55.11	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15333.3	B08		7	0015-0051	272.52	52.16	262	67.50	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19978.4	B08		7	0016-0050	486.01	50.03	449	81.26	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16612.0	B08		7	0017-0057	78.11	57.33	229	56.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17687.1	B08		7	0018-0063	120.28	62.76	458	79.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18709.0	B08		7	0019-0063	57.27	62.60	233	62.77	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15322.8	B08		7	0020-0064	310.19	63.67	254	74.08	0.582
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19905.1	B08		7	0021-0067	750.66	66.50	391	72.67	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19750.5	B08		7	0022-0066	821.45	66.51	304	65.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15269.6	B08		7	0023-0066	167.52	66.48	242	59.94	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13396.6	B08		7	0024-0067	451.50	67.38	306	67.84	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11258.5	B08		7	0025-0073	68.84	72.68	197	51.70	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18537.7	B08		7	0026-0078	911.74	78.18	401	74.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13443.6	B08		7	0027-0081	195.65	81.18	335	69.26	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18026.0	B08		7	0028-0083	493.62	83.30	468	86.91	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14235.2	B08		7	0029-0081	336.24	81.83	194	56.18	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13786.8	B08		7	0030-0084	688.64	84.51	298	66.67	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14765.3	B08		7	0031-0084	776.67	84.47	260	60.18	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14696.5	B08		7	0032-0087	403.82	87.15	260	59.60	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22258.3	B08		7	0033-0092	240.65	92.13	310	64.77	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15964.7	B08		7	0034-0096	739.27	96.03	240	58.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16463.6	B08		7	0035-0102	295.43	101.57	365	80.43	0.709
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13862.9	B08		7	0036-0106	440.25	106.12	284	64.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15598.2	B08		7	0037-0112	414.56	114.02	365	86.91	0.607
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13729.8	B08		7	0038-0113	24.04	114.25	259	58.77	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13833.8	B08		7	0039-0115	912.85	115.08	264	62.43	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17984.1	B08		7	0040-0112	91.25	111.96	205	54.28	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14086.9	B08		7	0041-0116	861.89	116.11	264	61.36	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19149.1	B08		7	0042-0122	319.98	122.32	317	69.60	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15282.0	B08		7	0043-0121	338.52	120.85	147	52.63	0.667
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16860.9	B08		7	0044-0123	389.16	122.64	301	66.43	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15663.2	B08		7	0045-0121	188.05	120.87	238	64.77	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20899.7	B08		7	0046-0130	584.23	129.68	444	82.08	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12326.2	B08		7	0047-0127	632.15	126.73	300	77.26	0.632
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18905.8	B08		7	0048-0128	236.19	127.72	257	57.70	0.970
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17871.2	B08		7	0049-0132	83.70	132.95	279	65.36	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19191.4	B08		7	0050-0132	157.49	131.97	151	45.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18097.7	B08		7	0051-0132	199.98	133.12	219	57.94	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14353.0	B08		7	0052-0135	440.86	136.01	267	62.77	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17558.7	B08		7	0053-0138	378.41	138.40	250	61.94	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15255.8	B08		7	0054-0143	802.02	142.93	505	87.84	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18841.2	B08		7	0055-0140	183.23	140.29	197	52.28	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21628.2	B08		7	0056-0141	168.37	141.83	204	53.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22972.3	B08		7	0057-0146	272.79	146.49	375	76.18	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19734.8	B08		7	0058-0143	290.74	142.61	123	42.28	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15806.8	B08		7	0059-0147	689.43	148.17	378	74.08	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18829.1	B08		7	0060-0151	888.71	150.40	366	70.77	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14777.2	B08		7	0061-0155	242.33	155.57	246	59.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17886.8	B08		7	0062-0159	495.41	159.53	476	81.26	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	24114.9	B08		7	0063-0154	140.59	153.43	151	49.36	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19793.9	B08		7	0064-0161	339.70	161.13	531	97.40	0.703
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	27910.1	B08		7	0065-0159	361.14	158.65	346	75.01	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17325.1	B08		7	0066-0159	674.90	159.46	220	57.60	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15002.5	B08		7	0067-0164	634.54	165.00	233	63.84	0.718
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22766.5	B08		7	0068-0163	134.49	163.21	162	51.60	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13738.0	B08		7	0069-0164	415.04	164.40	351	71.01	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13970.7	B08		7	0070-0164	465.84	164.38	268	60.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17566.7	B08		7	0071-0165	88.45	165.93	207	53.70	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17007.9	B08		7	0072-0167	43.25	167.63	240	56.28	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15848.5	B08		7	0073-0169	215.15	169.30	400	75.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14925.5	B08		7	0074-0174	818.62	173.99	505	87.26	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15035.0	B08		7	0075-0171	853.97	170.66	361	72.08	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14411.6	B08		7	0076-0171	607.12	171.03	221	55.70	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19581.0	B08		7	0077-0176	307.71	176.43	399	76.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17386.8	B08		7	0078-0174	773.89	174.10	219	53.94	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	26812.2	B08		7	0079-0173	920.75	174.10	151	66.43	0.430
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14966.3	B08		7	0080-0179	627.32	179.07	275	68.77	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16487.1	B08		7	0081-0183	92.24	182.24	227	58.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15002.9	B08		7	0082-0186	412.67	186.07	258	59.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13606.9	B08		7	0083-0191	529.97	191.30	400	74.91	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13573.4	B08		7	0084-0193	162.74	193.94	271	72.33	0.651
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21038.7	B08		7	0085-0194	571.70	194.47	302	64.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20814.7	B08		7	0086-0193	719.20	193.39	188	53.94	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22740.4	B08		7	0087-0196	899.44	197.36	350	72.18	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16710.9	B08		7	0088-0195	686.08	194.73	240	57.94	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15075.9	B08		7	0089-0197	218.70	197.96	244	59.36	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15316.7	B08		7	0090-0198	314.70	198.25	251	58.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18831.7	B08		7	0091-0196	613.26	196.59	204	56.87	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15161.3	B08		7	0092-0201	946.42	201.19	274	66.08	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16242.1	B08		7	0093-0206	58.01	206.48	258	61.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17488.1	B08		7	0094-0211	177.98	211.36	360	69.60	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21445.1	B08		7	0095-0216	397.84	216.51	337	69.26	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12701.3	B08		7	0096-0218	339.99	218.35	273	60.77	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20725.2	B08		7	0097-0221	569.60	222.01	391	87.50	0.642
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15341.6	B08		7	0098-0219	89.92	218.98	242	57.11	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16013.5	B08		7	0099-0225	446.62	225.98	396	76.43	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15650.3	B08		7	0100-0228	126.72	228.49	240	56.77	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17291.3	B08		7	0101-0228	413.78	228.49	276	61.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13423.5	B08		7	0102-0231	907.18	231.20	289	63.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16363.6	B08		7	0103-0232	720.98	231.94	236	62.67	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22621.2	B08		7	0104-0233	264.91	234.22	194	56.53	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19217.5	B08		7	0105-0234	283.80	234.69	332	68.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19554.1	B08		7	0106-0237	521.36	236.40	382	73.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20514.1	B08		7	0107-0236	947.56	236.18	340	68.77	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14144.1	B08		7	0108-0237	872.17	237.48	266	63.84	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22816.5	B08		7	0109-0245	843.77	243.71	350	102.57	0.418
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19200.0	B08		7	0110-0243	51.98	243.74	182	49.70	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18569.8	B08		7	0111-0243	604.19	243.46	216	59.36	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15241.1	B08		7	0112-0246	378.93	246.46	256	59.36	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16333.9	B08		7	0113-0249	463.00	249.54	233	56.53	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21668.8	B08		7	0114-0249	587.12	249.49	180	50.87	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11046.0	B08		7	0115-0254	128.47	254.68	307	80.57	0.594
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19590.4	B08		7	0116-0254	247.69	254.10	326	66.43	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16458.9	B08		7	0117-0256	397.74	256.62	240	57.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18666.9	B08		7	0118-0259	553.97	259.30	371	73.01	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13660.0	B08		7	0119-0257	323.31	257.59	255	59.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15783.6	B08		7	0120-0264	877.21	264.15	243	65.94	0.702
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19596.9	B08		7	0121-0264	429.23	263.74	193	51.11	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16194.7	B08		7	0122-0265	682.52	264.78	242	60.18	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14611.4	B08		7	0123-0268	23.52	267.27	312	68.67	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15285.0	B08		7	0124-0273	942.28	273.29	228	55.11	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12851.9	B08		7	0125-0277	472.77	276.83	285	65.36	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15201.0	B08		7	0126-0279	591.93	279.81	335	67.60	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17735.6	B08		7	0127-0280	373.41	281.31	303	65.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12053.0	B08		7	0128-0281	97.96	280.43	287	68.18	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15286.2	B08		7	0129-0289	160.03	289.59	504	84.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15537.0	B08		7	0130-0286	717.44	286.35	251	59.94	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13705.3	B08		7	0131-0285	226.22	284.88	147	47.46	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14595.9	B08		7	0132-0287	884.60	287.66	261	63.01	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18115.4	B08		7	0133-0287	266.28	286.81	204	54.28	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15751.3	B08		7	0134-0295	42.73	293.97	470	84.67	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17963.3	B08		7	0135-0290	409.83	289.56	218	55.11	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16936.7	B08		7	0136-0296	638.34	296.98	357	70.43	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16589.5	B08		7	0137-0296	95.19	296.13	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18139.8	B08		7	0138-0300	300.90	299.53	352	70.18	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13479.1	B08		7	0139-0299	441.91	299.04	285	62.53	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16772.9	B08		7	0140-0303	747.06	302.21	284	64.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15587.0	B08		7	0141-0300	226.96	300.39	100	38.04	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11574.4	B08		7	0142-0307	921.16	307.62	285	79.50	0.567
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13328.2	B08		7	0143-0304	356.23	304.27	278	65.01	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19263.0	B08		7	0144-0303	621.62	304.04	199	53.11	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14637.6	B08		7	0145-0309	250.39	309.05	279	69.01	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14493.3	B08		7	0146-0312	495.72	311.78	412	83.98	0.734
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16243.8	B08		7	0147-0310	729.52	310.80	232	57.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17450.9	B08		7	0148-0311	762.11	310.96	229	57.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16790.5	B08		7	0149-0310	528.20	310.63	234	58.28	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15761.7	B08		7	0150-0312	795.82	311.91	291	64.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15356.5	B08		7	0151-0316	235.32	316.79	240	70.43	0.608
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19664.8	B08		7	0152-0312	410.34	312.51	248	58.63	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12545.6	B08		7	0153-0317	371.38	316.56	293	65.94	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19206.5	B08		7	0154-0316	266.32	316.82	171	48.87	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18526.8	B08		7	0155-0319	546.92	318.83	210	54.18	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19539.4	B08		7	0156-0321	27.86	321.46	191	51.36	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21456.7	B08		7	0157-0328	430.10	328.68	339	67.94	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19730.0	B08		7	0158-0327	847.85	326.72	221	54.28	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20313.0	B08		7	0159-0326	410.89	326.20	166	48.39	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21050.2	B08		7	0160-0331	450.98	331.32	320	66.53	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14661.6	B08		7	0161-0334	292.22	334.82	267	65.94	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19514.2	B08		7	0162-0336	930.56	336.09	198	53.60	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	24788.7	B08		7	0163-0336	162.68	335.79	175	49.94	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17457.0	B08		7	0164-0338	896.94	338.98	324	67.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	24249.2	B08		7	0165-0338	660.25	337.98	156	50.87	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14866.6	B08		7	0166-0341	646.64	340.59	261	61.11	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20212.6	B08		7	0167-0340	675.12	339.91	190	52.77	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12803.6	B08		7	0168-0342	707.87	342.91	276	69.84	0.711
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17100.5	B08		7	0169-0342	784.65	342.46	217	55.36	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15093.0	B08		7	0170-0343	309.89	343.09	258	60.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	24999.9	B08		7	0171-0346	481.88	346.11	316	72.77	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19780.5	B08		7	0172-0349	217.80	349.32	361	71.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18403.8	B08		7	0173-0347	153.24	347.05	227	56.18	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21757.2	B08		7	0174-0350	859.26	351.10	336	68.53	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21994.9	B08		7	0175-0349	800.64	349.33	177	49.70	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14602.2	B08		7	0176-0353	338.93	352.34	261	60.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17051.8	B08		7	0177-0358	71.12	358.95	447	91.74	0.667
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17843.8	B08		7	0178-0353	817.46	353.46	233	59.70	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14951.3	B08		7	0179-0362	371.36	361.56	494	93.05	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18104.8	B08		7	0180-0367	99.04	367.18	454	85.74	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	27593.9	B08		7	0181-0359	462.03	360.16	146	45.21	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15264.9	B08		7	0182-0369	691.26	369.39	264	64.08	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18003.6	B08		7	0183-0370	447.16	369.83	216	55.11	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16543.7	B08		7	0184-0370	843.94	370.61	319	66.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14233.8	B08		7	0185-0371	278.60	372.16	262	63.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14711.3	B08		7	0186-0375	503.14	375.57	260	65.36	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14542.6	B08		7	0187-0374	307.18	373.51	277	65.36	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14808.2	B08		7	0188-0373	354.76	374.48	147	49.36	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19872.5	B08		7	0189-0376	381.94	376.76	278	67.01	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13781.5	B08		7	0190-0380	727.75	380.71	335	69.84	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17261.1	B08		7	0191-0380	526.81	381.04	221	57.36	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15367.3	B08		7	0192-0384	684.62	383.73	275	63.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17551.0	B08		7	0193-0390	164.13	389.70	472	83.36	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22326.1	B08		7	0194-0387	798.47	387.55	357	70.43	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23392.8	B08		7	0195-0388	927.26	388.88	312	65.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14975.9	B08		7	0196-0394	185.85	393.76	261	63.01	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18978.9	B08		7	0197-0395	116.26	395.13	255	58.77	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15677.1	B08		7	0198-0393	840.15	393.95	241	57.70	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19567.7	B08		7	0199-0399	899.11	399.12	309	65.36	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22365.3	B08		7	0200-0400	555.73	400.33	333	71.01	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19316.2	B08		7	0201-0402	94.97	402.82	390	74.43	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15940.4	B08		7	0202-0403	503.44	403.91	240	59.70	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23692.9	B08		7	0203-0402	782.10	402.91	155	50.87	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11456.7	B08		7	0204-0406	870.45	407.13	285	71.01	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13857.6	B08		7	0205-0405	281.16	404.51	254	62.77	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15495.8	B08		7	0206-0408	439.39	407.70	223	57.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15686.9	B08		7	0207-0407	677.66	407.11	250	57.94	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13305.3	B08		7	0208-0409	946.76	409.94	278	67.01	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14424.0	B08		7	0209-0408	50.70	408.74	253	61.70	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12403.4	B08		7	0210-0408	329.76	408.12	319	72.43	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	188.1	B08		7	0211-0412	228.68	412.13	306	65.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	24395.7	B08		7	0212-0413	582.83	413.25	313	67.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22653.5	B08		7	0213-0409	753.48	408.41	161	49.70	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16719.5	B08		7	0214-0416	308.23	416.71	224	61.36	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19292.2	B08		7	0215-0419	544.64	418.65	204	51.94	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13259.2	B08		7	0216-0420	627.16	420.38	308	67.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14290.3	B08		7	0217-0423	938.35	422.78	276	65.26	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14775.1	B08		7	0218-0427	816.11	427.07	261	61.70	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13057.7	B08		7	0219-0428	330.82	429.26	299	66.43	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15454.0	B08		7	0220-0429	710.81	428.85	298	66.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13844.1	B08		7	0221-0431	199.59	430.66	279	63.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12931.7	B08		7	0222-0432	784.78	431.99	288	65.60	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17382.9	B08		7	0223-0436	80.45	436.11	367	73.11	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18536.7	B08		7	0224-0434	530.11	433.20	296	67.60	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23587.1	B08		7	0225-0437	547.31	438.14	267	65.26	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15150.3	B08		7	0226-0438	24.77	437.88	236	59.70	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21781.2	B08		7	0227-0437	102.70	437.10	222	58.18	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18075.3	B08		7	0228-0438	689.99	437.92	218	56.28	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14448.9	B08		7	0229-0444	644.17	443.89	414	80.67	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14563.1	B08		7	0230-0445	349.35	444.63	254	62.18	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13156.8	B08		7	0231-0448	673.60	448.71	311	67.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17117.9	B08		7	0232-0451	760.98	450.72	222	61.94	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13287.8	B08		7	0233-0451	577.59	451.76	277	63.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	24119.2	B08		7	0234-0454	817.04	453.79	324	68.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13811.1	B08		7	0235-0456	455.98	456.45	269	64.18	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	24390.8	B08		7	0236-0460	63.98	460.09	299	63.94	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11772.5	B08		7	0237-0466	864.93	466.05	302	80.91	0.580
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14910.1	B08		7	0238-0464	356.84	463.88	256	60.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13279.8	B08		7	0239-0466	513.38	466.70	281	63.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18838.3	B08		7	0240-0467	328.45	467.72	371	83.84	0.663
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19137.6	B08		7	0241-0468	849.84	468.20	184	53.46	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22287.2	B08		7	0242-0472	906.09	471.68	340	76.67	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15251.2	B08		7	0243-0470	203.00	469.81	222	58.18	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15692.6	B08		7	0244-0472	236.38	472.69	220	59.01	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12490.9	B08		7	0245-0477	934.34	478.49	318	72.43	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14932.2	B08		7	0246-0481	651.26	482.10	510	106.57	0.564
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22837.1	B08		7	0247-0486	129.79	486.75	499	86.67	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15950.1	B08		7	0248-0482	398.08	481.83	240	57.60	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19603.1	B08		7	0249-0484	782.53	484.13	397	75.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20870.6	B08		7	0250-0491	555.13	492.15	336	68.43	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13552.8	B08		7	0251-0493	488.53	493.04	280	65.01	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13782.6	B08		7	0252-0496	630.32	496.96	275	61.01	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15102.5	B08		7	0253-0504	76.36	503.82	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14321.8	B08		7	0254-0512	563.18	512.38	275	61.11	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22422.2	B08		7	0255-0515	929.60	515.28	331	67.84	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17694.3	B08		7	0256-0515	303.66	514.76	221	56.18	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17231.3	B08		7	0257-0517	419.55	516.60	219	54.87	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14538.7	B08		7	0258-0520	523.11	521.12	339	71.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14722.7	B08		7	0259-0523	102.70	523.12	267	67.94	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15833.6	B08		7	0260-0520	194.12	520.44	217	55.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15282.6	B08		7	0261-0521	781.22	521.50	240	62.18	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20275.7	B08		7	0262-0522	715.60	522.41	182	49.11	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15768.5	B08		7	0263-0529	225.10	528.94	309	65.11	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20339.6	B08		7	0264-0527	285.61	527.28	236	57.70	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15355.7	B08		7	0265-0530	149.38	529.94	288	65.94	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16835.4	B08		7	0266-0534	429.34	534.91	260	62.43	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17202.5	B08		7	0267-0536	770.17	537.07	227	56.18	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17774.8	B08		7	0268-0540	906.22	540.02	407	76.43	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18289.7	B08		7	0269-0540	335.32	539.97	212	55.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14733.3	B08		7	0270-0545	548.09	545.33	251	59.94	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18341.5	B08		7	0271-0545	270.40	544.99	189	51.94	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17477.6	B08		7	0272-0546	447.50	545.93	228	58.43	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16924.1	B08		7	0273-0553	804.74	553.28	232	58.77	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18814.2	B08		7	0274-0549	859.05	549.05	126	43.46	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18697.3	B08		7	0275-0551	482.79	550.94	212	53.70	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14449.3	B08		7	0276-0552	392.00	551.27	300	69.60	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18124.8	B08		7	0277-0553	821.00	553.94	198	56.18	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13672.7	B08		7	0278-0555	301.57	555.59	283	65.94	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14662.9	B08		7	0279-0558	776.62	558.39	269	62.53	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22098.0	B08		7	0280-0559	689.71	560.15	226	62.77	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20443.5	B08		7	0281-0560	339.19	559.53	187	51.36	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18139.9	B08		7	0282-0564	852.72	564.30	217	55.84	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15368.5	B08		7	0283-0565	273.27	565.52	251	61.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14140.0	B08		7	0284-0566	215.27	567.71	321	73.01	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16256.5	B08		7	0285-0568	794.53	567.90	241	58.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13800.2	B08		7	0286-0568	574.60	568.25	313	68.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15173.3	B08		7	0287-0571	97.09	571.01	324	68.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17731.1	B08		7	0288-0572	358.39	571.60	225	57.70	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18705.3	B08		7	0289-0568	451.12	568.59	194	50.87	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16008.7	B08		7	0290-0571	514.70	571.55	238	57.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14976.8	B08		7	0291-0575	818.21	576.01	261	63.11	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15822.9	B08		7	0292-0573	627.10	573.01	252	58.87	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21662.9	B08		7	0293-0587	161.52	585.95	593	107.05	0.650
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19024.5	B08		7	0294-0580	382.48	581.18	206	56.04	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15047.0	B08		7	0295-0582	856.68	582.60	241	59.84	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20170.1	B08		7	0296-0581	454.66	581.62	195	53.21	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15243.8	B08		7	0297-0584	20.47	584.14	229	57.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19313.2	B08		7	0298-0589	65.54	589.46	360	71.36	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16167.7	B08		7	0299-0589	202.30	589.49	276	69.01	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16162.1	B08		7	0300-0586	306.59	585.47	227	56.53	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19873.8	B08		7	0301-0587	540.11	586.99	191	51.36	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17076.4	B08		7	0302-0589	419.81	589.22	243	57.11	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18378.0	B08		7	0303-0589	641.78	589.13	208	54.28	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17005.1	B08		7	0304-0591	870.52	591.42	226	55.11	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19633.3	B08		7	0305-0592	401.35	592.08	206	54.28	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19066.2	B08		7	0306-0595	386.10	595.23	181	51.80	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17934.8	B08		7	0307-0599	934.08	598.75	396	74.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12662.8	B08		7	0308-0597	468.94	597.78	296	63.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17468.4	B08		7	0309-0599	531.68	600.05	232	55.36	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16033.5	B08		7	0310-0600	586.68	599.78	239	57.70	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15931.7	B08		7	0311-0603	237.89	602.51	256	58.53	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14017.9	B08		7	0312-0603	747.56	603.22	140	46.28	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16534.9	B08		7	0313-0607	275.96	606.98	234	56.53	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19981.1	B08		7	0314-0618	761.53	616.65	395	87.26	0.652
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15853.0	B08		7	0315-0618	317.58	618.43	245	59.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20245.4	B08		7	0316-0620	798.63	619.75	372	73.60	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13905.4	B08		7	0317-0619	184.08	618.67	255	59.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18765.6	B08		7	0318-0619	536.33	619.55	203	52.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4669.5	B08		7	0319-0619	732.67	618.91	225	58.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13924.3	B08		7	0320-0624	75.32	624.49	297	67.26	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21146.9	B08		7	0321-0626	149.52	625.62	378	74.18	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14790.0	B08		7	0322-0624	587.75	624.19	255	60.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14719.7	B08		7	0323-0628	266.79	628.79	272	64.77	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14470.2	B08		7	0324-0626	224.98	625.70	269	60.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20585.2	B08		7	0325-0631	33.55	631.63	372	75.84	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21123.8	B08		7	0326-0630	380.71	630.34	182	50.28	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23790.0	B08		7	0327-0632	742.45	633.18	264	63.60	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15777.6	B08		7	0328-0632	870.00	633.29	240	62.77	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16293.3	B08		7	0329-0638	418.93	637.29	242	58.18	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15424.0	B08		7	0330-0635	486.04	635.24	265	64.53	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18992.1	B08		7	0331-0636	884.42	636.28	183	50.63	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16280.0	B08		7	0332-0640	652.10	639.58	235	59.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14342.5	B08		7	0333-0642	303.25	642.62	278	63.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18751.2	B08		7	0334-0643	369.37	643.58	193	51.70	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18248.7	B08		7	0335-0647	536.33	647.18	228	57.01	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18861.2	B08		7	0336-0648	701.14	648.33	301	63.60	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16496.1	B08		7	0337-0655	825.26	654.58	343	71.50	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19644.2	B08		7	0338-0652	905.80	652.94	180	51.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16205.6	B08		7	0339-0656	494.86	656.41	261	60.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17769.7	B08		7	0340-0655	647.89	656.23	214	54.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16203.3	B08		7	0341-0660	619.43	660.42	307	68.53	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11487.6	B08		7	0342-0660	103.73	660.38	202	60.18	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21445.9	B08		7	0343-0661	331.53	661.26	282	62.28	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18155.1	B08		7	0344-0658	369.54	658.31	227	57.11	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18835.5	B08		7	0345-0659	935.36	658.91	181	52.43	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17231.9	B08		7	0346-0660	447.04	660.05	247	59.11	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15477.6	B08		7	0347-0665	250.08	665.56	256	60.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12628.4	B08		7	0348-0662	37.36	662.14	140	45.94	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15376.8	B08		7	0349-0668	273.05	667.94	244	60.18	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19354.3	B08		7	0350-0671	564.20	671.06	415	79.50	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22347.1	B08		7	0351-0668	724.95	667.73	304	64.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18488.6	B08		7	0352-0666	922.79	665.38	205	57.36	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16651.9	B08		7	0353-0670	193.80	670.59	269	61.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15231.5	B08		7	0354-0673	768.30	672.51	256	59.60	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18113.0	B08		7	0355-0672	377.96	672.48	212	55.46	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17000.2	B08		7	0356-0674	861.90	673.49	332	68.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18229.7	B08		7	0357-0676	85.23	676.00	223	57.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12908.0	B08		7	0358-0677	797.05	677.26	267	63.01	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14104.9	B08		7	0359-0675	34.76	675.73	175	50.28	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19731.1	B08		7	0360-0676	703.10	676.08	198	57.60	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12725.2	B08		7	0361-0678	52.72	679.35	218	59.36	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22941.1	B08		7	0362-0683	685.57	684.28	648	111.05	0.660
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17513.5	B08		7	0363-0680	448.23	679.47	224	55.36	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13275.9	B08		7	0364-0685	843.10	686.08	260	61.36	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12935.0	B08		7	0365-0688	618.11	687.90	248	63.84	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17210.4	B08		7	0366-0686	340.20	686.29	226	55.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20721.1	B08		7	0367-0692	413.83	691.73	372	73.26	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	24479.7	B08		7	0368-0691	714.85	690.45	150	46.87	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15712.4	B08		7	0369-0694	912.92	694.90	229	57.94	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18570.4	B08		7	0370-0696	937.38	695.64	291	61.94	0.953
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15571.3	B08		7	0371-0697	52.33	696.50	224	55.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15900.6	B08		7	0372-0697	136.01	696.68	215	53.94	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12547.4	B08		7	0373-0702	234.35	703.26	290	67.36	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17028.1	B08		7	0374-0703	882.83	702.70	269	63.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16072.7	B08		7	0375-0704	371.40	704.40	237	58.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18492.7	B08		7	0376-0703	539.66	702.93	202	52.28	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23419.7	B08		7	0377-0700	690.84	700.22	159	45.70	0.957
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17020.7	B08		7	0378-0706	464.63	706.59	227	57.94	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17738.6	B08		7	0379-0706	646.96	706.78	211	53.11	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184816	1375315	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12475.7	B08		7	0380-0708	161.23	708.82	276	64.53	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18210.8	B08		8	0001-0027	605.94	27.87	215	56.28	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13145.5	B08		8	0002-0030	678.63	29.96	293	63.01	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18003.0	B08		8	0003-0030	332.84	29.76	212	53.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14939.7	B08		8	0004-0034	100.59	34.63	237	58.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16976.5	B08		8	0005-0030	274.05	30.58	219	59.70	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19324.3	B08		8	0006-0039	437.09	39.00	204	53.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17811.3	B08		8	0007-0041	321.69	41.81	212	54.28	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16548.5	B08		8	0008-0040	928.24	40.30	223	54.28	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13577.8	B08		8	0009-0043	461.70	44.14	285	63.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18673.2	B08		8	0010-0044	809.55	44.14	285	61.36	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13721.6	B08		8	0011-0045	569.92	43.93	174	54.43	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17344.3	B08		8	0012-0045	358.74	45.50	219	55.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	26689.7	B08		8	0013-0045	633.25	45.14	254	60.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13057.9	B08		8	0014-0047	122.29	46.71	280	66.18	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16859.0	B08		8	0015-0048	25.24	47.86	211	53.11	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19189.9	B08		8	0016-0048	185.64	48.59	289	64.18	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20568.3	B08		8	0017-0049	384.18	48.78	310	66.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16978.1	B08		8	0018-0049	307.42	48.87	215	54.87	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12734.8	B08		8	0019-0050	580.11	51.04	112	44.87	0.699
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19133.2	B08		8	0020-0053	753.84	52.66	215	54.28	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17927.2	B08		8	0021-0053	254.99	53.81	251	60.53	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19395.5	B08		8	0022-0056	493.18	56.48	338	69.01	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17934.8	B08		8	0023-0054	940.44	54.25	205	52.28	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16711.0	B08		8	0024-0061	241.09	61.83	193	56.77	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	25023.1	B08		8	0025-0056	768.83	55.64	147	45.80	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15231.2	B08		8	0026-0060	866.08	60.35	250	59.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14409.6	B08		8	0027-0063	559.18	62.41	294	67.60	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12816.1	B08		8	0028-0063	642.81	63.02	178	48.28	0.959
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14368.5	B08		8	0029-0064	701.82	64.72	262	60.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14591.0	B08		8	0030-0068	91.77	68.89	240	59.11	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13884.0	B08		8	0031-0070	346.19	69.91	273	61.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17410.8	B08		8	0032-0069	838.43	68.84	215	56.18	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23677.2	B08		8	0033-0070	765.62	69.56	157	46.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17162.4	B08		8	0034-0071	878.70	71.36	219	55.70	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16796.8	B08		8	0035-0075	248.18	76.27	218	55.36	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18859.0	B08		8	0036-0076	753.87	77.01	208	55.01	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19214.8	B08		8	0037-0078	789.59	77.65	266	62.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16423.4	B08		8	0038-0080	204.05	79.65	217	54.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18413.2	B08		8	0039-0082	535.30	81.33	202	55.46	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16929.8	B08		8	0040-0086	684.70	86.65	407	78.67	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18688.2	B08		8	0041-0081	911.11	81.40	246	57.70	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19533.2	B08		8	0042-0083	278.01	82.10	183	51.36	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18502.9	B08		8	0043-0083	422.56	82.95	209	52.87	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22587.5	B08		8	0044-0092	521.47	91.87	335	73.11	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14390.8	B08		8	0045-0087	654.93	87.18	272	62.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19631.3	B08		8	0046-0088	803.61	88.22	262	60.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13330.2	B08		8	0047-0085	312.89	85.51	156	48.04	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16176.3	B08		8	0048-0091	506.89	91.64	231	61.11	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19838.2	B08		8	0049-0093	265.32	92.69	347	69.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	32192.6	B08		8	0050-0089	466.44	89.42	126	64.67	0.379
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19389.2	B08		8	0051-0091	485.54	91.39	178	51.70	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14629.5	B08		8	0052-0095	578.56	94.28	158	52.53	0.720
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	25096.6	B08		8	0053-0098	235.72	97.49	144	47.60	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14592.2	B08		8	0054-0097	312.79	96.29	117	40.63	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16776.1	B08		8	0055-0101	196.52	101.22	216	55.70	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18439.2	B08		8	0056-0109	168.10	109.50	416	84.08	0.739
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15973.3	B08		8	0057-0109	61.26	110.18	302	65.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12601.7	B08		8	0058-0109	325.70	109.43	285	64.53	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	24366.7	B08		8	0059-0105	492.19	104.94	158	46.63	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	24523.4	B08		8	0060-0109	225.69	109.46	155	46.53	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13826.3	B08		8	0061-0110	418.68	110.04	266	61.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18479.6	B08		8	0062-0110	740.53	109.96	202	53.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14449.8	B08		8	0063-0116	365.54	115.83	258	59.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13789.7	B08		8	0064-0117	17.34	117.17	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19936.2	B08		8	0065-0117	710.91	117.16	339	67.60	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17884.3	B08		8	0066-0114	692.08	114.01	112	40.04	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15036.2	B08		8	0067-0116	945.56	116.40	143	45.11	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16817.0	B08		8	0068-0119	476.58	119.53	226	55.94	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15113.2	B08		8	0069-0120	214.16	121.08	218	57.84	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15899.4	B08		8	0070-0123	458.80	122.27	270	66.18	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13539.7	B08		8	0071-0128	621.93	128.49	282	65.11	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13872.2	B08		8	0072-0126	810.83	124.99	255	63.36	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16472.4	B08		8	0073-0129	254.02	128.83	222	57.36	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13515.9	B08		8	0074-0126	312.43	126.66	288	67.94	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16574.6	B08		8	0075-0127	651.45	127.21	274	62.53	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17060.4	B08		8	0076-0124	693.52	124.41	100	38.63	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12181.1	B08		8	0077-0134	544.06	133.88	328	69.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16030.7	B08		8	0078-0131	834.06	131.69	238	57.36	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21317.6	B08		8	0079-0134	916.21	133.84	333	69.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17127.6	B08		8	0080-0139	433.99	140.31	312	67.60	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20125.5	B08		8	0081-0141	742.85	142.35	182	53.36	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13824.0	B08		8	0082-0142	371.39	142.67	287	66.18	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18556.7	B08		8	0083-0142	691.60	143.08	137	49.70	0.697
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16649.6	B08		8	0084-0147	102.87	147.30	221	58.28	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17262.4	B08		8	0085-0146	870.70	146.58	274	63.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12402.9	B08		8	0086-0145	813.59	145.20	244	62.53	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18888.7	B08		8	0087-0147	260.69	146.47	195	52.53	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15443.5	B08		8	0088-0151	610.95	151.63	257	69.60	0.667
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18061.0	B08		8	0089-0151	508.14	151.35	210	54.77	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22770.6	B08		8	0090-0152	201.67	152.39	324	67.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18980.0	B08		8	0091-0153	752.90	153.76	193	51.70	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17528.7	B08		8	0092-0154	646.52	153.18	233	58.53	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13904.2	B08		8	0093-0163	790.71	165.01	286	78.43	0.584
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13553.5	B08		8	0094-0160	115.51	160.99	260	59.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12371.3	B08		8	0095-0163	155.98	162.80	258	62.43	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13070.1	B08		8	0096-0167	638.49	167.91	284	66.67	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12255.7	B08		8	0097-0169	319.81	169.39	287	62.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17910.9	B08		8	0098-0170	387.76	170.51	216	54.53	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13339.8	B08		8	0099-0172	718.99	171.98	280	64.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17262.4	B08		8	0100-0174	444.36	173.61	393	78.43	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17467.5	B08		8	0101-0173	363.23	173.68	207	54.53	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19820.8	B08		8	0102-0172	824.23	172.48	190	52.14	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21618.2	B08		8	0103-0173	839.23	173.39	161	48.63	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18693.9	B08		8	0104-0174	855.85	173.78	202	54.53	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	28370.5	B08		8	0105-0176	472.06	176.28	277	61.11	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19038.6	B08		8	0106-0176	589.15	176.50	204	53.11	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	30868.0	B08		8	0107-0174	24.47	175.02	132	43.46	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	29803.5	B08		8	0108-0181	916.02	180.69	140	89.98	0.217
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19907.8	B08		8	0109-0191	416.31	190.75	393	73.60	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17964.9	B08		8	0110-0190	557.40	189.97	233	57.36	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23555.4	B08		8	0111-0194	503.96	194.47	352	71.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	25575.7	B08		8	0112-0193	528.14	193.10	302	65.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16281.0	B08		8	0113-0191	576.48	190.90	248	57.70	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14647.9	B08		8	0114-0196	82.44	197.40	250	59.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22301.4	B08		8	0115-0199	731.41	199.55	326	71.84	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19712.8	B08		8	0116-0206	797.58	204.88	608	103.98	0.707
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19512.1	B08		8	0117-0200	600.24	198.90	321	67.84	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13614.8	B08		8	0118-0201	706.38	200.68	275	65.60	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14438.6	B08		8	0119-0200	105.70	199.53	251	60.77	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15188.2	B08		8	0120-0203	51.33	203.14	263	64.67	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12964.1	B08		8	0121-0201	945.35	201.25	242	64.77	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16236.6	B08		8	0122-0202	841.47	202.21	265	59.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11918.1	B08		8	0123-0204	360.88	204.41	293	66.18	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12588.3	B08		8	0124-0203	473.99	203.12	291	67.36	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	24495.0	B08		8	0125-0209	540.26	210.14	315	74.18	0.719
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22491.9	B08		8	0126-0207	210.90	207.35	301	65.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12890.9	B08		8	0127-0209	653.64	209.25	285	64.77	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21704.3	B08		8	0128-0216	905.41	216.77	342	71.60	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21025.1	B08		8	0129-0217	238.79	216.72	356	70.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17437.5	B08		8	0130-0219	326.08	218.78	230	67.11	0.642
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16226.4	B08		8	0131-0219	404.45	220.29	295	63.11	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15942.2	B08		8	0132-0222	573.44	222.43	240	57.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22550.5	B08		8	0133-0223	825.07	222.16	159	55.11	0.658
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13117.0	B08		8	0134-0228	177.37	228.44	252	65.60	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18171.2	B08		8	0135-0226	444.15	225.99	249	59.70	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14943.2	B08		8	0136-0226	297.91	225.97	241	57.01	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17611.1	B08		8	0137-0226	338.15	227.24	232	60.18	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18857.9	B08		8	0138-0225	836.01	225.90	134	47.94	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16786.1	B08		8	0139-0231	760.15	231.06	226	56.04	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17341.4	B08		8	0140-0233	362.12	232.89	237	60.18	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13624.7	B08		8	0141-0236	884.11	237.24	290	67.11	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20196.1	B08		8	0142-0238	52.62	238.34	342	68.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18646.5	B08		8	0143-0234	514.13	234.63	207	57.46	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15880.9	B08		8	0144-0239	844.35	239.44	239	58.77	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14522.2	B08		8	0145-0242	131.43	242.42	205	54.53	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21608.9	B08		8	0146-0241	497.89	242.11	176	49.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15561.4	B08		8	0147-0244	785.63	245.13	262	59.36	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18108.1	B08		8	0148-0244	401.72	243.93	213	54.53	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18002.1	B08		8	0149-0248	624.08	247.94	209	54.53	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15899.2	B08		8	0150-0249	726.50	248.48	254	59.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	24781.8	B08		8	0151-0250	757.15	250.54	325	72.18	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18549.5	B08		8	0152-0249	644.05	249.45	254	60.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23798.7	B08		8	0153-0252	104.77	251.94	312	65.11	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18433.5	B08		8	0154-0252	445.78	252.74	217	60.53	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19702.5	B08		8	0155-0256	571.64	257.18	211	59.70	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23184.5	B08		8	0156-0266	348.79	266.57	640	110.47	0.659
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14804.2	B08		8	0157-0258	883.69	257.58	273	61.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14094.3	B08		8	0158-0256	905.81	256.66	277	63.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16531.8	B08		8	0159-0260	833.84	260.57	489	90.08	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16400.4	B08		8	0160-0260	689.87	260.20	232	57.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23351.0	B08		8	0161-0262	492.09	262.56	290	63.60	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17840.2	B08		8	0162-0267	518.42	267.31	439	80.08	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13713.0	B08		8	0163-0265	186.17	265.60	250	78.91	0.505
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13713.0	B08		8	0164-0265	247.92	265.49	261	59.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16618.6	B08		8	0165-0270	618.28	270.58	224	61.94	0.734
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	24439.4	B08		8	0166-0265	797.52	264.67	151	49.11	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18711.8	B08		8	0167-0269	923.08	268.60	250	58.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19981.5	B08		8	0168-0275	409.94	274.74	383	74.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17325.0	B08		8	0169-0276	133.40	275.48	241	61.01	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15135.0	B08		8	0170-0275	47.24	275.34	223	55.11	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16716.1	B08		8	0171-0280	278.01	279.85	388	77.50	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21011.9	B08		8	0172-0279	562.46	279.94	194	57.36	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18784.4	B08		8	0173-0278	458.98	277.90	219	55.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14777.0	B08		8	0174-0278	715.69	277.13	240	59.94	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19820.0	B08		8	0175-0282	119.51	282.12	188	54.53	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19073.1	B08		8	0176-0280	332.96	280.84	132	43.56	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15600.4	B08		8	0177-0290	891.19	289.75	238	58.18	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18820.4	B08		8	0178-0292	298.21	292.89	218	54.53	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13417.7	B08		8	0179-0295	95.73	294.43	249	61.36	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19279.0	B08		8	0180-0294	330.03	293.71	196	53.46	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17073.8	B08		8	0181-0297	860.98	297.75	317	65.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18260.3	B08		8	0182-0297	512.10	296.55	221	56.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18362.6	B08		8	0183-0303	430.37	303.46	354	71.60	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21682.0	B08		8	0184-0303	479.32	302.65	346	68.18	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21428.4	B08		8	0185-0302	497.46	302.33	187	51.11	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16486.5	B08		8	0186-0303	716.93	302.65	222	57.11	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15689.8	B08		8	0187-0305	830.82	305.53	256	57.94	0.958
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11469.8	B08		8	0188-0310	25.65	309.68	263	66.77	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13311.0	B08		8	0189-0309	198.99	308.92	288	70.67	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23365.4	B08		8	0190-0310	787.30	310.84	332	70.18	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16949.2	B08		8	0191-0309	934.28	309.96	218	56.28	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12059.2	B08		8	0192-0313	234.95	313.59	264	67.01	0.739
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17654.6	B08		8	0193-0313	297.10	313.57	317	67.01	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17159.5	B08		8	0194-0316	613.92	317.18	222	57.70	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20411.5	B08		8	0195-0319	126.34	319.24	196	63.26	0.616
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	32372.8	B08		8	0196-0320	567.44	319.73	136	47.11	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19423.5	B08		8	0197-0323	279.05	323.73	192	51.46	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15620.0	B08		8	0198-0328	673.08	328.40	224	62.18	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18658.0	B08		8	0199-0326	330.82	326.80	227	55.94	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17012.6	B08		8	0200-0329	94.74	329.33	229	57.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16103.1	B08		8	0201-0330	718.20	329.79	235	56.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15207.5	B08		8	0202-0331	696.05	331.99	248	57.70	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12224.5	B08		8	0203-0328	485.85	327.96	134	46.87	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14102.6	B08		8	0204-0333	831.68	332.64	270	60.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21578.9	B08		8	0205-0335	182.20	335.61	329	67.36	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19660.4	B08		8	0206-0338	35.69	338.17	193	52.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19411.5	B08		8	0207-0338	283.63	337.80	194	52.28	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22883.3	B08		8	0208-0341	442.74	341.90	307	66.43	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13733.2	B08		8	0209-0343	495.31	344.36	429	88.67	0.686
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13727.9	B08		8	0210-0341	749.53	341.13	261	59.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	27888.0	B08		8	0211-0342	409.14	342.94	258	59.70	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16610.8	B08		8	0212-0344	786.04	343.56	228	55.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18031.1	B08		8	0213-0343	223.49	343.69	205	53.11	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14588.9	B08		8	0214-0345	72.07	344.02	253	60.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12300.6	B08		8	0215-0347	615.45	347.13	290	64.53	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14550.1	B08		8	0216-0349	847.39	348.96	278	64.08	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17590.6	B08		8	0217-0349	162.16	349.02	209	53.94	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15898.0	B08		8	0218-0352	904.73	351.46	230	59.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17449.7	B08		8	0219-0358	239.48	358.57	276	61.01	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22897.9	B08		8	0220-0361	372.20	361.46	328	68.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17464.0	B08		8	0221-0364	732.60	364.38	212	56.53	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12064.4	B08		8	0222-0365	669.58	364.77	308	69.94	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19355.9	B08		8	0223-0363	542.40	363.96	167	48.63	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14145.0	B08		8	0224-0367	825.59	367.27	264	63.01	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17378.0	B08		8	0225-0368	69.91	368.36	423	77.60	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23494.1	B08		8	0226-0367	509.82	366.75	165	49.11	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17439.8	B08		8	0227-0370	842.54	368.99	221	57.36	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21136.9	B08		8	0228-0370	904.68	370.38	299	63.94	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17648.2	B08		8	0229-0374	705.18	375.56	291	65.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23879.4	B08		8	0230-0380	229.26	379.63	336	69.01	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14893.4	B08		8	0231-0381	625.58	381.14	261	59.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23116.2	B08		8	0232-0380	538.41	379.26	186	52.28	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20759.0	B08		8	0233-0380	122.53	380.11	176	49.46	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16444.9	B08		8	0234-0390	459.42	389.07	472	94.81	0.660
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15533.2	B08		8	0235-0385	174.02	384.99	229	55.11	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22794.0	B08		8	0236-0390	32.31	390.91	315	65.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15494.3	B08		8	0237-0390	476.96	389.92	250	59.46	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	28581.2	B08		8	0238-0389	563.53	389.04	227	56.04	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16077.7	B08		8	0239-0392	96.37	392.44	221	54.53	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16067.0	B08		8	0240-0392	140.30	393.04	241	60.53	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18903.4	B08		8	0241-0394	517.34	394.43	226	57.36	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19756.1	B08		8	0242-0393	205.01	393.33	193	53.11	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17785.4	B08		8	0243-0396	357.48	395.76	326	68.43	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13779.9	B08		8	0244-0396	798.26	395.72	268	59.60	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20545.6	B08		8	0245-0393	115.88	393.18	177	49.70	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14017.1	B08		8	0246-0401	285.34	401.61	298	68.67	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14385.6	B08		8	0247-0403	854.48	404.25	271	62.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21248.2	B08		8	0248-0409	874.03	409.15	215	59.36	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19427.1	B08		8	0249-0410	535.95	410.12	210	57.21	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15417.9	B08		8	0250-0409	757.81	409.18	241	57.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16343.7	B08		8	0251-0408	385.95	408.25	148	47.36	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13190.1	B08		8	0252-0412	51.60	411.98	247	62.43	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20467.3	B08		8	0253-0413	306.91	413.24	351	68.77	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18162.2	B08		8	0254-0411	617.11	411.83	213	54.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22430.3	B08		8	0255-0413	920.61	413.25	248	59.11	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14204.9	B08		8	0256-0425	43.38	424.45	270	64.08	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14935.5	B08		8	0257-0424	197.36	424.82	291	65.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	29030.4	B08		8	0258-0426	840.62	426.82	249	59.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13646.3	B08		8	0259-0425	90.69	425.05	252	59.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14034.3	B08		8	0260-0426	395.24	426.38	188	54.18	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22320.9	B08		8	0261-0430	798.43	429.42	316	67.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13452.4	B08		8	0262-0428	429.05	427.54	272	61.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16463.4	B08		8	0263-0430	685.11	429.79	228	59.11	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16535.1	B08		8	0264-0430	536.49	429.89	224	59.21	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18746.5	B08		8	0265-0433	292.44	431.71	270	62.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18436.1	B08		8	0266-0433	463.81	433.41	344	70.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12211.1	B08		8	0267-0440	612.69	440.34	286	66.18	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18436.6	B08		8	0268-0440	376.98	439.41	296	67.36	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16522.9	B08		8	0269-0441	917.64	440.86	239	59.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23229.0	B08		8	0270-0441	571.71	441.23	324	67.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17040.0	B08		8	0271-0448	119.36	447.66	377	73.60	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17652.7	B08		8	0272-0444	709.38	444.02	214	53.70	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20554.4	B08		8	0273-0446	210.10	445.78	171	49.70	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17584.5	B08		8	0274-0450	251.93	449.17	467	84.33	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20682.5	B08		8	0275-0445	284.42	445.95	125	42.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15878.2	B08		8	0276-0447	758.43	447.39	273	63.36	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12855.4	B08		8	0277-0447	510.30	448.26	285	65.60	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17489.7	B08		8	0278-0451	197.74	451.73	214	54.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16916.8	B08		8	0279-0452	679.58	452.71	229	56.53	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14020.3	B08		8	0280-0455	414.52	455.68	259	65.26	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15941.3	B08		8	0281-0458	645.04	457.69	235	57.70	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16400.8	B08		8	0282-0461	893.09	460.31	237	61.11	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16278.6	B08		8	0283-0461	806.05	461.06	265	61.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12911.4	B08		8	0284-0460	849.37	459.94	300	73.26	0.703
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20378.4	B08		8	0285-0467	482.18	466.42	278	65.36	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18121.8	B08		8	0286-0467	502.80	466.67	202	52.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	27586.0	B08		8	0287-0468	175.68	468.11	131	44.39	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16761.4	B08		8	0288-0469	188.14	470.18	220	55.46	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	26368.9	B08		8	0289-0470	164.58	470.70	133	44.87	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14646.0	B08		8	0290-0473	445.19	473.32	256	60.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23543.0	B08		8	0291-0476	340.33	476.43	305	64.43	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17158.6	B08		8	0292-0475	146.13	474.35	224	54.53	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13832.1	B08		8	0293-0476	594.06	476.63	181	50.28	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17314.3	B08		8	0294-0475	282.54	475.44	216	54.53	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12479.9	B08		8	0295-0480	38.72	480.74	281	66.67	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15661.2	B08		8	0296-0475	863.09	475.58	237	58.28	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17227.2	B08		8	0297-0476	670.54	476.17	223	56.28	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22697.8	B08		8	0298-0483	521.14	482.66	460	89.98	0.714
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12032.5	B08		8	0299-0486	72.47	487.20	271	64.77	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16420.0	B08		8	0300-0491	98.43	491.48	476	90.33	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16024.9	B08		8	0301-0489	681.87	489.05	240	57.94	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21172.8	B08		8	0302-0495	317.38	494.84	179	53.36	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15685.0	B08		8	0303-0498	424.53	498.54	275	61.60	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20168.4	B08		8	0304-0496	801.89	496.68	186	52.53	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17308.9	B08		8	0305-0496	568.46	496.21	140	45.46	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15467.2	B08		8	0306-0500	925.96	500.83	237	59.36	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15000.7	B08		8	0307-0506	409.35	506.26	265	71.36	0.654
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15810.8	B08		8	0308-0503	162.81	503.82	231	57.94	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16210.7	B08		8	0309-0502	252.53	502.28	254	61.11	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18574.3	B08		8	0310-0502	720.89	503.30	199	55.11	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17547.2	B08		8	0311-0506	118.28	506.07	213	55.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16899.4	B08		8	0312-0506	213.48	506.27	246	58.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14306.8	B08		8	0313-0505	513.95	505.20	270	61.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14103.5	B08		8	0314-0512	391.39	512.53	273	65.26	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18449.4	B08		8	0315-0508	573.78	508.38	197	52.63	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15217.8	B08		8	0316-0513	459.25	513.30	269	62.77	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21304.4	B08		8	0317-0516	279.40	515.67	340	72.91	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22024.5	B08		8	0318-0517	34.47	517.38	330	67.01	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20533.2	B08		8	0319-0519	191.56	519.29	327	67.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16091.5	B08		8	0320-0520	598.95	520.02	222	58.43	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16932.0	B08		8	0321-0521	490.02	521.05	227	55.70	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13865.0	B08		8	0322-0523	544.13	524.15	269	79.01	0.541
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14576.7	B08		8	0323-0524	373.61	524.93	246	58.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17033.5	B08		8	0324-0524	249.55	524.74	219	54.87	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19183.0	B08		8	0325-0528	587.81	528.57	220	57.26	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17356.6	B08		8	0326-0528	661.83	528.57	227	57.11	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22395.4	B08		8	0327-0529	741.26	528.96	331	66.18	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21662.5	B08		8	0328-0529	265.76	529.33	168	49.11	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18356.1	B08		8	0329-0530	886.67	530.57	195	53.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18857.8	B08		8	0330-0536	475.34	535.73	334	73.36	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14411.8	B08		8	0331-0532	693.26	532.27	262	62.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17057.0	B08		8	0332-0535	904.34	535.08	217	57.11	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17657.0	B08		8	0333-0540	503.66	539.29	356	73.01	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21691.0	B08		8	0334-0536	837.33	536.46	168	51.11	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13845.4	B08		8	0335-0540	618.73	540.15	265	63.60	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14181.5	B08		8	0336-0545	108.17	545.82	246	60.77	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	27444.8	B08		8	0337-0540	310.74	540.38	112	45.11	0.692
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12571.1	B08		8	0338-0544	540.04	543.04	278	84.91	0.485
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16954.4	B08		8	0339-0543	647.59	542.83	260	59.94	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17187.6	B08		8	0340-0543	228.87	543.02	213	53.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20281.4	B08		8	0341-0547	440.74	547.05	393	74.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15586.2	B08		8	0342-0547	294.62	547.99	340	68.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15578.3	B08		8	0343-0549	63.74	548.50	494	85.84	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18886.6	B08		8	0344-0547	405.03	547.38	199	53.94	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15812.4	B08		8	0345-0553	720.38	553.08	424	78.91	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15232.9	B08		8	0346-0555	585.25	555.47	238	57.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17507.8	B08		8	0347-0557	930.45	557.56	203	53.94	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17532.3	B08		8	0348-0561	829.71	561.23	214	54.53	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20788.3	B08		8	0349-0561	149.59	561.09	177	51.11	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14332.7	B08		8	0350-0565	359.49	565.73	275	60.28	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14318.2	B08		8	0351-0567	899.27	567.38	262	59.60	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20018.0	B08		8	0352-0583	151.66	583.78	549	92.33	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19226.2	B08		8	0353-0575	301.99	574.27	211	54.53	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15243.1	B08		8	0354-0579	446.16	578.94	247	60.43	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15609.2	B08		8	0355-0580	653.80	579.80	251	60.77	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19447.6	B08		8	0356-0578	881.69	578.52	187	50.28	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13372.8	B08		8	0357-0582	591.28	583.00	268	61.26	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12278.0	B08		8	0358-0586	635.36	586.45	320	72.43	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12473.4	B08		8	0359-0585	522.96	585.30	305	67.36	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17277.4	B08		8	0360-0587	364.23	587.18	323	67.01	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	3825.8	B08		8	0361-0584	292.96	585.51	169	49.11	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14100.6	B08		8	0362-0586	710.05	586.60	261	61.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15910.7	B08		8	0363-0588	546.84	587.82	378	76.18	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18315.2	B08		8	0364-0585	746.54	585.66	197	52.28	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15276.3	B08		8	0365-0594	428.50	594.90	260	61.36	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23154.9	B08		8	0366-0591	791.24	591.44	157	44.87	0.980
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16556.1	B08		8	0367-0594	106.89	593.63	301	67.36	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20146.0	B08		8	0368-0597	409.77	597.79	382	73.26	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17939.5	B08		8	0369-0601	38.88	600.70	394	73.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17243.8	B08		8	0370-0599	245.03	599.26	215	57.11	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19426.0	B08		8	0371-0603	294.83	602.94	352	87.26	0.581
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16077.8	B08		8	0372-0603	122.93	603.29	228	56.77	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15645.3	B08		8	0373-0602	745.82	602.88	254	59.70	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18798.6	B08		8	0374-0608	772.61	607.70	396	82.08	0.739
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13776.9	B08		8	0375-0611	588.28	610.98	281	61.11	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13699.7	B08		8	0376-0612	691.92	612.85	280	65.36	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13561.0	B08		8	0377-0611	621.03	610.64	266	65.11	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16682.9	B08		8	0378-0615	660.18	615.09	219	54.77	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15234.3	B08		8	0379-0615	91.00	615.30	225	55.11	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12274.8	B08		8	0380-0622	353.66	621.48	274	67.60	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16697.2	B08		8	0381-0617	484.70	617.51	235	57.46	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18117.7	B08		8	0382-0619	283.71	620.14	193	51.46	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12834.4	B08		8	0383-0624	540.61	624.20	286	64.43	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16942.3	B08		8	0384-0623	809.43	623.21	223	55.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22221.7	B08		8	0385-0626	369.46	626.27	240	59.11	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17000.6	B08		8	0386-0628	750.05	628.17	455	80.08	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16545.2	B08		8	0387-0626	315.90	625.91	218	54.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16012.7	B08		8	0388-0630	400.01	630.46	315	65.01	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13618.6	B08		8	0389-0634	103.08	633.11	250	61.60	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14871.9	B08		8	0390-0633	301.76	632.85	182	52.77	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12978.7	B08		8	0391-0634	920.99	635.17	270	65.01	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21929.7	B08		8	0392-0641	826.35	642.57	525	91.01	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14373.6	B08		8	0393-0636	250.17	635.64	243	57.11	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	25384.3	B08		8	0394-0636	286.29	635.91	299	67.11	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19279.6	B08		8	0395-0640	56.08	640.78	309	64.18	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15548.7	B08		8	0396-0645	176.16	644.35	531	89.74	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17927.0	B08		8	0397-0642	149.11	641.65	448	83.26	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17624.7	B08		8	0398-0641	548.88	641.16	219	57.01	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15883.6	B08		8	0399-0644	331.95	643.38	244	59.60	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15213.4	B08		8	0400-0644	615.31	644.31	242	60.53	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12652.5	B08		8	0401-0653	518.96	653.04	290	69.36	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22773.6	B08		8	0402-0654	562.67	654.67	315	66.18	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16086.2	B08		8	0403-0658	878.27	658.10	486	88.33	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13408.5	B08		8	0404-0659	685.60	660.49	274	65.60	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	26982.0	B08		8	0405-0660	134.72	659.99	277	61.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17518.2	B08		8	0406-0659	651.26	658.94	214	56.18	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22743.0	B08		8	0407-0662	215.01	661.71	477	97.64	0.629
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20525.9	B08		8	0408-0660	432.11	659.62	345	68.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14573.8	B08		8	0409-0661	746.57	660.93	266	60.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12439.1	B08		8	0410-0660	941.90	660.60	248	60.28	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21899.9	B08		8	0411-0660	189.48	661.10	161	49.11	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19598.6	B08		8	0412-0661	39.92	660.81	174	50.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16253.4	B08		8	0413-0664	81.31	663.61	225	57.70	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18594.0	B08		8	0414-0668	27.47	667.37	212	59.36	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15842.9	B08		8	0415-0670	173.32	670.15	233	58.53	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18101.9	B08		8	0416-0671	593.71	671.10	209	53.94	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15429.9	B08		8	0417-0679	567.36	678.71	242	59.84	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12621.0	B08		8	0418-0680	633.95	680.76	292	63.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18832.4	B08		8	0419-0685	777.50	685.49	371	71.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20934.5	B08		8	0420-0687	429.91	687.24	392	75.01	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16985.0	B08		8	0421-0684	263.38	684.17	218	56.53	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15030.6	B08		8	0422-0686	584.10	686.88	285	67.01	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14358.0	B08		8	0423-0680	903.82	679.87	100	37.21	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15136.2	B08		8	0424-0688	864.67	688.04	231	55.36	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16074.7	B08		8	0425-0688	80.75	689.10	232	57.11	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15326.8	B08		8	0426-0690	240.48	690.82	319	66.43	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13233.4	B08		8	0427-0693	719.10	693.26	270	60.53	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15661.2	B08		8	0428-0691	901.19	691.00	113	40.63	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15829.5	B08		8	0429-0697	17.33	697.09	223	56.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19155.0	B08		8	0430-0698	42.08	697.67	293	61.94	0.960
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15980.2	B08		8	0431-0699	548.17	698.83	224	56.28	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12434.3	B08		8	0432-0702	522.67	703.01	282	71.01	0.703
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	24540.0	B08		8	0433-0703	351.47	703.31	310	65.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16895.3	B08		8	0434-0703	796.34	702.67	220	56.18	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17460.1	B08		8	0435-0702	574.57	702.78	210	54.28	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184817	1375316	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13147.9	B08		8	0436-0706	669.98	705.58	287	71.60	0.704
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16419.0	B08		9	0001-0029	375.41	28.74	246	63.11	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23176.1	B08		9	0002-0035	296.66	35.80	264	59.94	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14413.7	B08		9	0003-0036	644.36	36.42	315	66.53	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16767.2	B08		9	0004-0038	498.11	37.25	198	56.28	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17538.3	B08		9	0005-0041	524.43	41.73	478	87.74	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17818.5	B08		9	0006-0036	419.86	35.88	237	57.11	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13240.5	B08		9	0007-0037	916.03	37.79	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19020.5	B08		9	0008-0038	140.82	38.08	237	56.53	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14270.2	B08		9	0009-0041	868.08	40.29	256	63.26	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15429.6	B08		9	0010-0042	802.53	43.08	239	57.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13553.0	B08		9	0011-0045	752.63	45.65	300	67.94	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19086.6	B08		9	0012-0043	77.15	42.42	188	50.53	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17150.0	B08		9	0013-0043	22.75	43.23	221	55.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	25748.2	B08		9	0014-0048	195.35	48.09	125	41.11	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20979.9	B08		9	0015-0057	182.56	57.31	447	82.91	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16037.2	B08		9	0016-0059	157.91	60.02	233	61.01	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18588.1	B08		9	0017-0057	34.87	57.15	199	51.70	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11261.7	B08		9	0018-0056	285.96	56.48	248	60.77	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17461.2	B08		9	0019-0062	107.83	62.92	258	61.94	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17258.4	B08		9	0020-0064	915.19	64.42	323	65.60	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21969.0	B08		9	0021-0069	346.07	69.89	504	96.57	0.679
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19360.7	B08		9	0022-0063	704.13	62.44	191	53.70	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14505.9	B08		9	0023-0066	436.04	66.09	338	70.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14212.1	B08		9	0024-0068	580.73	68.94	270	62.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16944.3	B08		9	0025-0070	725.46	70.06	223	58.77	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14293.8	B08		9	0026-0072	284.31	72.25	291	63.36	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17896.8	B08		9	0027-0075	862.66	75.75	196	53.11	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15825.1	B08		9	0028-0081	662.91	82.52	347	71.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17311.8	B08		9	0029-0080	395.44	80.30	251	58.87	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15357.4	B08		9	0030-0082	932.73	81.71	281	61.60	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22504.2	B08		9	0031-0086	835.57	86.40	322	67.01	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13623.7	B08		9	0032-0088	176.88	88.51	268	61.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16160.5	B08		9	0033-0089	413.59	90.14	246	62.77	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13446.4	B08		9	0034-0092	612.75	92.05	284	68.08	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16128.3	B08		9	0035-0089	761.59	88.86	231	57.70	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17088.5	B08		9	0036-0095	240.04	95.34	359	70.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23148.1	B08		9	0037-0092	365.95	91.80	166	51.70	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21331.3	B08		9	0038-0097	107.13	96.97	346	69.01	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21693.3	B08		9	0039-0095	479.40	93.97	208	55.01	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	38688.0	B08		9	0040-0095	395.91	94.90	126	44.28	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	26273.8	B08		9	0041-0100	384.59	100.22	192	62.67	0.614
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13105.5	B08		9	0042-0101	710.55	101.66	287	74.08	0.657
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	24242.4	B08		9	0043-0110	644.32	111.09	321	72.18	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21422.4	B08		9	0044-0106	372.78	107.06	198	52.77	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22464.1	B08		9	0045-0110	466.14	110.96	338	70.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14838.0	B08		9	0046-0112	75.69	112.16	235	56.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14800.5	B08		9	0047-0116	36.68	116.61	256	63.01	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19122.8	B08		9	0048-0118	294.42	117.84	409	74.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13405.8	B08		9	0049-0119	431.62	119.28	337	71.84	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18205.4	B08		9	0050-0120	677.17	120.32	449	78.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14950.1	B08		9	0051-0121	411.39	121.23	277	62.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15256.2	B08		9	0052-0128	190.63	128.16	380	73.36	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14346.7	B08		9	0053-0126	224.06	125.99	270	63.94	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15901.9	B08		9	0054-0128	144.88	128.15	231	56.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15892.0	B08		9	0055-0133	746.35	133.64	381	73.26	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11961.5	B08		9	0056-0134	835.53	133.85	352	78.33	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19093.1	B08		9	0057-0139	253.74	138.75	396	74.67	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16505.3	B08		9	0058-0141	818.10	141.83	228	57.11	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14458.2	B08		9	0059-0144	47.69	143.22	250	61.36	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18014.7	B08		9	0060-0146	541.50	146.66	220	58.77	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16249.9	B08		9	0061-0150	866.35	150.41	235	57.60	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14752.2	B08		9	0062-0149	219.61	150.24	257	61.11	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16483.8	B08		9	0063-0153	936.51	153.32	219	56.53	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15243.7	B08		9	0064-0152	631.80	151.95	274	63.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14469.2	B08		9	0065-0156	715.63	156.14	264	59.94	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20675.5	B08		9	0066-0159	132.93	160.15	351	80.08	0.688
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17844.8	B08		9	0067-0159	577.05	159.47	210	55.70	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14993.5	B08		9	0068-0161	523.25	160.27	245	71.60	0.601
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13507.3	B08		9	0069-0166	589.08	166.62	279	68.18	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21746.8	B08		9	0070-0168	857.63	168.79	337	69.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17055.6	B08		9	0071-0168	163.28	168.37	218	58.77	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12128.0	B08		9	0072-0167	753.10	167.95	345	77.36	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17257.2	B08		9	0073-0170	813.41	169.51	207	59.11	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18544.6	B08		9	0074-0173	337.38	173.65	437	79.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15721.9	B08		9	0075-0173	53.07	173.78	231	57.94	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15059.1	B08		9	0076-0177	659.41	177.28	409	77.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17418.7	B08		9	0077-0177	903.32	177.17	420	77.26	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22367.9	B08		9	0078-0177	119.07	177.60	157	47.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	26066.0	B08		9	0079-0179	279.29	179.71	293	63.94	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15977.1	B08		9	0080-0180	544.45	179.49	254	59.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17245.6	B08		9	0081-0186	495.05	186.44	413	75.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12014.2	B08		9	0082-0189	700.98	189.95	318	74.67	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14919.3	B08		9	0083-0200	82.82	200.43	296	66.18	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13983.5	B08		9	0084-0201	898.68	200.80	261	61.84	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12962.6	B08		9	0085-0203	39.87	204.14	236	65.01	0.702
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20641.3	B08		9	0086-0210	142.72	209.61	345	69.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14220.2	B08		9	0087-0210	815.25	209.94	406	75.60	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21259.2	B08		9	0088-0215	585.72	215.59	294	65.60	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23889.7	B08		9	0089-0220	316.80	220.33	296	63.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16790.9	B08		9	0090-0225	761.42	225.12	457	83.26	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17510.6	B08		9	0091-0221	68.78	221.25	223	57.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16944.5	B08		9	0092-0222	712.47	222.20	219	55.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15660.9	B08		9	0093-0229	444.65	229.37	286	62.53	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15891.1	B08		9	0094-0229	257.22	228.54	248	60.77	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15058.7	B08		9	0095-0230	419.36	229.52	313	66.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16390.8	B08		9	0096-0228	934.52	228.45	208	55.11	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17727.0	B08		9	0097-0233	696.55	233.45	214	54.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20683.0	B08		9	0098-0232	866.73	232.18	273	61.60	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22446.8	B08		9	0099-0240	469.31	240.67	512	91.50	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	25532.4	B08		9	0100-0231	583.41	230.91	168	48.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12915.8	B08		9	0101-0237	641.00	236.87	303	71.01	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15016.1	B08		9	0102-0237	786.48	236.79	348	67.60	0.957
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15797.3	B08		9	0103-0238	568.60	238.28	246	62.18	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15103.2	B08		9	0104-0243	188.18	242.63	287	63.94	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20117.7	B08		9	0105-0245	37.25	244.38	184	53.70	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	27158.1	B08		9	0106-0247	51.01	246.24	250	65.36	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16008.5	B08		9	0107-0246	387.87	246.42	235	58.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18726.1	B08		9	0108-0247	668.56	246.78	218	58.53	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	30897.1	B08		9	0109-0246	67.09	246.25	134	44.04	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15693.7	B08		9	0110-0249	757.96	250.41	242	59.84	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19835.0	B08		9	0111-0251	114.69	250.68	376	73.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21684.7	B08		9	0112-0249	731.62	249.28	190	51.70	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16072.4	B08		9	0113-0256	95.29	255.88	233	57.46	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15882.6	B08		9	0114-0264	314.31	264.28	268	63.11	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17413.2	B08		9	0115-0263	73.71	263.86	225	61.36	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15511.6	B08		9	0116-0262	474.21	262.79	286	65.94	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16428.5	B08		9	0117-0270	339.27	270.00	284	63.36	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21840.4	B08		9	0118-0269	535.85	268.73	309	66.18	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19614.2	B08		9	0119-0269	182.69	270.82	188	52.63	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18530.4	B08		9	0120-0272	17.79	271.66	249	58.53	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14741.6	B08		9	0121-0275	763.22	275.32	256	58.53	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16545.6	B08		9	0122-0277	555.54	277.08	261	60.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21191.4	B08		9	0123-0284	50.90	284.12	340	70.53	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16081.2	B08		9	0124-0281	99.05	281.25	217	54.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14217.1	B08		9	0125-0287	246.12	287.94	272	67.84	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21374.2	B08		9	0126-0292	726.80	291.74	517	93.15	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19965.0	B08		9	0127-0290	183.49	289.35	416	76.18	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	25804.1	B08		9	0128-0289	334.17	289.12	270	59.94	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21200.8	B08		9	0129-0291	540.49	291.77	368	70.43	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16033.6	B08		9	0130-0292	449.98	292.00	252	57.11	0.971
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16217.6	B08		9	0131-0295	589.40	296.33	240	59.94	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18226.3	B08		9	0132-0294	801.72	294.94	278	69.84	0.716
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	25437.4	B08		9	0133-0295	493.60	294.97	291	63.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15201.7	B08		9	0134-0300	260.29	300.34	263	68.77	0.699
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16584.9	B08		9	0135-0306	171.30	306.21	233	57.94	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17157.6	B08		9	0136-0312	29.03	312.93	218	56.53	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14592.5	B08		9	0137-0311	895.81	310.71	243	58.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12233.9	B08		9	0138-0318	53.27	318.60	345	82.08	0.643
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18114.4	B08		9	0139-0316	771.09	315.11	296	64.53	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19278.6	B08		9	0140-0318	229.24	318.55	191	51.70	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17894.8	B08		9	0141-0320	438.45	319.63	210	55.70	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21868.7	B08		9	0142-0321	467.78	320.33	229	56.28	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14874.8	B08		9	0143-0321	317.76	321.39	263	67.36	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12879.9	B08		9	0144-0328	922.76	328.97	281	67.11	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18102.7	B08		9	0145-0327	186.14	327.13	204	54.53	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19947.0	B08		9	0146-0334	85.06	333.61	377	76.18	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17979.7	B08		9	0147-0328	528.84	327.56	216	57.70	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16991.6	B08		9	0148-0337	300.90	337.37	226	68.91	0.598
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19212.4	B08		9	0149-0338	407.57	338.42	370	72.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15682.5	B08		9	0150-0340	108.35	340.54	212	56.28	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16046.5	B08		9	0151-0341	495.40	341.38	246	59.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17994.3	B08		9	0152-0341	755.99	340.88	209	54.28	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16801.3	B08		9	0153-0343	626.36	343.83	258	58.77	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16417.1	B08		9	0154-0344	427.02	344.31	229	57.46	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16759.6	B08		9	0155-0345	682.42	345.77	237	57.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13556.0	B08		9	0156-0352	877.69	351.77	267	62.87	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17012.4	B08		9	0157-0354	511.28	354.98	227	59.94	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18061.0	B08		9	0158-0355	359.05	355.36	404	74.18	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15024.6	B08		9	0159-0357	108.57	356.48	250	58.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17564.3	B08		9	0160-0362	712.63	362.15	219	55.36	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15726.7	B08		9	0161-0364	854.69	363.71	235	58.77	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15242.4	B08		9	0162-0374	762.71	374.69	251	58.53	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22768.7	B08		9	0163-0382	541.62	381.84	369	69.84	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14507.0	B08		9	0164-0384	836.72	385.18	259	62.53	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17888.4	B08		9	0165-0388	132.56	388.06	423	79.84	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18718.9	B08		9	0166-0383	443.86	383.52	208	54.53	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15085.7	B08		9	0167-0385	591.05	385.30	269	63.36	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18837.0	B08		9	0168-0383	795.38	383.11	199	51.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14698.6	B08		9	0169-0386	880.30	385.53	249	63.84	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12995.7	B08		9	0170-0388	609.83	388.72	299	68.18	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17710.1	B08		9	0171-0392	751.60	392.00	346	68.18	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21403.1	B08		9	0172-0392	61.36	392.33	283	61.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23212.5	B08		9	0173-0398	557.28	397.94	324	66.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15983.6	B08		9	0174-0397	499.20	396.92	252	61.11	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14456.6	B08		9	0175-0403	283.02	403.64	278	66.53	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13459.6	B08		9	0176-0402	205.79	402.27	267	61.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16489.7	B08		9	0177-0403	233.59	403.91	230	58.28	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18344.8	B08		9	0178-0405	473.13	404.50	404	75.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15063.2	B08		9	0179-0406	83.40	406.15	256	65.60	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16135.7	B08		9	0180-0413	789.67	413.15	247	57.36	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17721.7	B08		9	0181-0416	426.35	416.54	220	56.53	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15431.1	B08		9	0182-0423	837.61	424.02	364	74.91	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17695.8	B08		9	0183-0421	305.15	420.27	213	56.53	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16973.4	B08		9	0184-0422	494.32	422.69	230	56.43	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19265.9	B08		9	0185-0426	371.17	426.66	319	67.01	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20085.4	B08		9	0186-0427	537.70	427.27	339	69.01	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18218.7	B08		9	0187-0432	685.33	431.98	231	59.36	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13595.9	B08		9	0188-0431	97.98	430.39	188	56.39	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15491.1	B08		9	0189-0433	54.32	433.29	233	60.53	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19264.3	B08		9	0190-0436	449.92	436.02	269	60.53	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15374.3	B08		9	0191-0442	519.64	442.54	258	64.87	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13949.7	B08		9	0192-0439	203.08	439.76	261	62.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	26700.4	B08		9	0193-0437	789.12	437.27	116	40.63	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17279.8	B08		9	0194-0440	878.12	440.65	189	52.77	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14109.4	B08		9	0195-0443	98.41	442.84	227	59.11	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17923.1	B08		9	0196-0447	570.66	447.10	432	77.26	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15243.7	B08		9	0197-0448	170.09	448.37	247	57.94	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16226.4	B08		9	0198-0446	269.82	445.98	162	47.70	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13605.8	B08		9	0199-0446	254.95	446.32	123	39.70	0.981
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16818.2	B08		9	0200-0452	673.57	452.65	230	79.15	0.461
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18975.4	B08		9	0201-0452	307.23	451.83	314	65.60	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16921.0	B08		9	0202-0455	458.89	454.01	262	61.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16345.0	B08		9	0203-0454	867.79	454.33	272	60.77	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14850.8	B08		9	0204-0457	197.88	457.55	260	59.94	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22327.3	B08		9	0205-0458	886.30	458.69	261	59.11	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13638.5	B08		9	0206-0461	116.98	460.20	312	66.77	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14812.7	B08		9	0207-0457	382.26	457.42	169	48.87	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16579.2	B08		9	0208-0462	262.87	461.81	282	64.18	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16997.5	B08		9	0209-0462	492.45	462.02	229	58.77	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22408.9	B08		9	0210-0465	652.17	465.62	167	52.53	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17816.1	B08		9	0211-0467	447.34	467.17	217	56.53	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18405.0	B08		9	0212-0471	237.87	471.44	203	54.53	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16542.7	B08		9	0213-0475	615.13	476.07	237	61.94	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17091.0	B08		9	0214-0474	890.92	474.25	224	58.77	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15360.1	B08		9	0215-0477	410.11	477.40	250	60.28	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16654.1	B08		9	0216-0481	835.88	480.63	245	68.43	0.658
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13344.4	B08		9	0217-0482	131.20	482.57	312	67.36	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16058.4	B08		9	0218-0485	789.47	484.56	241	57.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20936.7	B08		9	0219-0488	293.83	487.81	344	69.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16458.5	B08		9	0220-0493	57.35	493.06	480	85.50	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16843.7	B08		9	0221-0491	203.22	491.41	302	64.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15506.4	B08		9	0222-0490	177.03	490.29	235	56.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15050.3	B08		9	0223-0495	751.21	495.28	280	66.77	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14273.7	B08		9	0224-0498	80.23	499.11	399	74.43	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17604.5	B08		9	0225-0497	922.77	497.48	204	57.70	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16918.0	B08		9	0226-0502	236.73	501.88	415	75.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19471.6	B08		9	0227-0498	573.39	498.78	297	62.53	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	24652.5	B08		9	0228-0500	322.76	499.64	277	61.60	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15812.1	B08		9	0229-0502	506.79	501.80	248	58.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15306.3	B08		9	0230-0503	20.49	503.65	227	58.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19138.5	B08		9	0231-0503	613.53	503.98	219	57.60	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15351.8	B08		9	0232-0506	148.19	505.77	242	59.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18761.6	B08		9	0233-0507	431.14	506.84	291	62.53	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16256.6	B08		9	0234-0507	638.99	507.50	240	56.53	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21959.5	B08		9	0235-0513	402.86	513.41	325	66.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14336.8	B08		9	0236-0514	539.86	512.74	302	67.84	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14343.8	B08		9	0237-0515	869.62	515.16	264	61.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14851.8	B08		9	0238-0516	369.98	516.93	269	64.18	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17344.3	B08		9	0239-0519	104.22	518.97	321	67.26	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20548.7	B08		9	0240-0525	570.22	526.36	302	65.94	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18468.0	B08		9	0241-0528	304.28	527.73	282	63.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12779.8	B08		9	0242-0532	817.06	532.15	301	66.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21032.7	B08		9	0243-0529	424.39	528.53	175	47.94	0.957
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12310.0	B08		9	0244-0536	692.32	536.35	300	71.01	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12653.9	B08		9	0245-0535	203.65	535.32	324	70.77	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16167.8	B08		9	0246-0534	332.49	534.09	240	59.60	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16331.6	B08		9	0247-0535	479.98	535.04	241	57.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18024.6	B08		9	0248-0535	624.18	535.37	228	54.53	0.964
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13354.1	B08		9	0249-0541	520.93	541.71	289	66.08	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19683.8	B08		9	0250-0540	436.99	540.78	196	51.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15388.8	B08		9	0251-0542	849.90	542.58	274	61.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20358.5	B08		9	0252-0547	578.88	546.35	334	73.26	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15470.9	B08		9	0253-0547	64.50	546.90	227	56.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17192.2	B08		9	0254-0548	272.23	548.62	433	82.67	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20677.2	B08		9	0255-0549	125.58	549.29	309	65.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14817.3	B08		9	0256-0552	634.80	553.72	295	69.01	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21537.6	B08		9	0257-0554	757.50	554.76	286	61.94	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15236.5	B08		9	0258-0558	555.44	558.53	254	60.77	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17316.3	B08		9	0259-0560	24.96	560.43	200	53.70	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15959.2	B08		9	0260-0562	697.90	561.96	263	64.77	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15443.5	B08		9	0261-0563	849.83	563.63	267	62.77	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16176.2	B08		9	0262-0566	598.76	565.95	287	64.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16069.0	B08		9	0263-0565	51.84	565.11	217	53.94	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12880.5	B08		9	0264-0568	888.61	568.11	289	68.43	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15789.2	B08		9	0265-0572	386.02	571.90	243	58.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14060.3	B08		9	0266-0575	514.40	575.95	281	61.70	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20026.5	B08		9	0267-0581	532.87	581.25	353	71.94	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15621.1	B08		9	0268-0579	287.29	578.41	257	65.84	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12531.0	B08		9	0269-0584	864.73	583.81	303	73.26	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18092.6	B08		9	0270-0584	646.24	584.16	276	63.01	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15087.6	B08		9	0271-0585	50.25	586.00	238	56.53	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18729.4	B08		9	0272-0588	179.41	588.74	349	70.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19359.2	B08		9	0273-0590	332.10	590.35	315	67.36	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17759.8	B08		9	0274-0586	763.04	585.73	159	46.28	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15870.0	B08		9	0275-0592	716.93	591.83	260	62.43	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17444.8	B08		9	0276-0596	84.07	595.42	314	70.43	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14228.1	B08		9	0277-0596	569.57	597.08	525	102.57	0.627
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15969.3	B08		9	0278-0595	813.75	595.63	252	65.36	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17164.4	B08		9	0279-0592	473.14	591.49	225	56.87	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18415.5	B08		9	0280-0596	369.67	596.03	280	62.18	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17273.1	B08		9	0281-0596	774.53	596.67	295	65.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14899.3	B08		9	0282-0601	122.68	601.11	241	61.84	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15306.7	B08		9	0283-0598	437.42	599.28	254	61.94	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13931.7	B08		9	0284-0604	937.38	603.42	278	62.53	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16658.6	B08		9	0285-0604	397.84	603.82	232	55.36	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21080.1	B08		9	0286-0609	894.82	608.75	206	54.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16773.7	B08		9	0287-0616	115.39	616.74	322	71.60	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20720.9	B08		9	0288-0614	727.58	614.63	374	73.01	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17225.4	B08		9	0289-0615	291.21	615.32	234	60.18	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23816.3	B08		9	0290-0611	909.17	611.05	147	46.04	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15040.1	B08		9	0291-0616	59.21	615.88	279	62.18	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20385.2	B08		9	0292-0616	645.44	616.87	345	73.26	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16239.4	B08		9	0293-0617	868.69	617.47	490	92.81	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17292.0	B08		9	0294-0618	309.51	618.88	216	61.84	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19576.0	B08		9	0295-0618	274.72	618.27	204	54.53	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13661.7	B08		9	0296-0622	927.25	621.70	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18189.7	B08		9	0297-0624	218.76	623.81	309	63.60	0.960
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23428.7	B08		9	0298-0628	473.80	627.67	178	52.53	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20239.5	B08		9	0299-0629	88.26	629.56	283	62.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14590.6	B08		9	0300-0629	777.02	628.82	261	61.01	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14548.7	B08		9	0301-0635	568.32	635.08	290	73.84	0.668
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15835.8	B08		9	0302-0631	810.05	630.69	249	63.26	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17422.7	B08		9	0303-0630	383.60	630.36	218	53.36	0.962
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16017.5	B08		9	0304-0632	640.10	632.53	232	59.70	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19686.8	B08		9	0305-0633	902.89	632.87	350	68.18	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16112.6	B08		9	0306-0631	325.68	632.39	263	60.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	24027.8	B08		9	0307-0633	688.22	633.46	306	63.94	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14377.8	B08		9	0308-0640	182.52	640.32	330	69.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16479.1	B08		9	0309-0639	110.84	638.95	229	56.53	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19077.4	B08		9	0310-0642	264.97	641.97	190	53.36	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16514.0	B08		9	0311-0642	946.31	642.26	211	55.94	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21474.2	B08		9	0312-0653	717.73	653.94	494	85.15	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15434.4	B08		9	0313-0650	429.31	649.95	196	52.28	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13875.1	B08		9	0314-0655	504.15	656.17	268	64.18	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14635.0	B08		9	0315-0652	657.70	652.90	261	59.11	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22689.0	B08		9	0316-0654	70.78	654.67	174	51.11	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16705.1	B08		9	0317-0657	339.71	657.78	226	56.53	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14899.7	B08		9	0318-0655	383.03	655.64	149	48.87	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14451.6	B08		9	0319-0657	200.29	656.11	247	59.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11512.7	B08		9	0320-0658	839.59	659.58	154	49.70	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12274.7	B08		9	0321-0657	444.85	658.14	127	47.11	0.719
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17806.5	B08		9	0322-0661	623.12	662.42	258	63.60	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18430.7	B08		9	0323-0658	568.08	658.62	172	49.70	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18407.6	B08		9	0324-0659	790.18	659.37	206	54.28	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12801.6	B08		9	0325-0663	35.78	663.64	240	57.94	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17716.3	B08		9	0326-0662	404.60	661.96	211	57.36	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14666.0	B08		9	0327-0664	162.23	664.66	252	61.94	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14894.6	B08		9	0328-0670	140.52	670.03	284	64.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13466.3	B08		9	0329-0672	297.72	672.30	288	66.43	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16264.0	B08		9	0330-0674	875.21	673.40	244	60.53	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15269.3	B08		9	0331-0676	380.69	676.33	270	67.84	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14718.0	B08		9	0332-0675	91.03	674.87	253	59.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15006.8	B08		9	0333-0676	937.72	675.75	245	59.11	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19206.1	B08		9	0334-0674	786.59	674.75	198	50.87	0.962
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14953.4	B08		9	0335-0684	887.77	684.20	229	60.77	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14712.6	B08		9	0336-0686	264.85	686.00	246	60.53	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14987.1	B08		9	0337-0692	837.75	693.34	241	64.43	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15281.4	B08		9	0338-0695	451.42	695.09	247	59.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18929.3	B08		9	0339-0698	629.42	698.59	368	72.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13932.6	B08		9	0340-0696	691.70	698.16	252	70.43	0.638
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15760.1	B08		9	0341-0695	937.50	695.64	242	57.11	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13148.5	B08		9	0342-0697	110.29	698.24	232	66.18	0.666
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17174.4	B08		9	0343-0703	749.84	702.22	218	59.11	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17983.6	B08		9	0344-0703	45.50	703.45	308	66.43	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15224.5	B08		9	0345-0708	150.33	708.96	334	70.43	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12686.6	B08		9	0346-0706	185.63	705.56	275	66.43	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14986.0	B08		9	0347-0703	907.57	703.18	102	37.80	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1184818	1375317	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16132.3	B08		9	0348-0708	216.50	709.43	226	57.36	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16826.5	C08		1	0001-0025	822.14	25.96	373	78.43	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21538.5	C08		1	0002-0032	681.57	32.38	336	70.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15005.6	C08		1	0003-0031	209.13	31.38	259	59.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14131.1	C08		1	0004-0035	598.48	35.02	291	65.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13578.8	C08		1	0005-0033	294.09	33.97	277	61.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13964.6	C08		1	0006-0037	95.05	37.30	267	59.36	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17312.4	C08		1	0007-0038	133.57	38.49	299	64.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11903.1	C08		1	0008-0040	943.98	40.01	322	66.77	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14925.1	C08		1	0009-0040	72.15	41.03	262	61.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16553.6	C08		1	0010-0039	525.47	39.38	257	59.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20376.4	C08		1	0011-0041	554.92	42.34	237	63.60	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12854.5	C08		1	0012-0041	925.52	41.93	290	61.94	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13374.8	C08		1	0013-0045	740.21	45.84	288	63.84	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21344.2	C08		1	0014-0050	351.70	51.05	330	68.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15202.5	C08		1	0015-0054	703.39	54.41	393	100.57	0.488
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18252.1	C08		1	0016-0050	831.85	50.06	209	52.28	0.961
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13314.2	C08		1	0017-0054	308.76	53.84	288	64.43	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12079.5	C08		1	0018-0058	877.05	57.46	291	64.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12717.1	C08		1	0019-0061	784.13	62.60	326	70.18	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14369.7	C08		1	0020-0061	248.09	60.88	258	61.01	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14941.0	C08		1	0021-0063	901.93	63.40	246	58.18	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14637.3	C08		1	0022-0065	450.72	64.22	288	63.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13733.1	C08		1	0023-0070	278.90	71.24	278	66.18	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12770.6	C08		1	0024-0072	603.94	72.36	320	66.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14193.8	C08		1	0025-0072	740.78	71.77	255	64.43	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22830.2	C08		1	0026-0072	691.94	72.87	204	67.26	0.567
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14369.7	C08		1	0027-0072	50.25	71.85	260	59.94	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13239.9	C08		1	0028-0074	438.92	74.68	303	65.26	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13797.9	C08		1	0029-0079	190.55	76.48	356	97.64	0.469
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13041.5	C08		1	0030-0075	870.05	76.04	277	65.36	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12309.5	C08		1	0031-0085	158.34	84.95	308	67.60	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16355.2	C08		1	0032-0085	93.65	85.12	246	58.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13823.7	C08		1	0033-0086	125.51	86.38	303	68.08	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12700.1	C08		1	0034-0086	411.37	86.47	305	64.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12644.2	C08		1	0035-0086	333.45	86.21	307	67.36	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15827.4	C08		1	0036-0095	644.36	95.56	264	61.94	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15058.8	C08		1	0037-0095	520.50	94.48	257	62.77	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13022.7	C08		1	0038-0096	764.15	95.07	320	71.01	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20612.0	C08		1	0039-0100	537.98	100.04	222	57.94	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21111.8	C08		1	0040-0101	506.98	101.49	188	52.53	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14088.2	C08		1	0041-0103	259.99	103.05	262	59.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18594.2	C08		1	0042-0105	493.19	105.07	201	53.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14854.7	C08		1	0043-0106	37.63	106.01	252	59.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13638.9	C08		1	0044-0109	240.13	108.48	280	63.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13770.9	C08		1	0045-0108	558.40	108.86	306	65.36	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13858.2	C08		1	0046-0108	577.01	108.07	250	57.36	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11616.8	C08		1	0047-0107	811.47	107.51	328	67.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12487.5	C08		1	0048-0110	851.09	110.29	317	67.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15497.6	C08		1	0049-0108	445.47	107.83	261	66.77	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16350.2	C08		1	0050-0117	119.82	117.36	249	60.53	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21729.5	C08		1	0051-0119	649.82	119.59	358	69.60	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16229.6	C08		1	0052-0120	103.19	120.90	254	61.11	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13854.6	C08		1	0053-0119	946.75	118.29	260	63.60	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13367.5	C08		1	0054-0118	743.02	118.79	290	64.53	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14331.2	C08		1	0055-0121	58.32	121.55	260	60.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15545.8	C08		1	0056-0131	85.34	132.15	262	61.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12845.7	C08		1	0057-0131	452.43	130.72	300	64.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11750.4	C08		1	0058-0138	487.67	137.96	255	65.84	0.739
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11555.2	C08		1	0059-0137	502.83	137.54	193	57.01	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15621.7	C08		1	0060-0139	210.02	137.63	516	101.40	0.631
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16570.7	C08		1	0061-0138	670.61	138.33	241	56.53	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11932.2	C08		1	0062-0143	149.45	143.21	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15022.0	C08		1	0063-0140	372.06	140.09	251	59.01	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13459.9	C08		1	0064-0145	749.21	144.31	314	68.18	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11661.8	C08		1	0065-0145	920.96	145.33	331	71.50	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15180.0	C08		1	0066-0146	39.71	146.68	341	69.94	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14027.1	C08		1	0067-0147	173.79	147.27	267	61.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13528.9	C08		1	0068-0153	551.00	153.54	283	63.26	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14610.0	C08		1	0069-0151	813.05	150.94	259	59.36	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15301.3	C08		1	0070-0158	513.00	157.99	546	99.15	0.698
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11300.6	C08		1	0071-0153	446.25	153.63	170	52.77	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11670.7	C08		1	0072-0155	845.90	155.03	319	67.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15144.1	C08		1	0073-0154	334.70	154.51	259	60.18	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15879.2	C08		1	0074-0152	624.74	152.68	246	59.11	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13600.0	C08		1	0075-0156	784.87	156.36	297	65.60	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11480.9	C08		1	0076-0159	884.42	159.25	315	70.43	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11259.4	C08		1	0077-0160	127.31	160.31	303	65.36	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14298.9	C08		1	0078-0162	305.18	162.32	272	63.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12929.1	C08		1	0079-0168	288.46	168.54	311	67.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12450.0	C08		1	0080-0171	832.81	171.77	291	68.18	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13946.5	C08		1	0081-0174	42.34	174.21	262	63.36	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14317.8	C08		1	0082-0170	729.21	170.50	271	61.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13096.5	C08		1	0083-0173	590.40	173.08	296	63.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19774.0	C08		1	0084-0178	83.14	178.73	315	65.01	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15603.2	C08		1	0085-0177	171.65	177.29	246	57.36	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13537.8	C08		1	0086-0182	691.21	182.38	284	63.36	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15177.1	C08		1	0087-0186	447.87	186.68	253	59.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19038.9	C08		1	0088-0188	242.39	187.62	194	51.94	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	24464.6	C08		1	0089-0193	516.56	193.62	611	101.98	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12361.4	C08		1	0090-0190	635.08	190.19	316	70.43	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13075.6	C08		1	0091-0192	872.76	192.02	284	61.36	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13726.2	C08		1	0092-0193	736.41	192.47	313	65.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15160.7	C08		1	0093-0194	386.17	193.83	254	58.53	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12321.8	C08		1	0094-0194	823.62	193.96	316	67.84	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13367.5	C08		1	0095-0196	920.81	196.20	290	64.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12834.7	C08		1	0096-0196	427.88	196.19	297	65.01	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11697.2	C08		1	0097-0201	117.09	201.51	288	64.28	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13200.2	C08		1	0098-0201	53.21	201.78	281	60.77	0.956
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18149.7	C08		1	0099-0200	257.81	199.94	205	56.77	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16320.4	C08		1	0100-0203	208.24	203.37	234	55.94	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14033.2	C08		1	0101-0206	669.23	206.07	274	62.53	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19691.2	C08		1	0102-0208	574.16	208.16	397	73.84	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14535.4	C08		1	0103-0204	331.29	205.07	268	64.28	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16402.4	C08		1	0104-0211	807.63	211.72	465	80.08	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13797.3	C08		1	0105-0211	246.49	212.01	282	62.43	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14320.9	C08		1	0106-0213	766.71	214.14	272	61.60	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14873.4	C08		1	0107-0227	200.15	227.05	513	92.08	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20418.8	C08		1	0108-0228	722.25	228.10	375	72.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15923.6	C08		1	0109-0230	145.31	230.74	242	58.77	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18174.5	C08		1	0110-0231	695.49	230.67	231	55.36	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13623.3	C08		1	0111-0231	567.25	231.61	293	66.53	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14278.8	C08		1	0112-0236	127.92	236.17	260	61.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16339.0	C08		1	0113-0237	501.37	237.45	245	57.94	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13659.4	C08		1	0114-0236	799.39	236.30	397	79.70	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15496.9	C08		1	0115-0240	324.51	240.08	251	58.53	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11660.2	C08		1	0116-0244	296.32	243.88	305	66.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11799.5	C08		1	0117-0248	90.39	247.75	310	65.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23278.4	C08		1	0118-0248	683.41	248.56	344	67.60	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19124.8	C08		1	0119-0245	744.24	245.15	204	53.11	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19541.4	C08		1	0120-0245	763.73	245.53	199	51.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16307.7	C08		1	0121-0250	345.88	250.19	248	57.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19757.8	C08		1	0122-0255	833.72	255.63	376	75.26	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15509.2	C08		1	0123-0253	578.67	252.77	255	61.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12885.4	C08		1	0124-0257	141.20	256.83	286	63.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16143.3	C08		1	0125-0262	225.24	261.63	430	78.67	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12764.9	C08		1	0126-0259	74.74	259.19	315	66.53	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15064.0	C08		1	0127-0259	284.48	259.09	366	71.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23484.1	C08		1	0128-0259	366.80	258.66	326	67.01	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17091.1	C08		1	0129-0257	851.64	258.33	235	58.87	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15246.3	C08		1	0130-0267	526.09	266.69	533	94.57	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15138.4	C08		1	0131-0263	590.14	263.95	263	61.11	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22389.4	C08		1	0132-0266	877.93	266.67	240	58.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16959.5	C08		1	0133-0265	920.94	265.46	218	53.70	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19150.3	C08		1	0134-0271	614.64	271.53	413	74.67	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19855.5	C08		1	0135-0272	765.04	272.49	301	63.36	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21129.5	C08		1	0136-0272	934.67	272.12	175	51.36	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15504.3	C08		1	0137-0276	167.43	277.02	253	61.70	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11339.9	C08		1	0138-0276	674.37	275.96	323	67.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13302.6	C08		1	0139-0278	456.40	277.71	282	63.60	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14376.0	C08		1	0140-0279	829.32	278.74	284	64.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16299.9	C08		1	0141-0279	328.50	279.91	245	56.77	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19041.2	C08		1	0142-0287	283.61	286.97	406	75.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13483.8	C08		1	0143-0290	212.32	290.79	292	66.18	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11718.8	C08		1	0144-0287	406.95	287.56	318	70.77	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15707.9	C08		1	0145-0287	877.73	287.64	261	59.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23882.7	C08		1	0146-0284	940.74	284.64	148	44.28	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12109.7	C08		1	0147-0290	350.24	290.23	304	68.08	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13198.4	C08		1	0148-0293	88.23	293.47	271	63.36	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13876.1	C08		1	0149-0298	478.74	297.61	288	67.11	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11550.3	C08		1	0150-0299	30.29	299.17	312	65.11	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16269.5	C08		1	0151-0297	769.35	297.25	237	56.18	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14341.0	C08		1	0152-0298	577.12	298.30	242	62.18	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12155.4	C08		1	0153-0301	850.21	301.23	325	67.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15613.0	C08		1	0154-0301	793.81	300.67	249	59.60	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12022.4	C08		1	0155-0305	134.72	305.10	300	65.01	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11990.4	C08		1	0156-0305	415.61	306.08	322	69.60	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16018.3	C08		1	0157-0308	177.86	307.75	226	57.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16058.5	C08		1	0158-0311	161.71	310.71	226	56.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13855.4	C08		1	0159-0311	441.45	311.15	283	62.77	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15391.0	C08		1	0160-0310	572.11	310.90	264	63.70	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12135.5	C08		1	0161-0317	258.06	316.84	309	68.77	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11287.9	C08		1	0162-0320	664.01	318.99	331	66.77	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11448.2	C08		1	0163-0324	615.82	324.26	326	70.43	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12201.7	C08		1	0164-0324	23.47	324.39	299	63.60	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11901.7	C08		1	0165-0325	243.62	325.36	286	63.84	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14571.6	C08		1	0166-0325	394.36	325.64	297	64.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16898.4	C08		1	0167-0328	874.08	327.59	234	56.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15397.7	C08		1	0168-0328	899.15	329.03	260	61.94	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15086.1	C08		1	0169-0333	90.84	332.85	266	62.43	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13808.7	C08		1	0170-0333	126.02	332.87	298	67.60	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15801.6	C08		1	0171-0337	818.17	337.25	353	68.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16671.4	C08		1	0172-0336	529.02	336.98	248	59.94	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13979.5	C08		1	0173-0335	936.43	335.59	267	61.36	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16207.8	C08		1	0174-0342	377.70	341.70	254	63.60	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15467.2	C08		1	0175-0341	751.57	340.97	254	61.60	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17960.0	C08		1	0176-0344	76.38	343.86	228	55.36	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20174.4	C08		1	0177-0345	460.57	344.62	193	52.53	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13610.2	C08		1	0178-0351	681.74	350.99	338	69.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12954.4	C08		1	0179-0349	577.92	349.82	294	64.43	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13785.3	C08		1	0180-0351	291.85	350.98	292	63.84	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13866.1	C08		1	0181-0352	489.82	352.37	300	65.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15882.2	C08		1	0182-0352	327.35	351.69	252	61.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17592.8	C08		1	0183-0353	446.60	353.32	231	56.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15984.4	C08		1	0184-0354	805.06	354.07	247	59.70	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17079.1	C08		1	0185-0359	872.13	359.11	311	67.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21699.5	C08		1	0186-0363	132.70	363.09	329	68.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15125.7	C08		1	0187-0365	336.31	364.68	263	59.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12845.1	C08		1	0188-0364	410.22	363.79	327	69.01	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15555.9	C08		1	0189-0367	502.64	368.11	257	61.84	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13699.2	C08		1	0190-0376	921.44	376.79	551	108.95	0.583
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13639.3	C08		1	0191-0369	593.60	369.66	279	63.70	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13747.5	C08		1	0192-0375	268.02	375.42	298	69.36	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15036.5	C08		1	0193-0372	752.98	371.61	257	60.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9549.4	C08		1	0194-0377	634.41	376.32	349	72.43	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12629.6	C08		1	0195-0379	880.14	379.02	319	70.43	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14621.0	C08		1	0196-0377	119.73	376.80	305	72.77	0.724
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14618.7	C08		1	0197-0382	700.82	381.97	292	65.60	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12083.2	C08		1	0198-0382	220.40	381.71	287	64.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18093.6	C08		1	0199-0382	446.89	381.74	234	56.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13865.0	C08		1	0200-0384	428.95	384.84	299	64.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18617.8	C08		1	0201-0387	282.57	387.37	421	76.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15808.7	C08		1	0202-0387	25.30	387.85	243	61.94	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17486.9	C08		1	0203-0393	364.86	393.85	475	94.23	0.672
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13464.2	C08		1	0204-0386	840.01	386.59	291	66.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12005.7	C08		1	0205-0392	728.70	393.05	303	68.18	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15737.6	C08		1	0206-0395	87.04	395.30	245	57.94	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13815.5	C08		1	0207-0395	516.66	395.19	277	61.36	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14982.9	C08		1	0208-0404	108.05	404.45	252	58.18	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15891.6	C08		1	0209-0408	417.91	407.79	261	63.01	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13381.7	C08		1	0210-0413	504.12	413.06	284	62.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14185.1	C08		1	0211-0413	684.04	412.94	283	62.18	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10745.0	C08		1	0212-0418	45.73	418.54	308	64.18	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22122.1	C08		1	0213-0420	133.94	419.89	318	65.84	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11514.1	C08		1	0214-0424	879.01	423.32	332	79.74	0.656
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11973.6	C08		1	0215-0420	815.78	420.19	308	63.36	0.964
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18195.4	C08		1	0216-0420	439.51	420.26	208	54.04	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13581.4	C08		1	0217-0422	290.62	422.02	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10913.1	C08		1	0218-0426	192.46	426.07	432	78.43	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16203.2	C08		1	0219-0425	457.42	425.06	257	61.70	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13796.1	C08		1	0220-0425	908.76	426.11	267	63.94	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17928.3	C08		1	0221-0430	759.47	429.63	435	88.67	0.695
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12193.6	C08		1	0222-0428	253.32	428.39	295	66.18	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9147.3	C08		1	0223-0431	555.02	431.98	323	95.15	0.448
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13905.8	C08		1	0224-0430	599.73	430.23	285	65.60	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14510.6	C08		1	0225-0433	317.04	433.41	275	62.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11621.9	C08		1	0226-0433	103.24	433.39	402	75.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13419.5	C08		1	0227-0438	640.55	438.85	580	100.57	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14621.0	C08		1	0228-0435	845.96	435.40	258	62.28	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12087.7	C08		1	0229-0438	720.28	437.38	302	67.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19416.8	C08		1	0230-0439	18.11	439.59	340	68.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11327.3	C08		1	0231-0441	169.96	442.00	318	66.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16911.4	C08		1	0232-0444	771.12	444.45	230	57.36	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15302.9	C08		1	0233-0447	477.66	447.79	262	61.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15840.7	C08		1	0234-0456	438.10	457.77	540	95.40	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11597.7	C08		1	0235-0456	881.35	455.43	335	78.57	0.682
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12269.8	C08		1	0236-0456	265.11	456.45	313	65.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17829.1	C08		1	0237-0460	511.98	459.79	454	81.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18473.1	C08		1	0238-0456	409.18	456.62	214	53.36	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10064.0	C08		1	0239-0461	38.50	461.65	307	66.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11464.5	C08		1	0240-0462	165.64	462.71	309	71.60	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15757.0	C08		1	0241-0468	330.38	467.02	250	58.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17379.2	C08		1	0242-0470	569.44	470.56	357	69.84	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14452.1	C08		1	0243-0470	930.07	470.50	260	59.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11608.6	C08		1	0244-0471	789.81	471.64	322	67.01	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20357.0	C08		1	0245-0474	229.06	473.77	379	73.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16016.9	C08		1	0246-0471	387.85	471.68	248	58.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14094.8	C08		1	0247-0472	706.29	472.14	277	63.11	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16775.4	C08		1	0248-0481	321.87	481.24	242	58.77	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17711.5	C08		1	0249-0485	380.17	485.37	224	55.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11358.2	C08		1	0250-0486	625.83	486.05	324	66.18	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13650.8	C08		1	0251-0487	260.40	486.47	279	63.01	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13438.1	C08		1	0252-0488	501.49	489.01	313	66.77	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14184.2	C08		1	0253-0492	911.58	492.21	260	59.70	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22246.5	C08		1	0254-0494	593.95	494.04	348	70.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12174.4	C08		1	0255-0495	665.13	495.70	312	69.11	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16369.1	C08		1	0256-0494	159.72	493.86	232	57.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16140.0	C08		1	0257-0496	474.83	495.59	304	64.77	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15430.6	C08		1	0258-0500	942.76	500.59	410	78.43	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13175.0	C08		1	0259-0499	73.34	499.05	270	61.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17837.1	C08		1	0260-0501	746.05	501.11	444	77.26	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13580.5	C08		1	0261-0500	189.28	499.86	272	61.11	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18220.9	C08		1	0262-0505	546.03	505.10	455	80.91	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13704.0	C08		1	0263-0503	299.59	503.95	272	63.01	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13505.2	C08		1	0264-0501	110.04	501.73	271	61.70	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20844.2	C08		1	0265-0505	789.60	505.62	115	92.43	0.169
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14148.7	C08		1	0266-0510	829.21	510.02	266	60.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13284.4	C08		1	0267-0509	37.93	509.58	271	61.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22197.9	C08		1	0268-0511	426.05	511.33	325	66.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19890.9	C08		1	0269-0514	270.46	514.21	363	71.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13071.3	C08		1	0270-0511	672.74	511.00	271	68.28	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12593.3	C08		1	0271-0516	129.22	517.00	317	67.36	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13833.2	C08		1	0272-0516	194.76	516.95	280	64.53	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13791.5	C08		1	0273-0521	857.97	520.82	269	61.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14779.3	C08		1	0274-0520	584.05	520.77	274	60.77	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13808.8	C08		1	0275-0522	441.51	522.16	302	64.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14249.5	C08		1	0276-0522	713.75	522.25	263	61.70	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12857.1	C08		1	0277-0526	530.57	526.08	301	64.43	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16271.0	C08		1	0278-0533	763.47	532.72	242	59.36	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13926.8	C08		1	0279-0534	795.61	533.70	277	61.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12659.9	C08		1	0280-0533	83.50	533.87	305	73.01	0.719
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17707.6	C08		1	0281-0535	213.46	535.24	213	53.11	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11876.0	C08		1	0282-0539	273.70	539.14	294	68.67	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14716.0	C08		1	0283-0537	619.01	536.78	268	61.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22658.9	C08		1	0284-0544	727.47	543.99	343	68.43	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21849.7	C08		1	0285-0547	679.63	546.69	355	71.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15452.9	C08		1	0286-0547	351.77	547.50	250	59.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12268.3	C08		1	0287-0549	43.38	549.11	280	63.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14989.6	C08		1	0288-0548	164.29	548.21	254	59.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15696.7	C08		1	0289-0548	540.05	548.03	188	49.70	0.956
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13898.5	C08		1	0290-0550	835.32	549.74	270	61.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13881.4	C08		1	0291-0549	145.49	549.09	265	62.04	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13075.1	C08		1	0292-0552	920.15	551.59	294	63.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12406.1	C08		1	0293-0553	312.34	553.07	308	65.01	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18618.7	C08		1	0294-0553	786.10	553.31	341	71.84	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15095.5	C08		1	0295-0556	560.59	557.44	266	59.60	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12039.3	C08		1	0296-0559	390.52	558.51	297	64.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16033.4	C08		1	0297-0563	482.05	562.86	252	58.18	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13924.5	C08		1	0298-0563	675.45	563.22	272	63.11	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9336.6	C08		1	0299-0564	92.34	564.16	140	51.11	0.673
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14342.5	C08		1	0300-0569	793.86	569.65	318	66.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23382.9	C08		1	0301-0567	268.09	568.13	164	47.21	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13945.3	C08		1	0302-0571	593.86	571.40	272	60.53	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12624.2	C08		1	0303-0572	205.22	572.62	276	67.60	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21853.1	C08		1	0304-0571	518.31	570.42	129	68.53	0.345
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18323.3	C08		1	0305-0579	898.28	579.25	364	71.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12908.5	C08		1	0306-0575	245.48	575.14	169	47.46	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15927.0	C08		1	0307-0576	559.64	575.69	245	58.53	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13401.3	C08		1	0308-0578	732.89	578.70	294	64.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13189.4	C08		1	0309-0580	875.88	579.73	285	62.18	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12024.6	C08		1	0310-0581	82.77	581.36	293	63.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18458.1	C08		1	0311-0587	262.45	585.43	422	83.60	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16282.1	C08		1	0312-0584	449.27	583.89	246	57.11	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18272.9	C08		1	0313-0585	537.45	585.66	219	55.36	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11419.8	C08		1	0314-0588	301.52	587.94	322	67.60	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23758.1	C08		1	0315-0589	927.47	589.16	304	65.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14784.8	C08		1	0316-0589	150.69	589.40	378	72.77	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12518.7	C08		1	0317-0592	810.14	592.40	297	64.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12307.6	C08		1	0318-0595	27.14	595.40	266	63.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15948.8	C08		1	0319-0597	944.27	597.18	229	55.70	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15056.1	C08		1	0320-0605	525.30	604.34	263	62.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14148.8	C08		1	0321-0603	766.04	603.99	261	61.70	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14416.1	C08		1	0322-0607	199.34	607.04	248	62.77	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16650.7	C08		1	0323-0608	393.01	608.28	288	63.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12682.0	C08		1	0324-0609	74.76	609.25	262	59.60	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12402.5	C08		1	0325-0612	704.10	611.88	297	64.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11661.3	C08		1	0326-0614	844.13	613.52	296	63.60	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14490.6	C08		1	0327-0612	482.55	611.88	271	62.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17245.3	C08		1	0328-0621	28.06	620.90	218	54.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15480.0	C08		1	0329-0619	763.88	618.42	260	63.11	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12316.5	C08		1	0330-0624	650.46	623.74	294	66.43	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19130.3	C08		1	0331-0625	262.52	625.35	205	51.70	0.964
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16042.7	C08		1	0332-0633	595.61	632.78	244	57.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14902.9	C08		1	0333-0634	879.26	634.12	249	57.94	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15687.0	C08		1	0334-0638	623.32	638.35	297	62.77	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14626.4	C08		1	0335-0643	419.35	643.64	263	62.53	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13255.1	C08		1	0336-0646	176.89	645.51	593	98.57	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18046.7	C08		1	0337-0645	219.75	645.23	306	69.60	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13187.8	C08		1	0338-0648	126.69	647.81	281	64.77	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13845.6	C08		1	0339-0646	727.56	646.82	268	61.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13702.2	C08		1	0340-0650	88.89	650.61	376	73.01	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13206.8	C08		1	0341-0649	316.53	648.68	283	62.77	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12390.5	C08		1	0342-0650	522.00	651.01	317	68.43	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19199.9	C08		1	0343-0651	570.73	650.76	211	55.11	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12806.0	C08		1	0344-0651	800.58	651.10	287	63.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13804.8	C08		1	0345-0648	909.49	648.45	257	60.53	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12783.7	C08		1	0346-0654	254.61	654.82	304	67.36	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15235.9	C08		1	0347-0653	445.55	652.66	256	59.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13256.5	C08		1	0348-0654	367.50	653.95	286	62.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12599.1	C08		1	0349-0656	762.40	655.48	294	64.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14880.4	C08		1	0350-0664	667.52	664.31	302	63.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19232.4	C08		1	0351-0671	601.16	671.67	341	67.60	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15869.8	C08		1	0352-0672	812.39	672.34	244	58.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14317.0	C08		1	0353-0676	939.29	676.50	264	61.11	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15626.6	C08		1	0354-0678	275.20	678.07	250	57.70	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12462.5	C08		1	0355-0681	711.96	681.31	295	64.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14330.1	C08		1	0356-0682	315.97	682.29	268	61.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15056.3	C08		1	0357-0681	863.81	681.07	227	57.11	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17340.7	C08		1	0358-0683	583.00	683.42	165	46.87	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14319.7	C08		1	0359-0688	917.00	688.43	243	58.18	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13555.8	C08		1	0360-0688	653.24	687.57	269	60.28	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13906.2	C08		1	0361-0693	825.13	693.11	264	63.26	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12510.2	C08		1	0362-0692	465.12	692.45	299	67.60	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13116.8	C08		1	0363-0695	164.66	695.52	270	60.53	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11853.7	C08		1	0364-0697	406.64	696.45	298	62.77	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11935.8	C08		1	0365-0696	862.07	696.93	302	67.94	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14497.7	C08		1	0366-0699	197.60	698.93	257	59.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16499.9	C08		1	0367-0697	564.69	698.02	245	58.87	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15021.9	C08		1	0368-0700	335.60	700.91	255	58.77	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12128.6	C08		1	0369-0702	19.92	703.24	288	63.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11239.9	C08		1	0370-0705	367.96	704.81	288	66.67	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184729	1375318	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15042.2	C08		1	0371-0705	91.70	705.53	250	60.53	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12924.2	C08		2	0001-0024	128.41	23.60	288	63.84	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14266.2	C08		2	0002-0025	174.92	24.72	270	61.94	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14469.1	C08		2	0003-0032	871.75	31.68	248	60.77	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19401.7	C08		2	0004-0033	68.62	32.87	192	51.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10862.4	C08		2	0005-0040	397.91	40.47	375	72.18	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14345.3	C08		2	0006-0037	551.14	37.65	274	62.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15267.0	C08		2	0007-0038	680.72	39.05	242	56.77	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12294.6	C08		2	0008-0042	48.52	41.52	316	66.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12908.7	C08		2	0009-0043	30.09	43.27	294	62.53	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9808.8	C08		2	0010-0043	231.80	43.46	334	67.60	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14498.8	C08		2	0011-0044	186.15	45.23	269	63.26	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12203.0	C08		2	0012-0048	487.71	49.18	332	70.77	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12079.8	C08		2	0013-0047	649.05	47.26	310	64.53	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13889.1	C08		2	0014-0048	797.12	49.02	408	78.08	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18213.1	C08		2	0015-0052	99.99	52.40	411	74.67	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18158.2	C08		2	0016-0049	205.02	49.46	206	53.46	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13605.2	C08		2	0017-0052	737.79	51.91	283	62.18	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13275.1	C08		2	0018-0055	716.07	54.90	288	63.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18508.4	C08		2	0019-0055	576.86	55.80	420	81.60	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16659.5	C08		2	0020-0062	153.35	62.35	313	65.01	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13973.0	C08		2	0021-0066	837.30	66.55	305	69.26	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14783.9	C08		2	0022-0064	854.66	63.94	218	55.11	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13316.2	C08		2	0023-0066	291.41	66.74	292	65.60	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13807.8	C08		2	0024-0068	355.25	67.73	270	61.94	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14301.1	C08		2	0025-0071	448.16	70.63	285	63.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12223.3	C08		2	0026-0075	427.60	74.95	326	66.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14093.2	C08		2	0027-0075	776.54	75.29	255	58.28	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10903.3	C08		2	0028-0082	244.28	81.66	317	68.43	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17044.2	C08		2	0029-0084	285.37	84.39	339	73.60	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13235.8	C08		2	0030-0082	659.88	82.54	285	63.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14339.4	C08		2	0031-0087	605.90	89.87	370	80.18	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14119.6	C08		2	0032-0082	618.92	81.58	168	50.87	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16435.3	C08		2	0033-0085	328.68	85.58	227	56.28	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13678.2	C08		2	0034-0084	576.11	84.68	291	63.01	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12059.4	C08		2	0035-0088	830.95	88.00	311	65.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17325.3	C08		2	0036-0087	550.38	87.01	216	53.94	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14746.8	C08		2	0037-0091	72.87	91.06	245	65.84	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17225.9	C08		2	0038-0092	485.02	92.27	221	54.87	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17165.1	C08		2	0039-0092	774.10	91.27	225	57.36	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13346.5	C08		2	0040-0098	696.24	97.15	290	63.60	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12230.8	C08		2	0041-0102	296.21	101.87	305	65.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11090.3	C08		2	0042-0104	886.08	103.99	341	68.18	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14028.9	C08		2	0043-0106	204.77	105.73	293	64.18	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22391.9	C08		2	0044-0107	99.82	106.94	343	68.77	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15242.7	C08		2	0045-0110	741.92	109.44	252	62.28	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13706.0	C08		2	0046-0111	628.60	111.41	280	60.77	0.953
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12949.9	C08		2	0047-0113	944.04	114.24	441	81.50	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13824.4	C08		2	0048-0112	424.05	112.01	281	62.18	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11488.3	C08		2	0049-0115	340.36	115.59	316	65.60	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15158.4	C08		2	0050-0115	524.22	116.08	258	60.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13816.0	C08		2	0051-0116	404.44	116.68	286	62.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14096.5	C08		2	0052-0120	51.63	119.87	261	61.94	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10772.7	C08		2	0053-0122	257.66	121.89	391	76.08	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12413.9	C08		2	0054-0122	784.64	122.43	214	53.94	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11799.0	C08		2	0055-0124	572.99	124.69	321	66.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11904.9	C08		2	0056-0126	892.41	125.50	423	81.26	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11710.4	C08		2	0057-0128	359.94	128.35	310	65.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13288.4	C08		2	0058-0128	127.19	128.48	284	65.84	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19563.8	C08		2	0059-0130	172.43	130.44	391	73.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19010.0	C08		2	0060-0127	67.80	127.03	189	50.87	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14062.9	C08		2	0061-0131	621.82	131.00	285	64.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18285.0	C08		2	0062-0132	711.18	132.55	340	68.18	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12365.4	C08		2	0063-0137	516.40	137.02	356	72.91	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11638.7	C08		2	0064-0137	775.48	136.06	200	57.26	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15708.9	C08		2	0065-0140	460.31	140.21	426	77.01	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17609.3	C08		2	0066-0139	81.33	139.65	215	52.77	0.970
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14147.7	C08		2	0067-0140	823.51	140.83	256	60.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11668.4	C08		2	0068-0147	25.40	146.81	324	69.50	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15579.6	C08		2	0069-0150	221.02	149.90	439	80.43	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12902.4	C08		2	0070-0148	661.59	147.75	298	66.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	24227.9	C08		2	0071-0151	277.86	151.60	306	64.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14278.5	C08		2	0072-0150	620.04	149.78	315	67.60	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12632.9	C08		2	0073-0156	748.99	155.98	202	55.70	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18342.3	C08		2	0074-0162	485.58	162.08	325	69.36	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17972.0	C08		2	0075-0159	562.03	159.43	209	54.28	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21414.0	C08		2	0076-0160	681.59	160.78	171	51.36	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11060.5	C08		2	0077-0171	363.75	171.30	328	69.26	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11658.3	C08		2	0078-0170	929.17	169.79	323	68.18	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17873.9	C08		2	0079-0170	58.63	170.19	217	53.11	0.967
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13624.1	C08		2	0080-0171	155.29	171.07	270	63.60	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15218.2	C08		2	0081-0172	587.56	172.32	252	59.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14079.0	C08		2	0082-0174	416.12	173.89	277	60.77	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13770.6	C08		2	0083-0178	456.76	175.89	289	74.18	0.660
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10480.9	C08		2	0084-0175	280.35	175.27	341	71.01	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14504.2	C08		2	0085-0176	136.98	176.47	272	63.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15731.8	C08		2	0086-0179	526.31	179.88	250	58.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10857.8	C08		2	0087-0181	242.03	181.06	335	69.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11391.7	C08		2	0088-0183	781.58	182.81	340	69.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18809.8	C08		2	0089-0184	103.01	184.47	203	54.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12355.7	C08		2	0090-0188	599.94	188.31	310	66.18	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15804.3	C08		2	0091-0192	481.83	192.42	247	63.70	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12891.4	C08		2	0092-0195	425.92	194.89	295	66.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13207.8	C08		2	0093-0198	25.57	197.78	289	63.60	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14957.7	C08		2	0094-0197	114.02	196.94	260	63.60	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13218.5	C08		2	0095-0200	525.18	199.68	315	65.94	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15975.0	C08		2	0096-0207	650.18	206.99	239	59.11	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15519.2	C08		2	0097-0204	722.48	204.95	239	56.18	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12471.1	C08		2	0098-0205	182.25	204.45	297	67.36	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12634.2	C08		2	0099-0211	436.75	211.44	299	67.94	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13912.9	C08		2	0100-0209	55.77	209.90	260	61.36	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11999.4	C08		2	0101-0212	318.78	212.16	308	66.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17776.6	C08		2	0102-0220	586.21	220.27	445	81.26	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14494.4	C08		2	0103-0223	186.02	223.61	263	59.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12787.4	C08		2	0104-0225	229.36	225.31	286	63.70	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15157.1	C08		2	0105-0225	923.17	225.16	242	57.11	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14068.1	C08		2	0106-0227	610.82	226.84	275	60.77	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13722.5	C08		2	0107-0227	100.50	227.54	284	64.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12893.7	C08		2	0108-0230	790.69	229.96	292	65.01	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12601.7	C08		2	0109-0230	383.79	229.79	303	63.94	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14468.7	C08		2	0110-0232	505.35	232.95	268	61.94	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13695.5	C08		2	0111-0231	64.38	230.32	272	61.11	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13616.4	C08		2	0112-0233	469.77	232.81	290	63.36	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15877.9	C08		2	0113-0233	823.19	232.39	260	61.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15623.6	C08		2	0114-0235	667.08	235.64	249	59.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13334.2	C08		2	0115-0241	271.81	241.68	289	65.84	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14863.0	C08		2	0116-0245	139.28	244.70	550	87.74	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12105.4	C08		2	0117-0245	190.45	245.11	306	64.77	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15332.4	C08		2	0118-0244	426.11	244.68	265	60.53	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12271.3	C08		2	0119-0250	256.58	250.75	311	67.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13908.4	C08		2	0120-0254	553.92	254.42	325	66.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15787.9	C08		2	0121-0253	727.06	253.50	243	57.94	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18353.1	C08		2	0122-0254	885.66	254.38	199	53.36	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13641.5	C08		2	0123-0259	302.12	259.35	329	68.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11313.8	C08		2	0124-0260	748.76	259.74	392	74.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18729.9	C08		2	0125-0261	432.64	261.36	196	53.21	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12519.8	C08		2	0126-0268	343.10	268.18	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16501.3	C08		2	0127-0267	25.78	266.73	231	56.18	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18691.8	C08		2	0128-0266	78.02	266.30	192	51.70	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13242.1	C08		2	0129-0267	114.11	267.03	287	64.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14353.9	C08		2	0130-0266	815.10	266.10	269	61.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20333.7	C08		2	0131-0272	91.72	271.87	183	50.28	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13602.9	C08		2	0132-0273	203.04	273.31	316	68.77	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17384.1	C08		2	0133-0275	569.95	274.68	442	79.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20905.8	C08		2	0134-0274	39.33	273.68	180	51.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15639.4	C08		2	0135-0277	672.47	276.66	294	65.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12802.1	C08		2	0136-0278	287.66	278.62	311	77.74	0.647
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15763.9	C08		2	0137-0281	688.77	281.41	190	52.28	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13116.1	C08		2	0138-0284	222.82	283.66	313	66.53	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16992.3	C08		2	0139-0286	317.64	285.56	222	55.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22947.2	C08		2	0140-0286	45.41	286.24	160	46.28	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14492.6	C08		2	0141-0290	149.01	291.47	268	60.53	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18298.1	C08		2	0142-0293	422.51	293.81	423	75.84	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14939.6	C08		2	0143-0291	677.08	291.79	126	44.04	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16656.9	C08		2	0144-0296	375.86	295.72	231	56.53	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14021.9	C08		2	0145-0297	89.16	296.62	270	61.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11756.4	C08		2	0146-0295	125.55	295.30	340	70.43	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	34001.1	C08		2	0147-0295	480.48	294.97	101	38.97	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12331.7	C08		2	0148-0305	868.84	305.13	300	65.60	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16287.6	C08		2	0149-0310	390.61	310.17	246	60.28	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14841.0	C08		2	0150-0308	254.84	307.98	242	58.28	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18636.8	C08		2	0151-0313	171.36	313.64	405	74.18	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12905.3	C08		2	0152-0317	189.73	317.29	313	71.36	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15399.8	C08		2	0153-0316	589.99	315.67	255	61.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11930.2	C08		2	0154-0319	724.22	320.00	324	67.36	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13953.5	C08		2	0155-0321	260.97	321.64	282	68.77	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15350.3	C08		2	0156-0322	782.33	322.48	265	61.11	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14457.9	C08		2	0157-0322	765.53	321.86	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12998.6	C08		2	0158-0324	91.62	324.21	284	63.01	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18536.8	C08		2	0159-0324	203.04	324.48	204	54.04	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19981.4	C08		2	0160-0324	219.56	324.07	184	49.70	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14133.5	C08		2	0161-0326	319.77	326.20	239	59.60	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14255.9	C08		2	0162-0326	445.11	325.63	279	63.60	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13412.4	C08		2	0163-0328	745.68	327.32	292	63.36	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16351.9	C08		2	0164-0326	375.73	326.79	238	56.87	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13674.6	C08		2	0165-0328	799.72	328.72	283	62.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14425.2	C08		2	0166-0329	69.68	329.37	267	62.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14012.2	C08		2	0167-0332	828.95	332.49	265	59.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12520.6	C08		2	0168-0333	137.34	333.96	297	63.36	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13763.8	C08		2	0169-0337	333.87	337.33	476	82.67	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10431.9	C08		2	0170-0339	655.25	338.63	375	71.60	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13974.5	C08		2	0171-0337	41.30	337.01	267	59.94	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16093.4	C08		2	0172-0341	449.37	341.53	237	57.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15113.9	C08		2	0173-0344	578.50	344.16	261	59.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21671.7	C08		2	0174-0345	271.53	344.95	333	70.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13588.8	C08		2	0175-0362	199.91	361.99	283	62.18	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12534.0	C08		2	0176-0362	744.59	362.13	297	63.36	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16158.9	C08		2	0177-0367	844.22	367.25	476	86.67	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14073.8	C08		2	0178-0367	31.63	367.08	200	55.01	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13355.5	C08		2	0179-0368	356.06	368.90	286	63.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16004.7	C08		2	0180-0371	425.28	370.81	245	58.28	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14528.2	C08		2	0181-0373	472.93	373.74	266	60.18	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17058.9	C08		2	0182-0374	894.56	374.92	213	56.87	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13244.0	C08		2	0183-0377	113.54	377.52	265	61.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13079.5	C08		2	0184-0383	23.22	384.93	341	76.67	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14192.7	C08		2	0185-0378	156.27	377.70	268	60.53	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18747.7	C08		2	0186-0387	229.76	388.44	416	82.08	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16119.2	C08		2	0187-0383	267.30	383.62	237	57.60	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11612.0	C08		2	0188-0384	394.23	383.70	325	67.01	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11405.3	C08		2	0189-0383	521.82	382.94	130	43.46	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11227.5	C08		2	0190-0395	516.46	396.09	209	58.77	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15924.0	C08		2	0191-0398	438.54	398.30	245	57.60	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12644.9	C08		2	0192-0393	534.58	393.96	160	49.80	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14497.0	C08		2	0193-0400	62.70	399.55	259	61.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12499.8	C08		2	0194-0404	289.85	404.07	638	93.84	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15138.4	C08		2	0195-0400	365.27	399.62	250	59.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14865.7	C08		2	0196-0405	724.18	405.92	363	72.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10580.2	C08		2	0197-0409	829.94	409.26	358	70.43	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13957.8	C08		2	0198-0409	463.33	409.72	301	66.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10538.0	C08		2	0199-0405	535.33	405.06	151	46.04	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13299.0	C08		2	0200-0409	700.43	408.69	295	64.53	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12942.5	C08		2	0201-0409	380.18	410.01	304	65.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13794.8	C08		2	0202-0415	154.53	415.43	294	73.50	0.684
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12977.7	C08		2	0203-0416	884.62	415.94	289	64.53	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14848.4	C08		2	0204-0415	56.75	416.08	327	67.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13297.6	C08		2	0205-0416	925.04	416.90	278	64.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12382.6	C08		2	0206-0419	663.17	419.11	335	67.36	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16079.0	C08		2	0207-0420	264.27	421.78	251	59.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15853.5	C08		2	0208-0420	498.43	420.59	204	55.11	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15189.0	C08		2	0209-0422	133.84	422.17	248	58.28	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14426.9	C08		2	0210-0424	724.51	424.08	312	66.53	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13465.0	C08		2	0211-0427	13.61	427.56	258	62.53	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13279.2	C08		2	0212-0429	945.19	429.48	286	65.36	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12706.5	C08		2	0213-0428	701.23	428.05	270	62.53	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16517.7	C08		2	0214-0433	190.90	433.18	238	58.53	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14489.6	C08		2	0215-0434	225.32	434.19	271	61.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12639.1	C08		2	0216-0437	87.04	437.77	287	62.77	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16112.4	C08		2	0217-0435	173.26	435.41	244	58.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19586.8	C08		2	0218-0436	260.95	436.35	185	49.80	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12704.0	C08		2	0219-0441	873.85	440.57	308	64.28	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12366.5	C08		2	0220-0444	375.81	444.45	323	66.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21457.9	C08		2	0221-0446	566.04	446.26	348	69.84	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20311.1	C08		2	0222-0449	332.26	449.77	560	94.33	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12524.2	C08		2	0223-0447	424.52	447.61	335	67.94	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14012.2	C08		2	0224-0448	922.18	447.91	265	61.60	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13707.3	C08		2	0225-0449	462.86	449.06	289	65.01	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14569.2	C08		2	0226-0451	604.85	451.48	265	63.60	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13667.2	C08		2	0227-0459	549.21	459.53	351	69.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12622.0	C08		2	0228-0458	143.34	458.86	324	68.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15976.2	C08		2	0229-0459	261.60	459.85	248	57.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15780.4	C08		2	0230-0458	400.63	459.11	238	59.46	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13497.9	C08		2	0231-0466	491.10	466.15	301	69.60	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14496.7	C08		2	0232-0462	632.32	462.23	266	60.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14247.6	C08		2	0233-0472	34.89	471.98	262	59.11	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14201.9	C08		2	0234-0469	119.89	468.96	262	61.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16518.7	C08		2	0235-0477	405.92	477.24	489	96.67	0.658
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12625.1	C08		2	0236-0480	815.69	480.06	304	75.01	0.679
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14059.0	C08		2	0237-0479	914.13	478.71	270	61.11	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12453.5	C08		2	0238-0480	225.31	480.10	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16324.7	C08		2	0239-0477	326.87	477.58	241	59.94	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15142.6	C08		2	0240-0481	871.99	481.61	262	60.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15258.5	C08		2	0241-0484	568.43	484.08	272	61.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14993.3	C08		2	0242-0489	750.74	489.51	488	84.33	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13379.4	C08		2	0243-0488	169.56	487.86	284	62.18	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15827.4	C08		2	0244-0488	679.30	488.67	269	61.70	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18237.5	C08		2	0245-0488	307.68	487.95	359	71.60	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12186.6	C08		2	0246-0489	630.43	488.96	323	68.18	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13793.6	C08		2	0247-0493	16.24	493.55	254	59.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14440.6	C08		2	0248-0493	507.23	493.06	269	63.60	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14959.5	C08		2	0249-0502	47.73	502.09	427	77.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16099.9	C08		2	0250-0500	246.57	500.67	312	66.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18096.7	C08		2	0251-0500	533.77	500.29	219	54.53	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12768.5	C08		2	0252-0504	66.26	503.58	297	64.53	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11673.8	C08		2	0253-0505	699.10	505.70	368	73.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16496.1	C08		2	0254-0501	204.12	501.50	231	59.11	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16766.0	C08		2	0255-0502	433.05	502.56	215	54.87	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13260.0	C08		2	0256-0507	619.58	507.08	300	67.94	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13343.9	C08		2	0257-0511	948.45	510.67	280	67.26	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13618.8	C08		2	0258-0512	475.01	511.55	298	65.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14587.3	C08		2	0259-0513	867.81	513.90	265	61.36	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15825.9	C08		2	0260-0516	850.85	516.77	257	59.60	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14002.0	C08		2	0261-0516	146.95	516.06	263	59.36	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12965.0	C08		2	0262-0523	580.94	523.79	157	47.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10800.1	C08		2	0263-0524	902.61	524.32	334	71.01	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15375.7	C08		2	0264-0524	171.12	524.21	247	58.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15603.3	C08		2	0265-0529	743.25	528.55	460	81.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14577.1	C08		2	0266-0529	338.24	529.73	255	61.36	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11099.0	C08		2	0267-0531	547.18	530.79	348	70.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16191.3	C08		2	0268-0532	520.09	532.34	249	59.60	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13762.7	C08		2	0269-0534	822.04	534.95	290	65.36	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12109.0	C08		2	0270-0536	121.32	535.69	443	79.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12174.5	C08		2	0271-0536	253.91	537.11	303	64.77	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13126.4	C08		2	0272-0540	73.04	539.97	266	60.43	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14035.0	C08		2	0273-0540	438.67	540.09	274	60.53	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14007.8	C08		2	0274-0543	474.92	543.22	497	82.43	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15830.3	C08		2	0275-0543	495.38	542.73	251	57.94	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12687.8	C08		2	0276-0545	179.70	545.24	306	69.94	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12635.1	C08		2	0277-0548	795.48	548.99	303	64.43	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12907.8	C08		2	0278-0551	945.99	550.84	288	62.53	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12750.6	C08		2	0279-0553	24.96	553.10	285	62.18	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16759.7	C08		2	0280-0557	618.00	556.84	266	63.11	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17325.7	C08		2	0281-0561	641.94	560.82	711	101.98	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16405.9	C08		2	0282-0560	291.60	560.59	518	83.01	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16123.8	C08		2	0283-0562	86.27	562.76	232	58.18	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12407.6	C08		2	0284-0563	339.83	563.42	303	64.43	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11282.3	C08		2	0285-0564	707.60	563.60	155	50.53	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12713.8	C08		2	0286-0567	555.67	567.57	297	65.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12714.3	C08		2	0287-0568	213.50	569.92	207	64.43	0.627
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20868.3	C08		2	0288-0569	583.10	568.94	301	64.28	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12025.7	C08		2	0289-0573	171.22	574.28	290	66.77	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13721.2	C08		2	0290-0573	882.89	572.56	272	63.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14134.4	C08		2	0291-0573	241.29	573.36	271	60.53	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14449.7	C08		2	0292-0577	185.71	576.57	160	48.63	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13761.4	C08		2	0293-0579	907.88	578.08	277	63.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13764.9	C08		2	0294-0581	57.33	580.98	258	59.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11775.5	C08		2	0295-0587	724.98	587.15	316	67.60	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10799.0	C08		2	0296-0587	134.80	587.12	175	50.53	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15718.0	C08		2	0297-0588	505.48	588.00	251	57.60	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19079.3	C08		2	0298-0590	87.90	590.70	192	53.70	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22986.3	C08		2	0299-0591	31.88	590.68	317	65.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14385.7	C08		2	0300-0591	764.21	591.57	269	61.36	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13515.4	C08		2	0301-0596	797.64	596.34	275	64.18	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15658.8	C08		2	0302-0598	49.01	598.53	246	58.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16342.7	C08		2	0303-0601	207.24	601.43	355	70.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11472.7	C08		2	0304-0599	600.60	599.30	324	68.18	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11315.5	C08		2	0305-0602	438.82	602.72	334	68.18	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14937.0	C08		2	0306-0603	746.91	602.13	251	59.84	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14619.8	C08		2	0307-0606	543.49	606.34	266	60.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11263.7	C08		2	0308-0604	250.39	605.09	296	66.18	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14104.0	C08		2	0309-0609	387.02	608.81	269	63.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13250.7	C08		2	0310-0608	335.62	607.84	280	64.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16519.4	C08		2	0311-0610	944.87	609.75	210	53.11	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14554.1	C08		2	0312-0613	119.39	614.07	255	64.77	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16145.6	C08		2	0313-0615	291.31	615.17	248	60.18	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15702.5	C08		2	0314-0621	566.88	622.06	251	60.77	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15198.8	C08		2	0315-0625	840.51	624.99	239	57.36	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16076.7	C08		2	0316-0628	67.91	628.06	236	55.70	0.956
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14404.6	C08		2	0317-0627	266.18	626.84	274	63.94	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15453.7	C08		2	0318-0632	346.98	632.17	263	60.43	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12345.1	C08		2	0319-0634	393.30	633.93	334	75.01	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10347.9	C08		2	0320-0634	670.15	633.03	101	41.70	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13388.7	C08		2	0321-0638	851.24	638.19	292	64.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16168.6	C08		2	0322-0639	445.95	639.26	253	59.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14923.8	C08		2	0323-0642	157.39	640.87	253	62.28	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15186.9	C08		2	0324-0640	174.32	640.06	262	61.46	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11685.5	C08		2	0325-0644	425.47	643.95	353	70.77	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15898.5	C08		2	0326-0644	307.30	643.62	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12196.4	C08		2	0327-0645	630.33	645.35	309	65.01	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12516.7	C08		2	0328-0648	727.88	648.50	296	64.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14008.3	C08		2	0329-0647	119.09	647.07	268	60.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12311.0	C08		2	0330-0650	679.59	650.26	310	68.77	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11764.0	C08		2	0331-0650	246.41	650.38	298	69.36	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13760.4	C08		2	0332-0650	13.97	649.82	250	58.87	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16277.6	C08		2	0333-0650	470.51	649.83	248	60.87	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14492.5	C08		2	0334-0653	588.67	652.30	269	62.77	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15848.2	C08		2	0335-0655	563.64	655.36	249	59.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12256.9	C08		2	0336-0655	263.18	654.92	281	64.77	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12494.2	C08		2	0337-0669	407.40	670.15	329	70.43	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14627.3	C08		2	0338-0669	371.39	669.49	271	61.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14115.4	C08		2	0339-0674	544.22	674.03	278	64.53	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11537.7	C08		2	0340-0674	283.60	674.11	316	67.60	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15392.3	C08		2	0341-0677	50.74	676.48	504	93.74	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16341.4	C08		2	0342-0677	529.26	677.28	241	57.70	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18374.4	C08		2	0343-0679	637.19	678.71	458	80.43	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12505.7	C08		2	0344-0684	829.52	684.32	312	64.77	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13861.5	C08		2	0345-0685	100.70	685.98	251	58.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14674.1	C08		2	0346-0687	352.25	686.86	227	58.28	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12835.7	C08		2	0347-0686	391.95	685.78	302	65.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18169.4	C08		2	0348-0689	565.33	688.86	432	79.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22112.1	C08		2	0349-0687	806.47	688.39	341	72.43	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14234.2	C08		2	0350-0690	21.42	689.99	247	57.36	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12488.8	C08		2	0351-0690	142.77	690.36	295	65.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20174.3	C08		2	0352-0694	479.41	694.54	338	67.60	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12363.7	C08		2	0353-0700	209.29	699.63	276	63.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16283.0	C08		2	0354-0697	630.69	697.57	233	57.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13867.9	C08		2	0355-0699	247.97	699.45	266	60.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15800.3	C08		2	0356-0702	759.80	701.69	264	60.43	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184730	1375319	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13266.6	C08		2	0357-0710	176.17	709.98	264	60.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16973.8	C08		3	0001-0023	532.57	23.39	244	57.60	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16261.6	C08		3	0002-0028	327.48	30.03	247	65.36	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14783.2	C08		3	0003-0029	465.12	29.36	299	67.01	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15831.4	C08		3	0004-0029	685.49	28.96	237	60.63	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16950.0	C08		3	0005-0029	253.25	28.93	221	54.53	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11426.4	C08		3	0006-0032	58.32	32.64	327	66.43	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13878.8	C08		3	0007-0031	771.33	31.27	277	60.77	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16834.2	C08		3	0008-0032	938.39	31.96	323	66.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17380.2	C08		3	0009-0032	428.60	32.82	242	58.28	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15413.6	C08		3	0010-0041	489.88	41.38	564	96.57	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12651.0	C08		3	0011-0034	658.31	34.47	313	66.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11417.6	C08		3	0012-0040	199.61	39.73	314	70.18	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14743.5	C08		3	0013-0039	448.67	39.33	289	63.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17605.7	C08		3	0014-0037	547.08	37.85	227	57.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15942.3	C08		3	0015-0041	721.42	40.98	365	73.01	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14044.3	C08		3	0016-0039	566.60	40.06	313	69.01	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12893.7	C08		3	0017-0040	922.00	40.34	223	66.67	0.630
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14082.0	C08		3	0018-0044	596.63	44.21	304	66.43	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19347.9	C08		3	0019-0041	813.20	41.28	179	51.46	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11176.4	C08		3	0020-0049	113.44	49.20	334	67.84	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14946.0	C08		3	0021-0053	359.25	53.25	278	65.01	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15454.4	C08		3	0022-0049	430.55	48.90	263	61.11	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13472.0	C08		3	0023-0055	223.57	55.22	314	66.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21822.2	C08		3	0024-0053	396.70	52.83	352	69.01	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16815.3	C08		3	0025-0055	809.25	55.67	224	55.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12039.5	C08		3	0026-0059	148.23	58.99	225	59.60	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15577.5	C08		3	0027-0064	280.55	64.35	314	67.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15380.2	C08		3	0028-0063	544.03	63.30	254	57.70	0.959
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11758.9	C08		3	0029-0064	884.27	64.14	186	51.70	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15040.7	C08		3	0030-0066	516.31	65.67	264	63.36	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11770.0	C08		3	0031-0066	137.84	67.13	100	36.87	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13562.4	C08		3	0032-0073	467.13	73.35	280	67.84	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15985.4	C08		3	0033-0082	290.55	82.99	431	79.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11950.2	C08		3	0034-0081	885.37	80.56	222	56.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23211.6	C08		3	0035-0084	53.08	83.10	310	65.84	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12411.0	C08		3	0036-0084	137.48	84.03	298	65.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16182.5	C08		3	0037-0082	269.27	81.66	220	57.46	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13086.7	C08		3	0038-0085	905.06	84.63	292	63.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15946.3	C08		3	0039-0088	663.25	88.70	423	77.50	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12360.6	C08		3	0040-0087	397.19	87.20	335	70.08	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16454.8	C08		3	0041-0091	639.02	90.74	485	81.01	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15077.6	C08		3	0042-0087	769.24	87.52	258	59.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13671.2	C08		3	0043-0090	219.09	90.97	283	63.01	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11811.9	C08		3	0044-0097	238.14	97.34	325	69.60	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11814.7	C08		3	0045-0100	948.51	100.66	304	64.18	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12918.5	C08		3	0046-0106	703.27	106.15	301	71.01	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11977.3	C08		3	0047-0104	412.83	104.58	343	69.36	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15533.2	C08		3	0048-0106	858.33	105.98	240	57.94	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12284.6	C08		3	0049-0114	169.00	114.22	297	65.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16924.3	C08		3	0050-0112	786.67	113.07	223	55.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13301.1	C08		3	0051-0116	38.58	116.93	429	80.08	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12670.2	C08		3	0052-0116	528.84	115.97	313	66.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23432.8	C08		3	0053-0119	387.92	119.01	319	66.18	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17726.0	C08		3	0054-0132	365.36	135.16	821	132.47	0.588
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11219.1	C08		3	0055-0129	748.67	130.15	442	92.23	0.653
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18900.6	C08		3	0056-0128	920.91	127.37	349	69.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14449.9	C08		3	0057-0125	566.78	124.73	293	63.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12782.6	C08		3	0058-0127	626.53	128.10	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10044.5	C08		3	0059-0130	770.46	128.58	300	69.01	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16754.3	C08		3	0060-0135	789.23	134.60	222	61.60	0.735
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12588.7	C08		3	0061-0134	817.31	134.17	319	68.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14352.1	C08		3	0062-0142	89.03	141.16	280	67.11	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17046.7	C08		3	0063-0141	165.57	141.85	330	68.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16665.1	C08		3	0064-0138	224.78	138.64	223	55.70	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14911.8	C08		3	0065-0141	396.66	141.25	271	61.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14725.7	C08		3	0066-0141	497.15	141.74	275	63.11	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14431.7	C08		3	0067-0142	861.03	142.03	262	59.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16045.6	C08		3	0068-0142	337.85	142.39	270	65.11	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14753.4	C08		3	0069-0145	703.67	145.81	261	61.36	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13554.0	C08		3	0070-0148	266.12	148.80	285	65.60	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11087.8	C08		3	0071-0155	897.36	154.70	365	73.26	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14500.2	C08		3	0072-0152	653.92	152.55	284	64.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12799.0	C08		3	0073-0161	237.53	161.53	297	65.01	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15065.7	C08		3	0074-0164	69.27	165.07	267	63.60	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16035.8	C08		3	0075-0164	520.53	163.95	253	61.01	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19422.2	C08		3	0076-0166	620.29	165.68	383	73.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14504.5	C08		3	0077-0164	465.07	164.49	227	57.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18057.0	C08		3	0078-0165	749.54	165.08	432	77.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11017.8	C08		3	0079-0172	869.02	171.91	382	74.33	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11876.0	C08		3	0080-0173	23.84	172.42	302	65.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13376.9	C08		3	0081-0174	592.35	173.61	452	83.84	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12906.3	C08		3	0082-0174	274.69	173.21	288	67.36	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15761.9	C08		3	0083-0178	545.77	178.99	262	66.53	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10194.7	C08		3	0084-0178	148.43	178.01	338	73.84	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18105.8	C08		3	0085-0176	514.15	177.00	189	52.77	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15748.8	C08		3	0086-0177	679.31	177.37	240	58.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15795.1	C08		3	0087-0181	696.46	181.97	249	59.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14813.4	C08		3	0088-0180	794.34	180.45	254	60.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16998.7	C08		3	0089-0181	108.76	180.88	230	55.11	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11904.3	C08		3	0090-0193	414.72	192.56	330	68.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16515.8	C08		3	0091-0190	64.99	189.93	227	55.11	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16984.2	C08		3	0092-0195	99.27	195.98	234	56.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14688.4	C08		3	0093-0196	202.97	195.97	316	69.01	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10195.7	C08		3	0094-0198	831.79	197.32	370	75.60	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15829.2	C08		3	0095-0197	49.38	196.72	237	58.18	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16718.9	C08		3	0096-0197	513.77	197.29	315	65.01	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14119.3	C08		3	0097-0204	457.17	203.08	271	61.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12447.9	C08		3	0098-0203	704.26	203.91	332	73.01	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10413.9	C08		3	0099-0204	354.49	204.48	347	73.01	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10548.2	C08		3	0100-0208	569.50	207.85	443	78.67	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13777.6	C08		3	0101-0210	948.56	209.54	264	63.11	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14638.8	C08		3	0102-0214	469.57	213.88	255	59.94	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10092.1	C08		3	0103-0225	924.52	225.67	367	87.15	0.607
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12428.7	C08		3	0104-0228	644.11	227.88	315	70.77	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12912.8	C08		3	0105-0225	61.98	224.71	299	70.67	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12159.8	C08		3	0106-0225	160.87	224.84	322	69.84	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12735.0	C08		3	0107-0229	862.41	228.41	317	68.67	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15528.4	C08		3	0108-0228	18.02	227.83	235	55.94	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13756.8	C08		3	0109-0234	751.08	233.32	289	64.18	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16293.4	C08		3	0110-0236	782.55	236.23	246	57.36	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11658.0	C08		3	0111-0240	93.05	240.20	308	66.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13041.3	C08		3	0112-0238	892.29	239.00	287	65.01	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12559.0	C08		3	0113-0240	235.55	240.11	332	67.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13369.5	C08		3	0114-0237	585.30	237.86	152	46.87	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12676.1	C08		3	0115-0241	269.32	240.96	307	66.77	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14950.5	C08		3	0116-0248	610.00	249.03	258	62.28	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9792.4	C08		3	0117-0246	373.04	246.03	343	76.43	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16135.8	C08		3	0118-0248	765.67	248.01	239	67.01	0.669
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16203.2	C08		3	0119-0248	806.76	248.02	239	55.70	0.968
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	26536.8	C08		3	0120-0251	678.80	251.79	260	59.94	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9037.0	C08		3	0121-0250	583.42	250.39	234	68.04	0.635
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12503.1	C08		3	0122-0258	131.40	259.27	494	84.33	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13891.6	C08		3	0123-0256	150.97	255.71	274	63.84	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13808.9	C08		3	0124-0260	490.75	261.11	264	64.18	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14807.1	C08		3	0125-0261	49.17	260.94	240	58.77	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14141.2	C08		3	0126-0261	447.80	260.90	268	65.01	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14334.1	C08		3	0127-0266	406.69	265.92	281	63.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15844.1	C08		3	0128-0263	942.26	262.18	227	57.70	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17102.0	C08		3	0129-0266	729.09	265.65	222	54.53	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9977.1	C08		3	0130-0271	632.23	271.21	387	98.47	0.502
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17978.4	C08		3	0131-0276	877.95	276.41	209	53.46	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22189.3	C08		3	0132-0280	532.20	280.58	357	69.01	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12004.8	C08		3	0133-0283	898.83	283.28	321	65.60	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12845.5	C08		3	0134-0287	309.24	286.78	291	63.60	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13907.5	C08		3	0135-0290	800.71	289.32	280	63.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16890.9	C08		3	0136-0289	858.29	289.80	228	56.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14036.5	C08		3	0137-0293	677.33	293.41	287	63.94	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12375.4	C08		3	0138-0291	459.36	291.79	320	66.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11030.6	C08		3	0139-0297	354.38	297.64	401	79.50	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19043.3	C08		3	0140-0294	757.01	294.27	198	55.11	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13244.6	C08		3	0141-0299	576.94	298.66	443	79.60	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13969.8	C08		3	0142-0298	265.74	298.65	267	61.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14210.2	C08		3	0143-0299	72.18	299.74	253	58.77	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16439.1	C08		3	0144-0304	788.08	303.48	234	59.01	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12857.7	C08		3	0145-0311	518.79	311.58	293	63.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12584.4	C08		3	0146-0311	866.10	311.35	321	66.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11176.1	C08		3	0147-0313	114.14	313.03	312	67.84	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12186.7	C08		3	0148-0316	281.76	314.32	322	72.77	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15554.8	C08		3	0149-0314	216.74	314.24	240	57.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20529.9	C08		3	0150-0316	462.68	315.95	374	71.84	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13748.9	C08		3	0151-0312	671.78	312.33	293	66.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11254.1	C08		3	0152-0319	404.30	319.33	365	90.33	0.562
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12329.8	C08		3	0153-0317	916.73	316.91	325	68.43	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10231.5	C08		3	0154-0321	486.15	320.62	376	90.91	0.572
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15657.9	C08		3	0155-0321	749.58	321.63	264	61.94	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16753.1	C08		3	0156-0320	800.65	320.44	228	56.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15019.8	C08		3	0157-0322	187.82	322.48	247	57.11	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13951.0	C08		3	0158-0325	595.66	325.86	278	63.70	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12649.8	C08		3	0159-0330	310.51	329.78	303	69.60	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13103.6	C08		3	0160-0335	57.67	335.14	295	64.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15733.9	C08		3	0161-0340	769.12	339.27	267	65.36	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14852.5	C08		3	0162-0337	643.36	337.38	259	60.28	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18441.2	C08		3	0163-0342	782.81	341.49	203	57.11	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16244.0	C08		3	0164-0342	707.27	341.53	243	57.94	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15500.6	C08		3	0165-0347	686.39	347.35	273	61.11	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13238.6	C08		3	0166-0349	864.22	349.06	308	67.60	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13206.3	C08		3	0167-0353	197.73	352.76	262	66.18	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12884.2	C08		3	0168-0356	948.80	356.74	354	73.50	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15355.5	C08		3	0169-0351	635.22	351.36	265	63.94	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11077.9	C08		3	0170-0352	215.58	351.55	130	45.36	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13967.7	C08		3	0171-0355	559.53	355.31	290	65.60	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14064.5	C08		3	0172-0358	54.25	359.06	261	61.01	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19123.4	C08		3	0173-0363	341.37	363.34	449	81.01	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18309.9	C08		3	0174-0359	778.66	359.31	223	55.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11704.3	C08		3	0175-0363	359.28	363.10	324	70.53	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10817.3	C08		3	0176-0367	464.46	366.77	345	71.01	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13988.9	C08		3	0177-0367	727.94	367.19	277	61.36	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16715.6	C08		3	0178-0368	906.35	368.80	281	62.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15758.6	C08		3	0179-0368	189.77	367.86	245	57.36	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13483.7	C08		3	0180-0369	213.15	368.99	220	53.94	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12678.7	C08		3	0181-0372	857.11	373.24	323	71.60	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15228.9	C08		3	0182-0374	698.26	374.09	239	60.18	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12449.8	C08		3	0183-0377	303.40	376.96	313	67.01	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16069.7	C08		3	0184-0377	544.99	377.60	241	59.36	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19680.9	C08		3	0185-0383	44.56	382.58	380	73.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15989.4	C08		3	0186-0389	434.90	390.02	536	103.40	0.630
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12757.8	C08		3	0187-0382	792.69	380.81	322	71.84	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12152.7	C08		3	0188-0387	381.32	386.98	316	72.77	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13722.5	C08		3	0189-0390	610.76	389.98	481	86.33	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13869.0	C08		3	0190-0389	695.86	388.97	303	68.43	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12804.1	C08		3	0191-0392	841.59	392.05	299	65.94	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17853.1	C08		3	0192-0394	134.16	394.28	212	54.53	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15396.7	C08		3	0193-0398	670.63	398.30	256	59.11	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12931.1	C08		3	0194-0402	272.23	402.84	428	76.91	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13287.5	C08		3	0195-0408	507.87	407.51	311	66.53	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12115.9	C08		3	0196-0410	807.87	410.34	346	69.84	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14122.4	C08		3	0197-0409	472.96	409.63	281	61.60	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13900.9	C08		3	0198-0411	322.05	410.94	282	63.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12037.0	C08		3	0199-0413	571.30	413.44	318	66.53	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11778.7	C08		3	0200-0414	759.60	414.30	348	71.84	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13856.7	C08		3	0201-0414	89.37	414.72	261	60.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12651.3	C08		3	0202-0417	190.24	417.81	315	66.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13072.9	C08		3	0203-0419	20.26	419.74	274	65.36	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11481.0	C08		3	0204-0425	422.94	424.10	347	74.43	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13727.9	C08		3	0205-0422	719.69	422.40	292	65.36	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13461.8	C08		3	0206-0425	354.68	425.44	306	65.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19109.4	C08		3	0207-0429	315.29	430.42	404	77.50	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13307.0	C08		3	0208-0427	212.29	427.79	284	63.94	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11684.3	C08		3	0209-0429	585.97	429.94	328	67.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13271.4	C08		3	0210-0432	39.94	432.05	266	62.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18897.2	C08		3	0211-0433	109.61	432.71	202	55.11	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12896.6	C08		3	0212-0438	716.99	437.68	332	76.43	0.714
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15840.6	C08		3	0213-0443	151.37	443.99	239	57.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15225.3	C08		3	0214-0441	866.29	441.56	144	48.04	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13590.9	C08		3	0215-0448	705.39	449.09	366	71.84	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19067.4	C08		3	0216-0445	115.33	445.73	189	51.94	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13674.6	C08		3	0217-0444	904.95	445.08	292	66.53	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23416.3	C08		3	0218-0450	642.85	450.12	331	87.74	0.540
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12515.6	C08		3	0219-0449	247.18	448.68	163	52.18	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13793.1	C08		3	0220-0450	17.02	450.61	255	60.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17559.5	C08		3	0221-0451	528.31	450.92	220	56.87	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16423.5	C08		3	0222-0450	169.22	450.25	225	55.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13075.2	C08		3	0223-0451	232.54	451.54	225	62.28	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12583.1	C08		3	0224-0452	283.27	452.69	218	63.01	0.690
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19850.8	C08		3	0225-0452	833.38	452.54	187	51.46	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18713.9	C08		3	0226-0454	884.15	454.05	199	53.11	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13837.5	C08		3	0227-0451	868.05	451.00	108	41.80	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18405.8	C08		3	0228-0460	783.55	460.00	397	73.60	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	24632.2	C08		3	0229-0457	81.69	456.53	160	48.53	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17296.9	C08		3	0230-0459	599.55	459.37	223	55.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15271.4	C08		3	0231-0467	409.14	467.44	277	63.94	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20147.7	C08		3	0232-0463	896.21	463.67	180	50.53	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	24123.2	C08		3	0233-0471	73.92	471.13	260	60.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11861.9	C08		3	0234-0470	370.62	469.91	330	66.77	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19895.0	C08		3	0235-0470	909.28	470.32	193	54.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23122.7	C08		3	0236-0474	658.09	474.07	236	108.47	0.252
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13405.8	C08		3	0237-0477	757.68	477.45	310	68.18	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13268.7	C08		3	0238-0483	861.58	482.86	294	67.36	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12252.1	C08		3	0239-0482	135.99	482.81	302	65.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12295.3	C08		3	0240-0481	782.06	481.84	320	70.18	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15091.7	C08		3	0241-0484	619.12	484.95	307	67.60	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16870.8	C08		3	0242-0487	230.78	487.27	221	56.77	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16014.2	C08		3	0243-0488	501.96	488.48	303	95.15	0.421
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12971.1	C08		3	0244-0492	845.54	492.39	295	67.01	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14328.1	C08		3	0245-0496	592.35	495.95	308	67.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10433.0	C08		3	0246-0494	948.35	494.15	209	56.28	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14485.7	C08		3	0247-0495	927.22	495.11	272	63.11	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13351.5	C08		3	0248-0497	887.16	497.36	310	68.43	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13923.4	C08		3	0249-0508	730.86	507.47	308	68.18	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14648.4	C08		3	0250-0510	714.33	510.41	265	63.11	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10085.2	C08		3	0251-0505	944.95	505.82	128	46.63	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19595.1	C08		3	0252-0511	456.37	510.33	310	65.94	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13384.5	C08		3	0253-0513	43.13	513.37	269	63.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16200.8	C08		3	0254-0516	514.45	515.97	247	62.18	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13315.0	C08		3	0255-0520	646.15	520.03	381	72.67	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13059.4	C08		3	0256-0519	399.86	519.23	316	67.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12494.3	C08		3	0257-0522	197.60	521.91	304	64.77	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14942.5	C08		3	0258-0524	879.76	523.49	273	63.36	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12293.5	C08		3	0259-0526	159.70	527.09	306	67.94	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14838.7	C08		3	0260-0523	483.04	523.55	269	63.94	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10571.8	C08		3	0261-0531	810.81	531.43	365	72.18	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14624.9	C08		3	0262-0528	565.57	527.76	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12321.3	C08		3	0263-0530	782.86	529.80	316	67.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14172.4	C08		3	0264-0530	756.84	529.87	273	60.77	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17617.6	C08		3	0265-0531	367.86	531.22	203	54.04	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11937.1	C08		3	0266-0534	608.04	534.55	326	68.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10705.8	C08		3	0267-0537	119.51	536.59	320	66.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13981.1	C08		3	0268-0538	740.19	538.23	288	63.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16559.2	C08		3	0269-0546	675.65	545.16	234	61.70	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13717.2	C08		3	0270-0549	529.42	550.06	285	65.60	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12398.9	C08		3	0271-0551	426.59	551.08	333	68.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12255.0	C08		3	0272-0551	267.71	551.18	295	63.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15700.3	C08		3	0273-0550	703.60	550.46	250	58.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13063.7	C08		3	0274-0554	40.63	553.53	281	62.53	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14277.5	C08		3	0275-0553	861.92	552.97	283	63.11	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13839.2	C08		3	0276-0552	904.61	552.64	264	62.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15979.1	C08		3	0277-0562	81.73	563.11	229	57.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12893.1	C08		3	0278-0560	180.90	560.41	289	65.11	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18209.0	C08		3	0279-0564	689.94	564.74	395	73.60	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17533.5	C08		3	0280-0566	65.60	566.35	283	61.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13468.6	C08		3	0281-0566	890.89	566.66	302	64.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14260.9	C08		3	0282-0568	447.87	568.48	399	73.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11697.6	C08		3	0283-0567	848.99	567.07	160	48.04	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14902.9	C08		3	0284-0568	726.85	569.11	263	59.46	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12101.3	C08		3	0285-0574	501.01	573.94	304	68.18	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13079.1	C08		3	0286-0576	103.26	576.46	271	63.11	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12115.1	C08		3	0287-0577	288.58	576.72	309	67.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19026.9	C08		3	0288-0571	588.60	571.12	203	56.28	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13672.8	C08		3	0289-0580	322.17	580.19	286	62.18	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13347.5	C08		3	0290-0582	304.21	582.90	279	63.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18473.9	C08		3	0291-0587	610.80	586.71	430	81.26	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11085.0	C08		3	0292-0583	908.91	583.67	336	71.60	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18128.8	C08		3	0293-0587	357.14	587.71	211	54.87	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19008.5	C08		3	0294-0583	584.48	583.09	206	56.28	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13760.1	C08		3	0295-0584	760.43	583.31	202	53.11	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15801.1	C08		3	0296-0586	839.51	587.03	244	59.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17183.0	C08		3	0297-0588	726.94	587.22	223	56.28	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12584.2	C08		3	0298-0592	227.26	591.41	284	62.43	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14566.8	C08		3	0299-0596	537.39	596.63	274	62.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18954.0	C08		3	0300-0596	628.00	596.63	204	54.53	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13357.6	C08		3	0301-0598	53.36	598.16	263	59.36	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11785.7	C08		3	0302-0601	490.88	601.10	323	68.18	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12177.6	C08		3	0303-0598	800.23	598.26	318	66.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13410.1	C08		3	0304-0606	86.25	606.24	265	59.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13015.2	C08		3	0305-0606	873.17	605.88	286	63.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14136.7	C08		3	0306-0605	758.47	605.61	197	56.18	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11744.8	C08		3	0307-0612	193.94	611.97	326	68.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12018.6	C08		3	0308-0612	153.56	612.34	281	63.36	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17325.3	C08		3	0309-0612	39.38	612.41	207	52.87	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17094.0	C08		3	0310-0617	654.98	617.44	437	77.26	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16253.2	C08		3	0311-0620	691.40	620.80	264	62.77	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12438.3	C08		3	0312-0622	316.84	621.70	292	62.77	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18256.0	C08		3	0313-0628	613.04	628.45	215	54.87	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17530.1	C08		3	0314-0632	119.71	632.15	422	75.36	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13213.7	C08		3	0315-0630	340.94	629.63	275	65.60	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14415.0	C08		3	0316-0635	406.97	634.37	580	95.98	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14130.5	C08		3	0317-0634	44.10	633.95	263	62.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14508.5	C08		3	0318-0637	939.48	637.54	249	58.53	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18318.4	C08		3	0319-0643	596.50	643.24	346	69.60	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13409.1	C08		3	0320-0642	345.82	643.74	326	71.01	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17807.6	C08		3	0321-0643	892.99	643.52	199	54.87	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16850.0	C08		3	0322-0645	755.67	644.84	283	62.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13021.9	C08		3	0323-0647	849.47	645.85	284	66.43	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17672.6	C08		3	0324-0645	915.19	645.36	189	50.53	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14553.9	C08		3	0325-0648	719.79	648.20	266	63.60	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14697.2	C08		3	0326-0650	46.59	649.98	241	58.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13901.2	C08		3	0327-0654	672.21	654.89	277	62.77	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13178.4	C08		3	0328-0659	482.69	658.41	319	68.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13655.5	C08		3	0329-0656	415.05	657.27	273	64.18	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16563.2	C08		3	0330-0661	817.85	661.10	226	55.11	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14461.4	C08		3	0331-0662	381.27	662.38	254	60.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13663.1	C08		3	0332-0664	602.31	664.16	276	61.94	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17509.7	C08		3	0333-0665	260.71	665.53	161	46.87	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11662.4	C08		3	0334-0669	166.07	669.08	291	63.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11946.8	C08		3	0335-0673	211.95	673.34	288	68.53	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21944.7	C08		3	0336-0672	244.53	673.82	262	64.53	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14792.0	C08		3	0337-0678	779.05	677.79	266	59.36	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13089.9	C08		3	0338-0679	734.95	678.14	297	63.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13322.9	C08		3	0339-0681	865.04	680.29	300	66.77	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13093.1	C08		3	0340-0682	910.16	681.82	303	65.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13882.4	C08		3	0341-0682	754.15	682.31	293	63.01	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15488.1	C08		3	0342-0681	883.02	681.72	260	61.01	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14096.6	C08		3	0343-0681	559.94	681.50	269	63.36	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14237.0	C08		3	0344-0687	817.17	687.40	326	67.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15004.0	C08		3	0345-0688	615.97	687.25	257	61.11	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12656.8	C08		3	0346-0694	384.31	694.38	318	68.53	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11522.9	C08		3	0347-0697	418.34	698.00	305	66.77	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13522.5	C08		3	0348-0701	679.16	701.08	282	67.36	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15691.1	C08		3	0349-0701	229.03	700.26	253	67.84	0.691
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15290.8	C08		3	0350-0705	619.82	705.13	278	63.94	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15805.8	C08		3	0351-0702	848.61	702.61	245	59.94	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11866.8	C08		3	0352-0709	943.83	708.13	287	64.77	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12682.7	C08		3	0353-0709	56.23	709.62	258	61.70	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184731	1375320	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12990.7	C08		3	0354-0711	333.46	711.20	309	69.11	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14517.9	C08		4	0001-0023	195.30	23.30	268	61.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17148.6	C08		4	0002-0022	562.22	22.54	257	61.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14471.7	C08		4	0003-0021	820.66	21.45	146	46.04	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12939.7	C08		4	0004-0026	17.68	27.12	282	63.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15209.1	C08		4	0005-0025	333.33	25.35	262	59.36	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11613.9	C08		4	0006-0029	365.76	29.28	324	70.67	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15333.2	C08		4	0007-0029	89.76	29.68	255	61.36	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21778.5	C08		4	0008-0033	621.79	33.53	356	70.43	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12172.6	C08		4	0009-0038	108.79	38.32	321	66.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13093.2	C08		4	0010-0042	214.26	42.85	281	64.77	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14899.0	C08		4	0011-0045	786.35	45.55	257	61.11	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15505.2	C08		4	0012-0046	321.66	46.11	241	57.11	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13563.7	C08		4	0013-0046	703.80	46.36	280	65.11	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16061.0	C08		4	0014-0048	943.16	49.11	232	56.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16641.5	C08		4	0015-0055	52.27	55.75	711	116.13	0.663
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14494.6	C08		4	0016-0052	448.90	51.61	395	72.77	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13009.9	C08		4	0017-0056	116.59	56.15	287	64.77	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16827.2	C08		4	0018-0057	857.49	56.52	218	55.11	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13364.4	C08		4	0019-0062	138.71	62.85	301	69.26	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11287.7	C08		4	0020-0063	660.87	63.64	333	68.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15411.5	C08		4	0021-0063	268.62	63.38	243	59.60	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12058.1	C08		4	0022-0067	498.94	66.82	322	70.18	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15836.6	C08		4	0023-0063	541.75	63.22	257	60.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14831.4	C08		4	0024-0062	762.42	62.81	263	60.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12397.5	C08		4	0025-0065	921.79	64.05	293	66.43	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14372.5	C08		4	0026-0072	306.40	72.35	280	63.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17623.2	C08		4	0027-0072	555.04	71.69	231	57.94	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12655.0	C08		4	0028-0077	228.36	77.22	311	66.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	26282.6	C08		4	0029-0080	255.87	80.63	419	76.08	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16088.3	C08		4	0030-0080	861.20	80.08	233	56.87	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13313.0	C08		4	0031-0080	902.41	80.33	276	62.77	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13928.4	C08		4	0032-0083	625.71	83.44	278	63.94	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17937.9	C08		4	0033-0083	563.68	83.38	211	54.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15192.1	C08		4	0034-0086	418.74	86.24	264	60.43	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15342.6	C08		4	0035-0087	108.03	87.68	255	60.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18775.6	C08		4	0036-0093	591.99	93.38	413	82.08	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13796.9	C08		4	0037-0086	761.03	86.31	272	63.94	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12970.6	C08		4	0038-0087	185.57	87.49	289	61.94	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10548.5	C08		4	0039-0093	461.42	93.14	342	73.74	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12848.5	C08		4	0040-0092	701.97	91.78	300	66.18	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12786.5	C08		4	0041-0100	738.97	99.96	308	65.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14483.9	C08		4	0042-0102	52.13	101.74	260	59.94	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21481.6	C08		4	0043-0110	367.52	110.02	740	103.30	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	25810.1	C08		4	0044-0103	837.97	102.66	133	98.13	0.174
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12640.6	C08		4	0045-0104	544.63	104.79	309	65.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11945.7	C08		4	0046-0107	942.98	106.80	304	64.77	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18373.6	C08		4	0047-0107	89.01	106.82	202	55.11	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13285.5	C08		4	0048-0112	288.36	112.59	289	63.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16080.6	C08		4	0049-0118	163.66	118.71	229	59.70	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14109.3	C08		4	0050-0121	427.35	120.78	283	63.26	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23896.9	C08		4	0051-0128	672.34	128.38	325	67.01	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15150.9	C08		4	0052-0132	440.24	131.62	293	65.26	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14728.7	C08		4	0053-0132	641.24	132.40	265	63.01	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16516.6	C08		4	0054-0135	321.50	135.13	286	69.11	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15629.8	C08		4	0055-0133	195.76	132.94	243	58.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19348.7	C08		4	0056-0141	832.51	140.76	395	73.01	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14439.8	C08		4	0057-0141	698.12	140.93	279	61.94	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13313.5	C08		4	0058-0144	401.87	144.67	298	65.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13785.4	C08		4	0059-0141	608.51	141.51	293	63.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19564.0	C08		4	0060-0143	890.55	143.94	350	69.01	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13818.2	C08		4	0061-0147	281.89	147.32	272	62.53	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15967.0	C08		4	0062-0155	211.91	154.96	244	59.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15151.7	C08		4	0063-0155	546.55	155.53	283	63.70	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16511.6	C08		4	0064-0157	650.36	156.76	250	58.18	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17030.1	C08		4	0065-0162	471.64	161.79	460	83.98	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18830.0	C08		4	0066-0162	875.55	162.57	335	67.01	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8011.5	C08		4	0067-0165	392.06	164.70	252	60.87	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14557.2	C08		4	0068-0162	908.00	162.89	262	59.11	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14180.9	C08		4	0069-0166	15.51	165.91	257	61.01	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15367.0	C08		4	0070-0165	626.78	165.37	265	61.36	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13018.1	C08		4	0071-0169	55.25	169.81	268	63.94	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11896.8	C08		4	0072-0173	930.06	173.44	334	73.60	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15689.4	C08		4	0073-0171	572.45	171.06	277	65.01	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13382.8	C08		4	0074-0175	117.62	175.02	347	70.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18964.7	C08		4	0075-0174	608.69	174.77	343	72.67	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18024.6	C08		4	0076-0176	709.60	175.55	246	58.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15761.3	C08		4	0077-0182	743.35	181.60	249	57.94	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11332.6	C08		4	0078-0187	260.34	187.52	305	68.43	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14648.3	C08		4	0079-0187	396.30	186.68	288	65.01	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14420.4	C08		4	0080-0189	524.11	189.77	271	62.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10398.4	C08		4	0081-0192	303.68	191.71	332	70.77	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15108.0	C08		4	0082-0193	77.16	194.14	250	58.87	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17017.4	C08		4	0083-0204	189.14	203.70	711	106.91	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16530.5	C08		4	0084-0195	564.72	195.48	236	56.53	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19684.7	C08		4	0085-0197	603.83	197.14	195	51.70	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12916.1	C08		4	0086-0201	361.27	201.37	278	62.18	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14473.4	C08		4	0087-0203	910.95	203.03	256	64.53	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20866.7	C08		4	0088-0200	621.21	201.45	183	52.53	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11283.5	C08		4	0089-0208	451.61	208.79	227	59.94	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17538.3	C08		4	0090-0205	142.26	204.59	219	54.53	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15171.4	C08		4	0091-0211	77.12	210.81	245	58.63	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12943.1	C08		4	0092-0214	212.55	213.45	279	62.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13344.0	C08		4	0093-0215	882.23	215.37	291	63.36	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14458.8	C08		4	0094-0218	788.07	218.22	272	63.94	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11612.8	C08		4	0095-0220	822.27	219.43	310	65.36	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14588.1	C08		4	0096-0221	236.96	221.31	270	60.18	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14522.9	C08		4	0097-0223	700.20	224.18	270	61.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15867.1	C08		4	0098-0225	11.64	225.33	233	56.28	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14425.8	C08		4	0099-0224	907.71	224.45	290	74.43	0.658
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13152.7	C08		4	0100-0231	46.45	231.41	275	62.18	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21224.2	C08		4	0101-0231	289.29	231.64	353	70.18	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14809.9	C08		4	0102-0233	398.28	233.18	267	64.18	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15948.3	C08		4	0103-0237	156.70	237.75	481	90.57	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15071.8	C08		4	0104-0241	555.48	240.85	356	74.91	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15541.2	C08		4	0105-0241	479.61	240.40	254	60.28	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18261.2	C08		4	0106-0245	716.17	245.07	436	77.60	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17208.9	C08		4	0107-0247	327.17	247.13	466	82.43	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9661.1	C08		4	0108-0246	134.48	245.89	176	49.36	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14467.0	C08		4	0109-0253	433.59	253.15	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16380.2	C08		4	0110-0253	587.73	252.99	305	65.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14284.5	C08		4	0111-0256	80.26	256.04	257	61.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15235.2	C08		4	0112-0257	247.39	255.62	261	61.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13788.3	C08		4	0113-0256	364.30	256.01	292	63.94	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15897.2	C08		4	0114-0254	936.70	254.54	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15048.7	C08		4	0115-0257	755.30	256.76	273	62.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12659.1	C08		4	0116-0257	864.11	257.95	306	66.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15969.4	C08		4	0117-0258	384.05	257.99	249	58.28	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15031.2	C08		4	0118-0260	777.97	259.88	263	59.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13473.6	C08		4	0119-0265	223.78	265.45	272	63.94	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13917.7	C08		4	0120-0264	502.47	264.27	314	66.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14842.0	C08		4	0121-0265	114.70	264.56	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14834.7	C08		4	0122-0271	280.71	271.29	271	61.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14355.4	C08		4	0123-0271	834.78	271.50	274	61.01	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12926.3	C08		4	0124-0274	894.80	274.10	305	65.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14439.4	C08		4	0125-0278	522.30	279.48	304	69.01	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13281.0	C08		4	0126-0276	602.65	276.21	294	62.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17999.7	C08		4	0127-0284	128.97	286.07	617	101.40	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16435.0	C08		4	0128-0277	254.08	276.78	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11531.4	C08		4	0129-0286	42.86	285.69	296	64.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12530.9	C08		4	0130-0286	158.65	286.05	218	55.70	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22759.7	C08		4	0131-0288	942.68	288.02	330	69.01	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13195.0	C08		4	0132-0289	406.39	289.20	301	67.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14662.3	C08		4	0133-0289	695.37	289.37	262	62.18	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15045.6	C08		4	0134-0294	340.79	295.23	513	90.91	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14159.2	C08		4	0135-0293	917.77	293.73	271	61.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18466.5	C08		4	0136-0296	250.70	296.90	422	77.84	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15057.2	C08		4	0137-0293	712.56	293.65	264	63.36	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15879.6	C08		4	0138-0294	560.23	293.96	274	64.43	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14414.3	C08		4	0139-0299	471.38	299.56	304	65.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13935.1	C08		4	0140-0301	392.38	301.52	280	64.18	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11576.4	C08		4	0141-0307	13.11	307.38	287	63.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20099.1	C08		4	0142-0306	80.29	306.31	181	50.87	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15861.1	C08		4	0143-0307	523.17	306.77	252	59.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17512.7	C08		4	0144-0306	612.94	307.01	227	54.77	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13860.3	C08		4	0145-0309	816.53	308.49	292	66.77	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14007.9	C08		4	0146-0315	425.75	315.11	295	63.01	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12443.8	C08		4	0147-0319	940.38	319.78	301	64.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12849.1	C08		4	0148-0318	803.67	318.62	290	69.84	0.747
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14972.4	C08		4	0149-0317	849.12	317.73	271	60.18	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	24283.2	C08		4	0150-0323	559.21	322.24	321	73.26	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17564.6	C08		4	0151-0321	87.18	321.12	225	56.28	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14582.5	C08		4	0152-0322	452.39	323.15	367	71.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16352.7	C08		4	0153-0327	162.06	328.11	249	59.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15224.5	C08		4	0154-0330	710.27	330.78	319	65.36	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14810.0	C08		4	0155-0328	886.53	328.26	263	60.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14381.1	C08		4	0156-0338	594.01	337.91	595	97.98	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13087.9	C08		4	0157-0337	646.17	337.01	297	63.60	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14167.2	C08		4	0158-0337	116.88	337.20	284	63.36	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14722.3	C08		4	0159-0341	39.77	340.92	273	63.60	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13759.4	C08		4	0160-0341	454.84	340.21	289	67.11	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15624.7	C08		4	0161-0346	304.57	345.75	260	61.36	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14949.1	C08		4	0162-0346	271.11	346.10	266	59.11	0.957
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11835.8	C08		4	0163-0350	752.50	350.43	324	67.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15087.0	C08		4	0164-0350	384.43	350.60	255	57.94	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16446.4	C08		4	0165-0356	74.61	354.29	497	93.74	0.711
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11448.8	C08		4	0166-0357	29.79	358.18	297	66.18	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20429.7	C08		4	0167-0358	176.42	358.89	387	72.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13392.0	C08		4	0168-0359	793.52	358.98	294	63.84	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13759.7	C08		4	0169-0361	514.26	361.31	283	61.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13672.7	C08		4	0170-0360	594.36	360.58	300	66.43	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14026.6	C08		4	0171-0361	685.12	361.13	274	61.11	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12103.6	C08		4	0172-0365	840.24	364.88	336	71.26	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14743.2	C08		4	0173-0368	155.00	368.36	278	62.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13932.7	C08		4	0174-0368	933.68	367.98	277	63.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14964.2	C08		4	0175-0368	547.58	368.08	268	61.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14300.9	C08		4	0176-0373	905.43	372.43	254	62.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12501.9	C08		4	0177-0378	76.68	377.50	293	64.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19988.0	C08		4	0178-0379	403.55	378.78	400	75.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15290.3	C08		4	0179-0381	916.77	381.15	265	65.11	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15784.3	C08		4	0180-0380	783.74	380.76	267	61.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13756.6	C08		4	0181-0381	868.36	381.50	273	62.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15010.1	C08		4	0182-0380	582.62	380.44	267	62.77	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14415.2	C08		4	0183-0387	197.99	387.76	271	62.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14535.7	C08		4	0184-0388	386.37	388.18	276	63.60	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19084.0	C08		4	0185-0393	451.71	392.80	425	77.50	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16162.9	C08		4	0186-0392	327.20	391.44	230	59.01	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12337.7	C08		4	0187-0391	646.40	391.28	327	69.60	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15046.9	C08		4	0188-0393	265.53	394.10	264	71.60	0.647
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16899.9	C08		4	0189-0398	487.40	398.43	243	57.94	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18805.9	C08		4	0190-0407	338.35	406.82	452	79.26	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12811.9	C08		4	0191-0407	428.75	406.70	308	67.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13429.7	C08		4	0192-0406	835.29	405.58	284	63.36	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14190.7	C08		4	0193-0406	219.83	405.82	314	75.01	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18757.7	C08		4	0194-0412	39.19	412.53	379	73.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12574.0	C08		4	0195-0414	718.29	413.31	316	70.67	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13130.6	C08		4	0196-0415	616.94	415.67	305	71.11	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15544.0	C08		4	0197-0418	537.24	418.53	261	60.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15477.0	C08		4	0198-0419	314.66	418.81	257	60.77	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16594.2	C08		4	0199-0423	23.37	424.02	327	68.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12658.6	C08		4	0200-0426	443.84	426.38	435	78.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16666.5	C08		4	0201-0422	497.94	422.24	234	59.94	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15633.4	C08		4	0202-0421	782.63	422.18	227	57.46	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15576.4	C08		4	0203-0428	102.54	428.54	257	59.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18189.4	C08		4	0204-0428	353.63	428.13	233	58.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15126.7	C08		4	0205-0431	175.61	431.06	260	61.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20726.5	C08		4	0206-0436	869.49	435.52	344	69.26	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12972.3	C08		4	0207-0437	399.03	437.24	300	65.84	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14773.3	C08		4	0208-0435	785.70	435.21	299	67.46	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13360.6	C08		4	0209-0442	844.50	442.06	300	68.08	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14030.5	C08		4	0210-0439	899.85	439.43	274	63.94	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13855.5	C08		4	0211-0444	533.74	444.45	275	63.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12143.5	C08		4	0212-0451	210.14	451.51	293	67.01	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16536.7	C08		4	0213-0452	160.79	452.29	236	59.70	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14491.1	C08		4	0214-0454	600.75	454.31	294	65.60	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15275.6	C08		4	0215-0451	736.90	451.79	266	61.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15700.5	C08		4	0216-0454	895.33	454.25	259	61.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12688.7	C08		4	0217-0458	478.62	458.38	287	65.84	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16416.7	C08		4	0218-0461	694.69	460.92	532	86.91	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12107.6	C08		4	0219-0459	44.19	459.42	281	64.43	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13395.3	C08		4	0220-0459	342.19	460.03	284	62.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16498.9	C08		4	0221-0462	933.42	462.17	236	57.70	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15150.8	C08		4	0222-0465	256.68	465.55	257	60.77	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12888.1	C08		4	0223-0471	643.70	471.56	319	67.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13813.0	C08		4	0224-0473	375.99	473.75	283	64.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13260.2	C08		4	0225-0478	95.76	477.80	297	67.94	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12646.1	C08		4	0226-0480	226.39	480.27	289	68.53	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15372.8	C08		4	0227-0482	578.29	482.37	597	107.88	0.645
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12938.5	C08		4	0228-0482	355.23	481.80	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13896.0	C08		4	0229-0483	515.35	483.79	278	63.70	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11206.2	C08		4	0230-0487	464.61	487.29	316	68.67	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16334.9	C08		4	0231-0486	656.31	486.55	381	76.18	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14625.2	C08		4	0232-0489	306.55	488.32	222	57.60	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12217.4	C08		4	0233-0491	261.19	491.53	318	66.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14607.0	C08		4	0234-0492	900.56	491.75	258	62.43	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23100.2	C08		4	0235-0493	119.60	493.37	322	66.43	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11761.0	C08		4	0236-0493	532.25	493.24	329	67.36	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13165.3	C08		4	0237-0496	152.27	496.95	290	63.60	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13889.8	C08		4	0238-0498	496.09	498.57	275	61.36	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15540.2	C08		4	0239-0506	296.91	506.63	510	89.40	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21477.0	C08		4	0240-0503	747.65	501.76	382	82.77	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11360.2	C08		4	0241-0505	190.44	504.87	303	66.43	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14476.5	C08		4	0242-0506	585.31	506.50	368	79.01	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20355.9	C08		4	0243-0506	914.71	505.80	385	72.08	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14756.7	C08		4	0244-0507	75.06	506.49	407	77.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15183.3	C08		4	0245-0508	940.54	508.37	248	59.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14751.9	C08		4	0246-0514	460.98	514.37	282	66.18	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15537.7	C08		4	0247-0515	344.87	515.17	256	58.77	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22329.4	C08		4	0248-0513	752.20	513.18	104	37.56	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13466.6	C08		4	0249-0519	797.87	519.53	305	66.77	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18651.1	C08		4	0250-0523	21.03	522.78	367	71.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14997.7	C08		4	0251-0524	677.56	524.40	267	63.11	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12798.8	C08		4	0252-0525	857.33	525.76	293	63.60	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15392.6	C08		4	0253-0528	605.21	528.13	260	60.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14374.4	C08		4	0254-0530	81.41	530.67	265	59.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13001.2	C08		4	0255-0532	425.71	531.58	294	64.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21655.6	C08		4	0256-0534	143.33	533.49	348	69.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12728.5	C08		4	0257-0536	337.79	536.17	304	64.77	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13984.5	C08		4	0258-0540	705.37	540.44	283	67.60	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13430.1	C08		4	0259-0540	375.55	540.29	282	61.36	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14315.6	C08		4	0260-0542	264.94	543.10	283	64.18	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16945.6	C08		4	0261-0540	769.06	541.00	227	55.70	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20968.3	C08		4	0262-0546	504.88	544.75	144	58.18	0.535
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16511.2	C08		4	0263-0545	786.77	545.17	241	58.28	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14638.3	C08		4	0264-0548	466.92	548.01	289	65.60	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11558.5	C08		4	0265-0551	193.95	551.35	335	75.36	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13236.0	C08		4	0266-0551	210.43	550.77	270	61.70	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17087.9	C08		4	0267-0553	564.18	553.75	284	62.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11867.1	C08		4	0268-0551	918.25	551.13	317	66.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21000.2	C08		4	0269-0550	498.75	550.63	113	46.04	0.670
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11154.9	C08		4	0270-0553	125.79	553.98	155	46.87	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20580.6	C08		4	0271-0563	41.40	563.91	377	82.43	0.697
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11582.3	C08		4	0272-0562	294.63	562.32	316	67.60	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16440.0	C08		4	0273-0561	645.15	561.41	241	61.36	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14882.0	C08		4	0274-0566	848.78	566.92	594	97.40	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14691.4	C08		4	0275-0565	518.57	564.82	266	61.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	28359.1	C08		4	0276-0565	593.65	565.42	274	60.77	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13808.3	C08		4	0277-0568	97.71	568.65	271	62.77	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14490.3	C08		4	0278-0566	436.79	566.91	284	68.43	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15431.4	C08		4	0279-0583	385.93	583.07	254	58.53	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14216.4	C08		4	0280-0582	551.56	582.54	274	61.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15135.9	C08		4	0281-0586	588.04	585.62	294	67.60	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11328.6	C08		4	0282-0585	806.99	584.50	330	70.43	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12320.5	C08		4	0283-0588	656.39	587.82	317	68.67	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16129.4	C08		4	0284-0585	915.70	585.09	232	55.94	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16413.6	C08		4	0285-0586	752.14	586.11	259	59.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13868.8	C08		4	0286-0589	453.57	588.43	297	65.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13756.9	C08		4	0287-0596	680.62	596.36	294	65.01	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15086.7	C08		4	0288-0597	370.78	597.13	269	60.87	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14424.1	C08		4	0289-0598	906.51	598.67	284	67.01	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16192.6	C08		4	0290-0602	472.15	602.78	265	62.77	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12375.1	C08		4	0291-0606	407.31	605.77	311	66.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13823.5	C08		4	0292-0610	596.24	611.18	339	74.43	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15167.9	C08		4	0293-0606	124.51	606.33	248	59.11	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11624.5	C08		4	0294-0604	150.87	603.91	160	48.87	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14787.0	C08		4	0295-0608	221.37	608.45	282	67.01	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13134.6	C08		4	0296-0611	107.12	611.29	310	67.60	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19643.7	C08		4	0297-0608	891.26	607.66	201	53.36	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14491.8	C08		4	0298-0617	251.36	617.11	262	63.26	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12561.7	C08		4	0299-0617	546.69	617.58	314	66.18	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13444.5	C08		4	0300-0621	164.67	621.23	270	65.70	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16159.5	C08		4	0301-0617	298.05	616.51	243	57.36	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14970.1	C08		4	0302-0623	508.75	622.51	536	104.13	0.621
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12436.7	C08		4	0303-0621	860.48	620.95	301	66.53	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12612.6	C08		4	0304-0621	89.78	621.50	220	54.18	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16322.3	C08		4	0305-0626	363.21	626.25	240	63.84	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12342.4	C08		4	0306-0623	19.85	623.15	257	57.94	0.962
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13256.3	C08		4	0307-0626	446.30	626.23	296	65.84	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12466.1	C08		4	0308-0628	276.95	627.68	296	65.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13540.6	C08		4	0309-0632	393.23	631.71	281	63.60	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14913.9	C08		4	0310-0629	712.87	629.97	259	61.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15054.4	C08		4	0311-0633	197.52	634.07	279	62.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16860.0	C08		4	0312-0642	488.06	641.33	754	112.47	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14601.1	C08		4	0313-0637	829.47	636.54	263	61.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17096.9	C08		4	0314-0644	345.03	644.26	229	55.70	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13970.4	C08		4	0315-0641	608.85	641.57	282	65.36	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21392.7	C08		4	0316-0647	814.22	647.40	352	70.67	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13165.6	C08		4	0317-0648	411.99	648.90	283	67.84	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12784.5	C08		4	0318-0654	217.20	652.52	594	101.74	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23978.4	C08		4	0319-0647	372.52	646.90	117	54.67	0.492
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20236.8	C08		4	0320-0651	366.21	653.00	129	56.43	0.509
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13933.1	C08		4	0321-0657	751.75	656.75	276	64.77	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14918.3	C08		4	0322-0661	29.53	660.50	527	89.26	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12574.5	C08		4	0323-0658	948.14	657.79	286	63.60	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15172.0	C08		4	0324-0664	526.90	664.58	255	62.53	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15251.7	C08		4	0325-0661	625.34	660.88	249	57.94	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13114.2	C08		4	0326-0664	562.53	664.41	309	68.43	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14261.2	C08		4	0327-0667	784.11	667.20	269	63.36	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11649.1	C08		4	0328-0665	139.16	664.90	285	63.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14991.7	C08		4	0329-0670	586.29	670.21	256	59.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16019.8	C08		4	0330-0670	914.77	670.05	225	54.87	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12711.3	C08		4	0331-0674	415.34	674.71	314	66.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11792.1	C08		4	0332-0677	471.76	677.87	291	65.94	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14058.2	C08		4	0333-0679	539.42	678.57	287	67.36	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12841.2	C08		4	0334-0682	65.29	680.87	252	65.36	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12468.4	C08		4	0335-0683	495.42	683.29	294	66.53	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15681.0	C08		4	0336-0681	348.32	681.31	250	58.18	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14267.5	C08		4	0337-0682	512.00	682.29	273	61.21	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15142.2	C08		4	0338-0685	29.24	685.85	265	61.36	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11788.0	C08		4	0339-0687	261.52	686.48	285	65.36	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15411.8	C08		4	0340-0687	845.32	687.10	233	56.18	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14726.8	C08		4	0341-0692	717.19	692.78	251	61.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19226.6	C08		4	0342-0691	292.89	692.24	199	53.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13272.4	C08		4	0343-0694	754.00	694.29	290	65.60	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13470.4	C08		4	0344-0696	193.12	695.75	276	62.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15700.2	C08		4	0345-0697	54.64	698.43	341	70.43	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16994.7	C08		4	0346-0696	135.31	695.85	323	66.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11933.2	C08		4	0347-0699	793.59	700.20	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14351.2	C08		4	0348-0699	474.12	699.64	273	62.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13120.7	C08		4	0349-0701	733.39	701.49	303	67.36	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10985.8	C08		4	0350-0705	877.22	705.20	108	42.04	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12797.1	C08		4	0351-0707	930.89	707.77	266	65.01	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184732	1375321	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13327.0	C08		4	0352-0710	358.48	709.73	291	63.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12628.4	C08		5	0001-0025	207.22	24.73	281	63.36	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16830.7	C08		5	0002-0023	628.36	23.18	228	56.28	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15962.8	C08		5	0003-0027	757.57	26.69	263	60.43	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14185.0	C08		5	0004-0025	245.80	25.00	263	60.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13582.6	C08		5	0005-0035	174.04	35.25	268	60.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17035.9	C08		5	0006-0036	402.63	35.76	271	61.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14219.1	C08		5	0007-0037	66.40	37.22	253	59.11	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15619.2	C08		5	0008-0039	746.47	39.01	243	59.84	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12892.4	C08		5	0009-0041	937.37	41.10	272	64.18	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14633.0	C08		5	0010-0045	583.63	46.23	377	80.18	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17020.2	C08		5	0011-0041	602.48	40.47	210	54.87	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12852.2	C08		5	0012-0046	510.44	45.61	319	65.01	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16700.0	C08		5	0013-0047	417.06	47.14	262	70.67	0.659
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14995.3	C08		5	0014-0048	325.88	48.14	252	59.70	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15938.2	C08		5	0015-0048	864.11	48.79	362	71.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15412.5	C08		5	0016-0051	538.31	51.75	284	63.94	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13448.4	C08		5	0017-0049	663.18	49.26	245	56.77	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16407.8	C08		5	0018-0051	47.74	51.33	240	58.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14633.3	C08		5	0019-0051	887.77	51.56	252	57.94	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16307.4	C08		5	0020-0056	264.29	55.56	497	91.74	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17477.6	C08		5	0021-0055	482.62	55.53	232	56.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12364.2	C08		5	0022-0063	305.30	62.56	282	66.67	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12724.6	C08		5	0023-0062	186.19	63.10	290	65.60	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17735.6	C08		5	0024-0064	806.78	64.54	201	56.43	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12554.1	C08		5	0025-0067	26.26	66.14	274	64.43	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15127.0	C08		5	0026-0066	117.58	65.66	227	59.60	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13105.7	C08		5	0027-0071	231.30	71.55	281	65.60	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13997.8	C08		5	0028-0071	753.60	71.94	276	61.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14845.8	C08		5	0029-0072	559.09	72.36	265	60.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13316.5	C08		5	0030-0076	379.29	75.97	313	67.01	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14927.5	C08		5	0031-0080	123.83	80.49	366	76.18	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13572.3	C08		5	0032-0075	165.25	74.41	288	65.70	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14955.8	C08		5	0033-0078	613.99	77.76	256	58.53	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13726.5	C08		5	0034-0079	923.97	79.38	259	59.70	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13619.1	C08		5	0035-0081	60.39	81.99	265	64.18	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13078.7	C08		5	0036-0084	505.04	84.26	310	65.94	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11839.8	C08		5	0037-0090	693.12	90.15	316	68.18	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13262.9	C08		5	0038-0088	724.22	87.61	299	63.60	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16066.9	C08		5	0039-0087	254.08	87.36	238	58.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15365.3	C08		5	0040-0089	87.63	89.57	252	58.53	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11411.9	C08		5	0041-0090	184.69	90.96	419	81.26	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17357.8	C08		5	0042-0094	281.23	94.20	346	70.18	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14800.2	C08		5	0043-0093	162.46	93.63	217	59.70	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12903.0	C08		5	0044-0097	316.17	98.03	272	60.77	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12088.0	C08		5	0045-0105	858.99	106.45	309	76.77	0.659
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10535.4	C08		5	0046-0101	651.89	101.10	345	69.84	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14083.5	C08		5	0047-0102	503.46	101.78	273	62.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12145.5	C08		5	0048-0105	894.66	104.84	302	69.84	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15420.4	C08		5	0049-0105	342.24	105.07	235	55.94	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13293.6	C08		5	0050-0107	788.00	107.40	286	64.77	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12397.2	C08		5	0051-0109	47.58	108.98	289	62.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23075.6	C08		5	0052-0108	208.12	107.97	321	66.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14414.3	C08		5	0053-0109	829.80	108.41	263	60.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17306.9	C08		5	0054-0110	550.61	109.80	235	57.46	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12066.1	C08		5	0055-0114	939.47	113.65	286	65.94	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18018.4	C08		5	0056-0114	535.56	114.61	220	58.18	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14511.8	C08		5	0057-0115	814.85	115.25	248	61.60	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12623.5	C08		5	0058-0116	125.20	116.96	275	64.67	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15113.6	C08		5	0059-0116	583.58	116.19	253	57.94	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15839.4	C08		5	0060-0117	451.18	117.39	235	63.01	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14959.0	C08		5	0061-0130	293.94	130.74	532	96.57	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19739.2	C08		5	0062-0127	763.95	126.43	390	74.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12808.0	C08		5	0063-0129	241.70	129.15	279	63.01	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12349.8	C08		5	0064-0128	945.76	129.18	307	67.60	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13723.5	C08		5	0065-0130	709.15	129.47	285	63.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11908.5	C08		5	0066-0132	205.96	132.26	302	67.01	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12588.6	C08		5	0067-0131	83.68	131.34	282	64.77	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16826.0	C08		5	0068-0132	462.85	132.67	223	56.63	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11283.5	C08		5	0069-0142	511.66	141.97	346	70.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14557.0	C08		5	0070-0142	779.76	142.04	281	64.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12385.2	C08		5	0071-0146	124.86	145.69	304	69.01	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14904.9	C08		5	0072-0147	401.83	145.94	226	60.53	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14848.9	C08		5	0073-0149	538.49	149.60	263	65.01	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13144.6	C08		5	0074-0148	704.63	148.28	295	65.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15585.5	C08		5	0075-0148	826.93	148.52	278	62.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12899.2	C08		5	0076-0150	644.94	149.72	309	65.36	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17903.6	C08		5	0077-0148	467.80	148.00	227	55.70	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14477.4	C08		5	0078-0154	206.08	154.12	273	60.77	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17384.6	C08		5	0079-0155	564.25	155.96	469	80.08	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13943.6	C08		5	0080-0153	71.19	152.62	267	62.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14683.5	C08		5	0081-0156	224.25	156.24	260	59.70	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12368.4	C08		5	0082-0159	918.75	158.85	309	71.36	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13558.1	C08		5	0083-0161	670.33	161.54	283	65.26	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17372.0	C08		5	0084-0159	901.80	159.44	190	52.28	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16515.4	C08		5	0085-0161	411.74	160.23	259	61.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14650.6	C08		5	0086-0164	12.84	165.13	248	57.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16566.9	C08		5	0087-0167	149.27	167.38	232	56.18	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14633.3	C08		5	0088-0168	837.22	167.15	248	61.94	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12096.2	C08		5	0089-0175	34.74	175.89	304	70.77	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13701.0	C08		5	0090-0176	348.13	175.84	308	67.60	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17937.5	C08		5	0091-0176	595.11	176.03	445	77.26	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15144.9	C08		5	0092-0177	174.77	177.75	256	58.18	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12967.4	C08		5	0093-0179	752.26	178.85	297	65.60	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15797.6	C08		5	0094-0182	139.86	182.31	239	57.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15182.5	C08		5	0095-0179	480.19	178.89	257	60.53	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14945.9	C08		5	0096-0180	773.20	180.22	253	59.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15213.1	C08		5	0097-0178	819.77	178.06	127	42.97	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14729.6	C08		5	0098-0181	830.53	181.19	108	38.39	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13147.5	C08		5	0099-0189	195.63	189.09	273	62.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15394.4	C08		5	0100-0194	94.39	194.00	361	74.43	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16052.2	C08		5	0101-0192	356.51	192.32	250	61.60	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12755.7	C08		5	0102-0193	111.20	192.63	270	61.70	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18858.9	C08		5	0103-0196	316.62	195.93	423	74.43	0.960
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18020.7	C08		5	0104-0192	277.15	191.83	127	62.43	0.410
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12816.9	C08		5	0105-0197	255.39	196.94	291	65.11	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14749.9	C08		5	0106-0199	238.00	199.22	270	60.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12948.2	C08		5	0107-0197	755.16	197.21	333	73.84	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15376.8	C08		5	0108-0203	377.95	202.93	389	73.84	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16858.1	C08		5	0109-0202	729.24	202.66	282	62.28	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14629.3	C08		5	0110-0205	15.79	205.08	242	62.53	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13498.4	C08		5	0111-0201	152.68	200.91	278	65.11	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18352.6	C08		5	0112-0213	531.46	212.95	638	109.64	0.667
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13414.9	C08		5	0113-0208	451.28	209.15	386	77.60	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14189.3	C08		5	0114-0207	707.83	207.15	275	61.70	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14814.1	C08		5	0115-0208	417.03	208.07	264	60.77	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21583.0	C08		5	0116-0212	806.62	212.34	352	71.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16455.6	C08		5	0117-0213	468.08	213.85	235	59.11	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12828.3	C08		5	0118-0215	79.24	215.03	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14635.2	C08		5	0119-0216	916.03	216.05	260	60.18	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14947.8	C08		5	0120-0216	754.19	217.04	271	60.53	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13933.7	C08		5	0121-0220	861.49	220.57	261	61.46	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16735.6	C08		5	0122-0220	846.92	220.50	226	56.53	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16725.4	C08		5	0123-0220	155.45	219.99	235	58.53	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17719.2	C08		5	0124-0227	305.10	227.85	461	79.84	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16936.9	C08		5	0125-0230	209.14	229.56	465	82.18	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18380.6	C08		5	0126-0228	629.67	228.20	214	54.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11380.2	C08		5	0127-0234	566.31	234.22	319	71.60	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20427.7	C08		5	0128-0234	179.64	233.99	323	67.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16034.2	C08		5	0129-0235	160.19	235.37	256	64.18	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17869.4	C08		5	0130-0236	282.88	236.18	299	64.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18075.2	C08		5	0131-0236	649.81	235.52	223	55.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14905.8	C08		5	0132-0237	120.78	237.25	243	58.18	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16563.7	C08		5	0133-0245	368.24	245.87	246	57.60	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12809.3	C08		5	0134-0246	583.97	245.73	309	67.70	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14624.8	C08		5	0135-0246	746.79	246.21	272	67.01	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16407.7	C08		5	0136-0251	154.83	251.42	213	57.36	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15950.8	C08		5	0137-0257	41.66	256.83	302	66.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13641.8	C08		5	0138-0261	915.84	261.05	264	62.77	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14684.2	C08		5	0139-0268	672.13	267.50	285	65.01	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11107.6	C08		5	0140-0270	701.57	270.34	435	77.26	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13949.1	C08		5	0141-0268	165.69	268.34	279	64.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17517.5	C08		5	0142-0271	272.79	270.58	228	59.01	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13064.7	C08		5	0143-0272	781.36	271.85	315	68.18	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16887.1	C08		5	0144-0274	218.26	274.24	234	58.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15295.5	C08		5	0145-0274	336.63	274.33	263	61.36	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20147.2	C08		5	0146-0275	403.63	274.97	100	53.94	0.432
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14555.8	C08		5	0147-0277	614.54	277.62	293	63.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14480.8	C08		5	0148-0282	637.91	282.17	280	62.18	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18660.5	C08		5	0149-0285	826.66	284.99	417	75.84	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16493.2	C08		5	0150-0283	727.36	283.45	236	57.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16887.7	C08		5	0151-0284	368.25	284.96	238	57.36	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13262.7	C08		5	0152-0286	122.52	286.93	271	62.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12734.8	C08		5	0153-0288	523.62	287.86	321	69.26	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21737.1	C08		5	0154-0290	47.31	290.37	349	69.01	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13211.0	C08		5	0155-0288	145.49	288.97	279	64.43	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12888.5	C08		5	0156-0293	892.36	293.38	289	65.60	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14463.4	C08		5	0157-0292	100.14	291.43	254	61.94	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16676.1	C08		5	0158-0290	326.27	290.42	232	60.18	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14488.2	C08		5	0159-0294	83.86	294.02	274	62.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11633.2	C08		5	0160-0293	484.95	293.15	340	72.18	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14203.1	C08		5	0161-0296	22.78	295.96	261	59.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15379.7	C08		5	0162-0297	451.94	296.90	263	62.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20978.6	C08		5	0163-0298	240.29	298.78	366	71.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18070.7	C08		5	0164-0302	652.45	303.48	138	61.94	0.452
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14128.5	C08		5	0165-0304	280.60	304.06	270	61.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12533.9	C08		5	0166-0305	217.05	305.63	289	63.84	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10644.8	C08		5	0167-0307	930.59	307.42	323	67.01	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14366.3	C08		5	0168-0310	729.44	309.48	269	62.18	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13919.8	C08		5	0169-0312	158.18	312.84	271	59.94	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13434.7	C08		5	0170-0316	189.03	316.58	267	63.36	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15110.8	C08		5	0171-0316	69.13	316.27	257	58.53	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14700.6	C08		5	0172-0318	89.27	318.53	265	59.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13349.8	C08		5	0173-0317	799.68	316.63	286	63.60	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12570.5	C08		5	0174-0321	45.21	322.00	284	63.36	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15379.7	C08		5	0175-0320	845.17	320.63	253	58.18	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14817.3	C08		5	0176-0320	136.44	320.06	267	61.70	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13820.3	C08		5	0177-0322	397.22	323.48	278	62.87	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17222.0	C08		5	0178-0322	870.34	322.03	266	60.18	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18814.7	C08		5	0179-0331	461.27	330.50	403	123.30	0.333
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15473.9	C08		5	0180-0327	348.68	327.24	254	59.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13980.5	C08		5	0181-0336	635.50	336.28	311	67.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14552.4	C08		5	0182-0339	704.62	340.13	296	69.01	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20904.8	C08		5	0183-0339	450.08	339.58	202	57.36	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16731.5	C08		5	0184-0341	684.57	341.42	259	59.11	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14708.3	C08		5	0185-0342	157.89	341.75	248	58.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16045.7	C08		5	0186-0341	401.12	341.19	280	63.11	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14470.8	C08		5	0187-0342	227.55	343.12	260	58.53	0.954
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14055.8	C08		5	0188-0349	287.08	348.91	530	90.08	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12327.5	C08		5	0189-0348	528.05	348.36	309	64.77	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19626.2	C08		5	0190-0349	862.51	349.51	310	65.70	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13512.3	C08		5	0191-0350	111.55	349.91	286	63.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14431.8	C08		5	0192-0351	185.97	351.54	249	59.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16505.0	C08		5	0193-0351	484.60	351.12	260	59.46	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15002.1	C08		5	0194-0351	626.22	351.50	270	60.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14090.0	C08		5	0195-0355	259.67	355.61	272	62.43	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18197.5	C08		5	0196-0355	379.09	355.60	217	55.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12982.5	C08		5	0197-0357	925.07	357.27	292	67.01	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15719.0	C08		5	0198-0359	132.19	358.49	242	57.36	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18694.4	C08		5	0199-0358	402.98	357.83	219	56.53	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12691.8	C08		5	0200-0360	231.80	360.52	300	66.53	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11881.8	C08		5	0201-0363	330.82	363.80	293	67.84	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21357.6	C08		5	0202-0362	570.58	361.86	347	68.43	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13677.7	C08		5	0203-0363	801.77	362.94	302	65.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15719.9	C08		5	0204-0362	692.19	362.38	273	62.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14959.5	C08		5	0205-0362	455.04	362.52	265	59.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19783.6	C08		5	0206-0367	753.07	367.37	195	53.70	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13175.0	C08		5	0207-0370	250.40	370.10	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16287.8	C08		5	0208-0367	489.65	367.26	252	61.70	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13876.3	C08		5	0209-0370	38.62	370.24	269	61.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12401.8	C08		5	0210-0371	65.11	370.95	267	63.60	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14750.8	C08		5	0211-0379	16.47	379.21	528	92.33	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21147.2	C08		5	0212-0374	897.56	373.81	358	70.43	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18278.3	C08		5	0213-0374	392.69	373.41	227	57.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16439.5	C08		5	0214-0372	607.12	372.07	244	59.70	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15833.2	C08		5	0215-0377	715.45	377.60	258	60.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14010.8	C08		5	0216-0380	170.63	380.29	261	60.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14087.2	C08		5	0217-0380	79.57	380.62	269	65.94	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16742.2	C08		5	0218-0380	826.62	380.14	234	67.94	0.637
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14730.5	C08		5	0219-0385	845.60	385.45	276	64.77	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13389.9	C08		5	0220-0393	409.82	393.55	669	106.13	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20105.6	C08		5	0221-0388	931.71	388.88	307	65.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14181.9	C08		5	0222-0389	620.66	388.59	300	65.94	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13718.3	C08		5	0223-0391	280.28	391.24	286	63.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18050.7	C08		5	0224-0394	742.34	394.65	218	56.28	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19978.2	C08		5	0225-0397	576.47	397.02	193	53.11	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17044.3	C08		5	0226-0408	234.72	408.22	478	85.98	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16591.6	C08		5	0227-0401	128.22	400.74	230	57.70	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15383.0	C08		5	0228-0403	640.40	402.75	245	59.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16930.6	C08		5	0229-0402	674.17	402.64	236	56.87	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15194.4	C08		5	0230-0407	256.61	407.32	259	58.53	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13779.7	C08		5	0231-0408	197.58	408.15	263	62.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14425.8	C08		5	0232-0408	809.21	408.51	286	65.11	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16383.1	C08		5	0233-0413	653.05	413.47	257	58.53	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15807.5	C08		5	0234-0413	121.53	413.71	248	60.53	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13084.1	C08		5	0235-0415	880.15	415.33	325	70.18	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14496.9	C08		5	0236-0415	332.75	415.60	283	61.36	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14873.5	C08		5	0237-0420	699.61	420.50	272	61.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18682.8	C08		5	0238-0421	179.91	421.12	203	53.36	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	24858.2	C08		5	0239-0422	547.27	421.79	185	51.94	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16496.8	C08		5	0240-0423	604.43	422.81	241	56.53	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12965.8	C08		5	0241-0425	750.67	425.26	311	67.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11170.2	C08		5	0242-0428	861.17	428.79	347	72.43	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13071.4	C08		5	0243-0429	357.07	429.49	449	79.01	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15163.4	C08		5	0244-0427	425.56	426.68	266	62.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13555.2	C08		5	0245-0428	813.06	427.42	298	67.36	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22120.7	C08		5	0246-0429	910.70	428.36	341	67.60	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17307.7	C08		5	0247-0432	534.22	431.66	315	71.01	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14638.4	C08		5	0248-0432	446.12	431.85	275	61.36	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13997.8	C08		5	0249-0435	62.73	435.07	267	60.53	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17876.8	C08		5	0250-0437	691.92	437.49	220	55.11	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16829.5	C08		5	0251-0441	127.60	441.77	461	86.33	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14227.1	C08		5	0252-0442	555.58	441.73	334	74.43	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15265.1	C08		5	0253-0442	168.94	442.03	258	60.87	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15811.0	C08		5	0254-0445	236.30	444.92	500	88.91	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13654.0	C08		5	0255-0445	612.34	445.07	298	64.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13242.4	C08		5	0256-0447	719.95	447.96	315	72.43	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14840.2	C08		5	0257-0445	380.07	445.62	201	53.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12199.8	C08		5	0258-0449	909.18	450.90	311	69.84	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12547.2	C08		5	0259-0453	469.88	453.62	288	63.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14557.5	C08		5	0260-0452	66.84	451.78	252	60.18	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15165.9	C08		5	0261-0456	201.00	456.33	242	58.53	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20143.6	C08		5	0262-0458	181.80	458.11	142	57.01	0.549
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16594.9	C08		5	0263-0464	794.80	464.01	517	83.26	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16932.6	C08		5	0264-0460	504.68	460.60	232	55.36	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12733.6	C08		5	0265-0463	416.40	463.13	287	63.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17398.6	C08		5	0266-0463	661.43	462.91	449	82.43	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14450.0	C08		5	0267-0465	556.12	465.52	281	61.84	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16179.4	C08		5	0268-0464	38.15	464.42	234	57.11	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14182.1	C08		5	0269-0468	577.43	468.57	287	61.94	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18098.8	C08		5	0270-0473	300.85	472.61	357	71.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15359.8	C08		5	0271-0468	741.95	468.06	257	59.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13620.6	C08		5	0272-0472	885.89	472.06	331	67.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13867.0	C08		5	0273-0473	402.60	473.38	290	65.26	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12389.3	C08		5	0274-0479	229.15	479.36	269	63.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17367.3	C08		5	0275-0484	122.14	484.11	446	81.01	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15859.7	C08		5	0276-0489	271.42	487.98	509	94.57	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14341.7	C08		5	0277-0482	846.77	481.46	271	61.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12789.4	C08		5	0278-0484	334.88	483.78	279	63.36	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15121.9	C08		5	0279-0495	616.96	495.63	262	61.60	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14962.9	C08		5	0280-0493	792.78	494.13	275	65.60	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16578.8	C08		5	0281-0496	452.03	495.40	259	59.36	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16764.0	C08		5	0282-0497	717.65	497.06	232	59.36	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16478.5	C08		5	0283-0501	197.27	500.70	468	85.74	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13949.8	C08		5	0284-0499	473.75	499.76	257	61.94	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13562.4	C08		5	0285-0501	96.90	501.47	294	65.01	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15440.8	C08		5	0286-0501	901.81	501.38	250	58.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13261.6	C08		5	0287-0502	370.13	501.78	271	62.77	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15534.2	C08		5	0288-0503	936.65	503.74	242	57.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15960.4	C08		5	0289-0504	493.62	504.39	252	59.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14674.1	C08		5	0290-0506	631.65	505.45	265	64.18	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19532.9	C08		5	0291-0507	19.27	507.99	386	74.33	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15654.4	C08		5	0292-0509	249.77	508.81	512	95.40	0.707
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14621.2	C08		5	0293-0509	557.64	509.71	257	65.01	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14809.1	C08		5	0294-0511	442.12	511.25	301	66.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15388.7	C08		5	0295-0510	45.20	510.71	245	58.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12285.9	C08		5	0296-0513	334.12	513.95	289	62.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15100.0	C08		5	0297-0514	286.74	514.68	251	57.94	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10912.0	C08		5	0298-0515	832.59	515.15	339	71.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21146.5	C08		5	0299-0515	468.55	515.56	195	53.70	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16345.3	C08		5	0300-0519	138.33	518.67	241	59.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15163.6	C08		5	0301-0519	526.25	519.51	272	60.53	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13039.1	C08		5	0302-0520	92.26	520.68	300	70.18	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16764.5	C08		5	0303-0523	624.45	523.58	297	65.01	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14530.3	C08		5	0304-0525	394.75	525.32	283	66.43	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14317.8	C08		5	0305-0528	769.98	528.55	280	67.50	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13848.5	C08		5	0306-0532	425.08	531.78	268	63.11	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12569.4	C08		5	0307-0533	151.14	533.56	258	63.01	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23833.9	C08		5	0308-0534	197.35	533.64	319	73.84	0.735
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14223.1	C08		5	0309-0539	534.98	538.32	273	65.60	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18466.1	C08		5	0310-0537	607.50	537.37	220	54.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11675.9	C08		5	0311-0541	382.06	542.72	366	75.01	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12221.1	C08		5	0312-0541	832.18	541.50	310	67.36	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21579.1	C08		5	0313-0543	470.35	543.09	177	48.53	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17039.2	C08		5	0314-0551	946.10	550.58	385	77.36	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16674.0	C08		5	0315-0546	321.13	546.71	242	57.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16175.3	C08		5	0316-0548	678.45	548.70	313	65.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14444.6	C08		5	0317-0546	741.53	546.09	268	60.18	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13190.0	C08		5	0318-0551	553.24	551.57	308	68.43	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12603.7	C08		5	0319-0551	99.70	551.78	270	60.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10649.5	C08		5	0320-0553	231.82	553.69	305	70.08	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11630.1	C08		5	0321-0553	22.92	553.49	287	63.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13355.4	C08		5	0322-0559	495.91	559.76	300	70.28	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13730.9	C08		5	0323-0559	389.91	558.86	287	63.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11836.7	C08		5	0324-0559	821.93	559.31	314	67.36	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15918.6	C08		5	0325-0559	248.37	560.21	257	63.36	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15302.4	C08		5	0326-0562	168.02	561.67	248	62.77	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15171.5	C08		5	0327-0564	702.70	564.62	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13491.9	C08		5	0328-0567	510.91	566.78	301	69.11	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16755.4	C08		5	0329-0564	315.06	563.80	239	59.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16293.7	C08		5	0330-0566	736.12	565.92	242	57.36	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12847.0	C08		5	0331-0569	150.59	569.48	302	65.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18795.3	C08		5	0332-0567	677.72	567.46	254	60.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12713.7	C08		5	0333-0571	274.35	571.63	273	66.67	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17048.0	C08		5	0334-0576	918.32	576.50	354	70.18	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15239.2	C08		5	0335-0575	342.32	575.76	263	64.28	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19820.1	C08		5	0336-0577	429.97	576.35	383	73.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14622.6	C08		5	0337-0578	632.34	578.02	292	65.94	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11353.1	C08		5	0338-0575	859.79	575.79	290	71.36	0.716
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16041.5	C08		5	0339-0580	67.90	580.53	477	87.74	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16331.9	C08		5	0340-0581	898.80	581.22	331	68.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14148.3	C08		5	0341-0583	574.86	583.16	299	66.77	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14994.8	C08		5	0342-0579	91.81	578.80	240	58.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14815.6	C08		5	0343-0582	313.75	583.24	272	64.28	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17584.1	C08		5	0344-0581	391.81	581.10	270	60.18	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17683.2	C08		5	0345-0581	716.10	581.79	223	55.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14985.7	C08		5	0346-0582	362.15	581.71	266	62.28	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13112.4	C08		5	0347-0580	790.21	579.80	287	68.53	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16286.5	C08		5	0348-0584	229.14	583.82	241	58.28	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16247.8	C08		5	0349-0587	20.24	587.47	224	55.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12683.5	C08		5	0350-0596	595.37	596.05	322	69.84	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12991.8	C08		5	0351-0600	354.65	600.31	282	62.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14082.2	C08		5	0352-0608	474.80	606.92	607	102.57	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12750.3	C08		5	0353-0601	167.12	600.87	304	66.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15394.2	C08		5	0354-0609	148.91	609.45	253	61.11	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12810.5	C08		5	0355-0610	719.24	610.32	321	66.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12755.0	C08		5	0356-0610	533.40	608.97	311	69.26	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15918.5	C08		5	0357-0610	187.17	610.71	253	59.70	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14478.7	C08		5	0358-0611	258.04	611.58	267	61.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13940.4	C08		5	0359-0613	805.81	613.19	270	61.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12142.1	C08		5	0360-0613	940.84	612.97	258	63.01	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12984.4	C08		5	0361-0617	413.46	616.96	307	68.08	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16889.4	C08		5	0362-0616	61.84	615.87	222	55.11	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13918.6	C08		5	0363-0614	320.99	615.05	262	61.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12576.2	C08		5	0364-0616	295.85	616.52	265	59.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13130.7	C08		5	0365-0619	385.46	618.83	296	65.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14429.1	C08		5	0366-0620	207.44	620.08	266	60.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18742.9	C08		5	0367-0623	671.13	622.99	256	59.36	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15979.8	C08		5	0368-0624	137.19	624.25	240	57.70	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12310.9	C08		5	0369-0629	444.51	629.51	296	65.94	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14788.8	C08		5	0370-0629	186.09	628.77	271	62.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13984.9	C08		5	0371-0634	897.40	633.89	524	91.64	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14006.4	C08		5	0372-0633	864.86	633.43	286	63.60	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12825.2	C08		5	0373-0634	497.57	633.42	289	62.53	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12179.5	C08		5	0374-0647	794.04	647.11	321	69.50	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16749.8	C08		5	0375-0647	539.38	647.38	241	57.70	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18006.3	C08		5	0376-0649	154.97	648.54	220	54.53	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19269.6	C08		5	0377-0647	646.40	647.40	204	53.11	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14981.0	C08		5	0378-0651	195.60	651.23	248	57.70	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12931.1	C08		5	0379-0652	247.90	652.79	293	63.94	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12856.1	C08		5	0380-0650	817.91	650.42	277	63.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11552.7	C08		5	0381-0648	335.51	648.81	154	48.63	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16241.3	C08		5	0382-0654	433.37	654.60	247	57.94	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19528.3	C08		5	0383-0655	686.50	654.73	395	73.84	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13818.7	C08		5	0384-0656	555.80	656.01	283	64.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12893.1	C08		5	0385-0660	52.60	659.90	289	62.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11983.5	C08		5	0386-0661	313.70	661.95	212	55.70	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18598.6	C08		5	0387-0662	629.58	661.88	213	56.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12764.3	C08		5	0388-0664	337.75	662.55	268	63.01	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13180.7	C08		5	0389-0668	589.42	667.54	275	63.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15786.8	C08		5	0390-0666	147.08	666.75	252	61.60	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14358.6	C08		5	0391-0666	671.76	667.21	262	63.01	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12626.0	C08		5	0392-0669	739.67	669.43	297	65.01	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12259.6	C08		5	0393-0679	330.09	679.10	404	84.57	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16100.6	C08		5	0394-0672	19.02	672.27	225	57.94	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18049.2	C08		5	0395-0674	160.45	674.70	206	54.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11824.6	C08		5	0396-0676	930.18	676.57	245	64.18	0.747
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17972.5	C08		5	0397-0683	405.39	682.87	637	109.54	0.667
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13206.7	C08		5	0398-0675	547.03	675.66	282	63.94	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12076.0	C08		5	0399-0678	284.16	677.62	271	60.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17367.4	C08		5	0400-0680	625.14	680.18	214	55.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13447.5	C08		5	0401-0684	804.27	684.54	262	59.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14902.8	C08		5	0402-0687	751.15	687.58	259	61.94	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10175.0	C08		5	0403-0688	348.96	687.26	159	58.43	0.585
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13548.0	C08		5	0404-0688	897.14	688.21	252	60.77	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18024.9	C08		5	0405-0691	869.78	690.90	275	78.67	0.558
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16072.1	C08		5	0406-0690	205.49	690.05	230	56.53	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16707.3	C08		5	0407-0690	683.30	690.68	230	56.77	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15897.9	C08		5	0408-0693	612.16	693.49	247	58.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13322.3	C08		5	0409-0706	467.36	706.23	279	61.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14349.7	C08		5	0410-0706	549.06	706.22	255	59.01	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13176.1	C08		5	0411-0709	35.80	710.01	288	66.77	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16035.0	C08		5	0412-0708	182.19	708.34	229	56.53	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13548.2	C08		5	0413-0709	233.40	709.62	261	59.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184733	1375322	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12190.1	C08		5	0414-0710	56.38	709.78	280	65.94	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12399.6	C08		6	0001-0023	416.28	23.63	327	71.01	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13939.9	C08		6	0002-0027	676.92	26.76	287	65.94	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15843.9	C08		6	0003-0027	227.08	26.02	257	69.60	0.667
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15704.6	C08		6	0004-0031	617.58	31.04	275	63.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16646.6	C08		6	0005-0028	846.42	28.00	237	59.94	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12554.3	C08		6	0006-0034	941.60	33.31	301	65.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13085.6	C08		6	0007-0035	54.36	34.91	270	63.70	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13153.3	C08		6	0008-0036	331.47	37.01	311	69.36	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14116.6	C08		6	0009-0047	440.88	47.58	646	109.88	0.672
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19750.1	C08		6	0010-0041	515.00	41.24	407	74.08	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13151.4	C08		6	0011-0044	31.94	44.26	257	62.77	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10482.2	C08		6	0012-0042	91.51	42.05	298	65.26	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13231.7	C08		6	0013-0043	788.36	43.35	291	63.11	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14739.7	C08		6	0014-0043	641.23	43.00	272	64.53	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21492.0	C08		6	0015-0043	838.81	43.77	348	70.77	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19084.9	C08		6	0016-0048	351.26	47.98	345	68.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12818.3	C08		6	0017-0050	557.36	49.98	316	65.84	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14286.3	C08		6	0018-0056	256.61	56.18	262	60.53	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18138.7	C08		6	0019-0060	857.26	60.45	424	84.91	0.739
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19338.1	C08		6	0020-0058	283.61	58.25	216	55.60	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18986.8	C08		6	0021-0057	302.72	56.67	194	53.11	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14424.1	C08		6	0022-0056	466.92	56.20	294	66.18	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14296.2	C08		6	0023-0058	170.81	57.00	285	73.84	0.657
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16039.1	C08		6	0024-0060	224.81	58.82	486	99.40	0.618
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14875.0	C08		6	0025-0071	610.72	70.65	290	64.53	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12667.1	C08		6	0026-0071	707.96	71.26	316	65.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14621.9	C08		6	0027-0070	53.10	70.92	267	65.60	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13062.4	C08		6	0028-0075	520.80	74.96	302	64.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14208.2	C08		6	0029-0075	161.24	74.69	204	55.94	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22524.6	C08		6	0030-0081	905.91	81.12	542	88.57	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15652.9	C08		6	0031-0077	134.01	77.10	233	58.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13615.7	C08		6	0032-0082	18.69	82.46	248	60.18	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11571.0	C08		6	0033-0086	284.39	86.76	297	64.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15496.3	C08		6	0034-0086	173.60	86.45	261	65.36	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16843.5	C08		6	0035-0090	927.11	89.89	390	78.18	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19196.0	C08		6	0036-0092	722.25	92.38	341	69.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10724.7	C08		6	0037-0095	346.33	95.23	319	67.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13434.6	C08		6	0038-0098	391.71	98.21	293	65.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	24112.7	C08		6	0039-0096	766.53	96.92	175	49.46	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16068.1	C08		6	0040-0101	64.36	100.97	241	64.28	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16237.8	C08		6	0041-0101	96.92	101.23	221	56.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14142.6	C08		6	0042-0104	835.92	104.70	279	63.60	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15827.7	C08		6	0043-0106	601.66	106.72	274	63.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16293.1	C08		6	0044-0104	916.53	104.14	224	58.18	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13135.6	C08		6	0045-0106	799.62	106.51	315	68.77	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11735.1	C08		6	0046-0108	535.89	108.15	327	66.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15441.5	C08		6	0047-0111	651.77	112.71	282	62.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12327.1	C08		6	0048-0117	34.30	117.20	284	65.60	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16092.8	C08		6	0049-0115	577.40	115.08	245	58.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21074.0	C08		6	0050-0120	617.95	120.33	382	73.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11371.2	C08		6	0051-0118	135.04	118.42	287	70.18	0.732
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14387.2	C08		6	0052-0121	491.85	120.78	273	62.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19715.1	C08		6	0053-0119	376.22	120.22	193	50.87	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15095.6	C08		6	0054-0123	462.38	123.29	262	58.77	0.953
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17103.2	C08		6	0055-0125	853.84	124.76	210	57.60	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14103.8	C08		6	0056-0126	235.33	125.45	140	50.53	0.689
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14102.8	C08		6	0057-0128	680.24	129.14	265	60.18	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14911.3	C08		6	0058-0127	904.54	127.02	257	59.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12371.9	C08		6	0059-0131	40.69	132.16	280	65.60	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12990.1	C08		6	0060-0135	423.61	135.31	289	63.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14377.1	C08		6	0061-0133	716.97	133.81	268	63.70	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18866.0	C08		6	0062-0135	377.72	135.14	202	53.46	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14782.8	C08		6	0063-0142	340.72	141.79	264	63.01	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16865.8	C08		6	0064-0142	817.92	142.04	234	58.43	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13673.2	C08		6	0065-0144	514.97	144.61	291	63.36	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15683.7	C08		6	0066-0144	251.74	145.29	181	56.53	0.712
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16380.1	C08		6	0067-0144	594.22	144.32	242	58.53	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11333.0	C08		6	0068-0147	159.52	146.71	303	67.01	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16597.1	C08		6	0069-0150	764.60	150.14	234	56.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15532.4	C08		6	0070-0158	303.10	158.52	238	57.70	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18593.6	C08		6	0071-0157	888.64	157.38	362	71.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17100.1	C08		6	0072-0157	825.04	157.14	224	57.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19292.4	C08		6	0073-0163	537.54	161.94	332	68.77	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21053.3	C08		6	0074-0157	588.91	158.29	128	42.39	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16026.6	C08		6	0075-0161	614.35	161.31	263	60.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15314.4	C08		6	0076-0162	747.17	161.79	249	58.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18407.1	C08		6	0077-0163	676.84	163.38	424	77.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15118.0	C08		6	0078-0166	166.00	166.54	242	59.11	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17610.1	C08		6	0079-0166	400.03	166.05	225	57.70	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13839.7	C08		6	0080-0169	487.03	168.76	277	62.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11737.7	C08		6	0081-0171	109.83	171.44	282	64.77	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20791.5	C08		6	0082-0172	591.26	172.29	241	63.70	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13144.9	C08		6	0083-0182	835.67	182.33	328	69.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13021.7	C08		6	0084-0184	172.45	184.33	281	65.94	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21220.7	C08		6	0085-0186	705.00	185.93	345	68.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15326.5	C08		6	0086-0187	75.88	187.63	216	56.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13966.2	C08		6	0087-0187	859.67	187.16	303	68.43	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13547.0	C08		6	0088-0188	60.61	188.80	270	61.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20586.1	C08		6	0089-0187	803.04	186.83	178	60.18	0.618
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12445.5	C08		6	0090-0191	672.91	190.78	309	70.18	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15141.6	C08		6	0091-0193	940.32	193.32	259	59.70	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13892.0	C08		6	0092-0198	822.87	198.48	341	74.67	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13417.8	C08		6	0093-0203	625.45	203.38	295	65.84	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15628.3	C08		6	0094-0202	909.82	202.56	250	58.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23106.3	C08		6	0095-0201	807.76	202.00	102	63.01	0.323
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11279.4	C08		6	0096-0206	129.34	206.23	298	64.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14642.6	C08		6	0097-0209	397.85	209.34	257	61.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17055.0	C08		6	0098-0211	432.42	211.02	231	61.11	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15703.3	C08		6	0099-0210	500.04	211.04	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13370.2	C08		6	0100-0210	568.93	209.67	290	63.60	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12597.2	C08		6	0101-0215	215.75	215.14	308	65.01	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15129.4	C08		6	0102-0218	279.31	219.19	265	61.46	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14700.6	C08		6	0103-0222	723.31	222.66	271	62.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13306.3	C08		6	0104-0225	618.20	224.48	300	63.60	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18174.5	C08		6	0105-0229	887.94	229.13	329	68.18	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22069.5	C08		6	0106-0231	59.71	230.72	334	66.77	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10829.0	C08		6	0107-0236	91.16	236.34	285	63.26	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21508.4	C08		6	0108-0237	773.38	237.52	324	67.36	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14643.0	C08		6	0109-0236	279.03	236.04	389	74.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14035.4	C08		6	0110-0236	669.75	236.45	282	62.43	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11543.8	C08		6	0111-0238	343.16	238.63	321	67.84	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13433.3	C08		6	0112-0242	573.88	243.29	297	69.84	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13848.2	C08		6	0113-0244	756.21	244.60	290	66.18	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15644.1	C08		6	0114-0240	940.51	240.31	252	60.77	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12224.2	C08		6	0115-0247	198.46	246.56	301	67.84	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16628.1	C08		6	0116-0247	874.65	247.80	241	57.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11668.2	C08		6	0117-0251	833.26	251.71	322	76.91	0.684
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14823.4	C08		6	0118-0254	386.96	253.92	280	66.67	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13990.5	C08		6	0119-0254	542.86	253.92	303	64.77	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15382.3	C08		6	0120-0252	181.83	252.52	254	61.36	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14929.0	C08		6	0121-0253	560.66	254.21	262	62.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13879.7	C08		6	0122-0256	469.07	255.36	254	64.53	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14688.8	C08		6	0123-0259	334.87	258.49	264	63.70	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14056.9	C08		6	0124-0263	605.14	262.77	302	65.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17395.9	C08		6	0125-0261	147.85	260.95	217	53.46	0.954
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20433.1	C08		6	0126-0264	729.34	264.18	365	74.08	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15910.3	C08		6	0127-0274	797.83	272.58	730	118.71	0.651
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14231.6	C08		6	0128-0265	913.08	265.02	285	63.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15091.9	C08		6	0129-0268	368.30	267.57	260	61.01	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12444.0	C08		6	0130-0271	50.84	271.45	275	64.18	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16826.6	C08		6	0131-0275	466.40	274.78	474	81.26	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12615.3	C08		6	0132-0271	683.27	271.56	311	66.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14436.9	C08		6	0133-0272	566.82	272.48	293	64.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13133.2	C08		6	0134-0285	173.94	285.56	273	63.11	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13628.0	C08		6	0135-0291	636.52	291.53	287	61.36	0.958
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13878.2	C08		6	0136-0297	351.39	296.39	280	67.84	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14767.6	C08		6	0137-0295	554.38	295.52	265	61.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12233.0	C08		6	0138-0295	254.50	295.29	293	65.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13106.8	C08		6	0139-0296	850.40	297.06	334	67.01	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17749.1	C08		6	0140-0298	712.21	299.02	442	94.08	0.627
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12321.9	C08		6	0141-0302	901.12	301.88	321	69.60	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14840.6	C08		6	0142-0301	666.58	301.64	262	59.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12920.3	C08		6	0143-0307	917.49	306.26	335	71.01	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14791.6	C08		6	0144-0311	771.61	312.57	588	94.81	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15188.9	C08		6	0145-0307	375.36	307.73	255	58.77	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10574.6	C08		6	0146-0310	25.03	310.38	279	61.94	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14995.2	C08		6	0147-0312	509.64	311.64	257	60.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20134.5	C08		6	0148-0317	462.42	314.77	271	76.33	0.585
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15895.8	C08		6	0149-0313	945.18	313.34	263	62.87	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12860.9	C08		6	0150-0327	581.53	327.68	325	69.36	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15839.4	C08		6	0151-0323	859.49	323.86	256	63.94	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20736.2	C08		6	0152-0328	930.26	328.02	378	71.36	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12016.0	C08		6	0153-0332	300.21	332.99	315	73.01	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16797.5	C08		6	0154-0332	136.47	332.64	402	73.84	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22527.8	C08		6	0155-0331	741.68	331.35	299	63.36	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11025.7	C08		6	0156-0334	415.15	333.75	322	69.26	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15273.7	C08		6	0157-0336	57.05	335.97	361	70.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11600.9	C08		6	0158-0336	705.21	336.45	327	70.18	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17199.8	C08		6	0159-0337	247.85	337.10	231	57.94	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16635.2	C08		6	0160-0338	873.94	339.03	219	55.80	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15049.5	C08		6	0161-0346	319.24	345.76	246	62.28	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11704.9	C08		6	0162-0347	649.01	347.45	361	70.43	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14756.6	C08		6	0163-0346	262.33	345.89	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18245.7	C08		6	0164-0346	195.54	347.46	207	57.94	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18032.1	C08		6	0165-0349	751.50	349.29	219	55.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19835.5	C08		6	0166-0351	433.65	351.56	202	55.94	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17514.5	C08		6	0167-0355	275.20	356.19	224	54.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16624.1	C08		6	0168-0358	330.88	357.70	234	60.18	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16309.0	C08		6	0169-0358	510.68	358.42	247	66.67	0.698
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17601.2	C08		6	0170-0353	874.29	352.74	227	58.28	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13393.8	C08		6	0171-0360	458.55	360.08	306	69.94	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12932.5	C08		6	0172-0356	782.57	356.41	305	64.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13625.0	C08		6	0173-0359	612.70	359.17	310	65.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12522.4	C08		6	0174-0360	19.86	360.13	273	65.84	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17989.3	C08		6	0175-0362	759.16	362.11	203	55.94	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10668.0	C08		6	0176-0365	107.78	365.12	297	67.36	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13649.8	C08		6	0177-0369	650.63	368.91	309	65.36	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16663.2	C08		6	0178-0368	427.61	368.25	236	56.87	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14798.4	C08		6	0179-0370	895.90	370.77	278	63.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15670.7	C08		6	0180-0371	917.35	371.10	266	62.43	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14012.7	C08		6	0181-0378	630.45	378.26	301	65.60	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19076.6	C08		6	0182-0380	518.18	380.51	214	56.53	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15231.1	C08		6	0183-0380	806.29	380.14	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12228.9	C08		6	0184-0387	132.88	387.35	285	63.94	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15679.4	C08		6	0185-0388	874.32	387.72	253	62.77	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19210.0	C08		6	0186-0391	26.53	391.88	312	65.01	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13921.5	C08		6	0187-0392	680.81	391.79	302	64.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13924.9	C08		6	0188-0400	718.10	399.93	292	65.36	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19731.8	C08		6	0189-0398	935.14	397.83	207	54.53	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15201.0	C08		6	0190-0401	766.60	400.19	271	62.43	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13529.1	C08		6	0191-0399	913.54	399.39	284	62.53	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13038.0	C08		6	0192-0405	563.90	405.58	300	64.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14164.4	C08		6	0193-0411	271.86	410.40	553	103.30	0.651
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14035.1	C08		6	0194-0408	529.67	408.35	277	62.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15020.0	C08		6	0195-0409	753.00	409.86	266	63.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12094.9	C08		6	0196-0412	855.78	412.42	248	60.43	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17522.1	C08		6	0197-0413	71.26	413.34	383	73.36	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11544.7	C08		6	0198-0418	106.82	418.53	319	68.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10668.1	C08		6	0199-0423	452.60	421.94	336	71.01	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13550.2	C08		6	0200-0425	791.00	425.65	290	64.53	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16030.8	C08		6	0201-0424	807.62	423.86	267	62.53	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16223.2	C08		6	0202-0429	398.58	429.08	509	89.74	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12839.6	C08		6	0203-0426	839.61	426.67	230	58.18	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16492.7	C08		6	0204-0424	125.23	424.74	219	57.70	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13799.9	C08		6	0205-0430	238.86	429.93	284	65.01	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14684.1	C08		6	0206-0431	597.16	431.73	291	64.43	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17581.4	C08		6	0207-0432	349.09	432.09	224	57.11	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13658.4	C08		6	0208-0441	207.55	440.41	573	90.33	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14017.6	C08		6	0209-0439	417.80	439.51	276	63.94	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13485.5	C08		6	0210-0442	168.49	442.08	272	60.77	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15267.3	C08		6	0211-0442	623.74	441.87	263	58.53	0.965
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17554.7	C08		6	0212-0442	651.19	442.34	231	56.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17661.0	C08		6	0213-0445	705.41	445.49	224	61.84	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12944.0	C08		6	0214-0443	85.27	443.29	281	64.77	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12405.8	C08		6	0215-0449	263.69	449.21	290	65.84	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19909.1	C08		6	0216-0455	601.71	455.23	403	75.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17922.7	C08		6	0217-0454	928.96	453.89	209	55.11	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17125.2	C08		6	0218-0456	369.96	456.02	224	55.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13255.7	C08		6	0219-0458	284.97	458.20	295	63.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15258.7	C08		6	0220-0459	943.71	459.04	258	60.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13385.2	C08		6	0221-0461	875.56	460.42	304	63.94	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15383.6	C08		6	0222-0459	82.57	458.98	243	58.53	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14837.7	C08		6	0223-0462	308.85	462.86	247	59.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16270.2	C08		6	0224-0467	636.12	467.79	262	65.01	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14261.8	C08		6	0225-0464	133.52	463.37	241	63.36	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16347.4	C08		6	0226-0466	799.00	466.29	240	57.46	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16549.0	C08		6	0227-0467	814.53	466.96	274	63.11	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12731.5	C08		6	0228-0471	698.92	470.94	320	67.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19475.6	C08		6	0229-0472	764.64	471.85	388	74.08	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14561.5	C08		6	0230-0471	216.16	471.88	246	59.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12558.1	C08		6	0231-0474	430.19	473.76	325	70.43	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14044.7	C08		6	0232-0475	125.39	475.45	271	64.77	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15923.8	C08		6	0233-0477	601.43	476.81	257	59.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15820.6	C08		6	0234-0480	543.61	480.42	248	58.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11639.2	C08		6	0235-0485	754.39	485.62	321	69.01	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11642.9	C08		6	0236-0487	833.43	487.54	169	51.94	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14271.2	C08		6	0237-0489	147.26	489.54	262	60.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13879.8	C08		6	0238-0488	520.89	488.47	281	62.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14818.5	C08		6	0239-0489	211.36	489.19	253	59.11	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16336.8	C08		6	0240-0488	260.82	488.71	235	57.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21206.5	C08		6	0241-0491	897.82	492.01	384	73.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12672.1	C08		6	0242-0496	108.89	496.36	258	60.53	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17439.4	C08		6	0243-0498	794.85	497.72	251	66.53	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12503.7	C08		6	0244-0502	61.85	502.04	264	61.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14702.0	C08		6	0245-0501	431.48	500.98	254	61.60	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13080.7	C08		6	0246-0503	937.07	503.41	305	65.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21395.2	C08		6	0247-0505	703.45	504.80	339	68.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19707.4	C08		6	0248-0503	810.14	503.90	196	54.04	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15605.5	C08		6	0249-0506	31.37	506.93	235	57.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15996.3	C08		6	0250-0507	586.64	507.21	243	58.53	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14580.0	C08		6	0251-0508	414.86	507.96	281	63.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15994.0	C08		6	0252-0508	345.69	507.83	243	59.11	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17626.5	C08		6	0253-0512	150.39	512.45	210	52.87	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22338.0	C08		6	0254-0514	456.22	515.05	348	70.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15772.2	C08		6	0255-0516	164.03	515.62	232	59.46	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13478.8	C08		6	0256-0521	826.80	521.72	313	71.01	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17226.1	C08		6	0257-0523	945.53	522.89	229	56.53	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16506.2	C08		6	0258-0526	105.07	526.30	388	72.43	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12315.0	C08		6	0259-0522	268.65	522.06	172	50.87	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17150.6	C08		6	0260-0526	664.33	526.56	233	57.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11677.0	C08		6	0261-0527	250.42	526.89	188	53.11	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11806.5	C08		6	0262-0527	381.97	527.90	304	66.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13071.0	C08		6	0263-0528	611.87	528.20	324	68.43	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14685.5	C08		6	0264-0529	437.19	529.34	264	59.94	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14296.5	C08		6	0265-0535	483.76	535.17	268	63.36	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15861.3	C08		6	0266-0537	901.00	537.63	246	57.60	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14323.0	C08		6	0267-0541	269.74	541.75	257	61.01	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13949.0	C08		6	0268-0544	829.03	543.72	294	66.18	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16528.3	C08		6	0269-0554	41.10	553.69	394	79.60	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13984.5	C08		6	0270-0551	571.25	551.38	298	63.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12908.6	C08		6	0271-0551	62.85	551.76	261	61.26	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12085.1	C08		6	0272-0551	931.25	551.41	306	67.60	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14879.8	C08		6	0273-0553	753.50	553.00	266	60.18	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15506.2	C08		6	0274-0553	869.76	553.40	256	61.11	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13398.1	C08		6	0275-0557	389.14	557.68	305	66.77	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14192.1	C08		6	0276-0558	694.81	558.28	271	61.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17292.3	C08		6	0277-0564	160.05	564.71	337	67.01	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15024.3	C08		6	0278-0566	80.09	565.96	235	59.36	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13604.1	C08		6	0279-0572	425.35	572.97	289	64.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15102.7	C08		6	0280-0571	641.61	572.09	266	60.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14126.1	C08		6	0281-0573	137.07	573.98	236	59.36	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15439.4	C08		6	0282-0573	444.69	573.46	262	61.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15969.3	C08		6	0283-0579	51.66	578.45	330	70.53	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12852.6	C08		6	0284-0579	325.79	579.36	274	62.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13869.7	C08		6	0285-0578	843.81	579.39	334	69.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14564.7	C08		6	0286-0581	120.36	580.63	248	58.28	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11751.5	C08		6	0287-0584	914.41	584.32	316	66.18	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13905.8	C08		6	0288-0586	224.69	586.27	267	61.70	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12676.7	C08		6	0289-0591	744.26	590.33	323	68.18	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12615.1	C08		6	0290-0592	357.62	591.89	378	71.84	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15743.3	C08		6	0291-0589	447.52	589.20	262	62.53	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12968.3	C08		6	0292-0594	397.81	594.55	286	64.77	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14634.2	C08		6	0293-0596	478.63	597.04	265	60.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14506.5	C08		6	0294-0600	548.72	600.30	269	59.70	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11231.0	C08		6	0295-0606	768.79	606.37	348	75.50	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15350.4	C08		6	0296-0608	453.66	607.22	275	63.46	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11984.3	C08		6	0297-0611	871.03	611.29	313	65.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12960.6	C08		6	0298-0613	608.91	612.29	306	66.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14128.0	C08		6	0299-0612	155.25	612.80	258	66.77	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12533.8	C08		6	0300-0616	281.60	616.02	269	61.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18500.3	C08		6	0301-0621	101.66	620.83	457	83.26	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11463.0	C08		6	0302-0616	242.90	616.27	280	64.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13753.1	C08		6	0303-0619	793.31	619.27	289	65.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12067.1	C08		6	0304-0616	35.45	615.89	238	60.18	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15506.6	C08		6	0305-0619	934.38	618.80	234	59.70	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16526.0	C08		6	0306-0622	715.31	622.01	232	56.18	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14330.0	C08		6	0307-0623	490.18	623.40	266	61.60	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13070.4	C08		6	0308-0625	892.09	625.63	320	68.18	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17359.6	C08		6	0309-0627	922.07	627.14	220	57.94	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12059.7	C08		6	0310-0633	652.51	633.11	316	65.84	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15179.4	C08		6	0311-0633	318.81	632.76	239	59.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21021.5	C08		6	0312-0636	362.01	636.69	341	69.84	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12440.8	C08		6	0313-0638	466.43	637.42	320	68.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13872.9	C08		6	0314-0642	67.30	642.39	465	81.84	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17552.7	C08		6	0315-0639	244.92	639.76	419	78.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17054.9	C08		6	0316-0639	559.40	639.37	227	59.01	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17149.3	C08		6	0317-0639	817.75	639.85	284	61.60	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12249.2	C08		6	0318-0646	718.33	646.71	316	71.60	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16903.0	C08		6	0319-0647	754.67	646.84	230	57.60	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15559.6	C08		6	0320-0649	447.54	648.81	246	57.94	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14082.2	C08		6	0321-0652	950.46	652.40	258	59.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18268.6	C08		6	0322-0653	368.94	653.00	209	56.53	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18707.6	C08		6	0323-0657	286.04	657.54	398	75.84	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13776.6	C08		6	0324-0657	420.01	656.43	218	56.77	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15664.2	C08		6	0325-0659	874.28	659.13	245	58.53	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11583.0	C08		6	0326-0659	245.72	659.02	300	66.77	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10283.1	C08		6	0327-0665	617.34	666.04	321	69.84	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13956.4	C08		6	0328-0666	734.34	665.61	289	65.01	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12815.9	C08		6	0329-0670	799.68	670.44	295	71.50	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14363.1	C08		6	0330-0676	165.38	676.19	237	56.77	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11757.1	C08		6	0331-0679	24.32	679.38	222	60.18	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14757.9	C08		6	0332-0679	281.96	678.70	245	63.94	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12315.5	C08		6	0333-0681	852.07	682.12	305	65.36	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11652.1	C08		6	0334-0684	480.38	683.80	293	67.36	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14987.3	C08		6	0335-0683	870.51	683.10	248	62.18	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17725.6	C08		6	0336-0686	518.61	686.26	352	68.77	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16019.2	C08		6	0337-0683	715.86	683.20	246	59.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14987.1	C08		6	0338-0688	230.41	688.88	253	60.18	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11134.1	C08		6	0339-0689	103.32	689.98	231	58.53	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10433.0	C08		6	0340-0693	583.34	693.72	373	76.08	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184734	1375323	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14406.1	C08		6	0341-0701	163.75	701.44	242	58.28	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15918.1	C08		7	0001-0023	51.83	23.84	298	69.84	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11088.0	C08		7	0002-0026	872.40	25.70	203	61.60	0.672
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13583.7	C08		7	0003-0025	731.35	25.70	305	67.94	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13761.9	C08		7	0004-0031	928.55	31.22	283	66.18	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13043.3	C08		7	0005-0034	824.17	35.30	298	65.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12607.7	C08		7	0006-0035	617.33	35.30	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13500.3	C08		7	0007-0034	356.66	33.84	315	65.94	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15157.6	C08		7	0008-0037	580.19	36.57	282	63.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10446.8	C08		7	0009-0037	316.66	36.54	320	71.60	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14216.7	C08		7	0010-0036	32.18	36.12	266	61.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15867.6	C08		7	0011-0037	90.78	38.03	232	57.70	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15792.2	C08		7	0012-0043	840.82	43.08	252	58.28	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12872.6	C08		7	0013-0044	643.67	43.90	303	65.94	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12700.1	C08		7	0014-0048	19.83	48.94	291	63.60	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9771.6	C08		7	0015-0053	249.97	53.20	305	64.53	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14413.2	C08		7	0016-0055	90.75	55.31	288	65.94	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14362.8	C08		7	0017-0057	556.33	57.88	320	67.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13005.7	C08		7	0018-0057	409.54	57.82	326	68.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14372.3	C08		7	0019-0062	520.71	62.39	288	63.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17560.2	C08		7	0020-0064	837.98	65.31	438	89.84	0.682
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12385.4	C08		7	0021-0061	944.96	60.36	110	42.04	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16974.7	C08		7	0022-0063	177.25	63.58	268	62.18	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15912.6	C08		7	0023-0067	871.06	67.00	240	61.84	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15351.4	C08		7	0024-0064	113.77	64.84	266	63.94	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18920.0	C08		7	0025-0073	730.13	72.18	431	81.01	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18398.5	C08		7	0026-0077	24.61	76.57	208	54.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12602.2	C08		7	0027-0087	684.99	87.09	311	67.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12296.1	C08		7	0028-0087	251.91	87.09	337	69.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13013.9	C08		7	0029-0087	288.99	87.22	286	62.53	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14255.0	C08		7	0030-0097	586.15	96.15	584	110.23	0.604
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10094.6	C08		7	0031-0088	132.75	87.65	315	69.01	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14370.1	C08		7	0032-0087	200.86	87.04	298	64.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12768.7	C08		7	0033-0087	361.81	87.33	303	64.77	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14334.7	C08		7	0034-0091	448.08	91.39	393	77.01	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21129.7	C08		7	0035-0092	17.29	92.61	173	49.94	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13727.4	C08		7	0036-0095	722.59	94.21	265	63.60	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12536.7	C08		7	0037-0100	638.36	99.46	299	66.18	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13067.0	C08		7	0038-0102	816.65	102.78	353	74.08	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14756.9	C08		7	0039-0102	694.93	102.80	276	65.94	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12903.7	C08		7	0040-0106	621.07	106.28	316	67.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14400.1	C08		7	0041-0106	787.14	105.81	284	65.01	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12658.8	C08		7	0042-0108	440.48	108.24	311	67.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13457.5	C08		7	0043-0110	510.10	110.55	295	64.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14679.9	C08		7	0044-0109	766.18	108.84	275	62.53	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14511.9	C08		7	0045-0113	314.83	112.82	264	59.94	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12460.7	C08		7	0046-0115	914.68	115.50	288	63.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11980.5	C08		7	0047-0116	91.75	116.26	293	62.77	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12998.3	C08		7	0048-0117	563.72	117.16	314	65.60	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11289.7	C08		7	0049-0116	351.44	116.42	305	66.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10711.7	C08		7	0050-0123	180.27	122.55	320	70.18	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17763.5	C08		7	0051-0128	251.79	127.33	470	88.57	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15104.3	C08		7	0052-0120	404.21	120.23	270	62.53	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14512.2	C08		7	0053-0122	67.75	122.10	269	60.28	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12102.6	C08		7	0054-0128	728.23	127.56	314	68.43	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15165.2	C08		7	0055-0129	226.70	128.77	264	60.77	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21120.4	C08		7	0056-0130	853.09	130.34	358	69.60	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12646.0	C08		7	0057-0131	893.96	131.48	307	65.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14710.2	C08		7	0058-0133	668.02	134.08	273	64.18	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14452.7	C08		7	0059-0136	10.94	136.29	264	59.11	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11735.7	C08		7	0060-0141	311.82	141.79	298	65.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11123.4	C08		7	0061-0143	141.61	143.51	294	65.01	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13097.1	C08		7	0062-0143	722.81	144.64	318	71.26	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14284.1	C08		7	0063-0147	212.29	146.48	286	63.70	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14128.2	C08		7	0064-0152	192.31	151.77	275	66.18	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11265.3	C08		7	0065-0151	635.38	151.20	336	69.11	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15154.3	C08		7	0066-0160	561.54	160.14	535	98.57	0.692
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11643.0	C08		7	0067-0153	791.77	152.66	322	67.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16542.9	C08		7	0068-0157	417.30	157.18	496	84.08	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12561.2	C08		7	0069-0160	95.47	160.60	301	64.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11774.2	C08		7	0070-0162	816.09	162.44	317	67.01	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13937.3	C08		7	0071-0162	354.78	162.27	283	68.43	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17401.0	C08		7	0072-0166	235.28	166.37	452	78.43	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17570.2	C08		7	0073-0169	947.12	169.62	436	77.50	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15211.1	C08		7	0074-0168	27.73	168.95	257	59.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14648.1	C08		7	0075-0167	650.18	167.83	282	63.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13134.5	C08		7	0076-0170	492.83	170.51	237	58.77	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13844.2	C08		7	0077-0173	187.93	172.95	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12351.8	C08		7	0078-0171	706.65	171.49	311	68.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14217.9	C08		7	0079-0173	366.75	173.55	297	67.01	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10531.2	C08		7	0080-0173	479.10	174.12	130	47.46	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14835.4	C08		7	0081-0174	47.24	175.03	264	60.77	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13949.0	C08		7	0082-0176	425.03	175.77	300	65.60	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10637.6	C08		7	0083-0181	306.37	181.78	380	72.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14040.7	C08		7	0084-0184	131.58	183.79	278	62.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12507.6	C08		7	0085-0185	518.78	185.64	312	65.60	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14820.5	C08		7	0086-0186	549.39	185.57	270	66.08	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12780.4	C08		7	0087-0185	848.61	185.47	297	64.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14630.4	C08		7	0088-0189	673.09	189.38	273	60.53	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15012.6	C08		7	0089-0190	380.05	189.97	274	61.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19907.3	C08		7	0090-0193	99.98	191.93	164	69.26	0.430
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14588.0	C08		7	0091-0192	702.90	192.63	273	60.77	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14928.9	C08		7	0092-0194	628.35	194.17	269	62.18	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16099.4	C08		7	0093-0198	586.04	197.99	258	59.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13986.4	C08		7	0094-0201	417.61	201.11	287	64.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10287.1	C08		7	0095-0201	42.76	201.33	298	66.08	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15817.7	C08		7	0096-0201	872.92	201.31	246	58.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14604.0	C08		7	0097-0202	306.87	201.56	294	63.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19686.7	C08		7	0098-0204	754.31	203.36	420	82.43	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13711.8	C08		7	0099-0203	239.40	202.95	291	63.60	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13311.3	C08		7	0100-0205	436.00	204.90	300	67.01	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15688.3	C08		7	0101-0207	892.77	207.98	246	57.36	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14557.2	C08		7	0102-0213	353.83	213.62	279	61.94	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14131.3	C08		7	0103-0214	850.75	214.10	297	67.01	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14359.0	C08		7	0104-0213	925.26	213.62	261	59.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14203.9	C08		7	0105-0216	140.33	216.11	277	61.60	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12023.3	C08		7	0106-0218	448.62	218.90	296	65.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17366.5	C08		7	0107-0217	547.32	216.90	235	56.53	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13947.3	C08		7	0108-0216	734.27	216.55	278	63.94	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12515.2	C08		7	0109-0222	203.83	221.45	318	67.36	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12421.9	C08		7	0110-0221	314.48	220.98	295	66.67	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11559.7	C08		7	0111-0222	394.80	221.93	308	66.18	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12809.2	C08		7	0112-0220	493.45	219.93	292	65.60	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14938.4	C08		7	0113-0225	124.54	226.17	266	61.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18868.3	C08		7	0114-0229	825.06	229.84	372	72.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13568.0	C08		7	0115-0228	613.49	228.12	286	63.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16537.5	C08		7	0116-0232	560.43	232.21	247	58.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13228.6	C08		7	0117-0229	686.19	229.62	305	68.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14100.5	C08		7	0118-0238	248.32	238.50	299	65.60	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16388.4	C08		7	0119-0243	123.31	242.39	241	58.87	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14167.1	C08		7	0120-0245	676.71	245.31	306	72.77	0.726
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11744.7	C08		7	0121-0250	341.73	250.33	328	67.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10597.2	C08		7	0122-0257	274.37	257.90	311	68.43	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12606.5	C08		7	0123-0259	512.98	259.48	298	67.94	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14597.3	C08		7	0124-0255	86.50	255.95	260	59.11	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12784.6	C08		7	0125-0257	381.59	257.67	288	62.53	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13695.9	C08		7	0126-0261	157.63	261.08	323	67.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12602.4	C08		7	0127-0261	480.12	261.93	293	64.18	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13368.9	C08		7	0128-0261	434.67	261.82	291	64.53	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13316.8	C08		7	0129-0267	177.11	266.96	476	83.84	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11859.5	C08		7	0130-0262	319.73	262.56	312	65.60	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14460.0	C08		7	0131-0262	908.50	262.01	260	61.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14762.8	C08		7	0132-0264	610.11	263.52	277	63.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14620.0	C08		7	0133-0266	633.45	266.54	293	63.94	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13477.0	C08		7	0134-0270	225.67	270.95	303	71.26	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13056.9	C08		7	0135-0275	848.09	274.96	591	103.05	0.699
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16607.8	C08		7	0136-0270	563.50	270.12	245	56.53	0.964
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14606.1	C08		7	0137-0273	923.56	272.85	264	62.28	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11032.0	C08		7	0138-0275	36.30	275.45	296	66.18	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15692.3	C08		7	0139-0276	74.24	275.93	249	65.46	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14629.2	C08		7	0140-0272	710.08	272.03	295	68.18	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18335.2	C08		7	0141-0279	875.73	278.69	210	55.94	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13087.8	C08		7	0142-0280	436.92	279.64	319	66.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13260.4	C08		7	0143-0283	376.15	283.21	297	65.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12666.8	C08		7	0144-0283	791.94	283.20	287	64.77	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13908.7	C08		7	0145-0284	394.43	284.19	285	62.53	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14793.0	C08		7	0146-0287	280.72	287.25	263	60.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16755.2	C08		7	0147-0290	884.23	291.40	239	57.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12875.8	C08		7	0148-0293	518.71	293.39	317	68.08	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12629.8	C08		7	0149-0291	610.49	291.17	303	66.53	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14841.3	C08		7	0150-0292	686.06	292.11	296	68.18	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16692.9	C08		7	0151-0296	263.56	296.73	307	108.71	0.326
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16411.0	C08		7	0152-0297	142.76	296.77	247	58.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15240.3	C08		7	0153-0298	700.97	298.74	265	63.36	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14691.2	C08		7	0154-0299	754.67	298.77	304	65.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16056.6	C08		7	0155-0304	472.50	304.34	414	76.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12478.5	C08		7	0156-0301	564.05	301.27	298	64.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17079.3	C08		7	0157-0305	335.27	304.40	377	72.67	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14234.2	C08		7	0158-0305	293.40	305.22	296	63.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12866.7	C08		7	0159-0303	409.14	303.46	295	64.28	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14607.4	C08		7	0160-0309	742.48	309.82	249	59.84	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12579.4	C08		7	0161-0313	442.94	313.73	318	65.60	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17689.5	C08		7	0162-0318	942.53	318.48	418	76.08	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15748.6	C08		7	0163-0322	870.12	321.84	473	82.43	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12227.7	C08		7	0164-0320	325.90	321.12	282	65.01	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16172.7	C08		7	0165-0318	74.38	317.81	250	58.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14891.8	C08		7	0166-0319	776.38	318.80	223	55.11	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16002.9	C08		7	0167-0321	384.45	321.54	317	67.01	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14299.6	C08		7	0168-0326	801.22	326.23	276	62.53	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17117.2	C08		7	0169-0326	100.75	325.66	233	55.94	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14363.5	C08		7	0170-0328	540.33	328.26	275	61.94	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11531.1	C08		7	0171-0325	618.90	325.47	308	69.11	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16031.1	C08		7	0172-0332	355.64	332.73	326	66.43	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14759.2	C08		7	0173-0333	827.91	332.60	260	61.94	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10780.9	C08		7	0174-0333	59.54	333.52	229	57.94	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12524.5	C08		7	0175-0340	679.98	340.54	324	70.28	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14996.4	C08		7	0176-0341	182.75	341.17	277	67.60	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14974.8	C08		7	0177-0337	234.22	337.39	279	65.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10796.3	C08		7	0178-0341	393.39	341.51	322	67.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15600.9	C08		7	0179-0344	273.12	344.76	273	60.53	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14990.2	C08		7	0180-0347	443.34	347.29	297	69.50	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14304.2	C08		7	0181-0345	903.28	345.78	250	58.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21564.3	C08		7	0182-0349	511.96	349.53	294	97.64	0.388
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12442.8	C08		7	0183-0352	834.55	351.67	322	68.18	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18364.2	C08		7	0184-0351	480.64	350.76	450	82.43	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14361.0	C08		7	0185-0349	596.52	349.28	272	61.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14250.3	C08		7	0186-0351	734.48	350.94	281	62.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11336.0	C08		7	0187-0354	21.01	354.39	300	63.36	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15691.5	C08		7	0188-0357	136.51	357.68	257	62.77	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15108.6	C08		7	0189-0363	277.83	363.11	282	65.36	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12956.9	C08		7	0190-0369	804.38	370.02	353	76.91	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14009.7	C08		7	0191-0370	623.76	369.67	290	63.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11923.0	C08		7	0192-0371	729.37	370.37	299	70.43	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13115.1	C08		7	0193-0371	883.25	370.76	286	62.18	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17619.4	C08		7	0194-0370	421.52	370.61	212	52.87	0.953
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16733.0	C08		7	0195-0373	440.77	372.81	369	71.94	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14061.2	C08		7	0196-0375	244.52	375.02	278	61.36	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13926.9	C08		7	0197-0386	779.94	386.38	519	100.33	0.648
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13579.0	C08		7	0198-0377	71.45	377.30	298	66.53	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12398.0	C08		7	0199-0381	358.69	381.63	304	67.26	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14855.7	C08		7	0200-0384	480.38	383.90	280	62.53	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13142.3	C08		7	0201-0383	594.58	383.38	302	67.36	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16663.9	C08		7	0202-0387	497.35	387.35	255	59.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14765.9	C08		7	0203-0388	159.68	388.14	279	64.18	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12334.4	C08		7	0204-0387	211.60	387.59	296	66.43	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16464.6	C08		7	0205-0389	307.95	388.57	241	57.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14892.0	C08		7	0206-0391	538.00	391.84	277	63.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22487.9	C08		7	0207-0391	340.85	392.48	347	75.50	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13183.4	C08		7	0208-0391	895.57	390.50	309	67.60	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11571.9	C08		7	0209-0392	273.69	392.24	311	66.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13801.3	C08		7	0210-0392	731.74	391.93	291	66.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13271.4	C08		7	0211-0394	685.93	394.07	333	70.43	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14857.0	C08		7	0212-0397	667.40	397.52	258	63.94	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14032.2	C08		7	0213-0399	588.90	399.42	299	66.77	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12672.5	C08		7	0214-0400	944.59	400.47	310	69.01	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14262.1	C08		7	0215-0405	62.74	405.46	318	72.28	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14552.6	C08		7	0216-0403	315.97	403.96	284	64.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15232.6	C08		7	0217-0403	136.00	402.95	262	59.36	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14673.3	C08		7	0218-0405	648.86	405.48	283	64.18	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14146.4	C08		7	0219-0408	242.85	408.79	298	64.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14626.2	C08		7	0220-0407	454.24	407.57	291	63.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12670.7	C08		7	0221-0408	727.38	408.60	319	67.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12630.8	C08		7	0222-0413	806.08	413.94	299	65.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14628.2	C08		7	0223-0413	848.18	413.71	226	57.70	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15770.6	C08		7	0224-0424	158.66	424.24	430	77.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17151.3	C08		7	0225-0426	575.46	425.45	392	95.88	0.536
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14504.8	C08		7	0226-0424	443.56	423.89	283	62.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17315.0	C08		7	0227-0428	70.13	428.66	468	82.77	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16477.8	C08		7	0228-0429	302.95	428.77	307	67.84	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20397.6	C08		7	0229-0433	604.50	433.16	423	82.33	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14005.2	C08		7	0230-0432	651.00	431.62	293	64.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11238.1	C08		7	0231-0429	917.79	429.61	133	42.87	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12827.0	C08		7	0232-0435	902.21	434.55	192	52.18	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13611.7	C08		7	0233-0439	201.66	439.00	288	64.18	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12575.3	C08		7	0234-0441	136.25	440.56	313	66.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13654.8	C08		7	0235-0451	551.08	451.54	738	125.30	0.591
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12014.6	C08		7	0236-0447	733.50	447.24	319	66.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19016.8	C08		7	0237-0448	237.40	448.75	413	75.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12676.9	C08		7	0238-0451	171.67	451.56	290	65.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15671.4	C08		7	0239-0452	50.62	451.91	266	63.94	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15676.9	C08		7	0240-0449	372.36	448.99	256	62.53	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15840.3	C08		7	0241-0451	479.06	451.16	238	58.18	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17088.5	C08		7	0242-0467	133.33	469.17	904	137.10	0.604
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17202.6	C08		7	0243-0458	493.89	458.38	335	69.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14093.8	C08		7	0244-0458	332.53	458.42	279	63.01	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15427.5	C08		7	0245-0460	632.80	460.02	261	66.43	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14757.7	C08		7	0246-0456	274.08	455.57	268	61.70	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19413.7	C08		7	0247-0458	414.12	457.91	197	52.28	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15099.8	C08		7	0248-0463	79.81	463.03	259	62.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14954.1	C08		7	0249-0468	822.05	468.25	531	87.15	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18847.6	C08		7	0250-0465	393.47	464.98	215	54.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	1147.2	C08		7	0251-0465	800.97	465.27	182	52.04	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17009.8	C08		7	0252-0466	695.06	466.10	242	59.36	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12811.7	C08		7	0253-0468	778.09	468.76	311	67.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12822.5	C08		7	0254-0471	731.50	470.88	306	65.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15787.4	C08		7	0255-0481	682.59	481.48	527	94.08	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13742.2	C08		7	0256-0475	432.38	475.66	298	63.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13113.2	C08		7	0257-0476	888.40	476.51	278	63.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14330.9	C08		7	0258-0476	863.53	476.24	285	64.77	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12855.7	C08		7	0259-0479	615.49	479.10	308	65.84	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12695.4	C08		7	0260-0480	758.16	480.43	318	69.60	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17003.0	C08		7	0261-0489	489.59	489.12	471	81.26	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14334.6	C08		7	0262-0486	905.96	486.58	296	64.18	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13774.4	C08		7	0263-0490	579.07	489.41	186	57.60	0.705
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15191.1	C08		7	0264-0493	259.07	493.34	275	60.77	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13405.1	C08		7	0265-0497	773.89	497.11	282	64.77	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15549.6	C08		7	0266-0497	234.03	496.95	259	58.53	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15282.5	C08		7	0267-0502	658.63	502.20	266	60.18	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9935.6	C08		7	0268-0503	846.58	503.79	333	68.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13304.2	C08		7	0269-0506	122.20	506.82	276	62.53	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11387.6	C08		7	0270-0508	532.58	508.24	317	65.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18364.8	C08		7	0271-0513	340.54	511.95	653	107.40	0.711
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12149.3	C08		7	0272-0511	201.18	511.35	298	66.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14758.7	C08		7	0273-0509	374.99	510.00	260	58.77	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13996.0	C08		7	0274-0514	779.70	514.47	297	65.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13518.5	C08		7	0275-0514	163.92	514.24	276	63.60	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13532.3	C08		7	0276-0515	474.02	515.23	306	64.43	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13940.9	C08		7	0277-0520	285.23	519.48	281	66.43	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14090.2	C08		7	0278-0523	554.66	522.46	299	65.60	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11281.9	C08		7	0279-0527	595.61	527.94	333	69.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14012.1	C08		7	0280-0530	462.19	530.53	273	65.26	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12157.2	C08		7	0281-0531	50.04	531.24	281	65.01	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12639.6	C08		7	0282-0532	83.20	532.26	287	62.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17318.5	C08		7	0283-0538	235.20	538.13	469	80.08	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13921.4	C08		7	0284-0537	720.99	537.06	278	66.43	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14002.9	C08		7	0285-0537	643.63	536.71	328	67.84	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15660.4	C08		7	0286-0536	769.83	536.82	260	64.67	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12773.2	C08		7	0287-0539	187.08	539.05	290	69.50	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14906.5	C08		7	0288-0536	390.77	535.62	261	61.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11608.4	C08		7	0289-0539	914.20	540.18	320	67.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19062.1	C08		7	0290-0544	701.47	543.96	434	77.74	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12177.1	C08		7	0291-0544	12.36	544.12	314	67.84	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16539.4	C08		7	0292-0543	264.67	542.86	258	59.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16261.5	C08		7	0293-0551	298.73	551.61	248	58.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14454.4	C08		7	0294-0551	213.99	551.36	300	65.70	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12947.7	C08		7	0295-0553	929.54	553.86	299	66.18	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11190.9	C08		7	0296-0558	801.50	557.38	377	72.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14046.4	C08		7	0297-0559	382.14	558.96	278	63.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13410.0	C08		7	0298-0561	350.08	560.94	292	64.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15645.9	C08		7	0299-0562	322.63	561.88	258	59.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15196.3	C08		7	0300-0563	518.11	563.04	271	61.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16265.9	C08		7	0301-0564	133.95	564.75	242	57.11	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11993.2	C08		7	0302-0569	241.13	569.70	307	67.01	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14975.8	C08		7	0303-0571	696.96	572.13	336	72.43	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12563.4	C08		7	0304-0571	588.57	571.12	288	63.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19309.5	C08		7	0305-0579	282.97	579.38	397	73.60	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18452.4	C08		7	0306-0585	763.47	587.36	746	117.64	0.677
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12549.1	C08		7	0307-0579	94.84	579.64	289	64.43	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15168.5	C08		7	0308-0576	649.55	576.07	254	59.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12383.1	C08		7	0309-0583	415.09	583.38	302	67.94	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14298.2	C08		7	0310-0583	893.16	583.45	375	71.60	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15394.1	C08		7	0311-0584	615.58	583.79	264	60.77	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12728.4	C08		7	0312-0588	460.21	588.56	306	64.53	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15433.3	C08		7	0313-0591	583.80	591.02	473	82.18	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13579.1	C08		7	0314-0595	538.06	595.67	433	77.01	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13924.4	C08		7	0315-0592	700.27	592.00	281	62.87	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12820.6	C08		7	0316-0599	945.31	598.79	258	64.43	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14850.5	C08		7	0317-0599	353.56	599.04	283	64.04	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19494.3	C08		7	0318-0605	336.14	604.94	412	78.18	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14924.1	C08		7	0319-0602	56.90	602.87	252	59.70	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14394.7	C08		7	0320-0606	399.11	607.57	277	63.11	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13246.1	C08		7	0321-0609	855.32	609.79	272	62.53	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14895.3	C08		7	0322-0613	636.26	612.94	273	64.77	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11472.8	C08		7	0323-0613	936.53	613.28	315	67.84	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15695.9	C08		7	0324-0612	678.10	613.04	256	60.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16652.4	C08		7	0325-0621	104.10	620.20	457	78.43	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16018.7	C08		7	0326-0623	291.51	624.26	627	100.91	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18085.6	C08		7	0327-0629	395.95	629.48	448	79.60	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12914.6	C08		7	0328-0628	572.60	628.89	290	62.77	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13154.6	C08		7	0329-0632	748.01	632.18	289	64.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15983.9	C08		7	0330-0636	776.79	636.68	256	60.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13252.1	C08		7	0331-0640	373.08	640.16	281	62.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13679.3	C08		7	0332-0647	710.25	648.24	283	65.60	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15326.5	C08		7	0333-0651	822.58	651.72	261	61.94	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12171.7	C08		7	0334-0652	204.53	653.05	300	64.18	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13261.4	C08		7	0335-0655	48.52	654.60	298	66.77	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12641.9	C08		7	0336-0658	138.48	657.73	287	62.77	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12076.7	C08		7	0337-0660	500.08	659.81	310	69.36	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13983.9	C08		7	0338-0659	631.58	659.79	261	60.87	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11468.8	C08		7	0339-0663	91.38	663.46	295	63.36	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14192.1	C08		7	0340-0661	302.24	661.91	258	61.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10609.7	C08		7	0341-0665	867.73	665.18	310	67.60	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13711.9	C08		7	0342-0670	424.56	670.17	396	75.84	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15602.9	C08		7	0343-0666	665.60	666.59	260	59.11	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14939.1	C08		7	0344-0668	699.28	668.58	267	61.94	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14628.6	C08		7	0345-0667	566.92	667.45	265	64.53	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16158.7	C08		7	0346-0674	186.53	673.98	438	80.18	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17931.6	C08		7	0347-0677	313.68	677.71	433	78.43	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16717.8	C08		7	0348-0676	807.34	676.26	246	58.18	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14767.7	C08		7	0349-0677	628.99	676.79	257	63.21	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13016.5	C08		7	0350-0679	645.06	678.65	325	71.94	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14205.7	C08		7	0351-0682	946.39	682.20	232	58.53	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16037.6	C08		7	0352-0684	666.11	684.21	246	57.70	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19872.6	C08		7	0353-0687	759.57	688.18	370	71.84	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20290.2	C08		7	0354-0687	736.92	686.21	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11080.6	C08		7	0355-0688	24.13	688.30	298	65.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18622.6	C08		7	0356-0691	252.88	690.83	430	77.26	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14416.6	C08		7	0357-0688	713.65	688.11	263	63.36	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12184.3	C08		7	0358-0693	469.47	692.93	302	67.70	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13457.1	C08		7	0359-0691	123.37	691.78	285	63.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12935.3	C08		7	0360-0698	43.62	698.59	290	65.60	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14887.6	C08		7	0361-0698	939.07	698.25	235	59.36	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11574.8	C08		7	0362-0700	533.23	700.56	301	65.60	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19102.5	C08		7	0363-0702	438.97	702.40	410	75.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12717.5	C08		7	0364-0702	374.62	702.30	278	61.36	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15932.4	C08		7	0365-0705	762.74	705.83	240	58.87	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184735	1375324	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20274.1	C08		7	0366-0710	613.25	710.49	186	53.36	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14687.2	C08		8	0001-0030	465.68	30.42	295	61.94	0.966
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15090.7	C08		8	0002-0031	547.19	30.38	278	62.18	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16011.1	C08		8	0003-0033	709.44	32.90	255	63.84	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13810.3	C08		8	0004-0033	33.60	33.54	273	64.77	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16453.1	C08		8	0005-0032	180.29	32.17	229	56.53	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21296.3	C08		8	0006-0032	778.32	31.86	180	51.11	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12765.8	C08		8	0007-0033	54.01	33.46	295	67.70	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13840.3	C08		8	0008-0033	231.55	33.54	264	59.11	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16090.9	C08		8	0009-0037	693.47	37.68	251	59.94	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14415.1	C08		8	0010-0039	522.67	38.53	294	65.94	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22022.0	C08		8	0011-0040	792.13	40.86	333	76.91	0.707
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13318.1	C08		8	0012-0042	311.06	41.33	294	65.26	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18985.4	C08		8	0013-0048	380.46	46.13	438	89.84	0.682
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20242.6	C08		8	0014-0045	501.66	45.04	449	78.67	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21835.3	C08		8	0015-0044	660.94	45.37	156	80.91	0.299
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14416.1	C08		8	0016-0054	712.35	54.21	264	66.18	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15013.8	C08		8	0017-0053	742.37	52.85	277	63.84	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12612.2	C08		8	0018-0056	837.09	55.92	164	55.11	0.679
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14377.3	C08		8	0019-0057	860.26	57.03	272	62.18	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21615.0	C08		8	0020-0059	448.63	59.29	134	60.18	0.465
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14921.6	C08		8	0021-0068	67.82	67.59	498	87.50	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14335.3	C08		8	0022-0064	909.20	64.16	300	67.36	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18462.3	C08		8	0023-0062	790.69	61.81	207	52.28	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17673.2	C08		8	0024-0063	121.72	63.89	242	57.36	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9967.5	C08		8	0025-0067	286.68	66.55	297	76.57	0.637
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12358.6	C08		8	0026-0067	591.04	66.94	314	70.77	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12921.2	C08		8	0027-0063	50.38	63.06	108	40.63	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17986.2	C08		8	0028-0074	188.81	72.64	695	116.23	0.647
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15806.7	C08		8	0029-0069	345.83	69.59	243	57.11	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15385.6	C08		8	0030-0071	848.67	70.96	252	61.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23885.1	C08		8	0031-0073	106.00	73.30	218	58.77	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15639.4	C08		8	0032-0080	165.89	77.84	532	95.36	0.735
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13578.3	C08		8	0033-0075	629.52	75.54	309	69.26	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13359.4	C08		8	0034-0073	932.67	73.63	278	64.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15272.1	C08		8	0035-0074	236.53	74.59	247	59.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13663.8	C08		8	0036-0081	544.67	81.33	299	68.43	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12550.1	C08		8	0037-0087	824.73	86.97	303	67.84	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12484.6	C08		8	0038-0086	481.64	86.30	296	64.67	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13718.5	C08		8	0039-0086	319.20	85.87	282	62.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15752.6	C08		8	0040-0089	665.56	89.80	432	80.67	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	25472.5	C08		8	0041-0100	83.83	100.10	294	64.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13861.4	C08		8	0042-0100	227.32	99.74	258	63.36	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16386.2	C08		8	0043-0099	773.95	99.27	234	56.87	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14108.6	C08		8	0044-0100	367.51	100.60	291	65.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15461.9	C08		8	0045-0100	757.50	100.78	259	58.87	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14493.2	C08		8	0046-0108	581.33	108.58	288	65.01	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12139.2	C08		8	0047-0110	902.90	110.16	303	64.18	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14075.8	C08		8	0048-0110	821.66	109.99	266	61.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17163.9	C08		8	0049-0111	720.99	110.99	228	55.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12485.1	C08		8	0050-0117	19.36	117.48	250	58.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18791.5	C08		8	0051-0122	401.85	120.99	617	103.15	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15821.9	C08		8	0052-0117	602.92	117.43	243	58.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14713.2	C08		8	0053-0117	536.09	116.93	268	61.94	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16230.9	C08		8	0054-0123	645.10	123.14	239	57.36	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15385.9	C08		8	0055-0126	433.22	126.58	256	59.36	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11852.2	C08		8	0056-0125	475.67	125.87	307	65.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23282.7	C08		8	0057-0131	104.76	131.71	320	68.43	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17404.0	C08		8	0058-0129	288.05	129.53	218	55.11	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17779.4	C08		8	0059-0135	847.79	134.33	444	84.91	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17880.8	C08		8	0060-0132	811.21	132.13	224	56.63	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14292.0	C08		8	0061-0135	207.21	134.94	252	61.36	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14276.6	C08		8	0062-0138	798.43	138.91	261	64.28	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13147.1	C08		8	0063-0140	527.91	140.89	280	63.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12634.5	C08		8	0064-0142	711.25	142.30	314	70.43	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16827.6	C08		8	0065-0142	375.28	142.34	231	56.28	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14133.3	C08		8	0066-0143	476.59	142.54	270	62.53	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13146.9	C08		8	0067-0148	775.29	148.00	280	62.18	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12537.2	C08		8	0068-0152	124.19	152.91	275	63.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16096.9	C08		8	0069-0148	299.03	147.82	247	59.70	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19206.9	C08		8	0070-0152	814.13	152.03	197	51.70	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14905.8	C08		8	0071-0155	675.60	155.47	270	63.60	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14854.8	C08		8	0072-0155	741.61	154.87	253	59.94	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14745.4	C08		8	0073-0159	614.15	159.31	289	65.70	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21331.4	C08		8	0074-0158	355.70	157.95	353	69.01	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13268.2	C08		8	0075-0158	72.97	157.87	271	61.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12544.2	C08		8	0076-0166	468.52	166.65	303	69.60	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17028.8	C08		8	0077-0171	52.32	171.42	447	79.50	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13414.5	C08		8	0078-0173	161.92	173.06	261	61.36	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15139.3	C08		8	0079-0173	222.76	173.00	257	59.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12379.9	C08		8	0080-0169	397.95	169.91	274	67.94	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17318.0	C08		8	0081-0172	449.89	172.11	212	55.70	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14817.8	C08		8	0082-0176	674.84	176.11	285	66.18	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18587.7	C08		8	0083-0184	538.83	184.41	214	56.53	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13351.5	C08		8	0084-0186	105.76	186.28	271	60.18	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15342.7	C08		8	0085-0190	896.93	190.67	512	89.74	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16267.4	C08		8	0086-0197	328.77	196.94	376	71.60	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16138.0	C08		8	0087-0194	398.31	194.01	237	58.18	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15098.4	C08		8	0088-0198	481.48	198.28	282	64.53	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12852.8	C08		8	0089-0200	669.44	199.84	309	70.18	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12266.4	C08		8	0090-0199	286.00	199.11	279	63.36	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17943.1	C08		8	0091-0199	513.10	198.22	311	69.11	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12570.9	C08		8	0092-0203	773.71	202.19	159	50.18	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11020.6	C08		8	0093-0208	848.75	208.73	304	70.91	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18212.3	C08		8	0094-0208	385.94	208.71	392	80.33	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12544.8	C08		8	0095-0210	762.42	209.98	316	75.74	0.692
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12230.2	C08		8	0096-0210	784.83	210.44	120	41.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14782.8	C08		8	0097-0214	718.57	214.37	222	59.36	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14397.3	C08		8	0098-0215	30.22	215.69	254	59.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15112.0	C08		8	0099-0214	509.59	215.05	284	65.36	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18653.6	C08		8	0100-0221	901.61	221.67	392	74.67	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15051.7	C08		8	0101-0219	401.57	219.53	273	63.01	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17177.2	C08		8	0102-0227	600.21	227.79	229	56.53	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14564.3	C08		8	0103-0228	180.24	228.63	265	62.77	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12656.9	C08		8	0104-0232	123.88	234.13	341	79.26	0.682
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16639.0	C08		8	0105-0230	684.46	229.47	250	59.70	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15050.5	C08		8	0106-0230	821.39	229.68	262	60.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17554.2	C08		8	0107-0228	846.38	228.77	224	55.36	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21303.4	C08		8	0108-0235	216.03	234.74	373	71.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15941.6	C08		8	0109-0233	263.29	233.49	159	47.46	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14615.2	C08		8	0110-0241	702.98	240.60	210	55.94	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17534.0	C08		8	0111-0244	483.81	244.58	343	71.01	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17729.6	C08		8	0112-0247	651.99	247.34	454	81.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14377.9	C08		8	0113-0246	183.27	246.76	242	59.46	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13730.8	C08		8	0114-0247	567.50	246.42	307	65.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14318.0	C08		8	0115-0248	622.51	248.87	293	63.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13651.8	C08		8	0116-0251	64.62	250.71	270	66.67	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13697.4	C08		8	0117-0252	339.09	252.28	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21076.7	C08		8	0118-0252	746.86	252.39	370	71.26	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12083.0	C08		8	0119-0253	909.42	252.76	302	68.18	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12438.1	C08		8	0120-0256	927.02	256.12	338	72.18	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18491.1	C08		8	0121-0257	507.86	257.96	460	79.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16203.5	C08		8	0122-0257	775.18	257.04	242	57.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13625.3	C08		8	0123-0263	113.49	262.03	264	61.26	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14314.3	C08		8	0124-0265	13.44	264.14	247	61.60	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18059.0	C08		8	0125-0266	570.91	266.69	224	54.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15580.0	C08		8	0126-0270	431.50	270.56	276	63.36	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16101.7	C08		8	0127-0271	642.41	271.75	266	63.11	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14506.4	C08		8	0128-0275	28.09	274.67	247	61.36	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10697.9	C08		8	0129-0273	96.59	273.71	293	71.15	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14604.0	C08		8	0130-0278	177.48	278.78	258	61.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14187.2	C08		8	0131-0275	348.47	275.37	282	62.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13971.7	C08		8	0132-0282	790.68	282.00	280	63.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17906.6	C08		8	0133-0280	616.38	280.19	218	54.53	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16003.4	C08		8	0134-0286	411.59	286.65	516	86.43	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16502.1	C08		8	0135-0289	593.91	290.18	522	96.33	0.707
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15807.4	C08		8	0136-0291	657.83	291.43	401	77.60	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15031.0	C08		8	0137-0292	198.52	292.19	254	62.77	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15013.6	C08		8	0138-0291	503.11	291.22	264	61.36	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15231.0	C08		8	0139-0293	169.12	293.03	223	57.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12905.8	C08		8	0140-0296	858.63	296.66	278	65.70	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13582.1	C08		8	0141-0296	473.07	295.39	310	66.43	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17441.8	C08		8	0142-0296	631.22	296.87	243	59.94	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14520.1	C08		8	0143-0300	872.90	300.22	285	64.87	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11889.0	C08		8	0144-0300	97.94	300.00	282	66.18	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16152.3	C08		8	0145-0308	702.25	308.18	503	88.43	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15891.8	C08		8	0146-0309	152.79	309.85	475	88.57	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14513.8	C08		8	0147-0310	280.31	309.79	416	77.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16152.6	C08		8	0148-0310	386.42	309.73	244	58.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15022.8	C08		8	0149-0309	745.08	308.93	281	62.18	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11856.8	C08		8	0150-0315	216.42	314.77	287	65.60	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17384.7	C08		8	0151-0320	47.35	320.46	420	75.26	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16852.4	C08		8	0152-0320	593.64	319.21	252	59.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12084.7	C08		8	0153-0325	528.95	325.66	304	66.77	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13066.8	C08		8	0154-0325	422.95	324.32	285	64.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11450.0	C08		8	0155-0325	910.94	325.64	306	67.84	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12968.8	C08		8	0156-0327	98.64	326.80	373	76.08	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16030.7	C08		8	0157-0326	326.66	326.76	238	58.18	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11385.9	C08		8	0158-0337	772.26	337.59	305	66.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15042.9	C08		8	0159-0341	818.10	341.48	280	65.01	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15932.3	C08		8	0160-0339	871.33	338.94	242	59.11	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12945.4	C08		8	0161-0345	115.39	344.75	275	62.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21710.3	C08		8	0162-0348	525.87	348.58	366	73.84	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15704.2	C08		8	0163-0345	711.92	344.44	249	59.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14313.9	C08		8	0164-0352	559.11	352.20	276	61.94	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14899.3	C08		8	0165-0351	597.71	351.17	268	60.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14356.9	C08		8	0166-0352	682.45	351.91	255	62.77	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14172.2	C08		8	0167-0352	731.46	352.60	283	62.18	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16133.7	C08		8	0168-0359	263.84	359.46	487	88.91	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14129.0	C08		8	0169-0354	210.23	354.93	263	59.60	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15982.4	C08		8	0170-0356	631.68	356.32	268	61.11	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14990.6	C08		8	0171-0356	355.10	356.18	258	59.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10649.9	C08		8	0172-0357	416.89	357.57	307	70.43	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13940.2	C08		8	0173-0357	925.03	357.68	273	61.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12234.6	C08		8	0174-0361	468.53	360.83	292	64.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12577.8	C08		8	0175-0362	649.11	362.38	323	69.60	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17174.7	C08		8	0176-0365	171.66	365.70	227	55.70	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13139.4	C08		8	0177-0365	288.04	365.90	287	67.60	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15269.4	C08		8	0178-0366	59.86	366.56	248	58.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20726.8	C08		8	0179-0380	760.61	380.58	357	70.18	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16235.1	C08		8	0180-0380	811.00	379.21	217	55.01	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13508.7	C08		8	0181-0383	196.62	383.55	280	62.18	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14310.4	C08		8	0182-0384	217.55	384.18	269	61.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20662.6	C08		8	0183-0383	334.32	383.75	119	50.04	0.597
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13814.6	C08		8	0184-0389	824.12	389.42	309	65.11	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14267.5	C08		8	0185-0388	948.43	389.19	264	59.70	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	25290.9	C08		8	0186-0396	578.23	395.14	311	67.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11760.2	C08		8	0187-0396	492.26	397.89	297	69.84	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13917.0	C08		8	0188-0398	874.23	398.40	276	62.77	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22891.2	C08		8	0189-0402	378.12	401.83	338	72.67	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13326.5	C08		8	0190-0397	921.02	397.62	284	63.01	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12831.5	C08		8	0191-0401	295.72	402.10	276	61.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12689.6	C08		8	0192-0402	49.43	402.45	275	65.60	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16639.1	C08		8	0193-0404	558.15	404.14	249	59.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21454.4	C08		8	0194-0404	725.10	404.57	103	63.50	0.321
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15818.5	C08		8	0195-0418	319.07	417.56	255	60.28	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19946.9	C08		8	0196-0418	390.15	417.76	412	76.08	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13092.7	C08		8	0197-0420	245.09	420.66	268	64.43	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21151.5	C08		8	0198-0420	684.61	420.01	187	50.53	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16227.9	C08		8	0199-0423	613.93	423.00	244	58.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14776.6	C08		8	0200-0424	562.83	424.34	275	60.77	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13083.1	C08		8	0201-0426	180.00	427.29	275	63.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15854.0	C08		8	0202-0426	827.92	426.59	247	57.70	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15910.6	C08		8	0203-0432	147.17	431.93	238	57.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13571.1	C08		8	0204-0434	261.57	433.98	293	67.94	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13894.1	C08		8	0205-0437	846.62	437.04	304	67.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13996.1	C08		8	0206-0442	340.32	442.00	273	63.36	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17898.0	C08		8	0207-0440	699.29	439.71	234	55.94	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18084.0	C08		8	0208-0442	417.13	442.32	230	56.28	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18500.6	C08		8	0209-0444	718.59	444.25	348	69.60	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14151.7	C08		8	0210-0444	545.86	444.24	272	61.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16043.5	C08		8	0211-0445	458.64	445.50	258	59.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14621.0	C08		8	0212-0448	868.82	448.96	248	59.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17569.2	C08		8	0213-0449	925.97	448.03	219	57.11	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11251.1	C08		8	0214-0453	372.89	453.38	318	70.67	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14162.1	C08		8	0215-0453	608.77	452.64	278	62.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15998.7	C08		8	0216-0458	565.00	458.24	488	82.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15484.7	C08		8	0217-0461	64.26	460.83	476	83.74	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13953.1	C08		8	0218-0461	387.49	461.48	279	63.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15672.9	C08		8	0219-0460	837.21	459.77	248	58.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15882.3	C08		8	0220-0461	921.28	462.13	248	62.77	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17770.9	C08		8	0221-0462	256.23	461.92	220	54.53	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19198.1	C08		8	0222-0461	282.52	461.62	206	54.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16594.2	C08		8	0223-0463	668.71	463.60	263	64.18	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12472.1	C08		8	0224-0467	319.69	467.01	282	63.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17014.6	C08		8	0225-0464	804.55	463.14	229	56.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14425.6	C08		8	0226-0471	787.93	471.14	285	63.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13036.2	C08		8	0227-0477	149.23	477.60	560	102.57	0.669
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18835.8	C08		8	0228-0474	640.90	473.26	224	54.53	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13624.9	C08		8	0229-0477	425.01	478.02	269	62.18	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14406.0	C08		8	0230-0478	292.01	479.06	271	64.53	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17301.5	C08		8	0231-0481	678.51	481.71	247	59.11	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	25023.6	C08		8	0232-0479	711.23	479.80	241	57.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14419.1	C08		8	0233-0479	902.02	479.72	270	60.53	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16457.8	C08		8	0234-0481	941.03	481.25	232	57.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	26469.9	C08		8	0235-0484	211.36	483.62	105	43.11	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	24661.0	C08		8	0236-0487	201.58	488.12	131	48.53	0.699
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17157.6	C08		8	0237-0487	269.16	487.87	231	58.53	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14569.8	C08		8	0238-0489	620.16	488.89	288	65.11	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17707.7	C08		8	0239-0492	554.03	492.40	349	70.67	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16449.6	C08		8	0240-0491	365.53	491.03	225	56.18	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15373.7	C08		8	0241-0500	171.28	499.87	344	68.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17099.9	C08		8	0242-0498	716.02	498.20	226	60.43	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14962.8	C08		8	0243-0497	109.61	497.63	238	59.60	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14692.8	C08		8	0244-0500	238.91	501.10	239	58.87	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15484.3	C08		8	0245-0502	380.62	502.20	268	63.01	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16047.7	C08		8	0246-0507	930.95	506.66	409	77.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17545.1	C08		8	0247-0504	625.16	504.98	238	60.28	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16805.9	C08		8	0248-0503	273.40	503.05	238	58.28	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15287.4	C08		8	0249-0514	89.34	515.12	507	91.15	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15884.4	C08		8	0250-0509	438.00	509.74	255	58.53	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17813.5	C08		8	0251-0510	696.79	510.30	311	66.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15484.1	C08		8	0252-0512	878.28	512.44	244	59.46	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20632.9	C08		8	0253-0514	310.30	513.18	186	51.70	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16636.2	C08		8	0254-0515	201.80	515.64	228	56.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13639.7	C08		8	0255-0517	759.40	516.79	294	64.67	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16176.5	C08		8	0256-0519	811.58	519.44	486	87.98	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14353.7	C08		8	0257-0516	596.04	516.40	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13457.9	C08		8	0258-0520	237.04	519.50	330	71.11	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15872.5	C08		8	0259-0522	253.68	522.36	228	59.11	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14049.9	C08		8	0260-0523	488.73	522.70	295	62.77	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17807.7	C08		8	0261-0524	661.48	523.87	227	55.70	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17758.0	C08		8	0262-0527	742.40	526.95	260	60.43	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14044.2	C08		8	0263-0530	876.58	529.37	283	62.77	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14424.6	C08		8	0264-0532	356.26	532.79	284	62.53	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15568.8	C08		8	0265-0533	279.96	532.58	250	58.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16260.0	C08		8	0266-0533	631.26	533.79	257	59.60	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14160.3	C08		8	0267-0540	312.82	539.80	275	63.11	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14773.0	C08		8	0268-0544	136.31	544.19	542	91.15	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11409.4	C08		8	0269-0542	19.31	542.57	283	65.01	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18471.9	C08		8	0270-0541	710.78	541.56	213	55.11	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14255.2	C08		8	0271-0547	528.35	547.46	266	63.60	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18768.8	C08		8	0272-0547	659.37	547.28	221	55.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13899.2	C08		8	0273-0548	340.98	548.12	299	66.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15336.2	C08		8	0274-0551	158.34	550.80	237	57.70	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21466.1	C08		8	0275-0558	593.14	559.17	376	84.43	0.663
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15872.8	C08		8	0276-0557	882.02	557.74	446	77.60	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12848.7	C08		8	0277-0555	34.35	555.92	277	66.43	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13272.1	C08		8	0278-0558	212.69	558.00	294	64.53	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17197.6	C08		8	0279-0556	618.51	556.04	242	56.53	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16556.7	C08		8	0280-0557	686.65	556.60	238	59.60	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13521.1	C08		8	0281-0560	179.36	560.21	253	62.77	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16688.2	C08		8	0282-0558	246.73	557.92	240	58.77	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15097.7	C08		8	0283-0562	830.98	562.33	447	79.26	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12422.3	C08		8	0284-0566	803.90	565.85	314	66.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13772.5	C08		8	0285-0569	497.77	569.36	276	64.53	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13722.4	C08		8	0286-0567	759.84	567.25	272	63.01	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14251.7	C08		8	0287-0569	119.71	570.06	268	63.94	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14317.3	C08		8	0288-0571	461.61	571.35	266	61.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16411.2	C08		8	0289-0580	59.92	580.69	231	56.87	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16279.4	C08		8	0290-0579	303.55	579.25	251	58.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16504.0	C08		8	0291-0579	624.67	579.37	252	58.53	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14785.2	C08		8	0292-0583	361.19	583.79	256	61.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16611.3	C08		8	0293-0587	654.64	588.15	349	74.33	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13263.8	C08		8	0294-0589	456.73	589.69	307	70.18	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13413.9	C08		8	0295-0586	529.34	586.84	286	61.94	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17690.8	C08		8	0296-0586	117.58	586.24	206	54.97	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16241.9	C08		8	0297-0596	295.90	596.50	237	62.77	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18633.0	C08		8	0298-0593	868.74	593.33	202	51.70	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12960.1	C08		8	0299-0601	50.38	600.85	254	64.43	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19002.2	C08		8	0300-0599	701.52	599.57	413	75.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12207.8	C08		8	0301-0598	843.25	598.26	291	64.67	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16822.3	C08		8	0302-0600	63.45	600.21	210	57.46	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12833.2	C08		8	0303-0602	559.38	602.13	283	63.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10060.6	C08		8	0304-0602	185.08	602.33	240	61.01	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13225.1	C08		8	0305-0601	405.74	600.46	280	65.70	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13019.5	C08		8	0306-0605	120.49	605.06	281	62.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16289.4	C08		8	0307-0607	825.57	607.00	248	58.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16061.8	C08		8	0308-0611	359.21	612.16	250	61.94	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12567.5	C08		8	0309-0610	721.85	609.54	302	65.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13243.7	C08		8	0310-0613	943.88	612.85	291	65.60	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11691.0	C08		8	0311-0615	41.12	614.97	308	69.50	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16213.6	C08		8	0312-0615	239.39	614.86	257	61.70	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13770.3	C08		8	0313-0616	916.21	616.39	283	64.08	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10923.2	C08		8	0314-0618	207.71	618.12	223	60.77	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11846.7	C08		8	0315-0617	761.84	618.20	286	63.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16693.0	C08		8	0316-0618	306.06	618.28	239	56.53	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12972.8	C08		8	0317-0620	588.43	620.73	279	62.43	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15575.5	C08		8	0318-0622	404.32	622.59	304	64.18	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13149.6	C08		8	0319-0629	517.58	629.12	284	63.84	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14982.8	C08		8	0320-0632	459.52	631.89	370	71.84	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15968.3	C08		8	0321-0636	76.39	636.01	364	70.18	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16751.0	C08		8	0322-0637	110.24	637.03	317	65.36	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21092.6	C08		8	0323-0640	879.84	640.53	526	93.74	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14148.6	C08		8	0324-0639	391.61	638.97	319	68.18	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13874.2	C08		8	0325-0643	248.85	643.59	323	70.43	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12393.5	C08		8	0326-0645	505.10	645.84	306	66.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14755.4	C08		8	0327-0645	768.94	645.84	266	62.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16503.3	C08		8	0328-0651	671.28	651.61	246	60.18	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15775.1	C08		8	0329-0653	706.64	652.08	543	92.91	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15611.3	C08		8	0330-0654	300.37	654.17	247	58.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10490.7	C08		8	0331-0656	925.47	655.80	301	68.08	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13613.6	C08		8	0332-0656	362.05	656.09	299	64.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10725.0	C08		8	0333-0658	141.52	658.42	252	70.67	0.634
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12685.5	C08		8	0334-0658	97.64	658.60	267	61.94	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11652.0	C08		8	0335-0662	326.33	662.00	309	69.01	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11085.8	C08		8	0336-0664	412.07	664.33	320	67.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14560.8	C08		8	0337-0663	542.20	662.74	269	62.53	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14968.3	C08		8	0338-0671	679.72	670.55	583	99.98	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13674.6	C08		8	0339-0670	559.96	669.94	306	65.94	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16005.0	C08		8	0340-0671	522.06	670.94	257	60.53	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14689.8	C08		8	0341-0676	839.62	675.96	277	64.43	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12987.4	C08		8	0342-0677	592.10	676.95	301	64.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14830.5	C08		8	0343-0681	426.87	681.11	257	61.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16971.2	C08		8	0344-0680	825.91	680.22	200	55.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17562.8	C08		8	0345-0681	496.51	681.74	226	55.94	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14792.4	C08		8	0346-0684	50.65	684.36	234	58.53	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14216.2	C08		8	0347-0689	254.18	690.21	283	64.43	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15850.9	C08		8	0348-0688	868.57	687.80	244	57.70	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15665.6	C08		8	0349-0690	188.82	689.63	237	57.70	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14295.8	C08		8	0350-0690	937.26	690.82	252	61.11	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11817.5	C08		8	0351-0694	901.66	693.47	276	65.60	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11721.2	C08		8	0352-0701	762.65	700.30	321	72.77	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15441.5	C08		8	0353-0700	43.43	700.32	233	61.01	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13960.8	C08		8	0354-0703	119.57	703.64	249	58.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14243.4	C08		8	0355-0705	520.70	705.43	283	62.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15177.9	C08		8	0356-0706	389.73	707.25	207	55.94	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184736	1375325	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12629.9	C08		8	0357-0707	328.37	707.55	294	67.70	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15029.1	C08		9	0001-0024	161.85	25.29	246	59.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17825.9	C08		9	0002-0035	665.72	35.66	214	57.11	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17648.0	C08		9	0003-0039	312.75	39.43	433	76.67	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12325.7	C08		9	0004-0037	420.03	37.46	346	69.01	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11923.4	C08		9	0005-0040	374.47	40.18	320	66.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12688.7	C08		9	0006-0045	820.05	45.39	381	73.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11778.0	C08		9	0007-0047	72.02	46.73	268	64.18	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16081.6	C08		9	0008-0049	676.39	49.76	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23709.4	C08		9	0009-0050	207.06	50.12	309	65.01	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15844.4	C08		9	0010-0052	170.76	52.19	245	58.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20608.9	C08		9	0011-0055	511.16	55.20	391	73.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15092.5	C08		9	0012-0055	553.62	56.11	265	61.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13772.9	C08		9	0013-0056	84.67	55.33	253	63.60	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12743.2	C08		9	0014-0060	764.20	59.77	410	76.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14427.8	C08		9	0015-0057	111.31	57.22	247	63.94	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13281.0	C08		9	0016-0063	641.28	63.47	291	67.11	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13163.6	C08		9	0017-0063	618.58	62.86	295	65.70	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13985.1	C08		9	0018-0066	660.27	66.16	281	62.18	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14389.8	C08		9	0019-0065	260.89	65.33	267	59.94	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14072.3	C08		9	0020-0065	919.29	65.62	278	62.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13599.3	C08		9	0021-0068	834.44	67.84	321	68.43	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13828.2	C08		9	0022-0074	466.68	74.75	307	65.11	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13562.9	C08		9	0023-0076	27.12	76.64	262	61.60	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13496.1	C08		9	0024-0077	188.25	77.36	293	67.01	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15076.7	C08		9	0025-0078	237.21	78.41	255	61.01	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9611.3	C08		9	0026-0083	329.86	83.01	316	70.08	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15950.0	C08		9	0027-0090	387.72	90.27	630	94.81	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15823.1	C08		9	0028-0084	822.71	84.46	238	56.77	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12480.1	C08		9	0029-0087	949.16	87.00	283	63.01	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15050.6	C08		9	0030-0088	499.50	88.20	272	61.36	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16923.2	C08		9	0031-0095	273.32	94.68	232	57.60	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13429.5	C08		9	0032-0099	837.52	99.21	297	64.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18029.8	C08		9	0033-0103	732.27	102.56	218	57.36	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14294.6	C08		9	0034-0103	439.24	102.90	295	65.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15566.2	C08		9	0035-0104	717.93	103.97	242	57.70	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13187.8	C08		9	0036-0107	610.82	107.38	251	58.28	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15148.7	C08		9	0037-0108	762.14	108.40	290	63.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15421.3	C08		9	0038-0114	213.27	114.06	257	59.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13338.5	C08		9	0039-0119	68.38	119.09	248	64.87	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20614.2	C08		9	0040-0120	50.66	120.43	362	73.36	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13307.0	C08		9	0041-0121	287.36	120.29	279	61.11	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15915.5	C08		9	0042-0121	647.54	121.67	265	61.11	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13927.7	C08		9	0043-0121	943.79	120.02	245	59.94	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	25529.1	C08		9	0044-0122	243.16	121.57	263	83.50	0.474
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12018.8	C08		9	0045-0124	862.97	124.53	312	66.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13424.7	C08		9	0046-0126	496.69	125.44	297	64.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17147.0	C08		9	0047-0131	422.92	130.66	210	55.01	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19331.2	C08		9	0048-0130	383.67	130.77	198	53.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15706.5	C08		9	0049-0133	667.11	133.29	248	58.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14574.3	C08		9	0050-0138	68.40	138.48	334	74.77	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17116.7	C08		9	0051-0142	113.99	141.80	371	73.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13186.4	C08		9	0052-0142	192.16	141.80	284	66.67	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14610.1	C08		9	0053-0140	302.18	140.57	275	62.04	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14627.9	C08		9	0054-0143	433.34	143.34	286	62.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16327.6	C08		9	0055-0141	733.55	141.16	244	57.36	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12268.9	C08		9	0056-0142	885.59	142.48	299	63.84	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17429.3	C08		9	0057-0139	772.04	139.76	219	54.87	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19417.7	C08		9	0058-0145	230.77	145.19	399	73.01	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14552.7	C08		9	0059-0147	345.61	146.60	335	67.84	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13061.6	C08		9	0060-0146	132.54	146.26	261	61.94	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17703.1	C08		9	0061-0159	616.86	156.80	390	84.91	0.680
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17096.7	C08		9	0062-0152	166.12	151.85	223	57.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12582.0	C08		9	0063-0153	634.50	153.00	116	38.97	0.960
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11367.4	C08		9	0064-0156	770.74	155.75	343	68.87	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17201.0	C08		9	0065-0156	449.47	155.91	231	55.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14081.6	C08		9	0066-0156	302.96	155.49	244	60.28	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17167.4	C08		9	0067-0162	490.83	162.58	358	71.26	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17836.2	C08		9	0068-0165	572.41	165.15	422	76.18	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14301.8	C08		9	0069-0166	807.34	166.84	302	69.60	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16533.9	C08		9	0070-0170	532.91	170.34	246	59.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16105.2	C08		9	0071-0173	140.65	173.84	242	57.70	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14004.4	C08		9	0072-0177	414.21	176.85	464	80.67	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13241.3	C08		9	0073-0177	251.09	177.59	287	62.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17639.0	C08		9	0074-0177	660.80	177.44	227	56.53	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11352.4	C08		9	0075-0182	827.81	182.46	333	68.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17430.6	C08		9	0076-0186	396.07	188.05	451	86.67	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13604.7	C08		9	0077-0185	750.71	185.11	320	66.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12521.8	C08		9	0078-0184	456.37	184.52	346	75.84	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12505.1	C08		9	0079-0186	559.50	186.39	310	65.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16492.2	C08		9	0080-0189	116.64	189.13	234	55.94	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11883.2	C08		9	0081-0188	167.35	187.41	309	70.53	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18309.5	C08		9	0082-0191	520.39	190.47	422	77.84	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12896.5	C08		9	0083-0192	77.49	191.97	280	63.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14003.4	C08		9	0084-0193	187.40	192.97	270	61.94	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11074.6	C08		9	0085-0191	902.35	191.72	342	71.11	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15609.3	C08		9	0086-0196	324.22	196.80	336	67.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16377.4	C08		9	0087-0199	842.93	200.02	236	57.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17679.2	C08		9	0088-0210	372.57	210.16	458	81.84	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16337.4	C08		9	0089-0206	233.49	206.79	240	58.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12663.2	C08		9	0090-0207	900.41	206.94	299	67.70	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14229.3	C08		9	0091-0211	734.28	211.95	285	63.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11442.0	C08		9	0092-0214	251.54	213.93	326	72.77	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13184.2	C08		9	0093-0211	773.03	210.77	302	64.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17493.1	C08		9	0094-0219	463.37	219.42	274	64.53	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16703.4	C08		9	0095-0217	682.78	217.22	230	57.36	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16567.9	C08		9	0096-0219	500.76	219.35	234	57.70	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16488.8	C08		9	0097-0222	127.39	221.66	282	63.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14220.8	C08		9	0098-0220	637.31	220.35	277	61.36	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15623.8	C08		9	0099-0221	78.75	221.20	239	62.18	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13286.7	C08		9	0100-0222	206.90	222.08	262	62.18	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15644.0	C08		9	0101-0227	722.82	226.89	261	63.36	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13020.4	C08		9	0102-0224	928.66	223.68	354	71.01	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19452.2	C08		9	0103-0227	522.97	227.72	319	67.36	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16706.2	C08		9	0104-0238	321.22	237.77	481	81.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20099.3	C08		9	0105-0231	741.47	231.83	261	62.87	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19173.8	C08		9	0106-0236	137.63	236.28	389	72.43	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11804.4	C08		9	0107-0237	777.38	237.02	324	69.01	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11022.5	C08		9	0108-0238	853.32	238.03	340	72.08	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12295.0	C08		9	0109-0238	916.87	238.35	294	65.70	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20791.0	C08		9	0110-0240	623.11	240.28	311	65.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11309.5	C08		9	0111-0243	71.18	243.47	298	66.77	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15267.2	C08		9	0112-0247	451.64	247.20	263	59.36	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14813.1	C08		9	0113-0247	227.38	246.53	271	60.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15835.0	C08		9	0114-0252	290.88	251.22	323	68.08	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13947.4	C08		9	0115-0251	178.20	251.43	263	58.53	0.965
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20106.5	C08		9	0116-0252	539.18	251.95	102	77.98	0.211
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12240.2	C08		9	0117-0259	21.87	259.08	306	69.01	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16018.5	C08		9	0118-0257	148.94	257.02	237	57.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17077.2	C08		9	0119-0257	338.39	257.67	235	56.53	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15715.4	C08		9	0120-0259	806.27	259.06	291	63.11	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15794.1	C08		9	0121-0263	711.79	263.00	343	70.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16629.3	C08		9	0122-0264	280.54	265.02	288	64.08	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15893.2	C08		9	0123-0260	430.89	259.94	241	60.53	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16457.7	C08		9	0124-0264	683.93	264.17	260	60.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15023.2	C08		9	0125-0264	875.82	264.11	313	68.18	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14824.9	C08		9	0126-0271	96.00	269.37	542	99.15	0.693
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15658.6	C08		9	0127-0266	851.68	266.28	250	60.18	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16449.3	C08		9	0128-0268	651.45	267.92	241	61.01	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13725.6	C08		9	0129-0269	616.96	268.57	313	66.77	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12008.5	C08		9	0130-0270	215.06	270.05	331	70.18	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13831.6	C08		9	0131-0275	124.19	275.22	276	64.18	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15144.0	C08		9	0132-0276	434.10	275.58	263	61.11	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16267.1	C08		9	0133-0277	320.08	277.26	241	59.36	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15241.3	C08		9	0134-0281	232.65	281.28	261	61.11	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15694.8	C08		9	0135-0284	345.92	284.36	258	59.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13104.7	C08		9	0136-0289	67.16	289.77	297	68.18	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14726.0	C08		9	0137-0288	931.47	288.01	293	65.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14134.6	C08		9	0138-0291	169.84	291.45	302	65.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15071.2	C08		9	0139-0293	132.68	292.15	267	64.53	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13598.2	C08		9	0140-0292	731.38	291.66	311	69.60	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18323.0	C08		9	0141-0299	107.70	299.35	444	81.84	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16530.6	C08		9	0142-0298	434.80	298.10	239	56.53	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17523.4	C08		9	0143-0303	239.39	302.15	539	92.91	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13144.6	C08		9	0144-0300	377.66	300.14	294	64.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20476.0	C08		9	0145-0302	549.83	302.46	337	66.77	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12982.6	C08		9	0146-0301	764.47	301.35	306	65.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11839.8	C08		9	0147-0309	392.37	309.45	358	77.36	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18223.4	C08		9	0148-0309	347.42	309.38	218	60.28	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13248.5	C08		9	0149-0310	896.98	310.50	288	62.18	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18928.8	C08		9	0150-0311	577.44	310.83	300	63.36	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15636.6	C08		9	0151-0312	216.08	312.50	255	60.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13181.0	C08		9	0152-0314	494.42	314.03	302	69.26	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15903.3	C08		9	0153-0316	284.47	316.16	255	61.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18120.1	C08		9	0154-0318	168.21	318.26	221	53.94	0.954
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20367.4	C08		9	0155-0317	772.86	317.30	215	55.11	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14089.1	C08		9	0156-0326	316.42	327.16	303	68.43	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14175.2	C08		9	0157-0329	100.11	329.05	280	63.01	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15789.4	C08		9	0158-0328	399.84	329.06	255	61.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12196.0	C08		9	0159-0331	473.65	331.97	309	69.94	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15757.6	C08		9	0160-0335	827.11	334.40	269	65.01	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13898.1	C08		9	0161-0334	653.21	334.08	294	63.94	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16922.0	C08		9	0162-0337	158.65	337.24	315	66.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12664.1	C08		9	0163-0339	906.65	338.05	301	66.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22282.1	C08		9	0164-0341	280.12	341.05	159	46.87	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14900.1	C08		9	0165-0346	405.37	345.82	260	64.53	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15819.7	C08		9	0166-0346	501.49	346.23	253	57.94	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15160.5	C08		9	0167-0349	610.54	349.77	277	61.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15821.5	C08		9	0168-0351	141.79	350.62	239	59.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20713.5	C08		9	0169-0351	658.83	350.93	212	54.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22928.0	C08		9	0170-0350	285.21	350.41	164	53.70	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17435.6	C08		9	0171-0356	820.54	356.82	457	79.50	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14896.9	C08		9	0172-0356	448.40	356.50	293	63.26	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15238.5	C08		9	0173-0355	476.70	354.62	261	60.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14052.0	C08		9	0174-0357	577.40	356.95	299	68.77	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16477.5	C08		9	0175-0358	238.80	359.38	238	58.18	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16149.3	C08		9	0176-0357	419.39	357.22	250	59.70	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12305.9	C08		9	0177-0361	555.88	361.12	311	71.01	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16413.3	C08		9	0178-0361	65.88	360.72	247	58.18	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13712.8	C08		9	0179-0361	19.97	360.70	264	61.11	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15687.9	C08		9	0180-0361	132.83	362.58	260	61.84	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10508.6	C08		9	0181-0364	345.75	364.55	320	67.84	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18606.6	C08		9	0182-0362	689.31	362.03	220	55.11	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17429.5	C08		9	0183-0365	192.24	365.31	356	69.60	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14803.8	C08		9	0184-0369	298.99	368.75	288	61.36	0.961
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10974.1	C08		9	0185-0376	361.42	376.48	319	71.11	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18681.1	C08		9	0186-0374	649.12	373.54	234	59.11	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14813.5	C08		9	0187-0380	597.95	380.23	274	64.18	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17059.7	C08		9	0188-0380	707.53	380.45	241	58.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16828.7	C08		9	0189-0381	678.68	381.16	240	57.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15309.4	C08		9	0190-0381	225.76	381.28	250	57.94	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14675.2	C08		9	0191-0383	756.09	383.91	241	59.94	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16339.0	C08		9	0192-0391	779.07	391.01	340	72.67	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15996.5	C08		9	0193-0390	799.10	391.04	245	59.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13789.2	C08		9	0194-0392	89.33	392.36	270	62.18	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14264.4	C08		9	0195-0391	43.24	392.06	257	60.53	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12991.5	C08		9	0196-0395	609.25	395.53	320	67.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17663.8	C08		9	0197-0393	699.56	393.71	208	55.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13059.8	C08		9	0198-0400	15.94	400.42	270	60.18	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14388.3	C08		9	0199-0400	309.65	400.91	265	59.36	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13435.2	C08		9	0200-0400	833.98	400.08	295	62.53	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14895.2	C08		9	0201-0407	902.30	406.64	274	62.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12442.1	C08		9	0202-0412	521.72	412.19	305	67.94	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16735.2	C08		9	0203-0408	697.46	408.03	236	57.11	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15814.8	C08		9	0204-0421	330.18	420.87	469	82.57	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18051.8	C08		9	0205-0416	730.08	415.55	217	55.36	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13875.3	C08		9	0206-0421	857.42	421.28	284	64.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14859.2	C08		9	0207-0424	657.84	423.98	250	59.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14642.3	C08		9	0208-0430	96.02	429.79	282	62.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18785.5	C08		9	0209-0430	53.43	430.31	184	59.36	0.656
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14312.9	C08		9	0210-0429	272.80	429.35	252	63.70	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15667.1	C08		9	0211-0436	937.67	435.69	355	72.18	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14869.9	C08		9	0212-0434	404.28	434.71	268	60.53	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16135.7	C08		9	0213-0434	221.85	434.00	235	56.53	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19317.2	C08		9	0214-0437	835.72	437.04	437	77.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13227.5	C08		9	0215-0433	741.32	433.53	271	64.28	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13596.0	C08		9	0216-0441	183.31	440.67	278	63.36	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16280.4	C08		9	0217-0445	118.89	445.84	253	59.94	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13640.2	C08		9	0218-0445	276.34	444.55	334	71.01	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21850.0	C08		9	0219-0446	568.93	446.43	359	69.60	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14497.5	C08		9	0220-0450	509.86	450.39	295	67.26	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17110.9	C08		9	0221-0451	20.54	450.78	221	57.11	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15155.7	C08		9	0222-0451	92.12	451.47	252	58.53	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14948.1	C08		9	0223-0455	199.91	454.64	259	58.87	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14260.2	C08		9	0224-0457	140.99	457.34	266	61.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12757.2	C08		9	0225-0458	292.70	459.22	301	65.50	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15571.7	C08		9	0226-0464	16.19	464.87	249	61.70	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21029.1	C08		9	0227-0466	246.15	466.00	365	69.84	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17859.9	C08		9	0228-0465	774.80	465.10	224	57.11	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18329.4	C08		9	0229-0473	845.32	474.29	456	80.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13587.7	C08		9	0230-0473	943.11	472.67	290	64.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17502.7	C08		9	0231-0474	586.90	473.65	236	56.77	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16500.0	C08		9	0232-0477	117.41	476.98	231	56.53	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15598.4	C08		9	0233-0479	533.86	479.51	256	61.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19052.1	C08		9	0234-0477	780.99	477.30	204	56.87	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9043.2	C08		9	0235-0486	732.95	485.44	478	90.33	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16319.8	C08		9	0236-0484	35.89	484.22	231	57.36	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18205.9	C08		9	0237-0489	799.12	490.26	263	62.53	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17637.0	C08		9	0238-0492	865.20	491.40	373	74.08	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15946.1	C08		9	0239-0491	170.18	491.71	244	57.70	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13944.5	C08		9	0240-0494	360.13	494.65	280	61.11	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16546.6	C08		9	0241-0496	397.72	496.43	237	57.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13441.9	C08		9	0242-0497	709.02	498.02	186	53.36	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14155.5	C08		9	0243-0501	889.82	500.72	276	63.01	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15752.1	C08		9	0244-0501	745.35	500.87	258	59.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15651.8	C08		9	0245-0509	25.61	509.50	411	76.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14991.5	C08		9	0246-0506	187.12	506.63	263	64.18	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13773.4	C08		9	0247-0508	630.19	507.52	302	65.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15877.2	C08		9	0248-0509	793.51	508.92	295	66.53	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16387.1	C08		9	0249-0513	765.22	513.46	253	60.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15613.4	C08		9	0250-0515	427.69	515.11	257	60.53	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13867.3	C08		9	0251-0520	600.81	520.37	291	64.43	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15248.0	C08		9	0252-0521	190.24	520.79	236	61.94	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13767.2	C08		9	0253-0526	312.34	526.57	272	63.26	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17277.7	C08		9	0254-0523	382.37	523.68	259	60.87	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14008.4	C08		9	0255-0532	900.91	532.53	282	61.60	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12918.1	C08		9	0256-0534	743.07	534.31	283	63.60	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16296.9	C08		9	0257-0536	72.15	535.68	229	58.18	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15650.2	C08		9	0258-0536	345.34	536.25	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16590.5	C08		9	0259-0541	115.02	540.89	231	57.11	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16452.3	C08		9	0260-0541	388.16	540.96	250	62.04	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14533.5	C08		9	0261-0544	146.31	544.72	261	59.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20664.3	C08		9	0262-0550	208.62	549.77	372	71.01	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15448.8	C08		9	0263-0549	530.58	548.82	256	59.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13384.7	C08		9	0264-0552	65.45	553.53	305	69.74	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15050.0	C08		9	0265-0551	462.86	551.05	255	61.36	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13906.2	C08		9	0266-0558	187.19	558.95	291	65.11	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14843.6	C08		9	0267-0560	131.96	560.28	266	60.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16479.7	C08		9	0268-0560	300.81	559.95	236	57.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10934.3	C08		9	0269-0562	939.43	562.66	339	69.60	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13176.0	C08		9	0270-0563	49.26	563.13	288	64.18	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14873.0	C08		9	0271-0564	85.36	565.00	271	66.43	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15865.1	C08		9	0272-0566	339.62	565.46	310	65.36	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13114.0	C08		9	0273-0569	464.96	569.44	300	63.36	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13066.1	C08		9	0274-0575	736.81	575.78	288	64.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12004.6	C08		9	0275-0577	412.79	577.08	301	67.36	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14740.9	C08		9	0276-0584	694.25	583.79	271	64.53	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13679.5	C08		9	0277-0583	193.20	583.45	294	65.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13489.9	C08		9	0278-0588	385.14	587.73	347	73.36	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11031.8	C08		9	0279-0589	72.04	589.28	271	63.70	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14309.6	C08		9	0280-0593	212.91	593.17	300	64.53	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14697.8	C08		9	0281-0595	369.24	595.55	270	63.94	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12935.3	C08		9	0282-0597	146.27	597.00	301	64.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15385.7	C08		9	0283-0600	756.21	600.54	250	60.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15093.5	C08		9	0284-0609	524.75	609.24	263	60.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13434.4	C08		9	0285-0616	38.28	615.69	283	63.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12840.4	C08		9	0286-0619	933.03	619.84	281	62.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14793.6	C08		9	0287-0622	196.88	622.44	282	62.87	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12968.9	C08		9	0288-0623	881.73	623.66	287	62.77	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14214.6	C08		9	0289-0627	467.98	627.32	335	68.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13169.4	C08		9	0290-0632	89.86	632.14	284	64.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14769.0	C08		9	0291-0637	150.45	637.26	292	63.36	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18145.7	C08		9	0292-0649	202.97	648.00	683	104.33	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15516.6	C08		9	0293-0648	124.90	648.49	260	61.36	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13382.8	C08		9	0294-0651	511.67	651.43	319	67.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15221.0	C08		9	0295-0651	69.79	650.22	248	61.36	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14865.1	C08		9	0296-0650	744.16	649.99	267	60.53	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16429.0	C08		9	0297-0650	263.16	650.76	250	60.53	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10483.4	C08		9	0298-0659	19.67	658.90	268	63.60	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13246.1	C08		9	0299-0665	66.46	665.98	267	64.77	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15488.3	C08		9	0300-0668	184.98	667.40	248	60.77	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14174.5	C08		9	0301-0666	264.82	665.46	286	72.77	0.679
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15386.7	C08		9	0302-0671	207.75	671.46	339	71.94	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14043.7	C08		9	0303-0668	387.01	668.37	303	66.43	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12602.8	C08		9	0304-0669	475.83	669.81	291	64.77	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14731.9	C08		9	0305-0673	781.40	673.09	311	67.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17860.6	C08		9	0306-0675	172.35	675.41	223	57.70	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13767.8	C08		9	0307-0677	111.57	677.69	283	61.36	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14650.1	C08		9	0308-0683	936.29	683.92	458	86.43	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14648.3	C08		9	0309-0678	251.31	678.44	264	60.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16284.1	C08		9	0310-0684	140.58	684.18	241	63.11	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14970.7	C08		9	0311-0690	321.34	691.53	581	89.74	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16219.5	C08		9	0312-0689	360.96	689.61	257	60.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14531.0	C08		9	0313-0693	31.45	693.71	260	61.70	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13978.4	C08		9	0314-0695	888.76	694.75	257	61.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14064.1	C08		9	0315-0695	57.33	695.07	272	64.18	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15009.9	C08		9	0316-0699	199.59	698.64	226	56.67	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12995.2	C08		9	0317-0702	750.25	702.11	297	63.60	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13169.4	C08		9	0318-0703	950.13	704.06	183	53.70	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12687.4	C08		9	0319-0704	937.61	703.39	120	41.56	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1184737	1375326	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14896.8	C08		9	0320-0707	214.24	708.02	262	62.18	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11025.8	D08		1	0001-0031	502.05	32.10	433	78.91	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10521.4	D08		1	0002-0035	683.37	35.30	402	74.43	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11080.3	D08		1	0003-0039	168.05	39.26	489	82.67	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10532.1	D08		1	0004-0037	106.24	37.36	378	72.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10868.5	D08		1	0005-0049	326.88	48.58	751	107.30	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10808.0	D08		1	0006-0044	231.54	43.76	386	72.67	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11947.9	D08		1	0007-0053	916.42	53.65	703	101.50	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9254.0	D08		1	0008-0051	573.73	51.36	507	86.18	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10178.3	D08		1	0009-0051	450.99	50.66	464	82.91	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10632.9	D08		1	0010-0054	799.48	53.77	390	77.26	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10829.4	D08		1	0011-0059	633.85	59.36	412	77.50	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10694.7	D08		1	0012-0069	747.78	68.50	777	107.05	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9543.1	D08		1	0013-0069	470.40	69.42	494	89.26	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10438.9	D08		1	0014-0072	394.62	72.16	441	76.43	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9351.1	D08		1	0015-0074	600.83	74.82	443	84.08	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10100.1	D08		1	0016-0076	493.85	76.67	503	87.60	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10763.1	D08		1	0017-0075	232.83	75.37	381	73.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9811.2	D08		1	0018-0075	574.54	74.86	434	79.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10337.4	D08		1	0019-0079	724.21	79.27	424	78.08	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10674.7	D08		1	0020-0082	109.11	82.07	363	71.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11328.4	D08		1	0021-0086	26.13	85.99	531	87.50	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11165.3	D08		1	0022-0086	935.26	86.56	381	73.50	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9984.8	D08		1	0023-0096	306.50	96.09	417	79.36	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10711.1	D08		1	0024-0106	533.49	106.01	807	108.23	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9839.8	D08		1	0025-0101	285.13	101.97	407	79.01	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9980.7	D08		1	0026-0103	635.68	103.29	852	117.54	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9180.5	D08		1	0027-0105	186.52	104.86	373	75.26	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10723.2	D08		1	0028-0108	789.69	108.23	359	73.60	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11570.2	D08		1	0029-0112	834.07	111.51	371	73.01	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10541.7	D08		1	0030-0113	391.56	113.78	401	74.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10906.8	D08		1	0031-0115	699.70	115.21	399	75.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10227.6	D08		1	0032-0123	159.83	123.97	830	116.37	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10116.2	D08		1	0033-0117	446.57	117.74	434	79.50	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10046.4	D08		1	0034-0120	612.49	120.72	422	79.15	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10876.0	D08		1	0035-0121	926.26	121.01	392	72.18	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10383.3	D08		1	0036-0123	73.44	123.49	376	71.01	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10292.8	D08		1	0037-0126	735.15	126.18	452	81.26	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10099.6	D08		1	0038-0134	420.57	133.51	950	125.88	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10532.4	D08		1	0039-0128	783.39	127.59	449	85.26	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12737.0	D08		1	0040-0144	506.95	143.84	677	95.50	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10583.9	D08		1	0041-0143	905.12	143.51	392	73.60	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10897.9	D08		1	0042-0142	824.88	142.30	383	75.26	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10576.9	D08		1	0043-0146	297.25	145.43	396	74.08	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10363.0	D08		1	0044-0158	642.35	158.75	393	74.67	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10680.5	D08		1	0045-0159	714.83	158.98	388	76.67	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11200.0	D08		1	0046-0164	277.35	164.21	729	105.05	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10619.8	D08		1	0047-0160	227.30	159.90	390	76.08	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10701.9	D08		1	0048-0166	117.67	165.95	373	72.67	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10628.7	D08		1	0049-0166	578.16	166.33	390	74.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9706.5	D08		1	0050-0180	678.45	180.31	399	78.33	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10569.6	D08		1	0051-0179	809.52	179.24	398	73.84	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9546.4	D08		1	0052-0180	338.38	179.91	418	81.01	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10379.0	D08		1	0053-0181	167.78	181.14	400	75.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10690.6	D08		1	0054-0182	444.35	182.31	382	73.84	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10510.9	D08		1	0055-0187	316.80	187.46	409	78.77	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10567.6	D08		1	0056-0187	207.94	187.03	397	77.50	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10779.5	D08		1	0057-0194	513.29	194.35	400	73.26	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10485.8	D08		1	0058-0197	940.92	197.02	399	76.43	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10583.5	D08		1	0059-0199	37.04	199.58	382	73.84	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10933.3	D08		1	0060-0209	253.78	208.26	925	123.78	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10751.1	D08		1	0061-0198	887.77	198.92	427	75.84	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10817.0	D08		1	0062-0199	798.35	199.86	390	73.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10852.5	D08		1	0063-0201	719.56	201.34	398	76.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13058.5	D08		1	0064-0206	71.18	205.95	602	90.91	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10873.2	D08		1	0065-0204	764.36	204.33	390	73.26	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11224.2	D08		1	0066-0207	562.41	208.31	379	75.94	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10369.1	D08		1	0067-0213	135.78	212.78	380	75.50	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10823.1	D08		1	0068-0221	927.57	220.99	385	72.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13358.2	D08		1	0069-0227	202.54	226.91	603	97.98	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10595.2	D08		1	0070-0224	615.97	224.41	409	76.67	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10796.6	D08		1	0071-0224	851.76	224.07	404	75.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11888.8	D08		1	0072-0232	271.35	234.30	725	103.78	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9904.6	D08		1	0073-0227	357.51	227.54	399	78.33	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10867.0	D08		1	0074-0229	482.77	228.83	357	74.18	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9600.8	D08		1	0075-0229	563.89	228.90	504	88.77	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11845.7	D08		1	0076-0238	890.09	239.12	727	104.13	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10681.6	D08		1	0077-0237	506.66	236.92	730	101.50	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9625.2	D08		1	0078-0240	540.09	240.67	552	94.91	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10363.5	D08		1	0079-0236	136.86	236.60	377	74.18	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11015.1	D08		1	0080-0242	58.13	242.18	440	77.84	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9664.9	D08		1	0081-0256	20.39	256.84	381	76.08	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10613.7	D08		1	0082-0258	459.44	258.25	392	73.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10259.3	D08		1	0083-0259	112.01	259.70	374	75.26	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10679.3	D08		1	0084-0271	746.54	271.87	414	75.60	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10784.5	D08		1	0085-0273	854.96	273.67	395	74.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10778.8	D08		1	0086-0279	180.41	278.30	384	73.01	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10804.3	D08		1	0087-0280	697.87	280.13	419	78.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10325.7	D08		1	0088-0281	315.70	280.31	405	76.67	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10517.6	D08		1	0089-0282	813.95	282.55	410	77.26	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10677.1	D08		1	0090-0287	936.07	287.70	382	73.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10126.6	D08		1	0091-0289	296.01	290.63	412	80.67	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10949.2	D08		1	0092-0294	641.46	293.41	420	77.26	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11623.0	D08		1	0093-0299	840.45	299.21	344	68.18	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11014.8	D08		1	0094-0300	899.82	300.36	385	72.43	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11635.8	D08		1	0095-0304	436.31	304.50	925	116.23	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10843.2	D08		1	0096-0303	219.20	302.97	382	71.60	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10847.8	D08		1	0097-0306	109.51	306.11	396	77.26	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12829.2	D08		1	0098-0310	175.48	310.67	613	96.81	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10660.0	D08		1	0099-0305	37.12	304.96	376	74.08	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11014.6	D08		1	0100-0309	549.31	309.07	383	71.60	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10507.3	D08		1	0101-0319	681.97	319.46	401	75.01	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10328.2	D08		1	0102-0319	393.65	319.13	386	73.84	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11078.1	D08		1	0103-0327	934.12	327.39	370	71.26	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11172.1	D08		1	0104-0333	774.77	333.03	392	73.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10272.6	D08		1	0105-0333	582.47	333.28	913	135.05	0.629
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11074.7	D08		1	0106-0336	729.96	335.83	392	73.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10692.4	D08		1	0107-0340	823.92	339.51	324	70.33	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11029.5	D08		1	0108-0344	144.33	344.39	395	74.08	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10192.7	D08		1	0109-0345	180.49	344.57	405	77.50	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10386.0	D08		1	0110-0347	37.82	347.41	374	73.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8233.9	D08		1	0111-0354	298.60	353.98	743	108.13	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10904.1	D08		1	0112-0351	352.83	351.52	398	74.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10511.3	D08		1	0113-0354	106.35	354.35	382	73.84	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11130.5	D08		1	0114-0357	622.14	357.04	652	97.98	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9958.0	D08		1	0115-0365	201.37	366.55	896	121.98	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9763.8	D08		1	0116-0370	707.79	370.13	433	79.50	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11070.1	D08		1	0117-0373	644.17	373.30	598	93.74	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13932.4	D08		1	0118-0373	567.86	374.36	591	92.18	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12120.5	D08		1	0119-0382	920.26	382.67	916	122.23	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11166.6	D08		1	0120-0375	771.27	375.83	427	77.50	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11152.2	D08		1	0121-0381	879.09	380.59	377	71.84	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11035.6	D08		1	0122-0383	134.35	382.33	377	72.91	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10370.2	D08		1	0123-0388	404.24	388.60	396	75.26	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9554.0	D08		1	0124-0397	151.05	397.56	433	81.15	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9713.9	D08		1	0125-0400	578.04	398.64	909	124.47	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10955.2	D08		1	0126-0397	686.35	397.94	414	75.84	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10975.7	D08		1	0127-0402	757.16	401.49	427	78.67	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10441.3	D08		1	0128-0407	603.82	407.99	414	77.74	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10164.4	D08		1	0129-0416	320.94	415.48	832	111.64	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10681.1	D08		1	0130-0412	201.41	411.91	398	75.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11522.0	D08		1	0131-0412	876.19	412.31	396	74.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9009.3	D08		1	0132-0420	769.40	420.86	452	86.91	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10719.0	D08		1	0133-0428	492.31	428.55	399	75.84	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10974.5	D08		1	0134-0433	432.61	433.37	389	73.84	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10915.2	D08		1	0135-0433	655.07	433.40	396	74.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10092.6	D08		1	0136-0446	370.45	445.64	871	123.88	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10908.9	D08		1	0137-0443	99.12	443.74	373	70.43	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11263.2	D08		1	0138-0446	931.58	445.38	330	72.77	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10833.8	D08		1	0139-0446	464.85	446.15	392	73.26	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11243.2	D08		1	0140-0449	914.46	449.53	412	80.18	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10568.7	D08		1	0141-0450	293.65	450.79	391	75.50	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11888.2	D08		1	0142-0453	562.54	453.36	701	99.64	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10716.2	D08		1	0143-0449	715.45	448.99	390	76.08	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9917.0	D08		1	0144-0454	142.77	454.03	401	77.50	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9944.5	D08		1	0145-0455	946.44	455.06	407	78.08	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10719.7	D08		1	0146-0465	186.09	465.22	378	73.50	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10593.6	D08		1	0147-0473	48.87	472.73	757	108.81	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11115.6	D08		1	0148-0468	763.11	467.65	373	73.26	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11716.8	D08		1	0149-0479	695.70	479.85	998	122.81	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10946.4	D08		1	0150-0476	640.27	476.07	384	73.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10469.9	D08		1	0151-0480	336.26	480.21	402	76.77	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11019.4	D08		1	0152-0483	393.22	482.93	564	89.98	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10278.9	D08		1	0153-0480	849.69	480.79	391	74.77	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10552.7	D08		1	0154-0484	443.37	484.11	426	77.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11098.4	D08		1	0155-0484	213.28	483.94	379	71.60	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10047.7	D08		1	0156-0487	770.70	487.97	410	79.15	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10683.3	D08		1	0157-0490	533.71	490.14	403	78.08	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10943.6	D08		1	0158-0489	573.51	488.99	384	74.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9793.2	D08		1	0159-0488	313.19	488.37	428	79.60	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10536.7	D08		1	0160-0497	87.71	497.66	366	71.84	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10377.0	D08		1	0161-0499	866.23	499.79	410	78.08	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11234.1	D08		1	0162-0499	922.02	498.94	359	69.60	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9981.4	D08		1	0163-0506	45.32	507.06	382	78.91	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11079.4	D08		1	0164-0508	817.58	507.77	374	72.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10807.7	D08		1	0165-0509	17.93	509.60	362	72.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9113.7	D08		1	0166-0510	188.53	509.87	383	71.84	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10212.3	D08		1	0167-0512	606.62	511.74	393	76.08	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11016.8	D08		1	0168-0513	745.60	513.60	376	73.01	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9840.6	D08		1	0169-0513	487.28	512.82	395	76.08	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10260.6	D08		1	0170-0517	895.51	516.63	393	75.50	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10960.8	D08		1	0171-0521	326.02	521.07	373	71.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10866.8	D08		1	0172-0523	118.03	523.23	386	72.18	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10716.1	D08		1	0173-0525	289.17	524.87	410	76.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10391.0	D08		1	0174-0525	420.66	525.54	395	76.08	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10364.1	D08		1	0175-0528	648.78	528.16	396	74.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10905.7	D08		1	0176-0530	163.13	530.49	391	74.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10956.2	D08		1	0177-0530	771.34	530.25	390	73.01	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10647.1	D08		1	0178-0533	199.57	533.05	381	73.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10766.6	D08		1	0179-0540	385.59	540.73	417	78.91	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10662.9	D08		1	0180-0539	543.36	539.82	398	75.84	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9709.2	D08		1	0181-0547	897.72	547.42	433	85.40	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11177.3	D08		1	0182-0544	40.20	544.43	338	70.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10102.9	D08		1	0183-0548	473.27	547.35	620	101.40	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11990.3	D08		1	0184-0562	275.66	562.66	620	92.91	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10420.4	D08		1	0185-0571	557.83	571.47	817	113.78	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10480.2	D08		1	0186-0565	658.42	565.82	393	73.84	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10989.3	D08		1	0187-0570	94.36	570.37	340	68.18	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10650.1	D08		1	0188-0570	756.96	569.72	404	76.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10038.3	D08		1	0189-0573	890.54	574.05	415	78.43	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10466.0	D08		1	0190-0575	718.87	575.35	418	79.15	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10367.9	D08		1	0191-0584	443.06	584.72	994	128.02	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10262.7	D08		1	0192-0581	202.82	581.40	407	77.84	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11276.6	D08		1	0193-0584	360.11	584.44	373	73.26	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10850.4	D08		1	0194-0585	610.58	584.79	382	73.26	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10531.6	D08		1	0195-0583	861.48	583.27	393	78.33	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10566.8	D08		1	0196-0591	809.80	591.24	406	78.91	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9304.7	D08		1	0197-0602	194.05	601.73	235	60.77	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10236.2	D08		1	0198-0606	401.04	605.93	421	77.26	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9891.9	D08		1	0199-0607	249.23	606.40	392	78.67	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10686.7	D08		1	0200-0607	715.39	607.94	388	76.67	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10674.4	D08		1	0201-0609	886.12	609.68	379	75.84	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10756.9	D08		1	0202-0613	662.08	613.08	400	74.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9585.1	D08		1	0203-0613	81.87	613.13	432	82.81	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10784.3	D08		1	0204-0619	359.78	619.40	408	77.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10229.5	D08		1	0205-0623	500.22	622.62	416	77.50	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10840.1	D08		1	0206-0632	54.26	631.53	380	72.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9785.2	D08		1	0207-0634	156.18	634.61	438	77.84	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10022.1	D08		1	0208-0632	314.53	632.31	371	75.60	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9744.8	D08		1	0209-0635	337.73	634.71	468	90.18	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10844.2	D08		1	0210-0639	845.81	638.80	759	104.33	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9573.4	D08		1	0211-0637	182.83	636.98	452	85.40	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9533.7	D08		1	0212-0638	479.84	638.61	466	84.91	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8084.5	D08		1	0213-0643	360.80	643.00	528	91.84	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11003.5	D08		1	0214-0643	403.72	643.53	391	72.43	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10605.1	D08		1	0215-0644	797.68	644.62	380	74.43	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10855.3	D08		1	0216-0648	23.17	647.57	369	76.18	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10169.8	D08		1	0217-0653	447.13	653.51	845	118.02	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10599.4	D08		1	0218-0650	266.50	650.23	286	67.60	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10884.8	D08		1	0219-0650	606.93	650.53	444	79.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10779.3	D08		1	0220-0654	76.29	654.09	364	70.43	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10787.6	D08		1	0221-0657	213.13	657.27	388	76.08	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10825.8	D08		1	0222-0660	914.73	660.25	368	72.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10131.0	D08		1	0223-0665	714.94	664.98	405	77.01	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9412.7	D08		1	0224-0666	743.38	666.07	459	82.91	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10768.7	D08		1	0225-0666	648.30	666.58	374	70.43	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12242.7	D08		1	0226-0675	326.89	674.93	673	97.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11256.4	D08		1	0227-0680	772.33	679.99	356	70.43	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11199.0	D08		1	0228-0688	812.57	689.08	726	108.43	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10590.8	D08		1	0229-0686	489.12	685.84	367	75.74	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10726.8	D08		1	0230-0687	143.02	687.83	440	78.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10125.6	D08		1	0231-0690	871.85	690.33	358	72.43	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9806.7	D08		1	0232-0690	191.96	690.27	398	77.50	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9596.7	D08		1	0233-0696	352.59	695.18	460	83.50	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9958.2	D08		1	0234-0700	530.30	700.74	818	111.88	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10420.7	D08		1	0235-0700	579.33	700.33	362	73.50	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184612	1375327	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10369.9	D08		1	0236-0705	67.56	705.01	383	74.08	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11699.6	D08		3	0001-0032	610.87	32.70	388	77.15	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11354.8	D08		3	0002-0038	761.28	37.99	356	70.43	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11597.1	D08		3	0003-0042	860.23	42.15	366	72.18	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11077.9	D08		3	0004-0041	227.10	41.65	345	72.67	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11323.2	D08		3	0005-0043	410.65	43.52	431	78.67	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10729.3	D08		3	0006-0044	45.88	44.22	373	79.60	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11440.6	D08		3	0007-0047	258.54	47.53	359	75.98	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12131.0	D08		3	0008-0045	550.76	44.87	362	72.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11117.0	D08		3	0009-0049	839.59	49.01	381	77.50	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11850.1	D08		3	0010-0051	694.22	51.36	349	70.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10746.8	D08		3	0011-0053	23.37	52.47	350	73.01	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9803.2	D08		3	0012-0055	131.62	55.52	364	76.67	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10801.3	D08		3	0013-0058	54.92	58.96	377	80.43	0.732
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11336.4	D08		3	0014-0064	74.21	63.65	384	77.26	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11334.0	D08		3	0015-0063	927.38	63.53	352	71.26	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11131.4	D08		3	0016-0065	350.14	65.53	386	73.84	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11128.9	D08		3	0017-0069	250.38	69.79	363	77.26	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10943.7	D08		3	0018-0067	904.78	67.76	366	72.33	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11073.1	D08		3	0019-0072	180.20	72.28	368	75.74	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11253.0	D08		3	0020-0072	231.46	72.41	371	74.87	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11488.8	D08		3	0021-0073	787.16	73.24	361	74.08	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11224.9	D08		3	0022-0080	733.46	80.24	325	113.64	0.316
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11401.4	D08		3	0023-0086	89.85	85.99	341	71.84	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12264.5	D08		3	0024-0091	165.10	92.46	712	105.40	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11696.9	D08		3	0025-0088	659.30	87.84	389	77.50	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11613.4	D08		3	0026-0087	685.00	87.49	373	74.33	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12270.3	D08		3	0027-0089	473.46	89.44	376	74.91	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12007.8	D08		3	0028-0091	502.43	91.20	384	76.91	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10888.3	D08		3	0029-0090	753.67	90.95	380	74.08	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12201.2	D08		3	0030-0093	429.24	93.02	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11031.2	D08		3	0031-0093	230.83	92.37	369	72.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11963.2	D08		3	0032-0097	546.64	97.18	360	72.67	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11591.4	D08		3	0033-0098	833.39	98.43	356	70.18	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11368.2	D08		3	0034-0105	125.31	106.25	731	109.54	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11999.7	D08		3	0035-0102	376.54	102.10	373	73.84	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14270.4	D08		3	0036-0106	904.74	106.07	302	66.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11406.6	D08		3	0037-0110	488.71	110.65	412	86.57	0.691
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11561.3	D08		3	0038-0113	641.59	113.02	367	75.84	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10947.2	D08		3	0039-0114	312.85	115.19	368	72.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11886.4	D08		3	0040-0116	69.56	116.39	359	76.33	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11611.5	D08		3	0041-0123	31.77	123.36	329	69.01	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12446.9	D08		3	0042-0121	723.76	121.05	350	73.84	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13863.6	D08		3	0043-0132	913.74	132.69	582	92.81	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11062.8	D08		3	0044-0129	456.50	128.80	387	75.50	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12310.0	D08		3	0045-0131	273.44	130.78	321	67.94	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9294.0	D08		3	0046-0132	293.91	132.21	440	84.67	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11782.5	D08		3	0047-0136	627.21	136.50	365	74.33	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11266.6	D08		3	0048-0138	384.28	138.48	386	75.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11520.8	D08		3	0049-0139	491.76	139.37	370	75.26	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11576.5	D08		3	0050-0142	83.52	141.45	354	71.01	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12259.0	D08		3	0051-0142	173.87	142.35	347	72.08	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11981.4	D08		3	0052-0141	810.52	140.67	331	69.84	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11963.9	D08		3	0053-0148	544.92	147.95	411	76.91	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13428.0	D08		3	0054-0150	859.07	149.48	299	66.18	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10967.0	D08		3	0055-0153	243.01	153.61	398	76.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11886.7	D08		3	0056-0154	761.70	154.94	330	68.28	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10594.8	D08		3	0057-0158	219.30	157.52	385	77.50	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12064.2	D08		3	0058-0163	139.16	162.74	404	77.26	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12144.0	D08		3	0059-0165	43.97	164.94	345	69.84	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10637.5	D08		3	0060-0169	414.27	168.40	409	78.91	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11694.5	D08		3	0061-0166	592.25	165.95	388	77.50	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12010.3	D08		3	0062-0171	912.62	171.55	375	73.50	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11923.5	D08		3	0063-0179	646.07	177.21	720	110.61	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11729.8	D08		3	0064-0173	850.67	172.97	350	69.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10825.4	D08		3	0065-0181	434.16	179.91	762	118.51	0.682
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13891.5	D08		3	0066-0175	759.81	175.04	560	90.18	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11737.8	D08		3	0067-0178	879.52	178.93	356	73.01	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11566.5	D08		3	0068-0178	341.98	177.70	347	70.43	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10989.7	D08		3	0069-0196	97.38	195.27	747	118.95	0.663
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11952.2	D08		3	0070-0195	488.00	194.77	353	72.67	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12933.3	D08		3	0071-0195	523.35	194.58	307	65.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11775.6	D08		3	0072-0197	687.05	197.04	347	73.26	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11442.0	D08		3	0073-0198	557.78	198.27	394	76.18	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11409.1	D08		3	0074-0202	742.04	202.12	370	73.26	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11277.1	D08		3	0075-0205	147.56	205.28	333	70.43	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11389.6	D08		3	0076-0206	387.38	207.07	366	76.33	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10691.2	D08		3	0077-0207	296.40	206.55	341	72.91	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10676.4	D08		3	0078-0210	650.95	210.77	392	76.43	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11584.9	D08		3	0079-0213	252.24	212.90	344	70.67	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12054.2	D08		3	0080-0212	787.19	212.30	356	70.18	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10727.6	D08		3	0081-0215	82.89	215.35	335	72.43	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12386.5	D08		3	0082-0215	903.13	215.44	324	71.26	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11817.6	D08		3	0083-0214	361.40	214.09	349	74.57	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11805.5	D08		3	0084-0220	196.70	219.96	359	72.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10975.3	D08		3	0085-0221	607.95	221.25	364	73.36	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12097.9	D08		3	0086-0224	414.68	224.53	323	67.01	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11324.4	D08		3	0087-0234	477.37	234.22	752	114.95	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10961.8	D08		3	0088-0233	941.28	233.09	368	71.01	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10633.4	D08		3	0089-0234	649.87	234.42	381	79.50	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10542.8	D08		3	0090-0235	41.27	235.00	329	71.74	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12475.6	D08		3	0091-0238	109.05	238.19	359	74.91	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10940.5	D08		3	0092-0244	607.29	243.39	370	77.36	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10097.3	D08		3	0093-0246	299.57	245.76	362	86.81	0.604
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12088.2	D08		3	0094-0245	164.28	245.60	361	72.43	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12160.1	D08		3	0095-0246	673.03	245.73	328	69.70	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12087.9	D08		3	0096-0247	762.15	246.68	347	68.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11775.2	D08		3	0097-0248	868.88	248.01	373	73.26	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10931.3	D08		3	0098-0249	373.11	248.75	358	76.33	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10896.1	D08		3	0099-0249	552.28	249.29	371	75.74	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12346.7	D08		3	0100-0251	693.24	251.37	374	76.18	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11202.5	D08		3	0101-0252	811.85	252.49	441	81.84	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11683.6	D08		3	0102-0258	249.65	258.22	341	71.84	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12000.8	D08		3	0103-0259	944.24	258.82	301	67.60	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11923.1	D08		3	0104-0265	587.53	265.22	377	73.26	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11597.3	D08		3	0105-0267	341.59	266.56	373	74.67	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11734.6	D08		3	0106-0268	312.72	268.76	348	77.50	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11497.8	D08		3	0107-0267	24.76	267.70	326	69.84	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12214.0	D08		3	0108-0283	649.13	284.09	965	130.61	0.711
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10002.8	D08		3	0109-0273	627.87	274.18	281	66.28	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11931.1	D08		3	0110-0277	156.82	276.89	359	72.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13151.1	D08		3	0111-0276	609.90	276.26	304	65.11	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11046.0	D08		3	0112-0282	79.15	282.69	371	75.50	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14092.2	D08		3	0113-0280	897.30	280.57	260	86.23	0.439
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11644.9	D08		3	0114-0281	410.64	281.07	378	75.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12663.3	D08		3	0115-0283	207.48	282.75	296	63.60	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11185.2	D08		3	0116-0280	688.08	279.99	198	53.60	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11673.5	D08		3	0117-0285	118.58	285.09	470	87.50	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11173.5	D08		3	0118-0288	850.70	288.52	361	72.08	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12065.0	D08		3	0119-0290	251.86	290.01	326	69.26	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12304.1	D08		3	0120-0295	573.61	295.23	352	70.67	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12022.3	D08		3	0121-0308	528.74	309.81	752	114.71	0.718
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10768.7	D08		3	0122-0303	354.73	302.37	387	81.74	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11336.2	D08		3	0123-0314	395.21	313.95	362	76.57	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10927.6	D08		3	0124-0313	466.54	313.88	394	77.50	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11250.9	D08		3	0125-0313	915.48	313.75	355	73.84	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10375.2	D08		3	0126-0316	28.55	315.24	376	77.98	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10410.6	D08		3	0127-0317	283.02	317.11	315	65.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10641.9	D08		3	0128-0319	102.04	319.05	333	71.01	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11746.0	D08		3	0129-0328	423.72	328.52	377	75.50	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11387.1	D08		3	0130-0330	854.33	329.72	363	74.91	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11720.8	D08		3	0131-0330	592.86	329.42	402	81.84	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10745.2	D08		3	0132-0332	142.97	332.76	382	76.08	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11393.8	D08		3	0133-0336	321.90	335.75	386	81.98	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11522.5	D08		3	0134-0338	833.06	338.06	514	88.67	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11643.7	D08		3	0135-0338	236.53	338.87	364	74.91	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11976.2	D08		3	0136-0339	675.27	339.86	348	71.84	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11958.3	D08		3	0137-0341	539.42	341.78	376	73.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12045.7	D08		3	0138-0342	45.16	342.09	343	72.67	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11872.8	D08		3	0139-0341	360.98	341.59	365	71.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12191.5	D08		3	0140-0342	741.96	343.01	367	72.43	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12497.8	D08		3	0141-0343	814.07	343.20	311	71.01	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10407.4	D08		3	0142-0352	180.69	352.91	376	80.91	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10141.8	D08		3	0143-0351	911.96	351.27	378	74.91	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11465.6	D08		3	0144-0354	313.52	354.52	377	78.33	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10762.9	D08		3	0145-0355	79.89	355.22	324	72.57	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11796.8	D08		3	0146-0364	113.88	364.88	334	72.91	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11456.8	D08		3	0147-0368	472.96	368.59	712	106.57	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10957.0	D08		3	0148-0373	521.62	372.76	374	76.33	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11579.8	D08		3	0149-0376	665.34	376.52	366	74.91	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10526.4	D08		3	0150-0376	394.46	376.46	359	71.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11230.1	D08		3	0151-0374	711.16	374.31	395	76.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11177.1	D08		3	0152-0378	147.07	378.11	334	78.57	0.680
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10323.0	D08		3	0153-0378	329.62	377.69	360	78.33	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10931.5	D08		3	0154-0382	866.90	381.25	375	76.91	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11951.8	D08		3	0155-0381	32.21	381.87	321	68.43	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11712.9	D08		3	0156-0381	919.31	381.04	350	70.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12139.9	D08		3	0157-0384	258.75	383.93	340	71.26	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11097.5	D08		3	0158-0388	195.57	388.17	350	74.33	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11997.1	D08		3	0159-0387	732.51	386.63	311	66.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11757.2	D08		3	0160-0389	547.02	389.11	374	74.91	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11467.1	D08		3	0161-0395	231.76	395.64	345	74.91	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11616.7	D08		3	0162-0395	819.43	395.72	362	71.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12142.1	D08		3	0163-0396	119.41	396.33	326	69.26	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12859.6	D08		3	0164-0398	477.43	398.21	310	64.77	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11317.6	D08		3	0165-0399	751.44	398.79	398	77.74	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11900.0	D08		3	0166-0402	304.30	401.92	380	73.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11042.1	D08		3	0167-0410	371.75	410.15	720	105.88	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10675.1	D08		3	0168-0403	438.20	403.57	370	74.08	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10857.5	D08		3	0169-0421	593.76	420.87	363	78.91	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11890.2	D08		3	0170-0421	718.80	421.57	380	77.15	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11511.5	D08		3	0171-0423	774.90	423.59	361	75.84	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10432.5	D08		3	0172-0428	33.62	428.69	325	72.91	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11023.4	D08		3	0173-0431	269.61	431.74	353	76.91	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11177.1	D08		3	0174-0431	528.13	432.17	372	77.94	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12704.2	D08		3	0175-0436	693.67	436.44	627	99.64	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11619.8	D08		3	0176-0447	421.89	446.54	748	106.95	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12200.6	D08		3	0177-0440	641.30	440.64	368	74.57	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11446.8	D08		3	0178-0446	162.63	445.35	712	105.88	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16718.8	D08		3	0179-0443	218.47	442.01	246	66.18	0.706
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10283.6	D08		3	0180-0444	231.04	446.37	219	63.70	0.678
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11716.9	D08		3	0181-0448	196.51	448.67	338	72.43	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11440.9	D08		3	0182-0447	315.10	447.79	367	74.91	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10780.2	D08		3	0183-0452	248.41	451.51	349	71.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10720.5	D08		3	0184-0455	527.89	453.68	409	81.84	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10364.5	D08		3	0185-0461	105.25	461.70	375	81.15	0.716
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10669.0	D08		3	0186-0463	71.14	463.23	353	73.26	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12091.0	D08		3	0187-0465	761.22	465.32	369	71.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10743.0	D08		3	0188-0473	624.44	473.31	375	72.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11070.4	D08		3	0189-0476	471.95	476.54	334	72.91	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11502.5	D08		3	0190-0475	851.66	474.90	353	71.01	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10459.8	D08		3	0191-0476	125.82	475.90	352	77.98	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10389.1	D08		3	0192-0482	929.08	482.82	380	78.33	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10967.1	D08		3	0193-0481	238.90	481.00	375	78.57	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10685.3	D08		3	0194-0484	565.52	484.47	368	73.26	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11471.0	D08		3	0195-0488	798.10	488.09	378	76.43	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11287.9	D08		3	0196-0490	720.05	490.02	371	72.67	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11514.1	D08		3	0197-0495	687.56	495.55	364	71.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10554.6	D08		3	0198-0502	601.36	502.21	361	73.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11013.7	D08		3	0199-0504	491.17	503.98	359	76.08	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11034.7	D08		3	0200-0507	230.55	507.90	370	78.33	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11827.4	D08		3	0201-0504	441.48	503.77	353	71.26	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11745.6	D08		3	0202-0506	356.38	506.34	353	72.43	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10434.0	D08		3	0203-0506	76.00	505.92	340	70.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10858.8	D08		3	0204-0510	806.46	509.69	392	81.40	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11111.5	D08		3	0205-0523	274.92	522.77	728	119.78	0.638
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12066.3	D08		3	0206-0520	851.06	520.43	723	112.13	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12934.5	D08		3	0207-0523	183.08	523.49	582	96.81	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11260.1	D08		3	0208-0520	757.32	519.80	372	73.60	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11295.4	D08		3	0209-0522	314.99	522.71	377	72.67	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11743.4	D08		3	0210-0522	481.03	522.56	359	72.67	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11910.6	D08		3	0211-0527	637.44	527.40	373	76.33	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12716.6	D08		3	0212-0525	673.36	524.83	333	68.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12124.5	D08		3	0213-0538	359.97	537.89	341	72.91	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11401.1	D08		3	0214-0537	580.54	536.99	352	72.67	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11107.3	D08		3	0215-0541	941.09	541.53	352	74.57	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10638.3	D08		3	0216-0542	537.15	541.76	363	72.67	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10761.2	D08		3	0217-0557	213.58	557.20	748	119.92	0.654
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10656.4	D08		3	0218-0553	484.31	553.43	396	77.26	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11734.7	D08		3	0219-0554	506.06	554.20	357	72.53	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11581.5	D08		3	0220-0556	736.72	556.00	352	72.91	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11861.6	D08		3	0221-0560	682.76	559.13	385	76.67	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11093.0	D08		3	0222-0561	74.33	561.65	327	68.67	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11329.8	D08		3	0223-0565	910.29	565.48	745	106.57	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13470.6	D08		3	0224-0565	782.87	565.60	625	96.57	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10454.2	D08		3	0225-0567	301.69	568.06	352	79.74	0.696
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12437.8	D08		3	0226-0569	343.30	569.80	330	68.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11923.2	D08		3	0227-0571	427.05	571.92	349	71.84	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11272.3	D08		3	0228-0587	52.37	586.47	695	104.57	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10505.3	D08		3	0229-0589	257.48	589.00	357	73.60	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10611.1	D08		3	0230-0588	216.44	588.13	373	76.08	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11478.7	D08		3	0231-0588	675.96	588.21	372	74.08	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10915.4	D08		3	0232-0589	132.62	588.97	371	74.91	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11310.1	D08		3	0233-0596	504.56	596.61	816	112.13	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11989.8	D08		3	0234-0590	747.04	590.11	349	71.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12660.2	D08		3	0235-0598	541.23	597.72	647	103.40	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9886.9	D08		3	0236-0596	632.60	596.40	377	78.57	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10691.2	D08		3	0237-0603	585.14	603.71	378	75.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14817.6	D08		3	0238-0600	373.07	600.30	254	59.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12665.2	D08		3	0239-0603	923.84	602.96	310	66.43	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10725.0	D08		3	0240-0604	114.56	604.19	360	79.15	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13940.5	D08		3	0241-0621	767.20	622.36	953	139.78	0.613
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11019.1	D08		3	0242-0608	873.87	607.69	343	75.15	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9679.5	D08		3	0243-0619	887.26	619.02	411	81.15	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11447.8	D08		3	0244-0617	824.32	617.02	347	70.67	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12689.7	D08		3	0245-0621	358.11	621.50	605	95.40	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10526.8	D08		3	0246-0620	736.77	620.01	369	81.98	0.690
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10884.2	D08		3	0247-0619	389.04	619.47	348	72.08	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12097.3	D08		3	0248-0626	210.28	626.97	308	71.36	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11454.8	D08		3	0249-0631	692.35	631.02	357	79.98	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13703.9	D08		3	0250-0632	846.96	632.32	249	57.36	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12110.3	D08		3	0251-0636	620.94	636.44	368	73.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10585.0	D08		3	0252-0638	328.05	638.02	417	85.15	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11679.9	D08		3	0253-0642	35.07	642.13	314	71.01	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11437.4	D08		3	0254-0643	168.48	643.62	337	71.50	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10632.5	D08		3	0255-0645	212.27	643.20	363	77.60	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11956.3	D08		3	0256-0650	129.25	650.17	437	81.74	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14448.9	D08		3	0257-0649	798.87	649.68	206	73.50	0.479
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11867.1	D08		3	0258-0654	92.12	653.99	352	70.67	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11692.3	D08		3	0259-0653	558.56	653.05	375	73.84	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12355.5	D08		3	0260-0653	675.92	653.29	342	73.84	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11016.0	D08		3	0261-0659	342.21	659.10	369	83.98	0.657
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10871.1	D08		3	0262-0660	203.39	661.36	396	79.98	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11157.0	D08		3	0263-0663	904.83	662.51	330	69.26	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9425.6	D08		3	0264-0667	947.34	667.52	341	73.84	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12173.8	D08		3	0265-0669	683.59	669.86	372	78.43	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11336.3	D08		3	0266-0674	610.07	674.02	369	74.91	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11149.9	D08		3	0267-0672	488.26	672.92	362	72.67	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11901.9	D08		3	0268-0675	720.71	675.02	357	74.67	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11881.7	D08		3	0269-0685	89.67	685.35	313	65.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11294.6	D08		3	0270-0684	138.76	684.98	315	66.43	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10785.2	D08		3	0271-0688	179.16	688.67	338	71.50	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11864.4	D08		3	0272-0690	896.32	690.52	318	72.33	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12396.0	D08		3	0273-0700	25.13	699.98	615	97.40	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9698.8	D08		3	0274-0697	699.75	697.18	375	76.08	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12964.1	D08		3	0275-0693	363.48	693.79	196	72.77	0.465
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184614	1375329	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10860.8	D08		3	0276-0707	831.30	707.12	348	71.70	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10278.4	D08		4	0001-0039	733.93	39.86	628	95.74	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11061.4	D08		4	0002-0049	816.27	48.21	984	128.23	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8215.2	D08		4	0003-0047	340.50	45.67	547	92.47	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9398.7	D08		4	0004-0045	603.98	44.77	467	82.91	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9987.8	D08		4	0005-0048	902.79	48.58	451	79.50	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8000.1	D08		4	0006-0049	366.86	49.04	475	82.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9025.8	D08		4	0007-0053	759.08	52.52	483	88.67	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9866.8	D08		4	0008-0055	249.77	55.49	442	78.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10397.3	D08		4	0009-0056	945.82	56.49	406	75.26	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9623.4	D08		4	0010-0056	99.02	56.17	435	83.50	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9321.6	D08		4	0011-0061	322.34	62.53	456	81.98	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8224.5	D08		4	0012-0064	75.47	64.64	501	87.94	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8933.1	D08		4	0013-0066	620.14	67.05	499	85.98	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9585.1	D08		4	0014-0071	446.82	70.23	938	125.44	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10000.3	D08		4	0015-0073	669.51	73.09	432	76.43	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9187.3	D08		4	0016-0077	835.66	77.03	516	88.71	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9707.2	D08		4	0017-0077	744.64	78.29	438	80.43	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9474.2	D08		4	0018-0080	545.97	80.59	922	121.30	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9422.6	D08		4	0019-0086	80.39	85.76	433	82.08	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10454.4	D08		4	0020-0090	179.51	90.53	727	103.64	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9283.0	D08		4	0021-0096	849.52	96.88	428	81.15	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10882.5	D08		4	0022-0097	118.83	97.58	763	103.40	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9354.1	D08		4	0023-0100	519.10	99.71	481	85.74	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9352.5	D08		4	0024-0100	348.91	100.90	383	75.50	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9787.1	D08		4	0025-0102	889.05	102.48	431	77.26	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10070.1	D08		4	0026-0105	706.22	105.50	424	76.67	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9367.9	D08		4	0027-0114	78.30	115.10	429	85.26	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9804.6	D08		4	0028-0113	624.49	113.53	484	84.33	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9968.3	D08		4	0029-0115	801.67	114.62	416	77.50	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9845.1	D08		4	0030-0116	387.80	116.12	561	90.08	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9855.8	D08		4	0031-0123	266.03	123.08	434	78.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9855.8	D08		4	0032-0124	770.35	123.97	438	80.91	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10076.1	D08		4	0033-0124	676.92	124.50	422	76.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9850.0	D08		4	0034-0142	319.72	142.15	433	79.74	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9843.0	D08		4	0035-0148	217.28	148.11	423	76.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9702.2	D08		4	0036-0153	718.54	153.51	431	82.77	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10089.5	D08		4	0037-0159	843.33	158.44	853	112.71	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9916.4	D08		4	0038-0158	145.77	159.32	864	116.23	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9588.7	D08		4	0039-0168	270.56	168.62	924	119.88	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9904.1	D08		4	0040-0168	358.99	168.27	488	84.33	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9844.7	D08		4	0041-0166	664.94	166.66	434	79.50	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9614.2	D08		4	0042-0172	406.55	172.28	479	82.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10186.8	D08		4	0043-0173	716.05	172.21	435	79.11	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9883.4	D08		4	0044-0175	24.26	175.99	395	75.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9114.9	D08		4	0045-0180	572.58	180.40	513	88.91	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9872.5	D08		4	0046-0181	609.93	180.72	439	78.08	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9160.6	D08		4	0047-0184	543.08	183.36	499	87.40	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9573.7	D08		4	0048-0185	883.86	185.73	451	79.26	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9875.8	D08		4	0049-0195	792.79	195.10	446	78.91	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9427.5	D08		4	0050-0195	215.19	194.82	391	71.60	0.958
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8422.3	D08		4	0051-0196	183.93	196.02	391	72.18	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12595.9	D08		4	0052-0198	266.48	198.05	625	94.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9936.3	D08		4	0053-0197	858.04	196.41	430	79.50	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9452.3	D08		4	0054-0201	452.45	201.56	438	79.50	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9768.8	D08		4	0055-0201	145.36	200.44	437	79.26	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9826.0	D08		4	0056-0202	916.56	202.45	431	77.26	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9090.9	D08		4	0057-0213	537.22	213.14	511	91.40	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9823.9	D08		4	0058-0212	735.76	212.22	435	81.50	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9894.2	D08		4	0059-0225	336.76	224.68	832	114.81	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9872.0	D08		4	0060-0227	206.08	226.23	399	79.15	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9475.1	D08		4	0061-0226	418.21	226.03	428	79.50	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10656.8	D08		4	0062-0227	890.19	227.21	818	116.67	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9864.5	D08		4	0063-0245	648.73	245.57	889	123.05	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9232.5	D08		4	0064-0239	554.99	239.38	488	86.33	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8878.8	D08		4	0065-0248	196.20	249.17	476	90.81	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10112.8	D08		4	0066-0249	602.93	249.45	434	78.33	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9876.0	D08		4	0067-0255	723.00	255.13	440	78.67	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9775.9	D08		4	0068-0258	391.21	258.14	441	77.26	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9865.1	D08		4	0069-0263	692.44	264.22	439	79.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9887.4	D08		4	0070-0268	225.86	267.89	430	78.91	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9807.8	D08		4	0071-0267	259.01	267.57	426	79.50	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9821.7	D08		4	0072-0273	54.20	273.66	414	80.33	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9798.8	D08		4	0073-0275	426.18	274.91	483	83.50	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9166.5	D08		4	0074-0282	565.08	282.42	965	129.78	0.720
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9729.2	D08		4	0075-0274	917.38	275.01	446	79.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9500.1	D08		4	0076-0276	842.17	276.79	446	82.91	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9083.4	D08		4	0077-0286	325.72	285.68	477	84.91	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9008.7	D08		4	0078-0291	690.26	290.59	484	87.01	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9695.3	D08		4	0079-0289	163.66	288.76	423	75.26	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7980.4	D08		4	0080-0295	69.01	296.21	555	93.01	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10281.7	D08		4	0081-0298	631.28	298.98	823	111.30	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10207.4	D08		4	0082-0297	92.75	297.45	410	76.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9900.3	D08		4	0083-0298	486.50	297.74	444	79.50	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10076.6	D08		4	0084-0296	730.71	296.02	421	77.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10360.4	D08		4	0085-0309	336.67	309.13	741	102.91	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9912.8	D08		4	0086-0310	792.80	310.62	440	79.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8759.3	D08		4	0087-0314	583.95	314.44	503	91.84	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9614.0	D08		4	0088-0319	915.92	319.07	927	119.20	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10056.9	D08		4	0089-0323	526.57	322.61	442	78.08	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9501.7	D08		4	0090-0329	369.87	328.39	447	80.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10229.4	D08		4	0091-0333	741.86	333.44	431	77.26	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9447.7	D08		4	0092-0335	405.26	335.05	449	79.50	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9929.6	D08		4	0093-0338	442.23	337.84	665	97.64	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10077.1	D08		4	0094-0339	696.49	338.86	459	81.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9638.6	D08		4	0095-0341	573.65	341.09	457	84.91	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9301.3	D08		4	0096-0341	279.50	340.56	475	82.91	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9690.8	D08		4	0097-0345	217.15	344.72	442	78.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9015.3	D08		4	0098-0350	353.90	350.58	483	87.74	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9711.5	D08		4	0099-0350	829.44	351.06	433	78.33	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9692.5	D08		4	0100-0357	882.34	358.36	885	117.54	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9945.5	D08		4	0101-0353	512.95	353.82	454	80.08	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9213.6	D08		4	0102-0357	263.78	357.96	479	86.23	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9201.7	D08		4	0103-0361	645.71	361.63	519	88.67	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9358.9	D08		4	0104-0364	616.45	364.48	490	86.57	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10033.2	D08		4	0105-0365	788.10	365.64	480	81.84	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9765.2	D08		4	0106-0369	420.08	369.56	434	79.26	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10215.1	D08		4	0107-0378	935.44	378.34	450	80.67	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	222.4	D08		4	0108-0378	149.62	378.56	429	75.84	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9203.5	D08		4	0109-0384	640.88	384.35	489	87.60	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9621.4	D08		4	0110-0384	307.53	384.07	449	79.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8907.7	D08		4	0111-0390	83.47	390.26	414	78.33	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10767.0	D08		4	0112-0398	358.78	397.74	826	108.47	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9560.1	D08		4	0113-0398	798.87	397.96	445	84.33	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8069.6	D08		4	0114-0402	595.24	401.63	512	86.23	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9125.9	D08		4	0115-0405	654.01	406.06	567	92.57	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9822.6	D08		4	0116-0405	260.98	405.31	536	88.57	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9532.7	D08		4	0117-0411	535.96	411.71	918	120.23	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9932.9	D08		4	0118-0415	484.12	415.53	806	109.74	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9878.3	D08		4	0119-0415	210.19	414.84	911	116.23	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9828.9	D08		4	0120-0419	869.62	418.01	472	82.08	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10377.6	D08		4	0121-0420	459.39	420.85	457	85.01	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9134.9	D08		4	0122-0423	568.03	423.12	489	85.01	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9190.3	D08		4	0123-0427	783.26	427.75	947	124.47	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9843.8	D08		4	0124-0426	125.16	426.22	419	76.91	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9946.0	D08		4	0125-0431	755.86	431.24	422	80.77	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9998.2	D08		4	0126-0432	385.87	432.72	436	78.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9963.6	D08		4	0127-0435	285.51	435.86	415	75.01	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9763.2	D08		4	0128-0441	66.09	440.53	406	76.43	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10436.8	D08		4	0129-0448	28.71	448.46	574	88.67	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9716.4	D08		4	0130-0449	849.09	449.39	468	81.26	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9964.9	D08		4	0131-0449	896.40	449.15	435	81.15	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9876.9	D08		4	0132-0455	176.90	455.44	435	78.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9447.9	D08		4	0133-0461	630.96	461.45	461	83.74	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9637.2	D08		4	0134-0465	564.54	465.61	437	78.08	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9390.1	D08		4	0135-0465	763.23	465.37	464	82.43	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9412.6	D08		4	0136-0472	232.27	472.22	487	86.57	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9290.3	D08		4	0137-0470	509.73	470.31	422	79.36	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9815.2	D08		4	0138-0469	699.93	469.21	469	81.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9205.6	D08		4	0139-0472	734.89	472.71	504	85.15	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10864.3	D08		4	0140-0473	528.11	473.56	367	75.94	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8933.3	D08		4	0141-0478	96.54	477.90	456	84.08	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9908.8	D08		4	0142-0476	414.40	476.81	439	79.50	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9529.8	D08		4	0143-0484	252.34	484.70	460	84.57	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9958.7	D08		4	0144-0488	937.61	487.58	406	76.08	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9514.2	D08		4	0145-0487	820.13	486.87	287	65.84	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9878.0	D08		4	0146-0491	902.85	490.85	434	78.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8892.4	D08		4	0147-0493	703.55	492.97	483	86.43	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9938.6	D08		4	0148-0496	143.65	496.51	421	78.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9831.5	D08		4	0149-0501	304.77	501.57	431	77.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9865.9	D08		4	0150-0506	60.78	505.86	443	79.26	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8997.7	D08		4	0151-0510	915.79	510.77	476	84.33	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9872.5	D08		4	0152-0512	522.77	512.19	463	82.57	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9765.4	D08		4	0153-0518	459.30	518.98	448	80.08	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9812.1	D08		4	0154-0525	620.07	525.23	571	92.33	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9415.2	D08		4	0155-0527	836.57	527.33	282	64.18	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9918.6	D08		4	0156-0529	360.05	529.94	429	79.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9415.1	D08		4	0157-0536	213.40	535.85	972	125.30	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9537.5	D08		4	0158-0534	407.41	533.57	504	85.74	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9307.5	D08		4	0159-0535	579.10	535.16	529	91.40	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9936.4	D08		4	0160-0534	23.69	534.42	407	75.26	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9494.2	D08		4	0161-0535	718.74	534.88	466	81.26	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9906.1	D08		4	0162-0550	73.80	550.34	433	80.08	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9636.8	D08		4	0163-0551	781.30	551.45	459	79.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8518.3	D08		4	0164-0552	361.37	551.17	526	89.60	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9936.7	D08		4	0165-0554	444.12	555.08	426	78.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9617.0	D08		4	0166-0560	496.05	559.90	449	79.26	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9209.8	D08		4	0167-0561	717.51	561.75	514	86.33	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8990.6	D08		4	0168-0562	409.60	562.68	472	82.33	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8364.6	D08		4	0169-0567	933.70	566.31	553	96.13	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9823.8	D08		4	0170-0565	628.41	565.59	465	80.67	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9878.0	D08		4	0171-0568	32.00	567.88	411	75.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9360.1	D08		4	0172-0573	259.57	571.93	451	81.40	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9835.7	D08		4	0173-0574	546.75	574.82	461	81.26	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10070.4	D08		4	0174-0577	109.77	577.72	423	75.26	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9786.2	D08		4	0175-0581	316.05	581.14	554	88.08	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10846.6	D08		4	0176-0584	909.84	584.85	803	114.95	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9692.9	D08		4	0177-0579	803.61	578.83	480	81.50	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9039.3	D08		4	0178-0581	649.40	580.88	509	88.81	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9127.0	D08		4	0179-0590	244.16	591.10	457	84.23	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9631.6	D08		4	0180-0594	470.06	594.13	422	77.01	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9844.6	D08		4	0181-0595	357.99	594.48	437	77.84	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9487.1	D08		4	0182-0601	707.62	600.99	472	81.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9721.1	D08		4	0183-0603	861.60	603.94	748	106.91	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10022.0	D08		4	0184-0602	593.70	602.36	432	78.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9007.1	D08		4	0185-0605	803.17	605.81	480	84.53	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9861.7	D08		4	0186-0605	189.40	604.80	467	80.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9581.3	D08		4	0187-0605	682.74	605.51	455	78.67	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9837.2	D08		4	0188-0608	829.34	608.71	803	110.53	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9893.3	D08		4	0189-0609	407.77	609.26	430	77.84	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9200.0	D08		4	0190-0617	48.28	617.11	419	76.08	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9465.4	D08		4	0191-0618	73.94	618.25	435	80.33	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9877.5	D08		4	0192-0620	534.59	620.39	454	83.15	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9390.9	D08		4	0193-0629	652.35	629.74	426	76.43	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9577.5	D08		4	0194-0630	464.45	630.65	459	81.50	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9896.8	D08		4	0195-0631	347.40	631.22	432	76.43	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11087.5	D08		4	0196-0637	166.84	637.00	673	98.81	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10165.6	D08		4	0197-0633	766.19	633.25	448	77.84	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9937.9	D08		4	0198-0637	824.14	634.50	444	83.50	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9843.1	D08		4	0199-0647	616.31	647.51	434	80.08	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9276.8	D08		4	0200-0648	893.26	647.73	452	83.74	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10070.8	D08		4	0201-0647	413.25	647.58	436	79.74	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9154.1	D08		4	0202-0649	811.68	650.31	462	82.47	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9750.9	D08		4	0203-0655	284.65	655.64	972	129.68	0.726
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9991.4	D08		4	0204-0650	16.51	650.72	409	75.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10133.1	D08		4	0205-0652	564.80	652.91	437	77.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9479.7	D08		4	0206-0655	245.76	654.93	477	87.40	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10552.8	D08		4	0207-0654	60.03	654.59	350	73.36	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10041.4	D08		4	0208-0664	490.73	665.09	551	88.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9338.0	D08		4	0209-0666	107.18	667.24	437	78.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9500.0	D08		4	0210-0670	130.35	670.03	437	81.01	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9054.8	D08		4	0211-0673	66.05	672.95	487	87.01	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9927.9	D08		4	0212-0675	315.43	675.38	458	79.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9636.1	D08		4	0213-0674	384.40	674.78	439	78.91	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9703.6	D08		4	0214-0676	671.90	676.16	437	77.84	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9970.4	D08		4	0215-0677	806.78	677.74	428	79.98	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9665.5	D08		4	0216-0678	219.18	677.65	431	79.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9170.9	D08		4	0217-0680	741.32	680.44	490	87.40	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9899.1	D08		4	0218-0687	521.67	686.81	448	80.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9434.5	D08		4	0219-0690	185.53	690.11	483	87.15	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9765.1	D08		4	0220-0691	426.22	691.59	414	78.18	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8041.2	D08		4	0221-0698	66.48	698.47	483	87.01	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8739.2	D08		4	0222-0697	210.17	697.67	479	90.91	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9289.1	D08		4	0223-0698	848.47	697.67	448	77.84	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184615	1375330	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10946.7	D08		4	0224-0707	801.44	707.13	338	68.77	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10811.5	D08		5	0001-0033	823.63	32.06	394	74.57	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9912.6	D08		5	0002-0040	391.44	40.78	457	81.84	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10904.4	D08		5	0003-0045	808.53	46.12	380	75.15	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10641.2	D08		5	0004-0045	921.84	46.04	389	78.18	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10768.5	D08		5	0005-0057	318.33	57.37	778	114.23	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10378.3	D08		5	0006-0057	470.15	57.03	421	78.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10707.2	D08		5	0007-0059	50.54	59.00	386	73.84	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11931.8	D08		5	0008-0059	875.92	59.73	269	82.67	0.495
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9812.7	D08		5	0009-0064	397.42	64.22	486	85.84	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10266.1	D08		5	0010-0072	670.92	70.92	819	114.67	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9506.6	D08		5	0011-0071	701.38	70.53	485	87.26	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10427.1	D08		5	0012-0078	543.90	78.14	825	118.71	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10382.7	D08		5	0013-0079	388.66	79.65	130	44.87	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12353.2	D08		5	0014-0085	382.58	87.38	154	58.53	0.565
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11567.1	D08		5	0015-0088	516.98	88.31	354	71.94	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10661.1	D08		5	0016-0093	277.12	93.36	398	75.50	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10259.4	D08		5	0017-0096	633.80	96.06	425	79.26	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10567.0	D08		5	0018-0092	945.00	92.43	416	78.43	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10428.2	D08		5	0019-0099	599.93	98.67	415	77.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10378.6	D08		5	0020-0098	798.67	98.19	423	77.84	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10443.8	D08		5	0021-0100	350.48	100.44	400	75.84	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10682.0	D08		5	0022-0103	71.65	102.95	395	74.67	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12192.0	D08		5	0023-0108	561.28	107.76	640	93.74	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9746.8	D08		5	0024-0112	237.80	112.01	503	85.60	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10249.8	D08		5	0025-0115	454.33	115.52	438	81.74	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10640.5	D08		5	0026-0117	179.42	116.83	392	74.67	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10803.4	D08		5	0027-0118	842.12	118.62	387	73.84	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12459.8	D08		5	0028-0128	945.20	127.33	658	98.67	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9511.8	D08		5	0029-0147	230.98	146.68	883	128.37	0.673
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10333.2	D08		5	0030-0139	417.82	138.92	432	76.43	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10039.4	D08		5	0031-0140	799.39	139.77	419	79.01	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10596.5	D08		5	0032-0143	72.31	143.04	380	72.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10252.3	D08		5	0033-0146	778.08	146.59	408	77.01	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10269.5	D08		5	0034-0149	501.54	148.63	457	80.08	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10733.1	D08		5	0035-0147	714.83	147.15	405	76.08	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10309.0	D08		5	0036-0160	304.21	160.53	837	111.54	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10481.2	D08		5	0037-0160	551.40	160.00	437	81.26	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10437.7	D08		5	0038-0159	625.81	159.03	413	75.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10865.4	D08		5	0039-0163	379.49	163.25	810	111.15	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9733.7	D08		5	0040-0174	218.07	175.08	417	82.33	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9954.7	D08		5	0041-0179	124.30	179.69	857	121.40	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10407.2	D08		5	0042-0182	593.02	181.99	397	76.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10617.5	D08		5	0043-0184	800.09	184.08	393	76.33	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9866.5	D08		5	0044-0195	190.64	195.14	411	81.74	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10833.1	D08		5	0045-0200	860.90	200.69	769	107.64	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10360.3	D08		5	0046-0195	714.01	195.36	418	78.43	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10322.7	D08		5	0047-0204	21.44	204.91	378	76.08	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10564.9	D08		5	0048-0205	71.47	204.85	372	72.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10918.3	D08		5	0049-0211	769.60	211.45	384	74.43	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10452.8	D08		5	0050-0211	468.68	211.28	418	76.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10606.1	D08		5	0051-0214	390.48	213.72	396	75.26	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9818.7	D08		5	0052-0214	734.86	213.37	442	81.01	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9817.1	D08		5	0053-0216	210.48	216.18	445	86.91	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12754.2	D08		5	0054-0212	116.41	212.94	148	51.70	0.696
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10425.1	D08		5	0055-0217	343.50	217.58	399	75.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11636.9	D08		5	0056-0219	649.48	218.86	377	75.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10726.5	D08		5	0057-0225	668.86	226.35	406	82.08	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10938.2	D08		5	0058-0233	554.22	233.81	778	108.23	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10567.4	D08		5	0059-0240	133.89	240.37	385	76.08	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10667.4	D08		5	0060-0248	172.10	248.69	390	74.08	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10491.6	D08		5	0061-0249	56.46	249.02	394	76.08	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10574.6	D08		5	0062-0252	262.48	252.37	426	77.01	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10515.2	D08		5	0063-0252	522.43	252.74	411	80.91	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10930.4	D08		5	0064-0259	941.70	259.65	758	108.71	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10069.9	D08		5	0065-0263	621.63	263.24	862	124.51	0.699
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10533.3	D08		5	0066-0268	474.24	267.82	820	112.81	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10721.8	D08		5	0067-0265	748.25	265.65	425	76.67	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9860.3	D08		5	0068-0268	784.21	268.90	423	82.57	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9871.2	D08		5	0069-0274	346.42	275.00	450	80.43	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10960.2	D08		5	0070-0280	397.61	280.07	764	105.54	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10522.7	D08		5	0071-0274	865.76	273.84	395	74.08	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10609.9	D08		5	0072-0278	121.12	277.83	379	73.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10580.3	D08		5	0073-0277	22.55	277.44	368	73.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10360.5	D08		5	0074-0285	547.62	284.98	407	77.74	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10003.8	D08		5	0075-0285	323.56	284.72	457	81.26	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10379.2	D08		5	0076-0287	260.67	287.23	413	79.50	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10799.8	D08		5	0077-0301	806.06	301.60	896	117.40	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10560.6	D08		5	0078-0301	685.93	301.04	293	63.94	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10397.7	D08		5	0079-0310	430.22	310.43	398	80.33	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10376.1	D08		5	0080-0316	97.58	316.25	428	80.33	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10889.2	D08		5	0081-0314	859.62	313.58	405	78.57	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10081.0	D08		5	0082-0321	21.04	321.60	824	115.68	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9725.5	D08		5	0083-0314	518.69	314.61	381	77.84	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10389.9	D08		5	0084-0323	283.64	323.05	405	78.08	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10346.3	D08		5	0085-0327	344.62	327.27	406	78.33	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10506.5	D08		5	0086-0328	873.27	329.35	403	77.50	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12637.3	D08		5	0087-0330	907.98	329.91	310	64.77	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10243.2	D08		5	0088-0333	223.33	333.96	410	75.26	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11815.8	D08		5	0089-0337	410.57	337.30	756	107.74	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10098.2	D08		5	0090-0338	169.04	337.99	379	77.50	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10245.7	D08		5	0091-0336	660.17	336.80	610	97.15	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10751.9	D08		5	0092-0343	929.00	343.31	782	113.88	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10338.5	D08		5	0093-0344	722.89	344.38	405	76.67	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11148.6	D08		5	0094-0351	438.25	351.57	739	106.57	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10516.1	D08		5	0095-0346	552.67	346.48	413	77.26	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9443.1	D08		5	0096-0347	786.35	346.22	441	83.60	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10656.3	D08		5	0097-0354	761.47	354.39	397	77.84	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10526.9	D08		5	0098-0359	854.76	359.24	407	77.50	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10476.9	D08		5	0099-0360	135.44	360.45	392	76.91	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10921.3	D08		5	0100-0363	589.18	362.90	402	74.43	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10318.0	D08		5	0101-0367	273.26	367.66	450	81.74	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11012.2	D08		5	0102-0365	897.87	364.97	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10767.7	D08		5	0103-0376	484.26	375.96	819	108.71	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10402.3	D08		5	0104-0375	377.85	374.63	416	78.08	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9845.3	D08		5	0105-0378	304.46	378.42	424	78.67	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10294.4	D08		5	0106-0380	40.49	380.98	425	78.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10692.3	D08		5	0107-0386	833.52	386.16	399	75.84	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10483.8	D08		5	0108-0388	630.64	387.98	450	82.33	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10346.1	D08		5	0109-0396	411.42	396.40	397	76.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10242.5	D08		5	0110-0401	740.54	401.57	418	77.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10345.0	D08		5	0111-0404	366.68	404.38	414	76.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10557.6	D08		5	0112-0406	217.90	406.82	369	74.67	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10442.7	D08		5	0113-0408	175.02	408.75	399	76.91	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9975.9	D08		5	0114-0411	715.24	410.60	451	84.33	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9306.7	D08		5	0115-0412	535.17	412.48	466	85.15	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11150.9	D08		5	0116-0418	907.23	417.81	194	52.53	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10458.0	D08		5	0117-0426	802.16	426.03	435	81.74	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10780.3	D08		5	0118-0427	257.71	426.72	386	73.84	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9839.4	D08		5	0119-0427	610.99	426.01	452	86.57	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10173.6	D08		5	0120-0427	511.47	427.34	436	80.91	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10532.8	D08		5	0121-0426	869.44	427.90	301	66.28	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9779.0	D08		5	0122-0430	942.75	429.56	334	72.77	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10390.0	D08		5	0123-0433	475.18	432.91	417	79.50	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10121.9	D08		5	0124-0438	60.42	438.38	370	77.50	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10988.3	D08		5	0125-0443	929.10	443.80	381	72.91	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10196.0	D08		5	0126-0447	231.28	446.57	418	88.08	0.677
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9773.0	D08		5	0127-0447	869.40	446.16	338	70.87	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10401.6	D08		5	0128-0455	318.95	455.36	393	78.33	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11664.3	D08		5	0129-0462	835.61	462.47	606	91.50	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10422.4	D08		5	0130-0461	121.51	461.01	426	79.50	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10779.0	D08		5	0131-0460	443.24	460.54	409	77.50	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10370.9	D08		5	0132-0462	254.37	461.53	431	78.43	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9810.0	D08		5	0133-0466	215.21	467.13	426	78.91	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10575.1	D08		5	0134-0467	783.67	467.61	406	76.67	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10763.7	D08		5	0135-0472	525.52	471.82	416	76.91	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10683.5	D08		5	0136-0482	99.73	482.31	414	75.26	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10318.8	D08		5	0137-0485	143.43	484.89	386	75.26	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12840.2	D08		5	0138-0485	294.49	485.32	292	62.77	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10311.3	D08		5	0139-0490	42.99	490.22	383	74.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10701.6	D08		5	0140-0493	370.45	493.36	377	74.91	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10446.1	D08		5	0141-0496	644.54	496.59	415	76.91	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10106.3	D08		5	0142-0498	489.71	498.57	453	82.33	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11273.6	D08		5	0143-0502	831.89	502.01	368	72.67	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10279.8	D08		5	0144-0505	939.56	504.88	436	78.08	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9519.9	D08		5	0145-0508	68.46	508.47	432	79.94	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11289.6	D08		5	0146-0511	887.28	511.66	578	90.08	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9624.4	D08		5	0147-0513	20.77	513.26	404	82.08	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10076.7	D08		5	0148-0521	754.52	520.67	409	79.50	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10681.6	D08		5	0149-0523	586.44	523.30	406	78.57	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10562.9	D08		5	0150-0524	298.76	524.83	424	77.26	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10250.6	D08		5	0151-0525	442.76	524.94	407	78.67	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10433.0	D08		5	0152-0528	529.27	528.32	415	77.50	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11373.9	D08		5	0153-0532	108.82	532.31	738	105.64	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10120.6	D08		5	0154-0531	148.05	531.10	448	80.57	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10742.7	D08		5	0155-0529	482.41	529.37	398	74.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10217.1	D08		5	0156-0530	666.31	530.21	407	77.50	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10163.0	D08		5	0157-0531	67.98	529.96	405	77.36	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10781.0	D08		5	0158-0535	709.02	534.75	398	76.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10034.4	D08		5	0159-0550	905.81	549.96	845	121.64	0.718
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10867.6	D08		5	0160-0541	804.22	541.10	367	73.26	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10288.9	D08		5	0161-0543	390.29	543.81	425	79.01	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10144.3	D08		5	0162-0553	412.75	553.04	430	81.26	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9892.7	D08		5	0163-0559	149.09	559.16	557	89.98	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10656.3	D08		5	0164-0560	464.84	560.33	400	78.33	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10361.3	D08		5	0165-0569	757.35	568.12	809	107.88	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10169.5	D08		5	0166-0564	348.33	564.29	444	81.98	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9376.8	D08		5	0167-0569	39.10	568.04	453	84.47	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10657.5	D08		5	0168-0567	599.41	567.21	398	75.84	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10215.5	D08		5	0169-0582	279.61	582.60	861	126.71	0.674
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10379.2	D08		5	0170-0581	25.58	580.97	352	75.15	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10780.5	D08		5	0171-0579	110.23	579.37	378	73.84	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10340.2	D08		5	0172-0581	667.06	581.06	445	80.57	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9477.4	D08		5	0173-0584	58.54	584.46	433	79.15	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9667.7	D08		5	0174-0598	387.24	598.06	913	122.51	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11358.5	D08		5	0175-0592	848.30	591.58	355	69.01	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10791.0	D08		5	0176-0601	452.23	600.94	405	78.57	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10487.5	D08		5	0177-0604	636.33	604.11	417	77.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10412.2	D08		5	0178-0605	707.85	604.88	396	75.84	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10335.6	D08		5	0179-0603	894.34	602.57	424	80.67	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12755.5	D08		5	0180-0611	815.51	611.80	316	65.60	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10697.3	D08		5	0181-0617	749.57	616.84	418	75.84	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10423.9	D08		5	0182-0619	670.03	619.32	407	77.50	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9902.7	D08		5	0183-0627	85.01	627.41	849	117.20	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10246.3	D08		5	0184-0623	380.27	623.57	412	79.98	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10538.2	D08		5	0185-0624	486.57	623.68	408	75.50	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10089.0	D08		5	0186-0636	229.62	636.89	400	80.23	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10551.2	D08		5	0187-0637	896.43	636.89	386	74.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10936.0	D08		5	0188-0639	432.10	639.78	760	107.01	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9739.1	D08		5	0189-0641	399.89	641.34	684	104.91	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10616.5	D08		5	0190-0639	702.72	639.73	363	71.70	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11243.1	D08		5	0191-0641	684.59	641.16	340	70.04	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10921.3	D08		5	0192-0641	833.67	641.18	407	77.26	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10586.8	D08		5	0193-0641	578.90	641.25	386	74.67	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10398.1	D08		5	0194-0644	503.10	644.83	399	75.84	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11060.5	D08		5	0195-0646	792.39	647.04	771	113.05	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10467.7	D08		5	0196-0651	154.62	650.94	391	77.84	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10412.1	D08		5	0197-0653	362.74	653.67	433	81.50	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9950.9	D08		5	0198-0669	557.75	669.58	859	118.02	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10477.4	D08		5	0199-0667	730.14	666.77	409	76.33	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10803.1	D08		5	0200-0669	620.03	669.13	394	76.33	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10704.9	D08		5	0201-0668	678.40	668.34	407	77.26	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10540.7	D08		5	0202-0675	431.90	674.98	414	76.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10653.5	D08		5	0203-0674	318.41	674.03	391	77.01	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10646.9	D08		5	0204-0680	259.83	680.16	394	74.67	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10587.5	D08		5	0205-0682	774.12	682.45	378	72.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10193.6	D08		5	0206-0694	727.59	694.73	419	81.15	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10581.5	D08		5	0207-0694	519.50	694.35	396	74.67	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11258.4	D08		5	0208-0699	210.55	699.05	729	105.88	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10979.0	D08		5	0209-0698	806.63	698.16	371	73.26	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10636.5	D08		5	0210-0704	886.47	704.50	369	71.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184616	1375331	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10761.2	D08		5	0211-0706	606.42	706.48	384	75.50	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11044.4	D08		6	0001-0031	828.76	31.67	370	71.94	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11007.5	D08		6	0002-0037	847.51	38.12	368	77.60	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11129.1	D08		6	0003-0036	327.60	35.24	339	72.43	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10217.3	D08		6	0004-0042	302.39	41.52	863	121.78	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13254.5	D08		6	0005-0040	923.26	40.40	314	67.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11845.5	D08		6	0006-0048	798.39	47.76	768	107.98	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11217.1	D08		6	0007-0042	130.25	42.06	351	69.60	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11108.4	D08		6	0008-0045	391.38	45.09	404	77.50	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10762.3	D08		6	0009-0049	556.89	49.61	411	80.43	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10902.2	D08		6	0010-0048	597.94	48.65	393	75.50	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11576.5	D08		6	0011-0048	16.62	48.20	323	75.01	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10164.3	D08		6	0012-0053	446.87	53.50	949	121.15	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10766.1	D08		6	0013-0051	666.15	50.88	389	74.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10904.5	D08		6	0014-0065	197.75	64.91	752	110.71	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10752.9	D08		6	0015-0066	900.72	66.61	403	75.84	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9703.3	D08		6	0016-0075	285.42	75.45	803	119.44	0.707
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10834.2	D08		6	0017-0073	628.35	74.13	785	115.64	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11172.8	D08		6	0018-0074	434.92	74.70	330	70.77	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11546.9	D08		6	0019-0078	746.11	77.93	391	73.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11352.4	D08		6	0020-0087	113.81	87.17	714	109.40	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10775.1	D08		6	0021-0082	859.99	81.94	372	74.91	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11416.0	D08		6	0022-0085	374.04	84.87	392	73.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10801.3	D08		6	0023-0094	723.11	93.67	421	78.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10995.6	D08		6	0024-0093	487.55	92.71	394	76.43	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10862.5	D08		6	0025-0094	774.76	94.30	418	78.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11050.0	D08		6	0026-0095	39.55	95.36	380	73.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12736.2	D08		6	0027-0102	836.77	101.45	590	115.05	0.560
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11205.7	D08		6	0028-0099	255.89	99.19	382	75.50	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11443.1	D08		6	0029-0100	595.90	99.78	365	72.67	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11332.4	D08		6	0030-0109	422.07	109.20	401	74.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10711.1	D08		6	0031-0126	484.81	126.11	881	126.71	0.690
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12567.0	D08		6	0032-0131	39.36	130.44	645	96.08	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10912.8	D08		6	0033-0131	549.78	131.58	381	73.84	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11195.4	D08		6	0034-0131	623.75	131.32	378	73.01	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10687.4	D08		6	0035-0132	172.95	132.44	376	77.26	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11044.6	D08		6	0036-0138	663.74	138.16	402	76.08	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11023.5	D08		6	0037-0140	893.42	140.11	365	71.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11027.2	D08		6	0038-0141	808.06	140.48	388	75.84	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10972.5	D08		6	0039-0144	271.47	144.83	389	76.57	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11097.0	D08		6	0040-0146	420.14	146.29	720	105.98	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11763.9	D08		6	0041-0145	457.69	145.41	336	70.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11907.1	D08		6	0042-0145	731.89	144.61	357	71.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10420.5	D08		6	0043-0147	106.08	147.62	398	74.67	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10194.3	D08		6	0044-0146	132.63	146.74	389	80.57	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10088.2	D08		6	0045-0148	301.61	148.60	373	73.50	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10824.6	D08		6	0046-0148	505.48	148.16	399	77.01	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11344.9	D08		6	0047-0149	838.37	149.10	369	72.67	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9276.4	D08		6	0048-0153	190.42	152.90	356	80.43	0.692
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10678.7	D08		6	0049-0159	767.90	159.50	381	75.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10167.1	D08		6	0050-0159	605.24	159.53	411	76.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10350.1	D08		6	0051-0163	326.95	162.93	371	72.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10860.6	D08		6	0052-0162	560.70	162.97	397	76.67	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10290.7	D08		6	0053-0165	928.56	164.82	391	73.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11215.9	D08		6	0054-0167	685.73	167.59	399	73.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10874.7	D08		6	0055-0167	474.63	166.86	391	76.18	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11329.3	D08		6	0056-0171	364.60	171.26	369	73.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10255.1	D08		6	0057-0177	70.64	177.11	396	78.18	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10975.9	D08		6	0058-0178	578.94	178.43	399	75.84	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11814.0	D08		6	0059-0178	93.26	177.67	356	71.94	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11496.7	D08		6	0060-0180	519.28	180.24	369	71.26	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12243.3	D08		6	0061-0188	811.84	187.98	356	71.60	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11220.7	D08		6	0062-0188	732.47	188.22	376	73.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11526.1	D08		6	0063-0188	398.67	187.91	374	72.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10734.4	D08		6	0064-0188	459.42	188.42	391	75.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11200.2	D08		6	0065-0192	707.38	192.26	387	74.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11013.7	D08		6	0066-0194	832.11	193.10	379	75.84	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10982.6	D08		6	0067-0201	129.67	201.14	384	77.26	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11351.2	D08		6	0068-0203	551.30	203.08	376	73.50	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12548.3	D08		6	0069-0204	902.38	204.65	333	66.77	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11287.2	D08		6	0070-0206	355.13	206.40	358	74.43	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10439.7	D08		6	0071-0212	635.35	212.48	399	75.01	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11017.7	D08		6	0072-0214	848.73	215.28	377	77.60	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11936.8	D08		6	0073-0218	932.27	216.97	345	69.26	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11114.4	D08		6	0074-0220	522.35	220.95	391	73.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9842.9	D08		6	0075-0221	324.97	222.47	425	81.01	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10529.4	D08		6	0076-0230	353.42	229.76	822	112.23	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10116.5	D08		6	0077-0233	441.72	232.72	428	80.91	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11259.2	D08		6	0078-0234	887.17	234.36	369	71.36	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11139.7	D08		6	0079-0237	83.22	237.34	399	76.67	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10785.6	D08		6	0080-0240	933.40	241.20	378	72.08	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11246.7	D08		6	0081-0243	854.49	242.67	365	73.84	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11423.4	D08		6	0082-0245	401.20	245.71	365	71.84	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10230.5	D08		6	0083-0244	460.99	244.95	355	75.60	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10633.1	D08		6	0084-0250	217.98	250.08	357	76.33	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11717.1	D08		6	0085-0253	628.92	252.95	378	72.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10594.6	D08		6	0086-0253	263.39	253.75	360	73.26	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11090.7	D08		6	0087-0262	36.17	262.36	722	103.05	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11498.2	D08		6	0088-0260	310.00	260.65	362	73.50	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11489.5	D08		6	0089-0260	102.18	261.17	346	70.43	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12308.4	D08		6	0090-0268	185.69	268.48	884	146.51	0.518
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11234.1	D08		6	0091-0263	454.94	263.11	449	84.67	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11240.3	D08		6	0092-0262	553.62	262.03	325	66.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11483.3	D08		6	0093-0270	678.00	270.01	375	72.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11824.7	D08		6	0094-0273	586.06	273.25	364	72.08	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11270.5	D08		6	0095-0275	369.55	275.52	397	75.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11877.5	D08		6	0096-0276	849.51	275.27	363	72.91	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11169.4	D08		6	0097-0278	235.02	278.33	349	72.43	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11143.1	D08		6	0098-0284	128.71	284.50	355	74.08	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11053.9	D08		6	0099-0287	632.49	287.12	274	61.84	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10461.9	D08		6	0100-0292	864.52	292.16	407	77.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10963.4	D08		6	0101-0296	383.05	296.44	374	73.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10217.5	D08		6	0102-0297	407.90	296.89	387	73.01	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11196.9	D08		6	0103-0297	509.90	297.42	392	72.43	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11334.2	D08		6	0104-0298	44.09	298.72	352	72.08	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11551.4	D08		6	0105-0303	766.26	302.90	352	73.26	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11008.1	D08		6	0106-0310	276.35	310.18	394	75.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11413.6	D08		6	0107-0310	593.44	310.26	370	72.67	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11082.4	D08		6	0108-0310	548.75	310.52	382	74.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11710.0	D08		6	0109-0311	832.11	310.47	382	73.26	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10807.5	D08		6	0110-0315	475.27	315.03	395	74.18	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12756.4	D08		6	0111-0319	683.10	318.92	642	100.47	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10812.9	D08		6	0112-0319	301.13	319.45	382	73.84	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11798.0	D08		6	0113-0327	211.18	328.27	839	117.88	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11087.0	D08		6	0114-0320	566.22	320.72	385	75.50	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13426.7	D08		6	0115-0320	898.68	319.64	306	67.84	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11405.6	D08		6	0116-0322	354.69	321.99	394	75.50	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11653.9	D08		6	0117-0322	717.14	322.36	564	101.26	0.691
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10095.1	D08		6	0118-0328	640.59	328.33	362	75.26	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10257.5	D08		6	0119-0334	269.16	334.69	433	86.08	0.734
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10749.6	D08		6	0120-0332	495.27	331.52	399	74.18	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10204.2	D08		6	0121-0337	817.75	337.00	419	78.33	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16953.4	D08		6	0122-0339	909.62	339.16	468	81.74	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10592.7	D08		6	0123-0340	792.67	339.73	461	82.33	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11084.9	D08		6	0124-0346	23.77	346.14	733	109.64	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9798.1	D08		6	0125-0347	629.09	348.15	482	91.15	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10950.2	D08		6	0126-0349	772.87	349.59	347	73.74	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12075.6	D08		6	0127-0350	932.91	350.68	699	110.81	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11971.3	D08		6	0128-0353	876.46	352.96	385	73.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11390.9	D08		6	0129-0358	727.31	358.52	378	72.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10728.9	D08		6	0130-0371	408.14	370.44	795	118.02	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12521.8	D08		6	0131-0366	226.35	365.77	908	116.33	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11544.0	D08		6	0132-0372	118.56	372.22	342	68.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10621.5	D08		6	0133-0380	171.75	380.43	359	71.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11402.5	D08		6	0134-0381	686.19	380.93	378	72.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11559.8	D08		6	0135-0386	356.86	385.91	362	71.84	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11908.2	D08		6	0136-0386	898.63	385.61	350	70.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11093.7	D08		6	0137-0389	582.02	388.69	403	77.26	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10602.3	D08		6	0138-0393	465.08	393.73	397	76.33	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11650.9	D08		6	0139-0396	531.89	396.65	383	73.60	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10572.2	D08		6	0140-0398	404.18	398.80	397	75.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11601.2	D08		6	0141-0399	263.14	398.89	376	72.43	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11101.1	D08		6	0142-0406	755.66	406.81	828	112.81	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11351.5	D08		6	0143-0400	846.75	399.69	373	72.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11031.5	D08		6	0144-0404	713.06	404.11	418	78.91	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11599.1	D08		6	0145-0406	671.17	405.85	361	71.26	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10113.4	D08		6	0146-0413	138.98	413.47	371	79.74	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11360.6	D08		6	0147-0418	488.43	418.69	409	76.08	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11043.5	D08		6	0148-0420	205.89	419.93	366	72.67	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11131.3	D08		6	0149-0430	813.04	431.09	381	73.26	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11625.1	D08		6	0150-0431	347.02	431.33	380	73.01	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11281.5	D08		6	0151-0432	434.56	432.26	372	75.26	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11155.1	D08		6	0152-0433	386.89	433.27	332	67.01	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11165.3	D08		6	0153-0436	534.23	436.43	387	74.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11167.4	D08		6	0154-0436	566.83	435.94	392	77.50	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11405.7	D08		6	0155-0448	223.60	447.98	776	111.20	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9986.8	D08		6	0156-0444	25.13	445.46	410	79.64	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11489.6	D08		6	0157-0442	879.80	442.45	368	73.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10889.2	D08		6	0158-0453	629.25	451.93	805	122.61	0.673
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14155.2	D08		6	0159-0450	286.83	449.76	498	109.40	0.523
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9983.4	D08		6	0160-0455	546.95	455.76	440	81.26	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10642.0	D08		6	0161-0473	695.65	471.41	849	123.44	0.700
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11441.1	D08		6	0162-0463	767.08	463.73	453	79.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12164.9	D08		6	0163-0470	934.85	469.19	674	102.33	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11577.6	D08		6	0164-0464	910.91	463.51	355	70.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11277.0	D08		6	0165-0469	376.31	469.53	372	70.18	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10410.4	D08		6	0166-0471	177.58	471.75	413	78.67	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11509.2	D08		6	0167-0472	54.05	472.63	343	69.01	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10812.4	D08		6	0168-0475	592.81	474.91	415	75.26	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11480.3	D08		6	0169-0480	324.79	480.81	759	105.74	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11679.5	D08		6	0170-0479	435.04	479.50	376	72.18	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10439.4	D08		6	0171-0483	813.03	483.23	375	74.43	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6744.6	D08		6	0172-0490	770.88	489.39	662	102.91	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10766.0	D08		6	0173-0486	201.54	486.03	380	75.60	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11918.3	D08		6	0174-0487	278.85	487.89	358	69.84	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11636.3	D08		6	0175-0490	245.27	490.50	362	71.84	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11279.1	D08		6	0176-0491	477.77	491.04	428	78.08	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10581.7	D08		6	0177-0498	678.58	499.23	426	79.74	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10096.5	D08		6	0178-0503	118.99	502.66	441	82.57	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11343.6	D08		6	0179-0501	369.40	501.07	369	71.01	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10415.9	D08		6	0180-0503	572.50	503.11	376	74.08	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10711.5	D08		6	0181-0507	34.40	507.78	383	74.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11104.0	D08		6	0182-0509	934.67	508.54	372	73.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11421.0	D08		6	0183-0515	705.36	514.46	392	76.08	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11016.8	D08		6	0184-0512	735.76	512.62	377	75.26	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11867.8	D08		6	0185-0515	198.35	514.67	343	69.60	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11136.8	D08		6	0186-0516	403.12	516.95	377	75.50	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10046.2	D08		6	0187-0528	142.35	527.67	783	122.61	0.655
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10467.0	D08		6	0188-0521	640.20	521.47	403	76.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11642.1	D08		6	0189-0526	248.39	526.31	355	74.91	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11593.6	D08		6	0190-0528	434.65	528.06	364	72.08	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11816.5	D08		6	0191-0539	888.16	539.47	358	68.43	0.961
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11020.8	D08		6	0192-0542	349.12	542.31	386	77.74	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11580.8	D08		6	0193-0550	301.34	550.65	719	105.05	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10946.7	D08		6	0194-0551	111.29	551.67	350	72.91	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11503.5	D08		6	0195-0554	594.03	554.14	397	74.43	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10708.8	D08		6	0196-0555	943.52	555.19	380	73.50	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11627.6	D08		6	0197-0560	443.60	560.66	366	71.84	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11120.6	D08		6	0198-0565	548.38	565.67	372	72.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11003.7	D08		6	0199-0566	171.46	566.61	359	71.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10130.2	D08		6	0200-0571	341.12	571.02	415	82.57	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11602.9	D08		6	0201-0577	784.16	577.07	769	108.81	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10465.4	D08		6	0202-0572	251.05	572.93	407	78.67	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11305.2	D08		6	0203-0572	619.51	572.04	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11564.9	D08		6	0204-0579	74.03	580.39	662	103.40	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11043.4	D08		6	0205-0580	287.78	580.05	376	74.43	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10689.1	D08		6	0206-0579	367.26	578.81	401	77.74	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11752.1	D08		6	0207-0580	819.65	579.49	354	70.43	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11255.2	D08		6	0208-0580	416.10	580.75	378	72.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10892.4	D08		6	0209-0590	474.71	590.58	792	118.47	0.709
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11052.6	D08		6	0210-0582	229.54	582.17	384	74.43	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11518.2	D08		6	0211-0584	716.08	583.65	355	71.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11417.1	D08		6	0212-0590	110.68	589.95	361	72.91	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10343.1	D08		6	0213-0593	326.52	594.57	419	80.91	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11800.5	D08		6	0214-0597	508.27	597.88	502	83.50	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10410.6	D08		6	0215-0598	50.21	597.98	354	72.43	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10846.9	D08		6	0216-0597	558.93	597.18	395	77.01	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12027.4	D08		6	0217-0607	748.76	606.91	688	100.23	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10714.6	D08		6	0218-0603	376.33	604.40	395	79.74	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10765.0	D08		6	0219-0605	166.55	604.53	415	78.18	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11269.3	D08		6	0220-0611	220.68	610.92	370	74.67	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10607.5	D08		6	0221-0613	581.72	612.72	410	78.18	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11359.9	D08		6	0222-0616	412.19	617.09	369	73.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12364.7	D08		6	0223-0624	98.62	624.57	714	100.81	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10326.6	D08		6	0224-0625	180.36	625.83	398	80.43	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11037.4	D08		6	0225-0623	537.52	622.87	384	75.26	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11271.3	D08		6	0226-0635	454.28	635.05	378	73.01	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11613.3	D08		6	0227-0640	821.88	639.14	554	88.57	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13164.2	D08		6	0228-0644	624.45	644.80	425	77.26	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10725.1	D08		6	0229-0645	276.57	645.18	379	74.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11941.4	D08		6	0230-0648	571.47	648.92	714	103.40	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10703.5	D08		6	0231-0647	189.76	646.38	378	79.26	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10964.9	D08		6	0232-0654	371.70	653.98	762	108.47	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11001.6	D08		6	0233-0654	804.65	654.82	380	74.91	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10892.1	D08		6	0234-0650	679.35	650.37	197	55.11	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10830.2	D08		6	0235-0661	46.26	661.50	326	70.18	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10496.1	D08		6	0236-0663	320.64	663.16	378	72.67	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11574.2	D08		6	0237-0666	492.29	665.81	354	70.43	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10863.5	D08		6	0238-0670	135.52	670.49	346	73.26	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10140.9	D08		6	0239-0671	107.79	671.25	366	74.91	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10809.4	D08		6	0240-0676	444.57	675.86	391	73.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11314.1	D08		6	0241-0677	193.75	677.33	365	71.84	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11125.5	D08		6	0242-0680	830.19	680.26	357	70.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10833.5	D08		6	0243-0683	520.86	683.19	371	75.74	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10978.7	D08		6	0244-0686	287.13	685.70	375	73.26	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11600.3	D08		6	0245-0693	909.27	692.95	359	69.84	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10900.2	D08		6	0246-0696	601.90	695.47	367	73.98	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13558.6	D08		6	0247-0703	803.69	703.90	373	74.43	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11800.0	D08		6	0248-0703	212.96	703.48	341	67.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184617	1375332	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11120.9	D08		6	0249-0708	315.46	708.28	363	75.01	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10759.6	D08		7	0001-0038	138.70	38.64	783	109.88	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11329.6	D08		7	0002-0034	800.14	34.58	338	69.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10341.5	D08		7	0003-0039	895.20	39.35	401	77.26	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9293.4	D08		7	0004-0038	601.43	38.88	500	84.91	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10218.7	D08		7	0005-0042	281.00	42.21	836	111.64	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9155.8	D08		7	0006-0049	348.32	49.45	926	126.02	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10152.3	D08		7	0007-0044	702.80	44.53	423	77.26	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9871.2	D08		7	0008-0059	821.65	58.95	463	82.91	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9725.7	D08		7	0009-0066	79.13	65.78	449	81.15	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11274.3	D08		7	0010-0071	851.75	70.91	773	109.64	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9433.7	D08		7	0011-0070	394.91	69.33	475	86.91	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9666.9	D08		7	0012-0068	431.23	68.86	349	75.84	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9463.6	D08		7	0013-0078	251.23	76.72	434	79.74	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9866.6	D08		7	0014-0081	185.35	81.82	462	82.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10408.6	D08		7	0015-0087	704.28	87.06	423	77.26	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10021.7	D08		7	0016-0086	911.36	85.55	459	81.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9015.7	D08		7	0017-0090	439.34	90.38	570	96.67	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9197.9	D08		7	0018-0090	387.39	89.99	430	83.01	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10064.3	D08		7	0019-0089	534.01	89.23	451	81.50	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10505.5	D08		7	0020-0091	755.54	92.27	522	89.74	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9121.0	D08		7	0021-0091	938.49	90.77	487	85.50	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10089.9	D08		7	0022-0092	650.55	92.57	472	82.08	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9484.3	D08		7	0023-0093	237.84	94.47	446	80.57	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9960.3	D08		7	0024-0094	319.02	94.51	414	78.91	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10089.1	D08		7	0025-0096	815.37	96.64	456	87.40	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9834.5	D08		7	0026-0095	69.91	95.59	424	79.74	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10963.0	D08		7	0027-0098	845.18	97.93	502	87.15	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9756.8	D08		7	0028-0105	118.84	105.54	422	79.26	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11428.2	D08		7	0029-0106	732.48	106.57	433	80.91	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9593.3	D08		7	0030-0121	299.24	120.12	332	71.50	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10187.1	D08		7	0031-0124	358.14	124.35	404	76.67	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10074.7	D08		7	0032-0127	686.23	126.65	419	77.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10101.3	D08		7	0033-0126	894.96	126.18	404	76.67	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10111.2	D08		7	0034-0127	281.81	128.32	393	78.08	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9817.7	D08		7	0035-0134	17.37	135.18	431	82.91	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10304.9	D08		7	0036-0135	649.93	135.03	457	80.33	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10014.6	D08		7	0037-0137	769.78	137.10	439	82.91	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9007.7	D08		7	0038-0140	523.99	140.31	478	84.33	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10315.6	D08		7	0039-0142	721.43	141.48	426	78.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9770.0	D08		7	0040-0146	451.98	146.47	778	109.74	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9807.8	D08		7	0041-0146	107.97	146.29	445	79.26	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9530.3	D08		7	0042-0148	135.96	147.29	444	84.33	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10266.3	D08		7	0043-0149	316.88	149.62	395	74.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9814.6	D08		7	0044-0154	781.79	154.36	461	87.15	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9044.3	D08		7	0045-0156	845.85	156.05	488	85.74	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9450.8	D08		7	0046-0162	363.17	161.47	444	84.67	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9333.3	D08		7	0047-0166	385.36	167.21	434	82.77	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10089.4	D08		7	0048-0172	184.53	172.77	562	92.81	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10410.1	D08		7	0049-0173	454.80	171.96	385	78.18	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9282.9	D08		7	0050-0177	288.22	177.19	491	92.81	0.716
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9957.6	D08		7	0051-0178	528.37	178.22	462	85.15	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9500.6	D08		7	0052-0182	51.09	181.36	409	81.05	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10938.6	D08		7	0053-0194	217.97	194.61	776	108.47	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9283.0	D08		7	0054-0197	36.31	198.74	416	81.15	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10172.5	D08		7	0055-0194	138.10	194.57	402	78.08	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10024.1	D08		7	0056-0201	825.33	201.22	458	81.50	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9332.6	D08		7	0057-0208	730.55	207.85	446	88.57	0.714
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9835.7	D08		7	0058-0208	651.04	208.27	465	82.33	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10629.2	D08		7	0059-0209	931.10	209.15	402	78.18	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9947.9	D08		7	0060-0210	274.48	209.99	433	78.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9863.0	D08		7	0061-0213	760.79	212.74	447	80.91	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10081.3	D08		7	0062-0214	792.02	214.30	410	78.33	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10114.0	D08		7	0063-0221	335.11	221.41	436	81.50	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10069.8	D08		7	0064-0221	686.85	220.76	434	77.26	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10729.1	D08		7	0065-0226	873.19	225.05	349	72.33	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9628.7	D08		7	0066-0235	496.90	234.92	499	86.57	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10237.1	D08		7	0067-0239	853.50	238.86	887	116.37	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10043.3	D08		7	0068-0242	232.59	242.28	472	86.57	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11050.0	D08		7	0069-0250	596.44	249.54	397	76.81	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10262.4	D08		7	0070-0250	392.33	250.19	439	78.08	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9054.0	D08		7	0071-0253	203.63	253.94	172	82.91	0.314
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8909.7	D08		7	0072-0262	582.42	264.15	519	91.64	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9878.9	D08		7	0073-0274	91.69	274.93	849	123.54	0.699
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9902.9	D08		7	0074-0270	456.40	270.98	443	81.50	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10284.3	D08		7	0075-0276	191.03	275.28	408	79.40	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10080.4	D08		7	0076-0275	698.99	275.48	495	84.91	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10053.2	D08		7	0077-0279	151.50	279.75	427	83.40	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9791.7	D08		7	0078-0280	370.65	281.07	732	107.64	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9826.4	D08		7	0079-0279	493.68	278.87	455	82.33	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9469.2	D08		7	0080-0284	593.04	284.29	489	89.26	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9669.6	D08		7	0081-0295	181.32	296.34	462	87.15	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10876.0	D08		7	0082-0293	287.27	293.14	439	78.08	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8561.2	D08		7	0083-0293	398.40	293.43	479	89.15	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10474.1	D08		7	0084-0295	218.71	295.12	453	81.84	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10157.9	D08		7	0085-0315	421.37	315.20	835	113.88	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10467.7	D08		7	0086-0310	316.18	309.58	428	79.74	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9646.3	D08		7	0087-0314	523.18	314.28	453	82.91	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10247.9	D08		7	0088-0316	619.29	316.35	441	79.26	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10095.0	D08		7	0089-0316	210.40	316.01	418	82.43	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10139.3	D08		7	0090-0329	749.51	328.37	902	121.64	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9657.3	D08		7	0091-0324	675.43	324.14	441	81.60	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8739.7	D08		7	0092-0324	697.35	323.76	542	89.01	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10136.4	D08		7	0093-0330	923.70	330.27	449	81.74	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10226.7	D08		7	0094-0333	865.05	333.11	417	79.50	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10472.8	D08		7	0095-0334	184.98	334.20	426	78.08	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10643.3	D08		7	0096-0340	353.74	339.76	780	111.88	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9472.9	D08		7	0097-0337	503.83	337.39	471	87.98	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9294.5	D08		7	0098-0342	475.99	341.85	503	87.40	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9568.7	D08		7	0099-0352	433.49	352.00	279	62.18	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9984.9	D08		7	0100-0355	632.91	355.63	454	79.26	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10270.8	D08		7	0101-0357	886.90	357.71	400	75.01	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11252.4	D08		7	0102-0365	831.24	365.48	778	105.64	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9783.5	D08		7	0103-0372	28.17	372.53	757	109.84	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8977.1	D08		7	0104-0379	122.49	379.22	502	90.18	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10117.0	D08		7	0105-0383	142.26	381.40	342	74.43	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9655.4	D08		7	0106-0384	326.48	383.91	537	91.15	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9994.8	D08		7	0107-0385	592.79	385.21	478	82.91	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10233.4	D08		7	0108-0390	198.62	390.20	396	77.26	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10215.8	D08		7	0109-0390	648.07	390.05	430	79.26	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8964.4	D08		7	0110-0392	353.79	391.83	524	97.64	0.691
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9604.1	D08		7	0111-0395	155.03	396.14	484	86.81	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9658.8	D08		7	0112-0393	388.35	393.40	457	80.91	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9964.3	D08		7	0113-0401	715.27	400.99	439	83.74	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10308.7	D08		7	0114-0401	910.08	400.87	410	77.26	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10086.0	D08		7	0115-0402	80.39	401.50	410	78.08	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10288.4	D08		7	0116-0408	115.91	409.20	851	116.95	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10036.5	D08		7	0117-0406	47.71	407.15	428	79.60	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9809.8	D08		7	0118-0417	672.49	417.03	472	85.50	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10158.9	D08		7	0119-0419	258.24	419.29	418	75.26	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9767.6	D08		7	0120-0419	852.42	418.87	438	77.84	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9611.2	D08		7	0121-0422	462.95	422.00	463	84.57	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11053.5	D08		7	0122-0428	737.20	428.53	799	106.23	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10062.9	D08		7	0123-0426	357.00	426.46	420	78.91	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10117.0	D08		7	0124-0433	207.82	432.94	401	76.67	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10288.2	D08		7	0125-0439	548.38	439.23	853	114.71	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10135.3	D08		7	0126-0445	130.87	445.13	436	81.15	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10081.2	D08		7	0127-0446	872.69	446.15	435	79.50	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9682.1	D08		7	0128-0450	177.60	449.89	471	86.57	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10952.0	D08		7	0129-0458	504.55	457.94	831	112.13	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10034.2	D08		7	0130-0453	617.91	452.19	430	79.98	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10098.4	D08		7	0131-0460	330.60	460.23	433	78.08	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9061.7	D08		7	0132-0469	633.26	470.21	488	85.40	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10011.6	D08		7	0133-0468	685.96	468.34	437	78.91	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9720.9	D08		7	0134-0469	439.37	469.24	443	79.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10701.3	D08		7	0135-0469	568.45	470.06	280	84.08	0.498
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10581.8	D08		7	0136-0482	928.02	481.95	894	116.95	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9966.7	D08		7	0137-0483	224.25	482.98	421	78.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9839.7	D08		7	0138-0488	77.97	488.45	444	86.23	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10374.8	D08		7	0139-0489	119.46	489.20	400	77.74	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10049.2	D08		7	0140-0503	605.96	503.79	865	116.95	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9533.9	D08		7	0141-0497	448.54	497.80	458	85.15	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9879.6	D08		7	0142-0497	732.17	496.51	436	82.33	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10134.3	D08		7	0143-0497	846.56	496.51	448	80.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10879.3	D08		7	0144-0503	791.27	504.05	818	111.40	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10256.7	D08		7	0145-0504	534.13	504.29	423	77.26	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11490.4	D08		7	0146-0515	397.56	515.35	711	101.40	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9979.6	D08		7	0147-0514	492.38	514.36	432	78.08	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10090.0	D08		7	0148-0520	198.34	520.33	422	77.84	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9695.5	D08		7	0149-0530	560.96	529.57	474	82.57	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9654.9	D08		7	0150-0531	79.84	531.52	448	83.74	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9401.8	D08		7	0151-0534	692.82	534.27	465	85.74	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10344.0	D08		7	0152-0535	859.44	536.14	554	92.47	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10721.5	D08		7	0153-0539	427.78	539.12	414	80.67	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10207.5	D08		7	0154-0547	781.55	547.27	855	118.27	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9710.5	D08		7	0155-0543	216.52	543.56	474	84.33	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10168.2	D08		7	0156-0545	16.05	545.35	394	75.60	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9700.8	D08		7	0157-0546	129.51	546.04	410	80.81	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9216.8	D08		7	0158-0546	542.56	547.35	493	85.98	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9864.9	D08		7	0159-0548	312.37	548.53	846	119.05	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9497.2	D08		7	0160-0556	876.68	556.26	486	84.33	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11771.9	D08		7	0161-0559	421.15	559.94	631	96.91	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10033.8	D08		7	0162-0558	643.98	558.24	421	78.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9552.7	D08		7	0163-0559	697.13	559.46	444	83.50	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10185.0	D08		7	0164-0570	241.67	569.63	417	77.50	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9934.4	D08		7	0165-0574	335.74	574.52	423	81.98	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9721.4	D08		7	0166-0582	939.06	582.12	412	79.60	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11092.9	D08		7	0167-0585	53.65	585.14	766	105.64	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10188.8	D08		7	0168-0583	619.72	583.61	431	76.43	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10242.1	D08		7	0169-0585	567.84	585.96	426	78.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10128.2	D08		7	0170-0587	200.56	587.01	459	81.50	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10144.4	D08		7	0171-0586	381.16	586.27	433	80.91	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9955.9	D08		7	0172-0602	84.26	601.97	412	79.98	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10076.5	D08		7	0173-0608	779.71	607.96	426	77.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9721.3	D08		7	0174-0610	934.27	610.47	448	84.91	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9653.6	D08		7	0175-0612	143.13	612.04	417	84.57	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10054.8	D08		7	0176-0613	692.71	612.59	428	79.26	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10226.3	D08		7	0177-0615	439.99	614.55	437	80.08	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9874.7	D08		7	0178-0622	309.28	622.42	452	80.91	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9951.6	D08		7	0179-0623	216.34	623.50	469	83.26	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9599.2	D08		7	0180-0634	512.13	633.38	446	82.33	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10003.5	D08		7	0181-0636	62.85	636.45	401	76.67	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10321.0	D08		7	0182-0643	332.89	641.98	838	120.13	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9691.5	D08		7	0183-0645	399.66	644.48	449	81.84	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8697.1	D08		7	0184-0647	279.46	648.02	378	80.33	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10201.8	D08		7	0185-0651	639.67	650.98	435	79.01	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9522.5	D08		7	0186-0651	360.99	651.61	463	84.08	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9575.6	D08		7	0187-0655	250.20	654.26	469	86.57	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9329.4	D08		7	0188-0659	500.84	660.70	463	85.74	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10754.0	D08		7	0189-0655	433.42	656.14	379	75.70	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9964.6	D08		7	0190-0660	835.93	660.18	449	80.91	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9154.7	D08		7	0191-0669	391.30	670.27	462	88.81	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10288.3	D08		7	0192-0667	17.13	667.33	458	80.91	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9624.7	D08		7	0193-0667	193.70	667.19	437	79.50	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9742.0	D08		7	0194-0664	222.97	664.04	250	64.43	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10171.9	D08		7	0195-0669	130.34	669.31	415	83.15	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9754.7	D08		7	0196-0671	563.62	671.83	434	80.33	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10280.5	D08		7	0197-0674	744.60	674.36	401	75.50	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10315.9	D08		7	0198-0675	434.96	673.95	430	80.53	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9418.9	D08		7	0199-0680	247.12	680.98	481	89.15	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10431.7	D08		7	0200-0680	297.85	680.08	407	76.43	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10201.9	D08		7	0201-0679	881.66	679.17	397	75.01	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10167.6	D08		7	0202-0683	463.49	683.36	413	78.33	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9959.1	D08		7	0203-0689	910.76	689.07	428	78.67	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10144.5	D08		7	0204-0690	55.66	689.63	424	76.67	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9549.2	D08		7	0205-0698	689.45	697.40	443	86.23	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10347.2	D08		7	0206-0698	656.88	697.85	407	79.15	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10051.8	D08		7	0207-0703	605.62	703.64	412	76.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10284.2	D08		7	0208-0704	351.70	704.08	420	77.26	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9307.2	D08		7	0209-0704	531.98	704.73	484	84.67	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10518.4	D08		7	0210-0704	215.33	704.39	385	72.43	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184618	1375333	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9425.4	D08		7	0211-0709	508.12	709.51	296	69.84	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10935.1	D08		8	0001-0032	884.95	31.78	381	72.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10130.3	D08		8	0002-0036	369.69	35.91	465	82.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10463.0	D08		8	0003-0034	604.87	34.26	413	78.08	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9813.2	D08		8	0004-0039	695.81	39.74	434	85.64	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9329.8	D08		8	0005-0039	424.75	39.71	513	90.57	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10439.8	D08		8	0006-0042	59.13	41.84	406	76.67	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9744.6	D08		8	0007-0042	116.37	41.58	475	85.40	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9272.4	D08		8	0008-0053	446.51	51.28	509	86.23	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9755.2	D08		8	0009-0060	500.17	59.63	448	81.74	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9453.1	D08		8	0010-0061	133.24	61.79	472	84.33	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10750.5	D08		8	0011-0062	572.17	62.39	818	115.78	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10173.2	D08		8	0012-0065	460.15	66.11	402	78.23	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10680.5	D08		8	0013-0063	918.16	63.17	393	76.33	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10761.8	D08		8	0014-0066	744.30	66.04	400	75.01	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10576.1	D08		8	0015-0073	691.30	73.55	412	75.01	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9118.8	D08		8	0016-0073	860.83	73.44	448	82.57	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10309.2	D08		8	0017-0075	834.89	75.31	412	77.26	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10400.1	D08		8	0018-0078	776.98	78.13	421	78.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10172.5	D08		8	0019-0082	174.03	82.31	390	78.08	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10334.9	D08		8	0020-0083	273.25	83.30	414	77.26	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10020.0	D08		8	0021-0092	219.98	92.53	851	121.05	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7908.1	D08		8	0022-0085	109.71	85.02	386	72.43	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9877.0	D08		8	0023-0088	17.17	87.83	451	82.08	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9657.2	D08		8	0024-0093	44.18	92.84	455	81.50	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10284.3	D08		8	0025-0094	894.42	94.34	407	76.43	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9792.7	D08		8	0026-0098	431.25	98.10	437	83.15	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10353.2	D08		8	0027-0100	366.00	100.19	409	76.67	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11119.6	D08		8	0028-0110	622.43	110.49	865	119.98	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9626.9	D08		8	0029-0107	652.75	107.06	446	81.01	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10324.3	D08		8	0030-0111	703.55	110.95	404	76.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10584.1	D08		8	0031-0113	73.92	113.83	409	77.84	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10221.8	D08		8	0032-0114	142.14	114.63	404	78.91	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10636.4	D08		8	0033-0116	682.50	115.95	406	75.36	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10039.2	D08		8	0034-0119	820.27	119.15	422	77.26	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10015.4	D08		8	0035-0132	728.98	132.30	480	86.57	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10465.9	D08		8	0036-0131	552.04	130.76	407	76.67	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9374.4	D08		8	0037-0141	469.46	141.36	908	135.68	0.620
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11043.2	D08		8	0038-0132	614.30	132.68	390	79.36	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10956.6	D08		8	0039-0144	279.56	144.71	608	95.64	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10332.5	D08		8	0040-0143	414.75	143.33	406	77.50	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10348.8	D08		8	0041-0154	61.26	154.33	437	80.33	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10321.1	D08		8	0042-0153	869.81	153.09	405	77.26	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9667.9	D08		8	0043-0157	138.42	157.09	429	82.08	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10313.9	D08		8	0044-0157	562.84	158.13	412	80.33	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9876.0	D08		8	0045-0159	165.70	159.40	498	90.81	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10411.8	D08		8	0046-0165	521.33	164.82	413	76.67	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10496.1	D08		8	0047-0167	739.78	167.56	428	78.08	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10257.9	D08		8	0048-0168	624.74	168.55	454	80.77	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9968.9	D08		8	0049-0183	567.41	184.60	849	121.78	0.719
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10062.6	D08		8	0050-0183	384.62	183.38	418	79.50	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9842.1	D08		8	0051-0184	277.53	185.34	517	86.53	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10991.2	D08		8	0052-0184	694.35	183.56	388	75.26	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9818.3	D08		8	0053-0186	890.52	186.22	434	79.84	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10033.8	D08		8	0054-0195	913.07	195.23	848	119.15	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12295.3	D08		8	0055-0198	206.93	198.85	984	120.71	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9993.3	D08		8	0056-0192	625.24	191.31	474	84.18	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12271.8	D08		8	0057-0200	484.87	201.08	671	104.37	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10265.1	D08		8	0058-0199	359.06	199.18	446	83.15	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10095.7	D08		8	0059-0200	527.88	200.43	408	79.15	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10290.9	D08		8	0060-0204	711.12	205.37	848	118.13	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10370.1	D08		8	0061-0205	666.68	205.58	439	80.67	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10454.1	D08		8	0062-0206	779.10	206.07	414	77.26	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9557.9	D08		8	0063-0214	276.88	213.77	792	116.43	0.734
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10262.2	D08		8	0064-0211	35.92	211.97	421	83.01	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9966.6	D08		8	0065-0211	447.74	211.02	441	84.23	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9968.0	D08		8	0066-0216	96.43	217.15	848	116.71	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9744.5	D08		8	0067-0217	253.06	216.84	436	81.01	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10369.5	D08		8	0068-0224	158.37	224.36	418	77.50	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10296.4	D08		8	0069-0228	583.30	228.46	464	85.15	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10620.5	D08		8	0070-0226	851.41	226.38	407	75.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10332.1	D08		8	0071-0237	309.49	237.76	822	113.40	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9526.0	D08		8	0072-0241	284.94	240.54	473	87.36	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10351.5	D08		8	0073-0242	529.69	242.68	413	77.26	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9996.6	D08		8	0074-0240	630.78	239.82	350	72.67	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10546.5	D08		8	0075-0244	789.97	244.51	403	78.33	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9654.3	D08		8	0076-0247	607.99	247.34	445	82.91	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10092.6	D08		8	0077-0260	332.57	260.05	459	82.67	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11087.7	D08		8	0078-0259	477.08	259.25	378	72.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10212.0	D08		8	0079-0260	692.38	261.20	452	80.53	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10278.8	D08		8	0080-0277	257.21	277.66	846	112.37	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9422.2	D08		8	0081-0276	832.37	276.41	609	96.33	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10489.7	D08		8	0082-0274	77.86	273.62	372	74.33	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10349.6	D08		8	0083-0277	649.69	277.28	452	78.67	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10509.8	D08		8	0084-0279	438.27	278.77	417	77.26	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10502.2	D08		8	0085-0284	185.71	284.27	400	77.74	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13330.2	D08		8	0086-0282	884.17	282.00	325	67.01	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10358.4	D08		8	0087-0284	913.06	284.55	406	75.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10457.3	D08		8	0088-0285	118.78	285.70	421	81.40	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10025.2	D08		8	0089-0284	691.85	283.76	461	83.36	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10399.4	D08		8	0090-0286	590.33	286.02	441	83.40	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9633.2	D08		8	0091-0289	62.19	290.24	495	87.05	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10312.1	D08		8	0092-0289	215.23	288.87	428	76.67	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11241.3	D08		8	0093-0292	545.64	292.36	775	106.23	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11158.5	D08		8	0094-0292	733.36	292.72	814	108.57	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9911.2	D08		8	0095-0292	385.56	292.55	865	120.81	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9835.2	D08		8	0096-0294	505.09	292.74	453	88.47	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10307.1	D08		8	0097-0301	945.77	302.32	413	79.26	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10277.0	D08		8	0098-0321	99.54	320.91	400	76.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10192.3	D08		8	0099-0321	502.87	321.41	431	77.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10165.1	D08		8	0100-0319	659.31	318.85	429	79.26	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10443.6	D08		8	0101-0336	890.29	336.90	826	119.68	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10240.2	D08		8	0102-0329	912.12	328.16	412	82.33	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10279.7	D08		8	0103-0332	28.83	332.23	415	79.15	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10091.2	D08		8	0104-0336	249.69	335.89	411	79.74	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10094.6	D08		8	0105-0334	844.38	334.08	456	79.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10799.4	D08		8	0106-0339	425.15	339.81	395	77.60	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9628.2	D08		8	0107-0340	652.93	341.37	469	84.91	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9121.4	D08		8	0108-0342	342.76	342.06	413	78.67	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9805.5	D08		8	0109-0341	386.82	341.56	467	83.50	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10546.0	D08		8	0110-0342	786.67	342.22	406	76.67	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9839.1	D08		8	0111-0348	449.67	347.65	724	104.91	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10073.2	D08		8	0112-0347	166.15	347.14	412	77.50	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10389.9	D08		8	0113-0358	547.03	358.86	868	122.85	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10488.9	D08		8	0114-0349	211.63	349.20	437	79.50	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10590.1	D08		8	0115-0357	711.60	357.80	419	78.91	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9693.1	D08		8	0116-0363	399.47	362.29	445	81.84	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9962.3	D08		8	0117-0372	497.55	372.35	460	81.84	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10030.9	D08		8	0118-0374	757.54	374.67	449	80.91	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10300.3	D08		8	0119-0376	601.74	376.51	426	79.74	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9864.0	D08		8	0120-0378	784.90	377.44	438	79.50	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9983.3	D08		8	0121-0381	304.43	382.27	420	80.18	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10317.4	D08		8	0122-0389	60.15	389.85	389	76.33	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10298.8	D08		8	0123-0393	428.91	394.39	864	118.37	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10683.0	D08		8	0124-0400	117.36	399.99	841	114.13	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9794.5	D08		8	0125-0391	520.05	391.20	456	84.91	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10592.4	D08		8	0126-0394	689.93	393.77	429	76.43	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10052.8	D08		8	0127-0396	907.28	396.73	421	79.84	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10054.8	D08		8	0128-0401	177.10	400.90	434	80.08	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10533.7	D08		8	0129-0403	15.32	402.92	373	72.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9534.3	D08		8	0130-0407	308.11	406.08	476	84.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10817.9	D08		8	0131-0405	651.10	405.55	421	78.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11279.5	D08		8	0132-0411	850.74	411.27	371	71.60	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10490.8	D08		8	0133-0413	581.10	413.40	417	79.74	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10438.4	D08		8	0134-0426	901.74	426.81	747	111.15	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10212.3	D08		8	0135-0421	543.54	421.25	415	78.08	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9473.7	D08		8	0136-0426	135.22	426.07	471	82.91	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10737.4	D08		8	0137-0427	707.94	427.17	405	75.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10337.8	D08		8	0138-0427	750.29	427.15	422	75.84	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9260.8	D08		8	0139-0434	360.23	432.85	438	79.40	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10920.2	D08		8	0140-0443	91.35	443.73	610	94.33	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11197.2	D08		8	0141-0443	856.02	443.55	415	77.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9763.3	D08		8	0142-0443	661.35	442.96	454	83.26	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10791.7	D08		8	0143-0444	808.91	444.31	394	76.08	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9170.4	D08		8	0144-0453	345.48	453.66	469	86.81	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10465.2	D08		8	0145-0451	637.49	450.89	417	77.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10338.2	D08		8	0146-0454	399.22	454.11	446	81.01	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8993.0	D08		8	0147-0455	420.93	455.57	486	86.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11596.4	D08		8	0148-0465	921.78	465.12	432	78.43	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10281.4	D08		8	0149-0465	558.52	464.69	343	71.26	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9954.2	D08		8	0150-0471	252.94	470.44	407	78.77	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10274.7	D08		8	0151-0477	732.29	477.24	423	78.91	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10703.2	D08		8	0152-0476	882.86	476.52	399	73.84	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10595.5	D08		8	0153-0485	32.98	484.12	857	113.54	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10195.2	D08		8	0154-0480	451.55	479.73	419	78.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10265.3	D08		8	0155-0481	500.13	481.23	432	84.33	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9770.4	D08		8	0156-0483	808.31	482.90	444	80.08	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9480.0	D08		8	0157-0482	830.66	481.79	391	81.01	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10624.5	D08		8	0158-0482	622.88	482.80	407	76.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10302.6	D08		8	0159-0485	145.41	485.34	387	77.50	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10534.6	D08		8	0160-0486	206.87	486.52	415	77.50	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10624.6	D08		8	0161-0488	778.91	488.46	406	77.50	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9884.5	D08		8	0162-0493	848.55	493.51	516	89.50	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9366.7	D08		8	0163-0488	409.37	488.78	298	66.08	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10492.4	D08		8	0164-0493	365.42	493.59	435	79.50	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10375.9	D08		8	0165-0496	569.92	495.85	422	79.50	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9904.7	D08		8	0166-0505	741.58	505.90	442	83.60	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10098.7	D08		8	0167-0506	480.71	505.89	443	81.84	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7769.7	D08		8	0168-0518	915.18	518.32	720	110.57	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10335.9	D08		8	0169-0515	647.73	514.94	420	78.08	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10224.4	D08		8	0170-0518	256.99	518.51	433	79.50	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9425.8	D08		8	0171-0523	135.34	522.72	392	76.08	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9774.1	D08		8	0172-0526	814.97	525.92	410	80.33	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10203.8	D08		8	0173-0526	194.48	526.48	394	76.08	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	181.8	D08		8	0174-0525	931.41	524.85	175	53.11	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9862.5	D08		8	0175-0535	746.35	535.25	891	126.47	0.700
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9689.3	D08		8	0176-0527	460.85	527.21	391	72.77	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10420.5	D08		8	0177-0528	366.17	528.27	407	78.67	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10708.1	D08		8	0178-0533	545.31	532.49	555	92.57	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10541.8	D08		8	0179-0544	226.15	544.19	422	78.08	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9939.7	D08		8	0180-0546	793.33	547.02	405	80.91	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10556.0	D08		8	0181-0552	696.30	551.94	410	78.67	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9513.5	D08		8	0182-0560	85.58	559.71	859	121.54	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10655.5	D08		8	0183-0556	404.04	556.74	407	75.50	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10500.0	D08		8	0184-0562	515.01	562.26	465	81.50	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9960.1	D08		8	0185-0564	800.48	565.21	445	86.08	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10374.4	D08		8	0186-0569	173.02	569.09	399	75.50	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10625.3	D08		8	0187-0573	556.41	572.86	403	75.60	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10062.7	D08		8	0188-0578	641.51	577.83	422	78.08	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10435.3	D08		8	0189-0579	740.58	578.80	406	75.50	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12161.2	D08		8	0190-0580	875.42	580.14	437	78.67	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9787.7	D08		8	0191-0585	44.22	584.44	406	84.81	0.709
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10553.3	D08		8	0192-0581	586.30	581.20	404	75.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10345.7	D08		8	0193-0583	324.64	583.53	438	79.50	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10208.1	D08		8	0194-0589	212.22	589.69	435	82.08	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10706.3	D08		8	0195-0595	263.91	595.35	398	77.50	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9649.1	D08		8	0196-0598	426.67	598.42	443	82.08	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10007.7	D08		8	0197-0612	39.00	612.44	432	80.57	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11175.4	D08		8	0198-0611	929.51	611.62	403	79.26	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11820.9	D08		8	0199-0621	82.16	621.05	720	100.57	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10747.3	D08		8	0200-0621	208.06	621.77	573	90.33	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10961.9	D08		8	0201-0619	718.53	619.30	403	74.67	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9748.1	D08		8	0202-0622	429.32	621.30	451	81.26	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10715.9	D08		8	0203-0624	604.82	624.31	425	79.98	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10310.7	D08		8	0204-0627	514.44	626.81	430	80.33	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10497.0	D08		8	0205-0639	318.06	638.75	414	76.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11636.8	D08		8	0206-0639	773.47	638.91	418	77.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9582.6	D08		8	0207-0641	142.44	641.40	392	76.57	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9927.7	D08		8	0208-0646	177.28	646.96	409	76.67	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10283.2	D08		8	0209-0650	67.26	650.15	436	79.26	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10346.4	D08		8	0210-0654	406.54	654.12	430	80.33	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10425.6	D08		8	0211-0660	226.56	660.44	421	78.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5010.1	D08		8	0212-0678	607.91	679.11	851	119.88	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13027.2	D08		8	0213-0674	926.64	673.75	396	75.26	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9651.7	D08		8	0214-0684	414.35	684.91	457	82.67	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10447.3	D08		8	0215-0693	180.42	693.41	765	108.13	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10281.4	D08		8	0216-0691	15.47	691.18	411	78.57	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9752.1	D08		8	0217-0695	389.16	695.35	428	82.57	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184619	1375334	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10170.8	D08		8	0218-0706	316.19	706.84	392	73.26	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13868.7	D08		9	0001-0031	802.21	31.36	377	73.60	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11362.4	D08		9	0002-0031	211.44	31.27	365	70.43	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11580.1	D08		9	0003-0036	582.69	37.25	373	73.74	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10217.1	D08		9	0004-0037	315.18	36.46	417	77.94	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10306.3	D08		9	0005-0040	243.56	39.76	391	75.26	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10742.1	D08		9	0006-0040	69.25	40.63	358	71.26	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10626.8	D08		9	0007-0043	158.62	42.87	383	74.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10596.4	D08		9	0008-0044	549.39	44.18	431	78.67	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14581.3	D08		9	0009-0044	838.91	44.74	396	74.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10697.6	D08		9	0010-0049	433.97	48.43	422	76.43	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10271.6	D08		9	0011-0056	108.85	56.12	370	71.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11136.2	D08		9	0012-0061	197.89	61.33	371	70.18	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10913.4	D08		9	0013-0063	232.85	63.48	376	74.77	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11267.9	D08		9	0014-0066	12.61	65.95	363	72.67	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10297.5	D08		9	0015-0074	412.99	73.90	420	78.18	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10103.6	D08		9	0016-0073	311.53	73.06	398	75.60	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10248.2	D08		9	0017-0078	615.73	77.56	424	77.84	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10913.1	D08		9	0018-0078	693.87	78.19	421	80.91	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10928.8	D08		9	0019-0081	174.00	80.92	364	74.43	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10935.9	D08		9	0020-0082	740.74	81.87	394	75.26	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10428.6	D08		9	0021-0084	358.91	84.33	395	74.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11107.0	D08		9	0022-0085	480.27	85.05	398	73.60	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11190.4	D08		9	0023-0091	867.98	90.87	374	72.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9678.1	D08		9	0024-0095	909.04	95.92	425	77.84	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10840.3	D08		9	0025-0095	122.55	94.82	359	70.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10218.0	D08		9	0026-0096	307.62	95.97	396	75.84	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9895.4	D08		9	0027-0100	709.31	100.82	473	83.26	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10938.9	D08		9	0028-0104	165.47	104.90	558	90.91	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10682.9	D08		9	0029-0102	609.70	102.70	415	76.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9346.1	D08		9	0030-0104	250.84	103.66	451	81.64	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10938.0	D08		9	0031-0101	932.48	101.56	414	79.11	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10684.6	D08		9	0032-0111	651.76	110.71	396	74.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10953.8	D08		9	0033-0117	265.59	118.91	350	71.15	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11227.7	D08		9	0034-0120	94.20	120.25	375	72.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9923.8	D08		9	0035-0127	711.28	125.36	426	82.33	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10143.1	D08		9	0036-0130	208.51	130.00	397	76.67	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11027.0	D08		9	0037-0134	141.97	134.27	378	75.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10476.2	D08		9	0038-0135	693.09	136.57	410	78.08	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12710.0	D08		9	0039-0138	866.97	137.64	357	70.43	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11352.9	D08		9	0040-0139	51.12	140.05	347	69.01	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10438.8	D08		9	0041-0140	353.61	139.65	376	72.18	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10467.5	D08		9	0042-0139	414.94	138.93	402	79.60	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10678.0	D08		9	0043-0140	286.49	139.79	389	74.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10143.3	D08		9	0044-0140	439.97	140.48	424	77.94	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10786.2	D08		9	0045-0145	914.10	145.16	386	72.43	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10090.8	D08		9	0046-0149	481.63	148.96	445	79.26	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10465.9	D08		9	0047-0159	553.86	159.17	840	114.91	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10121.2	D08		9	0048-0153	211.82	153.04	407	76.43	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10638.9	D08		9	0049-0159	99.45	159.36	413	77.74	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10080.5	D08		9	0050-0159	341.79	159.62	373	73.84	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11157.5	D08		9	0051-0159	277.39	159.59	351	69.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10411.9	D08		9	0052-0163	636.04	163.74	429	78.77	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10221.0	D08		9	0053-0163	660.28	162.67	412	76.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11112.0	D08		9	0054-0169	602.12	169.55	466	80.18	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10288.3	D08		9	0055-0169	465.80	168.72	422	78.67	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10794.3	D08		9	0056-0173	48.26	174.07	357	72.43	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9947.5	D08		9	0057-0179	376.57	178.90	426	79.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12561.6	D08		9	0058-0180	860.74	180.33	366	70.77	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10707.9	D08		9	0059-0187	683.04	187.15	393	76.43	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11085.6	D08		9	0060-0186	178.54	186.46	374	72.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10558.2	D08		9	0061-0196	298.97	196.05	817	112.91	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11526.1	D08		9	0062-0196	783.01	196.00	386	74.91	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10477.5	D08		9	0063-0204	102.44	205.02	417	78.91	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10992.3	D08		9	0064-0206	210.89	206.94	381	77.60	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10274.9	D08		9	0065-0209	412.21	209.50	459	80.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10687.3	D08		9	0066-0212	241.57	212.44	368	74.43	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10793.9	D08		9	0067-0210	391.73	210.62	391	73.70	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11803.0	D08		9	0068-0214	460.20	214.19	731	100.81	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9837.9	D08		9	0069-0212	681.99	212.12	440	80.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10851.6	D08		9	0070-0211	641.53	211.36	385	75.26	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11218.4	D08		9	0071-0215	571.82	215.76	385	74.67	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10742.2	D08		9	0072-0221	357.76	220.80	429	79.26	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10140.8	D08		9	0073-0222	309.49	222.98	389	78.18	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11114.0	D08		9	0074-0223	739.20	223.72	392	76.08	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10190.7	D08		9	0075-0227	205.50	226.76	434	80.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11307.4	D08		9	0076-0233	522.04	232.65	722	103.40	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11093.2	D08		9	0077-0233	717.89	233.06	548	93.40	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11714.2	D08		9	0078-0232	882.86	231.82	374	71.60	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10238.6	D08		9	0079-0242	370.93	242.04	567	91.74	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11135.9	D08		9	0080-0244	793.57	244.69	404	75.26	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10795.5	D08		9	0081-0247	296.20	247.12	377	73.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10682.7	D08		9	0082-0251	259.12	251.10	369	72.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11088.7	D08		9	0083-0251	549.31	251.59	444	78.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10821.8	D08		9	0084-0250	180.46	250.07	376	73.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11043.8	D08		9	0085-0252	587.08	251.82	386	75.84	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10565.1	D08		9	0086-0255	153.26	255.91	388	75.50	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10988.9	D08		9	0087-0256	77.61	256.50	386	74.43	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10898.2	D08		9	0088-0258	514.86	258.37	395	75.84	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10729.5	D08		9	0089-0258	846.26	258.51	396	73.01	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12278.8	D08		9	0090-0264	324.38	263.88	658	94.91	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10453.6	D08		9	0091-0262	671.84	262.19	432	80.91	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10849.5	D08		9	0092-0257	915.92	257.74	364	71.94	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11005.8	D08		9	0093-0264	887.34	264.27	349	75.36	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10646.5	D08		9	0094-0273	410.97	273.28	409	75.01	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11554.5	D08		9	0095-0274	472.81	274.16	308	64.77	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10350.6	D08		9	0096-0280	581.72	280.94	420	76.08	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10776.7	D08		9	0097-0281	658.64	281.64	406	74.67	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11324.6	D08		9	0098-0283	791.94	282.76	373	73.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11321.1	D08		9	0099-0282	893.76	282.59	393	79.70	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11100.8	D08		9	0100-0289	208.49	288.97	393	76.08	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11041.3	D08		9	0101-0297	517.43	296.76	791	111.40	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10855.1	D08		9	0102-0291	73.87	291.40	377	71.84	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10565.2	D08		9	0103-0295	920.34	294.67	394	75.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10994.4	D08		9	0104-0296	719.32	296.25	389	76.08	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11033.8	D08		9	0105-0297	820.86	296.95	387	73.84	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11425.5	D08		9	0106-0304	162.89	304.23	724	104.57	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10891.8	D08		9	0107-0296	383.18	295.94	379	73.01	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10536.3	D08		9	0108-0298	261.09	298.23	391	73.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10968.8	D08		9	0109-0301	126.12	301.54	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10050.1	D08		9	0110-0301	900.33	301.91	402	82.18	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10407.1	D08		9	0111-0305	40.73	305.65	391	77.01	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9941.0	D08		9	0112-0306	200.21	307.44	419	82.91	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10876.5	D08		9	0113-0312	434.13	312.14	409	75.26	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10960.5	D08		9	0114-0316	880.46	315.48	381	73.50	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10411.4	D08		9	0115-0323	60.64	322.66	395	77.84	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11182.5	D08		9	0116-0324	317.09	323.94	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11084.9	D08		9	0117-0326	248.09	326.70	408	73.60	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11249.0	D08		9	0118-0325	635.30	324.89	385	73.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10584.8	D08		9	0119-0328	373.64	328.69	414	76.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10990.5	D08		9	0120-0333	478.24	333.17	391	73.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10403.2	D08		9	0121-0334	518.50	334.38	419	77.01	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10722.0	D08		9	0122-0340	574.93	340.26	413	75.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10452.2	D08		9	0123-0342	132.05	341.66	397	74.08	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11053.2	D08		9	0124-0346	929.21	345.80	380	75.94	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11325.8	D08		9	0125-0351	225.07	350.96	642	95.74	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11107.4	D08		9	0126-0349	846.02	349.50	381	73.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10065.5	D08		9	0127-0354	682.81	354.31	438	83.98	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11337.3	D08		9	0128-0358	520.07	357.55	423	78.18	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10582.4	D08		9	0129-0361	313.84	360.59	408	78.18	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10561.4	D08		9	0130-0361	810.32	360.87	426	77.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10949.4	D08		9	0131-0368	888.14	368.11	827	118.81	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10987.3	D08		9	0132-0365	295.33	366.12	359	75.21	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10374.5	D08		9	0133-0368	275.28	367.58	453	82.04	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9504.1	D08		9	0134-0369	122.11	369.40	389	76.43	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10433.3	D08		9	0135-0373	189.40	373.03	404	79.15	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10560.3	D08		9	0136-0384	71.53	384.19	382	74.43	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11119.7	D08		9	0137-0388	237.86	388.08	742	104.23	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8745.2	D08		9	0138-0391	207.08	391.67	461	83.84	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11286.5	D08		9	0139-0390	590.14	390.31	388	74.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10771.6	D08		9	0140-0391	753.46	391.08	394	74.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13693.3	D08		9	0141-0405	506.02	405.02	627	95.64	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10967.4	D08		9	0142-0409	630.87	409.11	412	75.60	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12417.3	D08		9	0143-0415	912.32	415.15	681	102.81	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11218.9	D08		9	0144-0413	410.62	413.37	395	73.84	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11304.6	D08		9	0145-0416	296.49	416.09	609	92.91	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10761.5	D08		9	0146-0415	210.30	414.22	360	72.53	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11916.3	D08		9	0147-0421	943.69	422.81	390	94.57	0.548
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10432.0	D08		9	0148-0424	144.14	422.40	940	120.95	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11123.5	D08		9	0149-0418	568.80	418.83	391	73.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11094.5	D08		9	0150-0426	458.36	426.56	387	71.60	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9145.5	D08		9	0151-0433	80.54	432.57	370	74.91	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10948.5	D08		9	0152-0439	352.40	439.52	386	74.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10140.7	D08		9	0153-0447	256.37	447.18	381	78.67	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11179.9	D08		9	0154-0450	757.46	449.77	377	73.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11132.0	D08		9	0155-0454	560.48	453.62	385	73.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12696.9	D08		9	0156-0458	870.25	458.05	663	95.74	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9751.6	D08		9	0157-0458	205.69	458.53	371	71.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10746.1	D08		9	0158-0458	329.27	458.74	406	75.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11285.3	D08		9	0159-0458	650.51	458.66	398	75.26	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11839.2	D08		9	0160-0462	520.47	462.25	402	75.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10103.9	D08		9	0161-0467	263.57	467.17	452	83.26	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12245.4	D08		9	0162-0468	16.54	467.93	374	71.84	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10732.2	D08		9	0163-0472	403.79	472.47	402	76.18	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12204.1	D08		9	0164-0477	903.92	477.48	517	86.33	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10373.8	D08		9	0165-0492	90.84	491.39	786	115.40	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11629.3	D08		9	0166-0487	942.99	487.59	362	71.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10606.8	D08		9	0167-0499	186.12	500.16	391	75.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10962.9	D08		9	0168-0502	514.94	502.30	403	74.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11518.3	D08		9	0169-0509	862.02	509.84	373	71.84	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12038.0	D08		9	0170-0512	468.13	511.72	397	75.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10994.9	D08		9	0171-0513	775.33	513.07	380	74.67	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10646.0	D08		9	0172-0517	556.44	516.30	415	79.50	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11985.8	D08		9	0173-0520	270.30	519.66	642	94.33	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9356.1	D08		9	0174-0520	181.41	520.11	444	82.18	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11389.6	D08		9	0175-0532	226.41	531.71	396	73.84	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14839.3	D08		9	0176-0537	542.74	538.48	362	74.77	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11842.9	D08		9	0177-0540	403.69	540.32	346	69.94	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16267.0	D08		9	0178-0545	561.00	545.00	297	67.60	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11067.8	D08		9	0179-0544	944.64	544.28	384	73.26	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11507.6	D08		9	0180-0546	841.98	546.34	389	72.43	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11029.6	D08		9	0181-0550	301.68	550.16	392	73.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11820.0	D08		9	0182-0561	415.75	561.58	694	106.23	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14631.1	D08		9	0183-0555	544.47	555.11	252	61.46	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11939.4	D08		9	0184-0562	514.95	562.28	417	76.67	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10510.5	D08		9	0185-0569	793.03	569.10	400	75.84	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10050.2	D08		9	0186-0572	258.47	571.14	339	70.91	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11164.4	D08		9	0187-0582	210.17	582.11	368	73.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9762.7	D08		9	0188-0584	273.44	585.56	492	85.88	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10444.4	D08		9	0189-0583	903.29	582.47	449	79.50	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11157.2	D08		9	0190-0586	660.06	585.62	380	73.84	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11270.7	D08		9	0191-0595	175.90	595.08	377	73.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11158.4	D08		9	0192-0601	327.94	601.43	383	73.01	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11512.2	D08		9	0193-0602	461.92	602.65	373	71.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10711.3	D08		9	0194-0611	659.43	611.53	398	74.67	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10500.7	D08		9	0195-0611	904.60	611.52	385	73.26	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11298.1	D08		9	0196-0615	23.70	614.59	387	75.01	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11945.5	D08		9	0197-0621	489.54	621.59	400	74.43	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13733.4	D08		9	0198-0623	814.69	623.36	394	74.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10657.4	D08		9	0199-0627	281.70	626.41	385	73.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10864.2	D08		9	0200-0631	862.18	631.39	385	73.60	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12834.2	D08		9	0201-0634	165.99	634.41	427	77.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11120.7	D08		9	0202-0648	628.33	646.60	406	78.33	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12149.0	D08		9	0203-0647	399.11	647.27	413	76.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11343.8	D08		9	0204-0647	522.59	648.08	369	73.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11412.0	D08		9	0205-0652	900.01	652.45	351	69.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12336.9	D08		9	0206-0655	100.16	655.09	375	76.33	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11860.2	D08		9	0207-0663	616.05	664.54	508	86.57	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12515.7	D08		9	0208-0667	123.12	666.61	455	80.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11345.7	D08		9	0209-0669	561.54	668.87	382	72.43	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12788.2	D08		9	0210-0676	20.62	676.36	402	73.84	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11286.3	D08		9	0211-0678	512.28	677.79	408	75.50	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10285.0	D08		9	0212-0678	676.22	677.75	470	82.08	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12768.8	D08		9	0213-0694	165.23	693.52	415	76.91	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11161.8	D08		9	0214-0699	536.83	699.76	921	117.30	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13207.9	D08		9	0215-0693	258.74	693.52	405	75.26	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11000.6	D08		9	0216-0696	605.92	696.41	379	73.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184620	1375335	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10861.9	D08		9	0217-0700	784.99	699.49	381	74.67	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9026.2	E08		1	0001-0030	45.07	30.65	419	80.67	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9425.7	E08		1	0002-0042	167.76	42.28	443	77.60	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9746.7	E08		1	0003-0041	625.93	41.06	415	75.01	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10171.0	E08		1	0004-0042	714.23	42.07	387	73.01	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9138.3	E08		1	0005-0046	412.33	45.77	490	84.57	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9143.6	E08		1	0006-0048	453.57	48.42	492	82.08	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9155.2	E08		1	0007-0053	567.12	53.63	471	82.08	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8956.8	E08		1	0008-0063	182.59	62.93	485	84.33	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10254.4	E08		1	0009-0067	34.57	67.11	550	86.91	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9688.4	E08		1	0010-0075	78.32	74.79	442	77.84	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9281.8	E08		1	0011-0073	829.94	73.27	221	56.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9289.3	E08		1	0012-0088	611.67	88.17	454	79.26	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8863.2	E08		1	0013-0088	502.07	88.60	548	90.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9002.6	E08		1	0014-0086	852.50	87.02	282	66.53	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9489.5	E08		1	0015-0091	719.29	91.65	462	80.08	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9592.8	E08		1	0016-0091	524.71	92.67	373	76.53	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9729.7	E08		1	0017-0098	47.05	98.76	435	77.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9368.6	E08		1	0018-0100	168.02	100.31	424	76.43	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9632.0	E08		1	0019-0100	281.75	99.91	402	73.60	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9870.5	E08		1	0020-0101	804.02	101.06	404	76.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9823.4	E08		1	0021-0101	759.55	101.44	445	79.84	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10057.0	E08		1	0022-0107	241.68	107.62	782	109.05	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9493.5	E08		1	0023-0107	355.42	107.05	439	76.43	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9460.3	E08		1	0024-0114	690.88	114.24	486	81.84	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8891.0	E08		1	0025-0121	127.38	120.85	508	89.74	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9080.5	E08		1	0026-0128	900.25	128.11	430	79.60	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10430.7	E08		1	0027-0133	881.34	132.98	363	74.18	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9118.4	E08		1	0028-0136	456.29	136.38	497	86.77	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8711.2	E08		1	0029-0143	481.89	143.29	489	88.67	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9493.5	E08		1	0030-0146	52.86	146.04	428	76.43	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9671.0	E08		1	0031-0149	733.33	148.93	470	84.08	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9532.3	E08		1	0032-0152	636.15	151.24	411	81.50	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9390.7	E08		1	0033-0156	179.65	155.98	413	75.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9463.9	E08		1	0034-0158	695.52	158.70	454	79.26	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9666.2	E08		1	0035-0163	356.63	163.51	438	80.67	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9176.9	E08		1	0036-0167	538.52	166.59	422	77.26	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8607.6	E08		1	0037-0167	625.67	168.24	495	85.74	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10760.6	E08		1	0038-0181	256.69	180.51	798	105.40	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11299.1	E08		1	0039-0177	940.24	176.77	643	113.98	0.622
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9904.9	E08		1	0040-0182	919.56	184.38	246	70.43	0.623
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9205.9	E08		1	0041-0188	417.75	187.91	483	82.91	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9789.9	E08		1	0042-0193	890.39	193.06	442	76.67	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9325.9	E08		1	0043-0198	114.34	198.34	433	77.84	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9423.3	E08		1	0044-0197	159.98	196.69	427	75.84	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9419.8	E08		1	0045-0199	194.67	198.65	454	80.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9662.2	E08		1	0046-0201	473.12	201.79	429	77.26	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9607.4	E08		1	0047-0203	52.74	203.81	405	75.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8731.7	E08		1	0048-0205	90.17	204.94	458	80.91	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9547.4	E08		1	0049-0205	597.63	204.93	433	76.43	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10195.8	E08		1	0050-0207	801.58	207.66	443	78.67	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10312.4	E08		1	0051-0216	416.35	216.78	451	79.50	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9495.4	E08		1	0052-0222	646.65	223.11	432	79.50	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10054.0	E08		1	0053-0228	871.80	227.91	434	78.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9373.1	E08		1	0054-0226	549.57	226.53	449	78.43	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9820.3	E08		1	0055-0228	840.53	228.39	456	82.33	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9613.7	E08		1	0056-0230	38.92	230.56	395	73.26	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9626.7	E08		1	0057-0245	203.72	245.39	997	129.78	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9567.5	E08		1	0058-0242	477.31	241.90	432	77.26	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9758.4	E08		1	0059-0243	328.76	243.39	580	90.08	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11302.6	E08		1	0060-0251	898.82	251.02	446	77.84	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9573.8	E08		1	0061-0252	519.77	252.54	428	77.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9450.2	E08		1	0062-0253	294.10	253.48	444	77.84	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9905.7	E08		1	0063-0253	767.58	253.20	426	77.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9622.3	E08		1	0064-0262	151.82	262.30	429	77.01	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10866.5	E08		1	0065-0269	833.89	269.22	638	92.91	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10690.7	E08		1	0066-0272	70.77	270.22	706	105.30	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9418.8	E08		1	0067-0269	232.72	268.95	431	77.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9192.9	E08		1	0068-0269	364.87	269.58	436	79.50	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9519.9	E08		1	0069-0270	581.58	269.89	455	79.26	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9591.9	E08		1	0070-0281	485.61	280.87	432	78.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10543.0	E08		1	0071-0289	84.53	290.53	682	104.71	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9109.5	E08		1	0072-0289	194.45	288.69	460	80.67	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9337.4	E08		1	0073-0288	264.75	288.32	431	77.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9510.5	E08		1	0074-0293	797.62	293.31	481	84.08	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9835.1	E08		1	0075-0305	755.92	305.48	433	77.26	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9559.6	E08		1	0076-0304	24.11	305.07	407	77.26	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9693.1	E08		1	0077-0304	106.05	305.36	391	74.08	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9310.5	E08		1	0078-0311	708.14	311.30	480	83.74	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9608.9	E08		1	0079-0324	426.88	324.06	459	80.67	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9605.4	E08		1	0080-0325	155.70	324.92	410	75.26	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9658.8	E08		1	0081-0325	510.81	325.96	429	79.50	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9698.2	E08		1	0082-0328	277.00	327.76	413	75.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9671.6	E08		1	0083-0342	555.08	342.00	894	117.64	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10566.2	E08		1	0084-0345	354.40	344.76	908	122.57	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9879.3	E08		1	0085-0336	328.34	336.14	460	79.60	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9360.3	E08		1	0086-0337	189.42	337.44	426	77.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9352.2	E08		1	0087-0339	465.96	338.48	395	75.70	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9267.4	E08		1	0088-0339	801.06	339.25	480	81.26	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9174.3	E08		1	0089-0341	484.56	340.81	352	70.87	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9618.6	E08		1	0090-0351	904.71	350.58	428	78.08	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9046.2	E08		1	0091-0352	928.99	351.53	454	80.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9720.6	E08		1	0092-0351	95.71	351.12	406	75.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9790.2	E08		1	0093-0357	647.60	356.77	433	78.91	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9300.6	E08		1	0094-0370	457.83	370.44	943	123.64	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10339.2	E08		1	0095-0361	501.42	360.90	351	71.94	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9442.7	E08		1	0096-0371	663.63	371.45	456	84.57	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9467.2	E08		1	0097-0368	188.22	368.04	436	79.50	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9348.1	E08		1	0098-0371	596.97	371.40	448	79.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8850.9	E08		1	0099-0370	63.32	370.48	412	78.08	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9323.4	E08		1	0100-0369	275.88	369.77	423	76.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11419.3	E08		1	0101-0379	508.26	379.37	483	86.67	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9863.3	E08		1	0102-0380	816.50	380.84	437	79.50	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8980.1	E08		1	0103-0392	674.25	392.50	491	83.26	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9241.7	E08		1	0104-0392	134.34	392.60	425	76.43	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9036.7	E08		1	0105-0395	787.89	394.74	460	80.08	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9797.3	E08		1	0106-0397	710.62	397.69	428	77.84	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9395.9	E08		1	0107-0404	622.35	404.81	425	77.26	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11852.2	E08		1	0108-0408	927.12	408.71	622	92.91	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8710.6	E08		1	0109-0408	202.68	407.87	460	82.08	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9992.8	E08		1	0110-0410	447.45	410.02	447	79.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9709.7	E08		1	0111-0410	524.60	409.87	428	77.26	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8963.2	E08		1	0112-0412	230.55	412.57	450	80.08	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9455.0	E08		1	0113-0421	62.27	421.92	824	114.71	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8850.8	E08		1	0114-0414	389.83	414.33	420	76.91	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9479.5	E08		1	0115-0418	264.20	418.41	416	76.67	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9788.1	E08		1	0116-0419	884.01	419.03	418	77.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9238.5	E08		1	0117-0420	149.68	421.22	460	85.50	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9432.2	E08		1	0118-0424	786.24	424.27	462	82.18	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9495.8	E08		1	0119-0424	585.75	424.81	484	82.08	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9215.1	E08		1	0120-0424	113.98	424.14	456	78.67	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9742.3	E08		1	0121-0430	738.05	430.83	419	75.84	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9643.3	E08		1	0122-0437	548.25	437.22	430	77.26	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9467.7	E08		1	0123-0443	679.62	443.50	452	78.43	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9054.4	E08		1	0124-0452	452.68	451.69	956	125.68	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9322.7	E08		1	0125-0455	21.35	455.63	811	114.33	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10547.1	E08		1	0126-0448	861.22	449.47	388	74.04	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9876.3	E08		1	0127-0452	942.36	452.57	419	78.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9590.0	E08		1	0128-0455	97.13	455.50	413	79.84	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9263.2	E08		1	0129-0458	378.27	458.43	435	76.67	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9246.2	E08		1	0130-0461	192.39	459.84	436	78.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9687.1	E08		1	0131-0460	249.49	459.97	406	74.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9689.0	E08		1	0132-0463	493.64	462.81	434	78.08	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9596.7	E08		1	0133-0462	739.66	462.49	417	77.26	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9620.8	E08		1	0134-0470	301.00	469.97	456	82.08	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9620.3	E08		1	0135-0469	532.78	469.25	421	78.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9933.4	E08		1	0136-0467	582.60	466.82	405	74.18	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9300.3	E08		1	0137-0473	855.50	471.79	473	91.84	0.705
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7825.4	E08		1	0138-0475	110.41	475.53	551	93.60	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8949.7	E08		1	0139-0477	875.10	477.05	463	83.15	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9775.9	E08		1	0140-0476	680.21	476.62	444	77.84	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9487.8	E08		1	0141-0480	136.78	480.05	414	77.36	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9166.3	E08		1	0142-0490	209.33	490.94	904	124.23	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9620.7	E08		1	0143-0486	620.14	486.40	460	80.67	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9588.3	E08		1	0144-0485	752.77	484.45	423	76.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9662.8	E08		1	0145-0495	165.67	495.01	458	79.26	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8783.3	E08		1	0146-0498	885.52	498.56	448	80.33	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9845.0	E08		1	0147-0496	358.26	496.12	412	75.84	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9549.1	E08		1	0148-0502	272.90	501.84	428	78.08	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9537.9	E08		1	0149-0503	538.56	503.36	440	79.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9741.8	E08		1	0150-0504	591.68	504.75	436	77.84	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8879.5	E08		1	0151-0508	54.27	507.66	446	82.33	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9654.5	E08		1	0152-0510	455.95	510.37	437	78.91	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9255.8	E08		1	0153-0520	219.13	519.44	450	81.36	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9097.4	E08		1	0154-0522	187.38	522.40	432	83.50	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10095.1	E08		1	0155-0523	792.97	523.36	427	78.67	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9829.2	E08		1	0156-0527	307.68	528.11	430	80.53	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8830.3	E08		1	0157-0531	68.21	531.31	459	82.08	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9777.7	E08		1	0158-0529	624.88	529.41	418	77.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9806.2	E08		1	0159-0530	716.03	530.46	419	75.84	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14934.8	E08		1	0160-0529	850.33	529.04	149	80.57	0.288
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9492.5	E08		1	0161-0537	112.53	537.02	423	76.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8963.9	E08		1	0162-0543	18.86	543.23	388	76.08	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9089.1	E08		1	0163-0545	650.13	545.60	446	80.33	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9354.5	E08		1	0164-0546	936.83	546.77	456	82.43	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9775.6	E08		1	0165-0547	407.42	546.67	432	77.26	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9007.9	E08		1	0166-0549	307.82	547.82	469	84.53	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9664.5	E08		1	0167-0550	162.08	550.18	396	76.43	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9653.6	E08		1	0168-0550	588.08	550.21	436	76.43	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9452.9	E08		1	0169-0558	202.67	558.45	848	115.54	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8883.3	E08		1	0170-0555	49.17	555.21	173	51.11	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9580.3	E08		1	0171-0559	264.46	558.77	440	77.60	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9084.5	E08		1	0172-0567	884.03	567.85	446	79.84	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9516.9	E08		1	0173-0568	916.26	568.48	440	81.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9342.4	E08		1	0174-0569	340.67	568.74	461	80.91	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10234.5	E08		1	0175-0575	375.94	575.06	717	100.57	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9523.8	E08		1	0176-0572	492.05	571.93	452	79.26	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9511.4	E08		1	0177-0584	120.96	583.77	855	117.50	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9458.9	E08		1	0178-0588	729.45	587.53	442	78.67	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9442.9	E08		1	0179-0600	777.15	599.75	450	80.67	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9727.6	E08		1	0180-0601	931.97	601.38	424	78.91	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9821.5	E08		1	0181-0604	627.24	604.09	475	82.91	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9452.4	E08		1	0182-0606	347.15	606.58	459	81.26	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9370.2	E08		1	0183-0618	391.24	618.44	390	73.84	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8525.2	E08		1	0184-0620	797.93	620.38	546	91.60	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10172.4	E08		1	0185-0637	64.60	637.63	890	119.30	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8460.1	E08		1	0186-0631	719.70	631.93	467	81.60	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9454.1	E08		1	0187-0631	176.97	631.35	403	76.67	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9782.6	E08		1	0188-0631	697.91	631.62	408	74.53	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9186.7	E08		1	0189-0632	215.71	632.05	430	79.50	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8851.7	E08		1	0190-0637	18.73	637.73	398	78.91	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9671.4	E08		1	0191-0635	553.23	634.85	420	77.26	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9238.2	E08		1	0192-0640	93.70	640.64	451	79.74	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9554.2	E08		1	0193-0639	869.53	638.74	414	76.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9674.5	E08		1	0194-0643	330.43	643.90	423	76.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9525.5	E08		1	0195-0655	426.54	655.75	880	119.05	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9772.7	E08		1	0196-0651	773.20	651.09	440	77.84	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9370.5	E08		1	0197-0655	649.45	655.53	469	82.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10054.9	E08		1	0198-0655	388.48	654.75	422	78.67	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9588.2	E08		1	0199-0654	481.44	654.30	409	75.01	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9517.1	E08		1	0200-0660	517.44	660.08	452	80.91	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9832.9	E08		1	0201-0661	932.46	661.06	366	71.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9670.1	E08		1	0202-0662	256.71	662.73	437	83.60	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9568.7	E08		1	0203-0666	826.30	664.91	413	79.15	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10144.5	E08		1	0204-0678	175.43	678.36	407	77.11	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9815.6	E08		1	0205-0678	554.22	678.45	450	81.26	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9093.6	E08		1	0206-0678	633.42	677.98	463	82.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9178.0	E08		1	0207-0678	841.42	678.77	388	74.33	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9114.8	E08		1	0208-0682	195.20	682.98	450	81.11	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8916.8	E08		1	0209-0683	262.51	682.34	435	82.18	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9628.1	E08		1	0210-0688	499.60	687.89	420	78.43	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9957.9	E08		1	0211-0690	890.26	690.34	383	71.60	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9646.4	E08		1	0212-0693	757.85	693.38	439	78.08	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9269.4	E08		1	0213-0695	110.13	695.18	404	77.50	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8609.5	E08		1	0214-0702	565.03	701.68	495	86.08	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9576.2	E08		1	0215-0707	378.50	706.73	399	75.84	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184441	1375336	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10265.3	E08		1	0216-0708	471.87	707.00	351	73.26	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10420.9	E08		2	0001-0027	890.67	26.94	374	73.01	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10111.1	E08		2	0002-0034	802.74	33.78	411	77.26	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10388.7	E08		2	0003-0044	398.89	44.05	408	77.50	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10032.7	E08		2	0004-0045	267.59	45.26	384	75.01	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10003.6	E08		2	0005-0060	539.47	60.49	420	77.26	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9097.0	E08		2	0006-0061	333.18	61.84	459	82.67	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9946.1	E08		2	0007-0062	725.90	61.80	405	76.67	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10913.1	E08		2	0008-0070	697.13	69.59	751	109.40	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10062.4	E08		2	0009-0064	854.95	64.08	402	74.43	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10186.1	E08		2	0010-0068	564.60	67.98	393	74.43	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10240.5	E08		2	0011-0069	311.70	68.45	377	75.60	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10231.5	E08		2	0012-0074	139.75	73.75	380	73.26	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10221.0	E08		2	0013-0079	623.33	79.13	403	75.84	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8879.8	E08		2	0014-0080	806.89	80.21	477	87.26	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9886.0	E08		2	0015-0080	193.12	80.01	410	78.33	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9918.0	E08		2	0016-0080	243.00	80.22	382	75.26	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9870.9	E08		2	0017-0079	410.94	79.08	423	77.60	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10909.0	E08		2	0018-0084	785.43	83.93	358	70.53	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9205.1	E08		2	0019-0093	67.94	93.43	387	76.08	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10753.6	E08		2	0020-0097	274.93	97.74	306	64.77	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10405.2	E08		2	0021-0104	136.10	104.59	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9849.8	E08		2	0022-0108	442.80	108.17	426	76.43	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10176.6	E08		2	0023-0111	362.97	110.55	364	71.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10340.0	E08		2	0024-0121	683.13	121.47	785	109.88	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10225.4	E08		2	0025-0123	483.35	123.12	381	73.26	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9638.1	E08		2	0026-0127	775.47	127.33	423	78.67	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9431.8	E08		2	0027-0130	354.62	131.04	437	81.50	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10314.1	E08		2	0028-0133	175.78	133.20	395	76.08	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9908.2	E08		2	0029-0133	850.39	133.45	427	78.67	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9396.8	E08		2	0030-0135	378.24	135.97	430	77.26	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9859.5	E08		2	0031-0140	234.73	139.82	400	76.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10095.8	E08		2	0032-0138	422.68	138.62	400	76.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11145.9	E08		2	0033-0147	100.48	147.50	491	83.50	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9777.1	E08		2	0034-0148	724.33	148.39	411	77.50	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10579.3	E08		2	0035-0149	909.00	149.21	391	75.60	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10388.3	E08		2	0036-0161	572.53	161.61	429	78.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9554.4	E08		2	0037-0166	805.96	164.76	428	77.98	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10274.6	E08		2	0038-0167	461.77	167.52	388	73.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10484.6	E08		2	0039-0169	138.99	169.37	396	73.01	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9917.2	E08		2	0040-0176	668.51	175.77	408	76.08	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8977.3	E08		2	0041-0170	27.63	170.20	115	43.11	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9995.5	E08		2	0042-0177	314.08	177.40	384	74.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11939.1	E08		2	0043-0179	46.42	178.70	548	92.57	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10356.9	E08		2	0044-0178	790.37	179.08	372	73.74	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9949.4	E08		2	0045-0182	402.87	182.10	409	75.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9318.1	E08		2	0046-0193	513.15	193.35	924	119.05	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9708.1	E08		2	0047-0184	24.07	185.47	235	66.43	0.669
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10382.1	E08		2	0048-0187	77.70	186.86	377	72.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10186.1	E08		2	0049-0187	877.36	186.70	392	74.08	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9903.5	E08		2	0050-0195	621.74	195.76	405	75.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9901.6	E08		2	0051-0193	258.36	193.62	382	75.60	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9657.4	E08		2	0052-0194	724.88	193.94	428	82.08	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9013.0	E08		2	0053-0203	168.99	203.55	395	76.67	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10008.5	E08		2	0054-0206	420.38	205.55	442	79.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9904.7	E08		2	0055-0207	827.80	207.35	418	75.01	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9960.8	E08		2	0056-0210	51.74	209.85	399	75.50	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9803.1	E08		2	0057-0222	369.13	222.56	396	74.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12868.6	E08		2	0058-0220	809.97	219.30	252	61.84	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9745.5	E08		2	0059-0225	138.35	225.82	377	76.33	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10535.6	E08		2	0060-0225	744.58	224.81	387	72.43	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8702.3	E08		2	0061-0227	215.53	227.48	439	82.67	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9455.1	E08		2	0062-0227	794.99	228.06	380	80.18	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7358.3	E08		2	0063-0238	563.83	238.32	597	91.26	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9054.1	E08		2	0064-0234	268.82	234.46	438	79.01	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9802.8	E08		2	0065-0248	329.53	248.37	391	74.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9969.2	E08		2	0066-0248	76.01	248.58	386	72.43	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9576.8	E08		2	0067-0258	791.77	257.78	926	128.23	0.708
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9583.7	E08		2	0068-0251	221.60	250.53	395	78.67	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9986.7	E08		2	0069-0251	679.71	251.58	412	75.01	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11017.9	E08		2	0070-0256	913.82	256.63	581	89.50	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10515.4	E08		2	0071-0260	634.98	259.87	382	72.77	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9035.2	E08		2	0072-0266	169.77	266.61	555	96.23	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9714.5	E08		2	0073-0264	451.20	264.72	414	76.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9315.9	E08		2	0074-0266	525.51	266.37	435	83.74	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9960.9	E08		2	0075-0274	371.77	274.85	796	111.64	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9895.8	E08		2	0076-0271	411.01	271.76	403	74.67	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9865.1	E08		2	0077-0270	500.82	269.96	400	77.01	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9725.7	E08		2	0078-0293	308.49	292.92	419	77.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9870.4	E08		2	0079-0294	470.07	294.22	400	77.50	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10061.2	E08		2	0080-0297	67.35	297.65	383	73.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10774.3	E08		2	0081-0302	901.77	302.16	369	72.87	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10795.3	E08		2	0082-0302	923.60	301.95	389	74.28	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10141.7	E08		2	0083-0305	581.73	305.14	373	71.84	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10168.7	E08		2	0084-0310	171.84	310.52	381	72.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	304.2	E08		2	0085-0312	544.73	312.04	408	74.18	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6210.5	E08		2	0086-0313	622.31	313.79	659	123.98	0.539
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10227.6	E08		2	0087-0318	272.44	318.88	401	73.36	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9359.6	E08		2	0088-0327	478.15	327.67	419	81.50	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10169.3	E08		2	0089-0329	142.75	328.87	383	71.60	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9794.7	E08		2	0090-0336	451.27	335.94	416	79.50	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9780.0	E08		2	0091-0339	252.17	339.52	404	75.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10123.4	E08		2	0092-0342	303.53	342.63	382	73.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9262.6	E08		2	0093-0344	403.85	343.81	406	78.91	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10811.4	E08		2	0094-0347	823.72	347.14	383	72.43	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9967.5	E08		2	0095-0348	69.00	348.26	383	74.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9734.7	E08		2	0096-0348	226.00	348.72	398	75.84	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9610.1	E08		2	0097-0352	33.51	352.30	399	76.91	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10390.2	E08		2	0098-0351	882.76	350.71	322	69.70	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9987.2	E08		2	0099-0362	151.49	362.52	394	74.67	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9663.1	E08		2	0100-0367	622.50	367.96	417	75.84	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9772.5	E08		2	0101-0371	347.12	371.36	439	78.67	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8468.5	E08		2	0102-0372	879.45	371.13	475	87.50	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10168.8	E08		2	0103-0380	574.82	380.03	402	76.08	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9708.2	E08		2	0104-0390	709.91	389.84	825	113.88	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10010.7	E08		2	0105-0388	95.79	388.54	386	75.50	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9310.2	E08		2	0106-0388	199.33	387.52	442	82.33	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9769.2	E08		2	0107-0390	526.13	389.65	420	80.57	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10316.2	E08		2	0108-0401	820.21	401.50	419	77.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9319.8	E08		2	0109-0402	510.01	403.04	445	80.08	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9589.4	E08		2	0110-0402	654.01	401.98	422	76.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10091.2	E08		2	0111-0406	219.36	406.64	536	89.64	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10785.4	E08		2	0112-0404	292.52	404.38	753	105.50	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11513.5	E08		2	0113-0409	30.77	409.53	628	93.15	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10174.3	E08		2	0114-0406	173.15	406.25	382	73.84	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10259.5	E08		2	0115-0408	120.03	408.10	388	75.26	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9665.3	E08		2	0116-0410	779.56	411.26	437	84.43	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10486.2	E08		2	0117-0413	750.21	412.69	398	75.60	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9106.2	E08		2	0118-0441	495.53	441.66	922	128.81	0.698
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9822.5	E08		2	0119-0435	202.35	435.47	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10197.4	E08		2	0120-0436	438.90	436.64	395	75.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9666.6	E08		2	0121-0439	144.52	438.62	374	72.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10112.4	E08		2	0122-0444	560.08	444.52	417	76.43	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9996.5	E08		2	0123-0453	46.63	453.32	389	75.84	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11873.1	E08		2	0124-0451	476.99	452.07	314	69.94	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	639.0	E08		2	0125-0449	761.44	448.87	161	77.50	0.337
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9956.5	E08		2	0126-0454	380.38	454.11	412	76.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10178.0	E08		2	0127-0457	649.09	457.94	398	76.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10380.3	E08		2	0128-0460	248.91	459.73	375	74.91	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9629.1	E08		2	0129-0471	91.12	471.08	805	114.47	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10466.8	E08		2	0130-0466	923.56	466.10	402	74.67	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10514.2	E08		2	0131-0477	221.96	477.90	722	103.05	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9757.1	E08		2	0132-0473	126.82	472.96	380	72.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11825.7	E08		2	0133-0472	870.35	472.08	319	66.18	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10125.8	E08		2	0134-0475	296.63	475.43	382	75.50	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9956.9	E08		2	0135-0477	173.58	476.81	382	73.84	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9298.1	E08		2	0136-0481	602.06	481.41	489	82.67	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10234.5	E08		2	0137-0490	676.30	490.47	392	75.26	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11021.3	E08		2	0138-0500	890.82	500.70	374	72.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9073.4	E08		2	0139-0501	940.01	500.65	370	73.01	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9354.4	E08		2	0140-0499	617.99	499.08	269	64.43	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10506.0	E08		2	0141-0506	302.68	506.09	559	89.40	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9408.1	E08		2	0142-0504	163.22	503.63	432	81.40	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10659.9	E08		2	0143-0504	847.40	504.03	393	74.43	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11169.5	E08		2	0144-0513	603.02	513.03	283	82.08	0.528
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10441.4	E08		2	0145-0527	375.90	526.51	730	103.05	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8718.8	E08		2	0146-0531	777.66	531.02	435	78.67	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10270.0	E08		2	0147-0540	145.54	540.61	745	109.15	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10008.7	E08		2	0148-0533	531.60	533.96	399	77.50	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10084.5	E08		2	0149-0534	666.34	534.51	401	74.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12765.3	E08		2	0150-0541	707.75	541.05	253	77.84	0.525
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9969.9	E08		2	0151-0547	41.41	547.08	409	78.67	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10258.9	E08		2	0152-0548	73.99	548.39	407	75.26	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10353.6	E08		2	0153-0555	105.27	555.72	398	75.84	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7879.7	E08		2	0154-0551	653.87	551.61	207	52.53	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8967.5	E08		2	0155-0558	832.33	558.28	416	79.26	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9743.7	E08		2	0156-0559	572.73	560.47	817	118.57	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10455.4	E08		2	0157-0560	929.68	559.82	380	74.43	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9455.9	E08		2	0158-0569	20.54	569.14	412	80.33	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10037.0	E08		2	0159-0566	270.34	566.66	420	77.26	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10204.1	E08		2	0160-0576	633.39	576.43	400	73.60	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11731.0	E08		2	0161-0581	471.44	581.79	526	85.50	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9555.8	E08		2	0162-0580	347.13	580.43	396	75.84	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10262.0	E08		2	0163-0582	505.16	581.77	399	73.84	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10471.2	E08		2	0164-0589	591.50	589.08	371	71.26	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10756.3	E08		2	0165-0591	682.30	591.53	370	71.84	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9874.4	E08		2	0166-0600	105.82	600.27	371	71.60	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10382.3	E08		2	0167-0601	285.15	601.69	377	71.84	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9985.8	E08		2	0168-0600	717.83	600.31	422	77.84	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9960.0	E08		2	0169-0602	35.81	602.43	398	73.84	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9368.6	E08		2	0170-0604	200.19	604.23	457	82.08	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10213.6	E08		2	0171-0604	540.79	603.75	393	73.84	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9676.3	E08		2	0172-0609	327.17	609.00	407	77.26	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9988.7	E08		2	0173-0609	774.63	609.18	414	75.36	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9456.6	E08		2	0174-0613	797.36	612.87	461	80.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9203.1	E08		2	0175-0626	196.09	626.48	437	81.60	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9995.3	E08		2	0176-0632	421.06	632.33	407	77.26	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9845.4	E08		2	0177-0646	106.32	646.56	414	76.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9016.7	E08		2	0178-0660	737.33	659.93	429	84.47	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10089.6	E08		2	0179-0657	466.58	656.53	399	79.26	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10185.8	E08		2	0180-0660	350.58	660.47	385	73.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10473.9	E08		2	0181-0661	524.65	661.60	401	74.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9508.7	E08		2	0182-0661	774.24	662.08	435	81.74	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9925.9	E08		2	0183-0662	36.19	661.90	361	71.84	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9778.5	E08		2	0184-0671	157.97	671.75	818	111.40	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10033.9	E08		2	0185-0662	872.90	662.01	666	128.61	0.506
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10140.0	E08		2	0186-0666	289.22	666.21	380	74.08	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9059.1	E08		2	0187-0674	70.95	674.70	366	75.01	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10214.0	E08		2	0188-0677	235.00	676.63	377	73.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10469.2	E08		2	0189-0684	563.26	684.31	396	73.84	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9158.8	E08		2	0190-0691	449.32	690.88	405	76.91	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10330.8	E08		2	0191-0696	716.43	696.13	248	75.50	0.547
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9833.0	E08		2	0192-0702	342.18	702.41	490	87.40	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184442	1375337	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10182.9	E08		2	0193-0702	591.30	701.65	379	73.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10683.7	E08		3	0001-0028	415.24	28.39	399	76.08	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10394.5	E08		3	0002-0036	582.81	36.50	835	114.95	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13189.2	E08		3	0003-0047	790.25	47.08	573	92.81	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11327.5	E08		3	0004-0047	632.71	47.54	348	69.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9853.1	E08		3	0005-0049	842.21	49.68	380	74.08	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11416.7	E08		3	0006-0059	49.64	58.78	679	99.98	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9888.6	E08		3	0007-0060	451.37	60.22	416	75.84	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11651.0	E08		3	0008-0064	479.63	62.90	740	108.81	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10376.1	E08		3	0009-0067	192.44	67.96	397	75.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10685.5	E08		3	0010-0067	523.81	67.54	485	83.26	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9809.8	E08		3	0011-0073	252.22	73.24	390	75.50	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10169.6	E08		3	0012-0076	425.67	75.91	395	75.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11753.4	E08		3	0013-0076	760.09	75.86	341	69.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11113.2	E08		3	0014-0076	803.99	77.07	365	72.18	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10452.9	E08		3	0015-0079	104.63	79.58	364	71.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9932.4	E08		3	0016-0081	144.10	81.90	430	80.08	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9387.6	E08		3	0017-0087	231.50	86.77	441	82.91	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10449.3	E08		3	0018-0093	904.56	92.91	288	64.18	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10658.2	E08		3	0019-0099	632.40	98.90	380	75.50	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10027.6	E08		3	0020-0099	801.64	99.31	406	77.36	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9909.1	E08		3	0021-0101	606.85	101.13	443	82.33	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10075.6	E08		3	0022-0104	69.86	104.40	367	71.60	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10279.3	E08		3	0023-0109	554.71	109.17	424	76.67	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10591.6	E08		3	0024-0111	520.13	111.51	384	73.01	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10434.9	E08		3	0025-0117	491.15	117.00	391	73.36	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10138.6	E08		3	0026-0121	454.17	121.55	394	75.94	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11287.7	E08		3	0027-0120	664.67	120.27	349	68.77	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9605.4	E08		3	0028-0125	605.34	126.10	451	82.43	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10924.1	E08		3	0029-0128	760.48	127.64	369	73.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9999.3	E08		3	0030-0133	283.91	133.14	379	77.74	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11677.6	E08		3	0031-0139	43.87	140.08	647	96.33	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10575.4	E08		3	0032-0141	838.44	141.63	356	70.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9449.4	E08		3	0033-0144	462.69	143.91	345	71.60	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9819.5	E08		3	0034-0147	403.48	147.68	423	79.74	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10705.6	E08		3	0035-0145	556.73	145.56	373	72.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10309.7	E08		3	0036-0148	936.63	147.82	359	70.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9847.4	E08		3	0037-0161	105.56	160.15	819	113.74	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10388.5	E08		3	0038-0161	159.37	161.40	377	74.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10988.3	E08		3	0039-0164	694.96	163.46	415	78.57	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10794.4	E08		3	0040-0165	620.89	164.85	366	71.84	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10767.3	E08		3	0041-0168	542.45	167.59	374	70.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9875.1	E08		3	0042-0172	861.79	172.65	398	74.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10337.6	E08		3	0043-0174	581.78	175.04	388	72.43	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11624.2	E08		3	0044-0177	683.05	178.30	328	70.91	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9804.3	E08		3	0045-0180	195.44	180.37	403	77.84	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13904.3	E08		3	0046-0181	308.26	180.58	310	72.53	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12082.1	E08		3	0047-0192	761.51	191.65	599	91.26	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10347.6	E08		3	0048-0194	31.71	193.70	709	107.74	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13077.4	E08		3	0049-0193	307.19	192.85	192	57.11	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10700.1	E08		3	0050-0210	253.54	209.53	363	71.26	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10669.9	E08		3	0051-0214	662.03	214.98	374	73.84	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10480.9	E08		3	0052-0225	202.17	225.33	359	70.67	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10771.1	E08		3	0053-0233	894.48	232.88	741	113.20	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9757.5	E08		3	0054-0226	681.37	224.84	416	77.74	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10950.7	E08		3	0055-0226	622.13	226.02	368	72.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9804.1	E08		3	0056-0230	231.70	229.44	406	77.50	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10777.1	E08		3	0057-0229	432.85	229.64	372	71.84	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10490.4	E08		3	0058-0233	377.23	232.95	380	72.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9321.5	E08		3	0059-0238	698.28	238.85	444	79.15	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9027.5	E08		3	0060-0239	113.51	238.68	366	72.67	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10938.1	E08		3	0061-0248	500.11	247.44	356	70.67	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11166.4	E08		3	0062-0251	752.47	251.41	385	75.26	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9739.8	E08		3	0063-0256	162.63	255.61	376	76.91	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9923.4	E08		3	0064-0276	640.98	276.20	848	126.02	0.671
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10389.4	E08		3	0065-0267	864.53	267.31	398	74.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11144.0	E08		3	0066-0277	682.08	277.03	520	85.50	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10530.3	E08		3	0067-0280	937.73	280.03	369	72.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9785.4	E08		3	0068-0282	619.21	283.03	418	80.67	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9376.3	E08		3	0069-0283	243.07	283.34	402	77.50	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10444.1	E08		3	0070-0286	502.83	286.56	398	75.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11608.6	E08		3	0071-0297	168.63	296.89	692	98.33	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10934.7	E08		3	0072-0293	818.20	293.63	379	73.01	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10527.3	E08		3	0073-0295	365.72	296.06	381	73.26	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11059.2	E08		3	0074-0299	700.88	298.65	369	72.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9267.5	E08		3	0075-0304	116.70	303.98	384	75.26	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9896.7	E08		3	0076-0316	211.94	316.42	415	75.01	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10677.8	E08		3	0077-0329	802.76	329.64	374	71.01	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10106.5	E08		3	0078-0326	851.75	326.91	277	65.60	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10512.2	E08		3	0079-0340	682.57	340.35	401	76.67	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11475.4	E08		3	0080-0346	414.42	345.62	377	70.77	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9879.3	E08		3	0081-0351	596.96	351.22	418	77.60	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10685.3	E08		3	0082-0353	446.26	353.58	383	73.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10731.7	E08		3	0083-0355	895.73	355.83	370	72.67	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9415.7	E08		3	0084-0363	202.60	363.08	387	74.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9103.4	E08		3	0085-0368	142.99	367.77	372	77.84	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10097.3	E08		3	0086-0368	796.25	368.49	398	75.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10545.9	E08		3	0087-0370	633.01	370.73	390	73.84	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11816.7	E08		3	0088-0373	817.02	373.12	337	67.11	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9828.8	E08		3	0089-0376	858.96	376.34	183	53.94	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10667.3	E08		3	0090-0381	323.92	381.41	369	71.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10566.5	E08		3	0091-0384	710.82	384.50	772	107.74	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9847.0	E08		3	0092-0392	230.06	392.60	411	78.91	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10670.8	E08		3	0093-0389	667.16	389.10	379	75.01	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11041.8	E08		3	0094-0390	911.86	389.80	341	71.60	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10667.2	E08		3	0095-0393	139.73	394.28	338	68.18	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10481.0	E08		3	0096-0397	444.60	396.62	591	99.84	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11530.0	E08		3	0097-0399	533.28	399.79	365	72.67	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9934.8	E08		3	0098-0402	246.58	402.44	379	75.26	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10233.3	E08		3	0099-0404	357.90	403.92	369	72.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10125.2	E08		3	0100-0415	486.20	414.77	845	118.61	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10033.3	E08		3	0101-0421	164.73	421.37	387	76.43	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9924.9	E08		3	0102-0421	285.05	421.10	395	73.84	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10002.8	E08		3	0103-0427	465.41	427.88	436	79.98	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9825.2	E08		3	0104-0427	322.12	427.69	395	73.26	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10967.8	E08		3	0105-0430	638.37	430.24	746	107.05	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10791.0	E08		3	0106-0430	686.73	430.73	378	73.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9920.1	E08		3	0107-0434	108.10	433.85	387	73.84	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10108.7	E08		3	0108-0437	59.84	437.40	376	72.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11297.2	E08		3	0109-0439	611.79	439.72	327	67.26	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8571.2	E08		3	0110-0452	856.28	453.15	186	66.77	0.524
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11001.1	E08		3	0111-0462	894.04	461.91	377	72.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10103.1	E08		3	0112-0469	598.73	470.62	823	111.54	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9987.3	E08		3	0113-0466	199.40	465.88	395	76.43	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10708.9	E08		3	0114-0463	864.99	464.80	169	61.11	0.569
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10568.5	E08		3	0115-0468	18.62	468.60	375	72.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10365.1	E08		3	0116-0477	537.51	477.00	395	73.84	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10563.5	E08		3	0117-0480	53.51	480.49	349	71.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9730.3	E08		3	0118-0489	512.63	489.10	419	78.33	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10339.3	E08		3	0119-0487	713.79	487.75	393	75.01	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10808.1	E08		3	0120-0488	757.30	487.96	396	76.43	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10488.6	E08		3	0121-0496	472.71	496.72	389	73.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10763.6	E08		3	0122-0498	409.66	497.78	366	71.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9078.9	E08		3	0123-0503	35.08	503.00	328	68.77	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9571.1	E08		3	0124-0506	169.29	506.84	401	77.60	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11929.0	E08		3	0125-0503	870.94	502.71	369	74.43	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10127.9	E08		3	0126-0513	109.46	513.19	361	72.43	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10415.0	E08		3	0127-0525	449.52	527.03	799	124.81	0.645
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10590.2	E08		3	0128-0515	252.53	515.56	362	73.84	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9397.6	E08		3	0129-0517	190.70	517.05	390	76.33	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11456.5	E08		3	0130-0517	776.83	517.42	340	68.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10910.5	E08		3	0131-0515	808.51	515.00	361	70.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10303.2	E08		3	0132-0521	742.37	520.71	393	75.26	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10246.7	E08		3	0133-0523	296.24	523.06	380	73.26	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11253.4	E08		3	0134-0527	339.69	527.96	523	127.30	0.406
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10148.4	E08		3	0135-0526	587.22	526.52	410	75.36	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10511.1	E08		3	0136-0530	680.35	529.55	417	77.26	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10800.8	E08		3	0137-0531	419.13	531.53	366	72.43	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9866.1	E08		3	0138-0534	548.07	534.35	414	78.08	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10512.0	E08		3	0139-0540	362.14	540.66	391	77.50	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10313.6	E08		3	0140-0545	139.63	544.61	373	77.50	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9120.1	E08		3	0141-0549	525.84	548.52	465	82.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10036.2	E08		3	0142-0556	83.76	556.33	752	107.40	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7773.1	E08		3	0143-0545	688.86	545.38	210	58.77	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10447.6	E08		3	0144-0552	271.47	551.69	372	76.08	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10316.9	E08		3	0145-0557	400.75	557.74	400	75.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9868.0	E08		3	0146-0558	57.64	557.53	415	78.67	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11945.0	E08		3	0147-0557	669.21	557.34	312	65.36	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10553.5	E08		3	0148-0562	24.51	562.19	357	71.60	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10003.0	E08		3	0149-0563	135.43	563.83	398	77.84	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10543.0	E08		3	0150-0563	342.88	563.66	410	79.01	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9421.3	E08		3	0151-0571	182.53	571.83	359	72.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9526.7	E08		3	0152-0581	582.33	580.93	438	79.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10686.7	E08		3	0153-0590	358.55	589.37	813	117.40	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10755.3	E08		3	0154-0586	902.42	586.52	384	73.26	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10526.4	E08		3	0155-0589	448.82	589.10	400	76.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10470.9	E08		3	0156-0593	768.02	593.82	407	74.08	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10945.0	E08		3	0157-0595	502.68	596.04	364	71.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9872.5	E08		3	0158-0604	831.40	603.98	362	73.60	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9229.7	E08		3	0159-0609	640.19	610.11	432	80.33	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10988.2	E08		3	0160-0611	850.23	611.63	370	74.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11243.9	E08		3	0161-0615	610.75	615.08	382	74.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10281.1	E08		3	0162-0628	536.77	627.71	417	78.08	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10655.7	E08		3	0163-0629	888.03	629.44	361	69.84	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9810.3	E08		3	0164-0638	173.63	638.96	773	108.23	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10857.4	E08		3	0165-0632	368.35	632.47	374	72.18	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10657.6	E08		3	0166-0635	289.51	635.13	365	72.43	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10862.2	E08		3	0167-0635	466.65	635.64	364	71.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10170.9	E08		3	0168-0640	241.54	639.77	373	75.01	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11041.9	E08		3	0169-0646	811.99	645.99	397	76.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11380.1	E08		3	0170-0653	50.79	652.78	721	100.23	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10286.9	E08		3	0171-0657	403.07	657.42	389	75.94	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10298.1	E08		3	0172-0669	131.11	669.24	419	79.74	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10791.0	E08		3	0173-0666	790.26	666.03	364	71.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9969.9	E08		3	0174-0669	769.70	669.44	437	82.67	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9657.2	E08		3	0175-0670	282.60	669.71	408	77.50	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9956.8	E08		3	0176-0670	336.02	669.89	373	72.67	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11107.2	E08		3	0177-0676	711.71	675.45	327	70.67	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8788.9	E08		3	0178-0675	902.93	675.77	440	80.57	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9480.7	E08		3	0179-0678	399.08	677.28	461	83.26	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10676.2	E08		3	0180-0679	461.52	678.85	335	71.70	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10449.5	E08		3	0181-0681	480.11	681.06	401	74.87	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9393.9	E08		3	0182-0683	883.11	684.29	410	76.33	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10619.4	E08		3	0183-0686	522.20	685.85	368	71.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9092.1	E08		3	0184-0687	119.99	686.81	247	61.26	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9901.0	E08		3	0185-0690	171.31	690.63	386	73.84	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8982.8	E08		3	0186-0692	290.70	692.65	416	78.67	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10708.3	E08		3	0187-0693	698.95	693.60	331	68.43	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9701.3	E08		3	0188-0696	753.16	696.63	394	74.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184443	1375338	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10616.5	E08		3	0189-0702	238.41	702.66	741	105.40	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9616.9	E08		4	0001-0029	376.31	29.33	422	79.50	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9572.5	E08		4	0002-0030	469.53	29.71	401	77.50	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9942.1	E08		4	0003-0032	326.73	31.62	416	76.67	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10126.0	E08		4	0004-0035	166.80	35.50	385	74.67	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10170.4	E08		4	0005-0034	539.01	34.48	445	82.43	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10392.0	E08		4	0006-0034	38.45	34.57	375	74.33	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10194.5	E08		4	0007-0036	206.75	36.76	415	80.57	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9566.9	E08		4	0008-0042	639.40	41.71	375	73.50	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9285.9	E08		4	0009-0047	481.05	47.22	481	85.98	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9725.0	E08		4	0010-0051	403.40	51.21	468	82.33	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9152.5	E08		4	0011-0061	606.13	61.23	465	82.08	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9354.2	E08		4	0012-0061	870.01	62.05	423	76.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10122.5	E08		4	0013-0064	814.30	64.40	384	72.77	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9657.9	E08		4	0014-0070	776.89	69.91	432	80.08	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9574.1	E08		4	0015-0069	362.99	69.22	421	80.33	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9744.1	E08		4	0016-0075	690.51	75.10	436	78.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9800.1	E08		4	0017-0076	236.77	76.65	410	77.50	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9093.7	E08		4	0018-0077	538.56	77.41	475	87.15	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10627.2	E08		4	0019-0084	839.75	83.66	374	72.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8739.4	E08		4	0020-0087	511.66	87.27	484	87.15	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9572.2	E08		4	0021-0100	67.65	99.83	411	77.26	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9653.7	E08		4	0022-0102	191.26	101.85	442	80.67	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9831.6	E08		4	0023-0106	411.29	105.96	766	104.91	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9816.4	E08		4	0024-0103	436.90	103.15	459	81.36	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9729.4	E08		4	0025-0103	24.48	103.70	398	75.84	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9332.0	E08		4	0026-0108	564.96	108.42	928	128.95	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9612.2	E08		4	0027-0110	667.55	110.64	870	122.95	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10083.5	E08		4	0028-0108	915.24	107.70	423	78.43	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9034.1	E08		4	0029-0119	369.86	119.71	872	117.64	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10359.1	E08		4	0030-0117	483.56	116.96	693	99.98	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9363.9	E08		4	0031-0133	735.08	133.36	872	128.51	0.664
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9919.4	E08		4	0032-0132	793.21	132.41	434	79.50	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9911.5	E08		4	0033-0135	590.91	134.99	441	78.91	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9417.4	E08		4	0034-0138	284.81	138.69	455	83.15	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9718.5	E08		4	0035-0141	624.33	140.81	426	82.57	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8768.8	E08		4	0036-0140	258.61	140.15	317	69.50	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9953.6	E08		4	0037-0144	195.41	144.54	413	77.50	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10261.7	E08		4	0038-0144	893.43	144.56	395	74.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9584.0	E08		4	0039-0148	364.65	148.27	417	80.33	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9529.8	E08		4	0040-0164	122.86	165.55	853	117.78	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8781.8	E08		4	0041-0158	345.00	157.93	466	85.15	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10031.0	E08		4	0042-0158	658.78	158.60	415	76.67	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9839.7	E08		4	0043-0162	39.75	161.75	398	74.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9123.2	E08		4	0044-0163	477.58	162.65	392	73.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9478.6	E08		4	0045-0171	757.86	171.71	411	81.50	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9724.1	E08		4	0046-0179	690.09	179.95	451	82.91	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9273.4	E08		4	0047-0181	509.76	179.71	436	82.47	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9453.3	E08		4	0048-0180	423.86	179.86	449	82.91	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9342.3	E08		4	0049-0188	634.58	188.58	481	83.74	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9077.0	E08		4	0050-0191	491.16	193.10	435	82.33	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9815.4	E08		4	0051-0192	794.75	192.31	428	78.08	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9263.9	E08		4	0052-0197	550.39	197.01	414	79.26	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10095.9	E08		4	0053-0197	831.67	197.45	401	76.08	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8512.8	E08		4	0054-0202	411.77	202.14	485	90.33	0.747
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8978.8	E08		4	0055-0211	606.56	211.27	947	125.44	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9110.4	E08		4	0056-0206	385.02	206.39	456	82.67	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9131.2	E08		4	0057-0209	242.02	207.81	446	81.88	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9598.5	E08		4	0058-0212	67.31	211.81	423	79.26	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9834.9	E08		4	0059-0210	286.99	210.26	423	78.08	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9847.3	E08		4	0060-0216	726.80	215.88	427	77.50	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9460.6	E08		4	0061-0221	226.57	222.17	395	78.23	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8550.8	E08		4	0062-0222	544.15	222.08	490	86.18	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9490.0	E08		4	0063-0220	777.29	220.48	419	76.67	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9919.2	E08		4	0064-0230	350.24	230.09	407	76.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9616.0	E08		4	0065-0235	698.65	235.23	431	82.81	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9999.9	E08		4	0066-0235	390.33	235.47	392	75.50	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9719.1	E08		4	0067-0243	108.57	243.69	401	77.50	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9725.0	E08		4	0068-0246	838.49	246.20	452	80.91	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9550.6	E08		4	0069-0248	543.64	247.86	431	78.43	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10062.3	E08		4	0070-0248	753.37	248.95	404	77.50	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9114.7	E08		4	0071-0248	451.53	248.74	468	84.77	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9649.6	E08		4	0072-0252	323.73	252.20	406	77.26	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9404.1	E08		4	0073-0254	473.20	254.32	420	80.18	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10760.3	E08		4	0074-0255	912.05	255.95	362	71.26	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9243.9	E08		4	0075-0258	640.31	258.51	486	85.50	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9135.5	E08		4	0076-0260	665.44	259.77	452	83.50	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9872.3	E08		4	0077-0263	872.41	263.11	474	83.50	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10035.3	E08		4	0078-0266	367.06	265.64	415	76.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10192.5	E08		4	0079-0268	780.52	268.02	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9762.2	E08		4	0080-0274	179.37	274.15	430	77.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10116.2	E08		4	0081-0280	251.34	280.48	399	75.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9729.4	E08		4	0082-0286	526.38	286.29	418	77.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11365.5	E08		4	0083-0291	805.27	290.90	691	98.57	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9759.6	E08		4	0084-0289	415.43	289.20	429	80.08	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9754.5	E08		4	0085-0303	165.61	303.77	430	77.84	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9338.3	E08		4	0086-0308	709.10	308.30	472	83.26	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9697.0	E08		4	0087-0311	288.03	311.72	406	79.50	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9583.1	E08		4	0088-0312	901.72	311.94	422	76.43	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9286.4	E08		4	0089-0318	685.82	317.83	441	80.67	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10822.5	E08		4	0090-0323	249.96	323.02	742	104.47	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10041.8	E08		4	0091-0322	624.79	322.52	399	76.08	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10143.6	E08		4	0092-0322	943.40	322.65	381	73.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9797.8	E08		4	0093-0347	676.81	348.17	412	76.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9745.4	E08		4	0094-0349	750.47	349.19	842	119.64	0.739
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9952.4	E08		4	0095-0349	136.05	348.74	396	76.91	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9809.6	E08		4	0096-0353	704.85	353.22	416	78.91	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9860.6	E08		4	0097-0361	338.63	362.11	810	111.88	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9309.0	E08		4	0098-0357	564.43	357.09	460	82.77	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9327.2	E08		4	0099-0359	203.75	359.23	427	80.33	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9859.9	E08		4	0100-0362	531.38	361.51	870	114.57	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9845.0	E08		4	0101-0364	616.58	364.28	423	75.84	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8974.4	E08		4	0102-0370	180.75	369.39	448	80.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9855.0	E08		4	0103-0375	83.23	375.25	391	78.33	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9811.2	E08		4	0104-0377	425.81	377.11	425	78.91	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9046.6	E08		4	0105-0386	288.74	385.59	897	123.88	0.734
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11338.6	E08		4	0106-0384	871.17	383.61	342	68.18	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10138.2	E08		4	0107-0389	24.18	389.00	376	74.67	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9415.3	E08		4	0108-0387	258.24	387.51	410	78.53	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9573.6	E08		4	0109-0393	491.32	393.10	437	83.15	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9701.9	E08		4	0110-0396	552.04	394.76	415	80.23	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10090.1	E08		4	0111-0398	738.64	397.49	397	74.43	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10005.9	E08		4	0112-0399	684.04	398.75	412	76.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12071.1	E08		4	0113-0407	389.42	406.76	529	94.91	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9649.4	E08		4	0114-0407	589.34	406.88	420	78.67	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10293.1	E08		4	0115-0406	920.59	406.58	440	77.26	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10952.9	E08		4	0116-0413	532.50	414.86	753	104.47	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9833.3	E08		4	0117-0413	233.92	412.73	412	77.26	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9816.5	E08		4	0118-0411	359.40	410.70	415	78.08	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9991.2	E08		4	0119-0413	630.06	411.74	381	77.64	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9803.0	E08		4	0120-0419	285.91	418.45	839	108.81	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8721.9	E08		4	0121-0421	695.14	420.42	479	90.81	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9976.8	E08		4	0122-0419	436.31	419.40	407	76.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9962.7	E08		4	0123-0425	110.14	425.64	562	94.81	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9482.7	E08		4	0124-0426	645.96	426.73	455	80.57	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10309.1	E08		4	0125-0425	866.84	425.04	392	76.91	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4654.0	E08		4	0126-0426	382.97	426.70	214	60.77	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9782.4	E08		4	0127-0431	777.43	430.82	454	83.15	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9889.6	E08		4	0128-0436	705.74	437.07	413	81.98	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10076.6	E08		4	0129-0435	319.58	435.80	410	76.08	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10737.2	E08		4	0130-0446	599.20	446.02	744	100.81	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10003.7	E08		4	0131-0448	163.99	448.51	430	78.08	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9878.4	E08		4	0132-0456	276.89	456.42	424	78.08	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10234.7	E08		4	0133-0459	905.75	457.52	380	75.98	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10040.0	E08		4	0134-0468	888.60	469.74	418	79.74	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11183.8	E08		4	0135-0474	695.70	474.53	764	106.23	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9836.3	E08		4	0136-0477	370.65	476.79	426	80.81	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9389.2	E08		4	0137-0481	112.68	481.24	401	78.33	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9927.5	E08		4	0138-0488	213.74	488.34	406	78.67	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9766.4	E08		4	0139-0486	603.59	485.86	424	78.91	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9382.2	E08		4	0140-0492	76.49	492.01	442	82.33	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9825.9	E08		4	0141-0490	307.38	490.29	448	81.50	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9065.5	E08		4	0142-0495	355.80	495.48	508	86.57	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9748.4	E08		4	0143-0498	530.91	497.54	426	78.43	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9857.1	E08		4	0144-0508	936.11	508.18	411	76.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10127.3	E08		4	0145-0516	640.42	515.71	391	73.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9473.1	E08		4	0146-0518	385.44	518.92	445	83.98	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9363.8	E08		4	0147-0526	569.04	526.32	431	80.33	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9921.9	E08		4	0148-0525	428.94	525.80	418	80.33	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9495.3	E08		4	0149-0528	701.21	528.02	431	79.50	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9692.6	E08		4	0150-0535	118.78	535.26	432	80.91	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8994.9	E08		4	0151-0535	367.11	534.85	449	81.74	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9824.9	E08		4	0152-0538	154.87	538.00	401	75.74	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9042.0	E08		4	0153-0542	403.90	541.72	447	84.33	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9956.1	E08		4	0154-0546	617.77	545.48	421	78.67	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10715.9	E08		4	0155-0553	247.29	552.85	707	100.23	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9865.4	E08		4	0156-0546	851.67	546.21	400	76.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10049.0	E08		4	0157-0551	755.90	550.92	400	75.01	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10111.5	E08		4	0158-0555	509.69	555.50	513	86.33	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9539.4	E08		4	0159-0566	449.55	566.71	846	114.47	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9685.5	E08		4	0160-0565	325.54	565.58	446	78.91	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9854.0	E08		4	0161-0565	718.66	565.16	417	77.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9954.6	E08		4	0162-0578	581.05	578.21	405	77.26	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9758.5	E08		4	0163-0584	352.77	585.09	409	78.91	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10260.4	E08		4	0164-0586	644.49	587.18	809	110.81	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9193.4	E08		4	0165-0599	386.32	598.68	902	122.02	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9747.8	E08		4	0166-0597	820.30	597.28	403	79.50	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9631.9	E08		4	0167-0597	902.14	597.37	399	74.43	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9869.2	E08		4	0168-0601	522.22	601.39	413	77.84	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10028.8	E08		4	0169-0610	858.65	610.57	427	79.50	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9655.8	E08		4	0170-0611	197.02	610.95	439	80.91	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9671.6	E08		4	0171-0610	713.64	610.13	416	77.84	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10728.3	E08		4	0172-0612	777.81	612.44	373	70.77	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9943.8	E08		4	0173-0617	442.56	617.16	390	75.50	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9955.5	E08		4	0174-0620	300.22	620.31	408	74.43	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9620.8	E08		4	0175-0623	818.13	622.92	476	84.08	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9838.8	E08		4	0176-0632	66.66	631.38	777	109.05	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9458.4	E08		4	0177-0638	333.96	638.20	438	79.74	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9933.5	E08		4	0178-0639	645.90	638.83	415	75.84	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9777.0	E08		4	0179-0644	254.30	643.97	410	75.84	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8626.2	E08		4	0180-0644	766.71	644.46	248	87.50	0.407
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10260.7	E08		4	0181-0649	475.70	648.79	796	111.64	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10401.7	E08		4	0182-0654	885.78	655.00	352	69.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9718.3	E08		4	0183-0656	36.38	656.07	390	73.26	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9398.6	E08		4	0184-0658	820.16	658.20	417	75.84	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9646.9	E08		4	0185-0666	109.47	665.99	445	80.91	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9656.6	E08		4	0186-0668	931.79	667.74	379	73.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9317.2	E08		4	0187-0670	764.69	670.90	426	79.74	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9282.5	E08		4	0188-0670	515.22	671.01	430	81.40	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9769.5	E08		4	0189-0672	228.59	672.38	446	80.67	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9701.1	E08		4	0190-0677	711.19	677.12	407	78.33	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9707.4	E08		4	0191-0680	362.66	680.49	407	74.18	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9867.8	E08		4	0192-0682	674.03	681.82	403	75.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9540.1	E08		4	0193-0688	31.90	688.55	387	75.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8945.2	E08		4	0194-0700	913.09	698.64	422	81.15	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8843.3	E08		4	0195-0699	177.40	699.16	425	77.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9376.7	E08		4	0196-0706	896.96	706.45	370	76.67	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9975.3	E08		4	0197-0705	451.24	705.04	393	73.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184444	1375339	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10239.9	E08		4	0198-0706	841.19	706.47	391	73.84	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11662.5	E08		5	0001-0036	912.92	36.08	697	97.74	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12918.7	E08		5	0002-0037	400.71	36.02	190	56.53	0.747
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9062.7	E08		5	0003-0042	383.54	44.47	533	95.15	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10161.0	E08		5	0004-0043	672.96	42.74	427	77.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6279.5	E08		5	0005-0047	55.66	46.50	612	93.98	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8235.5	E08		5	0006-0047	87.28	46.68	387	97.15	0.515
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10092.5	E08		5	0007-0044	186.17	44.47	395	73.84	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9170.7	E08		5	0008-0047	226.42	47.21	458	83.15	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10078.1	E08		5	0009-0048	129.84	47.85	425	77.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11178.5	E08		5	0010-0050	790.39	50.36	408	77.74	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	254.6	E08		5	0011-0051	101.71	52.26	139	54.53	0.587
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9734.2	E08		5	0012-0057	312.17	57.19	430	79.26	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9712.4	E08		5	0013-0068	489.97	68.32	441	79.50	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9760.4	E08		5	0014-0073	372.57	73.36	407	74.43	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9833.4	E08		5	0015-0074	412.97	74.21	406	77.50	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10516.3	E08		5	0016-0082	710.92	82.13	436	77.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10305.2	E08		5	0017-0089	155.98	89.08	370	72.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10583.4	E08		5	0018-0098	744.01	98.60	365	71.26	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10009.8	E08		5	0019-0101	112.51	100.66	349	70.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9820.5	E08		5	0020-0107	189.04	107.38	386	77.50	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11278.7	E08		5	0021-0106	912.13	105.94	263	75.50	0.580
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9847.6	E08		5	0022-0110	20.05	109.88	419	79.74	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9753.9	E08		5	0023-0113	684.55	113.61	430	78.08	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8816.2	E08		5	0024-0134	634.63	132.56	822	126.37	0.647
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9590.1	E08		5	0025-0135	217.50	135.58	433	79.84	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9924.4	E08		5	0026-0138	151.19	137.96	392	74.67	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9806.5	E08		5	0027-0139	694.30	139.48	432	78.91	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8872.3	E08		5	0028-0138	506.42	138.97	366	71.26	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10589.3	E08		5	0029-0153	739.43	153.21	377	71.01	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10141.4	E08		5	0030-0155	266.99	155.23	390	74.08	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9956.1	E08		5	0031-0158	364.21	158.24	390	74.43	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11134.6	E08		5	0032-0157	789.19	157.46	339	69.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10001.8	E08		5	0033-0161	428.45	161.27	415	79.15	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9517.5	E08		5	0034-0162	606.91	162.23	471	85.98	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10083.2	E08		5	0035-0164	102.21	164.37	385	74.91	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9739.9	E08		5	0036-0170	393.74	169.85	402	75.84	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10693.9	E08		5	0037-0173	45.29	173.71	724	105.50	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13863.1	E08		5	0038-0176	559.97	176.57	534	125.44	0.426
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9926.1	E08		5	0039-0182	182.79	182.45	382	74.33	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10181.8	E08		5	0040-0184	824.00	184.55	431	79.84	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10098.4	E08		5	0041-0189	630.02	190.57	822	113.54	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8948.9	E08		5	0042-0185	228.36	183.91	443	87.05	0.735
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10352.2	E08		5	0043-0202	452.20	201.93	838	110.57	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9607.9	E08		5	0044-0195	279.94	195.23	410	77.01	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9301.3	E08		5	0045-0202	155.62	202.56	473	86.08	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10404.4	E08		5	0046-0201	527.69	201.62	461	81.84	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10102.2	E08		5	0047-0203	752.82	203.24	401	76.08	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9825.0	E08		5	0048-0210	326.39	209.37	856	119.20	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9555.8	E08		5	0049-0207	228.68	207.78	408	82.23	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9943.0	E08		5	0050-0218	126.09	217.93	392	77.74	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10123.8	E08		5	0051-0219	938.78	219.02	391	74.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10190.0	E08		5	0052-0223	167.61	222.46	356	76.43	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10166.9	E08		5	0053-0229	91.30	229.29	380	74.67	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9914.0	E08		5	0054-0229	780.61	229.64	408	76.67	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11676.8	E08		5	0055-0233	833.52	233.37	660	96.57	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9790.9	E08		5	0056-0232	898.40	232.45	416	76.67	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10455.0	E08		5	0057-0241	397.59	241.52	526	87.74	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10308.6	E08		5	0058-0244	649.02	244.50	374	70.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10197.1	E08		5	0059-0248	294.41	247.83	388	74.67	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10527.4	E08		5	0060-0250	614.43	250.41	465	83.74	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9568.9	E08		5	0061-0253	247.78	252.38	415	81.40	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8420.9	E08		5	0062-0253	514.90	252.80	430	80.91	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9670.1	E08		5	0063-0254	738.72	254.37	418	79.01	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10233.2	E08		5	0064-0258	16.81	258.04	373	73.26	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9855.8	E08		5	0065-0260	71.67	260.48	388	73.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9757.4	E08		5	0066-0260	337.57	260.69	413	76.67	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9937.6	E08		5	0067-0261	717.98	261.28	407	79.26	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9605.8	E08		5	0068-0261	359.63	260.89	371	71.70	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10780.9	E08		5	0069-0268	867.65	268.12	368	72.08	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9551.0	E08		5	0070-0271	812.16	270.97	430	79.50	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9758.4	E08		5	0071-0274	164.80	274.49	398	76.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9517.5	E08		5	0072-0282	833.97	281.78	441	82.91	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10533.8	E08		5	0073-0285	930.92	285.11	411	75.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9511.3	E08		5	0074-0291	91.17	291.53	396	75.26	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10009.9	E08		5	0075-0291	480.15	291.94	443	80.33	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9987.2	E08		5	0076-0290	541.98	289.68	413	80.33	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9621.9	E08		5	0077-0297	744.79	296.42	423	79.74	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10173.1	E08		5	0078-0298	638.64	298.19	436	79.50	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9717.8	E08		5	0079-0299	696.64	299.44	421	77.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9383.4	E08		5	0080-0310	859.34	310.60	433	79.26	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10194.1	E08		5	0081-0311	211.24	311.25	384	73.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10348.1	E08		5	0082-0317	458.01	318.23	597	94.81	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9294.8	E08		5	0083-0316	756.38	317.12	453	82.08	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8911.8	E08		5	0084-0320	547.00	320.09	475	92.23	0.702
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10063.2	E08		5	0085-0322	522.21	322.03	409	79.84	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10157.9	E08		5	0086-0325	48.41	324.90	371	73.50	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9991.6	E08		5	0087-0325	111.70	324.44	389	75.01	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10022.8	E08		5	0088-0329	314.40	328.83	415	76.08	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10088.0	E08		5	0089-0331	582.08	332.17	403	76.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9442.4	E08		5	0090-0333	673.06	333.28	435	80.08	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9956.2	E08		5	0091-0331	899.74	331.41	398	77.26	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10209.5	E08		5	0092-0338	172.43	338.13	383	74.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10238.8	E08		5	0093-0339	223.79	339.76	383	74.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10233.2	E08		5	0094-0347	779.18	347.30	388	76.33	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9273.5	E08		5	0095-0349	689.37	349.18	454	81.74	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10092.4	E08		5	0096-0349	144.38	349.49	383	74.08	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8998.0	E08		5	0097-0351	272.80	350.88	394	76.08	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10519.0	E08		5	0098-0356	645.18	355.75	398	76.67	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9646.4	E08		5	0099-0371	89.56	371.12	398	75.26	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10141.1	E08		5	0100-0371	750.34	370.95	394	79.15	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9602.9	E08		5	0101-0375	859.09	374.62	419	77.50	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10154.6	E08		5	0102-0377	235.32	377.50	785	116.95	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9532.8	E08		5	0103-0385	597.11	385.01	934	125.68	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9869.0	E08		5	0104-0389	304.30	388.70	858	119.68	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9848.7	E08		5	0105-0383	122.06	383.52	392	76.57	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9324.4	E08		5	0106-0388	549.09	386.78	494	88.57	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9327.8	E08		5	0107-0388	493.48	388.54	448	86.57	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8997.0	E08		5	0108-0392	464.63	392.49	458	82.91	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10089.5	E08		5	0109-0398	361.87	397.81	415	76.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9785.8	E08		5	0110-0397	729.47	397.47	422	77.50	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10385.4	E08		5	0111-0402	644.21	402.75	401	75.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10229.1	E08		5	0112-0408	25.84	408.78	427	77.50	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9684.8	E08		5	0113-0412	687.08	412.42	423	78.67	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8384.0	E08		5	0114-0420	131.98	419.92	301	71.11	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9100.6	E08		5	0115-0420	149.08	419.68	190	53.21	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9981.0	E08		5	0116-0426	598.50	426.01	414	77.50	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9157.5	E08		5	0117-0428	881.31	428.51	431	80.33	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9899.0	E08		5	0118-0433	743.77	432.91	402	76.67	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9946.1	E08		5	0119-0436	519.01	436.38	420	78.08	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8964.5	E08		5	0120-0440	203.93	440.29	462	83.84	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8923.6	E08		5	0121-0442	226.39	442.23	462	81.60	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9852.5	E08		5	0122-0442	259.99	441.96	399	75.50	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9716.9	E08		5	0123-0442	396.28	441.63	404	77.26	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10260.6	E08		5	0124-0452	828.09	451.93	481	81.01	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10033.6	E08		5	0125-0454	567.20	454.24	407	76.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9809.1	E08		5	0126-0458	60.38	458.16	396	77.26	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9648.3	E08		5	0127-0464	462.94	463.98	444	82.91	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9991.1	E08		5	0128-0462	682.87	461.98	412	76.91	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11412.4	E08		5	0129-0466	727.81	466.33	689	100.47	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9985.5	E08		5	0130-0462	939.93	462.33	386	73.01	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10190.4	E08		5	0131-0480	545.63	480.82	800	118.71	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9294.2	E08		5	0132-0475	595.64	476.17	420	82.33	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9737.9	E08		5	0133-0486	337.27	486.65	436	83.40	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9906.2	E08		5	0134-0487	654.85	487.16	421	78.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10107.9	E08		5	0135-0498	312.01	498.08	791	114.95	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9731.3	E08		5	0136-0500	732.05	500.30	421	78.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9893.7	E08		5	0137-0510	41.05	510.31	392	74.67	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9655.4	E08		5	0138-0511	901.81	511.56	447	79.50	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9767.4	E08		5	0139-0514	171.32	513.56	408	78.57	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9909.4	E08		5	0140-0515	814.29	515.03	404	77.26	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10148.4	E08		5	0141-0517	762.03	517.57	409	75.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10064.5	E08		5	0142-0518	524.67	518.08	411	77.26	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10140.1	E08		5	0143-0530	669.23	530.32	405	76.67	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10035.1	E08		5	0144-0535	381.83	535.94	398	75.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9823.8	E08		5	0145-0537	450.65	536.69	413	79.26	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10086.6	E08		5	0146-0540	496.57	540.79	433	77.01	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9689.7	E08		5	0147-0543	575.29	542.93	427	80.33	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9868.6	E08		5	0148-0551	803.26	551.15	813	113.05	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11215.7	E08		5	0149-0551	922.87	550.54	310	66.18	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9622.9	E08		5	0150-0562	119.28	562.25	412	78.33	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10358.3	E08		5	0151-0565	243.17	565.20	397	74.91	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9940.3	E08		5	0152-0565	856.86	565.48	401	73.84	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9883.5	E08		5	0153-0572	309.73	571.73	409	79.50	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10816.4	E08		5	0154-0576	918.68	577.10	561	89.15	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10067.5	E08		5	0155-0579	350.68	579.12	403	75.50	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10052.4	E08		5	0156-0580	58.30	579.86	385	74.67	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10833.6	E08		5	0157-0584	284.01	584.18	751	105.64	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9566.6	E08		5	0158-0590	578.60	590.09	424	82.08	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10458.2	E08		5	0159-0593	777.12	593.57	371	75.74	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10043.3	E08		5	0160-0595	468.12	594.79	435	77.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10309.6	E08		5	0161-0607	390.67	607.42	853	115.88	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10774.3	E08		5	0162-0605	848.16	605.02	340	68.18	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10389.5	E08		5	0163-0609	726.45	609.57	390	73.26	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10192.5	E08		5	0164-0611	150.33	610.49	400	76.33	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9837.8	E08		5	0165-0614	112.83	614.69	392	74.08	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10128.7	E08		5	0166-0619	311.78	619.52	400	77.74	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9806.2	E08		5	0167-0620	53.42	619.82	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8941.8	E08		5	0168-0621	536.05	620.32	336	70.43	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10069.4	E08		5	0169-0626	822.73	625.75	397	76.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9957.9	E08		5	0170-0623	269.05	623.42	417	77.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9676.3	E08		5	0171-0630	552.07	630.35	420	83.50	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9688.0	E08		5	0172-0631	442.94	631.56	409	77.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10051.2	E08		5	0173-0635	917.01	635.15	376	74.08	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9837.5	E08		5	0174-0635	859.67	635.02	418	77.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9524.8	E08		5	0175-0649	331.63	649.34	432	80.33	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9510.4	E08		5	0176-0651	801.96	651.19	436	82.33	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10384.6	E08		5	0177-0648	142.89	648.94	365	74.43	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10090.8	E08		5	0178-0653	87.19	652.94	379	76.33	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12258.1	E08		5	0179-0654	490.62	655.31	427	97.40	0.566
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10164.0	E08		5	0180-0654	290.92	654.14	391	75.26	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9760.2	E08		5	0181-0658	122.51	658.29	430	78.08	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11814.3	E08		5	0182-0660	943.92	659.79	269	61.36	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9844.1	E08		5	0183-0665	450.32	665.15	408	76.67	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9966.0	E08		5	0184-0666	711.38	665.77	407	78.08	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10254.6	E08		5	0185-0665	388.66	665.79	387	76.08	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9862.6	E08		5	0186-0667	530.37	666.86	408	77.74	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9735.7	E08		5	0187-0670	36.41	670.08	383	75.50	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10341.1	E08		5	0188-0670	867.56	669.86	372	72.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9901.0	E08		5	0189-0687	601.90	686.94	404	75.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10205.7	E08		5	0190-0689	805.54	688.90	400	76.67	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10102.6	E08		5	0191-0691	754.41	691.52	398	75.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9975.8	E08		5	0192-0694	706.03	694.46	414	77.50	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9606.4	E08		5	0193-0695	182.32	695.39	392	74.67	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9962.2	E08		5	0194-0698	408.47	698.36	394	76.08	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9301.4	E08		5	0195-0701	18.07	700.07	363	77.40	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9967.0	E08		5	0196-0700	311.11	700.68	390	74.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184445	1375340	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9927.3	E08		5	0197-0707	882.43	706.19	366	72.81	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9526.3	E08		6	0001-0039	609.10	39.78	429	78.67	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10425.6	E08		6	0002-0037	360.26	37.48	370	71.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9932.9	E08		6	0003-0043	130.87	43.35	415	76.67	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9729.9	E08		6	0004-0044	937.28	43.85	447	83.26	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10461.2	E08		6	0005-0046	666.80	46.34	393	73.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9774.5	E08		6	0006-0051	182.30	50.93	439	79.84	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9982.8	E08		6	0007-0052	403.43	51.91	456	80.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9852.6	E08		6	0008-0056	835.63	55.83	437	82.67	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9974.5	E08		6	0009-0054	547.64	54.10	424	77.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9892.4	E08		6	0010-0056	445.92	56.36	434	79.26	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10592.9	E08		6	0011-0055	865.44	55.01	398	73.84	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8817.3	E08		6	0012-0056	99.44	56.56	204	59.36	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10483.4	E08		6	0013-0056	709.53	56.49	394	73.84	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9379.4	E08		6	0014-0057	56.19	57.15	276	62.77	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9267.9	E08		6	0015-0061	291.50	60.35	420	80.23	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11256.2	E08		6	0016-0071	649.24	69.38	188	65.01	0.559
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9497.1	E08		6	0017-0075	273.94	76.36	420	78.33	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10159.9	E08		6	0018-0082	865.23	82.94	421	76.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10393.9	E08		6	0019-0087	100.68	87.47	401	75.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10718.8	E08		6	0020-0085	790.76	85.89	405	77.01	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10032.6	E08		6	0021-0099	595.58	98.77	410	75.84	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10174.2	E08		6	0022-0100	401.27	100.66	401	75.26	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11781.7	E08		6	0023-0104	359.67	103.66	639	92.91	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10402.3	E08		6	0024-0101	917.18	101.30	370	71.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9818.9	E08		6	0025-0102	147.44	102.15	426	79.01	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9925.1	E08		6	0026-0104	203.96	103.60	391	73.84	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9730.4	E08		6	0027-0111	687.18	111.25	425	77.26	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9800.3	E08		6	0028-0114	311.62	114.67	409	76.67	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10174.4	E08		6	0029-0126	567.48	126.76	529	119.88	0.463
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10316.9	E08		6	0030-0124	514.48	124.06	399	73.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10250.6	E08		6	0031-0134	874.24	134.51	416	75.26	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10223.3	E08		6	0032-0136	443.35	136.30	428	77.26	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9703.6	E08		6	0033-0137	221.07	136.76	398	74.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9756.0	E08		6	0034-0138	802.41	138.59	416	75.01	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10099.5	E08		6	0035-0141	845.01	141.60	424	79.50	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10060.3	E08		6	0036-0145	932.34	145.11	411	78.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9942.0	E08		6	0037-0156	316.95	156.18	405	75.26	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11404.7	E08		6	0038-0173	180.35	172.98	600	120.37	0.520
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10675.7	E08		6	0039-0171	928.07	170.09	399	76.53	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10843.7	E08		6	0040-0176	889.94	176.64	383	76.67	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9769.5	E08		6	0041-0180	641.53	180.47	408	74.43	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9560.6	E08		6	0042-0181	254.12	181.22	431	79.84	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10839.5	E08		6	0043-0180	575.01	180.53	356	69.01	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8815.2	E08		6	0044-0185	769.00	185.35	487	85.84	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10774.2	E08		6	0045-0201	840.71	200.64	409	78.91	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9831.2	E08		6	0046-0201	402.79	201.96	404	75.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9536.7	E08		6	0047-0217	557.64	217.97	437	78.18	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10213.6	E08		6	0048-0222	65.75	222.55	402	75.84	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10098.7	E08		6	0049-0222	33.66	222.01	378	71.84	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9058.3	E08		6	0050-0230	461.89	228.95	884	118.71	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9793.3	E08		6	0051-0224	894.28	224.40	424	78.08	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10065.1	E08		6	0052-0235	146.72	235.75	423	77.26	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10231.5	E08		6	0053-0238	241.90	238.00	383	73.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11797.5	E08		6	0054-0237	315.12	237.17	411	77.01	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9989.1	E08		6	0055-0243	565.44	243.58	481	82.43	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	237.3	E08		6	0056-0246	675.69	246.47	385	73.26	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9934.0	E08		6	0057-0251	200.63	251.72	394	73.84	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10330.7	E08		6	0058-0254	390.06	254.58	396	73.01	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9933.3	E08		6	0059-0256	274.78	255.92	404	76.28	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9538.7	E08		6	0060-0258	297.14	258.14	451	81.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10073.0	E08		6	0061-0258	122.38	258.27	395	76.67	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10428.3	E08		6	0062-0262	826.81	262.42	397	77.74	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9954.4	E08		6	0063-0265	364.08	265.39	397	75.50	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10098.8	E08		6	0064-0266	66.07	266.07	380	73.01	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9972.9	E08		6	0065-0268	780.41	269.04	384	78.91	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10304.6	E08		6	0066-0276	942.40	276.55	414	77.26	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10245.0	E08		6	0067-0284	864.62	284.60	393	75.01	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10185.6	E08		6	0068-0288	919.98	288.51	425	80.67	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10384.2	E08		6	0069-0287	25.72	287.87	402	74.18	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10122.2	E08		6	0070-0291	794.39	291.48	427	84.91	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10233.3	E08		6	0071-0291	340.77	290.88	388	74.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9902.5	E08		6	0072-0292	733.23	292.36	414	78.08	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10719.3	E08		6	0073-0302	700.29	302.29	365	70.18	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9666.7	E08		6	0074-0307	593.62	308.24	459	83.98	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9509.1	E08		6	0075-0308	389.89	307.90	416	75.60	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10752.1	E08		6	0076-0316	97.64	316.85	772	105.98	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10163.3	E08		6	0077-0322	160.15	322.59	425	78.08	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10021.0	E08		6	0078-0323	429.71	323.83	412	76.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10315.7	E08		6	0079-0325	620.50	325.40	390	74.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10669.7	E08		6	0080-0324	673.88	324.71	368	71.01	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9813.1	E08		6	0081-0326	298.88	326.11	431	79.50	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10572.4	E08		6	0082-0338	840.47	338.66	399	74.43	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9709.3	E08		6	0083-0343	945.96	343.78	423	76.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10352.6	E08		6	0084-0348	94.01	348.05	361	75.26	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9936.8	E08		6	0085-0349	192.31	348.83	427	79.26	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10226.3	E08		6	0086-0355	743.75	355.90	402	75.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11164.8	E08		6	0087-0359	863.28	359.07	375	71.01	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9537.8	E08		6	0088-0361	410.56	360.93	417	76.91	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10282.8	E08		6	0089-0362	549.72	362.11	395	73.60	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8750.3	E08		6	0090-0366	86.07	366.13	430	81.84	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9641.0	E08		6	0091-0368	605.95	368.15	466	81.26	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10018.4	E08		6	0092-0368	461.92	368.59	404	75.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10002.9	E08		6	0093-0369	503.73	369.03	421	75.84	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11138.9	E08		6	0094-0388	126.33	388.29	676	96.33	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9973.5	E08		6	0095-0389	272.93	389.65	406	78.08	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10387.9	E08		6	0096-0397	897.17	397.47	378	76.08	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11302.8	E08		6	0097-0399	741.89	399.01	357	69.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10288.7	E08		6	0098-0401	489.83	401.65	393	73.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9966.7	E08		6	0099-0415	558.39	414.76	891	120.47	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10776.0	E08		6	0100-0418	759.37	417.69	385	73.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9867.8	E08		6	0101-0419	131.28	419.56	412	75.01	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9970.7	E08		6	0102-0428	222.85	428.22	398	75.84	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10069.9	E08		6	0103-0438	440.00	437.97	811	112.57	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10210.7	E08		6	0104-0429	888.69	429.98	388	77.26	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9786.5	E08		6	0105-0432	604.99	432.84	420	76.43	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10633.9	E08		6	0106-0431	803.92	430.66	397	75.01	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8389.0	E08		6	0107-0445	845.80	445.48	452	81.74	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9869.3	E08		6	0108-0449	472.86	450.16	419	76.43	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10032.1	E08		6	0109-0451	399.60	450.90	407	74.43	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10853.6	E08		6	0110-0452	901.77	451.81	344	68.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10710.6	E08		6	0111-0457	510.59	457.67	365	71.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9953.9	E08		6	0112-0458	271.58	458.37	398	75.26	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9479.7	E08		6	0113-0464	362.29	463.93	415	76.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9905.2	E08		6	0114-0465	34.79	465.26	372	71.01	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10213.7	E08		6	0115-0468	319.64	468.73	386	75.50	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9577.1	E08		6	0116-0468	204.85	468.31	403	74.43	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10061.3	E08		6	0117-0472	589.04	472.62	410	77.84	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10079.1	E08		6	0118-0485	130.94	485.17	784	114.57	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10238.7	E08		6	0119-0480	559.70	480.70	401	74.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9932.5	E08		6	0120-0485	765.12	485.12	414	75.01	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9343.4	E08		6	0121-0488	817.96	488.82	421	77.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9965.9	E08		6	0122-0487	700.13	487.33	456	79.60	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9961.6	E08		6	0123-0494	467.40	493.91	413	75.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10505.7	E08		6	0124-0497	519.65	497.45	378	73.01	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9459.6	E08		6	0125-0503	71.84	502.98	397	73.60	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9133.7	E08		6	0126-0510	312.54	510.67	394	76.91	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8908.0	E08		6	0127-0525	839.74	525.65	437	78.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9981.4	E08		6	0128-0527	540.65	527.67	412	75.26	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10741.7	E08		6	0129-0528	685.34	528.07	370	72.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9152.4	E08		6	0130-0531	408.66	531.66	427	82.91	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9637.2	E08		6	0131-0545	184.59	545.56	423	77.26	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10292.5	E08		6	0132-0550	783.64	550.56	434	78.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9463.5	E08		6	0133-0554	16.21	553.55	343	69.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10005.6	E08		6	0134-0558	889.37	558.36	399	75.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10289.6	E08		6	0135-0563	292.95	563.04	416	75.01	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10059.8	E08		6	0136-0566	246.05	566.66	403	75.26	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10100.3	E08		6	0137-0574	207.12	574.39	383	73.01	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10603.6	E08		6	0138-0580	407.06	580.07	744	102.91	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10127.9	E08		6	0139-0579	123.64	579.43	381	73.84	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12290.9	E08		6	0140-0584	648.20	584.41	298	79.26	0.596
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9997.5	E08		6	0141-0588	340.02	588.45	389	76.08	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9627.5	E08		6	0142-0591	512.96	591.21	414	76.08	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9020.2	E08		6	0143-0592	930.00	592.72	460	79.84	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10118.6	E08		6	0144-0600	604.74	599.99	396	74.67	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10754.4	E08		6	0145-0610	674.51	609.31	411	75.26	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9888.0	E08		6	0146-0613	833.51	613.41	434	77.26	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9713.9	E08		6	0147-0616	47.33	616.58	414	76.08	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9781.5	E08		6	0148-0615	120.49	615.56	390	73.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10009.8	E08		6	0149-0618	286.91	617.98	407	78.08	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9989.8	E08		6	0150-0621	579.64	621.75	407	74.43	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9373.5	E08		6	0151-0630	264.54	630.19	456	79.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11277.3	E08		6	0152-0633	530.57	633.89	542	86.91	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9875.3	E08		6	0153-0633	175.78	633.64	416	77.01	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9756.2	E08		6	0154-0644	342.89	645.15	398	75.50	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10189.9	E08		6	0155-0643	423.03	642.72	391	74.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10251.1	E08		6	0156-0649	707.56	648.55	332	71.60	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9733.9	E08		6	0157-0651	879.79	651.82	403	75.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11715.4	E08		6	0158-0654	830.07	653.96	335	68.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9234.7	E08		6	0159-0659	73.10	659.24	383	74.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10439.4	E08		6	0160-0662	37.75	662.74	306	64.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9448.2	E08		6	0161-0664	699.20	664.39	367	72.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10041.9	E08		6	0162-0669	294.23	669.17	425	77.84	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11463.4	E08		6	0163-0672	755.14	671.70	314	65.01	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9641.1	E08		6	0164-0685	651.76	685.15	402	76.43	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9578.5	E08		6	0165-0690	191.80	689.38	504	90.08	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10021.6	E08		6	0166-0688	241.93	688.34	391	75.26	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9750.4	E08		6	0167-0688	860.00	687.87	391	76.67	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10005.2	E08		6	0168-0695	394.10	695.29	375	75.84	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10616.7	E08		6	0169-0692	684.52	691.77	372	73.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8956.7	E08		6	0170-0698	175.02	699.26	445	82.67	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11765.4	E08		6	0171-0696	775.38	696.07	302	63.36	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10423.1	E08		6	0172-0701	605.07	701.16	380	72.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8970.5	E08		6	0173-0702	95.54	701.63	451	85.60	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8475.3	E08		6	0174-0704	120.66	703.75	188	52.63	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184446	1375341	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10177.6	E08		6	0175-0709	319.30	709.24	414	81.01	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10179.2	E08		7	0001-0031	448.84	30.88	428	78.08	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10772.5	E08		7	0002-0032	838.72	31.96	384	75.50	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11302.0	E08		7	0003-0036	597.08	35.70	508	86.43	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10217.2	E08		7	0004-0040	660.75	40.02	389	73.26	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9749.8	E08		7	0005-0043	46.37	43.18	436	80.08	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8977.7	E08		7	0006-0046	171.75	45.61	395	76.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10216.8	E08		7	0007-0056	779.49	56.58	762	105.40	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9475.4	E08		7	0008-0053	366.46	52.98	413	77.84	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9647.9	E08		7	0009-0061	736.50	60.83	821	110.33	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9190.3	E08		7	0010-0059	514.63	59.64	469	80.67	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9096.7	E08		7	0011-0060	622.88	60.55	447	81.01	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9849.7	E08		7	0012-0062	112.13	62.35	400	73.84	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10213.9	E08		7	0013-0064	827.38	64.14	397	73.01	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9855.2	E08		7	0014-0065	209.40	65.33	397	75.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9726.6	E08		7	0015-0068	474.31	68.46	445	77.84	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9681.6	E08		7	0016-0073	759.50	73.09	441	82.33	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9749.0	E08		7	0017-0071	25.96	71.16	395	74.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9682.3	E08		7	0018-0075	168.45	75.59	400	75.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9077.3	E08		7	0019-0076	649.96	75.19	460	84.91	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10060.9	E08		7	0020-0076	914.47	76.08	389	74.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9803.2	E08		7	0021-0081	412.73	81.20	410	77.01	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11513.5	E08		7	0022-0081	855.73	80.86	331	68.67	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10281.5	E08		7	0023-0090	806.94	90.08	426	77.50	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9187.9	E08		7	0024-0097	123.66	96.62	861	120.47	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10175.5	E08		7	0025-0100	724.72	101.48	808	111.30	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9207.9	E08		7	0026-0096	869.09	97.42	428	79.74	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9789.7	E08		7	0027-0096	384.45	96.22	436	77.26	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9632.2	E08		7	0028-0096	561.68	96.12	419	76.08	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10328.8	E08		7	0029-0103	764.31	103.27	401	74.08	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10071.3	E08		7	0030-0109	829.68	109.22	415	77.74	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10068.3	E08		7	0031-0108	325.77	108.69	389	74.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9608.5	E08		7	0032-0109	935.60	108.20	397	76.91	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10006.3	E08		7	0033-0115	706.49	115.81	360	73.50	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9013.6	E08		7	0034-0122	118.91	122.52	429	82.18	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9621.0	E08		7	0035-0124	923.18	123.79	412	82.23	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10224.6	E08		7	0036-0135	292.88	135.00	383	73.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9731.7	E08		7	0037-0135	354.72	135.33	404	75.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10490.1	E08		7	0038-0139	914.80	139.85	373	76.91	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9443.5	E08		7	0039-0143	59.89	143.01	419	81.84	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9984.4	E08		7	0040-0142	508.69	142.10	427	75.84	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9561.5	E08		7	0041-0140	651.23	140.11	271	60.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9217.0	E08		7	0042-0143	114.36	144.08	452	82.77	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9856.6	E08		7	0043-0145	174.82	145.47	397	74.43	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9398.2	E08		7	0044-0150	430.95	150.59	605	95.36	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10110.2	E08		7	0045-0151	682.39	151.18	397	75.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10986.9	E08		7	0046-0151	472.56	151.08	281	60.53	0.964
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8582.8	E08		7	0047-0153	408.79	153.93	304	67.94	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10064.8	E08		7	0048-0155	769.28	154.23	416	77.01	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9707.5	E08		7	0049-0160	729.61	159.76	426	78.91	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9484.9	E08		7	0050-0171	710.91	171.77	471	83.15	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9726.7	E08		7	0051-0176	84.38	176.01	398	74.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10062.2	E08		7	0052-0179	757.95	179.10	405	74.67	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10441.8	E08		7	0053-0183	829.21	183.92	409	76.18	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9935.5	E08		7	0054-0182	399.69	182.76	395	74.67	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10123.1	E08		7	0055-0190	561.34	189.93	399	74.43	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11126.4	E08		7	0056-0202	470.42	202.54	999	119.88	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9915.5	E08		7	0057-0196	663.68	196.18	453	79.26	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9703.8	E08		7	0058-0195	880.66	195.17	430	79.50	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9008.2	E08		7	0059-0196	922.97	196.10	429	78.67	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10057.3	E08		7	0060-0202	796.04	201.96	411	75.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10050.2	E08		7	0061-0206	348.07	206.46	389	73.01	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9023.4	E08		7	0062-0209	516.77	208.98	444	83.01	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9437.0	E08		7	0063-0220	186.65	219.98	420	76.33	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12004.2	E08		7	0064-0229	52.67	230.01	832	116.71	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9375.8	E08		7	0065-0221	413.57	222.10	437	84.18	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9692.9	E08		7	0066-0223	154.97	223.16	415	76.67	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9783.9	E08		7	0067-0225	212.81	225.04	416	76.67	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9763.1	E08		7	0068-0236	277.65	236.50	804	114.33	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9293.2	E08		7	0069-0230	717.96	230.20	468	83.26	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9782.6	E08		7	0070-0231	512.52	230.88	408	78.18	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9962.2	E08		7	0071-0231	660.78	231.47	409	76.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9273.4	E08		7	0072-0234	552.17	234.52	465	80.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9425.1	E08		7	0073-0235	743.94	234.70	468	82.91	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9906.7	E08		7	0074-0240	921.31	240.17	436	78.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9545.9	E08		7	0075-0244	349.58	244.76	421	79.50	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9082.3	E08		7	0076-0242	419.81	240.95	462	91.01	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9580.6	E08		7	0077-0245	587.43	245.28	446	79.26	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9831.4	E08		7	0078-0245	616.80	245.35	467	82.33	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9982.4	E08		7	0079-0256	244.72	256.65	411	74.43	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9984.3	E08		7	0080-0256	165.72	256.33	403	75.26	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9697.9	E08		7	0081-0256	546.41	255.98	391	77.36	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8958.5	E08		7	0082-0260	401.71	260.65	446	79.84	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10104.6	E08		7	0083-0261	770.98	261.39	409	76.08	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9926.9	E08		7	0084-0275	859.66	275.10	420	81.50	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10098.0	E08		7	0085-0280	15.81	280.22	382	76.08	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10004.4	E08		7	0086-0283	911.46	282.82	394	77.84	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10126.5	E08		7	0087-0287	812.91	286.93	384	75.26	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8907.5	E08		7	0088-0291	361.58	290.96	385	73.26	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9700.4	E08		7	0089-0296	449.18	296.56	453	80.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9860.3	E08		7	0090-0299	207.78	299.43	414	77.74	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9562.8	E08		7	0091-0300	615.41	300.01	425	79.26	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10122.2	E08		7	0092-0302	783.03	301.18	396	76.33	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9695.6	E08		7	0093-0305	287.31	304.99	408	75.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10016.1	E08		7	0094-0308	523.05	306.75	406	77.74	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9821.1	E08		7	0095-0304	581.87	304.39	434	78.08	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9669.7	E08		7	0096-0313	940.51	313.37	444	82.43	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10258.5	E08		7	0097-0310	418.35	310.49	410	75.84	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8889.6	E08		7	0098-0313	352.30	313.57	476	86.08	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10319.9	E08		7	0099-0311	766.95	312.50	385	76.33	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8622.2	E08		7	0100-0326	514.28	327.72	504	86.57	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8918.4	E08		7	0101-0333	365.09	333.64	458	82.67	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9397.5	E08		7	0102-0336	262.15	336.27	411	78.08	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9750.8	E08		7	0103-0346	486.60	346.09	878	119.64	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10178.4	E08		7	0104-0339	795.17	339.92	407	75.26	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10068.8	E08		7	0105-0340	576.51	340.22	421	76.67	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9937.7	E08		7	0106-0349	751.18	349.39	815	118.37	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9604.3	E08		7	0107-0342	176.49	342.38	406	75.26	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9843.5	E08		7	0108-0352	838.85	352.49	419	77.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8663.6	E08		7	0109-0353	37.15	353.91	411	77.26	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9270.1	E08		7	0110-0354	196.64	354.38	249	64.18	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9899.6	E08		7	0111-0357	911.74	356.92	410	77.50	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9967.4	E08		7	0112-0362	721.35	361.82	401	73.60	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9735.1	E08		7	0113-0375	307.67	373.54	822	118.37	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9405.8	E08		7	0114-0372	576.22	372.32	426	78.08	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10080.1	E08		7	0115-0379	255.42	379.49	555	88.33	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10721.8	E08		7	0116-0379	104.36	379.35	412	75.84	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9661.7	E08		7	0117-0383	353.55	383.66	403	78.08	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9982.9	E08		7	0118-0393	729.49	393.01	419	76.43	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9773.3	E08		7	0119-0399	411.40	399.13	422	78.67	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10096.5	E08		7	0120-0400	896.04	400.17	430	77.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9890.4	E08		7	0121-0412	547.67	412.36	432	77.26	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9766.7	E08		7	0122-0417	477.90	416.96	424	78.43	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10314.8	E08		7	0123-0421	798.64	421.39	816	108.13	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9452.0	E08		7	0124-0418	288.39	418.77	420	76.67	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9943.0	E08		7	0125-0422	221.78	422.33	394	75.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8748.9	E08		7	0126-0427	674.72	427.78	474	84.57	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9188.0	E08		7	0127-0435	647.25	434.77	971	126.37	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9388.6	E08		7	0128-0432	22.64	432.45	395	74.67	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9318.4	E08		7	0129-0428	852.61	427.21	311	66.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9728.2	E08		7	0130-0436	442.88	436.49	421	78.67	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9948.9	E08		7	0131-0438	413.29	438.11	427	78.91	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9671.6	E08		7	0132-0448	594.07	448.69	427	78.67	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9815.6	E08		7	0133-0449	916.60	449.00	410	75.84	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9784.0	E08		7	0134-0458	778.28	457.50	871	115.05	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9895.2	E08		7	0135-0453	284.13	453.88	402	74.67	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10303.9	E08		7	0136-0456	158.85	455.93	521	84.33	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9426.6	E08		7	0137-0458	703.47	458.41	431	80.91	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9951.0	E08		7	0138-0460	527.10	460.81	427	79.50	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10028.4	E08		7	0139-0461	851.90	460.82	426	77.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10083.7	E08		7	0140-0471	339.98	470.78	775	109.98	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9691.9	E08		7	0141-0483	82.00	482.90	404	76.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10141.3	E08		7	0142-0491	574.07	490.87	423	76.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10059.3	E08		7	0143-0493	110.84	492.98	414	76.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10111.3	E08		7	0144-0496	268.05	496.37	397	73.60	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10123.8	E08		7	0145-0497	225.62	496.98	383	72.43	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9027.6	E08		7	0146-0502	948.73	502.04	404	79.26	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10244.6	E08		7	0147-0507	728.18	506.57	400	77.60	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10189.9	E08		7	0148-0507	897.43	506.76	385	73.26	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9397.5	E08		7	0149-0515	409.47	515.53	400	75.84	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10237.1	E08		7	0150-0519	585.04	519.69	406	75.26	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9897.7	E08		7	0151-0524	723.90	525.32	292	66.18	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10101.5	E08		7	0152-0526	646.35	526.17	363	72.67	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9892.9	E08		7	0153-0530	160.90	531.09	418	77.11	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9722.7	E08		7	0154-0528	794.84	527.92	437	84.43	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9926.8	E08		7	0155-0538	62.81	537.91	537	87.26	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9929.8	E08		7	0156-0539	94.34	539.64	421	75.84	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9734.9	E08		7	0157-0537	526.23	537.55	407	76.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8914.3	E08		7	0158-0547	636.52	547.51	481	86.33	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9807.0	E08		7	0159-0546	361.37	546.65	416	76.67	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8878.8	E08		7	0160-0556	161.11	554.96	470	83.36	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10482.7	E08		7	0161-0556	830.91	556.71	355	72.08	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9506.0	E08		7	0162-0562	286.89	562.71	427	76.67	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10130.2	E08		7	0163-0563	565.56	563.25	427	76.43	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10096.6	E08		7	0164-0562	879.38	562.67	401	76.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9285.2	E08		7	0165-0563	239.98	563.72	432	77.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10639.2	E08		7	0166-0566	456.03	566.66	814	114.23	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10224.0	E08		7	0167-0578	40.49	578.42	753	104.81	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9991.8	E08		7	0168-0576	380.31	576.15	402	73.60	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10832.9	E08		7	0169-0594	904.98	594.13	711	103.64	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9843.6	E08		7	0170-0596	88.73	596.10	376	73.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9389.2	E08		7	0171-0605	117.62	605.11	407	76.67	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9895.1	E08		7	0172-0608	251.39	608.26	407	75.26	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10078.5	E08		7	0173-0609	171.24	609.16	393	73.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9363.7	E08		7	0174-0609	623.41	609.05	462	82.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9535.6	E08		7	0175-0622	508.45	622.39	442	79.26	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9749.7	E08		7	0176-0622	537.13	621.59	421	76.08	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10348.4	E08		7	0177-0629	839.20	629.32	388	73.60	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9860.6	E08		7	0178-0630	458.46	629.99	392	73.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9700.6	E08		7	0179-0630	375.06	630.96	424	77.84	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8821.6	E08		7	0180-0634	120.29	634.40	434	83.15	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10157.7	E08		7	0181-0638	566.69	638.48	419	78.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9670.2	E08		7	0182-0643	82.73	643.20	390	75.50	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5950.9	E08		7	0183-0641	31.35	641.60	353	68.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9868.2	E08		7	0184-0645	289.37	645.10	406	73.60	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9458.1	E08		7	0185-0644	599.43	644.18	456	81.50	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9688.9	E08		7	0186-0648	147.44	647.92	408	74.18	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10346.9	E08		7	0187-0651	710.26	650.69	404	75.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9872.4	E08		7	0188-0653	250.53	653.75	401	76.08	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9683.3	E08		7	0189-0657	392.64	657.16	439	78.43	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9665.9	E08		7	0190-0667	804.84	668.45	855	117.30	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9894.7	E08		7	0191-0664	204.68	664.59	410	75.01	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10120.3	E08		7	0192-0667	461.60	667.58	383	72.43	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10447.0	E08		7	0193-0668	870.91	668.58	360	70.43	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10267.6	E08		7	0194-0671	620.80	671.53	382	72.43	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10835.8	E08		7	0195-0682	727.61	681.81	759	105.74	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10012.3	E08		7	0196-0689	30.58	689.00	400	74.43	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10532.3	E08		7	0197-0698	843.13	698.26	329	72.43	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10772.0	E08		7	0198-0696	915.86	696.39	333	68.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11178.3	E08		7	0199-0702	286.34	702.25	615	92.91	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11356.6	E08		7	0200-0701	588.98	700.78	613	93.26	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9629.3	E08		7	0201-0703	676.76	703.24	449	80.08	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9517.5	E08		7	0202-0705	860.74	704.81	415	78.77	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184447	1375342	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10565.8	E08		7	0203-0706	339.00	705.36	365	71.01	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10386.7	E08		8	0001-0027	12.86	26.76	131	43.70	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9768.5	E08		8	0002-0034	878.19	33.39	456	81.98	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10429.5	E08		8	0003-0038	137.55	38.18	360	70.18	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9965.5	E08		8	0004-0036	208.64	36.46	369	71.26	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10161.9	E08		8	0005-0037	928.11	37.23	403	75.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9524.0	E08		8	0006-0039	338.64	39.54	422	77.50	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10868.7	E08		8	0007-0043	830.27	43.72	342	67.60	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10381.3	E08		8	0008-0044	858.88	44.83	369	73.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10102.6	E08		8	0009-0049	252.72	49.24	380	73.84	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11395.0	E08		8	0010-0052	703.68	51.91	725	99.74	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10451.1	E08		8	0011-0054	106.15	53.85	358	70.18	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9679.9	E08		8	0012-0056	435.56	56.02	435	77.26	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9867.8	E08		8	0013-0068	387.24	68.15	402	73.84	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9902.7	E08		8	0014-0072	502.28	72.23	432	79.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10565.0	E08		8	0015-0075	198.47	75.77	388	72.77	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9488.0	E08		8	0016-0076	825.57	76.69	447	78.67	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9800.4	E08		8	0017-0075	916.38	76.13	387	74.67	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10270.5	E08		8	0018-0078	19.55	78.07	365	71.01	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10037.2	E08		8	0019-0081	710.84	81.37	413	75.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9555.7	E08		8	0020-0090	169.84	90.08	388	74.67	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10167.0	E08		8	0021-0089	279.57	89.50	379	73.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10172.4	E08		8	0022-0093	359.40	92.93	391	73.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10168.3	E08		8	0023-0101	97.26	101.04	385	71.84	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9986.1	E08		8	0024-0106	129.43	105.80	377	72.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9748.9	E08		8	0025-0107	912.97	106.51	390	73.01	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9690.8	E08		8	0026-0111	40.25	110.23	367	75.40	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10484.4	E08		8	0027-0114	536.93	113.63	388	72.18	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11372.8	E08		8	0028-0121	790.30	121.16	840	112.08	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9312.3	E08		8	0029-0118	182.89	118.63	396	76.77	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9517.3	E08		8	0030-0117	426.66	117.08	409	75.26	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9832.3	E08		8	0031-0132	24.01	133.27	791	113.54	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9439.2	E08		8	0032-0129	510.23	128.96	385	73.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9973.0	E08		8	0033-0134	659.27	134.22	381	75.84	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10395.8	E08		8	0034-0142	147.05	142.44	399	74.18	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9698.8	E08		8	0035-0142	349.62	142.04	399	76.43	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9061.8	E08		8	0036-0143	184.85	143.18	431	79.94	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10364.1	E08		8	0037-0147	561.04	146.72	400	73.60	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9068.3	E08		8	0038-0152	592.10	151.51	558	98.57	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10074.7	E08		8	0039-0146	775.62	146.78	412	75.01	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10092.0	E08		8	0040-0154	270.66	154.46	398	73.01	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10299.7	E08		8	0041-0154	708.75	154.15	387	71.60	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10395.6	E08		8	0042-0155	221.46	155.64	376	71.01	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9682.5	E08		8	0043-0156	921.65	156.62	398	74.67	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10695.2	E08		8	0044-0157	303.73	157.44	396	73.60	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11493.2	E08		8	0045-0159	833.62	159.60	351	69.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9445.5	E08		8	0046-0166	471.01	165.99	897	114.81	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9986.4	E08		8	0047-0162	890.05	161.56	396	74.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9410.2	E08		8	0048-0161	61.84	161.17	363	71.60	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10290.6	E08		8	0049-0166	187.42	165.14	380	74.53	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9874.2	E08		8	0050-0166	341.97	166.42	401	75.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9765.7	E08		8	0051-0169	377.65	169.22	399	77.26	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10221.3	E08		8	0052-0167	102.73	166.88	363	71.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11148.9	E08		8	0053-0187	938.78	187.67	341	68.18	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10316.4	E08		8	0054-0188	676.21	188.44	420	76.67	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11199.5	E08		8	0055-0187	778.88	187.08	345	69.01	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10412.5	E08		8	0056-0189	823.38	189.83	386	71.60	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10490.2	E08		8	0057-0191	643.60	191.60	416	76.67	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10020.9	E08		8	0058-0194	529.74	194.47	406	75.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9743.5	E08		8	0059-0197	390.61	197.85	434	81.01	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8875.3	E08		8	0060-0198	28.08	198.47	395	78.67	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9908.8	E08		8	0061-0207	234.56	207.06	394	73.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9660.4	E08		8	0062-0210	98.04	210.49	783	110.81	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9953.6	E08		8	0063-0205	730.77	205.93	405	76.87	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9780.4	E08		8	0064-0210	51.96	209.98	417	77.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9589.0	E08		8	0065-0226	150.93	226.45	882	119.20	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10422.7	E08		8	0066-0227	766.45	227.43	385	74.43	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10272.6	E08		8	0067-0225	732.13	224.55	379	74.28	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10116.6	E08		8	0068-0230	517.07	230.49	396	75.26	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10113.6	E08		8	0069-0229	455.43	228.84	391	72.43	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10202.5	E08		8	0070-0234	704.14	234.14	436	77.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10362.5	E08		8	0071-0233	801.86	233.75	412	77.74	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9999.3	E08		8	0072-0235	280.81	235.53	442	79.50	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10041.6	E08		8	0073-0242	26.40	242.17	397	75.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10243.6	E08		8	0074-0239	883.39	239.10	387	73.26	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10308.7	E08		8	0075-0243	827.50	243.32	380	73.01	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9703.1	E08		8	0076-0245	304.28	244.81	430	84.08	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10216.4	E08		8	0077-0248	207.90	247.89	429	77.26	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9715.6	E08		8	0078-0247	338.34	247.62	403	76.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10172.2	E08		8	0079-0253	364.00	253.03	387	73.60	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12036.7	E08		8	0080-0269	645.93	267.39	970	133.05	0.689
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9681.5	E08		8	0081-0258	123.48	258.55	377	72.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9722.5	E08		8	0082-0263	453.70	263.14	404	75.26	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9397.1	E08		8	0083-0264	317.89	264.40	448	82.08	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8987.3	E08		8	0084-0266	75.47	265.97	413	76.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9522.2	E08		8	0085-0265	503.36	265.50	404	74.67	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9607.8	E08		8	0086-0267	273.87	266.82	456	81.15	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9142.1	E08		8	0087-0282	253.98	282.02	486	84.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10172.3	E08		8	0088-0285	16.72	284.89	358	71.60	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10002.1	E08		8	0089-0283	874.71	283.66	396	74.67	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10175.4	E08		8	0090-0301	365.86	301.03	389	73.01	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10157.6	E08		8	0091-0303	85.07	303.28	374	71.60	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10343.2	E08		8	0092-0305	493.41	304.96	634	98.57	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10507.2	E08		8	0093-0304	646.32	304.07	373	70.18	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10285.1	E08		8	0094-0307	801.56	307.47	422	76.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9822.3	E08		8	0095-0313	152.47	313.01	416	78.43	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9832.6	E08		8	0096-0315	45.71	315.47	403	79.01	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10122.2	E08		8	0097-0317	107.42	316.99	421	77.26	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9550.7	E08		8	0098-0324	435.57	323.86	409	76.08	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9813.5	E08		8	0099-0329	225.64	330.02	805	109.54	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12644.4	E08		8	0100-0323	884.08	323.71	276	59.94	0.965
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10253.5	E08		8	0101-0331	923.08	331.31	395	75.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9856.8	E08		8	0102-0334	353.64	334.44	365	71.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10010.6	E08		8	0103-0337	170.74	336.54	362	73.94	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11135.5	E08		8	0104-0338	558.10	338.35	477	80.67	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8542.4	E08		8	0105-0339	149.93	340.00	471	84.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10256.7	E08		8	0106-0341	811.52	341.33	405	75.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10542.4	E08		8	0107-0351	410.83	350.90	374	71.60	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	161.1	E08		8	0108-0353	298.83	353.05	332	67.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10556.0	E08		8	0109-0354	493.00	354.82	371	70.18	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10219.1	E08		8	0110-0358	665.66	358.28	390	74.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10087.8	E08		8	0111-0359	17.15	358.98	363	71.60	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10863.9	E08		8	0112-0357	346.39	357.41	317	65.36	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10201.6	E08		8	0113-0358	901.62	358.35	389	74.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10146.4	E08		8	0114-0371	862.43	370.96	842	117.15	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10369.4	E08		8	0115-0374	738.95	374.20	390	73.84	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10025.6	E08		8	0116-0377	785.88	377.58	417	77.84	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10876.0	E08		8	0117-0382	335.79	382.26	393	73.26	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10060.7	E08		8	0118-0394	112.36	393.65	782	110.37	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9991.3	E08		8	0119-0387	274.56	387.16	394	74.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9855.4	E08		8	0120-0390	208.40	390.43	381	74.91	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10088.8	E08		8	0121-0389	479.21	388.90	386	72.43	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9566.6	E08		8	0122-0401	168.44	400.19	458	87.26	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10562.8	E08		8	0123-0402	565.48	401.81	380	72.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9916.4	E08		8	0124-0406	362.72	406.66	424	79.84	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10347.0	E08		8	0125-0409	434.57	409.45	394	75.60	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9949.4	E08		8	0126-0412	476.60	412.46	404	75.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9796.6	E08		8	0127-0421	609.03	421.87	466	80.91	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9856.8	E08		8	0128-0421	828.47	421.78	413	76.67	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10015.8	E08		8	0129-0422	193.23	422.30	385	71.60	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10135.2	E08		8	0130-0421	261.09	421.26	380	73.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9876.5	E08		8	0131-0421	928.44	421.32	423	79.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9784.3	E08		8	0132-0431	84.88	431.14	373	73.26	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10006.4	E08		8	0133-0429	901.87	428.91	391	76.18	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10321.0	E08		8	0134-0434	390.13	434.87	380	73.01	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10249.4	E08		8	0135-0439	573.78	438.71	432	77.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10209.0	E08		8	0136-0443	677.38	443.35	419	75.01	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10199.6	E08		8	0137-0443	127.46	443.00	401	75.50	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10142.9	E08		8	0138-0443	298.30	442.84	387	74.67	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10203.6	E08		8	0139-0445	250.82	443.39	360	72.91	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10059.4	E08		8	0140-0451	21.71	450.93	367	71.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8108.3	E08		8	0141-0451	57.31	451.96	366	71.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10440.6	E08		8	0142-0456	266.57	457.00	385	74.57	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10081.3	E08		8	0143-0456	757.54	456.78	401	73.84	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10948.3	E08		8	0144-0465	695.31	464.74	333	66.77	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9996.6	E08		8	0145-0475	624.02	474.88	775	109.64	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10234.0	E08		8	0146-0472	545.34	472.55	230	55.94	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11099.8	E08		8	0147-0479	826.55	478.30	624	92.33	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10091.8	E08		8	0148-0480	103.11	480.20	386	73.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11376.3	E08		8	0149-0482	470.82	480.83	343	70.91	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10431.2	E08		8	0150-0483	257.38	482.81	373	70.77	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9609.3	E08		8	0151-0487	382.59	487.61	326	65.94	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9032.7	E08		8	0152-0497	88.68	497.40	427	77.50	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10485.8	E08		8	0153-0501	942.80	501.31	378	74.77	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9137.2	E08		8	0154-0504	53.78	503.94	355	73.60	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9721.5	E08		8	0155-0502	837.74	503.28	408	79.26	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9479.1	E08		8	0156-0506	117.26	506.08	442	81.01	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9675.3	E08		8	0157-0508	692.35	507.93	420	76.08	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10295.4	E08		8	0158-0510	631.74	509.82	395	73.84	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11373.4	E08		8	0159-0518	344.60	518.30	623	92.33	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11949.5	E08		8	0160-0520	502.68	521.89	473	97.40	0.627
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9667.0	E08		8	0161-0519	179.67	519.43	392	73.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9162.7	E08		8	0162-0531	133.80	531.30	437	83.50	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9605.2	E08		8	0163-0530	683.66	531.47	424	77.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9243.1	E08		8	0164-0535	109.15	534.66	422	78.08	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10389.3	E08		8	0165-0538	262.29	538.48	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10009.1	E08		8	0166-0546	422.62	547.19	423	78.43	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10395.4	E08		8	0167-0548	772.56	547.66	381	73.84	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16397.1	E08		8	0168-0549	741.84	549.81	294	64.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11224.9	E08		8	0169-0552	689.00	552.49	408	78.18	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9918.8	E08		8	0170-0554	612.03	554.10	392	73.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10147.8	E08		8	0171-0558	572.27	558.01	387	73.01	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9940.1	E08		8	0172-0558	818.49	558.24	379	72.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10087.2	E08		8	0173-0559	239.19	559.34	388	74.08	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10033.0	E08		8	0174-0567	401.42	566.65	432	77.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10274.4	E08		8	0175-0569	72.52	568.92	371	71.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10081.0	E08		8	0176-0568	115.15	567.72	380	74.08	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10292.6	E08		8	0177-0571	928.14	571.53	366	71.01	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10177.7	E08		8	0178-0573	894.54	573.35	385	73.26	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10700.7	E08		8	0179-0573	472.87	572.73	373	71.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9943.3	E08		8	0180-0578	365.59	578.38	422	77.94	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9861.7	E08		8	0181-0577	620.21	577.65	398	74.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10713.1	E08		8	0182-0579	657.58	579.15	397	75.50	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11699.8	E08		8	0183-0579	130.71	579.51	295	63.84	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14219.9	E08		8	0184-0586	870.14	586.32	352	70.43	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10548.1	E08		8	0185-0593	306.08	592.85	380	72.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10541.6	E08		8	0186-0591	574.66	591.46	375	72.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9785.8	E08		8	0187-0600	798.09	600.44	796	109.88	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9924.9	E08		8	0188-0598	344.16	598.08	407	76.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9496.0	E08		8	0189-0598	649.17	599.12	377	74.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10113.2	E08		8	0190-0606	189.49	605.77	406	77.11	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10389.6	E08		8	0191-0611	212.45	611.06	398	76.77	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10397.2	E08		8	0192-0609	498.57	609.64	381	75.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10271.1	E08		8	0193-0620	745.01	619.76	770	112.47	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10714.0	E08		8	0194-0615	622.23	614.51	375	72.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10200.3	E08		8	0195-0619	247.53	619.43	377	71.01	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10174.0	E08		8	0196-0623	315.00	623.18	422	76.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10775.1	E08		8	0197-0630	449.89	629.80	367	71.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9903.1	E08		8	0198-0630	117.57	630.45	386	73.01	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9585.1	E08		8	0199-0634	145.21	633.58	394	75.50	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11086.8	E08		8	0200-0633	650.83	633.13	404	76.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9795.1	E08		8	0201-0634	411.77	634.57	416	76.18	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12353.5	E08		8	0202-0633	940.43	632.74	121	41.80	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9630.9	E08		8	0203-0642	389.05	641.84	422	77.84	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10457.5	E08		8	0204-0644	535.73	644.60	394	73.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10265.4	E08		8	0205-0650	577.45	650.84	386	72.18	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9385.7	E08		8	0206-0655	104.11	655.06	400	79.01	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10471.4	E08		8	0207-0656	784.90	656.57	391	73.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10678.7	E08		8	0208-0657	274.18	656.98	365	71.01	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10253.0	E08		8	0209-0660	515.41	660.89	414	75.84	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10019.2	E08		8	0210-0662	465.97	662.53	397	74.18	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9997.3	E08		8	0211-0663	862.67	663.21	420	76.43	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9956.3	E08		8	0212-0675	611.14	675.90	404	78.91	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10206.3	E08		8	0213-0687	236.25	687.72	410	77.01	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11350.2	E08		8	0214-0688	937.61	688.35	351	72.18	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9761.3	E08		8	0215-0687	135.56	687.26	385	73.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9614.4	E08		8	0216-0690	767.50	688.49	390	77.98	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9545.9	E08		8	0217-0695	630.66	695.62	404	78.43	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10391.6	E08		8	0218-0698	20.54	698.45	342	67.84	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184448	1375343	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10859.3	E08		8	0219-0705	876.06	705.52	417	76.91	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10673.0	E08		9	0001-0035	446.94	35.52	381	76.53	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9272.3	E08		9	0002-0030	118.26	29.91	194	54.53	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9947.2	E08		9	0003-0037	467.14	37.29	461	81.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10406.4	E08		9	0004-0035	317.27	34.86	407	80.43	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10055.2	E08		9	0005-0039	22.73	39.90	388	76.91	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9783.6	E08		9	0006-0041	859.08	41.53	402	77.74	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10122.0	E08		9	0007-0048	501.51	48.32	417	77.26	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9854.4	E08		9	0008-0052	92.29	52.34	375	72.67	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10253.1	E08		9	0009-0051	682.41	51.08	408	75.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7864.1	E08		9	0010-0056	198.24	54.50	521	106.81	0.574
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11260.9	E08		9	0011-0053	750.74	53.84	362	71.60	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9821.7	E08		9	0012-0058	180.23	60.22	233	72.08	0.564
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9854.9	E08		9	0013-0059	124.69	58.76	368	74.67	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11079.3	E08		9	0014-0065	905.51	65.74	347	70.43	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10559.7	E08		9	0015-0067	424.89	67.01	396	75.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11511.8	E08		9	0016-0068	807.95	68.14	355	68.77	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11277.6	E08		9	0017-0080	716.35	80.08	379	75.36	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10455.7	E08		9	0018-0076	289.50	76.64	363	72.43	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9521.9	E08		9	0019-0079	840.09	78.86	418	77.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10295.1	E08		9	0020-0082	469.22	81.80	358	71.60	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10204.1	E08		9	0021-0086	533.45	85.87	390	75.84	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10873.6	E08		9	0022-0091	923.79	90.75	578	92.57	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9156.0	E08		9	0023-0090	79.93	89.86	378	73.50	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10603.6	E08		9	0024-0097	361.02	97.13	367	73.26	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9813.7	E08		9	0025-0100	832.20	99.85	407	77.84	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10635.1	E08		9	0026-0104	944.59	104.47	361	71.84	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11400.4	E08		9	0027-0114	400.72	115.10	887	115.98	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11731.7	E08		9	0028-0113	501.62	112.70	613	91.74	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10444.8	E08		9	0029-0124	118.68	124.31	366	71.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10017.5	E08		9	0030-0133	74.11	134.00	385	77.60	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10333.4	E08		9	0031-0136	215.57	136.49	367	71.60	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9857.8	E08		9	0032-0137	304.29	137.25	382	75.26	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9800.7	E08		9	0033-0142	849.97	142.28	397	76.67	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11247.2	E08		9	0034-0153	773.45	152.25	340	70.33	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9570.3	E08		9	0035-0155	71.06	153.87	405	76.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10169.4	E08		9	0036-0157	644.08	156.94	390	76.08	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9652.3	E08		9	0037-0159	16.79	159.26	372	72.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10619.1	E08		9	0038-0164	786.81	165.90	382	73.74	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11499.2	E08		9	0039-0170	711.99	170.25	341	68.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10845.5	E08		9	0040-0179	734.38	179.20	399	77.26	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9531.5	E08		9	0041-0182	557.51	181.49	421	78.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9307.9	E08		9	0042-0181	472.02	180.70	441	80.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10437.8	E08		9	0043-0183	320.29	182.67	391	75.26	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10917.6	E08		9	0044-0190	33.68	190.27	339	69.01	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10783.5	E08		9	0045-0190	662.58	189.98	368	74.43	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11882.9	E08		9	0046-0201	870.57	199.09	990	127.54	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10606.8	E08		9	0047-0198	642.58	198.23	392	75.60	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10925.7	E08		9	0048-0198	62.31	198.18	337	69.26	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10084.0	E08		9	0049-0204	137.30	204.06	380	75.84	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11253.6	E08		9	0050-0204	931.35	203.84	337	68.18	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10030.5	E08		9	0051-0207	116.09	206.71	381	75.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9361.1	E08		9	0052-0218	365.71	218.11	398	77.50	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10678.1	E08		9	0053-0223	202.20	223.22	396	76.08	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9009.5	E08		9	0054-0235	446.43	235.83	404	77.74	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10564.1	E08		9	0055-0234	300.74	233.79	385	75.26	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10307.8	E08		9	0056-0237	852.00	237.08	388	73.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11268.7	E08		9	0057-0246	898.77	247.10	689	110.37	0.711
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10331.6	E08		9	0058-0245	510.67	246.13	412	75.26	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10476.4	E08		9	0059-0250	571.60	249.66	391	73.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10780.0	E08		9	0060-0254	95.42	254.05	353	68.18	0.954
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10298.5	E08		9	0061-0261	257.36	261.65	412	80.43	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10878.9	E08		9	0062-0264	925.97	264.27	369	71.01	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11565.7	E08		9	0063-0267	276.08	268.10	156	48.87	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9629.2	E08		9	0064-0295	116.10	293.14	552	94.23	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10953.6	E08		9	0065-0296	865.27	296.47	330	67.94	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10876.7	E08		9	0066-0308	601.08	308.01	785	119.10	0.695
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10530.7	E08		9	0067-0312	311.36	313.08	807	110.37	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9283.3	E08		9	0068-0306	62.59	305.93	393	78.33	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10476.7	E08		9	0069-0310	160.91	310.08	362	74.91	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10188.3	E08		9	0070-0311	534.74	311.75	392	75.01	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11225.0	E08		9	0071-0312	103.15	311.94	275	61.36	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12417.2	E08		9	0072-0316	463.24	315.59	409	77.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10485.7	E08		9	0073-0318	253.19	318.38	397	76.33	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9808.7	E08		9	0074-0321	48.06	322.47	448	79.50	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12289.9	E08		9	0075-0322	843.07	321.93	318	66.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	3974.4	E08		9	0076-0329	410.85	329.14	331	68.43	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10396.4	E08		9	0077-0334	18.36	333.96	364	73.50	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12983.9	E08		9	0078-0336	359.49	336.39	397	73.84	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10484.4	E08		9	0079-0361	46.64	361.56	375	76.18	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10913.1	E08		9	0080-0363	143.77	363.02	715	101.05	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13137.2	E08		9	0081-0357	942.03	357.06	341	68.18	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11323.5	E08		9	0082-0367	914.25	366.85	224	76.43	0.482
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10548.8	E08		9	0083-0371	291.66	371.35	368	72.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10096.3	E08		9	0084-0386	92.84	386.67	367	72.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10374.3	E08		9	0085-0400	243.83	400.34	375	73.26	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13654.1	E08		9	0086-0401	306.84	401.24	393	74.67	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9535.2	E08		9	0087-0409	193.29	408.93	388	73.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9805.5	E08		9	0088-0412	70.60	412.71	370	71.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10594.2	E08		9	0089-0421	506.18	420.74	402	75.50	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10256.5	E08		9	0090-0424	23.89	424.00	390	75.60	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9990.2	E08		9	0091-0438	122.48	438.09	377	74.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10168.4	E08		9	0092-0457	67.82	457.34	362	71.60	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11264.3	E08		9	0093-0460	378.98	459.94	408	74.43	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11879.4	E08		9	0094-0472	844.58	471.93	371	74.43	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9511.7	E08		9	0095-0493	233.99	494.65	661	106.23	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11045.9	E08		9	0096-0496	541.76	496.72	360	71.84	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9463.1	E08		9	0097-0502	57.45	502.91	432	82.28	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10321.3	E08		9	0098-0504	37.64	504.09	357	72.53	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12169.9	E08		9	0099-0505	610.27	505.12	422	75.26	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12123.6	E08		9	0100-0519	323.28	519.04	444	79.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9994.4	E08		9	0101-0523	206.62	522.81	376	73.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10644.9	E08		9	0102-0523	59.79	522.94	350	71.70	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9332.6	E08		9	0103-0540	338.97	540.23	445	79.26	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10802.3	E08		9	0104-0545	381.48	545.16	362	70.53	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11335.1	E08		9	0105-0545	571.83	544.20	311	67.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10446.8	E08		9	0106-0559	562.79	560.54	389	75.26	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10678.4	E08		9	0107-0574	22.91	574.25	342	69.60	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10535.2	E08		9	0108-0576	608.85	576.94	389	74.91	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13141.0	E08		9	0109-0587	590.60	587.81	393	75.26	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10598.1	E08		9	0110-0594	360.80	594.71	372	72.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10552.3	E08		9	0111-0597	50.96	597.50	346	71.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12007.3	E08		9	0112-0619	538.40	618.84	271	59.94	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8870.4	E08		9	0113-0632	114.79	632.78	368	71.84	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10658.7	E08		9	0114-0633	916.89	632.73	349	70.77	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10187.1	E08		9	0115-0637	723.10	636.85	398	76.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12892.7	E08		9	0116-0635	35.78	635.56	114	43.46	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12350.9	E08		9	0117-0647	330.91	646.43	963	121.30	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10425.2	E08		9	0118-0643	95.21	643.10	364	74.08	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11145.2	E08		9	0119-0646	831.47	646.01	365	71.84	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14698.8	E08		9	0120-0664	884.80	664.40	591	92.33	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10692.3	E08		9	0121-0688	282.03	688.56	384	75.84	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11035.6	E08		9	0122-0691	32.07	691.03	364	72.43	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11040.7	E08		9	0123-0696	492.71	697.00	914	118.23	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9965.0	E08		9	0124-0692	101.63	692.07	400	76.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9631.2	E08		9	0125-0695	371.28	694.61	380	75.50	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11201.0	E08		9	0126-0700	602.27	699.55	456	83.74	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1184449	1375344	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10435.0	E08		9	0127-0701	453.77	701.32	370	71.84	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11756.9	F08		1	0001-0030	110.32	30.57	334	66.77	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10751.2	F08		1	0002-0030	292.69	29.76	335	69.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11916.8	F08		1	0003-0033	788.07	32.87	308	63.94	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10427.6	F08		1	0004-0036	632.11	35.77	388	76.67	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10912.2	F08		1	0005-0039	856.44	39.34	340	71.26	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10972.6	F08		1	0006-0046	812.65	45.96	342	69.60	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13495.7	F08		1	0007-0045	447.90	44.91	293	63.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10369.3	F08		1	0008-0050	42.39	51.20	369	72.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12239.8	F08		1	0009-0052	596.09	52.45	328	69.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8681.6	F08		1	0010-0056	175.27	55.94	409	77.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11593.3	F08		1	0011-0064	115.82	64.58	333	67.26	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9777.4	F08		1	0012-0066	924.28	65.51	402	78.08	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11086.6	F08		1	0013-0084	473.86	84.49	348	69.60	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14207.8	F08		1	0014-0088	249.65	88.08	246	61.84	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10417.6	F08		1	0015-0090	298.93	89.70	343	71.01	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12081.7	F08		1	0016-0097	626.12	97.82	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9289.8	F08		1	0017-0100	812.67	99.51	412	75.26	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11578.8	F08		1	0018-0101	37.70	101.14	322	67.01	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9638.9	F08		1	0019-0109	158.33	109.14	367	74.67	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14764.8	F08		1	0020-0110	918.49	110.83	230	55.70	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12226.3	F08		1	0021-0117	383.49	117.08	301	63.60	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10579.9	F08		1	0022-0120	224.09	120.30	352	71.84	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11775.3	F08		1	0023-0128	92.30	128.42	330	68.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10836.3	F08		1	0024-0129	304.76	129.88	332	69.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10416.6	F08		1	0025-0132	888.55	131.89	382	74.67	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9526.1	F08		1	0026-0133	624.07	132.24	400	75.84	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9857.6	F08		1	0027-0136	189.70	136.50	377	71.84	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11186.5	F08		1	0028-0139	38.80	139.33	355	71.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10871.2	F08		1	0029-0156	502.25	156.41	361	72.77	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13300.7	F08		1	0030-0159	245.97	159.58	262	60.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12136.9	F08		1	0031-0162	542.47	162.08	305	66.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9079.4	F08		1	0032-0170	856.80	169.98	448	81.26	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12066.3	F08		1	0033-0175	32.65	174.76	287	62.77	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10083.1	F08		1	0034-0180	296.19	180.25	357	70.67	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10259.7	F08		1	0035-0181	102.62	181.53	348	70.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10491.7	F08		1	0036-0191	622.34	191.15	356	70.53	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10394.9	F08		1	0037-0209	549.09	209.23	362	71.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11796.0	F08		1	0038-0216	173.16	216.49	298	64.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14046.1	F08		1	0039-0214	415.90	214.79	279	65.70	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11650.3	F08		1	0040-0218	132.55	218.67	313	65.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10908.2	F08		1	0041-0222	910.76	222.53	352	71.36	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10468.5	F08		1	0042-0227	265.38	226.89	346	70.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10425.2	F08		1	0043-0236	190.99	236.66	350	69.01	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11212.6	F08		1	0044-0238	460.98	238.44	327	74.08	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10717.3	F08		1	0045-0242	620.41	241.77	371	73.26	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12691.9	F08		1	0046-0241	540.92	241.27	310	65.11	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22585.8	F08		1	0047-0241	410.05	241.48	113	37.80	0.994
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10856.3	F08		1	0048-0250	839.25	249.93	357	73.26	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10506.7	F08		1	0049-0261	137.07	261.05	352	71.26	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9819.2	F08		1	0050-0262	571.15	261.52	381	73.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10634.5	F08		1	0051-0266	475.39	266.69	348	70.77	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11221.2	F08		1	0052-0270	530.89	271.01	334	69.84	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9317.0	F08		1	0053-0273	75.30	273.01	386	72.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12968.1	F08		1	0054-0279	210.55	279.03	249	60.43	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11807.9	F08		1	0055-0279	382.62	278.80	308	67.36	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11812.4	F08		1	0056-0282	904.38	282.65	390	74.43	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11257.8	F08		1	0057-0287	15.18	287.71	332	67.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10875.6	F08		1	0058-0300	517.08	299.90	373	73.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11729.4	F08		1	0059-0329	669.56	330.57	345	70.43	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11492.8	F08		1	0060-0329	210.55	329.94	319	64.77	0.956
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11663.7	F08		1	0061-0342	802.79	343.15	334	72.67	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10168.4	F08		1	0062-0344	183.62	344.44	354	70.43	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11895.9	F08		1	0063-0346	343.07	345.89	306	64.77	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13223.2	F08		1	0064-0343	518.02	343.86	284	64.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11289.3	F08		1	0065-0349	610.56	349.57	361	71.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12271.7	F08		1	0066-0349	313.63	348.58	294	67.26	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12902.6	F08		1	0067-0352	260.23	352.27	281	67.11	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13686.0	F08		1	0068-0354	442.75	354.67	287	63.94	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11837.4	F08		1	0069-0363	480.92	363.36	340	69.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11862.4	F08		1	0070-0367	299.40	366.87	304	65.36	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11778.0	F08		1	0071-0365	834.10	365.25	322	69.01	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12793.7	F08		1	0072-0368	527.07	367.61	294	64.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10907.0	F08		1	0073-0382	713.27	382.72	345	71.50	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10265.9	F08		1	0074-0384	173.41	384.36	362	72.77	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11222.6	F08		1	0075-0391	638.78	392.22	333	68.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11146.7	F08		1	0076-0405	573.29	404.87	344	69.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10237.1	F08		1	0077-0406	83.10	406.45	337	72.08	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11865.2	F08		1	0078-0409	594.00	410.00	382	76.43	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16291.6	F08		1	0079-0416	504.68	415.87	285	67.01	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13116.6	F08		1	0080-0418	699.52	417.20	307	69.50	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14720.9	F08		1	0081-0418	203.10	417.77	265	61.36	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11803.2	F08		1	0082-0428	690.61	428.69	321	68.91	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10175.9	F08		1	0083-0435	651.67	435.56	372	72.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11138.7	F08		1	0084-0437	450.85	437.17	367	70.77	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13536.7	F08		1	0085-0435	195.15	435.23	264	61.36	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9484.2	F08		1	0086-0441	111.14	440.70	368	73.84	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13841.2	F08		1	0087-0436	937.32	436.53	267	61.70	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14646.7	F08		1	0088-0444	253.50	444.16	346	118.71	0.309
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10100.8	F08		1	0089-0455	397.40	455.25	368	71.01	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16056.5	F08		1	0090-0464	825.17	463.78	237	57.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12358.3	F08		1	0091-0485	605.91	485.29	412	87.15	0.682
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10584.4	F08		1	0092-0484	359.10	485.15	381	72.18	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11390.0	F08		1	0093-0490	141.87	490.27	500	83.26	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12380.8	F08		1	0094-0485	304.73	485.23	290	63.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9906.7	F08		1	0095-0491	754.70	490.13	391	73.84	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12548.4	F08		1	0096-0498	265.06	497.74	288	63.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15227.9	F08		1	0097-0502	612.95	502.59	117	44.87	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11275.1	F08		1	0098-0527	10.59	527.92	305	65.70	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9624.7	F08		1	0099-0529	57.86	529.03	358	73.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12193.8	F08		1	0100-0535	452.49	535.43	640	112.47	0.636
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11440.8	F08		1	0101-0544	105.27	544.43	300	68.18	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10656.3	F08		1	0102-0546	231.84	545.25	339	71.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13816.9	F08		1	0103-0553	623.75	553.28	268	62.43	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12364.6	F08		1	0104-0555	850.95	555.28	286	62.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10455.8	F08		1	0105-0568	48.18	568.35	360	72.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10870.7	F08		1	0106-0574	819.63	574.22	350	69.11	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11774.4	F08		1	0107-0583	783.20	583.27	312	66.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11860.9	F08		1	0108-0584	710.81	582.51	423	89.50	0.664
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10799.0	F08		1	0109-0601	38.32	600.89	321	67.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10079.2	F08		1	0110-0600	607.81	600.05	367	76.08	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9822.8	F08		1	0111-0606	660.58	605.85	371	69.60	0.962
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11497.2	F08		1	0112-0610	748.21	610.84	319	68.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13936.8	F08		1	0113-0613	409.35	613.53	265	61.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12307.5	F08		1	0114-0617	366.01	617.49	295	65.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11385.2	F08		1	0115-0636	47.83	636.91	302	65.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12793.4	F08		1	0116-0637	228.92	636.45	239	59.84	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11602.2	F08		1	0117-0641	105.73	640.57	304	66.43	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12766.7	F08		1	0118-0640	623.25	640.90	283	65.50	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10606.8	F08		1	0119-0647	682.37	646.90	347	69.36	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11894.2	F08		1	0120-0655	768.36	655.13	297	65.11	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10912.3	F08		1	0121-0662	135.28	662.55	313	68.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13364.1	F08		1	0122-0666	210.92	665.60	261	60.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12585.0	F08		1	0123-0671	801.92	670.94	284	69.94	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14406.8	F08		1	0124-0667	75.29	666.23	255	61.01	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9090.2	F08		1	0125-0677	59.44	677.46	367	73.74	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14692.0	F08		1	0126-0683	690.93	683.68	237	57.11	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9238.4	F08		1	0127-0686	20.18	685.76	352	73.26	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13996.7	F08		1	0128-0684	273.91	684.26	249	60.87	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12059.5	F08		1	0129-0693	915.46	693.02	290	65.36	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184738	1375345	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9975.6	F08		1	0130-0701	579.21	702.80	368	72.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14606.8	F08		2	0001-0044	402.32	43.52	252	60.87	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10301.9	F08		2	0002-0047	546.79	46.75	377	74.43	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9803.6	F08		2	0003-0045	673.20	45.53	381	73.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13547.1	F08		2	0004-0049	443.67	49.45	286	65.01	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10311.5	F08		2	0005-0054	106.51	53.86	348	73.26	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13016.6	F08		2	0006-0052	743.31	52.03	279	62.43	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12860.1	F08		2	0007-0054	139.17	54.86	280	64.43	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9979.7	F08		2	0008-0067	28.86	65.71	380	74.67	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12366.8	F08		2	0009-0077	470.04	76.71	312	68.18	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12241.3	F08		2	0010-0072	721.48	72.01	287	65.94	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12802.5	F08		2	0011-0074	183.67	73.87	277	62.28	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13606.0	F08		2	0012-0080	815.81	78.97	283	65.50	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13056.8	F08		2	0013-0082	518.19	82.42	330	77.50	0.690
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12627.1	F08		2	0014-0083	889.92	82.14	281	62.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11213.4	F08		2	0015-0093	931.34	92.92	316	69.26	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9188.6	F08		2	0016-0102	144.94	102.35	374	75.50	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15752.0	F08		2	0017-0105	565.73	104.91	454	81.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14546.3	F08		2	0018-0111	22.99	111.27	235	56.53	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11246.9	F08		2	0019-0113	657.25	112.56	319	68.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14497.7	F08		2	0020-0117	207.77	117.49	239	59.70	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14357.5	F08		2	0021-0119	230.19	119.39	242	60.53	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12537.0	F08		2	0022-0134	856.86	133.97	276	62.43	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10828.7	F08		2	0023-0138	939.43	137.65	329	70.43	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10418.2	F08		2	0024-0143	330.89	143.01	345	68.77	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10799.3	F08		2	0025-0151	69.43	151.02	317	67.84	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17656.8	F08		2	0026-0156	215.70	157.45	411	85.50	0.707
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11533.9	F08		2	0027-0157	165.99	157.66	306	66.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13333.3	F08		2	0028-0162	411.80	162.46	265	61.36	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13866.5	F08		2	0029-0166	749.08	166.72	255	59.36	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10342.3	F08		2	0030-0170	119.40	169.22	339	71.01	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15672.4	F08		2	0031-0169	139.86	169.16	344	68.53	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9754.4	F08		2	0032-0176	510.70	176.42	377	72.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15783.9	F08		2	0033-0172	635.63	171.65	154	45.94	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11862.9	F08		2	0034-0178	457.29	178.32	334	68.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15683.7	F08		2	0035-0181	626.08	181.30	201	55.01	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14938.0	F08		2	0036-0187	645.35	186.92	276	63.60	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16809.1	F08		2	0037-0189	845.17	189.53	216	59.60	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11886.9	F08		2	0038-0193	325.10	193.61	304	64.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10495.4	F08		2	0039-0198	409.45	197.88	339	70.18	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9276.1	F08		2	0040-0209	535.17	208.71	386	73.26	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10987.0	F08		2	0041-0222	15.25	222.86	325	68.53	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11909.2	F08		2	0042-0224	616.40	224.46	300	65.01	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12957.5	F08		2	0043-0226	843.78	226.33	273	63.60	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11772.0	F08		2	0044-0230	121.18	229.88	332	68.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12695.3	F08		2	0045-0228	239.63	228.40	268	65.01	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11436.7	F08		2	0046-0230	652.00	230.29	317	67.84	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8966.6	F08		2	0047-0233	715.12	232.41	190	55.11	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13355.8	F08		2	0048-0235	323.12	235.58	304	71.11	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11368.9	F08		2	0049-0245	404.92	245.37	349	71.84	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12674.4	F08		2	0050-0250	276.28	249.47	274	63.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13528.2	F08		2	0051-0264	929.92	263.21	249	63.01	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11539.5	F08		2	0052-0261	191.74	262.17	309	69.36	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15785.7	F08		2	0053-0261	360.66	261.16	226	56.04	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10317.8	F08		2	0054-0268	54.40	268.60	344	69.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14955.7	F08		2	0055-0269	887.42	269.70	221	56.87	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12813.8	F08		2	0056-0270	341.91	269.66	282	63.94	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11979.2	F08		2	0057-0270	377.36	269.33	302	67.01	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10646.1	F08		2	0058-0280	724.41	279.94	346	72.18	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13524.7	F08		2	0059-0287	837.58	288.01	278	63.36	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15458.0	F08		2	0060-0297	127.28	297.86	214	57.94	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10229.9	F08		2	0061-0310	855.99	310.23	349	72.77	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12568.6	F08		2	0062-0317	259.32	317.68	288	65.70	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11009.4	F08		2	0063-0316	721.99	316.46	335	70.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11851.6	F08		2	0064-0321	376.65	320.95	305	66.67	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12798.8	F08		2	0065-0326	445.77	327.05	286	61.36	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11517.8	F08		2	0066-0330	180.19	329.23	325	67.36	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12078.1	F08		2	0067-0342	868.58	341.35	293	64.18	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11648.1	F08		2	0068-0348	366.56	348.52	336	68.18	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10294.5	F08		2	0069-0351	922.88	351.54	356	73.01	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10720.0	F08		2	0070-0356	941.20	356.11	350	71.60	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11810.5	F08		2	0071-0357	153.69	357.39	612	108.23	0.657
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13128.0	F08		2	0072-0374	406.60	374.81	483	84.43	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11501.7	F08		2	0073-0383	289.40	383.00	313	67.94	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14381.8	F08		2	0074-0383	102.55	383.68	245	59.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12502.0	F08		2	0075-0385	593.84	385.36	304	67.84	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12286.5	F08		2	0076-0387	356.28	387.46	294	66.43	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11227.2	F08		2	0077-0393	141.79	393.65	318	69.26	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11114.8	F08		2	0078-0397	212.63	398.04	322	65.60	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10194.3	F08		2	0079-0404	652.55	404.88	359	70.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9396.7	F08		2	0080-0409	431.96	408.57	379	72.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12590.1	F08		2	0081-0430	485.77	430.66	314	68.18	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11163.8	F08		2	0082-0436	193.76	436.75	316	68.43	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12476.8	F08		2	0083-0436	587.81	435.82	323	69.01	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13500.0	F08		2	0084-0437	42.06	436.96	271	61.11	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15165.0	F08		2	0085-0437	821.66	437.77	223	56.77	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15170.3	F08		2	0086-0448	660.63	448.83	239	58.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9823.0	F08		2	0087-0453	54.39	453.00	355	70.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14320.2	F08		2	0088-0459	340.67	458.85	249	61.84	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14756.3	F08		2	0089-0458	740.67	458.64	236	59.70	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11113.1	F08		2	0090-0467	519.60	467.21	345	69.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16928.5	F08		2	0091-0479	573.14	478.52	194	66.43	0.552
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11053.1	F08		2	0092-0489	169.47	489.35	315	70.77	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9029.4	F08		2	0093-0519	590.31	518.90	428	82.08	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11058.2	F08		2	0094-0517	202.43	517.49	317	67.36	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15238.5	F08		2	0095-0523	87.21	522.84	469	81.50	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12305.8	F08		2	0096-0521	771.81	521.83	313	68.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12023.9	F08		2	0097-0538	125.28	538.27	288	62.53	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14131.6	F08		2	0098-0537	646.98	536.44	248	62.18	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10100.1	F08		2	0099-0545	186.16	545.47	349	70.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10374.6	F08		2	0100-0562	460.22	561.46	366	74.43	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12350.9	F08		2	0101-0559	846.47	559.65	280	61.60	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11681.5	F08		2	0102-0581	830.65	580.36	296	64.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12365.9	F08		2	0103-0584	729.87	584.27	309	67.94	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10347.6	F08		2	0104-0583	136.86	584.11	355	70.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10631.7	F08		2	0105-0593	204.94	592.65	333	67.84	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10330.4	F08		2	0106-0599	657.62	599.28	352	72.77	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8336.2	F08		2	0107-0612	401.82	612.35	416	77.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10622.8	F08		2	0108-0613	282.94	613.38	336	69.60	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9877.5	F08		2	0109-0617	794.31	617.48	364	74.43	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11802.7	F08		2	0110-0627	564.76	627.74	304	68.33	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13898.8	F08		2	0111-0628	503.68	628.54	265	60.43	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10538.0	F08		2	0112-0640	468.48	639.76	358	74.77	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13125.5	F08		2	0113-0637	533.36	637.27	300	64.43	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12187.7	F08		2	0114-0638	142.53	638.49	284	62.28	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12322.7	F08		2	0115-0642	923.09	642.55	259	61.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15009.5	F08		2	0116-0649	490.89	649.79	358	75.60	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10199.9	F08		2	0117-0649	649.70	649.95	364	70.43	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14184.7	F08		2	0118-0651	340.95	651.50	256	60.53	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10554.1	F08		2	0119-0655	74.76	655.35	333	67.01	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11282.4	F08		2	0120-0656	384.32	656.20	315	68.43	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13938.2	F08		2	0121-0657	846.70	657.62	241	65.01	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12840.6	F08		2	0122-0664	526.49	664.41	282	62.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12604.1	F08		2	0123-0666	164.78	666.26	272	63.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10457.5	F08		2	0124-0667	290.75	666.98	342	68.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10682.1	F08		2	0125-0682	731.33	682.52	336	69.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12085.1	F08		2	0126-0684	931.88	683.94	264	62.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12054.0	F08		2	0127-0694	19.90	693.98	297	67.60	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11197.9	F08		2	0128-0705	744.81	704.87	312	65.84	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13778.9	F08		2	0129-0706	272.33	705.97	274	61.70	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184739	1375346	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12997.0	F08		2	0130-0704	664.77	704.13	313	65.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12666.1	F08		3	0001-0050	476.08	49.13	337	67.70	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13050.4	F08		3	0002-0055	782.98	55.56	261	61.11	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14658.3	F08		3	0003-0061	427.72	60.68	259	63.26	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13052.2	F08		3	0004-0062	393.22	62.02	308	63.36	0.964
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13005.8	F08		3	0005-0065	594.31	65.58	268	65.11	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12181.1	F08		3	0006-0068	325.54	68.02	284	62.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12790.2	F08		3	0007-0074	358.23	74.13	275	61.94	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13843.2	F08		3	0008-0089	435.52	89.44	268	60.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11482.6	F08		3	0009-0095	26.42	95.35	307	67.84	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19305.9	F08		3	0010-0109	138.49	108.04	205	67.26	0.570
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16091.9	F08		3	0011-0121	338.26	120.75	128	83.98	0.228
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15709.9	F08		3	0012-0130	591.11	130.17	181	52.87	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11170.8	F08		3	0013-0135	62.32	134.57	325	67.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11823.5	F08		3	0014-0142	436.10	142.21	309	66.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11018.3	F08		3	0015-0139	714.84	139.16	329	69.84	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11333.1	F08		3	0016-0141	34.55	140.24	322	71.01	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11781.5	F08		3	0017-0151	362.17	151.19	344	69.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11156.7	F08		3	0018-0146	686.46	146.15	203	58.28	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16370.6	F08		3	0019-0162	798.40	161.54	373	72.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12238.9	F08		3	0020-0164	305.82	164.51	279	61.94	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10429.1	F08		3	0021-0169	524.17	169.68	355	70.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11259.7	F08		3	0022-0176	41.37	176.90	331	73.50	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12047.5	F08		3	0023-0177	832.00	178.04	298	65.26	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11402.4	F08		3	0024-0180	761.07	179.65	319	70.18	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16537.6	F08		3	0025-0177	491.67	177.39	215	55.11	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10753.4	F08		3	0026-0188	796.60	188.30	334	69.36	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17332.6	F08		3	0027-0192	111.65	192.79	198	51.11	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12979.1	F08		3	0028-0201	382.46	201.75	271	63.26	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10804.0	F08		3	0029-0205	201.11	204.61	346	71.11	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10339.1	F08		3	0030-0209	706.89	208.43	356	71.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14114.6	F08		3	0031-0212	450.10	211.48	257	58.77	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10560.3	F08		3	0032-0220	833.52	220.04	327	70.67	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13663.9	F08		3	0033-0220	134.00	220.04	250	59.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11636.6	F08		3	0034-0227	404.98	227.52	305	64.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15876.9	F08		3	0035-0230	513.44	230.31	226	62.77	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15340.1	F08		3	0036-0234	547.93	234.56	240	58.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13306.4	F08		3	0037-0237	281.30	237.36	268	63.11	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14712.0	F08		3	0038-0255	675.34	254.68	236	58.53	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11441.1	F08		3	0039-0258	799.14	258.45	311	66.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15337.8	F08		3	0040-0262	553.47	262.69	241	58.53	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13471.5	F08		3	0041-0266	25.16	265.73	251	63.01	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12339.8	F08		3	0042-0265	863.12	265.41	274	63.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14112.9	F08		3	0043-0265	141.87	264.90	244	59.94	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19502.4	F08		3	0044-0269	487.64	268.24	132	54.77	0.553
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15829.8	F08		3	0045-0276	280.84	276.59	386	73.26	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13338.7	F08		3	0046-0283	412.01	282.93	270	61.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15429.5	F08		3	0047-0287	480.67	286.13	285	76.33	0.615
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10528.4	F08		3	0048-0285	614.69	285.54	353	71.01	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11498.7	F08		3	0049-0296	198.32	296.29	316	68.77	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11464.0	F08		3	0050-0294	808.99	294.66	306	65.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17217.4	F08		3	0051-0300	332.45	299.79	423	75.84	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12850.6	F08		3	0052-0300	512.00	299.74	300	64.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14108.1	F08		3	0053-0297	560.29	297.60	266	59.70	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11415.0	F08		3	0054-0305	631.55	304.42	320	68.18	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12183.3	F08		3	0055-0306	733.69	306.77	268	63.26	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14232.9	F08		3	0056-0305	416.53	305.25	160	48.63	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17359.4	F08		3	0057-0317	101.43	316.75	262	61.60	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9409.0	F08		3	0058-0318	58.86	318.20	366	72.08	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10293.5	F08		3	0059-0321	912.88	321.82	329	68.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14491.1	F08		3	0060-0321	412.84	321.14	247	64.77	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11978.3	F08		3	0061-0347	476.90	347.05	328	68.67	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12332.9	F08		3	0062-0349	536.15	349.97	293	67.11	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14834.5	F08		3	0063-0352	322.80	351.71	344	72.43	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17406.0	F08		3	0064-0354	218.01	354.14	410	78.43	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9385.1	F08		3	0065-0351	905.20	351.25	201	57.36	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10312.4	F08		3	0066-0354	18.49	354.18	350	72.18	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10634.5	F08		3	0067-0359	36.63	358.66	327	71.60	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11466.5	F08		3	0068-0361	443.07	361.30	317	74.77	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11524.4	F08		3	0069-0364	167.12	363.84	301	66.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9808.8	F08		3	0070-0375	797.76	374.43	377	74.43	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17953.5	F08		3	0071-0376	407.77	376.33	403	74.43	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13885.0	F08		3	0072-0383	548.09	383.47	271	61.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13062.2	F08		3	0073-0386	55.28	386.66	263	61.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10296.1	F08		3	0074-0389	468.20	389.24	355	71.01	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11204.1	F08		3	0075-0397	757.28	397.31	318	66.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11813.2	F08		3	0076-0407	593.49	407.72	303	65.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10674.7	F08		3	0077-0411	77.32	411.36	338	74.53	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9188.2	F08		3	0078-0415	667.54	414.74	411	79.26	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11858.8	F08		3	0079-0419	610.37	419.36	314	70.53	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11183.3	F08		3	0080-0418	171.29	417.35	336	70.67	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13179.4	F08		3	0081-0420	436.94	420.27	281	66.43	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13574.3	F08		3	0082-0432	899.32	432.10	265	65.60	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12046.1	F08		3	0083-0438	699.89	438.70	296	63.11	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10231.8	F08		3	0084-0444	43.31	444.10	338	70.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9059.7	F08		3	0085-0456	495.79	456.18	406	77.50	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11198.0	F08		3	0086-0460	909.25	460.74	187	53.94	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11537.9	F08		3	0087-0465	185.70	465.70	314	67.94	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10781.9	F08		3	0088-0474	639.22	474.30	345	69.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10446.5	F08		3	0089-0477	108.91	477.06	326	70.43	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13624.4	F08		3	0090-0483	496.72	482.98	270	66.43	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9575.7	F08		3	0091-0489	136.73	489.56	356	70.18	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13168.0	F08		3	0092-0490	780.75	490.99	267	61.36	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10794.1	F08		3	0093-0495	49.45	494.62	325	71.01	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11900.2	F08		3	0094-0500	347.91	499.38	295	64.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10665.2	F08		3	0095-0505	919.44	505.45	336	70.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13214.3	F08		3	0096-0508	250.88	507.89	557	95.74	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11578.8	F08		3	0097-0510	377.92	509.40	309	65.01	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10057.8	F08		3	0098-0527	730.49	527.19	370	73.60	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10943.4	F08		3	0099-0528	126.47	527.79	363	75.26	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12271.1	F08		3	0100-0534	225.35	534.16	299	67.01	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12957.4	F08		3	0101-0536	332.81	536.80	270	62.18	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10677.6	F08		3	0102-0543	554.02	544.15	343	69.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9767.3	F08		3	0103-0559	286.52	558.77	368	74.18	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10082.8	F08		3	0104-0566	404.65	567.19	357	75.60	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10322.2	F08		3	0105-0571	119.84	570.90	342	68.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11702.0	F08		3	0106-0577	154.39	576.28	301	68.43	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12252.2	F08		3	0107-0591	260.04	590.74	287	68.67	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11746.8	F08		3	0108-0616	365.65	616.72	298	71.50	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15447.7	F08		3	0109-0615	867.81	615.37	216	57.36	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14427.5	F08		3	0110-0619	937.72	619.86	247	60.53	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9415.4	F08		3	0111-0617	586.76	617.38	390	76.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10422.5	F08		3	0112-0630	903.23	629.42	344	73.50	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11391.4	F08		3	0113-0631	686.81	631.00	315	66.43	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11384.9	F08		3	0114-0638	664.80	638.76	311	67.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9220.1	F08		3	0115-0642	347.01	643.02	393	73.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12538.8	F08		3	0116-0644	17.93	645.04	252	59.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10600.2	F08		3	0117-0648	121.67	648.11	346	72.18	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14254.0	F08		3	0118-0651	291.92	651.05	242	62.77	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10404.8	F08		3	0119-0654	805.48	654.07	367	80.57	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15574.2	F08		3	0120-0652	309.59	653.07	239	60.77	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11527.0	F08		3	0121-0658	176.52	658.47	307	64.77	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11426.3	F08		3	0122-0658	839.55	658.18	315	69.84	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11201.3	F08		3	0123-0665	557.91	665.19	318	65.60	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11416.0	F08		3	0124-0672	147.01	672.49	294	63.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12000.6	F08		3	0125-0682	690.56	682.16	287	63.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16494.6	F08		3	0126-0686	535.26	685.35	203	55.21	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12238.4	F08		3	0127-0686	26.79	686.38	256	61.11	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11642.2	F08		3	0128-0694	675.48	694.25	328	67.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12807.4	F08		3	0129-0694	879.58	694.71	250	59.94	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12252.4	F08		3	0130-0704	182.73	704.55	273	61.60	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184740	1375347	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12944.5	F08		3	0131-0705	571.76	705.50	261	61.94	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13386.0	F08		4	0001-0029	171.82	29.32	261	60.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12751.0	F08		4	0002-0029	195.04	28.79	276	62.28	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13449.9	F08		4	0003-0032	144.75	32.73	257	61.70	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9924.2	F08		4	0004-0037	371.19	36.91	404	78.43	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10096.4	F08		4	0005-0064	872.22	63.25	356	72.43	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12368.6	F08		4	0006-0066	791.10	66.43	289	63.84	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14796.3	F08		4	0007-0069	51.72	68.97	255	61.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9678.8	F08		4	0008-0073	575.33	73.58	383	72.18	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10963.0	F08		4	0009-0076	110.78	76.17	321	67.94	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10742.1	F08		4	0010-0081	129.33	81.01	329	68.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10802.2	F08		4	0011-0096	634.11	95.81	337	70.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11051.1	F08		4	0012-0099	658.30	99.12	333	67.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9608.1	F08		4	0013-0106	475.01	106.70	414	83.26	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12140.0	F08		4	0014-0113	291.14	113.27	168	62.18	0.546
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11864.2	F08		4	0015-0121	83.65	120.58	291	65.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14640.9	F08		4	0016-0123	752.18	123.22	242	61.94	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17271.9	F08		4	0017-0121	785.98	121.79	202	51.94	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12102.5	F08		4	0018-0130	765.98	129.70	307	67.60	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11603.1	F08		4	0019-0132	574.14	131.92	314	67.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14732.0	F08		4	0020-0134	331.23	133.99	233	59.60	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12088.1	F08		4	0021-0136	432.75	135.71	287	64.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16377.2	F08		4	0022-0159	807.45	159.14	211	57.11	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13611.5	F08		4	0023-0161	233.88	160.59	280	61.94	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11274.7	F08		4	0024-0161	49.25	161.54	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12119.4	F08		4	0025-0164	601.52	164.49	295	64.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11465.5	F08		4	0026-0206	90.26	206.84	298	64.53	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12838.8	F08		4	0027-0209	531.51	209.16	307	68.18	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9786.2	F08		4	0028-0216	759.32	217.08	373	77.01	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11520.7	F08		4	0029-0212	912.03	211.82	314	67.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9753.8	F08		4	0030-0220	638.13	219.53	359	73.84	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11162.8	F08		4	0031-0225	408.56	225.08	339	71.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14354.5	F08		4	0032-0233	179.43	233.32	244	59.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11252.9	F08		4	0033-0240	333.77	239.81	310	66.43	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15686.2	F08		4	0034-0248	851.08	248.98	214	56.04	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9830.8	F08		4	0035-0257	43.47	257.21	343	70.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14991.4	F08		4	0036-0259	664.07	259.11	241	61.36	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13078.9	F08		4	0037-0270	424.07	270.27	299	66.18	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10366.8	F08		4	0038-0273	376.22	273.53	333	67.36	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14494.9	F08		4	0039-0272	180.26	272.05	242	58.77	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16350.1	F08		4	0040-0293	717.39	293.01	452	78.67	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10644.0	F08		4	0041-0297	20.10	297.46	353	70.18	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11363.2	F08		4	0042-0306	120.00	305.13	301	67.26	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13080.2	F08		4	0043-0306	917.57	306.35	266	63.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12994.1	F08		4	0044-0307	538.95	307.10	280	61.60	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14921.9	F08		4	0045-0309	667.97	309.75	240	61.60	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8548.5	F08		4	0046-0306	58.29	305.81	108	71.26	0.267
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11789.1	F08		4	0047-0311	377.59	311.42	323	68.77	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13004.3	F08		4	0048-0325	400.90	325.45	277	65.60	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10346.9	F08		4	0049-0329	359.73	329.52	366	72.43	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11871.3	F08		4	0050-0341	175.33	341.14	295	67.36	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12035.5	F08		4	0051-0338	296.96	338.14	314	68.43	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12864.1	F08		4	0052-0335	911.15	335.22	279	63.36	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12155.0	F08		4	0053-0339	454.32	339.21	317	67.60	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15047.7	F08		4	0054-0340	751.27	340.20	239	56.53	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15423.8	F08		4	0055-0347	199.86	347.24	232	57.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13519.9	F08		4	0056-0348	898.53	348.06	261	62.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14033.9	F08		4	0057-0353	925.53	352.89	270	61.94	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14891.8	F08		4	0058-0370	645.70	369.78	240	56.53	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11946.5	F08		4	0059-0374	765.64	375.08	305	63.60	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11556.3	F08		4	0060-0377	230.62	377.83	321	67.84	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14940.2	F08		4	0061-0375	75.09	374.82	228	58.87	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14232.8	F08		4	0062-0397	347.58	396.96	251	61.01	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13516.9	F08		4	0063-0400	196.29	400.36	253	59.11	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12875.2	F08		4	0064-0399	845.43	399.14	274	61.11	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11876.2	F08		4	0065-0405	765.45	405.15	309	65.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11629.8	F08		4	0066-0407	710.17	407.47	313	64.43	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13451.2	F08		4	0067-0411	327.72	411.45	279	64.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15205.5	F08		4	0068-0425	935.39	425.27	246	64.28	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13026.6	F08		4	0069-0426	227.43	425.84	276	63.60	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15779.7	F08		4	0070-0433	826.67	433.62	366	73.01	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12169.1	F08		4	0071-0433	792.34	434.04	296	65.26	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10089.1	F08		4	0072-0439	880.69	439.79	390	75.84	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11732.9	F08		4	0073-0458	342.98	457.95	303	68.53	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10890.3	F08		4	0074-0466	560.47	466.09	336	71.01	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14484.8	F08		4	0075-0477	753.31	477.02	509	85.50	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10571.3	F08		4	0076-0487	519.08	487.44	347	70.43	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15116.0	F08		4	0077-0489	901.11	489.35	224	59.70	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11206.0	F08		4	0078-0497	148.51	496.66	310	65.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10685.9	F08		4	0079-0504	288.85	504.09	327	67.26	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12857.2	F08		4	0080-0502	21.26	502.29	265	65.60	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11961.4	F08		4	0081-0502	230.11	502.30	295	68.43	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14112.1	F08		4	0082-0507	702.74	507.36	250	59.94	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11921.1	F08		4	0083-0518	434.28	517.40	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12461.9	F08		4	0084-0517	327.21	518.02	295	65.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16271.5	F08		4	0085-0532	654.71	531.73	370	71.36	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11974.3	F08		4	0086-0535	143.11	534.87	285	64.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10174.0	F08		4	0087-0536	197.18	535.93	334	68.18	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12435.3	F08		4	0088-0538	519.41	538.85	295	65.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15046.8	F08		4	0089-0547	598.89	547.62	236	57.11	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15633.6	F08		4	0090-0553	770.22	549.80	273	100.71	0.338
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10859.1	F08		4	0091-0553	308.70	552.52	334	68.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10477.4	F08		4	0092-0554	236.15	553.92	325	72.18	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15549.7	F08		4	0093-0553	374.13	553.74	227	60.43	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11167.7	F08		4	0094-0561	844.19	562.12	348	72.67	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15244.4	F08		4	0095-0561	791.09	560.82	264	83.50	0.476
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12225.7	F08		4	0096-0566	270.03	566.14	283	65.84	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	147.0	F08		4	0097-0565	19.85	565.60	260	60.53	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12032.5	F08		4	0098-0581	691.35	581.50	300	65.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12352.1	F08		4	0099-0583	767.19	583.34	293	65.11	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12462.7	F08		4	0100-0587	159.33	587.68	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13319.1	F08		4	0101-0593	844.08	593.08	290	64.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13666.3	F08		4	0102-0608	700.30	608.59	351	72.18	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13509.8	F08		4	0103-0611	330.70	610.79	260	62.18	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11284.5	F08		4	0104-0612	306.01	612.01	306	65.11	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9204.8	F08		4	0105-0615	576.64	615.24	375	74.67	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12057.3	F08		4	0106-0617	891.27	617.43	316	67.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13907.5	F08		4	0107-0628	95.11	628.12	255	61.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15790.2	F08		4	0108-0631	374.02	631.06	239	59.11	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11693.3	F08		4	0109-0636	235.67	635.97	293	68.77	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15605.9	F08		4	0110-0634	316.13	633.75	228	58.87	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9836.3	F08		4	0111-0647	665.33	646.45	365	72.18	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11837.1	F08		4	0112-0653	495.85	653.47	310	65.36	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10292.6	F08		4	0113-0659	788.18	658.88	344	69.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8316.8	F08		4	0114-0659	552.10	659.61	283	67.50	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10562.8	F08		4	0115-0666	282.01	665.44	321	67.60	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11085.8	F08		4	0116-0668	727.49	667.81	322	67.60	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14737.5	F08		4	0117-0680	397.53	679.43	239	57.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13036.6	F08		4	0118-0686	292.84	686.66	270	61.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11002.4	F08		4	0119-0695	861.38	694.59	324	73.50	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11053.1	F08		4	0120-0698	161.50	698.70	379	76.53	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11459.0	F08		4	0121-0700	903.67	700.99	382	111.88	0.383
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11840.5	F08		4	0122-0702	144.98	702.79	376	75.94	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15749.1	F08		4	0123-0699	828.87	699.10	217	57.60	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14004.4	F08		4	0124-0700	594.34	699.65	244	60.43	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184741	1375348	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12434.7	F08		4	0125-0701	642.94	700.49	282	62.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9487.8	F08		5	0001-0034	395.08	34.47	406	75.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10293.4	F08		5	0002-0038	646.42	38.21	370	70.77	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10850.5	F08		5	0003-0036	895.51	36.62	132	44.87	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11723.9	F08		5	0004-0053	63.91	53.11	294	64.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12745.8	F08		5	0005-0056	130.66	56.10	288	64.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13947.9	F08		5	0006-0053	176.55	53.72	267	61.94	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11287.3	F08		5	0007-0057	930.89	57.41	309	65.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11666.6	F08		5	0008-0059	214.33	59.15	311	67.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11053.4	F08		5	0009-0059	820.16	60.31	321	68.43	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14731.4	F08		5	0010-0064	611.99	63.41	263	61.11	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10450.3	F08		5	0011-0067	82.12	67.22	330	67.60	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13273.1	F08		5	0012-0070	116.97	70.49	285	65.60	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12748.8	F08		5	0013-0071	460.49	70.35	324	68.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8111.2	F08		5	0014-0076	867.42	76.30	428	91.40	0.644
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12571.5	F08		5	0015-0075	301.28	74.78	281	63.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11248.8	F08		5	0016-0074	439.08	73.56	341	70.18	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8923.3	F08		5	0017-0079	544.63	79.97	407	77.26	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9456.3	F08		5	0018-0077	652.81	76.34	386	75.60	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11448.3	F08		5	0019-0082	157.42	81.90	300	66.77	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10970.2	F08		5	0020-0085	343.85	86.51	368	83.84	0.658
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12511.6	F08		5	0021-0089	282.47	89.26	281	61.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10471.5	F08		5	0022-0092	892.22	92.42	341	70.18	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12154.3	F08		5	0023-0095	483.90	95.58	329	71.01	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13342.7	F08		5	0024-0109	219.92	109.22	269	61.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11178.3	F08		5	0025-0113	338.05	113.44	337	68.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14086.7	F08		5	0026-0111	115.25	110.85	245	61.94	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11988.3	F08		5	0027-0114	386.41	114.78	323	70.08	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10202.1	F08		5	0028-0114	427.91	114.12	383	73.60	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11027.4	F08		5	0029-0121	903.82	121.33	326	67.84	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12896.0	F08		5	0030-0131	793.61	131.16	271	63.84	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12816.9	F08		5	0031-0133	734.79	133.74	301	66.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13364.0	F08		5	0032-0134	751.30	133.33	292	63.70	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15568.3	F08		5	0033-0132	385.79	132.09	222	55.70	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9129.1	F08		5	0034-0138	86.64	137.47	341	69.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13491.1	F08		5	0035-0139	163.72	139.59	258	66.77	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9146.3	F08		5	0036-0145	476.49	144.75	396	74.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11024.8	F08		5	0037-0157	213.74	156.88	316	68.43	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9780.4	F08		5	0038-0169	274.16	168.88	351	71.01	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16599.7	F08		5	0039-0173	609.16	173.16	404	76.08	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	23809.1	F08		5	0040-0175	653.57	175.14	222	66.43	0.632
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13985.4	F08		5	0041-0186	692.54	186.11	259	61.84	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12341.5	F08		5	0042-0189	790.81	189.35	316	66.18	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10789.4	F08		5	0043-0194	433.89	195.30	340	69.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11669.0	F08		5	0044-0192	569.76	192.11	337	69.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13763.9	F08		5	0045-0194	511.55	194.18	281	67.60	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12444.4	F08		5	0046-0198	605.20	198.50	312	67.01	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15402.8	F08		5	0047-0206	138.63	206.49	216	56.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11357.4	F08		5	0048-0211	405.29	211.43	319	71.36	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13795.1	F08		5	0049-0209	751.75	209.63	284	63.01	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13787.0	F08		5	0050-0211	70.94	211.56	255	59.36	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20450.3	F08		5	0051-0213	693.64	213.26	347	68.43	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11420.0	F08		5	0052-0213	17.38	213.79	300	66.18	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11367.6	F08		5	0053-0213	227.18	213.03	327	71.60	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16987.3	F08		5	0054-0215	509.11	214.86	203	52.53	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15820.9	F08		5	0055-0227	876.19	227.30	204	55.11	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13358.4	F08		5	0056-0234	567.51	233.40	287	68.08	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10125.7	F08		5	0057-0240	663.89	240.33	359	72.67	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10783.0	F08		5	0058-0241	438.76	241.98	335	68.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13717.1	F08		5	0059-0243	527.92	243.78	266	63.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11883.1	F08		5	0060-0247	706.19	247.96	330	70.77	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15533.0	F08		5	0061-0249	754.11	249.02	234	57.36	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9861.5	F08		5	0062-0254	389.43	254.59	364	70.67	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15131.7	F08		5	0063-0261	206.44	260.22	459	86.33	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16142.6	F08		5	0064-0270	895.35	270.24	417	76.67	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11494.7	F08		5	0065-0270	599.22	270.41	322	66.77	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11359.9	F08		5	0066-0273	348.28	273.69	299	66.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14995.7	F08		5	0067-0276	448.25	276.64	239	58.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11350.2	F08		5	0068-0278	835.77	278.27	321	71.01	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10368.9	F08		5	0069-0279	292.09	279.55	344	68.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10987.5	F08		5	0070-0281	537.85	281.40	333	68.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10936.4	F08		5	0071-0280	677.23	279.89	332	75.26	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11221.6	F08		5	0072-0296	347.47	296.08	330	69.11	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10863.6	F08		5	0073-0299	635.45	299.89	346	73.94	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12281.5	F08		5	0074-0297	788.73	297.15	291	66.43	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11936.4	F08		5	0075-0304	875.72	303.01	289	70.18	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11508.8	F08		5	0076-0304	729.81	304.02	340	68.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12854.8	F08		5	0077-0308	23.08	308.11	265	63.01	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11314.2	F08		5	0078-0305	939.78	305.35	304	67.11	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11958.3	F08		5	0079-0310	179.55	310.39	294	64.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10255.7	F08		5	0080-0311	598.75	311.32	354	71.84	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12167.8	F08		5	0081-0313	143.45	313.92	286	64.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10425.4	F08		5	0082-0313	690.74	313.03	348	77.26	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11780.0	F08		5	0083-0319	850.96	319.47	303	65.01	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11760.8	F08		5	0084-0322	104.40	321.87	295	62.77	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12052.5	F08		5	0085-0336	533.22	336.35	305	64.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12284.6	F08		5	0086-0337	16.83	337.26	281	63.70	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15620.6	F08		5	0087-0351	708.97	350.24	940	130.02	0.699
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10381.9	F08		5	0088-0353	484.07	354.05	355	77.60	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13818.1	F08		5	0089-0355	30.81	354.84	268	61.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11878.1	F08		5	0090-0368	604.98	368.12	312	65.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11419.9	F08		5	0091-0375	822.27	374.97	333	69.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15368.1	F08		5	0092-0381	723.88	381.54	231	58.77	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10773.1	F08		5	0093-0387	124.99	387.97	340	73.01	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12516.3	F08		5	0094-0394	576.29	394.42	289	63.11	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15390.0	F08		5	0095-0397	186.52	397.07	209	54.28	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11998.3	F08		5	0096-0402	650.80	402.61	306	65.01	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12262.3	F08		5	0097-0403	301.55	402.35	283	62.77	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12371.5	F08		5	0098-0407	729.66	406.83	335	68.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12869.6	F08		5	0099-0411	271.43	411.55	382	72.77	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11789.2	F08		5	0100-0411	806.69	411.17	317	66.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12987.2	F08		5	0101-0410	931.79	410.06	268	63.01	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12818.8	F08		5	0102-0416	163.49	417.53	505	84.33	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13312.0	F08		5	0103-0412	488.23	411.26	280	63.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11979.3	F08		5	0104-0415	603.65	415.15	316	68.18	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10197.4	F08		5	0105-0423	356.28	423.04	348	72.43	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14715.2	F08		5	0106-0427	40.59	427.14	247	64.53	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15546.6	F08		5	0107-0430	435.55	429.89	458	82.33	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13188.2	F08		5	0108-0440	211.05	440.67	269	62.77	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14726.3	F08		5	0109-0439	640.00	439.36	249	57.94	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13322.9	F08		5	0110-0442	417.16	442.94	262	61.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11765.3	F08		5	0111-0443	899.55	443.27	301	64.18	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10346.6	F08		5	0112-0447	476.08	447.55	363	70.67	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11434.4	F08		5	0113-0451	734.64	451.15	297	66.18	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10508.5	F08		5	0114-0456	242.30	455.90	332	69.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12406.7	F08		5	0115-0451	578.34	451.24	303	68.77	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12997.0	F08		5	0116-0469	58.94	469.69	252	61.60	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10779.6	F08		5	0117-0471	351.25	471.21	327	70.43	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15986.1	F08		5	0118-0472	551.99	471.88	329	67.11	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13674.1	F08		5	0119-0472	203.72	471.30	258	61.94	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14115.9	F08		5	0120-0478	503.26	478.79	262	67.11	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10673.6	F08		5	0121-0485	856.17	484.58	358	83.15	0.651
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13358.3	F08		5	0122-0485	677.69	485.26	282	61.36	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9868.4	F08		5	0123-0487	399.87	488.02	359	73.50	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12458.1	F08		5	0124-0490	440.42	490.09	294	65.01	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10330.3	F08		5	0125-0498	773.48	496.68	378	75.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11901.7	F08		5	0126-0496	309.69	496.05	294	69.84	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10580.9	F08		5	0127-0509	643.66	509.29	335	73.94	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11201.3	F08		5	0128-0509	589.08	509.68	338	69.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12957.3	F08		5	0129-0513	89.09	513.87	285	64.77	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10936.5	F08		5	0130-0514	719.54	514.93	320	72.91	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11812.2	F08		5	0131-0519	469.01	520.32	309	67.60	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10898.0	F08		5	0132-0523	618.72	522.90	329	77.36	0.691
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11246.3	F08		5	0133-0522	938.32	521.96	292	66.77	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14747.3	F08		5	0134-0534	72.21	534.62	230	59.60	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11342.8	F08		5	0135-0544	644.19	544.29	316	68.18	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16224.6	F08		5	0136-0567	420.55	567.04	430	77.84	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11423.0	F08		5	0137-0566	673.03	565.57	335	73.26	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11898.5	F08		5	0138-0565	870.81	565.19	320	72.18	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13203.3	F08		5	0139-0575	833.54	575.28	278	69.11	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16343.6	F08		5	0140-0590	131.65	590.88	210	55.11	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13124.4	F08		5	0141-0611	130.17	611.79	263	59.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9126.1	F08		5	0142-0617	860.75	617.22	361	73.26	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11249.5	F08		5	0143-0636	322.12	636.25	311	65.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12246.0	F08		5	0144-0638	552.97	637.55	285	63.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13334.8	F08		5	0145-0636	143.55	636.61	256	67.94	0.697
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11489.6	F08		5	0146-0646	243.79	646.06	331	70.53	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12372.1	F08		5	0147-0645	569.15	644.80	289	64.53	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12334.9	F08		5	0148-0656	209.72	658.89	589	110.33	0.608
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11485.1	F08		5	0149-0649	392.44	648.81	314	67.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14958.9	F08		5	0150-0651	477.69	651.41	393	74.43	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13337.6	F08		5	0151-0651	648.86	650.78	265	63.26	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12941.0	F08		5	0152-0656	839.71	656.03	262	65.60	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10321.8	F08		5	0153-0652	916.58	652.30	326	69.94	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10473.9	F08		5	0154-0660	61.87	660.43	318	67.84	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10213.7	F08		5	0155-0669	717.31	668.92	367	74.33	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12729.0	F08		5	0156-0675	309.34	674.77	300	67.01	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10878.6	F08		5	0157-0674	400.17	675.66	347	73.84	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10861.6	F08		5	0158-0679	451.47	679.38	325	69.84	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20902.7	F08		5	0159-0684	636.39	684.58	320	66.18	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184742	1375349	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9454.9	F08		5	0160-0696	906.66	696.33	348	73.01	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10749.1	F08		6	0001-0040	323.34	40.63	347	73.01	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13266.1	F08		6	0002-0047	782.00	47.24	273	67.26	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13971.2	F08		6	0003-0053	426.76	53.37	270	66.67	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12385.1	F08		6	0004-0055	149.57	55.43	286	63.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11302.2	F08		6	0005-0060	25.83	60.11	304	64.77	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13995.7	F08		6	0006-0061	823.37	60.79	253	65.84	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14367.3	F08		6	0007-0067	247.36	66.94	265	65.60	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10540.0	F08		6	0008-0077	673.88	77.38	377	71.84	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11060.5	F08		6	0009-0084	318.86	83.55	340	71.26	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12358.7	F08		6	0010-0082	527.49	83.00	305	64.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11751.9	F08		6	0011-0087	691.40	87.25	305	68.43	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12561.4	F08		6	0012-0093	196.33	91.42	299	70.18	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14618.1	F08		6	0013-0093	411.70	93.66	250	59.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12844.9	F08		6	0014-0104	612.42	106.23	346	102.23	0.416
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10182.2	F08		6	0015-0107	853.40	107.97	367	72.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10301.4	F08		6	0016-0113	298.91	113.41	347	71.84	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12429.1	F08		6	0017-0113	172.37	112.80	285	62.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15709.9	F08		6	0018-0114	334.39	113.57	226	58.53	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12557.7	F08		6	0019-0121	811.87	120.64	294	66.77	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12344.5	F08		6	0020-0128	489.88	127.29	314	69.50	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11230.5	F08		6	0021-0127	261.73	127.59	320	69.01	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9449.0	F08		6	0022-0130	584.41	129.80	379	79.50	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15623.5	F08		6	0023-0141	433.17	141.59	228	55.36	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9712.8	F08		6	0024-0149	770.71	149.75	427	77.26	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8943.5	F08		6	0025-0149	541.38	150.44	409	76.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11970.6	F08		6	0026-0155	854.32	156.19	321	72.18	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11294.5	F08		6	0027-0161	680.29	160.66	346	72.43	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14780.8	F08		6	0028-0164	506.03	165.14	481	90.91	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14974.8	F08		6	0029-0162	369.59	161.90	232	59.36	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14341.5	F08		6	0030-0164	279.54	163.75	252	61.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11916.7	F08		6	0031-0172	236.80	172.17	301	64.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10923.5	F08		6	0032-0176	320.72	175.64	352	72.18	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11814.8	F08		6	0033-0175	898.76	174.31	325	73.01	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15518.1	F08		6	0034-0174	375.98	174.89	226	57.46	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10416.0	F08		6	0035-0181	405.96	181.83	347	77.84	0.720
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9573.8	F08		6	0036-0184	582.05	185.12	389	76.43	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16891.7	F08		6	0037-0189	183.13	190.35	103	56.77	0.402
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9726.9	F08		6	0038-0195	864.81	196.10	382	72.43	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9759.0	F08		6	0039-0206	939.73	206.24	363	72.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13774.9	F08		6	0040-0212	24.77	212.32	133	93.78	0.190
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10258.0	F08		6	0041-0211	247.08	211.41	342	71.84	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13065.8	F08		6	0042-0228	579.14	227.70	277	62.53	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11885.2	F08		6	0043-0232	258.80	231.53	298	66.43	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11580.1	F08		6	0044-0238	813.54	237.94	339	80.43	0.659
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15024.8	F08		6	0045-0241	724.82	241.12	241	61.01	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11931.1	F08		6	0046-0251	149.32	251.35	290	64.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12025.0	F08		6	0047-0255	441.49	255.10	296	63.94	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9823.0	F08		6	0048-0257	311.88	256.26	359	71.84	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12979.8	F08		6	0049-0262	774.37	261.17	308	71.01	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11297.8	F08		6	0050-0263	807.80	263.63	324	69.84	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10304.5	F08		6	0051-0265	748.05	265.21	392	77.26	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14721.2	F08		6	0052-0271	841.51	269.91	483	88.81	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12956.2	F08		6	0053-0273	604.82	273.45	298	69.01	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11209.1	F08		6	0054-0275	192.07	275.02	310	67.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10098.8	F08		6	0055-0285	273.81	284.59	342	71.11	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13637.9	F08		6	0056-0288	315.97	287.75	255	58.53	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17959.1	F08		6	0057-0288	238.03	289.05	118	69.84	0.304
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10552.5	F08		6	0058-0297	110.60	297.43	375	74.77	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9305.1	F08		6	0059-0300	402.45	299.81	395	73.01	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11421.0	F08		6	0060-0300	332.60	301.04	309	66.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11320.9	F08		6	0061-0304	919.18	304.82	341	79.26	0.682
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11258.1	F08		6	0062-0303	872.22	303.19	317	67.01	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10391.8	F08		6	0063-0307	380.17	306.95	348	69.84	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11089.8	F08		6	0064-0308	34.85	308.19	303	66.53	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11167.1	F08		6	0065-0314	529.80	314.65	360	71.84	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12675.8	F08		6	0066-0312	737.90	311.53	283	61.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14461.6	F08		6	0067-0319	460.36	319.32	245	57.94	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10555.0	F08		6	0068-0327	176.31	327.19	334	67.84	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10075.7	F08		6	0069-0327	267.39	326.87	358	72.43	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8883.8	F08		6	0070-0345	345.65	345.61	399	78.08	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9994.2	F08		6	0071-0349	652.12	348.88	388	74.67	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12015.0	F08		6	0072-0351	229.47	350.89	306	67.26	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12510.2	F08		6	0073-0357	860.37	356.93	306	69.01	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11346.6	F08		6	0074-0364	724.31	363.77	340	68.18	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14424.6	F08		6	0075-0367	220.38	367.40	249	61.60	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10381.7	F08		6	0076-0375	307.06	375.11	344	72.77	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9684.9	F08		6	0077-0374	379.82	374.77	371	73.84	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9894.3	F08		6	0078-0378	523.40	378.00	387	76.43	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16461.0	F08		6	0079-0372	777.01	372.70	209	54.28	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15567.3	F08		6	0080-0374	795.86	374.76	239	57.11	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11091.7	F08		6	0081-0390	896.09	390.31	343	70.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11683.0	F08		6	0082-0396	270.34	396.79	301	66.43	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12772.4	F08		6	0083-0400	75.64	400.55	294	63.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11101.4	F08		6	0084-0408	198.73	407.56	319	69.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11374.0	F08		6	0085-0407	558.86	406.76	351	70.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11475.1	F08		6	0086-0411	830.09	410.68	323	70.28	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12352.1	F08		6	0087-0413	26.87	412.80	273	63.01	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11554.9	F08		6	0088-0420	388.43	419.57	320	67.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11214.3	F08		6	0089-0420	699.00	419.51	331	69.01	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12177.1	F08		6	0090-0426	929.04	426.58	303	74.77	0.681
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13292.0	F08		6	0091-0422	80.11	422.33	281	63.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12332.0	F08		6	0092-0422	269.24	422.52	297	65.60	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15406.9	F08		6	0093-0425	495.24	425.58	231	61.70	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12939.2	F08		6	0094-0426	942.53	425.21	293	70.18	0.747
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12344.1	F08		6	0095-0427	654.26	427.01	298	65.01	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15095.5	F08		6	0096-0434	732.15	434.32	345	70.28	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10521.1	F08		6	0097-0434	899.88	434.35	368	72.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11128.4	F08		6	0098-0440	787.04	439.64	350	71.26	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14233.5	F08		6	0099-0444	313.51	444.25	248	63.70	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12206.8	F08		6	0100-0457	612.48	456.44	301	65.60	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11909.8	F08		6	0101-0466	541.75	465.82	314	67.84	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13079.0	F08		6	0102-0469	457.06	467.95	300	69.84	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10928.2	F08		6	0103-0472	899.47	472.04	331	68.43	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11995.2	F08		6	0104-0472	158.56	471.82	129	71.26	0.319
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13476.1	F08		6	0105-0483	421.15	482.38	284	65.01	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13103.9	F08		6	0106-0490	252.39	489.66	277	68.18	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11596.8	F08		6	0107-0488	290.18	488.41	322	68.43	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12366.9	F08		6	0108-0490	467.28	490.61	295	65.70	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12814.7	F08		6	0109-0495	132.47	495.84	269	67.70	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12734.3	F08		6	0110-0491	408.30	491.61	275	63.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11304.5	F08		6	0111-0497	182.57	498.42	305	67.94	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11419.0	F08		6	0112-0499	660.07	499.59	318	69.01	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10695.9	F08		6	0113-0502	370.65	502.53	343	74.43	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11939.0	F08		6	0114-0509	588.39	509.07	310	67.84	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10685.9	F08		6	0115-0515	827.71	515.63	344	68.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13653.1	F08		6	0116-0520	888.52	520.32	253	60.53	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10501.4	F08		6	0117-0522	753.11	521.82	355	70.08	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11054.2	F08		6	0118-0525	33.42	524.89	304	68.43	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12708.1	F08		6	0119-0523	315.91	522.86	302	65.94	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15593.1	F08		6	0120-0530	921.48	530.74	210	53.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11322.4	F08		6	0121-0538	399.98	537.73	342	69.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11322.6	F08		6	0122-0541	48.54	540.58	328	68.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12001.9	F08		6	0123-0546	728.83	546.54	317	66.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10165.5	F08		6	0124-0550	442.78	549.81	360	71.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11483.2	F08		6	0125-0555	695.22	557.17	392	118.13	0.353
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11742.7	F08		6	0126-0558	273.97	559.61	375	88.33	0.604
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10009.7	F08		6	0127-0558	504.41	558.87	368	73.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10572.4	F08		6	0128-0560	633.43	560.60	357	74.43	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10978.2	F08		6	0129-0564	806.22	564.04	342	73.60	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10473.9	F08		6	0130-0572	573.03	573.00	363	76.08	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15215.3	F08		6	0131-0570	899.87	570.25	219	55.70	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12847.8	F08		6	0132-0581	58.91	581.53	285	62.18	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11531.2	F08		6	0133-0585	191.91	585.57	308	69.26	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9350.3	F08		6	0134-0581	760.19	580.73	169	51.36	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12106.0	F08		6	0135-0586	779.09	586.58	318	73.70	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10829.0	F08		6	0136-0593	393.16	593.77	325	68.77	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10204.1	F08		6	0137-0598	524.28	598.86	360	74.43	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13379.9	F08		6	0138-0604	407.96	603.66	268	60.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11819.7	F08		6	0139-0606	719.80	606.67	342	71.60	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11129.9	F08		6	0140-0610	668.02	609.38	332	71.60	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10257.2	F08		6	0141-0610	944.17	610.24	325	67.36	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10864.3	F08		6	0142-0624	254.48	624.73	435	81.36	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15092.1	F08		6	0143-0620	473.85	620.29	254	59.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11274.7	F08		6	0144-0625	498.09	624.46	322	69.60	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17250.8	F08		6	0145-0621	588.56	622.24	126	47.11	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12794.9	F08		6	0146-0626	604.38	625.56	306	69.36	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13013.1	F08		6	0147-0631	399.30	631.24	270	60.18	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10804.7	F08		6	0148-0643	820.36	643.79	331	69.60	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9441.5	F08		6	0149-0647	762.95	647.48	391	74.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11341.5	F08		6	0150-0647	185.53	647.15	314	69.01	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15104.6	F08		6	0151-0650	467.28	649.78	254	58.53	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8847.8	F08		6	0152-0655	654.47	655.82	408	83.15	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11212.8	F08		6	0153-0657	227.78	657.24	307	67.36	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8891.3	F08		6	0154-0663	678.83	662.86	420	78.08	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16367.1	F08		6	0155-0660	152.33	659.97	228	56.28	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8768.6	F08		6	0156-0664	317.48	664.23	379	78.43	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17155.6	F08		6	0157-0667	131.53	667.22	214	54.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9834.4	F08		6	0158-0685	754.34	685.71	364	73.26	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11709.6	F08		6	0159-0683	214.80	683.17	312	65.01	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13297.6	F08		6	0160-0691	383.37	691.24	545	87.15	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10233.6	F08		6	0161-0691	921.86	691.84	327	67.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11284.2	F08		6	0162-0695	699.02	694.81	134	44.04	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13217.7	F08		6	0163-0703	335.59	703.62	544	86.91	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11622.5	F08		6	0164-0697	712.80	697.08	155	46.39	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9769.5	F08		6	0165-0703	115.04	703.15	344	69.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184743	1375350	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12934.1	F08		6	0166-0708	252.76	707.97	278	62.53	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13846.1	F08		7	0001-0033	92.68	32.93	251	60.18	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12522.3	F08		7	0002-0044	386.80	44.51	294	62.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13771.1	F08		7	0003-0048	477.35	48.14	278	66.67	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12978.1	F08		7	0004-0060	407.20	59.76	285	63.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15549.9	F08		7	0005-0062	678.12	62.81	233	55.36	0.956
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15836.9	F08		7	0006-0083	498.41	83.94	245	59.11	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12958.1	F08		7	0007-0088	102.28	88.41	272	64.28	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15113.9	F08		7	0008-0090	312.19	90.06	243	58.28	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14164.1	F08		7	0009-0088	857.80	88.23	243	58.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15603.5	F08		7	0010-0091	568.14	91.09	249	59.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13054.9	F08		7	0011-0090	922.36	90.77	285	69.36	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10461.4	F08		7	0012-0096	804.71	96.45	347	71.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12689.3	F08		7	0013-0099	159.09	99.23	396	76.91	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13597.7	F08		7	0014-0101	457.94	101.78	288	63.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16107.2	F08		7	0015-0105	635.09	105.00	234	59.36	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16046.5	F08		7	0016-0119	523.81	119.55	222	58.18	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17527.9	F08		7	0017-0126	686.97	125.86	193	53.94	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11770.7	F08		7	0018-0126	88.93	126.97	301	67.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13201.3	F08		7	0019-0132	641.72	132.74	273	63.60	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10696.2	F08		7	0020-0131	188.37	132.20	306	72.77	0.726
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13226.4	F08		7	0021-0135	281.43	134.70	262	61.60	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10186.5	F08		7	0022-0140	900.77	139.76	353	73.26	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12671.5	F08		7	0023-0140	559.10	140.54	300	64.43	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11939.4	F08		7	0024-0146	372.83	146.27	317	70.18	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10286.3	F08		7	0025-0153	132.29	153.66	301	66.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11069.9	F08		7	0026-0155	245.36	155.87	315	67.84	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12049.7	F08		7	0027-0154	331.26	154.32	290	63.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13228.8	F08		7	0028-0159	830.05	159.13	536	87.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12092.7	F08		7	0029-0163	779.09	162.97	296	65.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13672.2	F08		7	0030-0173	445.86	172.75	269	62.87	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10272.6	F08		7	0031-0180	31.92	180.27	332	72.43	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12125.8	F08		7	0032-0182	770.41	182.44	294	64.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15852.4	F08		7	0033-0201	821.36	201.88	239	57.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14920.9	F08		7	0034-0203	154.35	202.98	230	56.53	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13288.3	F08		7	0035-0230	658.69	229.95	258	61.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11401.8	F08		7	0036-0236	902.31	237.44	323	75.50	0.712
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18441.5	F08		7	0037-0240	807.18	241.35	115	44.53	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13069.2	F08		7	0038-0265	518.79	264.69	312	69.26	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15336.9	F08		7	0039-0265	544.89	264.71	246	64.18	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15346.9	F08		7	0040-0268	690.63	268.72	226	56.87	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13082.5	F08		7	0041-0273	36.28	273.02	267	65.01	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12569.4	F08		7	0042-0272	803.84	272.63	286	72.08	0.692
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14643.0	F08		7	0043-0279	430.76	279.79	262	60.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10621.8	F08		7	0044-0284	235.60	284.60	328	67.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12542.0	F08		7	0045-0288	629.87	288.63	303	65.01	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11685.4	F08		7	0046-0291	776.86	291.35	339	74.67	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12585.1	F08		7	0047-0299	663.58	299.86	310	67.94	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10017.2	F08		7	0048-0307	180.09	307.59	328	67.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11526.0	F08		7	0049-0307	322.57	307.02	304	65.36	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15668.5	F08		7	0050-0317	748.57	316.98	227	58.18	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15652.8	F08		7	0051-0317	637.80	317.35	248	58.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10245.2	F08		7	0052-0333	847.17	332.72	343	70.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14417.9	F08		7	0053-0334	147.60	333.67	253	61.70	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12798.9	F08		7	0054-0339	491.89	339.39	291	66.53	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19848.7	F08		7	0055-0352	133.12	352.78	247	64.43	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12472.0	F08		7	0056-0355	729.67	355.23	293	63.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13176.9	F08		7	0057-0366	284.61	366.61	267	59.70	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12376.8	F08		7	0058-0377	900.04	377.04	305	72.18	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10988.5	F08		7	0059-0377	130.33	376.64	342	70.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10239.5	F08		7	0060-0382	614.20	382.79	380	73.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12256.8	F08		7	0061-0386	419.80	385.79	329	69.84	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12134.7	F08		7	0062-0384	562.34	383.61	317	66.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11245.7	F08		7	0063-0392	845.59	392.78	308	67.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12290.6	F08		7	0064-0396	676.19	396.86	321	68.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10517.7	F08		7	0065-0397	781.94	396.61	342	69.84	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12289.8	F08		7	0066-0399	58.99	398.31	273	63.60	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11251.7	F08		7	0067-0409	352.76	410.17	340	72.67	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12982.4	F08		7	0068-0417	292.67	417.10	285	67.84	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12311.9	F08		7	0069-0423	37.19	423.02	275	69.26	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14412.9	F08		7	0070-0419	533.04	419.50	266	63.70	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12186.4	F08		7	0071-0426	229.90	425.89	293	66.43	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11925.7	F08		7	0072-0438	885.79	438.02	319	70.77	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16067.5	F08		7	0073-0437	138.79	436.51	217	59.94	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10768.3	F08		7	0074-0443	717.99	443.46	337	69.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12564.8	F08		7	0075-0448	449.95	447.65	306	67.84	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16001.2	F08		7	0076-0447	484.62	447.15	225	58.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13571.7	F08		7	0077-0453	631.77	455.68	387	93.98	0.551
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18757.7	F08		7	0078-0449	298.81	448.89	269	66.43	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21011.9	F08		7	0079-0468	104.09	467.16	106	44.53	0.672
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12531.3	F08		7	0080-0479	201.56	479.53	320	69.60	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10881.4	F08		7	0081-0481	581.58	480.98	335	68.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15268.9	F08		7	0082-0486	529.78	486.59	233	58.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12558.2	F08		7	0083-0494	302.87	494.27	285	62.43	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10535.0	F08		7	0084-0495	229.49	495.57	325	68.77	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12443.5	F08		7	0085-0499	904.47	499.00	292	65.60	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10652.4	F08		7	0086-0504	28.67	504.31	308	66.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11083.1	F08		7	0087-0508	444.17	508.44	343	70.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12657.5	F08		7	0088-0525	890.82	525.58	277	65.70	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10574.2	F08		7	0089-0535	193.24	534.84	316	68.77	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13277.1	F08		7	0090-0539	300.64	539.10	270	63.01	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11939.4	F08		7	0091-0539	379.44	538.81	304	65.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12930.8	F08		7	0092-0542	25.51	542.80	256	64.43	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16632.6	F08		7	0093-0549	343.44	548.80	214	55.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14015.1	F08		7	0094-0552	637.08	552.27	261	60.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13038.5	F08		7	0095-0574	164.62	573.41	429	86.08	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15599.1	F08		7	0096-0571	672.22	571.83	228	55.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12875.5	F08		7	0097-0573	507.45	573.46	280	63.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12077.5	F08		7	0098-0581	822.58	581.20	290	67.26	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8713.6	F08		7	0099-0592	714.37	592.57	393	83.74	0.704
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14614.0	F08		7	0100-0604	631.20	604.27	236	60.18	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12389.3	F08		7	0101-0615	95.84	614.75	325	69.36	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12312.3	F08		7	0102-0617	583.01	617.18	308	67.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10040.9	F08		7	0103-0632	208.27	633.24	340	68.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17313.3	F08		7	0104-0635	394.14	634.30	172	52.53	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13082.1	F08		7	0105-0642	602.53	640.54	365	120.71	0.315
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15427.1	F08		7	0106-0646	152.95	645.38	213	59.94	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14839.0	F08		7	0107-0649	403.03	649.67	189	54.53	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17913.7	F08		7	0108-0646	479.26	645.61	195	67.60	0.536
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12676.1	F08		7	0109-0654	434.14	654.28	282	62.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13596.9	F08		7	0110-0661	551.17	661.16	255	58.53	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10424.4	F08		7	0111-0676	429.53	676.20	341	69.50	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13124.6	F08		7	0112-0674	830.80	674.11	271	65.60	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10782.7	F08		7	0113-0679	201.81	678.48	306	66.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11776.3	F08		7	0114-0686	459.50	686.25	297	67.01	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12704.5	F08		7	0115-0687	594.89	687.09	301	69.36	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14166.1	F08		7	0116-0700	860.31	700.06	228	58.77	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184744	1375351	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8606.7	F08		7	0117-0712	829.75	712.75	159	50.04	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13921.4	F08		8	0001-0033	547.49	33.04	276	63.36	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13275.9	F08		8	0002-0039	390.98	39.49	312	68.87	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10520.6	F08		8	0003-0040	117.38	39.09	364	73.84	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14235.2	F08		8	0004-0043	468.83	43.14	273	63.60	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10601.7	F08		8	0005-0051	61.97	51.24	324	67.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12921.3	F08		8	0006-0057	813.53	56.57	270	65.60	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11265.9	F08		8	0007-0061	423.49	62.30	351	70.67	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13537.7	F08		8	0008-0063	351.36	64.01	288	63.94	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15550.2	F08		8	0009-0073	188.66	73.62	234	58.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14872.4	F08		8	0010-0078	534.60	77.39	546	85.74	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10997.6	F08		8	0011-0090	591.13	91.05	359	73.84	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12465.1	F08		8	0012-0093	27.34	92.73	300	71.60	0.735
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10950.4	F08		8	0013-0098	151.25	98.63	321	70.18	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13406.0	F08		8	0014-0094	862.10	94.33	251	58.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12318.9	F08		8	0015-0107	399.16	107.89	351	69.60	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11764.9	F08		8	0016-0116	77.68	116.31	300	65.60	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12319.0	F08		8	0017-0119	94.58	118.73	270	66.18	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11348.4	F08		8	0018-0117	144.91	118.43	327	67.94	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12390.4	F08		8	0019-0126	297.21	126.26	313	66.77	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14049.6	F08		8	0020-0127	571.17	127.19	260	64.67	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11567.6	F08		8	0021-0132	461.59	131.56	320	67.60	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16303.4	F08		8	0022-0137	524.65	137.50	266	61.46	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10448.3	F08		8	0023-0143	182.96	143.82	360	72.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12203.6	F08		8	0024-0144	858.72	143.84	286	62.53	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10098.3	F08		8	0025-0148	116.34	148.61	341	68.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16578.2	F08		8	0026-0148	631.03	147.91	212	54.53	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10616.2	F08		8	0027-0163	384.92	163.20	349	70.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14691.8	F08		8	0028-0162	498.33	161.44	241	60.77	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11697.5	F08		8	0029-0179	255.75	179.69	303	66.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11025.7	F08		8	0030-0193	903.86	192.59	363	77.60	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10882.0	F08		8	0031-0192	128.31	192.14	319	68.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12850.1	F08		8	0032-0198	834.68	198.26	273	61.36	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12573.1	F08		8	0033-0199	509.73	199.88	314	73.60	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10445.3	F08		8	0034-0200	934.39	200.06	339	68.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11672.1	F08		8	0035-0203	451.50	203.05	309	66.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13329.4	F08		8	0036-0212	809.27	211.52	260	59.94	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11658.8	F08		8	0037-0212	298.17	211.31	305	67.36	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9890.4	F08		8	0038-0219	171.70	218.50	349	70.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10041.0	F08		8	0039-0233	637.45	233.56	392	80.67	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12300.6	F08		8	0040-0231	389.44	231.39	302	67.36	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15113.0	F08		8	0041-0237	69.26	237.61	245	60.43	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13387.9	F08		8	0042-0246	216.23	246.26	271	64.43	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14661.9	F08		8	0043-0252	368.24	252.48	258	60.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11648.8	F08		8	0044-0255	555.78	254.76	308	67.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9725.9	F08		8	0045-0255	786.48	254.80	372	71.60	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12489.3	F08		8	0046-0255	269.76	254.60	284	66.43	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11601.2	F08		8	0047-0254	91.96	254.52	319	73.70	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14644.0	F08		8	0048-0259	345.30	258.91	262	60.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9961.1	F08		8	0049-0267	175.50	267.03	342	69.60	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12211.6	F08		8	0050-0268	413.70	268.21	323	71.50	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11300.1	F08		8	0051-0269	476.36	269.60	262	62.87	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11294.0	F08		8	0052-0267	608.28	266.91	333	69.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14103.6	F08		8	0053-0276	824.72	276.05	241	71.26	0.596
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11843.2	F08		8	0054-0280	327.52	280.38	308	69.94	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11993.9	F08		8	0055-0286	908.01	285.70	313	68.53	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11993.0	F08		8	0056-0287	257.30	287.08	289	64.18	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12736.8	F08		8	0057-0296	114.24	295.98	271	60.28	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11473.6	F08		8	0058-0301	527.71	301.18	325	70.43	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9711.9	F08		8	0059-0303	773.32	302.44	372	73.26	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13412.0	F08		8	0060-0301	67.03	300.89	265	60.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11028.3	F08		8	0061-0306	726.59	306.20	334	67.60	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10476.1	F08		8	0062-0307	454.46	307.65	280	64.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10540.1	F08		8	0063-0312	484.66	310.84	355	71.01	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11483.8	F08		8	0064-0309	802.16	310.13	312	67.01	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11743.1	F08		8	0065-0309	596.25	308.86	334	68.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11241.8	F08		8	0066-0316	693.21	316.50	327	69.94	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16289.0	F08		8	0067-0314	860.26	314.34	217	55.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12248.6	F08		8	0068-0321	66.27	321.41	288	64.18	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10803.4	F08		8	0069-0340	518.16	340.62	344	70.18	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11379.1	F08		8	0070-0341	265.73	342.16	331	68.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11744.5	F08		8	0071-0351	434.28	351.13	305	66.53	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10457.3	F08		8	0072-0351	157.55	350.65	335	67.60	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11046.9	F08		8	0073-0357	716.82	357.73	333	68.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14987.1	F08		8	0074-0359	201.87	358.41	290	62.18	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12436.7	F08		8	0075-0364	109.18	363.74	280	62.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14062.8	F08		8	0076-0362	599.31	361.65	263	64.53	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12559.2	F08		8	0077-0367	693.55	366.93	294	66.18	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12093.7	F08		8	0078-0368	311.75	368.05	298	66.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9807.3	F08		8	0079-0377	779.65	376.56	371	72.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11171.8	F08		8	0080-0388	69.99	388.89	308	67.60	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10309.2	F08		8	0081-0390	343.64	390.06	371	73.84	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14317.3	F08		8	0082-0386	263.47	386.26	253	61.11	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8934.4	F08		8	0083-0391	908.93	390.40	404	73.60	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13251.1	F08		8	0084-0391	611.42	391.77	274	69.50	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11487.3	F08		8	0085-0394	117.33	393.86	319	67.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14620.9	F08		8	0086-0399	228.50	398.65	247	60.53	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16050.2	F08		8	0087-0408	842.54	408.45	219	54.63	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10509.2	F08		8	0088-0416	556.27	416.95	354	69.60	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10267.6	F08		8	0089-0420	159.54	420.41	357	71.50	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13081.3	F08		8	0090-0423	731.25	422.91	279	63.01	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13738.7	F08		8	0091-0428	804.60	428.93	253	61.36	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11283.7	F08		8	0092-0436	487.98	436.01	325	66.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11145.2	F08		8	0093-0438	450.52	438.13	320	69.84	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14794.0	F08		8	0094-0441	747.09	440.58	241	61.11	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10751.4	F08		8	0095-0449	897.52	449.38	338	69.84	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13863.6	F08		8	0096-0449	761.52	449.23	256	62.53	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10223.5	F08		8	0097-0454	127.49	454.78	354	70.18	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10654.9	F08		8	0098-0459	837.61	458.78	342	69.84	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13192.4	F08		8	0099-0464	52.51	464.29	258	63.01	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12852.5	F08		8	0100-0475	743.13	475.27	277	63.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10660.9	F08		8	0101-0501	414.64	501.00	335	69.60	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11126.7	F08		8	0102-0507	566.44	507.64	333	69.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11753.9	F08		8	0103-0514	374.99	514.14	306	65.94	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9161.5	F08		8	0104-0513	334.32	513.20	159	48.53	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9300.0	F08		8	0105-0524	327.91	524.49	200	53.94	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13480.9	F08		8	0106-0524	268.31	524.45	261	62.53	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12875.8	F08		8	0107-0531	853.53	531.31	273	60.77	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10298.0	F08		8	0108-0535	604.96	534.87	366	72.18	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10991.2	F08		8	0109-0571	800.98	571.40	335	71.01	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11851.7	F08		8	0110-0569	210.82	568.62	319	65.60	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12855.6	F08		8	0111-0577	472.98	576.95	286	63.60	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12484.8	F08		8	0112-0581	98.85	581.31	272	62.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9614.6	F08		8	0113-0580	145.09	579.96	365	73.01	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10885.9	F08		8	0114-0590	882.83	590.92	326	71.26	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11371.0	F08		8	0115-0597	725.29	596.96	315	68.18	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10211.7	F08		8	0116-0597	624.95	597.75	362	73.26	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13731.6	F08		8	0117-0611	935.55	610.24	234	62.43	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10095.0	F08		8	0118-0618	164.12	619.05	342	69.84	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10262.8	F08		8	0119-0619	390.63	619.56	358	72.18	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9494.3	F08		8	0120-0624	311.05	624.35	393	74.53	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10493.4	F08		8	0121-0633	257.00	633.60	354	72.18	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14447.4	F08		8	0122-0629	887.85	629.27	229	59.36	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11018.1	F08		8	0123-0631	485.97	631.58	369	71.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9303.1	F08		8	0124-0644	205.67	643.32	267	76.91	0.567
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10768.1	F08		8	0125-0646	113.81	646.09	315	68.28	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11484.1	F08		8	0126-0648	646.66	648.33	311	64.77	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13430.1	F08		8	0127-0652	188.70	652.10	313	72.77	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15985.2	F08		8	0128-0662	807.99	662.37	371	72.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11974.9	F08		8	0129-0679	279.00	679.25	308	66.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12369.0	F08		8	0130-0681	511.91	681.69	286	62.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13103.2	F08		8	0131-0683	818.41	683.45	254	62.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10573.1	F08		8	0132-0700	318.53	700.43	351	71.84	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12428.4	F08		8	0133-0700	869.85	700.89	257	62.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11239.6	F08		8	0134-0703	138.26	703.54	301	64.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184745	1375352	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10733.3	F08		8	0135-0707	51.06	707.80	312	67.60	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10069.9	F08		9	0001-0027	112.91	26.93	344	68.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13247.2	F08		9	0002-0032	250.70	31.94	275	63.11	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10888.0	F08		9	0003-0037	590.02	36.73	360	76.08	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12265.1	F08		9	0004-0035	182.72	34.71	298	68.18	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14368.2	F08		9	0005-0039	511.18	38.74	272	60.53	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13661.4	F08		9	0006-0052	462.31	52.06	326	68.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11163.4	F08		9	0007-0061	289.42	61.34	340	69.84	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10413.0	F08		9	0008-0060	744.10	60.15	375	75.84	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13023.7	F08		9	0009-0059	539.40	60.03	288	63.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13461.1	F08		9	0010-0067	666.69	67.26	265	60.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11808.8	F08		9	0011-0067	106.69	66.90	298	65.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11285.8	F08		9	0012-0074	577.54	74.11	328	69.36	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11092.4	F08		9	0013-0085	351.37	85.44	320	68.77	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9534.5	F08		9	0014-0091	628.73	91.14	393	77.01	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12883.8	F08		9	0015-0103	150.33	103.48	271	69.26	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8140.3	F08		9	0016-0108	400.39	108.07	454	80.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13239.4	F08		9	0017-0105	858.93	105.72	285	66.53	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11696.8	F08		9	0018-0113	289.82	113.21	327	67.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14863.7	F08		9	0019-0109	606.04	109.78	240	56.53	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16216.0	F08		9	0020-0117	768.48	117.04	247	62.77	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9418.9	F08		9	0021-0125	539.18	124.32	438	80.67	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15242.8	F08		9	0022-0121	873.87	121.45	166	52.53	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12269.1	F08		9	0023-0127	260.01	127.38	302	67.01	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11078.6	F08		9	0024-0138	476.79	138.03	340	71.60	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10707.0	F08		9	0025-0149	319.13	148.94	327	67.11	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13516.0	F08		9	0026-0148	749.13	148.30	298	66.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12409.1	F08		9	0027-0158	503.51	157.38	320	73.60	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13085.7	F08		9	0028-0161	88.66	161.07	266	64.91	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14250.2	F08		9	0029-0159	241.91	159.07	237	59.01	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15635.9	F08		9	0030-0167	191.21	167.88	216	55.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12025.2	F08		9	0031-0175	444.89	175.23	302	65.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	29356.6	F08		9	0032-0173	811.23	174.00	102	37.46	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15071.5	F08		9	0033-0186	771.64	186.50	258	63.36	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13628.9	F08		9	0034-0192	90.66	192.61	247	62.18	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12650.9	F08		9	0035-0195	168.87	195.46	266	68.77	0.707
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15200.4	F08		9	0036-0192	373.20	191.67	246	60.77	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15154.6	F08		9	0037-0199	632.74	199.12	474	83.26	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9772.0	F08		9	0038-0200	943.12	200.57	395	77.50	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10355.3	F08		9	0039-0204	909.33	203.92	372	77.84	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10360.5	F08		9	0040-0203	29.78	202.97	327	68.18	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12651.8	F08		9	0041-0216	678.42	216.04	314	73.01	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14269.2	F08		9	0042-0214	529.80	214.47	277	61.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16955.3	F08		9	0043-0235	813.79	235.09	281	65.01	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14153.9	F08		9	0044-0237	767.12	236.64	289	67.84	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11240.3	F08		9	0045-0242	731.53	242.09	337	71.36	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13204.1	F08		9	0046-0239	229.65	240.27	253	58.87	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13620.9	F08		9	0047-0249	661.57	249.17	263	64.77	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11208.0	F08		9	0048-0252	46.14	252.59	303	63.94	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12961.0	F08		9	0049-0253	277.61	253.04	272	61.36	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10520.3	F08		9	0050-0260	938.09	260.43	364	71.50	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12894.0	F08		9	0051-0257	230.00	257.15	285	65.70	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12315.9	F08		9	0052-0266	426.54	266.69	295	65.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13894.3	F08		9	0053-0266	532.37	266.41	288	62.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11291.2	F08		9	0054-0275	141.22	275.50	320	67.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9825.3	F08		9	0055-0280	890.30	279.55	407	79.26	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12816.2	F08		9	0056-0282	381.39	281.55	283	62.18	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11961.4	F08		9	0057-0285	623.90	284.88	302	67.84	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13471.3	F08		9	0058-0298	223.21	298.43	264	59.60	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13318.4	F08		9	0059-0308	484.54	308.19	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11077.1	F08		9	0060-0313	56.31	313.12	372	74.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11891.1	F08		9	0061-0322	259.07	322.01	308	67.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12693.0	F08		9	0062-0327	728.12	326.58	310	69.36	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10530.6	F08		9	0063-0334	925.85	333.62	351	70.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11067.4	F08		9	0064-0333	831.25	333.40	333	69.26	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12883.3	F08		9	0065-0341	545.88	341.42	289	63.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12009.6	F08		9	0066-0341	871.51	341.54	301	64.43	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9665.4	F08		9	0067-0346	43.39	345.92	356	69.01	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10533.2	F08		9	0068-0350	225.43	350.33	358	73.26	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13957.8	F08		9	0069-0364	425.99	364.39	291	69.36	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11708.9	F08		9	0070-0363	784.03	363.41	333	68.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10313.8	F08		9	0071-0368	75.81	368.43	329	66.77	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10410.1	F08		9	0072-0370	728.14	370.19	368	71.84	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9875.2	F08		9	0073-0377	675.67	377.52	431	94.81	0.603
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14268.1	F08		9	0074-0384	562.15	380.29	405	96.47	0.547
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9784.8	F08		9	0075-0380	839.73	380.27	381	72.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12066.9	F08		9	0076-0395	607.01	394.57	312	70.67	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13796.6	F08		9	0077-0401	333.46	400.98	249	60.53	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12878.0	F08		9	0078-0401	429.53	401.57	283	62.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16327.3	F08		9	0079-0413	477.40	413.11	239	58.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11845.1	F08		9	0080-0418	752.22	417.97	326	67.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10824.7	F08		9	0081-0423	108.15	423.49	312	66.77	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10708.4	F08		9	0082-0422	136.76	422.43	323	67.84	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13069.8	F08		9	0083-0431	926.94	431.35	264	63.70	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12321.7	F08		9	0084-0436	663.61	435.45	326	68.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12174.8	F08		9	0085-0441	846.39	442.19	308	68.67	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10661.2	F08		9	0086-0453	788.02	452.55	346	70.43	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11459.9	F08		9	0087-0457	627.33	457.38	328	68.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12857.0	F08		9	0088-0460	250.17	459.58	271	62.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13872.8	F08		9	0089-0460	360.06	459.62	272	61.36	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10413.7	F08		9	0090-0466	762.09	465.46	350	71.01	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12537.7	F08		9	0091-0473	583.58	473.73	297	64.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12730.9	F08		9	0092-0483	354.63	482.60	295	64.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13103.7	F08		9	0093-0490	838.00	490.06	300	64.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11412.5	F08		9	0094-0496	656.41	496.27	342	72.53	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12584.7	F08		9	0095-0495	418.64	495.14	284	62.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11564.8	F08		9	0096-0498	792.53	497.76	331	69.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10409.8	F08		9	0097-0496	774.17	495.84	350	71.94	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12105.8	F08		9	0098-0499	52.74	498.30	283	62.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13351.1	F08		9	0099-0501	727.06	500.76	271	61.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13933.5	F08		9	0100-0505	207.71	504.91	249	58.18	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12601.5	F08		9	0101-0521	78.62	521.30	261	65.01	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10159.8	F08		9	0102-0521	614.23	521.50	371	70.18	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12527.1	F08		9	0103-0525	681.54	525.40	290	65.36	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12297.1	F08		9	0104-0524	710.85	524.45	293	63.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10905.4	F08		9	0105-0536	359.76	536.61	335	68.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10649.6	F08		9	0106-0539	624.88	539.71	358	72.08	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12993.0	F08		9	0107-0545	414.30	545.05	278	68.08	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11938.5	F08		9	0108-0543	740.94	544.00	305	65.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11263.7	F08		9	0109-0551	127.64	551.73	323	70.67	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12952.2	F08		9	0110-0555	376.56	555.19	274	60.77	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10470.2	F08		9	0111-0559	311.67	559.17	348	69.60	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12698.2	F08		9	0112-0570	464.67	570.15	303	67.60	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12994.5	F08		9	0113-0577	227.99	580.26	291	83.15	0.529
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11573.5	F08		9	0114-0584	723.59	584.53	331	68.67	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11709.9	F08		9	0115-0592	144.52	592.32	318	69.26	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11366.5	F08		9	0116-0591	674.89	590.99	317	66.53	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10889.0	F08		9	0117-0600	594.64	600.11	339	70.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11821.1	F08		9	0118-0599	296.56	598.65	303	67.84	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10356.9	F08		9	0119-0597	805.83	597.68	333	75.84	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12191.0	F08		9	0120-0602	928.18	602.38	277	62.77	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11741.6	F08		9	0121-0606	412.90	606.62	306	66.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11009.0	F08		9	0122-0607	466.79	607.03	331	67.84	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13995.2	F08		9	0123-0613	30.57	613.25	236	60.77	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14620.1	F08		9	0124-0615	239.99	615.89	244	63.94	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11360.7	F08		9	0125-0617	908.56	617.47	303	66.53	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8306.2	F08		9	0126-0625	671.13	625.54	417	79.26	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15331.3	F08		9	0127-0638	544.10	637.32	277	67.01	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10549.1	F08		9	0128-0648	205.49	647.63	330	67.60	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11567.0	F08		9	0129-0652	501.09	652.73	310	66.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11062.0	F08		9	0130-0658	185.37	657.89	315	67.84	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11859.0	F08		9	0131-0664	921.81	663.93	269	61.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12993.1	F08		9	0132-0667	677.49	666.70	275	62.18	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12847.9	F08		9	0133-0671	770.94	672.08	269	66.18	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12705.5	F08		9	0134-0674	398.05	674.25	276	63.36	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10991.9	F08		9	0135-0680	852.31	679.91	486	84.67	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11586.2	F08		9	0136-0682	319.34	683.00	307	65.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1184746	1375353	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12950.3	F08		9	0137-0685	378.24	685.79	273	61.36	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12858.4	G08		1	0001-0032	204.59	33.10	257	63.01	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16017.0	G08		1	0002-0042	496.41	42.05	229	59.11	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10278.0	G08		1	0003-0056	98.31	56.55	335	72.08	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11044.8	G08		1	0004-0065	935.15	65.24	324	68.43	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13279.2	G08		1	0005-0075	282.41	75.08	268	64.04	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10192.3	G08		1	0006-0076	711.31	75.89	364	71.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15713.3	G08		1	0007-0083	664.99	83.53	405	80.57	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10295.8	G08		1	0008-0092	730.56	92.42	348	71.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15576.1	G08		1	0009-0092	567.38	92.61	154	68.43	0.413
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13710.2	G08		1	0010-0096	262.76	96.42	254	69.26	0.665
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11668.8	G08		1	0011-0100	77.40	101.22	295	66.18	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11271.0	G08		1	0012-0106	712.96	105.19	322	72.33	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17300.5	G08		1	0013-0107	844.87	105.02	171	73.50	0.398
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11721.1	G08		1	0014-0122	896.06	121.71	302	66.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11877.3	G08		1	0015-0194	835.35	194.66	279	62.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9650.4	G08		1	0016-0199	185.62	199.26	102	39.21	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16091.3	G08		1	0017-0225	584.08	224.71	214	58.04	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15553.7	G08		1	0018-0242	806.26	241.74	215	62.04	0.702
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13190.1	G08		1	0019-0268	829.39	268.12	262	59.36	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13640.2	G08		1	0020-0280	887.64	280.48	237	60.28	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14717.2	G08		1	0021-0288	639.34	288.26	221	57.94	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13290.0	G08		1	0022-0302	32.27	302.53	235	64.18	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16425.1	G08		1	0023-0306	478.27	306.20	195	58.18	0.724
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12007.8	G08		1	0024-0323	657.51	324.42	284	64.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12829.8	G08		1	0025-0343	280.32	343.85	258	62.53	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15570.1	G08		1	0026-0365	47.51	365.09	214	54.87	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15511.2	G08		1	0027-0369	350.54	368.34	227	62.87	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14180.0	G08		1	0028-0364	510.31	363.63	226	58.77	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12501.8	G08		1	0029-0367	623.42	366.98	274	63.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17093.4	G08		1	0030-0365	742.98	365.12	193	57.36	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	194.0	G08		1	0031-0368	147.46	368.35	242	61.36	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14468.2	G08		1	0032-0373	306.88	373.44	229	61.11	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14098.2	G08		1	0033-0383	675.69	383.47	240	63.11	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12069.0	G08		1	0034-0389	935.70	389.37	282	67.60	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16298.1	G08		1	0035-0407	210.27	407.15	209	58.77	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15534.5	G08		1	0036-0414	70.13	414.26	215	57.70	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15472.3	G08		1	0037-0416	890.73	415.95	225	57.70	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12997.6	G08		1	0038-0438	666.57	438.67	262	64.53	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18943.7	G08		1	0039-0444	858.60	443.31	109	75.98	0.237
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17464.2	G08		1	0040-0457	419.20	458.00	233	57.36	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14239.0	G08		1	0041-0462	730.98	462.08	237	61.94	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16192.3	G08		1	0042-0498	314.58	498.27	227	59.60	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11375.0	G08		1	0043-0524	563.97	524.23	303	66.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15917.2	G08		1	0044-0527	829.85	527.56	240	62.77	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16260.0	G08		1	0045-0536	719.53	536.54	205	58.18	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13148.8	G08		1	0046-0539	360.16	539.84	277	72.43	0.664
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12430.4	G08		1	0047-0539	688.61	539.21	272	60.77	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16415.1	G08		1	0048-0541	636.49	541.13	202	54.18	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12007.3	G08		1	0049-0548	12.47	547.60	261	61.36	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15430.1	G08		1	0050-0558	95.67	558.64	212	58.18	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11255.9	G08		1	0051-0568	648.28	568.31	304	68.18	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11533.6	G08		1	0052-0569	834.65	569.67	293	66.43	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13211.5	G08		1	0053-0605	697.52	605.52	252	58.77	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10400.3	G08		1	0054-0610	547.24	610.47	328	69.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16615.8	G08		1	0055-0610	598.30	610.74	166	53.94	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16623.0	G08		1	0056-0639	326.67	638.87	198	53.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16196.9	G08		1	0057-0697	329.28	697.00	230	59.84	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184585	1375354	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13978.6	G08		1	0058-0706	735.74	705.51	250	73.60	0.580
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14397.4	G08		2	0001-0033	490.85	32.69	260	66.28	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10733.3	G08		2	0002-0065	39.68	65.16	334	70.43	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11050.1	G08		2	0003-0071	263.62	70.95	321	73.26	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12107.0	G08		2	0004-0104	246.65	104.64	292	75.50	0.644
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11966.9	G08		2	0005-0207	403.66	206.99	276	68.18	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15400.0	G08		2	0006-0218	447.01	218.02	223	66.43	0.635
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17116.4	G08		2	0007-0233	670.79	232.76	279	104.81	0.319
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10666.1	G08		2	0008-0248	396.52	248.61	314	69.84	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15917.8	G08		2	0009-0248	449.88	249.51	100	47.46	0.558
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17063.1	G08		2	0010-0282	915.46	282.98	120	50.77	0.585
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11355.2	G08		2	0011-0354	665.79	353.71	302	68.18	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11420.3	G08		2	0012-0389	40.48	389.26	286	68.18	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14450.0	G08		2	0013-0396	667.73	395.75	228	57.01	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12578.3	G08		2	0014-0408	655.79	407.55	276	66.08	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12644.7	G08		2	0015-0409	559.15	408.44	277	64.18	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11062.8	G08		2	0016-0459	258.19	459.85	306	66.18	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14055.1	G08		2	0017-0511	49.96	511.64	225	57.70	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12067.3	G08		2	0018-0515	114.80	515.24	268	63.60	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14453.9	G08		2	0019-0613	133.89	613.28	223	60.53	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13376.6	G08		2	0020-0618	504.01	618.58	259	63.36	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11520.2	G08		2	0021-0635	637.25	635.23	302	66.53	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11945.4	G08		2	0022-0639	285.94	639.91	297	66.18	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12212.5	G08		2	0023-0644	591.27	644.02	278	63.70	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11491.1	G08		2	0024-0650	538.77	650.29	296	64.53	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11568.0	G08		2	0025-0654	224.91	653.80	279	63.70	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10872.1	G08		2	0026-0669	100.45	669.38	299	65.36	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10122.9	G08		2	0027-0672	582.47	672.12	374	76.08	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12589.3	G08		2	0028-0672	305.14	673.35	281	64.53	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	25389.7	G08		2	0029-0686	316.60	686.53	125	45.11	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11392.8	G08		2	0030-0691	559.22	690.33	333	73.01	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11978.2	G08		2	0031-0697	615.07	697.26	277	62.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184586	1375355	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	26320.7	G08		2	0032-0703	912.12	702.79	115	40.28	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17495.8	G08		3	0001-0051	392.71	51.40	201	55.36	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12859.9	G08		3	0002-0075	222.13	75.24	244	59.36	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12947.1	G08		3	0003-0084	824.96	84.25	264	61.94	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13296.0	G08		3	0004-0098	283.01	98.19	236	61.26	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15958.4	G08		3	0005-0107	865.02	107.68	209	59.26	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15702.4	G08		3	0006-0109	428.96	108.97	213	54.53	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18237.9	G08		3	0007-0117	337.10	117.22	177	52.18	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14611.3	G08		3	0008-0120	858.06	120.25	224	55.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22642.2	G08		3	0009-0140	463.15	140.84	127	57.60	0.481
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14117.5	G08		3	0010-0154	925.91	153.92	225	57.36	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11811.7	G08		3	0011-0159	132.00	159.59	256	62.53	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10691.5	G08		3	0012-0161	248.69	161.09	118	40.28	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10577.7	G08		3	0013-0170	238.79	170.81	151	46.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16719.4	G08		3	0014-0176	428.50	176.01	204	58.18	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12409.1	G08		3	0015-0181	503.87	181.33	291	66.77	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19158.9	G08		3	0016-0180	529.81	180.56	171	50.53	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18679.9	G08		3	0017-0197	582.62	198.37	177	56.18	0.705
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15796.5	G08		3	0018-0200	927.92	200.57	216	59.60	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22659.4	G08		3	0019-0218	416.36	218.30	165	50.04	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18568.8	G08		3	0020-0225	645.39	226.73	372	80.08	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11432.0	G08		3	0021-0230	534.48	231.10	267	63.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11265.8	G08		3	0022-0244	246.67	242.06	190	58.87	0.689
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14643.5	G08		3	0023-0252	396.23	252.19	223	54.53	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12333.0	G08		3	0024-0254	528.93	254.27	270	65.01	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10525.4	G08		3	0025-0258	249.56	257.64	117	41.70	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10459.9	G08		3	0026-0275	172.46	274.70	276	67.84	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12881.9	G08		3	0027-0281	631.58	281.17	262	59.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16652.9	G08		3	0028-0283	13.67	282.64	191	56.77	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14710.4	G08		3	0029-0291	854.26	290.53	224	59.60	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15966.4	G08		3	0030-0303	103.18	303.57	207	57.36	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21538.9	G08		3	0031-0312	777.94	311.63	151	51.46	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15624.8	G08		3	0032-0322	487.29	322.50	214	56.77	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13093.0	G08		3	0033-0343	170.81	343.65	233	58.28	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15693.7	G08		3	0034-0384	852.19	384.44	220	55.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13802.3	G08		3	0035-0385	203.48	384.96	224	61.70	0.739
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12226.9	G08		3	0036-0396	810.66	396.52	284	63.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13266.7	G08		3	0037-0402	50.40	402.63	241	60.77	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13816.7	G08		3	0038-0407	742.68	408.20	266	64.18	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12681.3	G08		3	0039-0408	893.26	407.85	285	67.26	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15382.8	G08		3	0040-0454	910.50	453.38	237	58.77	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13420.1	G08		3	0041-0486	783.43	486.83	257	62.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14455.4	G08		3	0042-0489	453.81	489.03	234	57.36	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13217.5	G08		3	0043-0499	369.03	498.82	247	60.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13587.9	G08		3	0044-0535	663.85	535.40	257	62.87	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14273.5	G08		3	0045-0539	343.31	539.41	471	89.74	0.735
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19034.4	G08		3	0046-0531	785.86	531.44	177	51.11	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13217.5	G08		3	0047-0549	945.50	548.90	266	68.63	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10328.9	G08		3	0048-0558	808.51	557.74	322	68.18	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18267.6	G08		3	0049-0560	315.90	559.69	220	93.40	0.317
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12444.8	G08		3	0050-0565	444.93	564.88	283	66.18	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14140.7	G08		3	0051-0575	624.95	575.22	373	72.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12591.8	G08		3	0052-0581	325.62	582.28	262	61.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10944.9	G08		3	0053-0609	835.51	610.13	302	66.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16527.6	G08		3	0054-0645	276.97	644.96	208	56.87	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12562.0	G08		3	0055-0663	699.65	662.76	264	65.36	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14930.4	G08		3	0056-0664	832.78	663.96	216	59.84	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14899.8	G08		3	0057-0666	97.42	666.26	212	53.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184587	1375356	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12626.0	G08		3	0058-0670	618.50	669.36	259	66.43	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16718.7	G08		4	0001-0035	57.39	34.95	202	56.77	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12758.1	G08		4	0002-0036	140.39	36.89	263	67.26	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12055.0	G08		4	0003-0065	897.16	64.19	268	63.26	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14236.8	G08		4	0004-0069	704.73	69.69	260	63.70	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12482.9	G08		4	0005-0087	675.87	87.02	277	61.70	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13209.8	G08		4	0006-0092	168.03	92.02	326	72.91	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12850.4	G08		4	0007-0097	488.16	97.07	264	62.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13790.3	G08		4	0008-0106	695.79	107.02	267	67.26	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13882.1	G08		4	0009-0129	134.25	130.00	186	56.87	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14567.6	G08		4	0010-0144	683.46	144.16	250	68.77	0.664
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13034.3	G08		4	0011-0184	270.60	185.09	156	47.46	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12517.6	G08		4	0012-0184	258.83	184.32	117	42.63	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13963.3	G08		4	0013-0198	252.47	198.14	271	61.60	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11597.5	G08		4	0014-0202	271.16	202.46	228	62.77	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15720.4	G08		4	0015-0222	683.17	222.21	211	63.60	0.656
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12745.5	G08		4	0016-0223	626.05	223.64	268	61.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10104.1	G08		4	0017-0230	296.16	230.32	363	80.67	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12955.6	G08		4	0018-0236	870.80	235.72	251	60.53	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16669.9	G08		4	0019-0248	297.88	248.35	171	67.84	0.467
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14596.4	G08		4	0020-0251	61.22	251.90	222	54.77	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12711.1	G08		4	0021-0252	929.07	252.31	258	60.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13279.5	G08		4	0022-0261	757.81	261.64	281	65.01	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14903.8	G08		4	0023-0260	858.20	260.13	218	61.70	0.720
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13720.9	G08		4	0024-0273	154.52	273.23	239	64.53	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11815.6	G08		4	0025-0274	848.11	274.54	288	65.94	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16663.7	G08		4	0026-0278	57.57	278.85	196	52.53	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15326.9	G08		4	0027-0290	821.95	289.82	232	58.53	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10768.9	G08		4	0028-0297	30.71	296.88	302	66.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18953.2	G08		4	0029-0300	383.48	300.35	174	49.11	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17142.0	G08		4	0030-0308	258.64	308.85	209	57.60	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12791.2	G08		4	0031-0310	101.43	310.42	257	62.53	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12720.4	G08		4	0032-0312	542.78	311.58	301	68.77	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15109.8	G08		4	0033-0325	554.36	324.38	243	67.01	0.680
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17155.2	G08		4	0034-0343	635.95	342.84	195	59.01	0.704
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18162.9	G08		4	0035-0351	370.80	351.24	187	53.70	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10037.1	G08		4	0036-0350	928.55	349.11	162	51.94	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10451.4	G08		4	0037-0355	938.44	356.34	139	44.28	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15694.4	G08		4	0038-0361	218.64	361.70	202	57.11	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17215.9	G08		4	0039-0373	278.48	373.34	189	51.46	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15071.6	G08		4	0040-0382	801.04	382.03	194	55.70	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12973.7	G08		4	0041-0388	284.57	388.10	256	62.53	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11641.9	G08		4	0042-0391	415.82	392.06	295	67.36	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13349.2	G08		4	0043-0390	53.66	390.17	240	60.18	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11689.7	G08		4	0044-0393	267.09	393.23	290	67.26	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14974.5	G08		4	0045-0401	830.60	401.78	210	53.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14414.7	G08		4	0046-0420	198.06	419.82	219	57.46	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13123.6	G08		4	0047-0424	944.84	423.39	270	62.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13072.4	G08		4	0048-0440	392.04	441.07	265	65.84	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14945.7	G08		4	0049-0447	554.05	446.96	215	56.18	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16768.1	G08		4	0050-0446	249.81	446.92	191	53.11	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14273.4	G08		4	0051-0477	904.87	477.53	234	57.70	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12360.1	G08		4	0052-0487	80.59	487.68	262	62.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16949.4	G08		4	0053-0502	230.11	501.89	197	53.46	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21850.2	G08		4	0054-0517	391.63	517.07	253	75.60	0.556
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15382.4	G08		4	0055-0521	120.17	521.56	214	55.36	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13063.1	G08		4	0056-0523	287.43	523.01	270	63.60	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14940.3	G08		4	0057-0530	144.08	530.84	219	55.46	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17292.9	G08		4	0058-0560	596.96	558.50	392	91.74	0.585
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17554.5	G08		4	0059-0564	877.39	564.54	192	51.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13502.1	G08		4	0060-0577	810.69	577.11	389	74.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12857.1	G08		4	0061-0591	113.98	591.55	247	59.94	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12053.8	G08		4	0062-0606	659.17	606.68	297	78.57	0.605
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16558.9	G08		4	0063-0617	452.28	617.65	211	56.77	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14484.8	G08		4	0064-0621	193.27	621.27	221	60.43	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13957.4	G08		4	0065-0637	190.91	637.47	228	60.18	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12263.8	G08		4	0066-0644	397.00	643.71	282	63.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17122.4	G08		4	0067-0653	92.97	652.55	189	56.53	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19887.8	G08		4	0068-0654	106.20	654.06	160	50.04	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14176.7	G08		4	0069-0663	678.63	663.18	247	64.43	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17314.5	G08		4	0070-0690	349.11	690.26	383	72.67	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12059.0	G08		4	0071-0691	367.79	690.82	276	66.18	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10826.6	G08		4	0072-0704	542.80	703.81	309	68.43	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12176.6	G08		4	0073-0703	589.98	703.36	281	69.11	0.739
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17390.1	G08		4	0074-0703	739.02	703.26	199	52.77	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184588	1375357	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12727.0	G08		4	0075-0707	196.86	706.90	154	46.53	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14484.9	G08		5	0001-0032	541.11	31.09	192	60.18	0.666
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14512.9	G08		5	0002-0042	152.37	43.12	227	64.53	0.685
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16484.1	G08		5	0003-0068	371.04	67.99	204	61.46	0.679
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13569.3	G08		5	0004-0094	130.78	94.41	220	57.70	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17209.5	G08		5	0005-0108	685.92	107.88	189	51.94	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13055.0	G08		5	0006-0108	655.21	107.84	265	63.36	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15219.5	G08		5	0007-0126	291.19	126.62	202	56.18	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14847.8	G08		5	0008-0163	606.40	162.70	224	68.43	0.601
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12736.0	G08		5	0009-0165	343.14	165.05	250	63.50	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13138.7	G08		5	0010-0175	940.52	174.15	253	63.11	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13979.1	G08		5	0011-0181	825.03	181.58	243	58.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15024.6	G08		5	0012-0189	442.10	189.27	227	64.18	0.692
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19030.3	G08		5	0013-0195	722.38	195.82	185	73.50	0.430
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11129.8	G08		5	0014-0222	93.53	222.62	278	65.94	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16970.2	G08		5	0015-0237	567.80	237.45	194	55.46	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11961.7	G08		5	0016-0239	139.04	239.55	271	62.77	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15067.0	G08		5	0017-0241	470.04	240.31	223	57.46	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16857.3	G08		5	0018-0240	624.42	240.17	185	53.36	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17329.1	G08		5	0019-0248	823.85	247.79	175	69.26	0.459
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12443.2	G08		5	0020-0253	34.52	253.68	252	59.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11196.8	G08		5	0021-0263	132.45	263.34	299	67.84	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11496.4	G08		5	0022-0282	865.29	281.23	145	48.53	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11937.5	G08		5	0023-0292	260.85	292.40	275	62.18	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11492.8	G08		5	0024-0289	871.90	290.19	120	44.28	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12216.3	G08		5	0025-0292	905.12	292.44	265	63.01	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17467.6	G08		5	0026-0292	213.98	291.51	103	49.46	0.529
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12029.3	G08		5	0027-0316	61.57	315.91	259	68.53	0.693
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16636.9	G08		5	0028-0324	909.41	324.06	225	55.11	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9910.2	G08		5	0029-0351	34.16	350.35	160	51.11	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10455.5	G08		5	0030-0356	852.99	356.90	319	68.18	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10221.8	G08		5	0031-0357	43.91	357.60	134	43.46	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14998.5	G08		5	0032-0370	916.33	370.90	242	64.53	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12653.7	G08		5	0033-0388	478.45	387.91	263	61.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18164.5	G08		5	0034-0396	394.79	396.25	187	51.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14270.9	G08		5	0035-0412	692.19	411.81	233	56.28	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19906.5	G08		5	0036-0419	429.87	419.08	156	58.77	0.568
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12950.2	G08		5	0037-0425	50.46	424.75	261	63.60	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11572.8	G08		5	0038-0484	95.58	484.30	269	62.18	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16877.2	G08		5	0039-0483	930.96	483.42	201	53.70	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15936.5	G08		5	0040-0494	633.21	493.73	212	62.28	0.687
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13432.2	G08		5	0041-0497	769.80	497.55	253	61.70	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11743.2	G08		5	0042-0508	329.53	508.48	329	72.43	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14749.9	G08		5	0043-0527	286.51	526.75	220	61.01	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17360.9	G08		5	0044-0535	622.69	534.63	187	56.28	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15554.0	G08		5	0045-0550	220.89	550.54	202	57.94	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17678.6	G08		5	0046-0548	249.45	548.43	172	52.28	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19914.5	G08		5	0047-0563	153.70	562.95	110	53.36	0.486
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12729.6	G08		5	0048-0583	634.62	583.75	264	63.84	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17287.2	G08		5	0049-0594	129.69	594.89	191	54.18	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14557.8	G08		5	0050-0606	526.68	606.72	254	62.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13664.3	G08		5	0051-0621	548.39	620.38	261	60.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19649.9	G08		5	0052-0633	394.79	633.43	175	57.94	0.655
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12974.8	G08		5	0053-0649	879.38	648.46	267	62.77	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14632.6	G08		5	0054-0658	86.40	658.34	208	66.04	0.599
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14889.2	G08		5	0055-0659	146.43	658.61	215	57.11	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14808.8	G08		5	0056-0676	660.44	675.54	242	63.36	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	3630.4	G08		5	0057-0680	392.72	679.46	237	61.94	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19747.6	G08		5	0058-0686	413.76	685.86	186	51.70	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17780.3	G08		5	0059-0701	377.39	701.40	197	55.70	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184589	1375358	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17907.1	G08		5	0060-0703	482.30	702.70	182	64.67	0.547
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13908.2	G08		6	0001-0056	930.28	56.78	245	59.11	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14969.0	G08		6	0002-0062	146.01	62.35	215	56.77	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11952.3	G08		6	0003-0073	880.87	72.50	278	64.43	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19057.5	G08		6	0004-0082	78.92	81.60	182	51.94	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13052.0	G08		6	0005-0093	752.88	94.14	288	67.01	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16992.6	G08		6	0006-0112	641.80	112.21	197	57.60	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10839.6	G08		6	0007-0120	317.19	120.41	213	53.11	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15716.7	G08		6	0008-0124	828.85	124.44	232	71.98	0.563
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13579.1	G08		6	0009-0133	761.87	133.64	241	61.01	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11335.3	G08		6	0010-0139	111.89	138.66	274	63.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11364.1	G08		6	0011-0145	96.13	144.50	281	64.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11774.0	G08		6	0012-0150	731.23	150.14	297	66.18	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14912.3	G08		6	0013-0153	946.07	153.21	217	55.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12940.6	G08		6	0014-0157	818.91	157.09	266	65.01	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12668.2	G08		6	0015-0177	35.63	176.53	252	61.11	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20237.1	G08		6	0016-0179	810.78	179.02	141	59.60	0.499
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11095.7	G08		6	0017-0183	491.89	183.08	192	56.43	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12758.4	G08		6	0018-0187	116.46	188.41	137	46.63	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11725.5	G08		6	0019-0200	117.38	199.99	117	41.80	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12501.4	G08		6	0020-0220	67.60	220.10	243	57.70	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12914.2	G08		6	0021-0225	588.78	225.28	263	64.43	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16148.2	G08		6	0022-0261	649.15	261.19	225	59.70	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15840.6	G08		6	0023-0323	648.24	322.86	229	59.94	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17944.5	G08		6	0024-0328	763.41	329.02	193	57.11	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13583.8	G08		6	0025-0339	100.89	339.06	230	57.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12551.3	G08		6	0026-0347	418.78	347.62	272	65.60	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10406.7	G08		6	0027-0369	308.09	369.43	309	66.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14141.2	G08		6	0028-0373	11.55	373.61	238	63.11	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14588.8	G08		6	0029-0373	577.93	372.96	231	62.63	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9938.2	G08		6	0030-0403	351.02	403.11	335	70.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13491.6	G08		6	0031-0413	837.42	412.60	249	59.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12185.4	G08		6	0032-0418	255.47	418.73	301	69.01	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18182.8	G08		6	0033-0426	394.41	426.17	186	53.46	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13655.6	G08		6	0034-0432	873.70	432.07	251	60.53	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15501.9	G08		6	0035-0454	596.99	454.12	299	82.91	0.547
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16236.3	G08		6	0036-0486	26.23	486.05	202	55.11	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13297.1	G08		6	0037-0513	579.88	512.79	289	64.53	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11279.8	G08		6	0038-0542	313.65	541.48	130	43.94	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11170.3	G08		6	0039-0546	303.22	547.24	144	45.11	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15726.6	G08		6	0040-0554	190.36	554.58	209	53.36	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20844.1	G08		6	0041-0567	183.14	566.73	172	51.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11079.1	G08		6	0042-0568	321.68	568.31	295	65.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11904.0	G08		6	0043-0582	382.57	582.43	275	67.70	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15301.0	G08		6	0044-0604	753.16	604.08	233	58.53	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17709.4	G08		6	0045-0611	859.18	611.21	210	59.36	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18421.0	G08		6	0046-0612	890.31	612.54	187	57.94	0.700
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16418.3	G08		6	0047-0614	613.01	614.72	215	56.87	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11262.5	G08		6	0048-0640	352.25	639.51	291	66.43	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15483.0	G08		6	0049-0646	575.91	645.49	232	59.60	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16591.3	G08		6	0050-0650	617.75	651.14	208	57.84	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14701.8	G08		6	0051-0653	123.89	653.61	205	60.53	0.703
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14438.9	G08		6	0052-0677	466.12	677.74	244	59.94	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17019.4	G08		6	0053-0686	593.53	685.73	205	59.94	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14371.2	G08		6	0054-0691	513.60	691.38	248	61.60	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11509.6	G08		6	0055-0700	351.11	699.46	279	62.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11924.5	G08		6	0056-0709	218.08	709.28	259	60.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184590	1375359	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15953.9	G08		6	0057-0709	832.68	709.43	206	58.28	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17091.6	G08		7	0001-0053	156.06	53.48	189	52.87	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15027.3	G08		7	0002-0055	530.23	55.22	234	56.87	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16004.0	G08		7	0003-0059	856.52	59.19	222	59.46	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21205.8	G08		7	0004-0066	818.80	66.19	139	61.60	0.460
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15586.8	G08		7	0005-0108	391.66	108.22	211	60.04	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13325.8	G08		7	0006-0106	876.52	106.30	260	62.77	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17920.6	G08		7	0007-0126	468.55	126.58	207	53.11	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15025.6	G08		7	0008-0146	857.50	145.91	227	61.60	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19127.7	G08		7	0009-0151	424.38	151.78	184	51.46	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13641.6	G08		7	0010-0155	165.33	155.02	235	60.53	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9307.4	G08		7	0011-0169	384.99	168.53	333	77.26	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12969.3	G08		7	0012-0218	214.01	218.13	266	65.01	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13348.8	G08		7	0013-0232	844.78	232.79	244	59.94	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16953.5	G08		7	0014-0246	70.36	245.62	187	57.01	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16945.0	G08		7	0015-0269	254.98	267.70	124	52.87	0.557
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17352.4	G08		7	0016-0278	542.09	277.90	194	55.01	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14698.0	G08		7	0017-0285	589.69	285.54	227	55.70	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14358.2	G08		7	0018-0295	792.60	296.21	261	62.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11084.2	G08		7	0019-0312	44.10	311.83	284	64.53	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14781.1	G08		7	0020-0310	581.07	310.05	230	59.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19203.0	G08		7	0021-0318	797.42	318.62	355	71.01	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14483.4	G08		7	0022-0320	20.50	319.46	217	56.28	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12367.6	G08		7	0023-0342	903.18	342.01	285	63.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15402.2	G08		7	0024-0346	432.50	346.92	216	56.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12558.6	G08		7	0025-0359	304.40	359.04	277	66.18	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18285.7	G08		7	0026-0385	226.98	385.39	107	39.46	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11979.1	G08		7	0027-0408	323.36	408.03	298	66.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11129.1	G08		7	0028-0414	130.61	414.08	313	71.50	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13069.1	G08		7	0029-0412	876.71	411.44	249	59.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16258.3	G08		7	0030-0415	227.08	415.55	205	57.01	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14562.2	G08		7	0031-0458	218.58	458.05	226	59.84	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12269.4	G08		7	0032-0465	900.13	464.79	272	63.01	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19509.8	G08		7	0033-0480	673.05	480.64	163	60.18	0.566
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12286.7	G08		7	0034-0483	154.74	483.15	141	46.87	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15625.6	G08		7	0035-0492	825.90	492.18	214	57.36	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11690.7	G08		7	0036-0494	159.32	495.01	131	49.46	0.673
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12588.2	G08		7	0037-0540	317.29	539.62	261	62.53	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16969.3	G08		7	0038-0537	118.17	537.42	196	57.36	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12420.1	G08		7	0039-0548	749.08	548.28	132	45.36	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11619.4	G08		7	0040-0555	541.81	554.98	291	65.26	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14420.8	G08		7	0041-0557	214.72	557.44	222	57.36	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12825.3	G08		7	0042-0555	735.78	555.98	120	42.28	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14029.9	G08		7	0043-0571	865.45	571.98	235	59.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11242.0	G08		7	0044-0581	458.87	581.32	299	65.26	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16259.3	G08		7	0045-0580	338.24	579.59	201	56.04	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12849.2	G08		7	0046-0584	557.07	584.80	257	61.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15662.9	G08		7	0047-0590	146.42	590.52	220	59.21	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10587.9	G08		7	0048-0590	379.40	589.54	316	66.67	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10296.7	G08		7	0049-0587	725.42	587.60	147	45.11	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10943.0	G08		7	0050-0596	715.02	597.07	151	46.87	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12908.2	G08		7	0051-0647	709.92	647.29	279	62.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16433.7	G08		7	0052-0649	283.27	650.15	195	53.94	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13222.6	G08		7	0053-0663	760.22	663.21	252	61.60	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10230.2	G08		7	0054-0665	58.61	665.53	298	63.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14067.0	G08		7	0055-0677	779.19	677.03	238	61.60	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17671.7	G08		7	0056-0692	383.49	691.93	179	49.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184591	1375360	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16857.3	G08		7	0057-0691	471.18	691.53	195	56.87	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11500.5	G08		8	0001-0031	936.98	31.62	278	65.60	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17240.3	G08		8	0002-0054	801.15	53.88	209	56.87	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15613.6	G08		8	0003-0061	843.75	61.43	216	66.04	0.622
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18245.1	G08		8	0004-0072	744.01	72.77	201	59.70	0.709
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14390.8	G08		8	0005-0110	290.92	109.83	264	63.01	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16808.8	G08		8	0006-0124	868.05	124.44	204	55.36	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12806.4	G08		8	0007-0136	397.97	136.22	279	62.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15758.0	G08		8	0008-0157	297.33	157.19	199	51.11	0.957
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12393.8	G08		8	0009-0177	236.55	176.67	260	64.53	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15958.0	G08		8	0010-0177	353.95	177.55	204	52.28	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14971.5	G08		8	0011-0182	141.63	182.29	215	60.43	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12900.6	G08		8	0012-0184	417.53	184.50	266	63.84	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16420.4	G08		8	0013-0195	580.65	195.20	189	53.11	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14627.6	G08		8	0014-0207	918.96	206.97	220	55.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15546.3	G08		8	0015-0214	236.87	214.53	211	59.01	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15714.5	G08		8	0016-0241	897.47	241.14	199	55.36	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15613.8	G08		8	0017-0260	527.98	260.45	217	56.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12965.7	G08		8	0018-0264	450.21	263.65	272	63.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12038.2	G08		8	0019-0297	861.92	297.03	274	63.94	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12364.4	G08		8	0020-0298	714.96	298.45	291	64.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11350.0	G08		8	0021-0330	699.62	330.32	173	47.46	0.965
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12789.7	G08		8	0022-0334	721.44	334.50	230	69.26	0.603
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10666.1	G08		8	0023-0343	708.13	343.65	123	45.11	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13228.1	G08		8	0024-0356	95.62	357.04	246	59.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10493.9	G08		8	0025-0358	770.82	358.20	230	63.60	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12712.9	G08		8	0026-0376	353.60	378.03	264	77.26	0.556
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15235.2	G08		8	0027-0378	259.72	378.03	213	55.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10028.9	G08		8	0028-0380	688.59	380.85	231	62.77	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11363.4	G08		8	0029-0388	424.72	387.92	305	67.84	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9995.4	G08		8	0030-0393	795.82	392.83	329	69.36	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17160.6	G08		8	0031-0421	214.39	421.11	189	56.53	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15195.2	G08		8	0032-0423	584.17	423.57	283	64.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16496.2	G08		8	0033-0426	527.98	426.91	228	57.70	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11738.0	G08		8	0034-0431	469.27	430.90	295	64.53	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15752.8	G08		8	0035-0446	174.24	446.17	205	59.26	0.734
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11939.6	G08		8	0036-0465	93.35	465.85	268	64.18	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18484.7	G08		8	0037-0478	172.46	478.59	190	52.77	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19009.9	G08		8	0038-0478	451.26	478.26	172	50.18	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14667.8	G08		8	0039-0485	204.35	484.39	245	61.60	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12571.7	G08		8	0040-0493	109.12	493.18	278	65.94	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12186.9	G08		8	0041-0514	550.29	513.57	307	69.94	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11943.3	G08		8	0042-0513	707.35	513.93	288	62.18	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13250.3	G08		8	0043-0518	868.54	518.43	202	61.01	0.682
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10213.8	G08		8	0044-0518	406.70	519.39	142	45.21	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17028.1	G08		8	0045-0536	565.66	536.59	212	64.04	0.650
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10324.8	G08		8	0046-0533	407.92	532.20	168	48.63	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14321.8	G08		8	0047-0534	301.31	534.72	230	59.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13548.7	G08		8	0048-0548	192.92	547.90	260	61.36	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11636.9	G08		8	0049-0556	511.92	556.09	302	66.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17148.6	G08		8	0050-0566	299.97	566.75	193	53.60	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11661.1	G08		8	0051-0580	924.69	579.23	294	65.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12064.2	G08		8	0052-0589	270.62	588.33	268	63.11	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	24534.5	G08		8	0053-0595	880.07	594.80	355	73.36	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11996.5	G08		8	0054-0610	218.90	609.47	260	67.84	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13438.0	G08		8	0055-0621	146.69	622.02	198	57.11	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13799.9	G08		8	0056-0621	290.70	621.09	249	60.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15682.6	G08		8	0057-0639	577.61	640.06	225	62.53	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16058.9	G08		8	0058-0657	135.73	657.10	210	61.70	0.693
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12191.4	G08		8	0059-0652	674.40	652.07	277	69.36	0.724
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19280.3	G08		8	0060-0666	415.93	666.00	171	55.11	0.707
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19470.7	G08		8	0061-0699	370.97	699.10	183	51.70	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13143.1	G08		8	0062-0701	133.33	701.42	195	51.70	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184592	1375361	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	143.1	G08		8	0063-0709	842.07	709.27	198	51.70	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11399.1	G08		9	0001-0034	31.77	34.33	273	65.01	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13526.3	G08		9	0002-0034	411.40	35.09	286	64.77	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13071.8	G08		9	0003-0040	489.21	39.94	280	65.84	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13150.1	G08		9	0004-0049	727.83	49.69	258	61.11	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22662.7	G08		9	0005-0071	43.56	71.40	286	64.28	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13225.1	G08		9	0006-0103	476.99	103.18	279	61.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13323.4	G08		9	0007-0106	354.74	106.26	246	59.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14279.4	G08		9	0008-0118	570.68	118.15	240	60.53	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16056.5	G08		9	0009-0145	347.01	145.15	199	53.11	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16943.2	G08		9	0010-0148	694.70	149.05	194	59.36	0.692
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15552.1	G08		9	0011-0150	125.25	150.20	225	59.46	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13535.9	G08		9	0012-0157	97.26	157.47	266	59.11	0.957
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13458.9	G08		9	0013-0183	323.97	183.54	246	61.60	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14543.0	G08		9	0014-0194	251.35	194.46	224	57.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12727.6	G08		9	0015-0206	858.14	205.90	261	62.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14538.2	G08		9	0016-0210	14.17	209.59	216	55.60	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17184.9	G08		9	0017-0211	377.37	210.79	172	54.04	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16888.2	G08		9	0018-0224	388.18	223.96	199	56.53	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15753.9	G08		9	0019-0235	80.57	235.54	201	56.18	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13016.5	G08		9	0020-0244	687.08	243.72	274	63.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13907.6	G08		9	0021-0246	299.45	245.54	343	72.43	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14058.4	G08		9	0022-0255	445.90	255.26	242	57.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14906.3	G08		9	0023-0268	478.14	267.59	245	58.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11346.2	G08		9	0024-0306	621.04	306.21	306	65.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13218.6	G08		9	0025-0336	263.52	336.65	255	77.50	0.534
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11749.1	G08		9	0026-0338	565.15	337.78	294	65.60	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14456.5	G08		9	0027-0352	423.01	352.32	230	57.36	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17761.8	G08		9	0028-0359	647.64	359.30	201	52.04	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9927.7	G08		9	0029-0366	121.04	366.56	347	72.08	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12839.1	G08		9	0030-0371	599.07	371.81	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11413.7	G08		9	0031-0392	112.90	392.27	302	70.18	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16562.6	G08		9	0032-0394	544.89	393.62	265	87.64	0.434
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16066.0	G08		9	0033-0396	427.88	397.25	206	56.77	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13084.9	G08		9	0034-0412	642.60	412.11	280	69.26	0.734
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16665.1	G08		9	0035-0416	462.97	416.38	197	60.28	0.681
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13866.2	G08		9	0036-0419	369.72	418.83	238	60.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12435.5	G08		9	0037-0428	443.00	427.25	275	64.77	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12585.2	G08		9	0038-0429	515.38	429.72	271	61.70	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13754.2	G08		9	0039-0440	364.69	440.16	252	61.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19766.9	G08		9	0040-0502	687.24	501.40	247	61.36	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22740.5	G08		9	0041-0505	670.84	506.14	206	54.63	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11428.8	G08		9	0042-0526	480.04	525.65	299	66.77	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13073.7	G08		9	0043-0560	241.00	560.24	284	66.77	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11499.8	G08		9	0044-0582	19.55	581.95	287	64.53	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18098.0	G08		9	0045-0581	306.88	581.25	226	58.18	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12353.7	G08		9	0046-0596	783.57	595.75	266	63.84	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14699.0	G08		9	0047-0601	698.86	601.44	250	62.53	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13243.8	G08		9	0048-0605	942.34	604.53	260	67.01	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10522.8	G08		9	0049-0613	300.09	612.81	325	66.43	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1184593	1375362	Cycle-1			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12202.5	G08		9	0050-0664	878.63	665.31	280	63.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9099.4	B08		1	0001-0030	113.89	29.84	299	67.60	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9468.8	B08		1	0002-0029	168.91	28.72	294	66.18	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12365.6	B08		1	0003-0033	263.30	34.12	210	55.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9797.6	B08		1	0004-0039	463.46	39.70	310	65.36	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10328.0	B08		1	0005-0040	504.82	41.10	293	68.67	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9951.7	B08		1	0006-0040	720.01	40.44	289	75.74	0.633
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14038.1	B08		1	0007-0041	803.55	41.85	444	87.50	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10941.1	B08		1	0008-0042	418.82	41.04	267	61.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15661.9	B08		1	0009-0042	87.75	42.02	158	48.63	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13463.1	B08		1	0010-0045	289.33	45.56	376	71.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12136.0	B08		1	0011-0044	589.42	44.68	234	56.28	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12068.3	B08		1	0012-0045	693.34	45.35	223	54.87	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15242.9	B08		1	0013-0042	652.67	42.21	177	52.63	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14815.9	B08		1	0014-0047	771.72	47.09	254	59.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9791.1	B08		1	0015-0051	172.16	51.15	276	61.94	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10757.5	B08		1	0016-0050	534.61	50.03	323	66.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13906.7	B08		1	0017-0053	219.63	53.47	374	71.60	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11145.3	B08		1	0018-0052	134.85	52.43	234	56.53	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15915.7	B08		1	0019-0058	657.13	57.83	342	70.77	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12120.2	B08		1	0020-0061	258.75	61.24	390	73.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10514.7	B08		1	0021-0063	335.34	62.34	338	68.43	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11039.4	B08		1	0022-0062	630.45	62.65	266	64.28	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11500.5	B08		1	0023-0061	68.12	60.80	231	55.11	0.956
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13221.6	B08		1	0024-0069	569.59	69.83	433	81.26	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10696.9	B08		1	0025-0071	383.06	70.47	307	65.36	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11343.3	B08		1	0026-0072	533.10	71.85	285	67.60	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9485.9	B08		1	0027-0075	85.61	75.59	300	66.18	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11140.6	B08		1	0028-0072	179.49	71.47	229	60.28	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10609.3	B08		1	0029-0075	115.54	75.69	250	60.53	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11428.2	B08		1	0030-0081	364.92	80.88	146	47.46	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11543.6	B08		1	0031-0080	619.08	80.64	222	57.94	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11029.8	B08		1	0032-0081	759.36	80.85	245	58.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11173.4	B08		1	0033-0081	321.95	81.50	130	42.63	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13516.0	B08		1	0034-0088	460.95	87.74	314	66.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11269.6	B08		1	0035-0084	310.93	84.24	113	39.80	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10129.2	B08		1	0036-0090	175.85	90.55	267	61.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10540.4	B08		1	0037-0090	214.71	89.20	254	62.77	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9953.2	B08		1	0038-0092	424.90	91.91	289	65.01	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11585.3	B08		1	0039-0091	680.90	91.72	234	58.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9937.0	B08		1	0040-0094	944.76	95.13	265	65.01	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14857.3	B08		1	0041-0095	625.03	94.75	328	69.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11718.8	B08		1	0042-0103	829.16	103.44	270	62.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10398.9	B08		1	0043-0104	239.83	104.03	255	65.26	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14712.9	B08		1	0044-0104	882.82	104.11	328	67.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10076.4	B08		1	0045-0110	922.35	110.33	335	73.84	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11044.2	B08		1	0046-0109	293.74	110.26	248	62.77	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13231.8	B08		1	0047-0112	493.79	112.96	362	71.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12500.1	B08		1	0048-0114	778.16	114.52	464	84.43	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10764.7	B08		1	0049-0116	112.41	116.63	359	88.08	0.581
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11780.6	B08		1	0050-0116	259.31	115.12	221	56.77	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10771.7	B08		1	0051-0116	647.23	117.24	258	60.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11451.1	B08		1	0052-0117	677.05	116.66	246	60.77	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14424.2	B08		1	0053-0121	836.66	121.20	367	74.18	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9825.5	B08		1	0054-0122	164.49	121.49	263	63.01	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10746.5	B08		1	0055-0120	281.99	120.20	154	46.53	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10897.1	B08		1	0056-0125	949.09	125.05	224	54.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10468.8	B08		1	0057-0128	199.33	128.54	327	68.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13661.4	B08		1	0058-0126	268.66	127.47	256	63.50	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8680.2	B08		1	0059-0129	408.85	128.58	321	73.50	0.747
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11614.3	B08		1	0060-0132	426.69	132.76	233	57.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10405.7	B08		1	0061-0136	630.94	135.58	383	73.94	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11165.8	B08		1	0062-0137	26.05	136.99	233	57.60	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8846.8	B08		1	0063-0137	373.17	137.60	319	72.91	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15686.5	B08		1	0064-0139	329.68	138.96	328	66.18	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17158.0	B08		1	0065-0140	731.73	139.63	294	63.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13935.2	B08		1	0066-0148	178.70	148.16	375	71.84	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11196.9	B08		1	0067-0146	940.07	145.73	218	55.36	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10480.6	B08		1	0068-0149	527.48	149.03	352	71.60	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11496.3	B08		1	0069-0149	37.87	149.11	235	57.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11093.8	B08		1	0070-0150	469.38	149.40	312	67.11	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12114.5	B08		1	0071-0150	596.87	150.27	252	60.53	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9603.5	B08		1	0072-0152	796.78	151.98	299	66.18	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14895.9	B08		1	0073-0159	225.58	157.45	570	99.74	0.720
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10113.5	B08		1	0074-0155	282.20	154.87	260	62.18	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16920.2	B08		1	0075-0157	632.64	157.02	313	76.43	0.673
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12300.8	B08		1	0076-0158	153.69	157.45	204	55.70	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11895.4	B08		1	0077-0163	328.00	163.42	260	61.01	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11326.2	B08		1	0078-0163	125.94	162.81	221	58.77	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10735.1	B08		1	0079-0165	582.66	164.81	259	59.01	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13764.9	B08		1	0080-0168	806.15	168.59	186	50.28	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11106.2	B08		1	0081-0173	353.97	173.37	375	73.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13231.5	B08		1	0082-0176	393.44	175.46	308	66.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15834.5	B08		1	0083-0181	81.01	179.70	679	108.81	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12587.7	B08		1	0084-0181	37.82	180.94	317	68.67	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11303.4	B08		1	0085-0183	495.13	183.84	242	61.11	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10561.2	B08		1	0086-0186	183.20	185.11	281	70.77	0.705
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9505.2	B08		1	0087-0183	529.17	183.34	292	66.77	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16204.6	B08		1	0088-0188	592.87	187.56	324	71.26	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10507.6	B08		1	0089-0188	151.31	188.09	239	63.01	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10276.5	B08		1	0090-0186	472.32	186.20	273	62.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15328.3	B08		1	0091-0190	645.42	190.40	355	72.77	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10257.0	B08		1	0092-0189	740.53	189.40	262	61.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11748.8	B08		1	0093-0189	916.61	189.99	213	55.94	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12118.6	B08		1	0094-0199	661.63	199.51	212	54.53	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12133.8	B08		1	0095-0202	325.65	202.00	219	55.36	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13319.4	B08		1	0096-0203	781.21	202.87	198	52.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9881.4	B08		1	0097-0207	126.70	206.94	259	64.43	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10825.8	B08		1	0098-0208	842.96	208.21	277	62.53	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11702.1	B08		1	0099-0207	893.22	207.79	217	56.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10718.1	B08		1	0100-0211	47.78	209.92	245	71.84	0.597
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12804.7	B08		1	0101-0214	541.25	215.01	299	63.94	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14250.7	B08		1	0102-0214	757.81	214.78	388	73.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15491.3	B08		1	0103-0216	410.24	216.66	161	46.77	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10452.5	B08		1	0104-0223	491.65	222.90	275	63.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13041.2	B08		1	0105-0224	660.52	224.84	193	55.70	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12307.2	B08		1	0106-0227	19.25	227.66	223	54.77	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11496.3	B08		1	0107-0228	641.43	228.26	277	63.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10470.0	B08		1	0108-0230	932.04	229.58	285	68.67	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13615.1	B08		1	0109-0231	142.62	231.60	386	74.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11614.4	B08		1	0110-0230	561.73	229.80	229	55.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11162.7	B08		1	0111-0232	381.62	230.95	268	61.11	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10446.6	B08		1	0112-0230	462.01	230.23	249	61.11	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14073.8	B08		1	0113-0233	211.55	233.28	153	48.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16455.4	B08		1	0114-0243	589.35	243.57	309	68.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12308.1	B08		1	0115-0246	199.44	247.53	276	74.43	0.626
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14762.1	B08		1	0116-0244	317.01	244.90	203	53.11	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14279.0	B08		1	0117-0248	76.81	248.53	326	67.01	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14556.9	B08		1	0118-0247	524.13	246.74	325	66.18	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10769.2	B08		1	0119-0247	711.89	247.02	255	60.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13878.6	B08		1	0120-0248	409.52	248.96	336	67.60	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13208.7	B08		1	0121-0249	739.54	249.33	291	62.18	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9894.4	B08		1	0122-0250	840.18	251.21	283	64.43	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12178.9	B08		1	0123-0247	102.44	248.22	225	58.28	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15987.9	B08		1	0124-0252	47.31	252.01	327	67.26	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13005.0	B08		1	0125-0251	779.24	251.24	413	77.84	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11761.4	B08		1	0126-0257	151.50	256.98	248	61.36	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12558.7	B08		1	0127-0260	804.47	259.44	328	74.18	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12036.4	B08		1	0128-0261	359.21	260.93	227	57.94	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13131.4	B08		1	0129-0264	229.84	263.90	281	63.94	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11062.1	B08		1	0130-0263	576.99	262.76	251	59.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15943.3	B08		1	0131-0263	342.33	262.78	170	48.28	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10057.7	B08		1	0132-0265	453.23	264.74	269	63.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11148.7	B08		1	0133-0267	184.02	266.99	243	60.53	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16943.0	B08		1	0134-0271	400.65	271.07	303	64.43	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14948.6	B08		1	0135-0282	715.90	282.51	614	104.57	0.706
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10482.9	B08		1	0136-0278	136.40	278.88	316	67.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11414.4	B08		1	0137-0276	499.36	276.36	316	67.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12050.9	B08		1	0138-0278	325.49	278.13	242	57.11	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12886.7	B08		1	0139-0279	115.90	278.85	204	52.53	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13138.1	B08		1	0140-0280	248.03	279.94	274	63.70	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16370.8	B08		1	0141-0280	233.47	280.45	153	47.56	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12890.2	B08		1	0142-0283	831.39	284.12	232	58.77	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14258.1	B08		1	0143-0289	784.07	289.05	364	71.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12003.3	B08		1	0144-0285	871.41	284.96	211	56.04	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10758.0	B08		1	0145-0290	63.79	289.94	259	61.94	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10637.9	B08		1	0146-0294	198.94	293.80	275	68.77	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13395.8	B08		1	0147-0295	251.29	295.72	194	54.53	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10976.3	B08		1	0148-0293	442.69	293.36	247	58.28	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12949.4	B08		1	0149-0295	947.72	294.55	176	50.18	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11134.3	B08		1	0150-0299	539.19	299.01	298	64.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10770.5	B08		1	0151-0299	361.35	299.51	251	57.70	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10958.2	B08		1	0152-0298	577.27	297.82	248	60.53	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11971.8	B08		1	0153-0300	153.20	300.76	218	54.53	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11927.0	B08		1	0154-0304	861.89	303.83	366	74.53	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13269.6	B08		1	0155-0308	69.46	309.04	291	69.60	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11456.0	B08		1	0156-0307	940.82	307.36	244	61.60	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11583.9	B08		1	0157-0306	775.28	306.47	235	57.60	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11256.7	B08		1	0158-0309	925.21	309.35	226	56.28	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12012.0	B08		1	0159-0309	318.39	309.17	272	61.36	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13226.9	B08		1	0160-0314	651.65	313.60	420	79.50	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12445.3	B08		1	0161-0312	467.93	312.35	213	54.28	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9962.0	B08		1	0162-0317	437.95	317.77	267	64.53	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10686.3	B08		1	0163-0318	698.19	319.21	278	66.53	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13190.9	B08		1	0164-0322	42.02	322.21	328	67.94	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14878.0	B08		1	0165-0320	770.32	320.36	168	53.36	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13342.9	B08		1	0166-0327	754.43	327.63	324	66.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10823.7	B08		1	0167-0326	246.13	326.12	244	58.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10618.8	B08		1	0168-0330	596.47	330.76	289	65.60	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12164.4	B08		1	0169-0330	195.74	329.79	222	56.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12341.3	B08		1	0170-0331	512.72	332.12	223	57.11	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13000.6	B08		1	0171-0336	874.34	337.08	218	56.77	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13255.5	B08		1	0172-0340	922.60	340.37	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13915.7	B08		1	0173-0341	99.15	341.72	292	64.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12121.9	B08		1	0174-0341	120.32	340.55	219	53.11	0.976
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11900.0	B08		1	0175-0342	317.87	341.87	240	57.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12068.5	B08		1	0176-0344	477.32	345.31	233	58.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10095.2	B08		1	0177-0343	360.24	343.09	266	60.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14738.3	B08		1	0178-0348	187.38	348.07	297	64.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10641.4	B08		1	0179-0347	401.52	347.12	252	62.18	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11285.3	B08		1	0180-0348	451.21	348.03	240	59.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14374.3	B08		1	0181-0350	819.68	350.80	359	70.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10316.1	B08		1	0182-0357	235.83	357.38	253	60.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12442.9	B08		1	0183-0356	496.35	355.69	222	57.36	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13639.6	B08		1	0184-0358	158.02	357.54	284	62.43	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9937.8	B08		1	0185-0357	671.00	357.74	234	55.94	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13349.8	B08		1	0186-0359	721.04	359.92	342	71.84	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10398.8	B08		1	0187-0360	752.93	360.36	252	59.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13127.4	B08		1	0188-0365	470.68	365.36	211	57.36	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13987.3	B08		1	0189-0369	836.38	369.52	373	72.53	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13764.3	B08		1	0190-0368	510.44	367.95	374	72.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9998.9	B08		1	0191-0368	29.10	368.35	287	63.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16173.9	B08		1	0192-0368	85.72	368.45	306	65.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11568.0	B08		1	0193-0369	285.20	368.86	294	63.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12155.2	B08		1	0194-0369	644.13	368.90	224	53.70	0.976
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8841.8	B08		1	0195-0371	882.48	372.11	301	84.08	0.535
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17470.9	B08		1	0196-0372	342.42	372.83	297	62.43	0.958
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12676.7	B08		1	0197-0377	903.49	377.77	282	62.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11894.0	B08		1	0198-0382	236.02	382.05	232	61.01	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9954.6	B08		1	0199-0381	465.07	380.93	279	62.18	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10724.0	B08		1	0200-0382	422.53	381.58	245	57.01	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10552.9	B08		1	0201-0384	59.38	384.08	255	60.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10269.5	B08		1	0202-0382	204.75	382.54	279	65.60	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10550.8	B08		1	0203-0384	656.24	384.72	261	60.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8862.9	B08		1	0204-0387	568.05	386.72	328	69.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9946.0	B08		1	0205-0391	518.32	391.39	283	61.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13091.6	B08		1	0206-0390	169.49	389.75	206	54.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9400.5	B08		1	0207-0395	261.77	395.35	279	63.60	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10237.3	B08		1	0208-0395	803.93	394.56	282	63.94	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9885.8	B08		1	0209-0397	83.60	397.43	279	63.36	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13641.9	B08		1	0210-0404	36.94	403.87	278	63.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10599.7	B08		1	0211-0407	730.02	407.84	315	66.18	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8861.7	B08		1	0212-0408	843.73	407.57	293	64.18	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9617.1	B08		1	0213-0410	440.38	410.24	296	63.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8425.2	B08		1	0214-0410	550.82	411.36	275	66.43	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13428.4	B08		1	0215-0413	243.15	413.15	243	60.18	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10198.5	B08		1	0216-0413	516.77	413.09	281	62.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11967.7	B08		1	0217-0413	808.27	412.54	221	53.94	0.954
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13128.2	B08		1	0218-0414	919.87	414.30	185	55.60	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13377.1	B08		1	0219-0416	79.17	416.04	377	71.94	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11048.5	B08		1	0220-0418	163.55	418.03	252	61.36	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11897.6	B08		1	0221-0421	785.55	421.04	344	69.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11168.2	B08		1	0222-0422	409.14	422.85	249	63.01	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10894.3	B08		1	0223-0423	497.98	423.57	253	59.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11805.3	B08		1	0224-0424	532.48	424.18	237	58.04	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12656.1	B08		1	0225-0424	26.41	423.48	304	69.01	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17648.7	B08		1	0226-0426	354.97	425.99	314	67.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14861.8	B08		1	0227-0423	871.09	422.31	179	50.87	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12316.5	B08		1	0228-0427	250.22	427.44	230	57.70	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11353.5	B08		1	0229-0430	206.78	429.65	150	48.28	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12815.9	B08		1	0230-0433	719.33	433.69	222	55.70	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12904.3	B08		1	0231-0434	267.33	434.36	214	54.28	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11441.1	B08		1	0232-0437	480.58	437.58	240	60.18	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14724.4	B08		1	0233-0440	939.21	439.67	353	68.18	0.954
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17043.8	B08		1	0234-0439	609.39	439.19	305	65.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14112.7	B08		1	0235-0441	87.56	441.59	397	78.77	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14353.7	B08		1	0236-0444	313.31	444.10	226	55.60	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13231.5	B08		1	0237-0449	566.89	449.14	471	87.74	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10733.4	B08		1	0238-0447	895.02	446.89	305	64.18	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11460.5	B08		1	0239-0451	447.93	451.30	249	59.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13519.3	B08		1	0240-0452	203.76	451.83	338	69.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11131.0	B08		1	0241-0452	707.34	452.53	248	58.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9470.9	B08		1	0242-0455	138.82	455.82	272	61.11	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11012.6	B08		1	0243-0455	169.80	454.52	249	57.94	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11601.7	B08		1	0244-0455	764.11	454.42	229	57.60	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10563.7	B08		1	0245-0460	338.08	460.12	261	59.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10972.4	B08		1	0246-0458	522.70	457.57	260	71.36	0.642
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11321.1	B08		1	0247-0462	684.36	462.23	245	58.53	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17652.9	B08		1	0248-0461	929.63	463.41	105	54.28	0.448
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11576.7	B08		1	0249-0463	266.08	463.29	234	56.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12011.8	B08		1	0250-0462	371.30	462.35	222	54.28	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10968.4	B08		1	0251-0465	192.92	465.25	236	56.77	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11791.6	B08		1	0252-0469	19.74	469.00	232	58.18	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11080.0	B08		1	0253-0468	56.76	468.68	245	59.70	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16048.6	B08		1	0254-0473	454.50	473.71	359	71.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9826.0	B08		1	0255-0471	784.17	470.63	284	63.01	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9584.5	B08		1	0256-0471	889.75	471.18	283	62.28	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18340.2	B08		1	0257-0476	110.21	476.73	284	80.67	0.548
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12960.9	B08		1	0258-0477	231.35	477.52	324	67.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13770.8	B08		1	0259-0477	939.35	477.30	305	64.18	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14030.6	B08		1	0260-0489	638.05	489.37	596	101.64	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12618.7	B08		1	0261-0485	756.79	486.02	376	71.84	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10077.9	B08		1	0262-0487	288.53	487.51	264	65.01	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11025.2	B08		1	0263-0486	314.59	485.45	245	59.94	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9605.0	B08		1	0264-0485	553.80	484.53	283	67.36	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10364.8	B08		1	0265-0484	369.54	483.67	268	64.28	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13292.2	B08		1	0266-0491	519.97	491.55	338	72.67	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13009.7	B08		1	0267-0497	99.83	497.16	370	71.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9589.9	B08		1	0268-0498	409.74	499.31	354	71.01	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9082.4	B08		1	0269-0498	872.62	499.24	184	54.18	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11751.0	B08		1	0270-0500	148.78	500.06	228	57.36	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10457.3	B08		1	0271-0503	468.71	503.63	320	68.43	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13772.5	B08		1	0272-0503	77.11	502.93	272	61.11	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9633.5	B08		1	0273-0505	268.93	504.90	270	68.43	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11684.8	B08		1	0274-0509	305.30	509.88	233	57.94	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16189.7	B08		1	0275-0517	207.07	517.49	344	71.01	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9598.8	B08		1	0276-0519	598.46	519.13	290	66.43	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11681.5	B08		1	0277-0518	854.85	517.24	228	61.11	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11279.0	B08		1	0278-0521	933.70	520.66	393	76.43	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11113.0	B08		1	0279-0520	166.61	520.71	241	58.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14240.6	B08		1	0280-0521	238.19	521.80	373	71.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12842.5	B08		1	0281-0521	411.27	521.04	435	79.26	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9434.9	B08		1	0282-0526	563.97	525.63	293	69.01	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10980.0	B08		1	0283-0522	34.32	522.15	220	58.77	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10895.0	B08		1	0284-0523	332.36	523.14	263	59.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11650.3	B08		1	0285-0523	894.77	523.05	222	57.94	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9712.1	B08		1	0286-0527	122.79	526.75	271	60.53	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8204.4	B08		1	0287-0530	535.34	531.28	286	74.67	0.645
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10652.6	B08		1	0288-0525	792.52	525.08	151	48.53	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12486.6	B08		1	0289-0529	377.36	529.29	221	54.53	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12282.2	B08		1	0290-0532	22.59	531.68	118	40.63	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16028.2	B08		1	0291-0534	849.54	533.57	281	64.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8849.6	B08		1	0292-0538	758.80	536.71	288	66.18	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11410.3	B08		1	0293-0538	190.19	539.06	304	68.43	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9859.5	B08		1	0294-0538	155.18	538.33	266	59.94	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8785.2	B08		1	0295-0540	274.52	540.55	302	67.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11427.4	B08		1	0296-0539	584.34	539.26	237	58.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11857.4	B08		1	0297-0541	34.95	541.02	186	53.11	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13395.3	B08		1	0298-0540	246.64	540.12	226	56.28	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11801.8	B08		1	0299-0540	619.66	540.31	228	56.28	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13420.4	B08		1	0300-0546	430.62	546.55	216	53.70	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10802.9	B08		1	0301-0550	48.08	551.22	273	61.11	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14002.8	B08		1	0302-0555	646.66	554.99	394	76.43	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9715.6	B08		1	0303-0551	880.94	551.27	291	63.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14251.2	B08		1	0304-0553	813.38	553.13	188	52.53	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12454.5	B08		1	0305-0557	216.26	557.91	246	60.53	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14875.6	B08		1	0306-0557	115.55	556.04	350	73.01	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12099.2	B08		1	0307-0557	241.89	557.57	344	69.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15593.0	B08		1	0308-0559	407.13	559.18	323	69.01	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11899.5	B08		1	0309-0560	168.93	559.78	333	71.50	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11007.8	B08		1	0310-0556	922.23	556.72	246	58.87	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13830.6	B08		1	0311-0559	458.31	559.38	200	54.53	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11824.5	B08		1	0312-0561	942.12	561.30	280	61.70	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9049.4	B08		1	0313-0565	523.32	564.27	301	67.94	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8933.4	B08		1	0314-0566	762.34	565.33	293	71.50	0.720
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14144.4	B08		1	0315-0564	798.47	565.28	374	85.84	0.638
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11709.5	B08		1	0316-0567	437.78	566.43	249	59.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13616.3	B08		1	0317-0573	192.43	574.30	411	84.33	0.726
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9923.0	B08		1	0318-0569	601.57	568.93	289	69.26	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14979.3	B08		1	0319-0570	381.08	570.75	320	65.60	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11537.1	B08		1	0320-0576	233.09	576.66	252	63.36	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17882.0	B08		1	0321-0575	697.19	575.95	224	56.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14992.3	B08		1	0322-0580	545.77	580.03	344	71.60	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9160.5	B08		1	0323-0577	251.94	576.50	225	55.36	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11566.8	B08		1	0324-0581	58.38	582.52	240	63.60	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9880.0	B08		1	0325-0583	630.98	583.13	273	65.01	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11368.0	B08		1	0326-0585	565.54	585.96	451	83.01	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10175.9	B08		1	0327-0581	463.23	580.17	265	65.11	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12586.9	B08		1	0328-0585	265.66	585.19	263	65.01	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11357.9	B08		1	0329-0588	28.86	587.78	250	61.26	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14938.3	B08		1	0330-0593	115.61	594.13	357	70.18	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10490.3	B08		1	0331-0591	593.95	590.81	268	66.67	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13351.0	B08		1	0332-0591	143.19	591.45	241	57.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10666.6	B08		1	0333-0592	225.25	592.21	260	62.53	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9823.5	B08		1	0334-0594	384.87	594.79	297	66.18	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14406.7	B08		1	0335-0597	284.93	597.01	365	71.26	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11881.5	B08		1	0336-0594	674.84	594.10	229	56.53	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15619.9	B08		1	0337-0592	712.12	592.96	178	51.21	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9668.6	B08		1	0338-0605	414.43	604.17	293	66.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12115.1	B08		1	0339-0605	806.30	605.10	223	55.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12156.0	B08		1	0340-0607	592.13	607.88	231	55.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11441.8	B08		1	0341-0609	744.09	608.82	287	62.77	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10757.8	B08		1	0342-0611	273.89	611.90	251	60.77	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10795.7	B08		1	0343-0612	849.76	611.86	288	65.01	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14180.6	B08		1	0344-0613	153.75	612.82	195	55.36	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11781.2	B08		1	0345-0614	302.75	614.32	232	55.70	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10730.4	B08		1	0346-0616	76.07	616.27	260	59.94	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13729.3	B08		1	0347-0618	198.86	617.72	200	57.60	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15594.0	B08		1	0348-0616	901.75	616.17	251	59.94	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10819.3	B08		1	0349-0620	479.57	620.33	262	63.01	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15868.5	B08		1	0350-0619	681.57	619.71	274	61.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16175.2	B08		1	0351-0623	362.48	623.47	330	71.36	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11007.1	B08		1	0352-0630	892.17	629.37	254	61.01	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10372.4	B08		1	0353-0630	162.83	629.67	272	62.53	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13604.7	B08		1	0354-0629	806.37	629.13	187	53.70	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15715.9	B08		1	0355-0635	848.75	635.77	360	72.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9588.2	B08		1	0356-0634	489.75	634.91	317	71.84	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11178.0	B08		1	0357-0634	93.78	634.92	259	59.60	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13641.3	B08		1	0358-0636	243.32	636.51	374	72.67	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13238.0	B08		1	0359-0638	562.17	638.24	302	63.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11465.4	B08		1	0360-0642	508.02	640.75	239	59.60	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9989.3	B08		1	0361-0644	63.05	643.58	112	40.28	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11766.3	B08		1	0362-0644	693.93	644.85	228	56.87	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10200.0	B08		1	0363-0647	734.79	647.28	278	62.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11838.0	B08		1	0364-0650	783.99	651.00	192	58.53	0.704
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10828.8	B08		1	0365-0650	313.67	650.57	254	60.77	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10428.8	B08		1	0366-0649	401.23	648.55	262	61.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17117.1	B08		1	0367-0653	199.09	653.50	315	65.60	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12119.4	B08		1	0368-0653	447.88	652.57	345	68.77	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10733.2	B08		1	0369-0651	74.63	651.70	142	47.11	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18054.9	B08		1	0370-0663	237.20	663.32	593	97.98	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10208.6	B08		1	0371-0654	359.27	653.72	266	61.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10667.0	B08		1	0372-0659	46.25	659.41	273	61.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14662.0	B08		1	0373-0661	180.10	661.22	361	70.43	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10115.0	B08		1	0374-0661	327.81	660.85	284	63.01	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11944.3	B08		1	0375-0662	546.66	662.74	419	79.01	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10072.7	B08		1	0376-0664	121.03	664.38	276	64.18	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11618.8	B08		1	0377-0664	659.96	664.11	233	56.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10949.4	B08		1	0378-0665	939.18	664.58	280	64.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10240.0	B08		1	0379-0673	144.32	672.28	278	65.01	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18981.7	B08		1	0380-0675	705.98	673.83	168	59.94	0.588
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13275.2	B08		1	0381-0680	166.68	679.72	399	75.84	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11024.2	B08		1	0382-0679	285.98	678.49	255	61.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10594.3	B08		1	0383-0685	536.72	684.90	266	62.53	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12024.4	B08		1	0384-0684	365.64	683.42	216	57.36	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11860.9	B08		1	0385-0685	615.32	684.80	227	56.28	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11792.4	B08		1	0386-0686	309.17	686.79	228	56.28	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11107.0	B08		1	0387-0688	428.60	688.45	236	58.53	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17655.7	B08		1	0388-0688	264.40	688.51	320	67.11	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15126.7	B08		1	0389-0693	352.59	693.35	387	80.91	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16977.9	B08		1	0390-0688	916.93	687.99	140	47.11	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10902.5	B08		1	0391-0691	104.52	691.01	261	62.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10789.1	B08		1	0392-0693	133.18	692.16	261	63.70	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10162.1	B08		1	0393-0693	653.79	693.70	266	61.60	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16805.8	B08		1	0394-0693	720.47	693.60	320	65.84	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12784.5	B08		1	0395-0697	50.81	697.15	422	77.26	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11807.4	B08		1	0396-0697	878.17	697.43	330	67.01	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14071.6	B08		1	0397-0697	926.54	697.25	159	47.70	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11563.3	B08		1	0398-0698	944.56	697.57	170	51.11	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8860.4	B08		1	0399-0703	691.43	704.31	281	67.26	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10602.3	B08		1	0400-0706	315.64	706.08	250	63.01	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10944.9	B08		1	0401-0708	492.58	708.06	259	65.01	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12149.5	B08		1	0402-0710	415.79	710.17	212	52.87	0.953
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185107	1375309	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10780.1	B08		1	0403-0710	233.22	710.48	313	67.11	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12501.0	B08		2	0001-0029	259.68	29.83	527	96.57	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12261.1	B08		2	0002-0033	541.09	33.64	296	71.01	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11710.2	B08		2	0003-0034	151.54	34.40	223	55.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14374.0	B08		2	0004-0036	220.81	37.59	352	74.67	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12322.0	B08		2	0005-0036	793.54	36.16	268	61.11	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9852.8	B08		2	0006-0036	936.35	36.88	247	59.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11082.0	B08		2	0007-0038	126.12	39.14	253	58.53	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15510.3	B08		2	0008-0039	584.93	39.38	349	71.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9423.4	B08		2	0009-0042	767.09	42.65	281	62.53	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9948.1	B08		2	0010-0042	828.89	42.74	279	65.60	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11886.5	B08		2	0011-0049	53.05	49.74	437	85.26	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13877.1	B08		2	0012-0047	919.83	46.92	347	72.08	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13749.1	B08		2	0013-0046	639.79	45.79	330	68.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11551.4	B08		2	0014-0047	96.27	48.60	394	79.26	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15190.3	B08		2	0015-0048	735.18	48.81	336	69.01	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10376.4	B08		2	0016-0061	412.86	62.80	586	130.95	0.429
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10258.4	B08		2	0017-0052	199.96	51.48	256	60.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11144.9	B08		2	0018-0058	900.74	58.85	226	57.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11205.7	B08		2	0019-0060	248.56	59.83	237	58.87	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10219.0	B08		2	0020-0067	388.09	66.98	509	92.33	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9832.4	B08		2	0021-0062	828.67	62.91	291	70.18	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12440.9	B08		2	0022-0068	511.07	68.64	316	64.53	0.954
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13567.4	B08		2	0023-0071	734.71	70.64	328	67.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12975.5	B08		2	0024-0068	932.37	68.17	302	64.53	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12487.9	B08		2	0025-0072	673.71	72.26	200	52.53	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13371.3	B08		2	0026-0078	847.67	78.25	315	66.18	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8378.5	B08		2	0027-0081	341.98	81.08	352	81.84	0.660
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12080.9	B08		2	0028-0086	225.89	85.71	231	56.53	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8231.4	B08		2	0029-0093	68.18	93.30	308	80.08	0.603
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12280.5	B08		2	0030-0090	920.38	89.70	417	77.50	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11034.0	B08		2	0031-0089	162.29	89.72	246	60.43	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13722.3	B08		2	0032-0093	563.27	93.05	241	57.70	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16153.6	B08		2	0033-0096	697.39	95.95	324	66.43	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9927.2	B08		2	0034-0098	37.60	98.62	268	66.18	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11404.8	B08		2	0035-0097	782.11	98.03	395	73.26	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10945.1	B08		2	0036-0095	830.61	94.67	292	64.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8197.2	B08		2	0037-0095	141.99	95.57	298	73.26	0.698
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12124.1	B08		2	0038-0097	604.69	97.28	212	55.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9126.1	B08		2	0039-0102	647.74	101.72	272	61.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11827.1	B08		2	0040-0105	174.15	103.92	313	73.50	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11483.5	B08		2	0041-0104	294.08	103.98	338	70.18	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10894.8	B08		2	0042-0104	885.71	105.02	275	63.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11543.3	B08		2	0043-0114	713.14	113.75	286	61.94	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10297.3	B08		2	0044-0114	828.93	114.14	248	58.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9225.8	B08		2	0045-0119	450.89	118.43	288	67.01	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7768.2	B08		2	0046-0122	931.96	121.35	274	80.57	0.530
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11502.4	B08		2	0047-0123	516.32	123.01	286	63.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11704.6	B08		2	0048-0122	563.25	122.04	263	59.11	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9824.0	B08		2	0049-0128	97.77	128.00	262	60.53	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10915.1	B08		2	0050-0129	42.10	128.79	231	55.36	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10657.3	B08		2	0051-0128	207.62	128.42	259	59.60	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11993.3	B08		2	0052-0133	604.70	133.19	360	70.43	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10642.5	B08		2	0053-0130	759.25	130.71	251	58.18	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12062.0	B08		2	0054-0136	72.94	136.44	208	54.28	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10643.8	B08		2	0055-0137	550.32	136.78	274	61.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12263.2	B08		2	0056-0137	777.44	137.14	222	55.11	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12352.1	B08		2	0057-0137	794.18	136.40	218	53.70	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11779.3	B08		2	0058-0145	727.37	145.32	444	78.18	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11173.2	B08		2	0059-0142	874.27	142.34	224	55.36	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10276.1	B08		2	0060-0144	934.42	143.85	249	58.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8701.4	B08		2	0061-0148	155.76	148.52	292	65.84	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11115.4	B08		2	0062-0149	33.25	149.15	222	54.77	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10607.5	B08		2	0063-0150	106.39	149.81	237	57.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12684.3	B08		2	0064-0155	200.80	155.72	393	73.60	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10559.0	B08		2	0065-0155	471.21	154.30	254	59.01	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10125.2	B08		2	0066-0154	558.32	154.44	292	63.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16329.8	B08		2	0067-0154	254.47	153.92	308	67.36	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12624.8	B08		2	0068-0160	620.04	160.01	404	74.43	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14477.1	B08		2	0069-0164	917.28	164.36	356	70.43	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11663.4	B08		2	0070-0164	175.67	164.23	215	55.36	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12783.1	B08		2	0071-0167	665.68	166.85	405	73.94	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10374.8	B08		2	0072-0167	497.26	168.27	252	60.53	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11283.3	B08		2	0073-0168	67.29	167.45	226	57.70	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12922.4	B08		2	0074-0170	262.45	170.60	324	66.18	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13175.5	B08		2	0075-0172	753.94	172.38	431	78.91	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9308.8	B08		2	0076-0173	146.52	173.59	272	67.01	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14951.0	B08		2	0077-0178	596.57	178.25	306	65.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15260.8	B08		2	0078-0182	240.50	181.00	298	71.26	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10982.9	B08		2	0079-0182	734.11	182.39	234	58.53	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10270.6	B08		2	0080-0185	187.08	185.78	241	57.70	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9639.6	B08		2	0081-0186	122.92	186.07	343	74.67	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12233.5	B08		2	0082-0188	225.70	188.67	261	62.53	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13346.0	B08		2	0083-0191	677.56	192.15	364	71.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10715.0	B08		2	0084-0189	840.43	189.39	214	53.94	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12568.6	B08		2	0085-0194	563.06	194.27	385	72.18	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13325.9	B08		2	0086-0199	890.42	197.48	769	109.64	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12510.9	B08		2	0087-0193	258.30	193.27	200	52.77	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13358.6	B08		2	0088-0195	501.35	195.42	397	73.84	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15140.3	B08		2	0089-0203	329.23	203.08	327	67.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10745.8	B08		2	0090-0201	414.67	201.15	261	61.11	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11197.8	B08		2	0091-0203	943.10	202.94	298	63.36	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13672.8	B08		2	0092-0208	723.00	207.81	312	66.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10409.1	B08		2	0093-0208	386.86	207.98	248	58.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14912.2	B08		2	0094-0215	917.90	216.26	350	78.43	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12253.4	B08		2	0095-0213	164.52	213.57	360	71.01	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14610.9	B08		2	0096-0210	456.56	209.86	212	53.60	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11689.1	B08		2	0097-0211	269.62	210.63	212	55.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9288.0	B08		2	0098-0211	832.42	210.58	239	59.70	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13167.5	B08		2	0099-0217	693.56	217.43	398	75.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11612.5	B08		2	0100-0214	756.57	214.54	358	71.01	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11363.9	B08		2	0101-0219	443.84	218.95	289	65.60	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9955.0	B08		2	0102-0222	496.94	222.16	260	62.77	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11858.8	B08		2	0103-0228	869.43	228.89	429	80.91	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10141.4	B08		2	0104-0228	674.85	228.32	255	59.94	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10267.4	B08		2	0105-0234	25.12	233.33	292	68.43	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17890.2	B08		2	0106-0234	179.97	233.59	273	62.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17055.9	B08		2	0107-0231	759.55	230.71	145	45.56	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16976.4	B08		2	0108-0232	746.58	232.09	152	44.63	0.959
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12323.4	B08		2	0109-0240	201.34	240.69	354	69.60	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10098.5	B08		2	0110-0242	934.14	243.11	233	57.70	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9439.8	B08		2	0111-0246	816.39	245.60	275	63.84	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13452.3	B08		2	0112-0247	365.66	247.19	372	74.91	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10342.9	B08		2	0113-0249	780.40	249.74	260	63.01	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14045.9	B08		2	0114-0249	297.44	249.34	298	63.36	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13166.6	B08		2	0115-0256	481.04	256.10	403	83.74	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13239.8	B08		2	0116-0254	250.33	253.89	294	62.18	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13646.5	B08		2	0117-0253	66.16	253.85	295	64.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12098.3	B08		2	0118-0252	126.71	252.34	209	53.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13669.0	B08		2	0119-0259	149.90	258.96	393	73.60	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14784.5	B08		2	0120-0256	537.78	256.26	177	50.28	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15168.1	B08		2	0121-0260	519.45	260.14	348	75.84	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14743.8	B08		2	0122-0259	871.05	259.54	336	67.94	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12348.7	B08		2	0123-0261	412.65	261.32	297	64.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13192.8	B08		2	0124-0260	934.80	260.40	352	73.94	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11876.1	B08		2	0125-0264	282.78	263.77	217	55.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10982.9	B08		2	0126-0264	376.20	263.74	338	74.08	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16009.8	B08		2	0127-0265	343.44	265.30	320	66.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11874.8	B08		2	0128-0269	75.62	269.45	217	57.36	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15110.8	B08		2	0129-0270	241.05	269.89	292	63.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9619.7	B08		2	0130-0273	432.94	273.97	335	74.43	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10333.9	B08		2	0131-0274	761.98	273.08	264	64.53	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11538.8	B08		2	0132-0271	195.98	272.06	227	57.11	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10235.2	B08		2	0133-0274	687.54	274.55	410	79.60	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13843.5	B08		2	0134-0275	830.69	275.44	266	59.94	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10989.4	B08		2	0135-0277	718.89	277.48	276	60.77	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10979.8	B08		2	0136-0281	935.66	281.24	230	56.28	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9888.8	B08		2	0137-0286	67.07	286.17	261	64.18	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12042.8	B08		2	0138-0280	280.48	280.84	127	40.97	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11823.7	B08		2	0139-0289	85.91	287.86	217	55.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14322.9	B08		2	0140-0289	152.32	289.26	336	71.84	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11756.4	B08		2	0141-0293	537.38	292.84	374	74.18	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9363.5	B08		2	0142-0292	678.60	291.79	270	61.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10719.6	B08		2	0143-0296	882.82	296.27	234	59.11	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11465.4	B08		2	0144-0293	280.31	292.82	140	42.63	0.968
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12969.6	B08		2	0145-0298	40.65	298.33	181	49.94	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13957.2	B08		2	0146-0298	168.05	298.25	178	50.04	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12230.4	B08		2	0147-0303	768.05	302.95	314	67.84	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9397.5	B08		2	0148-0306	818.96	306.25	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12438.4	B08		2	0149-0306	550.67	305.06	341	76.67	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9831.1	B08		2	0150-0306	208.60	307.31	266	62.53	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11225.8	B08		2	0151-0311	33.99	311.18	233	60.18	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12901.1	B08		2	0152-0309	289.20	309.28	199	53.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11126.3	B08		2	0153-0312	18.54	312.73	229	55.70	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12540.6	B08		2	0154-0314	258.62	313.18	237	56.77	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13533.3	B08		2	0155-0313	347.76	313.31	209	54.04	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13378.5	B08		2	0156-0312	363.62	311.97	194	53.46	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10844.8	B08		2	0157-0321	490.22	320.56	399	77.84	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11888.2	B08		2	0158-0323	747.11	323.03	315	69.60	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10163.3	B08		2	0159-0324	590.58	323.80	257	62.28	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14132.3	B08		2	0160-0325	105.60	325.09	308	65.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12946.4	B08		2	0161-0327	604.71	327.85	195	52.63	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10891.8	B08		2	0162-0330	370.30	330.08	241	59.36	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9714.9	B08		2	0163-0331	246.12	331.06	328	68.77	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11812.0	B08		2	0164-0335	620.25	335.80	228	57.94	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14624.3	B08		2	0165-0338	914.11	337.65	337	69.26	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10497.9	B08		2	0166-0335	393.51	335.78	105	38.63	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16243.8	B08		2	0167-0337	227.09	336.83	153	45.11	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10932.2	B08		2	0168-0339	382.31	339.19	161	47.46	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9242.9	B08		2	0169-0342	57.86	342.30	285	70.77	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10021.0	B08		2	0170-0343	99.70	343.97	255	59.94	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9500.1	B08		2	0171-0346	464.96	346.86	304	68.77	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10817.9	B08		2	0172-0350	422.90	350.26	367	74.43	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10047.8	B08		2	0173-0355	124.11	355.02	258	62.67	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10840.7	B08		2	0174-0361	929.03	360.97	564	97.98	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10568.4	B08		2	0175-0356	543.50	355.84	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13179.9	B08		2	0176-0356	230.26	356.87	241	58.28	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11197.7	B08		2	0177-0359	656.85	359.38	304	65.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9564.6	B08		2	0178-0360	177.76	360.20	279	62.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12557.3	B08		2	0179-0359	626.60	359.51	217	54.28	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9174.2	B08		2	0180-0362	749.40	362.25	293	65.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11464.9	B08		2	0181-0365	65.16	364.96	220	57.94	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11369.2	B08		2	0182-0361	295.52	360.80	227	58.87	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13542.9	B08		2	0183-0367	321.79	367.32	204	54.53	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14386.0	B08		2	0184-0372	494.01	372.56	361	73.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12222.7	B08		2	0185-0380	438.30	380.98	434	80.33	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11480.6	B08		2	0186-0377	680.65	377.04	328	67.70	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10262.2	B08		2	0187-0378	885.68	377.64	448	79.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13000.3	B08		2	0188-0377	155.27	378.24	193	51.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11871.4	B08		2	0189-0382	203.77	382.92	217	64.08	0.664
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10185.0	B08		2	0190-0383	47.43	383.61	293	65.84	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8247.1	B08		2	0191-0389	360.18	390.60	317	79.84	0.625
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11040.2	B08		2	0192-0383	725.92	383.52	256	62.28	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15359.0	B08		2	0193-0393	183.07	392.87	351	71.84	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14269.1	B08		2	0194-0395	779.94	395.27	248	57.36	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11768.6	B08		2	0195-0398	88.89	398.15	280	63.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9903.5	B08		2	0196-0404	140.56	404.60	305	65.36	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14528.7	B08		2	0197-0408	229.43	408.85	175	51.70	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8278.7	B08		2	0198-0413	464.92	411.27	358	79.84	0.706
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9662.8	B08		2	0199-0413	926.13	412.15	263	61.70	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12988.6	B08		2	0200-0412	870.18	412.74	200	51.70	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10537.4	B08		2	0201-0419	156.19	419.70	250	65.36	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13065.9	B08		2	0202-0419	668.32	417.98	380	76.67	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10326.8	B08		2	0203-0421	113.25	420.36	310	69.84	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13001.5	B08		2	0204-0421	619.70	420.79	195	53.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8180.7	B08		2	0205-0422	731.26	421.55	354	80.91	0.680
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16128.1	B08		2	0206-0422	58.16	422.39	308	66.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8857.0	B08		2	0207-0424	694.88	425.02	328	69.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10470.2	B08		2	0208-0430	509.50	430.00	397	78.67	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12028.5	B08		2	0209-0430	238.31	430.70	262	64.43	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13928.5	B08		2	0210-0434	99.29	433.29	399	81.74	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15970.4	B08		2	0211-0432	192.14	432.66	306	64.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11605.7	B08		2	0212-0433	630.83	432.85	278	61.60	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11378.4	B08		2	0213-0434	768.89	433.81	220	57.46	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11822.9	B08		2	0214-0435	782.32	434.83	214	54.63	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10934.0	B08		2	0215-0442	809.55	442.16	233	61.11	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14564.9	B08		2	0216-0443	32.31	443.20	349	69.01	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11534.4	B08		2	0217-0446	937.21	447.18	437	81.26	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11069.2	B08		2	0218-0440	881.26	440.24	239	59.11	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9682.2	B08		2	0219-0442	399.14	441.87	294	65.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12630.6	B08		2	0220-0443	117.82	442.56	192	53.11	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12687.4	B08		2	0221-0451	573.60	451.88	375	84.08	0.667
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10681.3	B08		2	0222-0455	172.70	455.66	538	97.15	0.716
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10874.2	B08		2	0223-0447	159.35	447.29	107	39.11	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9606.9	B08		2	0224-0452	504.40	453.06	294	70.43	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11956.2	B08		2	0225-0451	248.87	451.17	219	59.70	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9948.3	B08		2	0226-0460	434.28	461.51	361	74.91	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10065.2	B08		2	0227-0453	465.39	453.60	198	58.63	0.724
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10527.3	B08		2	0228-0457	762.01	457.02	269	63.36	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11722.8	B08		2	0229-0458	127.88	457.68	242	60.18	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12249.0	B08		2	0230-0458	310.68	458.39	250	59.11	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13097.9	B08		2	0231-0464	534.43	464.78	362	73.84	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17504.0	B08		2	0232-0465	15.86	463.09	121	65.11	0.359
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10514.6	B08		2	0233-0469	221.42	470.41	351	69.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15153.1	B08		2	0234-0470	858.17	471.00	295	63.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16783.3	B08		2	0235-0474	776.93	473.51	149	46.87	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13744.7	B08		2	0236-0481	32.34	481.04	295	63.36	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10674.5	B08		2	0237-0480	596.84	479.91	259	59.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14336.0	B08		2	0238-0481	712.94	481.18	237	56.28	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11173.7	B08		2	0239-0481	811.78	481.81	243	57.36	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12100.3	B08		2	0240-0482	346.62	482.36	157	46.87	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11902.8	B08		2	0241-0485	334.30	485.46	209	58.04	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7636.6	B08		2	0242-0487	401.77	486.60	330	85.98	0.561
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18318.3	B08		2	0243-0484	794.52	484.85	134	44.04	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11576.3	B08		2	0244-0490	268.59	489.77	219	55.70	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10144.8	B08		2	0245-0495	739.34	495.18	514	90.91	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8801.5	B08		2	0246-0489	873.21	488.82	152	47.70	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12571.8	B08		2	0247-0496	912.94	496.14	442	88.57	0.708
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10340.5	B08		2	0248-0498	569.45	497.41	356	72.77	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10033.4	B08		2	0249-0496	153.46	496.54	305	63.36	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12674.0	B08		2	0250-0496	181.71	495.69	317	65.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10712.7	B08		2	0251-0495	689.16	495.01	254	63.36	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8811.1	B08		2	0252-0495	883.61	495.94	150	46.28	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11703.5	B08		2	0253-0508	654.92	508.22	408	73.94	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11048.0	B08		2	0254-0509	417.01	509.34	242	57.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9068.4	B08		2	0255-0512	221.16	512.13	295	65.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13083.6	B08		2	0256-0512	503.00	512.88	347	68.18	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8869.2	B08		2	0257-0517	108.91	517.87	304	71.26	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11861.7	B08		2	0258-0518	598.24	518.38	446	79.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11024.6	B08		2	0259-0519	266.95	518.57	261	62.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10305.4	B08		2	0260-0516	810.10	516.24	257	60.53	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11935.9	B08		2	0261-0516	901.90	515.64	216	56.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11767.7	B08		2	0262-0520	54.58	519.61	347	69.26	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13325.1	B08		2	0263-0517	693.80	518.29	260	60.28	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10968.6	B08		2	0264-0524	26.70	524.17	391	76.77	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9352.4	B08		2	0265-0524	292.11	523.96	313	66.18	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9192.0	B08		2	0266-0527	129.44	527.45	284	64.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13142.9	B08		2	0267-0528	464.51	528.09	334	68.08	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11983.9	B08		2	0268-0527	331.11	526.84	215	55.94	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9449.5	B08		2	0269-0529	767.18	529.22	288	65.11	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12962.4	B08		2	0270-0535	741.89	534.71	357	70.08	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8528.2	B08		2	0271-0534	170.99	534.05	301	68.77	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11699.6	B08		2	0272-0534	898.09	534.73	223	54.77	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13881.1	B08		2	0273-0537	371.82	537.32	366	71.01	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13267.3	B08		2	0274-0537	692.61	537.02	392	78.18	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10050.7	B08		2	0275-0539	311.64	538.90	281	63.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9866.0	B08		2	0276-0540	807.08	541.01	261	62.53	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11258.8	B08		2	0277-0547	92.38	547.24	225	55.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11828.9	B08		2	0278-0551	216.53	551.61	221	54.28	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15427.6	B08		2	0279-0554	258.15	553.87	246	59.11	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10335.3	B08		2	0280-0553	701.75	552.83	276	66.43	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11805.9	B08		2	0281-0560	189.67	560.55	376	75.36	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7464.3	B08		2	0282-0556	419.16	556.52	241	76.67	0.515
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11899.8	B08		2	0283-0557	573.40	556.84	232	56.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19421.8	B08		2	0284-0561	395.29	560.88	517	89.84	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11330.2	B08		2	0285-0557	489.28	557.20	298	73.60	0.691
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14547.6	B08		2	0286-0561	684.81	560.97	284	62.53	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10792.4	B08		2	0287-0563	53.34	564.04	254	64.77	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11594.4	B08		2	0288-0564	34.75	564.91	277	61.11	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9956.0	B08		2	0289-0564	800.42	563.66	262	62.43	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10460.8	B08		2	0290-0565	132.69	565.45	282	60.77	0.960
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10279.6	B08		2	0291-0569	298.45	569.75	305	66.77	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9920.9	B08		2	0292-0566	734.45	566.03	160	46.63	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9543.5	B08		2	0293-0572	546.80	572.13	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9392.1	B08		2	0294-0567	721.99	567.97	117	40.39	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10384.9	B08		2	0295-0569	337.10	569.57	268	62.77	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10673.0	B08		2	0296-0578	823.42	578.32	245	60.18	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11424.6	B08		2	0297-0576	861.26	576.46	224	58.77	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12442.2	B08		2	0298-0582	740.73	581.99	369	77.26	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10708.0	B08		2	0299-0583	563.98	583.98	248	59.46	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12040.7	B08		2	0300-0586	173.73	586.22	307	65.36	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10992.0	B08		2	0301-0583	658.97	583.84	245	57.11	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10590.0	B08		2	0302-0585	793.90	585.11	248	58.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9063.2	B08		2	0303-0590	227.90	590.27	281	63.11	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14905.6	B08		2	0304-0591	99.57	591.34	294	62.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12784.6	B08		2	0305-0593	505.03	593.37	339	69.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11505.6	B08		2	0306-0592	593.21	591.77	223	56.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12592.8	B08		2	0307-0597	133.78	597.69	338	71.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13400.6	B08		2	0308-0597	75.00	597.76	377	73.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9943.5	B08		2	0309-0598	764.49	598.03	268	61.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12905.2	B08		2	0310-0602	262.69	602.14	245	58.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9088.1	B08		2	0311-0603	370.78	603.27	328	68.53	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14603.6	B08		2	0312-0610	883.28	609.88	539	91.15	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15274.9	B08		2	0313-0609	585.95	609.56	224	57.01	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11964.9	B08		2	0314-0613	841.15	613.76	411	79.26	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11738.5	B08		2	0315-0612	936.63	612.62	227	55.94	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10091.1	B08		2	0316-0617	288.69	617.92	377	74.77	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10657.5	B08		2	0317-0614	609.59	615.13	257	63.60	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10079.2	B08		2	0318-0620	799.21	619.85	258	64.28	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9935.2	B08		2	0319-0620	96.60	619.31	283	61.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12199.2	B08		2	0320-0622	162.75	622.53	248	60.28	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15714.8	B08		2	0321-0633	664.99	632.93	460	84.43	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18299.2	B08		2	0322-0636	342.57	636.72	552	91.50	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18115.0	B08		2	0323-0632	681.91	632.43	285	65.94	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12848.1	B08		2	0324-0636	909.48	635.73	392	75.84	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9883.4	B08		2	0325-0637	212.47	637.09	316	74.08	0.724
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12275.1	B08		2	0326-0639	419.96	639.41	505	90.57	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15374.8	B08		2	0327-0635	300.04	635.24	160	46.87	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15691.7	B08		2	0328-0634	311.80	633.78	111	39.56	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13198.6	B08		2	0329-0639	774.09	638.73	357	70.43	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10058.3	B08		2	0330-0640	47.64	639.90	268	61.01	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11453.0	B08		2	0331-0644	575.29	645.64	468	86.33	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9803.3	B08		2	0332-0637	497.09	637.30	111	40.04	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12079.3	B08		2	0333-0645	364.75	645.34	289	61.94	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11488.7	B08		2	0334-0652	503.38	652.97	353	73.01	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11260.8	B08		2	0335-0651	433.80	651.83	219	56.77	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14980.0	B08		2	0336-0656	474.14	655.54	417	82.91	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12049.8	B08		2	0337-0653	132.62	653.87	156	47.21	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13055.0	B08		2	0338-0660	148.53	660.75	228	58.53	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12750.7	B08		2	0339-0665	873.42	665.35	320	67.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11116.4	B08		2	0340-0664	794.21	664.84	230	54.77	0.964
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11954.4	B08		2	0341-0664	345.09	664.25	223	59.70	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10988.0	B08		2	0342-0668	31.79	668.05	280	65.60	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12603.3	B08		2	0343-0666	133.65	665.65	163	48.04	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11902.4	B08		2	0344-0673	488.29	673.97	375	76.77	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13327.6	B08		2	0345-0677	471.11	677.26	388	79.26	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13128.6	B08		2	0346-0674	676.26	675.27	352	69.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8694.8	B08		2	0347-0682	833.49	682.02	319	71.60	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10169.0	B08		2	0348-0681	177.91	682.12	282	64.43	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12365.8	B08		2	0349-0684	536.57	684.33	210	54.28	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15996.2	B08		2	0350-0684	270.18	683.97	243	59.11	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11633.1	B08		2	0351-0692	297.50	692.96	233	58.53	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13345.6	B08		2	0352-0688	897.09	688.15	191	53.94	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10969.2	B08		2	0353-0692	388.37	692.13	236	57.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13075.6	B08		2	0354-0695	559.28	695.50	349	71.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8556.5	B08		2	0355-0695	83.03	695.50	268	60.53	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11248.8	B08		2	0356-0697	649.23	697.13	455	80.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11773.0	B08		2	0357-0696	766.83	695.63	319	67.01	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14733.0	B08		2	0358-0700	19.22	700.80	156	47.46	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8978.0	B08		2	0359-0704	105.76	704.14	283	68.08	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10140.9	B08		2	0360-0701	846.09	700.80	249	58.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14160.5	B08		2	0361-0702	620.75	701.43	199	53.11	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11612.5	B08		2	0362-0702	37.15	701.76	192	53.11	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11976.9	B08		2	0363-0704	937.46	703.67	299	63.84	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9125.5	B08		2	0364-0708	355.31	708.03	272	62.53	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15537.0	B08		2	0365-0708	207.17	708.01	325	66.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10551.6	B08		2	0366-0708	440.81	708.12	253	58.77	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185108	1375310	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8415.6	B08		2	0367-0710	121.34	709.93	207	56.53	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10749.9	B08		3	0001-0032	174.22	32.04	249	67.01	0.697
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9998.9	B08		3	0002-0031	771.20	30.98	281	63.11	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10027.4	B08		3	0003-0035	76.25	35.00	272	62.53	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11167.1	B08		3	0004-0037	608.80	37.00	478	85.15	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15963.3	B08		3	0005-0036	648.22	35.64	324	66.18	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12395.2	B08		3	0006-0041	489.76	40.64	488	83.98	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10020.8	B08		3	0007-0040	30.61	40.30	250	60.18	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12084.0	B08		3	0008-0043	704.69	44.35	231	60.87	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11688.4	B08		3	0009-0047	530.33	47.51	250	59.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12446.1	B08		3	0010-0054	456.56	54.71	277	61.36	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14285.9	B08		3	0011-0058	476.96	59.41	445	79.50	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15294.4	B08		3	0012-0058	93.16	59.16	330	67.36	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10849.2	B08		3	0013-0055	207.76	54.54	245	60.77	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10787.4	B08		3	0014-0057	753.82	57.12	256	65.70	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14710.5	B08		3	0015-0060	911.18	59.84	358	69.01	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12318.5	B08		3	0016-0062	426.79	61.94	262	59.84	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9492.8	B08		3	0017-0064	817.54	63.85	291	69.60	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11979.3	B08		3	0018-0062	151.02	62.27	218	57.36	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12112.6	B08		3	0019-0063	563.29	63.40	270	65.01	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18570.4	B08		3	0020-0064	397.98	64.32	303	69.70	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16389.4	B08		3	0021-0069	373.29	69.18	358	74.43	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17072.3	B08		3	0022-0070	444.27	70.30	315	71.01	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10457.4	B08		3	0023-0071	685.11	71.36	324	67.36	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13160.7	B08		3	0024-0071	26.79	71.61	292	63.94	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13220.2	B08		3	0025-0078	63.72	77.41	368	76.08	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12214.3	B08		3	0026-0077	152.86	78.01	324	68.18	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10506.9	B08		3	0027-0076	180.82	77.29	251	61.01	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11658.6	B08		3	0028-0084	869.55	83.92	383	84.18	0.679
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12398.5	B08		3	0029-0081	349.15	80.59	353	70.18	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12799.2	B08		3	0030-0079	97.96	78.72	198	53.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10416.3	B08		3	0031-0081	595.59	80.53	323	70.18	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10477.1	B08		3	0032-0080	291.88	80.04	261	59.60	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10472.5	B08		3	0033-0079	750.97	79.77	269	64.43	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14226.3	B08		3	0034-0082	330.41	82.15	181	54.63	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10490.8	B08		3	0035-0087	940.87	86.52	272	61.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14842.9	B08		3	0036-0088	373.60	88.65	217	53.36	0.958
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11372.3	B08		3	0037-0092	638.43	92.74	241	59.60	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12911.3	B08		3	0038-0091	398.46	91.50	215	55.36	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11003.9	B08		3	0039-0093	565.31	92.96	263	62.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10890.3	B08		3	0040-0098	497.76	98.43	517	84.08	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9549.5	B08		3	0041-0094	191.15	94.77	294	63.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12704.0	B08		3	0042-0099	838.70	99.71	305	67.36	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10218.1	B08		3	0043-0098	448.56	98.24	272	63.01	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10822.1	B08		3	0044-0099	241.85	98.73	246	58.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8961.0	B08		3	0045-0103	791.31	103.40	351	70.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12752.7	B08		3	0046-0107	332.07	106.69	355	72.18	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10071.7	B08		3	0047-0105	545.14	104.91	297	63.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14133.3	B08		3	0048-0109	816.08	108.63	189	55.36	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15173.2	B08		3	0049-0110	101.79	110.50	272	61.60	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13344.0	B08		3	0050-0111	216.70	110.96	304	65.01	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9876.3	B08		3	0051-0111	413.08	111.64	277	62.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15524.5	B08		3	0052-0114	920.64	114.63	335	66.77	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17238.6	B08		3	0053-0117	699.14	116.59	301	64.18	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10621.4	B08		3	0054-0123	493.78	122.81	262	60.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7689.9	B08		3	0055-0125	27.26	124.27	249	74.91	0.558
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9964.2	B08		3	0056-0124	546.77	125.24	276	65.01	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13275.7	B08		3	0057-0125	448.58	125.20	208	55.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12559.1	B08		3	0058-0133	739.38	133.47	362	84.67	0.635
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10731.6	B08		3	0059-0131	145.90	131.35	332	68.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12136.5	B08		3	0060-0134	207.45	132.73	501	95.74	0.687
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11320.3	B08		3	0061-0135	350.90	134.26	255	58.77	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12118.4	B08		3	0062-0136	872.25	136.23	326	66.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11932.1	B08		3	0063-0136	625.52	136.69	299	63.11	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17152.0	B08		3	0064-0147	169.60	147.13	413	77.50	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9998.3	B08		3	0065-0144	487.88	143.45	271	61.60	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11825.3	B08		3	0066-0143	536.82	142.94	241	59.36	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17117.4	B08		3	0067-0146	275.38	145.38	227	58.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10440.5	B08		3	0068-0147	28.95	147.38	243	58.18	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12907.8	B08		3	0069-0153	309.34	153.10	345	69.84	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18252.6	B08		3	0070-0156	204.86	155.46	204	92.81	0.298
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10534.3	B08		3	0071-0156	387.05	156.20	257	60.53	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11941.8	B08		3	0072-0155	469.56	155.29	230	58.77	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9890.2	B08		3	0073-0154	646.67	152.89	117	43.11	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7888.5	B08		3	0074-0160	722.52	160.55	319	75.50	0.703
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10700.3	B08		3	0075-0159	637.21	159.56	218	57.60	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11938.0	B08		3	0076-0159	779.82	159.08	225	56.28	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13954.7	B08		3	0077-0162	914.86	162.86	346	71.84	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13470.9	B08		3	0078-0167	815.28	167.59	368	75.60	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13459.8	B08		3	0079-0169	271.03	171.52	394	86.33	0.664
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12571.3	B08		3	0080-0168	751.03	167.95	468	85.15	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12483.8	B08		3	0081-0169	186.94	169.00	201	54.53	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12610.2	B08		3	0082-0167	695.55	166.22	183	51.94	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11150.3	B08		3	0083-0170	509.31	169.78	270	61.94	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14627.0	B08		3	0084-0175	838.62	175.55	367	82.08	0.684
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12890.8	B08		3	0085-0171	483.51	171.08	214	55.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12063.6	B08		3	0086-0172	684.74	173.33	136	44.53	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13263.4	B08		3	0087-0178	314.28	178.44	403	76.33	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12156.9	B08		3	0088-0177	66.17	177.18	206	53.70	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12500.7	B08		3	0089-0177	102.73	176.82	203	53.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10605.5	B08		3	0090-0179	253.70	178.90	239	63.60	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12010.7	B08		3	0091-0179	554.12	179.02	349	69.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16654.1	B08		3	0092-0179	444.19	179.66	221	53.11	0.984
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14899.9	B08		3	0093-0183	621.51	182.60	365	70.18	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11247.3	B08		3	0094-0185	210.48	185.09	250	60.18	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12964.3	B08		3	0095-0190	876.28	190.12	404	75.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11856.0	B08		3	0096-0188	297.16	188.57	244	58.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13997.7	B08		3	0097-0188	370.51	188.18	292	67.60	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15198.3	B08		3	0098-0188	48.45	188.21	160	46.87	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12708.1	B08		3	0099-0191	339.92	191.37	276	61.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11755.6	B08		3	0100-0196	594.81	196.46	314	68.18	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13576.0	B08		3	0101-0199	914.47	198.34	298	66.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9373.6	B08		3	0102-0199	146.75	199.92	273	65.84	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12413.9	B08		3	0103-0202	173.10	202.21	303	65.84	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12733.0	B08		3	0104-0201	280.82	200.74	205	55.11	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12061.9	B08		3	0105-0203	402.51	203.32	287	61.94	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17734.4	B08		3	0106-0203	628.31	203.10	297	63.01	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14026.2	B08		3	0107-0204	366.33	204.23	184	51.11	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11329.5	B08		3	0108-0207	37.62	206.55	290	63.70	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10908.8	B08		3	0109-0207	893.74	207.76	249	60.43	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11031.3	B08		3	0110-0207	239.23	207.31	240	58.77	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10408.6	B08		3	0111-0208	948.07	208.67	267	60.43	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11189.7	B08		3	0112-0208	75.39	208.20	233	55.94	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10785.4	B08		3	0113-0209	551.99	209.65	257	59.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11205.7	B08		3	0114-0215	332.77	214.78	256	62.18	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13363.5	B08		3	0115-0220	115.19	220.15	386	74.43	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13914.6	B08		3	0116-0222	660.54	222.51	396	76.43	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9736.9	B08		3	0117-0219	850.80	219.39	168	53.36	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11969.4	B08		3	0118-0219	712.14	219.64	223	54.28	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10815.1	B08		3	0119-0221	286.32	222.07	258	61.01	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11966.6	B08		3	0120-0221	794.26	222.20	231	66.43	0.658
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15209.2	B08		3	0121-0224	354.14	224.73	337	69.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16774.3	B08		3	0122-0224	369.58	223.65	158	48.87	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14282.8	B08		3	0123-0227	613.88	227.23	233	58.28	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18171.5	B08		3	0124-0231	675.39	231.75	274	66.77	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16147.9	B08		3	0125-0237	219.89	236.54	310	68.18	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11394.2	B08		3	0126-0234	892.81	234.08	245	57.94	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15942.3	B08		3	0127-0238	828.42	238.70	314	66.18	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12591.9	B08		3	0128-0240	750.33	241.09	427	77.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10222.2	B08		3	0129-0243	411.02	244.58	306	68.18	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14622.5	B08		3	0130-0240	546.09	240.52	318	66.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17519.9	B08		3	0131-0244	566.82	244.27	300	64.18	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14321.3	B08		3	0132-0242	609.87	242.66	240	57.11	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10707.5	B08		3	0133-0246	923.15	246.57	256	64.18	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10063.7	B08		3	0134-0246	28.55	246.73	236	58.04	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10491.3	B08		3	0135-0247	204.55	247.05	275	63.94	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8208.1	B08		3	0136-0246	363.41	246.31	316	80.08	0.619
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10853.0	B08		3	0137-0249	494.35	248.84	250	59.26	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15246.7	B08		3	0138-0250	706.94	250.18	191	58.77	0.695
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10394.6	B08		3	0139-0256	100.15	256.98	240	66.53	0.681
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11639.6	B08		3	0140-0254	524.48	253.29	231	58.77	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14341.9	B08		3	0141-0252	723.12	252.69	191	51.11	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11506.2	B08		3	0142-0256	140.11	256.38	229	57.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12230.5	B08		3	0143-0257	158.04	257.32	212	57.36	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10640.7	B08		3	0144-0254	74.64	253.97	230	58.28	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12852.7	B08		3	0145-0256	307.56	255.86	206	54.28	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10539.2	B08		3	0146-0258	260.05	258.96	250	60.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10133.4	B08		3	0147-0265	589.80	263.58	278	65.94	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13116.4	B08		3	0148-0264	29.42	263.98	343	71.94	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10477.6	B08		3	0149-0269	464.95	269.24	284	64.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12989.5	B08		3	0150-0269	534.17	268.97	227	55.94	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14864.3	B08		3	0151-0271	775.21	271.35	302	65.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11584.5	B08		3	0152-0270	794.95	271.04	250	58.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8399.7	B08		3	0153-0275	631.78	274.75	307	69.60	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9549.5	B08		3	0154-0278	240.09	278.70	298	65.01	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14616.8	B08		3	0155-0278	841.64	278.32	175	52.18	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10922.7	B08		3	0156-0281	88.55	280.69	227	57.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12920.6	B08		3	0157-0279	735.63	279.66	312	67.01	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10129.1	B08		3	0158-0283	395.38	282.92	275	65.01	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10805.6	B08		3	0159-0286	274.36	287.66	322	67.60	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11270.0	B08		3	0160-0284	30.22	284.54	225	56.53	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9094.1	B08		3	0161-0286	122.17	287.01	279	63.60	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14651.4	B08		3	0162-0291	459.86	291.26	412	79.26	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14921.2	B08		3	0163-0287	941.61	287.60	362	71.60	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10646.2	B08		3	0164-0287	359.90	286.65	248	65.26	0.732
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10191.9	B08		3	0165-0289	160.78	289.29	255	58.53	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10534.4	B08		3	0166-0289	181.17	289.44	248	59.36	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13911.9	B08		3	0167-0292	833.48	292.34	404	76.67	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12567.4	B08		3	0168-0290	660.97	290.34	213	55.11	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10543.6	B08		3	0169-0292	813.19	291.83	258	64.18	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11368.0	B08		3	0170-0296	420.18	296.51	238	58.28	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11749.9	B08		3	0171-0295	676.56	294.96	235	58.28	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10356.1	B08		3	0172-0301	925.83	300.69	304	66.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13087.5	B08		3	0173-0301	883.05	301.44	343	68.43	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12599.2	B08		3	0174-0301	219.00	301.60	201	56.18	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14572.9	B08		3	0175-0309	106.17	309.78	331	67.84	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10838.3	B08		3	0176-0311	136.06	311.08	235	57.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8603.6	B08		3	0177-0315	459.87	315.36	306	67.84	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14644.9	B08		3	0178-0315	584.40	314.75	368	70.53	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14624.1	B08		3	0179-0316	734.41	316.36	369	73.84	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11267.5	B08		3	0180-0316	187.10	316.32	224	54.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11348.0	B08		3	0181-0318	254.15	318.24	231	57.94	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10922.3	B08		3	0182-0318	651.34	318.24	294	63.94	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12373.4	B08		3	0183-0323	410.89	322.62	364	73.84	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18335.8	B08		3	0184-0329	875.26	329.64	266	60.18	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12388.8	B08		3	0185-0328	286.92	328.69	215	53.70	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8708.7	B08		3	0186-0335	804.34	336.40	317	70.67	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14895.7	B08		3	0187-0334	360.46	334.07	193	51.11	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13398.4	B08		3	0188-0335	387.43	335.21	269	61.36	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8919.2	B08		3	0189-0335	536.82	335.92	294	64.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15149.4	B08		3	0190-0335	204.81	335.14	228	55.11	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16038.7	B08		3	0191-0338	650.73	337.72	323	67.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14729.3	B08		3	0192-0339	346.72	339.63	174	52.28	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14203.9	B08		3	0193-0341	725.24	341.64	215	54.28	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10934.7	B08		3	0194-0346	243.63	345.99	277	63.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11917.2	B08		3	0195-0345	317.67	345.39	210	58.77	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11125.7	B08		3	0196-0343	107.28	343.76	273	64.18	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9881.4	B08		3	0197-0344	608.80	343.82	285	64.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13782.6	B08		3	0198-0353	291.95	352.69	379	72.43	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11517.0	B08		3	0199-0354	331.61	354.07	229	56.87	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12883.7	B08		3	0200-0355	425.40	355.58	273	62.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12884.9	B08		3	0201-0355	828.37	355.45	372	72.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15289.7	B08		3	0202-0356	19.52	356.46	186	52.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11365.3	B08		3	0203-0358	179.96	357.71	224	55.70	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12222.5	B08		3	0204-0356	347.30	355.98	226	56.87	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11820.4	B08		3	0205-0356	452.60	356.90	253	59.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13356.8	B08		3	0206-0359	402.75	359.21	322	65.94	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13010.2	B08		3	0207-0355	684.95	355.37	203	55.70	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9978.9	B08		3	0208-0357	483.80	358.09	169	51.11	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16506.0	B08		3	0209-0358	112.39	358.32	148	45.46	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8735.7	B08		3	0210-0367	589.51	368.23	600	167.82	0.268
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15634.5	B08		3	0211-0365	513.79	364.74	343	70.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9228.0	B08		3	0212-0362	928.13	361.92	149	49.70	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10968.9	B08		3	0213-0365	165.18	365.39	230	59.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8847.8	B08		3	0214-0369	26.07	370.68	286	71.01	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13634.5	B08		3	0215-0367	315.45	367.37	307	66.43	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16790.5	B08		3	0216-0367	651.27	367.38	319	68.18	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12561.0	B08		3	0217-0371	910.25	370.76	309	70.43	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13420.0	B08		3	0218-0371	875.06	370.77	305	66.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12072.9	B08		3	0219-0371	374.83	371.79	255	60.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15198.2	B08		3	0220-0374	263.29	374.75	348	71.26	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10167.3	B08		3	0221-0377	712.73	377.14	273	63.36	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10171.1	B08		3	0222-0379	762.43	379.09	281	65.01	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12102.7	B08		3	0223-0379	841.85	379.72	226	58.77	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9540.7	B08		3	0224-0379	147.84	379.00	276	64.77	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9998.0	B08		3	0225-0383	54.65	383.69	298	68.18	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10352.3	B08		3	0226-0382	546.20	382.45	304	65.36	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11752.2	B08		3	0227-0383	352.41	382.21	226	57.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11071.8	B08		3	0228-0382	503.03	382.35	258	60.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11538.9	B08		3	0229-0382	89.21	382.66	219	53.70	0.954
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12212.6	B08		3	0230-0384	103.89	384.05	200	57.11	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11979.1	B08		3	0231-0384	685.58	384.47	259	60.28	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12737.4	B08		3	0232-0389	133.82	389.88	204	54.18	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11475.4	B08		3	0233-0392	335.87	392.05	229	61.11	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14435.5	B08		3	0234-0397	943.98	397.69	349	70.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9014.0	B08		3	0235-0396	248.74	396.06	266	64.77	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11465.4	B08		3	0236-0399	358.81	399.31	264	63.01	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8731.5	B08		3	0237-0396	400.64	395.69	284	70.77	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14978.8	B08		3	0238-0401	869.31	401.46	353	70.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15095.1	B08		3	0239-0399	477.95	398.80	152	47.46	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14251.1	B08		3	0240-0400	688.60	398.59	162	49.70	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12229.4	B08		3	0241-0409	450.59	409.76	472	81.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13404.1	B08		3	0242-0406	677.98	406.95	201	54.43	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9610.9	B08		3	0243-0410	59.30	410.76	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12224.5	B08		3	0244-0410	326.43	410.31	290	64.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11130.3	B08		3	0245-0411	187.48	411.62	229	59.01	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10804.9	B08		3	0246-0411	814.94	410.92	258	64.18	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10741.5	B08		3	0247-0413	918.78	412.65	255	61.01	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16373.1	B08		3	0248-0420	645.90	419.43	683	107.30	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13329.4	B08		3	0249-0418	594.22	418.68	419	80.33	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11041.3	B08		3	0250-0418	709.45	418.12	500	89.98	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9350.5	B08		3	0251-0416	20.37	415.64	244	59.36	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11341.1	B08		3	0252-0418	237.53	417.22	230	59.01	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11322.0	B08		3	0253-0418	369.35	417.47	296	64.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12131.9	B08		3	0254-0418	210.59	417.84	204	54.77	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13737.8	B08		3	0255-0419	164.81	418.96	326	69.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13741.9	B08		3	0256-0421	283.97	421.68	294	63.01	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10552.3	B08		3	0257-0425	308.25	424.38	257	60.53	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12280.8	B08		3	0258-0428	786.09	428.42	228	56.77	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10445.6	B08		3	0259-0425	862.34	425.22	116	41.21	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11834.5	B08		3	0260-0432	503.87	432.37	225	59.60	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9040.3	B08		3	0261-0435	408.07	435.04	291	69.60	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11015.2	B08		3	0262-0437	862.54	437.07	128	41.80	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11164.7	B08		3	0263-0442	807.62	442.76	329	75.26	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10133.8	B08		3	0264-0443	888.83	442.33	332	69.26	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13439.8	B08		3	0265-0443	531.39	443.83	328	67.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11005.5	B08		3	0266-0450	31.80	450.55	432	79.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10070.1	B08		3	0267-0449	933.81	450.02	256	61.11	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9209.2	B08		3	0268-0451	72.30	451.27	263	62.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9587.3	B08		3	0269-0453	371.01	453.85	319	68.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11867.4	B08		3	0270-0451	699.44	451.53	254	59.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8542.9	B08		3	0271-0455	185.28	455.49	283	65.01	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11225.8	B08		3	0272-0453	247.81	453.68	216	55.11	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11324.6	B08		3	0273-0455	748.33	454.75	174	50.63	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11269.5	B08		3	0274-0454	759.92	453.92	166	49.80	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12565.8	B08		3	0275-0454	508.66	454.74	219	59.36	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13578.9	B08		3	0276-0459	681.14	458.94	406	74.67	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8490.0	B08		3	0277-0458	140.86	458.00	306	64.77	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12970.1	B08		3	0278-0458	447.06	457.61	270	62.18	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10326.5	B08		3	0279-0458	311.78	458.48	236	58.18	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12003.4	B08		3	0280-0461	92.82	461.21	289	63.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10598.7	B08		3	0281-0466	276.12	465.89	268	62.77	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10841.3	B08		3	0282-0466	422.12	466.59	247	57.94	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10243.6	B08		3	0283-0469	324.75	469.28	258	60.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11647.5	B08		3	0284-0469	295.54	469.85	274	61.94	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11433.5	B08		3	0285-0473	383.72	473.38	260	61.01	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11289.7	B08		3	0286-0472	836.60	472.36	236	57.11	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12963.5	B08		3	0287-0476	177.39	476.77	357	72.33	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11545.7	B08		3	0288-0474	697.65	474.06	246	57.94	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15513.4	B08		3	0289-0476	722.76	476.66	332	68.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11223.9	B08		3	0290-0475	259.18	475.33	251	59.70	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11509.0	B08		3	0291-0478	204.42	479.05	212	56.77	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11208.1	B08		3	0292-0480	771.22	479.94	365	75.01	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11265.6	B08		3	0293-0480	363.30	480.13	231	56.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12541.7	B08		3	0294-0480	560.68	479.96	209	59.46	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10864.3	B08		3	0295-0484	501.01	484.07	285	62.53	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9307.4	B08		3	0296-0487	51.52	486.82	251	61.70	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12046.0	B08		3	0297-0486	616.39	487.05	226	56.53	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12822.5	B08		3	0298-0487	342.67	487.35	238	57.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10427.8	B08		3	0299-0488	826.68	488.29	293	62.77	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13868.3	B08		3	0300-0490	596.29	489.20	265	63.60	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13755.1	B08		3	0301-0495	558.65	494.36	331	69.94	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12738.7	B08		3	0302-0502	582.49	500.85	221	60.77	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8889.2	B08		3	0303-0500	808.99	500.75	139	45.70	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10202.9	B08		3	0304-0506	271.95	507.29	292	65.36	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15225.9	B08		3	0305-0506	197.87	506.15	325	67.94	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13787.6	B08		3	0306-0504	326.24	504.30	201	54.53	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13081.2	B08		3	0307-0506	749.41	506.57	218	54.87	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13701.9	B08		3	0308-0512	233.99	511.86	404	77.84	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10438.0	B08		3	0309-0508	309.33	507.70	254	59.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14390.9	B08		3	0310-0512	409.95	512.07	328	68.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14322.1	B08		3	0311-0512	920.21	511.04	368	74.43	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9968.3	B08		3	0312-0511	945.71	510.79	299	69.01	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10755.1	B08		3	0313-0513	162.91	512.93	234	55.70	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10664.0	B08		3	0314-0519	641.88	518.69	471	82.08	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10135.8	B08		3	0315-0518	433.87	518.13	300	65.60	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8781.4	B08		3	0316-0515	807.92	515.37	204	53.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12150.7	B08		3	0317-0516	879.29	515.82	275	62.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13206.7	B08		3	0318-0520	468.34	519.83	387	74.18	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10401.4	B08		3	0319-0525	92.32	525.27	242	61.94	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11221.1	B08		3	0320-0528	892.42	527.57	242	59.94	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9885.8	B08		3	0321-0534	563.20	534.52	290	64.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13911.2	B08		3	0322-0538	930.82	537.99	358	70.43	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11319.0	B08		3	0323-0544	338.86	544.18	447	80.08	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14365.9	B08		3	0324-0543	615.93	543.94	313	68.87	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12612.3	B08		3	0325-0545	291.44	545.26	385	74.91	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12671.1	B08		3	0326-0543	687.91	543.10	258	62.43	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12455.9	B08		3	0327-0542	802.99	542.92	224	57.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10958.2	B08		3	0328-0547	65.80	547.79	283	70.53	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13218.9	B08		3	0329-0545	519.42	545.54	393	73.26	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10029.1	B08		3	0330-0548	752.79	547.78	327	67.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13606.8	B08		3	0331-0547	817.45	547.43	200	54.28	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10786.8	B08		3	0332-0555	168.11	555.12	253	58.53	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14803.2	B08		3	0333-0554	206.92	554.21	165	48.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11343.7	B08		3	0334-0557	241.60	557.24	219	55.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13347.8	B08		3	0335-0558	680.32	558.84	172	50.04	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10321.8	B08		3	0336-0560	260.65	560.75	258	60.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8916.0	B08		3	0337-0560	437.42	560.49	282	66.18	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13268.8	B08		3	0338-0561	383.72	561.24	199	52.28	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10223.6	B08		3	0339-0564	908.31	563.81	257	60.77	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13072.7	B08		3	0340-0563	362.71	562.57	209	53.11	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11476.6	B08		3	0341-0565	113.81	566.31	220	55.70	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8385.4	B08		3	0342-0563	560.33	563.84	161	49.21	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14320.9	B08		3	0343-0574	707.12	574.45	382	76.18	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12388.9	B08		3	0344-0567	729.32	567.42	211	56.87	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9021.8	B08		3	0345-0577	307.82	577.16	266	66.18	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10793.2	B08		3	0346-0574	484.36	573.74	284	64.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11160.6	B08		3	0347-0578	839.35	579.04	248	60.53	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7841.7	B08		3	0348-0574	557.43	574.80	134	51.70	0.630
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11193.2	B08		3	0349-0579	81.38	579.01	225	56.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12538.5	B08		3	0350-0583	166.37	583.62	332	67.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13055.6	B08		3	0351-0583	187.26	583.22	278	61.46	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11518.3	B08		3	0352-0587	388.61	587.01	346	70.91	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8815.1	B08		3	0353-0587	584.27	587.10	318	81.50	0.602
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18850.8	B08		3	0354-0584	877.49	584.68	133	42.87	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11256.1	B08		3	0355-0588	898.46	588.43	311	67.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11656.1	B08		3	0356-0589	350.30	589.33	209	55.94	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18442.3	B08		3	0357-0588	862.60	588.17	134	44.28	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11619.4	B08		3	0358-0597	844.23	597.76	370	74.67	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15008.6	B08		3	0359-0594	253.57	593.03	169	49.36	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11638.0	B08		3	0360-0595	633.32	595.37	269	61.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9533.7	B08		3	0361-0598	524.68	598.04	293	62.77	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10960.1	B08		3	0362-0599	764.00	599.49	279	73.50	0.649
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11011.5	B08		3	0363-0604	126.58	605.15	339	68.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14432.4	B08		3	0364-0601	263.36	601.01	180	52.77	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9147.7	B08		3	0365-0605	322.60	606.03	261	62.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10140.9	B08		3	0366-0602	426.77	602.43	267	62.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14444.7	B08		3	0367-0605	554.18	605.19	350	68.18	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12596.7	B08		3	0368-0603	687.74	604.19	132	42.39	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12951.0	B08		3	0369-0607	616.33	606.87	234	59.84	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10909.3	B08		3	0370-0609	487.93	608.84	297	66.43	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10063.5	B08		3	0371-0608	936.57	607.73	257	64.77	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10663.0	B08		3	0372-0614	411.37	614.44	324	66.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9863.8	B08		3	0373-0613	439.78	613.99	280	63.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13234.2	B08		3	0374-0611	721.30	611.18	193	58.77	0.702
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11575.5	B08		3	0375-0615	30.94	616.00	225	55.36	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9018.3	B08		3	0376-0618	339.28	617.59	279	61.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10473.7	B08		3	0377-0620	63.06	620.52	228	58.53	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12725.8	B08		3	0378-0621	692.34	620.81	285	66.53	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16471.5	B08		3	0379-0621	883.29	620.36	279	63.11	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11519.3	B08		3	0380-0623	179.48	623.20	323	67.01	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10454.9	B08		3	0381-0621	232.61	622.39	272	61.11	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11115.7	B08		3	0382-0622	299.86	622.00	314	67.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13460.5	B08		3	0383-0621	263.45	621.84	183	52.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14130.9	B08		3	0384-0624	603.64	624.42	363	71.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10518.3	B08		3	0385-0625	751.75	625.19	266	63.11	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13135.3	B08		3	0386-0628	812.46	628.17	378	73.01	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11523.4	B08		3	0387-0628	276.37	628.67	229	57.70	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13738.4	B08		3	0388-0628	556.75	628.93	195	53.46	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9198.0	B08		3	0389-0637	876.35	637.96	295	68.43	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12605.8	B08		3	0390-0637	771.26	636.84	209	55.70	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11926.3	B08		3	0391-0639	114.14	640.11	204	52.87	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11715.6	B08		3	0392-0642	350.54	642.19	281	64.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11546.6	B08		3	0393-0640	514.81	640.74	269	61.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12290.3	B08		3	0394-0643	895.73	643.48	375	73.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10012.2	B08		3	0395-0642	204.93	642.22	248	60.18	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13508.0	B08		3	0396-0640	164.94	640.47	181	51.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17163.9	B08		3	0397-0642	556.40	641.47	162	48.63	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11212.0	B08		3	0398-0648	659.03	648.60	327	66.18	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14826.6	B08		3	0399-0653	247.53	653.51	371	75.01	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11252.7	B08		3	0400-0654	388.11	654.36	401	76.43	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14984.4	B08		3	0401-0651	946.17	650.54	275	62.53	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11239.0	B08		3	0402-0656	425.26	656.70	372	71.60	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13302.1	B08		3	0403-0657	713.38	657.91	343	69.26	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10977.6	B08		3	0404-0661	108.19	660.40	327	71.36	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12776.5	B08		3	0405-0660	620.19	659.78	295	64.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10159.1	B08		3	0406-0660	553.77	659.85	269	60.53	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9446.8	B08		3	0407-0660	898.74	660.46	275	66.18	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10050.7	B08		3	0408-0661	175.78	660.96	239	61.60	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10133.7	B08		3	0409-0663	830.21	663.20	256	62.18	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10454.8	B08		3	0410-0663	806.27	663.94	252	60.53	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11107.1	B08		3	0411-0669	321.28	668.18	225	57.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11468.6	B08		3	0412-0674	687.29	674.80	384	75.50	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8895.5	B08		3	0413-0673	473.43	673.39	270	61.11	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10726.9	B08		3	0414-0674	732.78	674.35	260	59.11	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11083.0	B08		3	0415-0675	339.94	674.90	231	57.36	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9466.2	B08		3	0416-0680	911.95	680.09	390	111.88	0.392
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9935.9	B08		3	0417-0678	44.44	677.83	235	60.43	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10429.8	B08		3	0418-0681	448.52	681.25	260	61.36	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10962.1	B08		3	0419-0681	250.43	681.15	231	56.53	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11186.9	B08		3	0420-0682	310.84	682.87	248	58.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17069.0	B08		3	0421-0681	600.75	681.92	187	55.46	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16393.0	B08		3	0422-0682	392.98	682.79	147	46.63	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9177.4	B08		3	0423-0691	70.94	690.67	280	73.84	0.645
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10370.1	B08		3	0424-0686	842.30	686.28	245	59.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10102.6	B08		3	0425-0688	171.82	688.70	240	58.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10941.4	B08		3	0426-0691	568.47	691.37	235	62.77	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16058.5	B08		3	0427-0690	817.05	690.09	266	62.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10275.0	B08		3	0428-0693	204.94	693.32	427	79.84	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11202.2	B08		3	0429-0690	520.23	689.89	241	58.53	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10490.4	B08		3	0430-0695	880.75	694.32	235	59.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10740.1	B08		3	0431-0696	240.36	695.66	237	57.60	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12221.6	B08		3	0432-0695	294.42	694.86	346	69.94	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17803.0	B08		3	0433-0699	599.55	698.54	340	85.01	0.591
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9739.0	B08		3	0434-0697	389.64	697.22	344	71.84	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9811.2	B08		3	0435-0698	119.26	699.23	252	61.26	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11799.8	B08		3	0436-0707	31.70	707.18	300	66.08	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185109	1375311	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10907.2	B08		3	0437-0708	278.88	708.13	245	57.94	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12222.5	B08		4	0001-0025	601.39	24.22	237	57.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11563.0	B08		4	0002-0026	295.33	26.23	228	57.11	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11990.7	B08		4	0003-0028	414.67	27.91	247	60.53	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17455.9	B08		4	0004-0028	250.53	27.82	319	67.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15293.0	B08		4	0005-0032	338.83	32.81	380	77.84	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10782.8	B08		4	0006-0030	90.85	30.14	263	62.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10650.2	B08		4	0007-0032	119.56	31.29	266	64.53	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10494.3	B08		4	0008-0032	639.87	33.10	275	62.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16657.0	B08		4	0009-0033	706.63	33.30	326	67.26	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17550.3	B08		4	0010-0027	902.79	26.86	134	46.28	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13113.6	B08		4	0011-0036	37.02	36.05	423	77.26	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12097.3	B08		4	0012-0036	864.18	36.52	334	67.01	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14081.9	B08		4	0013-0036	912.23	36.29	173	49.46	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12152.6	B08		4	0014-0037	930.80	36.59	178	52.28	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9133.3	B08		4	0015-0043	677.40	43.66	298	68.08	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10660.4	B08		4	0016-0045	301.85	45.54	255	63.01	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11338.5	B08		4	0017-0051	613.77	48.86	342	82.91	0.625
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11899.2	B08		4	0018-0051	75.69	51.44	486	82.08	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11989.0	B08		4	0019-0048	478.80	47.48	271	66.18	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10840.6	B08		4	0020-0047	936.14	47.06	211	59.36	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12928.8	B08		4	0021-0050	401.86	49.78	218	54.53	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10803.8	B08		4	0022-0050	219.40	49.85	318	68.18	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12513.6	B08		4	0023-0058	740.53	58.83	424	78.57	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11127.7	B08		4	0024-0055	14.62	55.08	250	63.36	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12291.6	B08		4	0025-0056	524.41	56.31	353	71.26	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13003.4	B08		4	0026-0058	888.84	59.06	392	75.01	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18872.7	B08		4	0027-0060	161.25	60.71	268	70.18	0.684
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10137.6	B08		4	0028-0058	312.75	57.64	272	62.53	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9435.9	B08		4	0029-0060	712.81	59.97	208	60.18	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11302.3	B08		4	0030-0062	766.83	63.27	211	54.87	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10707.3	B08		4	0031-0067	475.75	67.22	283	62.28	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12170.5	B08		4	0032-0069	538.58	69.33	492	86.33	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10858.7	B08		4	0033-0067	812.44	67.35	244	59.01	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9546.4	B08		4	0034-0078	318.23	77.48	282	65.01	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10919.1	B08		4	0035-0080	447.27	80.88	269	61.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11290.6	B08		4	0036-0083	227.30	83.62	238	57.70	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9692.7	B08		4	0037-0088	414.50	87.90	319	68.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10575.3	B08		4	0038-0090	269.16	90.06	247	59.70	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9230.7	B08		4	0039-0091	381.61	91.52	302	64.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10790.4	B08		4	0040-0094	159.26	95.10	397	74.08	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10830.9	B08		4	0041-0092	54.99	92.34	244	59.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18215.4	B08		4	0042-0093	914.93	93.62	295	64.53	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11209.5	B08		4	0043-0097	678.35	97.15	251	59.94	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10893.3	B08		4	0044-0100	209.86	100.34	241	57.11	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11721.3	B08		4	0045-0106	848.60	106.41	340	68.77	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8573.3	B08		4	0046-0104	798.65	103.91	138	47.21	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8329.9	B08		4	0047-0104	810.06	105.10	155	47.21	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11152.1	B08		4	0048-0109	245.63	109.06	236	56.53	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9763.9	B08		4	0049-0113	274.94	112.69	293	69.26	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9149.5	B08		4	0050-0111	326.72	110.87	297	65.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9791.6	B08		4	0051-0119	62.82	119.71	273	61.60	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12043.2	B08		4	0052-0123	742.79	123.25	327	67.94	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10511.9	B08		4	0053-0130	181.11	130.31	271	64.77	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10196.4	B08		4	0054-0129	601.27	129.58	255	63.60	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15903.8	B08		4	0055-0131	483.49	131.95	328	116.47	0.304
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9274.6	B08		4	0056-0131	714.45	131.62	301	67.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10875.5	B08		4	0057-0133	237.78	133.58	318	66.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11675.7	B08		4	0058-0134	84.87	133.92	219	55.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10490.1	B08		4	0059-0139	381.43	139.74	258	60.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12694.8	B08		4	0060-0141	350.79	140.88	431	83.84	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16458.2	B08		4	0061-0143	205.07	142.99	327	77.50	0.684
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8714.3	B08		4	0062-0141	302.22	141.46	315	73.60	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9225.1	B08		4	0063-0146	540.29	146.95	291	68.77	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11436.8	B08		4	0064-0146	578.61	146.38	219	60.53	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13607.5	B08		4	0065-0146	858.94	145.96	342	69.26	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12693.1	B08		4	0066-0146	610.35	145.78	215	53.46	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15526.6	B08		4	0067-0146	690.83	146.41	168	48.63	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11325.5	B08		4	0068-0154	145.03	154.58	440	78.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15666.9	B08		4	0069-0150	766.39	150.31	307	64.18	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11694.4	B08		4	0070-0149	434.55	149.47	229	58.28	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9414.2	B08		4	0071-0150	941.52	150.18	274	63.11	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11224.5	B08		4	0072-0152	63.41	152.90	231	58.43	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10325.9	B08		4	0073-0154	235.64	154.02	260	59.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8377.5	B08		4	0074-0156	501.76	155.35	336	70.67	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11113.6	B08		4	0075-0157	85.02	157.84	241	57.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16191.5	B08		4	0076-0158	632.22	157.63	165	47.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11893.3	B08		4	0077-0159	100.79	159.94	187	50.63	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11113.1	B08		4	0078-0160	656.24	160.82	256	62.77	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10667.2	B08		4	0079-0170	22.33	169.11	241	60.28	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11346.1	B08		4	0080-0178	791.21	178.94	515	84.91	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10771.5	B08		4	0081-0181	448.03	180.50	247	63.26	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9308.2	B08		4	0082-0182	233.32	181.46	300	68.18	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10379.6	B08		4	0083-0180	310.78	180.92	232	56.28	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11016.9	B08		4	0084-0185	70.87	183.78	239	60.77	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14510.5	B08		4	0085-0186	549.29	186.57	365	70.67	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9059.6	B08		4	0086-0189	897.78	188.80	401	76.08	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11077.3	B08		4	0087-0189	670.54	188.33	240	58.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14678.7	B08		4	0088-0192	286.83	192.36	336	70.08	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13158.4	B08		4	0089-0193	616.47	193.71	205	55.11	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12187.4	B08		4	0090-0199	343.20	198.44	387	74.91	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9337.2	B08		4	0091-0197	474.47	197.98	279	62.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15214.3	B08		4	0092-0200	270.94	200.21	198	54.53	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11857.3	B08		4	0093-0201	515.72	200.27	291	64.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9906.0	B08		4	0094-0203	936.46	203.12	246	60.43	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9820.0	B08		4	0095-0209	22.00	209.14	321	76.18	0.695
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14889.5	B08		4	0096-0205	578.42	204.94	380	71.36	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12314.0	B08		4	0097-0203	380.38	202.68	222	56.28	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12406.6	B08		4	0098-0204	131.18	204.17	215	55.94	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10988.1	B08		4	0099-0207	617.57	207.58	247	61.70	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14480.1	B08		4	0100-0214	706.96	213.52	297	64.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12475.2	B08		4	0101-0217	272.55	216.54	216	59.36	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9769.7	B08		4	0102-0218	120.50	218.74	275	64.53	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12574.1	B08		4	0103-0223	558.63	223.58	465	84.08	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12780.5	B08		4	0104-0220	86.17	220.59	199	52.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10714.7	B08		4	0105-0222	632.34	222.35	268	62.43	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10634.9	B08		4	0106-0223	422.80	223.32	251	59.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10561.1	B08		4	0107-0228	60.11	227.98	256	60.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10295.1	B08		4	0108-0226	587.53	226.41	257	59.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11239.8	B08		4	0109-0228	479.79	228.88	256	63.01	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11054.0	B08		4	0110-0231	242.52	231.78	371	74.18	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11780.6	B08		4	0111-0231	454.26	230.39	231	55.70	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12715.6	B08		4	0112-0240	795.06	239.85	337	68.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11901.5	B08		4	0113-0239	370.73	238.64	297	64.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14548.0	B08		4	0114-0238	395.07	237.47	198	53.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12796.2	B08		4	0115-0238	31.13	238.21	231	57.36	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13486.2	B08		4	0116-0243	163.34	243.94	364	71.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14498.9	B08		4	0117-0242	542.80	242.93	185	55.46	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14839.8	B08		4	0118-0243	855.25	243.75	187	51.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12767.3	B08		4	0119-0246	261.20	246.46	213	54.53	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11449.3	B08		4	0120-0247	506.41	247.48	233	56.28	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10267.1	B08		4	0121-0253	424.23	252.69	261	61.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10103.5	B08		4	0122-0257	16.82	256.93	287	63.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10727.2	B08		4	0123-0259	587.93	260.00	252	65.01	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17945.7	B08		4	0124-0255	869.18	255.90	154	73.74	0.356
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15112.8	B08		4	0125-0257	549.07	256.53	179	52.53	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12998.7	B08		4	0126-0259	820.99	259.13	215	56.53	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9059.3	B08		4	0127-0263	896.26	264.51	303	67.60	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11437.1	B08		4	0128-0265	370.12	264.64	226	55.70	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10047.9	B08		4	0129-0272	749.01	271.91	526	86.91	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11525.5	B08		4	0130-0270	108.85	270.49	342	69.60	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14394.5	B08		4	0131-0264	258.33	264.53	181	49.46	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20414.3	B08		4	0132-0268	199.78	268.16	272	61.36	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14399.2	B08		4	0133-0266	434.03	266.36	181	50.04	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11544.5	B08		4	0134-0270	132.52	270.68	237	57.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21968.5	B08		4	0135-0272	383.11	270.73	158	51.11	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11496.0	B08		4	0136-0275	601.91	274.79	252	59.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12900.0	B08		4	0137-0278	569.84	278.36	308	65.26	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11144.6	B08		4	0138-0278	50.14	278.38	250	59.11	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10229.3	B08		4	0139-0278	214.25	278.96	272	61.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14432.8	B08		4	0140-0278	396.04	277.77	240	59.60	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12953.7	B08		4	0141-0279	414.23	279.20	221	57.36	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10889.1	B08		4	0142-0287	479.47	286.64	258	61.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11085.3	B08		4	0143-0291	253.75	291.05	235	60.53	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11735.0	B08		4	0144-0290	556.80	290.27	231	61.01	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9283.6	B08		4	0145-0292	804.57	291.33	267	67.94	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10879.3	B08		4	0146-0293	833.47	292.81	236	57.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17460.6	B08		4	0147-0290	116.51	290.99	150	46.87	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12174.4	B08		4	0148-0291	134.88	291.50	224	54.28	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10451.3	B08		4	0149-0295	170.41	295.48	256	59.36	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15655.8	B08		4	0150-0300	79.90	299.71	377	73.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20764.8	B08		4	0151-0297	340.36	297.42	224	65.01	0.666
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14390.4	B08		4	0152-0306	848.96	306.04	363	70.43	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10725.3	B08		4	0153-0305	580.13	305.85	263	61.60	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10955.1	B08		4	0154-0306	266.38	306.65	255	63.70	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13238.1	B08		4	0155-0304	426.22	304.47	293	70.28	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12484.5	B08		4	0156-0308	771.97	308.78	268	61.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11118.4	B08		4	0157-0310	701.07	310.10	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11521.4	B08		4	0158-0314	241.79	314.07	223	55.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13227.0	B08		4	0159-0318	864.87	318.80	329	69.84	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14203.9	B08		4	0160-0316	426.73	316.36	194	54.87	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11044.4	B08		4	0161-0320	304.77	321.14	227	56.28	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14785.5	B08		4	0162-0327	383.06	326.66	361	74.53	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14024.9	B08		4	0163-0332	509.64	331.99	402	77.50	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9496.7	B08		4	0164-0335	204.03	334.75	270	60.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14475.2	B08		4	0165-0344	355.36	343.79	402	75.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11894.4	B08		4	0166-0339	57.70	339.44	229	57.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14374.6	B08		4	0167-0345	257.77	345.48	367	71.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10088.5	B08		4	0168-0348	683.97	347.91	269	62.18	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9574.8	B08		4	0169-0349	923.36	349.53	318	67.01	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9979.8	B08		4	0170-0350	306.71	349.98	262	60.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12776.0	B08		4	0171-0349	798.73	349.42	249	64.18	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17027.4	B08		4	0172-0354	856.66	353.38	287	62.43	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10803.8	B08		4	0173-0354	27.62	354.81	251	69.84	0.647
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13687.8	B08		4	0174-0361	69.30	360.62	363	70.77	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11708.7	B08		4	0175-0361	794.64	361.10	169	49.70	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15490.4	B08		4	0176-0366	871.02	366.20	355	72.18	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12678.7	B08		4	0177-0369	145.55	369.24	223	55.11	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10920.7	B08		4	0178-0381	287.82	381.21	479	88.33	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11512.7	B08		4	0179-0378	334.49	378.08	223	57.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9631.4	B08		4	0180-0384	670.09	383.67	289	64.18	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11463.9	B08		4	0181-0383	851.40	383.37	236	57.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10437.2	B08		4	0182-0383	917.72	383.24	299	64.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12070.6	B08		4	0183-0386	576.32	386.15	240	59.84	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14939.2	B08		4	0184-0387	418.73	387.11	311	64.18	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14704.2	B08		4	0185-0390	124.30	390.25	186	53.36	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8440.6	B08		4	0186-0394	365.20	394.49	281	66.67	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11323.5	B08		4	0187-0391	494.81	391.49	250	62.18	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9257.3	B08		4	0188-0398	183.49	398.08	301	66.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10863.5	B08		4	0189-0400	98.22	399.80	254	77.84	0.527
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14209.9	B08		4	0190-0400	135.37	401.02	223	54.77	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11568.7	B08		4	0191-0405	156.03	405.04	308	66.43	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11486.3	B08		4	0192-0408	821.50	408.19	249	62.77	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16660.7	B08		4	0193-0411	614.01	410.08	287	65.01	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17674.8	B08		4	0194-0410	649.13	410.07	302	67.01	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15407.2	B08		4	0195-0417	395.36	417.62	367	72.67	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10841.8	B08		4	0196-0415	479.20	415.09	240	58.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12381.2	B08		4	0197-0416	556.77	415.96	302	66.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12082.8	B08		4	0198-0417	942.83	416.70	256	59.11	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11180.2	B08		4	0199-0419	913.28	418.81	232	57.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11194.1	B08		4	0200-0427	43.01	427.15	337	67.36	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10384.7	B08		4	0201-0426	245.01	425.35	253	63.36	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18485.8	B08		4	0202-0432	322.69	431.90	417	78.08	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12067.3	B08		4	0203-0430	351.01	431.03	219	58.53	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10519.5	B08		4	0204-0437	619.88	438.32	364	82.43	0.673
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11424.5	B08		4	0205-0437	93.59	437.36	451	82.08	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11671.0	B08		4	0206-0436	698.93	436.19	371	71.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13603.1	B08		4	0207-0440	172.17	439.91	341	68.18	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10469.7	B08		4	0208-0441	829.11	440.75	250	61.11	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14575.3	B08		4	0209-0443	796.47	444.09	188	50.53	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11392.1	B08		4	0210-0449	400.15	449.28	231	57.11	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11272.5	B08		4	0211-0454	763.35	453.28	232	57.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12569.3	B08		4	0212-0458	906.67	457.70	363	71.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16141.5	B08		4	0213-0460	423.06	460.13	251	60.28	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11101.8	B08		4	0214-0461	634.10	461.13	243	57.11	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9888.4	B08		4	0215-0463	862.53	463.11	269	61.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10731.3	B08		4	0216-0465	240.80	466.18	243	59.60	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10015.6	B08		4	0217-0464	500.68	464.47	268	60.87	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12129.5	B08		4	0218-0465	736.76	464.94	140	46.04	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12690.1	B08		4	0219-0467	924.68	467.49	402	74.18	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10846.1	B08		4	0220-0465	106.92	465.57	237	58.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10236.3	B08		4	0221-0473	551.33	473.05	269	63.94	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15599.0	B08		4	0222-0466	748.72	466.50	110	38.63	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12242.9	B08		4	0223-0472	41.64	471.90	337	70.43	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12122.3	B08		4	0224-0474	434.46	474.20	297	66.77	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15927.7	B08		4	0225-0476	573.17	476.07	272	62.53	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9847.6	B08		4	0226-0478	296.05	477.74	264	63.26	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15566.5	B08		4	0227-0477	587.41	477.46	213	54.63	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11071.7	B08		4	0228-0477	624.85	477.87	249	57.36	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10541.8	B08		4	0229-0478	773.47	478.74	248	62.43	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12601.1	B08		4	0230-0479	751.17	479.18	167	47.11	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9933.3	B08		4	0231-0481	825.06	480.57	285	64.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11486.5	B08		4	0232-0485	189.56	485.76	327	69.60	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11721.6	B08		4	0233-0485	165.66	485.49	220	53.94	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10964.4	B08		4	0234-0487	331.71	486.88	242	60.28	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11169.3	B08		4	0235-0487	404.26	487.00	244	60.53	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11138.4	B08		4	0236-0489	876.92	489.21	241	57.11	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12025.1	B08		4	0237-0487	97.63	488.05	206	58.53	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10061.7	B08		4	0238-0491	603.73	490.85	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12637.0	B08		4	0239-0491	674.89	490.66	282	62.43	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10992.1	B08		4	0240-0491	378.68	492.19	243	59.11	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13224.5	B08		4	0241-0496	123.05	495.88	287	63.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13862.4	B08		4	0242-0494	814.64	495.00	192	53.11	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10114.1	B08		4	0243-0502	713.55	501.65	378	75.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15680.4	B08		4	0244-0499	510.71	499.10	178	50.87	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18022.8	B08		4	0245-0502	247.12	501.64	313	66.77	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8634.0	B08		4	0246-0503	465.57	503.07	296	69.36	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12514.2	B08		4	0247-0504	207.05	503.81	213	55.46	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12280.7	B08		4	0248-0505	317.37	506.23	205	58.87	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19330.5	B08		4	0249-0505	526.72	504.67	133	44.04	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12468.9	B08		4	0250-0509	893.48	509.56	256	58.53	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11757.9	B08		4	0251-0510	769.85	509.88	229	57.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10111.6	B08		4	0252-0515	912.53	515.34	272	63.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13144.8	B08		4	0253-0516	166.09	516.56	195	52.53	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12945.5	B08		4	0254-0519	324.07	518.57	206	56.53	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11620.6	B08		4	0255-0523	62.95	523.51	283	62.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11132.0	B08		4	0256-0521	408.93	520.60	252	59.01	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13796.1	B08		4	0257-0523	632.41	523.01	299	65.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10558.0	B08		4	0258-0524	349.28	523.74	255	61.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19903.0	B08		4	0259-0525	35.65	525.09	254	65.84	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8820.6	B08		4	0260-0525	667.34	525.91	286	66.43	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11905.8	B08		4	0261-0529	219.15	529.19	279	66.43	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15079.2	B08		4	0262-0527	823.19	526.28	182	51.11	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13034.5	B08		4	0263-0529	189.07	529.13	203	53.11	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10024.2	B08		4	0264-0535	305.67	536.40	353	71.94	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10467.7	B08		4	0265-0536	271.64	534.96	247	62.87	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10063.9	B08		4	0266-0538	853.41	538.09	256	62.43	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12791.4	B08		4	0267-0543	519.43	543.96	379	74.67	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10720.8	B08		4	0268-0543	462.46	543.84	146	47.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8828.9	B08		4	0269-0545	612.72	545.77	302	66.67	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10105.9	B08		4	0270-0546	483.70	546.75	285	67.60	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10479.4	B08		4	0271-0546	120.03	546.11	297	64.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12899.0	B08		4	0272-0551	386.36	551.34	382	75.50	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9957.1	B08		4	0273-0545	452.01	545.29	113	39.21	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13232.6	B08		4	0274-0549	826.28	549.64	208	55.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12109.0	B08		4	0275-0553	769.54	553.39	208	57.01	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10345.3	B08		4	0276-0553	896.29	553.02	252	59.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11453.3	B08		4	0277-0556	169.22	558.38	335	78.18	0.689
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13246.8	B08		4	0278-0552	257.75	552.29	134	46.04	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11492.7	B08		4	0279-0555	927.66	554.65	218	53.70	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11657.5	B08		4	0280-0562	695.36	561.59	340	69.84	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11040.9	B08		4	0281-0560	39.92	559.67	217	54.28	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12365.3	B08		4	0282-0559	792.50	558.57	225	55.94	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10289.0	B08		4	0283-0562	661.76	562.49	244	58.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10850.0	B08		4	0284-0566	442.11	565.66	250	59.11	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16092.2	B08		4	0285-0571	626.34	571.54	350	72.91	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10930.4	B08		4	0286-0573	745.64	573.60	268	64.28	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12537.1	B08		4	0287-0579	202.08	578.90	254	59.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10543.7	B08		4	0288-0580	355.71	580.32	261	71.26	0.646
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10512.7	B08		4	0289-0578	55.91	579.20	240	59.11	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12631.5	B08		4	0290-0584	101.22	583.64	271	62.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9168.2	B08		4	0291-0587	896.46	587.20	239	57.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12186.1	B08		4	0292-0590	503.77	590.15	227	55.70	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8809.6	B08		4	0293-0593	414.11	594.58	329	71.01	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8855.6	B08		4	0294-0594	466.09	594.47	170	48.63	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12737.9	B08		4	0295-0595	631.79	594.98	228	56.28	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11552.2	B08		4	0296-0599	330.30	599.10	240	58.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11304.1	B08		4	0297-0600	878.35	600.18	225	56.87	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16318.4	B08		4	0298-0604	265.33	603.70	313	65.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11036.1	B08		4	0299-0605	521.43	604.79	295	64.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16675.1	B08		4	0300-0603	612.33	602.58	160	46.87	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10821.8	B08		4	0301-0605	933.74	605.18	223	55.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9850.1	B08		4	0302-0606	483.26	606.68	184	53.36	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15427.9	B08		4	0303-0607	792.06	607.40	263	59.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11900.9	B08		4	0304-0610	238.36	610.41	227	56.28	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12404.3	B08		4	0305-0612	213.73	611.44	215	55.70	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15769.3	B08		4	0306-0615	619.13	615.35	176	49.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10696.3	B08		4	0307-0622	857.02	622.48	252	59.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13418.4	B08		4	0308-0620	180.51	620.54	198	53.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10554.2	B08		4	0309-0621	647.58	621.74	256	60.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9340.8	B08		4	0310-0626	931.96	626.09	277	71.60	0.679
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10329.0	B08		4	0311-0627	369.29	627.77	272	62.18	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14089.3	B08		4	0312-0628	240.10	627.52	191	51.11	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12078.8	B08		4	0313-0631	112.43	631.22	295	62.77	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10566.7	B08		4	0314-0631	594.04	631.05	250	59.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11460.6	B08		4	0315-0634	396.37	634.05	245	61.60	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13965.8	B08		4	0316-0636	439.91	636.09	375	71.60	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11021.8	B08		4	0317-0638	518.47	638.36	294	65.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12314.1	B08		4	0318-0638	851.28	638.87	219	54.87	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13410.1	B08		4	0319-0639	71.19	639.60	175	49.80	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11374.9	B08		4	0320-0643	355.90	642.50	300	67.50	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13125.0	B08		4	0321-0643	720.20	643.02	246	59.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11355.2	B08		4	0322-0650	276.52	648.14	493	95.50	0.679
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13823.5	B08		4	0323-0648	471.83	647.96	344	69.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9642.3	B08		4	0324-0643	623.44	642.89	206	61.36	0.688
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12049.9	B08		4	0325-0651	550.39	650.86	460	82.33	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13028.4	B08		4	0326-0649	751.38	649.17	248	62.53	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10721.0	B08		4	0327-0655	677.54	656.14	307	64.18	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10966.0	B08		4	0328-0657	92.49	656.86	234	56.28	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10795.5	B08		4	0329-0665	419.08	665.94	283	62.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14249.5	B08		4	0330-0665	464.09	665.02	258	60.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13712.8	B08		4	0331-0668	138.91	668.35	265	62.18	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11521.5	B08		4	0332-0670	579.98	670.48	218	55.70	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13590.5	B08		4	0333-0669	157.98	669.52	183	52.53	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13665.4	B08		4	0334-0677	304.96	677.31	383	75.01	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15872.2	B08		4	0335-0676	369.06	676.55	337	71.84	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11946.6	B08		4	0336-0676	106.14	676.43	226	57.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9366.1	B08		4	0337-0681	489.96	681.89	293	70.53	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10473.4	B08		4	0338-0679	219.54	679.54	244	57.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17131.6	B08		4	0339-0682	439.59	681.45	316	65.60	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16774.8	B08		4	0340-0682	341.94	682.00	147	49.11	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14678.4	B08		4	0341-0686	771.81	686.37	246	59.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16663.9	B08		4	0342-0687	352.74	686.86	160	48.87	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11126.7	B08		4	0343-0689	66.90	688.40	228	58.28	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12118.7	B08		4	0344-0695	584.28	694.25	440	78.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10368.9	B08		4	0345-0693	190.14	693.68	257	58.77	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9536.8	B08		4	0346-0694	508.55	695.05	278	66.18	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12965.8	B08		4	0347-0699	91.54	698.54	186	51.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9634.8	B08		4	0348-0701	321.09	700.57	259	61.94	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8499.7	B08		4	0349-0701	852.08	700.68	243	63.01	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11575.4	B08		4	0350-0704	139.10	703.95	232	56.18	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20050.9	B08		4	0351-0707	82.78	707.84	131	43.11	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11089.9	B08		4	0352-0709	249.40	709.38	245	58.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185110	1375312	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11026.1	B08		4	0353-0708	826.55	707.85	222	55.36	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11467.4	B08		5	0001-0030	295.53	30.88	233	58.53	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13474.0	B08		5	0002-0025	894.81	25.66	191	53.70	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8634.7	B08		5	0003-0032	81.20	32.85	281	64.43	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11554.8	B08		5	0004-0030	386.33	30.11	243	57.36	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14006.9	B08		5	0005-0033	557.30	33.38	357	71.01	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11547.6	B08		5	0006-0035	647.06	35.19	464	81.50	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11909.7	B08		5	0007-0034	764.63	33.50	320	66.43	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13777.9	B08		5	0008-0038	17.47	38.56	167	48.28	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10193.6	B08		5	0009-0038	843.73	38.50	257	60.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9194.4	B08		5	0010-0042	103.70	41.70	286	67.01	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11115.3	B08		5	0011-0044	38.23	44.27	412	80.67	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14560.0	B08		5	0012-0040	618.67	39.46	201	53.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12292.1	B08		5	0013-0041	935.18	41.15	306	66.08	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15576.5	B08		5	0014-0045	205.15	45.67	328	68.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9317.5	B08		5	0015-0046	353.28	45.99	285	63.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11347.8	B08		5	0016-0046	438.62	46.09	260	60.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8541.7	B08		5	0017-0047	119.53	46.85	227	64.53	0.685
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12838.8	B08		5	0018-0053	699.81	51.11	402	85.50	0.691
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12250.4	B08		5	0019-0054	728.32	54.59	354	69.26	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12197.1	B08		5	0020-0053	890.76	53.19	218	61.84	0.716
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16430.0	B08		5	0021-0058	502.59	57.05	187	55.01	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8466.9	B08		5	0022-0061	125.53	61.72	186	57.60	0.705
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11923.3	B08		5	0023-0061	392.17	61.28	300	68.77	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11348.0	B08		5	0024-0063	865.42	63.69	284	63.36	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13394.6	B08		5	0025-0063	445.32	62.52	211	55.11	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11584.6	B08		5	0026-0068	600.83	67.82	454	81.74	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14448.9	B08		5	0027-0065	641.80	65.14	294	62.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17017.0	B08		5	0028-0072	240.01	71.95	365	82.33	0.677
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10126.1	B08		5	0029-0078	458.41	79.37	349	74.67	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9383.6	B08		5	0030-0074	786.62	75.24	278	64.53	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11533.6	B08		5	0031-0083	537.97	83.52	521	87.84	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11166.0	B08		5	0032-0080	179.82	80.24	229	56.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10761.8	B08		5	0033-0081	307.41	81.64	241	59.36	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11341.8	B08		5	0034-0088	583.99	88.43	520	87.50	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11073.5	B08		5	0035-0088	146.95	87.66	229	58.53	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11760.4	B08		5	0036-0087	849.53	86.85	227	55.94	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10119.1	B08		5	0037-0091	693.33	91.22	257	63.60	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8521.7	B08		5	0038-0093	756.68	92.98	318	65.84	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11188.5	B08		5	0039-0093	325.58	92.74	406	75.60	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17816.0	B08		5	0040-0095	19.60	95.63	297	63.70	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9759.9	B08		5	0041-0096	621.58	96.99	278	64.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11590.0	B08		5	0042-0096	919.57	96.30	211	53.11	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10722.1	B08		5	0043-0099	829.40	98.50	296	63.94	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11850.6	B08		5	0044-0098	366.33	98.06	223	56.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16034.8	B08		5	0045-0102	285.85	102.24	239	58.77	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8787.3	B08		5	0046-0102	477.28	102.34	344	72.43	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11108.1	B08		5	0047-0105	179.89	105.00	227	57.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10564.4	B08		5	0048-0104	387.49	104.30	273	63.36	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13338.9	B08		5	0049-0110	219.10	111.22	376	75.01	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11582.9	B08		5	0050-0115	432.47	114.86	232	56.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12321.1	B08		5	0051-0122	262.18	122.33	412	75.26	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14484.2	B08		5	0052-0121	613.89	121.83	356	69.60	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14194.7	B08		5	0053-0123	124.96	123.50	317	64.77	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15402.6	B08		5	0054-0127	499.69	125.98	329	73.01	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11423.7	B08		5	0055-0125	317.65	125.28	227	55.94	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12928.8	B08		5	0056-0131	934.50	130.73	378	75.50	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12583.6	B08		5	0057-0128	671.91	127.74	201	52.53	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11249.9	B08		5	0058-0129	98.76	129.47	303	69.36	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13081.8	B08		5	0059-0132	181.45	131.89	279	62.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12524.6	B08		5	0060-0135	445.04	135.96	391	73.26	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9456.0	B08		5	0061-0134	731.47	134.75	276	64.18	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9982.0	B08		5	0062-0138	792.76	138.55	261	59.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11274.0	B08		5	0063-0135	814.56	134.93	256	61.70	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11686.9	B08		5	0064-0142	529.19	142.32	257	60.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10902.4	B08		5	0065-0141	863.11	141.44	233	57.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10006.8	B08		5	0066-0142	911.83	142.77	267	63.60	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14205.3	B08		5	0067-0154	221.83	153.34	667	103.64	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12512.8	B08		5	0068-0147	339.76	146.34	344	69.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10921.8	B08		5	0069-0146	572.14	145.82	248	57.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12273.2	B08		5	0070-0147	654.58	147.15	297	64.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13135.9	B08		5	0071-0147	817.26	148.11	194	56.04	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10695.2	B08		5	0072-0149	362.62	149.64	258	63.11	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10937.1	B08		5	0073-0153	468.98	152.96	303	65.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9123.0	B08		5	0074-0152	46.23	152.22	276	62.53	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12512.9	B08		5	0075-0155	326.26	154.69	198	53.60	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12717.4	B08		5	0076-0158	131.27	157.77	294	64.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9429.6	B08		5	0077-0160	412.59	160.42	281	64.53	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11503.9	B08		5	0078-0159	860.83	159.21	240	58.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11280.4	B08		5	0079-0168	300.99	166.56	212	59.11	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8927.3	B08		5	0080-0169	563.53	168.26	300	72.43	0.719
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13871.6	B08		5	0081-0169	283.17	169.11	340	70.77	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13025.2	B08		5	0082-0170	520.66	170.02	368	70.43	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8064.5	B08		5	0083-0173	714.30	172.85	300	76.43	0.645
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12434.9	B08		5	0084-0176	599.34	175.96	280	65.94	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10342.4	B08		5	0085-0177	767.45	177.37	261	62.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13037.3	B08		5	0086-0183	297.78	183.35	207	53.70	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10434.0	B08		5	0087-0188	458.13	187.82	262	61.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13806.7	B08		5	0088-0186	827.90	186.74	189	55.36	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15254.4	B08		5	0089-0190	123.16	189.82	298	64.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11134.6	B08		5	0090-0189	743.36	189.75	238	57.70	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11714.3	B08		5	0091-0191	435.58	190.96	270	59.94	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7655.9	B08		5	0092-0192	688.43	191.92	324	67.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10522.6	B08		5	0093-0195	802.67	195.07	270	67.26	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10760.2	B08		5	0094-0197	379.86	197.12	323	66.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10582.1	B08		5	0095-0200	532.69	199.42	324	68.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13986.9	B08		5	0096-0199	294.42	199.07	185	53.11	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14221.1	B08		5	0097-0201	256.90	201.30	177	48.87	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14349.2	B08		5	0098-0202	489.30	202.45	295	62.77	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9152.2	B08		5	0099-0205	89.56	204.45	266	63.60	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8283.7	B08		5	0100-0202	599.49	200.85	172	53.70	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12276.5	B08		5	0101-0203	855.77	204.11	257	60.28	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9647.1	B08		5	0102-0205	41.27	205.25	244	59.60	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12509.3	B08		5	0103-0209	559.41	208.92	460	83.26	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14419.6	B08		5	0104-0209	818.71	209.27	352	69.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10752.7	B08		5	0105-0212	363.48	212.07	256	61.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9048.5	B08		5	0106-0207	608.13	207.61	120	42.28	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15537.2	B08		5	0107-0213	243.40	213.91	322	69.26	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12025.2	B08		5	0108-0216	625.16	216.59	319	66.18	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11326.8	B08		5	0109-0223	312.51	224.14	373	80.33	0.726
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11309.2	B08		5	0110-0221	154.93	221.42	238	57.70	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9968.1	B08		5	0111-0222	388.83	221.77	269	61.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10798.4	B08		5	0112-0224	462.43	223.48	257	59.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10865.0	B08		5	0113-0227	527.41	227.24	242	57.46	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11699.4	B08		5	0114-0231	138.45	230.97	229	55.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12416.8	B08		5	0115-0231	354.39	231.96	211	54.53	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14877.0	B08		5	0116-0235	717.67	234.91	391	75.01	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12419.1	B08		5	0117-0232	327.87	231.96	209	53.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10424.0	B08		5	0118-0233	485.95	233.10	274	61.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12877.9	B08		5	0119-0234	549.68	234.97	201	53.36	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8508.8	B08		5	0120-0236	920.16	237.33	301	67.84	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11763.3	B08		5	0121-0238	698.47	238.19	231	56.53	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8605.4	B08		5	0122-0243	786.65	243.09	305	70.43	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13752.4	B08		5	0123-0243	182.01	242.88	185	52.53	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13687.5	B08		5	0124-0247	806.30	247.73	346	69.01	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10721.9	B08		5	0125-0248	342.03	248.20	243	61.60	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12216.5	B08		5	0126-0246	747.93	245.72	211	53.70	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9534.7	B08		5	0127-0251	627.61	251.69	278	63.70	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10259.6	B08		5	0128-0251	839.54	251.41	302	67.01	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8693.2	B08		5	0129-0253	672.20	253.35	290	66.67	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12191.7	B08		5	0130-0255	416.23	254.89	359	69.60	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10060.8	B08		5	0131-0257	234.72	258.05	280	62.18	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10910.3	B08		5	0132-0258	926.87	258.22	304	65.01	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14321.3	B08		5	0133-0259	529.60	259.62	179	50.28	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12638.6	B08		5	0134-0263	370.21	262.63	206	54.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9983.4	B08		5	0135-0265	886.90	264.94	301	63.94	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10915.9	B08		5	0136-0267	603.02	266.82	234	57.94	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9815.8	B08		5	0137-0271	722.33	270.70	281	65.26	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9009.1	B08		5	0138-0274	788.48	273.86	302	64.67	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10374.8	B08		5	0139-0274	286.41	274.47	246	58.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13332.3	B08		5	0140-0275	578.73	274.92	399	75.84	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13395.3	B08		5	0141-0278	471.49	278.13	376	72.43	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8217.3	B08		5	0142-0279	763.35	279.52	327	70.77	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14340.3	B08		5	0143-0285	683.06	284.72	557	96.81	0.747
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10137.5	B08		5	0144-0283	157.84	283.31	270	62.28	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10390.6	B08		5	0145-0282	931.41	282.99	332	68.77	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9745.8	B08		5	0146-0285	305.08	285.40	281	66.43	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9503.8	B08		5	0147-0289	855.11	291.27	292	73.26	0.684
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8885.6	B08		5	0148-0292	652.58	292.68	293	64.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10597.0	B08		5	0149-0293	254.65	293.39	363	72.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14939.8	B08		5	0150-0292	351.44	291.95	169	50.53	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11560.5	B08		5	0151-0296	832.99	296.12	326	66.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11328.7	B08		5	0152-0301	386.36	301.03	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11219.5	B08		5	0153-0297	621.94	297.75	232	59.46	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12004.4	B08		5	0154-0306	946.53	306.29	208	58.53	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10274.0	B08		5	0155-0305	480.20	305.32	257	61.94	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15137.5	B08		5	0156-0306	344.77	306.66	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10277.1	B08		5	0157-0310	929.56	310.24	264	59.36	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11403.7	B08		5	0158-0311	743.22	311.03	377	73.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14262.0	B08		5	0159-0312	518.81	312.77	358	71.01	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10406.3	B08		5	0160-0319	431.69	319.49	278	62.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9490.3	B08		5	0161-0321	867.44	320.62	300	65.01	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14125.5	B08		5	0162-0322	603.54	321.53	290	64.77	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14049.1	B08		5	0163-0324	762.76	324.64	284	64.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11352.8	B08		5	0164-0324	697.15	324.25	312	65.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11522.7	B08		5	0165-0328	256.84	329.58	236	62.77	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11919.2	B08		5	0166-0330	903.78	330.83	318	65.94	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10424.7	B08		5	0167-0332	640.93	332.77	255	59.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14838.9	B08		5	0168-0334	385.47	335.14	313	70.43	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11848.5	B08		5	0169-0339	199.53	339.86	402	79.26	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14929.3	B08		5	0170-0337	336.46	336.80	347	68.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11265.3	B08		5	0171-0337	109.22	337.39	234	55.70	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13892.9	B08		5	0172-0341	728.54	341.60	301	64.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8892.9	B08		5	0173-0348	247.30	348.39	312	73.01	0.735
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10020.0	B08		5	0174-0347	518.90	347.95	266	61.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16273.1	B08		5	0175-0350	550.53	349.87	304	66.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9212.1	B08		5	0176-0351	28.14	351.54	308	65.01	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10278.4	B08		5	0177-0351	671.10	352.07	300	66.43	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10707.4	B08		5	0178-0351	288.63	351.57	242	57.36	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14692.5	B08		5	0179-0353	605.08	353.64	328	67.84	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12308.3	B08		5	0180-0350	388.40	350.64	213	55.70	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9813.6	B08		5	0181-0355	313.02	354.74	290	68.67	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9340.4	B08		5	0182-0363	367.52	363.21	367	73.74	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11043.7	B08		5	0183-0361	868.51	361.52	228	55.70	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10876.2	B08		5	0184-0364	481.68	364.53	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12226.8	B08		5	0185-0366	744.53	366.18	361	73.84	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10257.9	B08		5	0186-0370	155.81	369.80	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12070.9	B08		5	0187-0368	583.87	367.91	293	63.01	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9929.1	B08		5	0188-0369	793.88	369.56	267	62.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9433.5	B08		5	0189-0374	425.48	374.39	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8280.0	B08		5	0190-0376	815.09	375.59	267	71.01	0.665
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15310.4	B08		5	0191-0377	708.52	377.08	346	67.60	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10840.5	B08		5	0192-0379	228.04	379.25	321	67.60	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14635.2	B08		5	0193-0382	762.06	381.50	344	70.18	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10080.5	B08		5	0194-0384	331.51	384.50	264	59.94	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9625.3	B08		5	0195-0383	57.91	383.42	245	60.18	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8975.9	B08		5	0196-0384	638.43	383.82	173	55.36	0.709
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9951.5	B08		5	0197-0385	22.61	385.34	298	64.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11031.8	B08		5	0198-0387	437.65	386.44	260	61.70	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11693.3	B08		5	0199-0387	264.16	387.60	220	54.87	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7976.5	B08		5	0200-0388	941.49	389.46	247	73.26	0.578
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9928.3	B08		5	0201-0387	298.35	387.32	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17328.7	B08		5	0202-0388	545.48	388.10	243	57.70	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12428.3	B08		5	0203-0390	123.06	389.49	212	55.36	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14567.3	B08		5	0204-0390	474.10	389.95	175	51.36	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9214.4	B08		5	0205-0398	374.06	400.10	337	75.60	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11391.3	B08		5	0206-0399	415.64	399.44	436	78.33	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10236.6	B08		5	0207-0397	845.35	396.76	330	67.36	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7669.5	B08		5	0208-0396	924.48	396.26	284	64.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9676.0	B08		5	0209-0400	96.75	399.85	268	60.53	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13160.8	B08		5	0210-0400	184.98	400.23	329	68.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11491.6	B08		5	0211-0402	596.83	402.10	318	65.94	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12109.3	B08		5	0212-0400	767.01	400.97	234	57.11	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10998.9	B08		5	0213-0402	234.24	403.18	236	57.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9494.3	B08		5	0214-0405	880.80	404.72	302	65.84	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13766.1	B08		5	0215-0408	503.17	407.93	387	73.84	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12278.0	B08		5	0216-0412	850.68	411.78	215	55.70	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9934.9	B08		5	0217-0418	295.11	418.75	263	60.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9017.3	B08		5	0218-0417	753.99	417.39	295	65.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11697.9	B08		5	0219-0419	47.72	418.73	257	58.53	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10410.2	B08		5	0220-0418	264.96	418.82	253	58.77	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14464.2	B08		5	0221-0420	553.94	420.70	336	68.08	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10666.1	B08		5	0222-0421	18.23	420.86	230	57.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13653.4	B08		5	0223-0423	649.21	422.77	326	67.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11272.5	B08		5	0224-0419	716.50	418.66	237	59.36	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10003.2	B08		5	0225-0423	159.47	423.16	268	60.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15536.8	B08		5	0226-0425	207.15	424.76	172	50.63	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11779.7	B08		5	0227-0427	249.84	426.62	227	60.18	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17179.4	B08		5	0228-0427	107.31	427.34	224	63.70	0.694
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20602.2	B08		5	0229-0429	93.76	430.11	133	48.53	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10147.9	B08		5	0230-0431	771.38	430.11	262	61.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9599.3	B08		5	0231-0434	318.65	433.86	279	61.60	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8913.5	B08		5	0232-0436	825.71	436.90	333	77.26	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12054.8	B08		5	0233-0434	357.52	434.58	213	55.11	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11715.4	B08		5	0234-0436	338.58	436.41	238	56.77	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11047.9	B08		5	0235-0440	453.24	439.97	251	59.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12140.2	B08		5	0236-0440	716.10	440.61	294	67.01	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8931.1	B08		5	0237-0446	893.39	445.58	305	64.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10634.6	B08		5	0238-0446	397.03	446.42	252	59.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14232.1	B08		5	0239-0446	759.84	446.37	329	66.53	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10963.9	B08		5	0240-0453	613.76	454.39	375	73.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10058.1	B08		5	0241-0451	254.41	451.25	265	60.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12902.9	B08		5	0242-0449	646.18	449.41	106	40.04	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8991.1	B08		5	0243-0454	851.35	454.92	285	66.18	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13410.4	B08		5	0244-0454	459.56	455.29	210	58.53	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10766.9	B08		5	0245-0457	416.62	458.31	258	66.28	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11674.4	B08		5	0246-0459	474.40	458.61	271	62.04	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9570.1	B08		5	0247-0463	580.88	463.68	282	64.53	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12401.3	B08		5	0248-0462	679.75	461.14	229	58.77	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11303.0	B08		5	0249-0466	315.02	467.28	416	85.15	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15956.5	B08		5	0250-0466	340.97	464.47	322	79.84	0.635
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13424.2	B08		5	0251-0467	388.98	466.28	351	71.01	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12156.7	B08		5	0252-0464	512.97	464.52	247	58.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9453.3	B08		5	0253-0468	540.87	467.65	321	68.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16605.6	B08		5	0254-0468	712.10	468.59	270	61.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12088.2	B08		5	0255-0469	29.72	469.57	398	73.60	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10866.3	B08		5	0256-0469	164.99	469.79	233	57.94	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13124.3	B08		5	0257-0469	362.12	469.38	203	53.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9443.5	B08		5	0258-0469	881.30	468.81	265	61.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13128.4	B08		5	0259-0476	686.25	474.81	263	66.67	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14637.9	B08		5	0260-0473	210.69	474.10	179	51.11	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11287.6	B08		5	0261-0474	566.06	474.60	193	54.18	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12341.0	B08		5	0262-0477	259.90	477.08	208	61.01	0.702
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10216.5	B08		5	0263-0478	916.21	478.80	260	64.18	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15743.2	B08		5	0264-0484	226.41	484.79	327	75.50	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15664.7	B08		5	0265-0486	669.26	486.42	312	65.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9887.5	B08		5	0266-0487	312.59	487.82	276	63.01	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11910.8	B08		5	0267-0486	388.91	486.62	233	59.36	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12075.1	B08		5	0268-0486	560.86	485.82	117	40.28	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14319.7	B08		5	0269-0495	621.80	496.89	534	92.91	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15694.1	B08		5	0270-0491	782.00	491.75	311	66.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11423.5	B08		5	0271-0491	816.80	492.21	224	56.53	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11487.9	B08		5	0272-0493	248.22	493.46	176	48.87	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10163.3	B08		5	0273-0500	654.32	501.07	277	63.94	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10724.8	B08		5	0274-0503	300.62	504.45	260	62.77	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14844.8	B08		5	0275-0506	798.25	505.60	326	70.53	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11131.6	B08		5	0276-0505	82.77	505.79	367	73.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12681.7	B08		5	0277-0504	208.16	504.19	201	51.94	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12115.6	B08		5	0278-0509	168.81	509.67	238	62.77	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14575.1	B08		5	0279-0509	454.85	508.90	311	65.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13888.0	B08		5	0280-0510	567.98	510.19	257	60.28	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12686.2	B08		5	0281-0508	251.51	507.81	140	46.39	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11612.8	B08		5	0282-0514	580.97	514.25	225	62.28	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12289.4	B08		5	0283-0513	947.71	513.22	271	60.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19596.5	B08		5	0284-0514	814.93	514.00	223	58.87	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10547.9	B08		5	0285-0515	766.65	516.13	269	60.28	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9667.2	B08		5	0286-0517	17.14	517.56	263	61.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12668.4	B08		5	0287-0518	185.06	519.87	257	64.77	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13073.2	B08		5	0288-0515	907.14	515.25	189	53.36	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10594.4	B08		5	0289-0520	851.89	519.62	257	59.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9808.1	B08		5	0290-0525	152.92	525.78	265	64.53	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12630.4	B08		5	0291-0523	500.45	522.77	313	65.01	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16795.7	B08		5	0292-0521	247.66	521.15	148	44.87	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10859.2	B08		5	0293-0526	310.58	526.06	250	61.36	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17393.3	B08		5	0294-0530	232.78	529.58	310	66.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13686.1	B08		5	0295-0528	699.51	528.23	219	54.87	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15143.5	B08		5	0296-0529	807.78	529.93	285	66.18	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11523.4	B08		5	0297-0529	602.50	528.81	243	57.36	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10760.2	B08		5	0298-0530	464.02	530.85	276	63.94	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13844.2	B08		5	0299-0535	526.23	535.26	278	62.53	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9478.3	B08		5	0300-0534	194.17	534.36	146	49.46	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10354.5	B08		5	0301-0537	631.59	536.87	273	62.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9242.6	B08		5	0302-0538	203.78	538.71	112	38.39	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11196.5	B08		5	0303-0541	943.14	542.26	251	61.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12303.2	B08		5	0304-0544	285.41	544.89	227	58.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11344.5	B08		5	0305-0542	66.73	542.40	222	54.53	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10840.8	B08		5	0306-0545	394.84	545.45	237	57.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15158.5	B08		5	0307-0547	416.32	546.55	299	65.60	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10700.2	B08		5	0308-0549	501.07	550.03	257	67.01	0.719
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12528.8	B08		5	0309-0548	914.84	547.20	322	67.60	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10681.3	B08		5	0310-0547	861.68	547.45	240	58.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10523.7	B08		5	0311-0550	333.81	549.73	238	60.43	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10772.5	B08		5	0312-0552	96.40	551.94	339	71.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18449.7	B08		5	0313-0550	271.40	550.14	145	47.70	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10761.7	B08		5	0314-0558	159.75	557.98	250	57.94	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11240.0	B08		5	0315-0557	32.26	556.67	214	53.70	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9841.5	B08		5	0316-0560	226.45	559.89	257	66.77	0.724
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9875.2	B08		5	0317-0563	884.68	563.30	252	60.53	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9627.1	B08		5	0318-0563	187.93	563.47	259	60.18	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12502.2	B08		5	0319-0566	488.24	566.76	425	80.43	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8689.9	B08		5	0320-0567	726.77	566.37	288	65.01	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16198.4	B08		5	0321-0570	782.32	570.74	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9409.3	B08		5	0322-0572	138.28	572.28	266	60.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9973.9	B08		5	0323-0577	605.38	577.36	304	65.01	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12154.1	B08		5	0324-0577	257.41	577.32	212	53.36	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10174.7	B08		5	0325-0584	826.31	584.13	267	61.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9821.5	B08		5	0326-0589	905.56	588.89	251	63.60	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12220.2	B08		5	0327-0591	303.02	590.39	204	53.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10221.9	B08		5	0328-0592	671.11	592.34	289	61.94	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8828.8	B08		5	0329-0594	218.77	593.42	285	65.01	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12218.9	B08		5	0330-0593	842.59	593.52	206	53.94	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11594.8	B08		5	0331-0597	890.09	598.13	215	55.70	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14583.5	B08		5	0332-0601	172.79	601.25	348	76.67	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10394.6	B08		5	0333-0602	495.55	601.80	263	59.60	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11416.7	B08		5	0334-0602	698.64	601.29	225	56.53	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9733.1	B08		5	0335-0605	348.19	605.29	285	67.50	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13115.2	B08		5	0336-0606	585.00	606.28	382	74.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10500.9	B08		5	0337-0607	38.14	607.31	229	58.18	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13904.3	B08		5	0338-0610	540.02	609.60	234	59.01	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9959.1	B08		5	0339-0610	417.90	610.62	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10612.8	B08		5	0340-0612	509.01	612.46	249	59.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12839.8	B08		5	0341-0611	793.96	611.55	308	64.77	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13638.3	B08		5	0342-0614	923.70	614.42	241	56.77	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11290.6	B08		5	0343-0616	320.44	616.36	299	65.26	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13447.4	B08		5	0344-0619	712.48	618.24	295	63.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11661.1	B08		5	0345-0621	215.75	620.77	456	88.91	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10176.1	B08		5	0346-0620	757.65	620.59	258	61.94	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11336.4	B08		5	0347-0622	453.10	622.06	232	56.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14622.5	B08		5	0348-0624	546.22	624.36	285	65.01	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10743.0	B08		5	0349-0623	174.39	622.87	236	56.53	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13948.6	B08		5	0350-0622	870.83	622.71	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12353.6	B08		5	0351-0628	605.87	627.99	397	76.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13047.8	B08		5	0352-0624	946.97	624.84	281	62.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9136.7	B08		5	0353-0628	36.42	628.14	277	72.43	0.664
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11622.9	B08		5	0354-0627	248.60	627.74	260	59.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11720.2	B08		5	0355-0629	830.24	628.84	222	63.26	0.697
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9586.9	B08		5	0356-0633	370.33	632.80	275	64.77	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12359.8	B08		5	0357-0636	408.74	635.45	333	70.18	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13600.5	B08		5	0358-0634	559.32	634.44	189	51.46	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10271.3	B08		5	0359-0638	768.63	638.12	249	61.11	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8983.1	B08		5	0360-0644	477.73	644.58	285	65.60	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11201.6	B08		5	0361-0646	141.04	646.00	238	58.53	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11333.1	B08		5	0362-0645	624.71	644.66	226	55.70	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10773.6	B08		5	0363-0648	565.94	648.44	244	60.53	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10404.5	B08		5	0364-0655	923.94	655.47	386	75.60	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13202.1	B08		5	0365-0654	227.52	653.58	294	63.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10903.7	B08		5	0366-0653	685.29	652.45	228	58.77	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9658.0	B08		5	0367-0655	855.20	655.65	287	62.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10105.4	B08		5	0368-0656	278.26	655.64	249	62.53	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10914.8	B08		5	0369-0655	514.61	654.75	228	56.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11171.0	B08		5	0370-0656	649.18	656.57	234	57.94	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10052.3	B08		5	0371-0656	726.71	655.54	244	57.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9599.7	B08		5	0372-0663	819.55	663.14	272	61.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10630.2	B08		5	0373-0663	156.97	663.83	233	57.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10665.8	B08		5	0374-0668	103.57	668.66	288	64.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11235.9	B08		5	0375-0668	297.00	668.30	230	56.77	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15170.3	B08		5	0376-0676	637.78	676.57	328	67.94	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12932.7	B08		5	0377-0675	746.61	675.50	218	56.28	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12883.1	B08		5	0378-0673	784.03	672.98	198	54.53	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11713.7	B08		5	0379-0680	130.23	679.86	225	55.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9665.2	B08		5	0380-0681	352.98	681.85	262	60.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12345.7	B08		5	0381-0678	400.87	678.35	219	56.53	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9431.9	B08		5	0382-0680	564.26	680.36	266	60.18	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10067.5	B08		5	0383-0681	809.99	680.69	259	58.53	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10213.8	B08		5	0384-0681	260.11	680.66	242	61.11	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10206.0	B08		5	0385-0682	443.93	681.27	251	58.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9337.1	B08		5	0386-0681	518.84	681.30	267	61.94	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11581.7	B08		5	0387-0689	851.09	689.63	349	71.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9944.1	B08		5	0388-0685	944.31	685.34	228	57.11	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10656.1	B08		5	0389-0689	331.92	689.08	240	58.28	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11599.1	B08		5	0390-0688	175.30	688.12	233	61.60	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11335.1	B08		5	0391-0697	481.88	696.74	235	59.11	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11817.1	B08		5	0392-0696	499.67	696.24	222	59.36	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13693.6	B08		5	0393-0699	454.71	698.92	176	50.28	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12956.4	B08		5	0394-0702	763.55	701.67	360	71.84	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10222.2	B08		5	0395-0702	181.65	702.87	251	59.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15029.2	B08		5	0396-0704	832.21	704.19	334	67.60	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9602.2	B08		5	0397-0706	628.57	706.03	292	65.36	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11688.9	B08		5	0398-0707	607.56	708.06	218	56.28	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11914.9	B08		5	0399-0710	334.25	709.85	209	53.11	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185111	1375313	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11152.6	B08		5	0400-0711	275.53	711.28	216	59.70	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11855.1	B08		6	0001-0028	566.76	28.73	247	61.36	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10410.9	B08		6	0002-0030	203.14	30.57	437	79.26	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16077.2	B08		6	0003-0027	815.03	27.38	269	60.53	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11979.1	B08		6	0004-0028	518.48	27.57	250	59.94	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10756.4	B08		6	0005-0032	878.67	31.47	241	60.18	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10747.0	B08		6	0006-0034	238.40	33.37	239	58.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12396.4	B08		6	0007-0032	292.61	32.32	341	69.11	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15787.6	B08		6	0008-0042	603.48	42.80	661	124.71	0.534
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10357.3	B08		6	0009-0035	387.87	34.87	352	71.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10086.7	B08		6	0010-0036	117.52	36.42	257	60.77	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12284.6	B08		6	0011-0044	29.89	44.06	304	66.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12446.8	B08		6	0012-0047	136.17	48.47	208	63.36	0.651
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10970.3	B08		6	0013-0046	277.18	45.73	246	58.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11104.4	B08		6	0014-0048	920.08	48.74	236	58.53	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11698.3	B08		6	0015-0053	47.84	53.09	219	56.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11878.7	B08		6	0016-0057	391.41	57.27	229	56.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11789.2	B08		6	0017-0059	692.75	59.01	218	55.94	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13853.5	B08		6	0018-0062	852.91	61.86	412	77.50	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8881.3	B08		6	0019-0057	351.17	57.35	167	50.28	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11027.6	B08		6	0020-0061	204.10	61.84	226	55.94	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11856.3	B08		6	0021-0063	730.17	63.45	233	59.11	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8015.2	B08		6	0022-0064	498.72	63.16	245	69.01	0.646
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10972.3	B08		6	0023-0063	678.46	63.79	253	60.53	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10951.1	B08		6	0024-0062	800.33	61.85	244	58.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9032.8	B08		6	0025-0068	226.95	67.53	270	62.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10845.8	B08		6	0026-0066	278.84	66.39	246	60.18	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13059.2	B08		6	0027-0072	181.60	72.64	259	59.60	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16430.2	B08		6	0028-0073	303.97	72.75	142	50.87	0.690
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14296.1	B08		6	0029-0075	873.16	74.78	181	55.46	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8673.5	B08		6	0030-0077	137.57	77.45	281	70.77	0.705
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12947.8	B08		6	0031-0072	369.31	71.86	216	56.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9815.6	B08		6	0032-0074	93.35	74.42	277	66.18	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11556.1	B08		6	0033-0076	749.60	75.53	247	60.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10979.9	B08		6	0034-0074	828.53	75.12	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7201.8	B08		6	0035-0074	468.50	73.93	140	53.60	0.612
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16186.8	B08		6	0036-0075	887.21	74.53	157	46.28	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14764.3	B08		6	0037-0076	291.02	76.96	172	51.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11929.1	B08		6	0038-0078	326.11	77.87	206	53.11	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10941.1	B08		6	0039-0081	945.11	81.27	264	61.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7290.8	B08		6	0040-0083	475.33	83.97	171	69.50	0.445
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12482.9	B08		6	0041-0084	646.17	83.21	217	57.01	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12143.4	B08		6	0042-0084	782.09	84.02	216	62.43	0.697
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14942.7	B08		6	0043-0090	621.04	89.96	363	79.50	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10592.7	B08		6	0044-0090	264.22	90.64	234	58.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16327.4	B08		6	0045-0094	656.83	94.92	306	66.08	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17228.9	B08		6	0046-0095	382.88	95.30	152	47.46	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12778.8	B08		6	0047-0096	915.08	96.39	207	53.70	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12990.5	B08		6	0048-0101	758.37	101.39	211	57.46	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17044.7	B08		6	0049-0100	845.38	100.20	293	63.94	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15053.6	B08		6	0050-0102	96.53	102.95	297	64.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11260.7	B08		6	0051-0101	298.56	101.23	244	58.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12033.0	B08		6	0052-0100	798.87	100.66	225	56.28	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14329.0	B08		6	0053-0104	198.14	103.63	280	61.60	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10829.6	B08		6	0054-0103	877.50	103.52	247	58.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10738.0	B08		6	0055-0102	942.13	102.05	251	59.70	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17283.7	B08		6	0056-0107	744.36	107.67	162	47.21	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17140.5	B08		6	0057-0108	391.85	108.59	153	45.46	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9381.3	B08		6	0058-0113	78.79	113.28	277	65.36	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11639.4	B08		6	0059-0113	242.98	113.41	218	53.70	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17746.8	B08		6	0060-0116	766.18	115.78	150	48.04	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13102.8	B08		6	0061-0116	804.17	116.51	207	54.28	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11662.0	B08		6	0062-0119	279.97	119.87	232	56.28	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12089.7	B08		6	0063-0123	914.69	123.08	259	61.01	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10206.4	B08		6	0064-0122	429.92	122.38	403	79.60	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11885.2	B08		6	0065-0128	842.71	127.97	474	112.37	0.472
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14921.2	B08		6	0066-0127	889.58	127.61	385	73.50	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14955.7	B08		6	0067-0125	389.34	124.73	336	69.36	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7614.3	B08		6	0068-0127	691.92	126.57	245	71.84	0.597
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11599.4	B08		6	0069-0127	175.41	127.89	218	53.36	0.962
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14777.4	B08		6	0070-0132	125.98	132.86	282	62.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12566.1	B08		6	0071-0134	29.09	133.61	376	76.08	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9097.6	B08		6	0072-0130	208.92	130.13	164	48.28	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13332.6	B08		6	0073-0131	813.04	132.02	186	52.87	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9758.0	B08		6	0074-0133	355.82	133.13	343	67.94	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9952.2	B08		6	0075-0138	732.48	138.25	276	61.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8978.9	B08		6	0076-0144	149.47	145.45	274	73.60	0.636
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11973.3	B08		6	0077-0140	309.01	139.24	216	55.94	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9774.6	B08		6	0078-0143	196.39	143.48	203	56.28	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9511.2	B08		6	0079-0149	786.60	150.31	291	65.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11022.6	B08		6	0080-0150	386.37	149.85	275	60.77	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11803.6	B08		6	0081-0148	817.30	148.22	250	75.01	0.558
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10920.5	B08		6	0082-0150	946.96	149.91	242	58.18	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16953.5	B08		6	0083-0153	273.24	154.02	289	65.01	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9901.9	B08		6	0084-0155	131.09	155.52	247	59.01	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14747.8	B08		6	0085-0157	246.98	157.73	337	69.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12560.3	B08		6	0086-0158	457.24	158.53	339	68.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10223.3	B08		6	0087-0158	208.77	158.21	242	58.18	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13689.0	B08		6	0088-0166	49.73	166.25	354	70.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10264.4	B08		6	0089-0166	287.54	166.76	248	58.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11085.8	B08		6	0090-0175	870.84	175.38	381	75.26	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9380.7	B08		6	0091-0172	735.60	172.28	234	59.36	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10865.0	B08		6	0092-0175	835.95	175.10	250	57.94	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12401.0	B08		6	0093-0179	464.94	179.35	215	56.28	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14589.9	B08		6	0094-0179	190.45	179.29	343	71.36	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12079.5	B08		6	0095-0182	76.79	183.02	272	67.01	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17934.2	B08		6	0096-0182	373.99	181.65	227	79.98	0.446
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9864.1	B08		6	0097-0181	690.04	180.83	277	62.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10499.7	B08		6	0098-0181	231.23	181.50	233	55.94	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15200.7	B08		6	0099-0183	917.64	183.66	167	53.60	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13830.7	B08		6	0100-0184	776.85	184.50	201	52.53	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12816.6	B08		6	0101-0185	758.74	184.56	217	53.36	0.958
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12296.7	B08		6	0102-0188	800.20	188.71	333	70.43	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10095.5	B08		6	0103-0190	397.97	190.57	256	61.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9531.8	B08		6	0104-0192	899.37	192.46	295	64.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13959.3	B08		6	0105-0200	108.71	200.14	359	70.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11166.8	B08		6	0106-0201	56.29	200.70	237	57.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11455.0	B08		6	0107-0200	681.99	201.10	237	62.18	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11895.9	B08		6	0108-0201	834.80	200.47	355	73.26	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10116.4	B08		6	0109-0203	176.64	202.27	263	66.18	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9867.0	B08		6	0110-0209	310.51	208.53	366	75.94	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12520.5	B08		6	0111-0209	472.29	209.39	215	55.94	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11759.6	B08		6	0112-0214	606.09	213.84	242	58.53	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12444.0	B08		6	0113-0214	818.32	214.27	239	57.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14526.7	B08		6	0114-0217	248.87	217.11	332	67.01	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14035.0	B08		6	0115-0217	500.00	216.60	186	49.94	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11011.5	B08		6	0116-0220	568.92	220.19	257	58.77	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16724.1	B08		6	0117-0224	726.78	223.78	320	67.60	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9920.5	B08		6	0118-0225	142.72	225.23	246	57.60	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11715.7	B08		6	0119-0226	234.60	227.06	200	53.70	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12271.3	B08		6	0120-0230	948.80	230.29	228	56.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16409.4	B08		6	0121-0228	659.39	227.78	153	49.80	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18125.4	B08		6	0122-0236	910.61	235.65	274	68.43	0.735
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12847.1	B08		6	0123-0235	375.34	234.72	210	54.04	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12057.6	B08		6	0124-0234	790.33	235.13	163	49.36	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17855.9	B08		6	0125-0238	896.97	238.66	203	60.77	0.691
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9257.6	B08		6	0126-0240	625.02	239.52	279	64.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11084.0	B08		6	0127-0246	178.90	245.48	428	85.50	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14261.3	B08		6	0128-0245	438.35	245.28	355	72.77	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9459.0	B08		6	0129-0245	646.48	243.67	266	67.60	0.732
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15507.9	B08		6	0130-0239	663.76	238.35	168	49.21	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11466.7	B08		6	0131-0243	67.63	243.52	213	56.28	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20005.3	B08		6	0132-0247	486.91	246.95	253	64.18	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10537.4	B08		6	0133-0248	531.09	248.44	249	61.01	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11384.3	B08		6	0134-0251	417.01	250.38	212	58.77	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9217.7	B08		6	0135-0253	118.79	252.54	264	60.43	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10495.3	B08		6	0136-0252	675.65	252.20	285	64.53	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10459.8	B08		6	0137-0256	749.14	256.19	300	66.18	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15148.1	B08		6	0138-0253	368.01	252.98	164	51.11	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8981.4	B08		6	0139-0259	598.98	259.20	285	64.87	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12638.4	B08		6	0140-0256	824.76	255.95	217	56.77	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11375.2	B08		6	0141-0259	797.20	259.04	239	58.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10616.8	B08		6	0142-0261	21.52	261.09	298	65.01	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12161.1	B08		6	0143-0259	875.37	259.08	221	56.77	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7423.8	B08		6	0144-0261	553.37	260.39	166	60.18	0.576
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13217.6	B08		6	0145-0263	328.58	263.39	305	65.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11172.0	B08		6	0146-0265	465.15	265.36	291	63.11	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14428.3	B08		6	0147-0271	68.92	272.53	363	108.23	0.389
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13270.6	B08		6	0148-0272	378.93	270.94	392	79.84	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16058.8	B08		6	0149-0267	850.10	267.54	159	47.70	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11831.0	B08		6	0150-0267	833.39	268.08	242	59.70	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10420.6	B08		6	0151-0270	502.39	270.25	255	61.11	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11341.7	B08		6	0152-0269	695.23	268.96	241	59.46	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7954.3	B08		6	0153-0274	150.00	273.10	270	66.43	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11382.9	B08		6	0154-0274	212.56	275.08	217	53.94	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7426.7	B08		6	0155-0272	548.82	271.76	128	44.87	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9835.2	B08		6	0156-0279	749.96	279.48	346	77.60	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13868.5	B08		6	0157-0284	596.70	283.79	306	64.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10152.7	B08		6	0158-0285	26.16	285.99	324	68.18	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12578.0	B08		6	0159-0287	859.77	287.10	212	55.36	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10739.4	B08		6	0160-0289	272.88	290.40	237	58.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12283.9	B08		6	0161-0300	476.24	299.32	489	97.88	0.641
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10859.5	B08		6	0162-0294	791.90	294.98	252	59.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10813.2	B08		6	0163-0297	932.42	297.09	289	64.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9398.1	B08		6	0164-0296	306.06	296.08	262	61.60	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10701.4	B08		6	0165-0298	403.47	297.49	312	65.60	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13810.7	B08		6	0166-0296	349.69	295.43	248	58.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9693.5	B08		6	0167-0295	433.52	295.30	274	64.77	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16552.3	B08		6	0168-0305	645.39	304.40	304	64.18	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15181.3	B08		6	0169-0305	706.26	305.14	243	59.11	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14984.6	B08		6	0170-0313	93.83	312.17	329	85.50	0.566
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11726.3	B08		6	0171-0309	41.27	308.98	197	57.11	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13296.0	B08		6	0172-0306	730.39	305.71	220	55.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8348.1	B08		6	0173-0312	150.84	313.41	276	66.77	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10138.5	B08		6	0174-0313	24.52	313.16	261	59.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11908.0	B08		6	0175-0313	793.17	313.02	264	59.70	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11506.2	B08		6	0176-0315	439.81	316.01	212	55.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11543.8	B08		6	0177-0317	396.13	317.87	407	81.01	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15469.7	B08		6	0178-0318	545.03	318.51	318	65.01	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10721.8	B08		6	0179-0327	754.74	327.17	263	61.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13320.2	B08		6	0180-0331	645.40	330.50	297	62.77	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12122.2	B08		6	0181-0334	491.61	334.18	219	55.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10004.8	B08		6	0182-0342	301.32	342.68	475	83.50	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11759.7	B08		6	0183-0340	61.74	339.55	158	51.11	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13304.7	B08		6	0184-0339	792.04	339.66	201	52.53	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11633.9	B08		6	0185-0342	72.89	343.66	231	63.11	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19926.6	B08		6	0186-0341	550.94	341.55	258	58.53	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13839.4	B08		6	0187-0345	938.04	345.64	413	76.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9853.0	B08		6	0188-0345	247.62	345.92	257	62.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12341.1	B08		6	0189-0345	736.76	345.12	222	56.18	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15902.8	B08		6	0190-0352	915.67	352.18	387	81.01	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11362.9	B08		6	0191-0352	377.14	351.79	219	57.70	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12533.4	B08		6	0192-0351	498.07	351.01	213	53.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17659.0	B08		6	0193-0353	692.35	352.74	324	67.36	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11928.5	B08		6	0194-0357	364.46	357.85	224	56.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11585.0	B08		6	0195-0360	461.11	360.46	289	67.84	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12393.2	B08		6	0196-0361	649.92	360.91	230	56.53	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12590.8	B08		6	0197-0363	727.33	363.16	361	72.08	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13534.9	B08		6	0198-0362	812.22	361.84	247	58.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17701.0	B08		6	0199-0362	324.84	362.43	285	62.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12556.3	B08		6	0200-0364	433.33	364.31	205	53.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12486.8	B08		6	0201-0369	678.26	369.38	217	56.77	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13400.4	B08		6	0202-0376	638.40	376.92	207	56.18	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15985.2	B08		6	0203-0372	911.90	372.84	164	47.21	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10725.7	B08		6	0204-0379	717.08	380.18	358	71.26	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8920.6	B08		6	0205-0383	151.22	382.57	305	66.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12153.6	B08		6	0206-0382	289.74	381.60	226	57.36	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10183.9	B08		6	0207-0386	890.49	386.72	261	61.84	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12417.8	B08		6	0208-0387	834.65	386.96	213	56.87	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10771.3	B08		6	0209-0390	82.98	390.33	240	58.77	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7826.0	B08		6	0210-0392	36.05	392.71	211	67.01	0.590
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10809.3	B08		6	0211-0392	183.93	392.40	256	60.53	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17902.5	B08		6	0212-0392	298.98	391.86	144	51.01	0.695
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9272.3	B08		6	0213-0394	114.07	394.56	296	64.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11925.3	B08		6	0214-0394	281.33	394.54	232	57.11	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12670.5	B08		6	0215-0394	412.94	394.12	236	58.18	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16214.4	B08		6	0216-0397	433.84	396.77	302	64.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11562.7	B08		6	0217-0397	808.95	397.53	287	63.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7537.7	B08		6	0218-0399	16.41	398.13	187	55.36	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16909.6	B08		6	0219-0397	306.38	397.19	106	41.46	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10096.0	B08		6	0220-0401	566.73	401.12	273	61.60	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11908.7	B08		6	0221-0400	702.01	399.92	259	60.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9828.3	B08		6	0222-0402	262.75	402.44	261	59.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10383.6	B08		6	0223-0402	896.29	402.41	262	64.28	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14333.2	B08		6	0224-0402	917.05	402.60	176	50.53	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14674.2	B08		6	0225-0402	210.70	402.36	213	55.46	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14821.1	B08		6	0226-0406	634.54	405.98	182	52.53	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11250.1	B08		6	0227-0407	617.53	407.50	242	58.04	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11841.6	B08		6	0228-0410	844.46	410.10	232	59.11	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10708.2	B08		6	0229-0414	863.80	414.11	264	61.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12801.3	B08		6	0230-0419	316.94	419.35	384	73.50	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10731.9	B08		6	0231-0416	247.34	416.66	321	66.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10690.3	B08		6	0232-0418	543.53	418.25	242	59.36	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11950.9	B08		6	0233-0420	160.59	420.35	351	71.84	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11118.9	B08		6	0234-0420	689.89	420.40	331	71.01	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15017.8	B08		6	0235-0417	919.49	417.35	174	48.04	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11809.0	B08		6	0236-0420	650.08	420.06	260	61.36	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10474.6	B08		6	0237-0424	349.77	424.67	239	59.84	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12838.2	B08		6	0238-0422	529.94	422.92	197	54.28	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8053.1	B08		6	0239-0422	766.88	421.56	159	53.94	0.687
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15781.3	B08		6	0240-0430	842.47	430.45	339	69.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8833.9	B08		6	0241-0430	118.40	430.35	258	61.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14184.1	B08		6	0242-0431	611.93	431.41	318	67.01	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12580.6	B08		6	0243-0431	914.42	431.01	211	57.36	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13391.7	B08		6	0244-0432	934.62	432.12	214	58.53	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8579.6	B08		6	0245-0435	49.57	435.67	253	58.28	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7677.1	B08		6	0246-0432	771.14	431.83	128	51.70	0.602
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13964.6	B08		6	0247-0434	896.37	433.69	188	51.94	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12672.9	B08		6	0248-0443	875.29	443.91	144	50.53	0.709
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9744.2	B08		6	0249-0443	261.47	443.67	254	59.11	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13510.4	B08		6	0250-0444	558.68	443.73	283	64.53	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9457.8	B08		6	0251-0449	448.25	449.72	290	66.77	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9964.7	B08		6	0252-0448	228.27	448.43	318	67.94	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13401.8	B08		6	0253-0454	590.24	454.84	417	75.01	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8483.1	B08		6	0254-0455	50.24	454.70	312	65.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13485.3	B08		6	0255-0452	174.21	452.40	213	55.80	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10422.5	B08		6	0256-0455	701.19	455.85	283	66.67	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13965.4	B08		6	0257-0452	853.43	452.66	186	53.70	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12689.8	B08		6	0258-0457	671.01	456.28	211	57.94	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12373.4	B08		6	0259-0458	464.15	458.21	320	68.18	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11847.7	B08		6	0260-0458	747.26	458.97	233	64.43	0.705
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8185.7	B08		6	0261-0462	420.15	463.25	341	75.50	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10515.6	B08		6	0262-0459	85.49	459.20	238	57.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12096.3	B08		6	0263-0459	507.37	459.32	214	54.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13898.6	B08		6	0264-0465	314.66	465.76	333	71.01	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13091.9	B08		6	0265-0466	136.07	466.13	354	71.11	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11365.4	B08		6	0266-0468	172.72	467.77	250	63.70	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10902.0	B08		6	0267-0473	491.59	472.88	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10829.3	B08		6	0268-0473	815.16	473.17	253	59.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10263.0	B08		6	0269-0478	780.69	477.91	325	68.77	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11709.9	B08		6	0270-0475	227.97	475.28	214	57.11	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10821.7	B08		6	0271-0480	211.70	481.35	251	62.18	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16356.4	B08		6	0272-0483	859.42	482.86	271	64.18	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12049.4	B08		6	0273-0485	752.35	484.85	237	60.87	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11725.6	B08		6	0274-0483	585.53	483.73	243	63.36	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11328.3	B08		6	0275-0484	385.51	485.19	164	50.87	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11099.6	B08		6	0276-0488	89.40	489.15	395	75.01	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11310.3	B08		6	0277-0489	296.69	488.85	244	58.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11377.3	B08		6	0278-0492	143.08	492.32	228	55.36	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11127.9	B08		6	0279-0491	336.64	491.70	220	56.28	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10819.2	B08		6	0280-0492	513.77	492.88	252	59.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9331.4	B08		6	0281-0498	48.00	498.20	251	59.94	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15227.1	B08		6	0282-0498	852.36	498.53	283	65.60	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9822.5	B08		6	0283-0500	111.63	500.19	240	58.77	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12314.3	B08		6	0284-0500	478.43	499.97	207	51.46	0.982
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12773.3	B08		6	0285-0501	795.41	501.71	210	53.70	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11542.8	B08		6	0286-0503	443.46	502.86	393	76.67	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15820.0	B08		6	0287-0504	559.57	504.46	323	67.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13476.6	B08		6	0288-0504	831.86	504.47	290	62.53	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13307.4	B08		6	0289-0505	333.16	504.68	199	54.87	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12405.2	B08		6	0290-0509	934.43	509.12	471	88.57	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12075.3	B08		6	0291-0510	601.38	510.61	350	70.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10192.7	B08		6	0292-0512	911.09	511.98	298	68.18	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11501.1	B08		6	0293-0514	516.97	514.15	236	57.70	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11680.4	B08		6	0294-0515	42.43	515.91	283	62.18	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9525.5	B08		6	0295-0516	653.99	516.16	302	66.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11131.0	B08		6	0296-0518	896.99	517.89	228	60.77	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11531.7	B08		6	0297-0518	64.81	518.39	236	56.77	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8463.4	B08		6	0298-0521	259.18	521.20	288	64.43	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13415.5	B08		6	0299-0522	759.26	522.01	321	66.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9117.3	B08		6	0300-0521	695.19	521.83	316	67.84	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11342.8	B08		6	0301-0524	307.39	524.49	237	63.60	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13054.6	B08		6	0302-0524	537.36	523.04	202	57.36	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15781.0	B08		6	0303-0526	738.26	525.71	335	67.11	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12759.7	B08		6	0304-0530	442.40	529.89	215	53.94	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9869.5	B08		6	0305-0529	222.70	529.77	259	62.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8897.3	B08		6	0306-0533	148.88	533.45	266	64.77	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10984.0	B08		6	0307-0537	520.57	536.09	307	66.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11796.5	B08		6	0308-0540	795.24	540.18	237	62.77	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10854.1	B08		6	0309-0541	927.11	540.64	263	61.36	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9585.6	B08		6	0310-0541	111.28	540.83	251	61.94	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15230.9	B08		6	0311-0538	356.39	538.08	144	45.36	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10849.0	B08		6	0312-0542	430.57	542.86	238	62.43	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10676.1	B08		6	0313-0544	37.62	545.15	245	60.18	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12594.1	B08		6	0314-0547	665.59	548.67	353	72.67	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11845.7	B08		6	0315-0546	456.52	545.84	221	57.36	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9813.9	B08		6	0316-0549	376.55	548.79	276	62.87	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9065.9	B08		6	0317-0551	228.15	552.09	280	66.77	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10575.4	B08		6	0318-0547	558.15	547.60	267	61.94	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12134.6	B08		6	0319-0549	84.88	549.15	205	52.28	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16347.1	B08		6	0320-0548	343.66	548.44	170	50.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11376.9	B08		6	0321-0550	623.33	550.48	234	56.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12511.5	B08		6	0322-0553	852.44	553.40	224	58.53	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11046.8	B08		6	0323-0552	702.41	551.60	300	63.36	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10859.5	B08		6	0324-0555	65.46	554.14	214	59.70	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21219.8	B08		6	0325-0559	412.48	559.15	240	58.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13209.7	B08		6	0326-0556	466.53	556.84	195	54.53	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11605.6	B08		6	0327-0560	785.46	559.58	267	62.43	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11282.7	B08		6	0328-0560	950.45	560.92	238	60.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8722.0	B08		6	0329-0566	215.30	565.75	257	61.70	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12387.5	B08		6	0330-0569	328.41	568.40	269	61.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9870.2	B08		6	0331-0574	461.56	575.67	264	67.36	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14100.0	B08		6	0332-0573	871.02	573.07	373	70.18	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10433.0	B08		6	0333-0572	501.78	572.33	159	49.11	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11375.0	B08		6	0334-0578	44.25	578.31	327	75.01	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14224.4	B08		6	0335-0576	831.51	575.40	184	50.87	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18204.3	B08		6	0336-0579	405.43	579.94	296	65.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10553.0	B08		6	0337-0580	940.14	579.77	260	61.94	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13492.5	B08		6	0338-0582	118.12	582.44	355	70.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9961.8	B08		6	0339-0581	545.71	581.43	267	62.43	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10375.2	B08		6	0340-0583	758.34	583.80	270	60.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12968.5	B08		6	0341-0590	861.76	590.73	212	56.28	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9145.3	B08		6	0342-0593	897.40	593.24	281	63.60	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9458.7	B08		6	0343-0595	503.64	594.99	153	46.28	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12375.9	B08		6	0344-0598	186.48	597.91	353	69.84	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10138.4	B08		6	0345-0598	925.56	598.86	254	59.11	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10803.6	B08		6	0346-0594	793.86	594.85	119	44.28	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8737.4	B08		6	0347-0601	45.57	601.17	270	62.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11562.4	B08		6	0348-0604	674.21	604.94	328	70.77	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11234.7	B08		6	0349-0605	300.47	604.75	327	68.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11064.0	B08		6	0350-0604	797.84	604.85	204	61.94	0.668
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9252.2	B08		6	0351-0610	121.59	610.26	241	58.53	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15679.5	B08		6	0352-0614	419.35	614.52	331	67.60	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13746.9	B08		6	0353-0617	18.20	617.26	228	54.53	0.964
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12799.3	B08		6	0354-0620	371.00	620.02	395	78.08	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10754.2	B08		6	0355-0618	818.54	619.07	286	63.11	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11123.4	B08		6	0356-0621	886.62	621.92	270	61.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8999.6	B08		6	0357-0624	540.31	624.49	305	65.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12650.1	B08		6	0358-0624	108.75	623.92	311	66.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9601.4	B08		6	0359-0624	238.42	623.48	277	64.53	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12755.9	B08		6	0360-0627	41.31	627.73	283	63.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12479.4	B08		6	0361-0632	771.16	631.75	395	74.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12327.1	B08		6	0362-0638	948.41	638.14	366	72.43	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17640.9	B08		6	0363-0639	381.42	638.47	293	64.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12026.4	B08		6	0364-0642	841.54	642.68	274	63.84	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10294.2	B08		6	0365-0646	214.06	645.66	254	63.11	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11321.9	B08		6	0366-0646	912.19	645.78	237	57.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10572.5	B08		6	0367-0648	64.54	648.32	224	56.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8484.9	B08		6	0368-0650	489.58	649.78	282	63.01	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10576.1	B08		6	0369-0653	422.26	652.20	405	76.67	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12475.4	B08		6	0370-0648	826.17	648.23	215	54.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9954.9	B08		6	0371-0653	113.86	652.70	231	58.87	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10987.6	B08		6	0372-0653	602.39	653.01	329	69.01	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10057.4	B08		6	0373-0658	18.30	658.28	370	72.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8974.3	B08		6	0374-0655	712.94	655.48	293	65.36	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16337.2	B08		6	0375-0658	328.43	658.02	305	64.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11048.4	B08		6	0376-0664	781.20	663.74	247	59.36	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10912.5	B08		6	0377-0662	900.70	662.82	224	56.53	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10274.6	B08		6	0378-0664	148.61	664.67	220	53.94	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11202.2	B08		6	0379-0663	524.35	662.59	272	61.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11037.2	B08		6	0380-0665	835.11	664.12	225	61.01	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12740.1	B08		6	0381-0673	210.21	673.07	188	52.87	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10771.2	B08		6	0382-0672	430.67	672.77	245	58.87	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12081.2	B08		6	0383-0673	822.78	674.69	235	58.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9235.5	B08		6	0384-0675	614.54	674.84	272	63.01	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11674.2	B08		6	0385-0674	859.84	673.39	222	57.01	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12670.1	B08		6	0386-0675	663.73	675.40	406	77.01	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11412.7	B08		6	0387-0677	744.93	677.07	237	59.11	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11034.4	B08		6	0388-0683	78.83	682.69	354	73.26	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10327.4	B08		6	0389-0681	930.27	681.12	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16390.8	B08		6	0390-0686	260.52	686.06	309	64.18	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12338.2	B08		6	0391-0684	802.37	683.50	206	53.11	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12257.9	B08		6	0392-0686	126.55	686.41	213	56.28	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15943.2	B08		6	0393-0687	406.24	687.58	300	63.60	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9964.9	B08		6	0394-0688	38.48	688.08	219	55.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11237.0	B08		6	0395-0692	336.61	691.64	260	61.01	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10290.2	B08		6	0396-0693	377.30	693.73	143	47.80	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10967.8	B08		6	0397-0694	473.18	694.78	246	59.94	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12692.4	B08		6	0398-0700	708.19	700.42	393	75.01	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10903.3	B08		6	0399-0699	725.25	699.07	256	59.70	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11897.3	B08		6	0400-0703	517.50	703.30	205	54.53	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13127.4	B08		6	0401-0706	576.37	706.19	196	53.94	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13734.8	B08		6	0402-0707	116.69	707.16	302	66.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185112	1375314	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10575.0	B08		6	0403-0709	376.77	708.80	241	61.70	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19808.6	B08		7	0001-0026	81.39	26.79	137	43.94	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11297.2	B08		7	0002-0029	247.78	28.87	248	59.11	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11532.4	B08		7	0003-0028	824.82	27.21	222	55.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14744.6	B08		7	0004-0033	560.84	33.13	299	64.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10559.8	B08		7	0005-0031	711.12	31.85	252	59.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12310.0	B08		7	0006-0036	632.02	36.41	452	80.08	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12409.7	B08		7	0007-0036	390.73	36.07	154	54.28	0.657
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11885.5	B08		7	0008-0040	52.67	39.62	298	66.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14765.1	B08		7	0009-0037	403.64	36.79	145	43.80	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15427.5	B08		7	0010-0043	16.80	44.41	162	53.70	0.706
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12950.6	B08		7	0011-0040	381.00	39.87	117	42.87	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12466.7	B08		7	0012-0047	30.32	48.28	217	59.94	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11421.9	B08		7	0013-0047	435.38	48.08	253	60.53	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11552.5	B08		7	0014-0046	920.57	45.84	220	55.11	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10794.9	B08		7	0015-0051	272.52	52.16	262	67.50	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14338.3	B08		7	0016-0050	486.01	50.03	449	81.26	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12147.4	B08		7	0017-0057	78.11	57.33	229	56.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12766.7	B08		7	0018-0063	120.28	62.76	458	79.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11659.1	B08		7	0019-0063	57.27	62.60	233	62.77	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10789.5	B08		7	0020-0064	310.19	63.67	254	74.08	0.582
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13802.0	B08		7	0021-0067	750.66	66.50	391	72.67	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13931.7	B08		7	0022-0066	821.45	66.51	304	65.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11019.7	B08		7	0023-0066	167.52	66.48	242	59.94	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9619.2	B08		7	0024-0067	451.50	67.38	306	67.84	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15104.3	B08		7	0025-0073	68.84	72.68	197	51.70	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12852.7	B08		7	0026-0078	911.74	78.18	401	74.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9867.9	B08		7	0027-0081	195.65	81.18	335	69.26	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12626.0	B08		7	0028-0083	493.62	83.30	468	86.91	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9869.6	B08		7	0029-0081	336.24	81.83	194	56.18	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9653.4	B08		7	0030-0084	688.64	84.51	298	66.67	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10328.3	B08		7	0031-0084	776.67	84.47	260	60.18	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10360.8	B08		7	0032-0087	403.82	87.15	260	59.60	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15602.0	B08		7	0033-0092	240.65	92.13	310	64.77	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11188.2	B08		7	0034-0096	739.27	96.03	240	58.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11479.7	B08		7	0035-0102	295.43	101.57	365	80.43	0.709
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9808.6	B08		7	0036-0106	440.25	106.12	284	64.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10867.4	B08		7	0037-0112	414.56	114.02	365	86.91	0.607
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9848.4	B08		7	0038-0113	24.04	114.25	259	58.77	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9658.8	B08		7	0039-0115	912.85	115.08	264	62.43	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12736.9	B08		7	0040-0112	91.25	111.96	205	54.28	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9763.2	B08		7	0041-0116	861.89	116.11	264	61.36	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13263.8	B08		7	0042-0122	319.98	122.32	317	69.60	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10382.3	B08		7	0043-0121	338.52	120.85	147	52.63	0.667
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11898.6	B08		7	0044-0123	389.16	122.64	301	66.43	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11102.8	B08		7	0045-0121	188.05	120.87	238	64.77	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14808.2	B08		7	0046-0130	584.23	129.68	444	82.08	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8620.6	B08		7	0047-0127	632.15	126.73	300	77.26	0.632
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13396.9	B08		7	0048-0128	236.19	127.72	257	57.70	0.970
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12561.9	B08		7	0049-0132	83.70	132.95	279	65.36	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13688.4	B08		7	0050-0132	157.49	131.97	151	45.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12615.4	B08		7	0051-0132	199.98	133.12	219	57.94	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10099.0	B08		7	0052-0135	440.86	136.01	267	62.77	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12183.6	B08		7	0053-0138	378.41	138.40	250	61.94	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10662.3	B08		7	0054-0143	802.02	142.93	505	87.84	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13739.3	B08		7	0055-0140	183.23	140.29	197	52.28	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15639.8	B08		7	0056-0141	168.37	141.83	204	53.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16289.5	B08		7	0057-0146	272.79	146.49	375	76.18	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13789.9	B08		7	0058-0143	290.74	142.61	123	42.28	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10978.1	B08		7	0059-0147	689.43	148.17	378	74.08	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12892.8	B08		7	0060-0151	888.71	150.40	366	70.77	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10324.9	B08		7	0061-0155	242.33	155.57	246	59.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12469.6	B08		7	0062-0159	495.41	159.53	476	81.26	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17036.3	B08		7	0063-0154	140.59	153.43	151	49.36	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13943.0	B08		7	0064-0161	339.70	161.13	531	97.40	0.703
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19853.3	B08		7	0065-0159	361.14	158.65	346	75.01	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11966.1	B08		7	0066-0159	674.90	159.46	220	57.60	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10464.2	B08		7	0067-0164	634.54	165.00	233	63.84	0.718
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15975.5	B08		7	0068-0163	134.49	163.21	162	51.60	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9619.3	B08		7	0069-0164	415.04	164.40	351	71.01	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9706.3	B08		7	0070-0164	465.84	164.38	268	60.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12584.2	B08		7	0071-0165	88.45	165.93	207	53.70	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11413.3	B08		7	0072-0167	43.25	167.63	240	56.28	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11143.3	B08		7	0073-0169	215.15	169.30	400	75.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10380.8	B08		7	0074-0174	818.62	173.99	505	87.26	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10380.1	B08		7	0075-0171	853.97	170.66	361	72.08	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10073.4	B08		7	0076-0171	607.12	171.03	221	55.70	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13858.0	B08		7	0077-0176	307.71	176.43	399	76.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12123.8	B08		7	0078-0174	773.89	174.10	219	53.94	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18730.3	B08		7	0079-0173	920.75	174.10	151	66.43	0.430
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10282.4	B08		7	0080-0179	627.32	179.07	275	68.77	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11813.1	B08		7	0081-0183	92.24	182.24	227	58.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10594.7	B08		7	0082-0186	412.67	186.07	258	59.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9607.8	B08		7	0083-0191	529.97	191.30	400	74.91	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9738.7	B08		7	0084-0193	162.74	193.94	271	72.33	0.651
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14612.6	B08		7	0085-0194	571.70	194.47	302	64.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14408.1	B08		7	0086-0193	719.20	193.39	188	53.94	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15723.0	B08		7	0087-0196	899.44	197.36	350	72.18	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11537.2	B08		7	0088-0195	686.08	194.73	240	57.94	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10508.4	B08		7	0089-0197	218.70	197.96	244	59.36	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10711.1	B08		7	0090-0198	314.70	198.25	251	58.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13468.8	B08		7	0091-0196	613.26	196.59	204	56.87	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10443.0	B08		7	0092-0201	946.42	201.19	274	66.08	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11464.9	B08		7	0093-0206	58.01	206.48	258	61.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12289.0	B08		7	0094-0211	177.98	211.36	360	69.60	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14842.5	B08		7	0095-0216	397.84	216.51	337	69.26	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9019.7	B08		7	0096-0218	339.99	218.35	273	60.77	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14492.2	B08		7	0097-0221	569.60	222.01	391	87.50	0.642
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10792.2	B08		7	0098-0219	89.92	218.98	242	57.11	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11155.1	B08		7	0099-0225	446.62	225.98	396	76.43	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10927.8	B08		7	0100-0228	126.72	228.49	240	56.77	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12150.7	B08		7	0101-0228	413.78	228.49	276	61.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9450.1	B08		7	0102-0231	907.18	231.20	289	63.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11905.8	B08		7	0103-0232	720.98	231.94	236	62.67	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15874.1	B08		7	0104-0233	264.91	234.22	194	56.53	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13322.5	B08		7	0105-0234	283.80	234.69	332	68.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13553.0	B08		7	0106-0237	521.36	236.40	382	73.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14091.6	B08		7	0107-0236	947.56	236.18	340	68.77	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9685.6	B08		7	0108-0237	872.17	237.48	266	63.84	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15108.1	B08		7	0109-0245	843.77	243.71	350	102.57	0.418
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14731.4	B08		7	0110-0243	51.98	243.74	182	49.70	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12783.5	B08		7	0111-0243	604.19	243.46	216	59.36	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10753.2	B08		7	0112-0246	378.93	246.46	256	59.36	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11344.6	B08		7	0113-0249	463.00	249.54	233	56.53	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14803.7	B08		7	0114-0249	587.12	249.49	180	50.87	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7681.7	B08		7	0115-0254	128.47	254.68	307	80.57	0.594
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13632.2	B08		7	0116-0254	247.69	254.10	326	66.43	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11593.7	B08		7	0117-0256	397.74	256.62	240	57.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12811.5	B08		7	0118-0259	553.97	259.30	371	73.01	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9640.3	B08		7	0119-0257	323.31	257.59	255	59.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10796.8	B08		7	0120-0264	877.21	264.15	243	65.94	0.702
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13774.7	B08		7	0121-0264	429.23	263.74	193	51.11	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11380.5	B08		7	0122-0265	682.52	264.78	242	60.18	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10378.1	B08		7	0123-0268	23.52	267.27	312	68.67	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10554.1	B08		7	0124-0273	942.28	273.29	228	55.11	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8975.8	B08		7	0125-0277	472.77	276.83	285	65.36	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10569.6	B08		7	0126-0279	591.93	279.81	335	67.60	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12380.4	B08		7	0127-0280	373.41	281.31	303	65.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8449.5	B08		7	0128-0281	97.96	280.43	287	68.18	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10870.2	B08		7	0129-0289	160.03	289.59	504	84.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10912.6	B08		7	0130-0286	717.44	286.35	251	59.94	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9536.3	B08		7	0131-0285	226.22	284.88	147	47.46	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10024.0	B08		7	0132-0287	884.60	287.66	261	63.01	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12480.8	B08		7	0133-0287	266.28	286.81	204	54.28	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11215.8	B08		7	0134-0295	42.73	293.97	470	84.67	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12540.3	B08		7	0135-0290	409.83	289.56	218	55.11	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11708.0	B08		7	0136-0296	638.34	296.98	357	70.43	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11805.8	B08		7	0137-0296	95.19	296.13	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12557.8	B08		7	0138-0300	300.90	299.53	352	70.18	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9434.8	B08		7	0139-0299	441.91	299.04	285	62.53	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11565.8	B08		7	0140-0303	747.06	302.21	284	64.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10948.4	B08		7	0141-0300	226.96	300.39	100	38.04	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7860.0	B08		7	0142-0307	921.16	307.62	285	79.50	0.567
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9289.7	B08		7	0143-0304	356.23	304.27	278	65.01	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13732.5	B08		7	0144-0303	621.62	304.04	199	53.11	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10306.1	B08		7	0145-0309	250.39	309.05	279	69.01	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10130.4	B08		7	0146-0312	495.72	311.78	412	83.98	0.734
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11319.8	B08		7	0147-0310	729.52	310.80	232	57.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12049.1	B08		7	0148-0311	762.11	310.96	229	57.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11586.5	B08		7	0149-0310	528.20	310.63	234	58.28	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10971.4	B08		7	0150-0312	795.82	311.91	291	64.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10765.4	B08		7	0151-0316	235.32	316.79	240	70.43	0.608
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13552.3	B08		7	0152-0312	410.34	312.51	248	58.63	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8771.2	B08		7	0153-0317	371.38	316.56	293	65.94	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13267.9	B08		7	0154-0316	266.32	316.82	171	48.87	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12724.7	B08		7	0155-0319	546.92	318.83	210	54.18	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13682.8	B08		7	0156-0321	27.86	321.46	191	51.36	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14790.1	B08		7	0157-0328	430.10	328.68	339	67.94	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13613.7	B08		7	0158-0327	847.85	326.72	221	54.28	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15129.2	B08		7	0159-0326	410.89	326.20	166	48.39	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14423.5	B08		7	0160-0331	450.98	331.32	320	66.53	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10424.0	B08		7	0161-0334	292.22	334.82	267	65.94	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13617.6	B08		7	0162-0336	930.56	336.09	198	53.60	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17910.6	B08		7	0163-0336	162.68	335.79	175	49.94	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12035.8	B08		7	0164-0338	896.94	338.98	324	67.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16753.9	B08		7	0165-0338	660.25	337.98	156	50.87	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10629.4	B08		7	0166-0341	646.64	340.59	261	61.11	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14100.9	B08		7	0167-0340	675.12	339.91	190	52.77	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8855.3	B08		7	0168-0342	707.87	342.91	276	69.84	0.711
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12849.0	B08		7	0169-0342	784.65	342.46	217	55.36	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10547.7	B08		7	0170-0343	309.89	343.09	258	60.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17475.8	B08		7	0171-0346	481.88	346.11	316	72.77	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14024.1	B08		7	0172-0349	217.80	349.32	361	71.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13156.2	B08		7	0173-0347	153.24	347.05	227	56.18	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14873.6	B08		7	0174-0350	859.26	351.10	336	68.53	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15325.3	B08		7	0175-0349	800.64	349.33	177	49.70	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10172.0	B08		7	0176-0353	338.93	352.34	261	60.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12243.8	B08		7	0177-0358	71.12	358.95	447	91.74	0.667
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12359.2	B08		7	0178-0353	817.46	353.46	233	59.70	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16077.6	B08		7	0179-0362	371.36	361.56	494	93.05	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12922.4	B08		7	0180-0367	99.04	367.18	454	85.74	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19498.2	B08		7	0181-0359	462.03	360.16	146	45.21	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10599.6	B08		7	0182-0369	691.26	369.39	264	64.08	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12371.6	B08		7	0183-0370	447.16	369.83	216	55.11	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11441.7	B08		7	0184-0370	843.94	370.61	319	66.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10130.4	B08		7	0185-0371	278.60	372.16	262	63.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10170.6	B08		7	0186-0375	503.14	375.57	260	65.36	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10246.7	B08		7	0187-0374	307.18	373.51	277	65.36	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19464.7	B08		7	0188-0373	354.76	374.48	147	49.36	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18285.6	B08		7	0189-0376	381.94	376.76	278	67.01	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9547.4	B08		7	0190-0380	727.75	380.71	335	69.84	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12019.2	B08		7	0191-0380	526.81	381.04	221	57.36	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10594.8	B08		7	0192-0384	684.62	383.73	275	63.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12415.8	B08		7	0193-0390	164.13	389.70	472	83.36	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15561.6	B08		7	0194-0387	798.47	387.55	357	70.43	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16141.0	B08		7	0195-0388	927.26	388.88	312	65.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10630.9	B08		7	0196-0394	185.85	393.76	261	63.01	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13622.3	B08		7	0197-0395	116.26	395.13	255	58.77	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10729.7	B08		7	0198-0393	840.15	393.95	241	57.70	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13414.4	B08		7	0199-0399	899.11	399.12	309	65.36	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15459.1	B08		7	0200-0400	555.73	400.33	333	71.01	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13689.8	B08		7	0201-0402	94.97	402.82	390	74.43	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11034.8	B08		7	0202-0403	503.44	403.91	240	59.70	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16151.2	B08		7	0203-0402	782.10	402.91	155	50.87	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7898.3	B08		7	0204-0406	870.45	407.13	285	71.01	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9918.9	B08		7	0205-0405	281.16	404.51	254	62.77	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12141.0	B08		7	0206-0408	439.39	407.70	223	57.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10862.4	B08		7	0207-0407	677.66	407.11	250	57.94	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9321.6	B08		7	0208-0409	946.76	409.94	278	67.01	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10307.5	B08		7	0209-0408	50.70	408.74	253	61.70	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8832.1	B08		7	0210-0408	329.76	408.12	319	72.43	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13623.6	B08		7	0211-0412	228.68	412.13	306	65.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17029.6	B08		7	0212-0413	582.83	413.25	313	67.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15417.6	B08		7	0213-0409	753.48	408.41	161	49.70	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11845.6	B08		7	0214-0416	308.23	416.71	224	61.36	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13334.5	B08		7	0215-0419	544.64	418.65	204	51.94	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9244.6	B08		7	0216-0420	627.16	420.38	308	67.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10053.7	B08		7	0217-0423	938.35	422.78	276	65.26	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10189.8	B08		7	0218-0427	816.11	427.07	261	61.70	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9282.4	B08		7	0219-0428	330.82	429.26	299	66.43	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10670.6	B08		7	0220-0429	710.81	428.85	298	66.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9837.1	B08		7	0221-0431	199.59	430.66	279	63.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8949.6	B08		7	0222-0432	784.78	431.99	288	65.60	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12502.8	B08		7	0223-0436	80.45	436.11	367	73.11	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13122.2	B08		7	0224-0434	530.11	433.20	296	67.60	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16527.4	B08		7	0225-0437	547.31	438.14	267	65.26	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11005.0	B08		7	0226-0438	24.77	437.88	236	59.70	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15518.2	B08		7	0227-0437	102.70	437.10	222	58.18	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12514.2	B08		7	0228-0438	689.99	437.92	218	56.28	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10144.5	B08		7	0229-0444	644.17	443.89	414	80.67	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10631.2	B08		7	0230-0445	349.35	444.63	254	62.18	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9205.8	B08		7	0231-0448	673.60	448.71	311	67.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11671.3	B08		7	0232-0451	760.98	450.72	222	61.94	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9258.8	B08		7	0233-0451	577.59	451.76	277	63.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16971.8	B08		7	0234-0454	817.04	453.79	324	68.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9981.1	B08		7	0235-0456	455.98	456.45	269	64.18	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17271.8	B08		7	0236-0460	63.98	460.09	299	63.94	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8154.7	B08		7	0237-0466	864.93	466.05	302	80.91	0.580
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10742.8	B08		7	0238-0464	356.84	463.88	256	60.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9256.1	B08		7	0239-0466	513.38	466.70	281	63.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14299.8	B08		7	0240-0467	328.45	467.72	371	83.84	0.663
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13312.4	B08		7	0241-0468	849.84	468.20	184	53.46	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15222.4	B08		7	0242-0472	906.09	471.68	340	76.67	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12961.4	B08		7	0243-0470	203.00	469.81	222	58.18	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11941.7	B08		7	0244-0472	236.38	472.69	220	59.01	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8687.8	B08		7	0245-0477	934.34	478.49	318	72.43	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10432.8	B08		7	0246-0481	651.26	482.10	510	106.57	0.564
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16390.4	B08		7	0247-0486	129.79	486.75	499	86.67	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11410.3	B08		7	0248-0482	398.08	481.83	240	57.60	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13524.8	B08		7	0249-0484	782.53	484.13	397	75.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14382.8	B08		7	0250-0491	555.13	492.15	336	68.43	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9350.8	B08		7	0251-0493	488.53	493.04	280	65.01	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9616.8	B08		7	0252-0496	630.32	496.96	275	61.01	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11275.5	B08		7	0253-0504	76.36	503.82	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9934.6	B08		7	0254-0512	563.18	512.38	275	61.11	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15583.0	B08		7	0255-0515	929.60	515.28	331	67.84	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12184.3	B08		7	0256-0515	303.66	514.76	221	56.18	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11842.7	B08		7	0257-0517	419.55	516.60	219	54.87	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10103.9	B08		7	0258-0520	523.11	521.12	339	71.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10664.5	B08		7	0259-0523	102.70	523.12	267	67.94	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12781.3	B08		7	0260-0520	194.12	520.44	217	55.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10542.7	B08		7	0261-0521	781.22	521.50	240	62.18	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14507.7	B08		7	0262-0522	715.60	522.41	182	49.11	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11407.4	B08		7	0263-0529	225.10	528.94	309	65.11	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13879.7	B08		7	0264-0527	285.61	527.28	236	57.70	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10779.1	B08		7	0265-0530	149.38	529.94	288	65.94	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11515.1	B08		7	0266-0534	429.34	534.91	260	62.43	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11708.6	B08		7	0267-0536	770.17	537.07	227	56.18	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12356.9	B08		7	0268-0540	906.22	540.02	407	76.43	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12601.4	B08		7	0269-0540	335.32	539.97	212	55.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10238.0	B08		7	0270-0545	548.09	545.33	251	59.94	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13834.3	B08		7	0271-0545	270.40	544.99	189	51.94	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11865.3	B08		7	0272-0546	447.50	545.93	228	58.43	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11641.4	B08		7	0273-0553	804.74	553.28	232	58.77	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13230.1	B08		7	0274-0549	859.05	549.05	126	43.46	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12639.3	B08		7	0275-0551	482.79	550.94	212	53.70	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9927.4	B08		7	0276-0552	392.00	551.27	300	69.60	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12428.0	B08		7	0277-0553	821.00	553.94	198	56.18	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9620.8	B08		7	0278-0555	301.57	555.59	283	65.94	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10138.3	B08		7	0279-0558	776.62	558.39	269	62.53	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15489.5	B08		7	0280-0559	689.71	560.15	226	62.77	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14003.4	B08		7	0281-0560	339.19	559.53	187	51.36	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12661.9	B08		7	0282-0564	852.72	564.30	217	55.84	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10687.5	B08		7	0283-0565	273.27	565.52	251	61.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10199.8	B08		7	0284-0566	215.27	567.71	321	73.01	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11137.7	B08		7	0285-0568	794.53	567.90	241	58.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9690.9	B08		7	0286-0568	574.60	568.25	313	68.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10862.1	B08		7	0287-0571	97.09	571.01	324	68.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12084.0	B08		7	0288-0572	358.39	571.60	225	57.70	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12820.8	B08		7	0289-0568	451.12	568.59	194	50.87	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11110.2	B08		7	0290-0571	514.70	571.55	238	57.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10459.8	B08		7	0291-0575	818.21	576.01	261	63.11	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11032.5	B08		7	0292-0573	627.10	573.01	252	58.87	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16060.3	B08		7	0293-0587	161.52	585.95	593	107.05	0.650
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12846.5	B08		7	0294-0580	382.48	581.18	206	56.04	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10431.5	B08		7	0295-0582	856.68	582.60	241	59.84	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14255.0	B08		7	0296-0581	454.66	581.62	195	53.21	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10924.7	B08		7	0297-0584	20.47	584.14	229	57.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13851.7	B08		7	0298-0589	65.54	589.46	360	71.36	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11226.1	B08		7	0299-0589	202.30	589.49	276	69.01	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11065.7	B08		7	0300-0586	306.59	585.47	227	56.53	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13923.1	B08		7	0301-0587	540.11	586.99	191	51.36	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11786.6	B08		7	0302-0589	419.81	589.22	243	57.11	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12792.6	B08		7	0303-0589	641.78	589.13	208	54.28	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11924.8	B08		7	0304-0591	870.52	591.42	226	55.11	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13716.8	B08		7	0305-0592	401.35	592.08	206	54.28	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14047.0	B08		7	0306-0595	386.10	595.23	181	51.80	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12517.4	B08		7	0307-0599	934.08	598.75	396	74.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9227.5	B08		7	0308-0597	468.94	597.78	296	63.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12271.0	B08		7	0309-0599	531.68	600.05	232	55.36	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11165.7	B08		7	0310-0600	586.68	599.78	239	57.70	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11128.1	B08		7	0311-0603	237.89	602.51	256	58.53	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18393.2	B08		7	0312-0603	747.56	603.22	140	46.28	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11360.5	B08		7	0313-0607	275.96	606.98	234	56.53	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13822.0	B08		7	0314-0618	761.53	616.65	395	87.26	0.652
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10865.6	B08		7	0315-0618	317.58	618.43	245	59.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13970.0	B08		7	0316-0620	798.63	619.75	372	73.60	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9854.8	B08		7	0317-0619	184.08	618.67	255	59.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13243.5	B08		7	0318-0619	536.33	619.55	203	52.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15601.7	B08		7	0319-0619	732.67	618.91	225	58.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9939.8	B08		7	0320-0624	75.32	624.49	297	67.26	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15075.1	B08		7	0321-0626	149.52	625.62	378	74.18	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10365.6	B08		7	0322-0624	587.75	624.19	255	60.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10340.2	B08		7	0323-0628	266.79	628.79	272	64.77	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10272.5	B08		7	0324-0626	224.98	625.70	269	60.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14660.8	B08		7	0325-0631	33.55	631.63	372	75.84	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14530.8	B08		7	0326-0630	380.71	630.34	182	50.28	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16552.0	B08		7	0327-0632	742.45	633.18	264	63.60	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10988.0	B08		7	0328-0632	870.00	633.29	240	62.77	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11201.8	B08		7	0329-0638	418.93	637.29	242	58.18	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10765.0	B08		7	0330-0635	486.04	635.24	265	64.53	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13621.2	B08		7	0331-0636	884.42	636.28	183	50.63	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11307.1	B08		7	0332-0640	652.10	639.58	235	59.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9940.0	B08		7	0333-0642	303.25	642.62	278	63.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12935.1	B08		7	0334-0643	369.37	643.58	193	51.70	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12749.7	B08		7	0335-0647	536.33	647.18	228	57.01	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13152.7	B08		7	0336-0648	701.14	648.33	301	63.60	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11503.7	B08		7	0337-0655	825.26	654.58	343	71.50	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13533.1	B08		7	0338-0652	905.80	652.94	180	51.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11347.3	B08		7	0339-0656	494.86	656.41	261	60.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12385.4	B08		7	0340-0655	647.89	656.23	214	54.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11387.6	B08		7	0341-0660	619.43	660.42	307	68.53	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8153.6	B08		7	0342-0660	103.73	660.38	202	60.18	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14972.6	B08		7	0343-0661	331.53	661.26	282	62.28	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12635.7	B08		7	0344-0658	369.54	658.31	227	57.11	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13493.3	B08		7	0345-0659	935.36	658.91	181	52.43	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11865.5	B08		7	0346-0660	447.04	660.05	247	59.11	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10757.7	B08		7	0347-0665	250.08	665.56	256	60.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8848.2	B08		7	0348-0662	37.36	662.14	140	45.94	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10717.1	B08		7	0349-0668	273.05	667.94	244	60.18	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13485.9	B08		7	0350-0671	564.20	671.06	415	79.50	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15686.9	B08		7	0351-0668	724.95	667.73	304	64.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12853.0	B08		7	0352-0666	922.79	665.38	205	57.36	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11637.0	B08		7	0353-0670	193.80	670.59	269	61.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10773.3	B08		7	0354-0673	768.30	672.51	256	59.60	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12704.6	B08		7	0355-0672	377.96	672.48	212	55.46	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11965.5	B08		7	0356-0674	861.90	673.49	332	68.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12555.1	B08		7	0357-0676	85.23	676.00	223	57.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9057.3	B08		7	0358-0677	797.05	677.26	267	63.01	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10032.5	B08		7	0359-0675	34.76	675.73	175	50.28	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13826.9	B08		7	0360-0676	703.10	676.08	198	57.60	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9106.1	B08		7	0361-0678	52.72	679.35	218	59.36	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16298.6	B08		7	0362-0683	685.57	684.28	648	111.05	0.660
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12336.7	B08		7	0363-0680	448.23	679.47	224	55.36	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9292.2	B08		7	0364-0685	843.10	686.08	260	61.36	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9235.9	B08		7	0365-0688	618.11	687.90	248	63.84	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11942.2	B08		7	0366-0686	340.20	686.29	226	55.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14470.5	B08		7	0367-0692	413.83	691.73	372	73.26	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17309.9	B08		7	0368-0691	714.85	690.45	150	46.87	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11002.9	B08		7	0369-0694	912.92	694.90	229	57.94	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13155.5	B08		7	0370-0696	937.38	695.64	291	61.94	0.953
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11110.2	B08		7	0371-0697	52.33	696.50	224	55.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11270.7	B08		7	0372-0697	136.01	696.68	215	53.94	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8883.9	B08		7	0373-0702	234.35	703.26	290	67.36	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12076.8	B08		7	0374-0703	882.83	702.70	269	63.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11147.5	B08		7	0375-0704	371.40	704.40	237	58.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12841.3	B08		7	0376-0703	539.66	702.93	202	52.28	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16607.8	B08		7	0377-0700	690.84	700.22	159	45.70	0.957
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11720.3	B08		7	0378-0706	464.63	706.59	227	57.94	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12362.1	B08		7	0379-0706	646.96	706.78	211	53.11	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185113	1375315	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8874.3	B08		7	0380-0708	161.23	708.82	276	64.53	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12404.5	B08		8	0001-0027	605.94	27.87	215	56.28	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9009.4	B08		8	0002-0030	678.63	29.96	293	63.01	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12168.6	B08		8	0003-0030	332.84	29.76	212	53.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10095.0	B08		8	0004-0034	100.59	34.63	237	58.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11292.0	B08		8	0005-0030	274.05	30.58	219	59.70	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13309.9	B08		8	0006-0039	437.09	39.00	204	53.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12062.0	B08		8	0007-0041	321.69	41.81	212	54.28	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11777.9	B08		8	0008-0040	928.24	40.30	223	54.28	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9615.1	B08		8	0009-0043	461.70	44.14	285	63.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12689.5	B08		8	0010-0044	809.55	44.14	285	61.36	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9525.7	B08		8	0011-0045	569.92	43.93	174	54.43	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11824.7	B08		8	0012-0045	358.74	45.50	219	55.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18466.1	B08		8	0013-0045	633.25	45.14	254	60.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8970.5	B08		8	0014-0047	122.29	46.71	280	66.18	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11248.0	B08		8	0015-0048	25.24	47.86	211	53.11	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13223.3	B08		8	0016-0048	185.64	48.59	289	64.18	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14285.0	B08		8	0017-0049	384.18	48.78	310	66.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11451.0	B08		8	0018-0049	307.42	48.87	215	54.87	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8773.7	B08		8	0019-0050	580.11	51.04	112	44.87	0.699
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12836.6	B08		8	0020-0053	753.84	52.66	215	54.28	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12443.2	B08		8	0021-0053	254.99	53.81	251	60.53	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13600.3	B08		8	0022-0056	493.18	56.48	338	69.01	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12644.7	B08		8	0023-0054	940.44	54.25	205	52.28	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11237.3	B08		8	0024-0061	241.09	61.83	193	56.77	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17655.4	B08		8	0025-0056	768.83	55.64	147	45.80	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10887.8	B08		8	0026-0060	866.08	60.35	250	59.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10041.0	B08		8	0027-0063	559.18	62.41	294	67.60	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8957.4	B08		8	0028-0063	642.81	63.02	178	48.28	0.959
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9904.5	B08		8	0029-0064	701.82	64.72	262	60.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9933.0	B08		8	0030-0068	91.77	68.89	240	59.11	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9544.3	B08		8	0031-0070	346.19	69.91	273	61.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11806.2	B08		8	0032-0069	838.43	68.84	215	56.18	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16785.9	B08		8	0033-0070	765.62	69.56	157	46.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12106.1	B08		8	0034-0071	878.70	71.36	219	55.70	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11453.9	B08		8	0035-0075	248.18	76.27	218	55.36	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12944.2	B08		8	0036-0076	753.87	77.01	208	55.01	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12999.1	B08		8	0037-0078	789.59	77.65	266	62.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11199.7	B08		8	0038-0080	204.05	79.65	217	54.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12767.9	B08		8	0039-0082	535.30	81.33	202	55.46	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11402.2	B08		8	0040-0086	684.70	86.65	407	78.67	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13064.2	B08		8	0041-0081	911.11	81.40	246	57.70	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13326.7	B08		8	0042-0083	278.01	82.10	183	51.36	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12613.1	B08		8	0043-0083	422.56	82.95	209	52.87	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15425.4	B08		8	0044-0092	521.47	91.87	335	73.11	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9905.2	B08		8	0045-0087	654.93	87.18	272	62.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13434.5	B08		8	0046-0088	803.61	88.22	262	60.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9125.1	B08		8	0047-0085	312.89	85.51	156	48.04	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11018.9	B08		8	0048-0091	506.89	91.64	231	61.11	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13444.8	B08		8	0049-0093	265.32	92.69	347	69.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21511.7	B08		8	0050-0089	466.44	89.42	126	64.67	0.379
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13914.0	B08		8	0051-0091	485.54	91.39	178	51.70	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9993.6	B08		8	0052-0095	578.56	94.28	158	52.53	0.720
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17491.9	B08		8	0053-0098	235.72	97.49	144	47.60	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9798.3	B08		8	0054-0097	312.79	96.29	117	40.63	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11146.8	B08		8	0055-0101	196.52	101.22	216	55.70	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12509.1	B08		8	0056-0109	168.10	109.50	416	84.08	0.739
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10846.1	B08		8	0057-0109	61.26	110.18	302	65.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8537.6	B08		8	0058-0109	325.70	109.43	285	64.53	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17020.6	B08		8	0059-0105	492.19	104.94	158	46.63	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17220.3	B08		8	0060-0109	225.69	109.46	155	46.53	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9547.2	B08		8	0061-0110	418.68	110.04	266	61.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12980.0	B08		8	0062-0110	740.53	109.96	202	53.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9785.5	B08		8	0063-0116	365.54	115.83	258	59.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9418.3	B08		8	0064-0117	17.34	117.17	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13519.4	B08		8	0065-0117	710.91	117.16	339	67.60	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12237.8	B08		8	0066-0114	692.08	114.01	112	40.04	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10308.3	B08		8	0067-0116	945.56	116.40	143	45.11	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11692.9	B08		8	0068-0119	476.58	119.53	226	55.94	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10208.5	B08		8	0069-0120	214.16	121.08	218	57.84	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10772.1	B08		8	0070-0123	458.80	122.27	270	66.18	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9230.1	B08		8	0071-0128	621.93	128.49	282	65.11	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10417.2	B08		8	0072-0126	810.83	124.99	255	63.36	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11092.8	B08		8	0073-0129	254.02	128.83	222	57.36	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9130.7	B08		8	0074-0126	312.43	126.66	288	67.94	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11331.6	B08		8	0075-0127	651.45	127.21	274	62.53	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11447.9	B08		8	0076-0124	693.52	124.41	100	38.63	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8616.8	B08		8	0077-0134	544.06	133.88	328	69.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11078.7	B08		8	0078-0131	834.06	131.69	238	57.36	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14622.4	B08		8	0079-0134	916.21	133.84	333	69.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11552.5	B08		8	0080-0139	433.99	140.31	312	67.60	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14021.3	B08		8	0081-0141	742.85	142.35	182	53.36	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9337.6	B08		8	0082-0142	371.39	142.67	287	66.18	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12623.0	B08		8	0083-0142	691.60	143.08	137	49.70	0.697
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11174.1	B08		8	0084-0147	102.87	147.30	221	58.28	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11792.4	B08		8	0085-0146	870.70	146.58	274	63.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8664.5	B08		8	0086-0145	813.59	145.20	244	62.53	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12652.0	B08		8	0087-0147	260.69	146.47	195	52.53	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10433.6	B08		8	0088-0151	610.95	151.63	257	69.60	0.667
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12086.4	B08		8	0089-0151	508.14	151.35	210	54.77	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15543.3	B08		8	0090-0152	201.67	152.39	324	67.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13362.9	B08		8	0091-0153	752.90	153.76	193	51.70	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11953.1	B08		8	0092-0154	646.52	153.18	233	58.53	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9585.3	B08		8	0093-0163	790.71	165.01	286	78.43	0.584
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9311.5	B08		8	0094-0160	115.51	160.99	260	59.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8281.0	B08		8	0095-0163	155.98	162.80	258	62.43	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8848.5	B08		8	0096-0167	638.49	167.91	284	66.67	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8185.4	B08		8	0097-0169	319.81	169.39	287	62.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11839.2	B08		8	0098-0170	387.76	170.51	216	54.53	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9399.8	B08		8	0099-0172	718.99	171.98	280	64.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11541.5	B08		8	0100-0174	444.36	173.61	393	78.43	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11889.0	B08		8	0101-0173	363.23	173.68	207	54.53	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13509.2	B08		8	0102-0172	824.23	172.48	190	52.14	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15268.8	B08		8	0103-0173	839.23	173.39	161	48.63	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12824.6	B08		8	0104-0174	855.85	173.78	202	54.53	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19508.3	B08		8	0105-0176	472.06	176.28	277	61.11	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12802.5	B08		8	0106-0176	589.15	176.50	204	53.11	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	21590.2	B08		8	0107-0174	24.47	175.02	132	43.46	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20104.8	B08		8	0108-0181	916.02	180.69	140	89.98	0.217
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13290.1	B08		8	0109-0191	416.31	190.75	393	73.60	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12052.7	B08		8	0110-0190	557.40	189.97	233	57.36	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15842.3	B08		8	0111-0194	503.96	194.47	352	71.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17697.0	B08		8	0112-0193	528.14	193.10	302	65.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11041.7	B08		8	0113-0191	576.48	190.90	248	57.70	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9947.4	B08		8	0114-0196	82.44	197.40	250	59.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15491.6	B08		8	0115-0199	731.41	199.55	326	71.84	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13760.5	B08		8	0116-0206	797.58	204.88	608	103.98	0.707
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12977.2	B08		8	0117-0200	600.24	198.90	321	67.84	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9423.5	B08		8	0118-0201	706.38	200.68	275	65.60	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9748.3	B08		8	0119-0200	105.70	199.53	251	60.77	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10120.4	B08		8	0120-0203	51.33	203.14	263	64.67	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8965.5	B08		8	0121-0201	945.35	201.25	242	64.77	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11240.7	B08		8	0122-0202	841.47	202.21	265	59.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8006.8	B08		8	0123-0204	360.88	204.41	293	66.18	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8603.5	B08		8	0124-0203	473.99	203.12	291	67.36	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16715.6	B08		8	0125-0209	540.26	210.14	315	74.18	0.719
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15015.6	B08		8	0126-0207	210.90	207.35	301	65.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9021.4	B08		8	0127-0209	653.64	209.25	285	64.77	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14787.8	B08		8	0128-0216	905.41	216.77	342	71.60	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14101.2	B08		8	0129-0217	238.79	216.72	356	70.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11803.8	B08		8	0130-0219	326.08	218.78	230	67.11	0.642
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11009.8	B08		8	0131-0219	404.45	220.29	295	63.11	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10747.2	B08		8	0132-0222	573.44	222.43	240	57.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14180.7	B08		8	0133-0223	825.07	222.16	159	55.11	0.658
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8814.9	B08		8	0134-0228	177.37	228.44	252	65.60	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12239.4	B08		8	0135-0226	444.15	225.99	249	59.70	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10191.7	B08		8	0136-0226	297.91	225.97	241	57.01	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11772.2	B08		8	0137-0226	338.15	227.24	232	60.18	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13586.2	B08		8	0138-0225	836.01	225.90	134	47.94	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11647.6	B08		8	0139-0231	760.15	231.06	226	56.04	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11426.2	B08		8	0140-0233	362.12	232.89	237	60.18	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9385.6	B08		8	0141-0236	884.11	237.24	290	67.11	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13472.3	B08		8	0142-0238	52.62	238.34	342	68.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12293.2	B08		8	0143-0234	514.13	234.63	207	57.46	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10940.8	B08		8	0144-0239	844.35	239.44	239	58.77	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9814.0	B08		8	0145-0242	131.43	242.42	205	54.53	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15199.8	B08		8	0146-0241	497.89	242.11	176	49.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10685.8	B08		8	0147-0244	785.63	245.13	262	59.36	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11911.3	B08		8	0148-0244	401.72	243.93	213	54.53	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12394.6	B08		8	0149-0248	624.08	247.94	209	54.53	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10866.3	B08		8	0150-0249	726.50	248.48	254	59.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16821.3	B08		8	0151-0250	757.15	250.54	325	72.18	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12907.4	B08		8	0152-0249	644.05	249.45	254	60.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16090.2	B08		8	0153-0252	104.77	251.94	312	65.11	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12391.0	B08		8	0154-0252	445.78	252.74	217	60.53	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13151.9	B08		8	0155-0256	571.64	257.18	211	59.70	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15829.2	B08		8	0156-0266	348.79	266.57	640	110.47	0.659
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10243.4	B08		8	0157-0258	883.69	257.58	273	61.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9792.9	B08		8	0158-0256	905.81	256.66	277	63.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11166.0	B08		8	0159-0260	833.84	260.57	489	90.08	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11114.3	B08		8	0160-0260	689.87	260.20	232	57.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15624.9	B08		8	0161-0262	492.09	262.56	290	63.60	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11920.2	B08		8	0162-0267	518.42	267.31	439	80.08	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9176.9	B08		8	0163-0265	186.17	265.60	250	78.91	0.505
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9308.3	B08		8	0164-0265	247.92	265.49	261	59.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11156.0	B08		8	0165-0270	618.28	270.58	224	61.94	0.734
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16711.8	B08		8	0166-0265	797.52	264.67	151	49.11	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13058.7	B08		8	0167-0269	923.08	268.60	250	58.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13330.6	B08		8	0168-0275	409.94	274.74	383	74.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11491.1	B08		8	0169-0276	133.40	275.48	241	61.01	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10151.4	B08		8	0170-0275	47.24	275.34	223	55.11	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11218.8	B08		8	0171-0280	278.01	279.85	388	77.50	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14029.1	B08		8	0172-0279	562.46	279.94	194	57.36	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12853.9	B08		8	0173-0278	458.98	277.90	219	55.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10730.8	B08		8	0174-0278	715.69	277.13	240	59.94	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13270.2	B08		8	0175-0282	119.51	282.12	188	54.53	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12714.6	B08		8	0176-0280	332.96	280.84	132	43.56	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10841.6	B08		8	0177-0290	891.19	289.75	238	58.18	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12759.5	B08		8	0178-0292	298.21	292.89	218	54.53	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9039.0	B08		8	0179-0295	95.73	294.43	249	61.36	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12800.1	B08		8	0180-0294	330.03	293.71	196	53.46	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11900.9	B08		8	0181-0297	860.98	297.75	317	65.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12793.8	B08		8	0182-0297	512.10	296.55	221	56.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12227.5	B08		8	0183-0303	430.37	303.46	354	71.60	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14497.4	B08		8	0184-0303	479.32	302.65	346	68.18	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14384.0	B08		8	0185-0302	497.46	302.33	187	51.11	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11335.1	B08		8	0186-0303	716.93	302.65	222	57.11	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10993.6	B08		8	0187-0305	830.82	305.53	256	57.94	0.958
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7555.5	B08		8	0188-0310	25.65	309.68	263	66.77	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8893.2	B08		8	0189-0309	198.99	308.92	288	70.67	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15876.3	B08		8	0190-0310	787.30	310.84	332	70.18	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11942.2	B08		8	0191-0309	934.28	309.96	218	56.28	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8039.9	B08		8	0192-0313	234.95	313.59	264	67.01	0.739
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11884.7	B08		8	0193-0313	297.10	313.57	317	67.01	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11634.2	B08		8	0194-0316	613.92	317.18	222	57.70	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12997.9	B08		8	0195-0319	126.34	319.24	196	63.26	0.616
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22381.7	B08		8	0196-0320	567.44	319.73	136	47.11	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13653.9	B08		8	0197-0323	279.05	323.73	192	51.46	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11488.3	B08		8	0198-0328	673.08	328.40	224	62.18	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12861.5	B08		8	0199-0326	330.82	326.80	227	55.94	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11358.7	B08		8	0200-0329	94.74	329.33	229	57.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11014.0	B08		8	0201-0330	718.20	329.79	235	56.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10409.5	B08		8	0202-0331	696.05	331.99	248	57.70	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8275.2	B08		8	0203-0328	485.85	327.96	134	46.87	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9663.5	B08		8	0204-0333	831.68	332.64	270	60.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14427.5	B08		8	0205-0335	182.20	335.61	329	67.36	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13222.3	B08		8	0206-0338	35.69	338.17	193	52.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13827.9	B08		8	0207-0338	283.63	337.80	194	52.28	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15641.7	B08		8	0208-0341	442.74	341.90	307	66.43	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9391.3	B08		8	0209-0343	495.31	344.36	429	88.67	0.686
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9568.5	B08		8	0210-0341	749.53	341.13	261	59.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18787.3	B08		8	0211-0342	409.14	342.94	258	59.70	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11674.4	B08		8	0212-0344	786.04	343.56	228	55.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11946.9	B08		8	0213-0343	223.49	343.69	205	53.11	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9810.3	B08		8	0214-0345	72.07	344.02	253	60.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8567.4	B08		8	0215-0347	615.45	347.13	290	64.53	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10123.3	B08		8	0216-0349	847.39	348.96	278	64.08	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11706.8	B08		8	0217-0349	162.16	349.02	209	53.94	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11275.6	B08		8	0218-0352	904.73	351.46	230	59.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11768.2	B08		8	0219-0358	239.48	358.57	276	61.01	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15348.9	B08		8	0220-0361	372.20	361.46	328	68.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12105.1	B08		8	0221-0364	732.60	364.38	212	56.53	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8389.3	B08		8	0222-0365	669.58	364.77	308	69.94	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13170.7	B08		8	0223-0363	542.40	363.96	167	48.63	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9822.2	B08		8	0224-0367	825.59	367.27	264	63.01	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11756.0	B08		8	0225-0368	69.91	368.36	423	77.60	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15572.1	B08		8	0226-0367	509.82	366.75	165	49.11	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11901.0	B08		8	0227-0370	842.54	368.99	221	57.36	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14588.9	B08		8	0228-0370	904.68	370.38	299	63.94	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12350.7	B08		8	0229-0374	705.18	375.56	291	65.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16688.6	B08		8	0230-0380	229.26	379.63	336	69.01	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10243.7	B08		8	0231-0381	625.58	381.14	261	59.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15629.4	B08		8	0232-0380	538.41	379.26	186	52.28	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13822.7	B08		8	0233-0380	122.53	380.11	176	49.46	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11221.3	B08		8	0234-0390	459.42	389.07	472	94.81	0.660
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10459.4	B08		8	0235-0385	174.02	384.99	229	55.11	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15260.7	B08		8	0236-0390	32.31	390.91	315	65.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10600.3	B08		8	0237-0390	476.96	389.92	250	59.46	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19422.9	B08		8	0238-0389	563.53	389.04	227	56.04	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10738.3	B08		8	0239-0392	96.37	392.44	221	54.53	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10792.2	B08		8	0240-0392	140.30	393.04	241	60.53	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12628.1	B08		8	0241-0394	517.34	394.43	226	57.36	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13112.6	B08		8	0242-0393	205.01	393.33	193	53.11	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12079.2	B08		8	0243-0396	357.48	395.76	326	68.43	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9686.4	B08		8	0244-0396	798.26	395.72	268	59.60	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13705.5	B08		8	0245-0393	115.88	393.18	177	49.70	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9422.2	B08		8	0246-0401	285.34	401.61	298	68.67	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9965.5	B08		8	0247-0403	854.48	404.25	271	62.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14612.8	B08		8	0248-0409	874.03	409.15	215	59.36	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13265.7	B08		8	0249-0410	535.95	410.12	210	57.21	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10641.6	B08		8	0250-0409	757.81	409.18	241	57.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11341.0	B08		8	0251-0408	385.95	408.25	148	47.36	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9027.3	B08		8	0252-0412	51.60	411.98	247	62.43	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13830.2	B08		8	0253-0413	306.91	413.24	351	68.77	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12395.1	B08		8	0254-0411	617.11	411.83	213	54.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15829.5	B08		8	0255-0413	920.61	413.25	248	59.11	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9788.5	B08		8	0256-0425	43.38	424.45	270	64.08	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10105.9	B08		8	0257-0424	197.36	424.82	291	65.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20000.9	B08		8	0258-0426	840.62	426.82	249	59.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9134.6	B08		8	0259-0425	90.69	425.05	252	59.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9802.3	B08		8	0260-0426	395.24	426.38	188	54.18	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15115.2	B08		8	0261-0430	798.43	429.42	316	67.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9020.1	B08		8	0262-0428	429.05	427.54	272	61.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11403.7	B08		8	0263-0430	685.11	429.79	228	59.11	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11099.8	B08		8	0264-0430	536.49	429.89	224	59.21	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12696.7	B08		8	0265-0433	292.44	431.71	270	62.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12402.9	B08		8	0266-0433	463.81	433.41	344	70.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8262.6	B08		8	0267-0440	612.69	440.34	286	66.18	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12363.2	B08		8	0268-0440	376.98	439.41	296	67.36	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11669.7	B08		8	0269-0441	917.64	440.86	239	59.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15872.1	B08		8	0270-0441	571.71	441.23	324	67.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11488.4	B08		8	0271-0448	119.36	447.66	377	73.60	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11937.9	B08		8	0272-0444	709.38	444.02	214	53.70	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13766.0	B08		8	0273-0446	210.10	445.78	171	49.70	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12106.1	B08		8	0274-0450	251.93	449.17	467	84.33	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13884.0	B08		8	0275-0445	284.42	445.95	125	42.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10937.9	B08		8	0276-0447	758.43	447.39	273	63.36	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8766.4	B08		8	0277-0447	510.30	448.26	285	65.60	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11726.5	B08		8	0278-0451	197.74	451.73	214	54.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11453.5	B08		8	0279-0452	679.58	452.71	229	56.53	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9468.1	B08		8	0280-0455	414.52	455.68	259	65.26	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10786.2	B08		8	0281-0458	645.04	457.69	235	57.70	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11425.8	B08		8	0282-0461	893.09	460.31	237	61.11	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11174.0	B08		8	0283-0461	806.05	461.06	265	61.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8902.6	B08		8	0284-0460	849.37	459.94	300	73.26	0.703
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13869.8	B08		8	0285-0467	482.18	466.42	278	65.36	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12704.6	B08		8	0286-0467	502.80	466.67	202	52.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19056.9	B08		8	0287-0468	175.68	468.11	131	44.39	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11159.2	B08		8	0288-0469	188.14	470.18	220	55.46	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18437.1	B08		8	0289-0470	164.58	470.70	133	44.87	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9888.2	B08		8	0290-0473	445.19	473.32	256	60.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16080.0	B08		8	0291-0476	340.33	476.43	305	64.43	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11490.5	B08		8	0292-0475	146.13	474.35	224	54.53	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9643.8	B08		8	0293-0476	594.06	476.63	181	50.28	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11898.1	B08		8	0294-0475	282.54	475.44	216	54.53	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8412.1	B08		8	0295-0480	38.72	480.74	281	66.67	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11182.7	B08		8	0296-0475	863.09	475.58	237	58.28	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11743.3	B08		8	0297-0476	670.54	476.17	223	56.28	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15644.0	B08		8	0298-0483	521.14	482.66	460	89.98	0.714
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8103.9	B08		8	0299-0486	72.47	487.20	271	64.77	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11415.4	B08		8	0300-0491	98.43	491.48	476	90.33	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10852.2	B08		8	0301-0489	681.87	489.05	240	57.94	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13974.6	B08		8	0302-0495	317.38	494.84	179	53.36	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10720.0	B08		8	0303-0498	424.53	498.54	275	61.60	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13602.6	B08		8	0304-0496	801.89	496.68	186	52.53	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11512.8	B08		8	0305-0496	568.46	496.21	140	45.46	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10710.8	B08		8	0306-0500	925.96	500.83	237	59.36	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10136.7	B08		8	0307-0506	409.35	506.26	265	71.36	0.654
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10663.5	B08		8	0308-0503	162.81	503.82	231	57.94	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11076.1	B08		8	0309-0502	252.53	502.28	254	61.11	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12616.6	B08		8	0310-0502	720.89	503.30	199	55.11	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11750.6	B08		8	0311-0506	118.28	506.07	213	55.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11431.9	B08		8	0312-0506	213.48	506.27	246	58.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9651.1	B08		8	0313-0505	513.95	505.20	270	61.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9459.4	B08		8	0314-0512	391.39	512.53	273	65.26	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12256.7	B08		8	0315-0508	573.78	508.38	197	52.63	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10541.3	B08		8	0316-0513	459.25	513.30	269	62.77	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14526.6	B08		8	0317-0516	279.40	515.67	340	72.91	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14884.4	B08		8	0318-0517	34.47	517.38	330	67.01	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13774.8	B08		8	0319-0519	191.56	519.29	327	67.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10952.4	B08		8	0320-0520	598.95	520.02	222	58.43	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11221.9	B08		8	0321-0521	490.02	521.05	227	55.70	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9473.3	B08		8	0322-0523	544.13	524.15	269	79.01	0.541
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9805.9	B08		8	0323-0524	373.61	524.93	246	58.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11615.5	B08		8	0324-0524	249.55	524.74	219	54.87	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13090.5	B08		8	0325-0528	587.81	528.57	220	57.26	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11944.6	B08		8	0326-0528	661.83	528.57	227	57.11	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15487.4	B08		8	0327-0529	741.26	528.96	331	66.18	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14381.7	B08		8	0328-0529	265.76	529.33	168	49.11	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13082.9	B08		8	0329-0530	886.67	530.57	195	53.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12669.6	B08		8	0330-0536	475.34	535.73	334	73.36	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9781.6	B08		8	0331-0532	693.26	532.27	262	62.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11785.8	B08		8	0332-0535	904.34	535.08	217	57.11	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11858.8	B08		8	0333-0540	503.66	539.29	356	73.01	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14759.5	B08		8	0334-0536	837.33	536.46	168	51.11	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9485.5	B08		8	0335-0540	618.73	540.15	265	63.60	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9669.3	B08		8	0336-0545	108.17	545.82	246	60.77	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20001.1	B08		8	0337-0540	310.74	540.38	112	45.11	0.692
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8576.5	B08		8	0338-0544	540.04	543.04	278	84.91	0.485
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11618.8	B08		8	0339-0543	647.59	542.83	260	59.94	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11554.0	B08		8	0340-0543	228.87	543.02	213	53.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13727.6	B08		8	0341-0547	440.74	547.05	393	74.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10621.2	B08		8	0342-0547	294.62	547.99	340	68.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10637.6	B08		8	0343-0549	63.74	548.50	494	85.84	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12504.6	B08		8	0344-0547	405.03	547.38	199	53.94	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10869.6	B08		8	0345-0553	720.38	553.08	424	78.91	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10365.2	B08		8	0346-0555	585.25	555.47	238	57.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12026.2	B08		8	0347-0557	930.45	557.56	203	53.94	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12051.1	B08		8	0348-0561	829.71	561.23	214	54.53	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13778.9	B08		8	0349-0561	149.59	561.09	177	51.11	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9864.5	B08		8	0350-0565	359.49	565.73	275	60.28	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9976.1	B08		8	0351-0567	899.27	567.38	262	59.60	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13713.0	B08		8	0352-0583	151.66	583.78	549	92.33	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11197.3	B08		8	0353-0575	301.99	574.27	211	54.53	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10331.3	B08		8	0354-0579	446.16	578.94	247	60.43	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10790.0	B08		8	0355-0580	653.80	579.80	251	60.77	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13447.9	B08		8	0356-0578	881.69	578.52	187	50.28	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9163.3	B08		8	0357-0582	591.28	583.00	268	61.26	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8493.7	B08		8	0358-0586	635.36	586.45	320	72.43	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8744.8	B08		8	0359-0585	522.96	585.30	305	67.36	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11711.9	B08		8	0360-0587	364.23	587.18	323	67.01	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14951.0	B08		8	0361-0584	292.96	585.51	169	49.11	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9708.7	B08		8	0362-0586	710.05	586.60	261	61.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10957.0	B08		8	0363-0588	546.84	587.82	378	76.18	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12862.7	B08		8	0364-0585	746.54	585.66	197	52.28	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10586.3	B08		8	0365-0594	428.50	594.90	260	61.36	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16548.8	B08		8	0366-0591	791.24	591.44	157	44.87	0.980
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11224.5	B08		8	0367-0594	106.89	593.63	301	67.36	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13631.2	B08		8	0368-0597	409.77	597.79	382	73.26	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12129.2	B08		8	0369-0601	38.88	600.70	394	73.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11756.3	B08		8	0370-0599	245.03	599.26	215	57.11	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20152.1	B08		8	0371-0603	294.83	602.94	352	87.26	0.581
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10973.4	B08		8	0372-0603	122.93	603.29	228	56.77	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10867.9	B08		8	0373-0602	745.82	602.88	254	59.70	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12810.9	B08		8	0374-0608	772.61	607.70	396	82.08	0.739
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10023.8	B08		8	0375-0611	588.28	610.98	281	61.11	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9497.9	B08		8	0376-0612	691.92	612.85	280	65.36	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9279.0	B08		8	0377-0611	621.03	610.64	266	65.11	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11342.0	B08		8	0378-0615	660.18	615.09	219	54.77	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10307.9	B08		8	0379-0615	91.00	615.30	225	55.11	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8284.1	B08		8	0380-0622	353.66	621.48	274	67.60	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11518.0	B08		8	0381-0617	484.70	617.51	235	57.46	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12838.5	B08		8	0382-0619	283.71	620.14	193	51.46	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8817.5	B08		8	0383-0624	540.61	624.20	286	64.43	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11452.3	B08		8	0384-0623	809.43	623.21	223	55.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15203.0	B08		8	0385-0626	369.46	626.27	240	59.11	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11782.4	B08		8	0386-0628	750.05	628.17	455	80.08	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11950.2	B08		8	0387-0626	315.90	625.91	218	54.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10960.6	B08		8	0388-0630	400.01	630.46	315	65.01	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9200.2	B08		8	0389-0634	103.08	633.11	250	61.60	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14837.9	B08		8	0390-0633	301.76	632.85	182	52.77	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9138.9	B08		8	0391-0634	920.99	635.17	270	65.01	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15301.4	B08		8	0392-0641	826.35	642.57	525	91.01	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9831.6	B08		8	0393-0636	250.17	635.64	243	57.11	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17978.0	B08		8	0394-0636	286.29	635.91	299	67.11	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13002.1	B08		8	0395-0640	56.08	640.78	309	64.18	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10984.5	B08		8	0396-0645	176.16	644.35	531	89.74	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12386.2	B08		8	0397-0642	149.11	641.65	448	83.26	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12063.4	B08		8	0398-0641	548.88	641.16	219	57.01	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11793.5	B08		8	0399-0644	331.95	643.38	244	59.60	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10327.4	B08		8	0400-0644	615.31	644.31	242	60.53	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8840.6	B08		8	0401-0653	518.96	653.04	290	69.36	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15601.9	B08		8	0402-0654	562.67	654.67	315	66.18	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11279.4	B08		8	0403-0658	878.27	658.10	486	88.33	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9283.3	B08		8	0404-0659	685.60	660.49	274	65.60	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19009.7	B08		8	0405-0660	134.72	659.99	277	61.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11862.8	B08		8	0406-0659	651.26	658.94	214	56.18	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15804.0	B08		8	0407-0662	215.01	661.71	477	97.64	0.629
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13965.4	B08		8	0408-0660	432.11	659.62	345	68.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10200.2	B08		8	0409-0661	746.57	660.93	266	60.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8737.5	B08		8	0410-0660	941.90	660.60	248	60.28	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15591.5	B08		8	0411-0660	189.48	661.10	161	49.11	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13337.1	B08		8	0412-0661	39.92	660.81	174	50.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11008.7	B08		8	0413-0664	81.31	663.61	225	57.70	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12687.4	B08		8	0414-0668	27.47	667.37	212	59.36	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10941.3	B08		8	0415-0670	173.32	670.15	233	58.53	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12410.2	B08		8	0416-0671	593.71	671.10	209	53.94	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10466.4	B08		8	0417-0679	567.36	678.71	242	59.84	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8818.1	B08		8	0418-0680	633.95	680.76	292	63.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13026.4	B08		8	0419-0685	777.50	685.49	371	71.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14254.2	B08		8	0420-0687	429.91	687.24	392	75.01	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11602.8	B08		8	0421-0684	263.38	684.17	218	56.53	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10391.8	B08		8	0422-0686	584.10	686.88	285	67.01	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10159.3	B08		8	0423-0680	903.82	679.87	100	37.21	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10670.1	B08		8	0424-0688	864.67	688.04	231	55.36	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10949.4	B08		8	0425-0688	80.75	689.10	232	57.11	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10591.8	B08		8	0426-0690	240.48	690.82	319	66.43	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9263.8	B08		8	0427-0693	719.10	693.26	270	60.53	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10909.1	B08		8	0428-0691	901.19	691.00	113	40.63	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10636.9	B08		8	0429-0697	17.33	697.09	223	56.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13017.7	B08		8	0430-0698	42.08	697.67	293	61.94	0.960
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11081.7	B08		8	0431-0699	548.17	698.83	224	56.28	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8641.4	B08		8	0432-0702	522.67	703.01	282	71.01	0.703
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17356.0	B08		8	0433-0703	351.47	703.31	310	65.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11763.6	B08		8	0434-0703	796.34	702.67	220	56.18	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11881.3	B08		8	0435-0702	574.57	702.78	210	54.28	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185114	1375316	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9092.4	B08		8	0436-0706	669.98	705.58	287	71.60	0.704
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11390.4	B08		9	0001-0029	375.41	28.74	246	63.11	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16127.3	B08		9	0002-0035	296.66	35.80	264	59.94	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10544.5	B08		9	0003-0036	644.36	36.42	315	66.53	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14740.9	B08		9	0004-0038	498.11	37.25	198	56.28	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12613.6	B08		9	0005-0041	524.43	41.73	478	87.74	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12771.4	B08		9	0006-0036	419.86	35.88	237	57.11	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9534.2	B08		9	0007-0037	916.03	37.79	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13165.2	B08		9	0008-0038	140.82	38.08	237	56.53	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10233.5	B08		9	0009-0041	868.08	40.29	256	63.26	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11115.0	B08		9	0010-0042	802.53	43.08	239	57.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9824.8	B08		9	0011-0045	752.63	45.65	300	67.94	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12942.2	B08		9	0012-0043	77.15	42.42	188	50.53	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11956.3	B08		9	0013-0043	22.75	43.23	221	55.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18193.0	B08		9	0014-0048	195.35	48.09	125	41.11	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14319.0	B08		9	0015-0057	182.56	57.31	447	82.91	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10843.1	B08		9	0016-0059	157.91	60.02	233	61.01	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12866.4	B08		9	0017-0057	34.87	57.15	199	51.70	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7907.7	B08		9	0018-0056	285.96	56.48	248	60.77	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12060.6	B08		9	0019-0062	107.83	62.92	258	61.94	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12483.0	B08		9	0020-0064	915.19	64.42	323	65.60	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15366.1	B08		9	0021-0069	346.07	69.89	504	96.57	0.679
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13992.2	B08		9	0022-0063	704.13	62.44	191	53.70	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10419.4	B08		9	0023-0066	436.04	66.09	338	70.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10703.6	B08		9	0024-0068	580.73	68.94	270	62.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12058.2	B08		9	0025-0070	725.46	70.06	223	58.77	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10022.9	B08		9	0026-0072	284.31	72.25	291	63.36	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13020.4	B08		9	0027-0075	862.66	75.75	196	53.11	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11333.3	B08		9	0028-0081	662.91	82.52	347	71.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11538.2	B08		9	0029-0080	395.44	80.30	251	58.87	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11283.1	B08		9	0030-0082	932.73	81.71	281	61.60	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16132.8	B08		9	0031-0086	835.57	86.40	322	67.01	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9421.5	B08		9	0032-0088	176.88	88.51	268	61.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11335.9	B08		9	0033-0089	413.59	90.14	246	62.77	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9538.7	B08		9	0034-0092	612.75	92.05	284	68.08	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11777.2	B08		9	0035-0089	761.59	88.86	231	57.70	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11802.6	B08		9	0036-0095	240.04	95.34	359	70.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16339.4	B08		9	0037-0092	365.95	91.80	166	51.70	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14740.9	B08		9	0038-0097	107.13	96.97	346	69.01	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15631.1	B08		9	0039-0095	479.40	93.97	208	55.01	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19912.1	B08		9	0040-0095	395.91	94.90	126	44.28	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18860.1	B08		9	0041-0100	384.59	100.22	192	62.67	0.614
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9325.0	B08		9	0042-0101	710.55	101.66	287	74.08	0.657
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17072.9	B08		9	0043-0110	644.32	111.09	321	72.18	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14989.3	B08		9	0044-0106	372.78	107.06	198	52.77	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16213.9	B08		9	0045-0110	466.14	110.96	338	70.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10001.7	B08		9	0046-0112	75.69	112.16	235	56.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9962.7	B08		9	0047-0116	36.68	116.61	256	63.01	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13166.4	B08		9	0048-0118	294.42	117.84	409	74.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9552.3	B08		9	0049-0119	431.62	119.28	337	71.84	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12896.9	B08		9	0050-0120	677.17	120.32	449	78.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10555.1	B08		9	0051-0121	411.39	121.23	277	62.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10538.3	B08		9	0052-0128	190.63	128.16	380	73.36	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9958.7	B08		9	0053-0126	224.06	125.99	270	63.94	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10729.9	B08		9	0054-0128	144.88	128.15	231	56.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11418.8	B08		9	0055-0133	746.35	133.64	381	73.26	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8550.6	B08		9	0056-0134	835.53	133.85	352	78.33	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13096.1	B08		9	0057-0139	253.74	138.75	396	74.67	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11949.6	B08		9	0058-0141	818.10	141.83	228	57.11	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9717.2	B08		9	0059-0144	47.69	143.22	250	61.36	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12702.2	B08		9	0060-0146	541.50	146.66	220	58.77	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11733.4	B08		9	0061-0150	866.35	150.41	235	57.60	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10161.6	B08		9	0062-0149	219.61	150.24	257	61.11	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12005.2	B08		9	0063-0153	936.51	153.32	219	56.53	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10882.5	B08		9	0064-0152	631.80	151.95	274	63.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10266.6	B08		9	0065-0156	715.63	156.14	264	59.94	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14175.2	B08		9	0066-0159	132.93	160.15	351	80.08	0.688
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12671.0	B08		9	0067-0159	577.05	159.47	210	55.70	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10928.7	B08		9	0068-0161	523.25	160.27	245	71.60	0.601
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9721.1	B08		9	0069-0166	589.08	166.62	279	68.18	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15624.7	B08		9	0070-0168	857.63	168.79	337	69.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11564.8	B08		9	0071-0168	163.28	168.37	218	58.77	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8596.2	B08		9	0072-0167	753.10	167.95	345	77.36	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12407.5	B08		9	0073-0170	813.41	169.51	207	59.11	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12708.9	B08		9	0074-0173	337.38	173.65	437	79.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10603.0	B08		9	0075-0173	53.07	173.78	231	57.94	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10845.0	B08		9	0076-0177	659.41	177.28	409	77.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12479.0	B08		9	0077-0177	903.32	177.17	420	77.26	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15620.8	B08		9	0078-0177	119.07	177.60	157	47.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18305.1	B08		9	0079-0179	279.29	179.71	293	63.94	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11214.5	B08		9	0080-0180	544.45	179.49	254	59.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12240.8	B08		9	0081-0186	495.05	186.44	413	75.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8812.1	B08		9	0082-0189	700.98	189.95	318	74.67	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10192.5	B08		9	0083-0200	82.82	200.43	296	66.18	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10140.0	B08		9	0084-0201	898.68	200.80	261	61.84	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8735.7	B08		9	0085-0203	39.87	204.14	236	65.01	0.702
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13985.2	B08		9	0086-0210	142.72	209.61	345	69.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10315.7	B08		9	0087-0210	815.25	209.94	406	75.60	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15194.1	B08		9	0088-0215	585.72	215.59	294	65.60	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16476.9	B08		9	0089-0220	316.80	220.33	296	63.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11987.6	B08		9	0090-0225	761.42	225.12	457	83.26	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11826.5	B08		9	0091-0221	68.78	221.25	223	57.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12547.7	B08		9	0092-0222	712.47	222.20	219	55.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10845.4	B08		9	0093-0229	444.65	229.37	286	62.53	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10894.0	B08		9	0094-0229	257.22	228.54	248	60.77	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10436.0	B08		9	0095-0230	419.36	229.52	313	66.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12626.9	B08		9	0096-0228	934.52	228.45	208	55.11	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12678.4	B08		9	0097-0233	696.55	233.45	214	54.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14953.3	B08		9	0098-0232	866.73	232.18	273	61.60	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15703.9	B08		9	0099-0240	469.31	240.67	512	91.50	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17107.5	B08		9	0100-0231	583.41	230.91	168	48.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9605.3	B08		9	0101-0237	641.00	236.87	303	71.01	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10859.1	B08		9	0102-0237	786.48	236.79	348	67.60	0.957
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11192.3	B08		9	0103-0238	568.60	238.28	246	62.18	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10423.5	B08		9	0104-0243	188.18	242.63	287	63.94	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13739.1	B08		9	0105-0245	37.25	244.38	184	53.70	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18311.1	B08		9	0106-0247	51.01	246.24	250	65.36	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10959.9	B08		9	0107-0246	387.87	246.42	235	58.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13398.9	B08		9	0108-0247	668.56	246.78	218	58.53	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20732.8	B08		9	0109-0246	67.09	246.25	134	44.04	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11344.5	B08		9	0110-0249	757.96	250.41	242	59.84	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13377.1	B08		9	0111-0251	114.69	250.68	376	73.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15400.3	B08		9	0112-0249	731.62	249.28	190	51.70	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10972.2	B08		9	0113-0256	95.29	255.88	233	57.46	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10986.8	B08		9	0114-0264	314.31	264.28	268	63.11	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11774.0	B08		9	0115-0263	73.71	263.86	225	61.36	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10904.8	B08		9	0116-0262	474.21	262.79	286	65.94	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11221.4	B08		9	0117-0270	339.27	270.00	284	63.36	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15334.5	B08		9	0118-0269	535.85	268.73	309	66.18	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13668.6	B08		9	0119-0269	182.69	270.82	188	52.63	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12655.3	B08		9	0120-0272	17.79	271.66	249	58.53	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10654.2	B08		9	0121-0275	763.22	275.32	256	58.53	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11692.5	B08		9	0122-0277	555.54	277.08	261	60.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14220.3	B08		9	0123-0284	50.90	284.12	340	70.53	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10832.2	B08		9	0124-0281	99.05	281.25	217	54.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9657.7	B08		9	0125-0287	246.12	287.94	272	67.84	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15185.8	B08		9	0126-0292	726.80	291.74	517	93.15	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13548.6	B08		9	0127-0290	183.49	289.35	416	76.18	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18224.7	B08		9	0128-0289	334.17	289.12	270	59.94	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15238.9	B08		9	0129-0291	540.49	291.77	368	70.43	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11235.8	B08		9	0130-0292	449.98	292.00	252	57.11	0.971
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11364.4	B08		9	0131-0295	589.40	296.33	240	59.94	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13331.7	B08		9	0132-0294	801.72	294.94	278	69.84	0.716
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17585.2	B08		9	0133-0295	493.60	294.97	291	63.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10342.0	B08		9	0134-0300	260.29	300.34	263	68.77	0.699
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11260.7	B08		9	0135-0306	171.30	306.21	233	57.94	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11658.0	B08		9	0136-0312	29.03	312.93	218	56.53	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11111.7	B08		9	0137-0311	895.81	310.71	243	58.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8361.1	B08		9	0138-0318	53.27	318.60	345	82.08	0.643
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13004.8	B08		9	0139-0316	771.09	315.11	296	64.53	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13173.5	B08		9	0140-0318	229.24	318.55	191	51.70	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12346.6	B08		9	0141-0320	438.45	319.63	210	55.70	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15225.1	B08		9	0142-0321	467.78	320.33	229	56.28	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10304.5	B08		9	0143-0321	317.76	321.39	263	67.36	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9835.9	B08		9	0144-0328	922.76	328.97	281	67.11	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12267.6	B08		9	0145-0327	186.14	327.13	204	54.53	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13498.8	B08		9	0146-0334	85.06	333.61	377	76.18	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12420.7	B08		9	0147-0328	528.84	327.56	216	57.70	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11505.4	B08		9	0148-0337	300.90	337.37	226	68.91	0.598
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13202.4	B08		9	0149-0338	407.57	338.42	370	72.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10708.2	B08		9	0150-0340	108.35	340.54	212	56.28	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11284.4	B08		9	0151-0341	495.40	341.38	246	59.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12841.4	B08		9	0152-0341	755.99	340.88	209	54.28	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11778.8	B08		9	0153-0343	626.36	343.83	258	58.77	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11319.3	B08		9	0154-0344	427.02	344.31	229	57.46	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12738.2	B08		9	0155-0345	682.42	345.77	237	57.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10315.7	B08		9	0156-0352	877.69	351.77	267	62.87	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11698.4	B08		9	0157-0354	511.28	354.98	227	59.94	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12454.7	B08		9	0158-0355	359.05	355.36	404	74.18	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10374.2	B08		9	0159-0357	108.57	356.48	250	58.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12480.9	B08		9	0160-0362	712.63	362.15	219	55.36	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11365.2	B08		9	0161-0364	854.69	363.71	235	58.77	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11034.0	B08		9	0162-0374	762.71	374.69	251	58.53	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16141.1	B08		9	0163-0382	541.62	381.84	369	69.84	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10639.3	B08		9	0164-0384	836.72	385.18	259	62.53	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12140.0	B08		9	0165-0388	132.56	388.06	423	79.84	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12883.5	B08		9	0166-0383	443.86	383.52	208	54.53	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11158.9	B08		9	0167-0385	591.05	385.30	269	63.36	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13431.9	B08		9	0168-0383	795.38	383.11	199	51.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10665.2	B08		9	0169-0386	880.30	385.53	249	63.84	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9432.3	B08		9	0170-0388	609.83	388.72	299	68.18	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12592.0	B08		9	0171-0392	751.60	392.00	346	68.18	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14445.0	B08		9	0172-0392	61.36	392.33	283	61.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16785.6	B08		9	0173-0398	557.28	397.94	324	66.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11140.2	B08		9	0174-0397	499.20	396.92	252	61.11	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9940.2	B08		9	0175-0403	283.02	403.64	278	66.53	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9260.1	B08		9	0176-0402	205.79	402.27	267	61.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11170.3	B08		9	0177-0403	233.59	403.91	230	58.28	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12668.4	B08		9	0178-0405	473.13	404.50	404	75.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10189.5	B08		9	0179-0406	83.40	406.15	256	65.60	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11449.0	B08		9	0180-0413	789.67	413.15	247	57.36	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12076.0	B08		9	0181-0416	426.35	416.54	220	56.53	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11097.8	B08		9	0182-0423	837.61	424.02	364	74.91	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11968.2	B08		9	0183-0421	305.15	420.27	213	56.53	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11740.1	B08		9	0184-0422	494.32	422.69	230	56.43	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13293.1	B08		9	0185-0426	371.17	426.66	319	67.01	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13916.5	B08		9	0186-0427	537.70	427.27	339	69.01	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13064.9	B08		9	0187-0432	685.33	431.98	231	59.36	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9242.4	B08		9	0188-0431	97.98	430.39	188	56.39	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10468.2	B08		9	0189-0433	54.32	433.29	233	60.53	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13414.0	B08		9	0190-0436	449.92	436.02	269	60.53	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10639.0	B08		9	0191-0442	519.64	442.54	258	64.87	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9554.8	B08		9	0192-0439	203.08	439.76	261	62.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18783.1	B08		9	0193-0437	789.12	437.27	116	40.63	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12622.2	B08		9	0194-0440	878.12	440.65	189	52.77	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9659.6	B08		9	0195-0443	98.41	442.84	227	59.11	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12486.9	B08		9	0196-0447	570.66	447.10	432	77.26	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10487.6	B08		9	0197-0448	170.09	448.37	247	57.94	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10917.5	B08		9	0198-0446	269.82	445.98	162	47.70	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9191.8	B08		9	0199-0446	254.95	446.32	123	39.70	0.981
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11784.2	B08		9	0200-0452	673.57	452.65	230	79.15	0.461
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13116.2	B08		9	0201-0452	307.23	451.83	314	65.60	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11955.8	B08		9	0202-0455	458.89	454.01	262	61.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11794.4	B08		9	0203-0454	867.79	454.33	272	60.77	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10260.9	B08		9	0204-0457	197.88	457.55	260	59.94	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16132.9	B08		9	0205-0458	886.30	458.69	261	59.11	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9481.4	B08		9	0206-0461	116.98	460.20	312	66.77	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10228.7	B08		9	0207-0457	382.26	457.42	169	48.87	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11190.6	B08		9	0208-0462	262.87	461.81	282	64.18	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11684.0	B08		9	0209-0462	492.45	462.02	229	58.77	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16548.3	B08		9	0210-0465	652.17	465.62	167	52.53	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12397.4	B08		9	0211-0467	447.34	467.17	217	56.53	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12487.4	B08		9	0212-0471	237.87	471.44	203	54.53	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11701.3	B08		9	0213-0475	615.13	476.07	237	61.94	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12329.2	B08		9	0214-0474	890.92	474.25	224	58.77	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10576.2	B08		9	0215-0477	410.11	477.40	250	60.28	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11808.4	B08		9	0216-0481	835.88	480.63	245	68.43	0.658
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9164.1	B08		9	0217-0482	131.20	482.57	312	67.36	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11737.8	B08		9	0218-0485	789.47	484.56	241	57.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14370.2	B08		9	0219-0488	293.83	487.81	344	69.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11263.3	B08		9	0220-0493	57.35	493.06	480	85.50	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11622.4	B08		9	0221-0491	203.22	491.41	302	64.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10605.4	B08		9	0222-0490	177.03	490.29	235	56.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10756.2	B08		9	0223-0495	751.21	495.28	280	66.77	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9924.8	B08		9	0224-0498	80.23	499.11	399	74.43	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12760.1	B08		9	0225-0497	922.77	497.48	204	57.70	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11636.8	B08		9	0226-0502	236.73	501.88	415	75.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13640.2	B08		9	0227-0498	573.39	498.78	297	62.53	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17185.0	B08		9	0228-0500	322.76	499.64	277	61.60	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11043.6	B08		9	0229-0502	506.79	501.80	248	58.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10393.5	B08		9	0230-0503	20.49	503.65	227	58.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13504.7	B08		9	0231-0503	613.53	503.98	219	57.60	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10446.2	B08		9	0232-0506	148.19	505.77	242	59.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13059.8	B08		9	0233-0507	431.14	506.84	291	62.53	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11558.8	B08		9	0234-0507	638.99	507.50	240	56.53	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15259.7	B08		9	0235-0513	402.86	513.41	325	66.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10168.7	B08		9	0236-0514	539.86	512.74	302	67.84	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10537.6	B08		9	0237-0515	869.62	515.16	264	61.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10376.5	B08		9	0238-0516	369.98	516.93	269	64.18	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11903.3	B08		9	0239-0519	104.22	518.97	321	67.26	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14470.1	B08		9	0240-0525	570.22	526.36	302	65.94	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12576.4	B08		9	0241-0528	304.28	527.73	282	63.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9179.1	B08		9	0242-0532	817.06	532.15	301	66.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15307.6	B08		9	0243-0529	424.39	528.53	175	47.94	0.957
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8771.6	B08		9	0244-0536	692.32	536.35	300	71.01	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8991.6	B08		9	0245-0535	203.65	535.32	324	70.77	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11222.1	B08		9	0246-0534	332.49	534.09	240	59.60	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11435.6	B08		9	0247-0535	479.98	535.04	241	57.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12924.4	B08		9	0248-0535	624.18	535.37	228	54.53	0.964
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9499.8	B08		9	0249-0541	520.93	541.71	289	66.08	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13742.2	B08		9	0250-0540	436.99	540.78	196	51.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11159.4	B08		9	0251-0542	849.90	542.58	274	61.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14257.8	B08		9	0252-0547	578.88	546.35	334	73.26	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10511.5	B08		9	0253-0547	64.50	546.90	227	56.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11852.1	B08		9	0254-0548	272.23	548.62	433	82.67	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14179.9	B08		9	0255-0549	125.58	549.29	309	65.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10528.1	B08		9	0256-0552	634.80	553.72	295	69.01	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15491.9	B08		9	0257-0554	757.50	554.76	286	61.94	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10823.7	B08		9	0258-0558	555.44	558.53	254	60.77	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11607.2	B08		9	0259-0560	24.96	560.43	200	53.70	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11569.0	B08		9	0260-0562	697.90	561.96	263	64.77	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11158.5	B08		9	0261-0563	849.83	563.63	267	62.77	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11465.2	B08		9	0262-0566	598.76	565.95	287	64.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11004.5	B08		9	0263-0565	51.84	565.11	217	53.94	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9411.6	B08		9	0264-0568	888.61	568.11	289	68.43	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10961.5	B08		9	0265-0572	386.02	571.90	243	58.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10151.0	B08		9	0266-0575	514.40	575.95	281	61.70	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13967.7	B08		9	0267-0581	532.87	581.25	353	71.94	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10746.3	B08		9	0268-0579	287.29	578.41	257	65.84	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9032.0	B08		9	0269-0584	864.73	583.81	303	73.26	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12903.2	B08		9	0270-0584	646.24	584.16	276	63.01	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10176.0	B08		9	0271-0585	50.25	586.00	238	56.53	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12794.0	B08		9	0272-0588	179.41	588.74	349	70.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13431.6	B08		9	0273-0590	332.10	590.35	315	67.36	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12892.0	B08		9	0274-0586	763.04	585.73	159	46.28	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11563.5	B08		9	0275-0592	716.93	591.83	260	62.43	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11764.9	B08		9	0276-0596	84.07	595.42	314	70.43	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10178.3	B08		9	0277-0596	569.57	597.08	525	102.57	0.627
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11523.3	B08		9	0278-0595	813.75	595.63	252	65.36	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11942.5	B08		9	0279-0592	473.14	591.49	225	56.87	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12684.4	B08		9	0280-0596	369.67	596.03	280	62.18	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12618.8	B08		9	0281-0596	774.53	596.67	295	65.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10396.2	B08		9	0282-0601	122.68	601.11	241	61.84	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10769.5	B08		9	0283-0598	437.42	599.28	254	61.94	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10218.6	B08		9	0284-0604	937.38	603.42	278	62.53	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11549.7	B08		9	0285-0604	397.84	603.82	232	55.36	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14758.2	B08		9	0286-0609	894.82	608.75	206	54.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11608.8	B08		9	0287-0616	115.39	616.74	322	71.60	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14758.2	B08		9	0288-0614	727.58	614.63	374	73.01	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11902.5	B08		9	0289-0615	291.21	615.32	234	60.18	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16676.1	B08		9	0290-0611	909.17	611.05	147	46.04	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10359.0	B08		9	0291-0616	59.21	615.88	279	62.18	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14526.5	B08		9	0292-0616	645.44	616.87	345	73.26	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11811.9	B08		9	0293-0617	868.69	617.47	490	92.81	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12035.1	B08		9	0294-0618	309.51	618.88	216	61.84	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13478.2	B08		9	0295-0618	274.72	618.27	204	54.53	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10039.3	B08		9	0296-0622	927.25	621.70	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12483.1	B08		9	0297-0624	218.76	623.81	309	63.60	0.960
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15462.2	B08		9	0298-0628	473.80	627.67	178	52.53	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13753.0	B08		9	0299-0629	88.26	629.56	283	62.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10576.5	B08		9	0300-0629	777.02	628.82	261	61.01	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10457.5	B08		9	0301-0635	568.32	635.08	290	73.84	0.668
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11486.6	B08		9	0302-0631	810.05	630.69	249	63.26	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12123.5	B08		9	0303-0630	383.60	630.36	218	53.36	0.962
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11441.0	B08		9	0304-0632	640.10	632.53	232	59.70	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14263.8	B08		9	0305-0633	902.89	632.87	350	68.18	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11063.3	B08		9	0306-0631	325.68	632.39	263	60.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17198.1	B08		9	0307-0633	688.22	633.46	306	63.94	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10037.0	B08		9	0308-0640	182.52	640.32	330	69.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11196.9	B08		9	0309-0639	110.84	638.95	229	56.53	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13121.3	B08		9	0310-0642	264.97	641.97	190	53.36	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11891.6	B08		9	0311-0642	946.31	642.26	211	55.94	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15601.0	B08		9	0312-0653	717.73	653.94	494	85.15	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10830.0	B08		9	0313-0650	429.31	649.95	196	52.28	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9752.5	B08		9	0314-0655	504.15	656.17	268	64.18	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10589.8	B08		9	0315-0652	657.70	652.90	261	59.11	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14633.3	B08		9	0316-0654	70.78	654.67	174	51.11	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11542.0	B08		9	0317-0657	339.71	657.78	226	56.53	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10156.7	B08		9	0318-0655	383.03	655.64	149	48.87	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9929.5	B08		9	0319-0657	200.29	656.11	247	59.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8159.9	B08		9	0320-0658	839.59	659.58	154	49.70	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8648.1	B08		9	0321-0657	444.85	658.14	127	47.11	0.719
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12707.7	B08		9	0322-0661	623.12	662.42	258	63.60	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15139.1	B08		9	0323-0658	568.08	658.62	172	49.70	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13129.0	B08		9	0324-0659	790.18	659.37	206	54.28	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8779.2	B08		9	0325-0663	35.78	663.64	240	57.94	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12288.1	B08		9	0326-0662	404.60	661.96	211	57.36	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10086.3	B08		9	0327-0664	162.23	664.66	252	61.94	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10409.5	B08		9	0328-0670	140.52	670.03	284	64.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9351.6	B08		9	0329-0672	297.72	672.30	288	66.43	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11791.3	B08		9	0330-0674	875.21	673.40	244	60.53	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10689.7	B08		9	0331-0676	380.69	676.33	270	67.84	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10228.4	B08		9	0332-0675	91.03	674.87	253	59.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11151.3	B08		9	0333-0676	937.72	675.75	245	59.11	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13782.8	B08		9	0334-0674	786.59	674.75	198	50.87	0.962
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10732.7	B08		9	0335-0684	887.77	684.20	229	60.77	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10213.7	B08		9	0336-0686	264.85	686.00	246	60.53	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10971.0	B08		9	0337-0692	837.75	693.34	241	64.43	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10674.9	B08		9	0338-0695	451.42	695.09	247	59.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13352.0	B08		9	0339-0698	629.42	698.59	368	72.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9992.0	B08		9	0340-0696	691.70	698.16	252	70.43	0.638
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11463.5	B08		9	0341-0695	937.50	695.64	242	57.11	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9148.8	B08		9	0342-0697	110.29	698.24	232	66.18	0.666
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12036.3	B08		9	0343-0703	749.84	702.22	218	59.11	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12325.7	B08		9	0344-0703	45.50	703.45	308	66.43	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10608.1	B08		9	0345-0708	150.33	708.96	334	70.43	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8877.7	B08		9	0346-0706	185.63	705.56	275	66.43	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10889.1	B08		9	0347-0703	907.57	703.18	102	37.80	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0	uM	48	hr	1185115	1375317	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11054.5	B08		9	0348-0708	216.50	709.43	226	57.36	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14831.6	C08		1	0001-0025	822.14	25.96	373	78.43	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15165.4	C08		1	0002-0032	681.57	32.38	336	70.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10361.7	C08		1	0003-0031	209.13	31.38	259	59.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9743.0	C08		1	0004-0035	598.48	35.02	291	65.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9451.3	C08		1	0005-0033	294.09	33.97	277	61.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10183.2	C08		1	0006-0037	95.05	37.30	267	59.36	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12415.6	C08		1	0007-0038	133.57	38.49	299	64.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8737.7	C08		1	0008-0040	943.98	40.01	322	66.77	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10799.8	C08		1	0009-0040	72.15	41.03	262	61.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11669.7	C08		1	0010-0039	525.47	39.38	257	59.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14569.6	C08		1	0011-0041	554.92	42.34	237	63.60	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9370.9	C08		1	0012-0041	925.52	41.93	290	61.94	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9908.5	C08		1	0013-0045	740.21	45.84	288	63.84	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15254.0	C08		1	0014-0050	351.70	51.05	330	68.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10971.2	C08		1	0015-0054	703.39	54.41	393	100.57	0.488
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13104.3	C08		1	0016-0050	831.85	50.06	209	52.28	0.961
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9213.1	C08		1	0017-0054	308.76	53.84	288	64.43	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8580.4	C08		1	0018-0058	877.05	57.46	291	64.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9001.2	C08		1	0019-0061	784.13	62.60	326	70.18	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9898.0	C08		1	0020-0061	248.09	60.88	258	61.01	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11332.4	C08		1	0021-0063	901.93	63.40	246	58.18	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10347.4	C08		1	0022-0065	450.72	64.22	288	63.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9580.3	C08		1	0023-0070	278.90	71.24	278	66.18	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9083.0	C08		1	0024-0072	603.94	72.36	320	66.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10055.1	C08		1	0025-0072	740.78	71.77	255	64.43	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15740.5	C08		1	0026-0072	691.94	72.87	204	67.26	0.567
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9876.9	C08		1	0027-0072	50.25	71.85	260	59.94	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9226.8	C08		1	0028-0074	438.92	74.68	303	65.26	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9950.2	C08		1	0029-0079	190.55	76.48	356	97.64	0.469
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9074.3	C08		1	0030-0075	870.05	76.04	277	65.36	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8634.5	C08		1	0031-0085	158.34	84.95	308	67.60	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11314.8	C08		1	0032-0085	93.65	85.12	246	58.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9585.1	C08		1	0033-0086	125.51	86.38	303	68.08	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8989.6	C08		1	0034-0086	411.37	86.47	305	64.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8797.2	C08		1	0035-0086	333.45	86.21	307	67.36	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10972.7	C08		1	0036-0095	644.36	95.56	264	61.94	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10540.9	C08		1	0037-0095	520.50	94.48	257	62.77	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9107.8	C08		1	0038-0096	764.15	95.07	320	71.01	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14436.3	C08		1	0039-0100	537.98	100.04	222	57.94	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15215.9	C08		1	0040-0101	506.98	101.49	188	52.53	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9776.8	C08		1	0041-0103	259.99	103.05	262	59.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13184.5	C08		1	0042-0105	493.19	105.07	201	53.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10325.2	C08		1	0043-0106	37.63	106.01	252	59.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9325.1	C08		1	0044-0109	240.13	108.48	280	63.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9514.0	C08		1	0045-0108	558.40	108.86	306	65.36	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9557.0	C08		1	0046-0108	577.01	108.07	250	57.36	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8031.5	C08		1	0047-0107	811.47	107.51	328	67.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8840.3	C08		1	0048-0110	851.09	110.29	317	67.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10541.1	C08		1	0049-0108	445.47	107.83	261	66.77	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11286.7	C08		1	0050-0117	119.82	117.36	249	60.53	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15365.7	C08		1	0051-0119	649.82	119.59	358	69.60	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11234.0	C08		1	0052-0120	103.19	120.90	254	61.11	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10098.2	C08		1	0053-0119	946.75	118.29	260	63.60	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9332.0	C08		1	0054-0118	743.02	118.79	290	64.53	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9785.2	C08		1	0055-0121	58.32	121.55	260	60.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10634.3	C08		1	0056-0131	85.34	132.15	262	61.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8907.8	C08		1	0057-0131	452.43	130.72	300	64.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8034.4	C08		1	0058-0138	487.67	137.96	255	65.84	0.739
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7703.5	C08		1	0059-0137	502.83	137.54	193	57.01	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10838.4	C08		1	0060-0139	210.02	137.63	516	101.40	0.631
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12006.9	C08		1	0061-0138	670.61	138.33	241	56.53	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8081.2	C08		1	0062-0143	149.45	143.21	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10249.6	C08		1	0063-0140	372.06	140.09	251	59.01	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9315.4	C08		1	0064-0145	749.21	144.31	314	68.18	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8175.7	C08		1	0065-0145	920.96	145.33	331	71.50	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10507.2	C08		1	0066-0146	39.71	146.68	341	69.94	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9612.5	C08		1	0067-0147	173.79	147.27	267	61.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9209.3	C08		1	0068-0153	551.00	153.54	283	63.26	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10247.0	C08		1	0069-0151	813.05	150.94	259	59.36	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10601.5	C08		1	0070-0158	513.00	157.99	546	99.15	0.698
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7577.8	C08		1	0071-0153	446.25	153.63	170	52.77	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8074.1	C08		1	0072-0155	845.90	155.03	319	67.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10324.3	C08		1	0073-0154	334.70	154.51	259	60.18	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10812.4	C08		1	0074-0152	624.74	152.68	246	59.11	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9687.3	C08		1	0075-0156	784.87	156.36	297	65.60	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7916.2	C08		1	0076-0159	884.42	159.25	315	70.43	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7768.6	C08		1	0077-0160	127.31	160.31	303	65.36	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9761.8	C08		1	0078-0162	305.18	162.32	272	63.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8781.6	C08		1	0079-0168	288.46	168.54	311	67.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8672.6	C08		1	0080-0171	832.81	171.77	291	68.18	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9709.0	C08		1	0081-0174	42.34	174.21	262	63.36	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9865.5	C08		1	0082-0170	729.21	170.50	271	61.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8950.3	C08		1	0083-0173	590.40	173.08	296	63.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13962.1	C08		1	0084-0178	83.14	178.73	315	65.01	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10694.4	C08		1	0085-0177	171.65	177.29	246	57.36	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9366.5	C08		1	0086-0182	691.21	182.38	284	63.36	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10333.9	C08		1	0087-0186	447.87	186.68	253	59.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13163.3	C08		1	0088-0188	242.39	187.62	194	51.94	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17685.9	C08		1	0089-0193	516.56	193.62	611	101.98	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8475.4	C08		1	0090-0190	635.08	190.19	316	70.43	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9114.5	C08		1	0091-0192	872.76	192.02	284	61.36	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9442.3	C08		1	0092-0193	736.41	192.47	313	65.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10291.9	C08		1	0093-0194	386.17	193.83	254	58.53	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8504.4	C08		1	0094-0194	823.62	193.96	316	67.84	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9287.7	C08		1	0095-0196	920.81	196.20	290	64.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8865.8	C08		1	0096-0196	427.88	196.19	297	65.01	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7942.9	C08		1	0097-0201	117.09	201.51	288	64.28	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9281.7	C08		1	0098-0201	53.21	201.78	281	60.77	0.956
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12686.8	C08		1	0099-0200	257.81	199.94	205	56.77	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11482.6	C08		1	0100-0203	208.24	203.37	234	55.94	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9450.6	C08		1	0101-0206	669.23	206.07	274	62.53	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13648.6	C08		1	0102-0208	574.16	208.16	397	73.84	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9679.4	C08		1	0103-0204	331.29	205.07	268	64.28	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11533.7	C08		1	0104-0211	807.63	211.72	465	80.08	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9733.5	C08		1	0105-0211	246.49	212.01	282	62.43	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9823.7	C08		1	0106-0213	766.71	214.14	272	61.60	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10408.1	C08		1	0107-0227	200.15	227.05	513	92.08	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14163.6	C08		1	0108-0228	722.25	228.10	375	72.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10866.7	C08		1	0109-0230	145.31	230.74	242	58.77	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13345.4	C08		1	0110-0231	695.49	230.67	231	55.36	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9402.5	C08		1	0111-0231	567.25	231.61	293	66.53	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9653.5	C08		1	0112-0236	127.92	236.17	260	61.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11036.6	C08		1	0113-0237	501.37	237.45	245	57.94	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9363.4	C08		1	0114-0236	799.39	236.30	397	79.70	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10389.1	C08		1	0115-0240	324.51	240.08	251	58.53	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8088.3	C08		1	0116-0244	296.32	243.88	305	66.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8093.9	C08		1	0117-0248	90.39	247.75	310	65.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16396.5	C08		1	0118-0248	683.41	248.56	344	67.60	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13825.7	C08		1	0119-0245	744.24	245.15	204	53.11	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13378.8	C08		1	0120-0245	763.73	245.53	199	51.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11220.8	C08		1	0121-0250	345.88	250.19	248	57.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13626.3	C08		1	0122-0255	833.72	255.63	376	75.26	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10359.2	C08		1	0123-0253	578.67	252.77	255	61.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8679.4	C08		1	0124-0257	141.20	256.83	286	63.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10976.3	C08		1	0125-0262	225.24	261.63	430	78.67	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8839.2	C08		1	0126-0259	74.74	259.19	315	66.53	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10432.6	C08		1	0127-0259	284.48	259.09	366	71.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16856.4	C08		1	0128-0259	366.80	258.66	326	67.01	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12086.1	C08		1	0129-0257	851.64	258.33	235	58.87	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10602.7	C08		1	0130-0267	526.09	266.69	533	94.57	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10065.6	C08		1	0131-0263	590.14	263.95	263	61.11	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16184.4	C08		1	0132-0266	877.93	266.67	240	58.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11942.3	C08		1	0133-0265	920.94	265.46	218	53.70	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13038.7	C08		1	0134-0271	614.64	271.53	413	74.67	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13839.7	C08		1	0135-0272	765.04	272.49	301	63.36	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15038.0	C08		1	0136-0272	934.67	272.12	175	51.36	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10402.2	C08		1	0137-0276	167.43	277.02	253	61.70	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7725.0	C08		1	0138-0276	674.37	275.96	323	67.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9035.3	C08		1	0139-0278	456.40	277.71	282	63.60	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9991.2	C08		1	0140-0279	829.32	278.74	284	64.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11170.5	C08		1	0141-0279	328.50	279.91	245	56.77	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13184.8	C08		1	0142-0287	283.61	286.97	406	75.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9090.9	C08		1	0143-0290	212.32	290.79	292	66.18	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8056.0	C08		1	0144-0287	406.95	287.56	318	70.77	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10779.7	C08		1	0145-0287	877.73	287.64	261	59.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17346.7	C08		1	0146-0284	940.74	284.64	148	44.28	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8372.4	C08		1	0147-0290	350.24	290.23	304	68.08	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8744.4	C08		1	0148-0293	88.23	293.47	271	63.36	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9260.6	C08		1	0149-0298	478.74	297.61	288	67.11	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8034.0	C08		1	0150-0299	30.29	299.17	312	65.11	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11347.5	C08		1	0151-0297	769.35	297.25	237	56.18	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9767.9	C08		1	0152-0298	577.12	298.30	242	62.18	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8206.3	C08		1	0153-0301	850.21	301.23	325	67.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10639.0	C08		1	0154-0301	793.81	300.67	249	59.60	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8060.1	C08		1	0155-0305	134.72	305.10	300	65.01	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8164.8	C08		1	0156-0305	415.61	306.08	322	69.60	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10830.5	C08		1	0157-0308	177.86	307.75	226	57.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10775.2	C08		1	0158-0311	161.71	310.71	226	56.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9275.2	C08		1	0159-0311	441.45	311.15	283	62.77	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10473.5	C08		1	0160-0310	572.11	310.90	264	63.70	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8450.9	C08		1	0161-0317	258.06	316.84	309	68.77	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7663.0	C08		1	0162-0320	664.01	318.99	331	66.77	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7760.8	C08		1	0163-0324	615.82	324.26	326	70.43	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8529.3	C08		1	0164-0324	23.47	324.39	299	63.60	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8353.1	C08		1	0165-0325	243.62	325.36	286	63.84	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10094.8	C08		1	0166-0325	394.36	325.64	297	64.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11376.2	C08		1	0167-0328	874.08	327.59	234	56.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10417.7	C08		1	0168-0328	899.15	329.03	260	61.94	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10281.4	C08		1	0169-0333	90.84	332.85	266	62.43	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9239.7	C08		1	0170-0333	126.02	332.87	298	67.60	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10983.6	C08		1	0171-0337	818.17	337.25	353	68.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11126.6	C08		1	0172-0336	529.02	336.98	248	59.94	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9683.8	C08		1	0173-0335	936.43	335.59	267	61.36	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10949.6	C08		1	0174-0342	377.70	341.70	254	63.60	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10783.2	C08		1	0175-0341	751.57	340.97	254	61.60	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12382.0	C08		1	0176-0344	76.38	343.86	228	55.36	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13691.9	C08		1	0177-0345	460.57	344.62	193	52.53	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9303.6	C08		1	0178-0351	681.74	350.99	338	69.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8749.5	C08		1	0179-0349	577.92	349.82	294	64.43	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9289.0	C08		1	0180-0351	291.85	350.98	292	63.84	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9393.8	C08		1	0181-0352	489.82	352.37	300	65.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10711.9	C08		1	0182-0352	327.35	351.69	252	61.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11821.4	C08		1	0183-0353	446.60	353.32	231	56.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10993.3	C08		1	0184-0354	805.06	354.07	247	59.70	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11765.0	C08		1	0185-0359	872.13	359.11	311	67.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15118.4	C08		1	0186-0363	132.70	363.09	329	68.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10058.0	C08		1	0187-0365	336.31	364.68	263	59.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8651.2	C08		1	0188-0364	410.22	363.79	327	69.01	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10355.6	C08		1	0189-0367	502.64	368.11	257	61.84	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9446.2	C08		1	0190-0376	921.44	376.79	551	108.95	0.583
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9069.3	C08		1	0191-0369	593.60	369.66	279	63.70	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9426.0	C08		1	0192-0375	268.02	375.42	298	69.36	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10083.9	C08		1	0193-0372	752.98	371.61	257	60.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6277.0	C08		1	0194-0377	634.41	376.32	349	72.43	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8556.5	C08		1	0195-0379	880.14	379.02	319	70.43	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10165.6	C08		1	0196-0377	119.73	376.80	305	72.77	0.724
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9849.1	C08		1	0197-0382	700.82	381.97	292	65.60	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8025.1	C08		1	0198-0382	220.40	381.71	287	64.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12601.7	C08		1	0199-0382	446.89	381.74	234	56.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9362.9	C08		1	0200-0384	428.95	384.84	299	64.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12776.6	C08		1	0201-0387	282.57	387.37	421	76.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10657.3	C08		1	0202-0387	25.30	387.85	243	61.94	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12060.9	C08		1	0203-0393	364.86	393.85	475	94.23	0.672
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9099.4	C08		1	0204-0386	840.01	386.59	291	66.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7913.7	C08		1	0205-0392	728.70	393.05	303	68.18	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10777.5	C08		1	0206-0395	87.04	395.30	245	57.94	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9149.1	C08		1	0207-0395	516.66	395.19	277	61.36	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9910.8	C08		1	0208-0404	108.05	404.45	252	58.18	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10522.3	C08		1	0209-0408	417.91	407.79	261	63.01	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8906.4	C08		1	0210-0413	504.12	413.06	284	62.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9490.1	C08		1	0211-0413	684.04	412.94	283	62.18	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7267.7	C08		1	0212-0418	45.73	418.54	308	64.18	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15132.8	C08		1	0213-0420	133.94	419.89	318	65.84	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7468.9	C08		1	0214-0424	879.01	423.32	332	79.74	0.656
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8113.0	C08		1	0215-0420	815.78	420.19	308	63.36	0.964
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12598.1	C08		1	0216-0420	439.51	420.26	208	54.04	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9116.0	C08		1	0217-0422	290.62	422.02	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7362.3	C08		1	0218-0426	192.46	426.07	432	78.43	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10934.0	C08		1	0219-0425	457.42	425.06	257	61.70	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9333.0	C08		1	0220-0425	908.76	426.11	267	63.94	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12206.8	C08		1	0221-0430	759.47	429.63	435	88.67	0.695
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7880.8	C08		1	0222-0428	253.32	428.39	295	66.18	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6016.3	C08		1	0223-0431	555.02	431.98	323	95.15	0.448
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9121.9	C08		1	0224-0430	599.73	430.23	285	65.60	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9488.4	C08		1	0225-0433	317.04	433.41	275	62.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7738.7	C08		1	0226-0433	103.24	433.39	402	75.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9113.9	C08		1	0227-0438	640.55	438.85	580	100.57	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9885.3	C08		1	0228-0435	845.96	435.40	258	62.28	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7993.5	C08		1	0229-0438	720.28	437.38	302	67.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13419.7	C08		1	0230-0439	18.11	439.59	340	68.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7500.6	C08		1	0231-0441	169.96	442.00	318	66.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11401.4	C08		1	0232-0444	771.12	444.45	230	57.36	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9955.7	C08		1	0233-0447	477.66	447.79	262	61.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10817.1	C08		1	0234-0456	438.10	457.77	540	95.40	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7506.1	C08		1	0235-0456	881.35	455.43	335	78.57	0.682
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8170.9	C08		1	0236-0456	265.11	456.45	313	65.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12135.2	C08		1	0237-0460	511.98	459.79	454	81.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12707.8	C08		1	0238-0456	409.18	456.62	214	53.36	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6702.6	C08		1	0239-0461	38.50	461.65	307	66.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7459.8	C08		1	0240-0462	165.64	462.71	309	71.60	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10383.8	C08		1	0241-0468	330.38	467.02	250	58.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11673.0	C08		1	0242-0470	569.44	470.56	357	69.84	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10125.6	C08		1	0243-0470	930.07	470.50	260	59.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7774.5	C08		1	0244-0471	789.81	471.64	322	67.01	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13811.5	C08		1	0245-0474	229.06	473.77	379	73.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10864.7	C08		1	0246-0471	387.85	471.68	248	58.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9382.8	C08		1	0247-0472	706.29	472.14	277	63.11	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11341.4	C08		1	0248-0481	321.87	481.24	242	58.77	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12168.7	C08		1	0249-0485	380.17	485.37	224	55.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7463.5	C08		1	0250-0486	625.83	486.05	324	66.18	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8913.5	C08		1	0251-0487	260.40	486.47	279	63.01	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8972.9	C08		1	0252-0488	501.49	489.01	313	66.77	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9672.6	C08		1	0253-0492	911.58	492.21	260	59.70	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15277.1	C08		1	0254-0494	593.95	494.04	348	70.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8187.9	C08		1	0255-0495	665.13	495.70	312	69.11	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10761.5	C08		1	0256-0494	159.72	493.86	232	57.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10944.5	C08		1	0257-0496	474.83	495.59	304	64.77	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10717.3	C08		1	0258-0500	942.76	500.59	410	78.43	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8617.0	C08		1	0259-0499	73.34	499.05	270	61.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11932.7	C08		1	0260-0501	746.05	501.11	444	77.26	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9030.9	C08		1	0261-0500	189.28	499.86	272	61.11	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12280.3	C08		1	0262-0505	546.03	505.10	455	80.91	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8927.6	C08		1	0263-0503	299.59	503.95	272	63.01	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8715.5	C08		1	0264-0501	110.04	501.73	271	61.70	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14205.4	C08		1	0265-0505	789.60	505.62	115	92.43	0.169
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9355.0	C08		1	0266-0510	829.21	510.02	266	60.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8812.4	C08		1	0267-0509	37.93	509.58	271	61.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15323.0	C08		1	0268-0511	426.05	511.33	325	66.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13411.2	C08		1	0269-0514	270.46	514.21	363	71.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8711.8	C08		1	0270-0511	672.74	511.00	271	68.28	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8720.8	C08		1	0271-0516	129.22	517.00	317	67.36	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9525.5	C08		1	0272-0516	194.76	516.95	280	64.53	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9140.0	C08		1	0273-0521	857.97	520.82	269	61.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9866.7	C08		1	0274-0520	584.05	520.77	274	60.77	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9554.2	C08		1	0275-0522	441.51	522.16	302	64.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9617.6	C08		1	0276-0522	713.75	522.25	263	61.70	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8583.2	C08		1	0277-0526	530.57	526.08	301	64.43	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11092.6	C08		1	0278-0533	763.47	532.72	242	59.36	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9513.8	C08		1	0279-0534	795.61	533.70	277	61.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8152.9	C08		1	0280-0533	83.50	533.87	305	73.01	0.719
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11682.7	C08		1	0281-0535	213.46	535.24	213	53.11	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7681.2	C08		1	0282-0539	273.70	539.14	294	68.67	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9726.1	C08		1	0283-0537	619.01	536.78	268	61.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15554.3	C08		1	0284-0544	727.47	543.99	343	68.43	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14976.6	C08		1	0285-0547	679.63	546.69	355	71.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10151.9	C08		1	0286-0547	351.77	547.50	250	59.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8088.2	C08		1	0287-0549	43.38	549.11	280	63.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9948.2	C08		1	0288-0548	164.29	548.21	254	59.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10184.4	C08		1	0289-0548	540.05	548.03	188	49.70	0.956
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9242.4	C08		1	0290-0550	835.32	549.74	270	61.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9307.0	C08		1	0291-0549	145.49	549.09	265	62.04	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8854.1	C08		1	0292-0552	920.15	551.59	294	63.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8263.6	C08		1	0293-0553	312.34	553.07	308	65.01	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12804.7	C08		1	0294-0553	786.10	553.31	341	71.84	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10060.6	C08		1	0295-0556	560.59	557.44	266	59.60	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7899.7	C08		1	0296-0559	390.52	558.51	297	64.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10582.2	C08		1	0297-0563	482.05	562.86	252	58.18	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9498.4	C08		1	0298-0563	675.45	563.22	272	63.11	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6047.0	C08		1	0299-0564	92.34	564.16	140	51.11	0.673
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9804.1	C08		1	0300-0569	793.86	569.65	318	66.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15660.5	C08		1	0301-0567	268.09	568.13	164	47.21	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9251.5	C08		1	0302-0571	593.86	571.40	272	60.53	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8104.7	C08		1	0303-0572	205.22	572.62	276	67.60	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15290.0	C08		1	0304-0571	518.31	570.42	129	68.53	0.345
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12309.1	C08		1	0305-0579	898.28	579.25	364	71.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8495.8	C08		1	0306-0575	245.48	575.14	169	47.46	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10676.9	C08		1	0307-0576	559.64	575.69	245	58.53	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9021.7	C08		1	0308-0578	732.89	578.70	294	64.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8899.2	C08		1	0309-0580	875.88	579.73	285	62.18	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7774.3	C08		1	0310-0581	82.77	581.36	293	63.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12976.5	C08		1	0311-0587	262.45	585.43	422	83.60	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10967.2	C08		1	0312-0584	449.27	583.89	246	57.11	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12532.8	C08		1	0313-0585	537.45	585.66	219	55.36	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7494.6	C08		1	0314-0588	301.52	587.94	322	67.60	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16670.9	C08		1	0315-0589	927.47	589.16	304	65.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9885.7	C08		1	0316-0589	150.69	589.40	378	72.77	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8226.2	C08		1	0317-0592	810.14	592.40	297	64.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8243.4	C08		1	0318-0595	27.14	595.40	266	63.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11154.5	C08		1	0319-0597	944.27	597.18	229	55.70	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9875.8	C08		1	0320-0605	525.30	604.34	263	62.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9574.9	C08		1	0321-0603	766.04	603.99	261	61.70	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9272.9	C08		1	0322-0607	199.34	607.04	248	62.77	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11117.9	C08		1	0323-0608	393.01	608.28	288	63.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8519.6	C08		1	0324-0609	74.76	609.25	262	59.60	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8130.1	C08		1	0325-0612	704.10	611.88	297	64.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7717.1	C08		1	0326-0614	844.13	613.52	296	63.60	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9635.8	C08		1	0327-0612	482.55	611.88	271	62.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11314.1	C08		1	0328-0621	28.06	620.90	218	54.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10517.7	C08		1	0329-0619	763.88	618.42	260	63.11	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8050.5	C08		1	0330-0624	650.46	623.74	294	66.43	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12589.7	C08		1	0331-0625	262.52	625.35	205	51.70	0.964
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10827.6	C08		1	0332-0633	595.61	632.78	244	57.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10405.4	C08		1	0333-0634	879.26	634.12	249	57.94	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10661.3	C08		1	0334-0638	623.32	638.35	297	62.77	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9595.1	C08		1	0335-0643	419.35	643.64	263	62.53	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9017.6	C08		1	0336-0646	176.89	645.51	593	98.57	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11807.1	C08		1	0337-0645	219.75	645.23	306	69.60	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8758.4	C08		1	0338-0648	126.69	647.81	281	64.77	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9445.3	C08		1	0339-0646	727.56	646.82	268	61.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9258.3	C08		1	0340-0650	88.89	650.61	376	73.01	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8678.3	C08		1	0341-0649	316.53	648.68	283	62.77	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8305.8	C08		1	0342-0650	522.00	651.01	317	68.43	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12579.8	C08		1	0343-0651	570.73	650.76	211	55.11	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8406.4	C08		1	0344-0651	800.58	651.10	287	63.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9185.6	C08		1	0345-0648	909.49	648.45	257	60.53	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8387.3	C08		1	0346-0654	254.61	654.82	304	67.36	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10028.8	C08		1	0347-0653	445.55	652.66	256	59.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8881.4	C08		1	0348-0654	367.50	653.95	286	62.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8375.9	C08		1	0349-0656	762.40	655.48	294	64.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9957.8	C08		1	0350-0664	667.52	664.31	302	63.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13029.1	C08		1	0351-0671	601.16	671.67	341	67.60	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10780.1	C08		1	0352-0672	812.39	672.34	244	58.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9685.8	C08		1	0353-0676	939.29	676.50	264	61.11	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10192.4	C08		1	0354-0678	275.20	678.07	250	57.70	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8431.2	C08		1	0355-0681	711.96	681.31	295	64.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9555.4	C08		1	0356-0682	315.97	682.29	268	61.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10134.9	C08		1	0357-0681	863.81	681.07	227	57.11	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11569.9	C08		1	0358-0683	583.00	683.42	165	46.87	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9591.6	C08		1	0359-0688	917.00	688.43	243	58.18	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8956.7	C08		1	0360-0688	653.24	687.57	269	60.28	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9436.6	C08		1	0361-0693	825.13	693.11	264	63.26	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8187.2	C08		1	0362-0692	465.12	692.45	299	67.60	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8785.9	C08		1	0363-0695	164.66	695.52	270	60.53	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7904.0	C08		1	0364-0697	406.64	696.45	298	62.77	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8156.7	C08		1	0365-0696	862.07	696.93	302	67.94	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9564.3	C08		1	0366-0699	197.60	698.93	257	59.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10703.1	C08		1	0367-0697	564.69	698.02	245	58.87	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9914.4	C08		1	0368-0700	335.60	700.91	255	58.77	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8161.7	C08		1	0369-0702	19.92	703.24	288	63.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7374.8	C08		1	0370-0705	367.96	704.81	288	66.67	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185026	1375318	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9902.0	C08		1	0371-0705	91.70	705.53	250	60.53	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8853.5	C08		2	0001-0024	128.41	23.60	288	63.84	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9633.5	C08		2	0002-0025	174.92	24.72	270	61.94	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10725.9	C08		2	0003-0032	871.75	31.68	248	60.77	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13304.0	C08		2	0004-0033	68.62	32.87	192	51.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7694.2	C08		2	0005-0040	397.91	40.47	375	72.18	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10285.3	C08		2	0006-0037	551.14	37.65	274	62.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11280.6	C08		2	0007-0038	680.72	39.05	242	56.77	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8423.2	C08		2	0008-0042	48.52	41.52	316	66.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9127.0	C08		2	0009-0043	30.09	43.27	294	62.53	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6630.9	C08		2	0010-0043	231.80	43.46	334	67.60	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10188.4	C08		2	0011-0044	186.15	45.23	269	63.26	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8790.1	C08		2	0012-0048	487.71	49.18	332	70.77	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8857.1	C08		2	0013-0047	649.05	47.26	310	64.53	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10037.3	C08		2	0014-0048	797.12	49.02	408	78.08	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12531.2	C08		2	0015-0052	99.99	52.40	411	74.67	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12548.4	C08		2	0016-0049	205.02	49.46	206	53.46	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9921.1	C08		2	0017-0052	737.79	51.91	283	62.18	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9732.6	C08		2	0018-0055	716.07	54.90	288	63.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13266.0	C08		2	0019-0055	576.86	55.80	420	81.60	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11544.4	C08		2	0020-0062	153.35	62.35	313	65.01	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10125.2	C08		2	0021-0066	837.30	66.55	305	69.26	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10991.7	C08		2	0022-0064	854.66	63.94	218	55.11	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9228.9	C08		2	0023-0066	291.41	66.74	292	65.60	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9755.0	C08		2	0024-0068	355.25	67.73	270	61.94	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10018.5	C08		2	0025-0071	448.16	70.63	285	63.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8769.4	C08		2	0026-0075	427.60	74.95	326	66.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10343.6	C08		2	0027-0075	776.54	75.29	255	58.28	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7423.4	C08		2	0028-0082	244.28	81.66	317	68.43	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11802.1	C08		2	0029-0084	285.37	84.39	339	73.60	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9876.5	C08		2	0030-0082	659.88	82.54	285	63.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10255.3	C08		2	0031-0087	605.90	89.87	370	80.18	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10413.5	C08		2	0032-0082	618.92	81.58	168	50.87	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11414.1	C08		2	0033-0085	328.68	85.58	227	56.28	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10019.6	C08		2	0034-0084	576.11	84.68	291	63.01	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8718.0	C08		2	0035-0088	830.95	88.00	311	65.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12576.0	C08		2	0036-0087	550.38	87.01	216	53.94	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9808.4	C08		2	0037-0091	72.87	91.06	245	65.84	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12434.3	C08		2	0038-0092	485.02	92.27	221	54.87	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12323.3	C08		2	0039-0092	774.10	91.27	225	57.36	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9536.6	C08		2	0040-0098	696.24	97.15	290	63.60	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8485.8	C08		2	0041-0102	296.21	101.87	305	65.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7864.5	C08		2	0042-0104	886.08	103.99	341	68.18	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9680.7	C08		2	0043-0106	204.77	105.73	293	64.18	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15660.1	C08		2	0044-0107	99.82	106.94	343	68.77	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10833.2	C08		2	0045-0110	741.92	109.44	252	62.28	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10039.1	C08		2	0046-0111	628.60	111.41	280	60.77	0.953
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9401.5	C08		2	0047-0113	944.04	114.24	441	81.50	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9555.4	C08		2	0048-0112	424.05	112.01	281	62.18	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7832.6	C08		2	0049-0115	340.36	115.59	316	65.60	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10442.6	C08		2	0050-0115	524.22	116.08	258	60.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9515.8	C08		2	0051-0116	404.44	116.68	286	62.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9832.1	C08		2	0052-0120	51.63	119.87	261	61.94	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7209.8	C08		2	0053-0122	257.66	121.89	391	76.08	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8861.8	C08		2	0054-0122	784.64	122.43	214	53.94	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8291.2	C08		2	0055-0124	572.99	124.69	321	66.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8461.4	C08		2	0056-0126	892.41	125.50	423	81.26	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8036.4	C08		2	0057-0128	359.94	128.35	310	65.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9000.9	C08		2	0058-0128	127.19	128.48	284	65.84	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13342.3	C08		2	0059-0130	172.43	130.44	391	73.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13287.7	C08		2	0060-0127	67.80	127.03	189	50.87	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10031.6	C08		2	0061-0131	621.82	131.00	285	64.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12881.8	C08		2	0062-0132	711.18	132.55	340	68.18	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8555.2	C08		2	0063-0137	516.40	137.02	356	72.91	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8237.3	C08		2	0064-0137	775.48	136.06	200	57.26	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10828.2	C08		2	0065-0140	460.31	140.21	426	77.01	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11723.3	C08		2	0066-0139	81.33	139.65	215	52.77	0.970
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10429.9	C08		2	0067-0140	823.51	140.83	256	60.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7697.5	C08		2	0068-0147	25.40	146.81	324	69.50	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10393.6	C08		2	0069-0150	221.02	149.90	439	80.43	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9219.8	C08		2	0070-0148	661.59	147.75	298	66.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16804.5	C08		2	0071-0151	277.86	151.60	306	64.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10038.0	C08		2	0072-0150	620.04	149.78	315	67.60	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8829.9	C08		2	0073-0156	748.99	155.98	202	55.70	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12628.8	C08		2	0074-0162	485.58	162.08	325	69.36	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12558.3	C08		2	0075-0159	562.03	159.43	209	54.28	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15376.7	C08		2	0076-0160	681.59	160.78	171	51.36	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7555.0	C08		2	0077-0171	363.75	171.30	328	69.26	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8339.1	C08		2	0078-0170	929.17	169.79	323	68.18	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11996.8	C08		2	0079-0170	58.63	170.19	217	53.11	0.967
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9000.3	C08		2	0080-0171	155.29	171.07	270	63.60	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10516.0	C08		2	0081-0172	587.56	172.32	252	59.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9491.2	C08		2	0082-0174	416.12	173.89	277	60.77	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10034.2	C08		2	0083-0178	456.76	175.89	289	74.18	0.660
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7041.3	C08		2	0084-0175	280.35	175.27	341	71.01	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9544.9	C08		2	0085-0176	136.98	176.47	272	63.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10824.9	C08		2	0086-0179	526.31	179.88	250	58.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7204.4	C08		2	0087-0181	242.03	181.06	335	69.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8031.8	C08		2	0088-0183	781.58	182.81	340	69.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12683.8	C08		2	0089-0184	103.01	184.47	203	54.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8505.1	C08		2	0090-0188	599.94	188.31	310	66.18	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10751.6	C08		2	0091-0192	481.83	192.42	247	63.70	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8727.3	C08		2	0092-0195	425.92	194.89	295	66.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8693.8	C08		2	0093-0198	25.57	197.78	289	63.60	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9898.0	C08		2	0094-0197	114.02	196.94	260	63.60	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9260.1	C08		2	0095-0200	525.18	199.68	315	65.94	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11289.8	C08		2	0096-0207	650.18	206.99	239	59.11	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10978.1	C08		2	0097-0204	722.48	204.95	239	56.18	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8144.4	C08		2	0098-0205	182.25	204.45	297	67.36	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8564.9	C08		2	0099-0211	436.75	211.44	299	67.94	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9280.7	C08		2	0100-0209	55.77	209.90	260	61.36	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8230.6	C08		2	0101-0212	318.78	212.16	308	66.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12183.0	C08		2	0102-0220	586.21	220.27	445	81.26	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9662.8	C08		2	0103-0223	186.02	223.61	263	59.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8336.6	C08		2	0104-0225	229.36	225.31	286	63.70	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10898.5	C08		2	0105-0225	923.17	225.16	242	57.11	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9741.8	C08		2	0106-0227	610.82	226.84	275	60.77	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8988.3	C08		2	0107-0227	100.50	227.54	284	64.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9210.5	C08		2	0108-0230	790.69	229.96	292	65.01	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8595.2	C08		2	0109-0230	383.79	229.79	303	63.94	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9814.5	C08		2	0110-0232	505.35	232.95	268	61.94	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9011.9	C08		2	0111-0231	64.38	230.32	272	61.11	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9296.3	C08		2	0112-0233	469.77	232.81	290	63.36	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11391.2	C08		2	0113-0233	823.19	232.39	260	61.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10976.5	C08		2	0114-0235	667.08	235.64	249	59.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8734.3	C08		2	0115-0241	271.81	241.68	289	65.84	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9878.8	C08		2	0116-0245	139.28	244.70	550	87.74	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7961.3	C08		2	0117-0245	190.45	245.11	306	64.77	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10325.5	C08		2	0118-0244	426.11	244.68	265	60.53	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8055.7	C08		2	0119-0250	256.58	250.75	311	67.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9528.2	C08		2	0120-0254	553.92	254.42	325	66.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11034.4	C08		2	0121-0253	727.06	253.50	243	57.94	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13439.8	C08		2	0122-0254	885.66	254.38	199	53.36	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9448.3	C08		2	0123-0259	302.12	259.35	329	68.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7797.6	C08		2	0124-0260	748.76	259.74	392	74.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12562.0	C08		2	0125-0261	432.64	261.36	196	53.21	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8359.3	C08		2	0126-0268	343.10	268.18	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11118.2	C08		2	0127-0267	25.78	266.73	231	56.18	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12436.8	C08		2	0128-0266	78.02	266.30	192	51.70	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8579.3	C08		2	0129-0267	114.11	267.03	287	64.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10107.8	C08		2	0130-0266	815.10	266.10	269	61.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13404.4	C08		2	0131-0272	91.72	271.87	183	50.28	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9093.7	C08		2	0132-0273	203.04	273.31	316	68.77	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11997.2	C08		2	0133-0275	569.95	274.68	442	79.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14103.0	C08		2	0134-0274	39.33	273.68	180	51.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11716.8	C08		2	0135-0277	672.47	276.66	294	65.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8396.5	C08		2	0136-0278	287.66	278.62	311	77.74	0.647
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11305.0	C08		2	0137-0281	688.77	281.41	190	52.28	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8607.9	C08		2	0138-0284	222.82	283.66	313	66.53	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11740.4	C08		2	0139-0286	317.64	285.56	222	55.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15827.9	C08		2	0140-0286	45.41	286.24	160	46.28	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9542.9	C08		2	0141-0290	149.01	291.47	268	60.53	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12323.4	C08		2	0142-0293	422.51	293.81	423	75.84	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10894.4	C08		2	0143-0291	677.08	291.79	126	44.04	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11103.2	C08		2	0144-0296	375.86	295.72	231	56.53	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9193.0	C08		2	0145-0297	89.16	296.62	270	61.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7600.5	C08		2	0146-0295	125.55	295.30	340	70.43	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	24267.0	C08		2	0147-0295	480.48	294.97	101	38.97	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8727.4	C08		2	0148-0305	868.84	305.13	300	65.60	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10791.5	C08		2	0149-0310	390.61	310.17	246	60.28	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9857.5	C08		2	0150-0308	254.84	307.98	242	58.28	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12680.1	C08		2	0151-0313	171.36	313.64	405	74.18	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8531.7	C08		2	0152-0317	189.73	317.29	313	71.36	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11727.4	C08		2	0153-0316	589.99	315.67	255	61.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8101.2	C08		2	0154-0319	724.22	320.00	324	67.36	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9190.4	C08		2	0155-0321	260.97	321.64	282	68.77	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10851.0	C08		2	0156-0322	782.33	322.48	265	61.11	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10313.6	C08		2	0157-0322	765.53	321.86	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8350.8	C08		2	0158-0324	91.62	324.21	284	63.01	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12502.9	C08		2	0159-0324	203.04	324.48	204	54.04	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13669.9	C08		2	0160-0324	219.56	324.07	184	49.70	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9409.3	C08		2	0161-0326	319.77	326.20	239	59.60	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9773.2	C08		2	0162-0326	445.11	325.63	279	63.60	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9479.4	C08		2	0163-0328	745.68	327.32	292	63.36	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10730.6	C08		2	0164-0326	375.73	326.79	238	56.87	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9755.0	C08		2	0165-0328	799.72	328.72	283	62.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9520.9	C08		2	0166-0329	69.68	329.37	267	62.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9804.5	C08		2	0167-0332	828.95	332.49	265	59.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8154.4	C08		2	0168-0333	137.34	333.96	297	63.36	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9343.0	C08		2	0169-0337	333.87	337.33	476	82.67	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7028.4	C08		2	0170-0339	655.25	338.63	375	71.60	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9146.8	C08		2	0171-0337	41.30	337.01	267	59.94	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10860.9	C08		2	0172-0341	449.37	341.53	237	57.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11259.7	C08		2	0173-0344	578.50	344.16	261	59.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14777.6	C08		2	0174-0345	271.53	344.95	333	70.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8942.5	C08		2	0175-0362	199.91	361.99	283	62.18	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8549.6	C08		2	0176-0362	744.59	362.13	297	63.36	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11358.9	C08		2	0177-0367	844.22	367.25	476	86.67	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9095.6	C08		2	0178-0367	31.63	367.08	200	55.01	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8834.7	C08		2	0179-0368	356.06	368.90	286	63.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10683.6	C08		2	0180-0371	425.28	370.81	245	58.28	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9758.7	C08		2	0181-0373	472.93	373.74	266	60.18	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12327.5	C08		2	0182-0374	894.56	374.92	213	56.87	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8602.5	C08		2	0183-0377	113.54	377.52	265	61.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8669.2	C08		2	0184-0383	23.22	384.93	341	76.67	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9287.8	C08		2	0185-0378	156.27	377.70	268	60.53	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12709.5	C08		2	0186-0387	229.76	388.44	416	82.08	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10306.8	C08		2	0187-0383	267.30	383.62	237	57.60	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7672.3	C08		2	0188-0384	394.23	383.70	325	67.01	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8468.3	C08		2	0189-0383	521.82	382.94	130	43.46	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7664.9	C08		2	0190-0395	516.46	396.09	209	58.77	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10587.1	C08		2	0191-0398	438.54	398.30	245	57.60	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8375.6	C08		2	0192-0393	534.58	393.96	160	49.80	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9839.5	C08		2	0193-0400	62.70	399.55	259	61.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8456.7	C08		2	0194-0404	289.85	404.07	638	93.84	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9918.0	C08		2	0195-0400	365.27	399.62	250	59.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10309.7	C08		2	0196-0405	724.18	405.92	363	72.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7175.8	C08		2	0197-0409	829.94	409.26	358	70.43	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9448.8	C08		2	0198-0409	463.33	409.72	301	66.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7097.8	C08		2	0199-0405	535.33	405.06	151	46.04	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9145.3	C08		2	0200-0409	700.43	408.69	295	64.53	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8869.6	C08		2	0201-0409	380.18	410.01	304	65.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8833.0	C08		2	0202-0415	154.53	415.43	294	73.50	0.684
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9002.5	C08		2	0203-0416	884.62	415.94	289	64.53	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9944.1	C08		2	0204-0415	56.75	416.08	327	67.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9258.5	C08		2	0205-0416	925.04	416.90	278	64.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8800.8	C08		2	0206-0419	663.17	419.11	335	67.36	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10344.8	C08		2	0207-0420	264.27	421.78	251	59.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11013.0	C08		2	0208-0420	498.43	420.59	204	55.11	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9876.6	C08		2	0209-0422	133.84	422.17	248	58.28	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10126.8	C08		2	0210-0424	724.51	424.08	312	66.53	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8666.7	C08		2	0211-0427	13.61	427.56	258	62.53	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9295.1	C08		2	0212-0429	945.19	429.48	286	65.36	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8696.1	C08		2	0213-0428	701.23	428.05	270	62.53	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10795.2	C08		2	0214-0433	190.90	433.18	238	58.53	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9643.5	C08		2	0215-0434	225.32	434.19	271	61.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8258.8	C08		2	0216-0437	87.04	437.77	287	62.77	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10719.8	C08		2	0217-0435	173.26	435.41	244	58.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13118.1	C08		2	0218-0436	260.95	436.35	185	49.80	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8873.9	C08		2	0219-0441	873.85	440.57	308	64.28	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8243.2	C08		2	0220-0444	375.81	444.45	323	66.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14714.7	C08		2	0221-0446	566.04	446.26	348	69.84	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13908.8	C08		2	0222-0449	332.26	449.77	560	94.33	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8401.5	C08		2	0223-0447	424.52	447.61	335	67.94	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9760.1	C08		2	0224-0448	922.18	447.91	265	61.60	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9268.1	C08		2	0225-0449	462.86	449.06	289	65.01	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9719.2	C08		2	0226-0451	604.85	451.48	265	63.60	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9685.4	C08		2	0227-0459	549.21	459.53	351	69.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8062.0	C08		2	0228-0458	143.34	458.86	324	68.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10128.1	C08		2	0229-0459	261.60	459.85	248	57.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10436.4	C08		2	0230-0458	400.63	459.11	238	59.46	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9324.6	C08		2	0231-0466	491.10	466.15	301	69.60	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9649.0	C08		2	0232-0462	632.32	462.23	266	60.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9505.1	C08		2	0233-0472	34.89	471.98	262	59.11	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9112.2	C08		2	0234-0469	119.89	468.96	262	61.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11412.7	C08		2	0235-0477	405.92	477.24	489	96.67	0.658
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8585.0	C08		2	0236-0480	815.69	480.06	304	75.01	0.679
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9854.0	C08		2	0237-0479	914.13	478.71	270	61.11	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8341.1	C08		2	0238-0480	225.31	480.10	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10777.6	C08		2	0239-0477	326.87	477.58	241	59.94	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10427.1	C08		2	0240-0481	871.99	481.61	262	60.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10015.5	C08		2	0241-0484	568.43	484.08	272	61.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10486.0	C08		2	0242-0489	750.74	489.51	488	84.33	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8694.4	C08		2	0243-0488	169.56	487.86	284	62.18	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10925.6	C08		2	0244-0488	679.30	488.67	269	61.70	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12333.6	C08		2	0245-0488	307.68	487.95	359	71.60	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8156.1	C08		2	0246-0489	630.43	488.96	323	68.18	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8960.8	C08		2	0247-0493	16.24	493.55	254	59.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9534.5	C08		2	0248-0493	507.23	493.06	269	63.60	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10036.0	C08		2	0249-0502	47.73	502.09	427	77.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10663.9	C08		2	0250-0500	246.57	500.67	312	66.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12292.7	C08		2	0251-0500	533.77	500.29	219	54.53	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8558.4	C08		2	0252-0504	66.26	503.58	297	64.53	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7786.7	C08		2	0253-0505	699.10	505.70	368	73.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10547.5	C08		2	0254-0501	204.12	501.50	231	59.11	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10903.6	C08		2	0255-0502	433.05	502.56	215	54.87	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8963.8	C08		2	0256-0507	619.58	507.08	300	67.94	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9183.9	C08		2	0257-0511	948.45	510.67	280	67.26	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8952.5	C08		2	0258-0512	475.01	511.55	298	65.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10306.2	C08		2	0259-0513	867.81	513.90	265	61.36	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10768.2	C08		2	0260-0516	850.85	516.77	257	59.60	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9014.7	C08		2	0261-0516	146.95	516.06	263	59.36	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8348.9	C08		2	0262-0523	580.94	523.79	157	47.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7204.9	C08		2	0263-0524	902.61	524.32	334	71.01	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10025.8	C08		2	0264-0524	171.12	524.21	247	58.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11101.8	C08		2	0265-0529	743.25	528.55	460	81.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9506.0	C08		2	0266-0529	338.24	529.73	255	61.36	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7190.8	C08		2	0267-0531	547.18	530.79	348	70.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11095.8	C08		2	0268-0532	520.09	532.34	249	59.60	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9450.7	C08		2	0269-0534	822.04	534.95	290	65.36	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7832.7	C08		2	0270-0536	121.32	535.69	443	79.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8023.5	C08		2	0271-0536	253.91	537.11	303	64.77	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8409.5	C08		2	0272-0540	73.04	539.97	266	60.43	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9100.6	C08		2	0273-0540	438.67	540.09	274	60.53	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9353.0	C08		2	0274-0543	474.92	543.22	497	82.43	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10988.7	C08		2	0275-0543	495.38	542.73	251	57.94	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8040.6	C08		2	0276-0545	179.70	545.24	306	69.94	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8522.7	C08		2	0277-0548	795.48	548.99	303	64.43	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9114.5	C08		2	0278-0551	945.99	550.84	288	62.53	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8189.9	C08		2	0279-0553	24.96	553.10	285	62.18	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11254.0	C08		2	0280-0557	618.00	556.84	266	63.11	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12066.0	C08		2	0281-0561	641.94	560.82	711	101.98	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10899.0	C08		2	0282-0560	291.60	560.59	518	83.01	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10141.4	C08		2	0283-0562	86.27	562.76	232	58.18	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8209.9	C08		2	0284-0563	339.83	563.42	303	64.43	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7255.3	C08		2	0285-0564	707.60	563.60	155	50.53	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8286.9	C08		2	0286-0567	555.67	567.57	297	65.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8110.2	C08		2	0287-0568	213.50	569.92	207	64.43	0.627
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14017.9	C08		2	0288-0569	583.10	568.94	301	64.28	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8061.2	C08		2	0289-0573	171.22	574.28	290	66.77	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9538.6	C08		2	0290-0573	882.89	572.56	272	63.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9208.8	C08		2	0291-0573	241.29	573.36	271	60.53	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9794.8	C08		2	0292-0577	185.71	576.57	160	48.63	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9571.6	C08		2	0293-0579	907.88	578.08	277	63.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8807.8	C08		2	0294-0581	57.33	580.98	258	59.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7871.1	C08		2	0295-0587	724.98	587.15	316	67.60	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7038.3	C08		2	0296-0587	134.80	587.12	175	50.53	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10426.0	C08		2	0297-0588	505.48	588.00	251	57.60	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12221.8	C08		2	0298-0590	87.90	590.70	192	53.70	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15584.1	C08		2	0299-0591	31.88	590.68	317	65.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9603.4	C08		2	0300-0591	764.21	591.57	269	61.36	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9150.9	C08		2	0301-0596	797.64	596.34	275	64.18	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10466.0	C08		2	0302-0598	49.01	598.53	246	58.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10742.6	C08		2	0303-0601	207.24	601.43	355	70.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7530.1	C08		2	0304-0599	600.60	599.30	324	68.18	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7369.0	C08		2	0305-0602	438.82	602.72	334	68.18	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9976.1	C08		2	0306-0603	746.91	602.13	251	59.84	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9619.5	C08		2	0307-0606	543.49	606.34	266	60.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7134.7	C08		2	0308-0604	250.39	605.09	296	66.18	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9070.4	C08		2	0309-0609	387.02	608.81	269	63.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8429.4	C08		2	0310-0608	335.62	607.84	280	64.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11757.9	C08		2	0311-0610	944.87	609.75	210	53.11	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9281.2	C08		2	0312-0613	119.39	614.07	255	64.77	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10161.2	C08		2	0313-0615	291.31	615.17	248	60.18	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10065.4	C08		2	0314-0621	566.88	622.06	251	60.77	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10723.5	C08		2	0315-0625	840.51	624.99	239	57.36	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10626.4	C08		2	0316-0628	67.91	628.06	236	55.70	0.956
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9155.3	C08		2	0317-0627	266.18	626.84	274	63.94	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10168.4	C08		2	0318-0632	346.98	632.17	263	60.43	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7902.7	C08		2	0319-0634	393.30	633.93	334	75.01	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6373.1	C08		2	0320-0634	670.15	633.03	101	41.70	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9213.3	C08		2	0321-0638	851.24	638.19	292	64.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10647.6	C08		2	0322-0639	445.95	639.26	253	59.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9947.6	C08		2	0323-0642	157.39	640.87	253	62.28	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10272.3	C08		2	0324-0640	174.32	640.06	262	61.46	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7502.1	C08		2	0325-0644	425.47	643.95	353	70.77	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10298.9	C08		2	0326-0644	307.30	643.62	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7956.2	C08		2	0327-0645	630.33	645.35	309	65.01	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8259.5	C08		2	0328-0648	727.88	648.50	296	64.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8867.4	C08		2	0329-0647	119.09	647.07	268	60.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8171.1	C08		2	0330-0650	679.59	650.26	310	68.77	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7532.0	C08		2	0331-0650	246.41	650.38	298	69.36	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8663.9	C08		2	0332-0650	13.97	649.82	250	58.87	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10694.4	C08		2	0333-0650	470.51	649.83	248	60.87	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9480.9	C08		2	0334-0653	588.67	652.30	269	62.77	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10135.1	C08		2	0335-0655	563.64	655.36	249	59.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8029.3	C08		2	0336-0655	263.18	654.92	281	64.77	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8131.4	C08		2	0337-0669	407.40	670.15	329	70.43	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9522.6	C08		2	0338-0669	371.39	669.49	271	61.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10631.7	C08		2	0339-0674	544.22	674.03	278	64.53	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7225.2	C08		2	0340-0674	283.60	674.11	316	67.60	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10489.0	C08		2	0341-0677	50.74	676.48	504	93.74	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11009.8	C08		2	0342-0677	529.26	677.28	241	57.70	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12319.5	C08		2	0343-0679	637.19	678.71	458	80.43	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8741.9	C08		2	0344-0684	829.52	684.32	312	64.77	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9058.3	C08		2	0345-0685	100.70	685.98	251	58.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11216.9	C08		2	0346-0687	352.25	686.86	227	58.28	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8498.9	C08		2	0347-0686	391.95	685.78	302	65.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11982.5	C08		2	0348-0689	565.33	688.86	432	79.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15538.5	C08		2	0349-0687	806.47	688.39	341	72.43	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9237.1	C08		2	0350-0690	21.42	689.99	247	57.36	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7990.3	C08		2	0351-0690	142.77	690.36	295	65.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13509.1	C08		2	0352-0694	479.41	694.54	338	67.60	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7817.1	C08		2	0353-0700	209.29	699.63	276	63.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10908.3	C08		2	0354-0697	630.69	697.57	233	57.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8940.0	C08		2	0355-0699	247.97	699.45	266	60.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11049.2	C08		2	0356-0702	759.80	701.69	264	60.43	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185027	1375319	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8484.3	C08		2	0357-0710	176.17	709.98	264	60.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12460.9	C08		3	0001-0023	532.57	23.39	244	57.60	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11526.1	C08		3	0002-0028	327.48	30.03	247	65.36	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11176.8	C08		3	0003-0029	465.12	29.36	299	67.01	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11748.2	C08		3	0004-0029	685.49	28.96	237	60.63	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12380.0	C08		3	0005-0029	253.25	28.93	221	54.53	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7897.1	C08		3	0006-0032	58.32	32.64	327	66.43	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10392.3	C08		3	0007-0031	771.33	31.27	277	60.77	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12744.7	C08		3	0008-0032	938.39	31.96	323	66.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12699.6	C08		3	0009-0032	428.60	32.82	242	58.28	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11303.7	C08		3	0010-0041	489.88	41.38	564	96.57	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9520.7	C08		3	0011-0034	658.31	34.47	313	66.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8033.7	C08		3	0012-0040	199.61	39.73	314	70.18	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10874.5	C08		3	0013-0039	448.67	39.33	289	63.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12969.8	C08		3	0014-0037	547.08	37.85	227	57.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11980.9	C08		3	0015-0041	721.42	40.98	365	73.01	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10512.8	C08		3	0016-0039	566.60	40.06	313	69.01	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9689.4	C08		3	0017-0040	922.00	40.34	223	66.67	0.630
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10376.0	C08		3	0018-0044	596.63	44.21	304	66.43	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14545.5	C08		3	0019-0041	813.20	41.28	179	51.46	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7801.6	C08		3	0020-0049	113.44	49.20	334	67.84	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10740.4	C08		3	0021-0053	359.25	53.25	278	65.01	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11202.3	C08		3	0022-0049	430.55	48.90	263	61.11	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9623.3	C08		3	0023-0055	223.57	55.22	314	66.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15787.7	C08		3	0024-0053	396.70	52.83	352	69.01	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12579.6	C08		3	0025-0055	809.25	55.67	224	55.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8494.8	C08		3	0026-0059	148.23	58.99	225	59.60	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11278.8	C08		3	0027-0064	280.55	64.35	314	67.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11806.4	C08		3	0028-0063	544.03	63.30	254	57.70	0.959
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8971.4	C08		3	0029-0064	884.27	64.14	186	51.70	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11447.1	C08		3	0030-0066	516.31	65.67	264	63.36	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8230.0	C08		3	0031-0066	137.84	67.13	100	36.87	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9955.5	C08		3	0032-0073	467.13	73.35	280	67.84	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11571.5	C08		3	0033-0082	290.55	82.99	431	79.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8907.9	C08		3	0034-0081	885.37	80.56	222	56.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16654.4	C08		3	0035-0084	53.08	83.10	310	65.84	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8736.4	C08		3	0036-0084	137.48	84.03	298	65.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11623.8	C08		3	0037-0082	269.27	81.66	220	57.46	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10016.3	C08		3	0038-0085	905.06	84.63	292	63.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11504.5	C08		3	0039-0088	663.25	88.70	423	77.50	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8845.5	C08		3	0040-0087	397.19	87.20	335	70.08	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12216.3	C08		3	0041-0091	639.02	90.74	485	81.01	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11102.7	C08		3	0042-0087	769.24	87.52	258	59.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9732.4	C08		3	0043-0090	219.09	90.97	283	63.01	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8553.2	C08		3	0044-0097	238.14	97.34	325	69.60	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9089.4	C08		3	0045-0100	948.51	100.66	304	64.18	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9625.6	C08		3	0046-0106	703.27	106.15	301	71.01	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8573.8	C08		3	0047-0104	412.83	104.58	343	69.36	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11581.9	C08		3	0048-0106	858.33	105.98	240	57.94	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8541.1	C08		3	0049-0114	169.00	114.22	297	65.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12641.0	C08		3	0050-0112	786.67	113.07	223	55.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9206.7	C08		3	0051-0116	38.58	116.93	429	80.08	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9250.3	C08		3	0052-0116	528.84	115.97	313	66.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17011.9	C08		3	0053-0119	387.92	119.01	319	66.18	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12811.3	C08		3	0054-0132	365.36	135.16	821	132.47	0.588
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8450.8	C08		3	0055-0129	748.67	130.15	442	92.23	0.653
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14340.7	C08		3	0056-0128	920.91	127.37	349	69.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10432.6	C08		3	0057-0125	566.78	124.73	293	63.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9607.9	C08		3	0058-0127	626.53	128.10	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7090.4	C08		3	0059-0130	770.46	128.58	300	69.01	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12594.8	C08		3	0060-0135	789.23	134.60	222	61.60	0.735
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9418.5	C08		3	0061-0134	817.31	134.17	319	68.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10167.4	C08		3	0062-0142	89.03	141.16	280	67.11	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11783.1	C08		3	0063-0141	165.57	141.85	330	68.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11868.3	C08		3	0064-0138	224.78	138.64	223	55.70	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10661.5	C08		3	0065-0141	396.66	141.25	271	61.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10710.1	C08		3	0066-0141	497.15	141.74	275	63.11	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10691.9	C08		3	0067-0142	861.03	142.03	262	59.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11636.5	C08		3	0068-0142	337.85	142.39	270	65.11	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10936.6	C08		3	0069-0145	703.67	145.81	261	61.36	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9604.0	C08		3	0070-0148	266.12	148.80	285	65.60	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8209.3	C08		3	0071-0155	897.36	154.70	365	73.26	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10600.8	C08		3	0072-0152	653.92	152.55	284	64.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9031.0	C08		3	0073-0161	237.53	161.53	297	65.01	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10536.8	C08		3	0074-0164	69.27	165.07	267	63.60	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11448.9	C08		3	0075-0164	520.53	163.95	253	61.01	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14157.8	C08		3	0076-0166	620.29	165.68	383	73.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10411.5	C08		3	0077-0164	465.07	164.49	227	57.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13009.7	C08		3	0078-0165	749.54	165.08	432	77.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8025.0	C08		3	0079-0172	869.02	171.91	382	74.33	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8118.2	C08		3	0080-0173	23.84	172.42	302	65.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9923.9	C08		3	0081-0174	592.35	173.61	452	83.84	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8929.0	C08		3	0082-0174	274.69	173.21	288	67.36	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11299.7	C08		3	0083-0178	545.77	178.99	262	66.53	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6822.1	C08		3	0084-0178	148.43	178.01	338	73.84	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13047.2	C08		3	0085-0176	514.15	177.00	189	52.77	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11956.3	C08		3	0086-0177	679.31	177.37	240	58.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11650.3	C08		3	0087-0181	696.46	181.97	249	59.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10949.6	C08		3	0088-0180	794.34	180.45	254	60.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12059.6	C08		3	0089-0181	108.76	180.88	230	55.11	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8474.3	C08		3	0090-0193	414.72	192.56	330	68.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11357.6	C08		3	0091-0190	64.99	189.93	227	55.11	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11906.5	C08		3	0092-0195	99.27	195.98	234	56.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10299.5	C08		3	0093-0196	202.97	195.97	316	69.01	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7220.1	C08		3	0094-0198	831.79	197.32	370	75.60	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10949.3	C08		3	0095-0197	49.38	196.72	237	58.18	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12147.0	C08		3	0096-0197	513.77	197.29	315	65.01	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10092.3	C08		3	0097-0204	457.17	203.08	271	61.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9070.9	C08		3	0098-0203	704.26	203.91	332	73.01	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7225.6	C08		3	0099-0204	354.49	204.48	347	73.01	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7891.2	C08		3	0100-0208	569.50	207.85	443	78.67	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10564.9	C08		3	0101-0210	948.56	209.54	264	63.11	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10505.9	C08		3	0102-0214	469.57	213.88	255	59.94	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7465.2	C08		3	0103-0225	924.52	225.67	367	87.15	0.607
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9121.7	C08		3	0104-0228	644.11	227.88	315	70.77	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8812.3	C08		3	0105-0225	61.98	224.71	299	70.67	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8218.3	C08		3	0106-0225	160.87	224.84	322	69.84	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9458.2	C08		3	0107-0229	862.41	228.41	317	68.67	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10564.6	C08		3	0108-0228	18.02	227.83	235	55.94	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10127.1	C08		3	0109-0234	751.08	233.32	289	64.18	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12060.1	C08		3	0110-0236	782.55	236.23	246	57.36	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8048.7	C08		3	0111-0240	93.05	240.20	308	66.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9791.5	C08		3	0112-0238	892.29	239.00	287	65.01	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8766.1	C08		3	0113-0240	235.55	240.11	332	67.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9897.3	C08		3	0114-0237	585.30	237.86	152	46.87	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8862.5	C08		3	0115-0241	269.32	240.96	307	66.77	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10836.6	C08		3	0116-0248	610.00	249.03	258	62.28	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6748.2	C08		3	0117-0246	373.04	246.03	343	76.43	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11802.2	C08		3	0118-0248	765.67	248.01	239	67.01	0.669
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12017.7	C08		3	0119-0248	806.76	248.02	239	55.70	0.968
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19571.5	C08		3	0120-0251	678.80	251.79	260	59.94	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15566.4	C08		3	0121-0250	583.42	250.39	234	68.04	0.635
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8565.0	C08		3	0122-0258	131.40	259.27	494	84.33	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9551.4	C08		3	0123-0256	150.97	255.71	274	63.84	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9961.0	C08		3	0124-0260	490.75	261.11	264	64.18	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10793.2	C08		3	0125-0261	49.17	260.94	240	58.77	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9999.6	C08		3	0126-0261	447.80	260.90	268	65.01	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10174.3	C08		3	0127-0266	406.69	265.92	281	63.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11981.7	C08		3	0128-0263	942.26	262.18	227	57.70	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12354.8	C08		3	0129-0266	729.09	265.65	222	54.53	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7106.5	C08		3	0130-0271	632.23	271.21	387	98.47	0.502
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13245.3	C08		3	0131-0276	877.95	276.41	209	53.46	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15934.9	C08		3	0132-0280	532.20	280.58	357	69.01	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9203.7	C08		3	0133-0283	898.83	283.28	321	65.60	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8929.1	C08		3	0134-0287	309.24	286.78	291	63.60	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10335.1	C08		3	0135-0290	800.71	289.32	280	63.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12622.9	C08		3	0136-0289	858.29	289.80	228	56.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10260.9	C08		3	0137-0293	677.33	293.41	287	63.94	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9060.2	C08		3	0138-0291	459.36	291.79	320	66.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7571.6	C08		3	0139-0297	354.38	297.64	401	79.50	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13926.9	C08		3	0140-0294	757.01	294.27	198	55.11	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9448.4	C08		3	0141-0299	576.94	298.66	443	79.60	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9651.1	C08		3	0142-0298	265.74	298.65	267	61.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9905.5	C08		3	0143-0299	72.18	299.74	253	58.77	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11977.9	C08		3	0144-0304	788.08	303.48	234	59.01	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9813.8	C08		3	0145-0311	518.79	311.58	293	63.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9322.6	C08		3	0146-0311	866.10	311.35	321	66.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7591.1	C08		3	0147-0313	114.14	313.03	312	67.84	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8299.1	C08		3	0148-0316	281.76	314.32	322	72.77	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10714.3	C08		3	0149-0314	216.74	314.24	240	57.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14374.8	C08		3	0150-0316	462.68	315.95	374	71.84	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10007.6	C08		3	0151-0312	671.78	312.33	293	66.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7947.3	C08		3	0152-0319	404.30	319.33	365	90.33	0.562
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9001.4	C08		3	0153-0317	916.73	316.91	325	68.43	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7081.1	C08		3	0154-0321	486.15	320.62	376	90.91	0.572
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11262.2	C08		3	0155-0321	749.58	321.63	264	61.94	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12209.1	C08		3	0156-0320	800.65	320.44	228	56.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10326.6	C08		3	0157-0322	187.82	322.48	247	57.11	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9978.7	C08		3	0158-0325	595.66	325.86	278	63.70	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8739.8	C08		3	0159-0330	310.51	329.78	303	69.60	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9177.9	C08		3	0160-0335	57.67	335.14	295	64.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11339.5	C08		3	0161-0340	769.12	339.27	267	65.36	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10651.5	C08		3	0162-0337	643.36	337.38	259	60.28	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13430.7	C08		3	0163-0342	782.81	341.49	203	57.11	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11614.4	C08		3	0164-0342	707.27	341.53	243	57.94	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11105.6	C08		3	0165-0347	686.39	347.35	273	61.11	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9704.8	C08		3	0166-0349	864.22	349.06	308	67.60	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8913.0	C08		3	0167-0353	197.73	352.76	262	66.18	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9609.7	C08		3	0168-0356	948.80	356.74	354	73.50	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10945.4	C08		3	0169-0351	635.22	351.36	265	63.94	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7259.3	C08		3	0170-0352	215.58	351.55	130	45.36	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10057.2	C08		3	0171-0355	559.53	355.31	290	65.60	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9597.4	C08		3	0172-0358	54.25	359.06	261	61.01	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13236.2	C08		3	0173-0363	341.37	363.34	449	81.01	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13175.4	C08		3	0174-0359	778.66	359.31	223	55.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8266.2	C08		3	0175-0363	359.28	363.10	324	70.53	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7594.0	C08		3	0176-0367	464.46	366.77	345	71.01	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10073.8	C08		3	0177-0367	727.94	367.19	277	61.36	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12299.3	C08		3	0178-0368	906.35	368.80	281	62.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10895.2	C08		3	0179-0368	189.77	367.86	245	57.36	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9054.3	C08		3	0180-0369	213.15	368.99	220	53.94	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9251.5	C08		3	0181-0372	857.11	373.24	323	71.60	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10991.4	C08		3	0182-0374	698.26	374.09	239	60.18	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8651.4	C08		3	0183-0377	303.40	376.96	313	67.01	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11478.0	C08		3	0184-0377	544.99	377.60	241	59.36	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13805.5	C08		3	0185-0383	44.56	382.58	380	73.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11267.4	C08		3	0186-0389	434.90	390.02	536	103.40	0.630
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9180.0	C08		3	0187-0382	792.69	380.81	322	71.84	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8463.0	C08		3	0188-0387	381.32	386.98	316	72.77	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9675.9	C08		3	0189-0390	610.76	389.98	481	86.33	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10021.7	C08		3	0190-0389	695.86	388.97	303	68.43	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9344.4	C08		3	0191-0392	841.59	392.05	299	65.94	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12373.0	C08		3	0192-0394	134.16	394.28	212	54.53	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11036.8	C08		3	0193-0398	670.63	398.30	256	59.11	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8911.3	C08		3	0194-0402	272.23	402.84	428	76.91	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9209.0	C08		3	0195-0408	507.87	407.51	311	66.53	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8689.5	C08		3	0196-0410	807.87	410.34	346	69.84	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9995.4	C08		3	0197-0409	472.96	409.63	281	61.60	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9614.3	C08		3	0198-0411	322.05	410.94	282	63.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8508.5	C08		3	0199-0413	571.30	413.44	318	66.53	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8471.1	C08		3	0200-0414	759.60	414.30	348	71.84	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9385.2	C08		3	0201-0414	89.37	414.72	261	60.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8735.8	C08		3	0202-0417	190.24	417.81	315	66.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8832.0	C08		3	0203-0419	20.26	419.74	274	65.36	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7888.6	C08		3	0204-0425	422.94	424.10	347	74.43	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9967.4	C08		3	0205-0422	719.69	422.40	292	65.36	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9282.0	C08		3	0206-0425	354.68	425.44	306	65.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13070.1	C08		3	0207-0429	315.29	430.42	404	77.50	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9173.3	C08		3	0208-0427	212.29	427.79	284	63.94	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8180.8	C08		3	0209-0429	585.97	429.94	328	67.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8970.8	C08		3	0210-0432	39.94	432.05	266	62.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12931.0	C08		3	0211-0433	109.61	432.71	202	55.11	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9391.5	C08		3	0212-0438	716.99	437.68	332	76.43	0.714
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10691.0	C08		3	0213-0443	151.37	443.99	239	57.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11220.8	C08		3	0214-0441	866.29	441.56	144	48.04	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9671.7	C08		3	0215-0448	705.39	449.09	366	71.84	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12819.5	C08		3	0216-0445	115.33	445.73	189	51.94	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9838.2	C08		3	0217-0444	904.95	445.08	292	66.53	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16767.4	C08		3	0218-0450	642.85	450.12	331	87.74	0.540
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8429.0	C08		3	0219-0449	247.18	448.68	163	52.18	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9279.1	C08		3	0220-0450	17.02	450.61	255	60.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12250.4	C08		3	0221-0451	528.31	450.92	220	56.87	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11353.7	C08		3	0222-0450	169.22	450.25	225	55.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8685.7	C08		3	0223-0451	232.54	451.54	225	62.28	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8299.6	C08		3	0224-0452	283.27	452.69	218	63.01	0.690
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14649.6	C08		3	0225-0452	833.38	452.54	187	51.46	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13909.4	C08		3	0226-0454	884.15	454.05	199	53.11	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10408.7	C08		3	0227-0451	868.05	451.00	108	41.80	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13232.9	C08		3	0228-0460	783.55	460.00	397	73.60	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14566.0	C08		3	0229-0457	81.69	456.53	160	48.53	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11785.8	C08		3	0230-0459	599.55	459.37	223	55.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10553.4	C08		3	0231-0467	409.14	467.44	277	63.94	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14620.0	C08		3	0232-0463	896.21	463.67	180	50.53	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10733.4	C08		3	0233-0471	73.92	471.13	260	60.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8379.6	C08		3	0234-0470	370.62	469.91	330	66.77	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14457.0	C08		3	0235-0470	909.28	470.32	193	54.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16565.8	C08		3	0236-0474	658.09	474.07	236	108.47	0.252
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9596.1	C08		3	0237-0477	757.68	477.45	310	68.18	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9620.7	C08		3	0238-0483	861.58	482.86	294	67.36	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8293.3	C08		3	0239-0482	135.99	482.81	302	65.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8837.2	C08		3	0240-0481	782.06	481.84	320	70.18	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10719.2	C08		3	0241-0484	619.12	484.95	307	67.60	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11688.7	C08		3	0242-0487	230.78	487.27	221	56.77	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11418.9	C08		3	0243-0488	501.96	488.48	303	95.15	0.421
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9329.1	C08		3	0244-0492	845.54	492.39	295	67.01	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10060.0	C08		3	0245-0496	592.35	495.95	308	67.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7455.0	C08		3	0246-0494	948.35	494.15	209	56.28	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10650.8	C08		3	0247-0495	927.22	495.11	272	63.11	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9624.7	C08		3	0248-0497	887.16	497.36	310	68.43	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10050.1	C08		3	0249-0508	730.86	507.47	308	68.18	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10373.9	C08		3	0250-0510	714.33	510.41	265	63.11	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7044.2	C08		3	0251-0505	944.95	505.82	128	46.63	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13436.8	C08		3	0252-0511	456.37	510.33	310	65.94	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9000.5	C08		3	0253-0513	43.13	513.37	269	63.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11067.4	C08		3	0254-0516	514.45	515.97	247	62.18	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9398.3	C08		3	0255-0520	646.15	520.03	381	72.67	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8961.2	C08		3	0256-0519	399.86	519.23	316	67.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8400.5	C08		3	0257-0522	197.60	521.91	304	64.77	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10795.1	C08		3	0258-0524	879.76	523.49	273	63.36	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8278.8	C08		3	0259-0526	159.70	527.09	306	67.94	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10156.7	C08		3	0260-0523	483.04	523.55	269	63.94	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7345.1	C08		3	0261-0531	810.81	531.43	365	72.18	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10270.1	C08		3	0262-0528	565.57	527.76	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8847.2	C08		3	0263-0530	782.86	529.80	316	67.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10209.5	C08		3	0264-0530	756.84	529.87	273	60.77	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12450.2	C08		3	0265-0531	367.86	531.22	203	54.04	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8345.5	C08		3	0266-0534	608.04	534.55	326	68.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7122.9	C08		3	0267-0537	119.51	536.59	320	66.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9844.6	C08		3	0268-0538	740.19	538.23	288	63.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11453.1	C08		3	0269-0546	675.65	545.16	234	61.70	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9547.0	C08		3	0270-0549	529.42	550.06	285	65.60	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8559.2	C08		3	0271-0551	426.59	551.08	333	68.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8247.5	C08		3	0272-0551	267.71	551.18	295	63.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11112.7	C08		3	0273-0550	703.60	550.46	250	58.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8906.0	C08		3	0274-0554	40.63	553.53	281	62.53	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10296.6	C08		3	0275-0553	861.92	552.97	283	63.11	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10027.7	C08		3	0276-0552	904.61	552.64	264	62.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10704.6	C08		3	0277-0562	81.73	563.11	229	57.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8701.9	C08		3	0278-0560	180.90	560.41	289	65.11	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12850.9	C08		3	0279-0564	689.94	564.74	395	73.60	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11779.3	C08		3	0280-0566	65.60	566.35	283	61.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9756.3	C08		3	0281-0566	890.89	566.66	302	64.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9912.1	C08		3	0282-0568	447.87	568.48	399	73.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8342.0	C08		3	0283-0567	848.99	567.07	160	48.04	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10532.5	C08		3	0284-0568	726.85	569.11	263	59.46	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8337.6	C08		3	0285-0574	501.01	573.94	304	68.18	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8731.8	C08		3	0286-0576	103.26	576.46	271	63.11	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8215.1	C08		3	0287-0577	288.58	576.72	309	67.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13335.2	C08		3	0288-0571	588.60	571.12	203	56.28	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9502.5	C08		3	0289-0580	322.17	580.19	286	62.18	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9323.0	C08		3	0290-0582	304.21	582.90	279	63.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13194.2	C08		3	0291-0587	610.80	586.71	430	81.26	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7682.8	C08		3	0292-0583	908.91	583.67	336	71.60	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12174.7	C08		3	0293-0587	357.14	587.71	211	54.87	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13536.1	C08		3	0294-0583	584.48	583.09	206	56.28	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9906.1	C08		3	0295-0584	760.43	583.31	202	53.11	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11092.5	C08		3	0296-0586	839.51	587.03	244	59.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12249.5	C08		3	0297-0588	726.94	587.22	223	56.28	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8432.6	C08		3	0298-0592	227.26	591.41	284	62.43	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9958.5	C08		3	0299-0596	537.39	596.63	274	62.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13476.4	C08		3	0300-0596	628.00	596.63	204	54.53	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9036.7	C08		3	0301-0598	53.36	598.16	263	59.36	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8051.8	C08		3	0302-0601	490.88	601.10	323	68.18	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8771.5	C08		3	0303-0598	800.23	598.26	318	66.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8999.9	C08		3	0304-0606	86.25	606.24	265	59.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9415.6	C08		3	0305-0606	873.17	605.88	286	63.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10039.2	C08		3	0306-0605	758.47	605.61	197	56.18	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7917.6	C08		3	0307-0612	193.94	611.97	326	68.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8157.6	C08		3	0308-0612	153.56	612.34	281	63.36	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11753.9	C08		3	0309-0612	39.38	612.41	207	52.87	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11973.5	C08		3	0310-0617	654.98	617.44	437	77.26	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11549.7	C08		3	0311-0620	691.40	620.80	264	62.77	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8390.8	C08		3	0312-0622	316.84	621.70	292	62.77	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12933.5	C08		3	0313-0628	613.04	628.45	215	54.87	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11806.5	C08		3	0314-0632	119.71	632.15	422	75.36	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9028.9	C08		3	0315-0630	340.94	629.63	275	65.60	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10265.5	C08		3	0316-0635	406.97	634.37	580	95.98	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9476.2	C08		3	0317-0634	44.10	633.95	263	62.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10560.5	C08		3	0318-0637	939.48	637.54	249	58.53	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13045.6	C08		3	0319-0643	596.50	643.24	346	69.60	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9340.3	C08		3	0320-0642	345.82	643.74	326	71.01	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13149.1	C08		3	0321-0643	892.99	643.52	199	54.87	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11906.8	C08		3	0322-0645	755.67	644.84	283	62.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9303.8	C08		3	0323-0647	849.47	645.85	284	66.43	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13492.2	C08		3	0324-0645	915.19	645.36	189	50.53	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10213.2	C08		3	0325-0648	719.79	648.20	266	63.60	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9943.5	C08		3	0326-0650	46.59	649.98	241	58.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9706.8	C08		3	0327-0654	672.21	654.89	277	62.77	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9169.7	C08		3	0328-0659	482.69	658.41	319	68.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9721.4	C08		3	0329-0656	415.05	657.27	273	64.18	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11782.5	C08		3	0330-0661	817.85	661.10	226	55.11	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9814.1	C08		3	0331-0662	381.27	662.38	254	60.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9551.4	C08		3	0332-0664	602.31	664.16	276	61.94	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11863.9	C08		3	0333-0665	260.71	665.53	161	46.87	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7771.1	C08		3	0334-0669	166.07	669.08	291	63.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7878.5	C08		3	0335-0673	211.95	673.34	288	68.53	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15208.1	C08		3	0336-0672	244.53	673.82	262	64.53	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10747.8	C08		3	0337-0678	779.05	677.79	266	59.36	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9256.2	C08		3	0338-0679	734.95	678.14	297	63.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9789.8	C08		3	0339-0681	865.04	680.29	300	66.77	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9647.6	C08		3	0340-0682	910.16	681.82	303	65.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10466.9	C08		3	0341-0682	754.15	682.31	293	63.01	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11171.5	C08		3	0342-0681	883.02	681.72	260	61.01	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9747.2	C08		3	0343-0681	559.94	681.50	269	63.36	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10475.1	C08		3	0344-0687	817.17	687.40	326	67.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10680.6	C08		3	0345-0688	615.97	687.25	257	61.11	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8880.1	C08		3	0346-0694	384.31	694.38	318	68.53	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8037.9	C08		3	0347-0697	418.34	698.00	305	66.77	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9399.5	C08		3	0348-0701	679.16	701.08	282	67.36	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10372.6	C08		3	0349-0701	229.03	700.26	253	67.84	0.691
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10778.2	C08		3	0350-0705	619.82	705.13	278	63.94	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11908.5	C08		3	0351-0702	848.61	702.61	245	59.94	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8561.6	C08		3	0352-0709	943.83	708.13	287	64.77	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8277.1	C08		3	0353-0709	56.23	709.62	258	61.70	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185028	1375320	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8715.5	C08		3	0354-0711	333.46	711.20	309	69.11	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9674.9	C08		4	0001-0023	195.30	23.30	268	61.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11660.3	C08		4	0002-0022	562.22	22.54	257	61.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9940.3	C08		4	0003-0021	820.66	21.45	146	46.04	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8064.9	C08		4	0004-0026	17.68	27.12	282	63.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10018.3	C08		4	0005-0025	333.33	25.35	262	59.36	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7612.0	C08		4	0006-0029	365.76	29.28	324	70.67	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10247.9	C08		4	0007-0029	89.76	29.68	255	61.36	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15070.2	C08		4	0008-0033	621.79	33.53	356	70.43	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8293.0	C08		4	0009-0038	108.79	38.32	321	66.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8468.8	C08		4	0010-0042	214.26	42.85	281	64.77	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10002.3	C08		4	0011-0045	786.35	45.55	257	61.11	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10441.3	C08		4	0012-0046	321.66	46.11	241	57.11	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9171.9	C08		4	0013-0046	703.80	46.36	280	65.11	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11340.4	C08		4	0014-0048	943.16	49.11	232	56.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11594.7	C08		4	0015-0055	52.27	55.75	711	116.13	0.663
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9908.5	C08		4	0016-0052	448.90	51.61	395	72.77	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8593.6	C08		4	0017-0056	116.59	56.15	287	64.77	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11889.1	C08		4	0018-0057	857.49	56.52	218	55.11	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8691.1	C08		4	0019-0062	138.71	62.85	301	69.26	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7451.4	C08		4	0020-0063	660.87	63.64	333	68.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10232.0	C08		4	0021-0063	268.62	63.38	243	59.60	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7958.1	C08		4	0022-0067	498.94	66.82	322	70.18	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11202.9	C08		4	0023-0063	541.75	63.22	257	60.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9828.8	C08		4	0024-0062	762.42	62.81	263	60.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8250.7	C08		4	0025-0065	921.79	64.05	293	66.43	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9361.2	C08		4	0026-0072	306.40	72.35	280	63.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12155.7	C08		4	0027-0072	555.04	71.69	231	57.94	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8229.2	C08		4	0028-0077	228.36	77.22	311	66.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12535.3	C08		4	0029-0080	255.87	80.63	419	76.08	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11347.1	C08		4	0030-0080	861.20	80.08	233	56.87	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8990.4	C08		4	0031-0080	902.41	80.33	276	62.77	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9161.4	C08		4	0032-0083	625.71	83.44	278	63.94	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12865.8	C08		4	0033-0083	563.68	83.38	211	54.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10313.7	C08		4	0034-0086	418.74	86.24	264	60.43	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9935.7	C08		4	0035-0087	108.03	87.68	255	60.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12494.7	C08		4	0036-0093	591.99	93.38	413	82.08	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9248.8	C08		4	0037-0086	761.03	86.31	272	63.94	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8504.6	C08		4	0038-0087	185.57	87.49	289	61.94	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6936.9	C08		4	0039-0093	461.42	93.14	342	73.74	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8478.6	C08		4	0040-0092	701.97	91.78	300	66.18	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8511.7	C08		4	0041-0100	738.97	99.96	308	65.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9800.4	C08		4	0042-0102	52.13	101.74	260	59.94	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15060.7	C08		4	0043-0110	367.52	110.02	740	103.30	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15786.7	C08		4	0044-0103	837.97	102.66	133	98.13	0.174
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8358.0	C08		4	0045-0104	544.63	104.79	309	65.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8289.1	C08		4	0046-0107	942.98	106.80	304	64.77	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12027.8	C08		4	0047-0107	89.01	106.82	202	55.11	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8640.5	C08		4	0048-0112	288.36	112.59	289	63.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10261.7	C08		4	0049-0118	163.66	118.71	229	59.70	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9577.3	C08		4	0050-0121	427.35	120.78	283	63.26	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17515.8	C08		4	0051-0128	672.34	128.38	325	67.01	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10309.8	C08		4	0052-0132	440.24	131.62	293	65.26	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9823.0	C08		4	0053-0132	641.24	132.40	265	63.01	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10672.1	C08		4	0054-0135	321.50	135.13	286	69.11	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10290.8	C08		4	0055-0133	195.76	132.94	243	58.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13043.9	C08		4	0056-0141	832.51	140.76	395	73.01	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10020.5	C08		4	0057-0141	698.12	140.93	279	61.94	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8306.8	C08		4	0058-0144	401.87	144.67	298	65.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8897.3	C08		4	0059-0141	608.51	141.51	293	63.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13476.7	C08		4	0060-0143	890.55	143.94	350	69.01	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8942.7	C08		4	0061-0147	281.89	147.32	272	62.53	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10405.2	C08		4	0062-0155	211.91	154.96	244	59.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9784.3	C08		4	0063-0155	546.55	155.53	283	63.70	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11244.3	C08		4	0064-0157	650.36	156.76	250	58.18	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12015.7	C08		4	0065-0162	471.64	161.79	460	83.98	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13005.9	C08		4	0066-0162	875.55	162.57	335	67.01	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11896.2	C08		4	0067-0165	392.06	164.70	252	60.87	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9878.2	C08		4	0068-0162	908.00	162.89	262	59.11	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9243.0	C08		4	0069-0166	15.51	165.91	257	61.01	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9955.8	C08		4	0070-0165	626.78	165.37	265	61.36	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8679.8	C08		4	0071-0169	55.25	169.81	268	63.94	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7963.3	C08		4	0072-0173	930.06	173.44	334	73.60	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10278.1	C08		4	0073-0171	572.45	171.06	277	65.01	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8895.1	C08		4	0074-0175	117.62	175.02	347	70.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13143.0	C08		4	0075-0174	608.69	174.77	343	72.67	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12483.0	C08		4	0076-0176	709.60	175.55	246	58.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11082.9	C08		4	0077-0182	743.35	181.60	249	57.94	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7146.3	C08		4	0078-0187	260.34	187.52	305	68.43	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10206.9	C08		4	0079-0187	396.30	186.68	288	65.01	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9421.9	C08		4	0080-0189	524.11	189.77	271	62.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6638.2	C08		4	0081-0192	303.68	191.71	332	70.77	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10295.4	C08		4	0082-0193	77.16	194.14	250	58.87	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11659.5	C08		4	0083-0204	189.14	203.70	711	106.91	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11154.6	C08		4	0084-0195	564.72	195.48	236	56.53	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13456.8	C08		4	0085-0197	603.83	197.14	195	51.70	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9036.6	C08		4	0086-0201	361.27	201.37	278	62.18	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9784.9	C08		4	0087-0203	910.95	203.03	256	64.53	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14071.4	C08		4	0088-0200	621.21	201.45	183	52.53	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11992.0	C08		4	0089-0208	451.61	208.79	227	59.94	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11230.0	C08		4	0090-0205	142.26	204.59	219	54.53	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10159.4	C08		4	0091-0211	77.12	210.81	245	58.63	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8500.4	C08		4	0092-0214	212.55	213.45	279	62.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8967.0	C08		4	0093-0215	882.23	215.37	291	63.36	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9458.1	C08		4	0094-0218	788.07	218.22	272	63.94	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7635.7	C08		4	0095-0220	822.27	219.43	310	65.36	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9498.5	C08		4	0096-0221	236.96	221.31	270	60.18	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9295.8	C08		4	0097-0223	700.20	224.18	270	61.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10498.5	C08		4	0098-0225	11.64	225.33	233	56.28	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10139.1	C08		4	0099-0224	907.71	224.45	290	74.43	0.658
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8505.3	C08		4	0100-0231	46.45	231.41	275	62.18	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14611.2	C08		4	0101-0231	289.29	231.64	353	70.18	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10012.4	C08		4	0102-0233	398.28	233.18	267	64.18	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10890.0	C08		4	0103-0237	156.70	237.75	481	90.57	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9675.3	C08		4	0104-0241	555.48	240.85	356	74.91	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10251.5	C08		4	0105-0241	479.61	240.40	254	60.28	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12045.5	C08		4	0106-0245	716.17	245.07	436	77.60	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11161.6	C08		4	0107-0247	327.17	247.13	466	82.43	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15136.2	C08		4	0108-0246	134.48	245.89	176	49.36	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9393.7	C08		4	0109-0253	433.59	253.15	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11024.4	C08		4	0110-0253	587.73	252.99	305	65.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9238.5	C08		4	0111-0256	80.26	256.04	257	61.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10409.5	C08		4	0112-0257	247.39	255.62	261	61.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9357.3	C08		4	0113-0256	364.30	256.01	292	63.94	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10710.8	C08		4	0114-0254	936.70	254.54	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10116.0	C08		4	0115-0257	755.30	256.76	273	62.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8180.0	C08		4	0116-0257	864.11	257.95	306	66.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10263.5	C08		4	0117-0258	384.05	257.99	249	58.28	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9889.3	C08		4	0118-0260	777.97	259.88	263	59.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8511.7	C08		4	0119-0265	223.78	265.45	272	63.94	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8972.6	C08		4	0120-0264	502.47	264.27	314	66.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9675.5	C08		4	0121-0265	114.70	264.56	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9784.9	C08		4	0122-0271	280.71	271.29	271	61.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9671.7	C08		4	0123-0271	834.78	271.50	274	61.01	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8726.4	C08		4	0124-0274	894.80	274.10	305	65.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9059.4	C08		4	0125-0278	522.30	279.48	304	69.01	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8541.2	C08		4	0126-0276	602.65	276.21	294	62.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12244.7	C08		4	0127-0284	128.97	286.07	617	101.40	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10831.9	C08		4	0128-0277	254.08	276.78	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7481.3	C08		4	0129-0286	42.86	285.69	296	64.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8397.8	C08		4	0130-0286	158.65	286.05	218	55.70	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15551.4	C08		4	0131-0288	942.68	288.02	330	69.01	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8350.0	C08		4	0132-0289	406.39	289.20	301	67.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9554.9	C08		4	0133-0289	695.37	289.37	262	62.18	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9923.4	C08		4	0134-0294	340.79	295.23	513	90.91	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9355.9	C08		4	0135-0293	917.77	293.73	271	61.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12563.6	C08		4	0136-0296	250.70	296.90	422	77.84	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10299.4	C08		4	0137-0293	712.56	293.65	264	63.36	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9904.9	C08		4	0138-0294	560.23	293.96	274	64.43	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9215.9	C08		4	0139-0299	471.38	299.56	304	65.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8767.5	C08		4	0140-0301	392.38	301.52	280	64.18	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7506.0	C08		4	0141-0307	13.11	307.38	287	63.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15177.8	C08		4	0142-0306	80.29	306.31	181	50.87	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9992.5	C08		4	0143-0307	523.17	306.77	252	59.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11281.6	C08		4	0144-0306	612.94	307.01	227	54.77	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9104.6	C08		4	0145-0309	816.53	308.49	292	66.77	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9123.7	C08		4	0146-0315	425.75	315.11	295	63.01	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8285.8	C08		4	0147-0319	940.38	319.78	301	64.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8135.7	C08		4	0148-0318	803.67	318.62	290	69.84	0.747
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9992.6	C08		4	0149-0317	849.12	317.73	271	60.18	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16688.6	C08		4	0150-0323	559.21	322.24	321	73.26	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12295.3	C08		4	0151-0321	87.18	321.12	225	56.28	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10042.8	C08		4	0152-0322	452.39	323.15	367	71.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10190.9	C08		4	0153-0327	162.06	328.11	249	59.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10317.7	C08		4	0154-0330	710.27	330.78	319	65.36	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9974.9	C08		4	0155-0328	886.53	328.26	263	60.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9490.6	C08		4	0156-0338	594.01	337.91	595	97.98	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8608.5	C08		4	0157-0337	646.17	337.01	297	63.60	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9250.0	C08		4	0158-0337	116.88	337.20	284	63.36	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9541.1	C08		4	0159-0341	39.77	340.92	273	63.60	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8995.5	C08		4	0160-0341	454.84	340.21	289	67.11	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10253.5	C08		4	0161-0346	304.57	345.75	260	61.36	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9502.9	C08		4	0162-0346	271.11	346.10	266	59.11	0.957
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7636.7	C08		4	0163-0350	752.50	350.43	324	67.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9443.3	C08		4	0164-0350	384.43	350.60	255	57.94	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11188.2	C08		4	0165-0356	74.61	354.29	497	93.74	0.711
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7423.0	C08		4	0166-0357	29.79	358.18	297	66.18	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13948.8	C08		4	0167-0358	176.42	358.89	387	72.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8716.9	C08		4	0168-0359	793.52	358.98	294	63.84	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8714.9	C08		4	0169-0361	514.26	361.31	283	61.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8837.1	C08		4	0170-0360	594.36	360.58	300	66.43	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9066.2	C08		4	0171-0361	685.12	361.13	274	61.11	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7732.3	C08		4	0172-0365	840.24	364.88	336	71.26	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9922.9	C08		4	0173-0368	155.00	368.36	278	62.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9184.0	C08		4	0174-0368	933.68	367.98	277	63.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9324.4	C08		4	0175-0368	547.58	368.08	268	61.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9482.2	C08		4	0176-0373	905.43	372.43	254	62.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7954.8	C08		4	0177-0378	76.68	377.50	293	64.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13500.8	C08		4	0178-0379	403.55	378.78	400	75.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10936.6	C08		4	0179-0381	916.77	381.15	265	65.11	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10191.4	C08		4	0180-0380	783.74	380.76	267	61.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8821.3	C08		4	0181-0381	868.36	381.50	273	62.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9289.3	C08		4	0182-0380	582.62	380.44	267	62.77	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8943.9	C08		4	0183-0387	197.99	387.76	271	62.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9554.8	C08		4	0184-0388	386.37	388.18	276	63.60	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12588.1	C08		4	0185-0393	451.71	392.80	425	77.50	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10463.5	C08		4	0186-0392	327.20	391.44	230	59.01	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7828.8	C08		4	0187-0391	646.40	391.28	327	69.60	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10305.5	C08		4	0188-0393	265.53	394.10	264	71.60	0.647
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10855.8	C08		4	0189-0398	487.40	398.43	243	57.94	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12908.2	C08		4	0190-0407	338.35	406.82	452	79.26	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8224.9	C08		4	0191-0407	428.75	406.70	308	67.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8542.5	C08		4	0192-0406	835.29	405.58	284	63.36	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9142.6	C08		4	0193-0406	219.83	405.82	314	75.01	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12460.1	C08		4	0194-0412	39.19	412.53	379	73.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7927.6	C08		4	0195-0414	718.29	413.31	316	70.67	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8150.6	C08		4	0196-0415	616.94	415.67	305	71.11	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10488.4	C08		4	0197-0418	537.24	418.53	261	60.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9581.2	C08		4	0198-0419	314.66	418.81	257	60.77	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11345.4	C08		4	0199-0423	23.37	424.02	327	68.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8129.8	C08		4	0200-0426	443.84	426.38	435	78.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10358.9	C08		4	0201-0422	497.94	422.24	234	59.94	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10422.3	C08		4	0202-0421	782.63	422.18	227	57.46	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10201.7	C08		4	0203-0428	102.54	428.54	257	59.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12355.9	C08		4	0204-0428	353.63	428.13	233	58.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9347.0	C08		4	0205-0431	175.61	431.06	260	61.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14353.0	C08		4	0206-0436	869.49	435.52	344	69.26	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7999.3	C08		4	0207-0437	399.03	437.24	300	65.84	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9712.0	C08		4	0208-0435	785.70	435.21	299	67.46	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8614.6	C08		4	0209-0442	844.50	442.06	300	68.08	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9302.7	C08		4	0210-0439	899.85	439.43	274	63.94	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8512.1	C08		4	0211-0444	533.74	444.45	275	63.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7581.1	C08		4	0212-0451	210.14	451.51	293	67.01	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10373.5	C08		4	0213-0452	160.79	452.29	236	59.70	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9060.3	C08		4	0214-0454	600.75	454.31	294	65.60	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9491.3	C08		4	0215-0451	736.90	451.79	266	61.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10509.2	C08		4	0216-0454	895.33	454.25	259	61.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7860.9	C08		4	0217-0458	478.62	458.38	287	65.84	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10613.3	C08		4	0218-0461	694.69	460.92	532	86.91	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7784.3	C08		4	0219-0459	44.19	459.42	281	64.43	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8268.1	C08		4	0220-0459	342.19	460.03	284	62.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10684.2	C08		4	0221-0462	933.42	462.17	236	57.70	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9438.6	C08		4	0222-0465	256.68	465.55	257	60.77	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8347.5	C08		4	0223-0471	643.70	471.56	319	67.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8682.7	C08		4	0224-0473	375.99	473.75	283	64.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8393.3	C08		4	0225-0478	95.76	477.80	297	67.94	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7823.5	C08		4	0226-0480	226.39	480.27	289	68.53	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10006.0	C08		4	0227-0482	578.29	482.37	597	107.88	0.645
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8197.4	C08		4	0228-0482	355.23	481.80	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8688.6	C08		4	0229-0483	515.35	483.79	278	63.70	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6968.8	C08		4	0230-0487	464.61	487.29	316	68.67	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10621.5	C08		4	0231-0486	656.31	486.55	381	76.18	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9205.3	C08		4	0232-0489	306.55	488.32	222	57.60	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7814.1	C08		4	0233-0491	261.19	491.53	318	66.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9513.3	C08		4	0234-0492	900.56	491.75	258	62.43	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16034.1	C08		4	0235-0493	119.60	493.37	322	66.43	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7538.3	C08		4	0236-0493	532.25	493.24	329	67.36	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8506.8	C08		4	0237-0496	152.27	496.95	290	63.60	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8615.3	C08		4	0238-0498	496.09	498.57	275	61.36	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10231.9	C08		4	0239-0506	296.91	506.63	510	89.40	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14053.4	C08		4	0240-0503	747.65	501.76	382	82.77	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7121.7	C08		4	0241-0505	190.44	504.87	303	66.43	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9637.8	C08		4	0242-0506	585.31	506.50	368	79.01	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13702.4	C08		4	0243-0506	914.71	505.80	385	72.08	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9572.3	C08		4	0244-0507	75.06	506.49	407	77.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10322.2	C08		4	0245-0508	940.54	508.37	248	59.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9110.6	C08		4	0246-0514	460.98	514.37	282	66.18	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9371.5	C08		4	0247-0515	344.87	515.17	256	58.77	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18569.2	C08		4	0248-0513	752.20	513.18	104	37.56	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8688.5	C08		4	0249-0519	797.87	519.53	305	66.77	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12336.4	C08		4	0250-0523	21.03	522.78	367	71.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9198.6	C08		4	0251-0524	677.56	524.40	267	63.11	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8133.5	C08		4	0252-0525	857.33	525.76	293	63.60	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9333.8	C08		4	0253-0528	605.21	528.13	260	60.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9051.0	C08		4	0254-0530	81.41	530.67	265	59.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8060.8	C08		4	0255-0532	425.71	531.58	294	64.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14743.4	C08		4	0256-0534	143.33	533.49	348	69.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8103.8	C08		4	0257-0536	337.79	536.17	304	64.77	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8788.3	C08		4	0258-0540	705.37	540.44	283	67.60	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8252.5	C08		4	0259-0540	375.55	540.29	282	61.36	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9131.0	C08		4	0260-0542	264.94	543.10	283	64.18	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10629.4	C08		4	0261-0540	769.06	541.00	227	55.70	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15875.1	C08		4	0262-0546	504.88	544.75	144	58.18	0.535
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10508.2	C08		4	0263-0545	786.77	545.17	241	58.28	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9046.3	C08		4	0264-0548	466.92	548.01	289	65.60	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7608.9	C08		4	0265-0551	193.95	551.35	335	75.36	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8752.7	C08		4	0266-0551	210.43	550.77	270	61.70	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11059.4	C08		4	0267-0553	564.18	553.75	284	62.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7480.5	C08		4	0268-0551	918.25	551.13	317	66.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15741.7	C08		4	0269-0550	498.75	550.63	113	46.04	0.670
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6695.5	C08		4	0270-0553	125.79	553.98	155	46.87	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14219.6	C08		4	0271-0563	41.40	563.91	377	82.43	0.697
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7205.1	C08		4	0272-0562	294.63	562.32	316	67.60	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10246.8	C08		4	0273-0561	645.15	561.41	241	61.36	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9821.4	C08		4	0274-0566	848.78	566.92	594	97.40	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9022.8	C08		4	0275-0565	518.57	564.82	266	61.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9006.7	C08		4	0276-0565	593.65	565.42	274	60.77	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8789.7	C08		4	0277-0568	97.71	568.65	271	62.77	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8817.0	C08		4	0278-0566	436.79	566.91	284	68.43	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9354.4	C08		4	0279-0583	385.93	583.07	254	58.53	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8754.0	C08		4	0280-0582	551.56	582.54	274	61.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9407.6	C08		4	0281-0586	588.04	585.62	294	67.60	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7095.3	C08		4	0282-0585	806.99	584.50	330	70.43	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7742.1	C08		4	0283-0588	656.39	587.82	317	68.67	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10813.8	C08		4	0284-0585	915.70	585.09	232	55.94	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10626.3	C08		4	0285-0586	752.14	586.11	259	59.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8695.6	C08		4	0286-0589	453.57	588.43	297	65.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8667.5	C08		4	0287-0596	680.62	596.36	294	65.01	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9168.0	C08		4	0288-0597	370.78	597.13	269	60.87	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9582.7	C08		4	0289-0598	906.51	598.67	284	67.01	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9882.3	C08		4	0290-0602	472.15	602.78	265	62.77	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7813.2	C08		4	0291-0606	407.31	605.77	311	66.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8688.1	C08		4	0292-0610	596.24	611.18	339	74.43	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9799.4	C08		4	0293-0606	124.51	606.33	248	59.11	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6870.0	C08		4	0294-0604	150.87	603.91	160	48.87	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9100.8	C08		4	0295-0608	221.37	608.45	282	67.01	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8686.7	C08		4	0296-0611	107.12	611.29	310	67.60	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13251.5	C08		4	0297-0608	891.26	607.66	201	53.36	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8908.0	C08		4	0298-0617	251.36	617.11	262	63.26	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7892.3	C08		4	0299-0617	546.69	617.58	314	66.18	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8227.2	C08		4	0300-0621	164.67	621.23	270	65.70	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10193.2	C08		4	0301-0617	298.05	616.51	243	57.36	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9450.7	C08		4	0302-0623	508.75	622.51	536	104.13	0.621
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7916.3	C08		4	0303-0621	860.48	620.95	301	66.53	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7810.1	C08		4	0304-0621	89.78	621.50	220	54.18	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9790.0	C08		4	0305-0626	363.21	626.25	240	63.84	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7843.5	C08		4	0306-0623	19.85	623.15	257	57.94	0.962
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8555.1	C08		4	0307-0626	446.30	626.23	296	65.84	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7591.4	C08		4	0308-0628	276.95	627.68	296	65.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8330.1	C08		4	0309-0632	393.23	631.71	281	63.60	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9471.2	C08		4	0310-0629	712.87	629.97	259	61.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9444.6	C08		4	0311-0633	197.52	634.07	279	62.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11121.1	C08		4	0312-0642	488.06	641.33	754	112.47	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9894.7	C08		4	0313-0637	829.47	636.54	263	61.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10755.4	C08		4	0314-0644	345.03	644.26	229	55.70	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8623.6	C08		4	0315-0641	608.85	641.57	282	65.36	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14179.3	C08		4	0316-0647	814.22	647.40	352	70.67	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8038.9	C08		4	0317-0648	411.99	648.90	283	67.84	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8422.7	C08		4	0318-0654	217.20	652.52	594	101.74	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17178.3	C08		4	0319-0647	372.52	646.90	117	54.67	0.492
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16091.0	C08		4	0320-0651	366.21	653.00	129	56.43	0.509
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8821.1	C08		4	0321-0657	751.75	656.75	276	64.77	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9914.3	C08		4	0322-0661	29.53	660.50	527	89.26	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7922.6	C08		4	0323-0658	948.14	657.79	286	63.60	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9480.7	C08		4	0324-0664	526.90	664.58	255	62.53	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9490.9	C08		4	0325-0661	625.34	660.88	249	57.94	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8189.7	C08		4	0326-0664	562.53	664.41	309	68.43	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8925.1	C08		4	0327-0667	784.11	667.20	269	63.36	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7428.5	C08		4	0328-0665	139.16	664.90	285	63.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9246.1	C08		4	0329-0670	586.29	670.21	256	59.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10643.1	C08		4	0330-0670	914.77	670.05	225	54.87	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7945.5	C08		4	0331-0674	415.34	674.71	314	66.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7197.6	C08		4	0332-0677	471.76	677.87	291	65.94	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9123.1	C08		4	0333-0679	539.42	678.57	287	67.36	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8018.5	C08		4	0334-0682	65.29	680.87	252	65.36	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7739.0	C08		4	0335-0683	495.42	683.29	294	66.53	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9566.2	C08		4	0336-0681	348.32	681.31	250	58.18	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9190.3	C08		4	0337-0682	512.00	682.29	273	61.21	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10093.6	C08		4	0338-0685	29.24	685.85	265	61.36	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7259.4	C08		4	0339-0687	261.52	686.48	285	65.36	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10073.8	C08		4	0340-0687	845.32	687.10	233	56.18	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9204.3	C08		4	0341-0692	717.19	692.78	251	61.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12887.7	C08		4	0342-0691	292.89	692.24	199	53.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8473.7	C08		4	0343-0694	754.00	694.29	290	65.60	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8476.6	C08		4	0344-0696	193.12	695.75	276	62.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10511.5	C08		4	0345-0697	54.64	698.43	341	70.43	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11059.5	C08		4	0346-0696	135.31	695.85	323	66.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7511.4	C08		4	0347-0699	793.59	700.20	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9052.6	C08		4	0348-0699	474.12	699.64	273	62.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8540.1	C08		4	0349-0701	733.39	701.49	303	67.36	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6726.3	C08		4	0350-0705	877.22	705.20	108	42.04	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8161.1	C08		4	0351-0707	930.89	707.77	266	65.01	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185029	1375321	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8347.2	C08		4	0352-0710	358.48	709.73	291	63.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7964.7	C08		5	0001-0025	207.22	24.73	281	63.36	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11482.7	C08		5	0002-0023	628.36	23.18	228	56.28	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11501.8	C08		5	0003-0027	757.57	26.69	263	60.43	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9132.9	C08		5	0004-0025	245.80	25.00	263	60.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8763.4	C08		5	0005-0035	174.04	35.25	268	60.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11632.3	C08		5	0006-0036	402.63	35.76	271	61.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9226.4	C08		5	0007-0037	66.40	37.22	253	59.11	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10586.0	C08		5	0008-0039	746.47	39.01	243	59.84	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8810.3	C08		5	0009-0041	937.37	41.10	272	64.18	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10192.1	C08		5	0010-0045	583.63	46.23	377	80.18	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13500.0	C08		5	0011-0041	602.48	40.47	210	54.87	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8820.6	C08		5	0012-0046	510.44	45.61	319	65.01	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11056.1	C08		5	0013-0047	417.06	47.14	262	70.67	0.659
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9759.8	C08		5	0014-0048	325.88	48.14	252	59.70	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11182.0	C08		5	0015-0048	864.11	48.79	362	71.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10416.8	C08		5	0016-0051	538.31	51.75	284	63.94	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9124.6	C08		5	0017-0049	663.18	49.26	245	56.77	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10637.7	C08		5	0018-0051	47.74	51.33	240	58.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10546.1	C08		5	0019-0051	887.77	51.56	252	57.94	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10916.9	C08		5	0020-0056	264.29	55.56	497	91.74	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12147.1	C08		5	0021-0055	482.62	55.53	232	56.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7828.2	C08		5	0022-0063	305.30	62.56	282	66.67	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8008.7	C08		5	0023-0062	186.19	63.10	290	65.60	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12520.6	C08		5	0024-0064	806.78	64.54	201	56.43	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7808.1	C08		5	0025-0067	26.26	66.14	274	64.43	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9916.5	C08		5	0026-0066	117.58	65.66	227	59.60	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8215.3	C08		5	0027-0071	231.30	71.55	281	65.60	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9694.8	C08		5	0028-0071	753.60	71.94	276	61.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9904.2	C08		5	0029-0072	559.09	72.36	265	60.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8750.6	C08		5	0030-0076	379.29	75.97	313	67.01	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9858.9	C08		5	0031-0080	123.83	80.49	366	76.18	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8628.3	C08		5	0032-0075	165.25	74.41	288	65.70	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9895.2	C08		5	0033-0078	613.99	77.76	256	58.53	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9229.3	C08		5	0034-0079	923.97	79.38	259	59.70	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8593.6	C08		5	0035-0081	60.39	81.99	265	64.18	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8904.3	C08		5	0036-0084	505.04	84.26	310	65.94	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7856.8	C08		5	0037-0090	693.12	90.15	316	68.18	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9138.1	C08		5	0038-0088	724.22	87.61	299	63.60	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10448.8	C08		5	0039-0087	254.08	87.36	238	58.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9714.5	C08		5	0040-0089	87.63	89.57	252	58.53	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7388.7	C08		5	0041-0090	184.69	90.96	419	81.26	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11367.2	C08		5	0042-0094	281.23	94.20	346	70.18	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9421.0	C08		5	0043-0093	162.46	93.63	217	59.70	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8165.2	C08		5	0044-0097	316.17	98.03	272	60.77	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8038.2	C08		5	0045-0105	858.99	106.45	309	76.77	0.659
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6959.8	C08		5	0046-0101	651.89	101.10	345	69.84	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9170.5	C08		5	0047-0102	503.46	101.78	273	62.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8062.7	C08		5	0048-0105	894.66	104.84	302	69.84	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9684.4	C08		5	0049-0105	342.24	105.07	235	55.94	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8867.3	C08		5	0050-0107	788.00	107.40	286	64.77	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7971.2	C08		5	0051-0109	47.58	108.98	289	62.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15703.8	C08		5	0052-0108	208.12	107.97	321	66.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10236.6	C08		5	0053-0109	829.80	108.41	263	60.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11672.4	C08		5	0054-0110	550.61	109.80	235	57.46	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8169.9	C08		5	0055-0114	939.47	113.65	286	65.94	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11809.9	C08		5	0056-0114	535.56	114.61	220	58.18	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9921.9	C08		5	0057-0115	814.85	115.25	248	61.60	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7965.1	C08		5	0058-0116	125.20	116.96	275	64.67	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10076.3	C08		5	0059-0116	583.58	116.19	253	57.94	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10109.8	C08		5	0060-0117	451.18	117.39	235	63.01	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9939.4	C08		5	0061-0130	293.94	130.74	532	96.57	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13682.5	C08		5	0062-0127	763.95	126.43	390	74.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8216.2	C08		5	0063-0129	241.70	129.15	279	63.01	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8242.6	C08		5	0064-0128	945.76	129.18	307	67.60	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9511.0	C08		5	0065-0130	709.15	129.47	285	63.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7497.2	C08		5	0066-0132	205.96	132.26	302	67.01	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7824.4	C08		5	0067-0131	83.68	131.34	282	64.77	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11462.9	C08		5	0068-0132	462.85	132.67	223	56.63	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7374.5	C08		5	0069-0142	511.66	141.97	346	70.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9713.3	C08		5	0070-0142	779.76	142.04	281	64.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7748.9	C08		5	0071-0146	124.86	145.69	304	69.01	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9663.0	C08		5	0072-0147	401.83	145.94	226	60.53	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9518.0	C08		5	0073-0149	538.49	149.60	263	65.01	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8607.1	C08		5	0074-0148	704.63	148.28	295	65.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10767.3	C08		5	0075-0148	826.93	148.52	278	62.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8831.4	C08		5	0076-0150	644.94	149.72	309	65.36	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12151.9	C08		5	0077-0148	467.80	148.00	227	55.70	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9402.7	C08		5	0078-0154	206.08	154.12	273	60.77	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11540.1	C08		5	0079-0155	564.25	155.96	469	80.08	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8745.8	C08		5	0080-0153	71.19	152.62	267	62.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9272.9	C08		5	0081-0156	224.25	156.24	260	59.70	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8189.0	C08		5	0082-0159	918.75	158.85	309	71.36	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8794.7	C08		5	0083-0161	670.33	161.54	283	65.26	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12030.5	C08		5	0084-0159	901.80	159.44	190	52.28	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11194.2	C08		5	0085-0161	411.74	160.23	259	61.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9241.5	C08		5	0086-0164	12.84	165.13	248	57.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10470.7	C08		5	0087-0167	149.27	167.38	232	56.18	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10046.1	C08		5	0088-0168	837.22	167.15	248	61.94	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7598.2	C08		5	0089-0175	34.74	175.89	304	70.77	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8862.1	C08		5	0090-0176	348.13	175.84	308	67.60	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11892.1	C08		5	0091-0176	595.11	176.03	445	77.26	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9377.9	C08		5	0092-0177	174.77	177.75	256	58.18	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8847.6	C08		5	0093-0179	752.26	178.85	297	65.60	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10357.0	C08		5	0094-0182	139.86	182.31	239	57.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9738.5	C08		5	0095-0179	480.19	178.89	257	60.53	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10054.1	C08		5	0096-0180	773.20	180.22	253	59.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10218.4	C08		5	0097-0178	819.77	178.06	127	42.97	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10065.8	C08		5	0098-0181	830.53	181.19	108	38.39	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8267.5	C08		5	0099-0189	195.63	189.09	273	62.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10039.4	C08		5	0100-0194	94.39	194.00	361	74.43	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10181.9	C08		5	0101-0192	356.51	192.32	250	61.60	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7964.7	C08		5	0102-0193	111.20	192.63	270	61.70	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12423.9	C08		5	0103-0196	316.62	195.93	423	74.43	0.960
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14384.9	C08		5	0104-0192	277.15	191.83	127	62.43	0.410
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8263.0	C08		5	0105-0197	255.39	196.94	291	65.11	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9571.2	C08		5	0106-0199	238.00	199.22	270	60.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8452.9	C08		5	0107-0197	755.16	197.21	333	73.84	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9938.7	C08		5	0108-0203	377.95	202.93	389	73.84	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11838.8	C08		5	0109-0202	729.24	202.66	282	62.28	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9223.8	C08		5	0110-0205	15.79	205.08	242	62.53	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8269.0	C08		5	0111-0201	152.68	200.91	278	65.11	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12167.3	C08		5	0112-0213	531.46	212.95	638	109.64	0.667
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9058.6	C08		5	0113-0208	451.28	209.15	386	77.60	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10300.4	C08		5	0114-0207	707.83	207.15	275	61.70	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9517.4	C08		5	0115-0208	417.03	208.07	264	60.77	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14949.7	C08		5	0116-0212	806.62	212.34	352	71.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11041.5	C08		5	0117-0213	468.08	213.85	235	59.11	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7922.2	C08		5	0118-0215	79.24	215.03	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10088.3	C08		5	0119-0216	916.03	216.05	260	60.18	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9886.5	C08		5	0120-0216	754.19	217.04	271	60.53	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9663.2	C08		5	0121-0220	861.49	220.57	261	61.46	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11513.3	C08		5	0122-0220	846.92	220.50	226	56.53	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10629.1	C08		5	0123-0220	155.45	219.99	235	58.53	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11696.2	C08		5	0124-0227	305.10	227.85	461	79.84	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11031.5	C08		5	0125-0230	209.14	229.56	465	82.18	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11873.8	C08		5	0126-0228	629.67	228.20	214	54.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7243.9	C08		5	0127-0234	566.31	234.22	319	71.60	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13540.1	C08		5	0128-0234	179.64	233.99	323	67.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10826.7	C08		5	0129-0235	160.19	235.37	256	64.18	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11764.4	C08		5	0130-0236	282.88	236.18	299	64.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11723.1	C08		5	0131-0236	649.81	235.52	223	55.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9351.1	C08		5	0132-0237	120.78	237.25	243	58.18	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10383.2	C08		5	0133-0245	368.24	245.87	246	57.60	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8318.2	C08		5	0134-0246	583.97	245.73	309	67.70	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9585.3	C08		5	0135-0246	746.79	246.21	272	67.01	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10776.8	C08		5	0136-0251	154.83	251.42	213	57.36	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9967.8	C08		5	0137-0257	41.66	256.83	302	66.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9721.6	C08		5	0138-0261	915.84	261.05	264	62.77	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9384.1	C08		5	0139-0268	672.13	267.50	285	65.01	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7355.4	C08		5	0140-0270	701.57	270.34	435	77.26	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8715.7	C08		5	0141-0268	165.69	268.34	279	64.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11170.2	C08		5	0142-0271	272.79	270.58	228	59.01	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8526.0	C08		5	0143-0272	781.36	271.85	315	68.18	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11057.2	C08		5	0144-0274	218.26	274.24	234	58.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9743.8	C08		5	0145-0274	336.63	274.33	263	61.36	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15172.5	C08		5	0146-0275	403.63	274.97	100	53.94	0.432
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9329.1	C08		5	0147-0277	614.54	277.62	293	63.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9328.5	C08		5	0148-0282	637.91	282.17	280	62.18	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12514.9	C08		5	0149-0285	826.66	284.99	417	75.84	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10965.8	C08		5	0150-0283	727.36	283.45	236	57.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10795.5	C08		5	0151-0284	368.25	284.96	238	57.36	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8220.4	C08		5	0152-0286	122.52	286.93	271	62.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8053.4	C08		5	0153-0288	523.62	287.86	321	69.26	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14374.0	C08		5	0154-0290	47.31	290.37	349	69.01	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8133.3	C08		5	0155-0288	145.49	288.97	279	64.43	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8422.2	C08		5	0156-0293	892.36	293.38	289	65.60	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8962.1	C08		5	0157-0292	100.14	291.43	254	61.94	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10878.0	C08		5	0158-0290	326.27	290.42	232	60.18	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9410.9	C08		5	0159-0294	83.86	294.02	274	62.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7506.9	C08		5	0160-0293	484.95	293.15	340	72.18	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8920.3	C08		5	0161-0296	22.78	295.96	261	59.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9695.6	C08		5	0162-0297	451.94	296.90	263	62.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14066.5	C08		5	0163-0298	240.29	298.78	366	71.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16276.5	C08		5	0164-0302	652.45	303.48	138	61.94	0.452
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9060.4	C08		5	0165-0304	280.60	304.06	270	61.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7917.8	C08		5	0166-0305	217.05	305.63	289	63.84	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6980.5	C08		5	0167-0307	930.59	307.42	323	67.01	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9509.1	C08		5	0168-0310	729.44	309.48	269	62.18	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8617.3	C08		5	0169-0312	158.18	312.84	271	59.94	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8215.3	C08		5	0170-0316	189.03	316.58	267	63.36	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9650.2	C08		5	0171-0316	69.13	316.27	257	58.53	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9175.9	C08		5	0172-0318	89.27	318.53	265	59.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8670.1	C08		5	0173-0317	799.68	316.63	286	63.60	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7978.7	C08		5	0174-0321	45.21	322.00	284	63.36	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10317.9	C08		5	0175-0320	845.17	320.63	253	58.18	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9036.9	C08		5	0176-0320	136.44	320.06	267	61.70	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9052.8	C08		5	0177-0322	397.22	323.48	278	62.87	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11901.6	C08		5	0178-0322	870.34	322.03	266	60.18	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13319.0	C08		5	0179-0331	461.27	330.50	403	123.30	0.333
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9695.9	C08		5	0180-0327	348.68	327.24	254	59.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9069.9	C08		5	0181-0336	635.50	336.28	311	67.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9584.5	C08		5	0182-0339	704.62	340.13	296	69.01	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13929.9	C08		5	0183-0339	450.08	339.58	202	57.36	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11406.6	C08		5	0184-0341	684.57	341.42	259	59.11	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9186.1	C08		5	0185-0342	157.89	341.75	248	58.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10654.2	C08		5	0186-0341	401.12	341.19	280	63.11	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8922.4	C08		5	0187-0342	227.55	343.12	260	58.53	0.954
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9183.7	C08		5	0188-0349	287.08	348.91	530	90.08	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7940.4	C08		5	0189-0348	528.05	348.36	309	64.77	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13271.9	C08		5	0190-0349	862.51	349.51	310	65.70	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8435.7	C08		5	0191-0350	111.55	349.91	286	63.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8784.5	C08		5	0192-0351	185.97	351.54	249	59.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10996.0	C08		5	0193-0351	484.60	351.12	260	59.46	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9618.3	C08		5	0194-0351	626.22	351.50	270	60.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8795.1	C08		5	0195-0355	259.67	355.61	272	62.43	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11701.9	C08		5	0196-0355	379.09	355.60	217	55.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8548.6	C08		5	0197-0357	925.07	357.27	292	67.01	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9846.8	C08		5	0198-0359	132.19	358.49	242	57.36	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12542.9	C08		5	0199-0358	402.98	357.83	219	56.53	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8259.2	C08		5	0200-0360	231.80	360.52	300	66.53	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7506.0	C08		5	0201-0363	330.82	363.80	293	67.84	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14328.5	C08		5	0202-0362	570.58	361.86	347	68.43	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9099.2	C08		5	0203-0363	801.77	362.94	302	65.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10421.2	C08		5	0204-0362	692.19	362.38	273	62.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9609.0	C08		5	0205-0362	455.04	362.52	265	59.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12711.0	C08		5	0206-0367	753.07	367.37	195	53.70	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8418.6	C08		5	0207-0370	250.40	370.10	267	60.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10354.3	C08		5	0208-0367	489.65	367.26	252	61.70	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8637.5	C08		5	0209-0370	38.62	370.24	269	61.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7918.2	C08		5	0210-0371	65.11	370.95	267	63.60	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9696.9	C08		5	0211-0379	16.47	379.21	528	92.33	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14433.6	C08		5	0212-0374	897.56	373.81	358	70.43	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12050.2	C08		5	0213-0374	392.69	373.41	227	57.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10547.0	C08		5	0214-0372	607.12	372.07	244	59.70	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10246.2	C08		5	0215-0377	715.45	377.60	258	60.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8760.7	C08		5	0216-0380	170.63	380.29	261	60.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8791.8	C08		5	0217-0380	79.57	380.62	269	65.94	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10965.7	C08		5	0218-0380	826.62	380.14	234	67.94	0.637
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9931.8	C08		5	0219-0385	845.60	385.45	276	64.77	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8814.1	C08		5	0220-0393	409.82	393.55	669	106.13	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13509.4	C08		5	0221-0388	931.71	388.88	307	65.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9150.6	C08		5	0222-0389	620.66	388.59	300	65.94	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8382.1	C08		5	0223-0391	280.28	391.24	286	63.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11404.8	C08		5	0224-0394	742.34	394.65	218	56.28	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13058.6	C08		5	0225-0397	576.47	397.02	193	53.11	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11124.1	C08		5	0226-0408	234.72	408.22	478	85.98	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10306.8	C08		5	0227-0401	128.22	400.74	230	57.70	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10050.6	C08		5	0228-0403	640.40	402.75	245	59.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10903.4	C08		5	0229-0402	674.17	402.64	236	56.87	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9741.7	C08		5	0230-0407	256.61	407.32	259	58.53	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8494.6	C08		5	0231-0408	197.58	408.15	263	62.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9365.6	C08		5	0232-0408	809.21	408.51	286	65.11	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10790.1	C08		5	0233-0413	653.05	413.47	257	58.53	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10182.5	C08		5	0234-0413	121.53	413.71	248	60.53	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8753.1	C08		5	0235-0415	880.15	415.33	325	70.18	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9022.4	C08		5	0236-0415	332.75	415.60	283	61.36	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9725.6	C08		5	0237-0420	699.61	420.50	272	61.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12000.8	C08		5	0238-0421	179.91	421.12	203	53.36	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19791.0	C08		5	0239-0422	547.27	421.79	185	51.94	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10699.4	C08		5	0240-0423	604.43	422.81	241	56.53	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8287.8	C08		5	0241-0425	750.67	425.26	311	67.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7176.1	C08		5	0242-0428	861.17	428.79	347	72.43	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8402.7	C08		5	0243-0429	357.07	429.49	449	79.01	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9569.5	C08		5	0244-0427	425.56	426.68	266	62.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9084.0	C08		5	0245-0428	813.06	427.42	298	67.36	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14947.1	C08		5	0246-0429	910.70	428.36	341	67.60	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10681.7	C08		5	0247-0432	534.22	431.66	315	71.01	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9191.3	C08		5	0248-0432	446.12	431.85	275	61.36	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8883.6	C08		5	0249-0435	62.73	435.07	267	60.53	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11922.5	C08		5	0250-0437	691.92	437.49	220	55.11	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10738.7	C08		5	0251-0441	127.60	441.77	461	86.33	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9619.9	C08		5	0252-0442	555.58	441.73	334	74.43	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9283.4	C08		5	0253-0442	168.94	442.03	258	60.87	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10052.2	C08		5	0254-0445	236.30	444.92	500	88.91	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8570.7	C08		5	0255-0445	612.34	445.07	298	64.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8553.2	C08		5	0256-0447	719.95	447.96	315	72.43	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9302.9	C08		5	0257-0445	380.07	445.62	201	53.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7916.8	C08		5	0258-0449	909.18	450.90	311	69.84	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7696.1	C08		5	0259-0453	469.88	453.62	288	63.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9162.4	C08		5	0260-0452	66.84	451.78	252	60.18	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9208.6	C08		5	0261-0456	201.00	456.33	242	58.53	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16494.7	C08		5	0262-0458	181.80	458.11	142	57.01	0.549
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11104.5	C08		5	0263-0464	794.80	464.01	517	83.26	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10632.2	C08		5	0264-0460	504.68	460.60	232	55.36	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8190.6	C08		5	0265-0463	416.40	463.13	287	63.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11620.1	C08		5	0266-0463	661.43	462.91	449	82.43	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9003.1	C08		5	0267-0465	556.12	465.52	281	61.84	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9916.7	C08		5	0268-0464	38.15	464.42	234	57.11	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9263.8	C08		5	0269-0468	577.43	468.57	287	61.94	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11679.0	C08		5	0270-0473	300.85	472.61	357	71.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9964.1	C08		5	0271-0468	741.95	468.06	257	59.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8922.9	C08		5	0272-0472	885.89	472.06	331	67.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8886.9	C08		5	0273-0473	402.60	473.38	290	65.26	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7727.7	C08		5	0274-0479	229.15	479.36	269	63.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11239.0	C08		5	0275-0484	122.14	484.11	446	81.01	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10150.9	C08		5	0276-0489	271.42	487.98	509	94.57	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9407.9	C08		5	0277-0482	846.77	481.46	271	61.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7915.7	C08		5	0278-0484	334.88	483.78	279	63.36	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9895.7	C08		5	0279-0495	616.96	495.63	262	61.60	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9539.8	C08		5	0280-0493	792.78	494.13	275	65.60	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10563.0	C08		5	0281-0496	452.03	495.40	259	59.36	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10706.7	C08		5	0282-0497	717.65	497.06	232	59.36	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10523.7	C08		5	0283-0501	197.27	500.70	468	85.74	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8779.6	C08		5	0284-0499	473.75	499.76	257	61.94	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8372.6	C08		5	0285-0501	96.90	501.47	294	65.01	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10065.9	C08		5	0286-0501	901.81	501.38	250	58.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8146.4	C08		5	0287-0502	370.13	501.78	271	62.77	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10439.5	C08		5	0288-0503	936.65	503.74	242	57.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10141.9	C08		5	0289-0504	493.62	504.39	252	59.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9867.1	C08		5	0290-0506	631.65	505.45	265	64.18	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12773.1	C08		5	0291-0507	19.27	507.99	386	74.33	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10068.5	C08		5	0292-0509	249.77	508.81	512	95.40	0.707
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8875.2	C08		5	0293-0509	557.64	509.71	257	65.01	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10552.6	C08		5	0294-0511	442.12	511.25	301	66.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9637.6	C08		5	0295-0510	45.20	510.71	245	58.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7581.0	C08		5	0296-0513	334.12	513.95	289	62.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9247.5	C08		5	0297-0514	286.74	514.68	251	57.94	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6926.5	C08		5	0298-0515	832.59	515.15	339	71.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14140.6	C08		5	0299-0515	468.55	515.56	195	53.70	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10465.7	C08		5	0300-0519	138.33	518.67	241	59.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9806.4	C08		5	0301-0519	526.25	519.51	272	60.53	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8121.9	C08		5	0302-0520	92.26	520.68	300	70.18	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10931.3	C08		5	0303-0523	624.45	523.58	297	65.01	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9225.7	C08		5	0304-0525	394.75	525.32	283	66.43	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9059.1	C08		5	0305-0528	769.98	528.55	280	67.50	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8376.2	C08		5	0306-0532	425.08	531.78	268	63.11	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7838.3	C08		5	0307-0533	151.14	533.56	258	63.01	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16304.7	C08		5	0308-0534	197.35	533.64	319	73.84	0.735
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8835.8	C08		5	0309-0539	534.98	538.32	273	65.60	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11927.8	C08		5	0310-0537	607.50	537.37	220	54.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7454.0	C08		5	0311-0541	382.06	542.72	366	75.01	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7842.2	C08		5	0312-0541	832.18	541.50	310	67.36	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14052.7	C08		5	0313-0543	470.35	543.09	177	48.53	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10468.9	C08		5	0314-0551	946.10	550.58	385	77.36	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10487.4	C08		5	0315-0546	321.13	546.71	242	57.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10578.3	C08		5	0316-0548	678.45	548.70	313	65.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9297.5	C08		5	0317-0546	741.53	546.09	268	60.18	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8540.1	C08		5	0318-0551	553.24	551.57	308	68.43	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7687.3	C08		5	0319-0551	99.70	551.78	270	60.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6830.6	C08		5	0320-0553	231.82	553.69	305	70.08	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7076.3	C08		5	0321-0553	22.92	553.49	287	63.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8428.9	C08		5	0322-0559	495.91	559.76	300	70.28	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8739.6	C08		5	0323-0559	389.91	558.86	287	63.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7624.6	C08		5	0324-0559	821.93	559.31	314	67.36	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9777.6	C08		5	0325-0559	248.37	560.21	257	63.36	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9399.1	C08		5	0326-0562	168.02	561.67	248	62.77	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9568.3	C08		5	0327-0564	702.70	564.62	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8687.9	C08		5	0328-0567	510.91	566.78	301	69.11	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10657.6	C08		5	0329-0564	315.06	563.80	239	59.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10240.7	C08		5	0330-0566	736.12	565.92	242	57.36	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8126.4	C08		5	0331-0569	150.59	569.48	302	65.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12676.3	C08		5	0332-0567	677.72	567.46	254	60.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7624.9	C08		5	0333-0571	274.35	571.63	273	66.67	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10838.6	C08		5	0334-0576	918.32	576.50	354	70.18	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9608.0	C08		5	0335-0575	342.32	575.76	263	64.28	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12844.2	C08		5	0336-0577	429.97	576.35	383	73.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9160.0	C08		5	0337-0578	632.34	578.02	292	65.94	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6803.2	C08		5	0338-0575	859.79	575.79	290	71.36	0.716
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10351.9	C08		5	0339-0580	67.90	580.53	477	87.74	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10239.6	C08		5	0340-0581	898.80	581.22	331	68.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8873.9	C08		5	0341-0583	574.86	583.16	299	66.77	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9170.0	C08		5	0342-0579	91.81	578.80	240	58.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9178.6	C08		5	0343-0582	313.75	583.24	272	64.28	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11203.5	C08		5	0344-0581	391.81	581.10	270	60.18	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11368.3	C08		5	0345-0581	716.10	581.79	223	55.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9514.5	C08		5	0346-0582	362.15	581.71	266	62.28	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8168.3	C08		5	0347-0580	790.21	579.80	287	68.53	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9900.2	C08		5	0348-0584	229.14	583.82	241	58.28	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10166.5	C08		5	0349-0587	20.24	587.47	224	55.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8073.6	C08		5	0350-0596	595.37	596.05	322	69.84	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8169.6	C08		5	0351-0600	354.65	600.31	282	62.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9046.2	C08		5	0352-0608	474.80	606.92	607	102.57	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7814.6	C08		5	0353-0601	167.12	600.87	304	66.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9603.9	C08		5	0354-0609	148.91	609.45	253	61.11	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8358.2	C08		5	0355-0610	719.24	610.32	321	66.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8042.4	C08		5	0356-0610	533.40	608.97	311	69.26	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9892.6	C08		5	0357-0610	187.17	610.71	253	59.70	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8836.8	C08		5	0358-0611	258.04	611.58	267	61.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8871.6	C08		5	0359-0613	805.81	613.19	270	61.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7198.3	C08		5	0360-0613	940.84	612.97	258	63.01	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8002.3	C08		5	0361-0617	413.46	616.96	307	68.08	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10592.6	C08		5	0362-0616	61.84	615.87	222	55.11	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8509.0	C08		5	0363-0614	320.99	615.05	262	61.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7750.3	C08		5	0364-0616	295.85	616.52	265	59.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8130.2	C08		5	0365-0619	385.46	618.83	296	65.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8749.0	C08		5	0366-0620	207.44	620.08	266	60.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12060.7	C08		5	0367-0623	671.13	622.99	256	59.36	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10095.7	C08		5	0368-0624	137.19	624.25	240	57.70	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8166.7	C08		5	0369-0629	444.51	629.51	296	65.94	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9458.7	C08		5	0370-0629	186.09	628.77	271	62.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8731.5	C08		5	0371-0634	897.40	633.89	524	91.64	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9077.5	C08		5	0372-0633	864.86	633.43	286	63.60	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7864.1	C08		5	0373-0634	497.57	633.42	289	62.53	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7733.9	C08		5	0374-0647	794.04	647.11	321	69.50	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10795.3	C08		5	0375-0647	539.38	647.38	241	57.70	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11536.9	C08		5	0376-0649	154.97	648.54	220	54.53	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12077.4	C08		5	0377-0647	646.40	647.40	204	53.11	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9147.0	C08		5	0378-0651	195.60	651.23	248	57.70	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7872.5	C08		5	0379-0652	247.90	652.79	293	63.94	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7841.1	C08		5	0380-0650	817.91	650.42	277	63.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7149.9	C08		5	0381-0648	335.51	648.81	154	48.63	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10135.8	C08		5	0382-0654	433.37	654.60	247	57.94	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12786.2	C08		5	0383-0655	686.50	654.73	395	73.84	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8881.9	C08		5	0384-0656	555.80	656.01	283	64.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7879.8	C08		5	0385-0660	52.60	659.90	289	62.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7317.7	C08		5	0386-0661	313.70	661.95	212	55.70	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11870.1	C08		5	0387-0662	629.58	661.88	213	56.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8453.9	C08		5	0388-0664	337.75	662.55	268	63.01	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8116.3	C08		5	0389-0668	589.42	667.54	275	63.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9964.3	C08		5	0390-0666	147.08	666.75	252	61.60	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9415.0	C08		5	0391-0666	671.76	667.21	262	63.01	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8083.5	C08		5	0392-0669	739.67	669.43	297	65.01	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8178.2	C08		5	0393-0679	330.09	679.10	404	84.57	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9976.6	C08		5	0394-0672	19.02	672.27	225	57.94	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11794.7	C08		5	0395-0674	160.45	674.70	206	54.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7060.6	C08		5	0396-0676	930.18	676.57	245	64.18	0.747
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11765.3	C08		5	0397-0683	405.39	682.87	637	109.54	0.667
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8225.0	C08		5	0398-0675	547.03	675.66	282	63.94	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7500.6	C08		5	0399-0678	284.16	677.62	271	60.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11617.4	C08		5	0400-0680	625.14	680.18	214	55.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8293.4	C08		5	0401-0684	804.27	684.54	262	59.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9645.5	C08		5	0402-0687	751.15	687.58	259	61.94	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6187.3	C08		5	0403-0688	348.96	687.26	159	58.43	0.585
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8330.1	C08		5	0404-0688	897.14	688.21	252	60.77	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11506.4	C08		5	0405-0691	869.78	690.90	275	78.67	0.558
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10060.5	C08		5	0406-0690	205.49	690.05	230	56.53	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10724.7	C08		5	0407-0690	683.30	690.68	230	56.77	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10491.8	C08		5	0408-0693	612.16	693.49	247	58.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8298.0	C08		5	0409-0706	467.36	706.23	279	61.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8959.2	C08		5	0410-0706	549.06	706.22	255	59.01	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8284.1	C08		5	0411-0709	35.80	710.01	288	66.77	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9651.2	C08		5	0412-0708	182.19	708.34	229	56.53	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8334.7	C08		5	0413-0709	233.40	709.62	261	59.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185030	1375322	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7498.2	C08		5	0414-0710	56.38	709.78	280	65.94	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8759.1	C08		6	0001-0023	416.28	23.63	327	71.01	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9790.9	C08		6	0002-0027	676.92	26.76	287	65.94	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10571.2	C08		6	0003-0027	227.08	26.02	257	69.60	0.667
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11239.6	C08		6	0004-0031	617.58	31.04	275	63.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12554.4	C08		6	0005-0028	846.42	28.00	237	59.94	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9116.7	C08		6	0006-0034	941.60	33.31	301	65.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8446.5	C08		6	0007-0035	54.36	34.91	270	63.70	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9017.5	C08		6	0008-0036	331.47	37.01	311	69.36	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10105.1	C08		6	0009-0047	440.88	47.58	646	109.88	0.672
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13957.2	C08		6	0010-0041	515.00	41.24	407	74.08	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8475.8	C08		6	0011-0044	31.94	44.26	257	62.77	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6808.5	C08		6	0012-0042	91.51	42.05	298	65.26	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9452.5	C08		6	0013-0043	788.36	43.35	291	63.11	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10370.7	C08		6	0014-0043	641.23	43.00	272	64.53	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15511.5	C08		6	0015-0043	838.81	43.77	348	70.77	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13130.5	C08		6	0016-0048	351.26	47.98	345	68.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9331.2	C08		6	0017-0050	557.36	49.98	316	65.84	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9704.0	C08		6	0018-0056	256.61	56.18	262	60.53	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13247.6	C08		6	0019-0060	857.26	60.45	424	84.91	0.739
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12835.6	C08		6	0020-0058	283.61	58.25	216	55.60	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13386.5	C08		6	0021-0057	302.72	56.67	194	53.11	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10163.1	C08		6	0022-0056	466.92	56.20	294	66.18	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9469.1	C08		6	0023-0058	170.81	57.00	285	73.84	0.657
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10908.3	C08		6	0024-0060	224.81	58.82	486	99.40	0.618
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10775.3	C08		6	0025-0071	610.72	70.65	290	64.53	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8875.3	C08		6	0026-0071	707.96	71.26	316	65.94	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9360.0	C08		6	0027-0070	53.10	70.92	267	65.60	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9218.5	C08		6	0028-0075	520.80	74.96	302	64.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9563.8	C08		6	0029-0075	161.24	74.69	204	55.94	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16146.9	C08		6	0030-0081	905.91	81.12	542	88.57	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10274.7	C08		6	0031-0077	134.01	77.10	233	58.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8731.1	C08		6	0032-0082	18.69	82.46	248	60.18	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7751.2	C08		6	0033-0086	284.39	86.76	297	64.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10312.4	C08		6	0034-0086	173.60	86.45	261	65.36	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12266.0	C08		6	0035-0090	927.11	89.89	390	78.18	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13599.8	C08		6	0036-0092	722.25	92.38	341	69.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7154.8	C08		6	0037-0095	346.33	95.23	319	67.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9275.4	C08		6	0038-0098	391.71	98.21	293	65.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17230.6	C08		6	0039-0096	766.53	96.92	175	49.46	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10248.2	C08		6	0040-0101	64.36	100.97	241	64.28	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10319.2	C08		6	0041-0101	96.92	101.23	221	56.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10127.4	C08		6	0042-0104	835.92	104.70	279	63.60	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11038.2	C08		6	0043-0106	601.66	106.72	274	63.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12187.7	C08		6	0044-0104	916.53	104.14	224	58.18	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9402.7	C08		6	0045-0106	799.62	106.51	315	68.77	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8168.4	C08		6	0046-0108	535.89	108.15	327	66.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10836.5	C08		6	0047-0111	651.77	112.71	282	62.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8016.0	C08		6	0048-0117	34.30	117.20	284	65.60	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11166.9	C08		6	0049-0115	577.40	115.08	245	58.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14834.9	C08		6	0050-0120	617.95	120.33	382	73.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7347.5	C08		6	0051-0118	135.04	118.42	287	70.18	0.732
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9769.0	C08		6	0052-0121	491.85	120.78	273	62.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13731.6	C08		6	0053-0119	376.22	120.22	193	50.87	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10197.0	C08		6	0054-0123	462.38	123.29	262	58.77	0.953
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12285.6	C08		6	0055-0125	853.84	124.76	210	57.60	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9816.1	C08		6	0056-0126	235.33	125.45	140	50.53	0.689
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10663.2	C08		6	0057-0128	680.24	129.14	265	60.18	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10875.5	C08		6	0058-0127	904.54	127.02	257	59.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8075.4	C08		6	0059-0131	40.69	132.16	280	65.60	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8961.7	C08		6	0060-0135	423.61	135.31	289	63.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10684.3	C08		6	0061-0133	716.97	133.81	268	63.70	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13210.6	C08		6	0062-0135	377.72	135.14	202	53.46	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10025.0	C08		6	0063-0142	340.72	141.79	264	63.01	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12125.0	C08		6	0064-0142	817.92	142.04	234	58.43	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9425.4	C08		6	0065-0144	514.97	144.61	291	63.36	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10982.8	C08		6	0066-0144	251.74	145.29	181	56.53	0.712
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11389.4	C08		6	0067-0144	594.22	144.32	242	58.53	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7267.4	C08		6	0068-0147	159.52	146.71	303	67.01	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12810.7	C08		6	0069-0150	764.60	150.14	234	56.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10554.4	C08		6	0070-0158	303.10	158.52	238	57.70	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13283.2	C08		6	0071-0157	888.64	157.38	362	71.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12591.0	C08		6	0072-0157	825.04	157.14	224	57.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13498.8	C08		6	0073-0163	537.54	161.94	332	68.77	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14522.3	C08		6	0074-0157	588.91	158.29	128	42.39	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10983.3	C08		6	0075-0161	614.35	161.31	263	60.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11921.9	C08		6	0076-0162	747.17	161.79	249	58.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12882.3	C08		6	0077-0163	676.84	163.38	424	77.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9745.0	C08		6	0078-0166	166.00	166.54	242	59.11	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11963.7	C08		6	0079-0166	400.03	166.05	225	57.70	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9407.7	C08		6	0080-0169	487.03	168.76	277	62.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7426.4	C08		6	0081-0171	109.83	171.44	282	64.77	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14518.0	C08		6	0082-0172	591.26	172.29	241	63.70	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9324.5	C08		6	0083-0182	835.67	182.33	328	69.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8348.2	C08		6	0084-0184	172.45	184.33	281	65.94	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15114.6	C08		6	0085-0186	705.00	185.93	345	68.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9918.3	C08		6	0086-0187	75.88	187.63	216	56.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9830.1	C08		6	0087-0187	859.67	187.16	303	68.43	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9018.9	C08		6	0088-0188	60.61	188.80	270	61.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15189.3	C08		6	0089-0187	803.04	186.83	178	60.18	0.618
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8748.7	C08		6	0090-0191	672.91	190.78	309	70.18	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10943.8	C08		6	0091-0193	940.32	193.32	259	59.70	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9763.3	C08		6	0092-0198	822.87	198.48	341	74.67	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9208.6	C08		6	0093-0203	625.45	203.38	295	65.84	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11183.5	C08		6	0094-0202	909.82	202.56	250	58.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17192.8	C08		6	0095-0201	807.76	202.00	102	63.01	0.323
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7106.9	C08		6	0096-0206	129.34	206.23	298	64.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9758.3	C08		6	0097-0209	397.85	209.34	257	61.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11537.4	C08		6	0098-0211	432.42	211.02	231	61.11	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10543.5	C08		6	0099-0210	500.04	211.04	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9247.6	C08		6	0100-0210	568.93	209.67	290	63.60	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8500.9	C08		6	0101-0215	215.75	215.14	308	65.01	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10292.6	C08		6	0102-0218	279.31	219.19	265	61.46	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10133.6	C08		6	0103-0222	723.31	222.66	271	62.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9240.5	C08		6	0104-0225	618.20	224.48	300	63.60	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12887.4	C08		6	0105-0229	887.94	229.13	329	68.18	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14419.2	C08		6	0106-0231	59.71	230.72	334	66.77	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6844.3	C08		6	0107-0236	91.16	236.34	285	63.26	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15249.6	C08		6	0108-0237	773.38	237.52	324	67.36	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10024.8	C08		6	0109-0236	279.03	236.04	389	74.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9701.5	C08		6	0110-0236	669.75	236.45	282	62.43	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7732.4	C08		6	0111-0238	343.16	238.63	321	67.84	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9153.1	C08		6	0112-0242	573.88	243.29	297	69.84	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9643.4	C08		6	0113-0244	756.21	244.60	290	66.18	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11225.8	C08		6	0114-0240	940.51	240.31	252	60.77	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7966.9	C08		6	0115-0247	198.46	246.56	301	67.84	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11774.6	C08		6	0116-0247	874.65	247.80	241	57.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7963.2	C08		6	0117-0251	833.26	251.71	322	76.91	0.684
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10225.0	C08		6	0118-0254	386.96	253.92	280	66.67	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9673.2	C08		6	0119-0254	542.86	253.92	303	64.77	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10224.8	C08		6	0120-0252	181.83	252.52	254	61.36	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10424.5	C08		6	0121-0253	560.66	254.21	262	62.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9386.5	C08		6	0122-0256	469.07	255.36	254	64.53	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9739.4	C08		6	0123-0259	334.87	258.49	264	63.70	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9759.7	C08		6	0124-0263	605.14	262.77	302	65.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11238.1	C08		6	0125-0261	147.85	260.95	217	53.46	0.954
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14118.8	C08		6	0126-0264	729.34	264.18	365	74.08	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11068.7	C08		6	0127-0274	797.83	272.58	730	118.71	0.651
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10198.0	C08		6	0128-0265	913.08	265.02	285	63.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10060.5	C08		6	0129-0268	368.30	267.57	260	61.01	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7990.1	C08		6	0130-0271	50.84	271.45	275	64.18	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11508.8	C08		6	0131-0275	466.40	274.78	474	81.26	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8649.4	C08		6	0132-0271	683.27	271.56	311	66.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9915.1	C08		6	0133-0272	566.82	272.48	293	64.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8599.5	C08		6	0134-0285	173.94	285.56	273	63.11	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9337.1	C08		6	0135-0291	636.52	291.53	287	61.36	0.958
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9465.8	C08		6	0136-0297	351.39	296.39	280	67.84	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10004.7	C08		6	0137-0295	554.38	295.52	265	61.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8181.0	C08		6	0138-0295	254.50	295.29	293	65.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9342.4	C08		6	0139-0296	850.40	297.06	334	67.01	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12193.0	C08		6	0140-0298	712.21	299.02	442	94.08	0.627
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8799.7	C08		6	0141-0302	901.12	301.88	321	69.60	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10067.9	C08		6	0142-0301	666.58	301.64	262	59.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9315.1	C08		6	0143-0307	917.49	306.26	335	71.01	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10468.5	C08		6	0144-0311	771.61	312.57	588	94.81	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10069.7	C08		6	0145-0307	375.36	307.73	255	58.77	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6797.3	C08		6	0146-0310	25.03	310.38	279	61.94	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10048.7	C08		6	0147-0312	509.64	311.64	257	60.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13846.8	C08		6	0148-0317	462.42	314.77	271	76.33	0.585
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11395.0	C08		6	0149-0313	945.18	313.34	263	62.87	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8865.8	C08		6	0150-0327	581.53	327.68	325	69.36	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10952.9	C08		6	0151-0323	859.49	323.86	256	63.94	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15019.3	C08		6	0152-0328	930.26	328.02	378	71.36	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7952.6	C08		6	0153-0332	300.21	332.99	315	73.01	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11168.1	C08		6	0154-0332	136.47	332.64	402	73.84	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16089.9	C08		6	0155-0331	741.68	331.35	299	63.36	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7378.8	C08		6	0156-0334	415.15	333.75	322	69.26	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10060.1	C08		6	0157-0336	57.05	335.97	361	70.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7897.5	C08		6	0158-0336	705.21	336.45	327	70.18	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11723.9	C08		6	0159-0337	247.85	337.10	231	57.94	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11891.9	C08		6	0160-0338	873.94	339.03	219	55.80	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9973.7	C08		6	0161-0346	319.24	345.76	246	62.28	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8071.4	C08		6	0162-0347	649.01	347.45	361	70.43	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9839.4	C08		6	0163-0346	262.33	345.89	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11921.1	C08		6	0164-0346	195.54	347.46	207	57.94	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12954.1	C08		6	0165-0349	751.50	349.29	219	55.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13296.9	C08		6	0166-0351	433.65	351.56	202	55.94	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12474.5	C08		6	0167-0355	275.20	356.19	224	54.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11104.8	C08		6	0168-0358	330.88	357.70	234	60.18	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10806.7	C08		6	0169-0358	510.68	358.42	247	66.67	0.698
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12414.9	C08		6	0170-0353	874.29	352.74	227	58.28	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9170.5	C08		6	0171-0360	458.55	360.08	306	69.94	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9036.1	C08		6	0172-0356	782.57	356.41	305	64.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9359.5	C08		6	0173-0359	612.70	359.17	310	65.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8130.8	C08		6	0174-0360	19.86	360.13	273	65.84	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12572.8	C08		6	0175-0362	759.16	362.11	203	55.94	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6967.3	C08		6	0176-0365	107.78	365.12	297	67.36	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9579.2	C08		6	0177-0369	650.63	368.91	309	65.36	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11530.3	C08		6	0178-0368	427.61	368.25	236	56.87	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10637.9	C08		6	0179-0370	895.90	370.77	278	63.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11362.2	C08		6	0180-0371	917.35	371.10	266	62.43	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9734.9	C08		6	0181-0378	630.45	378.26	301	65.60	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13029.2	C08		6	0182-0380	518.18	380.51	214	56.53	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10640.8	C08		6	0183-0380	806.29	380.14	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7983.3	C08		6	0184-0387	132.88	387.35	285	63.94	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10996.6	C08		6	0185-0388	874.32	387.72	253	62.77	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12711.9	C08		6	0186-0391	26.53	391.88	312	65.01	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9708.2	C08		6	0187-0392	680.81	391.79	302	64.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9542.8	C08		6	0188-0400	718.10	399.93	292	65.36	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13999.0	C08		6	0189-0398	935.14	397.83	207	54.53	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10628.7	C08		6	0190-0401	766.60	400.19	271	62.43	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9766.4	C08		6	0191-0399	913.54	399.39	284	62.53	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8827.8	C08		6	0192-0405	563.90	405.58	300	64.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9486.4	C08		6	0193-0411	271.86	410.40	553	103.30	0.651
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9492.6	C08		6	0194-0408	529.67	408.35	277	62.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10409.3	C08		6	0195-0409	753.00	409.86	266	63.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8405.4	C08		6	0196-0412	855.78	412.42	248	60.43	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11625.6	C08		6	0197-0413	71.26	413.34	383	73.36	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7885.2	C08		6	0198-0418	106.82	418.53	319	68.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7089.1	C08		6	0199-0423	452.60	421.94	336	71.01	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9466.6	C08		6	0200-0425	791.00	425.65	290	64.53	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11157.2	C08		6	0201-0424	807.62	423.86	267	62.53	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11054.7	C08		6	0202-0429	398.58	429.08	509	89.74	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8907.8	C08		6	0203-0426	839.61	426.67	230	58.18	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10822.6	C08		6	0204-0424	125.23	424.74	219	57.70	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8950.0	C08		6	0205-0430	238.86	429.93	284	65.01	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10048.0	C08		6	0206-0431	597.16	431.73	291	64.43	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11892.4	C08		6	0207-0432	349.09	432.09	224	57.11	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9156.1	C08		6	0208-0441	207.55	440.41	573	90.33	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9405.9	C08		6	0209-0439	417.80	439.51	276	63.94	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8698.5	C08		6	0210-0442	168.49	442.08	272	60.77	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10496.0	C08		6	0211-0442	623.74	441.87	263	58.53	0.965
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12385.1	C08		6	0212-0442	651.19	442.34	231	56.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11934.5	C08		6	0213-0445	705.41	445.49	224	61.84	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8386.2	C08		6	0214-0443	85.27	443.29	281	64.77	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7954.8	C08		6	0215-0449	263.69	449.21	290	65.84	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13607.6	C08		6	0216-0455	601.71	455.23	403	75.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12919.6	C08		6	0217-0454	928.96	453.89	209	55.11	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11675.6	C08		6	0218-0456	369.96	456.02	224	55.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8743.8	C08		6	0219-0458	284.97	458.20	295	63.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11065.8	C08		6	0220-0459	943.71	459.04	258	60.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9433.4	C08		6	0221-0461	875.56	460.42	304	63.94	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9997.2	C08		6	0222-0459	82.57	458.98	243	58.53	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9633.0	C08		6	0223-0462	308.85	462.86	247	59.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11058.8	C08		6	0224-0467	636.12	467.79	262	65.01	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9084.3	C08		6	0225-0464	133.52	463.37	241	63.36	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11303.7	C08		6	0226-0466	799.00	466.29	240	57.46	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11604.5	C08		6	0227-0467	814.53	466.96	274	63.11	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8930.1	C08		6	0228-0471	698.92	470.94	320	67.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13491.7	C08		6	0229-0472	764.64	471.85	388	74.08	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9221.8	C08		6	0230-0471	216.16	471.88	246	59.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8538.2	C08		6	0231-0474	430.19	473.76	325	70.43	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9123.4	C08		6	0232-0475	125.39	475.45	271	64.77	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10804.5	C08		6	0233-0477	601.43	476.81	257	59.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10568.0	C08		6	0234-0480	543.61	480.42	248	58.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8045.8	C08		6	0235-0485	754.39	485.62	321	69.01	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8065.5	C08		6	0236-0487	833.43	487.54	169	51.94	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8985.4	C08		6	0237-0489	147.26	489.54	262	60.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9373.2	C08		6	0238-0488	520.89	488.47	281	62.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9349.1	C08		6	0239-0489	211.36	489.19	253	59.11	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10432.7	C08		6	0240-0488	260.82	488.71	235	57.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14929.7	C08		6	0241-0491	897.82	492.01	384	73.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8000.8	C08		6	0242-0496	108.89	496.36	258	60.53	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12095.8	C08		6	0243-0498	794.85	497.72	251	66.53	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7674.2	C08		6	0244-0502	61.85	502.04	264	61.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9788.3	C08		6	0245-0501	431.48	500.98	254	61.60	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9261.1	C08		6	0246-0503	937.07	503.41	305	65.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14716.0	C08		6	0247-0505	703.45	504.80	339	68.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14044.2	C08		6	0248-0503	810.14	503.90	196	54.04	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9874.7	C08		6	0249-0506	31.37	506.93	235	57.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10724.5	C08		6	0250-0507	586.64	507.21	243	58.53	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9859.7	C08		6	0251-0508	414.86	507.96	281	63.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10523.5	C08		6	0252-0508	345.69	507.83	243	59.11	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10952.9	C08		6	0253-0512	150.39	512.45	210	52.87	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15160.7	C08		6	0254-0514	456.22	515.05	348	70.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9767.5	C08		6	0255-0516	164.03	515.62	232	59.46	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9501.4	C08		6	0256-0521	826.80	521.72	313	71.01	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12279.6	C08		6	0257-0523	945.53	522.89	229	56.53	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10225.1	C08		6	0258-0526	105.07	526.30	388	72.43	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7539.3	C08		6	0259-0522	268.65	522.06	172	50.87	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11883.3	C08		6	0260-0526	664.33	526.56	233	57.11	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7203.3	C08		6	0261-0527	250.42	526.89	188	53.11	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7656.2	C08		6	0262-0527	381.97	527.90	304	66.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8922.5	C08		6	0263-0528	611.87	528.20	324	68.43	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9756.5	C08		6	0264-0529	437.19	529.34	264	59.94	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9559.2	C08		6	0265-0535	483.76	535.17	268	63.36	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11194.0	C08		6	0266-0537	901.00	537.63	246	57.60	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9112.9	C08		6	0267-0541	269.74	541.75	257	61.01	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9647.7	C08		6	0268-0544	829.03	543.72	294	66.18	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10233.8	C08		6	0269-0554	41.10	553.69	394	79.60	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9591.5	C08		6	0270-0551	571.25	551.38	298	63.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7870.4	C08		6	0271-0551	62.85	551.76	261	61.26	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8478.4	C08		6	0272-0551	931.25	551.41	306	67.60	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10225.3	C08		6	0273-0553	753.50	553.00	266	60.18	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10798.8	C08		6	0274-0553	869.76	553.40	256	61.11	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8690.9	C08		6	0275-0557	389.14	557.68	305	66.77	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9684.2	C08		6	0276-0558	694.81	558.28	271	61.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10680.7	C08		6	0277-0564	160.05	564.71	337	67.01	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9075.0	C08		6	0278-0566	80.09	565.96	235	59.36	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9195.2	C08		6	0279-0572	425.35	572.97	289	64.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10206.2	C08		6	0280-0571	641.61	572.09	266	60.53	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8461.1	C08		6	0281-0573	137.07	573.98	236	59.36	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10343.4	C08		6	0282-0573	444.69	573.46	262	61.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9750.2	C08		6	0283-0579	51.66	578.45	330	70.53	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8217.7	C08		6	0284-0579	325.79	579.36	274	62.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9689.1	C08		6	0285-0578	843.81	579.39	334	69.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8974.7	C08		6	0286-0581	120.36	580.63	248	58.28	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8130.1	C08		6	0287-0584	914.41	584.32	316	66.18	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8658.3	C08		6	0288-0586	224.69	586.27	267	61.70	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8944.9	C08		6	0289-0591	744.26	590.33	323	68.18	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8139.4	C08		6	0290-0592	357.62	591.89	378	71.84	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10845.4	C08		6	0291-0589	447.52	589.20	262	62.53	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8415.1	C08		6	0292-0594	397.81	594.55	286	64.77	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10056.9	C08		6	0293-0596	478.63	597.04	265	60.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9672.6	C08		6	0294-0600	548.72	600.30	269	59.70	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7839.1	C08		6	0295-0606	768.79	606.37	348	75.50	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10388.0	C08		6	0296-0608	453.66	607.22	275	63.46	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8382.7	C08		6	0297-0611	871.03	611.29	313	65.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8800.7	C08		6	0298-0613	608.91	612.29	306	66.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8445.6	C08		6	0299-0612	155.25	612.80	258	66.77	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7789.9	C08		6	0300-0616	281.60	616.02	269	61.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11310.8	C08		6	0301-0621	101.66	620.83	457	83.26	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7026.9	C08		6	0302-0616	242.90	616.27	280	64.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9430.6	C08		6	0303-0619	793.31	619.27	289	65.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7193.3	C08		6	0304-0616	35.45	615.89	238	60.18	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11348.3	C08		6	0305-0619	934.38	618.80	234	59.70	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11341.2	C08		6	0306-0622	715.31	622.01	232	56.18	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9709.9	C08		6	0307-0623	490.18	623.40	266	61.60	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9213.2	C08		6	0308-0625	892.09	625.63	320	68.18	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12480.5	C08		6	0309-0627	922.07	627.14	220	57.94	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8194.1	C08		6	0310-0633	652.51	633.11	316	65.84	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9609.2	C08		6	0311-0633	318.81	632.76	239	59.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14047.5	C08		6	0312-0636	362.01	636.69	341	69.84	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8531.2	C08		6	0313-0638	466.43	637.42	320	68.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8401.3	C08		6	0314-0642	67.30	642.39	465	81.84	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11135.3	C08		6	0315-0639	244.92	639.76	419	78.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11359.8	C08		6	0316-0639	559.40	639.37	227	59.01	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12078.7	C08		6	0317-0639	817.75	639.85	284	61.60	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8608.1	C08		6	0318-0646	718.33	646.71	316	71.60	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11757.5	C08		6	0319-0647	754.67	646.84	230	57.60	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10367.6	C08		6	0320-0649	447.54	648.81	246	57.94	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10127.2	C08		6	0321-0652	950.46	652.40	258	59.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11920.5	C08		6	0322-0653	368.94	653.00	209	56.53	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12000.6	C08		6	0323-0657	286.04	657.54	398	75.84	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9033.9	C08		6	0324-0657	420.01	656.43	218	56.77	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11019.6	C08		6	0325-0659	874.28	659.13	245	58.53	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7339.9	C08		6	0326-0659	245.72	659.02	300	66.77	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6823.8	C08		6	0327-0665	617.34	666.04	321	69.84	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9642.9	C08		6	0328-0666	734.34	665.61	289	65.01	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8821.2	C08		6	0329-0670	799.68	670.44	295	71.50	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8798.8	C08		6	0330-0676	165.38	676.19	237	56.77	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7112.1	C08		6	0331-0679	24.32	679.38	222	60.18	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9500.0	C08		6	0332-0679	281.96	678.70	245	63.94	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8595.5	C08		6	0333-0681	852.07	682.12	305	65.36	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7836.7	C08		6	0334-0684	480.38	683.80	293	67.36	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10674.1	C08		6	0335-0683	870.51	683.10	248	62.18	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12012.9	C08		6	0336-0686	518.61	686.26	352	68.77	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11076.2	C08		6	0337-0683	715.86	683.20	246	59.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9349.0	C08		6	0338-0688	230.41	688.88	253	60.18	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6611.6	C08		6	0339-0689	103.32	689.98	231	58.53	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6966.5	C08		6	0340-0693	583.34	693.72	373	76.08	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185031	1375323	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8710.2	C08		6	0341-0701	163.75	701.44	242	58.28	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10883.0	C08		7	0001-0023	51.83	23.84	298	69.84	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6776.5	C08		7	0002-0026	872.40	25.70	203	61.60	0.672
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8710.4	C08		7	0003-0025	731.35	25.70	305	67.94	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8837.4	C08		7	0004-0031	928.55	31.22	283	66.18	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8258.0	C08		7	0005-0034	824.17	35.30	298	65.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7867.3	C08		7	0006-0035	617.33	35.30	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8666.9	C08		7	0007-0034	356.66	33.84	315	65.94	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9944.1	C08		7	0008-0037	580.19	36.57	282	63.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6563.2	C08		7	0009-0037	316.66	36.54	320	71.60	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9152.5	C08		7	0010-0036	32.18	36.12	266	61.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10453.6	C08		7	0011-0037	90.78	38.03	232	57.70	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10382.1	C08		7	0012-0043	840.82	43.08	252	58.28	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7970.7	C08		7	0013-0044	643.67	43.90	303	65.94	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8344.0	C08		7	0014-0048	19.83	48.94	291	63.60	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6297.2	C08		7	0015-0053	249.97	53.20	305	64.53	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10843.5	C08		7	0016-0055	90.75	55.31	288	65.94	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9180.4	C08		7	0017-0057	556.33	57.88	320	67.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8345.0	C08		7	0018-0057	409.54	57.82	326	68.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9143.0	C08		7	0019-0062	520.71	62.39	288	63.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11920.8	C08		7	0020-0064	837.98	65.31	438	89.84	0.682
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7702.5	C08		7	0021-0061	944.96	60.36	110	42.04	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11461.1	C08		7	0022-0063	177.25	63.58	268	62.18	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10102.7	C08		7	0023-0067	871.06	67.00	240	61.84	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9908.6	C08		7	0024-0064	113.77	64.84	266	63.94	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12491.5	C08		7	0025-0073	730.13	72.18	431	81.01	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12483.0	C08		7	0026-0077	24.61	76.57	208	54.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7910.6	C08		7	0027-0087	684.99	87.09	311	67.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7789.9	C08		7	0028-0087	251.91	87.09	337	69.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8049.6	C08		7	0029-0087	288.99	87.22	286	62.53	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9284.1	C08		7	0030-0097	586.15	96.15	584	110.23	0.604
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6388.5	C08		7	0031-0088	132.75	87.65	315	69.01	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9149.3	C08		7	0032-0087	200.86	87.04	298	64.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8026.9	C08		7	0033-0087	361.81	87.33	303	64.77	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9453.2	C08		7	0034-0091	448.08	91.39	393	77.01	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14770.6	C08		7	0035-0092	17.29	92.61	173	49.94	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8479.2	C08		7	0036-0095	722.59	94.21	265	63.60	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7985.7	C08		7	0037-0100	638.36	99.46	299	66.18	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9596.9	C08		7	0038-0102	816.65	102.78	353	74.08	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9326.5	C08		7	0039-0102	694.93	102.80	276	65.94	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8497.5	C08		7	0040-0106	621.07	106.28	316	67.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9199.3	C08		7	0041-0106	787.14	105.81	284	65.01	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8170.8	C08		7	0042-0108	440.48	108.24	311	67.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8402.0	C08		7	0043-0110	510.10	110.55	295	64.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9296.3	C08		7	0044-0109	766.18	108.84	275	62.53	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8891.1	C08		7	0045-0113	314.83	112.82	264	59.94	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7787.3	C08		7	0046-0115	914.68	115.50	288	63.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7510.9	C08		7	0047-0116	91.75	116.26	293	62.77	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8089.6	C08		7	0048-0117	563.72	117.16	314	65.60	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7068.1	C08		7	0049-0116	351.44	116.42	305	66.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6741.3	C08		7	0050-0123	180.27	122.55	320	70.18	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11928.6	C08		7	0051-0128	251.79	127.33	470	88.57	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9624.0	C08		7	0052-0120	404.21	120.23	270	62.53	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9498.0	C08		7	0053-0122	67.75	122.10	269	60.28	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7717.6	C08		7	0054-0128	728.23	127.56	314	68.43	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9415.8	C08		7	0055-0129	226.70	128.77	264	60.77	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14277.9	C08		7	0056-0130	853.09	130.34	358	69.60	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8122.5	C08		7	0057-0131	893.96	131.48	307	65.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8908.6	C08		7	0058-0133	668.02	134.08	273	64.18	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9180.1	C08		7	0059-0136	10.94	136.29	264	59.11	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7147.6	C08		7	0060-0141	311.82	141.79	298	65.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6966.9	C08		7	0061-0143	141.61	143.51	294	65.01	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8303.9	C08		7	0062-0143	722.81	144.64	318	71.26	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8852.1	C08		7	0063-0147	212.29	146.48	286	63.70	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9071.6	C08		7	0064-0152	192.31	151.77	275	66.18	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7104.2	C08		7	0065-0151	635.38	151.20	336	69.11	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9738.9	C08		7	0066-0160	561.54	160.14	535	98.57	0.692
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7223.6	C08		7	0067-0153	791.77	152.66	322	67.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10887.1	C08		7	0068-0157	417.30	157.18	496	84.08	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7985.3	C08		7	0069-0160	95.47	160.60	301	64.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7304.6	C08		7	0070-0162	816.09	162.44	317	67.01	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8621.1	C08		7	0071-0162	354.78	162.27	283	68.43	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11277.1	C08		7	0072-0166	235.28	166.37	452	78.43	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11559.5	C08		7	0073-0169	947.12	169.62	436	77.50	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9628.2	C08		7	0074-0168	27.73	168.95	257	59.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9123.7	C08		7	0075-0167	650.18	167.83	282	63.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8204.3	C08		7	0076-0170	492.83	170.51	237	58.77	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9297.8	C08		7	0077-0173	187.93	172.95	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7565.7	C08		7	0078-0171	706.65	171.49	311	68.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8833.7	C08		7	0079-0173	366.75	173.55	297	67.01	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6134.4	C08		7	0080-0173	479.10	174.12	130	47.46	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9174.8	C08		7	0081-0174	47.24	175.03	264	60.77	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8908.9	C08		7	0082-0176	425.03	175.77	300	65.60	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6991.6	C08		7	0083-0181	306.37	181.78	380	72.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8643.5	C08		7	0084-0184	131.58	183.79	278	62.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7913.2	C08		7	0085-0185	518.78	185.64	312	65.60	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9011.8	C08		7	0086-0186	549.39	185.57	270	66.08	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8208.7	C08		7	0087-0185	848.61	185.47	297	64.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8939.4	C08		7	0088-0189	673.09	189.38	273	60.53	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9249.4	C08		7	0089-0190	380.05	189.97	274	61.36	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15576.6	C08		7	0090-0193	99.98	191.93	164	69.26	0.430
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9043.6	C08		7	0091-0192	702.90	192.63	273	60.77	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9142.0	C08		7	0092-0194	628.35	194.17	269	62.18	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10025.1	C08		7	0093-0198	586.04	197.99	258	59.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8752.6	C08		7	0094-0201	417.61	201.11	287	64.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6452.3	C08		7	0095-0201	42.76	201.33	298	66.08	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9896.7	C08		7	0096-0201	872.92	201.31	246	58.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9307.4	C08		7	0097-0202	306.87	201.56	294	63.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13430.8	C08		7	0098-0204	754.31	203.36	420	82.43	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8237.1	C08		7	0099-0203	239.40	202.95	291	63.60	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8454.1	C08		7	0100-0205	436.00	204.90	300	67.01	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9918.1	C08		7	0101-0207	892.77	207.98	246	57.36	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8714.7	C08		7	0102-0213	353.83	213.62	279	61.94	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8750.7	C08		7	0103-0214	850.75	214.10	297	67.01	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9498.5	C08		7	0104-0213	925.26	213.62	261	59.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8976.8	C08		7	0105-0216	140.33	216.11	277	61.60	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7677.7	C08		7	0106-0218	448.62	218.90	296	65.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11241.3	C08		7	0107-0217	547.32	216.90	235	56.53	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8741.0	C08		7	0108-0216	734.27	216.55	278	63.94	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7769.1	C08		7	0109-0222	203.83	221.45	318	67.36	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7442.1	C08		7	0110-0221	314.48	220.98	295	66.67	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7115.9	C08		7	0111-0222	394.80	221.93	308	66.18	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7776.6	C08		7	0112-0220	493.45	219.93	292	65.60	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10103.6	C08		7	0113-0225	124.54	226.17	266	61.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12382.6	C08		7	0114-0229	825.06	229.84	372	72.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8374.7	C08		7	0115-0228	613.49	228.12	286	63.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10564.6	C08		7	0116-0232	560.43	232.21	247	58.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8295.3	C08		7	0117-0229	686.19	229.62	305	68.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8825.3	C08		7	0118-0238	248.32	238.50	299	65.60	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10690.3	C08		7	0119-0243	123.31	242.39	241	58.87	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8637.1	C08		7	0120-0245	676.71	245.31	306	72.77	0.726
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7267.5	C08		7	0121-0250	341.73	250.33	328	67.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6569.2	C08		7	0122-0257	274.37	257.90	311	68.43	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7580.3	C08		7	0123-0259	512.98	259.48	298	67.94	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9182.3	C08		7	0124-0255	86.50	255.95	260	59.11	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7727.1	C08		7	0125-0257	381.59	257.67	288	62.53	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9106.3	C08		7	0126-0261	157.63	261.08	323	67.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7649.3	C08		7	0127-0261	480.12	261.93	293	64.18	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8516.7	C08		7	0128-0261	434.67	261.82	291	64.53	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8554.2	C08		7	0129-0267	177.11	266.96	476	83.84	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7199.4	C08		7	0130-0262	319.73	262.56	312	65.60	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9249.4	C08		7	0131-0262	908.50	262.01	260	61.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9052.9	C08		7	0132-0264	610.11	263.52	277	63.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9080.5	C08		7	0133-0266	633.45	266.54	293	63.94	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8136.6	C08		7	0134-0270	225.67	270.95	303	71.26	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8390.3	C08		7	0135-0275	848.09	274.96	591	103.05	0.699
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10311.9	C08		7	0136-0270	563.50	270.12	245	56.53	0.964
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9341.5	C08		7	0137-0273	923.56	272.85	264	62.28	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7381.5	C08		7	0138-0275	36.30	275.45	296	66.18	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9970.7	C08		7	0139-0276	74.24	275.93	249	65.46	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9010.5	C08		7	0140-0272	710.08	272.03	295	68.18	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12094.8	C08		7	0141-0279	875.73	278.69	210	55.94	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8370.2	C08		7	0142-0280	436.92	279.64	319	66.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8315.6	C08		7	0143-0283	376.15	283.21	297	65.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7800.8	C08		7	0144-0283	791.94	283.20	287	64.77	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8542.2	C08		7	0145-0284	394.43	284.19	285	62.53	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9259.4	C08		7	0146-0287	280.72	287.25	263	60.53	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10933.1	C08		7	0147-0290	884.23	291.40	239	57.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7951.2	C08		7	0148-0293	518.71	293.39	317	68.08	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7841.2	C08		7	0149-0291	610.49	291.17	303	66.53	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9476.2	C08		7	0150-0292	686.06	292.11	296	68.18	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11977.6	C08		7	0151-0296	263.56	296.73	307	108.71	0.326
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10425.2	C08		7	0152-0297	142.76	296.77	247	58.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9737.6	C08		7	0153-0298	700.97	298.74	265	63.36	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9536.9	C08		7	0154-0299	754.67	298.77	304	65.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10255.0	C08		7	0155-0304	472.50	304.34	414	76.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7675.6	C08		7	0156-0301	564.05	301.27	298	64.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11577.3	C08		7	0157-0305	335.27	304.40	377	72.67	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8886.6	C08		7	0158-0305	293.40	305.22	296	63.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7735.2	C08		7	0159-0303	409.14	303.46	295	64.28	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9032.0	C08		7	0160-0309	742.48	309.82	249	59.84	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7858.0	C08		7	0161-0313	442.94	313.73	318	65.60	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11482.5	C08		7	0162-0318	942.53	318.48	418	76.08	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10091.5	C08		7	0163-0322	870.12	321.84	473	82.43	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7670.4	C08		7	0164-0320	325.90	321.12	282	65.01	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10289.9	C08		7	0165-0318	74.38	317.81	250	58.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9129.1	C08		7	0166-0319	776.38	318.80	223	55.11	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10400.9	C08		7	0167-0321	384.45	321.54	317	67.01	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8845.3	C08		7	0168-0326	801.22	326.23	276	62.53	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11012.9	C08		7	0169-0326	100.75	325.66	233	55.94	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8689.8	C08		7	0170-0328	540.33	328.26	275	61.94	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7182.4	C08		7	0171-0325	618.90	325.47	308	69.11	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9967.4	C08		7	0172-0332	355.64	332.73	326	66.43	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9180.8	C08		7	0173-0333	827.91	332.60	260	61.94	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11800.3	C08		7	0174-0333	59.54	333.52	229	57.94	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7793.4	C08		7	0175-0340	679.98	340.54	324	70.28	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9063.1	C08		7	0176-0341	182.75	341.17	277	67.60	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8979.3	C08		7	0177-0337	234.22	337.39	279	65.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6706.0	C08		7	0178-0341	393.39	341.51	322	67.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10159.8	C08		7	0179-0344	273.12	344.76	273	60.53	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9326.4	C08		7	0180-0347	443.34	347.29	297	69.50	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9065.2	C08		7	0181-0345	903.28	345.78	250	58.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13858.1	C08		7	0182-0349	511.96	349.53	294	97.64	0.388
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7967.6	C08		7	0183-0352	834.55	351.67	322	68.18	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12357.7	C08		7	0184-0351	480.64	350.76	450	82.43	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8878.4	C08		7	0185-0349	596.52	349.28	272	61.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8801.2	C08		7	0186-0351	734.48	350.94	281	62.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7583.6	C08		7	0187-0354	21.01	354.39	300	63.36	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9686.1	C08		7	0188-0357	136.51	357.68	257	62.77	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9389.9	C08		7	0189-0363	277.83	363.11	282	65.36	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8168.8	C08		7	0190-0369	804.38	370.02	353	76.91	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8555.1	C08		7	0191-0370	623.76	369.67	290	63.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7328.2	C08		7	0192-0371	729.37	370.37	299	70.43	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8262.5	C08		7	0193-0371	883.25	370.76	286	62.18	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11972.7	C08		7	0194-0370	421.52	370.61	212	52.87	0.953
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10980.9	C08		7	0195-0373	440.77	372.81	369	71.94	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8615.7	C08		7	0196-0375	244.52	375.02	278	61.36	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8897.5	C08		7	0197-0386	779.94	386.38	519	100.33	0.648
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8415.4	C08		7	0198-0377	71.45	377.30	298	66.53	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8014.1	C08		7	0199-0381	358.69	381.63	304	67.26	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9442.7	C08		7	0200-0384	480.38	383.90	280	62.53	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8259.2	C08		7	0201-0383	594.58	383.38	302	67.36	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11121.6	C08		7	0202-0387	497.35	387.35	255	59.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9303.4	C08		7	0203-0388	159.68	388.14	279	64.18	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7660.6	C08		7	0204-0387	211.60	387.59	296	66.43	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10418.8	C08		7	0205-0389	307.95	388.57	241	57.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9026.2	C08		7	0206-0391	538.00	391.84	277	63.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15799.3	C08		7	0207-0391	340.85	392.48	347	75.50	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8343.1	C08		7	0208-0391	895.57	390.50	309	67.60	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7041.9	C08		7	0209-0392	273.69	392.24	311	66.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8852.4	C08		7	0210-0392	731.74	391.93	291	66.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8562.0	C08		7	0211-0394	685.93	394.07	333	70.43	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9451.2	C08		7	0212-0397	667.40	397.52	258	63.94	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8884.2	C08		7	0213-0399	588.90	399.42	299	66.77	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7995.8	C08		7	0214-0400	944.59	400.47	310	69.01	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9353.8	C08		7	0215-0405	62.74	405.46	318	72.28	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9368.3	C08		7	0216-0403	315.97	403.96	284	64.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9553.3	C08		7	0217-0403	136.00	402.95	262	59.36	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9077.9	C08		7	0218-0405	648.86	405.48	283	64.18	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9241.5	C08		7	0219-0408	242.85	408.79	298	64.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9313.4	C08		7	0220-0407	454.24	407.57	291	63.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8191.4	C08		7	0221-0408	727.38	408.60	319	67.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7930.8	C08		7	0222-0413	806.08	413.94	299	65.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9090.7	C08		7	0223-0413	848.18	413.71	226	57.70	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10302.4	C08		7	0224-0424	158.66	424.24	430	77.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11212.0	C08		7	0225-0426	575.46	425.45	392	95.88	0.536
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9505.9	C08		7	0226-0424	443.56	423.89	283	62.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11968.6	C08		7	0227-0428	70.13	428.66	468	82.77	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10575.5	C08		7	0228-0429	302.95	428.77	307	67.84	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14229.6	C08		7	0229-0433	604.50	433.16	423	82.33	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8488.6	C08		7	0230-0432	651.00	431.62	293	64.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6674.8	C08		7	0231-0429	917.79	429.61	133	42.87	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7977.3	C08		7	0232-0435	902.21	434.55	192	52.18	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8511.3	C08		7	0233-0439	201.66	439.00	288	64.18	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7966.2	C08		7	0234-0441	136.25	440.56	313	66.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8831.1	C08		7	0235-0451	551.08	451.54	738	125.30	0.591
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7772.0	C08		7	0236-0447	733.50	447.24	319	66.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12886.5	C08		7	0237-0448	237.40	448.75	413	75.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7677.5	C08		7	0238-0451	171.67	451.56	290	65.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10029.9	C08		7	0239-0452	50.62	451.91	266	63.94	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9614.8	C08		7	0240-0449	372.36	448.99	256	62.53	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9962.5	C08		7	0241-0451	479.06	451.16	238	58.18	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11840.8	C08		7	0242-0467	133.33	469.17	904	137.10	0.604
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11576.5	C08		7	0243-0458	493.89	458.38	335	69.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8593.5	C08		7	0244-0458	332.53	458.42	279	63.01	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9109.2	C08		7	0245-0460	632.80	460.02	261	66.43	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8996.4	C08		7	0246-0456	274.08	455.57	268	61.70	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13877.7	C08		7	0247-0458	414.12	457.91	197	52.28	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9410.6	C08		7	0248-0463	79.81	463.03	259	62.77	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10256.6	C08		7	0249-0468	822.05	468.25	531	87.15	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12696.0	C08		7	0250-0465	393.47	464.98	215	54.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8044.0	C08		7	0251-0465	800.97	465.27	182	52.04	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10963.5	C08		7	0252-0466	695.06	466.10	242	59.36	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8386.1	C08		7	0253-0468	778.09	468.76	311	67.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7900.9	C08		7	0254-0471	731.50	470.88	306	65.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10444.3	C08		7	0255-0481	682.59	481.48	527	94.08	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8573.5	C08		7	0256-0475	432.38	475.66	298	63.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8300.7	C08		7	0257-0476	888.40	476.51	278	63.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8873.1	C08		7	0258-0476	863.53	476.24	285	64.77	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7910.2	C08		7	0259-0479	615.49	479.10	308	65.84	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8231.4	C08		7	0260-0480	758.16	480.43	318	69.60	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11107.2	C08		7	0261-0489	489.59	489.12	471	81.26	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9263.7	C08		7	0262-0486	905.96	486.58	296	64.18	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7990.7	C08		7	0263-0490	579.07	489.41	186	57.60	0.705
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9614.7	C08		7	0264-0493	259.07	493.34	275	60.77	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8587.0	C08		7	0265-0497	773.89	497.11	282	64.77	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9744.8	C08		7	0266-0497	234.03	496.95	259	58.53	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9214.1	C08		7	0267-0502	658.63	502.20	266	60.18	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6328.9	C08		7	0268-0503	846.58	503.79	333	68.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8131.0	C08		7	0269-0506	122.20	506.82	276	62.53	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7050.1	C08		7	0270-0508	532.58	508.24	317	65.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12732.9	C08		7	0271-0513	340.54	511.95	653	107.40	0.711
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7469.5	C08		7	0272-0511	201.18	511.35	298	66.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9166.8	C08		7	0273-0509	374.99	510.00	260	58.77	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9157.0	C08		7	0274-0514	779.70	514.47	297	65.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8238.5	C08		7	0275-0514	163.92	514.24	276	63.60	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8691.0	C08		7	0276-0515	474.02	515.23	306	64.43	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8309.2	C08		7	0277-0520	285.23	519.48	281	66.43	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8697.4	C08		7	0278-0523	554.66	522.46	299	65.60	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6923.7	C08		7	0279-0527	595.61	527.94	333	69.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8921.3	C08		7	0280-0530	462.19	530.53	273	65.26	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7392.9	C08		7	0281-0531	50.04	531.24	281	65.01	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7826.2	C08		7	0282-0532	83.20	532.26	287	62.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11484.4	C08		7	0283-0538	235.20	538.13	469	80.08	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8540.1	C08		7	0284-0537	720.99	537.06	278	66.43	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8731.6	C08		7	0285-0537	643.63	536.71	328	67.84	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9780.2	C08		7	0286-0536	769.83	536.82	260	64.67	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7632.7	C08		7	0287-0539	187.08	539.05	290	69.50	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9119.9	C08		7	0288-0536	390.77	535.62	261	61.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7545.9	C08		7	0289-0539	914.20	540.18	320	67.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12760.1	C08		7	0290-0544	701.47	543.96	434	77.74	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7578.5	C08		7	0291-0544	12.36	544.12	314	67.84	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10985.9	C08		7	0292-0543	264.67	542.86	258	59.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10472.2	C08		7	0293-0551	298.73	551.61	248	58.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9695.0	C08		7	0294-0551	213.99	551.36	300	65.70	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8225.2	C08		7	0295-0553	929.54	553.86	299	66.18	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7153.6	C08		7	0296-0558	801.50	557.38	377	72.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8615.9	C08		7	0297-0559	382.14	558.96	278	63.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8190.2	C08		7	0298-0561	350.08	560.94	292	64.18	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9873.1	C08		7	0299-0562	322.63	561.88	258	59.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9464.8	C08		7	0300-0563	518.11	563.04	271	61.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10452.0	C08		7	0301-0564	133.95	564.75	242	57.11	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7508.3	C08		7	0302-0569	241.13	569.70	307	67.01	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9625.4	C08		7	0303-0571	696.96	572.13	336	72.43	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8133.5	C08		7	0304-0571	588.57	571.12	288	63.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13178.7	C08		7	0305-0579	282.97	579.38	397	73.60	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12761.8	C08		7	0306-0585	763.47	587.36	746	117.64	0.677
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7648.8	C08		7	0307-0579	94.84	579.64	289	64.43	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9672.5	C08		7	0308-0576	649.55	576.07	254	59.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7363.3	C08		7	0309-0583	415.09	583.38	302	67.94	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9367.7	C08		7	0310-0583	893.16	583.45	375	71.60	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9486.3	C08		7	0311-0584	615.58	583.79	264	60.77	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8019.6	C08		7	0312-0588	460.21	588.56	306	64.53	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10433.1	C08		7	0313-0591	583.80	591.02	473	82.18	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8826.1	C08		7	0314-0595	538.06	595.67	433	77.01	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8870.7	C08		7	0315-0592	700.27	592.00	281	62.87	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8456.1	C08		7	0316-0599	945.31	598.79	258	64.43	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9598.6	C08		7	0317-0599	353.56	599.04	283	64.04	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13547.1	C08		7	0318-0605	336.14	604.94	412	78.18	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9266.4	C08		7	0319-0602	56.90	602.87	252	59.70	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8908.7	C08		7	0320-0606	399.11	607.57	277	63.11	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8354.1	C08		7	0321-0609	855.32	609.79	272	62.53	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9213.8	C08		7	0322-0613	636.26	612.94	273	64.77	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7745.2	C08		7	0323-0613	936.53	613.28	315	67.84	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9854.1	C08		7	0324-0612	678.10	613.04	256	60.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11047.8	C08		7	0325-0621	104.10	620.20	457	78.43	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10604.3	C08		7	0326-0623	291.51	624.26	627	100.91	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12608.5	C08		7	0327-0629	395.95	629.48	448	79.60	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8100.3	C08		7	0328-0628	572.60	628.89	290	62.77	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8223.4	C08		7	0329-0632	748.01	632.18	289	64.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10263.9	C08		7	0330-0636	776.79	636.68	256	60.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8284.8	C08		7	0331-0640	373.08	640.16	281	62.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8488.9	C08		7	0332-0647	710.25	648.24	283	65.60	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9658.5	C08		7	0333-0651	822.58	651.72	261	61.94	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7529.6	C08		7	0334-0652	204.53	653.05	300	64.18	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8073.7	C08		7	0335-0655	48.52	654.60	298	66.77	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7800.3	C08		7	0336-0658	138.48	657.73	287	62.77	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7347.4	C08		7	0337-0660	500.08	659.81	310	69.36	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8921.7	C08		7	0338-0659	631.58	659.79	261	60.87	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7138.8	C08		7	0339-0663	91.38	663.46	295	63.36	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8743.4	C08		7	0340-0661	302.24	661.91	258	61.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7004.9	C08		7	0341-0665	867.73	665.18	310	67.60	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8636.2	C08		7	0342-0670	424.56	670.17	396	75.84	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9965.4	C08		7	0343-0666	665.60	666.59	260	59.11	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9495.2	C08		7	0344-0668	699.28	668.58	267	61.94	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8950.2	C08		7	0345-0667	566.92	667.45	265	64.53	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10439.1	C08		7	0346-0674	186.53	673.98	438	80.18	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12353.6	C08		7	0347-0677	313.68	677.71	433	78.43	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12265.5	C08		7	0348-0676	807.34	676.26	246	58.18	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10016.4	C08		7	0349-0677	628.99	676.79	257	63.21	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8767.5	C08		7	0350-0679	645.06	678.65	325	71.94	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9617.3	C08		7	0351-0682	946.39	682.20	232	58.53	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10736.4	C08		7	0352-0684	666.11	684.21	246	57.70	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13594.9	C08		7	0353-0687	759.57	688.18	370	71.84	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13860.7	C08		7	0354-0687	736.92	686.21	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7262.6	C08		7	0355-0688	24.13	688.30	298	65.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12739.2	C08		7	0356-0691	252.88	690.83	430	77.26	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9306.0	C08		7	0357-0688	713.65	688.11	263	63.36	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7468.8	C08		7	0358-0693	469.47	692.93	302	67.70	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8360.1	C08		7	0359-0691	123.37	691.78	285	63.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8135.4	C08		7	0360-0698	43.62	698.59	290	65.60	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10368.5	C08		7	0361-0698	939.07	698.25	235	59.36	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7156.0	C08		7	0362-0700	533.23	700.56	301	65.60	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13105.1	C08		7	0363-0702	438.97	702.40	410	75.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7931.7	C08		7	0364-0702	374.62	702.30	278	61.36	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10449.7	C08		7	0365-0705	762.74	705.83	240	58.87	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185032	1375324	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13604.1	C08		7	0366-0710	613.25	710.49	186	53.36	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9163.6	C08		8	0001-0030	465.68	30.42	295	61.94	0.966
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9796.2	C08		8	0002-0031	547.19	30.38	278	62.18	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10259.0	C08		8	0003-0033	709.44	32.90	255	63.84	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8520.5	C08		8	0004-0033	33.60	33.54	273	64.77	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9833.3	C08		8	0005-0032	180.29	32.17	229	56.53	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13979.5	C08		8	0006-0032	778.32	31.86	180	51.11	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7830.6	C08		8	0007-0033	54.01	33.46	295	67.70	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8476.0	C08		8	0008-0033	231.55	33.54	264	59.11	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10359.7	C08		8	0009-0037	693.47	37.68	251	59.94	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9660.2	C08		8	0010-0039	522.67	38.53	294	65.94	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15094.8	C08		8	0011-0040	792.13	40.86	333	76.91	0.707
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8217.6	C08		8	0012-0042	311.06	41.33	294	65.26	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12670.7	C08		8	0013-0048	380.46	46.13	438	89.84	0.682
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13639.2	C08		8	0014-0045	501.66	45.04	449	78.67	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16335.1	C08		8	0015-0044	660.94	45.37	156	80.91	0.299
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9089.7	C08		8	0016-0054	712.35	54.21	264	66.18	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9651.2	C08		8	0017-0053	742.37	52.85	277	63.84	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7593.4	C08		8	0018-0056	837.09	55.92	164	55.11	0.679
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9353.4	C08		8	0019-0057	860.26	57.03	272	62.18	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15927.2	C08		8	0020-0059	448.63	59.29	134	60.18	0.465
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9698.6	C08		8	0021-0068	67.82	67.59	498	87.50	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9267.0	C08		8	0022-0064	909.20	64.16	300	67.36	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12165.3	C08		8	0023-0062	790.69	61.81	207	52.28	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11789.4	C08		8	0024-0063	121.72	63.89	242	57.36	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6447.1	C08		8	0025-0067	286.68	66.55	297	76.57	0.637
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7957.1	C08		8	0026-0067	591.04	66.94	314	70.77	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7344.7	C08		8	0027-0063	50.38	63.06	108	40.63	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12168.0	C08		8	0028-0074	188.81	72.64	695	116.23	0.647
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9722.3	C08		8	0029-0069	345.83	69.59	243	57.11	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10229.0	C08		8	0030-0071	848.67	70.96	252	61.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15288.8	C08		8	0031-0073	106.00	73.30	218	58.77	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10263.4	C08		8	0032-0080	165.89	77.84	532	95.36	0.735
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8628.5	C08		8	0033-0075	629.52	75.54	309	69.26	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8574.0	C08		8	0034-0073	932.67	73.63	278	64.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9257.1	C08		8	0035-0074	236.53	74.59	247	59.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8748.5	C08		8	0036-0081	544.67	81.33	299	68.43	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8245.3	C08		8	0037-0087	824.73	86.97	303	67.84	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7885.2	C08		8	0038-0086	481.64	86.30	296	64.67	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8591.0	C08		8	0039-0086	319.20	85.87	282	62.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10139.7	C08		8	0040-0089	665.56	89.80	432	80.67	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17411.7	C08		8	0041-0100	83.83	100.10	294	64.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8350.2	C08		8	0042-0100	227.32	99.74	258	63.36	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10975.1	C08		8	0043-0099	773.95	99.27	234	56.87	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8800.0	C08		8	0044-0100	367.51	100.60	291	65.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10710.2	C08		8	0045-0100	757.50	100.78	259	58.87	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9146.5	C08		8	0046-0108	581.33	108.58	288	65.01	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8080.7	C08		8	0047-0110	902.90	110.16	303	64.18	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9108.7	C08		8	0048-0110	821.66	109.99	266	61.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11309.9	C08		8	0049-0111	720.99	110.99	228	55.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7611.1	C08		8	0050-0117	19.36	117.48	250	58.77	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12443.8	C08		8	0051-0122	401.85	120.99	617	103.15	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9829.4	C08		8	0052-0117	602.92	117.43	243	58.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9267.7	C08		8	0053-0117	536.09	116.93	268	61.94	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10848.5	C08		8	0054-0123	645.10	123.14	239	57.36	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9566.9	C08		8	0055-0126	433.22	126.58	256	59.36	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7677.0	C08		8	0056-0125	475.67	125.87	307	65.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15600.3	C08		8	0057-0131	104.76	131.71	320	68.43	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10872.7	C08		8	0058-0129	288.05	129.53	218	55.11	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11758.7	C08		8	0059-0135	847.79	134.33	444	84.91	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12151.4	C08		8	0060-0132	811.21	132.13	224	56.63	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8508.0	C08		8	0061-0135	207.21	134.94	252	61.36	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9345.7	C08		8	0062-0138	798.43	138.91	261	64.28	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8121.6	C08		8	0063-0140	527.91	140.89	280	63.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7909.6	C08		8	0064-0142	711.25	142.30	314	70.43	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10817.5	C08		8	0065-0142	375.28	142.34	231	56.28	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9012.3	C08		8	0066-0143	476.59	142.54	270	62.53	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8421.7	C08		8	0067-0148	775.29	148.00	280	62.18	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7536.0	C08		8	0068-0152	124.19	152.91	275	63.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9698.0	C08		8	0069-0148	299.03	147.82	247	59.70	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13227.8	C08		8	0070-0152	814.13	152.03	197	51.70	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9395.8	C08		8	0071-0155	675.60	155.47	270	63.60	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9327.5	C08		8	0072-0155	741.61	154.87	253	59.94	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9002.8	C08		8	0073-0159	614.15	159.31	289	65.70	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14044.9	C08		8	0074-0158	355.70	157.95	353	69.01	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8045.4	C08		8	0075-0158	72.97	157.87	271	61.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8340.6	C08		8	0076-0166	468.52	166.65	303	69.60	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11028.1	C08		8	0077-0171	52.32	171.42	447	79.50	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8016.7	C08		8	0078-0173	161.92	173.06	261	61.36	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9176.4	C08		8	0079-0173	222.76	173.00	257	59.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7577.6	C08		8	0080-0169	397.95	169.91	274	67.94	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10893.8	C08		8	0081-0172	449.89	172.11	212	55.70	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9520.5	C08		8	0082-0176	674.84	176.11	285	66.18	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11761.4	C08		8	0083-0184	538.83	184.41	214	56.53	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8092.6	C08		8	0084-0186	105.76	186.28	271	60.18	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10413.4	C08		8	0085-0190	896.93	190.67	512	89.74	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10047.1	C08		8	0086-0197	328.77	196.94	376	71.60	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10202.0	C08		8	0087-0194	398.31	194.01	237	58.18	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9263.7	C08		8	0088-0198	481.48	198.28	282	64.53	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8236.6	C08		8	0089-0200	669.44	199.84	309	70.18	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7496.0	C08		8	0090-0199	286.00	199.11	279	63.36	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11757.8	C08		8	0091-0199	513.10	198.22	311	69.11	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8225.6	C08		8	0092-0203	773.71	202.19	159	50.18	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7038.9	C08		8	0093-0208	848.75	208.73	304	70.91	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11959.7	C08		8	0094-0208	385.94	208.71	392	80.33	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8225.3	C08		8	0095-0210	762.42	209.98	316	75.74	0.692
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7551.3	C08		8	0096-0210	784.83	210.44	120	41.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9088.5	C08		8	0097-0214	718.57	214.37	222	59.36	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8895.5	C08		8	0098-0215	30.22	215.69	254	59.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9424.7	C08		8	0099-0214	509.59	215.05	284	65.36	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12596.6	C08		8	0100-0221	901.61	221.67	392	74.67	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9475.2	C08		8	0101-0219	401.57	219.53	273	63.01	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10770.8	C08		8	0102-0227	600.21	227.79	229	56.53	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9135.2	C08		8	0103-0228	180.24	228.63	265	62.77	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7752.7	C08		8	0104-0232	123.88	234.13	341	79.26	0.682
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10385.9	C08		8	0105-0230	684.46	229.47	250	59.70	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10139.4	C08		8	0106-0230	821.39	229.68	262	60.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11743.4	C08		8	0107-0228	846.38	228.77	224	55.36	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13997.6	C08		8	0108-0235	216.03	234.74	373	71.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9166.6	C08		8	0109-0233	263.29	233.49	159	47.46	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8946.3	C08		8	0110-0241	702.98	240.60	210	55.94	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10891.0	C08		8	0111-0244	483.81	244.58	343	71.01	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11251.1	C08		8	0112-0247	651.99	247.34	454	81.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8905.7	C08		8	0113-0246	183.27	246.76	242	59.46	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8467.5	C08		8	0114-0247	567.50	246.42	307	65.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8754.3	C08		8	0115-0248	622.51	248.87	293	63.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8073.1	C08		8	0116-0251	64.62	250.71	270	66.67	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8587.9	C08		8	0117-0252	339.09	252.28	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13782.4	C08		8	0118-0252	746.86	252.39	370	71.26	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7994.2	C08		8	0119-0253	909.42	252.76	302	68.18	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8353.1	C08		8	0120-0256	927.02	256.12	338	72.18	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11908.6	C08		8	0121-0257	507.86	257.96	460	79.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10393.6	C08		8	0122-0257	775.18	257.04	242	57.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8545.1	C08		8	0123-0263	113.49	262.03	264	61.26	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8821.8	C08		8	0124-0265	13.44	264.14	247	61.60	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11905.4	C08		8	0125-0266	570.91	266.69	224	54.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9401.6	C08		8	0126-0270	431.50	270.56	276	63.36	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10043.8	C08		8	0127-0271	642.41	271.75	266	63.11	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8968.6	C08		8	0128-0275	28.09	274.67	247	61.36	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6855.6	C08		8	0129-0273	96.59	273.71	293	71.15	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9162.0	C08		8	0130-0278	177.48	278.78	258	61.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8659.7	C08		8	0131-0275	348.47	275.37	282	62.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9071.6	C08		8	0132-0282	790.68	282.00	280	63.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12799.2	C08		8	0133-0280	616.38	280.19	218	54.53	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10118.5	C08		8	0134-0286	411.59	286.65	516	86.43	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10463.4	C08		8	0135-0289	593.91	290.18	522	96.33	0.707
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10125.9	C08		8	0136-0291	657.83	291.43	401	77.60	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8863.3	C08		8	0137-0292	198.52	292.19	254	62.77	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9300.6	C08		8	0138-0291	503.11	291.22	264	61.36	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9449.6	C08		8	0139-0293	169.12	293.03	223	57.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8464.0	C08		8	0140-0296	858.63	296.66	278	65.70	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8428.8	C08		8	0141-0296	473.07	295.39	310	66.43	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10666.6	C08		8	0142-0296	631.22	296.87	243	59.94	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9687.7	C08		8	0143-0300	872.90	300.22	285	64.87	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7283.1	C08		8	0144-0300	97.94	300.00	282	66.18	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10641.7	C08		8	0145-0308	702.25	308.18	503	88.43	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10504.9	C08		8	0146-0309	152.79	309.85	475	88.57	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8936.8	C08		8	0147-0310	280.31	309.79	416	77.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9617.9	C08		8	0148-0310	386.42	309.73	244	58.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9457.8	C08		8	0149-0309	745.08	308.93	281	62.18	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7525.7	C08		8	0150-0315	216.42	314.77	287	65.60	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10897.2	C08		8	0151-0320	47.35	320.46	420	75.26	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10207.0	C08		8	0152-0320	593.64	319.21	252	59.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7591.1	C08		8	0153-0325	528.95	325.66	304	66.77	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8025.7	C08		8	0154-0325	422.95	324.32	285	64.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7383.6	C08		8	0155-0325	910.94	325.64	306	67.84	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8083.9	C08		8	0156-0327	98.64	326.80	373	76.08	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9571.6	C08		8	0157-0326	326.66	326.76	238	58.18	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7412.6	C08		8	0158-0337	772.26	337.59	305	66.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9618.6	C08		8	0159-0341	818.10	341.48	280	65.01	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10616.5	C08		8	0160-0339	871.33	338.94	242	59.11	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7808.4	C08		8	0161-0345	115.39	344.75	275	62.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14693.5	C08		8	0162-0348	525.87	348.58	366	73.84	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9647.4	C08		8	0163-0345	711.92	344.44	249	59.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8725.5	C08		8	0164-0352	559.11	352.20	276	61.94	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9108.6	C08		8	0165-0351	597.71	351.17	268	60.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8773.1	C08		8	0166-0352	682.45	351.91	255	62.77	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9010.6	C08		8	0167-0352	731.46	352.60	283	62.18	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10243.8	C08		8	0168-0359	263.84	359.46	487	88.91	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8439.7	C08		8	0169-0354	210.23	354.93	263	59.60	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10270.2	C08		8	0170-0356	631.68	356.32	268	61.11	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9122.1	C08		8	0171-0356	355.10	356.18	258	59.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6815.2	C08		8	0172-0357	416.89	357.57	307	70.43	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9073.1	C08		8	0173-0357	925.03	357.68	273	61.94	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7572.9	C08		8	0174-0361	468.53	360.83	292	64.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8126.7	C08		8	0175-0362	649.11	362.38	323	69.60	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10218.8	C08		8	0176-0365	171.66	365.70	227	55.70	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7912.0	C08		8	0177-0365	288.04	365.90	287	67.60	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9696.1	C08		8	0178-0366	59.86	366.56	248	58.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13660.7	C08		8	0179-0380	760.61	380.58	357	70.18	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10888.9	C08		8	0180-0380	811.00	379.21	217	55.01	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8432.6	C08		8	0181-0383	196.62	383.55	280	62.18	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8735.9	C08		8	0182-0384	217.55	384.18	269	61.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16055.0	C08		8	0183-0383	334.32	383.75	119	50.04	0.597
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9187.1	C08		8	0184-0389	824.12	389.42	309	65.11	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9349.9	C08		8	0185-0388	948.43	389.19	264	59.70	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17839.6	C08		8	0186-0396	578.23	395.14	311	67.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7167.4	C08		8	0187-0396	492.26	397.89	297	69.84	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9002.0	C08		8	0188-0398	874.23	398.40	276	62.77	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15477.5	C08		8	0189-0402	378.12	401.83	338	72.67	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8799.6	C08		8	0190-0397	921.02	397.62	284	63.01	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7685.8	C08		8	0191-0401	295.72	402.10	276	61.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7732.6	C08		8	0192-0402	49.43	402.45	275	65.60	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10667.5	C08		8	0193-0404	558.15	404.14	249	59.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15984.4	C08		8	0194-0404	725.10	404.57	103	63.50	0.321
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9425.7	C08		8	0195-0418	319.07	417.56	255	60.28	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13061.4	C08		8	0196-0418	390.15	417.76	412	76.08	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8174.0	C08		8	0197-0420	245.09	420.66	268	64.43	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13586.7	C08		8	0198-0420	684.61	420.01	187	50.53	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10013.4	C08		8	0199-0423	613.93	423.00	244	58.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9249.1	C08		8	0200-0424	562.83	424.34	275	60.77	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7979.1	C08		8	0201-0426	180.00	427.29	275	63.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10384.2	C08		8	0202-0426	827.92	426.59	247	57.70	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9523.5	C08		8	0203-0432	147.17	431.93	238	57.11	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8342.7	C08		8	0204-0434	261.57	433.98	293	67.94	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9107.4	C08		8	0205-0437	846.62	437.04	304	67.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8426.1	C08		8	0206-0442	340.32	442.00	273	63.36	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11556.8	C08		8	0207-0440	699.29	439.71	234	55.94	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11157.0	C08		8	0208-0442	417.13	442.32	230	56.28	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12025.9	C08		8	0209-0444	718.59	444.25	348	69.60	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8759.1	C08		8	0210-0444	545.86	444.24	272	61.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10240.9	C08		8	0211-0445	458.64	445.50	258	59.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9609.5	C08		8	0212-0448	868.82	448.96	248	59.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12039.4	C08		8	0213-0449	925.97	448.03	219	57.11	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7240.5	C08		8	0214-0453	372.89	453.38	318	70.67	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8730.4	C08		8	0215-0453	608.77	452.64	278	62.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10334.4	C08		8	0216-0458	565.00	458.24	488	82.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9815.7	C08		8	0217-0461	64.26	460.83	476	83.74	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8615.7	C08		8	0218-0461	387.49	461.48	279	63.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10197.2	C08		8	0219-0460	837.21	459.77	248	58.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10501.2	C08		8	0220-0461	921.28	462.13	248	62.77	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10543.4	C08		8	0221-0462	256.23	461.92	220	54.53	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12087.7	C08		8	0222-0461	282.52	461.62	206	54.53	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10496.7	C08		8	0223-0463	668.71	463.60	263	64.18	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7567.0	C08		8	0224-0467	319.69	467.01	282	63.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11920.1	C08		8	0225-0464	804.55	463.14	229	56.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9484.7	C08		8	0226-0471	787.93	471.14	285	63.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8264.6	C08		8	0227-0477	149.23	477.60	560	102.57	0.669
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11882.6	C08		8	0228-0474	640.90	473.26	224	54.53	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8169.9	C08		8	0229-0477	425.01	478.02	269	62.18	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8858.5	C08		8	0230-0478	292.01	479.06	271	64.53	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11409.2	C08		8	0231-0481	678.51	481.71	247	59.11	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16718.0	C08		8	0232-0479	711.23	479.80	241	57.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9456.6	C08		8	0233-0479	902.02	479.72	270	60.53	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10610.4	C08		8	0234-0481	941.03	481.25	232	57.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	19108.6	C08		8	0235-0484	211.36	483.62	105	43.11	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17783.2	C08		8	0236-0487	201.58	488.12	131	48.53	0.699
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10492.6	C08		8	0237-0487	269.16	487.87	231	58.53	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9283.9	C08		8	0238-0489	620.16	488.89	288	65.11	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11323.3	C08		8	0239-0492	554.03	492.40	349	70.67	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9954.3	C08		8	0240-0491	365.53	491.03	225	56.18	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9610.1	C08		8	0241-0500	171.28	499.87	344	68.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10766.3	C08		8	0242-0498	716.02	498.20	226	60.43	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8854.0	C08		8	0243-0497	109.61	497.63	238	59.60	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8885.0	C08		8	0244-0500	238.91	501.10	239	58.87	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9825.9	C08		8	0245-0502	380.62	502.20	268	63.01	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10844.9	C08		8	0246-0507	930.95	506.66	409	77.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11227.0	C08		8	0247-0504	625.16	504.98	238	60.28	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10774.5	C08		8	0248-0503	273.40	503.05	238	58.28	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9738.6	C08		8	0249-0514	89.34	515.12	507	91.15	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9743.2	C08		8	0250-0509	438.00	509.74	255	58.53	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11580.5	C08		8	0251-0510	696.79	510.30	311	66.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10213.4	C08		8	0252-0512	878.28	512.44	244	59.46	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14025.2	C08		8	0253-0514	310.30	513.18	186	51.70	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10219.3	C08		8	0254-0515	201.80	515.64	228	56.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9268.1	C08		8	0255-0517	759.40	516.79	294	64.67	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10916.5	C08		8	0256-0519	811.58	519.44	486	87.98	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8972.3	C08		8	0257-0516	596.04	516.40	298	65.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8993.0	C08		8	0258-0520	237.04	519.50	330	71.11	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9589.4	C08		8	0259-0522	253.68	522.36	228	59.11	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8718.4	C08		8	0260-0523	488.73	522.70	295	62.77	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11297.8	C08		8	0261-0524	661.48	523.87	227	55.70	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11712.3	C08		8	0262-0527	742.40	526.95	260	60.43	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9460.9	C08		8	0263-0530	876.58	529.37	283	62.77	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8931.4	C08		8	0264-0532	356.26	532.79	284	62.53	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9248.1	C08		8	0265-0533	279.96	532.58	250	58.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10401.8	C08		8	0266-0533	631.26	533.79	257	59.60	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8486.2	C08		8	0267-0540	312.82	539.80	275	63.11	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9272.3	C08		8	0268-0544	136.31	544.19	542	91.15	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7282.0	C08		8	0269-0542	19.31	542.57	283	65.01	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11809.1	C08		8	0270-0541	710.78	541.56	213	55.11	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8580.9	C08		8	0271-0547	528.35	547.46	266	63.60	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12166.5	C08		8	0272-0547	659.37	547.28	221	55.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8645.9	C08		8	0273-0548	340.98	548.12	299	66.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9103.3	C08		8	0274-0551	158.34	550.80	237	57.70	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14637.9	C08		8	0275-0558	593.14	559.17	376	84.43	0.663
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10648.0	C08		8	0276-0557	882.02	557.74	446	77.60	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7823.7	C08		8	0277-0555	34.35	555.92	277	66.43	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8122.6	C08		8	0278-0558	212.69	558.00	294	64.53	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10626.6	C08		8	0279-0556	618.51	556.04	242	56.53	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10324.1	C08		8	0280-0557	686.65	556.60	238	59.60	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8036.3	C08		8	0281-0560	179.36	560.21	253	62.77	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10191.9	C08		8	0282-0558	246.73	557.92	240	58.77	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10007.2	C08		8	0283-0562	830.98	562.33	447	79.26	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7996.3	C08		8	0284-0566	803.90	565.85	314	66.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8317.7	C08		8	0285-0569	497.77	569.36	276	64.53	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8661.4	C08		8	0286-0567	759.84	567.25	272	63.01	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8886.7	C08		8	0287-0569	119.71	570.06	268	63.94	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9151.2	C08		8	0288-0571	461.61	571.35	266	61.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10281.5	C08		8	0289-0580	59.92	580.69	231	56.87	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10324.7	C08		8	0290-0579	303.55	579.25	251	58.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10305.0	C08		8	0291-0579	624.67	579.37	252	58.53	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8871.9	C08		8	0292-0583	361.19	583.79	256	61.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10342.8	C08		8	0293-0587	654.64	588.15	349	74.33	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8555.4	C08		8	0294-0589	456.73	589.69	307	70.18	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8165.7	C08		8	0295-0586	529.34	586.84	286	61.94	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11268.4	C08		8	0296-0586	117.58	586.24	206	54.97	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9899.9	C08		8	0297-0596	295.90	596.50	237	62.77	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12369.7	C08		8	0298-0593	868.74	593.33	202	51.70	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8626.9	C08		8	0299-0601	50.38	600.85	254	64.43	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12391.4	C08		8	0300-0599	701.52	599.57	413	75.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7907.9	C08		8	0301-0598	843.25	598.26	291	64.67	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10687.1	C08		8	0302-0600	63.45	600.21	210	57.46	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7886.5	C08		8	0303-0602	559.38	602.13	283	63.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6228.3	C08		8	0304-0602	185.08	602.33	240	61.01	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7982.9	C08		8	0305-0601	405.74	600.46	280	65.70	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8372.8	C08		8	0306-0605	120.49	605.06	281	62.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10753.3	C08		8	0307-0607	825.57	607.00	248	58.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9753.0	C08		8	0308-0611	359.21	612.16	250	61.94	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8100.7	C08		8	0309-0610	721.85	609.54	302	65.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8600.9	C08		8	0310-0613	943.88	612.85	291	65.60	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7826.7	C08		8	0311-0615	41.12	614.97	308	69.50	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9677.0	C08		8	0312-0615	239.39	614.86	257	61.70	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8938.3	C08		8	0313-0616	916.21	616.39	283	64.08	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6597.7	C08		8	0314-0618	207.71	618.12	223	60.77	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7500.2	C08		8	0315-0617	761.84	618.20	286	63.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10550.3	C08		8	0316-0618	306.06	618.28	239	56.53	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8078.0	C08		8	0317-0620	588.43	620.73	279	62.43	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10118.6	C08		8	0318-0622	404.32	622.59	304	64.18	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8110.4	C08		8	0319-0629	517.58	629.12	284	63.84	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9544.1	C08		8	0320-0632	459.52	631.89	370	71.84	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9993.4	C08		8	0321-0636	76.39	636.01	364	70.18	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10495.1	C08		8	0322-0637	110.24	637.03	317	65.36	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14288.9	C08		8	0323-0640	879.84	640.53	526	93.74	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8826.4	C08		8	0324-0639	391.61	638.97	319	68.18	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8548.8	C08		8	0325-0643	248.85	643.59	323	70.43	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7733.8	C08		8	0326-0645	505.10	645.84	306	66.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9596.2	C08		8	0327-0645	768.94	645.84	266	62.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10574.1	C08		8	0328-0651	671.28	651.61	246	60.18	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10419.9	C08		8	0329-0653	706.64	652.08	543	92.91	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9255.2	C08		8	0330-0654	300.37	654.17	247	58.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6705.3	C08		8	0331-0656	925.47	655.80	301	68.08	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8511.2	C08		8	0332-0656	362.05	656.09	299	64.18	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6562.1	C08		8	0333-0658	141.52	658.42	252	70.67	0.634
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7909.9	C08		8	0334-0658	97.64	658.60	267	61.94	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7151.5	C08		8	0335-0662	326.33	662.00	309	69.01	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6829.1	C08		8	0336-0664	412.07	664.33	320	67.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9264.2	C08		8	0337-0663	542.20	662.74	269	62.53	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10082.0	C08		8	0338-0671	679.72	670.55	583	99.98	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8931.5	C08		8	0339-0670	559.96	669.94	306	65.94	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10123.7	C08		8	0340-0671	522.06	670.94	257	60.53	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10010.8	C08		8	0341-0676	839.62	675.96	277	64.43	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8094.2	C08		8	0342-0677	592.10	676.95	301	64.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9006.4	C08		8	0343-0681	426.87	681.11	257	61.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11209.6	C08		8	0344-0680	825.91	680.22	200	55.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11021.6	C08		8	0345-0681	496.51	681.74	226	55.94	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9503.5	C08		8	0346-0684	50.65	684.36	234	58.53	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8771.0	C08		8	0347-0689	254.18	690.21	283	64.43	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10263.4	C08		8	0348-0688	868.57	687.80	244	57.70	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9612.2	C08		8	0349-0690	188.82	689.63	237	57.70	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9563.7	C08		8	0350-0690	937.26	690.82	252	61.11	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7629.5	C08		8	0351-0694	901.66	693.47	276	65.60	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7431.7	C08		8	0352-0701	762.65	700.30	321	72.77	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10317.7	C08		8	0353-0700	43.43	700.32	233	61.01	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8420.3	C08		8	0354-0703	119.57	703.64	249	58.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8908.2	C08		8	0355-0705	520.70	705.43	283	62.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8873.5	C08		8	0356-0706	389.73	707.25	207	55.94	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185033	1375325	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7789.7	C08		8	0357-0707	328.37	707.55	294	67.70	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8829.3	C08		9	0001-0024	161.85	25.29	246	59.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12316.0	C08		9	0002-0035	665.72	35.66	214	57.11	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11684.9	C08		9	0003-0039	312.75	39.43	433	76.67	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8486.2	C08		9	0004-0037	420.03	37.46	346	69.01	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7931.8	C08		9	0005-0040	374.47	40.18	320	66.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8912.4	C08		9	0006-0045	820.05	45.39	381	73.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6976.8	C08		9	0007-0047	72.02	46.73	268	64.18	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11197.9	C08		9	0008-0049	676.39	49.76	243	59.36	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15514.2	C08		9	0009-0050	207.06	50.12	309	65.01	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9533.3	C08		9	0010-0052	170.76	52.19	245	58.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14392.7	C08		9	0011-0055	511.16	55.20	391	73.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10189.3	C08		9	0012-0055	553.62	56.11	265	61.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8165.4	C08		9	0013-0056	84.67	55.33	253	63.60	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8853.3	C08		9	0014-0060	764.20	59.77	410	76.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8286.4	C08		9	0015-0057	111.31	57.22	247	63.94	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8902.4	C08		9	0016-0063	641.28	63.47	291	67.11	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8818.0	C08		9	0017-0063	618.58	62.86	295	65.70	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9731.4	C08		9	0018-0066	660.27	66.16	281	62.18	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9338.3	C08		9	0019-0065	260.89	65.33	267	59.94	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10372.0	C08		9	0020-0065	919.29	65.62	278	62.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9701.1	C08		9	0021-0068	834.44	67.84	321	68.43	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9375.6	C08		9	0022-0074	466.68	74.75	307	65.11	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8058.3	C08		9	0023-0076	27.12	76.64	262	61.60	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8596.9	C08		9	0024-0077	188.25	77.36	293	67.01	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9671.3	C08		9	0025-0078	237.21	78.41	255	61.01	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6170.6	C08		9	0026-0083	329.86	83.01	316	70.08	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10593.9	C08		9	0027-0090	387.72	90.27	630	94.81	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11290.6	C08		9	0028-0084	822.71	84.46	238	56.77	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9125.9	C08		9	0029-0087	949.16	87.00	283	63.01	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10357.1	C08		9	0030-0088	499.50	88.20	272	61.36	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11057.1	C08		9	0031-0095	273.32	94.68	232	57.60	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9573.8	C08		9	0032-0099	837.52	99.21	297	64.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12829.8	C08		9	0033-0103	732.27	102.56	218	57.36	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9413.6	C08		9	0034-0103	439.24	102.90	295	65.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10789.4	C08		9	0035-0104	717.93	103.97	242	57.70	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14037.2	C08		9	0036-0107	610.82	107.38	251	58.28	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10421.2	C08		9	0037-0108	762.14	108.40	290	63.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10304.8	C08		9	0038-0114	213.27	114.06	257	59.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8871.0	C08		9	0039-0119	68.38	119.09	248	64.87	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13566.4	C08		9	0040-0120	50.66	120.43	362	73.36	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8513.4	C08		9	0041-0121	287.36	120.29	279	61.11	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10775.3	C08		9	0042-0121	647.54	121.67	265	61.11	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10062.6	C08		9	0043-0121	943.79	120.02	245	59.94	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17442.1	C08		9	0044-0122	243.16	121.57	263	83.50	0.474
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8582.1	C08		9	0045-0124	862.97	124.53	312	66.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8776.0	C08		9	0046-0126	496.69	125.44	297	64.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11674.8	C08		9	0047-0131	422.92	130.66	210	55.01	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13281.4	C08		9	0048-0130	383.67	130.77	198	53.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10639.9	C08		9	0049-0133	667.11	133.29	248	58.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9464.0	C08		9	0050-0138	68.40	138.48	334	74.77	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11210.1	C08		9	0051-0142	113.99	141.80	371	73.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8157.5	C08		9	0052-0142	192.16	141.80	284	66.67	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9757.7	C08		9	0053-0140	302.18	140.57	275	62.04	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9874.0	C08		9	0054-0143	433.34	143.34	286	62.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11314.2	C08		9	0055-0141	733.55	141.16	244	57.36	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8943.5	C08		9	0056-0142	885.59	142.48	299	63.84	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12421.5	C08		9	0057-0139	772.04	139.76	219	54.87	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12717.9	C08		9	0058-0145	230.77	145.19	399	73.01	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9470.3	C08		9	0059-0147	345.61	146.60	335	67.84	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8627.8	C08		9	0060-0146	132.54	146.26	261	61.94	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12097.1	C08		9	0061-0159	616.86	156.80	390	84.91	0.680
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11093.8	C08		9	0062-0152	166.12	151.85	223	57.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8716.8	C08		9	0063-0153	634.50	153.00	116	38.97	0.960
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7700.9	C08		9	0064-0156	770.74	155.75	343	68.87	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11444.1	C08		9	0065-0156	449.47	155.91	231	55.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9245.2	C08		9	0066-0156	302.96	155.49	244	60.28	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11339.1	C08		9	0067-0162	490.83	162.58	358	71.26	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12038.0	C08		9	0068-0165	572.41	165.15	422	76.18	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9872.7	C08		9	0069-0166	807.34	166.84	302	69.60	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11120.4	C08		9	0070-0170	532.91	170.34	246	59.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9957.2	C08		9	0071-0173	140.65	173.84	242	57.70	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9226.8	C08		9	0072-0177	414.21	176.85	464	80.67	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8558.2	C08		9	0073-0177	251.09	177.59	287	62.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12581.3	C08		9	0074-0177	660.80	177.44	227	56.53	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7686.6	C08		9	0075-0182	827.81	182.46	333	68.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11962.6	C08		9	0076-0186	396.07	188.05	451	86.67	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9392.2	C08		9	0077-0185	750.71	185.11	320	66.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8135.2	C08		9	0078-0184	456.37	184.52	346	75.84	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8318.8	C08		9	0079-0186	559.50	186.39	310	65.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10394.2	C08		9	0080-0189	116.64	189.13	234	55.94	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7590.2	C08		9	0081-0188	167.35	187.41	309	70.53	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12221.7	C08		9	0082-0191	520.39	190.47	422	77.84	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8080.0	C08		9	0083-0192	77.49	191.97	280	63.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9067.4	C08		9	0084-0193	187.40	192.97	270	61.94	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7650.3	C08		9	0085-0191	902.35	191.72	342	71.11	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10053.3	C08		9	0086-0196	324.22	196.80	336	67.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11518.8	C08		9	0087-0199	842.93	200.02	236	57.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11546.4	C08		9	0088-0210	372.57	210.16	458	81.84	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10355.0	C08		9	0089-0206	233.49	206.79	240	58.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8987.5	C08		9	0090-0207	900.41	206.94	299	67.70	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9752.3	C08		9	0091-0211	734.28	211.95	285	63.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7279.3	C08		9	0092-0214	251.54	213.93	326	72.77	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9090.5	C08		9	0093-0211	773.03	210.77	302	64.18	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11970.4	C08		9	0094-0219	463.37	219.42	274	64.53	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11925.0	C08		9	0095-0217	682.78	217.22	230	57.36	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11002.6	C08		9	0096-0219	500.76	219.35	234	57.70	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10718.8	C08		9	0097-0222	127.39	221.66	282	63.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9497.9	C08		9	0098-0220	637.31	220.35	277	61.36	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9580.4	C08		9	0099-0221	78.75	221.20	239	62.18	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8308.8	C08		9	0100-0222	206.90	222.08	262	62.18	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10889.5	C08		9	0101-0227	722.82	226.89	261	63.36	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9563.4	C08		9	0102-0224	928.66	223.68	354	71.01	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13148.4	C08		9	0103-0227	522.97	227.72	319	67.36	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10894.0	C08		9	0104-0238	321.22	237.77	481	81.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12564.8	C08		9	0105-0231	741.47	231.83	261	62.87	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12598.9	C08		9	0106-0236	137.63	236.28	389	72.43	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8026.9	C08		9	0107-0237	777.38	237.02	324	69.01	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7484.6	C08		9	0108-0238	853.32	238.03	340	72.08	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8601.6	C08		9	0109-0238	916.87	238.35	294	65.70	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14034.7	C08		9	0110-0240	623.11	240.28	311	65.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7033.7	C08		9	0111-0243	71.18	243.47	298	66.77	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9731.2	C08		9	0112-0247	451.64	247.20	263	59.36	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9225.2	C08		9	0113-0247	227.38	246.53	271	60.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10535.3	C08		9	0114-0252	290.88	251.22	323	68.08	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8747.8	C08		9	0115-0251	178.20	251.43	263	58.53	0.965
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13011.1	C08		9	0116-0252	539.18	251.95	102	77.98	0.211
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7787.3	C08		9	0117-0259	21.87	259.08	306	69.01	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9730.0	C08		9	0118-0257	148.94	257.02	237	57.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11482.5	C08		9	0119-0257	338.39	257.67	235	56.53	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11224.9	C08		9	0120-0259	806.27	259.06	291	63.11	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10661.4	C08		9	0121-0263	711.79	263.00	343	70.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10855.5	C08		9	0122-0264	280.54	265.02	288	64.08	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10416.9	C08		9	0123-0260	430.89	259.94	241	60.53	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11375.3	C08		9	0124-0264	683.93	264.17	260	60.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10516.4	C08		9	0125-0264	875.82	264.11	313	68.18	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9511.6	C08		9	0126-0271	96.00	269.37	542	99.15	0.693
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11140.2	C08		9	0127-0266	851.68	266.28	250	60.18	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11030.6	C08		9	0128-0268	651.45	267.92	241	61.01	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9338.7	C08		9	0129-0269	616.96	268.57	313	66.77	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7605.3	C08		9	0130-0270	215.06	270.05	331	70.18	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8729.3	C08		9	0131-0275	124.19	275.22	276	64.18	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10130.1	C08		9	0132-0276	434.10	275.58	263	61.11	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10667.2	C08		9	0133-0277	320.08	277.26	241	59.36	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9674.5	C08		9	0134-0281	232.65	281.28	261	61.11	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9894.5	C08		9	0135-0284	345.92	284.36	258	59.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8128.0	C08		9	0136-0289	67.16	289.77	297	68.18	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10717.1	C08		9	0137-0288	931.47	288.01	293	65.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8872.3	C08		9	0138-0291	169.84	291.45	302	65.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9934.9	C08		9	0139-0293	132.68	292.15	267	64.53	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9369.6	C08		9	0140-0292	731.38	291.66	311	69.60	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11961.0	C08		9	0141-0299	107.70	299.35	444	81.84	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10458.4	C08		9	0142-0298	434.80	298.10	239	56.53	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11928.5	C08		9	0143-0303	239.39	302.15	539	92.91	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8479.6	C08		9	0144-0300	377.66	300.14	294	64.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13831.1	C08		9	0145-0302	549.83	302.46	337	66.77	0.950
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8977.7	C08		9	0146-0301	764.47	301.35	306	65.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7749.4	C08		9	0147-0309	392.37	309.45	358	77.36	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11663.0	C08		9	0148-0309	347.42	309.38	218	60.28	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9302.1	C08		9	0149-0310	896.98	310.50	288	62.18	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12912.9	C08		9	0150-0311	577.44	310.83	300	63.36	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10026.9	C08		9	0151-0312	216.08	312.50	255	60.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8416.0	C08		9	0152-0314	494.42	314.03	302	69.26	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10405.4	C08		9	0153-0316	284.47	316.16	255	61.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11509.2	C08		9	0154-0318	168.21	318.26	221	53.94	0.954
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13196.3	C08		9	0155-0317	772.86	317.30	215	55.11	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9061.8	C08		9	0156-0326	316.42	327.16	303	68.43	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8791.9	C08		9	0157-0329	100.11	329.05	280	63.01	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10316.1	C08		9	0158-0328	399.84	329.06	255	61.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7935.3	C08		9	0159-0331	473.65	331.97	309	69.94	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10488.8	C08		9	0160-0335	827.11	334.40	269	65.01	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9216.3	C08		9	0161-0334	653.21	334.08	294	63.94	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11229.0	C08		9	0162-0337	158.65	337.24	315	66.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8890.9	C08		9	0163-0339	906.65	338.05	301	66.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15598.4	C08		9	0164-0341	280.12	341.05	159	46.87	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9911.7	C08		9	0165-0346	405.37	345.82	260	64.53	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10153.4	C08		9	0166-0346	501.49	346.23	253	57.94	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10465.1	C08		9	0167-0349	610.54	349.77	277	61.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9978.6	C08		9	0168-0351	141.79	350.62	239	59.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13864.8	C08		9	0169-0351	658.83	350.93	212	54.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15448.8	C08		9	0170-0350	285.21	350.41	164	53.70	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12244.7	C08		9	0171-0356	820.54	356.82	457	79.50	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9567.3	C08		9	0172-0356	448.40	356.50	293	63.26	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9673.0	C08		9	0173-0355	476.70	354.62	261	60.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9217.0	C08		9	0174-0357	577.40	356.95	299	68.77	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10557.8	C08		9	0175-0358	238.80	359.38	238	58.18	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10477.4	C08		9	0176-0357	419.39	357.22	250	59.70	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8029.9	C08		9	0177-0361	555.88	361.12	311	71.01	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10232.0	C08		9	0178-0361	65.88	360.72	247	58.18	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8456.0	C08		9	0179-0361	19.97	360.70	264	61.11	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10375.4	C08		9	0180-0361	132.83	362.58	260	61.84	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6780.6	C08		9	0181-0364	345.75	364.55	320	67.84	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12569.1	C08		9	0182-0362	689.31	362.03	220	55.11	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11282.9	C08		9	0183-0365	192.24	365.31	356	69.60	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9537.9	C08		9	0184-0369	298.99	368.75	288	61.36	0.961
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6958.9	C08		9	0185-0376	361.42	376.48	319	71.11	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12243.9	C08		9	0186-0374	649.12	373.54	234	59.11	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9981.2	C08		9	0187-0380	597.95	380.23	274	64.18	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11729.4	C08		9	0188-0380	707.53	380.45	241	58.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11603.2	C08		9	0189-0381	678.68	381.16	240	57.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9655.3	C08		9	0190-0381	225.76	381.28	250	57.94	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11683.2	C08		9	0191-0383	756.09	383.91	241	59.94	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12213.6	C08		9	0192-0391	779.07	391.01	340	72.67	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10813.1	C08		9	0193-0390	799.10	391.04	245	59.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8584.5	C08		9	0194-0392	89.33	392.36	270	62.18	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8772.2	C08		9	0195-0391	43.24	392.06	257	60.53	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8509.4	C08		9	0196-0395	609.25	395.53	320	67.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12381.4	C08		9	0197-0393	699.56	393.71	208	55.94	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8265.9	C08		9	0198-0400	15.94	400.42	270	60.18	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9278.2	C08		9	0199-0400	309.65	400.91	265	59.36	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9090.9	C08		9	0200-0400	833.98	400.08	295	62.53	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10128.6	C08		9	0201-0407	902.30	406.64	274	62.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8091.8	C08		9	0202-0412	521.72	412.19	305	67.94	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11719.9	C08		9	0203-0408	697.46	408.03	236	57.11	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10273.5	C08		9	0204-0421	330.18	420.87	469	82.57	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11858.2	C08		9	0205-0416	730.08	415.55	217	55.36	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9307.3	C08		9	0206-0421	857.42	421.28	284	64.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11208.7	C08		9	0207-0424	657.84	423.98	250	59.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9162.7	C08		9	0208-0430	96.02	429.79	282	62.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12304.7	C08		9	0209-0430	53.43	430.31	184	59.36	0.656
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9509.1	C08		9	0210-0429	272.80	429.35	252	63.70	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11266.7	C08		9	0211-0436	937.67	435.69	355	72.18	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10031.2	C08		9	0212-0434	404.28	434.71	268	60.53	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10518.5	C08		9	0213-0434	221.85	434.00	235	56.53	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13592.7	C08		9	0214-0437	835.72	437.04	437	77.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10021.1	C08		9	0215-0433	741.32	433.53	271	64.28	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8405.1	C08		9	0216-0441	183.31	440.67	278	63.36	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10087.6	C08		9	0217-0445	118.89	445.84	253	59.94	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9509.2	C08		9	0218-0445	276.34	444.55	334	71.01	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15188.0	C08		9	0219-0446	568.93	446.43	359	69.60	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9297.9	C08		9	0220-0450	509.86	450.39	295	67.26	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10862.2	C08		9	0221-0451	20.54	450.78	221	57.11	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9348.8	C08		9	0222-0451	92.12	451.47	252	58.53	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9403.2	C08		9	0223-0455	199.91	454.64	259	58.87	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8843.5	C08		9	0224-0457	140.99	457.34	266	61.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8608.9	C08		9	0225-0458	292.70	459.22	301	65.50	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9853.5	C08		9	0226-0464	16.19	464.87	249	61.70	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14065.1	C08		9	0227-0466	246.15	466.00	365	69.84	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12552.3	C08		9	0228-0465	774.80	465.10	224	57.11	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12923.0	C08		9	0229-0473	845.32	474.29	456	80.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9360.0	C08		9	0230-0473	943.11	472.67	290	64.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11111.8	C08		9	0231-0474	586.90	473.65	236	56.77	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10300.8	C08		9	0232-0477	117.41	476.98	231	56.53	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10061.5	C08		9	0233-0479	533.86	479.51	256	61.94	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13495.2	C08		9	0234-0477	780.99	477.30	204	56.87	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12317.3	C08		9	0235-0486	732.95	485.44	478	90.33	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9843.9	C08		9	0236-0484	35.89	484.22	231	57.36	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12249.0	C08		9	0237-0489	799.12	490.26	263	62.53	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12449.3	C08		9	0238-0492	865.20	491.40	373	74.08	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10112.5	C08		9	0239-0491	170.18	491.71	244	57.70	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8987.5	C08		9	0240-0494	360.13	494.65	280	61.11	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10890.0	C08		9	0241-0496	397.72	496.43	237	57.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15094.4	C08		9	0242-0497	709.02	498.02	186	53.36	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10038.6	C08		9	0243-0501	889.82	500.72	276	63.01	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11478.9	C08		9	0244-0501	745.35	500.87	258	59.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10043.2	C08		9	0245-0509	25.61	509.50	411	76.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9596.4	C08		9	0246-0506	187.12	506.63	263	64.18	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10416.0	C08		9	0247-0508	630.19	507.52	302	65.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11443.4	C08		9	0248-0509	793.51	508.92	295	66.53	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11515.7	C08		9	0249-0513	765.22	513.46	253	60.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10200.9	C08		9	0250-0515	427.69	515.11	257	60.53	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9236.3	C08		9	0251-0520	600.81	520.37	291	64.43	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9725.4	C08		9	0252-0521	190.24	520.79	236	61.94	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8623.1	C08		9	0253-0526	312.34	526.57	272	63.26	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11638.1	C08		9	0254-0523	382.37	523.68	259	60.87	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9985.3	C08		9	0255-0532	900.91	532.53	282	61.60	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9336.1	C08		9	0256-0534	743.07	534.31	283	63.60	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10445.7	C08		9	0257-0536	72.15	535.68	229	58.18	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10087.5	C08		9	0258-0536	345.34	536.25	264	60.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10525.8	C08		9	0259-0541	115.02	540.89	231	57.11	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10689.4	C08		9	0260-0541	388.16	540.96	250	62.04	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8992.9	C08		9	0261-0544	146.31	544.72	261	59.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14017.9	C08		9	0262-0550	208.62	549.77	372	71.01	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10189.4	C08		9	0263-0549	530.58	548.82	256	59.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8647.4	C08		9	0264-0552	65.45	553.53	305	69.74	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10045.1	C08		9	0265-0551	462.86	551.05	255	61.36	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8807.3	C08		9	0266-0558	187.19	558.95	291	65.11	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9473.8	C08		9	0267-0560	131.96	560.28	266	60.77	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10732.8	C08		9	0268-0560	300.81	559.95	236	57.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7469.0	C08		9	0269-0562	939.43	562.66	339	69.60	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8497.0	C08		9	0270-0563	49.26	563.13	288	64.18	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9169.1	C08		9	0271-0564	85.36	565.00	271	66.43	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10281.3	C08		9	0272-0566	339.62	565.46	310	65.36	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8727.3	C08		9	0273-0569	464.96	569.44	300	63.36	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9239.2	C08		9	0274-0575	736.81	575.78	288	64.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7632.8	C08		9	0275-0577	412.79	577.08	301	67.36	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10257.7	C08		9	0276-0584	694.25	583.79	271	64.53	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8712.8	C08		9	0277-0583	193.20	583.45	294	65.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9004.7	C08		9	0278-0588	385.14	587.73	347	73.36	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6993.5	C08		9	0279-0589	72.04	589.28	271	63.70	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9057.5	C08		9	0280-0593	212.91	593.17	300	64.53	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9476.4	C08		9	0281-0595	369.24	595.55	270	63.94	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8217.1	C08		9	0282-0597	146.27	597.00	301	64.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10421.5	C08		9	0283-0600	756.21	600.54	250	60.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10007.5	C08		9	0284-0609	524.75	609.24	263	60.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8340.9	C08		9	0285-0616	38.28	615.69	283	63.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9016.6	C08		9	0286-0619	933.03	619.84	281	62.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9479.7	C08		9	0287-0622	196.88	622.44	282	62.87	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9159.1	C08		9	0288-0623	881.73	623.66	287	62.77	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9378.5	C08		9	0289-0627	467.98	627.32	335	68.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8309.1	C08		9	0290-0632	89.86	632.14	284	64.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9297.8	C08		9	0291-0637	150.45	637.26	292	63.36	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12412.3	C08		9	0292-0649	202.97	648.00	683	104.33	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9740.6	C08		9	0293-0648	124.90	648.49	260	61.36	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8737.2	C08		9	0294-0651	511.67	651.43	319	67.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9727.8	C08		9	0295-0651	69.79	650.22	248	61.36	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9712.3	C08		9	0296-0650	744.16	649.99	267	60.53	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9647.1	C08		9	0297-0650	263.16	650.76	250	60.53	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6445.5	C08		9	0298-0659	19.67	658.90	268	63.60	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8758.8	C08		9	0299-0665	66.46	665.98	267	64.77	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10683.3	C08		9	0300-0668	184.98	667.40	248	60.77	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8586.0	C08		9	0301-0666	264.82	665.46	286	72.77	0.679
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10298.6	C08		9	0302-0671	207.75	671.46	339	71.94	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9132.9	C08		9	0303-0668	387.01	668.37	303	66.43	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8189.5	C08		9	0304-0669	475.83	669.81	291	64.77	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9480.3	C08		9	0305-0673	781.40	673.09	311	67.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11494.4	C08		9	0306-0675	172.35	675.41	223	57.70	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8795.2	C08		9	0307-0677	111.57	677.69	283	61.36	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10409.2	C08		9	0308-0683	936.29	683.92	458	86.43	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9424.2	C08		9	0309-0678	251.31	678.44	264	60.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10232.3	C08		9	0310-0684	140.58	684.18	241	63.11	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9919.9	C08		9	0311-0690	321.34	691.53	581	89.74	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10351.0	C08		9	0312-0689	360.96	689.61	257	60.18	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9081.4	C08		9	0313-0693	31.45	693.71	260	61.70	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9653.7	C08		9	0314-0695	888.76	694.75	257	61.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8915.2	C08		9	0315-0695	57.33	695.07	272	64.18	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9899.8	C08		9	0316-0699	199.59	698.64	226	56.67	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8908.2	C08		9	0317-0702	750.25	702.11	297	63.60	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9529.9	C08		9	0318-0703	950.13	704.06	183	53.70	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8876.8	C08		9	0319-0704	937.61	703.39	120	41.56	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.0316	uM	48	hr	1185034	1375326	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9626.6	C08		9	0320-0707	214.24	708.02	262	62.18	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6515.9	D08		1	0001-0031	502.05	32.10	433	78.91	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5947.2	D08		1	0002-0035	683.37	35.30	402	74.43	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6430.1	D08		1	0003-0039	168.05	39.26	489	82.67	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5563.5	D08		1	0004-0037	106.24	37.36	378	72.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7447.4	D08		1	0005-0049	326.88	48.58	751	107.30	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6331.9	D08		1	0006-0044	231.54	43.76	386	72.67	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7886.0	D08		1	0007-0053	916.42	53.65	703	101.50	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6066.8	D08		1	0008-0051	573.73	51.36	507	86.18	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6885.1	D08		1	0009-0051	450.99	50.66	464	82.91	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5738.2	D08		1	0010-0054	799.48	53.77	390	77.26	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6292.5	D08		1	0011-0059	633.85	59.36	412	77.50	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7126.5	D08		1	0012-0069	747.78	68.50	777	107.05	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6785.7	D08		1	0013-0069	470.40	69.42	494	89.26	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6203.8	D08		1	0014-0072	394.62	72.16	441	76.43	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5359.4	D08		1	0015-0074	600.83	74.82	443	84.08	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6237.4	D08		1	0016-0076	493.85	76.67	503	87.60	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5606.6	D08		1	0017-0075	232.83	75.37	381	73.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5921.4	D08		1	0018-0075	574.54	74.86	434	79.11	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6014.9	D08		1	0019-0079	724.21	79.27	424	78.08	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5381.8	D08		1	0020-0082	109.11	82.07	363	71.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7021.0	D08		1	0021-0086	26.13	85.99	531	87.50	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7017.6	D08		1	0022-0086	935.26	86.56	381	73.50	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5710.4	D08		1	0023-0096	306.50	96.09	417	79.36	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6988.5	D08		1	0024-0106	533.49	106.01	807	108.23	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5763.1	D08		1	0025-0101	285.13	101.97	407	79.01	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6390.4	D08		1	0026-0103	635.68	103.29	852	117.54	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4979.7	D08		1	0027-0105	186.52	104.86	373	75.26	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6382.9	D08		1	0028-0108	789.69	108.23	359	73.60	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7610.6	D08		1	0029-0112	834.07	111.51	371	73.01	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5932.2	D08		1	0030-0113	391.56	113.78	401	74.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6546.9	D08		1	0031-0115	699.70	115.21	399	75.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6239.0	D08		1	0032-0123	159.83	123.97	830	116.37	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6147.3	D08		1	0033-0117	446.57	117.74	434	79.50	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6012.9	D08		1	0034-0120	612.49	120.72	422	79.15	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6375.4	D08		1	0035-0121	926.26	121.01	392	72.18	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5303.0	D08		1	0036-0123	73.44	123.49	376	71.01	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5554.3	D08		1	0037-0126	735.15	126.18	452	81.26	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7013.5	D08		1	0038-0134	420.57	133.51	950	125.88	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6382.0	D08		1	0039-0128	783.39	127.59	449	85.26	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9355.0	D08		1	0040-0144	506.95	143.84	677	95.50	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6240.6	D08		1	0041-0143	905.12	143.51	392	73.60	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6021.0	D08		1	0042-0142	824.88	142.30	383	75.26	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5939.7	D08		1	0043-0146	297.25	145.43	396	74.08	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5373.2	D08		1	0044-0158	642.35	158.75	393	74.67	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5622.4	D08		1	0045-0159	714.83	158.98	388	76.67	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7469.1	D08		1	0046-0164	277.35	164.21	729	105.05	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5512.0	D08		1	0047-0160	227.30	159.90	390	76.08	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6628.1	D08		1	0048-0166	117.67	165.95	373	72.67	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5554.3	D08		1	0049-0166	578.16	166.33	390	74.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5183.3	D08		1	0050-0180	678.45	180.31	399	78.33	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6823.8	D08		1	0051-0179	809.52	179.24	398	73.84	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5475.5	D08		1	0052-0180	338.38	179.91	418	81.01	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5399.6	D08		1	0053-0181	167.78	181.14	400	75.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5577.4	D08		1	0054-0182	444.35	182.31	382	73.84	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5978.7	D08		1	0055-0187	316.80	187.46	409	78.77	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5712.0	D08		1	0056-0187	207.94	187.03	397	77.50	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5988.0	D08		1	0057-0194	513.29	194.35	400	73.26	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6440.5	D08		1	0058-0197	940.92	197.02	399	76.43	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5395.0	D08		1	0059-0199	37.04	199.58	382	73.84	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7251.8	D08		1	0060-0209	253.78	208.26	925	123.78	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5944.8	D08		1	0061-0198	887.77	198.92	427	75.84	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6912.9	D08		1	0062-0199	798.35	199.86	390	73.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5822.5	D08		1	0063-0201	719.56	201.34	398	76.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9479.0	D08		1	0064-0206	71.18	205.95	602	90.91	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5906.1	D08		1	0065-0204	764.36	204.33	390	73.26	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7049.0	D08		1	0066-0207	562.41	208.31	379	75.94	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5319.4	D08		1	0067-0213	135.78	212.78	380	75.50	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6043.8	D08		1	0068-0221	927.57	220.99	385	72.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10012.3	D08		1	0069-0227	202.54	226.91	603	97.98	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5533.4	D08		1	0070-0224	615.97	224.41	409	76.67	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6329.1	D08		1	0071-0224	851.76	224.07	404	75.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7991.1	D08		1	0072-0232	271.35	234.30	725	103.78	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5107.4	D08		1	0073-0227	357.51	227.54	399	78.33	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5633.3	D08		1	0074-0229	482.77	228.83	357	74.18	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7010.3	D08		1	0075-0229	563.89	228.90	504	88.77	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8124.9	D08		1	0076-0238	890.09	239.12	727	104.13	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7918.5	D08		1	0077-0237	506.66	236.92	730	101.50	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5703.8	D08		1	0078-0240	540.09	240.67	552	94.91	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7501.3	D08		1	0079-0236	136.86	236.60	377	74.18	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6499.5	D08		1	0080-0242	58.13	242.18	440	77.84	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5054.9	D08		1	0081-0256	20.39	256.84	381	76.08	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5339.1	D08		1	0082-0258	459.44	258.25	392	73.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5089.7	D08		1	0083-0259	112.01	259.70	374	75.26	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5802.5	D08		1	0084-0271	746.54	271.87	414	75.60	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6448.1	D08		1	0085-0273	854.96	273.67	395	74.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6377.6	D08		1	0086-0279	180.41	278.30	384	73.01	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6092.2	D08		1	0087-0280	697.87	280.13	419	78.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5714.3	D08		1	0088-0281	315.70	280.31	405	76.67	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5973.0	D08		1	0089-0282	813.95	282.55	410	77.26	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5593.1	D08		1	0090-0287	936.07	287.70	382	73.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6130.7	D08		1	0091-0289	296.01	290.63	412	80.67	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5907.2	D08		1	0092-0294	641.46	293.41	420	77.26	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8817.6	D08		1	0093-0299	840.45	299.21	344	68.18	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6438.7	D08		1	0094-0300	899.82	300.36	385	72.43	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7977.0	D08		1	0095-0304	436.31	304.50	925	116.23	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5973.4	D08		1	0096-0303	219.20	302.97	382	71.60	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5737.2	D08		1	0097-0306	109.51	306.11	396	77.26	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9010.7	D08		1	0098-0310	175.48	310.67	613	96.81	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5579.6	D08		1	0099-0305	37.12	304.96	376	74.08	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6832.4	D08		1	0100-0309	549.31	309.07	383	71.60	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5476.4	D08		1	0101-0319	681.97	319.46	401	75.01	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5170.6	D08		1	0102-0319	393.65	319.13	386	73.84	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6238.2	D08		1	0103-0327	934.12	327.39	370	71.26	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6430.9	D08		1	0104-0333	774.77	333.03	392	73.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6151.3	D08		1	0105-0333	582.47	333.28	913	135.05	0.629
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6635.7	D08		1	0106-0336	729.96	335.83	392	73.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5892.4	D08		1	0107-0340	823.92	339.51	324	70.33	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5791.6	D08		1	0108-0344	144.33	344.39	395	74.08	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5365.1	D08		1	0109-0345	180.49	344.57	405	77.50	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5133.8	D08		1	0110-0347	37.82	347.41	374	73.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7556.1	D08		1	0111-0354	298.60	353.98	743	108.13	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5808.9	D08		1	0112-0351	352.83	351.52	398	74.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6182.4	D08		1	0113-0354	106.35	354.35	382	73.84	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7602.1	D08		1	0114-0357	622.14	357.04	652	97.98	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6192.5	D08		1	0115-0365	201.37	366.55	896	121.98	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5202.7	D08		1	0116-0370	707.79	370.13	433	79.50	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7178.6	D08		1	0117-0373	644.17	373.30	598	93.74	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9753.5	D08		1	0118-0373	567.86	374.36	591	92.18	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8045.7	D08		1	0119-0382	920.26	382.67	916	122.23	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6499.2	D08		1	0120-0375	771.27	375.83	427	77.50	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6902.5	D08		1	0121-0381	879.09	380.59	377	71.84	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6213.7	D08		1	0122-0383	134.35	382.33	377	72.91	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5311.0	D08		1	0123-0388	404.24	388.60	396	75.26	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5742.5	D08		1	0124-0397	151.05	397.56	433	81.15	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6945.0	D08		1	0125-0400	578.04	398.64	909	124.47	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5899.9	D08		1	0126-0397	686.35	397.94	414	75.84	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6919.2	D08		1	0127-0402	757.16	401.49	427	78.67	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5975.0	D08		1	0128-0407	603.82	407.99	414	77.74	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5922.2	D08		1	0129-0416	320.94	415.48	832	111.64	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5692.4	D08		1	0130-0412	201.41	411.91	398	75.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7332.6	D08		1	0131-0412	876.19	412.31	396	74.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5337.2	D08		1	0132-0420	769.40	420.86	452	86.91	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6019.1	D08		1	0133-0428	492.31	428.55	399	75.84	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5655.6	D08		1	0134-0433	432.61	433.37	389	73.84	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5432.0	D08		1	0135-0433	655.07	433.40	396	74.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5806.2	D08		1	0136-0446	370.45	445.64	871	123.88	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5490.0	D08		1	0137-0443	99.12	443.74	373	70.43	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7433.4	D08		1	0138-0446	931.58	445.38	330	72.77	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6002.6	D08		1	0139-0446	464.85	446.15	392	73.26	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7274.6	D08		1	0140-0449	914.46	449.53	412	80.18	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6217.9	D08		1	0141-0450	293.65	450.79	391	75.50	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8072.8	D08		1	0142-0453	562.54	453.36	701	99.64	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5402.7	D08		1	0143-0449	715.45	448.99	390	76.08	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5256.1	D08		1	0144-0454	142.77	454.03	401	77.50	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6326.3	D08		1	0145-0455	946.44	455.06	407	78.08	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5643.1	D08		1	0146-0465	186.09	465.22	378	73.50	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6574.1	D08		1	0147-0473	48.87	472.73	757	108.81	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5705.9	D08		1	0148-0468	763.11	467.65	373	73.26	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7759.8	D08		1	0149-0479	695.70	479.85	998	122.81	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5610.9	D08		1	0150-0476	640.27	476.07	384	73.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5487.1	D08		1	0151-0480	336.26	480.21	402	76.77	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6302.9	D08		1	0152-0483	393.22	482.93	564	89.98	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6479.4	D08		1	0153-0480	849.69	480.79	391	74.77	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5303.6	D08		1	0154-0484	443.37	484.11	426	77.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5924.1	D08		1	0155-0484	213.28	483.94	379	71.60	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6948.2	D08		1	0156-0487	770.70	487.97	410	79.15	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5473.2	D08		1	0157-0490	533.71	490.14	403	78.08	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5553.8	D08		1	0158-0489	573.51	488.99	384	74.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6154.5	D08		1	0159-0488	313.19	488.37	428	79.60	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5086.3	D08		1	0160-0497	87.71	497.66	366	71.84	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6007.7	D08		1	0161-0499	866.23	499.79	410	78.08	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7135.8	D08		1	0162-0499	922.02	498.94	359	69.60	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4978.3	D08		1	0163-0506	45.32	507.06	382	78.91	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6568.3	D08		1	0164-0508	817.58	507.77	374	72.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5692.9	D08		1	0165-0509	17.93	509.60	362	72.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7918.4	D08		1	0166-0510	188.53	509.87	383	71.84	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5167.7	D08		1	0167-0512	606.62	511.74	393	76.08	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5959.8	D08		1	0168-0513	745.60	513.60	376	73.01	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5012.6	D08		1	0169-0513	487.28	512.82	395	76.08	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5337.9	D08		1	0170-0517	895.51	516.63	393	75.50	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5433.2	D08		1	0171-0521	326.02	521.07	373	71.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5709.7	D08		1	0172-0523	118.03	523.23	386	72.18	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5563.0	D08		1	0173-0525	289.17	524.87	410	76.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5200.6	D08		1	0174-0525	420.66	525.54	395	76.08	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5248.2	D08		1	0175-0528	648.78	528.16	396	74.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5835.5	D08		1	0176-0530	163.13	530.49	391	74.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6395.9	D08		1	0177-0530	771.34	530.25	390	73.01	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5328.2	D08		1	0178-0533	199.57	533.05	381	73.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5379.3	D08		1	0179-0540	385.59	540.73	417	78.91	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5557.3	D08		1	0180-0539	543.36	539.82	398	75.84	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5294.9	D08		1	0181-0547	897.72	547.42	433	85.40	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5358.9	D08		1	0182-0544	40.20	544.43	338	70.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6592.3	D08		1	0183-0548	473.27	547.35	620	101.40	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8206.7	D08		1	0184-0562	275.66	562.66	620	92.91	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6633.1	D08		1	0185-0571	557.83	571.47	817	113.78	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5351.6	D08		1	0186-0565	658.42	565.82	393	73.84	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6113.0	D08		1	0187-0570	94.36	570.37	340	68.18	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5743.0	D08		1	0188-0570	756.96	569.72	404	76.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6008.4	D08		1	0189-0573	890.54	574.05	415	78.43	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5919.1	D08		1	0190-0575	718.87	575.35	418	79.15	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6107.8	D08		1	0191-0584	443.06	584.72	994	128.02	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5565.2	D08		1	0192-0581	202.82	581.40	407	77.84	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5792.7	D08		1	0193-0584	360.11	584.44	373	73.26	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6267.6	D08		1	0194-0585	610.58	584.79	382	73.26	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6295.3	D08		1	0195-0583	861.48	583.27	393	78.33	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5767.4	D08		1	0196-0591	809.80	591.24	406	78.91	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4592.0	D08		1	0197-0602	194.05	601.73	235	60.77	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5259.5	D08		1	0198-0606	401.04	605.93	421	77.26	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4949.9	D08		1	0199-0607	249.23	606.40	392	78.67	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5574.9	D08		1	0200-0607	715.39	607.94	388	76.67	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5679.3	D08		1	0201-0609	886.12	609.68	379	75.84	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5850.4	D08		1	0202-0613	662.08	613.08	400	74.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5518.1	D08		1	0203-0613	81.87	613.13	432	82.81	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6260.3	D08		1	0204-0619	359.78	619.40	408	77.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5559.6	D08		1	0205-0623	500.22	622.62	416	77.50	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5597.3	D08		1	0206-0632	54.26	631.53	380	72.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5141.5	D08		1	0207-0634	156.18	634.61	438	77.84	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5520.0	D08		1	0208-0632	314.53	632.31	371	75.60	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5782.9	D08		1	0209-0635	337.73	634.71	468	90.18	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6780.1	D08		1	0210-0639	845.81	638.80	759	104.33	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5025.9	D08		1	0211-0637	182.83	636.98	452	85.40	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5519.4	D08		1	0212-0638	479.84	638.61	466	84.91	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5281.0	D08		1	0213-0643	360.80	643.00	528	91.84	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6440.3	D08		1	0214-0643	403.72	643.53	391	72.43	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5436.6	D08		1	0215-0644	797.68	644.62	380	74.43	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6195.9	D08		1	0216-0648	23.17	647.57	369	76.18	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6324.8	D08		1	0217-0653	447.13	653.51	845	118.02	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4862.6	D08		1	0218-0650	266.50	650.23	286	67.60	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6136.2	D08		1	0219-0650	606.93	650.53	444	79.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5711.6	D08		1	0220-0654	76.29	654.09	364	70.43	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5502.6	D08		1	0221-0657	213.13	657.27	388	76.08	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5653.4	D08		1	0222-0660	914.73	660.25	368	72.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6033.0	D08		1	0223-0665	714.94	664.98	405	77.01	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5089.7	D08		1	0224-0666	743.38	666.07	459	82.91	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6394.2	D08		1	0225-0666	648.30	666.58	374	70.43	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9089.3	D08		1	0226-0675	326.89	674.93	673	97.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7075.1	D08		1	0227-0680	772.33	679.99	356	70.43	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7246.7	D08		1	0228-0688	812.57	689.08	726	108.43	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5199.0	D08		1	0229-0686	489.12	685.84	367	75.74	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5480.2	D08		1	0230-0687	143.02	687.83	440	78.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5214.6	D08		1	0231-0690	871.85	690.33	358	72.43	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4965.1	D08		1	0232-0690	191.96	690.27	398	77.50	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5513.8	D08		1	0233-0696	352.59	695.18	460	83.50	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5764.1	D08		1	0234-0700	530.30	700.74	818	111.88	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5179.1	D08		1	0235-0700	579.33	700.33	362	73.50	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184990	1375327	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5257.3	D08		1	0236-0705	67.56	705.01	383	74.08	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7104.9	D08		3	0001-0032	610.87	32.70	388	77.15	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6776.2	D08		3	0002-0038	761.28	37.99	356	70.43	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7394.6	D08		3	0003-0042	860.23	42.15	366	72.18	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5978.4	D08		3	0004-0041	227.10	41.65	345	72.67	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7119.4	D08		3	0005-0043	410.65	43.52	431	78.67	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6965.9	D08		3	0006-0044	45.88	44.22	373	79.60	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6571.7	D08		3	0007-0047	258.54	47.53	359	75.98	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8019.7	D08		3	0008-0045	550.76	44.87	362	72.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6940.0	D08		3	0009-0049	839.59	49.01	381	77.50	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7368.0	D08		3	0010-0051	694.22	51.36	349	70.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6143.9	D08		3	0011-0053	23.37	52.47	350	73.01	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5526.7	D08		3	0012-0055	131.62	55.52	364	76.67	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7086.8	D08		3	0013-0058	54.92	58.96	377	80.43	0.732
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6921.1	D08		3	0014-0064	74.21	63.65	384	77.26	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7536.2	D08		3	0015-0063	927.38	63.53	352	71.26	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6548.4	D08		3	0016-0065	350.14	65.53	386	73.84	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7450.8	D08		3	0017-0069	250.38	69.79	363	77.26	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6753.8	D08		3	0018-0067	904.78	67.76	366	72.33	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6584.5	D08		3	0019-0072	180.20	72.28	368	75.74	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8417.6	D08		3	0020-0072	231.46	72.41	371	74.87	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7011.1	D08		3	0021-0073	787.16	73.24	361	74.08	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11969.5	D08		3	0022-0080	733.46	80.24	325	113.64	0.316
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6064.1	D08		3	0023-0086	89.85	85.99	341	71.84	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8523.5	D08		3	0024-0091	165.10	92.46	712	105.40	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7094.5	D08		3	0025-0088	659.30	87.84	389	77.50	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7186.8	D08		3	0026-0087	685.00	87.49	373	74.33	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8503.0	D08		3	0027-0089	473.46	89.44	376	74.91	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8159.2	D08		3	0028-0091	502.43	91.20	384	76.91	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6451.0	D08		3	0029-0090	753.67	90.95	380	74.08	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7810.2	D08		3	0030-0093	429.24	93.02	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6558.5	D08		3	0031-0093	230.83	92.37	369	72.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7199.4	D08		3	0032-0097	546.64	97.18	360	72.67	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7071.7	D08		3	0033-0098	833.39	98.43	356	70.18	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7126.7	D08		3	0034-0105	125.31	106.25	731	109.54	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7176.0	D08		3	0035-0102	376.54	102.10	373	73.84	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9805.6	D08		3	0036-0106	904.74	106.07	302	66.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7518.8	D08		3	0037-0110	488.71	110.65	412	86.57	0.691
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6588.2	D08		3	0038-0113	641.59	113.02	367	75.84	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6332.5	D08		3	0039-0114	312.85	115.19	368	72.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6659.7	D08		3	0040-0116	69.56	116.39	359	76.33	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6073.3	D08		3	0041-0123	31.77	123.36	329	69.01	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8440.3	D08		3	0042-0121	723.76	121.05	350	73.84	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9610.8	D08		3	0043-0132	913.74	132.69	582	92.81	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6421.0	D08		3	0044-0129	456.50	128.80	387	75.50	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7221.4	D08		3	0045-0131	273.44	130.78	321	67.94	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6193.0	D08		3	0046-0132	293.91	132.21	440	84.67	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6819.1	D08		3	0047-0136	627.21	136.50	365	74.33	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6562.5	D08		3	0048-0138	384.28	138.48	386	75.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6717.4	D08		3	0049-0139	491.76	139.37	370	75.26	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6435.4	D08		3	0050-0142	83.52	141.45	354	71.01	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7040.0	D08		3	0051-0142	173.87	142.35	347	72.08	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7328.0	D08		3	0052-0141	810.52	140.67	331	69.84	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7460.6	D08		3	0053-0148	544.92	147.95	411	76.91	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9486.7	D08		3	0054-0150	859.07	149.48	299	66.18	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6281.0	D08		3	0055-0153	243.01	153.61	398	76.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7561.6	D08		3	0056-0154	761.70	154.94	330	68.28	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6689.6	D08		3	0057-0158	219.30	157.52	385	77.50	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6929.8	D08		3	0058-0163	139.16	162.74	404	77.26	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6723.8	D08		3	0059-0165	43.97	164.94	345	69.84	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6647.1	D08		3	0060-0169	414.27	168.40	409	78.91	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6933.3	D08		3	0061-0166	592.25	165.95	388	77.50	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7468.5	D08		3	0062-0171	912.62	171.55	375	73.50	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8028.0	D08		3	0063-0179	646.07	177.21	720	110.61	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7607.1	D08		3	0064-0173	850.67	172.97	350	69.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6950.5	D08		3	0065-0181	434.16	179.91	762	118.51	0.682
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10142.0	D08		3	0066-0175	759.81	175.04	560	90.18	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7181.9	D08		3	0067-0178	879.52	178.93	356	73.01	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6196.2	D08		3	0068-0178	341.98	177.70	347	70.43	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7341.1	D08		3	0069-0196	97.38	195.27	747	118.95	0.663
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6809.5	D08		3	0070-0195	488.00	194.77	353	72.67	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10164.5	D08		3	0071-0195	523.35	194.58	307	65.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6799.7	D08		3	0072-0197	687.05	197.04	347	73.26	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6636.6	D08		3	0073-0198	557.78	198.27	394	76.18	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6674.3	D08		3	0074-0202	742.04	202.12	370	73.26	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5970.1	D08		3	0075-0205	147.56	205.28	333	70.43	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6689.3	D08		3	0076-0206	387.38	207.07	366	76.33	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5842.8	D08		3	0077-0207	296.40	206.55	341	72.91	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6038.2	D08		3	0078-0210	650.95	210.77	392	76.43	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6286.1	D08		3	0079-0213	252.24	212.90	344	70.67	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7325.6	D08		3	0080-0212	787.19	212.30	356	70.18	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5880.2	D08		3	0081-0215	82.89	215.35	335	72.43	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7757.7	D08		3	0082-0215	903.13	215.44	324	71.26	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6638.8	D08		3	0083-0214	361.40	214.09	349	74.57	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6633.3	D08		3	0084-0220	196.70	219.96	359	72.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6357.6	D08		3	0085-0221	607.95	221.25	364	73.36	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7519.1	D08		3	0086-0224	414.68	224.53	323	67.01	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7294.7	D08		3	0087-0234	477.37	234.22	752	114.95	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6560.3	D08		3	0088-0233	941.28	233.09	368	71.01	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6432.7	D08		3	0089-0234	649.87	234.42	381	79.50	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5621.8	D08		3	0090-0235	41.27	235.00	329	71.74	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8106.0	D08		3	0091-0238	109.05	238.19	359	74.91	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6245.7	D08		3	0092-0244	607.29	243.39	370	77.36	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5633.3	D08		3	0093-0246	299.57	245.76	362	86.81	0.604
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6755.5	D08		3	0094-0245	164.28	245.60	361	72.43	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7354.0	D08		3	0095-0246	673.03	245.73	328	69.70	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7185.5	D08		3	0096-0247	762.15	246.68	347	68.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7175.7	D08		3	0097-0248	868.88	248.01	373	73.26	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6062.7	D08		3	0098-0249	373.11	248.75	358	76.33	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6166.3	D08		3	0099-0249	552.28	249.29	371	75.74	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8555.2	D08		3	0100-0251	693.24	251.37	374	76.18	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6684.5	D08		3	0101-0252	811.85	252.49	441	81.84	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7136.4	D08		3	0102-0258	249.65	258.22	341	71.84	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7420.4	D08		3	0103-0259	944.24	258.82	301	67.60	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7267.3	D08		3	0104-0265	587.53	265.22	377	73.26	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6438.9	D08		3	0105-0267	341.59	266.56	373	74.67	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7031.7	D08		3	0106-0268	312.72	268.76	348	77.50	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6047.3	D08		3	0107-0267	24.76	267.70	326	69.84	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8289.7	D08		3	0108-0283	649.13	284.09	965	130.61	0.711
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6020.3	D08		3	0109-0273	627.87	274.18	281	66.28	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6623.6	D08		3	0110-0277	156.82	276.89	359	72.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10517.3	D08		3	0111-0276	609.90	276.26	304	65.11	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5974.9	D08		3	0112-0282	79.15	282.69	371	75.50	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9901.6	D08		3	0113-0280	897.30	280.57	260	86.23	0.439
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6588.6	D08		3	0114-0281	410.64	281.07	378	75.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9118.9	D08		3	0115-0283	207.48	282.75	296	63.60	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5575.5	D08		3	0116-0280	688.08	279.99	198	53.60	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6696.8	D08		3	0117-0285	118.58	285.09	470	87.50	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6597.6	D08		3	0118-0288	850.70	288.52	361	72.08	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7623.3	D08		3	0119-0290	251.86	290.01	326	69.26	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7656.8	D08		3	0120-0295	573.61	295.23	352	70.67	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7794.0	D08		3	0121-0308	528.74	309.81	752	114.71	0.718
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5874.9	D08		3	0122-0303	354.73	302.37	387	81.74	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6135.4	D08		3	0123-0314	395.21	313.95	362	76.57	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6077.6	D08		3	0124-0313	466.54	313.88	394	77.50	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6575.3	D08		3	0125-0313	915.48	313.75	355	73.84	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5999.6	D08		3	0126-0316	28.55	315.24	376	77.98	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8933.1	D08		3	0127-0317	283.02	317.11	315	65.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5652.4	D08		3	0128-0319	102.04	319.05	333	71.01	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6559.6	D08		3	0129-0328	423.72	328.52	377	75.50	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7039.1	D08		3	0130-0330	854.33	329.72	363	74.91	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7819.5	D08		3	0131-0330	592.86	329.42	402	81.84	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5779.0	D08		3	0132-0332	142.97	332.76	382	76.08	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7036.9	D08		3	0133-0336	321.90	335.75	386	81.98	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8507.9	D08		3	0134-0338	833.06	338.06	514	88.67	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6346.9	D08		3	0135-0338	236.53	338.87	364	74.91	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6792.5	D08		3	0136-0339	675.27	339.86	348	71.84	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6723.1	D08		3	0137-0341	539.42	341.78	376	73.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6497.8	D08		3	0138-0342	45.16	342.09	343	72.67	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6574.4	D08		3	0139-0341	360.98	341.59	365	71.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7232.0	D08		3	0140-0342	741.96	343.01	367	72.43	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7622.8	D08		3	0141-0343	814.07	343.20	311	71.01	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5623.1	D08		3	0142-0352	180.69	352.91	376	80.91	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5943.5	D08		3	0143-0351	911.96	351.27	378	74.91	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7156.1	D08		3	0144-0354	313.52	354.52	377	78.33	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5694.7	D08		3	0145-0355	79.89	355.22	324	72.57	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6439.9	D08		3	0146-0364	113.88	364.88	334	72.91	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7266.7	D08		3	0147-0368	472.96	368.59	712	106.57	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5966.9	D08		3	0148-0373	521.62	372.76	374	76.33	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6609.9	D08		3	0149-0376	665.34	376.52	366	74.91	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5760.5	D08		3	0150-0376	394.46	376.46	359	71.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6408.0	D08		3	0151-0374	711.16	374.31	395	76.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5915.6	D08		3	0152-0378	147.07	378.11	334	78.57	0.680
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5653.7	D08		3	0153-0378	329.62	377.69	360	78.33	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6295.1	D08		3	0154-0382	866.90	381.25	375	76.91	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6326.2	D08		3	0155-0381	32.21	381.87	321	68.43	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6983.1	D08		3	0156-0381	919.31	381.04	350	70.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7083.5	D08		3	0157-0384	258.75	383.93	340	71.26	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5840.7	D08		3	0158-0388	195.57	388.17	350	74.33	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9784.5	D08		3	0159-0387	732.51	386.63	311	66.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6761.1	D08		3	0160-0389	547.02	389.11	374	74.91	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6417.7	D08		3	0161-0395	231.76	395.64	345	74.91	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6842.4	D08		3	0162-0395	819.43	395.72	362	71.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6921.3	D08		3	0163-0396	119.41	396.33	326	69.26	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9317.3	D08		3	0164-0398	477.43	398.21	310	64.77	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6693.2	D08		3	0165-0399	751.44	398.79	398	77.74	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6864.0	D08		3	0166-0402	304.30	401.92	380	73.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6711.3	D08		3	0167-0410	371.75	410.15	720	105.88	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5955.2	D08		3	0168-0403	438.20	403.57	370	74.08	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6073.1	D08		3	0169-0421	593.76	420.87	363	78.91	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7340.7	D08		3	0170-0421	718.80	421.57	380	77.15	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6620.1	D08		3	0171-0423	774.90	423.59	361	75.84	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5507.0	D08		3	0172-0428	33.62	428.69	325	72.91	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5846.2	D08		3	0173-0431	269.61	431.74	353	76.91	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6625.6	D08		3	0174-0431	528.13	432.17	372	77.94	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8540.5	D08		3	0175-0436	693.67	436.44	627	99.64	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7151.2	D08		3	0176-0447	421.89	446.54	748	106.95	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6974.7	D08		3	0177-0440	641.30	440.64	368	74.57	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7104.0	D08		3	0178-0446	162.63	445.35	712	105.88	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12213.4	D08		3	0179-0443	218.47	442.01	246	66.18	0.706
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11868.7	D08		3	0180-0444	231.04	446.37	219	63.70	0.678
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6204.9	D08		3	0181-0448	196.51	448.67	338	72.43	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6185.6	D08		3	0182-0447	315.10	447.79	367	74.91	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5810.9	D08		3	0183-0452	248.41	451.51	349	71.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6514.4	D08		3	0184-0455	527.89	453.68	409	81.84	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5601.1	D08		3	0185-0461	105.25	461.70	375	81.15	0.716
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5693.0	D08		3	0186-0463	71.14	463.23	353	73.26	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7123.7	D08		3	0187-0465	761.22	465.32	369	71.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6000.4	D08		3	0188-0473	624.44	473.31	375	72.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5875.2	D08		3	0189-0476	471.95	476.54	334	72.91	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6648.6	D08		3	0190-0475	851.66	474.90	353	71.01	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5863.3	D08		3	0191-0476	125.82	475.90	352	77.98	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6188.0	D08		3	0192-0482	929.08	482.82	380	78.33	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6077.4	D08		3	0193-0481	238.90	481.00	375	78.57	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5869.4	D08		3	0194-0484	565.52	484.47	368	73.26	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7041.2	D08		3	0195-0488	798.10	488.09	378	76.43	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6691.7	D08		3	0196-0490	720.05	490.02	371	72.67	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6531.8	D08		3	0197-0495	687.56	495.55	364	71.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5901.0	D08		3	0198-0502	601.36	502.21	361	73.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6350.7	D08		3	0199-0504	491.17	503.98	359	76.08	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6117.0	D08		3	0200-0507	230.55	507.90	370	78.33	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6531.6	D08		3	0201-0504	441.48	503.77	353	71.26	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6362.6	D08		3	0202-0506	356.38	506.34	353	72.43	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5551.1	D08		3	0203-0506	76.00	505.92	340	70.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6692.6	D08		3	0204-0510	806.46	509.69	392	81.40	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6593.9	D08		3	0205-0523	274.92	522.77	728	119.78	0.638
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8048.1	D08		3	0206-0520	851.06	520.43	723	112.13	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8258.0	D08		3	0207-0523	183.08	523.49	582	96.81	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6424.6	D08		3	0208-0520	757.32	519.80	372	73.60	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6255.0	D08		3	0209-0522	314.99	522.71	377	72.67	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7203.1	D08		3	0210-0522	481.03	522.56	359	72.67	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7035.8	D08		3	0211-0527	637.44	527.40	373	76.33	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7714.6	D08		3	0212-0525	673.36	524.83	333	68.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6937.2	D08		3	0213-0538	359.97	537.89	341	72.91	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6225.6	D08		3	0214-0537	580.54	536.99	352	72.67	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6412.1	D08		3	0215-0541	941.09	541.53	352	74.57	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5840.0	D08		3	0216-0542	537.15	541.76	363	72.67	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6483.0	D08		3	0217-0557	213.58	557.20	748	119.92	0.654
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6463.7	D08		3	0218-0553	484.31	553.43	396	77.26	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6747.2	D08		3	0219-0554	506.06	554.20	357	72.53	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6631.7	D08		3	0220-0556	736.72	556.00	352	72.91	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6954.0	D08		3	0221-0560	682.76	559.13	385	76.67	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5722.2	D08		3	0222-0561	74.33	561.65	327	68.67	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7260.0	D08		3	0223-0565	910.29	565.48	745	106.57	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9275.0	D08		3	0224-0565	782.87	565.60	625	96.57	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5796.6	D08		3	0225-0567	301.69	568.06	352	79.74	0.696
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6833.0	D08		3	0226-0569	343.30	569.80	330	68.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6981.2	D08		3	0227-0571	427.05	571.92	349	71.84	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6901.7	D08		3	0228-0587	52.37	586.47	695	104.57	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5979.8	D08		3	0229-0589	257.48	589.00	357	73.60	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5989.6	D08		3	0230-0588	216.44	588.13	373	76.08	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6744.8	D08		3	0231-0588	675.96	588.21	372	74.08	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6013.4	D08		3	0232-0589	132.62	588.97	371	74.91	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7478.3	D08		3	0233-0596	504.56	596.61	816	112.13	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7175.8	D08		3	0234-0590	747.04	590.11	349	71.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8427.9	D08		3	0235-0598	541.23	597.72	647	103.40	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5652.1	D08		3	0236-0596	632.60	596.40	377	78.57	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5891.1	D08		3	0237-0603	585.14	603.71	378	75.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11443.6	D08		3	0238-0600	373.07	600.30	254	59.36	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7936.8	D08		3	0239-0603	923.84	602.96	310	66.43	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6157.1	D08		3	0240-0604	114.56	604.19	360	79.15	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9885.5	D08		3	0241-0621	767.20	622.36	953	139.78	0.613
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6535.1	D08		3	0242-0608	873.87	607.69	343	75.15	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6148.8	D08		3	0243-0619	887.26	619.02	411	81.15	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6474.1	D08		3	0244-0617	824.32	617.02	347	70.67	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7943.4	D08		3	0245-0621	358.11	621.50	605	95.40	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5840.6	D08		3	0246-0620	736.77	620.01	369	81.98	0.690
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8249.2	D08		3	0247-0619	389.04	619.47	348	72.08	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6949.2	D08		3	0248-0626	210.28	626.97	308	71.36	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6530.9	D08		3	0249-0631	692.35	631.02	357	79.98	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11188.5	D08		3	0250-0632	846.96	632.32	249	57.36	0.951
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7011.8	D08		3	0251-0636	620.94	636.44	368	73.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6168.3	D08		3	0252-0638	328.05	638.02	417	85.15	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5932.8	D08		3	0253-0642	35.07	642.13	314	71.01	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5998.4	D08		3	0254-0643	168.48	643.62	337	71.50	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8002.2	D08		3	0255-0645	212.27	643.20	363	77.60	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6768.0	D08		3	0256-0650	129.25	650.17	437	81.74	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11679.6	D08		3	0257-0649	798.87	649.68	206	73.50	0.479
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6649.2	D08		3	0258-0654	92.12	653.99	352	70.67	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6631.2	D08		3	0259-0653	558.56	653.05	375	73.84	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8055.8	D08		3	0260-0653	675.92	653.29	342	73.84	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6307.1	D08		3	0261-0659	342.21	659.10	369	83.98	0.657
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7272.6	D08		3	0262-0660	203.39	661.36	396	79.98	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6353.1	D08		3	0263-0663	904.83	662.51	330	69.26	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5560.4	D08		3	0264-0667	947.34	667.52	341	73.84	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8089.2	D08		3	0265-0669	683.59	669.86	372	78.43	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6460.4	D08		3	0266-0674	610.07	674.02	369	74.91	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6527.8	D08		3	0267-0672	488.26	672.92	362	72.67	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7524.6	D08		3	0268-0675	720.71	675.02	357	74.67	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6544.4	D08		3	0269-0685	89.67	685.35	313	65.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5838.4	D08		3	0270-0684	138.76	684.98	315	66.43	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5743.8	D08		3	0271-0688	179.16	688.67	338	71.50	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6783.9	D08		3	0272-0690	896.32	690.52	318	72.33	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7633.6	D08		3	0273-0700	25.13	699.98	615	97.40	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5437.1	D08		3	0274-0697	699.75	697.18	375	76.08	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11691.3	D08		3	0275-0693	363.48	693.79	196	72.77	0.465
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184992	1375329	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6630.4	D08		3	0276-0707	831.30	707.12	348	71.70	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6932.5	D08		4	0001-0039	733.93	39.86	628	95.74	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8196.4	D08		4	0002-0049	816.27	48.21	984	128.23	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5452.9	D08		4	0003-0047	340.50	45.67	547	92.47	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5645.2	D08		4	0004-0045	603.98	44.77	467	82.91	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5684.9	D08		4	0005-0048	902.79	48.58	451	79.50	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6927.1	D08		4	0006-0049	366.86	49.04	475	82.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5300.7	D08		4	0007-0053	759.08	52.52	483	88.67	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5429.6	D08		4	0008-0055	249.77	55.49	442	78.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5945.6	D08		4	0009-0056	945.82	56.49	406	75.26	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5089.1	D08		4	0010-0056	99.02	56.17	435	83.50	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6026.6	D08		4	0011-0061	322.34	62.53	456	81.98	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6034.3	D08		4	0012-0064	75.47	64.64	501	87.94	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5501.7	D08		4	0013-0066	620.14	67.05	499	85.98	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6176.2	D08		4	0014-0071	446.82	70.23	938	125.44	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5698.6	D08		4	0015-0073	669.51	73.09	432	76.43	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5852.8	D08		4	0016-0077	835.66	77.03	516	88.71	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5576.7	D08		4	0017-0077	744.64	78.29	438	80.43	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6552.0	D08		4	0018-0080	545.97	80.59	922	121.30	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5043.6	D08		4	0019-0086	80.39	85.76	433	82.08	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6735.2	D08		4	0020-0090	179.51	90.53	727	103.64	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5158.7	D08		4	0021-0096	849.52	96.88	428	81.15	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7257.2	D08		4	0022-0097	118.83	97.58	763	103.40	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5447.2	D08		4	0023-0100	519.10	99.71	481	85.74	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5219.1	D08		4	0024-0100	348.91	100.90	383	75.50	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5220.9	D08		4	0025-0102	889.05	102.48	431	77.26	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5636.2	D08		4	0026-0105	706.22	105.50	424	76.67	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4884.8	D08		4	0027-0114	78.30	115.10	429	85.26	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5567.2	D08		4	0028-0113	624.49	113.53	484	84.33	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5598.2	D08		4	0029-0115	801.67	114.62	416	77.50	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6084.7	D08		4	0030-0116	387.80	116.12	561	90.08	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5019.9	D08		4	0031-0123	266.03	123.08	434	78.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5616.4	D08		4	0032-0124	770.35	123.97	438	80.91	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5515.4	D08		4	0033-0124	676.92	124.50	422	76.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5230.4	D08		4	0034-0142	319.72	142.15	433	79.74	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4992.4	D08		4	0035-0148	217.28	148.11	423	76.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5991.4	D08		4	0036-0153	718.54	153.51	431	82.77	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6364.2	D08		4	0037-0159	843.33	158.44	853	112.71	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6209.9	D08		4	0038-0158	145.77	159.32	864	116.23	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6067.6	D08		4	0039-0168	270.56	168.62	924	119.88	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5560.5	D08		4	0040-0168	358.99	168.27	488	84.33	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5241.0	D08		4	0041-0166	664.94	166.66	434	79.50	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5262.9	D08		4	0042-0172	406.55	172.28	479	82.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5855.5	D08		4	0043-0173	716.05	172.21	435	79.11	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5272.0	D08		4	0044-0175	24.26	175.99	395	75.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5520.7	D08		4	0045-0180	572.58	180.40	513	88.91	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5600.1	D08		4	0046-0181	609.93	180.72	439	78.08	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5303.4	D08		4	0047-0184	543.08	183.36	499	87.40	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5532.9	D08		4	0048-0185	883.86	185.73	451	79.26	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5371.8	D08		4	0049-0195	792.79	195.10	446	78.91	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6678.6	D08		4	0050-0195	215.19	194.82	391	71.60	0.958
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7060.6	D08		4	0051-0196	183.93	196.02	391	72.18	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10045.0	D08		4	0052-0198	266.48	198.05	625	94.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5649.7	D08		4	0053-0197	858.04	196.41	430	79.50	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4695.3	D08		4	0054-0201	452.45	201.56	438	79.50	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5097.0	D08		4	0055-0201	145.36	200.44	437	79.26	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5398.9	D08		4	0056-0202	916.56	202.45	431	77.26	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5128.8	D08		4	0057-0213	537.22	213.14	511	91.40	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5012.0	D08		4	0058-0212	735.76	212.22	435	81.50	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6336.2	D08		4	0059-0225	336.76	224.68	832	114.81	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5435.7	D08		4	0060-0227	206.08	226.23	399	79.15	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4716.6	D08		4	0061-0226	418.21	226.03	428	79.50	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7316.5	D08		4	0062-0227	890.19	227.21	818	116.67	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5893.1	D08		4	0063-0245	648.73	245.57	889	123.05	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5116.4	D08		4	0064-0239	554.99	239.38	488	86.33	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5231.2	D08		4	0065-0248	196.20	249.17	476	90.81	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5465.9	D08		4	0066-0249	602.93	249.45	434	78.33	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5029.7	D08		4	0067-0255	723.00	255.13	440	78.67	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5122.4	D08		4	0068-0258	391.21	258.14	441	77.26	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5436.9	D08		4	0069-0263	692.44	264.22	439	79.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5311.7	D08		4	0070-0268	225.86	267.89	430	78.91	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4991.3	D08		4	0071-0267	259.01	267.57	426	79.50	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5100.7	D08		4	0072-0273	54.20	273.66	414	80.33	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5362.8	D08		4	0073-0275	426.18	274.91	483	83.50	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5924.1	D08		4	0074-0282	565.08	282.42	965	129.78	0.720
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5195.0	D08		4	0075-0274	917.38	275.01	446	79.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5053.8	D08		4	0076-0276	842.17	276.79	446	82.91	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5425.3	D08		4	0077-0286	325.72	285.68	477	84.91	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5195.1	D08		4	0078-0291	690.26	290.59	484	87.01	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6200.5	D08		4	0079-0289	163.66	288.76	423	75.26	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6109.9	D08		4	0080-0295	69.01	296.21	555	93.01	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6624.4	D08		4	0081-0298	631.28	298.98	823	111.30	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6266.0	D08		4	0082-0297	92.75	297.45	410	76.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5251.8	D08		4	0083-0298	486.50	297.74	444	79.50	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5215.4	D08		4	0084-0296	730.71	296.02	421	77.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6741.8	D08		4	0085-0309	336.67	309.13	741	102.91	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5386.3	D08		4	0086-0310	792.80	310.62	440	79.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5073.3	D08		4	0087-0314	583.95	314.44	503	91.84	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5879.2	D08		4	0088-0319	915.92	319.07	927	119.20	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5158.4	D08		4	0089-0323	526.57	322.61	442	78.08	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5055.4	D08		4	0090-0329	369.87	328.39	447	80.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5291.4	D08		4	0091-0333	741.86	333.44	431	77.26	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4810.0	D08		4	0092-0335	405.26	335.05	449	79.50	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5934.6	D08		4	0093-0338	442.23	337.84	665	97.64	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5964.1	D08		4	0094-0339	696.49	338.86	459	81.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4972.0	D08		4	0095-0341	573.65	341.09	457	84.91	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5185.1	D08		4	0096-0341	279.50	340.56	475	82.91	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5020.4	D08		4	0097-0345	217.15	344.72	442	78.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5156.8	D08		4	0098-0350	353.90	350.58	483	87.74	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4979.1	D08		4	0099-0350	829.44	351.06	433	78.33	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5854.6	D08		4	0100-0357	882.34	358.36	885	117.54	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5105.8	D08		4	0101-0353	512.95	353.82	454	80.08	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5248.1	D08		4	0102-0357	263.78	357.96	479	86.23	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5697.4	D08		4	0103-0361	645.71	361.63	519	88.67	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5715.4	D08		4	0104-0364	616.45	364.48	490	86.57	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5621.2	D08		4	0105-0365	788.10	365.64	480	81.84	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4876.3	D08		4	0106-0369	420.08	369.56	434	79.26	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5754.2	D08		4	0107-0378	935.44	378.34	450	80.67	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6511.2	D08		4	0108-0378	149.62	378.56	429	75.84	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5476.4	D08		4	0109-0384	640.88	384.35	489	87.60	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5154.6	D08		4	0110-0384	307.53	384.07	449	79.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4537.2	D08		4	0111-0390	83.47	390.26	414	78.33	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7192.3	D08		4	0112-0398	358.78	397.74	826	108.47	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5155.0	D08		4	0113-0398	798.87	397.96	445	84.33	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6381.8	D08		4	0114-0402	595.24	401.63	512	86.23	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6155.4	D08		4	0115-0405	654.01	406.06	567	92.57	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5554.8	D08		4	0116-0405	260.98	405.31	536	88.57	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6021.3	D08		4	0117-0411	535.96	411.71	918	120.23	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7223.6	D08		4	0118-0415	484.12	415.53	806	109.74	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6263.8	D08		4	0119-0415	210.19	414.84	911	116.23	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5425.7	D08		4	0120-0419	869.62	418.01	472	82.08	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5538.0	D08		4	0121-0420	459.39	420.85	457	85.01	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5214.5	D08		4	0122-0423	568.03	423.12	489	85.01	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5971.7	D08		4	0123-0427	783.26	427.75	947	124.47	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4984.7	D08		4	0124-0426	125.16	426.22	419	76.91	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7111.9	D08		4	0125-0431	755.86	431.24	422	80.77	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5064.0	D08		4	0126-0432	385.87	432.72	436	78.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5446.7	D08		4	0127-0435	285.51	435.86	415	75.01	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4800.3	D08		4	0128-0441	66.09	440.53	406	76.43	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6303.7	D08		4	0129-0448	28.71	448.46	574	88.67	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5156.9	D08		4	0130-0449	849.09	449.39	468	81.26	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5402.9	D08		4	0131-0449	896.40	449.15	435	81.15	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5000.8	D08		4	0132-0455	176.90	455.44	435	78.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4746.7	D08		4	0133-0461	630.96	461.45	461	83.74	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6967.6	D08		4	0134-0465	564.54	465.61	437	78.08	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5420.1	D08		4	0135-0465	763.23	465.37	464	82.43	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5170.8	D08		4	0136-0472	232.27	472.22	487	86.57	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8109.1	D08		4	0137-0470	509.73	470.31	422	79.36	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5749.9	D08		4	0138-0469	699.93	469.21	469	81.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5569.9	D08		4	0139-0472	734.89	472.71	504	85.15	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7582.2	D08		4	0140-0473	528.11	473.56	367	75.94	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4452.2	D08		4	0141-0478	96.54	477.90	456	84.08	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4989.6	D08		4	0142-0476	414.40	476.81	439	79.50	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6073.3	D08		4	0143-0484	252.34	484.70	460	84.57	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6309.9	D08		4	0144-0488	937.61	487.58	406	76.08	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4387.9	D08		4	0145-0487	820.13	486.87	287	65.84	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6001.6	D08		4	0146-0491	902.85	490.85	434	78.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5621.4	D08		4	0147-0493	703.55	492.97	483	86.43	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5011.4	D08		4	0148-0496	143.65	496.51	421	78.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5154.2	D08		4	0149-0501	304.77	501.57	431	77.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5483.9	D08		4	0150-0506	60.78	505.86	443	79.26	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5415.9	D08		4	0151-0510	915.79	510.77	476	84.33	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5081.4	D08		4	0152-0512	522.77	512.19	463	82.57	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4888.4	D08		4	0153-0518	459.30	518.98	448	80.08	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5295.1	D08		4	0154-0525	620.07	525.23	571	92.33	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4391.9	D08		4	0155-0527	836.57	527.33	282	64.18	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5751.8	D08		4	0156-0529	360.05	529.94	429	79.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5633.1	D08		4	0157-0536	213.40	535.85	972	125.30	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5160.7	D08		4	0158-0534	407.41	533.57	504	85.74	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4783.3	D08		4	0159-0535	579.10	535.16	529	91.40	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5674.1	D08		4	0160-0534	23.69	534.42	407	75.26	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5089.8	D08		4	0161-0535	718.74	534.88	466	81.26	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5489.3	D08		4	0162-0550	73.80	550.34	433	80.08	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5357.3	D08		4	0163-0551	781.30	551.45	459	79.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5673.0	D08		4	0164-0552	361.37	551.17	526	89.60	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5278.0	D08		4	0165-0554	444.12	555.08	426	78.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4803.5	D08		4	0166-0560	496.05	559.90	449	79.26	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5712.1	D08		4	0167-0561	717.51	561.75	514	86.33	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4923.4	D08		4	0168-0562	409.60	562.68	472	82.33	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5569.9	D08		4	0169-0567	933.70	566.31	553	96.13	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5389.7	D08		4	0170-0565	628.41	565.59	465	80.67	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5038.5	D08		4	0171-0568	32.00	567.88	411	75.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5844.3	D08		4	0172-0573	259.57	571.93	451	81.40	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5096.3	D08		4	0173-0574	546.75	574.82	461	81.26	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6252.3	D08		4	0174-0577	109.77	577.72	423	75.26	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5271.2	D08		4	0175-0581	316.05	581.14	554	88.08	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7304.0	D08		4	0176-0584	909.84	584.85	803	114.95	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5466.2	D08		4	0177-0579	803.61	578.83	480	81.50	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5467.7	D08		4	0178-0581	649.40	580.88	509	88.81	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5539.4	D08		4	0179-0590	244.16	591.10	457	84.23	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4696.4	D08		4	0180-0594	470.06	594.13	422	77.01	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4897.1	D08		4	0181-0595	357.99	594.48	437	77.84	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6563.3	D08		4	0182-0601	707.62	600.99	472	81.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6390.7	D08		4	0183-0603	861.60	603.94	748	106.91	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5476.5	D08		4	0184-0602	593.70	602.36	432	78.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6041.6	D08		4	0185-0605	803.17	605.81	480	84.53	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5312.9	D08		4	0186-0605	189.40	604.80	467	80.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5136.7	D08		4	0187-0605	682.74	605.51	455	78.67	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6767.2	D08		4	0188-0608	829.34	608.71	803	110.53	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4898.1	D08		4	0189-0609	407.77	609.26	430	77.84	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4603.1	D08		4	0190-0617	48.28	617.11	419	76.08	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5465.4	D08		4	0191-0618	73.94	618.25	435	80.33	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5177.1	D08		4	0192-0620	534.59	620.39	454	83.15	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6329.9	D08		4	0193-0629	652.35	629.74	426	76.43	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5058.5	D08		4	0194-0630	464.45	630.65	459	81.50	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5089.4	D08		4	0195-0631	347.40	631.22	432	76.43	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7816.1	D08		4	0196-0637	166.84	637.00	673	98.81	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5948.9	D08		4	0197-0633	766.19	633.25	448	77.84	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6653.3	D08		4	0198-0637	824.14	634.50	444	83.50	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5310.5	D08		4	0199-0647	616.31	647.51	434	80.08	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4753.7	D08		4	0200-0648	893.26	647.73	452	83.74	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5159.0	D08		4	0201-0647	413.25	647.58	436	79.74	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6095.9	D08		4	0202-0649	811.68	650.31	462	82.47	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6283.6	D08		4	0203-0655	284.65	655.64	972	129.68	0.726
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5268.3	D08		4	0204-0650	16.51	650.72	409	75.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6374.7	D08		4	0205-0652	564.80	652.91	437	77.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5231.5	D08		4	0206-0655	245.76	654.93	477	87.40	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5967.6	D08		4	0207-0654	60.03	654.59	350	73.36	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5585.9	D08		4	0208-0664	490.73	665.09	551	88.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6002.6	D08		4	0209-0666	107.18	667.24	437	78.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5803.6	D08		4	0210-0670	130.35	670.03	437	81.01	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5977.7	D08		4	0211-0673	66.05	672.95	487	87.01	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5269.8	D08		4	0212-0675	315.43	675.38	458	79.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4829.8	D08		4	0213-0674	384.40	674.78	439	78.91	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4878.0	D08		4	0214-0676	671.90	676.16	437	77.84	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6329.0	D08		4	0215-0677	806.78	677.74	428	79.98	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5979.8	D08		4	0216-0678	219.18	677.65	431	79.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4782.0	D08		4	0217-0680	741.32	680.44	490	87.40	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6067.0	D08		4	0218-0687	521.67	686.81	448	80.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5536.2	D08		4	0219-0690	185.53	690.11	483	87.15	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4685.2	D08		4	0220-0691	426.22	691.59	414	78.18	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5411.7	D08		4	0221-0698	66.48	698.47	483	87.01	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5602.9	D08		4	0222-0697	210.17	697.67	479	90.91	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4736.8	D08		4	0223-0698	848.47	697.67	448	77.84	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184993	1375330	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8091.3	D08		4	0224-0707	801.44	707.13	338	68.77	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6852.1	D08		5	0001-0033	823.63	32.06	394	74.57	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6820.8	D08		5	0002-0040	391.44	40.78	457	81.84	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6616.9	D08		5	0003-0045	808.53	46.12	380	75.15	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6428.3	D08		5	0004-0045	921.84	46.04	389	78.18	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7277.4	D08		5	0005-0057	318.33	57.37	778	114.23	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7182.7	D08		5	0006-0057	470.15	57.03	421	78.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5648.1	D08		5	0007-0059	50.54	59.00	386	73.84	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9874.6	D08		5	0008-0059	875.92	59.73	269	82.67	0.495
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6689.5	D08		5	0009-0064	397.42	64.22	486	85.84	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6545.4	D08		5	0010-0072	670.92	70.92	819	114.67	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6394.9	D08		5	0011-0071	701.38	70.53	485	87.26	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7884.0	D08		5	0012-0078	543.90	78.14	825	118.71	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10776.3	D08		5	0013-0079	388.66	79.65	130	44.87	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9756.5	D08		5	0014-0085	382.58	87.38	154	58.53	0.565
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7368.0	D08		5	0015-0088	516.98	88.31	354	71.94	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5738.2	D08		5	0016-0093	277.12	93.36	398	75.50	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5766.9	D08		5	0017-0096	633.80	96.06	425	79.26	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6133.0	D08		5	0018-0092	945.00	92.43	416	78.43	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5900.6	D08		5	0019-0099	599.93	98.67	415	77.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5876.0	D08		5	0020-0098	798.67	98.19	423	77.84	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5564.3	D08		5	0021-0100	350.48	100.44	400	75.84	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5827.8	D08		5	0022-0103	71.65	102.95	395	74.67	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8928.7	D08		5	0023-0108	561.28	107.76	640	93.74	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6070.5	D08		5	0024-0112	237.80	112.01	503	85.60	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5651.6	D08		5	0025-0115	454.33	115.52	438	81.74	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6146.4	D08		5	0026-0117	179.42	116.83	392	74.67	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6403.8	D08		5	0027-0118	842.12	118.62	387	73.84	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8631.3	D08		5	0028-0128	945.20	127.33	658	98.67	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6226.2	D08		5	0029-0147	230.98	146.68	883	128.37	0.673
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6360.1	D08		5	0030-0139	417.82	138.92	432	76.43	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6569.7	D08		5	0031-0140	799.39	139.77	419	79.01	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5247.1	D08		5	0032-0143	72.31	143.04	380	72.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5886.7	D08		5	0033-0146	778.08	146.59	408	77.01	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5611.2	D08		5	0034-0149	501.54	148.63	457	80.08	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6171.7	D08		5	0035-0147	714.83	147.15	405	76.08	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6800.6	D08		5	0036-0160	304.21	160.53	837	111.54	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5876.9	D08		5	0037-0160	551.40	160.00	437	81.26	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5971.9	D08		5	0038-0159	625.81	159.03	413	75.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7006.1	D08		5	0039-0163	379.49	163.25	810	111.15	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5234.1	D08		5	0040-0174	218.07	175.08	417	82.33	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6065.7	D08		5	0041-0179	124.30	179.69	857	121.40	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6196.7	D08		5	0042-0182	593.02	181.99	397	76.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5796.4	D08		5	0043-0184	800.09	184.08	393	76.33	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5309.3	D08		5	0044-0195	190.64	195.14	411	81.74	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7047.1	D08		5	0045-0200	860.90	200.69	769	107.64	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5975.3	D08		5	0046-0195	714.01	195.36	418	78.43	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5127.9	D08		5	0047-0204	21.44	204.91	378	76.08	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5266.7	D08		5	0048-0205	71.47	204.85	372	72.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5861.7	D08		5	0049-0211	769.60	211.45	384	74.43	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5844.9	D08		5	0050-0211	468.68	211.28	418	76.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5492.2	D08		5	0051-0214	390.48	213.72	396	75.26	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5461.2	D08		5	0052-0214	734.86	213.37	442	81.01	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5345.6	D08		5	0053-0216	210.48	216.18	445	86.91	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10073.9	D08		5	0054-0212	116.41	212.94	148	51.70	0.696
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6041.7	D08		5	0055-0217	343.50	217.58	399	75.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8638.8	D08		5	0056-0219	649.48	218.86	377	75.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6724.5	D08		5	0057-0225	668.86	226.35	406	82.08	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7169.0	D08		5	0058-0233	554.22	233.81	778	108.23	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5253.7	D08		5	0059-0240	133.89	240.37	385	76.08	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5342.9	D08		5	0060-0248	172.10	248.69	390	74.08	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5239.7	D08		5	0061-0249	56.46	249.02	394	76.08	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5964.4	D08		5	0062-0252	262.48	252.37	426	77.01	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5456.2	D08		5	0063-0252	522.43	252.74	411	80.91	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6928.5	D08		5	0064-0259	941.70	259.65	758	108.71	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6279.8	D08		5	0065-0263	621.63	263.24	862	124.51	0.699
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6297.7	D08		5	0066-0268	474.24	267.82	820	112.81	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6052.1	D08		5	0067-0265	748.25	265.65	425	76.67	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5143.3	D08		5	0068-0268	784.21	268.90	423	82.57	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6684.7	D08		5	0069-0274	346.42	275.00	450	80.43	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7308.9	D08		5	0070-0280	397.61	280.07	764	105.54	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5704.4	D08		5	0071-0274	865.76	273.84	395	74.08	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5496.4	D08		5	0072-0278	121.12	277.83	379	73.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4992.1	D08		5	0073-0277	22.55	277.44	368	73.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5208.3	D08		5	0074-0285	547.62	284.98	407	77.74	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6330.0	D08		5	0075-0285	323.56	284.72	457	81.26	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5252.3	D08		5	0076-0287	260.67	287.23	413	79.50	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6965.2	D08		5	0077-0301	806.06	301.60	896	117.40	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5447.4	D08		5	0078-0301	685.93	301.04	293	63.94	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5381.4	D08		5	0079-0310	430.22	310.43	398	80.33	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5552.9	D08		5	0080-0316	97.58	316.25	428	80.33	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6610.5	D08		5	0081-0314	859.62	313.58	405	78.57	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5610.3	D08		5	0082-0321	21.04	321.60	824	115.68	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5029.6	D08		5	0083-0314	518.69	314.61	381	77.84	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5773.5	D08		5	0084-0323	283.64	323.05	405	78.08	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5498.2	D08		5	0085-0327	344.62	327.27	406	78.33	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6668.9	D08		5	0086-0328	873.27	329.35	403	77.50	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9893.6	D08		5	0087-0330	907.98	329.91	310	64.77	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5731.7	D08		5	0088-0333	223.33	333.96	410	75.26	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8119.9	D08		5	0089-0337	410.57	337.30	756	107.74	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4936.1	D08		5	0090-0338	169.04	337.99	379	77.50	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5866.7	D08		5	0091-0336	660.17	336.80	610	97.15	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7002.3	D08		5	0092-0343	929.00	343.31	782	113.88	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6141.3	D08		5	0093-0344	722.89	344.38	405	76.67	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8095.0	D08		5	0094-0351	438.25	351.57	739	106.57	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5633.0	D08		5	0095-0346	552.67	346.48	413	77.26	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6138.2	D08		5	0096-0347	786.35	346.22	441	83.60	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6270.8	D08		5	0097-0354	761.47	354.39	397	77.84	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5536.6	D08		5	0098-0359	854.76	359.24	407	77.50	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5372.9	D08		5	0099-0360	135.44	360.45	392	76.91	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6761.9	D08		5	0100-0363	589.18	362.90	402	74.43	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6228.4	D08		5	0101-0367	273.26	367.66	450	81.74	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6479.0	D08		5	0102-0365	897.87	364.97	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6754.7	D08		5	0103-0376	484.26	375.96	819	108.71	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5167.3	D08		5	0104-0375	377.85	374.63	416	78.08	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4970.0	D08		5	0105-0378	304.46	378.42	424	78.67	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5457.9	D08		5	0106-0380	40.49	380.98	425	78.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5523.8	D08		5	0107-0386	833.52	386.16	399	75.84	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5583.7	D08		5	0108-0388	630.64	387.98	450	82.33	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6233.9	D08		5	0109-0396	411.42	396.40	397	76.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5624.2	D08		5	0110-0401	740.54	401.57	418	77.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5940.7	D08		5	0111-0404	366.68	404.38	414	76.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4997.4	D08		5	0112-0406	217.90	406.82	369	74.67	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5631.4	D08		5	0113-0408	175.02	408.75	399	76.91	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5790.5	D08		5	0114-0411	715.24	410.60	451	84.33	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5206.6	D08		5	0115-0412	535.17	412.48	466	85.15	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5297.0	D08		5	0116-0418	907.23	417.81	194	52.53	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5417.1	D08		5	0117-0426	802.16	426.03	435	81.74	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5552.4	D08		5	0118-0427	257.71	426.72	386	73.84	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5428.9	D08		5	0119-0427	610.99	426.01	452	86.57	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5293.1	D08		5	0120-0427	511.47	427.34	436	80.91	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5704.6	D08		5	0121-0426	869.44	427.90	301	66.28	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6419.5	D08		5	0122-0430	942.75	429.56	334	72.77	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5514.9	D08		5	0123-0433	475.18	432.91	417	79.50	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4933.0	D08		5	0124-0438	60.42	438.38	370	77.50	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6319.4	D08		5	0125-0443	929.10	443.80	381	72.91	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5200.3	D08		5	0126-0447	231.28	446.57	418	88.08	0.677
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5759.7	D08		5	0127-0447	869.40	446.16	338	70.87	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5116.3	D08		5	0128-0455	318.95	455.36	393	78.33	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7672.6	D08		5	0129-0462	835.61	462.47	606	91.50	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5935.9	D08		5	0130-0461	121.51	461.01	426	79.50	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5474.1	D08		5	0131-0460	443.24	460.54	409	77.50	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5981.0	D08		5	0132-0462	254.37	461.53	431	78.43	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6118.6	D08		5	0133-0466	215.21	467.13	426	78.91	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5406.5	D08		5	0134-0467	783.67	467.61	406	76.67	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5756.9	D08		5	0135-0472	525.52	471.82	416	76.91	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5614.9	D08		5	0136-0482	99.73	482.31	414	75.26	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4968.9	D08		5	0137-0485	143.43	484.89	386	75.26	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10107.5	D08		5	0138-0485	294.49	485.32	292	62.77	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5968.7	D08		5	0139-0490	42.99	490.22	383	74.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5214.1	D08		5	0140-0493	370.45	493.36	377	74.91	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5285.4	D08		5	0141-0496	644.54	496.59	415	76.91	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5217.8	D08		5	0142-0498	489.71	498.57	453	82.33	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6902.4	D08		5	0143-0502	831.89	502.01	368	72.67	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5540.0	D08		5	0144-0505	939.56	504.88	436	78.08	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6324.4	D08		5	0145-0508	68.46	508.47	432	79.94	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7178.2	D08		5	0146-0511	887.28	511.66	578	90.08	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5112.4	D08		5	0147-0513	20.77	513.26	404	82.08	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5272.6	D08		5	0148-0521	754.52	520.67	409	79.50	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5898.3	D08		5	0149-0523	586.44	523.30	406	78.57	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5458.1	D08		5	0150-0524	298.76	524.83	424	77.26	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5097.4	D08		5	0151-0525	442.76	524.94	407	78.67	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5450.9	D08		5	0152-0528	529.27	528.32	415	77.50	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7133.9	D08		5	0153-0532	108.82	532.31	738	105.64	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6122.8	D08		5	0154-0531	148.05	531.10	448	80.57	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5460.8	D08		5	0155-0529	482.41	529.37	398	74.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5263.0	D08		5	0156-0530	666.31	530.21	407	77.50	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5633.4	D08		5	0157-0531	67.98	529.96	405	77.36	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5775.3	D08		5	0158-0535	709.02	534.75	398	76.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6112.2	D08		5	0159-0550	905.81	549.96	845	121.64	0.718
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7514.6	D08		5	0160-0541	804.22	541.10	367	73.26	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6179.2	D08		5	0161-0543	390.29	543.81	425	79.01	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5623.0	D08		5	0162-0553	412.75	553.04	430	81.26	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5555.3	D08		5	0163-0559	149.09	559.16	557	89.98	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5331.5	D08		5	0164-0560	464.84	560.33	400	78.33	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6345.9	D08		5	0165-0569	757.35	568.12	809	107.88	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6302.8	D08		5	0166-0564	348.33	564.29	444	81.98	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5371.8	D08		5	0167-0569	39.10	568.04	453	84.47	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5663.4	D08		5	0168-0567	599.41	567.21	398	75.84	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5988.2	D08		5	0169-0582	279.61	582.60	861	126.71	0.674
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6317.9	D08		5	0170-0581	25.58	580.97	352	75.15	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5365.3	D08		5	0171-0579	110.23	579.37	378	73.84	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5881.2	D08		5	0172-0581	667.06	581.06	445	80.57	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5401.8	D08		5	0173-0584	58.54	584.46	433	79.15	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5661.9	D08		5	0174-0598	387.24	598.06	913	122.51	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7449.9	D08		5	0175-0592	848.30	591.58	355	69.01	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5510.0	D08		5	0176-0601	452.23	600.94	405	78.57	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5400.1	D08		5	0177-0604	636.33	604.11	417	77.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5653.3	D08		5	0178-0605	707.85	604.88	396	75.84	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5849.4	D08		5	0179-0603	894.34	602.57	424	80.67	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9501.8	D08		5	0180-0611	815.51	611.80	316	65.60	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6611.1	D08		5	0181-0617	749.57	616.84	418	75.84	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5304.5	D08		5	0182-0619	670.03	619.32	407	77.50	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5711.8	D08		5	0183-0627	85.01	627.41	849	117.20	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6619.1	D08		5	0184-0623	380.27	623.57	412	79.98	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6663.4	D08		5	0185-0624	486.57	623.68	408	75.50	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4891.0	D08		5	0186-0636	229.62	636.89	400	80.23	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5916.1	D08		5	0187-0637	896.43	636.89	386	74.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6743.9	D08		5	0188-0639	432.10	639.78	760	107.01	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7454.7	D08		5	0189-0641	399.89	641.34	684	104.91	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8242.4	D08		5	0190-0639	702.72	639.73	363	71.70	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8338.2	D08		5	0191-0641	684.59	641.16	340	70.04	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7077.1	D08		5	0192-0641	833.67	641.18	407	77.26	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6983.8	D08		5	0193-0641	578.90	641.25	386	74.67	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6009.5	D08		5	0194-0644	503.10	644.83	399	75.84	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7271.8	D08		5	0195-0646	792.39	647.04	771	113.05	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5147.6	D08		5	0196-0651	154.62	650.94	391	77.84	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5279.3	D08		5	0197-0653	362.74	653.67	433	81.50	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5783.0	D08		5	0198-0669	557.75	669.58	859	118.02	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5824.1	D08		5	0199-0667	730.14	666.77	409	76.33	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5874.9	D08		5	0200-0669	620.03	669.13	394	76.33	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5755.2	D08		5	0201-0668	678.40	668.34	407	77.26	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5426.6	D08		5	0202-0675	431.90	674.98	414	76.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5270.0	D08		5	0203-0674	318.41	674.03	391	77.01	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5516.7	D08		5	0204-0680	259.83	680.16	394	74.67	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5437.6	D08		5	0205-0682	774.12	682.45	378	72.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5507.1	D08		5	0206-0694	727.59	694.73	419	81.15	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5609.5	D08		5	0207-0694	519.50	694.35	396	74.67	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7122.4	D08		5	0208-0699	210.55	699.05	729	105.88	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6047.0	D08		5	0209-0698	806.63	698.16	371	73.26	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5876.2	D08		5	0210-0704	886.47	704.50	369	71.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184994	1375331	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5812.0	D08		5	0211-0706	606.42	706.48	384	75.50	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6752.5	D08		6	0001-0031	828.76	31.67	370	71.94	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6938.7	D08		6	0002-0037	847.51	38.12	368	77.60	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6265.7	D08		6	0003-0036	327.60	35.24	339	72.43	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6555.4	D08		6	0004-0042	302.39	41.52	863	121.78	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8781.8	D08		6	0005-0040	923.26	40.40	314	67.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7776.9	D08		6	0006-0048	798.39	47.76	768	107.98	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5774.7	D08		6	0007-0042	130.25	42.06	351	69.60	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6557.1	D08		6	0008-0045	391.38	45.09	404	77.50	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6254.4	D08		6	0009-0049	556.89	49.61	411	80.43	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6238.6	D08		6	0010-0048	597.94	48.65	393	75.50	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6002.4	D08		6	0011-0048	16.62	48.20	323	75.01	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7596.9	D08		6	0012-0053	446.87	53.50	949	121.15	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6026.5	D08		6	0013-0051	666.15	50.88	389	74.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6781.8	D08		6	0014-0065	197.75	64.91	752	110.71	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6374.3	D08		6	0015-0066	900.72	66.61	403	75.84	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5698.0	D08		6	0016-0075	285.42	75.45	803	119.44	0.707
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6939.1	D08		6	0017-0073	628.35	74.13	785	115.64	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6982.1	D08		6	0018-0074	434.92	74.70	330	70.77	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7095.2	D08		6	0019-0078	746.11	77.93	391	73.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7180.4	D08		6	0020-0087	113.81	87.17	714	109.40	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6332.9	D08		6	0021-0082	859.99	81.94	372	74.91	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6440.2	D08		6	0022-0085	374.04	84.87	392	73.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6318.2	D08		6	0023-0094	723.11	93.67	421	78.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6158.9	D08		6	0024-0093	487.55	92.71	394	76.43	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6322.9	D08		6	0025-0094	774.76	94.30	418	78.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5775.4	D08		6	0026-0095	39.55	95.36	380	73.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8598.9	D08		6	0027-0102	836.77	101.45	590	115.05	0.560
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5989.6	D08		6	0028-0099	255.89	99.19	382	75.50	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6920.4	D08		6	0029-0100	595.90	99.78	365	72.67	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6661.8	D08		6	0030-0109	422.07	109.20	401	74.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7425.2	D08		6	0031-0126	484.81	126.11	881	126.71	0.690
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8280.9	D08		6	0032-0131	39.36	130.44	645	96.08	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5852.7	D08		6	0033-0131	549.78	131.58	381	73.84	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6324.5	D08		6	0034-0131	623.75	131.32	378	73.01	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5736.8	D08		6	0035-0132	172.95	132.44	376	77.26	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6387.0	D08		6	0036-0138	663.74	138.16	402	76.08	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6363.7	D08		6	0037-0140	893.42	140.11	365	71.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6452.1	D08		6	0038-0141	808.06	140.48	388	75.84	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5778.8	D08		6	0039-0144	271.47	144.83	389	76.57	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7131.6	D08		6	0040-0146	420.14	146.29	720	105.98	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9159.3	D08		6	0041-0145	457.69	145.41	336	70.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7251.6	D08		6	0042-0145	731.89	144.61	357	71.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5849.6	D08		6	0043-0147	106.08	147.62	398	74.67	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5585.4	D08		6	0044-0146	132.63	146.74	389	80.57	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5277.7	D08		6	0045-0148	301.61	148.60	373	73.50	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6030.0	D08		6	0046-0148	505.48	148.16	399	77.01	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6851.8	D08		6	0047-0149	838.37	149.10	369	72.67	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4942.1	D08		6	0048-0153	190.42	152.90	356	80.43	0.692
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5891.8	D08		6	0049-0159	767.90	159.50	381	75.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5626.7	D08		6	0050-0159	605.24	159.53	411	76.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5391.8	D08		6	0051-0163	326.95	162.93	371	72.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6261.3	D08		6	0052-0162	560.70	162.97	397	76.67	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5885.5	D08		6	0053-0165	928.56	164.82	391	73.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6424.7	D08		6	0054-0167	685.73	167.59	399	73.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6041.6	D08		6	0055-0167	474.63	166.86	391	76.18	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6054.1	D08		6	0056-0171	364.60	171.26	369	73.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6646.7	D08		6	0057-0177	70.64	177.11	396	78.18	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7036.8	D08		6	0058-0178	578.94	178.43	399	75.84	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7331.1	D08		6	0059-0178	93.26	177.67	356	71.94	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6606.8	D08		6	0060-0180	519.28	180.24	369	71.26	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8481.8	D08		6	0061-0188	811.84	187.98	356	71.60	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6992.8	D08		6	0062-0188	732.47	188.22	376	73.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6385.7	D08		6	0063-0188	398.67	187.91	374	72.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5861.7	D08		6	0064-0188	459.42	188.42	391	75.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7019.6	D08		6	0065-0192	707.38	192.26	387	74.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7251.5	D08		6	0066-0194	832.11	193.10	379	75.84	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5822.5	D08		6	0067-0201	129.67	201.14	384	77.26	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6348.2	D08		6	0068-0203	551.30	203.08	376	73.50	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7747.8	D08		6	0069-0204	902.38	204.65	333	66.77	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6390.2	D08		6	0070-0206	355.13	206.40	358	74.43	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5814.7	D08		6	0071-0212	635.35	212.48	399	75.01	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6727.6	D08		6	0072-0214	848.73	215.28	377	77.60	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7651.9	D08		6	0073-0218	932.27	216.97	345	69.26	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6111.4	D08		6	0074-0220	522.35	220.95	391	73.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5697.5	D08		6	0075-0221	324.97	222.47	425	81.01	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7178.0	D08		6	0076-0230	353.42	229.76	822	112.23	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5787.1	D08		6	0077-0233	441.72	232.72	428	80.91	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6404.5	D08		6	0078-0234	887.17	234.36	369	71.36	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6354.8	D08		6	0079-0237	83.22	237.34	399	76.67	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6267.4	D08		6	0080-0240	933.40	241.20	378	72.08	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6539.5	D08		6	0081-0243	854.49	242.67	365	73.84	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6341.1	D08		6	0082-0245	401.20	245.71	365	71.84	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6419.5	D08		6	0083-0244	460.99	244.95	355	75.60	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5232.2	D08		6	0084-0250	217.98	250.08	357	76.33	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6908.3	D08		6	0085-0253	628.92	252.95	378	72.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5292.5	D08		6	0086-0253	263.39	253.75	360	73.26	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6698.8	D08		6	0087-0262	36.17	262.36	722	103.05	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6032.7	D08		6	0088-0260	310.00	260.65	362	73.50	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5823.0	D08		6	0089-0260	102.18	261.17	346	70.43	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8967.5	D08		6	0090-0268	185.69	268.48	884	146.51	0.518
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7172.2	D08		6	0091-0263	454.94	263.11	449	84.67	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9334.0	D08		6	0092-0262	553.62	262.03	325	66.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6520.5	D08		6	0093-0270	678.00	270.01	375	72.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7716.5	D08		6	0094-0273	586.06	273.25	364	72.08	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6404.0	D08		6	0095-0275	369.55	275.52	397	75.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8080.9	D08		6	0096-0276	849.51	275.27	363	72.91	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5493.6	D08		6	0097-0278	235.02	278.33	349	72.43	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5855.0	D08		6	0098-0284	128.71	284.50	355	74.08	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6427.4	D08		6	0099-0287	632.49	287.12	274	61.84	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6203.0	D08		6	0100-0292	864.52	292.16	407	77.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7024.2	D08		6	0101-0296	383.05	296.44	374	73.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7741.2	D08		6	0102-0297	407.90	296.89	387	73.01	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6205.8	D08		6	0103-0297	509.90	297.42	392	72.43	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5901.9	D08		6	0104-0298	44.09	298.72	352	72.08	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6630.3	D08		6	0105-0303	766.26	302.90	352	73.26	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6142.9	D08		6	0106-0310	276.35	310.18	394	75.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6718.8	D08		6	0107-0310	593.44	310.26	370	72.67	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6933.0	D08		6	0108-0310	548.75	310.52	382	74.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7493.8	D08		6	0109-0311	832.11	310.47	382	73.26	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5936.3	D08		6	0110-0315	475.27	315.03	395	74.18	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9288.0	D08		6	0111-0319	683.10	318.92	642	100.47	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5668.2	D08		6	0112-0319	301.13	319.45	382	73.84	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7605.2	D08		6	0113-0327	211.18	328.27	839	117.88	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6890.5	D08		6	0114-0320	566.22	320.72	385	75.50	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8985.0	D08		6	0115-0320	898.68	319.64	306	67.84	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6150.8	D08		6	0116-0322	354.69	321.99	394	75.50	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7476.0	D08		6	0117-0322	717.14	322.36	564	101.26	0.691
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5653.6	D08		6	0118-0328	640.59	328.33	362	75.26	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6252.4	D08		6	0119-0334	269.16	334.69	433	86.08	0.734
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6662.8	D08		6	0120-0332	495.27	331.52	399	74.18	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6199.5	D08		6	0121-0337	817.75	337.00	419	78.33	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12160.7	D08		6	0122-0339	909.62	339.16	468	81.74	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7172.1	D08		6	0123-0340	792.67	339.73	461	82.33	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6665.3	D08		6	0124-0346	23.77	346.14	733	109.64	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6142.3	D08		6	0125-0347	629.09	348.15	482	91.15	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6386.3	D08		6	0126-0349	772.87	349.59	347	73.74	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8355.3	D08		6	0127-0350	932.91	350.68	699	110.81	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7551.8	D08		6	0128-0353	876.46	352.96	385	73.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6341.0	D08		6	0129-0358	727.31	358.52	378	72.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6766.5	D08		6	0130-0371	408.14	370.44	795	118.02	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8153.1	D08		6	0131-0366	226.35	365.77	908	116.33	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7263.2	D08		6	0132-0372	118.56	372.22	342	68.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5357.8	D08		6	0133-0380	171.75	380.43	359	71.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6309.6	D08		6	0134-0381	686.19	380.93	378	72.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6118.9	D08		6	0135-0386	356.86	385.91	362	71.84	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7268.9	D08		6	0136-0386	898.63	385.61	350	70.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5888.3	D08		6	0137-0389	582.02	388.69	403	77.26	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5617.4	D08		6	0138-0393	465.08	393.73	397	76.33	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6446.8	D08		6	0139-0396	531.89	396.65	383	73.60	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6758.1	D08		6	0140-0398	404.18	398.80	397	75.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6279.0	D08		6	0141-0399	263.14	398.89	376	72.43	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6878.6	D08		6	0142-0406	755.66	406.81	828	112.81	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6563.7	D08		6	0143-0400	846.75	399.69	373	72.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6021.4	D08		6	0144-0404	713.06	404.11	418	78.91	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6323.2	D08		6	0145-0406	671.17	405.85	361	71.26	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5233.7	D08		6	0146-0413	138.98	413.47	371	79.74	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6504.1	D08		6	0147-0418	488.43	418.69	409	76.08	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5678.7	D08		6	0148-0420	205.89	419.93	366	72.67	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6354.8	D08		6	0149-0430	813.04	431.09	381	73.26	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6236.5	D08		6	0150-0431	347.02	431.33	380	73.01	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6073.8	D08		6	0151-0432	434.56	432.26	372	75.26	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8161.8	D08		6	0152-0433	386.89	433.27	332	67.01	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5961.1	D08		6	0153-0436	534.23	436.43	387	74.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6067.4	D08		6	0154-0436	566.83	435.94	392	77.50	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7388.0	D08		6	0155-0448	223.60	447.98	776	111.20	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5927.0	D08		6	0156-0444	25.13	445.46	410	79.64	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6799.7	D08		6	0157-0442	879.80	442.45	368	73.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6748.2	D08		6	0158-0453	629.25	451.93	805	122.61	0.673
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10287.9	D08		6	0159-0450	286.83	449.76	498	109.40	0.523
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6692.9	D08		6	0160-0455	546.95	455.76	440	81.26	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6522.9	D08		6	0161-0473	695.65	471.41	849	123.44	0.700
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6671.7	D08		6	0162-0463	767.08	463.73	453	79.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8272.9	D08		6	0163-0470	934.85	469.19	674	102.33	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7229.6	D08		6	0164-0464	910.91	463.51	355	70.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5756.1	D08		6	0165-0469	376.31	469.53	372	70.18	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6411.3	D08		6	0166-0471	177.58	471.75	413	78.67	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6407.3	D08		6	0167-0472	54.05	472.63	343	69.01	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5830.4	D08		6	0168-0475	592.81	474.91	415	75.26	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7124.1	D08		6	0169-0480	324.79	480.81	759	105.74	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6408.8	D08		6	0170-0479	435.04	479.50	376	72.18	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5782.7	D08		6	0171-0483	813.03	483.23	375	74.43	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9411.0	D08		6	0172-0490	770.88	489.39	662	102.91	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6118.1	D08		6	0173-0486	201.54	486.03	380	75.60	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7503.7	D08		6	0174-0487	278.85	487.89	358	69.84	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6133.9	D08		6	0175-0490	245.27	490.50	362	71.84	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6727.8	D08		6	0176-0491	477.77	491.04	428	78.08	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6687.6	D08		6	0177-0498	678.58	499.23	426	79.74	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5907.1	D08		6	0178-0503	118.99	502.66	441	82.57	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6021.0	D08		6	0179-0501	369.40	501.07	369	71.01	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5535.1	D08		6	0180-0503	572.50	503.11	376	74.08	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5453.5	D08		6	0181-0507	34.40	507.78	383	74.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6418.1	D08		6	0182-0509	934.67	508.54	372	73.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6733.6	D08		6	0183-0515	705.36	514.46	392	76.08	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6255.4	D08		6	0184-0512	735.76	512.62	377	75.26	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7565.8	D08		6	0185-0515	198.35	514.67	343	69.60	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5769.4	D08		6	0186-0516	403.12	516.95	377	75.50	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5787.6	D08		6	0187-0528	142.35	527.67	783	122.61	0.655
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5545.0	D08		6	0188-0521	640.20	521.47	403	76.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6485.3	D08		6	0189-0526	248.39	526.31	355	74.91	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6378.1	D08		6	0190-0528	434.65	528.06	364	72.08	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7147.1	D08		6	0191-0539	888.16	539.47	358	68.43	0.961
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5656.7	D08		6	0192-0542	349.12	542.31	386	77.74	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7178.6	D08		6	0193-0550	301.34	550.65	719	105.05	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5414.3	D08		6	0194-0551	111.29	551.67	350	72.91	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6419.2	D08		6	0195-0554	594.03	554.14	397	74.43	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6151.6	D08		6	0196-0555	943.52	555.19	380	73.50	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6448.1	D08		6	0197-0560	443.60	560.66	366	71.84	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5827.6	D08		6	0198-0565	548.38	565.67	372	72.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5553.3	D08		6	0199-0566	171.46	566.61	359	71.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5924.4	D08		6	0200-0571	341.12	571.02	415	82.57	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7754.5	D08		6	0201-0577	784.16	577.07	769	108.81	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6607.8	D08		6	0202-0572	251.05	572.93	407	78.67	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6213.8	D08		6	0203-0572	619.51	572.04	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8029.6	D08		6	0204-0579	74.03	580.39	662	103.40	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5998.4	D08		6	0205-0580	287.78	580.05	376	74.43	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5556.8	D08		6	0206-0579	367.26	578.81	401	77.74	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6719.0	D08		6	0207-0580	819.65	579.49	354	70.43	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6091.1	D08		6	0208-0580	416.10	580.75	378	72.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6691.4	D08		6	0209-0590	474.71	590.58	792	118.47	0.709
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5944.3	D08		6	0210-0582	229.54	582.17	384	74.43	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6794.0	D08		6	0211-0584	716.08	583.65	355	71.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5948.3	D08		6	0212-0590	110.68	589.95	361	72.91	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5815.4	D08		6	0213-0593	326.52	594.57	419	80.91	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7377.6	D08		6	0214-0597	508.27	597.88	502	83.50	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5256.2	D08		6	0215-0598	50.21	597.98	354	72.43	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5826.6	D08		6	0216-0597	558.93	597.18	395	77.01	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7803.0	D08		6	0217-0607	748.76	606.91	688	100.23	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6530.6	D08		6	0218-0603	376.33	604.40	395	79.74	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6018.8	D08		6	0219-0605	166.55	604.53	415	78.18	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5855.2	D08		6	0220-0611	220.68	610.92	370	74.67	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6222.2	D08		6	0221-0613	581.72	612.72	410	78.18	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5953.4	D08		6	0222-0616	412.19	617.09	369	73.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7767.7	D08		6	0223-0624	98.62	624.57	714	100.81	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7198.3	D08		6	0224-0625	180.36	625.83	398	80.43	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5946.4	D08		6	0225-0623	537.52	622.87	384	75.26	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5993.4	D08		6	0226-0635	454.28	635.05	378	73.01	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7631.6	D08		6	0227-0640	821.88	639.14	554	88.57	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6964.0	D08		6	0228-0644	624.45	644.80	425	77.26	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5543.1	D08		6	0229-0645	276.57	645.18	379	74.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7598.0	D08		6	0230-0648	571.47	648.92	714	103.40	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5991.9	D08		6	0231-0647	189.76	646.38	378	79.26	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6835.2	D08		6	0232-0654	371.70	653.98	762	108.47	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6311.7	D08		6	0233-0654	804.65	654.82	380	74.91	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5037.0	D08		6	0234-0650	679.35	650.37	197	55.11	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5247.9	D08		6	0235-0661	46.26	661.50	326	70.18	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5458.8	D08		6	0236-0663	320.64	663.16	378	72.67	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6192.2	D08		6	0237-0666	492.29	665.81	354	70.43	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5293.1	D08		6	0238-0670	135.52	670.49	346	73.26	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5240.5	D08		6	0239-0671	107.79	671.25	366	74.91	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5949.7	D08		6	0240-0676	444.57	675.86	391	73.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6403.8	D08		6	0241-0677	193.75	677.33	365	71.84	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6180.7	D08		6	0242-0680	830.19	680.26	357	70.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5693.8	D08		6	0243-0683	520.86	683.19	371	75.74	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5746.2	D08		6	0244-0686	287.13	685.70	375	73.26	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6362.1	D08		6	0245-0693	909.27	692.95	359	69.84	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6263.7	D08		6	0246-0696	601.90	695.47	367	73.98	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8104.2	D08		6	0247-0703	803.69	703.90	373	74.43	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6010.0	D08		6	0248-0703	212.96	703.48	341	67.94	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184995	1375332	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6477.5	D08		6	0249-0708	315.46	708.28	363	75.01	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6617.9	D08		7	0001-0038	138.70	38.64	783	109.88	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8462.1	D08		7	0002-0034	800.14	34.58	338	69.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5637.8	D08		7	0003-0039	895.20	39.35	401	77.26	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5020.9	D08		7	0004-0038	601.43	38.88	500	84.91	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6270.2	D08		7	0005-0042	281.00	42.21	836	111.64	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5568.1	D08		7	0006-0049	348.32	49.45	926	126.02	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6217.3	D08		7	0007-0044	702.80	44.53	423	77.26	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5507.3	D08		7	0008-0059	821.65	58.95	463	82.91	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5360.2	D08		7	0009-0066	79.13	65.78	449	81.15	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7872.5	D08		7	0010-0071	851.75	70.91	773	109.64	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5820.8	D08		7	0011-0070	394.91	69.33	475	86.91	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5778.0	D08		7	0012-0068	431.23	68.86	349	75.84	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5167.6	D08		7	0013-0078	251.23	76.72	434	79.74	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5237.8	D08		7	0014-0081	185.35	81.82	462	82.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5854.5	D08		7	0015-0087	704.28	87.06	423	77.26	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5649.2	D08		7	0016-0086	911.36	85.55	459	81.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5872.0	D08		7	0017-0090	439.34	90.38	570	96.67	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5194.3	D08		7	0018-0090	387.39	89.99	430	83.01	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6250.6	D08		7	0019-0089	534.01	89.23	451	81.50	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5440.4	D08		7	0020-0091	755.54	92.27	522	89.74	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5358.9	D08		7	0021-0091	938.49	90.77	487	85.50	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5359.9	D08		7	0022-0092	650.55	92.57	472	82.08	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5758.1	D08		7	0023-0093	237.84	94.47	446	80.57	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4970.9	D08		7	0024-0094	319.02	94.51	414	78.91	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5479.4	D08		7	0025-0096	815.37	96.64	456	87.40	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5039.4	D08		7	0026-0095	69.91	95.59	424	79.74	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6269.3	D08		7	0027-0098	845.18	97.93	502	87.15	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4788.0	D08		7	0028-0105	118.84	105.54	422	79.26	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6783.2	D08		7	0029-0106	732.48	106.57	433	80.91	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7232.9	D08		7	0030-0121	299.24	120.12	332	71.50	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5264.6	D08		7	0031-0124	358.14	124.35	404	76.67	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5196.7	D08		7	0032-0127	686.23	126.65	419	77.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5618.6	D08		7	0033-0126	894.96	126.18	404	76.67	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5800.9	D08		7	0034-0127	281.81	128.32	393	78.08	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5957.3	D08		7	0035-0134	17.37	135.18	431	82.91	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5510.0	D08		7	0036-0135	649.93	135.03	457	80.33	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5512.0	D08		7	0037-0137	769.78	137.10	439	82.91	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4747.3	D08		7	0038-0140	523.99	140.31	478	84.33	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5251.7	D08		7	0039-0142	721.43	141.48	426	78.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7324.1	D08		7	0040-0146	451.98	146.47	778	109.74	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5184.6	D08		7	0041-0146	107.97	146.29	445	79.26	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4991.1	D08		7	0042-0148	135.96	147.29	444	84.33	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4975.2	D08		7	0043-0149	316.88	149.62	395	74.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5695.3	D08		7	0044-0154	781.79	154.36	461	87.15	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4705.0	D08		7	0045-0156	845.85	156.05	488	85.74	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5293.0	D08		7	0046-0162	363.17	161.47	444	84.67	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5143.9	D08		7	0047-0166	385.36	167.21	434	82.77	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5972.7	D08		7	0048-0172	184.53	172.77	562	92.81	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5430.8	D08		7	0049-0173	454.80	171.96	385	78.18	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4803.0	D08		7	0050-0177	288.22	177.19	491	92.81	0.716
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5309.8	D08		7	0051-0178	528.37	178.22	462	85.15	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5120.0	D08		7	0052-0182	51.09	181.36	409	81.05	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7153.7	D08		7	0053-0194	217.97	194.61	776	108.47	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5168.0	D08		7	0054-0197	36.31	198.74	416	81.15	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5122.6	D08		7	0055-0194	138.10	194.57	402	78.08	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5411.5	D08		7	0056-0201	825.33	201.22	458	81.50	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4748.2	D08		7	0057-0208	730.55	207.85	446	88.57	0.714
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5223.1	D08		7	0058-0208	651.04	208.27	465	82.33	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6521.1	D08		7	0059-0209	931.10	209.15	402	78.18	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5146.5	D08		7	0060-0210	274.48	209.99	433	78.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5307.6	D08		7	0061-0213	760.79	212.74	447	80.91	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5447.5	D08		7	0062-0214	792.02	214.30	410	78.33	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5233.4	D08		7	0063-0221	335.11	221.41	436	81.50	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5723.5	D08		7	0064-0221	686.85	220.76	434	77.26	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5932.8	D08		7	0065-0226	873.19	225.05	349	72.33	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5020.9	D08		7	0066-0235	496.90	234.92	499	86.57	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7368.1	D08		7	0067-0239	853.50	238.86	887	116.37	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5692.8	D08		7	0068-0242	232.59	242.28	472	86.57	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7059.3	D08		7	0069-0250	596.44	249.54	397	76.81	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5336.7	D08		7	0070-0250	392.33	250.19	439	78.08	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11600.8	D08		7	0071-0253	203.63	253.94	172	82.91	0.314
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6690.9	D08		7	0072-0262	582.42	264.15	519	91.64	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5779.5	D08		7	0073-0274	91.69	274.93	849	123.54	0.699
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5069.6	D08		7	0074-0270	456.40	270.98	443	81.50	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6235.5	D08		7	0075-0276	191.03	275.28	408	79.40	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5334.7	D08		7	0076-0275	698.99	275.48	495	84.91	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5265.4	D08		7	0077-0279	151.50	279.75	427	83.40	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6242.7	D08		7	0078-0280	370.65	281.07	732	107.64	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5044.2	D08		7	0079-0279	493.68	278.87	455	82.33	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5279.5	D08		7	0080-0284	593.04	284.29	489	89.26	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6018.3	D08		7	0081-0295	181.32	296.34	462	87.15	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6161.5	D08		7	0082-0293	287.27	293.14	439	78.08	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5562.9	D08		7	0083-0293	398.40	293.43	479	89.15	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6815.1	D08		7	0084-0295	218.71	295.12	453	81.84	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6140.0	D08		7	0085-0315	421.37	315.20	835	113.88	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5210.2	D08		7	0086-0310	316.18	309.58	428	79.74	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5334.9	D08		7	0087-0314	523.18	314.28	453	82.91	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5981.7	D08		7	0088-0316	619.29	316.35	441	79.26	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6552.8	D08		7	0089-0316	210.40	316.01	418	82.43	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6540.2	D08		7	0090-0329	749.51	328.37	902	121.64	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4957.1	D08		7	0091-0324	675.43	324.14	441	81.60	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5278.2	D08		7	0092-0324	697.35	323.76	542	89.01	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5449.6	D08		7	0093-0330	923.70	330.27	449	81.74	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5485.5	D08		7	0094-0333	865.05	333.11	417	79.50	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5651.3	D08		7	0095-0334	184.98	334.20	426	78.08	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5906.3	D08		7	0096-0340	353.74	339.76	780	111.88	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5043.9	D08		7	0097-0337	503.83	337.39	471	87.98	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5241.4	D08		7	0098-0342	475.99	341.85	503	87.40	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5450.9	D08		7	0099-0352	433.49	352.00	279	62.18	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6157.9	D08		7	0100-0355	632.91	355.63	454	79.26	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5706.6	D08		7	0101-0357	886.90	357.71	400	75.01	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7604.6	D08		7	0102-0365	831.24	365.48	778	105.64	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6227.3	D08		7	0103-0372	28.17	372.53	757	109.84	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6242.5	D08		7	0104-0379	122.49	379.22	502	90.18	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6149.1	D08		7	0105-0383	142.26	381.40	342	74.43	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5015.4	D08		7	0106-0384	326.48	383.91	537	91.15	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5547.8	D08		7	0107-0385	592.79	385.21	478	82.91	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5350.0	D08		7	0108-0390	198.62	390.20	396	77.26	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5338.2	D08		7	0109-0390	648.07	390.05	430	79.26	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5379.7	D08		7	0110-0392	353.79	391.83	524	97.64	0.691
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5728.8	D08		7	0111-0395	155.03	396.14	484	86.81	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5172.8	D08		7	0112-0393	388.35	393.40	457	80.91	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5394.2	D08		7	0113-0401	715.27	400.99	439	83.74	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5546.4	D08		7	0114-0401	910.08	400.87	410	77.26	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5768.5	D08		7	0115-0402	80.39	401.50	410	78.08	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6568.2	D08		7	0116-0408	115.91	409.20	851	116.95	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5290.8	D08		7	0117-0406	47.71	407.15	428	79.60	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4987.6	D08		7	0118-0417	672.49	417.03	472	85.50	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5203.4	D08		7	0119-0419	258.24	419.29	418	75.26	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5172.4	D08		7	0120-0419	852.42	418.87	438	77.84	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4848.5	D08		7	0121-0422	462.95	422.00	463	84.57	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7520.2	D08		7	0122-0428	737.20	428.53	799	106.23	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4995.4	D08		7	0123-0426	357.00	426.46	420	78.91	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4947.0	D08		7	0124-0433	207.82	432.94	401	76.67	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6209.1	D08		7	0125-0439	548.38	439.23	853	114.71	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5104.0	D08		7	0126-0445	130.87	445.13	436	81.15	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5533.2	D08		7	0127-0446	872.69	446.15	435	79.50	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4877.9	D08		7	0128-0450	177.60	449.89	471	86.57	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7313.4	D08		7	0129-0458	504.55	457.94	831	112.13	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5604.4	D08		7	0130-0453	617.91	452.19	430	79.98	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5127.4	D08		7	0131-0460	330.60	460.23	433	78.08	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5403.6	D08		7	0132-0469	633.26	470.21	488	85.40	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5568.6	D08		7	0133-0468	685.96	468.34	437	78.91	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5399.8	D08		7	0134-0469	439.37	469.24	443	79.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9792.6	D08		7	0135-0469	568.45	470.06	280	84.08	0.498
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6712.4	D08		7	0136-0482	928.02	481.95	894	116.95	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5034.0	D08		7	0137-0483	224.25	482.98	421	78.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5019.0	D08		7	0138-0488	77.97	488.45	444	86.23	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5189.4	D08		7	0139-0489	119.46	489.20	400	77.74	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6531.2	D08		7	0140-0503	605.96	503.79	865	116.95	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5383.4	D08		7	0141-0497	448.54	497.80	458	85.15	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5294.7	D08		7	0142-0497	732.17	496.51	436	82.33	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5567.4	D08		7	0143-0497	846.56	496.51	448	80.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7086.8	D08		7	0144-0503	791.27	504.05	818	111.40	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5498.5	D08		7	0145-0504	534.13	504.29	423	77.26	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8598.8	D08		7	0146-0515	397.56	515.35	711	101.40	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5324.5	D08		7	0147-0514	492.38	514.36	432	78.08	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5100.8	D08		7	0148-0520	198.34	520.33	422	77.84	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5973.8	D08		7	0149-0530	560.96	529.57	474	82.57	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4811.2	D08		7	0150-0531	79.84	531.52	448	83.74	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5420.3	D08		7	0151-0534	692.82	534.27	465	85.74	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6337.2	D08		7	0152-0535	859.44	536.14	554	92.47	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6123.5	D08		7	0153-0539	427.78	539.12	414	80.67	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6605.7	D08		7	0154-0547	781.55	547.27	855	118.27	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5569.4	D08		7	0155-0543	216.52	543.56	474	84.33	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4853.8	D08		7	0156-0545	16.05	545.35	394	75.60	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4735.4	D08		7	0157-0546	129.51	546.04	410	80.81	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5300.0	D08		7	0158-0546	542.56	547.35	493	85.98	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6374.2	D08		7	0159-0548	312.37	548.53	846	119.05	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5724.7	D08		7	0160-0556	876.68	556.26	486	84.33	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8740.6	D08		7	0161-0559	421.15	559.94	631	96.91	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5956.3	D08		7	0162-0558	643.98	558.24	421	78.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5593.8	D08		7	0163-0559	697.13	559.46	444	83.50	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5179.7	D08		7	0164-0570	241.67	569.63	417	77.50	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5162.7	D08		7	0165-0574	335.74	574.52	423	81.98	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5952.8	D08		7	0166-0582	939.06	582.12	412	79.60	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7636.7	D08		7	0167-0585	53.65	585.14	766	105.64	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5749.7	D08		7	0168-0583	619.72	583.61	431	76.43	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5256.0	D08		7	0169-0585	567.84	585.96	426	78.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5484.0	D08		7	0170-0587	200.56	587.01	459	81.50	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5288.8	D08		7	0171-0586	381.16	586.27	433	80.91	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4948.4	D08		7	0172-0602	84.26	601.97	412	79.98	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5605.4	D08		7	0173-0608	779.71	607.96	426	77.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5930.0	D08		7	0174-0610	934.27	610.47	448	84.91	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4825.3	D08		7	0175-0612	143.13	612.04	417	84.57	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5317.4	D08		7	0176-0613	692.71	612.59	428	79.26	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5406.6	D08		7	0177-0615	439.99	614.55	437	80.08	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5382.5	D08		7	0178-0622	309.28	622.42	452	80.91	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6221.7	D08		7	0179-0623	216.34	623.50	469	83.26	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5137.3	D08		7	0180-0634	512.13	633.38	446	82.33	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5072.1	D08		7	0181-0636	62.85	636.45	401	76.67	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7397.8	D08		7	0182-0643	332.89	641.98	838	120.13	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5287.7	D08		7	0183-0645	399.66	644.48	449	81.84	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4685.7	D08		7	0184-0647	279.46	648.02	378	80.33	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5423.3	D08		7	0185-0651	639.67	650.98	435	79.01	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5620.0	D08		7	0186-0651	360.99	651.61	463	84.08	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5444.5	D08		7	0187-0655	250.20	654.26	469	86.57	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5719.3	D08		7	0188-0659	500.84	660.70	463	85.74	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6022.0	D08		7	0189-0655	433.42	656.14	379	75.70	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5416.0	D08		7	0190-0660	835.93	660.18	449	80.91	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5099.9	D08		7	0191-0669	391.30	670.27	462	88.81	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5431.0	D08		7	0192-0667	17.13	667.33	458	80.91	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5494.8	D08		7	0193-0667	193.70	667.19	437	79.50	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4621.2	D08		7	0194-0664	222.97	664.04	250	64.43	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5131.7	D08		7	0195-0669	130.34	669.31	415	83.15	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5041.8	D08		7	0196-0671	563.62	671.83	434	80.33	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6702.6	D08		7	0197-0674	744.60	674.36	401	75.50	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8347.5	D08		7	0198-0675	434.96	673.95	430	80.53	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5508.9	D08		7	0199-0680	247.12	680.98	481	89.15	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5392.4	D08		7	0200-0680	297.85	680.08	407	76.43	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5551.2	D08		7	0201-0679	881.66	679.17	397	75.01	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5325.5	D08		7	0202-0683	463.49	683.36	413	78.33	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5961.7	D08		7	0203-0689	910.76	689.07	428	78.67	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5287.2	D08		7	0204-0690	55.66	689.63	424	76.67	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5176.9	D08		7	0205-0698	689.45	697.40	443	86.23	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5343.5	D08		7	0206-0698	656.88	697.85	407	79.15	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5382.2	D08		7	0207-0703	605.62	703.64	412	76.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5785.3	D08		7	0208-0704	351.70	704.08	420	77.26	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5327.0	D08		7	0209-0704	531.98	704.73	484	84.67	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6547.6	D08		7	0210-0704	215.33	704.39	385	72.43	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184996	1375333	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4575.3	D08		7	0211-0709	508.12	709.51	296	69.84	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6233.9	D08		8	0001-0032	884.95	31.78	381	72.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5755.4	D08		8	0002-0036	369.69	35.91	465	82.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6096.0	D08		8	0003-0034	604.87	34.26	413	78.08	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5057.3	D08		8	0004-0039	695.81	39.74	434	85.64	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5779.4	D08		8	0005-0039	424.75	39.71	513	90.57	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5435.5	D08		8	0006-0042	59.13	41.84	406	76.67	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5417.1	D08		8	0007-0042	116.37	41.58	475	85.40	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6756.3	D08		8	0008-0053	446.51	51.28	509	86.23	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5190.5	D08		8	0009-0060	500.17	59.63	448	81.74	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6317.6	D08		8	0010-0061	133.24	61.79	472	84.33	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7366.7	D08		8	0011-0062	572.17	62.39	818	115.78	0.767
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5753.6	D08		8	0012-0065	460.15	66.11	402	78.23	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6367.4	D08		8	0013-0063	918.16	63.17	393	76.33	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6344.1	D08		8	0014-0066	744.30	66.04	400	75.01	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6566.9	D08		8	0015-0073	691.30	73.55	412	75.01	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5057.3	D08		8	0016-0073	860.83	73.44	448	82.57	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6002.8	D08		8	0017-0075	834.89	75.31	412	77.26	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5524.6	D08		8	0018-0078	776.98	78.13	421	78.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5066.9	D08		8	0019-0082	174.03	82.31	390	78.08	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5353.7	D08		8	0020-0083	273.25	83.30	414	77.26	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5865.0	D08		8	0021-0092	219.98	92.53	851	121.05	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7506.0	D08		8	0022-0085	109.71	85.02	386	72.43	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5324.1	D08		8	0023-0088	17.17	87.83	451	82.08	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5147.0	D08		8	0024-0093	44.18	92.84	455	81.50	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5479.7	D08		8	0025-0094	894.42	94.34	407	76.43	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5028.4	D08		8	0026-0098	431.25	98.10	437	83.15	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5559.7	D08		8	0027-0100	366.00	100.19	409	76.67	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8110.6	D08		8	0028-0110	622.43	110.49	865	119.98	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5823.2	D08		8	0029-0107	652.75	107.06	446	81.01	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5501.3	D08		8	0030-0111	703.55	110.95	404	76.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5622.6	D08		8	0031-0113	73.92	113.83	409	77.84	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4987.4	D08		8	0032-0114	142.14	114.63	404	78.91	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8409.3	D08		8	0033-0116	682.50	115.95	406	75.36	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5333.2	D08		8	0034-0119	820.27	119.15	422	77.26	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5431.0	D08		8	0035-0132	728.98	132.30	480	86.57	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5760.6	D08		8	0036-0131	552.04	130.76	407	76.67	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5395.7	D08		8	0037-0141	469.46	141.36	908	135.68	0.620
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7291.4	D08		8	0038-0132	614.30	132.68	390	79.36	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6803.2	D08		8	0039-0144	279.56	144.71	608	95.64	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5347.3	D08		8	0040-0143	414.75	143.33	406	77.50	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5300.4	D08		8	0041-0154	61.26	154.33	437	80.33	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5564.7	D08		8	0042-0153	869.81	153.09	405	77.26	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5120.9	D08		8	0043-0157	138.42	157.09	429	82.08	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6435.1	D08		8	0044-0157	562.84	158.13	412	80.33	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5161.6	D08		8	0045-0159	165.70	159.40	498	90.81	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5860.5	D08		8	0046-0165	521.33	164.82	413	76.67	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5921.1	D08		8	0047-0167	739.78	167.56	428	78.08	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6343.1	D08		8	0048-0168	624.74	168.55	454	80.77	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6815.3	D08		8	0049-0183	567.41	184.60	849	121.78	0.719
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5240.0	D08		8	0050-0183	384.62	183.38	418	79.50	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6084.7	D08		8	0051-0184	277.53	185.34	517	86.53	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7046.3	D08		8	0052-0184	694.35	183.56	388	75.26	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5780.8	D08		8	0053-0186	890.52	186.22	434	79.84	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6564.9	D08		8	0054-0195	913.07	195.23	848	119.15	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8657.9	D08		8	0055-0198	206.93	198.85	984	120.71	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6871.9	D08		8	0056-0192	625.24	191.31	474	84.18	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9769.0	D08		8	0057-0200	484.87	201.08	671	104.37	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5749.0	D08		8	0058-0199	359.06	199.18	446	83.15	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4987.9	D08		8	0059-0200	527.88	200.43	408	79.15	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6758.7	D08		8	0060-0204	711.12	205.37	848	118.13	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5520.4	D08		8	0061-0205	666.68	205.58	439	80.67	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5648.6	D08		8	0062-0206	779.10	206.07	414	77.26	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6249.4	D08		8	0063-0214	276.88	213.77	792	116.43	0.734
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6042.7	D08		8	0064-0211	35.92	211.97	421	83.01	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5248.2	D08		8	0065-0211	447.74	211.02	441	84.23	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5943.3	D08		8	0066-0216	96.43	217.15	848	116.71	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5504.8	D08		8	0067-0217	253.06	216.84	436	81.01	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5706.5	D08		8	0068-0224	158.37	224.36	418	77.50	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5578.9	D08		8	0069-0228	583.30	228.46	464	85.15	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6205.5	D08		8	0070-0226	851.41	226.38	407	75.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6952.1	D08		8	0071-0237	309.49	237.76	822	113.40	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6488.4	D08		8	0072-0241	284.94	240.54	473	87.36	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5252.9	D08		8	0073-0242	529.69	242.68	413	77.26	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5198.9	D08		8	0074-0240	630.78	239.82	350	72.67	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6090.2	D08		8	0075-0244	789.97	244.51	403	78.33	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6085.8	D08		8	0076-0247	607.99	247.34	445	82.91	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5414.0	D08		8	0077-0260	332.57	260.05	459	82.67	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7626.3	D08		8	0078-0259	477.08	259.25	378	72.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6116.7	D08		8	0079-0260	692.38	261.20	452	80.53	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6058.3	D08		8	0080-0277	257.21	277.66	846	112.37	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5848.5	D08		8	0081-0276	832.37	276.41	609	96.33	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5433.9	D08		8	0082-0274	77.86	273.62	372	74.33	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5654.0	D08		8	0083-0277	649.69	277.28	452	78.67	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5479.7	D08		8	0084-0279	438.27	278.77	417	77.26	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5299.1	D08		8	0085-0284	185.71	284.27	400	77.74	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10450.8	D08		8	0086-0282	884.17	282.00	325	67.01	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5581.2	D08		8	0087-0284	913.06	284.55	406	75.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5478.3	D08		8	0088-0285	118.78	285.70	421	81.40	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5878.6	D08		8	0089-0284	691.85	283.76	461	83.36	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5493.0	D08		8	0090-0286	590.33	286.02	441	83.40	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6665.0	D08		8	0091-0289	62.19	290.24	495	87.05	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5959.0	D08		8	0092-0289	215.23	288.87	428	76.67	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7546.6	D08		8	0093-0292	545.64	292.36	775	106.23	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7275.8	D08		8	0094-0292	733.36	292.72	814	108.57	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5795.6	D08		8	0095-0292	385.56	292.55	865	120.81	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5324.9	D08		8	0096-0294	505.09	292.74	453	88.47	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5750.1	D08		8	0097-0301	945.77	302.32	413	79.26	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5039.1	D08		8	0098-0321	99.54	320.91	400	76.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5580.0	D08		8	0099-0321	502.87	321.41	431	77.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5537.8	D08		8	0100-0319	659.31	318.85	429	79.26	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7044.8	D08		8	0101-0336	890.29	336.90	826	119.68	0.725
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5827.5	D08		8	0102-0329	912.12	328.16	412	82.33	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5157.6	D08		8	0103-0332	28.83	332.23	415	79.15	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4980.7	D08		8	0104-0336	249.69	335.89	411	79.74	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5398.2	D08		8	0105-0334	844.38	334.08	456	79.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5466.5	D08		8	0106-0339	425.15	339.81	395	77.60	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5676.7	D08		8	0107-0340	652.93	341.37	469	84.91	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4600.8	D08		8	0108-0342	342.76	342.06	413	78.67	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5685.4	D08		8	0109-0341	386.82	341.56	467	83.50	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5722.7	D08		8	0110-0342	786.67	342.22	406	76.67	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6780.8	D08		8	0111-0348	449.67	347.65	724	104.91	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4933.1	D08		8	0112-0347	166.15	347.14	412	77.50	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6516.3	D08		8	0113-0358	547.03	358.86	868	122.85	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5732.8	D08		8	0114-0349	211.63	349.20	437	79.50	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5839.9	D08		8	0115-0357	711.60	357.80	419	78.91	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5213.7	D08		8	0116-0363	399.47	362.29	445	81.84	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5784.1	D08		8	0117-0372	497.55	372.35	460	81.84	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5545.9	D08		8	0118-0374	757.54	374.67	449	80.91	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5693.2	D08		8	0119-0376	601.74	376.51	426	79.74	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5560.7	D08		8	0120-0378	784.90	377.44	438	79.50	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5516.6	D08		8	0121-0381	304.43	382.27	420	80.18	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5008.8	D08		8	0122-0389	60.15	389.85	389	76.33	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6410.5	D08		8	0123-0393	428.91	394.39	864	118.37	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6794.1	D08		8	0124-0400	117.36	399.99	841	114.13	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5726.6	D08		8	0125-0391	520.05	391.20	456	84.91	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5650.9	D08		8	0126-0394	689.93	393.77	429	76.43	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5669.0	D08		8	0127-0396	907.28	396.73	421	79.84	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5078.2	D08		8	0128-0401	177.10	400.90	434	80.08	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5173.4	D08		8	0129-0403	15.32	402.92	373	72.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5582.5	D08		8	0130-0407	308.11	406.08	476	84.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6161.2	D08		8	0131-0405	651.10	405.55	421	78.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6868.6	D08		8	0132-0411	850.74	411.27	371	71.60	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5492.9	D08		8	0133-0413	581.10	413.40	417	79.74	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6930.3	D08		8	0134-0426	901.74	426.81	747	111.15	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5740.2	D08		8	0135-0421	543.54	421.25	415	78.08	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5320.9	D08		8	0136-0426	135.22	426.07	471	82.91	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5649.4	D08		8	0137-0427	707.94	427.17	405	75.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5470.3	D08		8	0138-0427	750.29	427.15	422	75.84	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4904.9	D08		8	0139-0434	360.23	432.85	438	79.40	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6414.5	D08		8	0140-0443	91.35	443.73	610	94.33	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6361.7	D08		8	0141-0443	856.02	443.55	415	77.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5885.3	D08		8	0142-0443	661.35	442.96	454	83.26	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5724.9	D08		8	0143-0444	808.91	444.31	394	76.08	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5023.0	D08		8	0144-0453	345.48	453.66	469	86.81	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6180.0	D08		8	0145-0451	637.49	450.89	417	77.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5570.9	D08		8	0146-0454	399.22	454.11	446	81.01	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5322.6	D08		8	0147-0455	420.93	455.57	486	86.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6027.4	D08		8	0148-0465	921.78	465.12	432	78.43	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5544.0	D08		8	0149-0465	558.52	464.69	343	71.26	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5166.5	D08		8	0150-0471	252.94	470.44	407	78.77	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5468.3	D08		8	0151-0477	732.29	477.24	423	78.91	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5662.3	D08		8	0152-0476	882.86	476.52	399	73.84	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6386.6	D08		8	0153-0485	32.98	484.12	857	113.54	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5025.1	D08		8	0154-0480	451.55	479.73	419	78.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5380.9	D08		8	0155-0481	500.13	481.23	432	84.33	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5428.6	D08		8	0156-0483	808.31	482.90	444	80.08	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5906.9	D08		8	0157-0482	830.66	481.79	391	81.01	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6117.4	D08		8	0158-0482	622.88	482.80	407	76.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5069.1	D08		8	0159-0485	145.41	485.34	387	77.50	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5210.4	D08		8	0160-0486	206.87	486.52	415	77.50	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5581.5	D08		8	0161-0488	778.91	488.46	406	77.50	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6239.8	D08		8	0162-0493	848.55	493.51	516	89.50	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5818.8	D08		8	0163-0488	409.37	488.78	298	66.08	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5536.4	D08		8	0164-0493	365.42	493.59	435	79.50	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5373.9	D08		8	0165-0496	569.92	495.85	422	79.50	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5694.3	D08		8	0166-0505	741.58	505.90	442	83.60	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5444.3	D08		8	0167-0506	480.71	505.89	443	81.84	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11522.4	D08		8	0168-0518	915.18	518.32	720	110.57	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5564.5	D08		8	0169-0515	647.73	514.94	420	78.08	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5159.8	D08		8	0170-0518	256.99	518.51	433	79.50	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4660.4	D08		8	0171-0523	135.34	522.72	392	76.08	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5023.6	D08		8	0172-0526	814.97	525.92	410	80.33	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4970.9	D08		8	0173-0526	194.48	526.48	394	76.08	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10948.5	D08		8	0174-0525	931.41	524.85	175	53.11	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6150.2	D08		8	0175-0535	746.35	535.25	891	126.47	0.700
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7706.8	D08		8	0176-0527	460.85	527.21	391	72.77	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5323.3	D08		8	0177-0528	366.17	528.27	407	78.67	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6577.5	D08		8	0178-0533	545.31	532.49	555	92.57	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5635.9	D08		8	0179-0544	226.15	544.19	422	78.08	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5509.0	D08		8	0180-0546	793.33	547.02	405	80.91	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5794.9	D08		8	0181-0552	696.30	551.94	410	78.67	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5394.7	D08		8	0182-0560	85.58	559.71	859	121.54	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5455.2	D08		8	0183-0556	404.04	556.74	407	75.50	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6033.2	D08		8	0184-0562	515.01	562.26	465	81.50	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6032.3	D08		8	0185-0564	800.48	565.21	445	86.08	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5333.8	D08		8	0186-0569	173.02	569.09	399	75.50	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5683.1	D08		8	0187-0573	556.41	572.86	403	75.60	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5337.0	D08		8	0188-0578	641.51	577.83	422	78.08	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5581.6	D08		8	0189-0579	740.58	578.80	406	75.50	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6978.4	D08		8	0190-0580	875.42	580.14	437	78.67	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5520.8	D08		8	0191-0585	44.22	584.44	406	84.81	0.709
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5844.6	D08		8	0192-0581	586.30	581.20	404	75.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5280.1	D08		8	0193-0583	324.64	583.53	438	79.50	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5217.4	D08		8	0194-0589	212.22	589.69	435	82.08	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5520.0	D08		8	0195-0595	263.91	595.35	398	77.50	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5309.2	D08		8	0196-0598	426.67	598.42	443	82.08	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5629.4	D08		8	0197-0612	39.00	612.44	432	80.57	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6059.7	D08		8	0198-0611	929.51	611.62	403	79.26	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8015.1	D08		8	0199-0621	82.16	621.05	720	100.57	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6596.4	D08		8	0200-0621	208.06	621.77	573	90.33	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6086.3	D08		8	0201-0619	718.53	619.30	403	74.67	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5703.7	D08		8	0202-0622	429.32	621.30	451	81.26	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5952.5	D08		8	0203-0624	604.82	624.31	425	79.98	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5711.3	D08		8	0204-0627	514.44	626.81	430	80.33	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6291.4	D08		8	0205-0639	318.06	638.75	414	76.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6408.3	D08		8	0206-0639	773.47	638.91	418	77.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4743.0	D08		8	0207-0641	142.44	641.40	392	76.57	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4959.4	D08		8	0208-0646	177.28	646.96	409	76.67	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5364.9	D08		8	0209-0650	67.26	650.15	436	79.26	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5784.8	D08		8	0210-0654	406.54	654.12	430	80.33	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5722.2	D08		8	0211-0660	226.56	660.44	421	78.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7247.5	D08		8	0212-0678	607.91	679.11	851	119.88	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7586.7	D08		8	0213-0674	926.64	673.75	396	75.26	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5894.5	D08		8	0214-0684	414.35	684.91	457	82.67	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7480.7	D08		8	0215-0693	180.42	693.41	765	108.13	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5643.6	D08		8	0216-0691	15.47	691.18	411	78.57	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5601.7	D08		8	0217-0695	389.16	695.35	428	82.57	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184997	1375334	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5069.9	D08		8	0218-0706	316.19	706.84	392	73.26	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8429.5	D08		9	0001-0031	802.21	31.36	377	73.60	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6119.8	D08		9	0002-0031	211.44	31.27	365	70.43	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7660.7	D08		9	0003-0036	582.69	37.25	373	73.74	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6579.5	D08		9	0004-0037	315.18	36.46	417	77.94	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7033.7	D08		9	0005-0040	243.56	39.76	391	75.26	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5418.5	D08		9	0006-0040	69.25	40.63	358	71.26	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5503.4	D08		9	0007-0043	158.62	42.87	383	74.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6079.5	D08		9	0008-0044	549.39	44.18	431	78.67	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8687.6	D08		9	0009-0044	838.91	44.74	396	74.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6165.2	D08		9	0010-0049	433.97	48.43	422	76.43	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5218.0	D08		9	0011-0056	108.85	56.12	370	71.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6009.6	D08		9	0012-0061	197.89	61.33	371	70.18	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5795.0	D08		9	0013-0063	232.85	63.48	376	74.77	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6107.6	D08		9	0014-0066	12.61	65.95	363	72.67	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5551.6	D08		9	0015-0074	412.99	73.90	420	78.18	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6490.1	D08		9	0016-0073	311.53	73.06	398	75.60	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6090.6	D08		9	0017-0078	615.73	77.56	424	77.84	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6516.9	D08		9	0018-0078	693.87	78.19	421	80.91	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5944.9	D08		9	0019-0081	174.00	80.92	364	74.43	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6192.9	D08		9	0020-0082	740.74	81.87	394	75.26	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5635.1	D08		9	0021-0084	358.91	84.33	395	74.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6729.5	D08		9	0022-0085	480.27	85.05	398	73.60	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6422.3	D08		9	0023-0091	867.98	90.87	374	72.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5629.0	D08		9	0024-0095	909.04	95.92	425	77.84	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5468.9	D08		9	0025-0095	122.55	94.82	359	70.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5473.5	D08		9	0026-0096	307.62	95.97	396	75.84	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6509.7	D08		9	0027-0100	709.31	100.82	473	83.26	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7710.0	D08		9	0028-0104	165.47	104.90	558	90.91	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6636.3	D08		9	0029-0102	609.70	102.70	415	76.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5744.6	D08		9	0030-0104	250.84	103.66	451	81.64	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6730.8	D08		9	0031-0101	932.48	101.56	414	79.11	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5741.0	D08		9	0032-0111	651.76	110.71	396	74.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6229.4	D08		9	0033-0117	265.59	118.91	350	71.15	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5867.0	D08		9	0034-0120	94.20	120.25	375	72.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6233.3	D08		9	0035-0127	711.28	125.36	426	82.33	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5431.2	D08		9	0036-0130	208.51	130.00	397	76.67	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5966.3	D08		9	0037-0134	141.97	134.27	378	75.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6313.0	D08		9	0038-0135	693.09	136.57	410	78.08	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7642.5	D08		9	0039-0138	866.97	137.64	357	70.43	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7626.2	D08		9	0040-0139	51.12	140.05	347	69.01	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6973.3	D08		9	0041-0140	353.61	139.65	376	72.18	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5820.8	D08		9	0042-0139	414.94	138.93	402	79.60	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5839.1	D08		9	0043-0140	286.49	139.79	389	74.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6758.4	D08		9	0044-0140	439.97	140.48	424	77.94	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6305.7	D08		9	0045-0145	914.10	145.16	386	72.43	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5992.3	D08		9	0046-0149	481.63	148.96	445	79.26	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6370.4	D08		9	0047-0159	553.86	159.17	840	114.91	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5430.5	D08		9	0048-0153	211.82	153.04	407	76.43	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5570.4	D08		9	0049-0159	99.45	159.36	413	77.74	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7265.2	D08		9	0050-0159	341.79	159.62	373	73.84	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9578.1	D08		9	0051-0159	277.39	159.59	351	69.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6362.6	D08		9	0052-0163	636.04	163.74	429	78.77	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5816.1	D08		9	0053-0163	660.28	162.67	412	76.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6489.5	D08		9	0054-0169	602.12	169.55	466	80.18	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5691.3	D08		9	0055-0169	465.80	168.72	422	78.67	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5402.3	D08		9	0056-0173	48.26	174.07	357	72.43	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5306.4	D08		9	0057-0179	376.57	178.90	426	79.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7597.1	D08		9	0058-0180	860.74	180.33	366	70.77	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5961.6	D08		9	0059-0187	683.04	187.15	393	76.43	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5781.9	D08		9	0060-0186	178.54	186.46	374	72.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6707.1	D08		9	0061-0196	298.97	196.05	817	112.91	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6668.9	D08		9	0062-0196	783.01	196.00	386	74.91	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5552.4	D08		9	0063-0204	102.44	205.02	417	78.91	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6177.4	D08		9	0064-0206	210.89	206.94	381	77.60	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6353.2	D08		9	0065-0209	412.21	209.50	459	80.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5372.6	D08		9	0066-0212	241.57	212.44	368	74.43	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6409.3	D08		9	0067-0210	391.73	210.62	391	73.70	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7744.4	D08		9	0068-0214	460.20	214.19	731	100.81	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5859.2	D08		9	0069-0212	681.99	212.12	440	80.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5852.3	D08		9	0070-0211	641.53	211.36	385	75.26	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6249.4	D08		9	0071-0215	571.82	215.76	385	74.67	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6042.2	D08		9	0072-0221	357.76	220.80	429	79.26	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5510.7	D08		9	0073-0222	309.49	222.98	389	78.18	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6940.2	D08		9	0074-0223	739.20	223.72	392	76.08	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6126.3	D08		9	0075-0227	205.50	226.76	434	80.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8208.3	D08		9	0076-0233	522.04	232.65	722	103.40	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7391.6	D08		9	0077-0233	717.89	233.06	548	93.40	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7631.8	D08		9	0078-0232	882.86	231.82	374	71.60	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6452.6	D08		9	0079-0242	370.93	242.04	567	91.74	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6279.1	D08		9	0080-0244	793.57	244.69	404	75.26	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5594.8	D08		9	0081-0247	296.20	247.12	377	73.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5427.9	D08		9	0082-0251	259.12	251.10	369	72.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6227.3	D08		9	0083-0251	549.31	251.59	444	78.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6045.1	D08		9	0084-0250	180.46	250.07	376	73.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6284.0	D08		9	0085-0252	587.08	251.82	386	75.84	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5781.9	D08		9	0086-0255	153.26	255.91	388	75.50	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5578.9	D08		9	0087-0256	77.61	256.50	386	74.43	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6094.8	D08		9	0088-0258	514.86	258.37	395	75.84	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6129.6	D08		9	0089-0258	846.26	258.51	396	73.01	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8490.7	D08		9	0090-0264	324.38	263.88	658	94.91	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6010.2	D08		9	0091-0262	671.84	262.19	432	80.91	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6385.8	D08		9	0092-0257	915.92	257.74	364	71.94	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6807.4	D08		9	0093-0264	887.34	264.27	349	75.36	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5779.3	D08		9	0094-0273	410.97	273.28	409	75.01	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9919.3	D08		9	0095-0274	472.81	274.16	308	64.77	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5641.8	D08		9	0096-0280	581.72	280.94	420	76.08	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6637.4	D08		9	0097-0281	658.64	281.64	406	74.67	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6468.1	D08		9	0098-0283	791.94	282.76	373	73.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7621.1	D08		9	0099-0282	893.76	282.59	393	79.70	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6116.2	D08		9	0100-0289	208.49	288.97	393	76.08	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7112.6	D08		9	0101-0297	517.43	296.76	791	111.40	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5437.8	D08		9	0102-0291	73.87	291.40	377	71.84	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6593.0	D08		9	0103-0295	920.34	294.67	394	75.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6098.9	D08		9	0104-0296	719.32	296.25	389	76.08	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6309.0	D08		9	0105-0297	820.86	296.95	387	73.84	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7076.8	D08		9	0106-0304	162.89	304.23	724	104.57	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5766.9	D08		9	0107-0296	383.18	295.94	379	73.01	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5508.6	D08		9	0108-0298	261.09	298.23	391	73.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5516.7	D08		9	0109-0301	126.12	301.54	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6567.7	D08		9	0110-0301	900.33	301.91	402	82.18	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5502.4	D08		9	0111-0305	40.73	305.65	391	77.01	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5795.6	D08		9	0112-0306	200.21	307.44	419	82.91	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5776.1	D08		9	0113-0312	434.13	312.14	409	75.26	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6868.6	D08		9	0114-0316	880.46	315.48	381	73.50	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5371.3	D08		9	0115-0323	60.64	322.66	395	77.84	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5903.7	D08		9	0116-0324	317.09	323.94	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5948.1	D08		9	0117-0326	248.09	326.70	408	73.60	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6248.8	D08		9	0118-0325	635.30	324.89	385	73.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5604.3	D08		9	0119-0328	373.64	328.69	414	76.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5832.4	D08		9	0120-0333	478.24	333.17	391	73.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6328.4	D08		9	0121-0334	518.50	334.38	419	77.01	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5790.2	D08		9	0122-0340	574.93	340.26	413	75.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5485.8	D08		9	0123-0342	132.05	341.66	397	74.08	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6663.0	D08		9	0124-0346	929.21	345.80	380	75.94	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7165.4	D08		9	0125-0351	225.07	350.96	642	95.74	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6374.3	D08		9	0126-0349	846.02	349.50	381	73.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5504.7	D08		9	0127-0354	682.81	354.31	438	83.98	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6450.8	D08		9	0128-0358	520.07	357.55	423	78.18	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6531.1	D08		9	0129-0361	313.84	360.59	408	78.18	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5997.8	D08		9	0130-0361	810.32	360.87	426	77.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7146.3	D08		9	0131-0368	888.14	368.11	827	118.81	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6535.9	D08		9	0132-0365	295.33	366.12	359	75.21	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6448.3	D08		9	0133-0368	275.28	367.58	453	82.04	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4913.0	D08		9	0134-0369	122.11	369.40	389	76.43	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5640.8	D08		9	0135-0373	189.40	373.03	404	79.15	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5322.4	D08		9	0136-0384	71.53	384.19	382	74.43	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6932.0	D08		9	0137-0388	237.86	388.08	742	104.23	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7020.6	D08		9	0138-0391	207.08	391.67	461	83.84	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6240.9	D08		9	0139-0390	590.14	390.31	388	74.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6037.8	D08		9	0140-0391	753.46	391.08	394	74.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9861.1	D08		9	0141-0405	506.02	405.02	627	95.64	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6100.3	D08		9	0142-0409	630.87	409.11	412	75.60	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8404.3	D08		9	0143-0415	912.32	415.15	681	102.81	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6946.6	D08		9	0144-0413	410.62	413.37	395	73.84	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6954.8	D08		9	0145-0416	296.49	416.09	609	92.91	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7394.5	D08		9	0146-0415	210.30	414.22	360	72.53	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7739.7	D08		9	0147-0421	943.69	422.81	390	94.57	0.548
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6314.3	D08		9	0148-0424	144.14	422.40	940	120.95	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6308.5	D08		9	0149-0418	568.80	418.83	391	73.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6495.4	D08		9	0150-0426	458.36	426.56	387	71.60	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4754.5	D08		9	0151-0433	80.54	432.57	370	74.91	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6347.0	D08		9	0152-0439	352.40	439.52	386	74.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5308.8	D08		9	0153-0447	256.37	447.18	381	78.67	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6452.1	D08		9	0154-0450	757.46	449.77	377	73.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6113.4	D08		9	0155-0454	560.48	453.62	385	73.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8651.5	D08		9	0156-0458	870.25	458.05	663	95.74	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5047.0	D08		9	0157-0458	205.69	458.53	371	71.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5882.6	D08		9	0158-0458	329.27	458.74	406	75.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7034.3	D08		9	0159-0458	650.51	458.66	398	75.26	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6767.4	D08		9	0160-0462	520.47	462.25	402	75.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5651.9	D08		9	0161-0467	263.57	467.17	452	83.26	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5689.3	D08		9	0162-0468	16.54	467.93	374	71.84	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5696.1	D08		9	0163-0472	403.79	472.47	402	76.18	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7549.2	D08		9	0164-0477	903.92	477.48	517	86.33	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6060.5	D08		9	0165-0492	90.84	491.39	786	115.40	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6960.1	D08		9	0166-0487	942.99	487.59	362	71.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5769.3	D08		9	0167-0499	186.12	500.16	391	75.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5922.9	D08		9	0168-0502	514.94	502.30	403	74.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6861.7	D08		9	0169-0509	862.02	509.84	373	71.84	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6396.6	D08		9	0170-0512	468.13	511.72	397	75.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6321.2	D08		9	0171-0513	775.33	513.07	380	74.67	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6118.0	D08		9	0172-0517	556.44	516.30	415	79.50	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7696.8	D08		9	0173-0520	270.30	519.66	642	94.33	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5625.9	D08		9	0174-0520	181.41	520.11	444	82.18	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5905.8	D08		9	0175-0532	226.41	531.71	396	73.84	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8397.3	D08		9	0176-0537	542.74	538.48	362	74.77	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7105.5	D08		9	0177-0540	403.69	540.32	346	69.94	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8881.3	D08		9	0178-0545	561.00	545.00	297	67.60	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6502.6	D08		9	0179-0544	944.64	544.28	384	73.26	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7465.8	D08		9	0180-0546	841.98	546.34	389	72.43	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6137.7	D08		9	0181-0550	301.68	550.16	392	73.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7557.9	D08		9	0182-0561	415.75	561.58	694	106.23	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14506.2	D08		9	0183-0555	544.47	555.11	252	61.46	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6290.8	D08		9	0184-0562	514.95	562.28	417	76.67	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5756.0	D08		9	0185-0569	793.03	569.10	400	75.84	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5591.8	D08		9	0186-0572	258.47	571.14	339	70.91	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6043.3	D08		9	0187-0582	210.17	582.11	368	73.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6191.8	D08		9	0188-0584	273.44	585.56	492	85.88	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5984.1	D08		9	0189-0583	903.29	582.47	449	79.50	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6571.1	D08		9	0190-0586	660.06	585.62	380	73.84	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6173.2	D08		9	0191-0595	175.90	595.08	377	73.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6088.9	D08		9	0192-0601	327.94	601.43	383	73.01	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6190.1	D08		9	0193-0602	461.92	602.65	373	71.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6045.2	D08		9	0194-0611	659.43	611.53	398	74.67	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6276.7	D08		9	0195-0611	904.60	611.52	385	73.26	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5616.2	D08		9	0196-0615	23.70	614.59	387	75.01	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6764.6	D08		9	0197-0621	489.54	621.59	400	74.43	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8336.3	D08		9	0198-0623	814.69	623.36	394	74.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5489.5	D08		9	0199-0627	281.70	626.41	385	73.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6193.6	D08		9	0200-0631	862.18	631.39	385	73.60	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6746.5	D08		9	0201-0634	165.99	634.41	427	77.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6306.3	D08		9	0202-0648	628.33	646.60	406	78.33	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6462.6	D08		9	0203-0647	399.11	647.27	413	76.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7207.1	D08		9	0204-0647	522.59	648.08	369	73.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6828.9	D08		9	0205-0652	900.01	652.45	351	69.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5993.6	D08		9	0206-0655	100.16	655.09	375	76.33	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7646.7	D08		9	0207-0663	616.05	664.54	508	86.57	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7992.7	D08		9	0208-0667	123.12	666.61	455	80.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6385.4	D08		9	0209-0669	561.54	668.87	382	72.43	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7084.4	D08		9	0210-0676	20.62	676.36	402	73.84	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5671.1	D08		9	0211-0678	512.28	677.79	408	75.50	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5779.2	D08		9	0212-0678	676.22	677.75	470	82.08	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6951.1	D08		9	0213-0694	165.23	693.52	415	76.91	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7719.2	D08		9	0214-0699	536.83	699.76	921	117.30	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7560.1	D08		9	0215-0693	258.74	693.52	405	75.26	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6367.6	D08		9	0216-0696	605.92	696.41	379	73.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.1	uM	48	hr	1184998	1375335	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6400.5	D08		9	0217-0700	784.99	699.49	381	74.67	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5103.2	E08		1	0001-0030	45.07	30.65	419	80.67	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6360.4	E08		1	0002-0042	167.76	42.28	443	77.60	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6341.2	E08		1	0003-0041	625.93	41.06	415	75.01	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7429.2	E08		1	0004-0042	714.23	42.07	387	73.01	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6031.3	E08		1	0005-0046	412.33	45.77	490	84.57	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5685.7	E08		1	0006-0048	453.57	48.42	492	82.08	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5499.9	E08		1	0007-0053	567.12	53.63	471	82.08	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5714.7	E08		1	0008-0063	182.59	62.93	485	84.33	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7099.6	E08		1	0009-0067	34.57	67.11	550	86.91	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5938.9	E08		1	0010-0075	78.32	74.79	442	77.84	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5557.3	E08		1	0011-0073	829.94	73.27	221	56.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5310.4	E08		1	0012-0088	611.67	88.17	454	79.26	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6792.6	E08		1	0013-0088	502.07	88.60	548	90.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4990.8	E08		1	0014-0086	852.50	87.02	282	66.53	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6346.3	E08		1	0015-0091	719.29	91.65	462	80.08	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6428.3	E08		1	0016-0091	524.71	92.67	373	76.53	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5736.0	E08		1	0017-0098	47.05	98.76	435	77.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6275.4	E08		1	0018-0100	168.02	100.31	424	76.43	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5884.5	E08		1	0019-0100	281.75	99.91	402	73.60	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6354.6	E08		1	0020-0101	804.02	101.06	404	76.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6169.0	E08		1	0021-0101	759.55	101.44	445	79.84	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7208.2	E08		1	0022-0107	241.68	107.62	782	109.05	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5517.7	E08		1	0023-0107	355.42	107.05	439	76.43	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6000.3	E08		1	0024-0114	690.88	114.24	486	81.84	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5048.5	E08		1	0025-0121	127.38	120.85	508	89.74	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6892.2	E08		1	0026-0128	900.25	128.11	430	79.60	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6675.0	E08		1	0027-0133	881.34	132.98	363	74.18	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5838.1	E08		1	0028-0136	456.29	136.38	497	86.77	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5419.9	E08		1	0029-0143	481.89	143.29	489	88.67	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5477.7	E08		1	0030-0146	52.86	146.04	428	76.43	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5850.5	E08		1	0031-0149	733.33	148.93	470	84.08	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5799.3	E08		1	0032-0152	636.15	151.24	411	81.50	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5322.6	E08		1	0033-0156	179.65	155.98	413	75.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5630.7	E08		1	0034-0158	695.52	158.70	454	79.26	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6076.8	E08		1	0035-0163	356.63	163.51	438	80.67	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6253.9	E08		1	0036-0167	538.52	166.59	422	77.26	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5580.4	E08		1	0037-0167	625.67	168.24	495	85.74	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7810.3	E08		1	0038-0181	256.69	180.51	798	105.40	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7421.0	E08		1	0039-0177	940.24	176.77	643	113.98	0.622
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7926.0	E08		1	0040-0182	919.56	184.38	246	70.43	0.623
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5495.5	E08		1	0041-0188	417.75	187.91	483	82.91	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6068.4	E08		1	0042-0193	890.39	193.06	442	76.67	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5441.1	E08		1	0043-0198	114.34	198.34	433	77.84	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5593.7	E08		1	0044-0197	159.98	196.69	427	75.84	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5833.2	E08		1	0045-0199	194.67	198.65	454	80.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5692.1	E08		1	0046-0201	473.12	201.79	429	77.26	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5571.0	E08		1	0047-0203	52.74	203.81	405	75.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5210.4	E08		1	0048-0205	90.17	204.94	458	80.91	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5580.6	E08		1	0049-0205	597.63	204.93	433	76.43	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7059.4	E08		1	0050-0207	801.58	207.66	443	78.67	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5978.8	E08		1	0051-0216	416.35	216.78	451	79.50	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5353.9	E08		1	0052-0222	646.65	223.11	432	79.50	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6517.8	E08		1	0053-0228	871.80	227.91	434	78.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5249.6	E08		1	0054-0226	549.57	226.53	449	78.43	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6274.0	E08		1	0055-0228	840.53	228.39	456	82.33	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5413.2	E08		1	0056-0230	38.92	230.56	395	73.26	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6553.5	E08		1	0057-0245	203.72	245.39	997	129.78	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5252.2	E08		1	0058-0242	477.31	241.90	432	77.26	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6226.0	E08		1	0059-0243	328.76	243.39	580	90.08	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8318.2	E08		1	0060-0251	898.82	251.02	446	77.84	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5803.5	E08		1	0061-0252	519.77	252.54	428	77.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5444.2	E08		1	0062-0253	294.10	253.48	444	77.84	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5864.4	E08		1	0063-0253	767.58	253.20	426	77.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5349.2	E08		1	0064-0262	151.82	262.30	429	77.01	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7666.4	E08		1	0065-0269	833.89	269.22	638	92.91	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8150.3	E08		1	0066-0272	70.77	270.22	706	105.30	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5047.1	E08		1	0067-0269	232.72	268.95	431	77.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4926.9	E08		1	0068-0269	364.87	269.58	436	79.50	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6111.9	E08		1	0069-0270	581.58	269.89	455	79.26	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5451.4	E08		1	0070-0281	485.61	280.87	432	78.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7787.1	E08		1	0071-0289	84.53	290.53	682	104.71	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5026.3	E08		1	0072-0289	194.45	288.69	460	80.67	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4955.5	E08		1	0073-0288	264.75	288.32	431	77.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5569.9	E08		1	0074-0293	797.62	293.31	481	84.08	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5772.2	E08		1	0075-0305	755.92	305.48	433	77.26	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5594.7	E08		1	0076-0304	24.11	305.07	407	77.26	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5080.7	E08		1	0077-0304	106.05	305.36	391	74.08	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5429.1	E08		1	0078-0311	708.14	311.30	480	83.74	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5632.7	E08		1	0079-0324	426.88	324.06	459	80.67	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5719.5	E08		1	0080-0325	155.70	324.92	410	75.26	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5247.9	E08		1	0081-0325	510.81	325.96	429	79.50	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5493.5	E08		1	0082-0328	277.00	327.76	413	75.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6566.5	E08		1	0083-0342	555.08	342.00	894	117.64	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7523.5	E08		1	0084-0345	354.40	344.76	908	122.57	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5645.3	E08		1	0085-0336	328.34	336.14	460	79.60	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5802.4	E08		1	0086-0337	189.42	337.44	426	77.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8676.6	E08		1	0087-0339	465.96	338.48	395	75.70	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5257.9	E08		1	0088-0339	801.06	339.25	480	81.26	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9133.3	E08		1	0089-0341	484.56	340.81	352	70.87	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6006.2	E08		1	0090-0351	904.71	350.58	428	78.08	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5709.2	E08		1	0091-0352	928.99	351.53	454	80.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5105.3	E08		1	0092-0351	95.71	351.12	406	75.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6102.4	E08		1	0093-0357	647.60	356.77	433	78.91	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6481.3	E08		1	0094-0370	457.83	370.44	943	123.64	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6158.4	E08		1	0095-0361	501.42	360.90	351	71.94	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6787.1	E08		1	0096-0371	663.63	371.45	456	84.57	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5183.1	E08		1	0097-0368	188.22	368.04	436	79.50	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5270.3	E08		1	0098-0371	596.97	371.40	448	79.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4725.6	E08		1	0099-0370	63.32	370.48	412	78.08	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5080.7	E08		1	0100-0369	275.88	369.77	423	76.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8308.2	E08		1	0101-0379	508.26	379.37	483	86.67	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6990.1	E08		1	0102-0380	816.50	380.84	437	79.50	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6400.9	E08		1	0103-0392	674.25	392.50	491	83.26	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4933.1	E08		1	0104-0392	134.34	392.60	425	76.43	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6180.4	E08		1	0105-0395	787.89	394.74	460	80.08	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6381.9	E08		1	0106-0397	710.62	397.69	428	77.84	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5883.5	E08		1	0107-0404	622.35	404.81	425	77.26	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9012.5	E08		1	0108-0408	927.12	408.71	622	92.91	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4951.1	E08		1	0109-0408	202.68	407.87	460	82.08	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5856.2	E08		1	0110-0410	447.45	410.02	447	79.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5566.7	E08		1	0111-0410	524.60	409.87	428	77.26	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5023.6	E08		1	0112-0412	230.55	412.57	450	80.08	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5825.6	E08		1	0113-0421	62.27	421.92	824	114.71	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7007.7	E08		1	0114-0414	389.83	414.33	420	76.91	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5014.7	E08		1	0115-0418	264.20	418.41	416	76.67	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6141.7	E08		1	0116-0419	884.01	419.03	418	77.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5164.7	E08		1	0117-0420	149.68	421.22	460	85.50	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5984.4	E08		1	0118-0424	786.24	424.27	462	82.18	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6056.7	E08		1	0119-0424	585.75	424.81	484	82.08	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5017.8	E08		1	0120-0424	113.98	424.14	456	78.67	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5736.8	E08		1	0121-0430	738.05	430.83	419	75.84	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5729.3	E08		1	0122-0437	548.25	437.22	430	77.26	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5474.3	E08		1	0123-0443	679.62	443.50	452	78.43	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5643.5	E08		1	0124-0452	452.68	451.69	956	125.68	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5687.1	E08		1	0125-0455	21.35	455.63	811	114.33	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7163.9	E08		1	0126-0448	861.22	449.47	388	74.04	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5855.4	E08		1	0127-0452	942.36	452.57	419	78.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5237.4	E08		1	0128-0455	97.13	455.50	413	79.84	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6026.1	E08		1	0129-0458	378.27	458.43	435	76.67	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5136.6	E08		1	0130-0461	192.39	459.84	436	78.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5512.1	E08		1	0131-0460	249.49	459.97	406	74.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5393.9	E08		1	0132-0463	493.64	462.81	434	78.08	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6003.4	E08		1	0133-0462	739.66	462.49	417	77.26	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5589.0	E08		1	0134-0470	301.00	469.97	456	82.08	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5707.9	E08		1	0135-0469	532.78	469.25	421	78.43	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6509.2	E08		1	0136-0467	582.60	466.82	405	74.18	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6915.8	E08		1	0137-0473	855.50	471.79	473	91.84	0.705
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5692.0	E08		1	0138-0475	110.41	475.53	551	93.60	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6079.2	E08		1	0139-0477	875.10	477.05	463	83.15	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5515.9	E08		1	0140-0476	680.21	476.62	444	77.84	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5133.6	E08		1	0141-0480	136.78	480.05	414	77.36	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6339.1	E08		1	0142-0490	209.33	490.94	904	124.23	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5430.0	E08		1	0143-0486	620.14	486.40	460	80.67	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6103.3	E08		1	0144-0485	752.77	484.45	423	76.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5498.8	E08		1	0145-0495	165.67	495.01	458	79.26	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6289.6	E08		1	0146-0498	885.52	498.56	448	80.33	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5922.9	E08		1	0147-0496	358.26	496.12	412	75.84	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5266.3	E08		1	0148-0502	272.90	501.84	428	78.08	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5496.0	E08		1	0149-0503	538.56	503.36	440	79.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5934.7	E08		1	0150-0504	591.68	504.75	436	77.84	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4972.5	E08		1	0151-0508	54.27	507.66	446	82.33	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5891.9	E08		1	0152-0510	455.95	510.37	437	78.91	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5180.5	E08		1	0153-0520	219.13	519.44	450	81.36	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5221.3	E08		1	0154-0522	187.38	522.40	432	83.50	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6590.4	E08		1	0155-0523	792.97	523.36	427	78.67	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5830.9	E08		1	0156-0527	307.68	528.11	430	80.53	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5955.4	E08		1	0157-0531	68.21	531.31	459	82.08	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5661.5	E08		1	0158-0529	624.88	529.41	418	77.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5705.3	E08		1	0159-0530	716.03	530.46	419	75.84	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9741.3	E08		1	0160-0529	850.33	529.04	149	80.57	0.288
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6033.1	E08		1	0161-0537	112.53	537.02	423	76.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4682.7	E08		1	0162-0543	18.86	543.23	388	76.08	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5696.8	E08		1	0163-0545	650.13	545.60	446	80.33	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5979.1	E08		1	0164-0546	936.83	546.77	456	82.43	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5866.2	E08		1	0165-0547	407.42	546.67	432	77.26	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5870.5	E08		1	0166-0549	307.82	547.82	469	84.53	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5317.8	E08		1	0167-0550	162.08	550.18	396	76.43	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5527.4	E08		1	0168-0550	588.08	550.21	436	76.43	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5856.3	E08		1	0169-0558	202.67	558.45	848	115.54	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	3962.7	E08		1	0170-0555	49.17	555.21	173	51.11	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5563.9	E08		1	0171-0559	264.46	558.77	440	77.60	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5176.3	E08		1	0172-0567	884.03	567.85	446	79.84	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5814.4	E08		1	0173-0568	916.26	568.48	440	81.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6069.7	E08		1	0174-0569	340.67	568.74	461	80.91	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6934.1	E08		1	0175-0575	375.94	575.06	717	100.57	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5574.7	E08		1	0176-0572	492.05	571.93	452	79.26	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6231.4	E08		1	0177-0584	120.96	583.77	855	117.50	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5526.1	E08		1	0178-0588	729.45	587.53	442	78.67	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5669.1	E08		1	0179-0600	777.15	599.75	450	80.67	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5841.9	E08		1	0180-0601	931.97	601.38	424	78.91	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5822.1	E08		1	0181-0604	627.24	604.09	475	82.91	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5783.5	E08		1	0182-0606	347.15	606.58	459	81.26	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6540.9	E08		1	0183-0618	391.24	618.44	390	73.84	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5045.4	E08		1	0184-0620	797.93	620.38	546	91.60	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6311.7	E08		1	0185-0637	64.60	637.63	890	119.30	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5663.9	E08		1	0186-0631	719.70	631.93	467	81.60	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6108.0	E08		1	0187-0631	176.97	631.35	403	76.67	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6563.8	E08		1	0188-0631	697.91	631.62	408	74.53	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5074.5	E08		1	0189-0632	215.71	632.05	430	79.50	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4656.1	E08		1	0190-0637	18.73	637.73	398	78.91	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5342.9	E08		1	0191-0635	553.23	634.85	420	77.26	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5587.3	E08		1	0192-0640	93.70	640.64	451	79.74	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5492.4	E08		1	0193-0639	869.53	638.74	414	76.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6249.8	E08		1	0194-0643	330.43	643.90	423	76.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6398.7	E08		1	0195-0655	426.54	655.75	880	119.05	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5742.3	E08		1	0196-0651	773.20	651.09	440	77.84	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5638.1	E08		1	0197-0655	649.45	655.53	469	82.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6894.9	E08		1	0198-0655	388.48	654.75	422	78.67	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7338.1	E08		1	0199-0654	481.44	654.30	409	75.01	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5264.9	E08		1	0200-0660	517.44	660.08	452	80.91	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6120.3	E08		1	0201-0661	932.46	661.06	366	71.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6619.7	E08		1	0202-0662	256.71	662.73	437	83.60	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7158.8	E08		1	0203-0666	826.30	664.91	413	79.15	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6556.6	E08		1	0204-0678	175.43	678.36	407	77.11	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5363.0	E08		1	0205-0678	554.22	678.45	450	81.26	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5499.9	E08		1	0206-0678	633.42	677.98	463	82.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5603.4	E08		1	0207-0678	841.42	678.77	388	74.33	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6521.4	E08		1	0208-0682	195.20	682.98	450	81.11	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6209.6	E08		1	0209-0683	262.51	682.34	435	82.18	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5155.1	E08		1	0210-0688	499.60	687.89	420	78.43	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6327.6	E08		1	0211-0690	890.26	690.34	383	71.60	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5615.0	E08		1	0212-0693	757.85	693.38	439	78.08	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4912.9	E08		1	0213-0695	110.13	695.18	404	77.50	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6076.6	E08		1	0214-0702	565.03	701.68	495	86.08	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6176.9	E08		1	0215-0707	378.50	706.73	399	75.84	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185385	1375336	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8270.8	E08		1	0216-0708	471.87	707.00	351	73.26	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6574.7	E08		2	0001-0027	890.67	26.94	374	73.01	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6076.3	E08		2	0002-0034	802.74	33.78	411	77.26	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6736.9	E08		2	0003-0044	398.89	44.05	408	77.50	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5642.4	E08		2	0004-0045	267.59	45.26	384	75.01	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6396.0	E08		2	0005-0060	539.47	60.49	420	77.26	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6323.2	E08		2	0006-0061	333.18	61.84	459	82.67	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6119.2	E08		2	0007-0062	725.90	61.80	405	76.67	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7772.8	E08		2	0008-0070	697.13	69.59	751	109.40	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6169.1	E08		2	0009-0064	854.95	64.08	402	74.43	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8735.9	E08		2	0010-0068	564.60	67.98	393	74.43	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7007.8	E08		2	0011-0069	311.70	68.45	377	75.60	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5684.3	E08		2	0012-0074	139.75	73.75	380	73.26	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6524.7	E08		2	0013-0079	623.33	79.13	403	75.84	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5889.9	E08		2	0014-0080	806.89	80.21	477	87.26	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5576.6	E08		2	0015-0080	193.12	80.01	410	78.33	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5678.7	E08		2	0016-0080	243.00	80.22	382	75.26	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5984.8	E08		2	0017-0079	410.94	79.08	423	77.60	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7338.2	E08		2	0018-0084	785.43	83.93	358	70.53	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4975.9	E08		2	0019-0093	67.94	93.43	387	76.08	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9847.4	E08		2	0020-0097	274.93	97.74	306	64.77	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6746.1	E08		2	0021-0104	136.10	104.59	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5764.2	E08		2	0022-0108	442.80	108.17	426	76.43	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8760.4	E08		2	0023-0111	362.97	110.55	364	71.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6950.2	E08		2	0024-0121	683.13	121.47	785	109.88	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6863.4	E08		2	0025-0123	483.35	123.12	381	73.26	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5659.3	E08		2	0026-0127	775.47	127.33	423	78.67	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5828.2	E08		2	0027-0130	354.62	131.04	437	81.50	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6098.5	E08		2	0028-0133	175.78	133.20	395	76.08	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6004.5	E08		2	0029-0133	850.39	133.45	427	78.67	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5644.4	E08		2	0030-0135	378.24	135.97	430	77.26	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5566.7	E08		2	0031-0140	234.73	139.82	400	76.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6066.0	E08		2	0032-0138	422.68	138.62	400	76.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7864.0	E08		2	0033-0147	100.48	147.50	491	83.50	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5691.8	E08		2	0034-0148	724.33	148.39	411	77.50	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6907.0	E08		2	0035-0149	909.00	149.21	391	75.60	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6396.4	E08		2	0036-0161	572.53	161.61	429	78.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6383.3	E08		2	0037-0166	805.96	164.76	428	77.98	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6628.2	E08		2	0038-0167	461.77	167.52	388	73.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6665.3	E08		2	0039-0169	138.99	169.37	396	73.01	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5730.9	E08		2	0040-0176	668.51	175.77	408	76.08	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10779.0	E08		2	0041-0170	27.63	170.20	115	43.11	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5698.5	E08		2	0042-0177	314.08	177.40	384	74.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6923.3	E08		2	0043-0179	46.42	178.70	548	92.57	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6308.4	E08		2	0044-0178	790.37	179.08	372	73.74	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5730.8	E08		2	0045-0182	402.87	182.10	409	75.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6269.6	E08		2	0046-0193	513.15	193.35	924	119.05	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8715.7	E08		2	0047-0184	24.07	185.47	235	66.43	0.669
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6742.4	E08		2	0048-0187	77.70	186.86	377	72.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6140.0	E08		2	0049-0187	877.36	186.70	392	74.08	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5784.8	E08		2	0050-0195	621.74	195.76	405	75.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5395.2	E08		2	0051-0193	258.36	193.62	382	75.60	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5834.7	E08		2	0052-0194	724.88	193.94	428	82.08	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4949.5	E08		2	0053-0203	168.99	203.55	395	76.67	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7234.0	E08		2	0054-0206	420.38	205.55	442	79.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5898.3	E08		2	0055-0207	827.80	207.35	418	75.01	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5575.6	E08		2	0056-0210	51.74	209.85	399	75.50	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5518.4	E08		2	0057-0222	369.13	222.56	396	74.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9973.5	E08		2	0058-0220	809.97	219.30	252	61.84	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5236.5	E08		2	0059-0225	138.35	225.82	377	76.33	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6534.9	E08		2	0060-0225	744.58	224.81	387	72.43	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5263.5	E08		2	0061-0227	215.53	227.48	439	82.67	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6228.0	E08		2	0062-0227	794.99	228.06	380	80.18	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9700.1	E08		2	0063-0238	563.83	238.32	597	91.26	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5140.6	E08		2	0064-0234	268.82	234.46	438	79.01	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5459.7	E08		2	0065-0248	329.53	248.37	391	74.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5788.5	E08		2	0066-0248	76.01	248.58	386	72.43	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6561.7	E08		2	0067-0258	791.77	257.78	926	128.23	0.708
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5481.7	E08		2	0068-0251	221.60	250.53	395	78.67	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5892.9	E08		2	0069-0251	679.71	251.58	412	75.01	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7530.3	E08		2	0070-0256	913.82	256.63	581	89.50	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6850.0	E08		2	0071-0260	634.98	259.87	382	72.77	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5201.6	E08		2	0072-0266	169.77	266.61	555	96.23	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5540.7	E08		2	0073-0264	451.20	264.72	414	76.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5752.4	E08		2	0074-0266	525.51	266.37	435	83.74	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6624.4	E08		2	0075-0274	371.77	274.85	796	111.64	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5641.2	E08		2	0076-0271	411.01	271.76	403	74.67	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7103.3	E08		2	0077-0270	500.82	269.96	400	77.01	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5338.9	E08		2	0078-0293	308.49	292.92	419	77.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5679.4	E08		2	0079-0294	470.07	294.22	400	77.50	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5610.9	E08		2	0080-0297	67.35	297.65	383	73.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6814.0	E08		2	0081-0302	901.77	302.16	369	72.87	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8269.2	E08		2	0082-0302	923.60	301.95	389	74.28	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7126.1	E08		2	0083-0305	581.73	305.14	373	71.84	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5603.9	E08		2	0084-0310	171.84	310.52	381	72.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7317.3	E08		2	0085-0312	544.73	312.04	408	74.18	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8471.8	E08		2	0086-0313	622.31	313.79	659	123.98	0.539
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6045.3	E08		2	0087-0318	272.44	318.88	401	73.36	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5283.2	E08		2	0088-0327	478.15	327.67	419	81.50	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5666.9	E08		2	0089-0329	142.75	328.87	383	71.60	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6767.0	E08		2	0090-0336	451.27	335.94	416	79.50	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5493.2	E08		2	0091-0339	252.17	339.52	404	75.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7085.7	E08		2	0092-0342	303.53	342.63	382	73.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5125.6	E08		2	0093-0344	403.85	343.81	406	78.91	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7190.7	E08		2	0094-0347	823.72	347.14	383	72.43	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5475.5	E08		2	0095-0348	69.00	348.26	383	74.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5448.5	E08		2	0096-0348	226.00	348.72	398	75.84	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5473.3	E08		2	0097-0352	33.51	352.30	399	76.91	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9195.7	E08		2	0098-0351	882.76	350.71	322	69.70	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5652.2	E08		2	0099-0362	151.49	362.52	394	74.67	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5593.6	E08		2	0100-0367	622.50	367.96	417	75.84	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5736.6	E08		2	0101-0371	347.12	371.36	439	78.67	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5309.2	E08		2	0102-0372	879.45	371.13	475	87.50	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5890.2	E08		2	0103-0380	574.82	380.03	402	76.08	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6220.2	E08		2	0104-0390	709.91	389.84	825	113.88	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5675.9	E08		2	0105-0388	95.79	388.54	386	75.50	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5649.2	E08		2	0106-0388	199.33	387.52	442	82.33	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5764.7	E08		2	0107-0390	526.13	389.65	420	80.57	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6146.1	E08		2	0108-0401	820.21	401.50	419	77.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5894.5	E08		2	0109-0402	510.01	403.04	445	80.08	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5438.8	E08		2	0110-0402	654.01	401.98	422	76.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6510.8	E08		2	0111-0406	219.36	406.64	536	89.64	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7377.8	E08		2	0112-0404	292.52	404.38	753	105.50	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8407.7	E08		2	0113-0409	30.77	409.53	628	93.15	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5826.8	E08		2	0114-0406	173.15	406.25	382	73.84	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5839.6	E08		2	0115-0408	120.03	408.10	388	75.26	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5552.2	E08		2	0116-0410	779.56	411.26	437	84.43	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6436.8	E08		2	0117-0413	750.21	412.69	398	75.60	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6721.7	E08		2	0118-0441	495.53	441.66	922	128.81	0.698
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5317.6	E08		2	0119-0435	202.35	435.47	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6437.3	E08		2	0120-0436	438.90	436.64	395	75.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5198.8	E08		2	0121-0439	144.52	438.62	374	72.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5792.3	E08		2	0122-0444	560.08	444.52	417	76.43	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5498.0	E08		2	0123-0453	46.63	453.32	389	75.84	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7389.2	E08		2	0124-0451	476.99	452.07	314	69.94	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10777.1	E08		2	0125-0449	761.44	448.87	161	77.50	0.337
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5771.8	E08		2	0126-0454	380.38	454.11	412	76.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5896.2	E08		2	0127-0457	649.09	457.94	398	76.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6084.6	E08		2	0128-0460	248.91	459.73	375	74.91	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5855.9	E08		2	0129-0471	91.12	471.08	805	114.47	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6398.2	E08		2	0130-0466	923.56	466.10	402	74.67	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7044.6	E08		2	0131-0477	221.96	477.90	722	103.05	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5347.7	E08		2	0132-0473	126.82	472.96	380	72.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9593.4	E08		2	0133-0472	870.35	472.08	319	66.18	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6270.4	E08		2	0134-0475	296.63	475.43	382	75.50	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5443.7	E08		2	0135-0477	173.58	476.81	382	73.84	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7845.9	E08		2	0136-0481	602.06	481.41	489	82.67	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6037.3	E08		2	0137-0490	676.30	490.47	392	75.26	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7005.4	E08		2	0138-0500	890.82	500.70	374	72.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5164.2	E08		2	0139-0501	940.01	500.65	370	73.01	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4898.9	E08		2	0140-0499	617.99	499.08	269	64.43	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6904.7	E08		2	0141-0506	302.68	506.09	559	89.40	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5290.1	E08		2	0142-0504	163.22	503.63	432	81.40	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6758.2	E08		2	0143-0504	847.40	504.03	393	74.43	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10521.9	E08		2	0144-0513	603.02	513.03	283	82.08	0.528
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8603.8	E08		2	0145-0527	375.90	526.51	730	103.05	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5191.5	E08		2	0146-0531	777.66	531.02	435	78.67	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6642.4	E08		2	0147-0540	145.54	540.61	745	109.15	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5731.9	E08		2	0148-0533	531.60	533.96	399	77.50	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5977.7	E08		2	0149-0534	666.34	534.51	401	74.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10448.9	E08		2	0150-0541	707.75	541.05	253	77.84	0.525
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5759.7	E08		2	0151-0547	41.41	547.08	409	78.67	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6091.4	E08		2	0152-0548	73.99	548.39	407	75.26	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6611.6	E08		2	0153-0555	105.27	555.72	398	75.84	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9680.7	E08		2	0154-0551	653.87	551.61	207	52.53	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5124.3	E08		2	0155-0558	832.33	558.28	416	79.26	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6273.2	E08		2	0156-0559	572.73	560.47	817	118.57	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6155.4	E08		2	0157-0560	929.68	559.82	380	74.43	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5394.5	E08		2	0158-0569	20.54	569.14	412	80.33	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6022.7	E08		2	0159-0566	270.34	566.66	420	77.26	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5932.9	E08		2	0160-0576	633.39	576.43	400	73.60	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8672.6	E08		2	0161-0581	471.44	581.79	526	85.50	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5202.8	E08		2	0162-0580	347.13	580.43	396	75.84	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5781.0	E08		2	0163-0582	505.16	581.77	399	73.84	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6928.4	E08		2	0164-0589	591.50	589.08	371	71.26	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7256.8	E08		2	0165-0591	682.30	591.53	370	71.84	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5353.7	E08		2	0166-0600	105.82	600.27	371	71.60	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6321.6	E08		2	0167-0601	285.15	601.69	377	71.84	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5874.6	E08		2	0168-0600	717.83	600.31	422	77.84	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5575.2	E08		2	0169-0602	35.81	602.43	398	73.84	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5725.7	E08		2	0170-0604	200.19	604.23	457	82.08	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6154.3	E08		2	0171-0604	540.79	603.75	393	73.84	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5469.3	E08		2	0172-0609	327.17	609.00	407	77.26	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6211.8	E08		2	0173-0609	774.63	609.18	414	75.36	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6448.5	E08		2	0174-0613	797.36	612.87	461	80.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5583.1	E08		2	0175-0626	196.09	626.48	437	81.60	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6009.1	E08		2	0176-0632	421.06	632.33	407	77.26	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5911.3	E08		2	0177-0646	106.32	646.56	414	76.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5064.7	E08		2	0178-0660	737.33	659.93	429	84.47	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5951.8	E08		2	0179-0657	466.58	656.53	399	79.26	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5673.2	E08		2	0180-0660	350.58	660.47	385	73.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6321.9	E08		2	0181-0661	524.65	661.60	401	74.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5703.2	E08		2	0182-0661	774.24	662.08	435	81.74	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5762.9	E08		2	0183-0662	36.19	661.90	361	71.84	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6198.0	E08		2	0184-0671	157.97	671.75	818	111.40	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7444.1	E08		2	0185-0662	872.90	662.01	666	128.61	0.506
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5954.9	E08		2	0186-0666	289.22	666.21	380	74.08	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4706.7	E08		2	0187-0674	70.95	674.70	366	75.01	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5671.9	E08		2	0188-0677	235.00	676.63	377	73.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6350.1	E08		2	0189-0684	563.26	684.31	396	73.84	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5084.3	E08		2	0190-0691	449.32	690.88	405	76.91	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10461.0	E08		2	0191-0696	716.43	696.13	248	75.50	0.547
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5542.4	E08		2	0192-0702	342.18	702.41	490	87.40	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185386	1375337	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6098.9	E08		2	0193-0702	591.30	701.65	379	73.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6566.6	E08		3	0001-0028	415.24	28.39	399	76.08	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7305.7	E08		3	0002-0036	582.81	36.50	835	114.95	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9662.3	E08		3	0003-0047	790.25	47.08	573	92.81	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7467.7	E08		3	0004-0047	632.71	47.54	348	69.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6451.8	E08		3	0005-0049	842.21	49.68	380	74.08	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7938.3	E08		3	0006-0059	49.64	58.78	679	99.98	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6891.6	E08		3	0007-0060	451.37	60.22	416	75.84	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9158.5	E08		3	0008-0064	479.63	62.90	740	108.81	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6291.3	E08		3	0009-0067	192.44	67.96	397	75.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7263.6	E08		3	0010-0067	523.81	67.54	485	83.26	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5750.8	E08		3	0011-0073	252.22	73.24	390	75.50	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6379.3	E08		3	0012-0076	425.67	75.91	395	75.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8096.3	E08		3	0013-0076	760.09	75.86	341	69.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7605.8	E08		3	0014-0076	803.99	77.07	365	72.18	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6180.5	E08		3	0015-0079	104.63	79.58	364	71.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5759.7	E08		3	0016-0081	144.10	81.90	430	80.08	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6429.8	E08		3	0017-0087	231.50	86.77	441	82.91	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7408.1	E08		3	0018-0093	904.56	92.91	288	64.18	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6869.1	E08		3	0019-0099	632.40	98.90	380	75.50	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6909.6	E08		3	0020-0099	801.64	99.31	406	77.36	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6087.1	E08		3	0021-0101	606.85	101.13	443	82.33	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5815.9	E08		3	0022-0104	69.86	104.40	367	71.60	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6352.3	E08		3	0023-0109	554.71	109.17	424	76.67	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6562.2	E08		3	0024-0111	520.13	111.51	384	73.01	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6474.5	E08		3	0025-0117	491.15	117.00	391	73.36	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6058.9	E08		3	0026-0121	454.17	121.55	394	75.94	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7745.0	E08		3	0027-0120	664.67	120.27	349	68.77	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6019.4	E08		3	0028-0125	605.34	126.10	451	82.43	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7077.0	E08		3	0029-0128	760.48	127.64	369	73.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5672.9	E08		3	0030-0133	283.91	133.14	379	77.74	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8118.5	E08		3	0031-0139	43.87	140.08	647	96.33	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7336.2	E08		3	0032-0141	838.44	141.63	356	70.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5988.3	E08		3	0033-0144	462.69	143.91	345	71.60	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5929.2	E08		3	0034-0147	403.48	147.68	423	79.74	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6838.2	E08		3	0035-0145	556.73	145.56	373	72.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6727.4	E08		3	0036-0148	936.63	147.82	359	70.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6299.8	E08		3	0037-0161	105.56	160.15	819	113.74	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6017.3	E08		3	0038-0161	159.37	161.40	377	74.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7809.6	E08		3	0039-0164	694.96	163.46	415	78.57	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6883.6	E08		3	0040-0165	620.89	164.85	366	71.84	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7088.9	E08		3	0041-0168	542.45	167.59	374	70.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6310.7	E08		3	0042-0172	861.79	172.65	398	74.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6284.4	E08		3	0043-0174	581.78	175.04	388	72.43	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7949.0	E08		3	0044-0177	683.05	178.30	328	70.91	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5655.4	E08		3	0045-0180	195.44	180.37	403	77.84	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10759.0	E08		3	0046-0181	308.26	180.58	310	72.53	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8563.1	E08		3	0047-0192	761.51	191.65	599	91.26	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6808.5	E08		3	0048-0194	31.71	193.70	709	107.74	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10110.4	E08		3	0049-0193	307.19	192.85	192	57.11	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6435.3	E08		3	0050-0210	253.54	209.53	363	71.26	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6877.6	E08		3	0051-0214	662.03	214.98	374	73.84	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6689.5	E08		3	0052-0225	202.17	225.33	359	70.67	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7626.7	E08		3	0053-0233	894.48	232.88	741	113.20	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6462.4	E08		3	0054-0226	681.37	224.84	416	77.74	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7142.9	E08		3	0055-0226	622.13	226.02	368	72.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5608.0	E08		3	0056-0230	231.70	229.44	406	77.50	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6637.8	E08		3	0057-0229	432.85	229.64	372	71.84	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6287.0	E08		3	0058-0233	377.23	232.95	380	72.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6223.9	E08		3	0059-0238	698.28	238.85	444	79.15	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5122.0	E08		3	0060-0239	113.51	238.68	366	72.67	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7085.8	E08		3	0061-0248	500.11	247.44	356	70.67	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7196.1	E08		3	0062-0251	752.47	251.41	385	75.26	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5440.1	E08		3	0063-0256	162.63	255.61	376	76.91	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6917.7	E08		3	0064-0276	640.98	276.20	848	126.02	0.671
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6861.3	E08		3	0065-0267	864.53	267.31	398	74.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7365.7	E08		3	0066-0277	682.08	277.03	520	85.50	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7035.1	E08		3	0067-0280	937.73	280.03	369	72.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6068.3	E08		3	0068-0282	619.21	283.03	418	80.67	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5298.6	E08		3	0069-0283	243.07	283.34	402	77.50	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6417.9	E08		3	0070-0286	502.83	286.56	398	75.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8030.7	E08		3	0071-0297	168.63	296.89	692	98.33	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7228.4	E08		3	0072-0293	818.20	293.63	379	73.01	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6345.6	E08		3	0073-0295	365.72	296.06	381	73.26	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7202.4	E08		3	0074-0299	700.88	298.65	369	72.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5193.0	E08		3	0075-0304	116.70	303.98	384	75.26	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5684.8	E08		3	0076-0316	211.94	316.42	415	75.01	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7091.1	E08		3	0077-0329	802.76	329.64	374	71.01	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5993.4	E08		3	0078-0326	851.75	326.91	277	65.60	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6420.3	E08		3	0079-0340	682.57	340.35	401	76.67	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8058.1	E08		3	0080-0346	414.42	345.62	377	70.77	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5883.8	E08		3	0081-0351	596.96	351.22	418	77.60	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6347.0	E08		3	0082-0353	446.26	353.58	383	73.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6969.0	E08		3	0083-0355	895.73	355.83	370	72.67	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5303.7	E08		3	0084-0363	202.60	363.08	387	74.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5126.8	E08		3	0085-0368	142.99	367.77	372	77.84	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6575.6	E08		3	0086-0368	796.25	368.49	398	75.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6475.1	E08		3	0087-0370	633.01	370.73	390	73.84	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8654.8	E08		3	0088-0373	817.02	373.12	337	67.11	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5534.3	E08		3	0089-0376	858.96	376.34	183	53.94	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6165.2	E08		3	0090-0381	323.92	381.41	369	71.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7253.9	E08		3	0091-0384	710.82	384.50	772	107.74	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6088.1	E08		3	0092-0392	230.06	392.60	411	78.91	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6486.7	E08		3	0093-0389	667.16	389.10	379	75.01	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7407.9	E08		3	0094-0390	911.86	389.80	341	71.60	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8324.3	E08		3	0095-0393	139.73	394.28	338	68.18	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6947.4	E08		3	0096-0397	444.60	396.62	591	99.84	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7941.8	E08		3	0097-0399	533.28	399.79	365	72.67	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6168.0	E08		3	0098-0402	246.58	402.44	379	75.26	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5806.7	E08		3	0099-0404	357.90	403.92	369	72.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7037.5	E08		3	0100-0415	486.20	414.77	845	118.61	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5513.2	E08		3	0101-0421	164.73	421.37	387	76.43	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5571.7	E08		3	0102-0421	285.05	421.10	395	73.84	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6743.4	E08		3	0103-0427	465.41	427.88	436	79.98	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5601.0	E08		3	0104-0427	322.12	427.69	395	73.26	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7970.4	E08		3	0105-0430	638.37	430.24	746	107.05	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6875.2	E08		3	0106-0430	686.73	430.73	378	73.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5568.3	E08		3	0107-0434	108.10	433.85	387	73.84	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5488.3	E08		3	0108-0437	59.84	437.40	376	72.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8295.0	E08		3	0109-0439	611.79	439.72	327	67.26	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9401.1	E08		3	0110-0452	856.28	453.15	186	66.77	0.524
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7477.6	E08		3	0111-0462	894.04	461.91	377	72.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6561.7	E08		3	0112-0469	598.73	470.62	823	111.54	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5799.7	E08		3	0113-0466	199.40	465.88	395	76.43	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9787.4	E08		3	0114-0463	864.99	464.80	169	61.11	0.569
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5999.2	E08		3	0115-0468	18.62	468.60	375	72.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6268.4	E08		3	0116-0477	537.51	477.00	395	73.84	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5814.2	E08		3	0117-0480	53.51	480.49	349	71.60	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5662.7	E08		3	0118-0489	512.63	489.10	419	78.33	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6163.4	E08		3	0119-0487	713.79	487.75	393	75.01	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6866.1	E08		3	0120-0488	757.30	487.96	396	76.43	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6032.0	E08		3	0121-0496	472.71	496.72	389	73.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6219.0	E08		3	0122-0498	409.66	497.78	366	71.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5026.7	E08		3	0123-0503	35.08	503.00	328	68.77	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5758.8	E08		3	0124-0506	169.29	506.84	401	77.60	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8439.4	E08		3	0125-0503	870.94	502.71	369	74.43	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5497.6	E08		3	0126-0513	109.46	513.19	361	72.43	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6969.5	E08		3	0127-0525	449.52	527.03	799	124.81	0.645
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6307.4	E08		3	0128-0515	252.53	515.56	362	73.84	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5477.0	E08		3	0129-0517	190.70	517.05	390	76.33	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7827.6	E08		3	0130-0517	776.83	517.42	340	68.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7209.8	E08		3	0131-0515	808.51	515.00	361	70.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6129.4	E08		3	0132-0521	742.37	520.71	393	75.26	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6100.7	E08		3	0133-0523	296.24	523.06	380	73.26	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9316.2	E08		3	0134-0527	339.69	527.96	523	127.30	0.406
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6032.1	E08		3	0135-0526	587.22	526.52	410	75.36	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6655.5	E08		3	0136-0530	680.35	529.55	417	77.26	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6340.5	E08		3	0137-0531	419.13	531.53	366	72.43	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5864.2	E08		3	0138-0534	548.07	534.35	414	78.08	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7159.4	E08		3	0139-0540	362.14	540.66	391	77.50	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5953.6	E08		3	0140-0545	139.63	544.61	373	77.50	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5641.2	E08		3	0141-0549	525.84	548.52	465	82.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6439.3	E08		3	0142-0556	83.76	556.33	752	107.40	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5895.8	E08		3	0143-0545	688.86	545.38	210	58.77	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5999.1	E08		3	0144-0552	271.47	551.69	372	76.08	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6047.5	E08		3	0145-0557	400.75	557.74	400	75.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6011.4	E08		3	0146-0558	57.64	557.53	415	78.67	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8919.8	E08		3	0147-0557	669.21	557.34	312	65.36	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5787.4	E08		3	0148-0562	24.51	562.19	357	71.60	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6407.6	E08		3	0149-0563	135.43	563.83	398	77.84	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6775.4	E08		3	0150-0563	342.88	563.66	410	79.01	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5140.9	E08		3	0151-0571	182.53	571.83	359	72.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5777.8	E08		3	0152-0581	582.33	580.93	438	79.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7562.5	E08		3	0153-0590	358.55	589.37	813	117.40	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6972.6	E08		3	0154-0586	902.42	586.52	384	73.26	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6269.9	E08		3	0155-0589	448.82	589.10	400	76.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6636.8	E08		3	0156-0593	768.02	593.82	407	74.08	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6652.5	E08		3	0157-0595	502.68	596.04	364	71.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6378.3	E08		3	0158-0604	831.40	603.98	362	73.60	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5604.8	E08		3	0159-0609	640.19	610.11	432	80.33	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7793.8	E08		3	0160-0611	850.23	611.63	370	74.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7505.5	E08		3	0161-0615	610.75	615.08	382	74.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6060.8	E08		3	0162-0628	536.77	627.71	417	78.08	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6785.5	E08		3	0163-0629	888.03	629.44	361	69.84	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6162.2	E08		3	0164-0638	173.63	638.96	773	108.23	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6459.6	E08		3	0165-0632	368.35	632.47	374	72.18	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6404.1	E08		3	0166-0635	289.51	635.13	365	72.43	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6852.5	E08		3	0167-0635	466.65	635.64	364	71.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5568.0	E08		3	0168-0640	241.54	639.77	373	75.01	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7048.9	E08		3	0169-0646	811.99	645.99	397	76.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7852.4	E08		3	0170-0653	50.79	652.78	721	100.23	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5991.5	E08		3	0171-0657	403.07	657.42	389	75.94	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7360.0	E08		3	0172-0669	131.11	669.24	419	79.74	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6927.4	E08		3	0173-0666	790.26	666.03	364	71.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6865.7	E08		3	0174-0669	769.70	669.44	437	82.67	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5467.9	E08		3	0175-0670	282.60	669.71	408	77.50	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5550.9	E08		3	0176-0670	336.02	669.89	373	72.67	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7051.0	E08		3	0177-0676	711.71	675.45	327	70.67	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5801.9	E08		3	0178-0675	902.93	675.77	440	80.57	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6420.7	E08		3	0179-0678	399.08	677.28	461	83.26	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6868.1	E08		3	0180-0679	461.52	678.85	335	71.70	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6978.3	E08		3	0181-0681	480.11	681.06	401	74.87	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6106.3	E08		3	0182-0683	883.11	684.29	410	76.33	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6494.6	E08		3	0183-0686	522.20	685.85	368	71.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5076.1	E08		3	0184-0687	119.99	686.81	247	61.26	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5598.2	E08		3	0185-0690	171.31	690.63	386	73.84	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5283.9	E08		3	0186-0692	290.70	692.65	416	78.67	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9061.5	E08		3	0187-0693	698.95	693.60	331	68.43	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5870.3	E08		3	0188-0696	753.16	696.63	394	74.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185387	1375338	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6993.4	E08		3	0189-0702	238.41	702.66	741	105.40	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6763.7	E08		4	0001-0029	376.31	29.33	422	79.50	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8910.8	E08		4	0002-0030	469.53	29.71	401	77.50	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5863.3	E08		4	0003-0032	326.73	31.62	416	76.67	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5849.5	E08		4	0004-0035	166.80	35.50	385	74.67	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6568.0	E08		4	0005-0034	539.01	34.48	445	82.43	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5686.4	E08		4	0006-0034	38.45	34.57	375	74.33	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6130.8	E08		4	0007-0036	206.75	36.76	415	80.57	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5280.4	E08		4	0008-0042	639.40	41.71	375	73.50	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5566.1	E08		4	0009-0047	481.05	47.22	481	85.98	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6566.5	E08		4	0010-0051	403.40	51.21	468	82.33	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5157.4	E08		4	0011-0061	606.13	61.23	465	82.08	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5272.8	E08		4	0012-0061	870.01	62.05	423	76.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6434.3	E08		4	0013-0064	814.30	64.40	384	72.77	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5812.2	E08		4	0014-0070	776.89	69.91	432	80.08	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5892.1	E08		4	0015-0069	362.99	69.22	421	80.33	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5492.0	E08		4	0016-0075	690.51	75.10	436	78.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5502.7	E08		4	0017-0076	236.77	76.65	410	77.50	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5622.4	E08		4	0018-0077	538.56	77.41	475	87.15	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7010.9	E08		4	0019-0084	839.75	83.66	374	72.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5263.2	E08		4	0020-0087	511.66	87.27	484	87.15	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5332.7	E08		4	0021-0100	67.65	99.83	411	77.26	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5395.5	E08		4	0022-0102	191.26	101.85	442	80.67	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7113.2	E08		4	0023-0106	411.29	105.96	766	104.91	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6537.4	E08		4	0024-0103	436.90	103.15	459	81.36	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5391.0	E08		4	0025-0103	24.48	103.70	398	75.84	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6167.1	E08		4	0026-0108	564.96	108.42	928	128.95	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6185.2	E08		4	0027-0110	667.55	110.64	870	122.95	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6275.7	E08		4	0028-0108	915.24	107.70	423	78.43	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6546.3	E08		4	0029-0119	369.86	119.71	872	117.64	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7059.4	E08		4	0030-0117	483.56	116.96	693	99.98	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5925.4	E08		4	0031-0133	735.08	133.36	872	128.51	0.664
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5836.6	E08		4	0032-0132	793.21	132.41	434	79.50	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6068.8	E08		4	0033-0135	590.91	134.99	441	78.91	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5346.4	E08		4	0034-0138	284.81	138.69	455	83.15	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5513.6	E08		4	0035-0141	624.33	140.81	426	82.57	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5327.5	E08		4	0036-0140	258.61	140.15	317	69.50	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5862.3	E08		4	0037-0144	195.41	144.54	413	77.50	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6300.7	E08		4	0038-0144	893.43	144.56	395	74.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6082.0	E08		4	0039-0148	364.65	148.27	417	80.33	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6509.8	E08		4	0040-0164	122.86	165.55	853	117.78	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5672.0	E08		4	0041-0158	345.00	157.93	466	85.15	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5564.2	E08		4	0042-0158	658.78	158.60	415	76.67	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5463.6	E08		4	0043-0162	39.75	161.75	398	74.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6954.7	E08		4	0044-0163	477.58	162.65	392	73.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5180.1	E08		4	0045-0171	757.86	171.71	411	81.50	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5567.1	E08		4	0046-0179	690.09	179.95	451	82.91	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5710.3	E08		4	0047-0181	509.76	179.71	436	82.47	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6379.7	E08		4	0048-0180	423.86	179.86	449	82.91	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6073.3	E08		4	0049-0188	634.58	188.58	481	83.74	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5792.2	E08		4	0050-0191	491.16	193.10	435	82.33	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5537.5	E08		4	0051-0192	794.75	192.31	428	78.08	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6766.5	E08		4	0052-0197	550.39	197.01	414	79.26	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6300.1	E08		4	0053-0197	831.67	197.45	401	76.08	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5598.3	E08		4	0054-0202	411.77	202.14	485	90.33	0.747
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5770.8	E08		4	0055-0211	606.56	211.27	947	125.44	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5489.5	E08		4	0056-0206	385.02	206.39	456	82.67	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5732.0	E08		4	0057-0209	242.02	207.81	446	81.88	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5296.9	E08		4	0058-0212	67.31	211.81	423	79.26	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6045.1	E08		4	0059-0210	286.99	210.26	423	78.08	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5561.2	E08		4	0060-0216	726.80	215.88	427	77.50	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5819.4	E08		4	0061-0221	226.57	222.17	395	78.23	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6289.0	E08		4	0062-0222	544.15	222.08	490	86.18	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5204.9	E08		4	0063-0220	777.29	220.48	419	76.67	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5604.5	E08		4	0064-0230	350.24	230.09	407	76.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5975.3	E08		4	0065-0235	698.65	235.23	431	82.81	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6997.9	E08		4	0066-0235	390.33	235.47	392	75.50	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5219.9	E08		4	0067-0243	108.57	243.69	401	77.50	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5556.2	E08		4	0068-0246	838.49	246.20	452	80.91	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5569.2	E08		4	0069-0248	543.64	247.86	431	78.43	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5628.9	E08		4	0070-0248	753.37	248.95	404	77.50	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5715.7	E08		4	0071-0248	451.53	248.74	468	84.77	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5202.4	E08		4	0072-0252	323.73	252.20	406	77.26	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5805.1	E08		4	0073-0254	473.20	254.32	420	80.18	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7505.5	E08		4	0074-0255	912.05	255.95	362	71.26	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5916.2	E08		4	0075-0258	640.31	258.51	486	85.50	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5313.3	E08		4	0076-0260	665.44	259.77	452	83.50	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5667.1	E08		4	0077-0263	872.41	263.11	474	83.50	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5548.4	E08		4	0078-0266	367.06	265.64	415	76.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7434.9	E08		4	0079-0268	780.52	268.02	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5426.1	E08		4	0080-0274	179.37	274.15	430	77.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5514.2	E08		4	0081-0280	251.34	280.48	399	75.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6199.3	E08		4	0082-0286	526.38	286.29	418	77.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8470.7	E08		4	0083-0291	805.27	290.90	691	98.57	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5654.8	E08		4	0084-0289	415.43	289.20	429	80.08	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5255.3	E08		4	0085-0303	165.61	303.77	430	77.84	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6008.5	E08		4	0086-0308	709.10	308.30	472	83.26	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5117.1	E08		4	0087-0311	288.03	311.72	406	79.50	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5255.1	E08		4	0088-0312	901.72	311.94	422	76.43	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6132.2	E08		4	0089-0318	685.82	317.83	441	80.67	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7666.6	E08		4	0090-0323	249.96	323.02	742	104.47	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6223.7	E08		4	0091-0322	624.79	322.52	399	76.08	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6074.7	E08		4	0092-0322	943.40	322.65	381	73.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5785.7	E08		4	0093-0347	676.81	348.17	412	76.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6251.8	E08		4	0094-0349	750.47	349.19	842	119.64	0.739
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5245.9	E08		4	0095-0349	136.05	348.74	396	76.91	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6302.4	E08		4	0096-0353	704.85	353.22	416	78.91	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6613.3	E08		4	0097-0361	338.63	362.11	810	111.88	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5647.6	E08		4	0098-0357	564.43	357.09	460	82.77	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5351.8	E08		4	0099-0359	203.75	359.23	427	80.33	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6642.0	E08		4	0100-0362	531.38	361.51	870	114.57	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5873.5	E08		4	0101-0364	616.58	364.28	423	75.84	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5109.5	E08		4	0102-0370	180.75	369.39	448	80.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5291.9	E08		4	0103-0375	83.23	375.25	391	78.33	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5859.8	E08		4	0104-0377	425.81	377.11	425	78.91	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6499.2	E08		4	0105-0386	288.74	385.59	897	123.88	0.734
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9302.9	E08		4	0106-0384	871.17	383.61	342	68.18	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5582.2	E08		4	0107-0389	24.18	389.00	376	74.67	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6060.7	E08		4	0108-0387	258.24	387.51	410	78.53	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5162.8	E08		4	0109-0393	491.32	393.10	437	83.15	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5605.8	E08		4	0110-0396	552.04	394.76	415	80.23	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5647.1	E08		4	0111-0398	738.64	397.49	397	74.43	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6424.2	E08		4	0112-0399	684.04	398.75	412	76.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6603.2	E08		4	0113-0407	389.42	406.76	529	94.91	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5340.7	E08		4	0114-0407	589.34	406.88	420	78.67	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6264.0	E08		4	0115-0406	920.59	406.58	440	77.26	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8469.9	E08		4	0116-0413	532.50	414.86	753	104.47	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5391.8	E08		4	0117-0413	233.92	412.73	412	77.26	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5336.4	E08		4	0118-0411	359.40	410.70	415	78.08	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6434.3	E08		4	0119-0413	630.06	411.74	381	77.64	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6356.4	E08		4	0120-0419	285.91	418.45	839	108.81	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5844.3	E08		4	0121-0421	695.14	420.42	479	90.81	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5751.8	E08		4	0122-0419	436.31	419.40	407	76.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5885.0	E08		4	0123-0425	110.14	425.64	562	94.81	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6447.6	E08		4	0124-0426	645.96	426.73	455	80.57	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6302.0	E08		4	0125-0425	866.84	425.04	392	76.91	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9355.0	E08		4	0126-0426	382.97	426.70	214	60.77	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5657.3	E08		4	0127-0431	777.43	430.82	454	83.15	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6384.8	E08		4	0128-0436	705.74	437.07	413	81.98	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5448.3	E08		4	0129-0435	319.58	435.80	410	76.08	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7455.6	E08		4	0130-0446	599.20	446.02	744	100.81	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6381.8	E08		4	0131-0448	163.99	448.51	430	78.08	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5567.0	E08		4	0132-0456	276.89	456.42	424	78.08	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7004.8	E08		4	0133-0459	905.75	457.52	380	75.98	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6504.1	E08		4	0134-0468	888.60	469.74	418	79.74	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8288.2	E08		4	0135-0474	695.70	474.53	764	106.23	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5899.0	E08		4	0136-0477	370.65	476.79	426	80.81	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5217.1	E08		4	0137-0481	112.68	481.24	401	78.33	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5505.9	E08		4	0138-0488	213.74	488.34	406	78.67	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5344.6	E08		4	0139-0486	603.59	485.86	424	78.91	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5038.1	E08		4	0140-0492	76.49	492.01	442	82.33	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5539.1	E08		4	0141-0490	307.38	490.29	448	81.50	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6345.7	E08		4	0142-0495	355.80	495.48	508	86.57	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5459.9	E08		4	0143-0498	530.91	497.54	426	78.43	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5617.4	E08		4	0144-0508	936.11	508.18	411	76.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6635.6	E08		4	0145-0516	640.42	515.71	391	73.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5515.1	E08		4	0146-0518	385.44	518.92	445	83.98	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5122.7	E08		4	0147-0526	569.04	526.32	431	80.33	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5416.7	E08		4	0148-0525	428.94	525.80	418	80.33	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5267.8	E08		4	0149-0528	701.21	528.02	431	79.50	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5730.7	E08		4	0150-0535	118.78	535.26	432	80.91	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6266.9	E08		4	0151-0535	367.11	534.85	449	81.74	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5223.2	E08		4	0152-0538	154.87	538.00	401	75.74	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5625.0	E08		4	0153-0542	403.90	541.72	447	84.33	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5434.3	E08		4	0154-0546	617.77	545.48	421	78.67	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7757.4	E08		4	0155-0553	247.29	552.85	707	100.23	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6365.3	E08		4	0156-0546	851.67	546.21	400	76.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6065.0	E08		4	0157-0551	755.90	550.92	400	75.01	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6238.1	E08		4	0158-0555	509.69	555.50	513	86.33	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6087.1	E08		4	0159-0566	449.55	566.71	846	114.47	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5535.2	E08		4	0160-0565	325.54	565.58	446	78.91	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5472.0	E08		4	0161-0565	718.66	565.16	417	77.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5878.8	E08		4	0162-0578	581.05	578.21	405	77.26	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5456.9	E08		4	0163-0584	352.77	585.09	409	78.91	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7042.2	E08		4	0164-0586	644.49	587.18	809	110.81	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5959.1	E08		4	0165-0599	386.32	598.68	902	122.02	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6591.2	E08		4	0166-0597	820.30	597.28	403	79.50	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5298.1	E08		4	0167-0597	902.14	597.37	399	74.43	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5498.5	E08		4	0168-0601	522.22	601.39	413	77.84	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6498.7	E08		4	0169-0610	858.65	610.57	427	79.50	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5647.4	E08		4	0170-0611	197.02	610.95	439	80.91	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5402.7	E08		4	0171-0610	713.64	610.13	416	77.84	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7406.2	E08		4	0172-0612	777.81	612.44	373	70.77	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6744.7	E08		4	0173-0617	442.56	617.16	390	75.50	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5723.6	E08		4	0174-0620	300.22	620.31	408	74.43	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6286.6	E08		4	0175-0623	818.13	622.92	476	84.08	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6259.1	E08		4	0176-0632	66.66	631.38	777	109.05	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5185.6	E08		4	0177-0638	333.96	638.20	438	79.74	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5902.3	E08		4	0178-0639	645.90	638.83	415	75.84	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5589.7	E08		4	0179-0644	254.30	643.97	410	75.84	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9229.7	E08		4	0180-0644	766.71	644.46	248	87.50	0.407
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6855.1	E08		4	0181-0649	475.70	648.79	796	111.64	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6867.1	E08		4	0182-0654	885.78	655.00	352	69.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5384.0	E08		4	0183-0656	36.38	656.07	390	73.26	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5243.5	E08		4	0184-0658	820.16	658.20	417	75.84	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5447.8	E08		4	0185-0666	109.47	665.99	445	80.91	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5435.7	E08		4	0186-0668	931.79	667.74	379	73.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5099.9	E08		4	0187-0670	764.69	670.90	426	79.74	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4984.4	E08		4	0188-0670	515.22	671.01	430	81.40	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5776.9	E08		4	0189-0672	228.59	672.38	446	80.67	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5319.0	E08		4	0190-0677	711.19	677.12	407	78.33	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5201.8	E08		4	0191-0680	362.66	680.49	407	74.18	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5581.2	E08		4	0192-0682	674.03	681.82	403	75.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5590.4	E08		4	0193-0688	31.90	688.55	387	75.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5627.8	E08		4	0194-0700	913.09	698.64	422	81.15	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4997.6	E08		4	0195-0699	177.40	699.16	425	77.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5664.0	E08		4	0196-0706	896.96	706.45	370	76.67	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6259.8	E08		4	0197-0705	451.24	705.04	393	73.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185388	1375339	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6850.4	E08		4	0198-0706	841.19	706.47	391	73.84	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8267.8	E08		5	0001-0036	912.92	36.08	697	97.74	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10114.7	E08		5	0002-0037	400.71	36.02	190	56.53	0.747
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7608.5	E08		5	0003-0042	383.54	44.47	533	95.15	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6190.6	E08		5	0004-0043	672.96	42.74	427	77.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8913.9	E08		5	0005-0047	55.66	46.50	612	93.98	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8723.5	E08		5	0006-0047	87.28	46.68	387	97.15	0.515
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5659.2	E08		5	0007-0044	186.17	44.47	395	73.84	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5117.4	E08		5	0008-0047	226.42	47.21	458	83.15	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6284.5	E08		5	0009-0048	129.84	47.85	425	77.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7882.7	E08		5	0010-0050	790.39	50.36	408	77.74	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11086.4	E08		5	0011-0051	101.71	52.26	139	54.53	0.587
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5672.3	E08		5	0012-0057	312.17	57.19	430	79.26	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6477.8	E08		5	0013-0068	489.97	68.32	441	79.50	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5818.3	E08		5	0014-0073	372.57	73.36	407	74.43	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6310.7	E08		5	0015-0074	412.97	74.21	406	77.50	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6943.1	E08		5	0016-0082	710.92	82.13	436	77.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6567.2	E08		5	0017-0089	155.98	89.08	370	72.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7303.7	E08		5	0018-0098	744.01	98.60	365	71.26	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7437.0	E08		5	0019-0101	112.51	100.66	349	70.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5159.7	E08		5	0020-0107	189.04	107.38	386	77.50	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9615.2	E08		5	0021-0106	912.13	105.94	263	75.50	0.580
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5669.7	E08		5	0022-0110	20.05	109.88	419	79.74	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6383.7	E08		5	0023-0113	684.55	113.61	430	78.08	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6320.7	E08		5	0024-0134	634.63	132.56	822	126.37	0.647
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5226.8	E08		5	0025-0135	217.50	135.58	433	79.84	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5635.3	E08		5	0026-0138	151.19	137.96	392	74.67	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5983.7	E08		5	0027-0139	694.30	139.48	432	78.91	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7807.6	E08		5	0028-0138	506.42	138.97	366	71.26	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6850.9	E08		5	0029-0153	739.43	153.21	377	71.01	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6583.5	E08		5	0030-0155	266.99	155.23	390	74.08	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6041.9	E08		5	0031-0158	364.21	158.24	390	74.43	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7911.6	E08		5	0032-0157	789.19	157.46	339	69.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6514.4	E08		5	0033-0161	428.45	161.27	415	79.15	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6621.8	E08		5	0034-0162	606.91	162.23	471	85.98	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5555.8	E08		5	0035-0164	102.21	164.37	385	74.91	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6013.1	E08		5	0036-0170	393.74	169.85	402	75.84	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7836.3	E08		5	0037-0173	45.29	173.71	724	105.50	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8214.1	E08		5	0038-0176	559.97	176.57	534	125.44	0.426
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6070.9	E08		5	0039-0182	182.79	182.45	382	74.33	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6339.1	E08		5	0040-0184	824.00	184.55	431	79.84	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6770.9	E08		5	0041-0189	630.02	190.57	822	113.54	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5550.4	E08		5	0042-0185	228.36	183.91	443	87.05	0.735
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7306.1	E08		5	0043-0202	452.20	201.93	838	110.57	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6360.3	E08		5	0044-0195	279.94	195.23	410	77.01	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7337.4	E08		5	0045-0202	155.62	202.56	473	86.08	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6522.5	E08		5	0046-0201	527.69	201.62	461	81.84	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6195.2	E08		5	0047-0203	752.82	203.24	401	76.08	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6736.7	E08		5	0048-0210	326.39	209.37	856	119.20	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5232.5	E08		5	0049-0207	228.68	207.78	408	82.23	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5223.3	E08		5	0050-0218	126.09	217.93	392	77.74	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5967.7	E08		5	0051-0219	938.78	219.02	391	74.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5506.3	E08		5	0052-0223	167.61	222.46	356	76.43	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6413.8	E08		5	0053-0229	91.30	229.29	380	74.67	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5754.6	E08		5	0054-0229	780.61	229.64	408	76.67	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8291.0	E08		5	0055-0233	833.52	233.37	660	96.57	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5751.2	E08		5	0056-0232	898.40	232.45	416	76.67	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7058.3	E08		5	0057-0241	397.59	241.52	526	87.74	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6922.9	E08		5	0058-0244	649.02	244.50	374	70.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5478.2	E08		5	0059-0248	294.41	247.83	388	74.67	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7182.7	E08		5	0060-0250	614.43	250.41	465	83.74	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5205.8	E08		5	0061-0253	247.78	252.38	415	81.40	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4748.4	E08		5	0062-0253	514.90	252.80	430	80.91	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6336.4	E08		5	0063-0254	738.72	254.37	418	79.01	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6834.4	E08		5	0064-0258	16.81	258.04	373	73.26	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5142.5	E08		5	0065-0260	71.67	260.48	388	73.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5468.3	E08		5	0066-0260	337.57	260.69	413	76.67	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6335.5	E08		5	0067-0261	717.98	261.28	407	79.26	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9001.7	E08		5	0068-0261	359.63	260.89	371	71.70	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7252.1	E08		5	0069-0268	867.65	268.12	368	72.08	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5924.2	E08		5	0070-0271	812.16	270.97	430	79.50	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5572.2	E08		5	0071-0274	164.80	274.49	398	76.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5797.3	E08		5	0072-0282	833.97	281.78	441	82.91	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6437.0	E08		5	0073-0285	930.92	285.11	411	75.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5746.9	E08		5	0074-0291	91.17	291.53	396	75.26	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6232.9	E08		5	0075-0291	480.15	291.94	443	80.33	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5405.4	E08		5	0076-0290	541.98	289.68	413	80.33	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6027.3	E08		5	0077-0297	744.79	296.42	423	79.74	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6244.6	E08		5	0078-0298	638.64	298.19	436	79.50	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5426.4	E08		5	0079-0299	696.64	299.44	421	77.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5391.9	E08		5	0080-0310	859.34	310.60	433	79.26	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5772.0	E08		5	0081-0311	211.24	311.25	384	73.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6877.0	E08		5	0082-0317	458.01	318.23	597	94.81	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5605.3	E08		5	0083-0316	756.38	317.12	453	82.08	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5517.8	E08		5	0084-0320	547.00	320.09	475	92.23	0.702
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5822.1	E08		5	0085-0322	522.21	322.03	409	79.84	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5553.8	E08		5	0086-0325	48.41	324.90	371	73.50	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5238.6	E08		5	0087-0325	111.70	324.44	389	75.01	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6155.5	E08		5	0088-0329	314.40	328.83	415	76.08	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6086.4	E08		5	0089-0331	582.08	332.17	403	76.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5446.1	E08		5	0090-0333	673.06	333.28	435	80.08	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6058.5	E08		5	0091-0331	899.74	331.41	398	77.26	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5627.4	E08		5	0092-0338	172.43	338.13	383	74.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5566.0	E08		5	0093-0339	223.79	339.76	383	74.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6083.8	E08		5	0094-0347	779.18	347.30	388	76.33	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5702.2	E08		5	0095-0349	689.37	349.18	454	81.74	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5587.0	E08		5	0096-0349	144.38	349.49	383	74.08	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4800.5	E08		5	0097-0351	272.80	350.88	394	76.08	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6898.2	E08		5	0098-0356	645.18	355.75	398	76.67	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5126.5	E08		5	0099-0371	89.56	371.12	398	75.26	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6046.4	E08		5	0100-0371	750.34	370.95	394	79.15	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5570.8	E08		5	0101-0375	859.09	374.62	419	77.50	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6585.9	E08		5	0102-0377	235.32	377.50	785	116.95	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6178.5	E08		5	0103-0385	597.11	385.01	934	125.68	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6272.1	E08		5	0104-0389	304.30	388.70	858	119.68	0.753
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5299.4	E08		5	0105-0383	122.06	383.52	392	76.57	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5282.7	E08		5	0106-0388	549.09	386.78	494	88.57	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5719.5	E08		5	0107-0388	493.48	388.54	448	86.57	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5099.8	E08		5	0108-0392	464.63	392.49	458	82.91	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5810.7	E08		5	0109-0398	361.87	397.81	415	76.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5395.4	E08		5	0110-0397	729.47	397.47	422	77.50	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6615.6	E08		5	0111-0402	644.21	402.75	401	75.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5812.1	E08		5	0112-0408	25.84	408.78	427	77.50	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5444.9	E08		5	0113-0412	687.08	412.42	423	78.67	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4808.1	E08		5	0114-0420	131.98	419.92	301	71.11	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4628.8	E08		5	0115-0420	149.08	419.68	190	53.21	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6198.2	E08		5	0116-0426	598.50	426.01	414	77.50	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5328.9	E08		5	0117-0428	881.31	428.51	431	80.33	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5635.0	E08		5	0118-0433	743.77	432.91	402	76.67	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5479.1	E08		5	0119-0436	519.01	436.38	420	78.08	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5289.7	E08		5	0120-0440	203.93	440.29	462	83.84	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5284.2	E08		5	0121-0442	226.39	442.23	462	81.60	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6055.2	E08		5	0122-0442	259.99	441.96	399	75.50	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6169.2	E08		5	0123-0442	396.28	441.63	404	77.26	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6356.5	E08		5	0124-0452	828.09	451.93	481	81.01	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5394.9	E08		5	0125-0454	567.20	454.24	407	76.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5319.4	E08		5	0126-0458	60.38	458.16	396	77.26	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5447.4	E08		5	0127-0464	462.94	463.98	444	82.91	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5706.4	E08		5	0128-0462	682.87	461.98	412	76.91	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8161.9	E08		5	0129-0466	727.81	466.33	689	100.47	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6106.2	E08		5	0130-0462	939.93	462.33	386	73.01	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6851.2	E08		5	0131-0480	545.63	480.82	800	118.71	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5038.1	E08		5	0132-0475	595.64	476.17	420	82.33	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5698.9	E08		5	0133-0486	337.27	486.65	436	83.40	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5524.5	E08		5	0134-0487	654.85	487.16	421	78.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7215.2	E08		5	0135-0498	312.01	498.08	791	114.95	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5472.4	E08		5	0136-0500	732.05	500.30	421	78.91	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5334.0	E08		5	0137-0510	41.05	510.31	392	74.67	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5911.8	E08		5	0138-0511	901.81	511.56	447	79.50	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6111.7	E08		5	0139-0514	171.32	513.56	408	78.57	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5647.7	E08		5	0140-0515	814.29	515.03	404	77.26	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6137.5	E08		5	0141-0517	762.03	517.57	409	75.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5627.1	E08		5	0142-0518	524.67	518.08	411	77.26	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5709.5	E08		5	0143-0530	669.23	530.32	405	76.67	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6219.7	E08		5	0144-0535	381.83	535.94	398	75.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5807.2	E08		5	0145-0537	450.65	536.69	413	79.26	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5801.0	E08		5	0146-0540	496.57	540.79	433	77.01	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5411.3	E08		5	0147-0543	575.29	542.93	427	80.33	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6388.8	E08		5	0148-0551	803.26	551.15	813	113.05	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9364.7	E08		5	0149-0551	922.87	550.54	310	66.18	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5093.3	E08		5	0150-0562	119.28	562.25	412	78.33	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6379.0	E08		5	0151-0565	243.17	565.20	397	74.91	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5746.4	E08		5	0152-0565	856.86	565.48	401	73.84	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5270.6	E08		5	0153-0572	309.73	571.73	409	79.50	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7523.4	E08		5	0154-0576	918.68	577.10	561	89.15	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5816.2	E08		5	0155-0579	350.68	579.12	403	75.50	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5785.9	E08		5	0156-0580	58.30	579.86	385	74.67	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8087.1	E08		5	0157-0584	284.01	584.18	751	105.64	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5382.7	E08		5	0158-0590	578.60	590.09	424	82.08	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6852.4	E08		5	0159-0593	777.12	593.57	371	75.74	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5718.4	E08		5	0160-0595	468.12	594.79	435	77.84	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6714.4	E08		5	0161-0607	390.67	607.42	853	115.88	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6890.0	E08		5	0162-0605	848.16	605.02	340	68.18	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6296.5	E08		5	0163-0609	726.45	609.57	390	73.26	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6300.7	E08		5	0164-0611	150.33	610.49	400	76.33	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5234.9	E08		5	0165-0614	112.83	614.69	392	74.08	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5394.9	E08		5	0166-0619	311.78	619.52	400	77.74	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5123.2	E08		5	0167-0620	53.42	619.82	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8817.1	E08		5	0168-0621	536.05	620.32	336	70.43	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6423.2	E08		5	0169-0626	822.73	625.75	397	76.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5666.6	E08		5	0170-0623	269.05	623.42	417	77.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5805.8	E08		5	0171-0630	552.07	630.35	420	83.50	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5307.7	E08		5	0172-0631	442.94	631.56	409	77.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6027.6	E08		5	0173-0635	917.01	635.15	376	74.08	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5753.3	E08		5	0174-0635	859.67	635.02	418	77.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5514.8	E08		5	0175-0649	331.63	649.34	432	80.33	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5495.9	E08		5	0176-0651	801.96	651.19	436	82.33	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8333.5	E08		5	0177-0648	142.89	648.94	365	74.43	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5404.2	E08		5	0178-0653	87.19	652.94	379	76.33	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9896.2	E08		5	0179-0654	490.62	655.31	427	97.40	0.566
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5689.8	E08		5	0180-0654	290.92	654.14	391	75.26	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6043.3	E08		5	0181-0658	122.51	658.29	430	78.08	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8856.6	E08		5	0182-0660	943.92	659.79	269	61.36	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5538.9	E08		5	0183-0665	450.32	665.15	408	76.67	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5762.9	E08		5	0184-0666	711.38	665.77	407	78.08	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5913.2	E08		5	0185-0665	388.66	665.79	387	76.08	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5418.8	E08		5	0186-0667	530.37	666.86	408	77.74	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5289.5	E08		5	0187-0670	36.41	670.08	383	75.50	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6251.0	E08		5	0188-0670	867.56	669.86	372	72.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5597.0	E08		5	0189-0687	601.90	686.94	404	75.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6247.5	E08		5	0190-0689	805.54	688.90	400	76.67	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6446.5	E08		5	0191-0691	754.41	691.52	398	75.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6209.0	E08		5	0192-0694	706.03	694.46	414	77.50	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5141.0	E08		5	0193-0695	182.32	695.39	392	74.67	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5432.8	E08		5	0194-0698	408.47	698.36	394	76.08	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5247.3	E08		5	0195-0701	18.07	700.07	363	77.40	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5687.7	E08		5	0196-0700	311.11	700.68	390	74.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185389	1375340	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6227.0	E08		5	0197-0707	882.43	706.19	366	72.81	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5682.9	E08		6	0001-0039	609.10	39.78	429	78.67	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7369.4	E08		6	0002-0037	360.26	37.48	370	71.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5794.8	E08		6	0003-0043	130.87	43.35	415	76.67	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6602.6	E08		6	0004-0044	937.28	43.85	447	83.26	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6688.6	E08		6	0005-0046	666.80	46.34	393	73.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5627.0	E08		6	0006-0051	182.30	50.93	439	79.84	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6630.2	E08		6	0007-0052	403.43	51.91	456	80.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6070.8	E08		6	0008-0056	835.63	55.83	437	82.67	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6346.6	E08		6	0009-0054	547.64	54.10	424	77.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6237.8	E08		6	0010-0056	445.92	56.36	434	79.26	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7026.9	E08		6	0011-0055	865.44	55.01	398	73.84	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4322.3	E08		6	0012-0056	99.44	56.56	204	59.36	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6607.5	E08		6	0013-0056	709.53	56.49	394	73.84	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4781.7	E08		6	0014-0057	56.19	57.15	276	62.77	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5623.1	E08		6	0015-0061	291.50	60.35	420	80.23	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9689.4	E08		6	0016-0071	649.24	69.38	188	65.01	0.559
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5936.5	E08		6	0017-0075	273.94	76.36	420	78.33	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6557.3	E08		6	0018-0082	865.23	82.94	421	76.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6678.5	E08		6	0019-0087	100.68	87.47	401	75.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6852.3	E08		6	0020-0085	790.76	85.89	405	77.01	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6236.7	E08		6	0021-0099	595.58	98.77	410	75.84	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6118.2	E08		6	0022-0100	401.27	100.66	401	75.26	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8537.6	E08		6	0023-0104	359.67	103.66	639	92.91	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6715.3	E08		6	0024-0101	917.18	101.30	370	71.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5605.8	E08		6	0025-0102	147.44	102.15	426	79.01	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5687.3	E08		6	0026-0104	203.96	103.60	391	73.84	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5782.4	E08		6	0027-0111	687.18	111.25	425	77.26	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5588.7	E08		6	0028-0114	311.62	114.67	409	76.67	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10445.2	E08		6	0029-0126	567.48	126.76	529	119.88	0.463
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6315.2	E08		6	0030-0124	514.48	124.06	399	73.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6503.6	E08		6	0031-0134	874.24	134.51	416	75.26	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6364.2	E08		6	0032-0136	443.35	136.30	428	77.26	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5587.3	E08		6	0033-0137	221.07	136.76	398	74.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5997.7	E08		6	0034-0138	802.41	138.59	416	75.01	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6350.7	E08		6	0035-0141	845.01	141.60	424	79.50	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6764.7	E08		6	0036-0145	932.34	145.11	411	78.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5781.2	E08		6	0037-0156	316.95	156.18	405	75.26	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8549.1	E08		6	0038-0173	180.35	172.98	600	120.37	0.520
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7240.5	E08		6	0039-0171	928.07	170.09	399	76.53	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7179.5	E08		6	0040-0176	889.94	176.64	383	76.67	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5692.6	E08		6	0041-0180	641.53	180.47	408	74.43	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5463.3	E08		6	0042-0181	254.12	181.22	431	79.84	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7699.2	E08		6	0043-0180	575.01	180.53	356	69.01	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5333.7	E08		6	0044-0185	769.00	185.35	487	85.84	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7059.1	E08		6	0045-0201	840.71	200.64	409	78.91	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5591.3	E08		6	0046-0201	402.79	201.96	404	75.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5644.3	E08		6	0047-0217	557.64	217.97	437	78.18	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6066.2	E08		6	0048-0222	65.75	222.55	402	75.84	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5622.4	E08		6	0049-0222	33.66	222.01	378	71.84	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5947.7	E08		6	0050-0230	461.89	228.95	884	118.71	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6283.0	E08		6	0051-0224	894.28	224.40	424	78.08	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5984.0	E08		6	0052-0235	146.72	235.75	423	77.26	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5929.1	E08		6	0053-0238	241.90	238.00	383	73.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5583.2	E08		6	0054-0237	315.12	237.17	411	77.01	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7061.2	E08		6	0055-0243	565.44	243.58	481	82.43	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7189.5	E08		6	0056-0246	675.69	246.47	385	73.26	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5615.2	E08		6	0057-0251	200.63	251.72	394	73.84	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6598.2	E08		6	0058-0254	390.06	254.58	396	73.01	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6998.8	E08		6	0059-0256	274.78	255.92	404	76.28	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5920.0	E08		6	0060-0258	297.14	258.14	451	81.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5791.8	E08		6	0061-0258	122.38	258.27	395	76.67	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6447.0	E08		6	0062-0262	826.81	262.42	397	77.74	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5575.6	E08		6	0063-0265	364.08	265.39	397	75.50	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6474.0	E08		6	0064-0266	66.07	266.07	380	73.01	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6257.1	E08		6	0065-0268	780.41	269.04	384	78.91	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6723.6	E08		6	0066-0276	942.40	276.55	414	77.26	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6449.1	E08		6	0067-0284	864.62	284.60	393	75.01	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6511.0	E08		6	0068-0288	919.98	288.51	425	80.67	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5997.8	E08		6	0069-0287	25.72	287.87	402	74.18	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7235.1	E08		6	0070-0291	794.39	291.48	427	84.91	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5887.3	E08		6	0071-0291	340.77	290.88	388	74.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6089.1	E08		6	0072-0292	733.23	292.36	414	78.08	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6892.2	E08		6	0073-0302	700.29	302.29	365	70.18	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5729.5	E08		6	0074-0307	593.62	308.24	459	83.98	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5370.7	E08		6	0075-0308	389.89	307.90	416	75.60	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7275.7	E08		6	0076-0316	97.64	316.85	772	105.98	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5773.8	E08		6	0077-0322	160.15	322.59	425	78.08	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5829.7	E08		6	0078-0323	429.71	323.83	412	76.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6256.3	E08		6	0079-0325	620.50	325.40	390	74.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6847.6	E08		6	0080-0324	673.88	324.71	368	71.01	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5649.6	E08		6	0081-0326	298.88	326.11	431	79.50	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6859.5	E08		6	0082-0338	840.47	338.66	399	74.43	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5942.8	E08		6	0083-0343	945.96	343.78	423	76.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7480.9	E08		6	0084-0348	94.01	348.05	361	75.26	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5554.7	E08		6	0085-0349	192.31	348.83	427	79.26	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6679.7	E08		6	0086-0355	743.75	355.90	402	75.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7697.9	E08		6	0087-0359	863.28	359.07	375	71.01	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5510.6	E08		6	0088-0361	410.56	360.93	417	76.91	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6348.1	E08		6	0089-0362	549.72	362.11	395	73.60	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5269.0	E08		6	0090-0366	86.07	366.13	430	81.84	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5691.3	E08		6	0091-0368	605.95	368.15	466	81.26	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5784.3	E08		6	0092-0368	461.92	368.59	404	75.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5808.5	E08		6	0093-0369	503.73	369.03	421	75.84	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7725.4	E08		6	0094-0388	126.33	388.29	676	96.33	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5650.9	E08		6	0095-0389	272.93	389.65	406	78.08	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6528.8	E08		6	0096-0397	897.17	397.47	378	76.08	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7805.8	E08		6	0097-0399	741.89	399.01	357	69.60	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6367.1	E08		6	0098-0401	489.83	401.65	393	73.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6664.2	E08		6	0099-0415	558.39	414.76	891	120.47	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7539.9	E08		6	0100-0418	759.37	417.69	385	73.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5734.1	E08		6	0101-0419	131.28	419.56	412	75.01	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5800.1	E08		6	0102-0428	222.85	428.22	398	75.84	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6663.0	E08		6	0103-0438	440.00	437.97	811	112.57	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6320.7	E08		6	0104-0429	888.69	429.98	388	77.26	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5734.6	E08		6	0105-0432	604.99	432.84	420	76.43	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6821.5	E08		6	0106-0431	803.92	430.66	397	75.01	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5039.7	E08		6	0107-0445	845.80	445.48	452	81.74	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5677.9	E08		6	0108-0449	472.86	450.16	419	76.43	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5887.7	E08		6	0109-0451	399.60	450.90	407	74.43	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7968.3	E08		6	0110-0452	901.77	451.81	344	68.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7307.4	E08		6	0111-0457	510.59	457.67	365	71.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5593.9	E08		6	0112-0458	271.58	458.37	398	75.26	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5435.5	E08		6	0113-0464	362.29	463.93	415	76.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5650.0	E08		6	0114-0465	34.79	465.26	372	71.01	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5983.1	E08		6	0115-0468	319.64	468.73	386	75.50	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5304.5	E08		6	0116-0468	204.85	468.31	403	74.43	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5931.0	E08		6	0117-0472	589.04	472.62	410	77.84	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6509.1	E08		6	0118-0485	130.94	485.17	784	114.57	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6249.3	E08		6	0119-0480	559.70	480.70	401	74.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6216.2	E08		6	0120-0485	765.12	485.12	414	75.01	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5513.9	E08		6	0121-0488	817.96	488.82	421	77.84	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6241.0	E08		6	0122-0487	700.13	487.33	456	79.60	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5877.7	E08		6	0123-0494	467.40	493.91	413	75.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7060.0	E08		6	0124-0497	519.65	497.45	378	73.01	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5364.2	E08		6	0125-0503	71.84	502.98	397	73.60	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5595.9	E08		6	0126-0510	312.54	510.67	394	76.91	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5264.6	E08		6	0127-0525	839.74	525.65	437	78.43	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5877.0	E08		6	0128-0527	540.65	527.67	412	75.26	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6981.3	E08		6	0129-0528	685.34	528.07	370	72.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5267.6	E08		6	0130-0531	408.66	531.66	427	82.91	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5465.5	E08		6	0131-0545	184.59	545.56	423	77.26	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6596.8	E08		6	0132-0550	783.64	550.56	434	78.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8238.9	E08		6	0133-0554	16.21	553.55	343	69.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6325.1	E08		6	0134-0558	889.37	558.36	399	75.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6260.4	E08		6	0135-0563	292.95	563.04	416	75.01	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5990.8	E08		6	0136-0566	246.05	566.66	403	75.26	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5873.3	E08		6	0137-0574	207.12	574.39	383	73.01	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7252.9	E08		6	0138-0580	407.06	580.07	744	102.91	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5940.4	E08		6	0139-0579	123.64	579.43	381	73.84	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9804.6	E08		6	0140-0584	648.20	584.41	298	79.26	0.596
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5770.2	E08		6	0141-0588	340.02	588.45	389	76.08	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5672.7	E08		6	0142-0591	512.96	591.21	414	76.08	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6031.5	E08		6	0143-0592	930.00	592.72	460	79.84	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6146.6	E08		6	0144-0600	604.74	599.99	396	74.67	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7387.8	E08		6	0145-0610	674.51	609.31	411	75.26	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6425.7	E08		6	0146-0613	833.51	613.41	434	77.26	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5518.4	E08		6	0147-0616	47.33	616.58	414	76.08	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5731.6	E08		6	0148-0615	120.49	615.56	390	73.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6245.3	E08		6	0149-0618	286.91	617.98	407	78.08	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5917.9	E08		6	0150-0621	579.64	621.75	407	74.43	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6067.1	E08		6	0151-0630	264.54	630.19	456	79.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7926.2	E08		6	0152-0633	530.57	633.89	542	86.91	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5734.4	E08		6	0153-0633	175.78	633.64	416	77.01	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5531.3	E08		6	0154-0644	342.89	645.15	398	75.50	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6164.3	E08		6	0155-0643	423.03	642.72	391	74.43	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6553.7	E08		6	0156-0649	707.56	648.55	332	71.60	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6137.4	E08		6	0157-0651	879.79	651.82	403	75.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8079.5	E08		6	0158-0654	830.07	653.96	335	68.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5186.6	E08		6	0159-0659	73.10	659.24	383	74.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7904.8	E08		6	0160-0662	37.75	662.74	306	64.18	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6135.3	E08		6	0161-0664	699.20	664.39	367	72.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6015.6	E08		6	0162-0669	294.23	669.17	425	77.84	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8752.7	E08		6	0163-0672	755.14	671.70	314	65.01	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5619.9	E08		6	0164-0685	651.76	685.15	402	76.43	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6155.5	E08		6	0165-0690	191.80	689.38	504	90.08	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6053.9	E08		6	0166-0688	241.93	688.34	391	75.26	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6133.1	E08		6	0167-0688	860.00	687.87	391	76.67	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6511.0	E08		6	0168-0695	394.10	695.29	375	75.84	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6708.6	E08		6	0169-0692	684.52	691.77	372	73.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6068.6	E08		6	0170-0698	175.02	699.26	445	82.67	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8843.0	E08		6	0171-0696	775.38	696.07	302	63.36	0.945
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6481.4	E08		6	0172-0701	605.07	701.16	380	72.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6137.0	E08		6	0173-0702	95.54	701.63	451	85.60	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4626.6	E08		6	0174-0704	120.66	703.75	188	52.63	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185390	1375341	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6106.8	E08		6	0175-0709	319.30	709.24	414	81.01	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6916.5	E08		7	0001-0031	448.84	30.88	428	78.08	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7370.8	E08		7	0002-0032	838.72	31.96	384	75.50	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9527.5	E08		7	0003-0036	597.08	35.70	508	86.43	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6477.8	E08		7	0004-0040	660.75	40.02	389	73.26	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5721.8	E08		7	0005-0043	46.37	43.18	436	80.08	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8010.0	E08		7	0006-0046	171.75	45.61	395	76.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7102.7	E08		7	0007-0056	779.49	56.58	762	105.40	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6600.1	E08		7	0008-0053	366.46	52.98	413	77.84	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6638.4	E08		7	0009-0061	736.50	60.83	821	110.33	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5390.9	E08		7	0010-0059	514.63	59.64	469	80.67	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5637.5	E08		7	0011-0060	622.88	60.55	447	81.01	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5633.7	E08		7	0012-0062	112.13	62.35	400	73.84	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6097.2	E08		7	0013-0064	827.38	64.14	397	73.01	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5603.8	E08		7	0014-0065	209.40	65.33	397	75.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5618.2	E08		7	0015-0068	474.31	68.46	445	77.84	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6097.8	E08		7	0016-0073	759.50	73.09	441	82.33	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5436.8	E08		7	0017-0071	25.96	71.16	395	74.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5594.1	E08		7	0018-0075	168.45	75.59	400	75.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5364.3	E08		7	0019-0076	649.96	75.19	460	84.91	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6038.1	E08		7	0020-0076	914.47	76.08	389	74.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6748.3	E08		7	0021-0081	412.73	81.20	410	77.01	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7270.3	E08		7	0022-0081	855.73	80.86	331	68.67	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6472.5	E08		7	0023-0090	806.94	90.08	426	77.50	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6233.9	E08		7	0024-0097	123.66	96.62	861	120.47	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7496.4	E08		7	0025-0100	724.72	101.48	808	111.30	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6661.8	E08		7	0026-0096	869.09	97.42	428	79.74	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5832.0	E08		7	0027-0096	384.45	96.22	436	77.26	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5744.4	E08		7	0028-0096	561.68	96.12	419	76.08	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6362.2	E08		7	0029-0103	764.31	103.27	401	74.08	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5945.5	E08		7	0030-0109	829.68	109.22	415	77.74	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5849.8	E08		7	0031-0108	325.77	108.69	389	74.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5731.7	E08		7	0032-0109	935.60	108.20	397	76.91	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5769.8	E08		7	0033-0115	706.49	115.81	360	73.50	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5956.5	E08		7	0034-0122	118.91	122.52	429	82.18	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6777.4	E08		7	0035-0124	923.18	123.79	412	82.23	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6128.5	E08		7	0036-0135	292.88	135.00	383	73.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5360.7	E08		7	0037-0135	354.72	135.33	404	75.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6827.0	E08		7	0038-0139	914.80	139.85	373	76.91	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5163.8	E08		7	0039-0143	59.89	143.01	419	81.84	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5967.6	E08		7	0040-0142	508.69	142.10	427	75.84	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4966.1	E08		7	0041-0140	651.23	140.11	271	60.77	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5886.3	E08		7	0042-0143	114.36	144.08	452	82.77	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5676.6	E08		7	0043-0145	174.82	145.47	397	74.43	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6307.0	E08		7	0044-0150	430.95	150.59	605	95.36	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5842.6	E08		7	0045-0151	682.39	151.18	397	75.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10788.8	E08		7	0046-0151	472.56	151.08	281	60.53	0.964
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5068.1	E08		7	0047-0153	408.79	153.93	304	67.94	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6668.5	E08		7	0048-0155	769.28	154.23	416	77.01	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5873.6	E08		7	0049-0160	729.61	159.76	426	78.91	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6071.1	E08		7	0050-0171	710.91	171.77	471	83.15	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5968.7	E08		7	0051-0176	84.38	176.01	398	74.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6348.6	E08		7	0052-0179	757.95	179.10	405	74.67	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6866.1	E08		7	0053-0183	829.21	183.92	409	76.18	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6864.8	E08		7	0054-0182	399.69	182.76	395	74.67	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5516.2	E08		7	0055-0190	561.34	189.93	399	74.43	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7926.8	E08		7	0056-0202	470.42	202.54	999	119.88	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5889.7	E08		7	0057-0196	663.68	196.18	453	79.26	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5683.0	E08		7	0058-0195	880.66	195.17	430	79.50	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5304.2	E08		7	0059-0196	922.97	196.10	429	78.67	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5894.8	E08		7	0060-0202	796.04	201.96	411	75.01	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6482.1	E08		7	0061-0206	348.07	206.46	389	73.01	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5564.4	E08		7	0062-0209	516.77	208.98	444	83.01	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6105.8	E08		7	0063-0220	186.65	219.98	420	76.33	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7796.8	E08		7	0064-0229	52.67	230.01	832	116.71	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5757.9	E08		7	0065-0221	413.57	222.10	437	84.18	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5972.7	E08		7	0066-0223	154.97	223.16	415	76.67	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5339.4	E08		7	0067-0225	212.81	225.04	416	76.67	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6381.4	E08		7	0068-0236	277.65	236.50	804	114.33	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5691.0	E08		7	0069-0230	717.96	230.20	468	83.26	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6080.3	E08		7	0070-0231	512.52	230.88	408	78.18	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6115.2	E08		7	0071-0231	660.78	231.47	409	76.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5894.9	E08		7	0072-0234	552.17	234.52	465	80.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5838.5	E08		7	0073-0235	743.94	234.70	468	82.91	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5862.6	E08		7	0074-0240	921.31	240.17	436	78.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5183.6	E08		7	0075-0244	349.58	244.76	421	79.50	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5826.4	E08		7	0076-0242	419.81	240.95	462	91.01	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5561.6	E08		7	0077-0245	587.43	245.28	446	79.26	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6013.7	E08		7	0078-0245	616.80	245.35	467	82.33	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5546.0	E08		7	0079-0256	244.72	256.65	411	74.43	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5519.3	E08		7	0080-0256	165.72	256.33	403	75.26	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5634.6	E08		7	0081-0256	546.41	255.98	391	77.36	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4998.7	E08		7	0082-0260	401.71	260.65	446	79.84	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6353.4	E08		7	0083-0261	770.98	261.39	409	76.08	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6322.7	E08		7	0084-0275	859.66	275.10	420	81.50	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5425.9	E08		7	0085-0280	15.81	280.22	382	76.08	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5724.3	E08		7	0086-0283	911.46	282.82	394	77.84	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6964.8	E08		7	0087-0287	812.91	286.93	384	75.26	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7761.4	E08		7	0088-0291	361.58	290.96	385	73.26	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5917.9	E08		7	0089-0296	449.18	296.56	453	80.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5642.0	E08		7	0090-0299	207.78	299.43	414	77.74	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5301.7	E08		7	0091-0300	615.41	300.01	425	79.26	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6706.0	E08		7	0092-0302	783.03	301.18	396	76.33	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6451.1	E08		7	0093-0305	287.31	304.99	408	75.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6135.4	E08		7	0094-0308	523.05	306.75	406	77.74	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5553.0	E08		7	0095-0304	581.87	304.39	434	78.08	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5750.4	E08		7	0096-0313	940.51	313.37	444	82.43	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6361.6	E08		7	0097-0310	418.35	310.49	410	75.84	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5422.7	E08		7	0098-0313	352.30	313.57	476	86.08	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6860.2	E08		7	0099-0311	766.95	312.50	385	76.33	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5861.5	E08		7	0100-0326	514.28	327.72	504	86.57	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5290.9	E08		7	0101-0333	365.09	333.64	458	82.67	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5968.9	E08		7	0102-0336	262.15	336.27	411	78.08	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6587.7	E08		7	0103-0346	486.60	346.09	878	119.64	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5981.4	E08		7	0104-0339	795.17	339.92	407	75.26	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6129.0	E08		7	0105-0340	576.51	340.22	421	76.67	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6597.7	E08		7	0106-0349	751.18	349.39	815	118.37	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6652.3	E08		7	0107-0342	176.49	342.38	406	75.26	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5720.8	E08		7	0108-0352	838.85	352.49	419	77.84	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4776.6	E08		7	0109-0353	37.15	353.91	411	77.26	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4611.4	E08		7	0110-0354	196.64	354.38	249	64.18	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5673.6	E08		7	0111-0357	911.74	356.92	410	77.50	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5991.5	E08		7	0112-0362	721.35	361.82	401	73.60	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6390.2	E08		7	0113-0375	307.67	373.54	822	118.37	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5204.5	E08		7	0114-0372	576.22	372.32	426	78.08	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6433.0	E08		7	0115-0379	255.42	379.49	555	88.33	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5940.5	E08		7	0116-0379	104.36	379.35	412	75.84	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5757.8	E08		7	0117-0383	353.55	383.66	403	78.08	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5860.4	E08		7	0118-0393	729.49	393.01	419	76.43	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5445.6	E08		7	0119-0399	411.40	399.13	422	78.67	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6137.2	E08		7	0120-0400	896.04	400.17	430	77.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5770.3	E08		7	0121-0412	547.67	412.36	432	77.26	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5491.4	E08		7	0122-0417	477.90	416.96	424	78.43	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6998.2	E08		7	0123-0421	798.64	421.39	816	108.13	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5150.3	E08		7	0124-0418	288.39	418.77	420	76.67	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5964.9	E08		7	0125-0422	221.78	422.33	394	75.84	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5106.0	E08		7	0126-0427	674.72	427.78	474	84.57	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6190.3	E08		7	0127-0435	647.25	434.77	971	126.37	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5191.0	E08		7	0128-0432	22.64	432.45	395	74.67	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5542.5	E08		7	0129-0428	852.61	427.21	311	66.77	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5734.3	E08		7	0130-0436	442.88	436.49	421	78.67	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6210.8	E08		7	0131-0438	413.29	438.11	427	78.91	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5619.8	E08		7	0132-0448	594.07	448.69	427	78.67	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5942.6	E08		7	0133-0449	916.60	449.00	410	75.84	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6433.4	E08		7	0134-0458	778.28	457.50	871	115.05	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5973.0	E08		7	0135-0453	284.13	453.88	402	74.67	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6787.2	E08		7	0136-0456	158.85	455.93	521	84.33	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5245.4	E08		7	0137-0458	703.47	458.41	431	80.91	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6064.7	E08		7	0138-0460	527.10	460.81	427	79.50	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6126.9	E08		7	0139-0461	851.90	460.82	426	77.26	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7450.0	E08		7	0140-0471	339.98	470.78	775	109.98	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5473.0	E08		7	0141-0483	82.00	482.90	404	76.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6504.8	E08		7	0142-0491	574.07	490.87	423	76.67	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6413.5	E08		7	0143-0493	110.84	492.98	414	76.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5971.3	E08		7	0144-0496	268.05	496.37	397	73.60	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6121.9	E08		7	0145-0497	225.62	496.98	383	72.43	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5102.8	E08		7	0146-0502	948.73	502.04	404	79.26	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7343.5	E08		7	0147-0507	728.18	506.57	400	77.60	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6350.7	E08		7	0148-0507	897.43	506.76	385	73.26	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6186.5	E08		7	0149-0515	409.47	515.53	400	75.84	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6410.8	E08		7	0150-0519	585.04	519.69	406	75.26	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6206.8	E08		7	0151-0524	723.90	525.32	292	66.18	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6397.2	E08		7	0152-0526	646.35	526.17	363	72.67	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6227.8	E08		7	0153-0530	160.90	531.09	418	77.11	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6506.6	E08		7	0154-0528	794.84	527.92	437	84.43	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5959.2	E08		7	0155-0538	62.81	537.91	537	87.26	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6095.4	E08		7	0156-0539	94.34	539.64	421	75.84	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5732.8	E08		7	0157-0537	526.23	537.55	407	76.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6047.8	E08		7	0158-0547	636.52	547.51	481	86.33	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5652.0	E08		7	0159-0546	361.37	546.65	416	76.67	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5915.4	E08		7	0160-0556	161.11	554.96	470	83.36	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7694.4	E08		7	0161-0556	830.91	556.71	355	72.08	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5492.4	E08		7	0162-0562	286.89	562.71	427	76.67	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6338.4	E08		7	0163-0563	565.56	563.25	427	76.43	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6102.0	E08		7	0164-0562	879.38	562.67	401	76.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5139.1	E08		7	0165-0563	239.98	563.72	432	77.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7902.6	E08		7	0166-0566	456.03	566.66	814	114.23	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6923.7	E08		7	0167-0578	40.49	578.42	753	104.81	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6068.5	E08		7	0168-0576	380.31	576.15	402	73.60	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7828.7	E08		7	0169-0594	904.98	594.13	711	103.64	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6067.2	E08		7	0170-0596	88.73	596.10	376	73.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5268.0	E08		7	0171-0605	117.62	605.11	407	76.67	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5817.7	E08		7	0172-0608	251.39	608.26	407	75.26	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6136.9	E08		7	0173-0609	171.24	609.16	393	73.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5367.0	E08		7	0174-0609	623.41	609.05	462	82.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5422.4	E08		7	0175-0622	508.45	622.39	442	79.26	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6394.3	E08		7	0176-0622	537.13	621.59	421	76.08	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6321.2	E08		7	0177-0629	839.20	629.32	388	73.60	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6286.1	E08		7	0178-0630	458.46	629.99	392	73.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6917.2	E08		7	0179-0630	375.06	630.96	424	77.84	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4975.9	E08		7	0180-0634	120.29	634.40	434	83.15	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6678.2	E08		7	0181-0638	566.69	638.48	419	78.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5365.6	E08		7	0182-0643	82.73	643.20	390	75.50	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7703.1	E08		7	0183-0641	31.35	641.60	353	68.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5619.1	E08		7	0184-0645	289.37	645.10	406	73.60	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5687.9	E08		7	0185-0644	599.43	644.18	456	81.50	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5929.6	E08		7	0186-0648	147.44	647.92	408	74.18	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6476.0	E08		7	0187-0651	710.26	650.69	404	75.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5688.8	E08		7	0188-0653	250.53	653.75	401	76.08	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6926.2	E08		7	0189-0657	392.64	657.16	439	78.43	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6364.0	E08		7	0190-0667	804.84	668.45	855	117.30	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5909.9	E08		7	0191-0664	204.68	664.59	410	75.01	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6989.7	E08		7	0192-0667	461.60	667.58	383	72.43	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6328.4	E08		7	0193-0668	870.91	668.58	360	70.43	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6648.1	E08		7	0194-0671	620.80	671.53	382	72.43	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7595.6	E08		7	0195-0682	727.61	681.81	759	105.74	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6083.7	E08		7	0196-0689	30.58	689.00	400	74.43	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6292.7	E08		7	0197-0698	843.13	698.26	329	72.43	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7320.0	E08		7	0198-0696	915.86	696.39	333	68.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7536.4	E08		7	0199-0702	286.34	702.25	615	92.91	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7993.9	E08		7	0200-0701	588.98	700.78	613	93.26	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5736.7	E08		7	0201-0703	676.76	703.24	449	80.08	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6671.7	E08		7	0202-0705	860.74	704.81	415	78.77	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185391	1375342	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6828.5	E08		7	0203-0706	339.00	705.36	365	71.01	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4129.2	E08		8	0001-0027	12.86	26.76	131	43.70	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6413.6	E08		8	0002-0034	878.19	33.39	456	81.98	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6235.3	E08		8	0003-0038	137.55	38.18	360	70.18	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5416.7	E08		8	0004-0036	208.64	36.46	369	71.26	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6068.8	E08		8	0005-0037	928.11	37.23	403	75.01	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5389.0	E08		8	0006-0039	338.64	39.54	422	77.50	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7260.6	E08		8	0007-0043	830.27	43.72	342	67.60	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6474.8	E08		8	0008-0044	858.88	44.83	369	73.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5881.1	E08		8	0009-0049	252.72	49.24	380	73.84	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8160.8	E08		8	0010-0052	703.68	51.91	725	99.74	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6177.9	E08		8	0011-0054	106.15	53.85	358	70.18	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5864.8	E08		8	0012-0056	435.56	56.02	435	77.26	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5728.3	E08		8	0013-0068	387.24	68.15	402	73.84	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6761.5	E08		8	0014-0072	502.28	72.23	432	79.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7189.8	E08		8	0015-0075	198.47	75.77	388	72.77	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5631.9	E08		8	0016-0076	825.57	76.69	447	78.67	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5772.1	E08		8	0017-0075	916.38	76.13	387	74.67	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5667.9	E08		8	0018-0078	19.55	78.07	365	71.01	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5848.7	E08		8	0019-0081	710.84	81.37	413	75.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5303.1	E08		8	0020-0090	169.84	90.08	388	74.67	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6593.7	E08		8	0021-0089	279.57	89.50	379	73.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5948.8	E08		8	0022-0093	359.40	92.93	391	73.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5612.0	E08		8	0023-0101	97.26	101.04	385	71.84	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5479.8	E08		8	0024-0106	129.43	105.80	377	72.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5647.6	E08		8	0025-0107	912.97	106.51	390	73.01	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5493.3	E08		8	0026-0111	40.25	110.23	367	75.40	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6641.9	E08		8	0027-0114	536.93	113.63	388	72.18	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8323.3	E08		8	0028-0121	790.30	121.16	840	112.08	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6910.4	E08		8	0029-0118	182.89	118.63	396	76.77	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5374.9	E08		8	0030-0117	426.66	117.08	409	75.26	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6556.4	E08		8	0031-0132	24.01	133.27	791	113.54	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5426.7	E08		8	0032-0129	510.23	128.96	385	73.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5935.7	E08		8	0033-0134	659.27	134.22	381	75.84	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5848.8	E08		8	0034-0142	147.05	142.44	399	74.18	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5634.8	E08		8	0035-0142	349.62	142.04	399	76.43	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5712.6	E08		8	0036-0143	184.85	143.18	431	79.94	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6778.0	E08		8	0037-0147	561.04	146.72	400	73.60	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5423.7	E08		8	0038-0152	592.10	151.51	558	98.57	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5974.3	E08		8	0039-0146	775.62	146.78	412	75.01	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5954.8	E08		8	0040-0154	270.66	154.46	398	73.01	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5971.1	E08		8	0041-0154	708.75	154.15	387	71.60	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5919.3	E08		8	0042-0155	221.46	155.64	376	71.01	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5855.4	E08		8	0043-0156	921.65	156.62	398	74.67	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6985.9	E08		8	0044-0157	303.73	157.44	396	73.60	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7929.3	E08		8	0045-0159	833.62	159.60	351	69.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6244.9	E08		8	0046-0166	471.01	165.99	897	114.81	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6021.7	E08		8	0047-0162	890.05	161.56	396	74.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5022.4	E08		8	0048-0161	61.84	161.17	363	71.60	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6108.3	E08		8	0049-0166	187.42	165.14	380	74.53	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6077.2	E08		8	0050-0166	341.97	166.42	401	75.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5518.6	E08		8	0051-0169	377.65	169.22	399	77.26	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5618.3	E08		8	0052-0167	102.73	166.88	363	71.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7310.0	E08		8	0053-0187	938.78	187.67	341	68.18	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6148.2	E08		8	0054-0188	676.21	188.44	420	76.67	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7377.8	E08		8	0055-0187	778.88	187.08	345	69.01	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6280.1	E08		8	0056-0189	823.38	189.83	386	71.60	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6336.6	E08		8	0057-0191	643.60	191.60	416	76.67	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5922.3	E08		8	0058-0194	529.74	194.47	406	75.01	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5916.6	E08		8	0059-0197	390.61	197.85	434	81.01	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5060.0	E08		8	0060-0198	28.08	198.47	395	78.67	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5505.1	E08		8	0061-0207	234.56	207.06	394	73.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5923.1	E08		8	0062-0210	98.04	210.49	783	110.81	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6295.1	E08		8	0063-0205	730.77	205.93	405	76.87	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5431.6	E08		8	0064-0210	51.96	209.98	417	77.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5963.3	E08		8	0065-0226	150.93	226.45	882	119.20	0.780
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6150.0	E08		8	0066-0227	766.45	227.43	385	74.43	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6784.1	E08		8	0067-0225	732.13	224.55	379	74.28	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5843.8	E08		8	0068-0230	517.07	230.49	396	75.26	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6483.7	E08		8	0069-0229	455.43	228.84	391	72.43	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5995.5	E08		8	0070-0234	704.14	234.14	436	77.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6126.5	E08		8	0071-0233	801.86	233.75	412	77.74	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6046.4	E08		8	0072-0235	280.81	235.53	442	79.50	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5557.1	E08		8	0073-0242	26.40	242.17	397	75.26	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6226.3	E08		8	0074-0239	883.39	239.10	387	73.26	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6134.1	E08		8	0075-0243	827.50	243.32	380	73.01	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6436.0	E08		8	0076-0245	304.28	244.81	430	84.08	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6129.0	E08		8	0077-0248	207.90	247.89	429	77.26	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6240.6	E08		8	0078-0247	338.34	247.62	403	76.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5675.5	E08		8	0079-0253	364.00	253.03	387	73.60	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9433.0	E08		8	0080-0269	645.93	267.39	970	133.05	0.689
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5201.7	E08		8	0081-0258	123.48	258.55	377	72.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5403.1	E08		8	0082-0263	453.70	263.14	404	75.26	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7539.7	E08		8	0083-0264	317.89	264.40	448	82.08	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5119.9	E08		8	0084-0266	75.47	265.97	413	76.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5305.7	E08		8	0085-0265	503.36	265.50	404	74.67	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6091.5	E08		8	0086-0267	273.87	266.82	456	81.15	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5778.5	E08		8	0087-0282	253.98	282.02	486	84.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5356.8	E08		8	0088-0285	16.72	284.89	358	71.60	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5817.6	E08		8	0089-0283	874.71	283.66	396	74.67	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5685.8	E08		8	0090-0301	365.86	301.03	389	73.01	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5634.6	E08		8	0091-0303	85.07	303.28	374	71.60	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6819.9	E08		8	0092-0305	493.41	304.96	634	98.57	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7319.1	E08		8	0093-0304	646.32	304.07	373	70.18	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6081.7	E08		8	0094-0307	801.56	307.47	422	76.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6610.3	E08		8	0095-0313	152.47	313.01	416	78.43	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5437.6	E08		8	0096-0315	45.71	315.47	403	79.01	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5915.0	E08		8	0097-0317	107.42	316.99	421	77.26	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5340.3	E08		8	0098-0324	435.57	323.86	409	76.08	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6260.2	E08		8	0099-0329	225.64	330.02	805	109.54	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10757.3	E08		8	0100-0323	884.08	323.71	276	59.94	0.965
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6135.4	E08		8	0101-0331	923.08	331.31	395	75.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7875.9	E08		8	0102-0334	353.64	334.44	365	71.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5881.9	E08		8	0103-0337	170.74	336.54	362	73.94	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7750.2	E08		8	0104-0338	558.10	338.35	477	80.67	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5499.9	E08		8	0105-0339	149.93	340.00	471	84.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6107.6	E08		8	0106-0341	811.52	341.33	405	75.84	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7065.2	E08		8	0107-0351	410.83	350.90	374	71.60	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9080.4	E08		8	0108-0353	298.83	353.05	332	67.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8405.4	E08		8	0109-0354	493.00	354.82	371	70.18	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6251.2	E08		8	0110-0358	665.66	358.28	390	74.67	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5375.2	E08		8	0111-0359	17.15	358.98	363	71.60	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8951.4	E08		8	0112-0357	346.39	357.41	317	65.36	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6023.2	E08		8	0113-0358	901.62	358.35	389	74.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6724.9	E08		8	0114-0371	862.43	370.96	842	117.15	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6180.0	E08		8	0115-0374	738.95	374.20	390	73.84	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6028.6	E08		8	0116-0377	785.88	377.58	417	77.84	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7494.7	E08		8	0117-0382	335.79	382.26	393	73.26	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6592.4	E08		8	0118-0394	112.36	393.65	782	110.37	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5596.3	E08		8	0119-0387	274.56	387.16	394	74.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5370.3	E08		8	0120-0390	208.40	390.43	381	74.91	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6964.9	E08		8	0121-0389	479.21	388.90	386	72.43	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6045.3	E08		8	0122-0401	168.44	400.19	458	87.26	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6405.6	E08		8	0123-0402	565.48	401.81	380	72.18	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5503.3	E08		8	0124-0406	362.72	406.66	424	79.84	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6022.4	E08		8	0125-0409	434.57	409.45	394	75.60	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7089.5	E08		8	0126-0412	476.60	412.46	404	75.84	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5938.7	E08		8	0127-0421	609.03	421.87	466	80.91	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5706.9	E08		8	0128-0421	828.47	421.78	413	76.67	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5625.8	E08		8	0129-0422	193.23	422.30	385	71.60	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5733.1	E08		8	0130-0421	261.09	421.26	380	73.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6498.9	E08		8	0131-0421	928.44	421.32	423	79.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5274.0	E08		8	0132-0431	84.88	431.14	373	73.26	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6143.0	E08		8	0133-0429	901.87	428.91	391	76.18	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6180.0	E08		8	0134-0434	390.13	434.87	380	73.01	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5968.1	E08		8	0135-0439	573.78	438.71	432	77.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6064.8	E08		8	0136-0443	677.38	443.35	419	75.01	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5848.9	E08		8	0137-0443	127.46	443.00	401	75.50	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5675.4	E08		8	0138-0443	298.30	442.84	387	74.67	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6760.3	E08		8	0139-0445	250.82	443.39	360	72.91	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5535.3	E08		8	0140-0451	21.71	450.93	367	71.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4545.5	E08		8	0141-0451	57.31	451.96	366	71.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8019.1	E08		8	0142-0456	266.57	457.00	385	74.57	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5792.2	E08		8	0143-0456	757.54	456.78	401	73.84	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9237.0	E08		8	0144-0465	695.31	464.74	333	66.77	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6520.4	E08		8	0145-0475	624.02	474.88	775	109.64	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5768.5	E08		8	0146-0472	545.34	472.55	230	55.94	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7884.4	E08		8	0147-0479	826.55	478.30	624	92.33	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6523.5	E08		8	0148-0480	103.11	480.20	386	73.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6662.3	E08		8	0149-0482	470.82	480.83	343	70.91	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6026.8	E08		8	0150-0483	257.38	482.81	373	70.77	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9331.9	E08		8	0151-0487	382.59	487.61	326	65.94	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5669.6	E08		8	0152-0497	88.68	497.40	427	77.50	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6648.7	E08		8	0153-0501	942.80	501.31	378	74.77	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4941.5	E08		8	0154-0504	53.78	503.94	355	73.60	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5610.4	E08		8	0155-0502	837.74	503.28	408	79.26	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5666.6	E08		8	0156-0506	117.26	506.08	442	81.01	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6010.4	E08		8	0157-0508	692.35	507.93	420	76.08	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6075.4	E08		8	0158-0510	631.74	509.82	395	73.84	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7976.4	E08		8	0159-0518	344.60	518.30	623	92.33	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7878.2	E08		8	0160-0520	502.68	521.89	473	97.40	0.627
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5352.3	E08		8	0161-0519	179.67	519.43	392	73.01	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5577.0	E08		8	0162-0531	133.80	531.30	437	83.50	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6165.7	E08		8	0163-0530	683.66	531.47	424	77.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5494.7	E08		8	0164-0535	109.15	534.66	422	78.08	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5848.8	E08		8	0165-0538	262.29	538.48	378	73.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6141.5	E08		8	0166-0546	422.62	547.19	423	78.43	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6550.6	E08		8	0167-0548	772.56	547.66	381	73.84	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11423.7	E08		8	0168-0549	741.84	549.81	294	64.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7362.0	E08		8	0169-0552	689.00	552.49	408	78.18	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5586.2	E08		8	0170-0554	612.03	554.10	392	73.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5780.8	E08		8	0171-0558	572.27	558.01	387	73.01	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5715.3	E08		8	0172-0558	818.49	558.24	379	72.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5702.8	E08		8	0173-0559	239.19	559.34	388	74.08	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5820.8	E08		8	0174-0567	401.42	566.65	432	77.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5698.2	E08		8	0175-0569	72.52	568.92	371	71.84	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6073.2	E08		8	0176-0568	115.15	567.72	380	74.08	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6500.1	E08		8	0177-0571	928.14	571.53	366	71.01	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6276.0	E08		8	0178-0573	894.54	573.35	385	73.26	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6460.5	E08		8	0179-0573	472.87	572.73	373	71.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6263.9	E08		8	0180-0578	365.59	578.38	422	77.94	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5885.4	E08		8	0181-0577	620.21	577.65	398	74.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6416.3	E08		8	0182-0579	657.58	579.15	397	75.50	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8973.8	E08		8	0183-0579	130.71	579.51	295	63.84	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9368.6	E08		8	0184-0586	870.14	586.32	352	70.43	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6314.1	E08		8	0185-0593	306.08	592.85	380	72.43	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6166.5	E08		8	0186-0591	574.66	591.46	375	72.43	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6401.2	E08		8	0187-0600	798.09	600.44	796	109.88	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6106.8	E08		8	0188-0598	344.16	598.08	407	76.08	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6347.4	E08		8	0189-0598	649.17	599.12	377	74.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6643.8	E08		8	0190-0606	189.49	605.77	406	77.11	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6765.7	E08		8	0191-0611	212.45	611.06	398	76.77	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6388.6	E08		8	0192-0609	498.57	609.64	381	75.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6982.8	E08		8	0193-0620	745.01	619.76	770	112.47	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6402.9	E08		8	0194-0615	622.23	614.51	375	72.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5616.1	E08		8	0195-0619	247.53	619.43	377	71.01	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5885.1	E08		8	0196-0623	315.00	623.18	422	76.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6814.2	E08		8	0197-0630	449.89	629.80	367	71.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5891.9	E08		8	0198-0630	117.57	630.45	386	73.01	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5309.6	E08		8	0199-0634	145.21	633.58	394	75.50	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6380.3	E08		8	0200-0633	650.83	633.13	404	76.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5764.9	E08		8	0201-0634	411.77	634.57	416	76.18	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13891.7	E08		8	0202-0633	940.43	632.74	121	41.80	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6172.9	E08		8	0203-0642	389.05	641.84	422	77.84	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6956.7	E08		8	0204-0644	535.73	644.60	394	73.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5827.0	E08		8	0205-0650	577.45	650.84	386	72.18	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5431.3	E08		8	0206-0655	104.11	655.06	400	79.01	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6058.3	E08		8	0207-0656	784.90	656.57	391	73.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6913.6	E08		8	0208-0657	274.18	656.98	365	71.01	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6485.0	E08		8	0209-0660	515.41	660.89	414	75.84	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5839.6	E08		8	0210-0662	465.97	662.53	397	74.18	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6091.7	E08		8	0211-0663	862.67	663.21	420	76.43	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5776.7	E08		8	0212-0675	611.14	675.90	404	78.91	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6098.1	E08		8	0213-0687	236.25	687.72	410	77.01	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6506.1	E08		8	0214-0688	937.61	688.35	351	72.18	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5492.7	E08		8	0215-0687	135.56	687.26	385	73.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5903.1	E08		8	0216-0690	767.50	688.49	390	77.98	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6093.6	E08		8	0217-0695	630.66	695.62	404	78.43	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6674.5	E08		8	0218-0698	20.54	698.45	342	67.84	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185392	1375343	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6300.2	E08		8	0219-0705	876.06	705.52	417	76.91	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7272.2	E08		9	0001-0035	446.94	35.52	381	76.53	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	4783.1	E08		9	0002-0030	118.26	29.91	194	54.53	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7234.0	E08		9	0003-0037	467.14	37.29	461	81.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6371.2	E08		9	0004-0035	317.27	34.86	407	80.43	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5723.0	E08		9	0005-0039	22.73	39.90	388	76.91	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6124.8	E08		9	0006-0041	859.08	41.53	402	77.74	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6754.7	E08		9	0007-0048	501.51	48.32	417	77.26	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5533.8	E08		9	0008-0052	92.29	52.34	375	72.67	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6283.8	E08		9	0009-0051	682.41	51.08	408	75.01	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7309.1	E08		9	0010-0056	198.24	54.50	521	106.81	0.574
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7327.1	E08		9	0011-0053	750.74	53.84	362	71.60	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9108.1	E08		9	0012-0058	180.23	60.22	233	72.08	0.564
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5468.4	E08		9	0013-0059	124.69	58.76	368	74.67	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7538.4	E08		9	0014-0065	905.51	65.74	347	70.43	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7044.4	E08		9	0015-0067	424.89	67.01	396	75.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7935.5	E08		9	0016-0068	807.95	68.14	355	68.77	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8222.8	E08		9	0017-0080	716.35	80.08	379	75.36	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6269.2	E08		9	0018-0076	289.50	76.64	363	72.43	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6099.8	E08		9	0019-0079	840.09	78.86	418	77.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8724.0	E08		9	0020-0082	469.22	81.80	358	71.60	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6719.9	E08		9	0021-0086	533.45	85.87	390	75.84	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8170.7	E08		9	0022-0091	923.79	90.75	578	92.57	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5256.5	E08		9	0023-0090	79.93	89.86	378	73.50	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6464.3	E08		9	0024-0097	361.02	97.13	367	73.26	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6279.0	E08		9	0025-0100	832.20	99.85	407	77.84	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7052.0	E08		9	0026-0104	944.59	104.47	361	71.84	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8547.6	E08		9	0027-0114	400.72	115.10	887	115.98	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8606.5	E08		9	0028-0113	501.62	112.70	613	91.74	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5993.7	E08		9	0029-0124	118.68	124.31	366	71.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6327.2	E08		9	0030-0133	74.11	134.00	385	77.60	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5989.6	E08		9	0031-0136	215.57	136.49	367	71.60	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5633.4	E08		9	0032-0137	304.29	137.25	382	75.26	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6151.4	E08		9	0033-0142	849.97	142.28	397	76.67	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7642.3	E08		9	0034-0153	773.45	152.25	340	70.33	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6207.6	E08		9	0035-0155	71.06	153.87	405	76.53	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6236.2	E08		9	0036-0157	644.08	156.94	390	76.08	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5468.3	E08		9	0037-0159	16.79	159.26	372	72.43	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7596.7	E08		9	0038-0164	786.81	165.90	382	73.74	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8248.3	E08		9	0039-0170	711.99	170.25	341	68.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7731.0	E08		9	0040-0179	734.38	179.20	399	77.26	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5850.3	E08		9	0041-0182	557.51	181.49	421	78.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5536.5	E08		9	0042-0181	472.02	180.70	441	80.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6122.9	E08		9	0043-0183	320.29	182.67	391	75.26	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6856.3	E08		9	0044-0190	33.68	190.27	339	69.01	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8070.8	E08		9	0045-0190	662.58	189.98	368	74.43	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8590.5	E08		9	0046-0201	870.57	199.09	990	127.54	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6652.5	E08		9	0047-0198	642.58	198.23	392	75.60	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6855.8	E08		9	0048-0198	62.31	198.18	337	69.26	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6423.2	E08		9	0049-0204	137.30	204.06	380	75.84	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7675.4	E08		9	0050-0204	931.35	203.84	337	68.18	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6230.6	E08		9	0051-0207	116.09	206.71	381	75.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5337.5	E08		9	0052-0218	365.71	218.11	398	77.50	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6595.0	E08		9	0053-0223	202.20	223.22	396	76.08	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5251.9	E08		9	0054-0235	446.43	235.83	404	77.74	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6158.5	E08		9	0055-0234	300.74	233.79	385	75.26	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6530.8	E08		9	0056-0237	852.00	237.08	388	73.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7746.2	E08		9	0057-0246	898.77	247.10	689	110.37	0.711
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6157.0	E08		9	0058-0245	510.67	246.13	412	75.26	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6393.5	E08		9	0059-0250	571.60	249.66	391	73.01	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6273.6	E08		9	0060-0254	95.42	254.05	353	68.18	0.954
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6668.9	E08		9	0061-0261	257.36	261.65	412	80.43	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6953.7	E08		9	0062-0264	925.97	264.27	369	71.01	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8269.7	E08		9	0063-0267	276.08	268.10	156	48.87	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6163.7	E08		9	0064-0295	116.10	293.14	552	94.23	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10369.8	E08		9	0065-0296	865.27	296.47	330	67.94	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7207.4	E08		9	0066-0308	601.08	308.01	785	119.10	0.695
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6961.4	E08		9	0067-0312	311.36	313.08	807	110.37	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7113.8	E08		9	0068-0306	62.59	305.93	393	78.33	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6059.1	E08		9	0069-0310	160.91	310.08	362	74.91	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5921.3	E08		9	0070-0311	534.74	311.75	392	75.01	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8727.6	E08		9	0071-0312	103.15	311.94	275	61.36	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7715.0	E08		9	0072-0316	463.24	315.59	409	77.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6261.2	E08		9	0073-0318	253.19	318.38	397	76.33	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5820.4	E08		9	0074-0321	48.06	322.47	448	79.50	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8973.9	E08		9	0075-0322	843.07	321.93	318	66.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10180.4	E08		9	0076-0329	410.85	329.14	331	68.43	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5806.6	E08		9	0077-0334	18.36	333.96	364	73.50	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7866.9	E08		9	0078-0336	359.49	336.39	397	73.84	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5923.7	E08		9	0079-0361	46.64	361.56	375	76.18	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7307.0	E08		9	0080-0363	143.77	363.02	715	101.05	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8489.9	E08		9	0081-0357	942.03	357.06	341	68.18	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9977.3	E08		9	0082-0367	914.25	366.85	224	76.43	0.482
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6280.3	E08		9	0083-0371	291.66	371.35	368	72.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5686.8	E08		9	0084-0386	92.84	386.67	367	72.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6032.5	E08		9	0085-0400	243.83	400.34	375	73.26	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8915.1	E08		9	0086-0401	306.84	401.24	393	74.67	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5483.9	E08		9	0087-0409	193.29	408.93	388	73.84	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5495.2	E08		9	0088-0412	70.60	412.71	370	71.60	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6063.9	E08		9	0089-0421	506.18	420.74	402	75.50	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6057.6	E08		9	0090-0424	23.89	424.00	390	75.60	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5711.1	E08		9	0091-0438	122.48	438.09	377	74.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5700.6	E08		9	0092-0457	67.82	457.34	362	71.60	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6481.4	E08		9	0093-0460	378.98	459.94	408	74.43	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7343.1	E08		9	0094-0472	844.58	471.93	371	74.43	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5941.7	E08		9	0095-0493	233.99	494.65	661	106.23	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6962.9	E08		9	0096-0496	541.76	496.72	360	71.84	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6422.8	E08		9	0097-0502	57.45	502.91	432	82.28	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6410.3	E08		9	0098-0504	37.64	504.09	357	72.53	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7252.0	E08		9	0099-0505	610.27	505.12	422	75.26	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7124.9	E08		9	0100-0519	323.28	519.04	444	79.26	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5750.4	E08		9	0101-0523	206.62	522.81	376	73.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7335.6	E08		9	0102-0523	59.79	522.94	350	71.70	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5398.8	E08		9	0103-0540	338.97	540.23	445	79.26	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6665.8	E08		9	0104-0545	381.48	545.16	362	70.53	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8235.0	E08		9	0105-0545	571.83	544.20	311	67.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7518.2	E08		9	0106-0559	562.79	560.54	389	75.26	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6165.9	E08		9	0107-0574	22.91	574.25	342	69.60	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7051.5	E08		9	0108-0576	608.85	576.94	389	74.91	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8536.3	E08		9	0109-0587	590.60	587.81	393	75.26	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6296.8	E08		9	0110-0594	360.80	594.71	372	72.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6194.7	E08		9	0111-0597	50.96	597.50	346	71.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9967.3	E08		9	0112-0619	538.40	618.84	271	59.94	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5161.3	E08		9	0113-0632	114.79	632.78	368	71.84	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6946.8	E08		9	0114-0633	916.89	632.73	349	70.77	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6374.0	E08		9	0115-0637	723.10	636.85	398	76.08	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12720.6	E08		9	0116-0635	35.78	635.56	114	43.46	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8284.4	E08		9	0117-0647	330.91	646.43	963	121.30	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7377.0	E08		9	0118-0643	95.21	643.10	364	74.08	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7603.7	E08		9	0119-0646	831.47	646.01	365	71.84	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9935.7	E08		9	0120-0664	884.80	664.40	591	92.33	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5898.9	E08		9	0121-0688	282.03	688.56	384	75.84	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6014.4	E08		9	0122-0691	32.07	691.03	364	72.43	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7834.5	E08		9	0123-0696	492.71	697.00	914	118.23	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5914.3	E08		9	0124-0692	101.63	692.07	400	76.08	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	5725.9	E08		9	0125-0695	371.28	694.61	380	75.50	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7871.2	E08		9	0126-0700	602.27	699.55	456	83.74	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	0.316	uM	48	hr	1185393	1375344	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6224.6	E08		9	0127-0701	453.77	701.32	370	71.84	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8248.6	F08		1	0001-0030	110.32	30.57	334	66.77	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8137.1	F08		1	0002-0030	292.69	29.76	335	69.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9122.0	F08		1	0003-0033	788.07	32.87	308	63.94	0.947
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7877.4	F08		1	0004-0036	632.11	35.77	388	76.67	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8319.3	F08		1	0005-0039	856.44	39.34	340	71.26	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8294.2	F08		1	0006-0046	812.65	45.96	342	69.60	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10454.9	F08		1	0007-0045	447.90	44.91	293	63.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7544.0	F08		1	0008-0050	42.39	51.20	369	72.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9394.6	F08		1	0009-0052	596.09	52.45	328	69.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6301.2	F08		1	0010-0056	175.27	55.94	409	77.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8582.5	F08		1	0011-0064	115.82	64.58	333	67.26	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7477.7	F08		1	0012-0066	924.28	65.51	402	78.08	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8429.2	F08		1	0013-0084	473.86	84.49	348	69.60	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10636.3	F08		1	0014-0088	249.65	88.08	246	61.84	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7628.6	F08		1	0015-0090	298.93	89.70	343	71.01	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9123.2	F08		1	0016-0097	626.12	97.82	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6986.5	F08		1	0017-0100	812.67	99.51	412	75.26	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8541.1	F08		1	0018-0101	37.70	101.14	322	67.01	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6867.2	F08		1	0019-0109	158.33	109.14	367	74.67	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11660.6	F08		1	0020-0110	918.49	110.83	230	55.70	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9323.9	F08		1	0021-0117	383.49	117.08	301	63.60	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7788.0	F08		1	0022-0120	224.09	120.30	352	71.84	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8597.1	F08		1	0023-0128	92.30	128.42	330	68.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7861.4	F08		1	0024-0129	304.76	129.88	332	69.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8047.0	F08		1	0025-0132	888.55	131.89	382	74.67	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7031.0	F08		1	0026-0133	624.07	132.24	400	75.84	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7187.9	F08		1	0027-0136	189.70	136.50	377	71.84	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8089.4	F08		1	0028-0139	38.80	139.33	355	71.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8206.4	F08		1	0029-0156	502.25	156.41	361	72.77	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9946.6	F08		1	0030-0159	245.97	159.58	262	60.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9124.5	F08		1	0031-0162	542.47	162.08	305	66.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6743.6	F08		1	0032-0170	856.80	169.98	448	81.26	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8921.3	F08		1	0033-0175	32.65	174.76	287	62.77	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7330.5	F08		1	0034-0180	296.19	180.25	357	70.67	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7493.3	F08		1	0035-0181	102.62	181.53	348	70.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7797.0	F08		1	0036-0191	622.34	191.15	356	70.53	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7698.9	F08		1	0037-0209	549.09	209.23	362	71.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8751.8	F08		1	0038-0216	173.16	216.49	298	64.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10497.9	F08		1	0039-0214	415.90	214.79	279	65.70	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8761.7	F08		1	0040-0218	132.55	218.67	313	65.60	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8497.7	F08		1	0041-0222	910.76	222.53	352	71.36	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7657.9	F08		1	0042-0227	265.38	226.89	346	70.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7687.3	F08		1	0043-0236	190.99	236.66	350	69.01	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8202.1	F08		1	0044-0238	460.98	238.44	327	74.08	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8035.3	F08		1	0045-0242	620.41	241.77	371	73.26	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9490.3	F08		1	0046-0241	540.92	241.27	310	65.11	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22143.2	F08		1	0047-0241	410.05	241.48	113	37.80	0.994
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8117.1	F08		1	0048-0250	839.25	249.93	357	73.26	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7726.1	F08		1	0049-0261	137.07	261.05	352	71.26	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7145.6	F08		1	0050-0262	571.15	261.52	381	73.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7836.1	F08		1	0051-0266	475.39	266.69	348	70.77	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8335.9	F08		1	0052-0270	530.89	271.01	334	69.84	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6695.6	F08		1	0053-0273	75.30	273.01	386	72.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9515.1	F08		1	0054-0279	210.55	279.03	249	60.43	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8840.4	F08		1	0055-0279	382.62	278.80	308	67.36	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9079.3	F08		1	0056-0282	904.38	282.65	390	74.43	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8019.3	F08		1	0057-0287	15.18	287.71	332	67.36	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8143.6	F08		1	0058-0300	517.08	299.90	373	73.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8884.4	F08		1	0059-0329	669.56	330.57	345	70.43	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8450.5	F08		1	0060-0329	210.55	329.94	319	64.77	0.956
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8745.0	F08		1	0061-0342	802.79	343.15	334	72.67	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7406.8	F08		1	0062-0344	183.62	344.44	354	70.43	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8791.7	F08		1	0063-0346	343.07	345.89	306	64.77	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9927.0	F08		1	0064-0343	518.02	343.86	284	64.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8448.3	F08		1	0065-0349	610.56	349.57	361	71.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9110.6	F08		1	0066-0349	313.63	348.58	294	67.26	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9450.5	F08		1	0067-0352	260.23	352.27	281	67.11	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10232.0	F08		1	0068-0354	442.75	354.67	287	63.94	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8838.5	F08		1	0069-0363	480.92	363.36	340	69.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8821.3	F08		1	0070-0367	299.40	366.87	304	65.36	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8845.7	F08		1	0071-0365	834.10	365.25	322	69.01	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9749.2	F08		1	0072-0368	527.07	367.61	294	64.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7997.5	F08		1	0073-0382	713.27	382.72	345	71.50	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7383.8	F08		1	0074-0384	173.41	384.36	362	72.77	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8409.1	F08		1	0075-0391	638.78	392.22	333	68.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8317.4	F08		1	0076-0405	573.29	404.87	344	69.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7334.0	F08		1	0077-0406	83.10	406.45	337	72.08	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8651.8	F08		1	0078-0409	594.00	410.00	382	76.43	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11575.7	F08		1	0079-0416	504.68	415.87	285	67.01	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10146.1	F08		1	0080-0418	699.52	417.20	307	69.50	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10445.8	F08		1	0081-0418	203.10	417.77	265	61.36	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8844.1	F08		1	0082-0428	690.61	428.69	321	68.91	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7494.4	F08		1	0083-0435	651.67	435.56	372	72.67	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8264.1	F08		1	0084-0437	450.85	437.17	367	70.77	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10290.9	F08		1	0085-0435	195.15	435.23	264	61.36	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6757.7	F08		1	0086-0441	111.14	440.70	368	73.84	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10927.7	F08		1	0087-0436	937.32	436.53	267	61.70	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9703.6	F08		1	0088-0444	253.50	444.16	346	118.71	0.309
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7353.4	F08		1	0089-0455	397.40	455.25	368	71.01	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12085.3	F08		1	0090-0464	825.17	463.78	237	57.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9407.0	F08		1	0091-0485	605.91	485.29	412	87.15	0.682
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7790.1	F08		1	0092-0484	359.10	485.15	381	72.18	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8562.1	F08		1	0093-0490	141.87	490.27	500	83.26	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9252.8	F08		1	0094-0485	304.73	485.23	290	63.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7433.0	F08		1	0095-0491	754.70	490.13	391	73.84	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9349.1	F08		1	0096-0498	265.06	497.74	288	63.60	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12064.7	F08		1	0097-0502	612.95	502.59	117	44.87	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8200.1	F08		1	0098-0527	10.59	527.92	305	65.70	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6853.4	F08		1	0099-0529	57.86	529.03	358	73.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9288.5	F08		1	0100-0535	452.49	535.43	640	112.47	0.636
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8462.9	F08		1	0101-0544	105.27	544.43	300	68.18	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7837.8	F08		1	0102-0546	231.84	545.25	339	71.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10568.3	F08		1	0103-0553	623.75	553.28	268	62.43	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9371.1	F08		1	0104-0555	850.95	555.28	286	62.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7566.7	F08		1	0105-0568	48.18	568.35	360	72.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8058.8	F08		1	0106-0574	819.63	574.22	350	69.11	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8867.9	F08		1	0107-0583	783.20	583.27	312	66.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8464.6	F08		1	0108-0584	710.81	582.51	423	89.50	0.664
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7850.6	F08		1	0109-0601	38.32	600.89	321	67.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7371.2	F08		1	0110-0600	607.81	600.05	367	76.08	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7170.5	F08		1	0111-0606	660.58	605.85	371	69.60	0.962
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8529.8	F08		1	0112-0610	748.21	610.84	319	68.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10481.9	F08		1	0113-0613	409.35	613.53	265	61.94	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9264.3	F08		1	0114-0617	366.01	617.49	295	65.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8333.0	F08		1	0115-0636	47.83	636.91	302	65.01	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9479.6	F08		1	0116-0637	228.92	636.45	239	59.84	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8429.7	F08		1	0117-0641	105.73	640.57	304	66.43	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9604.7	F08		1	0118-0640	623.25	640.90	283	65.50	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7975.4	F08		1	0119-0647	682.37	646.90	347	69.36	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9167.3	F08		1	0120-0655	768.36	655.13	297	65.11	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7947.8	F08		1	0121-0662	135.28	662.55	313	68.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9997.8	F08		1	0122-0666	210.92	665.60	261	60.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9552.1	F08		1	0123-0671	801.92	670.94	284	69.94	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10997.0	F08		1	0124-0667	75.29	666.23	255	61.01	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6618.8	F08		1	0125-0677	59.44	677.46	367	73.74	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11325.9	F08		1	0126-0683	690.93	683.68	237	57.11	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6614.2	F08		1	0127-0686	20.18	685.76	352	73.26	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10483.2	F08		1	0128-0684	273.91	684.26	249	60.87	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9454.0	F08		1	0129-0693	915.46	693.02	290	65.36	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185394	1375345	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7224.5	F08		1	0130-0701	579.21	702.80	368	72.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11702.1	F08		2	0001-0044	402.32	43.52	252	60.87	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8295.3	F08		2	0002-0047	546.79	46.75	377	74.43	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7632.0	F08		2	0003-0045	673.20	45.53	381	73.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10910.2	F08		2	0004-0049	443.67	49.45	286	65.01	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7663.7	F08		2	0005-0054	106.51	53.86	348	73.26	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10406.6	F08		2	0006-0052	743.31	52.03	279	62.43	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9598.4	F08		2	0007-0054	139.17	54.86	280	64.43	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7347.3	F08		2	0008-0067	28.86	65.71	380	74.67	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9845.0	F08		2	0009-0077	470.04	76.71	312	68.18	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9800.5	F08		2	0010-0072	721.48	72.01	287	65.94	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9615.8	F08		2	0011-0074	183.67	73.87	277	62.28	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11208.5	F08		2	0012-0080	815.81	78.97	283	65.50	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9437.1	F08		2	0013-0082	518.19	82.42	330	77.50	0.690
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10272.5	F08		2	0014-0083	889.92	82.14	281	62.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9225.1	F08		2	0015-0093	931.34	92.92	316	69.26	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6825.0	F08		2	0016-0102	144.94	102.35	374	75.50	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12524.9	F08		2	0017-0105	565.73	104.91	454	81.26	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11065.9	F08		2	0018-0111	22.99	111.27	235	56.53	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9066.7	F08		2	0019-0113	657.25	112.56	319	68.43	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11083.3	F08		2	0020-0117	207.77	117.49	239	59.70	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10903.0	F08		2	0021-0119	230.19	119.39	242	60.53	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10359.7	F08		2	0022-0134	856.86	133.97	276	62.43	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8970.9	F08		2	0023-0138	939.43	137.65	329	70.43	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7835.3	F08		2	0024-0143	330.89	143.01	345	68.77	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8105.5	F08		2	0025-0151	69.43	151.02	317	67.84	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13763.7	F08		2	0026-0156	215.70	157.45	411	85.50	0.707
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8728.6	F08		2	0027-0157	165.99	157.66	306	66.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10357.7	F08		2	0028-0162	411.80	162.46	265	61.36	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11153.6	F08		2	0029-0166	749.08	166.72	255	59.36	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7964.0	F08		2	0030-0170	119.40	169.22	339	71.01	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12025.2	F08		2	0031-0169	139.86	169.16	344	68.53	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7389.4	F08		2	0032-0176	510.70	176.42	377	72.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12306.6	F08		2	0033-0172	635.63	171.65	154	45.94	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9188.8	F08		2	0034-0178	457.29	178.32	334	68.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12234.5	F08		2	0035-0181	626.08	181.30	201	55.01	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11678.9	F08		2	0036-0187	645.35	186.92	276	63.60	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13719.4	F08		2	0037-0189	845.17	189.53	216	59.60	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8952.0	F08		2	0038-0193	325.10	193.61	304	64.53	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8021.2	F08		2	0039-0198	409.45	197.88	339	70.18	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6931.5	F08		2	0040-0209	535.17	208.71	386	73.26	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8200.8	F08		2	0041-0222	15.25	222.86	325	68.53	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9222.2	F08		2	0042-0224	616.40	224.46	300	65.01	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10336.1	F08		2	0043-0226	843.78	226.33	273	63.60	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8718.7	F08		2	0044-0230	121.18	229.88	332	68.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9804.8	F08		2	0045-0228	239.63	228.40	268	65.01	0.797
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8875.1	F08		2	0046-0230	652.00	230.29	317	67.84	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6770.3	F08		2	0047-0233	715.12	232.41	190	55.11	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10258.2	F08		2	0048-0235	323.12	235.58	304	71.11	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8689.1	F08		2	0049-0245	404.92	245.37	349	71.84	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9718.0	F08		2	0050-0250	276.28	249.47	274	63.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10988.8	F08		2	0051-0264	929.92	263.21	249	63.01	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8586.3	F08		2	0052-0261	191.74	262.17	309	69.36	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12642.9	F08		2	0053-0261	360.66	261.16	226	56.04	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7794.8	F08		2	0054-0268	54.40	268.60	344	69.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12424.5	F08		2	0055-0269	887.42	269.70	221	56.87	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9758.2	F08		2	0056-0270	341.91	269.66	282	63.94	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9068.7	F08		2	0057-0270	377.36	269.33	302	67.01	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8290.1	F08		2	0058-0280	724.41	279.94	346	72.18	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10832.5	F08		2	0059-0287	837.58	288.01	278	63.36	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11769.9	F08		2	0060-0297	127.28	297.86	214	57.94	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8119.9	F08		2	0061-0310	855.99	310.23	349	72.77	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9283.2	F08		2	0062-0317	259.32	317.68	288	65.70	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8609.6	F08		2	0063-0316	721.99	316.46	335	70.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8940.3	F08		2	0064-0321	376.65	320.95	305	66.67	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9822.7	F08		2	0065-0326	445.77	327.05	286	61.36	0.955
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8615.4	F08		2	0066-0330	180.19	329.23	325	67.36	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9722.0	F08		2	0067-0342	868.58	341.35	293	64.18	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8876.3	F08		2	0068-0348	366.56	348.52	336	68.18	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8177.2	F08		2	0069-0351	922.88	351.54	356	73.01	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8642.9	F08		2	0070-0356	941.20	356.11	350	71.60	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8874.6	F08		2	0071-0357	153.69	357.39	612	108.23	0.657
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10001.5	F08		2	0072-0374	406.60	374.81	483	84.43	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8477.4	F08		2	0073-0383	289.40	383.00	313	67.94	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10733.2	F08		2	0074-0383	102.55	383.68	245	59.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9664.3	F08		2	0075-0385	593.84	385.36	304	67.84	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9189.0	F08		2	0076-0387	356.28	387.46	294	66.43	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8210.5	F08		2	0077-0393	141.79	393.65	318	69.26	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8170.9	F08		2	0078-0397	212.63	398.04	322	65.60	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7770.1	F08		2	0079-0404	652.55	404.88	359	70.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6928.8	F08		2	0080-0409	431.96	408.57	379	72.67	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9716.0	F08		2	0081-0430	485.77	430.66	314	68.18	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8205.4	F08		2	0082-0436	193.76	436.75	316	68.43	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9634.3	F08		2	0083-0436	587.81	435.82	323	69.01	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10244.5	F08		2	0084-0437	42.06	436.96	271	61.11	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13484.4	F08		2	0085-0437	821.66	437.77	223	56.77	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12478.3	F08		2	0086-0448	660.63	448.83	239	58.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7127.7	F08		2	0087-0453	54.39	453.00	355	70.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10717.0	F08		2	0088-0459	340.67	458.85	249	61.84	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12079.2	F08		2	0089-0458	740.67	458.64	236	59.70	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8527.8	F08		2	0090-0467	519.60	467.21	345	69.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13386.1	F08		2	0091-0479	573.14	478.52	194	66.43	0.552
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8091.8	F08		2	0092-0489	169.47	489.35	315	70.77	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6750.8	F08		2	0093-0519	590.31	518.90	428	82.08	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8252.6	F08		2	0094-0517	202.43	517.49	317	67.36	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11618.4	F08		2	0095-0523	87.21	522.84	469	81.50	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9616.4	F08		2	0096-0521	771.81	521.83	313	68.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8967.2	F08		2	0097-0538	125.28	538.27	288	62.53	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11112.4	F08		2	0098-0537	646.98	536.44	248	62.18	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7425.3	F08		2	0099-0545	186.16	545.47	349	70.43	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7759.0	F08		2	0100-0562	460.22	561.46	366	74.43	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10001.5	F08		2	0101-0559	846.47	559.65	280	61.60	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9382.0	F08		2	0102-0581	830.65	580.36	296	64.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9777.2	F08		2	0103-0584	729.87	584.27	309	67.94	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7690.0	F08		2	0104-0583	136.86	584.11	355	70.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7889.7	F08		2	0105-0593	204.94	592.65	333	67.84	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7846.3	F08		2	0106-0599	657.62	599.28	352	72.77	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6105.9	F08		2	0107-0612	401.82	612.35	416	77.26	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7970.7	F08		2	0108-0613	282.94	613.38	336	69.60	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7613.1	F08		2	0109-0617	794.31	617.48	364	74.43	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9133.2	F08		2	0110-0627	564.76	627.74	304	68.33	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10528.5	F08		2	0111-0628	503.68	628.54	265	60.43	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7929.4	F08		2	0112-0640	468.48	639.76	358	74.77	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10348.7	F08		2	0113-0637	533.36	637.27	300	64.43	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9077.2	F08		2	0114-0638	142.53	638.49	284	62.28	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10013.6	F08		2	0115-0642	923.09	642.55	259	61.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11524.0	F08		2	0116-0649	490.89	649.79	358	75.60	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7764.8	F08		2	0117-0649	649.70	649.95	364	70.43	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10927.4	F08		2	0118-0651	340.95	651.50	256	60.53	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8030.5	F08		2	0119-0655	74.76	655.35	333	67.01	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8509.2	F08		2	0120-0656	384.32	656.20	315	68.43	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10875.1	F08		2	0121-0657	846.70	657.62	241	65.01	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9831.7	F08		2	0122-0664	526.49	664.41	282	62.53	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9392.0	F08		2	0123-0666	164.78	666.26	272	63.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7721.9	F08		2	0124-0667	290.75	666.98	342	68.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8326.1	F08		2	0125-0682	731.33	682.52	336	69.26	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9633.8	F08		2	0126-0684	931.88	683.94	264	62.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9243.6	F08		2	0127-0694	19.90	693.98	297	67.60	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8824.5	F08		2	0128-0705	744.81	704.87	312	65.84	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10266.7	F08		2	0129-0706	272.33	705.97	274	61.70	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185395	1375346	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10147.8	F08		2	0130-0704	664.77	704.13	313	65.36	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10288.9	F08		3	0001-0050	476.08	49.13	337	67.70	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10836.7	F08		3	0002-0055	782.98	55.56	261	61.11	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12034.4	F08		3	0003-0061	427.72	60.68	259	63.26	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10468.5	F08		3	0004-0062	393.22	62.02	308	63.36	0.964
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10414.6	F08		3	0005-0065	594.31	65.58	268	65.11	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9696.9	F08		3	0006-0068	325.54	68.02	284	62.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10340.7	F08		3	0007-0074	358.23	74.13	275	61.94	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11276.6	F08		3	0008-0089	435.52	89.44	268	60.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8968.3	F08		3	0009-0095	26.42	95.35	307	67.84	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16111.6	F08		3	0010-0109	138.49	108.04	205	67.26	0.570
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13404.2	F08		3	0011-0121	338.26	120.75	128	83.98	0.228
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12429.0	F08		3	0012-0130	591.11	130.17	181	52.87	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8640.1	F08		3	0013-0135	62.32	134.57	325	67.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9445.7	F08		3	0014-0142	436.10	142.21	309	66.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8946.7	F08		3	0015-0139	714.84	139.16	329	69.84	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8697.1	F08		3	0016-0141	34.55	140.24	322	71.01	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9349.6	F08		3	0017-0151	362.17	151.19	344	69.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12562.1	F08		3	0018-0146	686.46	146.15	203	58.28	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13243.0	F08		3	0019-0162	798.40	161.54	373	72.43	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9688.1	F08		3	0020-0164	305.82	164.51	279	61.94	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8248.0	F08		3	0021-0169	524.17	169.68	355	70.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8802.1	F08		3	0022-0176	41.37	176.90	331	73.50	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9921.6	F08		3	0023-0177	832.00	178.04	298	65.26	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9231.9	F08		3	0024-0180	761.07	179.65	319	70.18	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13035.4	F08		3	0025-0177	491.67	177.39	215	55.11	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8665.4	F08		3	0026-0188	796.60	188.30	334	69.36	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14324.6	F08		3	0027-0192	111.65	192.79	198	51.11	0.952
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10298.7	F08		3	0028-0201	382.46	201.75	271	63.26	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8476.7	F08		3	0029-0205	201.11	204.61	346	71.11	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8210.7	F08		3	0030-0209	706.89	208.43	356	71.84	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11207.4	F08		3	0031-0212	450.10	211.48	257	58.77	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8536.8	F08		3	0032-0220	833.52	220.04	327	70.67	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10773.4	F08		3	0033-0220	134.00	220.04	250	59.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9320.0	F08		3	0034-0227	404.98	227.52	305	64.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12479.9	F08		3	0035-0230	513.44	230.31	226	62.77	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12249.3	F08		3	0036-0234	547.93	234.56	240	58.53	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10421.4	F08		3	0037-0237	281.30	237.36	268	63.11	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11877.3	F08		3	0038-0255	675.34	254.68	236	58.53	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9213.2	F08		3	0039-0258	799.14	258.45	311	66.43	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12030.1	F08		3	0040-0262	553.47	262.69	241	58.53	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10389.9	F08		3	0041-0266	25.16	265.73	251	63.01	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10108.2	F08		3	0042-0265	863.12	265.41	274	63.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10968.9	F08		3	0043-0265	141.87	264.90	244	59.94	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15431.8	F08		3	0044-0269	487.64	268.24	132	54.77	0.553
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12339.7	F08		3	0045-0276	280.84	276.59	386	73.26	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10589.3	F08		3	0046-0283	412.01	282.93	270	61.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12254.2	F08		3	0047-0287	480.67	286.13	285	76.33	0.615
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8293.1	F08		3	0048-0285	614.69	285.54	353	71.01	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9000.4	F08		3	0049-0296	198.32	296.29	316	68.77	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9307.1	F08		3	0050-0294	808.99	294.66	306	65.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13470.2	F08		3	0051-0300	332.45	299.79	423	75.84	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10325.4	F08		3	0052-0300	512.00	299.74	300	64.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11056.2	F08		3	0053-0297	560.29	297.60	266	59.70	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9053.0	F08		3	0054-0305	631.55	304.42	320	68.18	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9883.0	F08		3	0055-0306	733.69	306.77	268	63.26	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11081.8	F08		3	0056-0305	416.53	305.25	160	48.63	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13478.2	F08		3	0057-0317	101.43	316.75	262	61.60	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7077.1	F08		3	0058-0318	58.86	318.20	366	72.08	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8397.2	F08		3	0059-0321	912.88	321.82	329	68.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11407.0	F08		3	0060-0321	412.84	321.14	247	64.77	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9607.8	F08		3	0061-0347	476.90	347.05	328	68.67	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9756.7	F08		3	0062-0349	536.15	349.97	293	67.11	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11470.6	F08		3	0063-0352	322.80	351.71	344	72.43	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13581.5	F08		3	0064-0354	218.01	354.14	410	78.43	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7346.8	F08		3	0065-0351	905.20	351.25	201	57.36	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7974.8	F08		3	0066-0354	18.49	354.18	350	72.18	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8281.8	F08		3	0067-0359	36.63	358.66	327	71.60	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8962.8	F08		3	0068-0361	443.07	361.30	317	74.77	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9025.0	F08		3	0069-0364	167.12	363.84	301	66.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7687.5	F08		3	0070-0375	797.76	374.43	377	74.43	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14254.0	F08		3	0071-0376	407.77	376.33	403	74.43	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11579.3	F08		3	0072-0383	548.09	383.47	271	61.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10260.9	F08		3	0073-0386	55.28	386.66	263	61.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8035.2	F08		3	0074-0389	468.20	389.24	355	71.01	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8957.6	F08		3	0075-0397	757.28	397.31	318	66.43	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9383.8	F08		3	0076-0407	593.49	407.72	303	65.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8253.5	F08		3	0077-0411	77.32	411.36	338	74.53	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6983.2	F08		3	0078-0415	667.54	414.74	411	79.26	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9420.9	F08		3	0079-0419	610.37	419.36	314	70.53	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8679.4	F08		3	0080-0418	171.29	417.35	336	70.67	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10414.1	F08		3	0081-0420	436.94	420.27	281	66.43	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11131.8	F08		3	0082-0432	899.32	432.10	265	65.60	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9728.4	F08		3	0083-0438	699.89	438.70	296	63.11	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7818.2	F08		3	0084-0444	43.31	444.10	338	70.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6846.8	F08		3	0085-0456	495.79	456.18	406	77.50	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9121.5	F08		3	0086-0460	909.25	460.74	187	53.94	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8913.6	F08		3	0087-0465	185.70	465.70	314	67.94	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8288.9	F08		3	0088-0474	639.22	474.30	345	69.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7968.9	F08		3	0089-0477	108.91	477.06	326	70.43	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10652.3	F08		3	0090-0483	496.72	482.98	270	66.43	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7241.7	F08		3	0091-0489	136.73	489.56	356	70.18	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10596.4	F08		3	0092-0490	780.75	490.99	267	61.36	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8296.4	F08		3	0093-0495	49.45	494.62	325	71.01	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9309.7	F08		3	0094-0500	347.91	499.38	295	64.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8623.7	F08		3	0095-0505	919.44	505.45	336	70.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10373.4	F08		3	0096-0508	250.88	507.89	557	95.74	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8976.3	F08		3	0097-0510	377.92	509.40	309	65.01	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7770.8	F08		3	0098-0527	730.49	527.19	370	73.60	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8391.7	F08		3	0099-0528	126.47	527.79	363	75.26	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9471.6	F08		3	0100-0534	225.35	534.16	299	67.01	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10176.0	F08		3	0101-0536	332.81	536.80	270	62.18	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8320.5	F08		3	0102-0543	554.02	544.15	343	69.84	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7390.3	F08		3	0103-0559	286.52	558.77	368	74.18	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7774.4	F08		3	0104-0566	404.65	567.19	357	75.60	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7899.8	F08		3	0105-0571	119.84	570.90	342	68.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9097.5	F08		3	0106-0577	154.39	576.28	301	68.43	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9530.1	F08		3	0107-0591	260.04	590.74	287	68.67	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9183.8	F08		3	0108-0616	365.65	616.72	298	71.50	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12572.1	F08		3	0109-0615	867.81	615.37	216	57.36	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12113.1	F08		3	0110-0619	937.72	619.86	247	60.53	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7235.0	F08		3	0111-0617	586.76	617.38	390	76.77	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8377.2	F08		3	0112-0630	903.23	629.42	344	73.50	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9201.2	F08		3	0113-0631	686.81	631.00	315	66.43	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9149.3	F08		3	0114-0638	664.80	638.76	311	67.60	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6968.4	F08		3	0115-0642	347.01	643.02	393	73.01	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9797.7	F08		3	0116-0644	17.93	645.04	252	59.36	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8182.9	F08		3	0117-0648	121.67	648.11	346	72.18	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11275.0	F08		3	0118-0651	291.92	651.05	242	62.77	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8243.4	F08		3	0119-0654	805.48	654.07	367	80.57	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12171.7	F08		3	0120-0652	309.59	653.07	239	60.77	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9060.2	F08		3	0121-0658	176.52	658.47	307	64.77	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9205.0	F08		3	0122-0658	839.55	658.18	315	69.84	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8965.3	F08		3	0123-0665	557.91	665.19	318	65.60	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8984.6	F08		3	0124-0672	147.01	672.49	294	63.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9757.9	F08		3	0125-0682	690.56	682.16	287	63.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13398.2	F08		3	0126-0686	535.26	685.35	203	55.21	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9462.3	F08		3	0127-0686	26.79	686.38	256	61.11	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9226.1	F08		3	0128-0694	675.48	694.25	328	67.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10499.0	F08		3	0129-0694	879.58	694.71	250	59.94	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9582.5	F08		3	0130-0704	182.73	704.55	273	61.60	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185396	1375347	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10351.1	F08		3	0131-0705	571.76	705.50	261	61.94	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9848.2	F08		4	0001-0029	171.82	29.32	261	60.77	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9624.2	F08		4	0002-0029	195.04	28.79	276	62.28	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9808.2	F08		4	0003-0032	144.75	32.73	257	61.70	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7646.3	F08		4	0004-0037	371.19	36.91	404	78.43	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7487.4	F08		4	0005-0064	872.22	63.25	356	72.43	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9596.4	F08		4	0006-0066	791.10	66.43	289	63.84	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10777.3	F08		4	0007-0069	51.72	68.97	255	61.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7276.3	F08		4	0008-0073	575.33	73.58	383	72.18	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8182.5	F08		4	0009-0076	110.78	76.17	321	67.94	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7931.4	F08		4	0010-0081	129.33	81.01	329	68.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8095.3	F08		4	0011-0096	634.11	95.81	337	70.08	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8317.2	F08		4	0012-0099	658.30	99.12	333	67.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7279.6	F08		4	0013-0106	475.01	106.70	414	83.26	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14327.3	F08		4	0014-0113	291.14	113.27	168	62.18	0.546
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8843.0	F08		4	0015-0121	83.65	120.58	291	65.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11162.0	F08		4	0016-0123	752.18	123.22	242	61.94	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13708.4	F08		4	0017-0121	785.98	121.79	202	51.94	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9494.4	F08		4	0018-0130	765.98	129.70	307	67.60	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8778.3	F08		4	0019-0132	574.14	131.92	314	67.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10905.9	F08		4	0020-0134	331.23	133.99	233	59.60	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9130.5	F08		4	0021-0136	432.75	135.71	287	64.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12460.6	F08		4	0022-0159	807.45	159.14	211	57.11	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10264.6	F08		4	0023-0161	233.88	160.59	280	61.94	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8436.3	F08		4	0024-0161	49.25	161.54	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9109.3	F08		4	0025-0164	601.52	164.49	295	64.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8459.1	F08		4	0026-0206	90.26	206.84	298	64.53	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9686.1	F08		4	0027-0209	531.51	209.16	307	68.18	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7224.9	F08		4	0028-0216	759.32	217.08	373	77.01	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8866.8	F08		4	0029-0212	912.03	211.82	314	67.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7196.9	F08		4	0030-0220	638.13	219.53	359	73.84	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8212.8	F08		4	0031-0225	408.56	225.08	339	71.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10618.2	F08		4	0032-0233	179.43	233.32	244	59.11	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8105.0	F08		4	0033-0240	333.77	239.81	310	66.43	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12640.4	F08		4	0034-0248	851.08	248.98	214	56.04	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7107.0	F08		4	0035-0257	43.47	257.21	343	70.67	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11403.1	F08		4	0036-0259	664.07	259.11	241	61.36	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9394.9	F08		4	0037-0270	424.07	270.27	299	66.18	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7514.3	F08		4	0038-0273	376.22	273.53	333	67.36	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10761.8	F08		4	0039-0272	180.26	272.05	242	58.77	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12483.9	F08		4	0040-0293	717.39	293.01	452	78.67	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7835.5	F08		4	0041-0297	20.10	297.46	353	70.18	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8367.1	F08		4	0042-0306	120.00	305.13	301	67.26	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10195.0	F08		4	0043-0306	917.57	306.35	266	63.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9745.4	F08		4	0044-0307	538.95	307.10	280	61.60	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11342.9	F08		4	0045-0309	667.97	309.75	240	61.60	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11173.3	F08		4	0046-0306	58.29	305.81	108	71.26	0.267
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8516.1	F08		4	0047-0311	377.59	311.42	323	68.77	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9431.5	F08		4	0048-0325	400.90	325.45	277	65.60	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7388.1	F08		4	0049-0329	359.73	329.52	366	72.43	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8697.0	F08		4	0050-0341	175.33	341.14	295	67.36	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8645.3	F08		4	0051-0338	296.96	338.14	314	68.43	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9778.6	F08		4	0052-0335	911.15	335.22	279	63.36	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8966.2	F08		4	0053-0339	454.32	339.21	317	67.60	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11534.3	F08		4	0054-0340	751.27	340.20	239	56.53	0.940
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11490.3	F08		4	0055-0347	199.86	347.24	232	57.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10367.0	F08		4	0056-0348	898.53	348.06	261	62.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10868.2	F08		4	0057-0353	925.53	352.89	270	61.94	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11179.3	F08		4	0058-0370	645.70	369.78	240	56.53	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9017.4	F08		4	0059-0374	765.64	375.08	305	63.60	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8501.3	F08		4	0060-0377	230.62	377.83	321	67.84	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11092.6	F08		4	0061-0375	75.09	374.82	228	58.87	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10325.7	F08		4	0062-0397	347.58	396.96	251	61.01	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10108.3	F08		4	0063-0400	196.29	400.36	253	59.11	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9799.7	F08		4	0064-0399	845.43	399.14	274	61.11	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8995.1	F08		4	0065-0405	765.45	405.15	309	65.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8800.8	F08		4	0066-0407	710.17	407.47	313	64.43	0.948
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9839.2	F08		4	0067-0411	327.72	411.45	279	64.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11638.4	F08		4	0068-0425	935.39	425.27	246	64.28	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9557.7	F08		4	0069-0426	227.43	425.84	276	63.60	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12007.1	F08		4	0070-0433	826.67	433.62	366	73.01	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9154.3	F08		4	0071-0433	792.34	434.04	296	65.26	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7609.4	F08		4	0072-0439	880.69	439.79	390	75.84	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8523.8	F08		4	0073-0458	342.98	457.95	303	68.53	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8070.8	F08		4	0074-0466	560.47	466.09	336	71.01	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11037.6	F08		4	0075-0477	753.31	477.02	509	85.50	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7796.7	F08		4	0076-0487	519.08	487.44	347	70.43	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11446.0	F08		4	0077-0489	901.11	489.35	224	59.70	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8226.5	F08		4	0078-0497	148.51	496.66	310	65.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7707.1	F08		4	0079-0504	288.85	504.09	327	67.26	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9523.2	F08		4	0080-0502	21.26	502.29	265	65.60	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8732.6	F08		4	0081-0502	230.11	502.30	295	68.43	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10489.9	F08		4	0082-0507	702.74	507.36	250	59.94	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8895.5	F08		4	0083-0518	434.28	517.40	308	65.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9174.9	F08		4	0084-0517	327.21	518.02	295	65.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12374.1	F08		4	0085-0532	654.71	531.73	370	71.36	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8838.1	F08		4	0086-0535	143.11	534.87	285	64.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7359.9	F08		4	0087-0536	197.18	535.93	334	68.18	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9455.9	F08		4	0088-0538	519.41	538.85	295	65.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11386.7	F08		4	0089-0547	598.89	547.62	236	57.11	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12256.9	F08		4	0090-0553	770.22	549.80	273	100.71	0.338
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7966.2	F08		4	0091-0553	308.70	552.52	334	68.43	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7593.0	F08		4	0092-0554	236.15	553.92	325	72.18	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11763.0	F08		4	0093-0553	374.13	553.74	227	60.43	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8463.1	F08		4	0094-0561	844.19	562.12	348	72.67	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12152.3	F08		4	0095-0561	791.09	560.82	264	83.50	0.476
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8946.3	F08		4	0096-0566	270.03	566.14	283	65.84	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10030.8	F08		4	0097-0565	19.85	565.60	260	60.53	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9109.7	F08		4	0098-0581	691.35	581.50	300	65.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9398.6	F08		4	0099-0583	767.19	583.34	293	65.11	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9128.0	F08		4	0100-0587	159.33	587.68	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10168.4	F08		4	0101-0593	844.08	593.08	290	64.43	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10464.7	F08		4	0102-0608	700.30	608.59	351	72.18	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9961.9	F08		4	0103-0611	330.70	610.79	260	62.18	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8376.5	F08		4	0104-0612	306.01	612.01	306	65.11	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6667.0	F08		4	0105-0615	576.64	615.24	375	74.67	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9668.3	F08		4	0106-0617	891.27	617.43	316	67.36	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10679.3	F08		4	0107-0628	95.11	628.12	255	61.60	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12378.0	F08		4	0108-0631	374.02	631.06	239	59.11	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8438.5	F08		4	0109-0636	235.67	635.97	293	68.77	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11728.7	F08		4	0110-0634	316.13	633.75	228	58.87	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7187.1	F08		4	0111-0647	665.33	646.45	365	72.18	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8713.4	F08		4	0112-0653	495.85	653.47	310	65.36	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7692.3	F08		4	0113-0659	788.18	658.88	344	69.84	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6041.6	F08		4	0114-0659	552.10	659.61	283	67.50	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7660.1	F08		4	0115-0666	282.01	665.44	321	67.60	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8282.1	F08		4	0116-0668	727.49	667.81	322	67.60	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11167.9	F08		4	0117-0680	397.53	679.43	239	57.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9744.3	F08		4	0118-0686	292.84	686.66	270	61.36	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8407.9	F08		4	0119-0695	861.38	694.59	324	73.50	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8438.7	F08		4	0120-0698	161.50	698.70	379	76.53	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8601.6	F08		4	0121-0700	903.67	700.99	382	111.88	0.383
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9124.9	F08		4	0122-0702	144.98	702.79	376	75.94	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12047.0	F08		4	0123-0699	828.87	699.10	217	57.60	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10557.3	F08		4	0124-0700	594.34	699.65	244	60.43	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185397	1375348	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9409.0	F08		4	0125-0701	642.94	700.49	282	62.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7268.5	F08		5	0001-0034	395.08	34.47	406	75.84	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7917.5	F08		5	0002-0038	646.42	38.21	370	70.77	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8304.9	F08		5	0003-0036	895.51	36.62	132	44.87	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8670.6	F08		5	0004-0053	63.91	53.11	294	64.18	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9712.6	F08		5	0005-0056	130.66	56.10	288	64.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10458.6	F08		5	0006-0053	176.55	53.72	267	61.94	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9067.7	F08		5	0007-0057	930.89	57.41	309	65.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8725.4	F08		5	0008-0059	214.33	59.15	311	67.01	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8670.4	F08		5	0009-0059	820.16	60.31	321	68.43	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11644.0	F08		5	0010-0064	611.99	63.41	263	61.11	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7646.6	F08		5	0011-0067	82.12	67.22	330	67.60	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9940.9	F08		5	0012-0070	116.97	70.49	285	65.60	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9997.1	F08		5	0013-0071	460.49	70.35	324	68.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6102.2	F08		5	0014-0076	867.42	76.30	428	91.40	0.644
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9719.7	F08		5	0015-0075	301.28	74.78	281	63.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8654.9	F08		5	0016-0074	439.08	73.56	341	70.18	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6778.7	F08		5	0017-0079	544.63	79.97	407	77.26	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7101.3	F08		5	0018-0077	652.81	76.34	386	75.60	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8465.2	F08		5	0019-0082	157.42	81.90	300	66.77	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8649.7	F08		5	0020-0085	343.85	86.51	368	83.84	0.658
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9555.6	F08		5	0021-0089	282.47	89.26	281	61.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8290.3	F08		5	0022-0092	892.22	92.42	341	70.18	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9189.2	F08		5	0023-0095	483.90	95.58	329	71.01	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10031.5	F08		5	0024-0109	219.92	109.22	269	61.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8236.8	F08		5	0025-0113	338.05	113.44	337	68.77	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10431.8	F08		5	0026-0111	115.25	110.85	245	61.94	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9045.8	F08		5	0027-0114	386.41	114.78	323	70.08	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7600.4	F08		5	0028-0114	427.91	114.12	383	73.60	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8700.3	F08		5	0029-0121	903.82	121.33	326	67.84	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10159.9	F08		5	0030-0131	793.61	131.16	271	63.84	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10386.0	F08		5	0031-0133	734.79	133.74	301	66.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10669.0	F08		5	0032-0134	751.30	133.33	292	63.70	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12167.4	F08		5	0033-0132	385.79	132.09	222	55.70	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6719.6	F08		5	0034-0138	86.64	137.47	341	69.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9885.0	F08		5	0035-0139	163.72	139.59	258	66.77	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6827.1	F08		5	0036-0145	476.49	144.75	396	74.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8069.6	F08		5	0037-0157	213.74	156.88	316	68.43	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7168.9	F08		5	0038-0169	274.16	168.88	351	71.01	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12786.4	F08		5	0039-0173	609.16	173.16	404	76.08	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18839.5	F08		5	0040-0175	653.57	175.14	222	66.43	0.632
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10885.5	F08		5	0041-0186	692.54	186.11	259	61.84	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9675.4	F08		5	0042-0189	790.81	189.35	316	66.18	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8064.6	F08		5	0043-0194	433.89	195.30	340	69.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8856.1	F08		5	0044-0192	569.76	192.11	337	69.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10275.0	F08		5	0045-0194	511.55	194.18	281	67.60	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9552.7	F08		5	0046-0198	605.20	198.50	312	67.01	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11579.5	F08		5	0047-0206	138.63	206.49	216	56.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8421.5	F08		5	0048-0211	405.29	211.43	319	71.36	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10776.3	F08		5	0049-0209	751.75	209.63	284	63.01	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10233.0	F08		5	0050-0211	70.94	211.56	255	59.36	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16151.8	F08		5	0051-0213	693.64	213.26	347	68.43	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8351.7	F08		5	0052-0213	17.38	213.79	300	66.18	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8439.0	F08		5	0053-0213	227.18	213.03	327	71.60	0.802
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12992.1	F08		5	0054-0215	509.11	214.86	203	52.53	0.925
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13142.7	F08		5	0055-0227	876.19	227.30	204	55.11	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10146.7	F08		5	0056-0234	567.51	233.40	287	68.08	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7546.9	F08		5	0057-0240	663.89	240.33	359	72.67	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8200.2	F08		5	0058-0241	438.76	241.98	335	68.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10421.6	F08		5	0059-0243	527.92	243.78	266	63.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9147.2	F08		5	0060-0247	706.19	247.96	330	70.77	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11895.3	F08		5	0061-0249	754.11	249.02	234	57.36	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7318.7	F08		5	0062-0254	389.43	254.59	364	70.67	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11940.6	F08		5	0063-0261	206.44	260.22	459	86.33	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12759.6	F08		5	0064-0270	895.35	270.24	417	76.67	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8840.5	F08		5	0065-0270	599.22	270.41	322	66.77	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8831.1	F08		5	0066-0273	348.28	273.69	299	66.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11159.9	F08		5	0067-0276	448.25	276.64	239	58.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8999.4	F08		5	0068-0278	835.77	278.27	321	71.01	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7629.1	F08		5	0069-0279	292.09	279.55	344	68.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8284.9	F08		5	0070-0281	537.85	281.40	333	68.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8297.3	F08		5	0071-0280	677.23	279.89	332	75.26	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8782.5	F08		5	0072-0296	347.47	296.08	330	69.11	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8408.5	F08		5	0073-0299	635.45	299.89	346	73.94	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9806.0	F08		5	0074-0297	788.73	297.15	291	66.43	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9276.3	F08		5	0075-0304	875.72	303.01	289	70.18	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9245.0	F08		5	0076-0304	729.81	304.02	340	68.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9577.9	F08		5	0077-0308	23.08	308.11	265	63.01	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8881.0	F08		5	0078-0305	939.78	305.35	304	67.11	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8912.9	F08		5	0079-0310	179.55	310.39	294	64.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7748.6	F08		5	0080-0311	598.75	311.32	354	71.84	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9096.5	F08		5	0081-0313	143.45	313.92	286	64.18	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7818.9	F08		5	0082-0313	690.74	313.03	348	77.26	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9310.8	F08		5	0083-0319	850.96	319.47	303	65.01	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8800.9	F08		5	0084-0322	104.40	321.87	295	62.77	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9344.6	F08		5	0085-0336	533.22	336.35	305	64.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9154.9	F08		5	0086-0337	16.83	337.26	281	63.70	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12319.6	F08		5	0087-0351	708.97	350.24	940	130.02	0.699
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7674.9	F08		5	0088-0353	484.07	354.05	355	77.60	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10239.8	F08		5	0089-0355	30.81	354.84	268	61.36	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9123.7	F08		5	0090-0368	604.98	368.12	312	65.94	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9080.6	F08		5	0091-0375	822.27	374.97	333	69.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12139.3	F08		5	0092-0381	723.88	381.54	231	58.77	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7971.9	F08		5	0093-0387	124.99	387.97	340	73.01	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9587.5	F08		5	0094-0394	576.29	394.42	289	63.11	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12137.8	F08		5	0095-0397	186.52	397.07	209	54.28	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9339.1	F08		5	0096-0402	650.80	402.61	306	65.01	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9109.0	F08		5	0097-0403	301.55	402.35	283	62.77	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9651.6	F08		5	0098-0407	729.66	406.83	335	68.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9654.7	F08		5	0099-0411	271.43	411.55	382	72.77	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9200.7	F08		5	0100-0411	806.69	411.17	317	66.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10230.8	F08		5	0101-0410	931.79	410.06	268	63.01	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9692.4	F08		5	0102-0416	163.49	417.53	505	84.33	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9741.3	F08		5	0103-0412	488.23	411.26	280	63.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9099.6	F08		5	0104-0415	603.65	415.15	316	68.18	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7431.8	F08		5	0105-0423	356.28	423.04	348	72.43	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10845.9	F08		5	0106-0427	40.59	427.14	247	64.53	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12236.5	F08		5	0107-0430	435.55	429.89	458	82.33	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9581.4	F08		5	0108-0440	211.05	440.67	269	62.77	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11110.4	F08		5	0109-0439	640.00	439.36	249	57.94	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10142.0	F08		5	0110-0442	417.16	442.94	262	61.01	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9306.1	F08		5	0111-0443	899.55	443.27	301	64.18	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7895.8	F08		5	0112-0447	476.08	447.55	363	70.67	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8680.4	F08		5	0113-0451	734.64	451.15	297	66.18	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7739.0	F08		5	0114-0456	242.30	455.90	332	69.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9523.8	F08		5	0115-0451	578.34	451.24	303	68.77	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9904.5	F08		5	0116-0469	58.94	469.69	252	61.60	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7960.5	F08		5	0117-0471	351.25	471.21	327	70.43	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12166.4	F08		5	0118-0472	551.99	471.88	329	67.11	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9967.0	F08		5	0119-0472	203.72	471.30	258	61.94	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10273.2	F08		5	0120-0478	503.26	478.79	262	67.11	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8285.5	F08		5	0121-0485	856.17	484.58	358	83.15	0.651
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10139.3	F08		5	0122-0485	677.69	485.26	282	61.36	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7337.0	F08		5	0123-0487	399.87	488.02	359	73.50	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9304.6	F08		5	0124-0490	440.42	490.09	294	65.01	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7905.0	F08		5	0125-0498	773.48	496.68	378	75.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8794.1	F08		5	0126-0496	309.69	496.05	294	69.84	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7836.3	F08		5	0127-0509	643.66	509.29	335	73.94	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8566.2	F08		5	0128-0509	589.08	509.68	338	69.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9812.8	F08		5	0129-0513	89.09	513.87	285	64.77	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8410.6	F08		5	0130-0514	719.54	514.93	320	72.91	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8874.1	F08		5	0131-0519	469.01	520.32	309	67.60	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7961.3	F08		5	0132-0523	618.72	522.90	329	77.36	0.691
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9066.1	F08		5	0133-0522	938.32	521.96	292	66.77	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10942.5	F08		5	0134-0534	72.21	534.62	230	59.60	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8707.2	F08		5	0135-0544	644.19	544.29	316	68.18	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12317.4	F08		5	0136-0567	420.55	567.04	430	77.84	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8801.9	F08		5	0137-0566	673.03	565.57	335	73.26	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9377.8	F08		5	0138-0565	870.81	565.19	320	72.18	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10558.2	F08		5	0139-0575	833.54	575.28	278	69.11	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12399.6	F08		5	0140-0590	131.65	590.88	210	55.11	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9620.9	F08		5	0141-0611	130.17	611.79	263	59.94	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6905.9	F08		5	0142-0617	860.75	617.22	361	73.26	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8447.9	F08		5	0143-0636	322.12	636.25	311	65.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9495.6	F08		5	0144-0638	552.97	637.55	285	63.60	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9751.5	F08		5	0145-0636	143.55	636.61	256	67.94	0.697
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8546.7	F08		5	0146-0646	243.79	646.06	331	70.53	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9739.5	F08		5	0147-0645	569.15	644.80	289	64.53	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9392.3	F08		5	0148-0656	209.72	658.89	589	110.33	0.608
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8667.9	F08		5	0149-0649	392.44	648.81	314	67.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11531.9	F08		5	0150-0651	477.69	651.41	393	74.43	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10317.5	F08		5	0151-0651	648.86	650.78	265	63.26	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10356.2	F08		5	0152-0656	839.71	656.03	262	65.60	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8068.4	F08		5	0153-0652	916.58	652.30	326	69.94	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7641.0	F08		5	0154-0660	61.87	660.43	318	67.84	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7847.5	F08		5	0155-0669	717.31	668.92	367	74.33	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9769.0	F08		5	0156-0675	309.34	674.77	300	67.01	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8208.8	F08		5	0157-0674	400.17	675.66	347	73.84	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8235.9	F08		5	0158-0679	451.47	679.38	325	69.84	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16525.7	F08		5	0159-0684	636.39	684.58	320	66.18	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185398	1375349	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7226.7	F08		5	0160-0696	906.66	696.33	348	73.01	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8493.8	F08		6	0001-0040	323.34	40.63	347	73.01	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10597.5	F08		6	0002-0047	782.00	47.24	273	67.26	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11349.1	F08		6	0003-0053	426.76	53.37	270	66.67	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9669.6	F08		6	0004-0055	149.57	55.43	286	63.94	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8727.2	F08		6	0005-0060	25.83	60.11	304	64.77	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11221.3	F08		6	0006-0061	823.37	60.79	253	65.84	0.733
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11327.7	F08		6	0007-0067	247.36	66.94	265	65.60	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8342.1	F08		6	0008-0077	673.88	77.38	377	71.84	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8624.9	F08		6	0009-0084	318.86	83.55	340	71.26	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10114.5	F08		6	0010-0082	527.49	83.00	305	64.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9487.6	F08		6	0011-0087	691.40	87.25	305	68.43	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9742.4	F08		6	0012-0093	196.33	91.42	299	70.18	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11691.5	F08		6	0013-0093	411.70	93.66	250	59.60	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10197.3	F08		6	0014-0104	612.42	106.23	346	102.23	0.416
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8034.6	F08		6	0015-0107	853.40	107.97	367	72.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8026.5	F08		6	0016-0113	298.91	113.41	347	71.84	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9643.3	F08		6	0017-0113	172.37	112.80	285	62.77	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12289.8	F08		6	0018-0114	334.39	113.57	226	58.53	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10060.3	F08		6	0019-0121	811.87	120.64	294	66.77	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9787.2	F08		6	0020-0128	489.88	127.29	314	69.50	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8781.9	F08		6	0021-0127	261.73	127.59	320	69.01	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7335.6	F08		6	0022-0130	584.41	129.80	379	79.50	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12642.4	F08		6	0023-0141	433.17	141.59	228	55.36	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7621.2	F08		6	0024-0149	770.71	149.75	427	77.26	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6912.9	F08		6	0025-0149	541.38	150.44	409	76.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9603.9	F08		6	0026-0155	854.32	156.19	321	72.18	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8952.2	F08		6	0027-0161	680.29	160.66	346	72.43	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11890.8	F08		6	0028-0164	506.03	165.14	481	90.91	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11648.5	F08		6	0029-0162	369.59	161.90	232	59.36	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11027.7	F08		6	0030-0164	279.54	163.75	252	61.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9290.6	F08		6	0031-0172	236.80	172.17	301	64.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8442.8	F08		6	0032-0176	320.72	175.64	352	72.18	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9485.8	F08		6	0033-0175	898.76	174.31	325	73.01	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12082.7	F08		6	0034-0174	375.98	174.89	226	57.46	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8116.8	F08		6	0035-0181	405.96	181.83	347	77.84	0.720
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7426.8	F08		6	0036-0184	582.05	185.12	389	76.43	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14440.7	F08		6	0037-0189	183.13	190.35	103	56.77	0.402
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7593.2	F08		6	0038-0195	864.81	196.10	382	72.43	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7728.9	F08		6	0039-0206	939.73	206.24	363	72.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11771.5	F08		6	0040-0212	24.77	212.32	133	93.78	0.190
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7763.8	F08		6	0041-0211	247.08	211.41	342	71.84	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10606.7	F08		6	0042-0228	579.14	227.70	277	62.53	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9148.3	F08		6	0043-0232	258.80	231.53	298	66.43	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9294.8	F08		6	0044-0238	813.54	237.94	339	80.43	0.659
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11810.5	F08		6	0045-0241	724.82	241.12	241	61.01	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9266.2	F08		6	0046-0251	149.32	251.35	290	64.18	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9582.2	F08		6	0047-0255	441.49	255.10	296	63.94	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7431.9	F08		6	0048-0257	311.88	256.26	359	71.84	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10311.0	F08		6	0049-0262	774.37	261.17	308	71.01	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9121.1	F08		6	0050-0263	807.80	263.63	324	69.84	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8035.5	F08		6	0051-0265	748.05	265.21	392	77.26	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11703.8	F08		6	0052-0271	841.51	269.91	483	88.81	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10283.4	F08		6	0053-0273	604.82	273.45	298	69.01	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8629.5	F08		6	0054-0275	192.07	275.02	310	67.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7733.4	F08		6	0055-0285	273.81	284.59	342	71.11	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10741.5	F08		6	0056-0288	315.97	287.75	255	58.53	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14179.9	F08		6	0057-0288	238.03	289.05	118	69.84	0.304
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8073.9	F08		6	0058-0297	110.60	297.43	375	74.77	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7003.3	F08		6	0059-0300	402.45	299.81	395	73.01	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8914.3	F08		6	0060-0300	332.60	301.04	309	66.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9091.0	F08		6	0061-0304	919.18	304.82	341	79.26	0.682
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9119.2	F08		6	0062-0303	872.22	303.19	317	67.01	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7963.2	F08		6	0063-0307	380.17	306.95	348	69.84	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8415.2	F08		6	0064-0308	34.85	308.19	303	66.53	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8784.5	F08		6	0065-0314	529.80	314.65	360	71.84	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10176.1	F08		6	0066-0312	737.90	311.53	283	61.94	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11322.3	F08		6	0067-0319	460.36	319.32	245	57.94	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8116.8	F08		6	0068-0327	176.31	327.19	334	67.84	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7703.3	F08		6	0069-0327	267.39	326.87	358	72.43	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6613.4	F08		6	0070-0345	345.65	345.61	399	78.08	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7759.3	F08		6	0071-0349	652.12	348.88	388	74.67	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9299.4	F08		6	0072-0351	229.47	350.89	306	67.26	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9953.0	F08		6	0073-0357	860.37	356.93	306	69.01	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9028.2	F08		6	0074-0364	724.31	363.77	340	68.18	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11148.6	F08		6	0075-0367	220.38	367.40	249	61.60	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7873.5	F08		6	0076-0375	307.06	375.11	344	72.77	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7400.6	F08		6	0077-0374	379.82	374.77	371	73.84	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7579.3	F08		6	0078-0378	523.40	378.00	387	76.43	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13108.3	F08		6	0079-0372	777.01	372.70	209	54.28	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12501.1	F08		6	0080-0374	795.86	374.76	239	57.11	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8940.6	F08		6	0081-0390	896.09	390.31	343	70.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9088.9	F08		6	0082-0396	270.34	396.79	301	66.43	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10052.4	F08		6	0083-0400	75.64	400.55	294	63.60	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8647.5	F08		6	0084-0408	198.73	407.56	319	69.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8946.7	F08		6	0085-0407	558.86	406.76	351	70.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9237.0	F08		6	0086-0411	830.09	410.68	323	70.28	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9447.4	F08		6	0087-0413	26.87	412.80	273	63.01	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9023.7	F08		6	0088-0420	388.43	419.57	320	67.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8878.5	F08		6	0089-0420	699.00	419.51	331	69.01	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9688.8	F08		6	0090-0426	929.04	426.58	303	74.77	0.681
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10377.2	F08		6	0091-0422	80.11	422.33	281	63.01	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9533.4	F08		6	0092-0422	269.24	422.52	297	65.60	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11914.0	F08		6	0093-0425	495.24	425.58	231	61.70	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10358.0	F08		6	0094-0426	942.53	425.21	293	70.18	0.747
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9728.4	F08		6	0095-0427	654.26	427.01	298	65.01	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11889.6	F08		6	0096-0434	732.15	434.32	345	70.28	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8635.6	F08		6	0097-0434	899.88	434.35	368	72.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8757.5	F08		6	0098-0440	787.04	439.64	350	71.26	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11036.3	F08		6	0099-0444	313.51	444.25	248	63.70	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9685.6	F08		6	0100-0457	612.48	456.44	301	65.60	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9352.6	F08		6	0101-0466	541.75	465.82	314	67.84	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10192.1	F08		6	0102-0469	457.06	467.95	300	69.84	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8836.7	F08		6	0103-0472	899.47	472.04	331	68.43	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10832.3	F08		6	0104-0472	158.56	471.82	129	71.26	0.319
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10549.9	F08		6	0105-0483	421.15	482.38	284	65.01	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10061.8	F08		6	0106-0490	252.39	489.66	277	68.18	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9021.4	F08		6	0107-0488	290.18	488.41	322	68.43	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9636.8	F08		6	0108-0490	467.28	490.61	295	65.70	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9856.7	F08		6	0109-0495	132.47	495.84	269	67.70	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9972.2	F08		6	0110-0491	408.30	491.61	275	63.60	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8724.5	F08		6	0111-0497	182.57	498.42	305	67.94	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9042.9	F08		6	0112-0499	660.07	499.59	318	69.01	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8260.3	F08		6	0113-0502	370.65	502.53	343	74.43	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9356.7	F08		6	0114-0509	588.39	509.07	310	67.84	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8634.9	F08		6	0115-0515	827.71	515.63	344	68.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11041.1	F08		6	0116-0520	888.52	520.32	253	60.53	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8268.5	F08		6	0117-0522	753.11	521.82	355	70.08	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8679.8	F08		6	0118-0525	33.42	524.89	304	68.43	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9858.9	F08		6	0119-0523	315.91	522.86	302	65.94	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12694.9	F08		6	0120-0530	921.48	530.74	210	53.36	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8907.3	F08		6	0121-0538	399.98	537.73	342	69.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9031.5	F08		6	0122-0541	48.54	540.58	328	68.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9522.8	F08		6	0123-0546	728.83	546.54	317	66.43	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7839.3	F08		6	0124-0550	442.78	549.81	360	71.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8941.9	F08		6	0125-0555	695.22	557.17	392	118.13	0.353
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9186.8	F08		6	0126-0558	273.97	559.61	375	88.33	0.604
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7633.4	F08		6	0127-0558	504.41	558.87	368	73.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8287.9	F08		6	0128-0560	633.43	560.60	357	74.43	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8770.9	F08		6	0129-0564	806.22	564.04	342	73.60	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8148.7	F08		6	0130-0572	573.03	573.00	363	76.08	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12265.2	F08		6	0131-0570	899.87	570.25	219	55.70	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10020.4	F08		6	0132-0581	58.91	581.53	285	62.18	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8872.6	F08		6	0133-0585	191.91	585.57	308	69.26	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7295.0	F08		6	0134-0581	760.19	580.73	169	51.36	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9350.2	F08		6	0135-0586	779.09	586.58	318	73.70	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8362.5	F08		6	0136-0593	393.16	593.77	325	68.77	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7802.4	F08		6	0137-0598	524.28	598.86	360	74.43	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10520.7	F08		6	0138-0604	407.96	603.66	268	60.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9222.6	F08		6	0139-0606	719.80	606.67	342	71.60	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8705.0	F08		6	0140-0610	668.02	609.38	332	71.60	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8042.5	F08		6	0141-0610	944.17	610.24	325	67.36	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8379.9	F08		6	0142-0624	254.48	624.73	435	81.36	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11999.5	F08		6	0143-0620	473.85	620.29	254	59.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8829.5	F08		6	0144-0625	498.09	624.46	322	69.60	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12789.8	F08		6	0145-0621	588.56	622.24	126	47.11	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10216.4	F08		6	0146-0626	604.38	625.56	306	69.36	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10154.1	F08		6	0147-0631	399.30	631.24	270	60.18	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8572.9	F08		6	0148-0643	820.36	643.79	331	69.60	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7345.9	F08		6	0149-0647	762.95	647.48	391	74.67	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8782.4	F08		6	0150-0647	185.53	647.15	314	69.01	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11997.3	F08		6	0151-0650	467.28	649.78	254	58.53	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6613.7	F08		6	0152-0655	654.47	655.82	408	83.15	0.741
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8686.0	F08		6	0153-0657	227.78	657.24	307	67.36	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6713.6	F08		6	0154-0663	678.83	662.86	420	78.08	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12717.8	F08		6	0155-0660	152.33	659.97	228	56.28	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6515.2	F08		6	0156-0664	317.48	664.23	379	78.43	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13433.4	F08		6	0157-0667	131.53	667.22	214	54.77	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7580.0	F08		6	0158-0685	754.34	685.71	364	73.26	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9154.6	F08		6	0159-0683	214.80	683.17	312	65.01	0.928
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10471.1	F08		6	0160-0691	383.37	691.24	545	87.15	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8255.0	F08		6	0161-0691	921.86	691.84	327	67.01	0.915
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8991.8	F08		6	0162-0695	699.02	694.81	134	44.04	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10406.1	F08		6	0163-0703	335.59	703.62	544	86.91	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9413.9	F08		6	0164-0697	712.80	697.08	155	46.39	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7535.5	F08		6	0165-0703	115.04	703.15	344	69.01	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185399	1375350	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10030.2	F08		6	0166-0708	252.76	707.97	278	62.53	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10177.6	F08		7	0001-0033	92.68	32.93	251	60.18	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9630.8	F08		7	0002-0044	386.80	44.51	294	62.77	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10603.2	F08		7	0003-0048	477.35	48.14	278	66.67	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9954.0	F08		7	0004-0060	407.20	59.76	285	63.36	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11941.9	F08		7	0005-0062	678.12	62.81	233	55.36	0.956
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11973.1	F08		7	0006-0083	498.41	83.94	245	59.11	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9608.0	F08		7	0007-0088	102.28	88.41	272	64.28	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11481.6	F08		7	0008-0090	312.19	90.06	243	58.28	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11044.5	F08		7	0009-0088	857.80	88.23	243	58.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11925.1	F08		7	0010-0091	568.14	91.09	249	59.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10041.9	F08		7	0011-0090	922.36	90.77	285	69.36	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7950.4	F08		7	0012-0096	804.71	96.45	347	71.01	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9522.0	F08		7	0013-0099	159.09	99.23	396	76.91	0.841
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10216.1	F08		7	0014-0101	457.94	101.78	288	63.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12180.8	F08		7	0015-0105	635.09	105.00	234	59.36	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12041.0	F08		7	0016-0119	523.81	119.55	222	58.18	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13466.0	F08		7	0017-0126	686.97	125.86	193	53.94	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8733.0	F08		7	0018-0126	88.93	126.97	301	67.01	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9995.8	F08		7	0019-0132	641.72	132.74	273	63.60	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7845.9	F08		7	0020-0131	188.37	132.20	306	72.77	0.726
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9714.5	F08		7	0021-0135	281.43	134.70	262	61.60	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7667.8	F08		7	0022-0140	900.77	139.76	353	73.26	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9576.8	F08		7	0023-0140	559.10	140.54	300	64.43	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8968.0	F08		7	0024-0146	372.83	146.27	317	70.18	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7622.5	F08		7	0025-0153	132.29	153.66	301	66.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8202.4	F08		7	0026-0155	245.36	155.87	315	67.84	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8964.6	F08		7	0027-0154	331.26	154.32	290	63.94	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10180.1	F08		7	0028-0159	830.05	159.13	536	87.26	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9199.9	F08		7	0029-0163	779.09	162.97	296	65.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10230.9	F08		7	0030-0173	445.86	172.75	269	62.87	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7775.1	F08		7	0031-0180	31.92	180.27	332	72.43	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9298.5	F08		7	0032-0182	770.41	182.44	294	64.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12103.4	F08		7	0033-0201	821.36	201.88	239	57.94	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11199.1	F08		7	0034-0203	154.35	202.98	230	56.53	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10528.7	F08		7	0035-0230	658.69	229.95	258	61.36	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8819.0	F08		7	0036-0236	902.31	237.44	323	75.50	0.712
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13951.6	F08		7	0037-0240	807.18	241.35	115	44.53	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9765.7	F08		7	0038-0265	518.79	264.69	312	69.26	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11547.5	F08		7	0039-0265	544.89	264.71	246	64.18	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11886.1	F08		7	0040-0268	690.63	268.72	226	56.87	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9718.4	F08		7	0041-0273	36.28	273.02	267	65.01	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9534.0	F08		7	0042-0272	803.84	272.63	286	72.08	0.692
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10970.8	F08		7	0043-0279	430.76	279.79	262	60.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7860.8	F08		7	0044-0284	235.60	284.60	328	67.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9585.1	F08		7	0045-0288	629.87	288.63	303	65.01	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8803.3	F08		7	0046-0291	776.86	291.35	339	74.67	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9525.4	F08		7	0047-0299	663.58	299.86	310	67.94	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7415.2	F08		7	0048-0307	180.09	307.59	328	67.60	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8659.0	F08		7	0049-0307	322.57	307.02	304	65.36	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12054.7	F08		7	0050-0317	748.57	316.98	227	58.18	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11913.7	F08		7	0051-0317	637.80	317.35	248	58.53	0.910
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7827.1	F08		7	0052-0333	847.17	332.72	343	70.18	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10621.7	F08		7	0053-0334	147.60	333.67	253	61.70	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9583.6	F08		7	0054-0339	491.89	339.39	291	66.53	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13386.9	F08		7	0055-0352	133.12	352.78	247	64.43	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9499.2	F08		7	0056-0355	729.67	355.23	293	63.36	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9885.4	F08		7	0057-0366	284.61	366.61	267	59.70	0.941
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9704.5	F08		7	0058-0377	900.04	377.04	305	72.18	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8207.4	F08		7	0059-0377	130.33	376.64	342	70.08	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7714.6	F08		7	0060-0382	614.20	382.79	380	73.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9279.2	F08		7	0061-0386	419.80	385.79	329	69.84	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9291.3	F08		7	0062-0384	562.34	383.61	317	66.18	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8728.7	F08		7	0063-0392	845.59	392.78	308	67.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9329.1	F08		7	0064-0396	676.19	396.86	321	68.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7939.8	F08		7	0065-0397	781.94	396.61	342	69.84	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9216.7	F08		7	0066-0399	58.99	398.31	273	63.60	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8354.0	F08		7	0067-0409	352.76	410.17	340	72.67	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9792.5	F08		7	0068-0417	292.67	417.10	285	67.84	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8883.4	F08		7	0069-0423	37.19	423.02	275	69.26	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10860.0	F08		7	0070-0419	533.04	419.50	266	63.70	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9187.4	F08		7	0071-0426	229.90	425.89	293	66.43	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9298.3	F08		7	0072-0438	885.79	438.02	319	70.77	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11886.8	F08		7	0073-0437	138.79	436.51	217	59.94	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8174.5	F08		7	0074-0443	717.99	443.46	337	69.60	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9487.6	F08		7	0075-0448	449.95	447.65	306	67.84	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12277.7	F08		7	0076-0447	484.62	447.15	225	58.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10719.3	F08		7	0077-0453	631.77	455.68	387	93.98	0.551
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12686.1	F08		7	0078-0449	298.81	448.89	269	66.43	0.766
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13969.3	F08		7	0079-0468	104.09	467.16	106	44.53	0.672
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8974.7	F08		7	0080-0479	201.56	479.53	320	69.60	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8182.7	F08		7	0081-0481	581.58	480.98	335	68.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11508.4	F08		7	0082-0486	529.78	486.59	233	58.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9462.3	F08		7	0083-0494	302.87	494.27	285	62.43	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7902.8	F08		7	0084-0495	229.49	495.57	325	68.77	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9807.7	F08		7	0085-0499	904.47	499.00	292	65.60	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8033.6	F08		7	0086-0504	28.67	504.31	308	66.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8420.0	F08		7	0087-0508	444.17	508.44	343	70.43	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9645.0	F08		7	0088-0525	890.82	525.58	277	65.70	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7985.1	F08		7	0089-0535	193.24	534.84	316	68.77	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10176.6	F08		7	0090-0539	300.64	539.10	270	63.01	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9059.1	F08		7	0091-0539	379.44	538.81	304	65.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10204.0	F08		7	0092-0542	25.51	542.80	256	64.43	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12508.7	F08		7	0093-0549	343.44	548.80	214	55.70	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10792.8	F08		7	0094-0552	637.08	552.27	261	60.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9867.7	F08		7	0095-0574	164.62	573.41	429	86.08	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12367.8	F08		7	0096-0571	672.22	571.83	228	55.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9905.2	F08		7	0097-0573	507.45	573.46	280	63.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9301.4	F08		7	0098-0581	822.58	581.20	290	67.26	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6413.3	F08		7	0099-0592	714.37	592.57	393	83.74	0.704
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11342.7	F08		7	0100-0604	631.20	604.27	236	60.18	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8993.3	F08		7	0101-0615	95.84	614.75	325	69.36	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9513.5	F08		7	0102-0617	583.01	617.18	308	67.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7684.3	F08		7	0103-0632	208.27	633.24	340	68.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12539.8	F08		7	0104-0635	394.14	634.30	172	52.53	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10635.1	F08		7	0105-0642	602.53	640.54	365	120.71	0.315
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12021.2	F08		7	0106-0646	152.95	645.38	213	59.94	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10461.6	F08		7	0107-0649	403.03	649.67	189	54.53	0.799
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14526.7	F08		7	0108-0646	479.26	645.61	195	67.60	0.536
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9612.0	F08		7	0109-0654	434.14	654.28	282	62.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10537.3	F08		7	0110-0661	551.17	661.16	255	58.53	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8028.0	F08		7	0111-0676	429.53	676.20	341	69.50	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10738.2	F08		7	0112-0674	830.80	674.11	271	65.60	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8363.1	F08		7	0113-0679	201.81	678.48	306	66.67	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9036.5	F08		7	0114-0686	459.50	686.25	297	67.01	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9769.3	F08		7	0115-0687	594.89	687.09	301	69.36	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11366.3	F08		7	0116-0700	860.31	700.06	228	58.77	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185400	1375351	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6484.1	F08		7	0117-0712	829.75	712.75	159	50.04	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11016.3	F08		8	0001-0033	547.49	33.04	276	63.36	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10311.1	F08		8	0002-0039	390.98	39.49	312	68.87	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7741.2	F08		8	0003-0040	117.38	39.09	364	73.84	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11070.4	F08		8	0004-0043	468.83	43.14	273	63.60	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7850.6	F08		8	0005-0051	61.97	51.24	324	67.60	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10098.2	F08		8	0006-0057	813.53	56.57	270	65.60	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8869.1	F08		8	0007-0061	423.49	62.30	351	70.67	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10355.8	F08		8	0008-0063	351.36	64.01	288	63.94	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11872.8	F08		8	0009-0073	188.66	73.62	234	58.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11591.6	F08		8	0010-0078	534.60	77.39	546	85.74	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8478.8	F08		8	0011-0090	591.13	91.05	359	73.84	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9278.8	F08		8	0012-0093	27.34	92.73	300	71.60	0.735
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8106.6	F08		8	0013-0098	151.25	98.63	321	70.18	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10978.9	F08		8	0014-0094	862.10	94.33	251	58.77	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9539.9	F08		8	0015-0107	399.16	107.89	351	69.60	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8845.8	F08		8	0016-0116	77.68	116.31	300	65.60	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9199.9	F08		8	0017-0119	94.58	118.73	270	66.18	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8459.8	F08		8	0018-0117	144.91	118.43	327	67.94	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9345.0	F08		8	0019-0126	297.21	126.26	313	66.77	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11057.8	F08		8	0020-0127	571.17	127.19	260	64.67	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8737.0	F08		8	0021-0132	461.59	131.56	320	67.60	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12903.9	F08		8	0022-0137	524.65	137.50	266	61.46	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7790.7	F08		8	0023-0143	182.96	143.82	360	72.18	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9725.6	F08		8	0024-0144	858.72	143.84	286	62.53	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7418.8	F08		8	0025-0148	116.34	148.61	341	68.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13364.2	F08		8	0026-0148	631.03	147.91	212	54.53	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7946.5	F08		8	0027-0163	384.92	163.20	349	70.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11093.4	F08		8	0028-0162	498.33	161.44	241	60.77	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8639.2	F08		8	0029-0179	255.75	179.69	303	66.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8816.7	F08		8	0030-0193	903.86	192.59	363	77.60	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8039.6	F08		8	0031-0192	128.31	192.14	319	68.77	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10221.7	F08		8	0032-0198	834.68	198.26	273	61.36	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9552.3	F08		8	0033-0199	509.73	199.88	314	73.60	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8227.1	F08		8	0034-0200	934.39	200.06	339	68.77	0.901
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8821.3	F08		8	0035-0203	451.50	203.05	309	66.77	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10666.4	F08		8	0036-0212	809.27	211.52	260	59.94	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8624.8	F08		8	0037-0212	298.17	211.31	305	67.36	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7200.6	F08		8	0038-0219	171.70	218.50	349	70.18	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7569.9	F08		8	0039-0233	637.45	233.56	392	80.67	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9249.7	F08		8	0040-0231	389.44	231.39	302	67.36	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11317.4	F08		8	0041-0237	69.26	237.61	245	60.43	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9851.6	F08		8	0042-0246	216.23	246.26	271	64.43	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11326.8	F08		8	0043-0252	368.24	252.48	258	60.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8957.7	F08		8	0044-0255	555.78	254.76	308	67.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7551.1	F08		8	0045-0255	786.48	254.80	372	71.60	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9117.2	F08		8	0046-0255	269.76	254.60	284	66.43	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8419.3	F08		8	0047-0254	91.96	254.52	319	73.70	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11248.1	F08		8	0048-0259	345.30	258.91	262	60.77	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7396.2	F08		8	0049-0267	175.50	267.03	342	69.60	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9171.2	F08		8	0050-0268	413.70	268.21	323	71.50	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8405.9	F08		8	0051-0269	476.36	269.60	262	62.87	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8625.2	F08		8	0052-0267	608.28	266.91	333	69.01	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11398.4	F08		8	0053-0276	824.72	276.05	241	71.26	0.596
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8570.9	F08		8	0054-0280	327.52	280.38	308	69.94	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9564.2	F08		8	0055-0286	908.01	285.70	313	68.53	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9008.9	F08		8	0056-0287	257.30	287.08	289	64.18	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9453.3	F08		8	0057-0296	114.24	295.98	271	60.28	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8638.5	F08		8	0058-0301	527.71	301.18	325	70.43	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7492.4	F08		8	0059-0303	773.32	302.44	372	73.26	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10193.4	F08		8	0060-0301	67.03	300.89	265	60.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8540.8	F08		8	0061-0306	726.59	306.20	334	67.60	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7761.7	F08		8	0062-0307	454.46	307.65	280	64.77	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7843.7	F08		8	0063-0312	484.66	310.84	355	71.01	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9031.0	F08		8	0064-0309	802.16	310.13	312	67.01	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9095.5	F08		8	0065-0309	596.25	308.86	334	68.77	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8632.5	F08		8	0066-0316	693.21	316.50	327	69.94	0.840
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12774.0	F08		8	0067-0314	860.26	314.34	217	55.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9333.6	F08		8	0068-0321	66.27	321.41	288	64.18	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8050.9	F08		8	0069-0340	518.16	340.62	344	70.18	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8424.1	F08		8	0070-0341	265.73	342.16	331	68.18	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8900.6	F08		8	0071-0351	434.28	351.13	305	66.53	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7713.0	F08		8	0072-0351	157.55	350.65	335	67.60	0.921
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8596.5	F08		8	0073-0357	716.82	357.73	333	68.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11502.1	F08		8	0074-0359	201.87	358.41	290	62.18	0.942
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9309.3	F08		8	0075-0364	109.18	363.74	280	62.77	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10636.3	F08		8	0076-0362	599.31	361.65	263	64.53	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9665.9	F08		8	0077-0367	693.55	366.93	294	66.18	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9000.0	F08		8	0078-0368	311.75	368.05	298	66.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7504.9	F08		8	0079-0377	779.65	376.56	371	72.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8337.5	F08		8	0080-0388	69.99	388.89	308	67.60	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7696.8	F08		8	0081-0390	343.64	390.06	371	73.84	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11022.5	F08		8	0082-0386	263.47	386.26	253	61.11	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6777.1	F08		8	0083-0391	908.93	390.40	404	73.60	0.937
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10159.2	F08		8	0084-0391	611.42	391.77	274	69.50	0.713
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8571.1	F08		8	0085-0394	117.33	393.86	319	67.60	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11006.2	F08		8	0086-0399	228.50	398.65	247	60.53	0.847
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12622.6	F08		8	0087-0408	842.54	408.45	219	54.63	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7906.9	F08		8	0088-0416	556.27	416.95	354	69.60	0.918
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7773.8	F08		8	0089-0420	159.54	420.41	357	71.50	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10155.7	F08		8	0090-0423	731.25	422.91	279	63.01	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11136.5	F08		8	0091-0428	804.60	428.93	253	61.36	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8519.7	F08		8	0092-0436	487.98	436.01	325	66.77	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8446.4	F08		8	0093-0438	450.52	438.13	320	69.84	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11970.5	F08		8	0094-0441	747.09	440.58	241	61.11	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8469.7	F08		8	0095-0449	897.52	449.38	338	69.84	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10766.4	F08		8	0096-0449	761.52	449.23	256	62.53	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7679.5	F08		8	0097-0454	127.49	454.78	354	70.18	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8428.0	F08		8	0098-0459	837.61	458.78	342	69.84	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9716.7	F08		8	0099-0464	52.51	464.29	258	63.01	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10117.1	F08		8	0100-0475	743.13	475.27	277	63.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8092.4	F08		8	0101-0501	414.64	501.00	335	69.60	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8588.1	F08		8	0102-0507	566.44	507.64	333	69.60	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8855.7	F08		8	0103-0514	374.99	514.14	306	65.94	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6515.3	F08		8	0104-0513	334.32	513.20	159	48.53	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6771.1	F08		8	0105-0524	327.91	524.49	200	53.94	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10184.1	F08		8	0106-0524	268.31	524.45	261	62.53	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10455.2	F08		8	0107-0531	853.53	531.31	273	60.77	0.929
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7769.9	F08		8	0108-0535	604.96	534.87	366	72.18	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8753.4	F08		8	0109-0571	800.98	571.40	335	71.01	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8968.9	F08		8	0110-0569	210.82	568.62	319	65.60	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9879.6	F08		8	0111-0577	472.98	576.95	286	63.60	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9264.1	F08		8	0112-0581	98.85	581.31	272	62.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6911.8	F08		8	0113-0580	145.09	579.96	365	73.01	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8578.7	F08		8	0114-0590	882.83	590.92	326	71.26	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8961.2	F08		8	0115-0597	725.29	596.96	315	68.18	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7817.0	F08		8	0116-0597	624.95	597.75	362	73.26	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11364.7	F08		8	0117-0611	935.55	610.24	234	62.43	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7390.7	F08		8	0118-0618	164.12	619.05	342	69.84	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7726.5	F08		8	0119-0619	390.63	619.56	358	72.18	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6879.8	F08		8	0120-0624	311.05	624.35	393	74.53	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7619.3	F08		8	0121-0633	257.00	633.60	354	72.18	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11617.9	F08		8	0122-0629	887.85	629.27	229	59.36	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8883.4	F08		8	0123-0631	485.97	631.58	369	71.60	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6570.2	F08		8	0124-0644	205.67	643.32	267	76.91	0.567
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7977.1	F08		8	0125-0646	113.81	646.09	315	68.28	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9041.7	F08		8	0126-0648	646.66	648.33	311	64.77	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10475.9	F08		8	0127-0652	188.70	652.10	313	72.77	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12574.2	F08		8	0128-0662	807.99	662.37	371	72.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8924.3	F08		8	0129-0679	279.00	679.25	308	66.77	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9731.5	F08		8	0130-0681	511.91	681.69	286	62.77	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10580.6	F08		8	0131-0683	818.41	683.45	254	62.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7913.8	F08		8	0132-0700	318.53	700.43	351	71.84	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10271.7	F08		8	0133-0700	869.85	700.89	257	62.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8312.6	F08		8	0134-0703	138.26	703.54	301	64.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185401	1375352	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7915.8	F08		8	0135-0707	51.06	707.80	312	67.60	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7863.0	F08		9	0001-0027	112.91	26.93	344	68.77	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10208.4	F08		9	0002-0032	250.70	31.94	275	63.11	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8760.6	F08		9	0003-0037	590.02	36.73	360	76.08	0.782
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9496.5	F08		9	0004-0035	182.72	34.71	298	68.18	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11595.5	F08		9	0005-0039	511.18	38.74	272	60.53	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11008.3	F08		9	0006-0052	462.31	52.06	326	68.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8658.9	F08		9	0007-0061	289.42	61.34	340	69.84	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8183.2	F08		9	0008-0060	744.10	60.15	375	75.84	0.819
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10577.6	F08		9	0009-0059	539.40	60.03	288	63.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10792.5	F08		9	0010-0067	666.69	67.26	265	60.77	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9249.1	F08		9	0011-0067	106.69	66.90	298	65.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9024.4	F08		9	0012-0074	577.54	74.11	328	69.36	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8761.7	F08		9	0013-0085	351.37	85.44	320	68.77	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7349.0	F08		9	0014-0091	628.73	91.14	393	77.01	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9957.7	F08		9	0015-0103	150.33	103.48	271	69.26	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6200.1	F08		9	0016-0108	400.39	108.07	454	80.67	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10557.1	F08		9	0017-0105	858.93	105.72	285	66.53	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8994.5	F08		9	0018-0113	289.82	113.21	327	67.60	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11751.9	F08		9	0019-0109	606.04	109.78	240	56.53	0.944
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12467.8	F08		9	0020-0117	768.48	117.04	247	62.77	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7177.9	F08		9	0021-0125	539.18	124.32	438	80.67	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11749.0	F08		9	0022-0121	873.87	121.45	166	52.53	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9460.7	F08		9	0023-0127	260.01	127.38	302	67.01	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8711.8	F08		9	0024-0138	476.79	138.03	340	71.60	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8267.7	F08		9	0025-0149	319.13	148.94	327	67.11	0.912
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10431.7	F08		9	0026-0148	749.13	148.30	298	66.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9643.6	F08		9	0027-0158	503.51	157.38	320	73.60	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10191.2	F08		9	0028-0161	88.66	161.07	266	64.91	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10984.3	F08		9	0029-0159	241.91	159.07	237	59.01	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12100.4	F08		9	0030-0167	191.21	167.88	216	55.36	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9495.8	F08		9	0031-0175	444.89	175.23	302	65.11	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	22565.7	F08		9	0032-0173	811.23	174.00	102	37.46	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11429.0	F08		9	0033-0186	771.64	186.50	258	63.36	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10581.8	F08		9	0034-0192	90.66	192.61	247	62.18	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9750.4	F08		9	0035-0195	168.87	195.46	266	68.77	0.707
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11782.7	F08		9	0036-0192	373.20	191.67	246	60.77	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11668.5	F08		9	0037-0199	632.74	199.12	474	83.26	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7599.2	F08		9	0038-0200	943.12	200.57	395	77.50	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8043.9	F08		9	0039-0204	909.33	203.92	372	77.84	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7864.7	F08		9	0040-0203	29.78	202.97	327	68.18	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9745.9	F08		9	0041-0216	678.42	216.04	314	73.01	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11135.1	F08		9	0042-0214	529.80	214.47	277	61.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8895.7	F08		9	0043-0235	813.79	235.09	281	65.01	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10346.8	F08		9	0044-0237	767.12	236.64	289	67.84	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8594.2	F08		9	0045-0242	731.53	242.09	337	71.36	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10175.0	F08		9	0046-0239	229.65	240.27	253	58.87	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10453.8	F08		9	0047-0249	661.57	249.17	263	64.77	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8728.6	F08		9	0048-0252	46.14	252.59	303	63.94	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10117.3	F08		9	0049-0253	277.61	253.04	272	61.36	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8335.0	F08		9	0050-0260	938.09	260.43	364	71.50	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10042.1	F08		9	0051-0257	230.00	257.15	285	65.70	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9672.5	F08		9	0052-0266	426.54	266.69	295	65.01	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10859.2	F08		9	0053-0266	532.37	266.41	288	62.77	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8701.2	F08		9	0054-0275	141.22	275.50	320	67.01	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7278.2	F08		9	0055-0280	890.30	279.55	407	79.26	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10044.3	F08		9	0056-0282	381.39	281.55	283	62.18	0.920
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9360.0	F08		9	0057-0285	623.90	284.88	302	67.84	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10464.8	F08		9	0058-0298	223.21	298.43	264	59.60	0.934
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10449.2	F08		9	0059-0308	484.54	308.19	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8558.6	F08		9	0060-0313	56.31	313.12	372	74.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9256.0	F08		9	0061-0322	259.07	322.01	308	67.01	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9930.4	F08		9	0062-0327	728.12	326.58	310	69.36	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8356.6	F08		9	0063-0334	925.85	333.62	351	70.43	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8550.8	F08		9	0064-0333	831.25	333.40	333	69.26	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10080.8	F08		9	0065-0341	545.88	341.42	289	63.36	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9485.4	F08		9	0066-0341	871.51	341.54	301	64.43	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7286.8	F08		9	0067-0346	43.39	345.92	356	69.01	0.939
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8222.4	F08		9	0068-0350	225.43	350.33	358	73.26	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10843.4	F08		9	0069-0364	425.99	364.39	291	69.36	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9298.0	F08		9	0070-0363	784.03	363.41	333	68.77	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7946.1	F08		9	0071-0368	75.81	368.43	329	66.77	0.927
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7985.0	F08		9	0072-0370	728.14	370.19	368	71.84	0.896
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7575.3	F08		9	0073-0377	675.67	377.52	431	94.81	0.603
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11201.2	F08		9	0074-0384	562.15	380.29	405	96.47	0.547
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7488.2	F08		9	0075-0380	839.73	380.27	381	72.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9708.5	F08		9	0076-0395	607.01	394.57	312	70.67	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10798.0	F08		9	0077-0401	333.46	400.98	249	60.53	0.854
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10115.5	F08		9	0078-0401	429.53	401.57	283	62.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12833.2	F08		9	0079-0413	477.40	413.11	239	58.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9419.7	F08		9	0080-0418	752.22	417.97	326	67.94	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8348.4	F08		9	0081-0423	108.15	423.49	312	66.77	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8242.9	F08		9	0082-0422	136.76	422.43	323	67.84	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10652.1	F08		9	0083-0431	926.94	431.35	264	63.70	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9846.0	F08		9	0084-0436	663.61	435.45	326	68.77	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9710.2	F08		9	0085-0441	846.39	442.19	308	68.67	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8471.1	F08		9	0086-0453	788.02	452.55	346	70.43	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9037.8	F08		9	0087-0457	627.33	457.38	328	68.18	0.887
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10149.2	F08		9	0088-0460	250.17	459.58	271	62.18	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11122.8	F08		9	0089-0460	360.06	459.62	272	61.36	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8234.4	F08		9	0090-0466	762.09	465.46	350	71.01	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9859.0	F08		9	0091-0473	583.58	473.73	297	64.18	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10222.8	F08		9	0092-0483	354.63	482.60	295	64.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10521.8	F08		9	0093-0490	838.00	490.06	300	64.77	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9033.8	F08		9	0094-0496	656.41	496.27	342	72.53	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9951.8	F08		9	0095-0495	418.64	495.14	284	62.77	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9346.6	F08		9	0096-0498	792.53	497.76	331	69.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8184.6	F08		9	0097-0496	774.17	495.84	350	71.94	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9580.4	F08		9	0098-0499	52.74	498.30	283	62.43	0.913
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10690.9	F08		9	0099-0501	727.06	500.76	271	61.94	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10916.8	F08		9	0100-0505	207.71	504.91	249	58.18	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9783.8	F08		9	0101-0521	78.62	521.30	261	65.01	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7855.0	F08		9	0102-0521	614.23	521.50	371	70.18	0.946
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9978.0	F08		9	0103-0525	681.54	525.40	290	65.36	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9903.6	F08		9	0104-0524	710.85	524.45	293	63.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8597.0	F08		9	0105-0536	359.76	536.61	335	68.43	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8310.2	F08		9	0106-0539	624.88	539.71	358	72.08	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10144.0	F08		9	0107-0545	414.30	545.05	278	68.08	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9558.6	F08		9	0108-0543	740.94	544.00	305	65.94	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8683.6	F08		9	0109-0551	127.64	551.73	323	70.67	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10136.9	F08		9	0110-0555	376.56	555.19	274	60.77	0.932
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8120.3	F08		9	0111-0559	311.67	559.17	348	69.60	0.903
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10064.0	F08		9	0112-0570	464.67	570.15	303	67.60	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10552.9	F08		9	0113-0577	227.99	580.26	291	83.15	0.529
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8779.9	F08		9	0114-0584	723.59	584.53	331	68.67	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9137.6	F08		9	0115-0592	144.52	592.32	318	69.26	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9035.8	F08		9	0116-0591	674.89	590.99	317	66.53	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8518.3	F08		9	0117-0600	594.64	600.11	339	70.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9212.4	F08		9	0118-0599	296.56	598.65	303	67.84	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8094.3	F08		9	0119-0597	805.83	597.68	333	75.84	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9641.3	F08		9	0120-0602	928.18	602.38	277	62.77	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9131.0	F08		9	0121-0606	412.90	606.62	306	66.77	0.863
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8591.7	F08		9	0122-0607	466.79	607.03	331	67.84	0.904
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10990.7	F08		9	0123-0613	30.57	613.25	236	60.77	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11360.8	F08		9	0124-0615	239.99	615.89	244	63.94	0.750
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8905.1	F08		9	0125-0617	908.56	617.47	303	66.53	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	6321.0	F08		9	0126-0625	671.13	625.54	417	79.26	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11057.4	F08		9	0127-0638	544.10	637.32	277	67.01	0.775
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8231.6	F08		9	0128-0648	205.49	647.63	330	67.60	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9185.1	F08		9	0129-0652	501.09	652.73	310	66.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8715.8	F08		9	0130-0658	185.37	657.89	315	67.84	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9572.9	F08		9	0131-0664	921.81	663.93	269	61.11	0.905
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10069.3	F08		9	0132-0667	677.49	666.70	275	62.18	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9909.7	F08		9	0133-0671	770.94	672.08	269	66.18	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9916.3	F08		9	0134-0674	398.05	674.25	276	63.36	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8484.3	F08		9	0135-0680	852.31	679.91	486	84.67	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9148.5	F08		9	0136-0682	319.34	683.00	307	65.60	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	1	uM	48	hr	1185402	1375353	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10108.2	F08		9	0137-0685	378.24	685.79	273	61.36	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10577.5	G08		1	0001-0032	204.59	33.10	257	63.01	0.813
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13526.2	G08		1	0002-0042	496.41	42.05	229	59.11	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8559.6	G08		1	0003-0056	98.31	56.55	335	72.08	0.810
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9114.2	G08		1	0004-0065	935.15	65.24	324	68.43	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11187.2	G08		1	0005-0075	282.41	75.08	268	64.04	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8572.2	G08		1	0006-0076	711.31	75.89	364	71.60	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12809.5	G08		1	0007-0083	664.99	83.53	405	80.57	0.784
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9046.7	G08		1	0008-0092	730.56	92.42	348	71.01	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13632.9	G08		1	0009-0092	567.38	92.61	154	68.43	0.413
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11304.9	G08		1	0010-0096	262.76	96.42	254	69.26	0.665
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9599.2	G08		1	0011-0100	77.40	101.22	295	66.18	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9457.2	G08		1	0012-0106	712.96	105.19	322	72.33	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14708.7	G08		1	0013-0107	844.87	105.02	171	73.50	0.398
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9722.6	G08		1	0014-0122	896.06	121.71	302	66.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9897.5	G08		1	0015-0194	835.35	194.66	279	62.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15195.5	G08		1	0016-0199	185.62	199.26	102	39.21	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13226.3	G08		1	0017-0225	584.08	224.71	214	58.04	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12612.8	G08		1	0018-0242	806.26	241.74	215	62.04	0.702
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11012.7	G08		1	0019-0268	829.39	268.12	262	59.36	0.935
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11639.2	G08		1	0020-0280	887.64	280.48	237	60.28	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12202.7	G08		1	0021-0288	639.34	288.26	221	57.94	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10989.3	G08		1	0022-0302	32.27	302.53	235	64.18	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13631.8	G08		1	0023-0306	478.27	306.20	195	58.18	0.724
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10075.2	G08		1	0024-0323	657.51	324.42	284	64.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10624.6	G08		1	0025-0343	280.32	343.85	258	62.53	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12632.5	G08		1	0026-0365	47.51	365.09	214	54.87	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12712.1	G08		1	0027-0369	350.54	368.34	227	62.87	0.722
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12077.2	G08		1	0028-0364	510.31	363.63	226	58.77	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10377.3	G08		1	0029-0367	623.42	366.98	274	63.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14095.3	G08		1	0030-0365	742.98	365.12	193	57.36	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11785.7	G08		1	0031-0368	147.46	368.35	242	61.36	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11825.5	G08		1	0032-0373	306.88	373.44	229	61.11	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11652.6	G08		1	0033-0383	675.69	383.47	240	63.11	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10052.1	G08		1	0034-0389	935.70	389.37	282	67.60	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13296.2	G08		1	0035-0407	210.27	407.15	209	58.77	0.760
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12618.6	G08		1	0036-0414	70.13	414.26	215	57.70	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12537.9	G08		1	0037-0416	890.73	415.95	225	57.70	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10770.9	G08		1	0038-0438	666.57	438.67	262	64.53	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15303.7	G08		1	0039-0444	858.60	443.31	109	75.98	0.237
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13472.8	G08		1	0040-0457	419.20	458.00	233	57.36	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11715.4	G08		1	0041-0462	730.98	462.08	237	61.94	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12660.1	G08		1	0042-0498	314.58	498.27	227	59.60	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9475.5	G08		1	0043-0524	563.97	524.23	303	66.18	0.869
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12249.6	G08		1	0044-0527	829.85	527.56	240	62.77	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13243.3	G08		1	0045-0536	719.53	536.54	205	58.18	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11044.5	G08		1	0046-0539	360.16	539.84	277	72.43	0.664
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10369.6	G08		1	0047-0539	688.61	539.21	272	60.77	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13559.4	G08		1	0048-0541	636.49	541.13	202	54.18	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10033.6	G08		1	0049-0548	12.47	547.60	261	61.36	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12602.9	G08		1	0050-0558	95.67	558.64	212	58.18	0.787
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9377.6	G08		1	0051-0568	648.28	568.31	304	68.18	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9627.0	G08		1	0052-0569	834.65	569.67	293	66.43	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10964.7	G08		1	0053-0605	697.52	605.52	252	58.77	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8499.3	G08		1	0054-0610	547.24	610.47	328	69.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13705.6	G08		1	0055-0610	598.30	610.74	166	53.94	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13565.5	G08		1	0056-0639	326.67	638.87	198	53.11	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13101.2	G08		1	0057-0697	329.28	697.00	230	59.84	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185242	1375354	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11355.8	G08		1	0058-0706	735.74	705.51	250	73.60	0.580
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12190.0	G08		2	0001-0033	490.85	32.69	260	66.28	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8833.3	G08		2	0002-0065	39.68	65.16	334	70.43	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9311.3	G08		2	0003-0071	263.62	70.95	321	73.26	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10170.5	G08		2	0004-0104	246.65	104.64	292	75.50	0.644
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10160.7	G08		2	0005-0207	403.66	206.99	276	68.18	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12737.8	G08		2	0006-0218	447.01	218.02	223	66.43	0.635
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13881.7	G08		2	0007-0233	670.79	232.76	279	104.81	0.319
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9039.1	G08		2	0008-0248	396.52	248.61	314	69.84	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12911.0	G08		2	0009-0248	449.88	249.51	100	47.46	0.558
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13857.8	G08		2	0010-0282	915.46	282.98	120	50.77	0.585
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9566.9	G08		2	0011-0354	665.79	353.71	302	68.18	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9596.3	G08		2	0012-0389	40.48	389.26	286	68.18	0.773
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12208.8	G08		2	0013-0396	667.73	395.75	228	57.01	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10516.5	G08		2	0014-0408	655.79	407.55	276	66.08	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10756.2	G08		2	0015-0409	559.15	408.44	277	64.18	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9378.9	G08		2	0016-0459	258.19	459.85	306	66.18	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12050.3	G08		2	0017-0511	49.96	511.64	225	57.70	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10209.4	G08		2	0018-0515	114.80	515.24	268	63.60	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12036.4	G08		2	0019-0613	133.89	613.28	223	60.53	0.765
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11398.4	G08		2	0020-0618	504.01	618.58	259	63.36	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9576.7	G08		2	0021-0635	637.25	635.23	302	66.53	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9928.5	G08		2	0022-0639	285.94	639.91	297	66.18	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10207.3	G08		2	0023-0644	591.27	644.02	278	63.70	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9687.2	G08		2	0024-0650	538.77	650.29	296	64.53	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9746.3	G08		2	0025-0654	224.91	653.80	279	63.70	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9006.3	G08		2	0026-0669	100.45	669.38	299	65.36	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8420.7	G08		2	0027-0672	582.47	672.12	374	76.08	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10334.4	G08		2	0028-0672	305.14	673.35	281	64.53	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20452.7	G08		2	0029-0686	316.60	686.53	125	45.11	0.772
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9568.4	G08		2	0030-0691	559.22	690.33	333	73.01	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10145.1	G08		2	0031-0697	615.07	697.26	277	62.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185243	1375355	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	20793.6	G08		2	0032-0703	912.12	702.79	115	40.28	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14627.9	G08		3	0001-0051	392.71	51.40	201	55.36	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10517.6	G08		3	0002-0075	222.13	75.24	244	59.36	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10643.4	G08		3	0003-0084	824.96	84.25	264	61.94	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10829.0	G08		3	0004-0098	283.01	98.19	236	61.26	0.790
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12979.0	G08		3	0005-0107	865.02	107.68	209	59.26	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12835.4	G08		3	0006-0109	428.96	108.97	213	54.53	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14666.5	G08		3	0007-0117	337.10	117.22	177	52.18	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11885.8	G08		3	0008-0120	858.06	120.25	224	55.94	0.899
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18183.5	G08		3	0009-0140	463.15	140.84	127	57.60	0.481
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11525.7	G08		3	0010-0154	925.91	153.92	225	57.36	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9706.6	G08		3	0011-0159	132.00	159.59	256	62.53	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8702.7	G08		3	0012-0161	248.69	161.09	118	40.28	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8560.2	G08		3	0013-0170	238.79	170.81	151	46.53	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13619.8	G08		3	0014-0176	428.50	176.01	204	58.18	0.757
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10237.7	G08		3	0015-0181	503.87	181.33	291	66.77	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15732.1	G08		3	0016-0180	529.81	180.56	171	50.53	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15177.8	G08		3	0017-0197	582.62	198.37	177	56.18	0.705
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12730.1	G08		3	0018-0200	927.92	200.57	216	59.60	0.764
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17910.0	G08		3	0019-0218	416.36	218.30	165	50.04	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15013.6	G08		3	0020-0225	645.39	226.73	372	80.08	0.729
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10121.3	G08		3	0021-0230	534.48	231.10	267	63.26	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9000.7	G08		3	0022-0244	246.67	242.06	190	58.87	0.689
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11994.7	G08		3	0023-0252	396.23	252.19	223	54.53	0.943
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10076.9	G08		3	0024-0254	528.93	254.27	270	65.01	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8496.6	G08		3	0025-0258	249.56	257.64	117	41.70	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8568.5	G08		3	0026-0275	172.46	274.70	276	67.84	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10559.6	G08		3	0027-0281	631.58	281.17	262	59.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13399.3	G08		3	0028-0283	13.67	282.64	191	56.77	0.745
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12042.4	G08		3	0029-0291	854.26	290.53	224	59.60	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12812.3	G08		3	0030-0303	103.18	303.57	207	57.36	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17119.5	G08		3	0031-0312	777.94	311.63	151	51.46	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12616.2	G08		3	0032-0322	487.29	322.50	214	56.77	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10716.8	G08		3	0033-0343	170.81	343.65	233	58.28	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12789.8	G08		3	0034-0384	852.19	384.44	220	55.36	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11203.6	G08		3	0035-0385	203.48	384.96	224	61.70	0.739
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10191.4	G08		3	0036-0396	810.66	396.52	284	63.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10722.2	G08		3	0037-0402	50.40	402.63	241	60.77	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11280.9	G08		3	0038-0407	742.68	408.20	266	64.18	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10355.7	G08		3	0039-0408	893.26	407.85	285	67.26	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12408.3	G08		3	0040-0454	910.50	453.38	237	58.77	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10860.4	G08		3	0041-0486	783.43	486.83	257	62.18	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11831.0	G08		3	0042-0489	453.81	489.03	234	57.36	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10908.0	G08		3	0043-0499	369.03	498.82	247	60.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10940.1	G08		3	0044-0535	663.85	535.40	257	62.87	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11640.7	G08		3	0045-0539	343.31	539.41	471	89.74	0.735
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15594.1	G08		3	0046-0531	785.86	531.44	177	51.11	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10881.5	G08		3	0047-0549	945.50	548.90	266	68.63	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8386.5	G08		3	0048-0558	808.51	557.74	322	68.18	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14867.1	G08		3	0049-0560	315.90	559.69	220	93.40	0.317
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10090.3	G08		3	0050-0565	444.93	564.88	283	66.18	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11494.6	G08		3	0051-0575	624.95	575.22	373	72.18	0.900
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10307.8	G08		3	0052-0581	325.62	582.28	262	61.94	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8990.6	G08		3	0053-0609	835.51	610.13	302	66.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13378.3	G08		3	0054-0645	276.97	644.96	208	56.87	0.808
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10274.9	G08		3	0055-0663	699.65	662.76	264	65.36	0.777
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12233.0	G08		3	0056-0664	832.78	663.96	216	59.84	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12170.8	G08		3	0057-0666	97.42	666.26	212	53.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185244	1375356	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10242.3	G08		3	0058-0670	618.50	669.36	259	66.43	0.738
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13363.7	G08		4	0001-0035	57.39	34.95	202	56.77	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10481.5	G08		4	0002-0036	140.39	36.89	263	67.26	0.731
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9898.5	G08		4	0003-0065	897.16	64.19	268	63.26	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11618.5	G08		4	0004-0069	704.73	69.69	260	63.70	0.805
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10343.2	G08		4	0005-0087	675.87	87.02	277	61.70	0.914
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10312.7	G08		4	0006-0092	168.03	92.02	326	72.91	0.771
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10812.7	G08		4	0007-0097	488.16	97.07	264	62.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11324.6	G08		4	0008-0106	695.79	107.02	267	67.26	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11311.5	G08		4	0009-0129	134.25	130.00	186	56.87	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12012.8	G08		4	0010-0144	683.46	144.16	250	68.77	0.664
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10871.3	G08		4	0011-0184	270.60	185.09	156	47.46	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10391.1	G08		4	0012-0184	258.83	184.32	117	42.63	0.809
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11593.6	G08		4	0013-0198	252.47	198.14	271	61.60	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9614.4	G08		4	0014-0202	271.16	202.46	228	62.77	0.727
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12853.6	G08		4	0015-0222	683.17	222.21	211	63.60	0.656
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10568.7	G08		4	0016-0223	626.05	223.64	268	61.60	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8126.8	G08		4	0017-0230	296.16	230.32	363	80.67	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10938.8	G08		4	0018-0236	870.80	235.72	251	60.53	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14062.3	G08		4	0019-0248	297.88	248.35	171	67.84	0.467
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11864.5	G08		4	0020-0251	61.22	251.90	222	54.77	0.930
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10725.5	G08		4	0021-0252	929.07	252.31	258	60.77	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10891.9	G08		4	0022-0261	757.81	261.64	281	65.01	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12395.0	G08		4	0023-0260	858.20	260.13	218	61.70	0.720
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11300.3	G08		4	0024-0273	154.52	273.23	239	64.53	0.721
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9627.5	G08		4	0025-0274	848.11	274.54	288	65.94	0.832
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13533.4	G08		4	0026-0278	57.57	278.85	196	52.53	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12609.9	G08		4	0027-0290	821.95	289.82	232	58.53	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8827.7	G08		4	0028-0297	30.71	296.88	302	66.77	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15326.8	G08		4	0029-0300	383.48	300.35	174	49.11	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13867.2	G08		4	0030-0308	258.64	308.85	209	57.60	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10544.6	G08		4	0031-0310	101.43	310.42	257	62.53	0.826
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10343.7	G08		4	0032-0312	542.78	311.58	301	68.77	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12252.8	G08		4	0033-0325	554.36	324.38	243	67.01	0.680
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13924.4	G08		4	0034-0343	635.95	342.84	195	59.01	0.704
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14748.2	G08		4	0035-0351	370.80	351.24	187	53.70	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8335.0	G08		4	0036-0350	928.55	349.11	162	51.94	0.755
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8654.2	G08		4	0037-0355	938.44	356.34	139	44.28	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12883.6	G08		4	0038-0361	218.64	361.70	202	57.11	0.778
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14240.2	G08		4	0039-0373	278.48	373.34	189	51.46	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15516.0	G08		4	0040-0382	801.04	382.03	194	55.70	0.786
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10741.7	G08		4	0041-0388	284.57	388.10	256	62.53	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9787.4	G08		4	0042-0391	415.82	392.06	295	67.36	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10992.7	G08		4	0043-0390	53.66	390.17	240	60.18	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9699.6	G08		4	0044-0393	267.09	393.23	290	67.26	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12559.6	G08		4	0045-0401	830.60	401.78	210	53.94	0.907
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11760.1	G08		4	0046-0420	198.06	419.82	219	57.46	0.834
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10822.1	G08		4	0047-0424	944.84	423.39	270	62.77	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10808.7	G08		4	0048-0440	392.04	441.07	265	65.84	0.768
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12942.6	G08		4	0049-0447	554.05	446.96	215	56.18	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13476.3	G08		4	0050-0446	249.81	446.92	191	53.11	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11771.3	G08		4	0051-0477	904.87	477.53	234	57.70	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10278.4	G08		4	0052-0487	80.59	487.68	262	62.77	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13524.9	G08		4	0053-0502	230.11	501.89	197	53.46	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17621.8	G08		4	0054-0517	391.63	517.07	253	75.60	0.556
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12511.1	G08		4	0055-0521	120.17	521.56	214	55.36	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11037.9	G08		4	0056-0523	287.43	523.01	270	63.60	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12193.5	G08		4	0057-0530	144.08	530.84	219	55.46	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14192.9	G08		4	0058-0560	596.96	558.50	392	91.74	0.585
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14653.9	G08		4	0059-0564	877.39	564.54	192	51.11	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11174.4	G08		4	0060-0577	810.69	577.11	389	74.43	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10638.7	G08		4	0061-0591	113.98	591.55	247	59.94	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9838.6	G08		4	0062-0606	659.17	606.68	297	78.57	0.605
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13407.2	G08		4	0063-0617	452.28	617.65	211	56.77	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11889.7	G08		4	0064-0621	193.27	621.27	221	60.43	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11556.5	G08		4	0065-0637	190.91	637.47	228	60.18	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10086.9	G08		4	0066-0644	397.00	643.71	282	63.36	0.883
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14132.7	G08		4	0067-0653	92.97	652.55	189	56.53	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15849.7	G08		4	0068-0654	106.20	654.06	160	50.04	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11566.5	G08		4	0069-0663	678.63	663.18	247	64.43	0.748
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14143.4	G08		4	0070-0690	349.11	690.26	383	72.67	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10021.6	G08		4	0071-0691	367.79	690.82	276	66.18	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8845.8	G08		4	0072-0704	542.80	703.81	309	68.43	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10057.4	G08		4	0073-0703	589.98	703.36	281	69.11	0.739
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14310.8	G08		4	0074-0703	739.02	703.26	199	52.77	0.898
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185245	1375357	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10559.2	G08		4	0075-0707	196.86	706.90	154	46.53	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12208.6	G08		5	0001-0032	541.11	31.09	192	60.18	0.666
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12700.9	G08		5	0002-0042	152.37	43.12	227	64.53	0.685
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13907.5	G08		5	0003-0068	371.04	67.99	204	61.46	0.679
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11800.6	G08		5	0004-0094	130.78	94.41	220	57.70	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14317.2	G08		5	0005-0108	685.92	107.88	189	51.94	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10880.8	G08		5	0006-0108	655.21	107.84	265	63.36	0.830
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13264.5	G08		5	0007-0126	291.19	126.62	202	56.18	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12284.2	G08		5	0008-0163	606.40	162.70	224	68.43	0.601
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11121.0	G08		5	0009-0165	343.14	165.05	250	63.50	0.779
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10591.2	G08		5	0010-0175	940.52	174.15	253	63.11	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11365.5	G08		5	0011-0181	825.03	181.58	243	58.77	0.884
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12601.2	G08		5	0012-0189	442.10	189.27	227	64.18	0.692
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14972.2	G08		5	0013-0195	722.38	195.82	185	73.50	0.430
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9792.0	G08		5	0014-0222	93.53	222.62	278	65.94	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14181.0	G08		5	0015-0237	567.80	237.45	194	55.46	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10119.2	G08		5	0016-0239	139.04	239.55	271	62.77	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12654.2	G08		5	0017-0241	470.04	240.31	223	57.46	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14381.8	G08		5	0018-0240	624.42	240.17	185	53.36	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13451.4	G08		5	0019-0248	823.85	247.79	175	69.26	0.459
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10767.5	G08		5	0020-0253	34.52	253.68	252	59.11	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9127.2	G08		5	0021-0263	132.45	263.34	299	67.84	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9414.3	G08		5	0022-0282	865.29	281.23	145	48.53	0.774
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10156.0	G08		5	0023-0292	260.85	292.40	275	62.18	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9273.6	G08		5	0024-0289	871.90	290.19	120	44.28	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10012.4	G08		5	0025-0292	905.12	292.44	265	63.01	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14433.0	G08		5	0026-0292	213.98	291.51	103	49.46	0.529
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10327.7	G08		5	0027-0316	61.57	315.91	259	68.53	0.693
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13269.8	G08		5	0028-0324	909.41	324.06	225	55.11	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8312.2	G08		5	0029-0351	34.16	350.35	160	51.11	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8538.5	G08		5	0030-0356	852.99	356.90	319	68.18	0.862
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8613.8	G08		5	0031-0357	43.91	357.60	134	43.46	0.892
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12058.5	G08		5	0032-0370	916.33	370.90	242	64.53	0.730
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10991.0	G08		5	0033-0388	478.45	387.91	263	61.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14910.5	G08		5	0034-0396	394.79	396.25	187	51.94	0.871
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11931.2	G08		5	0035-0412	692.19	411.81	233	56.28	0.924
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16380.5	G08		5	0036-0419	429.87	419.08	156	58.77	0.568
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10884.1	G08		5	0037-0425	50.46	424.75	261	63.60	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9951.4	G08		5	0038-0484	95.58	484.30	269	62.18	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13440.4	G08		5	0039-0483	930.96	483.42	201	53.70	0.876
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13114.5	G08		5	0040-0494	633.21	493.73	212	62.28	0.687
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11080.4	G08		5	0041-0497	769.80	497.55	253	61.70	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8698.2	G08		5	0042-0508	329.53	508.48	329	72.43	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12486.3	G08		5	0043-0527	286.51	526.75	220	61.01	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14404.2	G08		5	0044-0535	622.69	534.63	187	56.28	0.742
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13126.9	G08		5	0045-0550	220.89	550.54	202	57.94	0.756
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15210.6	G08		5	0046-0548	249.45	548.43	172	52.28	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16072.3	G08		5	0047-0563	153.70	562.95	110	53.36	0.486
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10791.5	G08		5	0048-0583	634.62	583.75	264	63.84	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14671.4	G08		5	0049-0594	129.69	594.89	191	54.18	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12214.1	G08		5	0050-0606	526.68	606.72	254	62.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11482.3	G08		5	0051-0621	548.39	620.38	261	60.53	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15938.6	G08		5	0052-0633	394.79	633.43	175	57.94	0.655
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10653.9	G08		5	0053-0649	879.38	648.46	267	62.77	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12439.8	G08		5	0054-0658	86.40	658.34	208	66.04	0.599
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12393.9	G08		5	0055-0659	146.43	658.61	215	57.11	0.828
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12081.4	G08		5	0056-0676	660.44	675.54	242	63.36	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10751.0	G08		5	0057-0680	392.72	679.46	237	61.94	0.776
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15968.5	G08		5	0058-0686	413.76	685.86	186	51.70	0.875
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14569.6	G08		5	0059-0701	377.39	701.40	197	55.70	0.798
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185246	1375358	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14916.8	G08		5	0060-0703	482.30	702.70	182	64.67	0.547
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11371.7	G08		6	0001-0056	930.28	56.78	245	59.11	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12174.5	G08		6	0002-0062	146.01	62.35	215	56.77	0.838
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9801.3	G08		6	0003-0073	880.87	72.50	278	64.43	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14962.3	G08		6	0004-0082	78.92	81.60	182	51.94	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10569.6	G08		6	0005-0093	752.88	94.14	288	67.01	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13736.7	G08		6	0006-0112	641.80	112.21	197	57.60	0.746
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12844.7	G08		6	0007-0120	317.19	120.41	213	53.11	0.949
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12508.4	G08		6	0008-0124	828.85	124.44	232	71.98	0.563
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11150.5	G08		6	0009-0133	761.87	133.64	241	61.01	0.814
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9251.5	G08		6	0010-0139	111.89	138.66	274	63.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9227.5	G08		6	0011-0145	96.13	144.50	281	64.18	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9737.9	G08		6	0012-0150	731.23	150.14	297	66.18	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12191.4	G08		6	0013-0153	946.07	153.21	217	55.60	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10552.6	G08		6	0014-0157	818.91	157.09	266	65.01	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10264.0	G08		6	0015-0177	35.63	176.53	252	61.11	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16403.1	G08		6	0016-0179	810.78	179.02	141	59.60	0.499
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9089.7	G08		6	0017-0183	491.89	183.08	192	56.43	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10324.7	G08		6	0018-0187	116.46	188.41	137	46.63	0.792
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9747.4	G08		6	0019-0200	117.38	199.99	117	41.80	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10241.3	G08		6	0020-0220	67.60	220.10	243	57.70	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10632.7	G08		6	0021-0225	588.78	225.28	263	64.43	0.796
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12982.6	G08		6	0022-0261	649.15	261.19	225	59.70	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12785.3	G08		6	0023-0323	648.24	322.86	229	59.94	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14436.1	G08		6	0024-0328	763.41	329.02	193	57.11	0.744
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11016.2	G08		6	0025-0339	100.89	339.06	230	57.94	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10310.7	G08		6	0026-0347	418.78	347.62	272	65.60	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8482.5	G08		6	0027-0369	308.09	369.43	309	66.43	0.880
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11472.6	G08		6	0028-0373	11.55	373.61	238	63.11	0.751
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11870.4	G08		6	0029-0373	577.93	372.96	231	62.63	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8010.8	G08		6	0030-0403	351.02	403.11	335	70.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11174.6	G08		6	0031-0413	837.42	412.60	249	59.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10013.6	G08		6	0032-0418	255.47	418.73	301	69.01	0.794
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14634.5	G08		6	0033-0426	394.41	426.17	186	53.46	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11150.7	G08		6	0034-0432	873.70	432.07	251	60.53	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12706.9	G08		6	0035-0454	596.99	454.12	299	82.91	0.547
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13261.3	G08		6	0036-0486	26.23	486.05	202	55.11	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10730.4	G08		6	0037-0513	579.88	512.79	289	64.53	0.872
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9272.2	G08		6	0038-0542	313.65	541.48	130	43.94	0.846
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9194.0	G08		6	0039-0546	303.22	547.24	144	45.11	0.889
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12900.8	G08		6	0040-0554	190.36	554.58	209	53.36	0.923
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16312.7	G08		6	0041-0567	183.14	566.73	172	51.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9137.1	G08		6	0042-0568	321.68	568.31	295	65.60	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9764.6	G08		6	0043-0582	382.57	582.43	275	67.70	0.754
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12285.7	G08		6	0044-0604	753.16	604.08	233	58.53	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13677.3	G08		6	0045-0611	859.18	611.21	210	59.36	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14551.5	G08		6	0046-0612	890.31	612.54	187	57.94	0.700
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13451.3	G08		6	0047-0614	613.01	614.72	215	56.87	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9213.9	G08		6	0048-0640	352.25	639.51	291	66.43	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12616.5	G08		6	0049-0646	575.91	645.49	232	59.60	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13465.2	G08		6	0050-0650	617.75	651.14	208	57.84	0.781
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11978.2	G08		6	0051-0653	123.89	653.61	205	60.53	0.703
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11813.2	G08		6	0052-0677	466.12	677.74	244	59.94	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13714.2	G08		6	0053-0686	593.53	685.73	205	59.94	0.717
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11777.8	G08		6	0054-0691	513.60	691.38	248	61.60	0.821
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9526.9	G08		6	0055-0700	351.11	699.46	279	62.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9863.2	G08		6	0056-0709	218.08	709.28	259	60.77	0.881
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185247	1375359	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13126.1	G08		6	0057-0709	832.68	709.43	206	58.28	0.762
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14018.6	G08		7	0001-0053	156.06	53.48	189	52.87	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12523.9	G08		7	0002-0055	530.23	55.22	234	56.87	0.909
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12886.4	G08		7	0003-0059	856.52	59.19	222	59.46	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	16968.8	G08		7	0004-0066	818.80	66.19	139	61.60	0.460
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12576.6	G08		7	0005-0108	391.66	108.22	211	60.04	0.736
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10876.6	G08		7	0006-0106	876.52	106.30	260	62.77	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14720.6	G08		7	0007-0126	468.55	126.58	207	53.11	0.922
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12111.7	G08		7	0008-0146	857.50	145.91	227	61.60	0.752
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15491.1	G08		7	0009-0151	424.38	151.78	184	51.46	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11043.7	G08		7	0010-0155	165.33	155.02	235	60.53	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	7521.0	G08		7	0011-0169	384.99	168.53	333	77.26	0.701
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10576.5	G08		7	0012-0218	214.01	218.13	266	65.01	0.791
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10913.2	G08		7	0013-0232	844.78	232.79	244	59.94	0.853
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13637.9	G08		7	0014-0246	70.36	245.62	187	57.01	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13673.9	G08		7	0015-0269	254.98	267.70	124	52.87	0.557
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14061.9	G08		7	0016-0278	542.09	277.90	194	55.01	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11995.0	G08		7	0017-0285	589.69	285.54	227	55.70	0.919
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11833.7	G08		7	0018-0295	792.60	296.21	261	62.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9112.8	G08		7	0019-0312	44.10	311.83	284	64.53	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11998.3	G08		7	0020-0310	581.07	310.05	230	59.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15661.8	G08		7	0021-0318	797.42	318.62	355	71.01	0.885
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11854.7	G08		7	0022-0320	20.50	319.46	217	56.28	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10157.4	G08		7	0023-0342	903.18	342.01	285	63.01	0.902
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12776.7	G08		7	0024-0346	432.50	346.92	216	56.53	0.849
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10171.9	G08		7	0025-0359	304.40	359.04	277	66.18	0.795
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14355.0	G08		7	0026-0385	226.98	385.39	107	39.46	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9743.6	G08		7	0027-0408	323.36	408.03	298	66.18	0.855
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8883.3	G08		7	0028-0414	130.61	414.08	313	71.50	0.769
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10795.8	G08		7	0029-0412	876.71	411.44	249	59.36	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12956.1	G08		7	0030-0415	227.08	415.55	205	57.01	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11513.6	G08		7	0031-0458	218.58	458.05	226	59.84	0.793
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10321.5	G08		7	0032-0465	900.13	464.79	272	63.01	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15489.3	G08		7	0033-0480	673.05	480.64	163	60.18	0.566
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9977.8	G08		7	0034-0483	154.74	483.15	141	46.87	0.807
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12856.8	G08		7	0035-0492	825.90	492.18	214	57.36	0.817
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9543.4	G08		7	0036-0494	159.32	495.01	131	49.46	0.673
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10735.9	G08		7	0037-0540	317.29	539.62	261	62.53	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13633.1	G08		7	0038-0537	118.17	537.42	196	57.36	0.749
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10096.4	G08		7	0039-0548	749.08	548.28	132	45.36	0.806
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9480.3	G08		7	0040-0555	541.81	554.98	291	65.26	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11682.6	G08		7	0041-0557	214.72	557.44	222	57.36	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10505.7	G08		7	0042-0555	735.78	555.98	120	42.28	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11667.1	G08		7	0043-0571	865.45	571.98	235	59.60	0.831
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9276.3	G08		7	0044-0581	458.87	581.32	299	65.26	0.882
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13147.5	G08		7	0045-0580	338.24	579.59	201	56.04	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10553.6	G08		7	0046-0584	557.07	584.80	257	61.60	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12499.3	G08		7	0047-0590	146.42	590.52	220	59.21	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8614.9	G08		7	0048-0590	379.40	589.54	316	66.67	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8411.7	G08		7	0049-0587	725.42	587.60	147	45.11	0.908
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8956.4	G08		7	0050-0596	715.02	597.07	151	46.87	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10734.4	G08		7	0051-0647	709.92	647.29	279	62.77	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13417.7	G08		7	0052-0649	283.27	650.15	195	53.94	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11007.7	G08		7	0053-0663	760.22	663.21	252	61.60	0.835
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8373.3	G08		7	0054-0665	58.61	665.53	298	63.94	0.916
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11462.7	G08		7	0055-0677	779.19	677.03	238	61.60	0.788
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14665.3	G08		7	0056-0692	383.49	691.93	179	49.70	0.911
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185248	1375360	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13903.7	G08		7	0057-0691	471.18	691.53	195	56.87	0.758
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9389.2	G08		8	0001-0031	936.98	31.62	278	65.60	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14085.9	G08		8	0002-0054	801.15	53.88	209	56.87	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12713.0	G08		8	0003-0061	843.75	61.43	216	66.04	0.622
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14561.2	G08		8	0004-0072	744.01	72.77	201	59.70	0.709
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11788.3	G08		8	0005-0110	290.92	109.83	264	63.01	0.836
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13740.0	G08		8	0006-0124	868.05	124.44	204	55.36	0.837
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10738.8	G08		8	0007-0136	397.97	136.22	279	62.53	0.897
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12917.3	G08		8	0008-0157	297.33	157.19	199	51.11	0.957
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10103.1	G08		8	0009-0177	236.55	176.67	260	64.53	0.785
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13003.3	G08		8	0010-0177	353.95	177.55	204	52.28	0.938
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12237.7	G08		8	0011-0182	141.63	182.29	215	60.43	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10624.5	G08		8	0012-0184	417.53	184.50	266	63.84	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13352.0	G08		8	0013-0195	580.65	195.20	189	53.11	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12081.1	G08		8	0014-0207	918.96	206.97	220	55.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12493.3	G08		8	0015-0214	236.87	214.53	211	59.01	0.761
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12893.7	G08		8	0016-0241	897.47	241.14	199	55.36	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12792.1	G08		8	0017-0260	527.98	260.45	217	56.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10624.2	G08		8	0018-0264	450.21	263.65	272	63.36	0.852
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9995.9	G08		8	0019-0297	861.92	297.03	274	63.94	0.842
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10248.9	G08		8	0020-0298	714.96	298.45	291	64.18	0.888
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9357.6	G08		8	0021-0330	699.62	330.32	173	47.46	0.965
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10644.0	G08		8	0022-0334	721.44	334.50	230	69.26	0.603
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8676.1	G08		8	0023-0343	708.13	343.65	123	45.11	0.759
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10684.2	G08		8	0024-0356	95.62	357.04	246	59.36	0.877
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8502.8	G08		8	0025-0358	770.82	358.20	230	63.60	0.715
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10515.5	G08		8	0026-0376	353.60	378.03	264	77.26	0.556
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12410.2	G08		8	0027-0378	259.72	378.03	213	55.36	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8150.3	G08		8	0028-0380	688.59	380.85	231	62.77	0.737
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9318.7	G08		8	0029-0388	424.72	387.92	305	67.84	0.833
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8131.3	G08		8	0030-0393	795.82	392.83	329	69.36	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13874.3	G08		8	0031-0421	214.39	421.11	189	56.53	0.743
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11573.7	G08		8	0032-0423	584.17	423.57	283	64.67	0.850
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13508.8	G08		8	0033-0426	527.98	426.91	228	57.70	0.861
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9743.4	G08		8	0034-0431	469.27	430.90	295	64.53	0.890
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12654.4	G08		8	0035-0446	174.24	446.17	205	59.26	0.734
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9737.0	G08		8	0036-0465	93.35	465.85	268	64.18	0.818
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14714.2	G08		8	0037-0478	172.46	478.59	190	52.77	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15368.4	G08		8	0038-0478	451.26	478.26	172	50.18	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11935.2	G08		8	0039-0485	204.35	484.39	245	61.60	0.811
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10293.4	G08		8	0040-0493	109.12	493.18	278	65.94	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10021.6	G08		8	0041-0514	550.29	513.57	307	69.94	0.789
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9870.8	G08		8	0042-0513	707.35	513.93	288	62.18	0.936
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10774.0	G08		8	0043-0518	868.54	518.43	202	61.01	0.682
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8320.0	G08		8	0044-0518	406.70	519.39	142	45.21	0.873
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13740.6	G08		8	0045-0536	565.66	536.59	212	64.04	0.650
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8490.3	G08		8	0046-0533	407.92	532.20	168	48.63	0.893
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11618.7	G08		8	0047-0534	301.31	534.72	230	59.11	0.827
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11075.6	G08		8	0048-0548	192.92	547.90	260	61.36	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9651.9	G08		8	0049-0556	511.92	556.09	302	66.18	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13925.5	G08		8	0050-0566	299.97	566.75	193	53.60	0.844
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9731.8	G08		8	0051-0580	924.69	579.23	294	65.36	0.865
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9880.9	G08		8	0052-0589	270.62	588.33	268	63.11	0.845
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	17612.2	G08		8	0053-0595	880.07	594.80	355	73.36	0.829
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9762.2	G08		8	0054-0610	218.90	609.47	260	67.84	0.710
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11045.8	G08		8	0055-0621	146.69	622.02	198	57.11	0.763
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11341.6	G08		8	0056-0621	290.70	621.09	249	60.18	0.864
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12815.8	G08		8	0057-0639	577.61	640.06	225	62.53	0.723
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12992.9	G08		8	0058-0657	135.73	657.10	210	61.70	0.693
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10060.5	G08		8	0059-0652	674.40	652.07	277	69.36	0.724
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15761.2	G08		8	0060-0666	415.93	666.00	171	55.11	0.707
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15740.7	G08		8	0061-0699	370.97	699.10	183	51.70	0.860
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10848.1	G08		8	0062-0701	133.33	701.42	195	51.70	0.917
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185249	1375361	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12986.6	G08		8	0063-0709	842.07	709.27	198	51.70	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9329.0	G08		9	0001-0034	31.77	34.33	273	65.01	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11492.0	G08		9	0002-0034	411.40	35.09	286	64.77	0.857
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10918.4	G08		9	0003-0040	489.21	39.94	280	65.84	0.812
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10800.8	G08		9	0004-0049	727.83	49.69	258	61.11	0.868
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	18288.8	G08		9	0005-0071	43.56	71.40	286	64.28	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11059.1	G08		9	0006-0103	476.99	103.18	279	61.36	0.931
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11097.5	G08		9	0007-0106	354.74	106.26	246	59.60	0.870
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11657.7	G08		9	0008-0118	570.68	118.15	240	60.53	0.823
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13122.8	G08		9	0009-0145	347.01	145.15	199	53.11	0.886
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13707.3	G08		9	0010-0148	694.70	149.05	194	59.36	0.692
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12730.0	G08		9	0011-0150	125.25	150.20	225	59.46	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11098.8	G08		9	0012-0157	97.26	157.47	266	59.11	0.957
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11041.7	G08		9	0013-0183	323.97	183.54	246	61.60	0.815
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11971.9	G08		9	0014-0194	251.35	194.46	224	57.36	0.856
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10265.3	G08		9	0015-0206	858.14	205.90	261	62.18	0.848
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11913.9	G08		9	0016-0210	14.17	209.59	216	55.60	0.878
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14118.2	G08		9	0017-0211	377.37	210.79	172	54.04	0.740
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13934.3	G08		9	0018-0224	388.18	223.96	199	56.53	0.783
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12900.8	G08		9	0019-0235	80.57	235.54	201	56.18	0.800
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10636.1	G08		9	0020-0244	687.08	243.72	274	63.36	0.858
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11452.0	G08		9	0021-0246	299.45	245.54	343	72.43	0.822
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11510.9	G08		9	0022-0255	445.90	255.26	242	57.94	0.906
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11919.6	G08		9	0023-0268	478.14	267.59	245	58.77	0.891
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9407.4	G08		9	0024-0306	621.04	306.21	306	65.60	0.894
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10883.9	G08		9	0025-0336	263.52	336.65	255	77.50	0.534
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9765.4	G08		9	0026-0338	565.15	337.78	294	65.60	0.859
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	12408.8	G08		9	0027-0352	423.01	352.32	230	57.36	0.879
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	14194.0	G08		9	0028-0359	647.64	359.30	201	52.04	0.933
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8086.5	G08		9	0029-0366	121.04	366.56	347	72.08	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10520.3	G08		9	0030-0371	599.07	371.81	274	62.77	0.874
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9548.1	G08		9	0031-0392	112.90	392.27	302	70.18	0.770
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13857.3	G08		9	0032-0394	544.89	393.62	265	87.64	0.434
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13094.0	G08		9	0033-0396	427.88	397.25	206	56.77	0.803
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10662.2	G08		9	0034-0412	642.60	412.11	280	69.26	0.734
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13831.6	G08		9	0035-0416	462.97	416.38	197	60.28	0.681
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11329.8	G08		9	0036-0419	369.72	418.83	238	60.53	0.816
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10388.4	G08		9	0037-0428	443.00	427.25	275	64.77	0.824
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10471.9	G08		9	0038-0429	515.38	429.72	271	61.70	0.895
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11162.5	G08		9	0039-0440	364.69	440.16	252	61.01	0.851
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13890.4	G08		9	0040-0502	687.24	501.40	247	61.36	0.825
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	15967.3	G08		9	0041-0505	670.84	506.14	206	54.63	0.867
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9550.2	G08		9	0042-0526	480.04	525.65	299	66.77	0.843
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10466.3	G08		9	0043-0560	241.00	560.24	284	66.77	0.801
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	9542.7	G08		9	0044-0582	19.55	581.95	287	64.53	0.866
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	13623.5	G08		9	0045-0581	306.88	581.25	226	58.18	0.839
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10000.5	G08		9	0046-0596	783.57	595.75	266	63.84	0.820
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	11876.3	G08		9	0047-0601	698.86	601.44	250	62.53	0.804
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10631.4	G08		9	0048-0605	942.34	604.53	260	67.01	0.728
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	8726.1	G08		9	0049-0613	300.09	612.81	325	66.43	0.926
50149-3	COLO 858	10068-101-1	Vemurafenib	3.16	uM	48	hr	1185250	1375362	Cycle-2			80007	rabbit IgG(H+L) / goat / cross-adsorbed	Hoechst			90003	Hoechst 33342	10079.3	G08		9	0050-0664	878.63	665.31	280	63.60	0.870
